,Word,T,P
0,Anesthesia,0,0
1,for,0,0
2,in,1,0
3,vitro,1,0
4,fertilization,1,0
5,:,1,1
6,the,0,0
7,addition,0,0
8,of,0,0
9,fentanyl,0,0
10,to,0,0
11,1.5,0,0
12,%,0,0
13,lidocaine,0,0
14,.,0,0
15,UNLABELLED,0,0
16,Ultrasonically,0,0
17,guided,0,0
18,transvaginal,0,0
19,oocyte,0,0
20,retrieval,0,0
21,is,0,0
22,relatively,0,0
23,short,0,0
24,procedure,0,0
25,that,0,0
26,is,0,0
27,performed,0,0
28,on,0,0
29,an,0,0
30,out-patient,0,1
31,basis,0,0
32,.,0,0
33,The,0,0
34,optimal,0,0
35,anesthetic,0,0
36,technique,0,0
37,should,0,0
38,allow,0,0
39,good,0,0
40,surgical,0,0
41,anesthesia,0,0
42,with,0,1
43,minimal,0,0
44,side,0,0
45,effects,0,0
46,",",0,0
47,a,0,0
48,short,0,0
49,recovery,0,0
50,time,0,0
51,",",0,0
52,and,0,0
53,",",0,0
54,if,0,0
55,possible,0,0
56,",",0,0
57,a,0,0
58,high,0,0
59,rate,0,0
60,of,0,0
61,successful,0,0
62,pregnancy,0,1
63,.,0,0
64,Spinal,0,0
65,anesthesia,0,0
66,is,0,0
67,often,0,0
68,used,0,0
69,in,0,0
70,this,0,0
71,institution,0,0
72,",",0,0
73,as,0,0
74,well,0,0
75,as,0,0
76,many,0,0
77,others,0,0
78,",",0,0
79,for,0,0
80,this,0,0
81,procedure,0,0
82,.,0,0
83,The,0,0
84,addition,0,0
85,of,0,0
86,fentanyl,0,0
87,may,0,0
88,be,0,0
89,effective,0,0
90,for,0,0
91,both,0,0
92,intraoperative,0,0
93,and,0,0
94,postoperative,0,0
95,pain,0,0
96,relief,0,0
97,.,0,0
98,We,0,0
99,assessed,0,0
100,the,0,0
101,effect,0,0
102,of,0,0
103,adding,0,0
104,fentanyl,0,0
105,to,0,0
106,1.5,0,0
107,%,0,0
108,lidocaine,0,0
109,in,0,0
110,women,1,1
111,undergoing,1,1
112,ultrasonically,1,0
113,guided,1,0
114,oocyte,1,0
115,retrieval,1,0
116,.,1,0
117,Seventy-eight,1,1
118,women,1,1
119,were,0,0
120,randomized,0,0
121,to,0,0
122,receive,0,0
123,45,0,0
124,mg,0,0
125,of,0,0
126,hyperbaric,0,0
127,1.5,0,0
128,%,0,0
129,lidocaine,0,0
130,with,0,0
131,or,0,0
132,without,0,1
133,10,0,0
134,microg,0,0
135,of,0,0
136,fentanyl,0,0
137,.,0,0
138,Visual,0,0
139,analog,0,0
140,scale,0,0
141,(,0,0
142,VAS,0,0
143,),0,0
144,pain,0,0
145,scores,0,0
146,were,0,0
147,lower,0,0
148,in,0,0
149,the,0,0
150,operating,0,0
151,room,0,0
152,(,0,0
153,OR,0,0
154,),0,0
155,(,0,0
156,P,0,0
157,<,0,0
158,0.05,0,0
159,),0,0
160,and,0,0
161,postanesthesia,0,0
162,care,0,0
163,unit,0,0
164,(,0,0
165,PACU,0,0
166,),0,0
167,(,0,0
168,P,0,0
169,<,0,0
170,0.0005,0,0
171,),0,0
172,for,0,0
173,the,0,0
174,group,0,0
175,that,0,0
176,received,0,0
177,fentanyl,0,0
178,.,0,0
179,In,0,0
180,addition,0,0
181,",",0,0
182,the,0,0
183,amount,0,0
184,of,0,0
185,narcotic,0,0
186,required,0,0
187,in,0,0
188,the,0,0
189,PACU,0,0
190,was,0,0
191,less,0,0
192,in,0,0
193,the,0,0
194,fentanyl,0,0
195,group,0,0
196,(,0,0
197,P,0,0
198,<,0,0
199,0.005,0,0
200,),0,0
201,.,0,0
202,There,0,0
203,was,0,0
204,no,0,0
205,difference,0,0
206,in,0,0
207,VAS,0,0
208,scores,0,0
209,the,0,0
210,evening,0,0
211,of,0,0
212,or,0,0
213,24,0,0
214,h,0,0
215,after,0,0
216,the,0,0
217,procedure,0,0
218,.,0,0
219,The,0,0
220,amount,0,0
221,of,0,0
222,analgesics,0,0
223,and,0,0
224,narcotics,0,0
225,required,0,0
226,after,0,0
227,discharge,0,0
228,was,0,0
229,the,0,0
230,same,0,0
231,for,0,0
232,both,0,0
233,groups,0,0
234,.,0,0
235,Timed,0,0
236,variables,0,0
237,",",0,0
238,such,0,0
239,as,0,0
240,time,0,0
241,to,0,0
242,urination,0,0
243,",",0,0
244,ambulation,0,0
245,",",0,0
246,and,0,0
247,discharge,0,0
248,",",0,0
249,were,0,0
250,the,0,0
251,same,0,0
252,for,0,0
253,both,0,0
254,groups,0,0
255,of,0,0
256,women,0,1
257,.,0,0
258,The,0,0
259,addition,0,0
260,of,0,0
261,fentanyl,0,0
262,to,0,0
263,lidocaine,0,0
264,for,0,0
265,transvaginal,0,0
266,oocyte,0,0
267,retrieval,0,0
268,results,0,0
269,in,0,0
270,a,0,0
271,more,0,0
272,comfortable,0,0
273,patient,0,0
274,in,0,0
275,the,0,0
276,OR,0,0
277,and,0,0
278,PACU,0,0
279,.,0,0
280,IMPLICATIONS,0,0
281,This,0,0
282,study,0,0
283,demonstrates,0,0
284,that,0,0
285,when,0,0
286,fentanyl,0,0
287,is,0,0
288,added,0,0
289,to,0,0
290,a,0,0
291,local,0,0
292,anesthetic,0,0
293,",",0,0
294,lidocaine,0,0
295,",",0,0
296,with,0,0
297,spinal,0,0
298,anesthesia,0,0
299,for,0,0
300,egg,0,0
301,retrieval,0,0
302,procedures,0,0
303,",",0,0
304,patients,0,1
305,are,0,0
306,more,0,0
307,comfortable,0,0
308,during,0,0
309,the,0,0
310,procedure,0,0
311,compared,0,0
312,with,0,1
313,those,0,1
314,who,0,1
315,receive,0,1
316,lidocaine,0,0
317,alone,0,0
318,.,0,0
319,In,0,0
320,addition,0,0
321,",",0,0
322,the,0,0
323,narcotic,0,0
324,requirements,0,0
325,of,0,0
326,patients,0,1
327,are,0,0
328,less,0,0
329,in,0,0
330,the,0,0
331,postanesthesia,0,0
332,care,0,0
333,unit,0,0
334,.,0,0
335,Effects,0,0
336,of,0,0
337,insufficient,0,0
338,sleep,0,0
339,on,0,0
340,blood,0,0
341,pressure,0,0
342,in,0,0
343,hypertensive,1,1
344,patients,1,1
345,:,1,1
346,a,0,0
347,24-h,0,0
348,study,0,0
349,.,0,0
350,The,0,0
351,influence,0,0
352,of,0,0
353,acute,0,1
354,sleep,0,0
355,deprivation,0,0
356,during,0,0
357,the,0,0
358,first,0,0
359,part,0,0
360,of,0,0
361,the,0,0
362,night,0,0
363,on,0,0
364,24-h,0,0
365,blood,0,0
366,pressure,0,0
367,monitoring,0,0
368,(,0,0
369,ABPM,0,0
370,),0,0
371,was,0,0
372,studied,0,1
373,in,0,0
374,36,1,1
375,never-treated,1,1
376,mild,1,1
377,to,1,0
378,moderate,1,1
379,hypertensive,1,1
380,patients,1,1
381,.,1,0
382,According,0,0
383,to,0,0
384,a,0,0
385,crossover,0,0
386,design,0,0
387,",",0,0
388,they,0,0
389,were,0,0
390,randomized,0,0
391,to,0,0
392,have,0,0
393,either,0,0
394,sleep,0,0
395,deprivation,0,0
396,or,0,0
397,a,0,0
398,full,0,0
399,night,0,0
400,'s,0,0
401,sleep,0,0
402,1,0,0
403,week,0,0
404,apart,0,0
405,",",0,0
406,during,0,0
407,which,0,0
408,they,0,0
409,were,0,0
410,monitored,0,0
411,with,0,1
412,ABPM,0,0
413,.,0,1
414,Urine,0,0
415,samples,0,0
416,for,0,0
417,analysis,0,0
418,of,0,0
419,nocturnal,0,0
420,urinary,0,0
421,excretion,0,0
422,of,0,0
423,norepinephrine,0,0
424,were,0,0
425,collected,0,0
426,.,0,0
427,During,0,0
428,the,0,0
429,sleep-deprivation,0,0
430,day,0,0
431,",",0,0
432,both,0,0
433,mean,0,0
434,24-h,0,0
435,blood,0,0
436,pressure,0,0
437,and,0,0
438,mean,0,0
439,24-h,0,0
440,heart,0,1
441,rate,0,0
442,were,0,0
443,higher,0,0
444,in,0,0
445,comparison,0,0
446,with,0,1
447,those,0,0
448,recorded,0,0
449,during,0,0
450,the,0,0
451,routine,0,0
452,workday,0,0
453,",",0,0
454,the,0,0
455,difference,0,0
456,being,0,0
457,more,0,0
458,pronounced,0,0
459,during,0,0
460,the,0,0
461,nighttime,0,0
462,(,0,0
463,P,0,0
464,<,0,0
465,.01,0,0
466,),0,0
467,.,0,0
468,Urinary,0,0
469,excretion,0,0
470,of,0,0
471,norepinephrine,0,0
472,showed,0,0
473,a,0,0
474,significant,0,0
475,increase,0,0
476,at,0,0
477,night,0,0
478,during,0,0
479,sleep,0,0
480,deprivation,0,0
481,(,0,0
482,P,0,0
483,<,0,0
484,.05,0,0
485,),0,0
486,.,0,0
487,Blood,0,0
488,pressure,0,0
489,and,0,0
490,heart,0,1
491,rate,0,0
492,significantly,0,0
493,increased,0,0
494,in,0,0
495,the,0,0
496,morning,0,0
497,after,0,0
498,a,0,0
499,sleep-insufficient,0,0
500,night,0,0
501,(,0,0
502,P,0,0
503,<,0,0
504,.05,0,0
505,),0,0
506,.,0,0
507,These,0,0
508,data,0,0
509,suggest,0,0
510,that,0,0
511,lack,0,0
512,of,0,0
513,sleep,0,0
514,in,0,0
515,hypertensive,0,1
516,patients,0,1
517,may,0,0
518,increase,0,0
519,sympathetic,0,0
520,nervous,0,0
521,activity,0,0
522,during,0,0
523,the,0,0
524,night,0,0
525,and,0,0
526,the,0,0
527,following,0,0
528,morning,0,0
529,",",0,0
530,leading,0,0
531,to,0,0
532,increased,0,0
533,blood,0,0
534,pressure,0,0
535,and,0,0
536,heart,0,1
537,rate,0,0
538,.,0,0
539,This,0,0
540,situation,0,0
541,might,0,0
542,represent,0,0
543,an,0,0
544,increased,0,0
545,risk,0,0
546,for,0,0
547,both,0,0
548,target,0,0
549,organ,0,0
550,damage,0,0
551,and,0,0
552,acute,0,1
553,cardiovascular,0,1
554,diseases,0,1
555,.,0,1
556,Masticatory,0,0
557,performance,0,0
558,and,0,0
559,chewing,0,0
560,experience,0,0
561,with,0,1
562,implant-retained,1,0
563,mandibular,1,1
564,overdentures,1,1
565,.,1,0
566,The,0,0
567,relationship,0,0
568,between,0,0
569,masticatory,0,1
570,performance,0,0
571,and,0,0
572,chewing,0,0
573,experience,0,0
574,has,0,0
575,not,0,0
576,yet,0,0
577,been,0,0
578,explored,0,0
579,for,0,0
580,patients,1,1
581,with,1,1
582,implant-retained,1,1
583,overdentures,1,1
584,.,1,1
585,Although,0,0
586,many,0,0
587,relationships,0,0
588,have,0,0
589,been,0,0
590,found,0,0
591,between,0,0
592,parameters,0,0
593,of,0,0
594,objective,0,0
595,and,0,0
596,subjective,0,0
597,oral,0,0
598,function,0,0
599,",",0,0
600,the,0,0
601,structure,0,0
602,of,0,0
603,these,0,0
604,relationships,0,0
605,remain,0,0
606,unclear,0,0
607,.,0,0
608,Therefore,0,0
609,",",0,0
610,we,0,0
611,studied,0,0
612,in,0,0
613,a,0,0
614,randomized,0,0
615,clinical,0,0
616,trial,0,0
617,the,0,0
618,relationship,0,0
619,between,0,0
620,the,0,0
621,comminution,0,0
622,of,0,0
623,an,0,0
624,artificial,0,0
625,test,0,0
626,food,0,0
627,",",0,0
628,i.e,0,0
629,.,0,0
630,masticatory,0,0
631,performance,0,0
632,",",0,0
633,and,0,0
634,the,0,0
635,subjective,0,0
636,chewing,0,0
637,experience,0,0
638,.,0,0
639,The,0,0
640,trial,0,0
641,involved,0,0
642,a,0,0
643,comparison,0,0
644,between,0,0
645,two,0,0
646,groups,0,0
647,receiving,0,1
648,implant,0,0
649,treatment,0,0
650,and,0,0
651,one,0,0
652,group,0,0
653,receiving,0,1
654,conventional,0,0
655,complete,0,1
656,dentures,0,0
657,(,0,0
658,CD,0,1
659,),0,0
660,.,0,0
661,The,0,0
662,implant,0,0
663,treatment,0,0
664,involved,0,0
665,either,0,0
666,a,0,0
667,mainly,0,0
668,implant-supported,0,0
669,mandibular,0,1
670,overdenture,0,0
671,on,0,0
672,a,0,0
673,transmandibular,0,0
674,implant,0,0
675,(,0,0
676,TMI,0,0
677,),0,0
678,or,0,0
679,an,0,0
680,implant-tissue-supported,0,0
681,mandibular,0,1
682,overdenture,0,1
683,on,0,0
684,two,0,0
685,IMZ,0,0
686,implants,0,1
687,(,0,0
688,IMZ,0,0
689,),0,0
690,.,0,0
691,Masticatory,0,0
692,performance,0,0
693,as,0,0
694,well,0,0
695,as,0,0
696,chewing,0,0
697,experience,0,0
698,were,0,0
699,substantially,0,0
700,better,0,0
701,for,0,0
702,the,0,0
703,implant-retained,0,0
704,overdentures,0,0
705,compared,0,0
706,with,0,1
707,the,0,0
708,complete,0,0
709,denture,0,0
710,group,0,0
711,.,0,0
712,No,0,0
713,significant,0,0
714,differences,0,0
715,emerged,0,0
716,between,0,0
717,the,0,0
718,TMI,0,0
719,and,0,0
720,the,0,0
721,IMZ,0,0
722,group,0,0
723,.,0,0
724,A,0,0
725,multiple,0,0
726,regression,0,0
727,analysis,0,0
728,did,0,0
729,not,0,0
730,provide,0,0
731,any,0,0
732,comprehensibility,0,0
733,in,0,0
734,the,0,0
735,relationship,0,0
736,between,0,0
737,masticatory,0,1
738,performance,0,0
739,and,0,0
740,the,0,0
741,variables,0,0
742,of,0,0
743,chewing,0,0
744,experience,0,0
745,.,0,0
746,In,0,0
747,the,0,0
748,linear,0,0
749,structural,0,0
750,relation,0,0
751,analysis,0,0
752,(,0,0
753,LISREL,0,0
754,),0,0
755,no,0,0
756,direct,0,0
757,relationship,0,0
758,was,0,0
759,found,0,0
760,between,0,0
761,masticatory,0,1
762,performance,0,0
763,and,0,0
764,functional,0,0
765,complaints,0,0
766,mandibular,0,1
767,denture,0,0
768,.,0,0
769,The,0,0
770,results,0,0
771,show,0,0
772,that,0,0
773,an,0,0
774,improvement,0,0
775,in,0,0
776,masticatory,0,1
777,performance,0,0
778,does,0,0
779,not,0,0
780,imply,0,0
781,the,0,0
782,same,0,0
783,improvement,0,0
784,in,0,0
785,chewing,0,0
786,experience,0,0
787,and,0,0
788,vice,0,0
789,versa,0,0
790,.,0,0
791,Comparison,0,0
792,of,0,0
793,patient-controlled,0,0
794,and,0,0
795,nurse-administered,0,0
796,analgesia,0,0
797,using,0,0
798,intravenous,0,0
799,fentanyl,0,0
800,during,1,0
801,labor,1,1
802,.,1,0
803,Preliminary,0,0
804,observations,0,0
805,have,0,0
806,shown,0,0
807,that,0,0
808,fentanyl,0,0
809,citrate,0,0
810,",",0,0
811,a,0,0
812,potent,0,0
813,narcotic,0,0
814,",",0,0
815,is,0,0
816,helpful,0,0
817,during,0,0
818,labor,0,1
819,without,0,1
820,undue,0,0
821,side,0,0
822,effects,0,0
823,.,0,0
824,This,0,0
825,randomized,0,0
826,prospective,0,0
827,investigation,0,0
828,compared,0,0
829,the,0,0
830,patient-controlled,0,0
831,administration,0,0
832,of,0,0
833,fentanyl,0,0
834,with,0,0
835,that,0,0
836,of,0,0
837,administration,0,0
838,by,0,0
839,nurses,0,1
840,on,0,0
841,request,0,0
842,.,0,0
843,Eighty,1,1
844,healthy,1,1
845,women,1,1
846,beginning,1,0
847,active,1,1
848,labor,1,1
849,(,1,0
850,cervical,1,1
851,dilation,1,0
852,4,1,0
853,cm,1,1
854,),1,0
855,at,1,0
856,term,1,0
857,were,1,0
858,assigned,1,0
859,to,1,0
860,receive,1,0
861,fentanyl,1,0
862,intravenously,1,0
863,by,1,0
864,either,1,0
865,patient-controlled,1,0
866,administration,1,0
867,(,1,0
868,n=37,1,1
869,),1,0
870,or,1,0
871,nurse,1,0
872,administration,1,0
873,on,1,0
874,demand,1,0
875,(,1,0
876,n=43,1,1
877,),1,0
878,.,0,0
879,Pain,0,0
880,intensity,0,0
881,measurements,0,0
882,during,0,0
883,early,0,1
884,and,0,0
885,late,0,1
886,labor,0,1
887,revealed,0,0
888,the,0,0
889,degree,0,0
890,of,0,0
891,analgesia,0,0
892,to,0,0
893,be,0,0
894,the,0,0
895,same,0,0
896,in,0,0
897,both,0,0
898,groups,0,0
899,.,0,0
900,The,0,0
901,delay,0,0
902,in,0,0
903,setting,0,0
904,up,0,0
905,the,0,0
906,infusion,0,0
907,system,0,0
908,and,0,0
909,the,0,0
910,short,0,0
911,time,0,0
912,between,0,0
913,requesting,0,0
914,analgesia,0,0
915,and,0,0
916,vaginal,0,0
917,delivery,0,0
918,were,0,0
919,limitations,0,0
920,with,0,1
921,self-administration,0,0
922,.,0,0
923,Maternal,0,0
924,oversedation,0,0
925,and,0,0
926,vomiting,0,0
927,did,0,0
928,not,0,0
929,occur,0,0
930,.,0,0
931,Neonatal,0,0
932,naloxone,0,0
933,therapy,0,0
934,was,0,0
935,used,0,0
936,infrequently,0,0
937,",",0,0
938,umbilical,0,0
939,serum,0,0
940,levels,0,0
941,of,0,0
942,fentanyl,0,0
943,were,0,0
944,the,0,0
945,same,0,0
946,in,0,0
947,both,0,0
948,groups,0,0
949,",",0,0
950,and,0,0
951,postnatal,0,0
952,neuroadaptive,0,0
953,testing,0,0
954,revealed,0,0
955,comparable,0,0
956,results,0,0
957,in,0,0
958,both,0,0
959,groups,0,0
960,.,0,0
961,Despite,0,0
962,the,0,0
963,usefulness,0,0
964,of,0,0
965,fentanyl,0,0
966,during,0,0
967,labor,0,1
968,",",0,0
969,administration,0,0
970,by,0,0
971,the,0,0
972,patient,0,0
973,had,0,0
974,no,0,0
975,advantages,0,0
976,over,0,0
977,administration,0,0
978,by,0,0
979,the,0,0
980,nurses,0,1
981,in,0,0
982,significantly,0,0
983,reducing,0,0
984,drug,0,0
985,use,0,0
986,",",0,0
987,improving,0,0
988,pain,0,0
989,relief,0,0
990,",",0,0
991,or,0,0
992,avoiding,0,0
993,drowsiness,0,0
994,.,0,0
995,Protocol,0,0
996,for,0,0
997,the,0,0
998,Multicenter,0,0
999,Acute,0,0
1000,Stroke,0,1
1001,Trial,0,0
1002,--,0,0
1003,thrombolysis,0,0
1004,study,0,0
1005,.,0,0
1006,The,0,0
1007,rationale,0,0
1008,for,0,0
1009,the,0,0
1010,Multicenter,0,0
1011,Acute,0,0
1012,Stroke,0,0
1013,Trial,0,0
1014,(,0,0
1015,MAST,0,0
1016,),0,0
1017,is,0,0
1018,presented,0,0
1019,in,0,0
1020,a,0,0
1021,companion,0,0
1022,article,0,0
1023,appearing,0,0
1024,in,0,0
1025,this,0,0
1026,issue,0,0
1027,.,0,0
1028,Acute,0,0
1029,ischaemic,0,1
1030,stroke,0,1
1031,is,0,0
1032,the,0,0
1033,third,0,0
1034,major,0,0
1035,cause,0,0
1036,of,0,0
1037,death,0,0
1038,in,0,0
1039,developed,0,0
1040,countries,0,0
1041,",",0,0
1042,and,0,0
1043,a,0,0
1044,major,0,0
1045,cause,0,0
1046,of,0,0
1047,disability,0,0
1048,.,0,0
1049,Despite,0,0
1050,a,0,0
1051,very,0,0
1052,poor,0,0
1053,prognosis,0,0
1054,",",0,0
1055,no,0,0
1056,treatment,0,0
1057,has,0,0
1058,demonstrated,0,0
1059,an,0,0
1060,efficacy,0,0
1061,in,0,0
1062,lowering,0,0
1063,the,0,0
1064,mortality,0,0
1065,and,0,0
1066,disability,0,0
1067,resulting,0,0
1068,from,0,0
1069,stroke,0,1
1070,events,0,0
1071,.,0,0
1072,Thrombolysis,0,0
1073,has,0,0
1074,been,0,0
1075,proven,0,0
1076,to,0,0
1077,reduce,0,0
1078,mortality,0,0
1079,in,0,0
1080,myocardial,0,0
1081,infarction,0,1
1082,",",0,0
1083,and,0,0
1084,it,0,0
1085,has,0,0
1086,been,0,0
1087,shown,0,0
1088,able,0,0
1089,to,0,0
1090,induce,0,0
1091,recanalisation,0,0
1092,when,0,0
1093,administered,0,0
1094,to,0,0
1095,acute,1,1
1096,stroke,1,1
1097,patients,1,1
1098,.,1,0
1099,A,0,0
1100,recent,0,0
1101,meta,0,0
1102,analysis,0,0
1103,of,0,0
1104,small-sized,0,0
1105,studies,0,0
1106,suggests,0,0
1107,that,0,0
1108,thrombolysis,0,0
1109,could,0,0
1110,offer,0,0
1111,some,0,0
1112,benefit,0,0
1113,to,0,0
1114,stroke,1,1
1115,patients,1,1
1116,",",0,0
1117,by,0,0
1118,reducing,0,0
1119,the,0,0
1120,mortality,0,0
1121,and,0,0
1122,severe,0,1
1123,invalidity,0,0
1124,by,0,0
1125,56,0,1
1126,%,0,0
1127,;,0,0
1128,these,0,0
1129,results,0,0
1130,need,0,0
1131,to,0,0
1132,be,0,0
1133,confirmed,0,0
1134,in,0,0
1135,adequately,0,0
1136,designed,0,0
1137,and,0,0
1138,sized,0,0
1139,studies,0,0
1140,.,0,1
1141,Rett,1,0
1142,syndrome,1,1
1143,:,1,1
1144,randomized,0,0
1145,controlled,0,0
1146,trial,0,0
1147,of,0,0
1148,L-carnitine,0,0
1149,.,0,0
1150,Rett,0,0
1151,syndrome,0,1
1152,is,0,0
1153,a,0,0
1154,severe,0,0
1155,neurodevelopmental,0,0
1156,disorder,0,1
1157,of,0,0
1158,unknown,0,0
1159,etiology,0,0
1160,",",0,0
1161,occurring,0,0
1162,almost,0,0
1163,exclusively,0,0
1164,in,0,0
1165,female,1,1
1166,patients,1,1
1167,.,1,0
1168,The,0,0
1169,etiology,0,0
1170,and,0,0
1171,functional,0,0
1172,significance,0,0
1173,of,0,0
1174,plasma,0,0
1175,carnitine,0,0
1176,deficiency,0,1
1177,seen,0,0
1178,in,0,0
1179,some,0,0
1180,patients,0,1
1181,with,0,1
1182,Rett,0,0
1183,syndrome,0,1
1184,is,0,0
1185,unknown,0,0
1186,.,0,0
1187,To,0,0
1188,investigate,0,0
1189,whether,0,0
1190,L-carnitine,0,0
1191,might,0,0
1192,be,0,0
1193,of,0,0
1194,benefit,0,0
1195,in,0,0
1196,Rett,0,0
1197,syndrome,0,1
1198,",",0,0
1199,a,0,0
1200,randomized,0,0
1201,",",0,0
1202,placebo-controlled,0,0
1203,",",0,0
1204,double-blind,0,0
1205,crossover,0,0
1206,trial,0,0
1207,of,0,0
1208,L-carnitine,0,0
1209,has,0,0
1210,been,0,0
1211,completed,0,0
1212,in,0,0
1213,35,1,1
1214,subjects,1,1
1215,.,1,1
1216,Eight-week,0,0
1217,treatment,0,0
1218,phases,0,0
1219,were,0,0
1220,completed,0,1
1221,for,0,0
1222,both,0,0
1223,a,0,0
1224,placebo,0,0
1225,and,0,0
1226,L-carnitine,0,0
1227,.,0,0
1228,Outcome,0,0
1229,was,0,0
1230,measured,0,0
1231,by,0,0
1232,parents/caregivers,0,0
1233,and,0,0
1234,at,0,0
1235,medical,0,0
1236,follow-up,0,0
1237,using,0,0
1238,three,0,0
1239,established,0,1
1240,tools,0,0
1241,:,0,1
1242,the,0,0
1243,Rett,0,0
1244,Syndrome,0,1
1245,Motor,0,0
1246,Behavioral,0,0
1247,Assessment,0,0
1248,",",0,0
1249,the,0,0
1250,Hand,0,0
1251,Apraxia,0,0
1252,Scale,0,0
1253,",",0,0
1254,and,0,0
1255,the,0,0
1256,Patient,0,0
1257,Well-Being,0,0
1258,Index,0,0
1259,.,0,0
1260,Analysis,0,0
1261,comparing,0,0
1262,change,0,0
1263,between,0,0
1264,baseline,0,0
1265,and,0,0
1266,week,0,0
1267,8,0,0
1268,of,0,0
1269,treatment,0,0
1270,for,0,0
1271,L-carnitine,0,0
1272,and,0,0
1273,the,0,0
1274,placebo,0,0
1275,showed,0,0
1276,that,0,0
1277,both,0,0
1278,parents/caregivers,0,0
1279,and,0,0
1280,medical,0,1
1281,follow-up,0,0
1282,detected,0,0
1283,improvements,0,0
1284,in,0,0
1285,the,0,0
1286,subjects,0,1
1287,',0,0
1288,well-being,0,0
1289,.,0,0
1290,In,0,0
1291,addition,0,0
1292,",",0,0
1293,medical,0,0
1294,review,0,0
1295,showed,0,0
1296,an,0,0
1297,improvement,0,0
1298,on,0,0
1299,the,0,0
1300,Hand,0,0
1301,Apraxia,0,0
1302,Scale,0,0
1303,for,0,0
1304,a,0,0
1305,higher,0,0
1306,proportion,0,0
1307,of,0,0
1308,girls,0,1
1309,on,0,0
1310,L-carnitine,0,0
1311,.,0,0
1312,Identification,0,0
1313,of,0,0
1314,predictors,0,0
1315,of,0,0
1316,clinical,0,0
1317,improvement,0,0
1318,has,0,0
1319,been,0,0
1320,limited,0,0
1321,by,0,0
1322,the,0,0
1323,power,0,0
1324,of,0,0
1325,the,0,0
1326,study,0,0
1327,.,0,0
1328,These,0,0
1329,findings,0,0
1330,suggest,0,0
1331,that,0,0
1332,L-carnitine,0,0
1333,is,0,0
1334,of,0,0
1335,benefit,0,0
1336,in,0,0
1337,some,0,0
1338,patients,1,1
1339,with,1,1
1340,Rett,1,0
1341,syndrome,1,1
1342,.,1,0
1343,While,0,0
1344,L-carnitine,0,0
1345,did,0,0
1346,not,0,0
1347,lead,0,0
1348,to,0,0
1349,major,0,0
1350,functional,0,0
1351,changes,0,0
1352,in,0,0
1353,ability,0,0
1354,",",0,0
1355,the,0,0
1356,type,0,0
1357,of,0,0
1358,changes,0,0
1359,reported,0,0
1360,could,0,0
1361,still,0,0
1362,have,0,0
1363,a,0,0
1364,substantial,0,0
1365,impact,0,0
1366,on,0,0
1367,the,0,0
1368,girls,0,1
1369,and,0,0
1370,their,0,1
1371,families,0,1
1372,.,0,0
1373,Information,0,0
1374,is,0,0
1375,still,0,0
1376,needed,0,0
1377,",",0,0
1378,however,0,0
1379,",",0,0
1380,to,0,0
1381,determine,0,0
1382,if,0,0
1383,only,0,0
1384,subgroups,0,0
1385,of,0,0
1386,girls,0,1
1387,with,0,1
1388,the,0,0
1389,disorder,0,1
1390,are,0,0
1391,responsive,0,0
1392,to,0,0
1393,L-carnitine,0,0
1394,and,0,0
1395,the,0,0
1396,appropriate,0,0
1397,duration,0,0
1398,of,0,0
1399,therapy,0,0
1400,.,0,0
1401,High-pressure,0,0
1402,",",0,0
1403,rapid-inflation,0,0
1404,pneumatic,0,0
1405,compression,0,0
1406,improves,0,0
1407,venous,0,0
1408,hemodynamics,0,0
1409,in,0,0
1410,healthy,1,1
1411,volunteers,1,1
1412,and,1,1
1413,patients,1,1
1414,who,1,1
1415,are,1,1
1416,post-thrombotic,1,1
1417,.,1,0
1418,PURPOSE,0,0
1419,Deep,1,0
1420,vein,1,0
1421,thrombosis,1,1
1422,(,1,0
1423,DVT,1,0
1424,),1,0
1425,is,0,0
1426,a,0,0
1427,preventable,0,0
1428,cause,0,0
1429,of,0,0
1430,morbidity,1,0
1431,and,1,0
1432,mortality,1,0
1433,in,1,1
1434,patients,1,1
1435,who,1,1
1436,are,1,1
1437,hospitalized,1,1
1438,.,1,0
1439,An,0,0
1440,important,0,0
1441,part,0,0
1442,of,0,0
1443,the,0,0
1444,mechanism,0,0
1445,of,0,0
1446,DVT,0,0
1447,prophylaxis,0,0
1448,with,0,1
1449,intermittent,0,1
1450,pneumatic,0,0
1451,compression,0,0
1452,(,0,0
1453,IPC,0,0
1454,),0,0
1455,is,0,0
1456,reduced,0,0
1457,venous,0,0
1458,stasis,0,0
1459,with,0,1
1460,increased,0,0
1461,velocity,0,0
1462,of,0,0
1463,venous,0,0
1464,return,0,0
1465,.,0,0
1466,The,0,0
1467,conventional,0,0
1468,methods,0,1
1469,of,0,0
1470,IPC,0,0
1471,use,0,0
1472,low,0,0
1473,pressure,0,0
1474,and,0,0
1475,slow,0,0
1476,inflation,0,0
1477,of,0,0
1478,the,0,0
1479,air,0,0
1480,bladder,0,1
1481,on,0,0
1482,the,0,0
1483,leg,0,0
1484,to,0,0
1485,augment,0,0
1486,venous,0,0
1487,return,0,0
1488,.,0,0
1489,Recently,0,0
1490,",",0,0
1491,compression,0,0
1492,devices,0,0
1493,have,0,0
1494,been,0,0
1495,designed,0,0
1496,that,0,0
1497,produce,0,0
1498,high,0,0
1499,pressure,0,0
1500,and,0,0
1501,rapid,0,0
1502,inflation,0,0
1503,of,0,0
1504,air,0,0
1505,cuffs,0,0
1506,on,0,0
1507,the,0,0
1508,plantar,0,0
1509,plexus,0,0
1510,of,0,0
1511,the,0,0
1512,foot,0,0
1513,and,0,0
1514,the,0,0
1515,calf,0,0
1516,.,0,0
1517,The,0,0
1518,purpose,0,0
1519,of,0,0
1520,this,0,0
1521,study,0,0
1522,is,0,0
1523,to,0,0
1524,evaluate,0,0
1525,the,0,0
1526,venous,0,0
1527,velocity,0,0
1528,response,0,0
1529,to,0,0
1530,high-pressure,0,0
1531,",",0,0
1532,rapid-inflation,0,0
1533,compression,0,0
1534,devices,0,0
1535,versus,0,0
1536,standard,0,0
1537,",",0,0
1538,low-pressure,0,0
1539,",",0,0
1540,slow-inflation,0,0
1541,compression,0,0
1542,devices,0,0
1543,in,0,0
1544,healthy,1,1
1545,volunteers,1,1
1546,and,1,0
1547,patients,1,1
1548,with,1,1
1549,severe,1,1
1550,post-thrombotic,1,0
1551,venous,1,1
1552,disease,1,1
1553,.,1,0
1554,METHOD,0,0
1555,Twenty-two,1,1
1556,lower,1,0
1557,extremities,1,0
1558,from,1,1
1559,healthy,1,1
1560,volunteers,1,1
1561,and,1,0
1562,11,1,1
1563,lower,1,0
1564,extremities,1,1
1565,from,1,1
1566,patients,1,1
1567,with,1,1
1568,class,1,1
1569,4,1,0
1570,to,1,0
1571,class,1,1
1572,6,1,0
1573,post-thrombotic,1,0
1574,chronic,1,1
1575,venous,1,1
1576,insufficiency,1,1
1577,were,1,0
1578,studied,1,0
1579,.,1,0
1580,With,0,0
1581,duplex,0,0
1582,ultrasound,0,0
1583,scanning,0,0
1584,(,0,0
1585,ATL-Ultramark,0,0
1586,9,0,0
1587,",",0,0
1588,Advanced,0,1
1589,Tech,0,1
1590,Laboratory,0,0
1591,",",0,0
1592,Bothell,0,0
1593,",",0,0
1594,Wash,0,0
1595,),0,0
1596,",",0,0
1597,acute,0,1
1598,DVT,0,0
1599,was,0,0
1600,excluded,0,0
1601,before,0,0
1602,subject,0,0
1603,evaluation,0,0
1604,.,0,0
1605,Venous,0,0
1606,velocities,0,0
1607,were,0,0
1608,monitored,0,0
1609,after,0,0
1610,the,0,0
1611,application,0,0
1612,of,0,0
1613,each,0,0
1614,of,0,0
1615,five,0,0
1616,IPC,0,0
1617,devices,0,0
1618,",",0,0
1619,with,0,1
1620,all,0,0
1621,the,0,0
1622,patients,0,1
1623,in,0,0
1624,the,0,0
1625,supine,0,0
1626,position,0,0
1627,.,0,0
1628,Three,0,0
1629,high-pressure,0,0
1630,",",0,0
1631,rapid-compression,0,0
1632,devices,0,0
1633,and,0,0
1634,two,0,0
1635,standard,0,0
1636,",",0,0
1637,low-pressure,0,0
1638,",",0,0
1639,slow-inflation,0,0
1640,compression,0,0
1641,devices,0,0
1642,were,0,0
1643,applied,0,0
1644,in,0,0
1645,a,0,0
1646,random,0,0
1647,sequence,0,0
1648,.,0,0
1649,Maximal,0,0
1650,venous,0,0
1651,velocities,0,0
1652,were,0,0
1653,obtained,0,0
1654,at,0,0
1655,the,0,0
1656,common,0,0
1657,femoral,0,0
1658,vein,0,0
1659,and,0,0
1660,the,0,0
1661,popliteal,0,0
1662,vein,0,0
1663,for,0,0
1664,all,0,0
1665,the,0,0
1666,devices,0,0
1667,and,0,0
1668,were,0,0
1669,recorded,0,0
1670,as,0,0
1671,the,0,0
1672,mean,0,0
1673,peak,0,0
1674,velocity,0,0
1675,of,0,0
1676,three,0,0
1677,compression,0,0
1678,cycles,0,0
1679,and,0,0
1680,compared,0,0
1681,with,0,1
1682,baseline,0,0
1683,velocities,0,0
1684,.,0,0
1685,RESULTS,0,0
1686,The,0,0
1687,baseline,0,0
1688,venous,0,0
1689,velocities,0,0
1690,were,0,0
1691,higher,0,0
1692,in,0,0
1693,the,0,0
1694,femoral,0,0
1695,veins,0,0
1696,than,0,0
1697,in,0,0
1698,the,0,0
1699,popliteal,0,1
1700,veins,0,0
1701,in,0,0
1702,both,0,0
1703,the,0,0
1704,volunteers,0,1
1705,and,0,0
1706,the,0,0
1707,post-thrombotic,0,0
1708,subjects,0,1
1709,.,0,1
1710,Standard,0,0
1711,and,0,0
1712,high-pressure,0,0
1713,",",0,0
1714,rapid-inflation,0,0
1715,compression,0,0
1716,significantly,0,0
1717,increased,0,0
1718,the,0,0
1719,popliteal,0,1
1720,and,0,0
1721,femoral,0,0
1722,vein,0,0
1723,velocities,0,0
1724,in,0,0
1725,healthy,0,1
1726,and,0,0
1727,post-thrombotic,0,1
1728,subjects,0,1
1729,.,0,0
1730,High-pressure,0,0
1731,",",0,0
1732,rapid-inflation,0,0
1733,compression,0,0
1734,produced,0,0
1735,significantly,0,0
1736,higher,0,0
1737,maximal,0,0
1738,venous,0,0
1739,velocities,0,0
1740,in,0,0
1741,the,0,0
1742,popliteal,0,1
1743,and,0,0
1744,femoral,0,0
1745,veins,0,0
1746,in,0,0
1747,both,0,0
1748,healthy,0,1
1749,volunteers,0,1
1750,and,0,1
1751,patients,0,1
1752,who,0,1
1753,were,0,1
1754,post-thrombotic,0,1
1755,as,0,0
1756,compared,0,0
1757,with,0,1
1758,standard,0,0
1759,compression,0,0
1760,.,0,0
1761,Compared,0,0
1762,with,0,0
1763,the,0,0
1764,healthy,0,1
1765,volunteers,0,1
1766,",",0,0
1767,the,0,1
1768,patients,0,1
1769,who,0,1
1770,were,0,1
1771,post-thrombotic,0,1
1772,had,0,0
1773,a,0,0
1774,significantly,0,0
1775,attenuated,0,0
1776,velocity,0,0
1777,response,0,0
1778,at,0,0
1779,both,0,0
1780,the,0,0
1781,popliteal,0,0
1782,and,0,0
1783,the,0,0
1784,femoral,0,0
1785,vein,0,1
1786,levels,0,0
1787,.,0,1
1788,CONCLUSION,0,0
1789,High-pressure,0,0
1790,",",0,0
1791,rapid-inflation,0,0
1792,pneumatic,0,0
1793,compression,0,0
1794,increases,0,0
1795,popliteal,0,1
1796,and,0,0
1797,femoral,0,0
1798,vein,0,0
1799,velocity,0,0
1800,as,0,0
1801,compared,0,0
1802,with,0,1
1803,standard,0,0
1804,",",0,0
1805,low-pressure,0,0
1806,",",0,0
1807,slow-inflation,0,0
1808,pneumatic,0,0
1809,compression,0,0
1810,.,0,0
1811,Patients,1,1
1812,with,1,1
1813,post-thrombotic,1,1
1814,venous,1,0
1815,disease,1,1
1816,have,0,0
1817,a,0,0
1818,compromised,0,0
1819,hemodynamic,0,0
1820,response,0,0
1821,to,0,0
1822,all,0,0
1823,IPC,0,0
1824,devices,0,0
1825,.,0,0
1826,However,0,0
1827,",",0,0
1828,an,0,0
1829,increased,0,0
1830,velocity,0,0
1831,response,0,0
1832,to,0,0
1833,the,0,0
1834,high-pressure,0,0
1835,",",0,0
1836,rapid-inflation,0,0
1837,compression,0,0
1838,device,0,0
1839,is,0,0
1840,preserved,0,0
1841,.,0,0
1842,High-pressure,0,0
1843,",",0,0
1844,rapid-inflation,0,0
1845,pneumatic,0,0
1846,compression,0,0
1847,may,0,0
1848,offer,0,0
1849,additional,0,0
1850,protection,0,0
1851,from,0,0
1852,thrombotic,0,0
1853,complications,0,0
1854,on,0,0
1855,the,0,0
1856,basis,0,0
1857,of,0,0
1858,an,0,0
1859,improved,0,0
1860,hemodynamic,0,0
1861,response,0,0
1862,",",0,0
1863,both,0,0
1864,in,0,0
1865,healthy,1,1
1866,volunteers,1,1
1867,and,1,0
1868,in,1,1
1869,patients,1,1
1870,who,1,1
1871,were,1,1
1872,post-thrombotic,1,1
1873,.,1,0
1874,Isradipine,0,0
1875,",",0,0
1876,raised,0,0
1877,glycosylated,0,0
1878,haemoglobin,0,0
1879,",",0,0
1880,and,0,0
1881,risk,1,0
1882,of,1,0
1883,cardiovascular,1,1
1884,events,1,0
1885,.,1,1
1886,Thrombolysis,0,0
1887,is,0,0
1888,superior,0,0
1889,to,0,0
1890,heparin,0,0
1891,for,0,0
1892,non-obstructive,1,1
1893,mitral,1,1
1894,mechanical,1,0
1895,valve,1,1
1896,thrombosis,1,1
1897,.,1,0
1898,BACKGROUND,0,0
1899,AND,0,0
1900,AIM,0,0
1901,OF,0,0
1902,THE,0,0
1903,STUDY,0,0
1904,Non-obstructive,1,1
1905,prosthetic,1,0
1906,valve,1,1
1907,thrombosis,1,1
1908,(,1,0
1909,PVT,1,0
1910,),1,0
1911,is,0,0
1912,a,0,0
1913,unique,0,0
1914,subset,0,0
1915,that,0,0
1916,features,0,0
1917,clinical,0,0
1918,presentation,0,0
1919,without,0,0
1920,heart,0,1
1921,failure,0,1
1922,",",0,0
1923,and,0,0
1924,may,0,0
1925,be,0,0
1926,asymptomatic,0,1
1927,.,0,0
1928,Thrombolysis,0,0
1929,has,0,0
1930,been,0,0
1931,accepted,0,0
1932,for,0,0
1933,obstructive,0,1
1934,PVT,0,0
1935,",",0,0
1936,but,0,0
1937,treatment,0,0
1938,strategies,0,0
1939,of,0,0
1940,non-obstructive,0,1
1941,PVT,0,0
1942,are,0,0
1943,controversial,0,0
1944,.,0,0
1945,This,0,0
1946,study,0,0
1947,compared,0,0
1948,the,0,0
1949,efficacy,0,0
1950,and,0,0
1951,safety,0,0
1952,of,0,0
1953,thrombolysis,0,0
1954,and,0,0
1955,heparin,0,0
1956,treatment,0,0
1957,in,0,0
1958,these,0,0
1959,patients,0,1
1960,.,0,0
1961,METHODS,0,0
1962,Between,0,0
1963,1993,0,1
1964,and,0,0
1965,1998,0,1
1966,",",0,0
1967,20,1,1
1968,consecutive,1,1
1969,patients,1,1
1970,were,1,0
1971,found,1,0
1972,by,1,0
1973,multiplane,1,0
1974,transesophageal,1,0
1975,echocardiography,1,0
1976,(,1,0
1977,TEE,1,0
1978,),1,0
1979,to,1,0
1980,have,1,0
1981,non-obstructive,1,1
1982,PVT,1,0
1983,.,1,1
1984,TEE,0,0
1985,was,0,0
1986,performed,0,0
1987,for,0,0
1988,peripheral,0,0
1989,embolism,0,1
1990,in,0,0
1991,two,0,0
1992,patients,0,1
1993,",",0,0
1994,stroke,0,1
1995,or,0,0
1996,transient,0,0
1997,ischemic,0,1
1998,attack,0,1
1999,in,0,0
2000,six,0,0
2001,",",0,0
2002,stroke,0,1
2003,and,0,0
2004,fever,0,0
2005,in,0,0
2006,two,0,0
2007,",",0,0
2008,fever,0,0
2009,in,0,0
2010,one,0,0
2011,patient,0,0
2012,",",0,0
2013,as,0,0
2014,a,0,0
2015,routine,0,0
2016,postoperative,0,0
2017,examination,0,0
2018,in,0,0
2019,two,0,0
2020,patients,0,1
2021,",",0,0
2022,and,0,0
2023,for,0,0
2024,other,0,0
2025,reasons,0,0
2026,in,0,0
2027,seven,0,1
2028,.,0,1
2029,Patients,0,1
2030,were,0,0
2031,allocated,0,0
2032,to,0,0
2033,two,0,0
2034,groups,0,0
2035,:,0,1
2036,group,0,0
2037,I,0,0
2038,(,0,0
2039,n,0,1
2040,=,0,0
2041,8,0,0
2042,),0,0
2043,received,0,0
2044,streptokinase-mediated,0,0
2045,fibrinolysis,0,0
2046,;,0,0
2047,group,0,0
2048,II,0,0
2049,(,0,0
2050,n,0,1
2051,=,0,0
2052,12,0,1
2053,),0,0
2054,received,0,0
2055,intravenous,0,0
2056,heparin,0,0
2057,by,0,0
2058,infusion,0,0
2059,.,0,0
2060,Treatment,0,0
2061,was,0,0
2062,monitored,0,0
2063,using,0,0
2064,TEE,0,0
2065,.,0,0
2066,RESULTS,0,0
2067,There,0,0
2068,was,0,0
2069,no,0,0
2070,difference,0,0
2071,between,0,0
2072,patient,0,0
2073,groups,0,0
2074,with,0,1
2075,regard,0,0
2076,to,0,0
2077,sex,0,0
2078,",",0,0
2079,age,0,1
2080,",",0,0
2081,type,0,0
2082,of,0,0
2083,prosthesis,0,1
2084,and,0,0
2085,time,0,0
2086,since,0,0
2087,operation,0,0
2088,",",0,0
2089,though,0,0
2090,anticoagulant,0,0
2091,status,0,0
2092,was,0,0
2093,more,0,0
2094,often,0,0
2095,inadequate,0,0
2096,in,0,0
2097,group,0,0
2098,II,0,1
2099,.,0,0
2100,By,0,0
2101,TEE,0,0
2102,",",0,0
2103,valve,0,1
2104,motion,0,0
2105,was,0,0
2106,normal,0,1
2107,in,0,0
2108,all,0,0
2109,patients,0,1
2110,.,0,0
2111,In,0,0
2112,group,0,0
2113,I,0,0
2114,",",0,0
2115,all,0,0
2116,thrombi,0,0
2117,were,0,0
2118,mobile,0,0
2119,and,0,0
2120,5-13,0,1
2121,mm,0,0
2122,in,0,0
2123,diameter,0,0
2124,;,0,0
2125,in,0,0
2126,group,0,0
2127,II,0,0
2128,",",0,0
2129,all,0,0
2130,thrombi,0,0
2131,but,0,0
2132,three,0,0
2133,were,0,0
2134,mobile,0,0
2135,and,0,0
2136,3-18,0,1
2137,mm,0,0
2138,in,0,0
2139,diameter,0,0
2140,.,0,0
2141,In,0,0
2142,group,0,0
2143,I,0,0
2144,",",0,0
2145,thrombolysis,0,0
2146,was,0,0
2147,successful,0,0
2148,in,0,0
2149,all,0,0
2150,patients,0,1
2151,",",0,0
2152,without,0,1
2153,complications,0,0
2154,",",0,0
2155,within,0,0
2156,6-72,0,0
2157,h.,0,0
2158,In,0,0
2159,group,0,0
2160,II,0,0
2161,",",0,0
2162,heparin,0,0
2163,treatment,0,0
2164,was,0,0
2165,successful,0,0
2166,in,0,0
2167,six,0,1
2168,patients,0,1
2169,in,0,0
2170,3-32,0,0
2171,days,0,0
2172,.,0,1
2173,In,0,0
2174,one,0,0
2175,patient,0,0
2176,",",0,0
2177,seven,0,0
2178,days,0,0
2179,',0,1
2180,of,0,0
2181,unsuccessful,0,1
2182,heparin,0,0
2183,was,0,0
2184,followed,0,0
2185,by,0,0
2186,two,0,0
2187,months,0,0
2188,',0,1
2189,successful,0,0
2190,coumarin,0,0
2191,therapy,0,0
2192,.,0,0
2193,Among,0,1
2194,five,0,0
2195,unsuccessful,0,1
2196,cases,0,0
2197,",",0,0
2198,the,0,0
2199,thrombus,0,0
2200,size,0,0
2201,increased,0,0
2202,in,0,0
2203,four,0,0
2204,(,0,0
2205,three,0,0
2206,became,0,0
2207,obstructive,0,1
2208,in,0,0
2209,7-35,0,1
2210,days,0,0
2211,),0,1
2212,;,0,0
2213,all,0,0
2214,four,0,0
2215,patients,0,1
2216,were,0,0
2217,switched,0,0
2218,to,0,0
2219,fibrinolysis,0,0
2220,",",0,0
2221,which,0,0
2222,was,0,0
2223,successful,0,0
2224,without,0,1
2225,complications,0,0
2226,in,0,0
2227,12-60,0,0
2228,h.,0,0
2229,The,0,0
2230,fifth,0,0
2231,patient,0,0
2232,developed,0,0
2233,a,0,0
2234,stroke,0,1
2235,after,0,0
2236,nine,0,1
2237,days,0,0
2238,of,0,0
2239,heparin,0,0
2240,treatment,0,0
2241,and,0,0
2242,was,0,0
2243,subsequently,0,0
2244,operated,0,1
2245,on,0,0
2246,.,0,0
2247,CONCLUSIONS,0,0
2248,Non-obstructive,0,0
2249,PVT,0,0
2250,may,0,0
2251,be,0,0
2252,asymptomatic,0,1
2253,in,0,0
2254,one-third,0,0
2255,of,0,0
2256,patients,0,1
2257,.,0,0
2258,Thrombolysis,0,0
2259,is,0,0
2260,an,0,0
2261,efficient,0,0
2262,and,0,0
2263,safe,0,0
2264,treatment,0,0
2265,",",0,0
2266,and,0,0
2267,may,0,0
2268,be,0,0
2269,first-line,0,0
2270,therapy,0,0
2271,if,0,0
2272,there,0,0
2273,is,0,0
2274,no,0,0
2275,contraindication,0,0
2276,.,0,0
2277,Heparin,0,0
2278,treatment,0,0
2279,was,0,0
2280,successful,0,0
2281,in,0,0
2282,about,0,0
2283,one-half,0,0
2284,of,0,0
2285,our,0,0
2286,cases,0,0
2287,in,0,0
2288,the,0,0
2289,presence,0,0
2290,of,0,0
2291,sessile,0,1
2292,or,0,0
2293,small,0,0
2294,thrombi,0,0
2295,and,0,0
2296,inadequate,0,0
2297,anticoagulant,0,0
2298,status,0,0
2299,.,0,0
2300,In,0,0
2301,unsuccessful,0,0
2302,cases,0,0
2303,",",0,0
2304,thrombi,0,0
2305,became,0,0
2306,obstructive,0,1
2307,or,0,0
2308,caused,0,0
2309,stroke,0,1
2310,during,0,0
2311,heparin,0,0
2312,therapy,0,0
2313,",",0,0
2314,the,0,0
2315,adequate,0,0
2316,duration,0,0
2317,of,0,0
2318,which,0,0
2319,remains,0,0
2320,unclear,0,0
2321,.,0,0
2322,Low-dose,0,0
2323,growth,0,0
2324,hormone,0,0
2325,treatment,0,0
2326,with,0,1
2327,diet,0,0
2328,restriction,0,0
2329,accelerates,0,0
2330,body,0,0
2331,fat,0,0
2332,loss,0,0
2333,",",0,0
2334,exerts,0,0
2335,anabolic,0,0
2336,effect,0,0
2337,and,0,0
2338,improves,0,0
2339,growth,0,0
2340,hormone,0,0
2341,secretory,0,0
2342,dysfunction,0,0
2343,in,0,0
2344,obese,1,1
2345,adults,1,1
2346,.,1,1
2347,Growth,0,0
2348,hormone,0,0
2349,(,0,0
2350,GH,0,0
2351,),0,0
2352,can,0,0
2353,induce,0,0
2354,an,0,0
2355,accelerated,0,0
2356,lipolysis,0,0
2357,.,0,0
2358,Impaired,0,0
2359,secretion,0,0
2360,of,0,0
2361,GH,0,0
2362,in,0,0
2363,obesity,0,1
2364,results,0,0
2365,in,0,0
2366,the,0,0
2367,consequent,0,0
2368,loss,0,0
2369,of,0,0
2370,the,0,0
2371,lipolytic,0,0
2372,effect,0,0
2373,of,0,0
2374,GH,0,0
2375,.,0,0
2376,Dietary,0,0
2377,restriction,0,0
2378,as,0,0
2379,a,0,0
2380,basic,0,0
2381,treatment,0,0
2382,for,0,0
2383,obesity,0,0
2384,is,0,0
2385,complicated,0,0
2386,by,0,0
2387,poor,0,0
2388,compliance,0,0
2389,",",0,0
2390,protein,0,0
2391,catabolism,0,0
2392,",",0,0
2393,and,0,0
2394,slow,0,0
2395,rates,0,0
2396,or,0,0
2397,weight,0,0
2398,loss,0,0
2399,.,0,0
2400,GH,0,0
2401,has,0,0
2402,an,0,0
2403,anabolic,0,0
2404,effect,0,0
2405,by,0,0
2406,increasing,0,0
2407,insulin-like,0,0
2408,growth,0,0
2409,factor,0,0
2410,(,0,0
2411,IGF,0,1
2412,),0,0
2413,-I,0,0
2414,.,0,0
2415,We,0,0
2416,investigated,0,0
2417,the,0,0
2418,effects,0,0
2419,of,0,0
2420,GH,0,0
2421,treatment,0,0
2422,and,0,0
2423,dietary,0,0
2424,restriction,0,0
2425,on,0,0
2426,lipolytic,0,0
2427,and,0,0
2428,anabolic,0,0
2429,actions,0,0
2430,",",0,0
2431,as,0,0
2432,well,0,0
2433,as,0,0
2434,the,0,0
2435,consequent,0,0
2436,changes,0,0
2437,in,0,0
2438,insulin,0,0
2439,and,0,0
2440,GH,0,0
2441,secretion,0,0
2442,in,0,0
2443,obesity,1,1
2444,.,1,0
2445,24,1,0
2446,obese,1,1
2447,subjects,1,1
2448,(,1,1
2449,22,1,1
2450,women,1,1
2451,and,1,0
2452,2,1,1
2453,men,1,1
2454,;,1,1
2455,22-46,1,1
2456,years,1,1
2457,old,1,1
2458,),1,0
2459,were,0,0
2460,fed,0,0
2461,a,0,0
2462,diet,0,0
2463,of,0,0
2464,25,0,0
2465,kcal/kg,0,0
2466,ideal,0,0
2467,body,0,1
2468,weight,0,0
2469,(,0,0
2470,IBW,0,0
2471,),0,0
2472,with,0,1
2473,1.2,0,0
2474,g,0,0
2475,protein/kg,0,0
2476,IBW,0,0
2477,daily,0,0
2478,and,0,0
2479,were,0,0
2480,treated,0,0
2481,with,0,1
2482,recombinant,0,0
2483,human,0,0
2484,GH,0,0
2485,(,0,0
2486,n,0,1
2487,=,0,0
2488,12,0,0
2489,",",0,0
2490,0.18,0,0
2491,U/kg,0,0
2492,IBW/week,0,0
2493,),0,0
2494,or,0,0
2495,placebo,0,0
2496,(,0,0
2497,n,0,1
2498,=,0,0
2499,12,0,0
2500,",",0,0
2501,vehicle,0,0
2502,injection,0,0
2503,),0,0
2504,in,0,0
2505,a,0,0
2506,12-week,0,0
2507,randomized,0,0
2508,",",0,0
2509,double-blind,0,0
2510,and,0,0
2511,placebo-controlled,0,0
2512,trial,0,0
2513,.,0,0
2514,GH,0,0
2515,treatment,0,0
2516,caused,0,0
2517,a,0,0
2518,1.6-fold,0,0
2519,increase,0,0
2520,in,0,0
2521,the,0,0
2522,fraction,0,0
2523,of,0,0
2524,body,0,0
2525,weight,0,0
2526,lost,0,0
2527,as,0,0
2528,fat,0,0
2529,and,0,0
2530,a,0,0
2531,greater,0,0
2532,loss,0,0
2533,of,0,0
2534,visceral,0,1
2535,fat,0,0
2536,area,0,0
2537,than,0,0
2538,placebo,0,0
2539,treatment,0,0
2540,(,0,0
2541,35.3,0,0
2542,vs.,0,0
2543,28.5,0,0
2544,%,0,0
2545,",",0,0
2546,p,0,0
2547,<,0,0
2548,0.05,0,0
2549,),0,0
2550,.,0,0
2551,In,0,0
2552,the,0,0
2553,placebo,0,0
2554,group,0,0
2555,",",0,0
2556,there,0,0
2557,was,0,0
2558,a,0,0
2559,loss,0,0
2560,in,0,0
2561,lean,0,0
2562,body,0,0
2563,mass,0,0
2564,(,0,0
2565,-2.62,0,0
2566,+/-,0,0
2567,1.51,0,0
2568,kg,0,1
2569,),0,0
2570,and,0,0
2571,a,0,0
2572,negative,0,0
2573,nitrogen,0,0
2574,balance,0,0
2575,(,0,0
2576,-4.52,0,0
2577,+/-,0,0
2578,3.51,0,0
2579,g/day,0,0
2580,),0,0
2581,.,0,0
2582,By,0,0
2583,contrast,0,0
2584,",",0,0
2585,the,0,0
2586,GH,0,0
2587,group,0,0
2588,increased,0,0
2589,in,0,0
2590,lean,0,0
2591,body,0,0
2592,mass,0,0
2593,(,0,0
2594,1.13,0,0
2595,+/-,0,0
2596,1.04,0,0
2597,kg,0,1
2598,),0,0
2599,and,0,0
2600,had,0,0
2601,a,0,0
2602,positive,0,0
2603,nitrogen,0,0
2604,balance,0,0
2605,(,0,0
2606,1.81,0,0
2607,+/-,0,0
2608,2.06,0,0
2609,g/day,0,0
2610,),0,0
2611,.,0,0
2612,GH,0,0
2613,injections,0,0
2614,caused,0,0
2615,a,0,0
2616,1.6-fold,0,0
2617,increase,0,0
2618,in,0,0
2619,IGF-I,0,0
2620,",",0,0
2621,despite,0,0
2622,caloric,0,0
2623,restriction,0,0
2624,.,0,0
2625,GH,0,0
2626,response,0,0
2627,to,0,0
2628,L-dopa,0,1
2629,stimulation,0,0
2630,was,0,0
2631,blunted,0,0
2632,in,0,0
2633,all,0,0
2634,subjects,0,1
2635,and,0,0
2636,it,0,0
2637,was,0,0
2638,increased,0,0
2639,after,0,0
2640,treatment,0,0
2641,in,0,0
2642,both,0,0
2643,groups,0,0
2644,.,0,0
2645,GH,0,0
2646,treatment,0,0
2647,did,0,0
2648,not,0,0
2649,induce,0,0
2650,a,0,0
2651,further,0,0
2652,increase,0,0
2653,in,0,0
2654,insulin,0,0
2655,levels,0,0
2656,during,0,0
2657,an,0,0
2658,oral,0,0
2659,glucose,0,0
2660,tolerance,0,0
2661,test,0,0
2662,(,0,0
2663,OGTT,0,0
2664,),0,0
2665,but,0,0
2666,significantly,0,0
2667,decreased,0,0
2668,free,0,0
2669,fatty,0,0
2670,acid,0,0
2671,(,0,0
2672,FFA,0,0
2673,),0,0
2674,levels,0,0
2675,during,0,0
2676,OGTT,0,0
2677,.,0,0
2678,The,0,0
2679,decrease,0,0
2680,in,0,0
2681,FFA,0,0
2682,area,0,0
2683,under,0,0
2684,the,0,0
2685,curve,0,0
2686,during,0,0
2687,OGTT,0,0
2688,was,0,0
2689,positively,0,0
2690,correlated,0,0
2691,with,0,0
2692,visceral,0,1
2693,fat,0,0
2694,loss,0,0
2695,.,0,0
2696,This,0,0
2697,study,0,0
2698,demonstrates,0,0
2699,that,0,0
2700,in,0,0
2701,obese,1,1
2702,subjects,1,1
2703,given,0,0
2704,a,0,0
2705,hypocaloric,0,0
2706,diet,0,0
2707,",",0,0
2708,GH,0,0
2709,accelerates,0,0
2710,body,0,0
2711,fat,0,0
2712,loss,0,0
2713,",",0,0
2714,exerts,0,0
2715,anabolic,0,0
2716,effects,0,0
2717,and,0,0
2718,improves,0,0
2719,GH,0,0
2720,secretion,0,0
2721,.,0,0
2722,These,0,0
2723,findings,0,0
2724,suggest,0,0
2725,a,0,0
2726,possible,0,0
2727,therapeutic,0,0
2728,role,0,0
2729,of,0,0
2730,low-dose,0,0
2731,GH,0,0
2732,with,0,1
2733,caloric,0,0
2734,restriction,0,0
2735,for,0,0
2736,obesity,0,1
2737,.,0,0
2738,Cycle,0,0
2739,control,0,0
2740,with,0,1
2741,oral,0,0
2742,contraceptives,0,0
2743,containing,0,1
2744,20,0,1
2745,micrograms,0,0
2746,of,0,0
2747,ethinyl,0,0
2748,estradiol,0,0
2749,.,0,0
2750,A,0,0
2751,multicenter,0,0
2752,",",0,0
2753,randomized,0,0
2754,comparison,0,0
2755,of,0,0
2756,levonorgestrel/ethinyl,0,0
2757,estradiol,0,0
2758,(,0,0
2759,100,0,0
2760,micrograms/20,0,0
2761,micrograms,0,0
2762,),0,0
2763,and,0,0
2764,norethindrone/ethinyl,0,0
2765,estradiol,0,0
2766,(,0,0
2767,1000,0,0
2768,micrograms/20,0,0
2769,micrograms,0,0
2770,),0,0
2771,.,0,0
2772,A,0,0
2773,randomized,0,0
2774,",",0,0
2775,open-label,0,0
2776,",",0,0
2777,multicenter,0,0
2778,study,0,0
2779,was,0,0
2780,undertaken,0,0
2781,to,0,0
2782,compare,0,0
2783,the,0,0
2784,effects,0,0
2785,of,0,0
2786,oral,0,0
2787,contraceptives,0,0
2788,(,0,0
2789,OC,0,0
2790,),0,0
2791,containing,0,0
2792,100,0,0
2793,micrograms,0,0
2794,levonorgestrel,0,0
2795,(,0,0
2796,LNG,0,1
2797,),0,0
2798,/20,0,0
2799,micrograms,0,0
2800,ethinyl,0,0
2801,estradiol,0,0
2802,(,0,0
2803,EE,0,0
2804,),0,0
2805,(,0,0
2806,Aless/Loette,0,0
2807,),0,0
2808,and,0,0
2809,1000,0,0
2810,micrograms,0,0
2811,norethindrone,0,0
2812,acetate,0,0
2813,(,0,0
2814,NETA,0,0
2815,),0,0
2816,/20,0,0
2817,micrograms,0,0
2818,EE,0,0
2819,(,0,0
2820,Loestrin,0,0
2821,Fe,0,0
2822,1/20,0,0
2823,),0,0
2824,on,0,0
2825,menstrual,0,1
2826,cycle,0,0
2827,control,0,0
2828,over,0,0
2829,four,0,0
2830,cycles,0,0
2831,of,0,0
2832,use,0,0
2833,.,0,0
2834,A,0,0
2835,total,0,0
2836,of,0,0
2837,84,1,1
2838,evaluable,1,1
2839,women,1,1
2840,provided,1,0
2841,274,1,1
2842,cycles,1,0
2843,of,1,0
2844,exposure,1,0
2845,in,1,0
2846,the,1,0
2847,LNG/EE,1,0
2848,group,1,0
2849,",",1,0
2850,and,1,0
2851,89,1,1
2852,women,1,1
2853,provided,1,0
2854,289,1,1
2855,cycles,1,0
2856,of,1,0
2857,exposure,1,0
2858,in,1,0
2859,the,1,0
2860,NETA/EE,1,0
2861,group,1,0
2862,.,1,0
2863,Overall,0,0
2864,",",0,0
2865,the,0,0
2866,LNG/EE,1,0
2867,group,1,0
2868,achieved,0,0
2869,a,0,0
2870,consistently,0,0
2871,higher,0,0
2872,percentage,0,0
2873,of,0,0
2874,normal,0,1
2875,menstrual,0,1
2876,cycles,0,0
2877,as,0,0
2878,well,0,0
2879,as,0,0
2880,a,0,0
2881,lower,0,0
2882,rate,0,0
2883,of,0,0
2884,intermenstrual,0,0
2885,bleeding,0,0
2886,and,0,0
2887,amenorrhea,0,0
2888,than,0,0
2889,the,0,0
2890,NETA/EE,0,0
2891,group,0,0
2892,.,0,0
2893,In,0,0
2894,cycle,0,0
2895,4,0,0
2896,",",0,0
2897,63.8,0,0
2898,%,0,0
2899,of,0,0
2900,cycles,0,0
2901,were,0,0
2902,normal,0,1
2903,in,0,0
2904,the,0,0
2905,LNG/EE,1,0
2906,group,1,0
2907,compared,0,0
2908,with,0,1
2909,41.9,0,0
2910,%,0,0
2911,in,0,0
2912,the,0,0
2913,NETA/EE,0,0
2914,group,0,0
2915,(,0,0
2916,p,0,0
2917,<,0,0
2918,0.005,0,0
2919,),0,0
2920,.,0,0
2921,Of,0,0
2922,the,0,0
2923,total,0,1
2924,cycles,0,0
2925,in,0,0
2926,the,0,0
2927,NETA/EE,1,0
2928,group,1,0
2929,",",0,0
2930,10,0,0
2931,%,0,0
2932,were,0,0
2933,amenorrheic,0,1
2934,",",0,0
2935,compared,0,0
2936,with,0,0
2937,1.1,0,0
2938,%,0,0
2939,in,0,0
2940,the,0,0
2941,LNG/EE,0,0
2942,group,0,0
2943,.,0,0
2944,The,0,0
2945,occurrence,0,0
2946,of,0,0
2947,bleeding,0,0
2948,and/or,0,0
2949,spotting,0,0
2950,was,0,0
2951,significantly,0,0
2952,lower,0,0
2953,in,0,0
2954,cycles,0,0
2955,2,0,1
2956,and,0,0
2957,3,0,0
2958,in,0,0
2959,the,0,0
2960,LNG/EE,1,0
2961,group,1,0
2962,(,0,0
2963,41.7,0,0
2964,%,0,0
2965,and,0,0
2966,34.8,0,0
2967,%,0,0
2968,",",0,0
2969,respectively,0,0
2970,),0,0
2971,compared,0,0
2972,with,0,0
2973,the,0,0
2974,NETA/EE,0,0
2975,group,0,0
2976,(,0,0
2977,62.3,0,0
2978,%,0,0
2979,and,0,0
2980,56.3,0,0
2981,%,0,0
2982,;,0,0
2983,p,0,0
2984,<,0,0
2985,0.05,0,0
2986,),0,0
2987,.,0,0
2988,Other,0,0
2989,cycle,0,0
2990,variables,0,0
2991,were,0,0
2992,generally,0,0
2993,similar,0,0
2994,between,0,0
2995,groups,0,0
2996,",",0,0
2997,as,0,0
2998,was,0,0
2999,the,0,0
3000,incidence,0,0
3001,of,0,0
3002,adverse,0,0
3003,events,0,0
3004,.,0,1
3005,These,0,0
3006,results,0,0
3007,demonstrate,0,0
3008,that,0,0
3009,good,0,0
3010,cycle,0,0
3011,control,0,0
3012,was,0,0
3013,achieved,0,0
3014,with,0,0
3015,an,0,0
3016,OC,0,0
3017,containing,0,0
3018,20,0,1
3019,micrograms,0,0
3020,EE,0,1
3021,and,0,0
3022,that,0,0
3023,100,0,0
3024,micrograms,0,0
3025,LNG/20,0,1
3026,micrograms,0,0
3027,EE,0,0
3028,produces,0,0
3029,better,0,0
3030,cycle,0,0
3031,control,0,0
3032,than,0,0
3033,1000,0,0
3034,micrograms,0,0
3035,NETA/20,0,1
3036,micrograms,0,0
3037,EE,0,1
3038,.,0,1
3039,Comparison,0,0
3040,of,0,0
3041,the,0,0
3042,relative,0,0
3043,efficacy,0,0
3044,of,0,0
3045,formoterol,0,0
3046,and,0,0
3047,salmeterol,0,0
3048,in,0,0
3049,asthmatic,1,1
3050,patients,1,1
3051,.,1,1
3052,Studies,0,0
3053,performed,0,0
3054,on,0,0
3055,airway,0,0
3056,smooth,0,0
3057,muscle,0,0
3058,in,0,0
3059,vitro,0,0
3060,have,0,0
3061,indicated,0,0
3062,that,0,0
3063,salmeterol,0,0
3064,is,0,0
3065,a,0,0
3066,partial,0,0
3067,agonist,0,0
3068,on,0,0
3069,the,0,0
3070,beta2-receptor,0,0
3071,in,0,0
3072,comparison,0,0
3073,to,0,0
3074,formoterol,0,0
3075,.,0,0
3076,In,0,0
3077,the,0,0
3078,present,0,0
3079,study,0,0
3080,we,0,0
3081,evaluated,0,0
3082,whether,0,0
3083,these,0,0
3084,pharmacological,0,0
3085,differences,0,0
3086,between,0,0
3087,salmeterol,0,0
3088,and,0,0
3089,formoterol,0,0
3090,also,0,0
3091,are,0,0
3092,applicable,0,0
3093,to,0,0
3094,asthmatic,1,1
3095,patients,1,1
3096,.,1,0
3097,The,0,0
3098,protective,0,0
3099,effects,0,0
3100,by,0,0
3101,increasing,0,0
3102,cumulative,0,0
3103,doses,0,0
3104,of,0,0
3105,formoterol,0,0
3106,(,0,0
3107,12,0,0
3108,",",0,0
3109,60,0,0
3110,",",0,0
3111,120,0,1
3112,micrograms,0,0
3113,),0,0
3114,and,0,0
3115,salmeterol,0,0
3116,(,0,0
3117,50,0,0
3118,",",0,0
3119,250,0,0
3120,",",0,0
3121,500,0,0
3122,micrograms,0,0
3123,),0,0
3124,on,0,0
3125,methacholine-induced,0,0
3126,bronchoconstriction,0,0
3127,were,0,0
3128,evaluated,0,0
3129,in,0,0
3130,a,0,0
3131,double-blind,0,0
3132,",",0,0
3133,crossover,0,0
3134,",",0,0
3135,placebo-controlled,0,0
3136,design,0,0
3137,.,0,1
3138,Patients,1,1
3139,were,0,0
3140,regularly,0,0
3141,treated,0,0
3142,with,0,0
3143,salbutamol,0,0
3144,200,0,0
3145,micrograms,0,0
3146,twice,0,0
3147,daily,0,0
3148,during,0,0
3149,the,0,0
3150,study,0,0
3151,period,0,0
3152,",",0,0
3153,to,0,0
3154,avoid,0,0
3155,variability,0,0
3156,in,0,0
3157,beta2-adrenoceptor,0,0
3158,tolerance,0,0
3159,.,0,0
3160,S-potassium,0,0
3161,",",0,0
3162,heart,0,1
3163,rate,0,0
3164,corrected,0,0
3165,Q-T,0,0
3166,interval,0,0
3167,(,0,0
3168,Q-Tc,0,0
3169,),0,0
3170,",",0,0
3171,and,0,0
3172,tremor,0,0
3173,score,0,0
3174,were,0,0
3175,followed,0,0
3176,as,0,0
3177,measures,0,0
3178,of,0,0
3179,systemic,0,0
3180,effects,0,0
3181,.,0,1
3182,Formoterol,0,0
3183,dose-dependently,0,0
3184,protected,0,0
3185,against,0,0
3186,methacholine,0,0
3187,responsiveness,0,0
3188,(,0,0
3189,4.6,0,0
3190,doubling,0,0
3191,doses,0,0
3192,after,0,0
3193,120,0,1
3194,micrograms,0,0
3195,),0,1
3196,.,0,0
3197,Salmeterol,0,0
3198,",",0,0
3199,however,0,0
3200,",",0,0
3201,showed,0,0
3202,a,0,0
3203,flatter,0,0
3204,dose-response,0,0
3205,curve,0,0
3206,",",0,0
3207,and,0,0
3208,a,0,0
3209,significantly,0,0
3210,weaker,0,0
3211,maximal,0,0
3212,protective,0,0
3213,effect,0,0
3214,(,0,0
3215,2.8,0,0
3216,doubling,0,0
3217,doses,0,0
3218,after,0,0
3219,250,0,0
3220,micrograms,0,0
3221,),0,1
3222,.,0,1
3223,Formoterol,0,0
3224,caused,0,0
3225,a,0,0
3226,significantly,0,0
3227,higher,0,0
3228,tremor,0,0
3229,score,0,0
3230,and,0,0
3231,a,0,0
3232,larger,0,0
3233,drop,0,0
3234,in,0,0
3235,S-potassium,0,0
3236,than,0,0
3237,salmeterol,0,0
3238,at,0,0
3239,the,0,0
3240,highest,0,0
3241,doses,0,0
3242,.,0,0
3243,These,0,0
3244,data,0,0
3245,show,0,0
3246,that,0,0
3247,salmeterol,0,0
3248,is,0,0
3249,a,0,0
3250,partial,0,0
3251,agonist,0,0
3252,on,0,0
3253,the,0,0
3254,beta2-receptor,0,0
3255,in,0,0
3256,relation,0,0
3257,to,0,0
3258,formoterol,0,0
3259,in,0,0
3260,human,0,0
3261,airways,0,1
3262,in,0,0
3263,vivo,0,0
3264,.,0,0
3265,Further,0,0
3266,studies,0,0
3267,are,0,0
3268,required,0,0
3269,to,0,0
3270,document,0,0
3271,the,0,0
3272,clinical,0,0
3273,consequences,0,0
3274,of,0,0
3275,this,0,0
3276,finding,0,0
3277,",",0,0
3278,for,0,0
3279,example,0,0
3280,in,0,0
3281,severe,1,1
3282,asthmatic,1,1
3283,patients,1,1
3284,.,1,1
3285,Moderate-intensity,0,0
3286,exercise,0,0
3287,training,0,0
3288,with,0,1
3289,elements,0,0
3290,of,0,0
3291,step,0,0
3292,aerobics,0,1
3293,in,0,0
3294,patients,1,1
3295,with,1,1
3296,severe,1,1
3297,chronic,1,1
3298,heart,1,1
3299,failure,1,1
3300,.,1,0
3301,OBJECTIVE,0,0
3302,To,0,0
3303,evaluate,0,0
3304,whether,0,0
3305,a,0,0
3306,specific,0,0
3307,program,0,0
3308,of,0,0
3309,moderate-intensity,0,0
3310,step,0,0
3311,aerobics,0,0
3312,training,0,0
3313,may,0,0
3314,be,0,0
3315,sufficient,0,0
3316,to,0,0
3317,improve,0,0
3318,the,0,0
3319,exercise,0,0
3320,tolerance,0,0
3321,of,0,0
3322,patients,1,1
3323,with,1,1
3324,severe,1,1
3325,chronic,1,1
3326,heart,1,1
3327,failure,1,1
3328,.,1,0
3329,PATIENTS,0,0
3330,Twenty-six,1,1
3331,patients,1,1
3332,(,1,1
3333,22,1,1
3334,men,1,1
3335,",",1,0
3336,4,1,0
3337,women,1,1
3338,;,1,0
3339,mean,1,1
3340,+/-,1,0
3341,SD,1,0
3342,age,1,1
3343,",",1,0
3344,54,1,1
3345,+/-,1,0
3346,9yrs,1,1
3347,),1,0
3348,with,1,0
3349,a,1,0
3350,history,1,0
3351,of,1,0
3352,severe,1,1
3353,chronic,1,1
3354,heart,1,1
3355,failure,1,1
3356,(,1,0
3357,left,1,0
3358,ventricular,1,0
3359,ejection,1,0
3360,fraction,1,0
3361,of,1,0
3362,18,1,1
3363,%,1,0
3364,+/-,1,0
3365,8,1,0
3366,%,1,0
3367,),1,0
3368,.,1,0
3369,STUDY,0,0
3370,DESIGN,0,0
3371,Prospective,0,0
3372,",",0,0
3373,randomized,0,0
3374,",",0,0
3375,controlled,0,0
3376,trial,0,0
3377,.,0,0
3378,Patients,0,1
3379,were,0,0
3380,randomized,0,0
3381,into,0,0
3382,exercise,0,0
3383,and,0,0
3384,control,0,0
3385,groups,0,0
3386,.,0,0
3387,All,0,0
3388,patients,0,1
3389,underwent,0,1
3390,a,0,0
3391,clinical,0,0
3392,examination,0,0
3393,and,0,0
3394,a,0,0
3395,ramp,0,0
3396,pattern,0,0
3397,cycle,0,0
3398,exercise,0,0
3399,test,0,0
3400,before,0,0
3401,and,0,0
3402,after,0,0
3403,the,0,0
3404,observation,0,0
3405,period,0,0
3406,.,0,0
3407,The,0,0
3408,exercise,0,0
3409,group,0,0
3410,underwent,0,1
3411,a,0,0
3412,moderate-intensity,0,0
3413,(,0,0
3414,50,0,0
3415,%,0,0
3416,of,0,0
3417,peak,0,0
3418,oxygen,0,0
3419,uptake,0,0
3420,),0,0
3421,12-week,0,0
3422,training,0,0
3423,program,0,0
3424,",",0,0
3425,progressing,0,0
3426,to,0,0
3427,100,0,0
3428,minutes,0,0
3429,per,0,0
3430,week,0,0
3431,of,0,0
3432,step,0,0
3433,aerobics,0,1
3434,and,0,0
3435,50,0,1
3436,minutes,0,0
3437,per,0,0
3438,week,0,0
3439,of,0,0
3440,cycling,0,0
3441,.,0,0
3442,The,0,0
3443,control,0,0
3444,group,0,0
3445,did,0,0
3446,not,0,0
3447,perform,0,0
3448,a,0,0
3449,training,0,0
3450,program,0,0
3451,.,0,0
3452,MAIN,0,0
3453,OUTCOME,0,0
3454,MEASURES,0,0
3455,Peak,0,0
3456,oxygen,0,0
3457,uptake,0,0
3458,",",0,0
3459,peak,0,0
3460,workload,0,0
3461,",",0,0
3462,percent,0,0
3463,of,0,0
3464,predicted,0,0
3465,power,0,0
3466,ability,0,0
3467,.,0,0
3468,RESULTS,0,0
3469,Significant,0,0
3470,increases,0,0
3471,in,0,0
3472,peak,0,0
3473,oxygen,0,0
3474,uptake,0,0
3475,(,0,0
3476,15,0,0
3477,+/-,0,0
3478,3.4,0,0
3479,to,0,0
3480,18.5,0,1
3481,+/-,0,0
3482,2.9mL/kg/min,0,0
3483,;,0,0
3484,p,0,0
3485,=,0,0
3486,.001,0,0
3487,),0,0
3488,",",0,0
3489,peak,0,0
3490,workload,0,0
3491,(,0,0
3492,77,0,1
3493,+/-,0,0
3494,26,0,1
3495,to,0,0
3496,99,0,1
3497,+/-,0,0
3498,31,0,1
3499,watts,0,0
3500,;,0,0
3501,p,0,0
3502,=,0,0
3503,.000,0,0
3504,),0,0
3505,",",0,0
3506,and,0,0
3507,percent,0,0
3508,of,0,0
3509,predicted,0,0
3510,power,0,0
3511,ability,0,0
3512,(,0,0
3513,43,0,0
3514,%,0,0
3515,+/-,0,0
3516,10,0,0
3517,%,0,0
3518,to,0,0
3519,56,0,0
3520,%,0,0
3521,+/-,0,0
3522,13,0,1
3523,%,0,0
3524,;,0,0
3525,p,0,0
3526,=,0,0
3527,.000,0,0
3528,),0,0
3529,were,0,0
3530,observed,0,0
3531,in,0,0
3532,the,0,0
3533,exercise,0,0
3534,group,0,0
3535,.,0,0
3536,No,0,0
3537,significant,0,0
3538,changes,0,0
3539,in,0,0
3540,baseline,0,0
3541,parameters,0,0
3542,occurred,0,0
3543,in,0,0
3544,the,0,0
3545,control,0,0
3546,group,0,0
3547,.,0,0
3548,There,0,0
3549,were,0,0
3550,no,0,0
3551,critical,0,0
3552,changes,0,0
3553,in,0,0
3554,heart,0,1
3555,rate,0,0
3556,or,0,0
3557,blood,0,0
3558,pressure,0,0
3559,in,0,0
3560,either,0,0
3561,group,0,0
3562,.,0,0
3563,CONCLUSION,0,0
3564,Moderate-intensity,0,0
3565,step,0,0
3566,aerobics,0,0
3567,training,0,0
3568,significantly,0,0
3569,increases,0,0
3570,peak,0,0
3571,oxygen,0,0
3572,uptake,0,0
3573,and,0,0
3574,peak,0,0
3575,workloads,0,0
3576,in,0,0
3577,patients,1,1
3578,with,1,1
3579,severe,1,1
3580,chronic,1,1
3581,heart,1,1
3582,failure,1,1
3583,.,1,0
3584,Preoperative,0,1
3585,small-dose,0,0
3586,ketamine,0,0
3587,has,0,0
3588,no,0,0
3589,preemptive,0,0
3590,analgesic,0,0
3591,effect,0,0
3592,in,0,0
3593,patients,1,1
3594,undergoing,1,1
3595,total,1,1
3596,mastectomy,1,1
3597,.,1,0
3598,UNLABELLED,0,0
3599,We,0,0
3600,evaluated,0,0
3601,the,0,0
3602,preemptive,0,0
3603,analgesic,0,0
3604,effect,0,0
3605,of,0,0
3606,a,0,0
3607,small,0,0
3608,dose,0,0
3609,of,0,0
3610,ketamine,0,0
3611,given,0,0
3612,before,0,0
3613,or,0,0
3614,immediately,0,0
3615,after,0,0
3616,surgery,0,1
3617,in,0,0
3618,a,0,0
3619,randomized,0,0
3620,",",0,0
3621,double-blinded,0,0
3622,study,0,0
3623,performed,0,0
3624,in,0,0
3625,128,1,1
3626,women,1,1
3627,undergoing,1,1
3628,total,1,1
3629,mastectomy,1,1
3630,.,1,0
3631,Group,0,0
3632,1,0,0
3633,patients,0,1
3634,received,0,0
3635,ketamine,0,0
3636,0.15,0,0
3637,mg/kg,0,0
3638,as,0,0
3639,a,0,0
3640,5-mL,0,0
3641,i.v,0,0
3642,.,0,0
3643,injection,0,0
3644,5,0,0
3645,min,0,0
3646,before,0,0
3647,surgery,0,1
3648,and,0,0
3649,isotonic,0,0
3650,saline,0,0
3651,5,0,0
3652,mL,0,0
3653,i.v,0,0
3654,.,0,0
3655,at,0,0
3656,the,0,0
3657,time,0,0
3658,of,0,0
3659,skin,0,0
3660,closure,0,1
3661,.,0,0
3662,Group,0,0
3663,2,0,0
3664,received,0,0
3665,5,0,0
3666,mL,0,0
3667,i.v,0,0
3668,.,0,0
3669,of,0,0
3670,isotonic,0,0
3671,saline,0,0
3672,",",0,0
3673,then,0,0
3674,0.15,0,0
3675,mg/kg,0,0
3676,i.v,0,0
3677,.,0,1
3678,ketamine,0,0
3679,.,0,0
3680,A,0,0
3681,standard,0,0
3682,general,0,1
3683,anesthesia,0,0
3684,procedure,0,0
3685,including,0,0
3686,sufentanil,0,0
3687,was,0,0
3688,used,0,0
3689,.,0,0
3690,In,0,0
3691,the,0,0
3692,recovery,0,0
3693,room,0,0
3694,",",0,0
3695,patient-controlled,0,0
3696,analgesia,0,0
3697,i.v,0,0
3698,.,0,0
3699,morphine,0,0
3700,was,0,0
3701,used,0,0
3702,for,0,0
3703,postoperative,0,0
3704,analgesia,0,0
3705,.,0,0
3706,Postoperative,0,0
3707,pain,0,0
3708,was,0,0
3709,assessed,0,0
3710,by,0,0
3711,measuring,0,0
3712,morphine,0,0
3713,consumption,0,0
3714,and,0,0
3715,visual,0,0
3716,analog,0,0
3717,scale,0,0
3718,pain,0,0
3719,scores,0,0
3720,.,0,0
3721,No,0,0
3722,significant,0,0
3723,intergroup,0,0
3724,differences,0,0
3725,were,0,0
3726,seen,0,0
3727,in,0,0
3728,the,0,0
3729,pain,0,0
3730,scores,0,0
3731,.,0,1
3732,Patient-controlled,0,0
3733,analgesia,0,0
3734,morphine,0,0
3735,consumption,0,0
3736,was,0,0
3737,lower,0,0
3738,during,0,0
3739,the,0,0
3740,first,0,0
3741,2,0,0
3742,h,0,0
3743,after,0,0
3744,surgery,0,1
3745,in,0,0
3746,patients,0,1
3747,given,0,0
3748,ketamine,0,0
3749,at,0,0
3750,the,0,0
3751,time,0,0
3752,of,0,0
3753,skin,0,0
3754,closure,0,1
3755,.,0,0
3756,No,0,0
3757,patient,0,0
3758,complained,0,0
3759,of,0,0
3760,hallucinations,0,0
3761,or,0,1
3762,nightmares,0,1
3763,.,0,0
3764,The,0,0
3765,incidence,0,0
3766,of,0,0
3767,adverse,0,0
3768,effects,0,0
3769,was,0,0
3770,not,0,0
3771,different,0,0
3772,between,0,0
3773,the,0,0
3774,two,0,0
3775,groups,0,0
3776,.,0,0
3777,In,0,0
3778,conclusion,0,0
3779,",",0,0
3780,administering,0,0
3781,ketamine,0,0
3782,at,0,0
3783,the,0,0
3784,end,0,0
3785,of,0,0
3786,surgery,0,0
3787,is,0,0
3788,more,0,0
3789,effective,0,0
3790,in,0,0
3791,reducing,0,0
3792,morphine,0,0
3793,consumption,0,0
3794,than,0,0
3795,it,0,0
3796,is,0,0
3797,when,0,0
3798,given,0,0
3799,before,0,0
3800,surgery,0,1
3801,.,0,0
3802,IMPLICATIONS,0,0
3803,We,0,0
3804,administered,0,0
3805,the,0,0
3806,same,0,0
3807,small,0,0
3808,dose,0,0
3809,of,0,0
3810,ketamine,0,0
3811,before,0,0
3812,or,0,0
3813,after,0,0
3814,surgery,0,1
3815,.,0,0
3816,The,0,0
3817,preoperative,0,0
3818,administration,0,0
3819,of,0,0
3820,0.15,0,0
3821,mg/kg,0,0
3822,ketamine,0,0
3823,in,0,0
3824,patients,1,1
3825,undergoing,1,1
3826,total,1,1
3827,mastectomy,1,1
3828,did,0,0
3829,not,0,0
3830,elicit,0,0
3831,a,0,0
3832,preemptive,0,0
3833,analgesic,0,0
3834,effect,0,0
3835,.,0,0
3836,Ketamine,0,0
3837,given,0,0
3838,at,0,0
3839,closure,0,0
3840,reduced,0,0
3841,the,0,0
3842,patient-controlled,0,0
3843,analgesia,0,0
3844,morphine,0,0
3845,requirement,0,0
3846,in,0,0
3847,the,0,0
3848,first,0,0
3849,2,0,0
3850,h,0,0
3851,after,0,0
3852,surgery,0,1
3853,.,0,0
3854,The,0,0
3855,effect,0,0
3856,of,0,0
3857,Cys,0,1
3858,LT1,0,0
3859,receptor,0,0
3860,blockade,0,0
3861,on,0,0
3862,airway,1,0
3863,responses,1,0
3864,to,1,0
3865,allergen,1,0
3866,.,1,0
3867,STUDY,0,0
3868,OBJECTIVE,0,0
3869,To,0,0
3870,evaluate,0,0
3871,the,0,0
3872,effect,0,0
3873,of,0,0
3874,a,0,0
3875,potent,0,0
3876,experimental,0,0
3877,leukotriene,0,0
3878,receptor,0,0
3879,antagonist,0,0
3880,",",0,0
3881,MK-571,0,0
3882,",",0,0
3883,on,0,0
3884,airway,1,0
3885,responses,1,0
3886,to,1,0
3887,inhaled,1,0
3888,allergen,1,0
3889,.,1,0
3890,DESIGN,0,0
3891,Randomized,0,0
3892,",",0,0
3893,double-blind,0,0
3894,",",0,0
3895,placebo-controlled,0,0
3896,",",0,0
3897,crossover,0,0
3898,trial,0,0
3899,.,0,0
3900,SETTING,0,0
3901,Clinical,0,0
3902,research,0,0
3903,center,0,1
3904,.,0,0
3905,SUBJECTS,0,0
3906,Eight,1,0
3907,male,1,1
3908,volunteers,1,1
3909,with,1,1
3910,allergic,1,1
3911,asthma,1,1
3912,.,1,0
3913,INTERVENTIONS,0,0
3914,An,0,0
3915,intravenous,0,0
3916,loading,0,0
3917,dose,0,0
3918,was,0,0
3919,followed,0,0
3920,by,0,0
3921,an,0,0
3922,8-hour,0,0
3923,infusion,0,0
3924,of,0,0
3925,MK-571,0,0
3926,or,0,0
3927,placebo,0,0
3928,",",0,0
3929,with,0,0
3930,a,0,0
3931,7-,0,0
3932,to,0,0
3933,14-day,0,0
3934,washout,0,0
3935,between,0,0
3936,treatments,0,0
3937,.,0,1
3938,Allergen,0,0
3939,challenge,0,0
3940,was,0,0
3941,performed,0,0
3942,after,0,0
3943,the,0,0
3944,loading,0,0
3945,dose,0,0
3946,and,0,0
3947,a,0,0
3948,histamine,0,0
3949,challenge,0,0
3950,was,0,0
3951,performed,0,0
3952,before,0,0
3953,and,0,0
3954,24,0,0
3955,hours,0,0
3956,after,0,0
3957,allergen,0,0
3958,.,0,0
3959,MEASUREMENTS,0,0
3960,AND,0,0
3961,MAIN,0,0
3962,RESULTS,0,0
3963,Forced,0,0
3964,expiratory,0,0
3965,volume,0,0
3966,in,0,0
3967,1,0,0
3968,second,0,0
3969,was,0,0
3970,measured,0,0
3971,serially,0,0
3972,.,0,0
3973,MK-571,0,0
3974,provided,0,0
3975,about,0,0
3976,50,0,0
3977,%,0,0
3978,protection,0,0
3979,during,0,0
3980,maximum,0,0
3981,early,0,1
3982,and,0,0
3983,late,0,1
3984,responses,0,0
3985,compared,0,0
3986,with,0,1
3987,placebo,0,0
3988,(,0,0
3989,p=0.005,0,0
3990,),0,0
3991,",",0,0
3992,but,0,0
3993,airway,0,0
3994,obstruction,0,1
3995,persisted,0,0
3996,8-24,0,0
3997,hours,0,0
3998,after,0,0
3999,allergen,0,0
4000,on,0,0
4001,both,0,0
4002,treatment,0,0
4003,days,0,0
4004,.,0,0
4005,Airway,0,0
4006,responsiveness,0,0
4007,to,0,0
4008,histamine,0,0
4009,was,0,0
4010,not,0,0
4011,significantly,0,0
4012,attenuated,0,0
4013,at,0,0
4014,24,0,0
4015,hours,0,0
4016,.,0,1
4017,CONCLUSION,0,0
4018,Blocking,0,0
4019,Cys,0,1
4020,LT1,0,0
4021,receptors,0,0
4022,for,0,0
4023,8,0,1
4024,hours,0,0
4025,attenuated,0,0
4026,the,0,0
4027,early,0,0
4028,and,0,0
4029,late,0,1
4030,responses,0,0
4031,but,0,0
4032,did,0,0
4033,not,0,0
4034,interrupt,0,0
4035,the,0,0
4036,cascade,0,0
4037,of,0,0
4038,events,0,0
4039,leading,0,0
4040,to,0,0
4041,subsequent,0,0
4042,allergen-induced,0,0
4043,airway,0,0
4044,obstruction,0,1
4045,and,0,0
4046,hyperreactivity,0,0
4047,.,0,0
4048,Comparison,0,0
4049,of,0,0
4050,antiresorptive,0,1
4051,activities,0,0
4052,of,0,0
4053,ipriflavone,0,0
4054,",",0,0
4055,an,0,0
4056,isoflavone,0,0
4057,derivative,0,0
4058,",",0,0
4059,and,0,0
4060,elcatonin,0,0
4061,",",0,0
4062,an,0,0
4063,eel,0,0
4064,carbocalcitonin,0,0
4065,.,0,0
4066,Thirty,1,1
4067,postmenopausal,1,1
4068,women,1,1
4069,with,1,1
4070,reduced,1,0
4071,bone,1,0
4072,mineral,1,0
4073,density,1,0
4074,were,1,0
4075,divided,1,0
4076,randomly,1,1
4077,into,1,0
4078,two,1,0
4079,groups,1,0
4080,based,1,0
4081,on,1,0
4082,the,1,0
4083,chronological,1,0
4084,sequence,1,0
4085,of,1,0
4086,their,1,0
4087,first,1,0
4088,visit,1,0
4089,to,1,0
4090,the,1,0
4091,Osteoporosis,1,1
4092,Clinic,1,0
4093,of,1,0
4094,Katsuragi,1,1
4095,Hospital,1,1
4096,.,1,0
4097,Group,0,0
4098,I,0,0
4099,was,0,0
4100,given,0,0
4101,600,0,0
4102,mg,0,0
4103,ipriflavone,0,0
4104,orally,0,0
4105,daily,0,0
4106,and,0,0
4107,group,0,0
4108,II,0,0
4109,was,0,0
4110,weekly,0,0
4111,injected,0,0
4112,intramuscularly,0,0
4113,with,0,1
4114,20,0,0
4115,units,0,0
4116,elcatonin,0,0
4117,",",0,0
4118,Asu1-7,0,0
4119,eel,0,0
4120,calcitonin,0,0
4121,(,0,0
4122,carbocalcitonin,0,0
4123,),0,0
4124,.,0,0
4125,Lumbar,0,0
4126,spine,0,0
4127,BMD,0,0
4128,was,0,0
4129,measured,0,0
4130,by,0,0
4131,dual-energy,0,0
4132,X-ray,0,0
4133,absorptiometry,0,0
4134,",",0,0
4135,and,0,0
4136,trabecular,0,0
4137,bone,0,0
4138,mineral,0,0
4139,density,0,0
4140,at,0,0
4141,the,0,0
4142,distal,0,0
4143,radius,0,0
4144,",",0,0
4145,cortical,0,0
4146,bone,0,0
4147,density,0,0
4148,",",0,0
4149,and,0,0
4150,relative,0,0
4151,cortical,0,0
4152,volume,0,0
4153,at,0,0
4154,the,0,0
4155,radial,0,0
4156,diaphysis,0,0
4157,by,0,0
4158,peripheral,0,0
4159,computed,0,0
4160,tomography,0,0
4161,before,0,0
4162,the,0,0
4163,beginning,0,0
4164,of,0,0
4165,the,0,0
4166,study,0,0
4167,and,0,0
4168,at,0,0
4169,the,0,0
4170,4th,0,0
4171,",",0,0
4172,8th,0,0
4173,",",0,0
4174,and,0,0
4175,12th,0,0
4176,month,0,0
4177,.,0,0
4178,Markers,0,0
4179,of,0,0
4180,bone,0,0
4181,metabolism,0,0
4182,--,0,0
4183,serum,0,0
4184,total,0,1
4185,alkaline,0,0
4186,phosphatase,0,0
4187,",",0,0
4188,bone-specific,0,0
4189,alkaline,0,0
4190,phosphatase,0,0
4191,",",0,0
4192,tartrate-resistant,0,0
4193,acid,0,0
4194,phosphatase,0,0
4195,",",0,0
4196,osteocalcin,0,0
4197,",",0,0
4198,intact,0,0
4199,osteocalcin,0,0
4200,",",0,0
4201,PICP,0,0
4202,and,0,0
4203,ICTP,0,0
4204,",",0,0
4205,and,0,0
4206,urinary,0,0
4207,pyridinoline,0,0
4208,",",0,0
4209,deoxypyridinoline,0,0
4210,",",0,0
4211,and,0,0
4212,calcium/creatinine,0,0
4213,(,0,0
4214,Ca/Cr,0,0
4215,),0,0
4216,--,0,0
4217,were,0,0
4218,also,0,0
4219,measured,0,0
4220,at,0,0
4221,the,0,0
4222,same,0,0
4223,interval,0,0
4224,.,0,0
4225,Plasma,0,0
4226,parathyroid,0,0
4227,hormone,0,0
4228,(,0,0
4229,PTH,0,0
4230,),0,0
4231,and,0,0
4232,calcitonin,0,0
4233,(,0,0
4234,CT,0,0
4235,),0,0
4236,were,0,0
4237,measured,0,0
4238,at,0,0
4239,the,0,0
4240,same,0,0
4241,time,0,0
4242,.,0,0
4243,Radial,0,0
4244,trabecular,0,0
4245,bone,0,0
4246,density,0,0
4247,showed,0,0
4248,a,0,0
4249,significantly,0,0
4250,higher,0,0
4251,rate,0,0
4252,of,0,0
4253,increase,0,0
4254,in,0,0
4255,group,0,0
4256,I,0,0
4257,(,0,0
4258,ipriflavone,0,0
4259,group,0,0
4260,),0,0
4261,than,0,0
4262,in,0,0
4263,group,0,0
4264,II,0,1
4265,(,0,0
4266,elcatonin,0,0
4267,group,0,0
4268,),0,0
4269,at,0,0
4270,the,0,0
4271,4th,0,0
4272,month,0,0
4273,",",0,0
4274,whereas,0,0
4275,lumbar,0,0
4276,spine,0,0
4277,BMD,0,0
4278,showed,0,0
4279,more,0,0
4280,pronounced,0,0
4281,increase,0,0
4282,in,0,0
4283,the,0,0
4284,elcatonin,0,0
4285,group,0,0
4286,than,0,0
4287,in,0,0
4288,the,0,0
4289,ipriflavone,0,0
4290,group,0,0
4291,throughout,0,0
4292,the,0,0
4293,study,0,0
4294,period,0,0
4295,.,0,0
4296,Bone,0,0
4297,metabolism,0,0
4298,markers,0,0
4299,tended,0,0
4300,to,0,0
4301,decline,0,0
4302,in,0,0
4303,both,0,0
4304,groups,0,0
4305,.,0,0
4306,Total,0,0
4307,and,0,0
4308,intact,0,0
4309,osteocalcin,0,0
4310,showed,0,0
4311,a,0,0
4312,significant,0,0
4313,fall,0,0
4314,from,0,0
4315,the,0,0
4316,baseline,0,0
4317,throughout,0,0
4318,the,0,0
4319,study,0,0
4320,period,0,0
4321,only,0,0
4322,in,0,0
4323,the,0,0
4324,ipriflavone,0,0
4325,group,0,0
4326,.,0,0
4327,Urine,0,0
4328,pyridinoline,0,0
4329,and,0,0
4330,deoxypyridinoline,0,0
4331,showed,0,0
4332,a,0,0
4333,significant,0,0
4334,fall,0,0
4335,from,0,0
4336,the,0,0
4337,baseline,0,0
4338,at,0,0
4339,the,0,0
4340,12th,0,0
4341,month,0,0
4342,only,0,0
4343,in,0,0
4344,the,0,0
4345,ipriflavone,0,0
4346,group,0,0
4347,.,0,0
4348,On,0,0
4349,comparing,0,0
4350,bone,0,0
4351,gainers,0,0
4352,with,0,1
4353,increase,0,0
4354,of,0,0
4355,lumbar,0,0
4356,spine,0,0
4357,BMD,0,1
4358,by,0,0
4359,2,0,0
4360,%,0,0
4361,or,0,0
4362,more,0,0
4363,with,0,1
4364,bone,0,0
4365,losers,0,0
4366,with,0,1
4367,a,0,0
4368,decrease,0,0
4369,by,0,0
4370,2,0,0
4371,%,0,0
4372,or,0,0
4373,more,0,0
4374,",",0,0
4375,only,0,0
4376,urine,0,0
4377,Ca/Cr,0,0
4378,was,0,0
4379,significantly,0,0
4380,different,0,0
4381,",",0,0
4382,lower,0,0
4383,in,0,0
4384,the,0,0
4385,former,0,0
4386,than,0,0
4387,in,0,0
4388,the,0,0
4389,latter,0,0
4390,",",0,0
4391,despite,0,0
4392,the,0,0
4393,general,0,1
4394,tendency,0,0
4395,for,0,0
4396,bone,0,0
4397,resorption,0,0
4398,markers,0,0
4399,to,0,0
4400,decrease,0,0
4401,in,0,0
4402,bone,0,0
4403,gainers,0,0
4404,and,0,0
4405,to,0,0
4406,increase,0,0
4407,in,0,0
4408,bone,0,0
4409,losers,0,0
4410,.,0,1
4411,Clinical,0,0
4412,effects,0,0
4413,of,0,0
4414,root,0,0
4415,instrumentation,0,0
4416,using,0,0
4417,conventional,0,0
4418,steel,0,0
4419,or,0,0
4420,non-tooth,0,0
4421,substance,0,0
4422,removing,0,0
4423,plastic,0,0
4424,curettes,0,0
4425,during,0,0
4426,supportive,0,0
4427,periodontal,0,1
4428,therapy,0,0
4429,(,0,0
4430,SPT,0,0
4431,),0,0
4432,.,0,0
4433,Although,0,0
4434,root,0,0
4435,instrumentation,0,0
4436,has,0,0
4437,been,0,0
4438,accepted,0,0
4439,as,0,0
4440,the,0,0
4441,most,0,0
4442,important,0,0
4443,cause-related,0,0
4444,treatment,0,0
4445,of,0,0
4446,periodontal,1,0
4447,diseases,1,1
4448,",",0,0
4449,repeated,0,0
4450,scaling,0,0
4451,and,0,0
4452,root,0,0
4453,planing,0,0
4454,may,0,0
4455,over,0,0
4456,time,0,0
4457,result,0,0
4458,in,0,0
4459,substantive,0,0
4460,loss,0,0
4461,of,0,0
4462,tooth,0,0
4463,substance,0,0
4464,and,0,0
4465,increased,0,0
4466,sensitivity,0,0
4467,of,0,0
4468,the,0,0
4469,teeth,0,1
4470,.,0,0
4471,In,0,0
4472,an,0,0
4473,effort,0,0
4474,to,0,0
4475,minimize,0,0
4476,these,0,0
4477,side,0,0
4478,effects,0,0
4479,of,0,0
4480,therapy,0,0
4481,",",0,0
4482,non-root,0,0
4483,substance,0,0
4484,removing,0,0
4485,curettes,0,0
4486,have,0,0
4487,been,0,0
4488,developed,0,0
4489,.,0,0
4490,However,0,0
4491,",",0,0
4492,the,0,0
4493,clinical,0,0
4494,effects,0,0
4495,of,0,0
4496,such,0,0
4497,plastic,0,1
4498,curettes,0,0
4499,with,0,1
4500,regard,0,0
4501,to,0,0
4502,the,0,0
4503,control,0,0
4504,of,0,0
4505,the,0,0
4506,periodontal,0,0
4507,infection,0,0
4508,has,0,0
4509,not,0,0
4510,yet,0,0
4511,been,0,0
4512,established,0,0
4513,.,0,0
4514,The,0,0
4515,aims,0,0
4516,of,0,0
4517,this,0,0
4518,study,0,0
4519,were,0,0
4520,",",0,0
4521,therefore,0,0
4522,",",0,0
4523,to,0,0
4524,compare,0,0
4525,the,0,0
4526,effects,0,0
4527,of,0,0
4528,root,0,0
4529,instrumentation,0,0
4530,using,0,0
4531,plastic,0,0
4532,curettes,0,0
4533,(,0,0
4534,Universal,0,0
4535,Perio,0,1
4536,Soft,0,0
4537,Scaler,0,0
4538,",",0,0
4539,Hawe-Neos,0,1
4540,Dental,0,0
4541,",",0,0
4542,Bioggio,0,1
4543,",",0,0
4544,TI,0,0
4545,",",0,0
4546,Switzerland,0,1
4547,),0,0
4548,versus,0,0
4549,conventional,0,0
4550,steel,0,0
4551,curettes,0,0
4552,on,0,0
4553,the,0,0
4554,periodontal,0,0
4555,conditions,0,0
4556,during,0,0
4557,supportive,0,0
4558,periodontal,0,1
4559,therapy,0,0
4560,.,0,1
4561,40,1,0
4562,subjects,1,1
4563,participated,1,1
4564,in,0,0
4565,this,0,0
4566,parallel,0,0
4567,",",0,0
4568,randomized,0,0
4569,",",0,0
4570,double,0,0
4571,blind,0,0
4572,",",0,0
4573,prospective,0,0
4574,longitudinal,0,1
4575,clinical,0,0
4576,study,0,0
4577,following,0,0
4578,active,1,0
4579,peridontal,1,0
4580,therapy,1,0
4581,.,1,1
4582,20,1,0
4583,subjects,1,1
4584,served,1,0
4585,as,1,0
4586,a,1,0
4587,control,1,0
4588,group,1,0
4589,and,1,0
4590,were,1,0
4591,treated,1,0
4592,with,1,1
4593,conventional,1,0
4594,steel,1,0
4595,curettes,1,0
4596,during,1,0
4597,a,1,0
4598,supportive,1,0
4599,periodontal,1,0
4600,care,1,0
4601,visit,1,0
4602,(,1,0
4603,SPT,1,0
4604,),1,0
4605,.,1,0
4606,The,0,0
4607,other,0,0
4608,20,1,0
4609,subjects,1,1
4610,",",0,0
4611,the,0,0
4612,experimental,0,0
4613,group,0,0
4614,",",0,0
4615,were,0,0
4616,treated,0,0
4617,using,0,0
4618,plastic,0,0
4619,curettes,0,0
4620,during,0,0
4621,a,0,0
4622,similar,0,0
4623,SPT,0,0
4624,visit,0,0
4625,.,0,0
4626,Clinical,0,0
4627,parameters,0,0
4628,",",0,0
4629,such,0,0
4630,as,0,0
4631,bleeding,1,0
4632,on,1,0
4633,probing,1,0
4634,(,1,0
4635,BOP,1,0
4636,),1,0
4637,and,1,0
4638,probing,1,0
4639,pocket,1,0
4640,depth,1,0
4641,(,1,0
4642,PPD,1,1
4643,),1,0
4644,",",0,0
4645,were,0,0
4646,assessed,0,0
4647,at,0,0
4648,baseline,0,0
4649,and,0,0
4650,3-6,0,1
4651,months,0,0
4652,later,0,0
4653,at,0,0
4654,the,0,0
4655,next,0,0
4656,regular,0,0
4657,SPT,0,1
4658,visit,0,0
4659,.,0,0
4660,In,0,0
4661,addition,0,0
4662,",",0,0
4663,the,0,0
4664,BOP,0,0
4665,percentage,0,0
4666,was,0,0
4667,determined,0,0
4668,10,0,0
4669,days,0,0
4670,following,0,0
4671,baseline,0,0
4672,.,0,0
4673,The,0,0
4674,results,0,0
4675,showed,0,0
4676,that,0,0
4677,there,0,0
4678,were,0,0
4679,no,0,0
4680,statistically,0,0
4681,significant,0,0
4682,differences,0,0
4683,between,0,0
4684,the,0,0
4685,2,0,0
4686,treatment,0,0
4687,modalities,0,0
4688,regarding,0,0
4689,BOP,0,1
4690,and,0,0
4691,PPD,0,1
4692,at,0,0
4693,any,0,0
4694,observation,0,0
4695,time,0,0
4696,.,0,0
4697,Both,0,0
4698,treatments,0,0
4699,were,0,0
4700,effective,0,0
4701,in,0,0
4702,reducing,0,0
4703,the,0,0
4704,BOP,0,0
4705,percentage,0,0
4706,which,0,0
4707,ranged,0,0
4708,from,0,0
4709,17-42,0,1
4710,%,0,0
4711,at,0,0
4712,baseline,0,0
4713,by,0,0
4714,about,0,0
4715,40,0,1
4716,%,0,0
4717,after,0,0
4718,10,0,0
4719,days,0,0
4720,(,0,0
4721,mean,0,1
4722,BOP,0,1
4723,baseline,0,0
4724,:,0,1
4725,26,0,0
4726,%,0,0
4727,",",0,0
4728,mean,0,0
4729,BOP,0,0
4730,after,0,0
4731,10,0,1
4732,days,0,0
4733,:,0,1
4734,16,0,1
4735,%,0,0
4736,),0,0
4737,.,0,0
4738,This,0,0
4739,clinical,0,0
4740,study,0,0
4741,suggests,0,0
4742,that,0,0
4743,non-root,0,0
4744,substance,0,0
4745,removing,0,0
4746,curettes,0,0
4747,may,0,0
4748,be,0,0
4749,valuable,0,0
4750,instruments,0,0
4751,for,0,0
4752,periodontally,0,1
4753,treated,0,1
4754,patients,0,1
4755,during,0,0
4756,maintenance,0,0
4757,care,0,0
4758,",",0,0
4759,thus,0,0
4760,minimizing,0,0
4761,trauma,0,1
4762,on,0,0
4763,the,0,0
4764,hard,0,0
4765,structures,0,0
4766,of,0,0
4767,the,0,0
4768,teeth,0,1
4769,.,0,0
4770,Ursodeoxycholic,0,0
4771,acid,0,0
4772,has,0,0
4773,no,0,0
4774,influence,0,0
4775,on,0,0
4776,function,0,0
4777,after,0,0
4778,restorative,0,0
4779,proctocolectomy,0,1
4780,in,0,0
4781,ulcerative,1,1
4782,colitis,1,1
4783,.,1,0
4784,BACKGROUND,0,0
4785,Poor,0,1
4786,pouch,0,0
4787,function,0,0
4788,is,0,0
4789,associated,0,0
4790,with,0,0
4791,impaired,0,0
4792,bile,0,0
4793,acid,0,0
4794,absorption,0,0
4795,and,0,0
4796,increased,0,0
4797,faecal,0,0
4798,loss,0,0
4799,of,0,0
4800,bile,0,0
4801,acids,0,0
4802,.,0,1
4803,Bile,0,0
4804,acid,0,0
4805,replacement,0,0
4806,therapy,0,0
4807,might,0,0
4808,therefore,0,0
4809,be,0,0
4810,of,0,0
4811,clinical,0,0
4812,benefit,0,0
4813,",",0,0
4814,provided,0,0
4815,that,0,0
4816,diarrhoea,0,0
4817,is,0,0
4818,not,0,0
4819,aggravated,0,0
4820,by,0,0
4821,therapy,0,0
4822,.,0,0
4823,AIM,0,0
4824,To,0,0
4825,investigate,0,0
4826,the,0,0
4827,role,0,0
4828,of,0,0
4829,exogenous,0,0
4830,bile,0,0
4831,acid,0,0
4832,therapy,0,0
4833,in,0,0
4834,patients,1,1
4835,with,1,1
4836,poor,1,1
4837,pouch,1,1
4838,function,1,0
4839,after,0,0
4840,restorative,0,0
4841,proctocolectomy,0,1
4842,for,0,0
4843,ulcerative,0,1
4844,colitis,0,1
4845,.,0,0
4846,PATIENTS,0,0
4847,AND,0,0
4848,METHODS,0,0
4849,Twenty,1,1
4850,ulcerative,1,1
4851,colitis,1,1
4852,patients,1,1
4853,with,1,1
4854,poor,1,1
4855,pouch,1,1
4856,function,1,0
4857,(,1,0
4858,score,1,0
4859,>,1,1
4860,4,1,0
4861,on,1,0
4862,a,1,0
4863,12-point,1,0
4864,score,1,0
4865,),1,0
4866,were,0,0
4867,recruited,0,1
4868,for,0,0
4869,inclusion,0,0
4870,to,0,0
4871,a,0,0
4872,prospective,0,0
4873,",",0,0
4874,randomized,0,0
4875,",",0,0
4876,double-blind,0,0
4877,crossover,0,0
4878,",",0,0
4879,placebo-controlled,0,0
4880,trial,0,0
4881,of,0,0
4882,ursodeoxycholic,0,0
4883,acid,0,0
4884,(,0,0
4885,10,0,0
4886,mg/kg,0,0
4887,per,0,0
4888,day,0,0
4889,in,0,0
4890,two,0,0
4891,divided,0,1
4892,doses,0,0
4893,for,0,0
4894,1,0,0
4895,month,0,0
4896,),0,0
4897,.,0,0
4898,RESULTS,0,0
4899,A,0,0
4900,total,1,0
4901,of,1,0
4902,16,1,1
4903,patients,1,1
4904,completed,1,1
4905,the,1,0
4906,study,1,0
4907,.,1,0
4908,There,0,0
4909,was,0,0
4910,no,0,0
4911,significant,0,0
4912,difference,0,0
4913,in,0,0
4914,the,0,0
4915,functional,0,0
4916,score,0,0
4917,or,0,0
4918,bowel,0,0
4919,frequency,0,0
4920,following,0,0
4921,treatment,0,0
4922,irrespective,0,0
4923,of,0,0
4924,whether,0,0
4925,the,0,0
4926,active,0,0
4927,treatment,0,0
4928,was,0,0
4929,given,0,0
4930,before,0,0
4931,or,0,0
4932,after,0,0
4933,placebo,0,0
4934,.,0,0
4935,CONCLUSIONS,0,0
4936,We,0,0
4937,conclude,0,0
4938,that,0,0
4939,ursodeoxycholic,0,1
4940,acid,0,0
4941,given,0,0
4942,over,0,0
4943,4,0,0
4944,weeks,0,0
4945,had,0,0
4946,no,0,0
4947,influence,0,0
4948,on,0,0
4949,functional,0,0
4950,score,0,0
4951,or,0,0
4952,bowel,0,0
4953,frequency,0,0
4954,after,0,0
4955,restorative,0,0
4956,proctocolectomy,0,1
4957,for,0,0
4958,U.C,0,0
4959,.,0,1
4960,Standard-dose,0,0
4961,lansoprazole,0,0
4962,is,0,0
4963,more,0,0
4964,effective,0,0
4965,than,0,0
4966,high-dose,0,0
4967,ranitidine,0,0
4968,in,0,0
4969,achieving,0,0
4970,endoscopic,0,0
4971,healing,0,0
4972,and,0,0
4973,symptom,0,0
4974,relief,0,0
4975,in,0,0
4976,patients,1,1
4977,with,1,1
4978,moderately,1,1
4979,severe,1,1
4980,reflux,1,1
4981,oesophagitis,1,1
4982,.,1,0
4983,The,0,0
4984,Dutch,0,0
4985,Lansoprazole,0,0
4986,Study,0,0
4987,Group,0,1
4988,.,0,0
4989,BACKGROUND,0,0
4990,In,0,0
4991,the,0,0
4992,treatment,0,0
4993,of,0,0
4994,reflux,0,0
4995,oesophagitis,0,1
4996,",",0,0
4997,H2-receptor,0,0
4998,antagonists,0,0
4999,are,0,0
5000,still,0,0
5001,widely,0,0
5002,used,0,0
5003,in,0,0
5004,spite,0,0
5005,of,0,0
5006,the,0,0
5007,apparent,0,0
5008,higher,0,0
5009,efficacy,0,0
5010,of,0,0
5011,proton,0,0
5012,pump,0,0
5013,inhibitors,0,0
5014,.,0,0
5015,In,0,0
5016,an,0,0
5017,attempt,0,0
5018,to,0,0
5019,compensate,0,0
5020,for,0,0
5021,the,0,0
5022,lower,0,0
5023,efficacy,0,0
5024,",",0,0
5025,H2-receptor,0,0
5026,antagonists,0,0
5027,are,0,0
5028,now,0,0
5029,increasingly,0,0
5030,being,0,0
5031,used,0,0
5032,at,0,0
5033,a,0,0
5034,higher,0,0
5035,dose,0,0
5036,.,0,0
5037,OBJECTIVE,0,0
5038,To,0,0
5039,assess,0,0
5040,whether,0,0
5041,or,0,0
5042,not,0,0
5043,standard-dose,0,0
5044,lansoprazole,0,0
5045,(,0,0
5046,30,0,0
5047,mg,0,0
5048,o.d,0,0
5049,.,0,0
5050,),0,0
5051,is,0,0
5052,more,0,0
5053,effective,0,0
5054,than,0,0
5055,high-dose,0,0
5056,ranitidine,0,0
5057,(,0,0
5058,300,0,0
5059,mg,0,0
5060,b.d,0,1
5061,.,0,0
5062,),0,0
5063,in,0,0
5064,moderately,0,0
5065,severe,0,1
5066,reflux,0,0
5067,oesophagitis,0,1
5068,(,0,0
5069,grades,0,1
5070,II-III,0,0
5071,),0,0
5072,.,0,0
5073,METHODS,0,0
5074,Lansoprazole,0,0
5075,or,0,0
5076,ranitidine,0,0
5077,was,0,0
5078,given,0,0
5079,to,0,0
5080,133,1,1
5081,patients,1,1
5082,for,0,0
5083,4-8,0,1
5084,weeks,0,0
5085,in,0,0
5086,a,0,0
5087,double-blind,0,0
5088,",",0,0
5089,randomized,0,0
5090,",",0,0
5091,parallel,0,0
5092,group,0,0
5093,",",0,0
5094,multicentre,0,0
5095,trial,0,0
5096,.,0,0
5097,RESULTS,0,0
5098,The,0,0
5099,percentage,0,0
5100,of,0,0
5101,patients,0,1
5102,with,0,1
5103,endoscopically-verified,0,1
5104,healing,0,0
5105,was,0,0
5106,significantly,0,0
5107,higher,0,0
5108,on,0,0
5109,lansoprazole,0,0
5110,than,0,0
5111,on,0,0
5112,ranitidine,0,0
5113,both,0,0
5114,after,0,0
5115,4,0,0
5116,weeks,0,0
5117,(,0,0
5118,79,0,1
5119,%,0,0
5120,vs.,0,0
5121,42,0,0
5122,%,0,0
5123,),0,0
5124,and,0,0
5125,8,0,0
5126,weeks,0,0
5127,(,0,0
5128,91,0,0
5129,%,0,0
5130,vs.,0,0
5131,66,0,0
5132,%,0,0
5133,),0,0
5134,",",0,0
5135,though,0,0
5136,smoking,0,0
5137,had,0,0
5138,a,0,0
5139,negative,0,0
5140,impact,0,0
5141,on,0,0
5142,oesophagitis,0,1
5143,healing,0,0
5144,with,0,1
5145,lansoprazole,0,0
5146,.,0,0
5147,Heartburn,0,0
5148,",",0,0
5149,retrosternal,0,0
5150,pain,0,0
5151,and,0,0
5152,belching,0,0
5153,improved,0,0
5154,significantly,0,0
5155,better,0,0
5156,with,0,0
5157,lansoprazole,0,0
5158,than,0,0
5159,with,0,1
5160,ranitidine,0,0
5161,",",0,0
5162,as,0,0
5163,did,0,0
5164,the,0,0
5165,patient-rated,0,0
5166,overall,0,0
5167,symptom,0,0
5168,severity,0,0
5169,.,0,0
5170,Relief,0,0
5171,of,0,0
5172,heartburn,0,0
5173,appeared,0,0
5174,somewhat,0,0
5175,faster,0,0
5176,with,0,0
5177,ranitidine,0,0
5178,",",0,0
5179,but,0,0
5180,was,0,0
5181,more,0,0
5182,pronounced,0,0
5183,with,0,0
5184,lansoprazole,0,0
5185,.,0,0
5186,The,0,0
5187,number,0,0
5188,of,0,0
5189,patients,0,1
5190,with,0,1
5191,adverse,0,0
5192,events,0,0
5193,was,0,0
5194,similar,0,0
5195,in,0,0
5196,both,0,0
5197,treatment,0,0
5198,groups,0,0
5199,.,0,1
5200,CONCLUSION,0,0
5201,Standard-dose,0,0
5202,lansoprazole,0,0
5203,is,0,0
5204,better,0,0
5205,than,0,0
5206,high-dose,0,0
5207,ranitidine,0,0
5208,in,0,0
5209,moderately,0,0
5210,severe,0,1
5211,reflux,0,1
5212,oesophagitis,0,1
5213,.,0,0
5214,Ciprofloxacin,0,0
5215,",",0,0
5216,lomefloxacin,0,0
5217,",",0,0
5218,or,0,0
5219,levofloxacin,0,0
5220,as,0,0
5221,treatment,0,0
5222,for,0,0
5223,chronic,1,1
5224,osteomyelitis,1,1
5225,.,1,0
5226,The,0,0
5227,efficacy,0,0
5228,and,0,0
5229,safety,0,0
5230,of,0,0
5231,three,0,0
5232,oral,0,0
5233,fluoroquinolones,0,0
5234,(,0,0
5235,lomefloxacin,0,0
5236,",",0,0
5237,levofloxacin,0,0
5238,",",0,0
5239,and,0,0
5240,ciprofloxacin,0,0
5241,),0,0
5242,for,0,0
5243,the,0,0
5244,treatment,0,0
5245,of,0,0
5246,chronic,0,1
5247,osteomyelitis,0,1
5248,were,0,0
5249,analyzed,0,0
5250,.,0,0
5251,Twenty-seven,1,1
5252,patients,1,1
5253,had,1,1
5254,documented,1,0
5255,infections,1,0
5256,with,1,1
5257,quinolone-sensitive,1,1
5258,organisms,1,0
5259,and,0,0
5260,received,0,0
5261,either,0,0
5262,lomefloxacin,0,0
5263,",",0,0
5264,levofloxacin,0,0
5265,",",0,0
5266,or,0,0
5267,ciprofloxacin,0,0
5268,.,0,0
5269,Levofloxacin,0,0
5270,was,0,0
5271,effective,0,0
5272,therapy,0,0
5273,for,0,0
5274,9,0,0
5275,of,0,0
5276,15,0,0
5277,(,0,0
5278,60,0,1
5279,%,0,0
5280,),0,0
5281,patients,0,1
5282,.,0,1
5283,Lomefloxacin,0,0
5284,was,0,0
5285,effective,0,0
5286,therapy,0,0
5287,for,0,0
5288,five,0,0
5289,of,0,0
5290,seven,0,1
5291,(,0,0
5292,71,0,1
5293,%,0,0
5294,),0,0
5295,patients,0,1
5296,",",0,0
5297,and,0,0
5298,ciprofloxacin,0,0
5299,was,0,0
5300,effective,0,0
5301,therapy,0,0
5302,for,0,0
5303,two,0,0
5304,of,0,0
5305,five,0,1
5306,patients,0,1
5307,(,0,0
5308,40,0,1
5309,%,0,0
5310,),0,0
5311,.,0,0
5312,Average,0,0
5313,follow-up,0,0
5314,was,0,0
5315,11.8,0,0
5316,months,0,0
5317,for,0,1
5318,patients,0,1
5319,who,0,1
5320,completed,0,1
5321,the,0,1
5322,course,0,0
5323,of,0,0
5324,therapy,0,0
5325,",",0,0
5326,and,0,0
5327,the,0,0
5328,average,0,0
5329,duration,0,0
5330,of,0,0
5331,therapy,0,0
5332,was,0,0
5333,60.6,0,0
5334,days,0,0
5335,.,0,1
5336,Gram-positive,0,0
5337,bacteria,0,0
5338,were,0,0
5339,isolated,0,0
5340,from,0,0
5341,18,0,1
5342,patients,0,1
5343,",",0,0
5344,and,0,0
5345,11,0,0
5346,patients,0,1
5347,were,0,0
5348,cured,0,0
5349,.,0,0
5350,Oral,0,0
5351,fluoroquinolones,0,0
5352,can,0,0
5353,be,0,0
5354,safe,0,0
5355,",",0,0
5356,effective,0,0
5357,therapy,0,0
5358,if,0,0
5359,they,0,0
5360,are,0,0
5361,given,0,0
5362,for,0,0
5363,a,0,0
5364,prolonged,0,0
5365,course,0,0
5366,as,0,0
5367,treatment,0,0
5368,for,0,0
5369,infections,0,0
5370,caused,0,0
5371,by,0,0
5372,susceptible,0,0
5373,gram-positive,0,0
5374,as,0,0
5375,well,0,0
5376,as,0,0
5377,gram-negative,0,0
5378,organisms,0,0
5379,and,0,0
5380,in,0,0
5381,combination,0,0
5382,with,0,1
5383,adequate,0,0
5384,surgical,0,1
5385,debridement,0,0
5386,.,0,0
5387,Partial,0,1
5388,depletion,0,0
5389,of,0,0
5390,tissue,0,0
5391,factor,0,0
5392,pathway,0,0
5393,inhibitor,0,0
5394,during,0,0
5395,subcutaneous,0,0
5396,administration,0,0
5397,of,0,0
5398,unfractionated,0,0
5399,heparin,0,0
5400,",",0,0
5401,but,0,0
5402,not,0,0
5403,with,0,0
5404,two,0,0
5405,low,0,0
5406,molecular,0,0
5407,weight,0,1
5408,heparins,0,0
5409,.,0,0
5410,Tissue,0,0
5411,factor,0,0
5412,pathway,0,0
5413,inhibitor,0,0
5414,(,0,0
5415,TFPI,0,0
5416,),0,0
5417,is,0,0
5418,released,0,0
5419,to,0,0
5420,circulating,0,0
5421,blood,0,0
5422,after,0,0
5423,intravenous,0,0
5424,(,0,0
5425,i.v,0,0
5426,.,0,0
5427,),0,0
5428,and,0,0
5429,subcutaneous,0,0
5430,(,0,0
5431,s.c.,0,0
5432,),0,0
5433,injections,0,0
5434,of,0,0
5435,heparins,0,0
5436,",",0,0
5437,and,0,0
5438,may,0,0
5439,thus,0,0
5440,contribute,0,0
5441,to,0,0
5442,the,0,0
5443,antithrombotic,0,0
5444,effect,0,0
5445,of,0,0
5446,heparins,0,0
5447,.,0,0
5448,We,0,0
5449,have,0,0
5450,recently,0,0
5451,shown,0,0
5452,that,0,0
5453,total,0,1
5454,TFPI,0,0
5455,activity,0,0
5456,",",0,0
5457,plasma,0,0
5458,free,0,0
5459,TFPI,0,0
5460,antigen,0,0
5461,",",0,0
5462,and,0,0
5463,heparin,0,0
5464,releasable,0,0
5465,TFPI,0,0
5466,were,0,0
5467,partially,0,0
5468,depleted,0,0
5469,during,0,0
5470,repeated,0,0
5471,and,0,0
5472,continuous,0,0
5473,i.v,0,0
5474,.,0,0
5475,infusion,0,0
5476,of,0,0
5477,unfractionated,0,0
5478,heparin,0,0
5479,(,0,0
5480,UFH,0,0
5481,),0,0
5482,",",0,0
5483,but,0,0
5484,not,0,0
5485,during,0,0
5486,s.c.,0,0
5487,treatment,0,0
5488,with,0,1
5489,a,0,0
5490,low,0,0
5491,molecular,0,0
5492,weight,0,0
5493,heparin,0,0
5494,(,0,0
5495,LMWH,0,0
5496,),0,0
5497,.,0,0
5498,The,0,0
5499,difference,0,0
5500,may,0,0
5501,be,0,0
5502,attributed,0,0
5503,to,0,0
5504,a,0,0
5505,different,0,0
5506,mode,0,0
5507,of,0,0
5508,action,0,0
5509,or,0,0
5510,the,0,0
5511,different,0,0
5512,mode,0,0
5513,of,0,0
5514,administration,0,0
5515,.,0,0
5516,In,0,0
5517,the,0,0
5518,present,0,0
5519,randomized,0,0
5520,cross-over,0,0
5521,study,0,0
5522,",",0,0
5523,s.c.,0,0
5524,administration,0,0
5525,of,0,0
5526,therapeutic,0,0
5527,doses,0,0
5528,of,0,0
5529,UFH,0,0
5530,was,0,0
5531,compared,0,0
5532,with,0,1
5533,s.c.,0,0
5534,administration,0,0
5535,of,0,0
5536,two,0,0
5537,LMWHs,0,0
5538,.,0,0
5539,12,1,0
5540,healthy,1,1
5541,male,1,1
5542,volunteers,1,1
5543,were,0,0
5544,treated,0,1
5545,for,0,0
5546,3,0,0
5547,d,0,0
5548,with,0,1
5549,UFH,0,0
5550,",",0,0
5551,250,0,0
5552,U/kg,0,0
5553,twice,0,0
5554,daily,0,0
5555,",",0,0
5556,dalteparin,0,0
5557,",",0,0
5558,200,0,0
5559,U/kg,0,0
5560,once,0,0
5561,daily,0,0
5562,",",0,0
5563,and,0,0
5564,enoxaparin,0,0
5565,",",0,0
5566,1.5,0,0
5567,mg/kg,0,0
5568,once,0,0
5569,daily,0,0
5570,.,0,0
5571,Six,1,1
5572,participants,1,1
5573,were,0,0
5574,also,0,0
5575,treated,0,0
5576,with,0,0
5577,UFH,0,0
5578,",",0,0
5579,300,0,0
5580,U/kg,0,0
5581,once,0,0
5582,daily,0,0
5583,.,0,0
5584,On,0,0
5585,day,0,0
5586,5,0,0
5587,a,0,0
5588,single,0,0
5589,dose,0,0
5590,of,0,0
5591,either,0,0
5592,drug,0,0
5593,was,0,0
5594,given,0,0
5595,.,0,0
5596,Peak,0,0
5597,levels,0,0
5598,of,0,0
5599,total,0,1
5600,TFPI,0,0
5601,activity,0,0
5602,and,0,0
5603,free,0,0
5604,TFPI,0,0
5605,antigen,0,0
5606,were,0,0
5607,detected,0,0
5608,1,0,0
5609,h,0,0
5610,after,0,0
5611,injection,0,0
5612,",",0,0
5613,whereas,0,0
5614,maximal,0,0
5615,prolongation,0,0
5616,of,0,0
5617,activated,0,0
5618,partial,0,0
5619,thromboplastin,0,0
5620,time,0,0
5621,(,0,0
5622,APTT,0,0
5623,),0,0
5624,and,0,0
5625,peak,0,0
5626,levels,0,0
5627,of,0,0
5628,anti-factor,0,0
5629,Xa,0,0
5630,activity,0,0
5631,and,0,0
5632,anti-factor,0,0
5633,IIa,0,0
5634,activity,0,0
5635,were,0,0
5636,detected,0,0
5637,after,0,0
5638,4,0,0
5639,h.,0,0
5640,On,0,0
5641,UFH,0,0
5642,administered,0,0
5643,twice,0,0
5644,daily,0,0
5645,",",0,0
5646,free,0,0
5647,TFPI,0,0
5648,antigen,0,0
5649,decreased,0,0
5650,by,0,0
5651,44,0,0
5652,%,0,0
5653,from,0,0
5654,baseline,0,0
5655,level,0,0
5656,before,0,0
5657,the,0,0
5658,first,0,0
5659,injection,0,0
5660,on,0,0
5661,day,0,0
5662,1,0,0
5663,to,0,0
5664,pre-injection,0,0
5665,level,0,0
5666,on,0,0
5667,day,0,0
5668,5,0,0
5669,.,0,0
5670,On,0,0
5671,UFH,0,0
5672,administered,0,0
5673,once,0,0
5674,daily,0,0
5675,",",0,0
5676,basal,0,0
5677,free,0,0
5678,TFPI,0,0
5679,antigen,0,0
5680,decreased,0,0
5681,by,0,0
5682,50,0,0
5683,%,0,0
5684,",",0,0
5685,56,0,0
5686,%,0,0
5687,and,0,0
5688,27,0,0
5689,%,0,0
5690,on,0,0
5691,day,0,0
5692,2,0,0
5693,",",0,0
5694,3,0,0
5695,and,0,0
5696,5,0,0
5697,respectively,0,0
5698,",",0,0
5699,compared,0,0
5700,with,0,0
5701,day,0,0
5702,1,0,0
5703,.,0,0
5704,Minimal,0,0
5705,depletion,0,0
5706,of,0,0
5707,TFPI,0,0
5708,was,0,0
5709,detected,0,0
5710,during,0,0
5711,treatment,0,0
5712,with,0,1
5713,LMWHs,0,0
5714,.,0,0
5715,The,0,0
5716,study,0,0
5717,demonstrates,0,0
5718,the,0,0
5719,different,0,0
5720,modes,0,0
5721,of,0,0
5722,action,0,0
5723,of,0,0
5724,LMWHs,0,0
5725,and,0,0
5726,UFH,0,0
5727,and,0,0
5728,may,0,0
5729,help,0,0
5730,to,0,0
5731,explain,0,0
5732,the,0,0
5733,superior,0,0
5734,antithrombotic,0,0
5735,efficacy,0,0
5736,of,0,0
5737,LMWHs,0,0
5738,.,0,1
5739,Early,0,0
5740,immunisation,0,0
5741,with,0,1
5742,hepatitis,0,1
5743,B,0,0
5744,vaccine,0,0
5745,:,0,1
5746,a,0,0
5747,five-year,0,0
5748,study,0,0
5749,.,0,0
5750,We,0,0
5751,evaluated,0,0
5752,the,0,0
5753,response,0,0
5754,to,0,0
5755,the,0,0
5756,recombinant,0,0
5757,Hepatitis,0,1
5758,B,0,0
5759,vaccine,0,0
5760,using,0,0
5761,an,0,0
5762,accelerated,0,0
5763,schedule,0,0
5764,versus,0,0
5765,the,0,0
5766,traditional,0,0
5767,schedule,0,0
5768,by,0,0
5769,studying,0,0
5770,the,0,0
5771,immunologic,0,0
5772,memory,0,0
5773,induced,0,0
5774,in,0,0
5775,200,1,0
5776,children,1,1
5777,with,1,1
5778,HBs-Ag,1,0
5779,negative,1,0
5780,mothers,1,1
5781,.,1,0
5782,At,0,0
5783,seroconversion,0,0
5784,",",0,0
5785,the,0,0
5786,traditional,0,0
5787,schedule,0,0
5788,presented,0,0
5789,a,0,0
5790,higher,0,0
5791,percentage,0,0
5792,of,0,0
5793,children,1,1
5794,with,1,1
5795,serum,1,0
5796,HBs-Ag,1,0
5797,concentrations,1,0
5798,over,1,0
5799,100,1,1
5800,mIU/ml,1,0
5801,than,1,0
5802,the,1,0
5803,accelerated,1,0
5804,schedule,1,0
5805,.,1,0
5806,After,0,0
5807,five,0,0
5808,years,0,1
5809,this,0,0
5810,difference,0,0
5811,was,0,0
5812,no,0,0
5813,longer,0,0
5814,statistically,0,0
5815,significant,0,0
5816,and,0,1
5817,children,1,1
5818,who,1,1
5819,presented,1,1
5820,anti-HBsAg,1,1
5821,concentrations,1,0
5822,below,1,1
5823,10,1,1
5824,mUI/ml,1,0
5825,received,0,0
5826,an,0,0
5827,additional,0,0
5828,booster,0,0
5829,dose,0,0
5830,which,0,0
5831,stimulated,0,0
5832,the,0,0
5833,antibody,0,0
5834,concentration,0,0
5835,to,0,0
5836,exceed,0,0
5837,100,0,0
5838,mIU/ml,0,0
5839,in,0,0
5840,all,0,0
5841,cases,0,0
5842,.,0,0
5843,Recombinant,0,0
5844,HBV,0,0
5845,vaccine,0,0
5846,induced,0,0
5847,better,0,0
5848,long,0,0
5849,term,0,0
5850,immunologic,0,0
5851,memory,0,0
5852,when,0,0
5853,it,0,0
5854,was,0,0
5855,administered,0,0
5856,earlier,0,0
5857,.,0,0
5858,The,0,0
5859,relationship,0,0
5860,between,0,0
5861,repetitive,0,0
5862,behaviors,0,0
5863,and,0,0
5864,growth,0,0
5865,hormone,0,0
5866,response,0,0
5867,to,0,0
5868,sumatriptan,0,0
5869,challenge,0,0
5870,in,0,0
5871,adult,1,1
5872,autistic,1,1
5873,disorder,1,1
5874,.,1,0
5875,Autism,0,0
5876,is,0,0
5877,heterogeneous,0,0
5878,with,0,0
5879,respect,0,0
5880,to,0,0
5881,clinical,0,0
5882,symptoms,0,0
5883,and,0,0
5884,etiology,0,0
5885,.,0,0
5886,To,0,0
5887,sort,0,0
5888,out,0,0
5889,this,0,0
5890,heterogeneity,0,0
5891,in,0,0
5892,autism,0,1
5893,",",0,0
5894,we,0,0
5895,investigated,0,0
5896,whether,0,0
5897,specific,0,0
5898,neurobiological,0,0
5899,markers,0,0
5900,vary,0,0
5901,in,0,0
5902,parallel,0,0
5903,to,0,0
5904,core,0,0
5905,symptomatology,0,0
5906,.,0,0
5907,Specifically,0,0
5908,",",0,0
5909,we,0,0
5910,assessed,0,0
5911,growth,0,0
5912,hormone,0,0
5913,response,0,0
5914,to,0,0
5915,the,0,0
5916,5-HT,0,0
5917,1d,0,0
5918,agonist,0,0
5919,",",0,0
5920,sumatriptan,0,0
5921,",",0,0
5922,and,0,0
5923,linked,0,0
5924,this,0,0
5925,measure,0,0
5926,of,0,0
5927,serotonergic,0,0
5928,function,0,0
5929,to,0,0
5930,the,0,0
5931,severity,0,0
5932,of,0,0
5933,repetitive,1,0
5934,behaviors,1,0
5935,in,1,0
5936,adult,1,1
5937,autistic,1,1
5938,patients,1,1
5939,.,1,1
5940,Eleven,1,0
5941,adult,1,1
5942,patients,1,1
5943,with,1,1
5944,autism,1,1
5945,or,1,0
5946,Asperger,1,1
5947,'s,1,0
5948,disorder,1,1
5949,were,1,0
5950,randomized,1,0
5951,to,0,0
5952,single,0,0
5953,dose,0,0
5954,sumatriptan,0,0
5955,(,0,0
5956,6,0,0
5957,mg,0,0
5958,SQ,0,0
5959,),0,0
5960,and,0,0
5961,placebo,0,0
5962,challenges,0,0
5963,",",0,0
5964,separated,0,0
5965,by,0,0
5966,a,0,0
5967,one-week,0,0
5968,interval,0,0
5969,.,0,0
5970,In,0,0
5971,adult,0,1
5972,autistic,0,1
5973,disorders,0,1
5974,",",0,0
5975,severity,0,0
5976,of,0,0
5977,repetitive,0,0
5978,behaviors,0,0
5979,at,0,0
5980,baseline,0,0
5981,",",0,0
5982,as,0,0
5983,measured,0,0
5984,by,0,0
5985,YBOCS-compulsion,0,0
5986,score,0,0
5987,",",0,0
5988,significantly,0,0
5989,positively,0,0
5990,correlated,0,0
5991,with,0,0
5992,both,0,0
5993,peak,0,0
5994,delta,0,0
5995,growth,0,0
5996,hormone,0,0
5997,response,0,0
5998,and,0,0
5999,area,0,0
6000,under,0,0
6001,the,0,0
6002,curve,0,0
6003,growth,0,0
6004,hormone,0,0
6005,response,0,0
6006,to,0,0
6007,sumatriptan,0,0
6008,.,0,0
6009,Thus,0,0
6010,",",0,0
6011,the,0,0
6012,severity,0,0
6013,of,0,0
6014,a,0,0
6015,specific,0,0
6016,behavioral,0,0
6017,dimension,0,0
6018,in,0,0
6019,autism,0,1
6020,(,0,0
6021,repetitive,0,0
6022,behaviors,0,0
6023,),0,0
6024,parallels,0,0
6025,the,0,0
6026,sensitivity,0,0
6027,of,0,0
6028,the,0,0
6029,5-HT,0,0
6030,1d,0,0
6031,receptor,0,0
6032,",",0,0
6033,as,0,0
6034,manifest,0,0
6035,by,0,0
6036,sumatriptan,0,0
6037,elicited,0,0
6038,GH,0,0
6039,response,0,0
6040,.,0,0
6041,Sun,1,0
6042,protection,1,0
6043,counseling,1,0
6044,for,1,0
6045,children,1,1
6046,:,1,1
6047,primary,0,0
6048,care,0,0
6049,practice,0,0
6050,patterns,0,0
6051,and,0,0
6052,effect,0,0
6053,of,0,0
6054,an,0,0
6055,intervention,0,0
6056,on,0,0
6057,clinicians,1,0
6058,.,1,1
6059,OBJECTIVES,0,0
6060,To,0,0
6061,describe,0,0
6062,current,0,0
6063,primary,0,0
6064,care,0,0
6065,sun,1,0
6066,protection,1,0
6067,advice,1,0
6068,for,1,0
6069,children,1,1
6070,and,0,0
6071,assess,0,0
6072,the,0,0
6073,effect,0,0
6074,on,0,0
6075,clinicians,0,0
6076,of,0,0
6077,an,0,0
6078,intervention,0,0
6079,to,0,0
6080,enhance,0,0
6081,their,0,0
6082,sun,0,0
6083,protection,0,0
6084,advocacy,0,0
6085,.,0,0
6086,SETTING,0,0
6087,Primary,1,0
6088,care,1,0
6089,practices,1,0
6090,caring,1,1
6091,for,1,0
6092,children,1,1
6093,in,1,0
6094,New,1,1
6095,Hampshire,1,1
6096,with,1,1
6097,special,1,0
6098,attention,1,0
6099,to,1,0
6100,clinicians,1,0
6101,serving,1,1
6102,10,1,1
6103,towns,1,1
6104,that,1,0
6105,were,1,0
6106,involved,1,0
6107,in,1,0
6108,a,1,0
6109,randomized,1,0
6110,controlled,1,0
6111,trial,1,0
6112,of,1,0
6113,the,1,0
6114,multicomponent,1,0
6115,SunSafe,1,0
6116,intervention,1,0
6117,involving,1,0
6118,schools,1,1
6119,",",1,0
6120,recreation,1,0
6121,areas,1,0
6122,",",1,0
6123,and,1,0
6124,primary,1,0
6125,care,1,1
6126,practices,1,0
6127,.,1,0
6128,DESIGN/INTERVENTION,0,0
6129,A,0,0
6130,statewide,0,0
6131,survey,0,1
6132,of,0,0
6133,all,1,0
6134,primary,1,0
6135,care,1,0
6136,clinicians,1,1
6137,serving,1,1
6138,children,1,1
6139,addressed,0,0
6140,their,0,0
6141,self-reported,0,0
6142,sun,0,0
6143,protection,0,0
6144,advocacy,0,0
6145,practices,0,1
6146,.,0,0
6147,Clinicians,1,0
6148,in,1,0
6149,10,1,1
6150,systematically,1,0
6151,selected,1,1
6152,rural,1,1
6153,towns,1,1
6154,were,0,0
6155,involved,0,0
6156,in,0,0
6157,the,0,0
6158,subsequent,0,0
6159,intervention,0,0
6160,study,0,0
6161,.,0,0
6162,The,0,0
6163,primary,0,0
6164,care,0,0
6165,intervention,0,0
6166,provided,0,0
6167,assistance,0,0
6168,to,0,0
6169,practices,0,0
6170,in,0,0
6171,establishing,0,0
6172,an,0,0
6173,office,0,1
6174,system,0,0
6175,that,0,0
6176,promoted,0,0
6177,sun,0,0
6178,protection,0,0
6179,advice,0,0
6180,to,0,0
6181,children,0,1
6182,and,0,0
6183,their,0,1
6184,parents,0,1
6185,during,0,0
6186,office,0,1
6187,visits,0,0
6188,.,0,1
6189,MAIN,0,0
6190,OUTCOME,0,0
6191,MEASURES,0,0
6192,Sun,0,0
6193,protection,0,0
6194,promotion,0,0
6195,activities,0,0
6196,of,0,0
6197,primary,0,1
6198,care,0,1
6199,clinicians,0,0
6200,as,0,0
6201,determined,0,0
6202,by,0,0
6203,their,0,0
6204,self,0,0
6205,report,0,0
6206,",",0,0
6207,research,0,0
6208,assistant,0,0
6209,observation,0,0
6210,",",0,0
6211,and,0,0
6212,parent,0,0
6213,interviews,0,0
6214,.,0,0
6215,RESULTS,0,0
6216,Of,0,0
6217,261,1,1
6218,eligible,1,1
6219,clinicians,1,0
6220,responding,1,0
6221,to,1,0
6222,the,1,0
6223,statewide,1,0
6224,survey,1,0
6225,",",0,0
6226,about,0,0
6227,half,0,0
6228,provide,0,0
6229,sun,0,0
6230,protection,0,0
6231,counseling,0,0
6232,most,0,0
6233,of,0,0
6234,the,0,0
6235,time,0,0
6236,or,0,0
6237,almost,0,0
6238,always,0,0
6239,during,0,0
6240,summer,0,0
6241,well,0,0
6242,care,0,0
6243,visits,0,0
6244,.,0,0
6245,Pediatricians,0,1
6246,do,0,0
6247,so,0,0
6248,more,0,0
6249,often,0,0
6250,than,0,0
6251,family,0,0
6252,physicians,0,1
6253,.,0,0
6254,Clinicians,0,0
6255,involved,0,0
6256,in,0,0
6257,the,0,0
6258,intervention,0,0
6259,increased,0,0
6260,their,0,0
6261,use,0,0
6262,of,0,0
6263,handouts,0,0
6264,",",0,0
6265,waiting,0,1
6266,room,0,0
6267,educational,0,0
6268,materials,0,0
6269,",",0,0
6270,and,0,0
6271,sunscreen,0,0
6272,samples,0,0
6273,.,0,0
6274,Compared,0,0
6275,with,0,0
6276,control,0,0
6277,town,0,1
6278,parents,0,1
6279,",",0,0
6280,parents,0,1
6281,in,0,0
6282,intervention,0,0
6283,towns,0,1
6284,reported,0,0
6285,an,0,0
6286,increase,0,0
6287,in,0,0
6288,clinician,0,0
6289,sun,0,0
6290,protection,0,0
6291,advice,0,0
6292,.,0,0
6293,CONCLUSIONS,0,0
6294,The,0,0
6295,SunSafe,0,0
6296,primary,0,0
6297,care,0,0
6298,intervention,0,0
6299,increased,0,0
6300,sun,0,0
6301,protection,0,0
6302,counseling,0,0
6303,activities,0,0
6304,of,0,0
6305,participating,1,1
6306,clinicians,1,0
6307,.,1,1
6308,A,0,0
6309,single-focus,0,0
6310,preventive,0,0
6311,service,0,1
6312,office,0,1
6313,system,0,0
6314,is,0,0
6315,feasible,0,0
6316,to,0,0
6317,include,0,0
6318,in,0,0
6319,community,0,1
6320,interventions,0,0
6321,to,0,0
6322,promote,0,0
6323,sun,0,0
6324,protection,0,0
6325,.,0,0
6326,Prediction,0,0
6327,of,0,0
6328,creatinine,0,0
6329,clearance,0,0
6330,from,0,0
6331,serum,0,0
6332,creatinine,0,0
6333,in,0,0
6334,patients,1,1
6335,with,1,1
6336,rheumatoid,1,1
6337,arthritis,1,1
6338,:,1,1
6339,comparison,0,0
6340,of,0,0
6341,six,0,0
6342,formulae,0,0
6343,and,0,0
6344,one,0,1
6345,nomogram,0,0
6346,.,0,0
6347,The,0,0
6348,estimation,0,0
6349,of,0,0
6350,glomerular,0,0
6351,filtration,0,0
6352,rate,0,0
6353,is,0,0
6354,important,0,0
6355,for,0,0
6356,the,0,0
6357,medical,0,0
6358,treatment,0,0
6359,of,0,0
6360,patients,1,1
6361,with,1,1
6362,rheumatoid,1,1
6363,arthritis,1,1
6364,(,1,0
6365,RA,1,0
6366,),1,0
6367,.,1,0
6368,However,0,0
6369,",",0,0
6370,the,0,0
6371,determination,0,0
6372,of,0,0
6373,endogenous,0,0
6374,creatinine,0,0
6375,clearance,0,0
6376,(,0,0
6377,Clcr,0,0
6378,),0,0
6379,from,0,0
6380,a,0,0
6381,24-h,0,0
6382,urine,0,0
6383,collection,0,0
6384,is,0,0
6385,an,0,0
6386,unreliable,0,0
6387,and,0,0
6388,time-consuming,0,0
6389,procedure,0,0
6390,.,0,0
6391,We,0,0
6392,therefore,0,0
6393,tested,0,0
6394,the,0,0
6395,accuracy,0,0
6396,of,0,0
6397,six,0,0
6398,equations,0,0
6399,and,0,0
6400,one,0,0
6401,nomogram,0,0
6402,for,0,0
6403,the,0,0
6404,prediction,0,0
6405,of,0,0
6406,Clcr,0,0
6407,from,0,0
6408,serum,0,0
6409,creatinine,0,0
6410,(,0,0
6411,Scr,0,0
6412,),0,0
6413,in,0,0
6414,38,1,1
6415,patients,1,1
6416,with,1,1
6417,RA,1,1
6418,and,1,0
6419,20,1,1
6420,controls,1,1
6421,.,1,0
6422,A,0,0
6423,positive,0,0
6424,correlation,0,0
6425,was,0,0
6426,found,0,0
6427,for,0,0
6428,all,0,0
6429,methods,0,0
6430,in,0,0
6431,the,0,0
6432,controls,0,0
6433,(,0,0
6434,r,0,0
6435,=,0,0
6436,0.83-0.94,0,0
6437,),0,0
6438,and,0,0
6439,RA,0,0
6440,patients,0,1
6441,(,0,0
6442,r,0,0
6443,=,0,0
6444,0.51-0.69,0,0
6445,),0,0
6446,.,0,0
6447,The,0,0
6448,methods,0,0
6449,did,0,0
6450,not,0,0
6451,overestimate,0,0
6452,Clcr,0,0
6453,in,0,0
6454,RA,0,0
6455,.,0,0
6456,In,0,0
6457,the,0,0
6458,RA,0,0
6459,group,0,0
6460,the,0,0
6461,simple,0,0
6462,formula,0,0
6463,published,0,0
6464,by,0,0
6465,Cockcroft,0,0
6466,[,0,0
6467,Clcr,0,0
6468,=,0,0
6469,(,0,0
6470,(,0,0
6471,140,0,1
6472,-,0,0
6473,age,0,1
6474,),0,0
6475,x,0,0
6476,body,0,0
6477,weight,0,0
6478,),0,0
6479,/,0,0
6480,(,0,0
6481,72,0,0
6482,x,0,0
6483,Scr,0,0
6484,),0,0
6485,",",0,0
6486,x,0,0
6487,0.85,0,0
6488,for,0,0
6489,females,0,1
6490,],0,0
6491,showed,0,0
6492,the,0,0
6493,best,0,0
6494,correlation,0,0
6495,with,0,0
6496,the,0,0
6497,measured,0,0
6498,Clcr,0,0
6499,.,0,0
6500,In,0,0
6501,RA,0,0
6502,the,0,0
6503,Cockroft,0,0
6504,formula,0,0
6505,can,0,0
6506,reliably,0,0
6507,be,0,0
6508,used,0,0
6509,to,0,0
6510,predict,0,0
6511,Clcr,0,0
6512,from,0,0
6513,Scr,0,1
6514,.,0,1
6515,Auditory,0,0
6516,integration,0,0
6517,training,0,0
6518,for,0,0
6519,children,1,1
6520,with,1,1
6521,autism,1,1
6522,:,1,1
6523,no,0,0
6524,behavioral,0,0
6525,benefits,0,0
6526,detected,0,0
6527,.,0,0
6528,Auditory,0,0
6529,integration,0,0
6530,training,0,0
6531,and,0,0
6532,a,0,0
6533,control,0,0
6534,treatment,0,0
6535,were,0,0
6536,provided,0,0
6537,for,0,0
6538,16,1,1
6539,children,1,1
6540,with,1,1
6541,autism,1,1
6542,in,0,0
6543,a,0,0
6544,crossover,0,0
6545,experimental,0,0
6546,design,0,0
6547,.,0,0
6548,Measures,0,0
6549,",",0,0
6550,blind,0,0
6551,to,0,0
6552,treatment,0,0
6553,order,0,0
6554,",",0,0
6555,included,0,0
6556,parent,0,0
6557,and,0,0
6558,teacher,0,0
6559,ratings,0,0
6560,of,0,0
6561,behavior,0,0
6562,",",0,0
6563,direct,0,0
6564,observational,0,1
6565,recordings,0,0
6566,",",0,0
6567,IQ,0,0
6568,",",0,0
6569,language,0,0
6570,",",0,0
6571,and,0,0
6572,social/adaptive,0,0
6573,tests,0,0
6574,.,0,1
6575,Significant,0,0
6576,differences,0,0
6577,tended,0,0
6578,to,0,0
6579,show,0,0
6580,that,0,0
6581,the,0,0
6582,control,0,0
6583,condition,0,0
6584,was,0,0
6585,superior,0,0
6586,on,0,0
6587,parent-rated,0,0
6588,measures,0,0
6589,of,0,0
6590,hyperactivity,0,0
6591,and,0,0
6592,on,0,0
6593,direct,0,0
6594,observational,0,1
6595,measures,0,0
6596,of,0,0
6597,ear-occlusion,0,1
6598,.,0,0
6599,No,0,0
6600,differences,0,0
6601,were,0,0
6602,detected,0,0
6603,on,0,0
6604,teacher-rated,0,0
6605,measures,0,0
6606,.,0,1
6607,Children,0,1
6608,'s,0,0
6609,IQs,0,0
6610,and,0,0
6611,language,0,0
6612,comprehension,0,0
6613,did,0,0
6614,not,0,0
6615,increase,0,0
6616,",",0,0
6617,but,0,0
6618,adaptive/social,0,0
6619,behavior,0,0
6620,scores,0,0
6621,and,0,0
6622,expressive,0,0
6623,language,0,0
6624,quotients,0,0
6625,decreased,0,0
6626,.,0,0
6627,The,0,0
6628,majority,0,0
6629,of,0,0
6630,parents,1,1
6631,(,0,0
6632,56,0,1
6633,%,0,0
6634,),0,0
6635,were,0,0
6636,unable,0,0
6637,to,0,0
6638,report,0,0
6639,in,0,0
6640,retrospect,0,0
6641,when,0,0
6642,their,0,0
6643,child,0,0
6644,had,0,0
6645,received,0,0
6646,auditory,0,0
6647,integration,0,0
6648,training,0,0
6649,.,0,0
6650,No,0,0
6651,individual,0,0
6652,child,1,1
6653,was,0,0
6654,identified,0,0
6655,as,0,0
6656,benefiting,0,0
6657,clinically,0,0
6658,or,0,0
6659,educationally,0,0
6660,from,0,0
6661,the,0,0
6662,treatment,0,0
6663,.,0,0
6664,Outcome,0,0
6665,of,0,0
6666,CNS,0,0
6667,disease,0,1
6668,at,0,0
6669,diagnosis,0,1
6670,in,0,0
6671,disseminated,1,1
6672,small,1,0
6673,noncleaved-cell,1,0
6674,lymphoma,1,1
6675,and,1,0
6676,B-cell,1,0
6677,leukemia,1,1
6678,:,1,1
6679,a,0,0
6680,Children,1,1
6681,'s,1,0
6682,Cancer,1,0
6683,Group,1,1
6684,study,1,0
6685,.,1,0
6686,PURPOSE,0,0
6687,To,0,0
6688,examine,0,0
6689,the,0,0
6690,impact,0,0
6691,of,0,0
6692,initial,0,0
6693,CNS,0,0
6694,involvement,0,0
6695,on,0,0
6696,outcome,0,0
6697,and,0,0
6698,patterns,0,0
6699,of,0,0
6700,failure,0,1
6701,in,0,0
6702,patients,1,1
6703,with,1,1
6704,disseminated,1,1
6705,small,1,0
6706,noncleaved-cell,1,0
6707,lymphoma,1,1
6708,and,1,0
6709,B-cell,1,0
6710,leukemia,1,1
6711,who,1,1
6712,were,1,1
6713,treated,1,1
6714,in,1,0
6715,four,1,0
6716,successive,1,1
6717,Children,1,1
6718,'s,1,1
6719,Cancer,1,0
6720,Group,1,1
6721,trials,1,0
6722,.,1,1
6723,PATIENTS,0,0
6724,AND,0,0
6725,METHODS,0,0
6726,Of,0,1
6727,462,1,1
6728,patients,1,1
6729,with,1,1
6730,disseminated,1,1
6731,disease,1,1
6732,",",1,0
6733,49,1,1
6734,(,1,0
6735,10.6,1,0
6736,%,1,0
6737,),1,0
6738,had,1,0
6739,CNS,1,0
6740,disease,1,1
6741,at,1,0
6742,diagnosis,1,1
6743,(,1,0
6744,CNS+,1,1
6745,),1,0
6746,.,1,0
6747,CNS,0,0
6748,disease,0,1
6749,included,0,1
6750,meningeal,0,1
6751,disease,0,1
6752,or,0,0
6753,CNS,0,0
6754,parenchymal,0,1
6755,masses,0,1
6756,with,0,1
6757,or,0,1
6758,without,0,1
6759,cranial,0,0
6760,neuropathies,0,0
6761,(,0,1
6762,CSF+/Mass,0,1
6763,;,0,0
6764,CNPs,0,0
6765,),0,0
6766,in,0,0
6767,36,0,1
6768,patients,0,1
6769,and,0,0
6770,isolated,0,0
6771,CNPs,0,0
6772,in,0,0
6773,13,0,0
6774,.,0,0
6775,Of,1,0
6776,the,1,0
6777,CNS+,1,0
6778,patients,1,1
6779,",",1,0
6780,28,1,1
6781,had,1,0
6782,M2,1,0
6783,(,1,0
6784,5,1,0
6785,%,1,0
6786,to,1,0
6787,25,1,0
6788,%,1,0
6789,blasts,1,0
6790,),1,0
6791,or,1,0
6792,M3,1,0
6793,(,1,0
6794,>,1,0
6795,25,1,0
6796,%,1,0
6797,blasts,1,0
6798,),1,0
6799,bone,1,0
6800,marrow,1,0
6801,involvement,1,0
6802,.,1,0
6803,All,1,0
6804,patients,1,1
6805,received,1,0
6806,protocol-based,1,0
6807,systemic,1,0
6808,and,1,0
6809,intrathecal,1,0
6810,chemotherapy,1,0
6811,.,1,0
6812,Thirty-six,0,1
6813,patients,0,1
6814,also,0,0
6815,received,0,0
6816,CNS,0,0
6817,irradiation,0,0
6818,.,0,1
6819,RESULTS,0,0
6820,Relapses,0,0
6821,occurred,0,0
6822,in,0,0
6823,21,0,1
6824,(,0,0
6825,43,0,1
6826,%,0,0
6827,),0,0
6828,of,0,0
6829,49,0,1
6830,patients,0,1
6831,",",0,0
6832,predominantly,0,0
6833,in,0,0
6834,the,0,0
6835,CNS,0,0
6836,(,0,0
6837,71,0,1
6838,%,0,0
6839,),0,0
6840,and,0,0
6841,bone,0,0
6842,marrow,0,0
6843,(,0,0
6844,52,0,0
6845,%,0,0
6846,),0,0
6847,.,0,0
6848,The,0,0
6849,3-year,0,0
6850,event-free,0,0
6851,survival,0,0
6852,+/-,0,0
6853,SE,0,0
6854,for,0,0
6855,all,0,0
6856,patients,0,1
6857,with,0,1
6858,CNS+,0,1
6859,disease,0,1
6860,was,0,0
6861,45,0,0
6862,%,0,0
6863,+/-,0,0
6864,7,0,0
6865,%,0,0
6866,.,0,0
6867,Patients,0,1
6868,with,0,1
6869,CSF+/Mass,0,0
6870,had,0,0
6871,a,0,0
6872,nominally,0,0
6873,higher,0,0
6874,treatment,0,0
6875,failure,0,1
6876,rate,0,0
6877,compared,0,0
6878,with,0,1
6879,patients,0,1
6880,with,0,1
6881,CNS-,0,0
6882,after,0,0
6883,adjusting,0,0
6884,for,0,0
6885,marrow,0,0
6886,status,0,0
6887,and,0,0
6888,lactate,0,0
6889,dehydrogenase,0,0
6890,(,0,0
6891,LDH,0,0
6892,),0,0
6893,diagnosis,0,0
6894,",",0,0
6895,with,0,0
6896,a,0,0
6897,relative,0,0
6898,failure,0,0
6899,rate,0,0
6900,(,0,0
6901,RFR,0,0
6902,),0,0
6903,of,0,0
6904,1.52,0,0
6905,(,0,0
6906,95,0,0
6907,%,0,0
6908,confidence,0,0
6909,interval,0,0
6910,[,0,0
6911,CI,0,0
6912,],0,0
6913,",",0,0
6914,0.88,0,0
6915,to,0,0
6916,2.6,0,0
6917,;,0,0
6918,P,0,0
6919,=.15,0,0
6920,),0,0
6921,.,0,0
6922,In,0,0
6923,comparison,0,0
6924,",",0,0
6925,the,0,0
6926,RFRs,0,0
6927,for,0,0
6928,patients,0,1
6929,with,0,1
6930,M2,0,0
6931,or,0,0
6932,M3,0,1
6933,marrow,0,0
6934,and,0,0
6935,for,0,0
6936,those,0,0
6937,with,0,1
6938,LDH,0,0
6939,levels,0,0
6940,greater,0,0
6941,than,0,0
6942,500,0,0
6943,IU/L,0,0
6944,after,0,0
6945,adjusting,0,0
6946,for,0,0
6947,CNS,0,0
6948,disease,0,1
6949,were,0,0
6950,1.4,0,0
6951,(,0,0
6952,95,0,0
6953,%,0,0
6954,CI,0,0
6955,",",0,0
6956,0.96,0,0
6957,to,0,0
6958,2.0,0,0
6959,;,0,0
6960,P,0,0
6961,=.029,0,0
6962,),0,0
6963,and,0,0
6964,2.2,0,0
6965,(,0,0
6966,95,0,0
6967,%,0,0
6968,CI,0,0
6969,",",0,0
6970,1.5,0,0
6971,to,0,0
6972,3.0,0,0
6973,;,0,0
6974,P,0,0
6975,<,0,0
6976,.001,0,0
6977,),0,0
6978,",",0,0
6979,respectively,0,0
6980,.,0,0
6981,The,0,0
6982,RFR,0,0
6983,for,0,0
6984,patients,0,1
6985,with,0,1
6986,isolated,0,1
6987,CNPs,0,0
6988,was,0,0
6989,0.87,0,0
6990,(,0,0
6991,95,0,0
6992,%,0,0
6993,CI,0,0
6994,",",0,0
6995,0.36,0,0
6996,to,0,0
6997,2.1,0,0
6998,;,0,0
6999,P,0,0
7000,=.76,0,0
7001,),0,0
7002,.,0,0
7003,CONCLUSION,0,0
7004,We,0,0
7005,conclude,0,0
7006,that,0,0
7007,",",0,0
7008,with,0,1
7009,the,0,0
7010,treatments,0,0
7011,used,0,0
7012,during,0,0
7013,the,0,0
7014,period,0,0
7015,covered,0,0
7016,by,0,0
7017,these,0,0
7018,studies,0,0
7019,",",0,0
7020,the,0,0
7021,presence,0,0
7022,of,0,0
7023,CSF+/Mass,0,0
7024,CNS,0,0
7025,disease,0,1
7026,at,0,0
7027,diagnosis,0,1
7028,was,0,0
7029,associated,0,0
7030,with,0,0
7031,a,0,0
7032,nominally,0,0
7033,worse,0,0
7034,outcome,0,0
7035,independent,0,0
7036,of,0,0
7037,initial,0,0
7038,bone,0,0
7039,marrow,0,0
7040,status,0,0
7041,and,0,0
7042,LDH,0,0
7043,level,0,0
7044,",",0,0
7045,but,0,0
7046,the,0,0
7047,effect,0,0
7048,was,0,0
7049,not,0,0
7050,statistically,0,0
7051,significant,0,0
7052,.,0,0
7053,A,0,0
7054,laser-powered,0,0
7055,hydrokinetic,0,0
7056,system,0,0
7057,for,0,0
7058,caries,0,1
7059,removal,0,0
7060,and,0,0
7061,cavity,0,0
7062,preparation,0,0
7063,.,0,0
7064,BACKGROUND,0,0
7065,Laser,0,0
7066,systems,0,0
7067,have,0,0
7068,been,0,0
7069,developed,0,0
7070,for,0,0
7071,the,0,0
7072,cutting,0,0
7073,of,0,0
7074,dental,0,1
7075,hard,0,0
7076,tissues,0,0
7077,.,0,0
7078,The,0,0
7079,erbium,0,0
7080,",",0,0
7081,chromium,0,0
7082,:,0,0
7083,yttrium-scandium-gallium-garnet,0,0
7084,",",0,0
7085,or,0,0
7086,Er,0,0
7087,",",0,0
7088,Cr,0,0
7089,:,0,0
7090,YSGG,0,0
7091,",",0,0
7092,laser,0,0
7093,system,0,0
7094,used,0,0
7095,in,0,0
7096,conjunction,0,0
7097,with,0,0
7098,an,0,0
7099,air-water,0,0
7100,spray,0,0
7101,has,0,0
7102,been,0,0
7103,shown,0,0
7104,to,0,0
7105,be,0,0
7106,efficacious,0,0
7107,in,0,0
7108,vitro,0,0
7109,for,0,0
7110,cavity,0,0
7111,preparation,0,0
7112,.,0,0
7113,METHODS,0,0
7114,The,0,0
7115,authors,0,0
7116,randomly,1,1
7117,selected,1,1
7118,subjects,1,1
7119,for,1,0
7120,cavity,1,0
7121,preparation,1,0
7122,with,1,1
7123,conventional,1,0
7124,air,1,0
7125,turbine/bur,1,0
7126,dental,1,1
7127,surgery,1,1
7128,or,1,0
7129,an,1,0
7130,Er,1,0
7131,",",1,0
7132,Cr,1,0
7133,:,1,1
7134,YSGG,1,0
7135,laser-powered,1,0
7136,system,1,0
7137,using,1,0
7138,a,1,0
7139,split-mouth,1,1
7140,design,1,0
7141,.,1,0
7142,They,0,0
7143,prepared,0,0
7144,Class,0,0
7145,I,0,0
7146,",",0,0
7147,III,0,0
7148,and,0,0
7149,V,0,0
7150,cavities,0,1
7151,",",0,0
7152,placed,0,0
7153,resin,0,0
7154,restorations,0,0
7155,and,0,0
7156,evaluated,0,0
7157,subjects,0,1
7158,on,0,0
7159,the,0,0
7160,day,0,0
7161,of,0,0
7162,the,0,0
7163,procedure,0,0
7164,and,0,0
7165,30,0,0
7166,days,0,0
7167,and,0,0
7168,six,0,1
7169,months,0,0
7170,postoperatively,0,0
7171,for,0,0
7172,pulp,0,0
7173,vitality,0,0
7174,",",0,0
7175,recurrent,0,1
7176,caries,0,0
7177,",",0,0
7178,pain,0,0
7179,and,0,0
7180,discomfort,0,0
7181,",",0,0
7182,and,0,0
7183,restoration,0,0
7184,retention,0,0
7185,.,0,0
7186,Sixty-seven,1,1
7187,subjects,1,1
7188,completed,1,1
7189,the,1,0
7190,study,1,0
7191,.,1,0
7192,RESULTS,0,0
7193,There,0,0
7194,were,0,0
7195,no,0,0
7196,statistical,0,0
7197,differences,0,0
7198,between,0,0
7199,the,0,0
7200,two,0,0
7201,treatment,0,0
7202,groups,0,0
7203,for,0,0
7204,the,0,0
7205,parameters,0,0
7206,measured,0,0
7207,with,0,1
7208,one,0,0
7209,exception,0,0
7210,;,0,0
7211,there,0,0
7212,was,0,0
7213,a,0,0
7214,statistically,0,0
7215,significant,0,0
7216,decrease,0,0
7217,in,0,0
7218,discomfort,0,0
7219,levels,0,0
7220,for,0,0
7221,the,0,0
7222,laser,0,0
7223,system,0,0
7224,at,0,0
7225,the,0,0
7226,time,0,0
7227,of,0,0
7228,cavity,0,0
7229,preparation,0,0
7230,for,0,1
7231,subjects,0,1
7232,who,0,1
7233,declined,0,1
7234,to,0,1
7235,receive,0,0
7236,local,0,0
7237,anesthetic,0,0
7238,.,0,0
7239,CONCLUSIONS,0,0
7240,The,0,0
7241,Er,0,0
7242,",",0,0
7243,Cr,0,0
7244,:,0,1
7245,YSGG,0,0
7246,laser,0,0
7247,system,0,0
7248,is,0,0
7249,effective,0,0
7250,for,0,0
7251,preparation,0,0
7252,of,0,0
7253,Class,0,0
7254,I,0,0
7255,",",0,0
7256,III,0,0
7257,and,0,0
7258,V,0,0
7259,cavities,0,1
7260,and,0,0
7261,resin,0,0
7262,restorations,0,0
7263,are,0,0
7264,retained,0,0
7265,by,0,0
7266,lased,0,0
7267,tooth,0,1
7268,surfaces,0,0
7269,.,0,1
7270,CLINICAL,0,0
7271,IMPLICATIONS,0,0
7272,Hard-tissue,0,0
7273,cutting,0,0
7274,lasers,0,0
7275,are,0,0
7276,being,0,0
7277,introduced,0,0
7278,for,0,0
7279,use,0,0
7280,in,0,0
7281,operative,0,0
7282,dentistry,0,1
7283,.,0,0
7284,In,0,0
7285,this,0,0
7286,study,0,0
7287,",",0,0
7288,an,0,0
7289,Er,0,0
7290,",",0,0
7291,Cr,0,0
7292,:,0,1
7293,YSGG,0,0
7294,laser,0,0
7295,has,0,0
7296,been,0,0
7297,shown,0,0
7298,to,0,0
7299,be,0,0
7300,effective,0,0
7301,for,0,0
7302,cavity,0,0
7303,preparation,0,0
7304,and,0,0
7305,restoration,0,0
7306,replacement,0,0
7307,.,0,0
7308,Atrophy,0,0
7309,and,0,0
7310,intestinal,1,1
7311,metaplasia,1,1
7312,one,0,0
7313,year,0,0
7314,after,0,0
7315,cure,0,0
7316,of,0,0
7317,H.,1,0
7318,pylori,1,1
7319,infection,1,1
7320,:,1,0
7321,a,0,0
7322,prospective,0,0
7323,",",0,0
7324,randomized,0,0
7325,study,0,0
7326,.,0,0
7327,BACKGROUND,0,0
7328,&,0,1
7329,AIMS,0,0
7330,Helicobacter,0,1
7331,pylori-infected,0,1
7332,gastric,0,0
7333,mucosa,0,1
7334,evolves,0,0
7335,through,0,0
7336,stages,0,0
7337,of,0,0
7338,chronic,0,1
7339,gastritis,0,1
7340,",",0,0
7341,intestinal,0,1
7342,metaplasia,0,1
7343,(,0,0
7344,IM,0,0
7345,),0,0
7346,",",0,0
7347,glandular,0,0
7348,atrophy,0,0
7349,(,0,0
7350,GA,0,0
7351,),0,0
7352,",",0,0
7353,and,0,0
7354,dysplasia,0,1
7355,before,0,0
7356,carcinoma,0,1
7357,develops,0,0
7358,.,0,0
7359,We,0,0
7360,studied,0,0
7361,if,0,0
7362,H.,0,0
7363,pylori,0,0
7364,eradication,0,0
7365,would,0,0
7366,alter,0,0
7367,the,0,0
7368,course,0,0
7369,of,0,0
7370,premalignant,0,1
7371,histologic,0,0
7372,changes,0,0
7373,in,0,0
7374,the,0,0
7375,stomach,0,0
7376,.,0,1
7377,METHODS,0,0
7378,Volunteers,1,1
7379,from,1,1
7380,the,1,0
7381,Yantai,1,1
7382,County,1,1
7383,in,1,0
7384,China,1,1
7385,underwent,1,1
7386,upper,1,0
7387,endoscopy,1,1
7388,with,1,1
7389,biopsy,1,0
7390,specimens,1,1
7391,obtained,1,0
7392,from,1,0
7393,the,1,0
7394,antrum,1,0
7395,and,1,0
7396,corpus,1,0
7397,.,1,0
7398,H.,1,0
7399,pylori-infected,1,1
7400,subjects,1,1
7401,were,0,0
7402,randomized,0,0
7403,to,0,0
7404,receive,0,0
7405,either,0,0
7406,a,0,0
7407,1-week,0,0
7408,course,0,0
7409,of,0,0
7410,omeprazole,0,0
7411,",",0,0
7412,amoxicillin,0,0
7413,",",0,0
7414,and,0,0
7415,clarithromycin,0,0
7416,(,0,0
7417,OAC,0,1
7418,),0,0
7419,or,0,0
7420,placebo,0,0
7421,.,0,0
7422,At,0,0
7423,1,0,0
7424,year,0,0
7425,",",0,0
7426,endoscopies,0,0
7427,with,0,1
7428,biopsies,0,1
7429,were,0,0
7430,repeated,0,0
7431,.,0,0
7432,RESULTS,0,0
7433,A,0,0
7434,total,1,0
7435,of,1,0
7436,587,1,1
7437,H.,1,1
7438,pylori-infected,1,1
7439,subjects,1,1
7440,were,1,0
7441,randomized,1,0
7442,to,1,0
7443,OAC,1,1
7444,(,0,0
7445,n,0,1
7446,=,0,0
7447,295,0,1
7448,),0,0
7449,and,0,0
7450,placebo,0,0
7451,(,0,0
7452,n,0,1
7453,=,0,0
7454,292,0,1
7455,),0,0
7456,.,0,0
7457,At,0,0
7458,1,0,0
7459,year,0,0
7460,",",0,0
7461,H.,0,0
7462,pylori,0,0
7463,was,0,0
7464,eradicated,0,0
7465,in,0,0
7466,226,0,1
7467,subjects,0,1
7468,assigned,0,1
7469,to,0,0
7470,OAC,0,1
7471,.,0,0
7472,In,0,0
7473,the,0,0
7474,placebo,0,0
7475,group,0,0
7476,",",0,0
7477,245,1,1
7478,patients,1,1
7479,remained,1,0
7480,H.,1,1
7481,pylori,1,0
7482,infected,1,1
7483,.,1,0
7484,Analysis,0,0
7485,of,0,0
7486,paired,0,0
7487,samples,0,0
7488,obtained,0,0
7489,from,0,0
7490,the,0,0
7491,same,0,0
7492,patients,0,1
7493,showed,0,0
7494,that,0,0
7495,acute,0,1
7496,and,0,0
7497,chronic,0,1
7498,gastritis,0,1
7499,decreased,0,0
7500,in,0,0
7501,both,0,0
7502,the,0,0
7503,antrum,0,0
7504,and,0,0
7505,corpus,0,0
7506,after,0,0
7507,H.,0,0
7508,pylori,0,0
7509,eradication,0,0
7510,(,0,0
7511,P,0,0
7512,<,0,0
7513,0.001,0,0
7514,),0,0
7515,and,0,0
7516,activity,0,0
7517,of,0,0
7518,IM,0,0
7519,decreased,0,0
7520,in,0,0
7521,antrum,0,1
7522,(,0,0
7523,P,0,0
7524,=,0,0
7525,0.014,0,0
7526,),0,0
7527,.,0,0
7528,In,0,0
7529,the,0,0
7530,H.,0,0
7531,pylori-infected,0,1
7532,group,0,0
7533,",",0,0
7534,antral,0,0
7535,biopsy,0,0
7536,specimens,0,0
7537,had,0,0
7538,more,0,0
7539,pronounced,0,0
7540,acute,0,0
7541,gastritis,0,1
7542,(,0,0
7543,P,0,0
7544,=,0,0
7545,0.01,0,0
7546,),0,0
7547,",",0,0
7548,whereas,0,0
7549,corpus,0,1
7550,specimens,0,1
7551,showed,0,0
7552,increased,0,0
7553,acute,0,1
7554,and,0,0
7555,chronic,0,1
7556,gastritis,0,1
7557,(,0,0
7558,P,0,0
7559,<,0,0
7560,0.001,0,0
7561,),0,0
7562,and,0,0
7563,a,0,0
7564,marginal,0,0
7565,increase,0,0
7566,in,0,0
7567,GA,0,0
7568,(,0,0
7569,P,0,0
7570,=,0,0
7571,0.052,0,0
7572,),0,0
7573,.,0,0
7574,When,0,0
7575,histologic,0,0
7576,changes,0,0
7577,were,0,0
7578,compared,0,0
7579,between,0,0
7580,the,0,0
7581,2,0,0
7582,groups,0,0
7583,",",0,0
7584,decrease,0,0
7585,in,0,0
7586,acute,0,1
7587,and,0,0
7588,chronic,0,1
7589,gastritis,0,1
7590,was,0,0
7591,more,0,0
7592,frequent,0,0
7593,after,0,0
7594,H.,0,1
7595,pylori,0,0
7596,eradication,0,0
7597,(,0,0
7598,P,0,0
7599,<,0,0
7600,0.001,0,0
7601,),0,0
7602,but,0,0
7603,changes,0,0
7604,in,0,0
7605,IM,0,1
7606,were,0,0
7607,similar,0,0
7608,.,0,0
7609,In,0,0
7610,the,0,0
7611,H.,0,0
7612,pylori-infected,0,1
7613,group,0,0
7614,",",0,0
7615,increase,0,0
7616,in,0,0
7617,GA,0,0
7618,was,0,0
7619,seen,0,0
7620,in,0,0
7621,the,0,0
7622,corpus,0,0
7623,(,0,0
7624,P,0,0
7625,=,0,0
7626,0.01,0,0
7627,),0,0
7628,.,0,0
7629,CONCLUSIONS,0,0
7630,At,0,0
7631,1,0,0
7632,year,0,0
7633,",",0,0
7634,H.,0,0
7635,pylori,0,0
7636,eradication,0,0
7637,is,0,0
7638,beneficial,0,0
7639,in,0,0
7640,preventing,0,0
7641,progression,0,0
7642,of,0,0
7643,pathologic,0,0
7644,changes,0,0
7645,of,0,0
7646,the,0,0
7647,gastric,0,0
7648,mucosa,0,1
7649,.,0,0
7650,The,0,0
7651,Finnish,1,1
7652,Diabetes,1,1
7653,Prevention,0,0
7654,Study,0,0
7655,.,0,0
7656,The,0,0
7657,aim,0,0
7658,of,0,0
7659,the,0,0
7660,Finnish,1,1
7661,Diabetes,1,1
7662,Prevention,0,0
7663,Study,0,0
7664,is,0,0
7665,to,0,0
7666,assess,0,0
7667,the,0,0
7668,efficacy,0,0
7669,of,0,0
7670,an,0,0
7671,intensive,0,0
7672,diet-exercise,0,0
7673,programme,0,0
7674,in,0,0
7675,preventing,0,0
7676,or,0,0
7677,delaying,0,0
7678,type,1,1
7679,2,1,0
7680,diabetes,1,1
7681,in,1,0
7682,individuals,1,1
7683,with,1,1
7684,impaired,1,1
7685,glucose,1,0
7686,tolerance,1,0
7687,(,1,0
7688,IGT,1,1
7689,),1,0
7690,and,0,0
7691,to,0,0
7692,evaluate,0,0
7693,the,0,0
7694,effect,0,0
7695,of,0,0
7696,the,0,0
7697,programme,0,0
7698,on,0,0
7699,the,0,0
7700,risk,0,0
7701,factors,0,0
7702,of,0,0
7703,atherosclerotic,0,1
7704,vascular,0,0
7705,diseases,0,1
7706,and,0,0
7707,the,0,0
7708,incidence,0,0
7709,of,0,0
7710,cardiovascular,0,1
7711,events,0,0
7712,.,0,0
7713,In,0,0
7714,this,0,0
7715,ongoing,0,0
7716,study,0,0
7717,",",0,0
7718,a,1,0
7719,total,1,0
7720,of,1,0
7721,523,1,1
7722,overweight,1,1
7723,subjects,1,1
7724,with,1,1
7725,IGT,1,1
7726,based,1,0
7727,on,1,0
7728,two,1,0
7729,oral,1,0
7730,glucose,1,0
7731,tolerance,1,0
7732,tests,1,0
7733,were,0,0
7734,randomized,0,0
7735,to,0,0
7736,either,0,0
7737,an,0,0
7738,intervention,1,0
7739,group,1,0
7740,or,0,0
7741,a,0,0
7742,control,1,0
7743,group,1,0
7744,.,1,0
7745,The,0,0
7746,main,0,0
7747,measure,0,0
7748,in,0,0
7749,the,0,0
7750,intervention,0,0
7751,group,0,0
7752,is,0,0
7753,individual,0,0
7754,dietary,0,0
7755,advice,0,0
7756,aimed,0,0
7757,at,0,0
7758,reducing,0,0
7759,weight,0,0
7760,and,0,0
7761,intake,0,0
7762,of,0,0
7763,saturated,0,0
7764,fat,0,0
7765,and,0,0
7766,increasing,0,0
7767,intake,0,0
7768,of,0,0
7769,dietary,0,0
7770,fibre,0,0
7771,.,0,0
7772,The,0,0
7773,intervention,0,0
7774,subjects,0,1
7775,are,0,0
7776,individually,0,0
7777,guided,0,0
7778,to,0,0
7779,increase,0,0
7780,their,0,0
7781,level,0,0
7782,of,0,0
7783,physical,0,0
7784,activity,0,0
7785,.,0,0
7786,The,0,0
7787,control,0,0
7788,group,0,0
7789,receives,0,0
7790,general,0,0
7791,information,0,0
7792,about,0,0
7793,the,0,0
7794,benefits,0,0
7795,of,0,0
7796,weight,0,0
7797,reduction,0,0
7798,",",0,0
7799,physical,0,0
7800,activity,0,0
7801,and,0,0
7802,healthy,0,1
7803,diet,0,0
7804,in,0,0
7805,the,0,0
7806,prevention,0,0
7807,of,0,0
7808,diabetes,0,1
7809,.,0,0
7810,A,0,0
7811,pilot,0,0
7812,study,0,0
7813,began,0,1
7814,in,0,0
7815,1993,0,1
7816,",",0,0
7817,and,0,0
7818,recruitment,0,0
7819,ended,0,0
7820,in,0,0
7821,1998,0,1
7822,.,0,0
7823,By,0,0
7824,the,0,0
7825,end,0,0
7826,of,0,0
7827,April,0,1
7828,1999,0,1
7829,there,0,0
7830,were,0,0
7831,65,0,1
7832,new,0,0
7833,cases,0,1
7834,of,0,0
7835,diabetes,0,1
7836,",",0,0
7837,34,0,1
7838,drop-outs,0,0
7839,and,0,0
7840,one,0,1
7841,death,0,0
7842,.,0,0
7843,The,0,0
7844,weight,0,0
7845,reduction,0,0
7846,was,0,0
7847,greater,0,0
7848,(,0,0
7849,-4.6,0,0
7850,kg,0,0
7851,),0,0
7852,at,0,0
7853,1,0,0
7854,year,0,0
7855,in,0,0
7856,the,0,0
7857,intervention,0,0
7858,group,0,0
7859,(,0,0
7860,n,0,1
7861,=,0,0
7862,152,0,1
7863,),0,0
7864,than,0,0
7865,in,0,0
7866,the,0,0
7867,control,0,0
7868,group,0,0
7869,(,0,0
7870,n,0,1
7871,=,0,0
7872,143,0,1
7873,",",0,0
7874,-0.9,0,0
7875,kg,0,0
7876,",",0,0
7877,P,0,0
7878,<,0,0
7879,0.0001,0,0
7880,),0,0
7881,",",0,0
7882,and,0,0
7883,this,0,0
7884,difference,0,0
7885,was,0,0
7886,sustained,0,0
7887,in,0,0
7888,the,0,0
7889,second,0,0
7890,year,0,0
7891,of,0,0
7892,follow-up,0,0
7893,.,0,0
7894,At,0,0
7895,1,0,0
7896,year,0,1
7897,43.4,0,0
7898,%,0,0
7899,and,0,0
7900,at,0,0
7901,2,0,0
7902,years,0,1
7903,41.8,0,1
7904,%,0,0
7905,of,0,0
7906,the,0,0
7907,intervention,0,0
7908,subjects,0,1
7909,had,0,0
7910,achieved,0,0
7911,a,0,0
7912,weight,0,0
7913,reduction,0,0
7914,of,0,0
7915,at,0,0
7916,least,0,0
7917,5,0,0
7918,kg,0,0
7919,",",0,0
7920,while,0,0
7921,the,0,0
7922,corresponding,0,0
7923,figures,0,0
7924,for,0,0
7925,the,0,0
7926,control,0,0
7927,subjects,0,1
7928,were,0,0
7929,14.0,0,0
7930,and,0,0
7931,12.0,0,0
7932,%,0,0
7933,(,0,0
7934,P,0,0
7935,<,0,0
7936,0.001,0,0
7937,between,0,0
7938,the,0,0
7939,groups,0,0
7940,),0,0
7941,.,0,0
7942,At,0,0
7943,1,0,0
7944,year,0,0
7945,the,0,0
7946,intervention,0,0
7947,group,0,0
7948,showed,0,0
7949,significantly,0,0
7950,greater,0,0
7951,reductions,0,0
7952,in,0,0
7953,2,0,0
7954,h,0,0
7955,glucose,0,0
7956,",",0,0
7957,fasting,0,0
7958,and,0,0
7959,2,0,0
7960,h,0,0
7961,insulin,0,0
7962,",",0,0
7963,systolic,0,0
7964,and,0,0
7965,diastolic,0,0
7966,blood,0,0
7967,pressure,0,0
7968,",",0,0
7969,and,0,0
7970,serum,0,0
7971,triglycerides,0,0
7972,.,0,0
7973,Most,0,0
7974,of,0,0
7975,the,0,0
7976,beneficial,0,0
7977,changes,0,0
7978,in,0,0
7979,cardiovascular,0,1
7980,risk,0,0
7981,factors,0,0
7982,were,0,0
7983,sustained,0,0
7984,for,0,0
7985,2,0,0
7986,years,0,1
7987,.,0,0
7988,These,0,0
7989,interim,0,0
7990,results,0,0
7991,of,0,0
7992,the,0,0
7993,ongoing,0,0
7994,Finnish,0,1
7995,Diabetes,0,1
7996,Prevention,0,0
7997,Study,0,0
7998,demonstrate,0,0
7999,the,0,0
8000,efficacy,0,0
8001,and,0,0
8002,feasibility,0,0
8003,of,0,0
8004,the,0,0
8005,lifestyle,0,0
8006,intervention,0,0
8007,programme,0,0
8008,.,0,0
8009,[,0,0
8010,Comparative,0,0
8011,study,0,0
8012,between,0,0
8013,5,0,0
8014,%,0,0
8015,prilocaine,0,0
8016,and,0,0
8017,2,0,0
8018,%,0,0
8019,mepivacaine,0,0
8020,by,0,0
8021,the,0,0
8022,subarachnoid,0,1
8023,route,0,0
8024,in,0,0
8025,transurethral,1,1
8026,resections,1,1
8027,],1,1
8028,.,0,0
8029,OBJECTIVE,0,0
8030,To,0,0
8031,compare,0,0
8032,the,0,0
8033,duration,0,0
8034,of,0,0
8035,spinal,0,0
8036,block,0,0
8037,with,0,1
8038,5,0,0
8039,%,0,0
8040,prilocaine,0,0
8041,and,0,0
8042,2,0,0
8043,%,0,0
8044,mepivacaine,0,0
8045,in,0,0
8046,short,1,0
8047,procedures,1,1
8048,for,1,0
8049,transurethral,1,1
8050,resection,1,1
8051,and,0,0
8052,to,0,0
8053,assess,0,0
8054,possible,0,0
8055,complications,0,0
8056,in,0,0
8057,the,0,0
8058,immediate,0,0
8059,postoperative,0,0
8060,period,0,0
8061,.,0,0
8062,MATERIAL,0,0
8063,AND,0,0
8064,METHODS,0,0
8065,Fifty-seven,1,1
8066,patients,1,1
8067,scheduled,1,1
8068,for,1,0
8069,transurethral,1,0
8070,resection,1,1
8071,of,1,0
8072,the,1,0
8073,prostate,1,1
8074,or,1,0
8075,a,1,0
8076,vesical,1,0
8077,tumor,1,0
8078,.,1,1
8079,Patients,1,1
8080,were,1,0
8081,ASA,1,0
8082,I-III,1,0
8083,",",1,0
8084,over,1,0
8085,55,1,1
8086,years,1,1
8087,of,1,0
8088,age,1,1
8089,and,0,0
8090,randomly,0,0
8091,assigned,0,0
8092,to,0,0
8093,two,0,0
8094,groups,0,0
8095,to,0,0
8096,receive,0,0
8097,5,0,0
8098,%,0,0
8099,prilocaine,0,0
8100,(,0,0
8101,1,0,0
8102,mg/kg,0,0
8103,",",0,0
8104,n,0,1
8105,=,0,0
8106,27,0,1
8107,),0,0
8108,or,0,0
8109,2,0,0
8110,%,0,0
8111,mepivacaine,0,0
8112,(,0,0
8113,0.8,0,0
8114,mg/kg,0,0
8115,",",0,0
8116,n,0,1
8117,=,0,0
8118,30,0,1
8119,),0,0
8120,.,0,0
8121,We,0,0
8122,collected,0,0
8123,data,0,0
8124,on,0,0
8125,anesthetic,0,0
8126,technique,0,0
8127,",",0,0
8128,levels,0,0
8129,of,0,0
8130,extension,0,0
8131,of,0,0
8132,motor,0,0
8133,and,0,0
8134,sensory,0,0
8135,blockades,0,0
8136,",",0,0
8137,duration,0,0
8138,of,0,0
8139,blockades,0,0
8140,and,0,0
8141,complications,0,0
8142,within,0,0
8143,the,0,0
8144,first,0,0
8145,24,0,0
8146,hours,0,0
8147,after,0,0
8148,surgery,0,1
8149,.,0,0
8150,RESULTS,0,0
8151,Demographic,0,0
8152,data,0,0
8153,",",0,0
8154,ASA,0,0
8155,classification,0,0
8156,and,0,0
8157,duration,0,0
8158,of,0,0
8159,surgery,0,1
8160,were,0,0
8161,similar,0,0
8162,in,0,0
8163,both,0,0
8164,groups,0,0
8165,.,0,0
8166,We,0,0
8167,found,0,0
8168,statistically,0,0
8169,significant,0,0
8170,differences,0,0
8171,(,0,0
8172,p,0,0
8173,<,0,0
8174,0.05,0,0
8175,),0,0
8176,in,0,0
8177,duration,0,0
8178,of,0,0
8179,sensory,0,0
8180,blockade,0,0
8181,(,0,0
8182,120.92,0,0
8183,+/-,0,0
8184,36.21,0,0
8185,min,0,0
8186,with,0,1
8187,prilocaine,0,0
8188,and,0,0
8189,145.83,0,0
8190,+/-,0,0
8191,35.81,0,0
8192,min,0,0
8193,with,0,1
8194,mepivacaine,0,0
8195,),0,0
8196,and,0,0
8197,in,0,0
8198,motor,0,0
8199,blockade,0,0
8200,(,0,0
8201,106.29,0,0
8202,+/-,0,0
8203,38.16,0,0
8204,min,0,0
8205,with,0,1
8206,prilocaine,0,0
8207,and,0,0
8208,133.16,0,0
8209,+/-,0,0
8210,42.21,0,0
8211,min,0,0
8212,with,0,1
8213,mepivacaine,0,0
8214,),0,0
8215,.,0,0
8216,Five,0,0
8217,cases,0,0
8218,of,0,0
8219,hypotension,0,0
8220,and,0,0
8221,4,0,0
8222,of,0,0
8223,bradycardia,0,0
8224,occurred,0,0
8225,in,0,0
8226,each,0,0
8227,group,0,0
8228,and,0,0
8229,one,0,0
8230,patient,0,0
8231,in,0,0
8232,the,0,0
8233,mepivacaine,0,0
8234,group,0,0
8235,suffered,0,0
8236,slight,0,0
8237,postoperative,0,0
8238,cephalea,0,0
8239,.,0,0
8240,CONCLUSIONS,0,0
8241,Both,0,0
8242,local,0,0
8243,anesthetics,0,0
8244,offer,0,0
8245,good,0,0
8246,surgical,0,1
8247,conditions,0,0
8248,with,0,1
8249,hemodynamic,0,0
8250,stability,0,0
8251,and,0,0
8252,few,0,0
8253,complications,0,0
8254,.,0,0
8255,The,0,0
8256,duration,0,0
8257,of,0,0
8258,sensory,0,0
8259,and,0,0
8260,motor,0,0
8261,blockade,0,0
8262,is,0,0
8263,shorter,0,0
8264,with,0,0
8265,prilocaine,0,0
8266,than,0,0
8267,with,0,0
8268,mepivacaine,0,0
8269,",",0,0
8270,making,0,0
8271,prilocaine,0,0
8272,more,0,0
8273,appropriate,0,0
8274,for,0,0
8275,short,0,1
8276,interventions,0,0
8277,.,0,1
8278,Combination,0,0
8279,hydrocodone,0,0
8280,and,0,0
8281,ibuprofen,0,0
8282,versus,0,0
8283,combination,0,0
8284,codeine,0,0
8285,and,0,0
8286,acetaminophen,0,0
8287,for,0,0
8288,the,0,0
8289,treatment,1,0
8290,of,1,0
8291,chronic,1,1
8292,pain,1,0
8293,.,1,0
8294,OBJECTIVE,0,0
8295,The,0,0
8296,objective,0,0
8297,of,0,0
8298,this,0,0
8299,study,0,0
8300,was,0,0
8301,to,0,0
8302,compare,0,0
8303,the,0,0
8304,effectiveness,0,0
8305,of,0,0
8306,combination,0,0
8307,hydrocodone,0,0
8308,7.5,0,0
8309,mg,0,0
8310,and,0,0
8311,ibuprofen,0,0
8312,200,0,0
8313,mg,0,0
8314,with,0,0
8315,that,0,0
8316,of,0,0
8317,combination,0,0
8318,codeine,0,0
8319,30,0,0
8320,mg,0,0
8321,and,0,0
8322,acetaminophen,0,0
8323,300,0,0
8324,mg,0,0
8325,for,0,0
8326,the,0,0
8327,treatment,0,0
8328,of,0,0
8329,chronic,0,1
8330,pain,0,0
8331,.,0,0
8332,BACKGROUND,0,0
8333,Hydrocodone,0,0
8334,7.5,0,0
8335,mg,0,0
8336,with,0,1
8337,ibuprofen,0,0
8338,200,0,0
8339,mg,0,0
8340,is,0,0
8341,the,0,0
8342,only,0,0
8343,approved,0,0
8344,fixed-dose,0,0
8345,combination,0,0
8346,analgesic,0,0
8347,containing,0,0
8348,an,0,0
8349,opioid,0,0
8350,and,0,0
8351,ibuprofen,0,0
8352,.,0,0
8353,METHODS,0,0
8354,In,0,0
8355,this,0,0
8356,randomized,0,0
8357,",",0,0
8358,parallel-group,0,0
8359,",",0,0
8360,double-blind,0,0
8361,",",0,0
8362,repeated-dose,0,0
8363,",",0,0
8364,active-comparator,0,0
8365,",",0,0
8366,4-week,0,0
8367,",",0,0
8368,multicenter,0,0
8369,study,0,0
8370,",",0,0
8371,469,1,0
8372,patients,1,1
8373,were,0,0
8374,randomly,0,1
8375,assigned,0,0
8376,to,0,0
8377,receive,0,0
8378,a,0,0
8379,1-tablet,0,0
8380,(,0,0
8381,n,0,1
8382,=,0,0
8383,156,0,1
8384,),0,0
8385,or,0,0
8386,2-tablet,0,0
8387,(,0,0
8388,n,0,1
8389,=,0,0
8390,153,0,1
8391,),0,0
8392,dose,0,0
8393,of,0,0
8394,combination,0,0
8395,hydrocodone,0,0
8396,7.5,0,0
8397,mg,0,0
8398,and,0,0
8399,ibuprofen,0,0
8400,200,0,0
8401,mg,0,0
8402,(,0,0
8403,HI1,0,0
8404,and,0,0
8405,HI2,0,0
8406,",",0,0
8407,respectively,0,0
8408,),0,0
8409,or,0,0
8410,a,0,0
8411,2-tablet,0,0
8412,dose,0,0
8413,of,0,0
8414,combination,0,0
8415,codeine,0,0
8416,30,0,0
8417,mg,0,0
8418,and,0,0
8419,acetaminophen,0,0
8420,300,0,0
8421,mg,0,0
8422,(,0,0
8423,CA,0,0
8424,",",0,0
8425,n,0,0
8426,=,0,0
8427,160,0,0
8428,),0,0
8429,",",0,0
8430,the,0,0
8431,active,0,0
8432,comparator,0,0
8433,",",0,0
8434,every,0,0
8435,6,0,0
8436,to,0,0
8437,8,0,0
8438,hours,0,0
8439,as,0,0
8440,needed,0,0
8441,for,0,0
8442,pain,0,0
8443,.,0,0
8444,Efficacy,0,0
8445,was,0,0
8446,measured,0,0
8447,through,0,0
8448,pain,0,0
8449,relief,0,0
8450,scores,0,0
8451,",",0,0
8452,number,0,0
8453,of,0,0
8454,daily,0,0
8455,doses,0,0
8456,of,0,0
8457,study,0,0
8458,medication,0,0
8459,",",0,0
8460,number,0,0
8461,of,0,0
8462,daily,0,0
8463,doses,0,0
8464,of,0,0
8465,supplemental,0,0
8466,analgesics,0,0
8467,",",0,0
8468,number,0,0
8469,of,0,0
8470,patients,0,1
8471,who,0,1
8472,discontinued,0,1
8473,therapy,0,1
8474,due,0,0
8475,to,0,0
8476,an,0,0
8477,unsatisfactory,0,0
8478,analgesic,0,0
8479,response,0,0
8480,",",0,0
8481,and,0,0
8482,global,0,0
8483,assessment,0,0
8484,scores,0,0
8485,.,0,0
8486,RESULTS,0,0
8487,Of,0,0
8488,the,0,0
8489,469,1,0
8490,patients,1,1
8491,",",1,0
8492,255,1,1
8493,(,1,0
8494,54.4,1,0
8495,%,1,0
8496,),1,0
8497,were,1,0
8498,female,1,1
8499,and,1,0
8500,214,1,1
8501,(,1,0
8502,45.6,1,0
8503,%,1,0
8504,),1,0
8505,were,1,0
8506,male,1,1
8507,.,1,0
8508,The,0,0
8509,mean,1,0
8510,age,1,1
8511,was,1,0
8512,51.1,1,0
8513,years,1,1
8514,.,1,1
8515,Types,1,0
8516,of,1,0
8517,chronic,1,1
8518,pain,1,0
8519,included,1,0
8520,back,1,0
8521,(,1,0
8522,214,1,1
8523,;,1,0
8524,45.6,1,0
8525,%,1,0
8526,),1,0
8527,",",1,0
8528,arthritic,1,1
8529,(,1,0
8530,145,1,1
8531,;,1,0
8532,30.9,1,0
8533,%,1,0
8534,),1,0
8535,",",1,0
8536,other,1,0
8537,musculoskeletal,1,1
8538,(,1,0
8539,65,1,1
8540,;,1,0
8541,13.9,1,0
8542,%,1,0
8543,),1,0
8544,",",1,0
8545,cancer,1,1
8546,(,1,0
8547,6,1,0
8548,;,1,0
8549,1.3,1,0
8550,%,1,0
8551,),1,0
8552,",",1,0
8553,diabetic,1,1
8554,neuropathic,1,1
8555,(,1,0
8556,3,1,0
8557,;,1,0
8558,0.6,1,0
8559,%,1,0
8560,),1,0
8561,",",1,0
8562,postherpetic,1,0
8563,neuralgic,1,0
8564,(,1,0
8565,5,1,0
8566,;,1,0
8567,1.1,1,0
8568,%,1,0
8569,),1,0
8570,",",1,0
8571,other,1,0
8572,neurologic,1,0
8573,(,1,0
8574,21,1,1
8575,;,1,0
8576,4.5,1,0
8577,%,1,0
8578,),1,0
8579,",",1,0
8580,and,1,0
8581,other,1,0
8582,unclassified,1,1
8583,chronic,1,1
8584,pain,1,0
8585,(,1,0
8586,10,1,1
8587,;,1,0
8588,2.1,1,0
8589,%,1,0
8590,),1,0
8591,.,0,0
8592,During,0,0
8593,the,0,0
8594,48,0,0
8595,hours,0,0
8596,prior,0,0
8597,to,0,0
8598,the,0,0
8599,study,0,0
8600,",",0,0
8601,351,0,1
8602,(,0,0
8603,74.8,0,0
8604,%,0,0
8605,),0,0
8606,patients,0,1
8607,had,0,0
8608,been,0,0
8609,treated,0,1
8610,with,0,0
8611,opioid,0,0
8612,or,0,0
8613,opioid-nonopioid,0,0
8614,combination,0,0
8615,analgesics,0,0
8616,.,0,0
8617,The,0,0
8618,overall,0,0
8619,mean,0,0
8620,daily,0,0
8621,pain,0,0
8622,relief,0,0
8623,score,0,0
8624,was,0,0
8625,significantly,0,0
8626,greater,0,0
8627,in,0,0
8628,the,0,0
8629,HI2,0,0
8630,group,0,0
8631,(,0,0
8632,2.25+/-0.89,0,0
8633,),0,0
8634,than,0,0
8635,in,0,0
8636,the,0,0
8637,HI1,0,0
8638,group,0,0
8639,(,0,0
8640,1.98+/-0.87,0,0
8641,),0,0
8642,(,0,0
8643,P,0,0
8644,=,0,0
8645,0.003,0,0
8646,),0,0
8647,or,0,0
8648,the,0,0
8649,CA,0,0
8650,group,0,0
8651,(,0,0
8652,1.85+/-0.96,0,0
8653,),0,0
8654,(,0,0
8655,P,0,0
8656,<,0,0
8657,0.001,0,0
8658,),0,0
8659,.,0,0
8660,The,0,0
8661,overall,0,0
8662,mean,0,0
8663,number,0,0
8664,of,0,0
8665,daily,0,0
8666,doses,0,0
8667,of,0,0
8668,study,0,0
8669,medication,0,0
8670,was,0,0
8671,significantly,0,0
8672,less,0,0
8673,in,0,0
8674,the,0,0
8675,HI2,0,0
8676,group,0,0
8677,(,0,0
8678,2.94+/-0.99,0,0
8679,),0,0
8680,than,0,0
8681,in,0,0
8682,the,0,0
8683,HI1,0,0
8684,group,0,0
8685,(,0,0
8686,3.23+/-0.76,0,0
8687,),0,0
8688,(,0,0
8689,P,0,0
8690,=,0,0
8691,0.036,0,0
8692,),0,0
8693,or,0,0
8694,the,0,0
8695,CA,0,0
8696,group,0,0
8697,(,0,0
8698,3.26+/-0.75,0,0
8699,),0,0
8700,(,0,0
8701,P,0,0
8702,=,0,0
8703,0.014,0,0
8704,),0,0
8705,.,0,0
8706,The,0,0
8707,overall,0,0
8708,mean,0,0
8709,number,0,0
8710,of,0,0
8711,daily,0,0
8712,doses,0,0
8713,of,0,0
8714,supplemental,0,1
8715,analgesics,0,0
8716,was,0,0
8717,significantly,0,0
8718,less,0,0
8719,in,0,0
8720,the,0,0
8721,HI2,0,0
8722,group,0,0
8723,(,0,0
8724,0.24+/-0.49,0,0
8725,),0,0
8726,than,0,0
8727,in,0,0
8728,the,0,0
8729,HI1,0,0
8730,group,0,0
8731,(,0,0
8732,0.34+/-0.58,0,0
8733,),0,0
8734,(,0,0
8735,P,0,0
8736,=,0,0
8737,0.021,0,0
8738,),0,0
8739,or,0,0
8740,CA,0,0
8741,group,0,0
8742,(,0,0
8743,0.49+/-0.85,0,0
8744,),0,0
8745,(,0,0
8746,P,0,0
8747,=,0,0
8748,0.010,0,0
8749,),0,0
8750,.,0,0
8751,The,0,0
8752,number,0,0
8753,of,0,0
8754,patients,0,1
8755,who,0,1
8756,discontinued,0,1
8757,treatment,0,1
8758,due,0,0
8759,to,0,0
8760,an,0,0
8761,unsatisfactory,0,0
8762,analgesic,0,0
8763,response,0,0
8764,was,0,0
8765,significantly,0,0
8766,less,0,0
8767,in,0,0
8768,the,0,0
8769,HI2,0,0
8770,group,0,0
8771,(,0,0
8772,2,0,0
8773,;,0,0
8774,1.3,0,0
8775,%,0,0
8776,),0,0
8777,than,0,0
8778,in,0,0
8779,the,0,0
8780,CA,0,0
8781,group,0,0
8782,(,0,0
8783,12,0,0
8784,;,0,0
8785,7.5,0,0
8786,%,0,0
8787,),0,0
8788,(,0,0
8789,P,0,0
8790,=,0,0
8791,0.008,0,0
8792,),0,0
8793,.,0,0
8794,HI2,0,0
8795,was,0,0
8796,more,0,0
8797,effective,0,0
8798,than,0,0
8799,HI1,0,1
8800,and,0,0
8801,CA,0,1
8802,as,0,0
8803,measured,0,0
8804,by,0,0
8805,pain,0,0
8806,relief,0,0
8807,scores,0,0
8808,for,0,0
8809,week,0,0
8810,1,0,0
8811,(,0,0
8812,P,0,0
8813,<,0,0
8814,0.001,0,0
8815,vs,0,0
8816,HI1,0,1
8817,and,0,0
8818,CA,0,1
8819,),0,0
8820,",",0,0
8821,week,0,0
8822,2,0,0
8823,(,0,0
8824,P,0,0
8825,<,0,0
8826,0.001,0,0
8827,vs,0,0
8828,HI1,0,1
8829,and,0,0
8830,CA,0,1
8831,),0,0
8832,",",0,0
8833,and,0,0
8834,week,0,0
8835,3,0,0
8836,(,0,0
8837,P,0,0
8838,=,0,0
8839,0.008,0,0
8840,vs,0,0
8841,HI1,0,1
8842,and,0,0
8843,P,0,0
8844,<,0,0
8845,0.001,0,0
8846,vs,0,0
8847,CA,0,1
8848,),0,0
8849,;,0,0
8850,daily,0,0
8851,doses,0,0
8852,of,0,0
8853,study,0,0
8854,medication,0,0
8855,for,0,0
8856,week,0,0
8857,1,0,0
8858,(,0,0
8859,P,0,0
8860,=,0,0
8861,0.019,0,0
8862,vs,0,0
8863,HI1,0,1
8864,and,0,0
8865,P,0,0
8866,=,0,0
8867,0.011,0,0
8868,vs,0,0
8869,CA,0,1
8870,),0,0
8871,;,0,0
8872,daily,0,0
8873,doses,0,0
8874,of,0,0
8875,supplemental,0,0
8876,analgesics,0,0
8877,for,0,0
8878,week,0,0
8879,1,0,0
8880,(,0,0
8881,P,0,0
8882,=,0,0
8883,0.010,0,0
8884,vs,0,0
8885,HI1,0,1
8886,and,0,0
8887,CA,0,1
8888,),0,0
8889,;,0,0
8890,and,0,0
8891,global,0,0
8892,assessment,0,0
8893,scores,0,0
8894,for,0,0
8895,week,0,0
8896,1,0,0
8897,(,0,0
8898,P,0,0
8899,=,0,0
8900,0.018,0,0
8901,vs,0,0
8902,HI1,0,1
8903,and,0,0
8904,P,0,0
8905,<,0,0
8906,0.001,0,0
8907,vs,0,0
8908,CA,0,1
8909,),0,0
8910,",",0,0
8911,week,0,0
8912,2,0,0
8913,(,0,0
8914,P,0,0
8915,=,0,0
8916,0.005,0,0
8917,vs,0,0
8918,HI1,0,1
8919,and,0,0
8920,P,0,0
8921,<,0,0
8922,0.001,0,0
8923,vs,0,0
8924,CA,0,1
8925,),0,0
8926,",",0,0
8927,and,0,0
8928,week,0,0
8929,4,0,0
8930,(,0,0
8931,P,0,0
8932,=,0,0
8933,0.013,0,0
8934,vs,0,0
8935,HI1,0,1
8936,and,0,0
8937,P,0,0
8938,=,0,0
8939,0.023,0,0
8940,vs,0,0
8941,CA,0,1
8942,),0,0
8943,.,0,0
8944,There,0,0
8945,were,0,0
8946,no,0,0
8947,significant,0,0
8948,differences,0,0
8949,between,0,0
8950,HI1,0,1
8951,and,0,0
8952,CA,0,0
8953,in,0,0
8954,any,0,0
8955,efficacy,0,0
8956,variable,0,0
8957,.,0,0
8958,There,0,0
8959,were,0,0
8960,no,0,0
8961,significant,0,0
8962,differences,0,0
8963,in,0,0
8964,the,0,0
8965,number,0,0
8966,of,0,0
8967,patients,0,1
8968,experiencing,0,1
8969,adverse,0,0
8970,events,0,0
8971,in,0,0
8972,the,0,0
8973,HI2,0,0
8974,(,0,0
8975,127,0,1
8976,;,0,0
8977,83,0,1
8978,%,0,0
8979,),0,0
8980,",",0,0
8981,HI1,0,0
8982,(,0,0
8983,124,0,1
8984,;,0,0
8985,79.5,0,0
8986,%,0,0
8987,),0,0
8988,",",0,0
8989,and,0,0
8990,CA,0,0
8991,(,0,0
8992,129,0,1
8993,;,0,0
8994,80.6,0,0
8995,%,0,0
8996,),0,0
8997,groups,0,0
8998,.,0,0
8999,However,0,0
9000,",",0,0
9001,the,0,0
9002,mean,0,0
9003,number,0,0
9004,of,0,1
9005,patients,0,1
9006,who,0,1
9007,discontinued,0,1
9008,treatment,0,1
9009,due,0,0
9010,to,0,0
9011,adverse,0,0
9012,events,0,0
9013,was,0,0
9014,significantly,0,0
9015,greater,0,0
9016,in,0,0
9017,the,0,0
9018,HI2,0,0
9019,group,0,0
9020,(,0,0
9021,40,0,1
9022,;,0,0
9023,26.1,0,0
9024,%,0,0
9025,),0,0
9026,than,0,0
9027,in,0,0
9028,the,0,0
9029,HI1,0,0
9030,group,0,0
9031,(,0,0
9032,23,0,1
9033,;,0,0
9034,14.7,0,0
9035,%,0,0
9036,),0,0
9037,(,0,0
9038,P,0,0
9039,=,0,0
9040,0.013,0,0
9041,),0,0
9042,.,0,0
9043,CONCLUSIONS,0,0
9044,The,0,0
9045,results,0,0
9046,of,0,0
9047,this,0,0
9048,study,0,0
9049,suggest,0,0
9050,that,0,0
9051,2-tablet,0,0
9052,doses,0,0
9053,of,0,0
9054,combination,0,0
9055,hydrocodone,0,0
9056,7.5,0,0
9057,mg,0,0
9058,and,0,0
9059,ibuprofen,0,0
9060,200,0,0
9061,mg,0,0
9062,may,0,0
9063,be,0,0
9064,more,0,0
9065,effective,0,0
9066,than,0,0
9067,either,0,0
9068,1-tablet,0,0
9069,doses,0,0
9070,of,0,0
9071,this,0,0
9072,combination,0,0
9073,or,0,0
9074,2-tablet,0,0
9075,doses,0,0
9076,of,0,0
9077,combination,0,0
9078,codeine,0,0
9079,30,0,0
9080,mg,0,0
9081,and,0,0
9082,acetaminophen,0,0
9083,300,0,0
9084,mg,0,0
9085,.,0,0
9086,Moreover,0,0
9087,",",0,0
9088,1-tablet,0,0
9089,doses,0,0
9090,of,0,0
9091,combination,0,0
9092,hydrocodone,0,0
9093,7.5,0,0
9094,mg,0,0
9095,and,0,0
9096,ibuprofen,0,0
9097,200,0,0
9098,mg,0,0
9099,may,0,0
9100,be,0,0
9101,as,0,0
9102,effective,0,0
9103,as,0,0
9104,2-tablet,0,0
9105,doses,0,0
9106,of,0,0
9107,combination,0,0
9108,codeine,0,0
9109,30,0,0
9110,mg,0,0
9111,and,0,0
9112,acetaminophen,0,0
9113,300,0,0
9114,mg,0,0
9115,.,0,0
9116,Physostigmine,0,0
9117,reverses,0,0
9118,propofol-induced,0,0
9119,unconsciousness,0,0
9120,and,0,0
9121,attenuation,0,0
9122,of,0,0
9123,the,0,0
9124,auditory,0,0
9125,steady,0,0
9126,state,0,0
9127,response,0,0
9128,and,0,0
9129,bispectral,0,0
9130,index,0,0
9131,in,0,0
9132,human,1,1
9133,volunteers,1,1
9134,.,1,0
9135,BACKGROUND,0,0
9136,It,0,0
9137,is,0,0
9138,postulated,0,0
9139,that,0,0
9140,alteration,0,0
9141,of,0,0
9142,central,0,0
9143,cholinergic,0,0
9144,transmission,0,0
9145,plays,0,0
9146,an,0,0
9147,important,0,0
9148,role,0,0
9149,in,0,0
9150,the,0,0
9151,mechanism,0,0
9152,by,0,0
9153,which,0,0
9154,anesthetics,0,0
9155,produce,0,0
9156,unconsciousness,0,0
9157,.,0,0
9158,The,0,0
9159,authors,0,0
9160,investigated,0,0
9161,the,0,0
9162,effect,0,0
9163,of,0,0
9164,altering,0,0
9165,central,0,0
9166,cholinergic,0,0
9167,transmission,0,0
9168,",",0,0
9169,by,0,0
9170,physostigmine,0,0
9171,and,0,0
9172,scopolamine,0,0
9173,",",0,0
9174,on,0,0
9175,unconsciousness,0,0
9176,produced,0,0
9177,by,0,0
9178,propofol,0,0
9179,.,0,0
9180,METHODS,0,0
9181,Propofol,0,0
9182,was,0,0
9183,administered,0,0
9184,to,0,0
9185,American,1,1
9186,Society,1,1
9187,of,1,0
9188,Anesthesiologists,1,1
9189,physical,1,0
9190,status,1,0
9191,1,1,0
9192,(,1,0
9193,n,1,1
9194,=,1,0
9195,17,1,1
9196,),1,0
9197,volunteers,1,1
9198,with,0,1
9199,use,0,0
9200,of,0,0
9201,a,0,0
9202,computer-controlled,0,0
9203,infusion,0,0
9204,pump,0,0
9205,at,0,0
9206,increasing,0,0
9207,concentrations,0,0
9208,until,0,1
9209,unconsciousness,0,0
9210,resulted,0,0
9211,(,0,0
9212,inability,0,0
9213,to,0,0
9214,respond,0,0
9215,to,0,0
9216,verbal,0,0
9217,commands,0,0
9218,",",0,0
9219,abolition,0,0
9220,of,0,0
9221,spontaneous,0,0
9222,movement,0,0
9223,),0,0
9224,.,0,0
9225,Central,0,0
9226,nervous,0,0
9227,system,0,0
9228,function,0,0
9229,was,0,0
9230,assessed,0,0
9231,by,0,0
9232,use,0,0
9233,of,0,0
9234,the,0,0
9235,Auditory,0,0
9236,Steady,0,0
9237,State,0,0
9238,Response,0,0
9239,(,0,0
9240,ASSR,0,1
9241,),0,0
9242,and,0,0
9243,Bispectral,0,0
9244,Index,0,0
9245,(,0,0
9246,BIS,0,0
9247,),0,0
9248,analysis,0,0
9249,of,0,0
9250,electrooculogram,0,0
9251,.,0,0
9252,During,0,0
9253,continuous,0,0
9254,administration,0,0
9255,of,0,0
9256,propofol,0,0
9257,",",0,0
9258,reversal,0,0
9259,of,0,0
9260,unconsciousness,0,0
9261,produced,0,0
9262,by,0,0
9263,physostigmine,0,0
9264,(,0,0
9265,28,0,0
9266,microgram/kg,0,0
9267,),0,0
9268,and,0,0
9269,block,0,0
9270,of,0,0
9271,this,0,0
9272,reversal,0,0
9273,by,0,0
9274,scopolamine,0,0
9275,(,0,0
9276,8.6,0,0
9277,microgram/kg,0,0
9278,),0,0
9279,were,0,0
9280,evaluated,0,0
9281,.,0,0
9282,RESULTS,0,0
9283,Propofol,0,0
9284,produced,0,0
9285,unconsciousness,0,0
9286,at,0,0
9287,a,0,0
9288,plasma,0,0
9289,concentration,0,0
9290,of,0,0
9291,3.2,0,0
9292,+/-,0,0
9293,0.8,0,0
9294,(,0,0
9295,+/-,0,0
9296,SD,0,0
9297,),0,0
9298,microgram/ml,0,0
9299,(,0,0
9300,n,0,1
9301,=,0,0
9302,17,0,1
9303,),0,0
9304,.,0,0
9305,Unconsciousness,0,0
9306,was,0,0
9307,associated,0,0
9308,with,0,1
9309,reductions,0,0
9310,in,0,0
9311,ASSR,0,1
9312,(,0,0
9313,0.10,0,0
9314,+/-,0,0
9315,0.08,0,0
9316,microV,0,0
9317,[,0,0
9318,awake,0,1
9319,baseline,0,0
9320,0.32,0,0
9321,+/-,0,0
9322,0.18,0,0
9323,microV,0,0
9324,],0,0
9325,",",0,0
9326,P,0,0
9327,<,0,0
9328,0.001,0,0
9329,),0,0
9330,and,0,0
9331,BIS,0,0
9332,(,0,0
9333,55.7,0,0
9334,+/-,0,0
9335,8.8,0,0
9336,[,0,0
9337,awake,0,1
9338,baseline,0,0
9339,92.4,0,0
9340,+/-,0,0
9341,3.9,0,0
9342,],0,0
9343,",",0,0
9344,P,0,0
9345,<,0,0
9346,0.001,0,0
9347,),0,0
9348,.,0,0
9349,Physostigmine,0,0
9350,restored,0,0
9351,consciousness,0,0
9352,in,0,0
9353,9,0,0
9354,of,0,0
9355,11,0,1
9356,subjects,0,1
9357,",",0,0
9358,with,0,1
9359,concomitant,0,0
9360,increases,0,0
9361,in,0,0
9362,ASSR,0,1
9363,(,0,0
9364,0.38,0,0
9365,+/-,0,0
9366,0.17,0,0
9367,microV,0,0
9368,",",0,0
9369,P,0,0
9370,<,0,0
9371,0.01,0,0
9372,),0,0
9373,and,0,0
9374,BIS,0,0
9375,(,0,0
9376,75.3,0,0
9377,+/-,0,0
9378,8.3,0,0
9379,",",0,0
9380,P,0,0
9381,<,0,0
9382,0.001,0,0
9383,),0,0
9384,.,0,0
9385,In,0,0
9386,all,0,0
9387,subjects,0,1
9388,(,0,0
9389,n,0,1
9390,=,0,0
9391,6,0,0
9392,),0,0
9393,scopolamine,0,0
9394,blocked,0,0
9395,the,0,0
9396,physostigmine-induced,0,0
9397,reversal,0,0
9398,of,0,0
9399,unconsciousness,0,0
9400,and,0,0
9401,the,0,0
9402,increase,0,0
9403,of,0,0
9404,the,0,0
9405,ASSR,0,1
9406,and,0,0
9407,BIS,0,0
9408,(,0,0
9409,ASSR,0,1
9410,and,0,0
9411,BIS,0,0
9412,during,0,0
9413,propofol-induced,0,0
9414,unconsciousness,0,1
9415,:,0,1
9416,0.09,0,0
9417,+/-,0,0
9418,0.09,0,0
9419,microV,0,0
9420,and,0,0
9421,58.2,0,0
9422,+/-,0,0
9423,7.5,0,0
9424,",",0,0
9425,respectively,0,0
9426,;,0,0
9427,ASSR,0,1
9428,and,0,0
9429,BIS,0,0
9430,after,0,0
9431,physostigmine,0,0
9432,administration,0,0
9433,:,0,1
9434,0.08,0,0
9435,+/-,0,0
9436,0.06,0,0
9437,microV,0,0
9438,and,0,0
9439,56.8,0,0
9440,+/-,0,0
9441,6.7,0,0
9442,",",0,0
9443,respectively,0,0
9444,",",0,0
9445,NS,0,0
9446,),0,0
9447,.,0,0
9448,CONCLUSIONS,0,0
9449,These,0,0
9450,findings,0,0
9451,suggest,0,0
9452,that,0,0
9453,the,0,0
9454,unconsciousness,0,0
9455,produced,0,0
9456,by,0,0
9457,propofol,0,0
9458,is,0,0
9459,mediated,0,0
9460,at,0,0
9461,least,0,0
9462,in,0,0
9463,part,0,0
9464,via,0,0
9465,interruption,0,0
9466,of,0,0
9467,central,0,0
9468,cholinergic,0,0
9469,muscarinic,0,0
9470,transmission,0,0
9471,.,0,0
9472,Uvulopalatopharyngoplasty,0,1
9473,versus,0,0
9474,laser,0,0
9475,assisted,0,1
9476,uvulopalatoplasty,0,1
9477,for,0,0
9478,the,0,0
9479,treatment,0,0
9480,of,0,0
9481,snoring,1,1
9482,:,1,1
9483,an,0,0
9484,objective,0,0
9485,randomised,0,0
9486,clinical,0,0
9487,trial,0,0
9488,.,0,0
9489,This,0,0
9490,study,0,0
9491,was,0,0
9492,designed,0,0
9493,to,0,0
9494,evaluate,0,0
9495,objectively,0,0
9496,the,0,0
9497,clinical,0,0
9498,effectiveness,0,0
9499,of,0,0
9500,surgery,0,1
9501,for,0,0
9502,snoring,0,1
9503,and,0,0
9504,to,0,0
9505,compare,0,0
9506,the,0,0
9507,results,0,0
9508,of,0,0
9509,conventional,0,0
9510,uvulopalatopharyngoplasty,0,1
9511,(,0,0
9512,UPPP,0,0
9513,),0,0
9514,and,0,0
9515,laser,0,0
9516,assisted,0,0
9517,uvulopalatoplasty,0,1
9518,(,0,0
9519,LAUP,0,0
9520,),0,0
9521,in,0,0
9522,the,0,0
9523,treatment,0,0
9524,of,0,0
9525,snoring,0,1
9526,.,0,1
9527,Patients,1,1
9528,who,1,1
9529,had,1,1
9530,been,1,1
9531,referred,1,1
9532,for,1,0
9533,investigation,1,0
9534,and,1,0
9535,treatment,1,0
9536,of,1,0
9537,their,1,0
9538,snoring,1,1
9539,were,1,0
9540,randomly,1,0
9541,allocated,1,0
9542,to,1,0
9543,receive,1,0
9544,either,1,0
9545,UPPP,1,0
9546,or,1,0
9547,LAUP,1,0
9548,.,1,0
9549,Forty-seven,1,1
9550,patients,1,1
9551,with,1,1
9552,confirmed,1,0
9553,palatal,1,1
9554,flutter,1,1
9555,had,1,0
9556,surgery,1,1
9557,and,1,0
9558,all,1,0
9559,of,1,0
9560,them,1,0
9561,had,1,0
9562,a,1,0
9563,preoperative,1,0
9564,and,1,0
9565,postoperative,1,0
9566,objective,1,0
9567,assessment,1,0
9568,of,1,0
9569,their,1,0
9570,snoring,1,1
9571,loudness,1,0
9572,and,1,0
9573,duration,1,0
9574,in,1,0
9575,the,1,0
9576,home,1,0
9577,.,1,0
9578,The,0,0
9579,recording,0,0
9580,device,0,0
9581,(,0,0
9582,Snore,0,1
9583,Box,0,0
9584,),0,0
9585,is,0,0
9586,simple,0,0
9587,for,0,0
9588,the,0,0
9589,patient,0,0
9590,to,0,0
9591,operate,0,0
9592,",",0,0
9593,portable,0,0
9594,with,0,0
9595,a,0,0
9596,built,0,0
9597,in,0,0
9598,microphone,0,0
9599,",",0,0
9600,and,0,0
9601,able,0,0
9602,to,0,0
9603,produce,0,0
9604,objective,0,0
9605,results,0,0
9606,",",0,0
9607,which,0,0
9608,can,0,0
9609,be,0,0
9610,automatically,0,0
9611,analysed,0,0
9612,.,0,0
9613,Of,0,0
9614,the,0,0
9615,38,0,1
9616,patients,0,1
9617,",",0,1
9618,who,0,1
9619,had,0,1
9620,technically,0,1
9621,valid,0,0
9622,recordings,0,0
9623,",",0,0
9624,22,0,1
9625,underwent,0,1
9626,LAUP,0,0
9627,and,0,0
9628,16,0,1
9629,UPPP,0,0
9630,.,0,0
9631,Overall,0,0
9632,the,0,0
9633,mean,0,0
9634,postoperative,0,0
9635,Snore,0,0
9636,Index,0,0
9637,(,0,0
9638,SI,0,0
9639,),0,0
9640,was,0,0
9641,less,0,0
9642,than,0,0
9643,the,0,0
9644,preoperative,0,0
9645,SI,0,0
9646,(,0,0
9647,P,0,0
9648,<,0,0
9649,0.0001,0,0
9650,),0,0
9651,",",0,0
9652,the,0,0
9653,average,0,0
9654,difference,0,0
9655,being,0,0
9656,78.2,0,0
9657,snores/h,0,0
9658,.,0,0
9659,There,0,0
9660,was,0,0
9661,no,0,0
9662,significant,0,0
9663,difference,0,0
9664,between,0,0
9665,the,0,0
9666,LAUP,0,0
9667,and,0,0
9668,UPPP,0,0
9669,regarding,0,0
9670,the,0,0
9671,fall,0,0
9672,in,0,0
9673,the,0,0
9674,SI,0,0
9675,.,0,0
9676,This,0,0
9677,study,0,0
9678,is,0,0
9679,the,0,0
9680,first,0,0
9681,objective,0,0
9682,comparative,0,0
9683,study,0,0
9684,to,0,0
9685,demonstrate,0,0
9686,the,0,0
9687,effectiveness,0,0
9688,of,0,0
9689,snoring,0,1
9690,surgery,0,1
9691,.,0,0
9692,Beta,0,0
9693,radiation,0,0
9694,as,0,0
9695,an,0,0
9696,adjunct,0,0
9697,to,0,0
9698,low-risk,1,1
9699,trabeculectomy,1,1
9700,.,1,0
9701,PURPOSE,0,0
9702,To,0,0
9703,assess,0,0
9704,a,0,0
9705,single,0,0
9706,dose,0,0
9707,of,0,0
9708,intraoperative,0,0
9709,beta,0,0
9710,radiation,0,0
9711,used,0,0
9712,to,0,0
9713,enhance,0,0
9714,the,0,0
9715,success,0,0
9716,rate,0,0
9717,of,0,0
9718,trabeculectomy,0,0
9719,in,0,0
9720,a,0,0
9721,population,1,1
9722,of,1,0
9723,low-risk,1,1
9724,glaucoma,1,1
9725,patients,1,1
9726,in,1,1
9727,whom,1,1
9728,antimetabolites,1,0
9729,might,1,1
9730,not,1,0
9731,be,1,0
9732,indicated,1,0
9733,.,1,0
9734,METHODS,0,0
9735,A,0,0
9736,prospective,0,0
9737,randomized,0,0
9738,trial,0,0
9739,of,0,0
9740,65,1,1
9741,eyes,1,1
9742,was,1,0
9743,designed,1,0
9744,",",1,0
9745,with,1,1
9746,31,1,1
9747,eyes,1,1
9748,receiving,1,1
9749,750,1,0
9750,rads,1,0
9751,of,1,0
9752,intraoperative,1,0
9753,beta,1,0
9754,radiation,1,0
9755,(,1,0
9756,group,1,0
9757,1,1,0
9758,),1,0
9759,",",1,0
9760,and,1,0
9761,34,1,1
9762,eyes,1,1
9763,receiving,1,1
9764,no,1,0
9765,supplementation,1,0
9766,(,1,0
9767,group,1,0
9768,2,1,0
9769,),1,0
9770,.,1,0
9771,RESULTS,0,0
9772,Mean,0,0
9773,follow-up,0,0
9774,time,0,0
9775,was,0,0
9776,24,0,0
9777,months,0,0
9778,.,0,1
9779,Mean,0,0
9780,postoperative,0,0
9781,intraocular,0,1
9782,pressure,0,0
9783,was,0,0
9784,12.2,0,0
9785,mmHg,0,0
9786,in,0,0
9787,group,0,0
9788,1,0,0
9789,",",0,0
9790,and,0,0
9791,13.7,0,0
9792,mmHg,0,0
9793,in,0,0
9794,group,0,0
9795,2,0,0
9796,(,0,0
9797,P,0,0
9798,=,0,0
9799,0.16,0,0
9800,),0,0
9801,.,0,0
9802,Mean,0,0
9803,decrease,0,0
9804,in,0,0
9805,intraocular,0,0
9806,pressure,0,0
9807,was,0,0
9808,10.3,0,0
9809,mmHg,0,0
9810,in,0,0
9811,group,0,0
9812,1,0,0
9813,",",0,0
9814,and,0,0
9815,9.3,0,0
9816,mmHg,0,0
9817,in,0,0
9818,group,0,0
9819,2,0,0
9820,(,0,0
9821,P,0,0
9822,=,0,0
9823,0.49,0,0
9824,),0,0
9825,.,0,0
9826,The,0,0
9827,two,0,0
9828,groups,0,0
9829,were,0,0
9830,not,0,0
9831,significantly,0,0
9832,different,0,0
9833,in,0,0
9834,terms,0,0
9835,of,0,0
9836,surgical,0,1
9837,complications,0,0
9838,.,0,0
9839,CONCLUSION,0,0
9840,For,0,0
9841,this,0,0
9842,population,0,1
9843,of,0,0
9844,low-risk,1,1
9845,patients,1,1
9846,",",0,0
9847,there,0,0
9848,was,0,0
9849,no,0,0
9850,significant,0,0
9851,difference,0,0
9852,in,0,0
9853,outcome,0,0
9854,after,0,0
9855,applications,0,0
9856,of,0,0
9857,a,0,0
9858,single,0,0
9859,intraoperative,0,0
9860,dose,0,0
9861,of,0,0
9862,beta,0,0
9863,radiation,0,0
9864,.,0,0
9865,Effect,0,0
9866,of,0,0
9867,systemic,0,0
9868,nitric,0,0
9869,oxide,0,0
9870,synthase,0,0
9871,inhibition,0,0
9872,on,0,0
9873,postexercise,1,0
9874,hypotension,1,0
9875,in,1,0
9876,humans,1,0
9877,.,1,0
9878,An,0,0
9879,acute,0,0
9880,bout,0,0
9881,of,0,0
9882,aerobic,0,0
9883,exercise,0,0
9884,results,0,0
9885,in,0,0
9886,a,0,0
9887,reduced,0,0
9888,blood,0,0
9889,pressure,0,0
9890,that,0,0
9891,lasts,0,0
9892,several,0,0
9893,hours,0,0
9894,.,0,1
9895,Animal,0,0
9896,studies,0,0
9897,suggest,0,0
9898,this,0,0
9899,response,0,0
9900,is,0,0
9901,mediated,0,0
9902,by,0,0
9903,increased,0,0
9904,production,0,0
9905,of,0,0
9906,nitric,0,0
9907,oxide,0,0
9908,.,0,0
9909,We,0,0
9910,tested,0,0
9911,the,0,0
9912,extent,0,0
9913,to,0,0
9914,which,0,0
9915,systemic,0,0
9916,nitric,0,0
9917,oxide,0,0
9918,synthase,0,0
9919,inhibition,0,0
9920,[,0,0
9921,N,0,1
9922,(,0,0
9923,G,0,0
9924,),0,0
9925,-monomethyl-L-arginine,0,0
9926,(,0,0
9927,L-NMMA,0,0
9928,),0,0
9929,],0,0
9930,can,0,0
9931,reverse,0,0
9932,the,0,0
9933,drop,0,0
9934,in,0,0
9935,blood,1,0
9936,pressure,1,0
9937,that,1,0
9938,occurs,1,0
9939,after,1,0
9940,exercise,1,0
9941,in,1,0
9942,humans,1,0
9943,.,1,1
9944,Eight,1,0
9945,healthy,1,1
9946,subjects,1,1
9947,underwent,0,1
9948,parallel,0,0
9949,experiments,0,0
9950,on,0,0
9951,2,0,1
9952,separate,0,1
9953,days,0,0
9954,.,0,0
9955,The,0,0
9956,order,0,0
9957,of,0,0
9958,the,0,0
9959,experiments,0,0
9960,was,0,0
9961,randomized,0,0
9962,between,0,0
9963,sham,0,0
9964,(,0,0
9965,60,0,0
9966,min,0,0
9967,of,0,0
9968,seated,0,0
9969,upright,0,0
9970,rest,0,0
9971,),0,0
9972,and,0,0
9973,exercise,0,0
9974,(,0,0
9975,60,0,0
9976,min,0,0
9977,of,0,0
9978,upright,0,0
9979,cycling,0,0
9980,at,0,0
9981,60,0,0
9982,%,0,0
9983,peak,0,0
9984,aerobic,0,0
9985,capacity,0,0
9986,),0,0
9987,.,0,0
9988,After,0,0
9989,both,0,0
9990,sham,0,0
9991,and,0,0
9992,exercise,0,0
9993,",",0,0
9994,subjects,0,1
9995,received,0,0
9996,",",0,0
9997,in,0,0
9998,sequence,0,0
9999,",",0,0
10000,systemic,0,0
10001,alpha-adrenergic,0,0
10002,blockade,0,0
10003,(,0,0
10004,phentolamine,0,0
10005,),0,0
10006,and,0,0
10007,L-NMMA,0,0
10008,.,0,0
10009,Phentolamine,0,0
10010,was,0,0
10011,given,0,0
10012,first,0,0
10013,to,0,0
10014,isolate,0,0
10015,the,0,0
10016,contribution,0,0
10017,of,0,0
10018,nitric,0,0
10019,oxide,0,0
10020,to,0,0
10021,postexercise,0,0
10022,hypotension,0,0
10023,by,0,0
10024,preventing,0,0
10025,reflex,0,0
10026,changes,0,0
10027,in,0,0
10028,sympathetic,0,0
10029,tone,0,0
10030,that,0,0
10031,result,0,0
10032,from,0,0
10033,systemic,0,0
10034,nitric,0,0
10035,oxide,0,0
10036,synthase,0,0
10037,inhibition,0,0
10038,and,0,0
10039,to,0,0
10040,control,0,0
10041,for,0,0
10042,alterations,0,0
10043,in,0,0
10044,resting,0,0
10045,sympathetic,0,0
10046,activity,0,0
10047,after,0,0
10048,exercise,0,0
10049,.,0,0
10050,During,0,0
10051,each,0,0
10052,condition,0,0
10053,",",0,0
10054,systemic,0,0
10055,and,0,0
10056,regional,0,1
10057,hemodynamics,0,0
10058,were,0,0
10059,measured,0,0
10060,.,0,0
10061,Throughout,0,0
10062,the,0,0
10063,study,0,0
10064,",",0,0
10065,arterial,0,0
10066,pressure,0,0
10067,and,0,0
10068,vascular,0,0
10069,resistances,0,0
10070,remained,0,0
10071,lower,0,0
10072,postexercise,0,0
10073,vs.,0,0
10074,postsham,0,0
10075,despite,0,0
10076,nitric,0,0
10077,oxide,0,0
10078,synthase,0,0
10079,inhibition,0,0
10080,(,0,0
10081,e.g.,0,0
10082,",",0,0
10083,mean,0,0
10084,arterial,0,0
10085,pressure,0,0
10086,after,0,0
10087,L-NMMA,0,0
10088,was,0,0
10089,108.0+/-2.4,0,0
10090,mmHg,0,0
10091,postsham,0,0
10092,vs.,0,0
10093,102.1+/-3.3,0,0
10094,mmHg,0,0
10095,postexercise,0,0
10096,;,0,0
10097,P,0,0
10098,<,0,0
10099,0.05,0,0
10100,),0,0
10101,.,0,0
10102,Thus,0,0
10103,it,0,0
10104,does,0,0
10105,not,0,0
10106,appear,0,0
10107,that,0,0
10108,postexercise,0,0
10109,hypotension,0,0
10110,is,0,0
10111,dependent,0,0
10112,on,0,0
10113,increased,0,0
10114,production,0,0
10115,of,0,0
10116,nitric,0,0
10117,oxide,0,0
10118,in,0,0
10119,humans,1,0
10120,.,1,1
10121,Comparison,0,0
10122,of,0,0
10123,alfentanil,0,0
10124,",",0,0
10125,fentanyl,0,0
10126,and,0,0
10127,sufentanil,0,0
10128,for,0,0
10129,total,0,1
10130,intravenous,0,0
10131,anaesthesia,0,1
10132,with,0,1
10133,propofol,0,0
10134,in,0,0
10135,patients,1,1
10136,undergoing,1,1
10137,coronary,1,1
10138,artery,1,1
10139,bypass,1,1
10140,surgery,1,1
10141,.,1,0
10142,We,0,0
10143,have,0,0
10144,studied,0,0
10145,the,0,0
10146,pharmacokinetics,0,0
10147,and,0,0
10148,pharmacodynamics,0,0
10149,of,0,0
10150,alfentanil,0,0
10151,",",0,0
10152,fentanyl,0,0
10153,and,0,0
10154,sufentanil,0,0
10155,together,0,0
10156,with,0,0
10157,propofol,0,0
10158,in,0,0
10159,patients,1,1
10160,undergoing,1,1
10161,coronary,1,1
10162,artery,1,1
10163,bypass,1,1
10164,graft,1,0
10165,surgery,1,1
10166,(,1,0
10167,CABG,1,0
10168,),1,0
10169,.,1,0
10170,Sixty,1,1
10171,patients,1,1
10172,(,1,0
10173,age,1,1
10174,40-73,1,1
10175,yr,1,1
10176,",",1,0
10177,56,1,0
10178,male,1,1
10179,),1,0
10180,were,1,0
10181,assigned,1,0
10182,randomly,1,0
10183,to,1,0
10184,receive,1,0
10185,alfentanil,1,0
10186,",",1,0
10187,fentanyl,1,0
10188,or,1,0
10189,sufentanil,1,0
10190,and,1,0
10191,propofol,1,0
10192,.,0,0
10193,Plasma,0,0
10194,concentrations,0,0
10195,of,0,0
10196,these,0,0
10197,drugs,0,0
10198,and,0,0
10199,times,0,0
10200,for,0,0
10201,the,0,0
10202,plasma,0,0
10203,concentration,0,0
10204,to,0,0
10205,decrease,0,0
10206,by,0,0
10207,50,0,0
10208,%,0,0
10209,(,0,0
10210,t50,0,0
10211,),0,0
10212,and,0,0
10213,80,0,0
10214,%,0,0
10215,(,0,0
10216,t80,0,0
10217,),0,0
10218,after,0,0
10219,cessation,0,0
10220,of,0,0
10221,the,0,0
10222,infusion,0,0
10223,were,0,0
10224,determined,0,0
10225,.,0,0
10226,Times,0,0
10227,were,0,0
10228,recorded,0,0
10229,to,0,0
10230,awakening,0,0
10231,and,0,0
10232,tracheal,0,1
10233,extubation,0,0
10234,.,0,0
10235,Total,0,0
10236,dose,0,0
10237,and,0,0
10238,plasma,0,0
10239,concentrations,0,0
10240,of,0,0
10241,propofol,0,0
10242,were,0,0
10243,similar,0,0
10244,in,0,0
10245,all,0,0
10246,groups,0,0
10247,.,0,0
10248,Mean,0,1
10249,total,0,1
10250,doses,0,0
10251,of,0,0
10252,alfentanil,0,0
10253,",",0,0
10254,fentanyl,0,0
10255,and,0,0
10256,sufentanil,0,0
10257,were,0,0
10258,443,0,1
10259,",",0,0
10260,45,0,0
10261,and,0,0
10262,4.4,0,0
10263,micrograms,0,0
10264,kg-1,0,0
10265,",",0,0
10266,respectively,0,0
10267,.,0,0
10268,Time,0,0
10269,to,0,0
10270,awakening,0,0
10271,did,0,0
10272,not,0,0
10273,differ,0,0
10274,significantly,0,0
10275,.,0,0
10276,In,0,0
10277,patients,0,1
10278,receiving,0,1
10279,fentanyl,0,0
10280,",",0,0
10281,the,0,0
10282,trachea,0,0
10283,was,0,0
10284,extubated,0,0
10285,on,0,0
10286,average,0,0
10287,2,0,0
10288,h,0,0
10289,later,0,0
10290,than,0,0
10291,in,0,0
10292,those,0,0
10293,receiving,0,0
10294,sufentanil,0,0
10295,and,0,0
10296,3,0,0
10297,h,0,0
10298,later,0,0
10299,than,0,0
10300,in,0,0
10301,those,0,0
10302,receiving,0,0
10303,alfentanil,0,0
10304,(,0,0
10305,P,0,0
10306,<,0,0
10307,0.05,0,0
10308,),0,0
10309,.,0,0
10310,The,0,0
10311,t80,0,0
10312,of,0,0
10313,fentanyl,0,0
10314,was,0,0
10315,longer,0,0
10316,(,0,0
10317,P,0,0
10318,<,0,0
10319,0.05,0,0
10320,),0,0
10321,than,0,0
10322,that,0,0
10323,of,0,0
10324,alfentanil,0,0
10325,or,0,0
10326,sufentanil,0,0
10327,",",0,0
10328,and,0,0
10329,there,0,0
10330,was,0,0
10331,a,0,0
10332,linear,0,0
10333,correlation,0,0
10334,between,0,0
10335,the,0,0
10336,t80,0,0
10337,of,0,0
10338,the,0,0
10339,opioid,0,0
10340,and,0,0
10341,the,0,0
10342,time,0,0
10343,to,0,0
10344,tracheal,0,1
10345,extubation,0,0
10346,(,0,0
10347,r,0,0
10348,=,0,0
10349,0.51,0,0
10350,;,0,0
10351,P,0,0
10352,<,0,0
10353,0.01,0,0
10354,),0,0
10355,.,0,0
10356,However,0,0
10357,",",0,0
10358,the,0,0
10359,t50,0,0
10360,values,0,0
10361,for,0,0
10362,these,0,0
10363,opioids,0,0
10364,were,0,0
10365,similar,0,0
10366,and,0,0
10367,did,0,0
10368,not,0,0
10369,correlate,0,0
10370,with,0,0
10371,recovery,0,0
10372,time,0,0
10373,.,0,0
10374,In,0,0
10375,conclusion,0,0
10376,",",0,0
10377,patients,1,1
10378,undergoing,1,1
10379,CABG,1,1
10380,and,0,1
10381,who,0,1
10382,were,0,1
10383,anaesthetized,0,1
10384,with,0,0
10385,fentanyl,0,0
10386,and,0,0
10387,propofol,0,0
10388,needed,0,0
10389,mechanical,0,0
10390,ventilatory,0,0
10391,support,0,0
10392,for,0,0
10393,a,0,0
10394,significantly,0,0
10395,longer,0,0
10396,time,0,0
10397,than,0,0
10398,those,0,0
10399,receiving,0,0
10400,alfentanil,0,0
10401,or,0,0
10402,sufentanil,0,0
10403,and,0,0
10404,propofol,0,0
10405,.,0,0
10406,On,0,0
10407,the,0,0
10408,basis,0,0
10409,of,0,0
10410,the,0,0
10411,interindividual,0,0
10412,variation,0,0
10413,observed,0,0
10414,",",0,0
10415,the,0,0
10416,time,0,0
10417,to,0,0
10418,tracheal,0,1
10419,extubation,0,0
10420,was,0,0
10421,most,0,0
10422,predictable,0,0
10423,in,0,0
10424,patients,0,1
10425,receiving,0,1
10426,alfentanil,0,0
10427,and,0,0
10428,most,0,0
10429,variable,0,0
10430,in,0,0
10431,patients,0,1
10432,receiving,0,1
10433,fentanyl,0,0
10434,",",0,0
10435,a,0,0
10436,finding,0,0
10437,which,0,0
10438,may,0,0
10439,be,0,0
10440,important,0,0
10441,if,0,0
10442,the,0,0
10443,patients,0,1
10444,are,0,0
10445,transferred,0,0
10446,to,0,0
10447,a,0,0
10448,step-down,0,0
10449,unit,0,0
10450,on,0,0
10451,the,0,0
10452,evening,0,0
10453,of,0,0
10454,the,0,0
10455,operation,0,0
10456,.,0,0
10457,Oral,0,0
10458,ciprofloxacin,0,0
10459,vs.,0,0
10460,intramuscular,0,0
10461,ceftriaxone,0,0
10462,as,0,0
10463,empiric,0,0
10464,treatment,0,0
10465,of,0,0
10466,acute,1,1
10467,invasive,1,0
10468,diarrhea,1,1
10469,in,1,0
10470,children,1,1
10471,.,1,1
10472,BACKGROUND,0,0
10473,Acute,0,0
10474,invasive,0,0
10475,diarrhea,0,0
10476,is,0,0
10477,a,0,0
10478,potentially,0,0
10479,serious,0,0
10480,condition,0,0
10481,in,0,0
10482,children,1,1
10483,.,1,0
10484,Because,0,0
10485,of,0,0
10486,the,0,0
10487,increasing,0,0
10488,resistance,0,0
10489,of,0,0
10490,enteric,0,0
10491,pathogens,0,0
10492,to,0,0
10493,commonly,0,0
10494,used,0,0
10495,oral,0,0
10496,antibiotics,0,0
10497,",",0,0
10498,intramuscular,0,0
10499,ceftriaxone,0,0
10500,has,0,0
10501,become,0,0
10502,the,0,0
10503,routine,0,0
10504,drug,0,0
10505,in,0,0
10506,the,0,0
10507,treatment,0,0
10508,of,0,0
10509,acute,0,1
10510,invasive,0,0
10511,diarrhea,0,1
10512,requiring,0,1
10513,an,0,0
10514,emergency,0,1
10515,visit,0,0
10516,in,0,0
10517,southern,0,1
10518,Israel,0,1
10519,.,0,0
10520,The,0,0
10521,inconvenience,0,0
10522,of,0,0
10523,this,0,0
10524,parenteral,0,1
10525,regimen,0,0
10526,created,0,0
10527,an,0,0
10528,increased,0,0
10529,need,0,0
10530,for,0,0
10531,oral,0,0
10532,pediatric,0,1
10533,formulations,0,0
10534,for,0,0
10535,the,0,0
10536,treatment,0,0
10537,of,0,0
10538,invasive,0,0
10539,diarrhea,0,1
10540,.,0,0
10541,OBJECTIVES,0,0
10542,To,0,0
10543,evaluate,0,0
10544,the,0,0
10545,efficacy,0,0
10546,and,0,0
10547,safety,0,0
10548,of,0,0
10549,a,0,0
10550,suspension,0,0
10551,formulation,0,0
10552,of,0,0
10553,ciprofloxacin,0,0
10554,in,0,0
10555,the,0,0
10556,treatment,0,0
10557,of,0,0
10558,acute,1,1
10559,invasive,1,0
10560,diarrhea,1,1
10561,in,1,0
10562,infants,1,1
10563,and,1,1
10564,children,1,1
10565,.,1,0
10566,PATIENTS,0,0
10567,AND,0,0
10568,METHODS,0,0
10569,From,1,1
10570,July,1,0
10571,1996,1,1
10572,through,1,0
10573,December,1,1
10574,1997,1,1
10575,",",1,0
10576,201,1,1
10577,evaluable,1,1
10578,children,1,1
10579,ages,1,1
10580,6,1,0
10581,months,1,0
10582,to,1,1
10583,10,1,1
10584,years,1,1
10585,(,1,0
10586,35,1,1
10587,%,1,0
10588,<,1,0
10589,1,1,0
10590,year,1,1
10591,;,1,0
10592,70,1,1
10593,%,1,0
10594,<,1,0
10595,3,1,0
10596,years,1,1
10597,),1,0
10598,presenting,1,1
10599,with,1,1
10600,acute,1,1
10601,invasive,1,0
10602,diarrhea,1,1
10603,at,1,0
10604,the,1,0
10605,Pediatric,1,1
10606,Emergency,1,1
10607,Room,1,0
10608,were,0,0
10609,randomized,0,0
10610,to,0,0
10611,receive,0,0
10612,either,0,0
10613,ciprofloxacin,0,0
10614,suspension,0,0
10615,(,0,0
10616,10,0,0
10617,mg/kg,0,0
10618,twice,0,0
10619,a,0,0
10620,day,0,0
10621,+,0,0
10622,im,0,1
10623,placebo,0,0
10624,;,0,0
10625,n,0,0
10626,=,0,0
10627,95,0,0
10628,),0,0
10629,or,0,0
10630,im,0,0
10631,ceftriaxone,0,0
10632,(,0,0
10633,50,0,0
10634,mg/kg/day,0,0
10635,+,0,0
10636,placebo,0,0
10637,suspension,0,0
10638,;,0,0
10639,n,0,0
10640,=,0,0
10641,106,0,1
10642,),0,0
10643,for,0,0
10644,3,0,0
10645,days,0,0
10646,in,0,0
10647,a,0,0
10648,double,0,0
10649,blind,0,0
10650,manner,0,0
10651,.,0,0
10652,Stool,0,0
10653,cultures,0,0
10654,for,0,0
10655,Shigella,0,0
10656,",",0,0
10657,Salmonella,0,1
10658,",",0,0
10659,Campylobacter,0,0
10660,spp,0,0
10661,.,0,0
10662,and,0,0
10663,diarrheagenic,0,0
10664,Escherichia,0,0
10665,coli,0,0
10666,were,0,0
10667,obtained,0,0
10668,on,0,0
10669,Days,0,0
10670,1,0,0
10671,",",0,0
10672,3,0,0
10673,",",0,0
10674,4,0,0
10675,to,0,0
10676,5,0,0
10677,and,0,0
10678,21,0,1
10679,+/-,0,0
10680,5,0,0
10681,.,0,0
10682,Clinical,0,0
10683,response,0,0
10684,and,0,0
10685,safety,0,0
10686,were,0,0
10687,assessed,0,0
10688,on,0,0
10689,Days,0,0
10690,1,0,0
10691,",",0,0
10692,2,0,0
10693,",",0,0
10694,3,0,0
10695,",",0,0
10696,4,0,0
10697,to,0,0
10698,5,0,0
10699,and,0,0
10700,21,0,1
10701,+/-,0,0
10702,5,0,0
10703,.,0,0
10704,RESULTS,0,0
10705,We,0,0
10706,isolated,0,0
10707,127,1,1
10708,pathogens,1,0
10709,from,1,1
10710,121,1,1
10711,(,1,0
10712,60,1,1
10713,%,1,0
10714,),1,1
10715,patients,1,1
10716,:,1,1
10717,73,0,1
10718,(,0,0
10719,57,0,1
10720,%,0,0
10721,),0,0
10722,Shigella,0,0
10723,;,0,0
10724,23,0,1
10725,(,0,0
10726,18,0,1
10727,%,0,0
10728,),0,0
10729,Salmonella,0,1
10730,;,0,0
10731,18,0,1
10732,(,0,0
10733,14,0,0
10734,%,0,0
10735,),0,0
10736,E.,0,0
10737,coli,0,0
10738,;,0,0
10739,and,0,0
10740,13,0,0
10741,(,0,0
10742,10,0,0
10743,%,0,0
10744,),0,0
10745,Campylobacter,0,0
10746,.,0,0
10747,Overall,0,0
10748,bacteriologic,0,0
10749,eradication,0,0
10750,on,0,0
10751,Day,0,0
10752,4,0,0
10753,to,0,0
10754,5,0,0
10755,was,0,0
10756,99,0,1
10757,%,0,0
10758,for,0,0
10759,Shigella,0,0
10760,",",0,0
10761,77,0,0
10762,%,0,0
10763,for,0,0
10764,Salmonella,0,1
10765,and,0,0
10766,77,0,0
10767,%,0,0
10768,for,0,0
10769,Campylobacter,0,0
10770,",",0,0
10771,with,0,0
10772,no,0,0
10773,difference,0,0
10774,between,0,0
10775,the,0,0
10776,2,0,0
10777,groups,0,0
10778,.,0,1
10779,Clinical,0,0
10780,cure,0,0
10781,or,0,0
10782,improvement,0,0
10783,was,0,0
10784,observed,0,0
10785,in,0,0
10786,100,0,0
10787,and,0,0
10788,99,0,1
10789,%,0,0
10790,of,0,0
10791,the,0,0
10792,ciprofloxacin,0,0
10793,and,0,0
10794,ceftriaxone,0,0
10795,groups,0,0
10796,",",0,0
10797,respectively,0,0
10798,.,0,0
10799,Serum,0,0
10800,ciprofloxacin,0,0
10801,values,0,0
10802,determined,0,0
10803,on,0,0
10804,Day,0,0
10805,3,0,0
10806,of,0,0
10807,the,0,0
10808,treatment,0,0
10809,were,0,0
10810,higher,0,0
10811,in,0,0
10812,the,0,0
10813,majority,0,0
10814,of,0,0
10815,patients,0,1
10816,than,0,0
10817,were,0,0
10818,the,0,0
10819,MIC50,0,0
10820,and,0,0
10821,MIC90,0,0
10822,values,0,0
10823,for,0,0
10824,the,0,0
10825,Shigella,0,0
10826,and,0,0
10827,Salmonella,0,1
10828,spp,0,0
10829,.,0,0
10830,isolated,0,0
10831,.,0,0
10832,Possible,0,0
10833,drug-related,0,0
10834,adverse,0,0
10835,events,0,0
10836,occurred,0,0
10837,in,0,0
10838,13,0,1
10839,patients,0,1
10840,[,0,0
10841,ciprofloxacin,0,0
10842,",",0,0
10843,8,0,0
10844,(,0,0
10845,8,0,0
10846,%,0,0
10847,),0,0
10848,;,0,0
10849,ceftriaxone,0,0
10850,",",0,0
10851,5,0,0
10852,(,0,0
10853,4.7,0,0
10854,%,0,0
10855,),0,0
10856,],0,0
10857,and,0,0
10858,were,0,0
10859,mild,0,0
10860,and,0,0
10861,transient,0,0
10862,.,0,0
10863,Joint,0,0
10864,examination,0,0
10865,was,0,0
10866,normal,0,1
10867,during,0,0
10868,and,0,0
10869,after,0,0
10870,completion,0,0
10871,of,0,0
10872,therapy,0,0
10873,in,0,0
10874,all,0,0
10875,patients,0,1
10876,.,0,0
10877,CONCLUSION,0,0
10878,Oral,0,0
10879,ciprofloxacin,0,0
10880,was,0,0
10881,as,0,0
10882,safe,0,0
10883,and,0,0
10884,effective,0,0
10885,as,0,0
10886,intramuscular,0,0
10887,ceftriaxone,0,0
10888,for,0,0
10889,the,0,0
10890,empiric,0,0
10891,treatment,0,0
10892,of,0,0
10893,acute,0,1
10894,invasive,0,0
10895,diarrhea,0,1
10896,in,0,0
10897,ambulatory,1,1
10898,pediatric,1,1
10899,patients,1,1
10900,requiring,1,1
10901,an,1,0
10902,emergency,1,1
10903,room,1,0
10904,visit,1,0
10905,.,1,0
10906,Measurement,0,0
10907,of,0,0
10908,peptidase,0,0
10909,activity,0,0
10910,and,0,0
10911,evaluation,0,0
10912,of,0,0
10913,effectiveness,0,0
10914,of,0,0
10915,administration,0,0
10916,of,0,0
10917,minocycline,0,0
10918,for,0,0
10919,treatment,0,0
10920,of,0,0
10921,dogs,1,1
10922,with,1,1
10923,periodontitis,1,1
10924,.,1,0
10925,OBJECTIVE,0,0
10926,To,0,0
10927,determine,0,0
10928,clinical,0,0
10929,",",0,0
10930,enzymatic,0,0
10931,",",0,0
10932,and,0,0
10933,microbiologic,0,0
10934,effects,0,0
10935,of,0,0
10936,controlled-release,0,0
10937,localized,0,0
10938,administration,0,0
10939,of,0,0
10940,minocycline,0,0
10941,on,0,0
10942,dogs,1,1
10943,with,1,1
10944,periodontitis,1,1
10945,.,1,0
10946,ANIMALS,0,0
10947,Five,1,0
10948,adult,1,1
10949,Beagles,1,1
10950,with,1,1
10951,periodontitis,1,1
10952,.,1,0
10953,PROCEDURE,0,0
10954,After,0,0
10955,tooth,0,0
10956,scaling,0,0
10957,and,0,0
10958,root,0,0
10959,planing,0,0
10960,",",0,0
10961,2,0,0
10962,treatment,0,0
10963,",",0,0
10964,1,0,0
10965,placebo,0,0
10966,",",0,0
10967,and,0,0
10968,1,0,0
10969,control,0,0
10970,site,0,0
10971,were,0,0
10972,selected,0,0
10973,for,0,0
10974,each,0,0
10975,dog,0,0
10976,.,0,0
10977,Treatment,0,0
10978,sites,0,0
10979,(,0,0
10980,n,0,1
10981,=,0,0
10982,10,0,1
10983,),0,0
10984,received,0,0
10985,a,0,0
10986,periodontal,0,0
10987,formulation,0,0
10988,of,0,0
10989,minocycline,0,0
10990,hydrochloride,0,0
10991,",",0,0
10992,placebo,0,0
10993,sites,0,0
10994,(,0,0
10995,5,0,0
10996,),0,0
10997,received,0,0
10998,ointment,0,0
10999,without,0,0
11000,minocycline,0,0
11001,",",0,0
11002,and,0,0
11003,control,0,0
11004,sites,0,0
11005,(,0,0
11006,5,0,0
11007,),0,0
11008,did,0,0
11009,not,0,0
11010,receive,0,0
11011,ointment,0,0
11012,.,0,0
11013,Treatments,0,0
11014,were,0,0
11015,administered,0,0
11016,4,0,0
11017,times,0,0
11018,at,0,0
11019,weekly,0,0
11020,intervals,0,0
11021,.,0,1
11022,Peptidase,0,0
11023,activity,0,0
11024,and,0,0
11025,clinical,0,0
11026,and,0,0
11027,microbiologic,0,0
11028,effects,0,0
11029,were,0,0
11030,evaluated,0,0
11031,and,0,0
11032,compared,0,0
11033,among,0,0
11034,sites,0,0
11035,for,0,0
11036,17,0,1
11037,weeks,0,0
11038,.,0,1
11039,RESULTS,0,0
11040,Bleeding,0,0
11041,of,0,0
11042,the,0,0
11043,gums,0,0
11044,on,0,0
11045,probing,0,0
11046,(,0,0
11047,BOP,0,0
11048,),0,0
11049,and,0,0
11050,pocket,0,0
11051,depth,0,0
11052,(,0,0
11053,PD,0,0
11054,),0,0
11055,improved,0,0
11056,at,0,0
11057,the,0,0
11058,treatment,0,0
11059,site,0,0
11060,and,0,0
11061,were,0,0
11062,maintained,0,0
11063,for,0,0
11064,13,0,0
11065,weeks,0,0
11066,after,0,0
11067,treatment,0,0
11068,.,0,0
11069,However,0,0
11070,",",0,0
11071,BOP,0,0
11072,and,0,0
11073,PD,0,0
11074,in,0,0
11075,placebo,0,0
11076,and,0,0
11077,control,0,0
11078,sites,0,0
11079,increased,0,0
11080,from,0,1
11081,weeks,0,0
11082,9,0,1
11083,to,0,1
11084,17,0,0
11085,Peptidase,0,0
11086,activity,0,0
11087,in,0,0
11088,the,0,0
11089,periodontal,0,0
11090,pocket,0,0
11091,decreased,0,0
11092,noticeably,0,0
11093,from,0,0
11094,week,0,0
11095,1,0,0
11096,to,0,0
11097,17,0,0
11098,",",0,0
11099,compared,0,0
11100,with,0,0
11101,baseline,0,0
11102,values,0,0
11103,for,0,0
11104,the,0,0
11105,treatment,0,0
11106,site,0,0
11107,.,0,0
11108,However,0,0
11109,",",0,0
11110,peptidase,0,0
11111,activity,0,0
11112,for,0,0
11113,placebo,0,0
11114,and,0,0
11115,control,0,0
11116,sites,0,0
11117,increased,0,0
11118,and,0,0
11119,were,0,0
11120,above,0,0
11121,baseline,0,0
11122,values,0,0
11123,on,0,0
11124,week,0,0
11125,9,0,0
11126,and,0,0
11127,week,0,0
11128,13,0,0
11129,",",0,0
11130,respectively,0,0
11131,.,0,0
11132,Total,0,0
11133,bacterial,0,0
11134,counts,0,0
11135,decreased,0,0
11136,by,0,0
11137,90,0,0
11138,%,0,0
11139,for,0,0
11140,treatment,0,0
11141,sites,0,0
11142,and,0,0
11143,remained,0,0
11144,at,0,0
11145,that,0,0
11146,value,0,0
11147,for,0,0
11148,13,0,1
11149,weeks,0,0
11150,.,0,0
11151,However,0,0
11152,",",0,0
11153,for,0,0
11154,placebo,0,0
11155,and,0,0
11156,control,0,0
11157,sites,0,0
11158,",",0,0
11159,bacterial,0,0
11160,counts,0,0
11161,increased,0,0
11162,and,0,0
11163,reached,0,0
11164,the,0,0
11165,baseline,0,0
11166,value,0,0
11167,on,0,0
11168,week,0,0
11169,17,0,1
11170,.,0,0
11171,CONCLUSIONS,0,0
11172,AND,0,0
11173,CLINICAL,0,1
11174,RELEVANCE,0,0
11175,Increased,0,0
11176,peptidase,0,0
11177,activity,0,0
11178,is,0,0
11179,correlated,0,0
11180,with,0,0
11181,the,0,0
11182,progression,0,0
11183,of,0,0
11184,periodontitis,1,1
11185,in,1,0
11186,dogs,1,1
11187,.,1,0
11188,Treatment,0,0
11189,with,0,0
11190,minocycline,0,0
11191,",",0,0
11192,using,0,0
11193,a,0,0
11194,localized,0,0
11195,delivery,0,0
11196,system,0,0
11197,",",0,0
11198,was,0,0
11199,effective,0,0
11200,in,0,0
11201,dogs,0,1
11202,for,0,0
11203,at,0,0
11204,least,0,0
11205,13,0,1
11206,weeks,0,0
11207,after,0,0
11208,cessation,0,0
11209,of,0,0
11210,drug,0,0
11211,administration,0,0
11212,.,0,0
11213,[,0,0
11214,Complication,0,0
11215,rate,0,0
11216,after,0,0
11217,gastrectomy,0,1
11218,and,0,0
11219,pouch,0,0
11220,reconstruction,0,1
11221,with,0,1
11222,Longmire,0,0
11223,interposition,0,1
11224,],0,0
11225,.,0,0
11226,BACKGROUND/AIMS,0,0
11227,To,0,0
11228,determine,0,0
11229,whether,0,0
11230,a,0,0
11231,Longmire-Interposition,0,0
11232,with,0,0
11233,or,0,0
11234,without,0,0
11235,a,0,0
11236,pouch,0,0
11237,used,0,0
11238,for,0,0
11239,reconstruction,0,0
11240,after,0,0
11241,gastrectomy,0,1
11242,influences,0,0
11243,the,0,0
11244,postoperative,0,0
11245,complication,0,0
11246,rate,0,0
11247,.,0,0
11248,METHODOLOGY,0,0
11249,49,1,1
11250,patients,1,1
11251,who,1,1
11252,underwent,1,1
11253,gastrectomy,1,1
11254,with,1,1
11255,Longmire-Interposition,1,1
11256,with,1,1
11257,(,1,0
11258,n,1,1
11259,=,1,0
11260,33,1,1
11261,),1,0
11262,or,1,0
11263,without,1,0
11264,(,1,0
11265,n,1,1
11266,=,1,0
11267,16,1,1
11268,),1,0
11269,an,1,0
11270,additional,1,0
11271,pouch,1,0
11272,and,1,0
11273,46,1,1
11274,patients,1,1
11275,with,1,1
11276,a,1,0
11277,Roux-en-Y-reconstruction,1,0
11278,were,0,0
11279,analysed,0,0
11280,retrospectively,0,0
11281,.,0,0
11282,Complication,0,0
11283,rate,0,0
11284,and,0,0
11285,mortality,0,0
11286,were,0,0
11287,studied,0,0
11288,.,0,0
11289,RESULTS,0,0
11290,There,0,0
11291,were,0,0
11292,no,0,0
11293,significant,0,0
11294,differences,0,0
11295,between,0,0
11296,the,0,0
11297,reconstruction,0,0
11298,groups,0,0
11299,for,0,0
11300,postoperative,0,0
11301,complications,0,0
11302,(,0,0
11303,Roux-en-Y,0,1
11304,vs.,0,0
11305,Longmire-Interposition,0,1
11306,with,0,1
11307,and,0,0
11308,without,0,1
11309,pouch,0,1
11310,:,0,1
11311,30.4,0,0
11312,%,0,0
11313,vs.,0,0
11314,28.6,0,0
11315,%,0,0
11316,for,0,0
11317,the,0,0
11318,morbidity,0,0
11319,;,0,0
11320,4.3,0,0
11321,%,0,0
11322,vs.,0,0
11323,4.1,0,0
11324,%,0,0
11325,for,0,0
11326,the,0,0
11327,mortality,0,0
11328,),0,0
11329,.,0,0
11330,CONCLUSION,0,0
11331,These,0,0
11332,findings,0,0
11333,suggest,0,0
11334,that,0,0
11335,a,0,0
11336,Longmire-Interposition,0,0
11337,with,0,0
11338,or,0,0
11339,without,0,0
11340,a,0,0
11341,pouch,0,0
11342,for,0,0
11343,reconstruction,0,0
11344,after,0,0
11345,total,0,0
11346,gastrectomy,0,1
11347,is,0,0
11348,not,0,0
11349,connected,0,0
11350,with,0,0
11351,a,0,0
11352,higher,0,0
11353,morbidity,0,0
11354,or,0,0
11355,mortality,0,0
11356,in,0,0
11357,comparison,0,0
11358,to,0,0
11359,a,0,0
11360,Roux-en-Y-reconstruction,0,0
11361,.,0,0
11362,Unopposed,0,0
11363,estrogen,0,0
11364,increases,0,0
11365,total,0,1
11366,plasma,0,0
11367,factor,0,0
11368,VII,0,0
11369,",",0,0
11370,but,0,0
11371,not,0,0
11372,active,0,0
11373,factor,0,0
11374,VII,0,0
11375,--,0,0
11376,a,0,0
11377,short-term,0,0
11378,placebo-controlled,0,0
11379,study,0,0
11380,in,0,0
11381,healthy,1,1
11382,postmenopausal,1,1
11383,women,1,1
11384,.,1,0
11385,Estrogen,0,0
11386,therapy,0,0
11387,may,0,0
11388,increase,0,0
11389,the,0,0
11390,risk,0,0
11391,of,0,0
11392,arterial,0,0
11393,thromboembolism,0,0
11394,",",0,0
11395,at,0,0
11396,least,0,0
11397,in,0,0
11398,the,0,0
11399,short,0,0
11400,term,0,0
11401,.,0,0
11402,In,0,0
11403,a,0,0
11404,randomized,0,0
11405,",",0,0
11406,double-blind,0,0
11407,and,0,0
11408,placebo-controlled,0,0
11409,study,0,0
11410,in,0,0
11411,25,1,0
11412,healthy,1,1
11413,postmenopausal,1,1
11414,women,1,1
11415,(,1,0
11416,52.5,1,0
11417,+/-,1,0
11418,2.8,1,0
11419,years,1,1
11420,),1,0
11421,",",0,0
11422,we,0,0
11423,therefore,0,0
11424,examined,0,0
11425,the,0,0
11426,short-term,0,0
11427,effect,0,0
11428,of,0,0
11429,unopposed,0,0
11430,estrogen,0,0
11431,on,0,0
11432,the,0,0
11433,fasting,0,0
11434,and,0,0
11435,fat-load-stimulated,0,0
11436,plasma,0,0
11437,levels,0,0
11438,of,0,0
11439,total,0,1
11440,factor,0,0
11441,VII,0,0
11442,versus,0,0
11443,active,0,0
11444,factor,0,0
11445,VII,0,0
11446,.,0,0
11447,Plasma,0,0
11448,total,0,1
11449,factor,0,0
11450,VII,0,0
11451,was,0,0
11452,measured,0,0
11453,by,0,0
11454,use,0,0
11455,of,0,0
11456,a,0,0
11457,chromogenic,0,0
11458,assay,0,0
11459,;,0,0
11460,plasma,0,0
11461,active,0,0
11462,FVII,0,0
11463,by,0,0
11464,a,0,0
11465,recently,0,0
11466,developed,0,0
11467,method,0,0
11468,using,0,0
11469,truncated,0,0
11470,tissue,0,0
11471,factor,0,0
11472,.,0,0
11473,As,0,0
11474,compared,0,0
11475,to,0,0
11476,placebo,0,0
11477,",",0,0
11478,8,0,0
11479,weeks,0,0
11480,of,0,0
11481,oral,0,0
11482,17beta-estradiol,0,0
11483,(,0,0
11484,2,0,0
11485,mg,0,0
11486,daily,0,0
11487,),0,0
11488,increased,0,0
11489,the,0,0
11490,mean,0,0
11491,fasting,0,0
11492,and,0,0
11493,postprandial,0,0
11494,plasma,0,0
11495,levels,0,0
11496,of,0,0
11497,total,0,1
11498,factor,0,0
11499,VII,0,0
11500,by,0,0
11501,17,0,0
11502,and,0,0
11503,21,0,1
11504,%,0,0
11505,points,0,0
11506,",",0,0
11507,respectively,0,0
11508,(,0,0
11509,both,0,0
11510,P,0,0
11511,<,0,0
11512,0.01,0,0
11513,),0,0
11514,",",0,0
11515,but,0,0
11516,did,0,0
11517,not,0,0
11518,affect,0,0
11519,the,0,0
11520,fasting,0,0
11521,and/or,0,0
11522,postprandial,0,0
11523,plasma,0,0
11524,levels,0,0
11525,of,0,0
11526,active,0,1
11527,factor,0,0
11528,VII,0,0
11529,(,0,0
11530,mean,0,0
11531,change,0,0
11532,both,0,0
11533,0.05,0,0
11534,ng/mL,0,0
11535,;,0,0
11536,P,0,0
11537,>,0,1
11538,0.35,0,0
11539,),0,0
11540,.,0,0
11541,Furthermore,0,0
11542,",",0,0
11543,the,0,0
11544,change,0,0
11545,in,0,0
11546,the,0,0
11547,fasting,0,0
11548,level,0,0
11549,of,0,0
11550,total,0,1
11551,factor,0,0
11552,VII,0,0
11553,after,0,0
11554,therapy,0,0
11555,was,0,0
11556,not,0,0
11557,associated,0,0
11558,with,0,0
11559,the,0,0
11560,change,0,0
11561,in,0,0
11562,the,0,0
11563,fasting,0,0
11564,level,0,0
11565,of,0,0
11566,active,0,0
11567,factor,0,0
11568,VII,0,0
11569,(,0,0
11570,r,0,0
11571,=,0,0
11572,0.27,0,0
11573,;,0,0
11574,P,0,0
11575,=,0,0
11576,0.21,0,0
11577,),0,0
11578,.,0,0
11579,These,0,0
11580,findings,0,0
11581,argue,0,0
11582,against,0,0
11583,the,0,0
11584,idea,0,0
11585,that,0,0
11586,elevated,0,0
11587,levels,0,0
11588,of,0,0
11589,total,0,1
11590,factor,0,0
11591,VII,0,0
11592,underlie,0,0
11593,an,0,0
11594,increased,0,0
11595,risk,0,0
11596,of,0,0
11597,arterial,0,0
11598,thromboembolism,0,1
11599,in,0,0
11600,postmenopausal,1,1
11601,women,1,1
11602,using,0,0
11603,unopposed,0,0
11604,estrogen,0,0
11605,replacement,0,1
11606,.,0,0
11607,Spatial,0,1
11608,orientation,0,0
11609,adjustments,0,0
11610,in,0,0
11611,children,1,1
11612,with,1,1
11613,autism,1,1
11614,in,1,0
11615,Hong,1,1
11616,Kong,1,1
11617,.,1,0
11618,Abnormal,0,0
11619,spatial,0,0
11620,orientation,0,0
11621,and,0,0
11622,body,0,0
11623,postures,0,0
11624,in,0,0
11625,children,1,1
11626,with,1,1
11627,autism,1,1
11628,often,0,0
11629,interfere,0,0
11630,with,0,0
11631,visual,0,0
11632,abilities,0,0
11633,to,0,0
11634,attend,0,1
11635,tasks,0,0
11636,and,0,0
11637,social,0,0
11638,interactions,0,0
11639,.,0,1
11640,Twenty-four,1,1
11641,children,1,1
11642,diagnosed,1,1
11643,with,1,1
11644,autism,1,1
11645,from,1,0
11646,Kowloon,1,0
11647,",",1,0
11648,Hong,1,1
11649,Kong,1,0
11650,were,0,0
11651,assessed,0,0
11652,for,0,0
11653,spatial,0,0
11654,orientation,0,0
11655,and,0,0
11656,spatial,0,0
11657,management,0,1
11658,abilities,0,0
11659,.,0,1
11660,Positive,0,0
11661,changes,0,0
11662,in,0,0
11663,spatial,0,0
11664,orientation,0,0
11665,were,0,0
11666,evident,0,0
11667,when,0,0
11668,the,0,0
11669,children,0,1
11670,wore,0,1
11671,ambient,0,0
11672,prism,0,0
11673,lenses,0,1
11674,and,0,0
11675,included,0,1
11676,changes,0,0
11677,in,0,0
11678,posture,0,0
11679,from,0,0
11680,slanted,0,0
11681,to,0,0
11682,erect,0,0
11683,.,0,0
11684,Adjustments,0,0
11685,in,0,0
11686,spatial,0,0
11687,management,0,0
11688,were,0,0
11689,evident,0,0
11690,in,0,0
11691,improved,0,0
11692,ball,0,0
11693,catching,0,0
11694,ability,0,0
11695,",",0,0
11696,a,0,0
11697,task,0,0
11698,requiring,0,0
11699,visual,0,0
11700,tracking,0,0
11701,and,0,0
11702,eye-hand,0,0
11703,coordination,0,0
11704,.,0,0
11705,The,0,0
11706,findings,0,0
11707,suggest,0,0
11708,that,0,0
11709,alterations,0,0
11710,to,0,0
11711,the,0,0
11712,sensory,0,0
11713,systems,0,0
11714,may,0,0
11715,lead,0,0
11716,to,0,0
11717,behavioral,0,0
11718,change,0,0
11719,in,0,0
11720,some,0,0
11721,children,0,1
11722,.,0,0
11723,The,0,0
11724,injured,1,1
11725,colon,1,1
11726,:,1,1
11727,therapeutic,0,0
11728,considerations,0,0
11729,.,0,0
11730,A,0,0
11731,prospective,0,0
11732,randomized,0,0
11733,study,1,0
11734,was,1,0
11735,carried,1,0
11736,out,1,0
11737,at,1,0
11738,the,1,0
11739,Detroit,1,1
11740,General,1,0
11741,Hospital,1,1
11742,over,1,0
11743,a,1,0
11744,two,1,0
11745,year,1,0
11746,period,1,0
11747,to,1,0
11748,evaluate,1,0
11749,methods,1,0
11750,of,1,0
11751,management,1,1
11752,in,1,0
11753,165,1,1
11754,patients,1,1
11755,with,1,1
11756,colonic,1,1
11757,injuries,1,1
11758,.,1,1
11759,Results,0,0
11760,of,0,0
11761,the,0,0
11762,study,0,0
11763,show,0,0
11764,that,0,0
11765,primary,0,0
11766,closure,0,0
11767,is,0,0
11768,a,0,0
11769,safe,0,0
11770,and,0,0
11771,reiable,0,0
11772,method,0,0
11773,of,0,0
11774,management,0,0
11775,when,0,0
11776,rigid,0,0
11777,criteria,0,1
11778,are,0,0
11779,incorporated,0,0
11780,in,0,0
11781,an,0,0
11782,ongoing,0,0
11783,protocol,0,0
11784,.,0,0
11785,Moreover,0,0
11786,",",0,0
11787,the,0,0
11788,technic,0,0
11789,of,0,0
11790,exteriorization,0,0
11791,is,0,0
11792,a,0,0
11793,safe,0,0
11794,adjunct,0,0
11795,to,0,0
11796,management,0,0
11797,and,0,0
11798,is,0,0
11799,recommended,0,0
11800,in,0,0
11801,any,1,0
11802,patient,1,0
11803,with,1,0
11804,a,1,0
11805,colonic,1,0
11806,injury,1,0
11807,above,1,0
11808,18,1,0
11809,cm,1,1
11810,in,0,0
11811,which,0,0
11812,one,0,0
11813,suture,0,0
11814,line,0,0
11815,is,0,0
11816,required,0,0
11817,and,0,0
11818,in,0,0
11819,which,0,0
11820,the,0,0
11821,additional,0,0
11822,operating,0,0
11823,time,0,0
11824,of,0,0
11825,twenty,0,1
11826,minutes,0,0
11827,will,0,0
11828,not,0,0
11829,compromise,0,0
11830,the,0,0
11831,management,0,0
11832,of,0,0
11833,secondary,0,0
11834,injuries,0,1
11835,.,0,1
11836,Patients,0,1
11837,not,0,0
11838,fulfilling,0,1
11839,these,0,0
11840,criteria,0,0
11841,should,0,0
11842,have,0,0
11843,primary,0,0
11844,colostomy,0,0
11845,.,0,0
11846,These,0,0
11847,principles,0,0
11848,make,0,0
11849,it,0,0
11850,possible,0,0
11851,to,0,0
11852,reduce,0,0
11853,the,0,0
11854,need,0,0
11855,for,0,0
11856,primary,0,0
11857,colostomy,0,1
11858,to,0,0
11859,approximately,0,0
11860,50,0,0
11861,per,0,0
11862,cent,0,0
11863,in,0,0
11864,a,0,0
11865,large,0,0
11866,ongoing,0,0
11867,group,0,0
11868,of,0,0
11869,patients,1,1
11870,with,1,1
11871,colonic,1,1
11872,injury,1,1
11873,.,1,0
11874,The,0,0
11875,effect,0,0
11876,of,0,0
11877,splinting,1,0
11878,of,1,0
11879,teeth,1,1
11880,in,1,0
11881,combination,1,0
11882,with,1,1
11883,reconstructive,1,0
11884,periodontal,1,0
11885,surgery,1,1
11886,in,1,0
11887,humans,1,0
11888,.,1,0
11889,The,0,0
11890,purpose,0,0
11891,of,0,0
11892,this,0,0
11893,study,0,0
11894,was,0,0
11895,to,0,0
11896,evaluate,0,0
11897,the,0,0
11898,effect,0,0
11899,of,0,0
11900,splinting,0,0
11901,teeth,0,1
11902,on,0,0
11903,the,0,0
11904,results,0,0
11905,of,0,0
11906,periodontal,0,1
11907,reconstructive,0,1
11908,surgery,0,1
11909,using,0,0
11910,a,0,0
11911,specific,0,0
11912,carbonate,0,0
11913,bone,0,0
11914,replacement,0,0
11915,graft,0,0
11916,(,0,0
11917,BRG,0,0
11918,),0,0
11919,material,0,1
11920,.,0,0
11921,Forty-five,1,1
11922,patients,1,1
11923,were,1,0
11924,randomly,1,1
11925,treated,1,0
11926,with,1,0
11927,a,1,0
11928,periodontal,1,0
11929,surgery,1,1
11930,approach,1,0
11931,.,1,0
11932,Natural,0,0
11933,coral,0,0
11934,calcium,0,0
11935,BRG,0,0
11936,was,0,0
11937,utilised,0,0
11938,in,0,0
11939,33,1,1
11940,patients,1,1
11941,.,1,0
11942,This,0,0
11943,33-patient,0,0
11944,group,0,0
11945,was,0,0
11946,divided,0,0
11947,into,0,0
11948,three,0,0
11949,equal,0,1
11950,groups,0,0
11951,.,0,0
11952,In,0,0
11953,the,0,0
11954,presplint,0,0
11955,group,0,0
11956,",",0,0
11957,teeth,0,1
11958,were,0,0
11959,splinted,0,0
11960,to,0,0
11961,at,0,0
11962,least,0,0
11963,two,0,0
11964,rigid,0,1
11965,teeth,0,1
11966,before,0,0
11967,surgery,0,1
11968,",",0,0
11969,in,0,0
11970,the,0,0
11971,postsplint,0,0
11972,group,0,0
11973,",",0,0
11974,teeth,0,1
11975,were,0,0
11976,splinted,0,0
11977,at,0,0
11978,suture,0,0
11979,removal,0,0
11980,",",0,0
11981,and,0,0
11982,in,0,0
11983,the,0,0
11984,nonsplint,0,0
11985,group,0,0
11986,",",0,0
11987,the,0,0
11988,treated,0,0
11989,teeth,0,1
11990,were,0,0
11991,not,0,0
11992,splinted,0,0
11993,at,0,0
11994,all,0,0
11995,.,0,0
11996,In,0,0
11997,12,0,0
11998,patients,0,1
11999,",",0,0
12000,teeth,0,1
12001,were,0,0
12002,treated,0,1
12003,with,0,1
12004,surgical,0,0
12005,debridement,0,0
12006,(,0,0
12007,DEBR,0,0
12008,),0,0
12009,alone,0,0
12010,and,0,0
12011,not,0,0
12012,splinted,0,0
12013,.,0,0
12014,Periodontal,0,0
12015,probing,0,0
12016,depth,0,0
12017,(,0,0
12018,PPD,0,1
12019,),0,0
12020,",",0,0
12021,clinical,0,0
12022,probing,0,0
12023,attachment,0,0
12024,level,0,0
12025,(,0,0
12026,CPAL,0,0
12027,),0,0
12028,",",0,0
12029,and,0,0
12030,tooth,0,0
12031,mobility,0,0
12032,were,0,0
12033,measured,0,0
12034,using,0,0
12035,desmodontometry,0,0
12036,(,0,0
12037,DDM,0,0
12038,),0,0
12039,and,0,0
12040,periotest,0,0
12041,(,0,0
12042,PTV,0,0
12043,),0,0
12044,with,0,1
12045,reproducible,0,0
12046,methods,0,1
12047,before,0,0
12048,surgery,0,1
12049,and,0,0
12050,at,0,0
12051,various,0,0
12052,periods,0,0
12053,up,0,0
12054,to,0,0
12055,1,0,0
12056,year,0,1
12057,afterwards,0,0
12058,.,0,0
12059,A,0,0
12060,decrease,0,0
12061,in,0,0
12062,PPD,0,1
12063,(,0,0
12064,5.4,0,0
12065,mm,0,0
12066,",",0,0
12067,SD,0,0
12068,1.4,0,0
12069,mm,0,0
12070,),0,0
12071,and,0,0
12072,tooth,0,0
12073,mobility,0,0
12074,(,0,0
12075,DDM-horizontal,0,0
12076,257,0,1
12077,microns,0,0
12078,",",0,0
12079,SD,0,1
12080,60,0,1
12081,microns,0,0
12082,),0,0
12083,and,0,0
12084,a,0,0
12085,gain,0,0
12086,of,0,0
12087,CPAL,0,0
12088,(,0,0
12089,5.1,0,0
12090,mm,0,0
12091,",",0,0
12092,SD,0,0
12093,1.4,0,0
12094,mm,0,0
12095,),0,0
12096,were,0,0
12097,seen,0,0
12098,following,0,0
12099,the,0,0
12100,use,0,0
12101,of,0,0
12102,BRG,0,0
12103,in,0,0
12104,presplint,0,0
12105,teeth,0,1
12106,.,0,0
12107,In,0,0
12108,the,0,0
12109,same,0,0
12110,group,0,0
12111,",",0,0
12112,PPD,0,0
12113,and,0,0
12114,tooth,0,1
12115,mobility,0,0
12116,were,0,0
12117,significantly,0,0
12118,reduced,0,0
12119,compared,0,0
12120,to,0,0
12121,nonsplint,0,0
12122,teeth,0,1
12123,.,0,0
12124,DEBR,0,0
12125,alone,0,0
12126,showed,0,0
12127,reductions,0,0
12128,in,0,0
12129,tooth,0,1
12130,mobility,0,0
12131,and,0,0
12132,PPD,0,1
12133,and,0,0
12134,a,0,0
12135,significantly,0,0
12136,smaller,0,0
12137,gain,0,0
12138,in,0,0
12139,CPAL,0,0
12140,than,0,0
12141,in,0,0
12142,presplint,0,0
12143,teeth,0,1
12144,treated,0,1
12145,with,0,1
12146,BRG,0,0
12147,.,0,0
12148,The,0,0
12149,less,0,0
12150,favourable,0,0
12151,improvement,0,0
12152,in,0,0
12153,periodontal,0,0
12154,function,0,0
12155,of,0,0
12156,postsplint,0,0
12157,or,0,0
12158,nonsplint,0,0
12159,teeth,0,1
12160,seemed,0,0
12161,to,0,0
12162,be,0,0
12163,due,0,0
12164,to,0,0
12165,the,0,0
12166,loss,0,0
12167,of,0,0
12168,BRG,0,0
12169,material,0,1
12170,caused,0,0
12171,by,0,0
12172,tooth,0,1
12173,mobility,0,0
12174,.,0,0
12175,These,0,0
12176,results,0,0
12177,indicate,0,0
12178,that,0,0
12179,an,0,0
12180,undisturbed,0,0
12181,wound,0,0
12182,healing,0,0
12183,process,0,0
12184,using,0,0
12185,BRG,0,0
12186,together,0,0
12187,with,0,0
12188,tooth,0,0
12189,stability,0,0
12190,is,0,0
12191,beneficial,0,0
12192,to,0,0
12193,overall,0,0
12194,clinical,0,0
12195,success,0,0
12196,.,0,0
12197,Simplified,0,0
12198,subjective,0,0
12199,workload,0,0
12200,assessment,0,0
12201,technique,0,0
12202,.,0,0
12203,Although,0,0
12204,the,0,0
12205,subjective,0,0
12206,workload,0,0
12207,assessment,0,0
12208,technique,0,0
12209,(,0,0
12210,SWAT,0,0
12211,),0,0
12212,has,0,0
12213,been,0,0
12214,widely,0,0
12215,used,0,0
12216,",",0,0
12217,it,0,0
12218,has,0,0
12219,two,0,0
12220,main,0,0
12221,problems,0,1
12222,:,0,1
12223,it,0,0
12224,is,0,0
12225,not,0,0
12226,very,0,0
12227,sensitive,0,0
12228,for,0,0
12229,low,0,0
12230,mental,0,1
12231,workloads,0,0
12232,and,0,0
12233,it,0,0
12234,requires,0,0
12235,a,0,0
12236,time-consuming,0,0
12237,card,0,0
12238,sorting,0,0
12239,pretask,0,0
12240,procedure,0,0
12241,.,0,0
12242,In,0,0
12243,this,0,0
12244,study,0,0
12245,are,0,0
12246,presented,0,0
12247,five,0,0
12248,variations,0,0
12249,of,0,0
12250,SWAT,0,1
12251,in,0,0
12252,an,0,0
12253,effort,0,0
12254,to,0,0
12255,overcome,0,0
12256,the,0,0
12257,limitations,0,0
12258,.,0,0
12259,Four,0,0
12260,of,0,0
12261,the,0,0
12262,variants,0,0
12263,used,0,0
12264,the,0,0
12265,continuous,0,0
12266,SWAT,0,0
12267,subscales,0,0
12268,while,0,0
12269,one,0,0
12270,used,0,0
12271,the,0,0
12272,discrete,0,0
12273,SWAT,0,0
12274,subscale,0,0
12275,.,0,0
12276,Fifteen,1,1
12277,subjects,1,1
12278,participated,1,1
12279,in,1,0
12280,the,1,0
12281,experiment,1,0
12282,.,1,0
12283,The,0,0
12284,scales,0,0
12285,were,0,0
12286,compared,0,0
12287,with,0,0
12288,the,0,0
12289,original,0,0
12290,SWAT,0,0
12291,scale,0,0
12292,in,0,0
12293,terms,0,0
12294,of,0,0
12295,sensitivity,0,0
12296,and,0,0
12297,pretask,0,0
12298,procedure,0,0
12299,completion,0,0
12300,time,0,0
12301,when,0,0
12302,performing,0,0
12303,arithmetic,0,0
12304,tasks,0,0
12305,.,0,1
12306,The,0,0
12307,results,0,0
12308,show,0,0
12309,that,0,0
12310,all,0,0
12311,four,0,0
12312,variants,0,0
12313,are,0,0
12314,more,0,0
12315,sensitive,0,0
12316,than,0,0
12317,the,0,0
12318,conventional,0,0
12319,SWAT,0,0
12320,scale,0,0
12321,and,0,0
12322,that,0,0
12323,the,0,0
12324,pairwise,0,0
12325,comparison,0,0
12326,procedure,0,0
12327,takes,0,0
12328,significantly,0,0
12329,less,0,0
12330,pretask,0,0
12331,completion,0,0
12332,time,0,0
12333,compared,0,0
12334,with,0,0
12335,the,0,0
12336,original,0,0
12337,SWAT,0,0
12338,scale,0,0
12339,.,0,0
12340,Thus,0,0
12341,",",0,0
12342,the,0,0
12343,conventional,0,0
12344,pretask,0,0
12345,procedure,0,0
12346,can,0,0
12347,be,0,0
12348,replaced,0,0
12349,by,0,0
12350,a,0,0
12351,simple,0,0
12352,unweighted,0,0
12353,averaging,0,0
12354,to,0,0
12355,yield,0,0
12356,a,0,0
12357,scale,0,0
12358,of,0,0
12359,high,0,0
12360,sensitivity,0,0
12361,.,0,0
12362,Comparison,0,0
12363,of,0,0
12364,provocative,0,0
12365,tests,0,0
12366,for,0,0
12367,unexplained,1,1
12368,syncope,1,1
12369,:,1,1
12370,isoprenaline,0,0
12371,and,0,0
12372,glyceryl,0,0
12373,trinitrate,0,0
12374,for,0,0
12375,diagnosing,0,0
12376,vasovagal,1,0
12377,syncope,1,1
12378,.,1,0
12379,AIMS,0,0
12380,To,0,0
12381,compare,0,0
12382,the,0,0
12383,sensitivity,0,0
12384,",",0,0
12385,specificity,0,0
12386,and,0,0
12387,adverse,0,0
12388,event,0,0
12389,profile,0,0
12390,of,0,0
12391,glyceryl,0,0
12392,trinitrate,0,0
12393,head-up,0,0
12394,tilt,0,0
12395,with,0,1
12396,isoprenaline,0,0
12397,head-up,0,0
12398,tilt,0,0
12399,in,0,0
12400,the,0,0
12401,diagnosis,0,0
12402,of,0,0
12403,vasovagal,0,0
12404,syncope,0,1
12405,in,0,0
12406,patients,1,1
12407,with,1,1
12408,unexplained,1,1
12409,syncope,1,1
12410,and,1,0
12411,healthy,1,1
12412,controls,1,1
12413,.,1,1
12414,METHODS,0,0
12415,AND,0,0
12416,RESULTS,0,0
12417,Forty-eight,1,1
12418,patients,1,1
12419,with,1,1
12420,unexplained,1,1
12421,syncope,1,1
12422,and,1,0
12423,negative,1,0
12424,passive,1,0
12425,head-up,1,0
12426,tilt,1,0
12427,at,1,0
12428,70,1,1
12429,degrees,1,0
12430,for,1,0
12431,40,1,1
12432,min,1,0
12433,",",1,0
12434,and,1,0
12435,14,1,0
12436,healthy,1,1
12437,controls,1,1
12438,underwent,0,1
12439,glyceryl,0,0
12440,trinitrate,0,0
12441,head-up,0,0
12442,tilt,0,0
12443,and,0,0
12444,isoprenaline,0,0
12445,head-up,0,0
12446,tilt,0,0
12447,(,0,0
12448,maximum,0,0
12449,dose,0,0
12450,5,0,0
12451,microg,0,0
12452,x,0,0
12453,min,0,0
12454,(,0,0
12455,-1,0,0
12456,),0,0
12457,),0,0
12458,one,0,0
12459,week,0,0
12460,apart,0,0
12461,in,0,0
12462,random,0,0
12463,order,0,0
12464,.,0,0
12465,Outcome,0,0
12466,measures,0,0
12467,were,0,0
12468,production,0,0
12469,of,0,0
12470,symptoms,0,0
12471,(,0,0
12472,syncope,0,1
12473,",",0,0
12474,pre-syncope,0,0
12475,),0,0
12476,with,0,0
12477,development,0,0
12478,of,0,0
12479,hypotension,0,0
12480,.,0,0
12481,In,0,0
12482,those,0,0
12483,with,0,0
12484,negative,1,0
12485,passive,1,0
12486,head-up,1,0
12487,tilt,1,0
12488,",",0,0
12489,the,0,0
12490,sensitivity,0,0
12491,of,0,0
12492,glyceryl,0,0
12493,trinitrate,0,0
12494,for,0,0
12495,diagnosing,0,0
12496,vasovagal,0,0
12497,syncope,0,1
12498,was,0,0
12499,48,0,0
12500,%,0,0
12501,and,0,0
12502,the,0,0
12503,specificity,0,0
12504,was,0,0
12505,71,0,1
12506,%,0,0
12507,.,0,0
12508,Glyceryl,0,0
12509,trinitrate,0,0
12510,was,0,0
12511,well,0,0
12512,tolerated,0,0
12513,.,0,0
12514,Isoprenaline,0,0
12515,sensitivity,0,0
12516,was,0,0
12517,21,0,1
12518,%,0,0
12519,with,0,1
12520,specificity,0,0
12521,64,0,0
12522,%,0,0
12523,.,0,0
12524,Side-effects,0,0
12525,prevented,0,0
12526,completion,0,0
12527,of,0,0
12528,the,0,0
12529,test,0,0
12530,in,0,0
12531,68,0,1
12532,%,0,0
12533,.,0,0
12534,Commonest,0,0
12535,adverse,0,0
12536,events,0,0
12537,were,0,0
12538,the,0,0
12539,development,0,0
12540,of,0,0
12541,hypertension,0,1
12542,or,0,0
12543,tachycardia,0,0
12544,and,0,0
12545,intolerable,0,0
12546,flushing,0,0
12547,or,0,0
12548,nausea,0,0
12549,.,0,0
12550,CONCLUSIONS,0,0
12551,Glyceryl,0,0
12552,trinitrate,0,0
12553,head-up,0,0
12554,tilt,0,0
12555,is,0,0
12556,as,0,0
12557,effective,0,0
12558,as,0,0
12559,isoprenaline,0,0
12560,head-up,0,0
12561,tilt,0,0
12562,as,0,0
12563,a,0,0
12564,provocative,0,0
12565,agent,0,0
12566,for,0,0
12567,vasovagal,0,0
12568,syncope,0,1
12569,and,0,0
12570,has,0,0
12571,a,0,0
12572,lower,0,0
12573,incidence,0,0
12574,of,0,0
12575,adverse,0,0
12576,events,0,0
12577,.,0,1
12578,Variability,0,0
12579,in,0,0
12580,isochronous,1,0
12581,tapping,1,0
12582,:,1,1
12583,higher,0,0
12584,order,0,0
12585,dependencies,0,0
12586,as,0,0
12587,a,0,0
12588,function,0,0
12589,of,0,0
12590,intertap,0,0
12591,interval,0,0
12592,.,0,0
12593,Isochronous,1,0
12594,serial,1,0
12595,interval,1,0
12596,production,1,0
12597,(,1,0
12598,ISIP,1,0
12599,),1,0
12600,data,0,0
12601,",",0,0
12602,as,0,0
12603,from,0,0
12604,unpaced,0,0
12605,finger,0,0
12606,tapping,0,0
12607,",",0,0
12608,exhibit,0,0
12609,higher,0,0
12610,order,0,0
12611,dependencies,0,0
12612,(,0,0
12613,drift,0,0
12614,),0,0
12615,.,0,0
12616,This,0,0
12617,fact,0,0
12618,has,0,0
12619,largely,0,0
12620,been,0,0
12621,ignored,0,0
12622,by,0,0
12623,the,0,0
12624,timing,0,0
12625,literature,0,0
12626,",",0,0
12627,one,0,0
12628,reason,0,0
12629,probably,0,0
12630,being,0,0
12631,that,0,0
12632,influential,0,0
12633,timing,0,0
12634,models,0,0
12635,assume,0,0
12636,random,0,0
12637,variability,0,0
12638,.,0,0
12639,Men,1,0
12640,and,1,0
12641,women,1,1
12642,",",1,0
12643,22-36,1,0
12644,years,1,1
12645,old,1,1
12646,",",0,0
12647,performed,0,0
12648,a,0,0
12649,synchronization-continuation,0,0
12650,task,0,0
12651,with,0,1
12652,intertap,0,0
12653,intervals,0,0
12654,(,0,0
12655,ITI,0,1
12656,),0,0
12657,from,0,0
12658,0.4,0,0
12659,s,0,0
12660,to,0,1
12661,2.2,0,0
12662,s.,0,0
12663,ISIP,0,1
12664,variability,0,0
12665,was,0,0
12666,partitioned,0,0
12667,into,0,1
12668,components,0,0
12669,attributable,0,0
12670,to,0,0
12671,drift,0,0
12672,and,0,0
12673,1st-order,0,0
12674,serial,0,0
12675,correlation,0,0
12676,",",0,0
12677,and,0,0
12678,the,0,0
12679,results,0,0
12680,indicate,0,0
12681,that,0,0
12682,(,0,0
12683,a,0,0
12684,),0,0
12685,drift,0,0
12686,contributes,0,0
12687,substantially,0,0
12688,to,0,0
12689,the,0,0
12690,dispersion,0,0
12691,for,0,0
12692,longer,0,0
12693,ITIs,0,0
12694,",",0,0
12695,(,0,0
12696,b,0,0
12697,),0,0
12698,drift,0,0
12699,and,0,0
12700,1st-order,0,0
12701,correlation,0,0
12702,are,0,0
12703,different,0,0
12704,functions,0,0
12705,of,0,0
12706,the,0,0
12707,ITI,0,0
12708,",",0,0
12709,and,0,0
12710,(,0,0
12711,c,0,0
12712,),0,0
12713,drift,0,0
12714,exhibits,0,0
12715,break,0,0
12716,close,0,0
12717,to,0,0
12718,1.0,0,0
12719,s,0,0
12720,and,0,0
12721,1.4,0,0
12722,s,0,0
12723,ITI,0,0
12724,.,0,0
12725,These,0,0
12726,breaks,0,0
12727,correspond,0,0
12728,to,0,0
12729,qualitative,0,0
12730,changes,0,0
12731,in,0,0
12732,performance,0,0
12733,for,0,0
12734,other,0,0
12735,temporal,0,0
12736,tasks,0,0
12737,",",0,0
12738,which,0,0
12739,suggests,0,0
12740,common,0,0
12741,timing,0,0
12742,processes,0,0
12743,across,0,0
12744,modalities,0,0
12745,and,0,1
12746,tasks,0,0
12747,.,0,1
12748,Physiologic,0,0
12749,modeling,0,0
12750,of,0,0
12751,the,0,0
12752,intravenous,0,0
12753,glucose,0,0
12754,tolerance,0,0
12755,test,0,0
12756,in,0,0
12757,type,1,1
12758,2,1,1
12759,diabetes,1,1
12760,:,1,1
12761,a,0,0
12762,new,0,0
12763,approach,0,0
12764,to,0,0
12765,the,0,0
12766,insulin,0,0
12767,compartment,0,0
12768,.,0,0
12769,The,0,0
12770,minimal,0,0
12771,model,0,0
12772,of,0,0
12773,Bergman,0,0
12774,et,0,0
12775,al,0,0
12776,has,0,0
12777,been,0,0
12778,used,0,0
12779,to,0,0
12780,yield,0,0
12781,estimates,0,0
12782,of,0,0
12783,insulin,0,0
12784,sensitivity,0,0
12785,(,0,0
12786,Si,0,0
12787,),0,0
12788,and,0,0
12789,glucose,0,0
12790,effectiveness,0,0
12791,(,0,0
12792,Sg,0,0
12793,),0,0
12794,in,0,0
12795,type,0,1
12796,2,0,0
12797,diabetes,0,1
12798,by,0,0
12799,incorporating,0,0
12800,exogenous,0,0
12801,insulin,0,0
12802,protocols,0,0
12803,into,0,0
12804,the,0,0
12805,regular,0,0
12806,intravenous,0,0
12807,glucose,0,0
12808,tolerance,0,0
12809,test,0,0
12810,(,0,0
12811,IVGTT,0,1
12812,),0,0
12813,.,0,0
12814,These,0,0
12815,estimates,0,0
12816,",",0,0
12817,however,0,0
12818,",",0,0
12819,are,0,0
12820,influenced,0,0
12821,by,0,0
12822,the,0,0
12823,degree,0,0
12824,to,0,0
12825,which,0,0
12826,the,0,0
12827,dose,0,0
12828,of,0,0
12829,exogenous,0,0
12830,insulin,0,0
12831,is,0,0
12832,greater,0,0
12833,than,0,0
12834,the,0,0
12835,physiologic,0,0
12836,response,0,0
12837,to,0,0
12838,a,0,0
12839,glucose,0,0
12840,load,0,0
12841,.,0,0
12842,Moreover,0,0
12843,",",0,0
12844,most,0,0
12845,studies,0,0
12846,have,0,0
12847,related,0,0
12848,to,0,0
12849,type,1,1
12850,2,1,0
12851,diabetes,1,1
12852,subjects,1,1
12853,whose,0,1
12854,diabetes,0,1
12855,was,0,1
12856,relatively,0,0
12857,mild,0,1
12858,in,0,0
12859,terms,0,0
12860,of,0,0
12861,therapeutic,0,0
12862,requirements,0,0
12863,.,0,0
12864,To,0,0
12865,develop,0,0
12866,a,0,0
12867,minimal,0,0
12868,disturbance,0,0
12869,approach,0,0
12870,in,0,0
12871,estimating,0,0
12872,Si,0,0
12873,and,0,0
12874,Sg,0,0
12875,in,0,0
12876,type,0,1
12877,2,0,0
12878,diabetes,0,1
12879,",",0,0
12880,we,0,0
12881,have,0,0
12882,used,0,0
12883,a,0,0
12884,reduced,0,0
12885,glucose,0,0
12886,load,0,0
12887,(,0,0
12888,200,0,0
12889,mg/kg,0,0
12890,),0,0
12891,and,0,0
12892,a,0,0
12893,physiologic,0,0
12894,insulin,0,0
12895,infusion,0,0
12896,throughout,0,0
12897,the,0,0
12898,IVGTT,0,0
12899,in,0,0
12900,a,0,0
12901,series,0,0
12902,of,0,0
12903,8,1,0
12904,patients,1,1
12905,",",1,0
12906,5,1,1
12907,of,1,0
12908,whom,1,1
12909,were,1,1
12910,insulin-requiring,1,1
12911,.,1,0
12912,Data,0,0
12913,from,0,0
12914,this,0,0
12915,approach,0,0
12916,were,0,0
12917,analyzed,0,0
12918,using,0,0
12919,the,0,0
12920,modelling,0,0
12921,program,0,0
12922,CONSAM,0,0
12923,to,0,0
12924,apply,0,0
12925,the,0,0
12926,Bergman,0,0
12927,model,0,0
12928,",",0,0
12929,either,0,0
12930,unmodified,0,0
12931,(,0,0
12932,BMM,0,1
12933,),0,0
12934,",",0,0
12935,or,0,0
12936,incorporating,0,0
12937,an,0,0
12938,additional,0,0
12939,delay,0,0
12940,element,0,0
12941,between,0,0
12942,the,0,0
12943,plasma,0,0
12944,and,0,0
12945,remote,0,0
12946,insulin,0,0
12947,compartments,0,0
12948,(,0,0
12949,MMD,0,0
12950,),0,0
12951,.,0,0
12952,Application,0,0
12953,of,0,0
12954,the,0,0
12955,MMD,0,0
12956,and,0,0
12957,extension,0,0
12958,of,0,0
12959,the,0,0
12960,IVGTT,0,0
12961,from,0,0
12962,3,0,0
12963,to,0,0
12964,5,0,0
12965,hours,0,0
12966,improved,0,0
12967,successful,0,0
12968,resolution,0,0
12969,of,0,0
12970,Si,0,0
12971,and,0,0
12972,Sg,0,0
12973,from,0,0
12974,37.5,0,0
12975,%,0,0
12976,(,0,0
12977,BMM,0,1
12978,",",0,0
12979,3-hour,0,0
12980,IVGTT,0,1
12981,),0,0
12982,to,0,0
12983,100,0,0
12984,%,0,0
12985,(,0,0
12986,MMD,0,0
12987,",",0,0
12988,5-hour,0,0
12989,IVGTT,0,1
12990,),0,0
12991,.,0,0
12992,Si,0,0
12993,was,0,0
12994,reduced,0,0
12995,in,0,0
12996,these,0,0
12997,type,0,0
12998,2,0,0
12999,diabetes,0,1
13000,patients,0,1
13001,compared,0,0
13002,with,0,1
13003,normal,0,1
13004,subjects,0,1
13005,(,0,0
13006,1.86,0,0
13007,+/-,0,0
13008,0.60,0,0
13009,v.,0,0
13010,8.65,0,0
13011,+/-,0,0
13012,2.27,0,0
13013,min,0,0
13014,(,0,0
13015,-1,0,0
13016,),0,0
13017,x,0,0
13018,microU,0,0
13019,(,0,0
13020,-1,0,0
13021,),0,0
13022,x,0,0
13023,mL,0,0
13024,x,0,0
13025,10,0,0
13026,(,0,0
13027,4,0,0
13028,),0,0
13029,P,0,0
13030,<,0,0
13031,.01,0,0
13032,),0,0
13033,.,0,0
13034,The,0,0
13035,results,0,0
13036,were,0,0
13037,validated,0,0
13038,in,0,0
13039,the,0,0
13040,type,1,1
13041,2,1,0
13042,diabetes,1,1
13043,group,1,0
13044,using,0,0
13045,a,0,0
13046,2-stage,0,0
13047,euglycemic,0,0
13048,clamp,0,0
13049,(,0,0
13050,(,0,0
13051,Si,0,0
13052,),0,0
13053,CLAMP,0,0
13054,=,0,0
13055,2.02,0,0
13056,+/-,0,0
13057,0.42,0,0
13058,min,0,0
13059,(,0,0
13060,-1,0,0
13061,),0,0
13062,x,0,0
13063,microU,0,0
13064,(,0,0
13065,-1,0,0
13066,),0,0
13067,x,0,0
13068,mL,0,0
13069,x,0,0
13070,10,0,0
13071,(,0,0
13072,4,0,0
13073,),0,0
13074,P,0,0
13075,>,0,1
13076,.4,0,0
13077,),0,0
13078,.,0,0
13079,Sg,0,0
13080,was,0,0
13081,not,0,0
13082,significantly,0,0
13083,reduced,0,0
13084,(,0,0
13085,2.00,0,0
13086,+/-,0,0
13087,0.25,0,0
13088,type,0,1
13089,2,0,0
13090,diabetes,0,1
13091,v.,0,0
13092,1.55,0,0
13093,+/-,0,0
13094,0.26,0,0
13095,normal,0,1
13096,min,0,0
13097,(,0,0
13098,-1,0,0
13099,),0,0
13100,x,0,0
13101,10,0,0
13102,(,0,0
13103,2,0,0
13104,),0,0
13105,),0,0
13106,.,0,0
13107,Data,0,0
13108,from,0,0
13109,a,0,0
13110,group,0,0
13111,of,0,0
13112,normal,1,1
13113,nondiabetic,1,1
13114,subjects,1,1
13115,was,0,0
13116,then,0,0
13117,analyzed,0,0
13118,using,0,0
13119,the,0,0
13120,MMD,0,0
13121,",",0,0
13122,but,0,0
13123,this,0,0
13124,approach,0,0
13125,did,0,0
13126,not,0,0
13127,enhance,0,0
13128,the,0,0
13129,fit,0,0
13130,of,0,0
13131,the,0,0
13132,model,0,0
13133,compared,0,0
13134,with,0,0
13135,the,0,0
13136,BMM,0,1
13137,.,0,0
13138,This,0,0
13139,result,0,0
13140,indicates,0,0
13141,that,0,0
13142,the,0,0
13143,delay,0,0
13144,in,0,0
13145,insulin,0,0
13146,action,0,0
13147,in,0,0
13148,type,0,1
13149,2,0,0
13150,diabetes,0,1
13151,represents,0,0
13152,an,0,0
13153,abnormality,0,0
13154,whereby,0,0
13155,the,0,0
13156,onset,0,0
13157,of,0,0
13158,insulin,0,0
13159,action,0,0
13160,can,0,0
13161,not,0,0
13162,be,0,0
13163,described,0,0
13164,as,0,0
13165,a,0,0
13166,single,0,0
13167,phase,0,0
13168,in,0,0
13169,the,0,0
13170,transfer,0,0
13171,of,0,0
13172,insulin,0,0
13173,from,0,0
13174,plasma,0,0
13175,to,0,0
13176,the,0,0
13177,remote,0,0
13178,compartment,0,0
13179,.,0,0
13180,It,0,0
13181,is,0,0
13182,postulated,0,0
13183,that,0,0
13184,the,0,0
13185,physiologic,0,0
13186,basis,0,0
13187,for,0,0
13188,this,0,0
13189,delayed,0,0
13190,action,0,0
13191,may,0,0
13192,relate,0,0
13193,to,0,0
13194,transcapillary,0,0
13195,endothelial,0,0
13196,transfer,0,0
13197,of,0,0
13198,insulin,0,0
13199,",",0,0
13200,this,0,0
13201,process,0,0
13202,limiting,0,0
13203,the,0,0
13204,rate,0,0
13205,of,0,0
13206,onset,0,0
13207,of,0,0
13208,insulin,0,0
13209,action,0,0
13210,.,0,0
13211,Comparative,0,0
13212,evaluation,0,0
13213,of,0,0
13214,calcium,0,0
13215,hydroxide,0,0
13216,and,0,0
13217,zinc,0,0
13218,oxide,0,0
13219,eugenol,0,0
13220,as,0,0
13221,root,1,0
13222,canal,1,1
13223,filling,1,0
13224,materials,1,1
13225,for,1,0
13226,primary,1,1
13227,molars,1,1
13228,:,1,1
13229,a,0,0
13230,clinical,0,0
13231,and,0,0
13232,radiographic,0,0
13233,study,0,0
13234,.,0,0
13235,Calcium,0,0
13236,hydroxide,0,0
13237,",",0,0
13238,a,0,0
13239,material,0,0
13240,widely,0,0
13241,used,0,0
13242,for,0,0
13243,the,0,0
13244,treatment,0,0
13245,of,0,0
13246,permanent,0,1
13247,teeth,0,1
13248,has,0,0
13249,not,0,0
13250,been,0,0
13251,used,0,0
13252,frequently,0,0
13253,for,0,0
13254,pulpectomy,0,0
13255,in,0,0
13256,primary,0,1
13257,teeth,0,1
13258,.,0,0
13259,A,0,0
13260,comparative,0,0
13261,evaluation,0,0
13262,of,0,0
13263,calcium,0,0
13264,hydroxide,0,0
13265,and,0,0
13266,zinc,0,0
13267,oxide,0,0
13268,eugenol,0,0
13269,used,0,0
13270,as,0,0
13271,root,0,0
13272,canal,0,1
13273,filling,0,0
13274,materials,0,1
13275,in,0,0
13276,primary,1,1
13277,molars,1,1
13278,is,0,0
13279,presented,0,0
13280,.,0,0
13281,A,0,0
13282,randomized,0,0
13283,controlled,0,0
13284,trial,0,0
13285,assessing,0,0
13286,the,0,0
13287,health,1,0
13288,economics,1,0
13289,of,1,0
13290,realtime,1,0
13291,teledermatology,1,0
13292,compared,1,0
13293,with,1,0
13294,conventional,1,0
13295,care,1,1
13296,:,1,1
13297,an,0,0
13298,urban,1,1
13299,versus,1,0
13300,rural,1,1
13301,perspective,1,0
13302,.,1,0
13303,A,0,0
13304,randomized,0,0
13305,controlled,0,0
13306,trial,0,0
13307,was,0,0
13308,carried,0,0
13309,out,0,0
13310,to,0,0
13311,measure,0,0
13312,the,0,0
13313,cost-effectiveness,0,0
13314,of,0,0
13315,realtime,0,0
13316,teledermatology,0,0
13317,compared,0,0
13318,with,0,0
13319,conventional,0,0
13320,outpatient,0,1
13321,dermatology,0,1
13322,care,0,0
13323,for,0,0
13324,patients,1,1
13325,from,1,1
13326,urban,1,1
13327,and,1,0
13328,rural,1,1
13329,areas,1,0
13330,.,1,1
13331,One,0,0
13332,urban,0,1
13333,and,0,0
13334,one,0,0
13335,rural,0,1
13336,health,0,1
13337,centre,0,1
13338,were,0,0
13339,linked,0,0
13340,to,0,0
13341,a,0,0
13342,regional,0,0
13343,hospital,0,0
13344,in,0,0
13345,Northern,0,1
13346,Ireland,0,1
13347,by,0,0
13348,ISDN,0,0
13349,at,0,0
13350,128,0,1
13351,kbit/s,0,0
13352,.,0,0
13353,Over,1,0
13354,two,1,0
13355,years,1,1
13356,",",1,0
13357,274,1,1
13358,patients,1,1
13359,required,1,0
13360,a,1,0
13361,hospital,1,0
13362,outpatient,1,1
13363,dermatology,1,1
13364,referral,1,1
13365,--,1,1
13366,126,1,1
13367,patients,1,1
13368,(,1,0
13369,46,1,1
13370,%,1,0
13371,),1,0
13372,were,0,0
13373,randomized,0,0
13374,to,0,0
13375,a,0,0
13376,telemedicine,0,0
13377,consultation,0,0
13378,and,0,0
13379,148,0,1
13380,(,0,0
13381,54,0,1
13382,%,0,0
13383,),0,0
13384,to,0,0
13385,a,0,0
13386,conventional,0,0
13387,hospital,0,0
13388,outpatient,0,1
13389,consultation,0,0
13390,.,0,0
13391,Of,0,0
13392,those,0,0
13393,seen,0,0
13394,by,0,0
13395,telemedicine,0,0
13396,",",0,0
13397,61,0,0
13398,%,0,0
13399,were,0,0
13400,registered,0,0
13401,with,0,0
13402,an,0,0
13403,urban,0,1
13404,practice,0,0
13405,",",0,0
13406,compared,0,0
13407,with,0,0
13408,71,0,1
13409,%,0,0
13410,of,0,0
13411,those,0,0
13412,seen,0,0
13413,conventionally,0,0
13414,.,0,0
13415,The,0,0
13416,clinical,0,0
13417,outcomes,0,0
13418,of,0,0
13419,the,0,0
13420,two,0,0
13421,types,0,0
13422,of,0,0
13423,consultation,0,0
13424,were,0,0
13425,similar,0,0
13426,--,0,0
13427,almost,0,0
13428,half,0,0
13429,the,0,0
13430,patients,0,1
13431,were,0,0
13432,managed,0,1
13433,after,0,0
13434,a,0,0
13435,single,0,0
13436,consultation,0,0
13437,with,0,0
13438,the,0,0
13439,dermatologist,0,0
13440,.,0,0
13441,The,0,0
13442,observed,0,0
13443,marginal,0,0
13444,cost,0,0
13445,per,0,0
13446,patient,0,0
13447,of,0,0
13448,the,0,0
13449,initial,0,0
13450,realtime,0,0
13451,teledermatology,0,0
13452,consultation,0,0
13453,was,0,0
13454,52.85,0,0
13455,Pounds,0,0
13456,for,0,0
13457,those,0,0
13458,in,0,0
13459,urban,0,1
13460,areas,0,0
13461,and,0,0
13462,59.93,0,0
13463,Pounds,0,0
13464,per,0,0
13465,patient,0,0
13466,for,0,0
13467,those,0,0
13468,from,0,0
13469,rural,0,1
13470,areas,0,0
13471,.,0,0
13472,The,0,0
13473,observed,0,0
13474,marginal,0,0
13475,cost,0,0
13476,of,0,0
13477,the,0,0
13478,initial,0,0
13479,conventional,0,0
13480,consultation,0,0
13481,was,0,0
13482,47.13,0,0
13483,Pounds,0,0
13484,for,0,0
13485,urban,1,1
13486,patients,1,1
13487,and,0,0
13488,48.77,0,0
13489,Pounds,0,0
13490,for,0,0
13491,rural,1,1
13492,patients,1,1
13493,.,1,0
13494,The,0,0
13495,total,0,0
13496,observed,0,0
13497,costs,0,0
13498,of,0,0
13499,teledermatology,0,0
13500,were,0,0
13501,higher,0,0
13502,than,0,0
13503,the,0,0
13504,costs,0,0
13505,of,0,0
13506,conventional,0,0
13507,care,0,0
13508,in,0,0
13509,both,0,0
13510,urban,0,1
13511,and,0,0
13512,rural,0,1
13513,areas,0,0
13514,",",0,0
13515,mainly,0,0
13516,because,0,0
13517,of,0,0
13518,the,0,0
13519,fixed,0,0
13520,equipment,0,0
13521,costs,0,0
13522,.,0,0
13523,Sensitivity,0,0
13524,analysis,0,0
13525,using,0,0
13526,a,0,0
13527,real-world,0,0
13528,scenario,0,0
13529,showed,0,0
13530,that,0,0
13531,in,1,0
13532,urban,1,1
13533,areas,1,0
13534,the,0,0
13535,average,0,0
13536,costs,0,0
13537,of,0,0
13538,the,0,0
13539,telemedicine,0,0
13540,and,0,0
13541,conventional,0,0
13542,consultations,0,0
13543,were,0,0
13544,about,0,0
13545,equal,0,0
13546,",",0,0
13547,while,0,0
13548,in,1,0
13549,rural,1,1
13550,areas,1,0
13551,the,0,0
13552,average,0,0
13553,cost,0,0
13554,of,0,0
13555,the,0,0
13556,telemedicine,0,0
13557,consultation,0,0
13558,was,0,0
13559,less,0,0
13560,than,0,0
13561,that,0,0
13562,of,0,0
13563,the,0,0
13564,conventional,0,0
13565,consultation,0,0
13566,.,0,0
13567,Clinical,0,0
13568,description,0,0
13569,of,0,0
13570,encephalopathic,0,1
13571,syndromes,0,0
13572,and,0,0
13573,risk,0,0
13574,factors,0,0
13575,for,0,0
13576,their,0,0
13577,occurrence,0,0
13578,and,0,0
13579,outcome,0,0
13580,during,0,0
13581,melarsoprol,0,0
13582,treatment,0,0
13583,of,0,0
13584,human,1,0
13585,African,1,1
13586,trypanosomiasis,1,1
13587,.,1,0
13588,Encephalopathies,0,0
13589,are,0,0
13590,the,0,0
13591,most,0,0
13592,feared,0,0
13593,complications,0,0
13594,of,0,0
13595,sleeping,0,0
13596,sickness,0,1
13597,treatment,0,0
13598,with,0,1
13599,melarsoprol,0,0
13600,.,0,0
13601,To,0,0
13602,investigate,0,0
13603,the,0,0
13604,existence,0,0
13605,of,0,0
13606,risk,0,0
13607,factors,0,0
13608,",",0,0
13609,the,0,0
13610,incidence,0,0
13611,of,0,0
13612,encephalopathic,0,1
13613,syndromes,0,0
13614,and,0,0
13615,the,0,0
13616,relationship,0,0
13617,between,0,0
13618,the,0,0
13619,development,0,0
13620,of,0,0
13621,different,0,0
13622,types,0,0
13623,of,0,0
13624,encephalopathies,0,1
13625,and,0,0
13626,the,0,0
13627,clinical,0,0
13628,outcome,0,0
13629,was,0,0
13630,studied,0,0
13631,in,0,0
13632,a,0,0
13633,clinical,0,0
13634,trial,0,0
13635,with,0,1
13636,588,1,1
13637,patients,1,1
13638,under,1,1
13639,treatment,1,0
13640,with,1,1
13641,melarsoprol,1,0
13642,.,1,0
13643,The,0,0
13644,38,1,0
13645,encephalopathy,1,0
13646,cases,1,1
13647,were,0,0
13648,classified,0,1
13649,into,0,1
13650,three,0,0
13651,types,0,0
13652,according,0,1
13653,to,0,0
13654,the,0,0
13655,leading,0,0
13656,clinical,0,0
13657,picture,0,0
13658,:,0,1
13659,coma,0,0
13660,type,0,0
13661,",",0,0
13662,convulsion,0,0
13663,type,0,1
13664,and,0,0
13665,psychotic,0,1
13666,reactions,0,0
13667,.,0,1
13668,Nine,1,0
13669,patients,1,1
13670,were,1,0
13671,attributed,1,0
13672,to,1,0
13673,the,1,0
13674,convulsion,1,0
13675,type,1,0
13676,",",0,0
13677,defined,0,0
13678,as,0,0
13679,a,0,0
13680,transient,0,0
13681,event,0,0
13682,of,0,0
13683,short,0,0
13684,duration,0,0
13685,with,0,1
13686,convulsions,0,0
13687,followed,0,0
13688,by,0,0
13689,a,0,0
13690,post-ictal,0,0
13691,phase,0,0
13692,",",0,0
13693,without,0,0
13694,signs,0,0
13695,of,0,0
13696,a,0,0
13697,generalized,0,0
13698,disease,0,1
13699,.,0,0
13700,None,0,0
13701,of,0,0
13702,these,0,0
13703,patients,0,1
13704,died,0,1
13705,from,0,0
13706,the,0,0
13707,reaction,0,0
13708,.,0,0
13709,Febrile,0,0
13710,reactions,0,0
13711,in,0,0
13712,the,0,0
13713,48,0,0
13714,h,0,0
13715,preceding,0,0
13716,the,0,0
13717,reaction,0,0
13718,were,0,0
13719,generally,0,0
13720,not,0,0
13721,observed,0,0
13722,in,0,0
13723,this,0,0
13724,group,0,0
13725,.,0,0
13726,Twenty-five,0,1
13727,patients,0,1
13728,were,0,0
13729,attributed,0,0
13730,to,0,0
13731,the,0,0
13732,coma,0,0
13733,type,0,0
13734,",",0,0
13735,which,0,0
13736,is,0,0
13737,a,0,0
13738,progredient,0,0
13739,coma,0,0
13740,lasting,0,0
13741,several,0,0
13742,days,0,0
13743,.,0,1
13744,Those,0,0
13745,patients,0,1
13746,often,0,0
13747,had,0,0
13748,signs,0,0
13749,of,0,0
13750,a,0,0
13751,generalized,0,0
13752,disease,0,1
13753,such,0,0
13754,as,0,0
13755,fever,0,0
13756,(,0,0
13757,84,0,1
13758,%,0,0
13759,),0,0
13760,",",0,0
13761,headache,0,0
13762,(,0,0
13763,72,0,0
13764,%,0,0
13765,),0,0
13766,or,0,0
13767,bullous,0,1
13768,skin,0,0
13769,(,0,0
13770,8,0,0
13771,%,0,0
13772,),0,0
13773,reactions,0,0
13774,.,0,0
13775,The,0,0
13776,risk,0,0
13777,of,0,0
13778,mortality,0,0
13779,was,0,0
13780,high,0,0
13781,in,0,0
13782,this,0,0
13783,group,0,0
13784,(,0,0
13785,52,0,0
13786,%,0,0
13787,),0,0
13788,.,0,0
13789,About,0,0
13790,14/16,0,0
13791,patients,0,1
13792,with,0,1
13793,encephalopathic,0,1
13794,syndrome,0,1
13795,of,0,0
13796,the,0,0
13797,coma,0,0
13798,type,0,1
13799,were,0,0
13800,infected,0,1
13801,with,0,1
13802,malaria,0,1
13803,.,0,1
13804,Patients,0,1
13805,with,0,1
13806,psychotic,0,1
13807,reactions,0,0
13808,or,0,1
13809,abnormal,0,0
13810,psychiatric,0,1
13811,behaviour,0,0
13812,(,0,0
13813,3/38,0,0
13814,),0,0
13815,and,0,0
13816,one,0,1
13817,patient,0,1
13818,who,0,1
13819,died,0,1
13820,after,0,1
13821,alcohol,0,1
13822,intake,0,0
13823,were,0,0
13824,excluded,0,0
13825,from,0,0
13826,the,0,0
13827,analysis,0,0
13828,.,0,0
13829,The,0,0
13830,overall,0,0
13831,rate,0,0
13832,of,0,0
13833,encephalopathic,0,1
13834,syndromes,0,0
13835,in,0,0
13836,the,0,0
13837,cases,0,0
13838,analysed,0,0
13839,(,0,0
13840,n=34,0,1
13841,),0,0
13842,was,0,0
13843,5.8,0,0
13844,%,0,0
13845,",",0,0
13846,of,0,0
13847,which,0,0
13848,38.2,0,0
13849,%,0,0
13850,died,0,1
13851,.,0,0
13852,We,0,0
13853,did,0,0
13854,not,0,0
13855,find,0,0
13856,any,0,0
13857,parameters,0,0
13858,of,0,0
13859,predictive,0,0
13860,value,0,0
13861,for,0,0
13862,the,0,0
13863,risk,0,0
13864,of,0,0
13865,developing,0,0
13866,an,0,0
13867,encephalopathic,0,0
13868,syndrome,0,1
13869,based,0,0
13870,on,0,0
13871,the,0,0
13872,symptoms,0,0
13873,and,0,0
13874,signs,0,0
13875,before,0,0
13876,treatment,0,0
13877,initiation,0,0
13878,.,0,0
13879,The,0,0
13880,appearance,0,0
13881,during,0,0
13882,treatment,0,0
13883,of,0,0
13884,febrile,0,1
13885,reactions,0,0
13886,(,0,0
13887,RR,0,0
13888,11.5,0,0
13889,),0,0
13890,",",0,0
13891,headache,0,0
13892,(,0,0
13893,RR,0,0
13894,2.5,0,0
13895,),0,0
13896,",",0,0
13897,bullous,0,1
13898,eruptions,0,0
13899,(,0,0
13900,RR,0,0
13901,4.5,0,0
13902,),0,0
13903,and,0,0
13904,systolic,0,0
13905,hypotension,0,0
13906,(,0,0
13907,RR,0,0
13908,2.6,0,0
13909,),0,0
13910,were,0,0
13911,associated,0,0
13912,with,0,0
13913,an,0,0
13914,increased,0,0
13915,risk,0,0
13916,for,0,0
13917,the,0,0
13918,occurrence,0,0
13919,of,0,0
13920,encephalopathic,0,1
13921,syndromes,0,0
13922,especially,0,0
13923,of,0,0
13924,the,0,0
13925,coma,0,0
13926,type,0,1
13927,.,0,0
13928,Clinical,0,0
13929,and,0,0
13930,microbial,0,0
13931,evaluation,0,0
13932,of,0,0
13933,a,0,0
13934,histatin-containing,0,0
13935,mouthrinse,0,0
13936,in,0,0
13937,humans,1,0
13938,with,1,1
13939,experimental,1,0
13940,gingivitis,1,1
13941,.,1,0
13942,OBJECTIVE,0,0
13943,P-113,0,0
13944,",",0,0
13945,a,0,0
13946,12,0,0
13947,amino,0,0
13948,acid,0,0
13949,histatin-based,0,0
13950,peptide,0,0
13951,",",0,0
13952,was,0,0
13953,evaluated,0,0
13954,in,0,0
13955,a,0,0
13956,mouthrinse,0,0
13957,formulation,0,0
13958,for,0,0
13959,safety,0,0
13960,",",0,0
13961,prevention,0,0
13962,of,0,0
13963,the,0,0
13964,development,0,0
13965,of,0,0
13966,experimental,0,0
13967,gingivitis,0,1
13968,",",0,0
13969,and,0,0
13970,for,0,0
13971,its,0,0
13972,effects,0,0
13973,on,0,0
13974,periodontal,0,1
13975,flora,0,1
13976,.,0,0
13977,METHOD,0,0
13978,159,1,0
13979,periodontally,1,1
13980,healthy,1,1
13981,subjects,1,1
13982,abstained,1,1
13983,from,1,0
13984,oral,1,0
13985,hygiene,1,1
13986,procedures,1,0
13987,and,0,0
13988,self-administered,0,0
13989,either,0,0
13990,0.005,0,0
13991,%,0,0
13992,",",0,0
13993,0.01,0,0
13994,%,0,0
13995,",",0,0
13996,0.05,0,0
13997,%,0,0
13998,P-113,0,0
13999,or,0,0
14000,placebo,0,0
14001,mouthrinse,0,0
14002,formulations,0,0
14003,twice,0,0
14004,daily,0,0
14005,over,0,0
14006,a,0,0
14007,four,0,0
14008,week,0,0
14009,treatment,0,0
14010,period,0,0
14011,.,0,0
14012,During,0,0
14013,this,0,0
14014,time,0,0
14015,",",0,0
14016,the,0,0
14017,safety,0,0
14018,",",0,0
14019,anti-plaque,0,0
14020,",",0,0
14021,and,0,0
14022,anti-gingivitis,0,0
14023,effects,0,0
14024,of,0,0
14025,P-113,0,1
14026,were,0,0
14027,evaluated,0,0
14028,.,0,0
14029,RESULTS,0,0
14030,There,0,0
14031,was,0,0
14032,a,0,0
14033,significant,0,0
14034,reduction,0,0
14035,in,0,0
14036,plaque,0,0
14037,(,0,0
14038,p=0.046,0,0
14039,),0,0
14040,and,0,0
14041,a,0,0
14042,reduction,0,0
14043,in,0,0
14044,gingivitis,0,1
14045,(,0,0
14046,p=0.086,0,0
14047,),0,0
14048,for,0,0
14049,subjects,0,1
14050,using,0,0
14051,0.01,0,0
14052,%,0,0
14053,P-113,0,1
14054,mouthrinse,0,0
14055,.,0,0
14056,Significantly,0,0
14057,more,0,0
14058,subjects,0,0
14059,in,0,0
14060,the,0,0
14061,0.01,0,0
14062,%,0,0
14063,and,0,0
14064,0.05,0,0
14065,%,0,0
14066,treatment,0,0
14067,groups,0,0
14068,showed,0,0
14069,a,0,0
14070,small,0,0
14071,increase,0,0
14072,in,0,0
14073,plaque,0,0
14074,index,0,0
14075,of,0,0
14076,<,0,0
14077,0.25,0,0
14078,as,0,0
14079,compared,0,0
14080,to,0,0
14081,the,0,0
14082,placebo,0,0
14083,group,0,0
14084,(,0,0
14085,p,0,0
14086,<,0,0
14087,0.05,0,0
14088,),0,0
14089,.,0,0
14090,Similar,0,0
14091,trends,0,0
14092,were,0,0
14093,noted,0,0
14094,for,0,0
14095,changes,0,0
14096,in,0,0
14097,the,0,0
14098,%,0,0
14099,of,0,0
14100,sites,0,0
14101,with,0,1
14102,bleeding,0,0
14103,on,0,0
14104,probing,0,0
14105,in,0,0
14106,the,0,0
14107,0.01,0,0
14108,%,0,0
14109,P-113,0,1
14110,group,0,0
14111,.,0,0
14112,There,0,0
14113,were,0,0
14114,no,0,0
14115,treatment-related,0,0
14116,adverse,0,0
14117,events,0,0
14118,",",0,0
14119,and,0,0
14120,there,0,0
14121,were,0,0
14122,no,0,0
14123,adverse,0,0
14124,shifts,0,0
14125,in,0,0
14126,supragingival,0,0
14127,microflora,0,0
14128,during,0,0
14129,the,0,0
14130,study,0,0
14131,.,0,0
14132,CONCLUSION,0,0
14133,These,0,0
14134,data,0,0
14135,suggest,0,0
14136,that,0,0
14137,P-113,0,0
14138,mouthrinse,0,0
14139,is,0,0
14140,safe,0,0
14141,and,0,0
14142,reduces,0,0
14143,plaque,1,0
14144,",",1,0
14145,gingivitis,1,0
14146,and,1,0
14147,gingival,1,0
14148,bleeding,1,0
14149,in,1,0
14150,the,1,0
14151,human,1,0
14152,experimental,1,0
14153,gingivitis,1,1
14154,model,1,0
14155,.,1,0
14156,L-arginine,0,0
14157,and,0,0
14158,S-nitrosoglutathione,0,0
14159,reduce,0,0
14160,embolization,0,0
14161,in,0,0
14162,humans,1,0
14163,.,1,1
14164,BACKGROUND,0,0
14165,L-Arginine,0,0
14166,reduces,0,0
14167,platelet,0,0
14168,aggregation,0,0
14169,and,0,0
14170,adhesion,0,0
14171,in,0,0
14172,ex,0,0
14173,vivo,0,0
14174,studies,0,0
14175,",",0,0
14176,but,0,0
14177,there,0,0
14178,is,0,0
14179,no,0,0
14180,evidence,0,0
14181,as,0,0
14182,yet,0,0
14183,that,0,0
14184,it,0,0
14185,has,0,0
14186,a,0,0
14187,therapeutic,0,0
14188,effect,0,0
14189,on,0,0
14190,clinical,0,0
14191,end,0,0
14192,points,0,0
14193,.,0,0
14194,Doppler,0,0
14195,ultrasound,0,0
14196,can,0,0
14197,detect,0,0
14198,cerebral,0,0
14199,emboli,0,0
14200,noninvasively,0,0
14201,.,0,0
14202,Such,0,0
14203,embolic,0,0
14204,signals,0,0
14205,are,0,0
14206,common,0,0
14207,after,0,0
14208,carotid,0,1
14209,endarterectomy,0,1
14210,",",0,0
14211,and,0,0
14212,their,0,0
14213,frequency,0,0
14214,predicts,0,0
14215,risk,0,0
14216,of,0,0
14217,stroke,0,1
14218,recurrence,0,0
14219,.,0,0
14220,We,0,0
14221,used,0,0
14222,this,0,0
14223,situation,0,0
14224,to,0,0
14225,determine,0,0
14226,the,0,0
14227,antiplatelet,0,0
14228,efficacy,0,0
14229,of,0,0
14230,L-arginine,0,0
14231,and,0,0
14232,S-nitrosoglutathione,0,0
14233,(,0,0
14234,GSNO,0,0
14235,),0,0
14236,",",0,0
14237,a,0,0
14238,physiological,0,0
14239,nitric,0,0
14240,oxide,0,0
14241,donor,0,1
14242,with,0,1
14243,possible,0,0
14244,platelet,0,0
14245,specificity,0,0
14246,.,0,0
14247,METHODS,0,0
14248,AND,0,0
14249,RESULTS,0,0
14250,Patients,1,1
14251,undergoing,1,1
14252,carotid,1,1
14253,endarterectomy,1,1
14254,were,0,0
14255,randomized,0,0
14256,in,0,0
14257,a,0,0
14258,double-blind,0,0
14259,manner,0,0
14260,between,0,0
14261,L-arginine,0,0
14262,(,1,0
14263,n=14,1,1
14264,),1,0
14265,",",0,0
14266,GSNO,0,0
14267,(,1,0
14268,n=14,1,1
14269,),1,0
14270,",",0,0
14271,or,0,0
14272,placebo,0,0
14273,(,1,0
14274,n=14,1,1
14275,),1,0
14276,administered,0,0
14277,intravenously,0,0
14278,for,0,0
14279,90,0,0
14280,minutes,0,0
14281,",",0,0
14282,starting,0,0
14283,30,0,0
14284,minutes,0,0
14285,after,0,0
14286,skin,0,1
14287,closure,0,1
14288,.,0,0
14289,All,1,0
14290,patients,1,1
14291,were,1,0
14292,pretreated,1,0
14293,with,1,0
14294,aspirin,1,0
14295,and,1,0
14296,given,1,0
14297,heparin,1,0
14298,during,1,0
14299,surgery,1,1
14300,.,1,0
14301,Transcranial,0,0
14302,Doppler,0,0
14303,recordings,0,0
14304,were,0,0
14305,made,0,0
14306,from,0,0
14307,the,0,0
14308,ipsilateral,0,0
14309,middle,0,1
14310,cerebral,0,1
14311,artery,0,1
14312,for,0,0
14313,4,0,0
14314,hours,0,0
14315,after,0,0
14316,surgery,0,1
14317,",",0,0
14318,beginning,0,0
14319,30,0,0
14320,minutes,0,0
14321,after,0,0
14322,skin,0,0
14323,closure,0,0
14324,",",0,0
14325,and,0,0
14326,also,0,0
14327,at,0,0
14328,6,0,0
14329,and,0,0
14330,24,0,0
14331,hours,0,0
14332,.,0,0
14333,There,0,0
14334,were,0,0
14335,highly,0,0
14336,significant,0,0
14337,reductions,0,0
14338,in,0,0
14339,the,0,0
14340,number,0,0
14341,of,0,0
14342,Doppler,0,0
14343,embolic,0,0
14344,signals,0,0
14345,in,0,0
14346,the,0,0
14347,L-arginine,0,0
14348,and,0,0
14349,GSNO,0,0
14350,groups,0,0
14351,;,0,0
14352,first,0,0
14353,4,0,0
14354,hours,0,0
14355,",",0,0
14356,median,0,0
14357,(,0,0
14358,range,0,0
14359,),0,0
14360,number,0,0
14361,of,0,0
14362,embolic,0,0
14363,signals,0,0
14364,",",0,0
14365,placebo,0,0
14366,44.7,0,0
14367,(,0,0
14368,6,0,0
14369,to,0,0
14370,778,0,1
14371,),0,0
14372,",",0,0
14373,L-arginine,0,0
14374,9.5,0,0
14375,(,0,0
14376,0,0,0
14377,to,0,0
14378,225,0,1
14379,),0,0
14380,",",0,0
14381,and,0,0
14382,GSNO,0,0
14383,0.8,0,0
14384,(,0,0
14385,0,0,0
14386,to,0,0
14387,8,0,0
14388,),0,0
14389,",",0,0
14390,both,0,0
14391,P,0,0
14392,<,0,0
14393,0.001,0,0
14394,versus,0,0
14395,control,0,0
14396,values,0,0
14397,.,0,0
14398,The,0,0
14399,reduction,0,0
14400,in,0,0
14401,the,0,0
14402,signals,0,0
14403,persisted,0,0
14404,at,0,0
14405,the,0,0
14406,24-hour,0,0
14407,recording,0,0
14408,.,0,0
14409,CONCLUSIONS,0,0
14410,Intravenous,0,0
14411,L-arginine,0,0
14412,and,0,0
14413,GSNO,0,0
14414,attenuate,0,0
14415,Doppler,0,0
14416,embolic,0,0
14417,signals,0,0
14418,in,0,0
14419,humans,0,1
14420,.,0,0
14421,Modulation,0,0
14422,of,0,0
14423,the,0,0
14424,NO,0,0
14425,system,0,0
14426,with,0,1
14427,these,0,0
14428,agents,0,0
14429,may,0,0
14430,have,0,0
14431,applications,0,0
14432,in,0,0
14433,the,0,0
14434,treatment,0,0
14435,of,0,0
14436,thromboembolic,1,0
14437,disease,1,1
14438,.,1,0
14439,This,0,0
14440,study,0,0
14441,demonstrates,0,0
14442,the,0,0
14443,potential,0,0
14444,application,0,0
14445,of,0,0
14446,ultrasonic,0,0
14447,embolic,0,0
14448,signal,0,0
14449,detection,0,0
14450,to,0,0
14451,examine,0,0
14452,the,0,0
14453,efficacy,0,0
14454,of,0,0
14455,new,0,0
14456,antiplatelet,0,0
14457,agents,0,0
14458,in,0,0
14459,relatively,1,0
14460,small,1,0
14461,numbers,1,0
14462,of,1,0
14463,patients,1,1
14464,.,1,1
14465,[,0,0
14466,Advantages,0,0
14467,of,0,0
14468,video,0,0
14469,assisted,0,0
14470,thoracic,0,1
14471,surgery,0,1
14472,in,0,0
14473,the,0,0
14474,treatment,0,0
14475,of,0,0
14476,spontaneous,1,0
14477,pneumothorax,1,0
14478,],1,0
14479,.,0,0
14480,Spontaneous,1,0
14481,pneumothorax,1,0
14482,(,1,0
14483,SP,1,1
14484,),1,0
14485,is,0,0
14486,a,0,0
14487,disabling,0,0
14488,condition,0,0
14489,mostly,0,0
14490,affecting,0,0
14491,young,1,1
14492,",",1,0
14493,thin,1,0
14494,and,1,0
14495,otherwise,1,1
14496,healthy,1,1
14497,males,1,1
14498,.,1,0
14499,It,0,0
14500,is,0,0
14501,usually,0,0
14502,caused,0,0
14503,by,0,0
14504,ruptured,0,1
14505,pleural,0,1
14506,blebs,0,1
14507,.,0,0
14508,The,0,0
14509,first,0,0
14510,treatment,0,0
14511,is,0,0
14512,the,0,0
14513,insertion,0,0
14514,of,0,0
14515,a,0,0
14516,chest,0,0
14517,tube,0,0
14518,(,0,0
14519,ICT,0,0
14520,),0,0
14521,but,0,0
14522,in,0,0
14523,a,0,0
14524,great,0,0
14525,number,0,0
14526,of,0,0
14527,patients,0,1
14528,there,0,0
14529,is,0,0
14530,recurrence,0,0
14531,of,0,0
14532,the,0,0
14533,disease,0,1
14534,.,0,0
14535,We,0,0
14536,believe,0,0
14537,that,0,0
14538,the,0,0
14539,video,0,0
14540,assisted,0,0
14541,thoracoscopy,0,0
14542,(,0,0
14543,VATS,0,0
14544,),0,0
14545,is,0,0
14546,the,0,0
14547,best,0,0
14548,treatment,0,0
14549,possible,0,0
14550,because,0,0
14551,it,0,0
14552,allows,0,0
14553,us,0,0
14554,to,0,0
14555,treat,0,0
14556,the,0,0
14557,ruptured,0,0
14558,bleb,0,0
14559,radically,0,1
14560,avoiding,0,0
14561,any,0,0
14562,recurrence,0,0
14563,.,0,0
14564,In,0,0
14565,order,0,0
14566,to,0,0
14567,prove,0,0
14568,it,0,0
14569,",",0,0
14570,40,1,1
14571,patients,1,1
14572,admitted,1,1
14573,in,1,0
14574,a,1,0
14575,five-year,1,0
14576,period,1,0
14577,",",1,0
14578,with,1,0
14579,a,1,0
14580,SP,1,1
14581,",",0,0
14582,were,0,0
14583,randomly,0,0
14584,assigned,0,0
14585,to,0,0
14586,be,0,0
14587,treated,0,0
14588,by,0,0
14589,ICT,0,0
14590,or,0,1
14591,VATS,0,0
14592,.,0,0
14593,The,0,0
14594,ICT,0,0
14595,patients,0,1
14596,were,0,0
14597,in,0,0
14598,the,0,0
14599,hospital,0,0
14600,a,0,0
14601,mean,0,0
14602,time,0,0
14603,of,0,0
14604,7.5,0,0
14605,(,0,0
14606,4,0,0
14607,to,0,0
14608,15,0,1
14609,),0,0
14610,days,0,0
14611,and,0,0
14612,the,0,0
14613,VATS,0,0
14614,patients,0,1
14615,",",0,0
14616,5.3,0,0
14617,(,0,0
14618,2,0,0
14619,to,0,0
14620,7,0,0
14621,),0,0
14622,days,0,0
14623,(,0,0
14624,P,0,0
14625,<,0,0
14626,.05,0,0
14627,),0,0
14628,.,0,0
14629,ICT,0,0
14630,patients,0,1
14631,required,0,0
14632,analgesic,0,0
14633,drugs,0,0
14634,during,0,0
14635,76.8,0,0
14636,+/-,0,0
14637,31,0,1
14638,hours,0,0
14639,and,0,0
14640,VATS,0,1
14641,patients,0,1
14642,38.4,0,0
14643,+/-,0,0
14644,13,0,1
14645,hours,0,0
14646,(,0,0
14647,p,0,0
14648,<,0,0
14649,.05,0,0
14650,),0,0
14651,.,0,0
14652,From,0,0
14653,the,0,0
14654,ICT,0,0
14655,group,0,0
14656,",",0,0
14657,8,0,0
14658,(,0,0
14659,53,0,1
14660,%,0,0
14661,),0,0
14662,patients,0,1
14663,had,0,0
14664,recurrence,0,0
14665,of,0,0
14666,the,0,0
14667,disease,0,1
14668,and,0,0
14669,6,0,0
14670,(,0,0
14671,40,0,1
14672,%,0,0
14673,),0,0
14674,had,0,0
14675,a,0,0
14676,prolonged,0,0
14677,air,0,0
14678,leak,0,0
14679,",",0,0
14680,while,0,0
14681,none,0,0
14682,of,0,0
14683,the,0,0
14684,patients,0,1
14685,of,0,0
14686,the,0,0
14687,VATS,0,0
14688,group,0,0
14689,had,0,0
14690,any,0,0
14691,complication,0,0
14692,(,0,0
14693,<,0,0
14694,.001,0,0
14695,),0,0
14696,.,0,0
14697,Cost,0,0
14698,of,0,0
14699,ICT,0,0
14700,and,0,0
14701,VATS,0,0
14702,were,0,0
14703,$,0,0
14704,850,0,1
14705,and,0,0
14706,$,0,0
14707,1730,0,0
14708,",",0,0
14709,respectively,0,0
14710,.,0,0
14711,According,0,0
14712,to,0,0
14713,these,0,0
14714,results,0,0
14715,",",0,0
14716,VATS,0,0
14717,should,0,0
14718,be,0,0
14719,the,0,0
14720,treatment,0,0
14721,of,0,0
14722,choice,0,0
14723,in,0,0
14724,SP,0,1
14725,patients,0,1
14726,.,0,0
14727,It,0,0
14728,treats,0,0
14729,the,0,0
14730,cause,0,0
14731,of,0,0
14732,the,0,0
14733,disease,0,1
14734,.,0,0
14735,It,0,0
14736,also,0,0
14737,reduces,0,0
14738,the,0,0
14739,hospitalization,0,0
14740,time,0,0
14741,",",0,0
14742,the,0,0
14743,use,0,0
14744,of,0,0
14745,analgesic,0,0
14746,drugs,0,0
14747,post,0,0
14748,surgery,0,1
14749,",",0,0
14750,decreases,0,0
14751,recurrence,0,0
14752,of,0,0
14753,the,0,0
14754,disease,0,1
14755,and,0,0
14756,the,0,0
14757,cost,0,0
14758,of,0,0
14759,the,0,0
14760,treatment,0,0
14761,.,0,0
14762,Moreover,0,0
14763,",",0,0
14764,the,0,0
14765,patients,0,1
14766,were,0,0
14767,back,0,0
14768,to,0,0
14769,work,0,0
14770,in,0,0
14771,less,0,0
14772,than,0,0
14773,10,0,1
14774,days,0,0
14775,.,0,1
14776,Dose,0,0
14777,response,0,0
14778,effect,0,0
14779,of,0,0
14780,cyclical,0,0
14781,medroxyprogesterone,0,0
14782,on,0,0
14783,blood,0,0
14784,pressure,0,0
14785,in,0,0
14786,postmenopausal,1,1
14787,women,1,1
14788,.,1,0
14789,OBJECTIVE,0,0
14790,This,0,0
14791,study,0,0
14792,was,0,0
14793,designed,0,0
14794,to,0,0
14795,compare,0,0
14796,with,0,0
14797,placebo,0,0
14798,the,0,0
14799,dose-response,0,0
14800,effect,0,0
14801,of,0,0
14802,cyclical,0,0
14803,doses,0,0
14804,of,0,0
14805,the,0,0
14806,C21,0,0
14807,progestogen,0,0
14808,",",0,0
14809,medroxyprogesterone,0,0
14810,acetate,0,0
14811,(,0,0
14812,MPA,0,0
14813,),0,0
14814,on,0,0
14815,blood,0,0
14816,pressure,0,0
14817,(,0,0
14818,BP,0,0
14819,),0,0
14820,when,0,0
14821,administered,0,0
14822,to,0,0
14823,normotensive,1,1
14824,postmenopausal,1,1
14825,women,1,1
14826,receiving,1,0
14827,a,1,0
14828,fixed,1,0
14829,mid-range,1,0
14830,daily,1,0
14831,dose,1,0
14832,of,1,0
14833,conjugated,1,0
14834,equine,1,1
14835,oestrogen,1,0
14836,(,1,0
14837,CEE,1,0
14838,),1,0
14839,.,1,0
14840,MATERIALS,0,0
14841,AND,0,0
14842,METHODS,0,0
14843,Twenty,1,1
14844,normotensive,1,1
14845,postmenopausal,1,1
14846,women,1,1
14847,(,1,0
14848,median,1,0
14849,age,1,1
14850,53,1,1
14851,years,1,1
14852,),1,0
14853,participated,0,1
14854,in,0,0
14855,the,0,0
14856,study,0,0
14857,which,0,0
14858,used,0,0
14859,a,0,0
14860,double-blind,0,0
14861,crossover,0,0
14862,design,0,0
14863,.,0,0
14864,There,0,0
14865,were,0,0
14866,four,0,0
14867,randomised,0,1
14868,treatment,0,0
14869,phases,0,0
14870,",",0,0
14871,each,0,0
14872,of,0,0
14873,4,0,0
14874,weeks,0,0
14875,duration,0,0
14876,.,0,0
14877,The,0,0
14878,four,0,0
14879,blinded,0,0
14880,treatments,0,0
14881,were,0,0
14882,MPA,0,0
14883,2.5,0,0
14884,mg,0,0
14885,",",0,0
14886,MPA,0,0
14887,5,0,0
14888,mg,0,0
14889,",",0,0
14890,MPA,0,0
14891,10,0,0
14892,mg,0,0
14893,and,0,0
14894,matching,0,0
14895,placebo,0,0
14896,",",0,0
14897,taken,0,0
14898,for,0,0
14899,the,0,0
14900,last,0,0
14901,14,0,0
14902,days,0,0
14903,of,0,0
14904,each,0,0
14905,28,0,0
14906,day,0,0
14907,treatment,0,0
14908,cycle,0,0
14909,.,0,0
14910,CEE,0,0
14911,0.625,0,0
14912,mg,0,0
14913,was,0,0
14914,also,0,0
14915,administered,0,0
14916,once,0,0
14917,daily,0,0
14918,as,0,0
14919,open,0,1
14920,labelled,0,0
14921,tablets,0,0
14922,to,0,0
14923,all,0,0
14924,subjects,0,1
14925,throughout,0,0
14926,the,0,0
14927,study,0,0
14928,.,0,0
14929,Clinic,0,0
14930,BP,0,0
14931,was,0,0
14932,measured,0,0
14933,weekly,0,0
14934,with,0,0
14935,the,0,0
14936,mean,0,0
14937,values,0,0
14938,of,0,0
14939,weeks,0,0
14940,3,0,0
14941,and,0,0
14942,4,0,0
14943,of,0,0
14944,each,0,0
14945,phase,0,0
14946,used,0,0
14947,for,0,0
14948,analysis,0,0
14949,.,0,0
14950,Ambulatory,0,0
14951,BP,0,0
14952,was,0,0
14953,performed,0,0
14954,in,0,0
14955,the,0,0
14956,final,0,0
14957,week,0,0
14958,of,0,0
14959,each,0,0
14960,phase,0,0
14961,.,0,0
14962,RESULTS,0,0
14963,Compared,0,0
14964,with,0,0
14965,the,0,0
14966,placebo,0,0
14967,phase,0,0
14968,",",0,0
14969,end,0,0
14970,of,0,0
14971,phase,0,0
14972,clinic,0,1
14973,BP,0,0
14974,was,0,0
14975,unchanged,0,0
14976,by,0,0
14977,any,0,0
14978,of,0,0
14979,the,0,0
14980,progestogen,0,0
14981,treatments,0,0
14982,.,0,0
14983,There,0,0
14984,was,0,0
14985,a,0,0
14986,dose-dependent,0,0
14987,decrease,0,0
14988,in,0,0
14989,ambulatory,0,0
14990,daytime,0,0
14991,diastolic,0,0
14992,and,0,0
14993,mean,0,0
14994,arterial,0,1
14995,BP,0,0
14996,with,0,1
14997,the,0,0
14998,progestogen,0,0
14999,treatments,0,0
15000,compared,0,0
15001,with,0,1
15002,placebo,0,0
15003,(,0,0
15004,P,0,0
15005,<,0,0
15006,0.05,0,0
15007,),0,0
15008,.,0,0
15009,CONCLUSION,0,0
15010,In,0,0
15011,a,0,0
15012,regimen,0,0
15013,of,0,0
15014,postmenopausal,0,1
15015,hormone,0,0
15016,replacement,0,0
15017,therapy,0,0
15018,with,0,0
15019,a,0,0
15020,fixed,0,0
15021,mid-range,0,0
15022,daily,0,0
15023,dose,0,0
15024,of,0,0
15025,CEE,0,0
15026,combined,0,0
15027,with,0,0
15028,a,0,0
15029,cyclical,0,0
15030,regimen,0,0
15031,of,0,0
15032,a,0,0
15033,C21,0,0
15034,progestogen,0,0
15035,spanning,0,0
15036,the,0,0
15037,current,0,0
15038,clinical,0,0
15039,dose,0,0
15040,range,0,0
15041,",",0,0
15042,the,0,0
15043,progestogen,0,0
15044,has,0,0
15045,either,0,0
15046,no,0,0
15047,effect,0,0
15048,or,0,0
15049,a,0,0
15050,small,0,0
15051,dose-dependent,0,0
15052,reduction,0,0
15053,in,0,0
15054,clinic,0,1
15055,and,0,0
15056,ambulatory,0,0
15057,BPs,0,0
15058,over,0,0
15059,one,0,0
15060,treatment,0,0
15061,cycle,0,0
15062,.,0,0
15063,Why,0,0
15064,were,0,0
15065,the,0,0
15066,results,0,0
15067,of,0,0
15068,the,0,0
15069,Heart,0,0
15070,Outcomes,0,0
15071,Prevention,0,0
15072,Evaluation,0,0
15073,(,0,0
15074,HOPE,0,1
15075,),0,0
15076,trial,0,0
15077,so,0,0
15078,astounding,0,0
15079,?,0,0
15080,The,0,0
15081,Heart,0,0
15082,Outcomes,0,0
15083,Prevention,0,0
15084,Evaluation,0,0
15085,(,0,0
15086,HOPE,0,1
15087,),0,0
15088,study,0,0
15089,was,0,0
15090,important,0,0
15091,because,0,0
15092,it,0,0
15093,showed,0,0
15094,the,0,0
15095,benefits,0,0
15096,of,0,0
15097,ramipril,0,0
15098,-,0,0
15099,an,0,0
15100,angiotensin-converting,0,0
15101,enzyme,0,0
15102,(,0,0
15103,ACE,0,0
15104,),0,0
15105,inhibitor,0,0
15106,-,0,0
15107,in,0,0
15108,patients,1,1
15109,at,1,0
15110,high,1,0
15111,risk,1,0
15112,for,1,0
15113,cardiovascular,1,1
15114,events,1,0
15115,.,1,0
15116,Treatment,0,0
15117,with,0,0
15118,ramipril,0,0
15119,significantly,0,0
15120,reduced,0,0
15121,the,0,0
15122,rates,0,0
15123,of,0,0
15124,death,0,0
15125,",",0,0
15126,myocardial,0,0
15127,infarction,0,0
15128,",",0,0
15129,stroke,0,0
15130,",",0,0
15131,coronary,0,0
15132,revascularization,0,0
15133,",",0,0
15134,cardiac,0,0
15135,arrest,0,1
15136,and,0,0
15137,heart,0,0
15138,failure,0,0
15139,",",0,0
15140,as,0,0
15141,well,0,0
15142,as,0,0
15143,the,0,0
15144,risk,0,0
15145,of,0,0
15146,diabetes-related,0,1
15147,complications,0,0
15148,and,0,0
15149,of,0,0
15150,diabetes,0,1
15151,itself,0,0
15152,.,0,0
15153,The,0,0
15154,effects,0,0
15155,of,0,0
15156,therapy,0,0
15157,with,0,1
15158,vitamin,0,0
15159,E,0,0
15160,were,0,0
15161,also,0,0
15162,evaluated,0,0
15163,",",0,0
15164,but,0,0
15165,no,0,0
15166,statistical,0,0
15167,benefits,0,0
15168,were,0,0
15169,shown,0,0
15170,.,0,0
15171,The,0,0
15172,benefits,0,0
15173,of,0,0
15174,ACE,0,0
15175,inhibitor,0,0
15176,therapy,0,0
15177,that,0,0
15178,were,0,0
15179,observed,0,0
15180,were,0,0
15181,likely,0,0
15182,due,0,0
15183,to,0,0
15184,a,0,0
15185,variety,0,0
15186,of,0,0
15187,mechanisms,0,0
15188,",",0,0
15189,not,0,0
15190,just,0,0
15191,a,0,0
15192,reduction,0,0
15193,in,0,0
15194,blood,0,0
15195,pressure,0,0
15196,.,0,0
15197,Four-year,0,1
15198,outcomes,0,0
15199,from,0,1
15200,adolescent,1,1
15201,alcohol,0,1
15202,and,0,0
15203,drug,0,0
15204,treatment,0,0
15205,.,0,0
15206,OBJECTIVE,0,0
15207,Knowledge,0,0
15208,of,0,0
15209,treatment,0,0
15210,response,0,0
15211,for,0,0
15212,alcohol,0,0
15213,and,0,0
15214,drug,0,0
15215,problems,0,1
15216,among,0,0
15217,adults,0,1
15218,is,0,0
15219,mounting,0,0
15220,;,0,0
15221,less,0,0
15222,is,0,0
15223,known,0,0
15224,about,0,0
15225,long-term,0,0
15226,outcome,0,0
15227,for,0,1
15228,adolescents,1,1
15229,who,1,1
15230,receive,1,1
15231,treatment,1,1
15232,for,1,0
15233,alcohol,1,0
15234,and,1,0
15235,drug,1,0
15236,problems,1,1
15237,.,1,0
15238,The,0,0
15239,current,0,0
15240,study,0,0
15241,examined,0,0
15242,youth,0,1
15243,substance,0,0
15244,involvement,0,0
15245,over,0,0
15246,4,0,0
15247,years,0,1
15248,(,0,0
15249,using,0,0
15250,five,0,1
15251,waves,0,0
15252,of,0,0
15253,data,0,0
15254,collection,0,0
15255,),0,0
15256,following,0,0
15257,treatment,0,0
15258,for,0,0
15259,alcohol,0,0
15260,and,0,0
15261,drug,0,0
15262,abuse,0,1
15263,.,0,0
15264,METHOD,0,0
15265,A,1,0
15266,cohort,1,1
15267,of,1,0
15268,youth,1,1
15269,(,1,0
15270,N,1,1
15271,=,1,0
15272,162,1,1
15273,",",1,0
15274,60,1,0
15275,%,1,0
15276,male,1,1
15277,),1,0
15278,treated,1,0
15279,during,1,0
15280,adolescence,1,1
15281,(,1,0
15282,mean,1,0
15283,age,1,1
15284,=,1,0
15285,16,1,1
15286,years,1,1
15287,),1,0
15288,was,1,0
15289,followed,1,0
15290,into,1,0
15291,young,1,1
15292,adulthood,1,1
15293,",",0,0
15294,a,0,0
15295,period,0,0
15296,associated,0,0
15297,with,0,0
15298,stabilization,0,0
15299,of,0,0
15300,alcohol,0,1
15301,use,0,0
15302,patterns,0,0
15303,and,0,0
15304,elevated,0,0
15305,risk,0,0
15306,for,0,0
15307,life,0,0
15308,problems,0,1
15309,secondary,0,0
15310,to,0,0
15311,both,0,0
15312,alcohol,0,0
15313,and,0,0
15314,drug,0,0
15315,use,0,0
15316,.,0,0
15317,Participants,1,1
15318,(,1,0
15319,14-18,1,1
15320,years,1,1
15321,old,1,1
15322,),1,0
15323,were,1,0
15324,consecutive,1,1
15325,admissions,1,1
15326,to,1,0
15327,inpatient,1,1
15328,adolescent,1,1
15329,alcohol,1,0
15330,and,1,0
15331,drug,1,0
15332,treatment,1,0
15333,centers,1,1
15334,in,1,0
15335,San,1,1
15336,Diego,1,1
15337,that,1,0
15338,were,1,0
15339,abstinence,1,0
15340,focused,1,0
15341,and,1,0
15342,based,1,0
15343,on,1,0
15344,the,1,0
15345,12-step,1,0
15346,approach,1,0
15347,.,1,0
15348,RESULTS,0,0
15349,Alcohol,0,0
15350,and,0,0
15351,other,0,0
15352,drug,0,0
15353,use,0,0
15354,were,0,0
15355,reduced,0,0
15356,during,0,0
15357,the,0,0
15358,4,0,0
15359,years,0,1
15360,posttreatment,0,0
15361,",",0,0
15362,with,0,0
15363,the,0,0
15364,exception,0,0
15365,of,0,0
15366,nicotine,0,0
15367,.,0,0
15368,The,0,0
15369,greatest,0,0
15370,prevalence,0,0
15371,reduction,0,0
15372,occurred,0,0
15373,for,0,0
15374,stimulants,0,0
15375,;,0,1
15376,modest,0,0
15377,changes,0,0
15378,were,0,0
15379,evident,0,0
15380,in,0,0
15381,alcohol,0,1
15382,and,0,0
15383,marijuana,0,0
15384,use,0,0
15385,.,0,0
15386,Nicotine,0,0
15387,was,0,0
15388,the,0,0
15389,most,0,0
15390,commonly,0,0
15391,used,0,0
15392,substance,0,0
15393,throughout,0,0
15394,the,0,0
15395,4,0,0
15396,years,0,1
15397,after,0,0
15398,treatment,0,0
15399,.,0,0
15400,Several,0,0
15401,distinct,0,0
15402,substance,0,0
15403,involvement,0,0
15404,trajectories,0,0
15405,were,0,0
15406,evident,0,0
15407,during,0,0
15408,the,0,0
15409,4,0,0
15410,years,0,1
15411,following,0,0
15412,treatment,0,0
15413,.,0,0
15414,CONCLUSIONS,0,0
15415,Alcohol,0,0
15416,and,0,0
15417,drug,0,0
15418,use,0,0
15419,patterns,0,0
15420,during,0,0
15421,the,0,0
15422,4,0,0
15423,years,0,1
15424,following,0,0
15425,treatment,0,0
15426,highlight,0,0
15427,both,0,0
15428,changes,0,0
15429,and,0,0
15430,diversity,0,0
15431,in,0,0
15432,substance,0,0
15433,involvement,0,0
15434,as,0,0
15435,youth,0,1
15436,make,0,0
15437,the,0,0
15438,transitions,0,0
15439,from,0,0
15440,middle,0,1
15441,to,0,0
15442,late,0,0
15443,adolescence,0,1
15444,and,0,0
15445,into,0,0
15446,young,0,1
15447,adulthood,0,1
15448,.,0,0
15449,Findings,0,0
15450,demonstrate,0,0
15451,the,0,0
15452,importance,0,0
15453,of,0,0
15454,identifying,0,0
15455,transitional,0,1
15456,periods,0,0
15457,and,0,0
15458,the,0,0
15459,need,0,0
15460,for,0,0
15461,alternative,0,0
15462,intervention,0,0
15463,strategies,0,0
15464,that,0,0
15465,may,0,0
15466,help,0,0
15467,the,0,0
15468,progression,0,0
15469,of,0,0
15470,this,0,0
15471,population,0,1
15472,into,0,0
15473,young,0,1
15474,adulthood,0,1
15475,.,0,0
15476,Effect,0,0
15477,of,0,0
15478,ischaemic,0,1
15479,preconditioning,0,0
15480,",",0,0
15481,cardiopulmonary,0,0
15482,bypass,0,1
15483,and,0,0
15484,myocardial,0,0
15485,ischaemic/reperfusion,0,0
15486,on,0,0
15487,free,0,0
15488,radical,0,0
15489,generation,0,0
15490,in,0,0
15491,CABG,1,0
15492,patients,1,1
15493,.,1,1
15494,OBJECTIVE,0,0
15495,To,0,0
15496,investigate,0,0
15497,the,0,0
15498,free,0,0
15499,radicals,0,0
15500,(,0,0
15501,FR,0,1
15502,),0,0
15503,generation,0,0
15504,after,0,0
15505,ischaemic,0,1
15506,preconditioning,0,0
15507,and,0,0
15508,cardiopulmonary,0,0
15509,bypass,0,1
15510,and,0,0
15511,during,0,0
15512,reperfusion,0,0
15513,in,0,0
15514,CABG,1,0
15515,patients,1,1
15516,",",0,0
15517,and,0,0
15518,the,0,0
15519,role,0,0
15520,of,0,0
15521,ischaemic,0,1
15522,preconditioning,0,0
15523,.,0,0
15524,METHODS,0,0
15525,Forty-three,1,1
15526,CABG,1,0
15527,patients,1,1
15528,were,0,0
15529,randomised,0,0
15530,into,0,0
15531,an,0,0
15532,ischaemic,0,1
15533,preconditioning,0,0
15534,and,0,0
15535,a,0,0
15536,control,0,0
15537,group,0,0
15538,.,0,0
15539,The,0,0
15540,protocol,0,0
15541,for,0,0
15542,ischaemic,0,1
15543,preconditioning,0,0
15544,was,0,0
15545,two,0,0
15546,cycles,0,0
15547,of,0,0
15548,2-min,0,0
15549,ischaemia,0,0
15550,followed,0,0
15551,by,0,0
15552,3-min,0,0
15553,reperfusion,0,0
15554,.,0,0
15555,Free,0,0
15556,radicals,0,0
15557,were,0,0
15558,measured,0,0
15559,using,0,0
15560,electron,0,0
15561,spin,0,0
15562,resonance,0,0
15563,spectroscopy,0,0
15564,.,0,0
15565,Global,0,0
15566,and,0,0
15567,right,0,0
15568,heart,0,1
15569,functions,0,0
15570,were,0,0
15571,collected,0,0
15572,.,0,0
15573,RESULTS,0,0
15574,The,0,0
15575,free,0,0
15576,radicals,0,0
15577,generation,0,0
15578,in,0,0
15579,coronary,0,1
15580,sinus,0,1
15581,blood,0,0
15582,in,0,0
15583,the,0,0
15584,ischaemic,0,1
15585,preconditioning,0,0
15586,group,0,0
15587,was,0,0
15588,9.7,0,0
15589,and,0,0
15590,16.6,0,0
15591,%,0,0
15592,after,0,0
15593,the,0,0
15594,ischaemic,0,1
15595,preconditioning,0,0
15596,protocol,0,0
15597,and,0,0
15598,10,0,0
15599,min,0,0
15600,after,0,0
15601,declamping,0,0
15602,",",0,0
15603,6.8,0,0
15604,and,0,0
15605,13.3,0,0
15606,%,0,0
15607,in,0,0
15608,the,0,0
15609,controls,0,0
15610,.,0,0
15611,The,0,0
15612,free,0,0
15613,radicals,0,0
15614,in,0,0
15615,arterial,0,1
15616,samples,0,0
15617,were,0,0
15618,",",0,0
15619,respectively,0,0
15620,",",0,0
15621,21,0,0
15622,",",0,0
15623,14,0,0
15624,",",0,0
15625,10,0,0
15626,and,0,0
15627,9,0,0
15628,%,0,0
15629,at,0,0
15630,10,0,0
15631,min,0,0
15632,",",0,0
15633,1,0,0
15634,",",0,0
15635,2,0,0
15636,and,0,0
15637,24,0,0
15638,h,0,0
15639,after,0,0
15640,reperfusion,0,0
15641,.,0,0
15642,Cardiac,0,0
15643,index,0,0
15644,(,0,0
15645,CI,0,0
15646,),0,0
15647,and,0,0
15648,right,0,0
15649,ventricular,0,0
15650,ejection,0,0
15651,fraction,0,0
15652,(,0,0
15653,RVEF,0,0
15654,),0,0
15655,were,0,0
15656,improved,0,0
15657,by,0,0
15658,ischaemic,0,1
15659,preconditioning,0,0
15660,.,0,0
15661,CONCLUSION,0,0
15662,Both,0,0
15663,ischaemic,0,1
15664,preconditioning,0,0
15665,and,0,0
15666,cardiopulmonary,0,1
15667,bypass,0,1
15668,induced,0,0
15669,free,0,0
15670,radicals,0,0
15671,generation,0,0
15672,.,0,0
15673,Although,0,0
15674,ischaemic,0,1
15675,preconditioning,0,0
15676,had,0,0
15677,no,0,0
15678,effect,0,0
15679,on,0,0
15680,free,0,0
15681,radicals,0,0
15682,generation,0,0
15683,after,0,0
15684,the,0,0
15685,operation,0,0
15686,",",0,0
15687,it,0,0
15688,protected,0,0
15689,against,0,0
15690,postoperative,0,0
15691,stunning,0,0
15692,.,0,0
15693,Lamotrigine,0,0
15694,therapy,0,0
15695,for,0,0
15696,autistic,1,1
15697,disorder,1,1
15698,:,1,1
15699,a,0,0
15700,randomized,0,0
15701,",",0,0
15702,double-blind,0,0
15703,",",0,0
15704,placebo-controlled,0,0
15705,trial,0,0
15706,.,0,0
15707,In,0,0
15708,autism,0,1
15709,",",0,0
15710,glutamate,0,0
15711,may,0,0
15712,be,0,0
15713,increased,0,0
15714,or,0,0
15715,its,0,0
15716,receptors,0,0
15717,up-regulated,0,0
15718,as,0,0
15719,part,0,0
15720,of,0,0
15721,an,0,0
15722,excitotoxic,0,0
15723,process,0,0
15724,that,0,0
15725,damages,0,0
15726,neural,0,0
15727,networks,0,0
15728,and,0,0
15729,subsequently,0,0
15730,contributes,0,0
15731,to,0,0
15732,behavioral,0,0
15733,and,0,0
15734,cognitive,0,0
15735,deficits,0,0
15736,seen,0,0
15737,in,0,0
15738,the,0,0
15739,disorder,0,1
15740,.,0,0
15741,This,0,0
15742,was,0,0
15743,a,0,0
15744,double-blind,0,0
15745,",",0,0
15746,placebo-controlled,0,0
15747,",",0,0
15748,parallel,0,0
15749,group,0,0
15750,study,0,0
15751,of,0,0
15752,lamotrigine,0,0
15753,",",0,0
15754,an,0,0
15755,agent,0,0
15756,that,0,0
15757,modulates,0,0
15758,glutamate,0,0
15759,release,0,0
15760,.,0,0
15761,Twenty-eight,1,1
15762,children,1,1
15763,(,1,1
15764,27,1,1
15765,boys,1,1
15766,),1,0
15767,ages,1,1
15768,3,1,0
15769,to,1,0
15770,11,1,1
15771,years,1,1
15772,(,1,0
15773,M,1,0
15774,=,1,0
15775,5.8,1,0
15776,),1,0
15777,with,1,1
15778,a,1,0
15779,primary,1,0
15780,diagnosis,1,1
15781,of,1,0
15782,autistic,1,1
15783,disorder,1,1
15784,received,1,0
15785,either,1,0
15786,placebo,1,0
15787,or,1,0
15788,lamotrigine,1,0
15789,twice,1,0
15790,daily,1,0
15791,.,1,0
15792,In,0,0
15793,children,0,1
15794,on,0,0
15795,lamotrigine,0,0
15796,",",0,0
15797,the,0,0
15798,drug,0,0
15799,was,0,0
15800,titrated,0,0
15801,upward,0,0
15802,over,0,0
15803,8,0,0
15804,weeks,0,0
15805,to,0,0
15806,reach,0,0
15807,a,0,0
15808,mean,0,0
15809,maintenance,0,0
15810,dose,0,0
15811,of,0,0
15812,5.0,0,0
15813,mg/kg,0,0
15814,per,0,0
15815,day,0,0
15816,.,0,0
15817,This,0,0
15818,dose,0,0
15819,was,0,0
15820,then,0,0
15821,maintained,0,0
15822,for,0,0
15823,4,0,0
15824,weeks,0,0
15825,.,0,0
15826,Following,0,0
15827,maintenance,0,0
15828,evaluations,0,0
15829,",",0,0
15830,the,0,0
15831,drug,0,0
15832,was,0,0
15833,tapered,0,0
15834,down,0,0
15835,over,0,0
15836,2,0,0
15837,weeks,0,0
15838,.,0,0
15839,The,0,0
15840,trial,0,0
15841,ended,0,0
15842,with,0,0
15843,a,0,0
15844,4-week,0,0
15845,drug-free,0,1
15846,period,0,0
15847,.,0,0
15848,Outcome,0,0
15849,measures,0,0
15850,included,0,0
15851,improvements,0,0
15852,in,0,0
15853,severity,0,0
15854,and,0,0
15855,behavioral,0,0
15856,features,0,0
15857,of,0,0
15858,autistic,0,1
15859,disorder,0,1
15860,(,0,0
15861,stereotypies,0,0
15862,",",0,0
15863,lethargy,0,0
15864,",",0,0
15865,irritability,0,0
15866,",",0,0
15867,hyperactivity,0,0
15868,",",0,0
15869,emotional,0,0
15870,reciprocity,0,0
15871,",",0,0
15872,sharing,0,0
15873,pleasures,0,0
15874,),0,1
15875,and,0,0
15876,improvements,0,0
15877,in,0,0
15878,language,0,0
15879,and,0,0
15880,communication,0,0
15881,",",0,0
15882,socialization,0,0
15883,",",0,0
15884,and,0,0
15885,daily,0,0
15886,living,0,1
15887,skills,0,0
15888,noted,0,0
15889,after,0,0
15890,12,0,0
15891,weeks,0,0
15892,(,0,0
15893,the,0,0
15894,end,0,0
15895,of,0,0
15896,a,0,0
15897,4-week,0,0
15898,maintenance,0,0
15899,phase,0,0
15900,),0,0
15901,.,0,0
15902,We,0,0
15903,did,0,0
15904,not,0,0
15905,find,0,0
15906,any,0,0
15907,significant,0,0
15908,differences,0,0
15909,in,0,0
15910,improvements,0,0
15911,between,0,0
15912,lamotrigine,0,0
15913,or,0,0
15914,placebo,0,0
15915,groups,0,0
15916,on,0,0
15917,the,0,0
15918,Autism,0,1
15919,Behavior,0,0
15920,Checklist,0,0
15921,",",0,0
15922,the,0,0
15923,Aberrant,0,0
15924,Behavior,0,0
15925,Checklist,0,0
15926,",",0,0
15927,the,0,0
15928,Vineland,0,0
15929,Adaptive,0,0
15930,Behavior,0,0
15931,scales,0,0
15932,",",0,0
15933,the,0,0
15934,PL-ADOS,0,0
15935,",",0,0
15936,or,0,1
15937,the,0,0
15938,CARS,0,0
15939,.,0,1
15940,Parent,0,1
15941,rating,0,0
15942,scales,0,0
15943,showed,0,0
15944,marked,0,0
15945,improvements,0,0
15946,",",0,0
15947,presumably,0,0
15948,due,0,0
15949,to,0,0
15950,expectations,0,0
15951,of,0,0
15952,benefits,0,0
15953,.,0,1
15954,Sulfasalazine,0,0
15955,decreases,0,0
15956,acute,0,1
15957,gastrointestinal,0,1
15958,complications,0,0
15959,due,0,0
15960,to,0,0
15961,pelvic,0,1
15962,radiotherapy,0,1
15963,.,0,0
15964,BACKGROUND,0,0
15965,Radiation-induced,0,0
15966,gastrointestinal,0,1
15967,toxicity,0,0
15968,is,0,0
15969,a,0,0
15970,significant,0,0
15971,concern,0,0
15972,for,0,1
15973,patients,1,1
15974,who,1,1
15975,are,1,0
15976,treated,1,1
15977,with,1,0
15978,this,1,0
15979,modality,1,0
15980,for,1,0
15981,pelvic,1,1
15982,malignancies,1,1
15983,.,1,1
15984,Eicosanoids,0,0
15985,and,0,0
15986,free,0,1
15987,radicals,0,0
15988,are,0,0
15989,thought,0,0
15990,to,0,0
15991,be,0,0
15992,among,0,0
15993,the,0,0
15994,reasons,0,0
15995,for,0,0
15996,this,0,0
15997,effect,0,0
15998,.,0,0
15999,Sulfasalazine,0,0
16000,is,0,0
16001,an,0,0
16002,inhibitor,0,0
16003,of,0,0
16004,their,0,0
16005,synthesis,0,0
16006,in,0,0
16007,the,0,0
16008,mucosa,0,1
16009,.,0,0
16010,OBJECTlVE,0,0
16011,:,0,0
16012,To,0,0
16013,determine,0,0
16014,whether,0,0
16015,sulfasalazine,0,0
16016,can,0,0
16017,reduce,0,0
16018,the,0,0
16019,radiation-induced,0,0
16020,acute,0,1
16021,gastrointestinal,0,1
16022,complications,0,0
16023,.,0,1
16024,METHODS,0,0
16025,In,0,0
16026,this,0,0
16027,prospective,0,0
16028,",",0,0
16029,double-blind,0,0
16030,study,0,0
16031,",",0,0
16032,31,1,1
16033,patients,1,1
16034,receiving,1,1
16035,pelvic,1,1
16036,radiotherapy,1,1
16037,were,0,0
16038,randomized,0,0
16039,to,0,0
16040,receive,0,0
16041,two,0,0
16042,sulfasalazine,0,0
16043,500-mg,0,0
16044,tablets,0,0
16045,twice,0,0
16046,daily,0,0
16047,or,0,0
16048,placebo,0,0
16049,",",0,0
16050,administered,0,0
16051,orally,0,0
16052,from,0,0
16053,the,0,0
16054,first,0,0
16055,day,0,0
16056,of,0,0
16057,irradiation,0,0
16058,.,0,1
16059,Patients,0,1
16060,were,0,0
16061,evaluated,0,0
16062,weekly,0,0
16063,",",0,0
16064,and,0,0
16065,gastrointestinal,0,1
16066,toxicities,0,0
16067,were,0,0
16068,graded,0,0
16069,according,0,0
16070,to,0,0
16071,the,0,0
16072,Late,0,0
16073,Effect,0,0
16074,of,0,0
16075,Normal,0,0
16076,Tissue-Subjective,0,0
16077,Objective,0,0
16078,Management,0,0
16079,Analytic,0,0
16080,(,0,0
16081,LENT-SOMA,0,0
16082,),0,0
16083,toxicity,0,0
16084,table,0,0
16085,during,0,0
16086,pelvic,0,1
16087,radiotherapy,0,1
16088,.,0,0
16089,On,0,0
16090,the,0,0
16091,last,0,0
16092,day,0,0
16093,of,0,0
16094,week,0,0
16095,5,0,0
16096,",",0,0
16097,the,0,0
16098,subjects,0,1
16099,were,0,0
16100,graded,0,0
16101,endoscopically,0,1
16102,",",0,0
16103,and,0,0
16104,biopsies,0,0
16105,taken,0,0
16106,from,0,0
16107,the,0,0
16108,rectum,0,0
16109,were,0,0
16110,classified,0,1
16111,histopathologically,0,1
16112,.,0,0
16113,RESULTS,0,0
16114,Groups,1,0
16115,did,1,0
16116,not,1,0
16117,differ,1,0
16118,in,1,0
16119,age,1,1
16120,",",1,0
16121,gender,1,0
16122,",",1,0
16123,tumor,1,0
16124,site,1,0
16125,",",1,0
16126,or,1,0
16127,irradiation,1,0
16128,procedure,1,0
16129,.,1,0
16130,During,0,0
16131,radiotherapy,0,0
16132,",",0,0
16133,grade,0,0
16134,2,0,0
16135,or,0,0
16136,higher,0,0
16137,gastrointestinal,0,1
16138,toxicity,0,0
16139,occurred,0,0
16140,in,0,0
16141,20,0,0
16142,%,0,0
16143,(,0,0
16144,3/15,0,0
16145,),0,0
16146,and,0,0
16147,63,0,0
16148,%,0,0
16149,(,0,0
16150,10/16,0,0
16151,),0,0
16152,of,0,0
16153,the,0,0
16154,sulfasalazine,0,0
16155,and,0,0
16156,placebo,0,0
16157,groups,0,0
16158,",",0,0
16159,respectively,0,0
16160,.,0,0
16161,This,0,0
16162,difference,0,0
16163,was,0,0
16164,significant,0,0
16165,(,0,0
16166,p,0,0
16167,=,0,0
16168,0.017,0,0
16169,),0,0
16170,.,0,0
16171,No,0,0
16172,statistically,0,0
16173,significant,0,0
16174,differences,0,0
16175,were,0,0
16176,found,0,0
16177,in,0,0
16178,endoscopic,0,0
16179,and,0,0
16180,histopathologic,0,0
16181,evaluations,0,0
16182,.,0,1
16183,CONCLUSIONS,0,0
16184,Sulfasalazine,0,0
16185,is,0,0
16186,effective,0,0
16187,in,0,0
16188,decreasing,0,0
16189,clinically,0,0
16190,acute,0,1
16191,gastrointestinal,0,1
16192,toxicities,0,0
16193,.,0,1
16194,Long-term,0,0
16195,follow-up,0,0
16196,with,0,1
16197,the,1,0
16198,subjects,1,1
16199,will,0,0
16200,help,0,0
16201,to,0,0
16202,determine,0,0
16203,the,0,0
16204,net,0,0
16205,effect,0,0
16206,of,0,0
16207,sulfasalazine,0,0
16208,on,0,0
16209,the,0,0
16210,radiation-induced,1,0
16211,gastrointestinal,1,1
16212,injuries,1,1
16213,.,1,1
16214,Matched-pair,0,0
16215,analysis,0,0
16216,of,0,0
16217,all-polyethylene,0,0
16218,versus,0,0
16219,metal-backed,0,0
16220,tibial,0,0
16221,components,0,0
16222,.,0,1
16223,Forty-eight,1,1
16224,matched,1,1
16225,pairs,1,1
16226,of,1,0
16227,osteoarthritic,1,1
16228,knees,1,1
16229,from,1,1
16230,patients,1,1
16231,who,1,1
16232,underwent,1,1
16233,primary,1,1
16234,total,1,1
16235,knee,1,1
16236,arthroplasty,1,1
16237,with,1,0
16238,a,1,0
16239,round-on-round,1,0
16240,",",1,0
16241,Apollo,1,1
16242,Knee,1,1
16243,System,1,0
16244,were,0,0
16245,studied,0,0
16246,to,0,0
16247,evaluate,0,0
16248,the,0,0
16249,outcome,0,0
16250,between,0,0
16251,all-polyethylene,0,0
16252,and,0,0
16253,metal-backed,0,0
16254,tibial,0,0
16255,components,0,0
16256,.,0,1
16257,Patients,1,1
16258,were,1,0
16259,matched,1,1
16260,for,1,0
16261,patient,1,0
16262,factors,1,0
16263,",",1,0
16264,preoperative,1,0
16265,deformities,1,0
16266,",",1,0
16267,cruciate,1,1
16268,salvage,1,0
16269,or,1,0
16270,sacrifice,1,0
16271,",",1,0
16272,and,1,0
16273,surgical,1,0
16274,technique,1,0
16275,.,1,0
16276,At,0,0
16277,the,0,0
16278,last,0,0
16279,follow-up,0,0
16280,(,0,0
16281,average,0,0
16282,",",0,0
16283,38.4,0,0
16284,months,0,0
16285,),0,0
16286,",",0,0
16287,there,0,0
16288,was,0,0
16289,no,0,0
16290,statistically,0,0
16291,significant,0,0
16292,difference,0,0
16293,in,0,0
16294,terms,0,0
16295,of,0,0
16296,knee,0,1
16297,scores,0,0
16298,",",0,0
16299,patient,0,0
16300,self-assessment,0,0
16301,",",0,0
16302,and,0,0
16303,radiographic,0,0
16304,outcomes,0,0
16305,.,0,0
16306,No,0,0
16307,component,0,0
16308,required,0,0
16309,revision,0,0
16310,",",0,0
16311,and,0,0
16312,no,0,0
16313,revisions,0,0
16314,were,0,0
16315,pending,0,0
16316,.,0,0
16317,Maintenance,0,0
16318,of,0,0
16319,these,0,0
16320,results,0,0
16321,over,0,0
16322,time,0,0
16323,would,0,0
16324,project,0,0
16325,into,0,0
16326,better,0,0
16327,long-term,0,0
16328,success,0,0
16329,for,0,0
16330,all-polyethylene,0,1
16331,tibial,0,0
16332,components,0,0
16333,because,0,0
16334,of,0,0
16335,the,0,0
16336,amount,0,0
16337,of,0,0
16338,wear,0,0
16339,and,0,0
16340,osteolysis,0,0
16341,with,0,1
16342,current,0,0
16343,modular,0,0
16344,metal-backed,0,0
16345,tibial,0,0
16346,components,0,0
16347,.,0,0
16348,We,0,0
16349,advocate,0,0
16350,the,0,0
16351,use,0,0
16352,of,0,0
16353,a,0,0
16354,more,0,0
16355,cost-effective,0,0
16356,all-polyethylene,0,0
16357,tibial,0,0
16358,component,0,0
16359,in,0,0
16360,elderly,1,1
16361,patients,1,1
16362,(,1,0
16363,>,1,1
16364,70,1,1
16365,years,1,1
16366,old,1,1
16367,),1,1
16368,who,0,1
16369,are,0,0
16370,not,0,1
16371,likely,0,0
16372,to,0,0
16373,need,0,0
16374,the,0,0
16375,versatility,0,0
16376,of,0,0
16377,exchange,0,0
16378,of,0,0
16379,a,0,0
16380,modular,0,0
16381,polyethylene,0,0
16382,insert,0,0
16383,because,0,0
16384,of,0,0
16385,wear,0,0
16386,.,0,0
16387,Induction,0,0
16388,versus,0,0
16389,noninduction,0,1
16390,in,0,0
16391,renal,1,1
16392,transplant,1,1
16393,recipients,1,1
16394,with,1,1
16395,tacrolimus-based,1,1
16396,immunosuppression,1,0
16397,.,1,0
16398,BACKGROUND,0,0
16399,The,0,0
16400,aim,0,0
16401,of,0,0
16402,this,0,0
16403,study,0,0
16404,was,0,0
16405,to,0,0
16406,compare,0,0
16407,the,0,0
16408,efficacy,0,0
16409,and,0,0
16410,safety,0,0
16411,of,0,0
16412,induction,0,0
16413,treatment,0,0
16414,with,0,1
16415,antithymocyte,0,0
16416,globulins,0,0
16417,(,0,0
16418,ATG,0,0
16419,),0,0
16420,followed,0,0
16421,by,0,0
16422,tacrolimus,0,0
16423,therapy,0,0
16424,with,0,1
16425,immediate,0,0
16426,tacrolimus,0,0
16427,therapy,0,0
16428,in,0,0
16429,renal,1,1
16430,transplant,1,1
16431,recipients,1,1
16432,.,1,0
16433,METHODS,0,0
16434,This,0,0
16435,12-month,0,0
16436,",",0,0
16437,open,0,0
16438,",",0,0
16439,prospective,0,0
16440,study,0,0
16441,was,0,0
16442,conducted,0,0
16443,in,0,0
16444,15,1,0
16445,centers,1,1
16446,in,1,0
16447,France,1,0
16448,and,1,0
16449,1,1,0
16450,center,1,1
16451,in,1,0
16452,Belgium,1,1
16453,;,1,0
16454,309,1,1
16455,patients,1,1
16456,were,1,0
16457,randomized,1,0
16458,to,1,0
16459,receive,1,0
16460,either,1,0
16461,induction,1,0
16462,therapy,1,0
16463,with,1,1
16464,ATG,1,0
16465,(,1,0
16466,n=151,1,1
16467,),1,0
16468,followed,1,0
16469,by,1,0
16470,initiation,1,0
16471,of,1,0
16472,tacrolimus,1,0
16473,on,1,0
16474,day,1,0
16475,9,1,0
16476,or,1,0
16477,immediate,1,0
16478,tacrolimus-based,1,0
16479,triple,1,0
16480,therapy,1,0
16481,(,1,0
16482,n=158,1,1
16483,),1,0
16484,.,1,0
16485,In,0,0
16486,both,0,0
16487,study,0,0
16488,arms,0,0
16489,",",0,0
16490,the,0,0
16491,initial,0,0
16492,daily,0,0
16493,tacrolimus,0,0
16494,dose,0,0
16495,was,0,0
16496,0.2,0,0
16497,mg/kg,0,0
16498,.,0,0
16499,Steroid,0,0
16500,boluses,0,0
16501,were,0,0
16502,given,0,0
16503,in,0,0
16504,the,0,0
16505,first,0,0
16506,2,0,0
16507,days,0,0
16508,and,0,0
16509,tapered,0,0
16510,thereafter,0,0
16511,from,0,0
16512,20,0,0
16513,mg/day,0,0
16514,to,0,0
16515,5,0,0
16516,mg/day,0,0
16517,.,0,0
16518,Azathioprine,0,0
16519,was,0,0
16520,administered,0,0
16521,at,0,0
16522,1-2,0,0
16523,mg/kg,0,0
16524,per,0,0
16525,day,0,0
16526,.,0,0
16527,RESULTS,0,0
16528,At,0,0
16529,month,0,0
16530,12,0,0
16531,",",0,0
16532,biopsy-confirmed,0,1
16533,acute,0,1
16534,rejections,0,1
16535,were,0,0
16536,reported,0,0
16537,for,0,0
16538,15.2,0,0
16539,%,0,0
16540,(,0,0
16541,induction,0,0
16542,),0,0
16543,and,0,0
16544,30.4,0,0
16545,%,0,0
16546,(,0,0
16547,noninduction,0,0
16548,),0,0
16549,of,0,0
16550,patients,0,1
16551,(,0,0
16552,P=0.001,0,0
16553,),0,0
16554,.,0,0
16555,The,0,0
16556,incidence,0,0
16557,of,0,0
16558,steroid-sensitive,0,1
16559,acute,0,1
16560,rejections,0,1
16561,was,0,0
16562,7.9,0,0
16563,%,0,0
16564,(,0,0
16565,induction,0,0
16566,),0,0
16567,and,0,0
16568,22.2,0,0
16569,%,0,0
16570,(,0,0
16571,noninduction,0,0
16572,),0,0
16573,(,0,0
16574,P=0.001,0,0
16575,),0,0
16576,.,0,0
16577,Steroid-resistant,0,0
16578,acute,0,1
16579,rejections,0,1
16580,were,0,0
16581,reported,0,0
16582,for,0,0
16583,8.6,0,0
16584,%,0,0
16585,(,0,0
16586,induction,0,0
16587,),0,0
16588,and,0,0
16589,8.9,0,0
16590,%,0,0
16591,(,0,0
16592,noninduction,0,0
16593,),0,0
16594,of,0,0
16595,patients,0,1
16596,.,0,0
16597,A,0,0
16598,total,0,0
16599,of,0,0
16600,nine,0,1
16601,patients,0,1
16602,died,0,1
16603,.,0,0
16604,Patient,0,0
16605,survival,0,0
16606,and,0,0
16607,graft,0,0
16608,survival,0,0
16609,at,0,0
16610,month,0,0
16611,12,0,0
16612,was,0,0
16613,similar,0,0
16614,in,0,0
16615,both,0,0
16616,treatment,0,0
16617,groups,0,0
16618,(,0,0
16619,97.4,0,0
16620,%,0,0
16621,vs.,0,0
16622,96.8,0,0
16623,%,0,0
16624,and,0,0
16625,92.1,0,0
16626,%,0,0
16627,vs.,0,0
16628,91.1,0,0
16629,%,0,0
16630,",",0,0
16631,respectively,0,0
16632,),0,0
16633,.,0,0
16634,Statistically,0,0
16635,significant,0,0
16636,differences,0,0
16637,in,0,0
16638,the,0,0
16639,incidence,0,0
16640,of,0,0
16641,adverse,0,0
16642,events,0,0
16643,were,0,0
16644,found,0,0
16645,for,0,0
16646,cytomegalovirus,0,1
16647,(,0,0
16648,CMV,0,0
16649,),0,0
16650,infection,0,0
16651,(,0,0
16652,induction,0,0
16653,",",0,0
16654,32.5,0,0
16655,%,0,0
16656,vs.,0,0
16657,noninduction,0,0
16658,",",0,0
16659,19.0,0,0
16660,%,0,0
16661,",",0,0
16662,P=0.009,0,0
16663,),0,0
16664,",",0,0
16665,leukopenia,0,0
16666,(,0,0
16667,37.3,0,0
16668,%,0,0
16669,vs.,0,0
16670,9.5,0,0
16671,%,0,0
16672,",",0,0
16673,P,0,0
16674,<,0,0
16675,0.001,0,0
16676,),0,0
16677,",",0,0
16678,fever,0,0
16679,(,0,0
16680,25.2,0,0
16681,%,0,0
16682,vs.,0,0
16683,10.1,0,0
16684,%,0,0
16685,",",0,0
16686,P=0.001,0,0
16687,),0,0
16688,",",0,0
16689,herpes,0,0
16690,simplex,0,0
16691,(,0,0
16692,17.9,0,0
16693,%,0,0
16694,vs.,0,0
16695,5.7,0,0
16696,%,0,0
16697,",",0,0
16698,P=0.001,0,0
16699,),0,0
16700,",",0,0
16701,and,0,0
16702,thrombocytopenia,0,0
16703,(,0,0
16704,11.3,0,0
16705,%,0,0
16706,vs.,0,0
16707,3.2,0,0
16708,%,0,0
16709,",",0,0
16710,P=0.007,0,0
16711,),0,0
16712,.,0,0
16713,In,0,0
16714,the,0,0
16715,induction,0,0
16716,group,0,0
16717,",",0,0
16718,serum,0,0
16719,sickness,0,0
16720,was,0,0
16721,observed,0,0
16722,in,0,0
16723,10.6,0,0
16724,%,0,0
16725,of,0,0
16726,patients,0,1
16727,.,0,0
16728,The,0,0
16729,incidence,0,0
16730,of,0,0
16731,new,0,0
16732,onset,0,1
16733,diabetes,0,1
16734,mellitus,0,1
16735,was,0,0
16736,3.4,0,0
16737,%,0,0
16738,(,0,0
16739,induction,0,0
16740,),0,0
16741,and,0,0
16742,4.5,0,0
16743,%,0,0
16744,(,0,0
16745,noninduction,0,1
16746,),0,0
16747,.,0,0
16748,CONCLUSION,0,0
16749,Low,0,1
16750,incidences,0,0
16751,of,0,0
16752,acute,0,1
16753,rejection,0,1
16754,were,0,0
16755,found,0,0
16756,in,0,0
16757,both,0,0
16758,treatment,0,0
16759,arms,0,0
16760,.,0,0
16761,Induction,0,0
16762,treatment,0,0
16763,with,0,0
16764,ATG,0,0
16765,has,0,0
16766,the,0,0
16767,advantage,0,0
16768,of,0,0
16769,a,0,0
16770,lower,0,0
16771,incidence,0,0
16772,of,0,0
16773,acute,0,1
16774,rejection,0,1
16775,",",0,0
16776,but,0,0
16777,it,0,0
16778,significantly,0,0
16779,increases,0,0
16780,adverse,0,0
16781,events,0,0
16782,",",0,0
16783,particularly,0,0
16784,CMV,0,0
16785,infection,0,0
16786,.,0,0
16787,Equivalent,0,0
16788,efficacy,0,0
16789,of,0,0
16790,mitomycin,0,0
16791,C,0,0
16792,plus,0,0
16793,doxorubicin,0,0
16794,instillation,0,0
16795,to,0,0
16796,bacillus,0,0
16797,Calmette-Guerin,0,0
16798,therapy,0,0
16799,for,0,0
16800,carcinoma,1,1
16801,in,1,0
16802,situ,1,0
16803,of,1,0
16804,the,1,0
16805,bladder,1,1
16806,.,1,0
16807,BACKGROUND,0,0
16808,To,0,0
16809,elucidate,0,0
16810,the,0,0
16811,most,0,0
16812,efficient,0,0
16813,topical,0,0
16814,therapy,0,0
16815,for,0,0
16816,carcinoma,0,1
16817,in,0,0
16818,situ,0,0
16819,of,0,0
16820,the,0,0
16821,bladder,0,0
16822,",",0,0
16823,the,0,0
16824,efficacy,0,0
16825,of,0,0
16826,intravesical,0,0
16827,mitomycin,0,0
16828,C,0,0
16829,plus,0,0
16830,doxorubicin,0,0
16831,therapy,0,0
16832,was,0,0
16833,compared,0,0
16834,with,0,1
16835,bacillus,0,0
16836,Calmette-Guerin,0,0
16837,(,0,0
16838,BCG,0,0
16839,),0,0
16840,therapy,0,0
16841,.,0,0
16842,The,0,0
16843,clinical,0,0
16844,behavior,0,0
16845,of,0,0
16846,the,0,0
16847,tumor,0,0
16848,was,0,0
16849,analysed,0,0
16850,according,0,0
16851,to,0,0
16852,the,0,0
16853,histological,0,0
16854,grade,0,0
16855,.,0,0
16856,METHODS,0,0
16857,Forty-two,1,1
16858,patients,1,1
16859,with,1,1
16860,carcinoma,1,1
16861,in,1,0
16862,situ,1,0
16863,of,1,0
16864,the,1,0
16865,bladder,1,1
16866,were,0,0
16867,randomized,0,0
16868,to,0,0
16869,intravesical,0,0
16870,BCG,0,0
16871,(,0,0
16872,21,0,1
16873,patients,0,1
16874,),0,0
16875,or,0,1
16876,mitomycin,0,0
16877,C,0,0
16878,plus,0,0
16879,doxorubicin,0,0
16880,sequential,0,0
16881,therapy,0,0
16882,(,0,0
16883,21,0,1
16884,patients,0,1
16885,),0,0
16886,as,0,0
16887,first,0,0
16888,line,0,1
16889,treatment,0,0
16890,.,0,0
16891,The,0,0
16892,non-responders,0,0
16893,underwent,0,1
16894,the,0,0
16895,subsequent,0,0
16896,instillation,0,0
16897,of,0,0
16898,the,0,0
16899,other,0,0
16900,intravesical,0,0
16901,therapy,0,0
16902,alternately,0,0
16903,.,0,0
16904,Of,1,0
16905,the,1,0
16906,patients,1,1
16907,",",1,0
16908,27,1,1
16909,had,1,0
16910,grade,1,0
16911,2,1,0
16912,and,1,0
16913,15,1,0
16914,had,1,0
16915,grade,1,0
16916,3,1,0
16917,cancer,1,1
16918,.,1,0
16919,RESULTS,0,0
16920,Both,0,0
16921,topical,0,0
16922,therapies,0,0
16923,were,0,0
16924,equally,0,0
16925,effective,0,0
16926,with,0,0
16927,initial,0,0
16928,response,0,0
16929,rates,0,0
16930,of,0,0
16931,86,0,1
16932,%,0,0
16933,(,0,0
16934,18/21,0,0
16935,),0,0
16936,for,0,0
16937,BCG,0,0
16938,and,0,0
16939,81,0,0
16940,%,0,0
16941,(,0,0
16942,17/21,0,0
16943,),0,0
16944,for,0,0
16945,mitomycin,0,0
16946,C,0,0
16947,plus,0,0
16948,doxorubicin,0,0
16949,",",0,0
16950,irrespective,0,0
16951,of,0,0
16952,the,0,0
16953,tumor,0,0
16954,grade,0,0
16955,.,0,0
16956,Of,0,0
16957,seven,0,0
16958,initial,0,0
16959,non-responders,0,0
16960,",",0,0
16961,five,0,1
16962,patients,0,1
16963,achieved,0,0
16964,a,0,0
16965,complete,0,0
16966,response,0,0
16967,by,0,0
16968,subsequent,0,0
16969,instillation,0,0
16970,",",0,0
16971,resulting,0,0
16972,in,0,0
16973,a,0,0
16974,total,0,0
16975,response,0,0
16976,rate,0,0
16977,of,0,0
16978,95,0,0
16979,%,0,0
16980,.,0,0
16981,After,0,0
16982,a,0,0
16983,mean,0,0
16984,follow-up,0,0
16985,of,0,0
16986,47,0,1
16987,months,0,0
16988,",",0,0
16989,five,0,1
16990,patients,0,1
16991,(,0,0
16992,12,0,0
16993,%,0,0
16994,),0,0
16995,developed,0,0
16996,disease,0,1
16997,progression,0,0
16998,.,0,0
16999,The,0,0
17000,progression,0,0
17001,rates,0,0
17002,were,0,0
17003,not,0,0
17004,different,0,0
17005,between,0,0
17006,the,0,0
17007,topical,0,0
17008,therapies,0,0
17009,",",0,0
17010,but,0,0
17011,were,0,0
17012,significantly,0,0
17013,higher,0,0
17014,in,0,0
17015,grade,0,0
17016,3,0,0
17017,than,0,0
17018,in,0,0
17019,grade,0,1
17020,2,0,1
17021,cases,0,1
17022,.,0,0
17023,CONCLUSION,0,0
17024,It,0,0
17025,appears,0,0
17026,likely,0,0
17027,that,0,0
17028,mitomycin,0,0
17029,C,0,0
17030,plus,0,0
17031,doxorubicin,0,0
17032,instillation,0,0
17033,has,0,0
17034,an,0,0
17035,equivalent,0,0
17036,efficacy,0,0
17037,to,0,0
17038,BCG,0,0
17039,as,0,0
17040,the,0,0
17041,initial,0,0
17042,therapy,0,0
17043,of,0,0
17044,carcinoma,0,1
17045,in,0,0
17046,situ,0,0
17047,and,0,0
17048,the,0,0
17049,combination,0,0
17050,of,0,0
17051,them,0,0
17052,would,0,0
17053,be,0,0
17054,the,0,0
17055,most,0,0
17056,efficient,0,0
17057,treatment,0,0
17058,for,0,0
17059,the,0,0
17060,disease,0,1
17061,.,0,0
17062,Moreover,0,0
17063,",",0,0
17064,histological,0,0
17065,grading,0,0
17066,would,0,0
17067,be,0,0
17068,clinically,0,0
17069,useful,0,0
17070,in,0,0
17071,defining,0,0
17072,the,0,0
17073,tumor,0,0
17074,characteristics,0,0
17075,and,0,0
17076,behavior,0,0
17077,of,0,0
17078,carcinoma,0,1
17079,in,0,0
17080,situ,0,0
17081,of,0,0
17082,the,0,0
17083,bladder,0,1
17084,.,0,0
17085,The,0,0
17086,role,0,0
17087,of,0,0
17088,radiography,0,0
17089,in,0,0
17090,primary,1,0
17091,care,1,1
17092,patients,1,1
17093,with,1,1
17094,low,1,0
17095,back,1,0
17096,pain,1,0
17097,of,1,0
17098,at,1,0
17099,least,1,0
17100,6,1,0
17101,weeks,1,0
17102,duration,1,0
17103,:,1,1
17104,a,0,0
17105,randomised,0,0
17106,(,0,0
17107,unblinded,0,0
17108,),0,0
17109,controlled,0,0
17110,trial,0,0
17111,.,0,0
17112,OBJECTIVES,0,0
17113,To,0,0
17114,test,0,0
17115,the,0,0
17116,hypotheses,0,0
17117,that,0,0
17118,:,0,1
17119,(,0,0
17120,1,0,0
17121,),0,0
17122,Lumbar,0,1
17123,spine,0,0
17124,radiography,0,0
17125,in,0,0
17126,primary,1,0
17127,care,1,1
17128,patients,1,1
17129,with,1,1
17130,low,1,0
17131,back,1,0
17132,pain,1,0
17133,is,0,0
17134,not,0,0
17135,associated,0,0
17136,with,0,0
17137,improved,0,0
17138,patient,0,0
17139,outcomes,0,0
17140,",",0,0
17141,including,0,0
17142,pain,0,0
17143,",",0,0
17144,disability,0,0
17145,",",0,0
17146,health,0,0
17147,status,0,0
17148,",",0,0
17149,sickness,0,0
17150,absence,0,0
17151,",",0,0
17152,reassurance,0,0
17153,",",0,0
17154,and,0,0
17155,patient,0,0
17156,satisfaction,0,0
17157,or,0,0
17158,belief,0,0
17159,in,0,0
17160,the,0,0
17161,value,0,0
17162,of,0,0
17163,radiography,0,0
17164,.,0,0
17165,(,0,0
17166,2,0,0
17167,),0,0
17168,Lumbar,0,1
17169,spine,0,0
17170,radiography,0,0
17171,in,0,0
17172,primary,1,0
17173,care,1,1
17174,patients,1,1
17175,with,1,1
17176,low,1,0
17177,back,1,0
17178,pain,1,0
17179,is,0,0
17180,not,0,0
17181,associated,0,0
17182,with,0,0
17183,changes,0,0
17184,in,0,0
17185,patient,0,0
17186,management,0,0
17187,",",0,0
17188,including,0,0
17189,medication,0,0
17190,use,0,0
17191,",",0,0
17192,and,0,0
17193,the,0,0
17194,use,0,0
17195,of,0,0
17196,primary,0,0
17197,and,0,0
17198,secondary,0,0
17199,care,0,0
17200,services,0,1
17201,",",0,0
17202,physical,0,0
17203,therapies,0,0
17204,and,0,0
17205,complementary,0,0
17206,therapies,0,0
17207,.,0,1
17208,(,0,0
17209,3,0,0
17210,),0,0
17211,Participants,0,1
17212,choosing,0,0
17213,their,0,0
17214,treatment,0,0
17215,group,0,0
17216,(,0,0
17217,i.e,0,0
17218,.,0,0
17219,radiography,0,0
17220,or,0,0
17221,no,0,0
17222,radiography,0,0
17223,),0,0
17224,do,0,0
17225,not,0,0
17226,have,0,0
17227,better,0,0
17228,outcomes,0,0
17229,than,0,0
17230,those,0,0
17231,randomised,0,0
17232,to,0,0
17233,a,0,0
17234,treatment,0,0
17235,group,0,0
17236,.,0,0
17237,(,0,0
17238,4,0,0
17239,),0,0
17240,Lumbar,0,1
17241,spine,0,0
17242,radiography,0,0
17243,is,0,0
17244,not,0,0
17245,cost-effective,0,0
17246,compared,0,0
17247,with,0,1
17248,usual,0,0
17249,care,0,0
17250,without,0,0
17251,lumbar,0,0
17252,spine,0,0
17253,radiography,0,0
17254,.,0,0
17255,DESIGN,0,0
17256,A,0,0
17257,randomised,0,0
17258,unblinded,0,0
17259,controlled,0,0
17260,trial,0,0
17261,.,0,0
17262,SETTING,0,0
17263,Seventy-three,1,1
17264,general,1,1
17265,practices,1,0
17266,in,1,0
17267,Nottingham,1,1
17268,",",1,0
17269,North,1,0
17270,Nottinghamshire,1,1
17271,",",1,0
17272,Southern,1,0
17273,Derbyshire,1,0
17274,",",1,0
17275,North,1,0
17276,Lincolnshire,1,1
17277,and,1,0
17278,North,1,1
17279,Leicestershire,1,1
17280,.,1,0
17281,Fifty-two,1,1
17282,practices,1,0
17283,recruited,1,1
17284,participants,1,1
17285,to,1,0
17286,the,1,0
17287,trial,1,0
17288,.,1,0
17289,SUBJECTS,0,0
17290,Randomised,0,0
17291,arm,0,0
17292,:,0,1
17293,421,1,1
17294,participants,1,1
17295,with,1,1
17296,low,1,0
17297,back,1,0
17298,pain,1,0
17299,",",1,0
17300,with,1,0
17301,median,1,0
17302,duration,1,0
17303,of,1,0
17304,10,1,1
17305,weeks,1,0
17306,.,1,1
17307,Patient,0,0
17308,preference,0,0
17309,arm,0,0
17310,:,0,1
17311,55,1,1
17312,participants,1,1
17313,with,1,1
17314,low,1,0
17315,back,1,0
17316,pain,1,0
17317,",",1,0
17318,with,1,0
17319,median,1,0
17320,duration,1,0
17321,of,1,0
17322,11,1,1
17323,weeks,1,0
17324,.,1,1
17325,INTERVENTION,0,0
17326,Lumbar,0,1
17327,spine,0,0
17328,radiography,0,0
17329,and,0,0
17330,usual,0,0
17331,care,0,0
17332,versus,0,0
17333,usual,0,0
17334,care,0,0
17335,without,0,1
17336,radiography,0,0
17337,.,0,0
17338,MAIN,0,0
17339,OUTCOME,0,0
17340,MEASURES,0,0
17341,Roland,0,1
17342,adaptation,0,0
17343,of,0,0
17344,the,0,0
17345,Sickness,0,0
17346,Impact,0,0
17347,Profile,0,0
17348,",",0,0
17349,visual,0,0
17350,analogue,0,0
17351,pain,0,0
17352,scale,0,0
17353,",",0,0
17354,health,0,0
17355,status,0,0
17356,scale,0,0
17357,",",0,0
17358,EuroQol,0,0
17359,",",0,0
17360,use,0,0
17361,of,0,0
17362,primary,0,0
17363,and,0,0
17364,secondary,0,0
17365,care,0,0
17366,services,0,0
17367,",",0,0
17368,and,0,0
17369,physical,0,0
17370,and,0,0
17371,complementary,0,0
17372,therapies,0,0
17373,",",0,0
17374,sickness,0,0
17375,absence,0,0
17376,",",0,0
17377,medication,0,0
17378,use,0,0
17379,",",0,0
17380,patient,0,0
17381,satisfaction,0,0
17382,",",0,0
17383,reassurance,0,0
17384,and,0,0
17385,belief,0,0
17386,in,0,0
17387,value,0,0
17388,of,0,0
17389,radiography,0,0
17390,at,0,0
17391,3,0,0
17392,and,0,0
17393,9,0,0
17394,months,0,0
17395,post-randomisation,0,0
17396,.,0,1
17397,RESULTS,0,0
17398,Participants,0,1
17399,randomised,0,1
17400,to,0,0
17401,receive,0,0
17402,an,0,0
17403,X-ray,0,0
17404,were,0,0
17405,more,0,0
17406,likely,0,0
17407,to,0,0
17408,report,0,0
17409,low,0,0
17410,back,0,0
17411,pain,0,0
17412,at,0,0
17413,3,0,0
17414,months,0,0
17415,(,0,0
17416,odds,0,0
17417,ratio,0,0
17418,(,0,0
17419,OR,0,0
17420,),0,0
17421,=,0,0
17422,1.56,0,0
17423,;,0,0
17424,95,0,0
17425,%,0,0
17426,confidence,0,0
17427,interval,0,0
17428,(,0,0
17429,CI,0,0
17430,),0,0
17431,",",0,0
17432,1.02,0,0
17433,to,0,0
17434,2.40,0,0
17435,),0,0
17436,and,0,0
17437,had,0,0
17438,a,0,0
17439,lower,0,0
17440,overall,0,0
17441,health,0,0
17442,status,0,0
17443,score,0,0
17444,(,0,0
17445,p,0,0
17446,=,0,0
17447,0.02,0,0
17448,),0,0
17449,.,0,0
17450,There,0,0
17451,were,0,0
17452,no,0,0
17453,differences,0,0
17454,in,0,0
17455,health,0,1
17456,or,0,0
17457,functional,0,0
17458,status,0,0
17459,at,0,0
17460,9,0,0
17461,months,0,0
17462,.,0,0
17463,A,0,0
17464,higher,0,0
17465,proportion,0,0
17466,of,0,0
17467,participants,0,1
17468,consulted,0,1
17469,the,0,0
17470,general,0,0
17471,practitioner,0,0
17472,(,0,0
17473,GP,0,0
17474,),0,0
17475,in,0,0
17476,the,0,0
17477,3,0,0
17478,months,0,0
17479,following,0,0
17480,an,0,0
17481,X-ray,0,0
17482,(,0,0
17483,OR,0,0
17484,=,0,0
17485,2.72,0,0
17486,;,0,0
17487,95,0,0
17488,%,0,0
17489,CI,0,0
17490,",",0,0
17491,1.80,0,0
17492,to,0,0
17493,4.10,0,0
17494,),0,0
17495,.,0,0
17496,There,0,0
17497,were,0,0
17498,no,0,0
17499,differences,0,0
17500,in,0,0
17501,use,0,0
17502,of,0,0
17503,any,0,0
17504,other,0,0
17505,services,0,0
17506,",",0,0
17507,medication,0,0
17508,use,0,0
17509,or,0,0
17510,sickness,0,0
17511,absence,0,0
17512,at,0,0
17513,3,0,0
17514,or,0,1
17515,9,0,1
17516,months,0,0
17517,.,0,0
17518,No,0,0
17519,serious,0,0
17520,spinal,0,0
17521,pathology,0,0
17522,was,0,0
17523,identified,0,0
17524,in,0,0
17525,either,0,0
17526,group,0,0
17527,.,0,0
17528,The,0,0
17529,commonest,0,0
17530,X-ray,0,0
17531,reports,0,0
17532,were,0,0
17533,of,0,0
17534,discovertebral,0,1
17535,degeneration,0,1
17536,and,0,0
17537,normal,0,1
17538,findings,0,0
17539,.,0,1
17540,Many,0,0
17541,patients,0,1
17542,did,0,0
17543,not,0,0
17544,perceive,0,0
17545,their,0,0
17546,information,0,0
17547,needs,0,0
17548,were,0,0
17549,met,0,1
17550,within,0,0
17551,the,0,0
17552,consultation,0,0
17553,.,0,0
17554,Satisfaction,0,0
17555,with,0,0
17556,care,0,0
17557,was,0,0
17558,greater,0,0
17559,in,0,0
17560,the,0,0
17561,group,0,0
17562,receiving,0,0
17563,radiography,0,0
17564,at,0,0
17565,9,0,0
17566,months,0,0
17567,.,0,1
17568,Participants,0,1
17569,randomised,0,0
17570,to,0,0
17571,receive,0,0
17572,an,0,0
17573,X-ray,0,0
17574,were,0,0
17575,not,0,0
17576,less,0,0
17577,worried,0,0
17578,",",0,0
17579,or,0,0
17580,more,0,0
17581,reassured,0,0
17582,about,0,0
17583,serious,0,0
17584,disease,0,1
17585,causing,0,0
17586,their,0,0
17587,low,0,0
17588,back,0,0
17589,pain,0,0
17590,.,0,0
17591,Satisfaction,0,0
17592,was,0,0
17593,associated,0,0
17594,with,0,1
17595,meeting,0,1
17596,participants,0,1
17597,',0,1
17598,information,0,0
17599,needs,0,0
17600,and,0,0
17601,reduced,0,0
17602,belief,0,0
17603,in,0,0
17604,the,0,0
17605,necessity,0,0
17606,for,0,0
17607,investigations,0,0
17608,for,0,0
17609,low,0,0
17610,back,0,0
17611,pain,0,0
17612,",",0,0
17613,including,0,0
17614,X-rays,0,0
17615,and,0,0
17616,blood,0,0
17617,tests,0,0
17618,.,0,0
17619,In,0,0
17620,both,0,0
17621,groups,0,0
17622,",",0,0
17623,at,0,0
17624,3,0,0
17625,and,0,0
17626,9,0,0
17627,months,0,0
17628,80,0,1
17629,%,0,0
17630,of,0,0
17631,participants,0,1
17632,would,0,0
17633,choose,0,0
17634,to,0,0
17635,have,0,0
17636,an,0,0
17637,X-ray,0,0
17638,if,0,0
17639,the,0,0
17640,choice,0,0
17641,was,0,0
17642,available,0,0
17643,.,0,0
17644,Participants,0,1
17645,in,0,0
17646,the,0,0
17647,patient,0,0
17648,preference,0,0
17649,group,0,0
17650,achieved,0,0
17651,marginally,0,0
17652,better,0,0
17653,outcomes,0,0
17654,than,0,0
17655,those,0,0
17656,randomised,0,0
17657,to,0,0
17658,a,0,0
17659,treatment,0,0
17660,group,0,0
17661,",",0,0
17662,but,0,0
17663,the,0,0
17664,clinical,0,0
17665,significance,0,0
17666,of,0,0
17667,these,0,0
17668,differences,0,0
17669,is,0,0
17670,unclear,0,0
17671,.,0,0
17672,Lumbar,0,0
17673,spine,0,0
17674,radiography,0,0
17675,was,0,0
17676,associated,0,0
17677,with,0,0
17678,a,0,0
17679,net,0,0
17680,economic,0,0
17681,loss,0,0
17682,at,0,0
17683,3,0,0
17684,and,0,0
17685,9,0,1
17686,months,0,0
17687,.,0,1
17688,CONCLUSIONS,0,0
17689,Lumbar,0,1
17690,spine,0,0
17691,radiography,0,0
17692,in,0,0
17693,primary,0,0
17694,care,0,1
17695,patients,0,1
17696,with,0,1
17697,low,0,0
17698,back,0,0
17699,pain,0,0
17700,of,0,0
17701,at,0,0
17702,least,0,0
17703,6,0,0
17704,weeks,0,0
17705,duration,0,0
17706,is,0,0
17707,not,0,0
17708,associated,0,0
17709,with,0,0
17710,improved,0,0
17711,functioning,0,0
17712,",",0,0
17713,severity,0,0
17714,of,0,0
17715,pain,0,0
17716,or,0,0
17717,overall,0,0
17718,health,0,0
17719,status,0,0
17720,",",0,0
17721,and,0,0
17722,is,0,0
17723,associated,0,0
17724,with,0,0
17725,an,0,0
17726,increase,0,0
17727,in,0,0
17728,GP,0,0
17729,workload,0,0
17730,.,0,0
17731,Participants,0,1
17732,receiving,0,1
17733,X-rays,0,0
17734,are,0,0
17735,more,0,0
17736,satisfied,0,0
17737,with,0,0
17738,their,0,0
17739,care,0,0
17740,",",0,0
17741,but,0,0
17742,are,0,0
17743,not,0,0
17744,less,0,0
17745,worried,0,0
17746,or,0,0
17747,more,0,0
17748,reassured,0,0
17749,about,0,0
17750,serious,0,0
17751,disease,0,1
17752,causing,0,0
17753,their,0,0
17754,low,0,0
17755,back,0,0
17756,pain,0,0
17757,.,0,0
17758,CONCLUSIONS,0,0
17759,-,0,0
17760,RECOMMENDATIONS,0,0
17761,FOR,0,0
17762,FURTHER,0,1
17763,RESEARCH,0,1
17764,:,0,1
17765,Further,0,0
17766,work,0,0
17767,is,0,0
17768,required,0,0
17769,to,0,0
17770,develop,0,0
17771,and,0,0
17772,test,0,0
17773,an,0,0
17774,educational,0,0
17775,package,0,0
17776,that,0,0
17777,educates,0,0
17778,patients,0,1
17779,and,0,0
17780,GPs,0,0
17781,about,0,0
17782,the,0,0
17783,utility,0,0
17784,of,0,0
17785,radiography,0,0
17786,and,0,0
17787,provides,0,0
17788,strategies,0,0
17789,for,0,0
17790,identifying,0,0
17791,and,0,0
17792,meeting,0,0
17793,the,0,0
17794,information,0,0
17795,needs,0,0
17796,of,0,0
17797,patients,0,1
17798,",",0,0
17799,and,0,0
17800,the,0,0
17801,needs,0,0
17802,of,0,0
17803,patients,0,1
17804,and,0,0
17805,GPs,0,0
17806,to,0,0
17807,be,0,0
17808,reassured,0,0
17809,about,0,0
17810,missing,0,0
17811,serious,0,0
17812,disease,0,1
17813,.,0,0
17814,Guidelines,0,0
17815,on,0,0
17816,the,0,0
17817,management,0,0
17818,of,0,0
17819,low,0,0
17820,back,0,0
17821,pain,0,0
17822,in,0,0
17823,primary,0,0
17824,care,0,0
17825,should,0,0
17826,be,0,0
17827,consistent,0,0
17828,about,0,0
17829,not,0,0
17830,recommending,0,0
17831,lumbar,0,0
17832,spine,0,0
17833,radiography,0,0
17834,in,0,0
17835,patients,0,1
17836,with,0,1
17837,low,0,0
17838,back,0,0
17839,pain,0,0
17840,in,0,0
17841,the,0,0
17842,absence,0,0
17843,of,0,0
17844,red,0,0
17845,flags,0,0
17846,for,0,0
17847,serious,0,0
17848,spinal,0,1
17849,pathology,0,0
17850,",",0,0
17851,even,0,0
17852,if,0,0
17853,the,0,0
17854,pain,0,0
17855,has,0,0
17856,persisted,0,0
17857,for,0,0
17858,at,0,0
17859,least,0,0
17860,6,0,0
17861,weeks,0,0
17862,.,0,1
17863,Prognostic,0,1
17864,significance,0,0
17865,of,0,0
17866,the,0,0
17867,dobutamine,0,0
17868,echocardiography,0,0
17869,test,0,0
17870,in,0,0
17871,idiopathic,1,1
17872,dilated,1,1
17873,cardiomyopathy,1,1
17874,.,1,0
17875,Dobutamine,0,0
17876,stress,0,0
17877,echo,0,0
17878,provides,0,0
17879,potentially,0,0
17880,useful,0,0
17881,information,0,0
17882,on,0,0
17883,idiopathic,1,1
17884,dilated,1,1
17885,cardiomyopathy,1,1
17886,(,1,0
17887,IDC,1,0
17888,),1,0
17889,.,1,0
17890,From,1,0
17891,February,1,1
17892,1,1,0
17893,",",1,0
17894,1997,1,1
17895,",",1,0
17896,to,1,0
17897,October,1,1
17898,1,1,0
17899,",",1,0
17900,1999,1,1
17901,",",1,0
17902,186,1,1
17903,patients,1,1
17904,(,1,1
17905,131,1,1
17906,men,1,1
17907,and,1,0
17908,55,1,1
17909,women,1,1
17910,",",1,0
17911,mean,1,0
17912,age,1,1
17913,56,1,1
17914,+/-,1,0
17915,12,1,1
17916,years,1,1
17917,),1,0
17918,with,1,1
17919,IDC,1,0
17920,",",1,0
17921,ejection,1,0
17922,fraction,1,0
17923,<,1,0
17924,35,1,0
17925,%,1,0
17926,",",1,0
17927,and,1,0
17928,angiographically,1,0
17929,normal,1,1
17930,coronary,1,1
17931,arteries,1,0
17932,were,1,0
17933,studied,1,1
17934,by,1,0
17935,high-dose,1,0
17936,(,1,0
17937,up,1,0
17938,to,1,0
17939,40,1,1
17940,micro/kg/min,1,0
17941,),1,0
17942,dobutamine,1,0
17943,echo,1,0
17944,in,1,0
17945,6,1,0
17946,centers,1,1
17947,",",1,0
17948,all,1,0
17949,quality,1,0
17950,controlled,1,0
17951,for,1,0
17952,stress,1,0
17953,echo,1,1
17954,reading,1,0
17955,.,1,0
17956,In,0,0
17957,all,0,0
17958,patients,0,1
17959,",",0,0
17960,wall,0,0
17961,motion,0,0
17962,score,0,0
17963,index,0,0
17964,(,0,0
17965,WMSI,0,0
17966,),0,0
17967,(,0,0
17968,from,0,0
17969,1,0,0
17970,=,0,0
17971,normal,0,1
17972,to,0,0
17973,4,0,0
17974,=,0,0
17975,dyskinetic,0,0
17976,in,0,0
17977,a,0,0
17978,16-,0,0
17979,segment,0,0
17980,model,0,0
17981,of,0,0
17982,the,0,0
17983,left,0,0
17984,ventricle,0,0
17985,),0,0
17986,was,0,0
17987,evaluated,0,0
17988,by,0,0
17989,echo,0,0
17990,at,0,0
17991,baseline,0,0
17992,and,0,0
17993,peak,0,0
17994,dobutamine,0,0
17995,.,0,0
17996,One,0,0
17997,hundred,0,1
17998,eighty-four,0,1
17999,patients,0,1
18000,were,0,0
18001,followed,0,0
18002,up,0,0
18003,(,0,0
18004,mean,0,0
18005,15,0,1
18006,+/-,0,0
18007,13,0,1
18008,months,0,0
18009,),0,0
18010,and,0,0
18011,only,0,0
18012,cardiac,0,0
18013,death,0,0
18014,was,0,0
18015,considered,0,0
18016,as,0,0
18017,an,0,0
18018,end,0,0
18019,point,0,0
18020,.,0,0
18021,There,0,0
18022,were,0,0
18023,29,0,1
18024,cardiac,0,1
18025,deaths,0,0
18026,.,0,1
18027,Significant,0,0
18028,parameters,0,0
18029,for,0,0
18030,survival,0,0
18031,prediction,0,0
18032,at,0,0
18033,univariate,0,0
18034,analysis,0,0
18035,are,0,0
18036,:,0,0
18037,DeltaWMSI,0,0
18038,(,0,0
18039,chi-square,0,0
18040,20.1,0,0
18041,;,0,0
18042,p,0,0
18043,<,0,0
18044,0.0000,0,0
18045,),0,0
18046,",",0,0
18047,New,0,1
18048,York,0,1
18049,Heart,0,0
18050,Association,0,0
18051,(,0,0
18052,NYHA,0,1
18053,),0,0
18054,class,0,1
18055,(,0,0
18056,chi-square,0,0
18057,17.57,0,0
18058,;,0,0
18059,p,0,0
18060,<,0,0
18061,0.0000,0,0
18062,),0,0
18063,",",0,0
18064,rest,0,0
18065,ejection,0,0
18066,fraction,0,0
18067,(,0,0
18068,chi-square,0,0
18069,10.41,0,0
18070,;,0,0
18071,p,0,0
18072,=,0,0
18073,0.0013,0,0
18074,),0,0
18075,",",0,0
18076,angiotensin-converting,0,0
18077,enzyme,0,0
18078,inhibitors,0,0
18079,(,0,0
18080,chi-square,0,0
18081,8.23,0,0
18082,;,0,0
18083,p,0,0
18084,=,0,0
18085,0.0041,0,0
18086,),0,0
18087,",",0,0
18088,and,0,0
18089,hypertension,0,1
18090,(,0,0
18091,chi-square,0,0
18092,8.08,0,0
18093,",",0,0
18094,p,0,0
18095,=,0,0
18096,0.0045,0,0
18097,),0,0
18098,.,0,0
18099,In,0,0
18100,the,0,0
18101,multivariate,0,0
18102,stepwise,0,0
18103,analysis,0,0
18104,only,0,0
18105,DeltaWMSI,0,0
18106,and,0,0
18107,NYHA,0,1
18108,were,0,0
18109,independent,0,0
18110,predictors,0,0
18111,of,0,0
18112,outcome,0,0
18113,(,0,0
18114,DeltaWMSI,0,0
18115,=,0,0
18116,hazard,0,0
18117,ratio,0,0
18118,0.02,0,0
18119,",",0,0
18120,p,0,0
18121,<,0,0
18122,0.0000,0,0
18123,;,0,0
18124,NYHA,0,1
18125,class,0,1
18126,=,0,0
18127,hazard,0,0
18128,ratio,0,0
18129,3.83,0,0
18130,",",0,0
18131,p,0,0
18132,<,0,0
18133,0.0000,0,0
18134,),0,0
18135,.,0,0
18136,Kaplan-Meier,0,0
18137,survival,0,0
18138,estimates,0,0
18139,showed,0,0
18140,a,0,0
18141,better,0,0
18142,outcome,0,0
18143,for,0,0
18144,patients,0,1
18145,with,0,1
18146,a,0,0
18147,large,0,0
18148,inotropic,0,0
18149,response,0,0
18150,(,0,0
18151,DeltaWMSI,0,0
18152,>,0,1
18153,or,0,0
18154,=0.44,0,0
18155,",",0,0
18156,a,0,0
18157,cutoff,0,0
18158,identified,0,0
18159,by,0,0
18160,receiver-operating,0,0
18161,characteristic,0,0
18162,curves,0,0
18163,analysis,0,0
18164,),0,0
18165,than,0,0
18166,for,0,0
18167,those,0,0
18168,with,0,0
18169,a,0,0
18170,small,0,0
18171,or,0,0
18172,no,0,0
18173,myocardial,0,0
18174,inotropic,0,0
18175,response,0,0
18176,to,0,0
18177,dobutamine,0,0
18178,(,0,0
18179,93.6,0,0
18180,%,0,0
18181,vs,0,0
18182,69.4,0,0
18183,%,0,0
18184,",",0,0
18185,p,0,0
18186,=,0,0
18187,0.00033,0,0
18188,),0,0
18189,.,0,0
18190,Thus,0,0
18191,",",0,0
18192,in,0,0
18193,patients,1,1
18194,with,1,1
18195,IDC,1,0
18196,",",0,0
18197,an,0,0
18198,extensive,0,0
18199,contractile,0,0
18200,reserve,0,0
18201,identified,0,0
18202,by,0,0
18203,high-dose,0,0
18204,dobutamine,0,0
18205,stress,0,0
18206,echocardiography,0,0
18207,is,0,0
18208,associated,0,0
18209,with,0,0
18210,a,0,0
18211,better,0,0
18212,survival,0,0
18213,.,0,0
18214,Capsular,0,1
18215,contracture,0,1
18216,around,0,0
18217,saline-filled,0,0
18218,fine,0,0
18219,textured,0,0
18220,and,0,0
18221,smooth,0,0
18222,mammary,0,1
18223,implants,0,1
18224,:,0,1
18225,a,0,0
18226,prospective,0,0
18227,7.5-year,0,1
18228,follow-up,0,0
18229,.,0,0
18230,In,0,0
18231,a,0,0
18232,previous,0,0
18233,prospective,0,0
18234,randomized,0,0
18235,clinical,0,0
18236,study,0,0
18237,comparing,0,0
18238,in,0,0
18239,the,0,0
18240,same,0,0
18241,patient,0,0
18242,textured,0,0
18243,and,0,0
18244,smooth,0,0
18245,saline-filled,0,0
18246,mammary,0,1
18247,implants,0,1
18248,(,0,0
18249,Biocell,0,0
18250,),0,0
18251,with,0,1
18252,large,0,0
18253,pore,0,0
18254,size,0,0
18255,(,0,0
18256,300,0,0
18257,to,0,0
18258,600,0,0
18259,microm,0,0
18260,),0,0
18261,",",0,0
18262,we,0,0
18263,saw,0,0
18264,no,0,0
18265,difference,0,0
18266,in,0,0
18267,capsular,0,0
18268,contracture,0,1
18269,.,0,0
18270,This,0,0
18271,study,0,0
18272,was,0,0
18273,undertaken,0,0
18274,in,0,0
18275,a,0,0
18276,similar,0,0
18277,way,0,0
18278,to,0,0
18279,compare,0,0
18280,capsular,0,0
18281,contracture,0,0
18282,around,0,0
18283,smooth,0,0
18284,and,0,0
18285,textured,0,0
18286,saline-filled,0,0
18287,prostheses,0,1
18288,with,0,1
18289,pores,0,0
18290,of,0,0
18291,small,0,0
18292,size,0,0
18293,.,0,0
18294,During,1,0
18295,a,1,0
18296,period,1,0
18297,of,1,0
18298,7.5,1,0
18299,years,1,1
18300,",",0,0
18301,the,0,0
18302,breast,0,1
18303,hardness,0,0
18304,was,0,0
18305,followed,0,0
18306,up,0,0
18307,",",0,0
18308,and,0,0
18309,at,0,0
18310,the,0,0
18311,end,0,0
18312,of,0,0
18313,the,0,0
18314,study,0,0
18315,patient,0,0
18316,satisfaction,0,0
18317,was,0,0
18318,evaluated,0,0
18319,.,0,0
18320,Twenty,1,1
18321,healthy,1,1
18322,women,1,1
18323,with,1,1
18324,a,1,0
18325,mean,1,0
18326,age,1,1
18327,of,1,0
18328,30,1,1
18329,years,1,1
18330,were,1,0
18331,operated,1,1
18332,on,1,0
18333,for,1,0
18334,breast,1,1
18335,augmentation,1,0
18336,.,1,0
18337,Two,0,0
18338,surgeons,0,0
18339,performed,0,0
18340,all,0,0
18341,operations,0,1
18342,in,0,0
18343,a,0,0
18344,standardized,0,0
18345,way,0,0
18346,.,0,0
18347,Each,0,0
18348,patient,0,0
18349,received,0,0
18350,subglandularly,0,1
18351,a,0,0
18352,Siltex,0,0
18353,textured,0,0
18354,saline-filled,0,0
18355,prosthesis,0,1
18356,with,0,0
18357,a,0,0
18358,pore,0,0
18359,size,0,0
18360,of,0,0
18361,30,0,0
18362,to,0,0
18363,70,0,1
18364,microm,0,0
18365,in,0,0
18366,one,0,0
18367,breast,0,1
18368,",",0,0
18369,and,0,0
18370,a,0,0
18371,smooth,0,0
18372,saline-filled,0,0
18373,prosthesis,0,1
18374,in,0,0
18375,the,0,0
18376,other,0,0
18377,.,0,0
18378,The,0,0
18379,hardness,0,0
18380,of,0,0
18381,the,0,0
18382,breasts,0,1
18383,was,0,0
18384,evaluated,0,0
18385,after,0,0
18386,0.5,0,0
18387,",",0,0
18388,1,0,0
18389,",",0,0
18390,and,0,0
18391,7.5,0,0
18392,years,0,1
18393,using,0,0
18394,Baker,0,0
18395,grading,0,0
18396,and,0,0
18397,applanation,0,0
18398,tonometry,0,0
18399,.,0,0
18400,Eighteen,1,1
18401,patients,1,1
18402,completed,1,1
18403,1-year,1,0
18404,and,1,0
18405,7.5-year,1,1
18406,follow-up,1,0
18407,.,1,1
18408,Two,0,0
18409,breasts,0,1
18410,with,0,1
18411,smooth,0,1
18412,prostheses,0,1
18413,were,0,0
18414,contracted,0,1
18415,after,0,0
18416,6,0,0
18417,months,0,0
18418,(,0,0
18419,Baker,0,0
18420,III,0,0
18421,or,0,0
18422,IV,0,0
18423,),0,0
18424,.,0,0
18425,After,0,0
18426,1,0,0
18427,year,0,0
18428,",",0,0
18429,four,0,0
18430,patients,0,1
18431,with,0,1
18432,smooth,0,1
18433,prostheses,0,1
18434,and,0,0
18435,one,0,0
18436,with,0,1
18437,a,0,0
18438,textured,0,0
18439,prosthesis,0,1
18440,had,0,0
18441,capsular,0,0
18442,contracture,0,0
18443,(,0,0
18444,p,0,0
18445,=,0,0
18446,0.34,0,0
18447,),0,0
18448,.,0,0
18449,Seven,0,0
18450,and,0,0
18451,one-half,0,0
18452,years,0,1
18453,after,0,0
18454,surgery,0,1
18455,",",0,0
18456,six,0,0
18457,patents,0,0
18458,with,0,1
18459,smooth,0,1
18460,and,0,0
18461,four,0,0
18462,with,0,1
18463,textured,0,0
18464,implants,0,1
18465,had,0,0
18466,contracture,0,1
18467,(,0,0
18468,p,0,0
18469,=,0,0
18470,0.66,0,0
18471,),0,0
18472,.,0,0
18473,On,0,0
18474,two,0,0
18475,patients,0,1
18476,with,0,1
18477,smooth,0,1
18478,prostheses,0,1
18479,and,0,0
18480,one,0,0
18481,patient,0,0
18482,with,0,1
18483,a,0,0
18484,textured,0,0
18485,prosthesis,0,0
18486,",",0,0
18487,the,0,0
18488,capsule,0,0
18489,around,0,0
18490,the,0,0
18491,implant,0,0
18492,hardened,0,0
18493,between,0,0
18494,6,0,0
18495,and,0,0
18496,12,0,1
18497,months,0,0
18498,.,0,1
18499,Between,0,0
18500,1,0,0
18501,year,0,0
18502,and,0,0
18503,7.5,0,0
18504,years,0,1
18505,",",0,0
18506,three,0,0
18507,breasts,0,1
18508,with,0,1
18509,smooth,0,1
18510,and,0,0
18511,textured,0,0
18512,implants,0,0
18513,contracted,0,1
18514,and,0,0
18515,one,0,0
18516,with,0,1
18517,a,0,0
18518,textured,0,0
18519,implant,0,0
18520,softened.The,0,0
18521,patients,0,1
18522,reported,0,0
18523,on,0,0
18524,a,0,0
18525,Visual,0,0
18526,Analogue,0,0
18527,Scale,0,0
18528,(,0,0
18529,1,0,0
18530,to,0,0
18531,10,0,0
18532,),0,0
18533,the,0,0
18534,impact,0,0
18535,of,0,0
18536,the,0,0
18537,augmentation,0,0
18538,on,0,0
18539,their,0,0
18540,quality,0,0
18541,of,0,0
18542,life,0,0
18543,to,0,0
18544,be,0,0
18545,9,0,0
18546,+/-,0,0
18547,1,0,0
18548,.,0,1
18549,Four,0,0
18550,patients,0,1
18551,preferred,0,0
18552,the,0,0
18553,breast,0,1
18554,with,0,0
18555,the,0,0
18556,smooth,0,0
18557,prosthesis,0,1
18558,",",0,0
18559,three,0,0
18560,preferred,0,0
18561,the,0,0
18562,breast,0,1
18563,with,0,0
18564,the,0,0
18565,textured,0,0
18566,prosthesis,0,0
18567,",",0,0
18568,and,0,0
18569,the,0,0
18570,others,0,0
18571,found,0,0
18572,both,0,0
18573,breasts,0,1
18574,equal,0,0
18575,.,0,0
18576,This,0,0
18577,study,0,0
18578,showed,0,0
18579,no,0,0
18580,significant,0,0
18581,difference,0,0
18582,of,0,0
18583,contracture,0,0
18584,with,0,1
18585,smooth,0,0
18586,versus,0,0
18587,fine,0,0
18588,textured,0,0
18589,implants,0,0
18590,.,0,0
18591,The,0,0
18592,majority,0,0
18593,of,0,0
18594,the,0,0
18595,patients,0,1
18596,preferred,0,0
18597,the,0,0
18598,smooth,0,0
18599,implants,0,0
18600,.,0,1
18601,The,0,0
18602,patients,0,1
18603,reported,0,0
18604,that,0,0
18605,the,0,0
18606,breast,0,1
18607,augmentation,0,0
18608,had,0,0
18609,had,0,0
18610,an,0,0
18611,extremely,0,0
18612,high,0,0
18613,impact,0,0
18614,on,0,0
18615,their,0,0
18616,quality,0,0
18617,of,0,0
18618,life,0,0
18619,.,0,0
18620,Physical,0,0
18621,activity,0,0
18622,in,0,0
18623,first-degree,1,1
18624,relatives,1,1
18625,of,1,0
18626,breast,1,1
18627,cancer,1,1
18628,patients,1,1
18629,.,1,0
18630,This,0,0
18631,study,0,0
18632,sought,0,0
18633,to,0,0
18634,evaluate,0,0
18635,physical,0,0
18636,activity,0,0
18637,in,0,0
18638,women,1,1
18639,at,1,0
18640,moderate,1,1
18641,risk,1,0
18642,for,1,0
18643,breast,1,1
18644,cancer,1,1
18645,",",0,0
18646,the,0,0
18647,correlates,0,0
18648,of,0,0
18649,engaging,0,0
18650,in,0,0
18651,regular,0,0
18652,physical,0,0
18653,activity,0,0
18654,",",0,0
18655,and,0,0
18656,whether,0,0
18657,physical,0,0
18658,activity,0,0
18659,relates,0,0
18660,to,0,0
18661,psychological,0,0
18662,well-being,0,0
18663,.,0,0
18664,The,0,0
18665,results,0,0
18666,revealed,0,0
18667,that,0,0
18668,55,1,1
18669,%,1,0
18670,of,1,0
18671,women,1,1
18672,were,1,0
18673,regularly,1,0
18674,active,1,0
18675,.,1,0
18676,Logistic,0,0
18677,regression,0,0
18678,models,0,0
18679,indicated,0,0
18680,that,0,0
18681,positive,0,0
18682,affect,0,0
18683,was,0,0
18684,associated,0,0
18685,with,0,1
18686,increased,0,0
18687,and,0,0
18688,negative,0,0
18689,affect,0,0
18690,was,0,0
18691,associated,0,0
18692,with,0,1
18693,decreased,0,0
18694,overall,0,0
18695,and,0,0
18696,leisure,0,1
18697,activity,0,0
18698,.,0,0
18699,Older,0,0
18700,",",0,0
18701,married,0,1
18702,",",0,0
18703,and,0,0
18704,employed,0,0
18705,women,0,1
18706,were,0,0
18707,more,0,0
18708,likely,0,0
18709,to,0,0
18710,engage,0,0
18711,in,0,0
18712,household/occupational,0,0
18713,activity,0,0
18714,",",0,0
18715,whereas,0,0
18716,women,0,1
18717,who,0,1
18718,perceived,0,0
18719,their,0,1
18720,risk,0,0
18721,for,0,0
18722,breast,0,1
18723,cancer,0,1
18724,as,0,0
18725,high,0,0
18726,were,0,0
18727,less,0,0
18728,likely,0,0
18729,.,0,0
18730,More,0,0
18731,educated,0,0
18732,women,0,1
18733,and,0,0
18734,those,0,0
18735,with,0,0
18736,higher,0,0
18737,perceived,0,0
18738,risk,0,0
18739,were,0,0
18740,more,0,0
18741,likely,0,0
18742,to,0,0
18743,engage,0,0
18744,in,0,0
18745,leisure,0,0
18746,activity,0,0
18747,",",0,0
18748,and,0,0
18749,married,0,1
18750,women,0,1
18751,were,0,0
18752,less,0,0
18753,likely,0,0
18754,.,0,0
18755,These,0,0
18756,results,0,0
18757,suggest,0,0
18758,a,0,0
18759,need,0,0
18760,to,0,0
18761,increase,0,0
18762,activity,0,0
18763,levels,0,0
18764,in,0,0
18765,women,1,1
18766,at,1,0
18767,moderate,1,1
18768,risk,1,0
18769,for,1,0
18770,breast,1,1
18771,cancer,1,1
18772,",",0,0
18773,provide,0,0
18774,variables,0,0
18775,upon,0,0
18776,which,0,0
18777,interventions,0,0
18778,can,0,0
18779,be,0,0
18780,tailored,0,0
18781,to,0,0
18782,promote,0,0
18783,activity,0,0
18784,",",0,0
18785,and,0,0
18786,point,0,0
18787,to,0,0
18788,psychological,0,0
18789,benefits,0,0
18790,of,0,0
18791,activity,0,0
18792,in,0,0
18793,this,0,0
18794,population,0,1
18795,.,0,0
18796,Dronabinol,0,0
18797,versus,0,0
18798,megestrol,0,0
18799,acetate,0,0
18800,versus,0,0
18801,combination,0,0
18802,therapy,0,0
18803,for,0,0
18804,cancer-associated,0,1
18805,anorexia,0,1
18806,:,0,1
18807,a,0,0
18808,North,0,0
18809,Central,0,0
18810,Cancer,0,1
18811,Treatment,0,0
18812,Group,0,1
18813,study,0,0
18814,.,0,0
18815,PURPOSE,0,0
18816,To,0,0
18817,determine,0,0
18818,whether,0,0
18819,dronabinol,0,0
18820,administered,0,0
18821,alone,0,0
18822,or,0,0
18823,with,0,0
18824,megestrol,0,1
18825,acetate,0,0
18826,was,0,0
18827,more,0,0
18828,",",0,0
18829,less,0,0
18830,",",0,0
18831,or,0,0
18832,equal,0,0
18833,in,0,0
18834,efficacy,0,0
18835,to,0,0
18836,single-agent,0,0
18837,megestrol,0,0
18838,acetate,0,0
18839,for,0,0
18840,palliating,0,0
18841,cancer-associated,0,1
18842,anorexia,0,1
18843,.,0,0
18844,PATIENTS,0,0
18845,AND,0,0
18846,METHODS,0,0
18847,Four,1,0
18848,hundred,1,1
18849,sixty-nine,1,1
18850,assessable,1,1
18851,advanced,1,1
18852,cancer,1,1
18853,patients,1,1
18854,were,1,0
18855,randomized,1,0
18856,to,1,0
18857,(,1,0
18858,1,1,0
18859,),1,0
18860,oral,1,0
18861,megestrol,1,1
18862,acetate,1,0
18863,800,1,0
18864,mg/d,1,0
18865,liquid,1,0
18866,suspension,1,0
18867,plus,1,0
18868,placebo,1,0
18869,",",1,0
18870,(,1,0
18871,2,1,0
18872,),1,0
18873,oral,1,0
18874,dronabinol,1,0
18875,2.5,1,0
18876,mg,1,0
18877,twice,1,0
18878,a,1,0
18879,day,1,0
18880,plus,1,0
18881,placebo,1,0
18882,",",1,0
18883,or,1,0
18884,(,1,0
18885,3,1,0
18886,),1,0
18887,both,1,0
18888,agents,1,0
18889,.,1,0
18890,Eligible,1,0
18891,patients,1,1
18892,acknowledged,1,0
18893,that,1,0
18894,loss,1,0
18895,of,1,0
18896,appetite,1,0
18897,or,1,0
18898,weight,1,0
18899,was,1,0
18900,a,1,0
18901,problem,1,0
18902,and,1,0
18903,reported,1,0
18904,the,1,0
18905,loss,1,0
18906,of,1,0
18907,5,1,0
18908,pounds,1,0
18909,or,1,1
18910,more,1,0
18911,during,1,0
18912,2,1,0
18913,months,1,0
18914,and/or,1,0
18915,a,1,0
18916,daily,1,0
18917,intake,1,0
18918,of,1,0
18919,less,1,0
18920,than,1,0
18921,20,1,0
18922,calories/kg,1,0
18923,of,1,0
18924,body,1,0
18925,weight,1,0
18926,.,1,0
18927,RESULTS,0,0
18928,Groups,0,0
18929,were,0,0
18930,comparable,0,0
18931,at,0,0
18932,baseline,0,0
18933,in,0,0
18934,age,0,1
18935,",",0,0
18936,sex,0,0
18937,",",0,0
18938,tumor,0,0
18939,type,0,0
18940,",",0,0
18941,weight,0,0
18942,loss,0,0
18943,",",0,0
18944,and,0,0
18945,performance,0,0
18946,status,0,0
18947,.,0,0
18948,A,0,0
18949,greater,0,0
18950,percentage,0,0
18951,of,0,0
18952,megestrol,1,1
18953,acetate-treated,1,1
18954,patients,1,1
18955,reported,0,0
18956,appetite,0,0
18957,improvement,0,0
18958,and,0,0
18959,weight,0,0
18960,gain,0,0
18961,compared,0,0
18962,with,0,1
18963,dronabinol-treated,1,0
18964,patients,1,1
18965,:,1,1
18966,75,0,1
18967,%,0,0
18968,versus,0,0
18969,49,0,1
18970,%,0,0
18971,(,0,0
18972,P,0,0
18973,=.0001,0,0
18974,),0,0
18975,for,0,0
18976,appetite,0,0
18977,and,0,0
18978,11,0,0
18979,%,0,0
18980,versus,0,0
18981,3,0,0
18982,%,0,0
18983,(,0,0
18984,P,0,0
18985,=.02,0,0
18986,),0,0
18987,for,0,0
18988,>,0,0
18989,or,0,0
18990,=,0,0
18991,10,0,0
18992,%,0,0
18993,baseline,0,0
18994,weight,0,0
18995,gain,0,0
18996,.,0,0
18997,Combination,0,0
18998,treatment,0,0
18999,resulted,0,0
19000,in,0,0
19001,no,0,0
19002,significant,0,0
19003,differences,0,0
19004,in,0,0
19005,appetite,0,0
19006,or,0,0
19007,weight,0,0
19008,compared,0,0
19009,with,0,0
19010,megestrol,0,0
19011,acetate,0,0
19012,alone,0,0
19013,.,0,0
19014,The,0,0
19015,Functional,0,0
19016,Assessment,0,0
19017,of,0,0
19018,Anorexia/Cachexia,0,0
19019,Therapy,0,0
19020,questionnaire,0,0
19021,",",0,0
19022,which,0,0
19023,emphasizes,0,0
19024,anorexia-related,0,0
19025,questions,0,0
19026,",",0,0
19027,demonstrated,0,0
19028,an,0,0
19029,improvement,0,0
19030,in,0,0
19031,quality,0,0
19032,of,0,0
19033,life,0,0
19034,(,0,0
19035,QOL,0,0
19036,),0,0
19037,among,0,0
19038,megestrol,1,1
19039,acetate-treated,1,1
19040,and,1,0
19041,combination-treated,1,0
19042,patients,1,1
19043,.,1,0
19044,The,0,0
19045,single-item,0,0
19046,Uniscale,0,0
19047,",",0,0
19048,a,0,0
19049,global,0,0
19050,QOL,0,0
19051,instrument,0,0
19052,",",0,0
19053,found,0,0
19054,comparable,0,0
19055,scores,0,0
19056,.,0,1
19057,Toxicity,0,0
19058,was,0,0
19059,also,0,0
19060,comparable,0,0
19061,",",0,0
19062,with,0,0
19063,the,0,0
19064,exception,0,0
19065,of,0,0
19066,an,0,0
19067,increased,0,0
19068,incidence,0,0
19069,of,0,0
19070,impotence,0,1
19071,among,0,1
19072,men,1,1
19073,who,1,1
19074,received,1,1
19075,megestrol,1,1
19076,acetate,1,0
19077,.,1,0
19078,CONCLUSION,0,0
19079,In,0,0
19080,the,0,0
19081,doses,0,0
19082,and,0,0
19083,schedules,0,0
19084,we,0,0
19085,studied,0,1
19086,",",0,0
19087,megestrol,0,0
19088,acetate,0,0
19089,provided,0,0
19090,superior,0,0
19091,anorexia,0,1
19092,palliation,0,1
19093,among,0,0
19094,advanced,1,1
19095,cancer,1,1
19096,patients,1,1
19097,compared,0,0
19098,with,0,1
19099,dronabinol,0,0
19100,alone,0,0
19101,.,0,0
19102,Combination,0,0
19103,therapy,0,0
19104,did,0,0
19105,not,0,0
19106,appear,0,0
19107,to,0,0
19108,confer,0,0
19109,additional,0,0
19110,benefit,0,0
19111,.,0,0
19112,Small-dose,0,0
19113,selective,0,0
19114,spinal,0,1
19115,anesthesia,0,0
19116,for,0,0
19117,short-duration,0,0
19118,outpatient,0,1
19119,laparoscopy,0,1
19120,:,0,1
19121,recovery,0,0
19122,characteristics,0,0
19123,compared,0,0
19124,with,0,1
19125,desflurane,0,0
19126,anesthesia,0,0
19127,.,0,0
19128,UNLABELLED,0,0
19129,We,0,0
19130,conducted,0,0
19131,a,0,0
19132,randomized,0,0
19133,controlled,0,0
19134,trial,0,0
19135,to,0,0
19136,compare,0,0
19137,the,0,0
19138,recovery,0,0
19139,characteristics,0,0
19140,of,0,0
19141,selective,0,0
19142,spinal,0,1
19143,anesthesia,0,0
19144,(,0,0
19145,SSA,0,0
19146,),0,0
19147,and,0,0
19148,desflurane,0,0
19149,anesthesia,0,0
19150,(,0,0
19151,DES,0,0
19152,),0,0
19153,in,0,0
19154,outpatient,1,1
19155,gynecological,1,1
19156,laparoscopy,1,1
19157,.,1,0
19158,Twenty,1,1
19159,ASA,1,0
19160,physical,1,0
19161,status,1,0
19162,I,1,0
19163,patients,1,1
19164,undergoing,1,1
19165,gynecological,1,1
19166,laparoscopy,1,1
19167,were,0,0
19168,randomized,0,0
19169,to,0,0
19170,receive,0,0
19171,either,0,0
19172,SSA,0,0
19173,with,0,1
19174,lidocaine,0,0
19175,10,0,1
19176,mg,0,0
19177,+,0,0
19178,sufentanil,0,0
19179,10,0,0
19180,microg,0,0
19181,or,0,0
19182,general,0,1
19183,anesthesia,0,0
19184,with,0,1
19185,DES,0,0
19186,and,0,0
19187,N,0,1
19188,(,0,0
19189,2,0,0
19190,),0,0
19191,O.,0,1
19192,Intraoperative,0,0
19193,conditions,0,0
19194,",",0,0
19195,recovery,0,0
19196,times,0,0
19197,",",0,0
19198,postanesthesia,0,1
19199,recovery,0,0
19200,scores,0,0
19201,",",0,0
19202,and,0,0
19203,postoperative,0,0
19204,outcomes,0,0
19205,were,0,0
19206,recorded,0,0
19207,.,0,0
19208,Intraoperative,0,0
19209,conditions,0,0
19210,were,0,0
19211,comparable,0,0
19212,in,0,0
19213,both,0,0
19214,groups,0,0
19215,.,0,0
19216,All,0,0
19217,patients,1,1
19218,in,0,0
19219,the,0,0
19220,SSA,1,0
19221,group,1,0
19222,were,0,0
19223,awake,0,0
19224,and,0,0
19225,oriented,0,0
19226,at,0,0
19227,the,0,0
19228,end,0,0
19229,of,0,0
19230,surgery,0,1
19231,",",0,0
19232,whereas,0,0
19233,patients,0,1
19234,in,0,0
19235,the,0,0
19236,DES,0,0
19237,group,0,0
19238,required,0,0
19239,7,0,0
19240,+/-,0,0
19241,2,0,0
19242,min,0,0
19243,for,0,0
19244,extubation,0,0
19245,and,0,0
19246,orientation,0,0
19247,.,0,0
19248,SSA,0,0
19249,patients,0,1
19250,had,0,0
19251,a,0,0
19252,significantly,0,0
19253,shorter,0,0
19254,time,0,0
19255,to,0,0
19256,straight,0,0
19257,leg,0,0
19258,raising,0,0
19259,(,0,0
19260,3,0,0
19261,+/-,0,0
19262,1,0,0
19263,min,0,0
19264,versus,0,0
19265,9,0,0
19266,+/-,0,0
19267,4,0,0
19268,min,0,0
19269,;,0,0
19270,P,0,0
19271,<,0,0
19272,0.0001,0,0
19273,),0,0
19274,and,0,0
19275,to,0,0
19276,ambulation,0,0
19277,(,0,0
19278,3,0,0
19279,+/-,0,0
19280,0.9,0,0
19281,min,0,0
19282,versus,0,0
19283,59,0,1
19284,+/-,0,0
19285,16,0,1
19286,min,0,0
19287,;,0,0
19288,P,0,0
19289,<,0,0
19290,0.0001,0,0
19291,),0,0
19292,compared,0,0
19293,with,0,0
19294,the,0,0
19295,DES,0,0
19296,group,0,0
19297,.,0,0
19298,SSA,0,0
19299,patients,0,1
19300,had,0,0
19301,significantly,0,0
19302,less,0,0
19303,postoperative,0,0
19304,pain,0,0
19305,than,0,0
19306,DES,0,0
19307,patients,0,1
19308,(,0,0
19309,P,0,0
19310,<,0,0
19311,0.05,0,0
19312,),0,0
19313,.,0,0
19314,We,0,0
19315,concluded,0,0
19316,that,0,0
19317,SSA,0,0
19318,was,0,0
19319,an,0,0
19320,effective,0,0
19321,alternative,0,0
19322,to,0,0
19323,DES,0,0
19324,for,0,0
19325,outpatient,0,1
19326,gynecological,0,1
19327,laparoscopy,0,1
19328,.,0,0
19329,IMPLICATIONS,0,0
19330,This,0,0
19331,study,0,0
19332,compared,0,0
19333,the,0,0
19334,use,0,0
19335,of,0,0
19336,a,0,0
19337,desflurane,0,0
19338,general,0,1
19339,anesthetic,0,0
19340,to,0,0
19341,a,0,0
19342,small-dose,0,0
19343,spinal,0,0
19344,anesthetic,0,0
19345,in,0,0
19346,ambulatory,0,0
19347,gynecological,0,1
19348,laparoscopy,0,1
19349,.,0,0
19350,Using,0,0
19351,the,0,0
19352,spinal,0,0
19353,technique,0,0
19354,",",0,0
19355,patients,0,1
19356,can,0,0
19357,walk,0,0
19358,from,0,0
19359,the,0,0
19360,operating,0,0
19361,room,0,0
19362,table,0,0
19363,to,0,0
19364,a,0,0
19365,stretcher,0,0
19366,on,0,0
19367,completion,0,0
19368,of,0,0
19369,surgery,0,1
19370,.,0,0
19371,Their,0,0
19372,recovery,0,0
19373,time,0,0
19374,was,0,0
19375,similar,0,0
19376,to,0,0
19377,that,0,0
19378,of,0,0
19379,the,0,0
19380,desflurane,1,0
19381,group,1,0
19382,.,1,0
19383,Changes,0,0
19384,in,0,0
19385,selected,0,1
19386,fitness,0,0
19387,parameters,0,0
19388,following,0,0
19389,six,0,1
19390,weeks,0,0
19391,of,0,0
19392,snowshoe,1,1
19393,training,1,0
19394,.,1,0
19395,BACKGROUND,0,0
19396,Recently,0,0
19397,",",0,0
19398,there,0,0
19399,has,0,0
19400,been,0,0
19401,an,0,0
19402,increase,0,0
19403,in,0,0
19404,popularity,0,0
19405,and,0,0
19406,participation,0,0
19407,in,0,0
19408,the,0,0
19409,sport,0,0
19410,of,0,0
19411,snowshoeing,0,0
19412,.,0,0
19413,While,0,0
19414,the,0,0
19415,sport,0,0
19416,has,0,0
19417,gained,0,0
19418,considerable,0,0
19419,recognition,0,0
19420,",",0,0
19421,to,0,0
19422,date,0,0
19423,there,0,0
19424,is,0,0
19425,little,0,0
19426,or,0,0
19427,no,0,0
19428,scientific,0,0
19429,research,0,0
19430,regarding,0,0
19431,training,0,0
19432,responses,0,0
19433,to,0,0
19434,snowshoeing,0,0
19435,as,0,0
19436,a,0,0
19437,form,0,0
19438,of,0,0
19439,exercise,0,0
19440,.,0,0
19441,Therefore,0,0
19442,",",0,0
19443,the,0,0
19444,purpose,0,0
19445,of,0,0
19446,this,0,0
19447,study,0,0
19448,was,0,0
19449,to,0,0
19450,determine,0,0
19451,whether,0,0
19452,snowshoe,0,0
19453,training,0,0
19454,could,0,0
19455,improve,0,0
19456,fitness,0,0
19457,measures,0,0
19458,.,0,0
19459,A,0,0
19460,further,0,0
19461,purpose,0,0
19462,was,0,0
19463,to,0,0
19464,compare,0,0
19465,responses,0,0
19466,from,0,0
19467,a,0,0
19468,snowshoe,0,0
19469,training,0,0
19470,program,0,0
19471,to,0,0
19472,a,0,0
19473,similarly,0,0
19474,designed,0,0
19475,run,0,0
19476,training,0,0
19477,program,0,0
19478,.,0,0
19479,METHODS,0,0
19480,This,0,0
19481,prospective,0,0
19482,",",0,0
19483,comparative,0,0
19484,study,0,0
19485,was,0,0
19486,conducted,0,0
19487,with,0,1
19488,healthy,1,1
19489,males,1,1
19490,and,1,0
19491,females,1,1
19492,between,1,0
19493,the,1,0
19494,ages,1,1
19495,of,1,0
19496,19,1,1
19497,and,1,0
19498,24,1,0
19499,.,1,0
19500,These,1,0
19501,subjects,1,1
19502,were,1,0
19503,recruited,1,1
19504,from,1,0
19505,the,1,0
19506,University,1,1
19507,of,1,0
19508,Vermont,1,1
19509,population,1,1
19510,and,1,0
19511,surrounding,1,0
19512,community,1,1
19513,.,1,0
19514,Following,0,0
19515,baseline,0,0
19516,measurements,0,0
19517,in,0,0
19518,VO2max,0,0
19519,",",0,0
19520,running,0,0
19521,time,0,0
19522,to,0,0
19523,exhaustion,0,0
19524,(,0,0
19525,RTE,0,0
19526,),0,0
19527,",",0,0
19528,and,0,0
19529,anthropometry,0,0
19530,",",0,0
19531,17,1,0
19532,subjects,1,1
19533,(,1,1
19534,10,1,1
19535,snowshoers,1,1
19536,and,1,0
19537,7,1,1
19538,runners,1,1
19539,),1,0
19540,participated,1,1
19541,in,0,0
19542,a,0,0
19543,six,0,0
19544,week,0,0
19545,conditioning,0,0
19546,program,0,0
19547,.,0,0
19548,Both,0,0
19549,groups,0,0
19550,exercised,0,0
19551,for,0,0
19552,30,0,1
19553,min,0,0
19554,at,0,0
19555,75-85,0,1
19556,%,0,0
19557,age,0,1
19558,predicted,0,0
19559,maximum,0,0
19560,heart,0,1
19561,rate,0,0
19562,",",0,0
19563,3-4,0,0
19564,times,0,0
19565,per,0,0
19566,week,0,0
19567,",",0,0
19568,for,0,0
19569,a,0,0
19570,total,0,1
19571,of,0,0
19572,18,0,1
19573,sessions,0,0
19574,.,0,1
19575,RESULTS,0,0
19576,VO2max,0,0
19577,improved,0,0
19578,significantly,0,0
19579,in,0,0
19580,both,0,0
19581,running,0,0
19582,and,0,0
19583,snowshoeing,0,0
19584,groups,0,0
19585,",",0,0
19586,6.3,0,0
19587,and,0,0
19588,8.5,0,0
19589,%,0,0
19590,",",0,0
19591,respectively,0,0
19592,.,0,0
19593,Run,0,0
19594,time,0,0
19595,to,0,0
19596,exhaustion,0,0
19597,also,0,0
19598,improved,0,0
19599,significantly,0,0
19600,in,0,0
19601,both,0,0
19602,groups,0,0
19603,",",0,0
19604,23.3,0,0
19605,and,0,0
19606,33.5,0,0
19607,%,0,0
19608,",",0,0
19609,respectively,0,0
19610,.,0,0
19611,There,0,0
19612,were,0,0
19613,no,0,0
19614,changes,0,0
19615,in,0,0
19616,anthropometry,0,0
19617,for,0,0
19618,either,0,0
19619,group,0,0
19620,.,0,0
19621,With,0,0
19622,the,0,0
19623,exception,0,0
19624,of,0,0
19625,RTE,0,0
19626,",",0,0
19627,there,0,0
19628,were,0,0
19629,no,0,0
19630,statistically,0,0
19631,significant,0,0
19632,differences,0,0
19633,between,0,0
19634,groups,0,0
19635,in,0,0
19636,any,0,0
19637,other,0,0
19638,measurements,0,0
19639,at,0,0
19640,baseline,0,0
19641,.,0,0
19642,CONCLUSIONS,0,0
19643,These,0,0
19644,results,0,0
19645,support,0,0
19646,the,0,0
19647,acceptability,0,0
19648,of,0,0
19649,snowshoeing,0,0
19650,as,0,0
19651,a,0,0
19652,valid,0,0
19653,means,0,0
19654,to,0,0
19655,improve,0,0
19656,or,0,0
19657,maintain,0,0
19658,cardiovascular,0,0
19659,endurance,0,0
19660,.,0,0
19661,[,0,0
19662,Efficacy,0,0
19663,and,0,0
19664,immune,0,0
19665,memory,0,0
19666,of,0,0
19667,plasma-derived,0,0
19668,hepatitis,1,1
19669,B,1,0
19670,vaccine,1,0
19671,11,1,1
19672,years,1,1
19673,after,1,0
19674,primary,1,1
19675,immunization,1,0
19676,],1,0
19677,.,0,0
19678,OBJECTIVE,0,0
19679,To,0,0
19680,evaluate,0,0
19681,the,0,0
19682,long-term,0,0
19683,efficacy,0,0
19684,of,0,0
19685,hepatitis,1,1
19686,B,1,0
19687,vaccine,1,0
19688,10,1,0
19689,years,1,1
19690,after,1,0
19691,primary,1,1
19692,immunization,1,0
19693,to,0,0
19694,provide,0,0
19695,scientific,0,0
19696,basis,0,0
19697,for,0,0
19698,the,0,0
19699,time,0,0
19700,of,0,0
19701,revaccination,0,1
19702,.,0,0
19703,METHODS,0,0
19704,The,0,0
19705,study,0,0
19706,was,0,0
19707,strictly,0,0
19708,designed,0,0
19709,with,0,0
19710,randomization,0,0
19711,",",0,0
19712,double-blinding,0,0
19713,",",0,0
19714,and,0,0
19715,placebo-controlled,0,0
19716,method,0,0
19717,to,0,0
19718,observe,0,0
19719,the,1,0
19720,efficacy,1,0
19721,and,1,0
19722,immune,1,0
19723,memory,1,0
19724,11,1,1
19725,years,1,1
19726,following,1,0
19727,hepatitis,1,1
19728,B,1,0
19729,vaccination,1,1
19730,.,1,0
19731,RESULTS,0,0
19732,Immunogenicity,0,0
19733,and,0,0
19734,protective,0,0
19735,rate,0,0
19736,of,0,0
19737,vaccine,0,0
19738,were,0,0
19739,still,0,0
19740,kept,0,0
19741,well,0,0
19742,11,0,0
19743,years,0,1
19744,after,0,0
19745,immunization,0,0
19746,with,0,1
19747,a,0,0
19748,protective,0,0
19749,rate,0,0
19750,against,0,0
19751,HBV,0,0
19752,infection,0,1
19753,of,0,0
19754,73.5,0,0
19755,%,0,0
19756,.,0,0
19757,But,0,0
19758,",",0,0
19759,there,0,0
19760,was,0,0
19761,no,0,0
19762,significant,0,0
19763,difference,0,0
19764,in,0,0
19765,HBV,0,1
19766,infection,0,1
19767,rates,0,0
19768,between,0,0
19769,vaccine,1,0
19770,group,1,0
19771,and,1,0
19772,placebo-controlled,1,0
19773,group,1,0
19774,(,0,0
19775,7.89,0,0
19776,%,0,0
19777,vs.,0,0
19778,13.25,0,0
19779,%,0,0
19780,",",0,0
19781,P,0,0
19782,>,0,1
19783,0.1,0,0
19784,),0,0
19785,nine,0,1
19786,to,0,0
19787,11,0,1
19788,years,0,1
19789,following,0,0
19790,immunization,0,0
19791,.,0,0
19792,There,0,0
19793,still,0,0
19794,existed,0,0
19795,immune,0,0
19796,memory,0,0
19797,11,0,1
19798,years,0,1
19799,after,0,0
19800,immunization,0,0
19801,",",0,0
19802,but,0,0
19803,it,0,0
19804,was,0,0
19805,significantly,0,0
19806,weaker,0,0
19807,than,0,0
19808,that,0,0
19809,within,0,0
19810,the,0,0
19811,first,0,0
19812,10,0,0
19813,years,0,1
19814,after,0,0
19815,immunization,0,0
19816,.,0,0
19817,CONCLUSION,0,0
19818,The,0,0
19819,efficacy,0,0
19820,of,0,0
19821,the,0,0
19822,vaccine,0,0
19823,had,0,0
19824,begun,0,0
19825,to,0,0
19826,drop,0,0
19827,11,0,0
19828,years,0,1
19829,after,0,0
19830,immunization,0,0
19831,",",0,0
19832,which,0,0
19833,should,0,0
19834,be,0,0
19835,followed,0,0
19836,up,0,0
19837,further,0,0
19838,to,0,0
19839,reach,0,0
19840,a,0,0
19841,clear,0,0
19842,conclusion,0,0
19843,.,0,0
19844,Effects,0,0
19845,of,0,0
19846,enalapril,0,0
19847,and,0,0
19848,eprosartan,0,0
19849,on,0,0
19850,the,0,0
19851,renal,0,0
19852,vascular,0,0
19853,nitric,0,0
19854,oxide,0,0
19855,system,0,0
19856,in,0,0
19857,human,1,0
19858,essential,1,1
19859,hypertension,1,1
19860,.,1,0
19861,BACKGROUND,0,0
19862,Experimental,0,0
19863,data,0,0
19864,in,0,0
19865,humans,0,0
19866,on,0,0
19867,the,0,0
19868,contribution,0,0
19869,of,0,0
19870,angiotensin-converting,0,0
19871,enzyme,0,0
19872,inhibitors,0,0
19873,and,0,0
19874,angiotensin,0,0
19875,II,0,0
19876,type,0,1
19877,1,0,0
19878,receptor,0,0
19879,blockers,0,0
19880,to,0,0
19881,the,0,0
19882,nitric,0,0
19883,oxide,0,0
19884,system,0,0
19885,of,0,0
19886,the,0,0
19887,renal,0,0
19888,vasculature,0,0
19889,are,0,0
19890,inconsistent,0,0
19891,.,0,0
19892,Enalapril,0,0
19893,and,0,0
19894,eprosartan,0,0
19895,",",0,0
19896,alone,0,0
19897,and,0,0
19898,in,0,0
19899,combination,0,0
19900,",",0,0
19901,were,0,0
19902,used,0,0
19903,to,0,0
19904,determine,0,0
19905,their,0,0
19906,short-term,0,0
19907,effects,0,0
19908,on,0,0
19909,the,0,0
19910,renal,0,0
19911,nitric,0,0
19912,oxide,0,0
19913,system,0,0
19914,and,0,0
19915,renal,0,1
19916,hemodynamics,0,0
19917,of,0,0
19918,human,1,1
19919,subjects,1,1
19920,with,1,1
19921,essential,1,1
19922,hypertension,1,1
19923,.,1,0
19924,METHODS,0,0
19925,Twenty,1,1
19926,male,1,1
19927,",",1,0
19928,white,1,1
19929,patients,1,1
19930,(,1,0
19931,27,1,1
19932,+/-,1,0
19933,1,1,0
19934,years,1,1
19935,),1,0
19936,with,1,1
19937,mild,1,1
19938,essential,1,1
19939,hypertension,1,1
19940,(,1,0
19941,143,1,1
19942,+/-,1,0
19943,11/95,1,1
19944,+/-,1,0
19945,6,1,0
19946,mm,1,0
19947,Hg,1,0
19948,),1,0
19949,were,0,0
19950,included,0,0
19951,in,0,0
19952,a,0,0
19953,double-blind,0,0
19954,",",0,0
19955,randomized,0,0
19956,",",0,0
19957,placebo-controlled,0,0
19958,",",0,0
19959,fourfold,0,0
19960,cross-over,0,0
19961,study,0,0
19962,with,0,0
19963,placebo,0,0
19964,",",0,0
19965,enalapril,0,0
19966,(,0,0
19967,20,0,0
19968,mg/day,0,0
19969,),0,0
19970,",",0,0
19971,eprosartan,0,0
19972,(,0,0
19973,600,0,0
19974,mg/day,0,0
19975,),0,0
19976,",",0,0
19977,or,0,0
19978,combination,0,0
19979,of,0,0
19980,both,0,0
19981,drugs,0,0
19982,(,0,0
19983,10,0,1
19984,and,0,0
19985,300,0,0
19986,mg/day,0,0
19987,",",0,0
19988,respectively,0,0
19989,),0,0
19990,each,0,0
19991,over,0,0
19992,a,0,0
19993,one,0,0
19994,week,0,0
19995,period,0,0
19996,followed,0,0
19997,by,0,0
19998,a,0,0
19999,two-week,0,0
20000,washout,0,0
20001,phase,0,0
20002,.,0,0
20003,After,0,0
20004,each,0,0
20005,study,0,0
20006,phase,0,0
20007,the,0,0
20008,glomerular,0,0
20009,filtration,0,0
20010,rate,0,0
20011,(,0,0
20012,GFR,0,0
20013,),0,0
20014,and,0,0
20015,renal,0,0
20016,plasma,0,0
20017,flow,0,0
20018,(,0,0
20019,RPF,0,0
20020,),0,0
20021,were,0,0
20022,determined,0,0
20023,.,0,0
20024,Basal,0,0
20025,nitric,0,0
20026,oxide,0,0
20027,synthesis,0,0
20028,of,0,0
20029,the,0,0
20030,renal,0,0
20031,vasculature,0,0
20032,was,0,0
20033,assessed,0,0
20034,by,0,0
20035,the,0,0
20036,decrease,0,0
20037,in,0,0
20038,RPF,0,0
20039,after,0,0
20040,inhibition,0,0
20041,of,0,0
20042,nitric,0,0
20043,oxide,0,0
20044,synthase,0,0
20045,with,0,1
20046,NG-monomethyl-L-arginine,0,0
20047,(,0,0
20048,L-NMMA,0,0
20049,;,0,0
20050,4.25,0,0
20051,mg/kg,0,0
20052,),0,0
20053,.,0,0
20054,RESULTS,0,0
20055,After,0,0
20056,one,0,0
20057,week,0,0
20058,of,0,0
20059,therapy,0,0
20060,",",0,0
20061,the,0,0
20062,combination,0,0
20063,therapy,0,0
20064,decreased,0,0
20065,casual,0,0
20066,blood,0,0
20067,pressure,0,0
20068,by,0,0
20069,5,0,0
20070,+/-,0,0
20071,2/3,0,1
20072,+/-,0,0
20073,1,0,0
20074,mm,0,0
20075,Hg,0,0
20076,versus,0,0
20077,placebo,0,0
20078,(,0,0
20079,P,0,0
20080,<,0,0
20081,0.01,0,0
20082,),0,0
20083,.,0,0
20084,Neither,0,0
20085,enalapril,0,0
20086,alone,0,0
20087,(,0,0
20088,-2,0,0
20089,+/-,0,0
20090,2/1,0,0
20091,+/-,0,0
20092,2,0,0
20093,mm,0,0
20094,Hg,0,0
20095,",",0,0
20096,NS,0,0
20097,vs.,0,0
20098,placebo,0,0
20099,),0,0
20100,nor,0,0
20101,eprosartan,0,0
20102,alone,0,0
20103,(,0,0
20104,-1,0,0
20105,+/-,0,0
20106,1/0,0,0
20107,+/-,0,0
20108,2,0,0
20109,mm,0,0
20110,Hg,0,0
20111,",",0,0
20112,NS,0,0
20113,vs.,0,0
20114,placebo,0,0
20115,),0,0
20116,had,0,0
20117,a,0,0
20118,clear-cut,0,0
20119,significant,0,0
20120,effect,0,0
20121,on,0,0
20122,casual,0,0
20123,blood,0,0
20124,pressure,0,0
20125,.,0,0
20126,In,0,0
20127,the,0,0
20128,combination,0,0
20129,phase,0,0
20130,",",0,0
20131,RPF,0,0
20132,increased,0,0
20133,by,0,0
20134,123,0,1
20135,+/-,0,0
20136,36,0,1
20137,mL/min,0,0
20138,(,0,0
20139,P,0,0
20140,<,0,0
20141,0.01,0,0
20142,),0,0
20143,.,0,0
20144,Neither,0,0
20145,enalapril,0,0
20146,alone,0,0
20147,(,0,0
20148,+59,0,0
20149,+/-,0,0
20150,46,0,1
20151,mL/min,0,0
20152,",",0,0
20153,P,0,0
20154,=,0,0
20155,0.21,0,0
20156,),0,0
20157,nor,0,0
20158,eprosartan,0,0
20159,alone,0,0
20160,(,0,0
20161,+113,0,0
20162,+/-,0,0
20163,51,0,1
20164,mL/min,0,0
20165,",",0,0
20166,P,0,0
20167,=,0,0
20168,0.06,0,0
20169,),0,0
20170,had,0,0
20171,a,0,0
20172,clear-cut,0,0
20173,significant,0,0
20174,effect,0,0
20175,on,0,0
20176,RPF,0,0
20177,.,0,0
20178,Changes,0,0
20179,of,0,0
20180,RPF,0,1
20181,induced,0,0
20182,by,0,0
20183,treatment,0,0
20184,correlated,0,0
20185,with,0,0
20186,the,0,0
20187,L-NMMA,0,0
20188,induced,0,0
20189,decrease,0,0
20190,in,0,0
20191,RPF,0,0
20192,in,0,0
20193,the,0,0
20194,combination,0,0
20195,(,0,0
20196,r,0,0
20197,=,0,0
20198,0.70,0,0
20199,",",0,0
20200,P,0,0
20201,<,0,0
20202,0.01,0,0
20203,),0,0
20204,and,0,0
20205,eprosartan,0,0
20206,phase,0,0
20207,(,0,0
20208,r,0,0
20209,=,0,0
20210,0.86,0,0
20211,",",0,0
20212,P,0,0
20213,<,0,0
20214,0.001,0,0
20215,),0,0
20216,",",0,0
20217,but,0,0
20218,not,0,0
20219,in,0,0
20220,the,0,0
20221,enalapril,0,0
20222,phase,0,0
20223,(,0,0
20224,r,0,0
20225,=,0,0
20226,-0.44,0,0
20227,",",0,0
20228,P,0,0
20229,=,0,0
20230,0.10,0,0
20231,),0,0
20232,.,0,0
20233,Renal,0,0
20234,vascular,0,0
20235,resistance,0,0
20236,was,0,0
20237,reduced,0,0
20238,by,0,0
20239,each,0,0
20240,active,0,0
20241,treatment,0,0
20242,with,0,0
20243,the,0,0
20244,most,0,0
20245,prominent,0,0
20246,reduction,0,0
20247,in,0,0
20248,the,0,0
20249,combination,0,0
20250,phase,0,0
20251,.,0,0
20252,GFR,0,0
20253,was,0,0
20254,unaffected,0,0
20255,by,0,0
20256,any,0,0
20257,treatment,0,0
20258,.,0,0
20259,CONCLUSIONS,0,0
20260,In,0,0
20261,contrast,0,0
20262,to,0,0
20263,the,0,0
20264,effects,0,0
20265,of,0,0
20266,either,0,0
20267,substance,0,0
20268,alone,0,0
20269,",",0,0
20270,a,0,0
20271,combination,0,0
20272,of,0,0
20273,half,0,0
20274,the,0,0
20275,dose,0,0
20276,of,0,0
20277,eprosartan,0,0
20278,with,0,1
20279,half,0,0
20280,the,0,0
20281,dose,0,0
20282,of,0,0
20283,enalapril,0,0
20284,had,0,0
20285,a,0,0
20286,prominent,0,0
20287,effect,0,0
20288,on,0,0
20289,renal,0,1
20290,perfusion,0,0
20291,.,0,0
20292,The,0,0
20293,effects,0,0
20294,of,0,0
20295,eprosartan,0,0
20296,on,0,0
20297,RPF,0,0
20298,are,0,0
20299,mediated,0,0
20300,",",0,0
20301,at,0,0
20302,least,0,0
20303,in,0,0
20304,part,0,0
20305,",",0,0
20306,by,0,0
20307,an,0,0
20308,increased,0,0
20309,bioavailability,0,0
20310,of,0,0
20311,nitric,0,0
20312,oxide,0,0
20313,in,0,0
20314,the,0,0
20315,renal,0,0
20316,vasculature,0,0
20317,.,0,0
20318,Regional,0,0
20319,ischemic,0,1
20320,preconditioning,0,0
20321,enhances,0,0
20322,myocardial,0,1
20323,performance,0,0
20324,in,0,0
20325,off-pump,0,1
20326,coronary,0,1
20327,artery,1,1
20328,bypass,1,1
20329,grafting,1,0
20330,.,1,0
20331,OBJECTIVES,0,0
20332,We,0,0
20333,intended,0,0
20334,to,0,0
20335,investigate,0,0
20336,whether,0,0
20337,ischemic,0,1
20338,preconditioning,0,0
20339,(,0,0
20340,IP,0,0
20341,),0,0
20342,enhances,0,0
20343,myocardial,0,0
20344,performance,0,0
20345,in,0,1
20346,patients,1,1
20347,who,1,1
20348,undergo,1,1
20349,off-pump,1,1
20350,coronary,1,1
20351,artery,1,1
20352,bypass,1,1
20353,grafting,1,0
20354,(,1,0
20355,CABG,1,0
20356,),1,0
20357,.,1,0
20358,DESIGN,0,0
20359,A,0,0
20360,controlled,0,0
20361,",",0,0
20362,randomized,0,0
20363,",",0,0
20364,prospective,0,0
20365,study,0,0
20366,.,0,0
20367,SETTING,0,0
20368,A,0,0
20369,university,0,1
20370,hospital,0,0
20371,.,0,0
20372,PATIENTS,0,0
20373,Thirty-two,1,1
20374,patients,1,1
20375,with,1,1
20376,left,1,1
20377,anterior,1,1
20378,descending,1,0
20379,coronary,1,1
20380,artery,1,1
20381,(,1,0
20382,LAD,1,0
20383,),1,0
20384,or,1,0
20385,two-vessel,1,0
20386,heart,1,1
20387,disease,1,1
20388,(,1,0
20389,including,1,0
20390,LAD,1,1
20391,),1,1
20392,who,1,1
20393,were,1,1
20394,to,1,1
20395,undergo,1,0
20396,off-pump,1,1
20397,CABG,1,0
20398,were,0,0
20399,randomized,0,0
20400,into,0,0
20401,an,0,0
20402,IP,0,0
20403,group,0,0
20404,and,0,0
20405,a,0,0
20406,control,0,0
20407,group,0,0
20408,.,0,0
20409,INTERVENTIONS,0,0
20410,IP,0,0
20411,was,0,0
20412,induced,0,0
20413,by,0,0
20414,occluding,0,0
20415,the,0,0
20416,LAD,0,0
20417,twice,0,0
20418,for,0,0
20419,a,0,0
20420,2-min,0,0
20421,period,0,0
20422,followed,0,0
20423,by,0,0
20424,3-min,0,0
20425,LAD,0,0
20426,reperfusion,0,0
20427,before,0,0
20428,bypass,0,1
20429,grafting,0,0
20430,of,0,0
20431,the,0,0
20432,first,0,0
20433,coronary,0,1
20434,vessel,0,0
20435,.,0,0
20436,MEASUREMENTS,0,0
20437,AND,0,0
20438,RESULTS,0,0
20439,Registration,0,0
20440,included,0,1
20441,hemodynamic,0,0
20442,data,0,0
20443,from,0,0
20444,the,0,0
20445,peripheral,0,0
20446,artery,0,1
20447,and,0,0
20448,the,0,0
20449,pulmonary,0,0
20450,artery,0,1
20451,",",0,0
20452,and,0,0
20453,the,0,0
20454,measurement,0,0
20455,of,0,0
20456,cardiac,0,0
20457,troponin,0,0
20458,I,0,0
20459,(,0,0
20460,CTnI,0,0
20461,),0,0
20462,and,0,0
20463,creatine,0,0
20464,kinase,0,0
20465,isoenzyme,0,0
20466,MB,0,0
20467,(,0,0
20468,CK-MB,0,0
20469,),0,0
20470,values,0,0
20471,.,0,1
20472,IP,0,0
20473,resulted,0,0
20474,in,0,0
20475,a,0,0
20476,complete,0,0
20477,recovery,0,0
20478,of,0,0
20479,the,0,0
20480,mean,0,0
20481,stroke,0,1
20482,volume,0,0
20483,index,0,0
20484,(,0,0
20485,SVI,0,0
20486,),0,0
20487,after,0,0
20488,the,0,0
20489,operation,0,0
20490,.,0,0
20491,In,0,0
20492,the,0,0
20493,control,0,0
20494,subjects,0,1
20495,",",0,0
20496,the,0,0
20497,mean,0,0
20498,SVI,0,0
20499,showed,0,0
20500,a,0,0
20501,significant,0,0
20502,reduction,0,0
20503,postoperatively,0,0
20504,(,0,0
20505,p,0,0
20506,=,0,0
20507,0.039,0,0
20508,),0,0
20509,.,0,0
20510,On,0,0
20511,the,0,0
20512,first,0,0
20513,postoperative,0,0
20514,day,0,0
20515,",",0,0
20516,the,0,0
20517,increase,0,0
20518,in,0,0
20519,the,0,0
20520,mean,0,0
20521,heart,0,0
20522,rate,0,0
20523,(,0,0
20524,HR,0,0
20525,),0,0
20526,was,0,0
20527,also,0,0
20528,significantly,0,0
20529,lower,0,0
20530,in,0,0
20531,the,0,0
20532,IP,0,0
20533,patients,0,1
20534,.,0,0
20535,The,0,0
20536,CTnI,0,0
20537,level,0,0
20538,was,0,0
20539,statistically,0,0
20540,significantly,0,0
20541,lower,0,0
20542,in,0,0
20543,the,0,0
20544,IP,0,0
20545,group,0,0
20546,(,0,0
20547,p,0,0
20548,=,0,0
20549,0.043,0,0
20550,),0,0
20551,",",0,0
20552,and,0,0
20553,IP,0,0
20554,patients,0,1
20555,tended,0,0
20556,to,0,0
20557,have,0,0
20558,a,0,0
20559,smaller,0,0
20560,CK-MB,0,0
20561,release,0,0
20562,after,0,0
20563,surgery,0,1
20564,(,0,0
20565,not,0,0
20566,significant,0,0
20567,),0,0
20568,.,0,0
20569,The,0,0
20570,duration,0,0
20571,of,0,0
20572,mechanical,0,0
20573,ventilation,0,0
20574,",",0,0
20575,the,0,0
20576,length,0,0
20577,of,0,0
20578,stay,0,0
20579,in,0,0
20580,the,0,0
20581,ICU,0,0
20582,",",0,0
20583,and,0,0
20584,the,0,0
20585,use,0,0
20586,of,0,0
20587,inotropic,0,0
20588,medication,0,0
20589,did,0,0
20590,not,0,0
20591,increase,0,0
20592,after,0,0
20593,the,0,0
20594,IP,0,0
20595,protocol,0,0
20596,.,0,0
20597,CONCLUSIONS,0,0
20598,Two,0,1
20599,cycles,0,0
20600,of,0,0
20601,regional,0,1
20602,2-min,0,0
20603,IP,0,0
20604,in,0,0
20605,the,0,0
20606,LAD,0,0
20607,",",0,0
20608,followed,0,0
20609,by,0,0
20610,3,0,0
20611,min,0,0
20612,of,0,0
20613,reperfusion,0,0
20614,",",0,0
20615,proved,0,0
20616,to,0,0
20617,be,0,0
20618,applicable,0,0
20619,and,0,0
20620,safe,0,0
20621,in,0,0
20622,patients,1,1
20623,undergoing,1,1
20624,off-pump,1,1
20625,myocardial,1,1
20626,revascularization,1,0
20627,",",0,0
20628,it,0,0
20629,tended,0,0
20630,to,0,0
20631,decrease,0,0
20632,the,0,0
20633,immediate,0,0
20634,myocardial,0,0
20635,enzyme,0,0
20636,release,0,0
20637,",",0,0
20638,it,0,0
20639,prohibited,0,0
20640,the,0,0
20641,postoperative,0,0
20642,increase,0,0
20643,in,0,0
20644,HR,0,0
20645,",",0,0
20646,and,0,0
20647,it,0,0
20648,enhanced,0,0
20649,the,0,0
20650,recovery,0,0
20651,of,0,0
20652,SVI,0,0
20653,.,0,1
20654,N-butyl,0,0
20655,cyanoacrylate,0,0
20656,embolization,0,0
20657,of,0,0
20658,cerebral,0,1
20659,arteriovenous,0,1
20660,malformations,0,1
20661,:,0,1
20662,results,0,0
20663,of,0,0
20664,a,0,0
20665,prospective,0,0
20666,",",0,0
20667,randomized,0,0
20668,",",0,0
20669,multi-center,0,0
20670,trial,0,0
20671,.,0,0
20672,BACKGROUND,0,0
20673,AND,0,0
20674,PURPOSE,0,0
20675,Liquid,0,0
20676,N-butyl,0,0
20677,cyanoacrylate,0,0
20678,(,0,0
20679,n-BCA,0,0
20680,),0,0
20681,use,0,0
20682,for,0,0
20683,the,0,0
20684,treatment,0,0
20685,of,0,0
20686,arteriovenous,0,1
20687,malformations,0,1
20688,(,0,0
20689,AVM,0,0
20690,),0,0
20691,in,0,0
20692,the,0,0
20693,brain,0,0
20694,has,0,0
20695,become,0,0
20696,part,0,0
20697,of,0,0
20698,medical,0,1
20699,practice,0,0
20700,.,0,0
20701,However,0,0
20702,",",0,0
20703,no,0,0
20704,study,0,0
20705,has,0,0
20706,led,0,0
20707,to,0,0
20708,the,0,0
20709,Food,0,0
20710,and,0,0
20711,Drug,0,0
20712,Administration,0,0
20713,'s,0,0
20714,approval,0,0
20715,of,0,0
20716,n-BCA,0,0
20717,for,0,0
20718,intravascular,0,0
20719,use,0,0
20720,.,0,0
20721,The,0,0
20722,purpose,0,0
20723,of,0,0
20724,this,0,0
20725,study,0,0
20726,was,0,0
20727,to,0,0
20728,verify,0,0
20729,the,0,0
20730,effectiveness,0,0
20731,and,0,0
20732,safety,0,0
20733,of,0,0
20734,an,0,0
20735,n-BCA/Tantalum,0,0
20736,Powder/Ethiodized,0,0
20737,Oil,0,0
20738,mixture,0,0
20739,",",0,0
20740,compared,0,0
20741,with,0,0
20742,conventional,0,0
20743,treatment,0,0
20744,(,0,0
20745,Trufill,0,0
20746,polyvinyl,0,0
20747,alcohol,0,0
20748,[,0,0
20749,PVA,0,0
20750,],0,0
20751,),0,0
20752,for,0,0
20753,preoperative,0,0
20754,embolization,0,0
20755,of,0,0
20756,cerebral,0,1
20757,AVM,0,0
20758,.,0,1
20759,METHODS,0,0
20760,Between,1,0
20761,October,1,1
20762,15,1,0
20763,",",1,0
20764,1996,1,1
20765,",",1,0
20766,and,1,0
20767,March,1,0
20768,24,1,0
20769,",",1,0
20770,1999,1,1
20771,",",1,0
20772,104,1,1
20773,patients,1,1
20774,at,1,0
20775,13,1,1
20776,centers,1,1
20777,were,1,0
20778,prospectively,1,1
20779,randomized,1,0
20780,to,0,0
20781,undergo,0,0
20782,embolization,0,0
20783,using,0,0
20784,an,0,0
20785,n-BCA/Tantalum,0,0
20786,Powder/Ethiodol,0,0
20787,mixture,0,0
20788,or,0,0
20789,Trufill,0,0
20790,PVA,0,0
20791,.,0,0
20792,The,0,0
20793,pre-embolization,0,0
20794,therapy,0,0
20795,goals,0,0
20796,were,0,0
20797,determined,0,0
20798,in,0,0
20799,terms,0,0
20800,of,0,0
20801,the,0,0
20802,number,0,0
20803,of,0,0
20804,pedicles,0,0
20805,to,0,0
20806,be,0,0
20807,embolized,0,0
20808,and,0,0
20809,the,0,0
20810,percent,0,0
20811,of,0,0
20812,nidus,0,0
20813,reduction,0,0
20814,expected,0,0
20815,.,0,0
20816,Embolization,0,0
20817,results,0,0
20818,were,0,0
20819,evaluated,0,0
20820,by,0,0
20821,a,0,0
20822,central,0,0
20823,laboratory,0,0
20824,.,0,0
20825,Subsequent,0,0
20826,surgical,0,0
20827,resection,0,1
20828,data,0,0
20829,were,0,0
20830,recorded,0,0
20831,.,0,0
20832,Safety,0,0
20833,evaluation,0,0
20834,data,0,0
20835,included,0,1
20836,recording,0,0
20837,device,0,0
20838,complications,0,0
20839,",",0,0
20840,procedure,0,0
20841,complications,0,0
20842,",",0,0
20843,and,0,0
20844,intracranial,0,1
20845,events/overall,0,0
20846,neurologic,0,0
20847,outcomes,0,0
20848,",",0,0
20849,which,0,0
20850,could,0,0
20851,be,0,0
20852,either,0,0
20853,device-related,0,0
20854,",",0,0
20855,procedure-related,0,0
20856,",",0,0
20857,or,0,0
20858,both,0,0
20859,.,0,0
20860,RESULTS,0,0
20861,The,0,0
20862,reduction,0,0
20863,of,0,0
20864,AVM,0,0
20865,dimensions,0,0
20866,(,0,0
20867,79.4,0,0
20868,%,0,0
20869,in,0,0
20870,the,0,0
20871,n-BCA,0,0
20872,group,0,0
20873,and,0,0
20874,86.9,0,0
20875,%,0,0
20876,in,0,0
20877,the,0,0
20878,PVA,0,0
20879,group,0,0
20880,),0,0
20881,and,0,0
20882,the,0,0
20883,mean,0,0
20884,number,0,0
20885,of,0,0
20886,vessels,0,0
20887,embolized,0,0
20888,(,0,0
20889,2.2,0,0
20890,in,0,0
20891,the,0,0
20892,n-BCA,0,0
20893,group,0,0
20894,and,0,0
20895,2.1,0,0
20896,in,0,0
20897,the,0,0
20898,PVA,0,0
20899,group,0,0
20900,),0,0
20901,was,0,0
20902,similar,0,0
20903,in,0,0
20904,the,0,0
20905,two,0,0
20906,groups,0,0
20907,.,0,1
20908,Coils,0,0
20909,were,0,0
20910,used,0,0
20911,more,0,0
20912,commonly,0,0
20913,with,0,0
20914,PVA,0,0
20915,embolization,0,0
20916,(,0,0
20917,P,0,0
20918,<,0,0
20919,.0001,0,0
20920,),0,0
20921,.,0,0
20922,No,0,0
20923,differences,0,0
20924,were,0,0
20925,detected,0,0
20926,in,0,0
20927,surgical,0,0
20928,resection,0,1
20929,time,0,0
20930,",",0,0
20931,number,0,0
20932,of,0,0
20933,patients,0,1
20934,who,0,1
20935,required,0,1
20936,transfusion,0,0
20937,",",0,0
20938,volume,0,0
20939,and,0,0
20940,number,0,0
20941,of,0,0
20942,transfusion,0,0
20943,units,0,0
20944,",",0,0
20945,or,0,0
20946,type,0,0
20947,and,0,0
20948,volume,0,0
20949,of,0,0
20950,fluid,0,0
20951,replacement,0,1
20952,.,0,0
20953,Glasgow,0,0
20954,Outcome,0,0
20955,Scale,0,0
20956,scores,0,0
20957,were,0,0
20958,not,0,0
20959,significantly,0,0
20960,different,0,0
20961,between,0,0
20962,the,0,0
20963,two,0,0
20964,groups,0,0
20965,before,0,0
20966,treatment,0,0
20967,",",0,0
20968,after,0,0
20969,embolization,0,0
20970,",",0,0
20971,or,0,0
20972,after,0,0
20973,resection,0,1
20974,.,0,0
20975,Two,0,0
20976,of,0,0
20977,42,0,1
20978,patients,0,1
20979,who,0,1
20980,underwent,0,1
20981,resection,0,1
20982,and,0,0
20983,had,0,0
20984,been,0,0
20985,treated,0,1
20986,with,0,1
20987,n-BCA,0,0
20988,experienced,0,0
20989,post-resection,0,0
20990,hematoma,0,0
20991,",",0,0
20992,compared,0,0
20993,with,0,0
20994,eight,0,1
20995,of,0,0
20996,45,0,1
20997,patients,0,1
20998,who,0,1
20999,underwent,0,1
21000,resection,0,1
21001,and,0,0
21002,had,0,0
21003,been,0,0
21004,treated,0,1
21005,with,0,0
21006,PVA,0,0
21007,(,0,0
21008,P,0,0
21009,<,0,0
21010,.05,0,0
21011,),0,0
21012,.,0,0
21013,CONCLUSION,0,0
21014,This,0,0
21015,prospective,0,0
21016,",",0,0
21017,randomized,0,0
21018,trial,0,0
21019,showed,0,0
21020,that,0,0
21021,n-BCA,0,0
21022,is,0,0
21023,equivalent,0,0
21024,to,0,0
21025,PVA,0,0
21026,as,0,0
21027,a,0,0
21028,preoperative,0,0
21029,embolic,0,0
21030,agent,0,0
21031,for,0,0
21032,treatment,0,0
21033,of,0,0
21034,cerebral,1,1
21035,AVM,1,0
21036,as,0,0
21037,determined,0,0
21038,by,0,0
21039,percent,0,0
21040,of,0,0
21041,nidus,0,0
21042,reduction,0,0
21043,and,0,0
21044,number,0,0
21045,of,0,0
21046,feeding,0,0
21047,pedicles,0,1
21048,embolized,0,0
21049,.,0,1
21050,Treatment,0,0
21051,of,0,0
21052,acute,0,1
21053,ischaemic,0,1
21054,stroke,0,1
21055,with,0,0
21056,the,0,0
21057,low-affinity,0,0
21058,",",0,0
21059,use-dependent,0,0
21060,NMDA,0,0
21061,antagonist,0,0
21062,AR-R15896AR,0,0
21063,.,0,0
21064,A,0,0
21065,safety,0,0
21066,and,0,0
21067,tolerability,0,0
21068,study,0,0
21069,.,0,0
21070,BACKGROUND,0,0
21071,AND,0,0
21072,PURPOSE,0,0
21073,A,0,0
21074,low-affinity,0,0
21075,",",0,0
21076,use-dependent,0,0
21077,N-Methyl-D-Aspartate,0,0
21078,(,0,0
21079,NMDA,0,0
21080,),0,0
21081,antagonist,0,0
21082,AR-R15896AR,0,0
21083,has,0,0
21084,neuroprotective,0,0
21085,properties,0,0
21086,in,0,0
21087,animal,1,1
21088,models,1,0
21089,of,1,0
21090,ischaemic,1,1
21091,stroke,1,1
21092,.,1,0
21093,The,0,0
21094,aim,0,0
21095,of,0,0
21096,the,0,0
21097,present,0,0
21098,study,0,0
21099,was,0,0
21100,to,0,0
21101,examine,0,0
21102,the,0,0
21103,safety,0,0
21104,and,0,0
21105,tolerability,0,0
21106,of,0,0
21107,a,0,0
21108,new,0,0
21109,and,0,0
21110,higher,0,0
21111,dosage,0,0
21112,regimen,0,0
21113,that,0,0
21114,would,0,0
21115,enable,0,0
21116,acute,1,1
21117,stroke,1,1
21118,patients,1,1
21119,to,0,0
21120,achieve,0,0
21121,and,0,0
21122,maintain,0,0
21123,neuroprotective,0,0
21124,plasma,0,0
21125,concentrations,0,0
21126,.,0,0
21127,METHODS,0,0
21128,A,0,0
21129,randomised,0,0
21130,",",0,0
21131,multi-centre,0,0
21132,",",0,0
21133,double-blind,0,0
21134,",",0,0
21135,placebo-controlled,0,0
21136,",",0,0
21137,parallel,0,0
21138,group,0,0
21139,study,0,0
21140,was,0,0
21141,carried,0,0
21142,out,0,0
21143,at,0,0
21144,19,1,1
21145,centres,1,1
21146,in,1,0
21147,France,1,0
21148,",",1,0
21149,Germany,1,0
21150,and,1,0
21151,the,1,0
21152,Netherlands,1,0
21153,in,1,0
21154,patients,1,1
21155,with,1,1
21156,a,1,0
21157,clinical,1,0
21158,diagnosis,1,1
21159,of,1,0
21160,acute,1,1
21161,ischaemic,1,1
21162,stroke,1,1
21163,",",1,0
21164,and,1,0
21165,onset,1,0
21166,of,1,0
21167,symptoms,1,0
21168,within,1,1
21169,12,1,1
21170,hours,1,0
21171,before,1,0
21172,start,1,1
21173,of,1,0
21174,study,1,0
21175,drug,1,0
21176,administration,1,0
21177,.,1,0
21178,Two,0,0
21179,loading,0,0
21180,doses,0,0
21181,of,0,0
21182,3.5,0,0
21183,mg/kg,0,0
21184,of,0,0
21185,AR-R15896AR,0,0
21186,over,0,0
21187,60,0,1
21188,minutes,0,0
21189,",",0,0
21190,followed,0,0
21191,by,0,0
21192,a,0,0
21193,2.5,0,0
21194,mg/kg,0,0
21195,infusion,0,0
21196,over,0,0
21197,the,0,0
21198,next,0,0
21199,120,0,1
21200,minutes,0,0
21201,were,0,0
21202,given,0,0
21203,.,0,0
21204,Eight,0,0
21205,hours,0,0
21206,after,0,0
21207,the,0,0
21208,start,0,0
21209,of,0,0
21210,the,0,0
21211,loading,0,0
21212,dose,0,0
21213,infusion,0,0
21214,",",0,0
21215,the,0,0
21216,first,0,0
21217,maintenance,0,0
21218,dose,0,0
21219,(,0,0
21220,120,0,1
21221,mg,0,0
21222,),0,0
21223,was,0,0
21224,administered,0,0
21225,over,0,0
21226,60,0,1
21227,minutes,0,0
21228,.,0,1
21229,Eight,0,0
21230,further,0,0
21231,maintenance,0,0
21232,infusions,0,0
21233,were,0,0
21234,administered,0,0
21235,at,0,0
21236,intervals,0,0
21237,of,0,0
21238,8,0,0
21239,hours,0,0
21240,over,0,0
21241,a,0,0
21242,total,0,0
21243,treatment,0,0
21244,period,0,0
21245,of,0,0
21246,3,0,0
21247,days,0,0
21248,.,0,1
21249,Main,0,0
21250,variables,0,0
21251,were,0,0
21252,safety,0,0
21253,",",0,0
21254,tolerability,0,0
21255,and,0,0
21256,pharmacokinetics,0,0
21257,.,0,1
21258,Follow-up,0,0
21259,assessments,0,0
21260,also,0,0
21261,included,0,1
21262,the,0,0
21263,Barthel,0,0
21264,Index,0,0
21265,(,0,0
21266,BI,0,0
21267,),0,0
21268,and,0,0
21269,the,0,0
21270,NIH,0,0
21271,Stroke,0,0
21272,Scale,0,0
21273,(,0,0
21274,NIHSS,0,0
21275,),0,0
21276,at,0,0
21277,4-7,0,1
21278,days,0,0
21279,after,0,0
21280,the,0,0
21281,end,0,0
21282,of,0,0
21283,the,0,0
21284,last,0,0
21285,infusion,0,0
21286,and,0,0
21287,at,0,0
21288,30,0,0
21289,days,0,0
21290,after,0,0
21291,the,0,0
21292,onset,0,0
21293,of,0,0
21294,stroke,0,1
21295,.,0,0
21296,RESULTS,0,0
21297,103,1,1
21298,patients,1,1
21299,with,1,1
21300,acute,1,1
21301,ischaemic,1,1
21302,stroke,1,1
21303,were,1,0
21304,randomised,1,0
21305,to,0,0
21306,either,0,0
21307,treatment,0,0
21308,with,0,0
21309,AR-R15896AR,0,0
21310,(,0,0
21311,70,0,1
21312,patients,0,1
21313,),0,0
21314,or,0,0
21315,placebo,0,0
21316,(,0,0
21317,33,0,1
21318,patients,0,1
21319,),0,1
21320,.,0,1
21321,Mortality,0,0
21322,was,0,0
21323,not,0,0
21324,significantly,0,0
21325,different,0,0
21326,in,0,0
21327,the,0,0
21328,AR-R15896AR,0,0
21329,group,0,0
21330,compared,0,0
21331,with,0,0
21332,the,0,0
21333,placebo,0,0
21334,group,0,0
21335,(,0,0
21336,10,0,0
21337,%,0,0
21338,vs.,0,0
21339,6,0,0
21340,%,0,0
21341,),0,0
21342,.,0,0
21343,Serious,0,0
21344,adverse,0,0
21345,events,0,0
21346,during,0,0
21347,treatment,0,0
21348,due,0,0
21349,to,0,0
21350,psychiatric,0,1
21351,conditions,0,0
21352,were,0,0
21353,associated,0,0
21354,with,0,1
21355,AR-R15896AR,0,0
21356,(,0,0
21357,3,0,0
21358,vs.,0,0
21359,0,0,0
21360,),0,0
21361,.,0,0
21362,Other,0,0
21363,side,0,0
21364,effects,0,0
21365,were,0,0
21366,more,0,0
21367,common,0,0
21368,in,0,0
21369,the,0,0
21370,group,0,0
21371,treated,0,0
21372,with,0,1
21373,AR-R15896AR,0,0
21374,:,0,1
21375,vomiting,0,0
21376,(,0,0
21377,29,0,0
21378,%,0,0
21379,vs.,0,0
21380,9,0,0
21381,%,0,0
21382,),0,0
21383,",",0,0
21384,nausea,0,0
21385,(,0,0
21386,23,0,0
21387,%,0,0
21388,vs.,0,0
21389,12,0,0
21390,%,0,0
21391,),0,0
21392,",",0,0
21393,fever,0,0
21394,(,0,0
21395,17,0,0
21396,%,0,0
21397,vs.,0,0
21398,12,0,0
21399,%,0,0
21400,),0,0
21401,",",0,0
21402,agitation,0,0
21403,(,0,0
21404,7,0,0
21405,%,0,0
21406,vs.,0,0
21407,3,0,0
21408,%,0,0
21409,),0,0
21410,",",0,0
21411,dizziness,0,0
21412,(,0,0
21413,7,0,0
21414,%,0,0
21415,vs.,0,0
21416,0,0,0
21417,%,0,0
21418,),0,0
21419,",",0,0
21420,and,0,0
21421,hallucinations,0,0
21422,(,0,0
21423,6,0,0
21424,%,0,0
21425,vs.,0,0
21426,0,0,0
21427,%,0,0
21428,),0,0
21429,.,0,0
21430,No,0,0
21431,significant,0,0
21432,difference,0,0
21433,between,0,0
21434,the,0,0
21435,two,0,0
21436,groups,0,0
21437,(,0,0
21438,with,0,1
21439,respect,0,0
21440,to,0,0
21441,the,0,0
21442,proportions,0,0
21443,of,0,0
21444,patients,0,1
21445,with,0,1
21446,favourable,0,0
21447,outcome,0,0
21448,),0,0
21449,was,0,0
21450,detected,0,0
21451,in,0,0
21452,either,0,0
21453,the,0,0
21454,analysis,0,0
21455,of,0,0
21456,the,0,0
21457,BI,0,0
21458,or,0,0
21459,the,0,0
21460,NIHSS,0,0
21461,.,0,0
21462,Pharmacokinetic,0,0
21463,data,0,0
21464,showed,0,0
21465,that,0,0
21466,plasma,0,0
21467,concentrations,0,0
21468,of,0,0
21469,AR-R15896AR,0,0
21470,were,0,0
21471,in,0,0
21472,the,0,0
21473,expected,0,0
21474,neuroprotective,0,0
21475,range,0,0
21476,.,0,0
21477,CONCLUSION,0,0
21478,In,0,0
21479,most,0,0
21480,of,0,0
21481,the,0,0
21482,patients,0,1
21483,with,0,1
21484,acute,0,1
21485,stroke,0,1
21486,receiving,0,0
21487,AR-R15896AR,0,0
21488,the,0,0
21489,intended,0,0
21490,high,0,0
21491,plasma,0,0
21492,levels,0,0
21493,were,0,0
21494,reached,0,0
21495,within,0,0
21496,a,0,0
21497,short,0,0
21498,time,0,0
21499,period,0,0
21500,.,0,0
21501,However,0,0
21502,",",0,0
21503,active,0,0
21504,treatment,0,0
21505,produced,0,0
21506,more,0,0
21507,side,0,0
21508,effects,0,0
21509,than,0,0
21510,placebo,0,0
21511,",",0,0
21512,thus,0,0
21513,indicating,0,0
21514,safety,0,0
21515,concerns,0,0
21516,and,0,0
21517,tolerability,0,0
21518,issues,0,0
21519,for,0,0
21520,use,0,0
21521,in,0,0
21522,high,0,0
21523,doses,0,0
21524,in,0,0
21525,an,0,0
21526,acute,0,1
21527,stroke,0,1
21528,population,0,1
21529,.,0,0
21530,Prospective,0,0
21531,study,0,0
21532,of,0,0
21533,C-reactive,0,0
21534,protein,0,0
21535,",",0,0
21536,homocysteine,0,0
21537,",",0,0
21538,and,0,0
21539,plasma,0,0
21540,lipid,0,0
21541,levels,0,0
21542,as,0,0
21543,predictors,0,0
21544,of,0,0
21545,sudden,0,1
21546,cardiac,0,1
21547,death,0,0
21548,.,0,0
21549,BACKGROUND,0,0
21550,Sudden,0,0
21551,cardiac,0,0
21552,death,0,0
21553,(,0,0
21554,SCD,0,0
21555,),0,0
21556,is,0,0
21557,an,0,0
21558,important,0,0
21559,cause,0,0
21560,of,0,0
21561,mortality,0,0
21562,even,0,0
21563,among,0,0
21564,apparently,0,0
21565,healthy,0,1
21566,populations,0,1
21567,.,0,0
21568,However,0,0
21569,",",0,0
21570,our,0,0
21571,ability,0,0
21572,to,0,0
21573,identify,0,0
21574,those,0,0
21575,at,0,0
21576,risk,0,0
21577,for,0,0
21578,SCD,0,0
21579,in,0,0
21580,the,0,0
21581,general,0,0
21582,population,0,0
21583,is,0,0
21584,poor,0,0
21585,",",0,0
21586,and,0,0
21587,more,0,0
21588,specific,0,0
21589,markers,0,0
21590,are,0,0
21591,needed,0,0
21592,.,0,0
21593,METHODS,0,0
21594,AND,0,0
21595,RESULTS,0,0
21596,To,0,0
21597,compare,0,0
21598,and,0,0
21599,contrast,0,0
21600,the,0,0
21601,relative,0,0
21602,importance,0,0
21603,of,0,0
21604,C-reactive,0,0
21605,protein,0,0
21606,(,0,0
21607,CRP,0,0
21608,),0,0
21609,",",0,0
21610,homocysteine,0,0
21611,",",0,0
21612,and,0,0
21613,lipids,0,0
21614,as,0,0
21615,long-term,0,0
21616,predictors,0,0
21617,of,0,0
21618,SCD,0,0
21619,",",0,0
21620,we,0,0
21621,performed,0,0
21622,a,0,0
21623,prospective,0,0
21624,",",0,0
21625,nested,0,0
21626,",",0,0
21627,case-control,0,1
21628,analysis,0,0
21629,involving,0,0
21630,97,1,1
21631,cases,1,1
21632,of,1,0
21633,SCD,1,0
21634,among,1,0
21635,apparently,1,1
21636,healthy,1,1
21637,men,1,1
21638,enrolled,1,1
21639,in,1,0
21640,the,1,0
21641,Physician,1,0
21642,'s,1,0
21643,Health,1,0
21644,Study,1,0
21645,.,1,0
21646,Of,0,0
21647,these,0,0
21648,plasma,0,0
21649,markers,0,0
21650,measured,0,0
21651,",",0,0
21652,only,0,0
21653,baseline,0,0
21654,CRP,0,0
21655,levels,0,0
21656,were,0,0
21657,significantly,0,0
21658,associated,0,0
21659,with,0,0
21660,the,0,0
21661,risk,0,0
21662,of,0,0
21663,SCD,0,0
21664,over,0,0
21665,the,0,0
21666,ensuing,0,0
21667,17,0,0
21668,years,0,1
21669,of,0,0
21670,follow-up,0,0
21671,(,0,0
21672,P,0,0
21673,for,0,0
21674,trend=0.001,0,0
21675,),0,0
21676,.,0,0
21677,The,0,0
21678,increase,0,0
21679,in,0,0
21680,risk,0,0
21681,associated,0,0
21682,with,0,1
21683,CRP,0,1
21684,levels,0,0
21685,was,0,0
21686,primarily,0,0
21687,seen,0,0
21688,among,0,0
21689,men,0,1
21690,in,0,0
21691,the,0,0
21692,highest,0,0
21693,quartile,0,0
21694,",",0,0
21695,who,0,1
21696,were,0,1
21697,at,0,1
21698,a,0,0
21699,2.78-fold,0,0
21700,increased,0,0
21701,risk,0,0
21702,of,0,0
21703,SCD,0,0
21704,(,0,0
21705,95,0,0
21706,%,0,0
21707,CI,0,0
21708,1.35,0,0
21709,to,0,0
21710,5.72,0,0
21711,),0,0
21712,compared,0,0
21713,with,0,1
21714,men,0,1
21715,in,0,0
21716,the,0,0
21717,lowest,0,0
21718,quartile,0,0
21719,.,0,0
21720,These,0,0
21721,results,0,0
21722,were,0,0
21723,not,0,0
21724,significantly,0,0
21725,altered,0,0
21726,in,0,0
21727,analyses,0,0
21728,that,0,0
21729,(,0,0
21730,in,0,0
21731,addition,0,0
21732,to,0,0
21733,the,0,0
21734,matching,0,0
21735,variables,0,0
21736,of,0,0
21737,age,0,1
21738,and,0,0
21739,smoking,0,0
21740,status,0,0
21741,),0,0
21742,controlled,0,0
21743,for,0,0
21744,lipid,0,0
21745,parameters,0,0
21746,",",0,0
21747,homocysteine,0,0
21748,",",0,0
21749,and,0,0
21750,multiple,0,0
21751,cardiac,0,1
21752,risk,0,0
21753,factors,0,0
21754,(,0,0
21755,relative,0,0
21756,risk,0,0
21757,for,0,0
21758,highest,0,0
21759,versus,0,0
21760,lowest,0,0
21761,quartile,0,0
21762,2.65,0,0
21763,",",0,0
21764,95,0,0
21765,%,0,0
21766,CI,0,0
21767,0.79,0,0
21768,to,0,0
21769,8.83,0,0
21770,;,0,0
21771,P,0,0
21772,for,0,0
21773,trend=0.03,0,0
21774,),0,0
21775,.,0,0
21776,In,0,0
21777,contrast,0,0
21778,to,0,0
21779,the,0,0
21780,positive,0,0
21781,relationship,0,0
21782,observed,0,0
21783,for,0,0
21784,CRP,0,0
21785,",",0,0
21786,neither,0,0
21787,homocysteine,0,0
21788,nor,0,0
21789,lipid,0,0
21790,levels,0,0
21791,were,0,0
21792,significantly,0,0
21793,associated,0,0
21794,with,0,0
21795,risk,0,0
21796,of,0,0
21797,SCD,0,0
21798,.,0,0
21799,CONCLUSIONS,0,0
21800,These,0,0
21801,prospective,0,0
21802,data,0,0
21803,suggest,0,0
21804,that,0,0
21805,CRP,0,0
21806,levels,0,0
21807,may,0,0
21808,be,0,0
21809,useful,0,0
21810,in,0,0
21811,identifying,0,0
21812,apparently,1,1
21813,healthy,1,1
21814,men,1,1
21815,who,1,1
21816,are,1,0
21817,at,1,1
21818,an,1,0
21819,increased,1,0
21820,long-term,1,0
21821,risk,1,0
21822,of,1,0
21823,SCD,1,0
21824,.,1,1
21825,Clinically,0,0
21826,relevant,0,0
21827,improvement,0,0
21828,of,0,0
21829,recurrence-free,0,0
21830,survival,0,0
21831,with,0,1
21832,5-aminolevulinic,0,0
21833,acid,0,0
21834,induced,0,0
21835,fluorescence,0,0
21836,diagnosis,0,1
21837,in,0,0
21838,patients,1,1
21839,with,1,1
21840,superficial,1,1
21841,bladder,1,1
21842,tumors,1,1
21843,.,1,1
21844,PURPOSES,0,0
21845,Fluorescence,0,0
21846,diagnosis,0,1
21847,induced,0,0
21848,by,0,0
21849,5-aminolevulinic,0,0
21850,acid,0,0
21851,enables,0,0
21852,more,0,0
21853,thorough,0,0
21854,transurethral,0,0
21855,resection,0,1
21856,of,0,0
21857,superficial,1,0
21858,bladder,1,1
21859,carcinoma,1,1
21860,compared,0,0
21861,with,0,1
21862,conventional,0,0
21863,white,0,1
21864,light,0,0
21865,.,0,0
21866,We,0,0
21867,performed,0,0
21868,a,0,0
21869,prospective,0,0
21870,",",0,0
21871,single,0,0
21872,institution,0,1
21873,",",0,0
21874,randomized,0,0
21875,trial,0,0
21876,to,0,0
21877,investigate,0,0
21878,whether,0,0
21879,the,0,0
21880,residual,0,0
21881,tumor,0,0
21882,rate,0,0
21883,and,0,0
21884,long-term,0,0
21885,tumor,0,0
21886,recurrence,0,0
21887,can,0,0
21888,be,0,0
21889,decreased,0,0
21890,by,0,0
21891,fluorescence,0,0
21892,diagnosis,0,1
21893,.,0,0
21894,MATERIALS,0,0
21895,AND,0,0
21896,METHODS,0,0
21897,A,1,0
21898,total,1,1
21899,of,1,0
21900,301,1,1
21901,patients,1,1
21902,underwent,1,1
21903,transurethral,1,1
21904,resection,1,1
21905,of,1,0
21906,bladder,1,1
21907,tumors,1,1
21908,with,1,1
21909,white,1,1
21910,light,1,0
21911,or,1,0
21912,fluorescence,1,0
21913,diagnosis,1,1
21914,.,1,0
21915,Transurethral,0,0
21916,resection,0,0
21917,was,0,0
21918,repeated,0,0
21919,5,0,0
21920,to,0,0
21921,6,0,0
21922,weeks,0,0
21923,later,0,0
21924,to,0,0
21925,evaluate,0,0
21926,the,0,0
21927,residual,0,0
21928,tumor,0,0
21929,rate,0,0
21930,.,0,0
21931,To,0,0
21932,determine,0,0
21933,recurrence-free,0,0
21934,survival,0,0
21935,patient,0,0
21936,followup,0,0
21937,was,0,0
21938,performed,0,0
21939,every,0,0
21940,3,0,0
21941,months,0,0
21942,by,0,0
21943,white,0,1
21944,light,0,0
21945,cystoscopy,0,0
21946,and,0,0
21947,urine,0,0
21948,cytology,0,0
21949,.,0,0
21950,Recurrence-free,0,0
21951,survival,0,0
21952,was,0,0
21953,analyzed,0,0
21954,via,0,0
21955,Kaplan-Meier,0,0
21956,methods,0,1
21957,and,0,0
21958,multivariable,0,0
21959,Cox,0,0
21960,regression,0,0
21961,analysis,0,0
21962,.,0,0
21963,RESULTS,0,0
21964,A,1,0
21965,total,1,0
21966,of,1,0
21967,191,1,1
21968,patients,1,1
21969,with,1,1
21970,superficial,1,0
21971,bladder,1,1
21972,carcinoma,1,1
21973,were,1,0
21974,available,1,0
21975,for,0,0
21976,efficacy,0,0
21977,analysis,0,0
21978,.,0,0
21979,The,0,0
21980,residual,0,0
21981,tumor,0,0
21982,rate,0,0
21983,was,0,0
21984,25.2,0,0
21985,%,0,0
21986,in,0,0
21987,the,0,0
21988,white,0,1
21989,light,0,0
21990,arm,0,0
21991,versus,0,0
21992,4.5,0,0
21993,%,0,0
21994,in,0,0
21995,the,0,0
21996,fluorescence,0,0
21997,diagnosis,0,0
21998,arm,0,0
21999,(,0,0
22000,p,0,0
22001,<,0,0
22002,0.0001,0,0
22003,),0,0
22004,.,0,0
22005,Median,0,0
22006,followup,0,0
22007,in,0,0
22008,the,0,0
22009,white,0,1
22010,light,0,0
22011,arm,0,0
22012,in,0,0
22013,103,0,1
22014,cases,0,1
22015,was,0,0
22016,21.2,0,0
22017,months,0,0
22018,(,0,0
22019,range,0,0
22020,4,0,0
22021,to,0,0
22022,40,0,1
22023,),0,0
22024,compared,0,0
22025,with,0,1
22026,20.5,0,0
22027,(,0,0
22028,range,0,0
22029,3,0,0
22030,to,0,0
22031,40,0,1
22032,),0,0
22033,in,0,0
22034,the,0,0
22035,88,0,0
22036,in,0,0
22037,the,0,0
22038,fluorescence,0,0
22039,diagnosis,0,1
22040,arm,0,0
22041,.,0,0
22042,Recurrence-free,0,0
22043,survival,0,0
22044,in,0,0
22045,the,0,0
22046,fluorescence,0,0
22047,diagnosis,0,0
22048,group,0,0
22049,was,0,0
22050,89.6,0,0
22051,%,0,0
22052,after,0,0
22053,12,0,0
22054,and,0,0
22055,24,0,0
22056,months,0,0
22057,compared,0,0
22058,with,0,1
22059,73.8,0,0
22060,%,0,0
22061,and,0,0
22062,65.9,0,0
22063,%,0,0
22064,",",0,0
22065,respectively,0,0
22066,",",0,0
22067,in,0,0
22068,the,0,0
22069,white,0,1
22070,light,0,0
22071,group,0,0
22072,(,0,0
22073,p,0,0
22074,=,0,0
22075,0.004,0,0
22076,),0,0
22077,.,0,0
22078,This,0,0
22079,superiority,0,0
22080,proved,0,0
22081,to,0,0
22082,be,0,0
22083,independent,0,0
22084,of,0,0
22085,risk,0,0
22086,group,0,0
22087,.,0,0
22088,The,0,0
22089,adjusted,0,0
22090,hazard,0,0
22091,ratio,0,0
22092,of,0,0
22093,fluorescence,0,0
22094,diagnosis,0,1
22095,versus,0,0
22096,white,0,1
22097,light,0,0
22098,transurethral,0,1
22099,resection,0,1
22100,was,0,0
22101,0.33,0,0
22102,(,0,0
22103,95,0,0
22104,%,0,0
22105,confidence,0,0
22106,interval,0,0
22107,0.16,0,0
22108,to,0,0
22109,0.67,0,0
22110,),0,0
22111,.,0,0
22112,CONCLUSIONS,0,0
22113,Fluorescence,0,0
22114,diagnosis,0,0
22115,is,0,0
22116,significantly,0,0
22117,superior,0,0
22118,to,0,0
22119,conventional,0,0
22120,white,0,1
22121,light,0,0
22122,transurethral,0,1
22123,resection,0,1
22124,with,0,1
22125,respect,0,0
22126,to,0,0
22127,the,0,0
22128,residual,0,0
22129,tumor,0,0
22130,rate,0,0
22131,and,0,0
22132,recurrence-free,0,0
22133,survival,0,0
22134,.,0,0
22135,The,0,0
22136,differences,0,0
22137,in,0,0
22138,recurrence-free,0,0
22139,survival,0,0
22140,imply,0,0
22141,that,0,0
22142,fluorescence,0,0
22143,diagnosis,0,0
22144,is,0,0
22145,a,0,0
22146,clinically,0,0
22147,relevant,0,0
22148,procedure,0,0
22149,for,0,0
22150,decreasing,0,0
22151,the,0,0
22152,number,0,0
22153,of,0,0
22154,tumor,0,1
22155,recurrences,0,1
22156,.,0,1
22157,Clinical,0,0
22158,evaluation,0,0
22159,of,0,0
22160,the,0,0
22161,WOMAC,0,0
22162,3.0,0,0
22163,OA,0,0
22164,Index,0,0
22165,in,0,0
22166,numeric,0,0
22167,rating,0,0
22168,scale,0,0
22169,format,0,0
22170,using,0,0
22171,a,0,0
22172,computerized,0,0
22173,touch,0,0
22174,screen,0,0
22175,version,0,0
22176,.,0,0
22177,BACKGROUND,0,0
22178,The,0,0
22179,Western,0,0
22180,Ontario,0,0
22181,and,0,0
22182,McMaster,0,0
22183,Universities,0,1
22184,(,0,0
22185,WOMAC,0,0
22186,),0,0
22187,Osteoarthritis,0,1
22188,Index,0,0
22189,is,0,0
22190,a,0,0
22191,previously,0,0
22192,described,0,0
22193,self-administered,0,0
22194,questionnaire,0,0
22195,covering,0,1
22196,three,0,0
22197,domains,0,1
22198,:,0,1
22199,pain,0,0
22200,",",0,0
22201,stiffness,0,0
22202,and,0,0
22203,function,0,0
22204,.,0,0
22205,It,0,0
22206,has,0,0
22207,been,0,0
22208,validated,0,0
22209,in,0,0
22210,patients,0,1
22211,with,0,1
22212,osteoarthritis,1,1
22213,(,1,0
22214,OA,1,0
22215,),1,0
22216,of,1,0
22217,the,1,0
22218,hip,1,0
22219,or,1,0
22220,knee,1,1
22221,in,0,0
22222,a,0,0
22223,paper-based,0,0
22224,format,0,0
22225,.,0,0
22226,AIM,0,0
22227,To,0,0
22228,validate,0,0
22229,the,0,0
22230,WOMAC,0,0
22231,3.0,0,0
22232,using,0,0
22233,a,0,0
22234,numerical,0,0
22235,rating,0,0
22236,scale,0,0
22237,in,0,0
22238,a,0,0
22239,computerized,0,0
22240,touch,0,0
22241,screen,0,0
22242,format,0,0
22243,allowing,0,0
22244,immediate,0,0
22245,evaluation,0,0
22246,of,0,0
22247,the,0,0
22248,questionnaire,0,0
22249,.,0,0
22250,In,0,0
22251,the,0,0
22252,computed,0,0
22253,version,0,0
22254,cartoons,0,0
22255,",",0,0
22256,written,0,0
22257,and,0,0
22258,audio,0,0
22259,instruments,0,0
22260,were,0,0
22261,included,0,1
22262,in,0,0
22263,order,0,0
22264,facilitate,0,0
22265,application,0,0
22266,.,0,0
22267,METHODS,0,0
22268,Fifty,1,1
22269,patients,1,1
22270,",",1,0
22271,demographically,1,1
22272,balanced,1,0
22273,",",1,0
22274,with,1,0
22275,radiographically,1,1
22276,proven,1,0
22277,primary,1,0
22278,hip,1,1
22279,or,1,0
22280,knee,1,1
22281,OA,1,0
22282,completed,1,1
22283,the,1,0
22284,classical,1,0
22285,paper,1,0
22286,and,1,0
22287,the,1,0
22288,new,1,0
22289,computerized,1,0
22290,WOMAC,1,0
22291,version,1,0
22292,.,1,0
22293,Subjects,0,0
22294,were,0,0
22295,randomized,0,0
22296,either,0,0
22297,to,0,0
22298,paper,0,0
22299,format,0,0
22300,or,0,0
22301,computerized,0,0
22302,format,0,0
22303,first,0,0
22304,to,0,0
22305,balance,0,0
22306,possible,0,0
22307,order,0,0
22308,effects,0,0
22309,.,0,0
22310,RESULTS,0,0
22311,The,0,0
22312,intra-class,0,0
22313,correlation,0,0
22314,coefficients,0,0
22315,for,0,0
22316,pain,0,0
22317,",",0,0
22318,stiffness,0,0
22319,and,0,0
22320,function,0,0
22321,values,0,0
22322,were,0,0
22323,0.915,0,0
22324,",",0,0
22325,0.745,0,0
22326,and,0,0
22327,0.940,0,0
22328,",",0,0
22329,respectively,0,0
22330,.,0,0
22331,The,0,0
22332,Spearman,0,0
22333,correlation,0,0
22334,coefficients,0,0
22335,for,0,0
22336,pain,0,0
22337,",",0,0
22338,stiffness,0,0
22339,and,0,0
22340,function,0,0
22341,were,0,0
22342,0.88,0,0
22343,",",0,0
22344,0.77,0,0
22345,and,0,0
22346,0.87,0,0
22347,",",0,0
22348,respectively,0,0
22349,.,0,0
22350,CONCLUSION,0,0
22351,These,0,0
22352,data,0,0
22353,indicate,0,0
22354,that,0,0
22355,the,0,0
22356,computerized,0,0
22357,WOMAC,0,0
22358,OA,0,0
22359,index,0,0
22360,3.0,0,0
22361,is,0,0
22362,comparable,0,0
22363,to,0,0
22364,the,0,0
22365,paper,0,0
22366,WOMAC,0,0
22367,in,0,0
22368,all,0,0
22369,three,0,0
22370,dimensions,0,0
22371,.,0,0
22372,The,0,0
22373,computerized,0,0
22374,version,0,0
22375,would,0,0
22376,allow,0,0
22377,physicians,0,0
22378,to,0,0
22379,get,0,0
22380,an,0,0
22381,immediate,0,0
22382,result,0,0
22383,and,0,0
22384,if,0,0
22385,present,0,0
22386,a,0,0
22387,direct,0,0
22388,comparison,0,0
22389,with,0,1
22390,a,0,0
22391,previous,0,0
22392,exam,0,0
22393,.,0,0
22394,Marimastat,0,0
22395,as,0,0
22396,maintenance,0,0
22397,therapy,0,0
22398,for,0,0
22399,patients,1,1
22400,with,1,1
22401,advanced,1,1
22402,gastric,1,1
22403,cancer,1,1
22404,:,1,1
22405,a,0,0
22406,randomised,0,0
22407,trial,0,0
22408,.,0,0
22409,This,0,0
22410,randomised,0,0
22411,",",0,0
22412,double-blind,0,0
22413,",",0,0
22414,placebo-controlled,0,0
22415,study,0,0
22416,was,0,0
22417,designed,0,0
22418,to,0,0
22419,evaluate,0,0
22420,the,0,0
22421,ability,0,0
22422,of,0,0
22423,the,0,0
22424,orally,0,0
22425,administered,0,0
22426,matrix,0,0
22427,metalloproteinase,0,0
22428,inhibitor,0,0
22429,",",0,0
22430,marimastat,0,0
22431,",",0,0
22432,to,0,0
22433,prolong,0,0
22434,survival,0,0
22435,in,0,0
22436,patients,1,1
22437,with,1,1
22438,non-resectable,1,1
22439,gastric,1,1
22440,and,1,0
22441,gastro-oesophageal,1,1
22442,adenocarcinoma,1,1
22443,.,1,0
22444,Three,1,0
22445,hundred,1,1
22446,and,1,0
22447,sixty-nine,1,1
22448,patients,1,1
22449,with,1,1
22450,histological,1,0
22451,proof,1,0
22452,of,1,0
22453,adenocarcinoma,1,1
22454,",",1,0
22455,who,1,1
22456,had,1,1
22457,received,1,0
22458,no,1,0
22459,more,1,0
22460,than,1,0
22461,a,1,0
22462,single,1,0
22463,regimen,1,0
22464,of,1,0
22465,5-fluorouracil-based,1,0
22466,chemotherapy,1,0
22467,",",0,0
22468,were,0,0
22469,randomised,0,0
22470,to,0,0
22471,receive,0,0
22472,either,0,0
22473,marimastat,0,0
22474,(,0,0
22475,10,0,0
22476,mg,0,0
22477,b.d,0,1
22478,.,0,0
22479,),0,0
22480,or,0,0
22481,placebo,0,0
22482,.,0,0
22483,Patients,0,1
22484,were,0,0
22485,treated,0,1
22486,for,0,0
22487,as,0,0
22488,long,0,0
22489,as,0,0
22490,was,0,0
22491,tolerable,0,0
22492,.,0,0
22493,The,0,0
22494,primary,0,0
22495,endpoint,0,0
22496,was,0,0
22497,overall,0,0
22498,survival,0,0
22499,with,0,1
22500,secondary,0,0
22501,endpoints,0,0
22502,of,0,0
22503,time,0,0
22504,to,0,0
22505,disease,0,1
22506,progression,0,0
22507,and,0,0
22508,quality,0,0
22509,of,0,0
22510,life,0,0
22511,.,0,0
22512,At,0,0
22513,the,0,0
22514,point,0,0
22515,of,0,0
22516,protocol-defined,0,0
22517,study,0,0
22518,completion,0,0
22519,(,0,0
22520,85,0,0
22521,%,0,0
22522,mortality,0,0
22523,in,0,0
22524,the,0,0
22525,placebo,0,0
22526,arm,0,0
22527,),0,0
22528,there,0,0
22529,was,0,0
22530,a,0,0
22531,modest,0,0
22532,difference,0,0
22533,in,0,0
22534,survival,0,0
22535,in,0,0
22536,the,0,0
22537,intention-to-treat,0,0
22538,population,0,1
22539,in,0,0
22540,favour,0,0
22541,of,0,0
22542,marimastat,0,0
22543,(,0,0
22544,P=0.07,0,0
22545,log-rank,0,0
22546,test,0,0
22547,",",0,0
22548,hazard,0,0
22549,ratio=1.23,0,0
22550,(,0,0
22551,95,0,0
22552,%,0,0
22553,confidence,0,0
22554,interval,0,0
22555,0.98-1.55,0,0
22556,),0,0
22557,),0,0
22558,.,0,0
22559,This,0,0
22560,survival,0,0
22561,benefit,0,0
22562,was,0,0
22563,maintained,0,0
22564,over,0,0
22565,a,0,0
22566,further,0,0
22567,2,0,0
22568,years,0,1
22569,of,0,0
22570,follow-up,0,0
22571,(,0,0
22572,P=0.024,0,0
22573,",",0,0
22574,hazard,0,0
22575,ratio=1.27,0,0
22576,(,0,0
22577,1.03-1.57,0,0
22578,),0,0
22579,),0,0
22580,.,0,0
22581,The,0,0
22582,median,0,0
22583,survival,0,0
22584,was,0,0
22585,138,0,1
22586,days,0,0
22587,for,0,0
22588,placebo,0,0
22589,and,0,0
22590,160,0,1
22591,days,0,0
22592,for,0,0
22593,marimastat,0,0
22594,",",0,0
22595,with,0,0
22596,2-year,0,0
22597,survival,0,0
22598,of,0,0
22599,3,0,0
22600,%,0,0
22601,and,0,0
22602,9,0,0
22603,%,0,0
22604,respectively,0,0
22605,.,0,0
22606,A,0,0
22607,significant,0,0
22608,survival,0,0
22609,benefit,0,0
22610,was,0,0
22611,identified,0,0
22612,at,0,0
22613,study,0,0
22614,completion,0,0
22615,in,0,0
22616,the,0,0
22617,pre-defined,1,0
22618,sub-group,1,1
22619,of,1,0
22620,123,1,1
22621,patients,1,1
22622,who,1,1
22623,had,1,1
22624,received,1,1
22625,prior,1,0
22626,chemotherapy,1,0
22627,(,0,0
22628,P=0.045,0,0
22629,",",0,0
22630,hazard,0,0
22631,ratio=1.53,0,0
22632,(,0,0
22633,1.00-2.34,0,0
22634,),0,0
22635,),0,0
22636,.,0,0
22637,This,0,0
22638,benefit,0,0
22639,increased,0,0
22640,with,0,1
22641,2,0,0
22642,years,0,1
22643,additional,0,0
22644,follow-up,0,0
22645,(,0,0
22646,P=0.006,0,0
22647,",",0,0
22648,hazard,0,0
22649,ratio=1.68,0,0
22650,(,0,0
22651,1.16-2.44,0,0
22652,),0,0
22653,),0,0
22654,",",0,0
22655,with,0,0
22656,2-year,0,0
22657,survival,0,0
22658,of,0,0
22659,5,0,0
22660,%,0,0
22661,and,0,0
22662,18,0,0
22663,%,0,0
22664,respectively,0,0
22665,.,0,0
22666,Progression-free,0,0
22667,survival,0,0
22668,was,0,0
22669,also,0,0
22670,significantly,0,0
22671,longer,0,0
22672,for,0,0
22673,patients,0,1
22674,receiving,0,1
22675,marimastat,0,0
22676,compared,0,0
22677,to,0,0
22678,placebo,0,0
22679,(,0,0
22680,P=0.009,0,0
22681,",",0,0
22682,hazard,0,0
22683,ratio=1.32,0,0
22684,(,0,0
22685,1.07-1.63,0,0
22686,),0,0
22687,),0,0
22688,.,0,0
22689,Marimastat,0,0
22690,treatment,0,0
22691,was,0,0
22692,associated,0,0
22693,with,0,0
22694,the,0,0
22695,development,0,0
22696,of,0,0
22697,musculoskeletal,0,1
22698,pain,0,0
22699,and,0,0
22700,inflammation,0,0
22701,.,0,0
22702,Events,0,0
22703,of,0,0
22704,anaemia,0,1
22705,",",0,0
22706,abdominal,0,0
22707,pain,0,0
22708,",",0,0
22709,jaundice,0,1
22710,and,0,0
22711,weight,0,0
22712,loss,0,0
22713,were,0,0
22714,more,0,0
22715,common,0,0
22716,in,0,0
22717,the,0,0
22718,placebo,0,0
22719,arm,0,0
22720,.,0,0
22721,This,0,0
22722,is,0,0
22723,one,0,0
22724,of,0,0
22725,the,0,0
22726,first,0,0
22727,demonstrations,0,0
22728,of,0,0
22729,a,0,0
22730,therapeutic,0,0
22731,benefit,0,0
22732,for,0,0
22733,a,0,0
22734,matrix,0,0
22735,metalloproteinase,0,0
22736,inhibitor,0,0
22737,in,0,0
22738,cancer,0,1
22739,patients,0,1
22740,.,0,0
22741,The,0,0
22742,greatest,0,0
22743,benefit,0,0
22744,was,0,0
22745,observed,0,0
22746,in,0,1
22747,patients,1,1
22748,who,1,1
22749,had,1,1
22750,previously,1,1
22751,received,1,0
22752,chemotherapy,1,0
22753,.,1,0
22754,A,0,0
22755,further,0,0
22756,randomised,0,0
22757,study,0,0
22758,of,0,0
22759,marimastat,0,0
22760,in,0,0
22761,these,0,0
22762,patients,0,1
22763,is,0,0
22764,warranted,0,0
22765,.,0,0
22766,Double-blind,0,0
22767,placebo-controlled,0,0
22768,trial,0,0
22769,of,0,0
22770,secretin,0,0
22771,:,0,1
22772,effects,0,0
22773,on,0,0
22774,aberrant,0,1
22775,behavior,0,0
22776,in,0,0
22777,children,1,1
22778,with,1,1
22779,autism,1,1
22780,.,1,0
22781,Secretin,0,0
22782,has,0,0
22783,been,0,0
22784,proposed,0,0
22785,as,0,0
22786,a,0,0
22787,treatment,0,0
22788,alternative,0,0
22789,for,0,0
22790,autistic,1,1
22791,spectrum,1,1
22792,disorders,1,1
22793,",",0,0
22794,but,0,0
22795,empirical,0,0
22796,support,0,0
22797,is,0,0
22798,lacking,0,0
22799,.,0,0
22800,A,0,0
22801,double-blind,0,0
22802,placebo-controlled,0,0
22803,study,0,0
22804,examined,0,0
22805,the,0,0
22806,effect,0,0
22807,of,0,0
22808,a,0,0
22809,single,0,0
22810,dose,0,0
22811,of,0,0
22812,synthetic,0,0
22813,human,0,0
22814,secretin,0,0
22815,on,0,0
22816,aberrant,0,0
22817,behavior,0,0
22818,.,0,0
22819,Parent,1,0
22820,and,1,0
22821,teacher,1,0
22822,data,1,0
22823,from,1,0
22824,the,1,0
22825,Aberrant,1,0
22826,Behavior,1,0
22827,Checklist,1,0
22828,for,0,0
22829,eight,1,1
22830,male,1,1
22831,children,1,1
22832,were,0,0
22833,analyzed,0,0
22834,for,0,0
22835,reliable,0,0
22836,change,0,0
22837,in,0,0
22838,a,0,0
22839,clinical,0,0
22840,replication,0,0
22841,series,0,0
22842,.,0,0
22843,By,0,0
22844,parent,0,0
22845,and,0,0
22846,teacher,0,0
22847,report,0,0
22848,",",0,0
22849,the,0,0
22850,majority,0,0
22851,of,0,0
22852,change,0,0
22853,occurred,0,0
22854,either,0,0
22855,on,0,0
22856,the,0,0
22857,placebo,0,0
22858,trial,0,0
22859,or,0,0
22860,reflected,0,0
22861,deterioration,0,0
22862,subsequent,0,0
22863,to,0,0
22864,secretin,0,0
22865,infusion,0,0
22866,.,0,0
22867,Repeated-measures,0,0
22868,multivariate,0,0
22869,analysis,0,0
22870,of,0,0
22871,variance,0,0
22872,results,0,0
22873,were,0,0
22874,similar,0,0
22875,.,0,0
22876,Results,0,0
22877,are,0,0
22878,consistent,0,0
22879,with,0,1
22880,other,0,0
22881,studies,0,0
22882,",",0,0
22883,suggesting,0,0
22884,that,0,0
22885,secretin,0,0
22886,may,0,0
22887,not,0,0
22888,be,0,0
22889,an,0,0
22890,effective,0,0
22891,treatment,0,0
22892,option,0,0
22893,.,0,0
22894,Relation,0,0
22895,between,0,0
22896,early,0,0
22897,mitral,0,1
22898,regurgitation,0,0
22899,and,0,0
22900,left,0,0
22901,ventricular,0,0
22902,thrombus,0,0
22903,formation,0,0
22904,after,0,0
22905,acute,0,1
22906,myocardial,0,1
22907,infarction,0,1
22908,:,0,1
22909,results,0,0
22910,of,0,0
22911,the,0,0
22912,GISSI-3,0,0
22913,echo,0,0
22914,substudy,0,0
22915,.,0,0
22916,OBJECTIVE,0,0
22917,To,0,0
22918,evaluate,0,0
22919,the,0,0
22920,prevalence,0,0
22921,and,0,0
22922,correlates,0,0
22923,of,0,0
22924,left,0,1
22925,ventricular,0,0
22926,thrombosis,0,1
22927,in,0,0
22928,patients,1,1
22929,with,1,1
22930,acute,1,1
22931,myocardial,1,1
22932,infarction,1,1
22933,",",0,0
22934,and,0,0
22935,whether,0,0
22936,the,0,0
22937,occurrence,0,0
22938,of,0,0
22939,early,0,0
22940,mitral,0,1
22941,regurgitation,0,0
22942,has,0,0
22943,a,0,0
22944,protective,0,0
22945,effect,0,0
22946,against,0,0
22947,the,0,0
22948,formation,0,0
22949,of,0,0
22950,left,0,1
22951,ventricular,0,1
22952,thrombus,0,0
22953,.,0,0
22954,DESIGN,0,0
22955,AND,0,0
22956,SETTING,0,1
22957,Multicentre,0,1
22958,clinical,0,0
22959,trial,0,0
22960,carried,0,0
22961,out,0,0
22962,in,0,0
22963,47,1,1
22964,Italian,1,1
22965,coronary,1,1
22966,care,1,1
22967,units,1,0
22968,.,1,0
22969,PATIENTS,0,0
22970,AND,0,0
22971,METHODS,0,0
22972,757,1,1
22973,patients,1,1
22974,from,1,1
22975,the,1,0
22976,GISSI-3,1,0
22977,echo,1,0
22978,substudy,1,0
22979,population,1,1
22980,with,1,0
22981,their,1,0
22982,first,1,0
22983,acute,1,1
22984,myocardial,1,1
22985,infarct,1,0
22986,were,1,0
22987,studied,1,0
22988,by,0,0
22989,echocardiography,0,0
22990,at,0,0
22991,24-48,0,0
22992,hours,0,0
22993,from,0,1
22994,symptom,0,0
22995,onset,0,1
22996,(,0,0
22997,S1,0,1
22998,),0,0
22999,",",0,0
23000,at,0,0
23001,discharge,0,0
23002,(,0,0
23003,S2,0,0
23004,),0,0
23005,",",0,0
23006,at,0,0
23007,six,0,0
23008,weeks,0,0
23009,(,0,0
23010,S3,0,0
23011,),0,0
23012,",",0,0
23013,and,0,0
23014,at,0,0
23015,six,0,0
23016,months,0,0
23017,(,0,0
23018,S4,0,0
23019,),0,0
23020,.,0,0
23021,The,0,0
23022,diagnosis,0,0
23023,of,0,0
23024,left,0,1
23025,ventricular,0,1
23026,thrombosis,0,1
23027,was,0,0
23028,based,0,0
23029,on,0,0
23030,the,0,0
23031,detection,0,0
23032,of,0,0
23033,an,0,0
23034,echo,0,0
23035,dense,0,0
23036,mass,0,0
23037,with,0,1
23038,defined,0,0
23039,margins,0,1
23040,visible,0,0
23041,throughout,0,0
23042,the,0,0
23043,cardiac,0,0
23044,cycle,0,0
23045,in,0,0
23046,at,0,0
23047,least,0,0
23048,two,0,0
23049,orthogonal,0,0
23050,views,0,0
23051,.,0,1
23052,RESULTS,0,0
23053,In,0,0
23054,64,0,0
23055,patients,0,1
23056,(,0,0
23057,8,0,0
23058,%,0,0
23059,),0,0
23060,",",0,0
23061,left,0,0
23062,ventricular,0,0
23063,thrombosis,0,1
23064,was,0,0
23065,detected,0,0
23066,in,0,0
23067,one,0,0
23068,or,0,1
23069,more,0,0
23070,examinations,0,0
23071,.,0,0
23072,Compared,0,0
23073,with,0,0
23074,the,0,0
23075,remaining,0,0
23076,693,0,1
23077,patients,0,1
23078,",",0,0
23079,subjects,0,1
23080,with,0,1
23081,left,0,1
23082,ventricular,0,1
23083,thrombosis,0,1
23084,were,0,0
23085,older,0,1
23086,(,0,0
23087,mean,0,0
23088,(,0,0
23089,SD,0,0
23090,),0,0
23091,age,0,1
23092,:,0,1
23093,64.6,0,0
23094,(,0,0
23095,13.0,0,0
23096,),0,0
23097,v,0,0
23098,59.8,0,0
23099,(,0,0
23100,11.7,0,0
23101,),0,0
23102,years,0,1
23103,",",0,0
23104,p,0,0
23105,<,0,0
23106,0.005,0,0
23107,),0,0
23108,",",0,0
23109,and,0,0
23110,had,0,0
23111,larger,0,0
23112,infarcts,0,0
23113,(,0,0
23114,extent,0,0
23115,of,0,0
23116,wall,0,0
23117,motion,0,0
23118,asynergy,0,0
23119,:,0,1
23120,40.9,0,0
23121,(,0,0
23122,11.5,0,0
23123,),0,0
23124,%,0,0
23125,v,0,0
23126,24.9,0,0
23127,(,0,0
23128,14,0,0
23129,),0,0
23130,%,0,0
23131,",",0,0
23132,p,0,0
23133,<,0,0
23134,0.001,0,0
23135,),0,0
23136,",",0,0
23137,greater,0,0
23138,depression,0,0
23139,of,0,0
23140,left,0,1
23141,ventricular,0,0
23142,ejection,0,0
23143,fraction,0,0
23144,at,0,0
23145,S1,0,1
23146,(,0,0
23147,43.3,0,0
23148,(,0,0
23149,6.9,0,0
23150,),0,0
23151,%,0,0
23152,v,0,0
23153,48.1,0,0
23154,(,0,0
23155,6.8,0,0
23156,),0,0
23157,%,0,0
23158,",",0,0
23159,p,0,0
23160,<,0,0
23161,0.001,0,0
23162,),0,0
23163,",",0,0
23164,and,0,0
23165,greater,0,0
23166,left,0,1
23167,ventricular,0,0
23168,volumes,0,0
23169,at,0,0
23170,S1,0,1
23171,(,0,0
23172,end,0,0
23173,diastolic,0,0
23174,volume,0,0
23175,:,0,1
23176,87,0,0
23177,(,0,0
23178,22,0,1
23179,),0,0
23180,v,0,0
23181,78,0,1
23182,(,0,0
23183,18,0,1
23184,),0,0
23185,ml/m,0,0
23186,(,0,0
23187,2,0,0
23188,),0,0
23189,",",0,0
23190,p,0,0
23191,<,0,0
23192,0.001,0,0
23193,;,0,0
23194,end,0,0
23195,systolic,0,1
23196,volume,0,0
23197,:,0,1
23198,50,0,0
23199,(,0,0
23200,17,0,0
23201,),0,0
23202,v,0,0
23203,41,0,1
23204,(,0,0
23205,14,0,0
23206,),0,0
23207,ml/m,0,0
23208,(,0,0
23209,2,0,0
23210,),0,0
23211,",",0,0
23212,p,0,0
23213,<,0,0
23214,0.001,0,0
23215,),0,0
23216,.,0,0
23217,The,0,0
23218,prevalence,0,0
23219,of,0,0
23220,moderate,0,1
23221,to,0,0
23222,severe,0,1
23223,mitral,0,1
23224,regurgitation,0,0
23225,on,0,0
23226,colour,0,0
23227,Doppler,0,0
23228,at,0,0
23229,S1,0,1
23230,was,0,0
23231,greater,0,0
23232,in,0,1
23233,patients,0,1
23234,who,0,1
23235,had,0,1
23236,left,0,1
23237,ventricular,0,0
23238,thrombosis,0,1
23239,at,0,0
23240,any,0,0
23241,time,0,0
23242,(,0,0
23243,10.2,0,0
23244,%,0,0
23245,v,0,0
23246,4.2,0,0
23247,%,0,0
23248,",",0,0
23249,p,0,0
23250,<,0,0
23251,0.05,0,0
23252,),0,0
23253,.,0,0
23254,On,0,0
23255,stepwise,0,0
23256,multiple,0,0
23257,logistic,0,0
23258,regression,0,0
23259,analysis,0,0
23260,the,0,0
23261,only,0,0
23262,independent,0,0
23263,variables,0,0
23264,related,0,0
23265,to,0,0
23266,the,0,0
23267,presence,0,0
23268,of,0,0
23269,left,0,1
23270,ventricular,0,1
23271,thrombosis,0,1
23272,were,0,0
23273,the,0,0
23274,extent,0,0
23275,of,0,0
23276,wall,0,0
23277,motion,0,0
23278,asynergy,0,0
23279,and,0,0
23280,anterior,0,0
23281,site,0,0
23282,of,0,0
23283,infarction,0,1
23284,.,0,0
23285,CONCLUSIONS,0,0
23286,Left,0,0
23287,ventricular,0,0
23288,thrombosis,0,0
23289,is,0,0
23290,not,0,0
23291,reduced,0,0
23292,",",0,0
23293,and,0,0
23294,may,0,0
23295,even,0,0
23296,be,0,0
23297,increased,0,0
23298,",",0,0
23299,by,0,0
23300,early,0,0
23301,moderate,0,1
23302,to,0,0
23303,severe,0,1
23304,mitral,0,1
23305,regurgitation,0,0
23306,after,0,0
23307,acute,0,1
23308,myocardial,0,1
23309,infarction,0,1
23310,.,0,0
23311,The,0,0
23312,only,0,0
23313,independent,0,0
23314,determinant,0,0
23315,of,0,0
23316,left,0,1
23317,ventricular,0,0
23318,thrombosis,0,0
23319,is,0,0
23320,the,0,0
23321,extent,0,0
23322,of,0,0
23323,the,0,0
23324,akinetic-dyskinetic,0,0
23325,area,0,0
23326,detected,0,0
23327,on,0,0
23328,echocardiography,0,0
23329,between,0,0
23330,24-48,0,0
23331,hours,0,0
23332,from,0,1
23333,symptom,0,0
23334,onset,0,1
23335,.,0,0
23336,Effect,0,0
23337,of,0,0
23338,clinical,0,0
23339,pharmacy,0,1
23340,services,0,1
23341,on,0,0
23342,the,0,0
23343,blood,0,0
23344,pressure,0,0
23345,of,0,0
23346,African-American,1,1
23347,renal,1,1
23348,transplant,1,1
23349,patients,1,1
23350,.,1,0
23351,OBJECTIVE,0,0
23352,The,0,0
23353,objective,0,0
23354,of,0,0
23355,this,0,0
23356,study,0,0
23357,was,0,0
23358,to,0,0
23359,determine,0,0
23360,if,0,0
23361,African-American,1,1
23362,renal,1,1
23363,transplant,1,1
23364,patients,1,1
23365,who,0,1
23366,received,0,1
23367,direct,0,0
23368,patient,0,0
23369,care,0,0
23370,from,0,0
23371,a,0,0
23372,clinical,0,0
23373,pharmacist,0,0
23374,had,0,0
23375,better,0,0
23376,blood,0,0
23377,pressure,0,0
23378,control,0,0
23379,compared,0,0
23380,to,0,0
23381,African-American,1,1
23382,renal,1,1
23383,transplant,1,1
23384,patients,1,1
23385,who,1,1
23386,did,1,1
23387,not,1,1
23388,have,1,0
23389,clinical,1,0
23390,pharmacy,1,0
23391,services,1,1
23392,.,1,1
23393,METHODS,0,0
23394,Renal,1,0
23395,transplant,1,1
23396,patients,1,1
23397,were,0,0
23398,prospectively,0,1
23399,randomized,0,0
23400,into,0,0
23401,an,0,0
23402,intervention,0,0
23403,group,0,0
23404,or,0,0
23405,a,0,0
23406,control,0,0
23407,group,0,0
23408,.,0,0
23409,Patients,0,1
23410,in,0,0
23411,the,0,0
23412,intervention,0,0
23413,group,0,0
23414,received,0,0
23415,clinical,0,0
23416,pharmacy,0,0
23417,services,0,1
23418,that,0,0
23419,included,0,1
23420,a,0,0
23421,clinical,0,0
23422,pharmacist,0,0
23423,performing,0,0
23424,patient,0,0
23425,medication,0,0
23426,reviews,0,0
23427,",",0,0
23428,with,0,1
23429,emphasis,0,0
23430,on,0,0
23431,preventing,0,0
23432,or,0,0
23433,resolving,0,0
23434,medication-related,0,0
23435,problems,0,1
23436,and,0,0
23437,providing,0,0
23438,medication,0,0
23439,recommendations,0,1
23440,.,0,1
23441,Patients,0,1
23442,in,0,0
23443,the,0,0
23444,control,0,0
23445,group,0,0
23446,received,0,0
23447,routine,0,0
23448,clinic,0,1
23449,services,0,0
23450,",",0,0
23451,but,0,0
23452,had,0,0
23453,no,0,0
23454,clinical,0,0
23455,pharmacist,0,0
23456,interaction,0,0
23457,.,0,0
23458,Analysis,0,0
23459,was,0,0
23460,performed,0,0
23461,to,0,0
23462,detect,0,0
23463,differences,0,0
23464,between,0,0
23465,the,0,0
23466,intervention,0,0
23467,and,0,0
23468,control,0,0
23469,groups,0,0
23470,in,0,0
23471,baseline,0,0
23472,and,0,0
23473,quarterly,0,0
23474,systolic,0,0
23475,blood,0,0
23476,pressure,0,0
23477,(,0,0
23478,SBP,0,0
23479,),0,0
23480,and,0,0
23481,diastolic,0,0
23482,blood,0,0
23483,pressure,0,0
23484,(,0,0
23485,DBP,0,0
23486,),0,0
23487,for,0,0
23488,one,0,0
23489,year,0,0
23490,post-study,0,0
23491,enrollment,0,0
23492,.,0,0
23493,RESULTS,0,0
23494,There,0,0
23495,were,0,0
23496,no,0,0
23497,differences,0,0
23498,between,0,0
23499,the,0,0
23500,intervention,0,0
23501,(,1,0
23502,N,1,1
23503,=,1,0
23504,13,1,0
23505,),1,0
23506,and,0,0
23507,control,0,0
23508,(,1,0
23509,N,1,1
23510,=,1,0
23511,10,1,1
23512,),1,0
23513,groups,0,0
23514,in,0,0
23515,baseline,0,0
23516,blood,0,0
23517,pressures,0,0
23518,or,0,0
23519,in,0,0
23520,the,0,0
23521,percentage,0,0
23522,of,0,0
23523,hypertensive,0,1
23524,patients,0,1
23525,.,0,1
23526,Significant,0,0
23527,differences,0,0
23528,in,0,0
23529,the,0,0
23530,change,0,0
23531,in,0,0
23532,SBP,0,0
23533,and,0,0
23534,DBP,0,0
23535,from,0,0
23536,baseline,0,0
23537,between,0,0
23538,the,0,0
23539,intervention,0,0
23540,and,0,0
23541,control,0,0
23542,groups,0,0
23543,were,0,0
23544,observed,0,0
23545,at,0,0
23546,the,0,0
23547,second,0,0
23548,",",0,0
23549,third,0,0
23550,",",0,0
23551,and,0,0
23552,fourth,0,0
23553,quarters,0,1
23554,of,0,0
23555,the,0,0
23556,study,0,0
23557,",",0,0
23558,favoring,0,0
23559,the,0,0
23560,intervention,0,0
23561,group,0,0
23562,(,0,0
23563,P,0,0
23564,<,0,0
23565,.01,0,0
23566,),0,0
23567,.,0,0
23568,Mean,0,0
23569,SBP,0,0
23570,was,0,0
23571,significantly,0,0
23572,lower,0,0
23573,in,0,0
23574,the,0,0
23575,intervention,0,0
23576,group,0,0
23577,at,0,0
23578,the,0,0
23579,second,0,0
23580,(,0,0
23581,137.8,0,0
23582,+/-,0,0
23583,15.0,0,0
23584,vs,0,0
23585,168.9,0,0
23586,+/-,0,0
23587,15.3,0,0
23588,),0,0
23589,",",0,0
23590,third,0,0
23591,(,0,0
23592,135.9,0,0
23593,+/-,0,0
23594,11.7,0,0
23595,vs,0,0
23596,164.6,0,0
23597,+/-,0,0
23598,20.1,0,0
23599,),0,0
23600,",",0,0
23601,and,0,0
23602,fourth,0,0
23603,(,0,0
23604,145.3,0,0
23605,+/-,0,0
23606,16.8,0,0
23607,vs,0,0
23608,175.8,0,0
23609,+/-,0,0
23610,33.9,0,0
23611,),0,0
23612,quarters,0,1
23613,of,0,0
23614,the,0,0
23615,study,0,0
23616,(,0,0
23617,P,0,0
23618,<,0,0
23619,.05,0,0
23620,),0,0
23621,.,0,0
23622,Mean,0,0
23623,DBP,0,0
23624,was,0,0
23625,significantly,0,0
23626,lower,0,0
23627,in,0,0
23628,the,0,0
23629,intervention,0,0
23630,group,0,0
23631,at,0,0
23632,the,0,0
23633,second,0,0
23634,(,0,0
23635,76.0,0,0
23636,+/-,0,0
23637,11.8,0,0
23638,vs,0,0
23639,84.9,0,0
23640,+/-,0,0
23641,6.1,0,0
23642,),0,0
23643,and,0,0
23644,fourth,0,0
23645,(,0,0
23646,77.0,0,0
23647,+/-,0,0
23648,10.2,0,0
23649,vs,0,0
23650,91.8,0,0
23651,+/-,0,0
23652,12.0,0,0
23653,),0,0
23654,quarters,0,1
23655,(,0,0
23656,P,0,0
23657,<,0,0
23658,.05,0,0
23659,),0,0
23660,.,0,0
23661,CONCLUSION,0,0
23662,Direct,0,0
23663,patient,0,0
23664,care,0,0
23665,services,0,0
23666,provided,0,0
23667,by,0,0
23668,a,0,0
23669,clinical,0,0
23670,pharmacist,0,0
23671,",",0,0
23672,in,0,0
23673,addition,0,0
23674,to,0,0
23675,routine,0,0
23676,clinical,0,0
23677,services,0,0
23678,",",0,0
23679,have,0,0
23680,a,0,0
23681,positive,0,0
23682,effect,0,0
23683,on,0,0
23684,the,0,0
23685,blood,0,0
23686,pressure,0,0
23687,of,0,0
23688,African-American,1,1
23689,renal,1,1
23690,transplant,1,1
23691,patients,1,1
23692,.,1,0
23693,A,0,0
23694,multidisciplinary,0,0
23695,team,0,0
23696,that,0,0
23697,includes,0,0
23698,a,0,0
23699,clinical,0,0
23700,pharmacist,0,0
23701,is,0,0
23702,beneficial,0,0
23703,to,0,0
23704,patient,0,0
23705,care,0,0
23706,.,0,0
23707,Risperidone,0,0
23708,in,0,0
23709,children,1,1
23710,with,1,1
23711,autism,1,1
23712,and,1,0
23713,serious,1,0
23714,behavioral,1,1
23715,problems,1,1
23716,.,1,1
23717,BACKGROUND,0,0
23718,Atypical,0,1
23719,antipsychotic,0,0
23720,agents,0,0
23721,",",0,0
23722,which,0,0
23723,block,0,0
23724,postsynaptic,0,0
23725,dopamine,0,0
23726,and,0,0
23727,serotonin,0,0
23728,receptors,0,0
23729,",",0,0
23730,have,0,0
23731,advantages,0,0
23732,over,0,0
23733,traditional,0,0
23734,antipsychotic,0,0
23735,medications,0,0
23736,in,0,0
23737,the,0,0
23738,treatment,0,0
23739,of,0,0
23740,adults,0,1
23741,with,0,1
23742,schizophrenia,0,1
23743,and,0,0
23744,may,0,0
23745,be,0,0
23746,beneficial,0,0
23747,in,0,0
23748,children,0,1
23749,with,0,1
23750,autistic,0,1
23751,disorder,0,1
23752,who,0,1
23753,have,0,1
23754,serious,0,0
23755,behavioral,0,1
23756,disturbances,0,0
23757,.,0,0
23758,However,0,0
23759,",",0,0
23760,data,0,0
23761,on,0,0
23762,the,0,0
23763,safety,0,0
23764,and,0,0
23765,efficacy,0,0
23766,of,0,0
23767,atypical,0,1
23768,antipsychotic,0,0
23769,agents,0,0
23770,in,0,0
23771,children,0,1
23772,are,0,0
23773,limited,0,0
23774,.,0,0
23775,METHODS,0,0
23776,We,0,0
23777,conducted,0,0
23778,a,0,0
23779,multisite,0,0
23780,",",0,0
23781,randomized,0,0
23782,",",0,0
23783,double-blind,0,0
23784,trial,0,0
23785,of,0,0
23786,risperidone,0,0
23787,as,0,0
23788,compared,0,0
23789,with,0,1
23790,placebo,0,0
23791,for,0,0
23792,the,0,0
23793,treatment,1,0
23794,of,1,0
23795,autistic,1,1
23796,disorder,1,1
23797,accompanied,1,0
23798,by,1,0
23799,severe,1,1
23800,tantrums,1,0
23801,",",1,0
23802,aggression,1,0
23803,",",1,0
23804,or,1,0
23805,self-injurious,1,0
23806,behavior,1,0
23807,in,1,0
23808,children,1,1
23809,5,1,0
23810,to,1,1
23811,17,1,1
23812,years,1,1
23813,old,1,1
23814,.,1,0
23815,The,0,0
23816,primary,0,0
23817,outcome,0,0
23818,measures,0,0
23819,were,0,0
23820,the,0,0
23821,score,0,0
23822,on,0,0
23823,the,0,0
23824,Irritability,0,0
23825,subscale,0,0
23826,of,0,0
23827,the,0,0
23828,Aberrant,0,0
23829,Behavior,0,0
23830,Checklist,0,0
23831,and,0,0
23832,the,0,0
23833,rating,0,0
23834,on,0,0
23835,the,0,0
23836,Clinical,0,0
23837,Global,0,0
23838,Impressions,0,0
23839,-,0,0
23840,Improvement,0,0
23841,(,0,0
23842,CGI-I,0,0
23843,),0,0
23844,scale,0,0
23845,at,0,0
23846,eight,0,1
23847,weeks,0,0
23848,.,0,0
23849,RESULTS,0,0
23850,A,1,0
23851,total,1,0
23852,of,1,0
23853,101,1,1
23854,children,1,1
23855,(,1,1
23856,82,1,1
23857,boys,1,1
23858,and,1,0
23859,19,1,1
23860,girls,1,1
23861,;,1,0
23862,mean,1,0
23863,[,1,0
23864,+/-SD,1,0
23865,],1,0
23866,age,1,1
23867,",",1,0
23868,8.8+/-2.7,1,0
23869,years,1,1
23870,),1,0
23871,were,1,0
23872,randomly,1,0
23873,assigned,1,0
23874,to,1,0
23875,receive,1,0
23876,risperidone,1,0
23877,(,1,0
23878,49,1,1
23879,children,1,1
23880,),1,0
23881,or,1,0
23882,placebo,1,0
23883,(,1,0
23884,52,1,1
23885,),1,0
23886,.,0,0
23887,Treatment,0,0
23888,with,0,0
23889,risperidone,0,0
23890,for,0,0
23891,eight,0,1
23892,weeks,0,0
23893,(,0,0
23894,dose,0,0
23895,range,0,0
23896,",",0,0
23897,0.5,0,0
23898,to,0,0
23899,3.5,0,0
23900,mg,0,0
23901,per,0,0
23902,day,0,0
23903,),0,0
23904,resulted,0,0
23905,in,0,0
23906,a,0,0
23907,56.9,0,0
23908,percent,0,0
23909,reduction,0,0
23910,in,0,0
23911,the,0,0
23912,Irritability,0,0
23913,score,0,0
23914,",",0,0
23915,as,0,0
23916,compared,0,0
23917,with,0,1
23918,a,0,0
23919,14.1,0,0
23920,percent,0,0
23921,decrease,0,0
23922,in,0,0
23923,the,0,0
23924,placebo,0,0
23925,group,0,0
23926,(,0,0
23927,P,0,0
23928,<,0,0
23929,0.001,0,0
23930,),0,0
23931,.,0,0
23932,The,0,0
23933,rate,0,0
23934,of,0,0
23935,a,0,0
23936,positive,0,0
23937,response,0,0
23938,",",0,0
23939,defined,0,0
23940,as,0,0
23941,at,0,0
23942,least,0,0
23943,a,0,0
23944,25,0,0
23945,percent,0,0
23946,decrease,0,0
23947,in,0,0
23948,the,0,0
23949,Irritability,0,0
23950,score,0,0
23951,and,0,0
23952,a,0,0
23953,rating,0,0
23954,of,0,0
23955,much,0,0
23956,improved,0,0
23957,or,0,0
23958,very,0,0
23959,much,0,0
23960,improved,0,0
23961,on,0,0
23962,the,0,0
23963,CGI-I,0,0
23964,scale,0,0
23965,",",0,0
23966,was,0,0
23967,69,0,0
23968,percent,0,0
23969,in,0,0
23970,the,0,0
23971,risperidone,0,0
23972,group,0,0
23973,(,0,0
23974,34,0,1
23975,of,0,0
23976,49,0,1
23977,children,0,1
23978,had,0,0
23979,a,0,0
23980,positive,0,0
23981,response,0,0
23982,),0,0
23983,and,0,0
23984,12,0,0
23985,percent,0,0
23986,in,0,0
23987,the,0,0
23988,placebo,0,0
23989,group,0,0
23990,(,0,0
23991,6,0,0
23992,of,0,0
23993,52,0,1
23994,",",0,0
23995,P,0,0
23996,<,0,0
23997,0.001,0,0
23998,),0,0
23999,.,0,0
24000,Risperidone,0,0
24001,therapy,0,0
24002,was,0,0
24003,associated,0,0
24004,with,0,0
24005,an,0,0
24006,average,0,0
24007,weight,0,0
24008,gain,0,0
24009,of,0,0
24010,2.7+/-2.9,0,0
24011,kg,0,0
24012,",",0,0
24013,as,0,0
24014,compared,0,0
24015,with,0,1
24016,0.8+/-2.2,0,0
24017,kg,0,0
24018,with,0,1
24019,placebo,0,0
24020,(,0,0
24021,P,0,0
24022,<,0,0
24023,0.001,0,0
24024,),0,0
24025,.,0,0
24026,Increased,0,0
24027,appetite,0,0
24028,",",0,0
24029,fatigue,0,0
24030,",",0,0
24031,drowsiness,0,0
24032,",",0,0
24033,dizziness,0,0
24034,",",0,0
24035,and,0,0
24036,drooling,0,0
24037,were,0,0
24038,more,0,0
24039,common,0,0
24040,in,0,0
24041,the,0,0
24042,risperidone,0,0
24043,group,0,0
24044,than,0,0
24045,in,0,0
24046,the,0,0
24047,placebo,0,0
24048,group,0,0
24049,(,0,0
24050,P,0,0
24051,<,0,0
24052,0.05,0,0
24053,for,0,0
24054,each,0,0
24055,comparison,0,0
24056,),0,0
24057,.,0,0
24058,In,0,0
24059,two,0,0
24060,thirds,0,1
24061,of,0,0
24062,the,0,0
24063,children,0,1
24064,with,0,1
24065,a,0,0
24066,positive,0,0
24067,response,0,0
24068,to,0,0
24069,risperidone,0,0
24070,at,0,0
24071,eight,0,1
24072,weeks,0,0
24073,(,0,0
24074,23,0,1
24075,of,0,0
24076,34,0,1
24077,),0,0
24078,",",0,0
24079,the,0,0
24080,benefit,0,0
24081,was,0,0
24082,maintained,0,0
24083,at,0,0
24084,six,0,1
24085,months,0,0
24086,.,0,1
24087,CONCLUSIONS,0,0
24088,Risperidone,0,0
24089,was,0,0
24090,effective,0,0
24091,and,0,0
24092,well,0,0
24093,tolerated,0,0
24094,for,0,0
24095,the,0,0
24096,treatment,0,0
24097,of,0,0
24098,tantrums,0,0
24099,",",0,0
24100,aggression,0,0
24101,",",0,0
24102,or,0,0
24103,self-injurious,0,0
24104,behavior,0,0
24105,in,0,0
24106,children,1,1
24107,with,1,1
24108,autistic,1,1
24109,disorder,1,1
24110,.,1,0
24111,The,0,0
24112,short,0,0
24113,period,0,0
24114,of,0,0
24115,this,0,0
24116,trial,0,0
24117,limits,0,0
24118,inferences,0,0
24119,about,0,0
24120,adverse,0,0
24121,effects,0,0
24122,such,0,0
24123,as,0,0
24124,tardive,0,1
24125,dyskinesia,0,1
24126,.,0,0
24127,Cyclosporine,0,0
24128,inhibition,0,0
24129,of,0,0
24130,P-glycoprotein,0,0
24131,in,0,0
24132,chronic,1,1
24133,myeloid,1,1
24134,leukemia,1,1
24135,blast,1,0
24136,phase,1,0
24137,.,1,0
24138,Chronic,0,0
24139,myeloid,0,1
24140,leukemia,0,1
24141,blast,0,0
24142,phase,0,0
24143,(,0,0
24144,CML-BP,0,0
24145,),0,0
24146,cells,0,0
24147,commonly,0,0
24148,express,0,0
24149,the,0,0
24150,multidrug,0,0
24151,transporter,0,0
24152,",",0,0
24153,P-glycoprotein,0,0
24154,(,0,0
24155,Pgp,0,0
24156,),0,0
24157,.,0,0
24158,To,0,0
24159,determine,0,0
24160,whether,0,0
24161,Pgp,0,0
24162,inhibition,0,0
24163,improves,0,0
24164,treatment,0,0
24165,outcome,0,0
24166,in,0,0
24167,CML-BP,0,0
24168,",",0,0
24169,the,0,0
24170,Southwest,0,1
24171,Oncology,0,1
24172,Group,0,0
24173,performed,0,0
24174,a,0,0
24175,randomized,0,0
24176,",",0,0
24177,controlled,0,0
24178,trial,0,0
24179,testing,0,0
24180,the,0,0
24181,benefit,0,0
24182,of,0,0
24183,the,0,0
24184,Pgp,0,0
24185,modulator,0,0
24186,",",0,0
24187,cyclosporin,0,0
24188,A,0,0
24189,(,0,0
24190,CsA,0,0
24191,),0,0
24192,.,0,0
24193,Seventy-three,1,1
24194,eligible,1,1
24195,patients,1,1
24196,were,0,0
24197,assigned,0,0
24198,to,0,0
24199,treatment,0,0
24200,with,0,0
24201,cytarabine,0,0
24202,and,0,0
24203,infusional,0,0
24204,daunorubicin,0,0
24205,with,0,1
24206,or,0,0
24207,without,0,1
24208,intravenous,0,0
24209,CsA,0,0
24210,.,0,0
24211,Treatment,0,0
24212,with,0,0
24213,CsA,0,0
24214,yielded,0,0
24215,no,0,0
24216,improvement,0,0
24217,in,0,0
24218,treatment,0,0
24219,outcome,0,0
24220,as,0,0
24221,measured,0,0
24222,by,0,0
24223,the,0,0
24224,frequency,0,0
24225,of,0,0
24226,induction,0,0
24227,resistance,0,0
24228,(,0,0
24229,68,0,0
24230,%,0,0
24231,vs,0,0
24232,53,0,1
24233,%,0,0
24234,),0,0
24235,",",0,0
24236,rate,0,0
24237,of,0,0
24238,complete,0,0
24239,remission,0,1
24240,or,0,0
24241,restored,0,0
24242,chronic,0,1
24243,phase,0,0
24244,(,0,0
24245,CR/CP,0,0
24246,",",0,0
24247,8,0,0
24248,%,0,0
24249,vs,0,0
24250,30,0,0
24251,%,0,0
24252,),0,0
24253,",",0,0
24254,and,0,0
24255,survival,0,0
24256,(,0,0
24257,3,0,0
24258,vs,0,0
24259,5,0,0
24260,months,0,0
24261,),0,1
24262,.,0,0
24263,Blast,0,0
24264,expression,0,0
24265,of,0,0
24266,Pgp,0,0
24267,(,0,0
24268,63,0,1
24269,%,0,0
24270,),0,0
24271,and,0,0
24272,LRP,0,1
24273,(,0,0
24274,71,0,1
24275,%,0,0
24276,),0,0
24277,was,0,0
24278,common,0,0
24279,",",0,0
24280,whereas,0,0
24281,only,0,0
24282,Pgp,0,0
24283,adversely,0,0
24284,impacted,0,0
24285,the,0,0
24286,rate,0,0
24287,of,0,0
24288,CR/CP,0,0
24289,(,0,0
24290,P,0,0
24291,=.025,0,0
24292,),0,0
24293,.,0,0
24294,We,0,0
24295,conclude,0,0
24296,that,0,0
24297,Pgp,0,0
24298,has,0,0
24299,prognostic,0,0
24300,relevance,0,0
24301,in,0,0
24302,CML-BP,0,0
24303,but,0,0
24304,that,0,0
24305,the,0,0
24306,modulation,0,0
24307,of,0,0
24308,Pgp,0,0
24309,function,0,0
24310,with,0,1
24311,CsA,0,0
24312,as,0,0
24313,applied,0,0
24314,in,0,0
24315,this,0,0
24316,trial,0,0
24317,is,0,0
24318,ineffective,0,0
24319,.,0,0
24320,Home,0,0
24321,based,0,0
24322,management,0,0
24323,in,0,0
24324,multiple,1,0
24325,sclerosis,1,1
24326,:,1,1
24327,results,0,0
24328,of,0,0
24329,a,0,0
24330,randomised,0,0
24331,controlled,0,0
24332,trial,0,0
24333,.,0,0
24334,BACKGROUND,0,0
24335,Home,0,0
24336,based,0,0
24337,medical,0,0
24338,care,0,0
24339,is,0,0
24340,a,0,0
24341,popular,0,0
24342,alternative,0,0
24343,to,0,0
24344,standard,0,0
24345,hospital,0,0
24346,care,0,0
24347,but,0,0
24348,there,0,0
24349,is,0,0
24350,uncertainty,0,0
24351,about,0,0
24352,its,0,0
24353,cost-effectiveness,0,0
24354,.,0,0
24355,OBJECTIVES,0,0
24356,To,0,0
24357,compare,0,0
24358,the,0,0
24359,effectiveness,0,0
24360,and,0,0
24361,the,0,0
24362,costs,0,0
24363,of,0,0
24364,multidisciplinary,0,1
24365,home,0,1
24366,based,0,0
24367,care,0,0
24368,in,0,0
24369,multiple,1,0
24370,sclerosis,1,1
24371,with,0,1
24372,hospital,0,0
24373,care,0,0
24374,in,0,0
24375,a,0,0
24376,prospective,0,0
24377,randomised,0,0
24378,controlled,0,0
24379,trial,0,0
24380,with,0,0
24381,a,0,0
24382,one,0,0
24383,year,0,0
24384,follow,0,0
24385,up,0,0
24386,.,0,0
24387,METHODS,0,0
24388,201,1,1
24389,patients,1,1
24390,with,1,1
24391,clinically,1,0
24392,definite,1,0
24393,multiple,1,0
24394,sclerosis,1,1
24395,were,0,0
24396,studied,0,0
24397,.,0,0
24398,They,0,0
24399,were,0,0
24400,randomised,0,0
24401,in,0,0
24402,a,0,0
24403,ratio,0,0
24404,2:1,0,0
24405,to,0,0
24406,an,0,0
24407,intervention,0,0
24408,group,0,0
24409,(,0,0
24410,133,0,1
24411,),0,0
24412,or,0,0
24413,a,0,0
24414,control,0,0
24415,group,0,0
24416,(,0,0
24417,68,0,1
24418,),0,0
24419,.,0,0
24420,They,0,0
24421,were,0,0
24422,assessed,0,0
24423,at,0,0
24424,baseline,0,0
24425,and,0,0
24426,one,0,0
24427,year,0,0
24428,after,0,0
24429,randomisation,0,0
24430,with,0,1
24431,validated,0,0
24432,measures,0,0
24433,of,0,0
24434,physical,0,0
24435,and,0,0
24436,psychological,0,0
24437,impairment,0,0
24438,and,0,0
24439,quality,0,0
24440,of,0,0
24441,life,0,0
24442,(,0,0
24443,SF-36,0,0
24444,health,0,0
24445,survey,0,1
24446,),0,0
24447,.,0,0
24448,The,0,0
24449,costs,0,0
24450,to,0,0
24451,the,0,0
24452,National,0,0
24453,Health,0,0
24454,Service,0,0
24455,over,0,0
24456,the,0,0
24457,one,0,0
24458,year,0,0
24459,follow,0,0
24460,up,0,0
24461,were,0,0
24462,calculated,0,0
24463,by,0,0
24464,a,0,0
24465,cost,0,0
24466,minimisation,0,0
24467,analysis,0,0
24468,.,0,0
24469,RESULTS,0,0
24470,There,0,0
24471,were,0,0
24472,no,0,0
24473,differences,0,0
24474,in,0,0
24475,functional,0,0
24476,status,0,0
24477,between,0,0
24478,the,0,0
24479,home,0,0
24480,based,0,0
24481,care,0,0
24482,group,0,0
24483,and,0,0
24484,the,0,0
24485,hospital,0,0
24486,group,0,0
24487,.,0,0
24488,There,0,0
24489,was,0,0
24490,a,0,0
24491,significant,0,0
24492,difference,0,0
24493,between,0,0
24494,the,0,0
24495,two,0,0
24496,groups,0,0
24497,favouring,0,0
24498,home,0,1
24499,based,0,0
24500,management,0,0
24501,in,0,0
24502,four,0,0
24503,SF-36,0,0
24504,health,0,1
24505,dimensions-general,0,0
24506,health,0,0
24507,",",0,0
24508,bodily,0,0
24509,pain,0,0
24510,",",0,0
24511,role-emotional,0,0
24512,",",0,0
24513,and,0,0
24514,social,0,0
24515,functioning,0,0
24516,(,0,0
24517,all,0,0
24518,p,0,0
24519,<,0,0
24520,or,0,0
24521,=,0,0
24522,0.001,0,0
24523,),0,0
24524,.,0,0
24525,The,0,0
24526,cost,0,0
24527,of,0,0
24528,home,0,0
24529,based,0,0
24530,care,0,0
24531,was,0,0
24532,slightly,0,0
24533,less,0,0
24534,(,0,0
24535,822,0,1
24536,euros/patient/year,0,0
24537,),0,0
24538,than,0,0
24539,hospital,0,0
24540,care,0,0
24541,",",0,0
24542,mainly,0,0
24543,as,0,0
24544,a,0,0
24545,result,0,0
24546,of,0,0
24547,a,0,0
24548,reduction,0,0
24549,in,0,0
24550,hospital,0,1
24551,admissions,0,1
24552,.,0,1
24553,CONCLUSIONS,0,0
24554,Comprehensive,0,0
24555,planning,0,0
24556,of,0,0
24557,home,0,0
24558,based,0,0
24559,intervention,0,0
24560,implemented,0,0
24561,by,0,0
24562,an,0,0
24563,interdisciplinary,0,0
24564,team,0,0
24565,and,0,0
24566,designed,0,0
24567,specifically,0,0
24568,for,0,0
24569,people,0,1
24570,with,0,1
24571,multiple,0,0
24572,sclerosis,0,1
24573,may,0,0
24574,provide,0,0
24575,a,0,0
24576,cost-effective,0,0
24577,approach,0,0
24578,to,0,0
24579,management,0,0
24580,and,0,0
24581,improve,0,0
24582,the,0,0
24583,quality,0,0
24584,of,0,0
24585,life,0,0
24586,.,0,0
24587,Quality,0,0
24588,assurance,0,0
24589,in,0,0
24590,the,0,0
24591,EORTC,0,0
24592,22921,0,0
24593,trial,0,0
24594,on,0,0
24595,preoperative,0,0
24596,radiotherapy,0,1
24597,with,0,1
24598,or,0,0
24599,without,0,0
24600,chemotherapy,0,0
24601,for,0,0
24602,resectable,1,1
24603,rectal,1,1
24604,cancer,1,1
24605,:,1,1
24606,evaluation,0,0
24607,of,0,0
24608,the,0,0
24609,individual,0,0
24610,case,0,0
24611,review,0,0
24612,procedure,0,0
24613,.,0,0
24614,The,0,0
24615,aim,0,0
24616,of,0,0
24617,this,0,0
24618,study,0,0
24619,was,0,0
24620,to,0,0
24621,assess,0,0
24622,any,0,0
24623,inconsistency,0,0
24624,with,0,0
24625,the,0,0
24626,protocol,0,0
24627,guidelines,0,0
24628,for,0,0
24629,preoperative,0,0
24630,radiotherapy,0,1
24631,for,0,0
24632,rectal,1,1
24633,cancer,1,1
24634,among,0,0
24635,radiotherapy,1,1
24636,institutions,1,1
24637,participating,1,1
24638,in,1,0
24639,the,1,0
24640,framework,1,0
24641,of,1,0
24642,a,1,0
24643,multicentre,1,0
24644,phase-III,1,0
24645,European,1,1
24646,Organization,1,0
24647,for,1,0
24648,Research,1,0
24649,and,1,0
24650,Treatment,1,0
24651,of,1,0
24652,Cancer,1,0
24653,(,1,0
24654,EORTC,1,0
24655,),1,0
24656,clinical,1,0
24657,trial,1,0
24658,.,1,0
24659,Twelve,1,1
24660,radiotherapy,1,0
24661,departments,1,1
24662,with,1,1
24663,more,1,0
24664,than,1,0
24665,10,1,0
24666,%,1,0
24667,of,1,0
24668,the,1,0
24669,evaluable,1,1
24670,patients,1,1
24671,recruited,1,1
24672,in,1,0
24673,the,1,0
24674,trial,1,0
24675,",",0,0
24676,were,0,0
24677,invited,0,1
24678,to,0,0
24679,participate,0,0
24680,in,0,0
24681,this,0,0
24682,individual,0,0
24683,case,0,0
24684,review,0,0
24685,.,0,0
24686,Participating,1,1
24687,institutions,1,0
24688,were,0,0
24689,asked,0,0
24690,to,0,0
24691,send,0,0
24692,five,1,0
24693,full,1,0
24694,patient,1,0
24695,records,1,1
24696,with,1,1
24697,the,1,0
24698,chemotherapy,1,0
24699,charts,1,0
24700,",",1,0
24701,surgical,1,0
24702,and,1,0
24703,pathology,1,0
24704,reports,1,0
24705,",",1,0
24706,radiation,1,0
24707,treatment,1,0
24708,charts,1,0
24709,",",1,0
24710,treatment,1,0
24711,planning,1,0
24712,calculations,1,0
24713,",",1,0
24714,computed,1,0
24715,tomography,1,0
24716,(,1,0
24717,CT,1,0
24718,),1,0
24719,scans,1,0
24720,",",1,0
24721,portal,1,0
24722,images,1,0
24723,and,1,0
24724,follow-up,1,0
24725,charts,1,0
24726,.,1,0
24727,The,0,0
24728,sample,0,0
24729,of,0,0
24730,the,0,0
24731,5,1,0
24732,patients,1,1
24733,per,1,0
24734,institution,1,1
24735,was,1,0
24736,randomly,0,0
24737,selected,0,0
24738,at,0,0
24739,the,0,0
24740,EORTC,0,0
24741,Data,0,0
24742,Center,0,0
24743,.,0,0
24744,All,0,0
24745,12,0,0
24746,departments,0,1
24747,participated,0,1
24748,.,0,0
24749,In,0,0
24750,21,0,1
24751,(,0,0
24752,35,0,1
24753,%,0,0
24754,),0,0
24755,of,0,0
24756,the,0,0
24757,cases,0,0
24758,",",0,0
24759,a,0,0
24760,three-field,0,0
24761,technique,0,0
24762,with,0,1
24763,two,0,0
24764,lateral,0,0
24765,opposed,0,0
24766,wedge,0,0
24767,fields,0,0
24768,and,0,0
24769,a,0,0
24770,posterior,0,0
24771,field,0,0
24772,was,0,0
24773,used,0,0
24774,",",0,0
24775,while,0,0
24776,in,0,0
24777,39,0,1
24778,(,0,0
24779,65,0,1
24780,%,0,0
24781,),0,0
24782,of,0,0
24783,the,0,0
24784,cases,0,0
24785,a,0,0
24786,four-field,0,0
24787,pelvic,0,0
24788,box,0,0
24789,technique,0,0
24790,was,0,0
24791,used,0,0
24792,.,0,0
24793,All,0,0
24794,participants,0,0
24795,used,0,0
24796,linear,0,0
24797,accelerators,0,0
24798,with,0,1
24799,a,0,0
24800,minimum,0,0
24801,of,0,0
24802,6,0,0
24803,MeV,0,0
24804,photon-beam,0,0
24805,energy,0,0
24806,.,0,0
24807,In,0,0
24808,general,0,0
24809,",",0,0
24810,the,0,0
24811,patients,0,1
24812,were,0,0
24813,eligible,0,1
24814,",",0,0
24815,documentation,0,0
24816,of,0,0
24817,clinical,0,0
24818,data,0,0
24819,was,0,0
24820,fair,0,0
24821,to,0,0
24822,good,0,0
24823,and,0,0
24824,there,0,0
24825,were,0,0
24826,no,0,0
24827,systematic,0,0
24828,major,0,0
24829,protocol,0,0
24830,deviations,0,0
24831,.,0,0
24832,The,0,0
24833,actual,0,0
24834,total,0,1
24835,dose,0,0
24836,was,0,0
24837,44.7+/-a,0,0
24838,standard,0,0
24839,deviation,0,0
24840,(,0,0
24841,S.D,0,0
24842,.,0,0
24843,),0,0
24844,of,0,0
24845,4.6,0,0
24846,Gy,0,0
24847,.,0,0
24848,Some,0,0
24849,variation,0,0
24850,was,0,0
24851,found,0,0
24852,in,0,0
24853,the,0,0
24854,fraction,0,0
24855,size,0,0
24856,.,0,0
24857,All,0,0
24858,institutions,0,0
24859,complied,0,0
24860,with,0,1
24861,the,0,0
24862,protocol,0,0
24863,in,0,0
24864,specifying,0,0
24865,the,0,0
24866,reference,0,0
24867,dose,0,0
24868,at,0,0
24869,the,0,0
24870,ICRU,0,0
24871,point,0,0
24872,.,0,0
24873,The,0,0
24874,clinical,0,0
24875,target,0,0
24876,volume,0,0
24877,(,0,0
24878,CTV,0,0
24879,),0,0
24880,drawn,0,0
24881,on,0,0
24882,the,0,0
24883,CT,0,0
24884,scan,0,0
24885,was,0,0
24886,narrow,0,0
24887,in,0,0
24888,7,0,0
24889,(,0,0
24890,12,0,0
24891,%,0,0
24892,),0,0
24893,cases,0,0
24894,",",0,0
24895,but,0,0
24896,eventually,0,0
24897,the,0,0
24898,actually,0,0
24899,treated,0,0
24900,volumes,0,0
24901,in,0,0
24902,terms,0,0
24903,of,0,0
24904,planned,0,0
24905,treatment,0,0
24906,volume,0,0
24907,(,0,0
24908,PTV,0,0
24909,),0,0
24910,were,0,0
24911,correct,0,0
24912,.,0,0
24913,In,0,0
24914,two,0,0
24915,institutions,0,1
24916,",",0,0
24917,although,0,0
24918,the,0,0
24919,CTV,0,0
24920,was,0,0
24921,drawn,0,0
24922,correctly,0,0
24923,",",0,0
24924,the,0,0
24925,fields,0,0
24926,appeared,0,0
24927,to,0,0
24928,be,0,0
24929,narrow,0,0
24930,especially,0,0
24931,in,0,0
24932,cranio-caudal,0,0
24933,direction,0,0
24934,.,0,0
24935,Variations,0,0
24936,in,0,0
24937,treated,0,1
24938,volumes,0,0
24939,and,0,0
24940,total,0,1
24941,radiation,0,0
24942,dose,0,0
24943,were,0,0
24944,encountered,0,0
24945,in,0,0
24946,the,0,0
24947,individual,0,0
24948,case,0,0
24949,review,0,0
24950,.,0,0
24951,By,0,0
24952,providing,0,0
24953,recommendations,0,0
24954,early,0,1
24955,during,0,0
24956,the,0,0
24957,course,0,0
24958,of,0,0
24959,the,0,0
24960,trial,0,0
24961,",",0,0
24962,we,0,0
24963,expect,0,0
24964,to,0,0
24965,improve,0,0
24966,the,0,0
24967,inter-institutional,0,0
24968,consistency,0,0
24969,and,0,0
24970,to,0,0
24971,promote,0,0
24972,a,0,0
24973,high,0,0
24974,quality,0,0
24975,treatment,0,0
24976,in,0,0
24977,all,0,0
24978,of,0,0
24979,the,0,0
24980,participating,0,1
24981,institutions,0,0
24982,.,0,1
24983,14,0,0
24984,day,0,0
24985,endoscopy,0,1
24986,study,0,0
24987,comparing,0,0
24988,risedronate,0,0
24989,and,0,0
24990,alendronate,0,0
24991,in,0,0
24992,postmenopausal,1,1
24993,women,1,1
24994,stratified,1,1
24995,by,1,0
24996,Helicobacter,1,1
24997,pylori,1,1
24998,status,1,0
24999,.,1,1
25000,OBJECTIVE,0,0
25001,Bisphosphonates,0,0
25002,are,0,0
25003,effective,0,0
25004,treatment,0,0
25005,for,0,0
25006,osteoporosis,0,1
25007,but,0,0
25008,have,0,0
25009,been,0,0
25010,associated,0,0
25011,with,0,0
25012,gastrointestinal,0,1
25013,(,0,0
25014,GI,0,1
25015,),0,0
25016,mucosal,0,0
25017,injury,0,0
25018,.,0,0
25019,This,0,0
25020,study,0,0
25021,compared,0,0
25022,the,0,0
25023,incidence,0,0
25024,of,0,0
25025,gastric,0,1
25026,ulcers,0,1
25027,after,0,0
25028,treatment,0,0
25029,with,0,0
25030,risedronate,0,0
25031,",",0,0
25032,a,0,0
25033,pyridinyl,0,0
25034,bisphosphonate,0,0
25035,",",0,0
25036,or,0,0
25037,alendronate,0,0
25038,",",0,0
25039,a,0,0
25040,primary,0,0
25041,amino,0,0
25042,bisphosphonate,0,0
25043,",",0,0
25044,in,0,0
25045,healthy,1,1
25046,postmenopausal,1,1
25047,women,1,1
25048,stratified,1,1
25049,by,1,0
25050,Helicobacter,1,1
25051,pylori,1,1
25052,status,1,0
25053,.,1,1
25054,METHODS,0,0
25055,Subjects,0,1
25056,were,0,1
25057,randomized,0,1
25058,to,0,0
25059,receive,0,0
25060,risedronate,0,0
25061,5,0,0
25062,mg,0,0
25063,(,0,0
25064,n,0,1
25065,=,0,0
25066,318,0,1
25067,),0,0
25068,or,0,0
25069,alendronate,0,0
25070,10,0,0
25071,mg,0,0
25072,(,0,0
25073,n,0,1
25074,=,0,0
25075,317,0,1
25076,),0,0
25077,daily,0,0
25078,for,0,0
25079,14,0,0
25080,days,0,0
25081,.,0,1
25082,Endoscopy,0,0
25083,and,0,0
25084,evaluator-blind,0,0
25085,assessments,0,0
25086,of,0,0
25087,the,0,0
25088,esophageal,0,1
25089,",",0,0
25090,gastric,0,0
25091,",",0,0
25092,and,0,0
25093,duodenal,0,1
25094,mucosa,0,1
25095,were,0,0
25096,performed,0,0
25097,at,0,0
25098,baseline,0,0
25099,and,0,0
25100,on,0,0
25101,Days,0,0
25102,8,0,0
25103,and,0,0
25104,15,0,0
25105,.,0,0
25106,RESULTS,0,0
25107,Overall,0,0
25108,",",0,0
25109,gastric,0,1
25110,ulcers,0,0
25111,>,0,1
25112,or,0,0
25113,=,0,0
25114,3,0,0
25115,mm,0,0
25116,were,0,0
25117,observed,0,0
25118,in,0,0
25119,18,0,1
25120,(,0,0
25121,6.0,0,0
25122,%,0,0
25123,),0,0
25124,of,0,0
25125,300,0,0
25126,evaluable,0,1
25127,subjects,0,1
25128,in,0,0
25129,the,0,0
25130,risedronate,0,0
25131,group,0,0
25132,and,0,0
25133,36,0,0
25134,(,0,0
25135,12.1,0,0
25136,%,0,0
25137,),0,0
25138,of,0,0
25139,297,0,1
25140,in,0,0
25141,the,0,0
25142,alendronate,0,0
25143,group,0,0
25144,during,0,0
25145,treatment,0,0
25146,(,0,0
25147,p,0,0
25148,=,0,0
25149,0.013,0,0
25150,),0,0
25151,.,0,0
25152,On,0,0
25153,Day,0,0
25154,8,0,0
25155,",",0,0
25156,the,0,0
25157,incidences,0,0
25158,of,0,0
25159,gastric,0,1
25160,ulcers,0,1
25161,in,0,0
25162,the,0,0
25163,risedronate,0,0
25164,and,0,0
25165,alendronate,0,0
25166,groups,0,0
25167,were,0,0
25168,3.6,0,0
25169,%,0,0
25170,and,0,0
25171,6.6,0,0
25172,%,0,0
25173,",",0,0
25174,respectively,0,0
25175,(,0,0
25176,p,0,0
25177,=,0,0
25178,0.133,0,0
25179,),0,0
25180,",",0,0
25181,and,0,0
25182,on,0,0
25183,Day,0,0
25184,15,0,0
25185,",",0,0
25186,they,0,0
25187,were,0,0
25188,3.3,0,0
25189,%,0,0
25190,and,0,0
25191,8.7,0,0
25192,%,0,0
25193,(,0,0
25194,p,0,0
25195,=,0,0
25196,0.008,0,0
25197,),0,0
25198,.,0,0
25199,The,0,0
25200,incidence,0,0
25201,of,0,0
25202,gastric,0,1
25203,ulcers,0,1
25204,was,0,0
25205,not,0,0
25206,affected,0,0
25207,by,0,0
25208,H.,0,0
25209,pylori,0,1
25210,status,0,0
25211,.,0,0
25212,Mean,0,0
25213,gastric,0,0
25214,endoscopy,0,1
25215,scores,0,0
25216,at,0,0
25217,Days,0,0
25218,8,0,0
25219,and,0,0
25220,15,0,0
25221,were,0,0
25222,significantly,0,0
25223,lower,0,0
25224,in,0,0
25225,the,0,0
25226,risedronate,0,0
25227,group,0,0
25228,than,0,0
25229,in,0,0
25230,the,0,0
25231,alendronate,0,0
25232,group,0,0
25233,(,0,0
25234,p,0,0
25235,<,0,0
25236,0.001,0,0
25237,),0,0
25238,.,0,0
25239,Mean,0,0
25240,esophageal,0,1
25241,and,0,0
25242,duodenal,0,1
25243,endoscopy,0,1
25244,scores,0,0
25245,were,0,0
25246,similar,0,0
25247,in,0,0
25248,the,0,0
25249,2,0,0
25250,groups,0,0
25251,at,0,0
25252,Days,0,0
25253,8,0,0
25254,and,0,0
25255,15,0,0
25256,.,0,0
25257,When,0,0
25258,the,0,0
25259,treatment,0,0
25260,groups,0,0
25261,were,0,0
25262,combined,0,0
25263,",",0,0
25264,gastric,0,0
25265,endoscopy,0,1
25266,scores,0,0
25267,were,0,0
25268,significantly,0,0
25269,higher,0,0
25270,among,0,0
25271,H.,0,0
25272,pylori,0,1
25273,negative,0,0
25274,than,0,0
25275,H.,0,1
25276,pylori,0,1
25277,positive,0,0
25278,subjects,0,1
25279,at,0,0
25280,Days,0,0
25281,8,0,0
25282,and,0,0
25283,15,0,0
25284,(,0,0
25285,p,0,0
25286,<,0,0
25287,0.05,0,0
25288,),0,0
25289,.,0,0
25290,Upper,0,0
25291,GI,0,1
25292,adverse,0,0
25293,events,0,0
25294,were,0,0
25295,reported,0,0
25296,by,0,0
25297,18,0,1
25298,(,0,0
25299,5.7,0,0
25300,%,0,0
25301,),0,0
25302,subjects,0,1
25303,in,0,0
25304,the,0,0
25305,risedronate,0,0
25306,group,0,0
25307,(,0,0
25308,19,0,1
25309,events,0,0
25310,),0,0
25311,and,0,0
25312,28,0,0
25313,(,0,0
25314,8.8,0,0
25315,%,0,0
25316,),0,0
25317,subjects,0,1
25318,in,0,0
25319,the,0,0
25320,alendronate,0,0
25321,group,0,0
25322,(,0,0
25323,32,0,1
25324,events,0,0
25325,),0,1
25326,.,0,1
25327,Symptoms,0,0
25328,did,0,0
25329,not,0,0
25330,predict,0,0
25331,the,0,0
25332,presence,0,0
25333,of,0,0
25334,mucosal,0,0
25335,damage,0,0
25336,.,0,0
25337,CONCLUSION,0,0
25338,Risedronate,0,0
25339,was,0,0
25340,associated,0,0
25341,with,0,0
25342,a,0,0
25343,significantly,0,0
25344,lower,0,0
25345,incidence,0,0
25346,of,0,0
25347,gastric,0,1
25348,ulcers,0,1
25349,than,0,0
25350,alendronate,0,0
25351,.,0,0
25352,H.,0,0
25353,pylori,0,0
25354,infection,0,0
25355,did,0,0
25356,not,0,0
25357,increase,0,0
25358,the,0,0
25359,incidence,0,0
25360,of,0,0
25361,bisphosphonate,0,0
25362,related,0,0
25363,gastric,0,1
25364,ulcers,0,1
25365,.,0,1
25366,The,0,0
25367,findings,0,0
25368,from,0,0
25369,this,0,0
25370,14,0,0
25371,day,0,0
25372,study,0,0
25373,in,0,0
25374,healthy,0,1
25375,volunteers,0,1
25376,support,0,0
25377,the,0,0
25378,hypothesis,0,0
25379,that,0,0
25380,bisphosphonates,0,0
25381,may,0,0
25382,differ,0,0
25383,from,0,0
25384,one,0,0
25385,another,0,0
25386,in,0,0
25387,their,0,0
25388,potential,0,0
25389,to,0,0
25390,produce,0,0
25391,upper,0,0
25392,GI,0,0
25393,mucosal,0,0
25394,damage,0,0
25395,.,0,0
25396,Boosting,0,0
25397,uptake,0,0
25398,of,0,0
25399,influenza,0,1
25400,immunisation,0,0
25401,:,0,1
25402,a,0,0
25403,randomised,0,0
25404,controlled,0,0
25405,trial,0,0
25406,of,0,0
25407,telephone,0,0
25408,appointing,0,0
25409,in,0,0
25410,general,0,1
25411,practice,0,0
25412,.,0,0
25413,BACKGROUND,0,0
25414,Immunisation,0,0
25415,against,0,0
25416,influenza,0,0
25417,is,0,0
25418,an,0,0
25419,effective,0,0
25420,intervention,0,0
25421,that,0,0
25422,reduces,0,0
25423,serologically,0,0
25424,confirmed,0,0
25425,cases,0,0
25426,by,0,0
25427,between,0,0
25428,60,0,1
25429,%,0,0
25430,and,0,0
25431,70,0,1
25432,%,0,0
25433,.,0,0
25434,Almost,0,0
25435,all,0,0
25436,influenza,0,0
25437,immunisation,0,0
25438,in,0,0
25439,the,0,0
25440,UK,1,1
25441,is,0,0
25442,done,0,0
25443,within,0,0
25444,general,0,1
25445,practice,0,0
25446,.,0,0
25447,Current,0,0
25448,evidence,0,0
25449,on,0,0
25450,the,0,0
25451,effectiveness,0,0
25452,of,0,0
25453,patient,0,0
25454,reminders,0,0
25455,for,0,0
25456,all,0,0
25457,types,0,0
25458,of,0,0
25459,immunisation,0,0
25460,programmes,0,0
25461,is,0,0
25462,largely,0,0
25463,based,0,0
25464,on,0,0
25465,North,0,1
25466,American,0,1
25467,studies,0,0
25468,.,0,1
25469,AIM,0,0
25470,To,0,0
25471,determine,0,0
25472,whether,0,0
25473,telephone,0,0
25474,appointments,0,0
25475,offered,0,0
25476,bygeneral,0,1
25477,practice,0,0
25478,receptionists,0,0
25479,increase,0,0
25480,the,0,0
25481,uptake,0,0
25482,of,0,0
25483,irfluenza,0,1
25484,immunisation,0,0
25485,among,0,0
25486,the,0,0
25487,registered,1,0
25488,population,1,1
25489,aged,1,1
25490,over,1,0
25491,65,1,1
25492,years,1,1
25493,in,1,0
25494,east,1,1
25495,London,1,1
25496,practices,1,1
25497,.,1,1
25498,DESIGN,0,0
25499,OF,0,0
25500,STUDY,0,0
25501,Randomised,0,0
25502,controlled,0,0
25503,trial,0,0
25504,.,0,0
25505,SETTING,0,0
25506,Three,0,0
25507,research,0,0
25508,general,0,1
25509,practices,0,0
25510,within,0,0
25511,the,0,0
25512,East,1,0
25513,London,1,1
25514,and,1,0
25515,Essex,1,1
25516,network,1,0
25517,of,1,0
25518,researchers,1,0
25519,(,1,0
25520,ELENoR,1,0
25521,),1,0
25522,.,1,0
25523,METHOD,0,0
25524,Participants,1,1
25525,were,1,1
25526,"1,820",1,1
25527,low-risk,1,1
25528,patients,1,1
25529,aged,1,1
25530,65,1,1
25531,to,1,0
25532,74,1,1
25533,years,1,1
25534,who,1,1
25535,had,1,1
25536,not,1,1
25537,previously,1,0
25538,been,1,0
25539,in,1,0
25540,a,1,0
25541,recall,1,0
25542,system,1,0
25543,for,1,0
25544,influenza,1,1
25545,immunisation,1,0
25546,at,1,0
25547,their,1,0
25548,general,1,1
25549,practice,1,0
25550,.,1,0
25551,The,0,0
25552,intervention,0,0
25553,",",0,0
25554,during,0,0
25555,October,0,1
25556,2000,0,1
25557,",",0,0
25558,was,0,0
25559,a,0,0
25560,telephone,0,0
25561,call,0,0
25562,from,0,0
25563,the,0,0
25564,practice,0,0
25565,receptionist,0,0
25566,to,0,0
25567,intervention,0,0
25568,group,0,0
25569,households,0,0
25570,",",0,0
25571,offering,0,0
25572,an,0,0
25573,appointment,0,0
25574,for,0,0
25575,influenza,0,1
25576,immunisation,0,0
25577,at,0,0
25578,a,0,0
25579,nurse-run,0,0
25580,.,0,0
25581,clinic,0,0
25582,Main,0,0
25583,outcome,0,0
25584,measures,0,0
25585,were,0,0
25586,the,0,0
25587,numbers,0,0
25588,of,0,0
25589,individuals,0,1
25590,in,0,0
25591,each,0,0
25592,group,0,0
25593,receiving,0,0
25594,immunisation,0,0
25595,",",0,0
25596,and,0,0
25597,practice,0,0
25598,costs,0,0
25599,of,0,0
25600,a,0,0
25601,telephone-appointing,0,0
25602,programme,0,0
25603,.,0,0
25604,RESULTS,0,0
25605,intention,0,0
25606,to,0,0
25607,treat,0,0
25608,analysis,0,0
25609,showed,0,0
25610,an,0,0
25611,immunisation,0,0
25612,rate,0,0
25613,in,0,0
25614,the,0,0
25615,control,0,0
25616,group,0,0
25617,of,0,0
25618,44,0,0
25619,%,0,0
25620,",",0,0
25621,compared,0,0
25622,with,0,0
25623,50,0,0
25624,%,0,0
25625,in,0,0
25626,the,0,0
25627,intervention,0,0
25628,group,0,0
25629,(,0,0
25630,odds,0,0
25631,ratio,0,0
25632,=,0,0
25633,1.29,0,0
25634,",",0,0
25635,95,0,0
25636,%,0,0
25637,confidence,0,0
25638,interval,0,0
25639,=,0,0
25640,1.03,0,0
25641,to,0,0
25642,1.63,0,0
25643,),0,0
25644,.,0,0
25645,Of,0,0
25646,the,0,0
25647,patients,1,1
25648,making,1,0
25649,a,1,0
25650,telephone,1,0
25651,appointment,1,0
25652,",",0,0
25653,88,0,0
25654,%,0,0
25655,recieved,0,0
25656,immunisation,0,0
25657,",",0,0
25658,while,0,0
25659,22,0,0
25660,%,0,0
25661,of,0,0
25662,those,0,0
25663,not,0,0
25664,wanting,0,0
25665,an,0,0
25666,appointment,0,0
25667,went,0,0
25668,on,0,0
25669,to,0,0
25670,be,0,0
25671,immunised,0,0
25672,.,0,0
25673,In,0,0
25674,the,0,0
25675,controlgroup,0,0
25676,",",0,0
25677,income,0,0
25678,generated,0,0
25679,was,0,0
25680,11.35,0,0
25681,pounds,0,0
25682,per,0,0
25683,immunisation,0,0
25684,",",0,0
25685,for,0,0
25686,each,0,0
25687,additional,0,0
25688,immunisation,0,0
25689,in,0,0
25690,the,0,0
25691,intervention,0,0
25692,group,0,0
25693,the,0,0
25694,income,0,0
25695,was,0,0
25696,5.20,0,0
25697,pounds,0,0
25698,.,0,1
25699,The,0,0
25700,'number,0,0
25701,needed,0,0
25702,to,0,0
25703,telephone,0,0
25704,',0,0
25705,was,0,0
25706,17,0,0
25707,.,0,1
25708,CONCLUSION,0,0
25709,Uptake,0,0
25710,of,0,0
25711,influenza,0,1
25712,immunisation,0,0
25713,among,0,0
25714,the,0,0
25715,low-risk,1,0
25716,older,1,1
25717,population,1,1
25718,in,1,0
25719,inner-city,1,1
25720,areas,1,0
25721,can,0,0
25722,be,0,0
25723,boosted,0,0
25724,by,0,0
25725,around,0,0
25726,6,0,0
25727,%,0,0
25728,using,0,0
25729,a,0,0
25730,simple,0,0
25731,intervention,0,0
25732,by,0,0
25733,receptionists,0,0
25734,.,0,1
25735,Immunisation,0,0
25736,rates,0,0
25737,in,0,0
25738,this,0,0
25739,low-risk,0,0
25740,group,0,0
25741,fell,0,0
25742,well,0,0
25743,short,0,0
25744,of,0,0
25745,the,0,0
25746,60,0,0
25747,%,0,0
25748,government,0,1
25749,target,0,0
25750,.,0,0
25751,Improving,0,0
25752,immunisation,0,0
25753,rates,0,0
25754,will,0,0
25755,require,0,0
25756,a,0,0
25757,sustained,0,0
25758,public,0,1
25759,health,0,1
25760,campaign,0,0
25761,.,0,0
25762,Retaining,0,0
25763,the,0,0
25764,item-of-service,0,0
25765,payments,0,0
25766,to,0,0
25767,practices,0,0
25768,should,0,0
25769,support,0,0
25770,costs,0,0
25771,of,0,0
25772,practice-based,0,1
25773,interventions,0,0
25774,.,0,1
25775,Hysteroscopic,0,1
25776,transcervical,0,1
25777,endometrial,0,1
25778,resection,0,1
25779,versus,0,0
25780,thermal,0,0
25781,destruction,0,0
25782,for,0,0
25783,menorrhagia,0,1
25784,:,0,1
25785,a,0,0
25786,prospective,0,0
25787,randomized,0,0
25788,trial,0,0
25789,on,0,0
25790,satisfaction,0,0
25791,rate,0,0
25792,.,0,0
25793,OBJECTIVE,0,0
25794,The,0,0
25795,purpose,0,0
25796,of,0,0
25797,this,0,0
25798,study,0,0
25799,was,0,0
25800,to,0,0
25801,compare,0,0
25802,the,0,0
25803,satisfaction,0,0
25804,rate,0,0
25805,and,0,0
25806,the,0,0
25807,effectiveness,0,0
25808,of,0,0
25809,transcervical,0,1
25810,hysteroscopic,0,1
25811,endometrial,0,1
25812,resection,0,1
25813,and,0,0
25814,thermal,0,0
25815,destruction,0,0
25816,of,0,0
25817,the,0,0
25818,endometrium,0,0
25819,in,0,0
25820,the,0,0
25821,treatment,0,0
25822,of,0,0
25823,menorrhagia,1,1
25824,.,1,0
25825,STUDY,0,0
25826,DESIGN,0,0
25827,A,0,0
25828,prospective,0,0
25829,randomized,0,0
25830,trial,0,0
25831,with,0,1
25832,2,0,0
25833,years,0,1
25834,of,0,0
25835,follow-up,0,0
25836,was,0,0
25837,carried,0,0
25838,out,0,0
25839,in,0,0
25840,the,0,0
25841,Department,1,1
25842,of,1,0
25843,Gynecology,1,1
25844,of,1,0
25845,the,1,0
25846,University,1,1
25847,of,1,0
25848,Naples,1,0
25849,.,1,1
25850,Eighty-two,1,1
25851,patients,1,1
25852,who,1,1
25853,were,1,1
25854,affected,1,0
25855,by,1,0
25856,menorrhagia,1,1
25857,that,1,0
25858,was,1,0
25859,unresponsive,1,0
25860,to,1,0
25861,medical,1,1
25862,treatment,1,0
25863,were,0,0
25864,respectively,0,0
25865,randomized,0,0
25866,to,0,0
25867,transcervical,0,1
25868,hysteroscopic,0,1
25869,endometrial,0,1
25870,resection,0,0
25871,or,0,0
25872,to,0,0
25873,thermal,0,0
25874,destruction,0,0
25875,of,0,0
25876,the,0,0
25877,endometrium,0,0
25878,.,0,0
25879,Satisfaction,0,0
25880,rate,0,0
25881,",",0,0
25882,operative,0,0
25883,time,0,0
25884,",",0,0
25885,discharge,0,0
25886,time,0,0
25887,",",0,0
25888,complication,0,0
25889,rate,0,0
25890,",",0,0
25891,reintervention,0,0
25892,rate,0,0
25893,",",0,0
25894,and,0,0
25895,resumption,0,0
25896,of,0,0
25897,normal,0,1
25898,activity,0,0
25899,were,0,0
25900,evaluated,0,0
25901,in,0,0
25902,each,0,0
25903,group,0,0
25904,.,0,0
25905,RESULTS,0,0
25906,The,0,0
25907,satisfaction,0,0
25908,rate,0,0
25909,was,0,0
25910,significantly,0,0
25911,higher,0,0
25912,in,0,0
25913,the,0,0
25914,thermal,0,0
25915,destruction,0,0
25916,group,0,0
25917,.,0,0
25918,Operative,0,0
25919,time,0,0
25920,was,0,0
25921,significantly,0,0
25922,shorter,0,0
25923,in,0,0
25924,the,0,0
25925,thermal,0,0
25926,destruction,0,0
25927,group,0,0
25928,(,0,0
25929,24,0,0
25930,+/-,0,0
25931,4,0,0
25932,minutes,0,0
25933,vs,0,0
25934,37,0,1
25935,+/-,0,0
25936,6,0,0
25937,minutes,0,0
25938,),0,1
25939,.,0,0
25940,Intraoperative,0,0
25941,blood,0,0
25942,loss,0,0
25943,was,0,0
25944,significantly,0,0
25945,lower,0,0
25946,in,0,0
25947,the,0,0
25948,thermal,0,0
25949,destruction,0,0
25950,group,0,0
25951,(,0,0
25952,7.2,0,0
25953,+/-,0,0
25954,2.8,0,0
25955,mL,0,0
25956,vs,0,0
25957,89,0,1
25958,+/-,0,0
25959,38,0,1
25960,mL,0,0
25961,),0,0
25962,.,0,0
25963,Reintervention,0,0
25964,rates,0,0
25965,were,0,0
25966,higher,0,0
25967,in,0,0
25968,the,0,0
25969,transcervical,0,1
25970,hysteroscopic,0,1
25971,endometrial,0,1
25972,resection,0,0
25973,group,0,0
25974,",",0,0
25975,although,0,0
25976,postoperative,0,0
25977,pain,0,0
25978,was,0,0
25979,not,0,0
25980,significantly,0,0
25981,different,0,0
25982,between,0,0
25983,the,0,0
25984,two,0,0
25985,groups,0,0
25986,.,0,1
25987,Discharge,0,0
25988,time,0,0
25989,",",0,0
25990,complication,0,0
25991,rate,0,0
25992,",",0,0
25993,and,0,0
25994,resumption,0,0
25995,of,0,0
25996,normal,0,1
25997,activity,0,0
25998,were,0,0
25999,not,0,0
26000,significantly,0,0
26001,different,0,0
26002,between,0,0
26003,the,0,0
26004,two,0,0
26005,groups,0,0
26006,.,0,1
26007,CONCLUSION,0,0
26008,Thermal,0,0
26009,destruction,0,0
26010,of,0,0
26011,the,0,0
26012,endometrium,0,0
26013,for,0,0
26014,the,0,0
26015,treatment,0,0
26016,of,0,0
26017,menorrhagia,1,0
26018,should,0,0
26019,be,0,0
26020,considered,0,0
26021,an,0,0
26022,effective,0,0
26023,therapeutic,0,0
26024,option,0,0
26025,because,0,0
26026,of,0,0
26027,its,0,0
26028,acceptability,0,0
26029,among,0,0
26030,patients,0,1
26031,",",0,0
26032,shorter,0,0
26033,operative,0,0
26034,time,0,0
26035,",",0,0
26036,and,0,0
26037,lower,0,0
26038,blood,0,0
26039,loss,0,0
26040,.,0,0
26041,Combination,0,0
26042,of,0,0
26043,sotalol,0,0
26044,and,0,0
26045,magnesium,0,0
26046,prevents,0,0
26047,atrial,1,1
26048,fibrillation,1,1
26049,after,1,0
26050,coronary,1,1
26051,artery,1,1
26052,bypass,1,1
26053,grafting,1,1
26054,.,0,0
26055,BACKGROUND,0,0
26056,Atrial,0,0
26057,fibrillation,0,1
26058,(,0,0
26059,AF,0,0
26060,),0,0
26061,is,0,0
26062,a,0,0
26063,common,0,0
26064,complication,0,0
26065,reported,0,0
26066,in,0,0
26067,20,0,0
26068,%,0,0
26069,to,0,0
26070,40,0,0
26071,%,0,0
26072,of,0,0
26073,patients,1,1
26074,after,1,0
26075,coronary,1,1
26076,operations,1,1
26077,.,1,1
26078,Sotalol,0,0
26079,alone,0,0
26080,and,0,0
26081,magnesium,0,0
26082,alone,0,0
26083,have,0,0
26084,been,0,0
26085,shown,0,0
26086,to,0,0
26087,partially,0,0
26088,decrease,0,0
26089,the,0,0
26090,incidence,0,0
26091,of,0,0
26092,AF,0,0
26093,.,0,0
26094,The,0,0
26095,goal,0,0
26096,of,0,0
26097,this,0,0
26098,study,0,0
26099,was,0,0
26100,to,0,0
26101,evaluate,0,0
26102,the,0,0
26103,efficacy,0,0
26104,of,0,0
26105,these,0,0
26106,two,0,0
26107,pharmacological,0,0
26108,agents,0,0
26109,",",0,0
26110,used,0,0
26111,alone,0,0
26112,or,0,0
26113,in,0,0
26114,combination,0,0
26115,",",0,0
26116,to,0,0
26117,reduce,0,0
26118,postoperative,0,0
26119,AF,0,0
26120,.,0,1
26121,METHODS,0,0
26122,Two,1,1
26123,hundred,1,1
26124,seven,1,1
26125,consecutive,1,1
26126,coronary,1,1
26127,artery,1,1
26128,bypass,1,1
26129,patients,1,1
26130,(,1,0
26131,mean,1,1
26132,age,1,1
26133,62,1,1
26134,+/-,1,0
26135,11,1,1
26136,years,1,1
26137,),1,0
26138,were,0,0
26139,randomized,0,0
26140,to,0,0
26141,receive,0,0
26142,sotalol,0,0
26143,alone,0,0
26144,(,0,0
26145,80,0,0
26146,mg,0,0
26147,twice,0,0
26148,daily,0,0
26149,for,0,0
26150,5,0,0
26151,days,0,0
26152,starting,0,0
26153,from,0,0
26154,the,0,0
26155,morning,0,0
26156,of,0,0
26157,the,0,0
26158,first,0,0
26159,postoperative,0,0
26160,day,0,0
26161,),0,0
26162,(,0,0
26163,group,0,0
26164,S,0,0
26165,),0,0
26166,",",0,0
26167,magnesium,0,0
26168,alone,0,0
26169,(,0,0
26170,1.5,0,0
26171,g,0,0
26172,daily,0,0
26173,for,0,0
26174,6,0,0
26175,days,0,0
26176,starting,0,0
26177,in,0,0
26178,the,0,0
26179,operating,0,0
26180,room,0,0
26181,just,0,0
26182,before,0,0
26183,cardiopulmonary,0,0
26184,bypass,0,1
26185,),0,0
26186,(,0,0
26187,group,0,0
26188,M,0,0
26189,),0,0
26190,",",0,0
26191,both,0,0
26192,pharmacologic,0,0
26193,agents,0,0
26194,at,0,0
26195,the,0,0
26196,same,0,0
26197,dosages,0,0
26198,(,0,0
26199,group,0,0
26200,S+M,0,0
26201,),0,0
26202,",",0,0
26203,or,0,0
26204,no,0,0
26205,antiarrhythmic,0,0
26206,agents,0,0
26207,(,0,0
26208,group,0,0
26209,CTR,0,0
26210,),0,0
26211,.,0,0
26212,All,1,0
26213,patients,1,1
26214,with,1,0
26215,an,1,0
26216,ejection,1,0
26217,fraction,1,0
26218,less,1,0
26219,than,1,0
26220,0.40,1,0
26221,were,1,0
26222,excluded,1,0
26223,.,1,0
26224,RESULTS,0,0
26225,The,0,0
26226,incidence,0,0
26227,of,0,0
26228,postoperative,0,0
26229,AF,0,1
26230,was,0,0
26231,11.8,0,0
26232,%,0,0
26233,(,0,0
26234,6/51,0,0
26235,),0,0
26236,in,0,0
26237,the,0,0
26238,S,0,0
26239,group,0,0
26240,",",0,0
26241,14.8,0,0
26242,%,0,0
26243,(,0,0
26244,8/54,0,0
26245,),0,0
26246,in,0,0
26247,the,0,0
26248,M,0,0
26249,group,0,0
26250,",",0,0
26251,1.9,0,0
26252,%,0,0
26253,(,0,0
26254,1/52,0,0
26255,),0,0
26256,in,0,0
26257,the,0,0
26258,S+M,0,0
26259,group,0,0
26260,",",0,0
26261,and,0,0
26262,38,0,0
26263,%,0,0
26264,(,0,0
26265,19/50,0,0
26266,),0,0
26267,in,0,0
26268,the,0,0
26269,CTR,0,0
26270,group,0,0
26271,.,0,0
26272,The,0,0
26273,following,0,0
26274,differences,0,0
26275,were,0,1
26276,significant,0,0
26277,:,0,1
26278,group,0,0
26279,CTR,0,0
26280,versus,0,0
26281,groups,0,0
26282,S,0,0
26283,",",0,0
26284,M,0,0
26285,",",0,0
26286,and,0,0
26287,S+M,0,0
26288,with,0,1
26289,values,0,0
26290,of,0,0
26291,p,0,0
26292,=,0,0
26293,0.002,0,0
26294,",",0,0
26295,p,0,0
26296,=,0,0
26297,0.007,0,0
26298,and,0,0
26299,p,0,0
26300,<,0,0
26301,0.0001,0,0
26302,",",0,0
26303,respectively,0,0
26304,;,0,0
26305,and,0,0
26306,group,0,0
26307,S+M,0,0
26308,versus,0,0
26309,groups,0,0
26310,S,0,0
26311,and,0,0
26312,M,0,0
26313,with,0,1
26314,p,0,0
26315,=,0,0
26316,0.04,0,0
26317,and,0,0
26318,p,0,0
26319,=,0,0
26320,0.01,0,0
26321,",",0,0
26322,respectively,0,0
26323,.,0,0
26324,CONCLUSIONS,0,0
26325,Incidence,0,0
26326,of,0,0
26327,AF,0,0
26328,after,0,0
26329,coronary,0,1
26330,operation,0,0
26331,was,0,0
26332,significantly,0,0
26333,reduced,0,0
26334,by,0,0
26335,the,0,0
26336,administration,0,0
26337,of,0,0
26338,sotalol,0,0
26339,alone,0,0
26340,and,0,0
26341,magnesium,0,0
26342,alone,0,0
26343,;,0,0
26344,more,0,0
26345,importantly,0,0
26346,",",0,0
26347,the,0,0
26348,incidence,0,0
26349,was,0,0
26350,further,0,0
26351,reduced,0,0
26352,by,0,0
26353,combining,0,0
26354,these,0,0
26355,agents,0,0
26356,.,0,0
26357,Stepwise,0,0
26358,hook,0,0
26359,extension,0,0
26360,technique,0,0
26361,for,0,0
26362,radiofrequency,0,0
26363,ablation,0,0
26364,therapy,0,0
26365,of,0,0
26366,hepatocellular,1,1
26367,carcinoma,1,1
26368,.,1,0
26369,OBJECTIVE,0,0
26370,Our,0,0
26371,study,0,0
26372,was,0,0
26373,designed,0,0
26374,to,0,0
26375,examine,0,0
26376,the,0,0
26377,efficacy,0,0
26378,of,0,0
26379,stepwise,0,0
26380,hook,0,0
26381,extension,0,0
26382,technique,0,0
26383,for,0,0
26384,radiofrequency,0,0
26385,ablation,0,0
26386,(,0,0
26387,RFA,0,0
26388,),0,0
26389,therapy,0,0
26390,of,0,0
26391,hepatocellular,1,1
26392,carcinoma,1,1
26393,in,0,0
26394,a,0,0
26395,randomized,0,0
26396,controlled,0,0
26397,study,0,0
26398,.,0,0
26399,METHOD,0,0
26400,Twenty,1,1
26401,patients,1,1
26402,with,1,1
26403,hepatocellular,1,1
26404,carcinoma,1,1
26405,measuring,1,0
26406,<,1,0
26407,25,1,0
26408,mm,1,0
26409,were,0,0
26410,divided,0,0
26411,randomly,0,1
26412,into,0,0
26413,two,0,0
26414,equal,0,1
26415,groups,0,0
26416,.,0,1
26417,RFA,0,0
26418,was,0,0
26419,applied,0,0
26420,using,0,0
26421,our,0,0
26422,new,0,0
26423,stepwise,0,0
26424,hook,0,0
26425,extension,0,0
26426,technique,0,0
26427,in,0,0
26428,patients,0,1
26429,of,0,0
26430,group,0,0
26431,1,0,0
26432,",",0,0
26433,and,0,0
26434,the,0,0
26435,full,0,0
26436,extension,0,0
26437,method,0,0
26438,in,0,0
26439,group,0,0
26440,2,0,0
26441,.,0,0
26442,The,0,0
26443,10-hook,0,0
26444,electrode,0,0
26445,of,0,0
26446,LeVeen,0,0
26447,needle,0,0
26448,was,0,0
26449,deployed,0,0
26450,in,0,0
26451,four,0,0
26452,steps,0,1
26453,to,0,0
26454,full,0,0
26455,extension,0,0
26456,during,0,0
26457,ablation,0,0
26458,in,0,0
26459,group,0,0
26460,1,0,0
26461,",",0,0
26462,and,0,0
26463,full,0,0
26464,extension,0,0
26465,at,0,0
26466,start,0,0
26467,of,0,0
26468,treatment,0,0
26469,in,0,0
26470,group,0,0
26471,2,0,0
26472,.,0,0
26473,RESULTS,0,0
26474,Roll-off,0,0
26475,was,0,0
26476,achieved,0,0
26477,in,0,0
26478,all,0,0
26479,10,0,0
26480,patients,0,1
26481,of,0,0
26482,group,0,0
26483,1,0,0
26484,",",0,0
26485,indicative,0,0
26486,of,0,0
26487,sufficient,0,0
26488,tumor,0,0
26489,coagulation,0,0
26490,",",0,0
26491,but,0,0
26492,only,0,0
26493,in,0,0
26494,3,0,0
26495,of,0,0
26496,10,0,1
26497,patients,0,1
26498,of,0,0
26499,group,0,1
26500,2,0,0
26501,.,0,0
26502,The,0,0
26503,median,0,0
26504,time,0,0
26505,to,0,0
26506,completion,0,0
26507,of,0,0
26508,treatment,0,0
26509,was,0,0
26510,6,0,0
26511,min,0,0
26512,and,0,0
26513,55,0,1
26514,s,0,0
26515,(,0,0
26516,range,0,0
26517,3,0,0
26518,min,0,0
26519,to,0,0
26520,14,0,0
26521,min,0,0
26522,and,0,0
26523,3,0,0
26524,s,0,0
26525,),0,0
26526,and,0,0
26527,15,0,0
26528,min,0,0
26529,(,0,0
26530,6-15,0,1
26531,min,0,0
26532,),0,0
26533,",",0,0
26534,respectively,0,0
26535,.,0,0
26536,The,0,0
26537,total,0,0
26538,power,0,0
26539,output,0,0
26540,used,0,0
26541,for,0,0
26542,RF,0,0
26543,was,0,0
26544,lower,0,0
26545,in,0,0
26546,group,0,0
26547,1,0,0
26548,than,0,0
26549,in,0,0
26550,group,0,0
26551,2,0,0
26552,(,0,0
26553,median,0,0
26554,271,0,1
26555,vs.,0,0
26556,"1,045",0,1
26557,W.m,0,1
26558,),0,0
26559,.,0,0
26560,The,0,0
26561,diameters,0,0
26562,of,0,0
26563,RFA-induced,0,0
26564,lesions,0,1
26565,were,0,0
26566,not,0,0
26567,significantly,0,0
26568,different,0,0
26569,between,0,0
26570,the,0,0
26571,groups,0,0
26572,(,0,0
26573,group,0,1
26574,1,0,0
26575,:,0,1
26576,27,0,0
26577,",",0,0
26578,range,0,0
26579,23-37,0,1
26580,mm,0,0
26581,;,0,0
26582,group,0,0
26583,2,0,0
26584,:,0,1
26585,23,0,1
26586,",",0,0
26587,0-42,0,0
26588,mm,0,0
26589,),0,0
26590,.,0,0
26591,CONCLUSIONS,0,0
26592,Application,0,0
26593,of,0,0
26594,RFA,0,0
26595,using,0,0
26596,stepwise,0,0
26597,hook,0,0
26598,extension,0,0
26599,technique,0,0
26600,is,0,0
26601,superior,0,0
26602,to,0,0
26603,the,0,0
26604,full,0,0
26605,extension,0,0
26606,method,0,0
26607,since,0,0
26608,it,0,0
26609,produces,0,0
26610,the,0,0
26611,same,0,0
26612,therapeutic,0,0
26613,effects,0,0
26614,within,0,0
26615,a,0,0
26616,short,0,0
26617,period,0,0
26618,using,0,0
26619,a,0,0
26620,lower,0,0
26621,energy,0,0
26622,.,0,0
26623,Laser,0,0
26624,treatment,0,0
26625,of,0,0
26626,childhood,0,1
26627,haemangioma,0,1
26628,:,0,0
26629,progress,0,0
26630,or,0,0
26631,not,0,0
26632,?,0,0
26633,Effect,0,0
26634,of,0,0
26635,mycophenolate,0,0
26636,mofetil,0,0
26637,on,0,0
26638,the,0,0
26639,prevention,0,0
26640,of,0,0
26641,acute,1,1
26642,renal,1,1
26643,allograft,1,1
26644,rejection,1,1
26645,.,1,0
26646,7-hexanoyltaxol-eluting,0,0
26647,stent,0,0
26648,for,0,0
26649,prevention,0,0
26650,of,0,0
26651,neointimal,0,1
26652,growth,0,0
26653,:,0,1
26654,an,0,0
26655,intravascular,0,0
26656,ultrasound,0,0
26657,analysis,0,0
26658,from,0,0
26659,the,0,0
26660,Study,0,0
26661,to,0,0
26662,COmpare,0,0
26663,REstenosis,0,1
26664,rate,0,0
26665,between,0,0
26666,QueST,0,1
26667,and,0,0
26668,QuaDS-QP2,0,0
26669,(,0,0
26670,SCORE,0,0
26671,),0,0
26672,.,0,0
26673,BACKGROUND,0,0
26674,Inhibition,0,0
26675,of,0,0
26676,neointimal,0,1
26677,tissue,0,0
26678,growth,0,0
26679,has,0,0
26680,been,0,0
26681,demonstrated,0,0
26682,in,0,0
26683,preliminary,0,0
26684,human,0,1
26685,feasibility,0,0
26686,studies,0,0
26687,with,0,1
26688,a,0,0
26689,stent-based,0,0
26690,polymer,0,0
26691,sleeve,0,0
26692,delivering,0,0
26693,7-hexanoyltaxol,0,0
26694,.,0,0
26695,The,0,0
26696,Study,0,0
26697,to,0,0
26698,COmpare,0,0
26699,REstenosis,0,1
26700,rate,0,0
26701,between,0,0
26702,QueST,0,1
26703,and,0,0
26704,QuaDS-QP2,0,0
26705,(,0,0
26706,SCORE,0,0
26707,),0,0
26708,trial,0,0
26709,is,0,0
26710,a,0,0
26711,human,1,0
26712,",",0,0
26713,randomized,0,0
26714,",",0,0
26715,multicenter,0,0
26716,trial,0,0
26717,comparing,0,0
26718,7-hexanoyltaxol,0,0
26719,(,0,0
26720,QP2,0,1
26721,),0,0
26722,-eluting,0,0
26723,stents,0,0
26724,(,0,0
26725,qDES,0,0
26726,),0,0
26727,with,0,0
26728,bare,0,0
26729,metal,0,0
26730,stents,0,0
26731,(,0,0
26732,BMS,0,0
26733,),0,0
26734,in,0,0
26735,the,0,0
26736,treatment,1,0
26737,of,1,0
26738,de,1,0
26739,novo,1,0
26740,coronary,1,1
26741,lesions,1,1
26742,.,1,0
26743,The,0,0
26744,purpose,0,0
26745,of,0,0
26746,this,0,0
26747,substudy,0,0
26748,was,0,0
26749,to,0,0
26750,evaluate,0,0
26751,the,0,0
26752,acute,0,0
26753,expansion,0,0
26754,property,0,0
26755,and,0,0
26756,long-term,0,0
26757,neointimal,0,1
26758,responses,0,0
26759,of,0,0
26760,qDES,0,0
26761,compared,0,0
26762,with,0,1
26763,BMS,0,0
26764,as,0,0
26765,assessed,0,0
26766,by,0,0
26767,intravascular,0,0
26768,ultrasound,0,0
26769,(,0,0
26770,IVUS,0,0
26771,),0,0
26772,.,0,0
26773,METHODS,0,0
26774,AND,0,0
26775,RESULTS,0,0
26776,A,1,0
26777,total,1,1
26778,of,1,0
26779,122,1,1
26780,(,1,0
26781,qDES,1,0
26782,66,1,0
26783,",",1,0
26784,BMS,1,0
26785,56,1,1
26786,),1,0
26787,patients,1,1
26788,were,0,0
26789,enrolled,0,1
26790,into,0,0
26791,the,0,0
26792,IVUS,0,0
26793,substudy,0,0
26794,.,0,0
26795,All,0,0
26796,IVUS,0,0
26797,images,0,0
26798,(,0,0
26799,immediately,0,0
26800,after,0,0
26801,the,0,0
26802,procedure,0,0
26803,and,0,0
26804,at,0,0
26805,6-month,0,0
26806,follow-up,0,0
26807,),0,0
26808,were,0,0
26809,analyzed,0,0
26810,at,0,0
26811,an,0,0
26812,independent,0,0
26813,core,0,0
26814,laboratory,0,0
26815,in,0,0
26816,a,0,0
26817,blind,0,0
26818,manner,0,0
26819,.,0,0
26820,At,0,0
26821,baseline,0,0
26822,",",0,0
26823,qDES,0,0
26824,achieved,0,0
26825,stent,0,0
26826,expansion,0,0
26827,similar,0,0
26828,to,0,0
26829,BMS,0,0
26830,.,0,0
26831,At,0,0
26832,follow-up,0,0
26833,",",0,0
26834,qDES,0,0
26835,showed,0,0
26836,reduced,0,0
26837,neointimal,0,1
26838,growth,0,0
26839,by,0,0
26840,70,0,1
26841,%,0,0
26842,at,0,0
26843,the,0,0
26844,tightest,0,0
26845,cross,0,0
26846,section,0,0
26847,and,0,0
26848,by,0,0
26849,68,0,0
26850,%,0,0
26851,over,0,0
26852,the,0,0
26853,stented,0,0
26854,segment,0,0
26855,(,0,0
26856,P,0,0
26857,<,0,0
26858,0.0001,0,0
26859,for,0,0
26860,both,0,0
26861,),0,0
26862,",",0,0
26863,resulting,0,0
26864,in,0,0
26865,a,0,0
26866,significantly,0,0
26867,larger,0,0
26868,lumen,0,0
26869,in,0,0
26870,qDES,0,0
26871,than,0,0
26872,in,0,0
26873,BMS,0,0
26874,.,0,0
26875,Unlike,0,0
26876,intracoronary,0,0
26877,brachytherapy,0,1
26878,",",0,0
26879,there,0,0
26880,was,0,0
26881,no,0,0
26882,evidence,0,0
26883,of,0,0
26884,negative,0,0
26885,edge,0,0
26886,effects,0,0
26887,",",0,0
26888,unhealed,0,0
26889,dissections,0,1
26890,",",0,0
26891,or,0,0
26892,late,0,0
26893,stent-vessel,0,0
26894,wall,0,0
26895,malapposition,0,0
26896,over,0,0
26897,the,0,0
26898,stented,0,0
26899,and,0,0
26900,adjacent,0,1
26901,references,0,0
26902,segments,0,0
26903,in,0,0
26904,either,0,0
26905,group,0,0
26906,.,0,0
26907,CONCLUSIONS,0,0
26908,Detailed,0,0
26909,IVUS,0,0
26910,analysis,0,0
26911,revealed,0,0
26912,that,0,0
26913,qDES,0,0
26914,had,0,0
26915,comparable,0,0
26916,acute,0,1
26917,mechanical,0,0
26918,and,0,0
26919,superior,0,0
26920,long-term,0,0
26921,biological,0,0
26922,effects,0,0
26923,to,0,1
26924,BMS,0,0
26925,.,0,0
26926,Although,0,0
26927,the,0,0
26928,long-term,0,0
26929,benefits,0,0
26930,and,0,0
26931,limitations,0,0
26932,of,0,0
26933,this,0,0
26934,technology,0,0
26935,require,0,0
26936,further,0,0
26937,investigation,0,0
26938,",",0,0
26939,the,0,0
26940,reduction,0,0
26941,in,0,0
26942,neointimal,0,1
26943,thickenings,0,0
26944,demonstrated,0,0
26945,that,0,0
26946,local,0,0
26947,delivery,0,0
26948,of,0,0
26949,7-hexanoyltaxol,0,0
26950,through,0,0
26951,polymer,0,0
26952,sleeves,0,0
26953,augments,0,0
26954,conventional,0,1
26955,mechanical,0,0
26956,treatment,0,0
26957,of,0,0
26958,atherosclerotic,1,1
26959,disease,1,1
26960,.,1,0
26961,Multifaceted,0,0
26962,support,0,0
26963,to,0,0
26964,improve,0,0
26965,clinical,0,0
26966,decision,0,0
26967,making,0,0
26968,in,0,0
26969,diabetes,0,1
26970,care,0,1
26971,:,0,1
26972,a,0,0
26973,randomized,0,0
26974,controlled,0,0
26975,trial,0,0
26976,in,0,0
26977,general,0,1
26978,practice,0,0
26979,.,0,0
26980,AIMS,0,0
26981,To,0,0
26982,evaluate,0,0
26983,the,0,0
26984,effectiveness,0,0
26985,of,0,0
26986,a,0,0
26987,multifaceted,0,0
26988,intervention,0,0
26989,to,0,0
26990,improve,0,0
26991,the,0,0
26992,clinical,0,0
26993,decision,0,0
26994,making,0,0
26995,of,0,0
26996,general,1,1
26997,practitioners,1,1
26998,(,1,0
26999,GPs,1,0
27000,),1,0
27001,for,1,0
27002,patients,1,1
27003,with,1,1
27004,diabetes,1,1
27005,.,1,0
27006,To,0,0
27007,identify,0,0
27008,practice,0,0
27009,characteristics,0,0
27010,which,0,0
27011,predict,0,0
27012,success,0,0
27013,.,0,0
27014,METHODS,0,0
27015,Cluster,1,0
27016,randomized,1,0
27017,controlled,1,0
27018,trial,1,0
27019,with,1,1
27020,124,1,1
27021,practices,1,1
27022,and,1,0
27023,185,1,1
27024,GPs,1,0
27025,in,1,0
27026,The,1,0
27027,Netherlands,1,0
27028,.,1,0
27029,The,0,0
27030,intervention,0,0
27031,group,0,0
27032,received,0,0
27033,feedback,0,0
27034,reports,0,0
27035,and,0,0
27036,support,0,0
27037,from,0,0
27038,a,0,0
27039,facilitator,0,0
27040,;,0,0
27041,the,0,0
27042,control,0,0
27043,group,0,0
27044,received,0,0
27045,no,0,0
27046,special,0,0
27047,attention,0,0
27048,.,0,0
27049,Outcome,0,0
27050,measures,0,0
27051,were,0,0
27052,the,0,0
27053,compliance,0,0
27054,rates,0,0
27055,with,0,1
27056,evidence-based,0,0
27057,recommendations,0,0
27058,pertaining,0,0
27059,to,0,0
27060,discussion,0,0
27061,of,0,0
27062,body,0,0
27063,weight,0,0
27064,control,0,0
27065,",",0,0
27066,discussion,0,0
27067,of,0,0
27068,problems,0,1
27069,with,0,1
27070,medication,0,0
27071,",",0,0
27072,blood,0,0
27073,pressure,0,0
27074,measurement,0,0
27075,",",0,0
27076,foot,0,0
27077,examination,0,0
27078,",",0,0
27079,eye,0,0
27080,examination,0,0
27081,",",0,0
27082,initiating,0,0
27083,anti-diabetic,0,0
27084,medication,0,0
27085,or,0,0
27086,increasing,0,0
27087,the,0,0
27088,dosage,0,0
27089,in,0,0
27090,cases,0,0
27091,of,0,0
27092,uncontrolled,0,1
27093,blood,0,0
27094,glucose,0,0
27095,",",0,0
27096,and,0,0
27097,scheduling,0,0
27098,a,0,0
27099,follow-up,0,0
27100,appointment,0,0
27101,.,0,0
27102,RESULTS,0,0
27103,The,0,0
27104,GPs,0,0
27105,reported,0,0
27106,on,0,0
27107,their,0,0
27108,clinical,0,0
27109,decision,0,0
27110,making,0,0
27111,in,0,0
27112,1410,1,1
27113,consultations,1,0
27114,with,1,1
27115,Type,1,0
27116,2,1,1
27117,diabetic,1,1
27118,patients,1,1
27119,at,1,0
27120,baseline,1,0
27121,and,1,0
27122,1449,1,1
27123,consultations,1,0
27124,after,0,0
27125,the,0,0
27126,intervention,0,0
27127,period,0,0
27128,.,0,0
27129,The,0,0
27130,intervention,0,0
27131,resulted,0,0
27132,in,0,0
27133,statistically,0,0
27134,significant,0,0
27135,improvement,0,0
27136,for,0,0
27137,two,0,0
27138,of,0,0
27139,the,0,0
27140,seven,0,0
27141,outcome,0,0
27142,measures,0,0
27143,:,0,1
27144,foot,0,1
27145,examination,0,0
27146,(,0,0
27147,odds,0,0
27148,ratio,0,0
27149,1.68,0,0
27150,;,0,0
27151,95,0,0
27152,%,0,0
27153,confidence,0,0
27154,interval,0,0
27155,1.19-2.39,0,0
27156,),0,0
27157,and,0,0
27158,eye,0,0
27159,examination,0,0
27160,(,0,0
27161,1.52,0,0
27162,;,0,0
27163,1.07-2.16,0,0
27164,),0,0
27165,.,0,0
27166,Discussion,0,0
27167,of,0,0
27168,problems,0,1
27169,with,0,1
27170,medication,0,0
27171,showed,0,0
27172,a,0,0
27173,near,0,0
27174,significant,0,0
27175,trend,0,0
27176,towards,0,0
27177,increased,0,0
27178,benefit,0,0
27179,for,0,0
27180,the,0,0
27181,intervention,0,0
27182,group,0,0
27183,(,0,0
27184,1.52,0,0
27185,;,0,0
27186,0.99-2.32,0,0
27187,),0,0
27188,.,0,0
27189,Practice,0,0
27190,characteristics,0,0
27191,were,0,0
27192,not,0,0
27193,found,0,0
27194,to,0,0
27195,be,0,0
27196,related,0,0
27197,to,0,0
27198,the,0,0
27199,success,0,0
27200,of,0,0
27201,the,0,0
27202,intervention,0,0
27203,.,0,0
27204,CONCLUSIONS,0,0
27205,Feedback,0,0
27206,reports,0,0
27207,with,0,1
27208,support,0,0
27209,from,0,0
27210,facilitators,0,0
27211,appear,0,0
27212,to,0,0
27213,increase,0,0
27214,rates,0,0
27215,of,0,0
27216,foot,0,1
27217,examination,0,0
27218,and,0,0
27219,eye,0,0
27220,examination,0,0
27221,in,0,0
27222,general,0,1
27223,practice,0,0
27224,.,0,0
27225,Alternative,0,0
27226,interventions,0,0
27227,should,0,0
27228,be,0,0
27229,explored,0,0
27230,to,0,0
27231,improve,0,0
27232,the,0,0
27233,pursuit,0,0
27234,of,0,0
27235,metabolic,0,0
27236,control,0,0
27237,by,0,0
27238,GPs,0,0
27239,.,0,1
27240,Effect,0,0
27241,of,0,0
27242,macronutrient,0,0
27243,composition,0,0
27244,of,0,0
27245,the,0,0
27246,diet,0,0
27247,on,0,0
27248,the,0,0
27249,regulation,0,0
27250,of,0,0
27251,lipolysis,0,0
27252,in,0,0
27253,adipose,0,0
27254,tissue,0,0
27255,at,0,0
27256,rest,0,0
27257,and,0,0
27258,during,0,0
27259,exercise,0,0
27260,:,0,1
27261,microdialysis,0,0
27262,study,0,0
27263,.,0,0
27264,The,0,0
27265,aim,0,0
27266,of,0,0
27267,the,0,0
27268,present,0,0
27269,study,0,0
27270,was,0,0
27271,to,0,0
27272,elucidate,0,0
27273,",",0,0
27274,using,0,0
27275,a,0,0
27276,microdialysis,0,0
27277,technique,0,0
27278,",",0,0
27279,whether,0,0
27280,modifications,0,0
27281,in,0,0
27282,the,0,0
27283,proportion,0,0
27284,of,0,0
27285,fat,0,0
27286,in,0,0
27287,the,0,0
27288,diet,0,0
27289,influence,0,0
27290,lipid,0,0
27291,mobilization,0,0
27292,from,0,0
27293,adipose,0,0
27294,tissue,0,0
27295,in,0,0
27296,situ,0,0
27297,.,0,0
27298,Nine,1,0
27299,healthy,1,1
27300,volunteers,1,1
27301,(,1,0
27302,age,1,1
27303,",",1,0
27304,23.4,1,0
27305,+/-,1,0
27306,0.2,1,0
27307,years,1,1
27308,;,1,0
27309,body,1,0
27310,mas,1,1
27311,index,1,0
27312,[,1,0
27313,BMI,1,0
27314,],1,0
27315,",",1,0
27316,23.5,1,0
27317,+/-,1,0
27318,1.6,1,0
27319,kg/m,1,1
27320,(,1,0
27321,2,1,0
27322,),1,0
27323,),1,0
27324,were,0,0
27325,fed,0,0
27326,",",0,0
27327,in,0,0
27328,random,0,0
27329,order,0,0
27330,",",0,0
27331,with,0,0
27332,a,0,0
27333,high-fat,0,0
27334,diet,0,0
27335,(,0,0
27336,HFD,0,0
27337,),0,0
27338,(,0,0
27339,65,0,1
27340,%,0,0
27341,of,0,0
27342,energy,0,0
27343,content,0,0
27344,fat,0,0
27345,",",0,0
27346,15,0,0
27347,%,0,0
27348,protein,0,0
27349,",",0,0
27350,20,0,0
27351,%,0,0
27352,carbohydrate,0,0
27353,),0,0
27354,or,0,0
27355,a,0,0
27356,high-carbohydrate,0,0
27357,diet,0,0
27358,(,0,0
27359,HCD,0,0
27360,),0,0
27361,(,0,0
27362,70,0,1
27363,%,0,0
27364,carbohydrate,0,0
27365,",",0,0
27366,15,0,0
27367,%,0,0
27368,protein,0,0
27369,",",0,0
27370,15,0,0
27371,%,0,0
27372,fat,0,0
27373,),0,0
27374,for,0,0
27375,5,0,0
27376,days,0,0
27377,",",0,0
27378,with,0,1
27379,a,0,0
27380,washout,0,0
27381,period,0,0
27382,of,0,0
27383,10,0,0
27384,days,0,0
27385,between,0,0
27386,the,0,0
27387,diets,0,0
27388,.,0,0
27389,Subjects,0,1
27390,were,0,0
27391,studied,0,1
27392,in,0,0
27393,the,0,0
27394,fasting,0,0
27395,state,0,0
27396,on,0,0
27397,the,0,0
27398,morning,0,0
27399,following,0,0
27400,days,0,0
27401,4,0,0
27402,and,0,0
27403,5,0,0
27404,of,0,0
27405,each,0,0
27406,diet,0,0
27407,.,0,0
27408,We,0,0
27409,measured,0,0
27410,the,0,0
27411,concentration,0,0
27412,of,0,0
27413,extracellular,0,0
27414,glycerol,0,0
27415,(,0,0
27416,EGC,0,0
27417,),0,0
27418,in,0,0
27419,adipose,0,0
27420,tissue,0,0
27421,in,0,0
27422,response,0,0
27423,to,0,0
27424,(,0,0
27425,1,0,0
27426,),0,0
27427,pharmacologic,0,0
27428,stimulation,0,0
27429,with,0,0
27430,isoprenaline,0,0
27431,(,0,0
27432,1,0,0
27433,and,0,0
27434,10,0,0
27435,micromol/L,0,0
27436,),0,0
27437,in,0,0
27438,situ,0,0
27439,",",0,0
27440,(,0,0
27441,2,0,0
27442,),0,0
27443,stimulation,0,0
27444,with,0,1
27445,intravenous,0,0
27446,infusion,0,0
27447,of,0,0
27448,epinephrine,0,0
27449,(,0,0
27450,0.0375,0,0
27451,microg/min/kg,0,0
27452,body,0,0
27453,weight,0,0
27454,),0,0
27455,",",0,0
27456,and,0,0
27457,(,0,0
27458,3,0,0
27459,),0,0
27460,submaximal,0,0
27461,aerobic,0,0
27462,exercise,0,0
27463,(,0,0
27464,50,0,0
27465,%,0,0
27466,V*O2max,0,0
27467,",",0,0
27468,60-minute,0,0
27469,duration,0,0
27470,),0,0
27471,.,0,0
27472,No,0,0
27473,effect,0,0
27474,of,0,0
27475,the,0,0
27476,diet,0,0
27477,composition,0,0
27478,was,0,0
27479,found,0,0
27480,in,0,0
27481,the,0,0
27482,increases,0,0
27483,of,0,0
27484,EGC,0,0
27485,in,0,0
27486,response,0,0
27487,to,0,0
27488,isoprenaline,0,0
27489,(,0,0
27490,area,0,0
27491,under,0,0
27492,the,0,0
27493,curve,0,0
27494,[,0,0
27495,AUC,0,0
27496,],0,1
27497,:,0,1
27498,HFD,0,0
27499,",",0,0
27500,"1,534",0,1
27501,+/-,0,0
27502,370,0,1
27503,micromol/90,0,0
27504,min,0,0
27505,;,0,0
27506,HCD,0,0
27507,",",0,0
27508,"1,108",0,1
27509,+/-,0,0
27510,465,0,1
27511,micromol/90,0,0
27512,min,0,0
27513,;,0,0
27514,not,0,0
27515,significant,0,0
27516,[,0,0
27517,NS,0,0
27518,],0,0
27519,),0,0
27520,or,0,0
27521,epinephrine,0,0
27522,stimulations,0,0
27523,(,0,1
27524,AUC,0,0
27525,:,0,1
27526,HFD,0,0
27527,",",0,0
27528,190,0,1
27529,+/-,0,0
27530,92,0,1
27531,micromol/30,0,0
27532,min,0,0
27533,;,0,0
27534,HCD,0,0
27535,",",0,0
27536,251,0,1
27537,+/-,0,0
27538,298,0,1
27539,micromol/30,0,0
27540,min,0,0
27541,;,0,0
27542,NS,0,0
27543,),0,0
27544,.,0,0
27545,The,0,0
27546,exercise-induced,0,0
27547,increase,0,0
27548,in,0,0
27549,EGC,0,0
27550,was,0,0
27551,higher,0,0
27552,during,0,0
27553,the,0,0
27554,HFD,0,0
27555,(,0,0
27556,AUC,0,0
27557,:,0,1
27558,HFD,0,0
27559,",",0,0
27560,"1,641",0,1
27561,+/-,0,0
27562,181,0,1
27563,micromol/60,0,0
27564,min,0,0
27565,;,0,0
27566,HCD,0,0
27567,",",0,0
27568,963,0,1
27569,+/-,0,0
27570,156,0,1
27571,micromol/60,0,0
27572,min,0,0
27573,;,0,0
27574,P,0,0
27575,<,0,0
27576,.05,0,0
27577,),0,0
27578,and,0,0
27579,was,0,0
27580,associated,0,0
27581,with,0,0
27582,a,0,0
27583,higher,0,0
27584,exercise-induced,0,0
27585,response,0,0
27586,of,0,0
27587,norepinephrine,0,0
27588,(,0,0
27589,P,0,0
27590,<,0,0
27591,.05,0,0
27592,),0,0
27593,and,0,0
27594,epinephrine,0,0
27595,(,0,0
27596,P,0,0
27597,=.056,0,0
27598,),0,0
27599,and,0,0
27600,lower,0,0
27601,insulinemia,0,0
27602,during,0,0
27603,exercise,0,0
27604,.,0,0
27605,The,0,0
27606,results,0,0
27607,suggest,0,0
27608,that,0,0
27609,macronutrient,0,0
27610,composition,0,0
27611,of,0,0
27612,diet,0,0
27613,does,0,0
27614,not,0,0
27615,affect,0,0
27616,the,0,0
27617,beta-adrenergic,0,0
27618,responsiveness,0,0
27619,of,0,0
27620,adipose,0,0
27621,tissue,0,0
27622,to,0,0
27623,catecholamine,0,0
27624,action,0,0
27625,at,0,0
27626,rest,0,0
27627,.,0,0
27628,During,0,0
27629,exercise,0,0
27630,",",0,0
27631,the,0,0
27632,HFD,0,0
27633,promotes,0,0
27634,higher,0,0
27635,lipolysis,0,0
27636,in,0,0
27637,adipose,0,0
27638,tissue,0,0
27639,and,0,0
27640,this,0,0
27641,is,0,0
27642,associated,0,0
27643,with,0,0
27644,a,0,0
27645,higher,0,0
27646,catecholamine,0,0
27647,response,0,0
27648,and,0,0
27649,lower,0,0
27650,insulinemia,0,0
27651,.,0,0
27652,Combination,0,0
27653,therapy,0,0
27654,with,0,0
27655,methotrexate,0,0
27656,and,0,0
27657,hydroxychloroquine,0,0
27658,for,0,0
27659,rheumatoid,1,1
27660,arthritis,1,1
27661,increases,0,0
27662,exposure,0,0
27663,to,0,0
27664,methotrexate,0,0
27665,.,0,0
27666,OBJECTIVE,0,0
27667,To,0,0
27668,examine,0,0
27669,the,0,0
27670,bioavailability,0,0
27671,of,0,0
27672,methotrexate,0,0
27673,(,0,0
27674,MTX,0,0
27675,),0,0
27676,in,0,0
27677,the,0,0
27678,presence,0,0
27679,of,0,0
27680,hydroxychloroquine,0,0
27681,(,0,0
27682,HCQ,0,0
27683,),0,0
27684,",",0,0
27685,and,0,0
27686,vice,0,0
27687,versa,0,0
27688,",",0,0
27689,to,0,0
27690,determine,0,0
27691,a,0,0
27692,possible,0,0
27693,pharmacokinetic,0,0
27694,explanation,0,0
27695,for,0,0
27696,the,0,0
27697,observation,0,0
27698,that,0,0
27699,combination,0,0
27700,treatment,0,0
27701,of,0,0
27702,rheumatoid,0,1
27703,arthritis,0,1
27704,with,0,1
27705,MTX,0,0
27706,and,0,0
27707,HCQ,0,0
27708,has,0,0
27709,been,0,0
27710,shown,0,0
27711,",",0,0
27712,clinically,0,0
27713,",",0,0
27714,to,0,0
27715,be,0,0
27716,more,0,0
27717,potent,0,0
27718,than,0,0
27719,MTX,0,0
27720,used,0,0
27721,alone,0,0
27722,.,0,0
27723,METHODS,0,0
27724,In,0,0
27725,a,0,0
27726,randomized,0,0
27727,crossover,0,0
27728,study,0,0
27729,",",0,0
27730,10,1,0
27731,healthy,1,1
27732,subjects,1,1
27733,received,1,0
27734,",",0,0
27735,on,0,0
27736,each,0,0
27737,of,0,0
27738,5,0,0
27739,dosing,0,0
27740,occasions,0,0
27741,",",0,0
27742,MTX,0,0
27743,alone,0,0
27744,as,0,0
27745,tablets,0,0
27746,or,0,1
27747,intravenous,0,0
27748,solution,0,0
27749,",",0,0
27750,HCQ,0,0
27751,alone,0,0
27752,as,0,0
27753,a,0,0
27754,tablet,0,0
27755,or,0,0
27756,oral,0,0
27757,solution,0,0
27758,",",0,0
27759,or,0,0
27760,a,0,0
27761,coadministered,0,0
27762,dose,0,0
27763,of,0,0
27764,MTX,0,0
27765,tablets,0,0
27766,with,0,1
27767,an,0,0
27768,HCQ,0,0
27769,tablet,0,0
27770,.,0,0
27771,The,0,0
27772,area,0,0
27773,under,0,0
27774,the,0,0
27775,concentration-time,0,0
27776,curve,0,0
27777,(,0,0
27778,AUC,0,0
27779,),0,0
27780,was,0,0
27781,determined,0,0
27782,for,0,0
27783,each,0,0
27784,subject,0,0
27785,",",0,0
27786,on,0,0
27787,each,0,0
27788,dosing,0,0
27789,occasion,0,0
27790,",",0,0
27791,for,0,0
27792,each,0,0
27793,compound,0,0
27794,.,0,0
27795,RESULTS,0,0
27796,The,0,0
27797,mean,0,0
27798,AUC,0,0
27799,for,0,0
27800,MTX,0,0
27801,was,0,0
27802,increased,0,0
27803,(,0,0
27804,p,0,0
27805,=,0,0
27806,0.005,0,0
27807,),0,0
27808,and,0,0
27809,the,0,0
27810,maximum,0,0
27811,MTX,0,0
27812,concentration,0,0
27813,(,0,0
27814,Cmax,0,0
27815,),0,0
27816,decreased,0,0
27817,(,0,0
27818,p,0,0
27819,=,0,0
27820,0.025,0,0
27821,),0,0
27822,when,0,0
27823,MTX,0,0
27824,was,0,0
27825,coadministered,0,0
27826,with,0,0
27827,HCQ,0,0
27828,",",0,0
27829,compared,0,0
27830,to,0,0
27831,MTX,0,0
27832,administered,0,0
27833,alone,0,0
27834,.,0,0
27835,The,0,0
27836,time,0,0
27837,to,0,0
27838,reach,0,0
27839,Cmax,0,0
27840,for,0,0
27841,MTX,0,0
27842,administration,0,0
27843,",",0,0
27844,tmax,0,0
27845,",",0,0
27846,was,0,0
27847,also,0,0
27848,increased,0,0
27849,during,0,0
27850,the,0,0
27851,coadministration,0,0
27852,with,0,0
27853,HCQ,0,0
27854,(,0,0
27855,p,0,0
27856,=,0,0
27857,0.072,0,0
27858,),0,0
27859,.,0,0
27860,The,0,0
27861,AUC,0,0
27862,of,0,0
27863,HCQ,0,0
27864,showed,0,0
27865,no,0,0
27866,significant,0,0
27867,difference,0,0
27868,(,0,0
27869,p,0,0
27870,=,0,0
27871,0.957,0,0
27872,),0,0
27873,between,0,0
27874,any,0,0
27875,of,0,0
27876,the,0,0
27877,dosing,0,0
27878,occasions,0,0
27879,.,0,0
27880,CONCLUSION,0,0
27881,These,0,0
27882,results,0,0
27883,may,0,0
27884,explain,0,0
27885,the,0,0
27886,increased,0,0
27887,potency,0,0
27888,of,0,0
27889,the,0,0
27890,MTX-HCQ,0,0
27891,combination,0,0
27892,over,0,0
27893,MTX,0,0
27894,as,0,0
27895,a,0,0
27896,single,0,0
27897,agent,0,0
27898,and,0,0
27899,also,0,0
27900,the,0,0
27901,sustained,0,0
27902,effects,0,0
27903,of,0,0
27904,MTX,0,0
27905,when,0,0
27906,administered,0,0
27907,with,0,0
27908,HCQ,0,0
27909,.,0,0
27910,In,0,0
27911,addition,0,0
27912,",",0,0
27913,the,0,0
27914,reduced,0,0
27915,Cmax,0,0
27916,of,0,0
27917,MTX,0,0
27918,observed,0,0
27919,during,0,0
27920,the,0,0
27921,coadministration,0,0
27922,may,0,0
27923,explain,0,0
27924,diminution,0,0
27925,of,0,0
27926,acute,0,1
27927,liver,0,1
27928,adverse,0,0
27929,effects,0,0
27930,.,0,1
27931,Extra,0,0
27932,vigilance,0,0
27933,for,0,0
27934,MTX,0,0
27935,adverse,0,0
27936,effects,0,0
27937,during,0,0
27938,combination,0,0
27939,therapy,0,0
27940,with,0,0
27941,HCQ,0,0
27942,is,0,0
27943,recommended,0,0
27944,",",0,0
27945,especially,0,0
27946,if,0,0
27947,renal,0,0
27948,function,0,0
27949,is,0,0
27950,known,0,0
27951,to,0,0
27952,be,0,0
27953,decreased,0,0
27954,.,0,0
27955,Transurethral,1,1
27956,prostate,1,1
27957,resection,1,1
27958,and,0,0
27959,bleeding,0,0
27960,:,0,0
27961,a,0,0
27962,randomized,0,0
27963,",",0,0
27964,placebo,0,0
27965,controlled,0,0
27966,trial,0,0
27967,of,0,0
27968,role,0,0
27969,of,0,0
27970,finasteride,0,0
27971,for,0,0
27972,decreasing,0,0
27973,operative,0,0
27974,blood,0,0
27975,loss,0,0
27976,.,0,0
27977,PURPOSE,0,0
27978,Bleeding,0,0
27979,associated,0,0
27980,with,0,1
27981,transurethral,0,0
27982,prostate,0,1
27983,resection,0,0
27984,can,0,0
27985,often,0,0
27986,be,0,0
27987,significant,0,0
27988,and,0,0
27989,lead,0,0
27990,to,0,0
27991,increased,0,0
27992,morbidity,0,0
27993,and,0,0
27994,occasionally,0,0
27995,mortality,0,0
27996,.,0,0
27997,It,0,0
27998,has,0,0
27999,been,0,0
28000,shown,0,0
28001,that,0,0
28002,finasteride,0,0
28003,decreases,0,0
28004,bleeding,0,0
28005,in,0,0
28006,patients,1,1
28007,with,1,1
28008,hematuria,1,1
28009,of,1,0
28010,prostatic,1,1
28011,origin,1,1
28012,.,1,0
28013,We,0,0
28014,hypothesized,0,0
28015,that,0,0
28016,bleeding,0,0
28017,in,0,0
28018,patients,1,1
28019,undergoing,1,1
28020,transurethral,1,1
28021,prostate,1,1
28022,resection,1,0
28023,could,0,0
28024,be,0,0
28025,decreased,0,0
28026,by,0,0
28027,giving,0,0
28028,finasteride,0,0
28029,for,0,0
28030,2,0,0
28031,weeks,0,0
28032,before,0,0
28033,surgery,0,1
28034,.,0,0
28035,MATERIALS,0,0
28036,AND,0,0
28037,METHODS,0,0
28038,A,1,0
28039,total,1,1
28040,70,1,1
28041,patients,1,1
28042,scheduled,1,1
28043,to,1,0
28044,undergo,1,0
28045,elective,1,1
28046,transurethral,1,0
28047,prostate,1,1
28048,resection,1,1
28049,were,1,0
28050,randomized,1,0
28051,to,0,0
28052,receive,0,0
28053,5,0,0
28054,mg.,0,0
28055,finasteride,0,0
28056,daily,0,0
28057,or,0,0
28058,placebo,0,0
28059,for,0,0
28060,2,0,0
28061,weeks,0,0
28062,before,0,0
28063,surgery,0,1
28064,.,0,0
28065,Serum,0,0
28066,hemoglobin,0,0
28067,was,0,0
28068,measured,0,0
28069,before,0,0
28070,and,0,0
28071,after,0,0
28072,surgery,0,1
28073,",",0,0
28074,and,0,0
28075,the,0,0
28076,following,0,0
28077,day,0,0
28078,.,0,0
28079,The,0,0
28080,volume,0,0
28081,of,0,0
28082,irrigation,0,0
28083,fluid,0,0
28084,used,0,0
28085,and,0,0
28086,its,0,0
28087,hemoglobin,0,0
28088,concentration,0,0
28089,as,0,0
28090,well,0,0
28091,as,0,0
28092,resected,0,1
28093,prostate,0,1
28094,weight,0,0
28095,were,0,0
28096,recorded,0,0
28097,.,0,0
28098,RESULTS,0,0
28099,Of,0,0
28100,the,0,0
28101,68,1,1
28102,patients,1,1
28103,who,1,1
28104,underwent,1,1
28105,transurethral,1,1
28106,prostate,1,1
28107,resection,1,1
28108,2,0,0
28109,were,0,0
28110,withdrawn,0,0
28111,before,0,0
28112,surgery,0,0
28113,",",0,0
28114,and,0,0
28115,so,0,0
28116,32,0,0
28117,received,0,0
28118,finasteride,0,0
28119,and,0,0
28120,36,0,0
28121,received,0,0
28122,placebo,0,0
28123,.,0,0
28124,There,0,0
28125,was,0,0
28126,significantly,0,0
28127,less,0,0
28128,mean,0,0
28129,blood,0,0
28130,loss,0,0
28131,in,0,0
28132,irrigation,0,0
28133,fluid,0,0
28134,in,0,0
28135,the,0,0
28136,finasteride,0,0
28137,group,0,0
28138,than,0,0
28139,in,0,0
28140,the,0,0
28141,control,0,0
28142,group,0,0
28143,(,0,0
28144,43.6,0,0
28145,versus,0,0
28146,69.3,0,0
28147,gm,0,0
28148,.,0,0
28149,hemoglobin,0,0
28150,",",0,0
28151,p,0,0
28152,=,0,0
28153,0.011,0,0
28154,),0,0
28155,.,0,0
28156,The,0,0
28157,mean,0,0
28158,difference,0,0
28159,was,0,0
28160,more,0,0
28161,significant,0,0
28162,when,0,0
28163,blood,0,0
28164,loss,0,0
28165,per,0,0
28166,gm,0,0
28167,.,0,0
28168,resected,0,0
28169,prostate,0,1
28170,was,0,0
28171,calculated,0,0
28172,(,0,0
28173,2.65,0,0
28174,versus,0,0
28175,4.65,0,0
28176,gm,0,0
28177,.,0,0
28178,hemoglobin,0,0
28179,per,0,0
28180,gm,0,0
28181,.,0,0
28182,prostate,0,0
28183,",",0,0
28184,p,0,0
28185,<,0,0
28186,0.01,0,0
28187,),0,0
28188,.,0,0
28189,CONCLUSIONS,0,0
28190,This,0,0
28191,study,0,0
28192,shows,0,0
28193,that,0,0
28194,finasteride,0,0
28195,given,0,0
28196,for,0,0
28197,2,0,0
28198,weeks,0,0
28199,preoperatively,0,0
28200,decreases,0,0
28201,bleeding,0,0
28202,in,0,0
28203,patients,1,1
28204,undergoing,1,1
28205,transurethral,1,1
28206,prostate,1,1
28207,resection,1,1
28208,.,1,0
28209,Further,0,0
28210,study,0,0
28211,is,0,0
28212,required,0,0
28213,to,0,0
28214,determine,0,0
28215,the,0,0
28216,optimal,0,0
28217,timing,0,0
28218,and,0,0
28219,dose,0,0
28220,duration,0,0
28221,to,0,0
28222,minimize,0,0
28223,blood,0,0
28224,loss,0,0
28225,and,0,0
28226,identify,0,0
28227,how,0,0
28228,relevant,0,0
28229,such,0,0
28230,a,0,0
28231,decrease,0,0
28232,in,0,0
28233,bleeding,0,0
28234,is,0,0
28235,in,0,0
28236,clinical,0,0
28237,practice,0,0
28238,.,0,0
28239,Lamivudine,0,0
28240,300,0,0
28241,mg,0,0
28242,QD,0,0
28243,versus,0,0
28244,continued,0,0
28245,lamivudine,0,0
28246,150,0,0
28247,mg,0,0
28248,BID,0,1
28249,with,0,1
28250,stavudine,0,0
28251,and,0,0
28252,a,0,0
28253,protease,0,0
28254,inhibitor,0,0
28255,in,0,0
28256,suppressed,1,0
28257,patients,1,1
28258,.,1,1
28259,PURPOSE,0,0
28260,To,0,0
28261,compare,0,0
28262,the,0,0
28263,efficacy,0,0
28264,(,0,0
28265,sustained,0,0
28266,virologic,0,0
28267,suppression,0,0
28268,),0,0
28269,and,0,0
28270,safety/tolerability,0,0
28271,of,0,0
28272,a,0,0
28273,switch,0,0
28274,to,0,0
28275,lamivudine,0,0
28276,300,0,0
28277,mg,0,0
28278,once,0,0
28279,daily,0,0
28280,(,0,0
28281,QD,0,0
28282,),0,0
28283,versus,0,0
28284,continued,0,0
28285,lamivudine,0,0
28286,150,0,0
28287,mg,0,0
28288,twice,0,0
28289,daily,0,0
28290,(,0,0
28291,BID,0,0
28292,),0,0
28293,in,0,0
28294,virologically,1,1
28295,suppressed,1,0
28296,patients,1,1
28297,(,1,0
28298,HIV-1,1,1
28299,RNA,1,1
28300,<,1,0
28301,400,1,0
28302,copies/mL,1,0
28303,for,1,0
28304,>,1,0
28305,or,1,1
28306,=3,1,1
28307,months,1,0
28308,),1,0
28309,on,1,0
28310,stable,1,1
28311,(,1,0
28312,>,1,1
28313,or,1,1
28314,=6,1,0
28315,months,1,0
28316,),1,0
28317,therapy,1,0
28318,with,1,1
28319,lamivudine,0,0
28320,150,0,0
28321,mg,0,0
28322,BID,0,0
28323,plus,0,0
28324,stavudine,0,0
28325,and,0,0
28326,either,0,0
28327,indinavir,0,0
28328,or,0,0
28329,nelfinavir,0,0
28330,.,0,0
28331,METHOD,0,0
28332,Eighty-nine,1,1
28333,suppressed,1,0
28334,patients,1,1
28335,>,1,1
28336,or,1,1
28337,=18,1,1
28338,years,1,1
28339,old,1,1
28340,with,1,1
28341,CD4,1,1
28342,counts,1,0
28343,>,1,0
28344,50,1,0
28345,cells/mm,1,0
28346,(,1,0
28347,3,1,0
28348,),1,0
28349,were,0,0
28350,enrolled,0,1
28351,in,0,0
28352,this,0,0
28353,phase,0,0
28354,II,0,0
28355,",",0,0
28356,open-label,0,0
28357,",",0,0
28358,multicenter,0,0
28359,",",0,0
28360,randomized,0,0
28361,",",0,0
28362,stratified,0,0
28363,(,0,0
28364,by,0,0
28365,pretrial,0,0
28366,protease,0,0
28367,inhibitor,0,0
28368,[,0,0
28369,PI,0,0
28370,],0,0
28371,),0,0
28372,",",0,0
28373,parallel-group,0,0
28374,clinical,0,0
28375,trial,0,0
28376,.,0,0
28377,Eighty-one,1,1
28378,patients,1,1
28379,received,0,0
28380,either,0,0
28381,lamivudine,0,0
28382,300,0,0
28383,mg,0,0
28384,QD,0,0
28385,(,0,0
28386,n,0,1
28387,=,0,0
28388,39,0,1
28389,),0,0
28390,or,0,1
28391,150,0,0
28392,mg,0,0
28393,BID,0,1
28394,(,0,0
28395,n,0,1
28396,=,0,0
28397,42,0,1
28398,),0,0
28399,with,0,1
28400,their,0,0
28401,pretrial,0,0
28402,stavudine/PI,0,0
28403,regimens,0,0
28404,for,0,0
28405,24,0,1
28406,weeks,0,0
28407,.,0,0
28408,RESULTS,0,0
28409,A,0,0
28410,high,0,0
28411,rate,0,0
28412,of,0,0
28413,virologic,0,0
28414,suppression,0,0
28415,was,0,0
28416,sustained,0,0
28417,with,0,1
28418,both,0,0
28419,regimens,0,0
28420,throughout,0,0
28421,the,0,0
28422,trial,0,0
28423,.,0,0
28424,At,0,0
28425,week,0,0
28426,24,0,0
28427,",",0,0
28428,intent-to-treat,0,0
28429,:,0,0
28430,exposed,0,0
28431,(,0,0
28432,missing,0,0
28433,=,0,0
28434,failure,0,1
28435,),0,0
28436,analyses,0,0
28437,showed,0,0
28438,no,0,0
28439,statistically,0,0
28440,significant,0,0
28441,differences,0,0
28442,in,0,0
28443,the,0,0
28444,percentage,0,0
28445,of,0,0
28446,patients,0,1
28447,with,0,1
28448,HIV-1,0,1
28449,RNA,0,1
28450,<,0,0
28451,400,0,0
28452,copies/mL,0,0
28453,(,0,0
28454,95,0,0
28455,%,0,0
28456,[,0,0
28457,QD,0,0
28458,],0,0
28459,vs.,0,0
28460,90,0,0
28461,%,0,0
28462,[,0,0
28463,BID,0,1
28464,],0,0
28465,),0,0
28466,or,0,0
28467,<,0,0
28468,50,0,0
28469,copies/mL,0,0
28470,(,0,0
28471,82,0,1
28472,%,0,0
28473,[,0,0
28474,QD,0,0
28475,],0,0
28476,vs.,0,0
28477,81,0,1
28478,%,0,0
28479,[,0,0
28480,BID,0,1
28481,],0,0
28482,),0,0
28483,or,0,0
28484,in,0,0
28485,the,0,0
28486,median,0,0
28487,change,0,0
28488,from,0,0
28489,baseline,0,0
28490,in,0,0
28491,CD4,0,1
28492,counts,0,0
28493,(,0,0
28494,+42,0,0
28495,cells/mm,0,0
28496,(,0,0
28497,3,0,0
28498,),0,0
28499,[,0,0
28500,QD,0,0
28501,],0,0
28502,vs.,0,0
28503,+22,0,0
28504,cells/mm,0,0
28505,(,0,0
28506,3,0,0
28507,),0,0
28508,[,0,0
28509,BID,0,0
28510,],0,0
28511,),0,0
28512,.,0,0
28513,Both,0,0
28514,regimens,0,0
28515,were,0,0
28516,well,0,0
28517,tolerated,0,0
28518,.,0,0
28519,No,0,0
28520,patient,0,0
28521,experienced,0,0
28522,virologic,0,0
28523,failure,0,1
28524,",",0,0
28525,clinical,0,0
28526,disease,0,1
28527,progression,0,0
28528,",",0,0
28529,or,0,0
28530,a,0,0
28531,drug-related,0,0
28532,serious,0,0
28533,adverse,0,0
28534,event,0,0
28535,during,0,0
28536,the,0,0
28537,trial,0,0
28538,.,0,0
28539,Self-reported,0,0
28540,medication,0,0
28541,adherence,0,0
28542,was,0,0
28543,high,0,0
28544,in,0,0
28545,both,0,0
28546,groups,0,0
28547,.,0,1
28548,CONCLUSION,0,0
28549,Patients,1,1
28550,who,1,1
28551,experience,1,1
28552,virologic,1,0
28553,suppression,1,0
28554,with,1,1
28555,a,1,0
28556,regimen,1,0
28557,of,1,0
28558,lamivudine,1,0
28559,150,1,0
28560,mg,1,0
28561,BID,1,0
28562,in,1,0
28563,combination,1,0
28564,with,1,0
28565,stavudine/PI,1,0
28566,can,0,0
28567,maintain,0,0
28568,that,0,0
28569,suppression,0,0
28570,by,0,0
28571,continuing,0,0
28572,their,0,0
28573,regimen,0,0
28574,or,0,0
28575,switching,0,0
28576,to,0,0
28577,lamivudine,0,0
28578,300,0,0
28579,mg,0,0
28580,QD,0,0
28581,and,0,0
28582,continuing,0,0
28583,the,0,0
28584,other,0,0
28585,components,0,0
28586,.,0,1
28587,Adverse,0,0
28588,event,0,0
28589,profiles,0,0
28590,were,0,0
28591,comparable,0,0
28592,among,0,0
28593,treatment,0,0
28594,regimens,0,0
28595,",",0,0
28596,and,0,0
28597,no,0,0
28598,new,0,0
28599,safety,0,0
28600,concerns,0,0
28601,were,0,0
28602,raised,0,0
28603,.,0,0
28604,A,0,0
28605,randomized,0,0
28606,",",0,0
28607,double-blind,0,0
28608,",",0,0
28609,vehicle-controlled,0,0
28610,study,0,0
28611,to,0,0
28612,assess,0,0
28613,5,0,0
28614,%,0,0
28615,imiquimod,0,0
28616,cream,0,0
28617,for,0,0
28618,the,0,0
28619,treatment,0,0
28620,of,1,0
28621,multiple,1,0
28622,actinic,1,1
28623,keratoses,1,0
28624,.,1,1
28625,BACKGROUND,0,0
28626,Actinic,0,0
28627,keratoses,0,0
28628,(,0,0
28629,AKs,0,0
28630,),0,0
28631,are,0,0
28632,precancerous,0,1
28633,epidermal,0,1
28634,lesions,0,1
28635,found,0,0
28636,most,0,0
28637,frequently,0,0
28638,on,0,0
28639,areas,0,0
28640,of,0,0
28641,the,0,0
28642,skin,0,0
28643,exposed,0,0
28644,to,0,0
28645,the,0,0
28646,sun,0,0
28647,.,0,0
28648,Several,0,0
28649,case,0,0
28650,studies,0,0
28651,published,0,0
28652,recently,0,0
28653,have,0,0
28654,indicated,0,0
28655,that,0,0
28656,5,0,0
28657,%,0,0
28658,imiquimod,0,0
28659,cream,0,0
28660,",",0,0
28661,currently,0,0
28662,licensed,0,0
28663,for,0,0
28664,the,0,0
28665,treatment,0,0
28666,of,0,0
28667,genital,0,1
28668,warts,0,0
28669,",",0,0
28670,may,0,0
28671,be,0,0
28672,an,0,0
28673,effective,0,0
28674,treatment,0,0
28675,for,0,0
28676,AK,0,0
28677,.,0,0
28678,OBJECTIVE,0,0
28679,To,0,0
28680,assess,0,0
28681,the,0,0
28682,efficacy,0,0
28683,and,0,0
28684,safety,0,0
28685,of,0,0
28686,imiquimod,0,0
28687,for,0,0
28688,the,0,0
28689,treatment,0,0
28690,of,0,0
28691,AK,0,0
28692,.,0,1
28693,DESIGN,0,0
28694,Patients,0,1
28695,in,0,1
28696,this,0,0
28697,randomized,0,0
28698,",",0,0
28699,double-blind,0,0
28700,",",0,0
28701,vehicle-controlled,0,0
28702,study,0,0
28703,applied,0,0
28704,5,0,0
28705,%,0,0
28706,imiquimod,0,0
28707,cream,0,0
28708,or,0,0
28709,vehicle,0,0
28710,to,0,0
28711,AK,0,0
28712,lesions,0,1
28713,3,0,0
28714,times,0,0
28715,per,0,0
28716,week,0,0
28717,for,0,0
28718,a,0,0
28719,maximum,0,0
28720,of,0,0
28721,12,0,0
28722,weeks,0,0
28723,or,0,1
28724,until,0,1
28725,lesions,0,1
28726,had,0,1
28727,resolved,0,0
28728,.,0,0
28729,In,0,0
28730,the,0,0
28731,event,0,0
28732,of,0,0
28733,an,0,0
28734,adverse,0,0
28735,reaction,0,0
28736,",",0,0
28737,application,0,0
28738,of,0,0
28739,imiquimod,0,0
28740,was,0,0
28741,reduced,0,0
28742,to,0,0
28743,1,0,0
28744,or,0,1
28745,2,0,0
28746,times,0,0
28747,per,0,0
28748,week,0,0
28749,.,0,0
28750,Rest,0,0
28751,periods,0,0
28752,were,0,0
28753,also,0,0
28754,allowed,0,0
28755,if,0,0
28756,necessary,0,0
28757,.,0,0
28758,SETTING,0,0
28759,A,1,0
28760,specialized,1,0
28761,outpatient,1,1
28762,dermatology,1,1
28763,clinic,1,1
28764,within,1,0
28765,a,1,0
28766,state-funded,1,1
28767,hospital,1,0
28768,in,1,0
28769,Germany,1,0
28770,.,1,0
28771,PATIENTS,1,0
28772,The,1,0
28773,study,1,0
28774,population,1,1
28775,was,1,0
28776,aged,1,1
28777,45,1,1
28778,to,1,0
28779,85,1,1
28780,years,1,1
28781,.,1,1
28782,Of,1,0
28783,52,1,1
28784,patients,1,1
28785,screened,1,1
28786,",",1,0
28787,36,1,1
28788,men,1,1
28789,and,1,0
28790,women,1,1
28791,with,1,1
28792,AK,1,0
28793,confirmed,1,0
28794,by,1,0
28795,histological,1,0
28796,diagnosis,1,1
28797,were,1,0
28798,enrolled,1,1
28799,.,1,0
28800,Patients,1,1
28801,were,1,0
28802,excluded,1,0
28803,from,1,0
28804,the,1,0
28805,study,1,0
28806,if,1,0
28807,they,1,0
28808,did,1,0
28809,not,1,0
28810,have,1,0
28811,a,1,0
28812,histological,1,0
28813,diagnosis,1,1
28814,for,1,0
28815,AK,1,0
28816,",",1,0
28817,if,1,0
28818,they,1,0
28819,were,1,0
28820,older,1,1
28821,than,1,0
28822,85,1,1
28823,years,1,1
28824,",",1,0
28825,or,1,0
28826,if,1,0
28827,they,1,0
28828,did,1,0
28829,not,1,0
28830,comply,1,0
28831,with,1,0
28832,the,1,0
28833,protocol,1,0
28834,.,1,0
28835,All,1,0
28836,patients,1,1
28837,had,1,0
28838,responded,1,1
28839,to,1,0
28840,a,1,0
28841,notice,1,0
28842,asking,1,0
28843,for,1,0
28844,volunteers,1,1
28845,.,1,1
28846,MAIN,0,0
28847,OUTCOME,0,0
28848,MEASURES,0,0
28849,The,0,0
28850,number,0,0
28851,and,0,0
28852,appearance,0,0
28853,of,0,0
28854,lesions,0,1
28855,were,0,0
28856,evaluated,0,0
28857,before,0,0
28858,",",0,0
28859,during,0,0
28860,",",0,0
28861,and,0,0
28862,after,0,0
28863,treatment,0,0
28864,.,0,0
28865,All,0,0
28866,adverse,0,0
28867,effects,0,0
28868,were,0,0
28869,recorded,0,0
28870,.,0,0
28871,RESULTS,0,0
28872,Lesions,0,0
28873,treated,0,1
28874,with,0,1
28875,5,0,0
28876,%,0,0
28877,imiquimod,0,0
28878,cream,0,0
28879,were,0,0
28880,clinically,0,0
28881,cleared,0,0
28882,in,0,0
28883,21,0,1
28884,(,0,0
28885,84,0,1
28886,%,0,0
28887,),0,0
28888,of,0,0
28889,25,0,0
28890,patients,0,1
28891,and,0,0
28892,partially,0,0
28893,cleared,0,0
28894,in,0,0
28895,2,0,0
28896,(,0,0
28897,8,0,0
28898,%,0,0
28899,),0,0
28900,.,0,0
28901,Clearance,0,0
28902,was,0,0
28903,histologically,0,1
28904,confirmed,0,0
28905,2,0,0
28906,weeks,0,0
28907,after,0,0
28908,the,0,0
28909,last,0,0
28910,application,0,0
28911,of,0,0
28912,imiquimod,0,0
28913,in,0,0
28914,all,0,0
28915,patients,0,1
28916,clinically,0,0
28917,diagnosed,0,1
28918,as,0,0
28919,lesion,0,0
28920,free,0,0
28921,.,0,0
28922,Only,0,0
28923,10,0,0
28924,%,0,0
28925,of,0,0
28926,patients,0,1
28927,treated,0,1
28928,with,0,1
28929,imiquimod,0,0
28930,were,0,0
28931,clinically,0,0
28932,diagnosed,0,1
28933,with,0,0
28934,recurrence,0,0
28935,1,0,0
28936,year,0,0
28937,after,0,0
28938,treatment,0,0
28939,.,0,0
28940,No,0,0
28941,reduction,0,0
28942,in,0,0
28943,the,0,0
28944,size,0,0
28945,or,0,0
28946,number,0,0
28947,of,0,0
28948,AK,0,0
28949,lesions,0,1
28950,was,0,0
28951,observed,0,0
28952,in,0,0
28953,vehicle-treated,0,1
28954,patients,0,1
28955,.,0,1
28956,Adverse,0,0
28957,effects,0,0
28958,reported,0,0
28959,by,1,0
28960,patients,1,1
28961,treated,1,1
28962,with,1,1
28963,imiquimod,1,0
28964,included,0,1
28965,erythema,0,0
28966,",",0,0
28967,edema,0,0
28968,",",0,0
28969,induration,0,0
28970,",",0,0
28971,vesicles,0,0
28972,",",0,0
28973,erosion,0,0
28974,",",0,0
28975,ulceration,0,0
28976,",",0,0
28977,excoriation,0,0
28978,",",0,0
28979,and,0,0
28980,scabbing,0,0
28981,.,0,0
28982,However,0,0
28983,",",0,0
28984,imiquimod,0,0
28985,was,0,0
28986,well,0,0
28987,tolerated,0,0
28988,since,0,0
28989,all,0,0
28990,patients,0,1
28991,completed,0,1
28992,the,0,0
28993,12-week,0,0
28994,treatment,0,0
28995,.,0,0
28996,Only,0,0
28997,a,0,0
28998,few,0,0
28999,",",0,0
29000,mild,0,1
29001,adverse,0,0
29002,reactions,0,0
29003,to,0,0
29004,the,0,0
29005,vehicle,0,0
29006,cream,0,0
29007,were,0,0
29008,reported,0,0
29009,.,0,0
29010,CONCLUSION,0,0
29011,Application,0,0
29012,of,0,0
29013,5,0,0
29014,%,0,0
29015,imiquimod,0,0
29016,cream,0,0
29017,for,0,0
29018,12,0,0
29019,weeks,0,0
29020,is,0,0
29021,an,0,0
29022,effective,0,0
29023,and,0,0
29024,well-tolerated,0,0
29025,treatment,0,0
29026,for,0,0
29027,AK,0,0
29028,.,0,1
29029,Reactive,0,0
29030,balance,0,0
29031,adjustments,0,0
29032,to,0,0
29033,unexpected,1,0
29034,perturbations,1,0
29035,during,1,0
29036,human,1,1
29037,walking,1,0
29038,.,1,0
29039,The,0,0
29040,purpose,0,0
29041,of,0,0
29042,this,0,0
29043,investigation,0,0
29044,was,0,0
29045,to,0,0
29046,determine,0,0
29047,the,0,0
29048,effect,0,0
29049,of,0,0
29050,unexpected,0,0
29051,forward,0,0
29052,perturbations,0,0
29053,(,0,0
29054,FP,0,0
29055,),0,0
29056,during,0,0
29057,gait,0,0
29058,on,0,0
29059,lower,0,0
29060,extremity,0,0
29061,joint,0,0
29062,mechanics,0,0
29063,and,0,0
29064,muscle,0,0
29065,Electromyographic,0,0
29066,(,0,0
29067,EMG,0,0
29068,),0,0
29069,patterns,0,0
29070,in,0,0
29071,healthy,1,1
29072,adults,1,1
29073,.,1,1
29074,The,0,0
29075,muscles,0,0
29076,surrounding,0,0
29077,the,0,0
29078,hip,0,1
29079,were,0,0
29080,found,0,0
29081,to,0,0
29082,be,0,0
29083,most,0,0
29084,important,0,0
29085,in,0,0
29086,maintaining,0,0
29087,control,0,0
29088,of,0,0
29089,the,0,0
29090,trunk,0,0
29091,and,0,0
29092,preventing,0,0
29093,collapse,0,0
29094,in,0,0
29095,response,0,0
29096,to,0,0
29097,the,0,0
29098,FP,0,0
29099,.,0,0
29100,Distinct,0,0
29101,lower,0,0
29102,extremity,0,0
29103,joint,0,0
29104,moment,0,0
29105,and,0,0
29106,power,0,0
29107,patterns,0,0
29108,were,0,0
29109,observed,0,0
29110,in,0,0
29111,response,0,0
29112,to,0,0
29113,the,0,0
29114,FP,0,0
29115,but,0,0
29116,an,0,0
29117,overall,0,0
29118,positive,0,0
29119,moment,0,0
29120,of,0,0
29121,support,0,0
29122,(,0,0
29123,M,0,0
29124,(,0,0
29125,s,0,0
29126,),0,0
29127,),0,0
29128,was,0,0
29129,maintained,0,0
29130,.,0,0
29131,Therefore,0,0
29132,",",0,0
29133,reactive,0,0
29134,balance,0,0
29135,control,0,0
29136,was,0,0
29137,a,0,0
29138,synchronized,0,0
29139,effort,0,0
29140,of,0,0
29141,the,0,0
29142,lower,0,0
29143,extremity,0,0
29144,joints,0,0
29145,to,0,0
29146,prevent,0,0
29147,collapse,0,0
29148,during,0,0
29149,the,0,0
29150,FP,0,0
29151,.,0,0
29152,Pharmacokinetics,1,0
29153,of,1,0
29154,azithromycin,1,0
29155,in,1,0
29156,lung,1,0
29157,tissue,1,0
29158,",",1,0
29159,bronchial,1,0
29160,washing,1,0
29161,",",1,0
29162,and,1,0
29163,plasma,1,0
29164,in,1,0
29165,patients,1,1
29166,given,1,0
29167,multiple,1,0
29168,oral,1,0
29169,doses,1,0
29170,of,1,0
29171,500,1,0
29172,and,1,0
29173,1000,1,0
29174,mg,1,0
29175,daily,1,0
29176,.,1,0
29177,The,0,0
29178,present,0,0
29179,study,0,0
29180,compares,0,0
29181,the,0,0
29182,pharmacokinetics,1,0
29183,of,1,0
29184,azithromycin,1,0
29185,in,0,0
29186,plasma,0,0
29187,",",0,0
29188,lung,0,0
29189,tissue,0,0
29190,",",0,0
29191,and,0,0
29192,bronchial,0,1
29193,washing,0,0
29194,after,0,0
29195,oral,0,0
29196,administration,0,0
29197,of,0,0
29198,500,0,0
29199,mg,0,0
29200,(,0,0
29201,standard,0,0
29202,dose,0,0
29203,),0,0
29204,versus,0,0
29205,1000,0,0
29206,mg,0,0
29207,daily,0,0
29208,for,0,0
29209,3,0,0
29210,days,0,0
29211,.,0,1
29212,Samples,0,0
29213,were,0,0
29214,taken,0,0
29215,during,0,0
29216,surgery,0,1
29217,for,0,0
29218,lung,0,0
29219,resection,0,1
29220,at,0,0
29221,various,0,0
29222,time,0,0
29223,points,0,0
29224,up,0,0
29225,to,0,0
29226,204,0,1
29227,h,0,0
29228,after,0,0
29229,the,0,0
29230,last,0,0
29231,drug,0,0
29232,dose,0,0
29233,",",0,0
29234,and,0,0
29235,azithromycin,0,0
29236,levels,0,0
29237,were,0,0
29238,analyzed,0,0
29239,by,0,0
29240,HPLC,0,0
29241,method,0,0
29242,.,0,0
29243,Azithromycin,0,0
29244,was,0,0
29245,widely,0,0
29246,distributed,0,0
29247,within,0,0
29248,the,0,0
29249,lower,0,0
29250,respiratory,0,0
29251,tract,0,1
29252,;,0,0
29253,sustained,0,0
29254,concentrations,0,0
29255,of,0,0
29256,the,0,0
29257,drug,0,0
29258,were,0,0
29259,detectable,0,0
29260,at,0,0
29261,the,0,0
29262,last,0,0
29263,sampling,0,0
29264,time,0,0
29265,(,0,0
29266,204,0,1
29267,h,0,0
29268,),0,0
29269,in,0,0
29270,lung,0,0
29271,tissue,0,0
29272,and,0,0
29273,bronchial,0,1
29274,washing,0,0
29275,",",0,0
29276,with,0,0
29277,long,0,1
29278,terminal,0,1
29279,half-lives,0,0
29280,of,0,0
29281,132.86,0,0
29282,and,0,0
29283,74.32,0,0
29284,h,0,0
29285,at,0,0
29286,500,0,0
29287,mg,0,0
29288,daily,0,0
29289,and,0,0
29290,133.32,0,0
29291,and,0,0
29292,70.5,0,0
29293,h,0,0
29294,at,0,0
29295,1000,0,0
29296,mg,0,0
29297,daily,0,0
29298,",",0,0
29299,respectively,0,0
29300,.,0,0
29301,Doubling,0,0
29302,the,0,0
29303,drug,0,0
29304,dose,0,0
29305,resulted,0,0
29306,in,0,0
29307,a,0,0
29308,remarkable,0,0
29309,increase,0,0
29310,in,0,0
29311,lung,0,0
29312,area,0,0
29313,under,0,0
29314,the,0,0
29315,curve,0,0
29316,(,0,0
29317,AUC,0,0
29318,",",0,0
29319,1318,0,1
29320,hx,0,0
29321,microg,0,0
29322,g,0,0
29323,(,0,0
29324,-1,0,0
29325,),0,0
29326,vs,0,0
29327,2502,0,1
29328,hx,0,0
29329,microg,0,0
29330,g,0,0
29331,(,0,0
29332,-1,0,0
29333,),0,0
29334,),0,0
29335,and,0,0
29336,peak,0,0
29337,tissue,0,0
29338,concentration,0,0
29339,(,0,0
29340,9.13+/-0.53,0,0
29341,microg,0,0
29342,g,0,0
29343,(,0,0
29344,-1,0,0
29345,),0,0
29346,vs,0,0
29347,17.85+/-2.4,0,0
29348,microg,0,0
29349,g,0,0
29350,(,0,0
29351,-1,0,0
29352,),0,0
29353,),0,0
29354,.,0,0
29355,In,0,0
29356,addition,0,0
29357,to,0,0
29358,this,0,0
29359,",",0,0
29360,enhanced,0,0
29361,azithromycin,0,0
29362,penetration,0,0
29363,from,0,0
29364,plasma,0,0
29365,into,0,0
29366,bronchial,0,1
29367,secretion,0,0
29368,and,0,0
29369,lung,0,0
29370,tissue,0,0
29371,was,0,0
29372,evidenced,0,0
29373,by,0,0
29374,the,0,0
29375,increase,0,0
29376,in,0,0
29377,the,0,0
29378,ratio,0,0
29379,of,0,0
29380,AUC,0,0
29381,(,0,0
29382,bronchial,0,1
29383,washing,0,0
29384,),0,0
29385,versus,0,0
29386,AUC,0,0
29387,(,0,0
29388,plasma,0,0
29389,),0,0
29390,(,0,0
29391,2.96,0,0
29392,vs,0,0
29393,5.27,0,0
29394,at,0,0
29395,500,0,0
29396,and,0,0
29397,1000,0,0
29398,mg,0,0
29399,",",0,0
29400,respectively,0,0
29401,),0,0
29402,and,0,0
29403,AUC,0,0
29404,(,0,0
29405,lung,0,1
29406,),0,0
29407,versus,0,0
29408,AUC,0,0
29409,(,0,0
29410,plasma,0,0
29411,),0,0
29412,(,0,0
29413,64.35,0,0
29414,vs,0,0
29415,97.73,0,0
29416,at,0,0
29417,500,0,0
29418,and,0,0
29419,1000,0,0
29420,mg,0,0
29421,",",0,0
29422,respectively,0,0
29423,),0,0
29424,.,0,0
29425,In,0,0
29426,conclusion,0,0
29427,",",0,0
29428,the,0,0
29429,exposure,0,0
29430,of,0,0
29431,lung,0,1
29432,and,0,0
29433,bronchial,0,1
29434,washing,0,0
29435,to,0,0
29436,azithromycin,0,0
29437,is,0,0
29438,increased,0,0
29439,by,0,0
29440,doubling,0,0
29441,the,0,0
29442,dose,0,0
29443,",",0,0
29444,which,0,0
29445,results,0,0
29446,in,0,0
29447,favorable,0,0
29448,pharmacokinetic,0,0
29449,profile,0,0
29450,of,0,0
29451,the,0,0
29452,drug,0,0
29453,in,0,0
29454,the,0,0
29455,lower,0,0
29456,respiratory,0,0
29457,tract,0,1
29458,.,0,0
29459,Secretin,0,0
29460,and,0,0
29461,sleep,0,0
29462,in,0,0
29463,children,1,1
29464,with,1,1
29465,autism,1,1
29466,.,1,0
29467,The,0,0
29468,objectives,0,0
29469,of,0,0
29470,this,0,0
29471,pilot,0,0
29472,study,0,0
29473,were,0,0
29474,1,0,0
29475,),0,0
29476,to,0,0
29477,examine,0,0
29478,possible,0,0
29479,effects,0,0
29480,of,0,0
29481,secretin,0,0
29482,infusions,0,0
29483,on,0,0
29484,sleep-wake,0,1
29485,state,0,0
29486,organization,0,0
29487,in,0,0
29488,children,1,1
29489,with,1,1
29490,autism,1,1
29491,",",1,0
29492,and,1,0
29493,2,1,0
29494,),1,0
29495,to,1,0
29496,assess,1,0
29497,the,1,0
29498,feasibility,1,0
29499,of,1,0
29500,home,1,1
29501,recordings,1,0
29502,using,1,0
29503,time-lapse,1,0
29504,videosomnography,1,1
29505,in,1,0
29506,children,1,1
29507,with,1,1
29508,autism,1,1
29509,.,1,1
29510,Participants,1,1
29511,were,1,0
29512,a,1,0
29513,subset,1,0
29514,of,1,0
29515,subjects,1,1
29516,from,1,1
29517,two,1,0
29518,double,1,0
29519,blind,1,0
29520,",",1,0
29521,placebo-control,1,0
29522,",",1,0
29523,multi-center,1,0
29524,clinical,1,0
29525,trials,1,0
29526,.,1,1
29527,One,0,0
29528,trial,0,0
29529,",",0,0
29530,the,0,0
29531,UC,0,0
29532,Irvine,0,0
29533,study,0,0
29534,",",0,0
29535,assessed,0,0
29536,the,0,0
29537,effects,0,0
29538,of,0,0
29539,porcine,0,0
29540,secretin,0,0
29541,vs.,0,0
29542,saline,0,0
29543,infusions,0,0
29544,on,0,0
29545,children,0,1
29546,'s,0,1
29547,behavior,0,0
29548,",",0,0
29549,language,0,0
29550,and,0,0
29551,IQ,0,0
29552,.,0,0
29553,The,0,0
29554,UC,0,0
29555,Davis,0,1
29556,trial,0,0
29557,assessed,0,0
29558,the,0,0
29559,effects,0,0
29560,of,0,0
29561,synthetic,0,0
29562,human,0,0
29563,secretin,0,0
29564,vs.,0,0
29565,saline,0,0
29566,infusions,0,0
29567,on,0,0
29568,behavior,0,0
29569,",",0,0
29570,language,0,0
29571,and,0,0
29572,gastrointestinal,0,1
29573,function,0,0
29574,.,0,0
29575,The,0,0
29576,sleep,0,0
29577,study,0,0
29578,enrolled,1,1
29579,some,1,0
29580,of,1,0
29581,the,1,0
29582,children,1,1
29583,from,1,0
29584,each,1,0
29585,of,1,0
29586,the,1,0
29587,two,1,0
29588,trials,1,0
29589,to,0,0
29590,observe,0,0
29591,possible,0,0
29592,secretin,0,0
29593,effects,0,0
29594,on,0,0
29595,sleep,0,0
29596,.,0,0
29597,To,0,0
29598,examine,0,0
29599,sleep,0,0
29600,",",0,0
29601,the,0,0
29602,UC,0,0
29603,Irvine,0,0
29604,trial,0,0
29605,used,0,0
29606,the,0,0
29607,Children,0,1
29608,'s,0,0
29609,Sleep,0,0
29610,Habits,0,1
29611,Questionnaire,0,0
29612,and,0,0
29613,daily,0,0
29614,sleep,0,0
29615,diaries,0,0
29616,",",0,0
29617,whereas,0,0
29618,the,0,0
29619,UC,0,0
29620,Davis,0,1
29621,study,0,0
29622,used,0,0
29623,home-recorded,0,1
29624,time-lapse,0,0
29625,videosomnography,0,1
29626,.,0,0
29627,Because,0,0
29628,of,0,0
29629,the,0,0
29630,small,0,0
29631,sample,0,1
29632,size,0,0
29633,",",0,0
29634,the,0,0
29635,results,0,0
29636,from,0,0
29637,both,0,0
29638,trials,0,0
29639,are,0,0
29640,preliminary,0,0
29641,.,0,0
29642,They,0,0
29643,suggest,0,0
29644,that,0,0
29645,secretin,0,0
29646,",",0,0
29647,porcine,0,0
29648,or,0,0
29649,synthetic,0,0
29650,",",0,0
29651,does,0,0
29652,not,0,0
29653,improve,0,0
29654,sleep-wake,0,0
29655,state,0,0
29656,organization,0,0
29657,dramatically,0,0
29658,.,0,0
29659,Sulfadoxine/pyrimethamine,0,0
29660,alone,0,0
29661,or,0,0
29662,with,0,0
29663,amodiaquine,0,0
29664,or,0,0
29665,artesunate,0,0
29666,for,0,0
29667,treatment,0,0
29668,of,0,0
29669,uncomplicated,1,1
29670,malaria,1,1
29671,:,1,1
29672,a,0,0
29673,longitudinal,0,0
29674,randomised,0,0
29675,trial,0,0
29676,.,0,0
29677,BACKGROUND,0,0
29678,New,0,1
29679,antimalarial,0,1
29680,treatments,0,0
29681,are,0,0
29682,urgently,0,0
29683,needed,0,0
29684,in,0,0
29685,sub-Saharan,1,1
29686,Africa,1,1
29687,.,1,1
29688,Improved,0,0
29689,therapies,0,0
29690,should,0,0
29691,decrease,0,0
29692,failure,0,0
29693,rates,0,0
29694,in,0,0
29695,the,0,0
29696,short,0,0
29697,term,0,0
29698,",",0,0
29699,but,0,0
29700,their,0,0
29701,effect,0,0
29702,on,0,0
29703,incidence,0,0
29704,of,0,0
29705,subsequent,0,0
29706,episodes,0,0
29707,of,0,0
29708,malaria,0,1
29709,is,0,0
29710,little,0,0
29711,studied,0,0
29712,.,0,0
29713,We,0,0
29714,aimed,0,0
29715,to,0,0
29716,compare,0,0
29717,the,0,0
29718,short-term,0,0
29719,and,0,0
29720,long-term,0,0
29721,effectiveness,0,0
29722,of,0,0
29723,three,0,0
29724,antimalarial,0,1
29725,regimens,0,0
29726,in,0,0
29727,children,1,1
29728,from,1,1
29729,Kampala,1,1
29730,",",1,0
29731,Uganda,1,1
29732,.,1,0
29733,METHODS,0,0
29734,We,0,0
29735,randomly,0,1
29736,allocated,0,0
29737,healthy,1,1
29738,children,1,1
29739,aged,1,1
29740,6,1,0
29741,months,1,0
29742,to,1,1
29743,5,1,0
29744,years,1,1
29745,to,0,0
29746,receive,0,0
29747,25,0,0
29748,mg/kg,0,0
29749,sulfadoxine,0,0
29750,and,0,0
29751,1.25,0,0
29752,mg/kg,0,0
29753,pyrimethamine,0,0
29754,plus,0,0
29755,either,0,0
29756,placebo,0,0
29757,",",0,0
29758,25,0,0
29759,mg/kg,0,0
29760,amodiaquine,0,0
29761,",",0,0
29762,or,0,0
29763,12,0,0
29764,mg/kg,0,0
29765,artesunate,0,0
29766,.,0,1
29767,Participants,0,1
29768,were,0,0
29769,followed,0,0
29770,up,0,0
29771,for,0,0
29772,1,0,0
29773,year,0,0
29774,and,0,0
29775,received,0,0
29776,the,0,0
29777,same,0,0
29778,preassigned,0,0
29779,treatment,0,0
29780,for,0,0
29781,every,0,0
29782,new,0,0
29783,episode,0,1
29784,of,0,0
29785,uncomplicated,0,1
29786,malaria,0,1
29787,diagnosed,0,1
29788,during,0,0
29789,follow-up,0,0
29790,.,0,0
29791,Recrudescent,0,0
29792,and,0,0
29793,new,0,0
29794,infections,0,0
29795,were,0,0
29796,distinguished,0,0
29797,by,0,0
29798,comparison,0,0
29799,of,0,0
29800,polymorphisms,0,0
29801,in,0,0
29802,merozoite,0,0
29803,surface,0,0
29804,protein,0,0
29805,2,0,0
29806,(,0,0
29807,MSP2,0,1
29808,),0,0
29809,.,0,0
29810,Our,0,0
29811,primary,0,0
29812,endpoint,0,0
29813,was,0,0
29814,the,0,0
29815,total,0,0
29816,number,0,0
29817,of,0,0
29818,treatments,0,0
29819,for,0,0
29820,malaria,0,1
29821,per,0,0
29822,time,0,0
29823,at,0,0
29824,risk,0,0
29825,.,0,1
29826,Analyses,0,0
29827,were,0,0
29828,done,0,0
29829,per,0,0
29830,protocol,0,0
29831,.,0,0
29832,FINDINGS,0,0
29833,183,0,1
29834,(,0,0
29835,61,0,1
29836,%,0,0
29837,),0,0
29838,of,0,0
29839,316,1,1
29840,participants,1,1
29841,were,0,0
29842,diagnosed,0,1
29843,with,0,0
29844,at,0,0
29845,least,0,0
29846,one,0,0
29847,episode,0,1
29848,of,0,0
29849,uncomplicated,0,1
29850,malaria,0,1
29851,.,0,0
29852,A,0,0
29853,total,0,0
29854,of,0,0
29855,577,0,1
29856,episodes,0,0
29857,of,0,0
29858,uncomplicated,0,1
29859,Plasmodium,0,1
29860,falciparum,0,1
29861,malaria,0,1
29862,were,0,0
29863,treated,0,1
29864,with,0,1
29865,study,0,0
29866,drugs,0,0
29867,;,0,0
29868,all,0,0
29869,regimens,0,0
29870,were,0,0
29871,safe,0,0
29872,and,0,0
29873,well,0,0
29874,tolerated,0,0
29875,.,0,0
29876,Clinical,0,0
29877,treatment,0,0
29878,failure,0,1
29879,after,0,0
29880,14,0,0
29881,days,0,0
29882,was,0,0
29883,significantly,0,0
29884,more,0,0
29885,frequent,0,0
29886,in,0,0
29887,the,0,0
29888,sulfadoxine/pyrimethamine,0,0
29889,group,0,0
29890,(,0,0
29891,38,0,1
29892,of,0,0
29893,215,0,1
29894,",",0,0
29895,18,0,1
29896,%,0,0
29897,),0,0
29898,compared,0,0
29899,with,0,0
29900,either,0,0
29901,the,0,0
29902,sulfadoxine/pyrimethamine,0,0
29903,plus,0,0
29904,amodiaquine,0,0
29905,group,0,0
29906,(,0,0
29907,two,0,0
29908,of,0,0
29909,164,0,1
29910,",",0,0
29911,1,0,0
29912,%,0,0
29913,;,0,0
29914,p,0,0
29915,<,0,0
29916,0.0001,0,0
29917,),0,0
29918,or,0,0
29919,sulfadoxine/pyrimethamine,0,0
29920,plus,0,0
29921,artesunate,0,0
29922,group,0,0
29923,(,0,0
29924,one,0,0
29925,of,0,0
29926,198,0,1
29927,",",0,0
29928,1,0,0
29929,%,0,0
29930,;,0,0
29931,p,0,0
29932,<,0,0
29933,0.0001,0,0
29934,),0,0
29935,.,0,0
29936,After,0,0
29937,28,0,0
29938,and,0,0
29939,42,0,1
29940,days,0,0
29941,",",0,0
29942,patients,0,1
29943,in,0,0
29944,the,0,0
29945,sulfadoxine/pyrimethamine,0,0
29946,plus,0,0
29947,amodiaquine,0,0
29948,group,0,0
29949,were,0,0
29950,significantly,0,0
29951,less,0,0
29952,likely,0,0
29953,to,0,0
29954,develop,0,0
29955,malaria,0,1
29956,than,0,0
29957,were,0,0
29958,those,0,0
29959,in,0,0
29960,the,0,0
29961,other,0,0
29962,groups,0,0
29963,.,0,1
29964,Overall,0,0
29965,",",0,0
29966,sulfadoxine/pyrimethamine,0,0
29967,plus,0,0
29968,amodiaquine,0,0
29969,reduced,0,0
29970,the,0,0
29971,rate,0,0
29972,of,0,0
29973,subsequent,0,0
29974,treatments,0,0
29975,for,0,0
29976,malaria,0,1
29977,by,0,0
29978,54,0,1
29979,%,0,0
29980,(,0,0
29981,95,0,0
29982,%,0,0
29983,CI,0,0
29984,36-66,0,0
29985,",",0,0
29986,p,0,0
29987,<,0,0
29988,0.0001,0,0
29989,),0,0
29990,compared,0,0
29991,with,0,0
29992,sulfadoxine/,0,0
29993,pyrimethamine,0,0
29994,alone,0,0
29995,and,0,0
29996,by,0,0
29997,37,0,0
29998,%,0,0
29999,(,0,0
30000,12-54,0,0
30001,",",0,0
30002,p=0.007,0,0
30003,),0,0
30004,compared,0,0
30005,with,0,1
30006,sulfadoxine/pyrimethamine,0,0
30007,plus,0,0
30008,artesunate,0,0
30009,.,0,0
30010,INTERPRETATION,0,0
30011,Sulfadoxine/pyrimethamine,0,0
30012,plus,0,0
30013,amodiaquine,0,0
30014,could,0,0
30015,be,0,0
30016,used,0,0
30017,as,0,0
30018,an,0,0
30019,inexpensive,0,0
30020,regimen,0,0
30021,to,0,0
30022,decrease,0,0
30023,the,0,0
30024,rate,0,0
30025,of,0,0
30026,subsequent,0,0
30027,episodes,0,0
30028,of,0,0
30029,malaria,0,1
30030,.,0,0
30031,Trials,0,1
30032,and,0,1
30033,tribulations,0,0
30034,:,0,1
30035,current,0,0
30036,challenges,0,0
30037,in,0,0
30038,conducting,0,0
30039,clinical,0,0
30040,trials,0,0
30041,.,0,1
30042,Randomized,0,0
30043,controlled,0,0
30044,trials,0,0
30045,are,0,0
30046,the,0,0
30047,gold,0,0
30048,standard,0,0
30049,for,0,0
30050,the,0,0
30051,evaluation,0,0
30052,of,0,0
30053,new,0,0
30054,therapies,0,0
30055,and,0,0
30056,surgical,0,1
30057,procedures,0,0
30058,and,0,0
30059,as,0,0
30060,such,0,0
30061,require,0,0
30062,strict,0,0
30063,attention,0,0
30064,to,0,0
30065,study,0,0
30066,design,0,0
30067,and,0,0
30068,statistical,0,0
30069,analysis,0,0
30070,.,0,0
30071,There,0,0
30072,are,0,0
30073,",",0,0
30074,however,0,0
30075,",",0,0
30076,multiple,0,0
30077,challenges,0,0
30078,in,0,0
30079,conducting,0,0
30080,a,0,0
30081,well-designed,0,0
30082,clinical,0,0
30083,trial,0,0
30084,.,0,0
30085,This,0,0
30086,article,0,0
30087,describes,0,0
30088,the,0,0
30089,difficulties,0,0
30090,encountered,0,0
30091,at,0,0
30092,a,1,0
30093,single,1,0
30094,institution,1,1
30095,participating,1,1
30096,in,1,0
30097,a,1,0
30098,multicenter,1,0
30099,drug,1,0
30100,study,1,0
30101,and,0,0
30102,reviews,0,0
30103,the,0,0
30104,challenges,0,0
30105,involved,0,0
30106,in,0,0
30107,developing,0,0
30108,a,0,0
30109,high-quality,0,0
30110,randomized,0,0
30111,controlled,0,0
30112,study,0,0
30113,.,0,0
30114,Direct,0,0
30115,aortic,0,1
30116,cannulation,0,1
30117,in,0,0
30118,minimally,1,0
30119,invasive,1,0
30120,mitral-valve,1,1
30121,operations,1,1
30122,.,1,0
30123,The,0,0
30124,minimally,0,0
30125,invasive,0,0
30126,Port-Access,0,0
30127,(,0,0
30128,Heartport,0,0
30129,",",0,0
30130,Redwood,0,1
30131,City,0,0
30132,",",0,0
30133,CA,0,1
30134,),0,0
30135,approach,0,0
30136,in,0,0
30137,mitral-valve,0,1
30138,operations,0,1
30139,originally,0,1
30140,required,0,0
30141,femoral,0,0
30142,arterial,0,0
30143,cannulation,0,0
30144,",",0,0
30145,which,0,0
30146,is,0,0
30147,considered,0,0
30148,a,0,0
30149,disadvantage,0,0
30150,",",0,0
30151,especially,0,0
30152,in,0,0
30153,patients,1,1
30154,with,1,1
30155,peripheral,1,0
30156,vessel,1,0
30157,disease,1,1
30158,.,1,0
30159,In,0,0
30160,this,0,0
30161,study,0,0
30162,20,1,0
30163,patients,1,1
30164,were,1,0
30165,prospectively,1,1
30166,randomized,1,0
30167,into,1,0
30168,2,1,0
30169,groups,1,0
30170,",",1,0
30171,to,1,0
30172,undergo,1,0
30173,either,1,0
30174,standard,1,0
30175,femoral,1,0
30176,(,1,0
30177,group,1,0
30178,A,1,0
30179,),1,0
30180,or,1,0
30181,direct,1,0
30182,aortic,1,1
30183,cannulation,1,1
30184,(,1,0
30185,group,1,0
30186,B,1,0
30187,),1,0
30188,.,1,0
30189,Pre-,0,0
30190,and,0,0
30191,postoperative,0,0
30192,data,0,0
30193,as,0,0
30194,well,0,0
30195,as,0,0
30196,markers,0,0
30197,for,0,0
30198,myocardial,0,1
30199,damage,0,0
30200,were,0,0
30201,assessed,0,0
30202,.,0,0
30203,Postoperatively,0,0
30204,",",0,0
30205,patients,0,1
30206,of,0,0
30207,group,0,1
30208,B,0,0
30209,showed,0,0
30210,lower,0,0
30211,levels,0,0
30212,of,0,0
30213,damage,0,0
30214,",",0,0
30215,indicating,0,0
30216,that,0,0
30217,direct,0,0
30218,aortic,0,1
30219,cannulation,0,0
30220,might,0,0
30221,provide,0,0
30222,better,0,0
30223,myocardial,0,0
30224,protection,0,0
30225,.,0,0
30226,Furthermore,0,0
30227,",",0,0
30228,the,0,0
30229,direct,0,0
30230,aortic,0,1
30231,cannulation,0,0
30232,technique,0,0
30233,may,0,0
30234,eliminate,0,0
30235,complications,0,0
30236,associated,0,0
30237,with,0,1
30238,the,0,0
30239,standard,0,0
30240,femoral,0,0
30241,artery,0,1
30242,cannulation,0,1
30243,.,0,0
30244,Lack,0,0
30245,of,0,0
30246,benefit,0,0
30247,of,0,0
30248,intravenous,0,0
30249,synthetic,0,0
30250,human,0,0
30251,secretin,0,0
30252,in,0,0
30253,the,0,0
30254,treatment,0,0
30255,of,0,0
30256,autism,1,1
30257,.,1,0
30258,The,0,0
30259,objective,0,0
30260,of,0,0
30261,this,0,0
30262,study,0,0
30263,was,0,0
30264,to,0,0
30265,determine,0,0
30266,if,0,0
30267,an,0,0
30268,intravenous,0,0
30269,infusion,0,0
30270,of,0,0
30271,synthetic,0,0
30272,human,0,0
30273,secretin,0,0
30274,improves,0,0
30275,language,0,0
30276,and,0,0
30277,behavioral,0,0
30278,symptoms,0,0
30279,in,0,0
30280,children,1,1
30281,with,1,1
30282,autism,1,1
30283,.,1,0
30284,Forty-two,1,1
30285,children,1,1
30286,with,1,1
30287,the,1,0
30288,diagnosis,1,0
30289,of,1,0
30290,autism,1,1
30291,were,0,0
30292,randomized,0,0
30293,to,0,0
30294,one,0,0
30295,of,0,0
30296,two,0,0
30297,groups,0,0
30298,in,0,0
30299,this,0,0
30300,double-blind,0,0
30301,cross-over,0,0
30302,trial,0,0
30303,.,0,0
30304,One,0,0
30305,group,0,0
30306,received,0,0
30307,2,0,0
30308,IU/kg,0,0
30309,of,0,0
30310,intravenous,0,0
30311,synthetic,0,0
30312,human,0,0
30313,secretin,0,0
30314,at,0,0
30315,the,0,0
30316,first,0,0
30317,visit,0,0
30318,",",0,0
30319,followed,0,0
30320,by,0,0
30321,an,0,0
30322,equal,0,0
30323,volume,0,0
30324,of,0,0
30325,intravenous,0,0
30326,saline,0,0
30327,placebo,0,0
30328,at,0,0
30329,week,0,0
30330,6,0,0
30331,.,0,0
30332,The,0,0
30333,other,0,0
30334,group,0,0
30335,received,0,0
30336,treatments,0,0
30337,in,0,0
30338,the,0,0
30339,reverse,0,0
30340,order,0,0
30341,.,0,0
30342,All,0,0
30343,children,0,1
30344,were,0,0
30345,evaluated,0,0
30346,at,0,0
30347,weeks,0,0
30348,1,0,0
30349,",",0,0
30350,3,0,0
30351,",",0,0
30352,6,0,0
30353,",",0,0
30354,9,0,0
30355,",",0,0
30356,and,0,0
30357,12,0,0
30358,with,0,1
30359,standardized,0,0
30360,assessments,0,0
30361,of,0,0
30362,language,0,0
30363,",",0,0
30364,behavior,0,0
30365,",",0,0
30366,and,0,0
30367,autism,0,1
30368,symptomatology,0,0
30369,.,0,0
30370,There,0,0
30371,were,0,0
30372,no,0,0
30373,significant,0,0
30374,differences,0,0
30375,in,0,0
30376,the,0,0
30377,mean,0,0
30378,scores,0,0
30379,on,0,0
30380,any,0,0
30381,measure,0,0
30382,of,0,0
30383,language,0,0
30384,",",0,0
30385,behavior,0,0
30386,",",0,0
30387,or,0,0
30388,autism,0,1
30389,symptom,0,0
30390,severity,0,0
30391,after,0,0
30392,treatment,0,0
30393,with,0,1
30394,secretin,0,0
30395,compared,0,0
30396,to,0,0
30397,treatment,0,0
30398,with,0,1
30399,placebo,0,0
30400,.,0,0
30401,The,0,0
30402,results,0,0
30403,of,0,0
30404,this,0,0
30405,study,0,0
30406,do,0,0
30407,not,0,0
30408,support,0,0
30409,secretin,0,0
30410,as,0,0
30411,a,0,0
30412,treatment,0,0
30413,for,0,0
30414,autism,0,1
30415,.,0,0
30416,Long-term,0,0
30417,use,0,0
30418,of,0,0
30419,Viozan,0,0
30420,(,0,0
30421,sibenadet,0,0
30422,HCl,0,0
30423,),0,0
30424,in,0,0
30425,patients,1,1
30426,with,1,1
30427,chronic,1,1
30428,obstructive,1,1
30429,pulmonary,1,1
30430,disease,1,1
30431,:,1,1
30432,results,0,0
30433,of,0,0
30434,a,0,0
30435,1-year,0,0
30436,study,0,0
30437,.,0,0
30438,Viozan,0,0
30439,(,0,0
30440,sibenadet,0,0
30441,HCl,0,0
30442,",",0,0
30443,AR-C68397AA,0,0
30444,),0,0
30445,is,0,0
30446,a,0,0
30447,novel,0,0
30448,dual,0,0
30449,D2,0,0
30450,dopamine,0,0
30451,receptor,0,0
30452,",",0,0
30453,beta2-adrenoceptor,0,0
30454,agonist,0,0
30455,that,0,0
30456,has,0,0
30457,been,0,0
30458,investigated,0,0
30459,for,0,0
30460,efficacy,0,0
30461,in,0,0
30462,alleviating,0,0
30463,the,0,0
30464,symptoms,0,0
30465,of,0,0
30466,chronic,0,1
30467,obstructive,0,1
30468,pulmonary,0,1
30469,disease,0,1
30470,(,0,0
30471,COPD,0,0
30472,),0,0
30473,.,0,0
30474,The,0,0
30475,slowly,0,0
30476,progressive,0,0
30477,nature,0,0
30478,of,0,0
30479,this,0,0
30480,disease,0,0
30481,means,0,0
30482,that,0,0
30483,patients,0,0
30484,will,0,0
30485,require,0,0
30486,ongoing,0,0
30487,therapeutic,0,0
30488,management,0,0
30489,for,0,0
30490,many,0,0
30491,years,0,1
30492,",",0,0
30493,or,0,0
30494,even,0,0
30495,decades,0,0
30496,.,0,0
30497,With,0,1
30498,such,0,0
30499,long-term,0,0
30500,treatment,0,0
30501,",",0,0
30502,the,0,0
30503,safety,0,0
30504,profile,0,0
30505,of,0,0
30506,new,0,0
30507,agents,0,0
30508,will,0,0
30509,be,0,0
30510,of,0,0
30511,paramount,0,0
30512,importance,0,0
30513,.,0,0
30514,As,0,0
30515,part,0,0
30516,of,0,0
30517,the,0,0
30518,large-scale,0,0
30519,assessment,0,0
30520,of,0,0
30521,sibenadet,0,0
30522,",",0,0
30523,a,0,0
30524,12-month,0,0
30525,safety,0,0
30526,study,0,0
30527,has,0,0
30528,been,0,0
30529,conducted,0,0
30530,.,0,0
30531,Following,0,0
30532,completion,0,0
30533,of,0,0
30534,a,0,0
30535,2-week,0,0
30536,baseline,0,0
30537,period,0,0
30538,",",0,0
30539,435,1,1
30540,adults,1,1
30541,with,1,1
30542,stable,1,1
30543,",",1,0
30544,symptomatic,1,1
30545,",",1,0
30546,smoking-related,1,0
30547,COPD,1,0
30548,were,1,0
30549,randomized,1,0
30550,to,0,0
30551,receive,0,0
30552,either,0,0
30553,500,0,0
30554,microg,0,0
30555,sibenadet,0,0
30556,or,0,0
30557,placebo,0,0
30558,delivered,0,0
30559,via,0,0
30560,pressurized,0,0
30561,metered,0,0
30562,dose,0,0
30563,inhaler,0,0
30564,(,0,0
30565,pMDI,0,0
30566,),0,0
30567,",",0,0
30568,three,0,0
30569,times,0,0
30570,daily,0,0
30571,for,0,0
30572,52,0,1
30573,weeks,0,0
30574,.,0,1
30575,Sibenadet,0,0
30576,therapy,0,0
30577,was,0,0
30578,generally,0,0
30579,well,0,0
30580,tolerated,0,0
30581,",",0,0
30582,with,0,0
30583,the,0,0
30584,only,0,0
30585,notable,0,0
30586,differences,0,0
30587,seen,0,0
30588,in,0,0
30589,the,0,0
30590,incidence,0,0
30591,of,0,0
30592,tremor,0,0
30593,and,0,0
30594,taste,0,0
30595,of,0,0
30596,treatment,0,0
30597,(,0,0
30598,16.9,0,0
30599,%,0,0
30600,vs.,0,0
30601,4.1,0,0
30602,%,0,0
30603,and,0,0
30604,14.5,0,0
30605,%,0,0
30606,vs.,0,0
30607,4.1,0,0
30608,%,0,0
30609,in,0,0
30610,the,0,0
30611,sibenadet,0,0
30612,and,0,0
30613,placebo,0,0
30614,groups,0,0
30615,respectively,0,0
30616,),0,0
30617,.,0,0
30618,There,0,0
30619,were,0,0
30620,a,0,0
30621,total,0,0
30622,of,0,0
30623,79,1,1
30624,patients,1,1
30625,with,1,1
30626,serious,1,0
30627,adverse,1,0
30628,events,1,0
30629,(,1,0
30630,SAEs,1,0
30631,),1,0
30632,",",1,0
30633,43,1,0
30634,(,1,0
30635,14.8,1,0
30636,%,1,0
30637,),1,0
30638,in,1,0
30639,the,1,0
30640,sibenadet,1,0
30641,pMDI,1,0
30642,group,1,0
30643,and,1,0
30644,36,1,0
30645,(,1,0
30646,24.8,1,0
30647,%,1,0
30648,),1,0
30649,in,1,0
30650,the,1,0
30651,placebo,1,0
30652,group,1,0
30653,.,1,0
30654,No,0,0
30655,clinically,0,0
30656,significant,0,0
30657,abnormal,0,0
30658,laboratory,0,0
30659,values,0,0
30660,or,0,1
30661,overall,0,0
30662,differences,0,0
30663,between,0,0
30664,treatment,0,0
30665,groups,0,0
30666,were,0,0
30667,noted,0,0
30668,.,0,0
30669,Similarly,0,0
30670,",",0,0
30671,there,0,0
30672,were,0,0
30673,no,0,0
30674,clinically,0,0
30675,significant,0,0
30676,differences,0,0
30677,between,0,0
30678,the,0,0
30679,two,0,0
30680,treatment,0,0
30681,groups,0,0
30682,for,0,0
30683,cardiac,0,1
30684,variables,0,0
30685,",",0,0
30686,or,0,0
30687,in,0,0
30688,vital,0,0
30689,signs,0,0
30690,.,0,0
30691,The,0,0
30692,secondary,0,0
30693,variables,0,0
30694,showed,0,0
30695,no,0,0
30696,notable,0,0
30697,differences,0,0
30698,with,0,1
30699,respect,0,0
30700,to,0,0
30701,lung,0,0
30702,function,0,0
30703,",",0,0
30704,exacerbations,0,0
30705,or,0,0
30706,health-related,0,0
30707,quality,0,0
30708,of,0,0
30709,life,0,0
30710,.,0,0
30711,Due,0,0
30712,to,0,0
30713,the,0,0
30714,effective,0,0
30715,beta2-agonist,0,0
30716,properties,0,0
30717,",",0,0
30718,patients,0,1
30719,in,0,0
30720,the,0,0
30721,sibenadet,0,0
30722,group,0,0
30723,did,0,0
30724,",",0,0
30725,however,0,0
30726,",",0,0
30727,report,0,0
30728,reduced,0,0
30729,rescue,0,0
30730,medication,0,0
30731,usage,0,0
30732,at,0,0
30733,all,0,0
30734,timepoints,0,0
30735,.,0,0
30736,While,0,0
30737,the,0,0
30738,results,0,0
30739,of,0,0
30740,this,0,0
30741,study,0,0
30742,show,0,0
30743,that,0,0
30744,",",0,0
30745,overall,0,0
30746,",",0,0
30747,sibenadet,0,0
30748,therapy,0,0
30749,was,0,0
30750,well,0,0
30751,tolerated,0,0
30752,",",0,0
30753,the,0,0
30754,lack,0,0
30755,of,0,0
30756,sustained,0,0
30757,benefit,0,0
30758,reported,0,0
30759,in,0,0
30760,large-scale,0,0
30761,clinical,0,0
30762,efficacy,0,0
30763,studies,0,0
30764,means,0,0
30765,that,0,0
30766,sibenadet,0,0
30767,development,0,0
30768,will,0,0
30769,not,0,0
30770,be,0,0
30771,continued,0,0
30772,.,0,0
30773,Utilization,0,0
30774,of,0,0
30775,health,0,0
30776,care,0,0
30777,services,0,1
30778,by,0,0
30779,patients,1,1
30780,with,1,1
30781,chronic,1,1
30782,obstructive,1,1
30783,pulmonary,1,1
30784,disease,1,1
30785,.,1,0
30786,In,0,0
30787,order,0,0
30788,to,0,0
30789,identify,0,0
30790,healthcare,0,0
30791,resource,0,0
30792,use,0,0
30793,patterns,0,0
30794,associated,0,0
30795,with,0,1
30796,chronic,1,1
30797,obstructive,1,1
30798,pulmonary,1,1
30799,disease,1,1
30800,(,1,0
30801,COPD,1,0
30802,),1,0
30803,",",0,0
30804,resource,0,0
30805,utilization,0,0
30806,(,0,0
30807,RU,0,1
30808,),0,0
30809,data,0,0
30810,collection,0,0
30811,was,0,0
30812,integrated,0,0
30813,into,0,0
30814,a,0,0
30815,randomized,0,0
30816,",",0,0
30817,double-blind,0,0
30818,placebo-controlled,0,0
30819,study,0,0
30820,of,0,0
30821,Viozan,0,0
30822,(,0,0
30823,sibenadet,0,0
30824,HCl,0,0
30825,),0,0
30826,.,0,0
30827,This,0,0
30828,study,0,0
30829,enrolled,0,1
30830,patients,1,1
30831,with,1,1
30832,symptomatic,1,1
30833,",",1,0
30834,smoking-related,1,0
30835,COPD,1,0
30836,",",0,0
30837,randomized,0,0
30838,to,0,0
30839,receive,0,0
30840,sibenadet,0,0
30841,or,0,0
30842,placebo,0,0
30843,for,0,0
30844,a,0,0
30845,52-week,0,0
30846,treatment,0,0
30847,period,0,0
30848,.,0,0
30849,A,0,0
30850,questionnaire,0,0
30851,establishing,0,0
30852,typical,0,0
30853,pre-trial,0,0
30854,",",0,0
30855,COPD-related,0,0
30856,RU,0,1
30857,was,0,0
30858,completed,0,0
30859,by,0,0
30860,each,0,0
30861,patient,0,0
30862,.,0,0
30863,Subsequent,0,0
30864,data,0,0
30865,were,0,0
30866,collected,0,0
30867,by,0,0
30868,means,0,0
30869,of,0,0
30870,an,0,0
30871,Interactive,0,0
30872,Voice,0,0
30873,Response,0,0
30874,System,0,0
30875,(,0,0
30876,IVRS,0,0
30877,),0,0
30878,at,0,0
30879,30-day,0,0
30880,intervals,0,0
30881,(,0,0
30882,14,0,1
30883,time,0,0
30884,points,0,0
30885,),0,0
30886,during,0,0
30887,the,0,0
30888,study,0,0
30889,and,0,0
30890,in,0,0
30891,the,0,0
30892,follow-up,0,0
30893,period,0,0
30894,.,0,0
30895,The,0,0
30896,IVRS,0,0
30897,system,0,0
30898,facilitated,0,0
30899,data,0,0
30900,collection,0,0
30901,and,0,0
30902,minimized,0,0
30903,inconvenience,0,0
30904,to,0,0
30905,the,0,0
30906,patient,0,0
30907,.,0,0
30908,Compliance,0,0
30909,with,0,0
30910,the,0,0
30911,requirement,0,0
30912,to,0,0
30913,record,0,0
30914,details,0,0
30915,of,0,0
30916,the,0,0
30917,healthcare,0,0
30918,services,0,0
30919,during,0,0
30920,the,0,0
30921,year-long,0,0
30922,study,0,0
30923,was,0,0
30924,high,0,0
30925,.,0,0
30926,No,0,0
30927,overall,0,0
30928,trend,0,0
30929,for,0,0
30930,lower,0,0
30931,RU,0,1
30932,was,0,0
30933,associated,0,0
30934,with,0,1
30935,sibenadet,0,0
30936,therapy,0,0
30937,",",0,0
30938,which,0,0
30939,correlates,0,0
30940,with,0,0
30941,the,0,0
30942,lack,0,0
30943,of,0,0
30944,sustained,0,0
30945,clinical,0,0
30946,effect,0,0
30947,seen,0,0
30948,in,0,0
30949,studies,0,0
30950,conducted,0,0
30951,concurrently,0,0
30952,.,0,0
30953,These,0,0
30954,data,0,0
30955,do,0,0
30956,",",0,0
30957,however,0,0
30958,",",0,0
30959,provide,0,0
30960,valuable,0,0
30961,information,0,0
30962,on,0,0
30963,RU,0,1
30964,associated,0,0
30965,with,0,1
30966,COPD,0,0
30967,and,0,0
30968,insights,0,0
30969,into,0,1
30970,adjustments,0,0
30971,associated,0,0
30972,with,0,1
30973,changes,0,0
30974,in,0,0
30975,disease,0,1
30976,course,0,1
30977,.,0,0
30978,Physicians,0,1
30979,were,0,0
30980,seen,0,0
30981,to,0,0
30982,be,0,0
30983,the,0,0
30984,most,0,0
30985,common,0,0
30986,source,0,0
30987,of,0,0
30988,care,0,0
30989,for,0,0
30990,patients,0,1
30991,with,0,1
30992,COPD,0,0
30993,and,0,0
30994,more,0,0
30995,of,0,0
30996,the,0,0
30997,patients,1,1
30998,with,1,1
30999,severe,1,1
31000,COPD,1,0
31001,(,1,0
31002,stage,1,1
31003,III,1,0
31004,),1,0
31005,than,1,0
31006,mild,1,1
31007,(,1,0
31008,stage,1,1
31009,I,1,0
31010,),1,0
31011,were,0,0
31012,seen,0,0
31013,to,0,0
31014,utilize,0,0
31015,the,0,0
31016,most,0,0
31017,expensive,0,0
31018,resources,0,0
31019,(,0,0
31020,e.g,0,0
31021,.,0,0
31022,inpatient,0,0
31023,hospital,0,0
31024,care,0,1
31025,),0,0
31026,.,0,0
31027,For,0,0
31028,those,0,1
31029,patients,0,1
31030,who,0,1
31031,experienced,0,1
31032,an,0,1
31033,exacerbation,0,0
31034,during,0,0
31035,the,0,0
31036,trial,0,0
31037,(,0,0
31038,irrespective,0,0
31039,of,0,0
31040,treatment,0,0
31041,group,0,0
31042,),0,0
31043,",",0,0
31044,resource,0,0
31045,use,0,0
31046,was,0,0
31047,increased,0,0
31048,during,0,0
31049,the,0,0
31050,periods,0,0
31051,when,0,0
31052,an,0,0
31053,exacerbation,0,0
31054,was,0,0
31055,reported,0,0
31056,when,0,0
31057,compared,0,0
31058,with,0,0
31059,the,0,0
31060,periods,0,0
31061,before,0,0
31062,or,0,0
31063,after,0,0
31064,an,0,0
31065,exacerbation,0,0
31066,.,0,0
31067,The,0,0
31068,proportion,0,0
31069,of,0,0
31070,cases,0,0
31071,attending,0,1
31072,the,0,0
31073,physician,0,0
31074,doubled,0,0
31075,and,0,0
31076,with,0,0
31077,a,0,0
31078,trip,0,0
31079,to,0,0
31080,the,0,0
31081,Emergency,0,0
31082,Room,0,0
31083,(,0,0
31084,ER,0,1
31085,),0,0
31086,increased,0,0
31087,approximately,0,0
31088,ninefold,0,0
31089,during,0,0
31090,the,0,0
31091,reporting,0,0
31092,period,0,0
31093,in,0,0
31094,which,0,0
31095,the,0,0
31096,exacerbation,0,0
31097,occurred,0,0
31098,compared,0,0
31099,with,0,0
31100,the,0,0
31101,previous,0,0
31102,month,0,0
31103,.,0,0
31104,This,0,0
31105,study,0,0
31106,has,0,0
31107,shown,0,0
31108,that,0,0
31109,use,0,0
31110,of,0,0
31111,an,0,0
31112,IVRS,0,0
31113,",",0,0
31114,even,0,0
31115,in,0,0
31116,elderly,1,1
31117,patients,1,1
31118,",",0,0
31119,is,0,0
31120,an,0,0
31121,effective,0,0
31122,means,0,0
31123,of,0,0
31124,gathering,0,0
31125,RU,0,1
31126,data,0,0
31127,over,0,0
31128,long,0,1
31129,periods,0,0
31130,.,0,0
31131,The,0,0
31132,study,0,0
31133,findings,0,0
31134,suggest,0,0
31135,that,0,0
31136,the,0,0
31137,advent,0,0
31138,of,0,0
31139,effective,0,0
31140,therapeutic,0,0
31141,interventions,0,0
31142,",",0,0
31143,particularly,0,0
31144,any,0,0
31145,with,0,0
31146,the,0,0
31147,ability,0,0
31148,to,0,0
31149,minimize,0,0
31150,exacerbations,0,0
31151,and,0,0
31152,limit,0,0
31153,disease,0,1
31154,progression,0,0
31155,",",0,0
31156,could,0,0
31157,impact,0,0
31158,on,0,0
31159,the,0,0
31160,health,0,0
31161,care,0,0
31162,services,0,0
31163,used,0,0
31164,and,0,0
31165,potentially,0,0
31166,reduce,0,0
31167,associated,0,0
31168,costs,0,0
31169,.,0,1
31170,Low-dose,0,0
31171,mifepristone,0,0
31172,for,0,0
31173,uterine,0,1
31174,leiomyomata,0,1
31175,.,0,0
31176,OBJECTIVE,0,0
31177,To,0,0
31178,compare,0,0
31179,the,0,0
31180,effect,0,0
31181,of,0,0
31182,5,0,0
31183,and,0,0
31184,10,0,0
31185,mg,0,0
31186,of,0,0
31187,mifepristone,0,0
31188,on,0,0
31189,uterine,0,1
31190,leiomyoma,0,1
31191,size,0,0
31192,and,0,0
31193,symptoms,0,0
31194,",",0,0
31195,and,0,0
31196,to,0,0
31197,measure,0,0
31198,side,0,0
31199,effects,0,0
31200,.,0,1
31201,METHODS,0,0
31202,Forty,1,1
31203,premenopausal,1,1
31204,women,1,1
31205,with,1,1
31206,large,1,1
31207,",",1,0
31208,symptomatic,1,1
31209,leiomyomata,1,1
31210,were,0,0
31211,randomized,0,0
31212,to,0,0
31213,receive,0,0
31214,either,0,0
31215,5,0,0
31216,or,0,0
31217,10,0,0
31218,mg,0,0
31219,of,0,0
31220,mifepristone,0,0
31221,daily,0,0
31222,for,0,0
31223,6,0,0
31224,months,0,0
31225,in,0,0
31226,an,0,0
31227,open-label,0,0
31228,study,0,0
31229,.,0,0
31230,Uterine,0,0
31231,volume,0,0
31232,was,0,0
31233,measured,0,0
31234,at,0,0
31235,bimonthly,0,0
31236,intervals,0,0
31237,by,0,0
31238,sonography,0,0
31239,.,0,0
31240,Serum,0,0
31241,concentrations,0,0
31242,of,0,0
31243,hemoglobin,0,0
31244,levels,0,0
31245,",",0,0
31246,follicle-stimulating,0,0
31247,hormone,0,0
31248,",",0,0
31249,and,0,0
31250,liver,0,1
31251,enzymes,0,0
31252,were,0,0
31253,obtained,0,0
31254,",",0,0
31255,and,0,0
31256,endometrial,0,1
31257,samples,0,0
31258,",",0,0
31259,symptoms,0,0
31260,",",0,0
31261,and,0,0
31262,menstrual,0,1
31263,bleeding,0,0
31264,were,0,0
31265,also,0,0
31266,assessed,0,0
31267,.,0,0
31268,RESULTS,0,0
31269,Nineteen,1,1
31270,of,1,0
31271,20,1,1
31272,subjects,1,1
31273,taking,0,1
31274,5,0,0
31275,mg,0,0
31276,and,0,0
31277,all,0,0
31278,20,0,0
31279,subjects,0,1
31280,taking,0,1
31281,10,0,1
31282,mg,0,0
31283,completed,0,1
31284,all,0,0
31285,6,0,0
31286,months,0,0
31287,of,0,0
31288,the,0,0
31289,study,0,0
31290,.,0,0
31291,Mean,0,0
31292,uterine,0,1
31293,volume,0,0
31294,shrank,0,0
31295,by,0,0
31296,48,0,0
31297,%,0,0
31298,(,0,0
31299,P,0,0
31300,<,0,0
31301,.001,0,0
31302,),0,0
31303,in,0,0
31304,the,0,0
31305,5-mg,0,0
31306,group,0,0
31307,and,0,0
31308,49,0,1
31309,%,0,0
31310,(,0,0
31311,P,0,0
31312,<,0,0
31313,.001,0,0
31314,),0,0
31315,in,0,0
31316,the,0,0
31317,10-mg,0,0
31318,group,0,0
31319,",",0,0
31320,a,0,0
31321,nonsignificant,0,0
31322,difference,0,0
31323,.,0,0
31324,Leiomyoma-related,0,0
31325,symptoms,0,0
31326,were,0,0
31327,comparably,0,0
31328,reduced,0,0
31329,in,0,0
31330,both,0,0
31331,groups,0,0
31332,.,0,0
31333,Amenorrhea,0,1
31334,occurred,0,0
31335,in,0,0
31336,60-65,0,1
31337,%,0,0
31338,of,0,0
31339,both,0,0
31340,groups,0,0
31341,.,0,0
31342,Hemoglobin,0,0
31343,levels,0,0
31344,increased,0,0
31345,by,0,0
31346,2.5,0,0
31347,g/dL,0,0
31348,in,0,0
31349,anemic,0,1
31350,subjects,0,1
31351,.,0,0
31352,The,0,0
31353,incidence,0,0
31354,of,0,0
31355,hot,0,0
31356,flashes,0,0
31357,increased,0,0
31358,significantly,0,0
31359,over,0,0
31360,baseline,0,0
31361,in,0,0
31362,the,0,0
31363,10-mg,0,0
31364,group,0,0
31365,but,0,0
31366,not,0,0
31367,in,0,0
31368,the,0,0
31369,5-mg,0,0
31370,group,0,0
31371,.,0,0
31372,Simple,0,0
31373,endometrial,0,1
31374,hyperplasia,0,1
31375,occurred,0,0
31376,in,0,0
31377,28,0,0
31378,%,0,0
31379,of,0,0
31380,all,0,0
31381,subjects,0,1
31382,",",0,0
31383,with,0,0
31384,no,0,0
31385,difference,0,0
31386,between,0,0
31387,groups,0,0
31388,.,0,0
31389,No,0,0
31390,atypical,0,0
31391,hyperplasia,0,1
31392,was,0,0
31393,noted,0,0
31394,.,0,0
31395,CONCLUSION,0,0
31396,Mifepristone,0,0
31397,in,0,0
31398,doses,0,0
31399,of,0,0
31400,5,0,0
31401,mg,0,0
31402,or,0,1
31403,10,0,1
31404,mg,0,0
31405,results,0,0
31406,in,0,0
31407,comparable,0,0
31408,leiomyoma,0,1
31409,regression,0,0
31410,",",0,0
31411,improvement,0,0
31412,in,0,0
31413,symptoms,0,0
31414,",",0,0
31415,and,0,0
31416,few,0,0
31417,side,0,0
31418,effects,0,0
31419,.,0,0
31420,Further,0,0
31421,study,0,0
31422,is,0,0
31423,needed,0,0
31424,to,0,0
31425,assess,0,0
31426,the,0,0
31427,long-term,0,0
31428,safety,0,0
31429,and,0,0
31430,efficacy,0,0
31431,of,0,0
31432,low-dose,0,0
31433,mifepristone,0,0
31434,.,0,0
31435,Is,0,0
31436,a,0,0
31437,2-week,0,0
31438,duration,0,0
31439,sufficient,0,0
31440,for,0,0
31441,stenting,0,0
31442,in,0,0
31443,endopyelotomy,0,1
31444,?,0,0
31445,PURPOSE,0,0
31446,Internal,0,0
31447,stenting,0,0
31448,is,0,0
31449,an,0,0
31450,integral,0,0
31451,part,0,0
31452,of,0,0
31453,endopyelotomy,0,0
31454,.,0,0
31455,Studies,0,0
31456,in,0,0
31457,animals,1,0
31458,show,0,0
31459,good,0,0
31460,healing,0,0
31461,after,0,0
31462,1,0,0
31463,to,0,0
31464,2,0,0
31465,weeks,0,0
31466,of,0,0
31467,ureterotomy,0,1
31468,.,0,0
31469,Inherent,0,0
31470,stent,0,0
31471,related,0,0
31472,problems,0,0
31473,warrant,0,0
31474,a,0,0
31475,minimum,0,0
31476,possible,0,0
31477,duration,0,0
31478,of,0,0
31479,stenting,0,0
31480,without,0,0
31481,compromising,0,0
31482,the,0,0
31483,results,0,0
31484,of,0,0
31485,endopyelotomy,0,1
31486,.,0,0
31487,We,0,0
31488,performed,0,0
31489,a,0,0
31490,prospective,0,0
31491,randomized,0,0
31492,trial,0,0
31493,to,0,0
31494,evaluate,0,0
31495,the,0,0
31496,optimum,0,0
31497,duration,0,0
31498,of,0,0
31499,stenting,0,0
31500,after,0,0
31501,endopyelotomy,0,1
31502,.,0,0
31503,MATERIALS,0,0
31504,AND,0,0
31505,METHODS,0,0
31506,A,1,0
31507,total,1,1
31508,of,1,0
31509,57,1,1
31510,consecutive,1,1
31511,patients,1,1
31512,with,1,1
31513,primary,1,1
31514,ureteropelvic,1,1
31515,junction,1,0
31516,obstruction,1,1
31517,were,0,0
31518,randomized,0,0
31519,to,0,0
31520,undergo,0,0
31521,7/14Fr,0,0
31522,internal,0,0
31523,endopyelotomy,0,1
31524,stent,0,0
31525,placement,0,0
31526,for,0,0
31527,2,0,0
31528,(,0,0
31529,group,0,0
31530,1,0,0
31531,),0,0
31532,and,0,0
31533,4,0,0
31534,(,0,0
31535,group,0,0
31536,2,0,0
31537,),0,0
31538,weeks,0,0
31539,.,0,0
31540,A,1,0
31541,symptom,1,0
31542,based,1,0
31543,questionnaire,1,0
31544,was,1,0
31545,administered,1,0
31546,to,1,0
31547,all,1,0
31548,patients,1,1
31549,at,1,0
31550,stent,1,1
31551,removal,1,0
31552,.,0,0
31553,Followup,0,0
31554,was,0,0
31555,done,0,0
31556,with,0,1
31557,diuretic,0,0
31558,scanning,0,0
31559,at,0,0
31560,3,0,0
31561,",",0,0
31562,6,0,0
31563,",",0,0
31564,9,0,0
31565,and,0,0
31566,12,0,0
31567,months,0,0
31568,and,0,0
31569,then,0,0
31570,yearly,0,0
31571,",",0,0
31572,and,0,0
31573,thereafter,0,0
31574,with,0,0
31575,diuretic,0,0
31576,renography,0,0
31577,.,0,0
31578,RESULTS,0,0
31579,In,1,0
31580,each,1,0
31581,group,1,0
31582,26,1,0
31583,patients,1,1
31584,were,1,0
31585,available,1,0
31586,for,1,0
31587,evaluation,1,0
31588,.,1,0
31589,The,1,0
31590,2,1,0
31591,groups,1,0
31592,were,1,0
31593,comparable,1,0
31594,in,1,0
31595,terms,1,0
31596,of,1,0
31597,age,1,1
31598,",",1,0
31599,sex,1,0
31600,",",1,0
31601,symptoms,1,0
31602,and,1,0
31603,ipsilateral,1,1
31604,glomerular,1,0
31605,filtration,1,0
31606,rate,1,0
31607,.,1,0
31608,Mean,0,0
31609,followup,0,0
31610,was,0,0
31611,22.3,0,0
31612,(,0,0
31613,range,0,0
31614,12,0,0
31615,to,0,0
31616,36,0,1
31617,),0,0
31618,and,0,0
31619,21.3,0,0
31620,months,0,0
31621,(,0,0
31622,range,0,0
31623,12,0,0
31624,to,0,0
31625,35,0,1
31626,),0,0
31627,in,0,0
31628,groups,0,0
31629,1,0,0
31630,and,0,0
31631,2,0,0
31632,",",0,0
31633,respectively,0,0
31634,.,0,0
31635,At,0,0
31636,the,0,0
31637,end,0,0
31638,of,0,0
31639,1,0,0
31640,year,0,1
31641,24,0,0
31642,group,0,0
31643,1,0,0
31644,(,0,0
31645,92.3,0,0
31646,%,0,0
31647,),0,0
31648,and,0,0
31649,23,0,1
31650,group,0,0
31651,2,0,0
31652,(,0,0
31653,90.3,0,0
31654,%,0,0
31655,),0,0
31656,patients,0,1
31657,had,0,0
31658,an,0,0
31659,improved,0,0
31660,drainage,0,0
31661,pattern,0,0
31662,.,0,0
31663,This,0,0
31664,difference,0,0
31665,was,0,0
31666,not,0,0
31667,significant,0,0
31668,.,0,0
31669,Stent,0,0
31670,related,0,0
31671,symptoms,0,0
31672,were,0,0
31673,present,0,0
31674,in,0,0
31675,a,0,0
31676,good,0,0
31677,proportion,0,0
31678,of,0,0
31679,patients,0,1
31680,in,0,0
31681,groups,0,0
31682,1,0,0
31683,and,0,0
31684,2,0,0
31685,but,0,0
31686,there,0,0
31687,was,0,0
31688,a,0,0
31689,significant,0,0
31690,difference,0,0
31691,in,0,0
31692,the,0,0
31693,incidence,0,0
31694,of,0,0
31695,urinary,0,0
31696,tract,0,1
31697,infections,0,0
31698,(,0,0
31699,11.5,0,0
31700,%,0,0
31701,versus,0,0
31702,38.1,0,0
31703,%,0,0
31704,",",0,0
31705,p,0,0
31706,=,0,0
31707,0.04,0,0
31708,),0,0
31709,.,0,0
31710,Of,0,0
31711,the,0,0
31712,group,0,0
31713,2,0,0
31714,patients,0,1
31715,64,0,1
31716,%,0,0
31717,preferred,0,0
31718,2,0,0
31719,weeks,0,0
31720,of,0,0
31721,stenting,0,1
31722,.,0,1
31723,CONCLUSIONS,0,0
31724,Two,0,0
31725,weeks,0,0
31726,seems,0,0
31727,to,0,0
31728,be,0,0
31729,a,0,0
31730,sufficient,0,0
31731,duration,0,0
31732,to,0,0
31733,allow,0,0
31734,functional,0,0
31735,restoration,0,0
31736,across,0,0
31737,the,0,0
31738,ureteropelvic,0,1
31739,junction,0,0
31740,after,0,0
31741,endopyelotomy,0,0
31742,and,0,0
31743,decrease,0,0
31744,stent,0,0
31745,related,0,0
31746,complications,0,0
31747,.,0,1
31748,Randomized,0,0
31749,controlled,0,0
31750,trial,0,0
31751,evaluating,0,0
31752,the,0,0
31753,clinical,0,0
31754,benefit,0,0
31755,of,0,0
31756,montelukast,0,0
31757,for,0,0
31758,treating,0,0
31759,spring,0,1
31760,seasonal,0,1
31761,allergic,0,1
31762,rhinitis,0,1
31763,.,0,0
31764,BACKGROUND,0,0
31765,Symptoms,0,0
31766,of,0,0
31767,allergic,0,1
31768,rhinitis,0,1
31769,are,0,0
31770,mediated,0,0
31771,in,0,0
31772,part,0,0
31773,by,0,0
31774,cysteinyl,0,0
31775,leukotrienes,0,0
31776,.,0,0
31777,OBJECTIVE,0,0
31778,To,0,0
31779,evaluate,0,0
31780,the,0,0
31781,clinical,0,0
31782,benefit,0,0
31783,of,0,0
31784,montelukast,0,0
31785,",",0,0
31786,a,0,0
31787,cysteinyl,0,0
31788,leukotriene,0,0
31789,receptor,0,0
31790,antagonist,0,0
31791,",",0,0
31792,administered,0,0
31793,once,0,0
31794,daily,0,0
31795,for,0,0
31796,treating,0,0
31797,seasonal,0,1
31798,allergic,0,1
31799,rhinitis,0,1
31800,.,0,0
31801,METHODS,0,0
31802,This,1,0
31803,multicenter,1,0
31804,",",0,0
31805,randomized,0,0
31806,",",0,0
31807,double-blind,0,0
31808,",",0,0
31809,placebo-,0,0
31810,and,0,0
31811,active-controlled,0,0
31812,study,0,0
31813,enrolled,1,1
31814,"1,214",1,1
31815,healthy,1,1
31816,",",1,0
31817,nonsmoking,1,1
31818,outpatients,1,1
31819,aged,1,1
31820,15,1,0
31821,to,1,0
31822,85,1,1
31823,years,1,1
31824,with,1,1
31825,spring,1,1
31826,allergic,1,1
31827,rhinitis,1,1
31828,",",1,0
31829,positive,1,0
31830,skin,1,0
31831,test,1,0
31832,to,1,0
31833,a,1,0
31834,spring,1,0
31835,allergen,1,0
31836,",",1,0
31837,and,1,0
31838,predefined,1,0
31839,daytime,1,0
31840,nasal,1,0
31841,symptoms,1,0
31842,.,1,0
31843,After,0,0
31844,a,0,0
31845,3-,0,0
31846,to,0,0
31847,5-day,0,0
31848,placebo,0,0
31849,run-in,0,0
31850,period,0,0
31851,",",0,0
31852,patients,0,1
31853,were,0,0
31854,randomly,0,1
31855,assigned,0,0
31856,to,0,0
31857,treatment,0,0
31858,with,0,1
31859,montelukast,0,0
31860,10,0,0
31861,mg,0,0
31862,(,0,0
31863,n,0,1
31864,=,0,0
31865,522,0,1
31866,),0,0
31867,",",0,0
31868,loratadine,0,0
31869,10,0,0
31870,mg,0,0
31871,(,0,0
31872,n,0,1
31873,=,0,0
31874,171,0,1
31875,),0,0
31876,",",0,0
31877,or,0,0
31878,placebo,0,0
31879,(,0,0
31880,n,0,1
31881,=,0,0
31882,521,0,1
31883,),0,0
31884,once,0,0
31885,daily,0,0
31886,at,0,0
31887,bedtime,0,0
31888,for,0,0
31889,2,0,0
31890,weeks,0,0
31891,.,0,0
31892,During,0,0
31893,the,0,0
31894,run-in,0,0
31895,and,0,0
31896,treatment,0,0
31897,periods,0,0
31898,",",0,0
31899,symptoms,0,0
31900,were,0,0
31901,evaluated,0,0
31902,in,0,0
31903,a,0,0
31904,daily,0,0
31905,diary,0,0
31906,using,0,0
31907,a,0,0
31908,0,0,0
31909,(,0,0
31910,best,0,0
31911,),0,0
31912,to,0,0
31913,3,0,0
31914,(,0,0
31915,worst,0,0
31916,),0,0
31917,scale,0,0
31918,.,0,0
31919,RESULTS,0,0
31920,Baseline,0,0
31921,characteristics,0,0
31922,of,0,0
31923,randomized,0,1
31924,patients,0,1
31925,were,0,0
31926,clinically,0,0
31927,similar,0,0
31928,in,0,0
31929,the,0,0
31930,three,0,0
31931,treatment,0,0
31932,groups,0,0
31933,.,0,1
31934,Montelukast,0,0
31935,was,0,0
31936,significantly,0,0
31937,more,0,0
31938,effective,0,0
31939,than,0,0
31940,placebo,0,0
31941,(,0,0
31942,P,0,0
31943,=,0,0
31944,0.003,0,0
31945,),0,0
31946,in,0,0
31947,improving,0,0
31948,the,0,0
31949,daytime,0,0
31950,nasal,0,0
31951,symptoms,0,0
31952,score,0,0
31953,(,0,0
31954,difference,0,0
31955,in,0,0
31956,least,0,0
31957,square,0,0
31958,means,0,0
31959,",",0,0
31960,-0.09,0,0
31961,;,0,0
31962,95,0,0
31963,%,0,0
31964,confidence,0,0
31965,interval,0,0
31966,",",0,0
31967,-0.16,0,0
31968,",",0,0
31969,-0.03,0,0
31970,),0,0
31971,averaged,0,0
31972,over,0,0
31973,2,0,0
31974,weeks,0,0
31975,of,0,0
31976,therapy,0,0
31977,.,0,0
31978,The,0,0
31979,treatment,0,0
31980,effect,0,0
31981,of,0,0
31982,montelukast,0,0
31983,was,0,0
31984,significantly,0,0
31985,greater,0,0
31986,(,0,0
31987,P,0,0
31988,<,0,0
31989,0.05,0,0
31990,),0,0
31991,",",0,0
31992,relative,0,0
31993,to,0,0
31994,placebo,0,0
31995,",",0,0
31996,for,0,0
31997,all,0,0
31998,secondary,0,0
31999,endpoints,0,0
32000,",",0,0
32001,including,0,0
32002,nighttime,0,0
32003,symptoms,0,0
32004,and,0,0
32005,daytime,0,0
32006,eye,0,0
32007,symptoms,0,0
32008,",",0,0
32009,patient,0,0
32010,and,0,0
32011,physician,0,1
32012,global,0,0
32013,evaluations,0,0
32014,of,0,0
32015,allergic,0,1
32016,rhinitis,0,1
32017,",",0,0
32018,and,0,0
32019,rhinoconjunctivitis,0,0
32020,quality,0,0
32021,of,0,0
32022,life,0,0
32023,.,0,0
32024,Loratadine,0,0
32025,",",0,0
32026,which,0,0
32027,served,0,0
32028,as,0,0
32029,a,0,0
32030,positive,0,0
32031,control,0,0
32032,",",0,0
32033,was,0,0
32034,significantly,0,0
32035,more,0,0
32036,effective,0,0
32037,than,0,0
32038,placebo,0,0
32039,for,0,0
32040,most,0,0
32041,endpoints,0,0
32042,",",0,0
32043,validating,0,0
32044,the,0,0
32045,study,0,0
32046,results,0,0
32047,.,0,0
32048,Both,0,0
32049,montelukast,0,0
32050,and,0,0
32051,loratadine,0,0
32052,were,0,0
32053,well,0,0
32054,tolerated,0,0
32055,.,0,0
32056,CONCLUSION,0,0
32057,Therapy,0,0
32058,with,0,1
32059,montelukast,0,0
32060,significantly,0,0
32061,improves,0,0
32062,assessments,0,0
32063,of,0,0
32064,symptom,0,0
32065,severity,0,0
32066,as,0,0
32067,well,0,0
32068,as,0,0
32069,quality-of-life,0,0
32070,parameters,0,0
32071,for,0,0
32072,patients,1,1
32073,with,1,1
32074,seasonal,1,1
32075,allergic,1,1
32076,rhinitis,1,1
32077,.,1,0
32078,A,0,0
32079,single,0,0
32080,nasal,0,0
32081,allergen,0,0
32082,challenge,0,0
32083,increases,0,0
32084,induced,0,0
32085,sputum,0,1
32086,inflammatory,0,0
32087,markers,0,0
32088,in,0,0
32089,non-asthmatic,1,1
32090,subjects,1,1
32091,with,1,1
32092,seasonal,1,1
32093,allergic,1,1
32094,rhinitis,1,1
32095,:,1,1
32096,correlation,0,0
32097,with,0,1
32098,plasma,0,0
32099,interleukin-5,0,0
32100,.,0,1
32101,BACKGROUND,0,0
32102,Seasonal,0,0
32103,allergic,0,1
32104,rhinitis,0,1
32105,(,0,0
32106,SAR,0,0
32107,),0,0
32108,is,0,0
32109,a,0,0
32110,risk,1,0
32111,factor,1,0
32112,for,1,0
32113,asthma,1,1
32114,in,1,0
32115,affected,1,0
32116,individuals,1,1
32117,.,1,1
32118,Nasal,0,0
32119,allergic,0,0
32120,inflammation,0,0
32121,enhances,0,0
32122,bone-marrow,0,0
32123,eosinophil,0,0
32124,production,0,0
32125,",",0,0
32126,mainly,0,0
32127,via,0,0
32128,IL-5,0,0
32129,",",0,0
32130,and,0,0
32131,rhinitis,0,1
32132,patients,0,1
32133,have,0,0
32134,increased,0,0
32135,airway,0,0
32136,inflammation,0,0
32137,during,0,0
32138,the,0,0
32139,pollen,0,0
32140,season,0,0
32141,.,0,0
32142,OBJECTIVE,0,0
32143,To,0,0
32144,assess,0,0
32145,the,0,0
32146,impact,0,0
32147,of,0,0
32148,nasal,0,0
32149,allergy,0,1
32150,on,0,0
32151,sputum,0,0
32152,inflammatory,0,0
32153,markers,0,0
32154,.,0,0
32155,METHODS,0,0
32156,In,0,0
32157,an,0,0
32158,open-labelled,0,0
32159,",",0,0
32160,randomized,0,0
32161,",",0,0
32162,placebo-controlled,0,0
32163,cross-over,0,0
32164,study,0,0
32165,with,0,1
32166,16,1,1
32167,non-asthmatic,1,1
32168,SAR,1,0
32169,patients,1,1
32170,(,1,0
32171,median,1,0
32172,age,1,1
32173,25,1,0
32174,years,1,1
32175,",",1,0
32176,56,1,1
32177,%,1,0
32178,males,1,1
32179,),1,0
32180,",",0,0
32181,the,0,0
32182,effect,0,0
32183,of,0,0
32184,a,0,0
32185,single,0,0
32186,nasal,0,0
32187,allergen,0,0
32188,challenge,0,0
32189,performed,0,0
32190,out,0,0
32191,of,0,0
32192,season,0,0
32193,on,0,0
32194,induced,0,0
32195,sputum,0,1
32196,inflammatory,0,0
32197,parameters,0,0
32198,was,0,0
32199,evaluated,0,0
32200,.,0,0
32201,SAR,1,0
32202,patients,1,1
32203,were,1,0
32204,identified,1,0
32205,by,1,0
32206,history,1,0
32207,",",1,0
32208,skin-prick,1,0
32209,test,1,0
32210,and,1,0
32211,specific,1,0
32212,IgE,1,1
32213,.,1,0
32214,All,1,0
32215,patients,1,1
32216,had,1,0
32217,normal,1,1
32218,lung,1,1
32219,function/bronchial,1,0
32220,hyper-responsiveness,1,0
32221,out,1,0
32222,of,1,0
32223,season,1,0
32224,and,1,0
32225,a,1,0
32226,negative,1,0
32227,asthma/wheezing,1,1
32228,history,1,1
32229,.,1,0
32230,Sputum,0,0
32231,cells,0,0
32232,and,0,0
32233,supernatant,0,0
32234,levels,0,0
32235,of,0,0
32236,ECP,0,0
32237,",",0,0
32238,sICAM,0,0
32239,",",0,0
32240,IL-5,0,0
32241,and,0,0
32242,IL-10,0,0
32243,",",0,0
32244,and,0,0
32245,plasma,0,0
32246,levels,0,0
32247,of,0,0
32248,IL-5,0,0
32249,and,0,0
32250,ECP,0,0
32251,",",0,0
32252,were,0,0
32253,measured,0,0
32254,before,0,0
32255,and,0,0
32256,24,0,0
32257,h,0,0
32258,after,0,0
32259,nasal,0,0
32260,allergen,0,0
32261,challenge,0,0
32262,.,0,0
32263,After,0,0
32264,a,0,0
32265,washout,0,0
32266,period,0,0
32267,of,0,0
32268,at,0,0
32269,least,0,0
32270,4,0,0
32271,weeks,0,0
32272,",",0,0
32273,the,0,0
32274,procedure,0,0
32275,was,0,0
32276,repeated,0,0
32277,with,0,0
32278,placebo,0,0
32279,challenge,0,0
32280,(,0,0
32281,diluent,0,0
32282,),0,0
32283,.,0,0
32284,RESULTS,0,0
32285,Nasal,0,0
32286,allergen,0,0
32287,challenge,0,0
32288,led,0,0
32289,to,0,0
32290,an,0,0
32291,increase,0,0
32292,in,0,0
32293,sputum,0,0
32294,ECP,0,0
32295,(,0,0
32296,pre,0,0
32297,=,0,0
32298,60,0,1
32299,+/-,0,0
32300,12,0,0
32301,",",0,0
32302,post,0,0
32303,=,0,0
32304,212,0,1
32305,+/-,0,0
32306,63,0,1
32307,micro,0,0
32308,g/L,0,0
32309,",",0,0
32310,P,0,0
32311,=,0,0
32312,0.02,0,0
32313,vs.,0,0
32314,placebo,0,0
32315,),0,0
32316,",",0,0
32317,and,0,0
32318,sICAM,0,0
32319,(,0,0
32320,4.8,0,0
32321,+/-,0,0
32322,2.7,0,0
32323,to,0,0
32324,6.5,0,0
32325,+/-,0,0
32326,2.9,0,0
32327,ng/mL,0,0
32328,",",0,0
32329,P,0,0
32330,=,0,0
32331,0.02,0,0
32332,vs.,0,0
32333,placebo,0,0
32334,),0,0
32335,",",0,0
32336,whereas,0,0
32337,IL-10,0,0
32338,decreased,0,0
32339,after,0,0
32340,provocation,0,0
32341,(,0,0
32342,44,0,1
32343,+/-,0,0
32344,11,0,1
32345,to,0,0
32346,29,0,1
32347,+/-,0,0
32348,6,0,0
32349,pg/mL,0,0
32350,",",0,0
32351,P,0,0
32352,=,0,0
32353,0.06,0,0
32354,vs.,0,0
32355,placebo,0,0
32356,),0,0
32357,.,0,0
32358,Sputum,0,0
32359,IL-5,0,0
32360,was,0,0
32361,undetectable,0,0
32362,in,0,0
32363,all,0,0
32364,patients,0,1
32365,.,0,0
32366,The,0,0
32367,absolute,0,0
32368,number,0,0
32369,of,0,0
32370,blood,0,0
32371,and,0,0
32372,sputum,0,0
32373,eosinophils,0,0
32374,did,0,0
32375,not,0,0
32376,change,0,0
32377,significantly,0,0
32378,after,0,0
32379,allergen,0,0
32380,or,0,0
32381,placebo,0,0
32382,challenge,0,0
32383,(,0,0
32384,P,0,0
32385,>,0,1
32386,0.07,0,0
32387,",",0,0
32388,both,0,0
32389,comparisons,0,0
32390,),0,0
32391,.,0,1
32392,Plasma,0,0
32393,levels,0,0
32394,of,0,0
32395,IL-5,0,0
32396,increased,0,0
32397,after,0,0
32398,allergen,0,0
32399,challenge,0,0
32400,(,0,0
32401,8.7,0,0
32402,+/-,0,0
32403,2.9,0,0
32404,to,0,0
32405,14.5,0,0
32406,+/-,0,0
32407,3.9,0,0
32408,pg/mL,0,0
32409,",",0,0
32410,P,0,0
32411,=,0,0
32412,0.001,0,0
32413,),0,0
32414,",",0,0
32415,and,0,0
32416,the,0,0
32417,increase,0,0
32418,in,0,0
32419,plasma,0,0
32420,IL-5,0,0
32421,was,0,0
32422,positively,0,0
32423,correlated,0,0
32424,with,0,0
32425,the,0,0
32426,rise,0,0
32427,in,0,0
32428,sputum,0,0
32429,ECP,0,0
32430,in,0,0
32431,a,0,0
32432,subgroup,0,0
32433,of,0,0
32434,'responders,0,0
32435,',0,1
32436,(,0,0
32437,n,0,1
32438,=,0,0
32439,12,0,0
32440,",",0,0
32441,r,0,0
32442,=,0,0
32443,0.71,0,0
32444,",",0,0
32445,P,0,0
32446,=,0,0
32447,0.01,0,0
32448,),0,0
32449,.,0,0
32450,CONCLUSIONS,0,0
32451,A,0,0
32452,single,0,0
32453,nasal,0,0
32454,allergen,0,0
32455,challenge,0,0
32456,in,0,0
32457,SAR,1,0
32458,patients,1,1
32459,increased,0,0
32460,markers,0,0
32461,of,0,0
32462,allergic,0,1
32463,inflammation,0,0
32464,in,0,0
32465,the,0,0
32466,lower,0,0
32467,respiratory,0,0
32468,tract,0,0
32469,",",0,0
32470,possibly,0,0
32471,via,0,0
32472,pronounced,0,0
32473,activation,0,0
32474,of,0,0
32475,inflammatory,0,0
32476,cells,0,0
32477,through,0,0
32478,circulating,0,0
32479,immediate-type,0,1
32480,reaction,0,0
32481,cytokines,0,0
32482,like,0,0
32483,IL-5,0,0
32484,.,0,0
32485,These,0,0
32486,findings,0,0
32487,may,0,0
32488,provide,0,0
32489,additional,0,0
32490,explanatory,0,0
32491,data,0,0
32492,for,0,0
32493,the,0,0
32494,high,0,0
32495,susceptibility,0,0
32496,of,0,0
32497,SAR,1,0
32498,patients,1,1
32499,to,0,0
32500,incident,0,1
32501,asthma,0,1
32502,.,0,0
32503,Conscious,0,1
32504,analgesia/sedation,0,0
32505,with,0,1
32506,remifentanil,0,0
32507,and,0,0
32508,propofol,0,0
32509,versus,0,0
32510,total,0,1
32511,intravenous,0,0
32512,anesthesia,0,0
32513,with,0,0
32514,fentanyl,0,0
32515,",",0,0
32516,midazolam,0,0
32517,",",0,0
32518,and,0,0
32519,propofol,0,0
32520,for,0,0
32521,outpatient,1,1
32522,colonoscopy,1,1
32523,.,1,0
32524,BACKGROUND,0,0
32525,This,0,0
32526,study,0,0
32527,tested,0,0
32528,the,0,0
32529,hypothesis,0,0
32530,that,0,0
32531,",",0,0
32532,for,0,0
32533,colonoscopy,0,0
32534,",",0,0
32535,analgesia/sedation,0,0
32536,with,0,0
32537,remifentanil,0,0
32538,and,0,0
32539,propofol,0,0
32540,might,0,0
32541,be,0,0
32542,more,0,0
32543,effective,0,0
32544,compared,0,0
32545,with,0,0
32546,anesthesia,0,0
32547,by,0,0
32548,intravenous,0,0
32549,administration,0,0
32550,of,0,0
32551,midazolam,0,0
32552,",",0,0
32553,fentanyl,0,0
32554,",",0,0
32555,and,0,0
32556,propofol,0,0
32557,.,0,0
32558,METHODS,0,0
32559,In,0,0
32560,a,0,0
32561,prospective,0,0
32562,",",0,0
32563,randomized,0,0
32564,trial,0,0
32565,",",0,0
32566,100,1,0
32567,adult,1,1
32568,patients,1,1
32569,received,0,0
32570,either,0,0
32571,conscious,0,0
32572,analgesia/sedation,0,0
32573,(,1,0
32574,Sedation,1,0
32575,group,1,0
32576,),1,0
32577,or,0,0
32578,total,0,1
32579,intravenous,0,0
32580,anesthesia,0,0
32581,(,1,0
32582,TIVA,1,0
32583,group,1,0
32584,),1,0
32585,.,0,0
32586,Analgesia/sedation,0,0
32587,was,0,0
32588,achieved,0,0
32589,by,0,0
32590,infusion,0,0
32591,of,0,0
32592,remifentanil,0,0
32593,(,0,0
32594,0.20,0,0
32595,to,0,0
32596,0.25,0,0
32597,microg/kg/min,0,0
32598,),0,0
32599,and,0,0
32600,propofol,0,0
32601,in,0,0
32602,titrated,0,0
32603,doses,0,0
32604,.,0,1
32605,TIVA,0,0
32606,was,0,0
32607,induced,0,0
32608,by,0,0
32609,intravenous,0,0
32610,administration,0,0
32611,of,0,0
32612,fentanyl,0,0
32613,(,0,0
32614,2,0,0
32615,microg/kg,0,0
32616,),0,0
32617,",",0,0
32618,midazolam,0,0
32619,(,0,0
32620,0.05,0,0
32621,mg/kg,0,0
32622,),0,0
32623,and,0,0
32624,propofol,0,0
32625,(,0,0
32626,dosage,0,0
32627,titrated,0,0
32628,),0,0
32629,.,0,0
32630,Cardiorespiratory,0,0
32631,parameters,0,0
32632,and,0,0
32633,bispectral,0,0
32634,index,0,0
32635,were,0,0
32636,monitored,0,0
32637,and,0,0
32638,recorded,0,0
32639,.,0,0
32640,The,0,0
32641,quality,0,0
32642,of,0,0
32643,the,0,0
32644,analgesia,0,0
32645,was,0,0
32646,assessed,0,0
32647,with,0,0
32648,a,0,0
32649,Numerical,0,0
32650,Pain,0,0
32651,Rating,0,0
32652,Scale,0,0
32653,(,0,0
32654,NRS,0,0
32655,),0,0
32656,;,0,0
32657,recovery,0,0
32658,level,0,0
32659,and,0,0
32660,return,0,0
32661,of,0,0
32662,psychomotor,0,0
32663,efficiency,0,0
32664,were,0,0
32665,evaluated,0,0
32666,with,0,0
32667,",",0,0
32668,respectively,0,0
32669,",",0,0
32670,the,0,0
32671,Aldrete,0,0
32672,scale,0,0
32673,and,0,0
32674,a,0,0
32675,Modified,0,0
32676,Post,0,1
32677,Anesthesia,0,0
32678,Discharge,0,0
32679,Scoring,0,0
32680,(,0,0
32681,MPADS,0,0
32682,),0,0
32683,system,0,0
32684,.,0,0
32685,RESULTS,0,0
32686,Both,1,0
32687,groups,1,0
32688,of,1,0
32689,50,1,1
32690,patients,1,1
32691,were,1,0
32692,comparable,1,0
32693,with,1,1
32694,respect,1,0
32695,to,1,0
32696,demographic,1,0
32697,data,1,0
32698,",",1,0
32699,initial,1,0
32700,parameters,1,0
32701,",",1,0
32702,and,1,0
32703,duration,1,0
32704,of,1,0
32705,colonoscopy,1,1
32706,.,1,0
32707,All,0,0
32708,patients,0,1
32709,in,0,0
32710,the,0,0
32711,TIVA,0,0
32712,group,0,0
32713,found,0,0
32714,the,0,0
32715,colonoscopy,0,0
32716,painless,0,0
32717,(,0,0
32718,NRS,0,0
32719,score,0,0
32720,0,0,0
32721,),0,0
32722,.,0,0
32723,In,0,0
32724,the,0,0
32725,Sedation,0,0
32726,group,0,0
32727,",",0,0
32728,the,0,0
32729,average,0,0
32730,pain,0,0
32731,intensity,0,0
32732,score,0,0
32733,was,0,0
32734,0.4,0,0
32735,(,0,0
32736,0.8,0,0
32737,),0,0
32738,.,0,0
32739,There,0,0
32740,was,0,0
32741,a,0,0
32742,marked,0,0
32743,difference,0,0
32744,between,0,0
32745,the,0,0
32746,Sedation,0,0
32747,and,0,0
32748,TIVA,0,0
32749,groups,0,0
32750,with,0,1
32751,respect,0,0
32752,to,0,0
32753,the,0,0
32754,time,0,0
32755,from,0,0
32756,the,0,0
32757,end,0,0
32758,of,0,0
32759,the,0,0
32760,procedure,0,0
32761,until,0,0
32762,the,0,0
32763,maximum,0,0
32764,MPADS,0,0
32765,score,0,0
32766,was,0,0
32767,reached,0,0
32768,:,0,0
32769,respectively,0,0
32770,",",0,0
32771,-6.9,0,0
32772,(,0,0
32773,4.0,0,0
32774,),0,0
32775,versus,0,0
32776,25.7,0,0
32777,(,0,0
32778,8.4,0,0
32779,),0,0
32780,minutes,0,0
32781,(,0,0
32782,p,0,0
32783,<,0,0
32784,0.001,0,0
32785,),0,0
32786,.,0,0
32787,In,0,0
32788,the,0,0
32789,TIVA,0,0
32790,group,0,0
32791,",",0,0
32792,changes,0,0
32793,in,0,0
32794,mean,0,1
32795,arterial,0,1
32796,pressure,0,0
32797,and,0,0
32798,heart,0,1
32799,rate,0,0
32800,and,0,0
32801,signs,0,0
32802,of,0,0
32803,respiratory,0,0
32804,depression,0,1
32805,were,0,0
32806,significant,0,0
32807,(,0,0
32808,p,0,0
32809,<,0,0
32810,0.05,0,0
32811,),0,0
32812,.,0,0
32813,CONCLUSIONS,0,0
32814,Combined,0,0
32815,administration,0,0
32816,of,0,0
32817,remifentanil,0,0
32818,and,0,0
32819,propofol,0,0
32820,for,0,0
32821,colonoscopy,0,0
32822,provides,0,0
32823,sufficient,0,0
32824,analgesia,0,0
32825,",",0,0
32826,satisfactory,0,0
32827,hemodynamic,0,0
32828,stability,0,0
32829,",",0,0
32830,minor,0,0
32831,respiratory,0,0
32832,depression,0,0
32833,",",0,0
32834,and,0,0
32835,rapid,0,0
32836,recovery,0,0
32837,",",0,0
32838,and,0,0
32839,allows,0,0
32840,patients,0,1
32841,to,0,0
32842,be,0,0
32843,discharged,0,1
32844,approximately,0,0
32845,15,0,0
32846,minutes,0,0
32847,after,0,0
32848,the,0,0
32849,procedure,0,0
32850,.,0,0
32851,Comparison,0,0
32852,of,0,0
32853,the,0,0
32854,efficacy,0,0
32855,and,0,0
32856,safety,0,0
32857,of,0,0
32858,faropenem,0,0
32859,daloxate,0,0
32860,and,0,0
32861,cefuroxime,0,0
32862,axetil,0,0
32863,for,0,0
32864,the,0,0
32865,treatment,0,0
32866,of,0,0
32867,acute,1,1
32868,bacterial,1,0
32869,maxillary,1,1
32870,sinusitis,1,1
32871,in,1,0
32872,adults,1,1
32873,.,1,0
32874,In,0,0
32875,this,0,0
32876,multicentre,0,0
32877,",",0,0
32878,multinational,0,0
32879,",",0,0
32880,comparative,0,0
32881,",",0,0
32882,double-blind,0,0
32883,clinical,0,0
32884,trial,0,0
32885,",",0,0
32886,outpatients,1,1
32887,with,1,1
32888,both,1,0
32889,clinical,1,0
32890,signs,1,0
32891,and,1,0
32892,symptoms,1,0
32893,and,1,0
32894,radiographic,1,0
32895,evidence,1,0
32896,of,1,0
32897,acute,1,1
32898,sinusitis,1,1
32899,were,0,0
32900,randomly,0,0
32901,assigned,0,0
32902,to,0,0
32903,receive,0,0
32904,for,0,0
32905,7,0,0
32906,days,0,0
32907,either,0,0
32908,a,0,0
32909,twice-daily,0,0
32910,oral,0,0
32911,regimen,0,0
32912,of,0,0
32913,faropenem,0,0
32914,daloxate,0,0
32915,(,0,0
32916,300,0,0
32917,mg,0,0
32918,),0,0
32919,or,0,0
32920,a,0,0
32921,twice,0,0
32922,daily,0,0
32923,oral,0,0
32924,regimen,0,0
32925,of,0,0
32926,cefuroxime,0,0
32927,axetil,0,0
32928,(,0,0
32929,250,0,0
32930,mg,0,0
32931,),0,0
32932,.,0,0
32933,Among,0,1
32934,452,1,1
32935,patients,1,1
32936,considered,1,0
32937,valid,1,0
32938,for,1,0
32939,clinical,1,0
32940,efficacy,1,0
32941,",",0,0
32942,faropenem,0,0
32943,daloxate,0,0
32944,treatment,0,0
32945,was,0,0
32946,found,0,0
32947,to,0,0
32948,be,0,0
32949,statistically,0,0
32950,equivalent,0,0
32951,to,0,0
32952,cefuroxime,0,0
32953,axetil,0,0
32954,(,0,0
32955,89.0,0,0
32956,%,0,0
32957,vs.,0,0
32958,88.4,0,0
32959,%,0,0
32960,-95,0,0
32961,%,0,0
32962,CI=-5.2,0,0
32963,%,0,0
32964,;,0,0
32965,+6.4,0,0
32966,%,0,0
32967,),0,0
32968,at,0,0
32969,the,0,0
32970,7-16,0,1
32971,days,0,0
32972,post-therapy,0,0
32973,assessment,0,0
32974,.,0,0
32975,At,0,0
32976,28-35,0,1
32977,days,0,0
32978,post-therapy,0,0
32979,",",0,0
32980,the,0,0
32981,continued,0,0
32982,clinical,0,0
32983,cure,0,0
32984,rate,0,0
32985,in,0,0
32986,the,0,0
32987,faropenem,0,0
32988,daloxate,0,0
32989,group,0,0
32990,was,0,0
32991,92.6,0,0
32992,%,0,0
32993,and,0,0
32994,that,0,0
32995,for,0,0
32996,the,0,0
32997,cefuroxime,0,0
32998,axetil,0,0
32999,group,0,0
33000,was,0,0
33001,94.9,0,0
33002,%,0,0
33003,(,0,0
33004,95,0,0
33005,%,0,0
33006,CI,0,0
33007,:,0,1
33008,-6.8,0,0
33009,%,0,0
33010,;,0,0
33011,+1.2,0,0
33012,%,0,0
33013,),0,0
33014,.,0,0
33015,A,0,0
33016,total,0,0
33017,of,0,0
33018,148,0,1
33019,organisms,0,0
33020,was,0,0
33021,obtained,0,0
33022,in,0,0
33023,136,0,1
33024,microbiologically,0,0
33025,valid,0,0
33026,patients,0,1
33027,(,0,0
33028,30.1,0,0
33029,%,0,0
33030,),0,0
33031,.,0,0
33032,The,0,0
33033,predominant,0,0
33034,causative,0,0
33035,organisms,0,0
33036,were,0,0
33037,Streptococcus,0,0
33038,pneumoniae,0,1
33039,(,0,0
33040,47.1,0,0
33041,%,0,0
33042,),0,0
33043,",",0,0
33044,Haemophilus,0,0
33045,influenzae,0,0
33046,(,0,0
33047,30.1,0,0
33048,%,0,0
33049,),0,0
33050,",",0,0
33051,Staphylococcus,0,0
33052,aureus,0,0
33053,(,0,0
33054,14.7,0,0
33055,%,0,0
33056,),0,0
33057,and,0,0
33058,Moraxella,0,1
33059,catarrhalis,0,1
33060,(,0,0
33061,8.8,0,0
33062,%,0,0
33063,),0,0
33064,.,0,0
33065,The,0,0
33066,bacteriological,0,0
33067,success,0,0
33068,rate,0,0
33069,at,0,0
33070,the,0,0
33071,7-16,0,1
33072,days,0,0
33073,post-therapy,0,0
33074,evaluation,0,0
33075,was,0,0
33076,similar,0,0
33077,in,0,0
33078,both,0,0
33079,treatment,0,0
33080,groups,0,0
33081,:,0,1
33082,91.5,0,0
33083,%,0,0
33084,and,0,0
33085,90.8,0,0
33086,%,0,0
33087,in,0,0
33088,the,0,0
33089,faropenem,0,0
33090,daloxate,0,0
33091,and,0,0
33092,cefuroxime,0,0
33093,axetil,0,0
33094,groups,0,0
33095,",",0,0
33096,respectively,0,0
33097,(,0,0
33098,95,0,0
33099,%,0,0
33100,CI=-9.2,0,0
33101,%,0,0
33102,;,0,0
33103,+9.5,0,0
33104,%,0,0
33105,),0,0
33106,.,0,0
33107,Eradication,0,0
33108,or,0,0
33109,presumed,0,1
33110,eradication,0,0
33111,was,0,0
33112,detected,0,0
33113,for,0,0
33114,97.3,0,0
33115,%,0,0
33116,and,0,0
33117,96.3,0,0
33118,%,0,0
33119,of,0,0
33120,S.,0,1
33121,pneumoniae,0,1
33122,",",0,0
33123,85.0,0,0
33124,%,0,0
33125,and,0,0
33126,90.5,0,0
33127,%,0,0
33128,of,0,0
33129,H.,0,0
33130,influenzae,0,0
33131,",",0,0
33132,88.9,0,0
33133,%,0,0
33134,and,0,0
33135,90.9,0,0
33136,%,0,0
33137,of,0,0
33138,S.,0,1
33139,aureus,0,0
33140,and,0,0
33141,100.0,0,0
33142,%,0,0
33143,and,0,0
33144,83.3,0,0
33145,%,0,0
33146,of,0,0
33147,M.,0,1
33148,catarrhalis,0,1
33149,in,0,0
33150,faropenem,0,0
33151,daloxate,0,0
33152,and,0,0
33153,cefuroxime,0,0
33154,axetil,0,0
33155,recipients,0,1
33156,",",0,0
33157,respectively,0,0
33158,.,0,0
33159,At,0,0
33160,least,0,0
33161,one,0,0
33162,drug-related,0,0
33163,event,0,0
33164,was,0,0
33165,reported,0,0
33166,by,0,0
33167,9.5,0,0
33168,%,0,0
33169,of,0,0
33170,the,0,0
33171,faropenem,0,0
33172,daloxate-treated,0,0
33173,patients,0,1
33174,and,0,0
33175,by,0,0
33176,10.3,0,0
33177,%,0,0
33178,of,0,0
33179,those,0,1
33180,who,0,1
33181,received,0,0
33182,cefuroxime,0,1
33183,axetil,0,0
33184,.,0,0
33185,The,0,0
33186,most,0,0
33187,frequently,0,0
33188,reported,0,0
33189,drug-related,0,0
33190,events,0,0
33191,were,0,0
33192,diarrhoea,0,1
33193,(,0,0
33194,2.2,0,0
33195,%,0,0
33196,versus,0,0
33197,2.9,0,0
33198,%,0,0
33199,),0,0
33200,",",0,0
33201,nausea/vomiting,0,0
33202,(,0,0
33203,1.5,0,0
33204,%,0,0
33205,vs.,0,0
33206,0.7,0,0
33207,%,0,0
33208,),0,0
33209,",",0,0
33210,abdominal,0,0
33211,pain,0,0
33212,(,0,0
33213,0.7,0,0
33214,%,0,0
33215,vs,0,0
33216,1.5,0,0
33217,%,0,0
33218,),0,0
33219,and,0,0
33220,skin,0,0
33221,reactions,0,0
33222,(,0,0
33223,1.5,0,0
33224,%,0,0
33225,vs.,0,0
33226,1.1,0,0
33227,%,0,0
33228,),0,0
33229,.,0,0
33230,Overall,0,0
33231,",",0,0
33232,faropenem,0,0
33233,daloxate,0,0
33234,was,0,0
33235,at,0,0
33236,least,0,0
33237,as,0,0
33238,effective,0,0
33239,clinically,0,0
33240,and,0,0
33241,bacteriologically,0,0
33242,as,0,0
33243,cefuroxime,0,0
33244,axetil,0,0
33245,and,0,0
33246,was,0,0
33247,well,0,0
33248,tolerated,0,0
33249,.,0,0
33250,Comparison,0,0
33251,of,0,0
33252,the,0,0
33253,comet,0,0
33254,assay,0,0
33255,and,0,0
33256,the,0,0
33257,oxygen,0,0
33258,microelectrode,0,0
33259,for,0,0
33260,measuring,0,0
33261,tumor,0,0
33262,oxygenation,0,0
33263,in,0,0
33264,head-and-neck,1,1
33265,cancer,1,1
33266,patients,1,1
33267,.,1,0
33268,PURPOSE,0,0
33269,To,0,0
33270,compare,0,0
33271,the,0,0
33272,Eppendorf,0,0
33273,PO2,0,0
33274,histograph,0,0
33275,and,0,0
33276,the,0,0
33277,alkaline,0,0
33278,comet,0,0
33279,assay,0,0
33280,as,0,0
33281,methods,0,1
33282,of,0,0
33283,measuring,0,0
33284,tumor,0,0
33285,hypoxia,0,0
33286,in,0,0
33287,patients,1,1
33288,with,1,1
33289,head-and-neck,1,1
33290,squamous,1,1
33291,cell,1,1
33292,carcinomas,1,1
33293,.,1,0
33294,MATERIALS,0,0
33295,AND,0,0
33296,METHODS,0,0
33297,As,0,0
33298,part,0,0
33299,of,0,0
33300,a,0,0
33301,larger,0,0
33302,clinical,0,0
33303,trial,0,0
33304,",",0,0
33305,65,1,1
33306,patients,1,1
33307,with,1,1
33308,head-and-neck,1,1
33309,squamous,1,1
33310,cell,1,1
33311,carcinoma,1,1
33312,nodal,1,0
33313,metastasis,1,1
33314,underwent,0,1
33315,tumor,0,0
33316,oxygenation,0,0
33317,measurements,0,0
33318,with,0,1
33319,Eppendorf,0,1
33320,PO2,0,0
33321,histographs,0,0
33322,and,0,0
33323,comet,0,0
33324,assays,0,0
33325,",",0,0
33326,performed,0,0
33327,on,0,0
33328,fine-needle,0,1
33329,aspirates,0,1
33330,at,0,0
33331,1,0,0
33332,and,0,0
33333,2,0,0
33334,min,0,0
33335,after,0,0
33336,5,0,0
33337,Gy,0,0
33338,.,0,1
33339,Fifty-four,1,1
33340,patients,1,1
33341,had,1,1
33342,sufficient,1,0
33343,tumor,1,1
33344,cells,1,0
33345,for,1,0
33346,comet,1,0
33347,analysis,1,0
33348,at,0,0
33349,1,0,0
33350,min,0,0
33351,and,0,0
33352,26,0,0
33353,at,0,0
33354,both,0,0
33355,1,0,0
33356,and,0,0
33357,2,0,0
33358,min,0,0
33359,.,0,0
33360,Individual,0,0
33361,cells,0,0
33362,were,0,0
33363,examined,0,0
33364,for,0,0
33365,DNA,0,0
33366,single-strand,0,0
33367,breaks,0,0
33368,by,0,0
33369,alkaline,0,0
33370,gel,0,0
33371,electrophoresis,0,0
33372,",",0,0
33373,and,0,0
33374,the,0,0
33375,distribution,0,0
33376,of,0,0
33377,values,0,0
33378,was,0,0
33379,quantified,0,0
33380,using,0,0
33381,median,0,0
33382,tail,0,0
33383,moment,0,0
33384,(,0,0
33385,MTM,0,0
33386,),0,0
33387,.,0,0
33388,Nonirradiated,0,0
33389,tumor,0,0
33390,cells,0,0
33391,from,0,1
33392,pretreatment,0,0
33393,fine-needle,0,1
33394,aspirates,0,1
33395,received,0,0
33396,5,0,0
33397,Gy,0,0
33398,in,0,0
33399,vitro,0,0
33400,to,0,0
33401,establish,0,0
33402,the,0,0
33403,oxygenated,0,0
33404,response,0,0
33405,.,0,0
33406,RESULTS,0,0
33407,There,0,0
33408,was,0,0
33409,a,0,0
33410,significant,0,0
33411,correlation,0,0
33412,between,0,0
33413,the,0,0
33414,1-,0,0
33415,and,0,0
33416,2-min,0,0
33417,MTM,0,0
33418,(,0,0
33419,slope,0,0
33420,=,0,0
33421,0.77,0,0
33422,+/-,0,0
33423,0.03,0,0
33424,),0,0
33425,.,0,0
33426,There,0,0
33427,was,0,0
33428,no,0,0
33429,relationship,0,0
33430,between,0,0
33431,DNA,0,0
33432,damage,0,0
33433,in,0,0
33434,tumor,0,1
33435,cells,0,0
33436,irradiated,0,0
33437,in,0,0
33438,vitro,0,0
33439,and,0,0
33440,in,0,0
33441,vivo,0,0
33442,.,0,0
33443,No,0,0
33444,correlation,0,0
33445,was,0,0
33446,found,0,0
33447,between,0,0
33448,Eppendorf,0,1
33449,PO2,0,0
33450,measurements,0,0
33451,and,0,0
33452,comet,0,0
33453,MTM,0,0
33454,.,0,0
33455,There,0,0
33456,was,0,0
33457,a,0,0
33458,statistically,0,0
33459,significant,0,0
33460,correlation,0,0
33461,between,0,0
33462,the,0,0
33463,treatment,0,0
33464,response,0,0
33465,in,0,0
33466,the,0,0
33467,node,0,0
33468,studied,0,0
33469,and,0,0
33470,comet,0,0
33471,MTMs,0,0
33472,",",0,0
33473,whereas,0,0
33474,no,0,0
33475,correlation,0,0
33476,was,0,0
33477,observed,0,0
33478,between,0,0
33479,treatment,0,0
33480,response,0,0
33481,and,0,0
33482,Eppendorf,0,1
33483,measurements,0,0
33484,.,0,1
33485,CONCLUSIONS,0,0
33486,Comet,0,0
33487,assays,0,0
33488,are,0,0
33489,reproducible,0,0
33490,",",0,0
33491,as,0,0
33492,shown,0,0
33493,by,0,0
33494,biopsies,0,0
33495,at,0,0
33496,1,0,0
33497,and,0,0
33498,2,0,0
33499,min,0,0
33500,.,0,0
33501,Intertumor,0,0
33502,variation,0,0
33503,in,0,0
33504,the,0,0
33505,MTM,0,0
33506,is,0,0
33507,not,0,0
33508,a,0,0
33509,result,0,0
33510,of,0,0
33511,intrinsic,0,0
33512,radiosensitivity,0,0
33513,but,0,0
33514,of,0,0
33515,tumor,0,0
33516,hypoxia,0,0
33517,.,0,0
33518,There,0,0
33519,was,0,0
33520,no,0,0
33521,correlation,0,0
33522,between,0,0
33523,Eppendorf,0,1
33524,PO2,0,0
33525,measurements,0,0
33526,and,0,0
33527,comet,0,0
33528,MTM,0,0
33529,.,0,1
33530,Comet,0,0
33531,assays,0,0
33532,were,0,0
33533,better,0,0
33534,than,0,0
33535,Eppendorf,0,0
33536,in,0,0
33537,predicting,0,0
33538,treatment,0,0
33539,response,0,0
33540,as,0,0
33541,an,0,0
33542,end,0,0
33543,point,0,0
33544,for,0,0
33545,short-term,0,0
33546,outcome,0,0
33547,.,0,0
33548,Longer,0,0
33549,follow-up,0,0
33550,is,0,0
33551,needed,0,0
33552,to,0,0
33553,determine,0,0
33554,the,0,0
33555,role,0,0
33556,of,0,0
33557,the,0,0
33558,comet,0,0
33559,assay,0,0
33560,as,0,0
33561,a,0,0
33562,predictor,0,0
33563,for,0,0
33564,locoregional,0,0
33565,tumor,0,0
33566,control,0,0
33567,and,0,0
33568,survivals,0,0
33569,.,0,1
33570,Changing,0,0
33571,Childbirth,1,1
33572,:,1,1
33573,a,0,0
33574,pilot,0,0
33575,project,0,0
33576,.,0,0
33577,OBJECTIVE,0,0
33578,To,0,0
33579,compare,0,0
33580,the,0,0
33581,outcomes,0,0
33582,of,0,0
33583,an,0,0
33584,adapted,0,0
33585,pilot,0,0
33586,Changing,0,0
33587,Childbirth,0,1
33588,initiative,0,0
33589,providing,0,0
33590,continuity,0,0
33591,of,0,0
33592,care,0,0
33593,by,0,0
33594,a,0,0
33595,group,1,0
33596,of,1,0
33597,known,1,0
33598,midwives,1,1
33599,with,1,1
33600,traditional,1,0
33601,maternity,1,1
33602,care,1,0
33603,.,1,0
33604,DESIGN,0,0
33605,Between-groups,0,0
33606,trial,0,0
33607,to,0,0
33608,compare,0,0
33609,levels,0,0
33610,of,0,0
33611,satisfaction,0,0
33612,and,0,0
33613,clinical,0,0
33614,outcomes,0,0
33615,for,0,0
33616,two,1,0
33617,groups,1,0
33618,of,1,0
33619,women,1,1
33620,",",1,0
33621,cared,1,1
33622,for,1,0
33623,either,1,0
33624,under,1,0
33625,this,1,0
33626,Changing,1,0
33627,Childbirth,1,1
33628,scheme,1,0
33629,or,1,0
33630,the,1,0
33631,traditional,1,0
33632,model,1,0
33633,of,1,0
33634,care,1,0
33635,.,1,0
33636,METHOD,0,0
33637,Of,0,0
33638,the,0,0
33639,200,1,1
33640,women,1,1
33641,who,1,1
33642,agreed,1,1
33643,to,1,1
33644,participate,1,1
33645,in,1,0
33646,the,1,0
33647,project,1,0
33648,",",1,0
33649,100,1,0
33650,were,1,0
33651,randomly,1,1
33652,allocated,1,0
33653,to,1,0
33654,the,1,0
33655,pilot,1,0
33656,scheme,1,0
33657,and,1,0
33658,100,1,0
33659,to,1,0
33660,the,1,0
33661,traditional,1,0
33662,care,1,0
33663,package,1,0
33664,.,1,0
33665,During,0,0
33666,the,0,0
33667,postpartum,0,1
33668,period,0,0
33669,",",0,0
33670,information,0,0
33671,was,0,0
33672,collected,0,0
33673,via,0,0
33674,a,0,0
33675,questionnaire,0,0
33676,about,0,0
33677,participants,0,1
33678,',0,1
33679,levels,0,0
33680,of,0,0
33681,satisfaction,0,0
33682,with,0,0
33683,a,0,0
33684,variety,0,0
33685,of,0,0
33686,aspects,0,0
33687,of,0,0
33688,care,0,0
33689,provided,0,0
33690,during,0,0
33691,the,0,0
33692,antenatal,0,0
33693,",",0,0
33694,delivery,0,0
33695,and,0,0
33696,postpartum,0,1
33697,periods,0,0
33698,.,0,1
33699,Data,0,0
33700,about,0,0
33701,clinical,0,0
33702,outcomes,0,0
33703,for,0,0
33704,the,0,0
33705,two,0,0
33706,groups,0,0
33707,were,0,0
33708,also,0,0
33709,obtained,0,0
33710,.,0,0
33711,RESULTS,0,0
33712,Women,0,1
33713,in,0,0
33714,the,0,0
33715,pilot,0,0
33716,group,0,0
33717,had,0,0
33718,significantly,0,0
33719,more,0,0
33720,continuity,0,0
33721,of,0,0
33722,care,0,0
33723,throughout,0,0
33724,each,0,0
33725,of,0,0
33726,the,0,0
33727,three,0,0
33728,periods,0,0
33729,",",0,0
33730,were,0,0
33731,generally,0,0
33732,more,0,0
33733,satisfied,0,0
33734,with,0,0
33735,their,0,0
33736,care,0,0
33737,",",0,0
33738,felt,0,0
33739,that,0,0
33740,they,0,0
33741,had,0,0
33742,more,0,0
33743,choice,0,0
33744,over,0,0
33745,a,0,0
33746,variety,0,0
33747,of,0,0
33748,aspects,0,0
33749,of,0,0
33750,care,0,1
33751,and,0,0
33752,experienced,0,0
33753,no,0,0
33754,compromise,0,0
33755,in,0,0
33756,clinical,0,0
33757,outcomes,0,0
33758,(,0,0
33759,P,0,0
33760,=,0,0
33761,0.05,0,0
33762,or,0,0
33763,less,0,0
33764,in,0,0
33765,each,0,0
33766,case,0,0
33767,),0,0
33768,.,0,0
33769,IMPLICATIONS,0,0
33770,FOR,0,0
33771,PRACTICE,0,0
33772,Many,0,1
33773,previous,0,0
33774,attempts,0,0
33775,to,0,0
33776,introduce,0,0
33777,the,0,0
33778,Changing,0,0
33779,Childbirth,0,1
33780,initiative,0,0
33781,have,0,0
33782,revealed,0,0
33783,significant,0,0
33784,problems,0,0
33785,",",0,0
33786,particularly,0,0
33787,with,0,0
33788,regard,0,0
33789,to,0,0
33790,the,0,0
33791,continuity,0,0
33792,of,0,0
33793,carer,0,0
33794,requirement,0,0
33795,.,0,0
33796,Taking,0,0
33797,account,0,0
33798,of,0,0
33799,local,0,0
33800,health,0,1
33801,care,0,0
33802,needs,0,0
33803,and,0,0
33804,existing,0,0
33805,provision,0,0
33806,",",0,0
33807,the,0,0
33808,present,0,0
33809,study,0,0
33810,adapted,0,0
33811,this,0,0
33812,concept,0,0
33813,to,0,0
33814,continuity,0,0
33815,of,0,0
33816,care,0,0
33817,.,0,0
33818,This,0,0
33819,did,0,0
33820,not,0,0
33821,apparently,0,0
33822,affect,0,0
33823,any,0,0
33824,of,0,0
33825,the,0,0
33826,guiding,0,0
33827,principles,0,0
33828,contained,0,0
33829,in,0,0
33830,the,0,0
33831,original,0,0
33832,document,0,0
33833,",",0,0
33834,and,0,0
33835,yet,0,0
33836,enhanced,0,0
33837,satisfaction,0,0
33838,.,0,0
33839,It,0,0
33840,would,0,0
33841,appear,0,0
33842,that,0,0
33843,the,0,0
33844,Changing,0,0
33845,Childbirth,0,0
33846,agenda,0,0
33847,can,0,0
33848,be,0,0
33849,adapted,0,0
33850,and,0,0
33851,integrated,0,0
33852,with,0,0
33853,local,0,0
33854,health,0,1
33855,care,0,0
33856,situations,0,0
33857,without,0,1
33858,sacrificing,0,0
33859,any,0,0
33860,of,0,0
33861,the,0,0
33862,overarching,0,0
33863,principles,0,0
33864,.,0,1
33865,Service,0,0
33866,variation,0,0
33867,in,0,0
33868,baseline,0,0
33869,variables,0,0
33870,and,0,0
33871,prediction,0,0
33872,of,0,0
33873,risk,0,0
33874,in,0,0
33875,a,0,0
33876,randomised,0,0
33877,controlled,0,0
33878,trial,0,0
33879,of,0,0
33880,psychological,0,0
33881,treatment,0,0
33882,in,0,0
33883,repeated,0,0
33884,parasuicide,0,1
33885,:,0,1
33886,the,0,0
33887,POPMACT,0,0
33888,Study,0,0
33889,.,0,0
33890,The,0,0
33891,treatment,0,0
33892,protocol,0,0
33893,and,0,0
33894,baseline,0,0
33895,characteristics,0,0
33896,of,0,0
33897,480,1,0
33898,subjects,1,1
33899,with,1,1
33900,a,1,0
33901,history,1,0
33902,of,1,0
33903,repeated,1,0
33904,parasuicide,1,1
33905,recruited,0,1
33906,in,0,0
33907,five,0,1
33908,centres,0,1
33909,to,0,0
33910,a,0,0
33911,randomised,0,0
33912,therapeutic,0,0
33913,trial,0,0
33914,of,0,0
33915,manual,0,0
33916,assisted,0,1
33917,cognitive-behaviour,0,0
33918,therapy,0,0
33919,(,0,0
33920,MACT,0,0
33921,),0,0
33922,and,0,0
33923,treatment,0,0
33924,as,0,0
33925,usual,0,0
33926,(,0,0
33927,TAU,0,0
33928,),0,0
33929,are,0,0
33930,described,0,0
33931,.,0,0
33932,Most,1,0
33933,patients,1,1
33934,had,1,0
33935,significant,1,0
33936,anxiety,1,0
33937,and,1,0
33938,depressive,1,0
33939,disturbance,1,0
33940,with,1,1
33941,42,1,0
33942,%,1,0
33943,having,1,1
33944,a,1,0
33945,personality,1,1
33946,disorder,1,1
33947,.,1,0
33948,Variation,0,0
33949,in,0,0
33950,service,0,1
33951,policies,0,0
33952,influenced,0,0
33953,recruitment,0,0
33954,",",0,0
33955,with,0,0
33956,earlier,0,0
33957,assessment,0,0
33958,centres,0,1
33959,seeing,0,0
33960,people,0,1
33961,with,0,0
33962,more,0,0
33963,frequent,0,0
33964,episodes,0,0
33965,of,0,0
33966,self-harm,0,1
33967,and,0,0
33968,greater,0,0
33969,parasuicide,0,1
33970,risk,0,0
33971,than,0,0
33972,later,0,0
33973,ones,0,0
33974,.,0,0
33975,Parasuicide,0,1
33976,risk,0,0
33977,was,0,0
33978,also,0,0
33979,significantly,0,0
33980,greater,0,0
33981,in,0,0
33982,those,0,0
33983,with,0,0
33984,their,0,0
33985,first,0,0
33986,parasuicide,0,1
33987,episode,0,1
33988,at,0,0
33989,an,0,0
33990,earlier,0,0
33991,age,0,1
33992,and,0,0
33993,in,0,0
33994,those,0,0
33995,with,0,0
33996,a,0,0
33997,more,0,0
33998,recent,0,0
33999,latest,0,0
34000,episode,0,1
34001,.,0,0
34002,Safety,0,0
34003,of,0,0
34004,an,0,0
34005,astaxanthin-rich,0,0
34006,Haematococcus,0,0
34007,pluvialis,0,0
34008,algal,0,0
34009,extract,0,0
34010,:,0,1
34011,a,0,0
34012,randomized,0,0
34013,clinical,0,0
34014,trial,0,0
34015,.,0,0
34016,A,0,0
34017,growing,0,0
34018,body,0,0
34019,of,0,0
34020,scientific,0,0
34021,literature,0,0
34022,indicates,0,0
34023,that,0,0
34024,astaxanthin,0,0
34025,is,0,0
34026,a,0,0
34027,more,0,0
34028,powerful,0,0
34029,antioxidant,0,0
34030,than,0,0
34031,other,0,0
34032,carotenoids,0,0
34033,and,0,0
34034,vitamin,0,0
34035,E,0,0
34036,and,0,0
34037,may,0,0
34038,confer,0,0
34039,numerous,0,0
34040,health,0,1
34041,benefits,0,0
34042,.,0,0
34043,The,0,0
34044,purpose,0,0
34045,of,0,0
34046,this,0,0
34047,investigation,0,0
34048,was,0,0
34049,to,0,0
34050,conduct,0,0
34051,a,0,0
34052,human,0,0
34053,safety,0,0
34054,study,0,0
34055,with,0,0
34056,a,0,0
34057,Haematococcus,0,0
34058,pluvialis,0,0
34059,algal,0,0
34060,extract,0,0
34061,with,0,1
34062,high,0,0
34063,levels,0,0
34064,of,0,0
34065,astaxanthin,0,0
34066,.,0,0
34067,Thirty-five,1,1
34068,healthy,1,1
34069,adults,1,1
34070,age,1,1
34071,35-69,1,1
34072,years,1,1
34073,were,1,0
34074,enrolled,1,1
34075,in,1,0
34076,a,1,0
34077,randomized,1,0
34078,",",1,0
34079,double-blind,1,0
34080,",",1,0
34081,placebo-controlled,1,0
34082,trial,1,0
34083,of,1,0
34084,8,1,0
34085,weeks,1,0
34086,',1,1
34087,duration,1,0
34088,.,1,1
34089,All,1,0
34090,participants,1,1
34091,took,0,0
34092,three,0,0
34093,gelcaps,0,0
34094,per,0,0
34095,day,0,0
34096,",",0,0
34097,one,0,0
34098,at,0,0
34099,each,0,0
34100,meal,0,0
34101,.,0,0
34102,Nineteen,1,1
34103,participants,1,1
34104,received,1,0
34105,gelcaps,1,0
34106,with,0,1
34107,an,0,0
34108,algal,0,0
34109,extract,0,0
34110,in,0,0
34111,safflower,0,0
34112,oil,0,0
34113,",",0,0
34114,containing,0,0
34115,2,0,0
34116,mg,0,0
34117,of,0,0
34118,astaxanthin,0,0
34119,each,0,0
34120,(,0,0
34121,treatment,0,0
34122,),0,0
34123,;,0,0
34124,16,1,1
34125,participants,1,1
34126,received,1,0
34127,gelcaps,1,0
34128,containing,0,0
34129,safflower,0,0
34130,oil,0,0
34131,only,0,0
34132,(,0,0
34133,placebo,0,0
34134,),0,0
34135,.,0,0
34136,Blood,0,0
34137,pressure,0,0
34138,and,0,0
34139,blood,0,0
34140,chemistry,0,0
34141,tests,0,0
34142,",",0,0
34143,including,0,0
34144,a,0,0
34145,comprehensive,0,0
34146,metabolic,0,0
34147,panel,0,1
34148,and,0,0
34149,cell,0,0
34150,blood,0,0
34151,count,0,0
34152,",",0,0
34153,were,0,0
34154,conducted,0,0
34155,at,0,0
34156,the,0,0
34157,beginning,0,0
34158,of,0,0
34159,the,0,0
34160,trial,0,0
34161,and,0,0
34162,after,0,0
34163,4,0,0
34164,and,0,0
34165,8,0,0
34166,weeks,0,0
34167,of,0,0
34168,supplementation,0,0
34169,.,0,0
34170,No,0,0
34171,significant,0,0
34172,differences,0,0
34173,were,0,0
34174,detected,0,0
34175,between,0,0
34176,the,0,0
34177,treatment,0,0
34178,and,0,0
34179,the,0,0
34180,placebo,0,0
34181,groups,0,0
34182,after,0,0
34183,8,0,0
34184,weeks,0,0
34185,of,0,0
34186,supplementation,0,0
34187,with,0,1
34188,the,0,0
34189,algal,0,0
34190,extract,0,0
34191,in,0,0
34192,the,0,0
34193,parameters,0,0
34194,analyzed,0,0
34195,",",0,0
34196,except,0,0
34197,for,0,0
34198,serum,0,0
34199,calcium,0,0
34200,",",0,0
34201,total,0,0
34202,protein,0,0
34203,",",0,0
34204,and,0,0
34205,eosinophils,0,0
34206,(,0,0
34207,P,0,0
34208,<,0,0
34209,.01,0,0
34210,),0,0
34211,.,0,0
34212,Although,0,0
34213,the,0,0
34214,differences,0,0
34215,in,0,0
34216,these,0,0
34217,three,0,0
34218,parameters,0,0
34219,were,0,0
34220,statistically,0,0
34221,significant,0,0
34222,",",0,0
34223,they,0,0
34224,were,0,0
34225,very,0,0
34226,small,0,0
34227,and,0,0
34228,are,0,0
34229,of,0,0
34230,no,0,0
34231,clinical,0,0
34232,importance,0,0
34233,.,0,0
34234,These,0,0
34235,results,0,0
34236,reveal,0,0
34237,that,0,0
34238,6,0,0
34239,mg,0,0
34240,of,0,0
34241,astaxanthin,0,0
34242,per,0,0
34243,day,0,0
34244,from,0,0
34245,a,0,0
34246,H.,0,0
34247,pluvialis,0,0
34248,algal,0,0
34249,extract,0,0
34250,can,0,0
34251,be,0,0
34252,safely,0,0
34253,consumed,0,0
34254,by,0,0
34255,healthy,0,1
34256,adults,0,1
34257,.,0,1
34258,Prevention,0,0
34259,of,0,0
34260,coronary,1,1
34261,spasm,1,1
34262,by,0,0
34263,nicorandil,0,0
34264,:,0,1
34265,comparison,0,0
34266,with,0,1
34267,nifedipine,0,0
34268,.,0,0
34269,The,0,0
34270,efficacy,0,0
34271,of,0,0
34272,nicorandil,0,0
34273,was,0,0
34274,compared,0,0
34275,with,0,0
34276,that,0,0
34277,of,0,0
34278,nifedipine,0,0
34279,in,0,0
34280,13,1,0
34281,patients,1,1
34282,with,1,1
34283,vasospastic,1,1
34284,angina,1,1
34285,enrolled,0,1
34286,in,0,0
34287,a,0,0
34288,randomized,0,0
34289,",",0,0
34290,placebo-controlled,0,0
34291,",",0,0
34292,crossover,0,0
34293,study,0,0
34294,.,0,0
34295,All,1,0
34296,patients,1,1
34297,had,1,0
34298,a,1,0
34299,coronary,1,0
34300,spasm,1,1
34301,during,1,0
34302,coronary,1,1
34303,arteriography,1,0
34304,",",1,0
34305,either,1,0
34306,spontaneously,1,0
34307,or,1,0
34308,ergometrine-induced,1,0
34309,.,1,0
34310,During,0,0
34311,two,0,0
34312,consecutive,0,1
34313,periods,0,0
34314,of,0,0
34315,2,0,0
34316,days,0,0
34317,",",0,0
34318,patients,0,1
34319,received,0,0
34320,active,0,1
34321,drugs,0,0
34322,or,0,1
34323,placebo,0,0
34324,in,0,0
34325,a,0,0
34326,randomized,0,0
34327,order,0,0
34328,.,0,0
34329,Each,0,0
34330,patient,0,0
34331,received,0,0
34332,single,0,0
34333,oral,0,0
34334,doses,0,0
34335,of,0,0
34336,30,0,1
34337,mg,0,0
34338,nicorandil,0,0
34339,",",0,0
34340,10,0,0
34341,mg,0,0
34342,nifedipine,0,0
34343,",",0,0
34344,and,0,0
34345,",",0,0
34346,on,0,0
34347,2,0,0
34348,days,0,0
34349,",",0,0
34350,a,0,0
34351,placebo,0,0
34352,.,0,0
34353,One,0,0
34354,hour,0,0
34355,after,0,0
34356,drug,0,0
34357,intake,0,0
34358,",",0,0
34359,patients,0,1
34360,underwent,0,1
34361,an,0,0
34362,ergometrine,0,0
34363,test,0,0
34364,with,0,1
34365,increasing,0,0
34366,doses,0,0
34367,of,0,0
34368,Methergin,0,0
34369,(,0,0
34370,ergometrine,0,0
34371,),0,0
34372,(,0,0
34373,0.05,0,0
34374,",",0,0
34375,0.10,0,0
34376,",",0,0
34377,0.20,0,0
34378,",",0,0
34379,and,0,0
34380,0.40,0,0
34381,mg,0,0
34382,every,0,0
34383,5,0,0
34384,min,0,0
34385,),0,0
34386,.,0,0
34387,After,0,0
34388,placebo,0,0
34389,",",0,0
34390,the,0,0
34391,tests,0,0
34392,always,0,0
34393,were,0,0
34394,positive,0,0
34395,",",0,0
34396,and,0,0
34397,the,0,0
34398,ECG,0,0
34399,changes,0,0
34400,occurred,0,0
34401,at,0,0
34402,the,0,0
34403,same,0,0
34404,+/-,0,0
34405,1,0,0
34406,dose,0,0
34407,of,0,0
34408,ergometrine,0,0
34409,in,0,0
34410,10,0,0
34411,cases,0,0
34412,",",0,0
34413,showing,0,0
34414,good,0,0
34415,reproducibility,0,0
34416,.,0,0
34417,After,0,0
34418,nicorandil,0,0
34419,",",0,0
34420,the,0,0
34421,tests,0,0
34422,were,0,0
34423,negative,0,0
34424,in,0,0
34425,nine,0,1
34426,patients,0,1
34427,and,0,0
34428,positive,0,0
34429,for,0,0
34430,a,0,0
34431,higher,0,0
34432,or,0,0
34433,lower,0,0
34434,dose,0,0
34435,of,0,0
34436,ergometrine,0,0
34437,in,0,0
34438,three,0,0
34439,and,0,0
34440,one,0,0
34441,patient,0,0
34442,",",0,0
34443,respectively,0,0
34444,(,0,0
34445,p,0,0
34446,=,0,0
34447,0.0034,0,0
34448,vs.,0,0
34449,placebo,0,0
34450,),0,0
34451,.,0,0
34452,After,0,0
34453,nifedipine,0,0
34454,",",0,0
34455,the,0,0
34456,tests,0,0
34457,were,0,0
34458,negative,0,0
34459,in,0,0
34460,five,0,1
34461,patients,0,1
34462,and,0,0
34463,positive,0,0
34464,for,0,0
34465,a,0,0
34466,higher,0,0
34467,or,0,0
34468,the,0,0
34469,same,0,0
34470,dose,0,0
34471,of,0,0
34472,ergometrine,0,0
34473,in,0,0
34474,four,0,0
34475,and,0,0
34476,four,0,0
34477,patients,0,1
34478,",",0,0
34479,respectively,0,0
34480,(,0,0
34481,p,0,0
34482,=,0,0
34483,0.0039,0,0
34484,vs.,0,0
34485,placebo,0,0
34486,),0,0
34487,.,0,0
34488,Nifedipine,0,0
34489,(,0,0
34490,10,0,0
34491,mg,0,0
34492,),0,0
34493,and,0,0
34494,nicorandil,0,0
34495,(,0,0
34496,30,0,0
34497,mg,0,0
34498,),0,0
34499,were,0,0
34500,equally,0,0
34501,effective,0,0
34502,in,0,0
34503,eight,0,1
34504,patients,0,1
34505,;,0,0
34506,in,0,0
34507,the,0,0
34508,remaining,0,0
34509,five,0,0
34510,patients,0,1
34511,",",0,0
34512,nicorandil,0,0
34513,had,0,0
34514,better,0,0
34515,results,0,0
34516,(,0,0
34517,p,0,0
34518,=,0,0
34519,0.06,0,0
34520,),0,0
34521,.,0,0
34522,Nicorandil,0,0
34523,(,0,0
34524,30,0,0
34525,mg,0,0
34526,),0,0
34527,prevents,0,0
34528,ergometrine-induced,0,0
34529,coronary,0,1
34530,spasm,0,1
34531,.,0,0
34532,This,0,0
34533,compound,0,0
34534,may,0,0
34535,be,0,0
34536,beneficial,0,0
34537,in,0,0
34538,patients,1,1
34539,with,1,1
34540,vasospastic,1,1
34541,angina,1,1
34542,.,1,0
34543,[,0,0
34544,Long,0,1
34545,term,0,0
34546,observation,0,0
34547,in,0,0
34548,effects,0,0
34549,of,0,0
34550,potassium,0,0
34551,and,0,0
34552,calcium,0,0
34553,supplementation,0,0
34554,on,0,0
34555,arterial,0,0
34556,blood,0,0
34557,pressure,0,0
34558,and,0,0
34559,sodium,0,0
34560,metabolism,0,0
34561,in,0,0
34562,adolescents,1,1
34563,with,1,1
34564,higher,1,0
34565,blood,1,0
34566,pressure,1,0
34567,],1,0
34568,.,0,0
34569,OBJECTIVE,0,0
34570,To,0,0
34571,investigate,0,0
34572,the,0,0
34573,effects,0,0
34574,of,0,0
34575,potassium,0,0
34576,and,0,0
34577,calcium,0,0
34578,supplementation,0,0
34579,in,0,0
34580,table,0,0
34581,salt,0,0
34582,on,0,0
34583,reduction,0,0
34584,of,0,0
34585,arterial,0,0
34586,blood,0,0
34587,pressure,0,0
34588,and,0,0
34589,sodium,0,0
34590,metabolism,0,0
34591,in,0,0
34592,adolescents,1,1
34593,with,1,1
34594,higher,1,0
34595,blood,1,0
34596,pressure,1,0
34597,.,1,0
34598,METHODS,0,0
34599,A,0,0
34600,single,0,0
34601,blind,0,0
34602,placebo-controlled,0,0
34603,trial,0,0
34604,was,0,0
34605,carried,0,0
34606,out,0,0
34607,for,0,0
34608,two,0,0
34609,years,0,1
34610,in,0,0
34611,220,1,1
34612,adolescents,1,1
34613,with,1,1
34614,higher,1,0
34615,blood,1,0
34616,pressure,1,0
34617,",",1,0
34618,aged,1,1
34619,18,1,1
34620,-,1,0
34621,22,1,1
34622,years,1,1
34623,",",1,1
34624,who,1,1
34625,were,1,1
34626,randomly,1,1
34627,divided,1,0
34628,into,1,0
34629,supplementary,1,0
34630,group,1,0
34631,(,1,0
34632,n,1,1
34633,=,1,0
34634,110,1,1
34635,),1,0
34636,and,1,0
34637,control,1,0
34638,group,1,0
34639,(,1,0
34640,n,1,1
34641,=,1,0
34642,110,1,1
34643,),1,0
34644,.,1,0
34645,Each,1,0
34646,of,1,0
34647,the,1,0
34648,subjects,1,1
34649,in,1,0
34650,the,1,0
34651,supplementary,1,0
34652,group,1,0
34653,and,1,0
34654,their,1,0
34655,family,1,0
34656,members,1,1
34657,was,0,0
34658,given,0,0
34659,10,0,0
34660,mmol,0,0
34661,of,0,0
34662,potassium,0,0
34663,and,0,0
34664,10,0,0
34665,mmol,0,0
34666,of,0,0
34667,calcium,0,0
34668,mixed,0,0
34669,in,0,0
34670,their,0,0
34671,table,0,0
34672,salt,0,0
34673,daily,0,0
34674,for,0,0
34675,24,0,0
34676,months,0,0
34677,.,0,1
34678,RESULTS,0,0
34679,Night,0,0
34680,urinary,0,0
34681,sodium,0,0
34682,and,0,0
34683,potassium,0,0
34684,excretion,0,0
34685,increased,0,0
34686,(,0,0
34687,urinary,0,0
34688,Na,0,0
34689,(,0,0
34690,+,0,0
34691,),0,0
34692,",",0,0
34693,P,0,0
34694,<,0,0
34695,0.05,0,0
34696,;,0,0
34697,urinary,0,0
34698,K,0,0
34699,(,0,0
34700,+,0,0
34701,),0,0
34702,",",0,0
34703,P,0,0
34704,<,0,0
34705,0.01,0,0
34706,),0,0
34707,and,0,0
34708,blood,0,0
34709,pressure,0,0
34710,lowered,0,0
34711,by,0,0
34712,5.3,0,0
34713,mm,0,0
34714,Hg/1.8,0,0
34715,mm,0,0
34716,Hg,0,0
34717,in,0,0
34718,average,0,0
34719,from,0,0
34720,the,0,0
34721,baseline,0,0
34722,in,0,0
34723,the,0,0
34724,supplementary,0,0
34725,group,0,0
34726,two,0,0
34727,years,0,1
34728,after,0,0
34729,potassium,0,0
34730,and,0,0
34731,calcium,0,0
34732,supplementation,0,0
34733,",",0,0
34734,as,0,0
34735,compared,0,0
34736,with,0,0
34737,that,0,0
34738,in,0,0
34739,the,0,0
34740,control,0,0
34741,group,0,0
34742,increased,0,0
34743,by,0,0
34744,(,0,0
34745,1.3/1.7,0,0
34746,),0,0
34747,mm,0,0
34748,Hg,0,0
34749,.,0,0
34750,CONCLUSIONS,0,0
34751,Adequate,0,0
34752,supplement,0,0
34753,of,0,0
34754,potassium,0,0
34755,and,0,0
34756,calcium,0,0
34757,in,0,0
34758,daily,0,0
34759,table,0,0
34760,salt,0,0
34761,intake,0,0
34762,was,0,0
34763,an,0,0
34764,effective,0,0
34765,way,0,0
34766,to,0,0
34767,prevent,0,0
34768,form,0,0
34769,hypertension,0,1
34770,and,0,0
34771,could,0,0
34772,promote,0,0
34773,their,0,0
34774,urinary,0,0
34775,sodium,0,0
34776,excretion,0,0
34777,and,0,0
34778,reduction,0,0
34779,of,0,0
34780,arterial,0,0
34781,blood,0,0
34782,pressure,0,0
34783,in,0,0
34784,adolescents,1,1
34785,with,1,1
34786,higher,1,0
34787,blood,1,0
34788,pressure,1,0
34789,.,1,0
34790,Virtual,0,0
34791,reality,0,0
34792,intervention,0,0
34793,for,0,0
34794,older,1,1
34795,women,1,1
34796,with,1,1
34797,breast,1,1
34798,cancer,1,1
34799,.,1,0
34800,This,0,0
34801,study,0,0
34802,examined,0,0
34803,the,0,0
34804,effects,0,0
34805,of,0,0
34806,a,0,0
34807,virtual,0,0
34808,reality,0,0
34809,distraction,0,0
34810,intervention,0,0
34811,on,0,0
34812,chemotherapy-related,1,0
34813,symptom,1,0
34814,distress,1,1
34815,levels,1,0
34816,in,1,0
34817,16,1,1
34818,women,1,1
34819,aged,1,1
34820,50,1,0
34821,and,1,0
34822,older,1,1
34823,.,1,0
34824,A,0,0
34825,cross-over,0,0
34826,design,0,0
34827,was,0,0
34828,used,0,0
34829,to,0,0
34830,answer,0,0
34831,the,0,0
34832,following,0,0
34833,research,0,0
34834,questions,0,0
34835,:,0,1
34836,(,0,0
34837,1,0,0
34838,),0,0
34839,Is,0,0
34840,virtual,0,0
34841,reality,0,0
34842,an,0,0
34843,effective,0,0
34844,distraction,0,0
34845,intervention,0,0
34846,for,0,0
34847,reducing,0,0
34848,chemotherapy-related,0,0
34849,symptom,0,0
34850,distress,0,1
34851,levels,0,0
34852,in,0,0
34853,older,1,1
34854,women,1,1
34855,with,1,1
34856,breast,1,1
34857,cancer,1,1
34858,?,0,0
34859,(,0,0
34860,2,0,0
34861,),0,0
34862,Does,0,0
34863,virtual,0,0
34864,reality,0,0
34865,have,0,0
34866,a,0,0
34867,lasting,0,0
34868,effect,0,0
34869,?,0,0
34870,Chemotherapy,0,0
34871,treatments,0,0
34872,are,0,0
34873,intensive,0,0
34874,and,0,0
34875,difficult,0,0
34876,to,0,0
34877,endure,0,0
34878,.,0,0
34879,One,0,0
34880,way,0,0
34881,to,0,0
34882,cope,0,0
34883,with,0,0
34884,chemotherapy-related,0,0
34885,symptom,0,0
34886,distress,0,0
34887,is,0,0
34888,through,0,0
34889,the,0,0
34890,use,0,0
34891,of,0,0
34892,distraction,0,0
34893,.,0,0
34894,For,0,0
34895,this,0,0
34896,study,0,0
34897,",",0,0
34898,a,0,0
34899,head-mounted,0,0
34900,display,0,0
34901,(,0,0
34902,Sony,0,0
34903,PC,0,1
34904,Glasstron,0,0
34905,PLM,0,0
34906,-,0,0
34907,S700,0,0
34908,),0,0
34909,was,0,0
34910,used,0,0
34911,to,0,0
34912,display,0,0
34913,encompassing,0,0
34914,images,0,0
34915,and,0,0
34916,block,0,0
34917,competing,0,0
34918,stimuli,0,0
34919,during,0,0
34920,chemotherapy,0,1
34921,infusions,0,0
34922,.,0,1
34923,The,0,0
34924,Symptom,0,0
34925,Distress,0,0
34926,Scale,0,0
34927,(,0,0
34928,SDS,0,0
34929,),0,0
34930,",",0,0
34931,Revised,0,0
34932,Piper,0,0
34933,Fatigue,0,0
34934,Scale,0,0
34935,(,0,0
34936,PFS,0,0
34937,),0,0
34938,",",0,0
34939,and,0,0
34940,the,0,0
34941,State,0,0
34942,Anxiety,0,0
34943,Inventory,0,0
34944,(,0,0
34945,SAI,0,0
34946,),0,0
34947,were,0,0
34948,used,0,0
34949,to,0,0
34950,measure,0,0
34951,symptom,0,0
34952,distress,0,1
34953,.,0,0
34954,For,0,0
34955,two,0,0
34956,matched,0,1
34957,chemotherapy,0,0
34958,treatments,0,0
34959,",",0,0
34960,one,0,0
34961,pre-test,0,0
34962,and,0,0
34963,two,0,0
34964,post-test,0,0
34965,measures,0,0
34966,were,0,0
34967,employed,0,0
34968,.,0,0
34969,Participants,0,1
34970,were,0,0
34971,randomly,0,1
34972,assigned,0,0
34973,to,0,0
34974,receive,0,0
34975,the,0,0
34976,VR,0,0
34977,distraction,0,0
34978,intervention,0,0
34979,during,0,0
34980,one,0,0
34981,chemotherapy,0,0
34982,treatment,0,0
34983,and,0,0
34984,received,0,0
34985,no,0,0
34986,distraction,0,0
34987,intervention,0,0
34988,(,0,0
34989,control,0,0
34990,condition,0,0
34991,),0,0
34992,during,0,0
34993,an,0,0
34994,alternate,0,0
34995,chemotherapy,0,0
34996,treatment,0,0
34997,.,0,0
34998,Analysis,0,0
34999,using,0,0
35000,paired,0,0
35001,t-tests,0,0
35002,demonstrated,0,0
35003,a,0,0
35004,significant,0,0
35005,decrease,0,0
35006,in,0,0
35007,the,0,0
35008,SAI,0,0
35009,(,0,0
35010,p,0,0
35011,=,0,0
35012,0.10,0,0
35013,),0,0
35014,scores,0,0
35015,immediately,0,0
35016,following,0,0
35017,chemotherapy,0,0
35018,treatments,0,0
35019,when,0,0
35020,participants,0,1
35021,used,0,0
35022,VR,0,1
35023,.,0,0
35024,No,0,0
35025,significant,0,0
35026,changes,0,0
35027,were,0,0
35028,found,0,0
35029,in,0,0
35030,SDS,0,0
35031,or,0,1
35032,PFS,0,1
35033,values,0,0
35034,.,0,0
35035,There,0,0
35036,was,0,0
35037,a,0,0
35038,consistent,0,0
35039,trend,0,0
35040,toward,0,0
35041,improved,0,0
35042,symptoms,0,0
35043,on,0,0
35044,all,0,0
35045,measures,0,0
35046,48,0,0
35047,h,0,0
35048,following,0,0
35049,completion,0,0
35050,of,0,0
35051,chemotherapy,0,0
35052,.,0,0
35053,Evaluation,0,0
35054,of,0,0
35055,the,0,0
35056,intervention,0,0
35057,indicated,0,0
35058,that,0,0
35059,women,1,1
35060,thought,0,0
35061,the,0,0
35062,head,0,0
35063,mounted,0,0
35064,device,0,0
35065,was,0,0
35066,easy,0,0
35067,to,0,0
35068,use,0,0
35069,",",0,0
35070,they,0,0
35071,experienced,0,0
35072,no,0,0
35073,cybersickness,0,0
35074,",",0,0
35075,and,0,0
35076,100,0,0
35077,%,0,0
35078,would,0,0
35079,use,0,0
35080,VR,0,0
35081,again,0,0
35082,.,0,0
35083,Reduced,0,0
35084,platelet,0,0
35085,thromboxane,0,0
35086,formation,0,0
35087,after,0,0
35088,long-term,0,0
35089,administration,0,0
35090,of,0,0
35091,a,0,0
35092,dihydropyridine,0,0
35093,calcium,0,0
35094,channel,0,0
35095,blocker,0,0
35096,:,0,0
35097,a,0,0
35098,prospective,0,0
35099,",",0,0
35100,double-blind,0,0
35101,",",0,0
35102,placebo-controlled,0,0
35103,study,0,0
35104,with,0,1
35105,nitrendipine,0,0
35106,in,0,0
35107,borderline,1,1
35108,hypertensive,1,1
35109,patients,1,1
35110,with,1,1
35111,IDDM-type,1,0
35112,diabetes,1,1
35113,mellitus,1,1
35114,.,1,1
35115,Twenty-nine,1,1
35116,IDDM,1,0
35117,patients,1,1
35118,with,1,1
35119,borderline,1,1
35120,hypertension,1,1
35121,were,1,0
35122,randomly,1,0
35123,allocated,1,0
35124,to,0,0
35125,placebo,0,0
35126,or,0,0
35127,nitrendipine,0,0
35128,treatment,0,0
35129,.,0,0
35130,Nitrendipine,0,0
35131,was,0,0
35132,given,0,0
35133,orally,0,0
35134,at,0,0
35135,a,0,0
35136,dosage,0,0
35137,of,0,0
35138,20,0,1
35139,mg,0,0
35140,once,0,0
35141,daily,0,0
35142,over,0,0
35143,4,0,0
35144,weeks,0,0
35145,.,0,0
35146,Stimulated,0,0
35147,platelet,0,0
35148,thromboxane,0,0
35149,formation,0,0
35150,at,0,0
35151,rest,0,0
35152,and,0,0
35153,after,0,0
35154,standardized,0,0
35155,",",0,0
35156,non,0,0
35157,exhausting,0,0
35158,exercise,0,0
35159,was,0,0
35160,measured,0,0
35161,by,0,0
35162,standard,0,0
35163,methods,0,1
35164,.,0,0
35165,In,0,0
35166,addition,0,0
35167,",",0,0
35168,plasma,0,0
35169,levels,0,0
35170,of,0,0
35171,platelet,0,0
35172,factor,0,0
35173,4,0,0
35174,and,0,0
35175,aggregation,0,0
35176,responses,0,0
35177,to,0,0
35178,collagen,0,0
35179,and,0,0
35180,ADP,0,0
35181,were,0,0
35182,determined,0,0
35183,.,0,0
35184,In,0,0
35185,the,0,0
35186,treatment,0,0
35187,group,0,0
35188,thromboxane,0,0
35189,formation,0,0
35190,after,0,0
35191,stimulation,0,0
35192,with,0,1
35193,collagen,0,0
35194,(,0,0
35195,0.3,0,0
35196,and,0,0
35197,1.0,0,0
35198,micrograms/ml,0,0
35199,),0,0
35200,and,0,0
35201,1,0,0
35202,mM,0,0
35203,arachidonic,0,0
35204,acid,0,0
35205,(,0,0
35206,AA,0,0
35207,),0,0
35208,was,0,0
35209,reduced,0,0
35210,in,0,0
35211,the,0,0
35212,resting,0,0
35213,state,0,0
35214,.,0,0
35215,Exercise,0,0
35216,induced,0,0
35217,change,0,0
35218,of,0,0
35219,thromboxane,0,0
35220,synthesis,0,0
35221,in,0,0
35222,response,0,0
35223,to,0,0
35224,1.0,0,0
35225,micrograms/ml,0,0
35226,collagen,0,0
35227,was,0,0
35228,significantly,0,0
35229,lower,0,0
35230,as,0,0
35231,compared,0,0
35232,to,0,0
35233,placebo,0,0
35234,(,0,0
35235,p,0,0
35236,<,0,0
35237,0.05,0,0
35238,),0,0
35239,.,0,0
35240,In,0,0
35241,parallel,0,0
35242,",",0,0
35243,PF4,0,0
35244,plasma,0,0
35245,levels,0,0
35246,were,0,0
35247,significantly,0,0
35248,lowered,0,0
35249,(,0,0
35250,p,0,0
35251,<,0,0
35252,0.05,0,0
35253,),0,0
35254,.,0,0
35255,Whole,0,0
35256,blood,0,0
35257,aggregation,0,0
35258,after,0,0
35259,collagen,0,0
35260,stimulation,0,0
35261,(,0,0
35262,1.0,0,0
35263,micrograms/ml,0,0
35264,),0,0
35265,was,0,0
35266,reduced,0,0
35267,after,0,0
35268,4,0,0
35269,weeks,0,0
35270,of,0,0
35271,nitrendipine,0,0
35272,treatment,0,0
35273,",",0,0
35274,but,0,0
35275,ADP,0,0
35276,(,0,0
35277,5,0,0
35278,microM,0,0
35279,),0,0
35280,induced,0,0
35281,aggregation,0,0
35282,was,0,0
35283,not,0,0
35284,.,0,0
35285,These,0,0
35286,effects,0,0
35287,of,0,0
35288,nitrendipine,0,0
35289,were,0,0
35290,not,0,0
35291,seen,0,0
35292,in,0,0
35293,platelet,0,0
35294,rich,0,0
35295,plasma,0,0
35296,.,0,0
35297,In,0,0
35298,conclusion,0,0
35299,long-term,0,0
35300,nitrendipine,0,0
35301,treatment,0,0
35302,may,0,0
35303,inhibit,0,0
35304,collagen,0,0
35305,dependent,0,0
35306,platelet,0,0
35307,activation,0,0
35308,in,0,0
35309,the,0,0
35310,blood,0,0
35311,of,0,0
35312,diabetic,1,1
35313,patients,1,1
35314,with,1,1
35315,borderline,1,1
35316,hypertension,1,1
35317,.,1,0
35318,A,0,0
35319,comparative,0,0
35320,study,0,0
35321,of,0,0
35322,a,0,0
35323,new,0,0
35324,food,0,0
35325,supplement,0,0
35326,",",0,0
35327,ViviScal,0,0
35328,",",0,0
35329,with,0,0
35330,fish,0,0
35331,extract,0,0
35332,for,0,0
35333,the,0,0
35334,treatment,0,0
35335,of,0,0
35336,hereditary,1,1
35337,androgenic,1,0
35338,alopecia,1,1
35339,in,1,0
35340,young,1,1
35341,males,1,1
35342,.,1,0
35343,A,0,0
35344,controlled,0,0
35345,",",0,0
35346,randomized,0,0
35347,",",0,0
35348,double-blind,0,0
35349,",",0,0
35350,parallel-group,0,0
35351,study,0,0
35352,compared,0,0
35353,the,0,0
35354,effects,0,0
35355,of,0,0
35356,ViviScal,0,1
35357,(,0,0
35358,a,0,0
35359,new,0,0
35360,food,0,0
35361,supplement,0,0
35362,incorporating,0,0
35363,special,0,1
35364,marine,0,0
35365,extracts,0,0
35366,and,0,0
35367,a,0,0
35368,silica,0,0
35369,compound,0,0
35370,),0,0
35371,with,0,0
35372,those,0,0
35373,of,0,0
35374,a,0,0
35375,fish,0,0
35376,extract,0,0
35377,in,0,0
35378,the,0,0
35379,treatment,0,0
35380,of,0,0
35381,young,1,1
35382,males,1,1
35383,with,1,1
35384,hereditary,1,1
35385,androgenic,1,0
35386,alopecia,1,1
35387,.,1,0
35388,The,0,0
35389,pretreatment,0,0
35390,histological,0,0
35391,diagnosis,0,1
35392,was,0,0
35393,alopecia,1,1
35394,with,1,0
35395,a,1,0
35396,mild,1,0
35397,to,1,0
35398,moderate,1,1
35399,perifollicular,1,0
35400,inflammation,1,0
35401,zone,1,0
35402,.,1,0
35403,The,0,0
35404,study,0,0
35405,consisted,0,0
35406,of,0,0
35407,20,1,1
35408,subjects,1,1
35409,who,1,1
35410,received,1,1
35411,two,1,1
35412,tablets,1,0
35413,of,1,0
35414,ViviScal,1,0
35415,once,1,0
35416,daily,1,0
35417,and,1,0
35418,20,1,1
35419,who,1,1
35420,received,1,1
35421,two,1,1
35422,tablets,1,0
35423,of,1,0
35424,fish,1,0
35425,extract,1,0
35426,once,1,0
35427,daily,1,0
35428,for,1,0
35429,6,1,0
35430,months,1,0
35431,.,1,0
35432,The,1,0
35433,mean,1,0
35434,patient,1,0
35435,age,1,1
35436,and,1,0
35437,mean,1,0
35438,duration,1,0
35439,and,1,0
35440,severity,1,0
35441,of,1,0
35442,baldness,1,1
35443,compared,0,0
35444,well,0,0
35445,between,0,0
35446,the,0,0
35447,two,0,0
35448,groups,0,0
35449,.,0,1
35450,Most,1,0
35451,patients,1,1
35452,had,1,0
35453,been,1,0
35454,treated,1,1
35455,with,1,1
35456,long-term,1,0
35457,topical,1,0
35458,2,1,0
35459,%,1,0
35460,minoxidil,1,0
35461,for,1,0
35462,1,1,0
35463,year,1,0
35464,or,1,0
35465,more,1,0
35466,prior,0,0
35467,to,0,0
35468,the,0,0
35469,study,0,0
35470,.,0,0
35471,At,0,0
35472,baseline,0,0
35473,and,0,0
35474,after,0,0
35475,6,0,0
35476,months,0,0
35477,',0,0
35478,treatment,0,0
35479,",",0,0
35480,a,0,0
35481,biopsy,0,0
35482,was,0,0
35483,taken,0,0
35484,for,0,0
35485,histological,0,0
35486,examination,0,0
35487,.,0,0
35488,A,0,0
35489,non-vellus,0,0
35490,hair,0,1
35491,count,0,0
35492,was,0,0
35493,performed,0,0
35494,at,0,0
35495,baseline,0,0
35496,and,0,0
35497,after,0,0
35498,2,0,0
35499,",",0,0
35500,4,0,0
35501,and,0,0
35502,6,0,0
35503,months,0,0
35504,.,0,0
35505,In,0,0
35506,the,0,0
35507,fish,0,0
35508,extract,0,0
35509,treatment,0,0
35510,group,0,0
35511,three,1,0
35512,patients,1,1
35513,withdrew,1,0
35514,from,1,0
35515,the,1,0
35516,study,1,0
35517,before,1,0
35518,the,1,0
35519,fourth,1,0
35520,month,1,0
35521,due,1,0
35522,to,1,0
35523,lack,1,0
35524,of,1,0
35525,therapeutic,1,0
35526,effect,1,0
35527,.,1,0
35528,After,0,0
35529,6,0,0
35530,months,0,0
35531,',0,0
35532,treatment,0,0
35533,",",0,0
35534,patients,0,1
35535,receiving,0,1
35536,ViviScal,0,1
35537,showed,0,0
35538,a,0,0
35539,mean,0,0
35540,increase,0,0
35541,in,0,0
35542,non-vellus,0,0
35543,hair,0,1
35544,of,0,0
35545,38,0,1
35546,%,0,0
35547,compared,0,0
35548,with,0,0
35549,a,0,0
35550,2,0,0
35551,%,0,0
35552,increase,0,0
35553,in,0,0
35554,the,0,0
35555,fish,0,0
35556,extract,0,0
35557,treatment,0,0
35558,group,0,0
35559,(,0,0
35560,P,0,0
35561,<,0,0
35562,0.0001,0,0
35563,),0,0
35564,.,0,0
35565,In,0,0
35566,the,0,0
35567,ViviScal,0,0
35568,group,0,0
35569,",",0,0
35570,19,0,1
35571,(,0,0
35572,95,0,0
35573,%,0,0
35574,),0,0
35575,subjects,0,1
35576,showed,0,0
35577,both,0,0
35578,clinical,0,0
35579,and,0,0
35580,histological,0,0
35581,cure,0,0
35582,",",0,0
35583,whereas,0,0
35584,none,0,0
35585,treated,0,1
35586,with,0,0
35587,fish,0,0
35588,extract,0,0
35589,showed,0,0
35590,any,0,0
35591,clinical,0,0
35592,or,0,0
35593,histological,0,0
35594,difference,0,0
35595,after,0,0
35596,6,0,0
35597,months,0,0
35598,',0,1
35599,treatment,0,0
35600,(,0,0
35601,P,0,0
35602,<,0,0
35603,0.0001,0,0
35604,),0,0
35605,.,0,0
35606,In,0,0
35607,both,0,0
35608,groups,0,0
35609,",",0,0
35610,a,0,0
35611,minimal,0,0
35612,decrease,0,0
35613,in,0,0
35614,the,0,0
35615,erythemal,0,0
35616,index,0,0
35617,was,0,0
35618,observed,0,0
35619,.,0,0
35620,In,0,0
35621,conclusion,0,0
35622,",",0,0
35623,ViviScal,0,0
35624,appears,0,0
35625,to,0,0
35626,be,0,0
35627,the,0,0
35628,first,0,0
35629,highly,0,0
35630,active,0,0
35631,treatment,0,0
35632,for,0,0
35633,androgenic,0,0
35634,alopecia,0,1
35635,in,0,0
35636,young,0,1
35637,males,0,1
35638,.,0,1
35639,A,0,0
35640,prospective,0,0
35641,randomized,0,0
35642,trial,0,0
35643,of,0,0
35644,two,0,0
35645,different,0,0
35646,endoscopic,0,1
35647,resection,0,1
35648,techniques,0,0
35649,for,0,0
35650,early,1,1
35651,stage,1,1
35652,cancer,1,1
35653,of,1,0
35654,the,1,0
35655,esophagus,1,1
35656,.,1,0
35657,BACKGROUND,0,0
35658,A,0,0
35659,variety,0,0
35660,of,0,0
35661,different,0,0
35662,endoscopic,0,1
35663,resection,0,1
35664,techniques,0,0
35665,for,0,0
35666,early,0,1
35667,stage,0,1
35668,cancer,0,1
35669,of,0,0
35670,the,0,0
35671,upper,0,0
35672,GI,0,0
35673,tract,0,1
35674,have,0,0
35675,been,0,0
35676,described,0,0
35677,that,0,0
35678,are,0,0
35679,more,0,0
35680,effective,0,0
35681,than,0,0
35682,strip,0,0
35683,biopsy,0,0
35684,.,0,0
35685,However,0,0
35686,",",0,0
35687,there,0,0
35688,is,0,0
35689,no,0,0
35690,report,0,0
35691,of,0,0
35692,a,0,0
35693,prospective,0,0
35694,randomized,0,0
35695,comparison,0,0
35696,of,0,0
35697,different,0,0
35698,techniques,0,0
35699,.,0,1
35700,METHODS,0,0
35701,In,0,0
35702,a,0,0
35703,prospective,0,0
35704,randomized,0,0
35705,study,0,0
35706,",",0,0
35707,100,1,0
35708,consecutive,1,1
35709,endoscopic,1,1
35710,resections,1,1
35711,were,1,0
35712,performed,1,0
35713,in,1,0
35714,72,1,0
35715,patients,1,1
35716,with,1,1
35717,early,1,1
35718,stage,1,1
35719,esophageal,1,1
35720,cancer,1,1
35721,.,1,0
35722,Fifty,0,0
35723,endoscopic,0,0
35724,resections,0,1
35725,were,0,0
35726,performed,0,0
35727,with,0,0
35728,a,0,0
35729,suck-and-ligate,0,0
35730,device,0,0
35731,without,0,1
35732,prior,0,0
35733,submucosa,0,1
35734,injection,0,0
35735,and,0,0
35736,50,0,0
35737,with,0,0
35738,the,0,0
35739,cap,0,0
35740,technique,0,0
35741,with,0,1
35742,prior,0,0
35743,submucosa,0,1
35744,injection,0,0
35745,of,0,0
35746,a,0,0
35747,dilute,0,0
35748,saline,0,0
35749,solution,0,0
35750,of,0,0
35751,epinephrine,0,0
35752,.,0,0
35753,The,0,0
35754,main,0,0
35755,assessment,0,0
35756,criteria,0,1
35757,were,0,0
35758,maximum,0,0
35759,diameter,0,0
35760,of,0,0
35761,the,0,0
35762,resection,0,0
35763,specimen,0,0
35764,and,0,0
35765,of,0,0
35766,the,0,0
35767,resection,0,0
35768,area,0,0
35769,",",0,0
35770,and,0,0
35771,the,0,0
35772,complication,0,0
35773,rate,0,0
35774,.,0,0
35775,RESULTS,0,0
35776,No,0,0
35777,significant,0,0
35778,differences,0,0
35779,were,0,0
35780,observed,0,0
35781,between,0,0
35782,the,0,0
35783,two,0,0
35784,groups,0,0
35785,with,0,1
35786,regard,0,0
35787,to,0,0
35788,the,0,0
35789,maximum,0,0
35790,diameters,0,0
35791,and,0,0
35792,calculated,0,0
35793,area,0,0
35794,of,0,0
35795,the,0,0
35796,resected,0,1
35797,specimens,0,0
35798,(,0,0
35799,ligation,0,1
35800,group,0,0
35801,:,0,1
35802,16.4,0,0
35803,[,0,0
35804,4.0,0,0
35805,],0,0
35806,x,0,0
35807,11,0,1
35808,[,0,0
35809,3.1,0,0
35810,],0,1
35811,mm/185,0,0
35812,[,0,0
35813,84,0,1
35814,],0,0
35815,mm,0,0
35816,(,0,0
35817,2,0,0
35818,),0,0
35819,vs.,0,0
35820,cap,0,0
35821,group,0,0
35822,:,0,1
35823,15.5,0,0
35824,[,0,0
35825,4.1,0,0
35826,],0,0
35827,x,0,0
35828,10.7,0,0
35829,[,0,0
35830,2.7,0,0
35831,],0,1
35832,mm/168,0,0
35833,[,0,0
35834,83,0,0
35835,],0,0
35836,mm,0,0
35837,(,0,0
35838,2,0,0
35839,),0,0
35840,),0,0
35841,",",0,0
35842,or,0,0
35843,the,0,0
35844,maximum,0,0
35845,diameters,0,0
35846,and,0,0
35847,calculated,0,0
35848,area,0,0
35849,of,0,0
35850,the,0,0
35851,endoscopic,0,0
35852,resection,0,0
35853,ulcers,0,1
35854,after,0,0
35855,24,0,0
35856,hours,0,0
35857,(,0,0
35858,ligation,0,1
35859,group,0,0
35860,:,0,1
35861,20.6,0,0
35862,[,0,0
35863,4.8,0,0
35864,],0,0
35865,x,0,0
35866,14.3,0,0
35867,[,0,0
35868,4.5,0,0
35869,],0,1
35870,mm/314,0,0
35871,[,0,0
35872,160,0,1
35873,],0,0
35874,mm,0,0
35875,(,0,0
35876,2,0,0
35877,),0,0
35878,vs.,0,0
35879,cap,0,0
35880,group,0,0
35881,:,0,1
35882,18.9,0,0
35883,[,0,0
35884,5.1,0,0
35885,],0,0
35886,x,0,0
35887,12.9,0,0
35888,[,0,0
35889,3.8,0,0
35890,],0,1
35891,mm/260,0,0
35892,[,0,0
35893,145,0,0
35894,],0,0
35895,mm,0,0
35896,(,0,0
35897,2,0,0
35898,),0,0
35899,),0,0
35900,.,0,0
35901,There,0,0
35902,was,0,0
35903,only,0,0
35904,a,0,0
35905,slight,0,0
35906,advantage,0,0
35907,(,0,0
35908,greater,0,0
35909,diameter,0,0
35910,of,0,0
35911,resection,0,1
35912,specimens,0,1
35913,),0,0
35914,for,0,0
35915,the,0,0
35916,ligation,0,0
35917,group,0,0
35918,in,0,1
35919,patients,1,1
35920,who,1,1
35921,had,1,1
35922,prior,1,1
35923,endoscopic,1,1
35924,treatment,1,0
35925,.,1,0
35926,There,0,0
35927,was,0,0
35928,one,0,0
35929,minor,0,0
35930,episode,0,1
35931,of,0,0
35932,bleeding,0,0
35933,in,0,0
35934,each,0,0
35935,group,0,0
35936,;,0,0
35937,there,0,0
35938,was,0,0
35939,no,0,0
35940,severe,0,1
35941,complication,0,0
35942,.,0,0
35943,In,0,0
35944,41,0,1
35945,of,0,0
35946,72,0,1
35947,patients,0,1
35948,(,0,0
35949,57,0,1
35950,%,0,0
35951,),0,0
35952,",",0,0
35953,further,0,0
35954,endoscopic,0,0
35955,therapy,0,0
35956,after,0,0
35957,endoscopic,0,0
35958,resection,0,1
35959,was,0,0
35960,necessary,0,0
35961,because,0,0
35962,of,0,0
35963,residual,0,0
35964,neoplasia,0,1
35965,at,0,0
35966,the,0,0
35967,first,0,0
35968,follow-up,0,0
35969,endoscopy,0,1
35970,after,0,0
35971,resection,0,1
35972,(,0,0
35973,61,0,1
35974,of,0,0
35975,100,0,0
35976,resection,0,1
35977,specimens,0,1
35978,[,0,0
35979,61,0,0
35980,%,0,0
35981,],0,0
35982,had,0,0
35983,lateral,0,0
35984,margins,0,0
35985,that,0,0
35986,could,0,0
35987,not,0,0
35988,be,0,0
35989,evaluated,0,0
35990,because,0,0
35991,of,0,0
35992,coagulation,0,0
35993,artifact,0,0
35994,or,0,0
35995,contained,0,0
35996,malignancy,0,0
35997,but,0,0
35998,with,0,0
35999,the,0,0
36000,base,0,0
36001,of,0,0
36002,the,0,0
36003,lesion,0,0
36004,free,0,0
36005,of,0,0
36006,tumor,0,1
36007,),0,0
36008,.,0,0
36009,CONCLUSIONS,0,0
36010,The,0,0
36011,cap,0,0
36012,technique,0,0
36013,with,0,1
36014,submucosa,0,0
36015,injection,0,0
36016,and,0,0
36017,the,0,0
36018,ligation,0,0
36019,technique,0,0
36020,without,0,0
36021,submucosa,0,0
36022,injection,0,0
36023,are,0,0
36024,similar,0,0
36025,with,0,0
36026,respect,0,0
36027,to,0,0
36028,efficacy,0,0
36029,and,0,0
36030,safety,0,0
36031,for,0,0
36032,endoscopic,0,0
36033,resection,0,1
36034,of,0,0
36035,early,0,0
36036,stage,0,1
36037,esophageal,0,1
36038,cancers,0,1
36039,.,0,1
36040,Left,0,0
36041,ventricular,0,0
36042,mass,0,0
36043,regression,0,0
36044,in,0,0
36045,elderly,1,1
36046,hypertensives,1,1
36047,.,1,0
36048,It,0,0
36049,is,0,0
36050,now,0,0
36051,recognized,0,0
36052,that,0,0
36053,left,0,1
36054,ventricular,0,0
36055,hypertrophy,0,1
36056,(,0,0
36057,LVH,0,1
36058,),0,0
36059,",",0,0
36060,often,0,0
36061,associated,0,0
36062,with,0,0
36063,hypertension,0,1
36064,",",0,0
36065,is,0,0
36066,itself,0,0
36067,a,0,0
36068,risk,0,0
36069,factor,0,0
36070,for,0,0
36071,coronary,0,1
36072,disease,0,1
36073,in,0,0
36074,the,0,0
36075,elderly,0,1
36076,.,0,0
36077,Although,0,0
36078,many,0,0
36079,agents,0,0
36080,are,0,0
36081,capable,0,0
36082,of,0,0
36083,controlling,0,0
36084,blood,0,0
36085,pressure,0,0
36086,",",0,0
36087,the,0,0
36088,ability,0,0
36089,of,0,0
36090,these,0,0
36091,agents,0,0
36092,to,0,0
36093,induce,0,0
36094,regression,0,0
36095,of,0,0
36096,left,0,0
36097,ventricular,0,0
36098,(,0,0
36099,LV,0,0
36100,),0,0
36101,mass,0,0
36102,",",0,0
36103,and,0,0
36104,the,0,0
36105,effect,0,0
36106,of,0,0
36107,regression,0,0
36108,on,0,0
36109,diastolic,0,0
36110,relaxation,0,0
36111,and,0,0
36112,contractile,0,0
36113,indices,0,0
36114,in,0,0
36115,the,0,0
36116,elderly,0,1
36117,are,0,0
36118,less,0,0
36119,well,0,0
36120,known,0,0
36121,.,0,0
36122,Our,0,0
36123,study,0,0
36124,compared,0,0
36125,the,0,0
36126,ability,0,0
36127,of,0,0
36128,the,0,0
36129,calcium,0,0
36130,blocker,0,0
36131,",",0,0
36132,verapamil,0,0
36133,",",0,0
36134,and,0,0
36135,the,0,0
36136,beta-blocker,0,0
36137,",",0,0
36138,atenolol,0,0
36139,",",0,0
36140,to,0,0
36141,both,0,0
36142,control,0,0
36143,blood,0,0
36144,pressure,0,0
36145,(,0,0
36146,BP,0,0
36147,),0,0
36148,and,0,0
36149,to,0,0
36150,induce,0,0
36151,regression,0,0
36152,of,0,0
36153,LV,0,0
36154,mass,0,0
36155,in,0,0
36156,older,0,1
36157,hypertensives,0,1
36158,.,0,0
36159,In,0,0
36160,addition,0,0
36161,",",0,0
36162,the,0,0
36163,influence,0,0
36164,of,0,0
36165,regression,0,0
36166,on,0,0
36167,resting,0,0
36168,diastolic,0,0
36169,filling,0,0
36170,and,0,0
36171,on,0,0
36172,cardiac,0,0
36173,output,0,0
36174,and,0,0
36175,ejection,0,0
36176,fraction,0,0
36177,during,0,0
36178,rest,0,0
36179,and,0,0
36180,mild,0,1
36181,upright,0,0
36182,bicycle,0,0
36183,exercise,0,0
36184,were,0,0
36185,determined,0,0
36186,.,0,0
36187,Forty-two,1,1
36188,hypertensives,1,1
36189,60,1,1
36190,years,1,1
36191,of,1,0
36192,age,1,1
36193,or,1,0
36194,above,1,0
36195,",",1,0
36196,without,1,0
36197,evidence,1,0
36198,of,1,0
36199,ischemic,1,1
36200,disease,1,1
36201,underwent,0,1
36202,2-D,0,0
36203,echocardiographic,0,0
36204,evaluation,0,0
36205,of,0,0
36206,LV,0,0
36207,mass,0,0
36208,and,0,0
36209,gated,0,0
36210,blood,0,0
36211,pool,0,1
36212,scan,0,0
36213,determination,0,0
36214,of,0,0
36215,early,0,0
36216,diastolic,0,0
36217,filling,0,0
36218,",",0,0
36219,cardiac,0,0
36220,output,0,0
36221,and,0,0
36222,ejection,0,0
36223,fraction,0,0
36224,.,0,0
36225,They,0,0
36226,were,0,0
36227,then,0,0
36228,randomized,0,0
36229,to,0,0
36230,receive,0,0
36231,verapamil,0,0
36232,or,0,0
36233,atenolol,0,0
36234,during,0,0
36235,a,0,0
36236,four-week,0,0
36237,titration,0,0
36238,period,0,0
36239,so,0,0
36240,as,0,0
36241,to,0,0
36242,achieve,0,0
36243,a,0,0
36244,BP,0,0
36245,of,0,0
36246,less,0,0
36247,than,0,0
36248,160/90,0,1
36249,mm,0,0
36250,Hg,0,0
36251,.,0,0
36252,If,0,0
36253,BP,0,0
36254,was,0,0
36255,not,0,0
36256,controlled,0,0
36257,with,0,0
36258,either,0,0
36259,agent,0,0
36260,",",0,0
36261,chlorthalidone,0,0
36262,was,0,0
36263,added,0,0
36264,.,0,0
36265,Individuals,0,0
36266,whose,0,1
36267,BP,0,0
36268,was,0,1
36269,controlled,0,0
36270,continued,0,0
36271,on,0,0
36272,the,0,0
36273,protocol,0,0
36274,for,0,0
36275,six,0,1
36276,months,0,0
36277,.,0,0
36278,At,0,0
36279,that,0,0
36280,time,0,0
36281,",",0,0
36282,the,0,0
36283,echocardiographic,0,0
36284,and,0,0
36285,gated,0,0
36286,blood,0,0
36287,pool,0,1
36288,studies,0,0
36289,were,0,0
36290,repeated,0,0
36291,both,0,0
36292,on,0,0
36293,and,0,0
36294,after,0,0
36295,subsequent,0,0
36296,withdrawal,0,0
36297,of,0,0
36298,the,0,0
36299,study,0,0
36300,medications,0,0
36301,.,0,1
36302,Twenty-one,0,1
36303,patients,0,1
36304,were,0,0
36305,randomized,0,0
36306,to,0,0
36307,receive,0,0
36308,verapamil,0,0
36309,and,0,0
36310,21,0,1
36311,patients,0,1
36312,to,0,0
36313,receive,0,0
36314,atenolol,0,0
36315,.,0,0
36316,Blood,0,0
36317,pressure,0,0
36318,control,0,0
36319,was,0,0
36320,achieved,0,0
36321,with,0,0
36322,verapamil,0,0
36323,alone,0,0
36324,in,0,0
36325,18,0,0
36326,patients,0,1
36327,",",0,0
36328,but,0,0
36329,with,0,0
36330,atenolol,0,0
36331,alone,0,0
36332,in,0,0
36333,only,0,0
36334,8,0,0
36335,patients,0,1
36336,(,0,0
36337,p,0,0
36338,<,0,0
36339,0.01,0,0
36340,),0,0
36341,.,0,0
36342,(,0,0
36343,ABSTRACT,0,0
36344,TRUNCATED,0,0
36345,AT,0,0
36346,250,0,0
36347,WORDS,0,0
36348,),0,0
36349,Advice,0,0
36350,or,0,0
36351,exercise,0,0
36352,for,0,0
36353,chronic,1,1
36354,whiplash,1,1
36355,disorders,1,1
36356,?,0,0
36357,Design,0,0
36358,of,0,0
36359,a,0,0
36360,randomized,0,0
36361,controlled,0,0
36362,trial,0,0
36363,.,0,0
36364,BACKGROUND,0,0
36365,Whiplash-associated,1,0
36366,disorder,1,1
36367,(,0,0
36368,or,0,0
36369,whiplash,0,0
36370,),0,0
36371,is,0,0
36372,a,0,0
36373,common,0,0
36374,condition,0,0
36375,incurring,0,0
36376,considerable,0,0
36377,expense,0,0
36378,in,0,0
36379,social,0,0
36380,and,0,0
36381,economic,0,0
36382,terms,0,0
36383,.,0,0
36384,A,0,0
36385,lack,0,0
36386,of,0,0
36387,research,0,0
36388,on,0,0
36389,effective,0,0
36390,therapy,0,0
36391,for,0,0
36392,patients,1,1
36393,with,1,1
36394,chronic,1,1
36395,whiplash,1,1
36396,associated,1,0
36397,disorders,1,1
36398,prompted,0,0
36399,the,0,0
36400,design,0,0
36401,of,0,0
36402,the,0,0
36403,current,0,0
36404,study,0,0
36405,.,0,0
36406,The,0,0
36407,primary,0,0
36408,aim,0,0
36409,of,0,0
36410,this,0,0
36411,randomised,0,0
36412,controlled,0,0
36413,trial,0,0
36414,is,0,0
36415,to,0,0
36416,determine,0,0
36417,the,0,0
36418,effects,0,0
36419,of,0,0
36420,a,0,0
36421,physical,0,0
36422,activity,0,0
36423,program,0,0
36424,for,0,0
36425,people,1,1
36426,with,1,1
36427,chronic,1,1
36428,(,1,0
36429,symptoms,1,0
36430,of,1,0
36431,>,1,1
36432,3,1,0
36433,months,1,0
36434,duration,1,0
36435,),1,0
36436,whiplash,1,0
36437,.,1,0
36438,A,0,0
36439,secondary,0,0
36440,aim,0,0
36441,is,0,0
36442,to,0,0
36443,determine,0,0
36444,if,0,0
36445,pain,0,0
36446,severity,0,0
36447,",",0,0
36448,level,0,0
36449,of,0,0
36450,disability,0,0
36451,and,0,0
36452,fear,0,0
36453,of,0,0
36454,movement/,0,0
36455,(,0,0
36456,re,0,0
36457,),0,0
36458,injury,0,0
36459,predict,0,0
36460,response,0,0
36461,to,0,0
36462,a,0,0
36463,physical,0,0
36464,activity,0,0
36465,program,0,0
36466,.,0,0
36467,METHODS/DESIGN,0,0
36468,This,0,0
36469,paper,0,0
36470,presents,0,0
36471,the,0,0
36472,rationale,0,0
36473,and,0,0
36474,design,0,0
36475,of,0,0
36476,a,0,0
36477,randomised,0,0
36478,controlled,0,0
36479,trial,0,0
36480,examining,0,0
36481,the,0,0
36482,effects,0,0
36483,of,0,0
36484,advice,0,0
36485,and,0,0
36486,individualized,0,0
36487,sub-maximal,0,0
36488,exercise,0,0
36489,programs,0,0
36490,in,0,0
36491,the,0,0
36492,treatment,0,0
36493,of,0,0
36494,whiplash,1,1
36495,associated,1,0
36496,disorders,1,1
36497,.,1,0
36498,DISCUSSION,0,0
36499,This,0,0
36500,paper,0,0
36501,highlights,0,0
36502,the,0,0
36503,design,0,0
36504,",",0,0
36505,methods,0,0
36506,and,0,0
36507,operational,0,0
36508,aspects,0,0
36509,of,0,0
36510,a,0,0
36511,significant,0,0
36512,clinical,0,0
36513,trial,0,0
36514,in,0,0
36515,the,0,0
36516,area,0,0
36517,of,0,0
36518,whiplash,1,0
36519,and,1,0
36520,chronic,1,1
36521,pain,1,0
36522,.,1,0
36523,Investigation,0,0
36524,of,0,0
36525,erosion,0,0
36526,and,0,0
36527,abrasion,0,0
36528,on,0,0
36529,enamel,0,0
36530,and,0,0
36531,dentine,0,1
36532,:,0,0
36533,a,0,0
36534,model,0,0
36535,in,0,0
36536,situ,0,0
36537,using,0,0
36538,toothpastes,0,0
36539,of,0,0
36540,different,0,0
36541,abrasivity,0,0
36542,.,0,1
36543,BACKGROUND,0,0
36544,Studies,0,0
36545,in,0,1
36546,vitro,0,0
36547,suggest,0,0
36548,that,0,0
36549,abrasion,0,0
36550,and,0,0
36551,erosion,0,0
36552,may,0,0
36553,act,0,0
36554,synergistically,0,0
36555,to,0,0
36556,produce,0,0
36557,wear,0,0
36558,of,0,0
36559,enamel,0,0
36560,and,0,0
36561,dentine,0,1
36562,.,0,0
36563,Methods,0,0
36564,in,0,0
36565,situ,0,0
36566,are,0,0
36567,recently,0,0
36568,available,0,0
36569,to,0,0
36570,study,0,0
36571,separately,0,0
36572,erosion,0,0
36573,and,0,0
36574,abrasion,0,0
36575,of,0,0
36576,dental,0,1
36577,tissues,0,0
36578,.,0,0
36579,The,0,0
36580,aim,0,0
36581,of,0,0
36582,this,0,0
36583,study,0,0
36584,was,0,0
36585,to,0,0
36586,combine,0,0
36587,two,0,0
36588,in,0,0
36589,situ,0,0
36590,protocols,0,0
36591,to,0,0
36592,study,0,0
36593,the,0,0
36594,interplay,0,0
36595,between,0,0
36596,erosion,0,0
36597,and,0,0
36598,abrasion,0,0
36599,of,0,0
36600,enamel,0,0
36601,and,0,0
36602,dentine,0,1
36603,.,0,0
36604,METHOD,0,0
36605,The,0,0
36606,study,0,0
36607,was,0,0
36608,a,0,0
36609,single-blind,0,0
36610,",",0,0
36611,randomised,0,0
36612,",",0,0
36613,five-treatment,0,0
36614,cross-over,0,0
36615,design,0,0
36616,involving,0,0
36617,15,1,0
36618,healthy,1,1
36619,volunteers,1,1
36620,.,1,0
36621,During,0,0
36622,each,0,0
36623,10-day,0,0
36624,study,0,0
36625,period,0,0
36626,",",0,0
36627,subjects,1,1
36628,wore,1,1
36629,from,1,0
36630,0900,1,1
36631,to,1,0
36632,1700,1,0
36633,h,1,0
36634,an,1,0
36635,upper,1,0
36636,removable,1,0
36637,acrylic,1,0
36638,appliance,1,0
36639,holding,1,0
36640,one,1,0
36641,polished,1,0
36642,enamel,1,0
36643,and,1,0
36644,one,1,0
36645,polished,1,0
36646,dentine,1,1
36647,specimen,1,0
36648,.,1,0
36649,The,0,0
36650,specimen,0,0
36651,treatment,0,0
36652,regimens,0,0
36653,were,0,0
36654,:,0,1
36655,1,0,0
36656,.,0,0
36657,Drinking,0,0
36658,water,0,0
36659,and,0,0
36660,brushing,0,0
36661,with,0,1
36662,toothpaste,0,0
36663,A,0,0
36664,.,0,0
36665,2,0,0
36666,.,0,0
36667,Drinking,0,0
36668,water,0,0
36669,and,0,0
36670,brushing,0,0
36671,with,0,1
36672,toothpaste,0,0
36673,B,0,0
36674,.,0,0
36675,3,0,0
36676,.,0,0
36677,Drinking,0,0
36678,orange,0,0
36679,juice,0,0
36680,.,0,0
36681,4,0,0
36682,.,0,0
36683,Drinking,0,0
36684,orange,0,0
36685,juice,0,0
36686,and,0,0
36687,brushing,0,0
36688,with,0,1
36689,toothpaste,0,0
36690,A,0,0
36691,.,0,0
36692,5,0,0
36693,.,0,0
36694,Drinking,0,0
36695,orange,0,0
36696,juice,0,0
36697,and,0,0
36698,brushing,0,0
36699,with,0,1
36700,toothpaste,0,0
36701,B,0,0
36702,.,0,0
36703,Drinking,0,0
36704,and,0,0
36705,brushing,0,0
36706,times,0,0
36707,were,0,0
36708,around,0,0
36709,0900,0,1
36710,",",0,0
36711,1100,0,0
36712,",",0,0
36713,1300,0,0
36714,and,0,0
36715,1500,0,0
36716,h.,0,0
36717,Drinks,0,0
36718,were,0,0
36719,consumed,0,0
36720,as,0,0
36721,250,0,0
36722,ml,0,0
36723,over,0,0
36724,10,0,0
36725,min,0,0
36726,and,0,0
36727,brushing,0,0
36728,ex,0,0
36729,vivo,0,0
36730,for,0,0
36731,1,0,0
36732,min,0,0
36733,to,0,0
36734,each,0,0
36735,specimen,0,0
36736,.,0,0
36737,Measurement,0,0
36738,of,0,0
36739,tissue,0,0
36740,loss,0,0
36741,was,0,0
36742,made,0,0
36743,on,0,0
36744,days,0,0
36745,5,0,0
36746,and,0,0
36747,10,0,0
36748,of,0,0
36749,each,0,0
36750,period,0,0
36751,using,0,0
36752,a,0,0
36753,profilometer,0,0
36754,.,0,0
36755,RESULTS,0,0
36756,All,0,0
36757,treatments,0,0
36758,produced,0,0
36759,increasing,0,0
36760,tissue,0,0
36761,loss,0,0
36762,over,0,0
36763,time,0,0
36764,",",0,0
36765,which,0,0
36766,was,0,0
36767,considerably,0,0
36768,greater,0,0
36769,for,0,0
36770,dentine,0,0
36771,than,0,0
36772,enamel,0,0
36773,.,0,0
36774,For,0,0
36775,enamel,0,0
36776,",",0,0
36777,the,0,0
36778,data,0,0
36779,at,0,0
36780,days,0,0
36781,5,0,0
36782,and,0,0
36783,10,0,0
36784,showed,0,0
36785,a,0,0
36786,significant,0,0
36787,effect,0,0
36788,for,0,0
36789,erosion,0,0
36790,(,0,0
36791,i.e,0,0
36792,.,0,0
36793,orange,0,0
36794,juice,0,0
36795,was,0,0
36796,significantly,0,0
36797,more,0,0
36798,erosive,0,0
36799,than,0,0
36800,water,0,0
36801,),0,0
36802,",",0,0
36803,but,0,0
36804,no,0,0
36805,significant,0,0
36806,effect,0,0
36807,for,0,0
36808,abrasion,0,0
36809,(,0,0
36810,i.e,0,0
36811,.,0,0
36812,no,0,0
36813,significant,0,0
36814,difference,0,0
36815,between,0,0
36816,the,0,0
36817,two,0,0
36818,toothpaste,0,0
36819,treatments,0,0
36820,),0,0
36821,.,0,0
36822,The,0,0
36823,combined,0,0
36824,orange,0,0
36825,juice,0,0
36826,and,0,0
36827,toothpaste,0,0
36828,effects,0,0
36829,were,0,0
36830,directional,0,0
36831,for,0,0
36832,synergy,0,0
36833,but,0,0
36834,did,0,0
36835,not,0,0
36836,reach,0,0
36837,significance,0,0
36838,.,0,0
36839,For,0,0
36840,dentine,0,0
36841,at,0,0
36842,day,0,0
36843,10,0,0
36844,",",0,0
36845,many,0,1
36846,specimens,0,0
36847,exceeded,0,0
36848,the,0,0
36849,50,0,0
36850,microm,0,0
36851,set,0,0
36852,limit,0,0
36853,of,0,0
36854,the,0,0
36855,profilometer,0,0
36856,and,0,0
36857,only,0,0
36858,day,0,0
36859,5,0,0
36860,data,0,0
36861,were,0,0
36862,considered,0,0
36863,.,0,0
36864,There,0,0
36865,were,0,0
36866,significant,0,0
36867,effects,0,0
36868,for,0,0
36869,erosion,0,0
36870,(,0,0
36871,orange,0,0
36872,juice,0,0
36873,produced,0,0
36874,significantly,0,0
36875,more,0,0
36876,erosion,0,0
36877,than,0,0
36878,water,0,0
36879,),0,0
36880,and,0,0
36881,for,0,0
36882,abrasion,0,0
36883,(,0,0
36884,paste,0,0
36885,A,0,0
36886,was,0,0
36887,significantly,0,0
36888,more,0,0
36889,abrasive,0,0
36890,to,0,0
36891,dentine,0,0
36892,than,0,0
36893,paste,0,0
36894,B,0,0
36895,),0,0
36896,.,0,0
36897,The,0,0
36898,synergy,0,0
36899,effect,0,0
36900,could,0,0
36901,not,0,0
36902,be,0,0
36903,examined,0,0
36904,for,0,0
36905,dentine,0,1
36906,due,0,0
36907,to,0,0
36908,the,0,0
36909,truncation,0,0
36910,effect,0,0
36911,as,0,0
36912,the,0,0
36913,set,0,0
36914,limit,0,0
36915,of,0,0
36916,the,0,0
36917,profilometer,0,0
36918,was,0,0
36919,exceeded,0,0
36920,.,0,0
36921,CONCLUSIONS,0,0
36922,Erosion,0,0
36923,increases,0,0
36924,the,0,0
36925,susceptibility,0,0
36926,of,0,0
36927,enamel,0,0
36928,to,0,0
36929,toothpaste,0,0
36930,abrasion,0,0
36931,.,0,0
36932,Dentine,0,0
36933,is,0,0
36934,considerably,0,0
36935,more,0,0
36936,susceptible,0,0
36937,than,0,0
36938,enamel,0,0
36939,to,0,0
36940,erosion,0,0
36941,and,0,0
36942,abrasion,0,0
36943,alone,0,0
36944,or,0,0
36945,combined,0,0
36946,.,0,0
36947,Dentine,0,0
36948,loss,0,0
36949,appears,0,0
36950,to,0,0
36951,correlate,0,0
36952,with,0,0
36953,toothpaste,0,0
36954,abrasivity,0,0
36955,(,0,0
36956,RDA,0,0
36957,value,0,0
36958,),0,0
36959,.,0,0
36960,A,1,0
36961,controlled,1,0
36962,clinical,1,0
36963,trial,1,0
36964,of,1,0
36965,a,1,0
36966,muscle,1,0
36967,relaxant,1,0
36968,analgesic,1,0
36969,combination,1,0
36970,in,1,0
36971,the,1,0
36972,treatment,1,0
36973,of,1,0
36974,acute,1,1
36975,lumbago,1,1
36976,.,1,0
36977,Changes,0,0
36978,in,0,0
36979,calcanean,0,1
36980,bone,0,0
36981,mineral,0,0
36982,occurring,0,0
36983,spontaneously,0,0
36984,and,0,0
36985,during,0,0
36986,hormone,0,0
36987,replacement,0,0
36988,therapy,0,0
36989,in,0,0
36990,early,1,1
36991,post-menopausal,1,1
36992,women,1,1
36993,.,1,0
36994,The,0,0
36995,spontaneous,1,0
36996,calcanean,1,1
36997,bone,1,0
36998,loss,1,0
36999,occurring,1,0
37000,in,1,0
37001,healthy,1,1
37002,early,1,1
37003,post-menopausal,1,1
37004,women,1,1
37005,and,0,0
37006,the,0,0
37007,effect,0,0
37008,of,0,0
37009,two,0,0
37010,hormone,0,0
37011,replacement,0,1
37012,therapies,0,0
37013,(,0,0
37014,HRT,0,0
37015,'s,0,1
37016,),0,0
37017,were,0,0
37018,investigated,0,0
37019,in,0,0
37020,a,0,0
37021,longitudinal,0,1
37022,study,0,0
37023,.,0,0
37024,There,0,0
37025,was,0,0
37026,no,0,0
37027,difference,0,0
37028,between,0,0
37029,the,0,0
37030,right,0,0
37031,and,0,0
37032,left,0,1
37033,calcanean,0,1
37034,BMC,0,0
37035,or,0,0
37036,BMD,0,0
37037,(,0,0
37038,p,0,0
37039,>,0,1
37040,0.15,0,0
37041,),0,0
37042,.,0,0
37043,The,0,0
37044,spontaneous,0,0
37045,bone,0,0
37046,loss,0,0
37047,was,0,0
37048,similar,0,0
37049,at,0,0
37050,all,0,0
37051,the,0,0
37052,skeletal,0,0
37053,sites,0,0
37054,measured,0,0
37055,",",0,0
37056,with,0,0
37057,a,0,0
37058,mean,0,0
37059,spontaneous,0,0
37060,loss,0,0
37061,in,0,0
37062,calcanean,0,1
37063,BMD,0,1
37064,of,0,0
37065,1.6,0,0
37066,%,0,0
37067,over,0,0
37068,one,0,0
37069,year,0,0
37070,.,0,0
37071,Both,0,0
37072,HRT,0,0
37073,'s,0,0
37074,significantly,0,0
37075,(,0,0
37076,p,0,0
37077,<,0,0
37078,0.01,0,0
37079,),0,0
37080,prevented,0,0
37081,the,0,0
37082,bone,0,0
37083,loss,0,0
37084,from,0,0
37085,all,0,0
37086,skeletal,0,0
37087,sites,0,0
37088,irrespective,0,0
37089,of,0,0
37090,the,0,0
37091,weight-bearing,0,0
37092,or,0,0
37093,content,0,0
37094,of,0,0
37095,trabecular,0,0
37096,bone,0,0
37097,",",0,0
37098,and,0,0
37099,(,0,0
37100,for,0,0
37101,the,0,0
37102,weight-bearing,0,0
37103,bones,0,0
37104,),0,0
37105,there,0,0
37106,was,0,0
37107,even,0,0
37108,a,0,0
37109,gain,0,0
37110,in,0,0
37111,calcanean,0,1
37112,BMC,0,0
37113,and,0,0
37114,BMD,0,0
37115,and,0,0
37116,spinal,0,1
37117,BMD,0,0
37118,(,0,0
37119,p,0,0
37120,<,0,0
37121,0.01,0,0
37122,),0,0
37123,.,0,0
37124,Bone,0,0
37125,mineral,0,0
37126,of,0,0
37127,the,0,0
37128,calcaneus,0,0
37129,and,0,0
37130,the,0,0
37131,spine,0,0
37132,correlated,0,0
37133,equally,0,0
37134,to,0,0
37135,body,0,0
37136,weight,0,0
37137,(,0,0
37138,r,0,0
37139,approximately,0,0
37140,0.4,0,0
37141,",",0,0
37142,p,0,0
37143,<,0,0
37144,0.001,0,0
37145,),0,1
37146,",",0,0
37147,whereas,0,0
37148,bone,0,1
37149,mineral,0,1
37150,in,0,0
37151,the,0,0
37152,forearm,0,0
37153,was,0,0
37154,not,0,0
37155,correlated,0,0
37156,to,0,0
37157,body,0,0
37158,weight,0,0
37159,.,0,0
37160,The,0,0
37161,correlations,0,0
37162,between,0,0
37163,the,0,0
37164,changes,0,0
37165,in,0,0
37166,bone,0,0
37167,mineral,0,0
37168,at,0,0
37169,the,0,0
37170,sites,0,0
37171,measured,0,0
37172,were,0,0
37173,all,0,0
37174,significant,0,0
37175,(,0,0
37176,r,0,0
37177,approximately,0,0
37178,0.2-0.4,0,0
37179,),0,0
37180,.,0,0
37181,[,0,0
37182,Platelet,0,0
37183,serotonin,0,0
37184,in,0,0
37185,infantile,1,1
37186,autism,1,1
37187,.,1,0
37188,Cross-over,0,0
37189,effects,0,0
37190,of,0,0
37191,a,0,0
37192,dopamine,0,0
37193,agonist,0,0
37194,and,0,0
37195,an,0,0
37196,antagonist,0,0
37197,],0,0
37198,.,0,0
37199,In,0,0
37200,infantile,1,1
37201,autism,1,1
37202,",",0,0
37203,the,0,0
37204,serotoninergic,0,0
37205,(,0,0
37206,5-HT,0,0
37207,),0,0
37208,hypothesis,0,0
37209,is,0,0
37210,corroborated,0,0
37211,by,0,0
37212,biological,0,0
37213,dosages,0,0
37214,and,0,0
37215,therapeutic,0,0
37216,effects,0,0
37217,of,0,0
37218,fenfluramine,0,0
37219,which,0,0
37220,decrease,0,0
37221,blood,0,0
37222,serotonin,0,0
37223,.,0,0
37224,However,0,0
37225,other,0,0
37226,drugs,0,0
37227,",",0,0
37228,such,0,0
37229,as,0,0
37230,dopaminergic,0,0
37231,agonists,0,0
37232,or,0,1
37233,antagonists,0,0
37234,",",0,0
37235,have,0,0
37236,therapeutic,0,0
37237,effects,0,0
37238,.,0,0
37239,Therefore,0,0
37240,",",0,0
37241,we,0,0
37242,tested,0,0
37243,the,0,0
37244,hypothesis,0,0
37245,that,0,0
37246,two,0,0
37247,dopaminergic,0,0
37248,(,0,0
37249,DA,0,0
37250,),0,0
37251,drugs,0,0
37252,have,0,0
37253,a,0,0
37254,similar,0,0
37255,5-HT,0,0
37256,effect,0,0
37257,underlying,0,0
37258,the,0,0
37259,therapeutic,0,0
37260,efficiency,0,0
37261,.,0,0
37262,We,0,0
37263,evaluated,0,0
37264,in,0,0
37265,a,0,0
37266,randomized,0,0
37267,",",0,0
37268,double-blind,0,0
37269,and,0,0
37270,cross-over,0,0
37271,study,0,0
37272,",",0,0
37273,the,0,0
37274,effects,0,0
37275,of,0,0
37276,a,0,0
37277,DA,0,0
37278,agonist,0,0
37279,(,0,0
37280,bromocriptine,0,0
37281,),0,0
37282,and,0,0
37283,a,0,0
37284,DA,0,0
37285,antagonist,0,0
37286,(,0,0
37287,amisulpride,0,0
37288,),0,0
37289,on,0,0
37290,platelet,0,0
37291,5-HT,0,0
37292,in,0,0
37293,infantile,1,1
37294,autism,1,1
37295,.,1,0
37296,The,0,0
37297,prolactinemia,0,0
37298,",",0,0
37299,reflecting,0,0
37300,the,0,0
37301,DA,0,0
37302,action,0,0
37303,",",0,0
37304,has,0,0
37305,been,0,0
37306,also,0,0
37307,measured,0,0
37308,.,0,0
37309,Nine,1,0
37310,children,1,1
37311,",",1,0
37312,aged,1,1
37313,from,1,0
37314,4,1,0
37315,to,1,0
37316,13,1,0
37317,years,1,1
37318,",",1,0
37319,according,1,1
37320,to,1,0
37321,the,1,0
37322,DSM,1,0
37323,III,1,0
37324,for,1,0
37325,infantile,1,1
37326,autism,1,1
37327,",",0,0
37328,received,0,0
37329,either,0,0
37330,drug,0,0
37331,in,0,0
37332,a,0,0
37333,random,0,0
37334,order,0,0
37335,during,0,0
37336,four,0,0
37337,weeks,0,0
37338,with,0,1
37339,an,0,0
37340,in-between,0,0
37341,placebo,0,0
37342,period,0,0
37343,of,0,0
37344,six,0,1
37345,weeks,0,0
37346,.,0,1
37347,The,0,0
37348,dosages,0,0
37349,of,0,0
37350,platelet,0,0
37351,5-HT,0,0
37352,and,0,0
37353,serum,0,0
37354,prolactin,0,0
37355,were,0,0
37356,carried,0,0
37357,out,0,0
37358,at,0,0
37359,the,0,0
37360,beginning,0,0
37361,and,0,0
37362,at,0,0
37363,the,0,0
37364,end,0,0
37365,of,0,0
37366,every,0,0
37367,phase,0,0
37368,of,0,0
37369,treatment,0,0
37370,(,0,0
37371,active,0,0
37372,or,0,0
37373,placebo,0,0
37374,),0,0
37375,with,0,0
37376,radioenzymology,0,0
37377,and,0,0
37378,radioimmunoassay,0,0
37379,methods,0,1
37380,respectively,0,0
37381,.,0,0
37382,The,0,0
37383,principal,0,0
37384,results,0,0
37385,on,0,0
37386,serum,0,0
37387,prolactin,0,0
37388,show,0,0
37389,neither,0,0
37390,order,0,0
37391,x,0,0
37392,treatment,0,0
37393,interaction,0,0
37394,",",0,0
37395,nor,0,0
37396,order,0,0
37397,effect,0,0
37398,but,0,0
37399,a,0,0
37400,significant,0,0
37401,treatment,0,0
37402,effect,0,0
37403,(,0,0
37404,p,0,0
37405,<,0,0
37406,0.01,0,0
37407,),0,0
37408,:,0,0
37409,amisulpride,0,0
37410,increases,0,0
37411,serum,0,0
37412,prolactin,0,0
37413,whereas,0,0
37414,bromocriptine,0,0
37415,decreases,0,0
37416,according,0,0
37417,to,0,0
37418,the,0,0
37419,usual,0,0
37420,data,0,0
37421,.,0,0
37422,About,0,0
37423,platelet,0,0
37424,5-HT,0,0
37425,",",0,0
37426,there,0,0
37427,is,0,0
37428,neither,0,0
37429,order,0,0
37430,x,0,0
37431,treatment,0,0
37432,interaction,0,0
37433,",",0,0
37434,nor,0,0
37435,treatment,0,0
37436,effect,0,0
37437,but,0,0
37438,a,0,0
37439,significant,0,0
37440,order,0,0
37441,effect,0,0
37442,(,0,0
37443,p,0,0
37444,<,0,0
37445,0.01,0,0
37446,),0,0
37447,.,0,0
37448,Both,0,0
37449,drugs,0,0
37450,increase,0,0
37451,platelet,0,0
37452,5-HT,0,0
37453,in,0,0
37454,the,0,0
37455,first,0,0
37456,phase,0,0
37457,of,0,0
37458,treatment,0,0
37459,.,0,0
37460,This,0,0
37461,order,0,0
37462,effect,0,0
37463,could,0,0
37464,be,0,0
37465,explained,0,0
37466,by,0,0
37467,a,0,0
37468,remanent,0,0
37469,effect,0,0
37470,of,0,0
37471,amisulpride,0,0
37472,after,0,0
37473,6,0,0
37474,wash-out,0,0
37475,weeks,0,0
37476,.,0,1
37477,(,0,0
37478,ABSTRACT,0,0
37479,TRUNCATED,0,0
37480,AT,0,0
37481,250,0,0
37482,WORDS,0,0
37483,),0,0
37484,[,0,0
37485,Mitoxantrone,0,0
37486,(,0,0
37487,MTX,0,0
37488,),0,0
37489,versus,0,0
37490,mitomycin,0,0
37491,C,0,0
37492,(,0,0
37493,MMC,0,0
37494,),0,0
37495,in,0,0
37496,the,0,0
37497,ablative,0,0
37498,treatment,0,0
37499,of,1,0
37500,Ta,1,0
37501,",",1,0
37502,T1,1,0
37503,superficial,1,0
37504,bladder,1,1
37505,tumors,1,1
37506,.,1,1
37507,Phase,0,0
37508,III,0,0
37509,",",0,0
37510,randomized,0,0
37511,prospective,0,0
37512,study,0,0
37513,],0,0
37514,.,0,0
37515,A,0,0
37516,prospective,0,0
37517,randomized,0,0
37518,study,0,0
37519,was,0,0
37520,conducted,0,0
37521,to,0,0
37522,determine,0,0
37523,the,0,0
37524,ablation,0,0
37525,capacity,0,0
37526,of,0,0
37527,mitoxantrone,0,0
37528,in,0,0
37529,Ta-T1,0,0
37530,superficial,0,0
37531,bladder,0,1
37532,tumors,0,1
37533,versus,0,0
37534,mitomycin,0,0
37535,C,0,0
37536,",",0,0
37537,a,0,0
37538,drug,0,0
37539,whose,0,0
37540,intravesical,0,0
37541,ablation,0,1
37542,properties,0,0
37543,are,0,0
37544,well-known,0,0
37545,.,0,0
37546,Fifty-seven,1,1
37547,patients,1,1
37548,comprised,0,1
37549,the,0,0
37550,study,0,0
37551,.,0,0
37552,The,0,0
37553,tumor,0,0
37554,was,0,0
37555,not,0,0
37556,completely,0,0
37557,resected,0,0
37558,when,0,0
37559,the,0,0
37560,patient,0,0
37561,underwent,0,1
37562,TUR,0,0
37563,.,0,0
37564,This,0,0
37565,residual,0,0
37566,tumor,0,0
37567,was,0,0
37568,used,0,0
37569,as,0,0
37570,control,0,0
37571,.,0,0
37572,The,0,0
37573,patients,0,1
37574,were,0,0
37575,treated,0,1
37576,with,0,0
37577,either,0,0
37578,20,0,0
37579,mg,0,0
37580,Mitoxantrone,0,0
37581,or,0,1
37582,40,0,1
37583,mg,0,0
37584,mitomycin,0,0
37585,C,0,0
37586,weekly,0,0
37587,for,0,0
37588,8,0,0
37589,weeks,0,0
37590,and,0,0
37591,two,0,0
37592,other,0,0
37593,instillations,0,0
37594,every,0,0
37595,15,0,0
37596,days,0,0
37597,in,0,0
37598,50,0,1
37599,ml,0,0
37600,saline,0,0
37601,solution,0,0
37602,.,0,0
37603,Response,0,0
37604,to,0,0
37605,therapy,0,0
37606,was,0,0
37607,evaluated,0,0
37608,between,0,0
37609,the,0,0
37610,4th,0,0
37611,and,0,0
37612,8th,0,0
37613,week,0,0
37614,and,0,0
37615,classified,0,1
37616,as,0,0
37617,complete,0,0
37618,response,0,0
37619,(,0,0
37620,CR,0,0
37621,),0,0
37622,",",0,0
37623,defined,0,0
37624,as,0,0
37625,no,0,0
37626,gross,0,0
37627,and,0,0
37628,microscopic,0,0
37629,evidence,0,0
37630,of,0,0
37631,residual,0,0
37632,tumor,0,0
37633,",",0,0
37634,or,0,0
37635,no,0,0
37636,response,0,0
37637,(,0,0
37638,NR,0,0
37639,),0,0
37640,or,0,0
37641,therapeutic,0,0
37642,failure,0,1
37643,.,0,0
37644,CR,0,0
37645,was,0,0
37646,observed,0,0
37647,in,0,0
37648,77.7,0,0
37649,%,0,0
37650,of,0,0
37651,the,0,0
37652,patients,0,1
37653,treated,0,1
37654,with,0,1
37655,mitomycin,0,0
37656,C,0,0
37657,and,0,0
37658,in,0,0
37659,50,0,0
37660,%,0,0
37661,in,0,0
37662,those,0,0
37663,that,0,0
37664,had,0,0
37665,been,0,0
37666,treated,0,1
37667,with,0,1
37668,Mitoxantrone,0,0
37669,.,0,1
37670,Treatment,0,0
37671,was,0,0
37672,discontinued,0,0
37673,because,0,0
37674,of,0,0
37675,side,0,0
37676,effects,0,0
37677,in,0,0
37678,15,0,0
37679,%,0,0
37680,of,0,0
37681,the,0,0
37682,patients,0,1
37683,treated,0,1
37684,with,0,1
37685,mitomycin,0,0
37686,C,0,0
37687,and,0,0
37688,in,0,0
37689,63.4,0,0
37690,%,0,0
37691,of,0,0
37692,those,0,1
37693,who,0,1
37694,received,0,1
37695,Mitoxantrone,0,1
37696,.,0,0
37697,We,0,0
37698,can,0,0
37699,conclude,0,0
37700,from,0,0
37701,the,0,0
37702,results,0,0
37703,of,0,0
37704,the,0,0
37705,present,0,0
37706,study,0,0
37707,that,0,0
37708,Mitoxantrone,0,0
37709,is,0,0
37710,a,0,0
37711,useful,0,0
37712,agent,0,0
37713,for,0,0
37714,ablation,0,0
37715,therapy,0,0
37716,of,0,0
37717,superficial,1,0
37718,bladder,1,1
37719,tumors,1,1
37720,",",0,0
37721,although,0,0
37722,the,0,0
37723,high,0,0
37724,incidence,0,0
37725,of,0,0
37726,severe,0,1
37727,side,0,0
37728,effects,0,0
37729,warrants,0,0
37730,its,0,0
37731,limited,0,0
37732,use,0,0
37733,and,0,0
37734,at,0,0
37735,high,0,1
37736,dilutions,0,0
37737,.,0,1
37738,Oestrogen,0,0
37739,replacement,0,0
37740,after,1,0
37741,oophorectomy,1,1
37742,:,1,1
37743,comparison,0,0
37744,of,0,0
37745,patches,0,0
37746,and,0,1
37747,implants,0,1
37748,.,0,1
37749,Biodistribution,0,0
37750,of,0,0
37751,three,0,0
37752,photosensitizers,0,0
37753,in,0,0
37754,dogs,1,1
37755,with,1,1
37756,spontaneous,1,1
37757,tumors,1,1
37758,.,1,1
37759,Photodynamic,0,0
37760,therapy,0,0
37761,(,0,0
37762,PDT,0,0
37763,),0,0
37764,has,0,0
37765,been,0,0
37766,considered,0,0
37767,a,0,0
37768,potential,0,0
37769,method,0,0
37770,for,0,0
37771,tumor,0,0
37772,eradication,0,0
37773,.,0,0
37774,The,0,0
37775,present,0,0
37776,study,0,0
37777,was,0,0
37778,designed,0,0
37779,to,0,0
37780,assess,0,0
37781,the,0,0
37782,efficacy,0,0
37783,of,0,0
37784,PDT,0,1
37785,as,0,0
37786,an,0,0
37787,alternative,0,0
37788,treatment,0,0
37789,approach,0,0
37790,.,0,0
37791,Photosensitizers,0,0
37792,",",0,0
37793,such,0,0
37794,as,0,0
37795,porfimer,0,0
37796,sodium,0,0
37797,",",0,0
37798,tin,0,0
37799,ethyl,0,0
37800,etiopurpurin,0,0
37801,",",0,0
37802,and,0,0
37803,aluminum,0,0
37804,chlorophthalocyanine,0,0
37805,",",0,0
37806,were,0,0
37807,administered,0,0
37808,i.v,0,0
37809,.,0,0
37810,to,0,0
37811,dogs,1,1
37812,",",0,0
37813,and,0,0
37814,tissue,0,0
37815,samples,0,0
37816,were,0,0
37817,harvested,0,0
37818,24,0,0
37819,to,0,0
37820,300,0,0
37821,hours,0,0
37822,later,0,0
37823,.,0,0
37824,The,0,0
37825,uptake,0,0
37826,of,0,0
37827,the,0,0
37828,photosensitizers,0,0
37829,in,0,0
37830,tumor,0,1
37831,(,0,0
37832,fibrosarcoma,0,1
37833,),0,0
37834,and,0,0
37835,adjacent,0,0
37836,normal,0,1
37837,tissue,0,0
37838,biopsies,0,0
37839,was,0,0
37840,quantified,0,0
37841,by,0,0
37842,tissue,0,0
37843,solubilization,0,0
37844,technique,0,0
37845,and,0,0
37846,fluorimetry,0,0
37847,.,0,0
37848,In,0,0
37849,addition,0,0
37850,",",0,0
37851,the,0,0
37852,pharmacokinetics,0,0
37853,and,0,0
37854,selectivity,0,0
37855,of,0,0
37856,the,0,0
37857,photosensitizers,0,0
37858,were,0,0
37859,addressed,0,0
37860,by,0,0
37861,two-phase,0,0
37862,exponential,0,0
37863,function,0,0
37864,and,0,0
37865,specific,0,0
37866,uptake,0,0
37867,ratio,0,0
37868,",",0,0
37869,respectively,0,0
37870,.,0,0
37871,Porfimer,0,0
37872,sodium,0,0
37873,exhibited,0,0
37874,a,0,0
37875,longer,0,0
37876,elimination,0,0
37877,half-life,0,0
37878,(,0,0
37879,175.3,0,0
37880,hr,0,0
37881,),0,0
37882,",",0,0
37883,slower,0,0
37884,clearance,0,0
37885,(,0,0
37886,0.0028,0,0
37887,L/kg/hr,0,0
37888,),0,0
37889,",",0,0
37890,and,0,0
37891,a,0,0
37892,larger,0,0
37893,area,0,0
37894,under,0,0
37895,the,0,0
37896,curve,0,0
37897,(,0,0
37898,1075,0,0
37899,microg/g/hr,0,0
37900,),0,0
37901,in,0,0
37902,tumors,0,1
37903,than,0,0
37904,did,0,0
37905,tin,0,0
37906,ethyl,0,0
37907,etiopurpurin,0,0
37908,or,0,0
37909,aluminum,0,0
37910,chlorophthalocyanine,0,0
37911,.,0,0
37912,As,0,0
37913,a,0,0
37914,result,0,0
37915,",",0,0
37916,porfimer,0,0
37917,sodium,0,0
37918,showed,0,0
37919,a,0,0
37920,good,0,0
37921,selectivity,0,0
37922,in,0,0
37923,tumors,0,1
37924,located,0,0
37925,in,0,0
37926,muscle,0,0
37927,and,0,0
37928,skin,0,0
37929,.,0,0
37930,The,0,0
37931,study,0,0
37932,provided,0,0
37933,clinical,0,0
37934,information,0,0
37935,for,0,0
37936,determination,0,0
37937,of,0,0
37938,the,0,0
37939,efficacy,0,0
37940,of,0,0
37941,different,0,0
37942,PDT,0,1
37943,alternatives,0,0
37944,.,0,1
37945,Analgesic,0,0
37946,efficacy,0,0
37947,of,0,0
37948,low-dose,0,0
37949,diclofenac,0,0
37950,versus,0,0
37951,paracetamol,0,0
37952,and,0,0
37953,placebo,0,0
37954,in,0,0
37955,postoperative,1,0
37956,dental,1,1
37957,pain,1,0
37958,.,1,0
37959,AIMS,0,0
37960,To,0,0
37961,compare,0,0
37962,the,0,0
37963,efficacy,0,0
37964,and,0,0
37965,safety,0,0
37966,of,0,0
37967,diclofenac-K,0,0
37968,(,0,0
37969,12.5,0,0
37970,mg,0,0
37971,),0,0
37972,vs,0,0
37973,paracetamol,0,0
37974,(,0,0
37975,500,0,0
37976,mg,0,0
37977,),0,0
37978,and,0,0
37979,placebo,0,0
37980,given,0,0
37981,in,0,0
37982,a,0,0
37983,flexible,0,0
37984,dosage,0,0
37985,regimen,0,0
37986,to,0,0
37987,treat,0,0
37988,pain,1,0
37989,resulting,1,0
37990,from,1,0
37991,extraction,1,0
37992,of,1,0
37993,impacted,1,0
37994,third,1,1
37995,molar,1,0
37996,teeth,1,1
37997,.,1,0
37998,METHODS,0,0
37999,This,0,0
38000,was,0,0
38001,a,0,0
38002,2-day,0,0
38003,",",0,0
38004,double-blind,0,0
38005,",",0,0
38006,double-dummy,0,0
38007,",",0,0
38008,randomized,0,0
38009,",",0,0
38010,parallel-group,0,0
38011,",",0,0
38012,placebo-controlled,0,0
38013,study,0,0
38014,of,0,0
38015,diclofenac-K,0,0
38016,(,0,0
38017,12.5,0,0
38018,mg,0,0
38019,),0,0
38020,tablets,0,0
38021,vs,0,0
38022,paracetamol,0,0
38023,(,0,0
38024,500,0,0
38025,mg,0,0
38026,),0,0
38027,tablets,0,0
38028,and,0,0
38029,placebo,0,0
38030,in,0,0
38031,patients,1,1
38032,with,1,1
38033,moderate,1,1
38034,or,1,0
38035,severe,1,1
38036,pain,1,0
38037,within,1,0
38038,8,1,0
38039,hours,1,0
38040,of,1,0
38041,extraction,1,0
38042,of,1,0
38043,impacted,1,0
38044,third,1,1
38045,molars,1,1
38046,.,1,1
38047,RESULTS,0,0
38048,After,0,0
38049,the,0,0
38050,first,0,0
38051,2-tablet,0,0
38052,dose,0,0
38053,",",0,0
38054,patients,0,1
38055,took,0,0
38056,on,0,0
38057,average,0,0
38058,2.5,0,0
38059,additional,0,0
38060,tablets,0,0
38061,of,0,0
38062,diclofenac-K,0,0
38063,or,0,1
38064,2.4,0,0
38065,tablets,0,0
38066,of,0,0
38067,paracetamol,0,0
38068,",",0,0
38069,almost,0,0
38070,all,0,0
38071,as,0,0
38072,1-tablet,0,0
38073,doses,0,0
38074,.,0,1
38075,Most,0,0
38076,placebo,0,0
38077,patients,0,1
38078,discontinued,0,0
38079,by,0,0
38080,taking,0,0
38081,rescue,0,0
38082,medication,0,0
38083,(,0,0
38084,ibuprofen,0,0
38085,200,0,0
38086,mg,0,0
38087,),0,0
38088,on,0,0
38089,the,0,0
38090,first,0,0
38091,day,0,0
38092,.,0,0
38093,Pain,0,0
38094,relief,0,0
38095,after,0,0
38096,the,0,0
38097,initial,0,0
38098,dose,0,0
38099,of,0,0
38100,diclofenac-K,0,0
38101,(,0,0
38102,2,0,0
38103,x,0,0
38104,12.5,0,0
38105,mg,0,0
38106,),0,0
38107,was,0,0
38108,superior,0,0
38109,to,0,0
38110,placebo,0,0
38111,(,0,0
38112,P,0,0
38113,<,0,0
38114,.01,0,0
38115,for,0,0
38116,all,0,0
38117,efficacy,0,0
38118,outcomes,0,0
38119,),0,0
38120,and,0,0
38121,comparable,0,0
38122,to,0,0
38123,paracetamol,0,0
38124,(,0,0
38125,2,0,0
38126,x,0,0
38127,500,0,0
38128,mg,0,0
38129,),0,0
38130,.,0,0
38131,About,0,0
38132,30,0,0
38133,%,0,0
38134,of,0,0
38135,patients,0,1
38136,in,0,0
38137,each,0,0
38138,active,0,0
38139,treatment,0,0
38140,group,0,0
38141,took,0,0
38142,rescue,0,0
38143,medication,0,0
38144,during,0,0
38145,the,0,0
38146,study,0,0
38147,",",0,0
38148,compared,0,0
38149,to,0,0
38150,78,0,0
38151,%,0,0
38152,on,0,0
38153,placebo,0,0
38154,.,0,0
38155,About,0,0
38156,70,0,1
38157,%,0,0
38158,in,0,0
38159,each,0,0
38160,active,0,0
38161,treatment,0,0
38162,group,0,0
38163,considered,0,0
38164,the,0,0
38165,overall,0,0
38166,pain,0,0
38167,relief,0,0
38168,to,0,0
38169,be,0,0
38170,some,0,0
38171,",",0,0
38172,a,0,0
38173,lot,0,0
38174,",",0,0
38175,or,0,0
38176,complete,0,0
38177,compared,0,0
38178,to,0,0
38179,only,0,0
38180,15,0,0
38181,%,0,0
38182,on,0,0
38183,placebo,0,0
38184,.,0,0
38185,The,0,0
38186,incidence,0,0
38187,of,0,0
38188,adverse,0,0
38189,events,0,0
38190,in,0,0
38191,each,0,0
38192,active,0,0
38193,treatment,0,0
38194,group,0,0
38195,was,0,0
38196,low,0,0
38197,and,0,0
38198,comparable,0,0
38199,between,0,0
38200,the,0,0
38201,treatments,0,0
38202,.,0,0
38203,CONCLUSION,0,0
38204,An,0,0
38205,initial,0,0
38206,double-dose,0,0
38207,of,0,0
38208,diclofenac-K,0,0
38209,(,0,0
38210,2,0,0
38211,x,0,0
38212,12.5,0,0
38213,mg,0,0
38214,),0,0
38215,or,0,0
38216,paracetamol,0,0
38217,(,0,0
38218,2,0,0
38219,x,0,0
38220,500,0,0
38221,mg,0,0
38222,),0,0
38223,adequately,0,0
38224,relieved,0,0
38225,the,0,0
38226,most,0,0
38227,intense,0,0
38228,postoperative,1,0
38229,pain,1,0
38230,",",0,0
38231,and,0,0
38232,the,0,0
38233,flexible,0,0
38234,multiple,0,0
38235,dose,0,0
38236,regimen,0,0
38237,(,0,0
38238,1,0,0
38239,or,0,1
38240,2,0,0
38241,tablets,0,0
38242,),0,0
38243,maintained,0,0
38244,adequate,0,0
38245,pain,0,0
38246,relief,0,0
38247,thereafter,0,0
38248,.,0,0
38249,Most,0,0
38250,patients,0,1
38251,needed,0,0
38252,only,0,0
38253,1-tablet,0,0
38254,doses,0,0
38255,following,0,0
38256,the,0,0
38257,initial,0,0
38258,2-tablet,0,0
38259,dose,0,0
38260,.,0,0
38261,Safety,0,0
38262,of,0,0
38263,injectable,0,0
38264,opioid,0,0
38265,maintenance,0,0
38266,treatment,0,0
38267,for,0,0
38268,heroin,1,1
38269,dependence,1,0
38270,.,1,0
38271,BACKGROUND,0,0
38272,There,0,0
38273,is,0,0
38274,a,0,0
38275,growing,0,0
38276,debate,0,0
38277,about,0,0
38278,injectable,0,0
38279,opioid,0,0
38280,treatment,0,0
38281,programs,0,0
38282,in,0,0
38283,many,0,1
38284,Western,1,1
38285,countries,1,1
38286,.,1,0
38287,This,0,0
38288,is,0,0
38289,the,0,0
38290,first,0,0
38291,placebo-controlled,0,0
38292,study,0,0
38293,of,0,0
38294,the,0,0
38295,safety,0,0
38296,of,0,0
38297,injectable,0,0
38298,opioids,0,0
38299,in,0,0
38300,a,0,0
38301,controlled,0,0
38302,treatment,0,0
38303,setting,0,1
38304,.,0,0
38305,METHODS,0,0
38306,Twenty-five,1,1
38307,opioid-dependent,1,1
38308,patients,1,1
38309,on,1,0
38310,intravenous,1,0
38311,(,1,0
38312,IV,1,0
38313,),1,0
38314,heroin,1,1
38315,or,1,0
38316,IV,1,0
38317,methadone,1,1
38318,maintenance,1,0
38319,treatment,1,0
38320,were,0,0
38321,randomly,0,0
38322,assigned,0,0
38323,to,0,0
38324,either,0,0
38325,their,0,0
38326,individual,0,0
38327,prescribed,0,0
38328,IV,0,0
38329,maintenance,0,0
38330,dose,0,0
38331,or,0,0
38332,placebo,0,0
38333,.,0,0
38334,Acute,0,0
38335,drug,0,0
38336,effects,0,0
38337,were,0,0
38338,recorded,0,0
38339,",",0,0
38340,focusing,0,0
38341,on,0,0
38342,electrocardiography,0,0
38343,",",0,0
38344,respiratory,0,0
38345,movements,0,0
38346,",",0,0
38347,arterial,0,0
38348,blood,0,0
38349,oxygen,0,0
38350,saturation,0,0
38351,",",0,0
38352,and,0,0
38353,electroencephalography,0,0
38354,(,0,0
38355,EEG,0,0
38356,),0,0
38357,.,0,0
38358,RESULTS,0,0
38359,After,0,0
38360,heroin,0,1
38361,injection,0,0
38362,",",0,0
38363,marked,0,0
38364,respiratory,0,0
38365,depression,0,1
38366,progressing,0,1
38367,to,0,0
38368,a,0,0
38369,Cheyne-Stokes,0,0
38370,pattern,0,0
38371,occurred,0,0
38372,.,0,0
38373,Peripheral,0,0
38374,arterial,0,0
38375,blood,0,0
38376,oxygenation,0,0
38377,decreased,0,0
38378,to,0,0
38379,78.9,0,0
38380,+/-,0,0
38381,8.7,0,0
38382,%,0,0
38383,(,0,0
38384,mean,0,0
38385,+/-,0,0
38386,SD,0,0
38387,),0,0
38388,ranging,0,0
38389,from,0,0
38390,52,0,1
38391,%,0,0
38392,-90,0,0
38393,%,0,0
38394,.,0,0
38395,During,0,0
38396,hypoxia,0,0
38397,",",0,0
38398,7,0,0
38399,of,0,0
38400,the,0,0
38401,16,1,1
38402,subjects,1,1
38403,experienced,0,0
38404,intermittent,0,1
38405,and,0,0
38406,somewhat,0,0
38407,severe,0,1
38408,bradycardia,0,0
38409,.,0,1
38410,Five,0,0
38411,subjects,0,1
38412,exhibited,0,0
38413,paroxysmal,0,1
38414,EEG,0,0
38415,patterns,0,0
38416,.,0,0
38417,After,0,0
38418,methadone,0,0
38419,injection,0,0
38420,",",0,0
38421,respiratory,0,0
38422,depression,0,0
38423,was,0,0
38424,less,0,0
38425,pronounced,0,0
38426,than,0,0
38427,after,0,0
38428,heroin,0,1
38429,injection,0,0
38430,.,0,0
38431,No,0,0
38432,relevant,0,0
38433,bradycardia,0,0
38434,was,0,0
38435,noted,0,0
38436,.,0,0
38437,CONCLUSIONS,0,0
38438,Opioid,0,0
38439,doses,0,0
38440,commonly,0,0
38441,prescribed,0,0
38442,in,0,0
38443,IV,0,0
38444,opioid,0,0
38445,treatment,0,0
38446,induce,0,0
38447,marked,0,0
38448,respiratory,0,0
38449,and,0,0
38450,circulatory,0,0
38451,depression,0,0
38452,",",0,0
38453,as,0,0
38454,well,0,0
38455,as,0,0
38456,occasionally,0,0
38457,irregular,0,0
38458,paroxysmal,0,1
38459,EEG,0,0
38460,activity,0,0
38461,.,0,0
38462,Further,0,0
38463,studies,0,0
38464,are,0,0
38465,needed,0,0
38466,to,0,0
38467,optimize,0,0
38468,the,0,0
38469,clinical,0,0
38470,practice,0,0
38471,of,0,0
38472,IV,0,0
38473,opioid,0,0
38474,treatment,0,0
38475,to,0,0
38476,prevent,0,0
38477,serious,0,0
38478,complications,0,0
38479,.,0,0
38480,Moreover,0,0
38481,",",0,0
38482,the,0,0
38483,extent,0,0
38484,of,0,0
38485,the,0,0
38486,observed,0,0
38487,effects,0,0
38488,raises,0,0
38489,questions,0,0
38490,about,0,0
38491,the,0,0
38492,appropriateness,0,0
38493,of,0,0
38494,IV,0,0
38495,opioid,0,0
38496,treatment,0,0
38497,in,0,0
38498,the,0,0
38499,present,0,0
38500,form,0,0
38501,.,0,0
38502,Evaluation,0,0
38503,of,0,0
38504,umbilical,0,0
38505,cord,0,1
38506,serum,0,0
38507,therapy,0,0
38508,for,0,0
38509,persistent,1,1
38510,corneal,1,0
38511,epithelial,1,1
38512,defects,1,1
38513,.,1,1
38514,AIMS,0,0
38515,To,0,0
38516,evaluate,0,0
38517,umbilical,0,0
38518,cord,0,0
38519,serum,0,0
38520,therapy,0,0
38521,as,0,0
38522,a,0,0
38523,means,0,0
38524,of,0,0
38525,promoting,0,0
38526,the,0,0
38527,healing,0,0
38528,of,0,0
38529,persistent,1,1
38530,corneal,1,0
38531,epithelial,1,1
38532,defects,1,1
38533,.,1,1
38534,METHODS,0,0
38535,Umbilical,0,0
38536,cord,0,0
38537,serum,0,0
38538,or,0,0
38539,autologous,0,0
38540,serum,0,0
38541,drops,0,0
38542,were,0,0
38543,used,0,0
38544,to,0,0
38545,promote,0,0
38546,the,0,0
38547,healing,0,0
38548,of,0,0
38549,persistent,0,1
38550,epithelial,0,1
38551,defects,0,0
38552,.,0,0
38553,The,0,0
38554,study,0,0
38555,design,0,0
38556,was,0,0
38557,a,0,0
38558,prospective,0,0
38559,randomised,0,0
38560,controlled,0,0
38561,clinical,0,0
38562,trial,0,0
38563,.,0,1
38564,60,1,0
38565,eyes,1,1
38566,of,1,0
38567,59,1,1
38568,patients,1,1
38569,were,0,0
38570,divided,0,1
38571,into,0,1
38572,two,0,0
38573,groups,0,0
38574,",",0,0
38575,31,0,1
38576,in,0,0
38577,the,0,0
38578,cord,0,0
38579,serum,0,0
38580,group,0,0
38581,and,0,0
38582,29,0,0
38583,in,0,0
38584,the,0,0
38585,autologous,0,0
38586,serum,0,0
38587,control,0,0
38588,group,0,0
38589,.,0,0
38590,Epithelial,0,0
38591,defects,0,0
38592,measuring,0,0
38593,at,0,0
38594,least,0,0
38595,2,0,0
38596,mm,0,0
38597,in,0,0
38598,linear,0,0
38599,dimension,0,0
38600,resistant,0,1
38601,to,0,0
38602,conventional,0,0
38603,medical,0,1
38604,management,0,0
38605,were,0,0
38606,included,0,1
38607,.,0,0
38608,Serial,0,0
38609,measurements,0,0
38610,of,0,0
38611,the,0,0
38612,size,0,0
38613,of,0,0
38614,the,0,0
38615,epithelial,0,0
38616,defects-namely,0,0
38617,",",0,0
38618,two,0,0
38619,maximum,0,0
38620,linear,0,0
38621,dimensions,0,0
38622,perpendicular,0,0
38623,to,0,0
38624,each,0,0
38625,other,0,0
38626,",",0,0
38627,and,0,0
38628,the,0,0
38629,area,0,0
38630,and,0,0
38631,perimeter,0,0
38632,was,0,0
38633,done,0,0
38634,at,0,0
38635,start,0,0
38636,of,0,0
38637,therapy,0,0
38638,and,0,0
38639,follow,0,0
38640,up,0,0
38641,days,0,0
38642,3,0,0
38643,",",0,0
38644,7,0,0
38645,",",0,0
38646,14,0,0
38647,",",0,0
38648,21,0,1
38649,.,0,0
38650,Rate,0,0
38651,of,0,0
38652,healing,0,0
38653,of,0,0
38654,the,0,0
38655,epithelial,0,1
38656,defects,0,0
38657,were,0,0
38658,measured,0,0
38659,as,0,0
38660,percentage,0,0
38661,decrease,0,0
38662,from,0,0
38663,the,0,0
38664,baseline,0,0
38665,parameter,0,0
38666,at,0,0
38667,each,0,0
38668,subsequent,0,0
38669,follow,0,0
38670,up,0,0
38671,.,0,0
38672,The,0,0
38673,data,0,0
38674,were,0,0
38675,analysed,0,0
38676,by,0,0
38677,the,0,0
38678,non-parametric,0,0
38679,Wilcoxon,0,0
38680,rank,0,0
38681,sum,0,0
38682,test,0,0
38683,using,0,0
38684,STATA,0,0
38685,7.0,0,0
38686,.,0,0
38687,RESULTS,0,0
38688,The,0,0
38689,median,0,0
38690,percentage,0,0
38691,decrease,0,0
38692,in,0,0
38693,the,0,0
38694,size,0,0
38695,of,0,0
38696,the,0,0
38697,epithelial,0,0
38698,defect,0,0
38699,was,0,0
38700,significantly,0,0
38701,greater,0,0
38702,in,0,0
38703,the,0,0
38704,cord,0,0
38705,serum,0,0
38706,group,0,0
38707,at,0,0
38708,days,0,0
38709,7,0,0
38710,",",0,0
38711,14,0,0
38712,and,0,0
38713,21,0,1
38714,(,0,0
38715,p,0,0
38716,<,0,0
38717,0.05,0,0
38718,),0,0
38719,when,0,0
38720,measured,0,0
38721,in,0,0
38722,terms,0,0
38723,of,0,0
38724,the,0,0
38725,area,0,0
38726,and,0,0
38727,perimeter,0,0
38728,.,0,0
38729,A,0,0
38730,greater,0,0
38731,number,0,0
38732,of,0,0
38733,patients,0,1
38734,showed,0,0
38735,complete,0,0
38736,re-epithelialisation,0,0
38737,with,0,1
38738,umbilical,0,0
38739,cord,0,1
38740,serum,0,0
38741,(,0,0
38742,n,0,1
38743,=,0,0
38744,18,0,1
38745,),0,0
38746,than,0,0
38747,with,0,1
38748,autologous,0,0
38749,serum,0,0
38750,(,0,0
38751,n,0,1
38752,=,0,0
38753,11,0,1
38754,),0,0
38755,(,0,0
38756,Pearson,0,0
38757,chi,0,0
38758,=,0,0
38759,0.19,0,0
38760,),0,0
38761,.,0,0
38762,None,0,0
38763,of,0,0
38764,the,0,0
38765,patients,0,1
38766,reported,0,0
38767,any,0,0
38768,side,0,0
38769,effects,0,0
38770,or,0,0
38771,discomfort,0,0
38772,with,0,0
38773,either,0,0
38774,treatment,0,0
38775,.,0,0
38776,CONCLUSIONS,0,0
38777,Umbilical,0,0
38778,cord,0,0
38779,serum,0,0
38780,leads,0,0
38781,to,0,0
38782,faster,0,0
38783,healing,0,0
38784,of,0,0
38785,the,0,0
38786,persistent,0,1
38787,corneal,0,0
38788,epithelial,0,1
38789,defects,0,0
38790,refractory,0,1
38791,to,0,0
38792,all,0,0
38793,medical,0,0
38794,management,0,0
38795,compared,0,0
38796,to,0,0
38797,autologous,0,0
38798,serum,0,0
38799,.,0,0
38800,Efficacy,0,0
38801,of,0,0
38802,azithromycin,0,0
38803,for,0,0
38804,the,0,0
38805,treatment,0,0
38806,of,0,0
38807,feline,1,1
38808,chlamydophilosis,1,1
38809,.,1,0
38810,The,0,0
38811,current,0,0
38812,recommended,0,0
38813,treatment,0,0
38814,for,0,0
38815,feline,1,0
38816,chlamydophilosis,1,1
38817,involves,0,0
38818,daily,0,0
38819,oral,0,0
38820,administration,0,0
38821,of,0,0
38822,antimicrobials,0,0
38823,to,0,0
38824,all,0,0
38825,cats,1,1
38826,within,1,0
38827,an,1,0
38828,affected,1,0
38829,group,1,0
38830,for,0,0
38831,a,0,0
38832,prolonged,0,0
38833,period,0,0
38834,of,0,0
38835,time,0,0
38836,(,0,0
38837,4-6,0,1
38838,weeks,0,0
38839,),0,0
38840,.,0,0
38841,Not,0,0
38842,surprisingly,0,0
38843,",",0,0
38844,owner,0,0
38845,compliance,0,0
38846,can,0,0
38847,be,0,0
38848,poor,0,0
38849,resulting,0,0
38850,in,0,0
38851,apparent,0,0
38852,treatment,0,0
38853,failure,0,1
38854,.,0,0
38855,Recent,0,0
38856,anecdotal,0,0
38857,evidence,0,0
38858,",",0,0
38859,supported,0,0
38860,by,0,0
38861,its,0,0
38862,efficacy,0,0
38863,in,0,0
38864,the,0,0
38865,treatment,0,0
38866,of,0,0
38867,Chlamydia,0,1
38868,trachomatis,0,1
38869,infection,0,1
38870,in,0,0
38871,humans,0,0
38872,",",0,0
38873,has,0,0
38874,suggested,0,0
38875,that,0,0
38876,azithromycin,0,0
38877,may,0,0
38878,offer,0,0
38879,an,0,0
38880,alternative,0,0
38881,by,0,0
38882,allowing,0,0
38883,less,0,0
38884,frequent,0,0
38885,dosing,0,0
38886,for,0,0
38887,a,0,0
38888,shorter,0,0
38889,duration,0,0
38890,.,0,0
38891,A,0,0
38892,clinical,0,0
38893,trial,0,0
38894,was,0,0
38895,designed,0,0
38896,to,0,0
38897,evaluate,0,0
38898,the,0,0
38899,efficacy,0,0
38900,of,0,0
38901,azithromycin,0,0
38902,for,0,0
38903,the,0,0
38904,treatment,0,0
38905,of,0,0
38906,chlamydia,1,1
38907,(,1,0
38908,Chlamydophila,1,1
38909,felis,1,0
38910,),1,0
38911,infection,1,0
38912,in,1,0
38913,cats,1,1
38914,.,1,1
38915,Whilst,0,0
38916,azithromycin,0,0
38917,",",0,0
38918,given,0,0
38919,at,0,0
38920,10-15,0,1
38921,mg/kg,0,0
38922,daily,0,0
38923,for,0,0
38924,3,0,0
38925,days,0,0
38926,and,0,0
38927,then,0,0
38928,twice,0,0
38929,weekly,0,0
38930,",",0,0
38931,provided,0,0
38932,a,0,0
38933,similar,0,0
38934,",",0,0
38935,rapid,0,0
38936,resolution,0,0
38937,of,0,0
38938,clinical,0,0
38939,signs,0,0
38940,and,0,0
38941,negative,0,0
38942,isolation,0,0
38943,scores,0,0
38944,as,0,0
38945,doxycycline,0,0
38946,",",0,0
38947,C,0,0
38948,felis,0,0
38949,was,0,0
38950,re-isolated,0,0
38951,in,0,0
38952,four,0,0
38953,out,0,0
38954,of,0,0
38955,the,0,0
38956,five,1,0
38957,cats,1,1
38958,treated,1,1
38959,.,1,0
38960,Furthermore,0,0
38961,",",0,0
38962,even,0,0
38963,daily,0,0
38964,administration,0,0
38965,of,0,0
38966,azithromycin,0,0
38967,to,0,0
38968,chronically,0,1
38969,infected,0,1
38970,cats,0,1
38971,was,0,0
38972,ineffective,0,0
38973,in,0,0
38974,clearing,0,0
38975,infection,0,1
38976,.,0,0
38977,The,0,0
38978,azithromycin,0,0
38979,protocols,0,0
38980,used,0,0
38981,here,0,0
38982,were,0,0
38983,therefore,0,0
38984,found,0,0
38985,to,0,0
38986,be,0,0
38987,unsuccessful,0,0
38988,in,0,0
38989,eliminating,0,0
38990,the,0,0
38991,carriage,0,0
38992,of,0,0
38993,this,0,0
38994,strain,0,0
38995,of,0,0
38996,C,0,0
38997,felis,0,1
38998,.,0,0
38999,Future,0,0
39000,therapeutic,0,0
39001,directions,0,0
39002,for,0,0
39003,factor,0,0
39004,Xa,0,0
39005,inhibition,0,0
39006,in,0,0
39007,the,0,0
39008,prophylaxis,0,0
39009,and,0,0
39010,treatment,0,0
39011,of,0,0
39012,thrombotic,1,0
39013,disorders,1,1
39014,.,1,0
39015,The,0,0
39016,targeted,0,0
39017,mechanism,0,0
39018,of,0,0
39019,factor,0,0
39020,Xa,0,0
39021,inhibition,0,0
39022,has,0,0
39023,been,0,0
39024,studied,0,0
39025,extensively,0,0
39026,",",0,0
39027,initially,0,0
39028,as,0,0
39029,prophylaxis,0,0
39030,for,0,0
39031,venous,1,0
39032,thromboembolism,1,1
39033,(,1,0
39034,VTE,1,0
39035,),1,0
39036,in,1,0
39037,the,1,0
39038,orthopedic,1,1
39039,surgical,1,0
39040,setting,1,1
39041,.,1,0
39042,Future,0,0
39043,therapeutic,0,0
39044,directions,0,0
39045,for,0,0
39046,selective,0,0
39047,factor,0,0
39048,Xa,0,0
39049,inhibition,0,0
39050,in,0,0
39051,the,0,0
39052,management,0,0
39053,of,0,0
39054,other,0,0
39055,thrombotic,0,1
39056,diseases,0,1
39057,are,0,0
39058,discussed,0,0
39059,.,0,0
39060,Thromboembolic,0,0
39061,diseases,0,0
39062,can,0,0
39063,occur,0,0
39064,in,0,0
39065,the,0,0
39066,venous,0,0
39067,or,0,0
39068,arterial,0,1
39069,sides,0,0
39070,of,0,0
39071,the,0,0
39072,circulatory,0,0
39073,system,0,0
39074,.,0,0
39075,Factor,0,0
39076,Xa,0,0
39077,inhibition,0,0
39078,is,0,0
39079,a,0,0
39080,targeted,0,0
39081,approach,0,0
39082,to,0,0
39083,anticoagulation,0,0
39084,that,0,0
39085,resulted,0,0
39086,from,0,0
39087,significant,0,0
39088,advances,0,0
39089,in,0,0
39090,our,0,0
39091,understanding,0,0
39092,of,0,0
39093,the,0,0
39094,coagulation,0,0
39095,cascade,0,0
39096,.,0,0
39097,The,0,0
39098,factor,0,0
39099,Xa,0,0
39100,inhibitor,0,0
39101,fondaparinux,0,0
39102,has,0,0
39103,been,0,0
39104,studied,0,0
39105,extensively,0,0
39106,in,0,0
39107,the,0,0
39108,orthopedic,0,1
39109,surgical,0,0
39110,setting,0,1
39111,for,0,0
39112,the,0,0
39113,prophylaxis,0,0
39114,of,0,0
39115,VTE,0,0
39116,.,0,1
39117,Current,0,0
39118,investigations,0,0
39119,that,0,0
39120,are,0,0
39121,under,0,0
39122,way,0,0
39123,or,0,0
39124,completed,0,0
39125,evaluate,0,0
39126,the,0,0
39127,efficacy,0,0
39128,and,0,0
39129,safety,0,0
39130,of,0,0
39131,fondaparinux,0,0
39132,for,0,0
39133,the,0,0
39134,management,0,0
39135,of,0,0
39136,various,0,0
39137,thrombotic,0,1
39138,diseases,0,1
39139,.,0,0
39140,The,0,0
39141,future,0,0
39142,development,0,0
39143,of,0,0
39144,fondaparinux,0,0
39145,resides,0,0
39146,primarily,0,0
39147,in,0,0
39148,three,0,0
39149,therapeutic,0,1
39150,areas,0,0
39151,:,0,1
39152,prevention,0,0
39153,of,0,0
39154,VTE,0,0
39155,",",0,0
39156,treatment,0,0
39157,of,0,0
39158,VTE,0,0
39159,",",0,0
39160,and,0,0
39161,treatment,0,0
39162,of,0,0
39163,acute,0,1
39164,coronary,0,1
39165,syndromes,0,1
39166,.,0,0
39167,For,0,0
39168,the,0,0
39169,prevention,0,0
39170,of,0,0
39171,VTE,0,0
39172,",",0,0
39173,fondaparinux,0,0
39174,has,0,0
39175,been,0,0
39176,studied,0,0
39177,as,0,0
39178,extended,0,0
39179,prophylaxis,0,0
39180,following,0,0
39181,hip,0,1
39182,fracture,0,0
39183,surgery,0,1
39184,(,0,0
39185,PENTHIFRA,0,0
39186,Plus,0,1
39187,),0,0
39188,",",0,0
39189,for,0,0
39190,use,0,0
39191,in,0,0
39192,high-risk,0,1
39193,abdominal,0,1
39194,surgical,0,1
39195,patients,0,1
39196,(,0,0
39197,PEGASUS,0,1
39198,and,0,0
39199,APOLLO,0,0
39200,),0,0
39201,",",0,0
39202,and,0,0
39203,for,0,0
39204,use,0,0
39205,in,0,0
39206,medical,0,1
39207,patients,0,1
39208,(,0,0
39209,ARTEMIS,0,1
39210,),0,1
39211,.,0,0
39212,Studies,0,0
39213,evaluating,0,0
39214,fondaparinux,0,0
39215,for,0,0
39216,the,0,0
39217,treatment,0,0
39218,of,0,0
39219,VTE,0,0
39220,are,0,0
39221,part,0,0
39222,of,0,0
39223,the,0,0
39224,large,0,0
39225,MATISSE,0,0
39226,clinical,0,0
39227,program,0,0
39228,(,0,0
39229,MATISSE,0,0
39230,DVT,0,0
39231,and,0,0
39232,MATISSE,0,0
39233,PE,0,1
39234,),0,0
39235,.,0,0
39236,Fondaparinux,0,0
39237,was,0,0
39238,investigated,0,0
39239,in,0,0
39240,phase,0,0
39241,2,0,0
39242,studies,0,0
39243,for,0,0
39244,the,0,0
39245,treatment,0,0
39246,of,0,0
39247,acute,1,1
39248,coronary,1,1
39249,syndromes,1,0
39250,",",0,0
39251,including,0,0
39252,acute,0,1
39253,ST-segment,0,0
39254,myocardial,0,1
39255,infarction,0,1
39256,(,0,0
39257,PENTALYSE,0,0
39258,),0,0
39259,and,0,0
39260,unstable,0,1
39261,angina,0,1
39262,(,0,0
39263,PENTUA,0,0
39264,),0,0
39265,.,0,0
39266,Encouraging,0,0
39267,data,0,0
39268,from,0,1
39269,these,0,0
39270,trials,0,0
39271,are,0,0
39272,the,0,0
39273,basis,0,0
39274,for,0,0
39275,phase,0,0
39276,3,0,0
39277,programs,0,0
39278,in,0,0
39279,this,0,0
39280,area,0,0
39281,(,0,0
39282,MICHELANGELO,0,0
39283,),0,0
39284,.,0,0
39285,The,0,0
39286,orthopedic,0,0
39287,prophylactic,0,0
39288,and,0,0
39289,nonorthopedic,0,1
39290,clinical,0,0
39291,programs,0,0
39292,for,0,0
39293,fondaparinux,0,0
39294,in,0,0
39295,the,0,0
39296,management,0,0
39297,of,0,0
39298,thrombosis,0,1
39299,support,0,0
39300,the,0,0
39301,concept,0,0
39302,that,0,0
39303,targeted,0,0
39304,inhibition,0,0
39305,of,0,0
39306,coagulation,0,0
39307,is,0,0
39308,an,0,0
39309,effective,0,0
39310,advance,0,0
39311,in,0,0
39312,antithrombotic,0,0
39313,therapy,0,0
39314,.,0,0
39315,Bupropion,0,0
39316,SR,0,0
39317,and,0,0
39318,counseling,0,0
39319,for,0,0
39320,smoking,1,0
39321,cessation,1,0
39322,in,0,0
39323,actual,0,0
39324,practice,0,0
39325,:,0,1
39326,predictors,0,0
39327,of,0,0
39328,outcome,0,0
39329,.,0,0
39330,To,0,0
39331,date,0,0
39332,",",0,0
39333,only,0,0
39334,one,0,0
39335,study,0,0
39336,has,0,0
39337,been,0,0
39338,published,0,0
39339,on,0,0
39340,individual,0,0
39341,characteristics,0,0
39342,associated,0,0
39343,with,0,1
39344,outcome,0,0
39345,following,0,0
39346,standard,0,0
39347,treatment,0,0
39348,with,0,1
39349,bupropion,0,0
39350,SR,0,0
39351,for,0,0
39352,smoking,0,0
39353,cessation,0,0
39354,.,0,0
39355,To,0,0
39356,investigate,0,0
39357,treatment,0,0
39358,outcome,0,0
39359,beyond,0,0
39360,the,0,0
39361,6-week,0,0
39362,end-of-treatment,0,0
39363,point,0,0
39364,",",0,0
39365,the,0,0
39366,present,0,0
39367,study,0,0
39368,examined,0,0
39369,characteristics,0,0
39370,associated,0,0
39371,with,0,0
39372,more,0,0
39373,clinically,0,0
39374,relevant,0,0
39375,smoking,0,0
39376,endpoints,0,0
39377,following,0,0
39378,treatment,0,0
39379,with,0,1
39380,bupropion,0,0
39381,SR,0,0
39382,in,0,0
39383,a,0,0
39384,large,0,0
39385,health,0,0
39386,care,0,0
39387,system,0,0
39388,.,0,0
39389,A,0,0
39390,total,1,0
39391,of,1,0
39392,"1,524",1,1
39393,smokers,1,1
39394,(,1,1
39395,649,1,1
39396,men,1,1
39397,and,1,0
39398,875,1,1
39399,women,1,1
39400,),1,0
39401,of,1,0
39402,average,1,0
39403,age,1,1
39404,45.1,1,1
39405,years,1,1
39406,were,0,0
39407,randomized,0,0
39408,to,0,0
39409,receive,0,0
39410,one,0,0
39411,of,0,0
39412,four,0,1
39413,combinations,0,0
39414,of,0,0
39415,bupropion,0,0
39416,SR,0,0
39417,(,0,0
39418,150,0,0
39419,or,0,1
39420,300,0,0
39421,mg,0,0
39422,),0,0
39423,and,0,0
39424,behavioral,0,0
39425,counseling,0,0
39426,(,0,0
39427,tailored,0,0
39428,mailings,0,0
39429,or,0,1
39430,proactive,0,0
39431,telephone,0,0
39432,counseling,0,0
39433,),0,0
39434,and,0,0
39435,assessed,0,0
39436,for,0,0
39437,point-prevalent,0,0
39438,smoking,0,0
39439,status,0,0
39440,at,0,0
39441,3,0,0
39442,and,0,0
39443,12,0,1
39444,months,0,0
39445,.,0,1
39446,Multiple,0,0
39447,logistic,0,0
39448,regression,0,0
39449,analyses,0,0
39450,of,0,0
39451,potential,0,0
39452,risk,0,0
39453,factors,0,0
39454,for,0,0
39455,12-month,0,0
39456,point-prevalent,0,0
39457,smoking,0,0
39458,and,0,0
39459,for,0,0
39460,persistent,0,1
39461,smoking,0,0
39462,(,0,0
39463,point-prevalent,0,0
39464,smoking,0,0
39465,at,0,0
39466,both,0,0
39467,follow-ups,0,0
39468,),0,0
39469,following,0,0
39470,treatment,0,0
39471,were,0,0
39472,conducted,0,0
39473,for,0,0
39474,men,0,1
39475,and,0,0
39476,women,0,1
39477,combined,0,0
39478,and,0,0
39479,separately,0,0
39480,.,0,0
39481,Risk,0,0
39482,factors,0,0
39483,for,0,0
39484,smoking,0,0
39485,at,0,0
39486,both,0,0
39487,endpoints,0,0
39488,in,0,0
39489,the,0,0
39490,combined,0,0
39491,sample,0,1
39492,included,0,1
39493,treatment,0,0
39494,with,0,1
39495,tailored,0,0
39496,mailings,0,0
39497,",",0,0
39498,female,0,1
39499,gender,0,0
39500,",",0,0
39501,younger,0,1
39502,age,0,1
39503,",",0,0
39504,higher,0,0
39505,levels,0,0
39506,of,0,0
39507,tobacco,0,1
39508,dependence,0,0
39509,",",0,0
39510,shorter,0,0
39511,previous,0,0
39512,quit,0,0
39513,attempts,0,0
39514,",",0,0
39515,previous,0,0
39516,use,0,0
39517,of,0,0
39518,nicotine,0,0
39519,replacement,0,0
39520,therapy,0,0
39521,",",0,0
39522,and,0,0
39523,report,0,0
39524,of,0,0
39525,current,0,0
39526,depressive,0,0
39527,symptoms,0,0
39528,or,0,1
39529,lifetime,0,1
39530,depression,0,1
39531,.,0,0
39532,Risk,0,0
39533,factors,0,0
39534,for,0,0
39535,smoking,0,0
39536,following,0,0
39537,treatment,0,0
39538,identified,0,0
39539,in,0,0
39540,women,0,1
39541,only,0,0
39542,included,0,1
39543,treatment,0,0
39544,with,0,0
39545,the,0,0
39546,lower,0,0
39547,dose,0,0
39548,of,0,0
39549,bupropion,0,0
39550,SR,0,0
39551,",",0,0
39552,younger,0,1
39553,age,0,1
39554,",",0,0
39555,and,0,0
39556,higher,0,0
39557,perceived,0,0
39558,stress,0,0
39559,",",0,0
39560,whereas,0,0
39561,those,0,0
39562,that,0,0
39563,were,0,0
39564,unique,0,0
39565,to,0,0
39566,men,0,1
39567,included,0,1
39568,the,0,0
39569,presence,0,0
39570,of,0,0
39571,lifetime,0,0
39572,depression,0,1
39573,.,0,0
39574,The,0,0
39575,results,0,0
39576,are,0,0
39577,discussed,0,0
39578,in,0,0
39579,terms,0,0
39580,of,0,0
39581,their,0,1
39582,implications,0,0
39583,for,0,0
39584,the,0,0
39585,need,0,0
39586,for,0,0
39587,more,0,0
39588,effective,0,0
39589,treatments,0,0
39590,in,0,0
39591,general,0,1
39592,",",0,0
39593,and,0,0
39594,the,0,0
39595,role,0,0
39596,of,0,0
39597,individual,0,0
39598,differences,0,0
39599,in,0,0
39600,the,0,0
39601,likelihood,0,0
39602,of,0,0
39603,returning,0,0
39604,to,0,0
39605,smoking,0,0
39606,following,0,0
39607,treatment,0,0
39608,for,0,0
39609,quitting,0,0
39610,.,0,1
39611,Clinical,0,0
39612,and,0,0
39613,radiographic,0,0
39614,evaluation,0,0
39615,of,0,0
39616,guided,0,0
39617,tissue,0,0
39618,regeneration,0,0
39619,in,0,0
39620,the,0,0
39621,treatment,0,0
39622,of,0,0
39623,class,1,1
39624,II,1,1
39625,furcation,1,0
39626,defects,1,0
39627,.,1,0
39628,A,0,0
39629,randomized,0,0
39630,clinical,0,0
39631,trial,0,0
39632,.,0,0
39633,PURPOSE,0,0
39634,To,0,0
39635,evaluate,0,0
39636,the,0,0
39637,treatment,0,0
39638,outcomes,0,0
39639,after,0,0
39640,guided,0,0
39641,tissue,0,0
39642,regeneration,0,0
39643,(,0,0
39644,GTR,0,0
39645,),0,0
39646,with,0,0
39647,a,0,0
39648,bioabsorbable,0,0
39649,membrane,0,0
39650,in,0,0
39651,Class,1,0
39652,II,1,1
39653,furcation,1,0
39654,defects,1,0
39655,in,0,0
39656,mandibular,0,1
39657,molars,0,1
39658,.,0,0
39659,The,0,0
39660,open,0,0
39661,flap,0,0
39662,debridement,0,0
39663,(,0,0
39664,OFD,0,0
39665,),0,0
39666,was,0,0
39667,used,0,0
39668,as,0,0
39669,the,0,0
39670,control,0,0
39671,.,0,0
39672,METHODS,0,0
39673,Nine,1,0
39674,patients,1,1
39675,",",1,0
39676,with,1,1
39677,two,1,0
39678,comparable,1,0
39679,Class,1,0
39680,II,1,1
39681,furcation,1,0
39682,defects,1,0
39683,were,1,0
39684,included,1,1
39685,in,1,0
39686,the,1,0
39687,study,1,0
39688,.,1,0
39689,After,0,0
39690,initial,0,0
39691,preparation,0,0
39692,",",0,0
39693,the,0,0
39694,defects,0,0
39695,were,0,0
39696,randomly,0,1
39697,assigned,0,0
39698,in,0,0
39699,each,0,0
39700,patient,0,0
39701,to,0,0
39702,either,0,0
39703,GTR-group,1,0
39704,or,1,0
39705,OFD-group,1,0
39706,.,1,0
39707,Clinical,0,0
39708,parameters,0,0
39709,and,0,0
39710,standardized,0,0
39711,radiographs,0,1
39712,were,0,0
39713,obtained,0,0
39714,at,0,0
39715,baseline,0,0
39716,and,0,0
39717,6,0,0
39718,months,0,0
39719,after,0,0
39720,the,0,0
39721,surgeries,0,0
39722,.,0,0
39723,The,0,0
39724,radiographs,0,0
39725,were,0,0
39726,analyzed,0,0
39727,by,0,0
39728,subtraction,0,0
39729,radiography,0,0
39730,.,0,0
39731,RESULTS,0,0
39732,Comparing,0,0
39733,baseline,0,0
39734,to,0,0
39735,6-month,0,0
39736,results,0,0
39737,",",0,0
39738,both,0,0
39739,groups,0,0
39740,showed,0,0
39741,statistically,0,0
39742,significant,0,0
39743,probing,0,0
39744,depth,0,0
39745,reduction,0,0
39746,(,0,0
39747,PD,0,0
39748,),0,0
39749,",",0,0
39750,horizontal,0,0
39751,clinical,0,0
39752,attachment,0,0
39753,level,0,0
39754,(,0,0
39755,CAL-h,0,0
39756,),0,0
39757,gain,0,0
39758,",",0,0
39759,and,0,0
39760,increase,0,0
39761,in,0,0
39762,gingival,0,0
39763,recession,0,1
39764,(,0,0
39765,GR,0,0
39766,),0,0
39767,.,0,0
39768,The,0,0
39769,vertical,0,0
39770,clinical,0,0
39771,attachment,0,0
39772,level,0,0
39773,(,0,0
39774,CAL-v,0,0
39775,),0,0
39776,gain,0,0
39777,was,0,0
39778,statistically,0,0
39779,significant,0,0
39780,only,0,0
39781,for,0,0
39782,the,0,0
39783,OFD-group,0,0
39784,.,0,0
39785,Comparing,0,0
39786,the,0,0
39787,two,0,0
39788,treatments,0,0
39789,",",0,0
39790,no,0,0
39791,statistically,0,0
39792,significant,0,0
39793,differences,0,0
39794,were,0,0
39795,found,0,0
39796,in,0,0
39797,PD,0,0
39798,reduction,0,0
39799,(,0,0
39800,GTR,0,0
39801,:,0,1
39802,1.67,0,0
39803,mm,0,0
39804,;,0,0
39805,OFD,0,0
39806,:,0,1
39807,2.51,0,0
39808,mm,0,0
39809,",",0,0
39810,P,0,0
39811,=,0,0
39812,0.26,0,0
39813,),0,0
39814,",",0,0
39815,CAL-v,0,0
39816,gain,0,0
39817,(,0,0
39818,GTR,0,0
39819,:,0,1
39820,0.62,0,0
39821,mm,0,0
39822,;,0,0
39823,OFD,0,0
39824,:,0,1
39825,1.16,0,0
39826,mm,0,0
39827,",",0,0
39828,P=,0,0
39829,0.37,0,0
39830,),0,0
39831,",",0,0
39832,and,0,0
39833,GR,0,0
39834,increase,0,0
39835,(,0,0
39836,GTR,0,0
39837,:,0,1
39838,1.04,0,0
39839,mm,0,0
39840,;,0,0
39841,OFD,0,0
39842,:,0,1
39843,1.24,0,0
39844,mm,0,0
39845,",",0,0
39846,P,0,0
39847,=,0,0
39848,0.31,0,0
39849,),0,0
39850,.,0,0
39851,GTR,0,0
39852,provided,0,0
39853,complete,0,0
39854,closure,0,1
39855,of,0,0
39856,the,0,0
39857,furcation,0,0
39858,defect,0,0
39859,in,0,0
39860,two,0,0
39861,sites,0,1
39862,and,0,0
39863,superior,0,0
39864,horizontal,0,0
39865,clinical,0,0
39866,attachment,0,0
39867,level,0,0
39868,gain,0,0
39869,(,0,0
39870,GTR,0,0
39871,:,0,1
39872,2.27,0,0
39873,mm,0,0
39874,;,0,0
39875,OFD,0,0
39876,:,0,1
39877,1.01,0,0
39878,mm,0,0
39879,",",0,0
39880,P,0,0
39881,=,0,0
39882,0.05,0,0
39883,),0,0
39884,.,0,0
39885,Subtraction,0,0
39886,radiography,0,0
39887,showed,0,0
39888,significant,0,0
39889,difference,0,0
39890,in,0,0
39891,bone,0,0
39892,height,0,0
39893,change,0,0
39894,between,0,0
39895,GTR-group,0,0
39896,and,0,0
39897,OFD-group,0,0
39898,(,0,0
39899,-0.14,0,0
39900,mm,0,0
39901,and,0,0
39902,0.86,0,0
39903,mm,0,0
39904,",",0,0
39905,respectively,0,0
39906,;,0,0
39907,P,0,0
39908,=,0,0
39909,0.028,0,0
39910,),0,0
39911,at,0,0
39912,6,0,0
39913,months,0,0
39914,.,0,1
39915,Intervention,0,0
39916,in,0,0
39917,children,1,1
39918,with,1,1
39919,Developmental,1,1
39920,Coordination,1,0
39921,Disorder,1,1
39922,:,1,1
39923,the,0,0
39924,role,0,0
39925,of,0,0
39926,parents,1,1
39927,and,1,1
39928,teachers,1,1
39929,.,1,1
39930,BACKGROUND,0,0
39931,Children,1,1
39932,with,1,1
39933,Developmental,1,1
39934,Coordination,1,0
39935,Disorder,1,1
39936,(,1,0
39937,DCD,1,0
39938,),1,0
39939,are,0,0
39940,a,0,0
39941,heterogeneous,0,0
39942,group,0,0
39943,who,0,1
39944,have,0,0
39945,a,0,1
39946,marked,0,0
39947,impairment,0,0
39948,in,0,0
39949,the,0,0
39950,performance,0,0
39951,of,0,0
39952,functional,0,0
39953,skills,0,0
39954,.,0,0
39955,Provision,0,0
39956,for,0,0
39957,these,0,0
39958,children,0,1
39959,is,0,0
39960,usually,0,0
39961,made,0,0
39962,via,0,0
39963,a,0,0
39964,paediatrician,0,0
39965,through,0,0
39966,occupational,0,1
39967,or,0,0
39968,physiotherapy,0,1
39969,though,0,0
39970,",",0,0
39971,with,0,0
39972,a,0,0
39973,prevalence,0,0
39974,rate,0,0
39975,of,0,0
39976,5,0,0
39977,%,0,0
39978,",",0,0
39979,regular,0,0
39980,provision,0,0
39981,is,0,0
39982,not,0,0
39983,possible,0,0
39984,due,0,0
39985,to,0,0
39986,limited,0,0
39987,professional,0,1
39988,resources,0,0
39989,.,0,0
39990,AIMS,0,0
39991,The,0,0
39992,study,0,0
39993,aimed,0,0
39994,to,0,0
39995,determine,0,0
39996,the,0,0
39997,extent,0,0
39998,to,0,0
39999,which,0,0
40000,parents,1,1
40001,and,1,0
40002,teachers,1,1
40003,",",0,0
40004,with,0,0
40005,guidance,0,0
40006,",",0,0
40007,can,0,0
40008,assist,0,0
40009,in,0,0
40010,the,0,0
40011,management,0,0
40012,of,0,0
40013,children,1,1
40014,with,1,1
40015,DCD,1,0
40016,;,1,0
40017,whether,0,0
40018,children,1,1
40019,with,1,1
40020,DCD,1,0
40021,are,0,0
40022,helped,0,0
40023,in,0,0
40024,this,0,0
40025,way,0,0
40026,and,0,0
40027,how,0,0
40028,this,0,0
40029,may,0,0
40030,contribute,0,0
40031,to,0,0
40032,our,0,0
40033,understanding,0,0
40034,of,0,0
40035,the,0,0
40036,condition,0,0
40037,.,0,0
40038,SAMPLE,0,0
40039,Thirty-one,1,1
40040,children,1,1
40041,with,1,1
40042,DCD,1,0
40043,aged,1,1
40044,7,1,0
40045,to,1,0
40046,9,1,0
40047,years,1,1
40048,participated,1,1
40049,in,1,0
40050,the,1,0
40051,study,1,0
40052,.,1,0
40053,METHODS,0,0
40054,Following,0,0
40055,assessment,0,0
40056,",",0,0
40057,individual,0,0
40058,profiles,0,0
40059,were,0,0
40060,developed,0,0
40061,and,0,0
40062,each,0,0
40063,week,0,0
40064,teachers,1,1
40065,and,1,0
40066,parents,1,1
40067,were,0,0
40068,given,0,0
40069,guidelines,0,0
40070,for,0,0
40071,working,0,0
40072,with,0,1
40073,the,0,0
40074,children,0,1
40075,and,0,0
40076,each,0,0
40077,child,0,0
40078,had,0,0
40079,three,0,0
40080,to,0,0
40081,four,0,0
40082,sessions,0,0
40083,a,0,0
40084,week,0,0
40085,lasting,0,0
40086,approximately,0,0
40087,for,0,0
40088,20,0,1
40089,minutes,0,0
40090,.,0,1
40091,In,0,0
40092,Phase,0,0
40093,1,0,0
40094,",",0,0
40095,one,0,0
40096,group,0,0
40097,of,0,0
40098,children,0,1
40099,worked,0,1
40100,with,0,1
40101,teachers,0,1
40102,and,0,0
40103,the,0,0
40104,other,0,0
40105,group,0,0
40106,worked,0,0
40107,with,0,1
40108,parents,0,1
40109,.,0,1
40110,In,0,0
40111,Phase,0,0
40112,2,0,0
40113,",",0,0
40114,the,0,0
40115,two,0,0
40116,groups,0,0
40117,of,0,0
40118,children,0,1
40119,swapped,0,0
40120,over,0,0
40121,.,0,0
40122,The,0,0
40123,children,0,1
40124,were,0,0
40125,assessed,0,0
40126,regularly,0,0
40127,throughout,0,0
40128,the,0,0
40129,project,0,0
40130,using,0,0
40131,the,0,0
40132,Movement,0,0
40133,ABC,0,0
40134,",",0,0
40135,together,0,0
40136,with,0,0
40137,diaries,0,0
40138,and,0,0
40139,comments,0,0
40140,from,0,1
40141,teachers,0,1
40142,and,0,1
40143,parents,0,1
40144,.,0,0
40145,RESULTS,0,0
40146,At,0,0
40147,the,0,0
40148,end,0,0
40149,of,0,0
40150,the,0,0
40151,40-week,0,0
40152,study,0,0
40153,",",0,0
40154,27,1,0
40155,children,1,1
40156,showed,0,0
40157,significant,0,0
40158,improvement,0,0
40159,in,0,0
40160,their,0,0
40161,motor,0,0
40162,skills,0,0
40163,.,0,1
40164,CONCLUSIONS,0,0
40165,Both,0,0
40166,teachers,1,1
40167,and,1,0
40168,parents,1,1
40169,were,0,0
40170,able,0,0
40171,to,0,0
40172,provide,0,0
40173,effective,0,0
40174,intervention,0,0
40175,for,0,0
40176,the,0,0
40177,majority,0,0
40178,of,0,0
40179,the,0,0
40180,children,0,1
40181,.,0,0
40182,It,0,0
40183,is,0,0
40184,possible,0,0
40185,that,0,0
40186,the,0,1
40187,children,0,1
40188,who,0,1
40189,did,0,1
40190,not,0,1
40191,improve,0,0
40192,have,0,0
40193,difficulties,0,0
40194,that,0,0
40195,are,0,0
40196,of,0,0
40197,a,0,0
40198,more,0,0
40199,complex,0,0
40200,type,0,0
40201,which,0,0
40202,require,0,0
40203,more,0,0
40204,specialist,0,0
40205,therapy,0,0
40206,to,0,0
40207,meet,0,0
40208,their,0,0
40209,need,0,0
40210,.,0,0
40211,Single-needle,0,0
40212,acupuncture,0,0
40213,alleviates,0,0
40214,gag,0,0
40215,reflex,0,0
40216,during,1,0
40217,transesophageal,1,1
40218,echocardiography,1,0
40219,:,1,1
40220,a,0,0
40221,blinded,0,0
40222,",",0,0
40223,randomized,0,0
40224,",",0,0
40225,controlled,0,0
40226,pilot,0,0
40227,trial,0,0
40228,.,0,0
40229,OBJECTIVES,0,0
40230,To,0,0
40231,study,0,0
40232,the,0,0
40233,effect,0,0
40234,of,0,0
40235,single-needle,0,0
40236,acupuncture,0,0
40237,in,0,0
40238,suppressing,0,0
40239,gag-reflex,0,0
40240,in,0,0
40241,transesophageal,0,0
40242,echocardiography,0,0
40243,(,0,0
40244,TEE,0,0
40245,),0,0
40246,.,0,0
40247,DESIGN,0,0
40248,Prospective,0,0
40249,",",0,0
40250,blinded,0,0
40251,trial,0,0
40252,.,0,1
40253,Settings/locations,0,0
40254,:,0,1
40255,Patients,1,1
40256,with,1,1
40257,ischemic,1,1
40258,stroke,1,1
40259,or,1,0
40260,transient,1,0
40261,ischemic,1,1
40262,attack,1,1
40263,undergoing,1,1
40264,TEE,1,0
40265,because,1,0
40266,of,1,0
40267,presumed,1,1
40268,cardioembolic,1,1
40269,origin,1,0
40270,in,1,0
40271,a,1,0
40272,specialized,1,0
40273,stroke,1,1
40274,unit,1,0
40275,of,1,0
40276,the,1,0
40277,Johann,1,0
40278,Wolfgang,1,0
40279,Goethe-University,1,0
40280,",",1,0
40281,Frankfurt/Main,1,0
40282,",",1,0
40283,Germany,1,0
40284,.,1,0
40285,Subjects/Study,0,1
40286,interventions,0,0
40287,:,0,1
40288,Forty-one,1,1
40289,(,1,0
40290,41,1,1
40291,),1,0
40292,patients,1,1
40293,were,1,0
40294,studied,1,1
40295,.,1,0
40296,Patients,0,1
40297,received,0,0
40298,single-needle,0,0
40299,acupuncture,0,0
40300,with,0,1
40301,a,0,0
40302,0.2,0,0
40303,x,0,0
40304,13,0,0
40305,mm,0,0
40306,disposable,0,0
40307,acupuncture,0,0
40308,needle,0,0
40309,(,0,0
40310,Suzhou,0,1
40311,Medical,0,1
40312,Appliances,0,0
40313,",",0,0
40314,China,0,1
40315,),0,0
40316,",",0,0
40317,10-mm,0,0
40318,deep,0,0
40319,either,0,0
40320,at,0,0
40321,Chengjiang,0,1
40322,(,0,0
40323,midline,0,0
40324,between,0,0
40325,lower,0,0
40326,lip,0,0
40327,and,0,0
40328,chin,0,0
40329,),0,0
40330,or,0,0
40331,superficially,0,0
40332,at,0,0
40333,a,0,0
40334,sham,0,0
40335,point,0,0
40336,(,0,0
40337,tip,0,0
40338,of,0,0
40339,the,0,0
40340,chin,0,0
40341,),0,0
40342,during,0,0
40343,TEE,0,0
40344,or,0,0
40345,no,0,0
40346,acupuncture,0,0
40347,for,0,0
40348,alleviating,0,0
40349,gag,0,0
40350,reflex,0,0
40351,.,0,0
40352,OUTCOME,0,0
40353,MEASURES,0,0
40354,Severity,0,0
40355,of,0,0
40356,gagging,0,0
40357,was,0,0
40358,rated,0,0
40359,on,0,0
40360,a,0,0
40361,visual-analogue,0,0
40362,scale,0,0
40363,.,0,0
40364,RESULTS,0,0
40365,The,0,0
40366,acupuncture,0,0
40367,group,0,0
40368,experienced,0,0
40369,significantly,0,0
40370,less,0,0
40371,gagging,0,0
40372,than,0,0
40373,the,0,0
40374,sham,0,0
40375,group,0,0
40376,(,0,0
40377,p,0,0
40378,=,0,0
40379,0.037,0,0
40380,),0,0
40381,or,0,0
40382,the,0,0
40383,nonacupuncture,0,0
40384,group,0,0
40385,(,0,0
40386,p,0,0
40387,=,0,0
40388,0.013,0,0
40389,),0,0
40390,.,0,0
40391,CONCLUSIONS,0,0
40392,Acupuncture,0,0
40393,of,0,0
40394,CV24,0,0
40395,is,0,0
40396,an,0,0
40397,easy,0,0
40398,to,0,0
40399,apply,0,0
40400,and,0,0
40401,effective,0,0
40402,method,0,0
40403,to,0,0
40404,reduce,0,0
40405,gag,0,0
40406,reflex,0,0
40407,during,0,0
40408,TEE,0,0
40409,.,0,1
40410,Raising,0,0
40411,high-density,0,0
40412,lipoprotein,0,0
40413,in,0,0
40414,humans,0,0
40415,through,0,0
40416,inhibition,0,0
40417,of,0,0
40418,cholesteryl,0,0
40419,ester,0,0
40420,transfer,0,0
40421,protein,0,0
40422,:,0,0
40423,an,0,0
40424,initial,0,0
40425,multidose,0,0
40426,study,0,0
40427,of,0,0
40428,torcetrapib,0,0
40429,.,0,0
40430,OBJECTIVE,0,0
40431,The,0,0
40432,ability,0,0
40433,of,0,0
40434,the,0,0
40435,potent,0,0
40436,cholesteryl,0,0
40437,ester,0,0
40438,transfer,0,0
40439,protein,0,0
40440,(,0,0
40441,CETP,0,0
40442,),0,0
40443,inhibitor,0,0
40444,torcetrapib,0,0
40445,(,0,0
40446,"CP-529,414",0,0
40447,),0,0
40448,to,0,0
40449,raise,0,0
40450,high-density,0,0
40451,lipoprotein,0,0
40452,cholesterol,0,0
40453,(,0,0
40454,HDL-C,0,0
40455,),0,0
40456,levels,0,0
40457,in,0,0
40458,healthy,1,1
40459,young,1,1
40460,subjects,1,1
40461,was,0,0
40462,tested,0,0
40463,in,0,0
40464,this,0,0
40465,initial,0,0
40466,phase,0,0
40467,1,0,0
40468,multidose,0,0
40469,study,0,0
40470,.,0,0
40471,METHODS,0,0
40472,AND,0,0
40473,RESULTS,0,0
40474,Five,1,0
40475,groups,1,0
40476,of,1,0
40477,8,1,0
40478,subjects,1,1
40479,each,1,0
40480,were,0,0
40481,randomized,0,0
40482,to,0,0
40483,placebo,0,0
40484,(,0,0
40485,n=2,0,0
40486,),0,0
40487,or,0,0
40488,torcetrapib,0,0
40489,(,0,0
40490,n=6,0,0
40491,),0,0
40492,at,0,0
40493,10,0,0
40494,",",0,0
40495,30,0,0
40496,",",0,0
40497,60,0,0
40498,",",0,0
40499,and,0,0
40500,120,0,1
40501,mg,0,0
40502,daily,0,0
40503,and,0,0
40504,120,0,0
40505,mg,0,0
40506,twice,0,0
40507,daily,0,0
40508,for,0,0
40509,14,0,0
40510,days,0,0
40511,.,0,1
40512,Torcetrapib,0,0
40513,was,0,0
40514,well,0,0
40515,tolerated,0,0
40516,",",0,0
40517,with,0,0
40518,all,0,0
40519,treated,0,1
40520,subjects,0,1
40521,completing,0,0
40522,the,0,0
40523,study,0,0
40524,.,0,0
40525,The,0,0
40526,correlation,0,0
40527,of,0,0
40528,plasma,0,0
40529,drug,0,0
40530,levels,0,0
40531,with,0,1
40532,inhibition,0,0
40533,(,0,0
40534,EC50=43,0,0
40535,nM,0,0
40536,),0,0
40537,was,0,0
40538,as,0,0
40539,expected,0,0
40540,based,0,0
40541,on,0,0
40542,in,0,0
40543,vitro,0,0
40544,potency,0,0
40545,(,0,0
40546,IC50,0,0
40547,approximately,0,0
40548,50,0,0
40549,nM,0,0
40550,),0,0
40551,",",0,0
40552,and,0,0
40553,increases,0,0
40554,in,0,0
40555,CETP,0,0
40556,mass,0,0
40557,were,0,0
40558,consistent,0,0
40559,with,0,1
40560,the,0,0
40561,proposed,0,0
40562,mechanism,0,0
40563,of,0,0
40564,inhibition,0,0
40565,.,0,0
40566,CETP,0,0
40567,inhibition,0,0
40568,increased,0,0
40569,with,0,0
40570,escalating,0,0
40571,dose,0,0
40572,",",0,0
40573,leading,0,0
40574,to,0,0
40575,elevations,0,0
40576,of,0,0
40577,HDL-C,0,0
40578,of,0,0
40579,16,0,1
40580,%,0,0
40581,to,0,0
40582,91,0,0
40583,%,0,0
40584,.,0,0
40585,Total,0,0
40586,plasma,0,0
40587,cholesterol,0,0
40588,did,0,0
40589,not,0,0
40590,change,0,0
40591,significantly,0,0
40592,because,0,0
40593,of,0,0
40594,a,0,0
40595,reduction,0,0
40596,in,0,0
40597,nonHDL-C,0,0
40598,",",0,0
40599,including,0,0
40600,a,0,0
40601,21,0,1
40602,%,0,0
40603,to,0,0
40604,42,0,0
40605,%,0,0
40606,lowering,0,0
40607,of,0,0
40608,low-density,0,0
40609,lipoprotein,0,0
40610,cholesterol,0,0
40611,at,0,0
40612,the,0,0
40613,higher,0,0
40614,doses,0,0
40615,.,0,1
40616,Apolipoprotein,0,0
40617,A-I,0,0
40618,and,0,0
40619,E,0,0
40620,were,0,0
40621,elevated,0,0
40622,27,0,0
40623,%,0,0
40624,and,0,0
40625,66,0,0
40626,%,0,0
40627,",",0,0
40628,respectively,0,0
40629,",",0,0
40630,and,0,0
40631,apoB,0,0
40632,was,0,0
40633,reduced,0,0
40634,26,0,0
40635,%,0,0
40636,with,0,1
40637,120,0,1
40638,mg,0,0
40639,twice,0,0
40640,daily,0,0
40641,.,0,0
40642,Cholesteryl,0,0
40643,ester,0,0
40644,content,0,0
40645,decreased,0,0
40646,and,0,0
40647,triglyceride,0,0
40648,increased,0,0
40649,in,0,0
40650,the,0,0
40651,nonHDL,0,0
40652,plasma,0,0
40653,fraction,0,0
40654,",",0,0
40655,with,0,0
40656,contrasting,0,0
40657,changes,0,0
40658,occurring,0,1
40659,in,0,0
40660,HDL,0,0
40661,.,0,0
40662,CONCLUSIONS,0,0
40663,These,0,0
40664,effects,0,0
40665,of,0,0
40666,CETP,0,0
40667,inhibition,0,0
40668,resemble,0,0
40669,those,0,0
40670,observed,0,0
40671,in,0,0
40672,partial,0,0
40673,CETP,0,0
40674,deficiency,0,1
40675,.,0,0
40676,This,0,0
40677,work,0,0
40678,serves,0,0
40679,as,0,0
40680,a,0,0
40681,prelude,0,0
40682,to,0,0
40683,further,0,0
40684,studies,0,0
40685,in,0,0
40686,subjects,0,1
40687,with,0,1
40688,low,0,0
40689,HDL,0,0
40690,",",0,0
40691,or,0,0
40692,combinations,0,0
40693,of,0,0
40694,dyslipidemia,0,0
40695,",",0,0
40696,in,0,0
40697,assessing,0,0
40698,the,0,0
40699,role,0,0
40700,of,0,0
40701,CETP,0,0
40702,in,0,0
40703,atherosclerosis,0,1
40704,.,0,0
40705,The,0,0
40706,long-term,0,0
40707,effect,0,0
40708,of,0,0
40709,oxandrolone,0,1
40710,on,0,0
40711,hepatic,0,0
40712,acute,0,1
40713,phase,0,0
40714,proteins,0,0
40715,in,0,0
40716,severely,1,1
40717,burned,1,1
40718,children,1,1
40719,.,1,1
40720,BACKGROUND,0,0
40721,Acute,0,0
40722,phase,0,0
40723,protein,0,0
40724,production,0,0
40725,is,0,0
40726,a,0,0
40727,hallmark,0,0
40728,of,0,0
40729,severe,0,1
40730,burns,0,1
40731,.,0,1
40732,We,0,0
40733,wondered,0,0
40734,whether,0,0
40735,anabolic,0,0
40736,treatment,0,0
40737,with,0,0
40738,oxandrolone,0,0
40739,would,0,0
40740,affect,0,0
40741,these,0,0
40742,proteins,0,0
40743,.,0,0
40744,METHODS,0,0
40745,Thirty-five,1,1
40746,children,1,1
40747,with,1,1
40748,>,1,1
40749,or,1,0
40750,=40,1,1
40751,%,1,0
40752,total,1,1
40753,body,1,0
40754,surface,1,0
40755,area,1,0
40756,burns,1,1
40757,were,1,0
40758,randomized,1,0
40759,to,0,0
40760,receive,0,0
40761,either,0,0
40762,placebo,0,0
40763,or,0,0
40764,oxandrolone,0,1
40765,(,0,0
40766,0.1,0,0
40767,mg/kg,0,0
40768,by,0,0
40769,mouth,0,0
40770,twice,0,0
40771,daily,0,0
40772,),0,0
40773,from,0,0
40774,postoperative,0,0
40775,day,0,0
40776,5,0,0
40777,to,0,0
40778,1,0,0
40779,year,0,0
40780,postburn,0,0
40781,.,0,0
40782,Levels,0,0
40783,of,0,0
40784,constitutive,0,0
40785,proteins,0,0
40786,and,0,0
40787,acute,0,1
40788,phase,0,0
40789,proteins,0,0
40790,were,0,0
40791,measured,0,0
40792,at,0,0
40793,admission,0,0
40794,;,0,0
40795,at,0,0
40796,discharge,0,0
40797,;,0,0
40798,and,0,0
40799,at,0,0
40800,6,0,0
40801,",",0,0
40802,9,0,0
40803,",",0,0
40804,and,0,0
40805,12,0,0
40806,months,0,0
40807,after,0,0
40808,burn,0,1
40809,.,0,0
40810,Total,0,0
40811,albumin,0,0
40812,supplementation,0,0
40813,and,0,0
40814,hepatic,0,0
40815,transaminases,0,0
40816,were,0,0
40817,also,0,0
40818,assessed,0,0
40819,.,0,0
40820,RESULTS,0,0
40821,Constitutive,0,0
40822,proteins,0,0
40823,such,0,0
40824,as,0,0
40825,albumin,0,0
40826,",",0,0
40827,prealbumin,0,0
40828,",",0,0
40829,and,0,0
40830,retinol-binding,0,0
40831,protein,0,0
40832,levels,0,0
40833,increased,0,0
40834,(,0,0
40835,p,0,0
40836,<,0,0
40837,0.05,0,0
40838,),0,0
40839,",",0,0
40840,and,0,0
40841,acute,0,1
40842,phase,0,0
40843,proteins,0,0
40844,such,0,0
40845,as,0,0
40846,alpha,0,0
40847,1-acid,0,0
40848,glycoprotein,0,0
40849,",",0,0
40850,C3,0,0
40851,complement,0,0
40852,",",0,0
40853,alpha,0,0
40854,2-macroglobulin,0,0
40855,",",0,0
40856,and,0,0
40857,fibrinogen,0,0
40858,levels,0,0
40859,significantly,0,0
40860,decreased,0,0
40861,in,0,0
40862,the,0,0
40863,oxandrolone,0,0
40864,group,0,0
40865,compared,0,0
40866,with,0,0
40867,placebo,0,0
40868,(,0,0
40869,p,0,0
40870,<,0,0
40871,0.05,0,0
40872,),0,0
40873,.,0,0
40874,Albumin,0,0
40875,supplementation,0,0
40876,during,0,0
40877,the,0,0
40878,acute,0,1
40879,hospitalization,0,0
40880,was,0,0
40881,reduced,0,0
40882,in,0,0
40883,the,0,0
40884,oxandrolone,0,1
40885,group,0,0
40886,.,0,0
40887,Hepatic,0,0
40888,transaminases,0,0
40889,remained,0,0
40890,within,0,0
40891,normal,0,1
40892,levels,0,0
40893,.,0,1
40894,CONCLUSION,0,0
40895,Treatment,0,0
40896,with,0,1
40897,oxandrolone,0,1
40898,in,0,0
40899,severe,0,1
40900,burns,0,1
40901,significantly,0,0
40902,increases,0,0
40903,constitutive,0,0
40904,protein,0,0
40905,and,0,0
40906,reduces,0,0
40907,acute,0,1
40908,phase,0,0
40909,protein,0,0
40910,levels,0,0
40911,.,0,1
40912,Prospective,0,0
40913,",",0,0
40914,randomized,0,0
40915,trial,0,0
40916,of,0,0
40917,diclofenac,0,0
40918,and,0,0
40919,ketorolac,0,0
40920,after,0,0
40921,refractive,1,0
40922,surgery,1,1
40923,.,1,0
40924,PURPOSE,0,0
40925,To,0,0
40926,compare,0,0
40927,the,0,0
40928,effectiveness,0,0
40929,of,0,0
40930,diclofenac,0,0
40931,and,0,0
40932,ketorolac,0,0
40933,in,0,0
40934,relieving,0,0
40935,corneal,1,0
40936,pain,1,0
40937,after,1,0
40938,refractive,1,0
40939,surgery,1,1
40940,",",0,0
40941,and,0,0
40942,determine,0,0
40943,if,0,0
40944,there,0,0
40945,is,0,0
40946,a,0,0
40947,difference,0,0
40948,in,0,0
40949,stinging,0,0
40950,on,0,0
40951,instillation,0,0
40952,.,0,0
40953,METHODS,0,0
40954,Thirty,1,1
40955,patients,1,1
40956,were,0,0
40957,randomized,0,0
40958,prospectively,0,0
40959,to,0,0
40960,postoperative,0,0
40961,diclofenac,0,0
40962,in,0,0
40963,one,0,0
40964,eye,0,0
40965,and,0,0
40966,ketorolac,0,0
40967,in,0,0
40968,the,0,0
40969,other,0,0
40970,.,0,0
40971,Patients,0,1
40972,and,0,0
40973,surgeon,0,0
40974,did,0,0
40975,not,0,0
40976,know,0,0
40977,which,0,0
40978,medications,0,0
40979,were,0,0
40980,used,0,0
40981,.,0,0
40982,Ocular,0,0
40983,postoperative,0,0
40984,pain,0,0
40985,and,0,0
40986,discomfort,0,0
40987,on,0,0
40988,instillation,0,0
40989,of,0,0
40990,medication,0,0
40991,were,0,0
40992,measured,0,0
40993,after,0,0
40994,radial,0,0
40995,keratotomy,0,0
40996,with,0,1
40997,a,0,0
40998,visual,0,0
40999,analog,0,0
41000,scale,0,0
41001,and,0,0
41002,a,0,0
41003,questionnaire,0,0
41004,.,0,0
41005,RESULTS,0,0
41006,Both,0,0
41007,medications,0,0
41008,were,0,0
41009,highly,0,0
41010,effective,0,0
41011,in,0,0
41012,relieving,0,0
41013,pain,0,0
41014,.,0,0
41015,There,0,0
41016,was,0,0
41017,no,0,0
41018,significant,0,0
41019,difference,0,0
41020,in,0,0
41021,pain,0,0
41022,relief,0,0
41023,",",0,0
41024,or,0,0
41025,stinging,0,0
41026,on,0,0
41027,instillation,0,0
41028,(,0,0
41029,P,0,0
41030,=,0,0
41031,.29,0,0
41032,),0,0
41033,.,0,0
41034,CONCLUSION,0,0
41035,There,0,0
41036,was,0,0
41037,no,0,0
41038,statistical,0,0
41039,difference,0,0
41040,in,0,0
41041,the,0,0
41042,effectiveness,0,0
41043,of,0,0
41044,the,0,0
41045,medications,0,0
41046,on,0,0
41047,pain,0,0
41048,relief,0,0
41049,",",0,0
41050,or,0,0
41051,in,0,0
41052,stinging,0,0
41053,on,0,0
41054,instillation,0,0
41055,.,0,0
41056,Oscillatory,1,0
41057,potentials,1,0
41058,",",1,0
41059,retinopathy,1,0
41060,",",1,0
41061,and,1,0
41062,long-term,1,0
41063,glucose,1,0
41064,control,1,0
41065,in,1,0
41066,insulin-dependent,1,1
41067,diabetes,1,1
41068,.,1,0
41069,The,0,0
41070,main,0,0
41071,objective,0,0
41072,of,0,0
41073,the,0,0
41074,study,0,0
41075,was,0,0
41076,to,0,0
41077,assess,0,0
41078,effects,0,0
41079,of,0,0
41080,long-term,0,0
41081,lowering,0,0
41082,of,0,0
41083,glucosylated,0,0
41084,hemoglobin,0,0
41085,(,0,0
41086,HbA1,0,0
41087,%,0,0
41088,),0,0
41089,on,0,0
41090,neurosensory,0,0
41091,function,0,0
41092,in,0,0
41093,insulin-dependent,1,1
41094,diabetes,1,1
41095,.,1,1
41096,Individual,0,0
41097,(,0,0
41098,OP-1,0,0
41099,",",0,0
41100,OP-2,0,0
41101,",",0,0
41102,OP-3,0,0
41103,),0,0
41104,and,0,0
41105,summed,0,0
41106,(,0,0
41107,OP-sum,0,0
41108,),0,0
41109,amplitudes,0,0
41110,of,0,0
41111,oscillatory,0,0
41112,potentials,0,0
41113,(,0,0
41114,OPs,0,0
41115,),0,0
41116,of,0,0
41117,electroretinography,0,0
41118,were,0,0
41119,recorded,0,0
41120,at,0,0
41121,study,0,0
41122,start,0,1
41123,and,0,0
41124,7-years,0,0
41125,later,0,0
41126,in,0,0
41127,45,1,0
41128,patients,1,1
41129,(,0,0
41130,the,0,0
41131,Oslo,1,0
41132,study,0,0
41133,),0,0
41134,.,0,0
41135,As,0,0
41136,an,0,0
41137,overall,0,0
41138,7-year,0,0
41139,change,0,0
41140,",",0,0
41141,amplitudes,0,0
41142,of,0,0
41143,OP-2,0,0
41144,",",0,0
41145,OP-3,0,0
41146,and,0,0
41147,OP-sum,0,0
41148,were,0,0
41149,reduced,0,0
41150,(,0,0
41151,p,0,0
41152,<,0,0
41153,0.0001-0.01,0,0
41154,),0,0
41155,",",0,0
41156,retinopathy,0,0
41157,worsened,0,0
41158,(,0,0
41159,p,0,0
41160,=,0,0
41161,0.005,0,0
41162,),0,0
41163,",",0,0
41164,intraocular,0,0
41165,pressure,0,0
41166,decreased,0,0
41167,(,0,0
41168,p,0,0
41169,<,0,0
41170,0.001,0,0
41171,),0,0
41172,",",0,0
41173,systolic,0,0
41174,blood,0,0
41175,pressure,0,0
41176,increased,0,0
41177,(,0,0
41178,p,0,0
41179,<,0,0
41180,0.0002,0,0
41181,),0,0
41182,",",0,0
41183,and,0,0
41184,glycemic,0,0
41185,control,0,0
41186,improved,0,0
41187,from,0,0
41188,HbA1,0,0
41189,of,0,0
41190,11.2,0,0
41191,+/-,0,0
41192,2.2,0,0
41193,%,0,0
41194,at,0,0
41195,study,0,0
41196,start,0,1
41197,to,0,0
41198,a,0,0
41199,7-year,0,0
41200,cumulative,0,0
41201,mean,0,0
41202,of,0,0
41203,9.5,0,0
41204,+/-,0,0
41205,1.5,0,0
41206,%,0,0
41207,(,0,0
41208,p,0,0
41209,<,0,0
41210,0.0001,0,0
41211,),0,0
41212,.,0,0
41213,Multiple,0,0
41214,regression,0,0
41215,analysis,0,0
41216,did,0,0
41217,not,0,0
41218,identify,0,0
41219,any,0,0
41220,independent,0,0
41221,relations,0,0
41222,between,0,0
41223,change,0,0
41224,in,0,0
41225,OP-1,0,0
41226,",",0,0
41227,OP-2,0,0
41228,",",0,0
41229,OP-3,0,0
41230,",",0,0
41231,OP-sum,0,0
41232,and,0,0
41233,change,0,0
41234,in,0,0
41235,glycemic,0,0
41236,control,0,0
41237,or,0,0
41238,background,0,0
41239,variables,0,0
41240,",",0,0
41241,including,0,0
41242,change,0,0
41243,in,0,0
41244,age,0,1
41245,and,0,0
41246,duration,0,0
41247,of,0,0
41248,diabetes,0,1
41249,.,0,0
41250,However,0,0
41251,",",0,0
41252,cross-sectional,0,1
41253,observations,0,0
41254,at,0,0
41255,7,0,1
41256,years,0,1
41257,showed,0,0
41258,negative,0,0
41259,correlations,0,0
41260,between,0,0
41261,all,0,0
41262,OPs,0,0
41263,and,0,0
41264,age,0,1
41265,(,0,0
41266,p,0,0
41267,<,0,0
41268,0.0001-0.003,0,0
41269,),0,0
41270,",",0,0
41271,and,0,0
41272,between,0,0
41273,OP-3,0,0
41274,and,0,0
41275,duration,0,0
41276,(,0,0
41277,p,0,0
41278,=,0,0
41279,0.003,0,0
41280,),0,0
41281,and,0,0
41282,counts,0,0
41283,of,0,0
41284,microaneurysms,0,1
41285,(,0,0
41286,p,0,0
41287,=,0,0
41288,0.02,0,0
41289,),0,0
41290,.,0,0
41291,The,0,0
41292,data,0,0
41293,suggest,0,0
41294,that,0,0
41295,various,0,0
41296,clinical,0,0
41297,background,0,0
41298,variables,0,0
41299,may,0,0
41300,influence,0,0
41301,individual,0,0
41302,and,0,0
41303,summed,0,0
41304,amplitudes,0,0
41305,of,0,0
41306,OPs,0,0
41307,differently,0,0
41308,.,0,0
41309,Reduced,0,0
41310,neurosensory,0,0
41311,retinal,0,0
41312,function,0,0
41313,(,0,0
41314,OPs,0,0
41315,),0,0
41316,seemed,0,0
41317,to,0,0
41318,appear,0,0
41319,after,0,0
41320,7-years,0,0
41321,",",0,0
41322,independently,0,0
41323,of,0,0
41324,vascular,0,0
41325,defects,0,0
41326,of,0,0
41327,retinopathy,0,1
41328,and,0,0
41329,long-term,0,0
41330,improvement,0,0
41331,in,0,0
41332,glucose,0,0
41333,control,0,0
41334,.,0,0
41335,Reliance,0,0
41336,on,0,0
41337,visual,0,0
41338,information,0,0
41339,after,0,0
41340,stroke,0,1
41341,.,0,0
41342,Part,0,0
41343,II,0,0
41344,:,0,1
41345,Effectiveness,0,0
41346,of,0,0
41347,a,0,0
41348,balance,0,0
41349,rehabilitation,0,0
41350,program,0,0
41351,with,0,1
41352,visual,0,0
41353,cue,0,0
41354,deprivation,0,0
41355,after,1,0
41356,stroke,1,1
41357,:,1,1
41358,a,0,0
41359,randomized,0,0
41360,controlled,0,0
41361,trial,0,0
41362,.,0,0
41363,OBJECTIVE,0,0
41364,To,0,0
41365,test,0,0
41366,the,0,0
41367,hypothesis,0,0
41368,that,0,0
41369,balance,0,0
41370,rehabilitation,0,1
41371,with,0,1
41372,visual,0,0
41373,cue,0,0
41374,deprivation,0,0
41375,improves,0,0
41376,balance,0,0
41377,more,0,0
41378,effectively,0,0
41379,than,0,0
41380,rehabilitation,0,1
41381,with,0,1
41382,free,0,0
41383,vision,0,0
41384,.,0,0
41385,DESIGN,0,0
41386,Single-blind,0,0
41387,",",0,0
41388,randomized,0,0
41389,controlled,0,0
41390,trial,0,0
41391,.,0,0
41392,SETTING,0,0
41393,Public,1,0
41394,rehabilitation,1,1
41395,center,1,1
41396,in,1,0
41397,France,1,0
41398,.,1,1
41399,PARTICIPANTS,0,0
41400,Twenty,1,1
41401,patients,1,1
41402,with,1,1
41403,hemiplegia,1,1
41404,after,1,0
41405,a,1,0
41406,single-hemisphere,1,0
41407,stroke,1,1
41408,that,1,0
41409,occurred,1,0
41410,at,1,0
41411,least,1,0
41412,12,1,0
41413,months,1,0
41414,before,1,0
41415,the,1,0
41416,study,1,0
41417,.,1,1
41418,INTERVENTION,0,0
41419,Patients,0,1
41420,were,0,1
41421,randomly,0,1
41422,assigned,0,0
41423,to,0,0
41424,1,0,0
41425,of,0,0
41426,2,0,0
41427,balance,0,0
41428,rehabilitation,0,1
41429,programs-with,0,0
41430,and,0,0
41431,without,0,0
41432,visual,0,0
41433,cue,0,0
41434,deprivation,0,0
41435,.,0,0
41436,In,0,0
41437,all,0,0
41438,other,0,0
41439,respects,0,0
41440,",",0,0
41441,the,0,0
41442,programs,0,0
41443,were,0,0
41444,identical,0,0
41445,.,0,0
41446,Each,0,0
41447,lasted,0,0
41448,for,0,0
41449,1,0,0
41450,hour,0,0
41451,and,0,0
41452,was,0,0
41453,implemented,0,0
41454,5,0,0
41455,days,0,0
41456,a,0,0
41457,week,0,0
41458,for,0,0
41459,4,0,0
41460,weeks,0,0
41461,.,0,1
41462,All,1,0
41463,patients,1,1
41464,completed,1,0
41465,the,1,0
41466,program,1,0
41467,.,1,0
41468,Mean,0,0
41469,outcome,0,0
41470,measures,0,0
41471,Balance,0,0
41472,under,0,1
41473,6,0,0
41474,sensory,0,0
41475,conditions,0,0
41476,was,0,0
41477,assessed,0,0
41478,by,0,0
41479,computerized,0,0
41480,dynamic,0,0
41481,posturography,0,0
41482,(,0,0
41483,EquiTest,0,0
41484,),0,0
41485,",",0,0
41486,gait,0,0
41487,velocity,0,0
41488,",",0,0
41489,timed,0,0
41490,stair,0,0
41491,climbing,0,0
41492,",",0,0
41493,and,0,0
41494,self-assessment,0,0
41495,of,0,0
41496,ease,0,0
41497,of,0,0
41498,gait,0,0
41499,before,0,0
41500,and,0,0
41501,after,0,0
41502,program,0,0
41503,completion,0,0
41504,.,0,0
41505,RESULTS,0,0
41506,After,0,0
41507,completing,0,0
41508,the,0,0
41509,program,0,0
41510,",",0,0
41511,balance,0,0
41512,",",0,0
41513,gait,0,0
41514,velocity,0,0
41515,",",0,0
41516,and,0,0
41517,self-assessment,0,0
41518,of,0,0
41519,gait,0,0
41520,improved,0,0
41521,significantly,0,0
41522,in,0,0
41523,all,0,0
41524,patients,0,1
41525,.,0,0
41526,The,0,0
41527,improvements,0,0
41528,in,0,0
41529,gait,0,0
41530,velocity,0,0
41531,(,0,0
41532,P=,0,0
41533,.03,0,0
41534,),0,0
41535,and,0,0
41536,timed,0,0
41537,stair,0,0
41538,climbing,0,0
41539,(,0,0
41540,P=,0,0
41541,.01,0,0
41542,),0,0
41543,correlated,0,0
41544,significantly,0,0
41545,with,0,0
41546,improved,0,0
41547,balance,0,0
41548,.,0,0
41549,Balance,0,0
41550,improved,0,0
41551,more,0,0
41552,in,0,0
41553,the,0,0
41554,vision-deprived,0,0
41555,group,0,0
41556,than,0,0
41557,in,0,0
41558,the,0,0
41559,free-vision,0,0
41560,group,0,0
41561,.,0,0
41562,CONCLUSIONS,0,0
41563,Balance,0,0
41564,improved,0,0
41565,more,0,0
41566,after,0,0
41567,rehabilitation,0,0
41568,with,0,1
41569,visual,0,0
41570,deprivation,0,0
41571,than,0,0
41572,with,0,1
41573,free,0,1
41574,vision,0,0
41575,.,0,0
41576,Visual,0,0
41577,overuse,0,0
41578,may,0,0
41579,be,0,0
41580,a,0,0
41581,compensatory,0,0
41582,strategy,0,0
41583,for,0,0
41584,coping,0,0
41585,with,0,1
41586,initial,0,0
41587,imbalance,0,0
41588,exacerbated,0,0
41589,by,0,0
41590,traditional,0,0
41591,rehabilitation,0,1
41592,.,0,0
41593,Short-term,0,0
41594,fluoxetine,0,0
41595,monotherapy,0,0
41596,for,0,0
41597,bipolar,1,0
41598,type,1,1
41599,II,1,0
41600,or,1,0
41601,bipolar,1,1
41602,NOS,1,0
41603,major,1,0
41604,depression,1,1
41605,-,1,0
41606,low,1,0
41607,manic,1,1
41608,switch,1,0
41609,rate,1,0
41610,.,1,0
41611,OBJECTIVES,0,0
41612,Current,0,0
41613,guidelines,0,0
41614,for,0,0
41615,the,0,0
41616,initial,0,0
41617,treatment,0,0
41618,of,0,0
41619,bipolar,1,0
41620,type,1,1
41621,II,1,1
41622,(,1,0
41623,BP,1,0
41624,II,1,1
41625,),1,0
41626,major,1,0
41627,depressive,1,0
41628,episode,1,1
41629,(,1,0
41630,MDE,1,0
41631,),1,0
41632,recommend,0,0
41633,using,0,0
41634,either,0,0
41635,a,0,0
41636,mood,0,0
41637,stabilizer,0,0
41638,alone,0,0
41639,or,0,0
41640,a,0,0
41641,combination,0,0
41642,of,0,0
41643,a,0,0
41644,mood,0,0
41645,stabilizer,0,0
41646,plus,0,0
41647,a,0,0
41648,selective,0,0
41649,serotonin,0,0
41650,re-uptake,0,0
41651,inhibitor,0,0
41652,(,0,0
41653,SSRI,0,0
41654,),0,0
41655,.,0,0
41656,This,0,0
41657,recommendation,0,0
41658,is,0,0
41659,the,0,0
41660,result,0,0
41661,of,0,0
41662,concern,0,0
41663,over,0,0
41664,antidepressant-induced,0,0
41665,manic,0,1
41666,switch,0,0
41667,episodes,0,0
41668,.,0,0
41669,However,0,0
41670,",",0,0
41671,recent,0,0
41672,evidence,0,0
41673,suggests,0,0
41674,that,0,0
41675,the,0,0
41676,manic,0,0
41677,switch,0,0
41678,rate,0,0
41679,may,0,0
41680,be,0,0
41681,low,0,0
41682,in,0,0
41683,BP,0,0
41684,II,0,1
41685,MDE,0,0
41686,during,0,0
41687,SSRI,0,0
41688,therapy,0,0
41689,.,0,0
41690,METHODS,0,0
41691,As,1,0
41692,part,1,0
41693,of,1,0
41694,a,1,0
41695,randomized,1,0
41696,",",1,0
41697,double-blind,1,0
41698,",",1,0
41699,placebo-controlled,1,0
41700,relapse-prevention,1,0
41701,study,1,0
41702,of,1,0
41703,fluoxetine,1,0
41704,monotherapy,1,0
41705,in,1,0
41706,BP,1,0
41707,II,1,1
41708,MDE,1,0
41709,",",1,0
41710,37,1,1
41711,patients,1,1
41712,received,0,0
41713,open-label,0,0
41714,fluoxetine,0,0
41715,20,0,0
41716,mg,0,0
41717,every,0,0
41718,day,0,0
41719,for,0,0
41720,up,0,0
41721,to,0,0
41722,8,0,0
41723,weeks,0,0
41724,.,0,1
41725,Outcome,0,0
41726,measures,0,0
41727,included,0,1
41728,the,0,0
41729,Hamilton,0,0
41730,Depression,0,0
41731,Rating,0,0
41732,(,0,0
41733,HAM-D,0,0
41734,17,0,1
41735,),0,0
41736,rating,0,0
41737,and,0,0
41738,the,0,0
41739,Young,0,1
41740,Mania,0,1
41741,Rating,0,0
41742,(,0,0
41743,YMR,0,1
41744,),0,0
41745,scale,0,0
41746,.,0,0
41747,RESULTS,0,0
41748,Eleven,0,0
41749,of,0,0
41750,23,0,1
41751,patients,0,1
41752,(,0,0
41753,48,0,1
41754,%,0,0
41755,),0,1
41756,who,0,1
41757,completed,0,1
41758,8,0,1
41759,weeks,0,0
41760,of,0,0
41761,fluoxetine,0,0
41762,treatment,0,0
41763,showed,0,0
41764,a,0,0
41765,HAM-D,0,0
41766,17,0,0
41767,reduction,0,0
41768,of,0,0
41769,>,0,0
41770,or,0,0
41771,=50,0,1
41772,%,0,0
41773,",",0,0
41774,while,0,0
41775,14,0,0
41776,(,0,0
41777,38,0,1
41778,%,0,0
41779,),0,0
41780,of,0,0
41781,all,0,0
41782,treated,0,1
41783,patients,0,1
41784,had,0,0
41785,>,0,1
41786,or,0,0
41787,=50,0,1
41788,%,0,0
41789,reduction,0,0
41790,in,0,0
41791,baseline,0,0
41792,HAM-D,0,0
41793,17,0,1
41794,score,0,0
41795,.,0,0
41796,Using,0,0
41797,a,0,0
41798,conservative,0,0
41799,YMR,0,0
41800,score,0,0
41801,of,0,0
41802,>,0,0
41803,or,0,0
41804,=8,0,0
41805,to,0,0
41806,identify,0,0
41807,hypomanic,0,0
41808,symptoms,0,0
41809,",",0,0
41810,the,0,0
41811,frequency,0,0
41812,of,0,0
41813,patients,0,1
41814,with,0,1
41815,YMR,0,1
41816,score,0,0
41817,>,0,0
41818,or,0,0
41819,=8,0,0
41820,during,0,0
41821,fluoxetine,0,0
41822,did,0,0
41823,not,0,0
41824,differ,0,0
41825,from,0,0
41826,that,0,0
41827,seen,0,0
41828,during,0,0
41829,the,0,0
41830,screen,0,0
41831,and,0,0
41832,baseline,0,0
41833,period,0,0
41834,.,0,0
41835,Only,0,0
41836,three,0,0
41837,patients,0,1
41838,(,0,0
41839,7.3,0,0
41840,%,0,0
41841,),0,0
41842,had,0,0
41843,symptoms,0,0
41844,suggestive,0,0
41845,of,0,0
41846,hypomania,0,0
41847,",",0,0
41848,and,0,0
41849,only,0,0
41850,one,0,0
41851,patient,0,0
41852,stopped,0,0
41853,treatment,0,0
41854,because,0,0
41855,of,0,0
41856,a,0,0
41857,rapid,0,0
41858,mood,0,0
41859,swing,0,0
41860,into,0,0
41861,depression,0,1
41862,.,0,0
41863,LIMITATIONS,0,0
41864,Fluoxetine,0,0
41865,was,0,0
41866,given,0,0
41867,at,0,0
41868,a,0,0
41869,fixed,0,0
41870,dose,0,0
41871,of,0,0
41872,20,0,1
41873,mg,0,0
41874,everyday,0,0
41875,.,0,1
41876,Fluoxetine,0,0
41877,was,0,0
41878,prescribed,0,0
41879,in,0,0
41880,an,0,0
41881,open-label,0,0
41882,manner,0,0
41883,",",0,0
41884,and,0,0
41885,the,0,0
41886,sample,0,1
41887,size,0,0
41888,was,0,0
41889,limited,0,0
41890,.,0,0
41891,CONCLUSIONS,0,0
41892,These,0,0
41893,observations,0,0
41894,support,0,0
41895,the,0,0
41896,findings,0,0
41897,of,0,0
41898,a,0,0
41899,low,0,0
41900,manic,0,0
41901,switch,0,0
41902,rate,0,0
41903,during,0,0
41904,SSRI,0,0
41905,monotherapy,0,0
41906,of,0,0
41907,BP,0,0
41908,II,0,1
41909,MDE,0,0
41910,",",0,0
41911,and,0,0
41912,suggest,0,0
41913,that,0,0
41914,fluoxetine,0,0
41915,monotherapy,0,0
41916,may,0,0
41917,be,0,0
41918,a,0,0
41919,safe,0,0
41920,and,0,0
41921,effective,0,0
41922,initial,0,0
41923,treatment,0,0
41924,of,0,0
41925,BP,1,0
41926,II,1,1
41927,MDE,1,0
41928,.,1,0
41929,A,0,0
41930,pooled,0,0
41931,analysis,0,0
41932,of,0,0
41933,eastern,0,1
41934,cooperative,0,0
41935,oncology,0,1
41936,group,0,0
41937,and,0,0
41938,intergroup,0,0
41939,trials,0,0
41940,of,0,0
41941,adjuvant,0,1
41942,high-dose,0,0
41943,interferon,0,0
41944,for,0,0
41945,melanoma,1,1
41946,.,1,0
41947,PURPOSE,0,0
41948,Nearly,1,0
41949,2000,1,1
41950,patients,1,1
41951,with,1,1
41952,stage,1,1
41953,IIB,1,0
41954,and,1,0
41955,III,1,0
41956,melanoma,1,1
41957,have,1,0
41958,participated,1,1
41959,in,1,0
41960,four,1,0
41961,multicenter,1,0
41962,",",1,0
41963,randomized,1,0
41964,trials,1,0
41965,",",1,0
41966,conducted,1,0
41967,by,1,0
41968,the,1,0
41969,Eastern,1,1
41970,Cooperative,1,1
41971,Oncology,1,1
41972,Group,1,0
41973,and,1,0
41974,the,1,0
41975,Intergroup,1,0
41976,",",0,0
41977,investigating,0,0
41978,adjuvant,0,0
41979,high-dose,0,0
41980,IFN-alpha,0,0
41981,2b,0,0
41982,therapy,0,0
41983,.,0,0
41984,The,0,0
41985,objectives,0,0
41986,of,0,0
41987,this,0,0
41988,study,0,0
41989,were,0,0
41990,to,0,0
41991,update,0,0
41992,the,0,0
41993,analyses,0,0
41994,of,0,0
41995,each,0,0
41996,individual,0,0
41997,trial,0,0
41998,and,0,0
41999,to,0,0
42000,analyze,0,0
42001,prognostic,0,0
42002,factors,0,0
42003,and,0,0
42004,treatment,0,0
42005,effects,0,0
42006,based,0,0
42007,on,0,0
42008,pooled,0,0
42009,data,0,0
42010,.,0,1
42011,EXPERIMENTAL,0,0
42012,DESIGN,0,0
42013,Survival,0,0
42014,and,0,0
42015,disease,0,1
42016,status,0,0
42017,were,0,0
42018,updated,0,0
42019,to,0,0
42020,April,0,1
42021,2001,0,1
42022,.,0,0
42023,Analysis,0,0
42024,of,0,0
42025,prognostic,0,0
42026,factors,0,0
42027,using,0,0
42028,optimized,0,0
42029,statistical,0,0
42030,models,0,0
42031,was,0,0
42032,based,0,0
42033,on,0,0
42034,data,0,0
42035,from,0,1
42036,patients,1,1
42037,in,1,0
42038,E1684,1,0
42039,",",1,0
42040,E1690,1,0
42041,",",1,0
42042,E1694,1,0
42043,",",1,0
42044,and,1,0
42045,E2696,1,0
42046,.,1,0
42047,Analysis,0,0
42048,of,0,0
42049,treatment,0,0
42050,effects,0,0
42051,versus,0,0
42052,observation,0,0
42053,(,0,0
42054,Obs,0,0
42055,),0,0
42056,was,0,0
42057,based,0,0
42058,on,0,0
42059,data,0,0
42060,from,0,1
42061,713,1,1
42062,patients,1,1
42063,randomized,1,1
42064,to,0,0
42065,high-dose,0,0
42066,IFN-alpha,0,0
42067,2b,0,0
42068,(,0,0
42069,HDI,0,1
42070,),0,0
42071,or,0,0
42072,Obs,0,0
42073,in,0,0
42074,Trials,0,0
42075,E1684,0,0
42076,and,0,0
42077,E1690,0,0
42078,.,0,0
42079,RESULTS,0,0
42080,Updated,0,0
42081,analysis,0,0
42082,of,0,0
42083,E1684,0,0
42084,",",0,0
42085,E1690,0,0
42086,",",0,0
42087,and,0,0
42088,E1694,0,0
42089,confirmed,0,0
42090,their,0,0
42091,original,0,0
42092,conclusions,0,0
42093,",",0,0
42094,now,0,0
42095,at,0,0
42096,median,0,0
42097,follow-up,0,0
42098,intervals,0,0
42099,of,0,0
42100,2.1-12.6,0,0
42101,years,0,1
42102,.,0,0
42103,Based,0,0
42104,on,0,0
42105,two-sided,0,0
42106,univariate,0,0
42107,log-rank,0,0
42108,analysis,0,0
42109,of,0,0
42110,pooled,0,0
42111,data,0,0
42112,from,0,0
42113,E1684,0,0
42114,and,0,0
42115,E1690,0,0
42116,(,0,0
42117,median,0,0
42118,follow-up,0,0
42119,",",0,0
42120,7.2,0,0
42121,years,0,1
42122,),0,0
42123,",",0,0
42124,relapse-free,0,0
42125,survival,0,0
42126,(,0,0
42127,RFS,0,0
42128,),0,0
42129,-but,0,0
42130,not,0,0
42131,overall,0,0
42132,survival,0,0
42133,(,0,0
42134,OS,0,0
42135,),0,0
42136,-was,0,0
42137,significantly,0,0
42138,prolonged,0,0
42139,(,0,0
42140,two-sided,0,0
42141,log-rank,0,0
42142,P,0,0
42143,value,0,0
42144,=,0,0
42145,0.006,0,0
42146,),0,0
42147,for,0,0
42148,patients,0,1
42149,treated,0,1
42150,with,0,1
42151,HDI,0,1
42152,versus,0,0
42153,Obs,0,0
42154,.,0,0
42155,Among,0,0
42156,all,0,0
42157,patients,0,1
42158,",",0,0
42159,prognostic,0,0
42160,factors,0,0
42161,that,0,0
42162,significantly,0,0
42163,negatively,0,0
42164,impacted,0,0
42165,RFS,0,0
42166,and,0,0
42167,OS,0,0
42168,included,0,0
42169,ulceration,0,0
42170,",",0,0
42171,recurrent,0,1
42172,disease,0,1
42173,at,0,0
42174,entry,0,0
42175,",",0,0
42176,enrollment,0,0
42177,in,0,0
42178,E1684,0,0
42179,",",0,0
42180,and,0,0
42181,age,0,1
42182,>,0,1
42183,49,0,1
42184,years,0,1
42185,.,0,1
42186,Multivariate,0,0
42187,statistical,0,0
42188,models,0,0
42189,adjusting,0,0
42190,for,0,0
42191,these,0,0
42192,factors,0,0
42193,confirmed,0,0
42194,the,0,0
42195,statistically,0,0
42196,significant,0,0
42197,RFS,0,0
42198,benefit,0,0
42199,of,0,0
42200,HDI,0,1
42201,versus,0,0
42202,Obs,0,0
42203,but,0,0
42204,did,0,0
42205,not,0,0
42206,demonstrate,0,0
42207,a,0,0
42208,significant,0,0
42209,OS,0,0
42210,benefit,0,0
42211,in,0,0
42212,the,0,0
42213,pooled,0,0
42214,populations,0,1
42215,.,0,1
42216,CONCLUSIONS,0,0
42217,In,0,0
42218,patients,1,1
42219,with,1,1
42220,high-risk,1,1
42221,resected,1,1
42222,melanoma,1,1
42223,",",0,0
42224,HDI,0,0
42225,is,0,0
42226,effective,0,0
42227,adjuvant,0,0
42228,therapy,0,0
42229,with,0,1
42230,strong,0,0
42231,evidence,0,0
42232,for,0,0
42233,improved,0,0
42234,RFS,0,0
42235,and,0,0
42236,evidence,0,0
42237,for,0,0
42238,moderate,0,1
42239,improvement,0,0
42240,in,0,0
42241,OS,0,0
42242,based,0,0
42243,on,0,0
42244,two,0,0
42245,prospective,0,0
42246,randomized,0,0
42247,studies,0,0
42248,but,0,0
42249,not,0,0
42250,the,0,0
42251,pooled,0,0
42252,analysis,0,0
42253,.,0,0
42254,Analyses,0,0
42255,of,0,0
42256,predictors,0,0
42257,of,0,0
42258,relapse,0,0
42259,and,0,0
42260,response,0,0
42261,are,0,0
42262,now,0,0
42263,needed,0,0
42264,to,0,0
42265,improve,0,0
42266,the,0,0
42267,therapeutic,0,0
42268,value,0,0
42269,of,0,0
42270,this,0,0
42271,modality,0,0
42272,.,0,0
42273,Calcium,0,0
42274,chloride,0,0
42275,before,0,0
42276,i.v,0,0
42277,.,0,0
42278,diltiazem,0,0
42279,in,0,0
42280,the,0,0
42281,management,0,0
42282,of,0,0
42283,atrial,0,1
42284,fibrillation,0,1
42285,.,0,0
42286,Diltiazem,0,0
42287,is,0,0
42288,commonly,0,0
42289,used,0,0
42290,to,0,0
42291,treat,0,0
42292,atrial,1,1
42293,fibrillation,1,1
42294,or,1,0
42295,flutter,1,1
42296,(,1,0
42297,AFF,1,0
42298,),1,0
42299,with,0,1
42300,rapid,0,0
42301,ventricular,0,0
42302,response,0,0
42303,(,0,0
42304,RVR,0,0
42305,),0,0
42306,.,0,0
42307,Although,0,0
42308,it,0,0
42309,is,0,0
42310,very,0,0
42311,effective,0,0
42312,for,0,0
42313,rate,0,0
42314,control,0,0
42315,",",0,0
42316,up,0,0
42317,to,0,0
42318,an,0,0
42319,18,0,0
42320,%,0,0
42321,prevalence,0,0
42322,of,0,0
42323,reported,0,0
42324,diltiazem-induced,0,0
42325,hypotension,0,0
42326,[,0,0
42327,defined,0,0
42328,by,0,0
42329,systolic,0,0
42330,blood,0,0
42331,pressure,0,0
42332,(,0,0
42333,SBP,0,0
42334,),0,0
42335,<,0,0
42336,90,0,0
42337,mm,0,0
42338,Hg,0,0
42339,],0,0
42340,",",0,0
42341,and,0,0
42342,a,0,0
42343,mean,0,0
42344,of,0,0
42345,9.7,0,0
42346,%,0,0
42347,hypotension,0,0
42348,have,0,0
42349,been,0,0
42350,reported,0,0
42351,from,0,0
42352,several,0,0
42353,studies,0,0
42354,totaling,0,1
42355,over,1,0
42356,450,1,1
42357,patients,1,1
42358,.,1,0
42359,This,0,0
42360,hypotension,0,0
42361,may,0,0
42362,complicate,0,0
42363,therapy,0,0
42364,.,0,0
42365,Our,0,0
42366,objective,0,0
42367,was,0,0
42368,to,0,0
42369,determine,0,0
42370,if,0,0
42371,calcium,0,0
42372,chloride,0,0
42373,(,0,0
42374,CaCl,0,0
42375,(,0,0
42376,2,0,0
42377,),0,0
42378,),0,0
42379,pre-treatment,0,0
42380,would,0,0
42381,blunt,0,1
42382,a,0,0
42383,SBP,0,0
42384,drop,0,0
42385,after,0,0
42386,i.v,0,0
42387,.,0,0
42388,diltiazem,0,0
42389,",",0,0
42390,while,0,0
42391,allowing,0,0
42392,diltiazem,0,0
42393,to,0,0
42394,maintain,0,0
42395,its,0,0
42396,efficacy,0,0
42397,.,0,0
42398,A,0,0
42399,prospective,0,0
42400,",",0,0
42401,randomized,0,0
42402,",",0,0
42403,double-blind,0,0
42404,",",0,0
42405,placebo-controlled,0,0
42406,study,0,0
42407,was,0,0
42408,conducted,0,0
42409,.,0,0
42410,Seventy-eight,1,1
42411,patients,1,1
42412,with,1,1
42413,AFF,1,1
42414,and,1,0
42415,a,1,0
42416,ventricular,1,0
42417,rate,1,0
42418,of,1,0
42419,>,1,1
42420,/=,1,1
42421,120,1,1
42422,beats,1,0
42423,per,1,0
42424,minute,1,0
42425,were,1,0
42426,enrolled,1,1
42427,.,1,0
42428,Half,0,0
42429,received,0,0
42430,i.v,0,0
42431,.,0,0
42432,CaCl,0,0
42433,(,0,0
42434,2,0,0
42435,),0,0
42436,pre-treatment,0,0
42437,;,0,0
42438,the,0,0
42439,other,0,0
42440,half,0,0
42441,received,0,0
42442,placebo,0,0
42443,.,0,0
42444,All,0,0
42445,patients,0,1
42446,then,0,0
42447,received,0,0
42448,i.v,0,0
42449,.,0,0
42450,diltiazem,0,0
42451,in,0,0
42452,a,0,0
42453,standard,0,0
42454,",",0,0
42455,weight-based,0,0
42456,dose,0,0
42457,.,0,0
42458,A,0,0
42459,second,0,0
42460,dose,0,0
42461,of,0,0
42462,CaCl,0,0
42463,(,0,0
42464,2,0,0
42465,),0,0
42466,pre-treatment,0,0
42467,or,0,0
42468,placebo,0,0
42469,and,0,0
42470,diltiazem,0,0
42471,was,0,0
42472,given,0,0
42473,if,0,0
42474,clinically,0,0
42475,indicated,0,0
42476,for,0,0
42477,additional,0,0
42478,rate,0,0
42479,control,0,0
42480,.,0,0
42481,Both,0,0
42482,CaCl,0,0
42483,(,0,0
42484,2,0,0
42485,),0,0
42486,and,0,0
42487,placebo,0,0
42488,pre-treatment,0,0
42489,groups,0,0
42490,had,0,1
42491,equal,0,0
42492,lowering,0,0
42493,of,0,0
42494,heart,0,1
42495,rate,0,0
42496,(,0,0
42497,p,0,0
42498,<,0,0
42499,0.001,0,0
42500,),0,0
42501,.,0,0
42502,There,0,0
42503,were,0,0
42504,no,0,0
42505,adverse,0,0
42506,events,0,0
42507,in,0,0
42508,the,0,0
42509,calcium,0,0
42510,pre-treatment,0,0
42511,study,0,0
42512,arm,0,0
42513,.,0,0
42514,One,1,0
42515,patient,1,0
42516,in,1,0
42517,the,1,0
42518,placebo,1,0
42519,group,1,0
42520,became,0,0
42521,paradoxically,0,0
42522,more,0,0
42523,tachycardic,0,0
42524,and,0,0
42525,apneic,0,0
42526,after,0,0
42527,the,0,0
42528,diltiazem,0,0
42529,infusion,0,0
42530,.,0,0
42531,Although,0,0
42532,i.v,0,0
42533,.,0,0
42534,CaCl,0,0
42535,(,0,0
42536,2,0,0
42537,),0,0
42538,seems,0,0
42539,to,0,0
42540,be,0,0
42541,equally,0,0
42542,safe,0,0
42543,compared,0,0
42544,to,0,0
42545,placebo,0,0
42546,as,0,0
42547,a,0,0
42548,pre-treatment,0,0
42549,in,0,0
42550,the,0,0
42551,management,0,0
42552,of,0,0
42553,AFF,0,0
42554,with,0,1
42555,RVR,0,0
42556,",",0,0
42557,we,0,0
42558,were,0,0
42559,unable,0,0
42560,to,0,0
42561,find,0,0
42562,a,0,0
42563,statistically,0,0
42564,significant,0,0
42565,blunting,0,0
42566,of,0,0
42567,SBP,0,0
42568,drop,0,0
42569,with,0,1
42570,CaCl,0,0
42571,(,0,0
42572,2,0,0
42573,),0,0
42574,i.v,0,0
42575,.,0,0
42576,pre-treatment,0,0
42577,.,0,0
42578,Until,0,0
42579,further,0,0
42580,research,0,0
42581,determines,0,0
42582,a,0,0
42583,benefit,0,0
42584,exists,0,0
42585,",",0,0
42586,we,0,0
42587,can,0,0
42588,not,0,0
42589,recommend,0,0
42590,i.v,0,0
42591,.,0,0
42592,CaCl,0,0
42593,(,0,0
42594,2,0,0
42595,),0,0
42596,pre-treatment,0,0
42597,before,0,0
42598,diltiazem,0,0
42599,in,0,0
42600,the,0,0
42601,treatment,0,0
42602,of,0,0
42603,AFF,0,0
42604,with,0,1
42605,RVR,0,0
42606,.,0,1
42607,Gender,0,0
42608,difference,0,0
42609,in,0,0
42610,the,0,0
42611,response,0,0
42612,to,0,0
42613,an,0,0
42614,angiotensin-converting,0,0
42615,enzyme,0,0
42616,inhibitor,0,0
42617,and,0,0
42618,a,0,0
42619,diuretic,0,0
42620,in,0,0
42621,hypertensive,1,1
42622,patients,1,1
42623,of,1,0
42624,African,1,1
42625,descent,1,1
42626,.,1,0
42627,BACKGROUND,0,0
42628,The,0,0
42629,efficacy,0,0
42630,of,0,0
42631,angiotensin-converting,0,0
42632,enzyme,0,0
42633,(,0,0
42634,ACE,0,0
42635,),0,0
42636,inhibitors,0,0
42637,in,0,0
42638,decreasing,0,0
42639,blood,0,0
42640,pressure,0,0
42641,in,0,0
42642,African,1,1
42643,patients,1,1
42644,is,0,0
42645,controversial,0,0
42646,.,0,0
42647,OBJECTIVE,0,0
42648,We,0,0
42649,examined,0,0
42650,the,0,0
42651,ambulatory,0,0
42652,blood,0,0
42653,pressure,0,0
42654,(,0,0
42655,ABP,0,0
42656,),0,0
42657,response,0,0
42658,to,0,0
42659,a,0,0
42660,diuretic,0,0
42661,and,0,0
42662,an,0,0
42663,ACE,0,0
42664,inhibitor,0,0
42665,in,0,0
42666,hypertensive,0,1
42667,patients,1,1
42668,of,1,0
42669,East,1,0
42670,African,1,1
42671,descent,1,1
42672,and,0,0
42673,evaluated,0,0
42674,the,0,0
42675,individual,0,0
42676,characteristics,0,0
42677,that,0,0
42678,determined,0,0
42679,treatment,0,0
42680,efficacy,0,0
42681,.,0,0
42682,DESIGN,0,0
42683,A,0,0
42684,single-blind,0,0
42685,randomized,0,0
42686,AB/BA,0,0
42687,crossover,0,0
42688,design,0,0
42689,.,0,0
42690,SETTING,0,0
42691,Hypertensive,1,1
42692,families,1,1
42693,of,1,0
42694,East,1,0
42695,African,1,1
42696,descent,1,1
42697,from,1,0
42698,the,1,0
42699,general,1,1
42700,population,1,1
42701,in,1,0
42702,the,1,0
42703,Seychelles,1,1
42704,.,1,0
42705,PARTICIPANTS,0,0
42706,Fifty-two,1,1
42707,(,1,0
42708,29,1,1
42709,men,1,1
42710,and,1,0
42711,23,1,1
42712,women,1,1
42713,),1,0
42714,out,1,0
42715,of,1,0
42716,62,1,1
42717,eligible,1,1
42718,hypertensive,1,1
42719,patients,1,1
42720,were,1,0
42721,included.Main,1,1
42722,outcome,0,0
42723,measures,0,0
42724,ABP,0,0
42725,response,0,0
42726,to,0,0
42727,20,0,0
42728,mg,0,0
42729,lisinopril,0,0
42730,(,0,0
42731,LIS,0,0
42732,),0,0
42733,daily,0,0
42734,and,0,0
42735,25,0,0
42736,mg,0,0
42737,hydrochlorothiazide,0,0
42738,(,0,0
42739,HCT,0,0
42740,),0,0
42741,daily,0,0
42742,given,0,0
42743,for,0,0
42744,a,0,0
42745,4-week,0,0
42746,period,0,0
42747,.,0,0
42748,Results,0,0
42749,The,0,0
42750,daytime,0,0
42751,systolic/diastolic,0,0
42752,ABP,0,0
42753,response,0,0
42754,to,0,0
42755,HCT,0,0
42756,was,0,0
42757,4.9,0,0
42758,[,0,0
42759,95,0,0
42760,%,0,0
42761,confidence,0,0
42762,interval,0,0
42763,(,0,0
42764,CI,0,0
42765,),0,0
42766,1.2-8.6,0,0
42767,],0,0
42768,/3.6,0,0
42769,(,0,0
42770,1.0-6.2,0,0
42771,),0,0
42772,mmHg,0,0
42773,for,0,0
42774,men,0,1
42775,and,0,0
42776,12.9,0,0
42777,(,0,0
42778,9.2-16.6,0,0
42779,),0,0
42780,/6.3,0,0
42781,(,0,0
42782,3.7-8.8,0,0
42783,),0,0
42784,mmHg,0,0
42785,for,0,0
42786,women,0,1
42787,.,0,1
42788,With,0,0
42789,LIS,0,0
42790,the,0,0
42791,response,0,0
42792,was,0,0
42793,18.8,0,0
42794,(,0,0
42795,15.0-22.5,0,0
42796,),0,0
42797,/14.6,0,0
42798,(,0,0
42799,12.0-17.1,0,0
42800,),0,0
42801,mmHg,0,0
42802,for,0,0
42803,men,0,1
42804,and,0,0
42805,12.4,0,0
42806,(,0,0
42807,8.7-16.2,0,0
42808,),0,0
42809,/7.7,0,0
42810,(,0,0
42811,5.1-10.2,0,0
42812,),0,0
42813,mmHg,0,0
42814,for,0,0
42815,women,0,1
42816,.,0,0
42817,The,0,0
42818,night-time,0,0
42819,systolic/diastolic,0,0
42820,response,0,0
42821,to,0,0
42822,HCT,0,0
42823,was,0,0
42824,5.0,0,0
42825,(,0,0
42826,0.6-9.4,0,0
42827,),0,0
42828,/2.7,0,0
42829,[,0,0
42830,(,0,0
42831,-0.4,0,0
42832,),0,0
42833,-5.7,0,0
42834,],0,0
42835,mmHg,0,0
42836,for,0,0
42837,men,0,1
42838,and,0,0
42839,11.5,0,0
42840,(,0,0
42841,7.1-16.0,0,0
42842,),0,0
42843,/5.7,0,0
42844,(,0,0
42845,2.6-8.8,0,0
42846,),0,0
42847,mmHg,0,0
42848,for,0,0
42849,women,0,1
42850,",",0,0
42851,and,0,0
42852,to,0,0
42853,LIS,0,0
42854,was,0,0
42855,18.7,0,0
42856,(,0,0
42857,14.2-22.1,0,0
42858,),0,0
42859,/15.4,0,0
42860,(,0,0
42861,12.4-18.5,0,0
42862,),0,0
42863,mmHg,0,0
42864,for,0,0
42865,men,0,1
42866,and,0,0
42867,3.5,0,0
42868,[,0,0
42869,(,0,0
42870,-1.0,0,0
42871,),0,0
42872,-7.9,0,0
42873,],0,0
42874,/2.3,0,0
42875,[,0,0
42876,(,0,0
42877,-0.8,0,0
42878,),0,0
42879,-5.4,0,0
42880,],0,0
42881,mmHg,0,0
42882,for,0,0
42883,women,0,1
42884,.,0,1
42885,Linear,0,0
42886,regression,0,0
42887,analyses,0,0
42888,showed,0,0
42889,that,0,0
42890,gender,0,0
42891,is,0,0
42892,an,0,0
42893,independent,0,0
42894,predictor,0,0
42895,of,0,0
42896,the,0,0
42897,ABP,0,0
42898,responses,0,0
42899,to,0,0
42900,HCT,0,0
42901,and,0,0
42902,to,0,0
42903,LIS,0,0
42904,.,0,0
42905,CONCLUSIONS,0,0
42906,Hypertensive,0,1
42907,patients,0,1
42908,of,0,0
42909,African,0,1
42910,descent,0,1
42911,responded,0,1
42912,better,0,0
42913,to,0,0
42914,LIS,0,0
42915,than,0,0
42916,to,0,0
42917,HCT,0,0
42918,.,0,0
42919,Men,0,0
42920,responded,0,0
42921,better,0,0
42922,to,0,0
42923,LIS,0,0
42924,than,0,0
42925,to,0,0
42926,HCT,0,0
42927,and,0,0
42928,women,0,1
42929,responded,0,1
42930,similarly,0,0
42931,to,0,0
42932,both,0,0
42933,drugs,0,0
42934,.,0,0
42935,Effect,0,0
42936,of,0,0
42937,simvastatin,0,0
42938,and,0,0
42939,fenofibrate,0,0
42940,on,0,0
42941,endothelium,0,0
42942,in,0,0
42943,Type,1,0
42944,2,1,1
42945,diabetes,1,1
42946,.,1,1
42947,Statins,0,0
42948,and,0,0
42949,fibrates,0,0
42950,influence,0,0
42951,endothelial,0,0
42952,activity,0,0
42953,and,0,0
42954,consequently,0,0
42955,atherogenesis,0,0
42956,but,0,0
42957,the,0,0
42958,mechanisms,0,0
42959,are,0,0
42960,not,0,0
42961,well,0,0
42962,understood,0,0
42963,.,0,0
42964,Twenty,1,1
42965,Type,1,0
42966,2,1,0
42967,diabetic,1,1
42968,patients,1,1
42969,with,1,1
42970,dyslipidemia,1,1
42971,were,1,0
42972,treated,1,1
42973,3,0,0
42974,months,0,0
42975,with,0,1
42976,simvastatin,0,0
42977,(,0,0
42978,20,0,0
42979,mg,0,0
42980,daily,0,0
42981,),0,0
42982,and,0,0
42983,then,0,0
42984,3,0,0
42985,months,0,0
42986,with,0,1
42987,fenofibrate,0,0
42988,(,0,0
42989,200,0,0
42990,mg,0,0
42991,daily,0,0
42992,),0,0
42993,with,0,1
42994,2,0,0
42995,months,0,0
42996,of,0,0
42997,wash-out,0,0
42998,between,0,0
42999,the,0,0
43000,two,0,0
43001,treatments,0,0
43002,.,0,1
43003,Laboratory,0,0
43004,parameters,0,0
43005,of,0,0
43006,oxidative,0,0
43007,stress,0,0
43008,",",0,0
43009,fibrinolysis,0,0
43010,and,0,0
43011,endothelial,0,0
43012,function,0,0
43013,were,0,0
43014,evaluated,0,0
43015,before,0,0
43016,and,0,0
43017,at,0,0
43018,the,0,0
43019,end,0,0
43020,of,0,0
43021,each,0,0
43022,treatment,0,0
43023,period,0,0
43024,.,0,0
43025,The,0,0
43026,significant,0,0
43027,decrease,0,0
43028,in,0,0
43029,serum,0,0
43030,total,0,1
43031,and,0,0
43032,LDL-cholesterol,0,0
43033,concentrations,0,0
43034,(,0,0
43035,P,0,0
43036,<,0,0
43037,0.0001,0,0
43038,),0,0
43039,caused,0,0
43040,by,0,0
43041,simvastatin,0,0
43042,was,0,0
43043,associated,0,0
43044,with,0,0
43045,an,0,0
43046,increase,0,0
43047,in,0,0
43048,serum,0,0
43049,N-acetyl-beta-glucosaminidase,0,0
43050,activity,0,0
43051,(,0,0
43052,P,0,0
43053,<,0,0
43054,0.001,0,0
43055,),0,0
43056,",",0,0
43057,ascorbic,0,0
43058,acid,0,0
43059,(,0,0
43060,P,0,0
43061,<,0,0
43062,0.001,0,0
43063,),0,0
43064,",",0,0
43065,plasminogen,0,0
43066,activator,0,0
43067,inhibitor,0,0
43068,(,0,0
43069,PAI-1,0,0
43070,),0,0
43071,(,0,0
43072,P,0,0
43073,<,0,0
43074,0.01,0,0
43075,),0,0
43076,",",0,0
43077,vonWillebrand,0,0
43078,factor,0,0
43079,(,0,0
43080,P,0,0
43081,<,0,0
43082,0.05,0,0
43083,),0,0
43084,",",0,0
43085,E-selectin,0,0
43086,(,0,0
43087,P,0,0
43088,<,0,0
43089,0.01,0,0
43090,),0,0
43091,and,0,0
43092,vascular,0,0
43093,endothelial,0,0
43094,growth,0,0
43095,factor,0,0
43096,(,0,0
43097,P,0,0
43098,<,0,0
43099,0.05,0,0
43100,),0,0
43101,concentrations,0,0
43102,and,0,0
43103,with,0,1
43104,a,0,0
43105,decrease,0,0
43106,in,0,0
43107,plasma,0,0
43108,glutathione,0,0
43109,(,0,0
43110,P,0,0
43111,<,0,0
43112,0.01,0,0
43113,),0,1
43114,levels,0,0
43115,.,0,1
43116,Fenofibrate,0,0
43117,caused,0,0
43118,a,0,0
43119,significant,0,0
43120,decrease,0,0
43121,in,0,0
43122,serum,0,0
43123,triglyceride,0,0
43124,concentration,0,0
43125,(,0,0
43126,P,0,0
43127,<,0,0
43128,0.0001,0,0
43129,),0,0
43130,associated,0,0
43131,with,0,0
43132,a,0,0
43133,decrease,0,0
43134,in,0,0
43135,plasma,0,0
43136,malondialdehyde,0,0
43137,(,0,0
43138,P,0,0
43139,<,0,0
43140,0.001,0,0
43141,),0,0
43142,and,0,0
43143,an,0,0
43144,increase,0,0
43145,in,0,0
43146,plasma,0,0
43147,PAI-1,0,0
43148,(,0,0
43149,P,0,0
43150,<,0,0
43151,0.05,0,0
43152,),0,0
43153,and,0,0
43154,P-selectin,0,0
43155,(,0,0
43156,P,0,0
43157,<,0,0
43158,0.05,0,0
43159,),0,1
43160,concentrations,0,0
43161,.,0,0
43162,We,0,0
43163,conclude,0,0
43164,that,0,0
43165,simvastatin,0,0
43166,and,0,0
43167,fenofibrate,0,0
43168,interact,0,0
43169,",",0,0
43170,by,0,0
43171,different,0,0
43172,mechanisms,0,0
43173,",",0,0
43174,with,0,1
43175,oxidative,0,0
43176,stress,0,0
43177,",",0,0
43178,a,0,0
43179,key,0,0
43180,factor,0,0
43181,in,0,0
43182,the,0,0
43183,modification,0,0
43184,of,0,0
43185,fibrinolysis,0,0
43186,and,0,0
43187,endothelial,0,0
43188,function,0,0
43189,in,0,0
43190,Type,0,0
43191,2,0,1
43192,diabetes,0,1
43193,.,0,1
43194,Chronic,0,1
43195,fatigue,0,0
43196,syndrome,0,1
43197,versus,0,0
43198,neuroendocrineimmune,0,1
43199,dysfunction,0,1
43200,syndrome,0,1
43201,:,0,1
43202,differential,0,0
43203,attributions,0,0
43204,.,0,1
43205,Since,0,0
43206,1988,0,1
43207,",",0,0
43208,when,0,0
43209,the,0,0
43210,term,0,0
43211,chronic,0,1
43212,fatigue,0,0
43213,syndrome,0,1
43214,(,0,0
43215,CFS,0,0
43216,),0,0
43217,was,0,0
43218,coined,0,0
43219,",",0,0
43220,considerable,0,0
43221,discussion,0,0
43222,has,0,0
43223,occurred,0,0
43224,about,0,0
43225,stigma,0,0
43226,associated,0,0
43227,with,0,0
43228,this,0,0
43229,diagnostic,0,0
43230,term,0,0
43231,.,0,0
43232,In,0,0
43233,particular,0,0
43234,",",0,0
43235,patients,1,1
43236,with,1,1
43237,CFS,1,0
43238,have,0,0
43239,felt,0,0
43240,that,0,0
43241,this,0,0
43242,term,0,0
43243,trivializes,0,0
43244,the,0,0
43245,serious,0,0
43246,nature,0,0
43247,of,0,0
43248,this,0,0
43249,disorder,0,1
43250,.,0,0
43251,A,0,0
43252,Name,0,0
43253,Change,0,0
43254,Work,0,0
43255,group,0,0
43256,",",0,0
43257,appointed,0,0
43258,by,0,0
43259,the,0,0
43260,CFS,0,0
43261,Coordinating,0,0
43262,Committee,0,1
43263,",",0,0
43264,developed,0,0
43265,an,0,0
43266,umbrella,0,0
43267,term,0,0
43268,:,0,1
43269,chronic,0,1
43270,neuroendocrineimmune,0,1
43271,dysfunction,0,0
43272,syndrome,0,1
43273,(,0,0
43274,CNDS,0,0
43275,),0,0
43276,",",0,0
43277,and,0,0
43278,proposed,0,0
43279,that,0,0
43280,there,0,0
43281,would,0,0
43282,be,0,0
43283,sub-types,0,0
43284,under,0,0
43285,this,0,0
43286,term,0,0
43287,",",0,0
43288,one,0,0
43289,being,0,0
43290,CFS,0,0
43291,.,0,0
43292,The,0,0
43293,present,0,0
43294,study,0,0
43295,examined,0,0
43296,attributions,0,0
43297,of,0,0
43298,this,0,0
43299,new,0,0
43300,umbrella,0,0
43301,term,0,0
43302,when,0,0
43303,compared,0,0
43304,with,0,0
43305,CFS,0,0
43306,.,0,0
43307,Nurses,0,0
43308,and,0,0
43309,physician,0,1
43310,assistants,0,1
43311,(,0,0
43312,PAs,0,1
43313,),0,0
43314,were,0,0
43315,presented,0,0
43316,a,0,0
43317,case,0,0
43318,study,0,0
43319,of,0,0
43320,a,0,0
43321,patient,1,0
43322,with,1,0
43323,symptoms,1,0
43324,of,1,0
43325,CFS,1,0
43326,.,1,0
43327,They,0,0
43328,were,0,0
43329,told,0,0
43330,that,0,0
43331,the,0,0
43332,patient,1,0
43333,had,1,0
43334,either,1,0
43335,chronic,1,1
43336,fatigue,1,0
43337,syndrome,1,1
43338,",",1,0
43339,chronic,1,1
43340,neuroendocrineimmune,1,1
43341,dysfunction,1,0
43342,syndrome,1,1
43343,",",1,0
43344,or,1,0
43345,chronic,1,1
43346,neuroendocrineimmune,1,1
43347,dysfunction,1,0
43348,syndrome,1,1
43349,",",0,0
43350,which,0,0
43351,had,0,0
43352,formerly,0,0
43353,been,0,0
43354,called,0,0
43355,chronic,0,1
43356,fatigue,0,0
43357,syndrome,0,1
43358,.,0,0
43359,The,0,0
43360,different,0,0
43361,terms,0,0
43362,led,0,0
43363,to,0,0
43364,different,0,0
43365,attributions,0,0
43366,",",0,0
43367,with,0,1
43368,PA,0,0
43369,respondents,0,1
43370,rating,0,0
43371,the,0,0
43372,CNDS,0,0
43373,label,0,0
43374,as,0,0
43375,more,0,0
43376,severe,0,0
43377,.,0,0
43378,Results,0,0
43379,suggest,0,0
43380,that,0,0
43381,a,0,0
43382,more,0,0
43383,medical,0,0
43384,sounding,0,0
43385,term,0,0
43386,(,0,0
43387,CNDS,0,0
43388,),0,0
43389,may,0,0
43390,lead,0,0
43391,to,0,0
43392,attributions,0,0
43393,that,0,0
43394,this,0,0
43395,syndrome,0,1
43396,is,0,0
43397,a,0,0
43398,more,0,0
43399,serious,0,0
43400,",",0,0
43401,disabling,0,0
43402,illness,0,1
43403,.,0,0
43404,The,0,0
43405,policy,0,0
43406,implications,0,0
43407,of,0,0
43408,these,0,0
43409,findings,0,0
43410,are,0,0
43411,discussed,0,0
43412,.,0,0
43413,An,0,0
43414,open,0,0
43415,and,0,0
43416,randomized,0,0
43417,study,0,0
43418,comparing,0,0
43419,the,0,0
43420,efficacy,0,0
43421,of,0,0
43422,standard,0,0
43423,danazol,0,0
43424,and,0,0
43425,modified,0,0
43426,triptorelin,0,0
43427,regimens,0,0
43428,for,0,0
43429,postoperative,1,0
43430,disease,1,1
43431,management,1,0
43432,of,1,0
43433,moderate,1,1
43434,to,1,0
43435,severe,1,1
43436,endometriosis,1,1
43437,.,1,0
43438,OBJECTIVE,0,0
43439,To,0,0
43440,compare,0,0
43441,the,0,0
43442,efficacy,0,0
43443,of,0,0
43444,danazol,0,0
43445,and,0,0
43446,triptorelin,0,0
43447,(,0,0
43448,Decapeptyl,0,0
43449,CR,0,0
43450,",",0,0
43451,Ferring,0,0
43452,",",0,0
43453,Kiel,0,0
43454,",",0,0
43455,Germany,0,0
43456,),0,0
43457,in,0,0
43458,the,0,0
43459,management,0,0
43460,of,0,0
43461,moderate,0,1
43462,and,0,0
43463,severe,0,1
43464,endometriosis,0,1
43465,in,0,0
43466,terms,0,0
43467,of,0,0
43468,symptom,0,0
43469,control,0,0
43470,and,0,0
43471,revised,0,0
43472,American,0,1
43473,Fertility,0,1
43474,Society,0,1
43475,(,0,0
43476,AFS,0,0
43477,),0,0
43478,score,0,0
43479,reduction,0,0
43480,",",0,0
43481,and,0,0
43482,to,0,0
43483,evaluate,0,0
43484,the,0,0
43485,hormonal,0,0
43486,profile,0,0
43487,of,0,0
43488,patients,1,1
43489,treated,1,1
43490,with,1,1
43491,triptorelin,1,0
43492,every,1,0
43493,6,1,0
43494,weeks,1,0
43495,.,1,1
43496,DESIGN,0,0
43497,Open,0,0
43498,and,0,0
43499,randomized,0,0
43500,trial,0,0
43501,.,0,0
43502,SETTING,0,0
43503,Kwong,1,1
43504,Wah,1,0
43505,Hospital,1,1
43506,",",1,0
43507,a,1,0
43508,large,1,0
43509,public,1,1
43510,hospital,1,1
43511,in,1,0
43512,an,1,0
43513,urban,1,1
43514,location,1,0
43515,(,1,0
43516,Hong,1,1
43517,Kong,1,1
43518,),1,0
43519,.,1,0
43520,PATIENT,0,0
43521,(,0,0
43522,S,0,0
43523,),0,0
43524,Forty,1,1
43525,patients,1,1
43526,after,1,0
43527,their,1,1
43528,first,1,0
43529,conservative,1,0
43530,operation,1,0
43531,for,1,0
43532,endometriosis,1,1
43533,",",1,0
43534,with,1,0
43535,surgical,1,0
43536,confirmation,1,0
43537,of,1,0
43538,revised,1,0
43539,AFS,1,0
43540,stage,1,1
43541,III,1,0
43542,or,1,0
43543,IV,1,0
43544,endometriosis,1,1
43545,.,1,0
43546,INTERVENTION,0,0
43547,(,0,0
43548,S,0,0
43549,),0,0
43550,Postoperative,0,0
43551,6,0,0
43552,months,0,0
43553,',0,1
43554,therapy,0,0
43555,of,0,0
43556,danazol,0,0
43557,or,0,0
43558,triptorelin,0,0
43559,every,0,0
43560,6,0,0
43561,weeks,0,0
43562,",",0,0
43563,postmedical,0,1
43564,therapy,0,0
43565,second-look,0,1
43566,laparoscopy,0,1
43567,.,0,0
43568,MAIN,0,0
43569,OUTCOME,0,0
43570,MEASURE,0,0
43571,(,0,0
43572,S,0,0
43573,),0,0
43574,Symptom,0,0
43575,control,0,0
43576,and,0,0
43577,patients,0,1
43578,',0,0
43579,tolerance,0,0
43580,during,0,0
43581,medical,0,0
43582,therapy,0,0
43583,",",0,0
43584,posttherapy,0,0
43585,revised,0,0
43586,AFS,0,0
43587,score,0,0
43588,",",0,0
43589,hormonal,0,0
43590,profile,0,0
43591,during,0,0
43592,triptorelin,0,0
43593,therapy,0,0
43594,.,0,0
43595,RESULT,0,0
43596,(,0,0
43597,S,0,0
43598,),0,0
43599,Pain,0,0
43600,control,0,0
43601,was,0,0
43602,similar,0,0
43603,between,0,0
43604,danazol,0,0
43605,and,0,0
43606,triptorelin,0,0
43607,therapy,0,0
43608,.,0,0
43609,There,0,0
43610,was,0,0
43611,less,0,0
43612,breakthrough,0,0
43613,bleeding,0,0
43614,with,0,1
43615,triptorelin,0,0
43616,.,0,0
43617,More,0,0
43618,patients,0,1
43619,failed,0,0
43620,to,0,0
43621,complete,0,0
43622,the,0,0
43623,whole,0,0
43624,course,0,0
43625,of,0,0
43626,danazol,0,0
43627,because,0,0
43628,of,0,0
43629,its,0,0
43630,side,0,0
43631,effects,0,0
43632,.,0,0
43633,The,0,0
43634,revised,0,0
43635,AFS,0,0
43636,score,0,0
43637,at,0,0
43638,second-look,0,0
43639,laparoscopy,0,1
43640,did,0,0
43641,not,0,0
43642,show,0,0
43643,a,0,0
43644,significant,0,0
43645,difference,0,0
43646,between,0,0
43647,the,0,0
43648,two,0,0
43649,medications,0,0
43650,.,0,1
43651,Adequate,0,0
43652,pituitary,0,0
43653,suppression,0,0
43654,was,0,0
43655,observed,0,0
43656,with,0,0
43657,injection,0,0
43658,of,0,0
43659,triptorelin,0,0
43660,every,0,0
43661,6,0,0
43662,weeks,0,0
43663,.,0,1
43664,CONCLUSION,0,0
43665,(,0,0
43666,S,0,0
43667,),0,0
43668,Lengthening,0,0
43669,of,0,0
43670,triptorelin,0,0
43671,administration,0,0
43672,intervals,0,0
43673,from,0,1
43674,4,0,0
43675,weeks,0,0
43676,to,0,1
43677,6,0,0
43678,weeks,0,0
43679,is,0,0
43680,effective,0,0
43681,in,0,0
43682,maintaining,0,0
43683,a,0,0
43684,hypoestrogenic,0,1
43685,state,0,0
43686,.,0,1
43687,Patients,0,0
43688,were,0,0
43689,more,0,0
43690,compliant,0,0
43691,with,0,0
43692,triptorelin,0,0
43693,than,0,0
43694,danazol,0,0
43695,.,0,0
43696,Thus,0,0
43697,",",0,0
43698,triptorelin,0,0
43699,injection,0,0
43700,every,0,0
43701,6,0,0
43702,weeks,0,0
43703,is,0,0
43704,more,0,0
43705,cost-effective,0,0
43706,than,0,0
43707,conventional,0,0
43708,regimens,0,0
43709,.,0,1
43710,Patterning,0,0
43711,of,0,0
43712,pain,0,0
43713,and,0,0
43714,power,0,0
43715,with,0,1
43716,guided,0,0
43717,imagery,0,0
43718,.,0,0
43719,Using,0,0
43720,Martha,0,1
43721,Rogers,0,1
43722,',0,0
43723,science,0,0
43724,of,0,0
43725,unitary,0,0
43726,human,0,0
43727,beings,0,0
43728,",",0,0
43729,changes,0,0
43730,in,0,0
43731,pain,0,0
43732,and,0,0
43733,power,0,0
43734,among,0,0
43735,42,1,1
43736,patients,1,1
43737,were,0,0
43738,examined,0,0
43739,in,0,0
43740,relation,0,0
43741,to,0,0
43742,the,0,0
43743,use,0,0
43744,of,0,0
43745,a,0,0
43746,guided,0,0
43747,imagery,0,0
43748,modality,0,0
43749,.,0,0
43750,Participants,1,1
43751,were,1,0
43752,randomly,1,1
43753,assigned,1,0
43754,to,1,0
43755,treatment,1,0
43756,and,0,0
43757,control,0,0
43758,groups,0,0
43759,and,0,0
43760,repeated,0,0
43761,measures,0,0
43762,MANCOVA,0,0
43763,was,0,0
43764,used,0,0
43765,to,0,0
43766,detect,0,0
43767,differences,0,0
43768,in,0,0
43769,pain,0,0
43770,and,0,0
43771,power,0,0
43772,over,0,0
43773,a,0,0
43774,4-day,0,0
43775,period,0,0
43776,of,0,0
43777,time,0,0
43778,.,0,0
43779,The,0,0
43780,treatment,0,0
43781,group,0,0
43782,'s,0,0
43783,pain,0,0
43784,decreased,0,0
43785,during,0,0
43786,the,0,0
43787,last,0,0
43788,2,0,0
43789,days,0,0
43790,of,0,0
43791,the,0,0
43792,study,0,0
43793,.,0,0
43794,No,0,0
43795,differences,0,0
43796,in,0,0
43797,power,0,0
43798,emerged,0,0
43799,.,0,0
43800,Guided,0,0
43801,imagery,0,0
43802,appeared,0,0
43803,to,0,0
43804,have,0,0
43805,potential,0,0
43806,as,0,0
43807,a,0,0
43808,useful,0,0
43809,nursing,1,1
43810,modality,1,0
43811,for,1,0
43812,chronic,1,1
43813,pain,1,1
43814,sufferers,1,1
43815,.,1,1
43816,Chemotherapy,0,0
43817,for,0,0
43818,patients,1,1
43819,with,1,1
43820,non-small,1,1
43821,cell,1,1
43822,lung,1,1
43823,cancer,1,1
43824,:,1,0
43825,the,0,0
43826,surgical,0,0
43827,setting,0,0
43828,of,0,0
43829,the,0,0
43830,Big,0,0
43831,Lung,0,0
43832,Trial,0,0
43833,.,0,0
43834,OBJECTIVES,0,0
43835,The,0,0
43836,non-small,1,0
43837,cell,1,0
43838,lung,1,1
43839,cancer,1,1
43840,(,1,0
43841,NSCLC,1,0
43842,),1,0
43843,meta-analysis,0,0
43844,suggested,0,0
43845,a,0,0
43846,survival,0,0
43847,benefit,0,0
43848,for,0,0
43849,cisplatin-based,0,0
43850,chemotherapy,0,0
43851,when,0,0
43852,given,0,0
43853,in,0,0
43854,addition,0,0
43855,to,0,0
43856,surgery,0,1
43857,",",0,0
43858,radical,0,0
43859,radiotherapy,0,0
43860,or,0,0
43861,'best,0,0
43862,supportive,0,0
43863,care,0,0
43864,',0,0
43865,.,0,0
43866,However,0,0
43867,",",0,0
43868,it,0,0
43869,included,0,1
43870,many,0,0
43871,small,0,0
43872,trials,0,0
43873,and,0,0
43874,trials,0,0
43875,with,0,1
43876,differing,0,0
43877,eligibility,0,1
43878,criteria,0,1
43879,and,0,0
43880,chemotherapy,0,1
43881,regimens,0,0
43882,.,0,0
43883,The,0,0
43884,aim,0,0
43885,of,0,0
43886,the,0,0
43887,Big,0,0
43888,Lung,0,0
43889,Trial,0,0
43890,was,0,0
43891,therefore,0,0
43892,to,0,0
43893,run,0,0
43894,a,0,0
43895,large,0,0
43896,pragmatic,0,0
43897,trial,0,0
43898,to,0,0
43899,confirm,0,0
43900,the,0,0
43901,survival,0,0
43902,benefits,0,0
43903,seen,0,0
43904,in,0,0
43905,the,0,0
43906,meta-analysis,0,0
43907,.,0,0
43908,METHODS,0,0
43909,In,0,0
43910,the,0,0
43911,surgery,0,0
43912,setting,0,0
43913,",",0,0
43914,a,0,0
43915,total,0,0
43916,of,0,0
43917,381,1,1
43918,patients,1,1
43919,were,1,0
43920,randomised,1,0
43921,to,1,0
43922,chemotherapy,1,0
43923,(,1,0
43924,C,1,0
43925,",",1,0
43926,192,1,1
43927,patients,1,1
43928,),1,0
43929,or,1,0
43930,no,1,0
43931,chemotherapy,1,0
43932,(,1,0
43933,NoC,1,0
43934,",",1,0
43935,189,1,1
43936,patients,1,1
43937,),1,1
43938,.,1,1
43939,C,0,0
43940,was,0,0
43941,three,0,0
43942,3-weekly,0,0
43943,cycles,0,0
43944,of,0,0
43945,cisplatin/vindesine,0,0
43946,",",0,0
43947,mitomycin/ifosfamide/cisplatin,0,0
43948,",",0,0
43949,mitomycin/vinblastine/cisplatin,0,0
43950,or,0,0
43951,vinorelbine/cisplatin,0,0
43952,.,0,0
43953,RESULTS,0,0
43954,Chemotherapy,0,0
43955,was,0,0
43956,given,0,0
43957,before,0,0
43958,surgery,0,1
43959,in,0,0
43960,3,0,0
43961,%,0,0
43962,of,0,0
43963,patients,0,1
43964,whilst,0,0
43965,97,0,1
43966,%,0,0
43967,received,0,0
43968,adjuvant,0,0
43969,chemotherapy,0,0
43970,.,0,0
43971,Baseline,0,0
43972,characteristics,0,0
43973,were,0,0
43974,:,0,1
43975,median,0,0
43976,age,0,1
43977,61,0,1
43978,years,0,1
43979,",",0,0
43980,69,0,1
43981,%,0,0
43982,male,0,1
43983,",",0,0
43984,48,0,0
43985,%,0,0
43986,squamous,0,1
43987,cell,0,0
43988,",",0,0
43989,93,0,0
43990,%,0,0
43991,WHO,0,0
43992,PS,0,1
43993,0-1,0,0
43994,",",0,0
43995,27,0,0
43996,%,0,0
43997,stage,0,1
43998,I,0,0
43999,",",0,0
44000,38,0,0
44001,%,0,0
44002,stage,0,1
44003,II,0,0
44004,",",0,0
44005,and,0,0
44006,34,0,0
44007,%,0,0
44008,stage,0,1
44009,III,0,0
44010,.,0,0
44011,Complete,0,0
44012,resection,0,0
44013,was,0,0
44014,achieved,0,0
44015,in,0,0
44016,approximately,0,0
44017,95,0,0
44018,%,0,0
44019,of,0,0
44020,patients,0,1
44021,.,0,0
44022,In,0,0
44023,the,0,0
44024,C,0,0
44025,group,0,0
44026,",",0,0
44027,13,0,0
44028,%,0,0
44029,received,0,0
44030,no,0,0
44031,chemotherapy,0,0
44032,",",0,0
44033,21,0,1
44034,%,0,0
44035,one,0,0
44036,or,0,1
44037,two,0,0
44038,cycles,0,0
44039,",",0,0
44040,and,0,0
44041,64,0,0
44042,%,0,0
44043,all,0,0
44044,three,0,0
44045,cycles,0,0
44046,of,0,0
44047,their,0,1
44048,prescribed,0,0
44049,chemotherapy,0,0
44050,(,0,0
44051,60,0,0
44052,%,0,0
44053,of,0,0
44054,the,0,0
44055,latter,0,0
44056,with,0,0
44057,no,0,0
44058,delays,0,0
44059,or,0,0
44060,modification,0,0
44061,),0,0
44062,.,0,0
44063,30,0,0
44064,%,0,0
44065,had,0,0
44066,grade,0,0
44067,3/4,0,0
44068,toxicity,0,0
44069,",",0,0
44070,mainly,0,0
44071,haematological,0,0
44072,",",0,0
44073,nausea/vomiting,0,0
44074,and,0,0
44075,neutropenic,0,1
44076,fever,0,0
44077,",",0,0
44078,and,0,0
44079,six,0,0
44080,patients,0,1
44081,were,0,0
44082,reported,0,0
44083,as,0,0
44084,having,0,1
44085,a,0,0
44086,treatment-related,0,0
44087,death,0,0
44088,.,0,0
44089,198,0,0
44090,(,0,0
44091,52,0,1
44092,%,0,0
44093,),0,0
44094,of,0,0
44095,patients,0,1
44096,have,0,0
44097,died,0,1
44098,",",0,0
44099,but,0,0
44100,there,0,0
44101,is,0,0
44102,currently,0,0
44103,no,0,0
44104,evidence,0,0
44105,of,0,0
44106,a,0,0
44107,benefit,0,0
44108,in,0,0
44109,overall,0,0
44110,survival,0,0
44111,to,0,0
44112,the,0,0
44113,C,0,0
44114,group,0,0
44115,:,0,1
44116,HR,0,0
44117,1.02,0,0
44118,(,0,0
44119,95,0,0
44120,%,0,0
44121,CI,0,0
44122,0.77-1.35,0,0
44123,),0,0
44124,",",0,0
44125,P,0,0
44126,=,0,0
44127,0.90,0,0
44128,),0,0
44129,.,0,0
44130,CONCLUSIONS,0,0
44131,This,0,0
44132,trial,0,0
44133,has,0,0
44134,failed,0,0
44135,to,0,0
44136,observe,0,0
44137,a,0,0
44138,survival,0,0
44139,benefit,0,0
44140,with,0,1
44141,adjuvant,0,0
44142,chemotherapy,0,0
44143,following,0,0
44144,complete,0,0
44145,resection,0,1
44146,of,0,0
44147,stage,0,1
44148,I-III,0,0
44149,NSCLC,0,0
44150,.,0,0
44151,However,0,0
44152,",",0,0
44153,the,0,0
44154,hazard,0,0
44155,ratio,0,0
44156,and,0,0
44157,95,0,0
44158,%,0,0
44159,confidence,0,0
44160,intervals,0,0
44161,are,0,0
44162,consistent,0,0
44163,with,0,0
44164,the,0,0
44165,previously,0,0
44166,reported,0,0
44167,meta-analysis,0,0
44168,and,0,0
44169,two,0,0
44170,large,0,0
44171,recently,0,1
44172,reported,0,0
44173,trials,0,0
44174,",",0,0
44175,which,0,0
44176,suggest,0,0
44177,a,0,0
44178,small,0,0
44179,survival,0,0
44180,benefit,0,0
44181,with,0,1
44182,cisplatin-based,0,0
44183,chemotherapy,0,1
44184,.,0,0
44185,Untreated,1,0
44186,silicone,1,0
44187,breast,1,1
44188,implant,1,0
44189,rupture,1,0
44190,.,1,0
44191,Implant,0,0
44192,rupture,0,0
44193,is,0,0
44194,a,0,0
44195,well-known,0,0
44196,complication,0,0
44197,of,0,0
44198,breast,0,1
44199,implant,0,0
44200,surgery,0,0
44201,that,0,0
44202,can,0,0
44203,pass,0,0
44204,unnoticed,0,0
44205,by,0,0
44206,both,0,0
44207,patient,0,0
44208,and,0,0
44209,physician,0,0
44210,.,0,0
44211,To,0,0
44212,date,0,0
44213,",",0,0
44214,no,0,0
44215,prospective,0,0
44216,study,0,0
44217,has,0,0
44218,addressed,0,0
44219,the,0,0
44220,possible,0,0
44221,health,0,0
44222,implications,0,0
44223,of,0,0
44224,silicone,0,1
44225,breast,0,1
44226,implant,0,0
44227,rupture,0,0
44228,.,0,0
44229,The,0,0
44230,aim,0,0
44231,of,0,0
44232,the,0,0
44233,present,0,0
44234,study,0,0
44235,was,0,0
44236,to,0,0
44237,evaluate,0,0
44238,whether,0,0
44239,untreated,0,1
44240,ruptures,0,1
44241,are,0,0
44242,associated,0,0
44243,with,0,1
44244,changes,0,0
44245,over,0,0
44246,time,0,0
44247,in,0,0
44248,magnetic,0,0
44249,resonance,0,0
44250,imaging,0,0
44251,findings,0,0
44252,",",0,0
44253,serologic,0,0
44254,markers,0,0
44255,",",0,0
44256,or,0,0
44257,self-reported,0,0
44258,breast,0,1
44259,symptoms,0,0
44260,.,0,0
44261,A,0,0
44262,baseline,0,0
44263,magnetic,0,0
44264,resonance,0,0
44265,imaging,0,0
44266,examination,0,0
44267,was,0,0
44268,performed,0,0
44269,in,0,0
44270,1999,0,1
44271,on,0,0
44272,271,1,1
44273,women,1,1
44274,who,1,1
44275,were,1,1
44276,randomly,1,1
44277,chosen,1,0
44278,from,1,0
44279,a,1,0
44280,larger,1,0
44281,cohort,1,1
44282,of,1,0
44283,women,1,1
44284,having,1,1
44285,cosmetic,1,0
44286,breast,1,1
44287,implants,1,0
44288,for,1,0
44289,a,1,0
44290,median,1,0
44291,period,1,0
44292,of,1,0
44293,12,1,0
44294,years,1,1
44295,(,1,0
44296,range,1,0
44297,",",1,0
44298,3,1,0
44299,to,1,0
44300,25,1,0
44301,years,1,1
44302,),1,0
44303,.,1,0
44304,A,0,0
44305,follow-up,0,0
44306,magnetic,0,0
44307,resonance,0,0
44308,imaging,0,0
44309,examination,0,0
44310,was,0,0
44311,carried,0,0
44312,out,0,0
44313,in,0,0
44314,2001,0,1
44315,",",0,0
44316,excluding,0,1
44317,women,0,1
44318,who,0,1
44319,underwent,0,1
44320,explantation,0,1
44321,in,0,0
44322,the,0,0
44323,period,0,0
44324,between,0,0
44325,the,0,0
44326,two,0,0
44327,magnetic,0,0
44328,resonance,0,0
44329,imaging,0,0
44330,examinations,0,0
44331,(,0,0
44332,n,0,1
44333,=,0,0
44334,44,0,1
44335,),0,0
44336,.,0,0
44337,On,0,0
44338,the,0,0
44339,basis,0,0
44340,of,0,0
44341,these,0,0
44342,examinations,0,0
44343,",",0,0
44344,the,0,0
44345,authors,0,0
44346,identified,0,0
44347,64,1,1
44348,women,1,1
44349,who,1,1
44350,had,1,1
44351,at,1,1
44352,least,1,0
44353,one,1,0
44354,ruptured,1,1
44355,implant,1,0
44356,at,1,0
44357,the,1,0
44358,first,1,0
44359,magnetic,1,0
44360,resonance,1,0
44361,imaging,1,0
44362,examination,1,0
44363,and,0,0
44364,",",0,0
44365,for,0,0
44366,comparison,0,0
44367,",",0,0
44368,all,0,0
44369,women,0,1
44370,who,0,1
44371,had,0,1
44372,intact,0,1
44373,implants,0,0
44374,at,0,0
44375,both,0,0
44376,examinations,0,0
44377,(,0,0
44378,n,0,1
44379,=,0,0
44380,98,0,1
44381,),0,0
44382,.,0,0
44383,Magnetic,0,0
44384,resonance,0,0
44385,images,0,0
44386,from,0,0
44387,the,0,0
44388,two,0,0
44389,examinations,0,0
44390,were,0,0
44391,compared,0,0
44392,and,0,0
44393,changes,0,0
44394,in,0,0
44395,rupture,0,1
44396,configuration,0,0
44397,were,0,0
44398,evaluated,0,0
44399,.,0,0
44400,Comparisons,0,0
44401,were,0,0
44402,also,0,0
44403,made,0,0
44404,for,0,0
44405,self-reported,0,0
44406,breast,0,1
44407,symptoms,0,0
44408,occurring,0,1
44409,during,0,0
44410,the,0,0
44411,study,0,0
44412,period,0,0
44413,and,0,0
44414,for,0,0
44415,changes,0,0
44416,in,0,0
44417,serum,0,0
44418,values,0,0
44419,of,0,0
44420,antinuclear,0,1
44421,antibodies,0,0
44422,",",0,0
44423,rheumatoid,0,1
44424,factor,0,0
44425,",",0,0
44426,and,0,0
44427,cardiolipin,0,0
44428,antibodies,0,0
44429,immunoglobulin,0,0
44430,G,0,0
44431,and,0,0
44432,immunoglobulin,0,0
44433,M.,0,1
44434,The,0,0
44435,majority,0,0
44436,of,0,0
44437,the,0,0
44438,women,0,1
44439,with,0,1
44440,implant,0,0
44441,rupture,0,0
44442,had,0,0
44443,no,0,0
44444,visible,0,0
44445,magnetic,0,0
44446,resonance,0,0
44447,imaging,0,0
44448,changes,0,0
44449,of,0,0
44450,their,0,1
44451,ruptured,0,1
44452,implants,0,0
44453,.,0,1
44454,For,0,0
44455,11,0,0
44456,implants,0,1
44457,(,0,0
44458,11,0,1
44459,percent,0,0
44460,),0,0
44461,in,0,0
44462,10,0,0
44463,women,0,1
44464,",",0,0
44465,the,0,0
44466,authors,0,0
44467,observed,0,0
44468,progression,0,0
44469,of,0,0
44470,silicone,0,0
44471,seepage,0,0
44472,",",0,0
44473,either,0,0
44474,as,0,0
44475,a,0,0
44476,conversion,0,0
44477,from,0,0
44478,intracapsular,0,1
44479,into,0,1
44480,extracapsular,0,1
44481,rupture,0,0
44482,(,0,0
44483,n,0,1
44484,=,0,0
44485,7,0,0
44486,),0,0
44487,",",0,0
44488,as,0,0
44489,progression,0,0
44490,of,0,0
44491,extra-capsular,0,0
44492,silicone,0,1
44493,(,0,0
44494,n,0,1
44495,=,0,0
44496,3,0,0
44497,),0,0
44498,",",0,0
44499,or,0,0
44500,as,0,0
44501,increasing,0,0
44502,herniation,0,0
44503,of,0,0
44504,the,0,0
44505,silicone,0,0
44506,within,0,0
44507,the,0,0
44508,fibrous,0,0
44509,capsule,0,0
44510,(,0,0
44511,n,0,1
44512,=,0,0
44513,1,0,1
44514,),0,0
44515,;,0,0
44516,however,0,0
44517,",",0,0
44518,in,0,0
44519,most,0,0
44520,cases,0,0
44521,",",0,0
44522,these,0,0
44523,changes,0,0
44524,were,0,0
44525,minor,0,0
44526,.,0,0
44527,Some,0,0
44528,changes,0,0
44529,could,0,0
44530,be,0,0
44531,ascribed,0,0
44532,to,0,0
44533,trauma,0,1
44534,",",0,0
44535,but,0,0
44536,others,0,0
44537,seemed,0,0
44538,spontaneous,0,0
44539,.,0,0
44540,There,0,0
44541,was,0,0
44542,no,0,0
44543,increase,0,0
44544,in,0,0
44545,levels,0,0
44546,of,0,0
44547,autoantibodies,0,0
44548,during,0,0
44549,the,0,0
44550,study,0,0
44551,period,0,0
44552,in,0,0
44553,either,0,0
44554,study,0,0
44555,group,0,0
44556,.,0,0
44557,Women,0,0
44558,with,0,1
44559,untreated,0,1
44560,implant,0,1
44561,ruptures,0,1
44562,reported,0,0
44563,a,0,0
44564,significant,0,0
44565,increase,0,0
44566,in,0,0
44567,nonspecific,0,0
44568,breast,0,1
44569,changes,0,0
44570,(,0,0
44571,odds,0,0
44572,ratio,0,0
44573,",",0,0
44574,2.1,0,0
44575,;,0,0
44576,95,0,0
44577,percent,0,0
44578,confidence,0,0
44579,interval,0,0
44580,",",0,0
44581,1.2,0,0
44582,to,0,0
44583,3.8,0,0
44584,),0,0
44585,compared,0,0
44586,with,0,1
44587,women,0,1
44588,without,0,1
44589,ruptures,0,1
44590,.,0,0
44591,On,0,0
44592,the,0,0
44593,basis,0,0
44594,of,0,0
44595,this,0,0
44596,first,0,0
44597,study,0,0
44598,of,0,0
44599,women,0,1
44600,with,0,1
44601,untreated,0,1
44602,silicone,0,1
44603,breast,0,1
44604,implant,0,0
44605,rupture,0,0
44606,",",0,0
44607,the,0,0
44608,authors,0,0
44609,conclude,0,0
44610,that,0,0
44611,implant,0,0
44612,rupture,0,0
44613,is,0,0
44614,a,0,0
44615,relatively,0,0
44616,harmless,0,0
44617,condition,0,0
44618,",",0,0
44619,which,0,0
44620,only,0,0
44621,rarely,0,0
44622,progresses,0,0
44623,and,0,0
44624,gives,0,0
44625,rise,0,0
44626,to,0,0
44627,notable,0,0
44628,symptoms,0,0
44629,.,0,0
44630,Even,0,0
44631,so,0,0
44632,",",0,0
44633,because,0,0
44634,of,0,0
44635,a,0,0
44636,small,0,0
44637,risk,0,0
44638,of,0,0
44639,silicone,0,0
44640,spread,0,0
44641,",",0,0
44642,the,0,0
44643,authors,0,0
44644,suggest,0,0
44645,that,0,0
44646,women,0,1
44647,with,0,1
44648,implant,0,1
44649,ruptures,0,1
44650,be,0,0
44651,followed,0,0
44652,clinically,0,0
44653,",",0,0
44654,if,0,0
44655,not,0,0
44656,operated,0,1
44657,on,0,0
44658,.,0,0
44659,Because,0,0
44660,implant,0,0
44661,ruptures,0,1
44662,often,0,0
44663,occur,0,0
44664,asymptomatically,0,0
44665,",",0,0
44666,any,0,0
44667,woman,0,1
44668,with,0,0
44669,silicone,0,0
44670,implants,0,0
44671,",",0,0
44672,regardless,0,0
44673,of,0,0
44674,rupture,0,0
44675,status,0,0
44676,",",0,0
44677,should,0,0
44678,be,0,0
44679,evaluated,0,0
44680,at,0,0
44681,regular,0,0
44682,intervals,0,0
44683,.,0,1
44684,Public,0,1
44685,and,0,0
44686,private,0,1
44687,heart,0,1
44688,rate,0,0
44689,feedback,0,0
44690,in,0,0
44691,social,1,0
44692,phobia,1,0
44693,:,1,1
44694,a,0,0
44695,manipulation,0,0
44696,of,0,0
44697,anxiety,0,0
44698,visibility,0,0
44699,.,0,0
44700,According,0,0
44701,to,0,0
44702,cognitive,0,0
44703,behavioural,0,0
44704,models,0,0
44705,of,0,0
44706,social,0,0
44707,phobia,0,0
44708,",",0,0
44709,bodily,0,0
44710,symptoms,0,0
44711,are,0,0
44712,the,0,0
44713,main,0,0
44714,source,0,0
44715,of,0,0
44716,information,0,0
44717,concerning,0,0
44718,social,0,0
44719,evaluation,0,0
44720,for,0,0
44721,social,0,0
44722,phobics,0,1
44723,.,0,0
44724,Experience,0,0
44725,and,0,0
44726,perception,0,0
44727,of,0,0
44728,bodily,0,0
44729,symptoms,0,0
44730,therefore,0,0
44731,play,0,0
44732,an,0,0
44733,important,0,0
44734,role,0,0
44735,in,0,0
44736,social,0,0
44737,anxiety,0,0
44738,.,0,0
44739,In,0,0
44740,this,0,0
44741,study,0,0
44742,we,0,0
44743,evaluated,0,0
44744,the,0,0
44745,effects,0,0
44746,of,0,0
44747,anxiety,0,0
44748,visibility,0,0
44749,on,0,0
44750,patients,1,1
44751,and,1,0
44752,controls,1,1
44753,using,0,0
44754,feedback,0,0
44755,of,0,0
44756,veridical,0,0
44757,heart,0,1
44758,sounds,0,0
44759,.,0,0
44760,A,1,0
44761,total,1,0
44762,of,1,0
44763,32,1,1
44764,social,1,0
44765,phobics,1,1
44766,and,1,0
44767,32,1,1
44768,controls,1,1
44769,were,0,0
44770,asked,0,0
44771,twice,0,0
44772,to,0,0
44773,sit,0,0
44774,in,0,0
44775,a,0,0
44776,chair,0,0
44777,and,0,0
44778,appear,0,0
44779,relaxed,0,0
44780,while,0,0
44781,being,0,0
44782,evaluated,0,0
44783,.,0,0
44784,Half,0,0
44785,of,0,0
44786,the,0,0
44787,participants,0,1
44788,heard,0,0
44789,their,0,0
44790,heart,0,0
44791,sounds,0,0
44792,first,0,0
44793,via,0,0
44794,headphones,0,0
44795,and,0,0
44796,then,0,0
44797,via,0,0
44798,loudspeakers,0,0
44799,which,0,0
44800,were,0,0
44801,also,0,0
44802,audible,0,0
44803,to,0,0
44804,observers,0,0
44805,.,0,0
44806,The,0,0
44807,presentation,0,0
44808,order,0,0
44809,of,0,0
44810,the,0,0
44811,heart,0,1
44812,sound,0,0
44813,was,0,0
44814,reversed,0,0
44815,for,0,0
44816,the,0,0
44817,other,0,0
44818,half,0,0
44819,of,0,0
44820,the,0,0
44821,subjects,0,1
44822,.,0,0
44823,Social,1,0
44824,phobics,1,1
44825,reported,0,0
44826,substantially,0,0
44827,more,0,0
44828,anxiety,0,0
44829,than,0,0
44830,controls,0,0
44831,.,0,1
44832,Both,0,0
44833,groups,0,0
44834,showed,0,0
44835,habituation,0,0
44836,in,0,0
44837,heart,0,1
44838,rate,0,0
44839,from,0,0
44840,the,0,0
44841,first,0,0
44842,to,0,0
44843,the,0,0
44844,second,0,0
44845,presentation,0,0
44846,",",0,0
44847,and,0,0
44848,both,0,0
44849,groups,0,0
44850,reported,0,0
44851,perception,0,0
44852,of,0,0
44853,a,0,0
44854,higher,0,0
44855,heart,0,0
44856,rate,0,0
44857,",",0,0
44858,but,0,0
44859,only,0,0
44860,social,0,0
44861,phobics,0,1
44862,reported,0,0
44863,significantly,0,0
44864,more,0,0
44865,anxiety,0,0
44866,and,0,0
44867,were,0,0
44868,more,0,0
44869,worried,0,0
44870,about,0,0
44871,their,0,0
44872,heart,0,1
44873,rates,0,0
44874,in,0,0
44875,the,0,0
44876,public,0,1
44877,than,0,0
44878,in,0,0
44879,the,0,0
44880,private,0,1
44881,condition,0,0
44882,.,0,0
44883,These,0,0
44884,effects,0,0
44885,were,0,0
44886,in,0,0
44887,excess,0,0
44888,of,0,0
44889,actual,0,0
44890,heart,0,1
44891,rate,0,0
44892,differences,0,0
44893,.,0,0
44894,In,0,0
44895,conclusion,0,0
44896,",",0,0
44897,social,1,0
44898,phobics,1,1
44899,worried,0,0
44900,about,0,0
44901,the,0,0
44902,broadcast,0,0
44903,of,0,0
44904,a,0,0
44905,bodily,0,0
44906,anxiety,0,0
44907,symptom,0,0
44908,",",0,0
44909,whereas,0,0
44910,controls,0,0
44911,did,0,0
44912,not,0,0
44913,.,0,0
44914,Information,0,0
44915,about,0,0
44916,arousal,0,0
44917,made,0,0
44918,public,0,0
44919,has,0,0
44920,a,0,0
44921,strong,0,0
44922,potential,0,0
44923,to,0,0
44924,increase,0,0
44925,anxiety,0,0
44926,levels,0,0
44927,in,0,0
44928,social,0,0
44929,phobics,0,1
44930,.,0,1
44931,Why,0,0
44932,distinctive,0,0
44933,information,0,0
44934,reduces,0,0
44935,false,0,1
44936,memories,0,0
44937,:,0,1
44938,evidence,0,0
44939,for,0,0
44940,both,0,0
44941,impoverished,1,1
44942,relational-encoding,1,0
44943,and,1,0
44944,distinctiveness,1,0
44945,heuristic,1,0
44946,accounts,1,0
44947,.,1,1
44948,Two,0,1
44949,accounts,0,0
44950,explain,0,0
44951,why,0,0
44952,studying,0,0
44953,pictures,0,0
44954,reduces,0,0
44955,false,0,0
44956,memories,0,0
44957,within,0,0
44958,the,0,0
44959,Deese-Roediger-McDermott,0,0
44960,paradigm,0,0
44961,(,0,0
44962,J.,0,0
44963,Deese,0,1
44964,",",0,0
44965,1959,0,1
44966,;,0,0
44967,H.,0,1
44968,L.,0,0
44969,Roediger,0,1
44970,&,0,1
44971,K.,0,0
44972,B.,0,0
44973,McDermott,0,0
44974,",",0,0
44975,1995,0,1
44976,),0,0
44977,.,0,0
44978,The,0,0
44979,impoverished,0,1
44980,relational-encoding,0,0
44981,account,0,0
44982,suggests,0,0
44983,that,0,0
44984,studying,0,0
44985,pictures,0,0
44986,interferes,0,0
44987,with,0,0
44988,the,0,0
44989,encoding,0,0
44990,of,0,0
44991,relational,0,0
44992,information,0,0
44993,",",0,0
44994,which,0,0
44995,is,0,0
44996,the,0,0
44997,primary,0,0
44998,basis,0,0
44999,for,0,0
45000,false,0,1
45001,memories,0,0
45002,in,0,0
45003,this,0,0
45004,paradigm,0,0
45005,.,0,0
45006,Alternatively,0,0
45007,",",0,0
45008,the,0,0
45009,distinctiveness,0,0
45010,heuristic,0,0
45011,assumes,0,0
45012,that,0,0
45013,critical,0,0
45014,lures,0,0
45015,are,0,0
45016,actively,0,0
45017,withheld,0,0
45018,by,0,0
45019,the,0,0
45020,use,0,0
45021,of,0,0
45022,a,0,0
45023,retrieval,0,0
45024,strategy,0,0
45025,.,0,0
45026,When,0,0
45027,participants,1,1
45028,were,1,0
45029,given,1,0
45030,inclusion,1,0
45031,recall,1,0
45032,instructions,1,0
45033,to,1,0
45034,report,1,0
45035,studied,1,1
45036,items,1,0
45037,as,1,0
45038,well,1,0
45039,as,1,0
45040,related,1,0
45041,items,1,0
45042,",",0,0
45043,they,0,0
45044,still,0,0
45045,reported,0,0
45046,critical,0,0
45047,lures,0,0
45048,less,0,0
45049,often,0,0
45050,after,0,0
45051,picture,0,0
45052,encoding,0,0
45053,than,0,0
45054,they,0,0
45055,did,0,0
45056,after,0,0
45057,word,0,0
45058,encoding,0,0
45059,.,0,0
45060,As,0,0
45061,the,0,0
45062,impoverished,0,1
45063,relational-encoding,0,0
45064,account,0,0
45065,suggests,0,0
45066,",",0,0
45067,critical,0,0
45068,lures,0,0
45069,appear,0,0
45070,less,0,0
45071,likely,0,0
45072,to,0,0
45073,come,0,0
45074,to,0,0
45075,mind,0,0
45076,after,0,0
45077,picture,0,0
45078,encoding,0,0
45079,than,0,0
45080,they,0,0
45081,do,0,0
45082,after,0,0
45083,word,0,0
45084,encoding,0,0
45085,.,0,0
45086,However,0,0
45087,",",0,0
45088,the,0,0
45089,results,0,0
45090,from,0,0
45091,a,0,0
45092,postrecall,0,0
45093,recognition,0,0
45094,test,0,0
45095,provide,0,0
45096,evidence,0,0
45097,in,0,0
45098,favor,0,0
45099,of,0,0
45100,the,0,0
45101,distinctiveness,0,0
45102,heuristic,0,0
45103,.,0,0
45104,Effect,0,0
45105,of,0,0
45106,the,0,0
45107,dietary,0,0
45108,approaches,0,0
45109,to,0,0
45110,stop,0,0
45111,hypertension,0,1
45112,diet,0,0
45113,and,0,0
45114,reduced,0,0
45115,sodium,0,0
45116,intake,0,0
45117,on,0,0
45118,blood,0,0
45119,pressure,0,0
45120,control,0,0
45121,.,0,0
45122,The,0,0
45123,authors,0,0
45124,hypothesized,0,0
45125,that,0,0
45126,the,0,0
45127,Dietary,0,0
45128,Approaches,0,0
45129,to,0,0
45130,Stop,0,0
45131,Hypertension,0,0
45132,(,0,0
45133,DASH,0,0
45134,),0,0
45135,diet,0,0
45136,and,0,0
45137,reduced,0,0
45138,sodium,0,0
45139,intake,0,0
45140,would,0,0
45141,control,0,0
45142,stage,0,1
45143,1,0,0
45144,hypertension,0,1
45145,and,0,0
45146,reduce,0,0
45147,high-normal,0,0
45148,blood,0,0
45149,pressure,0,0
45150,(,0,0
45151,BP,0,0
45152,),0,0
45153,to,0,0
45154,optimal,0,0
45155,levels,0,0
45156,.,0,1
45157,Adults,1,1
45158,with,1,1
45159,systolic,1,1
45160,BP,1,0
45161,120-159,1,1
45162,mm,1,0
45163,Hg,1,0
45164,and,1,0
45165,diastolic,1,0
45166,BP,1,0
45167,80-95,1,1
45168,mm,1,0
45169,Hg,1,0
45170,were,0,0
45171,randomly,0,0
45172,assigned,0,0
45173,to,0,0
45174,receive,0,0
45175,the,0,0
45176,DASH,0,0
45177,diet,0,0
45178,or,0,0
45179,a,0,0
45180,typical,0,0
45181,American,0,1
45182,(,0,0
45183,control,0,0
45184,),0,0
45185,diet,0,0
45186,",",0,0
45187,consuming,0,0
45188,three,0,0
45189,different,0,0
45190,sodium,0,0
45191,intakes,0,0
45192,(,0,0
45193,higher=142,0,0
45194,mmol/d,0,0
45195,",",0,0
45196,intermediate=107,0,0
45197,mmol/d,0,0
45198,",",0,0
45199,and,0,0
45200,lower=65,0,0
45201,mmol/d,0,0
45202,),0,0
45203,for,0,0
45204,30,0,0
45205,days,0,0
45206,each,0,0
45207,.,0,0
45208,BP,0,0
45209,control,0,0
45210,was,0,0
45211,defined,0,0
45212,as,0,0
45213,systolic,0,1
45214,BP,0,0
45215,<,0,0
45216,140,0,1
45217,mm,0,0
45218,Hg,0,0
45219,and,0,0
45220,diastolic,0,0
45221,BP,0,0
45222,<,0,0
45223,90,0,0
45224,mm,0,0
45225,Hg,0,0
45226,.,0,0
45227,Among,0,1
45228,subjects,1,1
45229,with,1,1
45230,hypertension,1,1
45231,at,1,0
45232,baseline,1,0
45233,",",0,0
45234,at,0,0
45235,higher,0,0
45236,sodium,0,0
45237,intake,0,0
45238,the,0,0
45239,DASH,0,0
45240,diet,0,0
45241,increased,0,0
45242,BP,0,0
45243,control,0,0
45244,two-fold,0,0
45245,over,0,0
45246,control,0,0
45247,(,0,0
45248,63,0,0
45249,%,0,0
45250,vs.,0,0
45251,32,0,1
45252,%,0,0
45253,;,0,0
45254,95,0,0
45255,%,0,0
45256,confidence,0,0
45257,interval,0,0
45258,",",0,0
45259,1.4-2.9,0,0
45260,),0,0
45261,.,0,0
45262,Reducing,0,0
45263,sodium,0,0
45264,intake,0,0
45265,in,0,0
45266,the,0,0
45267,control,0,0
45268,diet,0,0
45269,group,0,0
45270,increased,0,0
45271,BP,0,0
45272,control,0,0
45273,2.3-fold,0,0
45274,(,0,0
45275,74,0,1
45276,%,0,0
45277,vs.,0,0
45278,32,0,1
45279,%,0,0
45280,;,0,0
45281,95,0,0
45282,%,0,0
45283,confidence,0,0
45284,interval,0,0
45285,",",0,0
45286,1.7-3.2,0,0
45287,),0,0
45288,.,0,0
45289,The,0,0
45290,maximum,0,0
45291,BP,0,0
45292,control,0,0
45293,rate,0,0
45294,(,0,0
45295,84,0,1
45296,%,0,0
45297,),0,0
45298,was,0,0
45299,achieved,0,0
45300,with,0,0
45301,the,0,0
45302,DASH/lower,0,0
45303,sodium,0,0
45304,diet,0,0
45305,.,0,0
45306,BP,0,0
45307,became,0,0
45308,normal,0,1
45309,or,0,0
45310,optimal,0,0
45311,in,0,0
45312,71,0,1
45313,%,0,0
45314,of,0,0
45315,persons,0,1
45316,consuming,0,0
45317,the,0,0
45318,control/lower,0,0
45319,sodium,0,0
45320,diet,0,0
45321,and,0,0
45322,77,0,0
45323,%,0,0
45324,of,0,0
45325,persons,0,1
45326,consuming,0,0
45327,the,0,0
45328,DASH/lower,0,0
45329,sodium,0,0
45330,diet,0,0
45331,.,0,0
45332,Both,0,0
45333,the,0,0
45334,DASH,0,0
45335,diet,0,0
45336,and,0,0
45337,reduced,0,0
45338,sodium,0,0
45339,intake,0,0
45340,improved,0,0
45341,BP,0,0
45342,control,0,0
45343,.,0,0
45344,Helicobacter,1,1
45345,pylori,1,0
45346,eradication,1,0
45347,in,1,0
45348,children,1,1
45349,and,1,0
45350,adolescents,1,1
45351,by,0,0
45352,a,0,0
45353,once,0,0
45354,daily,0,0
45355,6-day,0,0
45356,treatment,0,0
45357,with,0,1
45358,or,0,0
45359,without,0,0
45360,a,0,0
45361,proton,0,0
45362,pump,0,0
45363,inhibitor,0,0
45364,in,0,0
45365,a,0,0
45366,double-blind,0,0
45367,randomized,0,0
45368,trial,0,0
45369,.,0,0
45370,AIM,0,0
45371,To,0,0
45372,evaluate,0,0
45373,two,0,0
45374,simplified,0,0
45375,Helicobacter,0,1
45376,pylori,0,0
45377,eradication,0,0
45378,treatment,0,0
45379,alternatives,0,0
45380,for,0,0
45381,children,1,1
45382,and,1,1
45383,adolescents,1,1
45384,.,1,1
45385,METHODS,0,0
45386,Study,0,0
45387,subjects,0,1
45388,were,0,0
45389,identified,0,0
45390,by,0,0
45391,enzyme-linked,0,0
45392,immunosorbent,0,0
45393,assay,0,0
45394,and,0,0
45395,immunoblot,0,0
45396,in,0,0
45397,a,0,0
45398,family,0,0
45399,screening,0,0
45400,project,0,1
45401,.,0,0
45402,Helicobacter,1,0
45403,pylori,1,0
45404,infected,1,1
45405,10-21,1,0
45406,year,1,1
45407,olds,1,1
45408,were,1,0
45409,offered,1,0
45410,treatment,1,0
45411,",",1,0
45412,individuals,1,1
45413,with,1,1
45414,abdominal,1,1
45415,pain,1,0
45416,underwent,1,1
45417,upper,1,0
45418,endoscopy,1,1
45419,and,1,0
45420,those,1,0
45421,with,1,0
45422,peptic,1,1
45423,ulcers,1,1
45424,were,1,0
45425,excluded,1,0
45426,.,1,0
45427,Participants,0,1
45428,were,0,0
45429,randomized,0,0
45430,to,0,0
45431,either,0,0
45432,azithromycin,0,0
45433,500,0,0
45434,mg,0,0
45435,daily,0,0
45436,and,0,0
45437,tinidazole,0,0
45438,500,0,0
45439,mg,0,0
45440,two,0,0
45441,tablets,0,0
45442,daily,0,0
45443,in,0,0
45444,combination,0,0
45445,with,0,1
45446,lansoprasole,0,0
45447,30,0,1
45448,mg,0,0
45449,daily,0,0
45450,for,0,0
45451,6,0,0
45452,days,0,0
45453,(,0,0
45454,ATL-group,0,0
45455,),0,0
45456,or,0,0
45457,with,0,0
45458,placebo,0,0
45459,(,0,0
45460,ATP-group,0,0
45461,),0,0
45462,.,0,0
45463,Urea,0,0
45464,Breath,0,0
45465,Test,0,0
45466,was,0,0
45467,performed,0,0
45468,at,0,0
45469,inclusion,0,0
45470,and,0,0
45471,after,0,0
45472,a,0,0
45473,minimum,0,0
45474,of,0,0
45475,6,0,0
45476,weeks,0,0
45477,after,0,0
45478,end,0,0
45479,of,0,0
45480,therapy,0,0
45481,.,0,0
45482,RESULTS,0,0
45483,In,0,0
45484,total,0,1
45485,",",0,0
45486,131,1,0
45487,individuals,1,1
45488,were,1,0
45489,randomized,1,0
45490,",",1,0
45491,of,1,0
45492,whom,1,1
45493,31,1,1
45494,(,1,1
45495,24,1,0
45496,%,1,0
45497,),1,0
45498,had,1,0
45499,undergone,1,1
45500,upper,1,0
45501,endoscopy,1,1
45502,.,1,0
45503,Full,1,0
45504,compliance,1,0
45505,was,1,0
45506,achieved,1,0
45507,in,1,0
45508,93,1,0
45509,%,1,0
45510,(,1,0
45511,122,1,1
45512,of,1,0
45513,131,1,1
45514,),1,0
45515,.,1,0
45516,The,0,0
45517,intention-to-treat,0,0
45518,eradication,0,0
45519,rate,0,0
45520,was,0,0
45521,67,0,0
45522,%,0,0
45523,(,0,0
45524,44,0,1
45525,of,0,0
45526,66,0,1
45527,),0,0
45528,and,0,0
45529,58,0,1
45530,%,0,0
45531,(,0,0
45532,38,0,1
45533,of,0,0
45534,65,0,1
45535,),0,0
45536,for,0,0
45537,the,0,0
45538,ATL-,0,0
45539,and,0,0
45540,the,0,0
45541,ATP-group,0,0
45542,",",0,0
45543,respectively,0,0
45544,.,0,0
45545,CONCLUSION,0,0
45546,The,0,0
45547,double-blind,0,0
45548,randomized,0,0
45549,clinical,0,0
45550,trial,0,0
45551,did,0,0
45552,not,0,0
45553,identify,0,0
45554,a,0,0
45555,simplified,0,0
45556,",",0,0
45557,successful,0,0
45558,once,0,0
45559,daily,0,0
45560,H.,0,0
45561,pylori,0,0
45562,treatment,0,0
45563,for,0,0
45564,children,1,1
45565,and,1,1
45566,adolescents,1,1
45567,.,1,0
45568,Thus,0,0
45569,",",0,0
45570,twice,0,0
45571,daily,0,0
45572,proton,0,0
45573,pump,0,0
45574,inhibitor,0,0
45575,(,0,0
45576,PPI,0,0
45577,),0,0
45578,-based,0,0
45579,triple,0,0
45580,therapies,0,0
45581,for,0,0
45582,7,0,0
45583,days,0,0
45584,remain,0,0
45585,as,0,0
45586,the,0,0
45587,choice,0,0
45588,of,0,0
45589,treatment,0,0
45590,in,0,0
45591,children,1,1
45592,.,1,1
45593,Further,0,0
45594,",",0,0
45595,powerful,0,0
45596,and,0,0
45597,controlled,0,0
45598,studies,0,0
45599,are,0,0
45600,needed,0,0
45601,to,0,0
45602,elucidate,0,0
45603,the,0,0
45604,best,0,0
45605,treatment,0,0
45606,strategies,0,0
45607,for,0,0
45608,H.,0,1
45609,pylori,0,0
45610,eradication,0,0
45611,in,0,0
45612,this,0,0
45613,age,0,1
45614,group,0,0
45615,.,0,0
45616,[,0,0
45617,Structural,0,0
45618,and,0,0
45619,immunohistochemical,0,0
45620,changes,0,0
45621,of,0,0
45622,conjunctiva,0,1
45623,induced,0,0
45624,by,0,0
45625,topical,0,0
45626,glaucoma,0,1
45627,medication,0,0
45628,],0,0
45629,.,0,0
45630,PURPOSE,0,0
45631,The,0,0
45632,topical,0,0
45633,medication,0,0
45634,represents,0,0
45635,the,0,0
45636,first,0,0
45637,line,0,0
45638,therapy,0,0
45639,for,0,0
45640,the,0,0
45641,primary,0,0
45642,open,0,0
45643,angle,0,0
45644,glaucoma,0,1
45645,.,0,0
45646,The,0,0
45647,study,0,0
45648,is,0,0
45649,aimed,0,0
45650,at,0,0
45651,assessing,0,0
45652,the,0,0
45653,structural,0,0
45654,and,0,0
45655,immunohistochemical,0,0
45656,changes,0,0
45657,of,0,0
45658,conjunctiva,0,1
45659,induced,0,0
45660,by,0,0
45661,topical,0,0
45662,glaucoma,0,1
45663,medication,0,0
45664,.,0,0
45665,METHODS,0,0
45666,For,0,0
45667,this,0,0
45668,purpose,0,0
45669,",",0,0
45670,we,0,0
45671,carried,0,0
45672,out,0,0
45673,a,0,0
45674,40,0,0
45675,weeks,0,0
45676,",",0,0
45677,prospective,0,0
45678,",",0,0
45679,experimental,0,0
45680,",",0,0
45681,epidemiological-operational,0,0
45682,and,0,0
45683,randomized,0,0
45684,study,0,0
45685,enrolling,0,1
45686,18,1,1
45687,patients,1,1
45688,(,1,1
45689,36,1,1
45690,eyes,1,1
45691,),1,0
45692,with,1,1
45693,recently,1,0
45694,primary,1,0
45695,open,1,0
45696,angle,1,0
45697,glaucoma,1,1
45698,.,1,0
45699,The,0,0
45700,eyes,0,0
45701,were,0,0
45702,divided,0,0
45703,into,0,0
45704,treatment,0,0
45705,(,0,0
45706,non-selective,0,0
45707,beta,0,0
45708,blockers,0,0
45709,or,0,0
45710,selective,0,0
45711,",",0,0
45712,prostaglandin,0,0
45713,analogues,0,0
45714,",",0,0
45715,topical,0,0
45716,carbonic,0,0
45717,anhydrase,0,0
45718,inhibitors,0,0
45719,),0,0
45720,in,0,0
45721,four,0,1
45722,groups,0,0
45723,.,0,0
45724,The,0,0
45725,assessment,0,0
45726,was,0,0
45727,performed,0,0
45728,by,0,0
45729,comparison,0,0
45730,with,0,1
45731,control,1,0
45732,group,1,0
45733,(,1,0
45734,4,1,0
45735,patients,1,1
45736,),1,1
45737,who,1,1
45738,was,1,0
45739,instilled,1,0
45740,with,1,1
45741,natural,1,0
45742,tears,1,1
45743,(,1,0
45744,with,1,1
45745,different,1,0
45746,preservative,1,0
45747,),1,0
45748,.,1,0
45749,Both,0,0
45750,the,0,0
45751,cytology,0,0
45752,and,0,0
45753,the,0,0
45754,conjunctival,0,0
45755,biopsy,0,0
45756,specimens,0,1
45757,were,0,0
45758,investigated,0,0
45759,by,0,0
45760,histological,0,0
45761,exams,0,0
45762,and,0,0
45763,immunohistochemistry,0,0
45764,using,0,0
45765,different,0,0
45766,monoclonal,0,0
45767,antibodies,0,0
45768,.,0,0
45769,The,0,0
45770,study,0,0
45771,was,0,0
45772,performed,0,0
45773,by,0,0
45774,collaboration,0,0
45775,with,0,1
45776,The,0,0
45777,National,0,0
45778,Institute,0,0
45779,of,0,0
45780,Research,0,0
45781,and,0,0
45782,Development,0,0
45783,in,0,0
45784,Pathology,0,0
45785,and,0,0
45786,Biomedical,0,0
45787,Sciences-,0,0
45788,V.,0,0
45789,Babes,0,1
45790,-Bucharest,0,1
45791,.,0,0
45792,RESULTS,0,0
45793,The,0,0
45794,morphometric,0,0
45795,analysis,0,0
45796,of,0,0
45797,histological,0,0
45798,sections,0,1
45799,of,0,0
45800,conjunctiva,0,1
45801,showed,0,0
45802,the,0,0
45803,following,0,0
45804,changes,0,0
45805,:,0,1
45806,squamous,0,1
45807,metaplasia,0,1
45808,(,0,0
45809,significant,0,0
45810,increases,0,0
45811,in,0,0
45812,the,0,0
45813,thickness,0,0
45814,and,0,0
45815,number,0,0
45816,of,0,0
45817,epithelial,0,1
45818,cell,0,1
45819,layers,0,0
45820,),0,0
45821,",",0,0
45822,inflammation,0,0
45823,(,0,0
45824,increase,0,0
45825,the,0,0
45826,number,0,0
45827,of,0,0
45828,lymphocytes,0,0
45829,",",0,0
45830,macrophages,0,0
45831,and,0,0
45832,fibroblasts,0,1
45833,),0,0
45834,and,0,0
45835,subconjunctival,0,0
45836,fibrosis,0,0
45837,.,0,0
45838,According,0,0
45839,to,0,0
45840,the,0,0
45841,type,0,0
45842,of,0,0
45843,medication,0,0
45844,",",0,0
45845,we,0,0
45846,observed,0,0
45847,the,0,0
45848,significant,0,0
45849,increase,0,0
45850,of,0,0
45851,subepithelial,0,0
45852,collagen,0,0
45853,density,0,0
45854,and,0,0
45855,degenerative,0,1
45856,changes,0,0
45857,of,0,0
45858,fibrocytes,0,1
45859,",",0,0
45860,the,0,0
45861,reduction,0,0
45862,of,0,0
45863,extracellular,0,0
45864,matrix,0,0
45865,and,0,0
45866,also,0,0
45867,the,0,0
45868,up-regulation,0,0
45869,of,0,0
45870,antibodies,0,0
45871,against,0,0
45872,matrix,0,0
45873,metalloproteinase,0,0
45874,and,0,0
45875,allergic,0,1
45876,changes,0,0
45877,.,0,0
45878,According,0,0
45879,to,0,0
45880,structural,0,0
45881,changes,0,0
45882,",",0,0
45883,the,0,0
45884,immunohistochemistry,0,0
45885,confirmed,0,0
45886,the,0,0
45887,tendency,0,0
45888,of,0,0
45889,chronic,0,1
45890,inflammation,0,0
45891,.,0,0
45892,CONCLUSIONS,0,0
45893,This,0,0
45894,study,0,0
45895,revealed,0,0
45896,important,0,0
45897,structural,0,0
45898,and,0,0
45899,immunohistochemical,0,0
45900,changes,0,0
45901,of,0,0
45902,conjunctiva,0,1
45903,after,0,0
45904,topical,0,0
45905,glaucoma,0,1
45906,medication,0,0
45907,.,0,0
45908,The,0,0
45909,category,0,0
45910,and,0,0
45911,the,0,0
45912,intensity,0,0
45913,of,0,0
45914,these,0,0
45915,changes,0,0
45916,are,0,0
45917,dependent,0,0
45918,on,0,0
45919,the,0,0
45920,sort,0,0
45921,of,0,0
45922,therapy,0,0
45923,and,0,0
45924,the,0,0
45925,topical,0,0
45926,treatment,0,0
45927,period,0,0
45928,.,0,0
45929,The,0,0
45930,findings,0,0
45931,showed,0,0
45932,that,0,0
45933,benzalkonium,0,0
45934,chloride,0,0
45935,(,0,0
45936,the,0,0
45937,most,0,0
45938,common,0,0
45939,preservative,0,0
45940,of,0,0
45941,antiglaucoma,0,0
45942,drugs,0,0
45943,),0,0
45944,is,0,0
45945,a,0,0
45946,major,0,0
45947,factor,0,0
45948,for,0,0
45949,conjunctival,0,0
45950,metaplasia,0,1
45951,.,0,0
45952,Gonadotropin-releasing,1,0
45953,hormone,1,0
45954,agonist,1,0
45955,with,1,0
45956,or,1,0
45957,without,1,1
45958,raloxifene,1,0
45959,:,1,1
45960,effects,0,0
45961,on,0,0
45962,cognition,0,0
45963,",",0,0
45964,mood,0,0
45965,",",0,0
45966,and,0,0
45967,quality,0,0
45968,of,0,0
45969,life,0,0
45970,.,0,0
45971,IV,0,0
45972,amantadine,0,1
45973,improves,0,0
45974,chorea,1,1
45975,in,1,0
45976,Huntington,1,0
45977,'s,1,1
45978,disease,1,1
45979,:,1,1
45980,an,0,0
45981,acute,0,0
45982,randomized,0,0
45983,",",0,0
45984,controlled,0,0
45985,study,0,0
45986,.,0,0
45987,Once-daily,0,0
45988,versus,0,0
45989,twice-daily,0,0
45990,lamivudine,0,0
45991,",",0,0
45992,in,0,0
45993,combination,0,0
45994,with,0,1
45995,zidovudine,0,0
45996,and,0,0
45997,efavirenz,0,0
45998,",",0,0
45999,for,0,0
46000,the,0,0
46001,treatment,0,0
46002,of,0,0
46003,antiretroviral-naive,1,1
46004,adults,1,1
46005,with,1,1
46006,HIV,1,1
46007,infection,1,1
46008,:,1,1
46009,a,0,0
46010,randomized,0,0
46011,equivalence,0,0
46012,trial,0,0
46013,.,0,0
46014,A,0,0
46015,randomized,0,0
46016,",",0,0
46017,double-blind,0,0
46018,",",0,0
46019,double-dummy,0,0
46020,controlled,0,0
46021,",",0,0
46022,multicenter,0,0
46023,trial,0,0
46024,was,0,0
46025,conducted,0,0
46026,that,0,0
46027,involved,0,0
46028,554,1,1
46029,antiretroviral-naive,1,1
46030,human,1,0
46031,immunodeficiency,1,1
46032,virus-infected,1,1
46033,adults,1,1
46034,(,1,0
46035,plasma,1,0
46036,HIV,1,0
46037,type,1,1
46038,1,1,0
46039,[,1,0
46040,HIV-1,1,1
46041,],1,0
46042,RNA,1,0
46043,level,1,0
46044,",",1,0
46045,>,1,0
46046,or=400,1,0
46047,copies/mL,1,0
46048,;,1,0
46049,CD4,1,1
46050,(,1,0
46051,+,1,0
46052,),1,0
46053,cell,1,0
46054,count,1,0
46055,",",1,0
46056,>,1,0
46057,100,1,0
46058,cells/mm,1,0
46059,(,1,0
46060,3,1,0
46061,),1,0
46062,),1,0
46063,and,1,0
46064,compared,1,0
46065,a,1,0
46066,300-mg,1,0
46067,once-daily,1,0
46068,(,1,0
46069,q.d,1,0
46070,.,1,1
46071,),1,0
46072,regimen,1,0
46073,of,1,0
46074,lamivudine,1,0
46075,(,1,0
46076,3TC,1,0
46077,),1,0
46078,versus,1,0
46079,a,1,0
46080,150-mg,1,0
46081,twice-daily,1,0
46082,(,1,0
46083,b.i.d,1,0
46084,.,1,0
46085,),1,0
46086,regimen,1,0
46087,of,1,0
46088,3TC,1,0
46089,",",1,0
46090,combined,1,0
46091,with,1,0
46092,zidovudine,1,0
46093,(,1,0
46094,300,1,0
46095,mg,1,0
46096,b.i.d,1,0
46097,.,1,0
46098,),1,0
46099,and,1,0
46100,efavirenz,1,1
46101,(,1,0
46102,600,1,0
46103,mg,1,0
46104,q.d,1,0
46105,.,1,0
46106,),1,0
46107,",",1,0
46108,during,1,0
46109,a,1,0
46110,48-week,1,0
46111,period,1,0
46112,.,1,1
46113,Treatments,0,0
46114,were,0,0
46115,considered,0,0
46116,equivalent,0,0
46117,if,0,0
46118,the,0,0
46119,95,0,0
46120,%,0,0
46121,confidence,0,0
46122,interval,0,0
46123,(,0,0
46124,CI,0,0
46125,),0,0
46126,for,0,0
46127,the,0,0
46128,difference,0,0
46129,in,0,0
46130,proportions,0,0
46131,of,0,0
46132,patients,0,1
46133,achieving,0,0
46134,an,0,0
46135,HIV-1,0,0
46136,RNA,0,0
46137,level,0,0
46138,of,0,0
46139,<,0,0
46140,400,0,0
46141,copies/mL,0,0
46142,was,0,0
46143,within,0,0
46144,the,0,0
46145,bound,0,0
46146,of,0,0
46147,-12,0,0
46148,%,0,0
46149,to,0,0
46150,12,0,0
46151,%,0,0
46152,.,0,0
46153,At,0,0
46154,week,0,0
46155,48,0,0
46156,of,0,0
46157,the,0,0
46158,study,0,0
46159,",",0,0
46160,an,0,0
46161,intent-to-treat,0,0
46162,analysis,0,0
46163,in,0,0
46164,which,0,0
46165,patients,0,1
46166,with,0,1
46167,missing,0,0
46168,data,0,0
46169,were,0,0
46170,considered,0,0
46171,to,0,0
46172,have,0,0
46173,experienced,0,0
46174,treatment,0,0
46175,failure,0,1
46176,showed,0,0
46177,that,0,0
46178,the,0,0
46179,3TC,0,0
46180,q.d,0,0
46181,.,0,0
46182,and,0,0
46183,3TC,0,0
46184,b.i.d,0,0
46185,.,0,1
46186,regimens,0,0
46187,were,0,0
46188,equivalent,0,0
46189,(,0,0
46190,HIV-1,0,1
46191,RNA,0,1
46192,level,0,0
46193,<,0,0
46194,400,0,0
46195,copies/mL,0,0
46196,",",0,0
46197,178,0,1
46198,[,0,0
46199,64,0,0
46200,%,0,0
46201,],0,0
46202,of,0,0
46203,278,0,1
46204,vs.,0,0
46205,174,0,1
46206,[,0,0
46207,63,0,0
46208,%,0,0
46209,],0,0
46210,of,0,0
46211,276,0,1
46212,;,0,0
46213,treatment,0,0
46214,difference,0,0
46215,",",0,0
46216,1,0,0
46217,%,0,0
46218,[,0,0
46219,95,0,0
46220,%,0,0
46221,CI,0,0
46222,",",0,0
46223,-7.1,0,0
46224,%,0,0
46225,to,0,0
46226,8.9,0,0
46227,%,0,0
46228,],0,1
46229,;,0,0
46230,HIV-1,0,0
46231,RNA,0,0
46232,level,0,0
46233,<,0,0
46234,50,0,0
46235,copies/mL,0,0
46236,",",0,0
46237,165,0,1
46238,[,0,0
46239,59,0,1
46240,%,0,0
46241,],0,0
46242,of,0,0
46243,278,0,1
46244,vs.,0,0
46245,168,0,1
46246,[,0,0
46247,61,0,1
46248,%,0,0
46249,],0,0
46250,of,0,0
46251,276,0,1
46252,;,0,0
46253,treatment,0,0
46254,difference,0,0
46255,",",0,0
46256,1.7,0,0
46257,%,0,0
46258,[,0,0
46259,95,0,0
46260,%,0,0
46261,CI,0,0
46262,",",0,0
46263,-9.7,0,0
46264,%,0,0
46265,to,0,0
46266,6.6,0,0
46267,%,0,0
46268,],0,1
46269,),0,0
46270,.,0,0
46271,Median,0,0
46272,increase,0,0
46273,above,0,0
46274,baseline,0,0
46275,in,0,0
46276,CD4,0,1
46277,(,0,0
46278,+,0,0
46279,),0,0
46280,cell,0,0
46281,count,0,0
46282,was,0,0
46283,similar,0,0
46284,(,0,0
46285,q.d,0,0
46286,.,0,0
46287,group,0,0
46288,",",0,0
46289,+144,0,0
46290,cells/mm,0,0
46291,(,0,0
46292,3,0,0
46293,),0,0
46294,;,0,0
46295,b.i.d,0,0
46296,.,0,0
46297,group,0,0
46298,",",0,0
46299,+146,0,0
46300,cells/mm,0,0
46301,(,0,0
46302,3,0,0
46303,),0,0
46304,),0,0
46305,",",0,0
46306,and,0,0
46307,the,0,0
46308,incidences,0,0
46309,of,0,0
46310,adverse,0,0
46311,events,0,0
46312,",",0,0
46313,disease,0,1
46314,progression,0,0
46315,",",0,0
46316,and,0,0
46317,HIV-associated,0,0
46318,conditions,0,0
46319,were,0,1
46320,comparable,0,0
46321,.,0,0
46322,Caudal,0,0
46323,neostigmine,0,0
46324,with,0,0
46325,bupivacaine,0,0
46326,produces,0,0
46327,a,0,0
46328,dose-independent,0,0
46329,analgesic,0,0
46330,effect,0,0
46331,in,0,0
46332,children,1,1
46333,.,1,1
46334,PURPOSE,0,0
46335,To,0,0
46336,evaluate,0,0
46337,the,0,0
46338,analgesic,0,0
46339,efficacy,0,0
46340,and,0,0
46341,duration,0,0
46342,of,0,0
46343,varying,0,0
46344,doses,0,0
46345,of,0,0
46346,caudal,0,0
46347,neostigmine,0,0
46348,with,0,1
46349,plain,0,0
46350,bupivacaine,0,0
46351,and,0,0
46352,its,0,0
46353,side,0,0
46354,effects,0,0
46355,in,0,0
46356,children,1,1
46357,undergoing,1,1
46358,genito-urinary,1,1
46359,surgery,1,1
46360,.,1,0
46361,METHODS,0,0
46362,In,0,0
46363,a,0,0
46364,randomized,0,0
46365,double-blind,0,0
46366,prospective,0,0
46367,study,0,0
46368,80,1,1
46369,boys,1,1
46370,aged,1,1
46371,two,1,0
46372,to,1,0
46373,eight,1,1
46374,years,1,1
46375,scheduled,1,1
46376,for,1,0
46377,surgical,1,0
46378,repair,1,1
46379,of,1,0
46380,hypospadias,1,1
46381,were,1,0
46382,allocated,1,0
46383,randomly,1,1
46384,to,0,0
46385,one,0,0
46386,of,0,0
46387,four,0,1
46388,groups,0,0
46389,(,0,0
46390,n,0,1
46391,=,0,0
46392,20,0,0
46393,each,0,0
46394,),0,0
46395,and,0,0
46396,received,0,0
46397,either,0,0
46398,only,0,0
46399,caudal,1,0
46400,0.25,1,0
46401,%,1,0
46402,plain,1,0
46403,bupivacaine,1,0
46404,0.5,1,0
46405,mL.kg,1,0
46406,(,1,0
46407,-1,1,0
46408,),1,0
46409,(,1,0
46410,Group,1,0
46411,I,1,0
46412,),1,0
46413,or,0,0
46414,0.25,1,0
46415,%,1,0
46416,plain,1,0
46417,bupivacaine,1,0
46418,0.5,1,0
46419,mL.kg,1,0
46420,(,1,0
46421,-1,1,0
46422,),1,0
46423,with,1,0
46424,neostigmine,1,0
46425,(,1,0
46426,Groups,1,0
46427,II-IV,1,0
46428,),1,0
46429,in,0,0
46430,doses,0,0
46431,of,0,0
46432,2,0,0
46433,",",0,0
46434,3,0,0
46435,and,0,0
46436,4,0,0
46437,microg.kg,0,0
46438,(,0,0
46439,-1,0,0
46440,),0,0
46441,respectively,0,0
46442,.,0,0
46443,Postoperative,0,0
46444,pain,0,0
46445,was,0,0
46446,assessed,0,0
46447,for,0,0
46448,24,0,0
46449,hr,0,0
46450,using,0,0
46451,an,0,0
46452,objective,0,0
46453,pain,0,0
46454,score,0,0
46455,.,0,0
46456,Blood,0,0
46457,pressure,0,0
46458,",",0,0
46459,heart,0,0
46460,rate,0,0
46461,",",0,0
46462,oxygen,0,0
46463,saturation,0,0
46464,",",0,0
46465,total,0,0
46466,amount,0,0
46467,of,0,0
46468,analgesic,0,0
46469,consumed,0,0
46470,and,0,0
46471,adverse,0,0
46472,effects,0,0
46473,were,0,0
46474,also,0,0
46475,recorded,0,0
46476,.,0,0
46477,RESULTS,0,0
46478,The,0,0
46479,duration,0,0
46480,of,0,0
46481,postoperative,0,0
46482,analgesia,0,0
46483,in,0,0
46484,Group,0,0
46485,I,0,0
46486,(,0,0
46487,5.1,0,0
46488,+/-,0,0
46489,2.3,0,0
46490,hr,0,0
46491,),0,0
46492,was,0,0
46493,significantly,0,0
46494,shorter,0,0
46495,than,0,0
46496,in,0,0
46497,the,0,0
46498,other,0,0
46499,three,0,0
46500,groups,0,0
46501,(,0,0
46502,II,0,1
46503,-16.6,0,0
46504,+/-,0,0
46505,4.9,0,0
46506,hr,0,0
46507,;,0,0
46508,III,0,0
46509,-,0,0
46510,17.2,0,0
46511,+/-,0,0
46512,5.5,0,0
46513,hr,0,0
46514,;,0,0
46515,IV,0,0
46516,-,0,0
46517,17.0,0,0
46518,+/-,0,0
46519,5.8,0,0
46520,hr,0,0
46521,;,0,0
46522,P,0,0
46523,<,0,0
46524,0.05,0,0
46525,),0,0
46526,.,0,0
46527,Total,0,0
46528,analgesic,0,0
46529,(,0,0
46530,paracetamol,0,0
46531,),0,0
46532,consumption,0,0
46533,was,0,0
46534,significantly,0,0
46535,more,0,0
46536,in,0,0
46537,Group,0,0
46538,I,0,0
46539,(,0,0
46540,697.6,0,0
46541,+/-,0,0
46542,240.7,0,0
46543,mg,0,0
46544,),0,0
46545,than,0,0
46546,in,0,0
46547,the,0,0
46548,groups,0,0
46549,receiving,0,0
46550,caudal,0,0
46551,neostigmine,0,0
46552,(,0,0
46553,II,0,1
46554,-,0,0
46555,248.0,0,0
46556,+/-,0,0
46557,178.4,0,0
46558,;,0,0
46559,III,0,1
46560,-,0,0
46561,270.2,0,0
46562,+/-,0,0
46563,180.8,0,1
46564,and,0,0
46565,IV,0,0
46566,-230.6,0,0
46567,+/-,0,0
46568,166.9,0,0
46569,mg,0,0
46570,;,0,0
46571,P,0,0
46572,<,0,0
46573,0.05,0,0
46574,),0,0
46575,.,0,0
46576,Groups,0,0
46577,II,0,0
46578,",",0,0
46579,III,0,0
46580,and,0,0
46581,IV,0,0
46582,were,0,0
46583,comparable,0,0
46584,with,0,1
46585,regards,0,0
46586,to,0,0
46587,duration,0,0
46588,of,0,0
46589,postoperative,0,0
46590,analgesia,0,0
46591,and,0,0
46592,total,0,1
46593,analgesic,0,0
46594,consumption,0,0
46595,(,0,0
46596,P,0,0
46597,>,0,1
46598,0.05,0,0
46599,),0,0
46600,.,0,0
46601,Incidence,0,0
46602,of,0,0
46603,nausea,0,0
46604,and,0,0
46605,vomiting,0,0
46606,were,0,0
46607,comparable,0,0
46608,in,0,0
46609,all,0,0
46610,four,0,0
46611,groups,0,0
46612,.,0,0
46613,No,0,0
46614,significant,0,0
46615,alteration,0,0
46616,in,0,0
46617,vital,0,0
46618,signs,0,0
46619,or,0,1
46620,any,0,0
46621,other,0,0
46622,adverse,0,0
46623,effects,0,0
46624,were,0,0
46625,observed,0,0
46626,.,0,0
46627,CONCLUSIONS,0,0
46628,Caudal,0,0
46629,neostigmine,0,0
46630,(,0,0
46631,2,0,0
46632,",",0,0
46633,3,0,0
46634,and,0,0
46635,4,0,0
46636,microg.kg,0,0
46637,(,0,0
46638,-1,0,0
46639,),0,0
46640,),0,0
46641,with,0,0
46642,bupivacaine,0,0
46643,produces,0,0
46644,a,0,0
46645,dose-independent,0,0
46646,analgesic,0,0
46647,effect,0,0
46648,(,0,0
46649,approximately,0,0
46650,16-17,0,1
46651,hr,0,0
46652,),0,0
46653,in,0,0
46654,children,0,1
46655,as,0,0
46656,compared,0,0
46657,to,0,0
46658,those,0,0
46659,receiving,0,0
46660,caudal,0,0
46661,bupivacaine,0,0
46662,alone,0,0
46663,(,0,0
46664,approximately,0,0
46665,five,0,1
46666,hours,0,0
46667,),0,0
46668,and,0,0
46669,a,0,0
46670,reduction,0,0
46671,in,0,0
46672,postoperative,0,0
46673,rescue,0,0
46674,analgesic,0,0
46675,consumption,0,0
46676,without,0,0
46677,increasing,0,0
46678,the,0,0
46679,incidence,0,0
46680,of,0,0
46681,adverse,0,0
46682,effects,0,0
46683,.,0,1
46684,A,0,0
46685,double,0,0
46686,blind,0,0
46687,randomized,0,0
46688,trial,0,0
46689,to,0,0
46690,compare,0,0
46691,the,0,0
46692,effects,0,0
46693,of,0,0
46694,eprosartan,0,0
46695,and,0,0
46696,enalapril,0,0
46697,on,0,0
46698,blood,0,0
46699,pressure,0,0
46700,",",0,0
46701,platelets,0,0
46702,",",0,0
46703,and,0,0
46704,endothelium,0,0
46705,function,0,0
46706,in,0,0
46707,patients,1,1
46708,with,1,1
46709,essential,1,1
46710,hypertension,1,1
46711,.,1,0
46712,The,0,0
46713,renin-angiotensin,0,0
46714,system,0,0
46715,is,0,0
46716,the,0,0
46717,major,0,0
46718,contributor,0,0
46719,to,0,0
46720,development,0,0
46721,of,0,0
46722,hypertension,0,1
46723,",",0,0
46724,atherosclerosis,0,1
46725,",",0,0
46726,and,0,0
46727,many,0,0
46728,other,0,0
46729,cardiovascular,0,1
46730,diseases,0,1
46731,.,0,1
46732,Angiotensin,0,0
46733,II,0,0
46734,",",0,0
46735,one,0,0
46736,of,0,0
46737,the,0,0
46738,main,0,0
46739,effectors,0,0
46740,of,0,0
46741,this,0,0
46742,system,0,0
46743,",",0,0
46744,contributes,0,0
46745,to,0,0
46746,the,0,0
46747,pathogenesis,0,0
46748,of,0,0
46749,hypertension,0,1
46750,and,0,0
46751,plays,0,0
46752,an,0,0
46753,important,0,0
46754,role,0,0
46755,in,0,0
46756,monocyte,0,0
46757,",",0,0
46758,platelet,0,0
46759,",",0,0
46760,and,0,0
46761,endothelium,0,0
46762,interactions,0,0
46763,.,0,0
46764,The,0,0
46765,effects,0,0
46766,on,0,0
46767,platelet,0,0
46768,and,0,0
46769,endothelial,0,0
46770,function,0,0
46771,",",0,0
46772,either,0,0
46773,by,0,0
46774,angiotensin,0,0
46775,converting,0,0
46776,enzyme,0,0
46777,inhibitors,0,0
46778,or,0,1
46779,angiotensin,0,0
46780,receptor,0,0
46781,antagonists,0,0
46782,",",0,0
46783,are,0,0
46784,still,0,0
46785,not,0,0
46786,well,0,0
46787,understood,0,0
46788,.,0,0
46789,A,0,0
46790,double-blind,0,0
46791,",",0,0
46792,randomized,0,0
46793,",",0,0
46794,prospective,0,0
46795,trial,0,0
46796,of,0,0
46797,either,0,0
46798,enalapril,0,0
46799,(,0,0
46800,10-20,0,0
46801,mg,0,0
46802,daily,0,0
46803,),0,0
46804,or,0,0
46805,eprosartan,0,0
46806,(,0,0
46807,400-800,0,0
46808,mg,0,0
46809,daily,0,0
46810,),0,0
46811,over,0,0
46812,a,0,0
46813,10-week,0,0
46814,period,0,0
46815,was,0,0
46816,conducted,0,0
46817,in,0,0
46818,42,1,1
46819,patients,1,1
46820,(,1,1
46821,27,1,1
46822,males,1,1
46823,",",1,0
46824,15,1,1
46825,females,1,1
46826,),1,1
46827,.,1,0
46828,Platelet,0,0
46829,activation,0,0
46830,was,0,0
46831,evaluated,0,0
46832,by,0,0
46833,measuring,0,0
46834,platelet,0,0
46835,factor,0,0
46836,4,0,0
46837,(,0,0
46838,PF-4,0,0
46839,),0,0
46840,",",0,0
46841,beta-thromboglobulin,0,0
46842,(,0,0
46843,beta-TG,0,0
46844,),0,0
46845,",",0,0
46846,the,0,0
46847,ratio,0,0
46848,of,0,0
46849,platelet,0,0
46850,factor,0,0
46851,4,0,0
46852,to,0,0
46853,beta-thromboglobulin,0,0
46854,",",0,0
46855,and,0,0
46856,endothelial,0,0
46857,function,0,0
46858,by,0,0
46859,measuring,0,0
46860,total,0,1
46861,plasma,0,0
46862,nitrate,0,0
46863,levels,0,0
46864,",",0,0
46865,von,0,1
46866,Willebrand,0,0
46867,factor,0,0
46868,(,0,0
46869,vWF,0,0
46870,),0,0
46871,levels,0,0
46872,",",0,0
46873,and,0,0
46874,blood,0,0
46875,flow,0,0
46876,using,0,0
46877,venous,0,0
46878,occlusive,0,1
46879,plethysmography,0,0
46880,.,0,0
46881,After,0,0
46882,a,0,0
46883,10-week,0,0
46884,treatment,0,0
46885,with,0,1
46886,enalapril,0,0
46887,or,0,0
46888,eprosartan,0,0
46889,",",0,0
46890,the,0,0
46891,sitting,0,0
46892,blood,0,0
46893,pressure,0,0
46894,in,0,0
46895,both,0,0
46896,the,0,0
46897,enalapril,0,0
46898,group,0,0
46899,(,0,0
46900,from,0,0
46901,152.2,0,0
46902,+/-,0,0
46903,18.7,0,0
46904,mmHg,0,0
46905,to,0,0
46906,141.9,0,0
46907,+/-,0,0
46908,23.5,0,0
46909,mmHg,0,0
46910,",",0,0
46911,P,0,0
46912,<,0,0
46913,0.05,0,0
46914,),0,0
46915,and,0,0
46916,eprosartan,0,0
46917,group,0,0
46918,(,0,0
46919,from,0,0
46920,151,0,1
46921,+/-,0,0
46922,10.0,0,0
46923,mmHg,0,0
46924,to,0,0
46925,142.3,0,0
46926,+/-,0,0
46927,12.9,0,0
46928,mmHg,0,0
46929,",",0,0
46930,P,0,0
46931,<,0,0
46932,0.05,0,0
46933,),0,0
46934,was,0,0
46935,significantly,0,0
46936,reduced,0,0
46937,.,0,0
46938,Significant,0,0
46939,diastolic,0,0
46940,blood,0,0
46941,pressure,0,0
46942,(,0,0
46943,DPB,0,0
46944,),0,0
46945,reduction,0,0
46946,(,0,0
46947,from,0,0
46948,94,0,1
46949,+/-,0,0
46950,8.7,0,0
46951,to,0,0
46952,84.5,0,0
46953,+/-,0,0
46954,9.6,0,0
46955,mmHg,0,0
46956,",",0,0
46957,P,0,0
46958,<,0,0
46959,0.05,0,0
46960,),0,0
46961,and,0,0
46962,a,0,0
46963,greater,0,0
46964,DBP,0,0
46965,reduction,0,0
46966,response,0,0
46967,were,0,0
46968,found,0,0
46969,in,0,0
46970,the,0,0
46971,eprosartan,0,0
46972,group,0,0
46973,(,0,0
46974,63,0,0
46975,%,0,0
46976,in,0,0
46977,eprosartan,0,0
46978,versus,0,0
46979,25,0,0
46980,%,0,0
46981,in,0,0
46982,enalapril,0,0
46983,),0,0
46984,.,0,0
46985,Additionally,0,0
46986,",",0,0
46987,dose-dependent,0,0
46988,reductions,0,0
46989,in,0,0
46990,the,0,0
46991,indices,0,0
46992,of,0,0
46993,platelet,0,0
46994,activation,0,0
46995,and,0,0
46996,endothelial,0,0
46997,dysfunction,0,0
46998,were,0,0
46999,observed,0,0
47000,in,0,0
47001,patients,0,1
47002,administered,0,0
47003,high,0,1
47004,dose,0,0
47005,treatments,0,0
47006,of,0,0
47007,eprosartan,0,0
47008,and,0,0
47009,enalapril,0,0
47010,",",0,0
47011,and,0,0
47012,the,0,0
47013,beneficial,0,0
47014,effects,0,0
47015,of,0,0
47016,these,0,0
47017,agents,0,0
47018,were,0,0
47019,not,0,0
47020,correlated,0,0
47021,with,0,0
47022,the,0,0
47023,reduction,0,0
47024,of,0,0
47025,blood,0,0
47026,pressure,0,0
47027,using,0,0
47028,both,0,0
47029,agents,0,0
47030,.,0,0
47031,Eprosartan,0,0
47032,is,0,0
47033,effective,0,0
47034,and,0,0
47035,well-tolerated,0,0
47036,in,0,0
47037,the,0,0
47038,treatment,0,0
47039,of,0,0
47040,mid-to-moderate,0,0
47041,hypertension,0,1
47042,",",0,0
47043,and,0,0
47044,the,0,0
47045,DBP,0,0
47046,response,0,0
47047,reduction,0,0
47048,to,0,0
47049,eprosartin,0,0
47050,was,0,0
47051,better,0,0
47052,than,0,0
47053,that,0,0
47054,to,0,0
47055,enalapril,0,0
47056,.,0,0
47057,A,0,0
47058,high,0,0
47059,dose,0,0
47060,of,0,0
47061,either,0,0
47062,eprosartan,0,0
47063,or,0,0
47064,enalapril,0,0
47065,significantly,0,0
47066,decreased,0,0
47067,the,0,0
47068,indices,0,0
47069,of,0,0
47070,platelet,0,0
47071,activation,0,0
47072,and,0,0
47073,endothelial,0,0
47074,dysfunction,0,0
47075,in,0,0
47076,hypertensive,1,1
47077,patients,1,1
47078,.,1,1
47079,The,0,0
47080,benefits,0,0
47081,of,0,0
47082,both,0,0
47083,agents,0,0
47084,can,0,0
47085,not,0,0
47086,be,0,0
47087,explained,0,0
47088,solely,0,0
47089,by,0,0
47090,their,0,0
47091,antihypertensive,0,0
47092,effects,0,0
47093,and,0,0
47094,possibly,0,0
47095,may,0,0
47096,be,0,0
47097,mediated,0,0
47098,through,0,0
47099,their,0,0
47100,unique,0,0
47101,effect,0,0
47102,on,0,0
47103,angiotensin,0,0
47104,blockade,0,0
47105,.,0,0
47106,Low-dose,0,0
47107,oral,0,0
47108,etoposide-based,0,0
47109,induction,0,0
47110,regimen,0,0
47111,for,0,0
47112,children,1,1
47113,with,1,1
47114,acute,1,1
47115,lymphoblastic,1,1
47116,leukemia,1,1
47117,in,1,0
47118,first,1,0
47119,bone,1,0
47120,marrow,1,0
47121,relapse,1,0
47122,.,1,0
47123,We,0,0
47124,evaluated,0,0
47125,the,0,0
47126,clinical,0,0
47127,response,0,0
47128,to,0,0
47129,low-dose,0,0
47130,etoposide,0,0
47131,in,0,0
47132,relapsed,1,0
47133,acute,1,1
47134,lymphoblastic,1,1
47135,leukemia,1,1
47136,(,1,0
47137,ALL,1,0
47138,),1,0
47139,.,1,0
47140,Of,0,0
47141,the,0,0
47142,45,1,0
47143,patients,1,1
47144,with,1,1
47145,ALL,1,1
47146,in,1,0
47147,first,1,0
47148,bone,1,0
47149,marrow,1,0
47150,relapse,1,0
47151,enrolled,1,1
47152,on,0,0
47153,the,0,0
47154,ALL,0,0
47155,R15,0,0
47156,protocol,0,0
47157,",",0,0
47158,44,0,0
47159,had,0,0
47160,received,0,0
47161,epipodophyllotoxins,0,0
47162,during,0,0
47163,frontline,0,1
47164,therapy,0,0
47165,.,0,0
47166,In,0,0
47167,the,0,0
47168,first,0,0
47169,week,0,0
47170,of,0,0
47171,remission,0,0
47172,induction,0,0
47173,therapy,0,0
47174,",",0,0
47175,patients,0,1
47176,received,0,0
47177,etoposide,0,0
47178,(,0,0
47179,50,0,0
47180,mg/m,0,0
47181,(,0,0
47182,2,0,0
47183,),0,0
47184,per,0,0
47185,day,0,0
47186,),0,0
47187,administered,0,0
47188,orally,0,0
47189,as,0,0
47190,a,0,0
47191,single,0,0
47192,agent,0,0
47193,once,0,0
47194,or,0,0
47195,twice,0,0
47196,daily,0,0
47197,.,0,0
47198,On,0,0
47199,Day,0,0
47200,8,0,0
47201,",",0,0
47202,patients,0,1
47203,started,0,0
47204,to,0,0
47205,receive,0,0
47206,dexamethasone,0,0
47207,",",0,0
47208,vincristine,0,0
47209,",",0,0
47210,and,0,0
47211,L-asparaginase,0,0
47212,.,0,0
47213,Etoposide,0,0
47214,was,0,0
47215,administered,0,0
47216,until,0,0
47217,Day,0,0
47218,22,0,1
47219,.,0,1
47220,Two,0,0
47221,courses,0,0
47222,of,0,0
47223,consolidation,0,0
47224,therapy,0,0
47225,were,0,0
47226,followed,0,0
47227,by,0,0
47228,continuation,0,0
47229,therapy,0,0
47230,or,0,0
47231,hematopoietic,0,0
47232,stem,0,0
47233,cell,0,1
47234,transplantation,0,1
47235,.,0,0
47236,After,0,0
47237,7,0,0
47238,days,0,0
47239,of,0,0
47240,single-agent,0,0
47241,etoposide,0,0
47242,treatment,0,0
47243,",",0,0
47244,peripheral,0,0
47245,blast,0,0
47246,cell,0,1
47247,counts,0,0
47248,(,0,0
47249,P=0.013,0,0
47250,),0,0
47251,and,0,0
47252,percentages,0,0
47253,of,0,0
47254,bone,0,0
47255,marrow,0,1
47256,blasts,0,0
47257,(,0,0
47258,P=0.016,0,0
47259,),0,0
47260,were,0,0
47261,significantly,0,0
47262,reduced,0,0
47263,.,0,0
47264,In,0,0
47265,all,0,0
47266,",",0,0
47267,38,0,0
47268,(,0,0
47269,84.4,0,0
47270,%,0,0
47271,),0,0
47272,attained,0,0
47273,second,0,0
47274,remission,0,1
47275,.,0,0
47276,Only,0,0
47277,time,0,0
47278,to,0,0
47279,relapse,0,0
47280,was,0,0
47281,significantly,0,0
47282,associated,0,0
47283,with,0,0
47284,outcome,0,0
47285,(,0,0
47286,P=0.025,0,0
47287,),0,0
47288,:,0,1
47289,the,0,0
47290,5-year,0,0
47291,event-free,0,0
47292,survival,0,0
47293,estimates,0,0
47294,(,0,0
47295,+/-se,0,0
47296,),0,0
47297,were,0,0
47298,52.0+/-9.6,0,0
47299,%,0,0
47300,for,0,0
47301,those,0,0
47302,with,0,0
47303,late,0,0
47304,relapse,0,0
47305,and,0,0
47306,20.0+/-8.0,0,0
47307,%,0,0
47308,for,0,0
47309,those,0,0
47310,with,0,0
47311,early,0,0
47312,relapse,0,0
47313,.,0,0
47314,We,0,0
47315,conclude,0,0
47316,that,0,0
47317,low-dose,0,0
47318,etoposide,0,0
47319,administered,0,0
47320,orally,0,0
47321,has,0,0
47322,a,0,0
47323,cytoreductive,0,0
47324,effect,0,0
47325,in,0,0
47326,relapsed,0,1
47327,ALL,0,1
47328,.,0,0
47329,Absorption,0,0
47330,of,0,0
47331,intramuscular,0,0
47332,phenobarbitone,0,0
47333,in,0,0
47334,children,1,1
47335,with,1,1
47336,severe,1,1
47337,falciparum,1,0
47338,malaria,1,1
47339,.,1,0
47340,The,0,0
47341,absorption,0,0
47342,of,0,0
47343,intramuscular,0,0
47344,phenobarbitone,0,0
47345,7,0,0
47346,mg.kg-1,0,0
47347,was,0,0
47348,studied,0,1
47349,in,0,0
47350,11,1,1
47351,Karen,1,1
47352,children,1,1
47353,aged,1,1
47354,between,1,0
47355,1.7,1,0
47356,and,1,0
47357,11,1,0
47358,y,1,1
47359,with,1,1
47360,severe,1,1
47361,falciparum,1,0
47362,malaria,1,1
47363,.,1,0
47364,Eight,1,0
47365,of,1,0
47366,the,1,0
47367,children,1,1
47368,were,1,0
47369,comatose,1,1
47370,.,1,1
47371,Clinical,0,0
47372,findings,0,0
47373,were,0,0
47374,compared,0,0
47375,with,0,0
47376,those,0,0
47377,in,0,0
47378,9,1,0
47379,further,1,0
47380,children,1,1
47381,with,1,1
47382,severe,1,1
47383,malaria,1,1
47384,of,1,0
47385,similar,1,0
47386,age,1,1
47387,range,1,0
47388,(,1,0
47389,four,1,1
47390,of,1,1
47391,whom,1,1
47392,were,1,1
47393,unconscious,1,1
47394,),1,1
47395,",",0,0
47396,who,0,1
47397,received,0,1
47398,an,0,1
47399,identical,0,0
47400,placebo,0,0
47401,.,0,0
47402,One,0,0
47403,child,0,1
47404,",",0,0
47405,who,0,1
47406,had,0,1
47407,received,0,1
47408,placebo,0,0
47409,",",0,0
47410,had,0,0
47411,repeated,0,0
47412,convulsions,0,0
47413,and,0,0
47414,died,0,1
47415,1,0,0
47416,h,0,0
47417,after,0,0
47418,admission,0,0
47419,to,0,0
47420,hospital,0,0
47421,.,0,0
47422,The,0,0
47423,remainder,0,0
47424,made,0,0
47425,an,0,0
47426,uncomplicated,0,0
47427,recovery,0,0
47428,.,0,0
47429,There,0,0
47430,were,0,0
47431,no,0,0
47432,convulsions,0,0
47433,subsequent,0,0
47434,to,0,0
47435,treatment,0,0
47436,",",0,0
47437,although,0,0
47438,the,0,0
47439,study,0,0
47440,was,0,0
47441,too,0,0
47442,small,0,0
47443,to,0,0
47444,assess,0,0
47445,anticonvulsant,0,0
47446,efficacy,0,0
47447,.,0,0
47448,There,0,0
47449,was,0,0
47450,no,0,0
47451,observable,0,0
47452,toxicity,0,0
47453,",",0,0
47454,but,0,0
47455,phenobarbitone,0,0
47456,recipients,0,1
47457,had,0,0
47458,a,0,0
47459,significant,0,0
47460,tendency,0,0
47461,to,0,0
47462,deepen,0,0
47463,in,0,0
47464,their,0,0
47465,level,0,0
47466,of,0,0
47467,coma,0,0
47468,or,0,0
47469,to,0,0
47470,become,0,0
47471,sleepy,0,0
47472,within,0,0
47473,the,0,0
47474,4,0,0
47475,h,0,0
47476,after,0,0
47477,drug,0,0
47478,administration,0,0
47479,.,0,0
47480,Phenobarbitone,0,0
47481,was,0,0
47482,rapidly,0,0
47483,absorbed,0,0
47484,",",0,0
47485,reaching,0,0
47486,a,0,0
47487,mean,0,0
47488,(,0,0
47489,range,0,0
47490,),0,0
47491,peak,0,0
47492,concentration,0,0
47493,of,0,0
47494,34.2,0,0
47495,[,0,0
47496,29.3-42.6,0,0
47497,],0,0
47498,mumol.l-1,0,0
47499,in,0,0
47500,a,0,0
47501,median,0,0
47502,(,0,0
47503,range,0,0
47504,),0,0
47505,of,0,0
47506,4,0,0
47507,(,0,0
47508,2.5-12,0,0
47509,),0,0
47510,h.,0,0
47511,These,0,0
47512,values,0,0
47513,are,0,0
47514,comparable,0,0
47515,to,0,0
47516,those,0,0
47517,previously,0,0
47518,reported,0,0
47519,in,0,0
47520,healthy,0,1
47521,children,0,1
47522,and,0,0
47523,in,0,0
47524,children,0,1
47525,with,0,1
47526,febrile,0,1
47527,convulsions,0,0
47528,.,0,1
47529,Intramuscular,0,0
47530,phenobarbitone,0,0
47531,is,0,0
47532,well,0,0
47533,absorbed,0,0
47534,in,0,0
47535,children,1,1
47536,with,1,1
47537,severe,1,1
47538,malaria,1,1
47539,;,1,0
47540,the,0,0
47541,optimum,0,0
47542,prophylactic,0,0
47543,anticonvulsant,0,0
47544,dose,0,0
47545,remains,0,0
47546,to,0,0
47547,be,0,0
47548,determined,0,0
47549,.,0,0
47550,Position,0,0
47551,of,0,0
47552,anterior,0,0
47553,capsulorhexis,0,0
47554,and,0,0
47555,posterior,0,0
47556,capsule,0,0
47557,opacification,0,0
47558,.,0,0
47559,PURPOSE,0,0
47560,To,0,0
47561,evaluate,0,0
47562,whether,0,0
47563,the,0,0
47564,position,0,0
47565,of,0,0
47566,the,0,0
47567,anterior,0,0
47568,continuous,0,0
47569,curvilinear,0,0
47570,capsulorhexis,0,0
47571,influences,0,0
47572,the,0,0
47573,rate,0,0
47574,of,0,0
47575,posterior,0,0
47576,capsule,0,0
47577,opacification,0,0
47578,(,0,0
47579,PCO,0,0
47580,),0,0
47581,.,0,0
47582,METHODS,0,0
47583,A,1,0
47584,total,1,0
47585,of,1,0
47586,119,1,1
47587,patients,1,1
47588,",",1,0
47589,aged,1,1
47590,61-86,1,1
47591,years,1,1
47592,",",1,0
47593,underwent,1,1
47594,cataract,1,1
47595,surgery,1,1
47596,with,1,0
47597,phacoemulsification,1,0
47598,performed,1,0
47599,by,1,0
47600,a,1,0
47601,single,1,0
47602,surgeon,1,0
47603,.,1,0
47604,The,0,0
47605,patients,0,1
47606,were,0,0
47607,randomized,0,0
47608,to,0,0
47609,implantation,0,0
47610,with,0,0
47611,either,0,0
47612,a,0,0
47613,silicone,0,0
47614,intraocular,0,0
47615,lens,0,0
47616,(,0,0
47617,IOL,0,0
47618,),0,0
47619,(,0,0
47620,SI40NB,0,1
47621,",",0,0
47622,Allergan,0,0
47623,),0,0
47624,or,0,0
47625,an,0,0
47626,AcrySof,0,0
47627,IOL,0,0
47628,(,0,0
47629,MA60BM,0,0
47630,",",0,0
47631,Alcon,0,0
47632,),0,0
47633,.,0,0
47634,Three,0,0
47635,years,0,1
47636,after,0,0
47637,surgery,0,1
47638,",",0,0
47639,the,0,0
47640,rate,0,0
47641,of,0,0
47642,PCO,0,0
47643,was,0,0
47644,analysed,0,0
47645,using,0,0
47646,the,0,0
47647,evaluation,0,0
47648,of,0,0
47649,posterior,0,0
47650,capsule,0,0
47651,opacification,0,0
47652,computer,0,0
47653,software,0,0
47654,(,0,0
47655,EPCO,0,0
47656,),0,0
47657,.,0,0
47658,The,0,0
47659,results,0,0
47660,were,0,0
47661,related,0,0
47662,to,0,0
47663,the,0,0
47664,capsulorhexis,0,0
47665,position,0,0
47666,",",0,0
47667,which,0,0
47668,was,0,0
47669,assessed,0,0
47670,with,0,0
47671,a,0,0
47672,retroillumination,0,0
47673,photograph,0,0
47674,.,0,0
47675,RESULTS,0,0
47676,If,0,0
47677,the,0,0
47678,capsulorhexis,0,0
47679,was,0,0
47680,located,0,0
47681,partially,0,0
47682,or,0,0
47683,completely,0,0
47684,off,0,0
47685,the,0,0
47686,optics,0,0
47687,of,0,0
47688,the,0,0
47689,IOL,0,0
47690,",",0,0
47691,compared,0,0
47692,to,0,0
47693,totally,0,0
47694,on,0,0
47695,the,0,0
47696,IOL,0,0
47697,",",0,0
47698,significantly,0,0
47699,more,0,0
47700,PCO,0,0
47701,was,0,0
47702,found,0,0
47703,(,0,0
47704,p,0,0
47705,=,0,0
47706,0.0014,0,0
47707,),0,0
47708,.,0,0
47709,When,0,0
47710,comparing,0,0
47711,within,0,0
47712,each,0,0
47713,IOL,0,0
47714,type,0,1
47715,",",0,0
47716,patients,0,1
47717,with,0,1
47718,AcrySof,0,0
47719,IOLs,0,0
47720,were,0,0
47721,found,0,0
47722,to,0,0
47723,have,0,0
47724,significantly,0,0
47725,less,0,0
47726,PCO,0,0
47727,when,0,0
47728,the,0,0
47729,capsulorhexis,0,0
47730,was,0,0
47731,totally,0,0
47732,on,0,0
47733,the,0,0
47734,optic,0,0
47735,(,0,0
47736,p,0,0
47737,=,0,0
47738,0.0048,0,0
47739,),0,0
47740,.,0,0
47741,This,0,0
47742,difference,0,0
47743,was,0,0
47744,also,0,0
47745,significant,0,0
47746,in,0,0
47747,the,0,0
47748,silicone,0,0
47749,group,0,0
47750,(,0,0
47751,p,0,0
47752,=,0,0
47753,0.041,0,0
47754,),0,0
47755,.,0,0
47756,CONCLUSION,0,0
47757,A,0,0
47758,relatively,0,0
47759,small,0,0
47760,and,0,0
47761,central,0,0
47762,capsulorhexis,0,0
47763,allowing,0,0
47764,for,0,0
47765,the,0,0
47766,complete,0,0
47767,covering,0,0
47768,of,0,0
47769,the,0,0
47770,IOL,0,0
47771,optics,0,0
47772,by,0,0
47773,the,0,0
47774,rhexis,0,0
47775,edges,0,0
47776,seems,0,0
47777,to,0,0
47778,protect,0,0
47779,against,0,0
47780,PCO,0,0
47781,in,0,0
47782,cataract,0,1
47783,surgery,0,1
47784,",",0,0
47785,with,0,0
47786,both,0,0
47787,round-edged,0,0
47788,silicone,0,0
47789,IOLs,0,0
47790,and,0,0
47791,sharp-edged,0,0
47792,hydrophobic,0,0
47793,acrylic,0,1
47794,IOLs,0,0
47795,.,0,1
47796,Neridronate,0,0
47797,prevents,0,0
47798,bone,0,0
47799,loss,0,0
47800,in,0,0
47801,patients,1,1
47802,receiving,1,1
47803,androgen,1,0
47804,deprivation,1,0
47805,therapy,1,0
47806,for,1,0
47807,prostate,1,1
47808,cancer,1,1
47809,.,1,0
47810,UNLABELLED,0,0
47811,Today,0,0
47812,",",0,0
47813,androgen,0,0
47814,deprivation,0,0
47815,therapy,0,0
47816,is,0,0
47817,a,0,0
47818,cornerstone,0,0
47819,of,0,0
47820,treatment,0,0
47821,for,0,0
47822,advanced,1,1
47823,prostate,1,1
47824,cancer,1,1
47825,",",0,0
47826,although,0,0
47827,it,0,0
47828,presents,0,0
47829,important,0,0
47830,complications,0,0
47831,such,0,0
47832,as,0,0
47833,osteoporosis,0,1
47834,.,0,0
47835,Neridronate,0,0
47836,",",0,0
47837,a,0,0
47838,relatively,0,0
47839,new,0,0
47840,bisphosphonate,0,0
47841,",",0,0
47842,is,0,0
47843,able,0,0
47844,to,0,0
47845,prevent,0,0
47846,bone,0,0
47847,loss,0,0
47848,in,0,0
47849,patients,1,1
47850,with,1,1
47851,prostate,1,1
47852,cancer,1,1
47853,during,1,0
47854,androgen,1,0
47855,ablation,1,1
47856,.,1,0
47857,INTRODUCTION,0,0
47858,Androgen-deprivation,0,0
47859,therapy,0,0
47860,(,0,0
47861,ADT,0,0
47862,),0,0
47863,is,0,0
47864,a,0,0
47865,cornerstone,0,0
47866,of,0,0
47867,treatment,0,0
47868,for,0,0
47869,advanced,1,1
47870,prostate,1,1
47871,cancer,1,1
47872,.,1,0
47873,This,0,0
47874,therapy,0,0
47875,has,0,0
47876,iatrogenic,0,0
47877,complications,0,0
47878,",",0,0
47879,such,0,0
47880,as,0,0
47881,osteoporosis,0,1
47882,.,0,0
47883,The,0,0
47884,aim,0,0
47885,of,0,0
47886,our,0,0
47887,study,0,0
47888,was,0,0
47889,to,0,0
47890,evaluate,0,0
47891,the,0,0
47892,efficacy,0,0
47893,of,0,0
47894,neridronate,0,0
47895,",",0,0
47896,a,0,0
47897,relatively,0,0
47898,new,0,0
47899,bisphosphonate,0,0
47900,",",0,0
47901,to,0,0
47902,prevent,0,0
47903,bone,0,0
47904,loss,0,0
47905,during,0,0
47906,androgen,0,0
47907,ablation,0,1
47908,.,0,0
47909,MATERIALS,0,0
47910,AND,0,0
47911,METHODS,0,0
47912,Forty-eight,1,1
47913,osteoporotic,1,1
47914,patients,1,1
47915,with,1,1
47916,prostate,1,1
47917,cancer,1,1
47918,",",1,0
47919,treated,1,0
47920,with,1,0
47921,3-month,1,0
47922,depot,1,0
47923,triptorelina,1,0
47924,",",0,0
47925,were,0,0
47926,enrolled,0,1
47927,and,0,0
47928,randomly,0,0
47929,assigned,0,0
47930,to,0,0
47931,two,0,0
47932,different,0,0
47933,treatment,0,0
47934,groups,0,0
47935,:,0,1
47936,group,0,0
47937,A,0,0
47938,(,1,0
47939,n,1,1
47940,=,1,0
47941,24,1,0
47942,),1,0
47943,was,0,0
47944,treated,0,0
47945,with,0,0
47946,a,0,0
47947,daily,0,0
47948,calcium,0,0
47949,and,0,0
47950,cholecalciferol,0,0
47951,supplement,0,0
47952,(,0,0
47953,500,0,0
47954,mg,0,0
47955,of,0,0
47956,elemental,0,0
47957,calcium,0,0
47958,and,0,0
47959,400,0,0
47960,IU,0,0
47961,cholecalciferol,0,0
47962,),0,0
47963,",",0,0
47964,and,0,0
47965,group,0,0
47966,B,0,0
47967,(,1,0
47968,n,1,1
47969,=,1,0
47970,24,1,0
47971,),1,0
47972,received,0,0
47973,in,0,0
47974,addition,0,0
47975,to,0,0
47976,the,0,0
47977,same,0,0
47978,daily,0,0
47979,calcium,0,0
47980,and,0,0
47981,cholecalciferol,0,0
47982,supplement,0,0
47983,",",0,0
47984,25,0,0
47985,mg,0,0
47986,of,0,0
47987,neridronate,0,0
47988,given,0,0
47989,intramuscularly,0,0
47990,every,0,0
47991,month,0,0
47992,.,0,0
47993,All,0,0
47994,patients,0,1
47995,also,0,0
47996,received,0,0
47997,bicalutamide,0,0
47998,for,0,0
47999,4,0,0
48000,weeks,0,0
48001,.,0,1
48002,Lumbar,0,1
48003,and,0,0
48004,femoral,0,1
48005,BMD,0,1
48006,was,0,0
48007,evaluated,0,0
48008,by,0,0
48009,DXA,0,0
48010,at,0,0
48011,baseline,0,0
48012,and,0,0
48013,after,0,0
48014,1,0,0
48015,year,0,0
48016,of,0,0
48017,therapy,0,0
48018,;,0,0
48019,moreover,0,0
48020,",",0,0
48021,deoxypyridinoline,0,0
48022,(,0,0
48023,DPD,0,0
48024,),0,0
48025,and,0,0
48026,bone,0,0
48027,alkaline,0,0
48028,phosphatase,0,0
48029,(,0,0
48030,BALP,0,0
48031,),0,0
48032,were,0,0
48033,determined,0,0
48034,at,0,0
48035,the,0,0
48036,beginning,0,0
48037,",",0,0
48038,midway,0,0
48039,through,0,0
48040,",",0,0
48041,and,0,0
48042,at,0,0
48043,the,0,0
48044,end,0,0
48045,of,0,0
48046,the,0,0
48047,study,0,0
48048,.,0,0
48049,RESULTS,0,0
48050,After,0,0
48051,6,0,0
48052,and,0,0
48053,12,0,0
48054,months,0,0
48055,",",0,0
48056,whereas,0,0
48057,patients,0,1
48058,treated,0,1
48059,only,0,0
48060,with,0,0
48061,calcium,0,0
48062,and,0,0
48063,cholecalciferol,0,0
48064,(,0,0
48065,group,0,0
48066,A,0,0
48067,),0,0
48068,showed,0,0
48069,a,0,0
48070,marked,0,0
48071,bone,0,0
48072,loss,0,0
48073,",",0,0
48074,with,0,1
48075,increased,0,0
48076,levels,0,0
48077,of,0,0
48078,DPD,0,0
48079,and,0,0
48080,BALP,0,0
48081,compared,0,0
48082,with,0,1
48083,baseline,0,0
48084,values,0,0
48085,",",0,0
48086,patients,0,1
48087,treated,0,0
48088,also,0,0
48089,with,0,0
48090,neridronate,0,0
48091,(,0,0
48092,group,0,0
48093,B,0,0
48094,),0,0
48095,had,0,0
48096,substantially,0,0
48097,unchanged,0,0
48098,levels,0,0
48099,of,0,0
48100,these,0,0
48101,markers,0,0
48102,.,0,0
48103,After,0,0
48104,1,0,0
48105,year,0,0
48106,of,0,0
48107,treatment,0,0
48108,",",0,0
48109,lumbar,0,0
48110,and,0,0
48111,total,0,1
48112,hip,0,1
48113,BMD,0,0
48114,decreased,0,0
48115,significantly,0,0
48116,in,0,0
48117,patients,0,1
48118,treated,0,1
48119,only,0,0
48120,with,0,0
48121,calcium,0,0
48122,and,0,0
48123,cholecalciferol,0,0
48124,(,0,0
48125,group,0,0
48126,A,0,0
48127,),0,0
48128,",",0,0
48129,whereas,0,0
48130,it,0,0
48131,did,0,0
48132,not,0,0
48133,change,0,0
48134,significantly,0,0
48135,at,0,0
48136,any,0,0
48137,skeletal,0,0
48138,site,0,0
48139,in,0,0
48140,patients,0,1
48141,treated,0,1
48142,also,0,0
48143,with,0,0
48144,neridronate,0,0
48145,(,0,0
48146,group,0,0
48147,B,0,0
48148,),0,0
48149,.,0,0
48150,No,0,0
48151,relevant,0,0
48152,side,0,0
48153,effects,0,0
48154,were,0,0
48155,recorded,0,0
48156,during,0,0
48157,our,0,0
48158,study,0,0
48159,.,0,0
48160,CONCLUSIONS,0,0
48161,Neridronate,0,0
48162,is,0,0
48163,an,0,0
48164,effective,0,0
48165,treatment,0,0
48166,in,0,0
48167,preventing,0,0
48168,bone,0,0
48169,loss,0,0
48170,in,0,0
48171,the,0,0
48172,hip,0,0
48173,and,0,0
48174,lumbar,0,0
48175,spine,0,0
48176,in,0,0
48177,men,1,1
48178,receiving,1,1
48179,ADT,1,1
48180,for,1,0
48181,prostate,1,1
48182,cancer,1,1
48183,.,1,0
48184,Acid,0,0
48185,resistance,0,0
48186,of,0,0
48187,enamel,1,0
48188,subsurface,1,0
48189,lesions,1,1
48190,remineralized,1,0
48191,by,1,0
48192,a,1,0
48193,sugar-free,1,0
48194,chewing,1,0
48195,gum,1,0
48196,containing,1,0
48197,casein,1,0
48198,phosphopeptide-amorphous,1,0
48199,calcium,1,0
48200,phosphate,1,0
48201,.,1,0
48202,The,0,0
48203,aim,0,0
48204,of,0,0
48205,this,0,0
48206,clinical,0,0
48207,study,0,0
48208,was,0,0
48209,to,0,0
48210,investigate,0,0
48211,the,0,0
48212,acid,0,0
48213,resistance,0,0
48214,of,0,0
48215,enamel,1,0
48216,lesions,1,1
48217,remineralized,1,0
48218,in,1,0
48219,situ,1,0
48220,by,1,0
48221,a,1,0
48222,sugar-free,1,0
48223,chewing,1,0
48224,gum,1,0
48225,containing,1,0
48226,casein,1,0
48227,phosphopeptide-amorphous,1,0
48228,calcium,1,0
48229,phosphate,1,0
48230,nanocomplexes,1,0
48231,(,1,0
48232,CPP-ACP,1,0
48233,:,1,1
48234,Recaldent,1,0
48235,),1,0
48236,.,1,0
48237,The,0,0
48238,study,0,0
48239,utilized,0,0
48240,a,0,0
48241,double-blind,0,0
48242,",",0,0
48243,randomized,0,0
48244,",",0,0
48245,crossover,0,0
48246,design,0,0
48247,with,0,1
48248,two,0,0
48249,treatments,0,0
48250,:,0,1
48251,(,0,0
48252,i,0,0
48253,),0,0
48254,sugar-free,0,0
48255,gum,0,0
48256,containing,0,0
48257,18.8,0,0
48258,mg,0,0
48259,of,0,0
48260,CPP-ACP,0,0
48261,",",0,0
48262,and,0,0
48263,(,0,0
48264,ii,0,0
48265,),0,0
48266,sugar-free,0,0
48267,gum,0,0
48268,not,0,0
48269,containing,0,0
48270,CPP-ACP,0,0
48271,as,0,0
48272,control,0,0
48273,.,0,0
48274,Subjects,1,0
48275,wore,1,1
48276,removable,1,0
48277,palatal,1,0
48278,appliances,1,0
48279,with,1,1
48280,insets,1,0
48281,of,1,0
48282,human,1,0
48283,enamel,1,0
48284,containing,1,0
48285,demineralized,1,0
48286,subsurface,1,0
48287,lesions,1,1
48288,and,1,0
48289,chewed,1,0
48290,the,1,0
48291,gum,1,0
48292,for,1,0
48293,20,1,0
48294,min,1,0
48295,4,1,0
48296,times,1,0
48297,per,1,0
48298,day,1,0
48299,for,1,0
48300,14,1,1
48301,days,1,0
48302,.,1,0
48303,After,0,0
48304,each,0,0
48305,treatment,0,0
48306,the,0,0
48307,enamel,0,0
48308,slabs,0,0
48309,were,0,0
48310,removed,0,0
48311,and,0,0
48312,half,0,0
48313,of,0,0
48314,each,0,0
48315,lesion,0,0
48316,challenged,0,0
48317,with,0,0
48318,acid,0,0
48319,in,0,0
48320,vitro,0,0
48321,for,0,0
48322,8,0,0
48323,or,0,1
48324,16,0,1
48325,h.,0,0
48326,The,0,0
48327,level,0,0
48328,of,0,0
48329,remineralization,0,0
48330,was,0,0
48331,determined,0,0
48332,using,0,0
48333,microradiography,0,0
48334,.,0,0
48335,The,0,0
48336,gum,0,0
48337,containing,0,0
48338,CPP-ACP,0,0
48339,produced,0,0
48340,approximately,0,0
48341,twice,0,0
48342,the,0,0
48343,level,0,0
48344,of,0,0
48345,remineralization,0,0
48346,as,0,0
48347,the,0,0
48348,control,0,0
48349,sugar-free,0,0
48350,gum,0,0
48351,.,0,0
48352,The,0,0
48353,8-,0,0
48354,and,0,0
48355,16-hour,0,0
48356,acid,0,0
48357,challenge,0,0
48358,of,0,0
48359,the,0,0
48360,lesions,0,0
48361,remineralized,0,0
48362,with,0,1
48363,the,0,0
48364,control,0,0
48365,gum,0,0
48366,resulted,0,0
48367,in,0,0
48368,65.4,0,0
48369,and,0,0
48370,88.0,0,0
48371,%,0,0
48372,reductions,0,0
48373,",",0,0
48374,respectively,0,0
48375,",",0,0
48376,of,0,0
48377,deposited,0,0
48378,mineral,0,0
48379,",",0,0
48380,while,0,0
48381,for,0,0
48382,the,0,0
48383,CPP-ACP-remineralized,0,0
48384,lesions,0,0
48385,the,0,0
48386,corresponding,0,0
48387,reductions,0,0
48388,were,0,0
48389,30.5,0,0
48390,and,0,0
48391,41.8,0,0
48392,%,0,0
48393,.,0,0
48394,The,0,0
48395,acid,0,0
48396,challenge,0,0
48397,after,0,0
48398,in,0,0
48399,situ,0,0
48400,remineralization,0,0
48401,for,0,0
48402,both,0,0
48403,control,0,0
48404,and,0,0
48405,CPP-ACP-treated,0,0
48406,lesions,0,1
48407,resulted,0,0
48408,in,0,0
48409,demineralization,0,0
48410,underneath,0,0
48411,the,0,0
48412,remineralized,0,0
48413,zone,0,0
48414,",",0,0
48415,indicating,0,0
48416,that,0,0
48417,the,0,0
48418,remineralized,0,0
48419,mineral,0,0
48420,was,0,0
48421,more,0,0
48422,resistant,0,0
48423,to,0,0
48424,subsequent,0,0
48425,acid,0,0
48426,challenge,0,0
48427,.,0,0
48428,The,0,0
48429,results,0,0
48430,show,0,0
48431,that,0,0
48432,sugar-free,0,0
48433,gum,0,0
48434,containing,0,0
48435,CPP-ACP,0,0
48436,is,0,0
48437,superior,0,0
48438,to,0,0
48439,an,0,0
48440,equivalent,0,0
48441,gum,0,0
48442,not,0,0
48443,containing,0,0
48444,CPP-ACP,0,0
48445,in,0,0
48446,remineralization,0,0
48447,of,0,0
48448,enamel,0,0
48449,subsurface,0,0
48450,lesions,0,1
48451,in,0,0
48452,situ,0,0
48453,with,0,1
48454,mineral,0,0
48455,that,0,0
48456,is,0,0
48457,more,0,0
48458,resistant,0,0
48459,to,0,0
48460,subsequent,0,0
48461,acid,0,0
48462,challenge,0,0
48463,.,0,0
48464,Intranasal,0,1
48465,nicotine,0,0
48466,for,0,0
48467,postoperative,1,0
48468,pain,1,0
48469,treatment,1,0
48470,.,1,0
48471,BACKGROUND,0,0
48472,Despite,0,0
48473,pharmacological,0,0
48474,treatment,0,0
48475,",",0,0
48476,70-80,0,0
48477,%,0,0
48478,of,0,0
48479,patients,0,1
48480,report,0,0
48481,moderate,0,1
48482,to,0,0
48483,severe,0,1
48484,pain,0,0
48485,after,0,0
48486,surgery,0,1
48487,.,0,0
48488,Because,0,0
48489,nicotine,0,0
48490,has,0,0
48491,been,0,0
48492,reported,0,0
48493,to,0,0
48494,have,0,0
48495,analgesic,0,0
48496,properties,0,0
48497,in,0,0
48498,animal,0,1
48499,and,0,0
48500,human,0,0
48501,volunteer,0,1
48502,studies,0,0
48503,",",0,0
48504,the,0,0
48505,authors,0,0
48506,assessed,0,0
48507,the,0,0
48508,analgesic,0,0
48509,efficacy,0,0
48510,of,0,0
48511,a,0,0
48512,single,0,0
48513,3,0,0
48514,mg,0,0
48515,dose,0,0
48516,of,0,0
48517,nicotine,0,0
48518,nasal,0,0
48519,spray,0,0
48520,administered,0,0
48521,before,0,0
48522,emergence,0,0
48523,from,0,0
48524,general,0,1
48525,anesthesia,0,1
48526,.,0,0
48527,METHODS,0,0
48528,The,0,0
48529,authors,0,0
48530,conducted,0,0
48531,a,0,0
48532,randomized,0,0
48533,",",0,0
48534,double,0,0
48535,blind,0,0
48536,",",0,0
48537,placebo,0,0
48538,controlled,0,0
48539,trial,0,0
48540,of,0,0
48541,20,1,1
48542,healthy,1,1
48543,women,1,1
48544,(,1,0
48545,mean,1,1
48546,age,1,1
48547,45,1,1
48548,(,1,0
48549,SD,1,0
48550,8,1,0
48551,),1,0
48552,yr,1,1
48553,),1,1
48554,who,1,1
48555,were,1,1
48556,to,1,1
48557,undergo,1,0
48558,uterine,1,1
48559,surgery,1,1
48560,through,1,0
48561,a,1,0
48562,low,1,0
48563,transverse,1,0
48564,incision,1,0
48565,.,1,0
48566,After,0,0
48567,the,0,0
48568,conclusion,0,0
48569,of,0,0
48570,surgery,0,1
48571,but,0,0
48572,before,0,0
48573,emergence,0,0
48574,from,0,0
48575,general,0,1
48576,anesthesia,0,0
48577,",",0,0
48578,the,0,0
48579,anesthesiologist,0,0
48580,administered,0,0
48581,either,0,0
48582,nicotine,0,0
48583,nasal,0,0
48584,spray,0,0
48585,or,0,0
48586,a,0,0
48587,placebo,0,0
48588,.,0,0
48589,Numerical,0,0
48590,analog,0,0
48591,pain,0,0
48592,score,0,0
48593,and,0,0
48594,morphine,0,0
48595,utilization,0,0
48596,and,0,0
48597,hemodynamic,0,0
48598,values,0,0
48599,were,0,0
48600,measured,0,0
48601,for,0,0
48602,24,0,0
48603,h.,0,0
48604,RESULTS,0,0
48605,The,0,0
48606,patients,0,1
48607,treated,0,1
48608,with,0,1
48609,nicotine,0,0
48610,reported,0,0
48611,lower,0,0
48612,pain,0,0
48613,scores,0,0
48614,during,0,0
48615,the,0,0
48616,first,0,0
48617,hour,0,0
48618,after,0,0
48619,surgery,0,1
48620,(,0,0
48621,peak,0,0
48622,numerical,0,0
48623,analog,0,0
48624,score,0,0
48625,",",0,0
48626,7.6,0,0
48627,(,0,0
48628,SD,0,0
48629,1.4,0,0
48630,),0,0
48631,versus,0,0
48632,5.3,0,0
48633,(,0,0
48634,SD,0,0
48635,1.6,0,0
48636,),0,0
48637,;,0,0
48638,P,0,0
48639,<,0,0
48640,0.001,0,0
48641,),0,0
48642,and,0,0
48643,used,0,0
48644,half,0,0
48645,the,0,0
48646,amount,0,0
48647,of,0,0
48648,morphine,0,0
48649,as,0,0
48650,the,0,0
48651,control,0,0
48652,group,0,0
48653,(,0,0
48654,12,0,0
48655,(,0,0
48656,SD,0,0
48657,6,0,0
48658,),0,0
48659,versus,0,0
48660,6,0,0
48661,(,0,0
48662,SD,0,0
48663,5,0,0
48664,),0,0
48665,mg,0,0
48666,;,0,0
48667,P,0,0
48668,<,0,0
48669,0.05,0,0
48670,),0,1
48671,.,0,1
48672,Patients,0,1
48673,who,0,1
48674,received,0,1
48675,nicotine,0,0
48676,still,0,0
48677,reported,0,0
48678,less,0,0
48679,pain,0,0
48680,than,0,0
48681,those,0,0
48682,in,0,0
48683,the,0,0
48684,control,0,0
48685,group,0,0
48686,24,0,0
48687,h,0,0
48688,after,0,0
48689,surgery,0,1
48690,(,0,0
48691,1.5,0,0
48692,(,0,0
48693,SD,0,0
48694,0.5,0,0
48695,),0,0
48696,versus,0,0
48697,4.9,0,0
48698,(,0,0
48699,SD,0,0
48700,1.4,0,1
48701,),0,0
48702,;,0,0
48703,P,0,0
48704,<,0,0
48705,0.01,0,0
48706,),0,0
48707,.,0,0
48708,Systolic,0,1
48709,blood,0,0
48710,pressure,0,0
48711,was,0,0
48712,lower,0,0
48713,in,0,0
48714,the,0,0
48715,group,0,0
48716,that,0,0
48717,received,0,0
48718,nicotine,0,0
48719,(,0,0
48720,105,0,1
48721,(,0,0
48722,SD,0,0
48723,3,0,0
48724,),0,0
48725,versus,0,0
48726,122,0,1
48727,(,0,0
48728,SD,0,0
48729,3,0,0
48730,),0,0
48731,;,0,0
48732,P,0,0
48733,<,0,0
48734,0.001,0,0
48735,),0,0
48736,",",0,0
48737,but,0,0
48738,there,0,0
48739,was,0,0
48740,no,0,0
48741,difference,0,0
48742,in,0,0
48743,diastolic,0,0
48744,blood,0,0
48745,pressure,0,0
48746,or,0,0
48747,heart,0,1
48748,rate,0,0
48749,.,0,0
48750,CONCLUSIONS,0,0
48751,Treatment,0,0
48752,with,0,1
48753,a,0,0
48754,single,0,0
48755,dose,0,0
48756,of,0,0
48757,nicotine,0,0
48758,immediately,0,0
48759,before,0,0
48760,emergence,0,0
48761,from,0,0
48762,anesthesia,0,0
48763,was,0,0
48764,associated,0,0
48765,with,0,0
48766,significantly,0,0
48767,lower,0,0
48768,reported,0,0
48769,pain,0,0
48770,scores,0,0
48771,during,0,0
48772,the,0,0
48773,first,0,0
48774,day,0,0
48775,after,0,0
48776,surgery,0,1
48777,.,0,0
48778,The,0,0
48779,decreased,0,0
48780,pain,0,0
48781,was,0,0
48782,associated,0,0
48783,with,0,0
48784,a,0,0
48785,reduction,0,0
48786,in,0,0
48787,morphine,0,0
48788,utilization,0,0
48789,and,0,0
48790,the,0,0
48791,analgesic,0,0
48792,effect,0,0
48793,of,0,0
48794,nicotine,0,0
48795,was,0,0
48796,not,0,0
48797,associated,0,0
48798,with,0,0
48799,hypertension,0,1
48800,or,0,0
48801,tachycardia,0,0
48802,.,0,0
48803,A,0,0
48804,placebo,0,0
48805,controlled,0,0
48806,crossover,0,0
48807,trial,0,0
48808,of,0,0
48809,liquid,0,0
48810,fluoxetine,0,0
48811,on,0,0
48812,repetitive,0,0
48813,behaviors,0,0
48814,in,1,0
48815,childhood,1,1
48816,and,1,0
48817,adolescent,1,1
48818,autism,1,1
48819,.,1,0
48820,Repetitive,0,0
48821,behaviors,0,0
48822,are,0,0
48823,a,0,0
48824,core,0,0
48825,symptom,0,0
48826,domain,0,0
48827,in,0,0
48828,autism,0,1
48829,that,0,0
48830,has,0,0
48831,been,0,0
48832,linked,0,0
48833,to,0,0
48834,alterations,0,0
48835,in,0,0
48836,the,0,0
48837,serotonin,0,0
48838,system,0,0
48839,.,0,0
48840,While,0,0
48841,the,0,0
48842,selective,0,0
48843,serotonin-receptive,0,0
48844,inhibitor,0,0
48845,fluvoxamine,0,0
48846,has,0,0
48847,been,0,0
48848,shown,0,0
48849,to,0,0
48850,be,0,0
48851,effective,0,0
48852,in,0,0
48853,adults,0,1
48854,with,0,1
48855,autism,0,1
48856,",",0,0
48857,as,0,0
48858,yet,0,0
48859,no,0,0
48860,published,0,0
48861,placebo,0,0
48862,controlled,0,0
48863,trials,0,0
48864,with,0,1
48865,these,0,0
48866,agents,0,0
48867,document,0,0
48868,safety,0,0
48869,and,0,0
48870,efficacy,0,0
48871,in,0,0
48872,children,1,1
48873,with,1,1
48874,autism,1,1
48875,.,1,0
48876,This,0,0
48877,study,0,0
48878,examines,0,0
48879,the,0,0
48880,selective,0,0
48881,serotonin,0,0
48882,reuptake,0,0
48883,inhibitor,0,0
48884,liquid,0,0
48885,fluoxetine,0,0
48886,in,0,0
48887,the,0,0
48888,treatment,0,0
48889,of,0,0
48890,repetitive,1,0
48891,behaviors,1,0
48892,in,1,0
48893,childhood,1,1
48894,and,1,0
48895,adolescent,1,1
48896,autism,1,1
48897,spectrum,1,1
48898,disorders,1,1
48899,(,1,0
48900,ASDs,1,0
48901,),1,0
48902,.,1,0
48903,In,0,0
48904,total,0,0
48905,",",0,0
48906,45,1,0
48907,child,1,1
48908,or,1,1
48909,adolescent,1,1
48910,patients,1,1
48911,with,1,1
48912,ASD,1,1
48913,were,1,0
48914,randomized,1,0
48915,into,1,0
48916,two,1,0
48917,acute,1,1
48918,8-week,1,0
48919,phases,1,0
48920,in,1,0
48921,a,1,0
48922,double-blind,1,0
48923,placebo-controlled,1,0
48924,crossover,1,0
48925,study,1,0
48926,of,1,0
48927,liquid,1,0
48928,fluoxetine,1,0
48929,.,1,0
48930,Study,0,0
48931,design,0,0
48932,included,0,1
48933,two,0,0
48934,randomized,0,0
48935,8-week,0,0
48936,fluoxetine,0,0
48937,and,0,0
48938,placebo,0,0
48939,phases,0,0
48940,separated,0,0
48941,by,0,0
48942,a,0,0
48943,4-week,0,0
48944,washout,0,0
48945,phase,0,0
48946,.,0,0
48947,Outcome,0,0
48948,measures,0,0
48949,included,0,1
48950,measures,0,0
48951,of,0,0
48952,repetitive,0,0
48953,behaviors,0,0
48954,and,0,0
48955,global,0,0
48956,improvement,0,0
48957,.,0,0
48958,Low-dose,0,0
48959,liquid,0,0
48960,fluoxetine,0,0
48961,(,0,0
48962,mean,0,0
48963,final,0,0
48964,dose,0,0
48965,:,0,1
48966,9.9+/-4.35,0,0
48967,mg/day,0,0
48968,),0,0
48969,was,0,0
48970,superior,0,0
48971,to,0,0
48972,placebo,0,0
48973,in,0,0
48974,the,0,0
48975,treatment,0,0
48976,of,0,0
48977,repetitive,1,0
48978,behaviors,1,0
48979,by,0,0
48980,CY-BOCS,0,0
48981,compulsion,0,0
48982,scale,0,0
48983,.,0,0
48984,The,0,0
48985,effect,0,0
48986,size,0,0
48987,was,0,0
48988,in,0,0
48989,the,0,0
48990,moderate,0,1
48991,to,0,0
48992,large,0,0
48993,range,0,0
48994,",",0,0
48995,and,0,0
48996,the,0,0
48997,doses,0,0
48998,used,0,0
48999,were,0,0
49000,low,0,0
49001,.,0,0
49002,Liquid,0,0
49003,fluoxetine,0,0
49004,was,0,0
49005,only,0,0
49006,slightly,0,0
49007,",",0,0
49008,and,0,0
49009,not,0,0
49010,significantly,0,0
49011,",",0,0
49012,superior,0,0
49013,to,0,0
49014,placebo,0,0
49015,on,0,0
49016,CGI,0,0
49017,autism,0,1
49018,score,0,0
49019,partially,0,0
49020,due,0,0
49021,to,0,0
49022,a,0,0
49023,phase,0,0
49024,order,0,0
49025,effect,0,0
49026,.,0,0
49027,However,0,0
49028,",",0,0
49029,fluoxetine,0,0
49030,was,0,0
49031,marginally,0,0
49032,superior,0,0
49033,to,0,0
49034,placebo,0,0
49035,on,0,0
49036,a,0,0
49037,composite,0,0
49038,measure,0,0
49039,of,0,0
49040,global,0,0
49041,effectiveness,0,0
49042,.,0,0
49043,Liquid,0,0
49044,fluoxetine,0,0
49045,did,0,0
49046,not,0,0
49047,significantly,0,0
49048,differ,0,0
49049,from,0,0
49050,placebo,0,0
49051,on,0,0
49052,treatment,0,0
49053,emergent,0,1
49054,side,0,0
49055,effects,0,0
49056,.,0,0
49057,Liquid,0,0
49058,fluoxetine,0,0
49059,in,0,0
49060,low,0,0
49061,doses,0,0
49062,is,0,0
49063,more,0,0
49064,effective,0,0
49065,than,0,0
49066,placebo,0,0
49067,in,0,0
49068,the,0,0
49069,treatment,0,0
49070,of,0,0
49071,repetitive,0,0
49072,behaviors,0,0
49073,in,0,0
49074,childhood,0,1
49075,autism,0,1
49076,.,0,0
49077,Limitations,0,0
49078,include,0,0
49079,small,0,0
49080,sample,0,1
49081,size,0,0
49082,and,0,0
49083,the,0,0
49084,crossover,0,0
49085,design,0,0
49086,of,0,0
49087,the,0,0
49088,study,0,0
49089,.,0,0
49090,Further,0,0
49091,replication,0,0
49092,and,0,0
49093,long-term,0,0
49094,maintenance,0,0
49095,trials,0,0
49096,are,0,0
49097,needed,0,0
49098,.,0,0
49099,Randomized,0,0
49100,",",0,0
49101,double-blind,0,0
49102,",",0,0
49103,phase,0,0
49104,III,0,0
49105,",",0,0
49106,controlled,0,0
49107,trial,0,0
49108,comparing,0,0
49109,levobupivacaine,0,0
49110,0.25,0,0
49111,%,0,0
49112,",",0,0
49113,ropivacaine,0,0
49114,0.25,0,0
49115,%,0,0
49116,and,0,0
49117,bupivacaine,0,0
49118,0.25,0,0
49119,%,0,0
49120,by,0,0
49121,the,0,0
49122,caudal,1,0
49123,route,1,0
49124,in,1,0
49125,children,1,1
49126,.,1,0
49127,BACKGROUND,0,0
49128,The,0,0
49129,rationale,0,0
49130,for,0,0
49131,replacing,0,0
49132,racemic,0,0
49133,bupivacaine,0,0
49134,with,0,1
49135,the,0,0
49136,s-enantiomers,0,0
49137,levobupivacaine,0,0
49138,and,0,0
49139,ropivacaine,0,0
49140,is,0,0
49141,to,0,0
49142,provide,0,0
49143,a,0,0
49144,wider,0,0
49145,margin,0,0
49146,of,0,0
49147,safety,0,0
49148,with,0,1
49149,the,0,0
49150,same,0,0
49151,analgesic,0,0
49152,efficacy,0,0
49153,and,0,0
49154,less,0,0
49155,postoperative,0,0
49156,motor,0,0
49157,block,0,0
49158,.,0,0
49159,In,0,0
49160,a,0,0
49161,randomized,0,0
49162,",",0,0
49163,double-blind,0,0
49164,",",0,0
49165,phase,0,0
49166,III,0,0
49167,",",0,0
49168,controlled,0,0
49169,trial,0,0
49170,we,0,0
49171,compared,0,0
49172,the,0,0
49173,caudal,0,0
49174,administration,0,0
49175,of,0,0
49176,levobupivacaine,0,0
49177,0.25,0,0
49178,%,0,0
49179,and,0,0
49180,ropivacaine,0,0
49181,0.25,0,0
49182,%,0,0
49183,with,0,1
49184,bupivacaine,0,0
49185,0.25,0,0
49186,%,0,0
49187,in,0,0
49188,children,1,1
49189,.,1,1
49190,METHODS,0,0
49191,Ninety-nine,1,1
49192,ASA,1,0
49193,I-II,1,0
49194,children,1,1
49195,less,1,0
49196,than,1,0
49197,10,1,0
49198,yr,1,1
49199,old,1,1
49200,scheduled,1,1
49201,for,1,0
49202,elective,1,1
49203,sub-umbilical,1,1
49204,surgery,1,1
49205,were,0,0
49206,randomized,0,0
49207,to,0,0
49208,receive,0,0
49209,caudal,0,0
49210,block,0,0
49211,with,0,1
49212,bupivacaine,0,0
49213,0.25,0,0
49214,%,0,0
49215,",",0,0
49216,ropivacaine,0,0
49217,0.25,0,0
49218,%,0,0
49219,or,0,0
49220,levobupivacaine,0,0
49221,0.25,0,0
49222,%,0,0
49223,.,0,0
49224,The,0,0
49225,primary,0,0
49226,outcome,0,0
49227,of,0,0
49228,the,0,0
49229,study,0,0
49230,was,0,0
49231,the,0,0
49232,clinical,0,0
49233,efficacy,0,0
49234,of,0,0
49235,the,0,0
49236,caudal,0,0
49237,block,0,0
49238,during,0,0
49239,the,0,0
49240,operation,0,0
49241,.,0,0
49242,Secondary,0,0
49243,outcome,0,0
49244,measures,0,0
49245,were,0,0
49246,analgesic,0,0
49247,onset,0,0
49248,time,0,0
49249,",",0,0
49250,pain,0,0
49251,relief,0,0
49252,after,0,0
49253,the,0,0
49254,operation,0,0
49255,and,0,0
49256,residual,0,0
49257,motor,0,0
49258,blockade,0,0
49259,.,0,0
49260,RESULTS,0,0
49261,The,0,0
49262,proportion,0,0
49263,of,0,0
49264,children,0,1
49265,with,0,1
49266,effective,0,0
49267,analgesia,0,0
49268,during,0,0
49269,the,0,0
49270,operation,0,0
49271,was,0,0
49272,similar,0,0
49273,among,0,1
49274,groups,0,0
49275,.,0,0
49276,There,0,0
49277,were,0,0
49278,no,0,0
49279,significant,0,0
49280,differences,0,0
49281,in,0,0
49282,the,0,0
49283,analgesic,0,0
49284,onset,0,0
49285,time,0,0
49286,of,0,0
49287,the,0,0
49288,caudal,0,0
49289,block,0,0
49290,.,0,0
49291,Bupivacaine,0,0
49292,produced,0,0
49293,a,0,0
49294,significant,0,0
49295,incidence,0,0
49296,of,0,0
49297,residual,0,0
49298,motor,0,0
49299,block,0,0
49300,compared,0,0
49301,with,0,0
49302,levobupivacaine,0,0
49303,or,0,0
49304,ropivacaine,0,0
49305,at,0,0
49306,wake-up,0,0
49307,(,0,0
49308,P,0,0
49309,<,0,0
49310,0.01,0,0
49311,),0,0
49312,.,0,0
49313,There,0,0
49314,were,0,0
49315,no,0,0
49316,significant,0,0
49317,differences,0,0
49318,in,0,0
49319,the,0,0
49320,number,0,0
49321,of,0,0
49322,patients,0,1
49323,receiving,0,1
49324,rescue,0,0
49325,analgesia,0,0
49326,after,0,0
49327,surgery,0,1
49328,.,0,0
49329,However,0,0
49330,",",0,0
49331,analgesic,0,0
49332,block,0,0
49333,lasted,0,0
49334,significantly,0,0
49335,longer,0,0
49336,in,0,0
49337,patients,0,1
49338,receiving,0,1
49339,bupivacaine,0,0
49340,(,0,0
49341,P=0.03,0,0
49342,),0,0
49343,.,0,0
49344,CONCLUSION,0,0
49345,During,0,0
49346,sub-umbilical,0,0
49347,surgery,0,1
49348,",",0,0
49349,caudal,0,0
49350,levobupivacaine,0,0
49351,",",0,0
49352,ropivacaine,0,0
49353,and,0,0
49354,bupivacaine,0,0
49355,provided,0,0
49356,comparable,0,0
49357,analgesic,0,0
49358,efficacy,0,0
49359,.,0,0
49360,Bupivacaine,0,0
49361,produced,0,0
49362,a,0,0
49363,higher,0,0
49364,incidence,0,0
49365,of,0,0
49366,residual,0,0
49367,motor,0,0
49368,blockade,0,0
49369,and,0,0
49370,a,0,0
49371,longer,0,0
49372,analgesic,0,0
49373,block,0,0
49374,than,0,0
49375,ropivacaine,0,0
49376,and,0,0
49377,levobupivacaine,0,0
49378,.,0,0
49379,Group-based,0,1
49380,HIV,0,0
49381,risk,0,0
49382,reduction,0,0
49383,intervention,0,0
49384,for,0,0
49385,adolescent,1,1
49386,girls,1,1
49387,:,1,1
49388,evidence,0,0
49389,of,0,0
49390,feasibility,0,0
49391,and,0,0
49392,efficacy,0,0
49393,.,0,0
49394,The,0,0
49395,purposes,0,0
49396,of,0,0
49397,this,0,0
49398,pilot,0,0
49399,study,0,0
49400,were,0,0
49401,(,0,0
49402,a,0,0
49403,),0,0
49404,to,0,0
49405,assess,0,0
49406,the,0,0
49407,feasibility,0,0
49408,of,0,0
49409,a,0,0
49410,community-based,0,0
49411,",",0,0
49412,small,0,0
49413,group,0,0
49414,HIV,0,0
49415,risk,0,0
49416,reduction,0,0
49417,intervention,0,0
49418,with,0,1
49419,adolescent,1,1
49420,girls,1,1
49421,",",0,0
49422,and,0,0
49423,(,0,0
49424,b,0,0
49425,),0,0
49426,to,0,0
49427,obtain,0,0
49428,preliminary,0,0
49429,evidence,0,0
49430,of,0,0
49431,the,0,0
49432,efficacy,0,0
49433,of,0,0
49434,this,0,0
49435,theoretically-guided,0,0
49436,intervention,0,0
49437,using,0,0
49438,a,0,0
49439,controlled,0,0
49440,design,0,0
49441,.,0,0
49442,The,0,0
49443,feasibility,0,0
49444,of,0,0
49445,the,0,0
49446,intervention,0,0
49447,was,0,0
49448,demonstrated,0,0
49449,by,0,0
49450,successfully,0,0
49451,implementing,0,0
49452,it,0,0
49453,with,0,1
49454,33,1,1
49455,sexually-active,1,1
49456,",",1,0
49457,single,1,0
49458,girls,1,1
49459,.,1,1
49460,Preliminary,0,0
49461,evidence,0,0
49462,of,0,0
49463,the,0,0
49464,efficacy,0,0
49465,of,0,0
49466,the,0,0
49467,intervention,0,0
49468,was,0,0
49469,obtained,0,0
49470,using,0,0
49471,a,0,0
49472,randomized,0,0
49473,trial,0,0
49474,with,0,1
49475,62,1,1
49476,sexually-active,1,1
49477,",",1,0
49478,single,1,0
49479,girls,1,1
49480,.,1,1
49481,Data,0,0
49482,obtained,0,0
49483,at,0,0
49484,a,0,0
49485,3-month,0,0
49486,follow-up,0,0
49487,assessment,0,0
49488,showed,0,0
49489,that,0,0
49490,girls,1,1
49491,who,0,1
49492,received,0,1
49493,the,0,1
49494,HIV-related,0,0
49495,intervention,0,0
49496,improved,0,0
49497,their,0,0
49498,HIV-related,0,0
49499,knowledge,0,0
49500,and,0,0
49501,enhanced,0,0
49502,their,0,0
49503,motivation,0,0
49504,for,0,0
49505,risk,0,0
49506,reduction,0,0
49507,compared,0,0
49508,to,0,1
49509,girls,0,1
49510,who,0,1
49511,received,0,1
49512,a,0,1
49513,control,0,0
49514,(,0,0
49515,health,0,0
49516,promotion,0,0
49517,),0,0
49518,intervention,0,0
49519,.,0,0
49520,Effect,0,0
49521,sizes,0,0
49522,suggest,0,0
49523,that,0,0
49524,the,0,0
49525,HIV,0,0
49526,intervention,0,0
49527,also,0,0
49528,reduced,0,0
49529,several,0,0
49530,risk,0,0
49531,behaviors,0,0
49532,(,0,0
49533,e.g.,0,0
49534,",",0,0
49535,vaginal,0,0
49536,sex,0,0
49537,without,0,0
49538,a,0,0
49539,condom,0,0
49540,",",0,0
49541,giving,0,0
49542,oral,0,0
49543,sex,0,0
49544,",",0,0
49545,and,0,0
49546,alcohol,0,0
49547,and,0,0
49548,drug,0,0
49549,use,0,0
49550,before,0,0
49551,sex,0,0
49552,),0,0
49553,.,0,0
49554,Challenges,0,0
49555,to,0,0
49556,implementation,0,0
49557,and,0,0
49558,suggestions,0,0
49559,for,0,0
49560,intervention,0,0
49561,enhancement,0,0
49562,are,0,0
49563,discussed,0,0
49564,.,0,0
49565,Immunogenicity,0,0
49566,and,0,0
49567,reactogenicity,0,0
49568,of,0,0
49569,two,0,0
49570,regimens,0,0
49571,of,0,0
49572,diphtheria-tetanus-acellular,0,0
49573,pertussis-hepatitis,0,1
49574,B-inactivated,0,0
49575,polio,0,1
49576,and,0,0
49577,Haemophilus,0,0
49578,influenzae,0,0
49579,type,0,1
49580,b,0,0
49581,vaccines,0,0
49582,administered,0,0
49583,to,0,0
49584,infants,1,1
49585,primed,1,0
49586,at,1,0
49587,birth,1,1
49588,with,1,1
49589,hepatitis,1,1
49590,B,1,0
49591,vaccine,1,0
49592,.,1,0
49593,An,0,0
49594,open,0,0
49595,",",0,0
49596,randomized,0,0
49597,study,0,0
49598,evaluated,0,0
49599,the,0,0
49600,immune,0,0
49601,response,0,0
49602,and,0,0
49603,safety,0,0
49604,of,0,0
49605,two,0,0
49606,different,0,0
49607,regimens,0,0
49608,of,0,0
49609,diphtheria-tetanus-acellular,0,0
49610,pertussis-hepatitis,0,1
49611,B-inactivated,0,0
49612,poliovirus-Haemophilus,0,1
49613,influenzae,0,0
49614,type,0,1
49615,b,0,0
49616,(,0,0
49617,DTPa-HBV-IPV-Hib,0,0
49618,),0,0
49619,immunization,0,0
49620,in,0,0
49621,infants,1,1
49622,primed,1,0
49623,at,1,0
49624,birth,1,1
49625,with,1,1
49626,hepatitis,1,1
49627,B,1,0
49628,vaccine,1,0
49629,.,1,0
49630,One-half,0,0
49631,of,0,0
49632,the,0,0
49633,150,1,0
49634,healthy,1,1
49635,",",1,0
49636,full-term,1,1
49637,infants,1,1
49638,received,0,0
49639,a,0,0
49640,DTPa,0,0
49641,HBV-IPV-Hib,0,0
49642,vaccine,0,0
49643,at,0,0
49644,1,0,0
49645,1/2,0,0
49646,",",0,0
49647,3,0,0
49648,and,0,0
49649,5,0,0
49650,months,0,0
49651,of,0,0
49652,age,0,1
49653,;,0,0
49654,the,0,0
49655,other,0,0
49656,received,0,0
49657,a,0,0
49658,DTPa-IPV-Hib,0,0
49659,vaccine,0,0
49660,at,0,0
49661,1,0,0
49662,1/2,0,0
49663,",",0,0
49664,3,0,0
49665,and,0,0
49666,5,0,0
49667,months,0,0
49668,of,0,0
49669,age,0,1
49670,with,0,1
49671,separate,0,0
49672,HBV,0,1
49673,vaccine,0,0
49674,at,0,0
49675,1,0,0
49676,and,0,0
49677,5,0,0
49678,months,0,0
49679,of,0,0
49680,age,0,1
49681,.,0,0
49682,Immune,0,0
49683,response,0,0
49684,was,0,0
49685,similar,0,0
49686,following,0,0
49687,the,0,0
49688,two,0,0
49689,regimens,0,0
49690,with,0,1
49691,100,0,0
49692,%,0,0
49693,of,0,0
49694,the,0,0
49695,vaccinees,0,0
49696,seroprotected,0,0
49697,for,0,0
49698,HBV,0,0
49699,",",0,0
49700,diphtheria,0,0
49701,",",0,0
49702,tetanus,0,0
49703,",",0,0
49704,Hib,0,0
49705,and,0,0
49706,poliovirus,0,1
49707,types,0,0
49708,2,0,0
49709,and,0,1
49710,3,0,0
49711,diseases,0,1
49712,after,0,0
49713,the,0,0
49714,full,0,0
49715,vaccination,0,1
49716,course,0,0
49717,.,0,0
49718,One,0,0
49719,vaccinee,0,0
49720,in,0,0
49721,the,0,0
49722,DTPa,0,0
49723,HBV-HPV-,0,0
49724,Hib,0,0
49725,group,0,0
49726,failed,0,0
49727,to,0,0
49728,respond,0,0
49729,to,0,0
49730,the,0,0
49731,poliovirus,0,0
49732,type,0,1
49733,1,0,0
49734,antigen,0,0
49735,.,0,0
49736,Response,0,0
49737,to,0,0
49738,the,0,0
49739,three,0,0
49740,pertussis,0,0
49741,antigens,0,0
49742,ranged,0,0
49743,from,0,0
49744,92-97,0,0
49745,%,0,0
49746,in,0,0
49747,the,0,0
49748,DTPa-IPV-Hib,0,0
49749,plus,0,0
49750,separate,0,0
49751,HBV,0,0
49752,group,0,0
49753,and,0,0
49754,100,0,0
49755,%,0,0
49756,in,0,0
49757,the,0,0
49758,DTPa,0,0
49759,HBV-IPV-Hib,0,0
49760,group,0,0
49761,.,0,0
49762,The,0,0
49763,most,0,0
49764,frequently,0,0
49765,reported,0,0
49766,post-vaccination,0,0
49767,symptoms,0,0
49768,were,0,0
49769,irritability,0,0
49770,in,0,0
49771,the,0,0
49772,DTPa-IPV-Hib,0,0
49773,plus,0,0
49774,separate,0,0
49775,HBV,0,0
49776,group,0,0
49777,(,0,0
49778,49,0,1
49779,%,0,0
49780,of,0,0
49781,vaccinees,0,0
49782,),0,0
49783,and,0,0
49784,fever,0,0
49785,",",0,0
49786,defined,0,0
49787,as,0,0
49788,axillary,0,1
49789,temperature,0,0
49790,>,0,0
49791,or,0,0
49792,=37.5,0,0
49793,degrees,0,0
49794,C,0,0
49795,",",0,0
49796,in,0,0
49797,the,0,0
49798,DTPa,0,0
49799,HBV-,0,0
49800,IPV-Hib,0,0
49801,group,0,0
49802,(,0,0
49803,50,0,0
49804,%,0,0
49805,of,0,0
49806,vaccinees,0,1
49807,),0,1
49808,.,0,1
49809,Primary,0,1
49810,vitrectomy,0,1
49811,for,0,0
49812,combined,1,0
49813,rhegmatogenous,1,1
49814,retinal,1,0
49815,detachment,1,1
49816,and,1,0
49817,choroidal,1,1
49818,detachment,1,0
49819,with,1,1
49820,or,1,0
49821,without,1,1
49822,oral,1,0
49823,corticosteroids,1,0
49824,:,1,1
49825,a,0,0
49826,pilot,0,0
49827,study,0,0
49828,.,0,0
49829,PURPOSE,0,0
49830,The,0,0
49831,occurrence,0,0
49832,of,0,0
49833,choroidal,1,1
49834,detachment,1,1
49835,(,1,0
49836,CD,1,1
49837,),1,0
49838,in,1,0
49839,eyes,1,1
49840,with,1,1
49841,primary,1,1
49842,rhegmatogenous,1,1
49843,retinal,1,1
49844,detachment,1,1
49845,(,1,0
49846,RRD,1,0
49847,),1,0
49848,is,0,0
49849,relatively,0,0
49850,uncommon,0,0
49851,(,0,0
49852,2,0,0
49853,%,0,0
49854,-4.5,0,0
49855,%,0,0
49856,),0,0
49857,.,0,0
49858,Recent,0,0
49859,reports,0,0
49860,suggest,0,0
49861,that,0,0
49862,primary,0,0
49863,vitrectomy,0,1
49864,yields,0,0
49865,better,0,0
49866,anatomic,0,0
49867,success,0,0
49868,than,0,0
49869,scleral,0,1
49870,buckling,0,1
49871,.,0,0
49872,However,0,0
49873,",",0,0
49874,for,0,0
49875,these,0,0
49876,inflamed,1,1
49877,eyes,1,1
49878,with,1,1
49879,low,1,0
49880,intraocular,1,0
49881,pressure,1,0
49882,",",0,0
49883,the,0,0
49884,influence,0,0
49885,of,0,0
49886,preoperative,0,0
49887,oral,0,0
49888,steroids,0,0
49889,on,0,0
49890,reattachment,0,0
49891,rates,0,0
49892,has,0,0
49893,not,0,0
49894,been,0,0
49895,elucidated,0,0
49896,yet,0,0
49897,.,0,0
49898,METHODS,0,0
49899,Twenty,1,1
49900,eyes,1,1
49901,with,1,1
49902,combined,1,0
49903,RRD,1,0
49904,and,1,0
49905,CD,1,1
49906,that,1,0
49907,underwent,1,1
49908,primary,1,0
49909,vitrectomy,1,1
49910,were,0,0
49911,randomized,0,0
49912,to,0,0
49913,receive,0,0
49914,oral,0,0
49915,steroids,0,0
49916,(,0,0
49917,for,0,0
49918,1,0,0
49919,week,0,0
49920,),0,0
49921,or,0,0
49922,no,0,0
49923,oral,0,0
49924,steroids,0,0
49925,before,0,0
49926,surgery,0,1
49927,.,0,0
49928,RESULTS,0,0
49929,Preoperative,0,0
49930,clinical,0,0
49931,data,0,0
49932,such,0,0
49933,as,0,0
49934,mean,0,0
49935,age,0,1
49936,",",0,0
49937,lens,0,0
49938,status,0,0
49939,",",0,0
49940,Snellen,0,0
49941,visual,0,0
49942,acuity,0,0
49943,",",0,0
49944,duration,0,0
49945,of,0,0
49946,macular,0,1
49947,detachment,0,1
49948,",",0,0
49949,CD,0,0
49950,(,0,0
49951,size,0,0
49952,and,0,0
49953,extent,0,0
49954,),0,0
49955,",",0,0
49956,and,0,0
49957,retinal,0,0
49958,detachment,0,1
49959,characteristics,0,0
49960,(,0,0
49961,e.g.,0,0
49962,",",0,0
49963,extent,0,0
49964,",",0,0
49965,number,0,0
49966,of,0,0
49967,retinal,0,0
49968,breaks,0,0
49969,",",0,0
49970,atrophic,0,1
49971,or,0,0
49972,tractional,0,0
49973,retinal,0,0
49974,break,0,0
49975,",",0,0
49976,size,0,0
49977,of,0,0
49978,retinal,0,0
49979,break,0,0
49980,",",0,0
49981,and,0,0
49982,location,0,0
49983,of,0,0
49984,retinal,0,0
49985,break,0,0
49986,),0,0
49987,were,0,0
49988,similarly,0,0
49989,distributed,0,0
49990,in,0,0
49991,both,0,0
49992,groups,0,0
49993,.,0,0
49994,Single-operation,0,0
49995,anatomic,0,0
49996,success,0,0
49997,was,0,0
49998,81.8,0,0
49999,%,0,0
50000,(,0,0
50001,9/11,0,0
50002,),0,0
50003,among,0,0
50004,those,0,1
50005,patients,0,1
50006,who,0,1
50007,received,0,1
50008,preoperative,0,1
50009,oral,0,0
50010,steroids,0,0
50011,and,0,0
50012,was,0,0
50013,66.7,0,0
50014,%,0,0
50015,(,0,0
50016,6/9,0,0
50017,),0,0
50018,among,0,1
50019,those,0,1
50020,who,0,1
50021,did,0,0
50022,not,0,1
50023,receive,0,0
50024,preoperative,0,0
50025,oral,0,0
50026,steroids,0,0
50027,.,0,0
50028,After,0,0
50029,reoperation,0,0
50030,",",0,0
50031,anatomic,0,0
50032,success,0,0
50033,was,0,0
50034,100,0,0
50035,%,0,0
50036,in,0,0
50037,both,0,0
50038,groups,0,0
50039,.,0,0
50040,The,0,0
50041,mean,0,0
50042,follow-up,0,0
50043,was,0,0
50044,20.1,0,0
50045,months,0,0
50046,.,0,1
50047,CONCLUSION,0,0
50048,The,0,0
50049,results,0,0
50050,suggest,0,0
50051,that,0,0
50052,administration,0,0
50053,of,0,0
50054,oral,0,0
50055,steroids,0,0
50056,before,0,0
50057,primary,0,1
50058,vitrectomy,0,1
50059,in,0,0
50060,eyes,0,1
50061,with,0,1
50062,combined,1,0
50063,RRD,1,0
50064,and,1,0
50065,CD,1,0
50066,improves,1,0
50067,reattachment,0,0
50068,rates,0,0
50069,.,0,1
50070,[,0,0
50071,Relationship,0,0
50072,between,0,0
50073,sCD44v6,0,0
50074,expression,0,0
50075,and,0,0
50076,TCM,0,0
50077,differentiation,0,0
50078,type,0,1
50079,of,0,0
50080,gastric,1,1
50081,carcinoma,1,1
50082,patients,1,1
50083,and,0,0
50084,influence,0,0
50085,of,0,0
50086,weitai,0,0
50087,capsule,0,0
50088,on,0,0
50089,the,0,0
50090,expression,0,0
50091,],0,0
50092,.,0,0
50093,OBJECTIVE,0,0
50094,To,0,0
50095,explore,0,0
50096,the,0,0
50097,relationship,0,0
50098,of,0,0
50099,TCM,0,0
50100,type,0,1
50101,with,0,1
50102,serum,0,0
50103,level,0,0
50104,of,0,0
50105,soluble,0,0
50106,CD44v6,0,0
50107,(,0,0
50108,sCD44v6,0,0
50109,),0,0
50110,and,0,0
50111,different,0,0
50112,histologic,0,0
50113,parameters,0,0
50114,in,0,0
50115,gastric,1,1
50116,carcinoma,1,1
50117,patients,1,1
50118,and,0,0
50119,to,0,0
50120,observe,0,0
50121,the,0,0
50122,influence,0,0
50123,of,0,0
50124,Weitai,0,0
50125,capsule,0,0
50126,(,0,0
50127,WTC,0,0
50128,),0,0
50129,on,0,0
50130,the,0,0
50131,sCD44v6,0,0
50132,expression,0,0
50133,.,0,0
50134,METHODS,0,0
50135,TCM,0,0
50136,typing,0,0
50137,and,0,0
50138,sCD44v6,0,0
50139,expression,0,0
50140,were,0,0
50141,determined,0,0
50142,in,0,0
50143,all,1,0
50144,the,1,0
50145,enrolled,1,1
50146,patients,1,1
50147,(,1,0
50148,30,1,0
50149,in,1,0
50150,the,1,0
50151,control,1,0
50152,and,1,0
50153,32,1,0
50154,in,1,0
50155,the,1,0
50156,trial,1,0
50157,group,1,0
50158,),1,0
50159,before,1,0
50160,operation,1,0
50161,",",1,0
50162,and,1,0
50163,3-4,1,0
50164,courses,1,0
50165,of,1,0
50166,chemotherapy,1,0
50167,was,1,0
50168,applied,1,0
50169,to,1,0
50170,them,1,0
50171,from,1,0
50172,3-4,1,0
50173,weeks,1,0
50174,after,1,0
50175,operation,1,0
50176,.,1,0
50177,To,0,0
50178,the,0,0
50179,patients,0,1
50180,of,0,0
50181,trial,0,0
50182,group,0,0
50183,",",0,0
50184,oral,0,0
50185,administration,0,0
50186,of,0,0
50187,WTC,0,0
50188,was,0,0
50189,given,0,0
50190,additionally,0,0
50191,with,0,1
50192,4,0,0
50193,capsules,0,0
50194,",",0,0
50195,3,0,0
50196,times,0,0
50197,a,0,0
50198,day,0,0
50199,for,0,0
50200,consecutive,0,1
50201,3,0,0
50202,months,0,0
50203,.,0,1
50204,RESULTS,0,0
50205,sCD44v6,0,0
50206,was,0,0
50207,significantly,0,0
50208,positive,0,0
50209,correlated,0,0
50210,with,0,0
50211,the,0,0
50212,degree,0,0
50213,of,0,0
50214,cancer,0,1
50215,cell,0,0
50216,differentiation,0,0
50217,",",0,0
50218,infiltration,0,0
50219,and,0,0
50220,lymph,0,0
50221,node,0,0
50222,metastasis,0,1
50223,;,0,0
50224,(,0,0
50225,2,0,0
50226,),0,0
50227,Level,0,0
50228,of,0,0
50229,sCD44v6,0,0
50230,was,0,0
50231,the,0,0
50232,highest,0,0
50233,in,0,0
50234,patients,1,1
50235,of,1,0
50236,blood,1,0
50237,stasis,1,0
50238,type,1,0
50239,",",0,0
50240,as,0,0
50241,compared,0,0
50242,with,0,0
50243,that,0,0
50244,in,0,0
50245,the,0,0
50246,patients,1,1
50247,of,1,0
50248,Pi-deficiency,1,0
50249,type,1,1
50250,or,1,0
50251,of,1,0
50252,damp-heat,1,0
50253,type,1,1
50254,",",0,0
50255,the,0,0
50256,difference,0,0
50257,was,0,0
50258,significant,0,0
50259,;,0,0
50260,(,0,0
50261,3,0,0
50262,),0,0
50263,After,0,0
50264,ending,0,0
50265,treatment,0,0
50266,",",0,0
50267,level,0,0
50268,of,0,0
50269,sCD44v6,0,0
50270,in,0,0
50271,the,0,0
50272,trial,0,0
50273,group,0,0
50274,was,0,0
50275,significantly,0,0
50276,lower,0,0
50277,than,0,0
50278,that,0,0
50279,in,0,0
50280,the,0,0
50281,control,0,0
50282,group,0,0
50283,.,0,0
50284,CONCLUSION,0,0
50285,(,0,0
50286,1,0,0
50287,),0,0
50288,Serum,0,1
50289,level,0,0
50290,of,0,0
50291,sCD44v6,0,0
50292,could,0,0
50293,be,0,0
50294,taken,0,0
50295,as,0,0
50296,the,0,0
50297,criterion,0,0
50298,for,0,0
50299,evaluating,0,0
50300,the,0,0
50301,development,0,0
50302,and,0,0
50303,prognosis,0,0
50304,of,0,0
50305,gastric,0,0
50306,cancer,0,1
50307,",",0,0
50308,as,0,0
50309,well,0,0
50310,as,0,0
50311,the,0,0
50312,therapeutic,0,0
50313,target,0,0
50314,for,0,0
50315,anti-metastasis,0,0
50316,treatment,0,0
50317,;,0,0
50318,(,0,0
50319,2,0,0
50320,),0,0
50321,Serum,0,1
50322,level,0,0
50323,of,0,0
50324,sCD44v6,0,0
50325,is,0,0
50326,related,0,0
50327,to,0,0
50328,some,0,0
50329,extent,0,0
50330,with,0,0
50331,TCM,0,0
50332,type,0,1
50333,of,0,0
50334,blood,0,0
50335,stasis,0,0
50336,and,0,0
50337,Pi-deficiency,0,0
50338,;,0,0
50339,(,0,0
50340,3,0,0
50341,),0,0
50342,WTC,0,0
50343,combined,0,0
50344,with,0,0
50345,chemotherapy,0,0
50346,could,0,0
50347,further,0,0
50348,inhibit,0,0
50349,the,0,0
50350,expression,0,0
50351,of,0,0
50352,serum,0,0
50353,sCD44v6,0,0
50354,in,0,0
50355,gastric,0,1
50356,carcinoma,0,1
50357,patients,0,1
50358,.,0,1
50359,The,0,0
50360,overt,0,0
50361,aggression,0,0
50362,scale,0,0
50363,for,0,0
50364,rating,0,0
50365,aggression,0,1
50366,in,0,0
50367,outpatient,1,1
50368,youth,1,1
50369,with,1,1
50370,autistic,1,1
50371,disorder,1,1
50372,:,1,1
50373,preliminary,0,0
50374,findings,0,0
50375,.,0,0
50376,Aggression,0,0
50377,is,0,0
50378,a,0,0
50379,common,0,0
50380,and,0,0
50381,costly,0,0
50382,problem,0,0
50383,in,0,0
50384,youth,1,1
50385,with,1,1
50386,developmental,1,1
50387,disabilities,1,1
50388,.,1,1
50389,Rating,0,0
50390,scales,0,0
50391,that,0,0
50392,accurately,0,0
50393,capture,0,0
50394,and,0,0
50395,measure,0,0
50396,subtypes,0,0
50397,of,0,0
50398,aggression,0,1
50399,phenomenology,0,1
50400,",",0,0
50401,frequency,0,0
50402,and,0,0
50403,severity,0,0
50404,are,0,0
50405,urgently,0,0
50406,needed,0,0
50407,",",0,0
50408,in,0,0
50409,both,0,0
50410,clinical,0,0
50411,practice,0,0
50412,and,0,0
50413,research,0,0
50414,.,0,0
50415,The,0,0
50416,authors,0,0
50417,studied,0,1
50418,the,0,0
50419,Overt,0,0
50420,Aggression,0,0
50421,Scale,0,0
50422,(,0,0
50423,OAS,0,0
50424,),0,0
50425,in,0,0
50426,a,0,0
50427,preliminary,0,0
50428,sample,0,1
50429,of,0,0
50430,eight,1,1
50431,outpatients,1,1
50432,who,1,1
50433,participated,1,1
50434,in,1,1
50435,an,1,0
50436,ongoing,1,0
50437,placebo-controlled,1,0
50438,study,1,0
50439,of,1,0
50440,valproate,1,0
50441,for,1,0
50442,aggression,1,1
50443,in,1,0
50444,autism,1,1
50445,.,1,0
50446,Subjects,0,0
50447,',0,0
50448,OAS,0,0
50449,aggression,0,1
50450,scores,0,0
50451,showed,0,0
50452,significant,0,0
50453,correlation,0,0
50454,with,0,0
50455,the,0,0
50456,already,0,0
50457,validated,0,0
50458,retrospectively,0,0
50459,rated,0,0
50460,Aberrant,0,0
50461,Behavior,0,0
50462,Checklist,0,0
50463,Community,0,1
50464,Scale,0,0
50465,irritability,0,0
50466,subscale,0,0
50467,.,0,0
50468,Further,0,0
50469,study,0,0
50470,of,0,0
50471,the,0,0
50472,OAS,0,0
50473,in,0,0
50474,outpatients,0,1
50475,with,0,1
50476,aggression,0,1
50477,and,0,0
50478,developmental,0,0
50479,disabilities,0,0
50480,is,0,0
50481,warranted,0,0
50482,.,0,0
50483,Low-dose,0,0
50484,angiotensin,0,0
50485,II,0,1
50486,receptor,0,0
50487,antagonists,0,0
50488,and,0,0
50489,angiotensin,0,0
50490,II-converting,0,0
50491,enzyme,0,0
50492,inhibitors,0,0
50493,alone,0,0
50494,or,0,0
50495,in,0,0
50496,combination,0,0
50497,for,0,0
50498,treatment,0,0
50499,of,0,0
50500,primary,0,0
50501,glomerulonephritis,0,1
50502,.,0,0
50503,OBJECTIVE,0,0
50504,The,0,0
50505,renin-angiotensin,0,0
50506,system,0,0
50507,is,0,0
50508,thought,0,0
50509,to,0,0
50510,be,0,0
50511,involved,0,0
50512,in,0,0
50513,the,0,0
50514,progression,0,0
50515,of,0,0
50516,chronic,0,1
50517,renal,0,1
50518,diseases,0,1
50519,of,0,0
50520,both,0,0
50521,diabetic,0,1
50522,and,0,0
50523,non-diabetic,0,1
50524,origin,0,0
50525,.,0,0
50526,It,0,0
50527,has,0,0
50528,been,0,0
50529,confirmed,0,0
50530,that,0,0
50531,angiotensin-converting,0,0
50532,enzyme,0,0
50533,inhibitors,0,0
50534,(,0,0
50535,ACEIs,0,0
50536,),0,0
50537,and,0,0
50538,angiotensin,0,0
50539,II,0,0
50540,receptor,0,0
50541,blockers,0,0
50542,(,0,0
50543,ARBs,0,1
50544,),0,0
50545,reduce,0,0
50546,urinary,0,0
50547,protein,0,0
50548,excretion,0,0
50549,and,0,0
50550,attenuate,0,0
50551,the,0,0
50552,development,0,0
50553,of,0,0
50554,renal,0,1
50555,injury,0,1
50556,.,0,0
50557,Clinical,0,0
50558,data,0,0
50559,comparing,0,0
50560,the,0,0
50561,renal,0,1
50562,effects,0,0
50563,of,0,0
50564,ACEIs,0,0
50565,and,0,0
50566,ARBs,0,0
50567,",",0,0
50568,either,0,0
50569,singly,0,0
50570,or,0,0
50571,in,0,0
50572,combination,0,0
50573,",",0,0
50574,are,0,0
50575,scarce,0,0
50576,and,0,0
50577,usually,0,0
50578,concern,0,0
50579,the,0,0
50580,use,0,0
50581,of,0,0
50582,standard,0,0
50583,or,0,1
50584,high,0,0
50585,doses,0,0
50586,.,0,1
50587,MATERIAL,0,0
50588,AND,0,0
50589,METHODS,0,0
50590,This,0,0
50591,was,0,0
50592,a,0,0
50593,prospective,0,0
50594,",",0,0
50595,randomized,0,0
50596,",",0,0
50597,9-month,0,0
50598,study,0,0
50599,of,0,0
50600,the,0,0
50601,effects,0,0
50602,of,0,0
50603,low,0,0
50604,doses,0,0
50605,of,0,0
50606,losartan,0,0
50607,(,0,0
50608,25,0,0
50609,mg,0,0
50610,;,0,0
50611,n,0,0
50612,=,0,0
50613,18,0,1
50614,),0,0
50615,versus,0,0
50616,enalapril,0,0
50617,(,0,0
50618,10,0,0
50619,mg,0,0
50620,;,0,0
50621,n,0,0
50622,=,0,0
50623,18,0,1
50624,),0,0
50625,versus,0,0
50626,the,0,0
50627,combination,0,0
50628,of,0,0
50629,losartan,0,0
50630,(,0,0
50631,25,0,0
50632,mg,0,0
50633,),0,0
50634,and,0,0
50635,enalapril,0,0
50636,(,0,0
50637,10,0,0
50638,mg,0,0
50639,),0,0
50640,(,0,0
50641,n,0,1
50642,=,0,0
50643,16,0,1
50644,),0,0
50645,on,0,0
50646,proteinuria,0,0
50647,",",0,0
50648,kidney,0,0
50649,function,0,0
50650,and,0,0
50651,metabolic,0,0
50652,profile,0,0
50653,in,0,0
50654,54,1,1
50655,patients,1,1
50656,with,1,1
50657,biopsy-proven,1,1
50658,chronic,1,1
50659,glomerulonephritis,1,1
50660,",",1,0
50661,hypertension,1,1
50662,and,1,0
50663,normal,1,1
50664,or,1,0
50665,slightly,1,0
50666,impaired,1,0
50667,kidney,1,0
50668,function,1,0
50669,.,1,0
50670,The,0,0
50671,clinical,0,0
50672,evaluation,0,0
50673,and,0,0
50674,laboratory,0,0
50675,tests,0,0
50676,were,0,0
50677,performed,0,0
50678,before,0,0
50679,treatment,0,0
50680,(,0,0
50681,baseline,0,0
50682,),0,0
50683,and,0,0
50684,after,0,0
50685,3,0,0
50686,and,0,0
50687,9,0,0
50688,months,0,0
50689,of,0,0
50690,therapy,0,0
50691,.,0,0
50692,RESULTS,0,0
50693,After,0,0
50694,3,0,0
50695,months,0,0
50696,",",0,0
50697,significant,0,0
50698,decreases,0,0
50699,in,0,0
50700,proteinuria,0,0
50701,were,0,0
50702,observed,0,0
50703,in,0,0
50704,all,0,0
50705,groups,0,0
50706,:,0,1
50707,losartan,0,0
50708,",",0,0
50709,22.6,0,0
50710,%,0,0
50711,(,0,0
50712,p,0,0
50713,=,0,0
50714,0.02,0,0
50715,),0,0
50716,;,0,0
50717,enalapril,0,0
50718,",",0,0
50719,43,0,0
50720,%,0,0
50721,(,0,0
50722,p,0,0
50723,=,0,0
50724,0.012,0,0
50725,),0,0
50726,;,0,0
50727,and,0,0
50728,combined,0,0
50729,therapy,0,0
50730,",",0,0
50731,63,0,0
50732,%,0,0
50733,(,0,0
50734,p,0,0
50735,=,0,0
50736,0.001,0,0
50737,),0,0
50738,.,0,0
50739,This,0,0
50740,anti-proteinuric,0,0
50741,effect,0,0
50742,was,0,0
50743,even,0,0
50744,greater,0,0
50745,after,0,0
50746,9,0,0
50747,months,0,0
50748,of,0,0
50749,therapy,0,0
50750,:,0,1
50751,losartan,0,0
50752,",",0,0
50753,44.2,0,0
50754,%,0,0
50755,(,0,0
50756,p,0,0
50757,=,0,0
50758,0.02,0,0
50759,),0,0
50760,;,0,0
50761,enalapril,0,0
50762,",",0,0
50763,49.6,0,0
50764,%,0,0
50765,(,0,0
50766,p,0,0
50767,=,0,0
50768,0.02,0,0
50769,),0,0
50770,;,0,0
50771,and,0,0
50772,combined,0,0
50773,therapy,0,0
50774,",",0,0
50775,51,0,0
50776,%,0,0
50777,(,0,0
50778,p,0,0
50779,=,0,0
50780,0.003,0,0
50781,),0,0
50782,.,0,0
50783,There,0,0
50784,was,0,0
50785,no,0,0
50786,significant,0,0
50787,difference,0,0
50788,between,0,0
50789,losartan,0,0
50790,and,0,0
50791,enalapril,0,0
50792,with,0,0
50793,respect,0,0
50794,to,0,0
50795,their,0,0
50796,impact,0,0
50797,on,0,0
50798,proteinuria,0,0
50799,level,0,0
50800,.,0,0
50801,Proteinuria,0,0
50802,reduction,0,0
50803,was,0,0
50804,significantly,0,0
50805,greater,0,0
50806,in,0,0
50807,patients,0,1
50808,receiving,0,1
50809,combined,0,0
50810,therapy,0,0
50811,in,0,0
50812,comparison,0,0
50813,with,0,1
50814,losartan,0,0
50815,treatment,0,0
50816,after,0,0
50817,3,0,0
50818,months,0,0
50819,of,0,0
50820,therapy,0,0
50821,(,0,0
50822,p,0,0
50823,=,0,0
50824,0.02,0,0
50825,),0,0
50826,.,0,0
50827,Creatinine,0,0
50828,clearance,0,0
50829,and,0,0
50830,serum,0,0
50831,creatinine,0,0
50832,were,0,0
50833,stable,0,1
50834,during,0,0
50835,the,0,0
50836,entire,0,0
50837,study,0,0
50838,period,0,0
50839,in,0,0
50840,all,0,0
50841,patients,0,1
50842,.,0,0
50843,No,0,0
50844,significant,0,0
50845,changes,0,0
50846,in,0,0
50847,lipids,0,0
50848,",",0,0
50849,serum,0,0
50850,uric,0,0
50851,acid,0,0
50852,or,0,0
50853,protein,0,0
50854,levels,0,0
50855,were,0,0
50856,observed,0,0
50857,.,0,0
50858,CONCLUSIONS,0,0
50859,These,0,0
50860,results,0,0
50861,indicate,0,0
50862,that,0,0
50863,proteinuria,0,0
50864,is,0,0
50865,reduced,0,0
50866,by,0,0
50867,low,0,0
50868,doses,0,0
50869,of,0,0
50870,losartan,0,0
50871,or,0,0
50872,enalapril,0,0
50873,.,0,0
50874,The,0,0
50875,combination,0,0
50876,of,0,0
50877,these,0,0
50878,drugs,0,0
50879,seems,0,0
50880,to,0,0
50881,be,0,0
50882,beneficial,0,0
50883,and,0,0
50884,may,0,0
50885,offer,0,0
50886,an,0,0
50887,additional,0,0
50888,renoprotective,0,0
50889,effect,0,0
50890,.,0,0
50891,This,0,0
50892,needs,0,0
50893,to,0,0
50894,be,0,0
50895,confirmed,0,0
50896,in,0,0
50897,a,0,0
50898,study,0,0
50899,with,0,0
50900,a,0,0
50901,larger,0,0
50902,sample,0,1
50903,size,0,0
50904,.,0,0
50905,Effects,0,0
50906,of,0,0
50907,long-term,0,0
50908,vitamin,0,0
50909,E,0,0
50910,supplementation,0,0
50911,on,0,0
50912,cardiovascular,1,1
50913,events,1,0
50914,and,1,0
50915,cancer,1,1
50916,:,1,0
50917,a,0,0
50918,randomized,0,0
50919,controlled,0,0
50920,trial,0,0
50921,.,0,0
50922,CONTEXT,0,0
50923,Experimental,0,0
50924,and,0,0
50925,epidemiological,0,0
50926,data,0,0
50927,suggest,0,0
50928,that,0,0
50929,vitamin,0,0
50930,E,0,0
50931,supplementation,0,0
50932,may,0,0
50933,prevent,0,0
50934,cancer,1,1
50935,and,1,0
50936,cardiovascular,1,1
50937,events,1,0
50938,.,1,1
50939,Clinical,0,0
50940,trials,0,0
50941,have,0,0
50942,generally,0,0
50943,failed,0,0
50944,to,0,0
50945,confirm,0,0
50946,benefits,0,0
50947,",",0,0
50948,possibly,0,0
50949,due,0,0
50950,to,0,0
50951,their,0,0
50952,relatively,0,0
50953,short,0,0
50954,duration,0,0
50955,.,0,0
50956,OBJECTIVE,0,0
50957,To,0,0
50958,evaluate,0,0
50959,whether,0,0
50960,long-term,0,0
50961,supplementation,0,0
50962,with,0,1
50963,vitamin,0,0
50964,E,0,0
50965,decreases,0,0
50966,the,0,0
50967,risk,0,0
50968,of,0,0
50969,cancer,1,1
50970,",",1,0
50971,cancer,1,1
50972,death,1,0
50973,",",1,0
50974,and,1,0
50975,major,1,0
50976,cardiovascular,1,1
50977,events,1,0
50978,.,1,1
50979,DESIGN,0,0
50980,",",0,0
50981,SETTING,0,0
50982,",",0,0
50983,AND,0,0
50984,PATIENTS,0,0
50985,A,0,0
50986,randomized,0,0
50987,",",0,0
50988,double-blind,0,0
50989,",",0,0
50990,placebo-controlled,0,0
50991,international,1,0
50992,trial,0,0
50993,(,0,0
50994,the,0,0
50995,initial,0,0
50996,Heart,0,0
50997,Outcomes,0,0
50998,Prevention,0,0
50999,Evaluation,0,0
51000,[,0,0
51001,HOPE,0,1
51002,],0,0
51003,trial,0,0
51004,conducted,0,0
51005,between,0,0
51006,December,0,1
51007,21,0,1
51008,",",0,0
51009,1993,0,1
51010,",",0,0
51011,and,0,0
51012,April,0,0
51013,15,0,0
51014,",",0,0
51015,1999,0,1
51016,),0,0
51017,of,0,0
51018,patients,1,1
51019,at,1,0
51020,least,1,1
51021,55,1,1
51022,years,1,1
51023,old,1,1
51024,with,1,1
51025,vascular,1,0
51026,disease,1,1
51027,or,1,0
51028,diabetes,1,1
51029,mellitus,1,1
51030,was,1,0
51031,extended,1,0
51032,(,1,0
51033,HOPE-The,1,0
51034,Ongoing,1,0
51035,Outcomes,1,0
51036,[,1,0
51037,HOPE-TOO,1,0
51038,],1,0
51039,),1,0
51040,between,1,0
51041,April,1,1
51042,16,1,1
51043,",",1,0
51044,1999,1,1
51045,",",1,0
51046,and,1,0
51047,May,1,0
51048,26,1,0
51049,",",1,0
51050,2003,1,1
51051,.,1,0
51052,Of,0,0
51053,the,0,0
51054,initial,0,0
51055,267,1,1
51056,HOPE,1,1
51057,centers,1,1
51058,that,1,0
51059,had,1,0
51060,enrolled,1,1
51061,9541,1,1
51062,patients,1,1
51063,",",1,0
51064,174,1,1
51065,centers,1,1
51066,participated,1,1
51067,in,1,0
51068,the,1,0
51069,HOPE-TOO,1,0
51070,trial,1,0
51071,.,1,0
51072,Of,0,0
51073,7030,1,1
51074,patients,1,1
51075,enrolled,1,1
51076,at,1,0
51077,these,1,0
51078,centers,1,1
51079,",",1,0
51080,916,1,1
51081,were,1,0
51082,deceased,1,0
51083,at,1,0
51084,the,1,0
51085,beginning,1,0
51086,of,1,0
51087,the,1,0
51088,extension,1,0
51089,",",1,0
51090,1382,1,1
51091,refused,1,1
51092,participation,1,0
51093,",",1,0
51094,3994,1,0
51095,continued,1,0
51096,to,1,0
51097,take,1,0
51098,the,1,0
51099,study,1,0
51100,intervention,1,0
51101,",",1,0
51102,and,1,0
51103,738,1,1
51104,agreed,1,0
51105,to,1,0
51106,passive,1,0
51107,follow-up,1,0
51108,.,1,0
51109,Median,0,0
51110,duration,0,0
51111,of,0,0
51112,follow-up,0,0
51113,was,0,0
51114,7.0,0,0
51115,years,0,1
51116,.,0,1
51117,INTERVENTION,0,0
51118,Daily,0,0
51119,dose,0,0
51120,of,0,0
51121,natural,0,0
51122,source,0,0
51123,vitamin,0,0
51124,E,0,0
51125,(,0,0
51126,400,0,0
51127,IU,0,0
51128,),0,0
51129,or,0,0
51130,matching,0,0
51131,placebo,0,0
51132,.,0,0
51133,MAIN,0,0
51134,OUTCOME,0,0
51135,MEASURES,0,0
51136,Primary,0,1
51137,outcomes,0,0
51138,included,0,1
51139,cancer,0,1
51140,incidence,0,0
51141,",",0,0
51142,cancer,0,1
51143,deaths,0,0
51144,",",0,0
51145,and,0,0
51146,major,0,0
51147,cardiovascular,0,1
51148,events,0,0
51149,(,0,0
51150,myocardial,0,1
51151,infarction,0,1
51152,",",0,0
51153,stroke,0,0
51154,",",0,0
51155,and,0,0
51156,cardiovascular,0,0
51157,death,0,0
51158,),0,0
51159,.,0,0
51160,Secondary,0,0
51161,outcomes,0,0
51162,included,0,1
51163,heart,0,1
51164,failure,0,1
51165,",",0,0
51166,unstable,0,0
51167,angina,0,1
51168,",",0,0
51169,and,0,0
51170,revascularizations,0,0
51171,.,0,0
51172,RESULTS,0,0
51173,Among,0,1
51174,all,0,0
51175,HOPE,0,0
51176,patients,0,1
51177,",",0,0
51178,there,0,0
51179,were,0,0
51180,no,0,0
51181,significant,0,0
51182,differences,0,0
51183,in,0,0
51184,the,0,0
51185,primary,0,0
51186,analysis,0,0
51187,:,0,1
51188,for,0,0
51189,cancer,0,1
51190,incidence,0,0
51191,",",0,0
51192,there,0,0
51193,were,0,0
51194,552,0,1
51195,patients,0,1
51196,(,0,0
51197,11.6,0,0
51198,%,0,0
51199,),0,0
51200,in,0,0
51201,the,0,0
51202,vitamin,0,0
51203,E,0,0
51204,group,0,0
51205,vs,0,0
51206,586,0,1
51207,(,0,0
51208,12.3,0,0
51209,%,0,0
51210,),0,0
51211,in,0,0
51212,the,0,0
51213,placebo,0,0
51214,group,0,0
51215,(,0,0
51216,relative,0,0
51217,risk,0,0
51218,[,0,0
51219,RR,0,0
51220,],0,0
51221,",",0,0
51222,0.94,0,0
51223,;,0,0
51224,95,0,0
51225,%,0,0
51226,confidence,0,0
51227,interval,0,0
51228,[,0,0
51229,CI,0,0
51230,],0,0
51231,",",0,0
51232,0.84-1.06,0,0
51233,;,0,0
51234,P,0,0
51235,=,0,0
51236,.30,0,0
51237,),0,0
51238,;,0,0
51239,for,0,0
51240,cancer,0,1
51241,deaths,0,0
51242,",",0,0
51243,156,0,1
51244,(,0,0
51245,3.3,0,0
51246,%,0,0
51247,),0,0
51248,vs,0,0
51249,178,0,1
51250,(,0,0
51251,3.7,0,0
51252,%,0,0
51253,),0,0
51254,",",0,0
51255,respectively,0,0
51256,(,0,0
51257,RR,0,0
51258,",",0,0
51259,0.88,0,0
51260,;,0,0
51261,95,0,0
51262,%,0,0
51263,CI,0,0
51264,",",0,0
51265,0.71-1.09,0,0
51266,;,0,0
51267,P,0,0
51268,=,0,0
51269,.24,0,0
51270,),0,0
51271,;,0,0
51272,and,0,0
51273,for,0,0
51274,major,0,0
51275,cardiovascular,0,1
51276,events,0,0
51277,",",0,0
51278,1022,0,1
51279,(,0,0
51280,21.5,0,0
51281,%,0,0
51282,),0,0
51283,vs,0,0
51284,985,0,1
51285,(,0,0
51286,20.6,0,0
51287,%,0,0
51288,),0,0
51289,",",0,0
51290,respectively,0,0
51291,(,0,0
51292,RR,0,0
51293,",",0,0
51294,1.04,0,0
51295,;,0,0
51296,95,0,0
51297,%,0,0
51298,CI,0,0
51299,",",0,0
51300,0.96-1.14,0,0
51301,;,0,0
51302,P,0,0
51303,=,0,0
51304,.34,0,0
51305,),0,0
51306,.,0,0
51307,Patients,0,1
51308,in,0,0
51309,the,0,0
51310,vitamin,0,0
51311,E,0,0
51312,group,0,0
51313,had,0,0
51314,a,0,0
51315,higher,0,0
51316,risk,0,0
51317,of,0,0
51318,heart,0,1
51319,failure,0,1
51320,(,0,0
51321,RR,0,0
51322,",",0,0
51323,1.13,0,0
51324,;,0,0
51325,95,0,0
51326,%,0,0
51327,CI,0,0
51328,",",0,0
51329,1.01-1.26,0,0
51330,;,0,0
51331,P,0,0
51332,=,0,0
51333,.03,0,0
51334,),0,0
51335,and,0,0
51336,hospitalization,0,0
51337,for,0,0
51338,heart,0,1
51339,failure,0,1
51340,(,0,0
51341,RR,0,0
51342,",",0,0
51343,1.21,0,0
51344,;,0,0
51345,95,0,0
51346,%,0,0
51347,CI,0,0
51348,",",0,0
51349,1.00-1.47,0,0
51350,;,0,0
51351,P,0,0
51352,=,0,0
51353,.045,0,0
51354,),0,0
51355,.,0,0
51356,Similarly,0,0
51357,",",0,0
51358,among,0,0
51359,patients,0,1
51360,enrolled,0,1
51361,at,0,0
51362,the,0,0
51363,centers,0,1
51364,participating,0,1
51365,in,0,0
51366,the,0,0
51367,HOPE-TOO,0,0
51368,trial,0,0
51369,",",0,0
51370,there,0,0
51371,were,0,0
51372,no,0,0
51373,differences,0,0
51374,in,0,0
51375,cancer,0,1
51376,incidence,0,0
51377,",",0,0
51378,cancer,0,1
51379,deaths,0,0
51380,",",0,0
51381,and,0,0
51382,major,0,0
51383,cardiovascular,0,1
51384,events,0,0
51385,",",0,0
51386,but,0,0
51387,higher,0,0
51388,rates,0,0
51389,of,0,0
51390,heart,0,1
51391,failure,0,1
51392,and,0,0
51393,hospitalizations,0,1
51394,for,0,0
51395,heart,0,1
51396,failure,0,1
51397,.,0,0
51398,CONCLUSION,0,0
51399,In,0,0
51400,patients,1,1
51401,with,1,1
51402,vascular,1,0
51403,disease,1,1
51404,or,1,0
51405,diabetes,1,1
51406,mellitus,1,0
51407,",",0,0
51408,long-term,0,0
51409,vitamin,0,0
51410,E,0,0
51411,supplementation,0,0
51412,does,0,0
51413,not,0,0
51414,prevent,0,0
51415,cancer,0,1
51416,or,0,0
51417,major,0,0
51418,cardiovascular,0,1
51419,events,0,0
51420,and,0,0
51421,may,0,0
51422,increase,0,0
51423,the,0,0
51424,risk,0,0
51425,for,0,0
51426,heart,0,1
51427,failure,0,1
51428,.,0,0
51429,Effect,0,0
51430,of,0,0
51431,a,0,0
51432,nutritional,0,0
51433,supplement,0,0
51434,containing,0,0
51435,vitamin,0,0
51436,E,0,0
51437,",",0,0
51438,selenium,0,0
51439,",",0,0
51440,vitamin,0,0
51441,c,0,0
51442,and,0,0
51443,coenzyme,0,0
51444,Q10,0,0
51445,on,0,0
51446,serum,0,0
51447,PSA,0,0
51448,in,0,0
51449,patients,1,1
51450,with,1,1
51451,hormonally,1,1
51452,untreated,1,0
51453,carcinoma,1,1
51454,of,1,0
51455,the,1,0
51456,prostate,1,1
51457,:,1,0
51458,a,0,0
51459,randomised,0,0
51460,placebo-controlled,0,0
51461,study,0,0
51462,.,0,0
51463,OBJECTIVE,0,0
51464,To,0,0
51465,assess,0,0
51466,the,0,0
51467,effect,0,0
51468,of,0,0
51469,a,0,0
51470,nutritional,0,0
51471,supplement,0,0
51472,containing,0,0
51473,vitamin,0,0
51474,E,0,0
51475,",",0,0
51476,selenium,0,0
51477,",",0,0
51478,vitamin,0,0
51479,C,0,0
51480,and,0,0
51481,coenzyme,0,0
51482,Q10,0,0
51483,on,0,0
51484,changes,0,0
51485,in,0,0
51486,serum,0,0
51487,levels,0,0
51488,of,0,0
51489,PSA,0,1
51490,in,0,0
51491,patients,1,1
51492,with,1,1
51493,hormonally,1,1
51494,untreated,1,0
51495,carcinoma,1,1
51496,of,1,0
51497,the,1,0
51498,prostate,1,1
51499,and,1,0
51500,rising,1,0
51501,serum,1,0
51502,PSA,1,1
51503,levels,1,0
51504,.,1,1
51505,METHODS,0,0
51506,Eighty,1,1
51507,patients,1,1
51508,were,1,0
51509,randomised,1,0
51510,to,0,0
51511,receive,0,0
51512,a,0,0
51513,daily,0,0
51514,supplement,0,0
51515,with,0,0
51516,either,0,0
51517,vitamin,0,0
51518,E,0,0
51519,",",0,0
51520,selenium,0,0
51521,",",0,0
51522,vitamin,0,0
51523,C,0,0
51524,",",0,0
51525,coenzyme,0,0
51526,Q10,0,0
51527,(,0,0
51528,intervention,0,0
51529,group,0,0
51530,),0,0
51531,or,0,0
51532,placebo,0,0
51533,over,0,0
51534,21,0,1
51535,weeks,0,0
51536,.,0,1
51537,Serum,0,0
51538,levels,0,0
51539,of,0,0
51540,PSA,0,1
51541,were,0,0
51542,assessed,0,0
51543,at,0,0
51544,baseline,0,0
51545,(,0,0
51546,-2,0,0
51547,",",0,0
51548,-1,0,0
51549,",",0,0
51550,0,0,0
51551,weeks,0,0
51552,),0,0
51553,and,0,0
51554,after,0,0
51555,6,0,0
51556,",",0,0
51557,13,0,0
51558,",",0,0
51559,19,0,1
51560,",",0,0
51561,20,0,0
51562,and,0,0
51563,21,0,1
51564,weeks,0,0
51565,.,0,1
51566,Mean,0,0
51567,changes,0,0
51568,in,0,0
51569,log,0,0
51570,serum,0,0
51571,level,0,0
51572,of,0,0
51573,PSA,0,0
51574,",",0,0
51575,testosterone,0,0
51576,",",0,0
51577,dihydrotestosterone,0,0
51578,",",0,0
51579,luteinizing,0,0
51580,hormone,0,0
51581,and,0,0
51582,sex,0,0
51583,hormone,0,0
51584,binding,0,0
51585,globulin,0,0
51586,over,0,0
51587,21,0,1
51588,weeks,0,0
51589,between,0,0
51590,the,0,0
51591,verum,0,0
51592,and,0,0
51593,the,0,0
51594,placebo,0,0
51595,group,0,0
51596,were,0,0
51597,compared,0,0
51598,by,0,0
51599,analysis,0,0
51600,of,0,0
51601,covariance,0,0
51602,.,0,0
51603,RESULTS,0,0
51604,Seventy,1,1
51605,patients,1,1
51606,completed,1,1
51607,the,1,0
51608,study,1,0
51609,(,1,0
51610,36,1,1
51611,verum,1,0
51612,;,1,0
51613,34,1,1
51614,placebo,1,0
51615,),1,0
51616,.,1,0
51617,Compliance,0,0
51618,was,0,0
51619,>,0,0
51620,90,0,0
51621,%,0,0
51622,in,0,0
51623,all,0,0
51624,patients,0,1
51625,.,0,0
51626,In,0,0
51627,the,0,0
51628,intervention,0,0
51629,group,0,0
51630,",",0,0
51631,plasma,0,0
51632,levels,0,0
51633,of,0,0
51634,vitamin,0,0
51635,E,0,0
51636,",",0,0
51637,selenium,0,0
51638,and,0,0
51639,coenzyme,0,0
51640,Q10,0,0
51641,increased,0,0
51642,significantly,0,0
51643,over,0,0
51644,the,0,0
51645,21,0,1
51646,weeks,0,0
51647,study,0,1
51648,period,0,0
51649,.,0,0
51650,No,0,0
51651,significant,0,0
51652,differences,0,0
51653,in,0,0
51654,serum,0,0
51655,levels,0,0
51656,of,0,0
51657,PSA,0,0
51658,",",0,0
51659,testosterone,0,0
51660,",",0,0
51661,dihydrotestosterone,0,0
51662,",",0,0
51663,luteinizing,0,0
51664,hormone,0,0
51665,or,0,0
51666,sex,0,0
51667,hormone,0,0
51668,binding,0,0
51669,globulin,0,0
51670,(,0,0
51671,p,0,0
51672,>,0,1
51673,0.2,0,0
51674,),0,0
51675,were,0,0
51676,observed,0,0
51677,between,0,0
51678,the,0,0
51679,intervention,0,0
51680,and,0,0
51681,control,0,0
51682,group,0,0
51683,.,0,0
51684,CONCLUSION,0,0
51685,Our,0,0
51686,results,0,0
51687,indicate,0,0
51688,that,0,0
51689,supplementation,0,0
51690,of,0,0
51691,a,0,0
51692,combination,0,0
51693,of,0,0
51694,vitamin,0,0
51695,E,0,0
51696,",",0,0
51697,selenium,0,0
51698,",",0,0
51699,vitamin,0,0
51700,C,0,0
51701,and,0,0
51702,coenzyme-Q10,0,0
51703,does,0,0
51704,not,0,0
51705,affect,0,0
51706,serum,0,0
51707,level,0,0
51708,of,0,0
51709,PSA,0,0
51710,or,0,1
51711,hormone,0,0
51712,levels,0,0
51713,in,0,0
51714,patients,1,1
51715,with,1,1
51716,hormonally,1,1
51717,untreated,1,0
51718,carcinoma,1,1
51719,of,1,0
51720,the,1,0
51721,prostate,1,1
51722,.,1,0
51723,DNA,0,0
51724,as,0,0
51725,a,0,0
51726,carrier,0,0
51727,for,0,0
51728,anthracyclines,0,0
51729,in,0,0
51730,the,0,0
51731,treatment,1,0
51732,of,1,0
51733,acute,1,1
51734,myelocytic,1,1
51735,leukemia,1,1
51736,(,1,0
51737,AML,1,0
51738,),1,0
51739,.,1,0
51740,Comparison,0,0
51741,of,0,0
51742,warfarin,0,0
51743,and,0,0
51744,aspirin,0,0
51745,for,0,0
51746,symptomatic,0,1
51747,intracranial,0,1
51748,arterial,0,1
51749,stenosis,0,1
51750,.,0,0
51751,BACKGROUND,0,0
51752,Atherosclerotic,0,1
51753,intracranial,0,1
51754,arterial,0,0
51755,stenosis,0,1
51756,is,0,0
51757,an,0,0
51758,important,0,0
51759,cause,0,0
51760,of,0,0
51761,stroke,0,1
51762,.,0,0
51763,Warfarin,0,0
51764,is,0,0
51765,commonly,0,0
51766,used,0,0
51767,in,0,0
51768,preference,0,0
51769,to,0,0
51770,aspirin,0,0
51771,for,0,0
51772,this,0,0
51773,disorder,0,1
51774,",",0,0
51775,but,0,0
51776,these,0,0
51777,therapies,0,0
51778,have,0,0
51779,not,0,0
51780,been,0,0
51781,compared,0,0
51782,in,0,0
51783,a,0,0
51784,randomized,0,0
51785,trial,0,0
51786,.,0,0
51787,METHODS,0,0
51788,We,0,0
51789,randomly,0,1
51790,assigned,0,0
51791,patients,1,1
51792,with,1,1
51793,transient,1,0
51794,ischemic,1,1
51795,attack,1,1
51796,or,1,0
51797,stroke,1,1
51798,caused,1,0
51799,by,1,0
51800,angiographically,1,0
51801,verified,1,0
51802,50,1,0
51803,to,1,0
51804,99,1,1
51805,percent,1,0
51806,stenosis,1,1
51807,of,1,0
51808,a,1,0
51809,major,1,0
51810,intracranial,1,1
51811,artery,1,1
51812,to,0,0
51813,receive,0,0
51814,warfarin,0,0
51815,(,0,0
51816,target,0,0
51817,international,0,1
51818,normalized,0,0
51819,ratio,0,0
51820,",",0,0
51821,2.0,0,0
51822,to,0,0
51823,3.0,0,0
51824,),0,0
51825,or,0,0
51826,aspirin,0,0
51827,(,0,0
51828,1300,0,0
51829,mg,0,0
51830,per,0,0
51831,day,0,0
51832,),0,0
51833,in,0,0
51834,a,0,0
51835,double-blind,0,0
51836,",",0,0
51837,multicenter,0,0
51838,clinical,0,0
51839,trial,0,0
51840,.,0,0
51841,The,0,0
51842,primary,0,0
51843,end,0,0
51844,point,0,0
51845,was,0,0
51846,ischemic,0,1
51847,stroke,0,1
51848,",",0,0
51849,brain,0,0
51850,hemorrhage,0,0
51851,",",0,0
51852,or,0,0
51853,death,0,0
51854,from,0,0
51855,vascular,0,0
51856,causes,0,0
51857,other,0,0
51858,than,0,0
51859,stroke,0,1
51860,.,0,0
51861,RESULTS,0,0
51862,After,1,0
51863,569,1,1
51864,patients,1,1
51865,had,1,1
51866,undergone,1,1
51867,randomization,1,0
51868,",",1,0
51869,enrollment,1,0
51870,was,1,0
51871,stopped,1,0
51872,because,1,0
51873,of,1,0
51874,concerns,1,0
51875,about,1,0
51876,the,1,0
51877,safety,1,0
51878,of,1,0
51879,the,1,0
51880,patients,1,1
51881,who,1,1
51882,had,1,1
51883,been,1,1
51884,assigned,1,0
51885,to,1,0
51886,receive,1,0
51887,warfarin,1,0
51888,.,1,0
51889,During,0,0
51890,a,0,0
51891,mean,0,0
51892,follow-up,0,0
51893,period,0,0
51894,of,0,0
51895,1.8,0,0
51896,years,0,1
51897,",",0,0
51898,adverse,0,0
51899,events,0,0
51900,in,0,0
51901,the,0,0
51902,two,0,0
51903,groups,0,0
51904,included,0,1
51905,death,0,0
51906,(,0,0
51907,4.3,0,0
51908,percent,0,0
51909,in,0,0
51910,the,0,0
51911,aspirin,0,0
51912,group,0,0
51913,vs.,0,0
51914,9.7,0,0
51915,percent,0,0
51916,in,0,0
51917,the,0,0
51918,warfarin,0,0
51919,group,0,0
51920,;,0,0
51921,hazard,0,0
51922,ratio,0,0
51923,for,0,0
51924,aspirin,0,0
51925,relative,0,0
51926,to,0,0
51927,warfarin,0,0
51928,",",0,0
51929,0.46,0,0
51930,;,0,0
51931,95,0,0
51932,percent,0,0
51933,confidence,0,0
51934,interval,0,0
51935,",",0,0
51936,0.23,0,0
51937,to,0,0
51938,0.90,0,0
51939,;,0,0
51940,P=0.02,0,0
51941,),0,0
51942,",",0,0
51943,major,0,0
51944,hemorrhage,0,0
51945,(,0,0
51946,3.2,0,0
51947,percent,0,0
51948,vs.,0,0
51949,8.3,0,0
51950,percent,0,0
51951,",",0,0
51952,respectively,0,0
51953,;,0,0
51954,hazard,0,0
51955,ratio,0,0
51956,",",0,0
51957,0.39,0,0
51958,;,0,0
51959,95,0,0
51960,percent,0,0
51961,confidence,0,0
51962,interval,0,0
51963,",",0,0
51964,0.18,0,0
51965,to,0,0
51966,0.84,0,0
51967,;,0,0
51968,P=0.01,0,0
51969,),0,0
51970,",",0,0
51971,and,0,0
51972,myocardial,0,0
51973,infarction,0,1
51974,or,0,0
51975,sudden,0,0
51976,death,0,0
51977,(,0,0
51978,2.9,0,0
51979,percent,0,0
51980,vs.,0,0
51981,7.3,0,0
51982,percent,0,0
51983,",",0,0
51984,respectively,0,0
51985,;,0,0
51986,hazard,0,0
51987,ratio,0,0
51988,",",0,0
51989,0.40,0,0
51990,;,0,0
51991,95,0,0
51992,percent,0,0
51993,confidence,0,0
51994,interval,0,0
51995,",",0,0
51996,0.18,0,0
51997,to,0,0
51998,0.91,0,0
51999,;,0,0
52000,P=0.02,0,0
52001,),0,0
52002,.,0,0
52003,The,0,0
52004,rate,0,0
52005,of,0,0
52006,death,0,0
52007,from,0,0
52008,vascular,0,0
52009,causes,0,0
52010,was,0,0
52011,3.2,0,0
52012,percent,0,0
52013,in,0,0
52014,the,0,0
52015,aspirin,0,0
52016,group,0,0
52017,and,0,0
52018,5.9,0,0
52019,percent,0,0
52020,in,0,0
52021,the,0,0
52022,warfarin,0,0
52023,group,0,0
52024,(,0,0
52025,P=0.16,0,0
52026,),0,0
52027,;,0,0
52028,the,0,0
52029,rate,0,0
52030,of,0,0
52031,death,0,0
52032,from,0,0
52033,nonvascular,0,1
52034,causes,0,0
52035,was,0,0
52036,1.1,0,0
52037,percent,0,0
52038,and,0,0
52039,3.8,0,0
52040,percent,0,0
52041,",",0,0
52042,respectively,0,0
52043,(,0,0
52044,P=0.05,0,0
52045,),0,0
52046,.,0,0
52047,The,0,0
52048,primary,0,0
52049,end,0,0
52050,point,0,0
52051,occurred,0,0
52052,in,0,0
52053,22.1,0,0
52054,percent,0,0
52055,of,0,0
52056,the,0,0
52057,patients,0,1
52058,in,0,0
52059,the,0,0
52060,aspirin,0,0
52061,group,0,0
52062,and,0,0
52063,21.8,0,0
52064,percent,0,0
52065,of,0,0
52066,those,0,0
52067,in,0,0
52068,the,0,0
52069,warfarin,0,0
52070,group,0,0
52071,(,0,0
52072,hazard,0,0
52073,ratio,0,0
52074,",",0,0
52075,1.04,0,0
52076,;,0,0
52077,95,0,0
52078,percent,0,0
52079,confidence,0,0
52080,interval,0,0
52081,",",0,0
52082,0.73,0,0
52083,to,0,0
52084,1.48,0,0
52085,;,0,0
52086,P=0.83,0,0
52087,),0,0
52088,.,0,0
52089,CONCLUSIONS,0,0
52090,Warfarin,0,0
52091,was,0,0
52092,associated,0,0
52093,with,0,0
52094,significantly,0,0
52095,higher,0,0
52096,rates,0,0
52097,of,0,0
52098,adverse,0,0
52099,events,0,0
52100,and,0,0
52101,provided,0,0
52102,no,0,0
52103,benefit,0,0
52104,over,0,0
52105,aspirin,0,0
52106,in,0,0
52107,this,0,0
52108,trial,0,0
52109,.,0,0
52110,Aspirin,0,0
52111,should,0,0
52112,be,0,0
52113,used,0,0
52114,in,0,0
52115,preference,0,0
52116,to,0,0
52117,warfarin,0,0
52118,for,0,0
52119,patients,1,1
52120,with,1,1
52121,intracranial,1,1
52122,arterial,1,1
52123,stenosis,1,1
52124,.,1,0
52125,Development,0,0
52126,of,0,0
52127,the,0,0
52128,WAIS-III,0,0
52129,general,0,1
52130,ability,0,0
52131,index,0,0
52132,estimate,0,0
52133,(,0,0
52134,GAI-E,0,0
52135,),0,0
52136,.,0,0
52137,The,0,0
52138,WAIS-III,0,0
52139,General,0,1
52140,Ability,0,0
52141,Index,0,0
52142,(,0,0
52143,GAI,0,0
52144,;,0,0
52145,Tulsky,0,0
52146,",",0,0
52147,Saklofske,0,0
52148,",",0,0
52149,Wilkins,0,0
52150,",",0,0
52151,&,0,0
52152,Weiss,0,0
52153,",",0,0
52154,2001,0,1
52155,),0,0
52156,is,0,0
52157,a,0,0
52158,recently,0,0
52159,developed,0,0
52160,",",0,0
52161,6-subtest,0,0
52162,measure,0,0
52163,of,0,0
52164,global,0,0
52165,intellectual,0,1
52166,functioning,0,0
52167,.,0,0
52168,However,0,0
52169,",",0,0
52170,clinical,0,0
52171,use,0,0
52172,of,0,0
52173,the,0,0
52174,GAI,0,0
52175,is,0,0
52176,currently,0,0
52177,limited,0,0
52178,by,0,0
52179,the,0,0
52180,absence,0,0
52181,of,0,0
52182,a,0,0
52183,method,0,0
52184,to,0,0
52185,estimate,0,0
52186,premorbid,0,1
52187,functioning,0,0
52188,as,0,0
52189,measured,0,0
52190,by,0,0
52191,this,0,0
52192,index,0,0
52193,.,0,0
52194,The,0,0
52195,purpose,0,0
52196,of,0,0
52197,this,0,0
52198,study,0,0
52199,was,0,0
52200,to,0,0
52201,develop,0,0
52202,regression,0,0
52203,equations,0,0
52204,to,0,0
52205,estimate,0,0
52206,GAI,0,0
52207,scores,0,0
52208,from,0,1
52209,demographic,0,0
52210,variables,0,0
52211,and,0,0
52212,WAIS-III,0,0
52213,subtest,0,0
52214,performance,0,0
52215,.,0,0
52216,Participants,1,1
52217,consisted,1,0
52218,of,1,0
52219,those,1,0
52220,subjects,1,1
52221,in,1,0
52222,the,1,0
52223,WAIS-III,1,0
52224,standardization,1,0
52225,sample,1,1
52226,that,1,0
52227,has,1,0
52228,complete,1,0
52229,demographic,1,0
52230,data,1,0
52231,(,1,0
52232,"N=2,401",1,1
52233,),1,0
52234,and,1,0
52235,were,1,0
52236,randomly,1,0
52237,divided,1,0
52238,into,1,0
52239,two,1,0
52240,groups,1,0
52241,.,1,0
52242,The,0,0
52243,first,0,0
52244,group,0,0
52245,(,0,0
52246,"n=1,200",0,1
52247,),0,0
52248,was,0,0
52249,used,0,0
52250,to,0,0
52251,develop,0,0
52252,the,0,0
52253,formulas,0,0
52254,(,0,0
52255,i.e.,0,0
52256,",",0,0
52257,Development,0,0
52258,group,0,0
52259,),0,0
52260,and,0,0
52261,the,0,0
52262,second,0,0
52263,(,0,0
52264,"n=1,201",0,1
52265,),0,0
52266,group,0,0
52267,was,0,0
52268,used,0,0
52269,to,0,0
52270,validate,0,0
52271,the,0,0
52272,prediction,0,0
52273,algorithms,0,0
52274,(,0,0
52275,i.e.,0,0
52276,",",0,0
52277,Validation,0,0
52278,group,0,0
52279,),0,0
52280,.,0,0
52281,Demographic,0,0
52282,variables,0,0
52283,included,0,1
52284,age,0,1
52285,",",0,0
52286,education,0,0
52287,",",0,0
52288,ethnicity,0,0
52289,",",0,0
52290,gender,0,0
52291,and,0,0
52292,region,0,0
52293,of,0,0
52294,country,0,1
52295,.,0,0
52296,Subtest,0,0
52297,variables,0,0
52298,included,0,1
52299,vocabulary,0,0
52300,",",0,0
52301,information,0,0
52302,",",0,0
52303,picture,0,0
52304,completion,0,0
52305,",",0,0
52306,and,0,0
52307,matrix,0,0
52308,reasoning,0,0
52309,raw,0,0
52310,scores,0,0
52311,.,0,1
52312,Ten,0,1
52313,regression,0,0
52314,algorithms,0,0
52315,were,0,0
52316,generated,0,0
52317,designed,0,0
52318,to,0,0
52319,estimate,0,0
52320,GAI,0,0
52321,.,0,0
52322,The,0,0
52323,GAI-Estimate,0,0
52324,(,0,0
52325,GAI-E,0,0
52326,),0,0
52327,algorithms,0,0
52328,accounted,0,0
52329,for,0,0
52330,58,0,1
52331,%,0,0
52332,to,0,0
52333,82,0,0
52334,%,0,0
52335,of,0,0
52336,the,0,0
52337,variance,0,0
52338,.,0,0
52339,The,0,0
52340,standard,0,0
52341,error,0,0
52342,of,0,0
52343,estimate,0,0
52344,ranged,0,0
52345,from,0,0
52346,6.44,0,0
52347,to,0,0
52348,9.57,0,0
52349,.,0,0
52350,The,0,0
52351,correlations,0,0
52352,between,0,0
52353,actual,0,0
52354,and,0,0
52355,estimated,0,0
52356,GAI,0,0
52357,ranged,0,0
52358,from,0,0
52359,r=.76,0,0
52360,to,0,0
52361,r=.90,0,0
52362,.,0,0
52363,These,0,0
52364,algorithms,0,0
52365,provided,0,0
52366,accurate,0,0
52367,estimates,0,0
52368,of,0,0
52369,GAI,0,0
52370,in,0,0
52371,the,0,0
52372,WAIS-III,0,0
52373,standardization,0,0
52374,sample,0,1
52375,.,0,0
52376,Implications,0,0
52377,for,0,0
52378,estimating,0,0
52379,GAI,0,0
52380,in,0,0
52381,patients,1,1
52382,with,1,1
52383,known,1,0
52384,or,1,0
52385,suspected,1,1
52386,neurological,1,0
52387,dysfunction,1,0
52388,is,0,0
52389,discussed,0,0
52390,and,0,0
52391,future,0,0
52392,research,0,0
52393,is,0,0
52394,proposed,0,0
52395,.,0,0
52396,Dairy,0,1
52397,products,0,0
52398,do,0,0
52399,not,0,0
52400,lead,0,0
52401,to,0,0
52402,alterations,0,0
52403,in,0,0
52404,body,0,1
52405,weight,0,0
52406,or,0,0
52407,fat,0,0
52408,mass,0,0
52409,in,0,0
52410,young,1,1
52411,women,1,1
52412,in,0,0
52413,a,0,0
52414,1-y,0,0
52415,intervention,0,0
52416,.,0,0
52417,BACKGROUND,0,0
52418,Previous,0,0
52419,results,0,0
52420,suggested,0,0
52421,that,0,0
52422,increased,0,0
52423,intake,0,0
52424,of,0,0
52425,dairy,0,1
52426,calcium,0,0
52427,is,0,0
52428,associated,0,0
52429,with,0,0
52430,reduced,0,0
52431,weight,0,0
52432,and,0,0
52433,fat,0,0
52434,mass,0,0
52435,.,0,0
52436,OBJECTIVE,0,0
52437,The,0,0
52438,purpose,0,0
52439,of,0,0
52440,this,0,0
52441,study,0,0
52442,was,0,0
52443,to,0,0
52444,determine,0,0
52445,whether,0,0
52446,long-term,0,0
52447,increases,0,0
52448,in,0,0
52449,consumption,0,0
52450,of,0,0
52451,dairy,0,1
52452,calcium,0,0
52453,alter,0,0
52454,body,0,0
52455,weight,0,0
52456,and,0,0
52457,fat,0,0
52458,mass,0,0
52459,in,0,0
52460,young,1,1
52461,",",1,0
52462,healthy,1,1
52463,women,1,1
52464,.,1,1
52465,DESIGN,0,0
52466,We,0,0
52467,used,0,0
52468,a,0,0
52469,randomized,0,0
52470,",",0,0
52471,1-y,0,0
52472,intervention,0,0
52473,for,0,0
52474,dairy,0,1
52475,calcium,0,0
52476,.,0,0
52477,Subjects,1,0
52478,were,1,0
52479,155,1,1
52480,young,1,1
52481,(,1,0
52482,aged,1,1
52483,18-30,1,1
52484,y,1,1
52485,),1,0
52486,",",1,0
52487,healthy,1,1
52488,",",1,0
52489,normal-weight,1,0
52490,women,1,1
52491,with,1,1
52492,intake,1,0
52493,of,1,0
52494,dietary,1,0
52495,calcium,1,0
52496,<,1,0
52497,800,1,0
52498,mg/d,1,0
52499,and,1,0
52500,energy,1,0
52501,intake,1,0
52502,<,1,0
52503,/=,1,1
52504,2200,1,0
52505,kcal/d,1,0
52506,.,1,1
52507,Women,0,0
52508,were,0,0
52509,randomly,0,1
52510,assigned,0,0
52511,to,0,0
52512,1,0,0
52513,of,0,0
52514,3,0,0
52515,groups,0,0
52516,:,0,1
52517,1,0,0
52518,),0,0
52519,control,0,0
52520,:,0,1
52521,continue,0,0
52522,established,0,0
52523,dietary,0,0
52524,intake,0,0
52525,;,0,0
52526,2,0,0
52527,),0,0
52528,medium,0,0
52529,dairy,0,1
52530,:,0,0
52531,substitute,0,0
52532,dairy,0,1
52533,products,0,0
52534,to,0,0
52535,achieve,0,0
52536,intake,0,0
52537,of,0,0
52538,calcium,0,0
52539,of,0,0
52540,approximately,0,0
52541,1000-1100,0,0
52542,mg/d,0,0
52543,and,0,0
52544,maintain,0,0
52545,isocaloric,0,0
52546,intake,0,0
52547,;,0,0
52548,3,0,0
52549,),0,0
52550,high,0,0
52551,dairy,0,1
52552,:,0,1
52553,substitute,0,0
52554,dairy,0,1
52555,products,0,0
52556,to,0,0
52557,achieve,0,0
52558,intake,0,0
52559,of,0,0
52560,calcium,0,0
52561,of,0,0
52562,1300-1400,0,1
52563,mg/d,0,0
52564,and,0,0
52565,maintain,0,0
52566,isocaloric,0,0
52567,intake,0,0
52568,.,0,0
52569,The,0,0
52570,main,0,0
52571,outcome,0,0
52572,measures,0,0
52573,were,0,0
52574,1-y,0,1
52575,changes,0,0
52576,in,0,0
52577,body,0,1
52578,weight,0,0
52579,(,0,0
52580,in,0,0
52581,kg,0,0
52582,),0,0
52583,and,0,0
52584,fat,0,0
52585,mass,0,0
52586,(,0,0
52587,in,0,0
52588,kg,0,1
52589,),0,0
52590,.,0,0
52591,One,1,0
52592,hundred,1,1
52593,thirty-five,1,1
52594,women,1,1
52595,completed,1,1
52596,the,1,0
52597,trial,1,0
52598,.,1,0
52599,RESULTS,0,0
52600,Mean,0,1
52601,intakes,0,0
52602,of,0,0
52603,calcium,0,0
52604,during,0,0
52605,the,0,0
52606,intervention,0,0
52607,were,0,0
52608,742.4,0,0
52609,+/-,0,0
52610,321.5,0,0
52611,",",0,0
52612,1026.4,0,0
52613,+/-,0,0
52614,311.3,0,0
52615,",",0,0
52616,and,0,0
52617,1131.29,0,0
52618,+/-,0,0
52619,337.2,0,0
52620,mg/d,0,0
52621,for,0,0
52622,the,0,0
52623,control,0,0
52624,",",0,0
52625,medium-dairy,0,0
52626,",",0,0
52627,and,0,0
52628,high-dairy,0,0
52629,groups,0,0
52630,",",0,0
52631,respectively,0,0
52632,(,0,0
52633,P,0,0
52634,<,0,0
52635,0.0001,0,0
52636,),0,0
52637,.,0,0
52638,No,0,0
52639,significant,0,0
52640,differences,0,0
52641,were,0,0
52642,observed,0,0
52643,in,0,0
52644,the,0,0
52645,mean,0,0
52646,1-y,0,0
52647,change,0,0
52648,in,0,0
52649,body,0,0
52650,weight,0,0
52651,between,0,0
52652,the,0,0
52653,control,0,0
52654,",",0,0
52655,medium-dairy,0,0
52656,",",0,0
52657,and,0,0
52658,high-dairy,0,0
52659,groups,0,0
52660,(,0,0
52661,0.8,0,0
52662,+/-,0,0
52663,2.8,0,0
52664,",",0,0
52665,0.7,0,0
52666,+/-,0,0
52667,3.0,0,0
52668,",",0,0
52669,and,0,0
52670,1.5,0,0
52671,+/-,0,0
52672,4.1,0,0
52673,kg,0,0
52674,",",0,0
52675,respectively,0,0
52676,;,0,0
52677,P,0,0
52678,=,0,0
52679,0.45,0,0
52680,),0,0
52681,.,0,0
52682,No,0,0
52683,significant,0,0
52684,differences,0,0
52685,were,0,0
52686,observed,0,0
52687,in,0,0
52688,the,0,0
52689,mean,0,0
52690,1-y,0,0
52691,change,0,0
52692,in,0,0
52693,fat,0,0
52694,mass,0,0
52695,between,0,0
52696,the,0,0
52697,control,0,0
52698,",",0,0
52699,medium-dairy,0,0
52700,",",0,0
52701,and,0,0
52702,high-dairy,0,0
52703,groups,0,0
52704,(,0,0
52705,-0.5,0,0
52706,+/-,0,0
52707,2.5,0,0
52708,",",0,0
52709,0.3,0,0
52710,+/-,0,0
52711,2.7,0,0
52712,",",0,0
52713,and,0,0
52714,0.5,0,0
52715,+/-,0,0
52716,3.5,0,0
52717,kg,0,0
52718,",",0,0
52719,respectively,0,0
52720,;,0,0
52721,P,0,0
52722,=,0,0
52723,0.26,0,0
52724,),0,0
52725,.,0,0
52726,CONCLUSION,0,0
52727,Increased,0,0
52728,intake,0,0
52729,of,0,0
52730,dairy,0,1
52731,products,0,0
52732,does,0,0
52733,not,0,0
52734,alter,0,0
52735,body,0,0
52736,weight,0,0
52737,or,0,0
52738,fat,0,0
52739,mass,0,0
52740,in,0,0
52741,young,1,1
52742,",",1,0
52743,healthy,1,1
52744,women,1,1
52745,over,0,0
52746,1,0,1
52747,y,0,1
52748,.,0,1
52749,Comparative,0,0
52750,study,0,0
52751,of,0,0
52752,the,0,0
52753,efficacy,0,0
52754,of,0,0
52755,eprinomectin,0,0
52756,versus,0,0
52757,ivermectin,0,0
52758,",",0,0
52759,and,0,0
52760,field,0,0
52761,efficacy,0,0
52762,of,0,0
52763,eprinomectin,0,0
52764,only,0,0
52765,",",0,0
52766,for,0,0
52767,the,0,0
52768,treatment,0,0
52769,of,0,0
52770,chorioptic,1,0
52771,mange,1,1
52772,in,1,0
52773,alpacas,1,1
52774,.,1,0
52775,The,0,0
52776,efficacy,0,0
52777,of,0,0
52778,eprinomectin,0,0
52779,versus,0,0
52780,ivermectin,0,0
52781,(,0,0
52782,Study,0,0
52783,1,0,0
52784,:,0,1
52785,a,0,0
52786,single-centre,0,0
52787,",",0,0
52788,randomised,0,0
52789,",",0,0
52790,treatment-controlled,0,0
52791,",",0,0
52792,blinded,0,0
52793,field,0,0
52794,trial,0,0
52795,),0,0
52796,",",0,0
52797,and,0,0
52798,the,0,0
52799,field,0,0
52800,efficacy,0,0
52801,of,0,0
52802,eprinomectin,0,0
52803,(,0,0
52804,Study,0,0
52805,2,0,0
52806,:,0,1
52807,a,0,0
52808,single-centre,0,0
52809,",",0,0
52810,open,0,0
52811,",",0,0
52812,un-controlled,0,0
52813,field,0,0
52814,trial,0,0
52815,),0,0
52816,for,0,0
52817,the,0,0
52818,treatment,0,0
52819,of,0,0
52820,chorioptic,0,0
52821,infestation,0,1
52822,in,0,0
52823,naturally,1,0
52824,infested,1,1
52825,alpacas,1,1
52826,were,0,0
52827,assessed,0,0
52828,in,0,0
52829,two,0,0
52830,studies,0,0
52831,.,0,1
52832,Thirty,1,1
52833,alpacas,1,0
52834,",",1,0
52835,all,1,0
52836,positive,1,0
52837,for,1,0
52838,Chorioptes,1,0
52839,sp,1,0
52840,.,1,0
52841,mite,1,0
52842,",",1,0
52843,were,1,0
52844,randomly,1,0
52845,allocated,1,0
52846,to,1,0
52847,two,1,0
52848,treatment,1,0
52849,groups,1,0
52850,in,1,0
52851,Study,1,1
52852,1,1,0
52853,.,1,1
52854,Group,0,0
52855,A,0,0
52856,received,0,0
52857,a,0,0
52858,single,0,0
52859,topical,0,0
52860,administration,0,0
52861,of,0,0
52862,a,0,0
52863,0.5,0,0
52864,%,0,0
52865,formulation,0,0
52866,of,0,0
52867,eprinomectin,0,0
52868,at,0,0
52869,the,0,0
52870,dose,0,0
52871,rate,0,0
52872,of,0,0
52873,500mug/kg,0,0
52874,.,0,1
52875,Group,0,0
52876,B,0,0
52877,received,0,0
52878,three,0,0
52879,subcutaneous,0,1
52880,administrations,0,0
52881,at,0,0
52882,14,0,1
52883,days,0,0
52884,interval,0,0
52885,of,0,0
52886,a,0,0
52887,1,0,0
52888,%,0,0
52889,formulation,0,0
52890,of,0,0
52891,ivermectin,0,0
52892,at,0,0
52893,the,0,0
52894,dose,0,0
52895,rate,0,0
52896,of,0,0
52897,400mug/kg,0,0
52898,.,0,0
52899,Response,0,0
52900,to,0,0
52901,treatment,0,0
52902,was,0,0
52903,assessed,0,0
52904,by,0,0
52905,periodic,0,0
52906,mite,0,1
52907,count,0,0
52908,",",0,0
52909,and,0,0
52910,skin,0,0
52911,lesions,0,1
52912,scored,0,0
52913,.,0,0
52914,In,1,0
52915,Study,1,0
52916,2,1,0
52917,",",1,0
52918,one,1,0
52919,group,1,0
52920,of,1,0
52921,19,1,1
52922,alpacas,1,1
52923,received,1,0
52924,four,1,1
52925,administrations,1,0
52926,at,1,0
52927,weekly,1,0
52928,interval,1,0
52929,of,1,0
52930,topical,1,0
52931,eprinomectin,1,0
52932,at,1,0
52933,the,1,0
52934,dose,1,0
52935,rate,1,0
52936,of,1,0
52937,500mug/kg,1,0
52938,",",1,0
52939,and,1,0
52940,response,1,0
52941,to,1,0
52942,treatment,1,0
52943,was,1,0
52944,monitored,1,0
52945,by,1,0
52946,mite,1,1
52947,counts,1,0
52948,.,1,1
52949,No,0,0
52950,localised,0,0
52951,or,0,0
52952,systemic,0,0
52953,side,0,0
52954,effects,0,0
52955,were,0,0
52956,observed,0,0
52957,in,0,0
52958,either,0,0
52959,trial,0,0
52960,.,0,0
52961,There,0,0
52962,was,0,0
52963,a,0,0
52964,statistically,0,0
52965,significant,0,0
52966,decrease,0,0
52967,in,0,0
52968,mite,0,1
52969,counts,0,0
52970,on,0,0
52971,day,0,0
52972,7,0,0
52973,(,0,0
52974,P,0,0
52975,<,0,0
52976,0.001,0,0
52977,),0,0
52978,within,0,0
52979,treatment,0,0
52980,Groups,0,0
52981,A,0,0
52982,and,0,0
52983,B,0,0
52984,of,0,0
52985,Study,0,0
52986,1,0,0
52987,",",0,0
52988,but,0,0
52989,mite,0,1
52990,counts,0,0
52991,increased,0,0
52992,again,0,0
52993,on,0,0
52994,day,0,0
52995,14,0,0
52996,and,0,0
52997,remained,0,0
52998,high,0,0
52999,for,0,0
53000,the,0,0
53001,duration,0,0
53002,of,0,0
53003,the,0,0
53004,trial,0,0
53005,in,0,0
53006,both,0,0
53007,treatment,0,0
53008,groups,0,0
53009,.,0,0
53010,On,0,0
53011,day,0,0
53012,14,0,0
53013,of,0,0
53014,Study,0,0
53015,2,0,0
53016,",",0,0
53017,there,0,0
53018,was,0,0
53019,a,0,0
53020,statistically,0,0
53021,significant,0,0
53022,reduction,0,0
53023,in,0,0
53024,mite,0,1
53025,counts,0,0
53026,(,0,0
53027,P,0,0
53028,<,0,0
53029,0.008,0,0
53030,),0,0
53031,and,0,0
53032,the,0,0
53033,mite,0,1
53034,counts,0,0
53035,remained,0,0
53036,very,0,0
53037,low,0,0
53038,throughout,0,0
53039,the,0,0
53040,remainder,0,0
53041,of,0,0
53042,the,0,0
53043,study,0,0
53044,.,0,0
53045,The,0,0
53046,eprinomectin,0,0
53047,protocol,0,0
53048,employed,0,0
53049,in,0,0
53050,Study,0,0
53051,2,0,0
53052,",",0,0
53053,consisting,0,0
53054,of,0,0
53055,four,0,1
53056,weekly,0,0
53057,topical,0,0
53058,administrations,0,0
53059,at,0,0
53060,the,0,0
53061,dose,0,0
53062,rate,0,0
53063,of,0,0
53064,500mug/kg,0,0
53065,of,0,0
53066,body,0,0
53067,weight,0,0
53068,",",0,0
53069,proved,0,0
53070,highly,0,0
53071,effective,0,0
53072,at,0,0
53073,reducing,0,0
53074,the,0,0
53075,Chorioptes,1,0
53076,mite,1,1
53077,burden,1,1
53078,in,1,0
53079,alpacas,1,1
53080,.,1,0
53081,Effects,0,0
53082,of,0,0
53083,home,0,1
53084,strength,0,0
53085,training,0,0
53086,and,0,0
53087,stretching,0,0
53088,versus,0,0
53089,stretching,0,0
53090,alone,0,0
53091,after,1,0
53092,lumbar,1,0
53093,disk,1,1
53094,surgery,1,1
53095,:,1,0
53096,a,0,0
53097,randomized,0,0
53098,study,0,0
53099,with,0,1
53100,a,0,0
53101,1-year,0,0
53102,follow-up,0,0
53103,.,0,0
53104,OBJECTIVE,0,0
53105,To,0,0
53106,assess,0,0
53107,the,0,0
53108,adherence,0,0
53109,to,0,0
53110,and,0,0
53111,effects,0,0
53112,of,0,0
53113,a,0,0
53114,12-month,0,0
53115,combined,0,0
53116,strength,0,0
53117,and,0,0
53118,stretching,0,0
53119,home,0,0
53120,exercise,0,0
53121,regimen,0,0
53122,versus,0,0
53123,stretching,0,0
53124,alone,0,0
53125,",",0,0
53126,on,0,0
53127,patient,1,0
53128,outcome,1,0
53129,after,1,0
53130,lumbar,1,0
53131,disk,1,0
53132,surgery,1,1
53133,.,1,0
53134,DESIGN,0,0
53135,Randomized,0,0
53136,controlled,0,0
53137,trial,0,0
53138,.,0,0
53139,SETTING,0,0
53140,Departments,1,1
53141,of,1,0
53142,physical,1,0
53143,medicine,1,1
53144,and,1,0
53145,rehabilitation,1,1
53146,and,1,0
53147,orthopedics,1,0
53148,at,1,0
53149,a,1,0
53150,Finnish,1,1
53151,hospital,1,0
53152,.,1,1
53153,PARTICIPANTS,0,0
53154,Patients,1,1
53155,(,1,1
53156,N=126,1,0
53157,),1,0
53158,were,1,0
53159,randomized,1,0
53160,into,0,0
53161,either,0,0
53162,a,0,0
53163,combined,0,0
53164,strength,0,0
53165,training,0,0
53166,and,0,0
53167,stretching,0,0
53168,group,0,0
53169,(,0,0
53170,STG,0,0
53171,",",0,0
53172,n=65,0,1
53173,),0,0
53174,or,0,0
53175,a,0,0
53176,control,0,0
53177,group,0,0
53178,(,0,0
53179,CG,0,0
53180,",",0,0
53181,n=61,0,1
53182,),0,0
53183,.,0,0
53184,INTERVENTION,0,0
53185,The,0,0
53186,STG,0,0
53187,was,0,0
53188,instructed,0,0
53189,to,0,0
53190,perform,0,0
53191,strength,0,0
53192,training,0,0
53193,and,0,0
53194,both,0,0
53195,the,0,0
53196,STG,0,0
53197,and,0,0
53198,CG,0,0
53199,were,0,0
53200,instructed,0,0
53201,in,0,0
53202,the,0,0
53203,same,0,0
53204,stretching,0,0
53205,and,0,0
53206,stabilization,0,0
53207,exercises,0,0
53208,for,0,0
53209,12,0,1
53210,months,0,0
53211,.,0,1
53212,MAIN,0,0
53213,OUTCOME,0,0
53214,MEASURES,0,0
53215,Pain,0,0
53216,on,0,0
53217,the,0,0
53218,visual,0,0
53219,analog,0,0
53220,scale,0,0
53221,(,0,0
53222,VAS,0,0
53223,),0,0
53224,",",0,0
53225,the,0,0
53226,Oswestry,0,0
53227,and,0,0
53228,the,0,0
53229,Million,0,0
53230,disability,0,0
53231,indexes,0,0
53232,",",0,0
53233,isometric,0,0
53234,and,0,0
53235,dynamic,0,0
53236,trunk,0,0
53237,muscle,0,0
53238,strength,0,0
53239,",",0,0
53240,mobility,0,0
53241,in,0,0
53242,the,0,0
53243,lumbar,0,0
53244,spine,0,0
53245,",",0,0
53246,and,0,0
53247,straight-leg,0,0
53248,raising,0,0
53249,were,0,0
53250,measured,0,0
53251,.,0,0
53252,RESULTS,0,0
53253,The,0,0
53254,trial,0,0
53255,was,0,0
53256,completed,0,1
53257,by,0,0
53258,71,0,1
53259,%,0,0
53260,and,0,0
53261,77,0,0
53262,%,0,0
53263,of,0,0
53264,the,0,0
53265,patients,0,1
53266,from,0,0
53267,the,0,0
53268,STG,0,0
53269,and,0,0
53270,the,0,0
53271,CG,0,0
53272,",",0,0
53273,respectively,0,0
53274,.,0,0
53275,The,0,0
53276,mean,0,0
53277,strength,0,0
53278,training,0,0
53279,frequency,0,0
53280,decreased,0,0
53281,from,0,0
53282,1.5,0,0
53283,to,0,0
53284,0.6,0,0
53285,times,0,0
53286,a,0,0
53287,week,0,0
53288,in,0,0
53289,the,0,0
53290,STG,0,0
53291,during,0,0
53292,the,0,0
53293,intervention,0,0
53294,.,0,0
53295,The,0,0
53296,mean,0,0
53297,stretching,0,0
53298,frequency,0,0
53299,decreased,0,0
53300,from,0,0
53301,3.7,0,0
53302,to,0,0
53303,1.6,0,0
53304,times,0,0
53305,a,0,0
53306,week,0,0
53307,in,0,0
53308,both,0,0
53309,groups,0,0
53310,.,0,0
53311,Median,0,0
53312,back,0,0
53313,and,0,0
53314,leg,0,0
53315,pain,0,0
53316,varied,0,0
53317,between,0,0
53318,17,0,0
53319,and,0,0
53320,23,0,1
53321,mm,0,0
53322,(,0,0
53323,VAS,0,0
53324,),0,0
53325,",",0,0
53326,and,0,0
53327,the,0,0
53328,Million,0,0
53329,and,0,0
53330,Oswestry,0,1
53331,indices,0,0
53332,varied,0,0
53333,between,0,0
53334,14,0,0
53335,and,0,0
53336,23,0,1
53337,points,0,0
53338,2,0,1
53339,months,0,0
53340,postoperatively,0,0
53341,.,0,0
53342,No,0,0
53343,statistically,0,0
53344,significant,0,0
53345,changes,0,0
53346,took,0,0
53347,place,0,0
53348,in,0,0
53349,these,0,0
53350,outcome,0,0
53351,measures,0,0
53352,during,0,0
53353,the,0,0
53354,12-month,0,0
53355,follow-up,0,0
53356,in,0,0
53357,both,0,0
53358,groups,0,0
53359,.,0,0
53360,The,0,0
53361,changes,0,0
53362,in,0,0
53363,isometric,0,0
53364,trunk,0,1
53365,extension,0,0
53366,favored,0,0
53367,the,0,0
53368,STG,0,0
53369,(,0,0
53370,P,0,0
53371,=.016,0,0
53372,),0,0
53373,during,0,0
53374,the,0,0
53375,first,0,0
53376,2,0,0
53377,months,0,0
53378,.,0,0
53379,However,0,0
53380,",",0,0
53381,during,0,0
53382,the,0,0
53383,whole,0,0
53384,12-month,0,0
53385,training,0,0
53386,period,0,0
53387,",",0,0
53388,both,0,0
53389,dynamic,0,0
53390,and,0,0
53391,isometric,0,0
53392,back,0,0
53393,extension,0,0
53394,and,0,0
53395,flexion,0,0
53396,strength,0,0
53397,",",0,0
53398,as,0,0
53399,well,0,0
53400,as,0,0
53401,mobility,0,0
53402,of,0,0
53403,the,0,0
53404,spine,0,0
53405,and,0,0
53406,repetitive,0,0
53407,squat-test,0,0
53408,results,0,0
53409,",",0,0
53410,improved,0,0
53411,significantly,0,0
53412,in,0,0
53413,both,0,0
53414,groups,0,0
53415,",",0,0
53416,and,0,0
53417,no,0,0
53418,differences,0,0
53419,were,0,0
53420,found,0,0
53421,in,0,0
53422,any,0,0
53423,of,0,0
53424,the,0,0
53425,physical,0,0
53426,function,0,0
53427,parameters,0,0
53428,between,0,0
53429,the,0,0
53430,STG,0,0
53431,and,0,0
53432,CG,0,0
53433,.,0,0
53434,CONCLUSIONS,0,0
53435,At,0,0
53436,the,0,0
53437,12-month,0,0
53438,follow-up,0,0
53439,",",0,0
53440,no,0,0
53441,statistically,0,0
53442,significant,0,0
53443,changes,0,0
53444,were,0,0
53445,found,0,0
53446,in,0,0
53447,the,0,0
53448,physical,0,0
53449,function,0,0
53450,",",0,0
53451,pain,0,0
53452,",",0,0
53453,or,0,0
53454,disability,0,0
53455,measures,0,0
53456,between,0,0
53457,the,0,0
53458,groups,0,0
53459,.,0,0
53460,In,0,0
53461,the,0,0
53462,STG,0,0
53463,",",0,0
53464,training,0,0
53465,adherence,0,0
53466,with,0,1
53467,regard,0,0
53468,to,0,0
53469,training,0,0
53470,frequency,0,0
53471,and,0,0
53472,intensity,0,0
53473,remained,0,0
53474,too,0,0
53475,low,0,0
53476,to,0,0
53477,lead,0,0
53478,to,0,0
53479,specific,0,0
53480,training-induced,0,0
53481,adaptations,0,0
53482,in,0,0
53483,the,0,0
53484,neuromuscular,0,0
53485,system,0,0
53486,.,0,0
53487,Progressive,0,0
53488,loading,0,0
53489,",",0,0
53490,supervision,0,0
53491,of,0,0
53492,training,0,0
53493,",",0,0
53494,and,0,0
53495,psychosocial,0,0
53496,support,0,0
53497,is,0,0
53498,needed,0,0
53499,in,0,0
53500,long-term,0,0
53501,rehabilitation,0,1
53502,programs,0,0
53503,to,0,0
53504,maintain,0,0
53505,patient,0,0
53506,motivation,0,0
53507,.,0,0
53508,Lanthanum,0,0
53509,carbonate,0,0
53510,(,0,0
53511,Fosrenol,0,0
53512,),0,0
53513,efficacy,0,0
53514,and,0,0
53515,tolerability,0,0
53516,in,0,0
53517,the,0,0
53518,treatment,0,0
53519,of,0,0
53520,hyperphosphatemic,1,0
53521,patients,1,1
53522,with,1,1
53523,end-stage,1,1
53524,renal,1,1
53525,disease,1,1
53526,.,1,0
53527,AIMS,0,0
53528,High,0,0
53529,serum,0,0
53530,phosphorus,0,0
53531,levels,0,0
53532,are,0,0
53533,a,0,0
53534,common,0,0
53535,problem,0,0
53536,in,0,0
53537,patients,1,1
53538,receiving,1,1
53539,long-term,1,0
53540,dialysis,1,1
53541,treatment,1,0
53542,.,1,0
53543,Lanthanum,0,0
53544,carbonate,0,0
53545,(,0,0
53546,Fosrenol,0,0
53547,),0,0
53548,is,0,0
53549,a,0,0
53550,new,0,0
53551,non-aluminum,0,0
53552,",",0,0
53553,non-calcium,0,0
53554,phosphate,0,0
53555,binder,0,0
53556,developed,0,0
53557,for,0,0
53558,the,0,0
53559,treatment,0,0
53560,of,0,0
53561,hyperphosphatemia,0,0
53562,in,0,0
53563,patients,1,1
53564,with,1,1
53565,end-stage,1,1
53566,renal,1,1
53567,disease,1,1
53568,(,1,0
53569,ESRD,1,1
53570,),1,0
53571,.,1,0
53572,We,0,0
53573,report,0,0
53574,data,0,0
53575,from,0,0
53576,a,0,0
53577,recent,0,0
53578,trial,0,0
53579,",",0,0
53580,which,0,0
53581,",",0,0
53582,for,0,0
53583,the,0,0
53584,first,0,0
53585,time,0,0
53586,",",0,0
53587,assessed,0,0
53588,the,0,0
53589,efficacy,0,0
53590,and,0,0
53591,tolerability,0,0
53592,of,0,0
53593,lanthanum,0,0
53594,carbonate,0,0
53595,treatment,0,0
53596,",",0,0
53597,compared,0,0
53598,with,0,0
53599,placebo,0,0
53600,",",0,0
53601,in,0,0
53602,Chinese,1,1
53603,patients,1,1
53604,with,1,1
53605,ESRD,1,1
53606,.,1,0
53607,PATIENTS,0,0
53608,AND,0,0
53609,METHODS,0,0
53610,Following,0,0
53611,a,0,0
53612,one-,0,0
53613,to,0,0
53614,three-week,0,0
53615,washout,0,0
53616,phase,0,0
53617,and,0,0
53618,a,0,0
53619,four-week,0,0
53620,",",0,0
53621,open-label,0,0
53622,lanthanum,0,0
53623,carbonate,0,0
53624,dose-titration,0,0
53625,phase,0,0
53626,",",0,0
53627,male,1,1
53628,and,1,0
53629,female,1,1
53630,hemodialysis,1,1
53631,patients,1,1
53632,were,0,0
53633,randomized,0,0
53634,(,0,0
53635,1:1,0,0
53636,),0,0
53637,to,0,0
53638,receive,0,0
53639,either,0,0
53640,lanthanum,0,0
53641,carbonate,0,0
53642,or,0,0
53643,placebo,0,0
53644,for,0,0
53645,four,0,1
53646,weeks,0,0
53647,.,0,0
53648,The,0,0
53649,primary,0,0
53650,efficacy,0,0
53651,parameter,0,0
53652,of,0,0
53653,the,0,0
53654,study,0,0
53655,was,0,0
53656,the,0,0
53657,control,0,0
53658,of,0,0
53659,serum,0,0
53660,phosphorus,0,0
53661,levels,0,0
53662,(,0,0
53663,<,0,0
53664,or,0,0
53665,=1.8,0,0
53666,mmol/l,0,0
53667,[,0,0
53668,<,0,0
53669,or,0,0
53670,=,0,0
53671,5.6,0,0
53672,mg/dl,0,0
53673,],0,1
53674,),0,0
53675,.,0,0
53676,Secondary,0,0
53677,endpoints,0,0
53678,included,0,1
53679,the,0,0
53680,profile,0,0
53681,of,0,0
53682,serum,0,0
53683,phosphorus,0,0
53684,during,0,0
53685,titration,0,0
53686,and,0,0
53687,parathyroid,0,0
53688,hormone,0,0
53689,",",0,0
53690,calcium,0,0
53691,",",0,0
53692,and,0,0
53693,calcium,0,0
53694,x,0,0
53695,phosphorus,0,0
53696,(,0,0
53697,Ca,0,1
53698,x,0,0
53699,P,0,0
53700,),0,0
53701,product,0,0
53702,levels,0,0
53703,.,0,0
53704,The,0,0
53705,safety,0,0
53706,and,0,0
53707,tolerability,0,0
53708,of,0,0
53709,lanthanum,0,0
53710,carbonate,0,0
53711,were,0,0
53712,assessed,0,0
53713,by,0,0
53714,monitoring,0,0
53715,adverse,0,0
53716,events,0,0
53717,throughout,0,0
53718,the,0,0
53719,study,0,0
53720,.,0,0
53721,RESULTS,0,0
53722,Mean,0,0
53723,serum,0,0
53724,phosphorus,0,0
53725,level,0,0
53726,at,0,0
53727,the,0,0
53728,end,0,0
53729,of,0,0
53730,washout,0,0
53731,was,0,0
53732,2.5,0,0
53733,+/-,0,0
53734,0.5,0,0
53735,mmol/l,0,0
53736,(,0,0
53737,7.7,0,0
53738,+/-,0,0
53739,1.5,0,0
53740,mg/dl,0,0
53741,;,0,0
53742,n=73,1,1
53743,),1,0
53744,",",0,0
53745,and,0,0
53746,there,0,0
53747,was,0,0
53748,no,0,0
53749,evidence,0,0
53750,of,0,0
53751,a,0,0
53752,difference,0,0
53753,in,0,0
53754,levels,0,0
53755,between,0,0
53756,the,0,0
53757,treatment,0,0
53758,groups,0,0
53759,pre-randomization,0,0
53760,.,0,0
53761,At,0,0
53762,the,0,0
53763,end,0,0
53764,of,0,0
53765,the,0,0
53766,study,0,0
53767,",",0,0
53768,lanthanum,0,0
53769,carbonate-treated,0,0
53770,patients,0,1
53771,had,0,0
53772,significantly,0,0
53773,lower,0,0
53774,phosphorus,0,0
53775,levels,0,0
53776,(,0,0
53777,1.6,0,0
53778,+/-,0,0
53779,0.5,0,0
53780,mmol/l,0,0
53781,[,0,0
53782,5.1,0,0
53783,+/-,0,0
53784,1.5,0,0
53785,mg/dl,0,0
53786,],0,0
53787,;,0,0
53788,n=30,1,1
53789,),1,0
53790,than,0,0
53791,those,0,0
53792,receiving,0,0
53793,placebo,0,0
53794,(,0,0
53795,2.3,0,0
53796,+/-,0,0
53797,0.4,0,0
53798,mmol/l,0,0
53799,[,0,0
53800,7.2,0,0
53801,+/-,0,0
53802,1.3,0,0
53803,mg/dl,0,0
53804,],0,0
53805,;,0,0
53806,n=31,1,1
53807,;,1,0
53808,p,0,0
53809,<,0,0
53810,0.001,0,0
53811,),0,0
53812,.,0,0
53813,In,0,0
53814,addition,0,0
53815,",",0,0
53816,a,0,0
53817,significantly,0,0
53818,higher,0,0
53819,proportion,0,0
53820,of,0,0
53821,patients,0,1
53822,receiving,0,1
53823,lanthanum,0,0
53824,carbonate,0,0
53825,had,0,0
53826,controlled,0,0
53827,serum,0,0
53828,phosphorus,0,0
53829,levels,0,0
53830,(,0,0
53831,60,0,1
53832,%,0,0
53833,),0,0
53834,compared,0,0
53835,with,0,0
53836,the,0,0
53837,placebo,0,0
53838,group,0,0
53839,(,0,0
53840,10,0,0
53841,%,0,0
53842,;,0,0
53843,p,0,0
53844,<,0,0
53845,0.001,0,0
53846,),0,0
53847,.,0,0
53848,Ca,0,1
53849,x,0,0
53850,P,0,0
53851,product,0,0
53852,levels,0,0
53853,were,0,0
53854,also,0,0
53855,significantly,0,0
53856,lower,0,0
53857,in,0,0
53858,the,0,0
53859,lanthanum,0,0
53860,carbonate,0,0
53861,group,0,0
53862,at,0,0
53863,the,0,0
53864,end,0,0
53865,of,0,0
53866,randomized,0,0
53867,treatment,0,0
53868,(,0,0
53869,p,0,0
53870,<,0,0
53871,0.001,0,0
53872,),0,0
53873,.,0,0
53874,Lanthanum,0,0
53875,carbonate,0,0
53876,was,0,0
53877,well,0,0
53878,tolerated,0,0
53879,;,0,0
53880,only,0,0
53881,one,0,0
53882,serious,0,0
53883,adverse,0,0
53884,event,0,0
53885,was,0,0
53886,reported,0,0
53887,",",0,0
53888,which,0,0
53889,was,0,0
53890,unrelated,0,1
53891,to,0,0
53892,treatment,0,0
53893,.,0,0
53894,CONCLUSIONS,0,0
53895,Lanthanum,0,0
53896,carbonate,0,0
53897,was,0,0
53898,shown,0,0
53899,to,0,0
53900,be,0,0
53901,an,0,0
53902,effective,0,0
53903,and,0,0
53904,well-tolerated,0,0
53905,phosphate,0,0
53906,binder,0,0
53907,for,0,0
53908,the,0,0
53909,treatment,0,0
53910,of,0,0
53911,hyperphosphatemia,0,0
53912,in,0,0
53913,Chinese,1,1
53914,patients,1,1
53915,with,1,1
53916,ESRD,1,1
53917,.,1,0
53918,This,0,0
53919,finding,0,0
53920,supports,0,0
53921,the,0,0
53922,results,0,0
53923,of,0,0
53924,previous,0,1
53925,US,0,0
53926,and,0,0
53927,European,0,1
53928,studies,0,0
53929,",",0,0
53930,which,0,0
53931,have,0,0
53932,also,0,0
53933,shown,0,0
53934,that,0,0
53935,lanthanum,0,0
53936,carbonate,0,0
53937,treatment,0,0
53938,effectively,0,0
53939,controls,0,0
53940,serum,0,0
53941,phosphorus,0,0
53942,levels,0,0
53943,.,0,1
53944,Stapled,0,0
53945,hemorrhoidopexy,0,1
53946,versus,0,0
53947,milligan-morgan,0,1
53948,hemorrhoidectomy,1,1
53949,:,1,1
53950,a,0,0
53951,prospective,0,0
53952,",",0,0
53953,randomized,0,0
53954,",",0,0
53955,multicenter,0,0
53956,trial,0,0
53957,with,0,0
53958,2-year,0,0
53959,postoperative,0,0
53960,follow,0,0
53961,up,0,0
53962,.,0,0
53963,PURPOSE,0,0
53964,The,0,0
53965,purpose,0,0
53966,of,0,0
53967,this,0,0
53968,study,0,0
53969,was,0,0
53970,to,0,0
53971,compare,0,0
53972,the,0,0
53973,outcome,0,0
53974,of,0,0
53975,stapled,0,0
53976,hemorrhoidopexy,0,1
53977,(,0,0
53978,SH,0,0
53979,group,0,0
53980,),0,0
53981,performed,0,0
53982,using,0,0
53983,a,0,0
53984,circular,0,1
53985,stapler,0,0
53986,with,0,0
53987,that,0,0
53988,of,0,0
53989,the,0,0
53990,Milligan-Morgan,0,0
53991,technique,0,0
53992,(,0,0
53993,MM,0,0
53994,group,0,0
53995,),0,0
53996,.,0,0
53997,The,0,0
53998,goals,0,0
53999,of,0,0
54000,the,0,0
54001,study,0,0
54002,were,0,0
54003,to,0,0
54004,evaluate,0,0
54005,the,0,0
54006,efficacy,0,0
54007,and,0,0
54008,reproducibility,0,0
54009,of,0,0
54010,stapled,0,0
54011,hemorrhoidopexy,0,1
54012,and,0,0
54013,define,0,0
54014,its,0,0
54015,place,0,0
54016,among,0,0
54017,conventional,0,0
54018,techniques,0,0
54019,.,0,0
54020,METHODS,0,0
54021,A,0,0
54022,series,0,0
54023,of,0,0
54024,134,1,1
54025,patients,1,1
54026,were,1,0
54027,included,1,1
54028,at,1,0
54029,7,1,0
54030,hospital,1,1
54031,centers,1,1
54032,.,1,0
54033,They,0,0
54034,were,0,0
54035,randomized,0,0
54036,according,0,0
54037,to,0,0
54038,a,0,0
54039,single-masked,0,0
54040,design,0,0
54041,and,0,0
54042,stratified,0,0
54043,by,0,0
54044,center,0,1
54045,(,0,0
54046,with,0,0
54047,balancing,0,0
54048,every,0,0
54049,4,0,0
54050,patients,0,1
54051,),0,1
54052,.,0,1
54053,Patients,0,1
54054,were,0,0
54055,clinically,0,0
54056,evaluated,0,0
54057,preoperatively,0,0
54058,and,0,0
54059,at,0,0
54060,6,0,0
54061,weeks,0,0
54062,",",0,0
54063,1,0,0
54064,year,0,0
54065,",",0,0
54066,and,0,0
54067,a,0,0
54068,minimum,0,0
54069,of,0,0
54070,2,0,0
54071,years,0,1
54072,after,0,0
54073,treatment,0,0
54074,.,0,1
54075,Patients,0,1
54076,completed,0,0
54077,a,0,0
54078,questionnaire,0,0
54079,before,0,0
54080,and,0,0
54081,1,0,0
54082,year,0,0
54083,after,0,0
54084,surgery,0,1
54085,to,0,0
54086,evaluate,0,0
54087,symptoms,0,0
54088,",",0,0
54089,function,0,0
54090,",",0,0
54091,and,0,0
54092,overall,0,0
54093,satisfaction,0,0
54094,.,0,0
54095,RESULTS,0,0
54096,The,0,0
54097,mean,0,0
54098,follow-up,0,0
54099,period,0,0
54100,was,0,0
54101,2.21,0,0
54102,years,0,1
54103,+/-,0,0
54104,0.26,0,0
54105,(,0,0
54106,1.89-3.07,0,0
54107,),0,0
54108,.,0,0
54109,Nine,0,0
54110,patients,0,1
54111,(,0,0
54112,7,0,0
54113,%,0,0
54114,),0,0
54115,could,0,0
54116,not,0,0
54117,be,0,0
54118,monitored,0,0
54119,at,0,0
54120,1,0,0
54121,or,0,1
54122,2,0,0
54123,years,0,1
54124,",",0,0
54125,but,0,0
54126,4,0,0
54127,of,0,0
54128,these,0,0
54129,9,0,0
54130,nevertheless,0,0
54131,filled,0,0
54132,in,0,0
54133,the,0,0
54134,1-year,0,0
54135,questionnaire,0,0
54136,.,0,0
54137,The,0,0
54138,patients,0,1
54139,in,0,0
54140,the,0,0
54141,SH,0,0
54142,group,0,0
54143,experienced,0,0
54144,less,0,0
54145,postoperative,0,0
54146,pain/discomfort,0,0
54147,as,0,0
54148,scored,0,0
54149,by,0,0
54150,pain,0,0
54151,during,0,0
54152,bowel,0,0
54153,movement,0,0
54154,(,0,0
54155,P,0,0
54156,<,0,0
54157,0.001,0,0
54158,),0,0
54159,",",0,0
54160,total,0,1
54161,analgesic,0,0
54162,requirement,0,0
54163,over,0,0
54164,the,0,0
54165,first,0,0
54166,3,0,0
54167,days,0,0
54168,(,0,0
54169,according,0,1
54170,to,0,0
54171,the,0,0
54172,World,0,0
54173,Health,0,0
54174,Organization,0,0
54175,[,0,0
54176,WHO,0,0
54177,],0,0
54178,class,0,1
54179,II,0,1
54180,analgesics,0,0
54181,[,0,0
54182,P,0,0
54183,=,0,0
54184,0.002,0,0
54185,],0,0
54186,;,0,0
54187,class,0,1
54188,III,0,0
54189,[,0,0
54190,P,0,0
54191,=,0,0
54192,0.066,0,0
54193,],0,0
54194,),0,0
54195,",",0,0
54196,and,0,0
54197,per-patient,0,0
54198,consumption,0,0
54199,frequency,0,0
54200,of,0,0
54201,class,0,1
54202,III,0,1
54203,analgesics,0,0
54204,(,0,0
54205,P,0,0
54206,=,0,0
54207,0.089,0,0
54208,),0,0
54209,.,0,0
54210,A,0,0
54211,clear,0,0
54212,difference,0,0
54213,in,0,0
54214,morphine,0,0
54215,requirement,0,0
54216,became,0,0
54217,evident,0,0
54218,after,0,0
54219,24,0,0
54220,hours,0,0
54221,(,0,0
54222,P,0,0
54223,=,0,0
54224,0.010,0,0
54225,),0,0
54226,.,0,0
54227,Hospital,0,0
54228,stay,0,0
54229,was,0,0
54230,significantly,0,0
54231,shorter,0,0
54232,in,0,0
54233,the,0,0
54234,SH,0,0
54235,group,0,0
54236,(,0,0
54237,SH,0,0
54238,2.2,0,0
54239,+/-,0,0
54240,1.2,0,0
54241,[,0,0
54242,0,0,0
54243,;,0,0
54244,5.0,0,0
54245,],0,0
54246,versus,0,0
54247,MM,0,1
54248,3.1,0,0
54249,+/-,0,0
54250,1.7,0,0
54251,[,0,0
54252,1,0,0
54253,;,0,0
54254,8.0,0,0
54255,],0,0
54256,P,0,0
54257,<,0,0
54258,0.001,0,0
54259,),0,0
54260,.,0,0
54261,At,0,0
54262,1,0,0
54263,year,0,0
54264,",",0,0
54265,no,0,0
54266,differences,0,0
54267,in,0,0
54268,the,0,0
54269,resolution,0,0
54270,of,0,0
54271,symptoms,0,0
54272,were,0,0
54273,observed,0,0
54274,between,0,0
54275,the,0,0
54276,2,0,0
54277,groups,0,0
54278,",",0,0
54279,and,0,0
54280,over,0,0
54281,2,0,0
54282,years,0,1
54283,",",0,0
54284,the,0,0
54285,overall,0,0
54286,incidence,0,0
54287,of,0,0
54288,complications,0,0
54289,was,0,0
54290,the,0,0
54291,same,0,0
54292,",",0,0
54293,specifically,0,0
54294,fecaloma,0,1
54295,(,0,0
54296,P,0,0
54297,=,0,0
54298,0.003,0,0
54299,),0,0
54300,in,0,0
54301,the,0,0
54302,MM,0,0
54303,group,0,0
54304,and,0,0
54305,external,0,0
54306,hemorrhoidal,0,1
54307,thrombosis,0,1
54308,(,0,0
54309,P,0,0
54310,=,0,0
54311,0.006,0,0
54312,),0,0
54313,in,0,0
54314,the,0,0
54315,SH,0,0
54316,group,0,0
54317,.,0,0
54318,Impaired,0,0
54319,sphincter,0,0
54320,function,0,0
54321,was,0,0
54322,observed,0,0
54323,at,0,0
54324,1,0,0
54325,year,0,0
54326,with,0,1
54327,no,0,0
54328,significant,0,0
54329,difference,0,0
54330,between,0,0
54331,the,0,0
54332,groups,0,0
54333,for,0,0
54334,urgency,0,0
54335,(,0,0
54336,12,0,0
54337,%,0,0
54338,),0,0
54339,",",0,0
54340,continence,0,0
54341,problems,0,1
54342,(,0,0
54343,10,0,1
54344,%,0,0
54345,),0,0
54346,",",0,0
54347,or,0,0
54348,tenesmus,0,0
54349,(,0,0
54350,3,0,0
54351,%,0,0
54352,),0,0
54353,.,0,0
54354,No,0,0
54355,patient,0,0
54356,needed,0,0
54357,a,0,0
54358,second,0,0
54359,procedure,0,0
54360,for,0,0
54361,recurrence,0,0
54362,within,0,0
54363,2,0,0
54364,years,0,1
54365,",",0,0
54366,although,0,0
54367,partial,0,0
54368,residual,0,1
54369,prolapse,0,1
54370,was,0,0
54371,detected,0,0
54372,in,0,0
54373,4,0,0
54374,SH,0,0
54375,patients,0,1
54376,(,0,0
54377,7.5,0,0
54378,%,0,0
54379,),0,0
54380,versus,0,0
54381,1,0,0
54382,MM,0,0
54383,patient,0,0
54384,(,0,0
54385,1.8,0,0
54386,%,0,0
54387,),0,0
54388,(,0,0
54389,P,0,0
54390,=,0,0
54391,0.194,0,0
54392,),0,0
54393,.,0,0
54394,CONCLUSION,0,0
54395,Stapled,0,0
54396,hemorrhoidopexy,0,1
54397,causes,0,0
54398,significantly,0,0
54399,less,0,0
54400,postoperative,0,0
54401,pain,0,0
54402,.,0,0
54403,The,0,0
54404,technique,0,0
54405,is,0,0
54406,reproducible,0,0
54407,and,0,0
54408,can,0,0
54409,achieve,0,0
54410,comparable,0,0
54411,outcomes,0,0
54412,as,0,0
54413,those,0,0
54414,of,0,0
54415,the,0,0
54416,MM,0,0
54417,technique,0,0
54418,as,0,0
54419,long,0,0
54420,as,0,0
54421,the,0,0
54422,well-described,0,0
54423,steps,0,0
54424,of,0,0
54425,the,0,0
54426,technique,0,0
54427,are,0,0
54428,followed,0,0
54429,.,0,0
54430,Like,0,0
54431,with,0,0
54432,conventional,0,0
54433,surgery,0,1
54434,",",0,0
54435,anorectal,0,0
54436,dysfunction,0,0
54437,can,0,0
54438,occur,0,0
54439,after,0,0
54440,stapled,0,0
54441,hemorrhoidopexy,0,1
54442,in,0,0
54443,some,0,0
54444,patients,0,1
54445,.,0,0
54446,Its,0,0
54447,effectiveness,0,0
54448,in,0,0
54449,relieving,0,0
54450,symptoms,0,0
54451,is,0,0
54452,equivalent,0,0
54453,to,0,0
54454,conventional,0,0
54455,surgery,0,1
54456,",",0,0
54457,and,0,0
54458,the,0,0
54459,number,0,0
54460,of,0,0
54461,hemorrhoidal,0,1
54462,prolapse,0,1
54463,recurrences,0,0
54464,at,0,0
54465,2,0,0
54466,years,0,1
54467,is,0,0
54468,not,0,0
54469,significantly,0,0
54470,different,0,0
54471,.,0,0
54472,Hemorroidopexy,0,0
54473,is,0,0
54474,applicable,0,0
54475,for,0,0
54476,treating,0,0
54477,reducible,0,1
54478,hemorrhoidal,0,1
54479,prolapse,0,1
54480,.,0,0
54481,D-dimer,0,0
54482,predicts,0,0
54483,outcome,0,0
54484,after,0,0
54485,aneurysmal,0,1
54486,subarachnoid,1,1
54487,hemorrhage,1,1
54488,:,1,1
54489,no,0,0
54490,effect,0,0
54491,of,0,0
54492,thromboprophylaxis,0,0
54493,on,0,0
54494,coagulation,0,0
54495,activity,0,0
54496,.,0,0
54497,OBJECTIVE,0,0
54498,Approximately,0,0
54499,one-third,0,0
54500,of,0,0
54501,all,0,0
54502,patients,1,1
54503,with,1,1
54504,acute,1,1
54505,nontraumatic,1,1
54506,subarachnoid,1,1
54507,hemorrhage,1,1
54508,(,1,0
54509,SAH,1,0
54510,),1,0
54511,experience,0,0
54512,complications,0,0
54513,owing,0,0
54514,to,0,0
54515,delayed,0,0
54516,ischemic,0,1
54517,deficit,0,0
54518,.,0,0
54519,We,0,0
54520,reported,0,0
54521,recently,0,0
54522,that,0,0
54523,enoxaparin,0,0
54524,40,0,0
54525,mg,0,0
54526,once,0,0
54527,daily,0,0
54528,for,0,0
54529,10,0,0
54530,days,0,0
54531,seems,0,0
54532,safe,0,0
54533,and,0,0
54534,demonstrates,0,0
54535,thromboprophylactic,0,0
54536,efficacy,0,0
54537,",",0,0
54538,but,0,0
54539,it,0,0
54540,failed,0,0
54541,to,0,0
54542,improve,0,0
54543,outcome,0,0
54544,in,0,0
54545,a,0,0
54546,randomized,0,0
54547,SAH,0,0
54548,trial,0,0
54549,.,0,0
54550,In,0,0
54551,the,0,0
54552,present,0,0
54553,study,0,0
54554,",",0,0
54555,we,0,0
54556,assessed,0,0
54557,hemostatic,0,0
54558,variables,0,0
54559,associated,0,0
54560,with,0,1
54561,clinical,0,0
54562,status,0,0
54563,and,0,0
54564,outcome,0,0
54565,of,0,0
54566,SAH,0,0
54567,.,0,0
54568,We,0,0
54569,also,0,0
54570,monitored,0,0
54571,the,0,0
54572,effect,0,0
54573,of,0,0
54574,enoxaparin,0,0
54575,on,0,0
54576,activation,0,0
54577,of,0,0
54578,coagulation,0,0
54579,and,0,0
54580,fibrinolysis,0,0
54581,after,0,0
54582,closure,0,0
54583,of,0,0
54584,the,0,0
54585,ruptured,0,1
54586,aneurysm,0,1
54587,.,0,0
54588,METHODS,0,0
54589,Blood,0,0
54590,samples,0,0
54591,to,0,0
54592,measure,0,0
54593,activation,0,0
54594,of,0,0
54595,coagulation,0,0
54596,and,0,0
54597,fibrinolysis,0,0
54598,were,0,0
54599,collected,0,0
54600,from,0,0
54601,42,1,1
54602,patients,1,1
54603,participating,1,1
54604,in,1,0
54605,the,1,0
54606,enoxaparin,1,0
54607,trial,1,0
54608,for,1,0
54609,acute,1,1
54610,aneurysmal,1,1
54611,SAH,1,0
54612,at,1,0
54613,four,1,0
54614,time,1,0
54615,points,1,0
54616,:,1,1
54617,1,1,0
54618,),1,0
54619,at,1,0
54620,hospital,1,1
54621,admission,1,0
54622,;,1,0
54623,2,1,0
54624,),1,0
54625,12,1,0
54626,to,1,0
54627,24,1,0
54628,hours,1,0
54629,after,1,0
54630,aneurysm,1,1
54631,surgery,1,1
54632,but,1,0
54633,before,1,0
54634,initiation,1,0
54635,of,1,0
54636,enoxaparin,1,0
54637,therapy,1,0
54638,;,1,0
54639,3,1,0
54640,),1,0
54641,3,1,0
54642,hours,1,0
54643,after,1,0
54644,the,1,0
54645,first,1,0
54646,dose,1,0
54647,;,1,0
54648,and,1,0
54649,4,1,0
54650,),1,0
54651,at,1,0
54652,the,1,0
54653,conclusion,1,0
54654,of,1,0
54655,treatment,1,0
54656,.,1,0
54657,RESULTS,0,0
54658,At,0,0
54659,admission,0,0
54660,",",0,0
54661,several,0,0
54662,variables,0,0
54663,of,0,0
54664,coagulation,0,0
54665,and,0,0
54666,fibrinolysis,0,0
54667,were,0,0
54668,elevated,0,0
54669,and,0,0
54670,correlated,0,0
54671,well,0,0
54672,with,0,0
54673,clinical,0,0
54674,status,0,0
54675,.,0,0
54676,Specifically,0,0
54677,",",0,0
54678,D-dimer,0,0
54679,levels,0,0
54680,at,0,0
54681,all,0,0
54682,four,0,0
54683,time,0,0
54684,points,0,0
54685,correlated,0,0
54686,with,0,1
54687,patients,0,1
54688,',0,1
54689,long-term,0,0
54690,outcomes,0,0
54691,.,0,0
54692,A,0,0
54693,single,0,0
54694,dose,0,0
54695,of,0,0
54696,enoxaparin,0,0
54697,suppressed,0,0
54698,early,0,0
54699,coagulation,0,0
54700,activity,0,0
54701,",",0,0
54702,but,0,0
54703,thrombin,0,0
54704,generation,0,0
54705,was,0,0
54706,not,0,0
54707,inhibited,0,0
54708,during,0,0
54709,thromboprophylaxis,0,0
54710,.,0,0
54711,However,0,0
54712,",",0,0
54713,PAI-1,0,0
54714,activity,0,0
54715,was,0,0
54716,suppressed,0,0
54717,.,0,0
54718,CONCLUSION,0,0
54719,D-dimer,0,0
54720,offers,0,0
54721,a,0,0
54722,useful,0,0
54723,laboratory,0,0
54724,tool,0,0
54725,for,0,0
54726,assessing,0,0
54727,early,0,0
54728,and,0,0
54729,late,0,1
54730,clinical,0,0
54731,severity,0,0
54732,of,0,0
54733,SAH,0,0
54734,.,0,0
54735,A,0,0
54736,thromboprophylactic,0,0
54737,dose,0,0
54738,of,0,0
54739,enoxaparin,0,0
54740,inhibited,0,0
54741,PAI-1,0,0
54742,activity,0,0
54743,but,0,0
54744,failed,0,0
54745,to,0,0
54746,down-regulate,0,0
54747,coagulation,0,0
54748,activity,0,0
54749,and,0,0
54750,D-dimer,0,0
54751,.,0,0
54752,These,0,0
54753,findings,0,0
54754,are,0,0
54755,compatible,0,0
54756,with,0,0
54757,the,0,0
54758,lack,0,0
54759,of,0,0
54760,efficacy,0,0
54761,of,0,0
54762,enoxaparin,0,0
54763,in,0,0
54764,reducing,0,0
54765,ischemic,0,1
54766,deficit,0,0
54767,after,0,0
54768,SAH,0,0
54769,.,0,1
54770,Effect,0,0
54771,of,0,0
54772,cigarette,0,0
54773,smoking,0,0
54774,on,0,0
54775,gastric,0,0
54776,emptying,0,0
54777,of,0,0
54778,solids,0,0
54779,in,0,0
54780,Japanese,1,1
54781,smokers,1,1
54782,:,1,1
54783,a,0,0
54784,crossover,0,0
54785,study,0,0
54786,using,0,0
54787,the,0,0
54788,13C-octanoic,0,0
54789,acid,0,0
54790,breath,0,0
54791,test,0,0
54792,.,0,0
54793,BACKGROUND,0,0
54794,Cigarette,0,0
54795,smoking,0,0
54796,is,0,0
54797,associated,0,0
54798,with,0,0
54799,an,0,0
54800,increased,0,0
54801,risk,0,0
54802,of,0,0
54803,peptic,0,1
54804,ulcer,0,1
54805,and,0,0
54806,gastroesophageal,0,1
54807,reflux,0,1
54808,disease,0,1
54809,.,0,0
54810,Gastric,0,0
54811,emptying,0,0
54812,disorders,0,1
54813,may,0,0
54814,play,0,0
54815,a,0,0
54816,role,0,0
54817,in,0,0
54818,the,0,0
54819,development,0,0
54820,of,0,0
54821,these,0,0
54822,upper,0,0
54823,gastrointestinal,0,1
54824,diseases,0,1
54825,.,0,0
54826,Thus,0,0
54827,",",0,0
54828,studies,0,0
54829,examining,0,0
54830,a,0,0
54831,link,0,0
54832,between,0,0
54833,smoking,0,0
54834,and,0,0
54835,gastric,0,1
54836,emptying,0,0
54837,disorders,0,1
54838,have,0,0
54839,clinical,0,0
54840,relevance,0,0
54841,.,0,0
54842,This,0,0
54843,study,0,0
54844,was,0,0
54845,conducted,0,0
54846,to,0,0
54847,investigate,0,0
54848,the,0,0
54849,effect,0,0
54850,of,0,0
54851,smoking,0,0
54852,on,0,0
54853,gastric,0,1
54854,emptying,0,0
54855,of,0,0
54856,solids,0,0
54857,in,0,0
54858,Japanese,1,1
54859,smokers,1,1
54860,.,1,0
54861,METHODS,0,0
54862,The,0,0
54863,(,0,0
54864,13,0,0
54865,),0,0
54866,C-octanoic,0,0
54867,acid,0,0
54868,breath,0,0
54869,test,0,0
54870,was,0,0
54871,performed,0,0
54872,in,0,0
54873,eight,1,1
54874,male,1,1
54875,habitual,1,1
54876,smokers,1,1
54877,on,0,0
54878,two,0,0
54879,randomized,0,1
54880,occasions,0,0
54881,(,0,0
54882,either,0,0
54883,sham,0,0
54884,smoking,0,0
54885,or,0,0
54886,actively,0,0
54887,smoking,0,0
54888,),0,0
54889,.,0,0
54890,The,0,0
54891,time,0,0
54892,vs,0,0
54893,(,0,0
54894,13,0,0
54895,),0,0
54896,CO,0,0
54897,(,0,0
54898,2,0,0
54899,),0,0
54900,excretion,0,0
54901,rate,0,0
54902,curve,0,0
54903,was,0,0
54904,mathematically,0,0
54905,fitted,0,0
54906,to,0,0
54907,a,0,0
54908,conventional,0,0
54909,formula,0,0
54910,of,0,0
54911,y,0,1
54912,(,0,0
54913,t,0,0
54914,),0,0
54915,=,0,0
54916,m*k*beta*e,0,0
54917,(,0,0
54918,-k*t,0,0
54919,),0,0
54920,*,0,1
54921,(,0,0
54922,1,0,0
54923,-,0,0
54924,e,0,0
54925,(,0,0
54926,-k*t,0,0
54927,),0,0
54928,),0,0
54929,(,0,0
54930,beta-1,0,0
54931,),0,0
54932,",",0,0
54933,and,0,0
54934,the,0,0
54935,parameters,0,0
54936,of,0,0
54937,k,0,0
54938,and,0,0
54939,beta,0,0
54940,were,0,0
54941,determined,0,0
54942,:,0,1
54943,under,0,0
54944,the,0,0
54945,crossover,0,0
54946,protocol,0,0
54947,",",0,0
54948,a,0,0
54949,larger,0,0
54950,(,0,0
54951,smaller,0,0
54952,),0,0
54953,beta,0,0
54954,indicates,0,0
54955,slower,0,0
54956,(,0,0
54957,faster,0,0
54958,),0,0
54959,emptying,0,0
54960,in,0,0
54961,the,0,0
54962,early,0,0
54963,phase,0,0
54964,",",0,0
54965,and,0,0
54966,a,0,0
54967,larger,0,0
54968,(,0,0
54969,smaller,0,0
54970,),0,0
54971,k,0,0
54972,indicates,0,0
54973,faster,0,0
54974,(,0,0
54975,slower,0,0
54976,),0,0
54977,emptying,0,0
54978,in,0,0
54979,the,0,0
54980,later,0,0
54981,phase,0,0
54982,.,0,0
54983,The,0,0
54984,half,0,0
54985,(,0,0
54986,13,0,0
54987,),0,0
54988,CO,0,0
54989,(,0,0
54990,2,0,0
54991,),0,0
54992,excretion,0,0
54993,time,0,0
54994,(,0,0
54995,t,0,0
54996,(,0,0
54997,1/2b,0,0
54998,),0,0
54999,=,0,0
55000,-,0,0
55001,[,0,0
55002,ln,0,0
55003,(,0,0
55004,1,0,0
55005,-,0,0
55006,2,0,0
55007,(,0,0
55008,-1/beta,0,0
55009,),0,0
55010,),0,0
55011,],0,0
55012,/k,0,0
55013,),0,0
55014,and,0,0
55015,the,0,0
55016,time,0,0
55017,of,0,0
55018,maximal,0,0
55019,(,0,0
55020,13,0,0
55021,),0,0
55022,CO,0,0
55023,(,0,0
55024,2,0,0
55025,),0,0
55026,excretion,0,0
55027,rate,0,0
55028,(,0,0
55029,t,0,0
55030,(,0,0
55031,max,0,0
55032,),0,0
55033,=,0,0
55034,[,0,0
55035,lnbeta,0,0
55036,],0,0
55037,/k,0,0
55038,),0,0
55039,were,0,0
55040,also,0,0
55041,calculated,0,0
55042,.,0,0
55043,Between,0,0
55044,the,0,0
55045,two,0,0
55046,occasions,0,0
55047,",",0,0
55048,k,0,0
55049,",",0,0
55050,beta,0,0
55051,",",0,0
55052,t,0,0
55053,(,0,0
55054,1/2b,0,0
55055,),0,0
55056,",",0,0
55057,and,0,0
55058,t,0,0
55059,(,0,0
55060,max,0,1
55061,),0,0
55062,were,0,0
55063,compared,0,0
55064,by,0,0
55065,the,0,0
55066,Wilcoxon,0,0
55067,signed-rank,0,0
55068,test,0,0
55069,.,0,0
55070,RESULTS,0,0
55071,After,0,0
55072,smoking,0,0
55073,",",0,0
55074,k,0,0
55075,was,0,0
55076,significantly,0,0
55077,increased,0,0
55078,.,0,0
55079,No,0,0
55080,significant,0,0
55081,differences,0,0
55082,were,0,0
55083,found,0,0
55084,in,0,0
55085,beta,0,0
55086,",",0,0
55087,t,0,0
55088,(,0,0
55089,1/2,0,0
55090,),0,0
55091,",",0,0
55092,and,0,0
55093,t,0,0
55094,(,0,0
55095,max,0,0
55096,),0,0
55097,between,0,0
55098,the,0,0
55099,two,0,0
55100,occasions,0,0
55101,.,0,0
55102,CONCLUSIONS,0,0
55103,The,0,0
55104,increase,0,0
55105,in,0,0
55106,k,0,0
55107,suggests,0,0
55108,the,0,0
55109,acceleration,0,0
55110,of,0,0
55111,gastric,0,0
55112,emptying,0,0
55113,in,0,0
55114,the,0,0
55115,later,0,0
55116,phase,0,0
55117,.,0,0
55118,For,0,0
55119,the,0,0
55120,first,0,0
55121,time,0,0
55122,",",0,0
55123,this,0,0
55124,study,0,0
55125,has,0,0
55126,revealed,0,0
55127,that,0,0
55128,acute,0,1
55129,smoking,0,0
55130,speeds,0,0
55131,the,0,0
55132,gastric,0,0
55133,emptying,0,0
55134,of,0,0
55135,solids,0,0
55136,in,0,0
55137,Japanese,1,1
55138,habitual,1,1
55139,smokers,1,1
55140,.,1,1
55141,Administrative,0,1
55142,Data,0,0
55143,Feedback,0,0
55144,for,0,0
55145,Effective,0,0
55146,Cardiac,0,1
55147,Treatment,0,0
55148,:,0,1
55149,AFFECT,0,0
55150,",",0,0
55151,a,0,0
55152,cluster,0,0
55153,randomized,0,0
55154,trial,0,0
55155,.,0,0
55156,CONTEXT,0,0
55157,Hospital,0,1
55158,report,0,0
55159,cards,0,0
55160,are,0,0
55161,increasingly,0,0
55162,being,0,0
55163,implemented,0,0
55164,for,0,0
55165,quality,0,0
55166,improvement,0,0
55167,despite,0,0
55168,lack,0,0
55169,of,0,0
55170,strong,0,0
55171,evidence,0,0
55172,to,0,0
55173,support,0,0
55174,their,0,0
55175,use,0,0
55176,.,0,0
55177,OBJECTIVE,0,0
55178,To,0,0
55179,determine,0,0
55180,whether,0,0
55181,hospital,0,0
55182,report,0,0
55183,cards,0,0
55184,constructed,0,0
55185,using,0,0
55186,linked,0,0
55187,hospital,0,0
55188,and,0,0
55189,prescription,0,0
55190,administrative,0,1
55191,databases,0,0
55192,are,0,0
55193,effective,0,0
55194,for,0,0
55195,improving,0,0
55196,quality,0,0
55197,of,0,0
55198,care,0,0
55199,for,0,0
55200,acute,1,1
55201,myocardial,1,1
55202,infarction,1,1
55203,(,0,0
55204,AMI,0,1
55205,),0,0
55206,.,0,0
55207,DESIGN,0,0
55208,The,0,0
55209,Administrative,0,0
55210,Data,0,0
55211,Feedback,0,0
55212,for,0,0
55213,Effective,0,0
55214,Cardiac,0,0
55215,Treatment,0,0
55216,(,0,0
55217,AFFECT,0,0
55218,),0,0
55219,study,0,0
55220,",",0,0
55221,a,0,0
55222,cluster,0,0
55223,randomized,0,0
55224,trial,0,0
55225,.,0,0
55226,SETTING,0,0
55227,AND,0,0
55228,PATIENTS,0,0
55229,Patients,1,1
55230,with,1,1
55231,AMI,1,1
55232,who,1,1
55233,were,1,1
55234,admitted,1,1
55235,to,1,0
55236,76,1,1
55237,acute,1,1
55238,care,1,0
55239,hospitals,1,1
55240,in,1,0
55241,Quebec,1,1
55242,that,1,0
55243,treated,1,0
55244,at,1,0
55245,least,1,0
55246,30,1,1
55247,AMI,1,1
55248,patients,1,1
55249,per,1,0
55250,year,1,1
55251,between,1,0
55252,April,1,1
55253,1,1,0
55254,",",1,0
55255,1999,1,1
55256,",",1,0
55257,and,1,0
55258,March,1,0
55259,31,1,1
55260,",",1,0
55261,2003,1,1
55262,.,1,0
55263,INTERVENTION,0,0
55264,Hospitals,0,0
55265,were,0,0
55266,randomly,0,1
55267,assigned,0,0
55268,to,0,0
55269,receive,0,0
55270,rapid,1,0
55271,(,1,0
55272,immediate,1,0
55273,;,1,0
55274,n,1,1
55275,=,1,0
55276,38,1,1
55277,hospitals,1,1
55278,and,1,0
55279,2533,1,1
55280,patients,1,1
55281,),1,0
55282,or,1,0
55283,delayed,1,0
55284,(,1,0
55285,14,1,1
55286,months,1,0
55287,;,1,0
55288,n,1,1
55289,=,1,0
55290,38,1,1
55291,hospitals,1,1
55292,and,1,0
55293,3142,1,1
55294,patients,1,1
55295,),1,0
55296,confidential,0,0
55297,feedback,0,0
55298,on,0,0
55299,quality,0,0
55300,indicators,0,0
55301,constructed,0,0
55302,using,0,0
55303,administrative,0,1
55304,data,0,0
55305,.,0,1
55306,MAIN,0,0
55307,OUTCOME,0,0
55308,MEASURES,0,0
55309,Quality,0,0
55310,indicators,0,0
55311,pertaining,0,0
55312,to,0,0
55313,processes,0,0
55314,of,0,0
55315,care,0,1
55316,and,0,0
55317,outcomes,0,0
55318,of,0,0
55319,patients,0,1
55320,admitted,0,1
55321,between,0,0
55322,4,0,0
55323,and,0,0
55324,10,0,1
55325,months,0,0
55326,after,0,0
55327,randomization,0,0
55328,.,0,0
55329,The,0,0
55330,primary,0,0
55331,indicator,0,0
55332,was,0,0
55333,the,0,0
55334,proportion,0,0
55335,of,0,0
55336,elderly,0,1
55337,survivors,0,1
55338,of,0,0
55339,AMI,0,1
55340,at,0,0
55341,each,0,0
55342,study,0,1
55343,hospital,0,1
55344,who,0,1
55345,filled,0,1
55346,a,0,1
55347,prescription,0,0
55348,for,0,0
55349,a,0,0
55350,beta-blocker,0,0
55351,within,0,0
55352,30,0,0
55353,days,0,0
55354,after,0,0
55355,discharge,0,0
55356,.,0,0
55357,RESULTS,0,0
55358,At,0,0
55359,follow-up,0,0
55360,",",0,0
55361,adjusted,0,0
55362,prescription,0,0
55363,rates,0,0
55364,within,0,0
55365,30,0,1
55366,days,0,0
55367,after,0,0
55368,discharge,0,0
55369,were,0,0
55370,similar,0,0
55371,in,0,0
55372,the,0,0
55373,early,0,0
55374,vs,0,0
55375,late,0,1
55376,groups,0,0
55377,(,0,0
55378,for,0,0
55379,beta-blockers,0,0
55380,",",0,0
55381,odds,0,0
55382,ratio,0,0
55383,[,0,0
55384,OR,0,0
55385,],0,0
55386,",",0,0
55387,1.06,0,0
55388,;,0,0
55389,95,0,0
55390,%,0,0
55391,confidence,0,0
55392,interval,0,0
55393,[,0,0
55394,CI,0,0
55395,],0,0
55396,",",0,0
55397,0.82-1.37,0,0
55398,;,0,0
55399,for,0,0
55400,angiotensin-converting,0,0
55401,enzyme,0,0
55402,inhibitors,0,0
55403,",",0,0
55404,OR,0,0
55405,",",0,0
55406,1.17,0,0
55407,;,0,0
55408,95,0,0
55409,%,0,0
55410,CI,0,0
55411,",",0,0
55412,0.90-1.52,0,0
55413,;,0,0
55414,for,0,0
55415,lipid-lowering,0,0
55416,drugs,0,0
55417,",",0,0
55418,OR,0,0
55419,",",0,0
55420,1.14,0,0
55421,;,0,0
55422,95,0,0
55423,%,0,0
55424,CI,0,0
55425,",",0,0
55426,0.86-1.50,0,0
55427,;,0,0
55428,and,0,0
55429,for,0,0
55430,aspirin,0,0
55431,",",0,0
55432,OR,0,0
55433,",",0,0
55434,1.05,0,0
55435,;,0,0
55436,95,0,0
55437,%,0,0
55438,CI,0,0
55439,",",0,0
55440,0.84-1.33,0,0
55441,),0,0
55442,.,0,0
55443,In,0,0
55444,addition,0,0
55445,",",0,0
55446,adjusted,0,0
55447,mortality,0,0
55448,was,0,0
55449,similar,0,0
55450,in,0,0
55451,both,0,0
55452,groups,0,0
55453,",",0,0
55454,as,0,0
55455,were,0,0
55456,length,0,0
55457,of,0,0
55458,in-hospital,0,0
55459,stay,0,0
55460,",",0,0
55461,physician,0,0
55462,visits,0,0
55463,after,0,0
55464,discharge,0,0
55465,",",0,0
55466,waiting,0,0
55467,times,0,0
55468,for,0,0
55469,invasive,0,1
55470,cardiac,0,1
55471,procedures,0,0
55472,",",0,0
55473,and,0,0
55474,readmissions,0,0
55475,for,0,0
55476,cardiac,0,1
55477,complications,0,0
55478,.,0,1
55479,CONCLUSIONS,0,0
55480,Feedback,0,0
55481,based,0,0
55482,on,0,0
55483,one-time,0,0
55484,",",0,0
55485,confidential,0,0
55486,report,0,0
55487,cards,0,0
55488,constructed,0,0
55489,using,0,0
55490,administrative,0,1
55491,data,0,0
55492,is,0,0
55493,not,0,0
55494,an,0,0
55495,effective,0,0
55496,strategy,0,0
55497,for,0,0
55498,quality,0,0
55499,improvement,0,0
55500,regarding,0,0
55501,care,0,0
55502,of,0,0
55503,patients,1,1
55504,with,1,1
55505,AMI,1,1
55506,.,1,0
55507,A,0,0
55508,need,0,0
55509,exists,0,0
55510,for,0,0
55511,further,0,0
55512,studies,0,0
55513,to,0,0
55514,rigorously,0,0
55515,evaluate,0,0
55516,the,0,0
55517,effectiveness,0,0
55518,of,0,0
55519,more,0,0
55520,intensive,0,0
55521,report,0,0
55522,card,0,0
55523,interventions,0,0
55524,.,0,1
55525,Autism-Spectrum,0,1
55526,Quotient-Japanese,0,0
55527,version,0,0
55528,and,0,0
55529,its,0,0
55530,short,0,0
55531,forms,0,0
55532,for,0,0
55533,screening,1,1
55534,normally,1,1
55535,intelligent,1,0
55536,persons,1,1
55537,with,1,1
55538,pervasive,1,1
55539,developmental,1,1
55540,disorders,1,1
55541,.,1,0
55542,A,0,0
55543,Japanese,0,1
55544,version,0,0
55545,of,0,0
55546,the,0,0
55547,Autism,0,1
55548,Spectrum,0,1
55549,Quotient,0,0
55550,(,0,0
55551,AQ,0,1
55552,),0,0
55553,",",0,0
55554,AQ-J,0,0
55555,was,0,0
55556,administered,0,0
55557,to,0,0
55558,25,1,0
55559,normally,1,0
55560,intelligent,1,0
55561,high-functioning,1,1
55562,pervasive,1,0
55563,developmental,1,1
55564,disorder,1,1
55565,(,1,0
55566,HPDD,1,0
55567,),1,0
55568,patients,1,1
55569,(,1,0
55570,mean,1,0
55571,age,1,1
55572,",",1,0
55573,24.2,1,0
55574,years,1,1
55575,;,1,0
55576,24,1,0
55577,male,1,1
55578,",",1,0
55579,one,1,0
55580,female,1,1
55581,),1,0
55582,and,1,0
55583,215,1,1
55584,controls,1,1
55585,(,1,0
55586,mean,1,0
55587,age,1,1
55588,",",1,0
55589,30.4,1,0
55590,years,1,1
55591,;,1,0
55592,86,1,1
55593,male,1,1
55594,",",1,0
55595,129,1,1
55596,female,1,1
55597,),1,0
55598,randomly,1,0
55599,selected,1,0
55600,from,1,0
55601,the,1,0
55602,general,1,1
55603,population,1,1
55604,.,1,0
55605,The,0,0
55606,AQ-J,0,0
55607,had,0,0
55608,satisfactory,0,0
55609,internal,0,0
55610,consistency,0,0
55611,reliability,0,0
55612,(,0,0
55613,Cronbach,0,0
55614,'s,0,0
55615,alpha,0,0
55616,>,0,1
55617,0.70,0,0
55618,in,0,0
55619,the,0,0
55620,two,0,0
55621,groups,0,0
55622,),0,0
55623,",",0,0
55624,test-retest,0,0
55625,reliability,0,0
55626,",",0,0
55627,and,0,0
55628,discriminant,0,0
55629,validity,0,0
55630,[,0,0
55631,i.e,0,0
55632,.,0,0
55633,the,0,0
55634,AQ-J,0,0
55635,score,0,0
55636,was,0,0
55637,significantly,0,0
55638,higher,0,0
55639,in,0,0
55640,the,0,0
55641,HPDD,0,0
55642,(,0,0
55643,mean,0,0
55644,",",0,0
55645,29.6,0,0
55646,),0,0
55647,than,0,0
55648,controls,0,0
55649,(,0,0
55650,mean,0,0
55651,",",0,0
55652,22.2,0,0
55653,),0,0
55654,],0,0
55655,.,0,0
55656,At,0,0
55657,a,0,0
55658,cut-off,0,0
55659,of,0,0
55660,26,0,0
55661,",",0,0
55662,the,0,0
55663,AQ-J,0,0
55664,had,0,0
55665,satisfactory,0,0
55666,sensitivity,0,0
55667,",",0,0
55668,specificity,0,0
55669,",",0,0
55670,and,0,0
55671,negative,0,0
55672,predictive,0,0
55673,value,0,0
55674,",",0,0
55675,but,0,0
55676,it,0,0
55677,had,0,0
55678,low,0,0
55679,positive,0,0
55680,predictive,0,0
55681,value,0,0
55682,(,0,0
55683,0.24,0,0
55684,),0,0
55685,possibly,0,0
55686,due,0,0
55687,to,0,0
55688,the,0,0
55689,facts,0,0
55690,that,0,0
55691,the,0,0
55692,25,0,0
55693,mild,0,1
55694,HPDD,0,0
55695,patients,0,1
55696,scored,0,0
55697,lower,0,0
55698,and,0,0
55699,the,0,0
55700,controls,0,0
55701,scored,0,0
55702,higher,0,0
55703,on,0,0
55704,the,0,0
55705,AQ-J,0,0
55706,than,0,0
55707,British,0,1
55708,counterparts,0,1
55709,on,0,0
55710,the,0,0
55711,AQ,0,1
55712,.,0,0
55713,The,0,0
55714,AQ-J-21,0,0
55715,(,0,0
55716,consisting,0,0
55717,of,0,0
55718,21,0,1
55719,items,0,0
55720,significantly,0,0
55721,associated,0,0
55722,with,0,0
55723,HPDD,0,0
55724,diagnosis,0,1
55725,),0,0
55726,and,0,0
55727,the,0,0
55728,AQ-J-10,0,0
55729,(,0,0
55730,consisting,0,0
55731,of,0,0
55732,10,0,0
55733,of,0,0
55734,the,0,0
55735,21,0,1
55736,items,0,0
55737,with,0,1
55738,an,0,0
55739,effect,0,0
55740,size,0,0
55741,>,0,1
55742,0.17,0,0
55743,),0,0
55744,had,0,0
55745,higher,0,0
55746,",",0,0
55747,although,0,0
55748,not,0,0
55749,satisfactory,0,0
55750,",",0,0
55751,positive,0,0
55752,predictive,0,0
55753,values,0,0
55754,of,0,0
55755,0.35,0,0
55756,and,0,0
55757,0.46,0,0
55758,at,0,0
55759,cut-offs,0,0
55760,of,0,0
55761,12,0,0
55762,and,0,0
55763,7,0,0
55764,",",0,0
55765,respectively,0,0
55766,",",0,0
55767,than,0,0
55768,the,0,0
55769,AQ-J,0,0
55770,.,0,0
55771,The,0,0
55772,AQ-J,0,0
55773,and,0,0
55774,two,0,0
55775,short,0,0
55776,forms,0,0
55777,are,0,0
55778,useful,0,0
55779,not,0,0
55780,to,0,0
55781,predict,0,0
55782,but,0,0
55783,to,0,0
55784,rule,0,0
55785,out,0,0
55786,mild,0,0
55787,HPDD,0,0
55788,",",0,0
55789,the,0,0
55790,most,0,0
55791,difficult,0,0
55792,part,0,0
55793,of,0,0
55794,HPDD,0,0
55795,to,0,0
55796,be,0,0
55797,distinguished,0,0
55798,from,0,0
55799,non-PDD,0,0
55800,conditions,0,0
55801,",",0,0
55802,in,0,0
55803,persons,0,1
55804,scoring,0,0
55805,under,0,1
55806,the,0,0
55807,cut-offs,0,0
55808,and,0,0
55809,to,0,0
55810,consider,0,0
55811,professionals,0,1
55812,',0,0
55813,examination,0,0
55814,of,0,0
55815,HPDD,0,0
55816,in,0,0
55817,persons,0,1
55818,scoring,0,0
55819,over,0,0
55820,them,0,0
55821,",",0,0
55822,because,0,0
55823,their,0,0
55824,negative,0,0
55825,predictive,0,0
55826,values,0,0
55827,were,0,1
55828,satisfactory,0,0
55829,.,0,0
55830,Effect,0,0
55831,of,0,0
55832,mild,0,1
55833,endurance,0,0
55834,exercise,0,0
55835,training,0,0
55836,and,0,0
55837,pravastatin,0,0
55838,on,0,0
55839,peripheral,0,0
55840,vasodilatation,0,0
55841,of,0,0
55842,forearm,0,0
55843,resistance,0,0
55844,vessels,0,0
55845,in,0,0
55846,patients,1,1
55847,with,1,1
55848,coronary,1,1
55849,artery,1,1
55850,disease,1,1
55851,.,1,0
55852,BACKGROUND,0,0
55853,Improved,0,0
55854,endothelial,0,0
55855,function,0,0
55856,may,0,0
55857,contribute,0,0
55858,to,0,0
55859,the,0,0
55860,beneficial,0,0
55861,effects,0,0
55862,of,0,0
55863,cholesterol,0,0
55864,lowering,0,0
55865,therapy,0,0
55866,in,0,0
55867,patients,1,1
55868,with,1,1
55869,coronary,1,1
55870,artery,1,1
55871,disease,1,1
55872,(,1,0
55873,CAD,1,0
55874,),1,0
55875,",",0,0
55876,but,0,0
55877,results,0,0
55878,of,0,0
55879,the,0,0
55880,effect,0,0
55881,of,0,0
55882,statin,0,0
55883,therapy,0,0
55884,on,0,0
55885,endothelial,0,0
55886,function,0,0
55887,are,0,0
55888,disparate,0,0
55889,in,0,0
55890,these,0,0
55891,patients,0,1
55892,.,0,0
55893,Exercise,0,0
55894,training,0,0
55895,has,0,0
55896,been,0,0
55897,reported,0,0
55898,to,0,0
55899,improve,0,0
55900,endothelial,0,0
55901,function,0,0
55902,of,0,0
55903,patients,0,1
55904,at,0,0
55905,risk,0,0
55906,of,0,0
55907,or,0,0
55908,with,0,1
55909,established,0,0
55910,CAD,0,0
55911,.,0,0
55912,The,0,0
55913,goal,0,0
55914,of,0,0
55915,the,0,0
55916,study,0,0
55917,was,0,0
55918,to,0,0
55919,compare,0,0
55920,the,0,0
55921,effect,0,0
55922,of,0,0
55923,mild,0,1
55924,exercise,0,0
55925,training,0,0
55926,or,0,0
55927,statin,0,0
55928,therapy,0,0
55929,on,0,0
55930,forearm,0,0
55931,endothelial,0,0
55932,function,0,0
55933,in,0,0
55934,CAD,1,0
55935,patients,1,1
55936,with,1,1
55937,average,1,0
55938,cholesterol,1,0
55939,levels,1,0
55940,.,1,0
55941,DESIGN,0,0
55942,AND,0,0
55943,METHODS,0,0
55944,Twenty-eight,1,1
55945,sedentary,1,1
55946,male,1,1
55947,patients,1,1
55948,with,1,1
55949,angiographically,1,1
55950,documented,1,0
55951,CAD,1,0
55952,and,1,0
55953,average,1,0
55954,pretreatment,1,0
55955,total,1,1
55956,plasma,1,0
55957,cholesterol,1,0
55958,levels,1,0
55959,(,1,0
55960,5.1+/-0.9,1,0
55961,mmol/l,1,0
55962,),1,0
55963,aged,1,1
55964,42-75,1,0
55965,years,1,1
55966,were,1,0
55967,included,1,1
55968,.,1,0
55969,They,0,0
55970,were,0,0
55971,randomly,0,0
55972,assigned,0,0
55973,in,0,0
55974,a,0,0
55975,2,0,0
55976,:,0,1
55977,1,0,0
55978,order,0,0
55979,to,0,0
55980,either,0,0
55981,statin,0,0
55982,therapy,0,0
55983,(,0,0
55984,pravastatin,0,0
55985,",",0,0
55986,40,0,0
55987,mg,0,0
55988,daily,0,0
55989,),0,0
55990,or,0,0
55991,exercise,0,0
55992,training,0,0
55993,therapy,0,0
55994,(,0,0
55995,mild,0,0
55996,endurance,0,0
55997,exercise,0,0
55998,three,0,0
55999,or,0,0
56000,more,0,0
56001,times,0,0
56002,a,0,0
56003,week,0,0
56004,),0,0
56005,.,0,0
56006,The,0,0
56007,effects,0,0
56008,of,0,0
56009,10,0,1
56010,weeks,0,0
56011,of,0,0
56012,either,0,0
56013,treatment,0,0
56014,on,0,0
56015,endothelium-dependent,0,0
56016,and,0,0
56017,independent,0,0
56018,vasodilation,0,0
56019,of,0,0
56020,forearm,0,0
56021,resistance,0,0
56022,vessels,0,0
56023,was,0,0
56024,assessed,0,0
56025,by,0,0
56026,plethysmography,0,0
56027,.,0,0
56028,Cardiopulmonary,0,0
56029,exercise,0,0
56030,testing,0,0
56031,was,0,0
56032,performed,0,0
56033,at,0,0
56034,baseline,0,0
56035,and,0,0
56036,after,0,0
56037,10,0,1
56038,weeks,0,0
56039,.,0,1
56040,RESULTS,0,0
56041,Ten,0,1
56042,weeks,0,0
56043,of,0,0
56044,pravastatin,0,0
56045,therapy,0,0
56046,significantly,0,0
56047,reduced,0,0
56048,low-density,0,0
56049,lipoprotein,0,0
56050,cholesterol,0,0
56051,(,0,0
56052,from,0,0
56053,3.8+/-0.6,0,0
56054,to,0,0
56055,3.1+/-0.6,0,0
56056,mmol/l,0,0
56057,at,0,0
56058,study,0,0
56059,end,0,0
56060,",",0,0
56061,P=0.04,0,0
56062,),0,0
56063,and,0,0
56064,the,0,0
56065,ratio,0,0
56066,of,0,0
56067,total,0,1
56068,to,0,0
56069,high-density,0,0
56070,lipoprotein,0,0
56071,cholesterol,0,0
56072,(,0,0
56073,from,0,0
56074,4.9+/-0.8,0,0
56075,to,0,0
56076,3.7+/-0.7,0,0
56077,mmol/l,0,0
56078,",",0,0
56079,P=0.002,0,0
56080,),0,0
56081,.,0,0
56082,Exercise,0,0
56083,training,0,0
56084,did,0,0
56085,not,0,0
56086,significantly,0,0
56087,modify,0,0
56088,the,0,0
56089,lipid,0,0
56090,profile,0,0
56091,.,0,0
56092,Peak,0,0
56093,oxygen,0,0
56094,consumption,0,0
56095,",",0,0
56096,maximal,0,0
56097,achieved,0,0
56098,workload,0,0
56099,and,0,0
56100,exercise,0,0
56101,duration,0,0
56102,tended,0,0
56103,to,0,0
56104,improve,0,0
56105,in,0,0
56106,the,0,0
56107,exercise,0,0
56108,training,0,0
56109,group,0,0
56110,but,0,0
56111,remained,0,0
56112,unchanged,0,0
56113,in,0,0
56114,the,0,0
56115,pravastatin-treated,0,0
56116,group,0,0
56117,.,0,0
56118,Neither,0,0
56119,10,0,0
56120,weeks,0,0
56121,of,0,0
56122,pravastatin,0,0
56123,nor,0,0
56124,mild,0,1
56125,endurance,0,0
56126,exercise,0,0
56127,training,0,0
56128,improved,0,0
56129,endothelium-dependent,0,0
56130,or,0,0
56131,independent,0,0
56132,vasomotor,0,0
56133,function,0,0
56134,in,0,0
56135,forearm,0,0
56136,resistance,0,0
56137,vessels,0,0
56138,.,0,0
56139,CONCLUSIONS,0,0
56140,In,0,0
56141,patients,1,1
56142,with,1,1
56143,CAD,1,0
56144,and,1,0
56145,average,1,0
56146,cholesterol,1,0
56147,levels,1,0
56148,",",0,0
56149,10,0,1
56150,weeks,0,0
56151,of,0,0
56152,treatment,0,0
56153,with,0,1
56154,mild,0,1
56155,endurance,0,0
56156,exercise,0,0
56157,training,0,0
56158,or,0,0
56159,with,0,0
56160,pravastatin,0,0
56161,failed,0,0
56162,to,0,0
56163,improve,0,0
56164,endothelium-dependent,0,0
56165,or,0,0
56166,independent,0,0
56167,vasomotor,0,0
56168,function,0,0
56169,in,0,0
56170,forearm,0,0
56171,resistance,0,0
56172,vessels,0,0
56173,.,0,1
56174,Effect,0,0
56175,of,0,0
56176,exercise,0,0
56177,",",0,0
56178,training,0,0
56179,",",0,0
56180,and,0,0
56181,glycogen,0,0
56182,availability,0,0
56183,on,0,0
56184,IL-6,0,0
56185,receptor,0,0
56186,expression,0,0
56187,in,0,0
56188,human,1,0
56189,skeletal,1,0
56190,muscle,1,0
56191,.,1,0
56192,The,0,0
56193,cytokine,0,0
56194,interleukin-6,0,0
56195,(,0,0
56196,IL-6,0,0
56197,),0,0
56198,exerts,0,0
56199,it,0,0
56200,actions,0,0
56201,via,0,0
56202,the,0,0
56203,IL-6,0,0
56204,receptor,0,0
56205,(,0,0
56206,IL-6R,0,0
56207,),0,0
56208,in,0,0
56209,conjunction,0,0
56210,with,0,0
56211,the,0,0
56212,ubiquitously,0,0
56213,expressed,0,0
56214,gp130,0,0
56215,receptor,0,0
56216,.,0,0
56217,IL-6,0,0
56218,is,0,0
56219,tightly,0,0
56220,regulated,0,0
56221,in,0,0
56222,response,0,0
56223,to,0,0
56224,exercise,0,0
56225,",",0,0
56226,being,0,0
56227,affected,0,0
56228,by,0,0
56229,factors,0,0
56230,such,0,0
56231,as,0,0
56232,exercise,0,0
56233,intensity,0,0
56234,and,0,0
56235,duration,0,0
56236,",",0,0
56237,as,0,0
56238,well,0,0
56239,as,0,0
56240,energy,0,0
56241,availability,0,0
56242,.,0,0
56243,Although,0,0
56244,the,0,0
56245,IL-6,0,0
56246,response,0,0
56247,to,0,0
56248,exercise,0,0
56249,has,0,0
56250,been,0,0
56251,extensively,0,0
56252,studied,0,0
56253,",",0,0
56254,little,0,0
56255,is,0,0
56256,known,0,0
56257,about,0,0
56258,the,0,0
56259,regulation,0,0
56260,of,0,0
56261,the,0,0
56262,IL-6R,0,0
56263,response,0,0
56264,.,0,0
56265,In,0,0
56266,the,0,0
56267,present,0,0
56268,study,0,0
56269,",",0,0
56270,we,0,0
56271,aimed,0,0
56272,to,0,0
56273,investigate,0,0
56274,the,0,0
56275,effect,0,0
56276,of,0,0
56277,exercise,0,0
56278,",",0,0
56279,training,0,0
56280,",",0,0
56281,and,0,0
56282,glycogen,0,0
56283,availability,0,0
56284,",",0,0
56285,factors,0,0
56286,known,0,0
56287,to,0,0
56288,affect,0,0
56289,IL-6,0,0
56290,",",0,0
56291,on,0,0
56292,the,0,0
56293,regulation,0,0
56294,of,0,0
56295,gene,0,0
56296,expression,0,0
56297,of,0,0
56298,the,0,0
56299,IL-6R,0,0
56300,in,0,0
56301,human,0,0
56302,skeletal,0,0
56303,muscle,0,0
56304,.,0,0
56305,Human,1,0
56306,subjects,1,1
56307,performed,0,0
56308,either,0,0
56309,10,0,0
56310,wk,0,0
56311,of,0,0
56312,training,0,0
56313,with,0,1
56314,an,0,0
56315,acute,0,1
56316,exercise,0,0
56317,bout,0,0
56318,before,0,0
56319,and,0,0
56320,after,0,0
56321,the,0,0
56322,training,0,0
56323,period,0,0
56324,",",0,0
56325,or,0,0
56326,a,0,0
56327,low-glycogen,0,0
56328,vs.,0,0
56329,normal-glycogen,0,0
56330,acute,0,1
56331,exercise,0,0
56332,trial,0,0
56333,.,0,0
56334,The,0,0
56335,IL-6R,0,0
56336,mRNA,0,0
56337,response,0,0
56338,was,0,0
56339,evaluated,0,0
56340,in,0,0
56341,both,0,0
56342,trials,0,0
56343,.,0,0
56344,In,0,0
56345,response,0,0
56346,to,0,0
56347,acute,0,1
56348,exercise,0,0
56349,",",0,0
56350,an,0,0
56351,increase,0,0
56352,in,0,0
56353,IL-6R,0,0
56354,mRNA,0,0
56355,levels,0,0
56356,was,0,0
56357,observed,0,0
56358,.,0,0
56359,Neither,0,0
56360,training,0,0
56361,nor,0,0
56362,intramuscular,0,0
56363,glycogen,0,0
56364,levels,0,0
56365,had,0,0
56366,an,0,0
56367,effect,0,0
56368,on,0,0
56369,the,0,0
56370,IL-6R,0,0
56371,mRNA,0,0
56372,response,0,0
56373,to,0,0
56374,exercise,0,0
56375,.,0,0
56376,However,0,0
56377,",",0,0
56378,after,0,0
56379,10,0,0
56380,wk,0,0
56381,of,0,0
56382,training,0,0
56383,",",0,0
56384,the,0,0
56385,skeletal,0,0
56386,muscle,0,0
56387,expressed,0,0
56388,a,0,0
56389,higher,0,0
56390,mRNA,0,0
56391,level,0,0
56392,of,0,0
56393,IL-6R,0,0
56394,compared,0,0
56395,with,0,0
56396,before,0,0
56397,training,0,0
56398,.,0,0
56399,The,0,0
56400,present,0,0
56401,study,0,0
56402,demonstrated,0,0
56403,that,0,0
56404,the,0,0
56405,IL-6R,0,0
56406,gene,0,0
56407,expression,0,0
56408,levels,0,0
56409,in,0,0
56410,skeletal,0,0
56411,muscle,0,0
56412,are,0,0
56413,increased,0,0
56414,in,0,0
56415,response,0,0
56416,to,0,0
56417,acute,0,1
56418,exercise,0,0
56419,",",0,0
56420,a,0,0
56421,response,0,0
56422,that,0,0
56423,is,0,0
56424,very,0,0
56425,well,0,0
56426,conserved,0,0
56427,",",0,0
56428,being,0,0
56429,affected,0,0
56430,by,0,0
56431,neither,0,0
56432,training,0,0
56433,status,0,0
56434,nor,0,0
56435,intramuscular,0,0
56436,glycogen,0,0
56437,levels,0,0
56438,",",0,0
56439,as,0,0
56440,opposed,0,0
56441,to,0,0
56442,IL-6,0,0
56443,.,0,0
56444,However,0,0
56445,",",0,0
56446,after,0,0
56447,the,0,0
56448,training,0,0
56449,period,0,0
56450,",",0,0
56451,IL-6R,0,0
56452,mRNA,0,0
56453,production,0,0
56454,was,0,0
56455,increased,0,0
56456,in,0,0
56457,skeletal,0,0
56458,muscle,0,0
56459,",",0,0
56460,suggesting,0,0
56461,a,0,0
56462,sensitization,0,0
56463,of,0,0
56464,skeletal,0,0
56465,muscle,0,0
56466,to,0,0
56467,IL-6,0,0
56468,at,0,0
56469,rest,0,0
56470,.,0,0
56471,Open,1,0
56472,flap,1,0
56473,debridement,1,0
56474,with,0,0
56475,or,0,0
56476,without,0,0
56477,intentional,0,0
56478,cementum,0,1
56479,removal,0,0
56480,:,0,0
56481,a,0,0
56482,4-month,0,0
56483,follow-up,0,0
56484,.,0,0
56485,OBJECTIVES,0,0
56486,The,0,0
56487,aim,0,0
56488,of,0,0
56489,this,0,0
56490,study,0,0
56491,was,0,0
56492,to,0,0
56493,investigate,0,0
56494,the,0,0
56495,influence,0,0
56496,of,0,0
56497,cementum,0,0
56498,removal,0,0
56499,on,0,0
56500,periodontal,1,0
56501,repair,1,1
56502,.,1,0
56503,MATERIAL,0,0
56504,AND,0,0
56505,METHODS,0,0
56506,Forty,1,1
56507,subjects,1,1
56508,with,1,1
56509,chronic,1,1
56510,periodontitis,1,1
56511,and,1,0
56512,presenting,1,1
56513,",",1,0
56514,at,1,0
56515,least,1,0
56516,",",1,0
56517,two,1,0
56518,proximal,1,0
56519,sites,1,0
56520,in,1,0
56521,anterior,1,1
56522,teeth,1,1
56523,(,1,0
56524,upper,1,0
56525,or,1,0
56526,lower,1,0
56527,),1,0
56528,with,1,0
56529,probing,1,0
56530,depth,1,0
56531,>,1,1
56532,or,1,1
56533,=5,1,1
56534,mm,1,0
56535,were,1,0
56536,selected,1,1
56537,.,1,0
56538,After,0,0
56539,oral,0,0
56540,hygiene,0,1
56541,instructions,0,0
56542,and,0,0
56543,ultrasonic,0,0
56544,supragingival,0,0
56545,instrumentation,0,0
56546,",",0,0
56547,the,0,0
56548,subjects,0,1
56549,were,0,0
56550,randomly,0,1
56551,assigned,0,0
56552,for,0,0
56553,one,0,0
56554,of,0,0
56555,the,0,0
56556,following,0,0
56557,groups,0,0
56558,:,0,1
56559,CIC,0,0
56560,",",0,0
56561,scaled,0,0
56562,with,0,1
56563,Gracey,0,0
56564,curettes,0,0
56565,;,0,0
56566,CIUS,0,0
56567,",",0,0
56568,scaled,0,0
56569,with,0,0
56570,ultrasonic,0,0
56571,device,0,0
56572,;,0,0
56573,CDC,0,0
56574,",",0,0
56575,calculus,0,0
56576,deattachment,0,0
56577,with,0,1
56578,Gracey,0,0
56579,curettes,0,0
56580,and,0,0
56581,brushing,0,0
56582,with,0,1
56583,saline,0,0
56584,solution,0,0
56585,;,0,0
56586,and,0,0
56587,CDUS,0,0
56588,",",0,0
56589,calculus,0,0
56590,deattachment,0,0
56591,with,0,1
56592,ultrasonic,0,0
56593,device,0,0
56594,and,0,0
56595,brushing,0,0
56596,with,0,1
56597,saline,0,0
56598,solution,0,0
56599,.,0,0
56600,Full-thickness,0,0
56601,flaps,0,1
56602,were,0,0
56603,reflected,0,0
56604,and,0,0
56605,the,0,0
56606,instrumentation,0,0
56607,was,0,0
56608,performed,0,0
56609,with,0,0
56610,a,0,0
56611,clinical,0,0
56612,microscope,0,0
56613,.,0,0
56614,Probing,0,0
56615,depth,0,0
56616,(,0,0
56617,PD,0,0
56618,),0,0
56619,",",0,0
56620,relative,0,0
56621,gingival,0,0
56622,margin,0,0
56623,level,0,0
56624,(,0,0
56625,RGML,0,0
56626,),0,0
56627,and,0,0
56628,relative,0,0
56629,attachment,0,0
56630,level,0,0
56631,(,0,0
56632,RAL,0,0
56633,),0,0
56634,were,0,0
56635,registered,0,0
56636,at,0,0
56637,five,0,1
56638,experimental,0,1
56639,periods,0,0
56640,:,0,1
56641,baseline,0,0
56642,and,0,0
56643,30,0,0
56644,",",0,0
56645,60,0,0
56646,",",0,0
56647,90,0,0
56648,and,0,0
56649,120,0,1
56650,days,0,0
56651,postoperative,0,0
56652,.,0,0
56653,RESULTS,0,0
56654,All,0,0
56655,the,0,0
56656,approaches,0,0
56657,were,0,0
56658,able,0,0
56659,to,0,0
56660,markedly,0,0
56661,reduce,0,0
56662,the,0,0
56663,PD,0,0
56664,values,0,0
56665,from,0,0
56666,the,0,0
56667,baseline,0,0
56668,to,0,0
56669,the,0,0
56670,other,0,0
56671,evaluation,0,0
56672,periods,0,0
56673,(,0,0
56674,p,0,0
56675,<,0,0
56676,0.0001,0,0
56677,),0,0
56678,.,0,0
56679,The,0,0
56680,increase,0,0
56681,in,0,0
56682,RGML,0,0
56683,values,0,0
56684,was,0,0
56685,statistically,0,0
56686,significant,0,0
56687,only,0,0
56688,for,0,0
56689,the,0,0
56690,CDUS,0,0
56691,group,0,0
56692,.,0,0
56693,There,0,0
56694,were,0,0
56695,no,0,0
56696,statistically,0,0
56697,significant,0,0
56698,differences,0,0
56699,between,0,0
56700,the,0,0
56701,baseline,0,0
56702,and,0,0
56703,postoperative,0,0
56704,values,0,0
56705,in,0,0
56706,all,0,0
56707,groups,0,0
56708,for,0,0
56709,the,0,0
56710,RAL,0,0
56711,changes,0,0
56712,.,0,0
56713,The,0,0
56714,changes,0,0
56715,in,0,0
56716,RAL,0,0
56717,were,0,0
56718,statistically,0,0
56719,significant,0,0
56720,only,0,0
56721,among,0,0
56722,the,0,0
56723,groups,0,0
56724,CDC,0,1
56725,and,0,0
56726,CDUS,0,0
56727,(,0,0
56728,p,0,0
56729,<,0,0
56730,0.0001,0,0
56731,),0,0
56732,.,0,0
56733,CONCLUSION,0,0
56734,The,0,0
56735,conventional,0,0
56736,scaling,0,0
56737,and,0,0
56738,root,0,0
56739,planing,0,0
56740,and,0,0
56741,the,0,0
56742,calculus,0,0
56743,deattachment,0,0
56744,were,0,0
56745,effective,0,0
56746,in,0,0
56747,reducing,0,0
56748,the,0,0
56749,probing,0,0
56750,depth,0,0
56751,values,0,0
56752,",",0,0
56753,regardless,0,0
56754,of,0,0
56755,the,0,0
56756,instrumentation,0,0
56757,method,0,0
56758,.,0,0
56759,Effect,0,0
56760,of,0,0
56761,esomeprazole,0,0
56762,on,0,0
56763,nighttime,0,0
56764,heartburn,0,1
56765,and,0,0
56766,sleep,0,0
56767,quality,0,0
56768,in,0,0
56769,patients,1,1
56770,with,1,1
56771,GERD,1,1
56772,:,1,1
56773,a,0,0
56774,randomized,0,0
56775,",",0,0
56776,placebo-controlled,0,0
56777,trial,0,0
56778,.,0,0
56779,OBJECTIVES,0,0
56780,Sleep,0,0
56781,disturbances,0,0
56782,are,0,0
56783,common,0,0
56784,in,0,0
56785,patients,1,1
56786,with,1,1
56787,gastroesophageal,1,1
56788,reflux,1,1
56789,disease,1,1
56790,(,1,0
56791,GERD,1,0
56792,),1,0
56793,.,1,0
56794,This,0,0
56795,study,0,0
56796,examined,0,0
56797,the,0,0
56798,effects,0,0
56799,of,0,0
56800,esomeprazole,0,0
56801,on,0,0
56802,nighttime,0,0
56803,heartburn,0,0
56804,",",0,0
56805,GERD-related,0,0
56806,sleep,0,0
56807,disturbances,0,0
56808,",",0,0
56809,sleep,0,0
56810,quality,0,0
56811,",",0,0
56812,work,0,0
56813,productivity,0,0
56814,",",0,0
56815,and,0,0
56816,regular,0,0
56817,activities,0,0
56818,.,0,1
56819,METHODS,0,0
56820,This,0,0
56821,multicenter,0,0
56822,",",0,0
56823,randomized,0,0
56824,",",0,0
56825,double-blind,0,0
56826,",",0,0
56827,placebo-controlled,0,0
56828,trial,0,0
56829,included,0,1
56830,adults,1,1
56831,with,1,1
56832,GERD-associated,1,0
56833,sleep,1,0
56834,disturbances,1,0
56835,and,1,0
56836,moderate-to-severe,1,1
56837,nighttime,1,0
56838,heartburn,1,1
56839,(,1,0
56840,recorded,1,0
56841,by,1,0
56842,patient,1,0
56843,diary,1,0
56844,during,1,0
56845,screening,1,1
56846,),1,0
56847,.,1,1
56848,Patients,1,1
56849,received,1,0
56850,oral,1,0
56851,esomeprazole,1,0
56852,40,1,1
56853,mg,1,0
56854,(,1,0
56855,n,1,1
56856,=,1,0
56857,220,1,0
56858,),1,0
56859,or,1,0
56860,20,1,0
56861,mg,1,0
56862,(,1,0
56863,n,1,1
56864,=,1,0
56865,226,1,1
56866,),1,0
56867,or,1,0
56868,placebo,1,0
56869,(,1,0
56870,n,1,1
56871,=,1,0
56872,229,1,1
56873,),1,0
56874,once,1,0
56875,daily,1,0
56876,for,1,0
56877,4,1,0
56878,wk,1,0
56879,.,1,0
56880,The,0,0
56881,primary,0,0
56882,outcome,0,0
56883,was,0,0
56884,relief,0,0
56885,of,0,0
56886,nighttime,0,0
56887,heartburn,0,1
56888,.,0,0
56889,Secondary,0,0
56890,outcomes,0,0
56891,included,0,1
56892,resolution,0,0
56893,of,0,0
56894,sleep,0,0
56895,disturbances,0,0
56896,",",0,0
56897,sleep,0,0
56898,quality,0,0
56899,measured,0,0
56900,by,0,0
56901,the,0,0
56902,Pittsburgh,0,1
56903,Sleep,0,0
56904,Quality,0,0
56905,Index,0,0
56906,(,0,0
56907,PSQI,0,0
56908,),0,0
56909,questionnaire,0,0
56910,",",0,0
56911,and,0,0
56912,work,0,0
56913,productivity,0,0
56914,measured,0,0
56915,by,0,0
56916,the,0,0
56917,Work,0,0
56918,Productivity,0,0
56919,and,0,0
56920,Activity,0,0
56921,Impairment,0,0
56922,Questionnaire,0,0
56923,.,0,0
56924,RESULTS,0,0
56925,Nighttime,0,0
56926,heartburn,0,0
56927,was,0,0
56928,relieved,0,0
56929,in,0,0
56930,53.1,0,0
56931,%,0,0
56932,(,0,0
56933,111/209,0,0
56934,),0,0
56935,",",0,0
56936,50.5,0,0
56937,%,0,0
56938,(,0,0
56939,111/220,0,0
56940,),0,0
56941,",",0,0
56942,and,0,0
56943,12.7,0,0
56944,%,0,0
56945,(,0,0
56946,28/221,0,0
56947,),0,0
56948,of,0,1
56949,patients,0,1
56950,who,0,1
56951,received,0,1
56952,esomeprazole,0,1
56953,40,0,0
56954,mg,0,0
56955,",",0,0
56956,esomeprazole,0,0
56957,20,0,0
56958,mg,0,0
56959,",",0,0
56960,and,0,0
56961,placebo,0,0
56962,",",0,0
56963,respectively,0,0
56964,.,0,0
56965,Differences,0,0
56966,(,0,0
56967,95,0,0
56968,%,0,0
56969,CI,0,0
56970,),0,0
56971,versus,0,0
56972,placebo,0,0
56973,were,0,0
56974,40.5,0,0
56975,%,0,0
56976,(,0,0
56977,32.4,0,0
56978,%,0,0
56979,",",0,0
56980,48.5,0,0
56981,%,0,0
56982,),0,0
56983,and,0,0
56984,37.8,0,0
56985,%,0,0
56986,(,0,0
56987,29.9,0,0
56988,%,0,0
56989,",",0,0
56990,45.7,0,0
56991,%,0,0
56992,),0,0
56993,and,0,0
56994,were,0,0
56995,highly,0,0
56996,significant,0,0
56997,(,0,0
56998,p,0,0
56999,<,0,0
57000,0.0001,0,0
57001,),0,0
57002,.,0,0
57003,GERD-related,0,0
57004,sleep,0,0
57005,disturbances,0,0
57006,resolved,0,0
57007,in,0,0
57008,significantly,0,0
57009,more,0,0
57010,(,0,0
57011,p,0,0
57012,<,0,0
57013,0.0001,0,0
57014,),0,1
57015,patients,0,1
57016,who,0,1
57017,received,0,1
57018,esomeprazole,0,1
57019,40,0,1
57020,(,0,0
57021,73.7,0,0
57022,%,0,0
57023,),0,0
57024,or,0,0
57025,20,0,0
57026,mg,0,0
57027,(,0,0
57028,73.2,0,0
57029,%,0,0
57030,),0,0
57031,than,0,0
57032,in,0,0
57033,those,0,1
57034,who,0,1
57035,received,0,1
57036,placebo,0,1
57037,(,0,0
57038,41.2,0,0
57039,%,0,0
57040,),0,0
57041,.,0,0
57042,Both,0,0
57043,esomeprazole,0,0
57044,groups,0,0
57045,had,0,1
57046,greater,0,0
57047,PSQI,0,0
57048,global,0,0
57049,score,0,0
57050,changes,0,0
57051,from,0,0
57052,baseline,0,0
57053,(,0,0
57054,p,0,0
57055,<,0,0
57056,0.0001,0,0
57057,vs,0,0
57058,placebo,0,0
57059,),0,0
57060,and,0,0
57061,more,0,0
57062,(,0,0
57063,p,0,0
57064,<,0,0
57065,0.0001,0,0
57066,vs,0,0
57067,placebo,0,0
57068,),0,0
57069,work,0,0
57070,hours,0,0
57071,saved,0,0
57072,per,0,0
57073,week,0,0
57074,per,0,0
57075,patient,0,0
57076,compared,0,0
57077,with,0,0
57078,baseline,0,0
57079,(,0,0
57080,esomeprazole,0,0
57081,40,0,0
57082,mg,0,0
57083,",",0,0
57084,11.6,0,0
57085,h,0,0
57086,;,0,0
57087,esomeprazole,0,0
57088,20,0,0
57089,mg,0,0
57090,",",0,0
57091,12.3,0,0
57092,h,0,0
57093,;,0,0
57094,placebo,0,0
57095,",",0,0
57096,6.2,0,0
57097,h,0,0
57098,),0,0
57099,.,0,0
57100,CONCLUSIONS,0,0
57101,Esomeprazole,0,0
57102,reduced,0,0
57103,nighttime,0,0
57104,heartburn,0,0
57105,and,0,0
57106,GERD-related,0,0
57107,sleep,0,0
57108,disturbances,0,0
57109,and,0,0
57110,improved,0,0
57111,sleep,0,0
57112,quality,0,0
57113,and,0,0
57114,work,0,0
57115,productivity,0,0
57116,.,0,0
57117,Family,0,0
57118,education,0,0
57119,for,0,0
57120,people,1,1
57121,with,1,1
57122,schizophrenia,1,1
57123,in,1,0
57124,Beijing,1,1
57125,",",1,0
57126,China,1,1
57127,:,1,1
57128,randomised,0,0
57129,controlled,0,0
57130,trial,0,0
57131,.,0,0
57132,BACKGROUND,0,0
57133,Much,0,0
57134,of,0,0
57135,China,0,1
57136,lacks,0,0
57137,well-developed,0,0
57138,services,0,0
57139,for,0,0
57140,people,1,1
57141,with,1,1
57142,schizophrenia,1,1
57143,and,1,0
57144,their,1,0
57145,families,1,1
57146,",",0,0
57147,and,0,0
57148,most,0,0
57149,of,0,0
57150,the,0,0
57151,existing,0,0
57152,services,0,0
57153,focus,0,1
57154,on,0,0
57155,hospitals,0,1
57156,.,0,0
57157,There,0,0
57158,is,0,0
57159,a,0,0
57160,need,0,0
57161,for,0,0
57162,culturally,0,0
57163,sensitive,0,0
57164,family,0,0
57165,treatments,0,0
57166,offered,0,0
57167,by,0,0
57168,nurses,0,1
57169,.,0,1
57170,AIMS,0,0
57171,To,0,0
57172,conduct,0,0
57173,a,0,0
57174,longitudinal,0,0
57175,experimental,0,0
57176,study,0,0
57177,examining,0,0
57178,the,0,0
57179,effect,0,0
57180,of,0,0
57181,patient,0,0
57182,and,0,0
57183,family,0,0
57184,education,0,0
57185,in,0,0
57186,a,0,0
57187,sample,1,1
57188,of,1,0
57189,Chinese,1,1
57190,people,1,1
57191,with,1,1
57192,schizophrenia,1,1
57193,.,1,0
57194,METHOD,0,0
57195,A,0,0
57196,randomised,0,0
57197,controlled,0,0
57198,trial,0,0
57199,was,0,0
57200,conducted,0,0
57201,in,0,0
57202,a,0,0
57203,large,0,0
57204,hospital,0,0
57205,with,0,1
57206,a,0,0
57207,was,0,0
57208,conducted,0,0
57209,in,0,0
57210,a,0,0
57211,large,1,0
57212,hospital,1,0
57213,with,1,0
57214,a,1,0
57215,sample,1,1
57216,of,1,0
57217,101,1,1
57218,patients,1,1
57219,with,1,1
57220,schizophrenia,1,1
57221,and,1,0
57222,their,1,0
57223,families,1,1
57224,.,1,1
57225,Data,0,0
57226,were,0,0
57227,collected,0,0
57228,at,0,0
57229,admission,0,0
57230,and,0,0
57231,at,0,0
57232,discharge,0,0
57233,",",0,0
57234,and,0,0
57235,then,0,0
57236,at,0,0
57237,3,0,0
57238,and,0,0
57239,9,0,0
57240,months,0,0
57241,after,0,0
57242,discharge,0,0
57243,.,0,0
57244,The,0,0
57245,intervention,0,0
57246,group,0,0
57247,received,0,0
57248,family,0,0
57249,education,0,0
57250,",",0,0
57251,and,0,0
57252,data,0,0
57253,on,0,0
57254,their,0,0
57255,knowledge,0,0
57256,about,0,0
57257,schizophrenia,0,1
57258,",",0,0
57259,symptoms,0,0
57260,",",0,0
57261,functioning,0,0
57262,",",0,0
57263,psychosocial,0,0
57264,behaviour,0,0
57265,",",0,0
57266,relapse,0,0
57267,and,0,0
57268,medication,0,0
57269,adherence,0,0
57270,were,0,0
57271,collected,0,0
57272,and,0,0
57273,compared,0,0
57274,with,0,0
57275,the,0,0
57276,control,0,0
57277,group,0,0
57278,.,0,0
57279,RESULTS,0,0
57280,There,0,0
57281,was,0,0
57282,a,0,0
57283,significant,0,0
57284,improvement,0,0
57285,in,0,0
57286,knowledge,0,0
57287,about,0,0
57288,schizophrenia,0,1
57289,in,0,0
57290,the,0,0
57291,experimental,0,0
57292,group,0,0
57293,and,0,0
57294,a,0,0
57295,significant,0,0
57296,difference,0,0
57297,in,0,0
57298,symptom,0,0
57299,scores,0,0
57300,and,0,0
57301,functioning,0,0
57302,at,0,0
57303,9,0,0
57304,months,0,0
57305,after,0,0
57306,discharge,0,1
57307,.,0,1
57308,Patients,0,1
57309,who,0,1
57310,were,0,1
57311,nonadherent,0,1
57312,to,0,0
57313,medication,0,0
57314,regimens,0,0
57315,were,0,0
57316,more,0,0
57317,likely,0,0
57318,to,0,0
57319,relapse,0,0
57320,.,0,0
57321,CONCLUSIONS,0,0
57322,Family,0,0
57323,education,0,0
57324,on,0,0
57325,schizophrenia,0,1
57326,by,0,0
57327,nurses,0,1
57328,in,0,0
57329,China,0,1
57330,was,0,0
57331,effective,0,0
57332,in,0,0
57333,improving,0,0
57334,knowledge,0,0
57335,and,0,0
57336,promoting,0,0
57337,improvement,0,0
57338,in,0,0
57339,patients,0,1
57340,',0,1
57341,symptoms,0,0
57342,.,0,1
57343,Incidence,0,0
57344,of,0,0
57345,puberty,0,1
57346,in,0,0
57347,beef,1,1
57348,heifers,1,1
57349,fed,1,0
57350,high-,1,0
57351,or,1,1
57352,low-starch,1,0
57353,diets,1,0
57354,for,1,0
57355,different,1,0
57356,periods,1,0
57357,before,1,0
57358,breeding,1,1
57359,.,1,1
57360,Spring-born,1,1
57361,Hereford,1,1
57362,x,1,0
57363,Angus,1,1
57364,heifers,1,1
57365,(,1,0
57366,n,1,1
57367,=,1,0
57368,206,1,1
57369,),1,0
57370,were,0,0
57371,used,0,0
57372,to,0,0
57373,determine,0,0
57374,effects,0,0
57375,of,0,0
57376,energy,0,0
57377,supplementation,0,0
57378,programs,0,0
57379,and,0,0
57380,amount,0,0
57381,of,0,0
57382,starch,0,0
57383,in,0,0
57384,the,0,0
57385,diet,0,0
57386,on,0,0
57387,incidence,0,0
57388,of,0,0
57389,puberty,0,1
57390,.,0,0
57391,In,0,0
57392,Exp,0,0
57393,.,0,0
57394,1,0,0
57395,",",0,0
57396,heifers,1,1
57397,(,1,0
57398,205,1,1
57399,+/-,1,0
57400,5,1,0
57401,kg,1,1
57402,;,1,0
57403,n,1,0
57404,=,1,0
57405,68,1,1
57406,),1,0
57407,grazing,1,0
57408,dormant,1,0
57409,native,1,0
57410,pasture,1,0
57411,were,0,0
57412,fed,0,0
57413,0.9,0,0
57414,kg/d,0,0
57415,(,0,0
57416,as-fed,0,1
57417,basis,0,0
57418,),0,0
57419,of,0,0
57420,a,0,0
57421,42,0,0
57422,%,0,0
57423,CP,0,0
57424,supplement,0,0
57425,from,0,0
57426,November,0,1
57427,until,0,0
57428,February,0,1
57429,14,0,1
57430,.,0,1
57431,Heifers,1,0
57432,were,0,0
57433,stratified,0,0
57434,by,0,0
57435,weaning,0,0
57436,weight,0,0
57437,and,0,0
57438,allotted,0,0
57439,randomly,0,0
57440,to,0,0
57441,treatment,0,0
57442,before,0,0
57443,breeding,0,1
57444,(,0,0
57445,May,0,0
57446,to,0,0
57447,July,0,0
57448,),0,0
57449,.,0,0
57450,Treatments,0,0
57451,were,0,0
57452,1,0,0
57453,),0,0
57454,0.9,0,0
57455,kg,0,0
57456,(,0,0
57457,as-fed,0,0
57458,basis,0,0
57459,),0,0
57460,of,0,0
57461,a,0,0
57462,42,0,0
57463,%,0,0
57464,CP,0,0
57465,supplement/d,0,0
57466,and,0,0
57467,pasture,0,0
57468,(,0,0
57469,control,0,0
57470,),0,0
57471,;,0,0
57472,2,0,0
57473,),0,0
57474,a,0,0
57475,high-starch,0,0
57476,(,0,0
57477,HS,0,0
57478,),0,0
57479,diet,0,0
57480,(,0,0
57481,73,0,0
57482,%,0,0
57483,corn,0,1
57484,;,0,0
57485,53,0,0
57486,%,0,0
57487,starch,0,0
57488,),0,0
57489,fed,0,0
57490,in,0,0
57491,a,0,0
57492,drylot,0,1
57493,for,0,0
57494,60,0,0
57495,d,0,0
57496,(,0,0
57497,HS-60,0,0
57498,),0,0
57499,;,0,0
57500,3,0,0
57501,),0,0
57502,a,0,0
57503,HS,0,0
57504,diet,0,0
57505,fed,0,0
57506,in,0,0
57507,drylot,0,1
57508,for,0,0
57509,30,0,0
57510,d,0,0
57511,(,0,0
57512,HS-30,0,0
57513,),0,0
57514,;,0,0
57515,or,0,0
57516,4,0,0
57517,),0,0
57518,a,0,0
57519,low-starch,0,0
57520,(,0,0
57521,LS,0,0
57522,),0,0
57523,diet,0,0
57524,(,0,0
57525,49,0,1
57526,%,0,0
57527,corn,0,1
57528,;,0,0
57529,37,0,0
57530,%,0,0
57531,starch,0,0
57532,),0,0
57533,self-fed,0,0
57534,on,0,0
57535,pasture,0,0
57536,for,0,0
57537,30,0,0
57538,d,0,0
57539,(,0,0
57540,LS-30,0,0
57541,),0,0
57542,.,0,0
57543,The,0,0
57544,HS-60,0,0
57545,and,0,0
57546,HS-30,0,0
57547,heifers,0,1
57548,were,0,0
57549,limited-fed,0,0
57550,to,0,0
57551,gain,0,0
57552,0.9,0,0
57553,kg/d,0,0
57554,",",0,0
57555,and,0,0
57556,the,0,0
57557,LS-30,0,0
57558,heifers,0,1
57559,had,0,0
57560,ad,0,1
57561,libitum,0,0
57562,access,0,0
57563,to,0,0
57564,the,0,0
57565,diet,0,0
57566,.,0,0
57567,High-starch-60,0,0
57568,and,0,0
57569,LS-30,0,0
57570,heifers,0,1
57571,were,0,0
57572,heavier,0,0
57573,(,0,0
57574,P,0,0
57575,<,0,0
57576,0.05,0,0
57577,),0,0
57578,than,0,0
57579,control,0,0
57580,and,0,0
57581,HS-30,0,0
57582,heifers,0,1
57583,at,0,0
57584,the,0,0
57585,beginning,0,0
57586,of,0,0
57587,the,0,0
57588,breeding,0,0
57589,season,0,0
57590,.,0,0
57591,Thirty-one,0,1
57592,",",0,0
57593,25,0,0
57594,",",0,0
57595,and,0,0
57596,26,0,0
57597,%,0,0
57598,more,0,0
57599,HS-60,0,0
57600,heifers,0,1
57601,were,0,0
57602,pubertal,0,1
57603,(,0,0
57604,P,0,0
57605,<,0,0
57606,0.05,0,0
57607,),0,0
57608,on,0,0
57609,May,0,0
57610,1,0,0
57611,compared,0,0
57612,with,0,1
57613,LS-30,0,0
57614,",",0,0
57615,HS-30,0,0
57616,",",0,0
57617,and,0,0
57618,control,0,0
57619,heifers,0,1
57620,",",0,0
57621,respectively,0,0
57622,.,0,0
57623,At,0,0
57624,puberty,0,1
57625,",",0,0
57626,HS-60,0,0
57627,heifers,0,1
57628,were,0,0
57629,24,0,0
57630,and,0,0
57631,22,0,0
57632,d,0,0
57633,younger,0,1
57634,(,0,0
57635,P,0,0
57636,<,0,0
57637,0.05,0,0
57638,),0,0
57639,than,0,0
57640,LS-30,0,0
57641,and,0,0
57642,control,0,0
57643,heifers,0,1
57644,",",0,0
57645,and,0,0
57646,31,0,1
57647,kg,0,0
57648,lighter,0,1
57649,(,0,0
57650,P,0,0
57651,<,0,0
57652,0.01,0,0
57653,),0,0
57654,than,0,0
57655,LS-30,0,0
57656,heifers,0,1
57657,.,0,1
57658,In,0,0
57659,Exp,0,0
57660,.,0,0
57661,2,0,0
57662,",",0,0
57663,heifers,0,1
57664,grazed,0,0
57665,dormant,0,1
57666,pasture,0,0
57667,and,0,0
57668,were,0,0
57669,fed,0,0
57670,0.9,0,0
57671,kg,0,0
57672,(,0,0
57673,as-fed,0,1
57674,basis,0,0
57675,),0,0
57676,of,0,0
57677,a,0,0
57678,42,0,0
57679,%,0,0
57680,CP,0,0
57681,supplement/d,0,0
57682,from,0,0
57683,weaning,0,0
57684,in,0,0
57685,October,0,1
57686,to,0,0
57687,late,0,1
57688,February,0,1
57689,;,0,0
57690,then,0,0
57691,heifers,0,1
57692,were,0,0
57693,assigned,0,0
57694,randomly,0,1
57695,to,0,0
57696,treatments,0,0
57697,for,0,0
57698,60,0,1
57699,d,0,0
57700,before,0,0
57701,the,0,0
57702,breeding,0,0
57703,season,0,0
57704,.,0,0
57705,In,0,0
57706,two,0,0
57707,years,0,1
57708,",",0,0
57709,control,0,0
57710,heifers,0,1
57711,(,0,0
57712,n,0,1
57713,=,0,0
57714,46,0,1
57715,),0,0
57716,grazed,0,0
57717,pasture,0,0
57718,and,0,0
57719,received,0,0
57720,0.9,0,0
57721,kg,0,0
57722,of,0,0
57723,SBM,0,0
57724,supplement/d,0,0
57725,;,0,0
57726,LS,0,0
57727,(,0,0
57728,n,0,1
57729,=,0,0
57730,46,0,1
57731,),0,0
57732,heifers,0,1
57733,were,0,0
57734,self-fed,0,0
57735,a,0,0
57736,distiller,0,0
57737,'s,0,0
57738,grain,0,0
57739,and,0,0
57740,soybean,0,0
57741,hull-based,0,0
57742,diet,0,0
57743,in,0,0
57744,drylot,0,1
57745,;,0,0
57746,and,0,0
57747,HS,0,0
57748,heifers,0,1
57749,(,0,0
57750,n,0,1
57751,=,0,0
57752,46,0,1
57753,),0,0
57754,were,0,0
57755,limited-fed,0,0
57756,a,0,0
57757,corn-based,0,0
57758,diet,0,0
57759,in,0,0
57760,drylot,0,1
57761,.,0,0
57762,During,0,0
57763,treatment,0,0
57764,",",0,0
57765,HS,1,0
57766,and,1,0
57767,LS,1,0
57768,heifers,1,1
57769,had,0,0
57770,greater,0,0
57771,weight,0,0
57772,gains,0,0
57773,than,0,0
57774,control,0,1
57775,heifers,0,1
57776,.,0,1
57777,Pubertal,0,1
57778,BW,0,0
57779,(,0,0
57780,313,0,1
57781,+/-,0,0
57782,6,0,0
57783,kg,0,1
57784,),0,0
57785,was,0,0
57786,not,0,0
57787,influenced,0,0
57788,by,0,0
57789,treatment,0,0
57790,",",0,0
57791,but,0,0
57792,HS,1,0
57793,and,1,0
57794,LS,1,0
57795,heifers,1,1
57796,were,0,0
57797,younger,0,1
57798,(,0,0
57799,P,0,0
57800,<,0,0
57801,0.03,0,0
57802,),0,0
57803,than,0,0
57804,control,0,0
57805,heifers,0,1
57806,at,0,0
57807,puberty,0,1
57808,.,0,0
57809,During,0,0
57810,a,0,0
57811,60-d,0,0
57812,breeding,0,0
57813,period,0,0
57814,",",0,0
57815,the,0,0
57816,incidence,0,0
57817,of,0,0
57818,puberty,0,1
57819,was,0,0
57820,greater,0,0
57821,(,0,0
57822,P,0,0
57823,<,0,0
57824,0.05,0,0
57825,),0,0
57826,for,0,0
57827,HS,1,0
57828,and,1,0
57829,LS,1,0
57830,heifers,1,1
57831,than,0,0
57832,for,0,0
57833,control,0,0
57834,heifers,0,1
57835,and,0,0
57836,was,0,0
57837,greater,0,0
57838,(,0,0
57839,P,0,0
57840,<,0,0
57841,0.05,0,0
57842,),0,0
57843,in,0,0
57844,HS,0,0
57845,than,0,0
57846,in,0,0
57847,LS,0,0
57848,heifers,0,1
57849,in,0,0
57850,Year,0,1
57851,1,0,0
57852,.,0,0
57853,Feeding,0,0
57854,a,0,0
57855,LS,0,0
57856,or,0,0
57857,a,0,0
57858,HS,0,0
57859,diet,0,0
57860,for,0,0
57861,30,0,0
57862,d,0,0
57863,before,0,0
57864,breeding,0,0
57865,may,0,0
57866,be,0,0
57867,inadequate,0,0
57868,to,0,0
57869,stimulate,0,0
57870,puberty,0,1
57871,in,0,0
57872,beef,0,1
57873,heifers,1,1
57874,",",0,0
57875,but,0,0
57876,feeding,0,0
57877,a,0,0
57878,diet,0,0
57879,with,0,0
57880,a,0,0
57881,greater,0,0
57882,amount,0,0
57883,of,0,0
57884,starch,0,0
57885,for,0,0
57886,60,0,0
57887,d,0,0
57888,before,0,0
57889,breeding,0,0
57890,may,0,0
57891,increase,0,0
57892,the,0,0
57893,incidence,0,0
57894,of,0,0
57895,puberty,0,1
57896,during,0,0
57897,breeding,0,1
57898,of,0,0
57899,heifers,0,1
57900,that,0,0
57901,have,0,0
57902,inadequate,0,0
57903,yearling,0,1
57904,weight,0,0
57905,.,0,0
57906,Bronchial,0,0
57907,matrix,0,0
57908,and,0,0
57909,inflammation,0,0
57910,respond,0,0
57911,to,0,0
57912,inhaled,0,0
57913,steroids,0,0
57914,despite,0,0
57915,ongoing,0,0
57916,allergen,0,0
57917,exposure,0,0
57918,in,0,0
57919,asthma,1,1
57920,.,1,0
57921,BACKGROUND,0,0
57922,Inflammatory,0,0
57923,and,0,0
57924,structural,0,0
57925,changes,0,0
57926,of,0,0
57927,the,0,0
57928,airway,0,0
57929,mucosa,0,1
57930,are,0,0
57931,chronic,0,1
57932,features,0,0
57933,of,0,0
57934,asthma,0,1
57935,.,0,0
57936,The,0,0
57937,mechanisms,0,0
57938,underlying,0,0
57939,these,0,0
57940,changes,0,0
57941,and,0,0
57942,their,0,0
57943,modulation,0,0
57944,by,0,0
57945,steroid,0,0
57946,prophylaxis,0,0
57947,have,0,0
57948,not,0,0
57949,been,0,0
57950,clarified,0,0
57951,.,0,0
57952,OBJECTIVE,0,0
57953,We,0,0
57954,postulated,0,0
57955,that,0,0
57956,asymptomatic,0,1
57957,ongoing,0,0
57958,allergen,0,0
57959,exposure,0,0
57960,could,0,0
57961,drive,0,0
57962,airway,0,0
57963,inflammation,0,0
57964,as,0,0
57965,well,0,0
57966,as,0,0
57967,changes,0,0
57968,in,0,0
57969,the,0,0
57970,extracellular,0,0
57971,matrix,0,0
57972,(,0,0
57973,ECM,0,0
57974,),0,0
57975,",",0,0
57976,and,0,0
57977,that,0,0
57978,inhaled,0,0
57979,steroids,0,0
57980,could,0,0
57981,prevent,0,0
57982,this,0,0
57983,.,0,0
57984,METHODS,0,0
57985,Therefore,0,0
57986,",",0,0
57987,we,0,0
57988,exposed,0,0
57989,patients,1,1
57990,with,1,1
57991,mild,1,1
57992,asthma,1,1
57993,to,0,1
57994,2,0,0
57995,weeks,0,0
57996,of,0,0
57997,repeated,0,0
57998,low-dose,0,0
57999,allergen,0,0
58000,",",0,0
58001,with,0,0
58002,concomitant,0,0
58003,inhaled,0,0
58004,steroid,0,0
58005,or,0,0
58006,placebo,0,0
58007,treatment,0,0
58008,.,0,0
58009,Bronchial,0,0
58010,biopsies,0,0
58011,",",0,0
58012,which,0,0
58013,were,0,0
58014,taken,0,0
58015,before,0,0
58016,and,0,0
58017,after,0,0
58018,this,0,0
58019,exposure,0,0
58020,",",0,0
58021,were,0,0
58022,stained,0,0
58023,and,0,0
58024,digitally,0,0
58025,analysed,0,0
58026,.,0,0
58027,The,0,0
58028,ECM,0,0
58029,proteins,0,0
58030,in,0,0
58031,asthmatics,0,1
58032,were,0,0
58033,also,0,0
58034,compared,0,0
58035,with,0,0
58036,a,0,0
58037,normal,0,0
58038,control,0,0
58039,group,0,0
58040,.,0,0
58041,RESULTS,0,0
58042,Low-dose,0,0
58043,allergen,0,0
58044,exposure,0,0
58045,alone,0,0
58046,resulted,0,0
58047,in,0,0
58048,a,0,0
58049,significant,0,0
58050,increase,0,0
58051,of,0,0
58052,bronchial,0,1
58053,epithelial,0,1
58054,macrophages,0,0
58055,.,0,0
58056,Despite,0,0
58057,ongoing,0,0
58058,allergen,0,0
58059,exposure,0,0
58060,",",0,0
58061,inhaled,0,0
58062,steroids,0,0
58063,reduced,0,0
58064,the,0,0
58065,numbers,0,0
58066,of,0,0
58067,mucosal,0,0
58068,eosinophils,0,0
58069,",",0,0
58070,neutrophils,0,0
58071,and,0,0
58072,T,0,0
58073,lymphocytes,0,0
58074,.,0,0
58075,At,0,0
58076,baseline,0,0
58077,",",0,0
58078,the,0,0
58079,mean,0,0
58080,density,0,0
58081,of,0,0
58082,the,0,0
58083,proteoglycans,0,0
58084,(,0,0
58085,PGS,0,1
58086,),0,0
58087,biglycan,0,0
58088,and,0,0
58089,decorin,0,0
58090,were,0,0
58091,",",0,0
58092,respectively,0,0
58093,",",0,0
58094,higher,0,0
58095,and,0,0
58096,lower,0,0
58097,in,0,0
58098,the,0,0
58099,bronchial,0,1
58100,mucosa,0,1
58101,of,0,0
58102,asthmatics,0,1
58103,as,0,0
58104,compared,0,0
58105,with,0,1
58106,normal,0,1
58107,controls,0,1
58108,.,0,1
58109,Steroid,0,0
58110,treatment,0,0
58111,",",0,0
58112,during,0,0
58113,allergen,0,0
58114,exposure,0,0
58115,",",0,0
58116,increased,0,0
58117,the,0,0
58118,mean,0,0
58119,density,0,0
58120,of,0,0
58121,the,0,0
58122,PGS,0,0
58123,biglycan,0,0
58124,and,0,0
58125,versican,0,0
58126,.,0,0
58127,CONCLUSION,0,0
58128,We,0,0
58129,conclude,0,0
58130,that,0,0
58131,chronic,0,1
58132,allergen,0,0
58133,exposure,0,0
58134,induces,0,0
58135,inflammatory,0,0
58136,changes,0,0
58137,in,0,0
58138,the,0,0
58139,bronchial,0,1
58140,mucosa,0,1
58141,.,0,0
58142,Despite,0,0
58143,ongoing,0,0
58144,allergen,0,0
58145,exposure,0,0
58146,",",0,0
58147,steroid,0,0
58148,treatment,0,0
58149,decreases,0,0
58150,mucosal,0,0
58151,inflammatory,0,0
58152,cells,0,0
58153,while,0,0
58154,altering,0,0
58155,PG,0,1
58156,density,0,0
58157,.,0,0
58158,The,0,0
58159,latter,0,0
58160,observation,0,0
58161,highlights,0,0
58162,the,0,0
58163,need,0,0
58164,to,0,0
58165,examine,0,0
58166,steroid-induced,0,1
58167,changes,0,0
58168,closely,0,0
58169,in,0,0
58170,the,0,0
58171,airway,0,0
58172,structure,0,0
58173,in,0,0
58174,patients,1,1
58175,with,1,1
58176,asthma,1,1
58177,.,1,1
58178,Intervention,0,0
58179,pilot,0,0
58180,for,0,0
58181,parents,1,1
58182,of,1,0
58183,children,1,1
58184,with,1,1
58185,autistic,1,1
58186,spectrum,1,1
58187,disorder,1,1
58188,.,1,0
58189,Parents,1,0
58190,of,1,1
58191,children,1,1
58192,who,1,1
58193,receive,1,1
58194,the,1,0
58195,diagnosis,1,0
58196,of,1,0
58197,autistic,1,1
58198,spectrum,1,1
58199,disorder,1,1
58200,(,1,0
58201,ASD,1,1
58202,),1,0
58203,experience,0,0
58204,a,0,0
58205,situational,0,0
58206,crisis,0,0
58207,related,0,0
58208,to,0,0
58209,receiving,0,0
58210,the,0,0
58211,diagnosis,0,0
58212,",",0,0
58213,which,0,0
58214,causes,0,0
58215,feelings,0,0
58216,of,0,0
58217,distress,0,1
58218,and,0,0
58219,urgency,0,0
58220,to,0,0
58221,access,0,0
58222,services,0,0
58223,for,0,0
58224,the,0,0
58225,affected,0,0
58226,child,0,1
58227,.,0,0
58228,This,0,0
58229,paper,0,0
58230,describes,0,0
58231,a,0,0
58232,randomized,1,0
58233,trial,1,0
58234,(,1,0
58235,n,1,1
58236,=,1,0
58237,31,1,1
58238,),1,0
58239,that,1,0
58240,was,1,0
58241,conducted,1,0
58242,at,1,0
58243,a,1,0
58244,regional,1,0
58245,diagnostic,1,0
58246,center,1,1
58247,of,1,0
58248,a,1,0
58249,large,1,0
58250,metropolitan,1,1
58251,children,1,1
58252,'s,1,1
58253,hospital,1,1
58254,to,0,0
58255,(,0,0
58256,a,0,0
58257,),0,0
58258,refine,0,0
58259,a,0,0
58260,nursing,0,0
58261,intervention,0,0
58262,designed,0,0
58263,for,0,0
58264,parents,1,1
58265,of,1,0
58266,children,1,1
58267,with,1,1
58268,ASD,1,1
58269,and,0,0
58270,(,0,0
58271,b,0,0
58272,),0,0
58273,to,0,0
58274,identify,0,0
58275,methodological,0,0
58276,revisions,0,0
58277,for,0,0
58278,a,0,0
58279,larger,0,0
58280,study,0,0
58281,.,0,0
58282,A,0,0
58283,secondary,0,0
58284,purpose,0,0
58285,was,0,0
58286,to,0,0
58287,test,0,0
58288,the,0,0
58289,effects,0,0
58290,of,0,0
58291,a,0,0
58292,post-diagnosis,0,0
58293,nursing,0,1
58294,intervention,0,0
58295,on,0,0
58296,parents,0,1
58297,',0,1
58298,reports,0,0
58299,of,0,0
58300,stress,0,0
58301,",",0,0
58302,impact,0,0
58303,of,0,0
58304,event,0,0
58305,(,0,0
58306,diagnosis,0,1
58307,),0,0
58308,",",0,0
58309,and,0,0
58310,use,0,0
58311,of,0,0
58312,services,0,1
58313,after,0,0
58314,a,0,0
58315,child,1,0
58316,is,1,0
58317,newly,1,1
58318,diagnosed,1,1
58319,with,1,0
58320,ASD,1,1
58321,.,1,0
58322,The,0,0
58323,intervention,0,0
58324,consisted,0,0
58325,of,0,0
58326,usual,0,0
58327,care,0,0
58328,plus,0,0
58329,3,0,0
58330,hours,0,0
58331,contact,0,0
58332,with,0,1
58333,a,0,0
58334,pediatric,0,1
58335,nurse,0,0
58336,practitioner,0,1
58337,(,0,0
58338,PNP,0,0
58339,),0,0
58340,for,0,0
58341,counseling,0,0
58342,",",0,0
58343,instruction,0,0
58344,",",0,0
58345,and,0,0
58346,assistance,0,0
58347,with,0,0
58348,implementation,0,0
58349,of,0,0
58350,the,0,0
58351,recommended,0,0
58352,treatment,0,0
58353,plan,0,0
58354,.,0,0
58355,The,0,0
58356,control,0,0
58357,group,0,0
58358,received,0,0
58359,only,0,0
58360,the,0,0
58361,usual,0,0
58362,care,0,0
58363,post-diagnosis,0,0
58364,",",0,0
58365,which,0,0
58366,consisted,0,0
58367,of,0,0
58368,a,0,0
58369,1-hour,0,0
58370,consultation,0,0
58371,session,0,0
58372,to,0,0
58373,receive,0,0
58374,the,0,0
58375,results,0,0
58376,of,0,0
58377,diagnostic,0,0
58378,tests,0,0
58379,and,0,0
58380,a,0,0
58381,written,0,0
58382,copy,0,0
58383,of,0,0
58384,the,0,0
58385,recommended,0,0
58386,treatment,0,0
58387,plan,0,0
58388,provided,0,0
58389,by,0,0
58390,a,0,0
58391,developmental,0,0
58392,pediatrician,0,0
58393,and/or,0,0
58394,PNP,0,0
58395,.,0,0
58396,Between,0,0
58397,group,0,0
58398,differences,0,0
58399,in,0,0
58400,measures,0,0
58401,of,0,0
58402,impact,0,0
58403,of,0,0
58404,event,0,0
58405,and,0,0
58406,perceived,0,0
58407,stress,0,0
58408,were,0,0
58409,not,0,0
58410,statistically,0,0
58411,significant,0,0
58412,.,0,0
58413,This,0,0
58414,was,0,0
58415,attributed,0,0
58416,to,0,0
58417,a,0,0
58418,small,0,0
58419,sample,0,1
58420,size,0,0
58421,.,0,0
58422,A,0,0
58423,larger,0,0
58424,study,0,0
58425,is,0,0
58426,feasible,0,0
58427,and,0,0
58428,recommended,0,0
58429,with,0,0
58430,an,0,0
58431,expanded,0,0
58432,nursing,0,1
58433,intervention,0,0
58434,and,0,0
58435,a,0,0
58436,significantly,0,0
58437,larger,0,0
58438,sample,0,1
58439,recruited,0,1
58440,from,0,0
58441,an,0,0
58442,additional,0,0
58443,recruitment,0,0
58444,site,0,0
58445,.,0,0
58446,Nurses,0,0
58447,working,0,0
58448,with,0,1
58449,this,0,0
58450,special,0,0
58451,population,0,0
58452,must,0,0
58453,recognize,0,0
58454,that,0,0
58455,parents,0,1
58456,have,0,0
58457,information,0,0
58458,and,0,0
58459,counseling,0,0
58460,needs,0,0
58461,that,0,0
58462,begin,0,0
58463,after,0,0
58464,they,0,0
58465,receive,0,0
58466,the,0,0
58467,diagnosis,0,0
58468,of,0,0
58469,ASD,0,1
58470,for,0,0
58471,their,0,0
58472,child,0,0
58473,and,0,0
58474,can,0,0
58475,address,0,0
58476,these,0,0
58477,needs,0,0
58478,with,0,1
58479,a,0,0
58480,standardized,0,0
58481,nursing,0,1
58482,intervention,0,0
58483,.,0,0
58484,[,0,0
58485,Clinical,0,0
58486,study,0,0
58487,of,0,0
58488,feiyanqing,0,0
58489,rectum,0,1
58490,condensed,0,0
58491,liquid,0,0
58492,in,0,0
58493,treating,0,0
58494,36,0,1
58495,cases,0,1
58496,of,0,0
58497,children,0,1
58498,syncytial,0,1
58499,viral,0,0
58500,pneumonia,0,1
58501,],0,0
58502,.,0,0
58503,OBJECTIVE,0,0
58504,To,0,0
58505,evaluate,0,0
58506,the,0,0
58507,clinical,0,0
58508,efficacy,0,0
58509,and,0,0
58510,mechanism,0,0
58511,of,0,0
58512,Feiyangqin,0,0
58513,Rectum,0,1
58514,Condensed,0,1
58515,Liquid,0,0
58516,(,0,0
58517,FRCL,0,0
58518,),0,0
58519,in,0,0
58520,treating,0,0
58521,children,1,1
58522,syncytial,1,1
58523,viral,1,0
58524,pneumonia,1,1
58525,.,1,0
58526,Methods,0,0
58527,Seventy-two,1,1
58528,patients,1,1
58529,were,1,0
58530,randomly,1,1
58531,divided,1,0
58532,into,1,0
58533,two,1,0
58534,groups,1,0
58535,",",1,0
58536,the,1,0
58537,36,1,0
58538,patients,1,1
58539,in,1,0
58540,the,1,0
58541,treated,1,0
58542,group,1,0
58543,were,1,0
58544,treated,1,0
58545,with,1,0
58546,FRCL,1,0
58547,",",1,0
58548,and,1,0
58549,the,1,0
58550,other,1,0
58551,36,1,1
58552,patients,1,1
58553,in,1,0
58554,the,1,0
58555,control,1,0
58556,group,1,0
58557,simply,1,0
58558,treated,1,0
58559,with,1,0
58560,Western,1,1
58561,medicine,1,1
58562,.,1,0
58563,Efficacy,0,0
58564,of,0,0
58565,treatment,0,0
58566,on,0,0
58567,clinical,0,0
58568,condition,0,0
58569,and,0,0
58570,some,0,0
58571,immune,0,0
58572,function,0,0
58573,(,0,0
58574,IgA,0,0
58575,",",0,0
58576,IgG,0,0
58577,",",0,0
58578,CD3,0,0
58579,",",0,0
58580,CD4,0,1
58581,),0,0
58582,were,0,0
58583,observed,0,0
58584,.,0,0
58585,RESULTS,0,0
58586,In,0,0
58587,the,0,0
58588,treated,0,0
58589,group,0,0
58590,",",0,0
58591,28,0,0
58592,patients,0,1
58593,were,0,0
58594,cured,0,0
58595,(,0,0
58596,77.8,0,0
58597,%,0,0
58598,),0,0
58599,",",0,0
58600,treatment,0,0
58601,was,0,0
58602,markedly,0,0
58603,effective,0,0
58604,in,0,0
58605,4,0,0
58606,patients,0,1
58607,(,0,0
58608,11.1,0,0
58609,%,0,0
58610,),0,0
58611,",",0,0
58612,effective,0,0
58613,in,0,0
58614,2,0,0
58615,(,0,0
58616,5.5,0,0
58617,%,0,0
58618,),0,0
58619,and,0,0
58620,ineffective,0,0
58621,in,0,0
58622,2,0,0
58623,(,0,0
58624,5.6,0,0
58625,%,0,0
58626,),0,0
58627,",",0,0
58628,with,0,0
58629,the,0,0
58630,total,0,1
58631,effective,0,0
58632,rate,0,0
58633,of,0,0
58634,94.4,0,0
58635,%,0,0
58636,.,0,0
58637,The,0,0
58638,corresponding,0,0
58639,number,0,0
58640,in,0,0
58641,the,0,0
58642,control,0,0
58643,group,0,0
58644,was,0,0
58645,20,0,0
58646,(,0,0
58647,55.6,0,0
58648,%,0,0
58649,),0,0
58650,",",0,0
58651,7,0,0
58652,(,0,0
58653,19.4,0,0
58654,%,0,0
58655,),0,0
58656,",",0,0
58657,6,0,0
58658,(,0,0
58659,16.7,0,0
58660,%,0,0
58661,),0,0
58662,",",0,0
58663,3,0,0
58664,(,0,0
58665,8.3,0,0
58666,%,0,0
58667,),0,0
58668,and,0,0
58669,91.7,0,0
58670,%,0,0
58671,",",0,0
58672,respectively,0,0
58673,.,0,0
58674,The,0,0
58675,cure,0,0
58676,rate,0,0
58677,in,0,0
58678,the,0,0
58679,treated,0,0
58680,group,0,0
58681,was,0,0
58682,obviously,0,0
58683,superior,0,0
58684,to,0,0
58685,that,0,0
58686,in,0,0
58687,the,0,0
58688,control,0,0
58689,group,0,0
58690,(,0,0
58691,P,0,0
58692,<,0,0
58693,0.05,0,0
58694,),0,0
58695,.,0,0
58696,FRCL,0,0
58697,could,0,0
58698,improve,0,0
58699,serum,0,0
58700,IgA,0,0
58701,",",0,0
58702,IgG,0,0
58703,",",0,0
58704,CD3,0,0
58705,",",0,0
58706,CD4,0,1
58707,",",0,0
58708,and,0,0
58709,CD4/CD8,0,0
58710,",",0,0
58711,lower,0,0
58712,serum,0,0
58713,IgE,0,0
58714,",",0,0
58715,these,0,0
58716,indexes,0,0
58717,in,0,0
58718,the,0,0
58719,treated,0,0
58720,group,0,0
58721,were,0,0
58722,significantly,0,0
58723,different,0,0
58724,to,0,0
58725,those,0,0
58726,in,0,0
58727,the,0,0
58728,control,0,0
58729,group,0,0
58730,(,0,0
58731,P,0,0
58732,<,0,0
58733,0.05,0,0
58734,),0,0
58735,.,0,0
58736,CONCLUSION,0,0
58737,FRCL,0,0
58738,had,0,0
58739,the,0,0
58740,action,0,0
58741,in,0,0
58742,treating,0,0
58743,children,0,1
58744,syncytial,0,1
58745,viral,0,0
58746,pneumonia,0,1
58747,without,0,0
58748,any,0,0
58749,adverse,0,0
58750,reaction,0,0
58751,",",0,0
58752,one,0,0
58753,of,0,0
58754,its,0,0
58755,mechanisms,0,0
58756,might,0,0
58757,be,0,0
58758,related,0,0
58759,to,0,0
58760,its,0,0
58761,regulation,0,0
58762,on,0,0
58763,immune,0,0
58764,function,0,0
58765,.,0,0
58766,Safety,0,0
58767,and,0,0
58768,immunogenicity,0,0
58769,of,0,0
58770,IMVAMUNE,0,0
58771,",",0,0
58772,a,0,0
58773,promising,0,0
58774,candidate,0,0
58775,as,0,0
58776,a,0,0
58777,third,0,0
58778,generation,0,0
58779,smallpox,0,1
58780,vaccine,0,0
58781,.,0,0
58782,A,0,0
58783,Phase,0,0
58784,I,0,0
58785,trial,0,0
58786,was,0,0
58787,performed,0,0
58788,to,0,0
58789,investigate,0,0
58790,the,0,0
58791,safety,0,0
58792,and,0,0
58793,immunogenicity,0,0
58794,of,0,0
58795,the,0,0
58796,third,0,0
58797,generation,0,0
58798,smallpox,0,1
58799,vaccine,0,0
58800,MVA-BN,0,1
58801,(,0,0
58802,IMVAMUNE,0,0
58803,),0,0
58804,",",0,0
58805,a,0,0
58806,highly,0,0
58807,attenuated,0,0
58808,clone,0,0
58809,derived,0,0
58810,from,0,0
58811,the,0,0
58812,Modified,0,0
58813,Vaccinia,0,1
58814,Virus,0,1
58815,Ankara,0,1
58816,strain,0,0
58817,571,0,1
58818,",",0,0
58819,in,1,0
58820,naive,1,1
58821,and,1,0
58822,pre-immunized,1,0
58823,subjects,1,1
58824,.,1,0
58825,A,1,0
58826,total,1,0
58827,of,1,0
58828,86,1,1
58829,healthy,1,1
58830,subjects,1,1
58831,received,0,0
58832,the,0,0
58833,vaccine,0,0
58834,in,0,0
58835,five,0,1
58836,groups,0,0
58837,using,0,0
58838,different,0,0
58839,doses,0,0
58840,and,0,0
58841,routes,0,0
58842,of,0,0
58843,administration,0,0
58844,.,0,0
58845,All,0,0
58846,38,0,0
58847,subjects,0,1
58848,seroconverted,0,1
58849,in,0,0
58850,the,0,0
58851,groups,0,0
58852,receiving,0,0
58853,the,0,0
58854,highest,0,0
58855,dose,0,0
58856,(,0,0
58857,10,0,0
58858,(,0,0
58859,8,0,0
58860,),0,0
58861,TCID50,0,0
58862,),0,0
58863,.,0,0
58864,All,0,0
58865,vaccinations,0,0
58866,were,0,0
58867,well,0,0
58868,tolerated,0,0
58869,with,0,0
58870,mainly,0,0
58871,mild,0,1
58872,or,0,0
58873,moderate,0,1
58874,pain,0,0
58875,at,0,0
58876,the,0,0
58877,injection,0,0
58878,site,0,0
58879,being,0,0
58880,the,0,0
58881,most,0,0
58882,frequent,0,0
58883,symptom,0,0
58884,.,0,0
58885,The,0,0
58886,results,0,0
58887,indicate,0,0
58888,that,0,0
58889,MVA-BN,0,0
58890,has,0,0
58891,the,0,0
58892,potential,0,0
58893,to,0,0
58894,be,0,0
58895,developed,0,0
58896,as,0,0
58897,an,0,0
58898,efficient,0,0
58899,and,0,0
58900,safe,0,0
58901,alternative,0,0
58902,to,0,0
58903,the,0,0
58904,conventional,0,0
58905,smallpox,0,1
58906,vaccines,0,0
58907,such,0,0
58908,as,0,0
58909,Lister-Elstree,0,1
58910,or,0,1
58911,Dryvax,0,0
58912,.,0,0
58913,Unique,0,0
58914,attributes,0,0
58915,render,0,0
58916,it,0,0
58917,a,0,0
58918,promising,0,0
58919,candidate,0,0
58920,for,0,0
58921,prophylactic,0,0
58922,mass,0,0
58923,immunization,0,0
58924,",",0,0
58925,even,0,0
58926,in,0,0
58927,subjects,0,1
58928,for,0,1
58929,whom,0,1
58930,conventional,0,1
58931,smallpox,0,1
58932,vaccines,0,0
58933,are,0,0
58934,contraindicated,0,0
58935,.,0,0
58936,Using,0,0
58937,dietetic,0,1
58938,assistants,0,1
58939,to,0,0
58940,improve,0,0
58941,the,0,0
58942,outcome,0,0
58943,of,0,0
58944,hip,1,1
58945,fracture,1,1
58946,:,1,1
58947,a,0,0
58948,randomised,0,0
58949,controlled,0,0
58950,trial,0,0
58951,of,0,0
58952,nutritional,0,0
58953,support,0,0
58954,in,0,0
58955,an,0,0
58956,acute,1,1
58957,trauma,1,1
58958,ward,1,0
58959,.,1,0
58960,OBJECTIVE,0,0
58961,To,0,0
58962,examine,0,0
58963,how,0,0
58964,improved,0,0
58965,attention,0,0
58966,to,0,0
58967,nutritional,0,0
58968,status,0,0
58969,and,0,0
58970,dietary,0,0
58971,intake,0,0
58972,",",0,0
58973,achieved,0,0
58974,through,0,0
58975,the,0,0
58976,employment,0,0
58977,of,0,0
58978,dietetic,0,1
58979,assistants,0,1
58980,(,0,0
58981,DAs,0,1
58982,),0,0
58983,",",0,0
58984,will,0,0
58985,affect,0,0
58986,postoperative,0,0
58987,clinical,0,0
58988,outcome,0,0
58989,among,0,0
58990,elderly,1,1
58991,women,1,1
58992,with,1,1
58993,hip,1,1
58994,fracture,1,1
58995,.,1,0
58996,DESIGN,0,0
58997,Open,0,0
58998,prospective,0,0
58999,randomised,0,0
59000,controlled,0,0
59001,trial,0,0
59002,",",0,0
59003,comparing,0,0
59004,conventional,0,0
59005,nursing,0,1
59006,care,0,0
59007,with,0,0
59008,the,0,0
59009,additional,0,0
59010,nutritional,0,0
59011,support,0,0
59012,provided,0,0
59013,by,0,0
59014,DA,0,0
59015,.,0,1
59016,SETTING,0,0
59017,Thirty-eight,1,1
59018,bedded,1,1
59019,acute,1,1
59020,trauma,1,1
59021,ward,1,0
59022,in,1,0
59023,a,1,0
59024,teaching,1,0
59025,hospital,1,0
59026,.,1,0
59027,PARTICIPANTS,0,0
59028,All,1,0
59029,but,1,0
59030,11,1,0
59031,of,1,0
59032,344,1,1
59033,consecutive,1,1
59034,admissions,1,1
59035,with,1,1
59036,acute,1,1
59037,nonpathological,1,1
59038,hip,1,1
59039,fracture,1,0
59040,were,1,0
59041,approached,1,0
59042,.,1,0
59043,Three,1,0
59044,hundred,1,1
59045,and,1,0
59046,eighteen,1,1
59047,(,1,0
59048,93,1,1
59049,%,1,0
59050,),1,0
59051,agreed,1,0
59052,to,1,0
59053,inclusion,1,0
59054,.,1,0
59055,Sixteen,1,0
59056,were,1,0
59057,ineligible,1,1
59058,as,0,0
59059,they,0,0
59060,were,0,0
59061,immediately,0,0
59062,transferred,0,0
59063,to,0,0
59064,another,0,0
59065,acute,0,0
59066,ward,0,0
59067,",",0,0
59068,were,0,0
59069,managed,0,0
59070,conservatively,0,0
59071,or,0,0
59072,died,0,1
59073,preoperatively,0,0
59074,.,0,0
59075,PRIMARY,0,0
59076,OUTCOME,0,0
59077,MEASURE,0,0
59078,Postoperative,0,0
59079,mortality,0,0
59080,in,0,0
59081,the,0,0
59082,acute,0,1
59083,trauma,0,1
59084,unit,0,0
59085,.,0,0
59086,SECONDARY,0,0
59087,OUTCOME,0,0
59088,MEASURES,0,0
59089,Postoperative,0,0
59090,mortality,0,0
59091,at,0,0
59092,4,0,0
59093,months,0,0
59094,after,0,0
59095,fracture,0,0
59096,",",0,0
59097,length,0,0
59098,of,0,0
59099,stay,0,0
59100,",",0,0
59101,energy,0,0
59102,intake,0,0
59103,and,0,0
59104,nutritional,0,0
59105,status,0,0
59106,.,0,0
59107,RESULTS,0,0
59108,DA-supported,0,0
59109,participants,0,1
59110,were,0,0
59111,less,0,0
59112,likely,0,0
59113,to,0,0
59114,die,0,0
59115,in,0,0
59116,the,0,0
59117,acute,0,1
59118,ward,0,0
59119,(,0,0
59120,4.1,0,0
59121,versus,0,0
59122,10.1,0,0
59123,%,0,0
59124,",",0,0
59125,P,0,0
59126,=,0,0
59127,0.048,0,0
59128,),0,0
59129,.,0,0
59130,This,0,0
59131,effect,0,0
59132,was,0,0
59133,still,0,0
59134,apparent,0,0
59135,at,0,0
59136,4,0,0
59137,month,0,0
59138,follow-up,0,0
59139,(,0,0
59140,13.1,0,0
59141,versus,0,0
59142,22.9,0,0
59143,%,0,0
59144,",",0,0
59145,P,0,0
59146,=,0,0
59147,0.036,0,0
59148,),0,0
59149,.,0,0
59150,DA-supported,0,0
59151,subjects,0,1
59152,had,0,0
59153,significantly,0,0
59154,better,0,0
59155,mean,0,0
59156,daily,0,0
59157,energy,0,0
59158,intake,0,0
59159,(,0,0
59160,"1,105",0,1
59161,kcal,0,0
59162,versus,0,0
59163,756,0,1
59164,kcal/24,0,0
59165,h,0,0
59166,",",0,0
59167,95,0,0
59168,%,0,0
59169,CI,0,0
59170,259-440,0,0
59171,kcal/24,0,0
59172,h,0,0
59173,",",0,0
59174,P,0,0
59175,<,0,0
59176,0.001,0,0
59177,),0,0
59178,",",0,0
59179,significantly,0,0
59180,smaller,0,0
59181,reduction,0,0
59182,in,0,0
59183,mid-arm,0,0
59184,circumference,0,0
59185,during,0,0
59186,their,0,0
59187,inpatient,0,1
59188,stay,0,0
59189,(,0,0
59190,0.39,0,0
59191,cm,0,1
59192,",",0,0
59193,P,0,0
59194,=,0,0
59195,0.002,0,0
59196,),0,0
59197,and,0,0
59198,nonsignificantly,0,0
59199,favourable,0,0
59200,results,0,0
59201,for,0,0
59202,other,0,0
59203,anthropometric,0,0
59204,and,0,0
59205,laboratory,0,0
59206,measurements,0,0
59207,.,0,1
59208,CONCLUSION,0,0
59209,Dietetic,0,0
59210,or,0,0
59211,nutrition,0,1
59212,assistants,0,0
59213,are,0,0
59214,being,0,0
59215,introduced,0,0
59216,in,0,0
59217,units,0,0
59218,across,1,0
59219,the,1,0
59220,UK,1,1
59221,.,1,0
59222,This,0,0
59223,",",0,0
59224,the,0,0
59225,largest,0,0
59226,ever,0,0
59227,study,0,0
59228,of,0,0
59229,nutritional,0,0
59230,support,0,0
59231,after,0,0
59232,hip,0,0
59233,fracture,0,0
59234,",",0,0
59235,shows,0,0
59236,that,0,0
59237,their,0,0
59238,employment,0,0
59239,significantly,0,0
59240,reduced,0,0
59241,patients,0,1
59242,',0,0
59243,risk,0,0
59244,of,0,0
59245,dying,0,1
59246,in,0,0
59247,the,0,0
59248,acute,0,1
59249,trauma,0,1
59250,unit,0,0
59251,;,0,0
59252,an,0,0
59253,effect,0,0
59254,that,0,0
59255,persisted,0,0
59256,at,0,0
59257,4,0,0
59258,month,0,0
59259,follow-up,0,0
59260,.,0,0
59261,Pilot,0,0
59262,study,0,0
59263,of,0,0
59264,imiquimod,0,0
59265,5,0,0
59266,%,0,0
59267,cream,0,0
59268,as,0,0
59269,adjunctive,0,0
59270,therapy,0,0
59271,to,0,0
59272,curettage,0,0
59273,and,0,0
59274,electrodesiccation,0,0
59275,for,0,0
59276,nodular,1,1
59277,basal,1,0
59278,cell,1,1
59279,carcinoma,1,1
59280,.,1,0
59281,BACKGROUND,0,0
59282,Curettage,0,1
59283,and,0,0
59284,electrodesiccation,0,0
59285,(,0,0
59286,C,0,0
59287,&,0,1
59288,D,0,0
59289,),0,0
59290,is,0,0
59291,a,0,0
59292,widely,0,0
59293,used,0,0
59294,method,0,0
59295,to,0,0
59296,treat,0,0
59297,nodular,1,1
59298,basal,1,0
59299,cell,1,0
59300,carcinoma,1,1
59301,(,1,0
59302,BCC,1,0
59303,),1,0
59304,.,1,0
59305,However,0,0
59306,",",0,0
59307,residual,0,0
59308,tumor,0,0
59309,is,0,0
59310,present,0,0
59311,immediately,0,0
59312,after,0,0
59313,the,0,0
59314,procedure,0,0
59315,in,0,0
59316,approximately,0,0
59317,20,0,0
59318,to,0,0
59319,40,0,0
59320,%,0,0
59321,of,0,0
59322,cases,0,1
59323,.,0,1
59324,Imiquimod,0,0
59325,",",0,0
59326,a,0,0
59327,topical,0,0
59328,immune,0,0
59329,response,0,0
59330,modifier,0,0
59331,that,0,0
59332,targets,0,0
59333,Toll-like,0,0
59334,receptor,0,0
59335,7,0,0
59336,",",0,0
59337,is,0,0
59338,currently,0,0
59339,approved,0,0
59340,for,0,0
59341,superficial,0,0
59342,BCC,0,0
59343,.,0,0
59344,OBJECTIVE,0,0
59345,In,0,0
59346,a,0,0
59347,double-blind,0,0
59348,",",0,0
59349,vehicle-controlled,0,0
59350,study,0,0
59351,",",0,0
59352,the,0,0
59353,administration,0,0
59354,of,0,0
59355,imiquimod,0,0
59356,after,0,0
59357,C,0,0
59358,&,0,1
59359,D,0,0
59360,was,0,0
59361,investigated,0,0
59362,to,0,0
59363,determine,0,0
59364,if,0,0
59365,the,0,0
59366,combination,0,0
59367,regimen,0,0
59368,would,0,0
59369,reduce,0,0
59370,the,0,0
59371,frequency,0,0
59372,of,0,0
59373,residual,0,0
59374,tumor,0,0
59375,compared,0,0
59376,with,0,0
59377,C,0,0
59378,&,0,1
59379,D,0,0
59380,alone,0,0
59381,in,0,0
59382,patients,1,1
59383,with,1,1
59384,nodular,1,1
59385,BCC,1,0
59386,.,1,1
59387,METHODS,0,0
59388,Twenty,1,1
59389,patients,1,1
59390,received,0,0
59391,three,0,0
59392,cycles,0,0
59393,of,0,0
59394,C,0,0
59395,&,0,1
59396,D,0,0
59397,followed,0,0
59398,by,0,0
59399,imiquimod,0,0
59400,5,0,0
59401,%,0,0
59402,or,0,0
59403,vehicle,0,0
59404,cream,0,0
59405,once,0,0
59406,daily,0,0
59407,for,0,0
59408,1,0,0
59409,month,0,0
59410,as,0,0
59411,adjunctive,0,0
59412,therapy,0,0
59413,.,0,0
59414,The,0,0
59415,primary,0,0
59416,end,0,0
59417,point,0,0
59418,was,0,0
59419,the,0,0
59420,frequency,0,0
59421,of,0,0
59422,residual,0,0
59423,tumor,0,1
59424,.,0,0
59425,The,0,0
59426,secondary,0,0
59427,end,0,0
59428,points,0,0
59429,included,0,1
59430,the,0,0
59431,time,0,0
59432,to,0,0
59433,heal,0,0
59434,and,0,0
59435,cosmetic,0,0
59436,appearance,0,0
59437,.,0,0
59438,RESULTS,0,0
59439,Twenty,1,1
59440,patients,1,1
59441,were,0,0
59442,randomized,0,0
59443,to,0,0
59444,the,0,0
59445,imiquimod,1,0
59446,(,1,0
59447,n,1,1
59448,=,1,0
59449,10,1,1
59450,),1,0
59451,or,0,0
59452,vehicle,1,0
59453,(,1,0
59454,n,1,1
59455,=,1,0
59456,10,1,1
59457,),1,0
59458,treatment,0,0
59459,group,0,0
59460,.,0,0
59461,At,0,0
59462,8,0,0
59463,weeks,0,0
59464,",",0,0
59465,the,0,0
59466,proportion,0,0
59467,of,0,0
59468,patients,0,1
59469,with,0,1
59470,residual,0,1
59471,tumor,0,0
59472,was,0,0
59473,substantially,0,0
59474,decreased,0,0
59475,with,0,0
59476,imiquimod,0,0
59477,therapy,0,0
59478,(,0,0
59479,10,0,0
59480,%,0,0
59481,),0,0
59482,compared,0,0
59483,with,0,0
59484,vehicle,0,0
59485,(,0,0
59486,40,0,0
59487,%,0,0
59488,),0,0
59489,.,0,0
59490,Wounds,0,0
59491,in,0,0
59492,the,0,0
59493,vehicle,0,0
59494,group,0,0
59495,healed,0,0
59496,more,0,0
59497,quickly,0,0
59498,than,0,0
59499,those,0,0
59500,in,0,0
59501,the,0,0
59502,imiquimod,0,0
59503,group,0,0
59504,",",0,0
59505,although,0,0
59506,by,0,0
59507,8,0,0
59508,weeks,0,0
59509,",",0,0
59510,all,0,0
59511,excision,0,0
59512,sites,0,0
59513,were,0,0
59514,healed,0,0
59515,.,0,0
59516,The,0,0
59517,majority,0,0
59518,of,0,0
59519,scars,0,0
59520,in,0,0
59521,the,0,0
59522,control,0,0
59523,group,0,0
59524,were,0,0
59525,atrophic,0,1
59526,and,0,0
59527,hypopigmented,0,0
59528,",",0,0
59529,whereas,0,0
59530,most,0,0
59531,scars,0,0
59532,in,0,0
59533,the,0,0
59534,imiquimod,0,0
59535,group,0,0
59536,were,0,0
59537,flat,0,0
59538,and,0,0
59539,slightly,0,0
59540,pink,0,0
59541,.,0,0
59542,CONCLUSION,0,0
59543,Imiquimod,0,0
59544,5,0,0
59545,%,0,0
59546,cream,0,0
59547,once,0,0
59548,daily,0,0
59549,for,0,0
59550,1,0,0
59551,month,0,0
59552,as,0,0
59553,adjunctive,0,0
59554,therapy,0,0
59555,after,0,0
59556,C,0,0
59557,&,0,1
59558,D,0,0
59559,substantially,0,0
59560,reduced,0,0
59561,the,0,0
59562,frequency,0,0
59563,of,0,0
59564,residual,0,0
59565,tumor,0,1
59566,and,0,0
59567,improved,0,0
59568,the,0,0
59569,cosmetic,0,0
59570,appearance,0,0
59571,compared,0,0
59572,with,0,0
59573,C,0,0
59574,&,0,1
59575,D,0,0
59576,alone,0,0
59577,.,0,0
59578,These,0,0
59579,preliminary,0,0
59580,results,0,0
59581,suggest,0,0
59582,that,0,0
59583,further,0,0
59584,studies,0,0
59585,to,0,0
59586,investigate,0,0
59587,imiquimod,0,0
59588,adjunctive,0,0
59589,therapy,0,0
59590,are,0,0
59591,warranted,0,0
59592,.,0,0
59593,Similar,0,0
59594,compliance,0,0
59595,and,0,0
59596,effect,0,0
59597,of,0,0
59598,treatment,0,0
59599,in,0,0
59600,chronic,1,1
59601,hepatitis,1,1
59602,C,1,0
59603,resulting,1,0
59604,from,1,0
59605,intravenous,1,0
59606,drug,1,0
59607,use,1,0
59608,in,0,0
59609,comparison,0,0
59610,with,0,1
59611,other,0,0
59612,infection,0,1
59613,causes,0,0
59614,.,0,0
59615,OBJECTIVES,0,0
59616,There,0,0
59617,is,0,0
59618,some,0,0
59619,reluctance,0,0
59620,to,0,0
59621,treat,0,0
59622,intravenous,1,0
59623,drug,1,0
59624,users,1,1
59625,(,1,0
59626,IVDUs,1,0
59627,),1,0
59628,with,1,1
59629,chronic,1,1
59630,hepatitis,1,1
59631,C,1,0
59632,(,1,0
59633,CHC,1,0
59634,),1,0
59635,because,0,0
59636,of,0,0
59637,presumed,0,1
59638,lower,0,0
59639,compliance,0,0
59640,and,0,0
59641,response,0,0
59642,to,0,0
59643,antiviral,0,0
59644,therapy,0,0
59645,.,0,0
59646,We,0,0
59647,intended,0,0
59648,to,0,0
59649,evaluate,0,0
59650,the,0,0
59651,compliance,0,0
59652,and,0,0
59653,response,0,0
59654,to,0,0
59655,antiviral,0,0
59656,treatment,0,0
59657,for,0,0
59658,CHC,0,0
59659,in,0,0
59660,IVDUs,0,0
59661,compared,0,0
59662,with,0,1
59663,non-IVDUs,0,0
59664,.,0,0
59665,METHODS,0,0
59666,A,0,0
59667,retrospective,0,0
59668,cohort,0,1
59669,study,0,0
59670,--,0,0
59671,secondary,0,0
59672,analysis,0,0
59673,of,0,0
59674,the,0,0
59675,results,0,0
59676,of,0,0
59677,a,0,0
59678,treatment,1,0
59679,trial,1,0
59680,--,1,0
59681,was,1,0
59682,performed,1,0
59683,in,1,0
59684,Belgium,1,1
59685,and,1,0
59686,The,1,0
59687,Netherlands,1,0
59688,.,1,0
59689,A,1,0
59690,total,1,1
59691,of,1,0
59692,406,1,1
59693,previously,1,1
59694,untreated,1,1
59695,CHC,1,0
59696,patients,1,1
59697,",",1,0
59698,including,1,0
59699,98,1,1
59700,(,1,0
59701,24,1,0
59702,%,1,0
59703,),1,0
59704,IVDUs,1,0
59705,",",0,0
59706,were,0,0
59707,studied,0,0
59708,for,0,0
59709,compliance,0,0
59710,(,0,0
59711,presentation,0,0
59712,at,0,0
59713,the,0,0
59714,end,0,0
59715,of,0,0
59716,treatment,0,0
59717,),0,0
59718,",",0,0
59719,complete,0,0
59720,response,0,0
59721,(,0,0
59722,alanine,0,0
59723,aminotransferase,0,0
59724,within,0,0
59725,normal,0,1
59726,limits,0,0
59727,and,0,0
59728,serum,0,0
59729,hepatitis,0,1
59730,C,0,0
59731,virus,0,1
59732,polymerase,0,0
59733,chain,0,0
59734,reaction,0,0
59735,negative,0,0
59736,),0,0
59737,at,0,0
59738,the,0,0
59739,end,0,0
59740,of,0,0
59741,therapy,0,0
59742,and,0,0
59743,sustained,0,0
59744,virological,0,0
59745,response,0,0
59746,(,0,0
59747,SVR,0,0
59748,),0,0
59749,.,0,0
59750,RESULTS,0,0
59751,Non-compliance,0,0
59752,(,0,0
59753,8.2,0,0
59754,%,0,0
59755,),0,0
59756,in,0,0
59757,IVDUs,0,0
59758,was,0,0
59759,not,0,0
59760,different,0,0
59761,from,0,0
59762,non-IVDUs,0,0
59763,(,0,0
59764,6.8,0,0
59765,%,0,0
59766,),0,0
59767,(,0,0
59768,relative,0,0
59769,risk=1.20,0,0
59770,;,0,0
59771,95,0,0
59772,%,0,0
59773,confidence,0,0
59774,interval=0.55-2.62,0,0
59775,),0,0
59776,.,0,0
59777,Complete,0,0
59778,response,0,0
59779,after,0,0
59780,controlling,0,0
59781,for,0,0
59782,hepatitis,0,1
59783,C,0,0
59784,virus,0,1
59785,was,0,0
59786,similar,0,0
59787,(,0,0
59788,relative,0,0
59789,risk=1.19,0,0
59790,;,0,0
59791,95,0,0
59792,%,0,0
59793,confidence,0,0
59794,interval=0.89-1.60,0,0
59795,),0,0
59796,.,0,0
59797,Controlling,0,0
59798,for,0,0
59799,treatment,0,0
59800,arm,0,0
59801,",",0,0
59802,age,0,1
59803,",",0,0
59804,sex,0,0
59805,",",0,0
59806,presence,0,0
59807,of,0,0
59808,cirrhosis,0,1
59809,or,0,0
59810,hepatitis,0,1
59811,C,0,0
59812,virus,0,1
59813,viral,0,0
59814,load,0,0
59815,before,0,0
59816,treatment,0,0
59817,did,0,0
59818,not,0,0
59819,change,0,0
59820,these,0,0
59821,results,0,0
59822,.,0,0
59823,There,0,0
59824,was,0,0
59825,a,0,0
59826,marginally,0,0
59827,significant,0,0
59828,difference,0,0
59829,in,0,0
59830,the,0,0
59831,sustained,0,0
59832,virological,0,0
59833,response,0,0
59834,between,0,0
59835,IVDUs,0,0
59836,(,0,0
59837,46.6,0,0
59838,%,0,0
59839,),0,0
59840,and,0,0
59841,non-IVDUs,0,0
59842,(,0,0
59843,34.6,0,0
59844,%,0,0
59845,),0,0
59846,(,0,0
59847,relative,0,0
59848,risk=1.35,0,0
59849,;,0,0
59850,95,0,0
59851,%,0,0
59852,confidence,0,0
59853,interval=1.00-1.81,0,0
59854,),0,0
59855,",",0,0
59856,also,0,0
59857,disappearing,0,0
59858,after,0,0
59859,adjusting,0,0
59860,for,0,0
59861,genotype,0,0
59862,.,0,0
59863,No,0,0
59864,difference,0,0
59865,in,0,0
59866,compliance,0,0
59867,or,0,0
59868,sustained,0,0
59869,virological,0,0
59870,response,0,0
59871,was,0,0
59872,found,0,0
59873,between,0,0
59874,active,0,0
59875,and,0,0
59876,non-active,0,1
59877,IVDUs,0,0
59878,or,0,0
59879,between,0,0
59880,IVDU,0,0
59881,patients,0,1
59882,in,0,0
59883,or,0,0
59884,without,0,0
59885,a,0,0
59886,methadone,0,0
59887,maintenance,0,0
59888,program,0,0
59889,.,0,0
59890,CONCLUSIONS,0,0
59891,In,0,0
59892,this,0,0
59893,group,0,0
59894,of,0,0
59895,Benelux,1,0
59896,patients,1,1
59897,",",0,0
59898,IVDUs,0,0
59899,showed,0,0
59900,similar,0,0
59901,compliance,0,0
59902,and,0,0
59903,response,0,0
59904,to,0,0
59905,treatment,0,0
59906,with,0,0
59907,interferon,0,0
59908,and,0,0
59909,ribavirin,0,0
59910,compared,0,0
59911,with,0,1
59912,other,0,0
59913,patients,0,1
59914,with,0,1
59915,CHC,0,0
59916,infection,0,1
59917,.,0,0
59918,Therefore,0,0
59919,",",0,0
59920,it,0,0
59921,is,0,0
59922,no,0,0
59923,longer,0,0
59924,justifiable,0,0
59925,to,0,0
59926,withhold,0,0
59927,treatment,0,0
59928,to,0,0
59929,chronic,1,1
59930,hepatitis,1,1
59931,C,1,1
59932,patients,1,1
59933,who,1,1
59934,use,1,1
59935,intravenous,1,1
59936,drugs,1,0
59937,.,1,1
59938,Does,0,0
59939,a,0,0
59940,first,0,0
59941,trimester,0,1
59942,dating,0,0
59943,scan,0,0
59944,using,0,0
59945,crown,0,0
59946,rump,0,0
59947,length,0,0
59948,measurement,0,0
59949,reduce,0,0
59950,the,0,0
59951,rate,0,0
59952,of,0,0
59953,induction,0,0
59954,of,0,0
59955,labour,0,0
59956,for,0,0
59957,prolonged,0,0
59958,pregnancy,0,1
59959,?,0,0
59960,An,0,0
59961,uncompleted,0,0
59962,randomised,0,0
59963,controlled,0,0
59964,trial,0,0
59965,of,0,0
59966,463,1,1
59967,women,1,1
59968,.,1,1
59969,OBJECTIVE,0,0
59970,To,0,0
59971,evaluate,0,0
59972,the,0,0
59973,effect,0,0
59974,of,0,0
59975,a,0,0
59976,first,0,0
59977,trimester,0,1
59978,ultrasound,0,0
59979,dating,0,0
59980,scan,0,0
59981,on,0,0
59982,the,0,0
59983,rate,0,0
59984,of,0,0
59985,induction,0,0
59986,of,0,0
59987,labour,0,0
59988,for,0,0
59989,prolonged,0,0
59990,pregnancy,0,1
59991,.,0,0
59992,DESIGN,0,0
59993,Randomised,0,0
59994,controlled,0,0
59995,trial,0,0
59996,to,0,0
59997,include,0,0
59998,400,1,0
59999,women,1,1
60000,in,1,0
60001,each,1,0
60002,arm,1,0
60003,of,1,0
60004,the,1,0
60005,trial,1,0
60006,.,1,0
60007,SETTING,0,0
60008,Participating,1,1
60009,general,1,1
60010,practices,1,0
60011,and,1,0
60012,a,1,0
60013,district,1,1
60014,general,1,0
60015,teaching,1,0
60016,hospital,1,1
60017,.,1,0
60018,POPULATION,0,0
60019,Women,1,1
60020,attending,1,1
60021,their,1,0
60022,general,1,1
60023,practitioner,1,1
60024,in,1,0
60025,the,1,0
60026,first,1,0
60027,trimester,1,1
60028,to,1,0
60029,confirm,1,0
60030,pregnancy,1,0
60031,",",1,0
60032,in,1,0
60033,whom,1,1
60034,a,1,1
60035,first,1,1
60036,trimester,1,1
60037,ultrasound,1,0
60038,scan,1,0
60039,was,1,0
60040,not,1,0
60041,indicated,1,0
60042,.,1,0
60043,METHODS,0,0
60044,Women,0,1
60045,randomised,0,0
60046,to,0,0
60047,the,0,0
60048,study,0,0
60049,group,0,0
60050,(,0,0
60051,scan,0,0
60052,group,0,0
60053,),0,0
60054,underwent,0,1
60055,an,0,0
60056,ultrasound,0,0
60057,dating,0,0
60058,scan,0,0
60059,between,0,0
60060,8,0,0
60061,and,0,0
60062,12,0,0
60063,weeks,0,0
60064,",",0,0
60065,measuring,0,0
60066,crown-rump,0,1
60067,length,0,0
60068,.,0,0
60069,The,0,0
60070,estimated,0,0
60071,date,0,0
60072,of,0,0
60073,delivery,0,0
60074,(,0,0
60075,EDD,0,1
60076,),0,0
60077,was,0,0
60078,changed,0,0
60079,if,0,0
60080,there,0,0
60081,was,0,0
60082,a,0,0
60083,discrepancy,0,0
60084,of,0,0
60085,more,0,0
60086,than,0,0
60087,5,0,0
60088,days,0,0
60089,from,0,0
60090,the,0,0
60091,gestation,0,0
60092,",",0,0
60093,calculated,0,0
60094,from,0,0
60095,the,0,0
60096,last,0,0
60097,menstrual,0,1
60098,period,0,0
60099,(,0,0
60100,LMP,0,0
60101,),0,0
60102,.,0,0
60103,For,0,0
60104,the,0,0
60105,remaining,0,0
60106,women,0,1
60107,(,0,0
60108,no-scan,0,0
60109,group,0,0
60110,),0,0
60111,",",0,0
60112,gestation,0,0
60113,was,0,0
60114,determined,0,0
60115,using,0,0
60116,the,0,0
60117,LMP,0,0
60118,.,0,0
60119,MAIN,0,0
60120,OUTCOME,0,0
60121,MEASURES,0,0
60122,The,0,0
60123,rate,0,0
60124,of,0,0
60125,induction,0,0
60126,of,0,0
60127,labour,0,0
60128,for,0,0
60129,prolonged,0,0
60130,pregnancy,0,1
60131,.,0,0
60132,RESULTS,0,0
60133,Due,0,0
60134,to,0,0
60135,circumstances,0,0
60136,beyond,0,0
60137,the,0,0
60138,researchers,0,0
60139,',0,0
60140,control,0,0
60141,",",0,0
60142,recruitment,0,0
60143,was,0,0
60144,abandoned,0,0
60145,when,0,0
60146,463,1,1
60147,women,1,1
60148,had,1,1
60149,been,1,0
60150,enrolled,1,1
60151,.,1,0
60152,The,0,0
60153,EDD,0,1
60154,was,0,0
60155,adjusted,0,0
60156,in,0,0
60157,13,0,0
60158,(,0,0
60159,5.7,0,0
60160,%,0,0
60161,),0,0
60162,women,0,1
60163,in,0,0
60164,the,0,0
60165,scan,0,0
60166,group,0,0
60167,and,0,0
60168,in,0,0
60169,2,0,0
60170,(,0,0
60171,0.9,0,0
60172,%,0,0
60173,),0,0
60174,in,0,0
60175,the,0,0
60176,no-scan,0,0
60177,group,0,0
60178,.,0,0
60179,There,0,0
60180,was,0,0
60181,no,0,0
60182,difference,0,0
60183,in,0,0
60184,the,0,0
60185,rate,0,0
60186,of,0,0
60187,induction,0,0
60188,for,0,0
60189,prolonged,0,0
60190,pregnancy,0,1
60191,between,0,0
60192,the,0,0
60193,scan,0,0
60194,(,0,0
60195,19,0,1
60196,[,0,0
60197,8.2,0,0
60198,%,0,0
60199,],0,0
60200,),0,0
60201,and,0,0
60202,the,0,0
60203,no-scan,0,0
60204,(,0,0
60205,17,0,0
60206,[,0,0
60207,7.4,0,0
60208,%,0,0
60209,],0,1
60210,),0,0
60211,groups,0,0
60212,(,0,0
60213,relative,0,0
60214,risk,0,0
60215,1.10,0,0
60216,;,0,0
60217,95,0,0
60218,%,0,0
60219,CI,0,0
60220,0.59-2.07,0,0
60221,),0,0
60222,.,0,0
60223,CONCLUSIONS,0,0
60224,Acknowledging,0,0
60225,the,0,0
60226,reduced,0,0
60227,numbers,0,0
60228,recruited,0,1
60229,for,0,0
60230,study,0,0
60231,",",0,0
60232,it,0,0
60233,is,0,0
60234,concluded,0,0
60235,that,0,0
60236,there,0,0
60237,is,0,0
60238,no,0,0
60239,evidence,0,0
60240,that,0,0
60241,a,0,0
60242,first,0,0
60243,trimester,0,1
60244,ultrasound,0,0
60245,dating,0,0
60246,scan,0,0
60247,reduces,0,0
60248,the,0,0
60249,rate,0,0
60250,of,0,0
60251,induction,0,0
60252,of,0,0
60253,labour,0,0
60254,for,0,0
60255,prolonged,0,0
60256,pregnancy,0,1
60257,and,0,0
60258,may,0,0
60259,result,0,0
60260,in,0,0
60261,a,0,0
60262,more,0,0
60263,expensive,0,0
60264,healthcare,0,0
60265,strategy,0,0
60266,.,0,0
60267,[,0,0
60268,Comparison,0,0
60269,of,0,0
60270,the,0,0
60271,efficacy/tolerability,0,0
60272,ratio,0,0
60273,of,0,0
60274,cibenzoline,0,0
60275,and,0,0
60276,propafenone,0,0
60277,in,0,0
60278,the,0,0
60279,treatment,0,0
60280,of,0,0
60281,ventricular,1,0
60282,arrhythmia,1,1
60283,],1,0
60284,.,0,0
60285,Cibenzoline,0,0
60286,(,0,0
60287,C,0,0
60288,),0,0
60289,was,0,0
60290,compared,0,0
60291,with,0,0
60292,propafenone,0,0
60293,(,0,0
60294,P,0,0
60295,),0,0
60296,in,0,0
60297,18,1,1
60298,adult,1,1
60299,patients,1,1
60300,(,1,0
60301,7,1,0
60302,women,1,1
60303,and,1,0
60304,11,1,1
60305,men,1,1
60306,),1,0
60307,aged,1,1
60308,50,1,0
60309,+/-,1,0
60310,7,1,0
60311,in,0,0
60312,double-blind,0,0
60313,",",0,0
60314,placebo-controlled,0,0
60315,crossover,0,0
60316,trial,0,0
60317,.,0,0
60318,After,0,0
60319,a,0,0
60320,therapeutic,0,0
60321,wash-out,0,0
60322,period,0,0
60323,corresponding,0,0
60324,to,0,0
60325,5,0,0
60326,times,0,0
60327,the,0,0
60328,half-life,0,0
60329,of,0,0
60330,previous,0,0
60331,anti-arrhythmic,0,0
60332,drugs,0,0
60333,",",0,0
60334,patients,1,1
60335,with,1,1
60336,more,1,0
60337,than,1,0
60338,100,1,0
60339,premature,1,1
60340,ventricular,1,1
60341,contractions,1,0
60342,(,1,0
60343,PVC,1,1
60344,),1,0
60345,per,1,0
60346,hour,1,0
60347,in,1,0
60348,two,1,0
60349,24,1,0
60350,hour,1,0
60351,Holter,1,1
60352,records,1,0
60353,obtained,1,0
60354,at,1,0
60355,an,1,0
60356,interval,1,0
60357,of,1,0
60358,7,1,0
60359,days,1,0
60360,were,0,0
60361,treated,0,1
60362,in,0,0
60363,succession,0,0
60364,and,0,0
60365,after,0,0
60366,randomised,0,0
60367,by,0,0
60368,C,0,0
60369,(,0,0
60370,390,0,1
60371,mg/day,0,0
60372,in,0,0
60373,3,0,0
60374,divided,0,1
60375,doses,0,0
60376,),0,0
60377,and,0,0
60378,P,0,0
60379,(,0,0
60380,900,0,0
60381,mg/day,0,0
60382,in,0,0
60383,3,0,0
60384,divided,0,1
60385,doses,0,0
60386,),0,0
60387,for,0,0
60388,a,0,0
60389,period,0,0
60390,of,0,0
60391,two,0,0
60392,weeks,0,0
60393,",",0,0
60394,each,0,0
60395,active,0,0
60396,sequence,0,0
60397,being,0,0
60398,followed,0,0
60399,by,0,0
60400,a,0,0
60401,two,0,0
60402,week,0,0
60403,wash-out,0,0
60404,period,0,0
60405,.,0,0
60406,Efficacy,0,0
60407,(,0,0
60408,based,0,0
60409,upon,0,0
60410,the,0,0
60411,decrease,0,0
60412,in,0,0
60413,PVC/hour,0,0
60414,in,0,0
60415,a,0,0
60416,24,0,0
60417,hour,0,0
60418,Holter,0,0
60419,),0,0
60420,and,0,0
60421,tolerability,0,0
60422,were,0,0
60423,evaluated,0,0
60424,at,0,0
60425,the,0,0
60426,end,0,0
60427,of,0,0
60428,each,0,0
60429,sequence,0,0
60430,",",0,0
60431,with,0,1
60432,samples,0,0
60433,drawn,0,0
60434,at,0,0
60435,the,0,0
60436,same,0,0
60437,times,0,0
60438,for,0,0
60439,assay,0,0
60440,of,0,0
60441,the,0,0
60442,study,0,0
60443,drugs,0,0
60444,.,0,1
60445,Three,0,1
60446,patients,0,1
60447,dropped,0,0
60448,out,0,0
60449,of,0,0
60450,the,0,0
60451,trial,0,0
60452,",",0,0
60453,1,0,0
60454,with,0,0
60455,each,0,0
60456,active,0,0
60457,drug,0,0
60458,(,0,0
60459,for,0,0
60460,epigastric,0,1
60461,pain,0,0
60462,),0,0
60463,and,0,0
60464,1,0,0
60465,with,0,1
60466,dummy,0,1
60467,.,0,0
60468,No,0,0
60469,significant,0,0
60470,difference,0,0
60471,was,0,0
60472,seen,0,0
60473,between,0,0
60474,the,0,0
60475,two,0,0
60476,drugs,0,0
60477,regarding,0,0
60478,the,0,0
60479,decrease,0,0
60480,in,0,0
60481,the,0,0
60482,total,0,0
60483,number,0,0
60484,of,0,0
60485,PVC/hour,0,0
60486,in,0,0
60487,the,0,0
60488,15,0,0
60489,patients,0,1
60490,completing,0,0
60491,the,0,0
60492,cross-over,0,0
60493,protocol,0,0
60494,.,0,0
60495,A,0,0
60496,reduction,0,0
60497,in,0,0
60498,PVC/hour,0,0
60499,of,0,0
60500,more,0,0
60501,than,0,0
60502,70,0,1
60503,per,0,0
60504,cent,0,0
60505,was,0,0
60506,seen,0,0
60507,in,0,0
60508,7,0,0
60509,patients,0,1
60510,with,0,1
60511,C,0,0
60512,and,0,0
60513,in,0,0
60514,9,0,0
60515,patients,0,1
60516,with,0,1
60517,P.,0,1
60518,C,0,0
60519,was,0,0
60520,better,0,0
60521,tolerated,0,0
60522,than,0,0
60523,P,0,0
60524,on,0,0
60525,the,0,0
60526,basis,0,0
60527,of,0,0
60528,both,0,0
60529,clinical,0,0
60530,and,0,0
60531,electrocardiographic,0,1
60532,parameters,0,0
60533,.,0,1
60534,One,0,1
60535,patient,0,0
60536,developed,0,0
60537,troublesome,0,0
60538,adverse,0,0
60539,reactions,0,0
60540,with,0,1
60541,C,0,0
60542,as,0,0
60543,compared,0,0
60544,with,0,1
60545,4,0,0
60546,patients,0,1
60547,in,0,0
60548,the,0,0
60549,case,0,0
60550,of,0,0
60551,P.,0,0
60552,A,0,0
60553,more,0,0
60554,than,0,0
60555,20,0,0
60556,per,0,0
60557,cent,0,0
60558,increase,0,0
60559,in,0,0
60560,QRS,0,0
60561,was,0,0
60562,seen,0,0
60563,in,0,0
60564,7,0,0
60565,patients,0,1
60566,with,0,1
60567,C,0,0
60568,and,0,0
60569,in,0,0
60570,10,0,0
60571,patients,0,1
60572,with,0,1
60573,P,0,0
60574,",",0,0
60575,the,0,0
60576,figures,0,0
60577,for,0,0
60578,PR,0,0
60579,being,0,0
60580,2,0,0
60581,and,0,0
60582,6,0,0
60583,patients,0,1
60584,respectively,0,0
60585,.,0,0
60586,One,0,0
60587,patient,0,0
60588,showed,0,0
60589,a,0,0
60590,proarrhythmic,0,0
60591,effect,0,0
60592,with,0,1
60593,P.,0,1
60594,Plasma,0,0
60595,levels,0,0
60596,of,0,0
60597,C,0,0
60598,were,0,0
60599,significantly,0,0
60600,higher,0,0
60601,in,0,0
60602,responders,0,0
60603,(,0,0
60604,328,0,1
60605,+/-,0,0
60606,149,0,1
60607,ng/ml,0,0
60608,),0,0
60609,than,0,0
60610,in,0,0
60611,non-responders,0,0
60612,(,0,0
60613,137,0,1
60614,+/-,0,0
60615,41,0,1
60616,ng/ml,0,0
60617,",",0,0
60618,p,0,0
60619,less,0,0
60620,than,0,0
60621,0.05,0,0
60622,),0,0
60623,.,0,0
60624,No,0,0
60625,significant,0,0
60626,difference,0,0
60627,was,0,0
60628,found,0,0
60629,concerning,0,0
60630,plasma,0,0
60631,levels,0,0
60632,of,0,0
60633,P,0,0
60634,(,0,0
60635,578,0,1
60636,+/-,0,0
60637,477,0,1
60638,ng/ml,0,0
60639,compared,0,0
60640,with,0,1
60641,646,0,1
60642,+/-,0,0
60643,457,0,1
60644,ng/ml,0,0
60645,",",0,0
60646,p,0,0
60647,greater,0,0
60648,than,0,0
60649,0.05,0,0
60650,),0,0
60651,.,0,0
60652,In,0,0
60653,conclusion,0,0
60654,",",0,0
60655,the,0,0
60656,efficacy/tolerability,0,0
60657,ratio,0,0
60658,in,0,0
60659,this,0,0
60660,population,1,0
60661,with,1,0
60662,a,1,0
60663,low,1,0
60664,risk,1,0
60665,of,1,0
60666,serious,1,0
60667,rhythm,1,1
60668,events,1,0
60669,appeared,0,0
60670,to,0,0
60671,be,0,0
60672,better,0,0
60673,with,0,0
60674,C,0,0
60675,than,0,0
60676,with,0,1
60677,P,0,0
60678,.,0,1
60679,Effects,0,0
60680,of,0,0
60681,cooking,0,0
60682,plant,0,0
60683,oils,0,0
60684,on,0,0
60685,recurrent,0,1
60686,aphthous,0,1
60687,stomatitis,0,0
60688,:,0,1
60689,a,0,0
60690,randomized,0,0
60691,",",0,0
60692,placebo-controlled,0,0
60693,",",0,0
60694,double-blind,0,0
60695,trial,0,0
60696,.,0,0
60697,OBJECTIVE,0,0
60698,One-third,0,0
60699,of,0,0
60700,the,0,0
60701,total,0,0
60702,population,0,0
60703,seems,0,0
60704,to,0,0
60705,develop,0,0
60706,minor,0,0
60707,recurrent,1,1
60708,aphthous,1,1
60709,stomatitis,1,0
60710,(,1,0
60711,RAS,1,0
60712,),1,0
60713,during,0,0
60714,their,0,0
60715,lifetime,0,0
60716,.,0,0
60717,However,0,0
60718,",",0,0
60719,well-controlled,0,0
60720,dietary,0,0
60721,intervention,0,0
60722,studies,0,0
60723,to,0,0
60724,prevent,0,0
60725,minor,0,0
60726,RAS,0,0
60727,are,0,0
60728,very,0,0
60729,rare,0,0
60730,.,0,0
60731,The,0,0
60732,objective,0,0
60733,of,0,0
60734,the,0,0
60735,present,0,0
60736,study,0,0
60737,was,0,0
60738,to,0,0
60739,investigate,0,0
60740,whether,0,0
60741,the,0,0
60742,prevalence,0,0
60743,of,0,0
60744,RAS,0,0
60745,decreased,0,0
60746,with,0,0
60747,perilla,0,0
60748,oil,0,0
60749,(,0,0
60750,rich,0,0
60751,in,0,0
60752,alpha-linolenic,0,0
60753,acid,0,0
60754,),0,0
60755,.,0,0
60756,METHODS,0,0
60757,Thirty,1,1
60758,subjects,1,1
60759,(,1,0
60760,8,1,0
60761,men,1,1
60762,and,1,0
60763,22,1,1
60764,women,1,1
60765,),1,1
60766,who,1,1
60767,had,1,1
60768,minor,1,1
60769,RAS,1,0
60770,at,1,0
60771,least,1,0
60772,once,1,0
60773,a,1,0
60774,month,1,0
60775,were,0,0
60776,randomly,0,0
60777,allocated,0,0
60778,to,0,0
60779,a,0,0
60780,soybean,0,0
60781,oil,0,0
60782,group,0,0
60783,or,0,0
60784,a,0,0
60785,perilla,0,0
60786,oil,0,0
60787,group,0,0
60788,in,0,0
60789,a,0,0
60790,double-blind,0,0
60791,manner,0,0
60792,(,0,0
60793,experimental,0,0
60794,phase,0,0
60795,),0,0
60796,after,0,0
60797,a,0,0
60798,run-in,0,0
60799,phase,0,0
60800,of,0,0
60801,4,0,0
60802,mo,0,1
60803,during,0,0
60804,which,0,0
60805,subjects,0,1
60806,used,0,0
60807,a,0,0
60808,reference,0,0
60809,oil,0,0
60810,",",0,0
60811,the,0,0
60812,most,0,0
60813,popular,0,0
60814,cooking,0,0
60815,oil,0,0
60816,in,0,0
60817,Japan,0,1
60818,",",0,0
60819,or,0,0
60820,a,0,0
60821,50/50,0,0
60822,mixture,0,0
60823,of,0,0
60824,soybean,0,0
60825,oil,0,0
60826,and,0,0
60827,rapeseed,0,0
60828,oil,0,0
60829,.,0,0
60830,During,0,0
60831,the,0,0
60832,experimental,0,0
60833,phase,0,0
60834,",",0,0
60835,subjects,0,1
60836,were,0,0
60837,asked,0,0
60838,to,0,0
60839,use,0,0
60840,soybean,0,0
60841,oil,0,0
60842,or,0,0
60843,perilla,0,0
60844,oil,0,0
60845,as,0,0
60846,the,0,0
60847,sole,0,0
60848,cooking,0,0
60849,oil,0,0
60850,for,0,0
60851,8,0,0
60852,mo,0,1
60853,.,0,0
60854,Blood,0,0
60855,samples,0,0
60856,were,0,0
60857,collected,0,0
60858,at,0,0
60859,the,0,0
60860,start,0,0
60861,and,0,0
60862,end,0,0
60863,of,0,0
60864,the,0,0
60865,experimental,0,0
60866,phase,0,0
60867,for,0,0
60868,fatty,0,0
60869,acid,0,0
60870,analysis,0,0
60871,of,0,0
60872,total,0,1
60873,plasma,0,0
60874,phospholipid,0,0
60875,fraction,0,0
60876,.,0,0
60877,Occurrence,0,0
60878,and,0,0
60879,needed,0,0
60880,days,0,0
60881,for,0,0
60882,healing,0,0
60883,of,0,0
60884,minor,0,0
60885,RAS,0,0
60886,were,0,0
60887,recorded,0,0
60888,during,0,0
60889,the,0,0
60890,two,0,0
60891,phases,0,0
60892,and,0,0
60893,compared,0,0
60894,.,0,0
60895,RESULTS,0,0
60896,alpha-Linolenic,0,0
60897,acid,0,0
60898,concentrations,0,0
60899,in,0,0
60900,the,0,0
60901,plasma,0,0
60902,phospholipid,0,0
60903,fraction,0,0
60904,increased,0,0
60905,significantly,0,0
60906,in,0,0
60907,both,0,0
60908,groups,0,0
60909,during,0,0
60910,the,0,0
60911,experimental,0,0
60912,phase,0,0
60913,to,0,0
60914,a,0,0
60915,similar,0,0
60916,extent,0,0
60917,.,0,0
60918,The,0,0
60919,prevalence,0,0
60920,of,0,0
60921,minor,0,0
60922,RAS,0,0
60923,in,0,0
60924,the,0,0
60925,experimental,0,0
60926,phase,0,0
60927,decreased,0,0
60928,significantly,0,0
60929,in,0,0
60930,both,0,0
60931,groups,0,0
60932,compared,0,0
60933,with,0,1
60934,the,0,0
60935,run-in,0,0
60936,phase,0,0
60937,to,0,0
60938,a,0,0
60939,similar,0,0
60940,extent,0,0
60941,",",0,0
60942,without,0,0
60943,intergroup,0,0
60944,differences,0,0
60945,.,0,1
60946,CONCLUSION,0,0
60947,Perilla,0,0
60948,oil,0,0
60949,",",0,0
60950,which,0,0
60951,is,0,0
60952,rich,0,0
60953,in,0,0
60954,alpha-linolenic,0,0
60955,acid,0,0
60956,",",0,0
60957,was,0,0
60958,not,0,0
60959,superior,0,0
60960,to,0,0
60961,soybean,0,0
60962,oil,0,0
60963,in,0,0
60964,preventing,0,0
60965,minor,0,0
60966,RAS,0,0
60967,.,0,0
60968,There,0,0
60969,was,0,0
60970,a,0,0
60971,possibility,0,0
60972,that,0,0
60973,avoiding,0,0
60974,rapeseed,0,0
60975,oil,0,0
60976,might,0,0
60977,be,0,0
60978,beneficial,0,0
60979,for,0,0
60980,prevention,0,0
60981,of,0,0
60982,minor,0,0
60983,RAS,0,1
60984,.,0,1
60985,Evaluating,0,0
60986,erectile,1,1
60987,dysfunction,1,1
60988,:,1,1
60989,oral,0,0
60990,sildenafil,0,0
60991,versus,0,0
60992,intracavernosal,0,0
60993,injection,0,0
60994,of,0,0
60995,papaverine,0,0
60996,.,0,0
60997,BACKGROUND,0,0
60998,Intracavernosal,0,0
60999,injection,0,0
61000,of,0,0
61001,vasoactive,0,0
61002,drugs,0,0
61003,is,0,0
61004,an,0,0
61005,established,0,0
61006,method,0,0
61007,of,0,0
61008,evaluating,0,0
61009,erectile,0,1
61010,dysfunction,0,1
61011,.,0,0
61012,However,0,0
61013,",",0,0
61014,it,0,0
61015,is,0,0
61016,invasive,0,0
61017,and,0,0
61018,may,0,0
61019,be,0,0
61020,associated,0,0
61021,with,0,0
61022,pain,0,0
61023,and,0,0
61024,priapism,0,0
61025,.,0,0
61026,We,0,0
61027,investigated,0,0
61028,the,0,0
61029,use,0,0
61030,of,0,0
61031,oral,0,0
61032,sildenafil,0,0
61033,as,0,0
61034,a,0,0
61035,possible,0,0
61036,substitute,0,0
61037,for,0,0
61038,intracavernosal,0,0
61039,agents,0,0
61040,.,0,1
61041,METHODS,0,0
61042,Men,1,1
61043,with,1,1
61044,erectile,1,1
61045,dysfunction,1,1
61046,were,1,0
61047,randomized,1,0
61048,into,1,1
61049,two,1,0
61050,groups,1,0
61051,of,1,0
61052,25,1,0
61053,each,1,0
61054,.,1,0
61055,One,0,0
61056,group,0,0
61057,of,0,0
61058,25,1,0
61059,men,1,1
61060,received,0,0
61061,injection,0,0
61062,papaverine,0,0
61063,initially,0,0
61064,followed,0,0
61065,by,0,0
61066,oral,0,0
61067,sildenafil,0,0
61068,",",0,0
61069,and,0,0
61070,another,0,0
61071,25,0,0
61072,received,0,0
61073,oral,0,0
61074,sildenafil,0,0
61075,followed,0,0
61076,by,0,0
61077,injection,0,0
61078,papaverine,0,0
61079,.,0,0
61080,Genital,0,0
61081,self-stimulation,0,0
61082,was,0,0
61083,used,0,0
61084,in,0,0
61085,both,0,0
61086,the,0,0
61087,groups,0,0
61088,.,0,0
61089,Penile,0,1
61090,length,0,0
61091,and,0,0
61092,circumference,0,0
61093,as,0,0
61094,well,0,0
61095,as,0,0
61096,angle,0,0
61097,of,0,0
61098,erection,0,0
61099,",",0,0
61100,before,0,0
61101,and,0,0
61102,after,0,0
61103,each,0,0
61104,medication,0,0
61105,",",0,0
61106,were,0,0
61107,recorded,0,0
61108,.,0,0
61109,Two,0,0
61110,days,0,0
61111,later,0,0
61112,",",0,0
61113,the,0,0
61114,intervention,0,0
61115,arms,0,0
61116,were,0,0
61117,crossed,0,0
61118,over,0,0
61119,.,0,0
61120,Subjective,0,0
61121,responses,0,0
61122,were,0,0
61123,obtained,0,0
61124,.,0,0
61125,The,0,0
61126,effect,0,0
61127,of,0,0
61128,medication,0,0
61129,on,0,0
61130,each,0,0
61131,outcome,0,0
61132,variable,0,0
61133,was,0,0
61134,studied,0,0
61135,by,0,0
61136,using,0,0
61137,analysis,0,0
61138,of,0,0
61139,variance,0,0
61140,models,0,0
61141,in,0,0
61142,relation,0,0
61143,to,0,0
61144,patient,0,0
61145,",",0,0
61146,period,0,0
61147,and,0,0
61148,medication,0,0
61149,.,0,0
61150,RESULTS,0,0
61151,There,0,0
61152,was,0,0
61153,statistically,0,0
61154,significant,0,0
61155,improvement,0,0
61156,from,0,0
61157,the,0,0
61158,baseline,0,0
61159,value,0,0
61160,in,0,0
61161,both,0,0
61162,the,0,0
61163,arms,0,0
61164,",",0,0
61165,i.e,0,0
61166,injection,0,0
61167,papaverine,0,0
61168,and,0,0
61169,oral,0,0
61170,sildenafil,0,0
61171,(,0,0
61172,p,0,0
61173,<,0,0
61174,0.001,0,0
61175,",",0,0
61176,p,0,0
61177,<,0,0
61178,0.001,0,0
61179,",",0,0
61180,respectively,0,0
61181,),0,0
61182,for,0,0
61183,both,0,0
61184,penile,0,0
61185,length,0,0
61186,and,0,0
61187,circumference,0,0
61188,.,0,0
61189,No,0,0
61190,significant,0,0
61191,difference,0,0
61192,was,0,0
61193,observed,0,0
61194,between,0,0
61195,the,0,0
61196,two,0,0
61197,medications,0,0
61198,in,0,0
61199,the,0,0
61200,outcome,0,0
61201,measures,0,0
61202,.,0,1
61203,CONCLCUSION,0,0
61204,:,0,0
61205,Oral,0,0
61206,sildenafil,0,0
61207,was,0,0
61208,as,0,0
61209,effective,0,0
61210,as,0,0
61211,injection,0,0
61212,papaverine,0,0
61213,in,0,0
61214,evaluating,0,0
61215,erectile,1,1
61216,dysfunction,1,1
61217,.,1,0
61218,Pharmacokinetic,0,0
61219,and,0,0
61220,safety,0,0
61221,evaluation,0,0
61222,of,0,0
61223,high-dose,0,0
61224,combinations,0,0
61225,of,0,0
61226,fosamprenavir,0,0
61227,and,0,0
61228,ritonavir,0,0
61229,.,0,0
61230,High-dose,0,0
61231,combinations,0,0
61232,of,0,0
61233,fosamprenavir,0,0
61234,(,0,0
61235,FPV,0,1
61236,),0,0
61237,and,0,0
61238,ritonavir,0,0
61239,(,0,0
61240,RTV,0,0
61241,),0,0
61242,were,0,0
61243,evaluated,0,0
61244,in,0,0
61245,healthy,1,1
61246,adult,1,1
61247,subjects,1,1
61248,in,0,0
61249,order,0,0
61250,to,0,0
61251,select,0,0
61252,doses,0,0
61253,for,0,0
61254,further,0,0
61255,study,0,0
61256,in,0,0
61257,multiple,1,0
61258,protease,1,0
61259,inhibitor,1,0
61260,(,1,0
61261,PI,1,0
61262,),1,0
61263,-experienced,1,1
61264,patients,1,1
61265,infected,1,1
61266,with,1,1
61267,human,1,0
61268,immunodeficiency,1,1
61269,virus,1,1
61270,type,1,1
61271,1,1,0
61272,.,1,0
61273,Two,0,1
61274,high-dose,0,0
61275,regimens,0,0
61276,",",0,0
61277,FPV,0,1
61278,"1,400",0,0
61279,mg,0,0
61280,twice,0,0
61281,a,0,0
61282,day,0,0
61283,(,0,0
61284,BID,0,0
61285,),0,0
61286,plus,0,0
61287,RTV,0,0
61288,100,0,0
61289,mg,0,0
61290,BID,0,1
61291,and,0,0
61292,FPV,0,1
61293,"1,400",0,0
61294,mg,0,0
61295,BID,0,1
61296,plus,0,0
61297,RTV,0,0
61298,200,0,0
61299,mg,0,0
61300,BID,0,0
61301,",",0,0
61302,were,0,0
61303,planned,0,0
61304,to,0,0
61305,be,0,0
61306,compared,0,0
61307,to,0,0
61308,the,0,0
61309,approved,0,0
61310,regimen,0,0
61311,",",0,0
61312,FPV,0,1
61313,700,0,0
61314,mg,0,0
61315,BID,0,1
61316,plus,0,0
61317,RTV,0,0
61318,100,0,0
61319,mg,0,0
61320,BID,0,0
61321,",",0,0
61322,in,0,0
61323,a,0,0
61324,randomized,0,0
61325,three-period,0,0
61326,crossover,0,0
61327,study,0,0
61328,.,0,0
61329,Forty-two,1,1
61330,healthy,1,1
61331,adult,1,1
61332,subjects,1,1
61333,were,1,0
61334,enrolled,1,1
61335,",",0,0
61336,and,0,0
61337,39,0,1
61338,subjects,0,1
61339,completed,0,1
61340,period,0,0
61341,1,0,0
61342,.,0,0
61343,Due,0,0
61344,to,0,0
61345,marked,0,0
61346,hepatic,0,0
61347,transaminase,0,0
61348,elevations,0,0
61349,",",0,0
61350,predominantly,0,1
61351,with,0,0
61352,FPV,0,1
61353,"1,400",0,0
61354,mg,0,0
61355,BID,0,1
61356,plus,0,0
61357,RTV,0,0
61358,200,0,0
61359,mg,0,0
61360,BID,0,0
61361,",",0,0
61362,the,0,0
61363,study,0,0
61364,was,0,0
61365,terminated,0,0
61366,prematurely,0,1
61367,.,0,0
61368,For,0,0
61369,FPV,0,1
61370,"1,400",0,0
61371,mg,0,0
61372,BID,0,1
61373,plus,0,0
61374,RTV,0,0
61375,100,0,0
61376,mg,0,0
61377,BID,0,0
61378,",",0,0
61379,the,0,0
61380,values,0,0
61381,for,0,0
61382,plasma,0,0
61383,amprenavir,0,0
61384,(,0,0
61385,APV,0,0
61386,),0,0
61387,area,0,0
61388,under,0,0
61389,the,0,0
61390,concentration-time,0,0
61391,profile,0,0
61392,over,0,0
61393,the,0,0
61394,dosing,0,0
61395,interval,0,0
61396,(,0,0
61397,tau,0,0
61398,),0,0
61399,at,0,0
61400,steady,0,0
61401,state,0,1
61402,[,0,0
61403,AUC,0,0
61404,(,0,0
61405,0-tau,0,0
61406,),0,0
61407,],0,0
61408,",",0,0
61409,maximum,0,0
61410,concentration,0,0
61411,of,0,0
61412,drug,0,0
61413,in,0,0
61414,plasma,0,0
61415,(,0,0
61416,C,0,0
61417,(,0,0
61418,max,0,1
61419,),0,0
61420,),0,0
61421,",",0,0
61422,and,0,0
61423,plasma,0,0
61424,concentration,0,0
61425,at,0,0
61426,the,0,0
61427,end,0,0
61428,of,0,0
61429,tau,0,0
61430,at,0,0
61431,steady,0,0
61432,state,0,0
61433,(,0,0
61434,C,0,0
61435,(,0,0
61436,tau,0,0
61437,),0,0
61438,),0,0
61439,were,0,0
61440,54,0,0
61441,",",0,0
61442,81,0,0
61443,",",0,0
61444,and,0,0
61445,26,0,0
61446,%,0,0
61447,higher,0,0
61448,",",0,0
61449,respectively,0,0
61450,",",0,0
61451,and,0,0
61452,the,0,0
61453,values,0,0
61454,for,0,0
61455,plasma,0,0
61456,RTV,0,0
61457,AUC,0,0
61458,(,0,0
61459,0-tau,0,0
61460,),0,0
61461,",",0,0
61462,C,0,0
61463,(,0,0
61464,max,0,0
61465,),0,0
61466,",",0,0
61467,and,0,0
61468,C,0,0
61469,(,0,0
61470,tau,0,0
61471,),0,0
61472,were,0,0
61473,49,0,1
61474,%,0,0
61475,higher,0,0
61476,",",0,0
61477,71,0,0
61478,%,0,0
61479,higher,0,0
61480,",",0,0
61481,and,0,0
61482,11,0,0
61483,%,0,0
61484,lower,0,0
61485,",",0,0
61486,respectively,0,0
61487,",",0,0
61488,than,0,0
61489,those,0,0
61490,for,0,0
61491,FPV,0,1
61492,700,0,1
61493,mg,0,0
61494,BID,0,1
61495,plus,0,0
61496,RTV,0,0
61497,100,0,0
61498,mg,0,0
61499,BID,0,0
61500,.,0,0
61501,For,0,0
61502,FPV,0,1
61503,"1,400",0,0
61504,mg,0,0
61505,BID,0,1
61506,plus,0,0
61507,RTV,0,0
61508,200,0,0
61509,mg,0,0
61510,BID,0,0
61511,",",0,0
61512,the,0,0
61513,values,0,0
61514,for,0,0
61515,plasma,0,0
61516,APV,0,0
61517,AUC,0,0
61518,(,0,0
61519,0-tau,0,0
61520,),0,0
61521,",",0,0
61522,C,0,0
61523,(,0,0
61524,max,0,0
61525,),0,0
61526,",",0,0
61527,and,0,0
61528,C,0,0
61529,(,0,0
61530,tau,0,0
61531,),0,0
61532,were,0,0
61533,26,0,0
61534,",",0,0
61535,48,0,0
61536,",",0,0
61537,and,0,0
61538,32,0,0
61539,%,0,0
61540,higher,0,0
61541,",",0,0
61542,respectively,0,0
61543,",",0,0
61544,and,0,0
61545,the,0,0
61546,values,0,0
61547,for,0,0
61548,plasma,0,0
61549,RTV,0,0
61550,AUC,0,0
61551,(,0,0
61552,0-tau,0,0
61553,),0,0
61554,",",0,0
61555,C,0,0
61556,(,0,0
61557,max,0,0
61558,),0,0
61559,",",0,0
61560,and,0,0
61561,C,0,0
61562,(,0,0
61563,tau,0,0
61564,),0,0
61565,increased,0,0
61566,4.15-fold,0,0
61567,",",0,0
61568,4.17-fold,0,0
61569,",",0,0
61570,and,0,0
61571,3.99-fold,0,0
61572,",",0,0
61573,respectively,0,0
61574,",",0,0
61575,compared,0,0
61576,to,0,0
61577,those,0,0
61578,for,0,0
61579,FPV,0,1
61580,700,0,1
61581,mg,0,0
61582,BID,0,1
61583,plus,0,0
61584,RTV,0,0
61585,100,0,0
61586,mg,0,0
61587,BID,0,1
61588,.,0,0
61589,FPV,0,0
61590,"1,400",0,0
61591,mg,0,0
61592,BID,0,1
61593,plus,0,0
61594,RTV,0,0
61595,200,0,0
61596,mg,0,0
61597,BID,0,0
61598,is,0,0
61599,not,0,0
61600,recommended,0,0
61601,due,0,0
61602,to,0,0
61603,an,0,0
61604,increased,0,0
61605,rate,0,0
61606,of,0,0
61607,marked,0,0
61608,hepatic,0,0
61609,transaminase,0,0
61610,elevations,0,0
61611,and,0,0
61612,lack,0,0
61613,of,0,0
61614,pharmacokinetic,0,0
61615,advantage,0,0
61616,.,0,0
61617,FPV,0,0
61618,"1,400",0,0
61619,mg,0,0
61620,BID,0,1
61621,plus,0,0
61622,RTV,0,0
61623,100,0,0
61624,mg,0,0
61625,BID,0,0
61626,is,0,0
61627,currently,0,0
61628,under,0,0
61629,clinical,0,0
61630,evaluation,0,0
61631,in,0,0
61632,multiple,0,0
61633,PI-experienced,0,1
61634,patients,0,1
61635,.,0,1
61636,[,0,0
61637,Effect,0,0
61638,of,0,0
61639,Selaginella,0,0
61640,combined,0,0
61641,with,0,0
61642,radiotherapy,0,1
61643,on,0,0
61644,nasopharyngeal,1,1
61645,carcinoma,1,1
61646,],1,0
61647,.,0,0
61648,OBJECTIVE,0,0
61649,To,0,0
61650,observe,0,0
61651,the,0,0
61652,Chinese,0,1
61653,herbal,0,0
61654,medicine,0,1
61655,Selaginella-induced,0,0
61656,radiosensitization,0,0
61657,of,0,0
61658,terminal,1,0
61659,nasopharyngeal,1,1
61660,carcinoma,1,1
61661,(,1,0
61662,NPC,1,0
61663,),1,0
61664,.,1,0
61665,METHODS,0,0
61666,Totally,0,0
61667,180,1,0
61668,patients,1,1
61669,with,1,1
61670,NPC,1,0
61671,were,0,0
61672,divided,0,0
61673,equally,0,0
61674,into,0,0
61675,3,0,0
61676,groups,0,0
61677,with,0,1
61678,the,0,0
61679,same,0,0
61680,radiotherapeutic,0,1
61681,protocols,0,0
61682,.,0,1
61683,The,0,0
61684,patients,0,1
61685,in,0,0
61686,group,0,1
61687,A,0,0
61688,received,0,0
61689,radiotherapy,0,0
61690,alone,0,0
61691,",",0,0
61692,those,0,0
61693,in,0,0
61694,group,0,0
61695,B,0,0
61696,were,0,0
61697,given,0,0
61698,daily,0,0
61699,Selaginella,0,0
61700,(,0,0
61701,30,0,0
61702,g,0,0
61703,),0,0
61704,prepared,0,0
61705,into,0,0
61706,50,0,0
61707,ml,0,0
61708,decoction,0,0
61709,during,0,0
61710,the,0,0
61711,entire,0,0
61712,course,0,0
61713,of,0,0
61714,radiotherapy,0,0
61715,",",0,0
61716,and,0,0
61717,those,0,0
61718,in,0,0
61719,group,0,0
61720,C,0,0
61721,had,0,0
61722,Selaginella,0,1
61723,30,0,0
61724,g,0,0
61725,daily,0,0
61726,in,0,0
61727,the,0,0
61728,late,0,0
61729,course,0,0
61730,of,0,0
61731,radiotherapy,0,0
61732,.,0,0
61733,RESULTS,0,0
61734,The,0,0
61735,complete,0,0
61736,remission,0,0
61737,rate,0,0
61738,of,0,0
61739,nasopharyngeal,0,1
61740,primary,0,1
61741,lesions,0,1
61742,in,0,0
61743,groups,0,0
61744,B,0,1
61745,and,0,0
61746,C,0,0
61747,was,0,0
61748,significantly,0,0
61749,higher,0,0
61750,than,0,0
61751,that,0,0
61752,in,0,0
61753,group,0,0
61754,A,0,0
61755,",",0,0
61756,with,0,0
61757,also,0,0
61758,significantly,0,0
61759,higher,0,0
61760,complete,0,0
61761,remission,0,1
61762,rates,0,0
61763,of,0,0
61764,the,0,0
61765,cervical,0,1
61766,lymph,0,0
61767,nodes,0,0
61768,.,0,0
61769,The,0,0
61770,acute,0,0
61771,toxicity,0,0
61772,of,0,0
61773,the,0,0
61774,skin,0,0
61775,and,0,0
61776,mucous,0,1
61777,membrane,0,0
61778,was,0,0
61779,milder,0,0
61780,in,0,0
61781,the,0,0
61782,latter,0,0
61783,two,0,0
61784,groups,0,0
61785,",",0,0
61786,but,0,0
61787,the,0,0
61788,differences,0,0
61789,were,0,0
61790,not,0,0
61791,significant,0,0
61792,.,0,0
61793,CONCLUSION,0,0
61794,Selaginella,0,0
61795,may,0,0
61796,induce,0,0
61797,radiosensitization,0,0
61798,for,0,0
61799,terminal,1,0
61800,NPC,1,0
61801,and,0,0
61802,does,0,0
61803,not,0,0
61804,increase,0,0
61805,the,0,0
61806,acute,0,0
61807,toxicity,0,0
61808,of,0,0
61809,radiotherapy,0,1
61810,.,0,0
61811,Efficacy,0,0
61812,and,0,0
61813,safety,0,0
61814,of,0,0
61815,oral,0,0
61816,conivaptan,0,0
61817,:,0,1
61818,a,0,0
61819,V1A/V2,0,0
61820,vasopressin,0,0
61821,receptor,0,0
61822,antagonist,0,0
61823,",",0,0
61824,assessed,0,0
61825,in,0,0
61826,a,0,0
61827,randomized,0,0
61828,",",0,0
61829,placebo-controlled,0,0
61830,trial,0,0
61831,in,0,0
61832,patients,1,1
61833,with,1,1
61834,euvolemic,1,1
61835,or,1,0
61836,hypervolemic,1,0
61837,hyponatremia,1,0
61838,.,1,0
61839,CONTEXT,0,0
61840,Hyponatremia,0,0
61841,[,0,0
61842,serum,0,0
61843,sodium,0,0
61844,concentration,0,0
61845,(,0,0
61846,[,0,0
61847,Na,0,0
61848,(,0,0
61849,+,0,0
61850,),0,0
61851,],0,0
61852,),0,0
61853,",",0,0
61854,<,0,0
61855,135,0,1
61856,mEq/liter,0,0
61857,],0,0
61858,is,0,0
61859,the,0,0
61860,most,0,0
61861,common,0,0
61862,fluid,0,0
61863,and,0,0
61864,electrolyte,0,0
61865,abnormality,1,0
61866,among,1,0
61867,hospitalized,1,1
61868,patients,1,1
61869,.,1,0
61870,It,0,0
61871,is,0,0
61872,frequently,0,0
61873,caused,0,0
61874,by,0,0
61875,the,0,0
61876,inappropriate,0,0
61877,release,0,0
61878,of,0,0
61879,arginine,0,0
61880,vasopressin,0,0
61881,.,0,0
61882,OBJECTIVE,0,0
61883,The,0,0
61884,objective,0,0
61885,of,0,0
61886,this,0,0
61887,study,0,0
61888,was,0,0
61889,to,0,0
61890,evaluate,0,0
61891,the,0,0
61892,efficacy,0,0
61893,and,0,0
61894,safety,0,0
61895,of,0,0
61896,oral,0,0
61897,conivaptan,0,0
61898,",",0,0
61899,a,0,0
61900,vasopressin,0,0
61901,V,0,0
61902,(,0,0
61903,1A,0,0
61904,),0,0
61905,/V,0,0
61906,(,0,0
61907,2,0,0
61908,),0,0
61909,receptor,0,0
61910,antagonist,0,0
61911,",",0,0
61912,in,0,0
61913,patients,1,1
61914,with,1,1
61915,euvolemic,1,1
61916,or,1,0
61917,hypervolemic,1,0
61918,hyponatremia,1,0
61919,.,1,0
61920,DESIGN,0,0
61921,The,0,0
61922,study,0,0
61923,design,0,0
61924,was,0,0
61925,a,0,0
61926,5-d,0,0
61927,placebo-controlled,0,0
61928,",",0,0
61929,randomized,0,0
61930,",",0,0
61931,double-blind,0,0
61932,study,0,0
61933,.,0,0
61934,SETTING,0,0
61935,The,0,0
61936,study,0,0
61937,was,0,0
61938,performed,0,0
61939,at,1,0
61940,a,1,0
61941,hospital,1,0
61942,.,1,0
61943,INTERVENTION,0,0
61944,Oral,0,0
61945,conivaptan,0,0
61946,(,0,0
61947,40,0,0
61948,or,0,1
61949,80,0,1
61950,mg/d,0,0
61951,),0,0
61952,or,0,0
61953,placebo,0,0
61954,was,0,0
61955,given,0,0
61956,in,0,0
61957,two,0,0
61958,divided,0,1
61959,doses,0,0
61960,.,0,0
61961,PATIENTS,0,0
61962,Seventy-four,1,1
61963,patients,1,1
61964,(,1,0
61965,average,1,0
61966,baseline,1,0
61967,serum,1,0
61968,[,1,0
61969,Na,1,0
61970,(,1,0
61971,+,1,0
61972,),1,0
61973,],1,0
61974,",",1,0
61975,115,1,1
61976,to,1,0
61977,<,1,0
61978,130,1,1
61979,mEq/liter,1,0
61980,),1,0
61981,were,1,0
61982,studied,1,1
61983,.,1,0
61984,MAIN,0,0
61985,OUTCOME,0,0
61986,MEASURE,0,0
61987,The,0,0
61988,main,0,0
61989,outcome,0,0
61990,measure,0,0
61991,was,0,0
61992,the,0,0
61993,change,0,0
61994,from,0,0
61995,baseline,0,0
61996,in,0,0
61997,serum,0,0
61998,[,0,0
61999,Na,0,0
62000,(,0,0
62001,+,0,0
62002,),0,0
62003,],0,0
62004,area,0,0
62005,under,0,0
62006,the,0,0
62007,curve,0,0
62008,.,0,0
62009,RESULTS,0,0
62010,The,0,0
62011,least-squares,0,0
62012,mean,0,0
62013,change,0,0
62014,from,0,0
62015,baseline,0,0
62016,in,0,0
62017,the,0,0
62018,serum,0,0
62019,[,0,0
62020,Na,0,0
62021,(,0,0
62022,+,0,0
62023,),0,0
62024,],0,0
62025,area,0,0
62026,under,0,0
62027,the,0,0
62028,curve,0,0
62029,with,0,0
62030,conivaptan,0,0
62031,(,0,0
62032,40,0,0
62033,and,0,0
62034,80,0,1
62035,mg/d,0,0
62036,),0,0
62037,was,0,0
62038,2.0-fold,0,0
62039,(,0,0
62040,P,0,0
62041,=,0,0
62042,0.03,0,0
62043,),0,0
62044,and,0,0
62045,2.5-fold,0,0
62046,(,0,0
62047,P,0,0
62048,<,0,0
62049,0.001,0,0
62050,),0,0
62051,greater,0,0
62052,",",0,0
62053,respectively,0,0
62054,",",0,0
62055,than,0,0
62056,that,0,0
62057,with,0,0
62058,placebo,0,0
62059,.,0,0
62060,The,0,0
62061,median,0,0
62062,time,0,0
62063,to,0,0
62064,achieve,0,0
62065,a,0,0
62066,confirmed,0,0
62067,increase,0,0
62068,in,0,0
62069,serum,0,0
62070,[,0,0
62071,Na,0,1
62072,(,0,0
62073,+,0,0
62074,),0,0
62075,],0,0
62076,of,0,0
62077,4,0,0
62078,mEq/liter,0,1
62079,or,0,0
62080,more,0,0
62081,from,0,0
62082,baseline,0,0
62083,was,0,0
62084,71.7,0,0
62085,h,0,0
62086,for,0,0
62087,placebo,0,0
62088,",",0,0
62089,27.5,0,0
62090,h,0,0
62091,for,0,0
62092,40,0,1
62093,mg/d,0,0
62094,conivaptan,0,0
62095,(,0,0
62096,P,0,0
62097,=,0,0
62098,0.044,0,0
62099,),0,0
62100,",",0,0
62101,and,0,0
62102,12.1,0,0
62103,h,0,0
62104,for,0,0
62105,80,0,1
62106,mg/d,0,0
62107,conivaptan,0,0
62108,(,0,0
62109,P,0,0
62110,=,0,0
62111,0.002,0,0
62112,),0,0
62113,.,0,0
62114,The,0,0
62115,mean,0,0
62116,total,0,1
62117,times,0,0
62118,during,0,0
62119,which,0,0
62120,patients,0,1
62121,had,0,0
62122,a,0,0
62123,serum,0,0
62124,[,0,0
62125,Na,0,0
62126,(,0,0
62127,+,0,0
62128,),0,0
62129,],0,0
62130,level,0,0
62131,of,0,0
62132,4,0,0
62133,mEq/liter,0,1
62134,or,0,0
62135,more,0,0
62136,above,0,0
62137,baseline,0,0
62138,were,0,0
62139,46.5,0,0
62140,",",0,0
62141,69.8,0,0
62142,",",0,0
62143,and,0,0
62144,88.8,0,0
62145,h,0,0
62146,(,0,0
62147,P,0,0
62148,=,0,0
62149,0.001,0,0
62150,),0,0
62151,",",0,0
62152,respectively,0,0
62153,.,0,0
62154,The,0,0
62155,least-squares,0,0
62156,mean,0,0
62157,change,0,0
62158,in,0,0
62159,serum,0,0
62160,[,0,0
62161,Na,0,0
62162,(,0,0
62163,+,0,0
62164,),0,0
62165,],0,0
62166,from,0,0
62167,baseline,0,0
62168,to,0,0
62169,end,0,0
62170,of,0,0
62171,treatment,0,0
62172,was,0,0
62173,3.4,0,0
62174,mEq/liter,0,0
62175,for,0,0
62176,placebo,0,0
62177,",",0,0
62178,6.4,0,0
62179,mEq/liter,0,0
62180,for,0,0
62181,40,0,0
62182,mg/d,0,0
62183,conivaptan,0,0
62184,",",0,0
62185,and,0,0
62186,8.2,0,0
62187,mEq/liter,0,0
62188,for,0,0
62189,80,0,1
62190,mg/d,0,0
62191,conivaptan,0,0
62192,(,0,0
62193,P,0,0
62194,=,0,0
62195,0.002,0,0
62196,),0,0
62197,.,0,0
62198,A,0,0
62199,confirmed,0,0
62200,normal,0,1
62201,serum,0,0
62202,[,0,0
62203,Na,0,0
62204,(,0,0
62205,+,0,0
62206,),0,0
62207,],0,0
62208,(,0,0
62209,>,0,0
62210,/=135,0,1
62211,mEq/liter,0,1
62212,),0,0
62213,or,0,0
62214,increase,0,0
62215,of,0,0
62216,6,0,0
62217,mEq/liter,0,1
62218,or,0,0
62219,more,0,0
62220,was,0,0
62221,observed,0,0
62222,in,0,0
62223,48,0,0
62224,%,0,0
62225,of,0,0
62226,patients,0,1
62227,given,0,0
62228,placebo,0,0
62229,",",0,0
62230,71,0,1
62231,%,0,0
62232,given,0,0
62233,40,0,0
62234,mg/d,0,0
62235,conivaptan,0,0
62236,",",0,0
62237,and,0,0
62238,82,0,1
62239,%,0,0
62240,given,0,0
62241,80,0,0
62242,mg/d,0,0
62243,conivaptan,0,0
62244,(,0,0
62245,P,0,0
62246,=,0,0
62247,0.014,0,0
62248,),0,0
62249,.,0,0
62250,Headache,0,0
62251,",",0,0
62252,hypotension,0,0
62253,",",0,0
62254,nausea,0,0
62255,",",0,0
62256,constipation,0,0
62257,",",0,0
62258,and,0,0
62259,postural,0,0
62260,hypotension,0,0
62261,were,0,0
62262,the,0,0
62263,most,0,0
62264,common,0,0
62265,adverse,0,0
62266,events,0,0
62267,.,0,1
62268,CONCLUSION,0,0
62269,Oral,0,0
62270,conivaptan,0,0
62271,(,0,0
62272,40,0,0
62273,and,0,0
62274,80,0,1
62275,mg/d,0,0
62276,),0,0
62277,was,0,0
62278,well,0,0
62279,tolerated,0,0
62280,and,0,0
62281,efficacious,0,0
62282,in,0,0
62283,correcting,0,0
62284,serum,0,0
62285,[,0,0
62286,Na,0,0
62287,(,0,0
62288,+,0,0
62289,),0,0
62290,],0,0
62291,in,0,0
62292,hyponatremia,0,0
62293,.,0,0
62294,Evaluation,0,0
62295,of,0,0
62296,nonpharmacologic,0,0
62297,methods,0,1
62298,of,0,0
62299,pain,0,0
62300,and,0,0
62301,anxiety,0,0
62302,management,0,0
62303,for,0,0
62304,laceration,0,0
62305,repair,0,0
62306,in,0,0
62307,the,0,0
62308,pediatric,0,1
62309,emergency,0,1
62310,department,0,1
62311,.,0,0
62312,BACKGROUND,0,0
62313,Nonpharmacologic,0,0
62314,interventions,0,0
62315,",",0,0
62316,such,0,0
62317,as,0,0
62318,distraction,0,0
62319,",",0,0
62320,have,0,0
62321,been,0,0
62322,shown,0,0
62323,to,0,0
62324,be,0,0
62325,powerful,0,0
62326,adjuncts,0,0
62327,in,0,0
62328,reducing,0,0
62329,pain,0,0
62330,and,0,0
62331,anxiety,0,0
62332,in,0,0
62333,children,1,1
62334,with,1,1
62335,both,1,0
62336,acute,1,1
62337,and,1,0
62338,chronic,1,1
62339,painful,1,0
62340,conditions,1,0
62341,.,1,0
62342,There,0,0
62343,are,0,0
62344,no,0,0
62345,controlled,0,0
62346,studies,0,0
62347,evaluating,0,0
62348,these,0,0
62349,interventions,0,0
62350,as,0,0
62351,adjuncts,0,0
62352,to,0,0
62353,facilitate,0,0
62354,completion,0,0
62355,of,0,0
62356,painful,0,0
62357,procedures,0,1
62358,in,0,0
62359,the,0,0
62360,pediatric,0,1
62361,emergency,0,1
62362,department,0,1
62363,(,0,0
62364,ED,0,0
62365,),0,0
62366,.,0,0
62367,OBJECTIVE,0,0
62368,We,0,0
62369,assessed,0,0
62370,the,0,0
62371,effectiveness,0,0
62372,of,0,0
62373,distraction,0,0
62374,techniques,0,0
62375,in,0,0
62376,reducing,0,0
62377,the,0,0
62378,sensory,0,0
62379,and,0,0
62380,affective,0,1
62381,components,0,0
62382,of,0,0
62383,pain,0,0
62384,among,0,1
62385,pediatric,1,1
62386,patients,1,1
62387,undergoing,1,1
62388,laceration,1,0
62389,repair,1,0
62390,in,1,0
62391,the,1,0
62392,ED,1,0
62393,.,1,0
62394,METHODS,0,0
62395,Eligible,1,0
62396,children,1,1
62397,between,1,0
62398,6,1,0
62399,and,1,0
62400,18,1,1
62401,years,1,1
62402,of,1,0
62403,age,1,1
62404,(,1,0
62405,N,1,1
62406,=,1,0
62407,240,1,1
62408,),1,0
62409,presenting,1,1
62410,to,1,0
62411,the,1,0
62412,ED,1,0
62413,for,1,0
62414,laceration,1,0
62415,repair,1,0
62416,were,0,0
62417,randomly,0,0
62418,assigned,0,0
62419,to,0,0
62420,an,0,0
62421,intervention,0,0
62422,or,0,0
62423,control,0,0
62424,arm,0,0
62425,.,0,0
62426,Those,0,0
62427,assigned,0,0
62428,to,0,0
62429,the,0,0
62430,intervention,0,0
62431,arm,0,0
62432,were,0,0
62433,given,0,0
62434,a,0,0
62435,choice,0,0
62436,of,0,0
62437,age-appropriate,0,1
62438,distracters,0,0
62439,during,0,0
62440,laceration,0,0
62441,repair,0,1
62442,.,0,0
62443,Quantitative,0,0
62444,measures,0,0
62445,of,0,0
62446,pain,0,0
62447,intensity,0,0
62448,",",0,0
62449,situational,0,0
62450,anxiety,0,0
62451,",",0,0
62452,and,0,0
62453,pain,0,0
62454,distress,0,0
62455,(,0,0
62456,as,0,0
62457,perceived,0,0
62458,by,0,0
62459,the,0,0
62460,parent,0,0
62461,),0,0
62462,were,0,0
62463,assessed,0,0
62464,by,0,0
62465,using,0,0
62466,the,0,0
62467,7-point,0,0
62468,Facial,0,1
62469,Pain,0,0
62470,Scale,0,0
62471,",",0,0
62472,State,0,0
62473,Trait,0,1
62474,Anxiety,0,0
62475,Inventory,0,0
62476,for,0,0
62477,Children,0,1
62478,",",0,0
62479,and,0,0
62480,a,0,0
62481,visual,0,0
62482,analog,0,0
62483,scale,0,0
62484,",",0,0
62485,respectively,0,0
62486,",",0,0
62487,before,0,0
62488,and,0,0
62489,after,0,0
62490,laceration,0,0
62491,repair,0,0
62492,.,0,0
62493,The,0,0
62494,State,0,0
62495,Trait,0,1
62496,Anxiety,0,0
62497,Inventory,0,0
62498,for,0,0
62499,Children,0,1
62500,was,0,0
62501,performed,0,0
62502,in,0,0
62503,children,0,1
62504,>,0,1
62505,or,0,0
62506,=,0,0
62507,10,0,0
62508,years,0,1
62509,of,0,0
62510,age,0,1
62511,.,0,0
62512,RESULTS,0,0
62513,There,0,0
62514,was,0,0
62515,no,0,0
62516,difference,0,0
62517,in,0,0
62518,mean,0,0
62519,change,0,0
62520,in,0,0
62521,Facial,0,1
62522,Pain,0,0
62523,Scale,0,0
62524,scores,0,0
62525,between,0,0
62526,the,0,0
62527,control,0,0
62528,and,0,0
62529,the,0,0
62530,intervention,0,0
62531,groups,0,0
62532,in,0,0
62533,children,0,1
62534,<,0,0
62535,10,0,0
62536,years,0,1
62537,of,0,0
62538,age,0,1
62539,.,0,0
62540,Multivariate,0,0
62541,analysis,0,0
62542,in,0,0
62543,this,0,0
62544,same,0,0
62545,age,0,1
62546,group,0,0
62547,showed,0,0
62548,that,0,0
62549,the,0,0
62550,intervention,0,0
62551,was,0,0
62552,independently,0,0
62553,associated,0,0
62554,with,0,0
62555,a,0,0
62556,reduction,0,0
62557,in,0,0
62558,pain,0,0
62559,distress,0,1
62560,as,0,0
62561,perceived,0,0
62562,by,0,0
62563,parents,0,1
62564,based,0,0
62565,on,0,0
62566,the,0,0
62567,mean,0,0
62568,change,0,0
62569,in,0,0
62570,visual,0,0
62571,analog,0,0
62572,scale,0,0
62573,scores,0,0
62574,.,0,0
62575,In,0,0
62576,older,0,1
62577,children,0,1
62578,",",0,0
62579,the,0,0
62580,intervention,0,0
62581,was,0,0
62582,independently,0,0
62583,associated,0,0
62584,with,0,0
62585,reduction,0,0
62586,in,0,0
62587,situational,0,0
62588,anxiety,0,0
62589,but,0,0
62590,not,0,0
62591,in,0,0
62592,pain,0,0
62593,intensity,0,0
62594,or,0,0
62595,in,0,0
62596,parental,0,0
62597,perception,0,0
62598,of,0,0
62599,pain,0,0
62600,distress,0,1
62601,.,0,0
62602,CONCLUSIONS,0,0
62603,The,0,0
62604,use,0,0
62605,of,0,0
62606,distraction,0,0
62607,techniques,0,0
62608,is,0,0
62609,effective,0,0
62610,in,0,0
62611,reducing,0,0
62612,situational,0,0
62613,anxiety,0,0
62614,in,0,0
62615,older,1,1
62616,children,1,1
62617,and,0,0
62618,lowering,0,0
62619,parental,0,0
62620,perception,0,0
62621,of,0,0
62622,pain,0,0
62623,distress,0,1
62624,in,0,0
62625,younger,0,1
62626,children,0,1
62627,.,0,0
62628,This,0,0
62629,technique,0,0
62630,may,0,0
62631,have,0,0
62632,a,0,0
62633,role,0,0
62634,in,0,0
62635,improving,0,0
62636,the,0,0
62637,quality,0,0
62638,of,0,0
62639,management,0,0
62640,of,0,0
62641,procedural,0,0
62642,pain,0,0
62643,in,0,0
62644,a,0,0
62645,pediatric,0,1
62646,ED,0,0
62647,setting,0,1
62648,.,0,0
62649,The,0,0
62650,effect,0,0
62651,of,0,0
62652,a,0,0
62653,parent-implemented,0,0
62654,imitation,0,0
62655,intervention,0,0
62656,on,0,0
62657,spontaneous,0,0
62658,imitation,0,0
62659,skills,0,0
62660,in,0,0
62661,young,1,1
62662,children,1,1
62663,with,1,1
62664,autism,1,1
62665,.,1,0
62666,Children,1,1
62667,with,1,0
62668,autism,1,1
62669,exhibit,0,0
62670,significant,0,0
62671,deficits,0,0
62672,in,0,0
62673,their,0,0
62674,ability,0,0
62675,to,0,0
62676,spontaneously,0,0
62677,imitate,0,0
62678,the,0,0
62679,play,0,0
62680,actions,0,0
62681,and,0,0
62682,descriptive,0,0
62683,gestures,0,0
62684,of,0,0
62685,others,0,0
62686,.,0,1
62687,Reciprocal,0,0
62688,imitation,0,0
62689,training,0,0
62690,(,0,0
62691,RIT,0,0
62692,),0,0
62693,is,0,0
62694,a,0,0
62695,naturalistic,0,0
62696,imitation,0,0
62697,intervention,0,0
62698,designed,0,0
62699,to,0,0
62700,teach,0,0
62701,spontaneous,0,0
62702,imitation,0,0
62703,skills,0,0
62704,during,0,0
62705,play,0,0
62706,.,0,0
62707,This,0,0
62708,study,0,0
62709,assessed,0,0
62710,the,0,0
62711,effectiveness,0,0
62712,of,0,0
62713,parent-implemented,0,0
62714,RIT,0,0
62715,using,0,0
62716,a,0,0
62717,multiple-baseline,0,0
62718,design,0,0
62719,across,0,0
62720,three,1,0
62721,young,1,1
62722,children,1,1
62723,with,1,1
62724,autism,1,1
62725,and,1,0
62726,their,1,0
62727,mothers,1,1
62728,.,1,0
62729,After,0,0
62730,an,0,0
62731,initial,0,0
62732,baseline,0,0
62733,",",0,0
62734,mothers,0,1
62735,were,0,0
62736,taught,0,0
62737,to,0,0
62738,implement,0,0
62739,RIT,0,0
62740,techniques,0,0
62741,with,0,1
62742,their,0,0
62743,child,0,0
62744,twice,0,0
62745,a,0,0
62746,week,0,0
62747,for,0,0
62748,10,0,0
62749,weeks,0,0
62750,in,0,0
62751,a,0,0
62752,clinic,0,1
62753,setting,0,1
62754,.,0,1
62755,Two,0,0
62756,mothers,0,1
62757,were,0,0
62758,taught,0,0
62759,to,0,0
62760,use,0,0
62761,RIT,0,0
62762,to,0,0
62763,teach,0,0
62764,object,0,0
62765,imitation,0,0
62766,.,0,0
62767,The,0,0
62768,third,0,0
62769,mother,0,0
62770,was,0,0
62771,taught,0,0
62772,to,0,0
62773,use,0,0
62774,RIT,0,0
62775,to,0,0
62776,target,0,0
62777,both,0,0
62778,object,0,0
62779,and,0,0
62780,gesture,0,0
62781,imitation,0,0
62782,in,0,0
62783,a,0,0
62784,multiple-baseline,0,0
62785,design,0,0
62786,across,0,0
62787,behaviors,0,0
62788,.,0,1
62789,Generalization,0,0
62790,was,0,0
62791,assessed,0,0
62792,in,0,0
62793,the,0,0
62794,families,0,1
62795,',0,0
62796,homes,0,1
62797,at,0,0
62798,the,0,0
62799,end,0,0
62800,of,0,0
62801,treatment,0,0
62802,and,0,0
62803,a,0,0
62804,1-month,0,0
62805,follow-up,0,0
62806,.,0,1
62807,Parents,0,0
62808,learned,0,0
62809,to,0,0
62810,use,0,0
62811,the,0,0
62812,intervention,0,0
62813,strategies,0,0
62814,and,0,0
62815,their,0,1
62816,children,0,1
62817,exhibited,0,0
62818,increases,0,0
62819,in,0,0
62820,spontaneous,0,0
62821,imitation,0,0
62822,.,0,0
62823,These,0,0
62824,findings,0,0
62825,replicate,0,0
62826,the,0,0
62827,results,0,0
62828,from,0,0
62829,previous,0,1
62830,studies,0,0
62831,",",0,0
62832,indicating,0,0
62833,that,0,0
62834,RIT,0,0
62835,is,0,0
62836,effective,0,0
62837,for,0,0
62838,teaching,0,1
62839,imitation,0,0
62840,skills,0,0
62841,to,0,0
62842,young,1,1
62843,children,1,1
62844,with,1,1
62845,autism,1,1
62846,in,0,0
62847,a,0,0
62848,naturalistic,0,0
62849,setting,0,0
62850,and,0,0
62851,extend,0,0
62852,the,0,0
62853,findings,0,0
62854,to,0,0
62855,parents,1,1
62856,.,1,1
62857,Local,0,0
62858,immunotherapy,0,0
62859,by,0,0
62860,inhalation,0,0
62861,of,0,0
62862,a,0,0
62863,powder,0,0
62864,extract,0,0
62865,in,0,0
62866,asthma,0,1
62867,due,0,0
62868,to,0,0
62869,house,0,1
62870,dust,0,0
62871,mite,0,1
62872,Dermatophagoides,0,1
62873,pteronyssinus,0,0
62874,:,0,1
62875,a,0,0
62876,double-blind,0,0
62877,comparison,0,0
62878,with,0,1
62879,parenteral,0,1
62880,immunotherapy,0,0
62881,.,0,0
62882,To,0,0
62883,verify,0,0
62884,the,0,0
62885,efficacy,0,0
62886,and,0,0
62887,the,0,0
62888,tolerability,0,0
62889,of,0,0
62890,local,0,0
62891,immunotherapy,0,0
62892,(,0,0
62893,LI,0,0
62894,),0,0
62895,by,0,0
62896,inhalation,0,0
62897,of,0,0
62898,a,0,0
62899,powder,0,0
62900,extract,0,0
62901,of,0,0
62902,house,0,1
62903,dust,0,0
62904,mite,0,1
62905,(,0,0
62906,HDM,0,0
62907,),0,0
62908,",",0,0
62909,in,0,0
62910,comparison,0,0
62911,with,0,1
62912,parenteral,0,1
62913,immunotherapy,0,0
62914,(,0,0
62915,PI,0,0
62916,),0,0
62917,by,0,0
62918,injection,0,0
62919,",",0,0
62920,10,1,0
62921,patients,1,1
62922,with,1,1
62923,asthma,1,1
62924,due,1,0
62925,to,1,0
62926,HDM,1,0
62927,were,0,0
62928,studied,0,0
62929,in,0,0
62930,a,0,0
62931,blind,0,0
62932,fashion,0,0
62933,.,0,1
62934,5,0,0
62935,patients,0,1
62936,(,0,0
62937,Group,0,1
62938,A,0,0
62939,),0,0
62940,underwent,0,1
62941,LI,0,0
62942,and,0,0
62943,subcutaneous,0,0
62944,injections,0,0
62945,of,0,0
62946,placebo,0,0
62947,",",0,0
62948,5,0,0
62949,patients,0,1
62950,(,0,0
62951,Group,0,1
62952,B,0,0
62953,),0,0
62954,underwent,0,1
62955,PI,0,0
62956,and,0,0
62957,inhalation,0,0
62958,of,0,0
62959,lactose,0,0
62960,for,0,0
62961,6,0,0
62962,months,0,0
62963,.,0,0
62964,In,0,0
62965,both,0,0
62966,groups,0,0
62967,each,0,0
62968,inhalation,0,0
62969,was,0,0
62970,preceded,0,0
62971,by,0,0
62972,premedication,0,0
62973,with,0,1
62974,disodium,0,0
62975,cromoglycate,0,0
62976,(,0,0
62977,DSCG,0,0
62978,),0,0
62979,(,0,0
62980,40,0,0
62981,mg,0,0
62982,),0,0
62983,.,0,0
62984,In,0,0
62985,Group,0,0
62986,A,0,0
62987,a,0,0
62988,significant,0,0
62989,decrease,0,0
62990,in,0,0
62991,symptoms,0,0
62992,score,0,0
62993,and,0,0
62994,in,0,0
62995,peak,0,0
62996,expiratory,0,0
62997,flow,0,0
62998,(,0,0
62999,PEF,0,0
63000,),0,0
63001,-derived,0,0
63002,parameters,0,0
63003,was,0,0
63004,observed,0,0
63005,already,0,0
63006,after,0,0
63007,3,0,0
63008,months,0,0
63009,of,0,0
63010,treatment,0,0
63011,",",0,0
63012,and,0,0
63013,2,0,0
63014,patients,0,1
63015,lost,0,0
63016,the,0,0
63017,late,0,0
63018,component,0,0
63019,of,0,0
63020,the,0,0
63021,bronchial,0,1
63022,response,0,0
63023,to,0,0
63024,the,0,0
63025,challenge,0,0
63026,with,0,1
63027,HDM,0,0
63028,.,0,0
63029,No,0,0
63030,significant,0,0
63031,variation,0,0
63032,was,0,0
63033,found,0,0
63034,in,0,0
63035,bronchial,0,1
63036,responsiveness,0,0
63037,to,0,0
63038,methacholine,0,0
63039,and,0,0
63040,ultrasonically,0,0
63041,nebulized,0,0
63042,distilled,0,0
63043,water,0,0
63044,(,0,0
63045,UNDW,0,0
63046,),0,0
63047,and,0,0
63048,in,0,0
63049,immunologic,0,0
63050,humoral,0,0
63051,and,0,0
63052,cellular,0,0
63053,parameters,0,0
63054,in,0,0
63055,peripheral,0,0
63056,blood,0,0
63057,after,0,0
63058,treatment,0,0
63059,in,0,0
63060,either,0,0
63061,group,0,0
63062,.,0,0
63063,No,0,0
63064,local,0,0
63065,important,0,0
63066,adverse,0,0
63067,reactions,0,0
63068,were,0,0
63069,observed,0,0
63070,in,0,0
63071,Group,0,0
63072,A,0,0
63073,and,0,0
63074,no,0,0
63075,systemic,0,0
63076,side,0,0
63077,effects,0,0
63078,were,0,0
63079,observed,0,0
63080,in,0,0
63081,either,0,0
63082,group,0,0
63083,.,0,0
63084,We,0,0
63085,conclude,0,0
63086,that,0,0
63087,LI,0,0
63088,is,0,0
63089,as,0,0
63090,effective,0,0
63091,as,0,0
63092,PI,0,0
63093,",",0,0
63094,but,0,0
63095,more,0,0
63096,rapid,0,0
63097,in,0,0
63098,its,0,0
63099,action,0,0
63100,",",0,0
63101,in,0,0
63102,the,0,0
63103,treatment,0,0
63104,of,0,0
63105,asthma,0,1
63106,due,0,0
63107,to,0,1
63108,HDM,0,0
63109,.,0,0
63110,Moreover,0,0
63111,",",0,0
63112,LI,0,0
63113,is,0,0
63114,locally,0,0
63115,well,0,0
63116,tolerated,0,0
63117,",",0,0
63118,providing,0,0
63119,DSCG,0,0
63120,is,0,0
63121,inhaled,0,0
63122,before,0,0
63123,each,0,0
63124,therapeutic,0,0
63125,inhalation,0,0
63126,",",0,0
63127,and,0,0
63128,does,0,0
63129,not,0,0
63130,induce,0,0
63131,systemic,0,0
63132,side,0,0
63133,effects,0,0
63134,.,0,1
63135,Joint,0,0
63136,attention,0,0
63137,and,0,0
63138,symbolic,0,0
63139,play,0,0
63140,in,0,0
63141,young,1,1
63142,children,1,1
63143,with,1,1
63144,autism,1,1
63145,:,1,1
63146,a,0,0
63147,randomized,0,0
63148,controlled,0,0
63149,intervention,0,0
63150,study,0,0
63151,.,0,1
63152,BACKGROUND,0,0
63153,Delays,0,0
63154,and,0,1
63155,deficits,0,1
63156,in,0,0
63157,joint,0,0
63158,attention,0,0
63159,and,0,0
63160,symbolic,0,0
63161,play,0,0
63162,constitute,0,0
63163,two,0,0
63164,important,0,0
63165,developmental,0,1
63166,problems,0,1
63167,in,0,0
63168,young,1,1
63169,children,1,1
63170,with,1,1
63171,autism,1,1
63172,.,1,0
63173,These,0,0
63174,areas,0,0
63175,of,0,0
63176,deficit,0,0
63177,have,0,0
63178,been,0,0
63179,well,0,0
63180,studied,0,0
63181,in,0,0
63182,autism,0,1
63183,but,0,0
63184,have,0,0
63185,rarely,0,0
63186,been,0,0
63187,the,0,0
63188,focus,0,0
63189,of,0,0
63190,treatment,0,0
63191,efforts,0,0
63192,(,0,0
63193,see,0,0
63194,Kasari,0,0
63195,",",0,0
63196,Freeman,0,0
63197,",",0,0
63198,&,0,0
63199,Paparella,0,0
63200,",",0,0
63201,2001,0,1
63202,),0,0
63203,.,0,0
63204,In,0,0
63205,this,0,0
63206,study,0,0
63207,",",0,0
63208,we,0,0
63209,examine,0,0
63210,the,0,0
63211,efficacy,0,0
63212,of,0,0
63213,targeted,0,0
63214,interventions,0,0
63215,of,0,0
63216,joint,0,0
63217,attention,0,0
63218,and,0,0
63219,symbolic,0,0
63220,play,0,0
63221,.,0,1
63222,METHODS,0,0
63223,Participants,1,1
63224,were,1,1
63225,58,1,1
63226,children,1,1
63227,with,1,1
63228,autism,1,1
63229,aged,1,1
63230,3,1,0
63231,and,1,0
63232,4,1,0
63233,years,1,1
63234,(,1,1
63235,46,1,1
63236,boys,1,1
63237,),1,1
63238,.,1,1
63239,Children,0,1
63240,were,0,0
63241,randomized,0,0
63242,to,0,0
63243,a,0,0
63244,joint,0,0
63245,attention,0,0
63246,intervention,0,0
63247,",",0,0
63248,a,0,0
63249,symbolic,0,0
63250,play,0,0
63251,intervention,0,0
63252,",",0,0
63253,or,0,0
63254,control,0,0
63255,group,0,0
63256,.,0,0
63257,Interventions,0,0
63258,were,0,0
63259,conducted,0,1
63260,30,0,0
63261,minutes,0,0
63262,daily,0,0
63263,for,0,0
63264,5-6,0,1
63265,weeks,0,0
63266,.,0,0
63267,Both,0,0
63268,structured,0,0
63269,assessments,0,0
63270,of,0,0
63271,joint,0,0
63272,attention,0,0
63273,and,0,0
63274,play,0,0
63275,skills,0,0
63276,and,0,0
63277,mother-child,0,1
63278,interactions,0,0
63279,were,0,0
63280,collected,0,0
63281,pre,0,0
63282,and,0,0
63283,post,0,0
63284,intervention,0,0
63285,by,0,0
63286,independent,0,0
63287,assessors,0,0
63288,.,0,1
63289,RESULTS,0,0
63290,Results,0,0
63291,indicate,0,0
63292,that,0,0
63293,both,0,0
63294,intervention,0,0
63295,groups,0,0
63296,improved,0,0
63297,significantly,0,0
63298,over,0,0
63299,the,0,0
63300,control,0,0
63301,group,0,0
63302,on,0,0
63303,certain,0,0
63304,behaviors,0,0
63305,.,0,1
63306,Children,0,1
63307,in,0,0
63308,the,0,0
63309,joint,0,0
63310,attention,0,0
63311,intervention,0,0
63312,initiated,0,0
63313,significantly,0,0
63314,more,0,0
63315,showing,0,0
63316,and,0,0
63317,responsiveness,0,0
63318,to,0,0
63319,joint,0,0
63320,attention,0,0
63321,on,0,0
63322,the,0,0
63323,structured,0,0
63324,joint,0,0
63325,attention,0,0
63326,assessment,0,0
63327,and,0,0
63328,more,0,0
63329,child-initiated,0,0
63330,joint,0,0
63331,attention,0,0
63332,in,0,0
63333,the,0,0
63334,mother-child,0,1
63335,interaction,0,0
63336,.,0,0
63337,The,0,0
63338,children,0,1
63339,in,0,0
63340,the,0,0
63341,play,0,0
63342,group,0,0
63343,showed,0,0
63344,more,0,0
63345,diverse,0,1
63346,types,0,0
63347,of,0,0
63348,symbolic,0,0
63349,play,0,0
63350,in,0,0
63351,interaction,0,0
63352,with,0,1
63353,their,0,0
63354,mothers,0,1
63355,and,0,0
63356,higher,0,0
63357,play,0,0
63358,levels,0,0
63359,on,0,0
63360,both,0,0
63361,the,0,0
63362,play,0,0
63363,assessment,0,0
63364,and,0,0
63365,in,0,0
63366,interaction,0,0
63367,with,0,1
63368,their,0,0
63369,mothers,0,1
63370,.,0,0
63371,CONCLUSIONS,0,0
63372,This,0,0
63373,randomized,0,0
63374,controlled,0,0
63375,trial,0,0
63376,provides,0,0
63377,promising,0,0
63378,data,0,0
63379,on,0,0
63380,the,0,0
63381,specificity,0,0
63382,and,0,0
63383,generalizability,0,0
63384,of,0,0
63385,joint,0,0
63386,attention,0,0
63387,and,0,0
63388,play,0,0
63389,interventions,0,0
63390,for,0,0
63391,young,1,1
63392,children,1,1
63393,with,1,1
63394,autism,1,1
63395,.,1,0
63396,Future,0,0
63397,studies,0,0
63398,need,0,0
63399,to,0,0
63400,examine,0,0
63401,the,0,0
63402,long-term,0,0
63403,effects,0,0
63404,of,0,0
63405,these,0,0
63406,early,0,0
63407,interventions,0,0
63408,on,0,0
63409,children,0,1
63410,'s,0,1
63411,development,0,0
63412,.,0,1
63413,Effects,0,0
63414,of,0,0
63415,short-,0,0
63416,and,0,0
63417,long-term,0,0
63418,risperidone,0,0
63419,treatment,1,0
63420,on,1,0
63421,prolactin,1,0
63422,levels,1,0
63423,in,1,0
63424,children,1,1
63425,with,1,1
63426,autism,1,1
63427,.,1,0
63428,BACKGROUND,0,0
63429,The,0,0
63430,effects,0,0
63431,of,0,0
63432,short-,0,0
63433,and,0,0
63434,long-term,0,0
63435,risperidone,0,0
63436,treatment,0,0
63437,on,0,0
63438,serum,0,0
63439,prolactin,0,0
63440,were,0,0
63441,assessed,0,0
63442,in,0,0
63443,children,1,1
63444,and,1,0
63445,adolescents,1,1
63446,with,1,1
63447,autism,1,1
63448,.,1,1
63449,METHODS,0,0
63450,Patients,1,1
63451,with,1,1
63452,autism,1,1
63453,(,1,0
63454,N,1,1
63455,=,1,0
63456,101,1,1
63457,",",1,0
63458,5-17,1,1
63459,years,1,1
63460,of,1,0
63461,age,1,1
63462,),1,0
63463,were,0,0
63464,randomized,0,0
63465,to,0,0
63466,an,0,0
63467,8-week,0,0
63468,trial,0,0
63469,of,0,0
63470,risperidone,0,0
63471,or,0,0
63472,placebo,0,0
63473,and,0,0
63474,63,1,0
63475,then,1,0
63476,took,1,0
63477,part,1,0
63478,in,1,0
63479,a,1,0
63480,4-month,1,0
63481,open-label,1,0
63482,follow-up,1,0
63483,phase,1,0
63484,.,1,0
63485,Serum,0,0
63486,samples,0,0
63487,were,0,0
63488,obtained,0,0
63489,at,0,0
63490,Baseline,0,0
63491,and,0,0
63492,Week-8,0,0
63493,(,0,0
63494,N,0,1
63495,=,0,0
63496,78,0,1
63497,),0,0
63498,",",0,0
63499,and,0,0
63500,at,0,0
63501,6-month,0,0
63502,(,0,0
63503,N,0,1
63504,=,0,0
63505,43,0,1
63506,),0,0
63507,and,0,0
63508,22-month,0,0
63509,(,0,0
63510,N,0,1
63511,=,0,0
63512,30,0,0
63513,),0,0
63514,follow-up,0,0
63515,.,0,0
63516,Serum,0,0
63517,prolactin,0,0
63518,was,0,0
63519,determined,0,0
63520,by,0,0
63521,immunoradiometric,0,0
63522,assay,0,0
63523,;,0,0
63524,dopamine,0,0
63525,type-2,0,1
63526,receptor,0,0
63527,(,0,0
63528,DRD2,0,0
63529,),0,0
63530,polymorphisms,0,0
63531,were,0,0
63532,genotyped,0,0
63533,.,0,0
63534,RESULTS,0,0
63535,Baseline,0,0
63536,prolactin,0,0
63537,levels,0,0
63538,were,0,0
63539,similar,0,0
63540,in,0,0
63541,the,0,0
63542,risperidone,0,0
63543,(,0,0
63544,N,0,1
63545,=,0,0
63546,42,0,1
63547,),0,0
63548,and,0,0
63549,placebo,0,0
63550,(,0,0
63551,N,0,1
63552,=,0,0
63553,36,0,1
63554,),0,0
63555,groups,0,0
63556,(,0,0
63557,9.3,0,0
63558,+/-,0,0
63559,7.5,0,0
63560,and,0,0
63561,9.3,0,0
63562,+/-,0,0
63563,7.6,0,0
63564,ng/ml,0,0
63565,",",0,0
63566,respectively,0,0
63567,),0,0
63568,.,0,0
63569,After,0,0
63570,8,0,0
63571,weeks,0,0
63572,of,0,0
63573,risperidone,0,0
63574,",",0,0
63575,prolactin,0,0
63576,increased,0,0
63577,to,0,0
63578,39.0,0,0
63579,+/-,0,0
63580,19.2,0,0
63581,ng/ml,0,0
63582,",",0,0
63583,compared,0,0
63584,with,0,1
63585,10.1,0,0
63586,+/-,0,0
63587,8.8,0,0
63588,ng/ml,0,0
63589,for,0,0
63590,placebo,0,0
63591,(,0,0
63592,p,0,0
63593,<,0,0
63594,.0001,0,0
63595,),0,0
63596,.,0,0
63597,Prolactin,0,0
63598,levels,0,0
63599,were,0,0
63600,also,0,0
63601,significantly,0,0
63602,increased,0,0
63603,at,0,0
63604,6,0,0
63605,months,0,0
63606,(,0,0
63607,32.4,0,0
63608,+/-,0,0
63609,17.8,0,0
63610,ng/ml,0,0
63611,;,0,0
63612,N,0,1
63613,=,0,0
63614,43,0,0
63615,",",0,0
63616,p,0,0
63617,<,0,0
63618,.0001,0,0
63619,),0,0
63620,and,0,0
63621,at,0,0
63622,22,0,1
63623,months,0,0
63624,(,0,0
63625,N,0,1
63626,=,0,0
63627,30,0,0
63628,",",0,0
63629,25.3,0,0
63630,+/-,0,0
63631,15.6,0,0
63632,ng/ml,0,0
63633,",",0,0
63634,p,0,0
63635,<,0,0
63636,.0001,0,0
63637,),0,0
63638,.,0,0
63639,Prolactin,0,0
63640,levels,0,0
63641,were,0,0
63642,not,0,0
63643,associated,0,0
63644,with,0,0
63645,adverse,0,0
63646,effects,0,0
63647,and,0,0
63648,DRD2,0,0
63649,alleles,0,0
63650,(,0,0
63651,Taq1A,0,0
63652,",",0,0
63653,-141C,0,0
63654,Ins/Del,0,0
63655,",",0,0
63656,C957T,0,0
63657,),0,0
63658,did,0,0
63659,not,0,0
63660,significantly,0,0
63661,influence,0,0
63662,baseline,0,0
63663,levels,0,0
63664,or,0,1
63665,risperidone-induced,0,0
63666,increases,0,0
63667,in,0,0
63668,prolactin,0,0
63669,.,0,0
63670,CONCLUSIONS,0,0
63671,Risperidone,0,0
63672,treatment,0,0
63673,was,0,0
63674,associated,0,0
63675,with,0,1
63676,two-,0,0
63677,to,0,0
63678,four-fold,0,0
63679,mean,0,0
63680,increases,0,0
63681,in,0,0
63682,serum,0,0
63683,prolactin,0,0
63684,in,0,0
63685,children,1,1
63686,with,1,1
63687,autism,1,1
63688,.,1,0
63689,Although,0,0
63690,risperidone-induced,0,0
63691,increases,0,0
63692,tended,0,0
63693,to,0,0
63694,diminish,0,0
63695,with,0,0
63696,time,0,0
63697,",",0,0
63698,further,0,0
63699,research,0,0
63700,on,0,0
63701,the,0,0
63702,consequences,0,0
63703,of,0,0
63704,long-term,0,0
63705,prolactin,0,0
63706,elevations,0,0
63707,in,0,0
63708,children,1,1
63709,and,1,0
63710,adolescents,1,1
63711,is,0,0
63712,needed,0,0
63713,.,0,0
63714,POG,0,1
63715,8625,0,1
63716,:,0,1
63717,a,0,0
63718,randomized,0,0
63719,trial,0,0
63720,comparing,0,0
63721,chemotherapy,0,0
63722,with,0,1
63723,chemoradiotherapy,1,0
63724,for,1,0
63725,children,1,1
63726,and,1,0
63727,adolescents,1,1
63728,with,1,1
63729,Stages,1,0
63730,I,1,0
63731,",",1,0
63732,IIA,1,0
63733,",",1,0
63734,IIIA1,1,0
63735,Hodgkin,1,1
63736,Disease,1,1
63737,:,1,1
63738,a,0,0
63739,report,0,0
63740,from,0,0
63741,the,0,0
63742,Children,0,1
63743,'s,0,0
63744,Oncology,0,1
63745,Group,0,1
63746,.,0,0
63747,To,0,0
63748,determine,0,0
63749,if,0,0
63750,6,0,0
63751,courses,0,0
63752,of,0,0
63753,chemotherapy,0,0
63754,alone,0,0
63755,could,0,0
63756,achieve,0,0
63757,the,0,0
63758,same,0,0
63759,or,0,0
63760,better,0,0
63761,outcome,0,0
63762,than,0,0
63763,4,0,0
63764,courses,0,0
63765,of,0,0
63766,chemotherapy,0,0
63767,followed,0,0
63768,by,0,0
63769,radiation,0,0
63770,therapy,0,0
63771,(,0,0
63772,chemoradiotherapy,0,0
63773,),0,0
63774,in,0,0
63775,pediatric,1,1
63776,and,1,0
63777,adolescent,1,1
63778,patients,1,1
63779,with,1,1
63780,Hodgkin,1,1
63781,disease,1,1
63782,.,1,0
63783,Children,1,1
63784,<,1,0
63785,or,1,0
63786,=21,1,1
63787,years,1,1
63788,old,1,1
63789,with,1,1
63790,biopsy-proven,1,1
63791,",",1,0
63792,pathologically,1,1
63793,staged,1,0
63794,I,1,0
63795,",",1,0
63796,IIA,1,0
63797,",",1,0
63798,or,1,0
63799,IIIA1,1,0
63800,Hodgkin,1,1
63801,disease,1,1
63802,were,0,0
63803,randomly,0,1
63804,assigned,0,1
63805,6,0,0
63806,courses,0,0
63807,of,0,0
63808,alternating,0,0
63809,nitrogen,0,0
63810,mustard,0,0
63811,",",0,0
63812,oncovin,0,0
63813,",",0,0
63814,prednisone,0,0
63815,",",0,0
63816,and,0,0
63817,procarbazine/doxorubicin,0,0
63818,",",0,0
63819,bleomycin,0,0
63820,",",0,0
63821,vinblastine,0,0
63822,",",0,0
63823,and,0,0
63824,dacarbazine,0,0
63825,(,0,0
63826,treatment,0,0
63827,1,0,0
63828,),0,0
63829,or,0,1
63830,4,0,0
63831,courses,0,0
63832,of,0,0
63833,alternating,0,0
63834,nitrogen,0,0
63835,mustard,0,0
63836,",",0,0
63837,oncovin,0,0
63838,",",0,0
63839,prednisone,0,0
63840,",",0,0
63841,and,0,0
63842,procarbazine/doxorubicin,0,0
63843,",",0,0
63844,bleomycin,0,0
63845,",",0,0
63846,vinblastine,0,0
63847,",",0,0
63848,and,0,0
63849,dacarbazine,0,0
63850,+2550,0,0
63851,cGy,0,0
63852,involved-field,0,0
63853,radiotherapy,0,1
63854,(,0,0
63855,treatment,0,0
63856,2,0,0
63857,),0,0
63858,.,0,0
63859,The,0,0
63860,complete,0,0
63861,response,0,0
63862,rate,0,0
63863,was,0,0
63864,89,0,0
63865,%,0,0
63866,",",0,0
63867,with,0,0
63868,a,0,0
63869,complete,0,0
63870,response,0,0
63871,and,0,0
63872,partial,0,0
63873,response,0,0
63874,rate,0,0
63875,of,0,0
63876,99.4,0,0
63877,%,0,0
63878,.,0,0
63879,There,0,0
63880,was,0,0
63881,no,0,0
63882,statistically,0,0
63883,significant,0,0
63884,difference,0,0
63885,in,0,0
63886,event-free,0,0
63887,survival,0,0
63888,(,0,0
63889,EFS,0,0
63890,),0,0
63891,or,0,0
63892,overall,0,0
63893,survival,0,0
63894,between,0,0
63895,arms,0,0
63896,.,0,1
63897,The,0,0
63898,EFS,0,0
63899,for,0,0
63900,those,0,1
63901,who,0,1
63902,achieved,0,0
63903,an,0,1
63904,early,0,0
63905,complete,0,0
63906,response,0,0
63907,was,0,0
63908,significantly,0,0
63909,higher,0,0
63910,than,0,0
63911,for,0,0
63912,those,0,1
63913,who,0,1
63914,did,0,0
63915,not,0,1
63916,.,0,0
63917,For,0,0
63918,pediatric,1,1
63919,patients,1,1
63920,with,1,1
63921,asymptomatic,1,1
63922,low-stage,1,1
63923,and,1,0
63924,intermediate-stage,1,0
63925,Hodgkin,1,1
63926,disease,1,1
63927,",",0,0
63928,chemotherapy,0,0
63929,and,0,0
63930,chemoradiotherapy,0,0
63931,both,0,0
63932,resulted,0,0
63933,in,0,0
63934,3-year,0,0
63935,EFS,0,0
63936,of,0,0
63937,approximately,0,0
63938,90,0,0
63939,%,0,0
63940,and,0,0
63941,statistically,0,0
63942,indistinguishable,0,0
63943,8-year,0,0
63944,EFS,0,0
63945,and,0,0
63946,overall,0,0
63947,survival,0,0
63948,",",0,0
63949,without,0,0
63950,significant,0,0
63951,long-term,0,0
63952,toxicity,0,0
63953,.,0,0
63954,Early,0,0
63955,response,0,0
63956,to,0,0
63957,therapy,0,0
63958,was,0,0
63959,associated,0,0
63960,with,0,1
63961,higher,0,0
63962,EFS,0,0
63963,",",0,0
63964,a,0,0
63965,concept,0,0
63966,that,0,0
63967,has,0,0
63968,led,0,0
63969,to,0,0
63970,the,0,0
63971,Children,0,1
63972,'s,0,0
63973,Oncology,0,1
63974,Group,0,1
63975,paradigm,0,0
63976,of,0,0
63977,response-based,0,0
63978,risk-adapted,0,0
63979,therapy,0,0
63980,for,0,0
63981,pediatric,0,1
63982,Hodgkin,0,1
63983,disease,0,1
63984,.,0,0
63985,Psychological,0,1
63986,well-being,0,0
63987,correlates,0,0
63988,with,0,1
63989,free,0,1
63990,thyroxine,0,0
63991,but,0,0
63992,not,0,0
63993,free,0,0
63994,"3,5,3'-triiodothyronine",0,0
63995,levels,0,0
63996,in,0,0
63997,patients,1,1
63998,on,1,0
63999,thyroid,1,1
64000,hormone,1,0
64001,replacement,1,1
64002,.,1,0
64003,CONTEXT,0,0
64004,AND,0,0
64005,OBJECTIVE,0,0
64006,An,0,0
64007,association,0,0
64008,between,0,0
64009,mood,0,0
64010,disorders,0,1
64011,and,0,0
64012,overt,0,1
64013,thyroid,0,0
64014,dysfunction,0,0
64015,is,0,0
64016,well,0,0
64017,established,0,0
64018,",",0,0
64019,but,0,0
64020,there,0,0
64021,are,0,0
64022,few,0,0
64023,data,0,0
64024,on,0,0
64025,the,0,0
64026,potential,0,0
64027,for,0,0
64028,thyroid,0,1
64029,hormone,0,0
64030,levels,0,0
64031,closer,0,0
64032,to,0,0
64033,the,0,0
64034,reference,0,0
64035,range,0,0
64036,to,0,0
64037,correlate,0,0
64038,with,0,0
64039,psychological,0,0
64040,well-being,0,0
64041,.,0,0
64042,DESIGN,0,0
64043,",",0,0
64044,SETTING,0,0
64045,",",0,0
64046,AND,0,0
64047,PATIENTS,0,0
64048,We,0,0
64049,analyzed,0,0
64050,the,0,0
64051,relationship,0,0
64052,between,0,0
64053,psychological,0,0
64054,well-being,0,0
64055,and,0,0
64056,free,0,0
64057,T,0,0
64058,(,0,0
64059,4,0,0
64060,),0,0
64061,(,0,0
64062,fT4,0,0
64063,),0,0
64064,",",0,0
64065,free,0,0
64066,T,0,0
64067,(,0,0
64068,3,0,0
64069,),0,0
64070,(,0,0
64071,fT3,0,0
64072,),0,0
64073,",",0,0
64074,TSH,0,0
64075,",",0,0
64076,and,0,0
64077,total,0,0
64078,rT,0,0
64079,(,0,0
64080,3,0,0
64081,),0,0
64082,in,0,0
64083,697,1,1
64084,patients,1,1
64085,on,1,0
64086,thyroid,1,1
64087,hormone,1,0
64088,replacement,1,0
64089,therapy,1,0
64090,at,1,0
64091,entry,1,0
64092,to,1,0
64093,a,1,0
64094,randomized,1,0
64095,",",1,0
64096,controlled,1,0
64097,trial,1,0
64098,of,1,0
64099,combined,1,0
64100,T,1,0
64101,(,1,0
64102,4,1,0
64103,),1,0
64104,and,1,0
64105,T,1,0
64106,(,1,0
64107,3,1,0
64108,),1,0
64109,replacement,1,0
64110,therapy,1,0
64111,.,1,0
64112,All,1,0
64113,patients,1,1
64114,were,1,0
64115,on,1,0
64116,100,1,0
64117,mug,1,0
64118,or,1,0
64119,more,1,0
64120,T,1,0
64121,(,1,0
64122,4,1,0
64123,),1,0
64124,.,1,0
64125,INTERVENTIONS,0,0
64126,AND,0,0
64127,MAIN,0,0
64128,OUTCOME,0,0
64129,MEASURES,0,0
64130,Psychological,0,1
64131,well-being,0,0
64132,was,0,0
64133,assessed,0,0
64134,with,0,1
64135,General,0,1
64136,Health,0,0
64137,Questionnaire-12,0,0
64138,(,0,0
64139,GHQ-12,0,0
64140,),0,0
64141,",",0,0
64142,Thyroid,0,1
64143,Symptom,0,0
64144,Questionnaire,0,0
64145,",",0,0
64146,and,0,0
64147,Hospital,0,1
64148,Anxiety,0,0
64149,and,0,0
64150,Depression,0,0
64151,Scale,0,0
64152,.,0,0
64153,RESULTS,0,0
64154,fT,0,0
64155,(,0,0
64156,4,0,0
64157,),0,0
64158,and,0,0
64159,TSH,0,0
64160,showed,0,0
64161,a,0,0
64162,strong,0,0
64163,correlation,0,0
64164,with,0,1
64165,GHQ-12,0,0
64166,scores,0,0
64167,(,0,0
64168,fT4,0,1
64169,-,0,0
64170,b,0,0
64171,:,0,0
64172,-0.16,0,0
64173,",",0,0
64174,P,0,0
64175,=,0,0
64176,0.005,0,0
64177,;,0,0
64178,TSH,0,0
64179,-,0,0
64180,b,0,0
64181,:,0,1
64182,0.663,0,0
64183,",",0,0
64184,P,0,0
64185,=,0,0
64186,0.04,0,0
64187,),0,0
64188,.,0,0
64189,No,0,0
64190,correlations,0,0
64191,were,0,0
64192,seen,0,0
64193,between,0,0
64194,the,0,0
64195,GHQ,0,0
64196,scores,0,0
64197,and,0,0
64198,fT3,0,1
64199,(,0,0
64200,b,0,0
64201,:,0,1
64202,0.318,0,0
64203,",",0,0
64204,P,0,0
64205,=,0,0
64206,0.275,0,0
64207,),0,0
64208,",",0,0
64209,rT,0,0
64210,(,0,0
64211,3,0,0
64212,),0,0
64213,(,0,0
64214,b,0,0
64215,:,0,1
64216,0.095,0,0
64217,",",0,0
64218,P,0,0
64219,=,0,0
64220,0.95,0,0
64221,),0,0
64222,",",0,0
64223,rT,0,0
64224,(,0,0
64225,3,0,0
64226,),0,0
64227,to,0,0
64228,fT4,0,0
64229,ratio,0,0
64230,(,0,0
64231,b,0,0
64232,:,0,1
64233,71.83,0,0
64234,",",0,0
64235,P,0,0
64236,=,0,0
64237,0.09,0,0
64238,),0,0
64239,or,0,0
64240,fT3,0,0
64241,to,0,0
64242,rT,0,0
64243,(,0,0
64244,3,0,0
64245,),0,0
64246,ratio,0,0
64247,(,0,0
64248,b,0,0
64249,:,0,1
64250,0.05,0,0
64251,",",0,0
64252,P,0,0
64253,=,0,0
64254,0.32,0,0
64255,),0,0
64256,.,0,0
64257,The,0,0
64258,correlations,0,0
64259,remained,0,0
64260,when,0,0
64261,the,0,0
64262,data,0,0
64263,set,0,0
64264,was,0,0
64265,limited,0,0
64266,to,0,0
64267,patients,0,1
64268,with,0,1
64269,TSH,0,0
64270,in,0,0
64271,the,0,0
64272,range,0,0
64273,0.3-4.0,0,0
64274,mIU/liter,0,0
64275,.,0,0
64276,Similar,0,0
64277,correlations,0,0
64278,were,0,0
64279,seen,0,0
64280,with,0,0
64281,the,0,0
64282,Thyroid,0,1
64283,Symptom,0,0
64284,Questionnaire,0,0
64285,",",0,0
64286,although,0,0
64287,not,0,0
64288,with,0,0
64289,the,0,0
64290,Hospital,0,1
64291,Anxiety,0,0
64292,and,0,0
64293,Depression,0,0
64294,Scale,0,0
64295,scores,0,0
64296,.,0,1
64297,CONCLUSIONS,0,0
64298,Differences,0,0
64299,in,0,0
64300,fT4,0,1
64301,and,0,0
64302,TSH,0,0
64303,concentration,0,0
64304,",",0,0
64305,even,0,0
64306,within,0,0
64307,the,0,0
64308,reference,0,0
64309,range,0,0
64310,",",0,0
64311,may,0,0
64312,be,0,0
64313,a,0,0
64314,determinant,0,0
64315,of,0,0
64316,psychological,0,0
64317,well-being,0,0
64318,in,0,0
64319,treated,1,1
64320,hypothyroid,1,1
64321,patients,1,1
64322,although,0,0
64323,not,0,0
64324,necessarily,0,0
64325,with,0,0
64326,symptoms,0,0
64327,typical,0,1
64328,of,0,0
64329,anxiety,0,0
64330,or,0,0
64331,depression,0,1
64332,.,0,0
64333,Pelvic,0,0
64334,lymphadenectomy,0,0
64335,for,0,0
64336,cervical,1,1
64337,carcinoma,1,1
64338,:,1,1
64339,laparotomy,0,1
64340,extraperitoneal,0,1
64341,",",0,0
64342,transperitoneal,0,0
64343,or,0,0
64344,laparoscopic,0,0
64345,approach,0,0
64346,?,0,0
64347,A,0,0
64348,randomized,0,0
64349,study,0,0
64350,.,0,0
64351,OBJECTIVE,0,0
64352,To,0,0
64353,compare,0,0
64354,transperitoneal,0,0
64355,",",0,0
64356,extraperitoneal,0,1
64357,and,0,0
64358,laparoscopic,0,0
64359,pelvic,0,0
64360,lymphadenectomy,0,0
64361,in,0,0
64362,terms,0,0
64363,of,0,0
64364,feasibility,0,0
64365,and,0,0
64366,morbidity,0,0
64367,in,0,0
64368,patients,1,1
64369,affected,1,0
64370,by,1,0
64371,cervical,1,1
64372,cancer,1,1
64373,undergoing,1,1
64374,radical,1,0
64375,hysterectomy,1,1
64376,.,1,0
64377,METHODS,0,0
64378,Consecutive,1,1
64379,patients,1,1
64380,affected,1,0
64381,by,1,0
64382,stage,1,1
64383,IB-IIB,1,0
64384,cervical,1,1
64385,carcinoma,1,1
64386,scheduled,1,1
64387,for,1,0
64388,radical,1,0
64389,surgery,1,1
64390,entered,0,1
64391,the,0,0
64392,study,0,0
64393,.,0,0
64394,Patients,0,1
64395,were,0,0
64396,randomly,0,1
64397,assigned,0,0
64398,to,0,0
64399,transperitoneal,0,1
64400,(,0,0
64401,TPL,0,0
64402,),0,0
64403,",",0,0
64404,extraperitoneal,0,1
64405,(,0,0
64406,EPL,0,1
64407,),0,0
64408,or,0,0
64409,laparoscopic,0,0
64410,pelvic,0,1
64411,lymphadenectomy,0,0
64412,(,0,0
64413,LPL,0,0
64414,),0,0
64415,.,0,0
64416,All,1,0
64417,patients,1,1
64418,underwent,1,1
64419,classical,1,1
64420,radical,1,1
64421,hysterectomy,1,1
64422,.,1,0
64423,Perioperative,0,0
64424,data,0,0
64425,were,0,0
64426,recorded,0,0
64427,.,0,0
64428,Follow,0,0
64429,up,0,0
64430,examinations,0,0
64431,were,0,0
64432,performed,0,0
64433,at,0,0
64434,the,0,0
64435,15th,0,0
64436,",",0,0
64437,30th,0,0
64438,and,0,0
64439,60th,0,0
64440,day,0,0
64441,after,0,0
64442,surgery,0,1
64443,.,0,0
64444,RESULTS,0,0
64445,168,1,0
64446,patients,1,1
64447,entered,1,1
64448,the,1,0
64449,study,1,0
64450,.,1,0
64451,The,0,0
64452,mean,0,0
64453,operative,0,0
64454,times,0,0
64455,were,0,1
64456,:,0,1
64457,63+/-7.6,0,1
64458,",",0,0
64459,54+/-6.7,0,0
64460,and,0,0
64461,75+/-8.4,0,0
64462,min,0,0
64463,(,0,0
64464,TPL,0,0
64465,vs,0,0
64466,EPL,0,1
64467,P,0,0
64468,<,0,0
64469,0.001,0,0
64470,;,0,0
64471,EPL,0,1
64472,vs,0,0
64473,LPL,0,0
64474,P,0,0
64475,<,0,0
64476,0.001,0,0
64477,;,0,0
64478,TPL,0,0
64479,vs,0,0
64480,LPL,0,0
64481,P,0,0
64482,<,0,0
64483,0.001,0,0
64484,),0,0
64485,for,0,0
64486,TPL,0,0
64487,",",0,0
64488,EPL,0,0
64489,and,0,0
64490,LPL,0,0
64491,respectively,0,0
64492,.,0,0
64493,The,0,0
64494,feasibility,0,0
64495,of,0,0
64496,the,0,0
64497,procedures,0,0
64498,",",0,0
64499,analyzed,0,0
64500,on,0,0
64501,an,0,0
64502,intention-to-treat,0,0
64503,basis,0,0
64504,",",0,0
64505,was,0,0
64506,96,0,0
64507,%,0,0
64508,",",0,0
64509,93,0,0
64510,%,0,0
64511,and,0,0
64512,95,0,0
64513,%,0,0
64514,for,0,0
64515,TPL,0,0
64516,",",0,0
64517,EPL,0,0
64518,and,0,0
64519,LPL,0,0
64520,group,0,0
64521,respectively,0,0
64522,(,0,0
64523,P=ns,0,0
64524,),0,0
64525,.,0,0
64526,The,0,0
64527,average,0,0
64528,hospitalizations,0,1
64529,were,0,1
64530,:,0,1
64531,5.6+/-0.9,0,0
64532,",",0,0
64533,3.2+/-0.4,0,0
64534,and,0,0
64535,3.1+/-0.3,0,0
64536,days,0,0
64537,(,0,0
64538,TPL,0,0
64539,vs,0,0
64540,EPL,0,1
64541,P,0,0
64542,<,0,0
64543,0.001,0,0
64544,;,0,0
64545,TPL,0,0
64546,vs,0,0
64547,LPL,0,0
64548,P,0,0
64549,<,0,0
64550,0.001,0,0
64551,),0,0
64552,for,0,0
64553,TPL,0,0
64554,",",0,0
64555,EPL,0,0
64556,and,0,0
64557,LPL,0,0
64558,respectively,0,0
64559,.,0,0
64560,CONCLUSIONS,0,0
64561,EPL,0,0
64562,and,0,0
64563,LPL,0,0
64564,are,0,0
64565,as,0,0
64566,feasible,0,0
64567,and,0,0
64568,effective,0,0
64569,as,0,0
64570,TPL,0,0
64571,and,0,0
64572,can,0,0
64573,be,0,0
64574,adequately,0,0
64575,performed,0,0
64576,with,0,0
64577,a,0,0
64578,reasonable,0,0
64579,complication,0,0
64580,rate,0,0
64581,.,0,0
64582,LPL,0,0
64583,showed,0,0
64584,a,0,0
64585,statistically,0,0
64586,significant,0,0
64587,longer,0,0
64588,operative,0,0
64589,time,0,0
64590,.,0,0
64591,However,0,0
64592,",",0,0
64593,both,0,0
64594,EPL,0,0
64595,and,0,0
64596,LPL,0,0
64597,can,0,0
64598,minimize,0,0
64599,some,0,0
64600,postoperative,0,0
64601,complications,0,0
64602,reducing,0,0
64603,length,0,0
64604,of,0,0
64605,stay,0,0
64606,.,0,0
64607,Randomized,0,0
64608,comparison,0,0
64609,of,0,0
64610,two,0,0
64611,communication,0,0
64612,interventions,0,0
64613,for,0,0
64614,preschoolers,1,1
64615,with,1,1
64616,autism,1,1
64617,spectrum,1,1
64618,disorders,1,1
64619,.,1,0
64620,This,0,0
64621,randomized,0,0
64622,group,0,0
64623,experiment,0,0
64624,compared,0,0
64625,the,0,0
64626,efficacy,0,0
64627,of,0,0
64628,2,0,0
64629,communication,0,0
64630,interventions,0,0
64631,(,0,0
64632,Responsive,0,1
64633,Education,0,0
64634,and,0,0
64635,Prelinguistic,0,1
64636,Milieu,0,0
64637,Teaching,0,0
64638,[,0,0
64639,RPMT,0,0
64640,],0,0
64641,and,0,0
64642,the,0,0
64643,Picture,0,0
64644,Exchange,0,0
64645,Communication,0,0
64646,System,0,1
64647,[,0,0
64648,PECS,0,0
64649,],0,0
64650,),0,0
64651,in,0,0
64652,36,1,1
64653,preschoolers,1,1
64654,with,1,1
64655,autism,1,1
64656,spectrum,1,1
64657,disorders,1,1
64658,.,1,0
64659,Each,0,0
64660,treatment,0,0
64661,was,0,0
64662,delivered,0,0
64663,3,0,0
64664,times,0,0
64665,per,0,0
64666,week,0,0
64667,",",0,0
64668,in,0,0
64669,20-min,0,0
64670,sessions,0,0
64671,",",0,0
64672,for,0,0
64673,6,0,0
64674,months,0,0
64675,.,0,1
64676,The,0,0
64677,results,0,0
64678,revealed,0,0
64679,that,0,0
64680,the,0,0
64681,RPMT,0,0
64682,facilitated,0,0
64683,the,0,0
64684,frequency,0,0
64685,of,0,0
64686,generalized,0,0
64687,turn,0,0
64688,taking,0,0
64689,and,0,0
64690,generalized,0,0
64691,initiating,0,0
64692,joint,0,0
64693,attention,0,0
64694,more,0,0
64695,than,0,0
64696,did,0,0
64697,the,0,0
64698,PECS,0,0
64699,.,0,0
64700,The,0,0
64701,latter,0,0
64702,effect,0,0
64703,occurred,0,0
64704,only,0,0
64705,for,0,0
64706,children,0,1
64707,who,0,1
64708,began,0,1
64709,treatment,0,1
64710,with,0,0
64711,at,0,0
64712,least,0,0
64713,some,0,0
64714,initiating,0,0
64715,joint,0,0
64716,attention,0,0
64717,.,0,0
64718,In,0,0
64719,contrast,0,0
64720,",",0,0
64721,the,0,0
64722,PECS,0,0
64723,facilitated,0,0
64724,generalized,0,0
64725,requests,0,0
64726,more,0,0
64727,than,0,0
64728,the,0,0
64729,RPMT,0,0
64730,in,0,0
64731,children,0,1
64732,with,0,1
64733,very,0,0
64734,little,0,0
64735,initiating,0,0
64736,joint,0,0
64737,attention,0,0
64738,prior,0,0
64739,to,0,0
64740,treatment,0,0
64741,.,0,0
64742,These,0,0
64743,effect,0,0
64744,sizes,0,0
64745,were,0,0
64746,large,0,1
64747,.,0,0
64748,Effects,0,0
64749,of,0,1
64750,single,0,0
64751,doses,0,0
64752,of,0,0
64753,rabeprazole,0,0
64754,20,0,1
64755,mg,0,0
64756,and,0,0
64757,esomeprazole,0,0
64758,40,0,0
64759,mg,0,0
64760,on,0,0
64761,24-h,1,0
64762,intragastric,1,0
64763,pH,1,0
64764,in,1,0
64765,healthy,1,1
64766,subjects,1,1
64767,.,1,1
64768,OBJECTIVE,0,0
64769,To,0,0
64770,compare,0,0
64771,antisecretory,0,0
64772,effects,0,0
64773,of,0,0
64774,single,0,0
64775,doses,0,0
64776,of,0,0
64777,rabeprazole,0,0
64778,and,0,0
64779,esomeprazole,0,0
64780,.,0,0
64781,METHODS,0,0
64782,Open,0,0
64783,",",0,0
64784,randomised,0,0
64785,",",0,0
64786,2-way,0,0
64787,crossover,0,0
64788,",",0,0
64789,clinical,0,0
64790,pharmacology,0,0
64791,study,0,0
64792,.,0,0
64793,24,1,0
64794,healthy,1,1
64795,subjects,1,1
64796,(,1,1
64797,10,1,1
64798,men,1,1
64799,;,1,0
64800,mean,1,1
64801,age,1,1
64802,26.2,1,0
64803,y,1,1
64804,),1,0
64805,received,0,0
64806,a,0,0
64807,single,0,0
64808,dose,0,0
64809,of,0,0
64810,rabeprazole,0,0
64811,20,0,1
64812,mg,0,0
64813,or,0,0
64814,esomeprazole,0,0
64815,40,0,0
64816,mg,0,0
64817,",",0,0
64818,with,0,0
64819,a,0,0
64820,14-day,0,0
64821,'washout,0,0
64822,',0,0
64823,.,0,0
64824,Intragastric,0,0
64825,pH,0,0
64826,was,0,0
64827,recorded,0,0
64828,continuously,0,0
64829,from,0,0
64830,24,0,0
64831,h,0,0
64832,before,0,0
64833,to,0,0
64834,24,0,0
64835,h,0,0
64836,after,0,0
64837,dosing,0,0
64838,.,0,1
64839,RESULTS,0,0
64840,Mean,0,0
64841,intragastric,0,0
64842,pH,0,0
64843,was,0,0
64844,higher,0,0
64845,after,0,0
64846,esomeprazole,0,0
64847,than,0,0
64848,rabeprazole,0,0
64849,during,0,0
64850,0-5,0,1
64851,h,0,0
64852,after,0,0
64853,dosing,0,0
64854,(,0,0
64855,P=0.0001,0,0
64856,),0,0
64857,;,0,0
64858,the,0,0
64859,reverse,0,0
64860,was,0,0
64861,true,0,0
64862,from,0,0
64863,14-24,0,1
64864,h,0,0
64865,(,0,0
64866,P=0.0002,0,0
64867,),0,0
64868,.,0,0
64869,Mean,0,0
64870,%,0,0
64871,time,0,0
64872,pH,0,0
64873,>,0,1
64874,3,0,0
64875,and,0,0
64876,>,0,1
64877,4,0,0
64878,was,0,0
64879,greater,0,0
64880,after,0,0
64881,esomeprazole,0,0
64882,than,0,0
64883,rabeprazole,0,0
64884,during,0,0
64885,0-14,0,0
64886,h,0,0
64887,(,0,0
64888,P=0.041,0,0
64889,and,0,0
64890,0.044,0,0
64891,),0,0
64892,",",0,0
64893,but,0,0
64894,the,0,0
64895,reverse,0,0
64896,was,0,0
64897,true,0,0
64898,during,0,0
64899,14-24,0,1
64900,h,0,0
64901,(,0,0
64902,P=0.0005,0,0
64903,and,0,0
64904,0.001,0,0
64905,),0,0
64906,.,0,0
64907,In,0,0
64908,the,0,0
64909,0-24,0,0
64910,h,0,0
64911,interval,0,0
64912,as,0,0
64913,a,0,0
64914,whole,0,0
64915,",",0,0
64916,there,0,0
64917,was,0,0
64918,no,0,0
64919,difference,0,0
64920,between,0,0
64921,treatments,0,0
64922,in,0,0
64923,mean,0,1
64924,pH,0,0
64925,or,0,0
64926,%,0,0
64927,time,0,0
64928,pH,0,0
64929,>,0,1
64930,3,0,0
64931,or,0,1
64932,>,0,1
64933,4,0,0
64934,.,0,0
64935,CONCLUSION,0,0
64936,Single-dose,0,0
64937,rabeprazole,0,0
64938,20,0,1
64939,mg,0,0
64940,was,0,0
64941,as,0,0
64942,effective,0,0
64943,as,0,0
64944,esomeprazole,0,0
64945,40,0,1
64946,mg,0,0
64947,in,0,0
64948,increasing,0,0
64949,intragastric,0,0
64950,pH,0,0
64951,and,0,0
64952,maintaining,0,0
64953,pH,0,0
64954,>,0,1
64955,3,0,0
64956,and,0,0
64957,>,0,1
64958,4,0,0
64959,",",0,0
64960,despite,0,0
64961,the,0,0
64962,2-fold,0,0
64963,difference,0,0
64964,in,0,0
64965,dose,0,0
64966,.,0,0
64967,Long-term,0,0
64968,follow-up,0,0
64969,of,0,0
64970,the,0,0
64971,Stockholm,0,1
64972,randomized,0,0
64973,trials,0,0
64974,of,0,0
64975,postoperative,0,0
64976,radiation,0,0
64977,therapy,0,0
64978,versus,0,0
64979,adjuvant,0,0
64980,chemotherapy,0,0
64981,among,0,0
64982,'high,1,0
64983,risk,1,0
64984,',1,0
64985,pre-,1,0
64986,and,1,0
64987,postmenopausal,1,1
64988,breast,1,1
64989,cancer,1,1
64990,patients,1,1
64991,.,1,0
64992,For,0,0
64993,many,0,0
64994,years,0,1
64995,",",0,0
64996,loco-regional,0,0
64997,radiotherapy,0,0
64998,was,0,0
64999,the,0,0
65000,standard,0,0
65001,postoperative,0,0
65002,treatment,0,0
65003,for,0,0
65004,node,1,0
65005,positive,1,0
65006,breast,1,1
65007,cancer,1,1
65008,patients,1,1
65009,in,1,0
65010,Sweden,1,1
65011,.,1,0
65012,Because,0,0
65013,of,0,0
65014,encouraging,0,0
65015,results,0,0
65016,from,0,1
65017,trials,0,0
65018,of,0,0
65019,adjuvant,0,0
65020,chemotherapy,0,0
65021,in,0,0
65022,the,0,0
65023,mid,0,0
65024,1970s,0,0
65025,",",0,0
65026,the,1,0
65027,Stockholm,1,1
65028,Breast,1,0
65029,Cancer,1,0
65030,Study,1,0
65031,Group,1,0
65032,decided,0,0
65033,to,0,0
65034,directly,0,0
65035,compare,0,0
65036,postoperative,0,0
65037,radiation,0,0
65038,(,0,0
65039,RT,0,0
65040,),0,0
65041,with,0,1
65042,adjuvant,0,0
65043,CMF-type,0,0
65044,chemotherapy,0,0
65045,(,0,0
65046,CT,0,0
65047,),0,0
65048,.,0,0
65049,Long-term,0,0
65050,results,0,0
65051,are,0,0
65052,presented,0,0
65053,from,0,0
65054,two,0,0
65055,randomized,0,1
65056,trials,0,0
65057,of,0,0
65058,RT,0,1
65059,versus,0,0
65060,CT,0,0
65061,in,0,0
65062,pre-,1,0
65063,(,1,0
65064,n,1,1
65065,=,1,0
65066,547,1,1
65067,),1,0
65068,and,1,0
65069,postmenopausal,1,1
65070,(,1,0
65071,n,1,1
65072,=,1,0
65073,679,1,1
65074,),1,0
65075,patients,1,1
65076,",",1,0
65077,respectively,1,0
65078,",",1,0
65079,with,1,0
65080,node,1,0
65081,positive,1,0
65082,disease,1,1
65083,or,1,0
65084,a,1,0
65085,tumour,1,0
65086,diameter,1,0
65087,>,1,1
65088,30,1,0
65089,mm,1,0
65090,.,1,0
65091,RT,0,0
65092,substantially,0,0
65093,reduced,0,0
65094,loco-regional,0,0
65095,recurrences,0,0
65096,among,0,0
65097,both,0,0
65098,pre-,0,0
65099,and,0,0
65100,postmenopausal,0,1
65101,patients,0,1
65102,(,0,0
65103,relative,0,0
65104,hazard,0,0
65105,RT,0,0
65106,versus,0,0
65107,CT,0,0
65108,:,0,1
65109,0.67,0,0
65110,and,0,0
65111,0.43,0,0
65112,",",0,0
65113,respectively,0,0
65114,),0,0
65115,.,0,0
65116,Among,0,1
65117,premenopausal,0,1
65118,patients,0,1
65119,distant,0,1
65120,metastases,0,0
65121,occurred,0,0
65122,less,0,0
65123,frequently,0,0
65124,in,0,0
65125,the,0,0
65126,CT,0,0
65127,group,0,0
65128,(,0,0
65129,relative,0,0
65130,hazard,0,0
65131,:,0,1
65132,1.68,0,0
65133,",",0,0
65134,p,0,0
65135,>,0,1
65136,0.001,0,0
65137,),0,0
65138,resulting,0,0
65139,in,0,0
65140,an,0,0
65141,improved,0,0
65142,recurrence-free,0,0
65143,survival,0,0
65144,(,0,0
65145,p,0,0
65146,=,0,0
65147,0.04,0,0
65148,),0,0
65149,.,0,0
65150,Overall,0,0
65151,survival,0,0
65152,was,0,0
65153,also,0,0
65154,better,0,0
65155,with,0,0
65156,CT,0,0
65157,(,0,0
65158,cumulative,0,0
65159,survival,0,0
65160,at,0,0
65161,15,0,1
65162,years,0,1
65163,:,0,1
65164,50,0,0
65165,%,0,0
65166,and,0,0
65167,44,0,0
65168,%,0,0
65169,in,0,0
65170,the,0,0
65171,CT,0,0
65172,and,0,0
65173,RT,0,0
65174,groups,0,0
65175,",",0,0
65176,respectively,0,0
65177,),0,0
65178,but,0,0
65179,the,0,0
65180,difference,0,0
65181,was,0,0
65182,not,0,0
65183,statistically,0,0
65184,significant,0,0
65185,.,0,0
65186,Among,0,0
65187,the,0,0
65188,postmenopausal,0,1
65189,patients,0,1
65190,there,0,0
65191,were,0,0
65192,no,0,0
65193,substantial,0,0
65194,differences,0,0
65195,in,0,0
65196,terms,0,0
65197,of,0,0
65198,recurrence-free,0,0
65199,or,0,0
65200,overall,0,0
65201,survival,0,0
65202,between,0,0
65203,the,0,0
65204,treatment,0,0
65205,groups,0,0
65206,.,0,0
65207,The,0,0
65208,risk,0,0
65209,of,0,0
65210,a,0,0
65211,second,0,0
65212,primary,0,0
65213,malignancy,0,0
65214,",",0,0
65215,however,0,0
65216,",",0,0
65217,was,0,0
65218,doubled,0,0
65219,in,0,0
65220,the,0,0
65221,RT,0,0
65222,group,0,0
65223,(,0,0
65224,p,0,0
65225,>,0,1
65226,0.01,0,0
65227,),0,0
65228,.,0,0
65229,The,0,0
65230,most,0,0
65231,pronounced,0,0
65232,excess,0,0
65233,concerned,0,0
65234,second,0,0
65235,lung,0,1
65236,cancers,0,1
65237,occurring,0,1
65238,after,0,0
65239,10,0,1
65240,years,0,1
65241,.,0,0
65242,The,0,0
65243,cumulative,0,0
65244,incidence,0,0
65245,at,0,0
65246,20,0,1
65247,years,0,1
65248,was,0,0
65249,estimated,0,0
65250,at,0,0
65251,0.3,0,0
65252,%,0,0
65253,and,0,0
65254,3.7,0,0
65255,%,0,0
65256,in,0,0
65257,the,0,0
65258,CT,0,0
65259,and,0,0
65260,RT,0,0
65261,groups,0,0
65262,",",0,0
65263,respectively,0,0
65264,.,0,0
65265,The,0,0
65266,trials,0,0
65267,illustrate,0,0
65268,the,0,0
65269,role,0,0
65270,of,0,0
65271,radiotherapy,0,0
65272,in,0,0
65273,preventing,0,0
65274,loco-regional,0,1
65275,recurrences,0,0
65276,among,0,1
65277,high-risk,0,1
65278,patients,0,1
65279,",",0,0
65280,as,0,0
65281,well,0,0
65282,as,0,0
65283,the,0,0
65284,need,0,0
65285,for,0,0
65286,systemic,0,0
65287,treatment,0,0
65288,to,0,0
65289,control,0,0
65290,the,0,0
65291,disease,0,0
65292,systemically,0,0
65293,.,0,0
65294,Pharmacokinetic-pharmacodynamic,0,0
65295,relationship,0,0
65296,of,0,0
65297,rocuronium,1,0
65298,under,1,0
65299,stable,1,1
65300,nitrous,1,0
65301,oxide-fentanyl,1,0
65302,or,1,1
65303,nitrous,1,0
65304,oxide-sevoflurane,1,0
65305,anesthesia,1,1
65306,in,1,0
65307,children,1,1
65308,.,1,0
65309,BACKGROUND,0,0
65310,The,0,0
65311,aim,0,0
65312,of,0,0
65313,this,0,0
65314,study,0,0
65315,was,0,0
65316,to,0,0
65317,compare,0,0
65318,pharmacokinetics,0,0
65319,and,0,0
65320,pharmacokinetic-pharmacodynamic,0,0
65321,(,0,0
65322,PK-PD,0,0
65323,),0,0
65324,relationship,0,0
65325,of,0,0
65326,rocuronium,0,0
65327,in,0,0
65328,children,1,1
65329,anesthetized,1,1
65330,with,1,1
65331,nitrous,1,0
65332,oxide,1,0
65333,(,1,0
65334,N2O,1,0
65335,),1,0
65336,and,1,0
65337,fentanyl,1,0
65338,or,1,0
65339,with,1,0
65340,N2O,1,0
65341,and,1,0
65342,sevoflurane,1,0
65343,.,1,0
65344,METHODS,0,0
65345,Twenty-four,1,1
65346,children,1,1
65347,(,1,1
65348,3-11,1,1
65349,years,1,1
65350,old,1,1
65351,",",1,0
65352,ASA,1,0
65353,PS,1,1
65354,I,1,0
65355,or,1,0
65356,II,1,0
65357,),1,0
65358,were,1,0
65359,randomized,1,0
65360,to,0,0
65361,receive,0,0
65362,N2O/O2-fentanyl,0,0
65363,or,0,0
65364,N2O/O2-sevoflurane,0,0
65365,(,0,0
65366,one,0,0
65367,MAC,0,0
65368,),0,0
65369,anesthesia,0,0
65370,.,0,0
65371,Neuromuscular,0,0
65372,transmission,0,0
65373,was,0,0
65374,monitored,0,0
65375,electromyographically,0,0
65376,.,0,0
65377,Initial,0,0
65378,bolus,0,0
65379,dose,0,0
65380,of,0,0
65381,rocuronium,0,0
65382,",",0,0
65383,0.6,0,0
65384,mg,0,0
65385,x,0,0
65386,kg,0,0
65387,(,0,0
65388,-1,0,0
65389,),0,0
65390,was,0,0
65391,followed,0,0
65392,by,0,0
65393,continuous,0,0
65394,infusion,0,0
65395,",",0,0
65396,targeting,0,0
65397,at,0,0
65398,steady-state,0,0
65399,95,0,0
65400,%,0,0
65401,T1,0,0
65402,depression,0,1
65403,.,0,0
65404,Neuromuscular,0,0
65405,transmission,0,0
65406,was,0,0
65407,allowed,0,0
65408,to,0,0
65409,recover,0,0
65410,spontaneously,0,0
65411,.,0,0
65412,Plasma,0,0
65413,samples,0,0
65414,were,0,0
65415,collected,0,0
65416,at,0,0
65417,the,0,0
65418,moment,0,0
65419,of,0,0
65420,discontinuation,0,0
65421,of,0,0
65422,infusion,0,0
65423,",",0,0
65424,and,0,0
65425,10,0,0
65426,",",0,0
65427,20,0,0
65428,",",0,0
65429,30,0,0
65430,",",0,0
65431,50,0,0
65432,",",0,0
65433,60,0,1
65434,and,0,0
65435,75,0,1
65436,min,0,0
65437,afterwards,0,0
65438,.,0,1
65439,Concentrations,0,0
65440,of,0,0
65441,rocuronium,0,0
65442,were,0,0
65443,measured,0,0
65444,using,0,0
65445,high-performance,0,0
65446,liquid,0,0
65447,chromatography,0,0
65448,with,0,1
65449,electrochemical,0,0
65450,detection,0,0
65451,(,0,0
65452,HPLC-EC,0,0
65453,),0,0
65454,.,0,0
65455,Rocuronium,0,0
65456,PK,0,0
65457,was,0,0
65458,described,0,0
65459,by,0,0
65460,a,0,0
65461,two-compartment,0,0
65462,model,0,0
65463,and,0,0
65464,PD,0,0
65465,parameters,0,0
65466,were,0,0
65467,estimated,0,0
65468,using,0,0
65469,effect,0,0
65470,compartment,0,0
65471,and,0,0
65472,sigmoidal,0,0
65473,E,0,0
65474,(,0,0
65475,max,0,1
65476,),0,0
65477,models,0,0
65478,.,0,1
65479,RESULTS,0,0
65480,No,0,0
65481,differences,0,0
65482,in,0,0
65483,rocuronium,0,0
65484,PK,0,0
65485,parameters,0,0
65486,were,0,0
65487,observed,0,0
65488,between,0,0
65489,study,0,0
65490,groups,0,0
65491,.,0,1
65492,Clearance,0,0
65493,was,0,0
65494,3.91,0,0
65495,+/-,0,0
65496,2.07,0,0
65497,and,0,0
65498,3.62,0,0
65499,+/-,0,0
65500,0.80,0,0
65501,ml,0,0
65502,x,0,0
65503,min,0,0
65504,(,0,0
65505,-1,0,0
65506,),0,0
65507,x,0,0
65508,kg,0,0
65509,(,0,0
65510,-1,0,0
65511,),0,0
65512,in,0,0
65513,sevoflurane,0,0
65514,and,0,0
65515,fentanyl,0,0
65516,groups,0,0
65517,",",0,0
65518,respectively,0,0
65519,(,0,0
65520,P,0,0
65521,<,0,0
65522,0.65,0,0
65523,),0,0
65524,.,0,0
65525,Effect,0,0
65526,compartment,0,0
65527,concentrations,0,0
65528,corresponding,0,0
65529,to,0,0
65530,50,0,0
65531,%,0,0
65532,inhibition,0,0
65533,of,0,0
65534,T1,0,0
65535,(,0,0
65536,EC50,0,0
65537,),0,0
65538,were,0,0
65539,1.41,0,0
65540,+/-,0,0
65541,0.45,0,0
65542,and,0,0
65543,2.32,0,0
65544,+/-,0,0
65545,1.00,0,0
65546,microg,0,0
65547,x,0,0
65548,ml,0,0
65549,(,0,0
65550,-1,0,0
65551,),0,0
65552,(,0,0
65553,P,0,0
65554,<,0,0
65555,0.02,0,0
65556,),0,0
65557,",",0,0
65558,and,0,0
65559,rate,0,0
65560,constants,0,0
65561,for,0,0
65562,equilibration,0,0
65563,between,0,0
65564,plasma,0,0
65565,and,0,0
65566,effect,0,0
65567,compartment,0,0
65568,(,0,0
65569,k,0,0
65570,(,0,0
65571,e0,0,0
65572,),0,0
65573,),0,0
65574,values,0,0
65575,were,0,0
65576,0.10,0,0
65577,+/-,0,0
65578,0.04,0,0
65579,and,0,0
65580,0.24,0,0
65581,+/-,0,0
65582,0.14,0,0
65583,min,0,0
65584,(,0,0
65585,-1,0,0
65586,),0,0
65587,(,0,0
65588,P,0,0
65589,<,0,0
65590,0.009,0,0
65591,),0,0
65592,in,0,0
65593,sevoflurane,0,0
65594,and,0,0
65595,fentanyl,0,0
65596,groups,0,0
65597,",",0,0
65598,respectively,0,0
65599,.,0,0
65600,CONCLUSIONS,0,0
65601,Disposition,0,0
65602,of,0,0
65603,rocuronium,0,0
65604,was,0,0
65605,similar,0,0
65606,under,0,1
65607,stable,0,1
65608,N2O-fentanyl,0,0
65609,and,0,0
65610,N2O-sevoflurane,0,0
65611,anesthesia,0,0
65612,.,0,0
65613,Sevoflurane,0,0
65614,reduced,0,0
65615,rocuronium,0,0
65616,requirements,0,0
65617,as,0,0
65618,well,0,0
65619,as,0,0
65620,decreased,0,0
65621,EC50,0,0
65622,relevant,0,0
65623,to,0,0
65624,inhibition,0,0
65625,of,0,0
65626,T1,0,0
65627,and,0,0
65628,rocuronium,0,0
65629,transfer,0,0
65630,to,0,0
65631,effect,0,0
65632,compartment,0,0
65633,.,0,0
65634,Therefore,0,0
65635,",",0,0
65636,the,0,0
65637,potentiating,0,0
65638,effect,0,0
65639,of,0,0
65640,sevoflurane,0,0
65641,seems,0,0
65642,to,0,0
65643,be,0,0
65644,mainly,0,0
65645,of,0,0
65646,PD,0,0
65647,origin,0,0
65648,",",0,0
65649,probably,0,0
65650,due,0,0
65651,to,0,0
65652,an,0,0
65653,increased,0,0
65654,sensitivity,0,0
65655,of,0,0
65656,the,0,0
65657,neuromuscular,0,0
65658,junction,0,0
65659,.,0,0
65660,Dietary,0,0
65661,sodium,0,0
65662,intake,0,0
65663,modulates,0,0
65664,myocardial,1,0
65665,relaxation,1,0
65666,responsiveness,0,0
65667,to,0,0
65668,angiotensin,0,0
65669,II,0,0
65670,.,0,0
65671,Dietary,0,0
65672,sodium,0,0
65673,alters,0,0
65674,renovascular,0,1
65675,responsiveness,0,0
65676,to,0,0
65677,angiotensin,0,0
65678,II,0,0
65679,(,0,0
65680,Ang,0,0
65681,II,0,1
65682,),0,0
65683,in,0,0
65684,normal,1,1
65685,subjects,1,1
65686,.,1,0
65687,Evidence,0,0
65688,supports,0,0
65689,a,0,0
65690,connection,0,0
65691,among,0,0
65692,dietary,0,0
65693,sodium,0,0
65694,",",0,0
65695,the,0,0
65696,rennin-angiotensin,0,0
65697,system,0,0
65698,",",0,0
65699,and,0,0
65700,myocardial,0,0
65701,function,0,0
65702,.,0,0
65703,The,0,0
65704,authors,0,0
65705,hypothesized,0,0
65706,that,0,0
65707,a,0,0
65708,similar,0,0
65709,relationship,0,0
65710,would,0,0
65711,exist,0,0
65712,in,0,0
65713,the,0,0
65714,heart,0,0
65715,",",0,0
65716,and,0,0
65717,that,0,0
65718,the,0,0
65719,pattern,0,0
65720,of,0,0
65721,responses,0,0
65722,would,0,0
65723,be,0,0
65724,qualitatively,0,0
65725,similar,0,0
65726,to,0,0
65727,the,0,0
65728,renal,0,0
65729,vasculature,0,0
65730,.,0,0
65731,Thirteen,1,0
65732,healthy,1,1
65733,volunteers,1,1
65734,(,1,0
65735,aged,1,1
65736,38.6,1,0
65737,+/-,1,0
65738,4,1,0
65739,years,1,1
65740,),1,0
65741,entered,0,1
65742,a,0,0
65743,2,0,0
65744,week,0,0
65745,crossover,0,0
65746,design,0,0
65747,study,0,0
65748,(,0,0
65749,week,0,0
65750,1,0,0
65751,",",0,0
65752,high,0,0
65753,sodium,0,0
65754,diet,0,0
65755,[,0,0
65756,HS,0,1
65757,],0,0
65758,>,0,1
65759,200,0,0
65760,mmol,0,0
65761,Na/day,0,0
65762,;,0,0
65763,week,0,0
65764,2,0,0
65765,",",0,0
65766,low,0,0
65767,sodium,0,0
65768,diet,0,0
65769,[,0,0
65770,LS,0,0
65771,],0,0
65772,",",0,0
65773,<,0,0
65774,10,0,0
65775,mmol,0,0
65776,Na/day,0,0
65777,),0,0
65778,to,0,0
65779,investigate,0,0
65780,the,0,0
65781,influence,0,0
65782,of,0,0
65783,dietary,0,0
65784,sodium,0,0
65785,and,0,0
65786,Ang,0,0
65787,II,0,0
65788,on,0,0
65789,myocardial,0,1
65790,relaxation,0,0
65791,and,0,0
65792,renal,0,0
65793,blood,0,0
65794,flow,0,0
65795,(,0,0
65796,RBF,0,0
65797,),0,0
65798,.,0,0
65799,At,0,0
65800,the,0,0
65801,end,0,0
65802,of,0,0
65803,each,0,0
65804,study,0,0
65805,week,0,0
65806,",",0,0
65807,the,0,0
65808,authors,0,0
65809,assessed,0,0
65810,diastolic,0,0
65811,function,0,0
65812,(,0,0
65813,myocardial,0,1
65814,relaxation,0,0
65815,velocities,0,0
65816,[,0,0
65817,E,0,0
65818,',0,0
65819,],0,0
65820,using,0,0
65821,tissue,0,0
65822,Doppler,0,0
65823,imaging,0,0
65824,),0,0
65825,and,0,0
65826,RBF,0,0
65827,(,0,0
65828,para-aminohippurate,0,0
65829,clearance,0,0
65830,),0,0
65831,at,0,0
65832,baseline,0,0
65833,and,0,0
65834,after,0,0
65835,infusion,0,0
65836,of,0,0
65837,Ang,0,0
65838,II,0,1
65839,(,0,0
65840,3,0,0
65841,ng/kg/min,0,0
65842,x,0,0
65843,45,0,0
65844,min,0,0
65845,),0,0
65846,.,0,0
65847,On,0,0
65848,HS,0,0
65849,diet,0,0
65850,",",0,0
65851,E,0,0
65852,',0,0
65853,and,0,0
65854,RBF,0,0
65855,were,0,0
65856,higher,0,0
65857,than,0,0
65858,on,0,0
65859,LS,0,0
65860,diet,0,0
65861,(,0,0
65862,E,0,0
65863,',0,1
65864,14.0,0,0
65865,+/-,0,0
65866,1.2,0,0
65867,vs,0,0
65868,12.6,0,0
65869,+/-,0,0
65870,1.0,0,0
65871,cm/s,0,0
65872,",",0,0
65873,P,0,0
65874,=,0,0
65875,0.02,0,0
65876,;,0,0
65877,RBF,0,0
65878,596,0,1
65879,+/-,0,0
65880,24,0,0
65881,vs,0,0
65882,563,0,1
65883,+/-,0,0
65884,26,0,0
65885,mL/min,0,0
65886,",",0,0
65887,P,0,0
65888,=,0,0
65889,0.02,0,0
65890,),0,0
65891,.,0,0
65892,Dietary,0,0
65893,sodium,0,0
65894,significantly,0,0
65895,modulated,0,0
65896,E,0,0
65897,',0,0
65898,and,0,0
65899,RBF,0,0
65900,responsiveness,0,0
65901,to,0,0
65902,Ang,0,0
65903,II,0,0
65904,infusion,0,0
65905,in,0,0
65906,like,0,0
65907,manner,0,0
65908,.,0,0
65909,HS,0,0
65910,was,0,0
65911,associated,0,0
65912,with,0,1
65913,increased,0,0
65914,responsiveness,0,0
65915,compared,0,0
65916,with,0,0
65917,a,0,0
65918,blunted,0,0
65919,LS,0,0
65920,response,0,0
65921,(,0,0
65922,HS,0,0
65923,DeltaE,0,0
65924,',0,0
65925,-1.4,0,0
65926,+/-,0,0
65927,0.4,0,0
65928,cm/s,0,0
65929,vs,0,0
65930,LS,0,0
65931,DeltaE,0,0
65932,',0,0
65933,-0.1,0,0
65934,+/-,0,0
65935,0.3,0,0
65936,cm/s,0,0
65937,",",0,0
65938,P,0,0
65939,=,0,0
65940,0.02,0,0
65941,;,0,0
65942,HS,0,0
65943,DeltaRBF,0,0
65944,-135.2,0,0
65945,+/-,0,0
65946,13.2,0,0
65947,vs,0,0
65948,LS,0,0
65949,DeltaRBF,0,0
65950,-62.5,0,0
65951,+/-,0,0
65952,10.1,0,0
65953,mL/min,0,0
65954,",",0,0
65955,P,0,0
65956,<,0,0
65957,0.01,0,0
65958,),0,0
65959,.,0,0
65960,The,0,0
65961,authors,0,0
65962,describe,0,0
65963,for,0,0
65964,the,0,0
65965,first,0,0
65966,time,0,0
65967,that,0,0
65968,dietary,0,0
65969,sodium,0,0
65970,modulates,0,0
65971,myocardial,0,0
65972,relaxation,0,0
65973,and,0,0
65974,responsiveness,0,0
65975,to,0,0
65976,Ang,0,0
65977,II,0,0
65978,.,0,0
65979,It,0,0
65980,is,0,0
65981,important,0,0
65982,to,0,0
65983,consider,0,0
65984,dietary,0,0
65985,sodium,0,0
65986,intake,0,0
65987,when,0,0
65988,assessing,0,0
65989,diastolic,0,0
65990,function,0,0
65991,.,0,0
65992,Ang,0,0
65993,II,0,0
65994,may,0,0
65995,play,0,0
65996,a,0,0
65997,role,0,0
65998,in,0,0
65999,the,0,0
66000,interaction,0,0
66001,between,0,0
66002,dietary,0,0
66003,sodium,0,0
66004,and,0,0
66005,myocardial,0,1
66006,relaxation,0,0
66007,.,0,0
66008,Future,0,0
66009,research,0,0
66010,will,0,0
66011,investigate,0,0
66012,whether,0,0
66013,abnormalities,0,0
66014,in,0,0
66015,these,0,0
66016,mechanisms,0,0
66017,play,0,0
66018,a,0,0
66019,role,0,0
66020,in,0,0
66021,disorders,0,1
66022,of,0,0
66023,diastolic,0,1
66024,function,0,0
66025,.,0,0
66026,Effectiveness,0,0
66027,of,0,0
66028,a,0,0
66029,clinical,0,0
66030,intervention,0,0
66031,in,0,0
66032,improving,0,0
66033,pain,0,0
66034,control,0,0
66035,in,0,0
66036,outpatients,1,1
66037,with,1,1
66038,cancer,1,1
66039,treated,1,1
66040,by,1,0
66041,radiation,1,0
66042,therapy,1,0
66043,.,1,0
66044,PURPOSE,0,0
66045,To,0,0
66046,determine,0,0
66047,the,0,0
66048,effectiveness,0,0
66049,of,0,0
66050,a,0,0
66051,multicomponent,0,0
66052,clinical,0,0
66053,intervention,0,0
66054,to,0,0
66055,reduce,0,0
66056,pain,0,0
66057,in,0,0
66058,outpatients,1,1
66059,with,1,1
66060,cancer,1,1
66061,.,1,0
66062,METHODS,0,0
66063,AND,0,0
66064,MATERIALS,0,0
66065,Sixty-four,1,1
66066,patients,1,1
66067,were,0,0
66068,randomly,0,1
66069,assigned,0,0
66070,to,0,0
66071,receive,0,0
66072,either,0,0
66073,a,0,0
66074,clinical,0,0
66075,intervention,0,0
66076,including,0,0
66077,an,0,0
66078,information,0,0
66079,session,0,0
66080,",",0,0
66081,the,0,0
66082,use,0,0
66083,of,0,0
66084,a,0,0
66085,pain,0,0
66086,diary,0,0
66087,",",0,0
66088,and,0,0
66089,the,0,0
66090,possibility,0,0
66091,to,0,0
66092,contact,0,0
66093,a,0,0
66094,physician,0,0
66095,to,0,0
66096,adjust,0,0
66097,the,0,0
66098,pain,0,0
66099,medication,0,0
66100,",",0,0
66101,or,0,0
66102,the,0,0
66103,usual,0,0
66104,treatment,0,0
66105,of,0,0
66106,pain,0,0
66107,by,0,0
66108,the,0,0
66109,staff,0,0
66110,radiation,0,0
66111,oncologist,0,0
66112,.,0,0
66113,All,0,0
66114,patients,0,1
66115,reported,0,0
66116,their,0,0
66117,average,0,0
66118,and,0,0
66119,worst,0,0
66120,pain,0,0
66121,levels,0,0
66122,at,0,0
66123,baseline,0,0
66124,and,0,0
66125,2,0,0
66126,and,0,0
66127,3,0,0
66128,weeks,0,0
66129,after,0,0
66130,the,0,0
66131,start,0,0
66132,of,0,0
66133,the,0,0
66134,intervention,0,0
66135,.,0,0
66136,RESULTS,0,0
66137,The,0,0
66138,study,0,0
66139,groups,0,0
66140,were,0,0
66141,similar,0,0
66142,with,0,1
66143,respect,0,0
66144,to,0,0
66145,their,0,0
66146,baseline,0,0
66147,characteristics,0,0
66148,and,0,0
66149,pain,0,0
66150,levels,0,0
66151,at,0,0
66152,randomization,0,0
66153,.,0,0
66154,After,0,0
66155,3,0,0
66156,weeks,0,0
66157,",",0,0
66158,the,0,0
66159,average,0,0
66160,and,0,0
66161,worst,0,0
66162,pain,0,0
66163,experienced,0,0
66164,by,0,0
66165,patients,0,1
66166,randomized,0,0
66167,to,0,0
66168,the,0,0
66169,clinical,0,0
66170,intervention,0,0
66171,group,0,0
66172,was,0,0
66173,significantly,0,0
66174,inferior,0,0
66175,to,0,0
66176,the,0,0
66177,average,0,0
66178,pain,0,0
66179,experienced,0,0
66180,by,0,0
66181,patients,0,1
66182,in,0,0
66183,the,0,0
66184,control,0,0
66185,group,0,0
66186,(,0,0
66187,2.9/10,0,0
66188,vs.,0,0
66189,4.4/10,0,0
66190,and,0,0
66191,4.2/10,0,0
66192,vs.,0,0
66193,5.5/10,0,0
66194,",",0,0
66195,respectively,0,0
66196,),0,0
66197,.,0,0
66198,Results,0,0
66199,showed,0,0
66200,that,0,0
66201,the,0,0
66202,experimental,0,0
66203,group,0,0
66204,patients,0,1
66205,decreased,0,0
66206,their,0,0
66207,pain,0,0
66208,levels,0,0
66209,more,0,0
66210,than,0,0
66211,the,0,0
66212,control,0,0
66213,group,0,0
66214,patients,0,1
66215,did,0,0
66216,over,0,0
66217,time,0,0
66218,.,0,0
66219,CONCLUSION,0,0
66220,An,0,0
66221,intervention,0,0
66222,including,0,0
66223,patient,0,0
66224,education,0,0
66225,",",0,0
66226,a,0,0
66227,pain,0,0
66228,diary,0,0
66229,",",0,0
66230,and,0,0
66231,defining,0,0
66232,a,0,0
66233,procedure,0,0
66234,for,0,0
66235,therapeutic,0,0
66236,adjustments,0,0
66237,can,0,0
66238,be,0,0
66239,effective,0,0
66240,to,0,0
66241,improve,0,0
66242,pain,0,0
66243,relief,0,0
66244,in,0,0
66245,outpatients,1,1
66246,with,1,1
66247,cancer,1,1
66248,.,1,0
66249,A,0,0
66250,randomized,0,0
66251,comparison,0,0
66252,of,0,0
66253,the,0,0
66254,effect,0,0
66255,of,0,0
66256,two,0,0
66257,prelinguistic,0,1
66258,communication,0,0
66259,interventions,0,0
66260,on,0,0
66261,the,0,0
66262,acquisition,0,0
66263,of,0,0
66264,spoken,0,0
66265,communication,0,0
66266,in,0,0
66267,preschoolers,1,1
66268,with,1,1
66269,ASD,1,1
66270,.,1,0
66271,PURPOSE,0,0
66272,This,0,0
66273,randomized,0,0
66274,group,0,0
66275,experiment,0,0
66276,compared,0,0
66277,the,0,0
66278,efficacy,0,0
66279,of,0,0
66280,2,0,0
66281,communication,0,0
66282,interventions,0,0
66283,(,0,0
66284,Responsive,0,1
66285,Education,0,0
66286,and,0,0
66287,Prelinguistic,0,1
66288,Milieu,0,0
66289,Teaching,0,0
66290,[,0,0
66291,RPMT,0,0
66292,],0,0
66293,and,0,0
66294,the,0,0
66295,Picture,0,0
66296,Exchange,0,0
66297,Communication,0,0
66298,System,0,1
66299,[,0,0
66300,PECS,0,0
66301,],0,0
66302,),0,0
66303,on,0,0
66304,spoken,0,0
66305,communication,0,0
66306,in,0,0
66307,36,1,1
66308,preschoolers,1,1
66309,with,1,1
66310,autism,1,1
66311,spectrum,1,1
66312,disorders,1,1
66313,(,1,0
66314,ASD,1,1
66315,),1,0
66316,.,1,0
66317,METHOD,0,0
66318,Each,0,0
66319,treatment,0,0
66320,was,0,0
66321,delivered,0,0
66322,to,0,0
66323,children,0,1
66324,for,0,0
66325,a,0,0
66326,maximum,0,0
66327,total,0,1
66328,of,0,0
66329,24,0,0
66330,hr,0,0
66331,over,0,0
66332,a,0,0
66333,6-month,0,0
66334,period,0,0
66335,.,0,0
66336,Spoken,0,0
66337,communication,0,0
66338,was,0,0
66339,assessed,0,0
66340,in,0,0
66341,a,0,0
66342,rigorous,0,0
66343,test,0,0
66344,of,0,0
66345,generalization,0,0
66346,at,0,0
66347,pretreatment,0,0
66348,",",0,0
66349,posttreatment,0,0
66350,",",0,0
66351,and,0,0
66352,6-month,0,0
66353,follow-up,0,0
66354,periods,0,0
66355,.,0,1
66356,RESULTS,0,0
66357,PECS,0,0
66358,was,0,0
66359,more,0,0
66360,successful,0,0
66361,than,0,0
66362,RPMT,0,0
66363,in,0,0
66364,increasing,0,0
66365,the,0,0
66366,number,0,0
66367,of,0,0
66368,nonimitative,0,0
66369,spoken,0,0
66370,communication,0,0
66371,acts,0,0
66372,and,0,0
66373,the,0,0
66374,number,0,0
66375,of,0,0
66376,different,0,0
66377,nonimitative,0,1
66378,words,0,0
66379,used,0,0
66380,at,0,0
66381,the,0,0
66382,posttreatment,0,0
66383,period,0,0
66384,.,0,0
66385,Considering,0,0
66386,growth,0,0
66387,over,0,0
66388,all,0,0
66389,3,0,0
66390,measurement,0,0
66391,periods,0,0
66392,",",0,0
66393,an,0,0
66394,exploratory,0,0
66395,analysis,0,0
66396,showed,0,0
66397,that,0,0
66398,growth,0,0
66399,rate,0,0
66400,of,0,0
66401,the,0,0
66402,number,0,0
66403,of,0,0
66404,different,0,0
66405,nonimitative,0,1
66406,words,0,0
66407,was,0,0
66408,faster,0,0
66409,in,0,0
66410,the,0,0
66411,PECS,0,0
66412,group,0,0
66413,than,0,0
66414,in,0,0
66415,the,0,0
66416,RPMT,0,0
66417,group,0,0
66418,for,0,1
66419,children,0,1
66420,who,0,1
66421,began,0,1
66422,treatment,0,1
66423,with,0,0
66424,relatively,0,0
66425,high,0,0
66426,object,0,0
66427,exploration,0,0
66428,.,0,0
66429,In,0,0
66430,contrast,0,0
66431,",",0,0
66432,analogous,0,0
66433,slopes,0,0
66434,were,0,0
66435,steeper,0,0
66436,in,0,0
66437,the,0,0
66438,RPMT,0,0
66439,group,0,0
66440,than,0,0
66441,in,0,0
66442,the,0,0
66443,PECS,0,0
66444,group,0,0
66445,for,0,1
66446,children,0,1
66447,who,0,1
66448,began,0,1
66449,treatment,0,1
66450,with,0,0
66451,relatively,0,0
66452,low,0,0
66453,object,0,0
66454,exploration,0,1
66455,.,0,0
66456,A,0,0
66457,comparative,0,0
66458,study,0,0
66459,of,0,0
66460,the,0,0
66461,pharmacokinetics,0,0
66462,of,0,0
66463,ibuprofen,0,0
66464,arginate,0,0
66465,versus,0,0
66466,dexibuprofen,0,0
66467,in,0,0
66468,healthy,1,1
66469,volunteers,1,1
66470,.,1,1
66471,OBJECTIVE,0,0
66472,Ibuprofen,0,0
66473,arginate,0,0
66474,is,0,0
66475,a,0,0
66476,salt,0,0
66477,formulation,0,0
66478,of,0,0
66479,ibuprofen,0,0
66480,designed,0,0
66481,to,0,0
66482,reach,0,0
66483,target,0,0
66484,concentrations,0,0
66485,rapidly,0,0
66486,.,0,0
66487,The,0,0
66488,primary,0,0
66489,objective,0,0
66490,of,0,0
66491,this,0,0
66492,study,0,0
66493,was,0,0
66494,to,0,0
66495,compare,0,0
66496,the,0,0
66497,12-h,0,0
66498,pharmacokinetic,0,0
66499,profile,0,0
66500,of,0,0
66501,S,0,0
66502,(,0,0
66503,+,0,0
66504,),0,0
66505,-ibuprofen,0,0
66506,following,0,0
66507,administration,0,0
66508,of,0,0
66509,single,0,0
66510,doses,0,0
66511,of,0,0
66512,ibuprofen,0,0
66513,arginate,0,0
66514,(,0,0
66515,600,0,0
66516,mg,0,0
66517,),0,0
66518,and,0,0
66519,dexibuprofen,0,0
66520,(,0,0
66521,400,0,0
66522,mg,0,0
66523,),0,0
66524,in,0,0
66525,healthy,1,1
66526,volunteers,1,1
66527,.,1,1
66528,METHODS,0,0
66529,Twenty-four,1,1
66530,volunteers,1,1
66531,were,1,0
66532,recruited,1,1
66533,into,1,0
66534,an,1,0
66535,open-label,1,0
66536,",",1,0
66537,randomised,1,0
66538,",",1,0
66539,two-period,1,0
66540,",",1,0
66541,single-centre,1,0
66542,study,1,0
66543,with,0,1
66544,crossover,0,0
66545,design,0,0
66546,.,0,0
66547,RESULTS,0,0
66548,Both,0,0
66549,treatments,0,0
66550,were,0,0
66551,well,0,0
66552,tolerated,0,0
66553,.,0,0
66554,Ibuprofen,0,0
66555,arginate,0,0
66556,and,0,0
66557,dexibuprofen,0,0
66558,showed,0,0
66559,similar,0,0
66560,bioavailability,0,0
66561,for,0,0
66562,S,0,0
66563,(,0,0
66564,+,0,0
66565,),0,0
66566,-ibuprofen,0,0
66567,.,0,0
66568,Compared,0,0
66569,with,0,0
66570,dexibuprofen,0,0
66571,",",0,0
66572,ibuprofen,0,0
66573,arginate,0,0
66574,demonstrated,0,0
66575,a,0,0
66576,45,0,0
66577,%,0,0
66578,higher,0,0
66579,maximum,0,0
66580,concentration,0,0
66581,(,0,0
66582,C,0,0
66583,(,0,0
66584,max,0,1
66585,),0,0
66586,),0,0
66587,",",0,0
66588,and,0,0
66589,a,0,0
66590,time,0,0
66591,to,0,0
66592,peak,0,0
66593,concentration,0,0
66594,(,0,0
66595,T,0,0
66596,(,0,0
66597,max,0,1
66598,),0,0
66599,),0,0
66600,2,0,0
66601,h,0,0
66602,sooner,0,0
66603,.,0,0
66604,CONCLUSION,0,0
66605,Ibuprofen,0,0
66606,arginate,0,0
66607,approaches,0,0
66608,maximum,0,0
66609,concentrations,0,0
66610,of,0,0
66611,S,0,0
66612,(,0,0
66613,+,0,0
66614,),0,0
66615,-ibuprofen,0,0
66616,faster,0,0
66617,and,0,0
66618,higher,0,0
66619,than,0,0
66620,dexibuprofen,0,0
66621,.,0,0
66622,Risperidone,0,0
66623,in,0,0
66624,children,1,1
66625,with,1,1
66626,autism,1,1
66627,:,1,1
66628,randomized,0,0
66629,",",0,0
66630,placebo-controlled,0,0
66631,",",0,0
66632,double-blind,0,0
66633,study,0,0
66634,.,0,0
66635,Some,0,0
66636,open-label,0,0
66637,studies,0,0
66638,suggest,0,0
66639,that,0,0
66640,risperidone,0,0
66641,can,0,0
66642,be,0,0
66643,useful,0,0
66644,in,0,0
66645,the,0,0
66646,treatment,0,0
66647,of,0,0
66648,certain,0,0
66649,target,0,0
66650,symptoms,0,0
66651,in,0,0
66652,children,1,1
66653,with,1,1
66654,autism,1,1
66655,.,1,0
66656,We,0,0
66657,aimed,0,0
66658,to,0,0
66659,study,0,0
66660,whether,0,0
66661,the,0,0
66662,use,0,0
66663,of,0,0
66664,risperidone,0,0
66665,in,0,0
66666,comparison,0,0
66667,with,0,1
66668,placebo,0,0
66669,improved,0,0
66670,functioning,0,0
66671,in,0,0
66672,children,1,1
66673,with,1,1
66674,autism,1,1
66675,with,0,1
66676,regard,0,0
66677,to,0,0
66678,behavior,0,0
66679,(,0,0
66680,aggressiveness,0,0
66681,",",0,0
66682,hyperactivity,0,0
66683,",",0,0
66684,irritability,0,0
66685,),0,0
66686,",",0,0
66687,social,0,0
66688,and,0,0
66689,emotional,0,0
66690,responsiveness,0,0
66691,",",0,0
66692,and,0,0
66693,communication,0,0
66694,skills,0,0
66695,.,0,0
66696,We,0,0
66697,conducted,0,0
66698,a,0,0
66699,randomized,0,0
66700,",",0,0
66701,double-blind,0,0
66702,",",0,0
66703,placebo-controlled,0,0
66704,trial,0,0
66705,with,0,1
66706,40,1,1
66707,consecutive,1,1
66708,children,1,1
66709,with,1,1
66710,autism,1,1
66711,",",1,0
66712,whose,1,0
66713,ages,1,1
66714,ranged,1,1
66715,from,1,0
66716,2,1,0
66717,to,1,0
66718,9,1,0
66719,years,1,1
66720,",",1,1
66721,who,1,1
66722,were,1,1
66723,receiving,1,1
66724,either,1,0
66725,risperidone,1,0
66726,or,1,0
66727,placebo,1,0
66728,given,1,0
66729,orally,1,0
66730,at,1,0
66731,a,1,0
66732,dose,1,0
66733,of,1,0
66734,1,1,0
66735,mg/day,1,0
66736,for,1,0
66737,6,1,0
66738,months,1,0
66739,.,1,1
66740,Autism,0,1
66741,symptoms,0,0
66742,were,0,0
66743,monitored,0,0
66744,periodically,0,0
66745,.,0,0
66746,The,0,0
66747,outcome,0,0
66748,variables,0,0
66749,were,0,0
66750,total,0,1
66751,scores,0,0
66752,on,0,0
66753,the,0,0
66754,Childhood,0,1
66755,Autism,0,1
66756,Rating,0,0
66757,Scale,0,0
66758,(,0,0
66759,CARS,0,0
66760,),0,0
66761,and,0,0
66762,the,0,0
66763,Children,0,1
66764,'s,0,0
66765,Global,0,0
66766,Assessment,0,0
66767,Scale,0,0
66768,(,0,0
66769,CGAS,0,0
66770,),0,0
66771,after,0,0
66772,6,0,0
66773,months,0,0
66774,.,0,0
66775,Of,0,0
66776,the,0,0
66777,40,1,1
66778,children,1,1
66779,enrolled,1,1
66780,",",0,0
66781,39,0,0
66782,completed,0,0
66783,the,0,0
66784,trial,0,0
66785,over,0,0
66786,a,0,0
66787,period,0,0
66788,of,0,0
66789,18,0,1
66790,months,0,0
66791,;,0,0
66792,19,0,1
66793,received,0,0
66794,risperidone,0,0
66795,",",0,0
66796,and,0,0
66797,20,0,0
66798,received,0,0
66799,placebo,0,0
66800,.,0,0
66801,In,0,0
66802,the,0,0
66803,risperidone,0,0
66804,group,0,0
66805,",",0,0
66806,12,0,0
66807,of,0,0
66808,19,0,1
66809,children,0,1
66810,showed,0,0
66811,improvement,0,0
66812,in,0,0
66813,the,0,0
66814,total,0,1
66815,Childhood,0,1
66816,Autism,0,1
66817,Rating,0,0
66818,Scale,0,0
66819,score,0,0
66820,and,0,0
66821,17,0,0
66822,of,0,0
66823,19,0,1
66824,children,0,1
66825,in,0,0
66826,the,0,0
66827,Children,0,1
66828,'s,0,0
66829,Global,0,0
66830,Assessment,0,0
66831,Scale,0,0
66832,score,0,0
66833,compared,0,0
66834,with,0,1
66835,0,0,0
66836,of,0,0
66837,20,0,1
66838,children,0,1
66839,for,0,0
66840,the,0,0
66841,Childhood,0,1
66842,Autism,0,1
66843,Rating,0,0
66844,Scale,0,0
66845,score,0,0
66846,and,0,0
66847,2,0,0
66848,of,0,0
66849,20,0,1
66850,children,0,1
66851,for,0,0
66852,the,0,0
66853,Children,0,1
66854,'s,0,0
66855,Global,0,0
66856,Assessment,0,0
66857,Scale,0,0
66858,score,0,0
66859,in,0,0
66860,the,0,0
66861,placebo,0,0
66862,group,0,0
66863,(,0,0
66864,P,0,0
66865,<,0,0
66866,.001,0,0
66867,and,0,0
66868,P,0,0
66869,=,0,0
66870,.035,0,0
66871,",",0,0
66872,respectively,0,0
66873,),0,0
66874,.,0,0
66875,Risperidone,0,0
66876,also,0,0
66877,improved,0,0
66878,social,0,0
66879,responsiveness,0,0
66880,and,0,0
66881,nonverbal,0,0
66882,communication,0,0
66883,and,0,0
66884,reduced,0,0
66885,the,0,0
66886,symptoms,0,0
66887,of,0,0
66888,hyperactivity,0,0
66889,and,0,0
66890,aggression,0,1
66891,.,0,0
66892,Risperidone,0,0
66893,was,0,0
66894,associated,0,0
66895,with,0,0
66896,increased,0,0
66897,appetite,0,0
66898,and,0,0
66899,a,0,0
66900,mild,0,0
66901,weight,0,0
66902,gain,0,0
66903,",",0,0
66904,mild,0,0
66905,sedation,0,0
66906,in,0,0
66907,20,0,0
66908,%,0,0
66909,",",0,0
66910,and,0,0
66911,transient,0,0
66912,dyskinesias,0,0
66913,in,0,0
66914,three,0,0
66915,children,0,1
66916,.,0,1
66917,Risperidone,0,0
66918,improved,0,0
66919,global,0,0
66920,functioning,0,0
66921,and,0,0
66922,social,0,0
66923,responsiveness,0,0
66924,while,0,0
66925,reducing,0,0
66926,hyperactivity,0,0
66927,and,0,0
66928,aggression,0,1
66929,in,0,0
66930,children,1,1
66931,with,1,1
66932,autism,1,1
66933,and,0,0
66934,was,0,0
66935,well,0,0
66936,tolerated,0,0
66937,.,0,0
66938,Effectiveness,0,0
66939,of,0,0
66940,written,0,0
66941,guidelines,0,0
66942,on,0,0
66943,the,0,0
66944,appropriateness,0,0
66945,of,0,0
66946,thromboprophylaxis,1,0
66947,prescriptions,1,0
66948,for,1,0
66949,medical,1,1
66950,patients,1,1
66951,:,1,1
66952,a,0,0
66953,prospective,0,0
66954,randomized,0,0
66955,study,0,0
66956,.,0,0
66957,OBJECTIVE,0,0
66958,To,0,0
66959,assess,0,0
66960,the,0,0
66961,effectiveness,0,0
66962,of,0,0
66963,providing,0,0
66964,doctors,0,1
66965,with,0,1
66966,written,0,0
66967,thromboprophylaxis,0,0
66968,prescription,0,0
66969,aids,0,1
66970,based,0,0
66971,on,0,0
66972,current,0,0
66973,recommendations,0,0
66974,.,0,0
66975,DESIGN,0,0
66976,A,0,0
66977,prospective,0,0
66978,trial,0,0
66979,of,0,0
66980,specific,0,0
66981,anticoagulant,0,0
66982,prescription,0,1
66983,forms,0,0
66984,:,0,1
66985,a,0,0
66986,1-day,0,0
66987,survey,0,0
66988,before,0,0
66989,and,0,0
66990,after,0,0
66991,the,0,0
66992,intervention,0,0
66993,in,0,0
66994,each,0,0
66995,centre,0,1
66996,.,0,0
66997,SETTING,0,0
66998,30,1,0
66999,Internal,1,1
67000,Medicine,1,1
67001,departments,1,1
67002,of,1,0
67003,Assistance,1,0
67004,Publique-H?pitaux,1,1
67005,de,1,1
67006,Paris,1,0
67007,.,1,0
67008,SUBJECTS,1,0
67009,All,1,0
67010,inpatients,1,1
67011,were,1,0
67012,included,1,1
67013,",",1,0
67014,except,1,0
67015,those,1,1
67016,who,1,1
67017,were,1,1
67018,either,1,1
67019,admitted,1,1
67020,or,1,0
67021,discharged,1,1
67022,on,1,0
67023,the,1,0
67024,day,1,0
67025,of,1,0
67026,the,1,0
67027,survey,1,0
67028,",",1,0
67029,and,1,0
67030,those,1,0
67031,receiving,1,0
67032,curative,1,0
67033,anticoagulant,1,0
67034,treatment,1,0
67035,.,1,0
67036,INTERVENTIONS,0,0
67037,The,0,0
67038,study,0,0
67039,included,0,1
67040,three,0,0
67041,parts,0,0
67042,:,0,1
67043,(,0,0
67044,i,0,0
67045,),0,0
67046,a,0,0
67047,1-day,0,0
67048,baseline,0,0
67049,survey,0,1
67050,;,0,0
67051,(,0,0
67052,ii,0,0
67053,),0,0
67054,over,0,0
67055,the,0,0
67056,following,0,0
67057,3-month,0,0
67058,period,0,0
67059,",",0,0
67060,departments,0,1
67061,were,0,0
67062,randomized,0,0
67063,into,0,1
67064,two,0,0
67065,groups,0,0
67066,:,0,1
67067,all,0,0
67068,practitioners,0,0
67069,in,0,0
67070,wards,0,1
67071,allocated,0,0
67072,to,0,0
67073,the,0,0
67074,intervention,0,0
67075,group,0,0
67076,were,0,0
67077,required,0,0
67078,to,0,0
67079,systematically,0,0
67080,use,0,0
67081,specific,0,0
67082,anticoagulant,0,0
67083,prescription,0,0
67084,forms,0,0
67085,",",0,0
67086,whilst,0,0
67087,doctors,0,1
67088,in,0,0
67089,the,0,0
67090,control,0,0
67091,group,0,0
67092,continued,0,0
67093,prescribing,0,0
67094,according,0,1
67095,to,0,0
67096,their,0,0
67097,usual,0,0
67098,practices,0,0
67099,and,0,0
67100,(,0,0
67101,iii,0,0
67102,),0,0
67103,a,0,0
67104,1-day,0,0
67105,postintervention,0,0
67106,survey,0,1
67107,.,0,0
67108,MAIN,0,0
67109,OUTCOME,0,0
67110,MEASURE,0,0
67111,The,0,0
67112,proportion,0,0
67113,of,0,0
67114,prescriptions,0,0
67115,in,0,0
67116,accordance,0,0
67117,with,0,1
67118,the,0,0
67119,recommendations,0,0
67120,.,0,0
67121,RESULTS,1,0
67122,"1,469",1,1
67123,patients,1,1
67124,were,1,0
67125,included,1,1
67126,.,1,0
67127,The,0,0
67128,intervention,0,0
67129,produced,0,0
67130,a,0,0
67131,significant,0,0
67132,reduction,0,0
67133,in,0,0
67134,the,0,0
67135,frequency,0,0
67136,of,0,0
67137,over-prescriptions,0,0
67138,",",0,0
67139,from,0,0
67140,25,0,0
67141,%,0,0
67142,to,0,0
67143,14,0,0
67144,%,0,0
67145,of,0,0
67146,the,0,0
67147,patients,0,1
67148,who,0,1
67149,did,0,1
67150,not,0,1
67151,meet,0,0
67152,the,0,0
67153,guideline,0,0
67154,criteria,0,1
67155,(,0,0
67156,adjusted,0,0
67157,OR,0,0
67158,:,0,1
67159,0.3,0,0
67160,;,0,0
67161,95,0,0
67162,%,0,0
67163,CI,0,0
67164,:,0,1
67165,0.1-0.8,0,0
67166,),0,0
67167,.,0,0
67168,Using,0,0
67169,specific,0,0
67170,forms,0,0
67171,did,0,0
67172,not,0,0
67173,improve,0,0
67174,under-prescription,0,0
67175,of,0,0
67176,anticoagulants,0,0
67177,.,0,0
67178,A,0,0
67179,little,0,0
67180,over,0,0
67181,60,0,1
67182,%,0,0
67183,of,0,0
67184,the,0,0
67185,patients,0,1
67186,who,0,1
67187,met,0,1
67188,guideline,0,0
67189,criteria,0,1
67190,for,0,0
67191,thromboprophylaxis,0,1
67192,were,0,0
67193,prescribed,0,0
67194,anticoagulants,0,0
67195,in,0,0
67196,both,0,0
67197,intervention,0,0
67198,and,0,0
67199,control,0,0
67200,wards,0,1
67201,",",0,0
67202,either,0,0
67203,at,0,0
67204,baseline,0,0
67205,or,0,0
67206,after,0,0
67207,intervention,0,0
67208,.,0,0
67209,CONCLUSIONS,0,0
67210,Multitargeted,0,0
67211,interventions,0,0
67212,using,0,0
67213,a,0,0
67214,variety,0,0
67215,of,0,0
67216,means,0,0
67217,and,0,0
67218,strategies,0,0
67219,should,0,0
67220,still,0,0
67221,be,0,0
67222,considered,0,0
67223,to,0,0
67224,improve,0,0
67225,prescriptions,0,0
67226,that,0,0
67227,may,0,0
67228,have,0,0
67229,a,0,0
67230,significant,0,0
67231,impact,0,0
67232,on,0,0
67233,health,0,0
67234,expenses,0,0
67235,and,0,0
67236,",",0,0
67237,most,0,0
67238,importantly,0,0
67239,",",0,0
67240,on,0,0
67241,patients,0,1
67242,outcomes,0,0
67243,.,0,1
67244,Anecortave,0,0
67245,acetate,0,0
67246,treatment,0,0
67247,for,0,0
67248,retinal,1,0
67249,angiomatous,1,1
67250,proliferation,1,0
67251,:,1,1
67252,a,0,0
67253,pilot,0,0
67254,study,0,0
67255,.,0,0
67256,PURPOSE,0,0
67257,The,0,0
67258,purpose,0,0
67259,of,0,0
67260,this,0,0
67261,study,0,0
67262,was,0,0
67263,to,0,0
67264,evaluate,0,0
67265,anecortave,0,0
67266,acetate,0,0
67267,treatment,0,0
67268,of,0,0
67269,retinal,1,0
67270,angiomatous,1,1
67271,proliferation,1,0
67272,(,1,0
67273,RAP,1,1
67274,),1,0
67275,",",0,0
67276,a,0,0
67277,neovascular,0,0
67278,form,0,0
67279,of,0,0
67280,age-related,0,0
67281,macular,0,1
67282,degeneration,0,0
67283,",",0,0
67284,with,0,0
67285,specific,0,0
67286,regard,0,0
67287,to,0,0
67288,inhibition,0,0
67289,of,0,0
67290,neovascularization,0,0
67291,and,0,0
67292,maintenance,0,0
67293,of,0,0
67294,vision,0,0
67295,.,0,0
67296,METHODS,0,0
67297,Thirty-four,1,1
67298,patients,1,1
67299,with,1,1
67300,RAP,1,1
67301,with,1,1
67302,any,1,0
67303,stage,1,1
67304,of,1,0
67305,neovascularization,1,1
67306,were,0,0
67307,randomized,0,0
67308,1:1:1,0,1
67309,for,0,0
67310,treatment,0,0
67311,with,0,1
67312,three,0,0
67313,different,0,0
67314,quantities,0,0
67315,(,0,0
67316,30,0,0
67317,mg,0,0
67318,",",0,0
67319,15,0,0
67320,mg,0,0
67321,",",0,0
67322,3,0,0
67323,mg,0,0
67324,),0,0
67325,of,0,0
67326,anecortave,0,0
67327,acetate,0,0
67328,sterile,0,0
67329,suspension,0,0
67330,for,0,0
67331,juxtascleral,0,1
67332,administration,0,0
67333,.,0,0
67334,Best-corrected,0,0
67335,visual,0,0
67336,acuity,0,0
67337,(,0,0
67338,Early,0,0
67339,Treatment,0,0
67340,Diabetic,0,1
67341,Retinopathy,0,1
67342,Study,0,0
67343,chart,0,0
67344,),0,0
67345,",",0,0
67346,intraocular,0,0
67347,pressure,0,0
67348,measurement,0,0
67349,",",0,0
67350,biomicroscopy,0,0
67351,",",0,0
67352,funduscopy,0,0
67353,",",0,0
67354,digital,0,0
67355,fluorescein,0,0
67356,",",0,0
67357,and,0,0
67358,indocyanine,0,0
67359,green,0,0
67360,angiography,0,0
67361,were,0,0
67362,recorded,0,0
67363,at,0,0
67364,baseline,0,0
67365,and,0,0
67366,at,0,0
67367,3,0,0
67368,months,0,0
67369,.,0,0
67370,A,0,0
67371,6-month,0,0
67372,retreatment,0,0
67373,interval,0,0
67374,was,0,0
67375,established,0,0
67376,for,0,0
67377,this,0,0
67378,study,0,0
67379,with,0,0
67380,a,0,0
67381,follow-up,0,0
67382,of,0,0
67383,12,0,0
67384,months,0,0
67385,.,0,1
67386,In,0,0
67387,selected,0,1
67388,patients,0,1
67389,optical,0,0
67390,coherence,0,0
67391,tomography,0,0
67392,was,0,0
67393,performed,0,0
67394,.,0,0
67395,The,0,0
67396,outcomes,0,0
67397,were,0,0
67398,mean,0,1
67399,changes,0,0
67400,in,0,0
67401,visual,0,0
67402,acuity,0,0
67403,and,0,0
67404,lesion,0,0
67405,size,0,0
67406,at,0,0
67407,1,0,0
67408,year,0,0
67409,.,0,0
67410,RESULTS,0,0
67411,The,0,0
67412,detachment,0,0
67413,of,0,0
67414,the,0,0
67415,neurosensory,0,0
67416,retina,0,0
67417,and,0,0
67418,retinal,0,0
67419,pigment,0,0
67420,epithelium,0,1
67421,improved,0,0
67422,in,0,0
67423,all,0,0
67424,eyes,0,0
67425,",",0,0
67426,but,0,0
67427,all,0,0
67428,neovascular,0,1
67429,lesions,0,0
67430,increased,0,0
67431,in,0,0
67432,size,0,0
67433,.,0,0
67434,Vision,0,0
67435,loss,0,0
67436,occurred,0,0
67437,in,0,0
67438,the,0,0
67439,majority,0,0
67440,of,0,0
67441,study,0,0
67442,eyes,0,1
67443,(,0,0
67444,22,0,1
67445,out,0,0
67446,of,0,0
67447,34,0,1
67448,eyes,0,1
67449,",",0,0
67450,64.7,0,0
67451,%,0,0
67452,),0,0
67453,independent,0,0
67454,of,0,0
67455,the,0,0
67456,concentration,0,0
67457,administered,0,0
67458,.,0,0
67459,CONCLUSION,0,0
67460,The,0,0
67461,results,0,0
67462,suggest,0,0
67463,that,0,0
67464,a,0,0
67465,posterior,0,0
67466,juxtascleral,0,0
67467,injection,0,0
67468,of,0,0
67469,anecortave,0,0
67470,acetate,0,0
67471,reduces,0,0
67472,capillary,0,0
67473,permeability,0,0
67474,in,0,0
67475,patients,1,1
67476,with,1,1
67477,RAP,1,1
67478,.,1,0
67479,However,0,0
67480,",",0,0
67481,in,0,0
67482,spite,0,0
67483,of,0,0
67484,improvement,0,0
67485,of,0,0
67486,the,0,0
67487,exudation,0,0
67488,there,0,0
67489,is,0,0
67490,a,0,0
67491,progression,0,0
67492,of,0,0
67493,neovascularization,0,0
67494,and,0,0
67495,a,0,0
67496,significant,0,0
67497,loss,0,0
67498,of,0,0
67499,vision,0,0
67500,in,0,0
67501,all,0,0
67502,these,0,0
67503,patients,0,1
67504,.,0,0
67505,Like,0,0
67506,other,0,0
67507,monotherapeutic,0,0
67508,methods,0,1
67509,used,0,0
67510,to,0,0
67511,treat,0,0
67512,this,0,0
67513,variant,0,0
67514,of,0,0
67515,neovascular,0,1
67516,age-related,0,0
67517,macular,0,1
67518,degeneration,0,0
67519,",",0,0
67520,anecortave,0,0
67521,acetate,0,0
67522,alone,0,0
67523,does,0,0
67524,not,0,0
67525,appear,0,0
67526,to,0,0
67527,benefit,0,0
67528,these,0,0
67529,patients,0,1
67530,.,0,0
67531,Future,0,0
67532,studies,0,0
67533,should,0,0
67534,investigate,0,0
67535,a,0,0
67536,combination,0,0
67537,form,0,0
67538,of,0,0
67539,therapy,0,0
67540,.,0,0
67541,Use,0,0
67542,of,0,0
67543,an,0,0
67544,alpha,0,0
67545,1-blocker,0,0
67546,",",0,0
67547,YM617,0,0
67548,",",0,0
67549,in,0,0
67550,the,0,0
67551,treatment,0,0
67552,of,0,0
67553,benign,1,1
67554,prostatic,1,1
67555,hypertrophy,1,1
67556,.,1,0
67557,YM617,0,0
67558,Clinical,0,0
67559,Study,0,0
67560,Group,0,1
67561,.,0,0
67562,A,0,0
67563,recently,0,0
67564,synthesized,0,0
67565,alpha,0,0
67566,1-blocker,0,0
67567,",",0,0
67568,(,0,0
67569,R,0,0
67570,),0,0
67571,(,0,0
67572,-,0,0
67573,),0,0
67574,-5-,0,0
67575,[,0,0
67576,2-,0,0
67577,[,0,0
67578,[,0,0
67579,2-,0,0
67580,(,0,0
67581,o-ethoxyphenoxy,0,0
67582,),0,0
67583,ethyl,0,0
67584,],0,0
67585,amino,0,0
67586,],0,0
67587,propyl,0,0
67588,],0,0
67589,-2-,0,0
67590,methoxybenzenesulfonamide,0,0
67591,hydrochloride,0,0
67592,(,0,0
67593,YM617,0,0
67594,),0,0
67595,",",0,0
67596,was,0,0
67597,evaluated,0,0
67598,in,0,0
67599,270,1,1
67600,patients,1,1
67601,with,1,1
67602,benign,1,1
67603,prostatic,1,1
67604,hypertrophy,1,1
67605,in,0,0
67606,a,0,0
67607,double-blind,0,0
67608,study,0,0
67609,.,0,0
67610,After,0,0
67611,2,0,0
67612,weeks,0,0
67613,on,0,0
67614,placebo,0,0
67615,the,0,0
67616,patients,0,1
67617,were,0,0
67618,assigned,0,0
67619,at,0,0
67620,random,0,0
67621,to,0,0
67622,4,0,0
67623,groups,0,0
67624,:,0,1
67625,group,0,1
67626,P,0,0
67627,--,0,0
67628,placebo,0,0
67629,",",0,0
67630,group,0,0
67631,L,0,0
67632,--,0,0
67633,0.1,0,0
67634,mg.,0,0
67635,",",0,0
67636,group,0,0
67637,M,0,0
67638,--,0,0
67639,0.2,0,0
67640,mg.,0,0
67641,and,0,0
67642,group,0,0
67643,H,0,1
67644,--,0,0
67645,0.4,0,0
67646,mg.,0,0
67647,of,0,0
67648,YM617,0,0
67649,.,0,0
67650,Comparing,0,0
67651,the,0,0
67652,placebo,0,0
67653,to,0,0
67654,the,0,0
67655,treatment,0,0
67656,period,0,0
67657,",",0,0
67658,subjective,0,0
67659,symptoms,0,0
67660,",",0,0
67661,such,0,0
67662,as,0,0
67663,nocturia,0,0
67664,and,0,0
67665,urgency,0,0
67666,",",0,0
67667,were,0,0
67668,significantly,0,0
67669,decreased,0,0
67670,in,0,0
67671,group,0,0
67672,H,0,1
67673,(,0,0
67674,p,0,0
67675,less,0,0
67676,than,0,0
67677,0.01,0,0
67678,),0,0
67679,.,0,0
67680,The,0,0
67681,sensation,0,0
67682,of,0,0
67683,incomplete,0,0
67684,voiding,0,0
67685,was,0,0
67686,significantly,0,0
67687,improved,0,0
67688,in,0,0
67689,groups,0,0
67690,M,0,0
67691,and,0,0
67692,H,0,1
67693,(,0,0
67694,p,0,0
67695,less,0,0
67696,than,0,0
67697,0.01,0,0
67698,),0,0
67699,.,0,0
67700,However,0,0
67701,",",0,0
67702,the,0,0
67703,differences,0,0
67704,among,0,0
67705,the,0,0
67706,groups,0,0
67707,were,0,0
67708,statistically,0,0
67709,insignificant,0,0
67710,.,0,0
67711,Residual,0,0
67712,urine,0,0
67713,volume,0,0
67714,was,0,0
67715,significantly,0,0
67716,decreased,0,0
67717,in,0,0
67718,groups,0,0
67719,L,0,0
67720,",",0,0
67721,M,0,0
67722,and,0,0
67723,H,0,1
67724,after,0,0
67725,instillation,0,0
67726,of,0,0
67727,saline,0,0
67728,into,0,0
67729,the,0,0
67730,bladder,0,1
67731,(,0,0
67732,p,0,0
67733,less,0,0
67734,than,0,0
67735,0.01,0,0
67736,),0,0
67737,but,0,0
67738,not,0,0
67739,in,0,0
67740,group,0,0
67741,P.,0,0
67742,The,0,0
67743,maximum,0,0
67744,and,0,0
67745,average,0,0
67746,flow,0,0
67747,rates,0,0
67748,were,0,0
67749,significantly,0,0
67750,increased,0,0
67751,in,0,0
67752,groups,0,0
67753,L,0,0
67754,",",0,0
67755,M,0,0
67756,and,0,0
67757,H,0,1
67758,(,0,0
67759,p,0,0
67760,less,0,0
67761,than,0,0
67762,0.01,0,0
67763,),0,0
67764,but,0,0
67765,not,0,0
67766,in,0,0
67767,group,0,0
67768,P.,0,1
67769,Average,0,0
67770,flow,0,0
67771,rate,0,0
67772,showed,0,0
67773,significant,0,0
67774,differences,0,0
67775,between,0,0
67776,groups,0,0
67777,M,0,0
67778,or,0,1
67779,H,0,1
67780,versus,0,0
67781,group,0,0
67782,P.,0,0
67783,Neither,0,0
67784,orthostatic,0,0
67785,hypotension,0,0
67786,nor,0,0
67787,a,0,0
67788,decrease,0,0
67789,in,0,0
67790,blood,0,0
67791,pressure,0,0
67792,was,0,0
67793,noted,0,0
67794,.,0,0
67795,Adverse,0,0
67796,side,0,0
67797,effects,0,0
67798,and,0,0
67799,changes,0,0
67800,in,0,0
67801,laboratory,0,1
67802,data,0,0
67803,were,0,0
67804,all,0,0
67805,slight,0,0
67806,and,0,0
67807,disappeared,0,0
67808,when,0,0
67809,the,0,0
67810,second,0,0
67811,tests,0,0
67812,were,0,0
67813,performed,0,0
67814,.,0,0
67815,In,0,0
67816,summary,0,0
67817,",",0,0
67818,the,0,0
67819,irritative,0,0
67820,and,0,0
67821,obstructive,0,1
67822,symptoms,0,0
67823,caused,0,0
67824,by,0,0
67825,benign,0,1
67826,prostatic,0,1
67827,hypertrophy,0,1
67828,were,0,0
67829,decreased,0,0
67830,and,0,0
67831,urodynamic,0,0
67832,studies,0,0
67833,were,0,0
67834,markedly,0,0
67835,improved,0,0
67836,by,0,0
67837,the,0,0
67838,alpha,0,0
67839,1-blocker,0,0
67840,",",0,0
67841,YM617,0,0
67842,.,0,0
67843,The,0,0
67844,drug,0,0
67845,seems,0,0
67846,to,0,0
67847,be,0,0
67848,useful,0,0
67849,in,0,0
67850,the,0,0
67851,treatment,0,0
67852,of,0,0
67853,patients,1,1
67854,with,1,1
67855,benign,1,1
67856,prostatic,1,1
67857,hypertrophy,1,1
67858,.,1,0
67859,Nordic,0,0
67860,walking,0,0
67861,and,0,0
67862,chronic,0,1
67863,low,0,0
67864,back,0,1
67865,pain,0,0
67866,:,0,0
67867,design,0,0
67868,of,0,0
67869,a,0,0
67870,randomized,0,0
67871,clinical,0,0
67872,trial,0,0
67873,.,0,0
67874,BACKGROUND,0,0
67875,Low,0,1
67876,Back,0,0
67877,Pain,0,0
67878,is,0,0
67879,a,0,0
67880,major,0,0
67881,public,0,1
67882,health,0,0
67883,problem,0,0
67884,all,0,0
67885,over,0,0
67886,the,0,0
67887,western,0,1
67888,world,0,0
67889,.,0,0
67890,Active,0,0
67891,approaches,0,0
67892,including,0,0
67893,exercise,0,0
67894,in,0,0
67895,the,0,0
67896,treatment,0,0
67897,of,0,0
67898,low,0,0
67899,back,0,1
67900,pain,0,0
67901,results,0,0
67902,in,0,0
67903,better,0,0
67904,outcomes,0,0
67905,for,0,0
67906,patients,0,1
67907,",",0,0
67908,but,0,0
67909,it,0,0
67910,is,0,0
67911,not,0,0
67912,known,0,0
67913,exactly,0,0
67914,which,0,0
67915,types,0,0
67916,of,0,0
67917,back,0,1
67918,exercises,0,0
67919,are,0,0
67920,most,0,0
67921,beneficial,0,0
67922,or,0,0
67923,whether,0,0
67924,general,0,1
67925,physical,0,0
67926,activity,0,0
67927,provide,0,0
67928,similar,0,0
67929,benefits,0,0
67930,.,0,1
67931,Nordic,0,0
67932,Walking,0,0
67933,is,0,0
67934,a,0,0
67935,popular,0,0
67936,and,0,0
67937,fast,0,0
67938,growing,0,0
67939,type,0,1
67940,of,0,0
67941,exercise,0,0
67942,in,0,0
67943,Northern,0,1
67944,Europe,0,1
67945,.,0,0
67946,Initial,0,0
67947,studies,0,0
67948,have,0,0
67949,demonstrated,0,0
67950,that,0,0
67951,persons,0,1
67952,performing,0,0
67953,Nordic,0,1
67954,Walking,0,0
67955,are,0,0
67956,able,0,0
67957,to,0,0
67958,exercise,0,0
67959,longer,0,0
67960,and,0,0
67961,harder,0,0
67962,compared,0,0
67963,to,0,0
67964,normal,0,1
67965,walking,0,0
67966,thereby,0,0
67967,increasing,0,0
67968,their,0,0
67969,cardiovascular,0,1
67970,metabolism,0,0
67971,.,0,0
67972,Until,0,0
67973,now,0,0
67974,no,0,0
67975,studies,0,0
67976,have,0,0
67977,been,0,0
67978,performed,0,0
67979,to,0,0
67980,investigate,0,0
67981,whether,0,0
67982,Nordic,0,0
67983,Walking,0,0
67984,has,0,0
67985,beneficial,0,0
67986,effects,0,0
67987,in,0,0
67988,relation,0,0
67989,to,0,0
67990,low,0,0
67991,back,0,0
67992,pain,0,0
67993,.,0,0
67994,The,0,0
67995,primary,0,0
67996,aim,0,0
67997,of,0,0
67998,this,0,0
67999,study,0,0
68000,is,0,0
68001,to,0,0
68002,investigate,0,0
68003,whether,0,0
68004,supervised,0,0
68005,Nordic,0,0
68006,Walking,0,0
68007,can,0,0
68008,reduce,0,0
68009,pain,0,0
68010,and,0,0
68011,improve,0,0
68012,function,0,0
68013,in,1,0
68014,a,1,0
68015,population,1,1
68016,of,1,0
68017,chronic,1,1
68018,low,1,0
68019,back,1,1
68020,pain,1,0
68021,patients,1,1
68022,when,0,0
68023,compared,0,0
68024,to,0,0
68025,unsupervised,0,0
68026,Nordic,0,0
68027,Walking,0,0
68028,and,0,0
68029,advice,0,0
68030,to,0,0
68031,stay,0,0
68032,active,0,0
68033,.,0,0
68034,In,0,0
68035,addition,0,0
68036,we,0,0
68037,investigate,0,0
68038,whether,0,0
68039,there,0,0
68040,is,0,0
68041,an,0,0
68042,increase,0,0
68043,in,0,0
68044,the,0,0
68045,cardiovascular,0,0
68046,metabolism,0,0
68047,in,0,0
68048,persons,1,1
68049,performing,1,0
68050,supervised,1,0
68051,Nordic,1,1
68052,Walking,1,0
68053,compared,0,0
68054,to,0,1
68055,persons,1,1
68056,who,1,1
68057,are,1,0
68058,advised,1,0
68059,to,1,0
68060,stay,1,0
68061,active,1,0
68062,.,1,0
68063,Finally,0,0
68064,",",0,0
68065,we,0,0
68066,investigate,0,0
68067,whether,0,0
68068,there,0,0
68069,is,0,0
68070,a,0,0
68071,difference,0,0
68072,in,0,0
68073,compliance,0,0
68074,between,0,0
68075,persons,1,1
68076,receiving,1,1
68077,supervised,1,0
68078,Nordic,1,0
68079,Walking,1,0
68080,and,0,0
68081,persons,1,1
68082,doing,1,0
68083,unsupervised,1,1
68084,Nordic,1,1
68085,Walking,1,0
68086,.,1,0
68087,METHODS,0,0
68088,One,1,1
68089,hundred,1,1
68090,and,1,0
68091,fifty,1,1
68092,patients,1,1
68093,with,1,1
68094,low,1,0
68095,back,1,0
68096,pain,1,0
68097,for,1,0
68098,at,1,0
68099,least,1,0
68100,eight,1,1
68101,weeks,1,0
68102,and,1,0
68103,referred,1,1
68104,to,1,0
68105,a,1,0
68106,specialized,1,0
68107,secondary,1,0
68108,sector,1,0
68109,outpatient,1,1
68110,back,1,0
68111,pain,1,0
68112,clinic,1,0
68113,are,1,0
68114,included,1,0
68115,in,1,0
68116,the,1,0
68117,study,1,0
68118,.,1,0
68119,After,0,0
68120,completion,0,0
68121,of,0,0
68122,the,0,0
68123,standard,0,0
68124,back,0,0
68125,centre,0,1
68126,treatment,0,0
68127,patients,0,1
68128,are,0,0
68129,randomized,0,0
68130,into,0,0
68131,one,0,0
68132,of,0,0
68133,three,1,1
68134,groups,1,0
68135,:,1,1
68136,A,1,1
68137,),1,0
68138,Nordic,1,0
68139,Walking,1,0
68140,twice,1,0
68141,a,1,0
68142,week,1,0
68143,for,1,0
68144,eight,1,1
68145,weeks,1,0
68146,under,1,1
68147,supervision,1,0
68148,of,1,0
68149,a,1,0
68150,specially,1,0
68151,trained,1,0
68152,instructor,1,0
68153,;,1,0
68154,B,1,0
68155,),1,0
68156,Unsupervised,1,0
68157,Nordic,1,0
68158,Walking,1,0
68159,for,1,0
68160,eight,1,1
68161,weeks,1,0
68162,after,1,0
68163,one,1,0
68164,training,1,0
68165,session,1,0
68166,with,1,0
68167,an,1,0
68168,instructor,1,0
68169,;,1,0
68170,C,1,0
68171,),1,0
68172,A,1,0
68173,one,1,0
68174,hour,1,0
68175,motivational,1,0
68176,talk,1,0
68177,including,1,0
68178,advice,1,0
68179,to,1,0
68180,stay,1,0
68181,active,1,0
68182,.,1,0
68183,Outcome,0,0
68184,measures,0,0
68185,are,0,0
68186,pain,0,0
68187,",",0,0
68188,function,0,0
68189,",",0,0
68190,overall,0,0
68191,health,0,0
68192,",",0,0
68193,cardiovascular,0,0
68194,ability,0,0
68195,and,0,0
68196,activity,0,0
68197,level,0,0
68198,.,0,0
68199,RESULTS,0,0
68200,No,0,0
68201,results,0,0
68202,available,0,0
68203,at,0,0
68204,this,0,0
68205,point,0,0
68206,.,0,0
68207,DISCUSSION,0,0
68208,This,0,0
68209,study,0,0
68210,will,0,0
68211,investigate,0,0
68212,the,0,0
68213,effect,0,0
68214,of,0,0
68215,Nordic,0,0
68216,Walking,0,0
68217,on,0,0
68218,pain,0,0
68219,and,0,0
68220,function,0,0
68221,in,0,0
68222,a,0,0
68223,population,1,1
68224,of,1,0
68225,people,1,1
68226,with,1,1
68227,chronic,1,1
68228,LBP,1,0
68229,.,1,1
68230,Adenosinergic,0,0
68231,mechanisms,0,0
68232,contribute,0,0
68233,to,0,0
68234,individual,1,0
68235,differences,1,0
68236,in,1,0
68237,sleep,1,1
68238,deprivation-induced,1,0
68239,changes,0,0
68240,in,0,0
68241,neurobehavioral,0,0
68242,function,0,0
68243,and,0,0
68244,brain,0,0
68245,rhythmic,0,0
68246,activity,0,0
68247,.,0,0
68248,Large,0,0
68249,individual,0,0
68250,differences,0,0
68251,characterize,0,0
68252,the,0,0
68253,changes,0,0
68254,induced,0,0
68255,by,0,0
68256,sleep,0,0
68257,deprivation,0,0
68258,on,0,0
68259,neurobehavioral,0,0
68260,functions,0,0
68261,and,0,0
68262,rhythmic,0,0
68263,brain,0,0
68264,activity,0,0
68265,.,0,0
68266,To,0,0
68267,investigate,0,0
68268,adenosinergic,0,0
68269,mechanisms,0,0
68270,in,0,0
68271,these,0,0
68272,differences,0,0
68273,",",0,0
68274,we,0,0
68275,studied,0,0
68276,the,0,0
68277,effects,0,0
68278,of,0,0
68279,prolonged,0,0
68280,waking,0,0
68281,and,0,0
68282,the,0,0
68283,adenosine,0,0
68284,receptor,0,0
68285,antagonist,0,0
68286,caffeine,0,0
68287,on,0,0
68288,sustained,0,0
68289,vigilant,0,0
68290,attention,0,0
68291,and,0,0
68292,regional,0,0
68293,electroencephalogram,0,0
68294,(,0,0
68295,EEG,0,0
68296,),0,0
68297,power,0,0
68298,in,0,0
68299,the,0,0
68300,ranges,0,0
68301,of,0,0
68302,theta,0,0
68303,activity,0,0
68304,(,0,0
68305,6.25-8.25,0,0
68306,Hz,0,0
68307,),0,0
68308,in,0,0
68309,waking,0,0
68310,and,0,0
68311,the,0,0
68312,slow,0,0
68313,oscillation,0,0
68314,(,0,0
68315,<,0,0
68316,1,0,0
68317,Hz,0,0
68318,),0,0
68319,in,0,0
68320,sleep,0,0
68321,.,0,0
68322,Activity,0,0
68323,in,0,0
68324,these,0,0
68325,frequencies,0,0
68326,is,0,0
68327,functionally,0,0
68328,related,0,0
68329,to,0,0
68330,sleep,0,0
68331,deprivation,0,0
68332,.,0,0
68333,In,0,0
68334,12,1,0
68335,subjectively,1,0
68336,caffeine-sensitive,1,0
68337,and,1,0
68338,10,1,1
68339,-insensitive,1,1
68340,young,1,1
68341,men,1,1
68342,",",0,0
68343,psychomotor,0,0
68344,vigilance,0,0
68345,task,0,0
68346,(,0,0
68347,PVT,0,0
68348,),0,0
68349,performance,0,0
68350,and,0,0
68351,EEG,0,0
68352,were,0,0
68353,assessed,0,0
68354,at,0,0
68355,3,0,0
68356,h,0,0
68357,intervals,0,0
68358,before,0,0
68359,",",0,0
68360,during,0,0
68361,",",0,0
68362,and,0,0
68363,after,0,0
68364,one,0,0
68365,night,0,0
68366,without,0,1
68367,sleep,0,0
68368,.,0,0
68369,After,0,0
68370,11,0,0
68371,and,0,0
68372,23,0,1
68373,h,0,0
68374,waking,0,0
68375,",",0,0
68376,subjects,0,1
68377,received,0,0
68378,200,0,0
68379,mg,0,0
68380,caffeine,0,0
68381,and,0,0
68382,placebo,0,0
68383,in,0,0
68384,double-blind,0,0
68385,",",0,0
68386,cross-over,0,0
68387,manner,0,0
68388,.,0,0
68389,In,0,0
68390,the,0,0
68391,placebo,0,0
68392,condition,0,0
68393,",",0,0
68394,sleep,0,0
68395,deprivation,0,0
68396,impaired,0,0
68397,PVT,0,0
68398,speed,0,0
68399,more,0,0
68400,in,0,0
68401,caffeine-sensitive,0,0
68402,than,0,0
68403,in,0,0
68404,caffeine-insensitive,0,0
68405,men,0,1
68406,.,0,0
68407,This,0,0
68408,difference,0,0
68409,was,0,0
68410,counteracted,0,0
68411,by,0,0
68412,caffeine,0,0
68413,.,0,0
68414,Theta,0,0
68415,power,0,0
68416,in,0,0
68417,waking,0,0
68418,increased,0,0
68419,more,0,0
68420,in,0,0
68421,a,0,0
68422,frontal,0,0
68423,EEG,0,0
68424,derivation,0,0
68425,than,0,0
68426,in,0,0
68427,a,0,0
68428,posterior,0,0
68429,derivation,0,0
68430,.,0,0
68431,Caffeine,0,0
68432,attenuated,0,0
68433,this,0,0
68434,power,0,0
68435,gradient,0,0
68436,in,0,0
68437,caffeine,0,0
68438,sensitive,0,0
68439,subjects,0,1
68440,.,0,1
68441,Sleep,0,0
68442,loss,0,0
68443,also,0,0
68444,differently,0,0
68445,affected,0,0
68446,the,0,0
68447,power,0,0
68448,distribution,0,0
68449,<,0,0
68450,1,0,0
68451,Hz,0,0
68452,in,0,0
68453,non-rapid,0,0
68454,eye,0,0
68455,movement,0,0
68456,sleep,0,0
68457,between,0,0
68458,caffeine,0,0
68459,sensitive,0,0
68460,and,0,0
68461,insensitive,0,0
68462,subjects,0,1
68463,.,0,0
68464,Also,0,0
68465,",",0,0
68466,this,0,0
68467,difference,0,0
68468,was,0,0
68469,mirrored,0,0
68470,by,0,0
68471,the,0,0
68472,action,0,0
68473,of,0,0
68474,caffeine,0,0
68475,.,0,0
68476,The,0,0
68477,effects,0,0
68478,of,0,0
68479,sleep,0,0
68480,deprivation,0,0
68481,and,0,0
68482,caffeine,0,0
68483,on,0,0
68484,sustained,0,0
68485,attention,0,0
68486,and,0,0
68487,regional,0,0
68488,EEG,0,0
68489,power,0,0
68490,in,0,0
68491,waking,0,0
68492,and,0,0
68493,sleep,0,0
68494,were,0,0
68495,inversely,0,0
68496,related,0,0
68497,.,0,0
68498,These,0,0
68499,findings,0,0
68500,suggest,0,0
68501,that,0,0
68502,adenosinergic,0,0
68503,mechanisms,0,0
68504,contribute,0,0
68505,to,0,0
68506,individual,0,0
68507,differences,0,0
68508,in,0,0
68509,waking-induced,0,0
68510,impairment,0,0
68511,of,0,0
68512,neurobehavioral,0,0
68513,performance,0,0
68514,and,0,0
68515,functional,0,0
68516,aspects,0,0
68517,of,0,0
68518,EEG,0,0
68519,topography,0,0
68520,associated,0,0
68521,with,0,0
68522,sleep,0,0
68523,deprivation,0,1
68524,.,0,0
68525,Enhanced,0,0
68526,baroreceptor,0,0
68527,control,0,0
68528,of,0,0
68529,the,0,0
68530,cardiovascular,0,0
68531,system,0,0
68532,by,0,0
68533,polyunsaturated,0,0
68534,Fatty,0,0
68535,acids,0,0
68536,in,0,0
68537,heart,1,1
68538,failure,1,1
68539,patients,1,1
68540,.,1,0
68541,OBJECTIVES,0,0
68542,The,0,0
68543,intention,0,0
68544,of,0,0
68545,this,0,0
68546,study,0,0
68547,was,0,0
68548,to,0,0
68549,test,0,0
68550,the,0,0
68551,hypothesis,0,0
68552,that,0,0
68553,",",0,0
68554,in,0,0
68555,heart,1,1
68556,failure,1,1
68557,patients,1,1
68558,",",0,0
68559,dietary,0,0
68560,supplementation,0,0
68561,of,0,0
68562,polyunsaturated,0,0
68563,fatty,0,0
68564,acids,0,0
68565,(,0,0
68566,PUFA,0,0
68567,),0,0
68568,enhances,0,0
68569,arterial,0,0
68570,baroreceptor,0,0
68571,control,0,0
68572,of,0,0
68573,the,0,0
68574,cardiovascular,0,0
68575,system,0,0
68576,.,0,0
68577,BACKGROUND,0,0
68578,Administration,0,0
68579,of,0,0
68580,PUFA,0,0
68581,reduces,0,0
68582,the,0,0
68583,risk,0,0
68584,of,0,0
68585,life-threatening,0,0
68586,arrhythmias,0,1
68587,in,0,0
68588,patients,1,1
68589,surviving,1,1
68590,myocardial,1,1
68591,infarction,1,1
68592,.,1,0
68593,This,0,0
68594,might,0,0
68595,result,0,0
68596,from,0,0
68597,potentiation,0,0
68598,of,0,0
68599,arterial,0,1
68600,baroreflexes,0,0
68601,",",0,0
68602,but,0,0
68603,whether,0,0
68604,or,0,0
68605,not,0,0
68606,PUFA,0,0
68607,enhance,0,0
68608,baroreflex,0,0
68609,function,0,0
68610,has,0,0
68611,never,0,0
68612,been,0,0
68613,studied,0,0
68614,in,0,0
68615,humans,1,0
68616,.,1,1
68617,METHODS,0,0
68618,Patients,1,1
68619,with,1,1
68620,post-myocardial,1,1
68621,infarction,1,1
68622,left,1,1
68623,ventricular,1,0
68624,dysfunction,1,1
68625,underwent,0,1
68626,beat-to-beat,0,0
68627,blood,0,0
68628,pressure,0,0
68629,(,0,0
68630,BP,0,0
68631,),0,0
68632,(,0,0
68633,Finapres,0,0
68634,",",0,0
68635,Ohmeda,0,0
68636,Inc.,0,0
68637,",",0,0
68638,Englewood,0,0
68639,",",0,0
68640,Colorado,0,1
68641,),0,0
68642,and,0,0
68643,R-R,0,0
68644,interval,0,0
68645,(,0,0
68646,electrocardiogram,0,0
68647,),0,0
68648,recording,0,0
68649,;,0,0
68650,baroreceptor,0,0
68651,reflexes,0,0
68652,were,0,0
68653,assessed,0,0
68654,from,0,0
68655,the,0,0
68656,bradycardic,0,0
68657,and,0,0
68658,depressor,0,0
68659,responses,0,0
68660,to,0,0
68661,graded,0,0
68662,neck,0,1
68663,suction,0,0
68664,(,0,0
68665,NS,0,0
68666,),0,0
68667,as,0,0
68668,well,0,0
68669,as,0,0
68670,by,0,0
68671,computation,0,0
68672,of,0,0
68673,the,0,0
68674,alpha,0,0
68675,spontaneous,0,0
68676,baroreflex,0,0
68677,sensitivity,0,0
68678,index,0,0
68679,.,0,0
68680,Assessments,0,0
68681,were,0,0
68682,repeated,0,0
68683,after,0,0
68684,prolonged,0,0
68685,treatment,0,0
68686,with,0,1
68687,PUFA,0,0
68688,(,0,0
68689,2,0,0
68690,g/die,0,0
68691,",",0,0
68692,n,0,1
68693,=,0,0
68694,15,0,0
68695,),0,0
68696,or,0,0
68697,placebo,0,0
68698,(,0,0
68699,n,0,1
68700,=,0,0
68701,10,0,1
68702,),0,0
68703,.,0,0
68704,RESULTS,0,0
68705,Baseline,0,0
68706,BP,0,0
68707,and,0,0
68708,R-R,0,0
68709,interval,0,0
68710,were,0,0
68711,unaffected,0,0
68712,by,0,0
68713,PUFA,0,0
68714,.,0,0
68715,Both,0,0
68716,reflex,0,0
68717,depressor,0,0
68718,and,0,0
68719,bradycardic,0,0
68720,responses,0,0
68721,to,0,0
68722,NS,0,0
68723,increased,0,0
68724,after,0,0
68725,PUFA,0,0
68726,(,0,0
68727,respectively,0,0
68728,from,0,0
68729,-0.09,0,0
68730,+/-,0,0
68731,0.01,0,0
68732,to,0,0
68733,-0.16,0,0
68734,+/-,0,0
68735,0.01,0,0
68736,mm,0,0
68737,Hg,0,0
68738,x,0,0
68739,mm,0,0
68740,Hg,0,0
68741,(,0,0
68742,-1,0,0
68743,),0,0
68744,",",0,0
68745,p,0,0
68746,<,0,0
68747,0.01,0,0
68748,",",0,0
68749,and,0,0
68750,from,0,0
68751,1.25,0,0
68752,+/-,0,0
68753,0.9,0,0
68754,to,0,0
68755,1.76,0,0
68756,+/-,0,0
68757,1.1,0,0
68758,ms,0,0
68759,x,0,0
68760,mm,0,0
68761,Hg,0,0
68762,(,0,0
68763,-1,0,0
68764,),0,0
68765,",",0,0
68766,p,0,0
68767,<,0,0
68768,0.04,0,0
68769,),0,0
68770,but,0,0
68771,not,0,0
68772,after,0,0
68773,placebo,0,0
68774,.,0,0
68775,The,0,0
68776,spontaneous,0,0
68777,baroreflex,0,0
68778,sensitivity,0,0
68779,increased,0,0
68780,in,0,0
68781,the,0,0
68782,PUFA,0,0
68783,(,0,0
68784,from,0,0
68785,8.99,0,0
68786,+/-,0,0
68787,1.4,0,0
68788,to,0,0
68789,12.2,0,0
68790,+/-,0,0
68791,1.2,0,0
68792,ms,0,0
68793,x,0,0
68794,mm,0,0
68795,Hg,0,0
68796,(,0,0
68797,-1,0,0
68798,),0,0
68799,",",0,0
68800,p,0,0
68801,<,0,0
68802,0.02,0,0
68803,),0,0
68804,but,0,0
68805,not,0,0
68806,in,0,0
68807,the,0,0
68808,placebo,0,0
68809,group,0,0
68810,.,0,0
68811,Polyunsaturated,0,0
68812,fatty,0,0
68813,acids,0,0
68814,(,0,0
68815,but,0,0
68816,not,0,0
68817,placebo,0,0
68818,),0,0
68819,treatment,0,0
68820,also,0,0
68821,significantly,0,0
68822,increased,0,0
68823,R-R,0,0
68824,interval,0,0
68825,total,0,1
68826,variance,0,0
68827,and,0,0
68828,low-frequency,0,0
68829,and,0,0
68830,high-frequency,0,0
68831,spectral,0,0
68832,powers,0,0
68833,.,0,1
68834,CONCLUSIONS,0,0
68835,Dietary,0,0
68836,PUFA,0,0
68837,supplementation,0,0
68838,markedly,0,0
68839,potentiates,0,0
68840,baroreflex,0,0
68841,function,0,0
68842,and,0,0
68843,enhances,0,0
68844,heart,0,1
68845,rate,0,0
68846,variability,0,0
68847,in,0,0
68848,patients,1,1
68849,with,1,1
68850,stable,1,1
68851,congestive,1,1
68852,heart,1,1
68853,failure,1,1
68854,.,1,0
68855,[,0,0
68856,The,0,0
68857,effects,0,0
68858,of,0,0
68859,antidepressant,0,0
68860,treatment,0,0
68861,on,0,0
68862,efficacy,0,0
68863,of,0,0
68864,antihypertensive,0,0
68865,therapy,0,0
68866,in,0,0
68867,elderly,1,1
68868,hypertension,1,1
68869,],1,0
68870,.,0,0
68871,OBJECTIVE,0,0
68872,To,0,0
68873,explore,0,0
68874,the,0,0
68875,effect,0,0
68876,of,0,0
68877,antidepressant,0,0
68878,treatment,0,0
68879,on,0,0
68880,antihypertensive,0,0
68881,therapy,0,0
68882,of,0,0
68883,senile,1,1
68884,hypertension,1,1
68885,.,1,0
68886,METHODS,0,0
68887,138,1,1
68888,cases,1,1
68889,of,1,0
68890,senile,1,1
68891,hypertension,1,1
68892,complicating,1,1
68893,with,1,1
68894,depression,1,1
68895,were,1,0
68896,studied,1,1
68897,.,1,0
68898,103,1,1
68899,senile,1,1
68900,hypertensive,1,1
68901,patients,1,1
68902,without,1,1
68903,depression,1,1
68904,in,1,0
68905,the,1,0
68906,same,1,0
68907,period,1,0
68908,served,1,0
68909,as,1,0
68910,controls,1,1
68911,.,1,1
68912,The,0,0
68913,patients,0,1
68914,were,0,0
68915,randomly,0,1
68916,divided,0,0
68917,into,0,0
68918,3,0,0
68919,groups,0,0
68920,as,0,0
68921,A,0,0
68922,",",0,0
68923,B,0,0
68924,and,0,0
68925,C,0,0
68926,for,0,0
68927,study,0,0
68928,.,0,0
68929,12.5,0,0
68930,mg/d,0,0
68931,hydrochlorothiazide,0,0
68932,and,0,0
68933,30,0,0
68934,mg/d,0,0
68935,release-controlling,0,0
68936,tablets,0,0
68937,of,0,0
68938,nifedipine,0,0
68939,were,0,0
68940,orally,0,0
68941,administrated,0,0
68942,as,0,0
68943,basic,0,0
68944,antihypertensive,0,0
68945,medication,0,0
68946,each,0,0
68947,group,0,0
68948,.,0,0
68949,Besides,0,0
68950,",",0,0
68951,20,0,0
68952,mg/d,0,0
68953,fluoxetine,0,0
68954,was,0,0
68955,additionally,0,0
68956,given,0,0
68957,to,0,0
68958,groups,0,0
68959,A,0,0
68960,and,0,0
68961,one,0,0
68962,tablet,0,0
68963,of,0,0
68964,almitrine,0,0
68965,l/d,0,0
68966,and,0,0
68967,20,0,0
68968,mg,0,0
68969,oryzanol,0,0
68970,3/d,0,0
68971,were,0,0
68972,given,0,0
68973,to,0,0
68974,group,0,0
68975,B,0,0
68976,.,0,0
68977,The,0,0
68978,treatment,0,0
68979,lasted,0,0
68980,12,0,0
68981,weeks,0,0
68982,.,0,1
68983,RESULTS,0,0
68984,In,0,0
68985,comparison,0,0
68986,with,0,0
68987,pre-treatment,0,0
68988,",",0,0
68989,the,0,0
68990,blood,0,0
68991,pressure,0,0
68992,at,0,0
68993,base,0,0
68994,line,0,0
68995,in,0,0
68996,sitting,0,0
68997,position,0,0
68998,and,0,0
68999,the,0,0
69000,average,0,0
69001,circadian,0,0
69002,SBP,0,1
69003,and,0,0
69004,DBP,0,0
69005,monitored,0,0
69006,with,0,1
69007,24-hour,0,0
69008,ambulatory,0,1
69009,blood,0,0
69010,pressure,0,0
69011,monitoring,0,0
69012,(,0,0
69013,ABPM,0,0
69014,),0,0
69015,was,0,0
69016,remarkably,0,0
69017,decreased,0,0
69018,in,0,0
69019,group,0,0
69020,A,0,0
69021,with,0,1
69022,statistical,0,0
69023,significance,0,0
69024,(,0,0
69025,P,0,0
69026,<,0,0
69027,0.01,0,0
69028,),0,0
69029,.,0,0
69030,These,0,0
69031,blood,0,0
69032,pressure,0,0
69033,parameters,0,0
69034,in,0,0
69035,group,0,1
69036,B,0,0
69037,were,0,0
69038,also,0,0
69039,decreased,0,0
69040,as,0,0
69041,compared,0,0
69042,ith,0,0
69043,the,0,0
69044,pretreatment,0,0
69045,level,0,0
69046,brt,0,0
69047,with,0,0
69048,less,0,0
69049,statistical,0,0
69050,significance,0,0
69051,(,0,0
69052,P,0,0
69053,>,0,1
69054,0.05,0,0
69055,),0,0
69056,.,0,0
69057,It,0,0
69058,was,0,0
69059,also,0,0
69060,noted,0,0
69061,tha,0,0
69062,with,0,0
69063,the,0,0
69064,addition,0,0
69065,of,0,0
69066,antidepressant,0,0
69067,fluoxetine,0,0
69068,",",0,0
69069,the,0,0
69070,manifestations,0,0
69071,of,0,0
69072,depression,0,1
69073,ere,0,0
69074,alleviated,0,0
69075,as,0,0
69076,shown,0,0
69077,by,0,0
69078,Hamilton,0,0
69079,depression,0,1
69080,(,0,0
69081,HAMD,0,0
69082,),0,0
69083,scale,0,0
69084,.,0,0
69085,untoward,0,0
69086,reactions,0,0
69087,such,0,0
69088,as,0,0
69089,nausea,0,0
69090,",",0,0
69091,perspiration,0,0
69092,and,0,0
69093,skin,0,0
69094,rash,0,0
69095,were,0,0
69096,noted,0,0
69097,in,0,0
69098,a,0,0
69099,few,0,0
69100,patients,0,1
69101,",",0,0
69102,but,0,0
69103,none,0,0
69104,withdrew,0,0
69105,from,0,0
69106,the,0,0
69107,study,0,0
69108,.,0,0
69109,CONCLUSIONS,0,0
69110,Antidepressant,0,0
69111,and,0,0
69112,antianxiety,0,0
69113,treatment,0,0
69114,is,0,0
69115,of,0,0
69116,benefit,0,0
69117,to,0,0
69118,the,0,0
69119,antihypertensive,0,0
69120,therapy,0,0
69121,in,0,0
69122,senile,0,1
69123,hypertensive,0,1
69124,patients,0,1
69125,with,0,1
69126,complications,0,0
69127,of,0,0
69128,depression,0,1
69129,and/or,0,0
69130,anxiety,0,0
69131,neurosis,0,1
69132,.,0,0
69133,Based,0,0
69134,on,0,0
69135,the,0,0
69136,results,0,0
69137,of,0,0
69138,this,0,0
69139,study,0,0
69140,",",0,0
69141,it,0,0
69142,is,0,0
69143,suggested,0,0
69144,that,0,0
69145,routine,0,0
69146,administration,0,0
69147,of,0,0
69148,antidepressants,0,0
69149,and,0,0
69150,antianxiety,0,1
69151,drugs,0,0
69152,should,0,0
69153,be,0,0
69154,carried,0,0
69155,out,0,0
69156,in,0,0
69157,senile,1,1
69158,hypertensive,1,1
69159,patients,1,1
69160,complicating,0,1
69161,with,0,1
69162,depression,0,1
69163,or,0,0
69164,anxiety,0,0
69165,.,0,0
69166,Predictors,0,0
69167,of,0,0
69168,mental,0,1
69169,health,0,1
69170,problems,0,1
69171,and,0,0
69172,negative,0,0
69173,caregiving,0,0
69174,experiences,0,0
69175,in,0,0
69176,carers,1,1
69177,of,1,0
69178,adolescents,1,1
69179,with,1,1
69180,bulimia,1,1
69181,nervosa,1,1
69182,.,1,0
69183,OBJECTIVE,0,0
69184,This,0,0
69185,exploratory,0,0
69186,study,0,0
69187,focuses,0,0
69188,on,0,0
69189,the,0,0
69190,mental,0,0
69191,health,0,0
69192,(,0,0
69193,MH,0,1
69194,),0,0
69195,and,0,0
69196,caregiving,0,0
69197,experience,0,0
69198,of,0,0
69199,carers,0,1
69200,of,0,0
69201,adolescents,1,1
69202,with,1,1
69203,Bulimia,1,1
69204,Nervosa,1,1
69205,(,1,0
69206,BN,1,1
69207,),1,0
69208,/Eating,1,0
69209,Disorder,1,0
69210,not,1,0
69211,otherwise,1,0
69212,specified,1,0
69213,(,1,0
69214,EDNOS,1,0
69215,),1,0
69216,",",0,0
69217,aiming,0,0
69218,to,0,0
69219,determine,0,0
69220,:,0,1
69221,levels,0,0
69222,of,0,0
69223,MH,0,1
69224,problems,0,1
69225,in,0,0
69226,carers,0,1
69227,and,0,0
69228,if,0,0
69229,a,0,0
69230,negative,0,0
69231,experience,0,0
69232,of,0,0
69233,caregiving,0,0
69234,predicts,0,0
69235,carer,0,0
69236,MH,0,1
69237,status,0,0
69238,and,0,0
69239,which,0,0
69240,factors,0,0
69241,predict,0,0
69242,a,0,0
69243,negative,0,0
69244,experience,0,0
69245,of,0,0
69246,caregiving,0,0
69247,.,0,1
69248,METHOD,0,0
69249,Hundred,1,0
69250,and,1,0
69251,twelve,1,1
69252,carers,1,1
69253,and,1,0
69254,68,1,1
69255,adolescents,1,1
69256,with,1,1
69257,BN/EDNOS,1,1
69258,completed,1,1
69259,self-report,1,0
69260,measures,1,0
69261,(,1,0
69262,General,1,1
69263,Health,1,0
69264,Questionnaire,1,0
69265,",",1,0
69266,Experience,1,0
69267,of,1,0
69268,Caregiving,1,0
69269,Inventory,1,0
69270,",",1,0
69271,Level,1,0
69272,of,1,0
69273,Expressed,1,0
69274,Emotion,1,0
69275,",",1,0
69276,Self-report,1,0
69277,Family,1,0
69278,Inventory,1,0
69279,",",1,0
69280,Inventory,1,0
69281,of,1,0
69282,Interpersonal,1,1
69283,Problems,1,1
69284,),1,0
69285,.,0,0
69286,RESULTS,0,0
69287,Over,0,0
69288,half,0,0
69289,of,0,0
69290,the,0,0
69291,carers,0,1
69292,reported,0,0
69293,some,0,0
69294,MH,0,1
69295,problems,0,0
69296,and,0,0
69297,a,0,0
69298,minority,0,0
69299,(,0,0
69300,5.4,0,0
69301,%,0,0
69302,),0,0
69303,were,0,0
69304,experiencing,0,0
69305,considerable,0,0
69306,difficulties,0,0
69307,.,0,0
69308,A,0,0
69309,negative,0,0
69310,experience,0,0
69311,of,0,0
69312,caregiving,0,0
69313,predicted,0,0
69314,carer,0,0
69315,MH,0,1
69316,status,0,0
69317,.,0,0
69318,Higher,0,0
69319,weekly,0,0
69320,contact,0,0
69321,hours,0,0
69322,and,0,0
69323,patient,0,1
69324,ratings,0,0
69325,of,0,0
69326,expressed,0,0
69327,emotion,0,0
69328,(,0,0
69329,EE,0,0
69330,),0,0
69331,predicted,0,0
69332,a,0,0
69333,negative,0,0
69334,experience,0,0
69335,of,0,0
69336,caregiving,0,0
69337,.,0,1
69338,CONCLUSIONS,0,0
69339,Interventions,0,0
69340,focusing,0,0
69341,on,0,0
69342,reducing,0,0
69343,EE,0,0
69344,and,0,0
69345,contact,0,0
69346,hours,0,0
69347,could,0,0
69348,prove,0,0
69349,beneficial,0,0
69350,for,0,0
69351,both,0,0
69352,patient,1,0
69353,and,0,0
69354,caregiver,1,0
69355,outcomes,0,0
69356,.,0,1
69357,Parent,0,0
69358,satisfaction,0,0
69359,in,0,0
69360,a,0,0
69361,multi-site,0,0
69362,acute,0,1
69363,trial,0,0
69364,of,0,0
69365,risperidone,0,0
69366,in,0,0
69367,children,0,1
69368,with,0,1
69369,autism,0,1
69370,:,0,1
69371,a,0,0
69372,social,0,0
69373,validity,0,0
69374,study,0,0
69375,.,0,1
69376,RATIONALE,0,0
69377,Subjects,0,1
69378,who,0,1
69379,view,0,1
69380,experimental,0,1
69381,procedures,0,0
69382,as,0,0
69383,worthwhile,0,0
69384,are,0,0
69385,more,0,0
69386,likely,0,0
69387,to,0,0
69388,participate,0,1
69389,in,0,0
69390,clinical,0,0
69391,trials,0,0
69392,and,0,0
69393,comply,0,0
69394,with,0,1
69395,study,0,0
69396,procedures,0,0
69397,.,0,0
69398,Designing,0,0
69399,studies,0,0
69400,that,0,0
69401,consider,0,0
69402,the,0,0
69403,consumer,0,0
69404,'s,0,0
69405,perspective,0,0
69406,will,0,0
69407,help,0,0
69408,to,0,0
69409,forge,0,0
69410,a,0,0
69411,better,0,0
69412,alliance,0,0
69413,between,0,0
69414,participants,0,1
69415,and,0,1
69416,researchers,0,0
69417,.,0,1
69418,OBJECTIVE,0,0
69419,Participant,0,0
69420,satisfaction,0,0
69421,is,0,0
69422,seldom,0,0
69423,assessed,0,0
69424,in,0,0
69425,pharmacological,0,0
69426,research,0,0
69427,.,0,0
69428,In,0,0
69429,this,0,0
69430,paper,0,0
69431,",",0,0
69432,we,0,0
69433,report,0,0
69434,on,0,0
69435,parent,0,0
69436,satisfaction,0,0
69437,in,0,0
69438,a,0,0
69439,randomized,0,0
69440,clinical,0,0
69441,trial,0,0
69442,in,0,0
69443,children,1,1
69444,with,1,1
69445,autistic,1,1
69446,disorder,1,1
69447,and,1,0
69448,severely,1,1
69449,disruptive,1,0
69450,behavior,1,0
69451,.,1,0
69452,METHOD,0,0
69453,Parents,1,0
69454,of,1,0
69455,101,1,1
69456,children,1,1
69457,with,1,1
69458,autism,1,1
69459,who,1,1
69460,had,1,1
69461,participated,1,1
69462,in,1,0
69463,a,1,0
69464,multi-site,1,0
69465,8-week,1,0
69466,double-blind,1,0
69467,clinical,1,0
69468,trial,1,0
69469,of,1,0
69470,risperidone,1,0
69471,were,1,0
69472,given,1,0
69473,a,1,0
69474,questionnaire,1,0
69475,at,1,0
69476,the,1,0
69477,end,1,0
69478,to,1,0
69479,elicit,1,0
69480,their,1,0
69481,perceptions,1,0
69482,of,1,0
69483,the,1,0
69484,appropriateness,1,0
69485,and,1,0
69486,acceptability,1,0
69487,of,1,0
69488,clinical,1,0
69489,trial,1,1
69490,procedures,1,0
69491,.,1,0
69492,RESULTS,0,0
69493,Ninety-six,1,1
69494,(,1,0
69495,95.0,1,0
69496,%,1,0
69497,),1,0
69498,parents,1,1
69499,returned,1,0
69500,the,1,0
69501,questionnaire,1,0
69502,.,1,0
69503,Of,0,0
69504,these,0,0
69505,",",0,0
69506,80.0,0,0
69507,to,0,0
69508,96.8,0,1
69509,%,0,0
69510,",",0,0
69511,depending,0,0
69512,on,0,0
69513,the,0,0
69514,question,0,0
69515,",",0,0
69516,expressed,0,0
69517,satisfaction,0,0
69518,with,0,0
69519,their,0,0
69520,child,0,1
69521,'s,0,0
69522,research,0,0
69523,participation,0,0
69524,regardless,0,0
69525,of,0,0
69526,treatment,0,0
69527,outcome,0,0
69528,or,0,0
69529,assignment,0,0
69530,to,0,0
69531,active,0,0
69532,drug,0,0
69533,or,0,0
69534,placebo,0,0
69535,.,0,0
69536,In,0,0
69537,all,0,0
69538,",",0,0
69539,90.5,0,0
69540,%,0,0
69541,of,0,0
69542,parents,0,1
69543,indicated,0,0
69544,that,0,0
69545,they,0,0
69546,would,0,0
69547,definitely,0,0
69548,recommend,0,0
69549,the,0,0
69550,clinical,0,0
69551,trial,0,0
69552,to,0,0
69553,other,0,0
69554,families,0,1
69555,with,0,1
69556,similar,0,0
69557,children,0,1
69558,.,0,0
69559,A,0,0
69560,total,0,0
69561,of,0,0
69562,92.7,0,0
69563,%,0,0
69564,indicated,0,0
69565,that,0,0
69566,they,0,0
69567,would,0,0
69568,rejoin,0,0
69569,the,0,0
69570,clinical,0,0
69571,trial,0,0
69572,if,0,0
69573,they,0,0
69574,had,0,0
69575,to,0,0
69576,do,0,0
69577,it,0,0
69578,all,0,0
69579,over,0,0
69580,again,0,0
69581,.,0,0
69582,Ethnic,0,0
69583,minority,0,1
69584,subjects,0,1
69585,were,0,0
69586,more,0,0
69587,satisfied,0,0
69588,than,0,0
69589,white,0,1
69590,participants,0,1
69591,with,0,1
69592,the,0,0
69593,use,0,0
69594,of,0,0
69595,learning,0,0
69596,tests,0,0
69597,.,0,1
69598,CONCLUSIONS,0,0
69599,Parents,0,0
69600,of,0,1
69601,children,0,1
69602,participating,0,1
69603,in,0,0
69604,this,0,0
69605,trial,0,0
69606,were,0,0
69607,highly,0,0
69608,satisfied,0,0
69609,and,0,0
69610,supportive,0,0
69611,of,0,0
69612,the,0,0
69613,clinical,0,0
69614,trial,0,0
69615,procedures,0,1
69616,.,0,0
69617,Random,0,0
69618,assignment,0,0
69619,to,0,0
69620,drug,0,0
69621,or,0,0
69622,placebo,0,0
69623,and,0,0
69624,the,0,0
69625,clinical,0,0
69626,response,0,0
69627,of,0,0
69628,their,0,0
69629,children,0,1
69630,did,0,0
69631,not,0,0
69632,appear,0,0
69633,to,0,0
69634,influence,0,0
69635,their,0,0
69636,views,0,0
69637,.,0,0
69638,Further,0,0
69639,satisfaction,0,0
69640,studies,0,0
69641,of,0,0
69642,this,0,0
69643,sort,0,0
69644,are,0,0
69645,encouraged,0,0
69646,.,0,0
69647,The,0,0
69648,use,0,0
69649,of,0,0
69650,the,0,0
69651,Antenatal,0,0
69652,Psychosocial,0,0
69653,Health,0,0
69654,Assessment,0,0
69655,(,0,0
69656,ALPHA,0,0
69657,),0,0
69658,tool,0,0
69659,in,0,0
69660,the,0,0
69661,detection,0,0
69662,of,0,0
69663,psychosocial,0,0
69664,risk,0,0
69665,factors,0,0
69666,for,0,0
69667,postpartum,0,1
69668,depression,0,1
69669,:,0,1
69670,a,0,0
69671,randomized,0,0
69672,controlled,0,0
69673,trial,0,0
69674,.,0,0
69675,OBJECTIVE,0,0
69676,Eliciting,0,0
69677,known,0,0
69678,risk,0,0
69679,factors,0,0
69680,for,0,0
69681,postpartum,0,1
69682,depression,0,1
69683,(,0,0
69684,PPD,0,1
69685,),0,0
69686,during,0,0
69687,pregnancy,0,0
69688,may,0,0
69689,enable,0,0
69690,primary,0,0
69691,health,0,0
69692,care,0,0
69693,providers,0,0
69694,to,0,0
69695,identify,0,0
69696,women,0,1
69697,at,0,0
69698,increased,0,0
69699,risk,0,0
69700,of,0,0
69701,becoming,0,0
69702,depressed,0,1
69703,.,0,0
69704,The,0,0
69705,purpose,0,0
69706,of,0,0
69707,this,0,0
69708,study,0,0
69709,was,0,0
69710,to,0,0
69711,examine,0,0
69712,how,0,0
69713,well,0,0
69714,the,0,0
69715,Antenatal,0,0
69716,Psychosocial,0,0
69717,Health,0,0
69718,Assessment,0,0
69719,(,0,0
69720,ALPHA,0,0
69721,),0,0
69722,form,0,0
69723,identified,0,0
69724,antenatal,0,1
69725,risk,0,0
69726,factors,0,0
69727,for,0,0
69728,PPD,0,1
69729,",",0,0
69730,compared,0,0
69731,with,0,0
69732,routine,0,0
69733,care,0,0
69734,",",0,0
69735,in,0,0
69736,a,0,0
69737,sample,0,1
69738,of,0,0
69739,pregnant,1,1
69740,women,1,1
69741,.,1,0
69742,METHODS,0,0
69743,A,0,0
69744,randomized,0,0
69745,controlled,0,0
69746,trial,0,0
69747,was,0,0
69748,conducted,0,0
69749,to,0,0
69750,assess,0,0
69751,the,0,0
69752,effectiveness,0,0
69753,of,0,0
69754,the,0,0
69755,ALPHA,0,0
69756,form,0,0
69757,in,0,0
69758,detecting,0,0
69759,antenatal,0,1
69760,risk,0,0
69761,factors,0,0
69762,associated,0,0
69763,with,0,1
69764,the,0,0
69765,adverse,0,0
69766,postpartum,0,1
69767,outcomes,0,0
69768,of,0,0
69769,postpartum,0,1
69770,depression,0,0
69771,",",0,0
69772,intimate,0,0
69773,partner,0,0
69774,violence,0,0
69775,",",0,0
69776,child,0,0
69777,abuse,0,0
69778,",",0,0
69779,and,0,0
69780,couple,0,0
69781,dysfunction,0,0
69782,.,0,0
69783,The,1,0
69784,participants,1,0
69785,were,1,0
69786,primary,1,1
69787,antenatal,1,1
69788,care,1,1
69789,providers,1,1
69790,--,1,1
69791,family,1,1
69792,physicians,1,1
69793,",",1,0
69794,obstetricians,1,1
69795,",",1,0
69796,and,1,0
69797,midwives,1,1
69798,--,1,0
69799,from,1,0
69800,four,1,0
69801,diverse,1,1
69802,communities,1,1
69803,in,1,0
69804,Ontario,1,1
69805,.,1,0
69806,These,0,0
69807,providers,0,0
69808,were,0,0
69809,matched,0,1
69810,and,0,0
69811,then,0,0
69812,randomly,0,0
69813,allocated,0,0
69814,into,0,0
69815,the,0,0
69816,intervention,0,0
69817,group,0,0
69818,",",0,0
69819,who,0,1
69820,used,0,0
69821,the,0,1
69822,ALPHA,0,0
69823,form,0,0
69824,",",0,0
69825,or,0,0
69826,into,0,0
69827,the,0,0
69828,control,0,0
69829,group,0,0
69830,",",0,0
69831,who,0,1
69832,administered,0,0
69833,usual,0,1
69834,care,0,0
69835,.,0,0
69836,In,1,0
69837,total,1,0
69838,",",1,0
69839,227,1,1
69840,pregnant,1,1
69841,women,1,1
69842,were,1,1
69843,recruited,1,1
69844,:,1,1
69845,98,1,1
69846,in,1,0
69847,the,1,0
69848,ALPHA,1,0
69849,group,1,0
69850,and,1,0
69851,129,1,1
69852,in,1,0
69853,the,1,0
69854,control,1,0
69855,group,1,0
69856,.,1,0
69857,The,0,0
69858,data,0,0
69859,presented,0,0
69860,in,0,0
69861,this,0,0
69862,paper,0,0
69863,are,0,0
69864,from,0,0
69865,a,0,0
69866,secondary,0,0
69867,analysis,0,0
69868,focusing,0,0
69869,on,0,0
69870,PPD,0,1
69871,as,0,0
69872,the,0,0
69873,outcome,0,0
69874,.,0,1
69875,RESULTS,0,0
69876,Providers,0,0
69877,randomized,0,1
69878,to,0,0
69879,the,0,0
69880,ALPHA,0,0
69881,group,0,0
69882,identified,0,0
69883,a,0,0
69884,statistically,0,0
69885,significantly,0,0
69886,higher,0,0
69887,proportion,0,0
69888,of,0,0
69889,women,0,1
69890,with,0,1
69891,antenatal,0,1
69892,psychosocial,0,0
69893,risk,0,0
69894,factors,0,0
69895,for,0,0
69896,PPD,0,1
69897,(,0,0
69898,36,0,0
69899,%,0,0
69900,vs.,0,0
69901,26,0,0
69902,%,0,0
69903,),0,0
69904,and,0,0
69905,a,0,0
69906,significantly,0,0
69907,higher,0,0
69908,number,0,0
69909,of,0,0
69910,risk,0,0
69911,factors,0,0
69912,per,0,0
69913,woman,0,1
69914,compared,0,0
69915,with,0,0
69916,the,0,0
69917,control,0,0
69918,group,0,0
69919,(,0,0
69920,mean,0,0
69921,2.1,0,0
69922,vs.1.8,0,0
69923,),0,0
69924,(,0,0
69925,z,0,0
69926,=,0,0
69927,-1.96,0,0
69928,",",0,0
69929,P,0,0
69930,=,0,0
69931,0.05,0,0
69932,),0,0
69933,.,0,0
69934,Providers,0,0
69935,in,0,0
69936,the,0,0
69937,ALPHA,0,0
69938,group,0,0
69939,also,0,0
69940,identified,0,0
69941,significantly,0,0
69942,more,0,0
69943,women,0,1
69944,having,0,1
69945,a,0,0
69946,previous,0,0
69947,history,0,0
69948,of,0,0
69949,depression,0,1
69950,(,0,0
69951,16,0,0
69952,%,0,0
69953,vs.,0,0
69954,6,0,0
69955,%,0,0
69956,),0,0
69957,(,0,0
69958,chi2,0,0
69959,=,0,0
69960,5.243,0,0
69961,",",0,0
69962,df,0,0
69963,=,0,0
69964,1,0,0
69965,",",0,0
69966,P,0,0
69967,=,0,0
69968,0.03,0,0
69969,),0,0
69970,and,0,0
69971,[,0,0
69972,having,0,1
69973,],0,0
69974,witnessed,0,0
69975,or,0,0
69976,experienced,0,0
69977,abuse,0,1
69978,as,0,0
69979,a,0,0
69980,child,0,0
69981,(,0,0
69982,17,0,0
69983,%,0,0
69984,vs.,0,0
69985,3,0,0
69986,%,0,0
69987,),0,0
69988,(,0,0
69989,chi2,0,0
69990,=,0,0
69991,12.488,0,0
69992,",",0,0
69993,df,0,0
69994,=,0,0
69995,1,0,0
69996,",",0,0
69997,P,0,0
69998,=,0,0
69999,0.0005,0,0
70000,),0,0
70001,",",0,0
70002,which,0,0
70003,are,0,0
70004,both,0,0
70005,established,0,0
70006,risk,0,0
70007,factors,0,0
70008,for,0,0
70009,PPD,0,1
70010,.,0,0
70011,CONCLUSION,0,0
70012,The,0,0
70013,ALPHA,0,0
70014,provides,0,0
70015,a,0,0
70016,systematic,0,0
70017,means,0,0
70018,of,0,0
70019,eliciting,0,0
70020,antenatal,0,1
70021,psychosocial,0,1
70022,risk,0,0
70023,factors,0,0
70024,for,0,0
70025,PPD,0,1
70026,for,0,0
70027,primary,0,1
70028,care,0,1
70029,providers,0,0
70030,",",0,0
70031,and,0,0
70032,it,0,0
70033,may,0,0
70034,be,0,0
70035,particularly,0,0
70036,useful,0,0
70037,for,0,0
70038,raising,0,0
70039,and,0,0
70040,discussing,0,0
70041,sensitive,0,0
70042,issues,0,0
70043,.,0,0
70044,The,0,0
70045,detection,0,0
70046,of,0,0
70047,depressive,0,0
70048,symptomatology,0,0
70049,during,0,0
70050,pregnancy,0,0
70051,remains,0,0
70052,problematic,0,0
70053,",",0,0
70054,however,0,0
70055,",",0,0
70056,and,0,0
70057,detection,0,0
70058,may,0,0
70059,be,0,0
70060,improved,0,0
70061,by,0,0
70062,administering,0,0
70063,a,0,0
70064,simple,0,0
70065,standardized,0,0
70066,measure,0,0
70067,of,0,0
70068,depressive,0,0
70069,symptomatology,0,0
70070,during,0,0
70071,routine,0,0
70072,antenatal,0,1
70073,care,0,1
70074,.,0,0
70075,A,0,0
70076,double-blind,0,0
70077,placebo-controlled,0,0
70078,trial,0,0
70079,of,0,0
70080,zonisamide,0,0
70081,(,0,0
70082,zonegran,0,0
70083,),0,0
70084,in,0,0
70085,the,0,0
70086,treatment,0,0
70087,of,0,0
70088,essential,0,0
70089,tremor,0,0
70090,.,0,0
70091,Medical,0,0
70092,therapy,0,0
70093,for,0,0
70094,essential,1,0
70095,tremor,1,0
70096,(,1,0
70097,ET,1,0
70098,),1,0
70099,",",0,0
70100,a,0,0
70101,common,0,0
70102,movement,0,0
70103,disorder,0,1
70104,",",0,0
70105,is,0,0
70106,often,0,0
70107,inadequate,0,0
70108,.,0,0
70109,We,0,0
70110,performed,0,0
70111,a,0,0
70112,double-blind,0,0
70113,placebo-controlled,0,0
70114,randomized,0,0
70115,trial,0,0
70116,to,0,0
70117,evaluate,0,0
70118,the,0,0
70119,efficacy,0,0
70120,and,0,0
70121,tolerability,0,0
70122,of,0,0
70123,zonisamide,0,0
70124,(,0,0
70125,ZNS,0,0
70126,),0,0
70127,",",0,0
70128,an,0,0
70129,antiepileptic,0,0
70130,agent,0,0
70131,",",0,0
70132,in,0,0
70133,treating,0,0
70134,ET,0,0
70135,.,0,1
70136,Twenty,1,1
70137,patients,1,1
70138,(,1,0
70139,mean,1,0
70140,age,1,1
70141,",",1,0
70142,60,1,1
70143,+/-,1,0
70144,15,1,1
70145,years,1,1
70146,),1,0
70147,with,1,1
70148,ET,1,0
70149,were,0,0
70150,randomized,0,0
70151,to,0,0
70152,receive,0,0
70153,ZNS,0,0
70154,or,0,0
70155,placebo,0,0
70156,.,0,0
70157,ZNS,0,0
70158,was,0,0
70159,initiated,0,0
70160,at,0,0
70161,a,0,0
70162,dosage,0,0
70163,of,0,0
70164,100,0,0
70165,mg/day,0,0
70166,and,0,0
70167,escalated,0,0
70168,to,0,0
70169,200,0,0
70170,mg/day,0,0
70171,at,0,0
70172,day,0,0
70173,14,0,1
70174,.,0,1
70175,Patients,0,1
70176,were,0,0
70177,evaluated,0,0
70178,by,0,0
70179,accelerometry,0,0
70180,and,0,0
70181,the,0,0
70182,Fahn-Tolosa-Marin,0,0
70183,(,0,0
70184,FTM,0,0
70185,),0,0
70186,rating,0,0
70187,scale,0,0
70188,at,0,0
70189,baseline,0,0
70190,and,0,0
70191,days,0,0
70192,14,0,1
70193,and,0,0
70194,28,0,0
70195,",",0,0
70196,as,0,0
70197,well,0,0
70198,as,0,0
70199,the,0,0
70200,Clinical,0,0
70201,Global,0,0
70202,Impression,0,0
70203,(,0,0
70204,CGI-C,0,0
70205,),0,0
70206,scale,0,0
70207,at,0,0
70208,day,0,0
70209,28,0,0
70210,.,0,0
70211,At,0,0
70212,endpoint,0,0
70213,",",0,0
70214,subjects,0,1
70215,assigned,0,1
70216,to,0,0
70217,ZNS,0,0
70218,were,0,0
70219,taking,0,0
70220,a,0,0
70221,mean,0,0
70222,dosage,0,0
70223,of,0,0
70224,160,0,1
70225,+/-,0,0
70226,50,0,1
70227,mg/day,0,0
70228,.,0,0
70229,There,0,0
70230,were,0,0
70231,no,0,0
70232,significant,0,0
70233,improvements,0,0
70234,in,0,0
70235,the,0,0
70236,FTM,0,0
70237,total,0,0
70238,score,0,0
70239,or,0,0
70240,its,0,0
70241,subsections,0,0
70242,.,0,0
70243,Tremor,0,0
70244,amplitude,0,0
70245,as,0,0
70246,assessed,0,0
70247,by,0,0
70248,accelerometry,0,0
70249,significantly,0,0
70250,improved,0,0
70251,in,0,0
70252,the,0,0
70253,ZNS,0,0
70254,group,0,0
70255,compared,0,0
70256,to,0,0
70257,the,0,0
70258,placebo,0,0
70259,group,0,0
70260,at,0,0
70261,endpoint,0,0
70262,relative,0,0
70263,to,0,0
70264,baseline,0,0
70265,(,0,0
70266,-0.50,0,0
70267,+/-,0,0
70268,0.72,0,0
70269,vs.,0,0
70270,0.30,0,0
70271,+/-,0,0
70272,0.79,0,0
70273,m/s,0,0
70274,(,0,0
70275,2,0,0
70276,),0,0
70277,;,0,0
70278,P,0,0
70279,=,0,0
70280,0.03,0,0
70281,),0,0
70282,.,0,0
70283,On,0,0
70284,the,0,0
70285,CGI-C,0,0
70286,",",0,0
70287,60,0,0
70288,%,0,0
70289,(,0,0
70290,n,0,1
70291,=,0,0
70292,6,0,0
70293,),0,0
70294,of,0,0
70295,patients,0,1
70296,in,0,0
70297,the,0,0
70298,ZNS,0,0
70299,group,0,0
70300,felt,0,0
70301,that,0,0
70302,their,0,0
70303,tremor,0,0
70304,was,0,0
70305,unchanged,0,0
70306,",",0,0
70307,while,0,0
70308,the,0,0
70309,remaining,0,0
70310,patients,0,1
70311,felt,0,0
70312,that,0,0
70313,their,0,0
70314,tremor,0,0
70315,was,0,0
70316,minimally,0,0
70317,improved,0,0
70318,.,0,0
70319,Thirty,0,0
70320,percent,0,0
70321,(,0,0
70322,n,0,1
70323,=,0,0
70324,3,0,0
70325,),0,0
70326,of,0,0
70327,patients,0,1
70328,taking,0,1
70329,ZNS,0,0
70330,discontinued,0,0
70331,the,0,0
70332,study,0,0
70333,due,0,0
70334,to,0,0
70335,side,0,0
70336,effects,0,0
70337,(,0,0
70338,fatigue,0,0
70339,",",0,0
70340,headache,0,0
70341,",",0,0
70342,paresthesias,0,0
70343,),0,0
70344,while,0,0
70345,taking,0,0
70346,100,0,0
70347,mg,0,0
70348,per,0,0
70349,day,0,0
70350,.,0,0
70351,ZNS,0,0
70352,did,0,0
70353,not,0,0
70354,provide,0,0
70355,significant,0,0
70356,improvements,0,0
70357,in,0,0
70358,clinical,0,0
70359,rating,0,0
70360,scales,0,0
70361,at,0,0
70362,study,0,0
70363,endpoint,0,0
70364,compared,0,0
70365,to,0,0
70366,placebo,0,0
70367,and,0,0
70368,was,0,0
70369,only,0,0
70370,modestly,0,0
70371,well,0,0
70372,tolerated,0,0
70373,.,0,0
70374,ZNS,0,0
70375,was,0,0
70376,effective,0,0
70377,in,0,0
70378,reducing,0,0
70379,tremor,0,0
70380,amplitude,0,0
70381,as,0,0
70382,measured,0,0
70383,by,0,0
70384,accelerometry,0,0
70385,.,0,0
70386,Dofequidar,0,0
70387,fumarate,0,0
70388,(,0,0
70389,MS-209,0,0
70390,),0,0
70391,in,0,0
70392,combination,0,0
70393,with,0,0
70394,cyclophosphamide,0,0
70395,",",0,0
70396,doxorubicin,0,0
70397,",",0,0
70398,and,0,0
70399,fluorouracil,0,0
70400,for,0,0
70401,patients,1,1
70402,with,1,1
70403,advanced,1,1
70404,or,1,0
70405,recurrent,1,1
70406,breast,1,1
70407,cancer,1,1
70408,.,1,0
70409,PURPOSE,0,0
70410,To,0,0
70411,evaluate,0,0
70412,the,0,0
70413,efficacy,0,0
70414,and,0,0
70415,tolerability,0,0
70416,of,0,0
70417,dofequidar,0,0
70418,plus,0,0
70419,cyclophosphamide,0,0
70420,",",0,0
70421,doxorubicin,0,0
70422,",",0,0
70423,and,0,0
70424,fluorouracil,0,0
70425,(,0,0
70426,CAF,0,1
70427,),0,0
70428,therapy,0,0
70429,in,0,0
70430,comparison,0,0
70431,with,0,1
70432,CAF,0,0
70433,alone,0,0
70434,",",0,0
70435,in,0,0
70436,patients,1,1
70437,with,1,1
70438,advanced,1,1
70439,or,1,0
70440,recurrent,1,1
70441,breast,1,1
70442,cancer,1,1
70443,.,1,0
70444,Dofequidar,0,0
70445,is,0,0
70446,a,0,0
70447,novel,0,0
70448,",",0,0
70449,orally,0,0
70450,active,0,0
70451,quinoline,0,0
70452,derivative,0,0
70453,that,0,0
70454,reverses,0,0
70455,multidrug,0,0
70456,resistance,0,0
70457,.,0,0
70458,PATIENTS,0,0
70459,AND,0,0
70460,METHODS,0,0
70461,In,0,0
70462,this,0,0
70463,randomized,0,0
70464,",",0,0
70465,double-blind,0,0
70466,",",0,0
70467,placebo-controlled,0,0
70468,trial,0,0
70469,",",0,0
70470,patients,0,1
70471,were,0,0
70472,treated,0,1
70473,with,0,1
70474,six,0,0
70475,cycles,0,0
70476,of,0,0
70477,CAF,0,1
70478,therapy,0,0
70479,:,0,1
70480,28,0,0
70481,days/cycle,0,0
70482,",",0,0
70483,with,0,0
70484,doxorubicin,0,0
70485,(,0,0
70486,25,0,0
70487,mg/m2,0,0
70488,),0,0
70489,and,0,0
70490,fluorouracil,0,0
70491,(,0,0
70492,500,0,0
70493,mg/m2,0,0
70494,),0,0
70495,administered,0,0
70496,on,0,0
70497,days,0,0
70498,1,0,0
70499,and,0,0
70500,8,0,0
70501,and,0,0
70502,cyclophosphamide,0,0
70503,(,0,0
70504,100,0,0
70505,mg,0,0
70506,orally,0,0
70507,[,0,0
70508,PO,0,0
70509,],0,0
70510,),0,0
70511,administered,0,0
70512,on,0,0
70513,day,0,0
70514,1,0,0
70515,through,0,0
70516,14,0,1
70517,.,0,1
70518,Patients,0,1
70519,received,0,0
70520,dofequidar,0,0
70521,(,0,0
70522,900,0,0
70523,mg,0,0
70524,PO,0,0
70525,),0,0
70526,30,0,0
70527,minutes,0,0
70528,before,0,0
70529,each,0,0
70530,dose,0,0
70531,of,0,0
70532,doxorubicin,0,0
70533,.,0,0
70534,Primary,0,0
70535,end,0,0
70536,point,0,0
70537,was,0,0
70538,overall,0,0
70539,response,0,0
70540,rate,0,0
70541,(,0,0
70542,ORR,0,0
70543,;,0,0
70544,partial,0,0
70545,or,0,0
70546,complete,0,0
70547,response,0,0
70548,),0,0
70549,.,0,0
70550,In,0,0
70551,total,0,0
70552,",",0,0
70553,221,1,1
70554,patients,1,1
70555,were,1,1
70556,assessable,1,1
70557,.,1,0
70558,RESULTS,0,0
70559,ORR,0,0
70560,was,0,0
70561,42.6,0,0
70562,%,0,0
70563,for,0,0
70564,CAF,0,0
70565,compared,0,0
70566,with,0,1
70567,53.1,0,0
70568,%,0,0
70569,for,0,0
70570,dofequidar,0,0
70571,+,0,0
70572,CAF,0,0
70573,",",0,0
70574,a,0,0
70575,24.6,0,0
70576,%,0,0
70577,relative,0,0
70578,improvement,0,0
70579,and,0,0
70580,10.5,0,0
70581,%,0,0
70582,absolute,0,0
70583,increase,0,0
70584,(,0,0
70585,P,0,0
70586,=,0,0
70587,.077,0,0
70588,),0,0
70589,.,0,0
70590,There,0,0
70591,was,0,0
70592,a,0,0
70593,trend,0,0
70594,for,0,0
70595,prolonged,0,0
70596,progression-free,0,0
70597,survival,0,0
70598,(,0,0
70599,PFS,0,0
70600,;,0,0
70601,median,0,0
70602,241,0,1
70603,days,0,0
70604,for,0,0
70605,CAF,0,1
70606,v,0,0
70607,366,0,1
70608,days,0,0
70609,for,0,0
70610,dofequidar,0,1
70611,+,0,0
70612,CAF,0,1
70613,;,0,0
70614,P,0,0
70615,=,0,0
70616,.145,0,0
70617,),0,0
70618,.,0,0
70619,In,0,0
70620,retrospectively,0,0
70621,defined,0,0
70622,subgroups,0,0
70623,",",0,0
70624,significant,0,0
70625,improvement,0,0
70626,in,0,0
70627,PFS,0,0
70628,in,0,0
70629,favor,0,0
70630,of,0,0
70631,dofequidar,0,0
70632,was,0,0
70633,observed,0,0
70634,in,0,1
70635,patients,1,1
70636,who,1,1
70637,were,1,1
70638,premenopausal,1,1
70639,",",1,0
70640,had,1,0
70641,no,1,0
70642,prior,1,0
70643,therapy,1,0
70644,",",1,0
70645,and,1,0
70646,were,1,0
70647,stage,1,1
70648,IV,1,0
70649,at,1,0
70650,diagnosis,1,1
70651,with,1,1
70652,an,1,0
70653,intact,1,0
70654,primary,1,0
70655,tumor,1,1
70656,.,1,0
70657,Except,0,0
70658,for,0,0
70659,neutropenia,0,0
70660,and,0,0
70661,leukopenia,0,0
70662,",",0,0
70663,there,0,0
70664,was,0,0
70665,no,0,0
70666,statistically,0,0
70667,significant,0,0
70668,excess,0,0
70669,of,0,0
70670,grade,0,0
70671,3/4,0,0
70672,adverse,0,0
70673,events,0,0
70674,compared,0,0
70675,with,0,1
70676,CAF,0,1
70677,.,0,0
70678,Treatment,0,0
70679,with,0,0
70680,dofequidar,0,0
70681,did,0,0
70682,not,0,0
70683,affect,0,0
70684,the,0,0
70685,plasma,0,0
70686,concentration,0,0
70687,of,0,0
70688,doxorubicin,0,0
70689,.,0,0
70690,CONCLUSION,0,0
70691,Dofequidar,0,0
70692,+,0,0
70693,CAF,0,1
70694,was,0,0
70695,well,0,0
70696,tolerated,0,0
70697,and,0,0
70698,is,0,0
70699,suggested,0,0
70700,to,0,0
70701,have,0,0
70702,efficacy,0,0
70703,in,0,0
70704,patients,1,1
70705,who,1,1
70706,had,1,1
70707,not,1,1
70708,received,1,0
70709,prior,1,0
70710,therapy,1,0
70711,.,1,0
70712,Xuezhikang,0,0
70713,",",0,0
70714,an,0,0
70715,extract,0,0
70716,of,0,0
70717,cholestin,0,0
70718,",",0,0
70719,decreases,0,0
70720,plasma,0,0
70721,inflammatory,0,0
70722,markers,0,0
70723,and,0,0
70724,endothelin-1,0,0
70725,",",0,0
70726,improve,0,0
70727,exercise-induced,0,0
70728,ischemia,0,0
70729,and,0,0
70730,subjective,0,0
70731,feelings,0,0
70732,in,0,0
70733,patients,1,1
70734,with,1,1
70735,cardiac,1,1
70736,syndrome,1,1
70737,X,1,0
70738,.,1,0
70739,Previous,0,0
70740,studies,0,0
70741,have,0,0
70742,demonstrated,0,0
70743,that,0,0
70744,Xuezhikang,0,0
70745,",",0,0
70746,an,0,0
70747,extract,0,0
70748,of,0,0
70749,cholestin,0,0
70750,",",0,0
70751,available,0,0
70752,from,0,0
70753,Chinese,0,1
70754,red,0,0
70755,yeast,0,0
70756,rice,0,0
70757,",",0,0
70758,could,0,0
70759,effectively,0,0
70760,modify,0,0
70761,lipid,0,0
70762,profile,0,0
70763,.,0,0
70764,The,0,0
70765,present,0,0
70766,study,0,0
70767,was,0,0
70768,undertaken,0,0
70769,to,0,0
70770,investigate,0,0
70771,whether,0,0
70772,Xuezhikang,0,0
70773,could,0,0
70774,modify,0,0
70775,endothelin-1,0,0
70776,(,0,0
70777,ET-1,0,0
70778,),0,0
70779,",",0,0
70780,interleukin-6,0,0
70781,(,0,0
70782,IL-6,0,0
70783,),0,0
70784,",",0,0
70785,high-sensitivity,0,0
70786,C-reactive,0,0
70787,protein,0,0
70788,(,0,0
70789,CRP,0,0
70790,),0,0
70791,and,0,0
70792,exercise-induced,0,0
70793,ischemia,0,1
70794,in,0,0
70795,patients,1,1
70796,with,1,1
70797,cardiac,1,1
70798,syndrome,1,1
70799,X,1,0
70800,(,1,0
70801,CSX,1,1
70802,),1,0
70803,.,1,0
70804,Thirty-six,1,1
70805,patients,1,1
70806,with,1,1
70807,CSX,1,1
70808,were,0,0
70809,randomly,0,0
70810,assigned,0,0
70811,to,0,0
70812,1200,0,0
70813,mg/d,0,0
70814,of,0,0
70815,Xuezhikang,0,0
70816,or,0,0
70817,placebo,0,0
70818,group,0,0
70819,(,0,0
70820,n=18,0,1
70821,respectively,0,0
70822,),0,0
70823,.,0,0
70824,Blood,0,0
70825,samples,0,0
70826,were,0,0
70827,drawn,0,0
70828,at,0,0
70829,day,0,0
70830,0,0,0
70831,and,0,0
70832,day,0,0
70833,90,0,0
70834,for,0,0
70835,measuring,0,0
70836,above,0,1
70837,parameters,0,0
70838,.,0,0
70839,The,0,0
70840,treadmill,0,0
70841,exercise,0,0
70842,tests,0,0
70843,and,0,0
70844,subjective,0,0
70845,feelings,0,0
70846,were,0,0
70847,also,0,0
70848,assessed,0,0
70849,at,0,0
70850,day,0,0
70851,0,0,0
70852,and,0,0
70853,day,0,0
70854,90,0,0
70855,.,0,0
70856,The,0,0
70857,data,0,0
70858,showed,0,0
70859,that,0,0
70860,Xuezhikang,0,0
70861,therapy,0,0
70862,resulted,0,0
70863,in,0,0
70864,significant,0,0
70865,reductions,0,0
70866,in,0,0
70867,total,0,1
70868,cholesterol,0,0
70869,(,0,0
70870,TC,0,0
70871,",",0,0
70872,19,0,1
70873,%,0,0
70874,),0,0
70875,",",0,0
70876,low-density,0,0
70877,lipoprotein,0,0
70878,cholesterol,0,0
70879,(,0,0
70880,LDL-C,0,0
70881,),0,0
70882,(,0,0
70883,26,0,0
70884,%,0,0
70885,),0,0
70886,",",0,0
70887,and,0,0
70888,triglycerides,0,0
70889,(,0,0
70890,TG,0,0
70891,),0,0
70892,compared,0,0
70893,with,0,0
70894,baseline,0,0
70895,(,0,0
70896,16,0,0
70897,%,0,0
70898,",",0,0
70899,p,0,0
70900,<,0,0
70901,0.01,0,0
70902,respectively,0,0
70903,),0,0
70904,.,0,0
70905,The,0,0
70906,data,0,0
70907,also,0,0
70908,showed,0,0
70909,that,0,0
70910,Xuezhikang,0,0
70911,led,0,0
70912,significantly,0,0
70913,to,0,0
70914,reductions,0,0
70915,in,0,0
70916,median,0,0
70917,and,0,0
70918,log-CRP,0,0
70919,levels,0,0
70920,(,0,0
70921,38,0,1
70922,%,0,0
70923,and,0,0
70924,44,0,0
70925,%,0,0
70926,",",0,0
70927,p,0,0
70928,<,0,0
70929,0.01,0,0
70930,respectively,0,0
70931,),0,0
70932,",",0,0
70933,IL-6,0,0
70934,(,0,0
70935,20,0,0
70936,%,0,0
70937,",",0,0
70938,p,0,0
70939,<,0,0
70940,0.01,0,0
70941,),0,0
70942,",",0,0
70943,and,0,0
70944,ET-1,0,0
70945,(,0,0
70946,47,0,0
70947,%,0,0
70948,",",0,0
70949,p,0,0
70950,<,0,0
70951,0.01,0,0
70952,),0,0
70953,compared,0,0
70954,with,0,1
70955,baseline,0,0
70956,.,0,0
70957,The,0,0
70958,exercise,0,0
70959,duration,0,0
70960,",",0,0
70961,and,0,0
70962,time,0,0
70963,to,0,0
70964,1,0,0
70965,mm,0,0
70966,ST-segment,0,1
70967,depression,0,1
70968,was,0,0
70969,significantly,0,0
70970,prolonged,0,0
70971,after,0,0
70972,Xuezhikang,0,0
70973,therapy,0,0
70974,(,0,0
70975,9,0,0
70976,%,0,0
70977,and,0,0
70978,6,0,0
70979,%,0,0
70980,",",0,0
70981,p,0,0
70982,<,0,0
70983,0.05,0,0
70984,respectively,0,0
70985,),0,0
70986,accompanied,0,0
70987,by,0,0
70988,improvement,0,0
70989,of,0,0
70990,subjective,0,0
70991,feelings,0,0
70992,.,0,1
70993,Data,0,0
70994,suggested,0,0
70995,that,0,0
70996,the,0,0
70997,benefit,0,0
70998,of,0,0
70999,Xuezhikang,0,0
71000,resulted,0,0
71001,in,0,0
71002,significant,0,0
71003,modification,0,0
71004,vascular,0,0
71005,function,0,0
71006,by,0,0
71007,reduction,0,0
71008,of,0,0
71009,ET-1,0,0
71010,",",0,0
71011,inflammatory,0,0
71012,markers,0,0
71013,and,0,0
71014,LDL,0,0
71015,cholesterol,0,0
71016,",",0,0
71017,which,0,0
71018,may,0,0
71019,be,0,0
71020,clinically,0,0
71021,important,0,0
71022,for,0,0
71023,patients,1,1
71024,with,1,1
71025,CSX,1,1
71026,.,1,1
71027,Relationship,0,0
71028,of,0,0
71029,dietary,0,0
71030,intake,0,0
71031,to,0,0
71032,gastrointestinal,0,1
71033,symptoms,0,0
71034,in,0,0
71035,children,1,1
71036,with,1,1
71037,autistic,1,1
71038,spectrum,1,1
71039,disorders,1,1
71040,.,1,1
71041,BACKGROUND,0,0
71042,Gastrointestinal,0,0
71043,(,0,0
71044,GI,0,1
71045,),0,0
71046,symptoms,0,0
71047,and,0,0
71048,abnormalities,0,0
71049,in,0,0
71050,stool,0,0
71051,consistency,0,0
71052,are,0,0
71053,frequently,0,0
71054,reported,0,0
71055,by,0,0
71056,parents,1,1
71057,of,1,0
71058,children,1,1
71059,with,1,1
71060,autism,1,1
71061,spectrum,1,1
71062,disorders,1,1
71063,(,1,0
71064,ASD,1,1
71065,),1,0
71066,.,1,0
71067,The,0,0
71068,purpose,0,0
71069,of,0,0
71070,this,0,0
71071,study,0,0
71072,was,0,0
71073,to,0,0
71074,1,0,0
71075,),0,0
71076,describe,0,0
71077,dietary,0,0
71078,intake,0,0
71079,of,0,0
71080,a,0,0
71081,cohort,0,1
71082,of,0,0
71083,children,0,1
71084,with,0,1
71085,ASD,0,1
71086,compared,0,0
71087,with,0,1
71088,normative,0,0
71089,data,0,0
71090,and,0,0
71091,2,0,0
71092,),0,0
71093,determine,0,0
71094,whether,0,0
71095,GI,0,1
71096,symptoms,0,0
71097,and,0,0
71098,stool,0,0
71099,consistency,0,0
71100,are,0,0
71101,related,0,0
71102,to,0,0
71103,dietary,0,0
71104,intake,0,0
71105,.,0,0
71106,METHODS,0,0
71107,Data,1,0
71108,from,1,0
71109,diet,1,0
71110,diaries,1,0
71111,of,1,0
71112,children,1,1
71113,(,1,1
71114,3-8,1,1
71115,years,1,1
71116,),1,0
71117,with,1,1
71118,ASD,1,1
71119,(,1,0
71120,n,1,1
71121,=,1,0
71122,62,1,1
71123,),1,0
71124,were,1,0
71125,analyzed,1,0
71126,by,0,0
71127,a,0,0
71128,registered,0,0
71129,pediatric,0,1
71130,dietician,0,0
71131,to,0,0
71132,compare,0,0
71133,to,0,0
71134,RDA,0,0
71135,standards,0,0
71136,for,0,0
71137,total,0,1
71138,calories,0,0
71139,",",0,0
71140,protein,0,0
71141,",",0,0
71142,carbohydrate,0,0
71143,",",0,0
71144,and,0,0
71145,fat,0,0
71146,.,0,0
71147,Dietary,0,0
71148,intake,0,0
71149,was,0,0
71150,correlated,0,0
71151,with,0,1
71152,descriptors,0,0
71153,of,0,0
71154,stool,0,0
71155,consistency,0,0
71156,using,0,0
71157,cumulative,0,0
71158,logistic,0,0
71159,regression,0,0
71160,methods,0,1
71161,.,0,1
71162,RESULTS,0,0
71163,Intake,0,0
71164,of,0,0
71165,calories,0,0
71166,",",0,0
71167,carbohydrates,0,0
71168,",",0,0
71169,and,0,0
71170,fat,0,0
71171,were,0,0
71172,in,0,0
71173,the,0,0
71174,average,0,0
71175,range,0,0
71176,;,0,0
71177,protein,0,0
71178,intake,0,0
71179,was,0,0
71180,increased,0,0
71181,(,0,0
71182,211,0,1
71183,%,0,0
71184,of,0,0
71185,RDA,0,0
71186,),0,0
71187,.,0,0
71188,Reported,0,0
71189,frequency,0,0
71190,of,0,0
71191,GI,0,1
71192,abnormalities,0,0
71193,",",0,0
71194,including,0,0
71195,abnormal,0,0
71196,stool,0,0
71197,consistency,0,0
71198,(,0,0
71199,e.g.,0,0
71200,",",0,0
71201,bulky,0,1
71202,or,0,0
71203,loose,0,0
71204,),0,0
71205,",",0,0
71206,was,0,0
71207,increased,0,0
71208,(,0,0
71209,54,0,1
71210,%,0,0
71211,),0,0
71212,.,0,0
71213,No,0,0
71214,statistically,0,0
71215,significant,0,0
71216,relationships,0,0
71217,between,0,0
71218,stool,0,0
71219,consistency,0,0
71220,and,0,0
71221,dietary,0,0
71222,intake,0,0
71223,were,0,0
71224,observed,0,0
71225,.,0,0
71226,CONCLUSIONS,0,0
71227,In,0,0
71228,this,0,0
71229,sample,0,1
71230,",",0,0
71231,there,0,0
71232,was,0,0
71233,a,0,0
71234,high,0,0
71235,rate,0,0
71236,of,0,0
71237,reported,0,0
71238,gastrointestinal,0,1
71239,symptoms,0,0
71240,",",0,0
71241,despite,0,0
71242,lack,0,0
71243,of,0,0
71244,medical,0,1
71245,causes,0,0
71246,.,0,1
71247,Intake,0,0
71248,was,0,0
71249,adequate,0,0
71250,for,0,0
71251,calories,0,0
71252,and,0,0
71253,carbohydrates,0,0
71254,and,0,0
71255,increased,0,0
71256,for,0,0
71257,protein,0,0
71258,.,0,0
71259,The,0,0
71260,children,1,1
71261,did,0,0
71262,not,0,0
71263,exhibit,0,0
71264,excessive,0,0
71265,carbohydrate,0,0
71266,intake,0,0
71267,.,0,0
71268,There,0,0
71269,was,0,0
71270,no,0,0
71271,association,0,0
71272,of,0,0
71273,nutrient,0,0
71274,intake,0,0
71275,to,0,0
71276,changes,0,0
71277,in,0,0
71278,stool,0,0
71279,consistency,0,0
71280,.,0,0
71281,5,0,0
71282,alpha-metabolism,0,0
71283,in,0,0
71284,finasteride-treated,1,0
71285,subjects,1,1
71286,and,1,0
71287,male,1,1
71288,pseudohermaphrodites,1,1
71289,with,1,1
71290,inherited,1,1
71291,5,1,0
71292,alpha-reductase,1,1
71293,deficiency,1,1
71294,.,1,0
71295,A,0,0
71296,review,0,0
71297,.,0,0
71298,Male,1,0
71299,pseudohermaphrodites,1,1
71300,(,1,0
71301,MPHs,1,0
71302,),1,0
71303,with,1,1
71304,inherited,1,0
71305,5,1,0
71306,alpha-reductase,1,0
71307,deficiency,1,1
71308,and,1,0
71309,decreased,1,0
71310,dihydrotestosterone,1,0
71311,production,1,0
71312,have,0,0
71313,a,0,0
71314,global,0,0
71315,defect,0,0
71316,in,0,0
71317,5,0,0
71318,alpha-metabolism,0,0
71319,affecting,0,0
71320,both,0,0
71321,C19,0,0
71322,androgen,0,0
71323,metabolism,0,0
71324,and,0,0
71325,C21,0,0
71326,steroid,0,0
71327,metabolism,0,0
71328,.,0,0
71329,However,0,0
71330,",",0,0
71331,the,0,0
71332,decreased,0,0
71333,5,0,0
71334,alpha-reduction,0,0
71335,of,0,0
71336,testosterone,0,0
71337,to,0,0
71338,dihydrotestosterone,0,0
71339,is,0,0
71340,the,0,0
71341,only,0,0
71342,impaired,0,0
71343,steroid,0,0
71344,conversion,0,0
71345,to,0,0
71346,have,0,0
71347,clinical,0,0
71348,consequences,0,0
71349,",",0,0
71350,e.g.,0,0
71351,",",0,0
71352,ambiguous,0,0
71353,genitalia,0,0
71354,",",0,0
71355,impaired,0,0
71356,prostate,0,1
71357,differentiation,0,0
71358,and,0,0
71359,development,0,0
71360,",",0,0
71361,and,0,0
71362,decreased,0,0
71363,facial,0,0
71364,and,0,0
71365,body,0,0
71366,hair,0,1
71367,.,0,0
71368,The,1,0
71369,5,1,0
71370,alpha-steroid,1,0
71371,metabolite,1,0
71372,profile,1,0
71373,in,1,0
71374,the,1,0
71375,MPHs,1,0
71376,was,1,0
71377,compared,1,0
71378,with,1,0
71379,that,1,0
71380,of,1,0
71381,men,1,1
71382,with,1,1
71383,benign,1,1
71384,prostatic,1,1
71385,hyperplasia,1,1
71386,who,0,1
71387,were,0,1
71388,administered,0,1
71389,varying,0,0
71390,doses,0,0
71391,of,0,0
71392,the,0,0
71393,5,0,0
71394,alpha-reductase,0,0
71395,inhibitor,0,0
71396,finasteride,0,0
71397,.,0,0
71398,Finasteride,0,0
71399,was,0,0
71400,found,0,0
71401,to,0,0
71402,be,0,0
71403,a,0,0
71404,potent,0,0
71405,inhibitor,0,0
71406,of,0,0
71407,both,0,0
71408,C19,0,0
71409,androgen,0,0
71410,and,0,0
71411,C21,0,1
71412,5,0,0
71413,alpha-steroid,0,1
71414,metabolism,0,0
71415,affecting,0,0
71416,both,0,0
71417,hepatic,0,0
71418,and,0,0
71419,peripheral,0,0
71420,5,0,0
71421,alpha-metabolism,0,0
71422,.,0,0
71423,The,0,0
71424,5,0,0
71425,alpha-steroid,0,0
71426,metabolite,0,0
71427,profile,0,0
71428,was,0,0
71429,strikingly,0,0
71430,similar,0,0
71431,to,0,0
71432,that,0,0
71433,of,0,0
71434,MPHs,0,0
71435,with,0,1
71436,inherited,0,0
71437,5,0,0
71438,alpha-reductase,0,1
71439,deficiency,0,1
71440,.,0,0
71441,The,0,0
71442,data,0,0
71443,suggest,0,0
71444,that,0,0
71445,a,0,0
71446,5,0,0
71447,alpha-reductase,0,0
71448,gene,0,0
71449,codes,0,0
71450,for,0,0
71451,an,0,0
71452,enzyme,0,0
71453,with,0,0
71454,affinity,0,0
71455,for,0,0
71456,multiple,0,0
71457,steroid,0,0
71458,substrates,0,0
71459,.,0,1
71460,Effects,0,0
71461,of,0,0
71462,sibutramine,0,0
71463,on,0,0
71464,thermogenesis,0,0
71465,in,0,0
71466,obese,1,1
71467,patients,1,1
71468,assessed,0,0
71469,via,0,0
71470,immersion,0,0
71471,calorimetry,0,0
71472,.,0,0
71473,Glucose,0,0
71474,utilization,0,0
71475,studies,0,0
71476,show,0,0
71477,that,0,0
71478,sibutramine-induced,0,0
71479,thermogenesis,0,0
71480,is,0,0
71481,mediated,0,0
71482,via,0,0
71483,selective,0,0
71484,sympathetic,0,0
71485,activation,0,0
71486,of,0,0
71487,brown,0,1
71488,adipose,0,1
71489,tissue,0,0
71490,.,0,0
71491,The,0,0
71492,goal,0,0
71493,of,0,0
71494,the,0,0
71495,present,0,0
71496,study,0,0
71497,was,0,0
71498,to,0,0
71499,use,0,0
71500,a,0,0
71501,new,0,0
71502,calorimetry,0,0
71503,method,0,0
71504,in,0,0
71505,which,0,0
71506,resting,0,0
71507,metabolic,0,0
71508,rate,0,0
71509,is,0,0
71510,enhanced,0,0
71511,to,0,0
71512,evaluate,0,0
71513,the,0,0
71514,effects,0,0
71515,of,0,0
71516,sibutramine,0,0
71517,treatment,0,0
71518,on,0,0
71519,thermogenesis,0,0
71520,.,0,0
71521,Sixty,1,1
71522,obese,1,1
71523,women,1,1
71524,were,1,0
71525,included,1,1
71526,in,1,0
71527,the,1,0
71528,study,1,0
71529,.,1,0
71530,Subjects,0,0
71531,were,1,0
71532,divided,1,1
71533,into,1,0
71534,2,1,0
71535,equal,1,0
71536,groups-the,1,0
71537,placebo,0,0
71538,and,0,0
71539,sibutramine,0,0
71540,treatment,0,0
71541,groups,0,0
71542,.,0,0
71543,The,0,0
71544,sibutramine,0,0
71545,group,0,0
71546,was,0,0
71547,given,0,0
71548,sibutramine,0,0
71549,10,0,0
71550,mg,0,0
71551,daily,0,0
71552,for,0,0
71553,12,0,0
71554,wk,0,0
71555,.,0,0
71556,At,0,0
71557,baseline,0,0
71558,and,0,0
71559,at,0,0
71560,the,0,0
71561,end,0,0
71562,of,0,0
71563,the,0,0
71564,12-wk,0,0
71565,treatment,0,0
71566,period,0,0
71567,",",0,0
71568,thermogenic,0,0
71569,measurements,0,0
71570,were,0,0
71571,taken,0,0
71572,with,0,0
71573,the,0,0
71574,use,0,0
71575,of,0,0
71576,water,0,0
71577,immersion,0,0
71578,calorimetry,0,0
71579,.,0,0
71580,Subjects,0,0
71581,were,0,0
71582,examined,0,0
71583,at,0,0
71584,weeks,0,0
71585,4,0,0
71586,",",0,0
71587,8,0,0
71588,",",0,0
71589,and,0,0
71590,12,0,0
71591,of,0,0
71592,treatment,0,0
71593,to,0,0
71594,identify,0,0
71595,adverse,0,0
71596,effects,0,0
71597,.,0,1
71598,Body,0,0
71599,mass,0,0
71600,index,0,0
71601,",",0,0
71602,measured,0,0
71603,at,0,0
71604,31.5+/-2.05,0,0
71605,kg/m2,0,1
71606,in,0,0
71607,the,0,0
71608,placebo,0,0
71609,group,0,0
71610,",",0,0
71611,decreased,0,0
71612,to,0,0
71613,30.4+/-2.94,0,0
71614,kg/m,0,1
71615,(,0,0
71616,2,0,0
71617,),0,0
71618,after,0,0
71619,12,0,0
71620,wk,0,0
71621,(,0,0
71622,P=.07,0,0
71623,),0,0
71624,.,0,0
71625,In,0,0
71626,the,0,0
71627,sibutramine,0,0
71628,group,0,0
71629,",",0,0
71630,it,0,0
71631,decreased,0,0
71632,from,0,0
71633,33.5+/-4.1,0,0
71634,kg/m,0,1
71635,(,0,0
71636,2,0,0
71637,),0,0
71638,to,0,0
71639,30.9+/-4.8,0,0
71640,kg/m,0,1
71641,(,0,0
71642,2,0,0
71643,),0,0
71644,(,0,0
71645,P,0,0
71646,<,0,0
71647,.05,0,0
71648,),0,0
71649,.,0,0
71650,In,0,0
71651,the,0,0
71652,sibutramine,0,0
71653,group,0,0
71654,",",0,0
71655,mean,0,0
71656,thermogenic,0,0
71657,response,0,0
71658,changed,0,0
71659,from,0,0
71660,a,0,0
71661,baseline,0,0
71662,value,0,0
71663,of,0,0
71664,1.27+/-0.29,0,0
71665,kcal/kg/h,0,0
71666,to,0,0
71667,1.44+/-0.13,0,0
71668,kcal/kg/h,0,0
71669,after,0,0
71670,12,0,0
71671,wk,0,0
71672,of,0,0
71673,treatment,0,0
71674,.,0,0
71675,In,0,0
71676,the,0,0
71677,placebo,0,0
71678,group,0,0
71679,",",0,0
71680,the,0,0
71681,baseline,0,0
71682,value,0,0
71683,was,0,0
71684,1.56+/-0.27,0,0
71685,kcal/kg/h,0,0
71686,;,0,0
71687,it,0,0
71688,changed,0,0
71689,to,0,0
71690,1.33+/-0.36,0,0
71691,kcal/kg/h,0,0
71692,at,0,0
71693,the,0,0
71694,end,0,0
71695,of,0,0
71696,12,0,0
71697,wk,0,0
71698,.,0,0
71699,The,0,0
71700,findings,0,0
71701,of,0,0
71702,this,0,0
71703,study,0,0
71704,suggest,0,0
71705,that,0,0
71706,sibutramine,0,0
71707,treatment,0,0
71708,promotes,0,0
71709,thermogenesis,0,0
71710,",",0,0
71711,thus,0,0
71712,facilitating,0,0
71713,weight,0,0
71714,loss,0,0
71715,.,0,0
71716,Calorimetry,0,0
71717,enhances,0,0
71718,resting,0,0
71719,metabolism,0,0
71720,through,0,0
71721,more,0,0
71722,efficient,0,0
71723,heat,0,0
71724,transfer,0,0
71725,from,0,0
71726,the,0,0
71727,body,0,0
71728,.,0,0
71729,Desmopressin,0,0
71730,in,0,0
71731,the,0,0
71732,treatment,0,0
71733,of,0,0
71734,nocturia,1,0
71735,:,1,1
71736,a,0,0
71737,double-blind,0,0
71738,",",0,0
71739,placebo-controlled,0,0
71740,study,0,0
71741,.,0,0
71742,OBJECTIVES,0,0
71743,To,0,0
71744,investigate,0,0
71745,efficacy,0,0
71746,",",0,0
71747,safety,0,0
71748,",",0,0
71749,and,0,0
71750,impact,0,0
71751,on,0,0
71752,quality,0,0
71753,of,0,0
71754,sleep,0,0
71755,of,0,0
71756,desmopressin,0,0
71757,in,0,0
71758,the,0,0
71759,treatment,0,0
71760,of,0,0
71761,nocturia,0,0
71762,.,0,1
71763,METHODS,0,0
71764,Adults,1,1
71765,aged,1,1
71766,>,1,0
71767,or,1,0
71768,=18,1,1
71769,yr,1,1
71770,with,1,1
71771,nocturia,1,0
71772,(,1,0
71773,>,1,1
71774,or,1,0
71775,=2,1,0
71776,voids/night,1,0
71777,),1,0
71778,received,0,0
71779,desmopressin,0,0
71780,tablets,0,0
71781,(,0,0
71782,0.1,0,0
71783,",",0,0
71784,0.2,0,0
71785,",",0,0
71786,or,0,0
71787,0.4,0,0
71788,mg,0,0
71789,),0,0
71790,during,0,0
71791,a,0,0
71792,3-wk,0,0
71793,dose-titration,0,0
71794,period,0,0
71795,.,0,0
71796,Patients,0,0
71797,should,0,0
71798,show,0,0
71799,sufficient,0,0
71800,response,0,0
71801,during,0,0
71802,the,0,0
71803,dose-titration,0,0
71804,period,0,0
71805,(,0,0
71806,>,0,0
71807,or,0,1
71808,=20,0,1
71809,%,0,0
71810,reduction,0,0
71811,in,0,0
71812,nocturnal,0,0
71813,diuresis,0,0
71814,),0,0
71815,and,0,0
71816,a,0,0
71817,return,0,0
71818,of,0,0
71819,nocturnal,0,0
71820,diuresis,0,0
71821,to,0,0
71822,>,0,0
71823,or,0,0
71824,=80,0,0
71825,%,0,0
71826,of,0,0
71827,baseline,0,0
71828,levels,0,0
71829,during,0,0
71830,washout,0,0
71831,.,0,0
71832,Eligible,0,0
71833,patients,0,1
71834,then,0,0
71835,entered,0,1
71836,a,0,0
71837,3-wk,0,0
71838,double-blind,0,0
71839,treatment,0,0
71840,period,0,0
71841,and,0,0
71842,received,0,0
71843,either,0,0
71844,desmopressin,0,0
71845,or,0,0
71846,placebo,0,0
71847,.,0,0
71848,RESULTS,0,0
71849,127,1,1
71850,patients,1,1
71851,were,1,0
71852,randomised,1,0
71853,to,0,0
71854,either,0,0
71855,desmopressin,0,0
71856,(,0,0
71857,n=61,0,1
71858,),0,0
71859,or,0,0
71860,placebo,0,0
71861,(,0,0
71862,n=66,0,1
71863,),0,0
71864,.,0,0
71865,Twenty,0,1
71866,(,0,0
71867,33,0,1
71868,%,0,0
71869,),0,0
71870,desmopressin-treated,0,0
71871,patients,0,1
71872,compared,0,0
71873,with,0,1
71874,seven,0,0
71875,(,0,0
71876,11,0,0
71877,%,0,0
71878,),0,0
71879,placebo-treated,0,0
71880,patients,0,1
71881,showed,0,0
71882,a,0,0
71883,clinical,0,0
71884,response,0,0
71885,",",0,0
71886,defined,0,0
71887,as,0,0
71888,a,0,0
71889,>,0,0
71890,or,0,0
71891,=50,0,1
71892,%,0,0
71893,reduction,0,0
71894,in,0,0
71895,the,0,0
71896,number,0,0
71897,of,0,0
71898,nocturnal,0,0
71899,voids,0,0
71900,compared,0,0
71901,with,0,1
71902,baseline,0,0
71903,(,0,0
71904,p=0.0014,0,0
71905,),0,0
71906,.,0,0
71907,Compared,0,0
71908,with,0,0
71909,placebo,0,0
71910,",",0,0
71911,desmopressin,0,0
71912,resulted,0,0
71913,in,0,0
71914,a,0,0
71915,significant,0,0
71916,reduction,0,0
71917,in,0,0
71918,the,0,0
71919,mean,0,0
71920,number,0,0
71921,of,0,0
71922,nocturnal,0,0
71923,voids,0,0
71924,(,0,0
71925,39,0,1
71926,%,0,0
71927,reduction,0,0
71928,with,0,0
71929,desmopressin,0,0
71930,vs.,0,0
71931,15,0,0
71932,%,0,0
71933,with,0,1
71934,placebo,0,0
71935,;,0,0
71936,absolute,0,0
71937,difference,0,0
71938,-0.84,0,0
71939,",",0,0
71940,p,0,0
71941,<,0,0
71942,0.0001,0,0
71943,),0,0
71944,and,0,0
71945,duration,0,0
71946,of,0,0
71947,the,0,0
71948,first,0,0
71949,sleep,0,0
71950,period,0,0
71951,(,0,0
71952,prolonged,0,0
71953,by,0,0
71954,108,0,1
71955,min,0,0
71956,with,0,1
71957,desmopressin,0,0
71958,vs.,0,0
71959,41,0,1
71960,min,0,0
71961,with,0,1
71962,placebo,0,0
71963,;,0,0
71964,p,0,0
71965,<,0,0
71966,0.0001,0,0
71967,),0,0
71968,.,0,0
71969,Quality,0,0
71970,of,0,0
71971,sleep,0,0
71972,was,0,0
71973,also,0,0
71974,improved,0,0
71975,with,0,0
71976,desmopressin,0,0
71977,versus,0,0
71978,placebo,0,0
71979,(,0,0
71980,statistically,0,0
71981,significant,0,0
71982,for,0,0
71983,one,0,0
71984,of,0,0
71985,the,0,0
71986,two,0,0
71987,parameters,0,0
71988,evaluated,0,0
71989,),0,0
71990,.,0,0
71991,Adverse,0,0
71992,events,0,0
71993,were,0,0
71994,mainly,0,0
71995,mild,0,1
71996,.,0,0
71997,CONCLUSIONS,0,0
71998,Oral,0,0
71999,desmopressin,0,0
72000,tablets,0,0
72001,provide,0,0
72002,an,0,0
72003,effective,0,0
72004,and,0,0
72005,well-tolerated,0,0
72006,treatment,0,0
72007,for,0,0
72008,nocturia,0,0
72009,.,0,0
72010,Compared,0,0
72011,with,0,0
72012,placebo,0,0
72013,",",0,0
72014,nocturnal,0,0
72015,voiding,0,0
72016,frequency,0,0
72017,is,0,0
72018,reduced,0,0
72019,",",0,0
72020,duration,0,0
72021,of,0,0
72022,the,0,0
72023,first,0,0
72024,sleep,0,0
72025,period,0,0
72026,is,0,0
72027,increased,0,0
72028,",",0,0
72029,and,0,0
72030,sleep,0,0
72031,quality,0,0
72032,may,0,0
72033,be,0,0
72034,improved,0,0
72035,.,0,0
72036,Immediately,0,0
72037,restored,0,0
72038,",",0,0
72039,single-tapered,0,0
72040,implants,1,0
72041,in,1,0
72042,the,1,0
72043,anterior,1,0
72044,maxilla,1,1
72045,:,1,1
72046,prosthodontic,0,0
72047,and,0,0
72048,aesthetic,0,0
72049,outcomes,0,0
72050,after,0,0
72051,1,0,0
72052,year,0,1
72053,.,0,0
72054,BACKGROUND,0,0
72055,Conventional,0,0
72056,implant,0,0
72057,protocols,0,0
72058,advocate,0,0
72059,a,0,0
72060,two-stage,0,0
72061,technique,0,0
72062,with,0,0
72063,a,0,0
72064,load-free,0,0
72065,",",0,0
72066,submerged,0,0
72067,healing,0,0
72068,period,0,0
72069,.,0,0
72070,Recent,0,0
72071,studies,0,0
72072,suggest,0,0
72073,that,0,0
72074,immediate,0,0
72075,restoration,0,0
72076,of,0,0
72077,single,0,0
72078,implants,0,0
72079,may,0,0
72080,be,0,0
72081,a,0,0
72082,viable,0,0
72083,treatment,0,0
72084,option,0,0
72085,.,0,0
72086,PURPOSE,0,0
72087,The,0,0
72088,purpose,0,0
72089,of,0,0
72090,this,0,0
72091,study,0,0
72092,was,0,0
72093,to,0,0
72094,evaluate,0,0
72095,prosthodontic,1,0
72096,and,1,0
72097,aesthetic,1,0
72098,peri-implant,1,0
72099,mucosal,0,0
72100,outcomes,0,0
72101,of,0,0
72102,immediately,1,0
72103,restored,1,0
72104,",",1,0
72105,Southern,1,0
72106,single-tapered,1,0
72107,implants,1,0
72108,in,1,0
72109,the,1,0
72110,anterior,1,0
72111,maxilla,1,1
72112,after,1,0
72113,1,1,0
72114,year,1,1
72115,.,1,0
72116,MATERIALS,0,0
72117,AND,0,0
72118,METHODS,0,0
72119,Participants,1,1
72120,(,1,0
72121,mean,1,0
72122,age,1,1
72123,:,1,1
72124,43.25,1,0
72125,years,1,1
72126,;,1,0
72127,range,1,1
72128,:,1,1
72129,23-71,1,1
72130,years,1,1
72131,),1,0
72132,satisfying,1,0
72133,specified,1,0
72134,inclusion,1,1
72135,criteria,1,1
72136,were,0,0
72137,randomly,0,1
72138,allocated,0,0
72139,to,0,0
72140,conventional,0,0
72141,two-stage,0,0
72142,restoration,0,0
72143,(,0,0
72144,control,0,0
72145,group,0,0
72146,;,0,0
72147,n=14,0,1
72148,),0,0
72149,and,0,0
72150,immediate,0,0
72151,restoration,0,0
72152,groups,0,0
72153,(,0,0
72154,test,0,0
72155,group,0,0
72156,;,0,0
72157,n,0,1
72158,=14,0,1
72159,),0,0
72160,in,0,0
72161,a,0,0
72162,randomized,0,0
72163,controlled,0,0
72164,clinical,0,0
72165,trial,0,0
72166,.,0,0
72167,Tapered,0,0
72168,",",0,0
72169,roughened-surface,0,0
72170,Southern,0,1
72171,implants,0,1
72172,were,0,0
72173,placed,0,0
72174,using,0,0
72175,a,0,0
72176,standardized,0,0
72177,technique,0,0
72178,",",0,0
72179,and,0,0
72180,implant,0,0
72181,level,0,0
72182,bone,0,0
72183,impressions,0,0
72184,were,0,0
72185,made,0,0
72186,.,0,0
72187,Provisional,0,0
72188,screw-retained,0,0
72189,crowns,0,0
72190,",",0,0
72191,out,0,0
72192,of,0,0
72193,occlusion,0,0
72194,",",0,0
72195,were,0,0
72196,placed,0,0
72197,at,0,0
72198,second-stage,0,0
72199,surgery,0,1
72200,after,0,0
72201,26,0,1
72202,weeks,0,0
72203,for,0,0
72204,the,0,0
72205,conventional,0,0
72206,restoration,0,0
72207,group,0,0
72208,",",0,0
72209,and,0,0
72210,within,0,0
72211,4,0,0
72212,hours,0,0
72213,of,0,0
72214,implant,0,0
72215,placement,0,0
72216,for,0,0
72217,the,0,0
72218,immediate,0,0
72219,restoration,0,0
72220,group,0,0
72221,.,0,0
72222,Both,0,0
72223,groups,0,0
72224,had,0,0
72225,definitive,0,0
72226,screw-retained,0,0
72227,metal-ceramic,0,0
72228,crowns,0,0
72229,placed,0,0
72230,in,0,0
72231,occlusion,0,1
72232,8,0,0
72233,weeks,0,0
72234,later,0,0
72235,.,0,0
72236,Peri-implant,0,0
72237,mucosal,0,0
72238,response,0,0
72239,and,0,0
72240,papilla,0,0
72241,index,0,0
72242,were,0,0
72243,recorded,0,0
72244,4,0,0
72245,weeks,0,0
72246,after,0,0
72247,definitive,0,0
72248,crown,0,0
72249,placement,0,0
72250,to,0,0
72251,allow,0,0
72252,for,0,0
72253,mucosal,0,0
72254,maturation,0,0
72255,and,0,0
72256,at,0,0
72257,1,0,0
72258,year,0,1
72259,.,0,0
72260,Prosthodontic,0,0
72261,and,0,0
72262,aesthetic,0,0
72263,outcomes,0,0
72264,were,0,0
72265,assessed,0,0
72266,using,0,0
72267,established,0,0
72268,criteria,0,1
72269,.,0,0
72270,RESULTS,0,0
72271,There,0,0
72272,were,0,0
72273,no,0,0
72274,significant,0,0
72275,differences,0,0
72276,within,0,0
72277,",",0,0
72278,or,0,0
72279,between,0,0
72280,",",0,0
72281,the,0,0
72282,control,0,0
72283,and,0,0
72284,test,0,0
72285,groups,0,0
72286,for,0,0
72287,age,0,1
72288,",",0,0
72289,gender,0,0
72290,",",0,0
72291,bone,0,0
72292,quality,0,0
72293,or,0,0
72294,quantity,0,0
72295,",",0,0
72296,implant,0,0
72297,stability,0,0
72298,measurements,0,0
72299,at,0,0
72300,surgery,0,1
72301,",",0,0
72302,or,0,0
72303,implant,0,0
72304,length,0,0
72305,.,0,0
72306,There,0,0
72307,were,0,0
72308,no,0,0
72309,significant,0,0
72310,differences,0,0
72311,in,0,0
72312,the,0,0
72313,implant,0,0
72314,success,0,0
72315,rate,0,0
72316,as,0,0
72317,determined,0,0
72318,by,0,0
72319,radiographic,0,0
72320,bone,0,0
72321,loss,0,0
72322,and,0,0
72323,stability,0,0
72324,tests,0,0
72325,after,0,0
72326,1,0,0
72327,year,0,0
72328,.,0,0
72329,There,0,0
72330,were,0,0
72331,no,0,0
72332,significant,0,0
72333,differences,0,0
72334,in,0,0
72335,prosthodontic,0,1
72336,maintenance,0,0
72337,",",0,0
72338,peri-implant,0,0
72339,mucosal,0,0
72340,response,0,0
72341,",",0,0
72342,and,0,0
72343,papilla,0,0
72344,index,0,0
72345,between,0,0
72346,the,0,0
72347,two,0,0
72348,groups,0,0
72349,over,0,0
72350,1,0,0
72351,year,0,1
72352,.,0,0
72353,CONCLUSIONS,0,0
72354,Tapered,0,0
72355,",",0,0
72356,roughened-surface,0,0
72357,implants,0,0
72358,immediately,0,0
72359,restored,0,0
72360,with,0,0
72361,single,0,0
72362,provisional,0,0
72363,crowns,0,0
72364,at,0,0
72365,surgery,0,1
72366,and,0,0
72367,definitive,0,0
72368,crowns,0,1
72369,8,0,1
72370,weeks,0,0
72371,later,0,0
72372,were,0,0
72373,as,0,0
72374,prosthodontically,0,1
72375,and,0,0
72376,aesthetically,0,0
72377,successful,0,0
72378,as,0,0
72379,conventionally,0,1
72380,restored,0,0
72381,two-stage,0,0
72382,implants,0,0
72383,during,0,0
72384,the,0,0
72385,first,0,0
72386,year,0,0
72387,of,0,0
72388,service,0,0
72389,.,0,0
72390,Restoring,0,0
72391,single,0,0
72392,implants,0,0
72393,immediately,0,0
72394,with,0,1
72395,screw-retained,0,0
72396,crowns,0,0
72397,is,0,0
72398,an,0,0
72399,efficient,0,0
72400,procedure,0,0
72401,",",0,0
72402,but,0,0
72403,the,0,0
72404,short-term,0,0
72405,outcome,0,0
72406,is,0,0
72407,by,0,0
72408,no,0,0
72409,means,0,0
72410,superior,0,0
72411,to,0,0
72412,a,0,0
72413,conventional,0,0
72414,two-stage,0,0
72415,approach,0,0
72416,.,0,0
72417,Information,0,0
72418,source,0,0
72419,affects,0,0
72420,peers,0,0
72421,',0,0
72422,initial,0,0
72423,attitudes,0,0
72424,toward,0,0
72425,autism,1,1
72426,.,1,1
72427,Authors,0,0
72428,examined,0,0
72429,the,0,0
72430,effects,0,0
72431,of,0,0
72432,information,0,0
72433,source,0,0
72434,on,0,0
72435,peers,0,0
72436,',0,1
72437,cognitive,0,0
72438,and,0,0
72439,behavioral,0,0
72440,attitudes,0,0
72441,toward,0,0
72442,an,0,0
72443,unfamiliar,1,0
72444,child,1,0
72445,with,1,1
72446,autism,1,1
72447,.,1,0
72448,Children,1,1
72449,(,1,0
72450,N=296,1,0
72451,;,1,0
72452,M,1,0
72453,age=10.21,1,1
72454,years,1,1
72455,),1,0
72456,received,0,0
72457,information,0,0
72458,about,0,0
72459,an,0,0
72460,unfamiliar,1,0
72461,child,1,0
72462,with,1,1
72463,autism,1,1
72464,from,0,0
72465,one,0,0
72466,of,0,0
72467,the,0,0
72468,following,0,0
72469,sources,0,0
72470,:,0,1
72471,(,0,0
72472,a,0,0
72473,),0,0
72474,videotape,0,0
72475,",",0,0
72476,(,0,0
72477,b,0,0
72478,),0,0
72479,teacher,1,0
72480,",",0,0
72481,(,0,0
72482,c,0,0
72483,),0,0
72484,hypothetical,1,0
72485,mother,1,0
72486,",",0,0
72487,(,0,0
72488,d,0,0
72489,),0,0
72490,hypothetical,1,0
72491,father,1,0
72492,",",0,0
72493,or,0,0
72494,(,0,0
72495,e,0,0
72496,),0,0
72497,hypothetical,1,0
72498,doctor,1,0
72499,.,1,0
72500,Interactive,0,0
72501,effects,0,0
72502,between,0,0
72503,source,0,0
72504,",",0,0
72505,and,0,0
72506,sex,0,0
72507,and,0,0
72508,grade,0,0
72509,were,0,0
72510,found,0,0
72511,for,0,0
72512,cognitive,0,0
72513,and,0,0
72514,behavioral,0,1
72515,attitudes,0,0
72516,.,0,1
72517,Fifth-graders,1,1
72518,reported,0,0
72519,more,0,0
72520,favorable,0,0
72521,cognitive,0,0
72522,and,0,0
72523,behavioral,0,0
72524,attitudes,0,0
72525,when,0,0
72526,information,0,0
72527,was,0,0
72528,provided,0,0
72529,by,0,0
72530,extra-familial,0,1
72531,sources,0,0
72532,(,0,0
72533,i.e.,0,0
72534,",",0,0
72535,doctor,0,0
72536,),0,0
72537,versus,0,0
72538,parent,0,0
72539,sources,0,0
72540,.,0,1
72541,Mother,0,0
72542,yielded,0,0
72543,more,0,0
72544,persuasive,0,0
72545,effects,0,0
72546,on,0,0
72547,behavioral,0,1
72548,attitudes,0,0
72549,for,0,0
72550,third-graders,0,1
72551,versus,0,0
72552,fifth-graders,0,1
72553,.,0,1
72554,Attitudes,0,0
72555,toward,0,0
72556,autism,0,1
72557,differ,0,0
72558,depending,0,0
72559,on,0,0
72560,who,0,1
72561,provides,0,0
72562,information,0,0
72563,about,0,0
72564,the,0,0
72565,disability,0,0
72566,.,0,0
72567,Persuasion,0,0
72568,theory,0,0
72569,appears,0,0
72570,useful,0,0
72571,to,0,0
72572,guide,0,0
72573,evaluation,0,0
72574,of,0,0
72575,educational,0,0
72576,interventions,0,0
72577,to,0,0
72578,improve,0,0
72579,attitudes,0,0
72580,towards,0,0
72581,autism,0,1
72582,.,0,0
72583,Implications,0,0
72584,of,0,0
72585,the,0,0
72586,findings,0,0
72587,",",0,0
72588,study,0,0
72589,limitations,0,0
72590,",",0,0
72591,and,0,0
72592,recommendations,0,0
72593,for,0,0
72594,future,0,0
72595,research,0,0
72596,are,0,0
72597,discussed,0,0
72598,.,0,0
72599,Enhanced,0,0
72600,inotropic,0,0
72601,state,0,0
72602,of,0,0
72603,the,0,0
72604,failing,0,0
72605,left,0,0
72606,ventricle,0,0
72607,by,0,0
72608,cardiac,0,0
72609,contractility,0,0
72610,modulation,0,0
72611,electrical,0,0
72612,signals,0,0
72613,is,0,0
72614,not,0,0
72615,associated,0,0
72616,with,0,0
72617,increased,0,0
72618,myocardial,0,1
72619,oxygen,0,0
72620,consumption,0,0
72621,.,0,0
72622,BACKGROUND,0,0
72623,Previous,0,0
72624,studies,0,0
72625,in,0,0
72626,patients,1,1
72627,and,1,0
72628,in,1,0
72629,dogs,1,1
72630,with,1,1
72631,experimentally,1,0
72632,induced,1,0
72633,heart,1,0
72634,failure,1,1
72635,(,1,0
72636,HF,1,1
72637,),1,0
72638,showed,0,0
72639,that,0,0
72640,electrical,0,0
72641,signals,0,0
72642,applied,0,0
72643,to,0,0
72644,the,0,0
72645,failing,0,0
72646,myocardium,0,0
72647,during,0,0
72648,the,0,0
72649,absolute,0,0
72650,refractory,0,1
72651,period,0,0
72652,improved,0,0
72653,left,0,0
72654,ventricular,0,0
72655,(,0,0
72656,LV,0,0
72657,),0,0
72658,function,0,0
72659,.,0,0
72660,We,0,0
72661,examined,0,0
72662,the,0,0
72663,effects,0,0
72664,these,0,0
72665,same,0,0
72666,cardiac,0,0
72667,contractility,0,0
72668,modulating,0,0
72669,(,0,0
72670,CCM,0,0
72671,),0,0
72672,electrical,0,0
72673,signals,0,0
72674,on,0,0
72675,myocardial,0,1
72676,oxygen,0,0
72677,consumption,0,0
72678,(,0,0
72679,MVO,0,1
72680,(,0,0
72681,2,0,0
72682,),0,0
72683,),0,0
72684,in,0,0
72685,both,1,0
72686,patients,1,1
72687,and,1,0
72688,dogs,1,1
72689,with,1,1
72690,chronic,1,1
72691,HF,1,1
72692,.,1,0
72693,METHODS,0,0
72694,AND,0,0
72695,RESULTS,0,0
72696,Six,1,1
72697,dogs,1,1
72698,with,1,1
72699,microembolizations-induced,1,0
72700,HF,1,1
72701,and,1,0
72702,9,1,0
72703,HF,1,1
72704,patients,1,1
72705,underwent,1,1
72706,CCM,1,1
72707,leads,1,0
72708,and,1,0
72709,generator,1,0
72710,(,1,0
72711,OPTIMIZER,1,0
72712,II,1,1
72713,),1,0
72714,implantation,1,1
72715,.,1,0
72716,After,0,0
72717,baseline,0,0
72718,measurements,0,0
72719,",",0,0
72720,CCM,0,0
72721,signals,0,0
72722,were,0,0
72723,delivered,0,0
72724,continuously,0,0
72725,for,0,0
72726,2,0,0
72727,hours,0,0
72728,in,0,0
72729,dogs,0,1
72730,and,0,0
72731,for,0,0
72732,30,0,0
72733,minutes,0,0
72734,in,0,0
72735,patients,0,1
72736,.,0,1
72737,MVO,0,1
72738,(,0,0
72739,2,0,0
72740,),0,0
72741,was,0,0
72742,measured,0,0
72743,before,0,0
72744,and,0,0
72745,after,0,0
72746,CCM,0,0
72747,therapy,0,0
72748,.,0,0
72749,In,0,0
72750,dogs,0,1
72751,",",0,0
72752,CCM,0,0
72753,therapy,0,0
72754,increased,0,0
72755,LV,0,0
72756,ejection,0,0
72757,fraction,0,0
72758,at,0,0
72759,2,0,0
72760,hours,0,0
72761,(,0,0
72762,26,0,1
72763,+/-,0,0
72764,1,0,0
72765,versus,0,0
72766,31,0,1
72767,+/-,0,0
72768,2,0,0
72769,%,0,0
72770,",",0,0
72771,P,0,0
72772,=,0,0
72773,.001,0,0
72774,),0,0
72775,without,0,0
72776,increasing,0,0
72777,MVO,0,1
72778,(,0,0
72779,2,0,0
72780,),0,0
72781,(,0,0
72782,257,0,1
72783,+/-,0,0
72784,41,0,1
72785,versus,0,0
72786,180,0,1
72787,+/-,0,0
72788,34,0,1
72789,micromol/min,0,0
72790,),0,0
72791,.,0,0
72792,In,0,0
72793,patients,0,1
72794,",",0,0
72795,CCM,0,0
72796,therapy,0,0
72797,increased,0,0
72798,LV,0,0
72799,peak,0,0
72800,+dP/dt,0,0
72801,by,0,0
72802,10.1,0,0
72803,+/-,0,0
72804,1.5,0,0
72805,%,0,0
72806,.,0,0
72807,As,0,0
72808,with,0,0
72809,dogs,0,1
72810,",",0,0
72811,the,0,0
72812,increase,0,0
72813,in,0,0
72814,LV,0,0
72815,function,0,0
72816,after,0,0
72817,30,0,0
72818,minutes,0,0
72819,of,0,0
72820,CCM,0,0
72821,therapy,0,0
72822,was,0,0
72823,not,0,0
72824,associated,0,0
72825,with,0,0
72826,increased,0,0
72827,MVO,0,1
72828,(,0,0
72829,2,0,0
72830,),0,0
72831,(,0,0
72832,13.6,0,0
72833,+/-,0,0
72834,9.7,0,0
72835,versus,0,0
72836,12.5,0,0
72837,+/-,0,0
72838,7.2,0,0
72839,mL,0,0
72840,O,0,0
72841,(,0,0
72842,2,0,0
72843,),0,0
72844,/min,0,0
72845,),0,0
72846,.,0,0
72847,CONCLUSIONS,0,0
72848,The,0,0
72849,study,0,0
72850,results,0,0
72851,suggest,0,0
72852,that,0,0
72853,unlike,0,0
72854,cAMP-dependent,0,0
72855,positive,0,0
72856,inotropic,0,0
72857,drugs,0,0
72858,",",0,0
72859,the,0,0
72860,increase,0,0
72861,in,0,0
72862,LV,0,0
72863,function,0,0
72864,during,0,0
72865,CCM,0,0
72866,therapy,0,0
72867,is,0,0
72868,elicited,0,0
72869,without,0,0
72870,increasing,0,0
72871,MVO,0,1
72872,(,0,0
72873,2,0,0
72874,),0,0
72875,.,0,0
72876,Comparison,0,0
72877,of,0,0
72878,indicators,0,0
72879,for,0,0
72880,a,0,0
72881,primary,0,0
72882,care,0,0
72883,medical,0,1
72884,home,0,1
72885,between,0,0
72886,children,1,1
72887,with,1,1
72888,autism,1,1
72889,or,1,0
72890,asthma,1,1
72891,and,1,0
72892,other,1,0
72893,special,1,0
72894,health,1,1
72895,care,1,1
72896,needs,1,0
72897,:,1,1
72898,National,0,0
72899,Survey,0,0
72900,of,0,0
72901,Children,0,1
72902,'s,0,1
72903,Health,0,0
72904,.,0,1
72905,OBJECTIVE,0,0
72906,To,0,0
72907,assess,0,0
72908,the,0,0
72909,extent,0,0
72910,to,0,0
72911,which,0,0
72912,parents,1,1
72913,of,1,0
72914,children,1,1
72915,with,1,1
72916,autism,1,1
72917,compared,1,0
72918,with,1,1
72919,parents,1,1
72920,of,1,0
72921,children,1,1
72922,with,1,1
72923,asthma,1,1
72924,or,1,0
72925,other,1,0
72926,special,1,0
72927,health,1,0
72928,care,1,0
72929,needs,1,0
72930,report,0,0
72931,receiving,0,0
72932,primary,0,0
72933,care,0,0
72934,for,0,0
72935,their,0,0
72936,child,0,1
72937,consistent,0,0
72938,with,0,0
72939,the,0,0
72940,American,0,1
72941,Academy,0,1
72942,of,0,0
72943,Pediatrics,0,1
72944,medical,0,1
72945,home,0,1
72946,model,0,0
72947,.,0,0
72948,DESIGN,0,0
72949,Population-based,0,0
72950,cross-sectional,0,1
72951,study,0,0
72952,.,0,0
72953,SETTING,0,0
72954,National,0,0
72955,Survey,0,0
72956,for,0,0
72957,Children,0,1
72958,'s,0,1
72959,Health,0,0
72960,2003-2004,0,1
72961,telephone,0,0
72962,interview,0,0
72963,.,0,1
72964,PARTICIPANTS,0,0
72965,Parents,1,0
72966,of,1,1
72967,495,1,1
72968,children,1,1
72969,with,1,1
72970,autism,1,1
72971,",",1,0
72972,parents,1,1
72973,of,1,0
72974,6716,1,1
72975,children,1,1
72976,with,1,1
72977,asthma,1,1
72978,",",1,0
72979,and,1,0
72980,parents,1,1
72981,of,1,0
72982,"11,403",1,1
72983,children,1,1
72984,with,1,1
72985,other,1,0
72986,special,1,0
72987,health,1,0
72988,care,1,0
72989,needs,1,0
72990,without,1,0
72991,asthma,1,1
72992,.,1,1
72993,Main,0,0
72994,Exposures,0,0
72995,Autism,0,1
72996,and,0,1
72997,other,0,0
72998,special,0,0
72999,health,0,0
73000,care,0,0
73001,needs,0,0
73002,including,0,0
73003,asthma,0,1
73004,.,0,0
73005,MAIN,0,0
73006,OUTCOME,0,0
73007,MEASURES,0,0
73008,Medical,0,1
73009,home,0,0
73010,score,0,0
73011,and,0,0
73012,components,0,0
73013,of,0,0
73014,care,0,0
73015,",",0,0
73016,as,0,0
73017,follows,0,0
73018,:,0,0
73019,personal,0,0
73020,provider,0,0
73021,and,0,0
73022,preventive,0,0
73023,;,0,0
73024,family-centered,0,0
73025,",",0,0
73026,compassionate,0,0
73027,",",0,0
73028,and,0,0
73029,culturally,0,0
73030,appropriate,0,0
73031,;,0,0
73032,accessible,0,0
73033,;,0,0
73034,comprehensive,0,0
73035,;,0,0
73036,and,0,0
73037,coordinated,0,0
73038,.,0,0
73039,RESULTS,0,0
73040,The,0,0
73041,odds,0,0
73042,of,0,0
73043,parents,0,1
73044,reporting,0,0
73045,care,0,1
73046,consistent,0,0
73047,with,0,0
73048,that,0,0
73049,in,0,0
73050,a,0,0
73051,medical,0,0
73052,home,0,0
73053,were,0,0
73054,less,0,0
73055,likely,0,0
73056,for,0,0
73057,children,0,1
73058,with,0,1
73059,autism,0,1
73060,(,0,0
73061,odds,0,0
73062,ratio,0,0
73063,",",0,0
73064,0.45,0,0
73065,;,0,0
73066,95,0,0
73067,%,0,0
73068,confidence,0,0
73069,interval,0,0
73070,",",0,0
73071,0.30-0.66,0,0
73072,),0,0
73073,and,0,0
73074,more,0,0
73075,likely,0,0
73076,for,0,0
73077,children,0,1
73078,with,0,1
73079,asthma,0,1
73080,(,0,0
73081,odds,0,0
73082,ratio,0,0
73083,",",0,0
73084,1.17,0,0
73085,;,0,0
73086,95,0,0
73087,%,0,0
73088,confidence,0,0
73089,interval,0,0
73090,",",0,0
73091,1.06-1.30,0,0
73092,),0,0
73093,compared,0,0
73094,with,0,1
73095,children,0,1
73096,with,0,1
73097,other,0,0
73098,special,0,0
73099,health,0,1
73100,care,0,0
73101,needs,0,0
73102,(,0,0
73103,1,0,0
73104,[,0,0
73105,reference,0,0
73106,],0,0
73107,),0,0
73108,.,0,0
73109,These,0,0
73110,differences,0,0
73111,persisted,0,0
73112,even,0,0
73113,after,0,0
73114,controlling,0,0
73115,for,0,0
73116,condition,0,0
73117,severity,0,0
73118,",",0,0
73119,personal,0,0
73120,characteristics,0,0
73121,",",0,0
73122,and,0,0
73123,insurance,0,0
73124,status,0,0
73125,.,0,0
73126,Specific,0,0
73127,components,0,0
73128,of,0,0
73129,a,0,0
73130,medical,0,0
73131,home,0,0
73132,less,0,0
73133,prevalent,0,0
73134,among,0,0
73135,children,0,1
73136,with,0,1
73137,autism,0,1
73138,than,0,0
73139,among,0,0
73140,children,0,1
73141,with,0,1
73142,other,0,0
73143,special,0,0
73144,health,0,0
73145,care,0,0
73146,needs,0,0
73147,included,0,0
73148,family-centered,0,0
73149,",",0,0
73150,comprehensive,0,0
73151,",",0,0
73152,and,0,0
73153,coordinated,0,0
73154,care,0,0
73155,.,0,0
73156,CONCLUSION,0,0
73157,Although,0,0
73158,we,0,0
73159,could,0,0
73160,not,0,0
73161,evaluate,0,0
73162,the,0,0
73163,reasons,0,0
73164,why,0,0
73165,",",0,0
73166,a,0,0
73167,large,0,0
73168,percentage,0,0
73169,of,0,0
73170,children,0,1
73171,with,0,1
73172,autism,0,1
73173,do,0,0
73174,not,0,0
73175,receive,0,0
73176,primary,0,0
73177,care,0,0
73178,consistent,0,0
73179,with,0,0
73180,that,0,0
73181,in,0,0
73182,a,0,0
73183,medical,0,0
73184,home,0,1
73185,.,0,0
73186,Neurophysiological,0,0
73187,double-blind,0,0
73188,trial,0,0
73189,of,0,0
73190,a,0,0
73191,botulinum,0,0
73192,neurotoxin,0,0
73193,type,0,1
73194,a,0,0
73195,free,0,0
73196,of,0,0
73197,complexing,0,0
73198,proteins,0,0
73199,.,0,1
73200,OBJECTIVE,0,0
73201,Safety,0,0
73202,and,0,0
73203,efficacy,0,0
73204,of,0,0
73205,botulinum,0,0
73206,neurotoxin,0,0
73207,type,0,0
73208,A,0,0
73209,preparation,0,0
73210,NT,0,0
73211,201,0,1
73212,(,0,0
73213,Xeomin,0,0
73214,",",0,0
73215,Merz,0,0
73216,Pharmaceuticals,0,0
73217,GmbH,0,0
73218,",",0,0
73219,Frankfurt,0,0
73220,am,0,0
73221,Main,0,0
73222,",",0,0
73223,Germany,0,0
73224,),0,0
73225,were,0,0
73226,investigated,0,0
73227,over,0,0
73228,52,0,1
73229,weeks,0,0
73230,in,0,0
73231,a,0,0
73232,double-blind,0,0
73233,",",0,0
73234,randomized,1,0
73235,trial,1,0
73236,with,1,1
73237,32,1,1
73238,male,1,1
73239,volunteers,1,1
73240,.,1,1
73241,METHODS,0,0
73242,Electroneurographic,0,1
73243,assessments,0,0
73244,with,0,1
73245,surface,0,1
73246,electrodes,0,0
73247,were,0,0
73248,performed,0,0
73249,after,0,0
73250,single,0,0
73251,injections,0,0
73252,of,0,0
73253,NT,0,0
73254,201,0,1
73255,(,0,0
73256,2,0,0
73257,",",0,0
73258,4,0,0
73259,",",0,0
73260,16,0,0
73261,",",0,0
73262,or,0,0
73263,32,0,1
73264,units,0,0
73265,),0,0
73266,into,0,0
73267,the,0,0
73268,extensor,0,0
73269,digitorum,0,0
73270,brevis,0,0
73271,(,0,0
73272,EDB,0,0
73273,),0,0
73274,muscle,0,0
73275,and,0,0
73276,the,0,0
73277,same,0,0
73278,dose,0,0
73279,(,0,0
73280,Botox,0,0
73281,;,0,0
73282,Allergan,0,1
73283,Pharmaceuticals,0,0
73284,(,0,0
73285,Ireland,0,1
73286,),0,0
73287,Ltd.,0,0
73288,Westport,0,0
73289,",",0,0
73290,Ireland,0,1
73291,),0,0
73292,into,0,0
73293,the,0,0
73294,contralateral,0,1
73295,EDB,0,0
73296,.,0,1
73297,RESULTS,0,0
73298,All,0,0
73299,NT,0,0
73300,201,0,1
73301,and,0,0
73302,BTXCo,0,0
73303,doses,0,0
73304,achieved,0,0
73305,a,0,0
73306,statistically,0,0
73307,significant,0,0
73308,reduction,0,0
73309,of,0,0
73310,the,0,0
73311,compound,0,0
73312,muscle,0,0
73313,action,0,0
73314,potential,0,0
73315,M-wave,0,0
73316,amplitude,0,0
73317,in,0,0
73318,the,0,0
73319,EDB,0,0
73320,muscle,0,0
73321,.,0,0
73322,At,0,0
73323,week,0,0
73324,4,0,0
73325,",",0,0
73326,the,0,0
73327,highest,0,0
73328,dose,0,0
73329,was,0,0
73330,statistically,0,0
73331,significantly,0,0
73332,more,0,0
73333,effective,0,0
73334,than,0,0
73335,the,0,0
73336,lowest,0,0
73337,dose,0,0
73338,(,0,0
73339,NT,0,0
73340,201,0,1
73341,",",0,0
73342,P,0,0
73343,=,0,0
73344,0.019,0,0
73345,;,0,0
73346,95,0,0
73347,%,0,0
73348,confidence,0,0
73349,interval,0,0
73350,",",0,0
73351,0.195-1.370,0,0
73352,;,0,0
73353,and,0,0
73354,BTXCo,0,0
73355,",",0,0
73356,P,0,0
73357,=,0,0
73358,0.002,0,0
73359,;,0,0
73360,95,0,0
73361,%,0,0
73362,confidence,0,0
73363,interval,0,0
73364,",",0,0
73365,0.309-1.167,0,0
73366,),0,0
73367,.,0,0
73368,Duration,0,0
73369,of,0,0
73370,effect,0,0
73371,was,0,0
73372,dose,0,0
73373,dependent,0,0
73374,.,0,0
73375,The,0,0
73376,mean,0,0
73377,values,0,0
73378,of,0,0
73379,compound,0,0
73380,muscle,0,0
73381,action,0,0
73382,potential,0,0
73383,M-wave,0,0
73384,amplitudes,0,0
73385,in,0,0
73386,the,0,0
73387,adjacent,0,0
73388,muscles,0,0
73389,(,0,0
73390,abductor,0,1
73391,digiti,0,0
73392,quinti,0,0
73393,and,0,0
73394,abductor,0,0
73395,hallucis,0,1
73396,),0,0
73397,were,0,0
73398,above,0,0
73399,the,0,0
73400,predefined,0,0
73401,threshold,0,0
73402,of,0,0
73403,effect,0,0
73404,",",0,0
73405,indicating,0,0
73406,that,0,0
73407,there,0,0
73408,was,0,0
73409,no,0,0
73410,relevant,0,0
73411,diffusion-induced,0,0
73412,reduction,0,0
73413,of,0,0
73414,muscle,0,0
73415,activity,0,0
73416,.,0,0
73417,NT,0,0
73418,201,0,1
73419,and,0,0
73420,BTXCo,0,0
73421,were,0,0
73422,well,0,0
73423,tolerated,0,0
73424,.,0,0
73425,CONCLUSIONS,0,0
73426,NT,0,0
73427,201,0,1
73428,is,0,0
73429,effective,0,0
73430,and,0,0
73431,safe,0,0
73432,in,0,0
73433,inducing,0,0
73434,the,0,0
73435,desired,0,0
73436,paretic,0,0
73437,effect,0,0
73438,.,0,0
73439,Similar,0,0
73440,effects,0,0
73441,of,0,0
73442,rofecoxib,0,0
73443,and,0,0
73444,indomethacin,0,0
73445,on,0,0
73446,the,0,0
73447,incidence,0,0
73448,of,0,0
73449,heterotopic,0,1
73450,ossification,0,0
73451,after,1,0
73452,hip,1,1
73453,arthroplasty,1,1
73454,.,1,0
73455,BACKGROUND,0,0
73456,Although,0,0
73457,indomethacin,0,0
73458,is,0,0
73459,effective,0,0
73460,in,0,0
73461,preventing,0,0
73462,heterotopic,0,1
73463,ossification,0,0
73464,(,0,0
73465,HO,0,0
73466,),0,0
73467,after,0,0
73468,primary,1,0
73469,total,1,1
73470,hip,1,1
73471,arthroplasty,1,1
73472,",",0,0
73473,side,0,0
73474,effects,0,0
73475,are,0,0
73476,frequently,0,0
73477,observed,0,0
73478,.,0,0
73479,In,0,0
73480,the,0,0
73481,last,0,0
73482,decade,0,0
73483,a,0,0
73484,new,0,0
73485,class,0,1
73486,of,0,0
73487,drugs,0,0
73488,--,0,1
73489,the,0,0
73490,COX-2,0,0
73491,selective,0,0
73492,nonsteroidal,0,0
73493,anti-inflammatory,0,0
73494,drugs,0,0
73495,--,0,0
73496,has,0,0
73497,been,0,0
73498,developed,0,0
73499,.,0,0
73500,To,0,0
73501,investigate,0,0
73502,the,0,0
73503,effect,0,0
73504,of,0,0
73505,these,0,0
73506,COX-2,0,0
73507,selective,0,0
73508,NSAIDs,0,0
73509,on,0,0
73510,heterotopic,0,1
73511,ossification,0,0
73512,(,0,0
73513,HO,0,0
73514,),0,0
73515,after,0,0
73516,primary,0,0
73517,total,0,1
73518,hip,0,1
73519,arthroplasty,0,1
73520,(,0,0
73521,THA,0,0
73522,),0,0
73523,",",0,0
73524,we,0,0
73525,conducted,0,0
73526,a,0,0
73527,randomized,0,0
73528,controlled,0,0
73529,trial,0,0
73530,using,0,0
73531,either,0,0
73532,indomethacin,0,0
73533,or,0,0
73534,rofecoxib,0,0
73535,for,0,0
73536,7,0,0
73537,days,0,0
73538,.,0,1
73539,METHODS,0,0
73540,186,1,1
73541,patients,1,1
73542,received,1,0
73543,either,1,0
73544,indomethacin,1,0
73545,3,1,0
73546,times,1,0
73547,daily,1,0
73548,",",1,0
73549,or,1,0
73550,rofecoxib,1,0
73551,twice,1,0
73552,",",1,0
73553,and,1,0
73554,1,1,0
73555,placebo,1,0
73556,",",1,0
73557,daily,1,0
73558,for,1,0
73559,7,1,0
73560,days,1,0
73561,.,1,1
73562,HO,0,0
73563,was,0,0
73564,graded,0,0
73565,according,0,0
73566,to,0,0
73567,the,0,0
73568,1-year,0,0
73569,postoperative,0,0
73570,radiographs,0,1
73571,according,0,0
73572,to,0,0
73573,the,0,0
73574,Brooker,0,0
73575,classification,0,0
73576,.,0,0
73577,RESULTS,0,0
73578,12,1,0
73579,of,1,0
73580,the,1,0
73581,186,1,1
73582,patients,1,1
73583,included,1,1
73584,discontinued,1,0
73585,their,1,0
73586,medication,1,0
73587,before,1,0
73588,the,1,0
73589,end,1,0
73590,of,1,0
73591,the,1,0
73592,trial,1,0
73593,due,1,0
73594,to,1,0
73595,side,1,0
73596,effects,1,0
73597,.,1,0
73598,The,1,0
73599,remaining,1,0
73600,174,1,1
73601,patients,1,1
73602,were,1,0
73603,included,1,1
73604,in,1,0
73605,the,1,0
73606,analysis,1,0
73607,.,1,0
73608,In,1,0
73609,the,1,0
73610,indomethacin,1,0
73611,group,1,0
73612,(,1,0
73613,n,1,1
73614,=,1,0
73615,89,1,1
73616,),1,0
73617,",",1,0
73618,77,1,0
73619,patients,1,1
73620,(,1,0
73621,87,1,1
73622,%,1,0
73623,),1,0
73624,showed,1,0
73625,no,1,0
73626,HO,1,0
73627,",",1,0
73628,9,1,0
73629,showed,1,0
73630,HO,1,0
73631,of,1,0
73632,grade,1,0
73633,1,1,0
73634,and,1,0
73635,3,1,0
73636,showed,1,0
73637,HO,1,0
73638,of,1,0
73639,grade,1,0
73640,2,1,0
73641,according,1,0
73642,to,1,0
73643,the,1,0
73644,Brooker,1,0
73645,classification,1,0
73646,.,1,0
73647,In,1,0
73648,the,1,0
73649,rofecoxib,1,0
73650,group,1,0
73651,(,1,0
73652,n,1,1
73653,=,1,0
73654,85,1,1
73655,),1,0
73656,73,1,1
73657,patients,1,1
73658,(,1,0
73659,86,1,1
73660,%,1,0
73661,),1,0
73662,showed,1,0
73663,no,1,0
73664,ossification,1,0
73665,",",1,0
73666,9,1,0
73667,showed,1,0
73668,grade,1,0
73669,1,1,0
73670,",",1,0
73671,and,1,0
73672,3,1,0
73673,showed,1,0
73674,grade,1,1
73675,2,1,0
73676,.,1,0
73677,INTERPRETATION,0,0
73678,The,0,0
73679,prophylactic,0,0
73680,effect,0,0
73681,of,0,0
73682,rofecoxib,0,0
73683,for,0,0
73684,7,0,0
73685,days,0,0
73686,in,0,0
73687,preventing,0,0
73688,heterotopic,0,1
73689,ossification,0,0
73690,after,0,0
73691,primary,0,0
73692,total,0,1
73693,hip,0,1
73694,arthroplasty,0,1
73695,is,0,0
73696,comparable,0,0
73697,to,0,0
73698,the,0,0
73699,effect,0,0
73700,of,0,0
73701,indomethacin,0,0
73702,given,0,0
73703,for,0,0
73704,7,0,0
73705,days,0,0
73706,.,0,1
73707,These,0,0
73708,results,0,0
73709,indicate,0,0
73710,that,0,0
73711,the,0,0
73712,development,0,0
73713,of,0,0
73714,HO,0,0
73715,follows,0,0
73716,a,0,0
73717,COX-2,0,0
73718,pathway,0,0
73719,.,0,0
73720,Fine,0,0
73721,needle,0,0
73722,aspiration,0,0
73723,coupled,0,0
73724,with,0,1
73725,real-time,0,0
73726,PCR,0,0
73727,:,0,1
73728,a,0,0
73729,painless,0,0
73730,methodology,0,0
73731,to,0,0
73732,study,0,0
73733,adaptive,0,0
73734,functional,0,0
73735,changes,0,0
73736,in,0,0
73737,skeletal,0,0
73738,muscle,0,0
73739,.,0,0
73740,BACKGROUND,0,0
73741,AND,0,0
73742,AIM,0,0
73743,In,0,0
73744,this,0,0
73745,study,0,0
73746,we,0,0
73747,developed,0,0
73748,a,0,0
73749,new,0,0
73750,methodology,0,0
73751,for,0,0
73752,obtaining,0,0
73753,human,0,0
73754,skeletal,0,0
73755,muscle,0,0
73756,samples,0,0
73757,to,0,0
73758,evaluate,0,0
73759,gene,0,0
73760,expression,0,0
73761,.,0,0
73762,This,0,0
73763,approach,0,0
73764,is,0,0
73765,based,0,0
73766,on,0,0
73767,a,0,0
73768,fine,0,0
73769,needle,0,0
73770,aspiration,0,0
73771,technique,0,0
73772,",",0,0
73773,which,0,0
73774,allows,0,0
73775,us,0,0
73776,to,0,0
73777,extract,0,0
73778,a,0,0
73779,small,0,0
73780,tissue,0,0
73781,sample,0,1
73782,in,0,0
73783,a,0,0
73784,significantly,0,0
73785,less,0,0
73786,invasive,0,0
73787,manner,0,0
73788,than,0,0
73789,with,0,1
73790,classic,0,1
73791,biopsy,0,1
73792,.,0,0
73793,METHODS,0,0
73794,AND,0,0
73795,RESULTS,0,0
73796,Multiplex,0,0
73797,tandem,0,0
73798,RT-PCR,0,0
73799,was,0,0
73800,used,0,0
73801,to,0,0
73802,determine,0,0
73803,the,0,0
73804,mRNA,0,0
73805,levels,0,0
73806,of,0,0
73807,genes,0,0
73808,involved,0,0
73809,in,0,0
73810,ATP,0,0
73811,production,0,0
73812,and,0,0
73813,mitochondrial,0,0
73814,biogenesis,0,0
73815,in,0,0
73816,muscle,0,0
73817,tissue,0,0
73818,.,0,0
73819,Samples,0,0
73820,of,0,0
73821,vastus,0,1
73822,lateralis,0,0
73823,muscle,0,0
73824,were,0,0
73825,obtained,0,0
73826,from,0,0
73827,21,1,1
73828,healthy,1,1
73829,subjects,1,1
73830,with,1,1
73831,different,1,0
73832,fitness,1,0
73833,levels,1,0
73834,.,1,0
73835,The,0,0
73836,principal,0,0
73837,findings,0,0
73838,in,0,0
73839,our,0,0
73840,study,0,0
73841,show,0,0
73842,a,0,0
73843,strong,0,0
73844,correlation,0,0
73845,between,0,0
73846,PGC-1alpha,0,0
73847,and,0,0
73848,COX5B,0,0
73849,(,0,0
73850,p,0,0
73851,<,0,0
73852,0.001,0,0
73853,),0,0
73854,and,0,0
73855,between,0,0
73856,PGC-1alpha,0,0
73857,and,0,0
73858,MT-CO2,0,0
73859,(,0,0
73860,p=0.017,0,0
73861,),0,0
73862,expression,0,0
73863,.,0,0
73864,Furthermore,0,0
73865,",",0,0
73866,a,0,0
73867,significant,0,0
73868,positive,0,0
73869,correlation,0,0
73870,between,0,0
73871,mtDNA,0,0
73872,content,0,0
73873,and,0,0
73874,the,0,0
73875,percentage,0,0
73876,of,0,0
73877,MHCI,0,0
73878,present,0,0
73879,in,0,0
73880,the,0,0
73881,aspired,0,0
73882,samples,0,0
73883,were,0,0
73884,found,0,0
73885,(,0,0
73886,p=0.028,0,0
73887,),0,0
73888,.,0,0
73889,These,0,0
73890,data,0,0
73891,are,0,0
73892,in,0,0
73893,agreement,0,0
73894,with,0,1
73895,current,0,0
73896,knowledge,0,0
73897,on,0,0
73898,skeletal,0,0
73899,muscle,0,0
73900,physiology,0,0
73901,and,0,0
73902,show,0,0
73903,the,0,0
73904,reliability,0,0
73905,of,0,0
73906,the,0,0
73907,proposed,0,0
73908,method,0,0
73909,.,0,0
73910,CONCLUSION,0,0
73911,This,0,0
73912,painless,0,0
73913,methodology,0,0
73914,can,0,0
73915,be,0,0
73916,used,0,0
73917,to,0,0
73918,investigate,0,0
73919,",",0,0
73920,in,0,0
73921,vivo,0,0
73922,",",0,0
73923,human,0,0
73924,muscle,0,0
73925,RNA,0,1
73926,and,0,0
73927,DNA,0,0
73928,adaptations,0,0
73929,in,0,0
73930,response,0,0
73931,to,0,0
73932,either,0,0
73933,physiological,0,0
73934,and/or,0,0
73935,pharmacological,0,0
73936,stimuli,0,0
73937,.,0,0
73938,This,0,0
73939,method,0,0
73940,has,0,0
73941,major,0,0
73942,clinical,0,0
73943,relevance,0,0
73944,",",0,0
73945,such,0,0
73946,as,0,0
73947,its,0,0
73948,application,0,0
73949,in,0,0
73950,clarifying,0,0
73951,the,0,0
73952,mechanisms,0,0
73953,underling,0,0
73954,metabolic,0,0
73955,and,0,0
73956,systemic,0,0
73957,disorders,0,1
73958,.,0,1
73959,Trace,0,0
73960,element,0,0
73961,supplementation,0,0
73962,after,0,0
73963,major,1,0
73964,burns,1,1
73965,modulates,0,0
73966,antioxidant,0,0
73967,status,0,0
73968,and,0,0
73969,clinical,0,0
73970,course,0,0
73971,by,0,0
73972,way,0,0
73973,of,0,0
73974,increased,0,0
73975,tissue,0,0
73976,trace,0,0
73977,element,0,0
73978,concentrations,0,0
73979,.,0,0
73980,BACKGROUND,0,0
73981,After,0,0
73982,major,1,0
73983,burns,1,1
73984,",",1,0
73985,patients,1,1
73986,can,0,0
73987,develop,0,0
73988,nutritional,1,0
73989,deficiencies,1,0
73990,including,1,0
73991,trace,1,0
73992,element,1,0
73993,(,1,0
73994,TE,1,0
73995,),1,0
73996,deficiencies,1,0
73997,.,1,1
73998,Various,0,1
73999,complications,0,0
74000,",",0,0
74001,such,0,0
74002,as,0,0
74003,infections,0,0
74004,and,0,0
74005,delayed,0,0
74006,wound,0,0
74007,healing,0,0
74008,",",0,0
74009,influence,0,0
74010,the,0,0
74011,clinical,0,0
74012,course,0,0
74013,of,0,0
74014,such,0,0
74015,patients,0,1
74016,.,0,0
74017,OBJECTIVES,0,0
74018,We,0,0
74019,aimed,0,0
74020,to,0,0
74021,investigate,0,0
74022,the,0,0
74023,effects,0,0
74024,of,0,0
74025,large,0,1
74026,",",0,0
74027,intravenous,0,0
74028,doses,0,0
74029,of,0,0
74030,TE,0,0
74031,supplements,0,0
74032,on,0,0
74033,circulating,0,0
74034,and,0,0
74035,cutaneous,0,1
74036,TE,0,0
74037,tissue,0,0
74038,concentrations,0,0
74039,",",0,0
74040,on,0,0
74041,antioxidant,0,0
74042,status,0,0
74043,",",0,0
74044,and,0,0
74045,on,0,0
74046,clinical,0,0
74047,outcome,0,0
74048,after,0,0
74049,major,1,0
74050,burns,1,1
74051,.,1,1
74052,DESIGN,0,0
74053,This,0,0
74054,was,0,0
74055,a,0,0
74056,prospective,0,0
74057,",",0,0
74058,randomized,0,0
74059,",",0,0
74060,placebo-controlled,0,0
74061,trial,0,0
74062,in,0,0
74063,21,1,1
74064,patients,1,1
74065,aged,1,1
74066,35,1,1
74067,+/-,1,0
74068,11,1,1
74069,y,1,1
74070,(,1,0
74071,x,1,0
74072,+/-,1,0
74073,SD,1,0
74074,),1,0
74075,with,1,1
74076,burns,1,1
74077,on,1,0
74078,45,1,1
74079,+/-,1,0
74080,21,1,1
74081,%,1,0
74082,of,1,0
74083,their,1,0
74084,body,1,0
74085,surface,1,0
74086,area,1,0
74087,.,1,0
74088,Intravenous,0,0
74089,copper,0,0
74090,",",0,0
74091,selenium,0,0
74092,",",0,0
74093,and,0,0
74094,zinc,0,0
74095,(,0,0
74096,TE,0,0
74097,group,0,0
74098,),0,0
74099,or,0,0
74100,vehicle,0,0
74101,(,0,0
74102,V,0,0
74103,group,0,0
74104,),0,0
74105,was,0,0
74106,given,0,0
74107,with,0,0
74108,a,0,0
74109,saline,0,0
74110,solution,0,0
74111,for,0,0
74112,14-21,0,1
74113,d.,0,1
74114,Blood,0,0
74115,and,0,0
74116,urine,0,0
74117,samples,0,0
74118,were,0,0
74119,collected,0,0
74120,until,0,0
74121,day,0,0
74122,20,0,0
74123,",",0,0
74124,and,0,0
74125,skin,0,0
74126,biopsy,0,0
74127,specimens,0,1
74128,were,0,0
74129,collected,0,0
74130,on,0,0
74131,days,0,0
74132,3,0,0
74133,",",0,0
74134,10,0,0
74135,",",0,0
74136,and,0,0
74137,20,0,0
74138,.,0,0
74139,RESULTS,0,0
74140,The,0,0
74141,age,0,1
74142,of,0,0
74143,the,0,0
74144,patients,0,1
74145,and,0,0
74146,the,0,0
74147,severity,0,0
74148,of,0,0
74149,their,0,0
74150,burns,0,1
74151,did,0,0
74152,not,0,0
74153,differ,0,0
74154,significantly,0,0
74155,between,0,0
74156,the,0,0
74157,groups,0,0
74158,.,0,0
74159,Plasma,0,0
74160,TE,0,0
74161,concentrations,0,0
74162,were,0,0
74163,significantly,0,0
74164,higher,0,0
74165,in,0,0
74166,the,0,0
74167,TE,0,0
74168,group,0,0
74169,.,0,0
74170,In,0,0
74171,burned,0,1
74172,areas,0,0
74173,",",0,0
74174,skin,0,0
74175,contents,0,0
74176,of,0,0
74177,both,0,0
74178,selenium,0,0
74179,(,0,0
74180,P=0.05,0,0
74181,),0,0
74182,and,0,0
74183,zinc,0,0
74184,(,0,0
74185,P=0.04,0,0
74186,),0,0
74187,increased,0,0
74188,significantly,0,0
74189,by,0,0
74190,day,0,0
74191,20,0,1
74192,.,0,0
74193,Plasma,0,0
74194,and,0,0
74195,tissue,0,0
74196,antioxidant,0,0
74197,status,0,0
74198,was,0,0
74199,improved,0,0
74200,by,0,0
74201,supplementation,0,0
74202,.,0,0
74203,The,0,0
74204,number,0,0
74205,of,0,0
74206,infections,0,0
74207,in,0,0
74208,the,0,0
74209,first,0,0
74210,30,0,0
74211,d,0,0
74212,was,0,0
74213,significantly,0,0
74214,lower,0,0
74215,in,0,0
74216,the,0,0
74217,TE,0,0
74218,group,0,0
74219,(,0,0
74220,P=0.015,0,0
74221,),0,0
74222,",",0,0
74223,with,0,0
74224,a,0,0
74225,median,0,0
74226,number,0,0
74227,of,0,0
74228,2,0,0
74229,versus,0,0
74230,4,0,0
74231,infections,0,0
74232,per,0,0
74233,patient,0,0
74234,in,0,0
74235,the,0,0
74236,TE,0,0
74237,and,0,0
74238,V,0,0
74239,groups,0,0
74240,",",0,0
74241,respectively,0,0
74242,",",0,0
74243,as,0,0
74244,a,0,0
74245,result,0,0
74246,of,0,0
74247,a,0,0
74248,reduction,0,0
74249,in,0,0
74250,pulmonary,0,1
74251,infections,0,0
74252,(,0,0
74253,P=0.03,0,0
74254,),0,0
74255,.,0,0
74256,Wound,0,0
74257,healing,0,0
74258,was,0,0
74259,improved,0,0
74260,in,0,0
74261,the,0,0
74262,TE,0,0
74263,group,0,0
74264,",",0,0
74265,with,0,0
74266,lower,0,0
74267,requirements,0,0
74268,for,0,0
74269,regrafting,0,1
74270,(,0,0
74271,P=0.02,0,0
74272,),0,0
74273,.,0,0
74274,CONCLUSIONS,0,0
74275,TE,0,0
74276,supplementation,0,0
74277,was,0,0
74278,associated,0,0
74279,with,0,0
74280,higher,0,0
74281,circulating,0,0
74282,plasma,0,0
74283,and,0,0
74284,skin,0,0
74285,tissue,0,0
74286,contents,0,0
74287,of,0,0
74288,selenium,0,0
74289,and,0,0
74290,zinc,0,0
74291,and,0,0
74292,improved,0,0
74293,antioxidant,0,0
74294,status,0,0
74295,.,0,0
74296,These,0,0
74297,changes,0,0
74298,were,0,0
74299,associated,0,0
74300,with,0,1
74301,improved,0,0
74302,clinical,0,0
74303,outcome,0,0
74304,",",0,0
74305,including,0,0
74306,fewer,0,0
74307,pulmonary,0,1
74308,infections,0,0
74309,and,0,0
74310,better,0,0
74311,wound,0,0
74312,healing,0,0
74313,.,0,0
74314,The,0,0
74315,effectiveness,0,0
74316,of,0,0
74317,Picture,0,0
74318,Exchange,0,0
74319,Communication,0,0
74320,System,0,0
74321,(,0,0
74322,PECS,0,0
74323,),0,0
74324,training,0,0
74325,for,0,0
74326,teachers,1,1
74327,of,1,0
74328,children,1,1
74329,with,1,1
74330,autism,1,1
74331,:,1,1
74332,a,0,0
74333,pragmatic,0,0
74334,",",0,0
74335,group,0,0
74336,randomised,0,0
74337,controlled,0,0
74338,trial,0,0
74339,.,0,0
74340,OBJECTIVE,0,0
74341,To,0,0
74342,assess,0,0
74343,the,0,0
74344,effectiveness,0,0
74345,of,0,0
74346,expert,0,0
74347,training,0,0
74348,and,0,0
74349,consultancy,0,0
74350,for,0,0
74351,teachers,1,1
74352,of,1,0
74353,children,1,1
74354,with,1,1
74355,autism,1,1
74356,spectrum,1,1
74357,disorder,1,1
74358,in,0,0
74359,the,0,0
74360,use,0,0
74361,of,0,0
74362,the,0,0
74363,Picture,0,0
74364,Exchange,0,0
74365,Communication,0,0
74366,System,0,0
74367,(,0,0
74368,PECS,0,0
74369,),0,0
74370,.,0,0
74371,METHOD,0,0
74372,DESIGN,0,0
74373,Group,0,0
74374,randomised,0,0
74375,",",0,0
74376,controlled,0,0
74377,trial,0,0
74378,(,0,0
74379,3,0,0
74380,groups,0,0
74381,:,0,1
74382,immediate,0,0
74383,treatment,0,0
74384,",",0,0
74385,delayed,0,0
74386,treatment,0,0
74387,",",0,0
74388,no,0,0
74389,treatment,0,0
74390,),0,0
74391,.,0,0
74392,PARTICIPANTS,0,0
74393,84,1,1
74394,elementary,1,1
74395,school,1,1
74396,children,1,1
74397,",",1,0
74398,mean,1,0
74399,age,1,1
74400,6.8,1,0
74401,years,1,1
74402,.,1,0
74403,TREATMENT,0,0
74404,A,0,0
74405,2-day,0,0
74406,PECS,0,0
74407,workshop,0,1
74408,for,0,0
74409,teachers,1,1
74410,plus,0,0
74411,6,0,0
74412,half-day,0,0
74413,",",0,0
74414,school-based,0,1
74415,training,0,0
74416,sessions,0,0
74417,with,0,1
74418,expert,0,0
74419,consultants,0,1
74420,over,0,0
74421,5,0,1
74422,months,0,0
74423,.,0,1
74424,OUTCOME,0,1
74425,MEASURES,0,0
74426,Rates,0,0
74427,of,0,1
74428,:,0,1
74429,communicative,0,0
74430,initiations,0,0
74431,",",0,0
74432,use,0,0
74433,of,0,0
74434,PECS,0,0
74435,",",0,0
74436,and,0,0
74437,speech,0,0
74438,in,0,0
74439,the,0,0
74440,classroom,0,1
74441,;,0,0
74442,Autism,0,1
74443,Diagnostic,0,0
74444,Observation,0,0
74445,Schedule-Generic,0,0
74446,(,0,0
74447,ADOS-G,0,0
74448,),0,0
74449,domain,0,0
74450,scores,0,0
74451,for,0,0
74452,Communication,0,0
74453,and,0,0
74454,Reciprocal,0,0
74455,Social,0,0
74456,Interaction,0,0
74457,;,0,0
74458,scores,0,0
74459,on,0,0
74460,formal,0,0
74461,language,0,0
74462,tests,0,0
74463,.,0,0
74464,RESULTS,0,0
74465,Controlling,0,0
74466,for,0,0
74467,baseline,0,0
74468,age,0,1
74469,",",0,0
74470,developmental,0,0
74471,quotient,0,0
74472,(,0,0
74473,DQ,0,0
74474,),0,0
74475,and,0,0
74476,language,0,0
74477,;,0,0
74478,rates,0,0
74479,of,0,0
74480,initiations,0,0
74481,and,0,0
74482,PECS,0,0
74483,usage,0,0
74484,increased,0,0
74485,significantly,0,0
74486,immediately,0,0
74487,post-treatment,0,0
74488,(,0,0
74489,Odds,0,0
74490,Ratio,0,0
74491,(,0,0
74492,OR,0,0
74493,),0,0
74494,of,0,0
74495,being,0,0
74496,in,0,0
74497,a,0,0
74498,higher,0,0
74499,ordinal,0,0
74500,rate,0,0
74501,category,0,0
74502,2.72,0,0
74503,",",0,0
74504,95,0,0
74505,%,0,0
74506,confidence,0,0
74507,interval,0,0
74508,1.22-6.09,0,0
74509,",",0,0
74510,p,0,0
74511,<,0,0
74512,.05,0,0
74513,and,0,0
74514,OR,0,0
74515,3.90,0,0
74516,(,0,0
74517,95,0,0
74518,%,0,0
74519,CI,0,0
74520,1.75-8.68,0,0
74521,),0,0
74522,",",0,0
74523,p,0,0
74524,<,0,0
74525,.001,0,0
74526,",",0,0
74527,respectively,0,0
74528,),0,0
74529,.,0,0
74530,There,0,0
74531,were,0,0
74532,no,0,0
74533,increases,0,0
74534,in,0,0
74535,frequency,0,0
74536,of,0,0
74537,speech,0,0
74538,",",0,0
74539,or,0,0
74540,improvements,0,0
74541,in,0,0
74542,ADOS-G,0,1
74543,ratings,0,0
74544,or,0,0
74545,language,0,0
74546,test,0,0
74547,scores,0,0
74548,.,0,0
74549,CONCLUSIONS,0,0
74550,The,0,0
74551,results,0,0
74552,indicate,0,0
74553,modest,0,0
74554,effectiveness,0,0
74555,of,0,0
74556,PECS,0,0
74557,teacher,0,0
74558,training/consultancy,0,0
74559,.,0,0
74560,Rates,0,0
74561,of,0,0
74562,pupils,0,1
74563,',0,1
74564,initiations,0,0
74565,and,0,0
74566,use,0,0
74567,of,0,0
74568,symbols,0,0
74569,in,0,0
74570,the,0,0
74571,classroom,0,0
74572,increased,0,0
74573,",",0,0
74574,although,0,0
74575,there,0,0
74576,was,0,0
74577,no,0,0
74578,evidence,0,0
74579,of,0,0
74580,improvement,0,0
74581,in,0,0
74582,other,0,0
74583,areas,0,0
74584,of,0,0
74585,communication,0,0
74586,.,0,0
74587,TREATMENT,0,0
74588,effects,0,0
74589,were,0,0
74590,not,0,0
74591,maintained,0,0
74592,once,0,0
74593,active,0,0
74594,intervention,0,0
74595,ceased,0,0
74596,.,0,0
74597,Tacrolimus,0,0
74598,monotherapy,0,0
74599,without,0,1
74600,steroids,0,0
74601,after,1,0
74602,liver,1,1
74603,transplantation,1,1
74604,--,1,0
74605,a,1,0
74606,prospective,0,0
74607,randomized,0,0
74608,double-blinded,0,0
74609,placebo-controlled,0,0
74610,trial,0,0
74611,.,0,0
74612,Early,0,0
74613,steroid,0,0
74614,withdrawal,0,0
74615,after,1,0
74616,liver,1,1
74617,transplantation,1,1
74618,(,1,0
74619,LT,1,0
74620,),1,0
74621,is,0,0
74622,desirable,0,0
74623,in,0,0
74624,order,0,0
74625,to,0,0
74626,reduce,0,0
74627,steroid,0,0
74628,side,0,0
74629,effects,0,0
74630,.,0,1
74631,Between,1,0
74632,February,1,1
74633,2000,1,1
74634,and,1,0
74635,August,1,1
74636,2004,1,1
74637,",",1,0
74638,110,1,1
74639,patients,1,1
74640,after,1,0
74641,LT,1,0
74642,were,0,0
74643,included,0,1
74644,in,0,0
74645,this,0,0
74646,prospective,0,0
74647,",",0,0
74648,randomized,0,0
74649,",",0,0
74650,double-blind,0,0
74651,",",0,0
74652,placebo-controlled,0,0
74653,trial,0,0
74654,.,0,0
74655,Randomization,0,0
74656,was,0,0
74657,performed,0,0
74658,before,0,0
74659,LT,0,0
74660,.,0,0
74661,In,0,0
74662,all,0,0
74663,patients,0,1
74664,",",0,0
74665,tacrolimus,0,0
74666,was,0,0
74667,used,0,0
74668,without,0,0
74669,induction,0,0
74670,therapy,0,0
74671,.,0,0
74672,All,1,0
74673,patients,1,1
74674,received,1,0
74675,methylprednisolon,1,0
74676,for,1,0
74677,14,1,0
74678,days,1,0
74679,",",0,0
74680,thereafter,0,0
74681,a,0,0
74682,double-blinded,0,0
74683,medication,0,0
74684,containing,0,0
74685,either,0,0
74686,placebo,0,0
74687,(,0,0
74688,n,0,1
74689,=,0,0
74690,56,0,1
74691,),0,0
74692,or,0,0
74693,methylprednisolon,0,0
74694,(,0,0
74695,n,0,1
74696,=,0,0
74697,54,0,1
74698,),0,0
74699,for,0,0
74700,6,0,0
74701,months,0,0
74702,",",0,0
74703,which,0,0
74704,was,0,0
74705,completely,0,0
74706,stopped,0,0
74707,thereafter,0,0
74708,.,0,0
74709,End,0,0
74710,points,0,0
74711,were,0,0
74712,patient,0,0
74713,and,0,0
74714,graft,0,0
74715,survival,0,0
74716,",",0,0
74717,acute,0,1
74718,and,0,0
74719,chronic,0,1
74720,rejection,0,0
74721,",",0,0
74722,and,0,0
74723,incidence,0,0
74724,of,0,0
74725,steroid,0,0
74726,side,0,0
74727,effects,0,0
74728,during,0,0
74729,the,0,0
74730,first,0,0
74731,year,0,0
74732,after,1,0
74733,LT,1,0
74734,.,1,0
74735,One-year,0,0
74736,patient,0,0
74737,survival,0,0
74738,was,0,0
74739,85.7,0,0
74740,%,0,0
74741,(,0,0
74742,placebo,0,0
74743,),0,0
74744,and,0,0
74745,88.8,0,0
74746,%,0,0
74747,(,0,0
74748,steroid,0,0
74749,),0,0
74750,(,0,0
74751,p,0,0
74752,=,0,0
74753,0.572,0,0
74754,),0,0
74755,.,0,0
74756,Twenty-seven,0,1
74757,(,0,0
74758,48.2,0,0
74759,%,0,0
74760,),0,0
74761,and,0,0
74762,19,0,1
74763,(,0,0
74764,35.2,0,0
74765,%,0,0
74766,),0,0
74767,patients,0,1
74768,experienced,0,0
74769,acute,0,1
74770,rejection,0,1
74771,(,0,0
74772,placebo,0,0
74773,versus,0,0
74774,steroid,0,0
74775,",",0,0
74776,respectively,0,0
74777,;,0,0
74778,p,0,0
74779,=,0,0
74780,0.116,0,0
74781,),0,0
74782,.,0,0
74783,Two,0,0
74784,patients,0,1
74785,in,0,0
74786,the,0,0
74787,placebo,0,0
74788,group,0,0
74789,but,0,0
74790,none,0,0
74791,in,0,0
74792,the,0,0
74793,steroid,0,0
74794,group,0,0
74795,experienced,0,0
74796,chronic,0,1
74797,rejection,0,1
74798,(,0,0
74799,p,0,0
74800,=,0,0
74801,0.257,0,0
74802,),0,0
74803,.,0,0
74804,The,0,0
74805,rates,0,0
74806,of,0,0
74807,side,0,0
74808,effects,0,0
74809,were,0,0
74810,(,0,0
74811,placebo,0,0
74812,versus,0,0
74813,steroid,0,0
74814,",",0,0
74815,respectively,0,0
74816,),0,0
74817,:,0,0
74818,CMV,0,0
74819,infection,0,1
74820,25,0,0
74821,%,0,0
74822,versus,0,0
74823,33,0,1
74824,%,0,0
74825,(,0,0
74826,p,0,0
74827,=,0,0
74828,0.336,0,0
74829,),0,0
74830,",",0,0
74831,post-transplant,0,0
74832,diabetes,0,1
74833,30,0,1
74834,%,0,0
74835,versus,0,0
74836,53,0,1
74837,%,0,0
74838,(,0,0
74839,p,0,0
74840,=,0,0
74841,0.024,0,0
74842,),0,0
74843,",",0,0
74844,hypertension,0,1
74845,39,0,0
74846,%,0,0
74847,versus,0,0
74848,52,0,0
74849,%,0,0
74850,(,0,0
74851,p,0,0
74852,=,0,0
74853,0.248,0,0
74854,),0,0
74855,",",0,0
74856,hypercholesterolemia,0,1
74857,10,0,0
74858,%,0,0
74859,versus,0,0
74860,41,0,1
74861,%,0,0
74862,(,0,0
74863,p,0,0
74864,=,0,0
74865,0.002,0,0
74866,),0,0
74867,and,0,0
74868,hypertriglyceridemia,0,1
74869,32,0,0
74870,%,0,0
74871,versus,0,0
74872,54,0,1
74873,%,0,0
74874,(,0,0
74875,p,0,0
74876,=,0,0
74877,0.046,0,0
74878,),0,0
74879,.,0,0
74880,In,0,0
74881,conclusion,0,0
74882,",",0,0
74883,early,0,0
74884,steroid,0,0
74885,withdrawal,0,0
74886,after,1,0
74887,LT,1,0
74888,is,0,0
74889,feasible,0,0
74890,under,0,0
74891,tacrolimus,0,0
74892,monotherapy,0,0
74893,without,0,0
74894,increased,0,0
74895,rejection,0,1
74896,rates,0,0
74897,and,0,0
74898,with,0,1
74899,a,0,0
74900,lower,0,0
74901,rate,0,0
74902,of,0,0
74903,side,0,0
74904,effects,0,0
74905,.,0,1
74906,Comparison,0,0
74907,of,0,0
74908,the,0,0
74909,impact,0,0
74910,of,0,0
74911,vaginal,0,0
74912,and,0,0
74913,oral,0,0
74914,administration,0,0
74915,of,0,0
74916,combined,0,0
74917,hormonal,0,1
74918,contraceptives,0,0
74919,on,0,0
74920,hepatic,0,1
74921,proteins,0,0
74922,sensitive,0,0
74923,to,0,0
74924,estrogen,0,0
74925,.,0,0
74926,OBJECTIVE,0,0
74927,We,0,0
74928,evaluated,0,0
74929,the,0,0
74930,effects,0,0
74931,of,0,0
74932,a,0,0
74933,new,0,0
74934,combined,0,0
74935,hormonal,0,0
74936,contraceptive,0,1
74937,vaginal,0,1
74938,ring,0,0
74939,(,0,0
74940,CVR,0,0
74941,),0,0
74942,delivering,0,0
74943,the,0,0
74944,nonandrogenic,0,0
74945,progestin,0,0
74946,Nestorone,0,0
74947,(,0,0
74948,NES,0,0
74949,),0,0
74950,and,0,0
74951,ethinyl,0,0
74952,estradiol,0,0
74953,(,0,0
74954,EE,0,0
74955,),0,0
74956,on,0,0
74957,several,0,0
74958,key,0,0
74959,estrogen-sensitive,0,1
74960,hepatic,0,1
74961,proteins,0,0
74962,that,0,0
74963,may,0,0
74964,be,0,0
74965,markers,0,0
74966,for,0,0
74967,the,0,0
74968,risk,0,0
74969,of,0,0
74970,arterial,0,0
74971,or,0,0
74972,venous,0,0
74973,disease,0,1
74974,events,0,0
74975,and,0,0
74976,on,0,0
74977,blood,0,0
74978,pressure,0,0
74979,(,0,0
74980,BP,0,0
74981,),0,0
74982,.,0,0
74983,Because,0,0
74984,the,0,0
74985,pharmacologic,0,0
74986,androgenicity,0,0
74987,of,0,0
74988,the,0,0
74989,progestin,0,0
74990,in,0,0
74991,these,0,0
74992,formulations,0,0
74993,influences,0,0
74994,the,0,0
74995,hepatic,0,0
74996,impact,0,0
74997,of,0,0
74998,EE,0,0
74999,",",0,0
75000,we,0,0
75001,selected,0,0
75002,an,0,0
75003,oral,1,0
75004,contraceptive,1,0
75005,(,1,0
75006,OC,1,0
75007,),1,0
75008,delivering,0,0
75009,the,0,0
75010,androgenic,0,0
75011,progestin,0,0
75012,levonorgestrel,0,0
75013,(,0,0
75014,LNG,0,1
75015,),0,0
75016,and,0,0
75017,EE,0,0
75018,as,0,0
75019,the,0,0
75020,comparator,0,0
75021,.,0,0
75022,We,0,0
75023,also,0,0
75024,investigated,0,0
75025,the,0,0
75026,effect,0,0
75027,of,0,0
75028,delivery,0,0
75029,route,0,0
75030,",",0,0
75031,which,0,0
75032,is,0,0
75033,known,0,0
75034,to,0,0
75035,modify,0,0
75036,the,0,0
75037,hepatic,0,0
75038,effects,0,0
75039,of,0,0
75040,estradiol,0,0
75041,",",0,0
75042,but,0,0
75043,has,0,0
75044,not,0,0
75045,been,0,0
75046,widely,0,0
75047,studied,0,0
75048,with,0,0
75049,EE,0,0
75050,.,0,1
75051,STUDY,0,0
75052,METHODS,0,0
75053,Women,1,1
75054,",",1,0
75055,aged,1,1
75056,18-34,1,1
75057,years,1,1
75058,",",1,0
75059,with,1,1
75060,no,1,0
75061,contraindications,1,0
75062,to,1,0
75063,the,1,0
75064,use,1,0
75065,of,1,0
75066,combined,1,0
75067,OCs,1,0
75068,",",1,0
75069,were,1,0
75070,randomized,1,0
75071,to,1,0
75072,three,1,0
75073,cycles,1,0
75074,of,1,0
75075,treatment,1,0
75076,with,1,1
75077,a,1,0
75078,CVR,1,0
75079,delivering,1,0
75080,NES/EE,1,0
75081,(,1,0
75082,150/15,1,0
75083,microg/day,1,0
75084,),1,0
75085,or,1,0
75086,a,1,0
75087,combined,1,0
75088,OC,1,0
75089,providing,1,0
75090,LNG,1,1
75091,and,1,0
75092,EE,1,0
75093,(,1,0
75094,150/30,1,0
75095,microg,1,0
75096,per,1,0
75097,tablet,1,0
75098,),1,0
75099,.,0,0
75100,Each,0,0
75101,cycle,0,0
75102,consisted,0,0
75103,of,0,0
75104,21,0,1
75105,days,0,0
75106,of,0,0
75107,active,0,0
75108,treatment,0,0
75109,",",0,0
75110,followed,0,0
75111,by,0,0
75112,7,0,0
75113,days,0,0
75114,without,0,1
75115,treatment,0,0
75116,.,0,0
75117,During,0,0
75118,the,0,0
75119,last,0,0
75120,weeks,0,0
75121,of,0,0
75122,the,0,0
75123,pretreatment,0,0
75124,and,0,0
75125,third,0,0
75126,treatment,0,0
75127,cycles,0,0
75128,",",0,0
75129,blood,0,0
75130,samples,0,0
75131,were,0,0
75132,obtained,0,0
75133,for,0,0
75134,determinations,0,0
75135,of,0,0
75136,plasma,0,0
75137,concentrations,0,0
75138,of,0,0
75139,angiotensinogen,0,0
75140,",",0,0
75141,an,0,0
75142,estrogen-sensitive,0,0
75143,hepatic,0,0
75144,protein,0,0
75145,",",0,0
75146,and,0,0
75147,serum,0,0
75148,concentrations,0,0
75149,of,0,0
75150,sex,0,1
75151,hormone-binding,0,0
75152,globulin,0,0
75153,(,0,0
75154,SHBG,0,0
75155,),0,0
75156,",",0,0
75157,total,0,0
75158,cholesterol,0,0
75159,(,0,0
75160,TC,0,0
75161,),0,0
75162,",",0,0
75163,high-density,0,0
75164,lipoprotein,0,0
75165,cholesterol,0,0
75166,(,0,0
75167,HDL-C,0,0
75168,),0,0
75169,",",0,0
75170,low-density,0,0
75171,lipoprotein,0,0
75172,cholesterol,0,0
75173,(,0,0
75174,LDL-C,0,0
75175,),0,0
75176,",",0,0
75177,triglycerides,0,0
75178,(,0,0
75179,TG,0,0
75180,),0,0
75181,and,0,0
75182,estrogen-,0,1
75183,and,0,0
75184,androgen-sensitive,0,1
75185,proteins,0,0
75186,.,0,1
75187,BP,0,0
75188,was,0,0
75189,also,0,0
75190,measured,0,0
75191,.,0,0
75192,RESULTS,0,0
75193,Of,1,1
75194,47,1,1
75195,women,1,1
75196,randomized,1,0
75197,",",1,0
75198,45,1,0
75199,completed,1,0
75200,the,1,0
75201,study,1,0
75202,(,1,0
75203,CVR,1,0
75204,:,1,1
75205,23,1,1
75206,;,1,0
75207,OC,1,0
75208,:,1,1
75209,22,1,1
75210,),1,0
75211,.,1,0
75212,Within-group,0,0
75213,comparisons,0,0
75214,over,0,0
75215,time,0,0
75216,by,0,0
75217,repeated-measure,0,0
75218,analysis,0,0
75219,of,0,0
75220,variance,0,0
75221,demonstrated,0,0
75222,statistically,0,0
75223,significant,0,0
75224,changes,0,0
75225,over,0,0
75226,time,0,0
75227,with,0,1
75228,both,0,0
75229,treatments,0,0
75230,for,0,0
75231,all,0,0
75232,hepatic,0,0
75233,proteins,0,0
75234,(,0,0
75235,p,0,0
75236,<,0,0
75237,.02,0,0
75238,),0,0
75239,but,0,0
75240,not,0,0
75241,for,0,0
75242,TC,0,0
75243,.,0,0
75244,The,0,0
75245,within-group,0,0
75246,effects,0,0
75247,",",0,0
75248,presented,0,0
75249,as,0,0
75250,relative,0,0
75251,percent,0,0
75252,difference,0,0
75253,[,0,0
75254,95,0,0
75255,%,0,0
75256,confidence,0,0
75257,interval,0,0
75258,(,0,0
75259,CI,0,0
75260,),0,0
75261,],0,0
75262,",",0,0
75263,were,0,0
75264,greatest,0,0
75265,for,0,0
75266,angiotensinogen,0,0
75267,[,0,0
75268,CVR,0,0
75269,:,0,1
75270,227,0,1
75271,%,0,0
75272,(,0,0
75273,195-262,0,1
75274,%,0,0
75275,),0,0
75276,;,0,0
75277,OC,0,0
75278,:,0,1
75279,251.3,0,0
75280,%,0,0
75281,(,0,0
75282,218-288,0,0
75283,%,0,0
75284,),0,0
75285,],0,0
75286,and,0,0
75287,SHBG,0,0
75288,[,0,0
75289,CVR,0,0
75290,:,0,1
75291,306,0,1
75292,%,0,0
75293,(,0,0
75294,237-389,0,0
75295,%,0,0
75296,),0,0
75297,;,0,0
75298,OC,0,0
75299,:,0,1
75300,55,0,1
75301,%,0,0
75302,(,0,0
75303,30-86,0,1
75304,),0,0
75305,],0,0
75306,.,0,0
75307,Both,0,0
75308,treatments,0,0
75309,were,0,0
75310,associated,0,0
75311,with,0,1
75312,small,0,0
75313,changes,0,0
75314,in,0,0
75315,systolic,0,1
75316,BP,0,0
75317,and,0,0
75318,diastolic,0,0
75319,BP,0,0
75320,(,0,0
75321,DBP,0,0
75322,),0,0
75323,",",0,0
75324,but,0,0
75325,only,0,0
75326,the,0,0
75327,within-group,0,0
75328,change,0,0
75329,in,0,0
75330,DBP,0,0
75331,for,0,0
75332,the,0,0
75333,OC,0,0
75334,group,0,0
75335,was,0,0
75336,statistically,0,0
75337,significant,0,0
75338,(,0,0
75339,p,0,0
75340,=,0,0
75341,.04,0,0
75342,),0,0
75343,.,0,0
75344,Between-treatment,0,0
75345,comparisons,0,0
75346,of,0,0
75347,third,0,1
75348,treatment,0,0
75349,cycle,0,0
75350,mean,0,0
75351,values,0,0
75352,were,0,0
75353,performed,0,0
75354,by,0,0
75355,analysis,0,0
75356,of,0,0
75357,covariance,0,0
75358,(,0,0
75359,baseline,0,0
75360,values,0,0
75361,as,0,0
75362,covariate,0,0
75363,),0,0
75364,.,0,0
75365,No,0,0
75366,statistically,0,0
75367,significant,0,0
75368,between-treatment,0,0
75369,differences,0,0
75370,were,0,0
75371,found,0,0
75372,for,0,0
75373,angiotensinogen,0,0
75374,",",0,0
75375,sensitive,0,0
75376,only,0,0
75377,to,0,0
75378,estrogen,0,0
75379,",",0,0
75380,or,0,0
75381,BP,0,0
75382,.,0,0
75383,Statistically,0,0
75384,significant,0,0
75385,treatment,0,0
75386,differences,0,0
75387,were,0,0
75388,found,0,0
75389,for,0,0
75390,all,0,0
75391,estrogen-,0,1
75392,and,0,0
75393,androgen-sensitive,0,0
75394,proteins,0,0
75395,(,0,0
75396,p,0,0
75397,<,0,0
75398,or,0,0
75399,=,0,0
75400,.002,0,0
75401,),0,0
75402,but,0,0
75403,not,0,0
75404,for,0,0
75405,TC,0,0
75406,.,0,0
75407,When,0,0
75408,presented,0,0
75409,as,0,0
75410,relative,0,0
75411,percent,0,0
75412,difference,0,0
75413,between,0,0
75414,the,0,0
75415,effects,0,0
75416,of,0,0
75417,treatment,0,0
75418,(,0,0
75419,CVR-OC/OC,0,0
75420,;,0,0
75421,95,0,0
75422,%,0,0
75423,CI,0,0
75424,of,0,0
75425,percent,0,0
75426,difference,0,0
75427,),0,0
75428,",",0,0
75429,the,0,0
75430,difference,0,0
75431,was,0,0
75432,largest,0,0
75433,for,0,0
75434,SHBG,0,0
75435,(,0,0
75436,159,0,1
75437,%,0,0
75438,[,0,0
75439,117-210,0,1
75440,%,0,0
75441,],0,1
75442,),0,0
75443,;,0,0
75444,smaller,0,0
75445,relative,0,0
75446,percent,0,0
75447,differences,0,0
75448,were,0,0
75449,found,0,0
75450,for,0,0
75451,HDL-C,0,0
75452,[,0,0
75453,31.9,0,0
75454,%,0,0
75455,(,0,0
75456,18.5-46.8,0,0
75457,%,0,0
75458,),0,0
75459,],0,0
75460,",",0,0
75461,LDL-C,0,0
75462,[,0,0
75463,23.6,0,0
75464,%,0,0
75465,(,0,0
75466,33.4,0,0
75467,%,0,0
75468,to,0,0
75469,-2.4,0,0
75470,%,0,0
75471,),0,0
75472,],0,0
75473,and,0,0
75474,TG,0,0
75475,[,0,0
75476,39.0,0,0
75477,%,0,0
75478,(,0,0
75479,14.0-69.4,0,0
75480,%,0,0
75481,),0,0
75482,],0,0
75483,",",0,0
75484,but,0,0
75485,not,0,0
75486,TC,0,0
75487,.,0,0
75488,CONCLUSION,0,0
75489,Vaginal,0,0
75490,delivery,0,0
75491,of,0,0
75492,a,0,0
75493,combined,0,0
75494,hormonal,0,0
75495,contraceptive,0,0
75496,did,0,0
75497,not,0,0
75498,reduce,0,0
75499,the,0,0
75500,EE-associated,0,0
75501,changes,0,0
75502,in,0,0
75503,estrogen-sensitive,0,1
75504,hepatic,0,1
75505,proteins,0,0
75506,observed,0,0
75507,after,0,0
75508,use,0,0
75509,of,0,0
75510,a,0,0
75511,combined,0,0
75512,OC,0,0
75513,.,0,0
75514,Significant,0,0
75515,treatment,0,0
75516,differences,0,0
75517,between,0,0
75518,the,0,0
75519,NES/EE,0,0
75520,CVR,0,0
75521,and,0,0
75522,the,0,0
75523,LNG/EE,0,0
75524,OC,0,0
75525,were,0,0
75526,found,0,0
75527,for,0,0
75528,SHBG,0,0
75529,",",0,0
75530,HDL-C,0,0
75531,",",0,0
75532,LDL-C,0,0
75533,",",0,0
75534,and,0,0
75535,TG,0,0
75536,",",0,0
75537,proteins,0,0
75538,sensitive,0,0
75539,to,0,0
75540,androgen,0,0
75541,as,0,0
75542,well,0,0
75543,as,0,0
75544,estrogen,0,0
75545,.,0,0
75546,No,0,0
75547,treatment,0,0
75548,difference,0,0
75549,was,0,0
75550,observed,0,0
75551,for,0,0
75552,angiotensinogen,0,0
75553,",",0,0
75554,which,0,0
75555,is,0,0
75556,sensitive,0,0
75557,only,0,0
75558,to,0,0
75559,estrogen,0,0
75560,.,0,0
75561,The,0,0
75562,observed,0,0
75563,treatment,0,0
75564,differences,0,0
75565,were,0,0
75566,therefore,0,0
75567,most,0,0
75568,likely,0,0
75569,due,0,0
75570,to,0,0
75571,the,0,0
75572,difference,0,0
75573,in,0,0
75574,androgenicity,0,0
75575,between,0,0
75576,NES,0,0
75577,and,0,0
75578,LNG,0,1
75579,.,0,0
75580,A,0,0
75581,comparison,0,0
75582,of,0,0
75583,acceptance-,0,0
75584,and,0,0
75585,control-based,0,0
75586,strategies,0,0
75587,for,0,0
75588,coping,0,0
75589,with,0,1
75590,food,0,1
75591,cravings,0,0
75592,:,0,1
75593,an,0,0
75594,analog,0,0
75595,study,0,0
75596,.,0,0
75597,The,0,0
75598,present,0,0
75599,study,0,0
75600,utilized,0,0
75601,an,0,0
75602,analog,0,0
75603,paradigm,0,0
75604,to,0,0
75605,investigate,0,0
75606,the,0,0
75607,effectiveness,0,0
75608,of,0,0
75609,two,0,0
75610,strategies,0,0
75611,for,0,0
75612,coping,0,0
75613,with,0,1
75614,food,0,0
75615,cravings,0,0
75616,",",0,0
75617,which,0,0
75618,was,0,0
75619,theorized,0,0
75620,to,0,0
75621,be,0,0
75622,critical,0,0
75623,to,0,0
75624,the,0,0
75625,maintenance,0,0
75626,of,0,0
75627,weight,0,0
75628,loss,0,0
75629,.,0,0
75630,Ninety-eight,1,1
75631,undergraduate,1,1
75632,students,1,1
75633,were,1,0
75634,given,1,0
75635,transparent,1,0
75636,boxes,1,0
75637,of,1,0
75638,chocolate,1,0
75639,Hershey,1,0
75640,'s,1,0
75641,Kisses,1,0
75642,and,0,0
75643,instructed,0,0
75644,to,0,0
75645,keep,0,0
75646,the,0,0
75647,chocolates,0,0
75648,with,0,0
75649,them,0,0
75650,",",0,0
75651,but,0,0
75652,not,0,0
75653,to,0,0
75654,eat,0,0
75655,them,0,0
75656,",",0,0
75657,for,0,0
75658,48,0,0
75659,h.,0,0
75660,Before,0,0
75661,receiving,0,0
75662,the,0,0
75663,Kisses,0,0
75664,",",0,0
75665,participants,0,1
75666,were,0,0
75667,randomized,0,0
75668,to,0,0
75669,receive,0,0
75670,either,0,0
75671,(,0,0
75672,a,0,0
75673,),0,0
75674,no,0,0
75675,intervention,0,0
75676,",",0,0
75677,(,0,0
75678,b,0,0
75679,),0,0
75680,instruction,0,0
75681,in,0,0
75682,control-based,0,0
75683,coping,0,0
75684,strategies,0,0
75685,such,0,0
75686,as,0,0
75687,distraction,0,0
75688,and,0,0
75689,cognitive,0,0
75690,restructuring,0,0
75691,",",0,0
75692,or,0,0
75693,(,0,0
75694,c,0,0
75695,),0,0
75696,instruction,0,0
75697,in,0,0
75698,acceptance-based,0,0
75699,strategies,0,0
75700,such,0,0
75701,as,0,0
75702,experiential,0,0
75703,acceptance,0,0
75704,and,0,0
75705,defusion,0,0
75706,techniques,0,0
75707,.,0,1
75708,Measures,0,0
75709,included,0,1
75710,the,0,0
75711,Power,0,0
75712,of,0,0
75713,Food,0,0
75714,Scale,0,0
75715,(,0,0
75716,PFS,0,0
75717,;,0,0
75718,a,0,0
75719,measure,0,0
75720,of,0,0
75721,psychological,0,0
75722,sensitivity,0,0
75723,to,0,0
75724,the,0,0
75725,food,0,0
75726,environment,0,0
75727,),0,0
75728,",",0,0
75729,self-report,0,0
75730,ratings,0,0
75731,of,0,0
75732,chocolate,0,1
75733,cravings,0,0
75734,and,0,0
75735,surreptitiously,0,1
75736,recorded,0,0
75737,chocolate,0,0
75738,consumption,0,0
75739,.,0,0
75740,Results,0,0
75741,suggested,0,0
75742,that,0,0
75743,the,0,0
75744,effect,0,0
75745,of,0,0
75746,the,0,0
75747,intervention,0,0
75748,depended,0,0
75749,on,0,0
75750,baseline,0,0
75751,PFS,0,0
75752,levels,0,0
75753,",",0,0
75754,such,0,0
75755,that,0,0
75756,acceptance-based,0,0
75757,strategies,0,0
75758,were,0,0
75759,associated,0,0
75760,with,0,1
75761,better,0,0
75762,outcomes,0,0
75763,(,0,0
75764,cravings,0,0
75765,",",0,0
75766,consumption,0,0
75767,),0,0
75768,among,0,0
75769,those,0,0
75770,reporting,0,0
75771,the,0,0
75772,highest,0,0
75773,susceptibility,0,0
75774,to,0,0
75775,the,0,0
75776,presence,0,0
75777,of,0,0
75778,food,0,0
75779,",",0,0
75780,but,0,0
75781,greater,0,0
75782,cravings,0,0
75783,among,0,1
75784,those,0,1
75785,who,0,1
75786,scored,0,0
75787,lowest,0,1
75788,on,0,0
75789,the,0,0
75790,PFS,0,0
75791,.,0,0
75792,It,0,0
75793,was,0,0
75794,observed,0,0
75795,that,0,0
75796,craving,0,0
75797,self-report,0,0
75798,measures,0,0
75799,predicted,0,0
75800,chocolate,0,0
75801,consumption,0,0
75802,",",0,0
75803,and,0,0
75804,baseline,0,0
75805,PFS,0,0
75806,levels,0,0
75807,predicted,0,0
75808,both,0,0
75809,cravings,0,0
75810,and,0,0
75811,consumption,0,0
75812,.,0,0
75813,Results,0,0
75814,are,0,0
75815,discussed,0,0
75816,in,0,0
75817,terms,0,0
75818,of,0,0
75819,the,0,0
75820,implications,0,0
75821,for,0,0
75822,weight,0,0
75823,loss,0,0
75824,maintenance,0,0
75825,strategies,0,0
75826,.,0,1
75827,A,0,0
75828,randomized,0,0
75829,placebo-controlled,0,0
75830,trial,0,0
75831,comparing,0,0
75832,the,0,0
75833,efficacy,0,0
75834,of,0,0
75835,etoricoxib,0,0
75836,30,0,0
75837,mg,0,0
75838,and,0,0
75839,ibuprofen,0,0
75840,2400,0,0
75841,mg,0,0
75842,for,0,0
75843,the,0,0
75844,treatment,0,0
75845,of,0,0
75846,patients,1,1
75847,with,1,1
75848,osteoarthritis,1,1
75849,.,1,0
75850,OBJECTIVE,0,0
75851,We,0,0
75852,compared,0,0
75853,the,0,0
75854,efficacy,0,0
75855,of,0,0
75856,etoricoxib,0,0
75857,30,0,0
75858,mg,0,0
75859,to,0,0
75860,placebo,0,0
75861,and,0,0
75862,ibuprofen,0,0
75863,2400,0,0
75864,mg,0,0
75865,for,0,0
75866,the,0,0
75867,treatment,0,0
75868,of,0,0
75869,osteoarthritis,1,1
75870,(,1,0
75871,OA,1,0
75872,),1,0
75873,of,1,0
75874,the,1,0
75875,hip,1,0
75876,and,1,0
75877,knee,1,1
75878,.,1,0
75879,DESIGN,0,0
75880,In,0,0
75881,this,0,0
75882,12-week,0,0
75883,",",0,0
75884,randomized,0,0
75885,",",0,0
75886,double-blind,0,0
75887,",",0,0
75888,placebo-,0,0
75889,and,0,0
75890,active-comparator-controlled,0,0
75891,trial,0,0
75892,",",0,0
75893,548,1,1
75894,patients,1,1
75895,(,1,0
75896,median,1,0
75897,age,1,1
75898,63,1,1
75899,years,1,1
75900,),1,0
75901,with,1,1
75902,OA,1,0
75903,of,1,0
75904,the,1,0
75905,hip,1,0
75906,or,1,0
75907,knee,1,1
75908,were,1,0
75909,randomized,1,0
75910,to,0,0
75911,receive,0,0
75912,placebo,0,0
75913,",",0,0
75914,etoricoxib,0,0
75915,30,0,0
75916,mg,0,0
75917,q.d.,0,0
75918,",",0,0
75919,or,0,0
75920,ibuprofen,0,0
75921,800,0,0
75922,mg,0,0
75923,t.i.d,0,0
75924,.,0,0
75925,Demonstration,0,0
75926,of,0,0
75927,etoricoxib,0,0
75928,'s,0,0
75929,efficacy,0,0
75930,vs,0,0
75931,placebo,0,0
75932,and,0,0
75933,comparison,0,0
75934,of,0,0
75935,its,0,0
75936,efficacy,0,0
75937,to,0,0
75938,ibuprofen,0,0
75939,were,0,0
75940,assessed,0,0
75941,using,0,0
75942,three,0,0
75943,co-primary,0,0
75944,endpoints,0,0
75945,:,0,1
75946,Western,0,1
75947,Ontario,0,1
75948,and,0,0
75949,McMaster,0,0
75950,'s,0,1
75951,University,0,1
75952,Osteoarthritis,0,1
75953,Index,0,0
75954,(,0,0
75955,WOMAC,0,0
75956,),0,0
75957,Pain,0,0
75958,Subscale,0,0
75959,(,0,0
75960,WOMAC-PS,0,0
75961,),0,0
75962,;,0,0
75963,WOMAC,0,0
75964,Physical,0,0
75965,Function,0,0
75966,Subscale,0,0
75967,(,0,0
75968,WOMAC-PFS,0,0
75969,),0,0
75970,;,0,0
75971,and,0,0
75972,Patient,0,0
75973,Global,0,0
75974,Assessment,0,0
75975,of,0,0
75976,Disease,0,1
75977,Status,0,0
75978,(,0,0
75979,PGADS,0,1
75980,),0,0
75981,.,0,0
75982,Each,0,0
75983,primary,0,0
75984,endpoint,0,0
75985,utilizes,0,0
75986,a,0,0
75987,0-100,0,0
75988,mm,0,0
75989,visual,0,0
75990,analog,0,0
75991,scale,0,0
75992,.,0,0
75993,To,0,0
75994,demonstrate,0,0
75995,comparable,0,0
75996,efficacy,0,0
75997,of,0,0
75998,etoricoxib,0,0
75999,vs,0,0
76000,ibuprofen,0,0
76001,",",0,0
76002,the,0,0
76003,95,0,0
76004,%,0,0
76005,confidence,0,0
76006,intervals,0,0
76007,(,0,0
76008,CIs,0,0
76009,),0,0
76010,for,0,0
76011,the,0,0
76012,difference,0,0
76013,in,0,0
76014,the,0,0
76015,least,0,0
76016,squares,0,0
76017,(,0,0
76018,LS,0,0
76019,),0,0
76020,mean,0,0
76021,change,0,0
76022,over,0,0
76023,12,0,0
76024,weeks,0,0
76025,for,0,0
76026,all,0,0
76027,three,0,0
76028,co-primary,0,0
76029,endpoints,0,0
76030,had,0,0
76031,to,0,0
76032,fall,0,0
76033,within,0,0
76034,+/-10,0,0
76035,mm,0,0
76036,.,0,0
76037,Safety,0,0
76038,and,0,0
76039,tolerability,0,0
76040,data,0,0
76041,were,0,0
76042,collected,0,0
76043,throughout,0,0
76044,the,0,0
76045,study,0,0
76046,.,0,0
76047,RESULTS,0,0
76048,Mean,0,0
76049,baseline,0,0
76050,values,0,0
76051,for,0,0
76052,the,0,0
76053,three,0,0
76054,co-primary,0,0
76055,endpoints,0,0
76056,ranged,0,0
76057,from,0,0
76058,62.52,0,0
76059,to,0,0
76060,70.14,0,0
76061,mm,0,0
76062,.,0,0
76063,Both,0,0
76064,etoricoxib,0,0
76065,and,0,0
76066,ibuprofen,0,0
76067,demonstrated,0,0
76068,superior,0,0
76069,(,0,0
76070,P,0,0
76071,<,0,0
76072,or,0,0
76073,=0.002,0,0
76074,),0,0
76075,efficacy,0,0
76076,for,0,0
76077,all,0,0
76078,primary,0,1
76079,endpoints,0,0
76080,.,0,1
76081,The,0,0
76082,LS,0,0
76083,mean,0,0
76084,(,0,0
76085,mm,0,0
76086,),0,0
76087,changes,0,0
76088,(,0,0
76089,95,0,0
76090,%,0,0
76091,CI,0,0
76092,),0,0
76093,over,0,0
76094,12,0,0
76095,weeks,0,0
76096,for,0,0
76097,etoricoxib,0,0
76098,and,0,0
76099,ibuprofen,0,0
76100,",",0,0
76101,respectively,0,0
76102,",",0,0
76103,compared,0,0
76104,to,0,0
76105,placebo,0,0
76106,were,0,0
76107,given,0,0
76108,as,0,0
76109,follows,0,0
76110,:,0,1
76111,WOMAC-PS,0,0
76112,:,0,1
76113,-11.66,0,0
76114,(,0,0
76115,-16.31,0,0
76116,",",0,0
76117,-7.01,0,0
76118,),0,0
76119,and,0,0
76120,-7.62,0,0
76121,(,0,0
76122,-12.30,0,0
76123,",",0,0
76124,-2.94,0,0
76125,),0,0
76126,;,0,0
76127,WOMAC-PFS,0,0
76128,:,0,1
76129,-10.15,0,0
76130,(,0,0
76131,-14.74,0,0
76132,",",0,0
76133,-5.57,0,0
76134,),0,0
76135,and,0,0
76136,-7.23,0,0
76137,(,0,0
76138,-11.85,0,0
76139,",",0,0
76140,-2.61,0,0
76141,),0,0
76142,;,0,0
76143,PGADS,0,0
76144,:,0,1
76145,-11.65,0,0
76146,(,0,0
76147,-16.81,0,0
76148,",",0,0
76149,-6.50,0,0
76150,),0,0
76151,and,0,0
76152,-8.11,0,0
76153,(,0,0
76154,-13.30,0,0
76155,",",0,0
76156,-2.92,0,0
76157,),0,0
76158,.,0,0
76159,The,0,0
76160,efficacy,0,0
76161,of,0,0
76162,etoricoxib,0,0
76163,30,0,0
76164,mg,0,0
76165,was,0,0
76166,comparable,0,0
76167,to,0,0
76168,ibuprofen,0,0
76169,2400,0,0
76170,mg.,0,0
76171,All,0,1
76172,treatments,0,0
76173,were,0,0
76174,similarly,0,0
76175,well,0,0
76176,tolerated,0,0
76177,.,0,0
76178,CONCLUSION,0,0
76179,Treatment,0,0
76180,with,0,1
76181,etoricoxib,0,0
76182,30,0,0
76183,mg,0,0
76184,q.d,0,0
76185,.,0,0
76186,provides,0,0
76187,superior,0,0
76188,efficacy,0,0
76189,vs,0,0
76190,placebo,0,0
76191,and,0,0
76192,comparable,0,0
76193,clinical,0,0
76194,efficacy,0,0
76195,vs,0,0
76196,ibuprofen,0,0
76197,2400,0,0
76198,mg,0,0
76199,(,0,0
76200,800,0,0
76201,mg,0,0
76202,t.i.d,0,0
76203,.,0,0
76204,),0,0
76205,for,0,0
76206,the,0,0
76207,treatment,0,0
76208,of,0,0
76209,OA,1,0
76210,of,1,0
76211,the,1,0
76212,hip,1,0
76213,and,1,0
76214,knee,1,1
76215,.,1,0
76216,The,0,0
76217,EUROSCAN,1,0
76218,Study,1,0
76219,.,1,0
76220,EUROSCAN,1,0
76221,Steering,1,0
76222,Committee,1,1
76223,.,1,0
76224,[,0,0
76225,Potentials,0,0
76226,of,0,0
76227,monocular,0,1
76228,augmented,0,0
76229,reality,0,0
76230,technology,0,0
76231,in,0,0
76232,automobile,0,1
76233,production,0,0
76234,],0,0
76235,.,0,0
76236,INTRODUCTION,0,0
76237,Augmented,0,0
76238,reality,0,0
76239,(,0,0
76240,AR,0,0
76241,),0,0
76242,technologies,0,0
76243,can,0,0
76244,enrich,0,0
76245,the,0,0
76246,real,0,0
76247,environment,0,0
76248,with,0,1
76249,visual,0,0
76250,data,0,0
76251,",",0,0
76252,which,0,0
76253,has,0,0
76254,potential,0,0
76255,benefits,0,0
76256,for,0,0
76257,optimising,0,0
76258,the,0,0
76259,operator,0,0
76260,'s,0,0
76261,working,0,0
76262,process,0,0
76263,.,0,0
76264,It,0,0
76265,offers,0,0
76266,the,0,0
76267,possibility,0,0
76268,to,0,0
76269,provide,0,0
76270,context-sensitive,0,0
76271,information,0,0
76272,independently,0,0
76273,of,0,0
76274,the,0,0
76275,user,0,0
76276,'s,0,0
76277,location,0,0
76278,and,0,0
76279,position,0,0
76280,.,0,0
76281,Data,0,0
76282,are,0,0
76283,presented,0,0
76284,to,0,0
76285,the,0,0
76286,dominant,0,0
76287,eye,0,0
76288,on,0,0
76289,a,0,0
76290,semi-transparent,0,0
76291,mirror,0,0
76292,using,0,0
76293,a,0,0
76294,head-mounted,0,0
76295,display,0,0
76296,(,0,0
76297,HMD,0,0
76298,),0,0
76299,unit,0,0
76300,that,0,0
76301,works,0,0
76302,with,0,0
76303,retinal,0,0
76304,laser,0,0
76305,technology,0,0
76306,.,0,0
76307,In,0,0
76308,this,0,0
76309,study,0,0
76310,the,0,0
76311,potential,0,0
76312,benefits,0,0
76313,and,0,0
76314,drawbacks,0,0
76315,of,0,0
76316,this,0,0
76317,new,0,0
76318,AR,0,0
76319,technology,0,0
76320,were,0,0
76321,evaluated,0,0
76322,.,0,0
76323,MATERIALS,0,0
76324,AND,0,0
76325,METHODS,0,0
76326,45,1,1
76327,participants,1,1
76328,without,1,1
76329,any,1,0
76330,visual,1,0
76331,impairment,1,0
76332,were,0,0
76333,randomly,0,0
76334,assigned,0,0
76335,to,0,0
76336,3,0,0
76337,groups,0,0
76338,and,0,0
76339,completed,0,1
76340,a,0,0
76341,variety,0,0
76342,of,0,0
76343,tasks,0,0
76344,during,0,0
76345,a,0,0
76346,simulated,0,0
76347,working,0,0
76348,day,0,0
76349,.,0,0
76350,Group,0,0
76351,1,0,0
76352,received,0,0
76353,conventional,0,0
76354,working,0,0
76355,aids,0,1
76356,(,0,1
76357,paper-based,0,0
76358,documents,0,0
76359,),0,0
76360,to,0,0
76361,support,0,0
76362,the,0,0
76363,task,0,0
76364,processing,0,0
76365,.,0,0
76366,Group,0,0
76367,2,0,0
76368,additionally,0,0
76369,wore,0,1
76370,an,0,0
76371,HMD,0,0
76372,unit,0,0
76373,that,0,0
76374,was,0,0
76375,switched,0,0
76376,off,0,0
76377,.,0,0
76378,Group,0,0
76379,3,0,0
76380,wore,0,1
76381,a,0,0
76382,functioning,0,0
76383,HMD,0,0
76384,without,0,0
76385,any,0,0
76386,additional,0,0
76387,aids,0,1
76388,.,0,1
76389,Evaluation,0,0
76390,was,0,0
76391,carried,0,0
76392,out,0,0
76393,by,0,0
76394,means,0,0
76395,of,0,0
76396,a,0,0
76397,standardised,0,0
76398,questionnaire,0,0
76399,(,0,0
76400,BMS,0,0
76401,),0,0
76402,and,0,0
76403,a,0,0
76404,concentration,0,0
76405,test,0,0
76406,(,0,0
76407,d2,0,0
76408,Aufmerksamkeits-Belastungs-Test,0,0
76409,),0,0
76410,.,0,0
76411,RESULTS,0,0
76412,No,0,0
76413,significant,0,0
76414,differences,0,0
76415,between,0,0
76416,the,0,0
76417,3,0,0
76418,groups,0,0
76419,were,0,0
76420,found,0,0
76421,in,0,0
76422,terms,0,0
76423,of,0,0
76424,mental,0,1
76425,strain,0,0
76426,",",0,0
76427,concentration-test,0,0
76428,performance,0,0
76429,and,0,0
76430,physical,0,0
76431,or,0,1
76432,mental,0,1
76433,complaints,0,0
76434,reported,0,0
76435,in,0,0
76436,a,0,0
76437,follow-up,0,0
76438,interview,0,0
76439,.,0,0
76440,Around,0,0
76441,20,0,0
76442,%,0,0
76443,of,0,0
76444,the,0,0
76445,subjects,0,1
76446,noticed,0,0
76447,a,0,0
76448,higher,0,0
76449,pressure,0,0
76450,and,0,0
76451,blurred,0,0
76452,vision,0,0
76453,in,0,0
76454,both,0,0
76455,eyes,0,0
76456,as,0,0
76457,well,0,0
76458,as,0,0
76459,headaches,0,0
76460,.,0,1
76461,Half,0,0
76462,of,0,0
76463,the,0,0
76464,participants,0,1
76465,complained,0,0
76466,about,0,0
76467,deficiencies,0,0
76468,concerning,0,0
76469,the,0,0
76470,ergonomic,0,0
76471,hardware,0,0
76472,design,0,0
76473,of,0,0
76474,the,0,0
76475,AR,0,0
76476,system,0,0
76477,.,0,0
76478,DISCUSSION,0,0
76479,Changes,0,0
76480,in,0,0
76481,objective,0,0
76482,ophthalmological,0,1
76483,investigation,0,0
76484,parameters,0,0
76485,were,0,0
76486,not,0,0
76487,observed,0,0
76488,.,0,0
76489,Subjects,0,0
76490,reported,0,0
76491,reduced,0,0
76492,acceptance,0,0
76493,of,0,0
76494,the,0,0
76495,HMD,0,0
76496,based,0,0
76497,on,0,0
76498,non-ophthalmological,0,1
76499,reasons,0,0
76500,",",0,0
76501,for,0,0
76502,example,0,0
76503,",",0,0
76504,the,0,0
76505,weight,0,0
76506,of,0,0
76507,the,0,0
76508,unit,0,0
76509,or,0,0
76510,the,0,0
76511,length,0,0
76512,of,0,0
76513,the,0,0
76514,cable,0,0
76515,.,0,0
76516,However,0,0
76517,",",0,0
76518,for,0,0
76519,some,0,0
76520,specific,0,0
76521,working,0,0
76522,tasks,0,0
76523,",",0,0
76524,advantages,0,0
76525,in,0,0
76526,process,0,0
76527,optimisation,0,0
76528,and,0,0
76529,operator,0,0
76530,support,0,0
76531,were,0,0
76532,observed,0,0
76533,.,0,0
76534,[,0,0
76535,Effect,0,0
76536,of,0,0
76537,electroacununcture,0,0
76538,on,0,0
76539,sex,0,0
76540,hormone,0,0
76541,levels,0,0
76542,in,0,0
76543,patients,1,1
76544,with,1,1
76545,Sj?gren,1,1
76546,'s,1,1
76547,syndrome,1,1
76548,],1,1
76549,.,1,0
76550,OBJECTIVE,0,0
76551,To,0,0
76552,observe,0,0
76553,the,0,0
76554,effect,0,0
76555,of,0,0
76556,electroacupuncture,0,0
76557,(,0,0
76558,EA,0,0
76559,),0,0
76560,on,0,0
76561,serum,0,0
76562,testosterone,0,0
76563,(,0,0
76564,T,0,0
76565,),0,0
76566,",",0,0
76567,estradiol,0,0
76568,(,0,0
76569,F2,0,0
76570,),0,0
76571,",",0,0
76572,luteotropic,0,0
76573,hormone,0,0
76574,(,0,0
76575,LH,0,0
76576,),0,0
76577,",",0,0
76578,follicle-stimulating,0,0
76579,hormone,0,0
76580,(,0,0
76581,FSH,0,0
76582,),0,0
76583,",",0,0
76584,progesterone,0,0
76585,(,0,0
76586,P,0,0
76587,),0,0
76588,",",0,0
76589,and,0,0
76590,prolactin,0,0
76591,(,0,0
76592,PRL,0,0
76593,),0,0
76594,in,1,0
76595,patients,1,1
76596,with,1,1
76597,Sj?gren,1,1
76598,'s,1,1
76599,Syndrome,1,1
76600,(,1,1
76601,SS,1,0
76602,),1,0
76603,in,1,0
76604,order,0,0
76605,to,0,0
76606,analyze,0,0
76607,the,0,0
76608,correlation,0,0
76609,between,0,0
76610,the,0,0
76611,adjustment,0,0
76612,effect,0,0
76613,of,0,0
76614,EA,0,0
76615,and,0,0
76616,changes,0,0
76617,of,0,0
76618,hormone,0,0
76619,levels,0,0
76620,.,0,1
76621,METHODS,1,0
76622,Fifty-seven,1,1
76623,middle-aged,1,1
76624,and,1,0
76625,old,1,1
76626,women,1,1
76627,with,1,1
76628,SS,1,0
76629,were,1,0
76630,divided,0,0
76631,into,0,0
76632,medication,0,0
76633,group,0,0
76634,(,0,0
76635,n=27,0,1
76636,),0,0
76637,and,0,0
76638,acupuncture,0,0
76639,group,0,0
76640,(,0,0
76641,n=30,0,1
76642,),0,0
76643,.,0,0
76644,Patients,0,1
76645,in,0,0
76646,acupuncture,0,0
76647,group,0,0
76648,were,0,0
76649,treated,0,0
76650,with,0,1
76651,EA,0,0
76652,(,0,0
76653,80,0,0
76654,Hz,0,0
76655,",",0,0
76656,2.5,0,0
76657,mA,0,0
76658,),0,0
76659,of,0,0
76660,Shenshu,0,0
76661,(,0,0
76662,BL,0,0
76663,23,0,1
76664,),0,0
76665,",",0,0
76666,Taixi,0,0
76667,(,0,0
76668,KI,0,0
76669,3,0,0
76670,),0,0
76671,",",0,0
76672,Hegu,0,0
76673,(,0,0
76674,LI,0,0
76675,4,0,0
76676,),0,0
76677,",",0,0
76678,etc,0,0
76679,.,0,0
76680,for,0,0
76681,30,0,0
76682,min,0,0
76683,",",0,0
76684,once,0,0
76685,every,0,0
76686,other,0,0
76687,day,0,0
76688,",",0,0
76689,and,0,0
76690,those,0,0
76691,of,0,0
76692,medication,0,0
76693,group,0,0
76694,were,0,0
76695,treated,0,0
76696,with,0,1
76697,oral,0,0
76698,administration,0,0
76699,of,0,0
76700,hydroxyl-chloroquine,0,0
76701,(,0,0
76702,6,0,0
76703,mg/kg,0,0
76704,per,0,0
76705,day,0,0
76706,),0,0
76707,",",0,0
76708,oral,0,0
76709,transfer,0,0
76710,agent,0,0
76711,liquid,0,0
76712,",",0,0
76713,Vit,0,0
76714,B1,0,0
76715,",",0,0
76716,Vit,0,0
76717,B2,0,0
76718,",",0,0
76719,Vit,0,0
76720,C,0,0
76721,",",0,0
76722,fish-liver,0,0
76723,oil,0,0
76724,",",0,0
76725,one,0,0
76726,tablet/time,0,0
76727,",",0,0
76728,t.i.d.,0,0
76729,",",0,0
76730,and,0,0
76731,pilocarpine,0,0
76732,(,0,0
76733,20,0,0
76734,mg/d,0,0
76735,),0,0
76736,",",0,0
76737,continuously,0,0
76738,for,0,0
76739,2,0,0
76740,months,0,0
76741,.,0,1
76742,Venous,0,0
76743,blood,0,0
76744,samples,0,0
76745,were,0,0
76746,collected,0,0
76747,before,0,0
76748,and,0,0
76749,after,0,0
76750,the,0,0
76751,treatment,0,0
76752,to,0,0
76753,examine,0,0
76754,contents,0,0
76755,of,0,0
76756,the,0,0
76757,abovementioned,0,0
76758,sex,0,0
76759,hormones,0,0
76760,by,0,0
76761,using,0,0
76762,electro-chemiluminescent,0,0
76763,immunoassay,0,1
76764,(,0,0
76765,CLIA,0,0
76766,),0,0
76767,.,0,0
76768,RESULTS,0,0
76769,(,0,0
76770,1,0,0
76771,),0,0
76772,Before,0,0
76773,the,0,0
76774,treatment,0,0
76775,",",0,0
76776,no,0,0
76777,significant,0,0
76778,differences,0,0
76779,were,0,0
76780,found,0,0
76781,between,0,0
76782,two,0,0
76783,groups,0,0
76784,in,0,0
76785,the,0,0
76786,levels,0,0
76787,of,0,0
76788,serum,0,0
76789,T,0,0
76790,",",0,0
76791,E2,0,0
76792,",",0,0
76793,LH,0,0
76794,",",0,0
76795,FSH,0,0
76796,",",0,0
76797,P,0,0
76798,and,0,0
76799,PRL,0,0
76800,(,0,0
76801,P,0,0
76802,>,0,1
76803,0.05,0,0
76804,),0,0
76805,.,0,0
76806,After,0,0
76807,the,0,0
76808,treatment,0,0
76809,",",0,0
76810,self-comparison,0,0
76811,of,0,0
76812,each,0,0
76813,group,0,0
76814,showed,0,0
76815,that,0,0
76816,serum,0,0
76817,EF,0,1
76818,and,0,0
76819,T,0,0
76820,contents,0,0
76821,in,0,0
76822,acupuncture,0,0
76823,group,0,0
76824,increased,0,0
76825,significantly,0,0
76826,(,0,0
76827,P,0,0
76828,<,0,0
76829,0.01,0,0
76830,),0,0
76831,and,0,0
76832,serum,0,0
76833,LH,0,1
76834,content,0,0
76835,decreased,0,0
76836,significantly,0,0
76837,(,0,0
76838,P,0,0
76839,<,0,0
76840,0.01,0,0
76841,),0,0
76842,;,0,0
76843,while,0,0
76844,in,0,0
76845,medication,0,0
76846,group,0,0
76847,",",0,0
76848,only,0,0
76849,serum,0,0
76850,LH,0,0
76851,decreased,0,0
76852,markedly,0,0
76853,(,0,0
76854,P,0,0
76855,<,0,0
76856,0.05,0,0
76857,),0,0
76858,in,0,0
76859,comparison,0,0
76860,with,0,1
76861,its,0,0
76862,basic,0,0
76863,value,0,0
76864,of,0,0
76865,pretreatment,0,0
76866,.,0,0
76867,No,0,0
76868,significant,0,0
76869,changes,0,0
76870,were,0,0
76871,found,0,0
76872,in,0,0
76873,serum,0,0
76874,P,0,0
76875,",",0,0
76876,FSH,0,0
76877,and,0,0
76878,PRL,0,0
76879,levels,0,0
76880,in,0,0
76881,both,0,0
76882,groups,0,0
76883,after,0,0
76884,the,0,0
76885,treatment,0,0
76886,(,0,0
76887,P,0,0
76888,>,0,1
76889,0.05,0,0
76890,),0,0
76891,.,0,0
76892,The,0,0
76893,results,0,0
76894,suggested,0,0
76895,that,0,0
76896,the,0,0
76897,therapeutic,0,0
76898,effect,0,0
76899,of,0,0
76900,acupuncture,0,0
76901,group,0,0
76902,was,0,0
76903,better,0,0
76904,than,0,0
76905,that,0,0
76906,of,0,0
76907,medication,0,0
76908,group,0,0
76909,in,0,0
76910,regulating,0,0
76911,multiple,0,0
76912,sex,0,1
76913,hormones,0,0
76914,.,0,1
76915,CONCLUSION,0,0
76916,EA,0,0
76917,can,0,0
76918,effectively,0,0
76919,adjust,0,0
76920,E2,0,0
76921,",",0,0
76922,T,0,0
76923,and,0,0
76924,LH,0,1
76925,levels,0,0
76926,in,0,0
76927,Sj?gren,1,1
76928,'s,1,1
76929,Syndrome,1,1
76930,patients,1,1
76931,and,1,0
76932,improve,0,0
76933,most,0,0
76934,patients,0,1
76935,',0,1
76936,clinical,0,0
76937,symptoms,0,0
76938,",",0,0
76939,and,0,0
76940,the,0,0
76941,therapeutic,0,0
76942,effect,0,0
76943,of,0,0
76944,EA,0,0
76945,is,0,0
76946,better,0,0
76947,than,0,0
76948,that,0,0
76949,of,0,0
76950,medication,0,0
76951,.,0,0
76952,Should,0,0
76953,snacks,0,0
76954,be,0,0
76955,recommended,0,0
76956,in,0,0
76957,obesity,1,1
76958,treatment,1,0
76959,?,0,0
76960,A,0,0
76961,1-year,0,0
76962,randomized,0,0
76963,clinical,0,0
76964,trial,0,0
76965,.,0,0
76966,OBJECTIVE,0,0
76967,To,0,0
76968,study,0,0
76969,the,0,0
76970,effect,0,0
76971,to,0,0
76972,recommend,0,0
76973,no,0,0
76974,snacks,0,0
76975,vs,0,0
76976,three,0,0
76977,snacks,0,0
76978,per,0,0
76979,day,0,0
76980,on,0,0
76981,1-year,0,0
76982,weight,0,0
76983,loss,0,0
76984,.,0,0
76985,The,0,0
76986,hypothesis,0,0
76987,was,0,0
76988,that,0,0
76989,it,0,0
76990,is,0,0
76991,easier,0,0
76992,to,0,0
76993,control,0,0
76994,energy,0,0
76995,intake,0,0
76996,and,0,0
76997,lose,0,0
76998,weight,0,0
76999,if,0,0
77000,snacks,0,0
77001,in,0,0
77002,between,0,0
77003,meals,0,0
77004,are,0,0
77005,omitted,0,0
77006,.,0,0
77007,SUBJECTS/METHOD,0,0
77008,In,0,0
77009,total,0,1
77010,140,1,1
77011,patients,1,1
77012,(,1,1
77013,36,1,1
77014,men,1,1
77015,",",1,0
77016,104,1,1
77017,women,1,1
77018,),1,0
77019,",",1,0
77020,aged,1,1
77021,18-60,1,1
77022,years,1,1
77023,and,1,0
77024,body,1,0
77025,mass,1,0
77026,index,1,0
77027,>,1,0
77028,30,1,0
77029,kg/m,1,1
77030,(,1,0
77031,2,1,0
77032,),1,0
77033,were,1,0
77034,randomized,1,0
77035,and,1,0
77036,93,1,1
77037,patients,1,1
77038,(,1,1
77039,27,1,1
77040,men,1,1
77041,",",1,0
77042,66,1,1
77043,women,1,1
77044,),1,0
77045,completed,1,1
77046,the,1,0
77047,study,1,0
77048,.,1,0
77049,A,0,0
77050,1-year,0,0
77051,randomized,0,0
77052,intervention,0,0
77053,trial,0,0
77054,was,0,0
77055,conducted,0,0
77056,with,0,1
77057,two,0,0
77058,treatment,0,0
77059,arms,0,0
77060,with,0,1
77061,different,0,0
77062,eating,0,0
77063,frequencies,0,0
77064,;,0,0
77065,3,0,0
77066,meals/day,0,0
77067,(,0,0
77068,3M,0,0
77069,),0,0
77070,or,0,1
77071,3,0,0
77072,meals,0,0
77073,and,0,0
77074,3,0,0
77075,snacks/day,0,0
77076,(,0,0
77077,3+3M,0,1
77078,),0,0
77079,.,0,0
77080,The,0,0
77081,patients,0,1
77082,received,0,0
77083,regular,0,0
77084,and,0,0
77085,individualized,0,0
77086,counseling,0,0
77087,by,0,0
77088,dieticians,0,1
77089,.,0,0
77090,Information,0,0
77091,on,0,0
77092,eating,0,0
77093,patterns,0,0
77094,",",0,0
77095,dietary,0,0
77096,intake,0,0
77097,",",0,0
77098,weight,0,0
77099,and,0,0
77100,metabolic,0,0
77101,variables,0,0
77102,was,0,0
77103,collected,0,0
77104,at,0,0
77105,baseline,0,0
77106,and,0,0
77107,after,0,0
77108,1,0,0
77109,year,0,1
77110,.,0,0
77111,RESULTS,0,0
77112,Over,0,0
77113,1,0,0
77114,year,0,0
77115,the,0,0
77116,3M,0,0
77117,group,0,0
77118,reported,0,0
77119,a,0,0
77120,decrease,0,0
77121,in,0,0
77122,the,0,0
77123,number,0,0
77124,of,0,0
77125,snacks,0,0
77126,whereas,0,0
77127,the,0,0
77128,3+3M,0,0
77129,group,0,0
77130,reported,0,0
77131,an,0,0
77132,increase,0,0
77133,(,0,0
77134,-1.1,0,0
77135,vs,0,0
77136,+0.4,0,0
77137,snacks/day,0,0
77138,",",0,0
77139,respectively,0,0
77140,",",0,0
77141,P,0,0
77142,<,0,0
77143,0.0001,0,0
77144,),0,0
77145,.,0,0
77146,Both,0,0
77147,groups,0,0
77148,decreased,0,0
77149,energy,0,0
77150,intake,0,0
77151,and,0,0
77152,E,0,0
77153,%,0,0
77154,(,0,0
77155,energy,0,0
77156,percent,0,0
77157,),0,0
77158,fat,0,0
77159,and,0,0
77160,increased,0,0
77161,E,0,0
77162,%,0,0
77163,protein,0,0
77164,and,0,0
77165,fiber,0,0
77166,intake,0,0
77167,but,0,0
77168,there,0,0
77169,was,0,0
77170,no,0,0
77171,differences,0,0
77172,between,0,0
77173,the,0,0
77174,groups,0,0
77175,.,0,0
77176,Both,0,0
77177,groups,0,0
77178,lost,0,0
77179,weight,0,0
77180,",",0,0
77181,but,0,0
77182,there,0,0
77183,was,0,0
77184,no,0,0
77185,significant,0,0
77186,difference,0,0
77187,in,0,0
77188,weight,0,0
77189,loss,0,0
77190,after,0,0
77191,1,0,0
77192,year,0,0
77193,of,0,0
77194,treatment,0,0
77195,(,0,0
77196,3M,0,0
77197,vs,0,0
77198,3+3M=-4.1+/-6.1,0,0
77199,vs,0,0
77200,-5.9+/-9.4,0,0
77201,kg,0,1
77202,;,0,0
77203,P=0.31,0,0
77204,),0,0
77205,.,0,0
77206,Changes,0,0
77207,in,0,0
77208,metabolic,0,1
77209,variables,0,0
77210,did,0,0
77211,not,0,0
77212,differ,0,0
77213,between,0,0
77214,the,0,0
77215,groups,0,0
77216,",",0,0
77217,except,0,0
77218,for,0,0
77219,high-density,0,0
77220,lipoprotein,0,0
77221,that,0,0
77222,increased,0,0
77223,in,0,0
77224,the,0,0
77225,3M,0,0
77226,group,0,0
77227,but,0,0
77228,not,0,0
77229,in,0,0
77230,3+3M,0,0
77231,group,0,0
77232,(,0,0
77233,P,0,0
77234,<,0,0
77235,0.033,0,0
77236,for,0,0
77237,group,0,0
77238,difference,0,0
77239,),0,0
77240,.,0,0
77241,CONCLUSION,0,0
77242,Recommending,0,0
77243,snacks,0,0
77244,or,0,0
77245,not,0,0
77246,between,0,0
77247,meals,0,0
77248,does,0,0
77249,not,0,0
77250,influence,0,0
77251,1-year,0,0
77252,weight,0,0
77253,loss,0,0
77254,.,0,0
77255,Anti-inflammatory,0,0
77256,effects,0,0
77257,of,0,0
77258,inhaled,0,0
77259,carbon,0,0
77260,monoxide,0,0
77261,in,0,0
77262,patients,1,1
77263,with,1,1
77264,COPD,1,0
77265,:,1,1
77266,a,0,0
77267,pilot,0,0
77268,study,0,0
77269,.,0,0
77270,In,0,0
77271,vitro,0,0
77272,and,0,0
77273,in,0,0
77274,vivo,0,0
77275,studies,0,0
77276,have,0,0
77277,shown,0,0
77278,that,0,0
77279,carbon,0,0
77280,monoxide,0,0
77281,(,0,0
77282,CO,0,0
77283,),0,0
77284,has,0,0
77285,both,0,0
77286,anti-inflammatory,0,0
77287,and,0,0
77288,anti-oxidant,0,0
77289,capacities,0,1
77290,.,0,1
77291,Since,0,0
77292,chronic,0,1
77293,obstructive,0,1
77294,pulmonary,0,1
77295,disease,0,1
77296,(,0,0
77297,COPD,0,0
77298,),0,0
77299,is,0,0
77300,characterised,0,0
77301,by,0,0
77302,inflammation,0,0
77303,and,0,0
77304,oxidative,0,0
77305,stress,0,0
77306,",",0,0
77307,low-dose,0,0
77308,CO,0,0
77309,could,0,0
77310,be,0,0
77311,of,0,0
77312,therapeutic,0,0
77313,use,0,0
77314,.,0,0
77315,The,0,0
77316,aim,0,0
77317,of,0,0
77318,the,0,0
77319,present,0,0
77320,study,0,0
77321,was,0,0
77322,to,0,0
77323,investigate,0,0
77324,the,0,0
77325,feasibility,0,0
77326,and,0,0
77327,anti-inflammatory,0,0
77328,effects,0,0
77329,of,0,0
77330,100-125,0,1
77331,ppm,0,0
77332,CO,0,0
77333,inhalation,0,0
77334,in,0,0
77335,patients,1,1
77336,with,1,1
77337,stable,1,1
77338,COPD,1,0
77339,.,1,0
77340,In,0,0
77341,total,0,0
77342,",",0,0
77343,20,1,1
77344,ex-smoking,1,1
77345,COPD,1,0
77346,patients,1,1
77347,with,1,1
77348,post-bronchodilator,1,0
77349,forced,1,0
77350,expiratory,1,0
77351,volume,1,0
77352,in,1,0
77353,one,1,0
77354,second,1,0
77355,(,1,0
77356,FEV,1,0
77357,(,1,0
77358,1,1,0
77359,),1,0
77360,),1,0
77361,>,1,1
77362,1.20,1,0
77363,L,1,0
77364,and,1,0
77365,FEV,1,0
77366,(,1,0
77367,1,1,0
77368,),1,0
77369,/forced,1,0
77370,vital,1,0
77371,capacity,1,0
77372,<,1,0
77373,70,1,0
77374,%,1,0
77375,were,0,0
77376,enrolled,0,1
77377,in,0,0
77378,a,0,0
77379,randomised,0,0
77380,",",0,0
77381,placebo-controlled,0,0
77382,",",0,0
77383,crossover,0,0
77384,study,0,0
77385,.,0,0
77386,Effects,0,0
77387,on,0,0
77388,inflammation,0,0
77389,were,0,0
77390,measured,0,0
77391,in,0,0
77392,induced,0,0
77393,sputum,0,0
77394,and,0,0
77395,blood,0,0
77396,.,0,0
77397,CO,0,0
77398,inhalation,0,0
77399,was,0,0
77400,feasible,0,0
77401,and,0,0
77402,patients,0,1
77403,',0,1
77404,vital,0,0
77405,signs,0,0
77406,were,0,1
77407,unaffected,0,0
77408,;,0,0
77409,2,0,0
77410,h.day,0,0
77411,(,0,0
77412,-1,0,0
77413,),0,0
77414,inhalation,0,0
77415,of,0,0
77416,low-dose,0,0
77417,CO,0,0
77418,on,0,0
77419,4,0,0
77420,consecutive,0,1
77421,days,0,0
77422,led,0,0
77423,to,0,0
77424,a,0,0
77425,maximal,0,0
77426,individual,0,0
77427,carboxyhaemoglobin,0,0
77428,level,0,0
77429,of,0,0
77430,4.5,0,0
77431,%,0,0
77432,.,0,1
77433,Two,0,0
77434,exacerbations,0,0
77435,occurred,0,0
77436,in,0,0
77437,the,0,0
77438,CO,0,0
77439,period,0,0
77440,.,0,0
77441,CO,0,0
77442,inhalation,0,0
77443,led,0,0
77444,to,0,0
77445,trends,0,0
77446,in,0,0
77447,reduced,0,0
77448,sputum,0,1
77449,eosinophils,0,0
77450,(,0,0
77451,median,0,0
77452,reduction,0,0
77453,0.25,0,0
77454,%,0,0
77455,point,0,0
77456,),0,0
77457,and,0,0
77458,improved,0,0
77459,responsiveness,0,0
77460,to,0,0
77461,methacholine,0,0
77462,(,0,0
77463,median,0,0
77464,provocative,0,0
77465,concentration,0,0
77466,causing,0,0
77467,a,0,0
77468,20,0,0
77469,%,0,0
77470,fall,0,0
77471,in,0,0
77472,FEV,0,0
77473,(,0,0
77474,1,0,0
77475,),0,0
77476,0.85,0,0
77477,versus,0,0
77478,0.63,0,0
77479,mg.mL,0,0
77480,(,0,0
77481,-1,0,0
77482,),0,0
77483,),0,0
77484,.,0,0
77485,Inhalation,0,0
77486,of,0,0
77487,100-125,0,1
77488,ppm,0,0
77489,carbon,0,0
77490,monoxide,0,0
77491,by,0,0
77492,patients,1,1
77493,with,1,1
77494,chronic,1,1
77495,obstructive,1,1
77496,pulmonary,1,1
77497,disease,1,1
77498,in,1,0
77499,a,1,0
77500,stable,1,1
77501,phase,1,0
77502,was,0,0
77503,feasible,0,0
77504,and,0,0
77505,led,0,0
77506,to,0,0
77507,trends,0,0
77508,in,0,0
77509,reduction,0,0
77510,of,0,0
77511,sputum,0,0
77512,eosinophils,0,0
77513,and,0,0
77514,improvement,0,0
77515,of,0,0
77516,responsiveness,0,0
77517,to,0,0
77518,methacholine,0,0
77519,.,0,0
77520,Further,0,0
77521,studies,0,0
77522,need,0,0
77523,to,0,0
77524,confirm,0,0
77525,the,0,0
77526,safety,0,0
77527,and,0,0
77528,efficacy,0,0
77529,in,0,0
77530,inflammatory,1,0
77531,lung,1,1
77532,diseases,1,1
77533,.,1,1
77534,Clinical,0,0
77535,application,0,0
77536,of,0,0
77537,C-reactive,0,0
77538,protein,0,0
77539,across,0,0
77540,the,1,0
77541,spectrum,1,1
77542,of,1,0
77543,acute,1,1
77544,coronary,1,1
77545,syndromes,1,1
77546,.,1,1
77547,BACKGROUND,0,0
77548,High-sensitivity,0,0
77549,C-reactive,0,0
77550,protein,0,0
77551,(,0,0
77552,hsCRP,0,0
77553,),0,0
77554,is,0,0
77555,associated,0,0
77556,with,0,0
77557,adverse,0,0
77558,cardiovascular,0,1
77559,outcomes,0,0
77560,in,0,0
77561,acute,1,1
77562,coronary,1,1
77563,syndromes,1,1
77564,(,1,0
77565,ACS,1,0
77566,),1,0
77567,.,1,0
77568,The,0,0
77569,ability,0,0
77570,to,0,0
77571,formulate,0,0
77572,recommendations,0,0
77573,regarding,0,0
77574,clinical,0,0
77575,use,0,0
77576,of,0,0
77577,hsCRP,0,0
77578,is,0,0
77579,limited,0,0
77580,by,0,0
77581,a,0,0
77582,paucity,0,0
77583,of,0,0
77584,data,0,0
77585,regarding,0,0
77586,several,0,0
77587,key,0,0
77588,issues,0,0
77589,.,0,0
77590,The,0,0
77591,purpose,0,0
77592,of,0,0
77593,this,0,0
77594,study,0,0
77595,was,0,0
77596,to,0,0
77597,evaluate,0,0
77598,hsCRP,0,0
77599,across,0,0
77600,the,0,0
77601,spectrum,0,1
77602,of,0,0
77603,ACS,0,0
77604,.,0,0
77605,METHODS,0,0
77606,hsCRP,0,0
77607,was,0,0
77608,measured,0,0
77609,on,0,0
77610,admission,0,0
77611,in,0,0
77612,3225,1,1
77613,patients,1,1
77614,with,1,1
77615,ACS,1,0
77616,.,1,0
77617,hsCRP,0,0
77618,concentrations,0,0
77619,were,0,0
77620,compared,0,0
77621,in,0,1
77622,patients,0,1
77623,who,0,1
77624,suffered,0,1
77625,an,0,1
77626,adverse,0,0
77627,cardiac,0,0
77628,outcome,0,0
77629,within,0,0
77630,10,0,0
77631,months,0,0
77632,of,0,0
77633,study,0,0
77634,entry,0,0
77635,and,0,0
77636,in,0,1
77637,patients,0,1
77638,who,0,1
77639,had,0,1
77640,no,0,1
77641,adverse,0,0
77642,event,0,0
77643,.,0,0
77644,Because,0,0
77645,of,0,0
77646,heterogeneity,0,0
77647,in,0,0
77648,the,0,0
77649,relationship,0,0
77650,between,0,0
77651,hsCRP,0,0
77652,and,0,0
77653,clinical,0,0
77654,outcomes,0,0
77655,",",0,0
77656,evaluation,0,0
77657,was,0,0
77658,limited,0,0
77659,to,0,0
77660,patients,0,1
77661,from,0,1
77662,whom,0,1
77663,samples,0,1
77664,were,0,1
77665,collected,0,0
77666,within,0,0
77667,48,0,0
77668,h,0,0
77669,of,0,0
77670,symptom,0,0
77671,onset,0,1
77672,.,0,1
77673,RESULTS,0,0
77674,Patients,0,1
77675,in,0,1
77676,the,0,0
77677,highest,0,0
77678,quartile,0,0
77679,of,0,0
77680,hsCRP,0,0
77681,compared,0,0
77682,to,0,0
77683,those,0,0
77684,in,0,0
77685,the,0,0
77686,lowest,0,0
77687,quartile,0,0
77688,were,0,0
77689,at,0,0
77690,increased,0,0
77691,risk,0,0
77692,of,0,0
77693,death,0,0
77694,at,0,0
77695,30,0,0
77696,days,0,0
77697,[,0,0
77698,adjusted,0,0
77699,hazard,0,0
77700,ratio,0,0
77701,(,0,0
77702,adjHR,0,0
77703,),0,0
77704,4.6,0,0
77705,",",0,0
77706,P,0,0
77707,<,0,0
77708,0.001,0,0
77709,],0,0
77710,and,0,0
77711,10,0,0
77712,months,0,0
77713,(,0,0
77714,adjHR,0,0
77715,3.9,0,0
77716,",",0,0
77717,P,0,0
77718,<,0,0
77719,0.001,0,0
77720,),0,0
77721,.,0,0
77722,In,0,0
77723,patients,0,1
77724,with,0,1
77725,unstable,0,1
77726,angina/non-ST-elevation,0,1
77727,myocardial,0,1
77728,infarction,0,1
77729,(,0,0
77730,STEMI,0,0
77731,),0,0
77732,",",0,0
77733,hsCRP,0,0
77734,>,0,1
77735,3,0,0
77736,mg/L,0,0
77737,was,0,0
77738,associated,0,0
77739,with,0,1
77740,increased,0,0
77741,10-month,0,1
77742,mortality,0,0
77743,(,0,0
77744,adjHR,0,0
77745,2.3,0,0
77746,",",0,0
77747,P,0,0
77748,=,0,0
77749,0.002,0,0
77750,),0,0
77751,",",0,0
77752,whereas,0,0
77753,in,0,0
77754,STEMI,0,0
77755,a,0,0
77756,relationship,0,0
77757,with,0,0
77758,mortality,0,0
77759,was,0,0
77760,seen,0,0
77761,at,0,0
77762,hsCRP,0,0
77763,>,0,1
77764,10,0,0
77765,mg/L,0,0
77766,(,0,0
77767,adjHR,0,0
77768,3.0,0,0
77769,",",0,0
77770,P,0,0
77771,=,0,0
77772,0.008,0,0
77773,),0,0
77774,.,0,0
77775,Increased,0,0
77776,concentrations,0,0
77777,of,0,0
77778,hsCRP,0,0
77779,were,0,0
77780,strongly,0,0
77781,associated,0,0
77782,with,0,0
77783,the,0,0
77784,development,0,0
77785,of,0,0
77786,heart,0,1
77787,failure,0,1
77788,at,0,0
77789,30,0,0
77790,days,0,0
77791,(,0,0
77792,adjHR,0,0
77793,8.2,0,0
77794,",",0,0
77795,P,0,0
77796,=,0,0
77797,0.001,0,0
77798,),0,0
77799,and,0,0
77800,10,0,0
77801,months,0,0
77802,(,0,0
77803,adjHR,0,0
77804,2.6,0,0
77805,",",0,0
77806,P,0,0
77807,=,0,0
77808,0.014,0,0
77809,),0,0
77810,.,0,0
77811,CONCLUSION,0,0
77812,Increased,0,0
77813,baseline,0,0
77814,concentrations,0,0
77815,of,0,0
77816,hsCRP,0,0
77817,are,0,0
77818,strongly,0,0
77819,associated,0,0
77820,with,0,0
77821,mortality,0,0
77822,and,0,0
77823,heart,0,1
77824,failure,0,1
77825,across,0,0
77826,the,0,0
77827,ACS,0,0
77828,spectrum,0,1
77829,.,0,0
77830,hsCRP,0,0
77831,measurement,0,0
77832,should,0,0
77833,be,0,0
77834,performed,0,0
77835,early,0,0
77836,after,0,0
77837,presentation,0,0
77838,and,0,0
77839,index,0,0
77840,diagnosis-specific,0,0
77841,cutpoints,0,0
77842,should,0,0
77843,be,0,0
77844,used,0,0
77845,.,0,0
77846,[,0,0
77847,Observation,0,0
77848,on,0,0
77849,therapeutic,0,0
77850,effect,0,0
77851,of,0,0
77852,acupuncture,0,0
77853,on,0,0
77854,early,1,0
77855,peripheral,1,0
77856,facial,1,0
77857,paralysis,1,1
77858,],1,0
77859,.,0,0
77860,OBJECTIVE,0,0
77861,To,0,0
77862,observe,0,0
77863,therapeutic,0,0
77864,effects,0,0
77865,of,0,0
77866,acupuncture,0,0
77867,at,0,0
77868,different,0,0
77869,opportunities,0,0
77870,on,0,0
77871,peripheral,1,1
77872,facial,1,0
77873,paralysis,1,1
77874,.,1,0
77875,METHODS,0,0
77876,Fifty-two,1,1
77877,cases,1,0
77878,were,0,0
77879,randomly,0,1
77880,divided,0,0
77881,into,0,0
77882,a,0,0
77883,treatment,0,0
77884,group,0,0
77885,(,0,0
77886,n=28,0,1
77887,),0,0
77888,and,0,0
77889,a,0,0
77890,control,0,0
77891,group,0,0
77892,(,0,0
77893,n=24,0,1
77894,),0,0
77895,.,0,0
77896,The,0,0
77897,treatment,0,0
77898,group,0,0
77899,at,0,0
77900,the,0,0
77901,acute,0,1
77902,stage,0,1
77903,(,0,0
77904,1-10,0,0
77905,days,0,0
77906,),0,0
77907,were,0,0
77908,treated,0,0
77909,with,0,0
77910,acupuncture,0,0
77911,at,0,0
77912,Dicang,0,1
77913,(,0,0
77914,ST,0,1
77915,4,0,0
77916,),0,0
77917,",",0,0
77918,Jiache,0,0
77919,(,0,0
77920,ST,0,1
77921,6,0,0
77922,),0,0
77923,",",0,0
77924,Yangbai,0,0
77925,(,0,0
77926,GB,0,0
77927,14,0,0
77928,),0,0
77929,",",0,0
77930,etc.,0,0
77931,",",0,0
77932,with,0,0
77933,less,0,0
77934,than,0,0
77935,4,0,0
77936,points,0,0
77937,selected,0,1
77938,on,0,0
77939,the,0,0
77940,face,0,0
77941,and,0,0
77942,with,0,0
77943,shallow,0,0
77944,puncture,0,0
77945,",",0,0
77946,and,0,0
77947,10,0,0
77948,days,0,0
77949,later,0,0
77950,electroacupuncture,0,0
77951,were,0,0
77952,added,0,0
77953,at,0,0
77954,acupoints,0,0
77955,selected,0,1
77956,routinely,0,0
77957,;,0,0
77958,the,0,0
77959,control,0,0
77960,group,0,0
77961,were,0,0
77962,treated,0,0
77963,with,0,0
77964,the,0,0
77965,same,0,0
77966,methods,0,0
77967,as,0,0
77968,the,0,0
77969,treatment,0,0
77970,group,0,0
77971,but,0,0
77972,acupuncture,0,0
77973,was,0,0
77974,not,0,0
77975,given,0,0
77976,at,0,0
77977,the,0,0
77978,acute,0,1
77979,stage,0,1
77980,.,0,0
77981,RESULTS,0,0
77982,The,0,0
77983,cured,0,0
77984,rate,0,0
77985,of,0,0
77986,78.6,0,0
77987,%,0,0
77988,in,0,0
77989,the,0,0
77990,treatment,0,0
77991,group,0,0
77992,was,0,0
77993,significantly,0,0
77994,higher,0,0
77995,than,0,0
77996,50.0,0,0
77997,%,0,0
77998,in,0,0
77999,the,0,0
78000,control,0,0
78001,group,0,0
78002,(,0,0
78003,P,0,0
78004,<,0,0
78005,0.05,0,0
78006,),0,0
78007,.,0,0
78008,CONCLUSION,0,0
78009,Early,0,0
78010,acupuncture,0,0
78011,is,0,0
78012,a,0,0
78013,key,0,0
78014,for,0,0
78015,achieving,0,0
78016,the,0,0
78017,best,0,0
78018,therapeutic,0,0
78019,effect,0,0
78020,on,0,0
78021,facial,1,0
78022,paralysis,1,1
78023,.,1,0
78024,Are,0,0
78025,back,0,0
78026,supports,0,0
78027,plus,0,0
78028,education,0,0
78029,more,0,0
78030,effective,0,0
78031,than,0,0
78032,education,0,0
78033,alone,0,0
78034,in,0,0
78035,promoting,0,0
78036,recovery,1,0
78037,from,1,0
78038,low,1,0
78039,back,1,1
78040,pain,1,0
78041,?,0,0
78042,:,0,0
78043,Results,0,0
78044,from,0,0
78045,a,0,0
78046,randomized,0,0
78047,clinical,0,0
78048,trial,0,0
78049,.,0,0
78050,STUDY,0,0
78051,DESIGN,0,0
78052,Randomized,0,0
78053,clinical,0,0
78054,trial,0,0
78055,.,0,0
78056,OBJECTIVES,0,0
78057,To,0,0
78058,evaluate,0,0
78059,the,0,0
78060,effectiveness,0,0
78061,of,0,0
78062,a,0,0
78063,back,0,0
78064,support,0,0
78065,plus,0,0
78066,education,0,0
78067,versus,0,0
78068,education,0,0
78069,alone,0,0
78070,in,0,0
78071,promoting,0,0
78072,recovery,0,0
78073,from,0,0
78074,a,0,0
78075,work-related,1,0
78076,low,1,0
78077,back,1,0
78078,disorder,1,1
78079,(,1,0
78080,WR-LBD,1,0
78081,),1,0
78082,while,0,0
78083,simultaneously,0,0
78084,considering,0,0
78085,personal,0,0
78086,",",0,0
78087,health,0,0
78088,",",0,0
78089,and,0,0
78090,occupational,0,1
78091,factors,0,0
78092,and,0,0
78093,the,0,0
78094,impact,0,0
78095,of,0,0
78096,occupational,0,1
78097,factors,0,0
78098,on,0,0
78099,recovery,0,0
78100,.,0,0
78101,SUMMARY,0,0
78102,OF,0,0
78103,BACKGROUND,0,0
78104,DATA,0,1
78105,No,0,0
78106,randomized,0,0
78107,studies,0,0
78108,of,0,0
78109,active,1,1
78110,industrial,1,1
78111,workers,1,1
78112,with,1,1
78113,low,1,0
78114,back,1,1
78115,disorders,1,1
78116,exist,0,0
78117,regarding,0,0
78118,the,0,0
78119,effectiveness,0,0
78120,of,0,0
78121,back,0,0
78122,supports,0,0
78123,plus,0,0
78124,education,0,0
78125,.,0,0
78126,METHODS,0,0
78127,A,0,0
78128,total,0,1
78129,of,0,0
78130,433,1,1
78131,actively,1,0
78132,employed,1,0
78133,hourly,1,0
78134,union,1,1
78135,workers,1,1
78136,who,1,1
78137,had,1,1
78138,a,1,1
78139,recent,1,0
78140,diagnosis,1,0
78141,of,1,0
78142,a,1,0
78143,WR-LBD,1,0
78144,:,1,1
78145,1,1,0
78146,),1,1
78147,those,1,1
78148,who,1,1
78149,wore,1,1
78150,a,1,1
78151,specially,1,0
78152,designed,1,0
78153,back,1,0
78154,support,1,0
78155,plus,1,0
78156,received,1,0
78157,education,1,0
78158,on,1,0
78159,back,1,1
78160,health,1,1
78161,;,1,0
78162,and,1,0
78163,2,1,0
78164,),1,1
78165,those,1,1
78166,who,1,1
78167,received,1,1
78168,education,1,1
78169,on,1,0
78170,back,1,0
78171,health,1,0
78172,only,1,0
78173,.,1,0
78174,Demographic,0,0
78175,",",0,0
78176,health,0,0
78177,",",0,0
78178,medical,0,0
78179,",",0,0
78180,and,0,0
78181,occupational,0,1
78182,factors,0,0
78183,were,0,0
78184,obtained,0,0
78185,through,0,0
78186,interview,0,0
78187,or,0,0
78188,abstraction,0,0
78189,of,0,0
78190,computer,0,0
78191,files,0,0
78192,;,0,0
78193,individual,0,0
78194,ergonomic,0,0
78195,exposures,0,0
78196,were,0,0
78197,measured,0,0
78198,with,0,0
78199,a,0,0
78200,lumbar,0,0
78201,motion,0,0
78202,monitor,0,0
78203,.,0,0
78204,Outcomes,0,0
78205,evaluated,0,0
78206,over,0,0
78207,a,0,0
78208,12-month,0,0
78209,period,0,0
78210,included,0,1
78211,:,0,1
78212,self-reported,0,0
78213,measures,0,0
78214,of,0,0
78215,back,0,0
78216,pain,0,0
78217,",",0,0
78218,back,0,0
78219,pain,0,0
78220,disability,0,0
78221,level,0,0
78222,",",0,0
78223,physical,0,0
78224,health,0,0
78225,",",0,0
78226,mental,0,0
78227,health,0,0
78228,",",0,0
78229,and,0,0
78230,administrative,0,1
78231,measures,0,0
78232,of,0,0
78233,recurrence,0,0
78234,",",0,0
78235,lost,0,0
78236,work,0,0
78237,time,0,0
78238,",",0,0
78239,and,0,0
78240,medical,0,0
78241,care,0,0
78242,utilization,0,0
78243,.,0,0
78244,RESULTS,0,0
78245,There,0,0
78246,was,0,0
78247,no,0,0
78248,difference,0,0
78249,between,0,0
78250,the,0,0
78251,study,0,0
78252,groups,0,0
78253,with,0,1
78254,respect,0,0
78255,to,0,0
78256,mental,0,0
78257,or,0,0
78258,physical,0,0
78259,health,0,0
78260,",",0,0
78261,low,0,0
78262,back,0,0
78263,pain,0,0
78264,",",0,0
78265,back,0,0
78266,pain,0,0
78267,disability,0,0
78268,",",0,0
78269,neurogenic,0,1
78270,symptoms,0,0
78271,",",0,0
78272,lost,0,0
78273,work,0,0
78274,time,0,0
78275,",",0,0
78276,likelihood,0,0
78277,of,0,0
78278,recurrence,0,0
78279,of,0,0
78280,an,0,0
78281,episode,0,0
78282,of,0,0
78283,a,0,0
78284,back,0,0
78285,disorder,0,1
78286,",",0,0
78287,or,0,0
78288,other,0,0
78289,administrative,0,1
78290,measures,0,0
78291,of,0,0
78292,healthcare,0,0
78293,utilization,0,0
78294,or,0,0
78295,lost,0,0
78296,work,0,0
78297,time,0,0
78298,.,0,0
78299,However,0,0
78300,",",0,0
78301,significant,0,0
78302,decreases,0,0
78303,in,0,0
78304,low,0,0
78305,back,0,0
78306,pain,0,0
78307,",",0,0
78308,low,0,0
78309,back,0,0
78310,pain,0,0
78311,disability,0,0
78312,",",0,0
78313,neurogenic,0,1
78314,symptoms,0,0
78315,",",0,0
78316,and,0,0
78317,an,0,0
78318,increase,0,0
78319,in,0,0
78320,physical,0,0
78321,health,0,1
78322,were,0,0
78323,observed,0,0
78324,over,0,0
78325,the,0,0
78326,12,0,0
78327,months,0,0
78328,of,0,0
78329,observation,0,0
78330,in,0,0
78331,both,0,0
78332,study,0,0
78333,groups,0,0
78334,.,0,0
78335,The,0,0
78336,only,0,0
78337,occupational,0,1
78338,variable,0,0
78339,found,0,0
78340,to,0,0
78341,influence,0,0
78342,was,0,0
78343,plant,0,0
78344,group,0,0
78345,whereby,0,0
78346,service,0,1
78347,parts,0,0
78348,operations,0,1
78349,workers,0,1
78350,in,0,0
78351,the,0,0
78352,back,0,0
78353,support,0,0
78354,plus,0,0
78355,education,0,0
78356,group,0,0
78357,experienced,0,0
78358,a,0,0
78359,lower,0,0
78360,likelihood,0,0
78361,of,0,0
78362,WR-LBD,0,0
78363,recurrence,0,0
78364,.,0,0
78365,CONCLUSION,0,0
78366,Although,0,0
78367,there,0,0
78368,was,0,0
78369,no,0,0
78370,overall,0,0
78371,effect,0,0
78372,on,0,0
78373,self-reported,0,0
78374,recovery,0,0
78375,or,0,1
78376,administrative,0,1
78377,measures,0,0
78378,or,0,1
78379,lost,0,0
78380,work,0,0
78381,time,0,0
78382,between,0,0
78383,the,0,0
78384,study,0,0
78385,groups,0,0
78386,",",0,0
78387,a,0,0
78388,back,0,0
78389,support,0,0
78390,plus,0,0
78391,health,0,0
78392,education,0,0
78393,may,0,0
78394,have,0,0
78395,some,0,0
78396,value,0,0
78397,in,0,0
78398,preventing,0,0
78399,recurrent,0,1
78400,WR-LBD,0,0
78401,in,0,0
78402,industrial,1,1
78403,workers,1,1
78404,who,1,1
78405,work,1,1
78406,in,1,1
78407,psychosocial,1,0
78408,environments,1,0
78409,and,1,0
78410,perform,1,0
78411,manual,1,0
78412,material,1,1
78413,handling,1,0
78414,tasks,1,0
78415,similar,1,0
78416,to,1,0
78417,those,1,0
78418,found,1,0
78419,in,1,0
78420,parts,1,0
78421,distribution,1,0
78422,centers,1,1
78423,.,1,1
78424,Prevention,0,0
78425,of,0,0
78426,type,1,1
78427,2,1,0
78428,(,1,0
78429,non-insulin-dependent,1,1
78430,),1,0
78431,diabetes,1,1
78432,mellitus,1,1
78433,by,0,0
78434,diet,0,0
78435,and,0,0
78436,physical,0,0
78437,exercise,0,0
78438,.,0,0
78439,The,0,0
78440,6-year,0,0
78441,Malm?,0,0
78442,feasibility,0,0
78443,study,0,0
78444,.,0,0
78445,From,0,0
78446,a,0,0
78447,previously,0,0
78448,reported,0,0
78449,5-year,0,0
78450,screening,0,0
78451,programme,0,0
78452,of,1,0
78453,"6,956",1,1
78454,47-49-year-old,1,1
78455,Malm?,1,1
78456,males,1,1
78457,",",1,0
78458,a,1,0
78459,series,1,0
78460,of,1,0
78461,41,1,1
78462,subjects,1,1
78463,with,1,1
78464,early-stage,1,1
78465,Type,1,0
78466,2,1,0
78467,(,1,0
78468,non-insulin-dependent,1,1
78469,),1,0
78470,diabetes,1,1
78471,mellitus,1,1
78472,and,1,0
78473,181,1,1
78474,subjects,1,1
78475,with,1,1
78476,impaired,1,1
78477,glucose,1,0
78478,tolerance,1,0
78479,were,1,0
78480,selected,0,1
78481,for,0,0
78482,prospective,0,0
78483,study,0,0
78484,and,0,0
78485,to,0,0
78486,test,0,0
78487,the,0,0
78488,feasibility,0,0
78489,aspect,0,0
78490,of,0,0
78491,long-term,0,0
78492,intervention,0,0
78493,with,0,0
78494,an,0,0
78495,emphasis,0,0
78496,on,0,0
78497,life-style,0,0
78498,changes,0,0
78499,.,0,0
78500,A,0,0
78501,5-year,0,0
78502,protocol,0,0
78503,",",0,0
78504,including,0,0
78505,an,0,0
78506,initial,0,0
78507,6-months,0,0
78508,(,0,0
78509,randomised,0,0
78510,),0,0
78511,pilot,0,0
78512,study,0,0
78513,",",0,0
78514,consisting,0,0
78515,of,0,0
78516,dietary,0,0
78517,treatment,0,0
78518,and/or,0,0
78519,increase,0,0
78520,of,0,0
78521,physical,0,0
78522,activity,0,0
78523,or,0,0
78524,training,0,0
78525,with,0,1
78526,annual,0,0
78527,check-ups,0,0
78528,",",0,0
78529,was,0,0
78530,completed,0,0
78531,by,0,0
78532,90,0,0
78533,%,0,0
78534,of,0,0
78535,subjects,0,1
78536,.,0,1
78537,Body,0,0
78538,weight,0,0
78539,was,0,0
78540,reduced,0,0
78541,by,0,0
78542,2.3-3.7,0,0
78543,%,0,0
78544,among,0,0
78545,participants,0,1
78546,",",0,0
78547,whereas,0,0
78548,values,0,0
78549,increased,0,0
78550,by,0,0
78551,0.5-1.7,0,0
78552,%,0,0
78553,in,0,0
78554,non-intervened,0,0
78555,subjects,0,1
78556,with,0,1
78557,impaired,0,1
78558,glucose,0,0
78559,tolerance,0,0
78560,and,0,0
78561,in,0,0
78562,normal,0,1
78563,control,0,0
78564,subjects,0,1
78565,(,0,0
78566,p,0,0
78567,less,0,0
78568,than,0,0
78569,0.0001,0,0
78570,),0,1
78571,;,0,0
78572,maximal,0,0
78573,oxygen,0,0
78574,uptake,0,0
78575,(,0,0
78576,ml.min-1.kg-1,0,0
78577,),0,0
78578,was,0,0
78579,increased,0,0
78580,by,0,0
78581,10-14,0,0
78582,%,0,0
78583,vs,0,0
78584,decreased,0,0
78585,by,0,0
78586,5-9,0,1
78587,%,0,0
78588,",",0,0
78589,respectively,0,0
78590,(,0,0
78591,p,0,0
78592,less,0,0
78593,than,0,0
78594,0.0001,0,0
78595,),0,0
78596,.,0,0
78597,Glucose,0,0
78598,tolerance,0,0
78599,was,0,0
78600,normalized,0,0
78601,in,0,0
78602,greater,0,0
78603,than,0,0
78604,50,0,0
78605,%,0,0
78606,of,0,0
78607,subjects,0,1
78608,with,0,1
78609,impaired,0,1
78610,glucose,0,0
78611,tolerance,0,0
78612,",",0,0
78613,the,0,0
78614,accumulated,0,0
78615,incidence,0,0
78616,of,0,0
78617,diabetes,0,1
78618,was,0,0
78619,10.6,0,0
78620,%,0,0
78621,",",0,0
78622,and,0,0
78623,more,0,0
78624,than,0,0
78625,50,0,0
78626,%,0,0
78627,of,0,0
78628,the,0,0
78629,diabetic,0,1
78630,patients,0,1
78631,were,0,0
78632,in,0,0
78633,remission,0,0
78634,after,0,0
78635,a,0,0
78636,mean,0,0
78637,follow-up,0,0
78638,of,0,0
78639,6,0,0
78640,years,0,1
78641,.,0,1
78642,Blood,0,0
78643,pressure,0,0
78644,",",0,0
78645,lipids,0,0
78646,",",0,0
78647,and,0,0
78648,hyperinsulinaemia,0,0
78649,were,0,0
78650,reduced,0,0
78651,and,0,0
78652,early,0,0
78653,insulin,0,0
78654,responsiveness,0,0
78655,to,0,0
78656,glucose,0,0
78657,loading,0,0
78658,preserved,0,0
78659,.,0,0
78660,Improvement,0,0
78661,in,0,0
78662,glucose,0,0
78663,tolerance,0,0
78664,was,0,0
78665,correlated,0,0
78666,to,0,0
78667,weight,0,0
78668,reduction,0,0
78669,(,0,0
78670,r,0,0
78671,=,0,0
78672,0.19,0,0
78673,",",0,0
78674,p,0,0
78675,less,0,0
78676,than,0,0
78677,0.02,0,0
78678,),0,0
78679,and,0,0
78680,increased,0,0
78681,fitness,0,0
78682,(,0,0
78683,r,0,0
78684,=,0,0
78685,0.22,0,0
78686,",",0,0
78687,p,0,0
78688,less,0,0
78689,than,0,0
78690,0.02,0,0
78691,),0,0
78692,.,0,0
78693,Treatment,0,0
78694,was,0,0
78695,safe,0,0
78696,",",0,0
78697,and,0,0
78698,mortality,0,0
78699,was,0,0
78700,low,0,0
78701,(,0,0
78702,in,0,0
78703,fact,0,0
78704,33,0,1
78705,%,0,0
78706,lower,0,0
78707,than,0,0
78708,in,0,0
78709,the,0,0
78710,remainder,0,0
78711,of,0,0
78712,the,0,0
78713,cohort,0,1
78714,),0,0
78715,.,0,0
78716,(,0,0
78717,ABSTRACT,0,0
78718,TRUNCATED,0,0
78719,AT,0,0
78720,250,0,0
78721,WORDS,0,0
78722,),0,0
78723,Expectancies,0,0
78724,",",0,0
78725,not,0,0
78726,aroma,0,0
78727,",",0,0
78728,explain,0,0
78729,impact,0,0
78730,of,0,0
78731,lavender,0,0
78732,aromatherapy,0,0
78733,on,0,0
78734,psychophysiological,0,0
78735,indices,0,0
78736,of,0,0
78737,relaxation,0,0
78738,in,0,0
78739,young,1,1
78740,healthy,1,1
78741,women,1,1
78742,.,1,1
78743,OBJECTIVES,0,0
78744,In,0,0
78745,aromatherapy,0,0
78746,",",0,0
78747,lavender,0,0
78748,aroma,0,0
78749,is,0,0
78750,reputed,0,0
78751,to,0,0
78752,assist,0,0
78753,with,0,1
78754,relaxation,0,0
78755,.,0,0
78756,However,0,0
78757,",",0,0
78758,while,0,0
78759,there,0,0
78760,is,0,0
78761,much,0,0
78762,anecdotal,0,0
78763,evidence,0,0
78764,to,0,0
78765,that,0,0
78766,effect,0,0
78767,",",0,0
78768,the,0,0
78769,empirical,0,0
78770,literature,0,0
78771,is,0,0
78772,very,0,0
78773,inconsistent,0,0
78774,.,0,0
78775,Failure,0,0
78776,to,0,0
78777,employ,0,0
78778,adequate,0,0
78779,placebos,0,0
78780,",",0,0
78781,proper,0,0
78782,blinding,0,0
78783,",",0,0
78784,objective,0,0
78785,measures,0,0
78786,",",0,0
78787,or,0,0
78788,screening,0,0
78789,of,0,0
78790,prior,0,0
78791,beliefs,0,0
78792,about,0,0
78793,aromatherapy,0,0
78794,means,0,0
78795,that,0,0
78796,many,0,1
78797,previous,0,0
78798,findings,0,0
78799,could,0,0
78800,have,0,0
78801,been,0,0
78802,influenced,0,0
78803,by,0,0
78804,expectancy,0,0
78805,biases,0,0
78806,.,0,0
78807,The,0,0
78808,present,0,0
78809,study,0,0
78810,sought,0,0
78811,to,0,0
78812,establish,0,0
78813,whether,0,0
78814,lavender,0,0
78815,aroma,0,0
78816,and/or,0,0
78817,expectancies,0,0
78818,affect,0,0
78819,post-stress,0,0
78820,relaxation,0,0
78821,.,0,0
78822,DESIGN,0,0
78823,A,0,0
78824,double-blind,0,0
78825,",",0,0
78826,3,0,0
78827,(,0,0
78828,aroma,0,0
78829,),0,0
78830,x,0,0
78831,3,0,0
78832,(,0,0
78833,instruction,0,0
78834,),0,0
78835,x,0,0
78836,10,0,0
78837,(,0,0
78838,time,0,0
78839,in,0,0
78840,minutes,0,0
78841,),0,1
78842,mixed-factorial,0,0
78843,placebo-controlled,0,0
78844,trial,0,0
78845,.,0,0
78846,METHOD,0,0
78847,In,0,0
78848,a,0,0
78849,laboratory,0,0
78850,",",0,0
78851,96,1,0
78852,healthy,1,1
78853,undergraduate,1,1
78854,women,1,1
78855,were,0,0
78856,exposed,0,0
78857,to,0,0
78858,lavender,0,0
78859,",",0,0
78860,placebo,0,0
78861,",",0,0
78862,or,0,0
78863,no,0,0
78864,aroma,0,0
78865,during,0,0
78866,physiologically,0,0
78867,assessed,0,0
78868,relaxation,0,0
78869,after,0,0
78870,an,0,0
78871,arousing,0,0
78872,cognitive,0,0
78873,task,0,0
78874,.,0,0
78875,Where,0,0
78876,an,0,0
78877,aroma,0,0
78878,was,0,0
78879,presented,0,0
78880,",",0,0
78881,an,0,0
78882,instructional,0,0
78883,priming,0,0
78884,procedure,0,0
78885,was,0,0
78886,used,0,0
78887,to,0,0
78888,manipulate,0,0
78889,participants,0,1
78890,',0,0
78891,expectancies,0,0
78892,about,0,0
78893,the,0,0
78894,aroma,0,0
78895,'s,0,0
78896,likely,0,0
78897,impact,0,0
78898,on,0,0
78899,their,0,0
78900,ability,0,0
78901,to,0,0
78902,relax,0,0
78903,.,0,0
78904,RESULTS,0,0
78905,Results,0,0
78906,showed,0,0
78907,no,0,0
78908,effect,0,0
78909,of,0,0
78910,aroma,0,0
78911,on,0,0
78912,galvanic,0,0
78913,skin,0,0
78914,response,0,0
78915,during,0,0
78916,relaxation,0,0
78917,.,0,0
78918,However,0,0
78919,",",0,0
78920,the,0,0
78921,nature,0,0
78922,of,0,0
78923,instructional,0,0
78924,prime,0,0
78925,was,0,0
78926,associated,0,0
78927,with,0,1
78928,relaxation,0,0
78929,patterns,0,0
78930,:,0,0
78931,when,0,0
78932,expecting,0,0
78933,the,0,0
78934,aroma,0,0
78935,to,0,0
78936,inhibit,0,0
78937,them,0,0
78938,",",0,0
78939,participants,0,0
78940,relaxed,0,0
78941,more,0,0
78942,;,0,0
78943,when,0,0
78944,expecting,0,0
78945,facilitation,0,0
78946,",",0,0
78947,participants,0,0
78948,relaxed,0,0
78949,less,0,0
78950,.,0,0
78951,The,0,0
78952,effect,0,0
78953,was,0,0
78954,not,0,0
78955,seen,0,0
78956,with,0,0
78957,regard,0,0
78958,to,0,0
78959,self-reported,0,0
78960,relaxation,0,0
78961,(,0,0
78962,as,0,0
78963,represented,0,0
78964,by,0,0
78965,changes,0,0
78966,in,0,0
78967,state,0,0
78968,anxiety,0,0
78969,),0,0
78970,and,0,0
78971,was,0,0
78972,independent,0,0
78973,of,0,0
78974,ratings,0,0
78975,of,0,0
78976,attitudes,0,0
78977,towards,0,0
78978,aromatherapy,0,0
78979,.,0,0
78980,CONCLUSIONS,0,0
78981,The,0,0
78982,findings,0,0
78983,imply,0,0
78984,that,0,0
78985,the,0,0
78986,previous,0,0
78987,associations,0,0
78988,of,0,0
78989,lavender,0,0
78990,aroma,0,0
78991,with,0,1
78992,assisted,0,0
78993,relaxation,0,0
78994,may,0,0
78995,have,0,0
78996,been,0,0
78997,influenced,0,0
78998,by,0,0
78999,expectancy,0,0
79000,biases,0,0
79001,",",0,0
79002,and,0,0
79003,that,0,0
79004,the,0,0
79005,relevant,0,0
79006,expectancies,0,0
79007,are,0,0
79008,easily,0,0
79009,manipulable,0,0
79010,.,0,0
79011,Severe,0,1
79012,enteropathy,0,1
79013,among,0,0
79014,patients,1,1
79015,with,1,1
79016,stage,1,1
79017,II/III,1,0
79018,colon,1,1
79019,cancer,1,1
79020,treated,0,0
79021,on,0,0
79022,a,0,0
79023,randomized,0,0
79024,trial,0,0
79025,of,0,0
79026,bolus,0,0
79027,5-fluorouracil/leucovorin,0,0
79028,plus,0,0
79029,or,0,0
79030,minus,0,0
79031,oxaliplatin,0,0
79032,:,0,0
79033,a,0,0
79034,prospective,0,0
79035,analysis,0,0
79036,.,0,0
79037,BACKGROUND,0,0
79038,Cases,0,0
79039,of,0,0
79040,severe,0,1
79041,gastrointestinal,0,1
79042,toxicity,0,0
79043,were,0,0
79044,monitored,0,0
79045,prospectively,0,1
79046,during,0,0
79047,NSABP,0,0
79048,C-07,0,0
79049,",",0,0
79050,a,0,0
79051,randomized,0,0
79052,clinical,0,0
79053,trial,0,0
79054,of,0,0
79055,adjuvant,0,0
79056,therapy,0,0
79057,for,0,0
79058,patients,1,1
79059,with,1,1
79060,stage,1,1
79061,II/III,1,0
79062,colon,1,1
79063,cancer,1,1
79064,.,1,1
79065,METHODS,0,0
79066,Patients,0,1
79067,were,0,1
79068,treated,0,1
79069,with,0,1
79070,weekly,0,0
79071,bolus,0,0
79072,5-fluorouracil,0,0
79073,(,0,0
79074,5-FU,0,0
79075,),0,0
79076,and,0,0
79077,leucovorin,0,0
79078,(,0,0
79079,FL,0,1
79080,;,0,0
79081,Roswell,0,0
79082,Park,0,0
79083,Regimen,0,0
79084,),0,0
79085,or,0,0
79086,the,0,0
79087,same,0,0
79088,regimen,0,0
79089,plus,0,0
79090,oxaliplatin,0,0
79091,(,0,0
79092,FLOX,0,0
79093,),0,0
79094,.,0,0
79095,RESULTS,0,0
79096,Of,0,1
79097,1857,1,1
79098,patients,1,1
79099,",",1,0
79100,79,1,1
79101,(,1,0
79102,4.3,1,0
79103,%,1,0
79104,),1,0
79105,developed,1,0
79106,a,1,0
79107,syndrome,1,1
79108,of,1,0
79109,bowel,1,0
79110,wall,1,0
79111,injury,1,0
79112,(,1,0
79113,BWI,1,0
79114,",",1,0
79115,small,1,0
79116,or,1,0
79117,large,1,1
79118,),1,0
79119,characterized,1,0
79120,by,1,0
79121,hospitalization,1,0
79122,for,1,0
79123,the,1,0
79124,management,1,0
79125,of,1,0
79126,severe,1,1
79127,diarrhea,1,1
79128,or,1,0
79129,dehydration,1,0
79130,and,1,0
79131,radiographic,1,0
79132,or,1,0
79133,endoscopic,1,0
79134,evidence,1,0
79135,of,1,0
79136,bowel,1,0
79137,wall,1,0
79138,thickening,1,0
79139,or,1,0
79140,ulceration,1,0
79141,.,1,0
79142,Fifty-one,0,1
79143,(,0,0
79144,64.6,0,0
79145,%,0,0
79146,),0,0
79147,of,0,0
79148,these,0,0
79149,adverse,0,0
79150,events,0,0
79151,occurred,0,0
79152,in,0,0
79153,patients,0,1
79154,treated,0,1
79155,with,0,1
79156,FLOX,0,0
79157,and,0,0
79158,28,0,0
79159,(,0,0
79160,35.4,0,0
79161,%,0,0
79162,),0,0
79163,in,0,0
79164,those,0,0
79165,treated,0,0
79166,with,0,0
79167,FL,0,1
79168,(,0,0
79169,P,0,0
79170,<,0,0
79171,.01,0,0
79172,),0,0
79173,.,0,0
79174,Enteric,0,0
79175,sepsis,0,0
79176,(,0,0
79177,ES,0,0
79178,),0,0
79179,",",0,0
79180,characterized,0,0
79181,by,0,0
79182,grade,0,0
79183,3,0,0
79184,or,0,0
79185,greater,0,0
79186,diarrhea,0,1
79187,and,0,0
79188,grade,0,0
79189,4,0,0
79190,neutropenia,0,0
79191,with,0,1
79192,or,0,0
79193,without,0,0
79194,proven,0,0
79195,bacteremia,0,0
79196,occurred,0,0
79197,in,0,0
79198,22,0,1
79199,patients,0,1
79200,treated,0,1
79201,with,0,1
79202,FLOX,0,0
79203,",",0,0
79204,versus,0,0
79205,8,0,0
79206,in,0,0
79207,those,0,0
79208,treated,0,0
79209,with,0,0
79210,FL,0,1
79211,(,0,0
79212,P,0,0
79213,=,0,0
79214,.01,0,0
79215,),0,1
79216,.,0,0
79217,Patients,0,1
79218,>,0,1
79219,60,0,1
79220,years,0,1
79221,were,0,0
79222,at,0,0
79223,higher,0,0
79224,risk,0,0
79225,for,0,0
79226,BWI,0,0
79227,after,0,0
79228,treatment,0,0
79229,with,0,1
79230,FLOX,0,0
79231,(,0,0
79232,6.7,0,0
79233,%,0,0
79234,),0,0
79235,versus,0,0
79236,treatment,0,0
79237,with,0,1
79238,FL,0,1
79239,(,0,0
79240,2.9,0,0
79241,%,0,0
79242,",",0,0
79243,P,0,0
79244,<,0,0
79245,.01,0,0
79246,),0,0
79247,.,0,0
79248,Female,0,1
79249,patients,0,1
79250,had,0,0
79251,a,0,0
79252,higher,0,0
79253,incidence,0,0
79254,of,0,0
79255,BWI,0,0
79256,with,0,1
79257,FLOX,0,0
79258,(,0,0
79259,9.1,0,0
79260,%,0,0
79261,),0,0
79262,than,0,0
79263,with,0,1
79264,FL,0,1
79265,(,0,0
79266,3.9,0,0
79267,%,0,0
79268,",",0,0
79269,P,0,0
79270,<,0,0
79271,.01,0,0
79272,),0,0
79273,.,0,0
79274,Severe,0,0
79275,gastrointestinal,0,0
79276,toxicity,0,0
79277,usually,0,0
79278,occurred,0,0
79279,during,0,0
79280,the,0,0
79281,third,0,0
79282,or,0,0
79283,fourth,0,0
79284,week,0,0
79285,on,0,0
79286,the,0,0
79287,first,0,0
79288,cycle,0,0
79289,of,0,0
79290,therapy,0,0
79291,",",0,0
79292,required,0,0
79293,hospitalization,0,0
79294,",",0,0
79295,and,0,0
79296,was,0,0
79297,managed,0,1
79298,with,0,1
79299,fluids,0,0
79300,",",0,0
79301,antidiarrheals,0,0
79302,",",0,0
79303,and,0,0
79304,antibiotics,0,0
79305,.,0,0
79306,There,0,0
79307,were,0,0
79308,5,0,0
79309,deaths,0,0
79310,(,0,0
79311,0.3,0,0
79312,%,0,0
79313,),0,0
79314,due,0,0
79315,to,0,0
79316,enteropathy,0,1
79317,",",0,0
79318,2,0,0
79319,related,0,0
79320,to,0,0
79321,ES,0,0
79322,and,0,0
79323,3,0,0
79324,related,0,0
79325,to,0,0
79326,both,0,0
79327,BWI,0,0
79328,and,0,0
79329,ES,0,0
79330,.,0,0
79331,Seventy-one,0,1
79332,percent,0,0
79333,of,0,0
79334,patients,0,1
79335,resumed,0,0
79336,treatment,0,0
79337,with,0,1
79338,FL,0,0
79339,after,0,0
79340,recovery,0,0
79341,.,0,1
79342,CONCLUSIONS,0,0
79343,Patients,0,1
79344,treated,0,1
79345,with,0,1
79346,adjuvant,0,0
79347,FL,0,0
79348,should,0,0
79349,be,0,0
79350,closely,0,0
79351,monitored,0,0
79352,for,0,0
79353,diarrhea,0,1
79354,and,0,0
79355,aggressively,0,0
79356,managed,0,0
79357,",",0,0
79358,especially,0,0
79359,if,0,0
79360,oxaliplatin,0,0
79361,has,0,0
79362,been,0,0
79363,added,0,0
79364,to,0,0
79365,the,0,0
79366,regimen,0,0
79367,.,0,0
79368,Society,0,0
79369,.,0,0
79370,Transcutaneous,0,0
79371,electrical,0,0
79372,nerve,0,0
79373,stimulation,0,0
79374,combined,0,0
79375,with,0,0
79376,task-related,0,0
79377,training,0,0
79378,improves,0,0
79379,lower,0,0
79380,limb,0,1
79381,functions,0,0
79382,in,0,0
79383,subjects,1,1
79384,with,1,1
79385,chronic,1,1
79386,stroke,1,1
79387,.,1,0
79388,BACKGROUND,0,0
79389,AND,0,0
79390,PURPOSE,0,0
79391,Previous,0,0
79392,studies,0,0
79393,have,0,0
79394,shown,0,0
79395,that,0,0
79396,repeated,0,0
79397,sensory,0,0
79398,inputs,0,0
79399,could,0,0
79400,enhance,0,0
79401,brain,0,0
79402,plasticity,0,0
79403,and,0,0
79404,cortical,0,0
79405,motor,0,0
79406,output,0,0
79407,.,0,0
79408,The,0,0
79409,purpose,0,0
79410,of,0,0
79411,this,0,0
79412,study,0,0
79413,was,0,0
79414,to,0,0
79415,investigate,0,0
79416,whether,0,0
79417,combining,0,0
79418,electrically,0,0
79419,induced,0,0
79420,sensory,0,0
79421,inputs,0,0
79422,through,0,0
79423,transcutaneous,0,0
79424,electrical,0,0
79425,nerve,0,0
79426,stimulation,0,0
79427,(,0,0
79428,TENS,0,0
79429,),0,0
79430,with,0,1
79431,task-related,0,0
79432,training,0,0
79433,(,0,0
79434,TRT,0,0
79435,),0,0
79436,in,0,0
79437,a,0,0
79438,home-based,0,0
79439,program,0,0
79440,would,0,0
79441,augment,0,0
79442,voluntary,0,0
79443,motor,0,0
79444,output,0,0
79445,in,0,0
79446,chronic,1,1
79447,stroke,1,1
79448,survivors,1,1
79449,better,0,0
79450,than,0,0
79451,either,0,0
79452,treatment,0,0
79453,alone,0,0
79454,or,0,0
79455,no,0,0
79456,treatment,0,0
79457,.,0,0
79458,METHODS,0,0
79459,Eighty-eight,1,1
79460,patients,1,1
79461,with,1,1
79462,stroke,1,1
79463,were,0,0
79464,assigned,0,0
79465,randomly,0,0
79466,to,0,0
79467,receive,0,0
79468,a,0,0
79469,home-based,0,0
79470,program,0,0
79471,of,0,0
79472,(,0,0
79473,1,0,0
79474,),0,0
79475,TENS,0,0
79476,",",0,0
79477,(,0,0
79478,2,0,0
79479,),0,0
79480,TENS+TRT,0,0
79481,",",0,0
79482,(,0,0
79483,3,0,0
79484,),0,0
79485,placebo,0,0
79486,TENS+TRT,0,0
79487,",",0,0
79488,or,0,0
79489,(,0,0
79490,4,0,0
79491,),0,0
79492,no,0,0
79493,treatment,0,0
79494,(,0,0
79495,control,0,0
79496,),0,0
79497,5,0,0
79498,days,0,0
79499,a,0,0
79500,week,0,0
79501,for,0,0
79502,4,0,0
79503,weeks,0,0
79504,.,0,1
79505,Outcome,0,0
79506,measurements,0,0
79507,included,0,1
79508,Composite,0,0
79509,Spasticity,0,0
79510,Scale,0,0
79511,",",0,0
79512,peak,0,0
79513,torques,0,0
79514,generated,0,0
79515,during,0,0
79516,maximum,0,0
79517,isometric,0,0
79518,voluntary,0,0
79519,contraction,0,0
79520,of,0,0
79521,ankle,0,1
79522,dorsiflexors,0,1
79523,and,0,0
79524,plantarflexors,0,0
79525,",",0,0
79526,and,0,0
79527,gait,0,0
79528,velocity,0,0
79529,recorded,0,0
79530,at,0,0
79531,baseline,0,0
79532,",",0,0
79533,after,0,0
79534,2,0,0
79535,and,0,0
79536,4,0,0
79537,weeks,0,0
79538,of,0,0
79539,treatment,0,0
79540,",",0,0
79541,and,0,0
79542,4,0,0
79543,weeks,0,0
79544,after,0,0
79545,treatment,0,0
79546,ended,0,0
79547,.,0,0
79548,RESULTS,0,0
79549,When,0,0
79550,compared,0,0
79551,with,0,0
79552,TENS,0,0
79553,",",0,0
79554,the,0,0
79555,combined,0,0
79556,TENS+TRT,0,0
79557,group,0,0
79558,showed,0,0
79559,significantly,0,0
79560,greater,0,0
79561,improvement,0,0
79562,in,0,0
79563,ankle,0,0
79564,dorsiflexion,0,0
79565,torque,0,0
79566,at,0,0
79567,follow-up,0,0
79568,and,0,0
79569,in,0,0
79570,ankle,0,0
79571,plantarflexion,0,0
79572,torque,0,0
79573,at,0,0
79574,week,0,0
79575,2,0,0
79576,and,0,0
79577,follow-up,0,0
79578,(,0,0
79579,P,0,0
79580,<,0,0
79581,0.01,0,0
79582,),0,0
79583,.,0,0
79584,When,0,0
79585,compared,0,0
79586,with,0,0
79587,placebo+TRT,0,0
79588,",",0,0
79589,the,0,0
79590,TENS+TRT,0,0
79591,group,0,0
79592,produced,0,0
79593,earlier,0,0
79594,and,0,0
79595,greater,0,0
79596,reduction,0,0
79597,of,0,0
79598,plantarflexor,0,0
79599,spasticity,0,0
79600,and,0,0
79601,improvement,0,0
79602,in,0,0
79603,ankle,0,0
79604,dorsiflexion,0,0
79605,torque,0,0
79606,at,0,0
79607,week,0,0
79608,2,0,0
79609,(,0,0
79610,P,0,0
79611,<,0,0
79612,0.01,0,0
79613,),0,0
79614,.,0,0
79615,When,0,0
79616,compared,0,0
79617,with,0,0
79618,all,0,0
79619,3,0,0
79620,groups,0,0
79621,",",0,0
79622,the,0,0
79623,TENS+TRT,0,0
79624,group,0,0
79625,showed,0,0
79626,significantly,0,0
79627,greater,0,0
79628,improvement,0,0
79629,in,0,0
79630,gait,0,0
79631,velocity,0,0
79632,(,0,0
79633,P,0,0
79634,<,0,0
79635,0.01,0,0
79636,),0,0
79637,.,0,0
79638,CONCLUSIONS,0,0
79639,In,0,0
79640,patients,1,1
79641,with,1,1
79642,chronic,1,1
79643,stroke,1,1
79644,",",0,0
79645,20,0,0
79646,sessions,0,0
79647,of,0,0
79648,a,0,0
79649,combined,0,0
79650,TENS+TRT,0,0
79651,home-based,0,0
79652,program,0,0
79653,decreased,0,0
79654,plantarflexor,0,0
79655,spasticity,0,0
79656,",",0,0
79657,improved,0,0
79658,dorsiflexor,0,0
79659,and,0,0
79660,plantarflexor,0,0
79661,strength,0,0
79662,",",0,0
79663,and,0,0
79664,increased,0,0
79665,gait,0,0
79666,velocity,0,0
79667,significantly,0,0
79668,more,0,0
79669,than,0,0
79670,TENS,0,0
79671,alone,0,0
79672,",",0,0
79673,placebo+TRT,0,0
79674,",",0,0
79675,or,0,0
79676,no,0,0
79677,treatment,0,0
79678,.,0,0
79679,Such,0,0
79680,improvements,0,0
79681,can,0,0
79682,even,0,0
79683,be,0,0
79684,maintained,0,0
79685,4,0,0
79686,weeks,0,0
79687,after,0,0
79688,treatment,0,0
79689,ended,0,0
79690,.,0,0
79691,Covariation,0,0
79692,of,0,0
79693,adolescent,1,1
79694,physical,1,0
79695,activity,1,0
79696,and,0,0
79697,dietary,0,0
79698,behaviors,0,0
79699,over,0,0
79700,12,0,1
79701,months,0,0
79702,.,0,0
79703,PURPOSE,0,0
79704,This,0,0
79705,study,0,0
79706,examined,0,0
79707,covariation,0,0
79708,among,0,0
79709,changes,0,0
79710,in,0,0
79711,dietary,0,0
79712,",",0,0
79713,physical,0,0
79714,activity,0,0
79715,",",0,0
79716,and,0,0
79717,sedentary,0,1
79718,behaviors,0,0
79719,over,0,0
79720,12,0,1
79721,months,0,0
79722,among,0,1
79723,adolescents,1,1
79724,participating,1,1
79725,in,1,0
79726,a,1,0
79727,health,1,0
79728,behavior,1,0
79729,intervention,1,0
79730,.,1,0
79731,Evidence,0,0
79732,of,0,0
79733,covariation,0,0
79734,among,0,0
79735,behaviors,0,0
79736,would,0,0
79737,suggest,0,0
79738,multi-behavior,0,0
79739,interventions,0,0
79740,could,0,0
79741,have,0,0
79742,synergistic,0,0
79743,effects,0,0
79744,.,0,1
79745,METHODS,0,0
79746,Prospective,0,0
79747,analyses,0,0
79748,were,0,0
79749,conducted,0,0
79750,with,0,0
79751,baseline,0,0
79752,and,0,0
79753,12-month,0,0
79754,assessments,0,0
79755,from,0,0
79756,a,0,0
79757,randomized,0,0
79758,controlled,0,0
79759,trial,0,0
79760,to,0,0
79761,promote,0,0
79762,improved,0,0
79763,diet,0,0
79764,",",0,0
79765,physical,0,0
79766,activity,0,0
79767,",",0,0
79768,and,0,0
79769,sedentary,0,1
79770,behaviors,0,0
79771,(,0,0
79772,experimental,0,0
79773,condition,0,0
79774,),0,0
79775,or,0,0
79776,SUN,0,1
79777,protection,0,0
79778,behaviors,0,0
79779,(,0,0
79780,comparison,0,0
79781,condition,0,0
79782,),0,0
79783,.,0,0
79784,Participants,1,1
79785,were,1,0
79786,adolescent,1,1
79787,girls,1,1
79788,and,1,0
79789,boys,1,1
79790,(,1,0
79791,N,1,1
79792,=,1,0
79793,878,1,1
79794,),1,0
79795,aged,1,1
79796,11-15,1,1
79797,years,1,1
79798,on,1,0
79799,entry,1,0
79800,.,1,0
79801,The,0,0
79802,main,0,0
79803,outcomes,0,0
79804,were,0,0
79805,:,0,1
79806,diet,0,0
79807,",",0,0
79808,based,0,0
79809,on,0,0
79810,multiple,0,0
79811,24-hour,0,0
79812,recalls,0,0
79813,(,0,0
79814,total,0,1
79815,fat,0,0
79816,",",0,0
79817,grams,0,0
79818,of,0,0
79819,fiber,0,0
79820,",",0,0
79821,servings,0,0
79822,of,0,0
79823,fruit,0,0
79824,and,0,0
79825,vegetables,0,0
79826,",",0,0
79827,total,0,1
79828,calories,0,0
79829,),0,1
79830,;,0,0
79831,average,0,0
79832,daily,0,0
79833,energy,0,0
79834,expenditure,0,0
79835,(,0,0
79836,kcals/kg,0,0
79837,),0,0
79838,based,0,0
79839,on,0,0
79840,7-day,0,0
79841,physical,0,0
79842,activity,0,0
79843,recall,0,0
79844,interviews,0,0
79845,;,0,0
79846,daily,0,0
79847,minutes,0,0
79848,of,0,0
79849,moderate-vigorous,0,1
79850,physical,0,0
79851,activity,0,0
79852,minutes,0,0
79853,from,0,1
79854,accelerometery,0,0
79855,;,0,0
79856,and,0,0
79857,self-reported,0,0
79858,daily,0,0
79859,hours,0,0
79860,of,0,0
79861,sedentary,0,1
79862,behavior,0,0
79863,.,0,0
79864,RESULTS,0,0
79865,Covariation,0,0
79866,was,0,0
79867,found,0,0
79868,between,0,0
79869,fat,0,0
79870,and,0,0
79871,calories,0,0
79872,(,0,0
79873,r,0,0
79874,=,0,0
79875,.16,0,0
79876,),0,0
79877,",",0,0
79878,fiber,0,0
79879,and,0,0
79880,calories,0,0
79881,(,0,0
79882,r,0,0
79883,=,0,0
79884,.53,0,0
79885,),0,0
79886,",",0,0
79887,fiber,0,0
79888,and,0,0
79889,fruit/vegetables,0,0
79890,(,0,0
79891,r,0,0
79892,=,0,0
79893,.53,0,0
79894,),0,0
79895,",",0,0
79896,calories,0,0
79897,and,0,0
79898,fruit/vegetables,0,0
79899,(,0,0
79900,r,0,0
79901,=,0,0
79902,.34,0,0
79903,),0,0
79904,",",0,0
79905,and,0,0
79906,fruit,0,0
79907,and,0,0
79908,vegetables,0,0
79909,and,0,0
79910,sedentary,0,1
79911,behavior,0,0
79912,(,0,0
79913,r,0,0
79914,=,0,0
79915,-.12,0,0
79916,),0,0
79917,for,0,0
79918,the,0,0
79919,total,0,0
79920,sample,0,1
79921,(,0,0
79922,all,0,0
79923,p,0,0
79924,values,0,0
79925,<,0,0
79926,.01,0,0
79927,),0,0
79928,.,0,0
79929,The,0,0
79930,pattern,0,0
79931,of,0,0
79932,findings,0,0
79933,was,0,0
79934,similar,0,0
79935,for,0,0
79936,most,0,0
79937,subgroups,0,0
79938,defined,0,0
79939,by,0,0
79940,gender,0,0
79941,and,0,0
79942,study,0,0
79943,condition,0,0
79944,.,0,0
79945,CONCLUSIONS,0,0
79946,The,0,0
79947,strongest,0,0
79948,covariation,0,0
79949,was,0,0
79950,observed,0,0
79951,for,0,0
79952,diet,0,0
79953,variables,0,0
79954,that,0,0
79955,are,0,0
79956,inherently,0,0
79957,related,0,0
79958,(,0,0
79959,calories,0,0
79960,and,0,0
79961,fat,0,0
79962,",",0,0
79963,fiber,0,0
79964,",",0,0
79965,and,0,0
79966,fruit/vegetables,0,0
79967,),0,0
79968,.,0,0
79969,Little,0,0
79970,covariation,0,0
79971,was,0,0
79972,detected,0,0
79973,within,0,0
79974,or,0,0
79975,between,0,0
79976,other,0,0
79977,diet,0,0
79978,",",0,0
79979,physical,0,0
79980,activity,0,0
79981,and,0,0
79982,sedentary,0,1
79983,behavior,0,0
79984,domains,0,0
79985,suggesting,0,0
79986,that,0,0
79987,interventions,0,0
79988,to,0,0
79989,improve,0,0
79990,these,0,0
79991,behaviors,0,0
79992,in,0,0
79993,adolescents,1,1
79994,need,0,0
79995,to,0,0
79996,include,0,0
79997,specific,0,0
79998,program,0,0
79999,components,0,0
80000,for,0,0
80001,each,0,0
80002,target,0,0
80003,behavior,0,0
80004,of,0,0
80005,interest,0,0
80006,.,0,0
80007,Intra-operative,0,0
80008,antibiotic,0,0
80009,prophylaxis,0,0
80010,in,0,0
80011,neurosurgery,1,0
80012,.,1,0
80013,A,0,0
80014,prospective,0,0
80015,",",0,0
80016,randomized,0,0
80017,",",0,0
80018,controlled,0,0
80019,study,0,0
80020,on,0,0
80021,cefotiam,0,0
80022,.,0,0
80023,In,0,0
80024,this,0,0
80025,prospective,0,0
80026,",",0,0
80027,randomized,0,0
80028,and,0,0
80029,controlled,0,0
80030,study,0,0
80031,the,0,0
80032,effect,0,0
80033,of,0,0
80034,cefotiam,0,0
80035,for,0,0
80036,the,0,0
80037,prevention,0,0
80038,of,0,0
80039,wound,0,0
80040,infections,0,0
80041,following,0,0
80042,trepanations,1,0
80043,was,0,0
80044,investigated,0,0
80045,.,0,0
80046,The,0,0
80047,main,0,0
80048,interest,0,0
80049,was,0,0
80050,centered,0,0
80051,on,0,0
80052,the,0,0
80053,rate,0,0
80054,of,0,0
80055,post-operative,0,0
80056,bone,0,0
80057,flap,0,0
80058,infections,0,0
80059,requiring,0,1
80060,operative,0,0
80061,revision,0,1
80062,.,0,0
80063,Administration,0,0
80064,of,0,0
80065,cefotiam,0,0
80066,was,0,0
80067,randomized,0,0
80068,for,0,0
80069,patients,1,1
80070,undergoing,1,1
80071,major,1,1
80072,craniotomies,1,1
80073,.,1,0
80074,The,0,0
80075,antibiotic,0,0
80076,was,0,0
80077,administered,0,0
80078,intravenously,0,0
80079,in,0,0
80080,a,0,0
80081,single,0,0
80082,dose,0,0
80083,of,0,0
80084,2,0,0
80085,g,0,0
80086,with,0,1
80087,induction,0,0
80088,of,0,0
80089,anaesthesia,0,1
80090,.,0,0
80091,Only,1,0
80092,clean,1,0
80093,or,1,1
80094,clean,1,0
80095,contaminated,1,0
80096,cases,1,0
80097,were,1,0
80098,included,1,1
80099,.,1,0
80100,Excluded,1,0
80101,were,1,0
80102,contaminated,1,0
80103,cases,1,0
80104,",",1,0
80105,operations,1,1
80106,with,1,1
80107,a,1,0
80108,transnasal-transsphenoidal,1,0
80109,approach,1,0
80110,",",1,0
80111,shunt-operations,1,0
80112,and,1,0
80113,patients,1,1
80114,with,1,1
80115,any,1,0
80116,other,1,0
80117,preoperative,1,0
80118,infection,1,1
80119,or,1,0
80120,antibiotic,1,0
80121,therapy,1,0
80122,.,1,1
80123,Outpatients,1,1
80124,were,1,0
80125,excluded,1,0
80126,due,1,0
80127,to,1,0
80128,difficulties,1,0
80129,in,1,0
80130,obtaining,1,0
80131,sufficient,1,0
80132,clinical,1,0
80133,information,1,0
80134,.,1,0
80135,From,1,0
80136,originally,1,1
80137,918,1,1
80138,consecutive,1,1
80139,patients,1,1
80140,operated,1,1
80141,on,1,0
80142,711,1,1
80143,fulfilled,1,1
80144,the,1,0
80145,entry,1,0
80146,criteria,1,1
80147,.,1,0
80148,With,1,0
80149,regard,1,0
80150,to,1,0
80151,age,1,1
80152,",",1,0
80153,sex,1,0
80154,",",1,0
80155,diagnosis,1,0
80156,and,1,0
80157,the,1,0
80158,site,1,0
80159,of,1,0
80160,te,1,0
80161,trepanation,1,0
80162,",",1,0
80163,control,1,0
80164,patients,1,1
80165,(,1,0
80166,n,1,1
80167,=,1,0
80168,355,1,1
80169,),1,0
80170,and,1,0
80171,cefotiam,1,0
80172,treated,1,1
80173,patients,1,1
80174,(,1,0
80175,n,1,1
80176,=,1,0
80177,356,1,1
80178,),1,0
80179,were,1,0
80180,shown,1,0
80181,to,1,0
80182,be,1,0
80183,comparable,1,0
80184,.,1,0
80185,In,0,0
80186,the,0,0
80187,various,0,0
80188,subgroups,0,0
80189,formed,0,0
80190,for,0,0
80191,different,1,0
80192,primary,1,1
80193,diagnoses,1,1
80194,",",1,0
80195,concomitant,1,0
80196,steroidal,1,0
80197,therapy,1,0
80198,and,0,0
80199,concomitant,1,0
80200,severe,1,1
80201,internal,1,0
80202,medical,1,1
80203,diseases,1,1
80204,cefotiam,0,0
80205,treated,0,1
80206,patients,0,1
80207,and,0,0
80208,controls,0,1
80209,were,0,0
80210,comparable,0,0
80211,as,0,0
80212,well,0,0
80213,.,0,0
80214,A,0,0
80215,highly,0,0
80216,significant,0,0
80217,difference,0,0
80218,for,0,0
80219,bone,0,0
80220,flap,0,0
80221,infection,0,0
80222,could,0,0
80223,be,0,0
80224,shown,0,0
80225,with,0,0
80226,0.3,0,0
80227,%,0,0
80228,in,0,0
80229,the,0,0
80230,cefotiam,0,0
80231,group,0,0
80232,versus,0,0
80233,5.1,0,0
80234,%,0,0
80235,in,0,0
80236,the,0,0
80237,control,0,0
80238,group,0,0
80239,(,0,0
80240,p,0,0
80241,less,0,0
80242,than,0,0
80243,0.001,0,0
80244,),0,0
80245,.,0,0
80246,The,0,0
80247,overall,0,0
80248,rate,0,0
80249,of,0,0
80250,post-operative,0,0
80251,deep,0,1
80252,wound,0,0
80253,infections,0,0
80254,including,0,0
80255,meningitis,0,1
80256,and,0,0
80257,abscesses,0,0
80258,was,0,0
80259,also,0,0
80260,significantly,0,0
80261,(,0,0
80262,p,0,0
80263,less,0,0
80264,than,0,0
80265,0.005,0,0
80266,),0,0
80267,different,0,0
80268,with,0,1
80269,3.1,0,0
80270,%,0,0
80271,in,0,0
80272,the,0,0
80273,cefotiam,0,0
80274,versus,0,0
80275,9.0,0,0
80276,%,0,0
80277,in,0,0
80278,the,0,0
80279,control,0,0
80280,group,0,0
80281,.,0,0
80282,Thus,0,0
80283,it,0,0
80284,was,0,0
80285,concluded,0,0
80286,that,0,0
80287,a,0,0
80288,single,0,0
80289,dose,0,0
80290,of,0,0
80291,cefotiam,0,0
80292,significantly,0,0
80293,reduces,0,0
80294,post-operative,0,0
80295,deep,0,0
80296,wound,0,0
80297,infection,0,1
80298,.,0,0
80299,Comparison,0,0
80300,of,0,0
80301,long-term,0,0
80302,efficacy,0,0
80303,and,0,0
80304,safety,0,0
80305,of,0,0
80306,risperidone,0,0
80307,and,0,0
80308,haloperidol,0,0
80309,in,0,0
80310,children,1,1
80311,and,1,0
80312,adolescents,1,1
80313,with,1,1
80314,autistic,1,1
80315,disorder,1,1
80316,.,1,0
80317,An,0,0
80318,open,0,0
80319,label,0,0
80320,maintenance,0,0
80321,study,0,0
80322,.,0,0
80323,BACKGROUND,0,0
80324,The,0,0
80325,aim,0,0
80326,of,0,0
80327,the,0,0
80328,study,0,0
80329,was,0,0
80330,to,0,0
80331,investigate,0,0
80332,safety,0,0
80333,",",0,0
80334,efficacy,0,0
80335,and,0,0
80336,tolerability,0,0
80337,of,0,0
80338,risperidone,0,0
80339,in,0,0
80340,comparison,0,0
80341,with,0,1
80342,haloperidol,0,0
80343,in,0,0
80344,the,0,0
80345,long-term,0,0
80346,treatment,0,0
80347,of,0,0
80348,autistic,1,1
80349,disorder,1,1
80350,.,1,0
80351,METHODS,0,0
80352,This,0,0
80353,was,0,0
80354,an,0,0
80355,open-label,0,0
80356,continuation,0,0
80357,study,0,0
80358,of,0,0
80359,the,0,0
80360,randomized,0,0
80361,",",0,0
80362,double-blind,0,0
80363,",",0,0
80364,controlled,0,0
80365,trial,0,0
80366,of,0,0
80367,risperidone,0,0
80368,and,0,0
80369,haloperidol,0,0
80370,study,0,0
80371,for,0,0
80372,12,0,0
80373,week,0,0
80374,in,1,0
80375,autistic,1,1
80376,children,1,1
80377,and,1,1
80378,adolescents,1,1
80379,.,1,0
80380,A,1,0
80381,total,1,0
80382,of,1,0
80383,28,1,1
80384,subjects,1,1
80385,between,1,0
80386,8,1,0
80387,and,1,0
80388,18,1,1
80389,ages,1,1
80390,with,1,1
80391,autistic,1,1
80392,disorder,1,1
80393,were,0,0
80394,enrolled,0,1
80395,to,0,0
80396,the,0,0
80397,open,0,0
80398,label,0,0
80399,phase,0,0
80400,of,0,0
80401,the,0,0
80402,study,0,0
80403,.,0,0
80404,Behavioral,0,0
80405,rating,0,0
80406,scales,0,0
80407,(,0,0
80408,Clinical,0,0
80409,Global,0,1
80410,Impression,0,0
80411,Scale,0,0
80412,[,0,0
80413,CGI-I,0,0
80414,],0,0
80415,",",0,0
80416,Ritvo-Freeman,0,0
80417,Real,0,0
80418,Life,0,0
80419,Rating,0,0
80420,Scale,0,0
80421,[,0,0
80422,RF-RLRS,0,0
80423,],0,0
80424,),0,0
80425,",",0,0
80426,Aberrant,0,0
80427,Behavior,0,0
80428,Checklist,0,0
80429,[,0,0
80430,ABC,0,0
80431,],0,0
80432,",",0,0
80433,Turgay,0,1
80434,DSM-IV,0,0
80435,Pervasive,0,1
80436,Developmental,0,1
80437,Disorder,0,1
80438,Rating,0,0
80439,Scale,0,0
80440,[,0,0
80441,TPDDRS,0,1
80442,],0,0
80443,),0,0
80444,and,0,0
80445,safety,0,0
80446,assessment,0,0
80447,scales,0,0
80448,(,0,0
80449,Extrapyramidal,0,0
80450,Symptoms,0,0
80451,Rating,0,0
80452,Scale,0,0
80453,[,0,0
80454,ESRS,0,0
80455,],0,0
80456,",",0,0
80457,UKU-Side,0,0
80458,Effect,0,0
80459,Rating,0,0
80460,Scale,0,0
80461,),0,0
80462,were,0,0
80463,performed,0,0
80464,at,0,0
80465,12,0,0
80466,",",0,0
80467,16,0,0
80468,",",0,0
80469,20,0,0
80470,and,0,0
80471,24,0,0
80472,weeks,0,0
80473,",",0,0
80474,following,0,0
80475,the,0,0
80476,12,0,0
80477,week,0,0
80478,double-blind,0,0
80479,phase,0,0
80480,.,0,0
80481,Risperidone,0,0
80482,and,0,0
80483,haloperidol,0,0
80484,treatments,0,0
80485,were,0,0
80486,applied,0,0
80487,with,0,0
80488,a,0,0
80489,once,0,0
80490,daily,0,0
80491,dosage,0,0
80492,regimen,0,0
80493,as,0,0
80494,0.01-0.08,0,0
80495,mg/kg/day,0,0
80496,.,0,0
80497,RESULTS,0,0
80498,Risperidone,0,0
80499,led,0,0
80500,to,0,0
80501,a,0,0
80502,significant,0,0
80503,greater,0,0
80504,reduction,0,0
80505,on,0,0
80506,CGI,0,0
80507,scale,0,0
80508,.,0,0
80509,There,0,0
80510,was,0,0
80511,significant,0,0
80512,improvement,0,0
80513,on,0,0
80514,RF-RLRS,0,0
80515,sensory,0,0
80516,motor,0,0
80517,and,0,0
80518,language,0,0
80519,subscale,0,0
80520,and,0,0
80521,ABC,0,0
80522,scores,0,0
80523,in,0,0
80524,risperidone,0,0
80525,group,0,0
80526,.,0,0
80527,Weight,0,0
80528,gain,0,0
80529,was,0,0
80530,observed,0,0
80531,more,0,0
80532,frequently,0,0
80533,in,0,0
80534,the,0,0
80535,haloperidol,0,0
80536,group,0,0
80537,at,0,0
80538,week,0,0
80539,24,0,0
80540,.,0,0
80541,CONCLUSIONS,0,0
80542,These,0,0
80543,results,0,0
80544,demonstrate,0,0
80545,that,0,0
80546,risperidone,0,0
80547,is,0,0
80548,more,0,0
80549,efficacious,0,0
80550,and,0,0
80551,well,0,0
80552,tolerated,0,0
80553,than,0,0
80554,haloperidol,0,0
80555,in,0,0
80556,the,0,0
80557,long-term,0,0
80558,maintenance,0,0
80559,treatment,0,0
80560,of,0,0
80561,autistic,0,1
80562,disorder,0,1
80563,.,0,0
80564,The,0,0
80565,effect,0,0
80566,of,0,0
80567,oral,0,0
80568,sodium,0,0
80569,acetate,0,0
80570,administration,0,0
80571,on,0,0
80572,plasma,0,0
80573,acetate,0,0
80574,concentration,0,0
80575,and,0,0
80576,acid-base,0,0
80577,state,0,0
80578,in,0,0
80579,horses,1,1
80580,.,1,1
80581,AIM,0,0
80582,Sodium,0,0
80583,acetate,0,0
80584,(,0,0
80585,NaAcetate,0,0
80586,),0,0
80587,has,0,0
80588,received,0,0
80589,some,0,0
80590,attention,0,0
80591,as,0,0
80592,an,0,0
80593,alkalinizing,0,0
80594,agent,0,0
80595,and,0,0
80596,possible,0,0
80597,alternative,0,0
80598,energy,0,0
80599,source,0,0
80600,for,0,0
80601,the,0,0
80602,horse,0,0
80603,",",0,0
80604,however,0,0
80605,the,0,0
80606,effects,0,0
80607,of,0,0
80608,oral,0,0
80609,administration,0,0
80610,remain,0,0
80611,largely,0,0
80612,unknown,0,0
80613,.,0,0
80614,The,0,0
80615,present,0,0
80616,study,0,0
80617,used,0,0
80618,the,0,0
80619,physicochemical,0,0
80620,approach,0,0
80621,to,0,0
80622,characterize,0,0
80623,the,0,0
80624,changes,0,0
80625,in,0,0
80626,acid-base,0,0
80627,status,0,0
80628,occurring,0,0
80629,after,0,0
80630,oral,0,0
80631,NaAcetate/acetic,0,0
80632,acid,0,0
80633,(,0,0
80634,NAA,0,0
80635,),0,0
80636,administration,0,0
80637,in,0,0
80638,horses,0,1
80639,.,0,1
80640,METHODS,0,0
80641,Jugular,0,1
80642,venous,0,0
80643,blood,0,0
80644,was,0,0
80645,sampled,0,0
80646,from,0,0
80647,9,1,0
80648,exercise-conditioned,1,1
80649,horses,1,1
80650,on,1,0
80651,2,1,1
80652,separate,1,0
80653,occasions,1,0
80654,",",0,0
80655,at,0,0
80656,rest,0,0
80657,and,0,0
80658,for,0,0
80659,24,0,0
80660,h,0,0
80661,following,0,0
80662,a,0,0
80663,competition,0,0
80664,exercise,0,0
80665,test,0,0
80666,(,0,0
80667,CET,0,0
80668,),0,0
80669,designed,0,0
80670,to,0,0
80671,simulate,0,0
80672,the,0,0
80673,speed,0,0
80674,and,0,0
80675,endurance,0,0
80676,test,0,0
80677,of,0,0
80678,3-day,0,0
80679,event,0,0
80680,.,0,0
80681,Immediately,0,0
80682,after,0,0
80683,the,0,0
80684,CETs,0,0
80685,horses,0,1
80686,were,0,0
80687,allowed,0,0
80688,water,0,0
80689,ad,0,0
80690,libitum,0,0
80691,and,0,0
80692,either,0,0
80693,:,0,0
80694,1,0,0
80695,),0,0
80696,8,0,0
80697,L,0,0
80698,of,0,0
80699,a,0,0
80700,hypertonic,0,0
80701,NaAcetate/acetic,0,0
80702,acid,0,0
80703,solution,0,0
80704,via,0,0
80705,nasogastric,0,0
80706,tube,0,0
80707,followed,0,0
80708,by,0,0
80709,a,0,0
80710,typical,0,0
80711,hay/grain,0,0
80712,meal,0,0
80713,(,0,0
80714,NAA,0,0
80715,trial,0,0
80716,),0,0
80717,;,0,0
80718,or,0,0
80719,2,0,0
80720,),0,0
80721,a,0,0
80722,hay/grain,0,0
80723,meal,0,0
80724,alone,0,0
80725,(,0,0
80726,Control,0,0
80727,trial,0,0
80728,),0,0
80729,.,0,0
80730,RESULTS,0,0
80731,Oral,0,0
80732,NAA,0,0
80733,resulted,0,0
80734,in,0,0
80735,a,0,0
80736,profound,0,0
80737,plasma,0,0
80738,alkalosis,0,0
80739,marked,0,0
80740,by,0,0
80741,decreased,0,0
80742,plasma,0,0
80743,[,0,0
80744,H+,0,0
80745,],0,0
80746,and,0,0
80747,increased,0,0
80748,plasma,0,0
80749,[,0,0
80750,TCO2,0,0
80751,],0,0
80752,and,0,0
80753,[,0,0
80754,HCO3-,0,0
80755,],0,0
80756,compared,0,0
80757,to,0,0
80758,Control,0,0
80759,.,0,0
80760,The,0,0
80761,primary,0,0
80762,contributor,0,0
80763,to,0,0
80764,the,0,0
80765,plasma,0,0
80766,alkalosis,0,0
80767,was,0,0
80768,an,0,0
80769,increased,0,0
80770,[,0,0
80771,SID,0,0
80772,],0,0
80773,",",0,0
80774,as,0,0
80775,a,0,0
80776,result,0,0
80777,of,0,0
80778,increased,0,0
80779,plasma,0,0
80780,[,0,0
80781,Na+,0,0
80782,],0,0
80783,and,0,0
80784,decreased,0,0
80785,plasma,0,0
80786,[,0,0
80787,Cl-,0,0
80788,],0,0
80789,.,0,0
80790,An,0,0
80791,increased,0,0
80792,[,0,0
80793,Atot,0,0
80794,],0,0
80795,",",0,0
80796,due,0,0
80797,to,0,0
80798,increased,0,0
80799,[,0,0
80800,PP,0,0
80801,],0,0
80802,and,0,0
80803,a,0,0
80804,sustained,0,0
80805,increase,0,0
80806,in,0,0
80807,plasma,0,0
80808,[,0,0
80809,acetate,0,0
80810,],0,0
80811,",",0,0
80812,contributed,0,0
80813,a,0,0
80814,minor,0,0
80815,acidifying,0,0
80816,effect,0,0
80817,.,0,0
80818,CONCLUSION,0,0
80819,It,0,0
80820,is,0,0
80821,concluded,0,0
80822,that,0,0
80823,oral,0,0
80824,NaAcetate,0,0
80825,could,0,0
80826,be,0,0
80827,used,0,0
80828,as,0,0
80829,both,0,0
80830,an,0,0
80831,alkalinizing,0,0
80832,agent,0,0
80833,and,0,0
80834,an,0,0
80835,alternative,0,0
80836,energy,0,0
80837,source,0,0
80838,in,0,0
80839,the,0,0
80840,horse,1,0
80841,.,1,0
80842,Minimally,0,0
80843,invasive,0,0
80844,treatment,0,0
80845,combined,0,0
80846,with,0,0
80847,cytokine-induced,0,0
80848,killer,0,0
80849,cells,0,0
80850,therapy,0,0
80851,lower,0,0
80852,the,0,0
80853,short-term,0,0
80854,recurrence,0,0
80855,rates,0,0
80856,of,0,0
80857,hepatocellular,1,1
80858,carcinomas,1,1
80859,.,1,0
80860,The,0,0
80861,recurrence,0,0
80862,of,0,0
80863,hepatocellular,0,1
80864,carcinoma,0,1
80865,(,0,0
80866,HCC,0,0
80867,),0,0
80868,after,0,0
80869,minimally,0,0
80870,invasive,0,0
80871,therapy,0,0
80872,is,0,0
80873,frequent,0,0
80874,.,0,0
80875,Adoptive,0,0
80876,immunotherapy,0,0
80877,is,0,0
80878,thought,0,0
80879,to,0,0
80880,be,0,0
80881,an,0,0
80882,effective,0,0
80883,method,0,0
80884,to,0,0
80885,lower,0,0
80886,recurrence,0,0
80887,and,0,0
80888,metastasis,0,1
80889,rates,0,0
80890,of,0,0
80891,malignant,0,1
80892,tumors,0,1
80893,.,0,0
80894,Therefore,0,0
80895,",",0,0
80896,85,1,0
80897,HCC,1,0
80898,patients,1,1
80899,after,1,0
80900,transcatheter,1,1
80901,arterial,1,1
80902,chemoembolization,1,0
80903,and,1,0
80904,radiofrequency,1,0
80905,ablation,1,0
80906,therapy,1,0
80907,were,1,0
80908,randomized,1,0
80909,to,1,0
80910,immunotherapy,1,0
80911,group,1,0
80912,and,1,0
80913,no,1,0
80914,adjuvant,1,0
80915,therapy,1,0
80916,group,1,0
80917,.,1,0
80918,Autologous,0,0
80919,cytokine-induced,0,0
80920,killer,0,0
80921,(,0,0
80922,CIK,0,0
80923,),0,0
80924,cells,0,0
80925,were,0,0
80926,transfused,0,0
80927,via,0,0
80928,hepatic,0,0
80929,artery,0,1
80930,to,0,0
80931,the,0,0
80932,patients,0,1
80933,.,0,0
80934,The,0,0
80935,alteration,0,0
80936,of,0,0
80937,levels,0,0
80938,of,0,0
80939,lymphocyte,0,0
80940,subsets,0,0
80941,in,0,0
80942,peripheral,0,0
80943,blood,0,0
80944,of,0,0
80945,patients,0,1
80946,was,0,0
80947,examined,0,0
80948,by,0,0
80949,flow,0,0
80950,cytometry,0,0
80951,.,0,0
80952,All,1,0
80953,patients,1,1
80954,were,1,0
80955,screened,1,1
80956,by,1,0
80957,computed,1,0
80958,tomography,1,0
80959,every,1,0
80960,2,1,0
80961,months,1,0
80962,to,1,0
80963,observe,1,0
80964,the,1,0
80965,tumor,1,0
80966,recurrent,1,1
80967,conditions,1,0
80968,.,1,0
80969,After,0,0
80970,CIK,0,0
80971,cell,0,1
80972,infusions,0,0
80973,",",0,0
80974,the,0,0
80975,percentages,0,0
80976,of,0,0
80977,CD3+,0,0
80978,",",0,0
80979,CD4+,0,0
80980,",",0,0
80981,CD56+,0,0
80982,",",0,0
80983,CD3+CD56+,0,0
80984,cells,0,0
80985,",",0,0
80986,and,0,0
80987,CD4+/CD8+,0,0
80988,ratio,0,0
80989,increased,0,0
80990,from,0,0
80991,68.6+/-11.0,0,0
80992,%,0,0
80993,",",0,0
80994,31.1+/-9.0,0,0
80995,%,0,0
80996,",",0,0
80997,15.6+/-7.9,0,0
80998,%,0,0
80999,",",0,0
81000,5.2+/-3.1,0,0
81001,%,0,0
81002,",",0,0
81003,and,0,0
81004,1.1+/-0.5,0,0
81005,to,0,0
81006,70.7+/-10.1,0,0
81007,%,0,0
81008,",",0,0
81009,33.5+/-8.0,0,0
81010,%,0,0
81011,",",0,0
81012,18.4+/-9.4,0,0
81013,%,0,0
81014,",",0,0
81015,5.9+/-2.8,0,0
81016,%,0,0
81017,",",0,0
81018,and,0,0
81019,1.3+/-0.7,0,0
81020,",",0,0
81021,respectively,0,0
81022,(,0,0
81023,P,0,0
81024,<,0,0
81025,0.05,0,0
81026,),0,0
81027,;,0,0
81028,whereas,0,0
81029,the,0,0
81030,percentage,0,0
81031,of,0,0
81032,CD8,0,1
81033,cells,0,0
81034,decreased,0,0
81035,from,0,0
81036,31.1+/-7.8,0,0
81037,%,0,0
81038,to,0,0
81039,28.6+/-8.3,0,0
81040,%,0,0
81041,(,0,0
81042,P,0,0
81043,<,0,0
81044,0.05,0,0
81045,),0,0
81046,.,0,0
81047,The,0,0
81048,1-year,0,0
81049,and,0,0
81050,18-month,0,0
81051,recurrence,0,0
81052,rates,0,0
81053,of,0,0
81054,the,0,0
81055,study,0,0
81056,group,0,0
81057,were,0,0
81058,8.9,0,0
81059,%,0,0
81060,and,0,0
81061,15.6,0,0
81062,%,0,0
81063,",",0,0
81064,compared,0,0
81065,with,0,0
81066,30.0,0,0
81067,%,0,0
81068,and,0,0
81069,40.0,0,0
81070,%,0,0
81071,of,0,0
81072,the,0,0
81073,control,0,0
81074,group,0,0
81075,(,0,0
81076,both,0,0
81077,P,0,0
81078,value,0,0
81079,<,0,0
81080,0.05,0,0
81081,),0,0
81082,.,0,0
81083,The,0,0
81084,data,0,0
81085,suggest,0,0
81086,that,0,0
81087,CIK,0,0
81088,cell,0,0
81089,transfusion,0,0
81090,is,0,0
81091,an,0,0
81092,effective,0,0
81093,treatment,0,0
81094,.,0,0
81095,It,0,0
81096,can,0,0
81097,boost,0,0
81098,the,0,0
81099,immunologic,0,0
81100,function,0,0
81101,in,0,0
81102,HCC,1,0
81103,patients,1,1
81104,and,0,0
81105,plays,0,0
81106,an,0,0
81107,important,0,0
81108,role,0,0
81109,in,0,0
81110,reducing,0,0
81111,the,0,0
81112,recurrence,0,0
81113,rate,0,0
81114,of,0,0
81115,HCC,0,0
81116,.,0,1
81117,The,0,0
81118,cost-effectiveness,0,0
81119,of,0,0
81120,parasitologic,0,0
81121,diagnosis,0,1
81122,for,0,0
81123,malaria-suspected,1,1
81124,patients,1,1
81125,in,0,0
81126,an,0,0
81127,era,0,0
81128,of,0,0
81129,combination,0,0
81130,therapy,0,0
81131,.,0,0
81132,The,0,0
81133,introduction,0,0
81134,of,0,0
81135,artemisinin-based,0,0
81136,combination,0,0
81137,therapy,0,0
81138,in,0,0
81139,sub-Saharan,1,0
81140,Africa,1,0
81141,has,0,0
81142,prompted,0,0
81143,calls,0,0
81144,for,0,0
81145,increased,0,0
81146,use,0,0
81147,of,0,0
81148,parasitologic,0,0
81149,diagnosis,0,1
81150,for,0,0
81151,malaria,0,1
81152,.,0,0
81153,We,0,0
81154,evaluated,0,0
81155,the,0,0
81156,cost-effectiveness,0,0
81157,of,0,0
81158,rapid,0,0
81159,diagnostic,0,0
81160,tests,0,0
81161,(,0,0
81162,RDTs,0,0
81163,),0,0
81164,in,0,0
81165,comparison,0,0
81166,to,0,0
81167,microscopy,0,0
81168,in,0,0
81169,guiding,0,0
81170,treatment,0,0
81171,of,0,0
81172,non-severe,0,1
81173,febrile,0,1
81174,illness,0,1
81175,at,0,0
81176,varying,0,0
81177,levels,0,0
81178,of,0,0
81179,malaria,0,1
81180,endemicity,0,1
81181,using,0,0
81182,data,0,0
81183,on,0,0
81184,test,0,0
81185,accuracy,0,0
81186,and,0,0
81187,costs,0,0
81188,collected,0,0
81189,as,0,0
81190,part,0,0
81191,of,0,0
81192,a,0,0
81193,Tanzanian,1,1
81194,trial,1,0
81195,.,1,0
81196,If,0,0
81197,prescribers,0,0
81198,complied,0,1
81199,with,0,1
81200,current,0,0
81201,guidelines,0,0
81202,",",0,0
81203,microscopy,0,0
81204,would,0,0
81205,give,0,0
81206,rise,0,0
81207,to,0,0
81208,lower,0,0
81209,average,0,0
81210,costs,0,0
81211,per,0,0
81212,patient,0,0
81213,correctly,0,0
81214,treated,0,0
81215,than,0,0
81216,RDTs,0,0
81217,in,0,0
81218,areas,0,0
81219,of,0,0
81220,both,0,0
81221,high,0,0
81222,and,0,0
81223,low,0,0
81224,transmission,0,0
81225,.,0,0
81226,RDT,0,0
81227,introduction,0,0
81228,would,0,0
81229,result,0,0
81230,in,0,0
81231,an,0,0
81232,additional,0,0
81233,2.3,0,0
81234,%,0,0
81235,and,0,0
81236,9.4,0,0
81237,%,0,0
81238,of,0,0
81239,patients,0,1
81240,correctly,0,0
81241,treated,0,0
81242,",",0,0
81243,at,0,0
81244,an,0,0
81245,incremental,0,0
81246,cost,0,0
81247,of,0,0
81248,$,0,0
81249,25,0,0
81250,and,0,0
81251,$,0,0
81252,7,0,0
81253,in,0,0
81254,the,0,0
81255,low,0,0
81256,and,0,0
81257,high,0,0
81258,transmission,0,0
81259,settings,0,0
81260,",",0,0
81261,respectively,0,0
81262,.,0,0
81263,Cost-effectiveness,0,0
81264,would,0,0
81265,be,0,0
81266,worse,0,0
81267,if,0,0
81268,prescribers,0,0
81269,do,0,0
81270,not,0,0
81271,comply,0,0
81272,with,0,0
81273,test,0,0
81274,results,0,0
81275,.,0,0
81276,The,0,0
81277,cost,0,0
81278,of,0,0
81279,this,0,0
81280,additional,0,0
81281,benefit,0,0
81282,may,0,0
81283,be,0,0
81284,higher,0,0
81285,than,0,0
81286,many,0,0
81287,countries,0,0
81288,can,0,0
81289,afford,0,0
81290,without,0,0
81291,external,0,0
81292,assistance,0,0
81293,or,0,0
81294,lower,0,0
81295,RDT,0,0
81296,prices,0,0
81297,.,0,1
81298,Randomized,0,0
81299,",",0,0
81300,comparative,0,0
81301,study,0,0
81302,of,0,0
81303,the,0,0
81304,efficacy,0,0
81305,and,0,0
81306,safety,0,0
81307,of,0,0
81308,artesunate,0,0
81309,plus,0,0
81310,amodiaquine,0,0
81311,",",0,0
81312,administered,0,0
81313,as,0,0
81314,a,0,0
81315,single,0,0
81316,daily,0,0
81317,intake,0,0
81318,versus,0,0
81319,two,0,0
81320,daily,0,0
81321,intakes,0,0
81322,in,0,0
81323,the,0,0
81324,treatment,0,0
81325,of,0,0
81326,uncomplicated,1,1
81327,falciparum,1,0
81328,malaria,1,1
81329,.,1,0
81330,BACKGROUND,0,0
81331,Artesunate,0,0
81332,plus,0,0
81333,amodiaquine,0,0
81334,is,0,0
81335,a,0,0
81336,coblistered,0,0
81337,ACT,0,0
81338,",",0,0
81339,given,0,0
81340,as,0,0
81341,a,0,0
81342,single,0,0
81343,daily,0,0
81344,intake,0,0
81345,.,0,0
81346,It,0,0
81347,has,0,0
81348,been,0,0
81349,suggested,0,0
81350,that,0,0
81351,",",0,0
81352,in,0,0
81353,view,0,0
81354,of,0,0
81355,the,0,0
81356,number,0,0
81357,of,0,0
81358,tablets,0,0
81359,to,0,0
81360,be,0,0
81361,taken,0,0
81362,(,0,0
81363,particularly,0,0
81364,in,0,0
81365,adults,0,1
81366,),0,0
81367,",",0,0
81368,it,0,0
81369,may,0,0
81370,be,0,0
81371,possible,0,0
81372,to,0,0
81373,improve,0,0
81374,compliance,0,0
81375,by,0,0
81376,allowing,0,0
81377,patients,0,1
81378,to,0,0
81379,divide,0,0
81380,the,0,0
81381,daily,0,0
81382,dose,0,0
81383,.,0,0
81384,The,0,0
81385,objectives,0,0
81386,of,0,0
81387,this,0,0
81388,randomized,0,0
81389,",",0,0
81390,comparative,0,0
81391,",",0,0
81392,open-label,0,0
81393,",",0,0
81394,multicentre,1,0
81395,study,1,0
81396,",",1,0
81397,conducted,1,0
81398,in,1,0
81399,Senegal,1,1
81400,and,1,0
81401,in,1,0
81402,Cameroon,1,1
81403,in,1,0
81404,2005,1,1
81405,",",0,0
81406,was,0,0
81407,to,0,0
81408,demonstrate,0,0
81409,the,0,0
81410,non-inferiority,0,0
81411,and,0,0
81412,to,0,0
81413,compare,0,0
81414,the,0,0
81415,safety,0,0
81416,of,0,0
81417,artesunate,0,0
81418,plus,0,0
81419,amodiaquine,0,0
81420,",",0,0
81421,as,0,0
81422,a,0,0
81423,single,0,0
81424,daily,0,0
81425,intake,0,0
81426,versus,0,0
81427,two,0,0
81428,daily,0,0
81429,intakes,0,0
81430,.,0,0
81431,METHODS,0,0
81432,A,0,0
81433,three-day,0,0
81434,treatment,0,0
81435,period,0,0
81436,and,0,0
81437,14-day,0,0
81438,follow-up,0,0
81439,period,0,0
81440,was,0,0
81441,performed,0,0
81442,in,0,0
81443,any,1,0
81444,subject,1,0
81445,weighting,1,0
81446,more,1,0
81447,than,1,0
81448,10,1,0
81449,kg,1,0
81450,",",1,0
81451,presenting,1,1
81452,with,1,0
81453,a,1,0
81454,malaria,1,1
81455,paroxysm,1,0
81456,confirmed,1,0
81457,by,1,0
81458,parasitaemia,1,0
81459,>,1,0
81460,or,1,0
81461,=,1,0
81462,"1,000/microl",1,0
81463,",",1,0
81464,after,1,0
81465,informed,1,0
81466,consent,1,1
81467,.,1,1
81468,Patients,0,1
81469,were,0,0
81470,randomly,0,1
81471,allocated,0,0
81472,into,0,0
81473,one,0,0
81474,of,0,0
81475,the,0,0
81476,two,0,0
81477,regimens,0,0
81478,",",0,0
81479,with,0,1
81480,dosage,0,0
81481,according,0,1
81482,to,0,0
81483,bodyweight,0,0
81484,range,0,0
81485,.,0,0
81486,All,0,0
81487,products,0,0
81488,were,0,0
81489,administered,0,0
81490,by,0,0
81491,an,0,0
81492,authorized,0,0
81493,person,0,0
81494,",",0,0
81495,blinded,0,0
81496,to,0,0
81497,both,0,0
81498,the,0,0
81499,investigating,0,0
81500,physician,0,0
81501,and,0,0
81502,the,0,0
81503,biologist,0,0
81504,.,0,0
81505,The,0,0
81506,primary,0,0
81507,endpoint,0,0
81508,was,0,0
81509,an,0,0
81510,adequate,0,0
81511,response,0,0
81512,to,0,0
81513,treatment,0,0
81514,on,0,0
81515,D14,0,0
81516,(,0,0
81517,WHO,0,0
81518,definition,0,0
81519,),0,0
81520,.,0,0
81521,The,0,0
81522,two-sided,0,0
81523,90,0,0
81524,%,0,0
81525,confidence,0,0
81526,interval,0,0
81527,of,0,0
81528,the,0,0
81529,difference,0,0
81530,was,0,0
81531,calculated,0,0
81532,on,0,0
81533,intent,0,0
81534,to,0,0
81535,treat,0,0
81536,(,0,0
81537,ITT,0,0
81538,),0,0
81539,population,0,1
81540,;,0,0
81541,the,0,0
81542,acceptance,0,0
81543,limit,0,0
81544,for,0,0
81545,non-inferiority,0,0
81546,was,0,0
81547,3,0,0
81548,%,0,0
81549,.,0,0
81550,The,0,0
81551,safety,0,0
81552,was,0,0
81553,evaluated,0,0
81554,by,0,0
81555,incidence,0,0
81556,of,0,0
81557,adverse,0,0
81558,events,0,0
81559,.,0,1
81560,RESULTS,0,0
81561,Three-hundred,1,1
81562,and,1,0
81563,sixteen,1,1
81564,patients,1,1
81565,were,1,0
81566,included,1,1
81567,in,1,0
81568,the,1,0
81569,study,1,0
81570,.,1,0
81571,The,0,0
81572,two,0,0
81573,patient,0,0
81574,groups,0,0
81575,were,0,0
81576,strictly,0,0
81577,comparable,0,0
81578,on,0,0
81579,D0,0,0
81580,.,0,0
81581,The,0,0
81582,adequate,0,0
81583,responses,0,0
81584,to,0,0
81585,treatment,0,0
81586,were,0,0
81587,similar,0,0
81588,for,0,0
81589,the,0,0
81590,two,0,0
81591,treatment,0,0
81592,regimens,0,0
81593,on,0,0
81594,D14,0,0
81595,",",0,0
81596,PCR-corrected,0,0
81597,(,0,0
81598,"99,4",0,0
81599,%,0,0
81600,in,0,0
81601,the,0,0
81602,one-daily,0,0
81603,intake,0,0
81604,group,0,0
81605,versus,0,0
81606,"99,3",0,0
81607,%,0,0
81608,in,0,0
81609,the,0,0
81610,comparative,0,0
81611,group,0,0
81612,),0,0
81613,.,0,0
81614,The,0,0
81615,statistical,0,0
81616,analyses,0,0
81617,demonstrated,0,0
81618,the,0,0
81619,non-inferiority,0,0
81620,of,0,0
81621,administering,0,0
81622,artesunate/amodiaquine,0,0
81623,as,0,0
81624,two,0,0
81625,intakes,0,0
81626,.,0,0
81627,The,0,0
81628,drug,0,0
81629,was,0,0
81630,well,0,0
81631,tolerated,0,0
81632,.,0,0
81633,The,0,0
81634,main,0,0
81635,adverse,0,0
81636,events,0,0
81637,were,0,1
81638,gastrointestinal,0,1
81639,disorders,0,1
81640,(,0,0
81641,2.5,0,0
81642,%,0,0
81643,),0,0
81644,and,0,0
81645,pruritus,0,0
81646,(,0,0
81647,2.5,0,0
81648,%,0,0
81649,),0,0
81650,;,0,0
81651,safety,0,0
81652,profiles,0,0
81653,were,0,0
81654,similar,0,0
81655,in,0,0
81656,the,0,0
81657,two,0,0
81658,groups,0,0
81659,.,0,1
81660,CONCLUSION,0,0
81661,This,0,0
81662,pilot,0,0
81663,study,0,0
81664,confirms,0,0
81665,the,0,0
81666,efficacy,0,0
81667,and,0,0
81668,good,0,0
81669,tolerability,0,0
81670,of,0,0
81671,artesunate,0,0
81672,plus,0,0
81673,amodiaquine,0,0
81674,",",0,0
81675,administrated,0,0
81676,either,0,0
81677,in,0,0
81678,one,0,0
81679,or,0,1
81680,in,0,0
81681,two,0,0
81682,daily,0,0
81683,intakes,0,0
81684,.,0,1
81685,A,0,0
81686,field,0,0
81687,trial,0,0
81688,of,0,0
81689,production,0,0
81690,and,0,0
81691,financial,0,0
81692,consequences,0,0
81693,of,0,0
81694,helminthosis,0,1
81695,control,0,0
81696,in,0,0
81697,sheep,1,0
81698,production,1,0
81699,in,1,0
81700,Ethiopia,1,1
81701,.,1,0
81702,We,0,0
81703,used,0,0
81704,a,0,0
81705,partial-budget,0,0
81706,analysis,0,0
81707,to,0,0
81708,evaluate,0,0
81709,profitability,0,0
81710,of,0,0
81711,different,0,0
81712,management,0,1
81713,strategies,0,0
81714,of,0,0
81715,three,1,0
81716,genotypes,1,0
81717,of,1,0
81718,sheep,1,1
81719,in,1,0
81720,a,1,0
81721,2,1,0
81722,x,1,0
81723,2,1,0
81724,x,1,0
81725,3,1,0
81726,factorial,1,0
81727,experiment,1,0
81728,conducted,1,0
81729,at,1,0
81730,Debre,1,0
81731,Berhan,1,1
81732,research,1,0
81733,station,1,0
81734,in,1,0
81735,the,1,0
81736,central,1,0
81737,highlands,1,1
81738,of,1,0
81739,Ethiopia,1,1
81740,.,1,0
81741,This,0,0
81742,involved,0,0
81743,two,0,0
81744,anthelmintic-treatment,0,1
81745,levels,0,0
81746,(,0,0
81747,treated,0,1
81748,vs.,0,0
81749,non-treated,0,0
81750,),0,0
81751,",",0,0
81752,two,0,0
81753,supplementary,0,0
81754,nutrition,0,1
81755,levels,0,0
81756,(,0,0
81757,protein-energy,0,0
81758,supplementation,0,0
81759,yes/no,0,0
81760,),0,0
81761,and,0,0
81762,three,1,0
81763,genotypes,1,0
81764,:,1,1
81765,indigenous,1,1
81766,Menz,1,0
81767,(,1,0
81768,n=40,1,0
81769,),1,0
81770,",",1,0
81771,50,1,0
81772,%,1,0
81773,Awassi,1,0
81774,x,1,0
81775,50,1,0
81776,%,1,0
81777,Menz,1,0
81778,crosses,1,0
81779,(,1,0
81780,n=38,1,0
81781,),1,0
81782,and,1,0
81783,75,1,0
81784,%,1,0
81785,Awassi,1,0
81786,x,1,0
81787,25,1,0
81788,%,1,0
81789,Menz,1,0
81790,crosses,1,0
81791,(,1,0
81792,n=31,1,0
81793,),1,0
81794,.,1,0
81795,All,0,0
81796,sheep,1,0
81797,were,0,0
81798,exposed,0,0
81799,to,0,0
81800,natural,0,0
81801,sub-clinical,0,0
81802,helminthosis,0,1
81803,challenge,0,0
81804,.,0,0
81805,Supplemented,0,0
81806,sheep,0,0
81807,were,0,0
81808,offered,0,0
81809,a,0,0
81810,concentrate,0,0
81811,mix,0,0
81812,daily,0,0
81813,on,0,0
81814,an,0,0
81815,individual,0,0
81816,basis,0,0
81817,.,0,0
81818,Anthelmintic-treated,0,0
81819,sheep,0,0
81820,were,0,0
81821,drenched,0,0
81822,with,0,0
81823,fenbendazole,0,0
81824,against,0,0
81825,nematodes,0,1
81826,and,0,0
81827,with,0,1
81828,triclabendazole,0,0
81829,against,0,0
81830,trematodes,0,1
81831,.,0,1
81832,Data,0,0
81833,were,0,0
81834,collected,0,0
81835,during,0,0
81836,the,0,0
81837,experimental,0,0
81838,period,0,0
81839,(,0,0
81840,for,0,0
81841,10,0,1
81842,months,0,0
81843,from,0,0
81844,approximately,0,0
81845,1,0,0
81846,year,0,0
81847,of,0,0
81848,age,0,1
81849,),0,0
81850,on,0,0
81851,feed,0,0
81852,intake,0,0
81853,",",0,0
81854,live,0,0
81855,weight,0,0
81856,",",0,0
81857,eggs,0,0
81858,per,0,0
81859,gram,0,0
81860,(,0,0
81861,EPG,0,0
81862,),0,0
81863,of,0,0
81864,faeces,0,0
81865,",",0,0
81866,packed-cell,0,0
81867,volume,0,0
81868,(,0,0
81869,PCV,0,0
81870,),0,0
81871,",",0,0
81872,wool,0,0
81873,weight,0,0
81874,",",0,0
81875,and,0,0
81876,adult-worm,0,0
81877,burden,0,0
81878,.,0,0
81879,Actual,0,0
81880,market,0,0
81881,input,0,0
81882,and,0,0
81883,output,0,0
81884,prices,0,0
81885,were,0,0
81886,recorded,0,0
81887,.,0,0
81888,Supplemented,0,0
81889,sheep,0,0
81890,had,0,0
81891,significantly,0,0
81892,higher,0,0
81893,marginal,0,0
81894,profit,0,0
81895,(,0,0
81896,MP,0,0
81897,),0,0
81898,per,0,0
81899,sheep,0,0
81900,than,0,0
81901,non-supplemented,0,0
81902,sheep,0,1
81903,(,0,0
81904,ETB,0,0
81905,33,0,1
81906,vs.,0,0
81907,4,0,0
81908,),0,0
81909,.,0,0
81910,Likewise,0,0
81911,",",0,0
81912,anthelmintic,0,0
81913,treated,0,1
81914,sheep,0,0
81915,performed,0,0
81916,significantly,0,0
81917,better,0,0
81918,than,0,0
81919,their,0,0
81920,non-treated,0,0
81921,contemporaries,0,1
81922,(,0,0
81923,MP=ETB,0,0
81924,28,0,1
81925,vs.,0,0
81926,8,0,0
81927,),0,0
81928,.,0,0
81929,The,0,0
81930,75,0,0
81931,%,0,0
81932,Awassi,0,0
81933,crosses,0,0
81934,were,0,0
81935,least,0,1
81936,profitable,0,0
81937,.,0,0
81938,Cryotherapy,0,0
81939,does,0,0
81940,not,0,0
81941,affect,0,0
81942,peroneal,0,0
81943,reaction,0,0
81944,following,0,0
81945,sudden,0,1
81946,inversion,0,0
81947,.,0,0
81948,CONTEXT,0,0
81949,If,0,0
81950,ankle,0,1
81951,joint,0,0
81952,cryotherapy,0,0
81953,impairs,0,0
81954,the,0,0
81955,ability,0,0
81956,of,0,0
81957,the,0,0
81958,ankle,0,0
81959,musculature,0,0
81960,to,0,0
81961,counteract,0,0
81962,potentially,0,0
81963,injurious,0,0
81964,forces,0,0
81965,",",0,0
81966,the,0,0
81967,ankle,0,0
81968,is,0,0
81969,left,0,0
81970,vulnerable,0,0
81971,to,0,0
81972,injury,0,1
81973,.,0,0
81974,OBJECTIVE,0,0
81975,To,0,0
81976,compare,0,0
81977,peroneal,0,1
81978,reaction,0,0
81979,to,0,0
81980,sudden,0,0
81981,inversion,0,0
81982,following,0,0
81983,ankle,0,1
81984,joint,0,1
81985,cryotherapy,0,0
81986,.,0,0
81987,DESIGN,0,0
81988,Repeated,0,0
81989,measures,0,0
81990,design,0,0
81991,with,0,1
81992,independent,0,0
81993,variables,0,0
81994,",",0,0
81995,treatment,0,0
81996,(,0,0
81997,cryotherapy,0,0
81998,and,0,0
81999,control,0,0
82000,),0,0
82001,",",0,0
82002,and,0,0
82003,time,0,0
82004,(,0,0
82005,baseline,0,0
82006,",",0,0
82007,immediately,0,0
82008,post,0,0
82009,treatment,0,0
82010,",",0,0
82011,15,0,0
82012,minutes,0,0
82013,post,0,0
82014,treatment,0,0
82015,",",0,0
82016,and,0,0
82017,30,0,0
82018,minutes,0,0
82019,post,0,0
82020,treatment,0,0
82021,),0,0
82022,.,0,0
82023,SETTING,0,0
82024,University,1,1
82025,research,1,0
82026,laboratory,1,0
82027,.,1,0
82028,PATIENTS,0,0
82029,OR,0,0
82030,OTHER,0,0
82031,PARTICIPANTS,0,0
82032,Twenty-seven,1,1
82033,healthy,1,1
82034,volunteers,1,1
82035,.,1,1
82036,INTERVENTION,0,0
82037,(,0,0
82038,S,0,0
82039,),0,0
82040,An,0,0
82041,ice,0,0
82042,bag,0,0
82043,was,0,0
82044,secured,0,0
82045,to,0,0
82046,the,0,0
82047,lateral,0,0
82048,ankle,0,0
82049,joint,0,0
82050,for,0,0
82051,20,0,1
82052,minutes,0,0
82053,.,0,1
82054,MAIN,0,0
82055,OUTCOME,0,0
82056,MEASURES,0,0
82057,The,0,0
82058,onset,0,0
82059,and,0,0
82060,average,0,0
82061,root,0,0
82062,mean,0,0
82063,square,0,0
82064,amplitude,0,0
82065,of,0,0
82066,EMG,0,0
82067,activity,0,0
82068,in,0,0
82069,the,0,0
82070,peroneal,0,1
82071,muscles,0,0
82072,was,0,0
82073,calculated,0,0
82074,following,0,0
82075,the,0,0
82076,release,0,0
82077,of,0,0
82078,a,0,0
82079,trap,0,0
82080,door,0,0
82081,mechanism,0,0
82082,causing,0,0
82083,inversion,0,0
82084,.,0,0
82085,RESULTS,0,0
82086,There,0,0
82087,was,0,0
82088,no,0,0
82089,statistically,0,0
82090,significant,0,0
82091,change,0,0
82092,from,0,0
82093,baseline,0,0
82094,for,0,0
82095,peroneal,0,1
82096,reaction,0,0
82097,time,0,0
82098,or,0,0
82099,average,0,0
82100,peroneal,0,1
82101,muscle,0,0
82102,activity,0,0
82103,at,0,0
82104,any,0,0
82105,post,0,0
82106,treatment,0,0
82107,time,0,0
82108,.,0,0
82109,CONCLUSIONS,0,0
82110,Cryotherapy,0,0
82111,does,0,0
82112,not,0,0
82113,affect,0,0
82114,peroneal,0,0
82115,muscle,0,0
82116,reaction,0,0
82117,following,0,0
82118,sudden,0,0
82119,inversion,0,0
82120,perturbation,0,0
82121,.,0,0
82122,The,0,0
82123,impact,0,0
82124,of,0,0
82125,fasting,0,0
82126,and,0,0
82127,treatment,0,0
82128,omission,0,0
82129,on,0,0
82130,susceptibility,0,0
82131,to,0,0
82132,hypoglycaemia,0,0
82133,in,0,0
82134,children,1,1
82135,and,1,0
82136,adolescents,1,1
82137,with,1,1
82138,GH,1,0
82139,and,1,0
82140,cortisol,1,0
82141,insufficiency,1,1
82142,.,1,0
82143,OBJECTIVE,0,0
82144,Hypoglycaemia,0,0
82145,may,0,0
82146,be,0,0
82147,a,0,0
82148,frequent,0,0
82149,occurrence,0,0
82150,in,0,0
82151,young,1,1
82152,GH,1,0
82153,deficient,1,1
82154,patients,1,1
82155,and,0,0
82156,so,0,0
82157,we,0,0
82158,studied,0,0
82159,the,0,0
82160,response,0,0
82161,to,0,0
82162,fasting,0,0
82163,in,0,0
82164,children,1,1
82165,and,1,0
82166,adolescents,1,1
82167,with,1,1
82168,GH,1,0
82169,and/or,1,0
82170,cortisol,1,0
82171,deficiency,1,1
82172,.,1,0
82173,METHODS,0,0
82174,A,1,0
82175,total,1,1
82176,of,1,0
82177,20,1,1
82178,patients,1,1
82179,(,1,1
82180,2-18,1,1
82181,years,1,1
82182,),1,0
82183,fasted,1,1
82184,for,1,0
82185,14,1,0
82186,h,1,0
82187,(,1,0
82188,22.00-12.00,1,0
82189,h,1,0
82190,),1,0
82191,on,1,0
82192,two,1,0
82193,occasions,1,0
82194,as,0,0
82195,part,0,0
82196,of,0,0
82197,a,0,0
82198,randomized,0,0
82199,cross-over,0,0
82200,study,0,0
82201,.,0,0
82202,Fourteen,1,1
82203,had,1,0
82204,pituitary,1,0
82205,hormone,1,0
82206,deficiency,1,1
82207,(,1,0
82208,PHD,1,0
82209,),1,0
82210,including,1,0
82211,GH,1,0
82212,deficiency,1,1
82213,(,1,0
82214,GHD,1,0
82215,),1,0
82216,.,1,0
82217,Of,1,0
82218,the,1,0
82219,14,1,0
82220,patients,1,1
82221,",",1,0
82222,seven,1,1
82223,were,1,0
82224,ACTH,1,1
82225,sufficient,1,0
82226,(,1,0
82227,PHDC+,1,0
82228,),1,0
82229,and,1,0
82230,seven,1,0
82231,ACTH,1,1
82232,deficient,1,1
82233,(,1,0
82234,PHDC-,1,0
82235,),1,0
82236,.,1,0
82237,Six,1,0
82238,had,1,0
82239,primary,1,0
82240,adrenal,1,1
82241,failure,1,1
82242,(,1,0
82243,PAF,1,0
82244,),1,1
82245,.,1,0
82246,Subjects,0,1
82247,administered,0,0
82248,or,0,1
82249,omitted,0,0
82250,their,0,0
82251,normal,0,1
82252,dose,0,0
82253,of,0,0
82254,evening,0,0
82255,GH,0,0
82256,and/or,0,0
82257,morning,0,0
82258,hydrocortisone,0,0
82259,.,0,0
82260,Glucose,0,0
82261,",",0,0
82262,insulin,0,0
82263,",",0,0
82264,GH,0,0
82265,",",0,0
82266,cortisol,0,0
82267,",",0,0
82268,ketones,0,0
82269,and,0,0
82270,catecholamines,0,0
82271,were,0,0
82272,measured,0,0
82273,at,0,0
82274,04.00,0,0
82275,h,0,0
82276,and,0,0
82277,regularly,0,0
82278,from,0,0
82279,07.00,0,0
82280,to,0,0
82281,12.00,0,0
82282,h.,0,0
82283,Insulin,0,0
82284,sensitivity,0,0
82285,was,0,0
82286,assessed,0,0
82287,by,0,0
82288,HOMA,0,0
82289,and,0,0
82290,hypoglycaemia,0,0
82291,defined,0,0
82292,as,0,0
82293,a,0,0
82294,blood,0,0
82295,glucose,0,0
82296,(,0,0
82297,BG,0,1
82298,),0,0
82299,<,0,0
82300,/=,0,0
82301,3.3,0,0
82302,mmol/l,0,0
82303,.,0,0
82304,RESULTS,0,0
82305,BG,0,1
82306,was,0,0
82307,related,0,0
82308,to,0,0
82309,age,0,1
82310,and,0,0
82311,body,0,0
82312,mass,0,0
82313,index,0,0
82314,on,0,0
82315,treatment,0,0
82316,but,0,0
82317,no,0,0
82318,subject,0,0
82319,became,0,0
82320,hypoglycaemic,0,0
82321,on,0,0
82322,or,0,0
82323,off,0,0
82324,therapy,0,0
82325,prior,0,0
82326,to,0,0
82327,07.00,0,0
82328,h.,0,0
82329,Five,0,0
82330,children,0,1
82331,(,0,0
82332,aged,0,1
82333,3,0,0
82334,",",0,0
82335,4,0,0
82336,",",0,0
82337,7,0,0
82338,",",0,0
82339,8,0,0
82340,and,0,0
82341,11,0,1
82342,years,0,1
82343,),0,0
82344,were,0,0
82345,hypoglycaemic,0,0
82346,between,0,0
82347,07.00,0,0
82348,and,0,0
82349,12.00,0,0
82350,h,0,0
82351,off,0,0
82352,treatment,0,0
82353,.,0,0
82354,There,0,0
82355,was,0,0
82356,a,0,0
82357,positive,0,0
82358,relationship,0,0
82359,between,0,0
82360,GH,0,0
82361,AUC,0,0
82362,and,0,0
82363,minimum,0,0
82364,BG,0,1
82365,in,0,0
82366,patients,0,1
82367,with,0,1
82368,PHD,0,0
82369,on,0,0
82370,treatment,0,0
82371,(,0,0
82372,r,0,0
82373,(,0,0
82374,2,0,0
82375,),0,0
82376,=,0,0
82377,0.45,0,0
82378,",",0,0
82379,P,0,0
82380,=,0,0
82381,0.012,0,0
82382,),0,0
82383,with,0,0
82384,increased,0,0
82385,insulin,0,0
82386,sensitivity,0,0
82387,off,0,0
82388,treatment,0,0
82389,.,0,0
82390,Increased,0,0
82391,cortisol,0,0
82392,levels,0,0
82393,were,0,0
82394,seen,0,0
82395,in,0,0
82396,PHDC+,0,0
82397,patients,0,1
82398,off,0,0
82399,GH,0,0
82400,(,0,0
82401,P,0,0
82402,<,0,0
82403,0.001,0,0
82404,),0,0
82405,.,0,0
82406,A,0,0
82407,negative,0,0
82408,relationship,0,0
82409,was,0,0
82410,observed,0,0
82411,between,0,0
82412,minimum,0,0
82413,BG,0,1
82414,and,0,0
82415,adrenaline,0,0
82416,(,0,0
82417,r,0,0
82418,(,0,0
82419,2,0,0
82420,),0,0
82421,=,0,0
82422,0.37,0,0
82423,",",0,0
82424,P,0,0
82425,=,0,0
82426,0.01,0,0
82427,),0,0
82428,",",0,0
82429,ketone,0,0
82430,bodies,0,1
82431,(,0,0
82432,r,0,0
82433,(,0,0
82434,2,0,0
82435,),0,0
82436,=,0,0
82437,-0.20,0,0
82438,",",0,0
82439,P,0,0
82440,=,0,0
82441,0.05,0,0
82442,),0,0
82443,and,0,0
82444,NEFA,0,0
82445,(,0,0
82446,r,0,0
82447,(,0,0
82448,2,0,0
82449,),0,0
82450,=,0,0
82451,-0.35,0,0
82452,",",0,0
82453,P,0,0
82454,=,0,0
82455,0.02,0,0
82456,),0,0
82457,.,0,0
82458,Noradrenaline,0,0
82459,levels,0,0
82460,were,0,0
82461,reduced,0,0
82462,in,0,0
82463,patients,1,1
82464,with,1,1
82465,PHDC-,1,1
82466,.,1,1
82467,Low,0,0
82468,BMI,0,0
82469,(,0,0
82470,on,0,0
82471,treatment,0,0
82472,),0,0
82473,and,0,0
82474,young,0,1
82475,age,0,1
82476,(,0,0
82477,off,0,0
82478,treatment,0,0
82479,),0,0
82480,were,0,0
82481,determinants,0,0
82482,of,0,0
82483,low,0,1
82484,BG,0,1
82485,levels,0,0
82486,in,0,0
82487,a,0,0
82488,multiple,0,0
82489,regression,0,0
82490,model,0,0
82491,.,0,0
82492,CONCLUSIONS,0,0
82493,Unrecognized,0,0
82494,overnight,0,0
82495,hypoglycaemia,0,0
82496,in,0,0
82497,children,1,1
82498,and,1,0
82499,adolescents,1,1
82500,on,0,0
82501,pituitary,0,0
82502,hormone,0,0
82503,replacement,0,0
82504,is,0,0
82505,uncommon,0,0
82506,but,0,0
82507,BG,0,1
82508,levels,0,0
82509,quickly,0,0
82510,become,0,0
82511,abnormal,0,0
82512,when,0,0
82513,treatment,0,0
82514,and,0,0
82515,meals,0,0
82516,are,0,0
82517,omitted,0,0
82518,.,0,0
82519,The,0,0
82520,insulin,0,0
82521,antagonistic,0,0
82522,actions,0,0
82523,of,0,0
82524,GH,0,0
82525,are,0,0
82526,important,0,0
82527,in,0,0
82528,preventing,0,0
82529,hypoglycaemia,0,0
82530,.,0,0
82531,Patients,1,1
82532,with,1,1
82533,PHD,1,0
82534,have,0,0
82535,altered,0,0
82536,sympathetic,0,0
82537,nerve,0,0
82538,activity,0,0
82539,.,0,0
82540,[,0,0
82541,Effects,0,0
82542,of,0,0
82543,early,0,1
82544,acupuncture,0,0
82545,on,0,0
82546,motor,0,0
82547,function,0,0
82548,of,0,0
82549,the,0,0
82550,limb,0,0
82551,in,0,0
82552,the,0,0
82553,severe,1,1
82554,head,1,0
82555,injury,1,1
82556,patients,1,1
82557,],1,1
82558,.,0,0
82559,UNLABELLED,0,0
82560,OBJECTIVE,0,0
82561,;,0,0
82562,To,0,0
82563,observe,0,0
82564,the,0,0
82565,effects,0,0
82566,of,0,0
82567,early,0,1
82568,acupuncture,0,0
82569,on,0,0
82570,motor,0,0
82571,function,0,0
82572,of,0,0
82573,the,0,0
82574,limb,0,0
82575,in,0,0
82576,the,0,0
82577,severe,1,1
82578,head,1,0
82579,injury,1,1
82580,patients,1,1
82581,.,1,1
82582,METHODS,0,0
82583,Ninety-six,1,1
82584,patients,1,1
82585,were,0,0
82586,randomly,0,1
82587,divided,0,0
82588,into,0,0
82589,an,0,0
82590,observation,0,0
82591,group,0,0
82592,and,0,0
82593,a,0,0
82594,control,0,0
82595,group,0,0
82596,",",0,0
82597,48,1,0
82598,cases,1,0
82599,in,1,0
82600,each,1,0
82601,group,1,0
82602,.,1,0
82603,The,0,0
82604,patient,0,0
82605,in,0,0
82606,the,0,0
82607,control,0,0
82608,group,0,0
82609,were,0,0
82610,treated,0,0
82611,by,0,0
82612,routine,0,0
82613,treatment,0,0
82614,of,0,0
82615,neurosurgical,0,1
82616,operation,0,0
82617,and,0,0
82618,drug,0,0
82619,treatment,0,0
82620,(,0,0
82621,Mannitol,0,0
82622,",",0,0
82623,Citioline,0,0
82624,Sodium,0,0
82625,",",0,0
82626,Cefeazidime,0,0
82627,",",0,0
82628,etc.,0,0
82629,),0,0
82630,.,0,0
82631,While,0,0
82632,the,0,0
82633,patient,0,0
82634,in,0,0
82635,the,0,0
82636,observation,0,0
82637,group,0,0
82638,were,0,0
82639,treated,0,0
82640,by,0,0
82641,the,0,0
82642,routine,0,0
82643,treatment,0,0
82644,and,0,0
82645,acupuncture,0,0
82646,treatment,0,0
82647,48,0,0
82648,h,0,0
82649,(,0,0
82650,-1,0,0
82651,),0,0
82652,week,0,0
82653,after,0,0
82654,operation,0,0
82655,in,0,0
82656,different,0,0
82657,stages,0,1
82658,with,0,1
82659,different,0,0
82660,acupoints,0,0
82661,selected,0,0
82662,when,0,0
82663,the,0,0
82664,situation,0,0
82665,was,0,0
82666,stable,0,1
82667,.,0,0
82668,The,0,0
82669,selected,0,0
82670,main,0,0
82671,points,0,0
82672,were,0,0
82673,Neiguan,0,0
82674,(,0,0
82675,PC,0,0
82676,6,0,0
82677,),0,0
82678,",",0,0
82679,Qu-chi,0,1
82680,(,0,0
82681,LI,0,0
82682,11,0,1
82683,),0,0
82684,",",0,0
82685,Waiguan,0,0
82686,(,0,0
82687,TE,0,0
82688,5,0,0
82689,),0,0
82690,",",0,0
82691,Hegu,0,0
82692,(,0,0
82693,LI,0,0
82694,4,0,0
82695,),0,0
82696,",",0,0
82697,Binao,0,0
82698,(,0,0
82699,LI,0,0
82700,14,0,0
82701,),0,0
82702,",",0,0
82703,Jianyu,0,0
82704,(,0,0
82705,LI,0,0
82706,15,0,0
82707,),0,0
82708,",",0,0
82709,Fengshi,0,0
82710,(,0,0
82711,GB,0,0
82712,31,0,1
82713,),0,0
82714,",",0,0
82715,Xuehai,0,0
82716,(,0,0
82717,SP,0,1
82718,10,0,0
82719,),0,0
82720,",",0,0
82721,Yinlingquan,0,0
82722,(,0,0
82723,SP,0,1
82724,9,0,0
82725,),0,0
82726,",",0,0
82727,Sanyinjiao,0,0
82728,(,0,0
82729,SP,0,1
82730,6,0,0
82731,),0,0
82732,",",0,0
82733,Taichong,0,0
82734,(,0,0
82735,LR,0,0
82736,3,0,0
82737,),0,0
82738,",",0,0
82739,etc..,0,0
82740,The,0,0
82741,limb,0,0
82742,motor,0,0
82743,function,0,0
82744,was,0,0
82745,evaluated,0,0
82746,with,0,1
82747,Fugl-Meyer,0,0
82748,Assessment,0,0
82749,(,0,0
82750,FMA,0,0
82751,),0,0
82752,scale,0,0
82753,before,0,0
82754,treatment,0,0
82755,and,0,0
82756,after,0,0
82757,10-week,0,0
82758,treatment,0,0
82759,.,0,0
82760,RESULTS,0,0
82761,There,0,0
82762,was,0,0
82763,a,0,0
82764,significant,0,0
82765,improvement,0,0
82766,in,0,0
82767,the,0,0
82768,FMA,0,0
82769,score,0,0
82770,in,0,0
82771,the,0,0
82772,two,0,0
82773,groups,0,0
82774,after,0,0
82775,the,0,0
82776,treatment,0,0
82777,(,0,0
82778,P,0,0
82779,<,0,0
82780,0.01,0,0
82781,),0,0
82782,.,0,0
82783,The,0,0
82784,comparison,0,0
82785,between,0,0
82786,the,0,0
82787,two,0,0
82788,groups,0,0
82789,after,0,0
82790,the,0,0
82791,treatment,0,0
82792,showed,0,0
82793,that,0,0
82794,the,0,0
82795,improvement,0,0
82796,of,0,0
82797,FMA,0,0
82798,score,0,0
82799,in,0,0
82800,the,0,0
82801,observation,0,0
82802,group,0,0
82803,was,0,0
82804,significantly,0,0
82805,better,0,0
82806,than,0,0
82807,the,0,0
82808,control,0,0
82809,group,0,0
82810,(,0,0
82811,P,0,0
82812,<,0,0
82813,0.05,0,0
82814,or,0,0
82815,P,0,0
82816,<,0,0
82817,0.01,0,0
82818,),0,0
82819,.,0,0
82820,CONCLUSION,0,0
82821,Early,0,0
82822,acupuncture,0,0
82823,can,0,0
82824,improve,0,0
82825,the,0,0
82826,limb,0,0
82827,motor,0,0
82828,function,0,0
82829,in,0,0
82830,the,0,0
82831,severe,1,1
82832,head,1,0
82833,injury,1,1
82834,patients,1,1
82835,.,1,1
82836,Prospective,0,0
82837,randomized,0,0
82838,controlled,0,0
82839,trial,0,0
82840,to,0,0
82841,evaluate,0,0
82842,fast-track,1,0
82843,elective,1,1
82844,open,1,1
82845,infrarenal,1,1
82846,aneurysm,1,1
82847,repair,1,1
82848,.,1,0
82849,BACKGROUND,0,0
82850,AND,0,0
82851,AIMS,0,0
82852,Fast-track,0,0
82853,programs,0,0
82854,have,0,0
82855,been,0,0
82856,introduced,0,0
82857,in,0,0
82858,many,0,1
82859,surgical,0,1
82860,fields,0,0
82861,to,0,0
82862,minimize,0,0
82863,postoperative,0,0
82864,morbidity,0,0
82865,and,0,0
82866,mortality,0,0
82867,.,0,0
82868,Morbidity,0,0
82869,after,0,0
82870,elective,1,1
82871,open,1,1
82872,infrarenal,1,1
82873,aneurysm,1,0
82874,repair,1,0
82875,is,0,0
82876,as,0,0
82877,high,0,0
82878,as,0,0
82879,30,0,1
82880,%,0,0
82881,;,0,0
82882,mortality,0,0
82883,ranges,0,0
82884,up,0,0
82885,to,0,0
82886,10,0,1
82887,%,0,0
82888,.,0,0
82889,In,0,0
82890,terms,0,0
82891,of,0,0
82892,open,1,1
82893,infrarenal,1,1
82894,aneurysm,1,1
82895,repair,1,0
82896,",",0,0
82897,no,0,0
82898,randomized,0,0
82899,controlled,0,0
82900,trials,0,0
82901,exist,0,0
82902,to,0,0
82903,introduce,0,0
82904,and,0,0
82905,evaluate,0,0
82906,such,0,0
82907,patient,0,0
82908,care,0,1
82909,programs,0,0
82910,.,0,0
82911,MATERIALS,0,0
82912,AND,0,0
82913,METHODS,0,0
82914,This,0,0
82915,study,0,0
82916,involved,0,0
82917,prospective,0,0
82918,randomization,0,0
82919,of,0,0
82920,82,1,1
82921,patients,1,1
82922,in,1,0
82923,a,1,0
82924,traditional,1,0
82925,and,1,0
82926,a,1,0
82927,fast-track,1,0
82928,treatment,1,0
82929,arm,1,0
82930,.,1,0
82931,Main,0,0
82932,differences,0,0
82933,consisted,0,1
82934,in,0,0
82935,preoperative,0,0
82936,bowel,0,0
82937,washout,0,0
82938,(,0,0
82939,none,0,0
82940,vs.,0,0
82941,3,0,0
82942,l,0,0
82943,cleaning,0,0
82944,solution,0,0
82945,),0,0
82946,and,0,0
82947,analgesia,0,0
82948,(,0,0
82949,patient,0,0
82950,controlled,0,0
82951,analgesia,0,0
82952,vs.,0,0
82953,patient,0,0
82954,controlled,0,0
82955,epidural,0,0
82956,analgesia,0,0
82957,),0,0
82958,.,0,0
82959,Study,0,0
82960,endpoints,0,0
82961,were,0,0
82962,morbidity,0,0
82963,and,0,0
82964,mortality,0,0
82965,",",0,0
82966,need,0,0
82967,for,0,0
82968,postoperative,0,0
82969,mechanical,0,0
82970,ventilation,0,0
82971,",",0,0
82972,and,0,0
82973,length,0,0
82974,of,0,0
82975,stay,0,0
82976,(,0,0
82977,LOS,0,0
82978,),0,0
82979,on,0,0
82980,intensive,0,0
82981,care,0,0
82982,unit,0,0
82983,(,0,0
82984,ICU,0,0
82985,),0,0
82986,.,0,0
82987,RESULTS,0,0
82988,The,0,0
82989,need,0,0
82990,for,0,0
82991,assisted,0,0
82992,postoperative,0,0
82993,ventilation,0,0
82994,was,0,0
82995,significantly,0,0
82996,higher,0,0
82997,in,0,0
82998,the,0,0
82999,traditional,0,0
83000,group,0,0
83001,(,0,0
83002,33.3,0,0
83003,%,0,0
83004,vs.,0,0
83005,5.4,0,0
83006,%,0,0
83007,;,0,0
83008,p,0,0
83009,=,0,0
83010,0.011,0,0
83011,),0,0
83012,.,0,0
83013,Median,0,0
83014,LOS,0,0
83015,on,0,0
83016,ICU,0,0
83017,was,0,0
83018,shorter,0,0
83019,in,0,0
83020,the,0,0
83021,fast-track,0,0
83022,group,0,0
83023,",",0,0
83024,41,0,1
83025,vs.,0,0
83026,20,0,0
83027,h.,0,0
83028,The,0,0
83029,rate,0,0
83030,of,0,0
83031,postoperative,0,0
83032,medical,0,1
83033,complications,0,0
83034,was,0,0
83035,significantly,0,0
83036,lower,0,0
83037,in,0,0
83038,the,0,0
83039,fast-track,0,0
83040,group,0,0
83041,",",0,0
83042,16.2,0,0
83043,%,0,0
83044,vs.,0,0
83045,35.7,0,0
83046,%,0,0
83047,(,0,0
83048,p,0,0
83049,=,0,0
83050,0.045,0,0
83051,),0,0
83052,.,0,0
83053,CONCLUSION,0,0
83054,We,0,0
83055,introduced,0,0
83056,and,0,0
83057,evaluated,0,0
83058,an,0,0
83059,optimized,0,0
83060,patient,0,0
83061,care,0,0
83062,program,0,0
83063,for,0,0
83064,patients,1,1
83065,undergoing,1,1
83066,open,1,1
83067,infrarenal,1,1
83068,aortic,1,1
83069,aneurysm,1,1
83070,repair,1,0
83071,which,0,0
83072,showed,0,0
83073,a,0,0
83074,significant,0,0
83075,advantage,0,0
83076,for,0,0
83077,fast-track,0,0
83078,patients,0,1
83079,in,0,0
83080,terms,0,0
83081,of,0,0
83082,postoperative,0,0
83083,morbidity,0,0
83084,.,0,0
83085,Effect,0,0
83086,of,0,0
83087,erythromycin,0,0
83088,and,0,0
83089,gentamicin,0,0
83090,on,0,0
83091,abomasal,1,0
83092,emptying,1,0
83093,rate,1,0
83094,in,1,0
83095,suckling,1,1
83096,calves,1,1
83097,.,1,1
83098,BACKGROUND,0,0
83099,Commonly,0,0
83100,used,0,0
83101,dosage,0,0
83102,protocols,0,0
83103,for,0,0
83104,antimicrobial,0,0
83105,agents,0,0
83106,may,0,0
83107,alter,0,0
83108,the,0,0
83109,rate,0,0
83110,of,0,0
83111,gastric,0,1
83112,emptying,0,0
83113,.,0,1
83114,HYPOTHESIS,0,0
83115,Parenteral,0,0
83116,administration,0,0
83117,of,0,0
83118,erythromycin,0,0
83119,increases,0,0
83120,and,0,0
83121,gentamicin,0,0
83122,decreases,0,0
83123,the,0,0
83124,rate,0,0
83125,of,0,0
83126,abomasal,0,0
83127,emptying,0,0
83128,.,0,0
83129,ANIMALS,0,0
83130,Five,1,0
83131,male,1,1
83132,Holstein-Friesian,1,1
83133,calves,1,1
83134,(,1,1
83135,8-15,1,1
83136,days,1,0
83137,of,1,0
83138,age,1,1
83139,),1,0
83140,.,1,1
83141,METHODS,0,0
83142,Calves,0,1
83143,received,0,0
83144,each,0,0
83145,of,0,0
83146,the,0,0
83147,following,0,0
83148,4,0,0
83149,IM,0,1
83150,treatments,0,0
83151,in,0,0
83152,random,0,1
83153,order,0,0
83154,:,0,1
83155,control,0,0
83156,",",0,0
83157,2,0,0
83158,mL,0,0
83159,of,0,0
83160,0.9,0,0
83161,%,0,0
83162,NaCl,0,0
83163,;,0,0
83164,erythromycin,0,0
83165,",",0,0
83166,8.8,0,0
83167,mg/kg,0,0
83168,;,0,0
83169,low-dose,0,0
83170,gentamicin,0,0
83171,",",0,0
83172,4.4,0,0
83173,mg/kg,0,0
83174,;,0,0
83175,high-dose,0,0
83176,gentamicin,0,0
83177,",",0,0
83178,6.6,0,0
83179,mg/kg,0,0
83180,.,0,0
83181,Abomasal,0,0
83182,emptying,0,0
83183,rate,0,0
83184,was,0,0
83185,assessed,0,0
83186,by,0,0
83187,acetaminophen,0,0
83188,and,0,0
83189,glucose,0,0
83190,absorption,0,0
83191,.,0,1
83192,Calves,0,0
83193,were,0,0
83194,fed,0,0
83195,2,0,0
83196,L,0,0
83197,of,0,0
83198,cow,0,0
83199,'s,0,0
83200,milk,0,0
83201,containing,0,0
83202,acetaminophen,0,0
83203,(,0,0
83204,50,0,0
83205,mg/kg,0,0
83206,body,0,0
83207,weight,0,0
83208,),0,0
83209,30,0,0
83210,minutes,0,0
83211,after,0,0
83212,each,0,0
83213,treatment,0,0
83214,was,0,0
83215,administered,0,0
83216,",",0,0
83217,and,0,0
83218,jugular,0,0
83219,venous,0,0
83220,blood,0,0
83221,samples,0,0
83222,were,0,0
83223,obtained,0,0
83224,periodically,0,0
83225,after,0,0
83226,suckling,0,0
83227,.,0,0
83228,The,0,0
83229,maximum,0,0
83230,observed,0,0
83231,plasma,0,0
83232,acetaminophen,0,0
83233,concentration,0,0
83234,(,0,0
83235,actual,0,0
83236,C,0,0
83237,(,0,0
83238,max,0,1
83239,),0,0
83240,),0,0
83241,and,0,0
83242,time,0,0
83243,of,0,0
83244,actual,0,0
83245,C,0,0
83246,(,0,0
83247,max,0,0
83248,),0,0
83249,(,0,0
83250,actual,0,0
83251,T,0,0
83252,(,0,0
83253,max,0,1
83254,),0,0
83255,),0,0
83256,were,0,0
83257,determined,0,0
83258,",",0,0
83259,and,0,0
83260,pharmacokinetic,0,0
83261,modeling,0,0
83262,was,0,0
83263,used,0,0
83264,to,0,0
83265,calculate,0,0
83266,model,0,0
83267,C,0,0
83268,(,0,0
83269,max,0,0
83270,),0,0
83271,and,0,0
83272,model,0,0
83273,T,0,0
83274,(,0,0
83275,max,0,1
83276,),0,0
83277,.,0,0
83278,RESULTS,0,0
83279,Erythromycin,0,0
83280,increased,0,0
83281,abomasal,0,0
83282,emptying,0,0
83283,rate,0,0
83284,",",0,0
83285,as,0,0
83286,indicated,0,0
83287,by,0,0
83288,a,0,0
83289,shorter,0,0
83290,time,0,0
83291,to,0,0
83292,actual,0,0
83293,T,0,0
83294,(,0,0
83295,max,0,0
83296,),0,0
83297,and,0,0
83298,model,0,0
83299,T,0,0
83300,(,0,0
83301,max,0,0
83302,),0,0
83303,(,0,0
83304,P,0,0
83305,<,0,0
83306,.05,0,0
83307,),0,0
83308,.,0,0
83309,Abomasal,0,0
83310,emptying,0,0
83311,rate,0,0
83312,after,0,0
83313,injection,0,0
83314,of,0,0
83315,low-dose,0,0
83316,gentamicin,0,0
83317,was,0,0
83318,similar,0,0
83319,to,0,0
83320,that,0,0
83321,of,0,0
83322,control,0,0
83323,.,0,0
83324,Administration,0,0
83325,of,0,0
83326,high-dose,0,0
83327,gentamicin,0,0
83328,resulted,0,0
83329,in,0,0
83330,a,0,0
83331,longer,0,0
83332,time,0,0
83333,to,0,0
83334,actual,0,0
83335,T,0,0
83336,(,0,0
83337,max,0,0
83338,),0,0
83339,(,0,0
83340,P=,0,0
83341,.021,0,0
83342,),0,0
83343,but,0,0
83344,did,0,0
83345,not,0,0
83346,change,0,0
83347,model,0,0
83348,T,0,0
83349,(,0,0
83350,max,0,0
83351,),0,0
83352,(,0,0
83353,P=,0,0
83354,.62,0,0
83355,),0,0
83356,.,0,0
83357,CONCLUSIONS,0,0
83358,AND,0,0
83359,CLINICAL,0,1
83360,RELEVANCE,0,1
83361,IM,0,0
83362,injection,0,0
83363,of,0,0
83364,erythromycin,0,0
83365,increased,0,0
83366,abomasal,0,0
83367,emptying,0,0
83368,rate,0,0
83369,in,0,0
83370,dairy,1,1
83371,calves,1,1
83372,",",0,0
83373,whereas,0,0
83374,low-dose,0,0
83375,and,0,0
83376,high-dose,0,0
83377,gentamicin,0,0
83378,did,0,0
83379,not,0,0
83380,alter,0,0
83381,the,0,0
83382,rate,0,0
83383,of,0,0
83384,abomasal,0,0
83385,emptying,0,0
83386,as,0,0
83387,measured,0,0
83388,by,0,0
83389,acetaminophen,0,0
83390,kinetics,0,0
83391,and,0,0
83392,glucose,0,0
83393,absorption,0,0
83394,.,0,0
83395,The,0,0
83396,clinical,0,0
83397,relevance,0,0
83398,of,0,0
83399,these,0,0
83400,findings,0,0
83401,remains,0,0
83402,to,0,0
83403,be,0,0
83404,determined,0,0
83405,.,0,0
83406,Safety,0,0
83407,and,0,0
83408,tolerability,0,0
83409,of,0,0
83410,cold-adapted,0,0
83411,influenza,0,1
83412,vaccine,0,0
83413,",",0,0
83414,trivalent,0,0
83415,",",0,0
83416,in,0,0
83417,infants,1,1
83418,younger,1,1
83419,than,1,0
83420,6,1,0
83421,months,1,0
83422,of,1,0
83423,age,1,1
83424,.,1,0
83425,OBJECTIVE,0,0
83426,Young,1,1
83427,children,1,1
83428,are,0,0
83429,at,0,0
83430,high,0,0
83431,risk,0,0
83432,for,0,0
83433,influenza-related,0,0
83434,complications,0,0
83435,.,0,0
83436,Vaccination,0,0
83437,of,0,0
83438,close,0,0
83439,household,0,0
83440,contacts,0,0
83441,is,0,0
83442,recommended,0,0
83443,to,0,0
83444,provide,0,0
83445,indirect,0,0
83446,protection,0,0
83447,to,0,0
83448,children,1,1
83449,<,1,0
83450,6,1,0
83451,months,1,0
83452,of,1,0
83453,age,1,1
83454,.,1,0
83455,Studies,0,0
83456,have,0,0
83457,shown,0,0
83458,that,0,0
83459,live,0,0
83460,",",0,0
83461,cold-adapted,0,0
83462,influenza,0,1
83463,vaccine,0,0
83464,",",0,0
83465,trivalent,0,0
83466,",",0,0
83467,is,0,0
83468,efficacious,0,0
83469,in,0,0
83470,children,1,1
83471,.,1,0
83472,To,0,0
83473,assess,0,0
83474,the,0,0
83475,risks,0,0
83476,associated,0,0
83477,with,0,1
83478,inadvertent,0,0
83479,exposure,0,0
83480,of,0,0
83481,infants,0,1
83482,to,0,0
83483,vaccine,0,0
83484,viruses,0,0
83485,from,0,0
83486,vaccinated,0,1
83487,contacts,0,0
83488,",",0,0
83489,this,0,0
83490,study,0,0
83491,was,0,0
83492,designed,0,0
83493,to,0,0
83494,evaluate,0,0
83495,the,0,0
83496,safety,0,0
83497,and,0,0
83498,tolerability,0,0
83499,of,0,0
83500,cold-adapted,0,0
83501,influenza,0,1
83502,vaccine,0,0
83503,",",0,0
83504,trivalent,0,0
83505,",",0,0
83506,administered,0,0
83507,intranasally,0,0
83508,to,0,0
83509,healthy,1,1
83510,children,1,1
83511,6,1,0
83512,to,1,0
83513,<,1,0
83514,24,1,0
83515,weeks,1,0
83516,of,1,0
83517,age,1,1
83518,.,1,0
83519,METHODS,0,0
83520,Healthy,1,1
83521,infants,1,1
83522,aged,1,1
83523,6,1,0
83524,to,1,0
83525,<,1,0
83526,16,1,1
83527,weeks,1,0
83528,and,1,0
83529,16,1,1
83530,to,1,0
83531,<,1,0
83532,24,1,0
83533,weeks,1,0
83534,",",0,0
83535,respectively,0,0
83536,",",0,0
83537,were,0,0
83538,randomly,0,0
83539,assigned,0,0
83540,to,0,0
83541,receive,0,0
83542,2,0,0
83543,doses,0,0
83544,of,0,0
83545,influenza,0,1
83546,vaccine,0,0
83547,",",0,0
83548,or,0,0
83549,placebo,0,0
83550,intranasally,0,0
83551,35,0,0
83552,+/-,0,0
83553,7,0,0
83554,days,0,0
83555,apart,0,0
83556,.,0,0
83557,Reactogenicity,0,0
83558,events,0,0
83559,were,0,0
83560,monitored,0,0
83561,for,0,0
83562,11,0,1
83563,days,0,0
83564,after,0,0
83565,each,0,0
83566,dose,0,0
83567,.,0,0
83568,Other,0,0
83569,adverse,0,0
83570,events,0,0
83571,were,0,0
83572,monitored,0,0
83573,through,0,0
83574,28,0,0
83575,to,0,0
83576,35,0,1
83577,days,0,0
83578,after,0,0
83579,dose,0,0
83580,2,0,0
83581,.,0,0
83582,RESULTS,0,0
83583,Of,0,0
83584,the,0,0
83585,infants,1,1
83586,aged,1,1
83587,6,1,0
83588,to,1,0
83589,<,1,0
83590,16,1,1
83591,weeks,1,0
83592,",",0,0
83593,31,0,1
83594,received,0,0
83595,influenza,0,1
83596,vaccine,0,0
83597,and,0,0
83598,28,0,0
83599,received,0,0
83600,placebo,0,0
83601,",",0,0
83602,and,0,0
83603,of,0,0
83604,those,1,0
83605,aged,1,1
83606,16,1,0
83607,to,1,0
83608,<,1,0
83609,24,1,0
83610,weeks,1,0
83611,",",0,0
83612,30,0,0
83613,received,0,0
83614,influenza,0,1
83615,vaccine,0,0
83616,and,0,0
83617,31,0,1
83618,received,0,0
83619,placebo,0,0
83620,.,0,0
83621,In,0,0
83622,the,0,0
83623,6-,0,0
83624,to,0,0
83625,<,0,0
83626,16-week,0,0
83627,cohort,0,0
83628,",",0,0
83629,more,0,0
83630,influenza,0,0
83631,vaccine,0,0
83632,",",0,0
83633,recipients,0,1
83634,experienced,0,0
83635,irritability,0,0
83636,(,0,0
83637,66.7,0,0
83638,%,0,0
83639,vs,0,0
83640,35.7,0,0
83641,%,0,0
83642,),0,0
83643,and,0,0
83644,runny,0,0
83645,nose,0,1
83646,or,0,0
83647,nasal,0,0
83648,congestion,0,0
83649,(,0,0
83650,63.3,0,0
83651,%,0,0
83652,vs,0,0
83653,33.3,0,0
83654,%,0,0
83655,),0,0
83656,after,0,0
83657,dose,0,0
83658,1,0,0
83659,but,0,0
83660,not,0,0
83661,dose,0,0
83662,2,0,0
83663,.,0,0
83664,There,0,0
83665,were,0,0
83666,no,0,0
83667,significant,0,0
83668,increases,0,0
83669,in,0,0
83670,any,0,0
83671,other,0,0
83672,reactogenicity,0,0
83673,events,0,0
83674,or,0,1
83675,adverse,0,0
83676,events,0,0
83677,in,0,0
83678,the,0,0
83679,vaccine,0,0
83680,recipients,0,1
83681,compared,0,0
83682,with,0,1
83683,the,0,0
83684,placebo,0,0
83685,group,0,0
83686,.,0,0
83687,CONCLUSIONS,0,0
83688,Although,0,0
83689,there,0,0
83690,was,0,0
83691,an,0,0
83692,increase,0,0
83693,in,0,0
83694,mild,0,1
83695,reactogenicity,0,0
83696,events,0,0
83697,in,0,0
83698,children,1,1
83699,6,1,0
83700,to,1,0
83701,<,1,0
83702,16,1,1
83703,weeks,1,0
83704,of,1,0
83705,age,1,1
83706,",",0,0
83707,cold-adapted,0,0
83708,influenza,0,1
83709,vaccine,0,0
83710,",",0,0
83711,trivalent,0,0
83712,",",0,0
83713,was,0,0
83714,generally,0,0
83715,well,0,0
83716,tolerated,0,0
83717,in,0,0
83718,infants,1,1
83719,6,1,0
83720,to,1,0
83721,<,1,0
83722,24,1,0
83723,weeks,1,0
83724,of,1,0
83725,age,1,1
83726,.,1,0
83727,These,0,0
83728,findings,0,0
83729,support,0,0
83730,further,0,0
83731,evaluation,0,0
83732,of,0,0
83733,cold-adapted,0,0
83734,influenza,0,1
83735,vaccine,0,0
83736,",",0,0
83737,trivalent,0,0
83738,",",0,0
83739,in,0,0
83740,infants,1,1
83741,<,1,0
83742,6,1,0
83743,months,1,0
83744,of,1,0
83745,age,1,1
83746,.,1,0
83747,Closure,0,0
83748,of,0,0
83749,the,0,0
83750,femoral,0,0
83751,artery,0,1
83752,after,1,0
83753,cardiac,1,1
83754,catheterization,1,1
83755,:,1,1
83756,a,0,0
83757,comparison,0,0
83758,of,0,0
83759,Angio-Seal,0,0
83760,",",0,0
83761,StarClose,0,0
83762,",",0,0
83763,and,0,0
83764,manual,0,0
83765,compression,0,0
83766,.,0,0
83767,OBJECTIVES,0,0
83768,To,0,0
83769,compare,0,0
83770,Angio-Seal,0,0
83771,(,0,0
83772,AS,0,0
83773,),0,0
83774,and,0,0
83775,StarClose,0,0
83776,(,0,0
83777,SC,0,0
83778,),0,0
83779,and,0,0
83780,manual,0,0
83781,compression,0,0
83782,(,0,0
83783,MC,0,0
83784,),0,0
83785,on,0,0
83786,efficacy,0,0
83787,of,0,0
83788,hemostasis,0,0
83789,",",0,0
83790,complication,0,0
83791,rate,0,0
83792,",",0,0
83793,safety,0,0
83794,of,0,0
83795,early,0,0
83796,mobilization,0,0
83797,",",0,0
83798,and,0,0
83799,patient,0,0
83800,comfort,0,0
83801,.,0,0
83802,BACKGROUND,0,0
83803,Closure,0,0
83804,of,0,0
83805,the,0,0
83806,femoral,0,0
83807,artery,0,1
83808,after,0,0
83809,cardiac,0,0
83810,catheterization,0,1
83811,can,0,0
83812,be,0,0
83813,obtained,0,0
83814,through,0,0
83815,different,0,0
83816,methods,0,1
83817,.,0,0
83818,Today,0,0
83819,",",0,0
83820,physicians,0,0
83821,can,0,0
83822,choose,0,0
83823,from,0,0
83824,a,0,0
83825,number,0,0
83826,of,0,0
83827,different,0,0
83828,devices,0,0
83829,to,0,0
83830,achieve,0,0
83831,arterial,0,0
83832,closure,0,1
83833,.,0,0
83834,METHODS,0,0
83835,In,0,0
83836,a,0,0
83837,prospective,0,0
83838,trial,0,0
83839,450,1,0
83840,patients,1,1
83841,were,0,0
83842,randomized,0,0
83843,to,0,0
83844,AS,0,0
83845,",",0,0
83846,SC,0,0
83847,",",0,0
83848,or,0,0
83849,MC,0,0
83850,.,0,0
83851,Patients,0,1
83852,were,0,0
83853,mobilized,0,0
83854,1,0,0
83855,to,0,0
83856,2,0,0
83857,hr,0,0
83858,after,0,0
83859,device,0,0
83860,placement,0,0
83861,",",0,0
83862,and,0,0
83863,6,0,0
83864,hr,0,0
83865,after,0,0
83866,MC,0,0
83867,.,0,1
83868,Data,0,0
83869,were,0,0
83870,collected,0,0
83871,during,0,0
83872,hospital,0,0
83873,admission,0,0
83874,and,0,0
83875,by,0,0
83876,telephone,0,0
83877,at,0,0
83878,one,0,0
83879,month,0,0
83880,after,0,0
83881,hospital,0,1
83882,discharge,0,0
83883,.,0,1
83884,RESULTS,0,0
83885,Devices,0,0
83886,were,0,1
83887,used,0,0
83888,in,0,0
83889,138/150,0,0
83890,allocated,0,0
83891,to,0,0
83892,AS,0,0
83893,and,0,0
83894,124/150,0,0
83895,allocated,0,0
83896,to,0,0
83897,SC,0,0
83898,patients,0,1
83899,(,0,0
83900,92,0,1
83901,%,0,0
83902,vs.,0,0
83903,83,0,0
83904,%,0,0
83905,",",0,0
83906,P,0,0
83907,=,0,0
83908,0.015,0,0
83909,),0,0
83910,Patients,0,1
83911,with,0,1
83912,MC,0,0
83913,experienced,0,0
83914,more,0,0
83915,pain,0,0
83916,during,0,0
83917,sheath,0,0
83918,removal,0,0
83919,than,0,0
83920,patients,0,1
83921,receiving,0,1
83922,a,0,0
83923,device,0,0
83924,",",0,0
83925,and,0,0
83926,rated,0,0
83927,their,0,0
83928,period,0,0
83929,of,0,0
83930,bed,0,0
83931,rest,0,0
83932,as,0,0
83933,less,0,0
83934,comfortable,0,0
83935,.,0,0
83936,Oozing,0,0
83937,and,0,0
83938,need,0,0
83939,for,0,0
83940,pressure,0,0
83941,bandage,0,0
83942,at,0,0
83943,the,0,0
83944,puncture,0,0
83945,site,0,0
83946,were,0,0
83947,observed,0,0
83948,in,0,0
83949,37,0,1
83950,AS,0,1
83951,patients,0,1
83952,and,0,0
83953,57,0,1
83954,SC,0,0
83955,patients,0,1
83956,(,0,0
83957,25,0,0
83958,%,0,0
83959,vs.,0,0
83960,38,0,0
83961,%,0,0
83962,",",0,0
83963,P,0,0
83964,=,0,0
83965,0.002,0,0
83966,),0,0
83967,.,0,0
83968,Hematoma,0,0
83969,occurred,0,0
83970,in,0,0
83971,15,0,0
83972,AS,0,0
83973,patients,0,1
83974,",",0,0
83975,in,0,0
83976,17,0,1
83977,SC,0,0
83978,patients,0,1
83979,",",0,0
83980,and,0,0
83981,in,0,0
83982,14,0,0
83983,MC,0,0
83984,patients,0,1
83985,(,0,0
83986,11,0,1
83987,vs.,0,0
83988,14,0,0
83989,vs.,0,0
83990,9,0,0
83991,%,0,0
83992,",",0,0
83993,ns,0,0
83994,),0,0
83995,.,0,0
83996,CONCLUSION,0,0
83997,There,0,0
83998,is,0,0
83999,no,0,0
84000,difference,0,0
84001,in,0,0
84002,safety,0,0
84003,between,0,0
84004,the,0,0
84005,three,0,0
84006,methods,0,1
84007,of,0,0
84008,arterial,0,1
84009,closure,0,1
84010,.,0,0
84011,SC,0,0
84012,was,0,0
84013,more,0,0
84014,often,0,0
84015,not,0,0
84016,used,0,0
84017,or,0,0
84018,successfully,0,0
84019,deployed,0,0
84020,.,0,0
84021,SC,0,0
84022,patients,0,1
84023,more,0,0
84024,often,0,0
84025,had,0,0
84026,continuing,0,0
84027,oozing,0,0
84028,.,0,0
84029,On,0,0
84030,patient,0,0
84031,comfort,0,0
84032,",",0,0
84033,closure,0,1
84034,devices,0,0
84035,performed,0,0
84036,better,0,0
84037,than,0,0
84038,MC,0,0
84039,.,0,0
84040,Early,0,0
84041,ambulation,0,0
84042,in,0,0
84043,patients,0,1
84044,with,0,1
84045,a,0,0
84046,closure,0,0
84047,device,0,0
84048,is,0,0
84049,safe,0,0
84050,.,0,0
84051,AS,0,0
84052,is,0,0
84053,the,0,0
84054,preferred,0,0
84055,method,0,0
84056,of,0,0
84057,arterial,0,0
84058,closure,0,1
84059,after,0,0
84060,cardiac,0,0
84061,catheterization,0,1
84062,.,0,0
84063,Nurse,0,0
84064,and,0,0
84065,patient,0,0
84066,communication,0,0
84067,profiles,0,0
84068,in,0,0
84069,a,0,0
84070,home-based,1,0
84071,telehealth,1,0
84072,intervention,1,0
84073,for,0,0
84074,heart,0,1
84075,failure,0,1
84076,management,0,0
84077,.,0,0
84078,OBJECTIVE,0,0
84079,This,0,0
84080,study,0,0
84081,compared,0,0
84082,differences,0,0
84083,in,0,0
84084,nurse,1,1
84085,and,1,0
84086,patient,1,0
84087,communication,0,0
84088,profiles,0,0
84089,between,0,0
84090,two,0,0
84091,telehealth,0,1
84092,modes,0,0
84093,:,0,1
84094,telephone,0,0
84095,and,0,0
84096,videophone,0,0
84097,",",0,0
84098,and,0,0
84099,evaluated,0,0
84100,longitudinal,0,1
84101,changes,0,0
84102,in,0,0
84103,communication,0,0
84104,",",0,0
84105,nurse,0,0
84106,perceptions,0,0
84107,",",0,0
84108,and,0,0
84109,patient,0,0
84110,satisfaction,0,0
84111,.,0,1
84112,METHODS,0,0
84113,Subjects,1,1
84114,were,0,1
84115,enrolled,0,1
84116,in,0,0
84117,a,0,0
84118,randomized,1,0
84119,controlled,1,0
84120,clinical,1,0
84121,trial,1,0
84122,evaluating,0,0
84123,a,0,0
84124,90-day,0,0
84125,home-based,0,0
84126,intervention,0,0
84127,for,0,0
84128,heart,0,1
84129,failure,0,1
84130,.,0,0
84131,Telephone,1,0
84132,(,1,0
84133,n=14,1,1
84134,),1,0
84135,and,1,0
84136,videophone,1,0
84137,(,1,0
84138,n=14,1,1
84139,),1,0
84140,interactions,1,0
84141,were,0,0
84142,audio,0,0
84143,taped,0,0
84144,and,0,0
84145,analyzed,0,0
84146,using,0,0
84147,the,0,0
84148,Roter,0,0
84149,Interaction,0,0
84150,Analysis,0,0
84151,System,0,0
84152,.,0,1
84153,RESULTS,0,0
84154,Nurses,1,0
84155,were,0,0
84156,more,0,0
84157,likely,0,0
84158,to,0,0
84159,use,0,0
84160,open-ended,0,0
84161,questions,0,0
84162,",",0,0
84163,back-channel,0,0
84164,responses,0,0
84165,",",0,0
84166,friendly,0,0
84167,jokes,0,0
84168,",",0,0
84169,and,0,0
84170,checks,0,0
84171,for,0,0
84172,understanding,0,0
84173,on,0,0
84174,the,0,0
84175,telephone,0,0
84176,compared,0,0
84177,to,0,0
84178,videophone,0,0
84179,.,0,0
84180,Compliments,0,0
84181,given,0,0
84182,and,0,0
84183,partnership,0,0
84184,were,0,0
84185,more,0,0
84186,common,0,0
84187,on,0,0
84188,the,0,0
84189,videophone,0,0
84190,.,0,0
84191,Patients,1,0
84192,were,0,0
84193,more,0,0
84194,likely,0,0
84195,to,0,0
84196,give,0,0
84197,lifestyle,0,0
84198,information,0,0
84199,and,0,0
84200,approval,0,0
84201,comments,0,0
84202,on,0,0
84203,the,0,0
84204,telephone,0,0
84205,",",0,0
84206,and,0,0
84207,used,0,0
84208,more,0,0
84209,closed-ended,0,0
84210,questions,0,0
84211,on,0,0
84212,the,0,0
84213,videophone,0,0
84214,.,0,0
84215,Nurses,0,0
84216,perceptions,0,0
84217,of,0,0
84218,the,0,0
84219,interactions,0,0
84220,were,0,0
84221,not,0,0
84222,different,0,0
84223,between,0,0
84224,the,0,0
84225,telephone,0,0
84226,and,0,0
84227,videophone,0,0
84228,",",0,0
84229,nor,0,0
84230,did,0,0
84231,their,0,0
84232,perceptions,0,0
84233,change,0,0
84234,significantly,0,0
84235,over,0,0
84236,the,0,0
84237,course,0,0
84238,of,0,0
84239,the,0,0
84240,intervention,0,0
84241,.,0,0
84242,There,0,0
84243,were,0,0
84244,no,0,0
84245,significant,0,0
84246,differences,0,0
84247,in,0,0
84248,patient,0,0
84249,satisfaction,0,0
84250,between,0,0
84251,the,0,0
84252,telephone,0,0
84253,and,0,0
84254,videophone,0,0
84255,.,0,0
84256,CONCLUSIONS,0,0
84257,The,0,0
84258,results,0,0
84259,of,0,0
84260,this,0,0
84261,study,0,0
84262,did,0,0
84263,not,0,0
84264,support,0,0
84265,use,0,0
84266,of,0,0
84267,a,0,0
84268,videophone,0,0
84269,over,0,0
84270,the,0,0
84271,telephone,0,0
84272,.,0,0
84273,PRACTICE,0,0
84274,IMPLICATIONS,0,0
84275,It,0,0
84276,is,0,0
84277,critical,0,0
84278,to,0,0
84279,match,0,0
84280,technologies,0,0
84281,to,0,0
84282,patient,0,0
84283,needs,0,0
84284,and,0,0
84285,use,0,0
84286,the,0,0
84287,least,0,0
84288,complex,0,0
84289,technology,0,0
84290,possible,0,0
84291,.,0,0
84292,When,0,0
84293,considering,0,0
84294,use,0,0
84295,a,0,0
84296,videophone,0,0
84297,",",0,0
84298,health,0,0
84299,care,0,0
84300,providers,0,0
84301,should,0,0
84302,critically,0,0
84303,examine,0,0
84304,the,0,0
84305,trade-offs,0,0
84306,between,0,0
84307,additional,0,0
84308,complexities,0,0
84309,with,0,1
84310,the,0,0
84311,added,0,0
84312,value,0,0
84313,of,0,0
84314,the,0,0
84315,visual,0,0
84316,interaction,0,0
84317,.,0,0
84318,Pentoxifylline,0,0
84319,to,0,0
84320,treat,0,0
84321,radiation,1,0
84322,proctitis,1,0
84323,:,1,0
84324,a,0,0
84325,small,0,0
84326,and,0,0
84327,inconclusive,0,0
84328,randomised,0,0
84329,trial,0,0
84330,.,0,0
84331,This,0,0
84332,prospective,0,0
84333,randomised,0,0
84334,controlled,0,0
84335,study,1,0
84336,of,1,0
84337,40,1,0
84338,patients,1,1
84339,could,0,0
84340,not,0,0
84341,show,0,0
84342,a,0,0
84343,statistically,0,0
84344,significant,0,0
84345,advantage,0,0
84346,with,0,1
84347,6,0,0
84348,months,0,0
84349,of,0,0
84350,pentoxifylline,0,0
84351,compared,0,0
84352,with,0,1
84353,standard,0,0
84354,measures,0,0
84355,for,0,0
84356,late,0,1
84357,radiation-induced,0,0
84358,rectal,0,1
84359,bleeding,0,0
84360,.,0,0
84361,However,0,0
84362,",",0,0
84363,a,0,0
84364,modest,0,0
84365,benefit,0,0
84366,can,0,0
84367,not,0,0
84368,be,0,0
84369,excluded,0,0
84370,and,0,0
84371,larger,0,0
84372,randomised,0,0
84373,placebo-controlled,0,0
84374,trials,0,0
84375,with,0,1
84376,longer,0,0
84377,durations,0,0
84378,of,0,0
84379,pentoxifylline,0,0
84380,treatment,0,0
84381,may,0,0
84382,be,0,0
84383,justified,0,0
84384,.,0,0
84385,[,0,0
84386,Isometric,0,0
84387,hip,0,1
84388,muscle,0,0
84389,strength,0,0
84390,in,0,0
84391,posttraumatic,0,1
84392,below-knee,1,1
84393,amputees,1,1
84394,],1,1
84395,.,0,0
84396,BACKGROUND/AIM,0,0
84397,Traumas,0,1
84398,and,0,0
84399,war,0,1
84400,injuries,0,1
84401,",",0,0
84402,next,0,0
84403,to,0,0
84404,chronic,0,1
84405,occlusive,0,0
84406,artery,0,1
84407,disease,0,1
84408,and,0,0
84409,diabetes,0,1
84410,mellitus-derived,0,0
84411,complications,0,0
84412,",",0,0
84413,are,0,0
84414,the,0,0
84415,most,0,0
84416,frequent,0,0
84417,cause,0,0
84418,of,0,0
84419,the,0,0
84420,lower,0,0
84421,limbs,0,0
84422,amputation,0,0
84423,.,0,0
84424,They,0,0
84425,affect,0,0
84426,mostly,0,0
84427,younger,1,1
84428,population,1,0
84429,that,0,0
84430,need,0,0
84431,a,0,0
84432,higher,0,0
84433,level,0,0
84434,of,0,0
84435,activities,0,0
84436,as,0,0
84437,compared,0,0
84438,with,0,1
84439,the,0,0
84440,elderly,0,1
84441,.,0,0
84442,Medical,0,0
84443,rehabilitation,0,0
84444,is,0,0
84445,very,0,0
84446,significant,0,0
84447,for,0,0
84448,the,0,0
84449,muscle,0,0
84450,performance,0,0
84451,improvement,0,0
84452,in,0,0
84453,this,0,0
84454,population,0,0
84455,providing,0,0
84456,their,0,0
84457,social,0,0
84458,reintegration,0,1
84459,.,0,0
84460,The,0,0
84461,aim,0,0
84462,of,0,0
84463,this,0,0
84464,study,0,0
84465,was,0,0
84466,to,0,0
84467,investigate,0,0
84468,the,0,0
84469,effect,0,0
84470,of,0,0
84471,below-knee,0,1
84472,amputation,0,1
84473,on,0,0
84474,the,0,0
84475,hip,0,1
84476,isometric,0,0
84477,muscle,0,0
84478,strength,0,0
84479,and,0,0
84480,effect,0,0
84481,of,0,0
84482,rehabilitation,0,1
84483,on,0,0
84484,improvement,0,0
84485,of,0,0
84486,hip,0,1
84487,muscle,0,0
84488,strength,0,0
84489,in,0,0
84490,below-knee,1,1
84491,amputees,1,1
84492,",",1,0
84493,secondary,1,0
84494,to,1,0
84495,war,1,1
84496,wounding,1,0
84497,.,1,0
84498,METHODS,0,0
84499,Forty,1,1
84500,below-knee,1,1
84501,amputees,1,1
84502,(,1,0
84503,after,1,0
84504,war,1,1
84505,wounding,1,0
84506,),1,0
84507,",",1,0
84508,average,1,0
84509,age,1,1
84510,35.6,1,0
84511,+/-,1,0
84512,10.6,1,0
84513,years,1,1
84514,",",1,0
84515,that,1,0
84516,were,1,0
84517,included,1,1
84518,in,1,0
84519,primary,1,0
84520,rehabilitation,1,1
84521,program,1,0
84522,with,1,1
84523,prosthetics,1,0
84524,",",1,0
84525,were,1,0
84526,examined,1,0
84527,.,1,0
84528,Objective,0,0
84529,parameters,0,0
84530,were,0,0
84531,used,0,0
84532,to,0,0
84533,evaluate,0,0
84534,therapeutical,0,0
84535,effects,0,0
84536,.,0,1
84537,Isometric,0,0
84538,muscle,0,0
84539,strength,0,0
84540,of,0,0
84541,hip,0,1
84542,flexors,0,0
84543,",",0,0
84544,extensors,0,0
84545,",",0,0
84546,abductors,0,0
84547,and,0,0
84548,adductors,0,1
84549,was,0,0
84550,measured,0,0
84551,by,0,0
84552,dynamometer,0,0
84553,and,0,0
84554,expressed,0,0
84555,in,0,0
84556,Newton,0,1
84557,(,0,0
84558,N,0,1
84559,),0,0
84560,at,0,0
84561,admission,0,0
84562,",",0,0
84563,control,0,0
84564,and,0,0
84565,discharge,0,0
84566,for,0,0
84567,each,0,0
84568,patient,0,0
84569,.,0,0
84570,Average,0,0
84571,length,0,0
84572,of,0,0
84573,the,0,0
84574,treatment,0,0
84575,was,0,0
84576,51,0,1
84577,+/-,0,0
84578,34.1,0,0
84579,days,0,0
84580,.,0,1
84581,RESULTS,0,0
84582,For,0,0
84583,isometric,0,0
84584,hip,0,1
84585,flexors,0,0
84586,(,0,0
84587,t,0,0
84588,=,0,0
84589,-1.99346,0,0
84590,",",0,0
84591,p,0,0
84592,<,0,0
84593,0.05,0,0
84594,),0,0
84595,",",0,0
84596,extensors,0,0
84597,(,0,0
84598,t,0,0
84599,=,0,0
84600,-4.629073,0,0
84601,",",0,0
84602,p,0,0
84603,<,0,0
84604,0.001,0,0
84605,),0,0
84606,",",0,0
84607,abductors,0,0
84608,(,0,0
84609,t,0,0
84610,=,0,0
84611,-4.9408,0,0
84612,",",0,0
84613,p,0,0
84614,<,0,0
84615,0.001,0,0
84616,),0,0
84617,and,0,0
84618,adductors,0,1
84619,(,0,0
84620,t,0,0
84621,=,0,0
84622,-2.00228,0,0
84623,",",0,0
84624,p,0,0
84625,<,0,0
84626,0.05,0,0
84627,),0,0
84628,",",0,0
84629,muscle,0,0
84630,strength,0,0
84631,was,0,0
84632,significantly,0,0
84633,less,0,0
84634,on,0,0
84635,the,0,0
84636,amputated,0,0
84637,than,0,0
84638,on,0,0
84639,nonamputated,0,0
84640,side,0,0
84641,.,0,0
84642,The,0,0
84643,highest,0,0
84644,differences,0,0
84645,in,0,0
84646,muscle,0,0
84647,strength,0,0
84648,between,0,0
84649,amputated,0,0
84650,and,0,0
84651,nonamputated,0,0
84652,limbs,0,0
84653,were,0,0
84654,noted,0,0
84655,for,0,0
84656,hip,0,1
84657,abductors,0,0
84658,(,0,0
84659,26.6,0,0
84660,%,0,0
84661,),0,0
84662,and,0,0
84663,extensors,0,0
84664,(,0,0
84665,23.3,0,0
84666,%,0,0
84667,),0,0
84668,.,0,0
84669,There,0,0
84670,was,0,0
84671,significant,0,0
84672,improvement,0,0
84673,of,0,0
84674,mean,0,0
84675,values,0,0
84676,of,0,0
84677,strength,0,0
84678,for,0,0
84679,all,0,0
84680,examined,0,0
84681,hip,0,1
84682,muscles,0,0
84683,after,0,0
84684,rehabilitation,0,1
84685,and,0,0
84686,prosthetics,0,0
84687,for,0,0
84688,both,0,0
84689,legs,0,0
84690,in,0,0
84691,comparison,0,0
84692,to,0,0
84693,beginning,0,0
84694,of,0,0
84695,the,0,0
84696,therapy,0,0
84697,.,0,0
84698,The,0,0
84699,hip,0,0
84700,abductor,0,0
84701,on,0,0
84702,the,0,0
84703,amputated,0,0
84704,side,0,0
84705,was,0,0
84706,for,0,0
84707,19.4,0,0
84708,%,0,0
84709,weaker,0,0
84710,after,0,0
84711,rehabilitation,0,1
84712,in,0,0
84713,comparison,0,0
84714,to,0,0
84715,the,0,0
84716,non-amputated,0,0
84717,limb,0,0
84718,.,0,0
84719,CONCLUSION,0,0
84720,Decreases,0,0
84721,of,0,0
84722,isometric,0,0
84723,muscle,0,0
84724,strength,0,0
84725,in,0,0
84726,all,0,0
84727,examined,0,0
84728,hip,0,1
84729,muscles,0,0
84730,were,0,0
84731,observed,0,0
84732,",",0,0
84733,more,0,0
84734,in,0,0
84735,the,0,0
84736,amputated,0,0
84737,limb,0,0
84738,.,0,0
84739,Rehabilitation,0,0
84740,with,0,0
84741,prosthetics,0,0
84742,is,0,0
84743,a,0,0
84744,successful,0,0
84745,method,0,0
84746,for,0,0
84747,improving,0,0
84748,isometric,0,0
84749,hip,0,1
84750,muscle,0,0
84751,strength,0,0
84752,on,0,0
84753,the,0,0
84754,both,0,0
84755,",",0,0
84756,amputated,1,0
84757,and,1,0
84758,non-amputated,1,0
84759,limbs,1,0
84760,in,1,0
84761,war,1,1
84762,wounded,1,1
84763,below-knee,1,1
84764,amputees,1,1
84765,.,1,1
84766,Post-laparoscopic,1,1
84767,cholecystectomy,1,1
84768,pain,1,0
84769,:,1,1
84770,effects,0,0
84771,of,0,0
84772,intraperitoneal,0,0
84773,local,0,0
84774,anesthetics,0,0
84775,on,0,0
84776,pain,0,1
84777,control,0,0
84778,--,0,0
84779,a,0,0
84780,randomized,0,0
84781,prospective,0,0
84782,double-blinded,0,0
84783,placebo-controlled,0,0
84784,trial,0,0
84785,.,0,0
84786,Postoperative,1,0
84787,pain,1,0
84788,after,1,0
84789,laparoscopic,1,0
84790,cholecystectomy,1,1
84791,(,1,0
84792,LC,1,0
84793,),1,0
84794,is,0,0
84795,generally,0,0
84796,less,0,0
84797,than,0,0
84798,open,0,1
84799,cholecystectomy,0,1
84800,;,0,0
84801,however,0,0
84802,",",0,0
84803,the,0,0
84804,postoperative,0,0
84805,shoulder,0,0
84806,and,0,0
84807,abdominal,0,1
84808,pain,0,0
84809,experienced,0,0
84810,by,0,0
84811,patients,0,1
84812,still,0,0
84813,causes,0,0
84814,preventable,0,0
84815,distress,0,0
84816,.,0,0
84817,Intraperitoneal,0,0
84818,irrigation,0,0
84819,of,0,0
84820,the,0,0
84821,diaphragmatic,0,1
84822,surface,0,0
84823,and,0,0
84824,gallbladder,0,0
84825,fossa,0,0
84826,using,0,0
84827,normal,0,1
84828,saline,0,0
84829,",",0,0
84830,bupivacaine,0,0
84831,",",0,0
84832,or,0,0
84833,lignocaine,0,0
84834,may,0,0
84835,effectively,0,0
84836,control,0,0
84837,visceral,0,0
84838,abdominal,0,1
84839,pain,0,0
84840,after,0,0
84841,an,0,0
84842,LC,0,0
84843,.,0,0
84844,Two,1,0
84845,hundred,1,1
84846,patients,1,1
84847,with,1,1
84848,similar,1,0
84849,demographics,1,0
84850,undergoing,1,1
84851,elective,1,1
84852,LC,1,0
84853,were,0,0
84854,randomized,0,0
84855,to,0,0
84856,one,0,0
84857,of,0,0
84858,four,1,1
84859,groups,1,0
84860,of,1,0
84861,50,1,1
84862,patients,1,1
84863,each,1,0
84864,",",0,0
84865,including,0,0
84866,Group,0,0
84867,A,0,0
84868,placebo,0,0
84869,control,0,0
84870,",",0,0
84871,Group,0,0
84872,B,0,0
84873,with,0,1
84874,isotonic,0,0
84875,saline,0,0
84876,irrigation,0,0
84877,",",0,0
84878,Group,0,0
84879,C,0,0
84880,with,0,1
84881,bupivacaine,0,0
84882,irrigation,0,0
84883,",",0,0
84884,and,0,0
84885,Group,0,0
84886,D,0,0
84887,with,0,1
84888,lignocaine,0,0
84889,irrigation,0,0
84890,.,0,0
84891,All,0,0
84892,patients,1,1
84893,received,0,0
84894,preperitoneal,0,1
84895,abdominal,0,1
84896,wall,0,0
84897,infiltration,0,0
84898,with,0,1
84899,0.25,0,0
84900,per,0,0
84901,cent,0,0
84902,bupivacaine,0,0
84903,to,0,0
84904,control,0,0
84905,parietal,1,0
84906,(,1,0
84907,somatic,1,0
84908,),1,0
84909,abdominal,1,1
84910,pain,1,0
84911,.,1,0
84912,The,0,0
84913,visual,0,0
84914,analogue,0,0
84915,and,0,0
84916,verbal,0,0
84917,rating,0,0
84918,pain,0,0
84919,scores,0,0
84920,at,0,0
84921,0,0,0
84922,",",0,0
84923,4,0,0
84924,",",0,0
84925,8,0,0
84926,",",0,0
84927,12,0,0
84928,and,0,0
84929,24,0,0
84930,hours,0,0
84931,for,0,0
84932,both,0,0
84933,shoulder,0,0
84934,and,0,0
84935,abdominal,0,1
84936,pain,0,0
84937,were,0,0
84938,recorded,0,0
84939,in,0,0
84940,a,0,0
84941,prospective,0,0
84942,double-blind,0,0
84943,fashion,0,0
84944,at,0,0
84945,four,0,0
84946,points,0,0
84947,during,0,0
84948,the,0,0
84949,first,0,0
84950,24,0,0
84951,postoperative,0,0
84952,hours,0,0
84953,.,0,1
84954,Analgesia,0,0
84955,requirements,0,0
84956,",",0,0
84957,vital,0,0
84958,signs,0,0
84959,",",0,0
84960,blood,0,0
84961,glucose,0,0
84962,",",0,0
84963,and,0,0
84964,incidence,0,0
84965,of,0,0
84966,nausea,0,0
84967,and,0,0
84968,vomiting,0,0
84969,were,0,0
84970,also,0,0
84971,recorded,0,0
84972,.,0,0
84973,Patients,1,1
84974,in,1,0
84975,each,1,0
84976,group,1,0
84977,demonstrated,0,0
84978,a,0,0
84979,significant,0,0
84980,difference,0,0
84981,in,0,0
84982,visual,0,0
84983,analogue,0,0
84984,and,0,0
84985,verbal,0,0
84986,rating,0,0
84987,pain,0,0
84988,scores,0,0
84989,and,0,0
84990,analgesic,0,0
84991,consumption,0,0
84992,when,0,0
84993,compared,0,0
84994,with,0,0
84995,controls,0,1
84996,.,0,1
84997,Lignocaine,0,0
84998,controlled,0,0
84999,pain,0,0
85000,significantly,0,0
85001,better,0,0
85002,than,0,0
85003,saline,0,0
85004,or,0,0
85005,bupivacaine,0,0
85006,.,0,0
85007,Bowel,0,0
85008,function,0,0
85009,recovery,0,0
85010,was,0,0
85011,similar,0,0
85012,in,0,0
85013,all,1,0
85014,patients,1,1
85015,",",0,0
85016,and,0,0
85017,there,0,0
85018,were,0,0
85019,no,0,0
85020,significant,0,0
85021,complications,0,0
85022,.,0,0
85023,We,0,0
85024,conclude,0,0
85025,that,0,0
85026,intraperitoneal,0,0
85027,irrigation,0,0
85028,with,0,0
85029,either,0,0
85030,saline,0,0
85031,",",0,0
85032,bupivacaine,0,0
85033,",",0,0
85034,or,0,0
85035,lignocaine,0,0
85036,can,0,0
85037,significantly,0,0
85038,reduce,0,0
85039,visceral,0,0
85040,abdominal,0,1
85041,pain,0,0
85042,after,0,0
85043,LC,0,0
85044,.,0,1
85045,Lignocaine,0,0
85046,was,0,0
85047,the,0,0
85048,most,0,0
85049,efficacious,0,0
85050,local,0,0
85051,anesthetic,0,0
85052,in,0,0
85053,this,0,0
85054,trial,0,0
85055,and,0,0
85056,has,0,0
85057,a,0,0
85058,high,0,0
85059,safety,0,0
85060,profile,0,0
85061,when,0,0
85062,used,0,0
85063,at,0,0
85064,recommended,0,0
85065,doses,0,0
85066,.,0,1
85067,Determinants,0,0
85068,of,0,0
85069,improvement,0,0
85070,in,0,0
85071,walking,0,0
85072,capacity,0,0
85073,among,0,0
85074,individuals,1,1
85075,with,1,1
85076,chronic,1,1
85077,stroke,1,1
85078,following,0,0
85079,a,0,0
85080,multi-dimensional,0,0
85081,exercise,0,0
85082,program,0,0
85083,.,0,0
85084,OBJECTIVE,0,0
85085,To,0,0
85086,identify,0,0
85087,the,0,0
85088,determinants,0,0
85089,of,0,0
85090,improvement,0,0
85091,in,0,0
85092,walking,0,0
85093,capacity,0,0
85094,following,0,0
85095,therapeutic,0,0
85096,exercise,0,0
85097,in,0,0
85098,chronic,1,1
85099,stroke,1,1
85100,survivors,1,1
85101,.,1,0
85102,DESIGN,0,0
85103,A,0,0
85104,secondary,0,0
85105,analysis,0,0
85106,of,0,0
85107,data,0,0
85108,obtained,0,0
85109,from,0,0
85110,a,0,0
85111,prospective,0,0
85112,",",0,0
85113,single-blind,0,0
85114,",",0,0
85115,randomized,0,0
85116,controlled,0,0
85117,intervention,0,0
85118,trial,0,0
85119,.,0,0
85120,SUBJECTS,0,0
85121,Sixty-three,1,1
85122,community-dwelling,1,1
85123,individuals,1,1
85124,(,1,0
85125,mean,1,1
85126,age,1,1
85127,=,1,0
85128,65,1,1
85129,years,1,1
85130,",",1,0
85131,age,1,1
85132,range,1,0
85133,=,1,0
85134,50-87,1,1
85135,years,1,1
85136,),1,0
85137,with,1,1
85138,a,1,0
85139,chronic,1,1
85140,stroke,1,1
85141,(,1,0
85142,post-stroke,1,1
85143,duration,1,0
85144,:,1,1
85145,mean,1,0
85146,=,1,0
85147,5.5,1,0
85148,years,1,1
85149,",",1,0
85150,range,1,0
85151,=,1,0
85152,1-28,1,0
85153,years,1,1
85154,),1,1
85155,.,1,1
85156,METHODS,0,0
85157,Subjects,0,1
85158,were,0,1
85159,randomized,0,1
85160,into,0,0
85161,a,0,0
85162,leg,0,0
85163,exercise,0,0
85164,group,0,0
85165,(,0,0
85166,n,0,1
85167,=,0,0
85168,32,0,1
85169,),0,0
85170,or,0,0
85171,an,0,0
85172,arm,0,0
85173,exercise,0,0
85174,group,0,0
85175,(,0,0
85176,n,0,1
85177,=,0,0
85178,31,0,1
85179,),0,0
85180,.,0,0
85181,Subjects,0,0
85182,in,0,0
85183,each,0,0
85184,group,0,0
85185,underwent,0,1
85186,3,0,0
85187,1-hour,0,0
85188,exercise,0,0
85189,sessions,0,0
85190,per,0,0
85191,week,0,0
85192,for,0,0
85193,19,0,1
85194,weeks,0,0
85195,.,0,0
85196,Walking,0,0
85197,capacity,0,0
85198,",",0,0
85199,cardiorespiratory,0,0
85200,fitness,0,0
85201,",",0,0
85202,isometric,0,0
85203,knee,0,1
85204,extensor,0,0
85205,muscle,0,0
85206,strength,0,0
85207,",",0,0
85208,balance,0,0
85209,ability,0,0
85210,",",0,0
85211,and,0,0
85212,balance,0,0
85213,confidence,0,0
85214,were,0,0
85215,evaluated,0,0
85216,before,0,0
85217,and,0,0
85218,after,0,0
85219,the,0,0
85220,interventions,0,0
85221,.,0,0
85222,Multiple,0,0
85223,regression,0,0
85224,analysis,0,0
85225,was,0,0
85226,performed,0,0
85227,to,0,0
85228,identify,0,0
85229,the,0,0
85230,determinants,0,0
85231,of,0,0
85232,improvement,0,0
85233,in,0,0
85234,walking,0,0
85235,capacity,0,0
85236,.,0,0
85237,RESULTS,0,0
85238,After,0,0
85239,controlling,0,0
85240,for,0,0
85241,age,0,1
85242,",",0,0
85243,gender,0,0
85244,",",0,0
85245,post-stroke,0,0
85246,duration,0,0
85247,",",0,0
85248,and,0,0
85249,baseline,0,0
85250,walking,0,0
85251,capacity,0,0
85252,",",0,0
85253,gain,0,0
85254,in,0,0
85255,paretic,0,0
85256,leg,0,0
85257,muscle,0,0
85258,strength,0,0
85259,and,0,0
85260,peak,0,0
85261,oxygen,0,0
85262,consumption,0,0
85263,remained,0,0
85264,independently,0,0
85265,associated,0,0
85266,with,0,0
85267,gain,0,0
85268,in,0,0
85269,walking,0,0
85270,capacity,0,0
85271,(,0,0
85272,R2,0,1
85273,=,0,0
85274,0.229,0,0
85275,),0,0
85276,.,0,0
85277,CONCLUSION,0,0
85278,Enhancement,0,0
85279,of,0,0
85280,cardiorespiratory,0,0
85281,fitness,0,0
85282,and,0,0
85283,paretic,0,0
85284,leg,0,0
85285,muscle,0,0
85286,strength,0,0
85287,are,0,0
85288,both,0,0
85289,significant,0,0
85290,determinants,0,0
85291,in,0,0
85292,improving,0,0
85293,walking,0,0
85294,capacity,0,0
85295,among,0,0
85296,chronic,0,1
85297,stroke,0,1
85298,survivors,0,1
85299,.,0,0
85300,However,0,0
85301,",",0,0
85302,the,0,0
85303,rather,0,0
85304,weak,0,0
85305,relationship,0,0
85306,(,0,0
85307,R2,0,1
85308,=,0,0
85309,0.229,0,0
85310,),0,0
85311,indicates,0,0
85312,that,0,0
85313,other,0,0
85314,factors,0,0
85315,not,0,0
85316,measured,0,0
85317,in,0,0
85318,this,0,0
85319,study,0,0
85320,may,0,0
85321,also,0,0
85322,contribute,0,0
85323,to,0,0
85324,the,0,0
85325,improvement,0,0
85326,in,0,0
85327,walking,0,0
85328,capacity,0,0
85329,.,0,0
85330,Effect,0,0
85331,of,0,0
85332,intestinal,0,1
85333,production,0,0
85334,of,0,0
85335,equol,0,0
85336,on,0,0
85337,menopausal,1,1
85338,symptoms,1,0
85339,in,1,0
85340,women,1,1
85341,treated,1,1
85342,with,1,1
85343,soy,1,0
85344,isoflavones,1,0
85345,.,1,1
85346,OBJECTIVE,0,0
85347,To,0,0
85348,evaluate,0,0
85349,the,0,0
85350,effect,0,0
85351,of,0,0
85352,soy,0,0
85353,isoflavones,0,0
85354,on,0,0
85355,menopausal,0,1
85356,symptoms,0,0
85357,in,0,1
85358,women,1,1
85359,who,1,1
85360,do,1,1
85361,and,1,1
85362,who,1,1
85363,do,1,0
85364,not,1,0
85365,produce,1,0
85366,equol,1,0
85367,",",0,0
85368,a,0,0
85369,daidzein,0,0
85370,metabolite,0,0
85371,.,0,0
85372,METHOD,0,0
85373,A,0,0
85374,randomized,0,0
85375,",",0,0
85376,double-blind,0,0
85377,",",0,0
85378,placebo-controlled,0,0
85379,clinical,0,0
85380,trial,0,0
85381,was,0,0
85382,conducted,0,0
85383,over,0,0
85384,6,0,0
85385,months,0,0
85386,with,0,1
85387,96,1,1
85388,healthy,1,1
85389,menopausal,1,1
85390,women,1,1
85391,.,1,0
85392,After,0,0
85393,taking,0,0
85394,take,0,0
85395,135,0,1
85396,mg,0,0
85397,of,0,0
85398,isoflavones,0,0
85399,daily,0,0
85400,for,0,0
85401,1,0,0
85402,week,0,0
85403,",",0,0
85404,the,0,0
85405,women,0,1
85406,in,0,0
85407,the,0,0
85408,study,0,0
85409,group,0,0
85410,were,0,0
85411,assigned,0,0
85412,to,0,0
85413,the,0,0
85414,equol-producing,0,0
85415,(,0,0
85416,EP,0,0
85417,),0,0
85418,or,0,0
85419,the,0,0
85420,non-EP,0,0
85421,group,0,0
85422,according,0,0
85423,to,0,0
85424,the,0,0
85425,presence,0,0
85426,or,0,0
85427,absence,0,0
85428,of,0,0
85429,equol,0,0
85430,in,0,0
85431,their,0,0
85432,urine,0,0
85433,.,0,0
85434,Menopausal,0,0
85435,symptoms,0,0
85436,were,0,0
85437,evaluated,0,0
85438,using,0,0
85439,a,0,0
85440,modified,0,0
85441,Kupperman,0,0
85442,Index,0,0
85443,.,0,0
85444,RESULT,0,0
85445,Compared,0,0
85446,with,0,0
85447,the,0,0
85448,placebo,0,0
85449,group,0,0
85450,",",0,0
85451,the,0,0
85452,scores,0,0
85453,for,0,0
85454,hot,0,0
85455,flashes,0,0
85456,and,0,0
85457,excessive,0,0
85458,sweating,0,0
85459,were,0,0
85460,significantly,0,0
85461,reduced,0,0
85462,after,0,0
85463,3,0,0
85464,months,0,0
85465,",",0,0
85466,and,0,0
85467,the,0,0
85468,scores,0,0
85469,for,0,0
85470,weakness,0,0
85471,",",0,0
85472,palpitations,0,0
85473,",",0,0
85474,limb,0,0
85475,paresthesia,0,0
85476,",",0,0
85477,and,0,0
85478,total,0,1
85479,symptoms,0,0
85480,after,0,0
85481,6,0,0
85482,months,0,0
85483,",",0,0
85484,in,0,0
85485,the,0,0
85486,EP,0,0
85487,group,0,0
85488,only,0,0
85489,.,0,0
85490,CONCLUSIONS,0,0
85491,Isoflavone,0,0
85492,supplementation,0,0
85493,improves,0,0
85494,menopausal,0,1
85495,symptoms,0,0
85496,only,0,0
85497,in,0,0
85498,women,0,1
85499,with,0,1
85500,the,0,0
85501,ability,0,0
85502,to,0,0
85503,produce,0,0
85504,equol,0,0
85505,.,0,0
85506,Clinical,0,0
85507,trial,0,0
85508,:,0,1
85509,exposure,0,0
85510,to,0,0
85511,ribavirin,0,0
85512,predicts,0,0
85513,EVR,0,0
85514,and,0,0
85515,SVR,0,0
85516,in,0,0
85517,patients,1,1
85518,with,1,1
85519,HCV,1,0
85520,genotype,1,0
85521,1,1,0
85522,infection,1,0
85523,treated,1,1
85524,with,1,0
85525,peginterferon,1,0
85526,alpha-2a,1,0
85527,plus,1,0
85528,ribavirin,1,0
85529,.,1,0
85530,BACKGROUND,0,0
85531,The,0,0
85532,impact,0,0
85533,of,0,0
85534,reduced,0,0
85535,drug,0,0
85536,exposure,0,0
85537,on,0,0
85538,outcomes,0,0
85539,in,0,0
85540,patients,1,1
85541,with,1,1
85542,chronic,1,1
85543,hepatitis,1,1
85544,C,1,0
85545,has,0,0
85546,not,0,0
85547,been,0,0
85548,determined,0,0
85549,in,0,0
85550,routine,0,0
85551,clinical,0,0
85552,practice,0,0
85553,.,0,0
85554,AIM,0,0
85555,To,0,0
85556,examine,0,0
85557,the,0,0
85558,impact,0,0
85559,of,0,0
85560,exposure,0,0
85561,to,0,0
85562,peginterferon,0,0
85563,alpha-2a,0,0
85564,and,0,0
85565,ribavirin,0,0
85566,on,0,0
85567,early,0,0
85568,virological,0,0
85569,response,0,0
85570,(,0,0
85571,EVR,0,0
85572,),0,0
85573,and,0,0
85574,sustained,0,0
85575,virological,0,0
85576,response,0,0
85577,(,0,0
85578,SVR,0,0
85579,),0,0
85580,in,0,0
85581,treatment-naive,1,1
85582,patients,1,1
85583,with,1,1
85584,HCV,1,0
85585,genotype,1,0
85586,1,1,0
85587,infection,1,0
85588,enrolled,1,1
85589,in,1,0
85590,a,1,0
85591,large,1,0
85592,expanded,1,0
85593,access,1,0
85594,programme,1,0
85595,.,1,0
85596,METHODS,0,0
85597,Eight,1,0
85598,hundred,1,1
85599,and,1,0
85600,ninety-one,1,1
85601,patients,1,1
85602,treated,1,1
85603,for,1,0
85604,48,1,1
85605,weeks,1,0
85606,with,1,1
85607,an,1,0
85608,initial,1,0
85609,ribavirin,1,0
85610,dose,1,0
85611,of,1,0
85612,800,1,0
85613,or,1,1
85614,1000/1200,1,0
85615,mg/day,1,0
85616,were,0,0
85617,evaluated,0,0
85618,.,0,0
85619,Ribavirin,0,0
85620,1000,0,0
85621,mg/day,0,0
85622,(,0,0
85623,<,0,0
85624,75,0,1
85625,kg,0,1
85626,),0,0
85627,or,0,0
85628,1200,0,0
85629,mg/day,0,0
85630,(,0,0
85631,>,0,0
85632,or=75,0,1
85633,kg,0,0
85634,),0,0
85635,and,0,0
85636,peginterferon,0,0
85637,alpha-2a,0,0
85638,180,0,0
85639,microg/week,0,0
85640,were,0,0
85641,considered,0,0
85642,optimal,0,0
85643,.,0,0
85644,The,0,0
85645,impact,0,0
85646,of,0,0
85647,reduced,0,0
85648,drug,0,0
85649,exposure,0,0
85650,(,0,0
85651,expressed,0,0
85652,as,0,0
85653,a,0,0
85654,percentage,0,0
85655,of,0,0
85656,optimal,0,0
85657,),0,0
85658,on,0,0
85659,EVR,0,0
85660,and,0,0
85661,SVR,0,0
85662,was,0,0
85663,evaluated,0,0
85664,.,0,0
85665,RESULTS,0,0
85666,Mean,0,0
85667,ribavirin,0,0
85668,exposure,0,0
85669,in,0,0
85670,week,0,0
85671,0-12,0,0
85672,was,0,0
85673,70,0,1
85674,%,0,0
85675,and,0,0
85676,96,0,0
85677,%,0,0
85678,in,0,0
85679,patients,0,1
85680,assigned,0,1
85681,to,0,0
85682,ribavirin,0,0
85683,800,0,0
85684,and,0,0
85685,1000/1200,0,0
85686,mg/day,0,0
85687,",",0,0
85688,respectively,0,0
85689,.,0,0
85690,EVR,0,0
85691,and,0,0
85692,SVR,0,0
85693,rates,0,0
85694,were,0,0
85695,lower,0,0
85696,in,0,0
85697,patients,0,1
85698,assigned,0,1
85699,to,0,0
85700,ribavirin,0,0
85701,800,0,0
85702,than,0,0
85703,1000/1200,0,0
85704,mg/day,0,0
85705,(,0,0
85706,EVR,0,0
85707,",",0,0
85708,75,0,0
85709,%,0,0
85710,vs.,0,0
85711,84,0,0
85712,%,0,0
85713,",",0,0
85714,respectively,0,0
85715,",",0,0
85716,P,0,0
85717,<,0,0
85718,0.001,0,0
85719,;,0,0
85720,SVR,0,0
85721,",",0,0
85722,45,0,0
85723,%,0,0
85724,vs.,0,0
85725,54,0,0
85726,%,0,0
85727,",",0,0
85728,respectively,0,0
85729,",",0,0
85730,P,0,0
85731,=,0,0
85732,0.011,0,0
85733,),0,0
85734,.,0,0
85735,Furthermore,0,0
85736,",",0,0
85737,there,0,0
85738,was,0,0
85739,a,0,0
85740,strong,0,0
85741,correlation,0,0
85742,between,0,0
85743,achievement,0,0
85744,of,0,0
85745,EVR,0,0
85746,and,0,0
85747,SVR,0,0
85748,and,0,0
85749,ribavirin,0,0
85750,dose,0,0
85751,over,0,0
85752,the,0,0
85753,first,0,0
85754,12,0,0
85755,weeks,0,0
85756,expressed,0,0
85757,either,0,0
85758,as,0,0
85759,absolute,0,0
85760,dose,0,0
85761,or,0,0
85762,proportion,0,0
85763,of,0,0
85764,optimal,0,0
85765,dose,0,0
85766,received,0,0
85767,(,0,0
85768,P,0,0
85769,<,0,0
85770,0.001,0,0
85771,for,0,0
85772,both,0,0
85773,),0,0
85774,.,0,0
85775,CONCLUSIONS,0,0
85776,Ribavirin,0,0
85777,exposure,0,0
85778,to,0,0
85779,week,0,0
85780,12,0,0
85781,is,0,0
85782,significantly,0,0
85783,associated,0,0
85784,with,0,0
85785,EVR,0,0
85786,and,0,0
85787,SVR,0,0
85788,in,0,0
85789,genotype,1,0
85790,1,1,1
85791,patients,1,1
85792,.,1,1
85793,Maintenance,0,0
85794,of,0,0
85795,an,0,0
85796,optimal,0,0
85797,ribavirin,0,0
85798,dose,0,0
85799,is,0,0
85800,the,0,0
85801,most,0,0
85802,important,0,0
85803,modifiable,0,0
85804,factor,0,0
85805,during,0,0
85806,combination,0,0
85807,therapy,0,0
85808,for,0,0
85809,chronic,0,1
85810,hepatitis,0,1
85811,C,0,0
85812,.,0,0
85813,Effect,0,0
85814,of,0,0
85815,radiotherapy,0,0
85816,on,0,0
85817,blood,1,0
85818,lymphocyte,1,0
85819,population,1,1
85820,in,1,0
85821,mammary,1,1
85822,carcinoma,1,1
85823,.,1,0
85824,Does,0,0
85825,3-day,0,0
85826,course,0,0
85827,of,0,0
85828,oral,0,0
85829,amoxycillin,0,0
85830,benefit,0,0
85831,children,1,1
85832,of,1,0
85833,non-severe,1,1
85834,pneumonia,1,1
85835,with,1,1
85836,wheeze,1,0
85837,:,1,1
85838,a,0,0
85839,multicentric,0,0
85840,randomised,0,0
85841,controlled,0,0
85842,trial,0,0
85843,.,0,0
85844,BACKGROUND,0,0
85845,WHO-defined,0,0
85846,pneumonias,0,1
85847,",",0,0
85848,treated,0,0
85849,with,0,0
85850,antibiotics,0,0
85851,",",0,0
85852,are,0,0
85853,responsible,0,0
85854,for,0,0
85855,a,0,0
85856,significant,0,0
85857,proportion,0,0
85858,of,0,0
85859,childhood,0,1
85860,morbidity,0,0
85861,and,0,0
85862,mortality,0,0
85863,in,0,0
85864,the,0,0
85865,developing,1,0
85866,countries,1,0
85867,.,1,0
85868,Since,0,0
85869,substantial,0,0
85870,proportion,0,0
85871,pneumonias,0,1
85872,have,0,0
85873,a,0,0
85874,viral,0,0
85875,etiology,0,0
85876,",",0,0
85877,where,0,0
85878,children,0,1
85879,are,0,0
85880,more,0,0
85881,likely,0,0
85882,to,0,0
85883,present,0,0
85884,with,0,0
85885,wheeze,0,0
85886,",",0,0
85887,there,0,0
85888,is,0,0
85889,a,0,0
85890,concern,0,0
85891,that,0,0
85892,currently,0,0
85893,antibiotics,0,0
85894,are,0,0
85895,being,0,0
85896,over-prescribed,0,0
85897,for,0,0
85898,it,0,0
85899,.,0,0
85900,Hence,0,0
85901,the,0,0
85902,current,0,0
85903,trial,0,0
85904,was,0,0
85905,conducted,0,0
85906,with,0,0
85907,the,0,0
85908,objective,0,0
85909,to,0,0
85910,show,0,0
85911,the,0,0
85912,therapeutic,0,0
85913,equivalence,0,0
85914,of,0,0
85915,two,0,0
85916,treatments,0,0
85917,(,0,0
85918,placebo,0,0
85919,and,0,0
85920,amoxycillin,0,0
85921,),0,0
85922,for,0,0
85923,children,1,1
85924,presenting,1,1
85925,with,1,1
85926,non-severe,1,1
85927,pneumonia,1,1
85928,with,1,0
85929,wheeze,1,1
85930,",",1,0
85931,who,1,1
85932,have,1,0
85933,persistent,1,1
85934,fast,1,0
85935,breathing,1,0
85936,after,1,0
85937,nebulisation,1,0
85938,with,1,0
85939,salbutamol,1,0
85940,",",1,0
85941,and,1,0
85942,have,1,0
85943,normal,1,0
85944,chest,1,0
85945,radiograph,1,0
85946,.,1,0
85947,METHODOLOGY,0,0
85948,This,0,0
85949,multi-centric,0,0
85950,",",0,0
85951,randomised,0,0
85952,placebo,0,0
85953,controlled,0,0
85954,double,0,0
85955,blind,0,0
85956,clinical,0,0
85957,trial,0,0
85958,intended,0,0
85959,to,0,0
85960,investigate,0,0
85961,equivalent,0,0
85962,efficacy,0,0
85963,of,0,0
85964,placebo,0,0
85965,and,0,0
85966,amoxicillin,0,0
85967,and,0,0
85968,was,0,0
85969,conducted,0,0
85970,in,0,0
85971,ambulatory,0,1
85972,care,0,0
85973,settings,0,0
85974,in,0,0
85975,eight,1,1
85976,government,1,1
85977,hospitals,1,1
85978,in,1,0
85979,India,1,1
85980,.,1,1
85981,Participants,1,1
85982,were,1,0
85983,children,1,1
85984,aged,1,1
85985,2-59,1,1
85986,months,1,0
85987,of,1,0
85988,age,1,1
85989,",",0,0
85990,who,0,1
85991,received,0,1
85992,either,0,1
85993,oral,0,0
85994,amoxycillin,0,0
85995,(,0,0
85996,31-54,0,0
85997,mg/Kg/day,0,0
85998,",",0,0
85999,in,0,0
86000,three,0,0
86001,divided,0,1
86002,doses,0,0
86003,for,0,0
86004,three,0,1
86005,days,0,0
86006,),0,0
86007,or,0,0
86008,placebo,0,0
86009,",",0,0
86010,and,0,0
86011,standard,0,0
86012,bronchodilator,0,0
86013,therapy,0,0
86014,.,0,0
86015,Primary,0,0
86016,outcome,0,0
86017,was,0,0
86018,clinical,0,0
86019,failure,0,1
86020,on,0,0
86021,or,0,0
86022,before,0,0
86023,day-,0,0
86024,4,0,0
86025,.,0,1
86026,PRINCIPAL,0,0
86027,FINDINGS,0,0
86028,We,0,0
86029,randomized,0,0
86030,836,1,1
86031,cases,1,1
86032,in,1,0
86033,placebo,1,0
86034,and,1,0
86035,835,1,1
86036,in,1,0
86037,amoxycillin,1,0
86038,group,1,0
86039,.,1,0
86040,Clinical,0,0
86041,failures,0,0
86042,occurred,0,0
86043,in,0,0
86044,201,0,1
86045,(,0,0
86046,24.0,0,0
86047,%,0,0
86048,),0,0
86049,on,0,0
86050,placebo,0,0
86051,and,0,0
86052,166,0,1
86053,(,0,0
86054,19.9,0,0
86055,%,0,0
86056,),0,0
86057,on,0,0
86058,amoxycillin,0,0
86059,(,0,0
86060,risk,0,0
86061,difference,0,0
86062,4.2,0,0
86063,%,0,0
86064,in,0,0
86065,favour,0,0
86066,of,0,0
86067,antibiotic,0,0
86068,",",0,0
86069,95,0,0
86070,%,0,0
86071,CI,0,0
86072,:,0,1
86073,0.2,0,0
86074,to,0,0
86075,8.1,0,0
86076,),0,0
86077,.,0,0
86078,Adherence,0,0
86079,for,0,0
86080,both,0,0
86081,placebo,0,0
86082,and,0,0
86083,amoxycillin,0,0
86084,was,0,0
86085,>,0,0
86086,96,0,0
86087,%,0,0
86088,and,0,0
86089,98.9,0,0
86090,%,0,0
86091,subjects,0,1
86092,were,0,0
86093,followed,0,0
86094,up,0,0
86095,on,0,0
86096,day-,0,0
86097,4,0,0
86098,.,0,0
86099,Clinical,0,0
86100,failure,0,1
86101,was,0,0
86102,associated,0,0
86103,with,0,0
86104,(,0,0
86105,i,0,0
86106,),0,0
86107,placebo,0,0
86108,treatment,0,0
86109,(,0,0
86110,adjusted,0,0
86111,OR,0,0
86112,=,0,0
86113,1.28,0,0
86114,",",0,0
86115,95,0,0
86116,%,0,0
86117,CI,0,0
86118,:,0,1
86119,1.01,0,0
86120,to1.62,0,0
86121,),0,0
86122,",",0,0
86123,(,0,0
86124,ii,0,0
86125,),0,0
86126,excess,0,0
86127,respiratory,0,0
86128,rate,0,0
86129,of,0,0
86130,>,0,1
86131,10,0,1
86132,breaths,0,0
86133,per,0,0
86134,minute,0,0
86135,(,0,0
86136,adjusted,0,0
86137,OR,0,0
86138,=,0,0
86139,1.51,0,0
86140,",",0,0
86141,95,0,0
86142,%,0,0
86143,CI,0,0
86144,:,0,1
86145,1.19,0,0
86146,",",0,0
86147,1.92,0,0
86148,),0,0
86149,",",0,0
86150,(,0,0
86151,iii,0,0
86152,),0,0
86153,vomiting,0,0
86154,at,0,0
86155,enrolment,0,0
86156,(,0,0
86157,adjusted,0,0
86158,OR,0,0
86159,=,0,0
86160,1.49,0,0
86161,",",0,0
86162,95,0,0
86163,%,0,0
86164,CI,0,0
86165,:,0,1
86166,1.13,0,0
86167,",",0,0
86168,1.96,0,0
86169,),0,0
86170,",",0,0
86171,(,0,0
86172,iv,0,0
86173,),0,0
86174,history,0,0
86175,of,0,0
86176,use,0,0
86177,of,0,0
86178,broncho-dilators,0,0
86179,(,0,0
86180,adjusted,0,0
86181,OR,0,0
86182,=,0,0
86183,1.71,0,0
86184,",",0,0
86185,95,0,0
86186,%,0,0
86187,CI,0,0
86188,:,0,1
86189,1.30,0,0
86190,",",0,0
86191,2.24,0,0
86192,),0,0
86193,and,0,0
86194,(,0,0
86195,v,0,0
86196,),0,0
86197,non-adherence,0,0
86198,(,0,0
86199,adjusted,0,0
86200,OR,0,0
86201,=,0,0
86202,8.06,0,0
86203,",",0,0
86204,95,0,0
86205,%,0,0
86206,CI,0,0
86207,:,0,1
86208,4.36,0,0
86209,",",0,0
86210,14.92,0,0
86211,),0,0
86212,.,0,0
86213,CONCLUSIONS,0,0
86214,Treating,0,0
86215,children,1,1
86216,with,1,1
86217,non-severe,1,1
86218,pneumonia,1,1
86219,and,1,0
86220,wheeze,1,0
86221,with,0,0
86222,a,0,0
86223,placebo,0,0
86224,is,0,0
86225,not,0,0
86226,equivalent,0,0
86227,to,0,0
86228,treatment,0,0
86229,with,0,1
86230,oral,0,0
86231,amoxycillin,0,0
86232,.,0,0
86233,TRIAL,0,0
86234,REGISTRATION,0,0
86235,ClinicalTrials.gov,0,0
86236,NCT00407394,0,0
86237,.,0,0
86238,Predictive,0,0
86239,validity,0,0
86240,of,0,0
86241,a,0,0
86242,medication,0,0
86243,adherence,0,0
86244,measure,0,0
86245,in,0,0
86246,an,0,0
86247,outpatient,1,1
86248,setting,1,0
86249,.,1,0
86250,This,0,0
86251,study,0,0
86252,examines,0,0
86253,the,0,0
86254,psychometric,0,0
86255,properties,0,0
86256,and,0,0
86257,tests,0,0
86258,the,0,0
86259,concurrent,0,0
86260,and,0,0
86261,predictive,0,0
86262,validity,0,0
86263,of,0,0
86264,a,0,0
86265,structured,0,0
86266,",",0,0
86267,self-reported,0,0
86268,medication,0,0
86269,adherence,0,0
86270,measure,0,0
86271,in,0,0
86272,patients,1,1
86273,with,1,1
86274,hypertension,1,1
86275,.,1,0
86276,The,0,0
86277,authors,0,0
86278,also,0,0
86279,assessed,0,0
86280,various,0,0
86281,psychosocial,0,0
86282,determinants,0,0
86283,of,0,0
86284,adherence,0,0
86285,",",0,0
86286,such,0,0
86287,as,0,0
86288,knowledge,0,0
86289,",",0,0
86290,social,0,0
86291,support,0,0
86292,",",0,0
86293,satisfaction,0,0
86294,with,0,0
86295,care,0,0
86296,",",0,0
86297,and,0,0
86298,complexity,0,0
86299,of,0,0
86300,the,0,0
86301,medical,0,1
86302,regimen,0,0
86303,.,0,0
86304,A,1,0
86305,total,1,0
86306,of,1,0
86307,1367,1,1
86308,patients,1,1
86309,participated,1,1
86310,in,1,0
86311,the,1,0
86312,study,1,0
86313,;,1,0
86314,mean,1,0
86315,age,1,1
86316,was,1,0
86317,52.5,1,0
86318,years,1,1
86319,",",1,0
86320,40.8,1,0
86321,%,1,0
86322,were,1,0
86323,male,1,1
86324,",",1,0
86325,76.5,1,0
86326,%,1,0
86327,were,1,0
86328,black,1,1
86329,",",1,0
86330,50.8,1,0
86331,%,1,0
86332,graduated,1,1
86333,from,1,0
86334,high,1,0
86335,school,1,1
86336,",",1,0
86337,26,1,0
86338,%,1,0
86339,were,1,0
86340,married,1,1
86341,",",1,0
86342,and,1,0
86343,54.1,1,0
86344,%,1,0
86345,had,1,0
86346,income,1,0
86347,<,1,0
86348,$,1,0
86349,"5,000",1,0
86350,.,1,0
86351,The,0,0
86352,8-item,0,0
86353,medication,0,0
86354,adherence,0,0
86355,scale,0,0
86356,was,0,0
86357,reliable,0,0
86358,(,0,0
86359,alpha=.83,0,0
86360,),0,0
86361,and,0,0
86362,significantly,0,0
86363,associated,0,0
86364,with,0,0
86365,blood,0,0
86366,pressure,0,0
86367,control,0,0
86368,(,0,0
86369,P,0,0
86370,<,0,0
86371,.05,0,0
86372,),0,0
86373,.,0,0
86374,Using,0,0
86375,a,0,0
86376,cutpoint,0,0
86377,of,0,0
86378,<,0,0
86379,6,0,0
86380,",",0,0
86381,the,0,0
86382,sensitivity,0,0
86383,of,0,0
86384,the,0,0
86385,measure,0,0
86386,to,0,0
86387,identify,0,0
86388,patients,0,1
86389,with,0,1
86390,poor,0,1
86391,blood,0,0
86392,pressure,0,0
86393,control,0,0
86394,was,0,0
86395,estimated,0,0
86396,to,0,0
86397,be,0,0
86398,93,0,0
86399,%,0,0
86400,",",0,0
86401,and,0,0
86402,the,0,0
86403,specificity,0,0
86404,was,0,0
86405,53,0,1
86406,%,0,0
86407,.,0,0
86408,The,0,0
86409,medication,0,0
86410,adherence,0,0
86411,measure,0,0
86412,proved,0,0
86413,to,0,0
86414,be,0,0
86415,reliable,0,0
86416,",",0,0
86417,with,0,1
86418,good,0,0
86419,concurrent,0,0
86420,and,0,0
86421,predictive,0,0
86422,validity,0,0
86423,in,0,0
86424,primarily,1,0
86425,low-income,1,1
86426,",",1,0
86427,minority,1,1
86428,patients,1,1
86429,with,1,1
86430,hypertension,1,1
86431,and,0,0
86432,might,0,0
86433,function,0,0
86434,as,0,0
86435,a,0,0
86436,screening,0,0
86437,tool,0,0
86438,in,0,0
86439,outpatient,1,1
86440,settings,1,0
86441,with,0,1
86442,other,0,0
86443,patient,1,1
86444,groups,1,0
86445,.,1,1
86446,Effect,0,0
86447,of,0,0
86448,esomeprazole,0,0
86449,triple,0,0
86450,therapy,0,0
86451,on,0,0
86452,eradication,0,0
86453,rates,0,0
86454,of,0,0
86455,Helicobacter,0,1
86456,pylori,0,0
86457,",",0,0
86458,gastric,0,0
86459,ulcer,0,0
86460,healing,0,0
86461,and,0,0
86462,prevention,0,0
86463,of,0,0
86464,relapse,0,0
86465,in,0,0
86466,gastric,1,1
86467,ulcer,1,1
86468,patients,1,1
86469,.,1,1
86470,OBJECTIVES,0,0
86471,To,0,0
86472,compare,0,0
86473,esomeprazole-based,0,0
86474,triple,0,0
86475,therapy,0,0
86476,with,0,1
86477,esomeprazole,0,0
86478,alone,0,0
86479,for,0,0
86480,the,0,0
86481,eradication,0,0
86482,of,0,0
86483,Helicobacter,0,1
86484,pylori,0,0
86485,(,0,0
86486,H.,0,0
86487,pylori,0,0
86488,),0,0
86489,",",0,0
86490,healing,0,0
86491,of,0,0
86492,ulcer,0,1
86493,and,0,0
86494,prevention,0,0
86495,of,0,0
86496,relapse,0,0
86497,in,0,0
86498,H.,0,1
86499,pylori-related,0,1
86500,gastric,0,1
86501,ulcer,0,1
86502,(,0,0
86503,GU,0,0
86504,),0,0
86505,diseases,0,1
86506,.,0,0
86507,METHODS,0,0
86508,In,0,0
86509,this,0,0
86510,double-blind,0,0
86511,study,0,0
86512,",",0,0
86513,401,1,1
86514,H.,1,1
86515,pylori-positive,1,1
86516,patients,1,1
86517,with,1,1
86518,more,1,0
86519,than,1,0
86520,or,1,0
86521,equal,1,0
86522,to,1,0
86523,two,1,0
86524,GUs,1,0
86525,were,0,0
86526,randomized,0,0
86527,to,0,0
86528,:,0,0
86529,esomeprazole,0,0
86530,(,0,0
86531,20,0,0
86532,mg,0,0
86533,),0,0
86534,twice,0,0
86535,daily,0,0
86536,(,0,0
86537,bid,0,0
86538,),0,0
86539,and,0,0
86540,amoxicillin,0,0
86541,(,0,0
86542,1000,0,0
86543,mg,0,0
86544,),0,0
86545,bid,0,0
86546,and,0,0
86547,clarithromycin,0,0
86548,(,0,0
86549,500,0,0
86550,mg,0,0
86551,),0,0
86552,bid,0,0
86553,(,0,0
86554,EAC,0,0
86555,),0,0
86556,for,0,0
86557,1,0,0
86558,week,0,0
86559,",",0,0
86560,followed,0,0
86561,by,0,0
86562,placebo,0,0
86563,for,0,0
86564,3,0,0
86565,weeks,0,0
86566,(,0,0
86567,EAC,0,0
86568,and,0,0
86569,placebo,0,0
86570,),0,0
86571,;,0,0
86572,EAC,0,0
86573,for,0,0
86574,1,0,0
86575,week,0,0
86576,",",0,0
86577,followed,0,0
86578,by,0,0
86579,esomeprazole,0,0
86580,(,0,0
86581,20,0,0
86582,mg,0,0
86583,),0,0
86584,once,0,0
86585,daily,0,0
86586,(,0,0
86587,E20,0,0
86588,),0,0
86589,for,0,0
86590,3,0,0
86591,weeks,0,0
86592,(,0,0
86593,EAC,0,0
86594,and,0,0
86595,E20,0,0
86596,),0,0
86597,;,0,0
86598,or,0,0
86599,esomeprazole,0,0
86600,(,0,0
86601,20,0,0
86602,mg,0,0
86603,),0,0
86604,bid,0,0
86605,and,0,0
86606,placebo,0,0
86607,antimicrobials,0,0
86608,for,0,0
86609,1,0,0
86610,week,0,0
86611,",",0,0
86612,followed,0,0
86613,by,0,0
86614,E20,0,0
86615,for,0,0
86616,3,0,0
86617,weeks,0,0
86618,(,0,0
86619,E20,0,0
86620,bid,0,0
86621,and,0,0
86622,E20,0,0
86623,),0,0
86624,.,0,0
86625,Patients,1,1
86626,with,1,1
86627,unhealed,1,1
86628,GUs,1,0
86629,at,1,0
86630,4,1,0
86631,weeks,1,0
86632,received,0,0
86633,E20,0,0
86634,for,0,0
86635,an,0,0
86636,additional,0,0
86637,4,0,0
86638,weeks,0,0
86639,.,0,1
86640,Healed,1,0
86641,patients,1,1
86642,were,0,0
86643,followed,0,0
86644,up,0,0
86645,for,0,0
86646,12,0,0
86647,months,0,0
86648,.,0,1
86649,RESULTS,0,0
86650,Eradication,0,0
86651,rates,0,0
86652,at,0,0
86653,4,0,0
86654,weeks,0,0
86655,or,0,1
86656,8,0,0
86657,weeks,0,0
86658,were,0,0
86659,82,0,1
86660,%,0,0
86661,for,0,0
86662,EAC,0,0
86663,and,0,0
86664,E20,0,0
86665,",",0,0
86666,77,0,0
86667,%,0,0
86668,for,0,0
86669,EAC,0,0
86670,and,0,0
86671,placebo,0,0
86672,and,0,0
86673,9.5,0,0
86674,%,0,0
86675,for,0,0
86676,E20,0,0
86677,bid,0,0
86678,and,0,0
86679,E20,0,0
86680,(,0,0
86681,intention-to-treat,0,0
86682,analysis,0,0
86683,),0,0
86684,.,0,0
86685,Significantly,0,0
86686,more,0,0
86687,patients,0,0
86688,receiving,0,0
86689,EAC,0,0
86690,than,0,0
86691,those,0,0
86692,receiving,0,0
86693,esomeprazole,0,0
86694,alone,0,0
86695,remained,0,0
86696,free,0,0
86697,of,0,0
86698,GUs,0,0
86699,during,0,0
86700,follow-up,0,0
86701,[,0,0
86702,EAC,0,0
86703,and,0,0
86704,E20,0,0
86705,",",0,0
86706,90,0,0
86707,%,0,0
86708,;,0,0
86709,EAC,0,0
86710,and,0,0
86711,placebo,0,0
86712,",",0,0
86713,87,0,0
86714,%,0,0
86715,;,0,0
86716,P=0.0005,0,0
86717,for,0,0
86718,combined,0,0
86719,group,0,0
86720,vs.,0,0
86721,esomeprazole,0,0
86722,alone,0,0
86723,[,0,0
86724,E20,0,0
86725,bid,0,0
86726,and,0,0
86727,E20,0,0
86728,(,0,0
86729,74,0,1
86730,%,0,0
86731,),0,0
86732,],0,0
86733,.,0,0
86734,All,0,0
86735,treatments,0,0
86736,were,0,0
86737,well,0,0
86738,tolerated,0,0
86739,.,0,0
86740,CONCLUSION,0,0
86741,Esomeprazole-based,0,0
86742,triple,0,0
86743,therapy,0,0
86744,is,0,0
86745,effective,0,0
86746,for,0,0
86747,the,0,0
86748,eradication,0,0
86749,of,0,0
86750,H.,0,0
86751,pylori,0,0
86752,",",0,0
86753,healing,0,0
86754,of,0,0
86755,GU,0,0
86756,and,0,0
86757,prevention,0,0
86758,of,0,0
86759,relapse,0,0
86760,.,0,0
86761,Esomeprazole,0,0
86762,monotherapy,0,0
86763,for,0,0
86764,3,0,0
86765,weeks,0,0
86766,after,0,0
86767,triple,0,0
86768,therapy,0,0
86769,may,0,0
86770,be,0,0
86771,beneficial,0,0
86772,in,0,0
86773,terms,0,0
86774,of,0,0
86775,healing,0,0
86776,.,0,0
86777,Active,0,0
86778,symptom,0,0
86779,control,0,0
86780,with,0,0
86781,or,0,0
86782,without,0,0
86783,chemotherapy,0,0
86784,in,0,0
86785,the,0,0
86786,treatment,0,0
86787,of,0,0
86788,patients,1,1
86789,with,1,1
86790,malignant,1,1
86791,pleural,1,1
86792,mesothelioma,1,1
86793,(,1,0
86794,MS01,1,0
86795,),1,0
86796,:,1,0
86797,a,0,0
86798,multicentre,0,0
86799,randomised,0,0
86800,trial,0,0
86801,.,0,0
86802,BACKGROUND,0,0
86803,Malignant,0,0
86804,pleural,0,0
86805,mesothelioma,0,1
86806,is,0,0
86807,almost,0,0
86808,always,0,0
86809,fatal,0,0
86810,",",0,0
86811,and,0,0
86812,few,0,0
86813,treatment,0,0
86814,options,0,0
86815,are,0,0
86816,available,0,0
86817,.,0,0
86818,Although,0,0
86819,active,0,0
86820,symptom,0,0
86821,control,0,1
86822,(,0,0
86823,ASC,0,0
86824,),0,0
86825,has,0,0
86826,been,0,0
86827,recommended,0,0
86828,for,0,0
86829,the,0,0
86830,management,0,0
86831,of,0,0
86832,this,0,0
86833,disease,0,0
86834,",",0,0
86835,no,0,0
86836,consensus,0,0
86837,exists,0,0
86838,for,0,0
86839,the,0,0
86840,role,0,0
86841,of,0,0
86842,chemotherapy,0,0
86843,.,0,0
86844,We,0,0
86845,investigated,0,0
86846,whether,0,0
86847,the,0,0
86848,addition,0,0
86849,of,0,0
86850,chemotherapy,0,0
86851,to,0,0
86852,ASC,0,0
86853,improved,0,0
86854,survival,0,0
86855,and,0,0
86856,quality,0,0
86857,of,0,0
86858,life,0,0
86859,.,0,0
86860,METHODS,0,0
86861,409,1,1
86862,patients,1,1
86863,with,1,1
86864,malignant,1,1
86865,pleural,1,1
86866,mesothelioma,1,1
86867,",",1,0
86868,from,1,0
86869,76,1,1
86870,centres,1,1
86871,in,1,0
86872,the,1,0
86873,UK,1,1
86874,and,1,0
86875,two,1,0
86876,in,1,0
86877,Australia,1,1
86878,",",0,0
86879,were,0,0
86880,randomly,0,0
86881,assigned,0,0
86882,to,0,0
86883,ASC,0,0
86884,alone,0,0
86885,(,0,0
86886,treatment,0,0
86887,could,0,0
86888,include,0,0
86889,steroids,0,0
86890,",",0,0
86891,analgesic,0,0
86892,drugs,0,0
86893,",",0,0
86894,bronchodilators,0,0
86895,",",0,0
86896,palliative,0,1
86897,radiotherapy,0,0
86898,[,0,0
86899,n=136,0,1
86900,],0,0
86901,),0,0
86902,;,0,0
86903,to,0,0
86904,ASC,0,0
86905,plus,0,0
86906,MVP,0,0
86907,(,0,0
86908,four,0,0
86909,cycles,0,0
86910,of,0,0
86911,mitomycin,0,0
86912,6,0,0
86913,mg/m2,0,0
86914,",",0,0
86915,vinblastine,0,0
86916,6,0,0
86917,mg/m2,0,0
86918,",",0,0
86919,and,0,0
86920,cisplatin,0,0
86921,50,0,0
86922,mg/m2,0,0
86923,every,0,0
86924,3,0,0
86925,weeks,0,0
86926,[,0,0
86927,n=137,0,1
86928,],0,0
86929,),0,0
86930,;,0,0
86931,or,0,0
86932,to,0,0
86933,ASC,0,0
86934,plus,0,0
86935,vinorelbine,0,0
86936,(,0,0
86937,one,0,0
86938,injection,0,0
86939,of,0,0
86940,vinorelbine,0,0
86941,30,0,0
86942,mg/m2,0,0
86943,every,0,0
86944,week,0,0
86945,for,0,0
86946,12,0,0
86947,weeks,0,0
86948,[,0,0
86949,n=136,0,1
86950,],0,0
86951,),0,0
86952,.,0,0
86953,Randomisation,0,0
86954,was,0,0
86955,done,0,0
86956,by,0,0
86957,minimisation,0,0
86958,",",0,0
86959,with,0,0
86960,stratification,0,0
86961,for,0,0
86962,WHO,0,0
86963,performance,0,0
86964,status,0,1
86965,",",0,0
86966,histology,0,0
86967,",",0,0
86968,and,0,0
86969,centre,0,1
86970,.,0,0
86971,Follow-up,0,0
86972,was,0,0
86973,every,0,0
86974,3,0,0
86975,weeks,0,0
86976,to,0,1
86977,21,0,1
86978,weeks,0,0
86979,after,0,0
86980,randomisation,0,0
86981,",",0,0
86982,and,0,0
86983,every,0,0
86984,8,0,0
86985,weeks,0,0
86986,thereafter,0,0
86987,.,0,0
86988,Because,0,0
86989,of,0,0
86990,slow,0,0
86991,accrual,0,0
86992,",",0,0
86993,the,0,0
86994,two,0,0
86995,chemotherapy,0,0
86996,groups,0,0
86997,were,0,0
86998,combined,0,0
86999,and,0,0
87000,compared,0,0
87001,with,0,0
87002,ASC,0,0
87003,alone,0,0
87004,for,0,0
87005,the,0,0
87006,primary,0,0
87007,outcome,0,0
87008,of,0,0
87009,overall,0,0
87010,survival,0,0
87011,.,0,0
87012,Analysis,0,0
87013,was,0,0
87014,by,0,0
87015,intention,0,0
87016,to,0,0
87017,treat,0,0
87018,.,0,0
87019,This,0,0
87020,study,0,0
87021,is,0,0
87022,registered,0,0
87023,",",0,0
87024,number,0,0
87025,ISRCTN54469112,0,0
87026,.,0,0
87027,FINDINGS,0,0
87028,At,0,0
87029,the,0,0
87030,time,0,0
87031,of,0,0
87032,analysis,0,0
87033,",",0,0
87034,393,0,1
87035,(,0,0
87036,96,0,0
87037,%,0,0
87038,),0,0
87039,patients,0,1
87040,had,0,0
87041,died,0,1
87042,(,0,0
87043,ASC,0,0
87044,132,0,1
87045,[,0,0
87046,97,0,1
87047,%,0,0
87048,],0,0
87049,",",0,0
87050,ASC,0,0
87051,plus,0,0
87052,MVP,0,0
87053,132,0,1
87054,[,0,0
87055,96,0,0
87056,%,0,0
87057,],0,0
87058,",",0,0
87059,ASC,0,0
87060,plus,0,0
87061,vinorelbine,0,0
87062,129,0,1
87063,[,0,0
87064,95,0,0
87065,%,0,0
87066,],0,1
87067,),0,0
87068,.,0,0
87069,Compared,0,0
87070,with,0,0
87071,ASC,0,0
87072,alone,0,0
87073,",",0,0
87074,we,0,0
87075,noted,0,0
87076,a,0,0
87077,small,0,0
87078,",",0,0
87079,non-significant,0,0
87080,survival,0,0
87081,benefit,0,0
87082,for,0,0
87083,ASC,0,0
87084,plus,0,0
87085,chemotherapy,0,0
87086,(,0,0
87087,hazard,0,0
87088,ratio,0,0
87089,[,0,0
87090,HR,0,0
87091,],0,0
87092,0.89,0,0
87093,[,0,0
87094,95,0,0
87095,%,0,0
87096,CI,0,0
87097,0.72-1.10,0,0
87098,],0,0
87099,;,0,0
87100,p=0.29,0,0
87101,),0,0
87102,.,0,0
87103,Median,0,0
87104,survival,0,0
87105,was,0,0
87106,7.6,0,0
87107,months,0,0
87108,in,0,0
87109,the,0,0
87110,ASC,0,0
87111,alone,0,0
87112,group,0,0
87113,and,0,0
87114,8.5,0,0
87115,months,0,0
87116,in,0,0
87117,the,0,0
87118,ASC,0,0
87119,plus,0,0
87120,chemotherapy,0,0
87121,group,0,0
87122,.,0,0
87123,Exploratory,0,0
87124,analyses,0,0
87125,suggested,0,0
87126,a,0,0
87127,survival,0,0
87128,advantage,0,0
87129,for,0,0
87130,ASC,0,0
87131,plus,0,0
87132,vinorelbine,0,0
87133,compared,0,0
87134,with,0,1
87135,ASC,0,0
87136,alone,0,0
87137,(,0,0
87138,HR,0,0
87139,0.80,0,0
87140,[,0,0
87141,0.63-1.02,0,0
87142,],0,0
87143,;,0,0
87144,p=0.08,0,0
87145,),0,0
87146,",",0,0
87147,with,0,0
87148,a,0,0
87149,median,0,0
87150,survival,0,0
87151,of,0,0
87152,9.5,0,0
87153,months,0,0
87154,.,0,0
87155,There,0,0
87156,was,0,0
87157,no,0,0
87158,evidence,0,0
87159,of,0,0
87160,a,0,0
87161,survival,0,0
87162,benefit,0,0
87163,with,0,1
87164,ASC,0,0
87165,plus,0,0
87166,MVP,0,0
87167,(,0,0
87168,HR,0,0
87169,0.99,0,0
87170,[,0,0
87171,0.78-1.27,0,0
87172,],0,0
87173,;,0,0
87174,p=0.95,0,0
87175,),0,0
87176,.,0,0
87177,We,0,0
87178,observed,0,0
87179,no,0,0
87180,between-group,0,0
87181,differences,0,0
87182,in,0,0
87183,four,0,0
87184,predefined,0,0
87185,quality-of-life,0,0
87186,subscales,0,0
87187,(,0,0
87188,physical,0,0
87189,functioning,0,0
87190,",",0,0
87191,pain,0,0
87192,",",0,0
87193,dyspnoea,0,0
87194,",",0,0
87195,and,0,0
87196,global,0,0
87197,health,0,0
87198,status,0,0
87199,),0,0
87200,at,0,0
87201,any,0,0
87202,of,0,0
87203,the,0,0
87204,assessments,0,0
87205,in,0,0
87206,the,0,0
87207,first,0,0
87208,6,0,0
87209,months,0,0
87210,.,0,1
87211,INTERPRETATION,0,0
87212,The,0,0
87213,addition,0,0
87214,of,0,0
87215,chemotherapy,0,0
87216,to,0,0
87217,ASC,0,0
87218,offers,0,0
87219,no,0,0
87220,significant,0,0
87221,benefits,0,0
87222,in,0,0
87223,terms,0,0
87224,of,0,0
87225,overall,0,0
87226,survival,0,0
87227,or,0,0
87228,quality,0,0
87229,of,0,0
87230,life,0,0
87231,.,0,0
87232,However,0,0
87233,",",0,0
87234,exploratory,0,0
87235,analyses,0,0
87236,suggested,0,0
87237,that,0,0
87238,vinorelbine,0,0
87239,merits,0,0
87240,further,0,0
87241,investigation,0,0
87242,.,0,0
87243,Effects,0,0
87244,of,0,1
87245,20,0,1
87246,mg,0,0
87247,rosuvastatin,0,0
87248,on,0,0
87249,VLDL1-,0,0
87250,",",0,0
87251,VLDL2-,0,1
87252,",",0,0
87253,IDL-,0,0
87254,and,0,0
87255,LDL-ApoB,0,1
87256,kinetics,0,0
87257,in,0,0
87258,type,1,1
87259,2,1,1
87260,diabetes,1,1
87261,.,1,1
87262,AIMS/HYPOTHESIS,0,0
87263,In,0,0
87264,addition,0,0
87265,to,0,0
87266,its,0,0
87267,efficacy,0,0
87268,in,0,0
87269,reducing,0,0
87270,LDL-cholesterol,0,0
87271,",",0,0
87272,rosuvastatin,0,0
87273,has,0,0
87274,been,0,0
87275,shown,0,0
87276,to,0,0
87277,significantly,0,0
87278,decrease,0,0
87279,plasma,0,0
87280,triacylglycerol,0,0
87281,.,0,0
87282,The,0,0
87283,use,0,0
87284,of,0,0
87285,rosuvastatin,0,0
87286,may,0,0
87287,be,0,0
87288,beneficial,0,0
87289,in,0,0
87290,patients,1,1
87291,with,1,1
87292,type,1,1
87293,2,1,0
87294,diabetes,1,1
87295,",",0,1
87296,who,0,1
87297,usually,0,1
87298,have,0,1
87299,increased,0,0
87300,triacylglycerol,0,0
87301,levels,0,0
87302,.,0,0
87303,However,0,0
87304,",",0,0
87305,its,0,0
87306,effects,0,0
87307,on,0,0
87308,the,0,0
87309,metabolism,0,0
87310,of,0,0
87311,triacylglycerol-rich,0,0
87312,lipoproteins,0,0
87313,in,0,0
87314,type,1,1
87315,2,1,0
87316,diabetic,1,1
87317,patients,1,1
87318,remains,0,0
87319,unknown,0,0
87320,.,0,0
87321,METHODS,0,0
87322,We,0,0
87323,performed,0,0
87324,a,0,0
87325,randomised,0,0
87326,double-blind,0,0
87327,crossover,0,0
87328,trial,0,0
87329,of,0,0
87330,6-week,0,0
87331,treatment,0,0
87332,with,0,1
87333,placebo,0,0
87334,or,0,0
87335,rosuvastatin,0,0
87336,20,0,0
87337,mg,0,0
87338,in,0,0
87339,eight,1,1
87340,patients,1,1
87341,with,1,1
87342,type,1,1
87343,2,1,1
87344,diabetes,1,1
87345,who,1,1
87346,were,1,1
87347,being,1,1
87348,treated,1,1
87349,with,1,1
87350,oral,1,0
87351,glucose-lowering,1,0
87352,agents,1,0
87353,.,1,0
87354,In,0,0
87355,each,0,0
87356,patient,0,0
87357,",",0,0
87358,an,0,0
87359,in,0,0
87360,vivo,0,0
87361,kinetic,0,0
87362,study,0,0
87363,of,0,0
87364,apolipoprotein,0,0
87365,B,0,0
87366,(,0,0
87367,ApoB,0,0
87368,),0,0
87369,-containing,0,0
87370,lipoproteins,0,0
87371,with,0,1
87372,[,0,0
87373,13C,0,1
87374,],0,1
87375,leucine,0,0
87376,was,0,0
87377,performed,0,0
87378,at,0,0
87379,the,0,0
87380,end,0,0
87381,of,0,0
87382,each,0,0
87383,treatment,0,0
87384,period,0,0
87385,.,0,0
87386,A,0,0
87387,central,0,0
87388,randomisation,0,0
87389,centre,0,1
87390,used,0,0
87391,computer-generated,0,0
87392,tables,0,0
87393,to,0,0
87394,allocate,0,0
87395,treatments,0,0
87396,.,0,0
87397,Participants,0,1
87398,",",0,0
87399,caregivers,0,1
87400,and,0,0
87401,those,0,0
87402,assessing,0,0
87403,the,0,0
87404,outcomes,0,0
87405,were,0,0
87406,blinded,0,0
87407,to,0,0
87408,group,0,0
87409,assignment,0,0
87410,.,0,0
87411,RESULTS,0,0
87412,Rosuvastatin,0,0
87413,20,0,0
87414,mg,0,0
87415,significantly,0,0
87416,reduced,0,0
87417,plasma,0,0
87418,LDL-cholesterol,0,0
87419,",",0,0
87420,triacylglycerol,0,0
87421,and,0,0
87422,total,0,1
87423,ApoB,0,0
87424,.,0,0
87425,It,0,0
87426,also,0,0
87427,significantly,0,0
87428,reduced,0,0
87429,ApoB,0,0
87430,pool,0,1
87431,sizes,0,0
87432,of,0,0
87433,larger,0,0
87434,triacylglycerol-rich,0,0
87435,VLDL,0,0
87436,particles,0,0
87437,(,0,1
87438,VLDL1,0,1
87439,;,0,0
87440,p,0,0
87441,=,0,0
87442,0.011,0,0
87443,),0,0
87444,",",0,0
87445,smaller,0,0
87446,VLDL,0,0
87447,particles,0,0
87448,(,0,1
87449,VLDL2,0,0
87450,;,0,0
87451,p,0,0
87452,=,0,0
87453,0.011,0,0
87454,),0,0
87455,",",0,0
87456,intermediate,0,0
87457,density,0,0
87458,lipoprotein,0,0
87459,(,0,0
87460,IDL,0,0
87461,;,0,0
87462,p,0,0
87463,=,0,0
87464,0.011,0,0
87465,),0,0
87466,and,0,0
87467,LDL,0,0
87468,(,0,0
87469,p,0,0
87470,=,0,0
87471,0.011,0,0
87472,),0,0
87473,.,0,0
87474,This,0,0
87475,reduction,0,0
87476,was,0,0
87477,associated,0,0
87478,with,0,0
87479,a,0,0
87480,significant,0,0
87481,increase,0,0
87482,in,0,0
87483,the,0,0
87484,total,0,1
87485,fractional,0,0
87486,catabolic,0,0
87487,rate,0,0
87488,of,0,0
87489,VLDL1-ApoB,0,0
87490,(,0,0
87491,6.70,0,0
87492,+/-,0,0
87493,3.24,0,0
87494,vs,0,0
87495,4.52,0,0
87496,+/-,0,0
87497,2.34,0,0
87498,pool/day,0,0
87499,",",0,0
87500,p,0,0
87501,=,0,0
87502,0.049,0,0
87503,),0,0
87504,",",0,0
87505,VLDL2-ApoB,0,0
87506,(,0,0
87507,8.72,0,0
87508,+/-,0,0
87509,3.37,0,0
87510,vs,0,0
87511,5.36,0,0
87512,+/-,0,0
87513,2.64,0,0
87514,",",0,0
87515,p,0,0
87516,=,0,0
87517,0.011,0,0
87518,),0,0
87519,",",0,0
87520,IDL-ApoB,0,0
87521,(,0,0
87522,7.06,0,0
87523,+/-,0,0
87524,1.68,0,0
87525,vs,0,0
87526,4.21,0,0
87527,+/-,0,0
87528,1.51,0,0
87529,",",0,0
87530,p,0,0
87531,=,0,0
87532,0.011,0,0
87533,),0,0
87534,and,0,0
87535,LDL-ApoB,0,0
87536,(,0,0
87537,1.02,0,0
87538,+/-,0,0
87539,0.27,0,0
87540,vs,0,0
87541,0.59,0,0
87542,+/-,0,0
87543,0.13,0,0
87544,",",0,0
87545,p,0,0
87546,=,0,0
87547,0.011,0,0
87548,),0,1
87549,.,0,0
87550,Rosuvastatin,0,0
87551,did,0,0
87552,not,0,0
87553,change,0,0
87554,the,0,0
87555,production,0,0
87556,rates,0,0
87557,of,0,0
87558,VLDL2-,0,1
87559,",",0,0
87560,IDL-,0,0
87561,or,0,0
87562,LDL-,0,0
87563,",",0,0
87564,but,0,0
87565,did,0,0
87566,reduce,0,0
87567,VLDL1-ApoB,0,0
87568,production,0,0
87569,rate,0,0
87570,(,0,0
87571,12.4,0,0
87572,+/-,0,0
87573,4.5,0,0
87574,vs,0,0
87575,19.5,0,0
87576,+/-,0,0
87577,8.4,0,0
87578,mg,0,0
87579,kg,0,0
87580,(,0,0
87581,-1,0,0
87582,),0,0
87583,day,0,0
87584,(,0,0
87585,-1,0,0
87586,),0,0
87587,",",0,0
87588,p,0,0
87589,=,0,0
87590,0.035,0,0
87591,),0,0
87592,.,0,0
87593,No,0,0
87594,side,0,0
87595,effects,0,0
87596,of,0,0
87597,rosuvastatin,0,0
87598,were,0,0
87599,observed,0,0
87600,during,0,0
87601,the,0,0
87602,study,0,0
87603,.,0,0
87604,CONCLUSIONS/INTERPRETATION,0,0
87605,In,0,0
87606,type,1,1
87607,2,1,0
87608,diabetic,1,1
87609,patients,1,1
87610,rosuvastatin,0,0
87611,20,0,0
87612,mg,0,0
87613,not,0,0
87614,only,0,0
87615,induces,0,0
87616,a,0,0
87617,significant,0,0
87618,increase,0,0
87619,of,0,0
87620,LDL-ApoB,0,0
87621,catabolism,0,0
87622,(,0,0
87623,73,0,1
87624,%,0,0
87625,),0,0
87626,",",0,0
87627,but,0,0
87628,also,0,0
87629,has,0,0
87630,favourable,0,0
87631,effects,0,0
87632,on,0,0
87633,the,0,0
87634,catabolism,0,0
87635,of,0,0
87636,triacylglycerol-rich,0,0
87637,lipoproteins,0,0
87638,",",0,0
87639,e.g,0,0
87640,.,0,0
87641,a,0,0
87642,significant,0,0
87643,increase,0,0
87644,in,0,0
87645,the,0,0
87646,catabolism,0,0
87647,of,0,0
87648,VLDL1-ApoB,0,0
87649,(,0,0
87650,48,0,0
87651,%,0,0
87652,),0,0
87653,",",0,0
87654,VLDL2-ApoB,0,0
87655,(,0,0
87656,63,0,1
87657,%,0,0
87658,),0,0
87659,and,0,0
87660,IDL-ApoB,0,0
87661,(,0,0
87662,68,0,1
87663,%,0,0
87664,),0,0
87665,",",0,0
87666,and,0,0
87667,a,0,0
87668,reduction,0,0
87669,in,0,0
87670,the,0,0
87671,production,0,0
87672,rate,0,0
87673,of,0,0
87674,VLDL1-ApoB,0,0
87675,(,0,0
87676,-36,0,0
87677,%,0,0
87678,),0,0
87679,.,0,0
87680,The,0,0
87681,effects,0,0
87682,of,0,0
87683,rosuvastatin,0,0
87684,on,0,0
87685,the,0,0
87686,metabolism,0,0
87687,of,0,0
87688,triacylglycerol-rich,0,0
87689,lipoproteins,0,0
87690,may,0,0
87691,be,0,0
87692,beneficial,0,0
87693,for,0,0
87694,prevention,0,0
87695,of,0,0
87696,atherosclerosis,1,1
87697,in,1,0
87698,type,1,1
87699,2,1,0
87700,diabetic,1,1
87701,patients,1,1
87702,.,1,1
87703,A,0,0
87704,comparison,0,0
87705,of,0,0
87706,single-dose,0,0
87707,versus,0,0
87708,conventional-dose,0,0
87709,antibiotic,0,0
87710,treatment,0,0
87711,of,0,0
87712,bacteriuria,1,1
87713,in,1,0
87714,elderly,1,1
87715,women,1,1
87716,.,1,0
87717,The,0,0
87718,efficacy,0,0
87719,of,0,0
87720,single-dose,0,0
87721,antibiotic,0,0
87722,therapy,0,0
87723,for,0,0
87724,the,0,0
87725,treatment,0,0
87726,of,0,0
87727,bacteriuria,1,1
87728,in,1,0
87729,a,1,0
87730,group,1,0
87731,of,1,0
87732,non-catheterized,1,1
87733,elderly,1,1
87734,women,1,1
87735,was,0,0
87736,compared,0,0
87737,with,0,0
87738,that,0,0
87739,of,0,0
87740,conventional,0,0
87741,7-10,0,1
87742,day,0,0
87743,courses,0,0
87744,of,0,0
87745,antibiotic,0,0
87746,therapy,0,0
87747,.,0,0
87748,Thirty-one,1,1
87749,women,1,1
87750,received,1,0
87751,single-dose,1,0
87752,treatment,1,0
87753,and,1,0
87754,22,1,0
87755,conventional-dose,1,0
87756,treatment,1,0
87757,.,1,0
87758,The,0,0
87759,cure,0,0
87760,rates,0,0
87761,at,0,0
87762,1,0,0
87763,and,0,0
87764,6,0,0
87765,weeks,0,0
87766,for,0,0
87767,the,0,0
87768,single-dose,0,0
87769,treatments,0,0
87770,were,0,0
87771,52,0,1
87772,%,0,0
87773,and,0,0
87774,38,0,0
87775,%,0,0
87776,",",0,0
87777,respectively,0,0
87778,",",0,0
87779,and,0,0
87780,the,0,0
87781,cure,0,0
87782,rates,0,0
87783,for,0,0
87784,the,0,0
87785,conventional-dose,0,0
87786,treatments,0,0
87787,at,0,0
87788,1,0,0
87789,and,0,0
87790,6,0,0
87791,weeks,0,0
87792,were,0,0
87793,59,0,1
87794,%,0,0
87795,and,0,0
87796,52,0,0
87797,%,0,0
87798,",",0,0
87799,respectively,0,0
87800,.,0,0
87801,It,0,0
87802,is,0,0
87803,concluded,0,0
87804,that,0,0
87805,there,0,0
87806,may,0,0
87807,be,0,0
87808,a,0,0
87809,place,0,0
87810,for,0,0
87811,the,0,0
87812,use,0,0
87813,of,0,0
87814,single-dose,0,0
87815,antibiotic,0,0
87816,therapy,0,0
87817,for,0,0
87818,the,0,0
87819,treatment,0,0
87820,of,0,0
87821,selected,1,1
87822,elderly,1,1
87823,women,1,1
87824,with,1,1
87825,bacteriuria,1,1
87826,",",0,0
87827,but,0,0
87828,larger,0,0
87829,studies,0,0
87830,are,0,0
87831,needed,0,0
87832,.,0,0
87833,A,0,0
87834,comparison,0,0
87835,between,0,0
87836,the,0,0
87837,effect,0,0
87838,of,0,0
87839,oxytocin,0,0
87840,only,0,0
87841,and,0,0
87842,oxytocin,0,0
87843,plus,0,0
87844,propranolol,0,0
87845,on,0,0
87846,the,0,0
87847,labor,0,1
87848,(,0,0
87849,a,0,0
87850,double,0,0
87851,blind,0,0
87852,randomized,0,0
87853,trial,0,0
87854,),0,0
87855,.,0,0
87856,OBJECTIVE,0,0
87857,The,0,0
87858,comparison,0,0
87859,between,0,0
87860,the,0,0
87861,effect,0,0
87862,of,0,0
87863,oxytocin,0,0
87864,alone,0,0
87865,or,0,0
87866,in,0,0
87867,combination,0,0
87868,with,0,1
87869,propranolol,0,0
87870,on,0,0
87871,labor,0,1
87872,.,0,0
87873,METHODS,0,0
87874,A,0,0
87875,double,0,0
87876,blind,0,0
87877,randomized,0,0
87878,controlled,0,0
87879,trial,0,0
87880,was,0,0
87881,performed,0,0
87882,on,0,0
87883,150,1,0
87884,nulliparas,1,1
87885,with,1,1
87886,a,1,0
87887,gestational,1,1
87888,age,1,1
87889,of,1,0
87890,39-41,1,1
87891,weeks,1,0
87892,of,1,0
87893,pregnancy,1,1
87894,and,1,0
87895,a,1,0
87896,Bishop,1,0
87897,score,1,0
87898,of,1,0
87899,<,1,0
87900,or,1,0
87901,=5,1,0
87902,.,1,0
87903,In,0,0
87904,the,0,0
87905,first,0,0
87906,group,0,0
87907,(,0,0
87908,oxytocin,0,0
87909,group,0,0
87910,=,0,0
87911,75,0,0
87912,),0,0
87913,",",0,0
87914,oxytocin,0,0
87915,alone,0,0
87916,was,0,0
87917,used,0,0
87918,for,0,0
87919,induction,0,0
87920,of,0,0
87921,labor,0,1
87922,.,0,0
87923,In,0,0
87924,the,0,0
87925,second,0,0
87926,group,0,0
87927,(,0,0
87928,propranolol,0,0
87929,group,0,0
87930,=,0,0
87931,75,0,1
87932,cases,0,1
87933,),0,0
87934,",",0,0
87935,before,0,0
87936,the,0,0
87937,beginning,0,0
87938,of,0,0
87939,oxytocin,0,0
87940,",",0,0
87941,2,0,0
87942,mg,0,0
87943,propranolol,0,0
87944,was,0,0
87945,slowly,0,0
87946,injected,0,0
87947,intravenously,0,0
87948,then,0,0
87949,the,0,0
87950,oxytocin,0,0
87951,was,0,0
87952,initiated,0,0
87953,.,0,0
87954,RESULTS,0,0
87955,The,0,0
87956,number,0,0
87957,of,0,0
87958,patients,0,1
87959,who,0,1
87960,delivered,0,1
87961,in,0,1
87962,the,0,0
87963,first,0,0
87964,day,0,0
87965,showed,0,0
87966,no,0,0
87967,difference,0,0
87968,between,0,0
87969,the,0,0
87970,two,0,0
87971,groups,0,0
87972,.,0,0
87973,The,0,0
87974,mean,0,0
87975,duration,0,0
87976,for,0,0
87977,obtaining,0,0
87978,good,0,0
87979,contractions,0,0
87980,was,0,0
87981,shorter,0,0
87982,in,0,0
87983,the,0,0
87984,propranolol,0,0
87985,group,0,0
87986,in,0,0
87987,both,0,0
87988,the,0,0
87989,first,0,0
87990,and,0,0
87991,second,0,0
87992,day,0,0
87993,of,0,0
87994,induction,0,0
87995,The,0,0
87996,mean,0,0
87997,interval,0,0
87998,between,0,0
87999,the,0,0
88000,beginning,0,0
88001,of,0,0
88002,induction,0,0
88003,until,0,0
88004,the,0,0
88005,beginning,0,0
88006,of,0,0
88007,active,0,0
88008,phase,0,0
88009,at,0,0
88010,the,0,0
88011,first,0,0
88012,day,0,0
88013,of,0,0
88014,induction,0,0
88015,was,0,0
88016,shorter,0,0
88017,in,0,0
88018,the,0,0
88019,propranolol,0,0
88020,group,0,0
88021,.,0,0
88022,The,0,0
88023,mean,0,0
88024,interval,0,0
88025,between,0,0
88026,the,0,0
88027,beginning,0,0
88028,of,0,0
88029,induction,0,0
88030,until,0,0
88031,delivery,0,0
88032,at,0,0
88033,the,0,0
88034,first,0,0
88035,day,0,0
88036,of,0,0
88037,induction,0,0
88038,was,0,0
88039,shorter,0,0
88040,in,0,0
88041,the,0,0
88042,propranolol,0,0
88043,group,0,0
88044,.,0,0
88045,The,0,0
88046,amount,0,0
88047,of,0,0
88048,necessary,0,0
88049,oxytocin,0,0
88050,for,0,0
88051,the,0,0
88052,first,0,0
88053,day,0,0
88054,of,0,0
88055,induction,0,0
88056,was,0,0
88057,less,0,0
88058,in,0,0
88059,the,0,0
88060,propranolol,0,0
88061,group,0,0
88062,.,0,0
88063,CONCLUSION,0,0
88064,Propranolol,0,0
88065,may,0,0
88066,shorten,0,0
88067,the,0,0
88068,induction,0,0
88069,duration,0,0
88070,and,0,0
88071,labor,0,1
88072,and,0,0
88073,reduce,0,0
88074,the,0,0
88075,amount,0,0
88076,of,0,0
88077,necessary,0,0
88078,oxytocin,0,0
88079,.,0,0
88080,[,0,0
88081,No,0,0
88082,effect,0,0
88083,of,0,0
88084,spironolactone,0,0
88085,on,0,0
88086,bulimia,0,1
88087,nervosa,0,1
88088,symptoms,0,0
88089,],0,0
88090,.,0,0
88091,Some,0,0
88092,case,0,0
88093,reports,0,0
88094,mention,0,0
88095,that,0,0
88096,Spironolactone,0,0
88097,",",0,0
88098,a,0,0
88099,mineral,0,0
88100,corticoid,0,0
88101,antagonist,0,0
88102,and,0,0
88103,aldosterone,0,0
88104,antagonist,0,0
88105,",",0,0
88106,reduces,0,0
88107,binging,0,0
88108,in,0,0
88109,patients,1,1
88110,with,1,1
88111,bulimia,1,1
88112,nervosa,1,1
88113,.,1,0
88114,Therefore,0,0
88115,",",0,0
88116,we,0,0
88117,decided,0,0
88118,to,0,0
88119,study,0,0
88120,these,0,0
88121,findings,0,0
88122,by,0,0
88123,using,0,0
88124,a,0,0
88125,randomized,0,0
88126,",",0,0
88127,double-blind,0,0
88128,",",0,0
88129,placebo,0,0
88130,controlled,0,0
88131,study,0,0
88132,design,0,0
88133,.,0,0
88134,In,0,0
88135,one,0,0
88136,study,0,0
88137,arm,0,0
88138,",",0,0
88139,patients,1,1
88140,with,1,1
88141,bulimia,1,1
88142,nervosa,1,1
88143,were,0,0
88144,treated,0,1
88145,with,0,1
88146,150,0,0
88147,mg,0,0
88148,Spironolactone,0,1
88149,per,0,0
88150,day,0,0
88151,;,0,0
88152,in,0,0
88153,the,0,0
88154,other,0,0
88155,arm,0,0
88156,",",0,0
88157,patients,0,1
88158,received,0,0
88159,a,0,0
88160,placebo,0,0
88161,for,0,0
88162,a,0,0
88163,total,0,1
88164,of,0,0
88165,8,0,0
88166,weeks,0,0
88167,.,0,0
88168,The,0,0
88169,target,0,0
88170,variables,0,0
88171,were,0,0
88172,the,0,0
88173,number,0,0
88174,of,0,0
88175,binges,0,0
88176,and,0,0
88177,the,0,0
88178,bulimia,0,1
88179,scale,0,0
88180,of,0,0
88181,the,0,0
88182,Eating,0,0
88183,Disorder,0,0
88184,Inventory,0,0
88185,.,0,0
88186,The,1,0
88187,study,1,0
88188,included,1,1
88189,93,1,1
88190,patients,1,1
88191,.,1,1
88192,The,0,0
88193,results,0,0
88194,show,0,0
88195,that,0,0
88196,the,0,0
88197,number,0,0
88198,of,0,0
88199,binges,0,0
88200,and,0,0
88201,the,0,0
88202,scores,0,0
88203,on,0,0
88204,the,0,0
88205,bulimia,0,1
88206,scale,0,0
88207,decreased,0,0
88208,somewhat,0,0
88209,",",0,0
88210,but,0,0
88211,this,0,0
88212,occurred,0,0
88213,in,0,0
88214,both,0,0
88215,groups,0,0
88216,.,0,0
88217,We,0,0
88218,were,0,0
88219,not,0,0
88220,able,0,0
88221,to,0,0
88222,show,0,0
88223,any,0,0
88224,significant,0,0
88225,statistical,0,0
88226,differences,0,0
88227,between,0,0
88228,the,0,0
88229,Spironolactone,0,0
88230,group,0,0
88231,and,0,0
88232,the,0,0
88233,placebo,0,0
88234,group,0,0
88235,.,0,0
88236,Additional,0,0
88237,evaluations,0,0
88238,",",0,0
88239,executed,0,0
88240,with,0,0
88241,data,0,0
88242,from,0,1
88243,the,0,0
88244,Symptom-Check-List,0,0
88245,(,0,0
88246,SCL-90R,0,1
88247,),0,0
88248,and,0,0
88249,with,0,1
88250,other,0,0
88251,scales,0,0
88252,from,0,1
88253,the,0,0
88254,EDI-2,0,0
88255,also,0,0
88256,showed,0,0
88257,no,0,0
88258,effect,0,0
88259,of,0,0
88260,Spironolactone,0,0
88261,.,0,0
88262,Therefore,0,0
88263,",",0,0
88264,a,0,0
88265,treatment,0,0
88266,with,0,0
88267,Spironolactone,0,0
88268,seems,0,0
88269,to,0,0
88270,have,0,0
88271,no,0,0
88272,effect,0,0
88273,on,0,0
88274,bulimia,0,1
88275,nervosa,0,1
88276,symptoms,0,0
88277,.,0,1
88278,Smoking,0,0
88279,cessation,0,0
88280,with,0,1
88281,smokeless,0,0
88282,tobacco,0,1
88283,and,0,0
88284,group,0,0
88285,therapy,0,0
88286,:,0,0
88287,an,0,0
88288,open,0,0
88289,",",0,0
88290,randomized,0,0
88291,",",0,0
88292,controlled,0,0
88293,trial,0,0
88294,.,0,0
88295,Smokeless,0,0
88296,tobacco,0,0
88297,might,0,0
88298,be,0,0
88299,effective,0,0
88300,as,0,0
88301,an,0,0
88302,adjunct,0,0
88303,for,0,0
88304,smoking,0,0
88305,cessation,0,0
88306,.,0,0
88307,We,0,0
88308,evaluated,0,0
88309,the,0,0
88310,efficacy,0,0
88311,of,0,0
88312,smokeless,0,0
88313,tobacco,0,1
88314,and,0,0
88315,group,0,0
88316,support,0,0
88317,for,0,0
88318,smoking,0,0
88319,cessation,0,0
88320,in,0,0
88321,an,0,0
88322,open,0,0
88323,",",0,0
88324,randomized,0,0
88325,study,0,0
88326,that,0,0
88327,compared,0,0
88328,smokeless,0,0
88329,tobacco,0,1
88330,plus,0,0
88331,group,0,0
88332,support,0,0
88333,versus,0,0
88334,group,0,0
88335,support,0,0
88336,only,0,0
88337,.,0,0
88338,The,0,0
88339,study,1,0
88340,enrolled,1,1
88341,263,1,1
88342,healthy,1,1
88343,smokers,1,1
88344,(,1,0
88345,M,1,0
88346,(,1,0
88347,age,1,1
88348,),1,0
88349,=,1,0
88350,49,1,1
88351,years,1,1
88352,),1,1
88353,who,1,1
88354,smoked,1,1
88355,a,1,1
88356,mean,1,0
88357,of,1,0
88358,24,1,0
88359,cigarettes/day,1,0
88360,",",1,0
88361,with,1,0
88362,a,1,0
88363,mean,1,0
88364,of,1,0
88365,31,1,1
88366,pack-years,1,1
88367,.,1,1
88368,Smokeless,0,0
88369,tobacco,0,1
88370,was,0,0
88371,provided,0,0
88372,for,0,0
88373,7,0,0
88374,weeks,0,0
88375,(,0,0
88376,or,0,0
88377,up,0,0
88378,to,0,0
88379,12,0,0
88380,),0,0
88381,",",0,0
88382,combined,0,0
88383,with,0,0
88384,eight,0,1
88385,group,0,0
88386,support,0,0
88387,visits,0,0
88388,provided,0,0
88389,by,0,0
88390,nurses,0,1
88391,.,0,0
88392,The,0,0
88393,control,0,0
88394,group,0,0
88395,received,0,0
88396,group,0,0
88397,support,0,0
88398,only,0,0
88399,.,0,0
88400,Smoking,0,0
88401,cessation,0,0
88402,rates,0,0
88403,were,0,0
88404,statistically,0,0
88405,significantly,0,0
88406,better,0,0
88407,in,0,0
88408,the,0,0
88409,smokeless,0,0
88410,tobacco,0,0
88411,group,0,0
88412,than,0,0
88413,in,0,0
88414,the,0,0
88415,control,0,0
88416,group,0,0
88417,during,0,0
88418,the,0,0
88419,first,0,0
88420,7,0,0
88421,weeks,0,0
88422,.,0,0
88423,Point-prevalence,0,0
88424,abstinence,0,0
88425,rates,0,0
88426,at,0,0
88427,7,0,1
88428,weeks,0,0
88429,were,0,0
88430,36.4,0,0
88431,%,0,0
88432,versus,0,0
88433,20.8,0,0
88434,%,0,0
88435,(,0,0
88436,OR,0,0
88437,=,0,0
88438,2.52,0,0
88439,",",0,0
88440,p,0,0
88441,=,0,0
88442,.001,0,0
88443,),0,0
88444,",",0,0
88445,respectively,0,0
88446,;,0,0
88447,and,0,0
88448,continuous,0,0
88449,abstinence,0,0
88450,rates,0,0
88451,from,0,1
88452,weeks,0,0
88453,4,0,0
88454,to,0,1
88455,7,0,0
88456,were,0,0
88457,31.5,0,0
88458,%,0,0
88459,versus,0,0
88460,19.2,0,0
88461,%,0,0
88462,(,0,0
88463,OR,0,0
88464,=,0,0
88465,1.94,0,0
88466,",",0,0
88467,p,0,0
88468,=,0,0
88469,.023,0,0
88470,),0,0
88471,",",0,0
88472,respectively,0,0
88473,.,0,0
88474,The,0,0
88475,primary,0,0
88476,outcomes,0,0
88477,(,0,0
88478,i.e.,0,0
88479,",",0,0
88480,6-month,0,0
88481,point,0,0
88482,prevalence,0,1
88483,),0,0
88484,were,0,0
88485,23.1,0,0
88486,%,0,0
88487,versus,0,0
88488,20.8,0,0
88489,%,0,0
88490,",",0,0
88491,respectively,0,0
88492,(,0,0
88493,OR,0,0
88494,=,0,0
88495,1.31,0,0
88496,",",0,0
88497,ns,0,0
88498,),0,0
88499,.,0,0
88500,Smokeless,0,0
88501,tobacco,0,1
88502,was,0,0
88503,relatively,0,0
88504,well,0,0
88505,tolerated,0,0
88506,",",0,0
88507,although,0,0
88508,15,0,0
88509,subjects,0,1
88510,(,0,0
88511,11.2,0,0
88512,%,0,0
88513,),0,0
88514,stopped,0,0
88515,use,0,0
88516,due,0,0
88517,to,0,0
88518,adverse,0,0
88519,events,0,0
88520,.,0,0
88521,A,0,0
88522,total,0,0
88523,of,0,0
88524,25,0,0
88525,subjects,0,1
88526,(,0,0
88527,17.5,0,0
88528,%,0,0
88529,),0,0
88530,were,0,0
88531,still,0,0
88532,using,0,0
88533,smokeless,0,0
88534,tobacco,0,1
88535,after,0,0
88536,6,0,0
88537,months,0,0
88538,.,0,0
88539,This,0,0
88540,trial,0,0
88541,demonstrated,0,0
88542,short-term,0,0
88543,efficacy,0,0
88544,of,0,0
88545,smokeless,0,0
88546,tobacco,0,1
88547,in,0,0
88548,combination,0,0
88549,with,0,1
88550,group,0,0
88551,support,0,0
88552,for,0,0
88553,smoking,0,0
88554,cessation,0,0
88555,but,0,0
88556,no,0,0
88557,long-term,0,0
88558,efficacy,0,0
88559,.,0,0
88560,Social,0,1
88561,stories,0,0
88562,:,0,1
88563,mechanisms,0,0
88564,of,0,0
88565,effectiveness,0,0
88566,in,0,0
88567,increasing,0,0
88568,game,0,0
88569,play,0,0
88570,skills,0,0
88571,in,0,0
88572,children,1,1
88573,diagnosed,1,1
88574,with,1,1
88575,autism,1,1
88576,spectrum,1,1
88577,disorder,1,1
88578,using,0,0
88579,a,0,0
88580,pretest,0,0
88581,posttest,0,0
88582,repeated,0,0
88583,measures,0,0
88584,randomized,0,0
88585,control,0,0
88586,group,0,0
88587,design,0,0
88588,.,0,0
88589,An,0,0
88590,increasing,0,0
88591,body,0,0
88592,of,0,0
88593,literature,0,0
88594,has,0,0
88595,indicated,0,0
88596,that,0,0
88597,social,0,0
88598,stories,0,0
88599,are,0,0
88600,an,0,0
88601,effective,0,0
88602,way,0,0
88603,to,0,0
88604,teach,0,0
88605,individuals,1,1
88606,diagnosed,1,1
88607,with,1,1
88608,autism,1,1
88609,appropriate,0,0
88610,social,0,0
88611,behavior,0,0
88612,.,0,0
88613,This,0,0
88614,study,0,0
88615,compared,0,0
88616,two,0,0
88617,formats,0,0
88618,of,0,0
88619,a,0,0
88620,social,0,0
88621,story,0,0
88622,targeting,0,0
88623,the,0,0
88624,improvement,0,0
88625,of,0,0
88626,social,0,0
88627,skills,0,0
88628,during,0,0
88629,game,0,0
88630,play,0,0
88631,using,0,0
88632,a,0,0
88633,pretest,0,0
88634,posttest,0,0
88635,repeated,0,0
88636,measures,0,0
88637,randomized,0,0
88638,control,0,0
88639,group,0,0
88640,design,0,0
88641,.,0,0
88642,A,0,0
88643,total,0,0
88644,of,0,0
88645,45,1,1
88646,children,1,1
88647,diagnosed,1,1
88648,with,1,1
88649,Autism,1,1
88650,Spectrum,1,1
88651,Disorder,1,1
88652,(,1,0
88653,ASD,1,1
88654,),1,0
88655,ages,1,1
88656,7-14,1,0
88657,were,0,0
88658,randomly,0,1
88659,assigned,0,0
88660,to,0,0
88661,standard,0,0
88662,",",0,0
88663,directive,0,0
88664,",",0,0
88665,or,0,0
88666,control,0,0
88667,story,0,0
88668,conditions,0,0
88669,.,0,1
88670,Results,0,0
88671,demonstrated,0,0
88672,that,0,0
88673,the,0,0
88674,standard,0,0
88675,and,0,0
88676,directive,0,0
88677,story,0,0
88678,formats,0,0
88679,were,0,0
88680,equally,0,0
88681,as,0,0
88682,effective,0,0
88683,in,0,0
88684,eliciting,0,0
88685,",",0,0
88686,generalizing,0,0
88687,and,0,0
88688,maintaining,0,0
88689,the,0,0
88690,targeted,0,0
88691,social,0,0
88692,skills,0,0
88693,in,0,1
88694,participants,0,1
88695,who,0,1
88696,had,0,1
88697,prior,0,1
88698,game,0,0
88699,play,0,0
88700,experience,0,0
88701,and,0,0
88702,Verbal,0,0
88703,Comprehension,0,0
88704,Index,0,0
88705,(,0,0
88706,VCI,0,0
88707,),0,0
88708,scores,0,0
88709,from,0,0
88710,the,0,0
88711,WISC-IV,0,0
88712,intelligence,0,0
88713,test,0,0
88714,in,0,0
88715,the,0,0
88716,borderline,0,1
88717,range,0,0
88718,or,0,0
88719,above,0,0
88720,.,0,0
88721,Efficacy,0,0
88722,of,0,0
88723,latanoprost,0,0
88724,when,0,0
88725,stored,0,0
88726,at,0,0
88727,room,0,0
88728,temperature,0,0
88729,.,0,0
88730,We,0,0
88731,compared,0,0
88732,the,0,0
88733,ocular,0,0
88734,hypotensive,0,0
88735,effect,0,0
88736,for,0,0
88737,24,0,0
88738,hours,0,0
88739,and,0,0
88740,the,0,0
88741,tolerability,0,0
88742,of,0,0
88743,latanoprost,0,0
88744,stored,0,0
88745,at,0,0
88746,4,0,0
88747,degrees,0,0
88748,C,0,0
88749,and,0,0
88750,30,0,1
88751,degrees,0,0
88752,C.,0,0
88753,Seventeen,1,1
88754,healthy,1,1
88755,volunteers,1,1
88756,were,1,0
88757,included,1,1
88758,in,1,0
88759,this,1,0
88760,crossover,1,0
88761,trial,1,0
88762,.,1,0
88763,Latanoprost,0,0
88764,0.005,0,0
88765,%,0,0
88766,(,0,0
88767,Xalatan,0,0
88768,),0,0
88769,was,0,0
88770,stored,0,0
88771,at,0,0
88772,4,0,0
88773,degrees,0,0
88774,C,0,0
88775,or,0,1
88776,30,0,1
88777,degrees,0,0
88778,C,0,0
88779,for,0,0
88780,4,0,0
88781,weeks,0,0
88782,in,0,0
88783,the,0,0
88784,dark,0,0
88785,.,0,0
88786,The,0,0
88787,subjects,0,1
88788,enrolled,0,1
88789,to,0,0
88790,the,0,0
88791,study,0,0
88792,were,0,0
88793,randomly,0,0
88794,assigned,0,0
88795,to,0,0
88796,receive,0,0
88797,either,0,0
88798,latanoprost,0,0
88799,stored,0,0
88800,at,0,0
88801,4,0,0
88802,degrees,0,0
88803,C,0,0
88804,or,0,1
88805,that,0,0
88806,stored,0,0
88807,at,0,0
88808,30,0,1
88809,degrees,0,0
88810,C.,0,0
88811,The,0,0
88812,eye,0,0
88813,drop,0,0
88814,was,0,0
88815,applied,0,0
88816,to,0,0
88817,the,0,0
88818,right,0,0
88819,eye,0,0
88820,of,0,0
88821,each,0,0
88822,subject,0,0
88823,for,0,0
88824,3,0,0
88825,days,0,0
88826,.,0,0
88827,The,0,0
88828,left,0,0
88829,eye,0,0
88830,served,0,0
88831,as,0,0
88832,a,0,0
88833,control,0,0
88834,without,0,0
88835,administration,0,0
88836,.,0,0
88837,Slit-lamp,0,0
88838,biomicroscopy,0,0
88839,and,0,0
88840,circadian,0,0
88841,intra,0,0
88842,ocular,0,1
88843,pressure,0,0
88844,(,0,0
88845,IOP,0,0
88846,),0,0
88847,curve,0,0
88848,was,0,0
88849,performed,0,0
88850,at,0,0
88851,Day,0,0
88852,3,0,0
88853,",",0,0
88854,every,0,0
88855,3,0,0
88856,hours,0,0
88857,from,0,1
88858,6,0,0
88859,pm,0,1
88860,.,0,0
88861,This,0,0
88862,procedure,0,0
88863,was,0,0
88864,repeated,0,0
88865,7,0,0
88866,days,0,0
88867,after,0,0
88868,changing,0,0
88869,the,0,0
88870,drug,0,0
88871,from,0,0
88872,4,0,0
88873,degrees,0,0
88874,C,0,0
88875,to,0,0
88876,30,0,1
88877,degrees,0,0
88878,C,0,0
88879,or,0,0
88880,vice,0,0
88881,versa,0,0
88882,",",0,0
88883,and,0,0
88884,application,0,0
88885,to,0,0
88886,the,0,0
88887,left,0,0
88888,eye,0,0
88889,for,0,0
88890,3,0,0
88891,days,0,0
88892,.,0,1
88893,Eyes,0,0
88894,treated,0,1
88895,with,0,1
88896,latanoprost,0,0
88897,",",0,0
88898,stored,0,0
88899,both,0,0
88900,at,0,0
88901,4,0,0
88902,degrees,0,0
88903,C,0,0
88904,and,0,0
88905,30,0,1
88906,degrees,0,0
88907,C,0,0
88908,",",0,0
88909,achieved,0,0
88910,statistically,0,0
88911,significantly,0,0
88912,lower,0,0
88913,mean,0,0
88914,IOPs,0,0
88915,than,0,0
88916,untreated,0,1
88917,eyes,0,1
88918,at,0,0
88919,all,0,0
88920,time,0,0
88921,points,0,0
88922,",",0,0
88923,except,0,0
88924,at,0,0
88925,21,0,1
88926,hours,0,0
88927,treated,0,1
88928,by,0,0
88929,the,0,0
88930,drug,0,0
88931,stored,0,0
88932,at,0,0
88933,30,0,1
88934,degrees,0,0
88935,C.,0,0
88936,We,0,0
88937,subtracted,0,0
88938,the,0,0
88939,IOP,0,0
88940,of,0,0
88941,eyes,0,1
88942,receiving,0,1
88943,latanoprost,0,0
88944,from,0,0
88945,the,0,0
88946,IOP,0,0
88947,of,0,0
88948,untreated,0,1
88949,eyes,0,1
88950,for,0,0
88951,each,0,0
88952,time,0,0
88953,point,0,0
88954,to,0,0
88955,evaluate,0,0
88956,the,0,0
88957,efficacy,0,0
88958,of,0,0
88959,the,0,0
88960,eye,0,0
88961,drops,0,0
88962,(,0,0
88963,delta,0,0
88964,IOP,0,0
88965,),0,0
88966,.,0,0
88967,There,0,0
88968,were,0,0
88969,no,0,0
88970,statistically,0,0
88971,significant,0,0
88972,differences,0,0
88973,between,0,0
88974,the,0,0
88975,delta,0,0
88976,IOPs,0,0
88977,with,0,0
88978,the,0,0
88979,drug,0,0
88980,stored,0,0
88981,at,0,0
88982,4,0,0
88983,degrees,0,0
88984,C,0,0
88985,and,0,0
88986,30,0,1
88987,degrees,0,0
88988,C.,0,0
88989,During,0,0
88990,the,0,0
88991,study,0,0
88992,",",0,0
88993,no,0,0
88994,subject,0,0
88995,developed,0,0
88996,a,0,0
88997,serious,0,0
88998,adverse,0,0
88999,event,0,0
89000,.,0,0
89001,These,0,0
89002,results,0,0
89003,suggest,0,0
89004,that,0,0
89005,latanoprost,0,0
89006,stored,0,0
89007,at,0,0
89008,30,0,1
89009,degrees,0,0
89010,C,0,0
89011,for,0,0
89012,4,0,0
89013,weeks,0,0
89014,after,0,0
89015,opening,0,0
89016,the,0,0
89017,bottle,0,0
89018,remains,0,0
89019,as,0,0
89020,effective,0,0
89021,and,0,0
89022,safe,0,0
89023,as,0,0
89024,latanoprost,0,0
89025,stored,0,0
89026,under,0,0
89027,cold,0,0
89028,conditions,0,0
89029,.,0,1
89030,Treatment,0,0
89031,of,0,0
89032,posterior,1,0
89033,uveitis,1,1
89034,with,0,0
89035,a,0,0
89036,fluocinolone,0,0
89037,acetonide,0,0
89038,implant,0,0
89039,:,0,1
89040,three-year,0,0
89041,clinical,0,0
89042,trial,0,1
89043,results,0,0
89044,.,0,0
89045,OBJECTIVES,0,0
89046,To,0,0
89047,evaluate,0,0
89048,the,0,0
89049,safety,0,0
89050,and,0,0
89051,efficacy,0,0
89052,of,0,0
89053,0.59-mg,0,0
89054,and,0,0
89055,2.1-mg,0,0
89056,fluocinolone,0,0
89057,acetonide,0,0
89058,(,0,0
89059,FA,0,0
89060,),0,0
89061,intravitreous,0,0
89062,implants,0,0
89063,in,0,0
89064,noninfectious,1,1
89065,posterior,1,1
89066,uveitis,1,1
89067,.,1,0
89068,DESIGN,0,0
89069,A,0,0
89070,3-year,0,0
89071,",",0,0
89072,multicenter,0,0
89073,",",0,0
89074,randomized,0,0
89075,",",0,0
89076,historically,0,0
89077,controlled,0,0
89078,trial,0,0
89079,of,0,0
89080,the,0,0
89081,0.59-mg,1,0
89082,FA,1,0
89083,intravitreous,1,0
89084,implant,1,0
89085,in,1,0
89086,110,1,1
89087,patients,1,1
89088,and,1,0
89089,the,1,0
89090,2.1-mg,1,0
89091,FA,1,0
89092,intravitreous,1,0
89093,implant,1,0
89094,in,1,0
89095,168,1,1
89096,patients,1,1
89097,.,1,1
89098,MAIN,0,0
89099,OUTCOME,0,0
89100,MEASURES,0,0
89101,Recurrence,0,0
89102,rate,0,0
89103,",",0,0
89104,vision,0,0
89105,",",0,0
89106,and,0,0
89107,complications,0,0
89108,.,0,1
89109,RESULTS,0,0
89110,Uveitis,0,1
89111,recurrence,0,0
89112,was,0,0
89113,reduced,0,0
89114,in,0,0
89115,implanted,0,1
89116,eyes,0,1
89117,from,0,1
89118,62,0,1
89119,%,0,0
89120,(,0,0
89121,during,0,0
89122,the,0,0
89123,1-year,0,0
89124,preimplantation,0,0
89125,period,0,0
89126,),0,0
89127,to,0,0
89128,4,0,0
89129,%,0,0
89130,",",0,0
89131,10,0,0
89132,%,0,0
89133,",",0,0
89134,and,0,0
89135,20,0,0
89136,%,0,0
89137,during,0,0
89138,the,0,0
89139,1-,0,0
89140,",",0,0
89141,2-,0,0
89142,",",0,0
89143,and,0,0
89144,3-year,0,0
89145,postimplantation,0,0
89146,periods,0,0
89147,",",0,0
89148,respectively,0,0
89149,",",0,0
89150,for,0,0
89151,the,0,0
89152,0.59-mg,0,0
89153,dose,0,0
89154,group,0,0
89155,(,0,0
89156,P,0,0
89157,<,0,0
89158,.01,0,0
89159,),0,0
89160,and,0,0
89161,from,0,0
89162,58,0,1
89163,%,0,0
89164,to,0,0
89165,7,0,0
89166,%,0,0
89167,",",0,0
89168,17,0,0
89169,%,0,0
89170,",",0,0
89171,and,0,0
89172,41,0,1
89173,%,0,0
89174,",",0,0
89175,respectively,0,0
89176,",",0,0
89177,for,0,0
89178,the,0,0
89179,2.1-mg,0,0
89180,dose,0,0
89181,group,0,0
89182,(,0,0
89183,P,0,0
89184,<,0,0
89185,.01,0,0
89186,),0,0
89187,.,0,0
89188,More,0,0
89189,implanted,0,0
89190,eyes,0,0
89191,than,0,0
89192,nonimplanted,0,1
89193,eyes,0,1
89194,had,0,1
89195,improved,0,0
89196,visual,0,0
89197,acuity,0,0
89198,(,0,0
89199,P,0,0
89200,<,0,0
89201,.01,0,0
89202,),0,0
89203,.,0,0
89204,Implanted,0,0
89205,eyes,0,0
89206,had,0,0
89207,higher,0,0
89208,incidences,0,0
89209,of,0,0
89210,intraocular,0,1
89211,pressure,0,0
89212,elevation,0,0
89213,(,0,0
89214,>,0,0
89215,or,0,0
89216,=,0,0
89217,10,0,1
89218,mm,0,0
89219,Hg,0,0
89220,),0,0
89221,than,0,0
89222,nonimplanted,0,1
89223,eyes,0,1
89224,(,0,0
89225,P,0,0
89226,<,0,0
89227,.01,0,0
89228,),0,0
89229,",",0,0
89230,and,0,0
89231,glaucoma,0,1
89232,surgery,0,1
89233,was,0,0
89234,required,0,0
89235,in,0,0
89236,40,0,0
89237,%,0,0
89238,of,0,0
89239,implanted,0,1
89240,eyes,0,1
89241,vs,0,0
89242,2,0,0
89243,%,0,0
89244,of,0,0
89245,nonimplanted,0,1
89246,eyes,0,1
89247,(,0,0
89248,P,0,0
89249,<,0,0
89250,.01,0,0
89251,),0,1
89252,.,0,0
89253,Cataracts,0,0
89254,were,0,0
89255,extracted,0,1
89256,in,0,0
89257,93,0,0
89258,%,0,0
89259,of,0,0
89260,phakic,0,1
89261,implanted,0,1
89262,eyes,0,1
89263,vs,0,0
89264,20,0,0
89265,%,0,0
89266,of,0,0
89267,phakic,0,1
89268,nonimplanted,0,1
89269,eyes,0,1
89270,(,0,0
89271,P,0,0
89272,<,0,0
89273,.01,0,0
89274,),0,0
89275,.,0,0
89276,CONCLUSIONS,0,0
89277,The,0,0
89278,FA,0,0
89279,implant,0,0
89280,significantly,0,0
89281,reduced,0,0
89282,uveitis,0,1
89283,recurrence,0,0
89284,and,0,0
89285,improved,0,0
89286,or,0,0
89287,stabilized,0,0
89288,visual,0,0
89289,acuity,0,0
89290,in,0,0
89291,subjects,1,1
89292,with,1,1
89293,noninfectious,1,1
89294,posterior,1,1
89295,uveitis,1,1
89296,.,1,0
89297,Most,0,0
89298,subjects,0,1
89299,required,0,0
89300,cataract,0,1
89301,extraction,0,0
89302,",",0,0
89303,and,0,0
89304,a,0,0
89305,significant,0,0
89306,proportion,0,0
89307,required,0,0
89308,intraocular,0,0
89309,pressure-lowering,0,0
89310,surgery,0,1
89311,.,0,0
89312,APPLICATION,0,0
89313,TO,0,0
89314,CLINICAL,0,0
89315,PRACTICE,0,0
89316,The,0,0
89317,FA,0,0
89318,implant,0,0
89319,provides,0,0
89320,an,0,0
89321,alternative,0,0
89322,therapy,0,0
89323,for,0,0
89324,prolonged,0,0
89325,control,0,0
89326,of,0,0
89327,inflammation,0,0
89328,in,0,0
89329,noninfectious,0,1
89330,posterior,0,1
89331,uveitis,0,1
89332,.,0,0
89333,TRIAL,0,0
89334,REGISTRATION,0,0
89335,clinicaltrials.gov,0,0
89336,Identifier,0,0
89337,:,0,1
89338,NCT00407082,0,0
89339,.,0,0
89340,[,1,0
89341,The,1,0
89342,CARESS-in-AMI,1,0
89343,trial,1,0
89344,],1,0
89345,.,0,0
89346,Levels,0,0
89347,of,0,0
89348,opioid,1,0
89349,physical,1,0
89350,dependence,1,0
89351,in,1,0
89352,heroin,1,1
89353,addicts,1,1
89354,.,1,0
89355,The,0,0
89356,levels,0,0
89357,of,0,0
89358,opioid,0,0
89359,physical,0,0
89360,dependence,0,0
89361,in,0,0
89362,a,0,0
89363,group,0,0
89364,of,0,0
89365,long-term,1,0
89366,heroin,1,1
89367,addicts,1,1
89368,were,0,0
89369,ascertained,0,0
89370,by,0,0
89371,measuring,0,0
89372,the,0,0
89373,severity,0,0
89374,of,0,0
89375,the,0,0
89376,opioid,0,0
89377,withdrawal,0,0
89378,syndrome,0,1
89379,before,0,0
89380,and,0,0
89381,after,0,0
89382,pharmacological,0,0
89383,challenge,0,0
89384,with,0,1
89385,either,0,0
89386,0.4,0,0
89387,mg,0,0
89388,naloxone,0,0
89389,or,0,0
89390,placebo,0,0
89391,.,0,0
89392,Prior,0,0
89393,to,0,0
89394,challenge,0,0
89395,",",0,0
89396,patients,0,1
89397,manifested,0,0
89398,some,0,0
89399,subjective,0,0
89400,symptoms,0,0
89401,but,0,0
89402,few,0,0
89403,objective,0,0
89404,signs,0,0
89405,of,0,0
89406,opioid,0,1
89407,withdrawal,0,0
89408,.,0,1
89409,Patients,1,1
89410,who,1,1
89411,received,1,1
89412,placebo,1,1
89413,(,1,0
89414,n,1,1
89415,=,1,0
89416,18,1,1
89417,),1,0
89418,showed,0,0
89419,a,0,0
89420,significant,0,0
89421,increase,0,0
89422,in,0,0
89423,the,0,0
89424,mean,0,0
89425,score,0,0
89426,on,0,0
89427,one,0,0
89428,of,0,0
89429,three,0,0
89430,rating,0,0
89431,scales,0,0
89432,used,0,0
89433,to,0,0
89434,assess,0,0
89435,opioid,0,0
89436,withdrawal,0,0
89437,.,0,1
89438,Patients,1,1
89439,who,1,1
89440,received,1,1
89441,naloxone,1,0
89442,(,1,0
89443,n,1,1
89444,=,1,0
89445,58,1,1
89446,),1,0
89447,showed,0,0
89448,significant,0,0
89449,increases,0,0
89450,in,0,0
89451,mean,0,1
89452,scores,0,0
89453,on,0,0
89454,all,0,0
89455,three,0,0
89456,rating,0,0
89457,scales,0,0
89458,",",0,0
89459,but,0,0
89460,this,0,0
89461,was,0,0
89462,due,0,0
89463,primarily,0,0
89464,to,0,0
89465,increases,0,0
89466,observed,0,0
89467,in,0,0
89468,a,0,0
89469,minority,0,1
89470,of,0,0
89471,patients,0,1
89472,.,0,1
89473,Sixty-one,0,1
89474,percent,0,0
89475,of,0,0
89476,patients,0,1
89477,failed,0,0
89478,to,0,0
89479,manifest,0,0
89480,clinically,0,0
89481,significant,0,0
89482,changes,0,0
89483,in,0,0
89484,subjective,0,0
89485,symptoms,0,0
89486,",",0,0
89487,and,0,0
89488,74,0,0
89489,%,0,0
89490,of,0,0
89491,patients,0,1
89492,failed,0,0
89493,to,0,0
89494,manifest,0,0
89495,clinically,0,0
89496,significant,0,0
89497,changes,0,0
89498,in,0,0
89499,objective,0,0
89500,signs,0,0
89501,of,0,0
89502,opioid,0,0
89503,withdrawal,0,0
89504,following,0,0
89505,naloxone,0,0
89506,administration,0,0
89507,.,0,0
89508,The,0,0
89509,results,0,0
89510,suggest,0,0
89511,that,0,0
89512,a,0,0
89513,substantial,0,0
89514,subgroup,0,0
89515,of,0,0
89516,heroin,0,1
89517,addicts,0,1
89518,are,0,0
89519,able,0,0
89520,to,0,0
89521,use,0,0
89522,opioids,0,0
89523,regularly,0,0
89524,while,0,0
89525,maintaining,0,0
89526,relatively,0,0
89527,low,0,0
89528,levels,0,0
89529,of,0,0
89530,physical,0,0
89531,dependence,0,0
89532,.,0,0
89533,Need,0,0
89534,the,0,0
89535,thumb,0,0
89536,be,0,0
89537,immobilised,0,0
89538,in,0,0
89539,scaphoid,1,1
89540,fractures,1,1
89541,?,0,0
89542,A,0,0
89543,randomised,0,0
89544,prospective,0,0
89545,trial,0,0
89546,.,0,0
89547,Immobilisation,0,0
89548,of,0,0
89549,the,0,0
89550,thumb,0,0
89551,is,0,0
89552,widely,0,0
89553,believed,0,0
89554,to,0,0
89555,be,0,0
89556,important,0,0
89557,in,0,0
89558,the,0,0
89559,management,0,0
89560,of,0,0
89561,fractures,1,1
89562,of,1,0
89563,the,1,0
89564,carpal,1,0
89565,scaphoid,1,1
89566,.,1,0
89567,To,0,0
89568,assess,0,0
89569,the,0,0
89570,need,0,0
89571,for,0,0
89572,this,0,0
89573,",",0,0
89574,we,0,0
89575,randomly,0,0
89576,allocated,0,0
89577,392,1,1
89578,fresh,1,0
89579,fractures,1,1
89580,for,0,0
89581,treatment,0,0
89582,by,0,0
89583,either,0,0
89584,a,0,0
89585,forearm,0,0
89586,gauntlet,0,0
89587,(,0,0
89588,Colles,0,1
89589,',0,0
89590,),0,0
89591,cast,0,0
89592,",",0,0
89593,leaving,0,0
89594,the,0,0
89595,thumb,0,0
89596,free,0,0
89597,",",0,0
89598,or,0,0
89599,by,0,0
89600,a,0,0
89601,conventional,0,0
89602,'scaphoid,0,0
89603,',0,0
89604,plaster,0,0
89605,incorporating,0,0
89606,the,0,0
89607,thumb,0,0
89608,as,0,0
89609,far,0,0
89610,as,0,0
89611,its,0,0
89612,interphalangeal,0,1
89613,joint,0,0
89614,.,0,0
89615,In,0,0
89616,the,0,0
89617,292,1,1
89618,fractures,1,1
89619,which,0,0
89620,were,0,0
89621,followed,0,0
89622,for,0,0
89623,six,0,0
89624,months,0,0
89625,",",0,0
89626,the,0,0
89627,incidence,0,0
89628,of,0,0
89629,nonunion,0,1
89630,was,0,0
89631,independent,0,0
89632,of,0,0
89633,the,0,0
89634,type,0,0
89635,of,0,0
89636,cast,0,0
89637,used,0,0
89638,.,0,0
89639,Consumer-directed,0,0
89640,care,0,1
89641,for,0,0
89642,beneficiaries,1,1
89643,with,1,1
89644,mental,1,1
89645,illness,1,1
89646,:,1,1
89647,lessons,0,0
89648,from,0,1
89649,New,0,1
89650,Jersey,0,1
89651,'s,0,0
89652,Cash,0,0
89653,and,0,0
89654,Counseling,0,0
89655,program,0,0
89656,.,0,0
89657,OBJECTIVE,0,0
89658,Previous,0,0
89659,research,0,0
89660,from,0,0
89661,the,0,0
89662,Cash,1,0
89663,and,1,0
89664,Counseling,1,0
89665,Demonstration,1,0
89666,and,1,0
89667,Evaluation,1,0
89668,(,1,0
89669,CCDE,1,0
89670,),1,0
89671,programs,1,0
89672,in,1,0
89673,New,1,1
89674,Jersey,1,1
89675,",",1,0
89676,Arkansas,1,1
89677,",",1,0
89678,and,1,0
89679,Florida,1,0
89680,suggests,0,0
89681,that,0,0
89682,consumers,0,0
89683,',0,1
89684,control,0,0
89685,over,0,0
89686,personal,0,0
89687,care,0,0
89688,greatly,0,0
89689,improves,0,0
89690,their,0,0
89691,satisfaction,0,0
89692,with,0,1
89693,care,0,0
89694,arrangements,0,0
89695,and,0,0
89696,their,0,0
89697,outlook,0,0
89698,on,0,0
89699,life,0,0
89700,.,0,0
89701,Still,0,0
89702,",",0,0
89703,some,0,0
89704,argue,0,0
89705,that,0,0
89706,consumer-directed,0,0
89707,care,0,0
89708,may,0,0
89709,not,0,0
89710,be,0,0
89711,appropriate,0,0
89712,for,0,0
89713,consumers,0,0
89714,with,0,1
89715,a,0,0
89716,diagnosis,0,0
89717,of,0,0
89718,mental,0,1
89719,illness,0,1
89720,.,0,0
89721,This,0,0
89722,study,0,0
89723,examined,0,0
89724,the,0,0
89725,effectiveness,0,0
89726,of,0,0
89727,the,0,0
89728,CCDE,0,0
89729,program,0,0
89730,for,0,0
89731,those,1,0
89732,with,1,0
89733,a,1,0
89734,diagnosis,1,0
89735,of,1,0
89736,mental,1,1
89737,illness,1,1
89738,.,1,0
89739,METHODS,0,0
89740,This,0,0
89741,study,0,0
89742,examined,0,0
89743,nonelderly,1,1
89744,Medicaid,1,0
89745,beneficiaries,1,1
89746,in,1,0
89747,New,1,1
89748,Jersey,1,1
89749,with,1,0
89750,a,1,0
89751,diagnosis,1,0
89752,of,1,0
89753,mental,1,1
89754,illness,1,1
89755,and,1,0
89756,compared,1,0
89757,and,1,0
89758,contrasted,1,0
89759,the,1,0
89760,experiences,1,0
89761,of,1,0
89762,those,1,1
89763,in,1,0
89764,New,1,1
89765,Jersey,1,1
89766,'s,1,0
89767,CCDE,1,0
89768,program,1,1
89769,(,1,0
89770,N=109,1,0
89771,),1,0
89772,and,1,0
89773,those,1,1
89774,who,1,1
89775,received,1,1
89776,services,1,1
89777,provided,1,0
89778,by,1,0
89779,an,1,0
89780,agency,1,0
89781,(,1,0
89782,N=119,1,0
89783,),1,0
89784,.,1,0
89785,Logistic,0,0
89786,regression,0,0
89787,analyses,0,0
89788,were,0,0
89789,performed,0,0
89790,on,0,0
89791,baseline,0,0
89792,and,0,0
89793,nine-month,0,0
89794,follow-up,0,0
89795,data,0,0
89796,.,0,0
89797,RESULTS,0,0
89798,By,0,0
89799,examining,0,0
89800,outcome,0,0
89801,measures,0,0
89802,--,0,1
89803,including,0,0
89804,satisfaction,0,0
89805,with,0,1
89806,care,0,0
89807,arrangements,0,0
89808,",",0,0
89809,consumers,0,1
89810,',0,1
89811,perceptions,0,0
89812,of,0,1
89813,paid,0,0
89814,caregivers,0,1
89815,',0,1
89816,attitudes,0,0
89817,",",0,1
89818,unmet,0,1
89819,needs,0,0
89820,",",0,0
89821,adverse,0,0
89822,events,0,0
89823,",",0,0
89824,and,0,0
89825,satisfaction,0,0
89826,with,0,1
89827,life,0,0
89828,--,0,0
89829,this,0,0
89830,study,0,0
89831,offers,0,0
89832,evidence,0,0
89833,that,0,0
89834,",",0,0
89835,from,0,0
89836,the,0,0
89837,perspective,0,0
89838,of,0,0
89839,consumers,0,0
89840,",",0,0
89841,the,0,0
89842,CCDE,0,0
89843,program,0,0
89844,is,0,0
89845,appropriate,0,0
89846,for,0,0
89847,participants,0,1
89848,with,0,1
89849,a,0,0
89850,mental,0,0
89851,illness,0,1
89852,diagnosis,0,1
89853,.,0,0
89854,For,0,0
89855,most,0,0
89856,outcome,0,0
89857,measures,0,0
89858,the,0,0
89859,CCDE,0,0
89860,program,0,0
89861,demonstrated,0,0
89862,a,0,0
89863,positive,0,0
89864,effect,0,0
89865,after,0,0
89866,baseline,0,0
89867,characteristics,0,0
89868,were,0,0
89869,controlled,0,0
89870,for,0,0
89871,.,0,0
89872,The,0,0
89873,analysis,0,0
89874,of,0,0
89875,measures,0,0
89876,of,0,0
89877,adverse,0,0
89878,events,0,0
89879,",",0,0
89880,health,0,0
89881,problems,0,0
89882,",",0,0
89883,and,0,0
89884,general,0,1
89885,health,0,0
89886,status,0,0
89887,did,0,0
89888,not,0,0
89889,yield,0,0
89890,statistically,0,0
89891,significant,0,0
89892,differences,0,0
89893,between,0,0
89894,the,0,0
89895,control,0,0
89896,group,0,0
89897,and,0,0
89898,the,0,0
89899,treatment,0,0
89900,group,0,0
89901,",",0,0
89902,indicating,0,0
89903,that,0,0
89904,CCDE,0,0
89905,care,0,0
89906,was,0,0
89907,at,0,0
89908,least,0,0
89909,as,0,0
89910,safe,0,0
89911,as,0,0
89912,agency-directed,0,0
89913,care,0,1
89914,.,0,0
89915,CONCLUSIONS,0,0
89916,Considering,0,0
89917,the,0,0
89918,growing,0,0
89919,need,0,0
89920,for,0,0
89921,long-term,0,0
89922,care,0,1
89923,services,0,1
89924,and,0,0
89925,the,0,0
89926,limited,0,0
89927,resources,0,0
89928,available,0,0
89929,",",0,0
89930,a,0,0
89931,consumer-directed,0,0
89932,option,0,0
89933,can,0,0
89934,be,0,0
89935,a,0,0
89936,valuable,0,0
89937,alternative,0,0
89938,for,0,0
89939,persons,1,1
89940,with,1,1
89941,a,1,0
89942,diagnosis,1,0
89943,of,1,0
89944,mental,1,1
89945,illness,1,1
89946,.,1,0
89947,Comparison,0,0
89948,of,0,0
89949,40,0,1
89950,milliliters,0,0
89951,of,0,0
89952,0.25,0,0
89953,%,0,0
89954,intrapleural,0,0
89955,bupivacaine,0,0
89956,with,0,1
89957,epinephrine,0,0
89958,with,0,1
89959,20,0,1
89960,milliliters,0,0
89961,of,0,0
89962,0.5,0,0
89963,%,0,0
89964,intrapleural,0,0
89965,bupivacaine,0,0
89966,with,0,1
89967,epinephrine,0,0
89968,after,0,0
89969,cholecystectomy,0,1
89970,.,0,0
89971,To,0,0
89972,determine,0,0
89973,the,0,0
89974,influence,0,0
89975,of,0,0
89976,the,0,0
89977,volume,0,0
89978,of,0,0
89979,local,0,0
89980,anesthetic,0,0
89981,injected,0,0
89982,for,0,0
89983,intrapleural,0,0
89984,analgesia,0,0
89985,",",0,0
89986,40,1,1
89987,patients,1,1
89988,undergoing,1,1
89989,cholecystectomy,1,1
89990,were,1,0
89991,randomly,1,1
89992,allocated,1,0
89993,to,1,0
89994,two,1,0
89995,groups,1,0
89996,of,1,0
89997,20,1,1
89998,patients,1,1
89999,each,1,0
90000,.,1,0
90001,One,1,0
90002,group,1,0
90003,received,0,0
90004,40,0,0
90005,mL,0,0
90006,of,0,0
90007,0.25,0,0
90008,%,0,0
90009,bupivacaine,0,0
90010,with,0,0
90011,epinephrine,0,0
90012,injected,0,0
90013,intrapleurally,0,0
90014,postoperatively,0,0
90015,.,0,0
90016,The,1,0
90017,other,1,0
90018,group,1,0
90019,received,0,0
90020,20,0,0
90021,mL,0,0
90022,of,0,0
90023,0.5,0,0
90024,%,0,0
90025,bupivacaine,0,0
90026,with,0,1
90027,epinephrine,0,0
90028,.,0,0
90029,The,0,0
90030,onset,0,0
90031,time,0,0
90032,of,0,0
90033,analgesia,0,0
90034,was,0,0
90035,nearly,0,0
90036,the,0,0
90037,same,0,0
90038,in,0,0
90039,both,0,0
90040,groups,0,0
90041,and,0,0
90042,within,0,0
90043,25,0,0
90044,min,0,0
90045,all,0,0
90046,patients,1,1
90047,were,0,0
90048,nearly,0,0
90049,pain,0,0
90050,free,0,0
90051,.,0,0
90052,Our,0,0
90053,data,0,0
90054,demonstrate,0,0
90055,that,0,0
90056,100,0,0
90057,mg,0,0
90058,of,0,0
90059,bupivacaine,0,0
90060,with,0,1
90061,epinephrine,0,0
90062,elicits,0,0
90063,effective,0,0
90064,analgesia,0,0
90065,after,0,0
90066,cholecystectomy,0,1
90067,.,0,0
90068,There,0,0
90069,are,0,0
90070,only,0,0
90071,minor,0,0
90072,differences,0,0
90073,between,0,0
90074,20,0,1
90075,and,0,0
90076,40,0,0
90077,mL,0,0
90078,with,0,1
90079,regard,0,0
90080,to,0,0
90081,pain,0,0
90082,relief,0,0
90083,.,0,0
90084,The,0,0
90085,authors,0,0
90086,conclude,0,0
90087,that,0,0
90088,the,0,0
90089,volume,0,0
90090,of,0,0
90091,local,0,0
90092,anesthetic,0,0
90093,within,0,0
90094,the,0,0
90095,range,0,0
90096,of,0,0
90097,20-40,0,1
90098,mL,0,0
90099,in,0,0
90100,an,0,0
90101,adult,0,1
90102,has,0,0
90103,little,0,0
90104,influence,0,0
90105,on,0,0
90106,the,0,0
90107,extent,0,0
90108,or,0,0
90109,duration,0,0
90110,of,0,0
90111,intrapleural,0,0
90112,analgesia,0,0
90113,.,0,0
90114,Two-year,0,1
90115,prospective,0,0
90116,clinical,0,0
90117,comparison,0,0
90118,of,0,0
90119,immediate,0,0
90120,replacement,0,1
90121,vs.,0,0
90122,immediate,0,0
90123,restoration,0,0
90124,of,0,0
90125,single,1,0
90126,tooth,1,1
90127,in,1,0
90128,the,1,0
90129,esthetic,1,0
90130,zone,1,0
90131,.,1,0
90132,AIM,0,0
90133,To,0,0
90134,compare,0,0
90135,the,0,0
90136,immediate,0,0
90137,restoration,0,0
90138,of,0,0
90139,single,0,0
90140,implants,0,1
90141,in,0,0
90142,the,0,0
90143,esthetic,0,0
90144,zones,0,0
90145,performed,0,0
90146,on,0,0
90147,implants,0,0
90148,placed,0,0
90149,immediately,0,0
90150,after,0,0
90151,tooth,0,0
90152,extraction,0,0
90153,or,0,1
90154,8,0,0
90155,weeks,0,0
90156,later,0,0
90157,(,0,0
90158,immediate,0,0
90159,replacement,0,0
90160,vs.,0,0
90161,immediate,0,0
90162,restoration,0,0
90163,),0,0
90164,.,0,0
90165,METHODS,0,0
90166,Sixteen,1,1
90167,patients,1,1
90168,(,1,1
90169,10,1,1
90170,women,1,1
90171,and,1,0
90172,6,1,0
90173,men,1,1
90174,),1,0
90175,with,1,1
90176,a,1,0
90177,mean,1,0
90178,age,1,1
90179,of,1,0
90180,35,1,1
90181,years,1,1
90182,(,1,0
90183,ranging,1,0
90184,from,1,0
90185,21,1,1
90186,to,1,0
90187,49,1,1
90188,years,1,1
90189,old,1,1
90190,),1,0
90191,were,1,0
90192,treated,1,0
90193,from,1,0
90194,2004,1,1
90195,to,1,0
90196,2005,1,1
90197,for,1,0
90198,single-tooth,1,1
90199,replacement,1,0
90200,in,1,0
90201,the,1,0
90202,upper,1,0
90203,arch,1,1
90204,.,1,0
90205,The,1,0
90206,patients,1,1
90207,were,1,0
90208,randomly,1,1
90209,divided,1,0
90210,into,0,0
90211,two,0,0
90212,groups,0,0
90213,:,0,1
90214,in,0,0
90215,the,0,0
90216,test,0,0
90217,group,0,0
90218,patients,0,1
90219,received,0,0
90220,implants,0,0
90221,placed,0,0
90222,and,0,0
90223,restored,0,0
90224,(,0,0
90225,non-occlusal,0,0
90226,loading,0,0
90227,),0,0
90228,at,0,0
90229,the,0,0
90230,time,0,0
90231,of,0,0
90232,tooth,0,1
90233,extraction,0,0
90234,;,0,0
90235,in,0,0
90236,the,0,0
90237,control,0,0
90238,group,0,0
90239,implants,0,0
90240,were,0,0
90241,placed,0,0
90242,8,0,0
90243,weeks,0,0
90244,after,0,0
90245,tooth,0,1
90246,extraction,0,0
90247,and,0,0
90248,immediately,0,0
90249,restored,0,0
90250,.,0,0
90251,All,1,0
90252,the,1,0
90253,patients,1,1
90254,received,1,0
90255,tapered,1,0
90256,effect,1,0
90257,(,1,0
90258,TE,1,0
90259,),1,0
90260,implants,1,0
90261,from,1,0
90262,the,1,0
90263,Straumann,1,0
90264,Dental,1,0
90265,Implant,1,1
90266,System,1,0
90267,.,1,0
90268,The,0,0
90269,following,0,0
90270,parameters,0,0
90271,were,0,0
90272,evaluated,0,0
90273,at,0,0
90274,the,0,0
90275,moment,0,0
90276,of,0,0
90277,provisional,0,0
90278,restoration,0,0
90279,(,0,0
90280,within,0,0
90281,48,0,0
90282,h,0,0
90283,after,0,0
90284,implant,0,0
90285,placement,0,0
90286,),0,0
90287,and,0,0
90288,at,0,0
90289,the,0,0
90290,2,0,0
90291,years,0,1
90292,follow-up,0,0
90293,visit,0,0
90294,:,0,1
90295,marginal,0,0
90296,bone,0,0
90297,resorption,0,0
90298,",",0,0
90299,papilla,0,0
90300,index,0,0
90301,",",0,0
90302,position,0,0
90303,of,0,0
90304,the,0,0
90305,mucosal,0,0
90306,margin,0,0
90307,.,0,0
90308,The,0,0
90309,implant,0,0
90310,stability,0,0
90311,quotient,0,0
90312,was,0,0
90313,measured,0,0
90314,at,0,0
90315,the,0,0
90316,moment,0,0
90317,of,0,0
90318,implant,0,0
90319,placement,0,0
90320,and,0,0
90321,at,0,0
90322,the,0,0
90323,moment,0,0
90324,of,0,0
90325,the,0,0
90326,delivery,0,0
90327,of,0,0
90328,the,0,0
90329,definitive,0,0
90330,restoration,0,0
90331,.,0,0
90332,RESULTS,0,0
90333,No,0,0
90334,statistically,0,0
90335,significant,0,0
90336,differences,0,0
90337,were,0,0
90338,found,0,0
90339,in,0,0
90340,any,0,0
90341,of,0,0
90342,the,0,0
90343,studied,0,1
90344,parameters,0,0
90345,between,0,0
90346,the,0,0
90347,test,0,0
90348,and,0,0
90349,the,0,0
90350,control,0,0
90351,groups,0,0
90352,(,0,0
90353,P,0,0
90354,>,0,1
90355,0.05,0,0
90356,),0,0
90357,.,0,0
90358,The,0,0
90359,implant,0,0
90360,stability,0,0
90361,quotient,0,0
90362,values,0,0
90363,between,0,0
90364,the,0,0
90365,test,0,0
90366,and,0,0
90367,control,0,0
90368,groups,0,0
90369,were,0,0
90370,significant,0,0
90371,(,0,0
90372,P,0,0
90373,<,0,0
90374,0.05,0,0
90375,),0,0
90376,at,0,0
90377,the,0,0
90378,moment,0,0
90379,of,0,0
90380,implant,0,0
90381,placement,0,0
90382,but,0,0
90383,were,0,0
90384,no,0,0
90385,more,0,0
90386,significant,0,0
90387,at,0,0
90388,the,0,0
90389,loading,0,0
90390,of,0,0
90391,the,0,0
90392,definitive,0,0
90393,restoration,0,0
90394,(,0,0
90395,P,0,0
90396,>,0,1
90397,0.05,0,0
90398,),0,0
90399,.,0,0
90400,CONCLUSION,0,0
90401,The,0,0
90402,results,0,0
90403,of,0,0
90404,the,0,0
90405,present,0,0
90406,study,0,0
90407,suggest,0,0
90408,that,0,0
90409,immediate,0,0
90410,replacement,0,1
90411,without,0,1
90412,functional,0,0
90413,loading,0,0
90414,may,0,0
90415,be,0,0
90416,considered,0,0
90417,a,0,0
90418,valuable,0,0
90419,therapeutic,0,0
90420,option,0,0
90421,for,0,0
90422,selected,0,1
90423,cases,0,0
90424,of,0,0
90425,single-tooth,0,1
90426,replacement,0,0
90427,in,0,0
90428,the,0,0
90429,esthetic,0,0
90430,area,0,0
90431,when,0,0
90432,TE,0,0
90433,implants,0,0
90434,are,0,0
90435,used,0,0
90436,.,0,0
90437,Implant,0,0
90438,stability,0,0
90439,at,0,0
90440,the,0,0
90441,moment,0,0
90442,of,0,0
90443,implant,0,0
90444,placement,0,0
90445,is,0,0
90446,slightly,0,0
90447,inferior,0,0
90448,in,0,0
90449,the,0,0
90450,immediate,0,0
90451,replacement,0,0
90452,group,0,0
90453,",",0,0
90454,but,0,0
90455,it,0,0
90456,does,0,0
90457,not,0,0
90458,affect,0,0
90459,the,0,0
90460,treatment,0,0
90461,result,0,0
90462,.,0,0
90463,Visual,0,0
90464,field,0,0
90465,progression,0,0
90466,in,0,0
90467,the,0,0
90468,Collaborative,1,0
90469,Initial,1,0
90470,Glaucoma,1,1
90471,Treatment,1,0
90472,Study,1,0
90473,the,0,0
90474,impact,0,0
90475,of,0,0
90476,treatment,0,0
90477,and,0,0
90478,other,0,0
90479,baseline,0,0
90480,factors,0,0
90481,.,0,0
90482,PURPOSE,0,0
90483,To,0,0
90484,evaluate,0,0
90485,factors,0,0
90486,associated,0,0
90487,with,0,1
90488,visual,0,0
90489,field,0,0
90490,(,0,0
90491,VF,0,1
90492,),0,0
90493,progression,0,0
90494,",",0,0
90495,using,0,0
90496,all,0,0
90497,available,0,0
90498,follow-up,0,0
90499,through,0,0
90500,9,0,1
90501,years,0,1
90502,after,0,0
90503,treatment,0,0
90504,initiation,0,0
90505,",",0,0
90506,in,0,0
90507,the,0,0
90508,Collaborative,0,0
90509,Initial,0,0
90510,Glaucoma,0,1
90511,Treatment,0,0
90512,Study,0,0
90513,(,0,0
90514,CIGTS,0,0
90515,),0,0
90516,.,0,0
90517,DESIGN,0,0
90518,Longitudinal,0,0
90519,follow-up,0,0
90520,of,0,0
90521,participants,0,1
90522,enrolled,0,1
90523,in,0,0
90524,a,0,0
90525,randomized,0,0
90526,clinical,0,0
90527,trial,0,0
90528,.,0,0
90529,PARTICIPANTS,0,0
90530,Six,1,1
90531,hundred,1,1
90532,seven,1,0
90533,newly,1,1
90534,diagnosed,1,1
90535,glaucoma,1,1
90536,patients,1,1
90537,.,1,0
90538,METHODS,0,0
90539,In,0,0
90540,a,0,0
90541,randomized,0,0
90542,clinical,0,0
90543,trial,0,0
90544,",",0,0
90545,607,1,1
90546,subjects,1,1
90547,with,1,1
90548,newly,1,1
90549,diagnosed,1,1
90550,open-angle,1,1
90551,glaucoma,1,1
90552,initially,0,0
90553,were,0,0
90554,treated,0,0
90555,with,0,0
90556,either,0,0
90557,medication,0,0
90558,or,0,0
90559,trabeculectomy,0,0
90560,.,0,0
90561,After,0,0
90562,treatment,0,0
90563,initiation,0,0
90564,and,0,0
90565,early,0,0
90566,follow-up,0,0
90567,",",0,0
90568,subjects,0,1
90569,were,0,0
90570,evaluated,0,0
90571,clinically,0,0
90572,at,0,0
90573,6-month,0,0
90574,intervals,0,0
90575,.,0,1
90576,Study,0,0
90577,participants,0,1
90578,in,0,0
90579,both,0,0
90580,arms,0,0
90581,of,0,0
90582,the,0,0
90583,CIGTS,0,0
90584,were,0,0
90585,treated,0,0
90586,aggressively,0,0
90587,in,0,0
90588,an,0,0
90589,effort,0,0
90590,to,0,0
90591,reduce,0,0
90592,intraocular,0,0
90593,pressure,0,0
90594,(,0,0
90595,IOP,0,0
90596,),0,0
90597,to,0,0
90598,a,0,0
90599,level,0,0
90600,at,0,0
90601,or,0,0
90602,below,0,0
90603,a,0,0
90604,predetermined,0,0
90605,",",0,0
90606,eye-specific,0,0
90607,target,0,0
90608,pressure,0,0
90609,.,0,0
90610,Visual,0,0
90611,field,0,0
90612,progression,0,0
90613,was,0,0
90614,analyzed,0,0
90615,using,0,0
90616,repeated,0,0
90617,measures,0,0
90618,models,0,0
90619,.,0,1
90620,MAIN,0,0
90621,OUTCOME,0,0
90622,MEASURES,0,0
90623,Visual,0,0
90624,field,0,0
90625,progression,0,0
90626,",",0,0
90627,measured,0,0
90628,by,0,0
90629,Humphrey,0,1
90630,24-2,0,1
90631,full-threshold,0,0
90632,testing,0,0
90633,and,0,0
90634,assessed,0,0
90635,by,0,0
90636,the,0,0
90637,change,0,0
90638,in,0,0
90639,the,0,0
90640,mean,0,0
90641,deviation,0,0
90642,(,0,0
90643,MD,0,0
90644,),0,0
90645,",",0,0
90646,and,0,0
90647,an,0,0
90648,indicator,0,0
90649,of,0,0
90650,substantial,0,0
90651,worsening,0,0
90652,of,0,0
90653,the,0,0
90654,VF,0,1
90655,(,0,0
90656,MD,0,0
90657,decrease,0,0
90658,of,0,0
90659,>,0,0
90660,or,0,0
90661,=3,0,0
90662,dB,0,0
90663,from,0,0
90664,baseline,0,0
90665,),0,0
90666,",",0,0
90667,assessed,0,0
90668,at,0,0
90669,each,0,0
90670,follow-up,0,0
90671,visit,0,0
90672,.,0,0
90673,RESULTS,0,0
90674,Follow-up,0,0
90675,indicated,0,0
90676,minimal,0,0
90677,change,0,0
90678,from,0,0
90679,baseline,0,0
90680,in,0,0
90681,each,0,0
90682,initial,0,0
90683,treatment,0,0
90684,group,0,0
90685,'s,0,0
90686,average,0,0
90687,MD,0,1
90688,.,0,0
90689,However,0,0
90690,",",0,0
90691,at,0,0
90692,the,0,0
90693,8-year,0,0
90694,follow-up,0,0
90695,examination,0,0
90696,",",0,0
90697,substantial,0,0
90698,worsening,0,0
90699,(,0,0
90700,>,0,0
90701,or,0,0
90702,=3,0,0
90703,dB,0,0
90704,),0,0
90705,of,0,0
90706,MD,0,0
90707,from,0,0
90708,baseline,0,0
90709,was,0,0
90710,found,0,0
90711,in,0,0
90712,21.3,0,0
90713,%,0,0
90714,and,0,0
90715,25.5,0,0
90716,%,0,0
90717,of,0,0
90718,the,0,0
90719,initial,0,0
90720,surgery,0,1
90721,and,0,0
90722,initial,0,0
90723,medicine,0,1
90724,groups,0,0
90725,",",0,0
90726,respectively,0,0
90727,.,0,0
90728,The,0,0
90729,effect,0,0
90730,of,0,0
90731,initial,0,0
90732,treatment,0,0
90733,on,0,0
90734,subsequent,0,0
90735,VF,0,1
90736,loss,0,0
90737,was,0,0
90738,modified,0,0
90739,by,0,0
90740,time,0,0
90741,(,0,0
90742,P,0,0
90743,<,0,0
90744,0.0001,0,0
90745,),0,0
90746,",",0,0
90747,baseline,0,0
90748,MD,0,0
90749,(,0,0
90750,P,0,0
90751,=,0,0
90752,0.03,0,0
90753,),0,0
90754,",",0,0
90755,and,0,0
90756,diabetes,0,1
90757,(,0,0
90758,P,0,0
90759,=,0,0
90760,0.01,0,0
90761,),0,0
90762,.,0,0
90763,Initial,0,0
90764,surgery,0,1
90765,led,0,0
90766,to,0,0
90767,less,0,0
90768,VF,0,0
90769,progression,0,0
90770,than,0,0
90771,initial,0,0
90772,medicine,0,1
90773,in,0,0
90774,subjects,1,1
90775,with,1,1
90776,advanced,1,1
90777,VF,1,1
90778,loss,1,0
90779,at,1,0
90780,baseline,1,0
90781,",",0,0
90782,whereas,0,0
90783,subjects,1,1
90784,with,1,1
90785,diabetes,1,1
90786,had,0,0
90787,more,0,0
90788,VF,0,0
90789,loss,0,0
90790,over,0,0
90791,time,0,0
90792,if,0,0
90793,treated,0,0
90794,initially,0,0
90795,with,0,0
90796,surgery,0,1
90797,.,0,0
90798,CONCLUSIONS,0,0
90799,The,0,0
90800,CIGTS,0,0
90801,intervention,0,0
90802,protocol,0,0
90803,led,0,0
90804,to,0,0
90805,a,0,0
90806,lowering,0,0
90807,of,0,0
90808,IOP,0,0
90809,that,0,0
90810,persisted,0,0
90811,over,0,0
90812,time,0,0
90813,in,0,0
90814,both,0,0
90815,treatment,0,0
90816,groups,0,0
90817,.,0,0
90818,Progression,0,0
90819,in,0,0
90820,VF,0,1
90821,loss,0,0
90822,was,0,0
90823,seen,0,0
90824,in,0,0
90825,a,0,0
90826,subset,0,0
90827,",",0,0
90828,increasing,0,0
90829,to,0,0
90830,more,0,0
90831,than,0,0
90832,20,0,0
90833,%,0,0
90834,of,0,0
90835,the,0,0
90836,subjects,0,1
90837,.,0,0
90838,The,0,0
90839,findings,0,0
90840,regarding,0,0
90841,initial,0,0
90842,surgery,0,1
90843,being,0,0
90844,beneficial,0,0
90845,for,0,0
90846,subjects,1,1
90847,with,1,0
90848,more,1,0
90849,advanced,1,1
90850,VF,1,0
90851,loss,1,0
90852,at,1,0
90853,presentation,1,0
90854,",",0,0
90855,but,0,0
90856,detrimental,0,0
90857,for,0,0
90858,patients,1,1
90859,with,1,1
90860,diabetes,1,1
90861,",",0,0
90862,are,0,0
90863,noteworthy,0,0
90864,and,0,0
90865,warrant,0,0
90866,independent,0,0
90867,confirmation,0,0
90868,.,0,0
90869,FINANCIAL,0,0
90870,DISCLOSURE,0,0
90871,(,0,0
90872,S,0,0
90873,),0,0
90874,The,0,0
90875,author,0,0
90876,(,0,0
90877,s,0,0
90878,),0,0
90879,have,0,0
90880,no,0,0
90881,proprietary,0,0
90882,or,0,0
90883,commercial,0,0
90884,interest,0,0
90885,in,0,0
90886,any,0,0
90887,materials,0,0
90888,discussed,0,0
90889,in,0,0
90890,this,0,0
90891,article,0,0
90892,.,0,0
90893,Pre-operative,0,0
90894,radiochemotherapy,0,1
90895,for,0,0
90896,rectal,1,1
90897,cancer,1,1
90898,.,1,0
90899,A,0,0
90900,prospective,0,0
90901,randomized,0,0
90902,trial,0,0
90903,comparing,0,0
90904,pre-operative,0,0
90905,vs.,0,0
90906,postoperative,0,0
90907,radiochemotherapy,0,0
90908,in,0,0
90909,rectal,1,1
90910,cancer,1,1
90911,patients,1,1
90912,.,1,0
90913,PURPOSE,0,0
90914,The,0,0
90915,aim,0,0
90916,of,0,0
90917,the,0,0
90918,study,0,0
90919,was,0,0
90920,to,0,0
90921,find,0,0
90922,out,0,0
90923,whether,0,0
90924,pre-operative,0,0
90925,radiochemotherapy,0,1
90926,had,0,0
90927,any,0,0
90928,survival,0,0
90929,advantage,0,0
90930,over,0,0
90931,postoperative,0,0
90932,radiochemotherapy,0,1
90933,for,0,0
90934,rectal,1,1
90935,carcinoma,1,1
90936,patients,1,1
90937,without,1,1
90938,distant,1,0
90939,metastasis,1,1
90940,or,1,0
90941,peritoneal,1,1
90942,carcinomatosis,1,1
90943,.,1,0
90944,MATERIAL,0,0
90945,AND,0,0
90946,METHODS,0,0
90947,Between,1,0
90948,January,1,1
90949,1998,1,1
90950,and,1,0
90951,December,1,1
90952,2003,1,1
90953,",",1,0
90954,51,1,1
90955,rectal,1,1
90956,carcinoma,1,1
90957,patients,1,1
90958,without,1,1
90959,distant,1,0
90960,metastasis,1,1
90961,or,1,0
90962,peritoneal,1,1
90963,carcinomatosis,1,1
90964,were,0,0
90965,randomly,0,0
90966,divided,0,0
90967,into,0,0
90968,pre-operative,0,0
90969,(,0,0
90970,PRE,0,0
90971,),0,0
90972,and,0,0
90973,postoperative,0,0
90974,(,0,0
90975,POST,0,0
90976,),0,0
90977,radiochemotherapy,0,1
90978,groups,0,0
90979,.,0,1
90980,Twenty-six,0,1
90981,were,0,0
90982,assigned,0,0
90983,to,0,0
90984,the,0,0
90985,PRE,0,0
90986,group,0,0
90987,and,0,0
90988,were,0,0
90989,operated,0,1
90990,on,0,0
90991,5,0,0
90992,to,0,0
90993,8,0,0
90994,weeks,0,0
90995,after,0,0
90996,the,0,0
90997,completion,0,0
90998,of,0,0
90999,radiotherapy,0,0
91000,.,0,0
91001,The,0,0
91002,other,0,0
91003,25,0,0
91004,patients,0,1
91005,were,0,0
91006,operated,0,1
91007,on,0,0
91008,immediately,0,0
91009,and,0,0
91010,received,0,0
91011,radiotherapy,0,0
91012,postoperatively,0,0
91013,2,0,0
91014,to,0,0
91015,4,0,0
91016,weeks,0,0
91017,after,0,0
91018,surgery,0,1
91019,.,0,0
91020,The,0,0
91021,patients,0,1
91022,were,0,0
91023,followed,0,0
91024,up,0,0
91025,for,0,0
91026,between,0,0
91027,4,0,0
91028,to,0,0
91029,51,0,1
91030,months,0,0
91031,.,0,1
91032,RESULTS,0,0
91033,In,0,0
91034,the,0,0
91035,PRE,0,0
91036,group,0,0
91037,the,0,0
91038,rates,0,0
91039,of,0,0
91040,disease-free,0,0
91041,survival,0,0
91042,were,0,0
91043,92,0,0
91044,%,0,0
91045,",",0,0
91046,70,0,0
91047,%,0,0
91048,",",0,0
91049,56,0,0
91050,%,0,0
91051,and,0,0
91052,56,0,0
91053,%,0,0
91054,at,0,0
91055,the,0,0
91056,end,0,0
91057,of,0,0
91058,the,0,0
91059,1st,0,0
91060,",",0,0
91061,2nd,0,0
91062,",",0,0
91063,3rd,0,0
91064,and,0,0
91065,4th,0,0
91066,years,0,1
91067,",",0,0
91068,respectively,0,0
91069,.,0,0
91070,In,0,0
91071,the,0,0
91072,POST,0,0
91073,group,0,0
91074,those,0,0
91075,percentages,0,0
91076,were,0,0
91077,83,0,1
91078,%,0,0
91079,",",0,0
91080,68,0,0
91081,%,0,0
91082,",",0,0
91083,51,0,0
91084,%,0,0
91085,and,0,0
91086,51,0,0
91087,%,0,0
91088,at,0,0
91089,the,0,0
91090,1st,0,0
91091,",",0,0
91092,2nd,0,0
91093,",",0,0
91094,3rd,0,0
91095,and,0,0
91096,4th,0,0
91097,years,0,1
91098,",",0,0
91099,respectively,0,0
91100,(,0,0
91101,p,0,0
91102,=,0,0
91103,0.707,0,0
91104,),0,0
91105,.,0,0
91106,One-year,0,0
91107,and,0,0
91108,4-year,0,0
91109,overall,0,0
91110,survival,0,0
91111,rates,0,0
91112,in,0,0
91113,the,0,0
91114,PRE,0,0
91115,group,0,0
91116,were,0,0
91117,100,0,0
91118,%,0,0
91119,and,0,0
91120,86,0,0
91121,%,0,0
91122,respectively,0,0
91123,and,0,0
91124,100,0,0
91125,%,0,0
91126,and,0,0
91127,60,0,0
91128,%,0,0
91129,in,0,0
91130,the,0,0
91131,POST,0,0
91132,group,0,0
91133,(,0,0
91134,p,0,0
91135,=,0,0
91136,0.520,0,0
91137,),0,0
91138,.,0,0
91139,CONCLUSION,0,0
91140,No,0,0
91141,statistical,0,0
91142,difference,0,0
91143,was,0,0
91144,found,0,0
91145,between,0,0
91146,the,0,0
91147,survival,0,0
91148,rates,0,0
91149,of,0,0
91150,the,0,0
91151,rectal,1,1
91152,carcinoma,1,1
91153,patients,1,1
91154,receiving,0,0
91155,radiotherapy,0,1
91156,either,0,0
91157,pre-operatively,0,0
91158,or,0,0
91159,postoperatively,0,0
91160,.,0,0
91161,However,0,0
91162,",",0,0
91163,the,0,0
91164,disease-free,0,0
91165,survival,0,0
91166,rates,0,0
91167,of,0,0
91168,the,0,0
91169,PRE,0,0
91170,group,0,0
91171,were,0,0
91172,higher,0,0
91173,than,0,0
91174,the,0,0
91175,POST,0,0
91176,group,0,0
91177,'s,0,0
91178,during,0,0
91179,each,0,0
91180,year,0,0
91181,and,0,0
91182,overall,0,0
91183,survival,0,0
91184,rates,0,0
91185,were,0,0
91186,higher,0,0
91187,after,0,0
91188,the,0,0
91189,third,0,0
91190,and,0,0
91191,fourth,0,1
91192,years,0,1
91193,.,0,0
91194,We,0,0
91195,conclude,0,0
91196,that,0,0
91197,pre-operative,0,0
91198,radiotherapy,0,0
91199,is,0,0
91200,at,0,0
91201,least,0,0
91202,as,0,0
91203,effective,0,0
91204,as,0,0
91205,postoperative,0,0
91206,radiotherapy,0,1
91207,.,0,0
91208,Maintenance,0,0
91209,of,0,0
91210,response,0,0
91211,following,0,0
91212,stabilization,0,0
91213,of,0,0
91214,mixed,0,0
91215,index,0,0
91216,episodes,0,0
91217,with,0,1
91218,olanzapine,0,0
91219,monotherapy,0,0
91220,in,0,0
91221,a,0,0
91222,randomized,0,0
91223,",",0,0
91224,double-blind,0,0
91225,",",0,0
91226,placebo-controlled,0,0
91227,study,0,0
91228,of,0,0
91229,bipolar,1,0
91230,1,1,0
91231,disorder,1,1
91232,.,1,0
91233,BACKGROUND,0,0
91234,In,0,0
91235,a,0,0
91236,population,0,1
91237,of,0,0
91238,patients,1,1
91239,with,1,1
91240,manic,1,1
91241,and,1,0
91242,mixed,1,0
91243,mood,1,0
91244,episodes,1,0
91245,",",0,0
91246,olanzapine,0,0
91247,has,0,0
91248,proven,0,0
91249,effective,0,0
91250,in,0,0
91251,maintaining,0,0
91252,response,0,0
91253,",",0,0
91254,as,0,0
91255,compared,0,0
91256,to,0,0
91257,placebo,0,0
91258,.,0,0
91259,Whether,0,0
91260,this,0,0
91261,is,0,0
91262,true,0,0
91263,for,0,0
91264,the,0,0
91265,subpopulation,0,0
91266,of,0,0
91267,patients,0,1
91268,with,0,1
91269,a,0,0
91270,mixed,0,0
91271,index,0,0
91272,episode,0,0
91273,is,0,0
91274,not,0,0
91275,known,0,0
91276,.,0,0
91277,METHODS,0,0
91278,Post-hoc,0,0
91279,analyses,0,0
91280,were,0,0
91281,conducted,0,0
91282,on,0,0
91283,data,0,0
91284,from,0,1
91285,patients,1,1
91286,presenting,1,1
91287,with,1,1
91288,a,1,0
91289,mixed,1,0
91290,index,1,0
91291,episode,1,1
91292,who,1,1
91293,were,1,1
91294,enrolled,1,1
91295,in,1,0
91296,a,1,0
91297,larger,1,0
91298,double-blind,1,0
91299,",",1,0
91300,placebo-controlled,1,0
91301,trial,1,0
91302,.,1,1
91303,Patients,1,1
91304,who,1,1
91305,met,1,1
91306,remission,1,1
91307,criteria,1,1
91308,at,1,0
91309,2,1,1
91310,consecutive,1,1
91311,weekly,1,0
91312,visits,1,0
91313,during,1,0
91314,6,1,0
91315,to,1,0
91316,12,1,0
91317,weeks,1,0
91318,of,1,0
91319,open-label,1,1
91320,olanzapine,1,0
91321,treatment,1,0
91322,were,0,0
91323,randomly,0,0
91324,assigned,0,0
91325,to,0,0
91326,olanzapine,0,0
91327,or,0,0
91328,placebo,0,0
91329,treatment,0,0
91330,for,0,0
91331,48,0,1
91332,weeks,0,0
91333,.,0,0
91334,The,0,0
91335,incidence,0,0
91336,of,0,0
91337,and,0,0
91338,time,0,0
91339,to,0,0
91340,symptomatic,0,1
91341,relapse,0,0
91342,were,0,0
91343,calculated,0,0
91344,for,0,0
91345,any,0,0
91346,mood,0,0
91347,episode,0,0
91348,",",0,0
91349,and,0,0
91350,for,0,0
91351,depressive,0,0
91352,",",0,0
91353,manic,0,0
91354,",",0,0
91355,hypo-manic,0,0
91356,",",0,0
91357,and,0,0
91358,mixed,0,0
91359,mood,0,0
91360,episodes,0,0
91361,.,0,0
91362,RESULTS,0,0
91363,A,0,0
91364,total,0,0
91365,of,0,0
91366,121,1,1
91367,of,1,0
91368,304,1,1
91369,patients,1,1
91370,(,0,0
91371,39.8,0,0
91372,%,0,0
91373,),0,0
91374,met,0,1
91375,criteria,0,1
91376,for,0,0
91377,symptomatic,0,1
91378,remission,0,1
91379,in,0,0
91380,the,0,0
91381,open-label,0,0
91382,treatment,0,0
91383,phase,0,0
91384,and,0,0
91385,were,0,0
91386,randomly,0,0
91387,assigned,0,0
91388,to,0,0
91389,olanzapine,0,0
91390,(,0,0
91391,n=76,0,1
91392,),0,0
91393,or,0,0
91394,placebo,0,0
91395,(,0,0
91396,n=45,0,1
91397,),0,0
91398,.,0,0
91399,Compared,0,0
91400,to,0,0
91401,the,0,0
91402,placebo,0,0
91403,group,0,0
91404,",",0,0
91405,the,0,0
91406,olanzapine,0,0
91407,group,0,0
91408,had,0,0
91409,a,0,0
91410,lower,0,0
91411,incidence,0,0
91412,of,0,0
91413,(,0,0
91414,59.2,0,0
91415,%,0,0
91416,versus,0,0
91417,91.1,0,0
91418,%,0,0
91419,",",0,0
91420,p,0,0
91421,<,0,0
91422,0.001,0,0
91423,),0,0
91424,and,0,0
91425,a,0,0
91426,longer,0,0
91427,time,0,0
91428,to,0,0
91429,(,0,0
91430,46,0,0
91431,versus,0,0
91432,15,0,0
91433,days,0,0
91434,",",0,0
91435,p,0,0
91436,<,0,0
91437,0.001,0,0
91438,),0,0
91439,symptomatic,0,1
91440,relapse,0,0
91441,of,0,0
91442,any,0,0
91443,kind,0,0
91444,.,0,0
91445,Olanzapine-treated,0,0
91446,patients,0,1
91447,also,0,0
91448,experienced,0,0
91449,longer,0,0
91450,time,0,0
91451,to,0,0
91452,depressive,0,0
91453,symptomatic,0,1
91454,relapse,0,0
91455,(,0,0
91456,85,0,0
91457,versus,0,0
91458,22,0,1
91459,days,0,0
91460,",",0,0
91461,p=0.001,0,0
91462,),0,0
91463,and,0,0
91464,manic,0,1
91465,symptomatic,0,1
91466,relapse,0,0
91467,(,0,0
91468,too,0,0
91469,few,0,0
91470,relapses,0,0
91471,to,0,0
91472,calculate,0,0
91473,versus,0,0
91474,42,0,0
91475,days,0,0
91476,",",0,0
91477,p,0,0
91478,<,0,0
91479,0.001,0,0
91480,),0,0
91481,than,0,0
91482,did,0,0
91483,placebo-treated,0,0
91484,patients,0,1
91485,.,0,1
91486,CONCLUSIONS,0,0
91487,Compared,0,0
91488,with,0,0
91489,placebo,0,0
91490,",",0,0
91491,olanzapine,0,0
91492,treatment,0,0
91493,was,0,0
91494,associated,0,0
91495,with,0,0
91496,longer,0,0
91497,maintenance,0,0
91498,of,0,0
91499,response,0,0
91500,in,0,0
91501,patients,1,1
91502,presenting,1,1
91503,with,1,1
91504,a,1,0
91505,mixed,1,0
91506,index,1,0
91507,episode,1,1
91508,of,1,0
91509,bipolar,1,0
91510,I,1,0
91511,disorder,1,1
91512,.,1,0
91513,[,0,0
91514,Safety,0,0
91515,of,0,0
91516,adjuvant,0,0
91517,dose-dense,0,0
91518,chemotherapy,0,0
91519,with,0,1
91520,paclitaxel,0,0
91521,and,0,0
91522,epirubicin,0,0
91523,for,0,0
91524,high-risk,1,1
91525,breast,1,1
91526,cancer,1,1
91527,],1,0
91528,.,0,0
91529,OBJECTIVE,0,0
91530,To,0,0
91531,investigate,0,0
91532,the,0,0
91533,safety,0,0
91534,and,0,0
91535,tolerance,0,0
91536,of,0,0
91537,adjuvant,0,0
91538,dose-dense,0,0
91539,chemotherapy,0,0
91540,with,0,1
91541,paclitaxel,0,0
91542,and,0,0
91543,epirubicin,0,0
91544,for,0,0
91545,high-risk,1,1
91546,breast,1,1
91547,cancer,1,1
91548,.,1,0
91549,METHODS,0,0
91550,From,0,1
91551,January,0,1
91552,2004,0,1
91553,to,0,0
91554,December,0,1
91555,2006,0,1
91556,",",0,0
91557,101,1,1
91558,patients,1,1
91559,with,1,1
91560,high-risk,1,1
91561,breast,1,1
91562,cancer,1,1
91563,after,1,0
91564,surgical,1,0
91565,resection,1,1
91566,were,0,0
91567,enrolled,0,1
91568,into,0,0
91569,this,0,0
91570,study,0,0
91571,.,0,0
91572,The,0,0
91573,patients,0,1
91574,were,0,0
91575,divided,0,1
91576,into,0,1
91577,two,0,0
91578,groups,0,0
91579,:,0,1
91580,dose-dense,0,0
91581,and,0,0
91582,regular,0,0
91583,groups,0,0
91584,.,0,0
91585,Each,0,0
91586,patient,0,0
91587,received,0,0
91588,6,0,0
91589,cycles,0,0
91590,of,0,0
91591,chemotherapy,0,0
91592,with,0,1
91593,intravenous,0,0
91594,administration,0,0
91595,of,0,0
91596,paclitaxel,0,0
91597,(,0,0
91598,175,0,0
91599,mg/m2,0,0
91600,",",0,0
91601,on,0,0
91602,D3,0,0
91603,),0,0
91604,and,0,0
91605,epirubicin,0,0
91606,(,0,0
91607,60,0,0
91608,mg/m2,0,0
91609,",",0,0
91610,on,0,0
91611,Dl,0,1
91612,and,0,0
91613,D2,0,0
91614,),0,0
91615,.,0,0
91616,The,0,0
91617,dose-dense,0,0
91618,group,0,0
91619,had,0,0
91620,repeated,0,0
91621,treatment,0,0
91622,every,0,0
91623,two,0,0
91624,weeks,0,0
91625,",",0,0
91626,while,0,0
91627,the,0,0
91628,regular,0,0
91629,group,0,0
91630,repeated,0,0
91631,it,0,0
91632,every,0,0
91633,three,0,0
91634,weeks,0,0
91635,.,0,1
91636,G-CSF,0,0
91637,was,0,0
91638,used,0,0
91639,in,0,0
91640,a,0,0
91641,dose,0,0
91642,of,0,0
91643,3,0,0
91644,microg/kg,0,0
91645,on,0,0
91646,D5-D9,0,0
91647,during,0,0
91648,each,0,0
91649,cycle,0,0
91650,in,0,0
91651,the,0,0
91652,dose-dense,0,0
91653,group,0,0
91654,.,0,0
91655,While,0,0
91656,in,0,0
91657,the,0,0
91658,regular,0,0
91659,group,0,0
91660,",",0,0
91661,it,0,0
91662,was,0,0
91663,used,0,0
91664,only,0,0
91665,under,0,0
91666,the,0,0
91667,condition,0,0
91668,that,0,0
91669,grade,0,0
91670,II,0,1
91671,neutropenia,0,0
91672,occurred,0,0
91673,.,0,0
91674,RESULTS,0,0
91675,The,0,0
91676,toxicity,0,0
91677,could,0,0
91678,be,0,0
91679,evaluated,0,0
91680,in,0,0
91681,101,1,1
91682,patients,1,1
91683,.,1,1
91684,Major,0,0
91685,grade,0,0
91686,II-IV,0,1
91687,toxicities,0,0
91688,included,0,1
91689,:,0,1
91690,neutropenia,0,0
91691,",",0,0
91692,nausea,0,0
91693,",",0,0
91694,vomiting,0,0
91695,and,0,0
91696,alopecia,0,1
91697,.,0,0
91698,The,0,0
91699,incidence,0,0
91700,of,0,0
91701,grade,0,0
91702,III-IV,0,0
91703,neutropenia,0,0
91704,was,0,0
91705,16.0,0,0
91706,%,0,0
91707,in,0,0
91708,the,0,0
91709,dose-dense,0,0
91710,group,0,0
91711,versus,0,0
91712,54.9,0,0
91713,%,0,0
91714,in,0,0
91715,the,0,0
91716,regular,0,0
91717,group,0,0
91718,(,0,0
91719,P,0,0
91720,=,0,0
91721,0.000,0,0
91722,),0,0
91723,;,0,0
91724,postponing,0,0
91725,of,0,0
91726,chemotherapy,0,0
91727,was,0,0
91728,2.4,0,0
91729,%,0,0
91730,versus,0,0
91731,6.0,0,0
91732,%,0,0
91733,(,0,0
91734,P,0,0
91735,=,0,0
91736,0.027,0,0
91737,),0,0
91738,.,0,0
91739,Ninety-eight,1,1
91740,patients,1,1
91741,completed,1,1
91742,the,1,0
91743,chemotherapy,1,0
91744,as,1,0
91745,planed,1,0
91746,.,1,0
91747,After,0,0
91748,a,0,0
91749,median,0,0
91750,follow-up,0,0
91751,of,0,0
91752,24,0,0
91753,months,0,0
91754,",",0,0
91755,the,0,0
91756,median,0,0
91757,DFS,0,0
91758,and,0,0
91759,OS,0,0
91760,were,0,0
91761,not,0,0
91762,reached,0,0
91763,.,0,0
91764,The,0,0
91765,relapse-free,0,0
91766,rate,0,0
91767,and,0,0
91768,survival,0,0
91769,rate,0,0
91770,were,0,0
91771,89.8,0,0
91772,%,0,0
91773,and,0,0
91774,100,0,0
91775,%,0,0
91776,in,0,0
91777,the,0,0
91778,dose-dense,0,0
91779,group,0,0
91780,",",0,0
91781,which,0,0
91782,were,0,0
91783,87.8,0,0
91784,%,0,0
91785,and,0,0
91786,93.9,0,0
91787,%,0,0
91788,in,0,0
91789,the,0,0
91790,regular,0,0
91791,group,0,0
91792,.,0,0
91793,The,0,0
91794,relapse-free,0,0
91795,rate,0,0
91796,of,0,0
91797,the,0,0
91798,high-risk,0,1
91799,patients,0,1
91800,in,0,0
91801,the,0,0
91802,dose-dense,0,0
91803,group,0,0
91804,was,0,0
91805,86.8,0,0
91806,%,0,0
91807,versus,0,0
91808,81.3,0,0
91809,%,0,0
91810,in,0,0
91811,the,0,0
91812,regular,0,0
91813,group,0,0
91814,",",0,0
91815,and,0,0
91816,the,0,0
91817,corresponding,0,0
91818,survival,0,0
91819,rate,0,0
91820,was,0,0
91821,100,0,0
91822,%,0,0
91823,versus,0,0
91824,90.6,0,0
91825,%,0,0
91826,.,0,0
91827,CONCLUSION,0,0
91828,Adjuvant,0,0
91829,dose-dense,0,0
91830,chemotherapy,0,0
91831,with,0,1
91832,paclitaxel,0,0
91833,and,0,0
91834,epirubicin,0,0
91835,is,0,0
91836,safe,0,0
91837,",",0,0
91838,tolerable,0,0
91839,and,0,0
91840,promising,0,0
91841,for,0,0
91842,high-risk,1,1
91843,breast,1,1
91844,cancer,1,1
91845,.,1,0
91846,Altered,0,0
91847,growth,0,0
91848,hormone,0,0
91849,response,0,0
91850,after,0,0
91851,growth,0,0
91852,hormone,0,0
91853,releasing,0,0
91854,hormone,0,0
91855,administration,0,0
91856,in,0,0
91857,chronic,0,1
91858,renal,0,1
91859,failure,0,1
91860,.,0,0
91861,Eleven,1,0
91862,chronic,1,1
91863,renal,1,1
91864,failure,1,1
91865,patients,1,1
91866,and,1,0
91867,11,1,1
91868,matched,1,1
91869,controls,1,1
91870,",",0,0
91871,received,0,0
91872,growth,0,0
91873,hormone,0,0
91874,GHRH,0,0
91875,(,0,0
91876,1,0,0
91877,microgram/kg,0,0
91878,iv,0,0
91879,),0,0
91880,or,0,0
91881,TRH,0,0
91882,(,0,0
91883,400,0,0
91884,microgram,0,0
91885,iv,0,0
91886,),0,0
91887,on,0,0
91888,separate,0,0
91889,occasions,0,0
91890,",",0,0
91891,immediately,0,0
91892,before,0,0
91893,undergoing,0,1
91894,hemodialysis,0,1
91895,.,0,0
91896,GHRH-induced,0,0
91897,GH,0,0
91898,peak,0,0
91899,in,0,0
91900,uremics,0,0
91901,(,0,0
91902,22.7,0,0
91903,+/-,0,0
91904,5.2,0,0
91905,micrograms/l,0,0
91906,),0,0
91907,was,0,0
91908,not,0,0
91909,different,0,0
91910,from,0,0
91911,that,0,0
91912,obtained,0,0
91913,in,0,0
91914,control,0,0
91915,subjects,0,1
91916,(,0,0
91917,16.0,0,1
91918,+/-,0,0
91919,4.3,0,0
91920,micrograms/l,0,0
91921,),0,0
91922,.,0,0
91923,However,0,0
91924,",",0,0
91925,the,1,0
91926,uremic,1,0
91927,patients,1,1
91928,did,0,0
91929,not,0,0
91930,show,0,0
91931,the,0,0
91932,habitual,0,0
91933,post-peak,0,0
91934,fall,0,0
91935,",",0,0
91936,remaining,0,0
91937,GH,0,0
91938,levels,0,0
91939,over,0,0
91940,10,0,1
91941,micrograms/l,0,0
91942,till,0,1
91943,the,0,0
91944,end,0,0
91945,of,0,0
91946,the,0,0
91947,test,0,0
91948,.,0,0
91949,Differences,0,0
91950,between,0,0
91951,the,0,0
91952,two,0,0
91953,groups,0,0
91954,were,0,0
91955,significant,0,0
91956,(,0,0
91957,p,0,0
91958,less,0,0
91959,than,0,0
91960,0.05,0,0
91961,),0,0
91962,.,0,0
91963,Uremic,1,0
91964,patients,1,1
91965,showed,0,0
91966,PRL,0,0
91967,values,0,0
91968,higher,0,0
91969,than,0,0
91970,in,0,0
91971,controls,0,0
91972,",",0,0
91973,however,0,0
91974,their,0,0
91975,TRH-induced,0,0
91976,PRL,0,0
91977,peak,0,0
91978,(,0,0
91979,20.6,0,0
91980,+/-,0,0
91981,6.6,0,0
91982,micrograms/l,0,0
91983,),0,0
91984,was,0,0
91985,not,0,0
91986,different,0,0
91987,from,0,0
91988,that,0,0
91989,of,0,0
91990,controls,0,0
91991,(,0,0
91992,26.5,0,1
91993,+/-,0,0
91994,3.0,0,0
91995,micrograms/l,0,0
91996,),0,0
91997,.,0,0
91998,Again,0,0
91999,chronic,1,1
92000,renal,1,1
92001,failure,1,1
92002,patients,1,1
92003,showed,0,0
92004,PRL,0,0
92005,plasma,0,0
92006,values,0,0
92007,abnormally,0,0
92008,elevated,0,0
92009,till,0,0
92010,the,0,0
92011,end,0,0
92012,of,0,0
92013,the,0,0
92014,test,0,0
92015,.,0,0
92016,Differences,0,0
92017,between,0,0
92018,the,0,0
92019,two,0,0
92020,groups,0,0
92021,were,0,0
92022,significant,0,0
92023,(,0,0
92024,p,0,0
92025,less,0,0
92026,than,0,0
92027,0.05,0,0
92028,),0,0
92029,.,0,0
92030,Administration,0,0
92031,of,0,0
92032,placebo,0,0
92033,to,0,0
92034,a,0,0
92035,different,1,0
92036,group,1,0
92037,of,1,0
92038,seven,1,1
92039,uremic,1,1
92040,patients,1,1
92041,did,0,0
92042,not,0,0
92043,alter,0,0
92044,GH,0,0
92045,and,0,0
92046,PRL,0,0
92047,plasma,0,0
92048,levels,0,0
92049,.,0,0
92050,This,0,0
92051,sustained,0,0
92052,secretion,0,0
92053,of,0,0
92054,both,0,0
92055,GH,0,0
92056,and,0,0
92057,PRL,0,0
92058,in,0,0
92059,uremia,0,0
92060,could,0,0
92061,be,0,0
92062,attributed,0,0
92063,to,0,0
92064,reduced,0,0
92065,kidney,0,1
92066,clearance,0,0
92067,.,0,0
92068,However,0,0
92069,",",0,0
92070,when,0,0
92071,subjects,0,1
92072,were,0,0
92073,examined,0,0
92074,individually,0,0
92075,both,0,0
92076,the,0,0
92077,GHRH-,0,0
92078,and,0,0
92079,the,0,0
92080,TRH-induced,0,0
92081,hormonal,0,0
92082,peaks,0,0
92083,and,0,0
92084,the,0,0
92085,subsequent,0,0
92086,fall,0,0
92087,were,0,0
92088,not,0,0
92089,different,0,0
92090,in,0,0
92091,both,0,0
92092,groups,0,0
92093,.,0,0
92094,Unlike,0,0
92095,with,0,0
92096,controls,0,0
92097,",",0,0
92098,in,0,0
92099,uremic,1,0
92100,patients,1,1
92101,GHRH-stimulated,0,0
92102,GH,0,0
92103,and,0,0
92104,TRH-stimulated,0,0
92105,PRL/GH,0,0
92106,peaks,0,0
92107,were,0,0
92108,dispersed,0,0
92109,throughout,0,0
92110,the,0,0
92111,120,0,1
92112,min,0,0
92113,period,0,0
92114,.,0,0
92115,In,0,0
92116,controls,0,0
92117,GH,0,1
92118,and,0,0
92119,PRL,0,0
92120,peaks,0,0
92121,clustered,0,0
92122,around,0,0
92123,15-30,0,1
92124,min,0,0
92125,.,0,0
92126,The,0,0
92127,peak,0,0
92128,dispersion,0,0
92129,created,0,0
92130,a,0,0
92131,false,0,0
92132,impression,0,0
92133,of,0,0
92134,flattened,0,0
92135,curves,0,0
92136,or,0,1
92137,sustained,0,0
92138,hypersecretion,0,0
92139,in,0,0
92140,uremia,0,1
92141,.,0,0
92142,(,0,0
92143,ABSTRACT,0,0
92144,TRUNCATED,0,0
92145,AT,0,0
92146,250,0,0
92147,WORDS,0,0
92148,),0,0
92149,Comparison,0,0
92150,of,0,0
92151,propofol,0,0
92152,",",0,0
92153,droperidol,0,0
92154,",",0,0
92155,and,0,0
92156,metoclopramide,0,0
92157,for,0,0
92158,prophylaxis,1,0
92159,of,1,0
92160,postoperative,1,0
92161,nausea,1,0
92162,and,1,0
92163,vomiting,1,0
92164,after,1,0
92165,breast,1,1
92166,cancer,1,1
92167,surgery,1,1
92168,:,1,0
92169,a,0,0
92170,prospective,0,0
92171,",",0,0
92172,randomized,0,0
92173,",",0,0
92174,double-blind,0,0
92175,",",0,0
92176,placebo-controlled,0,0
92177,study,0,0
92178,in,0,0
92179,Japanese,1,1
92180,patients,1,1
92181,.,1,1
92182,BACKGROUND,0,0
92183,Breast,0,0
92184,cancer,0,1
92185,surgery,0,1
92186,performed,0,0
92187,with,0,0
92188,the,0,0
92189,patient,1,0
92190,under,1,0
92191,general,1,0
92192,anesthesia,1,0
92193,has,0,0
92194,been,0,0
92195,associated,0,0
92196,with,0,0
92197,a,0,0
92198,relatively,0,0
92199,high,0,0
92200,incidence,0,0
92201,of,0,0
92202,postoperative,0,0
92203,nausea,0,0
92204,and,0,0
92205,vomiting,0,0
92206,(,0,0
92207,PONV,0,0
92208,),0,0
92209,.,0,0
92210,Between,0,0
92211,60,0,0
92212,%,0,0
92213,and,0,0
92214,80,0,0
92215,%,0,0
92216,of,0,1
92217,patients,1,1
92218,who,0,1
92219,undergo,0,1
92220,mastectomy,0,1
92221,(,0,0
92222,with,0,1
92223,axillary,0,1
92224,dissection,0,1
92225,),0,0
92226,experience,0,0
92227,PONV,0,0
92228,.,0,0
92229,We,0,0
92230,previously,0,0
92231,reported,0,0
92232,that,0,0
92233,propofol,0,0
92234,at,0,0
92235,a,0,0
92236,subhypnotic,0,0
92237,dose,0,0
92238,of,0,0
92239,0.5,0,0
92240,mg/kg,0,0
92241,was,0,0
92242,more,0,0
92243,effective,0,0
92244,than,0,0
92245,placebo,0,0
92246,in,0,0
92247,preventing,0,0
92248,PONV,0,0
92249,in,0,1
92250,women,0,1
92251,who,0,1
92252,undergo,0,1
92253,mastectomy,0,1
92254,.,0,0
92255,OBJECTIVE,0,0
92256,The,0,0
92257,purpose,0,0
92258,of,0,0
92259,this,0,0
92260,study,0,0
92261,was,0,0
92262,to,0,0
92263,compare,0,0
92264,the,0,0
92265,efficacy,0,0
92266,of,0,0
92267,a,0,0
92268,subhypnotic,0,0
92269,dose,0,0
92270,of,0,0
92271,propofol,0,0
92272,with,0,1
92273,the,0,0
92274,conventional,0,0
92275,antiemetics,0,0
92276,droperidol,0,0
92277,and,0,0
92278,metoclopramide,0,0
92279,for,0,0
92280,the,0,0
92281,prophylaxis,0,0
92282,of,0,0
92283,PONV,0,0
92284,after,0,0
92285,breast,1,1
92286,cancer,1,1
92287,surgery,1,1
92288,in,1,0
92289,Japanese,1,1
92290,patients,1,1
92291,.,1,1
92292,METHODS,0,0
92293,In,0,0
92294,this,0,0
92295,prospective,0,0
92296,",",0,0
92297,randomized,0,0
92298,",",0,0
92299,double-blind,0,0
92300,",",0,0
92301,placebo-controlled,0,0
92302,study,0,0
92303,",",0,0
92304,Japanese,1,1
92305,women,1,1
92306,were,0,0
92307,randomized,0,0
92308,to,0,0
92309,1,0,0
92310,of,0,0
92311,4,0,0
92312,groups,0,0
92313,to,0,0
92314,receive,0,0
92315,IV,0,0
92316,administration,0,0
92317,of,0,0
92318,propofol,0,0
92319,0.5,0,0
92320,mg/kg,0,0
92321,",",0,0
92322,droperidol,0,0
92323,20,0,0
92324,microg/kg,0,0
92325,",",0,0
92326,metoclopramide,0,0
92327,0.2,0,0
92328,mg/kg,0,0
92329,",",0,0
92330,or,0,0
92331,placebo,0,0
92332,(,0,0
92333,isotonic,0,0
92334,saline,0,0
92335,),0,0
92336,immediately,0,0
92337,after,0,0
92338,skin,0,0
92339,suture,0,0
92340,.,0,0
92341,A,0,0
92342,standard,0,0
92343,general,0,1
92344,anesthetic,0,0
92345,technique,0,0
92346,",",0,0
92347,including,0,0
92348,sevoflurane,0,0
92349,and,0,0
92350,air,0,0
92351,in,0,0
92352,oxygen,0,0
92353,",",0,0
92354,was,0,0
92355,used,0,0
92356,.,0,0
92357,All,0,0
92358,episodes,0,0
92359,of,0,0
92360,PONV,0,0
92361,during,0,0
92362,the,0,0
92363,first,0,0
92364,24,0,0
92365,hours,0,0
92366,after,0,0
92367,anesthesia,0,1
92368,administration,0,0
92369,were,0,0
92370,recorded,0,0
92371,by,0,0
92372,an,0,1
92373,investigator,0,0
92374,who,0,1
92375,was,0,0
92376,blinded,0,1
92377,to,0,0
92378,treatment,0,0
92379,assignment,0,0
92380,.,0,0
92381,The,0,0
92382,investigator,0,0
92383,questioned,0,0
92384,the,0,0
92385,patients,0,1
92386,as,0,0
92387,to,0,0
92388,whether,0,0
92389,they,0,0
92390,experienced,0,0
92391,extrapyramidal,0,0
92392,symptoms,0,0
92393,.,0,0
92394,To,0,0
92395,maintain,0,0
92396,the,0,0
92397,integrity,0,0
92398,of,0,0
92399,the,0,0
92400,study,0,0
92401,results,0,0
92402,",",0,0
92403,none,0,0
92404,of,0,0
92405,the,0,0
92406,patients,0,1
92407,received,0,0
92408,preanesthetic,0,1
92409,medication,0,0
92410,.,0,0
92411,RESULTS,0,0
92412,A,1,0
92413,total,1,0
92414,of,1,0
92415,100,1,0
92416,women,1,1
92417,(,1,0
92418,mean,1,1
92419,[,1,0
92420,SD,1,0
92421,],1,0
92422,age,1,1
92423,",",1,0
92424,52,1,0
92425,[,1,0
92426,7,1,0
92427,],1,1
92428,years,1,1
92429,;,1,0
92430,height,1,0
92431,",",1,0
92432,154,1,1
92433,[,1,0
92434,6,1,0
92435,],1,0
92436,cm,1,1
92437,;,1,0
92438,weight,1,0
92439,",",1,0
92440,54,1,1
92441,[,1,0
92442,7,1,0
92443,],1,0
92444,kg,1,1
92445,),1,0
92446,were,1,0
92447,included,1,0
92448,in,1,0
92449,the,1,0
92450,study,1,0
92451,.,1,0
92452,Each,0,0
92453,study,0,0
92454,group,0,0
92455,comprised,0,1
92456,25,0,0
92457,patients,0,1
92458,.,0,0
92459,There,0,0
92460,were,0,0
92461,no,0,0
92462,significant,0,0
92463,differences,0,0
92464,between,0,0
92465,treatment,0,0
92466,groups,0,0
92467,with,0,1
92468,regard,0,0
92469,to,0,0
92470,patient,0,0
92471,demographics,0,0
92472,",",0,0
92473,surgery,0,1
92474,type,0,0
92475,",",0,0
92476,or,0,0
92477,awakening,0,0
92478,time,0,0
92479,.,0,0
92480,The,0,0
92481,prevalences,0,0
92482,of,0,0
92483,PONV,0,0
92484,0,0,0
92485,to,0,0
92486,24,0,0
92487,hours,0,0
92488,after,0,0
92489,anesthesia,0,1
92490,were,0,0
92491,28,0,0
92492,%,0,0
92493,with,0,1
92494,propofol,0,0
92495,(,0,0
92496,P,0,0
92497,=,0,0
92498,0.005,0,0
92499,),0,0
92500,",",0,0
92501,32,0,0
92502,%,0,0
92503,with,0,1
92504,droperidol,0,0
92505,(,0,0
92506,P,0,0
92507,=,0,0
92508,0.011,0,0
92509,),0,0
92510,",",0,0
92511,and,0,0
92512,60,0,0
92513,%,0,0
92514,with,0,1
92515,metoclopramide,0,0
92516,(,0,0
92517,P,0,0
92518,=,0,0
92519,NS,0,0
92520,),0,0
92521,",",0,0
92522,compared,0,0
92523,with,0,0
92524,placebo,0,0
92525,(,0,0
92526,68,0,1
92527,%,0,0
92528,),0,0
92529,.,0,0
92530,No,0,0
92531,significant,0,0
92532,difference,0,0
92533,in,0,0
92534,the,0,0
92535,prevalence,0,0
92536,of,0,0
92537,PONV,0,0
92538,was,0,0
92539,found,0,0
92540,between,0,0
92541,patients,0,1
92542,receiving,0,1
92543,propofol,0,0
92544,and,0,0
92545,those,0,0
92546,receiving,0,0
92547,droperidol,0,0
92548,",",0,0
92549,and,0,0
92550,propofol,0,0
92551,and,0,0
92552,droperidol,0,0
92553,were,0,0
92554,associated,0,0
92555,with,0,0
92556,significantly,0,0
92557,lower,0,0
92558,prevalences,0,0
92559,of,0,0
92560,PONV,0,0
92561,compared,0,0
92562,with,0,0
92563,metoclopramide,0,0
92564,(,0,0
92565,P,0,0
92566,=,0,0
92567,0.022,0,0
92568,and,0,0
92569,P,0,0
92570,=,0,0
92571,0.043,0,0
92572,",",0,0
92573,respectively,0,0
92574,),0,0
92575,.,0,0
92576,Extrapyramidal,0,0
92577,symptoms,0,0
92578,were,0,0
92579,not,0,0
92580,reported,0,0
92581,in,0,0
92582,any,0,0
92583,of,0,0
92584,the,0,0
92585,groups,0,0
92586,.,0,0
92587,CONCLUSIONS,0,0
92588,The,0,0
92589,prevalences,0,0
92590,of,0,0
92591,PONV,0,0
92592,were,0,0
92593,not,0,0
92594,significantly,0,0
92595,different,0,0
92596,between,0,0
92597,propofol,0,0
92598,0.5,0,0
92599,mg/kg,0,0
92600,and,0,0
92601,droperidol,0,0
92602,20,0,0
92603,microg/kg,0,0
92604,0,0,0
92605,to,0,0
92606,24,0,0
92607,hours,0,0
92608,after,0,0
92609,anesthesia,0,0
92610,in,0,0
92611,this,0,0
92612,small,0,0
92613,",",0,0
92614,select,0,0
92615,group,0,0
92616,of,0,0
92617,Japanese,0,1
92618,women,0,1
92619,who,0,1
92620,underwent,0,1
92621,breast,0,1
92622,cancer,0,1
92623,surgery,0,1
92624,.,0,0
92625,The,0,0
92626,prevalences,0,0
92627,of,0,0
92628,PONV,0,0
92629,were,0,0
92630,significantly,0,0
92631,lower,0,0
92632,with,0,0
92633,propofol,0,0
92634,and,0,0
92635,droperidol,0,0
92636,compared,0,0
92637,with,0,1
92638,metoclopramide,0,0
92639,0.2,0,0
92640,mg/kg,0,0
92641,and,0,0
92642,placebo,0,0
92643,.,0,0
92644,Measuring,0,0
92645,social,0,0
92646,cognition,0,0
92647,in,0,0
92648,adolescents,1,1
92649,:,1,1
92650,implications,0,0
92651,for,0,0
92652,students,1,1
92653,with,1,1
92654,TBI,1,1
92655,returning,1,0
92656,to,1,0
92657,school,1,1
92658,.,1,0
92659,In,0,0
92660,everyday,0,0
92661,adolescent,0,1
92662,communication,0,0
92663,",",0,0
92664,the,0,0
92665,ability,0,0
92666,to,0,0
92667,empathise,0,0
92668,with,0,0
92669,the,0,0
92670,mental,0,0
92671,state,0,0
92672,of,0,0
92673,others,0,0
92674,",",0,0
92675,recognise,0,0
92676,or,0,0
92677,infer,0,0
92678,intentions,0,0
92679,",",0,0
92680,or,0,0
92681,make,0,0
92682,judgements,0,0
92683,about,0,0
92684,emotional,0,0
92685,state,0,0
92686,",",0,0
92687,is,0,0
92688,a,0,0
92689,non-conscious,0,0
92690,but,0,0
92691,vital,0,0
92692,prerequisite,0,0
92693,of,0,0
92694,relating,0,0
92695,.,0,0
92696,Execution,0,0
92697,of,0,0
92698,these,0,0
92699,skills,0,0
92700,in,0,0
92701,social,0,0
92702,interactions,0,0
92703,supports,0,0
92704,both,0,0
92705,the,0,0
92706,exchange,0,0
92707,of,0,0
92708,social,0,0
92709,knowledge,0,0
92710,and,0,0
92711,also,0,0
92712,the,0,0
92713,development,0,0
92714,and,0,0
92715,maintenance,0,0
92716,of,0,0
92717,personal,0,1
92718,relationships,0,0
92719,.,0,0
92720,Thus,0,0
92721,",",0,0
92722,adolescents,1,1
92723,with,0,1
92724,impairments,0,0
92725,in,0,0
92726,these,0,0
92727,skills,0,0
92728,are,0,0
92729,at,0,0
92730,risk,0,0
92731,for,0,0
92732,a,0,0
92733,variety,0,0
92734,of,0,0
92735,negative,0,0
92736,outcomes,0,0
92737,.,0,0
92738,In,0,0
92739,this,0,0
92740,paper,0,0
92741,",",0,0
92742,we,0,0
92743,present,0,0
92744,data,0,0
92745,to,0,0
92746,illustrate,0,0
92747,that,0,0
92748,adolescents,1,1
92749,with,1,1
92750,traumatic,1,0
92751,brain,1,0
92752,injury,1,0
92753,(,1,0
92754,TBI,1,1
92755,),1,0
92756,are,0,0
92757,likely,0,0
92758,to,0,0
92759,have,0,0
92760,impairments,0,0
92761,in,0,0
92762,processes,0,0
92763,such,0,0
92764,as,0,0
92765,emotion,0,0
92766,recognition,0,0
92767,and,0,0
92768,mental,0,0
92769,state,0,0
92770,attribution,0,0
92771,",",0,0
92772,and,0,0
92773,that,0,0
92774,these,0,0
92775,might,0,0
92776,not,0,0
92777,be,0,0
92778,identified,0,0
92779,on,0,0
92780,standardised,0,0
92781,tests,0,0
92782,.,0,0
92783,This,0,0
92784,is,0,0
92785,considered,0,0
92786,from,0,0
92787,the,0,0
92788,perspective,0,0
92789,of,0,0
92790,clinical,0,0
92791,assessment,0,0
92792,and,0,0
92793,intervention,0,0
92794,in,0,0
92795,school,0,1
92796,contexts,0,0
92797,.,0,0
92798,Effectiveness,0,0
92799,of,0,0
92800,education,0,0
92801,for,0,0
92802,gastric,1,1
92803,cancer,1,1
92804,patients,1,1
92805,:,1,1
92806,a,0,0
92807,controlled,0,0
92808,prospective,0,0
92809,trial,0,0
92810,comparing,0,0
92811,interactive,0,0
92812,vs.,0,0
92813,lecture-based,0,0
92814,programs,0,0
92815,.,0,0
92816,OBJECTIVE,0,0
92817,Although,0,0
92818,patient,0,0
92819,education,0,0
92820,may,0,0
92821,enhance,0,0
92822,knowledge,0,0
92823,",",0,0
92824,coping,0,0
92825,with,0,0
92826,illness,0,1
92827,",",0,0
92828,and,0,0
92829,quality,0,0
92830,of,0,0
92831,life,0,0
92832,among,0,0
92833,cancer,1,1
92834,patients,1,1
92835,",",0,0
92836,it,0,0
92837,is,0,0
92838,uncertain,0,0
92839,which,0,0
92840,didactic,0,0
92841,method,0,0
92842,is,0,0
92843,most,0,0
92844,effective,0,0
92845,.,0,0
92846,We,0,0
92847,compared,0,0
92848,the,0,0
92849,impact,0,0
92850,of,0,0
92851,an,0,0
92852,interactive,0,0
92853,",",0,0
92854,patient-oriented,0,0
92855,group,0,0
92856,program,0,0
92857,to,0,0
92858,a,0,0
92859,lecture-based,0,0
92860,",",0,0
92861,information-only,0,0
92862,program,0,0
92863,in,0,0
92864,gastric,1,1
92865,cancer,1,1
92866,patients,1,1
92867,.,1,0
92868,METHODS,0,0
92869,In,0,0
92870,this,0,0
92871,prospective,0,0
92872,",",0,0
92873,controlled,0,0
92874,trial,0,0
92875,",",0,0
92876,121,1,1
92877,gastric,1,1
92878,cancer,1,1
92879,patients,1,1
92880,attending,1,1
92881,inpatient,1,1
92882,rehabilitation,1,1
92883,after,1,0
92884,surgical,1,0
92885,treatment,1,0
92886,received,0,0
92887,either,0,0
92888,the,0,0
92889,interactive,0,0
92890,intervention,0,0
92891,or,0,0
92892,lectures,0,0
92893,providing,0,0
92894,information,0,0
92895,.,0,0
92896,The,0,0
92897,outcomes,0,0
92898,were,0,0
92899,patients,0,1
92900,',0,1
92901,disease-related,0,0
92902,knowledge,0,0
92903,",",0,0
92904,active,0,0
92905,coping,0,0
92906,with,0,1
92907,illness,0,1
92908,",",0,0
92909,and,0,0
92910,quality,0,0
92911,of,0,0
92912,life,0,0
92913,(,0,0
92914,QoL,0,0
92915,),0,0
92916,at,0,0
92917,the,0,0
92918,end,0,0
92919,of,0,0
92920,their,0,0
92921,stay,0,0
92922,and,0,0
92923,6,0,0
92924,and,0,0
92925,12,0,0
92926,months,0,0
92927,thereafter,0,0
92928,.,0,0
92929,RESULTS,0,0
92930,Both,0,0
92931,groups,0,0
92932,improved,0,0
92933,their,0,0
92934,knowledge,0,0
92935,and,0,0
92936,QoL,0,0
92937,during,0,0
92938,rehabilitation,0,1
92939,;,0,0
92940,however,0,0
92941,",",0,0
92942,knowledge,0,0
92943,was,0,0
92944,significantly,0,0
92945,higher,0,0
92946,in,0,0
92947,the,0,0
92948,interactive,0,0
92949,group,0,0
92950,compared,0,0
92951,to,0,0
92952,the,0,0
92953,lecture,0,0
92954,group,0,0
92955,.,0,0
92956,This,0,0
92957,difference,0,0
92958,was,0,0
92959,maintained,0,0
92960,at,0,0
92961,the,0,0
92962,6-,0,0
92963,and,0,0
92964,12-months,0,0
92965,follow-ups,0,0
92966,.,0,0
92967,In,0,0
92968,addition,0,0
92969,",",0,0
92970,the,0,0
92971,interactive,0,0
92972,group,0,0
92973,proved,0,0
92974,superior,0,0
92975,to,0,0
92976,the,0,0
92977,lecture,0,0
92978,group,0,0
92979,regarding,0,0
92980,active,0,0
92981,coping,0,0
92982,with,0,1
92983,illness,0,1
92984,and,0,0
92985,QoL,0,0
92986,at,0,0
92987,the,0,0
92988,end,0,0
92989,of,0,0
92990,rehabilitation,0,0
92991,",",0,0
92992,but,0,0
92993,not,0,0
92994,during,0,0
92995,follow-up,0,0
92996,.,0,0
92997,CONCLUSIONS,0,0
92998,A,0,0
92999,structured,0,0
93000,",",0,0
93001,interactive,0,0
93002,patient,0,0
93003,education,0,0
93004,program,0,0
93005,proved,0,0
93006,superior,0,0
93007,to,0,0
93008,lecture-based,0,0
93009,provision,0,0
93010,of,0,0
93011,information,0,0
93012,in,0,0
93013,regards,0,0
93014,to,0,0
93015,short-term,0,0
93016,and,0,0
93017,long-term,0,0
93018,knowledge,0,0
93019,as,0,0
93020,well,0,0
93021,as,0,0
93022,short-term,0,0
93023,coping,0,0
93024,and,0,0
93025,QoL,0,0
93026,.,0,0
93027,PRACTICE,0,0
93028,IMPLICATIONS,0,0
93029,In,0,0
93030,gastric,0,1
93031,cancer,0,1
93032,patients,0,1
93033,",",0,0
93034,interactive,0,0
93035,patient,0,0
93036,education,0,0
93037,seems,0,0
93038,preferable,0,0
93039,over,0,0
93040,lectures,0,0
93041,.,0,1
93042,Netilmicin,0,0
93043,in,0,0
93044,the,0,0
93045,neonate,1,1
93046,:,1,0
93047,pharmacokinetic,0,0
93048,analysis,0,0
93049,and,0,0
93050,influence,0,0
93051,of,0,0
93052,parenteral,0,1
93053,nutrition,0,1
93054,.,0,0
93055,OBJECTIVE,0,0
93056,The,0,0
93057,aim,0,0
93058,of,0,0
93059,this,0,0
93060,study,0,0
93061,was,0,0
93062,to,0,0
93063,investigate,0,0
93064,the,0,0
93065,impact,0,0
93066,of,0,0
93067,parenteral,0,1
93068,nutrition,0,1
93069,on,0,0
93070,netilmicin,0,0
93071,pharmacokinetics,0,0
93072,in,0,0
93073,critically,1,0
93074,ill,1,1
93075,neonates,1,1
93076,during,1,0
93077,the,1,0
93078,first,1,0
93079,week,1,0
93080,of,1,0
93081,life,1,0
93082,.,1,0
93083,METHOD,0,0
93084,A,0,0
93085,total,0,1
93086,of,0,0
93087,200,1,0
93088,neonates,1,1
93089,(,1,1
93090,gestational,1,1
93091,ages,1,1
93092,26.4-41,1,1
93093,weeks,1,0
93094,),1,0
93095,treated,1,1
93096,with,1,0
93097,netilmicin,1,0
93098,(,1,0
93099,4-5,1,0
93100,mg/kg,1,0
93101,in,1,0
93102,extended,1,0
93103,dosing,1,0
93104,intervals,1,0
93105,),1,0
93106,for,1,0
93107,postnatal,1,0
93108,sepsis,1,0
93109,in,1,0
93110,the,1,0
93111,first,1,0
93112,week,1,0
93113,of,1,0
93114,life,1,0
93115,received,0,0
93116,either,0,0
93117,fluid,0,0
93118,therapy,0,0
93119,or,0,0
93120,parenteral,0,1
93121,nutrition,0,1
93122,.,0,0
93123,Netilmicin,0,0
93124,peak,0,0
93125,and,0,0
93126,trough,0,0
93127,serum,0,0
93128,concentrations,0,0
93129,were,0,0
93130,monitored,0,0
93131,and,0,0
93132,netilmicin,0,0
93133,pharmacokinetic,0,0
93134,parameters,0,0
93135,were,0,0
93136,compared,0,0
93137,with,0,0
93138,and,0,0
93139,without,0,0
93140,parenteral,0,1
93141,nutrition,0,1
93142,.,0,0
93143,RESULTS,0,0
93144,There,0,0
93145,were,0,0
93146,no,0,0
93147,statistically,0,0
93148,significant,0,0
93149,differences,0,0
93150,between,0,0
93151,the,0,0
93152,pharmacokinetic,0,0
93153,parameters,0,0
93154,of,0,0
93155,netilmicin,0,0
93156,(,0,0
93157,volume,0,0
93158,of,0,0
93159,distribution,0,0
93160,",",0,0
93161,elimination,0,0
93162,half-life,0,0
93163,",",0,0
93164,clearance,0,0
93165,),0,0
93166,in,0,0
93167,critically,1,0
93168,ill,1,1
93169,neonates,1,1
93170,>,1,1
93171,32,1,1
93172,weeks,1,0
93173,during,0,0
93174,the,0,0
93175,first,0,0
93176,week,0,0
93177,of,0,0
93178,life,0,0
93179,that,0,0
93180,received,0,0
93181,either,0,0
93182,fluid,0,0
93183,therapy,0,0
93184,or,0,0
93185,parenteral,0,1
93186,nutrition,0,0
93187,.,0,0
93188,For,0,0
93189,neonates,1,1
93190,<,1,0
93191,32,1,1
93192,weeks,1,0
93193,this,0,0
93194,comparison,0,0
93195,was,0,0
93196,not,0,0
93197,feasible,0,0
93198,as,0,0
93199,the,0,0
93200,majority,0,0
93201,were,0,0
93202,parenterally,0,0
93203,fed,0,0
93204,.,0,0
93205,CONCLUSION,0,0
93206,Provision,0,0
93207,of,0,0
93208,parenteral,0,1
93209,nutrition,0,1
93210,(,0,0
93211,versus,0,0
93212,fluid,0,0
93213,therapy,0,0
93214,),0,0
93215,in,0,0
93216,critically,1,0
93217,ill,1,1
93218,neonates,1,1
93219,>,1,1
93220,32,1,1
93221,weeks,1,0
93222,did,0,0
93223,not,0,0
93224,significantly,0,0
93225,affect,0,0
93226,netilmicin,0,0
93227,pharmacokinetics,0,0
93228,and,0,0
93229,therefore,0,0
93230,does,0,0
93231,not,0,0
93232,require,0,0
93233,modification,0,0
93234,of,0,0
93235,recommended,0,0
93236,netilmicin,0,0
93237,dosage,0,0
93238,regimens,0,0
93239,.,0,1
93240,Effects,0,0
93241,of,0,0
93242,propranolol,0,0
93243,on,0,0
93244,bone,0,0
93245,metabolism,0,0
93246,in,0,0
93247,the,0,0
93248,rat,1,0
93249,.,1,0
93250,Propranolol,0,0
93251,",",0,0
93252,a,0,0
93253,nonspecific,0,0
93254,beta-blocker,0,0
93255,has,0,0
93256,many,0,0
93257,physiologic,0,0
93258,effects,0,0
93259,.,0,1
93260,Its,0,0
93261,effects,0,0
93262,on,0,0
93263,bone,0,0
93264,in,0,0
93265,vivo,0,0
93266,are,0,0
93267,unknown,0,0
93268,",",0,0
93269,although,0,0
93270,beta,0,0
93271,receptor,0,0
93272,sites,0,0
93273,have,0,0
93274,been,0,0
93275,found,0,0
93276,on,0,0
93277,osteoblasts,0,1
93278,.,0,0
93279,In,0,0
93280,this,0,0
93281,study,0,0
93282,",",0,0
93283,the,0,0
93284,hypothesis,0,0
93285,tested,0,0
93286,was,0,0
93287,that,0,0
93288,low,0,0
93289,doses,0,0
93290,of,0,0
93291,propranolol,0,0
93292,could,0,0
93293,alter,0,0
93294,bone,0,0
93295,properties,0,0
93296,and,0,0
93297,enhance,0,0
93298,orthotopic,0,1
93299,endochondral,0,0
93300,bone,0,0
93301,formation,0,0
93302,.,0,0
93303,In,0,0
93304,a,0,0
93305,group,0,0
93306,of,0,0
93307,nonsurgical,1,1
93308,rats,1,1
93309,",",0,0
93310,propranolol,0,0
93311,treatment,0,0
93312,increased,0,0
93313,femoral,0,0
93314,torsional,0,0
93315,strength,0,0
93316,on,0,0
93317,biomechanical,0,0
93318,testing,0,0
93319,.,0,0
93320,In,0,0
93321,the,0,0
93322,rat,1,0
93323,surgical,1,0
93324,model,1,0
93325,used,0,0
93326,",",0,0
93327,right,0,0
93328,femora,0,1
93329,were,0,0
93330,fixed,0,0
93331,to,0,0
93332,a,0,0
93333,polyethylene,0,0
93334,plate,0,0
93335,and,0,0
93336,then,0,0
93337,defects,0,0
93338,were,0,0
93339,created,0,0
93340,mid-diaphysis,0,0
93341,and,0,0
93342,subsequently,0,0
93343,filled,0,0
93344,with,0,0
93345,demineralized,0,0
93346,bone,0,0
93347,matrix,0,0
93348,.,0,0
93349,These,0,0
93350,rats,1,1
93351,(,1,0
93352,defect,1,1
93353,rats,1,1
93354,),1,0
93355,were,0,0
93356,randomly,0,0
93357,divided,0,0
93358,into,0,0
93359,groups,0,0
93360,that,0,0
93361,were,0,0
93362,given,0,0
93363,propranolol,0,0
93364,or,0,0
93365,a,0,0
93366,saline,0,0
93367,carrier,0,0
93368,for,0,0
93369,19,0,1
93370,consecutive,0,1
93371,days,0,0
93372,.,0,0
93373,In,0,0
93374,the,0,0
93375,defect,1,0
93376,rats,1,1
93377,",",0,0
93378,increased,0,0
93379,trabecular,0,0
93380,femoral,0,1
93381,metaphyseal,0,1
93382,mineral,0,0
93383,apposition,0,0
93384,rates,0,0
93385,were,0,0
93386,observed,0,0
93387,in,0,0
93388,propranolol-treated,0,0
93389,groups,0,0
93390,.,0,1
93391,Densitometry,0,0
93392,and,0,0
93393,roentgenographic,0,0
93394,scoring,0,0
93395,of,0,0
93396,callus,0,0
93397,formation,0,0
93398,after,0,0
93399,12,0,0
93400,weeks,0,0
93401,in,0,0
93402,propranolol-treated,0,1
93403,rats,0,1
93404,revealed,0,0
93405,increased,0,0
93406,callus,0,0
93407,and,0,0
93408,bone,0,0
93409,union,0,0
93410,.,0,0
93411,The,0,0
93412,results,0,0
93413,of,0,0
93414,this,0,0
93415,study,0,0
93416,indicate,0,0
93417,that,0,0
93418,propranolol,0,0
93419,treatment,0,0
93420,can,0,0
93421,significantly,0,0
93422,affect,0,0
93423,bone,0,0
93424,properties,0,0
93425,.,0,1
93426,Development,0,0
93427,of,0,0
93428,a,0,0
93429,telehealth,0,0
93430,intervention,0,0
93431,for,0,0
93432,head,1,0
93433,and,1,0
93434,neck,1,1
93435,cancer,1,1
93436,patients,1,1
93437,.,1,0
93438,Treatment,0,0
93439,for,0,0
93440,head,1,0
93441,and,1,0
93442,neck,1,1
93443,cancer,1,1
93444,precipitates,0,0
93445,a,0,0
93446,myriad,0,0
93447,of,0,0
93448,distressing,0,0
93449,symptoms,0,0
93450,.,0,0
93451,Patients,0,1
93452,may,0,0
93453,be,0,0
93454,isolated,0,0
93455,both,0,0
93456,physically,0,0
93457,and,0,0
93458,socially,0,0
93459,and,0,0
93460,may,0,0
93461,lack,0,0
93462,the,0,0
93463,self-efficacy,0,0
93464,to,0,0
93465,report,0,0
93466,problems,0,0
93467,and,0,0
93468,participate,0,1
93469,as,0,0
93470,partners,0,0
93471,in,0,0
93472,their,0,1
93473,care,0,0
93474,.,0,0
93475,The,0,0
93476,goal,0,0
93477,of,0,0
93478,this,0,0
93479,project,0,0
93480,was,0,0
93481,to,0,0
93482,design,0,0
93483,a,0,0
93484,telehealth,0,0
93485,intervention,0,0
93486,to,0,0
93487,address,0,0
93488,such,0,0
93489,isolation,0,0
93490,",",0,0
93491,develop,0,0
93492,patient,0,0
93493,self-efficacy,0,0
93494,",",0,0
93495,and,0,0
93496,improve,0,0
93497,symptom,0,0
93498,management,0,0
93499,during,0,0
93500,the,0,0
93501,treatment,0,0
93502,experience,0,0
93503,.,0,0
93504,Participatory,0,0
93505,action,0,0
93506,research,0,0
93507,and,0,0
93508,a,0,0
93509,review,0,0
93510,of,0,0
93511,the,0,0
93512,literature,0,0
93513,were,0,0
93514,used,0,0
93515,to,0,0
93516,develop,0,0
93517,electronically,0,0
93518,administered,0,0
93519,symptom,0,0
93520,management,0,0
93521,algorithms,0,0
93522,addressing,0,0
93523,all,0,0
93524,major,0,0
93525,symptoms,0,0
93526,experienced,0,0
93527,by,0,0
93528,patients,1,1
93529,undergoing,1,1
93530,treatment,1,0
93531,for,1,0
93532,head,1,0
93533,and,1,0
93534,neck,1,1
93535,cancers,1,1
93536,.,1,1
93537,Daily,0,0
93538,questions,0,0
93539,and,0,0
93540,related,0,0
93541,messages,0,0
93542,were,0,0
93543,then,0,0
93544,programmed,0,0
93545,into,0,0
93546,an,0,0
93547,easy-to-use,0,0
93548,telehealth,0,0
93549,messaging,0,0
93550,device,0,0
93551,",",0,0
93552,the,0,0
93553,Health,0,0
93554,Buddy,0,0
93555,(,0,0
93556,R,0,0
93557,),0,0
93558,.,0,0
93559,Clinician,0,0
93560,and,0,0
93561,patient,0,0
93562,acceptance,0,0
93563,",",0,0
93564,feasibility,0,0
93565,",",0,0
93566,and,0,0
93567,technology,0,0
93568,issues,0,0
93569,were,0,0
93570,measured,0,0
93571,.,0,0
93572,Using,0,0
93573,participatory,0,0
93574,action,0,0
93575,research,0,0
93576,is,0,0
93577,an,0,0
93578,effective,0,0
93579,means,0,0
93580,for,0,0
93581,developing,0,0
93582,electronic,0,0
93583,algorithms,0,0
93584,acceptable,0,0
93585,to,0,0
93586,both,0,0
93587,clinicians,0,0
93588,and,0,0
93589,patients,0,1
93590,.,0,0
93591,The,0,0
93592,use,0,0
93593,of,0,0
93594,a,0,0
93595,simple,0,0
93596,tele-messaging,0,0
93597,device,0,0
93598,as,0,0
93599,an,0,0
93600,adjunct,0,0
93601,to,0,0
93602,symptom,0,0
93603,management,0,0
93604,is,0,0
93605,feasible,0,0
93606,",",0,0
93607,affordable,0,0
93608,",",0,0
93609,and,0,0
93610,acceptable,0,0
93611,to,0,0
93612,patients,0,1
93613,.,0,0
93614,This,0,0
93615,telehealth,0,0
93616,intervention,0,0
93617,provides,0,0
93618,support,0,0
93619,and,0,0
93620,education,0,0
93621,to,0,0
93622,patients,1,1
93623,undergoing,1,1
93624,treatment,1,0
93625,for,1,0
93626,head,1,0
93627,and,1,0
93628,neck,1,1
93629,cancers,1,1
93630,.,1,1
93631,Using,0,0
93632,a,0,0
93633,laryngeal,0,1
93634,tube,0,0
93635,suction-device,0,0
93636,(,0,0
93637,LTS-D,0,0
93638,),0,0
93639,reduces,0,0
93640,the,0,0
93641,no,0,0
93642,flow,0,0
93643,time,0,0
93644,in,0,0
93645,a,0,0
93646,single,0,0
93647,rescuer,0,0
93648,manikin,0,0
93649,study,0,0
93650,.,0,0
93651,BACKGROUND,0,0
93652,In,0,0
93653,2005,0,1
93654,",",0,0
93655,the,0,0
93656,European,0,1
93657,Resuscitation,0,0
93658,Council,0,0
93659,and,0,0
93660,the,0,0
93661,American,0,1
93662,Heart,0,0
93663,Association,0,0
93664,published,0,0
93665,new,0,0
93666,guidelines,0,0
93667,for,0,0
93668,Advanced,0,1
93669,Life,0,0
93670,Support,0,0
93671,.,0,0
93672,One,0,0
93673,of,0,0
93674,the,0,0
93675,points,0,0
93676,was,0,0
93677,to,0,0
93678,reduce,0,0
93679,the,0,0
93680,time,0,0
93681,without,0,0
93682,chest,0,0
93683,compressions,0,0
93684,in,0,0
93685,the,0,0
93686,first,0,0
93687,phase,0,0
93688,of,0,0
93689,cardiac,0,0
93690,arrest,0,1
93691,.,0,0
93692,OBJECTIVE,0,0
93693,We,0,0
93694,evaluated,0,0
93695,in,0,0
93696,a,0,0
93697,manikin,0,0
93698,model,0,0
93699,whether,0,0
93700,using,0,0
93701,the,0,0
93702,single-use,0,0
93703,laryngeal,0,1
93704,tube,0,0
93705,with,0,0
93706,suction,0,0
93707,option,0,0
93708,(,0,0
93709,LTS-D,0,0
93710,),0,0
93711,instead,0,0
93712,of,0,0
93713,endotracheal,0,0
93714,intubation,0,0
93715,(,0,0
93716,ET,0,0
93717,),0,0
93718,and,0,0
93719,bag-mask-valve,0,0
93720,ventilation,0,0
93721,(,0,0
93722,BMV,0,1
93723,),0,0
93724,for,0,0
93725,emergency,0,1
93726,airway,0,0
93727,management,0,0
93728,could,0,0
93729,reduce,0,0
93730,the,0,0
93731,no-flow,0,0
93732,time,0,0
93733,(,0,0
93734,NFT,0,1
93735,),0,0
93736,.,0,0
93737,The,0,0
93738,NFT,0,0
93739,is,0,0
93740,defined,0,0
93741,as,0,0
93742,the,0,0
93743,time,0,0
93744,during,0,0
93745,resuscitation,0,0
93746,when,0,0
93747,no,0,0
93748,chest,0,0
93749,compressions,0,0
93750,take,0,0
93751,place,0,0
93752,.,0,0
93753,METHODS,0,0
93754,A,0,0
93755,randomized,1,0
93756,",",1,0
93757,prospective,1,0
93758,study,1,0
93759,was,1,0
93760,undertaken,1,0
93761,with,1,1
93762,150,1,1
93763,volunteers,1,1
93764,who,1,1
93765,performed,1,1
93766,management,1,1
93767,of,1,0
93768,a,1,0
93769,standardized,1,0
93770,simulated,1,0
93771,cardiac,1,0
93772,arrest,1,1
93773,in,1,0
93774,a,1,0
93775,manikin,1,0
93776,.,1,0
93777,Every,0,0
93778,participant,0,0
93779,was,0,0
93780,randomized,0,0
93781,to,0,0
93782,one,0,0
93783,of,0,0
93784,three,0,0
93785,different,0,0
93786,airway,0,1
93787,management,0,0
93788,groups,0,0
93789,(,0,0
93790,LTS-D,0,0
93791,vs,0,0
93792,.,0,0
93793,ET,0,0
93794,vs.,0,0
93795,BMV,0,1
93796,),0,0
93797,.,0,0
93798,RESULTS,0,0
93799,The,0,0
93800,LTS-D,0,0
93801,was,0,0
93802,inserted,0,0
93803,significantly,0,0
93804,faster,0,0
93805,than,0,0
93806,the,0,0
93807,ET,0,0
93808,tube,0,0
93809,(,0,0
93810,15,0,0
93811,s,0,0
93812,vs.,0,0
93813,44,0,0
93814,s,0,0
93815,",",0,0
93816,respectively,0,0
93817,",",0,0
93818,p,0,0
93819,<,0,0
93820,0.01,0,0
93821,),0,0
93822,.,0,0
93823,During,0,0
93824,the,0,0
93825,cardiac,0,0
93826,arrest,0,0
93827,simulation,0,0
93828,",",0,0
93829,establishing,0,0
93830,and,0,0
93831,performing,0,0
93832,ventilation,0,0
93833,took,0,0
93834,an,0,0
93835,average,0,0
93836,of,0,0
93837,57,0,0
93838,s,0,0
93839,with,0,1
93840,the,0,0
93841,LTS-D,0,0
93842,compared,0,0
93843,to,0,0
93844,116,0,1
93845,s,0,0
93846,with,0,1
93847,ET,0,0
93848,and,0,0
93849,111,0,1
93850,s,0,0
93851,with,0,1
93852,the,0,0
93853,BMV,0,0
93854,.,0,0
93855,Using,0,0
93856,the,0,0
93857,LTS-D,0,0
93858,significantly,0,0
93859,reduced,0,0
93860,NFT,0,0
93861,compared,0,0
93862,to,0,0
93863,ET,0,0
93864,and,0,0
93865,the,0,0
93866,BMV,0,0
93867,(,0,0
93868,125,0,0
93869,s,0,0
93870,vs.,0,0
93871,207,0,1
93872,s,0,0
93873,vs.,0,0
93874,160,0,1
93875,s,0,0
93876,;,0,0
93877,p,0,0
93878,<,0,0
93879,0.01,0,0
93880,),0,0
93881,.,0,0
93882,CONCLUSIONS,0,0
93883,In,0,0
93884,our,0,0
93885,manikin,0,0
93886,study,0,0
93887,",",0,0
93888,NFT,0,0
93889,was,0,0
93890,reduced,0,0
93891,significantly,0,0
93892,when,0,0
93893,the,0,0
93894,LTS-D,0,0
93895,was,0,0
93896,used,0,0
93897,when,0,0
93898,compared,0,0
93899,to,0,0
93900,ET,0,0
93901,and,0,0
93902,BMV,0,1
93903,.,0,0
93904,The,0,0
93905,results,0,0
93906,of,0,0
93907,our,0,0
93908,manikin,0,0
93909,study,0,0
93910,suggest,0,0
93911,that,0,0
93912,for,0,0
93913,personnel,0,1
93914,not,0,0
93915,experienced,0,0
93916,in,0,0
93917,tracheal,0,1
93918,intubation,0,0
93919,",",0,0
93920,the,0,0
93921,LTS-D,0,0
93922,offers,0,0
93923,a,0,0
93924,good,0,0
93925,alternative,0,0
93926,to,0,0
93927,ET,0,0
93928,and,0,0
93929,BMV,0,0
93930,to,0,0
93931,manage,0,0
93932,the,0,0
93933,airway,0,0
93934,during,0,0
93935,resuscitation,0,0
93936,",",0,0
93937,and,0,0
93938,to,0,0
93939,avoid,0,0
93940,the,0,0
93941,failure,0,0
93942,to,0,0
93943,achieve,0,0
93944,tracheal,0,1
93945,intubation,0,0
93946,with,0,1
93947,the,0,0
93948,ET,0,0
93949,",",0,0
93950,and,0,0
93951,the,0,0
93952,failure,0,0
93953,to,0,0
93954,achieve,0,0
93955,adequate,0,0
93956,ventilation,0,0
93957,with,0,1
93958,the,0,0
93959,BMV,0,1
93960,.,0,0
93961,Cardiovascular,0,0
93962,safety,0,0
93963,and,0,0
93964,gastrointestinal,0,1
93965,tolerability,0,0
93966,of,0,0
93967,etoricoxib,0,0
93968,vs,0,0
93969,diclofenac,0,0
93970,in,0,0
93971,a,0,0
93972,randomized,0,0
93973,controlled,0,0
93974,clinical,0,0
93975,trial,0,0
93976,(,0,0
93977,The,0,0
93978,MEDAL,0,0
93979,study,0,0
93980,),0,0
93981,.,0,0
93982,OBJECTIVE,0,0
93983,To,0,0
93984,compare,0,0
93985,cardiovascular,0,0
93986,(,0,0
93987,CV,0,0
93988,),0,0
93989,and,0,0
93990,other,0,0
93991,safety,0,0
93992,and,0,0
93993,efficacy,0,0
93994,parameters,0,0
93995,of,0,0
93996,etoricoxib,0,0
93997,60,0,1
93998,and,0,0
93999,90,0,0
94000,mg,0,0
94001,",",0,0
94002,and,0,0
94003,diclofenac,0,0
94004,150,0,0
94005,mg.,0,0
94006,METHODS,0,0
94007,This,0,0
94008,double-blind,0,0
94009,study,0,0
94010,randomized,0,0
94011,OA,1,0
94012,patients,1,1
94013,to,0,0
94014,etoricoxib,0,0
94015,90,0,0
94016,mg,0,0
94017,",",0,0
94018,then,0,0
94019,to,0,0
94020,60,0,0
94021,mg,0,0
94022,once,0,0
94023,daily,0,0
94024,vs,0,0
94025,diclofenac,0,0
94026,75,0,0
94027,mg,0,0
94028,twice,0,0
94029,daily,0,0
94030,;,0,0
94031,RA,1,0
94032,patients,1,1
94033,were,0,0
94034,randomized,0,0
94035,to,0,0
94036,etoricoxib,0,0
94037,90,0,0
94038,mg,0,0
94039,once,0,0
94040,daily,0,0
94041,or,0,0
94042,diclofenac,0,0
94043,75,0,1
94044,mg,0,0
94045,twice,0,0
94046,daily,0,0
94047,.,0,0
94048,The,0,0
94049,primary,0,0
94050,endpoint,0,0
94051,was,0,0
94052,non-inferiority,0,0
94053,of,0,0
94054,etoricoxib,0,0
94055,vs,0,0
94056,diclofenac,0,0
94057,for,0,0
94058,thrombotic,0,0
94059,CV,0,0
94060,events,0,0
94061,(,0,0
94062,95,0,0
94063,%,0,0
94064,CI,0,0
94065,upper,0,0
94066,bound,0,0
94067,of,0,0
94068,hazard,0,0
94069,ratio,0,0
94070,<,0,0
94071,1.30,0,0
94072,),0,0
94073,.,0,0
94074,Other,0,0
94075,safety,0,0
94076,and,0,0
94077,efficacy,0,0
94078,parameters,0,0
94079,were,0,0
94080,evaluated,0,0
94081,in,0,0
94082,cohorts,0,0
94083,of,0,0
94084,patients,0,1
94085,based,0,0
94086,on,0,0
94087,etoricoxib,0,0
94088,dose,0,0
94089,and,0,0
94090,disease,0,1
94091,.,0,0
94092,RESULTS,0,0
94093,A,1,0
94094,total,1,0
94095,of,1,0
94096,23,1,1
94097,504,1,1
94098,patients,1,1
94099,were,0,0
94100,randomized,0,0
94101,with,0,1
94102,mean,0,0
94103,treatment,0,0
94104,duration,0,0
94105,from,0,0
94106,19.4,0,0
94107,to,0,0
94108,20.8,0,0
94109,months,0,0
94110,.,0,0
94111,The,0,0
94112,thrombotic,0,0
94113,CV,0,0
94114,risk,0,0
94115,hazard,0,0
94116,ratio,0,0
94117,(,0,0
94118,HR,0,0
94119,),0,0
94120,(,0,0
94121,etoricoxib,0,0
94122,to,0,0
94123,diclofenac,0,0
94124,),0,0
94125,was,0,0
94126,0.96,0,0
94127,(,0,0
94128,95,0,0
94129,%,0,0
94130,CI,0,0
94131,0.81,0,0
94132,",",0,0
94133,1.15,0,0
94134,),0,0
94135,",",0,0
94136,consistent,0,0
94137,with,0,0
94138,non-inferiority,0,0
94139,of,0,0
94140,etoricoxib,0,0
94141,to,0,0
94142,diclofenac,0,0
94143,.,0,0
94144,The,0,0
94145,cumulative,0,0
94146,gastrointestinal,0,1
94147,(,0,0
94148,GI,0,1
94149,),0,0
94150,/liver,0,0
94151,adverse,0,0
94152,events,0,0
94153,(,0,0
94154,AEs,0,0
94155,),0,0
94156,discontinuation,0,0
94157,rate,0,0
94158,was,0,0
94159,significantly,0,0
94160,lower,0,0
94161,for,0,0
94162,etoricoxib,0,0
94163,than,0,0
94164,diclofenac,0,0
94165,in,0,0
94166,each,0,0
94167,patient,0,0
94168,cohort,0,1
94169,;,0,0
94170,HR,0,0
94171,(,0,0
94172,95,0,0
94173,%,0,0
94174,CI,0,0
94175,),0,0
94176,of,0,0
94177,0.46,0,0
94178,(,0,0
94179,0.39,0,0
94180,",",0,0
94181,0.54,0,0
94182,),0,0
94183,",",0,0
94184,0.52,0,0
94185,(,0,0
94186,0.42,0,0
94187,",",0,0
94188,0.63,0,0
94189,),0,0
94190,and,0,0
94191,0.49,0,0
94192,(,0,0
94193,0.39,0,0
94194,",",0,0
94195,0.62,0,0
94196,),0,0
94197,for,0,0
94198,the,0,0
94199,60,0,0
94200,mg,0,0
94201,OA,0,0
94202,",",0,0
94203,90,0,0
94204,mg,0,0
94205,OA,0,0
94206,and,0,0
94207,RA,0,0
94208,cohorts,0,0
94209,.,0,0
94210,The,0,0
94211,maximum,0,0
94212,average,0,0
94213,change,0,0
94214,in,0,0
94215,systolic,0,0
94216,blood,0,0
94217,pressure,0,0
94218,(,0,0
94219,BP,0,0
94220,),0,0
94221,with,0,1
94222,etoricoxib,0,0
94223,was,0,0
94224,3.4-3.6,0,0
94225,mmHg,0,0
94226,(,0,0
94227,diastolic,0,1
94228,BP,0,0
94229,:,0,1
94230,1.0-1.5,0,0
94231,mmHg,0,0
94232,),0,0
94233,",",0,0
94234,while,0,0
94235,diclofenac,0,0
94236,produced,0,0
94237,a,0,0
94238,maximum,0,0
94239,average,0,0
94240,change,0,0
94241,of,0,0
94242,0.9-1.9,0,0
94243,mmHg,0,0
94244,(,0,0
94245,diastolic,0,1
94246,BP,0,0
94247,:,0,1
94248,0.0-0.5,0,0
94249,mmHg,0,0
94250,),0,0
94251,.,0,0
94252,Both,0,0
94253,agents,0,0
94254,resulted,0,0
94255,in,0,0
94256,similar,0,0
94257,efficacy,0,0
94258,regardless,0,0
94259,of,0,0
94260,etoricoxib,0,0
94261,dose,0,0
94262,.,0,0
94263,CONCLUSION,0,0
94264,Long-term,0,0
94265,etoricoxib,0,0
94266,use,0,0
94267,is,0,0
94268,associated,0,0
94269,with,0,0
94270,a,0,0
94271,risk,0,0
94272,of,0,0
94273,thrombotic,0,0
94274,CV,0,0
94275,events,0,0
94276,comparable,0,0
94277,with,0,1
94278,that,0,0
94279,of,0,0
94280,diclofenac,0,0
94281,.,0,0
94282,Compared,0,0
94283,with,0,0
94284,diclofenac,0,0
94285,",",0,0
94286,etoricoxib,0,0
94287,demonstrated,0,0
94288,a,0,0
94289,greater,0,0
94290,risk,0,0
94291,of,0,0
94292,renovascular,0,1
94293,AEs,0,0
94294,",",0,0
94295,but,0,0
94296,a,0,0
94297,more,0,0
94298,favourable,0,0
94299,GI/liver,0,0
94300,tolerability,0,0
94301,profile,0,0
94302,.,0,0
94303,[,0,0
94304,Efficacy,0,0
94305,of,0,0
94306,immunomodulating,0,0
94307,treatment,0,0
94308,in,0,0
94309,patients,1,1
94310,with,1,1
94311,different,1,0
94312,degrees,1,0
94313,of,1,0
94314,immunosuppression,1,0
94315,],1,0
94316,.,0,0
94317,Immunodepression,0,0
94318,is,0,0
94319,a,0,0
94320,common,0,0
94321,condition,0,0
94322,in,0,0
94323,patients,0,1
94324,undergoing,0,1
94325,elective,0,1
94326,operations,0,1
94327,and,0,0
94328,it,0,0
94329,constitutes,0,0
94330,a,0,0
94331,high,0,0
94332,risk,0,0
94333,for,0,0
94334,the,0,0
94335,onset,0,0
94336,of,0,0
94337,postoperative,0,0
94338,infective,0,1
94339,complications,0,0
94340,.,0,0
94341,The,0,0
94342,use,0,0
94343,of,0,0
94344,immunomodulatory,0,0
94345,drugs,0,0
94346,has,0,0
94347,proved,0,0
94348,useful,0,0
94349,in,0,0
94350,the,0,0
94351,prophylaxis,0,0
94352,of,0,0
94353,these,0,0
94354,complications,0,0
94355,",",0,0
94356,although,0,0
94357,the,0,0
94358,precise,0,0
94359,indications,0,0
94360,for,0,0
94361,each,0,0
94362,drug,0,0
94363,have,0,0
94364,not,0,0
94365,yet,0,0
94366,been,0,0
94367,clearly,0,0
94368,codified,0,0
94369,.,0,0
94370,The,0,0
94371,present,0,0
94372,study,0,0
94373,aimed,0,0
94374,to,0,0
94375,assess,0,0
94376,the,0,0
94377,effects,0,0
94378,of,0,0
94379,thymostimulin,0,0
94380,in,0,0
94381,patients,1,1
94382,with,1,1
94383,different,1,0
94384,degrees,1,0
94385,of,1,0
94386,immunodepression,1,0
94387,",",0,0
94388,by,0,0
94389,evaluating,0,0
94390,both,0,0
94391,the,0,0
94392,incidence,0,0
94393,of,0,0
94394,postoperative,0,0
94395,infections,0,0
94396,and,0,0
94397,the,0,0
94398,changes,0,0
94399,induced,0,0
94400,in,0,0
94401,various,0,0
94402,immunological,0,0
94403,parameters,0,0
94404,.,0,1
94405,The,0,0
94406,results,0,0
94407,obtained,0,0
94408,indicated,0,0
94409,that,0,0
94410,those,0,0
94411,subjects,0,1
94412,with,0,0
94413,the,0,0
94414,highest,0,0
94415,degree,0,0
94416,of,0,0
94417,immunodepression,0,0
94418,(,0,0
94419,hypo-anergic,0,0
94420,),0,0
94421,benefited,0,0
94422,most,0,0
94423,from,0,0
94424,drug,0,0
94425,therapy,0,0
94426,in,0,0
94427,comparison,0,0
94428,to,0,0
94429,those,0,0
94430,with,0,0
94431,a,0,0
94432,lesser,0,0
94433,degree,0,0
94434,of,0,0
94435,immunodepression,0,0
94436,(,0,0
94437,relatively,0,0
94438,hypo-ergic,0,1
94439,),0,0
94440,.,0,0
94441,The,0,0
94442,advantages,0,0
94443,were,0,0
94444,evident,0,0
94445,in,0,0
94446,hypo-anergic,0,1
94447,subjects,0,1
94448,both,0,0
94449,with,0,0
94450,regard,0,0
94451,to,0,0
94452,the,0,0
94453,frequency,0,0
94454,of,0,0
94455,early,0,1
94456,postoperative,0,0
94457,infections,0,0
94458,",",0,0
94459,and,0,0
94460,with,0,0
94461,regard,0,0
94462,to,0,0
94463,immunological,0,0
94464,parameters,0,0
94465,.,0,0
94466,On,0,0
94467,the,0,0
94468,other,0,0
94469,hand,0,0
94470,",",0,0
94471,in,0,0
94472,relatively,0,0
94473,hypo-ergic,0,0
94474,subjects,0,1
94475,",",0,0
94476,benefits,0,0
94477,were,0,0
94478,limited,0,0
94479,to,0,0
94480,the,0,0
94481,improvement,0,0
94482,of,0,0
94483,some,0,0
94484,immunological,0,0
94485,parameters,0,0
94486,.,0,0
94487,In,0,0
94488,our,0,0
94489,opinion,0,0
94490,",",0,0
94491,the,0,0
94492,use,0,0
94493,of,0,0
94494,thymostimulin,0,0
94495,is,0,0
94496,of,0,0
94497,particular,0,0
94498,use,0,0
94499,only,0,0
94500,in,0,0
94501,those,0,0
94502,subjects,0,1
94503,with,0,1
94504,marked,0,0
94505,immunodepression,0,0
94506,since,0,0
94507,the,0,0
94508,incidence,0,0
94509,of,0,0
94510,post-operative,0,0
94511,sepsis,0,0
94512,is,0,0
94513,highest,0,0
94514,in,0,0
94515,this,0,0
94516,group,0,0
94517,.,0,0
94518,Pharmacokinetics,0,0
94519,and,0,1
94520,pharmacodynamics,0,0
94521,of,0,0
94522,six,0,1
94523,epoetin,0,0
94524,alfa,0,0
94525,dosing,0,0
94526,regimens,0,0
94527,in,0,0
94528,anemic,1,1
94529,critically,1,0
94530,ill,1,1
94531,patients,1,1
94532,without,1,1
94533,acute,1,1
94534,blood,1,0
94535,loss,1,0
94536,.,1,0
94537,OBJECTIVE,0,0
94538,To,0,0
94539,describe,0,0
94540,the,0,0
94541,pharmacokinetic,0,0
94542,profiles,0,0
94543,of,0,0
94544,six,0,1
94545,different,0,0
94546,dosing,0,0
94547,regimens,0,0
94548,for,0,0
94549,epoetin,0,0
94550,alfa,0,0
94551,",",0,0
94552,and,0,0
94553,whether,0,0
94554,more,0,0
94555,rapid,0,0
94556,and,0,0
94557,robust,0,0
94558,reticulocytosis,0,0
94559,can,0,0
94560,be,0,0
94561,elicited,0,0
94562,with,0,0
94563,more,0,0
94564,frequent,0,0
94565,administration,0,0
94566,of,0,0
94567,epoetin,0,0
94568,alfa,0,0
94569,in,0,0
94570,anemic,1,1
94571,critically,1,0
94572,ill,1,1
94573,patients,1,1
94574,.,1,1
94575,DESIGN,0,0
94576,Randomized,0,0
94577,",",0,0
94578,open-label,0,0
94579,",",0,0
94580,multicenter,0,0
94581,",",0,0
94582,28-day,0,0
94583,clinical,0,0
94584,trial,0,0
94585,.,0,0
94586,SETTING,0,0
94587,Ten,1,1
94588,centers,1,1
94589,in,1,0
94590,the,1,0
94591,United,1,1
94592,States,1,0
94593,.,1,1
94594,PATIENTS,0,0
94595,Adult,1,0
94596,(,1,0
94597,age,1,1
94598,>,1,1
94599,or=18,1,1
94600,years,1,1
94601,),1,0
94602,critically,1,0
94603,ill,1,1
94604,patients,1,1
94605,with,1,1
94606,hemoglobin,1,0
94607,<,1,0
94608,or=12,1,0
94609,g/dL,1,0
94610,",",1,0
94611,expected,1,0
94612,hospitalization,1,0
94613,of,1,0
94614,>,1,1
94615,or=7,1,0
94616,days,1,0
94617,",",1,0
94618,with,1,0
94619,no,1,0
94620,ongoing,1,0
94621,acute,1,1
94622,blood,1,0
94623,loss,1,0
94624,.,1,0
94625,INTERVENTIONS,0,0
94626,One,0,1
94627,of,0,0
94628,six,0,0
94629,dosing,0,0
94630,epoetin,0,0
94631,alfa,0,0
94632,regimens,0,0
94633,for,0,0
94634,15,0,0
94635,days,0,0
94636,",",0,0
94637,as,0,0
94638,follows,0,0
94639,:,0,0
94640,"40,000",0,0
94641,IU,0,0
94642,once,0,0
94643,weekly,0,0
94644,",",0,0
94645,subcutaneously,0,0
94646,(,0,0
94647,group,0,0
94648,A,0,0
94649,),0,0
94650,or,0,0
94651,intravenously,0,0
94652,(,0,0
94653,IV,0,0
94654,),0,0
94655,(,0,0
94656,group,0,0
94657,B,0,1
94658,),0,0
94659,;,0,0
94660,"15,000",0,0
94661,IU,0,0
94662,every,0,0
94663,other,0,0
94664,day,0,0
94665,",",0,0
94666,subcutaneously,0,0
94667,(,0,0
94668,group,0,0
94669,C,0,0
94670,),0,0
94671,or,0,0
94672,IV,0,0
94673,(,0,0
94674,group,0,0
94675,D,0,0
94676,),0,0
94677,;,0,0
94678,or,0,0
94679,"40,000",0,0
94680,IU,0,0
94681,day,0,0
94682,1,0,0
94683,and,0,0
94684,3,0,0
94685,",",0,0
94686,subcutaneously,0,0
94687,(,0,0
94688,group,0,0
94689,E,0,0
94690,),0,0
94691,or,0,0
94692,IV,0,0
94693,(,0,0
94694,group,0,0
94695,F,0,0
94696,),0,0
94697,",",0,0
94698,followed,0,0
94699,by,0,0
94700,"15,000",0,0
94701,IU,0,0
94702,once,0,0
94703,every,0,0
94704,other,0,0
94705,day,0,0
94706,on,0,0
94707,[,0,0
94708,corrected,0,0
94709,],0,0
94710,days,0,0
94711,5-15,0,1
94712,[,0,0
94713,corrected,0,0
94714,],0,0
94715,MEASUREMENTS,0,0
94716,Serum,0,0
94717,erythropoietin,0,0
94718,concentration,0,0
94719,",",0,0
94720,absolute,0,0
94721,reticulocyte,0,0
94722,count,0,0
94723,",",0,0
94724,and,0,0
94725,adverse,0,0
94726,events,0,0
94727,.,0,1
94728,MAIN,0,0
94729,RESULTS,0,0
94730,Of,0,0
94731,the,0,0
94732,60,0,1
94733,patients,0,1
94734,who,0,1
94735,were,0,1
94736,enrolled,0,1
94737,(,0,0
94738,60,0,1
94739,%,0,0
94740,men,0,1
94741,",",0,0
94742,mean,0,0
94743,age,0,1
94744,53,0,1
94745,years,0,1
94746,",",0,0
94747,mean,0,1
94748,Acute,0,0
94749,Physiology,0,0
94750,and,0,0
94751,Chronic,0,1
94752,Health,0,0
94753,Evaluation,0,0
94754,II,0,0
94755,score,0,0
94756,",",0,0
94757,19.5,0,0
94758,),0,0
94759,",",0,0
94760,30,0,0
94761,were,0,0
94762,evaluable,0,1
94763,for,0,0
94764,both,0,0
94765,pharmacokinetics,0,0
94766,and,0,0
94767,pharmacodynamics,0,0
94768,(,0,0
94769,50,0,1
94770,%,0,0
94771,),0,0
94772,.,0,0
94773,Erythropoietin,0,0
94774,exposure,0,0
94775,was,0,0
94776,approximately,0,0
94777,ten,0,1
94778,times,0,0
94779,greater,0,0
94780,for,0,0
94781,IV,0,0
94782,dosing,0,0
94783,than,0,0
94784,for,0,0
94785,subcutaneous,0,1
94786,dosing,0,0
94787,.,0,0
94788,Mean,0,0
94789,absolute,0,0
94790,reticulocyte,0,0
94791,count,0,0
94792,peaked,0,0
94793,at,0,0
94794,day,0,0
94795,11,0,1
94796,or,0,0
94797,15,0,0
94798,in,0,0
94799,each,0,0
94800,group,0,0
94801,and,0,0
94802,appeared,0,0
94803,to,0,0
94804,be,0,0
94805,greater,0,0
94806,for,0,0
94807,subcutaneous,0,0
94808,dosing,0,0
94809,(,0,0
94810,mean,0,0
94811,peak,0,0
94812,response,0,0
94813,149-169,0,0
94814,x,0,0
94815,10,0,0
94816,(,0,0
94817,9,0,0
94818,),0,0
94819,/L,0,0
94820,),0,0
94821,compared,0,0
94822,with,0,0
94823,IV,0,0
94824,dosing,0,0
94825,(,0,0
94826,mean,0,0
94827,peak,0,0
94828,response,0,0
94829,138-147,0,1
94830,x,0,0
94831,10,0,0
94832,(,0,0
94833,9,0,0
94834,),0,0
94835,/L,0,0
94836,),0,0
94837,at,0,0
94838,most,0,0
94839,visits,0,0
94840,.,0,0
94841,The,0,0
94842,most,0,0
94843,frequently,0,0
94844,reported,0,0
94845,adverse,0,0
94846,events,0,0
94847,were,0,0
94848,pyrexia,0,0
94849,(,0,0
94850,18,0,1
94851,%,0,0
94852,),0,0
94853,",",0,0
94854,hypokalemia,0,0
94855,(,0,0
94856,15,0,0
94857,%,0,0
94858,),0,0
94859,",",0,0
94860,and,0,0
94861,hypophosphatemia,0,0
94862,(,0,0
94863,15,0,0
94864,%,0,0
94865,),0,0
94866,.,0,0
94867,CONCLUSIONS,0,0
94868,In,0,0
94869,this,0,0
94870,study,0,0
94871,of,0,0
94872,anemic,0,1
94873,critically,0,0
94874,ill,0,1
94875,patients,0,1
94876,treated,0,1
94877,with,0,1
94878,epoetin,0,0
94879,alfa,0,0
94880,",",0,0
94881,all,0,0
94882,dosing,0,0
94883,regimens,0,0
94884,were,0,0
94885,well,0,0
94886,tolerated,0,0
94887,and,0,0
94888,appeared,0,0
94889,to,0,0
94890,effect,0,0
94891,reticulocytosis,0,0
94892,",",0,0
94893,with,0,0
94894,a,0,0
94895,peak,0,0
94896,at,0,0
94897,day,0,0
94898,11,0,1
94899,or,0,0
94900,15,0,0
94901,in,0,0
94902,most,0,0
94903,patients,0,1
94904,.,0,0
94905,The,0,0
94906,pharmacokinetics,0,0
94907,of,0,0
94908,epoetin,0,0
94909,alfa,0,0
94910,did,0,0
94911,not,0,0
94912,predict,0,0
94913,pharmacodynamic,0,0
94914,response,0,0
94915,in,0,0
94916,anemic,0,1
94917,critically,0,0
94918,ill,0,1
94919,patients,0,1
94920,.,0,1
94921,Acute,0,0
94922,and,0,0
94923,short-term,0,0
94924,effects,0,0
94925,of,0,0
94926,secondhand,0,1
94927,smoke,0,0
94928,on,0,0
94929,lung,0,0
94930,function,0,0
94931,and,0,0
94932,cytokine,0,0
94933,production,0,0
94934,.,0,0
94935,RATIONALE,0,0
94936,The,0,0
94937,acute,0,0
94938,effect,0,0
94939,of,0,0
94940,secondhand,0,0
94941,smoke,0,1
94942,(,0,0
94943,SHS,0,0
94944,),0,0
94945,on,0,0
94946,lung,0,0
94947,function,0,0
94948,and,0,0
94949,the,0,0
94950,duration,0,0
94951,of,0,0
94952,system,0,0
94953,disruption,0,0
94954,remain,0,0
94955,unknown,0,0
94956,.,0,0
94957,OBJECTIVES,0,0
94958,To,0,0
94959,assess,0,0
94960,the,0,0
94961,SHS,0,0
94962,effects,0,0
94963,and,0,0
94964,their,0,0
94965,duration,0,0
94966,on,0,0
94967,lung,0,0
94968,function,0,0
94969,and,0,0
94970,inflammatory,0,0
94971,markers,0,0
94972,.,0,1
94973,METHODS,0,0
94974,In,0,0
94975,a,0,0
94976,randomized,0,0
94977,single-blind,0,0
94978,crossover,0,0
94979,experiment,0,0
94980,data,0,0
94981,were,0,0
94982,obtained,0,0
94983,from,0,0
94984,16,1,1
94985,(,1,0
94986,8,1,0
94987,women,1,1
94988,),1,1
94989,nonsmoking,1,1
94990,adults,1,1
94991,at,0,0
94992,baseline,0,0
94993,and,0,0
94994,at,0,0
94995,0,0,0
94996,",",0,0
94997,1,0,0
94998,",",0,0
94999,and,0,0
95000,3,0,0
95001,hours,0,0
95002,after,0,0
95003,a,0,0
95004,1-hour,0,0
95005,SHS,0,0
95006,exposure,0,0
95007,set,0,0
95008,at,0,0
95009,bar/restaurant,0,1
95010,SHS,0,0
95011,levels,0,0
95012,.,0,1
95013,MEASUREMENTS,0,0
95014,AND,0,0
95015,MAIN,0,0
95016,RESULTS,0,0
95017,Serum,0,1
95018,and,0,0
95019,urine,0,0
95020,cotinine,0,0
95021,",",0,0
95022,lung,0,0
95023,function,0,0
95024,",",0,0
95025,and,0,0
95026,cytokines,0,0
95027,IL-4,0,0
95028,",",0,0
95029,IL-5,0,0
95030,",",0,0
95031,IL-6,0,0
95032,",",0,0
95033,tumor,0,0
95034,necrosis,0,0
95035,factor,0,0
95036,(,0,0
95037,TNF,0,0
95038,),0,0
95039,-alpha,0,0
95040,",",0,0
95041,and,0,0
95042,IFN-gamma,0,0
95043,.,0,0
95044,At,0,0
95045,0,0,0
95046,hours,0,0
95047,most,0,0
95048,lung,0,1
95049,function,0,0
95050,parameters,0,0
95051,were,0,0
95052,significantly,0,0
95053,reduced,0,0
95054,(,0,0
95055,indicative,0,0
95056,:,0,1
95057,FEV,0,0
95058,(,0,0
95059,1,0,0
95060,),0,0
95061,",",0,0
95062,4.3,0,0
95063,+/-,0,0
95064,0.4,0,0
95065,vs.,0,0
95066,3.8,0,0
95067,+/-,0,0
95068,0.3,0,0
95069,L,0,0
95070,;,0,0
95071,FEV,0,0
95072,(,0,0
95073,1,0,0
95074,),0,0
95075,/FVC,0,0
95076,",",0,0
95077,0.9,0,0
95078,+/-,0,0
95079,0.1,0,0
95080,vs.,0,0
95081,0.8,0,0
95082,+/-,0,0
95083,0.1,0,0
95084,;,0,0
95085,P,0,0
95086,<,0,0
95087,0.05,0,0
95088,),0,0
95089,but,0,0
95090,at,0,0
95091,3,0,0
95092,hours,0,0
95093,they,0,0
95094,were,0,0
95095,at,0,0
95096,baseline,0,0
95097,levels,0,0
95098,.,0,0
95099,In,0,0
95100,contrast,0,0
95101,",",0,0
95102,cotinine,0,0
95103,(,0,0
95104,serum,0,0
95105,",",0,0
95106,8.9,0,0
95107,+/-,0,0
95108,3.2,0,0
95109,vs.,0,0
95110,35.5,0,0
95111,+/-,0,0
95112,10.2,0,0
95113,ng,0,0
95114,x,0,0
95115,ml,0,0
95116,(,0,0
95117,-1,0,0
95118,),0,0
95119,),0,0
95120,",",0,0
95121,IL-4,0,0
95122,(,0,0
95123,41.3,0,0
95124,+/-,0,0
95125,5.8,0,0
95126,vs.,0,0
95127,44.2,0,0
95128,+/-,0,0
95129,4.5,0,0
95130,pg,0,0
95131,x,0,0
95132,ml,0,0
95133,(,0,0
95134,-1,0,0
95135,),0,0
95136,),0,0
95137,",",0,0
95138,IL-5,0,0
95139,(,0,0
95140,36.1,0,0
95141,+/-,0,0
95142,3.2,0,0
95143,vs.,0,0
95144,60.1,0,0
95145,+/-,0,0
95146,7.0,0,0
95147,pg,0,0
95148,x,0,0
95149,ml,0,0
95150,(,0,0
95151,-1,0,0
95152,),0,0
95153,),0,0
95154,",",0,0
95155,IL-6,0,0
95156,(,0,0
95157,2.5,0,0
95158,+/-,0,0
95159,0.3,0,0
95160,vs.,0,0
95161,7.6,0,0
95162,+/-,0,0
95163,1.4,0,0
95164,pg,0,0
95165,x,0,0
95166,ml,0,0
95167,(,0,0
95168,-1,0,0
95169,),0,0
95170,),0,0
95171,and,0,0
95172,IFN-gamma,0,0
95173,(,0,0
95174,0.3,0,0
95175,+/-,0,0
95176,0.2,0,0
95177,vs.,0,0
95178,0.6,0,0
95179,+/-,0,0
95180,0.2,0,0
95181,IU,0,0
95182,x,0,0
95183,ml,0,0
95184,(,0,0
95185,-1,0,0
95186,),0,0
95187,),0,0
95188,at,0,0
95189,3,0,0
95190,hours,0,0
95191,were,0,0
95192,higher,0,0
95193,than,0,0
95194,at,0,0
95195,baseline,0,0
95196,(,0,0
95197,P,0,0
95198,<,0,0
95199,0.05,0,0
95200,),0,0
95201,.,0,0
95202,IL-4,0,0
95203,and,0,0
95204,TNF-alpha,0,0
95205,increased,0,0
95206,only,0,0
95207,in,0,0
95208,men,0,1
95209,",",0,0
95210,whereas,0,0
95211,IL-5,0,0
95212,",",0,0
95213,IL-6,0,0
95214,",",0,0
95215,and,0,0
95216,IFN-gamma,0,0
95217,were,0,0
95218,different,0,0
95219,between,0,0
95220,sexes,0,1
95221,after,0,0
95222,exposure,0,0
95223,(,0,0
95224,P,0,0
95225,<,0,0
95226,0.05,0,0
95227,),0,0
95228,.,0,0
95229,Regression,0,0
95230,analyses,0,0
95231,revealed,0,0
95232,inverse,0,0
95233,associations,0,0
95234,of,0,0
95235,FEV,0,0
95236,(,0,0
95237,1,0,0
95238,),0,0
95239,and,0,0
95240,FEV,0,0
95241,(,0,0
95242,1,0,0
95243,),0,0
95244,/FVC,0,0
95245,ratio,0,0
95246,with,0,1
95247,IL-5,0,0
95248,(,0,0
95249,P,0,0
95250,<,0,0
95251,0.05,0,0
95252,),0,0
95253,in,0,0
95254,men,0,1
95255,and,0,0
95256,with,0,1
95257,IL-5,0,0
95258,(,0,0
95259,P,0,0
95260,=,0,0
95261,0.01,0,0
95262,),0,0
95263,",",0,0
95264,IL-6,0,0
95265,(,0,0
95266,P,0,0
95267,<,0,0
95268,0.001,0,0
95269,),0,0
95270,",",0,0
95271,IFN-gamma,0,0
95272,(,0,0
95273,P,0,0
95274,=,0,0
95275,0.034,0,0
95276,),0,0
95277,and,0,0
95278,serum,0,0
95279,cotinine,0,0
95280,(,0,0
95281,P,0,0
95282,<,0,0
95283,0.001,0,0
95284,),0,0
95285,in,0,0
95286,women,0,1
95287,.,0,1
95288,CONCLUSIONS,0,0
95289,We,0,0
95290,conclude,0,0
95291,that,0,0
95292,1,0,0
95293,hour,0,0
95294,of,0,0
95295,SHS,0,0
95296,exposure,0,0
95297,at,0,0
95298,bar/restaurant,0,0
95299,levels,0,0
95300,is,0,0
95301,accompanied,0,0
95302,by,0,0
95303,significant,0,0
95304,decrements,0,0
95305,on,0,0
95306,lung,0,1
95307,function,0,0
95308,and,0,0
95309,marked,0,0
95310,increases,0,0
95311,in,0,0
95312,inflammatory,0,0
95313,cytokines,0,0
95314,",",0,0
95315,particularly,0,0
95316,in,0,0
95317,men,0,1
95318,.,0,0
95319,More,0,0
95320,importantly,0,0
95321,",",0,0
95322,whereas,0,0
95323,most,0,0
95324,smoke-induced,0,1
95325,effects,0,0
95326,on,0,0
95327,lung,0,1
95328,function,0,0
95329,appear,0,0
95330,to,0,0
95331,recede,0,0
95332,within,0,0
95333,60,0,0
95334,minutes,0,0
95335,",",0,0
95336,inflammatory,0,0
95337,cytokines,0,0
95338,remain,0,0
95339,elevated,0,0
95340,for,0,0
95341,at,0,0
95342,least,0,0
95343,3,0,0
95344,hours,0,0
95345,after,0,0
95346,exposure,0,0
95347,to,0,0
95348,SHS,0,0
95349,.,0,0
95350,Cognitive,0,0
95351,behavioral,0,0
95352,therapy,0,0
95353,for,0,0
95354,anxiety,1,0
95355,in,1,0
95356,children,1,1
95357,with,1,1
95358,autism,1,1
95359,spectrum,1,1
95360,disorders,1,1
95361,:,1,1
95362,a,0,0
95363,randomized,0,0
95364,",",0,0
95365,controlled,0,0
95366,trial,0,0
95367,.,0,0
95368,BACKGROUND,0,0
95369,Children,1,1
95370,with,1,1
95371,autism,1,1
95372,spectrum,1,1
95373,disorders,1,1
95374,often,0,0
95375,present,0,0
95376,with,0,0
95377,comorbid,1,1
95378,anxiety,1,0
95379,disorders,1,1
95380,that,1,0
95381,cause,1,0
95382,significant,1,0
95383,functional,1,0
95384,impairment,1,0
95385,.,1,0
95386,This,0,0
95387,study,0,0
95388,tested,0,0
95389,a,0,0
95390,modular,0,0
95391,cognitive,0,0
95392,behavioral,0,0
95393,therapy,0,0
95394,(,0,0
95395,CBT,0,0
95396,),0,0
95397,program,0,0
95398,for,0,0
95399,children,0,1
95400,with,0,1
95401,this,0,0
95402,profile,0,0
95403,.,0,0
95404,A,0,0
95405,standard,0,0
95406,CBT,0,0
95407,program,0,0
95408,was,0,0
95409,augmented,0,0
95410,with,0,1
95411,multiple,0,0
95412,treatment,0,0
95413,components,0,0
95414,designed,0,0
95415,to,0,0
95416,accommodate,0,0
95417,or,0,0
95418,remediate,0,0
95419,the,0,0
95420,social,0,0
95421,and,0,0
95422,adaptive,0,0
95423,skill,0,0
95424,deficits,0,0
95425,of,0,0
95426,children,1,1
95427,with,1,1
95428,ASD,1,1
95429,that,0,0
95430,could,0,0
95431,pose,0,0
95432,barriers,0,0
95433,to,0,0
95434,anxiety,0,0
95435,reduction,0,0
95436,.,0,0
95437,METHOD,0,0
95438,Forty,1,1
95439,children,1,1
95440,(,1,0
95441,7-11,1,1
95442,years,1,1
95443,old,1,1
95444,),1,0
95445,were,1,0
95446,randomly,1,0
95447,assigned,1,0
95448,to,0,0
95449,16,0,1
95450,sessions,0,0
95451,of,0,0
95452,CBT,0,0
95453,or,0,0
95454,a,0,0
95455,3-month,0,0
95456,waitlist,0,0
95457,(,0,0
95458,36,0,0
95459,completed,0,1
95460,treatment,0,0
95461,or,0,0
95462,waitlist,0,0
95463,),0,0
95464,.,0,0
95465,Therapists,0,0
95466,worked,0,0
95467,with,0,1
95468,individual,0,0
95469,families,0,1
95470,.,0,1
95471,The,0,0
95472,CBT,0,0
95473,model,0,0
95474,emphasized,0,0
95475,behavioral,0,0
95476,experimentation,0,0
95477,",",0,0
95478,parent-training,0,0
95479,",",0,0
95480,and,0,0
95481,school,0,1
95482,consultation,0,0
95483,.,0,0
95484,Independent,0,0
95485,evaluators,0,0
95486,blind,0,0
95487,to,0,0
95488,treatment,0,0
95489,condition,0,0
95490,conducted,0,0
95491,structured,0,0
95492,diagnostic,0,0
95493,interviews,0,1
95494,and,0,0
95495,parents,0,1
95496,and,0,0
95497,children,0,1
95498,completed,0,1
95499,anxiety,0,0
95500,symptom,0,0
95501,checklists,0,0
95502,at,0,0
95503,baseline,0,0
95504,and,0,0
95505,posttreatment/postwaitlist,0,0
95506,.,0,0
95507,RESULTS,0,0
95508,In,0,0
95509,intent-to-treat,0,0
95510,analyses,0,0
95511,",",0,0
95512,78.5,0,0
95513,%,0,0
95514,of,0,0
95515,the,0,0
95516,CBT,0,0
95517,group,0,0
95518,met,0,1
95519,Clinical,0,0
95520,Global,0,0
95521,Impressions-Improvement,0,0
95522,scale,0,0
95523,criteria,0,1
95524,for,0,0
95525,positive,0,0
95526,treatment,0,0
95527,response,0,0
95528,at,0,0
95529,posttreatment,0,0
95530,",",0,0
95531,as,0,0
95532,compared,0,0
95533,to,0,0
95534,only,0,0
95535,8.7,0,0
95536,%,0,0
95537,of,0,0
95538,the,0,0
95539,waitlist,0,0
95540,group,0,0
95541,.,0,0
95542,CBT,0,0
95543,also,0,0
95544,outperformed,0,0
95545,the,0,0
95546,waitlist,0,0
95547,on,0,0
95548,diagnostic,0,0
95549,outcomes,0,0
95550,and,0,0
95551,parent,0,0
95552,reports,0,0
95553,of,0,0
95554,child,0,1
95555,anxiety,0,0
95556,",",0,0
95557,but,0,0
95558,not,0,0
95559,children,0,1
95560,'s,0,1
95561,self-reports,0,0
95562,.,0,1
95563,Treatment,0,0
95564,gains,0,0
95565,were,0,0
95566,maintained,0,0
95567,at,0,0
95568,3-month,0,0
95569,follow-up,0,0
95570,.,0,0
95571,CONCLUSIONS,0,0
95572,The,0,0
95573,CBT,0,0
95574,manual,0,0
95575,employed,0,0
95576,in,0,0
95577,this,0,0
95578,study,0,0
95579,is,0,0
95580,one,0,0
95581,of,0,0
95582,the,0,0
95583,first,0,0
95584,adaptations,0,0
95585,of,0,0
95586,an,0,0
95587,evidence-based,0,0
95588,treatment,0,0
95589,for,0,0
95590,children,0,1
95591,with,0,1
95592,autism,0,1
95593,spectrum,0,1
95594,disorders,0,1
95595,.,0,0
95596,Remission,0,0
95597,of,0,0
95598,anxiety,0,0
95599,disorders,0,1
95600,appears,0,0
95601,to,0,0
95602,be,0,0
95603,an,0,0
95604,achievable,0,0
95605,goal,0,0
95606,among,0,0
95607,high-functioning,0,1
95608,children,0,1
95609,with,0,1
95610,autism,0,1
95611,.,0,0
95612,Feasibility,0,0
95613,of,0,0
95614,a,0,0
95615,telephone-based,0,0
95616,intervention,0,0
95617,for,0,0
95618,support,0,0
95619,persons,0,1
95620,to,0,0
95621,help,0,0
95622,smokers,1,1
95623,quit,1,0
95624,:,1,1
95625,a,0,0
95626,pilot,0,0
95627,study,0,0
95628,.,0,1
95629,BACKGROUND,0,0
95630,Nonsmokers,0,0
95631,have,0,0
95632,a,0,0
95633,potentially,0,0
95634,supportive,0,0
95635,role,0,0
95636,in,0,0
95637,tobacco,0,1
95638,cessation,0,0
95639,efforts,0,0
95640,.,0,0
95641,The,0,0
95642,present,0,0
95643,study,0,0
95644,examined,0,0
95645,the,0,0
95646,feasibility,0,0
95647,",",0,0
95648,acceptability,0,0
95649,",",0,0
95650,and,0,0
95651,potential,0,0
95652,efficacy,0,0
95653,of,0,0
95654,a,0,0
95655,telephone-based,0,0
95656,intervention,0,0
95657,for,0,0
95658,nonsmoking,1,1
95659,support,1,0
95660,persons,1,1
95661,.,1,1
95662,METHODS,0,0
95663,A,0,0
95664,total,0,1
95665,of,0,0
95666,59,1,1
95667,support,1,0
95668,persons,1,1
95669,(,1,0
95670,mean,1,1
95671,age,1,1
95672,=,1,0
95673,36,1,0
95674,years,1,1
95675,",",1,0
95676,92,1,0
95677,%,1,0
95678,female,1,1
95679,",",1,0
95680,95,1,0
95681,%,1,0
95682,White,1,1
95683,),1,0
95684,were,0,0
95685,randomly,0,0
95686,assigned,0,0
95687,to,0,0
95688,a,0,0
95689,control,0,0
95690,condition,0,0
95691,(,0,0
95692,N,0,1
95693,=,0,0
95694,30,0,1
95695,;,0,0
95696,written,0,0
95697,materials,0,0
95698,only,0,0
95699,),0,0
95700,or,0,0
95701,to,0,0
95702,a,0,0
95703,social,0,0
95704,cognitive,0,0
95705,theory-based,0,0
95706,intervention,0,0
95707,(,0,0
95708,N,0,1
95709,=,0,0
95710,29,0,1
95711,;,0,0
95712,written,0,0
95713,materials,0,0
95714,and,0,0
95715,5,0,0
95716,weekly,0,0
95717,",",0,0
95718,20-,0,1
95719,to,0,0
95720,30-min,0,0
95721,telephone,0,0
95722,counseling,0,0
95723,sessions,0,0
95724,),0,0
95725,.,0,0
95726,Both,0,0
95727,support,1,0
95728,persons,1,1
95729,and,0,0
95730,smokers,1,1
95731,completed,0,1
95732,assessments,0,0
95733,separately,0,0
95734,by,0,0
95735,mail,0,0
95736,at,0,0
95737,baseline,0,0
95738,and,0,0
95739,at,0,0
95740,weeks,0,0
95741,6,0,0
95742,(,0,0
95743,end,0,0
95744,of,0,0
95745,treatment,0,0
95746,),0,0
95747,and,0,0
95748,26,0,0
95749,.,0,0
95750,RESULTS,0,0
95751,Two,0,1
95752,thirds,0,0
95753,of,0,0
95754,the,0,0
95755,smokers,0,1
95756,reported,0,0
95757,low-moderate,0,0
95758,levels,0,0
95759,of,0,0
95760,motivation,0,0
95761,to,0,0
95762,quit,0,0
95763,at,0,0
95764,baseline,0,0
95765,as,0,0
95766,assessed,0,0
95767,by,0,0
95768,the,0,0
95769,contemplation,0,0
95770,ladder,0,0
95771,.,0,0
95772,Study,0,0
95773,retention,0,0
95774,rates,0,0
95775,were,0,0
95776,excellent,0,0
95777,",",0,0
95778,with,0,1
95779,95,0,0
95780,%,0,0
95781,of,0,0
95782,both,0,0
95783,support,0,0
95784,persons,0,1
95785,and,0,0
95786,smokers,0,1
95787,completing,0,0
95788,the,0,0
95789,week,0,0
95790,26,0,0
95791,assessment,0,0
95792,.,0,0
95793,Moreover,0,0
95794,",",0,0
95795,86,0,0
95796,%,0,0
95797,of,0,0
95798,support,0,0
95799,persons,0,1
95800,in,0,0
95801,the,0,0
95802,intervention,0,0
95803,group,0,0
95804,completed,0,0
95805,all,0,0
95806,five,0,0
95807,telephone,0,0
95808,sessions,0,0
95809,.,0,0
95810,Treatment,0,0
95811,acceptability,0,0
95812,was,0,0
95813,high,0,0
95814,for,0,0
95815,both,0,0
95816,support,0,0
95817,persons,0,1
95818,and,0,0
95819,smokers,0,1
95820,.,0,0
95821,Compared,0,0
95822,with,0,0
95823,the,0,0
95824,control,0,0
95825,condition,0,0
95826,",",0,0
95827,the,0,0
95828,intervention,0,0
95829,was,0,0
95830,associated,0,0
95831,with,0,0
95832,a,0,0
95833,significant,0,0
95834,increase,0,0
95835,in,0,0
95836,support,0,0
95837,person,0,0
95838,self-efficacy,0,0
95839,to,0,0
95840,help,0,0
95841,their,0,0
95842,smoker,0,1
95843,(,0,0
95844,p,0,0
95845,=,0,0
95846,.034,0,0
95847,),0,0
95848,and,0,0
95849,outcome,0,0
95850,expectancies,0,0
95851,(,0,0
95852,p,0,0
95853,=,0,0
95854,.025,0,0
95855,),0,0
95856,from,0,0
95857,baseline,0,0
95858,to,0,0
95859,week,0,0
95860,6,0,0
95861,.,0,0
95862,However,0,0
95863,",",0,0
95864,the,0,0
95865,intervention,0,0
95866,was,0,0
95867,not,0,0
95868,associated,0,0
95869,with,0,0
95870,higher,0,0
95871,smoking,0,0
95872,abstinence,0,0
95873,rates,0,0
95874,or,0,0
95875,quit,0,1
95876,attempts,0,0
95877,.,0,0
95878,DISCUSSION,0,0
95879,The,0,0
95880,program,0,0
95881,was,0,0
95882,successful,0,0
95883,in,0,0
95884,reaching,0,0
95885,smokers,0,1
95886,with,0,1
95887,lower,0,0
95888,levels,0,0
95889,of,0,0
95890,readiness,0,0
95891,to,0,0
95892,quit,0,0
95893,.,0,0
95894,The,0,0
95895,intervention,0,0
95896,was,0,0
95897,feasible,0,0
95898,and,0,0
95899,acceptable,0,0
95900,to,0,0
95901,both,0,0
95902,support,0,0
95903,persons,0,1
95904,and,0,0
95905,smokers,0,1
95906,.,0,0
95907,Although,0,0
95908,support,0,0
95909,persons,0,1
95910,and,0,0
95911,smokers,0,1
95912,can,0,0
95913,be,0,0
95914,engaged,0,0
95915,in,0,0
95916,this,0,0
95917,type,0,0
95918,of,0,0
95919,outreach,0,0
95920,program,0,0
95921,",",0,0
95922,refinements,0,0
95923,in,0,0
95924,the,0,0
95925,intervention,0,0
95926,approach,0,0
95927,are,0,0
95928,needed,0,0
95929,to,0,0
95930,improve,0,0
95931,the,0,0
95932,smoking,0,0
95933,outcomes,0,0
95934,.,0,1
95935,Rapid,0,0
95936,efficacy,0,0
95937,of,0,0
95938,the,0,0
95939,highly,0,0
95940,selective,0,0
95941,alpha1A-adrenoceptor,0,0
95942,antagonist,0,0
95943,silodosin,0,0
95944,in,0,0
95945,men,1,1
95946,with,1,1
95947,signs,1,0
95948,and,1,0
95949,symptoms,1,0
95950,of,1,0
95951,benign,1,1
95952,prostatic,1,1
95953,hyperplasia,1,1
95954,:,1,1
95955,pooled,0,0
95956,results,0,0
95957,of,0,0
95958,2,0,0
95959,phase,0,0
95960,3,0,0
95961,studies,0,0
95962,.,0,1
95963,PURPOSE,0,0
95964,We,0,0
95965,evaluated,0,0
95966,the,0,0
95967,efficacy,0,0
95968,and,0,0
95969,safety,0,0
95970,of,0,0
95971,silodosin,0,0
95972,for,0,0
95973,treatment,0,0
95974,of,0,0
95975,benign,0,1
95976,prostatic,0,1
95977,hyperplasia,0,1
95978,symptoms,0,0
95979,in,0,0
95980,2,0,0
95981,randomized,0,0
95982,",",0,0
95983,placebo,0,0
95984,controlled,0,0
95985,",",0,0
95986,phase,0,0
95987,3,0,0
95988,studies,0,0
95989,.,0,1
95990,MATERIALS,0,0
95991,AND,0,0
95992,METHODS,0,0
95993,Men,1,1
95994,50,1,1
95995,years,1,1
95996,or,1,1
95997,older,1,1
95998,with,1,0
95999,an,1,0
96000,International,1,1
96001,Prostate,1,1
96002,Symptom,1,0
96003,Score,1,0
96004,of,1,0
96005,13,1,0
96006,or,1,0
96007,greater,1,0
96008,and,1,0
96009,peak,1,0
96010,urinary,1,0
96011,flow,1,0
96012,rate,1,0
96013,of,1,0
96014,4,1,0
96015,to,1,0
96016,15,1,0
96017,ml,1,0
96018,per,1,0
96019,second,1,0
96020,received,1,0
96021,placebo,1,0
96022,or,1,0
96023,8,1,0
96024,mg,1,0
96025,silodosin,1,0
96026,daily,1,0
96027,with,1,1
96028,breakfast,1,0
96029,for,1,0
96030,12,1,0
96031,weeks,1,0
96032,.,1,0
96033,The,0,0
96034,primary,0,0
96035,end,0,0
96036,point,0,0
96037,was,0,0
96038,International,0,1
96039,Prostate,0,1
96040,Symptom,0,0
96041,Score,0,0
96042,change,0,0
96043,from,0,0
96044,baseline,0,0
96045,to,0,0
96046,last,0,0
96047,observation,0,0
96048,.,0,0
96049,Change,0,0
96050,in,0,0
96051,peak,0,0
96052,urinary,0,0
96053,flow,0,0
96054,rate,0,0
96055,was,0,0
96056,a,0,0
96057,secondary,0,0
96058,end,0,0
96059,point,0,0
96060,.,0,0
96061,Differences,0,0
96062,in,0,0
96063,treatment,0,0
96064,efficacy,0,0
96065,were,0,0
96066,assessed,0,0
96067,by,0,0
96068,ANCOVA,0,0
96069,.,0,0
96070,RESULTS,0,0
96071,Of,0,1
96072,923,1,1
96073,patients,1,1
96074,(,1,0
96075,mean,1,1
96076,age,1,1
96077,65,1,1
96078,years,1,1
96079,),1,1
96080,466,1,1
96081,received,1,0
96082,silodosin,1,0
96083,and,1,0
96084,457,1,1
96085,placebo,1,0
96086,.,1,0
96087,After,0,0
96088,0.5,0,0
96089,week,0,0
96090,(,0,0
96091,range,0,0
96092,3,0,0
96093,to,0,0
96094,4,0,0
96095,days,0,0
96096,),0,0
96097,of,0,0
96098,treatment,0,0
96099,patients,0,1
96100,receiving,0,0
96101,silodosin,0,0
96102,vs,0,0
96103,placebo,0,0
96104,achieved,0,0
96105,significant,0,0
96106,improvement,0,0
96107,in,0,0
96108,total,0,1
96109,International,0,1
96110,Prostate,0,1
96111,Symptom,0,0
96112,Score,0,0
96113,(,0,0
96114,difference,0,0
96115,-1.9,0,0
96116,",",0,0
96117,p,0,0
96118,<,0,0
96119,0.0001,0,0
96120,),0,0
96121,and,0,0
96122,irritative,0,0
96123,(,0,0
96124,-0.5,0,0
96125,",",0,0
96126,p,0,0
96127,=,0,0
96128,0.0002,0,0
96129,),0,0
96130,and,0,0
96131,obstructive,0,1
96132,(,0,0
96133,-1.4,0,0
96134,",",0,0
96135,p,0,0
96136,<,0,0
96137,0.0001,0,0
96138,),0,1
96139,subscores,0,0
96140,.,0,0
96141,The,0,0
96142,mean,0,0
96143,+/-,0,0
96144,SD,0,0
96145,change,0,0
96146,from,0,0
96147,baseline,0,0
96148,in,0,0
96149,total,0,1
96150,International,0,1
96151,Prostate,0,1
96152,Symptom,0,0
96153,Score,0,0
96154,was,0,0
96155,-4.2,0,0
96156,+/-,0,0
96157,5.3,0,0
96158,for,0,0
96159,silodosin,0,0
96160,vs,0,0
96161,-2.3,0,0
96162,+/-,0,0
96163,4.4,0,0
96164,for,0,0
96165,placebo,0,0
96166,.,0,0
96167,Differences,0,0
96168,(,0,0
96169,silodosin,0,0
96170,vs,0,0
96171,placebo,0,0
96172,),0,0
96173,in,0,0
96174,International,0,1
96175,Prostate,0,1
96176,Symptom,0,0
96177,Score,0,0
96178,and,0,0
96179,subscores,0,0
96180,increased,0,0
96181,by,0,0
96182,week,0,0
96183,12,0,0
96184,(,0,0
96185,p,0,0
96186,<,0,0
96187,0.0001,0,0
96188,),0,0
96189,.,0,0
96190,Mean,0,0
96191,change,0,0
96192,from,0,0
96193,baseline,0,0
96194,in,0,0
96195,peak,0,0
96196,urinary,0,0
96197,flow,0,0
96198,rate,0,0
96199,(,0,0
96200,ml,0,0
96201,per,0,0
96202,second,0,0
96203,),0,0
96204,2,0,0
96205,to,0,0
96206,6,0,0
96207,hours,0,0
96208,after,0,0
96209,initial,0,0
96210,dose,0,0
96211,was,0,0
96212,greater,0,0
96213,(,0,0
96214,p,0,0
96215,<,0,0
96216,0.0001,0,0
96217,),0,0
96218,with,0,0
96219,silodosin,0,0
96220,(,0,0
96221,2.8,0,0
96222,+/-,0,0
96223,3.4,0,0
96224,),0,0
96225,than,0,0
96226,placebo,0,0
96227,(,0,0
96228,1.5,0,0
96229,+/-,0,0
96230,3.8,0,0
96231,),0,0
96232,.,0,0
96233,Differences,0,0
96234,remained,0,0
96235,significant,0,0
96236,(,0,0
96237,p,0,0
96238,<,0,0
96239,0.001,0,0
96240,),0,0
96241,through,0,0
96242,week,0,0
96243,12,0,0
96244,.,0,0
96245,The,0,0
96246,most,0,0
96247,common,0,0
96248,treatment,0,0
96249,emergent,0,1
96250,adverse,0,0
96251,event,0,0
96252,was,0,0
96253,(,0,0
96254,mostly,0,0
96255,mild,0,1
96256,),0,0
96257,retrograde,0,0
96258,ejaculation,0,0
96259,(,0,0
96260,silodosin,0,0
96261,28.1,0,0
96262,%,0,0
96263,of,0,0
96264,patients,0,1
96265,",",0,0
96266,placebo,0,0
96267,0.9,0,0
96268,%,0,0
96269,),0,0
96270,.,0,0
96271,Few,0,0
96272,patients,0,1
96273,receiving,0,1
96274,silodosin,0,0
96275,(,0,0
96276,2.8,0,0
96277,%,0,0
96278,),0,0
96279,discontinued,0,0
96280,because,0,0
96281,of,0,0
96282,retrograde,0,1
96283,ejaculation,0,1
96284,.,0,0
96285,Proportions,0,0
96286,of,0,0
96287,patients,0,1
96288,with,0,1
96289,treatment,0,0
96290,emergent,0,1
96291,orthostatic,0,0
96292,hypotension,0,0
96293,were,0,0
96294,similar,0,0
96295,for,0,0
96296,silodosin,0,0
96297,(,0,0
96298,2.6,0,0
96299,%,0,0
96300,),0,0
96301,and,0,0
96302,placebo,0,0
96303,(,0,0
96304,1.5,0,0
96305,%,0,0
96306,),0,0
96307,.,0,0
96308,CONCLUSIONS,0,0
96309,Treatment,0,0
96310,with,0,1
96311,silodosin,0,0
96312,produced,0,0
96313,rapid,0,0
96314,improvement,0,0
96315,in,0,0
96316,urinary,0,0
96317,symptoms,0,0
96318,that,0,0
96319,was,0,0
96320,sustained,0,0
96321,for,0,0
96322,12,0,0
96323,weeks,0,0
96324,.,0,1
96325,Silodosin,0,0
96326,was,0,0
96327,well,0,0
96328,tolerated,0,0
96329,with,0,0
96330,a,0,0
96331,low,0,0
96332,incidence,0,0
96333,of,0,0
96334,orthostatic,0,0
96335,hypotension,0,0
96336,.,0,0
96337,The,0,0
96338,influence,0,0
96339,of,0,0
96340,dietary,0,0
96341,fibre,0,0
96342,source,0,0
96343,and,0,0
96344,gender,0,0
96345,on,0,0
96346,the,0,0
96347,postprandial,0,0
96348,glucose,0,0
96349,and,0,0
96350,lipid,0,0
96351,response,0,0
96352,in,0,0
96353,healthy,1,1
96354,subjects,1,1
96355,.,1,1
96356,BACKGROUND,0,0
96357,Consumption,0,0
96358,of,0,0
96359,soluble,0,0
96360,dietary,0,0
96361,fibre,0,0
96362,is,0,0
96363,correlated,0,0
96364,with,0,0
96365,decreased,0,0
96366,postprandial,0,0
96367,glucose,0,0
96368,and,0,0
96369,insulin,0,0
96370,responses,0,0
96371,and,0,0
96372,hence,0,0
96373,has,0,0
96374,beneficial,0,0
96375,effects,0,0
96376,on,0,0
96377,the,0,0
96378,metabolic,0,0
96379,syndrome,0,1
96380,.,0,0
96381,AIM,0,0
96382,OF,0,0
96383,THE,0,0
96384,STUDY,0,0
96385,To,0,0
96386,investigate,0,0
96387,the,0,0
96388,effects,0,0
96389,on,0,0
96390,postprandial,0,0
96391,glucose,0,0
96392,",",0,0
96393,insulin,0,0
96394,and,0,0
96395,triglyceride,0,0
96396,concentrations,0,0
96397,of,0,0
96398,meals,0,0
96399,enriched,0,0
96400,with,0,1
96401,soluble,0,0
96402,dietary,0,0
96403,fibres,0,0
96404,from,0,1
96405,oats,0,1
96406,",",0,0
96407,rye,0,0
96408,bran,0,0
96409,",",0,0
96410,sugar,0,0
96411,beet,0,0
96412,fibre,0,0
96413,or,0,0
96414,a,0,0
96415,mixture,0,0
96416,of,0,0
96417,these,0,0
96418,three,0,0
96419,fibres,0,0
96420,.,0,1
96421,METHODS,0,0
96422,Thirteen,1,1
96423,healthy,1,1
96424,human,1,0
96425,volunteers,1,1
96426,(,1,1
96427,6,1,0
96428,men,1,1
96429,and,1,0
96430,7,1,0
96431,women,1,1
96432,",",1,0
96433,aged,1,1
96434,20-28,1,0
96435,years,1,1
96436,),1,0
96437,were,0,0
96438,included,0,0
96439,in,0,0
96440,the,0,0
96441,study,0,0
96442,.,0,0
96443,The,0,0
96444,subjects,0,1
96445,came,0,1
96446,to,0,0
96447,the,0,0
96448,study,0,0
96449,centre,0,0
96450,once,0,0
96451,a,0,0
96452,week,0,0
96453,after,0,0
96454,an,0,0
96455,overnight,0,0
96456,fast,0,0
96457,to,0,0
96458,ingest,0,0
96459,test,0,0
96460,meals,0,0
96461,and,0,0
96462,a,0,0
96463,control,0,0
96464,meal,0,0
96465,in,0,0
96466,random,0,0
96467,order,0,0
96468,.,0,0
96469,The,0,0
96470,meals,0,0
96471,contained,0,0
96472,either,0,0
96473,oat,0,0
96474,powder,0,0
96475,(,0,0
96476,62,0,0
96477,g,0,0
96478,",",0,0
96479,of,0,0
96480,which,0,0
96481,2.7,0,0
96482,soluble,0,0
96483,fibre,0,0
96484,),0,0
96485,",",0,0
96486,rye,0,0
96487,bran,0,0
96488,(,0,0
96489,31,0,1
96490,g,0,0
96491,",",0,0
96492,of,0,0
96493,which,0,0
96494,1.7,0,0
96495,g,0,0
96496,soluble,0,0
96497,fibre,0,0
96498,),0,0
96499,",",0,0
96500,sugar,0,0
96501,beet,0,0
96502,fibre,0,0
96503,(,0,0
96504,19,0,1
96505,g,0,0
96506,",",0,0
96507,of,0,0
96508,which,0,0
96509,5,0,0
96510,g,0,0
96511,soluble,0,0
96512,fibre,0,0
96513,),0,0
96514,",",0,0
96515,a,0,0
96516,mixture,0,0
96517,of,0,0
96518,these,0,0
96519,three,0,0
96520,fibres,0,0
96521,(,0,0
96522,74,0,1
96523,g,0,0
96524,",",0,0
96525,of,0,0
96526,which,0,0
96527,1.7,0,0
96528,g,0,0
96529,soluble,0,0
96530,fibre,0,0
96531,from,0,0
96532,each,0,0
96533,source,0,0
96534,",",0,0
96535,giving,0,0
96536,5,0,0
96537,g,0,0
96538,soluble,0,0
96539,fibre,0,0
96540,),0,0
96541,or,0,0
96542,no,0,0
96543,added,0,0
96544,fibre,0,0
96545,(,0,0
96546,control,0,0
96547,),0,0
96548,and,0,0
96549,were,0,0
96550,all,0,0
96551,adjusted,0,0
96552,to,0,0
96553,contain,0,0
96554,the,0,0
96555,same,0,0
96556,total,0,1
96557,amount,0,0
96558,of,0,0
96559,available,0,0
96560,carbohydrates,0,0
96561,.,0,1
96562,Blood,0,0
96563,samples,0,0
96564,were,0,0
96565,drawn,0,0
96566,before,0,0
96567,and,0,0
96568,every,0,0
96569,30,0,0
96570,min,0,0
96571,up,0,0
96572,to,0,0
96573,180,0,0
96574,min,0,0
96575,after,0,0
96576,the,0,0
96577,meals,0,0
96578,.,0,0
96579,RESULTS,0,0
96580,Meals,0,0
96581,with,0,1
96582,rye,0,0
96583,bran,0,0
96584,gave,0,0
96585,a,0,0
96586,lower,0,0
96587,postprandial,0,0
96588,glucose,0,0
96589,peak,0,0
96590,when,0,0
96591,compared,0,0
96592,with,0,0
96593,the,0,0
96594,control,0,0
96595,meal,0,0
96596,",",0,0
96597,and,0,0
96598,this,0,0
96599,effect,0,0
96600,was,0,0
96601,more,0,0
96602,pronounced,0,0
96603,in,0,0
96604,women,0,1
96605,compared,0,0
96606,to,0,0
96607,men,0,1
96608,.,0,0
96609,Oat,0,0
96610,powder,0,0
96611,",",0,0
96612,containing,0,0
96613,a,0,0
96614,low,0,0
96615,amount,0,0
96616,of,0,0
96617,total,0,1
96618,fibre,0,0
96619,and,0,0
96620,a,0,0
96621,high,0,0
96622,amount,0,0
96623,of,0,0
96624,carbohydrates,0,0
96625,in,0,0
96626,liquid,0,0
96627,matrix,0,0
96628,",",0,0
96629,gave,0,0
96630,a,0,0
96631,higher,0,0
96632,incremental,0,0
96633,glucose,0,0
96634,peak,0,0
96635,concentration,0,0
96636,compared,0,0
96637,to,0,0
96638,rye,0,0
96639,bran,0,0
96640,and,0,0
96641,sugar,0,0
96642,beet,0,0
96643,fibre,0,0
96644,and,0,0
96645,higher,0,0
96646,insulin,0,0
96647,incremental,0,0
96648,area,0,0
96649,under,0,0
96650,curve,0,0
96651,compared,0,0
96652,to,0,0
96653,control,0,0
96654,.,0,0
96655,The,0,0
96656,oat,0,0
96657,powder,0,0
96658,also,0,0
96659,influenced,0,0
96660,the,0,0
96661,effects,0,0
96662,of,0,0
96663,the,0,0
96664,mixed,0,0
96665,meal,0,0
96666,",",0,0
96667,diminishing,0,0
96668,the,0,0
96669,glucose-lowering,0,0
96670,effects,0,0
96671,.,0,1
96672,Postprandial,0,0
96673,triglyceride,0,0
96674,levels,0,0
96675,tended,0,0
96676,to,0,0
96677,be,0,0
96678,higher,0,0
96679,after,0,0
96680,all,0,0
96681,fibre-rich,0,0
96682,meals,0,0
96683,",",0,0
96684,but,0,0
96685,only,0,0
96686,significant,0,0
96687,for,0,0
96688,oat,0,1
96689,powder,0,0
96690,and,0,0
96691,the,0,0
96692,mixed,0,0
96693,meal,0,0
96694,when,0,0
96695,compared,0,0
96696,with,0,0
96697,the,0,0
96698,control,0,0
96699,meal,0,0
96700,.,0,0
96701,CONCLUSIONS,0,0
96702,Postprandial,0,0
96703,glucose,0,0
96704,",",0,0
96705,insulin,0,0
96706,and,0,0
96707,triglyceride,0,0
96708,concentrations,0,0
96709,are,0,0
96710,influenced,0,0
96711,by,0,0
96712,dietary,0,0
96713,fibre-rich,0,0
96714,meals,0,0
96715,",",0,0
96716,depending,0,0
96717,on,0,0
96718,fibre,0,0
96719,source,0,0
96720,",",0,0
96721,dose,0,0
96722,of,0,0
96723,soluble,0,0
96724,and,0,0
96725,total,0,1
96726,fibre,0,0
96727,and,0,0
96728,possibly,0,0
96729,gender,0,0
96730,.,0,0
96731,Randomized,0,0
96732,clinical,0,0
96733,trial,0,0
96734,of,0,0
96735,balance-based,0,0
96736,torso,0,0
96737,weighting,0,0
96738,for,0,0
96739,improving,0,0
96740,upright,0,0
96741,mobility,0,0
96742,in,0,0
96743,people,1,1
96744,with,1,1
96745,multiple,1,0
96746,sclerosis,1,1
96747,.,1,0
96748,BACKGROUND,0,0
96749,Torso,0,0
96750,weighting,0,0
96751,has,0,0
96752,sometimes,0,0
96753,been,0,0
96754,effective,0,0
96755,for,0,0
96756,improving,0,0
96757,upright,0,0
96758,mobility,0,0
96759,in,0,0
96760,people,1,1
96761,with,1,1
96762,multiple,1,0
96763,sclerosis,1,1
96764,",",0,0
96765,but,0,0
96766,parameters,0,0
96767,for,0,0
96768,weighting,0,0
96769,have,0,0
96770,been,0,0
96771,inconsistent,0,0
96772,.,0,0
96773,OBJECTIVE,0,0
96774,To,0,0
96775,determine,0,0
96776,whether,0,0
96777,balance-based,0,0
96778,torso,0,0
96779,weighting,0,0
96780,(,0,0
96781,BBTW,0,0
96782,),0,0
96783,has,0,0
96784,immediate,0,0
96785,effects,0,0
96786,on,0,0
96787,upright,0,0
96788,mobility,0,0
96789,in,0,0
96790,people,0,1
96791,with,0,1
96792,multiple,1,0
96793,sclerosis,1,1
96794,.,1,0
96795,METHODS,0,0
96796,This,0,0
96797,was,0,0
96798,a,0,0
96799,2-phase,0,0
96800,randomized,0,0
96801,clinical,0,0
96802,trial,0,0
96803,.,0,0
96804,In,1,0
96805,phase,1,0
96806,1,1,0
96807,",",1,0
96808,36,1,1
96809,participants,1,1
96810,were,1,0
96811,randomly,1,1
96812,assigned,1,0
96813,to,1,0
96814,experimental,1,0
96815,and,1,0
96816,control,1,0
96817,groups,1,0
96818,.,1,0
96819,In,0,0
96820,phase,1,0
96821,2,1,0
96822,",",1,0
96823,the,1,0
96824,control,1,0
96825,group,1,0
96826,was,0,0
96827,subsequently,0,0
96828,randomized,0,0
96829,into,0,0
96830,2,0,0
96831,groups,0,0
96832,with,0,1
96833,alternate,0,0
96834,weight-placement,0,0
96835,.,0,0
96836,Tests,0,0
96837,of,0,0
96838,upright,0,0
96839,mobility,0,0
96840,included,0,1
96841,:,0,0
96842,timed,0,0
96843,up,0,0
96844,and,0,0
96845,go,0,0
96846,(,0,0
96847,TUG,0,0
96848,),0,0
96849,",",0,0
96850,sharpened,0,0
96851,Romberg,0,0
96852,",",0,0
96853,360-degree,0,0
96854,turns,0,0
96855,",",0,0
96856,25-foot,0,0
96857,walk,0,0
96858,",",0,0
96859,and,0,0
96860,computerized,0,0
96861,platform,0,0
96862,posturography,0,0
96863,.,0,0
96864,Participants,0,1
96865,were,0,0
96866,tested,0,0
96867,at,0,0
96868,baseline,0,0
96869,and,0,0
96870,again,0,0
96871,with,0,1
96872,weights,0,0
96873,placed,0,0
96874,according,0,1
96875,to,0,0
96876,group,0,0
96877,membership,0,0
96878,.,0,0
96879,In,0,0
96880,both,0,0
96881,phases,0,0
96882,",",0,0
96883,a,0,0
96884,physical,0,0
96885,therapist,0,0
96886,assessed,0,0
96887,balance,0,0
96888,for,0,0
96889,the,0,0
96890,BBTW,0,0
96891,group,0,0
96892,and,0,0
96893,then,0,0
96894,placed,0,0
96895,weights,0,0
96896,to,0,0
96897,decrease,0,0
96898,balance,0,0
96899,loss,0,0
96900,.,0,0
96901,In,0,0
96902,phase,0,0
96903,1,0,0
96904,",",0,0
96905,the,0,0
96906,control,0,0
96907,group,0,0
96908,had,0,0
96909,no,0,0
96910,weights,0,0
96911,placed,0,0
96912,.,0,0
96913,In,0,0
96914,phase,0,0
96915,2,0,0
96916,",",0,0
96917,the,0,0
96918,alternate,0,0
96919,treatment,0,0
96920,group,0,0
96921,received,0,0
96922,standard,0,0
96923,weight,0,0
96924,placement,0,0
96925,of,0,0
96926,1.5,0,0
96927,%,0,0
96928,body,0,0
96929,weight,0,0
96930,.,0,0
96931,RESULTS,0,0
96932,People,0,0
96933,with,0,1
96934,BBTW,0,0
96935,showed,0,0
96936,a,0,0
96937,significant,0,0
96938,improvement,0,0
96939,in,0,0
96940,the,0,0
96941,25-foot,0,0
96942,walk,0,0
96943,(,0,0
96944,P,0,0
96945,=,0,0
96946,.01,0,0
96947,),0,0
96948,over,0,0
96949,those,0,0
96950,with,0,0
96951,no,0,0
96952,weight,0,0
96953,",",0,0
96954,and,0,0
96955,the,0,0
96956,TUG,0,0
96957,(,0,0
96958,P,0,0
96959,=,0,0
96960,.01,0,0
96961,),0,0
96962,over,0,0
96963,those,0,0
96964,with,0,0
96965,standard,0,0
96966,weight,0,0
96967,placement,0,0
96968,.,0,0
96969,BBTW,0,0
96970,participants,0,1
96971,received,0,0
96972,an,0,0
96973,average,0,0
96974,of,0,0
96975,0.5,0,0
96976,kg,0,0
96977,",",0,0
96978,less,0,0
96979,than,0,0
96980,1.5,0,0
96981,%,0,0
96982,of,0,0
96983,any,0,0
96984,participant,0,0
96985,'s,0,0
96986,body,0,0
96987,weight,0,1
96988,.,0,0
96989,CONCLUSION,0,0
96990,BBTW,0,0
96991,can,0,0
96992,have,0,0
96993,immediate,0,0
96994,advantages,0,0
96995,over,0,0
96996,a,0,0
96997,nonweighted,0,0
96998,condition,0,0
96999,for,0,0
97000,gait,0,0
97001,velocity,0,0
97002,and,0,0
97003,over,0,0
97004,a,0,0
97005,standardized,0,0
97006,weighted,0,0
97007,condition,0,0
97008,for,0,0
97009,a,0,0
97010,functional,0,0
97011,activity,0,0
97012,in,0,0
97013,people,1,1
97014,with,1,1
97015,multiple,1,0
97016,sclerosis,1,1
97017,(,1,0
97018,MS,1,1
97019,),1,1
97020,who,0,1
97021,are,0,0
97022,ambulatory,0,1
97023,but,0,0
97024,have,0,0
97025,balance,0,0
97026,and,0,0
97027,mobility,0,0
97028,abnormalities,0,0
97029,.,0,1
97030,Transdermal,0,0
97031,scopolamine,0,0
97032,patch,0,0
97033,in,0,0
97034,addition,0,0
97035,to,0,0
97036,ondansetron,0,0
97037,for,0,0
97038,postoperative,0,0
97039,nausea,0,0
97040,and,0,0
97041,vomiting,0,0
97042,prophylaxis,0,0
97043,in,0,0
97044,patients,1,1
97045,undergoing,1,1
97046,ambulatory,1,1
97047,cosmetic,1,0
97048,surgery,1,1
97049,.,1,0
97050,STUDY,0,0
97051,OBJECTIVE,0,0
97052,To,0,0
97053,determine,0,0
97054,the,0,0
97055,efficacy,0,0
97056,of,0,0
97057,transdermal,0,0
97058,scopolamine,0,0
97059,in,0,0
97060,addition,0,0
97061,to,0,0
97062,ondansetron,0,0
97063,in,0,0
97064,decreasing,0,0
97065,the,0,0
97066,incidence,0,0
97067,of,0,0
97068,postoperative,1,0
97069,nausea,1,0
97070,and,1,0
97071,vomiting,1,0
97072,(,1,0
97073,PONV,1,0
97074,),1,0
97075,.,1,0
97076,DESIGN,0,0
97077,Randomized,0,0
97078,controlled,0,0
97079,trial,0,0
97080,.,0,0
97081,SETTING,0,0
97082,Academic,1,1
97083,hospital,1,0
97084,.,1,0
97085,PATIENTS,0,0
97086,126,1,1
97087,ASA,1,0
97088,physical,1,0
97089,status,1,0
97090,I,1,0
97091,and,1,0
97092,II,1,0
97093,patients,1,1
97094,undergoing,1,1
97095,outpatient,1,1
97096,plastic,1,0
97097,surgery,1,1
97098,with,1,1
97099,three,1,0
97100,or,1,0
97101,more,1,0
97102,risk,1,0
97103,factors,1,0
97104,for,1,0
97105,PONV,1,0
97106,.,1,1
97107,INTERVENTIONS,0,0
97108,Patients,0,1
97109,were,0,1
97110,randomly,0,1
97111,assigned,0,0
97112,to,0,0
97113,one,0,0
97114,of,0,0
97115,two,0,0
97116,groups,0,0
97117,to,0,0
97118,receive,0,0
97119,(,0,0
97120,Group,0,0
97121,1,0,0
97122,),0,0
97123,a,0,0
97124,transdermal,0,0
97125,scopolamine,0,0
97126,(,0,0
97127,TDS,0,0
97128,),0,0
97129,patch,0,0
97130,or,0,0
97131,(,0,0
97132,Group,0,1
97133,2,0,0
97134,),0,0
97135,",",0,0
97136,a,0,0
97137,placebo,0,0
97138,patch,0,0
97139,two,0,0
97140,hours,0,0
97141,before,0,0
97142,surgery,0,1
97143,.,0,0
97144,MEASUREMENTS,0,0
97145,Occurrence,0,0
97146,of,0,0
97147,vomiting,0,0
97148,",",0,0
97149,severity,0,0
97150,of,0,0
97151,nausea,0,0
97152,using,0,0
97153,a,0,0
97154,visual,0,0
97155,analog,0,0
97156,scale,0,0
97157,(,0,0
97158,VAS,0,0
97159,),0,0
97160,",",0,0
97161,rescue,0,0
97162,medication,0,0
97163,",",0,0
97164,pain,0,0
97165,intensity,0,0
97166,and,0,0
97167,pain,0,0
97168,medications,0,0
97169,",",0,0
97170,and,0,0
97171,side,0,0
97172,effects,0,0
97173,were,0,0
97174,recorded,0,0
97175,every,0,0
97176,hour,0,0
97177,until,0,0
97178,discharge,0,0
97179,from,0,0
97180,hospital,0,0
97181,",",0,0
97182,then,0,0
97183,every,0,0
97184,4,0,0
97185,hours,0,0
97186,thereafter,0,0
97187,for,0,0
97188,a,0,0
97189,total,0,1
97190,of,0,0
97191,24,0,0
97192,hours,0,0
97193,.,0,1
97194,MAIN,0,0
97195,RESULTS,0,0
97196,A,0,0
97197,statistically,0,0
97198,significant,0,0
97199,reduction,0,0
97200,in,0,0
97201,postoperative,0,0
97202,nausea,0,0
97203,between,0,0
97204,8,0,0
97205,and,0,0
97206,24,0,0
97207,hours,0,0
97208,in,0,0
97209,patients,0,1
97210,receiving,0,1
97211,TDS,0,1
97212,was,0,0
97213,noted,0,0
97214,.,0,0
97215,CONCLUSIONS,0,0
97216,Transdermal,0,0
97217,scopolamine,0,0
97218,in,0,0
97219,addition,0,0
97220,to,0,0
97221,ondansetron,0,0
97222,benefits,0,0
97223,patients,1,1
97224,at,1,0
97225,high,1,0
97226,risk,1,0
97227,for,1,0
97228,PONV,1,0
97229,undergoing,1,1
97230,outpatient,1,1
97231,plastic,1,0
97232,surgery,1,1
97233,for,0,0
97234,up,0,0
97235,to,0,0
97236,20,0,1
97237,hours,0,0
97238,after,0,0
97239,surgery,0,1
97240,.,0,0
97241,Folic,0,0
97242,acid-based,0,0
97243,intervention,0,0
97244,in,0,0
97245,non-ST,1,0
97246,elevation,1,0
97247,acute,1,1
97248,coronary,1,1
97249,syndromes,1,1
97250,.,1,0
97251,Homocysteinemia,0,0
97252,is,0,0
97253,a,0,0
97254,risk,0,0
97255,factor,0,0
97256,for,0,0
97257,cardiovascular,0,1
97258,diseases,0,1
97259,.,0,1
97260,Folic,0,0
97261,acid,0,0
97262,combined,0,0
97263,with,0,1
97264,vitamins,0,0
97265,B,0,1
97266,(,0,0
97267,6,0,0
97268,),0,0
97269,and,0,0
97270,B,0,0
97271,(,0,0
97272,12,0,0
97273,),0,0
97274,is,0,0
97275,effective,0,0
97276,in,0,0
97277,lowering,0,0
97278,homocysteine,0,0
97279,levels,0,0
97280,.,0,0
97281,This,0,0
97282,randomized,0,0
97283,placebo-controlled,0,0
97284,study,0,0
97285,was,0,0
97286,designed,0,0
97287,to,0,0
97288,determine,0,0
97289,the,0,0
97290,effect,0,0
97291,of,0,0
97292,a,0,0
97293,folic,0,0
97294,acid-based,0,0
97295,supplement,0,0
97296,on,0,0
97297,secondary,0,0
97298,prevention,0,0
97299,of,0,0
97300,clinical,0,0
97301,events,0,0
97302,in,0,0
97303,non-ST-segment,1,1
97304,elevation,1,0
97305,acute,1,1
97306,coronary,1,1
97307,syndromes,1,0
97308,.,1,0
97309,The,0,0
97310,study,0,0
97311,comprised,0,1
97312,240,1,0
97313,patients,1,1
97314,with,1,1
97315,either,1,0
97316,unstable,1,0
97317,angina,1,1
97318,or,1,0
97319,non-ST-elevation,1,0
97320,myocardial,1,1
97321,infarction,1,1
97322,in,1,0
97323,the,1,0
97324,previous,1,0
97325,2,1,1
97326,weeks,1,1
97327,who,0,1
97328,were,0,1
97329,randomized,0,1
97330,to,0,0
97331,a,0,0
97332,folate,0,0
97333,group,0,0
97334,(,0,0
97335,n,0,1
97336,=116,0,1
97337,),0,0
97338,or,0,0
97339,a,0,0
97340,placebo,0,0
97341,group,0,0
97342,(,0,0
97343,n,0,1
97344,=124,0,1
97345,),0,0
97346,.,0,0
97347,The,0,0
97348,folate,0,0
97349,group,0,0
97350,received,0,0
97351,1,0,0
97352,mg,0,0
97353,folic,0,0
97354,acid,0,0
97355,",",0,0
97356,400,0,0
97357,microg,0,0
97358,vitamin,0,0
97359,B,0,0
97360,(,0,0
97361,12,0,0
97362,),0,0
97363,",",0,0
97364,and,0,0
97365,10,0,0
97366,mg,0,0
97367,vitamin,0,0
97368,B,0,0
97369,(,0,0
97370,6,0,0
97371,),0,0
97372,daily,0,0
97373,.,0,0
97374,Clinical,0,0
97375,outcomes,0,0
97376,within,0,1
97377,6,0,0
97378,months,0,0
97379,were,0,0
97380,assessed,0,0
97381,.,0,0
97382,The,0,0
97383,composite,0,0
97384,endpoint,0,0
97385,of,0,0
97386,death,0,0
97387,",",0,0
97388,nonfatal,0,0
97389,acute,0,1
97390,coronary,0,1
97391,syndrome,0,1
97392,",",0,0
97393,and,0,0
97394,serious,0,0
97395,re-hospitalization,0,0
97396,was,0,0
97397,significantly,0,0
97398,higher,0,0
97399,in,0,0
97400,the,0,0
97401,folate,0,0
97402,group,0,0
97403,;,0,0
97404,serious,0,0
97405,re-hospitalization,0,0
97406,alone,0,0
97407,was,0,0
97408,significantly,0,0
97409,higher,0,0
97410,in,0,0
97411,this,0,0
97412,group,0,0
97413,.,0,0
97414,Advanced,0,0
97415,age,0,1
97416,and,0,0
97417,diabetes,0,1
97418,increased,0,0
97419,susceptibility,0,0
97420,to,0,0
97421,the,0,0
97422,composite,0,0
97423,outcome,0,0
97424,.,0,0
97425,Folic,0,0
97426,acid-based,0,0
97427,supplementation,0,0
97428,is,0,0
97429,not,0,0
97430,beneficial,0,0
97431,and,0,0
97432,may,0,0
97433,even,0,0
97434,be,0,0
97435,harmful,0,0
97436,in,0,0
97437,the,0,0
97438,secondary,0,0
97439,prevention,0,0
97440,of,0,0
97441,cardiovascular,0,1
97442,events,0,0
97443,in,0,0
97444,patients,0,1
97445,with,0,1
97446,unstable,0,1
97447,angina,0,1
97448,and,0,0
97449,non-ST-elevation,0,0
97450,myocardial,0,1
97451,infarction,0,1
97452,.,0,0
97453,Further,0,0
97454,studies,0,0
97455,on,0,0
97456,the,0,0
97457,safety,0,0
97458,of,0,0
97459,such,0,0
97460,supplements,0,0
97461,are,0,0
97462,suggested,0,0
97463,.,0,0
97464,Controlled,0,0
97465,Clinical,0,0
97466,Trials,0,0
97467,Registry,0,1
97468,no,0,0
97469,.,0,0
97470,ISRCTN30249553,0,0
97471,.,0,0
97472,Aerobic,0,1
97473,and,0,0
97474,strength,0,0
97475,training,0,0
97476,reduces,0,0
97477,adiposity,0,0
97478,in,0,0
97479,overweight,1,1
97480,Latina,1,1
97481,adolescents,1,1
97482,.,1,1
97483,PURPOSE,0,0
97484,To,0,0
97485,date,0,0
97486,",",0,0
97487,no,0,0
97488,study,0,0
97489,has,0,0
97490,examined,0,0
97491,the,0,0
97492,synergistic,0,0
97493,effects,0,0
97494,of,0,0
97495,a,0,0
97496,nutrition,0,0
97497,and,0,0
97498,combination,0,0
97499,of,0,0
97500,aerobic,0,0
97501,and,0,0
97502,strength,0,0
97503,training,0,0
97504,(,0,0
97505,CAST,0,0
97506,),0,0
97507,on,0,0
97508,both,0,0
97509,adiposity,0,0
97510,and,0,0
97511,metabolic,0,0
97512,parameters,0,0
97513,in,0,0
97514,overweight,1,1
97515,Latina,1,1
97516,adolescent,1,1
97517,females,1,1
97518,.,1,0
97519,The,0,0
97520,goal,0,0
97521,was,0,0
97522,to,0,0
97523,assess,0,0
97524,if,0,0
97525,a,0,0
97526,16-wk,0,0
97527,nutrition,0,0
97528,plus,0,0
97529,CAST,0,0
97530,pilot,0,0
97531,study,0,0
97532,had,0,0
97533,stronger,0,0
97534,effects,0,0
97535,on,0,0
97536,reducing,0,0
97537,adiposity,0,0
97538,and,0,0
97539,on,0,0
97540,improving,0,0
97541,glucose/insulin,0,0
97542,indices,0,0
97543,compared,0,0
97544,with,0,1
97545,control,0,0
97546,(,0,0
97547,C,0,0
97548,),0,0
97549,",",0,0
97550,nutrition,0,0
97551,only,0,0
97552,(,0,0
97553,N,0,1
97554,),0,0
97555,",",0,0
97556,and,0,0
97557,a,0,0
97558,nutrition,0,0
97559,plus,0,0
97560,strength,0,0
97561,training,0,0
97562,(,0,0
97563,N,0,1
97564,+,0,0
97565,ST,0,1
97566,),0,0
97567,groups,0,0
97568,.,0,0
97569,METHODS,0,0
97570,In,0,0
97571,a,0,0
97572,16-wk,0,0
97573,randomized,0,0
97574,trial,0,0
97575,",",0,0
97576,41,1,1
97577,overweight,1,1
97578,Latina,1,1
97579,girls,1,1
97580,(,1,0
97581,15.2,1,0
97582,+/-,1,0
97583,1.1,1,0
97584,yr,1,1
97585,),1,0
97586,were,0,0
97587,randomly,0,0
97588,assigned,0,0
97589,to,0,0
97590,C,0,0
97591,(,0,0
97592,n,0,1
97593,=,0,0
97594,7,0,0
97595,),0,0
97596,",",0,0
97597,N,0,1
97598,(,0,0
97599,n,0,1
97600,=,0,0
97601,10,0,1
97602,),0,0
97603,",",0,0
97604,N,0,1
97605,+,0,0
97606,ST,0,1
97607,(,0,0
97608,n,0,1
97609,=,0,0
97610,9,0,0
97611,),0,0
97612,",",0,0
97613,or,0,0
97614,N,0,1
97615,+,0,0
97616,CAST,0,0
97617,(,0,0
97618,n,0,1
97619,=,0,0
97620,15,0,1
97621,),0,0
97622,.,0,0
97623,All,0,0
97624,intervention,0,0
97625,groups,0,0
97626,received,0,0
97627,modified,0,0
97628,carbohydrate,0,0
97629,nutrition,0,1
97630,classes,0,1
97631,(,0,0
97632,once,0,0
97633,a,0,0
97634,week,0,0
97635,),0,0
97636,",",0,0
97637,whereas,0,0
97638,the,0,0
97639,N,0,1
97640,+,0,0
97641,ST,0,1
97642,also,0,0
97643,received,0,0
97644,strength,0,0
97645,training,0,0
97646,(,0,0
97647,twice,0,0
97648,a,0,0
97649,week,0,0
97650,),0,0
97651,and,0,0
97652,the,0,0
97653,N,0,1
97654,+,0,0
97655,CAST,0,0
97656,received,0,0
97657,a,0,0
97658,combination,0,0
97659,of,0,0
97660,strength,0,0
97661,and,0,0
97662,aerobic,0,0
97663,training,0,0
97664,(,0,0
97665,twice,0,0
97666,a,0,0
97667,week,0,0
97668,),0,0
97669,.,0,0
97670,The,0,0
97671,following,0,0
97672,were,0,0
97673,measured,0,0
97674,before,0,0
97675,and,0,0
97676,after,0,0
97677,intervention,0,0
97678,:,0,1
97679,strength,0,0
97680,by,0,0
97681,one,0,0
97682,repetition,0,0
97683,maximum,0,0
97684,",",0,0
97685,physical,0,0
97686,activity,0,0
97687,by,0,0
97688,the,0,0
97689,7-d,0,0
97690,accelerometry,0,0
97691,and,0,0
97692,the,0,0
97693,3-d,0,0
97694,physical,0,0
97695,activity,0,0
97696,recall,0,0
97697,",",0,0
97698,dietary,0,0
97699,intake,0,0
97700,by,0,0
97701,3-d,0,0
97702,records,0,0
97703,",",0,0
97704,body,0,0
97705,composition,0,0
97706,by,0,0
97707,dual-energy,0,0
97708,x-ray,0,0
97709,absorptiometry,0,1
97710,(,0,0
97711,DEXA,0,0
97712,),0,0
97713,",",0,0
97714,glucose/insulin,0,0
97715,indices,0,0
97716,by,0,0
97717,oral,0,0
97718,glucose,0,0
97719,tolerance,0,0
97720,test,0,0
97721,",",0,0
97722,and,0,0
97723,intravenous,0,0
97724,glucose,0,0
97725,tolerance,0,0
97726,test,0,0
97727,with,0,1
97728,minimal,0,0
97729,modeling,0,0
97730,.,0,0
97731,Across,0,0
97732,intervention,0,0
97733,group,0,0
97734,",",0,0
97735,effects,0,0
97736,were,0,0
97737,tested,0,0
97738,using,0,0
97739,ANCOVA,0,0
97740,with,0,1
97741,post,0,0
97742,hoc,0,0
97743,pairwise,0,0
97744,comparisons,0,0
97745,.,0,0
97746,RESULTS,0,0
97747,There,0,0
97748,were,0,0
97749,significant,0,0
97750,overall,0,0
97751,intervention,0,0
97752,effects,0,0
97753,for,0,0
97754,all,0,0
97755,adiposity,0,0
97756,measures,0,0
97757,(,0,0
97758,weight,0,0
97759,",",0,0
97760,body,0,0
97761,mass,0,0
97762,index,0,0
97763,[,0,0
97764,BMI,0,0
97765,],0,0
97766,",",0,0
97767,BMI,0,0
97768,z-scores,0,0
97769,",",0,0
97770,and,0,0
97771,DEXA,0,0
97772,total,0,1
97773,body,0,0
97774,fat,0,0
97775,),0,0
97776,",",0,0
97777,with,0,0
97778,a,0,0
97779,decrease,0,0
97780,of,0,0
97781,3,0,0
97782,%,0,0
97783,in,0,0
97784,the,0,0
97785,N,0,1
97786,+,0,0
97787,CAST,0,0
97788,group,0,0
97789,compared,0,0
97790,with,0,0
97791,a,0,0
97792,3,0,0
97793,%,0,0
97794,increase,0,0
97795,in,0,0
97796,the,0,0
97797,N,0,1
97798,+,0,0
97799,ST,0,1
97800,group,0,0
97801,(,0,0
97802,P,0,0
97803,<,0,0
97804,or,0,0
97805,=,0,0
97806,0.05,0,0
97807,),0,0
97808,.,0,0
97809,There,0,0
97810,was,0,0
97811,also,0,0
97812,an,0,0
97813,intervention,0,0
97814,effect,0,0
97815,for,0,0
97816,fasting,0,0
97817,glucose,0,0
97818,with,0,1
97819,the,0,0
97820,N,0,1
97821,group,0,0
97822,increasing,0,0
97823,by,0,0
97824,3,0,0
97825,%,0,0
97826,and,0,0
97827,the,0,0
97828,N,0,1
97829,+,0,0
97830,CAST,0,0
97831,group,0,0
97832,decreasing,0,0
97833,by,0,0
97834,4,0,0
97835,%,0,0
97836,(,0,0
97837,P,0,0
97838,<,0,0
97839,or,0,0
97840,=,0,0
97841,0.05,0,0
97842,),0,0
97843,.,0,0
97844,CONCLUSION,0,0
97845,The,0,0
97846,CAST,0,0
97847,was,0,0
97848,more,0,0
97849,effective,0,0
97850,than,0,0
97851,nutrition,0,0
97852,alone,0,0
97853,or,0,0
97854,nutrition,0,0
97855,plus,0,0
97856,strength,0,0
97857,training,0,0
97858,for,0,0
97859,reducing,0,0
97860,multiple,0,0
97861,adiposity,0,0
97862,outcomes,0,0
97863,and,0,0
97864,fasting,0,0
97865,glucose,0,0
97866,in,0,0
97867,overweight,1,1
97868,Latina,1,1
97869,girls,1,1
97870,.,1,0
97871,However,0,0
97872,",",0,0
97873,further,0,0
97874,research,0,0
97875,investigating,0,0
97876,and,0,0
97877,identifying,0,0
97878,intervention,0,0
97879,approaches,0,0
97880,that,0,0
97881,improve,0,0
97882,both,0,0
97883,adiposity,0,0
97884,and,0,0
97885,insulin,0,0
97886,indices,0,0
97887,",",0,0
97888,particularly,0,0
97889,in,0,0
97890,high-risk,0,1
97891,populations,0,1
97892,",",0,0
97893,are,0,0
97894,warranted,0,0
97895,.,0,0
97896,Emotional,0,0
97897,",",0,0
97898,motivational,0,0
97899,and,0,0
97900,interpersonal,0,0
97901,responsiveness,0,0
97902,of,0,0
97903,children,1,1
97904,with,1,1
97905,autism,1,1
97906,in,0,0
97907,improvisational,0,0
97908,music,0,0
97909,therapy,0,0
97910,.,0,0
97911,Through,0,0
97912,behavioural,0,0
97913,analysis,0,0
97914,",",0,0
97915,this,0,0
97916,study,0,0
97917,investigated,0,0
97918,the,0,0
97919,social-motivational,0,0
97920,aspects,0,0
97921,of,0,0
97922,musical,0,0
97923,interaction,0,0
97924,between,0,0
97925,the,0,0
97926,child,1,0
97927,and,0,0
97928,the,0,0
97929,therapist,0,0
97930,in,0,0
97931,improvisational,0,0
97932,music,0,0
97933,therapy,0,0
97934,by,0,0
97935,measuring,0,0
97936,emotional,0,0
97937,",",0,0
97938,motivational,0,0
97939,and,0,0
97940,interpersonal,0,0
97941,responsiveness,1,0
97942,in,1,0
97943,children,1,1
97944,with,1,1
97945,autism,1,1
97946,during,1,0
97947,joint,1,0
97948,engagement,1,0
97949,episodes,1,0
97950,.,1,0
97951,The,0,0
97952,randomized,0,0
97953,controlled,0,0
97954,study,0,0
97955,(,1,0
97956,n,1,1
97957,=,1,0
97958,10,1,1
97959,),1,0
97960,employed,0,0
97961,a,0,0
97962,single,0,0
97963,subject,0,0
97964,comparison,0,0
97965,design,0,0
97966,in,0,0
97967,two,0,0
97968,different,0,0
97969,conditions,0,0
97970,",",0,0
97971,improvisational,0,0
97972,music,0,0
97973,therapy,0,0
97974,and,0,0
97975,toy,0,0
97976,play,0,0
97977,sessions,0,0
97978,",",0,0
97979,and,0,0
97980,DVD,0,0
97981,analysis,0,0
97982,of,0,0
97983,sessions,0,0
97984,.,0,1
97985,Improvisational,0,0
97986,music,0,0
97987,therapy,0,0
97988,produced,0,0
97989,markedly,0,0
97990,more,0,0
97991,and,0,0
97992,longer,0,0
97993,events,0,0
97994,of,0,0
97995,'joy,0,0
97996,',0,0
97997,",",0,0
97998,'emotional,0,0
97999,synchronicity,0,0
98000,',0,0
98001,and,0,0
98002,'initiation,0,0
98003,of,0,0
98004,engagement,0,0
98005,',0,0
98006,behaviours,0,0
98007,in,0,0
98008,the,0,0
98009,children,0,1
98010,than,0,0
98011,toy,0,1
98012,play,0,0
98013,sessions,0,0
98014,.,0,0
98015,In,0,0
98016,response,0,0
98017,to,0,0
98018,the,0,0
98019,therapist,0,0
98020,'s,0,0
98021,interpersonal,0,0
98022,demands,0,0
98023,",",0,0
98024,'compliant,0,0
98025,(,0,0
98026,positive,0,0
98027,),0,0
98028,responses,0,0
98029,',0,0
98030,were,0,0
98031,observed,0,0
98032,more,0,0
98033,in,0,0
98034,music,0,0
98035,therapy,0,0
98036,than,0,0
98037,in,0,0
98038,toy,0,1
98039,play,0,0
98040,sessions,0,0
98041,",",0,0
98042,and,0,0
98043,'no,0,0
98044,responses,0,0
98045,',0,1
98046,were,0,0
98047,twice,0,0
98048,as,0,0
98049,frequent,0,0
98050,in,0,0
98051,toy,0,1
98052,play,0,0
98053,sessions,0,0
98054,as,0,0
98055,in,0,0
98056,music,0,0
98057,therapy,0,0
98058,.,0,0
98059,The,0,0
98060,results,0,0
98061,of,0,0
98062,this,0,0
98063,exploratory,0,0
98064,study,0,0
98065,found,0,0
98066,significant,0,0
98067,evidence,0,0
98068,supporting,0,0
98069,the,0,0
98070,value,0,0
98071,of,0,0
98072,music,0,0
98073,therapy,0,0
98074,in,0,0
98075,promoting,0,0
98076,social,0,0
98077,",",0,0
98078,emotional,0,0
98079,and,0,0
98080,motivational,0,0
98081,development,0,0
98082,in,0,0
98083,children,1,1
98084,with,1,1
98085,autism,1,1
98086,.,1,0
98087,A,0,0
98088,phase,0,0
98089,III,0,0
98090,clinical,0,0
98091,trial,0,0
98092,of,0,0
98093,exercise,0,0
98094,modalities,0,0
98095,on,0,0
98096,treatment,0,0
98097,side-effects,0,0
98098,in,0,0
98099,men,1,1
98100,receiving,1,1
98101,therapy,1,0
98102,for,1,0
98103,prostate,1,1
98104,cancer,1,1
98105,.,1,0
98106,BACKGROUND,0,0
98107,Androgen,0,0
98108,deprivation,0,0
98109,therapy,0,0
98110,(,0,0
98111,ADT,0,0
98112,),0,0
98113,is,0,0
98114,accompanied,0,0
98115,by,0,0
98116,a,0,0
98117,number,0,0
98118,of,0,0
98119,adverse,0,0
98120,side,0,0
98121,effects,0,0
98122,including,0,0
98123,reduced,0,0
98124,bone,0,0
98125,mass,0,0
98126,and,0,0
98127,increased,0,0
98128,risk,0,0
98129,for,0,0
98130,fracture,0,0
98131,",",0,0
98132,reduced,0,0
98133,lean,0,0
98134,mass,0,0
98135,and,0,0
98136,muscle,0,0
98137,strength,0,0
98138,",",0,0
98139,mood,0,0
98140,disturbance,0,0
98141,and,0,0
98142,increased,0,0
98143,fat,0,0
98144,mass,0,0
98145,compromising,0,0
98146,physical,0,0
98147,functioning,0,0
98148,",",0,0
98149,independence,0,0
98150,",",0,0
98151,and,0,0
98152,quality,0,0
98153,of,0,0
98154,life,0,0
98155,.,0,0
98156,The,0,0
98157,purpose,0,0
98158,of,0,0
98159,this,0,0
98160,investigation,0,0
98161,is,0,0
98162,to,0,0
98163,examine,0,0
98164,the,0,0
98165,effects,0,0
98166,of,0,0
98167,long,0,1
98168,term,0,0
98169,exercise,0,0
98170,on,0,0
98171,reversing,0,0
98172,musculoskeletal-related,0,0
98173,side,0,0
98174,effects,0,0
98175,",",0,0
98176,and,0,0
98177,cardiovascular,0,0
98178,and,0,0
98179,diabetes,0,1
98180,risk,0,0
98181,factors,0,0
98182,in,0,0
98183,men,1,1
98184,receiving,1,1
98185,androgen,1,0
98186,deprivation,1,0
98187,for,1,0
98188,their,1,0
98189,prostate,1,1
98190,cancer,1,1
98191,.,1,0
98192,Specifically,0,0
98193,",",0,0
98194,we,0,0
98195,aim,0,0
98196,to,0,0
98197,investigate,0,0
98198,the,0,0
98199,effects,0,0
98200,of,0,0
98201,a,0,0
98202,12-month,0,0
98203,exercise,0,0
98204,program,0,0
98205,designed,0,0
98206,to,0,0
98207,load,0,0
98208,the,0,0
98209,musculoskeletal,0,0
98210,system,0,0
98211,and,0,0
98212,reduce,0,0
98213,cardiovascular,0,0
98214,and,0,0
98215,diabetes,0,1
98216,disease,0,0
98217,progression,0,0
98218,on,0,0
98219,the,0,0
98220,following,0,0
98221,primary,0,1
98222,endpoints,0,0
98223,:,0,1
98224,1,0,0
98225,),0,0
98226,bone,0,0
98227,mineral,0,0
98228,density,0,0
98229,;,0,0
98230,2,0,0
98231,),0,0
98232,cardiorespiratory,0,0
98233,function,0,0
98234,and,0,0
98235,maximal,0,0
98236,oxygen,0,0
98237,capacity,0,0
98238,;,0,0
98239,3,0,0
98240,),0,0
98241,body,0,0
98242,composition,0,0
98243,(,0,0
98244,lean,0,0
98245,mass,0,0
98246,and,0,0
98247,fat,0,0
98248,mass,0,1
98249,),0,0
98250,;,0,0
98251,4,0,0
98252,),0,0
98253,blood,0,0
98254,pressure,0,0
98255,and,0,0
98256,cardiovascular,0,1
98257,function,0,0
98258,;,0,0
98259,5,0,0
98260,),0,0
98261,lipids,0,0
98262,and,0,0
98263,glycemic,0,0
98264,control,0,0
98265,;,0,0
98266,and,0,0
98267,6,0,0
98268,),0,0
98269,quality,0,0
98270,of,0,0
98271,life,0,0
98272,and,0,0
98273,psychological,0,0
98274,distress,0,1
98275,.,0,0
98276,METHODS/DESIGN,0,0
98277,Multi-site,0,0
98278,randomized,0,0
98279,controlled,0,0
98280,trial,0,0
98281,of,0,0
98282,195,1,1
98283,men,1,1
98284,(,1,1
98285,65,1,1
98286,subjects,1,1
98287,per,1,0
98288,arm,1,0
98289,),1,0
98290,undergoing,1,1
98291,treatment,1,0
98292,for,1,0
98293,prostate,1,1
98294,cancer,1,1
98295,involving,1,0
98296,ADT,1,1
98297,in,1,0
98298,the,1,0
98299,cities,1,1
98300,of,1,0
98301,Perth,1,1
98302,and,1,0
98303,Brisbane,1,1
98304,in,1,0
98305,Australia,1,1
98306,.,1,0
98307,Participants,0,1
98308,will,0,0
98309,be,0,0
98310,randomized,0,0
98311,to,0,0
98312,(,0,0
98313,1,0,0
98314,),0,0
98315,resistance/impact,0,0
98316,loading,0,0
98317,exercise,0,0
98318,",",0,0
98319,(,0,0
98320,2,0,0
98321,),0,0
98322,resistance/cardiovascular,0,0
98323,exercise,0,0
98324,groups,0,0
98325,and,0,0
98326,(,0,0
98327,3,0,0
98328,),0,0
98329,usual,0,0
98330,care/delayed,0,0
98331,exercise,0,0
98332,.,0,0
98333,Participants,0,0
98334,will,0,0
98335,then,0,0
98336,undergo,0,0
98337,progressive,0,0
98338,training,0,0
98339,for,0,0
98340,12,0,0
98341,months,0,0
98342,.,0,1
98343,Measurements,0,0
98344,for,0,0
98345,primary,0,1
98346,and,0,0
98347,secondary,0,0
98348,endpoints,0,0
98349,will,0,0
98350,take,0,0
98351,place,0,0
98352,at,0,0
98353,baseline,0,0
98354,",",0,0
98355,6,0,0
98356,and,0,0
98357,12,0,0
98358,months,0,0
98359,(,0,0
98360,end,0,0
98361,of,0,0
98362,the,0,0
98363,intervention,0,0
98364,),0,0
98365,.,0,0
98366,DISCUSSION,0,0
98367,The,0,0
98368,principal,0,0
98369,outcome,0,0
98370,of,0,0
98371,this,0,0
98372,project,0,0
98373,will,0,0
98374,be,0,0
98375,the,0,0
98376,determination,0,0
98377,of,0,0
98378,the,0,0
98379,strength,0,0
98380,of,0,0
98381,effect,0,0
98382,of,0,0
98383,exercise,0,0
98384,on,0,0
98385,the,0,0
98386,well,0,0
98387,established,0,0
98388,musculoskeletal,0,1
98389,",",0,0
98390,cardiovascular,0,0
98391,and,0,0
98392,insulin,0,0
98393,metabolism,0,0
98394,side,0,0
98395,effects,0,0
98396,of,0,0
98397,androgen,0,0
98398,deprivation,0,0
98399,in,0,0
98400,prostate,0,1
98401,cancer,0,1
98402,patients,0,1
98403,.,0,0
98404,As,0,0
98405,this,0,0
98406,project,0,0
98407,is,0,0
98408,much,0,0
98409,longer,0,0
98410,term,0,0
98411,than,0,0
98412,previous,0,0
98413,investigations,0,0
98414,in,0,0
98415,the,0,0
98416,area,0,0
98417,of,0,0
98418,exercise,0,0
98419,and,0,0
98420,cancer,0,1
98421,",",0,0
98422,we,0,0
98423,will,0,0
98424,gain,0,0
98425,knowledge,0,0
98426,as,0,0
98427,to,0,0
98428,the,0,0
98429,continuing,0,0
98430,effects,0,0
98431,of,0,0
98432,exercise,0,0
98433,in,0,0
98434,this,0,0
98435,patient,0,0
98436,population,0,0
98437,specifically,0,0
98438,targeting,0,0
98439,bone,0,0
98440,density,0,0
98441,",",0,0
98442,cardiovascular,0,0
98443,function,0,0
98444,",",0,0
98445,lean,0,0
98446,and,0,0
98447,fat,0,0
98448,mass,0,0
98449,",",0,0
98450,physical,0,0
98451,function,0,0
98452,and,0,0
98453,falls,0,0
98454,risk,0,0
98455,as,0,0
98456,primary,0,0
98457,study,0,1
98458,endpoints,0,0
98459,.,0,0
98460,In,0,0
98461,terms,0,0
98462,of,0,0
98463,advancement,0,0
98464,of,0,0
98465,prostate,0,1
98466,cancer,0,1
98467,care,0,0
98468,",",0,0
98469,we,0,0
98470,expect,0,0
98471,dissemination,0,0
98472,of,0,0
98473,the,0,0
98474,knowledge,0,0
98475,gained,0,0
98476,from,0,0
98477,this,0,0
98478,project,0,0
98479,to,0,0
98480,reduce,0,0
98481,fracture,0,0
98482,risk,0,0
98483,",",0,0
98484,improve,0,0
98485,physical,0,0
98486,and,0,0
98487,functional,0,0
98488,ability,0,0
98489,",",0,0
98490,quality,0,0
98491,of,0,0
98492,life,0,0
98493,and,0,0
98494,ultimately,0,0
98495,survival,0,0
98496,rate,0,0
98497,in,0,0
98498,this,0,0
98499,population,0,1
98500,.,0,0
98501,CLINICAL,0,0
98502,TRIAL,0,0
98503,REGISTRY,0,0
98504,A,0,0
98505,Phase,0,1
98506,III,0,0
98507,clinical,0,0
98508,trial,0,0
98509,of,0,0
98510,exercise,0,0
98511,modalities,0,0
98512,on,0,0
98513,treatment,0,0
98514,side-effects,0,0
98515,in,0,0
98516,men,0,1
98517,receiving,0,1
98518,therapy,0,0
98519,for,0,0
98520,prostate,0,1
98521,cancer,0,1
98522,;,0,0
98523,ACTRN12609000200280,0,0
98524,.,0,0
98525,Impact,0,0
98526,of,0,0
98527,preinduced,1,0
98528,quadriceps,1,0
98529,fatigue,1,0
98530,on,0,0
98531,exercise,0,0
98532,response,0,0
98533,in,0,0
98534,chronic,1,1
98535,obstructive,1,1
98536,pulmonary,1,1
98537,disease,1,1
98538,and,1,0
98539,healthy,1,1
98540,subjects,1,1
98541,.,1,0
98542,Exercise,0,0
98543,intolerance,0,0
98544,in,0,0
98545,chronic,1,1
98546,obstructive,1,1
98547,pulmonary,1,1
98548,disease,1,1
98549,(,1,0
98550,COPD,1,0
98551,),1,0
98552,results,0,0
98553,from,0,0
98554,a,0,0
98555,complex,0,0
98556,interaction,0,0
98557,between,0,0
98558,central,0,0
98559,(,0,0
98560,ventilatory,0,0
98561,),0,0
98562,and,0,0
98563,peripheral,0,0
98564,(,0,0
98565,limb,0,1
98566,muscles,0,0
98567,),0,1
98568,components,0,0
98569,of,0,0
98570,exercise,0,0
98571,limitation,0,0
98572,.,0,0
98573,The,0,0
98574,purpose,0,0
98575,of,0,0
98576,this,0,0
98577,study,0,0
98578,was,0,0
98579,to,0,0
98580,evaluate,0,0
98581,the,0,0
98582,influence,0,0
98583,of,0,0
98584,quadriceps,0,0
98585,muscle,0,0
98586,fatigue,0,0
98587,on,0,0
98588,exercise,0,0
98589,tolerance,0,0
98590,and,0,0
98591,ventilatory,0,0
98592,response,0,0
98593,during,0,0
98594,constant-workrate,0,0
98595,cycling,0,0
98596,exercise,0,0
98597,testing,0,0
98598,(,0,0
98599,CWT,0,0
98600,),0,0
98601,in,0,0
98602,patients,1,1
98603,with,1,1
98604,COPD,1,0
98605,and,1,0
98606,healthy,1,1
98607,subjects,1,1
98608,.,1,1
98609,Fifteen,1,1
98610,patients,1,1
98611,with,1,1
98612,COPD,1,0
98613,and,1,0
98614,nine,1,1
98615,age-matched,1,1
98616,healthy,1,1
98617,subjects,1,1
98618,performed,0,0
98619,",",0,0
98620,7,0,0
98621,days,0,0
98622,apart,0,0
98623,",",0,0
98624,two,0,0
98625,CWTs,0,0
98626,up,0,0
98627,to,0,0
98628,exhaustion,0,0
98629,at,0,0
98630,80,0,0
98631,%,0,0
98632,of,0,0
98633,their,0,0
98634,predetermined,0,0
98635,maximal,0,0
98636,work,0,0
98637,capacity,0,0
98638,.,0,0
98639,In,0,0
98640,a,0,0
98641,randomized,0,0
98642,order,0,0
98643,",",0,0
98644,one,0,0
98645,test,0,0
98646,was,0,0
98647,performed,0,0
98648,with,0,1
98649,preinduced,0,0
98650,quadriceps,0,0
98651,fatigue,0,0
98652,and,0,0
98653,the,0,0
98654,other,0,0
98655,in,0,0
98656,a,0,0
98657,fresh,0,0
98658,state,0,0
98659,.,0,0
98660,Quadriceps,0,0
98661,fatigue,0,0
98662,was,0,0
98663,produced,0,0
98664,by,0,0
98665,electrostimulation-induced,0,0
98666,contractions,0,0
98667,and,0,0
98668,quantified,0,0
98669,by,0,0
98670,maximal,0,0
98671,voluntary,0,0
98672,contraction,0,0
98673,and,0,0
98674,potentiated,0,0
98675,twitch,0,0
98676,force,0,0
98677,(,0,0
98678,TwQ,0,0
98679,(,0,0
98680,pot,0,0
98681,),0,0
98682,),0,0
98683,.,0,0
98684,Endurance,0,0
98685,time,0,0
98686,and,0,0
98687,ventilatory,0,0
98688,response,0,0
98689,during,0,0
98690,CWT,0,0
98691,were,0,0
98692,compared,0,0
98693,between,0,0
98694,fatigued,0,0
98695,and,0,0
98696,fresh,0,0
98697,state,0,0
98698,.,0,0
98699,Endurance,0,0
98700,time,0,0
98701,significantly,0,0
98702,decreased,0,0
98703,in,0,0
98704,the,0,0
98705,fatigued,0,0
98706,state,0,0
98707,compared,0,0
98708,with,0,0
98709,the,0,0
98710,fresh,0,0
98711,condition,0,0
98712,in,0,0
98713,COPD,0,0
98714,(,0,0
98715,356,0,1
98716,+/-,0,0
98717,69,0,1
98718,s,0,0
98719,vs.,0,0
98720,294,0,1
98721,+/-,0,0
98722,45,0,1
98723,s,0,0
98724,",",0,0
98725,P,0,0
98726,<,0,0
98727,0.05,0,0
98728,),0,0
98729,and,0,0
98730,controls,0,0
98731,(,0,0
98732,450,0,0
98733,+/-,0,0
98734,74,0,1
98735,s,0,0
98736,vs.,0,0
98737,340,0,1
98738,+/-,0,0
98739,45,0,1
98740,s,0,0
98741,",",0,0
98742,P,0,0
98743,<,0,0
98744,0.05,0,0
98745,),0,0
98746,.,0,0
98747,Controls,0,0
98748,showed,0,0
98749,significantly,0,0
98750,higher,0,0
98751,ventilation,0,0
98752,and,0,0
98753,end-exercise,0,0
98754,dyspnea,0,0
98755,scores,0,0
98756,in,0,0
98757,the,0,0
98758,fatigued,0,0
98759,condition,0,0
98760,",",0,0
98761,whereas,0,0
98762,",",0,0
98763,in,0,0
98764,COPD,0,0
98765,",",0,0
98766,fatigue,0,0
98767,did,0,0
98768,not,0,0
98769,influence,0,0
98770,ventilation,0,0
98771,or,0,0
98772,dyspnea,0,0
98773,during,0,0
98774,exercise,0,0
98775,.,0,0
98776,The,0,0
98777,degree,0,0
98778,of,0,0
98779,ventilatory,0,0
98780,limitation,0,0
98781,",",0,0
98782,as,0,0
98783,expressed,0,0
98784,by,0,0
98785,the,0,0
98786,Ve/maximum,0,0
98787,voluntary,0,0
98788,ventilation,0,0
98789,ratio,0,0
98790,",",0,0
98791,was,0,0
98792,similar,0,0
98793,in,0,0
98794,both,0,0
98795,conditions,0,0
98796,in,0,0
98797,patients,1,1
98798,with,1,1
98799,COPD,1,0
98800,.,1,0
98801,We,0,0
98802,conclude,0,0
98803,that,0,0
98804,it,0,0
98805,is,0,0
98806,possible,0,0
98807,to,0,0
98808,induce,0,0
98809,quadriceps,0,0
98810,fatigue,0,0
98811,by,0,0
98812,local,0,0
98813,electrostimulation-induced,0,0
98814,contractions,0,0
98815,.,0,1
98816,Our,0,0
98817,findings,0,0
98818,demonstrate,0,0
98819,that,0,0
98820,peripheral,1,0
98821,muscle,1,0
98822,fatigue,1,0
98823,is,0,0
98824,an,0,0
98825,additional,0,0
98826,important,0,0
98827,factor,0,0
98828,",",0,0
98829,besides,0,0
98830,intense,0,0
98831,dyspnea,0,0
98832,",",0,0
98833,that,0,0
98834,limits,0,0
98835,exercise,0,0
98836,tolerance,0,0
98837,in,0,0
98838,COPD,0,0
98839,.,0,1
98840,Verapamil,0,0
98841,augmentation,0,0
98842,of,0,0
98843,lithium,0,0
98844,treatment,0,0
98845,improves,0,0
98846,outcome,0,0
98847,in,0,0
98848,mania,0,1
98849,unresponsive,0,0
98850,to,0,0
98851,lithium,0,0
98852,alone,0,0
98853,:,0,0
98854,preliminary,0,0
98855,findings,0,0
98856,and,0,0
98857,a,0,0
98858,discussion,0,0
98859,of,0,0
98860,therapeutic,0,0
98861,mechanisms,0,0
98862,.,0,1
98863,OBJECTIVES,0,0
98864,Attenuation,0,0
98865,of,0,0
98866,protein,0,0
98867,kinase,0,0
98868,C,0,0
98869,(,0,0
98870,PKC,0,1
98871,),0,0
98872,is,0,0
98873,a,0,0
98874,mechanism,0,0
98875,common,0,0
98876,to,0,0
98877,both,0,0
98878,established,0,0
98879,(,0,0
98880,lithium,0,0
98881,",",0,0
98882,valproate,0,0
98883,),0,0
98884,and,0,0
98885,some,0,0
98886,novel,0,0
98887,(,0,0
98888,tamoxifen,0,0
98889,),0,0
98890,antimanic,0,0
98891,agents,0,0
98892,.,0,1
98893,Verapamil,0,0
98894,",",0,0
98895,although,0,0
98896,primarily,0,0
98897,known,0,0
98898,as,0,0
98899,a,0,0
98900,calcium,0,0
98901,channel,0,0
98902,blocker,0,0
98903,",",0,0
98904,also,0,0
98905,has,0,0
98906,PKC,0,1
98907,inhibitory,0,0
98908,activity,0,0
98909,.,0,0
98910,Verapamil,0,0
98911,has,0,0
98912,shown,0,0
98913,antimanic,0,0
98914,activity,0,0
98915,in,0,0
98916,some,0,0
98917,but,0,0
98918,not,0,0
98919,all,0,0
98920,studies,0,0
98921,.,0,0
98922,Therefore,0,0
98923,",",0,0
98924,we,0,0
98925,investigated,0,0
98926,verapamil,0,0
98927,",",0,0
98928,used,0,0
98929,alone,0,0
98930,or,0,0
98931,as,0,0
98932,an,0,0
98933,adjunctive,0,0
98934,treatment,0,0
98935,",",0,0
98936,in,0,0
98937,manic,1,1
98938,patients,1,1
98939,who,1,1
98940,did,1,1
98941,not,1,1
98942,respond,1,0
98943,to,1,0
98944,an,1,0
98945,initial,1,0
98946,adequate,1,0
98947,trial,1,0
98948,of,1,0
98949,lithium,1,0
98950,.,1,0
98951,METHODS,0,0
98952,Each,0,0
98953,study,0,0
98954,phase,0,0
98955,lasted,0,0
98956,three,0,0
98957,weeks,0,0
98958,.,0,1
98959,Subjects,0,1
98960,were,0,0
98961,treated,0,1
98962,openly,0,0
98963,with,0,0
98964,lithium,0,0
98965,in,0,0
98966,Phase,0,0
98967,1,0,0
98968,(,1,0
98969,n,1,1
98970,=,1,0
98971,45,1,1
98972,),1,0
98973,.,0,1
98974,Those,0,0
98975,who,0,0
98976,failed,0,0
98977,to,0,1
98978,respond,0,0
98979,were,0,0
98980,randomly,0,0
98981,assigned,0,0
98982,to,0,0
98983,double-blind,0,0
98984,treatment,0,0
98985,in,0,0
98986,Phase,0,0
98987,2,0,0
98988,with,0,1
98989,either,0,0
98990,verapamil,0,0
98991,(,0,0
98992,n,0,1
98993,=,0,0
98994,10,0,1
98995,),0,0
98996,or,0,0
98997,continued-lithium,0,0
98998,(,0,0
98999,n,0,1
99000,=,0,0
99001,8,0,0
99002,),0,0
99003,.,0,0
99004,Phase,0,0
99005,2,0,0
99006,nonresponders,0,0
99007,(,0,0
99008,n,0,1
99009,=,0,0
99010,10,0,1
99011,),0,0
99012,were,0,0
99013,assigned,0,0
99014,to,0,0
99015,combined,0,0
99016,verapamil/lithium,0,0
99017,in,0,0
99018,Phase,0,1
99019,3,0,0
99020,.,0,1
99021,RESULTS,0,0
99022,Response,0,0
99023,in,0,0
99024,Phase,0,1
99025,2,0,0
99026,did,0,0
99027,not,0,0
99028,differ,0,0
99029,significantly,0,0
99030,between,0,0
99031,verapamil,0,0
99032,and,0,0
99033,continued-lithium,0,0
99034,.,0,0
99035,During,0,0
99036,Phase,0,0
99037,3,0,0
99038,",",0,0
99039,response,0,0
99040,to,0,0
99041,combined,0,0
99042,treatment,0,0
99043,was,0,0
99044,significantly,0,0
99045,better,0,0
99046,than,0,0
99047,overall,0,0
99048,response,0,0
99049,to,0,0
99050,monotherapy,0,0
99051,in,0,0
99052,Phase,0,0
99053,2,0,0
99054,(,0,0
99055,Fisher,0,0
99056,'s,0,0
99057,Exact,0,0
99058,test,0,0
99059,",",0,0
99060,p,0,0
99061,=,0,0
99062,0.043,0,0
99063,),0,0
99064,.,0,0
99065,Mania,0,1
99066,ratings,0,0
99067,improved,0,0
99068,during,0,0
99069,combined,0,0
99070,treatment,0,0
99071,in,0,0
99072,Phase,0,0
99073,3,0,0
99074,by,0,0
99075,88.2,0,0
99076,%,0,0
99077,(,0,0
99078,linear,0,0
99079,mixed,0,0
99080,model,0,0
99081,analysis,0,0
99082,",",0,0
99083,F,0,0
99084,=,0,0
99085,4.34,0,0
99086,",",0,0
99087,p,0,0
99088,=,0,0
99089,0.013,0,0
99090,),0,0
99091,",",0,0
99092,compared,0,0
99093,with,0,0
99094,10.5,0,0
99095,%,0,0
99096,improvement,0,0
99097,during,0,0
99098,Phase,0,1
99099,2,0,0
99100,.,0,0
99101,CONCLUSIONS,0,0
99102,In,0,0
99103,this,0,0
99104,preliminary,0,0
99105,investigation,0,0
99106,",",0,0
99107,verapamil,0,0
99108,monotherapy,0,0
99109,did,0,0
99110,not,0,0
99111,demonstrate,0,0
99112,antimanic,0,0
99113,efficacy,0,0
99114,.,0,0
99115,By,0,0
99116,contrast,0,0
99117,",",0,0
99118,the,0,0
99119,combination,0,0
99120,of,0,0
99121,verapamil,0,0
99122,plus,0,0
99123,lithium,0,0
99124,was,0,0
99125,highly,0,0
99126,efficacious,0,0
99127,.,0,0
99128,Our,0,0
99129,findings,0,0
99130,thus,0,0
99131,suggest,0,0
99132,that,0,0
99133,verapamil,0,0
99134,may,0,0
99135,have,0,0
99136,potential,0,0
99137,utility,0,0
99138,as,0,0
99139,an,0,0
99140,adjunct,0,0
99141,to,0,0
99142,lithium,0,0
99143,.,0,0
99144,This,0,0
99145,effect,0,0
99146,may,0,0
99147,be,0,0
99148,mediated,0,0
99149,by,0,0
99150,additive,0,0
99151,actions,0,0
99152,on,0,0
99153,PKC,0,1
99154,inhibition,0,0
99155,",",0,0
99156,which,0,0
99157,may,0,0
99158,be,0,0
99159,an,0,0
99160,important,0,0
99161,mechanism,0,0
99162,for,0,0
99163,antimanic,0,0
99164,agents,0,0
99165,in,0,0
99166,general,0,1
99167,.,0,1
99168,[,0,0
99169,Clinical,0,0
99170,effect,0,0
99171,of,0,0
99172,transcatheter,0,1
99173,arterial,0,1
99174,chemoembolization,0,0
99175,combined,0,0
99176,with,0,0
99177,high,0,0
99178,intensity,0,0
99179,focused,0,0
99180,ultrasound,0,0
99181,ablation,0,0
99182,in,0,0
99183,treatment,0,0
99184,of,0,0
99185,large,1,0
99186,hepatocellular,1,1
99187,carcinoma,1,1
99188,],1,0
99189,.,0,0
99190,OBJECTIVE,0,0
99191,To,0,0
99192,investigate,0,0
99193,the,0,0
99194,clinical,0,0
99195,effect,0,0
99196,of,0,0
99197,transcatheter,0,1
99198,arterial,0,0
99199,chemoembolization,0,0
99200,(,0,0
99201,TACE,0,1
99202,),0,0
99203,combined,0,0
99204,with,0,0
99205,high,0,0
99206,intensity,0,0
99207,focused,0,0
99208,ultrasound,0,0
99209,(,0,0
99210,HIFU,0,0
99211,),0,0
99212,ablation,0,0
99213,in,0,0
99214,treatment,0,0
99215,of,0,0
99216,large,0,0
99217,hepatocellular,1,1
99218,carcinoma,1,1
99219,(,1,0
99220,HCC,1,0
99221,),1,0
99222,.,1,0
99223,METHODS,0,0
99224,Sixty-eight,1,1
99225,patients,1,1
99226,with,1,1
99227,unresectable,1,1
99228,HCC,1,0
99229,were,0,0
99230,randomized,0,0
99231,into,0,0
99232,2,0,0
99233,age,0,1
99234,",",0,0
99235,tumor,0,0
99236,size,0,0
99237,",",0,0
99238,TNM,0,0
99239,stages,0,0
99240,",",0,0
99241,and,0,0
99242,liver,0,1
99243,function,0,0
99244,grade-matched,0,1
99245,groups,0,0
99246,:,0,1
99247,TACE,0,1
99248,group,0,0
99249,(,0,0
99250,n=30,0,1
99251,),0,0
99252,undergoing,0,1
99253,TACE,0,1
99254,and,0,0
99255,TACE+HIFU,0,0
99256,group,0,0
99257,(,0,0
99258,n=38,0,1
99259,),0,0
99260,undergoing,0,1
99261,2-3,0,0
99262,weeks,0,0
99263,after,0,0
99264,TACE,0,1
99265,.,0,0
99266,A,0,0
99267,total,0,1
99268,of,0,0
99269,88,0,1
99270,tumors,0,1
99271,(,0,0
99272,9.3+/-3.2,0,0
99273,),0,0
99274,(,0,0
99275,5.0-14.5,0,0
99276,),0,0
99277,cm,0,1
99278,in,0,0
99279,diameter,0,0
99280,were,0,0
99281,detected,0,0
99282,",",0,0
99283,and,0,0
99284,the,0,0
99285,largest,0,0
99286,tumor,0,0
99287,in,0,0
99288,a,0,0
99289,specific,0,0
99290,patients,1,1
99291,with,1,1
99292,multiple,1,1
99293,lesions,1,1
99294,was,0,0
99295,selected,0,1
99296,for,0,0
99297,observation,0,0
99298,.,0,0
99299,Follow-up,0,0
99300,was,0,0
99301,conducted,0,0
99302,for,0,0
99303,(,0,0
99304,13+/-7,0,0
99305,),0,0
99306,(,0,0
99307,3-24,0,0
99308,),0,0
99309,months,0,0
99310,to,0,0
99311,observe,0,0
99312,the,0,0
99313,necrosis,0,0
99314,of,0,0
99315,tumor,0,0
99316,",",0,0
99317,size,0,0
99318,of,0,0
99319,tumor,0,0
99320,",",0,0
99321,local,0,0
99322,recurrence,0,0
99323,",",0,0
99324,and,0,0
99325,survival,0,0
99326,of,0,0
99327,patient,0,0
99328,.,0,0
99329,RESULTS,0,0
99330,The,0,0
99331,clinical,0,0
99332,symptom,0,0
99333,remission,0,1
99334,rate,0,0
99335,was,0,0
99336,90.6,0,0
99337,%,0,0
99338,(,0,0
99339,29/32,0,0
99340,),0,0
99341,in,0,0
99342,the,0,0
99343,TACE+HIFU,0,0
99344,group,0,0
99345,and,0,0
99346,70.8,0,0
99347,%,0,0
99348,(,0,0
99349,28/38,0,0
99350,),0,0
99351,in,0,0
99352,the,0,0
99353,TACE,0,0
99354,group,0,0
99355,.,0,0
99356,The,0,0
99357,tumor,0,0
99358,necrosis,0,0
99359,and,0,0
99360,minification,0,0
99361,rates,0,0
99362,of,0,0
99363,the,0,0
99364,TACE+HIFU,0,0
99365,and,0,0
99366,TACE,0,1
99367,groups,0,0
99368,were,0,0
99369,73.7,0,0
99370,%,0,0
99371,and,0,0
99372,68.4,0,0
99373,%,0,0
99374,respectively,0,0
99375,",",0,0
99376,both,0,0
99377,significantly,0,0
99378,higher,0,0
99379,than,0,0
99380,those,0,0
99381,of,0,0
99382,TACE,0,0
99383,group,0,0
99384,(,0,0
99385,26.7,0,0
99386,%,0,0
99387,and,0,0
99388,33.3,0,0
99389,%,0,0
99390,respectively,0,0
99391,",",0,0
99392,both,0,0
99393,P,0,0
99394,<,0,0
99395,0.01,0,0
99396,),0,0
99397,.,0,0
99398,The,0,0
99399,tumor,0,0
99400,local,0,0
99401,recurrence,0,0
99402,rate,0,0
99403,of,0,0
99404,the,0,0
99405,TACE+HIFU,0,0
99406,group,0,0
99407,was,0,0
99408,21.1,0,0
99409,%,0,0
99410,",",0,0
99411,not,0,0
99412,significantly,0,0
99413,different,0,0
99414,from,0,0
99415,that,0,0
99416,of,0,0
99417,the,0,0
99418,TACE,0,0
99419,group,0,0
99420,(,0,0
99421,33.3,0,0
99422,%,0,0
99423,",",0,0
99424,P,0,0
99425,>,0,1
99426,0.05,0,0
99427,),0,0
99428,.,0,0
99429,The,0,0
99430,median,0,0
99431,survival,0,0
99432,duration,0,0
99433,of,0,0
99434,the,0,0
99435,TACE+HIFU,0,0
99436,group,0,0
99437,was,0,0
99438,18,0,1
99439,months,0,0
99440,",",0,0
99441,significantly,0,0
99442,longer,0,0
99443,than,0,0
99444,that,0,0
99445,of,0,0
99446,the,0,0
99447,TACE,0,0
99448,group,0,0
99449,(,0,0
99450,10,0,0
99451,months,0,0
99452,",",0,0
99453,P,0,0
99454,<,0,0
99455,0.05,0,0
99456,),0,0
99457,.,0,0
99458,CONCLUSION,0,0
99459,Compared,0,0
99460,with,0,1
99461,the,0,0
99462,TACE,0,0
99463,therapy,0,0
99464,alone,0,0
99465,",",0,0
99466,the,0,0
99467,combination,0,0
99468,therapy,0,0
99469,improves,0,0
99470,the,0,0
99471,tumor,0,0
99472,necrosis,0,0
99473,rate,0,0
99474,and,0,0
99475,prolongs,0,0
99476,the,0,0
99477,patients,0,1
99478,',0,0
99479,survival,0,0
99480,duration,0,0
99481,.,0,0
99482,Treatment,1,0
99483,of,1,0
99484,hepatitis,1,1
99485,B,1,0
99486,virus,1,1
99487,infection,1,0
99488,with,1,1
99489,interferon,1,0
99490,.,1,0
99491,Factors,0,0
99492,predicting,0,0
99493,response,0,0
99494,to,0,0
99495,interferon,0,0
99496,.,0,0
99497,Several,0,0
99498,randomised,0,0
99499,controlled,0,0
99500,trials,0,0
99501,have,0,0
99502,been,0,0
99503,undertaken,0,0
99504,to,0,0
99505,evaluate,0,0
99506,the,0,0
99507,efficacy,0,0
99508,of,0,0
99509,alpha-interferon,0,0
99510,in,0,0
99511,the,0,0
99512,therapy,0,0
99513,of,0,0
99514,chronic,0,1
99515,hepatitis,0,1
99516,B,0,0
99517,.,0,0
99518,In,0,0
99519,patients,1,1
99520,with,1,1
99521,HBe,1,1
99522,antigen-positive,1,1
99523,disease,1,1
99524,acquired,1,0
99525,in,1,0
99526,adult,1,1
99527,life,1,0
99528,the,0,0
99529,response,0,0
99530,rates,0,0
99531,vary,0,0
99532,from,0,0
99533,25-50,0,1
99534,%,0,0
99535,.,0,0
99536,In,0,0
99537,those,0,0
99538,infected,0,1
99539,at,0,0
99540,birth,0,1
99541,",",0,0
99542,response,0,0
99543,rates,0,0
99544,are,0,0
99545,lower,0,0
99546,.,0,0
99547,Twenty-one,1,1
99548,pretreatment,1,0
99549,variables,1,0
99550,were,1,0
99551,assessed,1,0
99552,for,1,0
99553,their,1,0
99554,significance,1,0
99555,in,1,0
99556,response,1,0
99557,prediction,1,0
99558,using,1,0
99559,data,1,0
99560,from,1,1
99561,114,1,1
99562,patients,1,1
99563,given,1,0
99564,alpha-interferon,1,0
99565,for,1,0
99566,chronic,1,1
99567,hepatitis,1,1
99568,B,1,0
99569,virus,1,1
99570,infection,1,0
99571,.,1,0
99572,In,0,0
99573,those,0,1
99574,patients,0,1
99575,who,0,1
99576,had,0,1
99577,received,0,1
99578,a,0,0
99579,minimum,0,0
99580,of,0,0
99581,90,0,0
99582,million,0,1
99583,units,0,0
99584,per,0,0
99585,m2,0,1
99586,total,0,1
99587,dose,0,0
99588,over,0,0
99589,12,0,0
99590,weeks,0,0
99591,",",0,0
99592,a,0,0
99593,negative,0,0
99594,anti-human,0,0
99595,immunodeficiency,0,1
99596,virus,0,1
99597,antibody,0,0
99598,status,0,0
99599,(,0,0
99600,p,0,0
99601,less,0,0
99602,than,0,0
99603,0.001,0,0
99604,),0,0
99605,",",0,0
99606,chronic,0,1
99607,active,0,0
99608,hepatitis,0,1
99609,on,0,0
99610,liver,0,1
99611,biopsy,0,0
99612,(,0,0
99613,p,0,0
99614,less,0,0
99615,than,0,0
99616,0.005,0,0
99617,),0,0
99618,",",0,0
99619,high,0,0
99620,AST,0,0
99621,level,0,0
99622,(,0,0
99623,p,0,0
99624,less,0,0
99625,than,0,0
99626,0.001,0,0
99627,),0,0
99628,",",0,0
99629,low,0,0
99630,hepatitis,0,1
99631,B,0,0
99632,virus,0,1
99633,DNA,0,0
99634,level,0,0
99635,(,0,0
99636,p,0,0
99637,less,0,0
99638,than,0,0
99639,0.001,0,0
99640,),0,0
99641,and,0,0
99642,a,0,0
99643,history,0,0
99644,of,0,0
99645,acute,0,1
99646,hepatitis,0,1
99647,(,0,0
99648,p,0,0
99649,less,0,0
99650,than,0,0
99651,0.005,0,0
99652,),0,0
99653,were,0,0
99654,all,0,0
99655,associated,0,0
99656,with,0,0
99657,an,0,0
99658,increased,0,0
99659,likelihood,0,0
99660,of,0,0
99661,response,0,0
99662,on,0,0
99663,univariate,0,0
99664,analysis,0,0
99665,.,0,0
99666,On,0,0
99667,stepwise,0,0
99668,logistic,0,0
99669,regression,0,0
99670,analysis,0,0
99671,",",0,0
99672,hepatitis,0,1
99673,B,0,0
99674,virus,0,1
99675,DNA,0,0
99676,",",0,0
99677,AST,0,0
99678,and,0,0
99679,a,0,0
99680,history,0,0
99681,of,0,0
99682,acute,0,1
99683,hepatitis,0,1
99684,predicted,0,0
99685,response,0,0
99686,independently,0,0
99687,(,0,0
99688,p,0,0
99689,less,0,0
99690,than,0,0
99691,0.05,0,0
99692,),0,0
99693,.,0,0
99694,The,0,0
99695,most,0,0
99696,reliable,0,0
99697,combination,0,0
99698,of,0,0
99699,predictive,0,0
99700,factors,0,0
99701,was,0,0
99702,a,0,0
99703,negative,0,0
99704,anti-human,0,0
99705,immunodeficiency,0,1
99706,virus,0,1
99707,antibody,0,0
99708,status,0,0
99709,",",0,0
99710,with,0,0
99711,either,0,0
99712,a,0,0
99713,positive,0,0
99714,history,0,1
99715,of,0,0
99716,acute,0,1
99717,icteric,0,1
99718,hepatitis,0,1
99719,and,0,0
99720,AST,0,0
99721,greater,0,0
99722,than,0,0
99723,45,0,1
99724,IU,0,0
99725,per,0,0
99726,liter,0,0
99727,or,0,0
99728,no,0,0
99729,history,0,0
99730,of,0,0
99731,acute,0,1
99732,icteric,0,1
99733,hepatitis,0,1
99734,and,0,0
99735,AST,0,0
99736,greater,0,0
99737,than,0,0
99738,85,0,1
99739,IU,0,0
99740,per,0,0
99741,liter,0,0
99742,",",0,0
99743,which,0,0
99744,predicted,0,0
99745,response,0,0
99746,in,0,0
99747,77,0,0
99748,%,0,0
99749,with,0,0
99750,a,0,0
99751,specificity,0,0
99752,of,0,0
99753,79,0,0
99754,%,0,0
99755,(,0,0
99756,p,0,0
99757,less,0,0
99758,than,0,0
99759,0.001,0,0
99760,),0,0
99761,.,0,0
99762,The,0,0
99763,loss,0,0
99764,of,0,0
99765,HBsAg,0,0
99766,in,0,0
99767,addition,0,0
99768,to,0,0
99769,HBeAg,0,1
99770,and,0,0
99771,hepatitis,0,1
99772,B,0,0
99773,virus,0,1
99774,DNA,0,0
99775,was,0,0
99776,more,0,0
99777,likely,0,0
99778,to,0,0
99779,occur,0,0
99780,in,0,0
99781,patients,1,1
99782,with,0,1
99783,chronic,0,1
99784,infection,0,1
99785,of,0,0
99786,less,0,0
99787,than,0,0
99788,2,0,0
99789,years,0,1
99790,duration,0,0
99791,(,0,0
99792,p,0,0
99793,less,0,0
99794,than,0,0
99795,0.001,0,0
99796,),0,0
99797,.,0,0
99798,Seven-star,0,0
99799,needle,0,0
99800,stimulation,0,0
99801,improves,0,0
99802,language,0,0
99803,and,0,0
99804,social,0,0
99805,interaction,0,0
99806,of,0,0
99807,children,1,1
99808,with,1,1
99809,autistic,1,1
99810,spectrum,1,1
99811,disorders,1,1
99812,.,1,0
99813,This,0,0
99814,is,0,0
99815,a,0,0
99816,randomized,0,0
99817,controlled,0,0
99818,trial,0,0
99819,that,0,0
99820,aimed,0,0
99821,to,0,0
99822,evaluate,0,0
99823,the,0,0
99824,effect,0,0
99825,of,0,0
99826,the,0,0
99827,Seven-star,0,0
99828,Needle,0,0
99829,Stimulation,0,0
99830,treatment,0,0
99831,on,0,0
99832,children,1,1
99833,with,1,1
99834,Autistic,1,1
99835,Spectrum,1,1
99836,Disorders,1,1
99837,(,1,0
99838,ASD,1,1
99839,),1,0
99840,.,1,0
99841,Thirty-two,1,1
99842,children,1,1
99843,with,1,1
99844,ASD,1,1
99845,were,0,0
99846,assigned,0,0
99847,randomly,0,0
99848,into,0,0
99849,the,0,0
99850,treatment,0,0
99851,and,0,0
99852,control,0,0
99853,groups,0,0
99854,.,0,0
99855,Children,0,1
99856,in,0,0
99857,the,0,0
99858,treatment,1,0
99859,group,1,0
99860,underwent,0,1
99861,30,0,0
99862,sessions,0,0
99863,of,0,0
99864,stimulation,0,0
99865,over,0,0
99866,6,0,0
99867,weeks,0,0
99868,",",0,0
99869,while,0,0
99870,children,0,1
99871,in,0,0
99872,the,0,0
99873,control,1,0
99874,group,1,0
99875,were,0,0
99876,on,0,0
99877,a,0,0
99878,waiting,0,0
99879,list,0,0
99880,and,0,0
99881,did,0,0
99882,not,0,0
99883,receive,0,0
99884,treatment,0,0
99885,during,0,0
99886,this,0,0
99887,period,0,0
99888,of,0,0
99889,time,0,0
99890,.,0,0
99891,Intervention,0,0
99892,consisted,0,0
99893,of,0,0
99894,a,0,0
99895,treatment,0,0
99896,regime,0,0
99897,comprising,0,0
99898,of,0,0
99899,30,0,0
99900,sessions,0,0
99901,of,0,0
99902,Seven-star,0,0
99903,Needle,0,0
99904,Stimulation,0,0
99905,",",0,0
99906,delivered,0,0
99907,over,0,0
99908,6,0,0
99909,weeks,0,0
99910,.,0,0
99911,Each,0,0
99912,session,0,0
99913,lasted,0,0
99914,5,0,0
99915,to,0,0
99916,10,0,0
99917,min,0,0
99918,",",0,0
99919,children,0,1
99920,in,0,0
99921,the,0,0
99922,treatment,0,0
99923,group,0,0
99924,were,0,0
99925,stimulated,0,0
99926,at,0,0
99927,the,0,0
99928,front,0,0
99929,and,0,0
99930,back,0,0
99931,sides,0,0
99932,of,0,0
99933,their,0,0
99934,body,0,0
99935,and,0,0
99936,the,0,0
99937,head,0,0
99938,by,0,0
99939,using,0,0
99940,Seven-star,0,0
99941,Needles,0,0
99942,.,0,0
99943,The,0,0
99944,change,0,0
99945,in,0,0
99946,the,0,0
99947,children,0,1
99948,'s,0,0
99949,behavior,0,0
99950,was,0,0
99951,evaluated,0,0
99952,using,0,0
99953,parents,0,1
99954,',0,1
99955,report,0,0
99956,and,0,0
99957,neurophysiological,0,0
99958,changes,0,0
99959,were,0,0
99960,measured,0,0
99961,by,0,0
99962,quantitative,0,0
99963,EEG,0,0
99964,(,0,0
99965,qEEG,0,1
99966,),0,0
99967,.,0,0
99968,Results,0,0
99969,showed,0,0
99970,that,0,0
99971,the,0,0
99972,treatment,0,0
99973,group,0,0
99974,demonstrated,0,0
99975,significant,0,0
99976,improvement,0,0
99977,in,0,0
99978,language,0,0
99979,and,0,0
99980,social,0,0
99981,interaction,0,0
99982,",",0,0
99983,but,0,0
99984,not,0,0
99985,in,0,0
99986,stereotyped,0,0
99987,behavior,0,0
99988,or,0,0
99989,motor,0,0
99990,function,0,0
99991,",",0,0
99992,compared,0,0
99993,to,0,0
99994,the,0,0
99995,control,0,0
99996,group,0,0
99997,.,0,0
99998,qEEG,0,0
99999,spectral,0,0
100000,amplitudes,0,0
100001,in,0,0
100002,the,0,0
100003,treatment,0,0
100004,",",0,0
100005,but,0,0
100006,not,0,0
100007,in,0,0
100008,the,0,0
100009,control,0,0
100010,group,0,0
100011,",",0,0
100012,were,0,0
100013,also,0,0
100014,reduced,0,0
100015,significantly,0,0
100016,.,0,0
100017,The,0,0
100018,results,0,0
100019,suggested,0,0
100020,that,0,0
100021,Seven-star,0,0
100022,Needle,0,0
100023,Stimulation,0,0
100024,might,0,0
100025,be,0,0
100026,an,0,0
100027,effective,0,0
100028,intervention,0,0
100029,to,0,0
100030,improve,0,0
100031,language,0,0
100032,and,0,0
100033,social,0,0
100034,functioning,0,0
100035,of,0,0
100036,children,1,1
100037,with,1,1
100038,ASD,1,1
100039,.,1,1
100040,A,0,0
100041,double-blind,0,0
100042,placebo-controlled,0,0
100043,study,0,0
100044,to,0,0
100045,evaluate,0,0
100046,valacyclovir,0,0
100047,alone,0,0
100048,and,0,0
100049,with,0,0
100050,aspirin,0,0
100051,for,0,0
100052,asymptomatic,0,1
100053,HSV-1,0,0
100054,DNA,0,0
100055,shedding,0,0
100056,in,0,0
100057,human,1,1
100058,tears,1,1
100059,and,1,0
100060,saliva,1,0
100061,.,1,0
100062,PURPOSE,0,0
100063,To,0,0
100064,test,0,0
100065,the,0,0
100066,effect,0,0
100067,of,0,0
100068,valacyclovir,0,0
100069,alone,0,0
100070,and,0,0
100071,with,0,0
100072,aspirin,0,0
100073,on,0,0
100074,the,0,0
100075,asymptomatic,0,1
100076,shedding,0,0
100077,of,0,0
100078,HSV-1,0,0
100079,DNA,0,0
100080,in,0,0
100081,tears,1,1
100082,and,1,0
100083,saliva,1,0
100084,of,1,0
100085,healthy,1,1
100086,individuals,1,1
100087,.,1,1
100088,METHOD,0,0
100089,.,0,0
100090,The,1,0
100091,subjects,1,1
100092,(,1,0
100093,n,1,1
100094,=,1,0
100095,45,1,1
100096,),1,0
100097,were,0,0
100098,randomized,0,0
100099,into,0,1
100100,three,0,0
100101,groups,0,0
100102,without,0,1
100103,regard,0,0
100104,to,0,0
100105,age,0,1
100106,",",0,0
100107,sex,0,0
100108,",",0,0
100109,or,0,0
100110,race,0,0
100111,.,0,0
100112,Group,0,0
100113,1,0,0
100114,(,0,0
100115,n,0,1
100116,=,0,0
100117,14,0,1
100118,),0,0
100119,received,0,0
100120,the,0,0
100121,placebo,0,0
100122,",",0,0
100123,group,0,0
100124,2,0,0
100125,(,0,0
100126,n,0,1
100127,=,0,0
100128,15,0,1
100129,),0,0
100130,received,0,0
100131,a,0,0
100132,dose,0,0
100133,of,0,0
100134,500,0,0
100135,mg,0,0
100136,valacyclovir,0,0
100137,once,0,0
100138,daily,0,0
100139,",",0,0
100140,and,0,0
100141,group,0,0
100142,3,0,0
100143,(,0,0
100144,n,0,1
100145,=,0,0
100146,16,0,1
100147,),0,0
100148,received,0,0
100149,a,0,0
100150,dose,0,0
100151,of,0,0
100152,500,0,0
100153,mg,0,0
100154,valacyclovir,0,0
100155,once,0,0
100156,daily,0,0
100157,and,0,0
100158,350,0,0
100159,mg,0,0
100160,aspirin,0,0
100161,twice,0,0
100162,daily,0,0
100163,for,0,0
100164,30,0,0
100165,days,0,0
100166,.,0,1
100167,Ocular,0,1
100168,and,0,0
100169,oral,0,0
100170,swabs,0,1
100171,were,0,0
100172,collected,0,0
100173,twice,0,0
100174,daily,0,0
100175,for,0,0
100176,30,0,0
100177,days,0,0
100178,.,0,1
100179,DNA,0,0
100180,was,0,0
100181,extracted,0,0
100182,from,0,0
100183,all,0,0
100184,swabs,0,1
100185,and,0,0
100186,HSV-1,0,0
100187,DNA,0,0
100188,copy,0,0
100189,numbers,0,0
100190,were,0,0
100191,determined,0,0
100192,.,0,0
100193,Statistical,0,0
100194,analysis,0,0
100195,was,0,0
100196,performed,0,0
100197,to,0,0
100198,compare,0,0
100199,the,0,0
100200,DNA,0,0
100201,copy,0,0
100202,numbers,0,0
100203,of,0,0
100204,the,0,0
100205,three,0,0
100206,groups,0,0
100207,.,0,1
100208,RESULTS,0,0
100209,There,0,0
100210,was,0,0
100211,no,0,0
100212,significant,0,0
100213,difference,0,0
100214,in,0,0
100215,the,0,0
100216,HSV-1,0,0
100217,DNA,0,0
100218,copy,0,0
100219,numbers,0,0
100220,in,0,0
100221,the,0,0
100222,tears,0,1
100223,or,0,0
100224,saliva,0,0
100225,among,0,0
100226,any,0,0
100227,of,0,0
100228,the,0,0
100229,three,0,0
100230,treatment,0,0
100231,groups,0,0
100232,.,0,0
100233,The,0,0
100234,mean,0,0
100235,copy,0,0
100236,numbers,0,0
100237,+/-,0,0
100238,SE,0,0
100239,of,0,0
100240,mean,0,0
100241,(,0,0
100242,SEM,0,0
100243,),0,0
100244,of,0,0
100245,HSV-1,0,0
100246,DNA,0,0
100247,in,0,0
100248,tears,0,1
100249,were,0,1
100250,340,0,1
100251,+/-,0,0
100252,35,0,1
100253,",",0,0
100254,1074,0,1
100255,+/-,0,0
100256,320,0,0
100257,",",0,0
100258,and,0,0
100259,630,0,0
100260,+/-,0,0
100261,51,0,1
100262,for,0,0
100263,groups,0,0
100264,1,0,0
100265,",",0,0
100266,2,0,0
100267,",",0,0
100268,and,0,0
100269,3,0,0
100270,",",0,0
100271,and,0,0
100272,in,0,0
100273,saliva,0,0
100274,were,0,0
100275,238,0,1
100276,+/-,0,0
100277,35,0,1
100278,",",0,0
100279,963,0,1
100280,+/-,0,0
100281,462,0,1
100282,",",0,0
100283,and,0,0
100284,493,0,1
100285,+/-,0,0
100286,25,0,0
100287,",",0,0
100288,respectively,0,0
100289,",",0,0
100290,for,0,0
100291,groups,0,0
100292,1,0,0
100293,",",0,0
100294,2,0,0
100295,",",0,0
100296,and,0,0
100297,3,0,0
100298,.,0,0
100299,CONCLUSIONS,0,0
100300,No,0,0
100301,correlation,0,0
100302,was,0,0
100303,found,0,0
100304,between,0,0
100305,HSV-1,0,0
100306,shedding,0,0
100307,and,0,0
100308,valacyclovir,0,0
100309,and,0,0
100310,valacyclovir,0,0
100311,with,0,1
100312,aspirin,0,0
100313,treatment,0,0
100314,.,0,0
100315,The,0,0
100316,HSV-1,0,0
100317,DNA,0,0
100318,copy,0,0
100319,number,0,0
100320,was,0,0
100321,not,0,0
100322,reduced,0,0
100323,by,0,0
100324,treatment,0,0
100325,with,0,1
100326,500,0,0
100327,mg,0,0
100328,of,0,0
100329,valacyclovir,0,0
100330,daily,0,0
100331,or,0,0
100332,with,0,0
100333,a,0,0
100334,combination,0,0
100335,of,0,0
100336,daily,0,0
100337,valacyclovir,0,0
100338,(,0,0
100339,500,0,0
100340,mg,0,0
100341,),0,0
100342,plus,0,0
100343,twice-daily,0,0
100344,doses,0,0
100345,of,0,0
100346,aspirin,0,0
100347,(,0,0
100348,350,0,0
100349,mg,0,0
100350,),0,0
100351,over,0,0
100352,30,0,1
100353,days,0,0
100354,.,0,1
100355,A,0,0
100356,comparison,0,0
100357,of,0,0
100358,a,0,0
100359,spiritually,0,0
100360,based,0,0
100361,and,0,0
100362,non-spiritually,0,0
100363,based,0,0
100364,educational,0,0
100365,intervention,0,0
100366,for,0,0
100367,informed,0,0
100368,decision,0,0
100369,making,0,0
100370,for,0,0
100371,prostate,0,1
100372,cancer,0,1
100373,screening,0,0
100374,among,0,0
100375,church-attending,1,1
100376,African-American,1,1
100377,men,1,1
100378,.,1,1
100379,INTRODUCTION,0,0
100380,Health,0,0
100381,communication,0,0
100382,interventions,0,0
100383,have,0,0
100384,been,0,0
100385,modestly,0,0
100386,effective,0,0
100387,for,0,0
100388,increasing,0,0
100389,informed,0,0
100390,decision,0,0
100391,making,0,0
100392,for,0,0
100393,prostate,0,1
100394,cancer,0,1
100395,screening,0,0
100396,among,1,0
100397,African-American,1,1
100398,men,1,1
100399,;,1,0
100400,however,0,0
100401,",",0,0
100402,knowledge,0,0
100403,and,0,0
100404,informed,0,0
100405,decision,0,0
100406,making,0,0
100407,is,0,0
100408,still,0,0
100409,questionable,0,0
100410,even,0,0
100411,with,0,1
100412,screening,0,0
100413,.,0,1
100414,Church-based,0,0
100415,programs,0,0
100416,may,0,0
100417,be,0,0
100418,more,0,0
100419,effective,0,0
100420,if,0,0
100421,they,0,0
100422,are,0,0
100423,spiritually,0,0
100424,based,0,0
100425,in,0,0
100426,nature,0,0
100427,.,0,0
100428,OBJECTIVE,0,0
100429,The,0,0
100430,aims,0,0
100431,of,0,0
100432,the,0,0
100433,present,0,0
100434,study,0,0
100435,were,0,0
100436,to,0,0
100437,implement,0,0
100438,and,0,0
100439,provide,0,0
100440,an,0,0
100441,initial,0,0
100442,evaluation,0,0
100443,of,0,0
100444,a,0,0
100445,spiritually,0,0
100446,based,0,0
100447,prostate,0,0
100448,cancer,0,1
100449,screening,0,0
100450,informed,0,0
100451,decision,0,0
100452,making,0,0
100453,intervention,0,0
100454,for,0,0
100455,African-American,1,1
100456,men,1,1
100457,who,1,1
100458,attend,1,1
100459,church,1,1
100460,",",0,0
100461,and,0,0
100462,determine,0,0
100463,its,0,0
100464,efficacy,0,0
100465,for,0,0
100466,increasing,0,0
100467,informed,0,0
100468,decision,0,0
100469,making,0,0
100470,.,0,0
100471,DESIGN,0,0
100472,AND,0,0
100473,METHOD,0,0
100474,Churches,1,1
100475,were,0,0
100476,randomized,0,0
100477,to,0,0
100478,receive,0,0
100479,either,0,0
100480,the,0,0
100481,spiritually,0,0
100482,based,0,0
100483,or,0,0
100484,the,0,0
100485,non-spiritual,0,0
100486,intervention,0,0
100487,.,0,0
100488,Trained,0,0
100489,community,0,1
100490,health,0,0
100491,advisors,0,1
100492,",",0,1
100493,who,0,1
100494,were,0,1
100495,African-American,0,1
100496,male,0,1
100497,church,0,1
100498,members,0,1
100499,",",0,0
100500,led,0,0
100501,an,0,0
100502,educational,0,0
100503,session,0,0
100504,and,0,0
100505,distributed,0,0
100506,educational,0,0
100507,print,0,0
100508,materials,0,1
100509,.,0,1
100510,Participants,0,1
100511,completed,0,1
100512,baseline,0,0
100513,and,0,0
100514,immediate,0,0
100515,follow-up,0,0
100516,surveys,0,0
100517,to,0,0
100518,assess,0,0
100519,the,0,0
100520,intervention,0,0
100521,impact,0,0
100522,on,0,0
100523,study,0,0
100524,outcomes,0,0
100525,.,0,0
100526,RESULTS,0,0
100527,The,0,0
100528,spiritually,0,0
100529,based,0,0
100530,intervention,0,0
100531,appeared,0,0
100532,to,0,0
100533,be,0,0
100534,more,0,0
100535,effective,0,0
100536,in,0,0
100537,areas,0,0
100538,such,0,0
100539,as,0,0
100540,knowledge,0,0
100541,",",0,0
100542,and,0,0
100543,men,0,1
100544,read,0,0
100545,more,0,0
100546,of,0,0
100547,their,0,0
100548,materials,0,1
100549,in,0,0
100550,the,0,0
100551,spiritually,0,0
100552,based,0,0
100553,group,0,0
100554,than,0,0
100555,in,0,0
100556,the,0,0
100557,non-spiritual,0,0
100558,group,0,0
100559,.,0,0
100560,CONCLUSIONS,0,0
100561,Further,0,0
100562,examination,0,0
100563,of,0,0
100564,the,0,0
100565,efficacy,0,0
100566,of,0,0
100567,the,0,0
100568,spiritually,0,0
100569,based,0,0
100570,approach,0,0
100571,to,0,0
100572,health,0,0
100573,communication,0,0
100574,is,0,0
100575,warranted,0,0
100576,.,0,0
100577,[,0,0
100578,Effects,0,0
100579,of,0,0
100580,auditory,0,0
100581,integrative,0,0
100582,training,0,0
100583,on,0,0
100584,autistic,1,1
100585,children,1,1
100586,],1,1
100587,.,0,0
100588,OBJECTIVE,0,0
100589,To,0,0
100590,explore,0,0
100591,the,0,0
100592,short-term,0,0
100593,treatment,0,0
100594,effect,0,0
100595,of,0,0
100596,the,0,0
100597,auditory,0,0
100598,integrative,0,0
100599,training,0,0
100600,on,0,0
100601,autistic,1,1
100602,children,1,1
100603,and,0,0
100604,provide,0,0
100605,them,0,0
100606,with,0,0
100607,clinical,0,0
100608,support,0,0
100609,for,0,0
100610,rehabilitative,0,1
100611,treatment,0,0
100612,.,0,0
100613,METHODS,0,0
100614,A,1,0
100615,total,1,1
100616,of,1,0
100617,81,1,1
100618,cases,1,1
100619,of,1,0
100620,autistic,1,1
100621,children,1,1
100622,were,0,0
100623,selected,0,1
100624,through,0,0
100625,the,0,0
100626,standard,0,0
100627,of,0,0
100628,DSM-4,0,0
100629,and,0,0
100630,clinical,0,0
100631,case,0,0
100632,study,0,0
100633,was,0,0
100634,used,0,0
100635,.,0,0
100636,They,0,0
100637,were,0,0
100638,divided,1,0
100639,randomly,1,1
100640,into,1,0
100641,experimental,1,0
100642,group,1,0
100643,and,1,0
100644,control,1,0
100645,one,1,0
100646,",",0,0
100647,and,0,0
100648,respectively,0,0
100649,received,0,0
100650,auditory,0,0
100651,integrative,0,0
100652,training,0,0
100653,and,0,0
100654,no,0,0
100655,training,0,0
100656,based,0,0
100657,on,0,0
100658,the,0,0
100659,multiple,0,0
100660,therapies,0,0
100661,.,0,1
100662,The,0,0
100663,patients,0,1
100664,were,0,0
100665,investigated,0,0
100666,using,0,0
100667,clinical,0,0
100668,manifestation,0,0
100669,and,0,0
100670,Autism,0,1
100671,Behavior,0,0
100672,Checklist,0,0
100673,(,0,0
100674,ABC,0,0
100675,),0,0
100676,and,0,0
100677,intelligence,0,0
100678,quotient,0,0
100679,(,0,0
100680,IQ,0,0
100681,),0,0
100682,before,0,0
100683,and,0,0
100684,after,0,0
100685,six,0,0
100686,months,0,0
100687,of,0,0
100688,treatment,0,0
100689,.,0,0
100690,The,0,0
100691,effect,0,0
100692,was,0,0
100693,evaluated,0,0
100694,through,0,0
100695,the,0,0
100696,changes,0,0
100697,of,0,0
100698,clinical,0,0
100699,manifestations,0,0
100700,and,0,0
100701,scores,0,0
100702,of,0,0
100703,ABC,0,1
100704,and,0,0
100705,IQ,0,0
100706,.,0,0
100707,The,0,0
100708,changes,0,0
100709,of,0,0
100710,scores,0,0
100711,of,0,0
100712,IQ,0,0
100713,were,0,0
100714,determined,0,0
100715,with,0,1
100716,Gesell,0,0
100717,and,0,0
100718,WPPSI,0,0
100719,or,0,0
100720,WISC-R,0,0
100721,.,0,0
100722,RESULTS,0,0
100723,Compared,0,0
100724,with,0,1
100725,40,1,1
100726,patients,1,1
100727,of,1,0
100728,the,1,0
100729,control,1,0
100730,group,1,0
100731,after,1,0
100732,the,1,0
100733,six,1,0
100734,months,1,0
100735,of,1,0
100736,the,1,0
100737,auditory,1,0
100738,integrative,1,0
100739,training,1,0
100740,",",1,0
100741,41,1,1
100742,of,1,0
100743,the,1,0
100744,experimental,1,0
100745,group,1,0
100746,had,0,0
100747,greatly,0,0
100748,improved,0,0
100749,in,0,0
100750,many,0,0
100751,aspects,0,0
100752,",",0,0
100753,such,0,0
100754,as,0,0
100755,the,0,0
100756,disorders,0,1
100757,of,0,0
100758,their,0,0
100759,language,0,0
100760,",",0,0
100761,social,0,0
100762,interactions,0,0
100763,and,0,0
100764,typical,0,1
100765,behavior,0,0
100766,symptoms,0,0
100767,while,0,0
100768,they,0,0
100769,had,0,0
100770,not,0,0
100771,changed,0,0
100772,in,0,0
100773,their,0,0
100774,abnormal,0,0
100775,behaviors,0,0
100776,.,0,1
100777,The,0,0
100778,scores,0,0
100779,of,0,0
100780,IQ,0,0
100781,or,0,1
100782,DQ,0,0
100783,had,0,0
100784,increased,0,0
100785,and,0,0
100786,scores,0,0
100787,of,0,0
100788,ABC,0,1
100789,had,0,0
100790,dropped,0,0
100791,.,0,0
100792,The,0,0
100793,differences,0,0
100794,between,0,0
100795,the,0,0
100796,two,1,0
100797,groups,1,0
100798,were,0,0
100799,greatly,0,0
100800,significant,0,0
100801,in,0,0
100802,statistics,0,0
100803,(,0,0
100804,P,0,0
100805,<,0,0
100806,0.01,0,0
100807,),0,0
100808,.,0,0
100809,The,0,0
100810,decreasing,0,0
100811,level,0,0
100812,of,0,0
100813,both,0,0
100814,ABC,0,0
100815,scores,0,0
100816,and,0,0
100817,the,0,0
100818,increasing,0,0
100819,level,0,0
100820,of,0,0
100821,the,0,0
100822,IQ,0,0
100823,scores,0,0
100824,were,0,0
100825,negatively,0,0
100826,correlated,0,0
100827,with,0,0
100828,age,0,1
100829,",",0,0
100830,and,0,0
100831,the,0,0
100832,decreasing,0,0
100833,level,0,0
100834,of,0,0
100835,ABC,0,0
100836,scores,0,0
100837,was,0,0
100838,in,0,0
100839,line,0,0
100840,regression,0,0
100841,(,0,0
100842,positive,0,0
100843,correlation,0,0
100844,),0,0
100845,with,0,0
100846,base,0,0
100847,IQ,0,0
100848,.,0,0
100849,CONCLUSION,0,0
100850,The,0,0
100851,treatment,0,0
100852,of,0,0
100853,auditory,0,0
100854,integrative,0,0
100855,training,0,0
100856,(,0,0
100857,AIT,0,0
100858,),0,0
100859,could,0,0
100860,greatly,0,0
100861,improve,0,0
100862,on,0,0
100863,language,0,0
100864,disorders,0,1
100865,",",0,0
100866,the,0,0
100867,difficulties,0,0
100868,of,0,0
100869,social,0,0
100870,interactions,0,0
100871,",",0,0
100872,typical,0,1
100873,behavior,0,0
100874,symptoms,0,0
100875,and,0,0
100876,developmental,0,1
100877,levels,0,0
100878,",",0,0
100879,therefore,0,0
100880,it,0,0
100881,is,0,0
100882,positive,0,0
100883,to,0,0
100884,the,0,0
100885,autistic,1,1
100886,children,1,1
100887,in,0,0
100888,its,0,0
100889,short-term,0,0
100890,treatment,0,0
100891,effect,0,0
100892,.,0,0
100893,Phase,0,0
100894,III,0,0
100895,",",0,0
100896,randomised,0,0
100897,",",0,0
100898,multicentre,0,0
100899,trial,0,0
100900,of,0,0
100901,maintenance,0,0
100902,immunotherapy,0,0
100903,with,0,1
100904,low-dose,0,0
100905,interleukin-2,0,0
100906,and,0,0
100907,interferon-alpha,0,0
100908,for,0,0
100909,metastatic,1,1
100910,renal,1,1
100911,cell,1,1
100912,cancer,1,1
100913,.,1,0
100914,This,0,0
100915,is,0,0
100916,the,0,0
100917,first,0,0
100918,phase,0,0
100919,III,0,0
100920,randomised,0,0
100921,trial,0,0
100922,to,0,0
100923,evaluate,0,0
100924,maintenance,0,0
100925,immunotherapy,0,0
100926,in,0,0
100927,metastatic,1,1
100928,renal,1,1
100929,cell,1,0
100930,cancer,1,1
100931,(,0,0
100932,mRCC,0,0
100933,),0,0
100934,.,0,0
100935,Patients,1,1
100936,were,0,0
100937,randomised,0,0
100938,to,0,0
100939,receive,0,0
100940,treatment,0,0
100941,with,0,0
100942,a,0,0
100943,4-week,0,0
100944,cycle,0,0
100945,of,0,0
100946,subcutaneous,0,1
100947,low,0,1
100948,doses,0,0
100949,IL-2,0,1
100950,+,0,0
100951,IFN,0,1
100952,in,0,0
100953,months,0,0
100954,1,0,0
100955,",",0,0
100956,3,0,0
100957,and,0,0
100958,5,0,0
100959,",",0,0
100960,and,0,0
100961,then,0,0
100962,every,0,0
100963,3,0,0
100964,months,0,0
100965,until,0,0
100966,the,0,0
100967,first,0,0
100968,documented,0,0
100969,disease,0,1
100970,progression,0,0
100971,(,0,0
100972,arm,0,0
100973,A,0,0
100974,",",0,0
100975,suspension,0,0
100976,),0,0
100977,",",0,0
100978,or,0,0
100979,the,0,0
100980,same,0,0
100981,regimen,0,0
100982,",",0,0
100983,with,0,1
100984,chronic,0,1
100985,maintenance,0,0
100986,of,0,0
100987,immunotherapy,0,0
100988,",",0,0
100989,regardless,0,0
100990,of,0,0
100991,tumour,0,0
100992,response,0,0
100993,",",0,0
100994,until,0,0
100995,death,0,0
100996,or,0,0
100997,intolerable,0,0
100998,toxicity,0,0
100999,(,0,0
101000,arm,0,0
101001,B,0,0
101002,",",0,0
101003,maintenance,0,0
101004,),0,0
101005,.,0,0
101006,The,0,0
101007,primary,0,0
101008,endpoint,0,0
101009,was,0,0
101010,overall,0,0
101011,survival,0,0
101012,(,0,0
101013,OS,0,0
101014,),0,0
101015,;,0,0
101016,secondary,0,0
101017,endpoints,0,0
101018,were,0,0
101019,time,0,0
101020,from,0,0
101021,first,0,0
101022,progression,0,0
101023,to,0,0
101024,death,0,0
101025,(,0,0
101026,TFPTD,0,0
101027,),0,0
101028,and,0,0
101029,tolerability,0,0
101030,.,0,0
101031,One,1,0
101032,hundred,1,1
101033,and,1,0
101034,eighty-three,1,1
101035,patients,1,1
101036,were,1,0
101037,enrolled,1,1
101038,between,1,0
101039,January,1,1
101040,1998,1,1
101041,and,1,0
101042,November,1,1
101043,2003,1,1
101044,.,1,0
101045,After,0,0
101046,a,0,0
101047,median,0,0
101048,follow-up,0,0
101049,of,0,0
101050,53.9,0,0
101051,months,0,0
101052,",",0,0
101053,response,0,0
101054,rate,0,0
101055,",",0,0
101056,median,0,0
101057,OS,0,0
101058,and,0,0
101059,median,0,0
101060,TFPTD,0,0
101061,were,0,0
101062,14.7,0,0
101063,%,0,0
101064,(,0,0
101065,6.3,0,0
101066,%,0,0
101067,CR,0,0
101068,),0,0
101069,versus,0,0
101070,11.3,0,0
101071,%,0,0
101072,(,0,0
101073,5.5,0,0
101074,%,0,0
101075,CR,0,0
101076,),0,0
101077,",",0,0
101078,14,0,0
101079,versus,0,0
101080,14,0,0
101081,months,0,0
101082,",",0,0
101083,6,0,0
101084,versus,0,0
101085,5,0,0
101086,months,0,0
101087,",",0,0
101088,in,0,0
101089,arms,0,0
101090,A,0,1
101091,and,0,0
101092,B,0,0
101093,",",0,0
101094,respectively,0,0
101095,with,0,0
101096,no,0,0
101097,significant,0,0
101098,differences,0,0
101099,between,0,0
101100,the,0,0
101101,groups,0,0
101102,.,0,0
101103,Cox,0,0
101104,regression,0,0
101105,analysis,0,0
101106,showed,0,0
101107,that,0,0
101108,the,0,0
101109,use,0,0
101110,of,0,0
101111,chemotherapy,0,0
101112,after,0,0
101113,first,0,0
101114,progression,0,0
101115,(,0,0
101116,HR,0,0
101117,0.54,0,0
101118,;,0,0
101119,95,0,0
101120,%,0,0
101121,CI,0,0
101122,0.35-0.86,0,0
101123,;,0,0
101124,p,0,0
101125,=,0,0
101126,0.008,0,0
101127,),0,0
101128,",",0,0
101129,PS,0,0
101130,=,0,0
101131,0,0,0
101132,(,0,0
101133,HR,0,0
101134,0.53,0,0
101135,;,0,0
101136,95,0,0
101137,%,0,0
101138,CI,0,0
101139,0.35-0.81,0,0
101140,;,0,0
101141,p,0,0
101142,=,0,0
101143,0.001,0,0
101144,),0,0
101145,and,0,0
101146,female,0,1
101147,gender,0,0
101148,(,0,0
101149,HR,0,0
101150,0.63,0,0
101151,;,0,0
101152,95,0,0
101153,%,0,0
101154,CI,0,0
101155,0.41-0.98,0,0
101156,;,0,0
101157,p,0,0
101158,=,0,0
101159,0.038,0,0
101160,),0,0
101161,were,0,0
101162,significantly,0,0
101163,associated,0,0
101164,with,0,0
101165,a,0,0
101166,longer,0,0
101167,TFPTD,0,0
101168,;,0,0
101169,treatment,0,0
101170,arm,0,0
101171,was,0,0
101172,not,0,0
101173,significant,0,0
101174,(,0,0
101175,HR,0,0
101176,0.88,0,0
101177,;,0,0
101178,95,0,0
101179,%,0,0
101180,CI,0,0
101181,0.60-1.31,0,0
101182,;,0,0
101183,p,0,0
101184,=,0,0
101185,0.54,0,0
101186,),0,0
101187,.,0,0
101188,Toxicity,0,0
101189,was,0,0
101190,mainly,0,0
101191,limited,0,0
101192,to,0,0
101193,WHO,0,0
101194,grades,0,1
101195,1,0,0
101196,or,0,0
101197,2,0,0
101198,.,0,0
101199,Chronic,0,0
101200,maintenance,0,0
101201,immunotherapy,0,0
101202,after,0,0
101203,disease,0,1
101204,progression,0,0
101205,is,0,0
101206,feasible,0,0
101207,",",0,0
101208,but,0,0
101209,does,0,0
101210,not,0,0
101211,significantly,0,0
101212,increase,0,0
101213,OS,0,0
101214,or,0,0
101215,the,0,0
101216,TFPTD,0,0
101217,.,0,0
101218,The,0,0
101219,experience,0,0
101220,of,0,0
101221,pleasure,0,0
101222,before,0,0
101223,and,0,0
101224,after,0,0
101225,hearing,1,1
101226,rehabilitation,1,1
101227,.,1,0
101228,Hearing,1,0
101229,loss,1,0
101230,may,0,0
101231,lead,0,0
101232,to,0,0
101233,major,0,0
101234,changes,0,0
101235,in,0,0
101236,the,0,0
101237,social,0,0
101238,and,0,0
101239,emotional,0,0
101240,aspects,0,0
101241,of,0,0
101242,daily,0,0
101243,life,0,0
101244,.,0,0
101245,This,0,0
101246,follow-up,0,0
101247,study,0,0
101248,investigated,0,0
101249,the,0,0
101250,effect,0,0
101251,of,0,0
101252,hearing-aid,0,1
101253,use,0,0
101254,on,0,0
101255,emotional,0,0
101256,experience,0,0
101257,in,0,0
101258,adults,1,1
101259,with,1,1
101260,hearing,1,1
101261,impairment,1,0
101262,.,1,1
101263,Thirteen,1,0
101264,individuals,1,1
101265,with,1,1
101266,impaired,1,1
101267,hearing,1,1
101268,were,1,0
101269,tested,1,0
101270,before,1,0
101271,and,1,0
101272,after,1,0
101273,6,1,0
101274,months,1,0
101275,of,1,0
101276,hearing-aid,1,1
101277,use,1,0
101278,",",0,0
101279,and,0,0
101280,were,0,0
101281,compared,0,0
101282,with,0,1
101283,19,1,1
101284,individuals,1,1
101285,who,1,1
101286,had,1,1
101287,worn,1,1
101288,hearing,1,1
101289,aids,1,1
101290,for,1,0
101291,many,1,1
101292,years,1,1
101293,.,1,1
101294,The,0,0
101295,participants,0,0
101296,reported,0,0
101297,their,0,1
101298,daily,0,0
101299,emotional,0,0
101300,experiences,0,0
101301,",",0,0
101302,by,0,0
101303,completing,0,0
101304,questionnaires,0,0
101305,relating,0,0
101306,to,0,0
101307,sensory,0,0
101308,and,0,0
101309,social,0,0
101310,pleasure,0,0
101311,.,0,0
101312,After,0,0
101313,6,0,0
101314,months,0,0
101315,of,0,0
101316,hearing-aid,0,1
101317,use,0,0
101318,",",0,0
101319,individuals,0,1
101320,experienced,0,0
101321,more,0,0
101322,physical,0,0
101323,and,0,0
101324,social,0,0
101325,pleasure,0,0
101326,",",0,0
101327,whereas,0,0
101328,individuals,0,1
101329,using,0,0
101330,hearing,0,1
101331,aids,0,1
101332,for,0,0
101333,long,0,1
101334,periods,0,0
101335,of,0,0
101336,time,0,0
101337,reported,0,0
101338,similar,0,0
101339,levels,0,0
101340,of,0,0
101341,pleasure,0,0
101342,at,0,0
101343,the,0,0
101344,beginning,0,0
101345,and,0,0
101346,at,0,0
101347,the,0,0
101348,end,0,0
101349,of,0,0
101350,a,0,0
101351,6-month,0,0
101352,interval,0,0
101353,.,0,0
101354,The,0,0
101355,participants,0,0
101356,also,0,0
101357,performed,0,0
101358,a,0,0
101359,visual,0,0
101360,task,0,0
101361,",",0,0
101362,in,0,0
101363,which,0,0
101364,they,0,0
101365,rated,0,0
101366,the,0,0
101367,intensity,0,0
101368,of,0,0
101369,pleasure,0,0
101370,they,0,0
101371,experienced,0,0
101372,in,0,0
101373,response,0,0
101374,to,0,0
101375,emotionally,0,0
101376,positive,0,0
101377,and,0,0
101378,neutral,0,1
101379,pictures,0,0
101380,differing,0,0
101381,in,0,0
101382,luminance,0,0
101383,contrast,0,0
101384,.,0,0
101385,In,0,0
101386,this,0,0
101387,task,0,0
101388,",",0,0
101389,pleasure,0,0
101390,typically,0,0
101391,decreases,0,0
101392,with,0,0
101393,decreasing,0,0
101394,contrast,0,0
101395,of,0,0
101396,the,0,0
101397,positive,0,0
101398,images,0,0
101399,displayed,0,0
101400,.,0,0
101401,Once,0,0
101402,they,0,0
101403,had,0,0
101404,been,0,0
101405,fitted,0,0
101406,with,0,1
101407,hearing,0,1
101408,aids,0,1
101409,",",0,0
101410,the,0,0
101411,participants,0,1
101412,reported,0,0
101413,lower,0,0
101414,levels,0,0
101415,of,0,0
101416,pleasure,0,0
101417,",",0,0
101418,especially,0,0
101419,at,0,0
101420,low,0,0
101421,contrast,0,0
101422,.,0,0
101423,These,0,0
101424,findings,0,0
101425,highlight,0,0
101426,that,0,0
101427,the,0,0
101428,anhedonia,0,0
101429,scales,0,0
101430,provide,0,0
101431,a,0,0
101432,measure,0,0
101433,sensitive,0,0
101434,to,0,0
101435,emotional,0,0
101436,improvements,0,0
101437,that,0,0
101438,accompany,0,0
101439,the,0,0
101440,partial,0,0
101441,restoration,0,0
101442,of,0,0
101443,hearing,0,0
101444,function,0,0
101445,",",0,0
101446,although,0,0
101447,these,0,0
101448,scales,0,0
101449,were,0,0
101450,not,0,0
101451,specifically,0,0
101452,designed,0,0
101453,for,0,0
101454,hearing-impaired,0,1
101455,populations,0,1
101456,.,0,0
101457,In,0,0
101458,contrast,0,0
101459,",",0,0
101460,the,0,0
101461,surprising,0,0
101462,decrease,0,0
101463,in,0,0
101464,pleasure,0,0
101465,ratings,0,0
101466,for,0,0
101467,pictures,0,0
101468,after,0,0
101469,the,0,0
101470,introduction,0,0
101471,of,0,0
101472,hearing-aid,0,0
101473,use,0,0
101474,may,0,0
101475,be,0,0
101476,because,0,0
101477,of,0,0
101478,the,0,0
101479,compensation,0,0
101480,of,0,0
101481,hearing,0,0
101482,loss,0,0
101483,by,0,0
101484,changes,0,0
101485,in,0,0
101486,visual,0,0
101487,attention,0,0
101488,functions,0,0
101489,.,0,1
101490,Eye,0,0
101491,movements,0,0
101492,affirm,0,0
101493,:,0,1
101494,automatic,0,0
101495,overt,0,0
101496,gaze,0,0
101497,and,0,0
101498,arrow,0,0
101499,cueing,0,0
101500,for,0,0
101501,typical,1,1
101502,adults,1,1
101503,and,1,0
101504,adults,1,1
101505,with,1,1
101506,autism,1,1
101507,spectrum,1,1
101508,disorder,1,1
101509,.,1,0
101510,People,1,0
101511,with,1,0
101512,autism,1,1
101513,spectrum,1,1
101514,disorder,1,1
101515,(,1,0
101516,ASD,1,1
101517,),1,0
101518,show,0,0
101519,reduced,0,0
101520,interest,0,0
101521,towards,0,0
101522,social,0,0
101523,aspects,0,0
101524,of,0,0
101525,the,0,0
101526,environment,0,0
101527,and,0,0
101528,a,0,0
101529,lesser,0,0
101530,tendency,0,0
101531,to,0,0
101532,follow,0,0
101533,other,0,0
101534,people,0,1
101535,'s,0,1
101536,gaze,0,0
101537,in,0,0
101538,the,0,0
101539,real,0,0
101540,world,0,0
101541,.,0,0
101542,However,0,0
101543,",",0,0
101544,most,0,0
101545,studies,0,0
101546,have,0,0
101547,shown,0,0
101548,that,0,0
101549,people,1,1
101550,with,1,1
101551,ASD,1,1
101552,do,0,0
101553,respond,0,0
101554,to,0,0
101555,eye-gaze,0,0
101556,cues,0,0
101557,in,0,0
101558,experimental,0,0
101559,paradigms,0,0
101560,",",0,0
101561,though,0,0
101562,it,0,0
101563,is,0,0
101564,possible,0,0
101565,that,0,0
101566,this,0,0
101567,behaviour,0,0
101568,is,0,0
101569,based,0,0
101570,on,0,0
101571,an,0,0
101572,atypical,0,0
101573,strategy,0,0
101574,.,0,0
101575,We,0,0
101576,tested,0,0
101577,this,0,0
101578,possibility,0,0
101579,in,0,0
101580,adults,1,1
101581,with,1,1
101582,ASD,1,1
101583,using,0,0
101584,a,0,0
101585,cueing,0,0
101586,task,0,0
101587,combined,0,0
101588,with,0,0
101589,eye-movement,0,0
101590,recording,0,0
101591,.,0,0
101592,Both,0,0
101593,eye,0,0
101594,gaze,0,0
101595,and,0,0
101596,arrow,0,0
101597,pointing,0,0
101598,distractors,0,0
101599,resulted,0,0
101600,in,0,0
101601,overt,0,0
101602,cueing,0,0
101603,effects,0,0
101604,",",0,0
101605,both,0,0
101606,in,0,0
101607,terms,0,0
101608,of,0,0
101609,increased,0,0
101610,saccadic,0,0
101611,reaction,0,0
101612,times,0,0
101613,",",0,0
101614,and,0,0
101615,in,0,0
101616,proportions,0,0
101617,of,0,0
101618,saccades,0,0
101619,executed,0,0
101620,to,0,0
101621,the,0,0
101622,cued,0,0
101623,direction,0,0
101624,instead,0,0
101625,of,0,0
101626,to,0,0
101627,the,0,0
101628,target,0,0
101629,",",0,0
101630,for,0,0
101631,both,0,0
101632,participant,0,0
101633,groups,0,0
101634,.,0,1
101635,Our,0,0
101636,results,0,0
101637,confirm,0,0
101638,previous,0,0
101639,reports,0,0
101640,that,0,0
101641,eye,0,0
101642,gaze,0,0
101643,cues,0,0
101644,as,0,0
101645,well,0,0
101646,as,0,0
101647,arrow,0,0
101648,cues,0,0
101649,result,0,0
101650,in,0,0
101651,automatic,0,0
101652,orienting,0,0
101653,of,0,0
101654,overt,0,0
101655,attention,0,0
101656,.,0,0
101657,Moreover,0,0
101658,",",0,0
101659,since,0,0
101660,there,0,0
101661,were,0,0
101662,no,0,0
101663,group,0,0
101664,differences,0,0
101665,between,0,0
101666,arrow,0,0
101667,and,0,0
101668,eye,0,0
101669,gaze,0,0
101670,cues,0,0
101671,",",0,0
101672,we,0,0
101673,conclude,0,0
101674,that,0,0
101675,overt,0,0
101676,attentional,0,0
101677,orienting,0,0
101678,in,0,0
101679,ASD,0,1
101680,",",0,0
101681,at,0,0
101682,least,0,0
101683,in,0,0
101684,response,0,0
101685,to,0,0
101686,centrally,0,0
101687,presented,0,0
101688,schematic,0,0
101689,directional,0,0
101690,distractors,0,0
101691,",",0,0
101692,is,0,0
101693,typical,0,0
101694,.,0,0
101695,Direct,0,0
101696,evidence,0,0
101697,for,0,0
101698,spinal,0,0
101699,cord,0,1
101700,involvement,0,0
101701,in,0,0
101702,placebo,0,0
101703,analgesia,0,0
101704,.,0,0
101705,Placebo,0,0
101706,analgesia,0,0
101707,is,0,0
101708,a,0,0
101709,prime,0,0
101710,example,0,0
101711,of,0,0
101712,the,0,0
101713,impact,0,0
101714,that,0,0
101715,psychological,0,0
101716,factors,0,0
101717,have,0,0
101718,on,0,0
101719,pain,0,0
101720,perception,0,0
101721,.,0,0
101722,We,0,0
101723,used,0,0
101724,functional,0,0
101725,magnetic,0,0
101726,resonance,0,0
101727,imaging,0,0
101728,of,0,0
101729,the,0,0
101730,human,0,0
101731,spinal,0,0
101732,cord,0,1
101733,to,0,0
101734,test,0,0
101735,the,0,0
101736,hypothesis,0,0
101737,that,0,0
101738,placebo,0,0
101739,analgesia,0,0
101740,results,0,0
101741,in,0,0
101742,a,0,0
101743,reduction,0,0
101744,of,0,0
101745,nociceptive,1,0
101746,processing,1,0
101747,in,1,0
101748,the,1,0
101749,spinal,1,0
101750,cord,1,0
101751,.,1,0
101752,In,0,0
101753,line,0,0
101754,with,0,1
101755,behavioral,0,0
101756,data,0,0
101757,that,0,0
101758,show,0,0
101759,decreased,1,0
101760,pain,1,0
101761,responses,1,0
101762,under,1,0
101763,placebo,1,0
101764,",",0,0
101765,pain-related,0,0
101766,activity,0,0
101767,in,0,0
101768,the,0,0
101769,spinal,0,0
101770,cord,0,0
101771,is,0,0
101772,strongly,0,0
101773,reduced,0,0
101774,under,0,0
101775,placebo,0,0
101776,.,0,0
101777,These,0,0
101778,results,0,0
101779,provide,0,0
101780,direct,0,0
101781,evidence,0,0
101782,for,0,0
101783,spinal,0,0
101784,inhibition,0,0
101785,as,0,0
101786,one,0,0
101787,mechanism,0,0
101788,of,0,0
101789,placebo,0,0
101790,analgesia,0,0
101791,and,0,0
101792,highlight,0,0
101793,that,0,0
101794,psychological,0,0
101795,factors,0,0
101796,can,0,0
101797,act,0,0
101798,on,0,0
101799,the,0,0
101800,earliest,0,0
101801,stages,0,0
101802,of,0,0
101803,pain,0,0
101804,processing,0,0
101805,in,0,0
101806,the,0,0
101807,central,0,0
101808,nervous,0,0
101809,system,0,0
101810,.,0,0
101811,Enhancing,0,0
101812,antiepileptic,0,0
101813,drug,0,0
101814,adherence,0,0
101815,:,0,0
101816,a,0,0
101817,randomized,0,0
101818,controlled,0,0
101819,trial,0,0
101820,.,0,0
101821,Suboptimal,0,0
101822,adherence,0,0
101823,to,0,0
101824,antiepileptic,0,0
101825,drug,0,0
101826,(,0,0
101827,AED,0,0
101828,),0,0
101829,treatment,0,0
101830,is,0,0
101831,commonplace,0,0
101832,",",0,0
101833,and,0,0
101834,increases,0,0
101835,the,0,0
101836,risk,0,0
101837,of,0,0
101838,status,0,0
101839,epilepticus,0,1
101840,and,0,0
101841,sudden,0,1
101842,unexplained,0,1
101843,death,0,0
101844,in,0,0
101845,epilepsy,0,1
101846,.,0,0
101847,This,0,0
101848,randomized,0,0
101849,controlled,0,0
101850,trial,0,0
101851,was,0,0
101852,designed,0,0
101853,to,0,0
101854,demonstrate,0,0
101855,whether,0,0
101856,an,0,0
101857,implementation,0,0
101858,intention,0,0
101859,intervention,0,0
101860,involving,0,0
101861,the,0,0
101862,completion,0,0
101863,of,0,0
101864,a,0,0
101865,simple,0,0
101866,self-administered,0,0
101867,questionnaire,0,0
101868,linking,0,0
101869,the,0,0
101870,intention,0,0
101871,of,0,0
101872,taking,0,0
101873,medication,0,0
101874,with,0,1
101875,a,0,0
101876,particular,0,0
101877,time,0,0
101878,",",0,0
101879,place,0,0
101880,",",0,0
101881,and,0,0
101882,other,0,0
101883,activity,0,0
101884,can,0,0
101885,improve,0,0
101886,AED,0,0
101887,treatment,0,0
101888,schedule,0,0
101889,adherence,0,0
101890,.,0,0
101891,Of,0,0
101892,the,0,0
101893,81,1,0
101894,patients,1,1
101895,with,1,1
101896,epilepsy,1,1
101897,who,0,1
101898,were,0,1
101899,randomized,0,1
101900,",",0,0
101901,69,1,0
101902,completed,1,1
101903,a,1,0
101904,1-month,1,0
101905,monitoring,1,0
101906,period,1,0
101907,with,0,0
101908,an,0,0
101909,objective,0,0
101910,measure,0,0
101911,of,0,0
101912,tablet,0,0
101913,taking,0,0
101914,(,0,0
101915,electronic,0,0
101916,registration,0,0
101917,of,0,0
101918,pill,0,0
101919,bottle,0,0
101920,openings,0,0
101921,",",0,0
101922,Medication,0,0
101923,Event,0,0
101924,Monitoring,0,0
101925,System,0,1
101926,[,0,0
101927,MEMS,0,0
101928,],0,1
101929,),0,0
101930,.,0,0
101931,Intervention,0,0
101932,participants,0,1
101933,showed,0,0
101934,improved,0,0
101935,adherence,0,0
101936,relative,0,0
101937,to,0,0
101938,controls,0,0
101939,on,0,0
101940,all,0,0
101941,three,0,0
101942,outcomes,0,0
101943,:,0,1
101944,doses,0,0
101945,taken,0,0
101946,in,0,0
101947,total,0,1
101948,(,0,0
101949,93.4,0,0
101950,%,0,0
101951,vs.,0,0
101952,79.1,0,0
101953,%,0,0
101954,),0,0
101955,",",0,0
101956,days,0,0
101957,on,0,0
101958,which,0,0
101959,correct,0,0
101960,dose,0,0
101961,was,0,0
101962,taken,0,0
101963,(,0,0
101964,88.7,0,0
101965,%,0,0
101966,vs.,0,0
101967,65.3,0,0
101968,%,0,0
101969,),0,0
101970,",",0,0
101971,and,0,0
101972,doses,0,0
101973,taken,0,0
101974,on,0,0
101975,schedule,0,0
101976,(,0,0
101977,78.8,0,0
101978,%,0,0
101979,vs.,0,0
101980,55.3,0,0
101981,%,0,0
101982,),0,0
101983,(,0,0
101984,P,0,0
101985,<,0,0
101986,0.01,0,0
101987,),0,0
101988,.,0,0
101989,The,0,0
101990,implementation,0,0
101991,intention,0,0
101992,intervention,0,0
101993,may,0,0
101994,be,0,0
101995,an,0,0
101996,easy-to-administer,0,0
101997,and,0,0
101998,effective,0,0
101999,means,0,0
102000,of,0,0
102001,promoting,0,0
102002,AED,0,0
102003,adherence,0,0
102004,.,0,0
102005,Comparison,0,0
102006,of,0,0
102007,neurocognitive,0,0
102008,functioning,0,0
102009,in,0,0
102010,children,1,1
102011,previously,1,1
102012,randomly,1,1
102013,assigned,1,0
102014,to,1,0
102015,intrathecal,1,0
102016,methotrexate,1,0
102017,compared,0,0
102018,with,0,1
102019,triple,0,0
102020,intrathecal,0,0
102021,therapy,0,0
102022,for,0,0
102023,the,0,0
102024,treatment,0,0
102025,of,0,0
102026,childhood,1,1
102027,acute,1,1
102028,lymphoblastic,1,1
102029,leukemia,1,1
102030,.,1,0
102031,PURPOSE,0,0
102032,For,0,0
102033,the,0,0
102034,majority,0,0
102035,of,0,0
102036,children,1,1
102037,with,1,1
102038,acute,1,1
102039,lymphoblastic,1,1
102040,leukemia,1,1
102041,(,1,0
102042,ALL,1,0
102043,),1,0
102044,",",1,0
102045,CNS,1,0
102046,prophylaxis,1,0
102047,consists,1,0
102048,of,1,0
102049,either,1,0
102050,intrathecal,1,0
102051,(,1,0
102052,IT,1,0
102053,),1,0
102054,methotrexate,1,0
102055,or,1,0
102056,triple,1,0
102057,IT,1,0
102058,therapy,1,0
102059,(,1,0
102060,ie,1,0
102061,",",1,0
102062,methotrexate,1,0
102063,with,1,0
102064,both,1,0
102065,cytarabine,1,0
102066,and,1,0
102067,hydrocortisone,1,0
102068,),1,0
102069,.,1,0
102070,The,0,0
102071,long-term,0,0
102072,neurotoxicities,0,0
102073,of,0,0
102074,these,0,0
102075,two,0,0
102076,IT,0,0
102077,strategies,0,0
102078,have,0,0
102079,not,0,0
102080,yet,0,0
102081,been,0,0
102082,directly,0,0
102083,compared,0,0
102084,.,0,0
102085,PATIENTS,0,0
102086,AND,0,0
102087,METHODS,0,0
102088,In,0,0
102089,this,0,0
102090,multisite,0,0
102091,study,0,0
102092,",",0,0
102093,171,1,1
102094,children,1,1
102095,with,1,1
102096,standard-risk,1,1
102097,ALL,1,0
102098,",",1,0
102099,age,1,1
102100,1,1,0
102101,to,1,0
102102,9.99,1,0
102103,years,1,1
102104,at,1,0
102105,diagnosis,1,1
102106,",",1,0
102107,previously,1,0
102108,randomly,1,0
102109,assigned,1,0
102110,to,1,0
102111,IT,1,0
102112,methotrexate,1,0
102113,(,1,0
102114,n,1,1
102115,=,1,0
102116,82,1,1
102117,),1,0
102118,or,1,0
102119,to,1,0
102120,triple,1,0
102121,IT,1,0
102122,therapy,1,0
102123,(,1,0
102124,n,1,1
102125,=,1,0
102126,89,1,1
102127,),1,0
102128,on,1,0
102129,CCG,1,1
102130,1952,1,1
102131,",",1,0
102132,underwent,1,1
102133,neurocognitive,1,0
102134,evaluation,1,0
102135,by,1,0
102136,a,1,0
102137,licensed,1,1
102138,psychologist,1,0
102139,at,1,0
102140,a,1,0
102141,mean,1,0
102142,of,1,0
102143,5.9,1,0
102144,years,1,1
102145,after,1,0
102146,random,1,1
102147,assignment,1,0
102148,.,1,1
102149,RESULTS,0,0
102150,Patients,1,1
102151,who,1,1
102152,received,1,1
102153,IT,1,1
102154,methotrexate,1,0
102155,had,0,0
102156,a,0,0
102157,mean,0,0
102158,Processing,0,0
102159,Speed,0,0
102160,Index,0,0
102161,that,0,0
102162,was,0,0
102163,3.6,0,0
102164,points,0,0
102165,lower,0,0
102166,",",0,0
102167,about,0,0
102168,one,0,0
102169,fourth,0,0
102170,of,0,0
102171,a,0,0
102172,standard,0,0
102173,deviation,0,0
102174,",",0,0
102175,than,0,0
102176,those,0,1
102177,who,0,1
102178,received,0,1
102179,triple,0,1
102180,IT,0,0
102181,therapy,0,0
102182,(,0,0
102183,P,0,0
102184,=,0,0
102185,.04,0,0
102186,),0,0
102187,after,0,0
102188,analysis,0,0
102189,was,0,0
102190,adjusted,0,0
102191,for,0,0
102192,age,0,1
102193,",",0,0
102194,sex,0,0
102195,",",0,0
102196,and,0,0
102197,time,0,0
102198,since,0,0
102199,diagnosis,0,1
102200,.,0,0
102201,Likewise,0,0
102202,",",0,0
102203,19.5,1,0
102204,%,1,0
102205,of,1,0
102206,children,1,1
102207,in,1,0
102208,the,1,0
102209,IT,1,0
102210,methotrexate,1,0
102211,group,1,0
102212,had,0,0
102213,a,0,0
102214,Processing,0,0
102215,Speed,0,0
102216,Index,0,0
102217,score,0,0
102218,in,0,0
102219,the,0,0
102220,below-average,0,0
102221,range,0,0
102222,compared,0,0
102223,with,0,1
102224,6.9,0,0
102225,%,0,0
102226,in,0,0
102227,the,0,0
102228,triple,0,0
102229,IT,0,0
102230,therapy,0,0
102231,group,0,0
102232,(,0,0
102233,P,0,0
102234,=,0,0
102235,.02,0,0
102236,),0,0
102237,.,0,0
102238,Otherwise,0,0
102239,",",0,0
102240,the,0,0
102241,groups,0,0
102242,performed,0,0
102243,similarly,0,0
102244,on,0,0
102245,tests,0,0
102246,of,0,0
102247,full-scale,0,0
102248,intelligence,0,0
102249,quotient,0,0
102250,",",0,0
102251,academic,0,1
102252,achievement,0,0
102253,",",0,0
102254,attention/concentration,0,0
102255,",",0,0
102256,memory,0,0
102257,",",0,0
102258,and,0,0
102259,visual,0,0
102260,motor,0,0
102261,integration,0,0
102262,.,0,0
102263,The,0,0
102264,association,0,0
102265,of,0,0
102266,treatment,0,0
102267,with,0,1
102268,measures,0,0
102269,of,0,0
102270,cognitive,0,0
102271,functioning,0,0
102272,was,0,0
102273,not,0,0
102274,modified,0,0
102275,by,0,0
102276,sex,1,0
102277,or,1,0
102278,age,1,1
102279,at,1,0
102280,diagnosis,1,1
102281,.,1,0
102282,In,0,0
102283,the,0,0
102284,post-therapy,0,0
102285,period,0,0
102286,",",0,0
102287,there,0,0
102288,were,0,0
102289,no,0,0
102290,group,0,0
102291,differences,0,0
102292,in,0,0
102293,special,0,0
102294,education,0,0
102295,services,0,1
102296,",",0,0
102297,neurologic,0,0
102298,events,0,0
102299,",",0,0
102300,or,0,0
102301,use,0,0
102302,of,0,0
102303,psychotropic,0,0
102304,medications,0,0
102305,.,0,0
102306,CONCLUSION,0,0
102307,This,0,0
102308,study,0,0
102309,did,0,0
102310,not,0,0
102311,show,0,0
102312,any,0,0
102313,clinically,0,0
102314,meaningful,0,0
102315,differences,0,0
102316,in,0,0
102317,neurocognitive,0,0
102318,functioning,0,0
102319,between,0,0
102320,patients,0,1
102321,previously,0,1
102322,randomly,0,1
102323,assigned,0,0
102324,to,0,0
102325,IT,0,0
102326,methotrexate,0,0
102327,or,0,0
102328,triple,0,0
102329,IT,0,0
102330,therapy,0,0
102331,except,0,0
102332,for,0,0
102333,a,0,0
102334,small,0,0
102335,difference,0,0
102336,in,0,0
102337,processing,0,0
102338,speed,0,0
102339,in,0,0
102340,the,0,0
102341,IT,0,0
102342,methotrexate,0,0
102343,group,0,0
102344,.,0,0
102345,The,0,0
102346,effect,0,0
102347,of,0,0
102348,cessation,0,0
102349,of,0,0
102350,raloxifene,0,0
102351,treatment,0,0
102352,on,0,0
102353,bone,1,0
102354,turnover,1,0
102355,in,1,0
102356,postmenopausal,1,1
102357,women,1,1
102358,.,1,0
102359,There,0,0
102360,is,0,0
102361,evidence,0,0
102362,to,0,0
102363,suggest,0,0
102364,accelerated,1,0
102365,bone,1,0
102366,loss,1,0
102367,following,1,0
102368,estrogen,1,0
102369,cessation,1,0
102370,.,1,0
102371,The,0,0
102372,effect,0,0
102373,of,0,0
102374,cessation,0,0
102375,of,0,0
102376,raloxifene,0,0
102377,therapy,0,0
102378,on,0,0
102379,bone,0,0
102380,turnover,0,0
102381,is,0,0
102382,unknown,0,0
102383,.,0,0
102384,Our,0,0
102385,aim,0,0
102386,was,0,0
102387,to,0,0
102388,determine,0,0
102389,the,0,0
102390,effect,0,0
102391,of,0,0
102392,cessation,0,0
102393,of,0,0
102394,raloxifene,0,0
102395,treatment,0,0
102396,on,0,0
102397,bone,0,0
102398,turnover,0,0
102399,and,0,0
102400,bone,0,0
102401,mineral,0,0
102402,density,0,0
102403,(,0,0
102404,BMD,0,0
102405,),0,0
102406,in,0,0
102407,postmenopausal,1,1
102408,",",1,0
102409,osteopenic,1,1
102410,women,1,1
102411,.,1,1
102412,Women,1,1
102413,aged,1,1
102414,50,1,1
102415,to,1,0
102416,80,1,1
102417,years,1,1
102418,received,0,0
102419,raloxifene,0,0
102420,for,0,0
102421,96,0,0
102422,weeks,0,0
102423,and,0,0
102424,were,0,0
102425,then,0,0
102426,randomized,0,0
102427,to,0,0
102428,continue,0,0
102429,raloxifene,1,0
102430,(,1,0
102431,group,1,0
102432,1,1,0
102433,",",1,0
102434,n=20,1,1
102435,),1,0
102436,or,1,0
102437,placebo,1,0
102438,(,1,0
102439,group,1,0
102440,2,1,0
102441,",",1,0
102442,n=20,1,1
102443,),1,0
102444,for,1,0
102445,a,1,0
102446,further,1,0
102447,96,1,0
102448,weeks,1,0
102449,.,1,0
102450,A,1,0
102451,third,1,0
102452,group,1,0
102453,(,1,0
102454,group,1,0
102455,3,1,0
102456,",",1,0
102457,n=14,1,1
102458,),1,0
102459,received,1,0
102460,no,1,0
102461,treatment,1,0
102462,.,1,0
102463,Bone,0,0
102464,turnover,0,0
102465,markers,0,0
102466,and,0,0
102467,bone,0,0
102468,density,0,0
102469,(,0,0
102470,BMD,0,1
102471,),0,0
102472,were,0,0
102473,measured,0,0
102474,throughout,0,0
102475,the,0,0
102476,study,0,0
102477,.,0,0
102478,Raloxifene,0,0
102479,treatment,0,0
102480,for,0,0
102481,96,0,0
102482,weeks,0,0
102483,resulted,0,0
102484,in,0,0
102485,a,0,0
102486,decrease,0,0
102487,in,0,0
102488,bone,0,0
102489,turnover,0,0
102490,(,0,0
102491,PINP,0,0
102492,by,0,0
102493,31,0,1
102494,%,0,0
102495,),0,0
102496,and,0,0
102497,an,0,0
102498,increase,0,0
102499,in,0,0
102500,spine,0,0
102501,BMD,0,1
102502,(,0,0
102503,by,0,0
102504,2,0,0
102505,%,0,0
102506,),0,0
102507,but,0,0
102508,no,0,0
102509,change,0,0
102510,in,0,0
102511,hip,0,1
102512,BMD,0,1
102513,for,0,0
102514,groups,0,0
102515,1,0,0
102516,and,0,1
102517,2,0,0
102518,.,0,0
102519,Continuation,0,0
102520,of,0,0
102521,raloxifene,0,0
102522,(,0,0
102523,group,0,0
102524,1,0,0
102525,),0,0
102526,maintained,0,0
102527,these,0,0
102528,changes,0,0
102529,.,0,0
102530,Following,0,0
102531,cessation,0,0
102532,of,0,0
102533,raloxifene,0,0
102534,(,0,0
102535,group,0,0
102536,2,0,0
102537,),0,0
102538,",",0,0
102539,bone,0,0
102540,markers,0,0
102541,returned,0,0
102542,to,0,0
102543,baseline,0,0
102544,levels,0,0
102545,(,0,0
102546,by,0,0
102547,120,0,1
102548,weeks,0,0
102549,),0,1
102550,.,0,1
102551,Hip,0,0
102552,BMD,0,0
102553,was,0,0
102554,decreased,0,0
102555,by,0,0
102556,2,0,0
102557,%,0,0
102558,at,0,0
102559,192,0,1
102560,weeks,0,0
102561,compared,0,0
102562,to,0,0
102563,baseline,0,0
102564,.,0,0
102565,Bone,0,0
102566,markers,0,0
102567,in,0,0
102568,the,0,0
102569,controls,0,0
102570,(,0,0
102571,group,0,0
102572,3,0,0
102573,),0,0
102574,remained,0,0
102575,at,0,0
102576,the,0,0
102577,upper,0,0
102578,limit,0,0
102579,of,0,0
102580,the,0,0
102581,reference,0,0
102582,range,0,0
102583,throughout,0,0
102584,",",0,0
102585,with,0,1
102586,decreases,0,0
102587,in,0,0
102588,BMD,0,1
102589,of,0,0
102590,2.3,0,0
102591,%,0,0
102592,(,0,0
102593,spine,0,0
102594,),0,0
102595,and,0,0
102596,2.8,0,0
102597,%,0,0
102598,(,0,0
102599,hip,0,1
102600,),0,0
102601,.,0,0
102602,Bone,0,0
102603,loss,0,0
102604,following,0,0
102605,cessation,0,0
102606,of,0,0
102607,raloxifene,0,0
102608,therapy,0,0
102609,at,0,0
102610,96,0,0
102611,weeks,0,0
102612,was,0,0
102613,greater,0,0
102614,than,0,0
102615,in,0,0
102616,the,0,0
102617,control,0,0
102618,group,0,0
102619,",",0,0
102620,suggesting,0,0
102621,accelerated,1,0
102622,bone,1,0
102623,loss,1,0
102624,.,1,0
102625,The,0,0
102626,beneficial,0,0
102627,effect,0,0
102628,on,0,0
102629,bone,0,0
102630,turnover,0,0
102631,of,0,0
102632,96,0,0
102633,weeks,0,0
102634,of,0,0
102635,raloxifene,0,0
102636,was,0,0
102637,lost,0,0
102638,6,0,0
102639,months,0,0
102640,after,0,0
102641,cessation,0,0
102642,of,0,0
102643,treatment,0,0
102644,.,0,0
102645,Treatment,0,0
102646,of,0,0
102647,beta-hemolytic,1,0
102648,streptococcal,1,1
102649,pharyngitis,1,1
102650,with,0,1
102651,cefaclor,0,0
102652,or,0,0
102653,penicillin,0,0
102654,.,0,0
102655,Efficacy,0,0
102656,and,0,0
102657,interaction,0,0
102658,with,0,1
102659,beta-lactamase-producing,0,1
102660,organisms,0,0
102661,in,0,0
102662,the,0,0
102663,pharynx,0,1
102664,.,0,0
102665,The,0,0
102666,recommended,0,0
102667,treatment,0,0
102668,for,0,0
102669,group,1,0
102670,A,1,0
102671,beta-hemolytic,1,0
102672,streptococcal,1,0
102673,pharyngitis,1,1
102674,has,0,0
102675,continued,0,0
102676,to,0,0
102677,be,0,0
102678,penicillin,0,0
102679,given,0,0
102680,in,0,0
102681,parenteral,0,1
102682,or,0,0
102683,oral,0,0
102684,form,0,0
102685,.,0,0
102686,Treatment,0,0
102687,failures,0,0
102688,",",0,0
102689,as,0,0
102690,determined,0,0
102691,by,0,0
102692,the,0,0
102693,continued,0,0
102694,presence,0,0
102695,of,0,0
102696,the,0,0
102697,streptococcal,0,0
102698,organism,0,0
102699,in,0,0
102700,the,0,0
102701,pharynx,0,0
102702,",",0,0
102703,however,0,0
102704,",",0,0
102705,do,0,0
102706,occur,0,0
102707,in,0,0
102708,6,0,0
102709,%,0,0
102710,to,0,0
102711,25,0,0
102712,%,0,0
102713,of,0,0
102714,patients,0,1
102715,treated,0,1
102716,with,0,1
102717,penicillin,0,0
102718,.,0,0
102719,Furthermore,0,0
102720,",",0,0
102721,beta-lactamase,0,0
102722,produced,0,0
102723,by,0,0
102724,other,0,0
102725,bacteria,0,0
102726,in,0,0
102727,the,0,0
102728,pharynx,0,0
102729,could,0,0
102730,potentially,0,0
102731,inactivate,0,0
102732,the,0,0
102733,penicillin,0,0
102734,",",0,0
102735,resulting,0,0
102736,in,0,0
102737,increased,0,0
102738,treatment,0,0
102739,failures,0,0
102740,or,0,1
102741,infection,0,1
102742,relapses,0,0
102743,.,0,0
102744,A,0,0
102745,study,0,0
102746,was,0,0
102747,undertaken,0,0
102748,to,0,0
102749,compare,0,0
102750,the,0,0
102751,efficacy,0,0
102752,of,0,0
102753,cefaclor,0,0
102754,",",0,0
102755,which,0,0
102756,is,0,0
102757,relatively,0,0
102758,resistant,0,0
102759,to,0,0
102760,inactivation,0,0
102761,by,0,0
102762,beta-lactamase,0,0
102763,",",0,0
102764,with,0,0
102765,penicillin,0,0
102766,for,0,0
102767,eradicating,0,0
102768,the,0,0
102769,group,1,0
102770,A,1,0
102771,beta-hemolytic,1,0
102772,streptococcal,1,0
102773,organism,1,0
102774,from,1,0
102775,the,1,0
102776,throats,1,1
102777,of,1,0
102778,93,1,1
102779,patients,1,1
102780,with,1,1
102781,pharyngitis,1,1
102782,.,1,0
102783,Additionally,0,0
102784,",",0,0
102785,extensive,0,0
102786,cultures,0,0
102787,for,0,0
102788,potential,0,0
102789,beta-lactamase-producing,0,1
102790,organisms,0,0
102791,were,0,0
102792,conducted,0,0
102793,on,0,0
102794,37,1,1
102795,patients,1,1
102796,;,1,0
102797,27,1,1
102798,%,1,0
102799,of,1,0
102800,these,1,0
102801,had,1,0
102802,one,1,0
102803,or,1,0
102804,more,1,0
102805,pharyngeal,1,0
102806,organisms,1,0
102807,that,1,0
102808,were,1,0
102809,producing,1,0
102810,beta-lactamase,1,0
102811,.,1,0
102812,No,0,0
102813,statistically,0,0
102814,significant,0,0
102815,difference,0,0
102816,was,0,0
102817,found,0,0
102818,between,0,0
102819,the,0,0
102820,clinical,0,0
102821,responses,0,0
102822,or,0,1
102823,the,0,0
102824,bacteriological,0,0
102825,cure,0,0
102826,rates,0,0
102827,of,0,0
102828,those,0,0
102829,treated,0,0
102830,with,0,0
102831,cefaclor,0,0
102832,and,0,0
102833,those,0,0
102834,treated,0,0
102835,with,0,0
102836,penicillin,0,0
102837,when,0,0
102838,stratified,0,0
102839,by,0,0
102840,the,0,0
102841,presence,0,0
102842,or,0,0
102843,absence,0,0
102844,of,0,0
102845,beta-lactamase-producing,0,1
102846,organisms,0,0
102847,.,0,0
102848,The,0,0
102849,prevalence,0,0
102850,of,0,0
102851,beta-lactamase-producing,0,1
102852,organisms,0,0
102853,in,0,0
102854,the,0,0
102855,pharynx,0,0
102856,",",0,0
102857,however,0,0
102858,",",0,0
102859,was,0,0
102860,increased,0,0
102861,after,0,0
102862,treatment,0,0
102863,with,0,0
102864,penicillin,0,0
102865,",",0,0
102866,whereas,0,0
102867,no,0,0
102868,change,0,0
102869,was,0,0
102870,noted,0,0
102871,following,0,0
102872,treatment,0,0
102873,with,0,1
102874,cefaclor,0,0
102875,.,0,0
102876,Conjugated,0,0
102877,equine,0,0
102878,estrogen,0,0
102879,influence,0,0
102880,on,0,0
102881,mammographic,0,1
102882,density,0,0
102883,in,0,0
102884,postmenopausal,1,1
102885,women,1,1
102886,in,1,0
102887,a,1,0
102888,substudy,1,0
102889,of,1,0
102890,the,1,0
102891,women,1,1
102892,'s,1,0
102893,health,1,1
102894,initiative,1,1
102895,randomized,1,0
102896,trial,1,0
102897,.,1,0
102898,PURPOSE,0,0
102899,Increased,0,0
102900,mammographic,0,0
102901,density,0,0
102902,is,0,0
102903,associated,0,0
102904,with,0,0
102905,increased,0,0
102906,breast,0,1
102907,cancer,0,1
102908,risk,0,0
102909,and,0,0
102910,reduced,0,0
102911,sensitivity,0,0
102912,of,0,0
102913,screening,0,0
102914,mammography,0,1
102915,and,0,0
102916,is,0,0
102917,related,0,0
102918,to,0,0
102919,hormone,0,0
102920,exposure,0,0
102921,.,0,0
102922,However,0,0
102923,",",0,0
102924,the,0,0
102925,effects,0,0
102926,of,0,0
102927,conjugated,0,0
102928,equine,0,1
102929,estrogens,0,0
102930,(,0,0
102931,CEEs,0,1
102932,),0,0
102933,alone,0,0
102934,on,0,0
102935,mammographic,0,0
102936,density,0,0
102937,in,0,0
102938,diverse,1,1
102939,racial/ethnic,1,0
102940,populations,1,1
102941,are,0,0
102942,not,0,0
102943,established,0,0
102944,.,0,0
102945,We,0,0
102946,examined,0,0
102947,the,0,0
102948,effect,0,0
102949,of,0,0
102950,CEE,0,0
102951,alone,0,0
102952,on,0,0
102953,mammographic,0,0
102954,density,0,0
102955,in,0,0
102956,a,0,0
102957,subsample,1,1
102958,of,1,0
102959,the,1,0
102960,Women,1,1
102961,'s,1,0
102962,Health,1,0
102963,Initiative,1,0
102964,(,1,0
102965,WHI,1,0
102966,),1,0
102967,clinical,1,0
102968,trial,1,0
102969,participants,1,1
102970,.,1,1
102971,PATIENTS,0,0
102972,AND,0,0
102973,METHODS,0,0
102974,In,0,0
102975,the,0,0
102976,WHI,0,0
102977,trial,0,0
102978,",",0,0
102979,women,1,1
102980,were,0,0
102981,randomly,0,1
102982,assigned,0,0
102983,to,0,0
102984,daily,0,0
102985,CEE,0,0
102986,0.625,0,0
102987,mg,0,0
102988,or,0,0
102989,placebo,0,0
102990,.,0,0
102991,The,0,0
102992,effect,0,0
102993,of,0,0
102994,CEE,0,0
102995,on,0,0
102996,mammographic,0,1
102997,percent,0,0
102998,density,0,0
102999,was,0,0
103000,determined,0,0
103001,over,0,0
103002,1,0,0
103003,and,0,0
103004,2,0,0
103005,years,0,1
103006,in,0,0
103007,a,0,0
103008,stratified,0,0
103009,random,1,0
103010,sample,1,1
103011,of,1,0
103012,435,1,1
103013,racially,1,1
103014,and,1,0
103015,ethnically,1,1
103016,diverse,1,0
103017,participants,1,1
103018,from,1,1
103019,15,1,1
103020,of,1,0
103021,40,1,1
103022,WHI,1,0
103023,clinics,1,1
103024,.,1,1
103025,RESULTS,0,0
103026,Use,0,0
103027,of,0,0
103028,CEE,0,0
103029,resulted,0,0
103030,in,0,0
103031,mean,0,0
103032,increase,0,0
103033,in,0,0
103034,mammographic,0,1
103035,percent,0,0
103036,density,0,0
103037,of,0,0
103038,1.6,0,0
103039,percentage,0,0
103040,points,0,0
103041,(,0,0
103042,95,0,0
103043,%,0,0
103044,CI,0,0
103045,",",0,0
103046,0.8,0,0
103047,to,0,0
103048,2.4,0,0
103049,),0,0
103050,at,0,0
103051,year,0,0
103052,1,0,0
103053,compared,0,0
103054,with,0,1
103055,a,0,0
103056,mean,0,0
103057,decrease,0,0
103058,of,0,0
103059,1.0,0,0
103060,percentage,0,0
103061,point,0,0
103062,(,0,0
103063,95,0,0
103064,%,0,0
103065,CI,0,0
103066,",",0,0
103067,-1.7,0,0
103068,to,0,0
103069,-0.4,0,0
103070,),0,0
103071,in,0,0
103072,the,0,0
103073,placebo,0,0
103074,group,0,0
103075,(,0,0
103076,P,0,0
103077,<,0,0
103078,.001,0,0
103079,),0,0
103080,.,0,0
103081,The,0,0
103082,effect,0,0
103083,persisted,0,0
103084,for,0,0
103085,2,0,0
103086,years,0,1
103087,",",0,0
103088,with,0,1
103089,a,0,0
103090,mean,0,0
103091,increase,0,0
103092,of,0,0
103093,1.7,0,0
103094,percentage,0,0
103095,points,0,0
103096,(,0,0
103097,95,0,0
103098,%,0,0
103099,CI,0,0
103100,",",0,0
103101,0.7,0,0
103102,to,0,0
103103,2.7,0,0
103104,),0,0
103105,versus,0,0
103106,a,0,0
103107,mean,0,0
103108,decrease,0,0
103109,of,0,0
103110,1.2,0,0
103111,percentage,0,0
103112,points,0,0
103113,(,0,0
103114,95,0,0
103115,%,0,0
103116,CI,0,0
103117,",",0,0
103118,-1.8,0,0
103119,to,0,0
103120,-0.5,0,0
103121,;,0,0
103122,P,0,0
103123,<,0,0
103124,.001,0,0
103125,),0,0
103126,in,0,0
103127,the,0,0
103128,hormone,0,0
103129,and,0,0
103130,placebo,0,0
103131,groups,0,0
103132,",",0,0
103133,respectively,0,0
103134,.,0,0
103135,These,0,0
103136,effects,0,0
103137,were,0,0
103138,greater,0,0
103139,in,0,0
103140,women,1,1
103141,age,1,1
103142,60,1,1
103143,to,1,0
103144,79,1,1
103145,years,1,1
103146,(,0,0
103147,P,0,0
103148,=,0,0
103149,.03,0,0
103150,for,0,0
103151,interaction,0,0
103152,across,0,0
103153,age,0,1
103154,),0,0
103155,.,0,0
103156,CONCLUSION,0,0
103157,Use,0,0
103158,of,0,0
103159,CEE,0,0
103160,results,0,0
103161,in,0,0
103162,a,0,0
103163,modest,0,0
103164,but,0,0
103165,statistically,0,0
103166,significant,0,0
103167,increase,0,0
103168,in,0,0
103169,mammographic,0,1
103170,density,0,0
103171,that,0,0
103172,is,0,0
103173,sustained,0,0
103174,over,0,0
103175,at,0,0
103176,least,0,0
103177,a,0,0
103178,2-year,0,0
103179,period,0,0
103180,.,0,0
103181,The,0,0
103182,clinical,0,0
103183,significance,0,0
103184,of,0,0
103185,the,0,0
103186,CEE,0,0
103187,effect,0,0
103188,on,0,0
103189,mammographic,0,0
103190,density,0,0
103191,remains,0,0
103192,to,0,0
103193,be,0,0
103194,determined,0,0
103195,.,0,0
103196,First-line,0,0
103197,cisplatin,0,0
103198,with,0,0
103199,docetaxel,0,0
103200,or,0,0
103201,vinorelbine,0,0
103202,in,0,0
103203,patients,1,1
103204,with,1,1
103205,advanced,1,1
103206,non-small-cell,1,1
103207,lung,1,1
103208,cancer,1,1
103209,:,1,0
103210,a,0,0
103211,quality,1,0
103212,of,1,0
103213,life,1,0
103214,directed,1,0
103215,phase,1,0
103216,II,1,0
103217,randomized,1,0
103218,trial,1,0
103219,of,1,0
103220,Gruppo,1,0
103221,Oncologico,1,1
103222,Italia,1,1
103223,Meridionale,1,0
103224,.,1,0
103225,BACKGROUND,0,0
103226,Quality,0,0
103227,of,0,0
103228,life,0,0
103229,(,0,0
103230,QoL,0,0
103231,),0,0
103232,has,0,0
103233,gained,0,0
103234,greater,0,0
103235,importance,0,0
103236,in,0,0
103237,the,0,0
103238,management,0,0
103239,of,0,0
103240,metastatic,1,1
103241,non-small-cell,1,1
103242,lung,1,1
103243,cancer,1,1
103244,due,0,0
103245,to,0,0
103246,the,0,0
103247,palliative,0,0
103248,nature,0,0
103249,of,0,0
103250,treatment,0,0
103251,.,0,0
103252,Docetaxel,0,0
103253,(,0,0
103254,DCT,0,0
103255,),0,0
103256,and,0,0
103257,cisplatin,0,0
103258,(,0,0
103259,CDDP,0,0
103260,),0,0
103261,doublet,0,0
103262,has,0,0
103263,been,0,0
103264,reported,0,0
103265,to,0,0
103266,be,0,0
103267,associated,0,0
103268,to,0,0
103269,a,0,0
103270,better,0,0
103271,QoL,0,0
103272,than,0,0
103273,the,0,0
103274,weekly,0,0
103275,vinorelbine,0,0
103276,(,0,0
103277,VNR,0,0
103278,),0,0
103279,and,0,0
103280,CDDP,0,0
103281,regimen,0,0
103282,.,0,0
103283,Recently,0,0
103284,a,0,0
103285,newer,0,0
103286,more,0,0
103287,tolerated,0,0
103288,schedule,0,0
103289,of,0,0
103290,the,0,0
103291,VNR/CDDP,0,0
103292,regimen,0,0
103293,has,0,0
103294,been,0,0
103295,published,0,0
103296,and,0,0
103297,is,0,0
103298,widely,0,0
103299,employed,0,0
103300,in,0,0
103301,medical,0,1
103302,practice,0,0
103303,.,0,0
103304,The,0,0
103305,impact,0,0
103306,of,0,0
103307,these,0,0
103308,regimens,0,0
103309,on,0,0
103310,patients,0,1
103311,',0,1
103312,QoL,0,0
103313,as,0,0
103314,well,0,0
103315,as,0,0
103316,symptoms,0,0
103317,control,0,0
103318,and,0,0
103319,type,0,1
103320,and,0,0
103321,grading,0,0
103322,chemo-related,0,0
103323,side-effects,0,0
103324,has,0,0
103325,been,0,0
103326,compared,0,0
103327,prospectically,0,0
103328,.,0,1
103329,METHODS,0,0
103330,Patients,1,1
103331,received,0,1
103332,CDDP,0,1
103333,75,0,1
103334,mg/m,0,0
103335,(,0,0
103336,2,0,0
103337,),0,0
103338,plus,0,0
103339,DCT,0,0
103340,75,0,0
103341,mg/m,0,0
103342,(,0,0
103343,2,0,0
103344,),0,0
103345,on,0,0
103346,day,0,0
103347,1,0,0
103348,every,0,0
103349,weeks,0,0
103350,(,0,0
103351,arm,0,0
103352,A,0,0
103353,),0,0
103354,or,0,0
103355,CDDP,0,0
103356,80,0,0
103357,mg/m,0,0
103358,(,0,0
103359,2,0,0
103360,),0,0
103361,on,0,0
103362,day,0,0
103363,1,0,0
103364,plus,0,0
103365,VNR,0,1
103366,30,0,0
103367,mg/m,0,0
103368,(,0,0
103369,2,0,0
103370,),0,0
103371,day,0,0
103372,1,0,0
103373,and,0,0
103374,8,0,0
103375,every,0,0
103376,3,0,0
103377,weeks,0,0
103378,(,0,0
103379,arm,0,0
103380,B,0,0
103381,),0,0
103382,.,0,0
103383,G-CSF,0,0
103384,and/or,0,0
103385,EPO,0,1
103386,were,0,0
103387,employed,0,0
103388,as,0,0
103389,needed,0,0
103390,.,0,0
103391,Health-related,0,0
103392,QoL,0,0
103393,was,0,0
103394,assessed,0,0
103395,at,0,0
103396,entry,0,0
103397,and,0,0
103398,after,0,0
103399,every,0,0
103400,cycle,0,0
103401,by,0,0
103402,the,0,0
103403,EORTC-QLQ-C30,0,0
103404,and,0,0
103405,LC13,0,0
103406,questionnaires,0,0
103407,",",0,0
103408,toxicity,0,0
103409,by,0,0
103410,the,0,0
103411,NCI-NCCN,0,0
103412,CTC,0,0
103413,vs,0,0
103414,2,0,0
103415,",",0,0
103416,and,0,0
103417,intent-to-treat,0,0
103418,objective,0,0
103419,response,0,0
103420,by,0,0
103421,the,0,0
103422,Recist,0,0
103423,criteria,0,1
103424,.,0,0
103425,RESULTS,0,0
103426,The,0,0
103427,QoL,0,0
103428,questionnaires,0,0
103429,were,0,0
103430,completed,0,1
103431,by,0,0
103432,37,1,1
103433,pts,1,0
103434,(,1,0
103435,88,1,1
103436,%,1,0
103437,),1,0
103438,in,1,0
103439,the,1,0
103440,DCT/CDDP,1,0
103441,arm,1,0
103442,and,0,0
103443,39,1,1
103444,pts,1,0
103445,(,1,0
103446,87,1,1
103447,%,1,0
103448,),1,0
103449,in,1,0
103450,the,1,0
103451,VNR/CDDP,1,0
103452,one,1,0
103453,.,1,0
103454,Baseline,0,0
103455,mean,0,0
103456,scores,0,0
103457,and,0,0
103458,rates,0,0
103459,at,0,0
103460,which,0,0
103461,pts,0,0
103462,failed,0,0
103463,to,0,0
103464,complete,0,0
103465,QoL,0,0
103466,assessment,0,0
103467,were,0,0
103468,similar,0,0
103469,in,0,0
103470,the,0,0
103471,two,0,0
103472,arms,0,0
103473,.,0,1
103474,Global,0,0
103475,health,0,0
103476,status,0,0
103477,of,0,0
103478,the,0,0
103479,EORTC,0,0
103480,QLQ-C30,0,0
103481,scale,0,0
103482,and,0,0
103483,specific,0,0
103484,symptoms,0,0
103485,control,0,1
103486,(,0,0
103487,LC13,0,0
103488,module,0,0
103489,),0,0
103490,improved,0,0
103491,during,0,0
103492,treatment,0,0
103493,without,0,0
103494,any,0,0
103495,statistically,0,0
103496,significant,0,0
103497,difference,0,0
103498,between,0,0
103499,the,0,0
103500,two,0,0
103501,arms,0,0
103502,.,0,1
103503,Emotional,0,0
103504,functioning,0,0
103505,remained,0,0
103506,stable,0,1
103507,in,0,0
103508,both,0,0
103509,groups,0,0
103510,during,0,0
103511,treatment,0,0
103512,",",0,0
103513,whereas,0,0
103514,physical,0,0
103515,and,0,0
103516,role,0,0
103517,improved,0,0
103518,slightly,0,0
103519,.,0,0
103520,In,0,0
103521,the,0,0
103522,DCT/CDDP,0,0
103523,arm,0,0
103524,14,0,0
103525,pts,0,0
103526,(,0,0
103527,33,0,1
103528,%,0,0
103529,;,0,0
103530,95,0,0
103531,%,0,0
103532,CL,0,0
103533,24-40,0,0
103534,%,0,0
103535,),0,0
103536,had,0,0
103537,PR,0,0
103538,",",0,0
103539,and,0,0
103540,10,0,0
103541,(,0,0
103542,24,0,0
103543,%,0,0
103544,),0,0
103545,SD,0,0
103546,for,0,0
103547,a,0,0
103548,57,0,0
103549,%,0,0
103550,TGCR,0,0
103551,.,0,0
103552,In,0,0
103553,the,0,0
103554,VNR/CDDP,0,0
103555,arm,0,0
103556,12,0,0
103557,pts,0,0
103558,(,0,0
103559,27,0,1
103560,%,0,0
103561,),0,0
103562,achieved,0,0
103563,PR,0,0
103564,",",0,0
103565,18,0,0
103566,(,0,0
103567,41,0,1
103568,%,0,0
103569,),0,0
103570,SD,0,0
103571,a,0,0
103572,68,0,0
103573,%,0,0
103574,TGCR,0,0
103575,.,0,0
103576,Differences,0,0
103577,were,0,0
103578,not,0,0
103579,statistically,0,0
103580,significant,0,0
103581,.,0,0
103582,Median,0,0
103583,time-to-progression,0,0
103584,was,0,0
103585,4.2,0,0
103586,months,0,0
103587,in,0,0
103588,the,0,0
103589,DCT/CDDP,0,0
103590,arm,0,0
103591,and,0,0
103592,4.5,0,0
103593,months,0,0
103594,in,0,0
103595,the,0,0
103596,VNR/CDDP,0,0
103597,one,0,0
103598,",",0,0
103599,and,0,0
103600,median,0,0
103601,overall,0,0
103602,survival,0,0
103603,was,0,0
103604,12.1,0,0
103605,(,0,0
103606,range,0,0
103607,1-26+,0,0
103608,months,0,0
103609,),0,0
103610,and,0,0
103611,12.5,0,0
103612,months,0,0
103613,(,0,0
103614,range,0,1
103615,1-28+,0,0
103616,months,0,0
103617,),0,0
103618,for,0,0
103619,DCT/CDDP,0,0
103620,and,0,0
103621,VNR/CDDP,0,0
103622,arms,0,0
103623,",",0,0
103624,respectively,0,0
103625,.,0,0
103626,Febrile,0,0
103627,neutropenia,0,0
103628,rate,0,0
103629,was,0,0
103630,higher,0,0
103631,in,0,0
103632,the,0,0
103633,VNR/CDDP,0,0
103634,arm,0,0
103635,(,0,0
103636,p=0.02,0,0
103637,),0,0
103638,as,0,0
103639,well,0,0
103640,as,0,0
103641,G3-4,0,0
103642,anemia,0,1
103643,(,0,0
103644,p=0.005,0,0
103645,),0,0
103646,and,0,0
103647,G-CSF/EPO,0,0
103648,use,0,0
103649,(,0,0
103650,p=0.019,0,0
103651,),0,0
103652,.,0,0
103653,CONCLUSIONS,0,0
103654,Global,0,0
103655,and,0,0
103656,specific,0,0
103657,health-related,0,0
103658,QoL,0,0
103659,data,0,0
103660,similar,0,0
103661,in,0,0
103662,both,0,0
103663,treatment,0,0
103664,groups,0,0
103665,with,0,1
103666,no,0,0
103667,statistically,0,0
103668,significant,0,0
103669,difference,0,0
103670,.,0,0
103671,Efficacy,0,0
103672,measures,0,0
103673,",",0,0
103674,overall,0,0
103675,response,0,0
103676,rate,0,0
103677,",",0,0
103678,time-to-progression,0,0
103679,and,0,0
103680,overall,0,0
103681,survival,0,0
103682,were,0,0
103683,equivalent,0,0
103684,in,0,0
103685,both,0,0
103686,arms,0,0
103687,.,0,0
103688,However,0,0
103689,",",0,0
103690,severe,0,0
103691,anemia,0,1
103692,and,0,0
103693,febrile,0,1
103694,neutropenia,0,0
103695,are,0,0
103696,statistically,0,0
103697,more,0,0
103698,frequent,0,0
103699,in,0,0
103700,the,0,0
103701,VNR/CDDP,0,0
103702,arm,0,0
103703,than,0,0
103704,in,0,0
103705,the,0,0
103706,DCT/CDDP,0,0
103707,one,0,0
103708,.,0,0
103709,These,0,0
103710,data,0,0
103711,should,0,0
103712,be,0,0
103713,considered,0,0
103714,in,0,0
103715,treatment,0,0
103716,decision-making,0,0
103717,for,0,0
103718,pts,1,0
103719,with,1,1
103720,advanced,1,1
103721,non-small-cell,1,1
103722,lung,1,1
103723,cancer,1,1
103724,and,0,0
103725,for,0,0
103726,the,0,0
103727,design,0,0
103728,of,0,0
103729,future,0,0
103730,trials,0,0
103731,with,0,1
103732,chemotherapy,0,1
103733,plus,0,0
103734,biologics,0,0
103735,.,0,1
103736,In-season,0,1
103737,effect,0,0
103738,of,0,0
103739,short-term,0,0
103740,sprint,0,0
103741,and,0,0
103742,power,0,0
103743,training,0,0
103744,programs,0,0
103745,on,0,0
103746,elite,1,1
103747,junior,1,1
103748,soccer,1,1
103749,players,1,1
103750,.,1,0
103751,The,0,0
103752,aim,0,0
103753,of,0,0
103754,this,0,0
103755,study,0,0
103756,was,0,0
103757,to,0,0
103758,examine,0,0
103759,the,0,0
103760,effects,0,0
103761,of,0,0
103762,2,0,1
103763,in-season,0,0
103764,short-term,0,0
103765,sprint,0,0
103766,and,0,0
103767,power,0,0
103768,training,0,0
103769,protocols,0,0
103770,on,0,0
103771,vertical,0,0
103772,countermovement,0,0
103773,jump,0,0
103774,height,0,0
103775,(,0,0
103776,with,0,0
103777,or,0,0
103778,without,0,1
103779,arms,0,0
103780,),0,0
103781,",",0,0
103782,sprint,0,0
103783,(,0,0
103784,Sprint-15m,0,1
103785,),0,0
103786,speed,0,0
103787,",",0,0
103788,and,0,0
103789,agility,0,0
103790,(,0,0
103791,Agility-15m,0,0
103792,),0,0
103793,speed,0,0
103794,in,0,0
103795,male,1,1
103796,elite,1,1
103797,junior,1,1
103798,soccer,1,1
103799,players,1,1
103800,.,1,0
103801,Twenty,1,1
103802,highly,1,0
103803,trained,1,0
103804,soccer,1,0
103805,players,1,0
103806,(,1,0
103807,age,1,1
103808,18.3,1,0
103809,+/-,1,0
103810,0.6,1,0
103811,years,1,1
103812,",",1,0
103813,height,1,0
103814,177,1,1
103815,+/-,1,0
103816,4,1,0
103817,cm,1,1
103818,",",1,0
103819,body,1,0
103820,mass,1,0
103821,71.4,1,0
103822,+/-,1,0
103823,6.9,1,0
103824,kg,1,0
103825,",",1,0
103826,sum,1,0
103827,skinfolds,1,0
103828,48.1,1,0
103829,+/-,1,0
103830,11.4,1,0
103831,mm,1,0
103832,),1,0
103833,",",1,0
103834,members,1,0
103835,of,1,0
103836,a,1,0
103837,professional,1,0
103838,soccer,1,0
103839,academy,1,1
103840,",",0,0
103841,were,0,0
103842,randomly,0,0
103843,allocated,0,0
103844,to,0,0
103845,either,0,0
103846,a,0,0
103847,CONTRAST,0,0
103848,(,0,0
103849,n,0,1
103850,=,0,0
103851,10,0,1
103852,),0,0
103853,or,0,0
103854,SPRINT,0,0
103855,(,0,0
103856,n,0,1
103857,=,0,0
103858,10,0,1
103859,),0,0
103860,group,0,0
103861,.,0,0
103862,The,0,0
103863,training,0,0
103864,intervention,0,0
103865,consisted,0,0
103866,of,0,0
103867,6,0,0
103868,supervised,0,0
103869,training,0,0
103870,sessions,0,0
103871,over,0,0
103872,7,0,0
103873,weeks,0,0
103874,",",0,0
103875,targeting,0,0
103876,the,0,0
103877,improvement,0,0
103878,of,0,0
103879,the,0,0
103880,players,0,0
103881,',0,0
103882,speed,0,0
103883,and,0,0
103884,power,0,0
103885,.,0,0
103886,CONTRAST,0,0
103887,protocol,0,0
103888,consisted,0,0
103889,of,0,0
103890,alternating,0,0
103891,heavy-light,0,0
103892,resistance,0,0
103893,(,0,0
103894,15-50,0,0
103895,%,0,0
103896,body,0,0
103897,mass,0,0
103898,),0,0
103899,with,0,1
103900,soccer-specific,0,0
103901,drills,0,0
103902,(,0,1
103903,small-sided,0,0
103904,games,0,0
103905,or,0,1
103906,technical,0,0
103907,skills,0,0
103908,),0,1
103909,.,0,0
103910,SPRINT,0,0
103911,training,0,0
103912,protocol,0,0
103913,used,0,0
103914,line,0,0
103915,30-m,0,0
103916,sprints,0,0
103917,(,0,1
103918,2-4,0,1
103919,sets,0,0
103920,of,0,0
103921,4,0,0
103922,x,0,0
103923,30,0,0
103924,m,0,1
103925,with,0,1
103926,180,0,0
103927,and,0,0
103928,90,0,0
103929,seconds,0,0
103930,of,0,0
103931,recovery,0,0
103932,",",0,0
103933,respectively,0,0
103934,),0,0
103935,.,0,0
103936,At,0,0
103937,baseline,0,0
103938,no,0,0
103939,difference,0,0
103940,between,0,0
103941,physical,0,0
103942,test,0,0
103943,performance,0,0
103944,was,0,0
103945,evident,0,0
103946,between,0,0
103947,the,0,0
103948,2,0,0
103949,groups,0,0
103950,(,0,0
103951,p,0,0
103952,>,0,1
103953,0.05,0,0
103954,),0,0
103955,.,0,0
103956,No,0,0
103957,time,0,0
103958,x,0,0
103959,training,0,0
103960,group,0,0
103961,effect,0,0
103962,was,0,0
103963,found,0,0
103964,for,0,0
103965,any,0,0
103966,of,0,0
103967,the,0,0
103968,vertical,0,0
103969,jump,0,0
103970,and,0,0
103971,Agility-15m,0,0
103972,variables,0,0
103973,(,0,0
103974,p,0,0
103975,>,0,1
103976,0.05,0,0
103977,),0,0
103978,.,0,0
103979,A,0,0
103980,time,0,0
103981,x,0,0
103982,training,0,0
103983,group,0,0
103984,effect,0,0
103985,was,0,0
103986,found,0,0
103987,for,0,0
103988,Sprint-15m,0,1
103989,performance,0,0
103990,with,0,1
103991,the,0,0
103992,CONTRAST,0,0
103993,group,0,0
103994,showing,0,0
103995,significantly,0,0
103996,better,0,0
103997,scores,0,0
103998,than,0,0
103999,the,0,0
104000,SPRINT,0,0
104001,group,0,0
104002,(,0,0
104003,7.23,0,0
104004,+/-,0,0
104005,0.18,0,0
104006,vs.,0,0
104007,7.09,0,0
104008,+/-,0,0
104009,0.20,0,0
104010,m.s,0,0
104011,",",0,0
104012,p,0,0
104013,<,0,0
104014,0.01,0,0
104015,),0,0
104016,.,0,0
104017,In,0,0
104018,light,0,0
104019,of,0,0
104020,these,0,0
104021,findings,0,0
104022,CONTRAST,0,0
104023,training,0,0
104024,should,0,0
104025,be,0,0
104026,preferred,0,0
104027,to,0,0
104028,line,0,0
104029,sprint,0,0
104030,training,0,0
104031,in,0,0
104032,the,0,0
104033,short,0,0
104034,term,0,0
104035,in,0,0
104036,young,1,1
104037,elite,1,1
104038,soccer,1,1
104039,players,1,0
104040,when,0,0
104041,the,0,0
104042,aim,0,0
104043,is,0,0
104044,to,0,0
104045,improve,0,0
104046,soccer-specific,0,0
104047,sprint,0,0
104048,performance,0,0
104049,(,0,0
104050,15,0,0
104051,m,0,1
104052,),0,0
104053,during,0,0
104054,the,0,0
104055,competitive,0,0
104056,season,0,0
104057,.,0,0
104058,Intravenous,0,1
104059,platelet,0,0
104060,blockade,0,0
104061,with,0,0
104062,cangrelor,0,0
104063,during,0,0
104064,PCI,1,1
104065,.,1,1
104066,BACKGROUND,0,0
104067,Intravenous,0,0
104068,cangrelor,0,0
104069,",",0,0
104070,a,0,0
104071,rapid-acting,0,0
104072,",",0,0
104073,reversible,0,0
104074,adenosine,0,0
104075,diphosphate,0,0
104076,(,0,0
104077,ADP,0,0
104078,),0,0
104079,receptor,0,0
104080,antagonist,0,0
104081,",",0,0
104082,might,0,0
104083,reduce,0,0
104084,ischemic,0,1
104085,events,0,0
104086,during,0,0
104087,percutaneous,1,1
104088,coronary,1,1
104089,intervention,1,0
104090,(,1,0
104091,PCI,1,1
104092,),1,0
104093,.,1,0
104094,METHODS,0,0
104095,In,0,0
104096,this,0,0
104097,double-blind,0,0
104098,",",0,0
104099,placebo-controlled,0,0
104100,study,0,0
104101,",",0,0
104102,we,0,0
104103,randomly,0,1
104104,assigned,0,0
104105,5362,1,1
104106,patients,1,1
104107,who,1,1
104108,had,1,1
104109,not,1,1
104110,been,1,0
104111,treated,1,0
104112,with,1,0
104113,clopidogrel,1,0
104114,to,1,0
104115,receive,1,0
104116,either,1,0
104117,cangrelor,1,0
104118,or,1,0
104119,placebo,1,0
104120,at,1,0
104121,the,1,0
104122,time,1,0
104123,of,1,0
104124,PCI,1,0
104125,",",1,0
104126,followed,1,0
104127,by,1,0
104128,600,1,0
104129,mg,1,0
104130,of,1,0
104131,clopidogrel,1,1
104132,.,1,0
104133,The,0,0
104134,primary,0,0
104135,end,0,0
104136,point,0,0
104137,was,0,0
104138,a,0,0
104139,composite,0,0
104140,of,0,0
104141,death,0,0
104142,",",0,0
104143,myocardial,0,0
104144,infarction,0,0
104145,",",0,0
104146,or,0,0
104147,ischemia-driven,0,0
104148,revascularization,0,0
104149,at,0,0
104150,48,0,1
104151,hours,0,0
104152,.,0,1
104153,Enrollment,0,0
104154,was,0,0
104155,stopped,0,0
104156,when,0,0
104157,an,0,0
104158,interim,0,0
104159,analysis,0,0
104160,concluded,0,0
104161,that,0,0
104162,the,0,0
104163,trial,0,0
104164,would,0,0
104165,be,0,0
104166,unlikely,0,0
104167,to,0,0
104168,show,0,0
104169,superiority,0,0
104170,for,0,0
104171,the,0,0
104172,primary,0,0
104173,end,0,0
104174,point,0,0
104175,.,0,0
104176,RESULTS,0,0
104177,The,0,0
104178,primary,1,0
104179,end,1,0
104180,point,1,0
104181,occurred,1,0
104182,in,1,0
104183,185,1,1
104184,of,1,0
104185,2654,1,1
104186,patients,1,1
104187,receiving,1,1
104188,cangrelor,1,0
104189,(,1,0
104190,7.0,1,0
104191,%,1,0
104192,),1,0
104193,and,1,0
104194,in,1,0
104195,210,1,1
104196,of,1,0
104197,2641,1,1
104198,patients,1,1
104199,receiving,1,1
104200,placebo,1,0
104201,(,1,0
104202,8.0,1,0
104203,%,1,0
104204,),1,0
104205,(,0,0
104206,odds,0,0
104207,ratio,0,0
104208,in,0,0
104209,the,0,0
104210,cangrelor,0,0
104211,group,0,0
104212,",",0,0
104213,0.87,0,0
104214,;,0,0
104215,95,0,0
104216,%,0,0
104217,confidence,0,0
104218,interval,0,0
104219,[,0,0
104220,CI,0,0
104221,],0,0
104222,",",0,0
104223,0.71,0,0
104224,to,0,0
104225,1.07,0,0
104226,;,0,0
104227,P=0.17,0,0
104228,),0,0
104229,(,0,0
104230,modified,0,0
104231,intention-to-treat,0,0
104232,population,0,1
104233,adjusted,0,0
104234,for,0,0
104235,missing,0,0
104236,data,0,0
104237,),0,0
104238,.,0,0
104239,In,0,0
104240,the,0,0
104241,cangrelor,0,0
104242,group,0,0
104243,",",0,0
104244,as,0,0
104245,compared,0,0
104246,with,0,0
104247,the,0,0
104248,placebo,0,0
104249,group,0,0
104250,",",0,0
104251,two,0,0
104252,prespecified,0,0
104253,secondary,0,0
104254,end,0,0
104255,points,0,0
104256,were,0,0
104257,significantly,0,0
104258,reduced,0,0
104259,at,0,0
104260,48,0,1
104261,hours,0,0
104262,:,0,1
104263,the,0,0
104264,rate,0,0
104265,of,0,0
104266,stent,0,0
104267,thrombosis,0,1
104268,",",0,0
104269,from,0,0
104270,0.6,0,0
104271,%,0,0
104272,to,0,0
104273,0.2,0,0
104274,%,0,0
104275,(,0,0
104276,odds,0,0
104277,ratio,0,0
104278,",",0,0
104279,0.31,0,0
104280,;,0,0
104281,95,0,0
104282,%,0,0
104283,CI,0,0
104284,",",0,0
104285,0.11,0,0
104286,to,0,0
104287,0.85,0,0
104288,;,0,0
104289,P=0.02,0,0
104290,),0,0
104291,",",0,0
104292,and,0,0
104293,the,0,0
104294,rate,0,0
104295,of,0,0
104296,death,0,0
104297,from,0,0
104298,any,0,0
104299,cause,0,0
104300,",",0,0
104301,from,0,0
104302,0.7,0,0
104303,%,0,0
104304,to,0,0
104305,0.2,0,0
104306,%,0,0
104307,(,0,0
104308,odds,0,0
104309,ratio,0,0
104310,",",0,0
104311,0.33,0,0
104312,;,0,0
104313,95,0,0
104314,%,0,0
104315,CI,0,0
104316,",",0,0
104317,0.13,0,0
104318,to,0,0
104319,0.83,0,0
104320,;,0,0
104321,P=0.02,0,0
104322,),0,0
104323,.,0,0
104324,There,0,0
104325,was,0,0
104326,no,0,0
104327,significant,0,0
104328,difference,0,0
104329,in,0,0
104330,the,0,0
104331,rate,0,0
104332,of,0,0
104333,blood,0,0
104334,transfusion,0,0
104335,(,0,0
104336,1.0,0,0
104337,%,0,0
104338,in,0,0
104339,the,0,0
104340,cangrelor,0,0
104341,group,0,0
104342,and,0,0
104343,0.6,0,0
104344,%,0,0
104345,in,0,0
104346,the,0,0
104347,placebo,0,0
104348,group,0,0
104349,",",0,0
104350,P=0.13,0,0
104351,),0,0
104352,",",0,0
104353,though,0,0
104354,major,0,0
104355,bleeding,0,0
104356,on,0,0
104357,one,0,0
104358,scale,0,0
104359,was,0,0
104360,increased,0,0
104361,in,0,0
104362,the,0,0
104363,cangrelor,0,0
104364,group,0,0
104365,",",0,0
104366,from,0,0
104367,3.5,0,0
104368,%,0,0
104369,to,0,0
104370,5.5,0,0
104371,%,0,0
104372,(,0,0
104373,P,0,0
104374,<,0,0
104375,0.001,0,0
104376,),0,0
104377,",",0,0
104378,because,0,0
104379,of,0,0
104380,more,0,0
104381,groin,0,1
104382,hematomas,0,0
104383,.,0,0
104384,CONCLUSIONS,0,0
104385,The,0,0
104386,use,0,0
104387,of,0,0
104388,periprocedural,0,0
104389,cangrelor,0,0
104390,during,0,0
104391,PCI,0,0
104392,was,0,0
104393,not,0,0
104394,superior,0,0
104395,to,0,0
104396,placebo,0,0
104397,in,0,0
104398,reducing,0,0
104399,the,0,0
104400,primary,0,0
104401,end,0,0
104402,point,0,0
104403,.,0,0
104404,The,0,0
104405,prespecified,0,0
104406,secondary,0,0
104407,end,0,0
104408,points,0,0
104409,of,0,0
104410,stent,0,1
104411,thrombosis,0,1
104412,and,0,0
104413,death,0,0
104414,were,0,0
104415,lower,0,0
104416,in,0,0
104417,the,0,0
104418,cangrelor,0,0
104419,group,0,0
104420,",",0,0
104421,with,0,0
104422,no,0,0
104423,significant,0,0
104424,increase,0,0
104425,in,0,0
104426,the,0,0
104427,rate,0,0
104428,of,0,0
104429,transfusion,0,0
104430,.,0,0
104431,Further,0,0
104432,study,0,0
104433,of,0,0
104434,intravenous,0,0
104435,ADP,0,0
104436,blockade,0,0
104437,with,0,0
104438,cangrelor,0,0
104439,may,0,0
104440,be,0,0
104441,warranted,0,0
104442,.,0,0
104443,(,0,0
104444,ClinicalTrials.gov,0,0
104445,number,0,0
104446,",",0,0
104447,NCT00385138,0,0
104448,.,0,0
104449,),0,0
104450,Effect,0,0
104451,of,0,0
104452,device-guided,0,0
104453,breathing,0,0
104454,exercises,0,0
104455,on,0,0
104456,blood,0,0
104457,pressure,0,0
104458,in,0,0
104459,patients,1,1
104460,with,1,1
104461,hypertension,1,1
104462,:,1,1
104463,a,0,0
104464,randomized,0,0
104465,controlled,0,0
104466,trial,0,0
104467,.,0,0
104468,OBJECTIVE,0,0
104469,Hypertension,0,0
104470,is,0,0
104471,a,0,0
104472,chronic,0,0
104473,disorder,0,1
104474,with,0,1
104475,a,0,0
104476,high,0,0
104477,prevalence,0,0
104478,worldwide,0,0
104479,.,0,0
104480,Despite,0,0
104481,considerable,0,0
104482,efforts,0,0
104483,",",0,0
104484,it,0,0
104485,is,0,0
104486,sometimes,0,0
104487,hard,0,0
104488,to,0,0
104489,reach,0,0
104490,treatment,0,0
104491,goals,0,0
104492,for,0,0
104493,blood,0,0
104494,pressure,0,0
104495,(,0,0
104496,BP,0,0
104497,),0,0
104498,with,0,1
104499,classical,0,1
104500,treatment,0,0
104501,options,0,0
104502,.,0,0
104503,Reducing,0,0
104504,breathing,0,0
104505,frequency,0,0
104506,has,0,0
104507,been,0,0
104508,advocated,0,0
104509,as,0,0
104510,a,0,0
104511,method,0,0
104512,to,0,0
104513,reduce,0,0
104514,BP,0,0
104515,.,0,0
104516,METHODS,0,0
104517,A,0,0
104518,randomized,0,0
104519,",",0,0
104520,single-blind,0,0
104521,",",0,0
104522,controlled,0,0
104523,trial,0,0
104524,was,0,0
104525,conducted,0,0
104526,in,0,0
104527,30,1,1
104528,non-diabetic,1,1
104529,patients,1,1
104530,with,1,1
104531,hypertension,1,1
104532,over,0,0
104533,a,0,0
104534,period,0,0
104535,of,0,0
104536,9,0,0
104537,weeks,0,0
104538,to,0,0
104539,evaluate,0,0
104540,the,0,0
104541,effect,0,0
104542,of,0,0
104543,a,0,0
104544,device,0,0
104545,that,0,0
104546,helps,0,0
104547,to,0,0
104548,slow,0,0
104549,breathing,0,0
104550,(,0,0
104551,Resperate,0,0
104552,),0,0
104553,on,0,0
104554,BP,0,0
104555,and,0,0
104556,quality,0,0
104557,of,0,0
104558,life,0,0
104559,(,0,0
104560,QoL,0,0
104561,),0,0
104562,.,0,0
104563,The,0,0
104564,control,0,0
104565,group,0,0
104566,listened,0,0
104567,to,0,0
104568,music,0,0
104569,and,0,0
104570,used,0,0
104571,no,0,0
104572,other,0,0
104573,therapeutic,0,0
104574,device,0,0
104575,.,0,0
104576,RESULTS,0,0
104577,There,0,0
104578,was,0,0
104579,no,0,0
104580,significant,0,0
104581,difference,0,0
104582,in,0,0
104583,change,0,0
104584,in,0,0
104585,BP,0,0
104586,between,0,0
104587,intervention,0,0
104588,and,0,0
104589,control,0,0
104590,;,0,0
104591,BP,0,0
104592,-4.2,0,0
104593,mmHg,0,0
104594,(,0,0
104595,95,0,0
104596,%,0,0
104597,CI,0,0
104598,-12.4,0,0
104599,to,0,0
104600,3.9,0,0
104601,),0,0
104602,/-2.6,0,0
104603,mmHg,0,0
104604,(,0,0
104605,95,0,0
104606,%,0,0
104607,CI,0,0
104608,-8.4,0,0
104609,to,0,0
104610,3.3,0,0
104611,),0,0
104612,.,0,0
104613,This,0,0
104614,result,0,0
104615,did,0,0
104616,not,0,0
104617,alter,0,0
104618,in,0,0
104619,post,0,0
104620,hoc,0,0
104621,analyses,0,0
104622,",",0,0
104623,when,0,0
104624,patients,0,1
104625,not,0,0
104626,achieving,0,0
104627,target,0,0
104628,breathing,0,0
104629,frequency,0,0
104630,(,0,0
104631,<,0,0
104632,10,0,1
104633,breaths/min,0,0
104634,),0,0
104635,or,0,0
104636,non-compliant,0,0
104637,patients,0,1
104638,were,0,0
104639,excluded,0,0
104640,.,0,0
104641,QoL,0,0
104642,did,0,0
104643,not,0,0
104644,change,0,0
104645,over,0,0
104646,time,0,0
104647,.,0,0
104648,CONCLUSIONS,0,0
104649,We,0,0
104650,found,0,0
104651,no,0,0
104652,effect,0,0
104653,of,0,0
104654,the,0,0
104655,Resperate,0,0
104656,on,0,0
104657,BP,0,0
104658,or,0,1
104659,QoL,0,0
104660,compared,0,0
104661,with,0,0
104662,the,0,0
104663,control,0,0
104664,group,0,0
104665,.,0,0
104666,We,0,0
104667,conclude,0,0
104668,that,0,0
104669,",",0,0
104670,at,0,0
104671,this,0,0
104672,moment,0,0
104673,",",0,0
104674,this,0,0
104675,device,0,0
104676,has,0,0
104677,no,0,0
104678,added,0,0
104679,value,0,0
104680,in,0,0
104681,the,0,0
104682,treatment,0,0
104683,of,0,0
104684,hypertension,0,1
104685,.,0,0
104686,The,0,0
104687,effect,0,0
104688,of,0,0
104689,posture,0,0
104690,on,0,0
104691,Cheyne-Stokes,0,0
104692,respirations,0,1
104693,and,0,0
104694,hemodynamics,0,0
104695,in,0,0
104696,patients,1,1
104697,with,1,1
104698,heart,1,1
104699,failure,1,1
104700,.,1,0
104701,STUDY,0,0
104702,OBJECTIVES,0,0
104703,Cheyne-Stokes,0,1
104704,respirations,0,1
104705,occur,0,0
104706,in,0,0
104707,40,0,0
104708,%,0,0
104709,of,0,0
104710,patients,1,1
104711,with,1,1
104712,heart,1,1
104713,failure,1,1
104714,.,1,0
104715,Orthopnea,0,0
104716,is,0,0
104717,a,0,0
104718,cardinal,0,0
104719,symptom,0,0
104720,of,0,0
104721,heart,0,1
104722,failure,0,0
104723,and,0,0
104724,may,0,0
104725,affect,0,0
104726,the,0,0
104727,patient,0,0
104728,'s,0,0
104729,sleeping,0,0
104730,angle,0,0
104731,.,0,0
104732,The,0,0
104733,objective,0,0
104734,of,0,0
104735,this,0,0
104736,study,0,0
104737,was,0,0
104738,to,0,0
104739,assess,0,0
104740,the,0,0
104741,respiratory,0,0
104742,and,0,0
104743,hemodynamic,0,0
104744,response,0,0
104745,to,0,0
104746,sleeping,0,0
104747,angle,0,0
104748,in,0,0
104749,a,0,0
104750,group,1,0
104751,of,1,0
104752,subjects,1,1
104753,with,1,1
104754,stable,1,1
104755,heart,1,1
104756,failure,1,1
104757,.,1,0
104758,DESIGN,0,0
104759,Twenty-five,1,1
104760,patients,1,1
104761,underwent,0,1
104762,overnight,0,0
104763,polysomnography,0,1
104764,with,0,1
104765,simultaneous,0,0
104766,and,0,0
104767,continuous,0,0
104768,impedance,0,0
104769,cardiographic,0,1
104770,monitoring,0,0
104771,.,0,0
104772,Sleeping,0,0
104773,polysomnographic,0,0
104774,and,0,0
104775,impedance,0,0
104776,cardiographic,0,1
104777,data,0,0
104778,were,0,0
104779,recorded,0,0
104780,.,0,0
104781,SETTING,0,0
104782,The,0,0
104783,study,0,0
104784,was,0,0
104785,conducted,0,0
104786,in,0,0
104787,a,0,0
104788,sleep,0,0
104789,center,0,1
104790,.,0,0
104791,PATIENTS,0,0
104792,All,1,0
104793,25,1,0
104794,patients,1,1
104795,had,1,0
104796,clinically,1,0
104797,stable,1,1
104798,heart,1,0
104799,failure,1,1
104800,and,1,0
104801,left,1,0
104802,ventricular,1,0
104803,ejection,1,0
104804,fractions,1,0
104805,<,1,0
104806,40,1,1
104807,%,1,0
104808,.,1,0
104809,INTERVENTIONS,0,0
104810,The,0,0
104811,patients,0,1
104812,slept,0,0
104813,at,0,0
104814,0,0,0
104815,degrees,0,0
104816,",",0,0
104817,15,0,0
104818,degrees,0,0
104819,",",0,0
104820,30,0,0
104821,degrees,0,0
104822,",",0,0
104823,and,0,0
104824,45,0,0
104825,degrees,0,0
104826,in,0,0
104827,random,0,1
104828,order,0,0
104829,.,0,0
104830,MEASUREMENTS,0,0
104831,AND,0,0
104832,RESULTS,0,0
104833,Seventeen,0,1
104834,patients,0,1
104835,had,0,1
104836,Cheyne-Stokes,0,1
104837,apneas,0,0
104838,(,0,0
104839,index,0,0
104840,>,0,1
104841,5/h,0,1
104842,),0,0
104843,and,0,0
104844,23,0,1
104845,patients,0,1
104846,had,0,1
104847,hypopneas,0,0
104848,(,0,0
104849,index,0,0
104850,>,0,1
104851,5/h,0,1
104852,),0,0
104853,.,0,0
104854,The,0,0
104855,hypopnea,0,0
104856,index,0,0
104857,showed,0,0
104858,no,0,0
104859,response,0,0
104860,to,0,0
104861,sleeping,0,0
104862,angle,0,0
104863,.,0,0
104864,The,0,0
104865,Cheyne-Stokes,0,0
104866,apnea,0,1
104867,index,0,0
104868,decreased,0,0
104869,with,0,0
104870,increasing,0,0
104871,sleeping,0,0
104872,angle,0,0
104873,(,0,0
104874,P,0,0
104875,<,0,0
104876,0.001,0,0
104877,),0,0
104878,.,0,0
104879,This,0,0
104880,effect,0,0
104881,was,0,0
104882,seen,0,0
104883,only,0,0
104884,during,0,0
104885,supine,0,0
104886,sleep,0,0
104887,and,0,0
104888,non-rapid,0,0
104889,eye,0,0
104890,movement,0,0
104891,sleep,0,0
104892,and,0,0
104893,was,0,0
104894,absent,0,0
104895,in,0,0
104896,non-supine,0,0
104897,sleep,0,0
104898,",",0,0
104899,rapid,0,0
104900,eye,0,0
104901,movement,0,0
104902,sleep,0,0
104903,",",0,0
104904,and,0,0
104905,during,0,0
104906,periods,0,0
104907,of,0,0
104908,wakefulness,0,0
104909,.,0,0
104910,Thoracic,0,0
104911,fluid,0,0
104912,content,0,0
104913,index,0,0
104914,and,0,0
104915,left,0,1
104916,ventricular,0,0
104917,hemodynamics,0,0
104918,measured,0,0
104919,by,0,0
104920,impedance,0,0
104921,cardiography,0,0
104922,showed,0,0
104923,no,0,0
104924,response,0,0
104925,to,0,0
104926,sleeping,0,0
104927,angle,0,0
104928,.,0,0
104929,CONCLUSIONS,0,0
104930,Changing,0,0
104931,the,0,0
104932,heart,0,0
104933,failure,0,0
104934,patient,0,0
104935,'s,0,0
104936,sleeping,0,0
104937,angle,0,0
104938,from,0,1
104939,0,0,0
104940,degrees,0,0
104941,to,0,1
104942,45,0,1
104943,degrees,0,0
104944,results,0,0
104945,in,0,0
104946,a,0,0
104947,significant,0,0
104948,decrease,0,0
104949,in,0,0
104950,Cheyne-Stokes,0,0
104951,apneas,0,0
104952,.,0,0
104953,This,0,0
104954,decrease,0,0
104955,occurs,0,0
104956,on,0,0
104957,a,0,0
104958,constant,0,0
104959,base,0,0
104960,of,0,0
104961,hypopneas,0,0
104962,.,0,1
104963,The,0,0
104964,changes,0,0
104965,in,0,0
104966,Cheyne-Stokes,0,1
104967,apneas,0,0
104968,are,0,0
104969,not,0,0
104970,related,0,0
104971,to,0,0
104972,changes,0,0
104973,in,0,0
104974,lung,0,1
104975,congestion,0,0
104976,and,0,0
104977,left,0,1
104978,ventricular,0,0
104979,hemodynamics,0,0
104980,.,0,1
104981,Low-frequency,0,0
104982,repetitive,0,0
104983,transcranial,0,0
104984,magnetic,0,0
104985,stimulation,0,0
104986,(,0,0
104987,rTMS,0,0
104988,),0,0
104989,affects,0,0
104990,event-related,0,0
104991,potential,0,0
104992,measures,0,0
104993,of,0,0
104994,novelty,0,0
104995,processing,0,0
104996,in,0,0
104997,autism,1,1
104998,.,1,0
104999,In,0,0
105000,our,0,0
105001,previous,0,0
105002,study,0,0
105003,on,0,0
105004,individuals,1,1
105005,with,1,1
105006,autism,1,1
105007,spectrum,1,1
105008,disorder,1,1
105009,(,1,0
105010,ASD,1,1
105011,),1,0
105012,(,0,0
105013,Sokhadze,0,0
105014,et,0,0
105015,al.,0,0
105016,",",0,0
105017,Appl,0,0
105018,Psychophysiol,0,1
105019,Biofeedback,0,0
105020,34:37-51,0,1
105021,",",0,0
105022,2009a,0,0
105023,),0,0
105024,we,0,0
105025,reported,0,0
105026,abnormalities,0,0
105027,in,0,0
105028,the,0,0
105029,attention-orienting,0,0
105030,frontal,0,0
105031,event-related,0,0
105032,potentials,0,0
105033,(,0,0
105034,ERP,0,0
105035,),0,0
105036,and,0,0
105037,the,0,0
105038,sustained-attention,0,0
105039,centro-parietal,0,0
105040,ERPs,0,0
105041,in,0,0
105042,a,0,0
105043,visual,0,0
105044,oddball,0,0
105045,experiment,0,0
105046,.,0,0
105047,These,0,0
105048,results,0,0
105049,suggest,0,0
105050,that,0,0
105051,individuals,1,1
105052,with,1,1
105053,autism,1,1
105054,over-process,0,0
105055,information,0,0
105056,needed,0,0
105057,for,0,0
105058,the,0,0
105059,successful,0,0
105060,differentiation,0,0
105061,of,0,0
105062,target,0,0
105063,and,0,0
105064,novel,0,0
105065,stimuli,0,0
105066,.,0,0
105067,In,0,0
105068,the,0,0
105069,present,0,0
105070,study,0,0
105071,we,0,0
105072,examine,0,0
105073,the,0,0
105074,effects,0,0
105075,of,0,0
105076,low-frequency,0,0
105077,",",0,0
105078,repetitive,0,0
105079,Transcranial,0,0
105080,Magnetic,0,0
105081,Stimulation,0,0
105082,(,0,0
105083,rTMS,0,0
105084,),0,0
105085,on,0,0
105086,novelty,0,0
105087,processing,0,0
105088,as,0,0
105089,well,0,0
105090,as,0,0
105091,behavior,0,0
105092,and,0,0
105093,social,0,0
105094,functioning,0,0
105095,in,0,0
105096,13,1,0
105097,individuals,1,1
105098,with,1,1
105099,ASD,1,1
105100,.,1,0
105101,Our,0,0
105102,hypothesis,0,0
105103,was,0,0
105104,that,0,0
105105,low-frequency,0,0
105106,rTMS,0,0
105107,application,0,0
105108,to,0,0
105109,dorsolateral,0,0
105110,prefrontal,0,0
105111,cortex,0,0
105112,(,0,0
105113,DLFPC,0,0
105114,),0,0
105115,would,0,0
105116,result,0,0
105117,in,0,0
105118,an,0,0
105119,alteration,0,0
105120,of,0,0
105121,the,0,0
105122,cortical,0,0
105123,excitatory/inhibitory,0,0
105124,balance,0,0
105125,through,0,0
105126,the,0,0
105127,activation,0,0
105128,of,0,0
105129,inhibitory,0,0
105130,GABAergic,0,0
105131,double,0,0
105132,bouquet,0,1
105133,interneurons,0,0
105134,.,0,0
105135,We,0,0
105136,expected,0,0
105137,to,0,0
105138,find,0,0
105139,post-TMS,0,0
105140,differences,0,0
105141,in,0,0
105142,amplitude,0,0
105143,and,0,0
105144,latency,0,0
105145,of,0,0
105146,early,0,0
105147,and,0,0
105148,late,0,1
105149,ERP,0,0
105150,components,0,0
105151,.,0,0
105152,The,0,0
105153,results,0,0
105154,of,0,0
105155,our,0,0
105156,current,0,0
105157,study,0,0
105158,validate,0,0
105159,the,0,0
105160,use,0,0
105161,of,0,0
105162,low-frequency,0,0
105163,rTMS,0,0
105164,as,0,0
105165,a,0,0
105166,modulatory,0,0
105167,tool,0,0
105168,that,0,0
105169,altered,0,0
105170,the,0,0
105171,disrupted,0,0
105172,ratio,0,0
105173,of,0,0
105174,cortical,0,0
105175,excitation,0,0
105176,to,0,0
105177,inhibition,0,0
105178,in,0,0
105179,autism,0,1
105180,.,0,0
105181,After,0,0
105182,rTMS,0,0
105183,the,0,0
105184,parieto-occipital,0,0
105185,P50,0,0
105186,amplitude,0,0
105187,decreased,0,0
105188,to,0,0
105189,novel,0,0
105190,distracters,0,0
105191,but,0,0
105192,not,0,0
105193,to,0,0
105194,targets,0,0
105195,;,0,0
105196,also,0,0
105197,the,0,0
105198,amplitude,0,0
105199,and,0,0
105200,latency,0,0
105201,to,0,0
105202,targets,0,0
105203,increased,0,0
105204,for,0,0
105205,the,0,0
105206,frontal,0,0
105207,P50,0,0
105208,while,0,0
105209,decreasing,0,0
105210,to,0,0
105211,non-target,0,0
105212,stimuli,0,0
105213,.,0,1
105214,Low-frequency,0,0
105215,rTMS,0,0
105216,minimized,0,0
105217,early,0,0
105218,cortical,0,0
105219,responses,0,0
105220,to,0,0
105221,irrelevant,0,0
105222,stimuli,0,0
105223,and,0,0
105224,increased,0,0
105225,responses,0,0
105226,to,0,0
105227,relevant,0,0
105228,stimuli,0,0
105229,.,0,0
105230,Improved,0,0
105231,selectivity,0,0
105232,in,0,0
105233,early,0,1
105234,cortical,0,0
105235,responses,0,0
105236,lead,0,0
105237,to,0,0
105238,better,0,0
105239,stimulus,0,0
105240,differentiation,0,0
105241,at,0,0
105242,later-stage,0,0
105243,responses,0,0
105244,as,0,0
105245,was,0,0
105246,made,0,0
105247,evident,0,0
105248,by,0,0
105249,our,0,0
105250,P3b,0,0
105251,and,0,0
105252,P3a,0,0
105253,component,0,0
105254,findings,0,0
105255,.,0,0
105256,These,0,0
105257,results,0,0
105258,indicate,0,0
105259,a,0,0
105260,significant,0,0
105261,change,0,0
105262,in,0,0
105263,early,0,0
105264,",",0,0
105265,middle-latency,0,0
105266,and,0,0
105267,late,0,1
105268,ERP,0,0
105269,components,0,0
105270,at,0,0
105271,the,0,0
105272,frontal,0,0
105273,",",0,0
105274,centro-parietal,0,0
105275,",",0,0
105276,and,0,0
105277,parieto-occipital,0,0
105278,regions,0,0
105279,of,0,0
105280,interest,0,0
105281,in,0,0
105282,response,0,0
105283,to,0,0
105284,target,0,0
105285,and,0,0
105286,distracter,0,0
105287,stimuli,0,0
105288,as,0,0
105289,a,0,0
105290,result,0,0
105291,of,0,0
105292,rTMS,0,0
105293,treatment,0,0
105294,.,0,0
105295,Overall,0,0
105296,",",0,0
105297,our,0,0
105298,preliminary,0,0
105299,results,0,0
105300,show,0,0
105301,that,0,0
105302,rTMS,0,0
105303,may,0,0
105304,prove,0,0
105305,to,0,0
105306,be,0,0
105307,an,0,0
105308,important,0,0
105309,research,0,0
105310,tool,0,0
105311,or,0,0
105312,treatment,0,0
105313,modality,0,0
105314,in,0,0
105315,addressing,0,0
105316,the,0,0
105317,stimulus,0,0
105318,hypersensitivity,0,0
105319,characteristic,0,0
105320,of,0,0
105321,autism,0,1
105322,spectrum,0,1
105323,disorders,0,1
105324,.,0,1
105325,Different,0,0
105326,therapeutic,0,0
105327,modalities,0,0
105328,for,0,0
105329,treatment,0,0
105330,of,0,0
105331,melasma,0,1
105332,.,0,0
105333,BACKGROUND,0,0
105334,Chemical,0,0
105335,peels,0,1
105336,and,0,0
105337,topical,0,0
105338,depigmenting,0,0
105339,agents,0,0
105340,have,0,0
105341,become,0,0
105342,a,0,0
105343,popular,0,0
105344,modality,0,0
105345,in,0,0
105346,the,0,0
105347,treatment,0,0
105348,of,0,0
105349,melasma,0,1
105350,.,0,0
105351,AIMS,0,0
105352,To,0,0
105353,compare,0,0
105354,the,0,0
105355,clinical,0,0
105356,efficacy,0,0
105357,of,0,0
105358,trichloroacetic,0,0
105359,acid,0,0
105360,peel,0,0
105361,20,0,0
105362,%,0,0
105363,vs,0,0
105364,.,0,0
105365,Jessner,0,0
105366,'s,0,0
105367,solution,0,0
105368,peel,0,0
105369,vs.,0,0
105370,the,0,0
105371,topical,0,0
105372,mixture,0,0
105373,of,0,0
105374,hydroquinone,0,0
105375,2,0,0
105376,%,0,0
105377,and,0,0
105378,kojic,0,0
105379,acid,0,0
105380,.,0,0
105381,PATIENTS,0,0
105382,AND,0,0
105383,METHODS,0,0
105384,Forty,1,1
105385,five,1,1
105386,patients,1,1
105387,with,1,1
105388,melasma,1,1
105389,were,1,0
105390,randomly,1,1
105391,assigned,1,0
105392,into,1,0
105393,three,1,0
105394,groups,1,0
105395,of,1,0
105396,fifteen,1,1
105397,patients,1,1
105398,each,1,0
105399,.,1,0
105400,Group,0,0
105401,A,0,0
105402,received,0,0
105403,Jessner,0,0
105404,'s,0,0
105405,solution,0,0
105406,peel,0,0
105407,",",0,0
105408,group,0,0
105409,B,0,0
105410,received,0,0
105411,trichloroacetic,0,0
105412,acid,0,0
105413,peel,0,0
105414,20,0,0
105415,%,0,0
105416,",",0,0
105417,and,0,0
105418,group,0,0
105419,C,0,0
105420,received,0,0
105421,topical,0,0
105422,hydroquinone,0,0
105423,2,0,0
105424,%,0,0
105425,and,0,0
105426,kojic,0,0
105427,acid,0,0
105428,.,0,0
105429,All,0,0
105430,patients,0,1
105431,were,0,0
105432,seen,0,0
105433,in,0,0
105434,follow-up,0,0
105435,period,0,0
105436,after,0,0
105437,16,0,1
105438,weeks,0,0
105439,;,0,0
105440,clinical,0,0
105441,evaluation,0,0
105442,using,0,0
105443,Melasma,0,1
105444,Area,0,0
105445,and,0,0
105446,Severity,0,0
105447,Index,0,0
105448,(,0,0
105449,MASI,0,0
105450,),0,0
105451,score,0,0
105452,and,0,0
105453,photography,0,0
105454,were,0,0
105455,recorded,0,0
105456,before,0,0
105457,and,0,0
105458,after,0,0
105459,treatment,0,0
105460,and,0,0
105461,after,0,0
105462,16,0,1
105463,weeks,0,0
105464,.,0,1
105465,RESULTS,0,0
105466,There,0,0
105467,was,0,0
105468,a,0,0
105469,decrease,0,0
105470,in,0,0
105471,MASI,0,0
105472,score,0,0
105473,in,0,0
105474,all,0,0
105475,three,0,0
105476,groups,0,0
105477,after,0,0
105478,treatment,0,0
105479,and,0,0
105480,after,0,0
105481,follow-up,0,0
105482,period,0,0
105483,but,0,0
105484,after,0,0
105485,treatment,0,0
105486,MASI,0,0
105487,score,0,0
105488,was,0,0
105489,statistically,0,0
105490,significantly,0,0
105491,lower,0,0
105492,in,0,0
105493,group,0,0
105494,A,0,0
105495,than,0,0
105496,group,0,0
105497,C,0,0
105498,(,0,0
105499,P,0,0
105500,=,0,0
105501,0.01,0,0
105502,),0,0
105503,",",0,0
105504,and,0,0
105505,it,0,0
105506,was,0,0
105507,also,0,0
105508,statistically,0,0
105509,significantly,0,0
105510,lower,0,0
105511,in,0,0
105512,group,0,0
105513,B,0,0
105514,than,0,0
105515,group,0,0
105516,C,0,0
105517,(,0,0
105518,P,0,0
105519,<,0,0
105520,0.001,0,0
105521,),0,0
105522,but,0,0
105523,there,0,0
105524,was,0,0
105525,no,0,0
105526,statistically,0,0
105527,significant,0,0
105528,difference,0,0
105529,between,0,0
105530,groups,0,0
105531,A,0,1
105532,and,0,0
105533,B,0,0
105534,.,0,0
105535,After,0,0
105536,the,0,0
105537,follow-up,0,0
105538,period,0,0
105539,",",0,0
105540,MASI,0,0
105541,score,0,0
105542,was,0,0
105543,statistically,0,0
105544,significantly,0,0
105545,lower,0,0
105546,in,0,0
105547,group,0,0
105548,A,0,0
105549,than,0,0
105550,group,0,0
105551,C,0,0
105552,(,0,0
105553,P,0,0
105554,<,0,0
105555,0.001,0,0
105556,),0,0
105557,",",0,0
105558,statistically,0,0
105559,significantly,0,0
105560,lower,0,0
105561,in,0,0
105562,group,0,0
105563,B,0,0
105564,than,0,0
105565,group,0,0
105566,C,0,0
105567,(,0,0
105568,P,0,0
105569,<,0,0
105570,0.001,0,0
105571,),0,0
105572,",",0,0
105573,and,0,0
105574,statistically,0,0
105575,significantly,0,0
105576,lower,0,0
105577,in,0,0
105578,group,0,0
105579,B,0,0
105580,than,0,0
105581,group,0,0
105582,A,0,0
105583,(,0,0
105584,P,0,0
105585,=,0,0
105586,0.035,0,0
105587,),0,0
105588,.,0,0
105589,The,0,0
105590,statistical,0,0
105591,analysis,0,0
105592,was,0,0
105593,done,0,0
105594,through,0,0
105595,one-way,0,0
105596,anova,0,0
105597,followed,0,0
105598,by,0,0
105599,least,0,0
105600,significant,0,0
105601,difference,0,0
105602,(,0,0
105603,LSD,0,0
105604,),0,0
105605,.,0,0
105606,CONCLUSION,0,0
105607,Trichloroacetic,0,0
105608,acid,0,0
105609,20,0,0
105610,%,0,0
105611,showed,0,0
105612,better,0,0
105613,results,0,0
105614,than,0,0
105615,Jessner,0,1
105616,'s,0,0
105617,solution,0,0
105618,as,0,0
105619,peeling,0,0
105620,agent,0,0
105621,and,0,0
105622,hydroquinone,0,0
105623,2,0,0
105624,%,0,0
105625,with,0,1
105626,kojic,0,0
105627,acid,0,0
105628,as,0,0
105629,a,0,0
105630,topical,0,0
105631,agent,0,0
105632,in,0,0
105633,the,0,0
105634,treatment,0,0
105635,of,0,0
105636,melasma,1,1
105637,.,1,0
105638,The,0,0
105639,impact,0,0
105640,on,0,0
105641,outcome,0,0
105642,of,0,0
105643,the,0,0
105644,addition,0,0
105645,of,0,0
105646,all-trans,0,0
105647,retinoic,0,0
105648,acid,0,0
105649,to,0,0
105650,intensive,0,0
105651,chemotherapy,0,0
105652,in,0,0
105653,younger,1,1
105654,patients,1,1
105655,with,1,1
105656,nonacute,1,1
105657,promyelocytic,1,1
105658,acute,1,1
105659,myeloid,1,1
105660,leukemia,1,1
105661,:,1,1
105662,overall,0,0
105663,results,0,0
105664,and,0,0
105665,results,0,0
105666,in,0,0
105667,genotypic,1,0
105668,subgroups,1,0
105669,defined,1,0
105670,by,1,0
105671,mutations,1,0
105672,in,1,0
105673,NPM1,1,0
105674,",",1,0
105675,FLT3,1,0
105676,",",1,0
105677,and,1,0
105678,CEBPA,1,0
105679,.,1,0
105680,We,0,0
105681,investigated,0,0
105682,the,0,0
105683,benefit,0,0
105684,of,0,0
105685,adding,0,0
105686,all-trans,0,0
105687,retinoic,0,0
105688,acid,0,0
105689,(,0,0
105690,ATRA,0,0
105691,),0,0
105692,to,0,0
105693,chemotherapy,1,0
105694,for,1,0
105695,younger,1,1
105696,patients,1,1
105697,with,1,1
105698,nonacute,1,1
105699,promyelocytic,1,1
105700,acute,1,1
105701,myeloid,1,1
105702,leukemia,1,1
105703,and,1,0
105704,high-risk,1,1
105705,myelodysplastic,1,1
105706,syndrome,1,1
105707,",",0,0
105708,and,0,0
105709,considered,0,0
105710,interactions,0,0
105711,between,0,0
105712,treatment,0,0
105713,and,0,0
105714,molecular,0,0
105715,markers,0,0
105716,.,0,1
105717,Overall,0,0
105718,",",0,0
105719,1075,1,0
105720,patients,1,1
105721,less,1,0
105722,than,1,0
105723,60,1,0
105724,years,1,1
105725,of,1,0
105726,age,1,1
105727,were,0,0
105728,randomized,0,0
105729,to,0,0
105730,receive,0,0
105731,or,0,0
105732,not,0,0
105733,receive,0,0
105734,ATRA,0,0
105735,in,0,0
105736,addition,0,0
105737,to,0,0
105738,daunorubicin/Ara-C/thioguanine,0,0
105739,chemotherapy,0,0
105740,with,0,1
105741,Ara-C,0,0
105742,at,0,0
105743,standard,0,0
105744,or,0,0
105745,double,0,0
105746,standard,0,0
105747,dose,0,0
105748,.,0,0
105749,There,0,0
105750,were,0,0
105751,data,0,0
105752,on,0,0
105753,FLT3,0,1
105754,internal,0,0
105755,tandem,0,0
105756,duplications,0,0
105757,and,0,0
105758,NPM1,0,0
105759,mutations,0,0
105760,(,0,0
105761,n,0,1
105762,=,0,0
105763,592,0,1
105764,),0,0
105765,",",0,0
105766,CEBPA,0,0
105767,mutations,0,0
105768,(,0,0
105769,n,0,1
105770,=,0,0
105771,423,0,1
105772,),0,0
105773,",",0,0
105774,and,0,0
105775,MN1,0,0
105776,expression,0,0
105777,(,0,0
105778,n,0,1
105779,=,0,0
105780,195,0,1
105781,),0,0
105782,.,0,0
105783,The,0,0
105784,complete,0,0
105785,remission,0,0
105786,rate,0,0
105787,was,0,0
105788,68,0,0
105789,%,0,0
105790,with,0,1
105791,complete,0,0
105792,remission,0,1
105793,with,0,1
105794,incomplete,0,0
105795,count,0,0
105796,recovery,0,0
105797,in,0,0
105798,an,0,0
105799,additional,0,0
105800,16,0,1
105801,%,0,0
105802,;,0,0
105803,8-year,0,0
105804,overall,0,0
105805,survival,0,0
105806,was,0,0
105807,32,0,1
105808,%,0,0
105809,.,0,0
105810,There,0,0
105811,was,0,0
105812,no,0,0
105813,significant,0,0
105814,treatment,0,0
105815,effect,0,0
105816,for,0,0
105817,any,0,0
105818,outcome,0,0
105819,",",0,0
105820,with,0,0
105821,no,0,0
105822,significant,0,0
105823,interactions,0,0
105824,between,0,0
105825,treatment,0,0
105826,and,0,0
105827,demographics,0,0
105828,",",0,0
105829,or,0,0
105830,cytarabine,0,0
105831,randomization,0,0
105832,.,0,0
105833,Importantly,0,0
105834,",",0,0
105835,there,0,0
105836,were,0,0
105837,no,0,0
105838,interactions,0,0
105839,by,0,0
105840,FLT3/internal,0,0
105841,tandem,0,0
105842,duplications,0,0
105843,",",0,0
105844,NPM1,0,0
105845,",",0,0
105846,or,0,0
105847,CEBPA,0,0
105848,mutation,0,0
105849,.,0,0
105850,There,0,0
105851,was,0,0
105852,a,0,0
105853,suggestion,0,0
105854,that,0,0
105855,ATRA,0,0
105856,reduced,0,0
105857,relapse,0,0
105858,in,0,0
105859,patients,0,1
105860,with,0,1
105861,lower,0,0
105862,MN1,0,0
105863,levels,0,0
105864,",",0,0
105865,but,0,0
105866,no,0,0
105867,significant,0,0
105868,effect,0,0
105869,on,0,0
105870,overall,0,0
105871,survival,0,0
105872,.,0,1
105873,Results,0,0
105874,were,0,0
105875,consistent,0,0
105876,when,0,0
105877,restricted,0,0
105878,to,0,0
105879,patients,0,1
105880,with,0,1
105881,normal,0,1
105882,karyotype,0,1
105883,.,0,0
105884,ATRA,0,0
105885,has,0,0
105886,no,0,0
105887,overall,0,0
105888,effect,0,0
105889,on,0,0
105890,treatment,0,0
105891,outcomes,0,0
105892,in,0,0
105893,this,0,0
105894,group,0,0
105895,of,0,0
105896,patients,0,1
105897,.,0,0
105898,The,0,0
105899,study,0,0
105900,did,0,0
105901,not,0,0
105902,identify,0,0
105903,any,0,0
105904,subgroup,0,0
105905,of,0,0
105906,patients,0,1
105907,likely,0,0
105908,to,0,0
105909,derive,0,0
105910,a,0,0
105911,significant,0,0
105912,survival,0,0
105913,benefit,0,0
105914,from,0,0
105915,the,0,0
105916,addition,0,0
105917,of,0,0
105918,ATRA,0,0
105919,to,0,0
105920,chemotherapy,0,0
105921,.,0,0
105922,Ten-year,0,1
105923,incidence,0,0
105924,of,0,0
105925,myocardial,0,0
105926,infarction,0,1
105927,and,0,0
105928,prognosis,0,0
105929,after,0,0
105930,infarction,0,1
105931,.,0,0
105932,Department,0,0
105933,of,0,0
105934,Veterans,0,1
105935,Affairs,0,1
105936,Cooperative,0,1
105937,Study,0,0
105938,of,0,0
105939,Coronary,0,1
105940,Artery,0,1
105941,Bypass,0,0
105942,Surgery,0,1
105943,.,0,0
105944,BACKGROUND,0,0
105945,The,0,0
105946,10-year,0,0
105947,incidence,0,0
105948,of,0,0
105949,myocardial,0,0
105950,infarction,0,1
105951,(,0,0
105952,fatal,0,0
105953,and,0,0
105954,nonfatal,0,0
105955,),0,0
105956,and,0,0
105957,the,0,0
105958,prognosis,0,0
105959,after,0,0
105960,infarction,0,1
105961,were,0,0
105962,evaluated,0,0
105963,in,0,0
105964,686,1,1
105965,patients,1,1
105966,with,1,1
105967,stable,1,1
105968,angina,1,1
105969,who,0,1
105970,were,0,1
105971,randomly,0,1
105972,assigned,0,0
105973,to,0,0
105974,medical,0,0
105975,or,0,0
105976,surgical,0,0
105977,treatment,0,0
105978,in,0,0
105979,the,0,0
105980,Veterans,0,1
105981,Administration,0,1
105982,Cooperative,0,1
105983,Study,0,0
105984,of,0,0
105985,Coronary,0,1
105986,Artery,0,1
105987,Bypass,0,0
105988,Surgery,0,1
105989,.,0,0
105990,METHODS,0,0
105991,AND,0,0
105992,RESULTS,0,0
105993,Myocardial,0,1
105994,infarction,0,1
105995,was,0,0
105996,defined,0,0
105997,by,0,0
105998,either,0,0
105999,new,0,0
106000,Q,0,0
106001,wave,0,0
106002,findings,0,0
106003,or,0,1
106004,clinical,0,0
106005,symptoms,0,0
106006,compatible,0,0
106007,with,0,1
106008,myocardial,1,1
106009,infarction,1,1
106010,accompanied,1,0
106011,by,1,0
106012,serum,1,0
106013,enzyme,1,0
106014,elevations,1,0
106015,with,1,1
106016,or,1,1
106017,without,1,1
106018,electrocardiographic,1,1
106019,findings,0,0
106020,.,0,1
106021,Treatment,0,0
106022,comparisons,0,0
106023,were,0,0
106024,made,0,0
106025,according,0,0
106026,to,0,0
106027,original,0,0
106028,treatment,0,0
106029,assignment,0,0
106030,;,0,0
106031,35,0,0
106032,%,0,0
106033,of,0,0
106034,the,0,0
106035,medical,0,0
106036,cohort,0,0
106037,had,0,0
106038,bypass,0,1
106039,surgery,0,1
106040,during,0,0
106041,the,0,0
106042,10-year,0,1
106043,follow-up,0,0
106044,period,0,0
106045,.,0,0
106046,The,0,0
106047,overall,0,0
106048,cumulative,0,0
106049,infarction,0,1
106050,rate,0,0
106051,was,0,0
106052,somewhat,0,0
106053,higher,0,0
106054,in,0,0
106055,patients,0,1
106056,assigned,0,1
106057,to,0,0
106058,surgery,0,1
106059,(,0,0
106060,36,0,0
106061,%,0,0
106062,),0,0
106063,than,0,0
106064,in,0,0
106065,medical,0,1
106066,patients,0,1
106067,(,0,0
106068,31,0,1
106069,%,0,0
106070,),0,0
106071,(,0,0
106072,p,0,0
106073,=,0,0
106074,0.13,0,0
106075,),0,0
106076,due,0,0
106077,to,0,0
106078,perioperative,0,0
106079,infarctions,0,1
106080,(,0,0
106081,13,0,1
106082,%,0,0
106083,),0,0
106084,and,0,0
106085,an,0,0
106086,accelerated,0,0
106087,infarction,0,0
106088,rate,0,0
106089,after,0,0
106090,the,0,0
106091,fifth,0,0
106092,year,0,0
106093,of,0,0
106094,follow-up,0,0
106095,(,0,0
106096,average,0,0
106097,",",0,0
106098,2.4,0,0
106099,%,0,0
106100,/yr,0,0
106101,in,0,0
106102,the,0,0
106103,surgical,0,0
106104,group,0,0
106105,versus,0,0
106106,1.4,0,0
106107,%,0,0
106108,/yr,0,0
106109,in,0,0
106110,the,0,0
106111,medical,0,0
106112,group,0,0
106113,),0,0
106114,.,0,0
106115,The,0,0
106116,10-year,0,0
106117,cumulative,0,0
106118,incidence,0,0
106119,of,0,0
106120,death,0,0
106121,or,0,0
106122,myocardial,0,1
106123,infarction,0,1
106124,was,0,0
106125,also,0,0
106126,higher,0,0
106127,in,0,0
106128,surgical,0,0
106129,(,0,0
106130,54,0,1
106131,%,0,0
106132,),0,0
106133,than,0,0
106134,in,0,0
106135,medical,0,1
106136,(,0,0
106137,49,0,1
106138,%,0,0
106139,),0,0
106140,patients,0,1
106141,(,0,0
106142,p,0,0
106143,=,0,0
106144,0.20,0,0
106145,),0,0
106146,.,0,0
106147,According,0,0
106148,to,0,0
106149,the,0,0
106150,Cox,0,0
106151,model,0,0
106152,",",0,0
106153,the,0,0
106154,estimated,0,0
106155,risk,0,0
106156,of,0,0
106157,death,0,0
106158,after,0,0
106159,infarction,0,1
106160,was,0,0
106161,59,0,0
106162,%,0,0
106163,lower,0,0
106164,in,0,0
106165,surgical,0,0
106166,than,0,0
106167,in,0,0
106168,medical,0,1
106169,patients,0,1
106170,(,0,0
106171,p,0,0
106172,less,0,0
106173,than,0,0
106174,0.0001,0,0
106175,),0,0
106176,.,0,0
106177,The,0,0
106178,reduction,0,0
106179,in,0,0
106180,postinfarction,0,1
106181,mortality,0,0
106182,with,0,1
106183,surgery,0,1
106184,was,0,0
106185,most,0,0
106186,striking,0,0
106187,in,0,0
106188,the,0,0
106189,first,0,0
106190,month,0,0
106191,after,0,0
106192,the,0,0
106193,event,0,0
106194,:,0,0
106195,99,0,0
106196,%,0,0
106197,in,0,0
106198,the,0,0
106199,first,0,0
106200,month,0,0
106201,(,0,0
106202,p,0,0
106203,less,0,0
106204,than,0,0
106205,0.0001,0,0
106206,),0,0
106207,and,0,0
106208,49,0,1
106209,%,0,0
106210,subsequently,0,0
106211,(,0,0
106212,p,0,0
106213,less,0,0
106214,than,0,0
106215,0.0001,0,0
106216,),0,0
106217,.,0,0
106218,The,0,0
106219,estimated,0,0
106220,risk,0,0
106221,of,0,0
106222,death,0,0
106223,in,0,0
106224,the,0,0
106225,absence,0,0
106226,of,0,0
106227,infarction,0,1
106228,was,0,0
106229,nearly,0,0
106230,identical,0,0
106231,regardless,0,0
106232,of,0,0
106233,treatment,0,0
106234,(,0,0
106235,p,0,0
106236,=,0,0
106237,0.75,0,0
106238,),0,0
106239,.,0,0
106240,Exclusion,0,0
106241,of,0,0
106242,perioperative,0,0
106243,infarctions,0,1
106244,did,0,0
106245,not,0,0
106246,alter,0,0
106247,the,0,0
106248,findings,0,0
106249,.,0,0
106250,CONCLUSIONS,0,0
106251,Although,0,0
106252,surgery,0,1
106253,does,0,0
106254,not,0,0
106255,reduce,0,0
106256,the,0,0
106257,incidence,0,0
106258,of,0,0
106259,myocardial,0,0
106260,infarction,0,1
106261,overall,0,0
106262,",",0,0
106263,it,0,0
106264,does,0,0
106265,reduce,0,0
106266,the,0,0
106267,risk,0,0
106268,of,0,0
106269,mortality,0,0
106270,after,0,0
106271,infarction,0,0
106272,",",0,0
106273,particularly,0,0
106274,in,0,0
106275,the,0,0
106276,first,0,0
106277,30,0,0
106278,days,0,0
106279,after,0,0
106280,the,0,0
106281,event,0,0
106282,(,0,0
106283,fatal,0,1
106284,infarctions,0,1
106285,),0,1
106286,.,0,1
106287,Phase,0,0
106288,III,0,0
106289,",",0,0
106290,randomized,0,0
106291,",",0,0
106292,open-label,0,0
106293,study,0,0
106294,of,0,0
106295,daily,0,0
106296,imatinib,0,0
106297,mesylate,0,0
106298,400,0,0
106299,mg,0,0
106300,versus,0,0
106301,800,0,0
106302,mg,0,0
106303,in,0,0
106304,patients,1,1
106305,with,1,1
106306,newly,1,1
106307,diagnosed,1,1
106308,",",1,0
106309,previously,1,0
106310,untreated,1,0
106311,chronic,1,1
106312,myeloid,1,1
106313,leukemia,1,1
106314,in,1,0
106315,chronic,1,1
106316,phase,1,0
106317,using,0,0
106318,molecular,0,0
106319,end,0,0
106320,points,0,0
106321,:,0,1
106322,tyrosine,0,0
106323,kinase,0,0
106324,inhibitor,0,0
106325,optimization,0,0
106326,and,0,0
106327,selectivity,0,0
106328,study,0,0
106329,.,0,0
106330,PURPOSE,0,0
106331,To,0,0
106332,evaluate,0,0
106333,the,0,0
106334,safety,0,0
106335,and,0,0
106336,efficacy,0,0
106337,of,0,0
106338,initial,0,0
106339,treatment,0,0
106340,with,0,1
106341,imatinib,0,0
106342,mesylate,0,1
106343,800,0,0
106344,mg/d,0,0
106345,(,0,0
106346,400,0,0
106347,mg,0,0
106348,twice,0,0
106349,daily,0,0
106350,),0,0
106351,versus,0,0
106352,400,0,0
106353,mg/d,0,0
106354,in,0,0
106355,patients,1,1
106356,with,1,1
106357,newly,1,1
106358,diagnosed,1,1
106359,chronic,1,1
106360,myeloid,1,1
106361,leukemia,1,1
106362,in,1,0
106363,chronic,1,1
106364,phase,1,0
106365,.,1,0
106366,PATIENTS,0,0
106367,AND,0,0
106368,METHODS,0,0
106369,A,1,0
106370,total,1,1
106371,of,1,0
106372,476,1,1
106373,patients,1,1
106374,were,1,0
106375,randomly,1,1
106376,assigned,1,0
106377,2:1,0,0
106378,to,0,0
106379,imatinib,0,0
106380,800,0,0
106381,mg,0,0
106382,(,0,0
106383,n,0,1
106384,=,0,0
106385,319,0,1
106386,),0,0
106387,or,0,0
106388,400,0,0
106389,mg,0,0
106390,(,0,0
106391,n,0,1
106392,=,0,0
106393,157,0,1
106394,),0,0
106395,daily,0,0
106396,.,0,0
106397,The,0,0
106398,primary,0,0
106399,end,0,0
106400,point,0,0
106401,was,0,0
106402,the,0,0
106403,major,0,0
106404,molecular,0,0
106405,response,0,0
106406,(,0,0
106407,MMR,0,0
106408,),0,0
106409,rate,0,0
106410,at,0,0
106411,12,0,0
106412,months,0,0
106413,.,0,1
106414,RESULTS,0,0
106415,At,0,0
106416,12,0,0
106417,months,0,0
106418,",",0,0
106419,differences,0,0
106420,in,0,0
106421,MMR,0,0
106422,and,0,0
106423,complete,0,0
106424,cytogenetic,0,0
106425,response,0,0
106426,(,0,0
106427,CCyR,0,1
106428,),0,0
106429,rates,0,0
106430,were,0,0
106431,not,0,0
106432,statistically,0,0
106433,significant,0,0
106434,(,0,0
106435,MMR,0,0
106436,",",0,0
106437,46,0,0
106438,%,0,0
106439,v,0,0
106440,40,0,1
106441,%,0,0
106442,;,0,0
106443,P,0,0
106444,=,0,0
106445,.2035,0,0
106446,;,0,0
106447,CCyR,0,0
106448,",",0,0
106449,70,0,1
106450,%,0,0
106451,v,0,0
106452,66,0,1
106453,%,0,0
106454,;,0,0
106455,P,0,0
106456,=,0,0
106457,.3470,0,0
106458,),0,0
106459,.,0,0
106460,However,0,0
106461,",",0,0
106462,MMR,0,0
106463,occurred,0,0
106464,faster,0,0
106465,among,0,0
106466,patients,0,1
106467,randomly,0,1
106468,assigned,0,0
106469,to,0,0
106470,imatinib,0,0
106471,800,0,0
106472,mg/d,0,0
106473,",",0,1
106474,who,0,1
106475,had,0,1
106476,higher,0,1
106477,rates,0,0
106478,of,0,0
106479,MMR,0,0
106480,at,0,0
106481,3,0,0
106482,and,0,0
106483,6,0,0
106484,months,0,0
106485,compared,0,0
106486,with,0,1
106487,those,0,0
106488,in,0,0
106489,the,0,0
106490,imatinib,0,0
106491,400-mg/d,0,0
106492,arm,0,0
106493,(,0,0
106494,P,0,0
106495,=,0,0
106496,.0035,0,0
106497,by,0,0
106498,log-rank,0,0
106499,test,0,0
106500,),0,0
106501,.,0,0
106502,CCyR,0,0
106503,also,0,0
106504,occurred,0,0
106505,faster,0,0
106506,in,0,0
106507,the,0,0
106508,800-mg/d,0,0
106509,arm,0,0
106510,(,0,0
106511,CCyR,0,0
106512,at,0,0
106513,6,0,0
106514,months,0,0
106515,",",0,0
106516,57,0,1
106517,%,0,0
106518,v,0,0
106519,45,0,1
106520,%,0,0
106521,;,0,0
106522,P,0,0
106523,=,0,0
106524,.0146,0,0
106525,),0,0
106526,.,0,0
106527,The,0,0
106528,most,0,0
106529,common,0,0
106530,adverse,0,0
106531,events,0,0
106532,were,0,0
106533,edema,0,0
106534,",",0,0
106535,gastrointestinal,0,0
106536,problems,0,0
106537,",",0,0
106538,and,0,0
106539,rash,0,0
106540,",",0,0
106541,and,0,0
106542,all,0,0
106543,were,0,0
106544,more,0,0
106545,common,0,0
106546,in,0,0
106547,patients,0,1
106548,in,0,0
106549,the,0,0
106550,800-mg/d,0,0
106551,arm,0,0
106552,.,0,0
106553,Grades,0,0
106554,3,0,0
106555,to,0,0
106556,4,0,0
106557,hematologic,0,1
106558,toxicity,0,0
106559,also,0,0
106560,occurred,0,0
106561,more,0,0
106562,frequently,0,0
106563,in,0,0
106564,patients,0,1
106565,receiving,0,1
106566,imatinib,0,0
106567,800,0,0
106568,mg/d,0,0
106569,.,0,0
106570,CONCLUSION,0,0
106571,MMR,0,0
106572,rates,0,0
106573,at,0,0
106574,1,0,0
106575,year,0,0
106576,were,0,0
106577,similar,0,0
106578,with,0,1
106579,imatinib,0,0
106580,800,0,0
106581,mg/d,0,0
106582,and,0,0
106583,400,0,0
106584,mg/d,0,0
106585,",",0,0
106586,but,0,0
106587,MMR,0,0
106588,and,0,0
106589,CCyR,0,0
106590,occurred,0,0
106591,earlier,0,0
106592,in,0,0
106593,patients,0,1
106594,treated,0,1
106595,with,0,1
106596,800,0,0
106597,mg/d,0,0
106598,.,0,0
106599,Continued,0,0
106600,follow-up,0,0
106601,is,0,0
106602,needed,0,0
106603,to,0,0
106604,determine,0,0
106605,the,0,0
106606,clinical,0,0
106607,significance,0,0
106608,of,0,0
106609,earlier,0,0
106610,responses,0,0
106611,on,0,0
106612,high-dose,0,0
106613,imatinib,0,0
106614,.,0,0
106615,Divalproex,0,0
106616,sodium,0,0
106617,vs,0,0
106618,placebo,0,0
106619,for,0,0
106620,the,0,0
106621,treatment,0,0
106622,of,0,0
106623,irritability,0,0
106624,in,0,0
106625,children,1,1
106626,and,1,0
106627,adolescents,1,1
106628,with,1,1
106629,autism,1,1
106630,spectrum,1,1
106631,disorders,1,1
106632,.,1,0
106633,Autism,0,1
106634,spectrum,0,1
106635,disorders,0,1
106636,(,0,0
106637,ASDs,0,0
106638,),0,0
106639,are,0,0
106640,neurodevelopmental,0,0
106641,disorders,0,1
106642,characterized,0,0
106643,by,0,0
106644,social,0,0
106645,and,0,0
106646,language,0,0
106647,deficits,0,0
106648,and,0,0
106649,by,0,0
106650,repetitive,0,0
106651,behaviors,0,0
106652,and,0,1
106653,interests,0,0
106654,.,0,0
106655,Irritability/aggression,0,0
106656,is,0,0
106657,a,0,0
106658,significant,0,0
106659,comorbid,0,0
106660,symptom,0,0
106661,in,0,0
106662,this,0,0
106663,population,0,0
106664,",",0,0
106665,which,0,0
106666,greatly,0,0
106667,impacts,0,0
106668,burden,0,0
106669,of,0,0
106670,care,0,0
106671,.,0,0
106672,This,0,0
106673,study,0,0
106674,examined,0,0
106675,the,0,0
106676,effect,0,0
106677,of,0,0
106678,divalproex,0,0
106679,sodium,0,0
106680,for,0,0
106681,irritability/aggression,0,1
106682,in,0,0
106683,children,1,1
106684,and,1,0
106685,adolescents,1,1
106686,with,1,1
106687,ASD,1,1
106688,.,1,0
106689,This,0,0
106690,was,0,0
106691,a,0,0
106692,12-week,0,0
106693,randomized,0,0
106694,",",0,0
106695,double-blind,0,0
106696,",",0,0
106697,placebo-controlled,0,0
106698,trial,0,0
106699,.,0,0
106700,All,0,0
106701,efficacy,0,0
106702,measures,0,0
106703,were,0,0
106704,obtained,0,0
106705,by,0,0
106706,an,0,0
106707,independent,0,0
106708,evaluator,0,0
106709,blinded,0,0
106710,to,0,0
106711,randomization,0,0
106712,condition,0,0
106713,and,0,0
106714,side,0,0
106715,effects,0,0
106716,.,0,0
106717,A,0,0
106718,total,1,0
106719,of,1,0
106720,55,1,1
106721,subjects,1,1
106722,gavetheir,1,0
106723,consent,1,1
106724,and,1,0
106725,27,1,0
106726,were,1,0
106727,randomized,1,0
106728,in,1,0
106729,a,1,0
106730,1,1,0
106731,:,1,1
106732,1,1,0
106733,manner,1,0
106734,(,1,0
106735,mean,1,0
106736,age,1,1
106737,9.46+/-2.46,1,0
106738,",",1,0
106739,mean,1,0
106740,nonverbal,1,0
106741,IQ,1,0
106742,63.3+/-23.9,1,0
106743,),1,0
106744,.,1,0
106745,Two,0,0
106746,subjects,0,1
106747,from,0,0
106748,the,0,0
106749,active,0,0
106750,group,0,0
106751,and,0,0
106752,one,0,0
106753,subject,0,0
106754,from,0,0
106755,the,0,0
106756,placebo,0,0
106757,group,0,0
106758,discontinued,0,0
106759,the,0,0
106760,study,0,0
106761,because,0,0
106762,of,0,0
106763,either,0,0
106764,a,0,0
106765,lack,0,0
106766,of,0,0
106767,efficacy,0,0
106768,or,0,0
106769,side,0,0
106770,effects,0,0
106771,(,0,0
106772,increased,0,0
106773,irritability,0,0
106774,),0,0
106775,.,0,0
106776,Primary,0,0
106777,outcome,0,0
106778,measures,0,0
106779,were,0,1
106780,Aberrant,0,1
106781,Behavior,0,0
106782,Checklist-Irritability,0,0
106783,subscale,0,0
106784,and,0,0
106785,Clinical,0,0
106786,Global,0,0
106787,Impression-Improvement,0,0
106788,",",0,0
106789,which,0,0
106790,focused,0,0
106791,on,0,0
106792,irritability,0,0
106793,.,0,0
106794,Overall,0,0
106795,",",0,0
106796,62.5,0,0
106797,%,0,0
106798,of,0,0
106799,divalproex,0,0
106800,subjects,0,1
106801,vs,0,0
106802,9,0,0
106803,%,0,0
106804,of,0,0
106805,placebo,0,0
106806,subjects,0,1
106807,were,0,0
106808,responders,0,0
106809,(,0,0
106810,CGI-irritability,0,0
106811,OR,0,0
106812,:,0,1
106813,16.7,0,0
106814,",",0,0
106815,Fisher,0,0
106816,'s,0,0
106817,exact,0,0
106818,p=0.008,0,0
106819,),0,0
106820,.,0,0
106821,A,0,0
106822,statistically,0,0
106823,significant,0,0
106824,improvement,0,0
106825,was,0,0
106826,also,0,0
106827,noted,0,0
106828,on,0,0
106829,the,0,0
106830,ABC-Irritability,0,0
106831,subscale,0,0
106832,(,0,0
106833,p=0.048,0,0
106834,),0,0
106835,.,0,0
106836,There,0,0
106837,was,0,0
106838,a,0,0
106839,trend,0,0
106840,for,0,0
106841,responders,0,0
106842,to,0,0
106843,have,0,0
106844,higher,0,0
106845,valproate,0,0
106846,blood,0,0
106847,levels,0,0
106848,compared,0,0
106849,with,0,1
106850,nonresponders,0,0
106851,.,0,0
106852,This,0,0
106853,study,0,0
106854,suggests,0,0
106855,the,0,0
106856,efficacy,0,0
106857,of,0,0
106858,divalproex,0,0
106859,for,0,0
106860,the,0,0
106861,treatment,0,0
106862,of,0,0
106863,irritability,0,0
106864,in,0,0
106865,children,0,1
106866,and,0,0
106867,adolescents,0,1
106868,with,0,1
106869,ASD,0,1
106870,.,0,0
106871,Larger,0,0
106872,sample,0,1
106873,follow-up,0,0
106874,studies,0,0
106875,are,0,0
106876,warranted,0,0
106877,.,0,0
106878,Randomized,0,0
106879,clinical,0,0
106880,trial,0,0
106881,of,0,0
106882,radiofrequency,0,0
106883,ablation,0,0
106884,or,0,0
106885,conventional,0,0
106886,high,0,0
106887,ligation,0,0
106888,and,0,0
106889,stripping,0,0
106890,for,0,0
106891,great,1,0
106892,saphenous,1,1
106893,varicose,1,1
106894,veins,1,1
106895,.,1,0
106896,BACKGROUND,0,0
106897,This,0,0
106898,randomized,0,0
106899,clinical,0,0
106900,trial,0,0
106901,compared,0,0
106902,early,0,0
106903,outcomes,0,0
106904,after,0,0
106905,radiofrequency,0,0
106906,ablation,0,0
106907,(,0,0
106908,RFA,0,0
106909,),0,0
106910,and,0,0
106911,conventional,0,0
106912,surgery,0,1
106913,for,0,0
106914,varicose,0,0
106915,veins,0,1
106916,.,0,1
106917,METHODS,0,0
106918,Consecutive,1,1
106919,patients,1,1
106920,with,1,1
106921,symptomatic,1,1
106922,varicose,1,1
106923,veins,1,1
106924,due,1,0
106925,to,1,0
106926,isolated,1,0
106927,great,1,0
106928,saphenous,1,1
106929,vein,1,1
106930,(,1,0
106931,GSV,1,0
106932,),1,0
106933,incompetence,1,0
106934,and,1,0
106935,suitable,1,0
106936,for,1,0
106937,RFA,1,0
106938,were,0,0
106939,randomized,0,0
106940,to,0,0
106941,either,0,0
106942,RFA,0,0
106943,or,0,0
106944,conventional,0,0
106945,surgery,0,1
106946,(,0,0
106947,saphenofemoral,0,0
106948,disconnection,0,0
106949,and,0,0
106950,stripping,0,0
106951,),0,0
106952,.,0,0
106953,Clinical,0,0
106954,",",0,0
106955,radiological,0,0
106956,and,0,0
106957,patient-based,0,0
106958,outcomes,0,0
106959,were,0,0
106960,recorded,0,0
106961,at,0,0
106962,1,0,0
106963,and,0,0
106964,5,0,0
106965,weeks,0,0
106966,after,0,0
106967,intervention,0,0
106968,.,0,0
106969,RESULTS,0,0
106970,RFA,0,0
106971,resulted,0,0
106972,in,0,0
106973,successful,0,0
106974,obliteration,0,0
106975,of,0,0
106976,the,0,0
106977,GSV,1,0
106978,in,1,0
106979,all,1,0
106980,47,1,1
106981,patients,1,1
106982,.,1,1
106983,Complete,0,0
106984,above-knee,0,1
106985,stripping,0,0
106986,was,0,0
106987,unsuccessful,0,0
106988,in,0,0
106989,seven,0,1
106990,of,0,0
106991,41,0,1
106992,patients,0,1
106993,.,0,1
106994,RFA,0,0
106995,took,0,0
106996,longer,0,0
106997,than,0,0
106998,conventional,0,0
106999,surgery,0,1
107000,:,0,1
107001,median,0,0
107002,interquartile,0,0
107003,range,0,0
107004,76,0,1
107005,(,0,0
107006,67-84,0,1
107007,),0,0
107008,versus,0,0
107009,48,0,0
107010,(,0,0
107011,39-54,0,1
107012,),0,0
107013,min,0,0
107014,;,0,0
107015,P,0,0
107016,<,0,0
107017,0.001,0,0
107018,.,0,1
107019,Patients,0,1
107020,returned,0,0
107021,to,0,0
107022,their,0,0
107023,normal,0,1
107024,activities,0,0
107025,significantly,0,0
107026,earlier,0,0
107027,after,0,0
107028,RFA,0,0
107029,(,0,0
107030,median,0,0
107031,3,0,0
107032,(,0,0
107033,2-5,0,0
107034,),0,0
107035,versus,0,0
107036,12.5,0,0
107037,(,0,0
107038,4-21,0,0
107039,),0,1
107040,days,0,0
107041,;,0,0
107042,P,0,0
107043,<,0,0
107044,0.001,0,0
107045,),0,0
107046,.,0,0
107047,Postoperative,0,0
107048,pain,0,0
107049,was,0,0
107050,significantly,0,0
107051,less,0,0
107052,after,0,0
107053,RFA,0,0
107054,(,0,0
107055,median,0,0
107056,score,0,0
107057,on,0,0
107058,visual,0,0
107059,analogue,0,0
107060,scale,0,0
107061,1.70,0,0
107062,(,0,0
107063,0.50-4.30,0,0
107064,),0,0
107065,versus,0,0
107066,4.0,0,0
107067,(,0,0
107068,2.35-6.05,0,0
107069,),0,0
107070,;,0,0
107071,P,0,0
107072,=,0,0
107073,0.001,0,0
107074,),0,0
107075,.,0,0
107076,Patient,0,0
107077,satisfaction,0,0
107078,",",0,0
107079,quality,0,0
107080,of,0,0
107081,life,0,0
107082,improvement,0,0
107083,and,0,0
107084,analgesic,0,0
107085,requirements,0,0
107086,significantly,0,0
107087,favoured,0,0
107088,RFA,0,0
107089,.,0,0
107090,CONCLUSION,0,0
107091,RFA,0,0
107092,took,0,0
107093,longer,0,0
107094,to,0,0
107095,perform,0,0
107096,but,0,0
107097,resulted,0,0
107098,in,0,0
107099,a,0,0
107100,significantly,0,0
107101,better,0,0
107102,early,0,0
107103,outcome,0,0
107104,than,0,0
107105,conventional,0,0
107106,surgery,0,1
107107,in,0,0
107108,suitable,0,0
107109,patients,1,1
107110,with,1,1
107111,great,1,1
107112,saphenous,1,1
107113,varicose,1,1
107114,veins,1,1
107115,.,1,1
107116,[,0,0
107117,Gluten-free,0,0
107118,diet,0,0
107119,in,0,0
107120,infantile,1,1
107121,autism,1,1
107122,.,1,0
107123,A,0,0
107124,therapeutic,0,0
107125,trial,0,0
107126,],0,0
107127,.,0,0
107128,It,0,0
107129,has,0,0
107130,been,0,0
107131,postulated,0,0
107132,that,0,0
107133,there,0,0
107134,may,0,0
107135,be,0,0
107136,a,0,0
107137,connection,0,0
107138,between,0,0
107139,wheat-gluten/milk-casein,0,0
107140,and,0,0
107141,mental,0,1
107142,disorders,0,1
107143,such,0,0
107144,as,0,0
107145,schizophrenia,0,1
107146,",",0,0
107147,hyperactivity,0,0
107148,and,0,0
107149,autism,0,1
107150,.,0,0
107151,In,0,0
107152,this,0,0
107153,study,0,0
107154,seven,1,0
107155,patients,1,1
107156,with,1,1
107157,infantile,1,1
107158,autism,1,1
107159,",",1,0
107160,three,1,0
107161,before,1,0
107162,puberty,1,1
107163,and,1,0
107164,four,1,0
107165,after,1,0
107166,puberty,1,1
107167,",",0,0
107168,were,0,0
107169,given,0,0
107170,a,0,0
107171,gluten-free,0,0
107172,diet,0,0
107173,.,0,1
107174,Three,0,0
107175,children,0,1
107176,were,0,0
107177,provoked,0,0
107178,with,0,0
107179,gluten/placebo,0,0
107180,in,0,0
107181,a,0,0
107182,double-blind,0,0
107183,study,0,0
107184,.,0,0
107185,Four,0,0
107186,young,0,1
107187,patients,0,1
107188,participated,0,1
107189,in,0,0
107190,an,0,0
107191,open,0,0
107192,study,0,0
107193,and,0,0
107194,were,0,0
107195,given,0,0
107196,a,0,0
107197,gluten-free,0,0
107198,diet,0,0
107199,in,0,0
107200,six,0,1
107201,months,0,0
107202,.,0,1
107203,Behaviour,0,0
107204,was,0,0
107205,registered,0,0
107206,before,0,0
107207,",",0,0
107208,during,0,0
107209,and,0,0
107210,after,0,0
107211,the,0,0
107212,period,0,0
107213,with,0,0
107214,a,0,0
107215,gluten-free,0,0
107216,diet,0,0
107217,.,0,0
107218,Visual,0,0
107219,Analogue,0,0
107220,Scale,0,0
107221,and,0,0
107222,Real,0,0
107223,Life,0,0
107224,Rating,0,0
107225,Scale,0,0
107226,were,0,0
107227,used,0,0
107228,to,0,0
107229,register,0,0
107230,changes,0,0
107231,in,0,0
107232,behaviour,0,0
107233,.,0,0
107234,No,0,0
107235,connection,0,0
107236,was,0,0
107237,observed,0,0
107238,between,0,0
107239,gluten,0,0
107240,and,0,0
107241,behaviour,0,0
107242,typical,0,0
107243,for,0,0
107244,these,0,0
107245,patients,0,1
107246,.,0,0
107247,On,0,0
107248,the,0,0
107249,contrary,0,0
107250,",",0,0
107251,the,0,0
107252,gluten-free,0,0
107253,diet,0,0
107254,seemed,0,0
107255,to,0,0
107256,be,0,0
107257,another,0,0
107258,negative,0,0
107259,factor,0,0
107260,leading,0,0
107261,to,0,0
107262,further,0,0
107263,social,0,0
107264,isolation,0,0
107265,in,0,0
107266,this,0,0
107267,group,0,0
107268,of,0,0
107269,highly,1,0
107270,socially,1,1
107271,handicapped,1,1
107272,patients,1,1
107273,and,0,1
107274,families,0,1
107275,.,0,1
107276,A,0,0
107277,comparative,0,0
107278,study,0,0
107279,of,0,0
107280,the,0,0
107281,effects,0,0
107282,of,0,0
107283,local,0,0
107284,estrogen,0,0
107285,with,0,1
107286,or,0,0
107287,without,0,0
107288,local,0,0
107289,testosterone,0,1
107290,on,0,0
107291,vulvovaginal,1,1
107292,and,1,0
107293,sexual,1,0
107294,dysfunction,1,0
107295,in,1,0
107296,postmenopausal,1,1
107297,women,1,1
107298,.,1,0
107299,INTRODUCTION,0,0
107300,A,0,0
107301,significant,0,0
107302,number,0,0
107303,of,0,0
107304,postmenopausal,1,1
107305,women,1,1
107306,suffer,0,1
107307,from,0,0
107308,distressing,0,0
107309,problems,0,1
107310,because,0,0
107311,of,0,0
107312,urogenital,0,1
107313,atrophy,0,0
107314,secondary,0,0
107315,to,0,0
107316,the,0,0
107317,decline,0,0
107318,in,0,0
107319,circulating,0,0
107320,estrogen,0,1
107321,levels,0,0
107322,.,0,0
107323,Treatment,0,0
107324,with,0,1
107325,topical,0,0
107326,hormones,0,0
107327,may,0,0
107328,provide,0,0
107329,relief,0,0
107330,in,0,0
107331,such,0,0
107332,women,0,1
107333,when,0,0
107334,used,0,0
107335,judiciously,0,0
107336,.,0,0
107337,AIM,0,0
107338,To,0,0
107339,study,0,0
107340,the,0,0
107341,effects,0,0
107342,of,0,0
107343,local,0,0
107344,estrogen,0,0
107345,with,0,1
107346,or,0,0
107347,without,0,0
107348,local,0,0
107349,testosterone,0,1
107350,on,0,0
107351,urogenital,0,1
107352,and,0,0
107353,sexual,0,0
107354,health,0,0
107355,in,0,0
107356,postmenopausal,1,1
107357,women,1,1
107358,.,1,1
107359,METHODS,0,0
107360,Seventy-five,1,1
107361,postmenopausal,1,1
107362,women,1,1
107363,symptomatic,1,1
107364,for,1,0
107365,urogenital,1,1
107366,atrophy,1,0
107367,and,1,0
107368,sexual,1,0
107369,dysfunction,1,0
107370,were,0,0
107371,randomly,0,0
107372,divided,0,0
107373,into,0,0
107374,two,0,0
107375,study,0,0
107376,groups,0,0
107377,and,0,0
107378,one,0,0
107379,control,0,0
107380,group,0,0
107381,.,0,0
107382,The,0,0
107383,women,0,1
107384,in,0,0
107385,study,0,0
107386,group,0,0
107387,1,0,0
107388,received,0,0
107389,local,0,0
107390,estrogen,0,0
107391,cream,0,0
107392,;,0,0
107393,study,0,0
107394,group,0,0
107395,2,0,0
107396,received,0,0
107397,local,0,0
107398,estrogen,0,0
107399,and,0,0
107400,testosterone,0,0
107401,cream,0,0
107402,;,0,0
107403,the,0,0
107404,control,0,0
107405,group,0,0
107406,received,0,0
107407,nonhormonal,0,0
107408,lubricant,0,0
107409,KY,0,0
107410,gel,0,0
107411,for,0,0
107412,12,0,0
107413,weeks,0,0
107414,.,0,0
107415,The,0,0
107416,urogenital,0,0
107417,and,0,0
107418,sexuality,0,0
107419,score,0,0
107420,",",0,0
107421,along,0,0
107422,with,0,0
107423,the,0,0
107424,vaginal,0,0
107425,health,0,0
107426,index,0,0
107427,and,0,0
107428,the,0,0
107429,vaginal,0,0
107430,maturation,0,0
107431,index,0,0
107432,(,0,0
107433,VMI,0,0
107434,),0,0
107435,",",0,0
107436,was,0,0
107437,calculated,0,0
107438,at,0,0
107439,the,0,0
107440,beginning,0,0
107441,of,0,0
107442,therapy,0,0
107443,and,0,0
107444,12,0,0
107445,weeks,0,0
107446,later,0,0
107447,.,0,0
107448,MAIN,0,0
107449,OUTCOME,0,0
107450,MEASURES,0,0
107451,Changes,0,0
107452,in,0,0
107453,the,0,0
107454,urogenital,0,0
107455,and,0,0
107456,sexuality,0,0
107457,score,0,0
107458,along,0,0
107459,with,0,1
107460,vaginal,0,1
107461,health,0,0
107462,index,0,0
107463,and,0,0
107464,VMI,0,0
107465,.,0,0
107466,RESULTS,0,0
107467,After,0,0
107468,12,0,0
107469,weeks,0,0
107470,of,0,0
107471,therapy,0,0
107472,",",0,0
107473,there,0,0
107474,was,0,0
107475,a,0,0
107476,significant,0,0
107477,improvement,0,0
107478,in,0,0
107479,all,0,0
107480,the,0,0
107481,four,0,0
107482,study,0,0
107483,parameters,0,0
107484,",",0,0
107485,which,0,0
107486,correlated,0,0
107487,well,0,0
107488,with,0,0
107489,the,0,0
107490,improvement,0,0
107491,in,0,0
107492,symptoms,0,0
107493,of,0,0
107494,urogenital,0,1
107495,atrophy,0,0
107496,and,0,0
107497,sexual,0,0
107498,dysfunction,0,0
107499,in,0,0
107500,both,0,0
107501,the,0,0
107502,study,1,0
107503,groups,1,0
107504,as,0,0
107505,compared,0,0
107506,with,0,0
107507,the,0,0
107508,control,1,0
107509,group,1,0
107510,.,1,0
107511,Improvement,0,0
107512,in,0,0
107513,sexuality,0,0
107514,score,0,0
107515,was,0,0
107516,greatest,0,0
107517,with,0,1
107518,combined,0,0
107519,estrogen-androgen,0,1
107520,therapy,0,0
107521,.,0,0
107522,There,0,0
107523,were,0,0
107524,no,0,0
107525,adverse,0,0
107526,effects,0,0
107527,and,0,0
107528,the,0,0
107529,therapies,0,0
107530,were,0,0
107531,well,0,0
107532,accepted,0,0
107533,without,0,0
107534,any,0,0
107535,compliance,0,0
107536,issue,0,0
107537,.,0,0
107538,CONCLUSION,0,0
107539,Local,0,0
107540,estrogen,0,0
107541,either,0,0
107542,alone,0,0
107543,or,0,0
107544,with,0,0
107545,androgen,0,0
107546,is,0,0
107547,highly,0,0
107548,effective,0,0
107549,in,0,0
107550,relieving,0,0
107551,symptoms,0,0
107552,of,0,0
107553,urogenital,0,1
107554,atrophy,0,0
107555,and,0,0
107556,in,0,0
107557,improving,0,0
107558,sexual,0,0
107559,function,0,0
107560,in,0,0
107561,symptomatic,1,1
107562,postmenopausal,1,1
107563,women,1,1
107564,.,1,1
107565,Efficacy,0,0
107566,of,0,0
107567,omeprazole,0,0
107568,versus,0,0
107569,high-dose,0,0
107570,famotidine,0,0
107571,for,0,0
107572,prevention,0,0
107573,of,0,0
107574,exercise-induced,0,0
107575,gastritis,0,1
107576,in,0,0
107577,racing,1,0
107578,Alaskan,1,1
107579,sled,1,0
107580,dogs,1,1
107581,.,1,1
107582,BACKGROUND,0,0
107583,Omeprazole,0,0
107584,and,0,0
107585,famotidine,0,0
107586,both,0,0
107587,reduce,0,0
107588,severity,0,0
107589,of,0,0
107590,exercise-induced,0,0
107591,gastritis,0,1
107592,",",0,0
107593,but,0,0
107594,administering,0,0
107595,famotidine,0,0
107596,is,0,0
107597,easier,0,0
107598,than,0,0
107599,administering,0,0
107600,omeprazole,0,0
107601,during,0,0
107602,racing,0,0
107603,competition,0,0
107604,.,0,0
107605,HYPOTHESIS,0,0
107606,Famotidine,0,0
107607,is,0,0
107608,more,0,0
107609,efficacious,0,0
107610,than,0,0
107611,no,0,0
107612,treatment,0,0
107613,in,0,0
107614,reducing,0,0
107615,severity,0,0
107616,of,0,0
107617,exercise-induced,0,0
107618,gastritis,0,1
107619,;,0,0
107620,and,0,0
107621,high-dose,0,0
107622,famotidine,0,0
107623,is,0,0
107624,more,0,0
107625,efficacious,0,0
107626,than,0,0
107627,omeprazole,0,0
107628,in,0,0
107629,reducing,0,0
107630,severity,0,0
107631,of,0,0
107632,exercise-induced,0,0
107633,gastritis,0,1
107634,.,0,0
107635,ANIMALS,0,0
107636,Experiment,0,0
107637,1,0,0
107638,:,0,1
107639,Randomized,1,0
107640,placebo-controlled,1,0
107641,study,1,0
107642,",",1,0
107643,36,1,0
107644,sled,1,0
107645,dogs,1,1
107646,(,1,0
107647,3-8,1,1
107648,years,1,1
107649,),1,1
107650,;,1,0
107651,Experiment,0,0
107652,2,0,0
107653,:,0,1
107654,Randomized,1,0
107655,positive-control,1,0
107656,study,1,0
107657,",",1,0
107658,52,1,0
107659,sled,1,0
107660,dogs,1,1
107661,(,1,0
107662,2-8,1,0
107663,years,1,1
107664,),1,1
107665,.,1,1
107666,METHODS,0,0
107667,Experiment,0,0
107668,1,0,0
107669,:,0,1
107670,Equal,0,0
107671,numbers,0,0
107672,of,0,0
107673,dogs,1,1
107674,randomly,0,1
107675,assigned,0,0
107676,to,0,0
107677,famotidine,0,0
107678,(,0,0
107679,20,0,0
107680,mg,0,0
107681,q24h,0,0
107682,),0,0
107683,or,0,0
107684,no,0,0
107685,treatment,0,0
107686,groups,0,0
107687,.,0,1
107688,Gastroscopy,0,0
107689,was,0,0
107690,performed,0,0
107691,24,0,0
107692,hours,0,0
107693,after,0,0
107694,the,0,0
107695,dogs,0,1
107696,ran,0,0
107697,330,0,1
107698,miles,0,1
107699,.,0,1
107700,Mucosal,0,0
107701,appearance,0,0
107702,was,0,0
107703,blindly,0,0
107704,scored,0,0
107705,by,0,0
107706,previously,0,0
107707,described,0,0
107708,scoring,0,0
107709,system,0,0
107710,.,0,0
107711,Experiment,0,0
107712,2,0,0
107713,:,0,1
107714,Equal,0,0
107715,numbers,0,0
107716,of,0,0
107717,dogs,0,1
107718,randomly,0,1
107719,assigned,0,0
107720,to,0,0
107721,omeprazole,0,0
107722,(,0,0
107723,20,0,0
107724,mg,0,0
107725,q24h,0,0
107726,),0,0
107727,or,0,0
107728,high-dose,0,0
107729,famotidine,0,0
107730,(,0,0
107731,40,0,0
107732,mg,0,0
107733,q12h,0,0
107734,),0,0
107735,groups,0,0
107736,.,0,1
107737,Gastroscopy,0,0
107738,was,0,0
107739,performed,0,0
107740,48,0,0
107741,hours,0,0
107742,before,0,0
107743,and,0,0
107744,24,0,0
107745,hours,0,0
107746,after,0,0
107747,the,0,0
107748,dogs,0,1
107749,ran,0,0
107750,300,0,0
107751,miles,0,1
107752,.,0,1
107753,Mucosal,0,0
107754,appearance,0,0
107755,was,0,0
107756,blindly,0,0
107757,scored,0,0
107758,by,0,0
107759,previously,0,0
107760,described,0,0
107761,scoring,0,0
107762,system,0,0
107763,.,0,0
107764,RESULTS,0,0
107765,Famotidine,0,0
107766,reduced,0,0
107767,the,0,0
107768,prevalence,0,0
107769,of,0,0
107770,clinically,0,0
107771,relevant,0,0
107772,",",0,0
107773,exercise-induced,0,0
107774,gastric,0,1
107775,lesions,0,1
107776,compared,0,0
107777,with,0,1
107778,no,0,0
107779,treatment,0,0
107780,(,0,0
107781,7/16,0,0
107782,versus,0,0
107783,11/16,0,0
107784,",",0,0
107785,P,0,0
107786,=,0,0
107787,.031,0,0
107788,),0,0
107789,.,0,0
107790,Compared,0,0
107791,with,0,0
107792,high-dose,0,0
107793,famotidine,0,0
107794,",",0,0
107795,omeprazole,0,0
107796,significantly,0,0
107797,decreased,0,0
107798,the,0,0
107799,severity,0,0
107800,(,0,0
107801,0.4,0,0
107802,versus,0,0
107803,1.2,0,0
107804,",",0,0
107805,P,0,0
107806,=,0,0
107807,.0002,0,0
107808,),0,0
107809,and,0,0
107810,prevalence,0,0
107811,(,0,0
107812,2/23,0,0
107813,versus,0,0
107814,7/21,0,0
107815,",",0,0
107816,P,0,0
107817,=,0,0
107818,.049,0,0
107819,),0,0
107820,of,0,0
107821,gastric,0,1
107822,lesions,0,1
107823,.,0,1
107824,CONCLUSIONS,0,0
107825,AND,0,0
107826,CLINICAL,0,0
107827,RELEVANCE,0,0
107828,Although,0,0
107829,famotidine,0,0
107830,provides,0,0
107831,some,0,0
107832,benefit,0,0
107833,in,0,0
107834,the,0,0
107835,prevention,0,0
107836,of,0,0
107837,exercise-induced,0,0
107838,gastric,0,1
107839,lesions,0,1
107840,",",0,0
107841,omeprazole,0,0
107842,is,0,0
107843,superior,0,0
107844,to,0,0
107845,famotidine,0,0
107846,in,0,0
107847,preventing,0,0
107848,gastritis,0,1
107849,in,0,0
107850,dogs,1,1
107851,running,0,0
107852,300,0,1
107853,miles,0,1
107854,.,0,1
107855,Routine,0,0
107856,administration,0,0
107857,of,0,0
107858,omeprazole,0,0
107859,is,0,0
107860,recommended,0,0
107861,to,0,0
107862,prevent,0,0
107863,stress-associated,0,0
107864,gastric,0,0
107865,disease,0,1
107866,in,0,0
107867,exercising,1,0
107868,and,1,0
107869,racing,1,0
107870,Alaskan,1,1
107871,sled,1,0
107872,dogs,1,1
107873,.,1,1
107874,Effect,0,0
107875,of,0,0
107876,milrinone,0,0
107877,on,0,0
107878,short-term,0,0
107879,outcome,0,0
107880,of,0,0
107881,patients,1,1
107882,with,1,1
107883,myocardial,1,1
107884,dysfunction,1,1
107885,undergoing,1,1
107886,coronary,1,1
107887,artery,1,1
107888,bypass,1,1
107889,graft,1,0
107890,:,1,0
107891,A,0,0
107892,randomized,0,0
107893,controlled,0,0
107894,trial,0,0
107895,.,0,0
107896,BACKGROUND,0,0
107897,Myocardial,0,0
107898,dysfunction,0,0
107899,needing,0,1
107900,inotropic,0,0
107901,support,0,0
107902,is,0,0
107903,a,0,0
107904,typical,0,0
107905,complication,0,0
107906,after,0,0
107907,on-pump,0,0
107908,cardiac,0,1
107909,surgery,0,1
107910,.,0,0
107911,In,0,0
107912,this,0,0
107913,study,0,0
107914,",",0,0
107915,we,0,0
107916,evaluate,0,0
107917,the,0,0
107918,effect,0,0
107919,of,0,0
107920,milrinone,0,0
107921,on,0,0
107922,patients,1,1
107923,with,1,1
107924,ventricular,1,0
107925,dysfunction,1,1
107926,undergoing,1,1
107927,coronary,1,1
107928,artery,1,1
107929,bypass,1,1
107930,graft,1,0
107931,(,1,0
107932,CABG,1,0
107933,),1,0
107934,.,1,0
107935,METHODS,0,0
107936,Seventy,1,1
107937,patients,1,1
107938,with,1,1
107939,impaired,1,1
107940,left,1,1
107941,ventricular,1,0
107942,function,1,0
107943,[,1,0
107944,left,1,0
107945,ventricular,1,0
107946,ejection,1,0
107947,fraction,1,0
107948,(,1,0
107949,LVEF,1,1
107950,),1,0
107951,<,1,0
107952,35,1,0
107953,%,1,0
107954,],1,0
107955,undergoing,1,1
107956,on-pump,1,1
107957,CABG,1,0
107958,were,1,0
107959,enrolled,1,1
107960,.,1,0
107961,Patients,0,1
107962,were,0,0
107963,randomized,0,0
107964,to,0,0
107965,receive,0,0
107966,either,0,0
107967,an,0,0
107968,intraoperative,0,0
107969,bolus,0,0
107970,of,0,0
107971,milrinone,0,0
107972,(,0,0
107973,50,0,0
107974,microg/kg,0,0
107975,),0,0
107976,or,0,0
107977,saline,0,0
107978,as,0,0
107979,placebo,0,0
107980,followed,0,0
107981,by,0,0
107982,a,0,0
107983,24-hour,0,0
107984,infusion,0,0
107985,of,0,0
107986,each,0,0
107987,agent,0,0
107988,(,0,0
107989,0.5,0,0
107990,microg/kg/min,0,0
107991,),0,0
107992,.,0,0
107993,Hemodynamic,0,0
107994,parameters,0,0
107995,and,0,0
107996,transthoracic,0,1
107997,echocardiographic,0,0
107998,measurement,0,0
107999,of,0,0
108000,systolic,0,0
108001,and,0,0
108002,diastolic,0,1
108003,functions,0,0
108004,were,0,0
108005,the,0,0
108006,variables,0,0
108007,evaluated,0,0
108008,.,0,1
108009,RESULTS,0,0
108010,Serum,0,1
108011,levels,0,0
108012,of,0,0
108013,creatine,0,0
108014,phosphokinase,0,0
108015,(,0,0
108016,CPK,0,0
108017,),0,0
108018,",",0,0
108019,the,0,0
108020,MB,0,0
108021,isoenzyme,0,0
108022,of,0,0
108023,creatine,0,0
108024,kinase,0,0
108025,(,0,0
108026,CK-MB,0,0
108027,),0,0
108028,",",0,0
108029,occurrence,0,0
108030,of,0,0
108031,myocardial,0,0
108032,ischemia,0,1
108033,or,0,0
108034,infarction,0,0
108035,",",0,0
108036,and,0,0
108037,mean,0,0
108038,duration,0,0
108039,of,0,0
108040,using,0,0
108041,inotropic,0,0
108042,agents,0,0
108043,were,0,0
108044,significantly,0,0
108045,lower,0,0
108046,in,0,0
108047,the,0,0
108048,milrinone,0,0
108049,group,0,0
108050,(,0,0
108051,p,0,0
108052,<,0,0
108053,0.05,0,0
108054,),0,0
108055,.,0,0
108056,There,0,0
108057,were,0,0
108058,no,0,0
108059,significant,0,0
108060,differences,0,0
108061,between,0,0
108062,the,0,0
108063,two,0,0
108064,groups,0,0
108065,regarding,0,0
108066,the,0,0
108067,development,0,0
108068,of,0,0
108069,ventricular,0,0
108070,arrhythmia,0,0
108071,",",0,0
108072,duration,0,0
108073,of,0,0
108074,cardiopulmonary,0,0
108075,bypass,0,1
108076,",",0,0
108077,intra-aortic,0,0
108078,balloon,0,0
108079,pump,0,0
108080,and,0,0
108081,inotropic,0,0
108082,support,0,0
108083,requirement,0,0
108084,",",0,0
108085,duration,0,0
108086,of,0,0
108087,mechanical,0,0
108088,ventilation,0,0
108089,",",0,0
108090,duration,0,0
108091,of,0,0
108092,intensive,0,0
108093,care,0,0
108094,unit,0,0
108095,stay,0,0
108096,and,0,0
108097,mortality,0,0
108098,rate,0,0
108099,.,0,0
108100,Although,0,0
108101,mean,0,0
108102,pre-operative,0,0
108103,LVEF,0,1
108104,was,0,0
108105,significantly,0,0
108106,lower,0,0
108107,in,0,0
108108,the,0,0
108109,milrinone,0,0
108110,group,0,0
108111,",",0,0
108112,there,0,0
108113,was,0,0
108114,no,0,0
108115,significant,0,0
108116,difference,0,0
108117,between,0,0
108118,post-operative,0,0
108119,LVEFs,0,0
108120,.,0,0
108121,CONCLUSIONS,0,0
108122,We,0,0
108123,suggest,0,0
108124,that,0,0
108125,perioperative,0,0
108126,administration,0,0
108127,of,0,0
108128,milrinone,0,0
108129,in,0,0
108130,patients,1,1
108131,undergoing,1,1
108132,on-pump,1,1
108133,CABG,1,0
108134,",",0,0
108135,especially,0,0
108136,those,0,0
108137,with,0,0
108138,low,0,0
108139,LVEF,0,0
108140,",",0,0
108141,is,0,0
108142,beneficial,0,0
108143,.,0,0
108144,Comparable,0,0
108145,patencies,0,0
108146,of,0,0
108147,the,0,0
108148,radial,0,0
108149,artery,0,1
108150,and,0,0
108151,right,0,0
108152,internal,0,0
108153,thoracic,0,1
108154,artery,0,1
108155,or,0,0
108156,saphenous,0,0
108157,vein,0,0
108158,beyond,0,1
108159,5,0,1
108160,years,0,1
108161,:,0,1
108162,results,0,0
108163,from,0,0
108164,the,0,0
108165,Radial,0,1
108166,Artery,0,1
108167,Patency,0,0
108168,and,0,0
108169,Clinical,0,0
108170,Outcomes,0,0
108171,trial,0,0
108172,.,0,0
108173,OBJECTIVE,0,0
108174,To,0,0
108175,investigate,0,0
108176,the,0,0
108177,optimum,0,0
108178,conduit,0,0
108179,for,0,0
108180,coronary,0,1
108181,targets,0,0
108182,other,0,0
108183,than,0,0
108184,the,0,0
108185,left,0,0
108186,anterior,0,0
108187,descending,0,0
108188,artery,0,1
108189,",",0,0
108190,we,0,0
108191,evaluated,0,0
108192,long-term,0,0
108193,patencies,0,0
108194,and,0,0
108195,clinical,0,0
108196,outcomes,0,0
108197,of,0,0
108198,the,0,0
108199,radial,0,0
108200,artery,0,1
108201,",",0,0
108202,right,0,0
108203,internal,0,0
108204,thoracic,0,1
108205,artery,0,1
108206,",",0,0
108207,and,0,0
108208,saphenous,0,0
108209,vein,0,0
108210,through,0,0
108211,the,0,0
108212,Radial,0,1
108213,Artery,0,1
108214,Patency,0,0
108215,and,0,0
108216,Clinical,0,0
108217,Outcomes,0,0
108218,trial,0,0
108219,.,0,0
108220,METHODS,0,0
108221,As,0,0
108222,part,0,0
108223,of,0,0
108224,a,0,0
108225,10-year,0,0
108226,prospective,0,0
108227,",",0,0
108228,randomized,0,0
108229,",",0,0
108230,single-center,0,0
108231,trial,0,0
108232,",",0,0
108233,patients,1,1
108234,undergoing,1,1
108235,primary,1,1
108236,coronary,1,1
108237,surgery,1,1
108238,were,1,0
108239,allocated,1,0
108240,to,1,0
108241,the,1,0
108242,radial,1,0
108243,artery,1,1
108244,(,1,0
108245,n,1,1
108246,=,1,0
108247,198,1,1
108248,),1,0
108249,or,1,0
108250,free,1,0
108251,right,1,0
108252,internal,1,0
108253,thoracic,1,1
108254,artery,1,1
108255,(,1,0
108256,n,1,1
108257,=,1,0
108258,196,1,1
108259,),1,0
108260,if,1,0
108261,aged,1,1
108262,less,1,0
108263,than,1,0
108264,70,1,1
108265,years,1,1
108266,(,1,0
108267,group,1,0
108268,1,1,0
108269,),1,0
108270,",",1,0
108271,or,1,0
108272,radial,1,0
108273,artery,1,1
108274,(,1,0
108275,n,1,1
108276,=,1,0
108277,113,1,1
108278,),1,0
108279,or,1,0
108280,saphenous,1,0
108281,vein,1,0
108282,(,1,0
108283,n,1,1
108284,=,1,0
108285,112,1,1
108286,),1,0
108287,if,1,0
108288,aged,1,1
108289,at,1,0
108290,least,1,0
108291,70,1,1
108292,years,1,1
108293,(,1,0
108294,group,1,0
108295,2,1,0
108296,),1,0
108297,.,1,0
108298,All,1,0
108299,patients,1,1
108300,received,1,0
108301,a,1,0
108302,left,1,0
108303,internal,1,0
108304,thoracic,1,1
108305,artery,1,1
108306,to,1,0
108307,the,1,0
108308,left,1,0
108309,anterior,1,0
108310,descending,1,0
108311,",",0,0
108312,and,0,0
108313,the,0,0
108314,randomized,0,0
108315,conduit,0,0
108316,was,0,0
108317,used,0,0
108318,to,0,0
108319,graft,0,0
108320,the,0,0
108321,second,0,0
108322,largest,0,0
108323,target,0,0
108324,.,0,0
108325,Protocol-directed,0,0
108326,angiography,0,0
108327,has,0,0
108328,been,0,0
108329,performed,0,0
108330,at,0,0
108331,randomly,0,1
108332,assigned,0,0
108333,intervals,0,0
108334,",",0,0
108335,weighted,0,0
108336,toward,0,0
108337,the,0,0
108338,end,0,0
108339,of,0,0
108340,the,0,0
108341,study,0,0
108342,period,0,0
108343,.,0,0
108344,Grafts,0,0
108345,are,0,0
108346,defined,0,0
108347,as,0,0
108348,failed,0,0
108349,if,0,0
108350,there,0,0
108351,was,0,0
108352,occlusion,0,0
108353,",",0,0
108354,string,0,0
108355,sign,0,0
108356,",",0,0
108357,or,0,0
108358,greater,0,0
108359,than,0,0
108360,80,0,0
108361,%,0,0
108362,stenosis,0,1
108363,",",0,0
108364,independently,0,0
108365,reported,0,0
108366,by,0,0
108367,3,0,0
108368,assessors,0,0
108369,.,0,0
108370,Analysis,0,0
108371,is,0,0
108372,by,0,0
108373,intention,0,0
108374,to,0,0
108375,treat,0,0
108376,.,0,0
108377,RESULTS,0,0
108378,At,0,0
108379,mean,0,0
108380,follow,0,0
108381,up,0,0
108382,of,0,0
108383,5.5,0,0
108384,years,0,1
108385,",",0,0
108386,protocol,0,0
108387,angiography,0,0
108388,has,0,0
108389,been,0,0
108390,performed,0,0
108391,in,1,0
108392,groups,1,0
108393,1,1,0
108394,and,1,0
108395,2,1,0
108396,in,1,0
108397,237,1,1
108398,and,1,0
108399,113,1,1
108400,patients,1,1
108401,",",1,0
108402,respectively,1,0
108403,.,1,0
108404,There,0,0
108405,are,0,0
108406,no,0,0
108407,significant,0,0
108408,differences,0,0
108409,within,0,0
108410,each,0,0
108411,group,0,0
108412,in,0,0
108413,preoperative,0,0
108414,comorbidity,0,0
108415,",",0,0
108416,age,0,1
108417,",",0,0
108418,or,0,0
108419,urgency,0,0
108420,.,0,0
108421,Patencies,0,0
108422,were,0,0
108423,similar,0,0
108424,for,0,0
108425,either,0,0
108426,of,0,0
108427,the,0,0
108428,2,0,0
108429,conduits,0,0
108430,in,0,0
108431,each,0,0
108432,group,0,0
108433,(,0,0
108434,log,0,0
108435,rank,0,0
108436,analysis,0,0
108437,",",0,0
108438,P,0,0
108439,=,0,0
108440,.06,0,0
108441,and,0,0
108442,P,0,0
108443,=,0,0
108444,.54,0,0
108445,",",0,0
108446,respectively,0,0
108447,),0,0
108448,.,0,0
108449,The,0,0
108450,differences,0,0
108451,in,0,0
108452,estimated,0,0
108453,5-year,0,0
108454,patencies,0,0
108455,were,0,0
108456,6.6,0,0
108457,%,0,0
108458,(,0,0
108459,radial,0,0
108460,minus,0,0
108461,right,0,0
108462,internal,0,0
108463,thoracic,0,1
108464,artery,0,1
108465,),0,0
108466,in,0,0
108467,group,0,0
108468,1,0,0
108469,and,0,0
108470,2.9,0,0
108471,%,0,0
108472,(,0,0
108473,radial,0,0
108474,minus,0,0
108475,saphenous,0,0
108476,vein,0,0
108477,graft,0,0
108478,),0,0
108479,in,0,0
108480,group,0,0
108481,2,0,0
108482,.,0,0
108483,CONCLUSION,0,0
108484,At,0,0
108485,mean,0,0
108486,5-year,0,0
108487,angiography,0,0
108488,in,0,0
108489,largely,0,0
108490,asymptomatic,0,1
108491,patients,0,1
108492,",",0,0
108493,the,0,0
108494,selection,0,0
108495,of,0,0
108496,arterial,0,0
108497,or,0,0
108498,venous,0,0
108499,conduit,0,0
108500,for,0,0
108501,the,0,0
108502,second,0,0
108503,graft,0,0
108504,has,0,0
108505,not,0,0
108506,significantly,0,0
108507,affected,0,0
108508,patency,0,0
108509,.,0,0
108510,This,0,0
108511,finding,0,0
108512,offers,0,0
108513,surgeons,0,0
108514,",",0,0
108515,for,0,0
108516,now,0,0
108517,",",0,0
108518,enhanced,0,0
108519,flexibility,0,0
108520,in,0,0
108521,planning,0,0
108522,revascularization,0,1
108523,.,0,0
108524,Catheter,0,0
108525,ablation,0,0
108526,of,0,0
108527,stable,0,1
108528,ventricular,1,0
108529,tachycardia,1,0
108530,before,1,0
108531,defibrillator,1,0
108532,implantation,1,1
108533,in,1,0
108534,patients,1,1
108535,with,1,1
108536,coronary,1,1
108537,heart,1,1
108538,disease,1,1
108539,(,1,0
108540,VTACH,1,0
108541,),1,0
108542,:,1,0
108543,a,0,0
108544,multicentre,0,0
108545,randomised,0,0
108546,controlled,0,0
108547,trial,0,0
108548,.,0,0
108549,BACKGROUND,0,0
108550,In,0,0
108551,patients,1,1
108552,with,1,1
108553,ventricular,1,0
108554,tachycardia,1,1
108555,(,1,0
108556,VT,1,0
108557,),1,0
108558,and,1,0
108559,a,1,0
108560,history,1,0
108561,of,1,0
108562,myocardial,1,0
108563,infarction,1,1
108564,",",0,0
108565,intervention,0,0
108566,with,0,0
108567,an,0,0
108568,implantable,0,0
108569,cardioverter,0,1
108570,defibrillator,0,0
108571,(,0,0
108572,ICD,0,0
108573,),0,0
108574,can,0,0
108575,prevent,0,0
108576,sudden,0,0
108577,cardiac,0,0
108578,death,0,0
108579,and,0,0
108580,thereby,0,0
108581,reduce,0,0
108582,total,0,1
108583,mortality,0,0
108584,.,0,0
108585,However,0,0
108586,",",0,0
108587,ICD,0,0
108588,shocks,0,0
108589,are,0,0
108590,painful,0,0
108591,and,0,0
108592,do,0,0
108593,not,0,0
108594,provide,0,0
108595,complete,0,0
108596,protection,0,0
108597,against,0,0
108598,sudden,0,1
108599,cardiac,0,1
108600,death,0,0
108601,.,0,0
108602,We,0,0
108603,assessed,0,0
108604,the,0,0
108605,potential,0,0
108606,benefit,0,0
108607,of,0,0
108608,catheter,0,0
108609,ablation,0,0
108610,before,0,0
108611,implantation,0,0
108612,of,0,0
108613,a,0,0
108614,cardioverter,0,1
108615,defibrillator,0,0
108616,.,0,0
108617,METHODS,0,0
108618,The,1,0
108619,Ventricular,1,0
108620,Tachycardia,1,0
108621,Ablation,1,0
108622,in,1,0
108623,Coronary,1,1
108624,Heart,1,1
108625,Disease,1,1
108626,(,1,0
108627,VTACH,1,0
108628,),1,0
108629,study,1,0
108630,was,1,0
108631,a,1,0
108632,prospective,1,0
108633,",",1,0
108634,open,1,0
108635,",",1,0
108636,randomised,1,0
108637,controlled,1,0
108638,trial,1,0
108639,",",1,0
108640,undertaken,1,0
108641,in,1,0
108642,16,1,1
108643,centres,1,1
108644,in,1,0
108645,four,1,1
108646,European,1,1
108647,countries,1,1
108648,.,1,1
108649,Patients,1,1
108650,aged,1,1
108651,18-80,1,1
108652,years,1,1
108653,were,1,0
108654,eligible,1,1
108655,for,1,0
108656,enrolment,1,0
108657,if,1,0
108658,they,1,0
108659,had,1,0
108660,stable,1,1
108661,VT,1,0
108662,",",1,0
108663,previous,1,0
108664,myocardial,1,0
108665,infarction,1,1
108666,",",1,0
108667,and,1,0
108668,reduced,1,0
108669,left-ventricular,1,0
108670,ejection,1,0
108671,fraction,1,0
108672,(,1,0
108673,LVEF,1,1
108674,;,1,0
108675,<,1,0
108676,or=50,1,1
108677,%,1,0
108678,),1,0
108679,.,1,0
108680,110,1,0
108681,patients,1,1
108682,were,1,0
108683,randomly,1,1
108684,allocated,1,0
108685,in,1,0
108686,a,1,0
108687,1:1,1,0
108688,ratio,1,0
108689,to,0,0
108690,receive,0,0
108691,catheter,0,0
108692,ablation,0,0
108693,and,0,0
108694,an,0,0
108695,ICD,0,0
108696,(,0,0
108697,ablation,0,0
108698,group,0,0
108699,",",0,0
108700,n=54,0,1
108701,),0,0
108702,or,0,0
108703,ICD,0,0
108704,alone,0,0
108705,(,0,0
108706,control,0,0
108707,group,0,0
108708,",",0,0
108709,n=56,0,1
108710,),0,0
108711,.,0,0
108712,Randomisation,0,0
108713,was,0,0
108714,done,0,0
108715,by,0,0
108716,computer-generated,0,0
108717,randomly,0,1
108718,permuted,0,1
108719,blocks,0,0
108720,and,0,0
108721,stratified,0,0
108722,by,0,0
108723,centre,0,1
108724,and,0,0
108725,LVEF,0,0
108726,(,0,0
108727,<,0,0
108728,or=30,0,1
108729,%,0,0
108730,or,0,0
108731,>,0,0
108732,30,0,0
108733,%,0,0
108734,),0,0
108735,.,0,0
108736,Patients,0,1
108737,were,0,0
108738,followed,0,0
108739,up,0,0
108740,for,0,0
108741,at,0,0
108742,least,0,0
108743,1,0,0
108744,year,0,0
108745,.,0,0
108746,The,0,0
108747,primary,0,0
108748,endpoint,0,0
108749,was,0,0
108750,the,0,0
108751,time,0,0
108752,to,0,0
108753,first,0,0
108754,recurrence,0,0
108755,of,0,0
108756,VT,0,0
108757,or,0,0
108758,ventricular,0,0
108759,fibrillation,0,1
108760,(,0,0
108761,VF,0,1
108762,),0,0
108763,.,0,0
108764,Analysis,0,0
108765,was,0,0
108766,by,0,0
108767,intention,0,0
108768,to,0,0
108769,treat,0,0
108770,(,0,0
108771,ITT,0,0
108772,),0,0
108773,.,0,0
108774,This,0,0
108775,study,0,0
108776,is,0,0
108777,registered,0,0
108778,with,0,0
108779,ClinicalTrials.gov,0,0
108780,",",0,0
108781,number,0,0
108782,NCT00919373,0,0
108783,.,0,0
108784,FINDINGS,0,0
108785,107,1,1
108786,patients,1,1
108787,were,1,0
108788,included,1,1
108789,in,1,0
108790,the,1,0
108791,ITT,1,0
108792,population,1,0
108793,(,1,0
108794,ablation,1,0
108795,group,1,0
108796,",",1,0
108797,n=52,1,1
108798,;,1,0
108799,control,1,0
108800,group,1,0
108801,",",1,0
108802,n=55,1,1
108803,),1,0
108804,.,1,0
108805,Two,0,0
108806,patients,0,1
108807,(,0,0
108808,one,0,0
108809,in,0,0
108810,each,0,0
108811,group,0,0
108812,),0,0
108813,withdrew,0,0
108814,consent,0,0
108815,immediately,0,0
108816,after,0,0
108817,randomisation,0,0
108818,without,0,0
108819,any,0,0
108820,follow-up,0,0
108821,data,0,0
108822,and,0,0
108823,one,0,0
108824,patient,0,0
108825,(,0,0
108826,ablation,0,0
108827,group,0,0
108828,),0,0
108829,was,0,0
108830,excluded,0,0
108831,because,0,0
108832,of,0,0
108833,a,0,0
108834,protocol,0,0
108835,violaton,0,0
108836,.,0,0
108837,Mean,0,0
108838,follow-up,0,0
108839,was,0,0
108840,22.5,0,0
108841,months,0,0
108842,(,0,0
108843,SD,0,1
108844,9.0,0,0
108845,),0,0
108846,.,0,0
108847,Time,0,0
108848,to,0,0
108849,recurrence,0,0
108850,of,0,0
108851,VT,0,0
108852,or,0,1
108853,VF,0,0
108854,was,0,0
108855,longer,0,0
108856,in,0,0
108857,the,0,0
108858,ablation,0,0
108859,group,0,0
108860,(,0,0
108861,median,0,0
108862,18.6,0,0
108863,months,0,0
108864,[,0,0
108865,lower,0,0
108866,quartile,0,0
108867,2.4,0,0
108868,",",0,0
108869,upper,0,0
108870,quartile,0,0
108871,not,0,0
108872,determinable,0,0
108873,],0,0
108874,),0,0
108875,than,0,0
108876,in,0,0
108877,the,0,0
108878,control,0,0
108879,group,0,0
108880,(,0,0
108881,5.9,0,0
108882,months,0,0
108883,[,0,0
108884,IQR,0,0
108885,0.8-26.7,0,0
108886,],0,1
108887,),0,0
108888,.,0,0
108889,At,0,0
108890,2,0,0
108891,years,0,1
108892,",",0,0
108893,estimates,0,0
108894,for,0,0
108895,survival,0,0
108896,free,0,1
108897,from,0,0
108898,VT,0,0
108899,or,0,1
108900,VF,0,1
108901,were,0,0
108902,47,0,0
108903,%,0,0
108904,in,0,0
108905,the,0,0
108906,ablation,0,0
108907,group,0,0
108908,and,0,0
108909,29,0,0
108910,%,0,0
108911,in,0,0
108912,the,0,0
108913,control,0,0
108914,group,0,0
108915,(,0,0
108916,hazard,0,0
108917,ratio,0,0
108918,0.61,0,0
108919,;,0,0
108920,95,0,0
108921,%,0,0
108922,CI,0,0
108923,0.37-0.99,0,0
108924,;,0,0
108925,p=0.045,0,0
108926,),0,0
108927,.,0,0
108928,Complications,0,0
108929,related,0,0
108930,to,0,0
108931,the,0,0
108932,ablation,0,0
108933,procedure,0,0
108934,occurred,0,0
108935,in,0,0
108936,two,0,0
108937,patients,0,1
108938,;,0,0
108939,no,0,0
108940,deaths,0,0
108941,occurred,0,0
108942,within,0,0
108943,30,0,1
108944,days,0,0
108945,after,0,0
108946,ablation,0,1
108947,.,0,0
108948,15,0,0
108949,device-related,0,0
108950,complications,0,0
108951,requiring,0,1
108952,surgical,0,1
108953,intervention,0,0
108954,occurred,0,0
108955,in,0,0
108956,13,0,1
108957,patients,0,1
108958,(,0,0
108959,ablation,0,0
108960,group,0,0
108961,",",0,0
108962,four,0,0
108963,;,0,0
108964,control,0,0
108965,group,0,0
108966,",",0,0
108967,nine,0,1
108968,),0,0
108969,.,0,0
108970,Nine,1,0
108971,patients,1,1
108972,died,1,1
108973,during,1,0
108974,the,1,0
108975,study,1,0
108976,(,1,0
108977,ablation,1,0
108978,group,1,0
108979,",",1,0
108980,five,1,0
108981,;,1,0
108982,control,1,0
108983,group,1,0
108984,",",1,0
108985,four,1,0
108986,),1,0
108987,.,1,0
108988,INTERPRETATION,0,0
108989,Prophylactic,0,0
108990,VT,0,0
108991,ablation,0,0
108992,before,0,0
108993,defibrillator,0,0
108994,implantation,0,1
108995,seemed,0,0
108996,to,0,0
108997,prolong,0,0
108998,time,0,0
108999,to,0,0
109000,recurrence,0,0
109001,of,0,0
109002,VT,0,0
109003,in,0,0
109004,patients,1,1
109005,with,1,1
109006,stable,1,1
109007,VT,1,0
109008,",",1,0
109009,previous,1,0
109010,myocardial,1,0
109011,infarction,1,1
109012,",",1,0
109013,and,1,0
109014,reduced,1,0
109015,LVEF,1,0
109016,.,1,0
109017,Prophylactic,0,0
109018,catheter,0,0
109019,ablation,0,0
109020,should,0,0
109021,therefore,0,0
109022,be,0,0
109023,considered,0,0
109024,before,0,0
109025,implantation,0,0
109026,of,0,0
109027,a,0,0
109028,cardioverter,0,0
109029,defibrillator,0,0
109030,in,0,0
109031,such,0,0
109032,patients,0,1
109033,.,0,1
109034,FUNDING,0,0
109035,St,0,0
109036,Jude,0,1
109037,Medical,0,1
109038,.,0,0
109039,Hunter,0,0
109040,DBT,0,1
109041,project,0,1
109042,:,0,1
109043,randomized,0,0
109044,controlled,0,0
109045,trial,0,0
109046,of,0,0
109047,dialectical,0,0
109048,behaviour,0,0
109049,therapy,0,0
109050,in,0,0
109051,women,1,1
109052,with,1,1
109053,borderline,1,1
109054,personality,1,1
109055,disorder,1,1
109056,.,1,0
109057,OBJECTIVE,0,0
109058,Deliberate,0,0
109059,self-harm,0,1
109060,(,0,0
109061,DSH,0,0
109062,),0,0
109063,",",0,0
109064,general,0,0
109065,hospital,0,0
109066,admission,0,0
109067,and,0,0
109068,psychiatric,0,1
109069,hospital,0,0
109070,admission,0,0
109071,are,0,0
109072,common,0,0
109073,in,0,0
109074,women,1,1
109075,meeting,1,1
109076,criteria,1,1
109077,for,1,0
109078,borderline,1,1
109079,personality,1,1
109080,disorder,1,1
109081,(,1,0
109082,BPD,1,0
109083,),1,0
109084,.,1,0
109085,Dialectical,0,0
109086,behaviour,0,0
109087,therapy,0,0
109088,(,0,0
109089,DBT,0,0
109090,),0,0
109091,has,0,0
109092,been,0,0
109093,reported,0,0
109094,to,0,0
109095,be,0,0
109096,effective,0,0
109097,in,0,0
109098,reducing,0,0
109099,DSH,0,0
109100,and,0,0
109101,hospitalization,0,0
109102,.,0,0
109103,METHOD,0,0
109104,A,0,0
109105,randomized,0,0
109106,controlled,0,0
109107,trial,0,0
109108,of,0,0
109109,73,1,1
109110,female,1,1
109111,subjects,1,1
109112,meeting,1,1
109113,criteria,1,1
109114,for,1,0
109115,BPD,1,1
109116,was,0,0
109117,carried,0,0
109118,out,0,0
109119,with,0,1
109120,intention-to-treat,0,0
109121,analyses,0,0
109122,and,0,0
109123,per-protocol,0,0
109124,analyses,0,0
109125,.,0,0
109126,The,0,0
109127,intervention,0,0
109128,was,0,0
109129,DBT,0,0
109130,and,0,0
109131,the,0,0
109132,control,0,0
109133,condition,0,0
109134,was,0,0
109135,treatment,0,0
109136,as,0,0
109137,usual,0,0
109138,plus,0,0
109139,waiting,0,1
109140,list,0,0
109141,for,0,0
109142,DBT,0,1
109143,(,0,0
109144,TAU+WL,0,0
109145,),0,0
109146,",",0,0
109147,with,0,1
109148,outcomes,0,0
109149,measured,0,0
109150,after,0,0
109151,6,0,0
109152,months,0,0
109153,.,0,1
109154,Primary,0,1
109155,outcomes,0,0
109156,were,0,0
109157,differences,0,0
109158,in,0,0
109159,proportions,0,0
109160,and,0,0
109161,event,0,0
109162,rates,0,0
109163,of,0,0
109164,:,0,1
109165,any,0,0
109166,DSH,0,0
109167,;,0,0
109168,general,0,1
109169,hospital,0,0
109170,admission,0,0
109171,for,0,0
109172,DSH,0,0
109173,and,0,0
109174,any,0,0
109175,psychiatric,0,1
109176,admission,0,0
109177,;,0,0
109178,and,0,0
109179,mean,0,0
109180,difference,0,0
109181,in,0,0
109182,length,0,0
109183,of,0,0
109184,stay,0,0
109185,for,0,0
109186,any,0,0
109187,hospitalization,0,0
109188,.,0,0
109189,Secondary,0,0
109190,outcomes,0,0
109191,were,0,0
109192,disability,0,0
109193,and,0,0
109194,quality,0,0
109195,of,0,0
109196,life,0,0
109197,measures,0,0
109198,.,0,1
109199,RESULTS,0,0
109200,Both,0,0
109201,groups,0,0
109202,showed,0,0
109203,a,0,0
109204,reduction,0,0
109205,in,0,0
109206,DSH,0,0
109207,and,0,0
109208,hospitalizations,0,0
109209,",",0,0
109210,but,0,0
109211,there,0,0
109212,were,0,0
109213,no,0,0
109214,significant,0,0
109215,differences,0,0
109216,in,0,0
109217,DSH,0,0
109218,",",0,0
109219,hospital,0,0
109220,admissions,0,1
109221,or,0,1
109222,length,0,0
109223,of,0,0
109224,stay,0,0
109225,in,0,0
109226,hospital,0,0
109227,between,0,0
109228,groups,0,0
109229,.,0,1
109230,Disability,0,0
109231,(,0,0
109232,days,0,0
109233,spent,0,0
109234,in,0,0
109235,bed,0,0
109236,),0,0
109237,and,0,0
109238,quality,0,0
109239,of,0,0
109240,life,0,0
109241,(,0,0
109242,Physical,0,0
109243,",",0,0
109244,Psychological,0,1
109245,and,0,0
109246,Environmental,0,0
109247,domains,0,0
109248,),0,0
109249,were,0,0
109250,significantly,0,0
109251,improved,0,0
109252,for,0,0
109253,the,0,0
109254,DBT,0,0
109255,group,0,0
109256,.,0,0
109257,CONCLUSION,0,0
109258,DBT,0,0
109259,produced,0,0
109260,non-significant,0,0
109261,reductions,0,0
109262,in,0,0
109263,DSH,0,0
109264,and,0,0
109265,hospitalization,0,0
109266,when,0,0
109267,compared,0,0
109268,to,0,0
109269,the,0,0
109270,TAU+WL,0,0
109271,control,0,0
109272,",",0,0
109273,due,0,0
109274,in,0,0
109275,part,0,0
109276,to,0,0
109277,the,0,0
109278,lower,0,0
109279,than,0,0
109280,expected,0,0
109281,rates,0,0
109282,of,0,0
109283,hospitalization,0,0
109284,in,0,0
109285,the,0,0
109286,control,0,0
109287,condition,0,0
109288,.,0,0
109289,Nevertheless,0,0
109290,",",0,0
109291,DBT,0,0
109292,showed,0,0
109293,significant,0,0
109294,benefits,0,0
109295,for,0,0
109296,the,0,0
109297,secondary,0,0
109298,outcomes,0,0
109299,of,0,0
109300,improved,0,0
109301,disability,0,0
109302,and,0,0
109303,quality,0,0
109304,of,0,0
109305,life,0,0
109306,scores,0,0
109307,",",0,0
109308,a,0,0
109309,clinically,0,0
109310,useful,0,0
109311,result,0,0
109312,that,0,0
109313,is,0,0
109314,also,0,0
109315,in,0,0
109316,keeping,0,0
109317,with,0,1
109318,the,0,0
109319,theoretical,0,0
109320,constructs,0,0
109321,of,0,0
109322,the,0,0
109323,benefits,0,0
109324,of,0,0
109325,DBT,0,1
109326,.,0,1
109327,Enhancing,0,0
109328,caregiver,0,0
109329,health,0,1
109330,:,0,1
109331,findings,0,0
109332,from,0,0
109333,the,0,0
109334,resources,0,0
109335,for,0,0
109336,enhancing,0,0
109337,Alzheimer,1,1
109338,'s,1,0
109339,caregiver,1,0
109340,health,1,1
109341,II,1,0
109342,intervention,1,0
109343,.,1,0
109344,OBJECTIVES,0,0
109345,To,0,0
109346,examine,0,0
109347,the,0,0
109348,relationships,0,0
109349,between,0,0
109350,changes,0,0
109351,from,0,0
109352,baseline,0,0
109353,to,0,0
109354,post-Resources,0,0
109355,for,0,0
109356,Enhancing,0,0
109357,Alzheimer,0,1
109358,'s,0,1
109359,Caregiver,0,0
109360,Health,0,1
109361,(,0,0
109362,REACH,0,0
109363,),0,0
109364,intervention,0,0
109365,in,0,0
109366,caregiver,0,0
109367,(,0,0
109368,CG,0,0
109369,),0,0
109370,self-reported,0,0
109371,health,0,0
109372,",",0,0
109373,burden,0,0
109374,",",0,0
109375,and,0,0
109376,bother,0,0
109377,.,0,0
109378,DESIGN,0,0
109379,Randomized,0,0
109380,",",0,0
109381,multisite,0,0
109382,clinical,0,0
109383,trial,0,0
109384,.,0,0
109385,SETTING,0,0
109386,CG,1,0
109387,and,1,0
109388,care,1,0
109389,recipient,1,0
109390,(,1,0
109391,CR,1,0
109392,),1,0
109393,homes,1,1
109394,in,1,0
109395,five,1,1
109396,U.S.,1,1
109397,cities,1,1
109398,.,1,0
109399,PARTICIPANTS,0,0
109400,Four,1,0
109401,hundred,1,1
109402,ninety-five,1,1
109403,dementia,1,1
109404,CG,1,0
109405,and,1,0
109406,CR,1,0
109407,dyads,1,1
109408,(,1,0
109409,169,1,1
109410,Hispanic,1,1
109411,",",1,0
109412,160,1,1
109413,white,1,1
109414,",",1,0
109415,and,1,0
109416,166,1,1
109417,African,1,1
109418,American,1,1
109419,),1,0
109420,receiving,1,0
109421,intervention,1,0
109422,and,1,0
109423,their,1,0
109424,controls,1,0
109425,.,1,1
109426,INTERVENTION,0,0
109427,CGs,0,0
109428,were,0,0
109429,assigned,0,0
109430,to,0,0
109431,the,0,0
109432,REACH,0,0
109433,intervention,0,0
109434,or,0,0
109435,a,0,0
109436,no-treatment,0,0
109437,control,0,0
109438,group,0,0
109439,.,0,0
109440,Intervention,0,0
109441,subjects,0,1
109442,received,0,0
109443,individual,0,0
109444,risk,0,0
109445,profiles,0,0
109446,and,0,0
109447,the,0,0
109448,REACH,0,0
109449,intervention,0,0
109450,through,0,0
109451,nine,0,1
109452,in-home,0,0
109453,and,0,0
109454,three,0,0
109455,telephone,0,0
109456,sessions,0,0
109457,over,0,0
109458,6,0,1
109459,months,0,0
109460,.,0,0
109461,Control,0,0
109462,subjects,0,1
109463,received,0,0
109464,two,0,0
109465,brief,0,0
109466,check-in,0,0
109467,telephone,0,0
109468,calls,0,0
109469,during,0,0
109470,this,0,0
109471,6-month,0,0
109472,period,0,0
109473,.,0,0
109474,MEASUREMENTS,0,0
109475,The,0,0
109476,primary,0,0
109477,outcome,0,0
109478,was,0,0
109479,change,0,0
109480,in,0,0
109481,CG,0,0
109482,health,0,0
109483,status,0,0
109484,from,0,0
109485,baseline,0,0
109486,to,0,0
109487,after,0,0
109488,the,0,0
109489,intervention,0,0
109490,.,0,0
109491,Secondary,0,0
109492,outcomes,0,0
109493,were,0,0
109494,CG,0,0
109495,burden,0,0
109496,and,0,0
109497,bother,0,0
109498,after,0,0
109499,the,0,0
109500,intervention,0,0
109501,.,0,0
109502,RESULTS,0,0
109503,After,0,0
109504,the,0,0
109505,intervention,0,0
109506,",",0,0
109507,CGs,0,0
109508,reported,0,0
109509,better,0,0
109510,self-rated,0,0
109511,health,0,0
109512,",",0,0
109513,sleep,0,0
109514,quality,0,0
109515,",",0,0
109516,physical,0,0
109517,health,0,0
109518,",",0,0
109519,and,0,0
109520,emotional,0,0
109521,health,0,0
109522,",",0,0
109523,which,0,0
109524,was,0,0
109525,related,0,0
109526,to,0,0
109527,less,0,0
109528,burden,0,0
109529,and,0,0
109530,bother,0,0
109531,with,0,0
109532,their,0,0
109533,caregiving,0,0
109534,role,0,0
109535,than,0,0
109536,for,0,0
109537,CGs,0,0
109538,not,0,0
109539,receiving,0,0
109540,the,0,0
109541,intervention,0,0
109542,.,0,0
109543,Changes,0,0
109544,in,0,0
109545,depression,0,1
109546,appeared,0,0
109547,to,0,0
109548,mediate,0,0
109549,these,0,0
109550,relationships,0,0
109551,.,0,0
109552,Several,0,0
109553,racial,0,0
109554,and,0,0
109555,ethnic,0,1
109556,group,0,0
109557,differences,0,0
109558,existed,0,0
109559,in,0,0
109560,physical,0,0
109561,and,0,0
109562,emotional,0,0
109563,health,0,0
109564,",",0,0
109565,as,0,0
109566,well,0,0
109567,as,0,0
109568,in,0,0
109569,total,0,1
109570,frustration,0,0
109571,with,0,0
109572,caregiving,0,0
109573,",",0,0
109574,emotional,0,0
109575,burden,0,0
109576,",",0,0
109577,and,0,0
109578,CG-rated,0,0
109579,bother,0,0
109580,with,0,1
109581,CR,0,0
109582,'s,0,1
109583,activities,0,0
109584,of,0,0
109585,daily,0,0
109586,living,0,1
109587,and,0,0
109588,instrumental,0,0
109589,activities,0,0
109590,of,0,0
109591,daily,0,0
109592,living,0,1
109593,at,0,0
109594,baseline,0,0
109595,and,0,0
109596,at,0,0
109597,follow-up,0,0
109598,",",0,0
109599,although,0,0
109600,differences,0,0
109601,between,0,0
109602,baseline,0,0
109603,and,0,0
109604,posttest,0,0
109605,did,0,0
109606,not,0,0
109607,vary,0,0
109608,according,0,0
109609,to,0,0
109610,race,0,0
109611,.,0,0
109612,CONCLUSION,0,0
109613,A,0,0
109614,structured,0,0
109615,",",0,0
109616,multicomponent,0,0
109617,skills,0,0
109618,training,0,0
109619,intervention,0,0
109620,that,0,0
109621,targeted,0,0
109622,CG,0,0
109623,self-care,0,0
109624,behaviors,0,0
109625,as,0,0
109626,one,0,1
109627,of,0,0
109628,five,0,1
109629,target,0,0
109630,areas,0,0
109631,",",0,0
109632,improved,0,0
109633,self-reported,0,0
109634,health,0,0
109635,status,0,0
109636,",",0,0
109637,and,0,0
109638,decreased,0,0
109639,burden,0,0
109640,and,0,0
109641,bother,0,0
109642,in,0,0
109643,racially,1,1
109644,and,1,0
109645,ethnically,1,1
109646,diverse,1,0
109647,CGs,1,0
109648,of,1,0
109649,people,1,1
109650,with,1,1
109651,dementia,1,1
109652,.,1,0
109653,Pilot,0,0
109654,randomized,0,0
109655,controlled,0,0
109656,trial,0,0
109657,of,0,0
109658,Reciprocal,0,0
109659,Imitation,0,0
109660,Training,0,0
109661,for,0,0
109662,teaching,0,0
109663,elicited,0,0
109664,and,0,0
109665,spontaneous,0,0
109666,imitation,0,0
109667,to,0,0
109668,children,1,1
109669,with,1,1
109670,autism,1,1
109671,.,1,0
109672,Children,1,1
109673,with,1,0
109674,autism,1,1
109675,exhibit,0,0
109676,significant,0,0
109677,deficits,0,0
109678,in,0,0
109679,imitation,0,1
109680,skills,0,0
109681,.,0,1
109682,Reciprocal,0,0
109683,Imitation,0,0
109684,Training,0,0
109685,(,0,0
109686,RIT,0,0
109687,),0,0
109688,",",0,0
109689,a,0,0
109690,naturalistic,0,0
109691,imitation,0,0
109692,intervention,0,0
109693,",",0,0
109694,was,0,0
109695,developed,0,0
109696,to,0,0
109697,teach,0,0
109698,young,1,1
109699,children,1,1
109700,with,1,1
109701,autism,1,1
109702,to,0,0
109703,imitate,0,0
109704,during,0,0
109705,play,0,0
109706,.,0,0
109707,This,0,0
109708,study,0,0
109709,used,0,0
109710,a,0,0
109711,randomized,0,0
109712,controlled,0,0
109713,trial,0,0
109714,to,0,0
109715,evaluate,0,0
109716,the,0,0
109717,efficacy,0,0
109718,of,0,0
109719,RIT,0,0
109720,on,0,0
109721,elicited,0,0
109722,and,0,0
109723,spontaneous,0,0
109724,imitation,0,0
109725,skills,0,0
109726,in,0,0
109727,21,1,1
109728,young,1,1
109729,children,1,1
109730,with,1,1
109731,autism,1,1
109732,.,1,0
109733,Results,0,0
109734,found,0,0
109735,that,0,0
109736,children,0,1
109737,in,0,0
109738,the,0,0
109739,treatment,0,0
109740,group,0,0
109741,made,0,0
109742,significantly,0,0
109743,more,0,0
109744,gains,0,0
109745,in,0,0
109746,elicited,0,0
109747,and,0,0
109748,spontaneous,0,0
109749,imitation,0,0
109750,",",0,0
109751,replicating,0,0
109752,previous,0,0
109753,single-subject,0,1
109754,design,0,0
109755,studies,0,0
109756,.,0,0
109757,Number,0,0
109758,of,0,0
109759,spontaneous,0,0
109760,play,0,0
109761,acts,0,0
109762,at,0,0
109763,pre-treatment,0,0
109764,was,0,0
109765,related,0,0
109766,to,0,0
109767,improvements,0,0
109768,in,0,0
109769,imitation,0,0
109770,during,0,0
109771,the,0,0
109772,intervention,0,0
109773,",",0,0
109774,suggesting,0,0
109775,that,0,0
109776,children,0,1
109777,with,0,1
109778,a,0,0
109779,greater,0,0
109780,play,0,0
109781,repertoire,0,0
109782,make,0,0
109783,greater,0,0
109784,gains,0,0
109785,during,0,0
109786,RIT,0,1
109787,.,0,1
109788,A,0,0
109789,randomized,0,0
109790,",",0,0
109791,double-blind,0,0
109792,",",0,0
109793,placebo-controlled,0,0
109794,",",0,0
109795,phase,0,0
109796,I,0,0
109797,study,0,0
109798,of,0,0
109799,MEDI-545,0,0
109800,",",0,0
109801,an,0,0
109802,anti-interferon-alfa,0,0
109803,monoclonal,0,0
109804,antibody,0,0
109805,",",0,0
109806,in,0,0
109807,subjects,1,1
109808,with,1,1
109809,chronic,1,1
109810,psoriasis,1,1
109811,.,1,0
109812,BACKGROUND,0,0
109813,Interferon-alfa,0,0
109814,(,0,0
109815,IFN-alpha,0,0
109816,),0,0
109817,has,0,0
109818,been,0,0
109819,implicated,0,0
109820,in,0,0
109821,the,0,0
109822,pathogenesis,0,0
109823,of,0,0
109824,psoriasis,0,1
109825,.,0,0
109826,OBJECTIVE,0,0
109827,To,0,0
109828,evaluate,0,0
109829,the,0,0
109830,safety,0,0
109831,profile,0,0
109832,of,0,0
109833,MEDI-545,0,0
109834,",",0,0
109835,a,0,0
109836,fully,0,0
109837,human,0,0
109838,anti-IFN-alpha,0,0
109839,monoclonal,0,0
109840,antibody,0,0
109841,and,0,0
109842,to,0,0
109843,explore,0,0
109844,its,0,0
109845,effect,0,0
109846,on,0,0
109847,the,0,0
109848,involvement,0,0
109849,of,0,0
109850,type,0,1
109851,I,0,0
109852,IFN-alpha,0,0
109853,activity,0,0
109854,in,0,0
109855,the,0,0
109856,maintenance,0,0
109857,of,0,0
109858,established,0,0
109859,plaque,0,0
109860,psoriasis,0,1
109861,.,0,0
109862,METHODS,0,0
109863,We,0,0
109864,conducted,0,0
109865,an,0,0
109866,18-week,0,0
109867,",",0,0
109868,randomized,0,0
109869,",",0,0
109870,double-blind,0,0
109871,",",0,0
109872,placebo-controlled,0,0
109873,",",0,0
109874,dose-escalating,0,0
109875,study,0,0
109876,in,0,0
109877,36,1,1
109878,subjects,1,1
109879,with,1,1
109880,chronic,1,1
109881,plaque,1,0
109882,psoriasis,1,1
109883,.,1,0
109884,Subjects,0,0
109885,received,0,0
109886,one,0,0
109887,intravenous,0,0
109888,dose,0,0
109889,of,0,0
109890,MEDI-545,0,0
109891,(,0,0
109892,0.3-30.0,0,0
109893,mg/kg,0,0
109894,),0,0
109895,or,0,0
109896,placebo,0,0
109897,.,0,0
109898,Study,0,0
109899,outcomes,0,0
109900,were,0,0
109901,safety,0,0
109902,profile,0,0
109903,",",0,0
109904,pharmacokinetics,0,0
109905,",",0,0
109906,immunogenicity,0,0
109907,",",0,0
109908,and,0,0
109909,clinical,0,0
109910,effects,0,0
109911,.,0,1
109912,RESULTS,0,0
109913,There,0,0
109914,was,0,0
109915,no,0,0
109916,difference,0,0
109917,in,0,0
109918,adverse,0,0
109919,events,0,0
109920,between,0,0
109921,MEDI-545,0,0
109922,and,0,0
109923,placebo,0,0
109924,.,0,0
109925,Two,0,0
109926,serious,0,0
109927,adverse,0,0
109928,events,0,0
109929,were,0,1
109930,reported,0,0
109931,;,0,0
109932,one,0,0
109933,drug-related,0,0
109934,hypotensive,0,0
109935,infusion,0,0
109936,reaction,0,0
109937,occurred,0,0
109938,in,0,0
109939,one,0,0
109940,subject,0,0
109941,in,0,0
109942,the,0,0
109943,30.0,0,0
109944,mg/kg,0,0
109945,MEDI-545,0,0
109946,dose,0,0
109947,group,0,0
109948,",",0,0
109949,causing,0,0
109950,discontinuation,0,0
109951,of,0,0
109952,study,0,0
109953,drug,0,0
109954,in,0,0
109955,that,0,0
109956,subject,0,0
109957,and,0,0
109958,study,0,0
109959,dismissal,0,0
109960,of,0,0
109961,the,0,0
109962,other,0,0
109963,subjects,0,1
109964,in,0,0
109965,the,0,0
109966,same,0,0
109967,cohort,0,1
109968,;,0,0
109969,and,0,0
109970,a,0,0
109971,myocardial,0,0
109972,infarction,0,0
109973,occurred,0,0
109974,in,0,0
109975,one,0,0
109976,subject,0,0
109977,in,0,0
109978,the,0,0
109979,10,0,0
109980,mg/kg,0,0
109981,MEDI-545,0,0
109982,dose,0,0
109983,group,0,0
109984,",",0,0
109985,which,0,0
109986,was,0,0
109987,considered,0,0
109988,to,0,0
109989,be,0,0
109990,unrelated,0,1
109991,to,0,0
109992,treatment,0,0
109993,.,0,0
109994,MEDI-545,0,0
109995,was,0,0
109996,nonimmunogenic,0,0
109997,",",0,0
109998,had,0,0
109999,a,0,0
110000,half-life,0,0
110001,of,0,0
110002,21,0,1
110003,days,0,0
110004,",",0,0
110005,showed,0,0
110006,no,0,0
110007,significant,0,0
110008,inhibition,0,0
110009,of,0,0
110010,the,0,0
110011,type,0,1
110012,I,0,0
110013,IFN,0,0
110014,gene,0,0
110015,signature,0,0
110016,",",0,0
110017,and,0,0
110018,had,0,0
110019,no,0,0
110020,clinical,0,0
110021,activity,0,0
110022,.,0,0
110023,LIMITATIONS,0,0
110024,The,0,0
110025,study,0,0
110026,addressed,0,0
110027,only,0,0
110028,IFN-alpha,0,0
110029,and,0,0
110030,chronic,0,1
110031,psoriatic,0,1
110032,lesions,0,1
110033,.,0,0
110034,CONCLUSION,0,0
110035,The,0,0
110036,safety,0,0
110037,profile,0,0
110038,of,0,0
110039,MEDI-545,0,0
110040,supports,0,0
110041,further,0,0
110042,clinical,0,0
110043,development,0,0
110044,.,0,0
110045,IFN-alpha,0,0
110046,does,0,0
110047,not,0,0
110048,appear,0,0
110049,to,0,0
110050,be,0,0
110051,significantly,0,0
110052,involved,0,0
110053,in,0,0
110054,the,0,0
110055,maintenance,0,0
110056,of,0,0
110057,established,0,0
110058,plaque,0,0
110059,psoriasis,0,1
110060,.,0,0
110061,The,0,0
110062,development,0,0
110063,of,0,0
110064,a,0,0
110065,web-,0,0
110066,and,0,0
110067,a,0,0
110068,print-based,0,0
110069,decision,0,0
110070,aid,0,0
110071,for,0,0
110072,prostate,1,1
110073,cancer,1,1
110074,screening,0,1
110075,.,0,0
110076,BACKGROUND,0,0
110077,Whether,0,0
110078,early,0,0
110079,detection,0,0
110080,and,0,0
110081,treatment,0,0
110082,of,0,0
110083,prostate,0,1
110084,cancer,0,1
110085,(,0,0
110086,PCa,0,0
110087,),0,0
110088,will,0,0
110089,reduce,0,0
110090,disease-related,0,0
110091,mortality,0,0
110092,remains,0,0
110093,uncertain,0,0
110094,.,0,0
110095,As,0,0
110096,a,0,0
110097,result,0,0
110098,",",0,0
110099,tools,0,0
110100,are,0,0
110101,needed,0,0
110102,to,0,0
110103,facilitate,0,0
110104,informed,0,0
110105,decision,0,0
110106,making,0,0
110107,.,0,0
110108,While,0,0
110109,there,0,0
110110,have,0,0
110111,been,0,0
110112,several,0,0
110113,decision,0,0
110114,aids,0,1
110115,(,0,0
110116,DAs,0,1
110117,),0,0
110118,developed,0,0
110119,and,0,0
110120,tested,0,0
110121,",",0,0
110122,very,0,0
110123,few,0,0
110124,have,0,0
110125,included,0,0
110126,an,0,0
110127,exercise,0,0
110128,to,0,0
110129,help,0,0
110130,men,0,1
110131,clarify,0,0
110132,their,0,1
110133,values,0,0
110134,and,0,0
110135,preferences,0,0
110136,about,0,0
110137,PCa,0,0
110138,screening,0,1
110139,.,0,0
110140,Further,0,0
110141,",",0,0
110142,only,0,0
110143,one,0,0
110144,DA,0,0
110145,has,0,0
110146,utilized,0,0
110147,an,0,0
110148,interactive,0,0
110149,web-based,0,0
110150,format,0,0
110151,",",0,0
110152,which,0,0
110153,allows,0,0
110154,for,0,0
110155,an,0,0
110156,expansion,0,0
110157,and,0,0
110158,customization,0,0
110159,of,0,0
110160,the,0,0
110161,material,0,1
110162,.,0,0
110163,We,0,0
110164,describe,0,0
110165,the,0,0
110166,development,0,0
110167,of,0,0
110168,two,0,0
110169,DAs,0,1
110170,",",0,0
110171,a,0,0
110172,booklet,0,0
110173,and,0,0
110174,an,0,0
110175,interactive,0,0
110176,website,0,0
110177,",",0,0
110178,each,0,0
110179,with,0,0
110180,a,0,0
110181,values,0,0
110182,clarification,0,0
110183,component,0,0
110184,and,0,0
110185,designed,0,0
110186,for,0,0
110187,use,0,0
110188,in,0,0
110189,diverse,0,1
110190,settings,0,0
110191,.,0,1
110192,METHODS,0,0
110193,We,0,0
110194,conducted,0,0
110195,two,0,0
110196,feasibility,0,0
110197,studies,0,0
110198,to,0,0
110199,assess,0,0
110200,men,1,1
110201,'s,1,0
110202,(,1,0
110203,45-70,1,1
110204,years,1,1
110205,),1,0
110206,Internet,1,1
110207,access,1,0
110208,and,1,0
110209,their,1,0
110210,willingness,1,0
110211,to,1,0
110212,use,1,0
110213,a,1,0
110214,web-,1,0
110215,vs.,1,0
110216,a,1,0
110217,print-based,1,0
110218,tool,1,0
110219,.,1,0
110220,The,0,0
110221,booklet,0,0
110222,was,0,0
110223,adapted,0,0
110224,from,0,0
110225,two,0,0
110226,previous,0,1
110227,versions,0,0
110228,evaluated,0,0
110229,in,0,0
110230,randomized,0,0
110231,controlled,0,0
110232,trials,0,0
110233,(,0,0
110234,RCTs,0,0
110235,),0,0
110236,and,0,0
110237,the,0,0
110238,website,0,0
110239,was,0,0
110240,created,0,0
110241,to,0,0
110242,closely,0,0
110243,match,0,0
110244,the,0,0
110245,content,0,0
110246,of,0,0
110247,the,0,0
110248,revised,0,0
110249,booklet,0,0
110250,.,0,0
110251,Usability,0,0
110252,testing,0,0
110253,was,0,0
110254,conducted,0,0
110255,to,0,0
110256,obtain,0,0
110257,feedback,0,0
110258,regarding,0,0
110259,draft,0,0
110260,versions,0,0
110261,of,0,0
110262,the,0,0
110263,materials,0,0
110264,.,0,0
110265,The,0,0
110266,tools,0,0
110267,were,0,0
110268,also,0,0
110269,reviewed,0,0
110270,by,0,0
110271,a,0,0
110272,plain,0,0
110273,language,0,0
110274,expert,0,0
110275,and,0,0
110276,the,0,0
110277,interdisciplinary,0,0
110278,research,0,0
110279,team,0,0
110280,.,0,0
110281,Feedback,0,0
110282,on,0,0
110283,the,0,0
110284,content,0,0
110285,and,0,0
110286,presentation,0,0
110287,led,0,0
110288,to,0,0
110289,iterative,0,0
110290,modifications,0,0
110291,of,0,0
110292,the,0,0
110293,tools,0,0
110294,.,0,0
110295,RESULTS,0,0
110296,The,0,0
110297,feasibility,0,0
110298,studies,0,0
110299,confirmed,0,0
110300,that,0,0
110301,the,0,0
110302,Internet,0,0
110303,was,0,0
110304,a,0,0
110305,viable,0,0
110306,medium,0,0
110307,",",0,0
110308,as,0,0
110309,the,0,0
110310,majority,0,0
110311,of,0,0
110312,men,0,1
110313,used,0,0
110314,a,0,0
110315,computer,0,0
110316,",",0,0
110317,had,0,0
110318,access,0,0
110319,to,0,0
110320,the,0,0
110321,Internet,0,0
110322,",",0,0
110323,and,0,0
110324,Internet,0,0
110325,use,0,0
110326,increased,0,0
110327,over,0,0
110328,time,0,0
110329,.,0,0
110330,Feedback,0,0
110331,from,0,0
110332,the,0,0
110333,usability,0,0
110334,testing,0,0
110335,on,0,0
110336,the,0,0
110337,length,0,0
110338,",",0,0
110339,presentation,0,0
110340,",",0,0
110341,and,0,0
110342,content,0,0
110343,of,0,0
110344,the,0,0
110345,materials,0,0
110346,was,0,0
110347,incorporated,0,0
110348,into,0,0
110349,the,0,0
110350,final,0,0
110351,versions,0,0
110352,of,0,0
110353,the,0,0
110354,booklet,0,0
110355,and,0,0
110356,website,0,0
110357,.,0,0
110358,Both,0,0
110359,the,0,0
110360,feasibility,0,0
110361,studies,0,0
110362,and,0,0
110363,the,0,0
110364,usability,0,0
110365,testing,0,0
110366,highlighted,0,0
110367,the,0,0
110368,need,0,0
110369,to,0,0
110370,address,0,0
110371,men,1,1
110372,'s,1,0
110373,informed,1,0
110374,decision,1,0
110375,making,1,0
110376,regarding,0,0
110377,screening,0,1
110378,.,0,0
110379,CONCLUSIONS,0,0
110380,Informed,0,0
110381,decision,0,0
110382,making,0,0
110383,for,0,0
110384,PCa,0,0
110385,screening,0,0
110386,is,0,0
110387,crucial,0,0
110388,at,0,0
110389,present,0,0
110390,and,0,0
110391,may,0,0
110392,be,0,0
110393,important,0,0
110394,for,0,0
110395,some,0,0
110396,time,0,0
110397,",",0,0
110398,particularly,0,0
110399,if,0,0
110400,a,0,0
110401,definitive,0,0
110402,recommendation,0,0
110403,either,0,0
110404,for,0,0
110405,or,0,0
110406,against,0,0
110407,screening,0,0
110408,does,0,0
110409,not,0,0
110410,emerge,0,0
110411,from,0,0
110412,ongoing,0,0
110413,prostate,0,1
110414,cancer,0,1
110415,screening,0,1
110416,trials,0,0
110417,.,0,0
110418,We,0,0
110419,have,0,0
110420,detailed,0,0
110421,our,0,0
110422,efforts,0,0
110423,at,0,0
110424,developing,0,0
110425,print-,0,0
110426,and,0,0
110427,web-based,0,0
110428,DAs,0,1
110429,to,0,0
110430,assist,0,0
110431,men,0,1
110432,in,0,0
110433,determining,0,0
110434,how,0,0
110435,to,0,0
110436,best,0,0
110437,meet,0,0
110438,their,0,0
110439,PCa,0,0
110440,screening,0,1
110441,preferences,0,0
110442,.,0,0
110443,Following,0,0
110444,completion,0,0
110445,of,0,0
110446,our,0,0
110447,ongoing,0,0
110448,RCT,0,0
110449,designed,0,0
110450,to,0,0
110451,test,0,0
110452,these,0,0
110453,materials,0,0
110454,",",0,0
110455,our,0,0
110456,goal,0,0
110457,will,0,0
110458,be,0,0
110459,to,0,0
110460,develop,0,0
110461,a,0,0
110462,dissemination,0,0
110463,project,0,0
110464,for,0,0
110465,the,0,0
110466,more,0,0
110467,effective,0,0
110468,tool,0,0
110469,.,0,0
110470,TRIAL,0,0
110471,REGISTRATION,0,0
110472,NCT00623090,0,0
110473,.,0,0
110474,Final,0,0
110475,analysis,0,0
110476,of,0,0
110477,the,0,0
110478,UKLG,0,0
110479,LY02,0,0
110480,trial,0,0
110481,comparing,0,0
110482,6-8,0,1
110483,cycles,0,0
110484,of,0,0
110485,CHOP,0,0
110486,with,0,1
110487,3,0,0
110488,cycles,0,0
110489,of,0,0
110490,CHOP,0,0
110491,followed,0,0
110492,by,0,0
110493,a,0,0
110494,BEAM,0,0
110495,autograft,0,0
110496,in,0,0
110497,patients,1,1
110498,<,1,0
110499,65,1,1
110500,years,1,1
110501,with,1,1
110502,poor,1,1
110503,prognosis,1,0
110504,histologically,1,1
110505,aggressive,1,0
110506,NHL,1,1
110507,.,1,0
110508,This,0,0
110509,trial,0,0
110510,involved,0,0
110511,457,1,1
110512,patients,1,1
110513,and,0,0
110514,sought,0,0
110515,to,0,0
110516,assess,0,0
110517,the,0,0
110518,value,0,0
110519,of,0,0
110520,early,0,0
110521,intensification,0,0
110522,with,0,1
110523,autologous,0,0
110524,transplantation,0,1
110525,in,0,0
110526,patients,1,1
110527,with,1,1
110528,poor,1,1
110529,prognosis,1,0
110530,histologically,1,1
110531,aggressive,1,0
110532,non-Hodgkin,1,1
110533,lymphoma,1,1
110534,(,1,0
110535,NHL,1,1
110536,),1,0
110537,showing,1,0
110538,a,1,0
110539,response,1,0
110540,to,1,0
110541,initial,1,0
110542,CHOP,1,0
110543,(,1,0
110544,cyclophosphamide,1,0
110545,",",0,0
110546,doxorubicin,0,0
110547,",",0,0
110548,vincristine,0,0
110549,",",0,0
110550,prednisolone,0,0
110551,),0,0
110552,chemotherapy,0,0
110553,.,0,0
110554,Randomization,0,0
110555,was,0,0
110556,made,0,0
110557,at,0,0
110558,the,0,0
110559,time,0,0
110560,of,0,0
110561,diagnosis,0,1
110562,with,0,1
110563,223,0,1
110564,assigned,0,1
110565,to,0,0
110566,continuing,0,0
110567,CHOP,0,0
110568,and,0,0
110569,234,0,1
110570,to,0,0
110571,3,0,0
110572,cycles,0,0
110573,of,0,0
110574,CHOP,0,0
110575,followed,0,0
110576,by,0,0
110577,a,0,0
110578,BEAM,0,0
110579,(,0,0
110580,carmustine,0,0
110581,",",0,0
110582,etoposide,0,0
110583,",",0,0
110584,cytarabine,0,0
110585,",",0,0
110586,melphalan,0,0
110587,),0,0
110588,autograft,0,0
110589,.,0,0
110590,Analysis,0,0
110591,was,0,0
110592,on,0,0
110593,an,0,0
110594,intention,0,0
110595,to,0,0
110596,treat,0,0
110597,basis,0,0
110598,.,0,0
110599,After,0,0
110600,the,0,0
110601,initial,0,0
110602,three,0,0
110603,cycles,0,0
110604,of,0,0
110605,CHOP,0,0
110606,19,0,1
110607,%,0,0
110608,of,0,0
110609,the,0,0
110610,whole,0,0
110611,group,0,0
110612,were,0,0
110613,in,0,0
110614,complete,0,0
110615,response,0,0
110616,(,0,0
110617,CR,0,0
110618,),0,0
110619,and,0,0
110620,53,0,0
110621,%,0,0
110622,in,0,0
110623,partial,0,0
110624,remission,0,1
110625,(,0,0
110626,PR,0,0
110627,),0,0
110628,.,0,0
110629,At,0,0
110630,the,0,0
110631,end,0,0
110632,of,0,0
110633,treatment,0,0
110634,86,0,1
110635,%,0,0
110636,of,0,0
110637,patients,0,1
110638,in,0,0
110639,the,0,0
110640,CHOP,0,0
110641,arm,0,0
110642,had,0,0
110643,responded,0,1
110644,with,0,1
110645,58,0,1
110646,%,0,0
110647,in,0,0
110648,CR,0,0
110649,.,0,0
110650,In,0,0
110651,the,0,0
110652,high-dose,0,0
110653,therapy,0,0
110654,arm,0,0
110655,the,0,0
110656,overall,0,0
110657,response,0,0
110658,rate,0,0
110659,was,0,0
110660,83,0,0
110661,%,0,0
110662,with,0,1
110663,64,0,0
110664,%,0,0
110665,in,0,0
110666,CR,0,0
110667,(,0,0
110668,difference,0,0
110669,between,0,0
110670,arms,0,0
110671,not,0,0
110672,significant,0,0
110673,),0,0
110674,.,0,0
110675,The,0,0
110676,progression-free,0,0
110677,survival,0,0
110678,(,0,0
110679,PFS,0,0
110680,),0,0
110681,and,0,0
110682,overall,0,0
110683,survival,0,0
110684,at,0,0
110685,5,0,0
110686,years,0,1
110687,for,0,0
110688,the,0,0
110689,continuing,0,0
110690,CHOP,0,0
110691,arm,0,0
110692,were,0,0
110693,38,0,1
110694,%,0,0
110695,and,0,0
110696,50,0,0
110697,%,0,0
110698,respectively,0,0
110699,",",0,0
110700,and,0,0
110701,for,0,0
110702,the,0,0
110703,autograft,0,0
110704,arm,0,0
110705,were,0,0
110706,44,0,0
110707,%,0,0
110708,and,0,0
110709,50,0,0
110710,%,0,0
110711,(,0,0
110712,differences,0,0
110713,not,0,0
110714,significant,0,0
110715,),0,0
110716,.,0,0
110717,Of,0,0
110718,the,0,0
110719,patients,0,1
110720,who,0,1
110721,attained,0,1
110722,CR,0,1
110723,and,0,0
110724,subsequently,0,0
110725,relapsed,0,0
110726,",",0,0
110727,there,0,0
110728,were,0,0
110729,no,0,0
110730,long-term,0,0
110731,survivors,0,1
110732,in,0,0
110733,the,0,0
110734,autograft,0,1
110735,recipients,0,1
110736,compared,0,0
110737,to,0,0
110738,46,0,0
110739,%,0,0
110740,of,0,0
110741,the,0,0
110742,continuing,0,0
110743,CHOP,0,0
110744,recipients,0,1
110745,(,0,0
110746,P,0,0
110747,=,0,0
110748,0.0008,0,0
110749,),0,0
110750,.,0,0
110751,In,0,0
110752,conclusion,0,0
110753,",",0,0
110754,no,0,0
110755,survival,0,0
110756,benefit,0,0
110757,was,0,0
110758,demonstrated,0,0
110759,for,0,0
110760,an,0,0
110761,early,0,0
110762,autograft,0,0
110763,in,0,0
110764,first,0,0
110765,response,0,0
110766,.,0,0
110767,Promoting,0,0
110768,social,0,0
110769,skill,0,0
110770,development,0,0
110771,in,0,0
110772,children,1,1
110773,with,1,1
110774,pervasive,1,1
110775,developmental,1,1
110776,disorders,1,1
110777,:,1,1
110778,a,0,0
110779,feasibility,0,0
110780,and,0,0
110781,efficacy,0,0
110782,study,0,0
110783,.,0,0
110784,A,0,0
110785,randomized,0,0
110786,controlled,0,0
110787,design,0,0
110788,was,0,0
110789,employed,0,0
110790,to,0,0
110791,evaluate,0,0
110792,a,0,0
110793,social,0,0
110794,skills,0,0
110795,intervention,0,0
110796,for,0,0
110797,children,1,1
110798,with,1,1
110799,pervasive,1,1
110800,developmental,1,1
110801,disorders,1,1
110802,.,1,1
110803,Aims,0,0
110804,included,0,0
110805,evaluating,0,0
110806,the,0,0
110807,acceptability,0,0
110808,of,0,0
110809,the,0,0
110810,program,0,0
110811,and,0,0
110812,gathering,0,0
110813,preliminary,0,0
110814,evidence,0,0
110815,on,0,0
110816,efficacy,0,0
110817,.,0,0
110818,Forty-four,1,1
110819,children,1,1
110820,",",1,0
110821,ages,1,1
110822,8-11,1,1
110823,years,1,1
110824,",",1,0
110825,were,1,0
110826,randomly,1,0
110827,assigned,1,0
110828,to,1,0
110829,treatment,1,0
110830,or,1,0
110831,wait,1,0
110832,list,1,0
110833,.,1,0
110834,Treatment,0,0
110835,consisted,0,0
110836,of,0,0
110837,a,0,0
110838,16-week,0,0
110839,group,0,0
110840,intervention,0,0
110841,designed,0,0
110842,to,0,0
110843,teach,0,0
110844,appropriate,0,0
110845,social,0,0
110846,behavior,0,0
110847,.,0,0
110848,Between,0,0
110849,group,0,0
110850,comparisons,0,0
110851,showed,0,0
110852,that,0,0
110853,children,0,1
110854,in,0,0
110855,treatment,0,0
110856,were,0,0
110857,rated,0,0
110858,as,0,0
110859,improved,0,0
110860,on,0,0
110861,the,0,0
110862,primary,0,0
110863,outcome,0,0
110864,measure,0,0
110865,",",0,0
110866,(,0,0
110867,unblinded,0,0
110868,parent,0,0
110869,report,0,0
110870,),0,0
110871,",",0,0
110872,but,0,0
110873,not,0,0
110874,on,0,0
110875,the,0,0
110876,secondary,0,0
110877,outcome,0,0
110878,measure,0,0
110879,",",0,0
110880,a,0,0
110881,parent,0,0
110882,questionnaire,0,0
110883,.,0,0
110884,Parents,1,0
110885,reported,0,0
110886,a,0,0
110887,high,0,0
110888,level,0,0
110889,of,0,0
110890,satisfaction,0,0
110891,with,0,0
110892,the,0,0
110893,intervention,0,0
110894,.,0,0
110895,The,0,0
110896,study,0,0
110897,supports,0,0
110898,the,0,0
110899,feasibility,0,0
110900,of,0,0
110901,this,0,0
110902,intervention,0,0
110903,to,0,0
110904,families,1,1
110905,and,0,0
110906,highlights,0,0
110907,challenges,0,0
110908,for,0,0
110909,future,0,0
110910,research,0,0
110911,in,0,0
110912,social,0,0
110913,skills,0,0
110914,intervention,0,0
110915,.,0,1
110916,PSK,0,0
110917,may,0,0
110918,suppress,0,0
110919,CD57,0,0
110920,(,0,0
110921,+,0,0
110922,),0,0
110923,T,0,0
110924,cells,0,0
110925,to,0,0
110926,improve,0,0
110927,survival,0,0
110928,of,0,0
110929,advanced,1,1
110930,gastric,1,1
110931,cancer,1,1
110932,patients,1,1
110933,.,1,1
110934,BACKGROUND,0,0
110935,A,0,0
110936,recent,0,0
110937,report,0,0
110938,showed,0,0
110939,that,0,0
110940,oral,0,0
110941,adjuvant,0,0
110942,immunochemotherapy,0,0
110943,with,0,1
110944,protein-bound,0,0
110945,polysaccharide,0,0
110946,K,0,0
110947,(,0,0
110948,PSK,0,0
110949,),0,0
110950,and,0,0
110951,tegafur/uracil,0,0
110952,(,0,0
110953,UFT,0,0
110954,),0,0
110955,for,0,0
110956,stage,0,1
110957,II,0,1
110958,and,0,0
110959,III,0,0
110960,colorectal,0,1
110961,cancer,0,1
110962,improves,0,0
110963,overall,0,0
110964,survival,0,0
110965,compared,0,0
110966,with,0,0
110967,UFT,0,0
110968,alone,0,0
110969,.,0,0
110970,PSK,0,0
110971,has,0,0
110972,been,0,0
110973,supposed,0,0
110974,to,0,0
110975,improve,0,0
110976,survival,0,0
110977,through,0,0
110978,immunological,0,0
110979,mechanisms,0,0
110980,such,0,0
110981,as,0,0
110982,induction,0,0
110983,of,0,0
110984,cytokines,0,0
110985,",",0,0
110986,regulation,0,0
110987,of,0,0
110988,Th1/Th2,0,0
110989,balance,0,0
110990,",",0,0
110991,and,0,0
110992,inhibition,0,0
110993,of,0,0
110994,immunosuppressive,0,0
110995,molecules,0,0
110996,.,0,1
110997,METHODS,0,0
110998,We,0,0
110999,investigated,0,0
111000,the,0,0
111001,mechanisms,0,0
111002,by,0,0
111003,which,0,0
111004,PSK,0,0
111005,influences,0,0
111006,immunological,0,0
111007,parameters,0,0
111008,such,0,0
111009,as,0,0
111010,Th1,0,0
111011,cells,0,0
111012,(,0,0
111013,IFN-gamma-positive,0,1
111014,CD4,0,1
111015,(,0,0
111016,+,0,0
111017,),0,0
111018,T,0,0
111019,cells,0,0
111020,),0,0
111021,",",0,0
111022,Th2,0,0
111023,cells,0,0
111024,(,0,0
111025,IL-4-positive,0,0
111026,CD4,0,1
111027,(,0,0
111028,+,0,0
111029,),0,0
111030,T,0,0
111031,cells,0,0
111032,),0,0
111033,",",0,0
111034,Th1/Th2,0,0
111035,ratio,0,0
111036,",",0,0
111037,NKT,0,0
111038,cells,0,0
111039,(,0,0
111040,CD56,0,0
111041,(,0,0
111042,+,0,0
111043,),0,0
111044,T,0,0
111045,cells,0,0
111046,and,0,0
111047,CD57,0,0
111048,(,0,0
111049,+,0,0
111050,),0,0
111051,T,0,0
111052,cells,0,0
111053,),0,0
111054,",",0,0
111055,NK,0,0
111056,cells,0,0
111057,",",0,0
111058,and,0,0
111059,CD25,0,0
111060,(,0,0
111061,+,0,0
111062,),0,0
111063,CD4,0,1
111064,(,0,0
111065,+,0,0
111066,),0,0
111067,T,0,0
111068,cells,0,0
111069,in,0,0
111070,stage,1,1
111071,III,1,0
111072,gastric,1,1
111073,cancer,1,1
111074,patients,1,1
111075,.,1,1
111076,Patients,0,1
111077,were,0,0
111078,randomly,0,1
111079,assigned,0,0
111080,to,0,0
111081,receive,0,0
111082,either,0,0
111083,3,0,0
111084,g,0,0
111085,PSK,0,0
111086,plus,0,0
111087,300,0,0
111088,mg,0,0
111089,UFT,0,0
111090,(,0,0
111091,PSK,0,0
111092,group,0,0
111093,),0,0
111094,or,0,0
111095,300,0,0
111096,mg,0,0
111097,UFT,0,0
111098,alone,0,0
111099,(,0,0
111100,control,0,0
111101,),0,0
111102,orally,0,0
111103,each,0,0
111104,day,0,0
111105,for,0,0
111106,at,0,0
111107,least,0,0
111108,1,0,0
111109,year,0,0
111110,following,0,0
111111,their,0,0
111112,operation,0,0
111113,.,0,0
111114,RESULTS,0,0
111115,Twenty-one,1,1
111116,registered,1,0
111117,patients,1,1
111118,with,1,1
111119,stage,1,1
111120,III,1,0
111121,gastric,1,1
111122,cancer,1,1
111123,were,0,0
111124,analyzed,0,0
111125,.,0,0
111126,The,0,0
111127,3-year,0,0
111128,overall,0,0
111129,survival,0,0
111130,was,0,0
111131,62.2,0,0
111132,%,0,0
111133,in,0,0
111134,the,0,0
111135,PSK,0,0
111136,group,0,0
111137,(,0,0
111138,n,0,1
111139,=,0,0
111140,10,0,1
111141,),0,0
111142,and,0,0
111143,12.5,0,0
111144,%,0,0
111145,in,0,0
111146,the,0,0
111147,control,0,0
111148,group,0,0
111149,(,0,0
111150,n,0,1
111151,=,0,0
111152,11,0,1
111153,),0,0
111154,(,0,0
111155,P,0,0
111156,=,0,0
111157,0.038,0,0
111158,),0,0
111159,.,0,0
111160,Before,0,0
111161,operation,0,0
111162,",",0,0
111163,there,0,0
111164,were,0,0
111165,no,0,0
111166,significant,0,0
111167,differences,0,0
111168,in,0,0
111169,the,0,0
111170,proportions,0,0
111171,of,0,0
111172,Th1,0,0
111173,cells,0,0
111174,",",0,0
111175,Th2,0,0
111176,cells,0,0
111177,",",0,0
111178,Th1/Th2,0,0
111179,ratio,0,0
111180,",",0,0
111181,CD56,0,0
111182,(,0,0
111183,+,0,0
111184,),0,0
111185,T,0,0
111186,cells,0,0
111187,",",0,0
111188,CD57,0,0
111189,(,0,0
111190,+,0,0
111191,),0,0
111192,T,0,0
111193,cells,0,0
111194,",",0,0
111195,NK,0,0
111196,cells,0,0
111197,",",0,0
111198,and,0,0
111199,CD4,0,1
111200,(,0,0
111201,+,0,0
111202,),0,0
111203,CD25,0,0
111204,(,0,0
111205,+,0,0
111206,),0,0
111207,T,0,0
111208,cells,0,0
111209,between,0,0
111210,PSK,0,1
111211,and,0,0
111212,control,0,0
111213,groups,0,0
111214,.,0,0
111215,However,0,0
111216,",",0,0
111217,after,0,0
111218,operation,0,0
111219,",",0,0
111220,CD57,0,0
111221,(,0,0
111222,+,0,0
111223,),0,0
111224,T,0,0
111225,cells,0,0
111226,decreased,0,0
111227,significantly,0,0
111228,in,0,0
111229,the,0,0
111230,PSK,0,0
111231,group,0,0
111232,compared,0,0
111233,to,0,0
111234,the,0,0
111235,control,0,0
111236,(,0,0
111237,P,0,0
111238,=,0,0
111239,0.0486,0,0
111240,),0,0
111241,.,0,0
111242,When,0,0
111243,all,0,0
111244,patients,0,0
111245,were,0,0
111246,analyzed,0,0
111247,",",0,0
111248,patients,0,1
111249,with,0,1
111250,increased,0,0
111251,proportion,0,0
111252,(,0,0
111253,>,0,0
111254,18,0,1
111255,%,0,0
111256,),0,0
111257,of,0,0
111258,CD57,0,0
111259,(,0,0
111260,+,0,0
111261,),0,0
111262,T,0,0
111263,cells,0,0
111264,showed,0,0
111265,worse,0,0
111266,survival,0,0
111267,than,0,0
111268,those,0,0
111269,with,0,0
111270,lower,0,0
111271,(,0,0
111272,<,0,0
111273,or,0,0
111274,=,0,0
111275,18,0,1
111276,%,0,0
111277,),0,0
111278,CD57,0,0
111279,(,0,0
111280,+,0,0
111281,),0,0
111282,T,0,0
111283,cells,0,0
111284,(,0,0
111285,3-year,0,0
111286,survival,0,0
111287,",",0,0
111288,25.0,0,0
111289,and,0,0
111290,45.7,0,0
111291,%,0,0
111292,",",0,0
111293,respectively,0,0
111294,;,0,0
111295,P,0,0
111296,=,0,0
111297,0.046,0,0
111298,),0,0
111299,",",0,0
111300,consistent,0,0
111301,with,0,1
111302,our,0,0
111303,previous,0,0
111304,report,0,0
111305,that,0,0
111306,high,0,0
111307,CD57,0,0
111308,(,0,0
111309,+,0,0
111310,),0,0
111311,is,0,0
111312,an,0,0
111313,indicator,0,0
111314,of,0,0
111315,poor,0,0
111316,prognosis,0,1
111317,in,0,0
111318,patients,0,1
111319,with,0,1
111320,advanced,0,1
111321,gastric,0,1
111322,cancer,0,1
111323,.,0,0
111324,However,0,0
111325,",",0,0
111326,in,0,0
111327,the,0,0
111328,group,0,0
111329,treated,0,0
111330,with,0,1
111331,PSK,0,1
111332,+,0,0
111333,UFT,0,0
111334,",",0,0
111335,3-year,0,0
111336,survival,0,0
111337,of,0,0
111338,CD57-high,0,0
111339,patients,0,1
111340,was,0,0
111341,as,0,0
111342,great,0,0
111343,as,0,0
111344,that,0,0
111345,of,0,0
111346,CD57-low,0,0
111347,patients,0,1
111348,(,0,0
111349,66.7,0,0
111350,and,0,0
111351,51.4,0,0
111352,%,0,0
111353,",",0,0
111354,respectively,0,0
111355,;,0,0
111356,P,0,0
111357,=,0,0
111358,0.67,0,0
111359,),0,0
111360,.,0,0
111361,CONCLUSION,0,0
111362,The,0,0
111363,present,0,0
111364,findings,0,0
111365,suggest,0,0
111366,that,0,0
111367,PSK,0,0
111368,improves,0,0
111369,overall,0,0
111370,survival,0,0
111371,of,0,0
111372,stage,1,1
111373,III,1,0
111374,gastric,1,1
111375,cancer,1,1
111376,patients,1,1
111377,partly,0,0
111378,by,0,0
111379,inhibiting,0,0
111380,CD57,0,0
111381,(,0,0
111382,+,0,0
111383,),0,0
111384,T,0,0
111385,cells,0,0
111386,",",0,0
111387,a,0,0
111388,proven,0,0
111389,poor,0,1
111390,prognostic,0,0
111391,factor,0,0
111392,in,0,0
111393,advanced,0,1
111394,gastric,0,1
111395,cancer,0,1
111396,.,0,0
111397,Aminocaproic,0,0
111398,acid,0,0
111399,versus,0,0
111400,prednisone,0,0
111401,for,0,0
111402,the,0,0
111403,treatment,0,0
111404,of,0,0
111405,traumatic,1,0
111406,hyphema,1,1
111407,.,1,0
111408,A,0,0
111409,randomized,0,0
111410,clinical,0,0
111411,trial,0,0
111412,.,0,0
111413,One,1,0
111414,hundred,1,1
111415,twelve,1,1
111416,patients,1,1
111417,who,1,1
111418,sustained,1,1
111419,hyphema,1,1
111420,after,1,0
111421,blunt,1,1
111422,trauma,1,1
111423,were,1,0
111424,enrolled,1,1
111425,in,0,0
111426,a,0,0
111427,double-blind,0,0
111428,randomized,0,0
111429,clinical,0,0
111430,trial,0,0
111431,to,0,0
111432,determine,0,0
111433,the,0,0
111434,relative,0,0
111435,efficacies,0,0
111436,of,0,0
111437,aminocaproic,0,0
111438,acid,0,0
111439,(,0,0
111440,Amicar,0,0
111441,),0,0
111442,and,0,0
111443,systemic,0,0
111444,prednisone,0,0
111445,for,0,0
111446,reducing,0,0
111447,the,0,0
111448,rate,0,0
111449,of,0,0
111450,secondary,0,0
111451,hemorrhage,0,1
111452,.,0,0
111453,Fifty-six,0,1
111454,patients,0,1
111455,received,0,0
111456,an,0,0
111457,oral,0,0
111458,dosage,0,0
111459,of,0,0
111460,50,0,0
111461,mg/kg,0,0
111462,of,0,0
111463,aminocaproic,0,0
111464,acid,0,0
111465,every,0,0
111466,4,0,0
111467,hours,0,0
111468,for,0,0
111469,5,0,0
111470,days,0,0
111471,",",0,0
111472,up,0,0
111473,to,0,0
111474,a,0,0
111475,maximum,0,0
111476,of,0,0
111477,30,0,0
111478,g,0,0
111479,daily,0,0
111480,",",0,0
111481,and,0,0
111482,56,0,0
111483,patients,0,1
111484,received,0,0
111485,an,0,0
111486,oral,0,0
111487,dosage,0,0
111488,of,0,0
111489,40,0,0
111490,mg,0,0
111491,of,0,0
111492,prednisone,0,0
111493,daily,0,0
111494,(,0,0
111495,adjusted,0,0
111496,for,0,0
111497,weight,0,0
111498,),0,0
111499,in,0,0
111500,two,0,0
111501,divided,0,1
111502,doses,0,0
111503,.,0,1
111504,Placebo,0,0
111505,pills,0,0
111506,and,0,0
111507,liquids,0,0
111508,were,0,0
111509,given,0,0
111510,to,0,0
111511,each,0,0
111512,patient,0,0
111513,to,0,0
111514,mask,0,0
111515,the,0,0
111516,treatment,0,0
111517,schedules,0,0
111518,.,0,0
111519,There,0,0
111520,were,0,0
111521,no,0,0
111522,statistically,0,0
111523,significant,0,0
111524,differences,0,0
111525,between,0,0
111526,the,0,0
111527,patient,0,0
111528,populations,0,0
111529,for,0,0
111530,any,0,0
111531,demographic,0,0
111532,or,0,0
111533,clinical,0,0
111534,characteristic,0,0
111535,(,0,0
111536,e.g.,0,0
111537,",",0,0
111538,visual,0,0
111539,acuity,0,0
111540,",",0,0
111541,intraocular,0,0
111542,pressure,0,0
111543,[,0,0
111544,IOP,0,0
111545,],0,0
111546,",",0,0
111547,initial,0,0
111548,hyphema,0,1
111549,size,0,0
111550,),0,0
111551,measured,0,0
111552,in,0,0
111553,the,0,0
111554,study,0,0
111555,.,0,0
111556,Blacks,1,0
111557,comprised,1,1
111558,53,1,1
111559,%,1,0
111560,of,1,0
111561,the,1,0
111562,study,1,0
111563,population,1,0
111564,",",1,0
111565,and,1,0
111566,the,1,0
111567,mean,1,0
111568,age,1,1
111569,of,1,0
111570,the,1,0
111571,patients,1,1
111572,was,1,0
111573,23.5,1,0
111574,years,1,1
111575,.,1,1
111576,Four,0,0
111577,patients,0,1
111578,in,0,0
111579,each,0,0
111580,of,0,0
111581,the,0,0
111582,treatment,0,0
111583,groups,0,0
111584,experienced,0,0
111585,a,0,0
111586,secondary,0,0
111587,hemorrhage,0,0
111588,;,0,0
111589,the,0,0
111590,rebleed,0,0
111591,rate,0,0
111592,was,0,0
111593,7.1,0,0
111594,%,0,0
111595,in,0,0
111596,each,0,0
111597,group,0,0
111598,.,0,0
111599,Effects,0,0
111600,of,0,0
111601,early,0,1
111602,enteral,0,0
111603,feeding,0,0
111604,on,0,0
111605,fecal,0,1
111606,elastase,0,0
111607,1,0,0
111608,and,0,0
111609,plasma,0,0
111610,secretin,0,0
111611,.,0,0
111612,BACKGROUND,0,0
111613,Enteral,0,0
111614,feeding,0,0
111615,is,0,0
111616,known,0,0
111617,to,0,0
111618,be,0,0
111619,effective,0,0
111620,on,0,0
111621,the,0,0
111622,development,0,0
111623,of,0,0
111624,gut,0,0
111625,hormone,0,0
111626,secretion,0,0
111627,and,0,0
111628,pancreatic,0,1
111629,exocrine,0,1
111630,function,0,0
111631,.,0,0
111632,The,0,0
111633,aim,0,0
111634,of,0,0
111635,the,0,0
111636,present,0,0
111637,study,0,0
111638,was,0,0
111639,to,0,0
111640,examine,0,0
111641,the,0,0
111642,effects,0,0
111643,of,0,0
111644,extremely,0,0
111645,early,0,0
111646,enteral,0,0
111647,feedings,0,0
111648,on,0,0
111649,the,0,0
111650,development,0,0
111651,in,0,0
111652,very,1,0
111653,low-birthweight,1,1
111654,(,1,0
111655,VLBW,1,1
111656,),1,0
111657,infants,1,1
111658,.,1,1
111659,METHODS,0,0
111660,Fecal,0,0
111661,elastase,0,0
111662,1,0,0
111663,and,0,0
111664,plasma,0,0
111665,secretin,0,0
111666,concentrations,0,0
111667,were,0,0
111668,measured,0,0
111669,at,0,0
111670,four,0,0
111671,different,0,0
111672,periods,0,0
111673,during,0,0
111674,the,0,0
111675,first,0,0
111676,28,0,0
111677,days,0,0
111678,of,0,0
111679,life,0,0
111680,in,0,0
111681,VLBW,1,1
111682,infants,1,1
111683,",",0,0
111684,with,0,1
111685,extremely,0,0
111686,early,0,0
111687,enteral,0,0
111688,feeding,0,0
111689,starting,0,0
111690,within,0,0
111691,24,0,0
111692,h,0,0
111693,of,0,0
111694,birth,0,1
111695,",",0,0
111696,as,0,0
111697,well,0,0
111698,as,0,0
111699,in,0,0
111700,control,0,1
111701,infants,0,1
111702,.,0,1
111703,RESULTS,0,0
111704,Fecal,0,0
111705,concentrations,0,0
111706,of,0,0
111707,elastase,0,0
111708,1,0,0
111709,at,0,0
111710,7,0,0
111711,",",0,0
111712,14,0,0
111713,and,0,0
111714,28,0,1
111715,days,0,0
111716,after,0,0
111717,birth,0,1
111718,were,0,0
111719,significantly,0,0
111720,higher,0,0
111721,than,0,0
111722,those,0,0
111723,at,0,0
111724,1,0,0
111725,or,0,1
111726,2,0,0
111727,days,0,0
111728,in,0,0
111729,both,0,0
111730,the,0,0
111731,early,0,0
111732,feeding,0,0
111733,and,0,0
111734,control,0,0
111735,groups,0,0
111736,.,0,0
111737,Fecal,0,0
111738,elastase,0,0
111739,1,0,0
111740,levels,0,0
111741,in,0,0
111742,the,0,0
111743,early,0,0
111744,feeding,0,0
111745,group,0,0
111746,were,0,0
111747,significantly,0,0
111748,higher,0,0
111749,than,0,0
111750,those,0,0
111751,in,0,0
111752,the,0,0
111753,control,0,0
111754,group,0,0
111755,at,0,0
111756,7,0,0
111757,and,0,0
111758,14,0,0
111759,days,0,0
111760,after,0,0
111761,birth,0,1
111762,.,0,0
111763,The,0,0
111764,plasma,0,0
111765,concentration,0,0
111766,of,0,0
111767,secretin,0,0
111768,at,0,0
111769,14,0,0
111770,days,0,0
111771,after,0,0
111772,birth,0,1
111773,was,0,0
111774,significantly,0,0
111775,higher,0,0
111776,than,0,0
111777,that,0,0
111778,at,0,0
111779,1,0,0
111780,or,0,1
111781,2,0,0
111782,days,0,0
111783,and,0,0
111784,7,0,0
111785,days,0,0
111786,after,0,0
111787,birth,0,1
111788,in,0,0
111789,the,0,0
111790,early,0,0
111791,feeding,0,0
111792,group,0,0
111793,.,0,0
111794,No,0,0
111795,significant,0,0
111796,differences,0,0
111797,in,0,0
111798,plasma,0,0
111799,secretin,0,0
111800,levels,0,0
111801,were,0,0
111802,detected,0,0
111803,between,0,0
111804,the,0,0
111805,early,0,0
111806,feeding,0,0
111807,and,0,0
111808,control,0,0
111809,groups,0,0
111810,at,0,0
111811,1,0,0
111812,or,0,1
111813,2,0,0
111814,days,0,0
111815,",",0,0
111816,7,0,0
111817,days,0,0
111818,and,0,0
111819,28,0,1
111820,days,0,0
111821,after,0,0
111822,birth,0,1
111823,",",0,0
111824,but,0,0
111825,a,0,0
111826,significant,0,0
111827,difference,0,0
111828,in,0,0
111829,secretin,0,0
111830,level,0,0
111831,was,0,0
111832,observed,0,0
111833,between,0,0
111834,the,0,0
111835,two,0,0
111836,groups,0,0
111837,at,0,0
111838,14,0,1
111839,days,0,0
111840,after,0,0
111841,birth,0,1
111842,.,0,0
111843,CONCLUSIONS,0,0
111844,Extremely,0,0
111845,early,0,0
111846,enteral,0,0
111847,feedings,0,0
111848,may,0,0
111849,play,0,0
111850,an,0,0
111851,important,0,0
111852,role,0,0
111853,in,0,0
111854,the,0,0
111855,development,0,0
111856,of,0,0
111857,pancreatic,0,1
111858,exocrine,0,1
111859,function,0,0
111860,and,0,0
111861,secretin,0,0
111862,secretion,0,0
111863,in,0,0
111864,the,0,0
111865,early,0,0
111866,period,0,0
111867,of,0,0
111868,life,0,0
111869,in,0,0
111870,VLBW,1,1
111871,infants,1,1
111872,.,1,1
111873,Metformin,0,0
111874,",",0,0
111875,naltrexone,0,0
111876,",",0,0
111877,or,0,0
111878,the,0,0
111879,combination,0,0
111880,of,0,0
111881,prednisolone,0,0
111882,and,0,0
111883,antiandrogenic,0,0
111884,oral,0,0
111885,contraceptives,0,0
111886,as,0,0
111887,first-line,0,0
111888,therapy,0,0
111889,in,0,0
111890,hyperinsulinemic,1,1
111891,women,1,1
111892,with,1,1
111893,polycystic,1,1
111894,ovary,1,1
111895,syndrome,1,1
111896,.,1,0
111897,To,0,0
111898,compare,0,0
111899,the,0,0
111900,short-term,0,0
111901,effects,0,0
111902,of,0,0
111903,metformin,0,0
111904,(,0,0
111905,M,0,0
111906,),0,0
111907,",",0,0
111908,naltrexone,0,0
111909,(,0,0
111910,N,0,1
111911,),0,0
111912,",",0,0
111913,and,0,0
111914,a,0,0
111915,combination,0,0
111916,of,0,0
111917,OC,0,0
111918,and,0,0
111919,prednisolone,0,0
111920,(,0,0
111921,OC/Pr,0,0
111922,),0,0
111923,on,0,0
111924,the,0,0
111925,metabolic,0,0
111926,state,0,0
111927,and,0,0
111928,the,0,0
111929,ovarian,0,0
111930,function,0,0
111931,of,0,0
111932,PCOS,1,0
111933,women,1,1
111934,",",0,0
111935,we,0,0
111936,randomized,0,0
111937,29,1,1
111938,women,1,1
111939,to,0,0
111940,a,0,0
111941,3-month,0,0
111942,course,0,0
111943,of,0,0
111944,therapy,0,0
111945,.,0,0
111946,We,0,0
111947,observed,0,0
111948,significant,0,0
111949,improvements,0,0
111950,in,0,0
111951,hyperandrogenemia,0,1
111952,and,0,0
111953,ovulation,0,0
111954,rates,0,0
111955,in,0,0
111956,PCOS,1,0
111957,women,1,1
111958,of,0,0
111959,all,0,0
111960,three,0,0
111961,groups,0,0
111962,",",0,0
111963,in,0,0
111964,the,0,0
111965,absence,0,0
111966,of,0,0
111967,changes,0,0
111968,in,0,0
111969,the,0,0
111970,metabolic,0,0
111971,state,0,0
111972,",",0,0
111973,suggesting,0,0
111974,that,0,0
111975,insulin,0,0
111976,resistance,0,0
111977,in,0,0
111978,PCOS,1,0
111979,patients,1,1
111980,is,0,0
111981,only,0,0
111982,one,0,0
111983,of,0,0
111984,several,0,0
111985,factors,0,0
111986,leading,0,0
111987,to,0,0
111988,hyperandrogenemic,0,1
111989,ovarian,0,1
111990,failure,0,1
111991,.,0,0
111992,Teriparatide,0,0
111993,improves,0,0
111994,early,0,0
111995,callus,0,0
111996,formation,0,0
111997,in,0,0
111998,distal,1,0
111999,radial,1,1
112000,fractures,1,1
112001,.,1,1
112002,BACKGROUND,0,0
112003,Teriparatide,0,0
112004,(,0,0
112005,parathyreoid,0,1
112006,hormone,0,0
112007,;,0,0
112008,PTH,0,0
112009,1-34,0,0
112010,),0,0
112011,increases,0,0
112012,skeletal,0,0
112013,mass,0,0
112014,in,0,0
112015,humans,0,0
112016,and,0,0
112017,improves,0,0
112018,fracture,0,0
112019,healing,0,0
112020,in,0,0
112021,animals,0,0
112022,.,0,0
112023,A,0,0
112024,recent,0,0
112025,randomized,0,0
112026,multicenter,0,0
112027,trial,0,0
112028,of,0,0
112029,nonoperated,1,1
112030,distal,1,1
112031,radial,1,0
112032,fractures,1,1
112033,showed,0,0
112034,a,0,0
112035,moderate,0,1
112036,shortening,0,0
112037,of,0,0
112038,the,0,0
112039,time,0,0
112040,to,0,0
112041,restoration,0,0
112042,of,0,0
112043,cortical,0,0
112044,continuity,0,0
112045,by,0,0
112046,treatment,0,0
112047,with,0,1
112048,20,0,1
112049,microg,0,0
112050,(,0,0
112051,low-dose,0,0
112052,),0,0
112053,teriparatide,0,0
112054,per,0,0
112055,day,0,0
112056,",",0,0
112057,but,0,0
112058,not,0,0
112059,with,0,1
112060,40,0,0
112061,microg,0,0
112062,(,0,0
112063,high-dose,0,0
112064,),0,0
112065,.,0,0
112066,As,0,0
112067,radiographic,0,0
112068,cortical,0,0
112069,continuity,0,0
112070,appears,0,0
112071,late,0,0
112072,in,0,0
112073,the,0,0
112074,healing,0,0
112075,process,0,0
112076,",",0,0
112077,perhaps,0,0
112078,too,0,0
112079,late,0,0
112080,for,0,0
112081,clinical,0,0
112082,relevance,0,0
112083,",",0,0
112084,we,0,0
112085,studied,0,0
112086,the,0,0
112087,qualitative,0,0
112088,appearance,0,0
112089,of,0,0
112090,the,0,0
112091,callus,0,0
112092,5,0,0
112093,weeks,0,0
112094,after,0,0
112095,fracture,0,1
112096,.,0,0
112097,METHODS,0,0
112098,One,1,0
112099,third,1,0
112100,of,1,0
112101,the,1,0
112102,patients,1,1
112103,of,1,0
112104,the,1,0
112105,international,1,0
112106,trial,1,0
112107,were,1,0
112108,treated,1,0
112109,at,1,0
112110,Link?ping,1,0
112111,University,1,1
112112,Hospital,1,1
112113,.,1,0
112114,The,0,0
112115,multicenter,0,0
112116,trial,0,0
112117,did,0,0
112118,not,0,0
112119,evaluate,0,0
112120,early,0,0
112121,callus,0,0
112122,formation,0,0
112123,.,0,0
112124,We,0,0
112125,therefore,0,0
112126,made,0,0
112127,a,0,0
112128,blinded,0,0
112129,qualitative,0,0
112130,scoring,0,0
112131,of,0,0
112132,the,0,0
112133,callus,0,0
112134,at,0,0
112135,5,0,0
112136,weeks,0,0
112137,in,0,0
112138,our,1,1
112139,27,1,1
112140,patients,1,1
112141,.,1,1
112142,Callus,0,0
112143,formation,0,0
112144,was,0,0
112145,arbitrarily,0,0
112146,classified,0,1
112147,as,0,0
112148,rich,0,0
112149,",",0,0
112150,intermediate,0,0
112151,",",0,0
112152,or,0,0
112153,poor,0,1
112154,.,0,0
112155,RESULTS,0,0
112156,9,0,0
112157,patients,0,1
112158,were,0,0
112159,classified,0,1
112160,as,0,0
112161,rich,0,0
112162,(,0,0
112163,none,0,0
112164,had,0,0
112165,received,0,0
112166,placebo,0,0
112167,",",0,0
112168,3,0,0
112169,low-dose,0,0
112170,teriparatide,0,0
112171,",",0,0
112172,and,0,0
112173,6,0,0
112174,high-dose,0,0
112175,teriparatide,0,0
112176,),0,0
112177,.,0,0
112178,9,0,0
112179,patients,0,1
112180,were,0,0
112181,classified,0,1
112182,as,0,0
112183,intermediate,0,0
112184,(,0,0
112185,1,0,0
112186,had,0,0
112187,received,0,0
112188,placebo,0,0
112189,",",0,0
112190,5,0,0
112191,low-dose,0,0
112192,",",0,0
112193,and,0,0
112194,3,0,0
112195,high-dose,0,0
112196,),0,0
112197,.,0,0
112198,9,0,0
112199,patients,0,1
112200,were,0,0
112201,classified,0,1
112202,as,0,0
112203,poor,0,1
112204,(,0,0
112205,7,0,0
112206,had,0,0
112207,received,0,0
112208,placebo,0,0
112209,",",0,0
112210,1,0,0
112211,low-dose,0,0
112212,",",0,0
112213,and,0,0
112214,1,0,0
112215,high-dose,0,0
112216,),0,0
112217,(,0,0
112218,p,0,0
112219,<,0,0
112220,0.001,0,0
112221,),0,0
112222,.,0,0
112223,INTERPRETATION,0,0
112224,This,0,0
112225,is,0,0
112226,a,0,0
112227,post,0,0
112228,hoc,0,0
112229,subgroup,0,0
112230,analysis,0,0
112231,of,0,0
112232,an,0,0
112233,outcome,0,0
112234,variable,0,0
112235,",",0,0
112236,which,0,0
112237,was,0,0
112238,not,0,0
112239,in,0,0
112240,the,0,0
112241,official,0,0
112242,protocol,0,0
112243,.,0,0
112244,The,0,0
112245,results,0,0
112246,must,0,0
112247,therefore,0,0
112248,be,0,0
112249,interpreted,0,0
112250,with,0,0
112251,caution,0,0
112252,.,0,0
112253,However,0,0
112254,",",0,0
112255,in,0,0
112256,combination,0,0
112257,with,0,1
112258,the,0,0
112259,results,0,0
112260,of,0,0
112261,the,0,0
112262,larger,0,0
112263,trial,0,0
112264,",",0,0
112265,the,0,0
112266,data,0,0
112267,suggest,0,0
112268,that,0,0
112269,radiographic,0,0
112270,quality,0,0
112271,at,0,0
112272,an,0,0
112273,early,0,0
112274,time,0,0
112275,point,0,0
112276,might,0,0
112277,be,0,0
112278,a,0,0
112279,sensitive,0,0
112280,variable,0,0
112281,",",0,0
112282,perhaps,0,0
112283,better,0,0
112284,than,0,0
112285,time,0,0
112286,to,0,0
112287,cortical,0,0
112288,continuity,0,0
112289,.,0,0
112290,Moreover,0,0
112291,",",0,0
112292,teriparatide,0,0
112293,appeared,0,0
112294,to,0,0
112295,improve,0,0
112296,early,0,0
112297,callus,0,0
112298,formation,0,0
112299,in,1,0
112300,distal,1,0
112301,radial,1,1
112302,fractures,1,1
112303,.,1,1
112304,Effects,0,0
112305,of,0,0
112306,10,0,1
112307,Hz,0,0
112308,repetitive,0,0
112309,transcranial,0,0
112310,magnetic,0,0
112311,stimulation,0,0
112312,(,0,0
112313,rTMS,0,0
112314,),0,0
112315,on,0,0
112316,clinical,0,0
112317,global,0,0
112318,impression,0,0
112319,in,0,0
112320,chronic,1,1
112321,schizophrenia,1,1
112322,.,1,0
112323,UNLABELLED,0,0
112324,We,0,0
112325,conducted,0,0
112326,a,0,0
112327,randomized,0,0
112328,",",0,0
112329,sham-controlled,0,0
112330,repetitive,0,0
112331,transcranial,0,0
112332,magnetic,0,0
112333,stimulation,0,0
112334,(,0,0
112335,rTMS,0,0
112336,),0,0
112337,study,0,0
112338,in,0,0
112339,chronic,1,1
112340,schizophrenia,1,1
112341,in-patients,1,1
112342,(,1,0
112343,n=35,1,1
112344,),1,0
112345,to,0,0
112346,evaluate,0,0
112347,the,0,0
112348,therapeutic,0,0
112349,efficacy,0,0
112350,of,0,0
112351,10,0,0
112352,Hz,0,0
112353,stimulation,0,0
112354,.,0,0
112355,Patients,1,1
112356,",",0,0
112357,who,0,1
112358,were,0,1
112359,on,0,1
112360,stable,1,1
112361,antipsychotic,1,0
112362,treatment,1,0
112363,",",0,0
112364,were,0,0
112365,randomly,0,0
112366,assigned,0,0
112367,to,0,0
112368,the,0,0
112369,active,0,0
112370,or,0,0
112371,sham,0,0
112372,condition,0,0
112373,.,0,0
112374,In,0,0
112375,the,0,0
112376,active,0,0
112377,rTMS,0,0
112378,group,0,0
112379,",",0,0
112380,ten,0,1
112381,sessions,0,0
112382,with,0,1
112383,a,0,0
112384,total,0,1
112385,of,0,0
112386,"10,000",0,0
112387,stimuli,0,0
112388,were,0,0
112389,applied,0,0
112390,over,0,0
112391,the,0,0
112392,left,0,1
112393,dorsolateral,0,0
112394,prefrontal,0,0
112395,cortex,0,0
112396,at,0,0
112397,110,0,1
112398,%,0,0
112399,of,0,0
112400,motor,0,0
112401,threshold,0,0
112402,.,0,0
112403,The,0,0
112404,sham,0,0
112405,group,0,0
112406,received,0,0
112407,corresponding,0,0
112408,sham,0,0
112409,stimulation,0,0
112410,.,0,0
112411,Clinical,0,0
112412,improvement,0,0
112413,was,0,0
112414,measured,0,0
112415,by,0,0
112416,the,0,0
112417,Clinical,0,0
112418,Global,0,0
112419,Impression,0,0
112420,scale,0,0
112421,(,0,0
112422,primary,0,0
112423,outcome,0,0
112424,measure,0,0
112425,),0,0
112426,",",0,0
112427,the,0,0
112428,Global,0,0
112429,Assessment,0,0
112430,of,0,0
112431,Functioning,0,0
112432,Scale,0,0
112433,(,0,0
112434,GAF,0,0
112435,),0,0
112436,and,0,0
112437,the,0,0
112438,Positive,0,0
112439,and,0,0
112440,Negative,0,0
112441,Symptom,0,0
112442,Scale,0,0
112443,(,0,0
112444,PANSS,0,0
112445,;,0,0
112446,secondary,0,0
112447,outcome,0,0
112448,measures,0,0
112449,),0,0
112450,.,0,1
112451,Between-group,0,0
112452,comparisons,0,0
112453,revealed,0,0
112454,no,0,0
112455,significant,0,0
112456,differences,0,0
112457,in,0,0
112458,clinical,0,0
112459,outcome,0,0
112460,variables,0,0
112461,.,0,0
112462,Only,0,0
112463,a,0,0
112464,subgroup,0,0
112465,of,0,0
112466,patients,0,1
112467,with,0,1
112468,pronounced,0,0
112469,negative,0,0
112470,symptoms,0,0
112471,developed,0,0
112472,some,0,0
112473,clinical,0,0
112474,improvement,0,0
112475,as,0,0
112476,indicated,0,0
112477,by,0,0
112478,significant,0,0
112479,changes,0,0
112480,in,0,0
112481,the,0,0
112482,GAF-scale,0,0
112483,.,0,0
112484,Besides,0,0
112485,there,0,0
112486,is,0,0
112487,some,0,0
112488,evidence,0,0
112489,for,0,0
112490,a,0,0
112491,more,0,0
112492,favourable,0,0
112493,clinical,0,0
112494,outcome,0,0
112495,within,0,0
112496,this,0,0
112497,subgroup,0,0
112498,after,0,0
112499,rTMS,0,0
112500,in,0,0
112501,the,0,0
112502,CGI-S,0,0
112503,and,0,0
112504,PANSS,0,0
112505,negative,0,0
112506,scale,0,0
112507,",",0,0
112508,too,0,0
112509,.,0,0
112510,In,0,0
112511,line,0,0
112512,with,0,1
112513,earlier,0,0
112514,investigations,0,0
112515,",",0,0
112516,our,0,0
112517,results,0,0
112518,suggest,0,0
112519,a,0,0
112520,moderate,0,1
112521,-,0,0
112522,potentially,0,0
112523,clinically,0,0
112524,relevant,0,0
112525,-,0,0
112526,treatment,0,0
112527,effect,0,0
112528,of,0,0
112529,prefrontal,0,0
112530,10,0,1
112531,Hz,0,0
112532,rTMS,0,0
112533,stimulation,0,0
112534,in,0,0
112535,chronic,1,1
112536,patients,1,1
112537,.,1,0
112538,However,0,0
112539,",",0,0
112540,in,0,0
112541,our,0,0
112542,study,0,0
112543,this,0,0
112544,beneficial,0,0
112545,effect,0,0
112546,was,0,0
112547,restricted,0,0
112548,to,0,0
112549,subjects,0,1
112550,with,0,1
112551,pronounced,0,0
112552,negative,0,0
112553,symptoms,0,0
112554,.,0,1
112555,CLINICAL,0,0
112556,TRIAL,0,0
112557,REGISTRATION,0,0
112558,INFORMATION,0,0
112559,ClinicalTrial.gov,0,0
112560,Identifier,0,0
112561,:,0,1
112562,NCT00169689,0,0
112563,",",0,0
112564,http,0,0
112565,:,0,1
112566,//www.clinicaltrials.gov,0,0
112567,.,0,0
112568,The,0,0
112569,ScanBrit,0,0
112570,randomised,0,0
112571,",",0,0
112572,controlled,0,0
112573,",",0,0
112574,single-blind,0,0
112575,study,0,0
112576,of,0,0
112577,a,0,0
112578,gluten-,0,0
112579,and,0,0
112580,casein-free,0,0
112581,dietary,0,0
112582,intervention,0,0
112583,for,0,0
112584,children,1,1
112585,with,1,1
112586,autism,1,1
112587,spectrum,1,1
112588,disorders,1,1
112589,.,1,0
112590,There,0,0
112591,is,0,0
112592,increasing,0,0
112593,interest,0,0
112594,in,0,0
112595,the,0,0
112596,use,0,0
112597,of,0,0
112598,gluten-,0,0
112599,and,0,0
112600,casein-free,0,0
112601,diets,0,0
112602,for,0,0
112603,children,1,1
112604,with,1,1
112605,autism,1,1
112606,spectrum,1,1
112607,disorders,1,1
112608,(,1,0
112609,ASDs,1,0
112610,),1,0
112611,.,1,0
112612,We,0,0
112613,report,0,0
112614,results,0,0
112615,from,0,0
112616,a,0,0
112617,two-stage,0,0
112618,",",0,0
112619,24-month,0,0
112620,",",0,0
112621,randomised,0,0
112622,",",0,0
112623,controlled,0,0
112624,trial,0,0
112625,incorporating,0,0
112626,an,0,0
112627,adaptive,0,0
112628,'catch-up,0,1
112629,',0,0
112630,design,0,0
112631,and,0,0
112632,interim,0,0
112633,analysis,0,0
112634,.,0,0
112635,Stage,0,0
112636,1,0,0
112637,of,0,0
112638,the,0,0
112639,trial,0,0
112640,saw,0,0
112641,72,1,0
112642,Danish,1,1
112643,children,1,1
112644,(,1,0
112645,aged,1,1
112646,4,1,0
112647,years,1,1
112648,to,1,1
112649,10,1,1
112650,years,1,1
112651,11,1,1
112652,months,1,1
112653,),1,0
112654,assigned,1,0
112655,to,1,0
112656,diet,1,0
112657,(,1,0
112658,A,1,0
112659,),1,0
112660,or,1,0
112661,non-diet,1,0
112662,(,1,0
112663,B,1,0
112664,),1,0
112665,groups,1,0
112666,by,1,0
112667,stratified,1,1
112668,randomisation,1,0
112669,.,1,0
112670,Autism,0,1
112671,Diagnostic,0,0
112672,Observation,0,0
112673,Schedule,0,0
112674,(,0,0
112675,ADOS,0,0
112676,),0,0
112677,and,0,0
112678,the,0,0
112679,Gilliam,0,1
112680,Autism,0,1
112681,Rating,0,0
112682,Scale,0,0
112683,(,0,0
112684,GARS,0,0
112685,),0,0
112686,were,0,0
112687,used,0,0
112688,to,0,0
112689,assess,0,0
112690,core,0,0
112691,autism,0,1
112692,behaviours,0,0
112693,",",0,0
112694,Vineland,0,1
112695,Adaptive,0,0
112696,Behaviour,0,1
112697,Scales,0,0
112698,(,0,0
112699,VABS,0,0
112700,),0,0
112701,to,0,0
112702,ascertain,0,0
112703,developmental,0,0
112704,level,0,0
112705,",",0,0
112706,and,0,0
112707,Attention-Deficit,0,0
112708,Hyperactivity,0,0
112709,Disorder,0,1
112710,-,0,0
112711,IV,0,0
112712,scale,0,0
112713,(,0,0
112714,ADHD-IV,0,0
112715,),0,0
112716,to,0,0
112717,determine,0,0
112718,inattention,0,0
112719,and,0,0
112720,hyperactivity,0,0
112721,.,0,0
112722,Participants,0,1
112723,were,0,0
112724,tested,0,0
112725,at,0,0
112726,baseline,0,0
112727,",",0,0
112728,8,0,0
112729,",",0,0
112730,and,0,0
112731,12,0,0
112732,months,0,0
112733,.,0,0
112734,Based,0,0
112735,on,0,0
112736,per,0,0
112737,protocol,0,0
112738,repeated,0,0
112739,measures,0,0
112740,analysis,0,0
112741,",",0,0
112742,data,0,0
112743,for,0,0
112744,26,1,1
112745,diet,1,0
112746,children,1,1
112747,and,1,0
112748,29,1,1
112749,controls,1,1
112750,were,0,0
112751,available,0,0
112752,at,0,0
112753,12,0,1
112754,months,0,0
112755,.,0,0
112756,At,0,0
112757,this,0,0
112758,point,0,0
112759,",",0,0
112760,there,0,0
112761,was,0,0
112762,a,0,0
112763,significant,0,0
112764,improvement,0,0
112765,to,0,0
112766,mean,0,0
112767,diet,0,0
112768,group,0,0
112769,scores,0,0
112770,(,0,0
112771,time*treatment,0,0
112772,interaction,0,0
112773,),0,0
112774,on,0,0
112775,sub-domains,0,0
112776,of,0,0
112777,ADOS,0,0
112778,",",0,0
112779,GARS,0,0
112780,and,0,0
112781,ADHD-IV,0,0
112782,measures,0,0
112783,.,0,0
112784,Surpassing,0,0
112785,of,0,0
112786,predefined,0,0
112787,statistical,0,0
112788,thresholds,0,0
112789,as,0,0
112790,evidence,0,0
112791,of,0,0
112792,improvement,0,0
112793,in,0,0
112794,group,0,0
112795,A,0,0
112796,at,0,0
112797,12,0,0
112798,months,0,0
112799,sanctioned,0,0
112800,the,0,0
112801,re-assignment,0,0
112802,of,0,0
112803,group,0,0
112804,B,0,0
112805,participants,0,1
112806,to,0,0
112807,active,0,1
112808,dietary,0,0
112809,treatment,0,0
112810,.,0,0
112811,Stage,0,0
112812,2,0,0
112813,data,0,0
112814,for,0,0
112815,18,0,1
112816,group,0,0
112817,A,0,0
112818,and,0,0
112819,17,0,0
112820,group,0,0
112821,B,0,0
112822,participants,0,1
112823,were,0,0
112824,available,0,0
112825,at,0,0
112826,24,0,0
112827,months,0,0
112828,.,0,1
112829,Multiple,0,0
112830,scenario,0,0
112831,analysis,0,0
112832,based,0,0
112833,on,0,0
112834,inter-,0,0
112835,and,0,0
112836,intra-group,0,0
112837,comparisons,0,0
112838,showed,0,0
112839,some,0,0
112840,evidence,0,0
112841,of,0,0
112842,sustained,0,0
112843,clinical,0,0
112844,group,0,0
112845,improvements,0,0
112846,although,0,0
112847,possibly,0,0
112848,indicative,0,0
112849,of,0,0
112850,a,0,0
112851,plateau,0,0
112852,effect,0,0
112853,for,0,0
112854,intervention,0,0
112855,.,0,0
112856,Our,0,0
112857,results,0,0
112858,suggest,0,0
112859,that,0,0
112860,dietary,0,0
112861,intervention,0,0
112862,may,0,0
112863,positively,0,0
112864,affect,0,0
112865,developmental,0,0
112866,outcome,0,0
112867,for,0,0
112868,some,0,0
112869,children,1,1
112870,diagnosed,1,1
112871,with,1,1
112872,ASD,1,1
112873,.,1,0
112874,In,0,0
112875,the,0,0
112876,absence,0,0
112877,of,0,0
112878,a,0,0
112879,placebo,0,0
112880,condition,0,0
112881,to,0,0
112882,the,0,0
112883,current,0,0
112884,investigation,0,0
112885,",",0,0
112886,we,0,0
112887,are,0,0
112888,",",0,0
112889,however,0,0
112890,",",0,0
112891,unable,0,0
112892,to,0,0
112893,disqualify,0,0
112894,potential,0,0
112895,effects,0,0
112896,derived,0,1
112897,from,0,0
112898,intervention,0,0
112899,outside,0,0
112900,of,0,0
112901,dietary,0,0
112902,changes,0,0
112903,.,0,1
112904,Further,0,0
112905,studies,0,0
112906,are,0,0
112907,required,0,0
112908,to,0,0
112909,ascertain,0,0
112910,potential,0,0
112911,best-,0,0
112912,and,0,0
112913,non-responders,0,0
112914,to,0,0
112915,intervention,0,0
112916,.,0,0
112917,The,0,0
112918,study,0,0
112919,was,0,0
112920,registered,0,0
112921,with,0,0
112922,ClincialTrials.gov,0,0
112923,",",0,0
112924,number,0,0
112925,NCT00614198,0,0
112926,.,0,0
112927,Vinegar,0,0
112928,intake,0,0
112929,enhances,0,0
112930,flow-mediated,1,0
112931,vasodilatation,1,0
112932,via,0,0
112933,upregulation,0,0
112934,of,0,0
112935,endothelial,0,0
112936,nitric,0,0
112937,oxide,0,0
112938,synthase,0,0
112939,activity,0,0
112940,.,0,0
112941,This,0,0
112942,study,0,0
112943,examined,0,0
112944,the,0,0
112945,effect,0,0
112946,of,0,0
112947,acetate,0,0
112948,on,0,0
112949,endothelial,0,0
112950,nitric,0,0
112951,oxide,0,0
112952,synthase,0,0
112953,(,0,0
112954,eNOS,0,0
112955,),0,0
112956,in,0,0
112957,human,0,0
112958,umbilical,0,0
112959,vein,0,1
112960,endothelial,0,0
112961,cells,0,0
112962,(,0,0
112963,HUVECs,0,0
112964,),0,0
112965,by,0,0
112966,immunoblotting,0,0
112967,assay,0,0
112968,and,0,0
112969,the,0,0
112970,ability,0,0
112971,of,0,0
112972,acetic,0,0
112973,acid,0,0
112974,to,0,0
112975,upregulate,0,0
112976,flow-mediated,1,0
112977,vasodilatation,1,0
112978,in,1,0
112979,humans,1,0
112980,.,1,1
112981,In,0,0
112982,HUVECs,0,0
112983,",",0,0
112984,acetate,0,0
112985,induced,0,0
112986,a,0,0
112987,biphasic,0,0
112988,increase,0,0
112989,in,0,0
112990,the,0,0
112991,phosphorylated,0,0
112992,form,0,0
112993,of,0,0
112994,eNOS,0,0
112995,.,0,0
112996,The,0,0
112997,amount,0,0
112998,of,0,0
112999,phosphorylated,0,0
113000,eNOS,0,0
113001,was,0,0
113002,significantly,0,0
113003,increased,0,0
113004,by,0,0
113005,exposure,0,0
113006,to,0,0
113007,200,0,0
113008,mumol/l,0,0
113009,acetate,0,0
113010,for,0,0
113011,20,0,0
113012,min,0,0
113013,(,0,0
113014,early,0,0
113015,phase,0,0
113016,),0,0
113017,and,0,0
113018,for,0,0
113019,4,0,0
113020,h,0,0
113021,(,0,0
113022,late,0,1
113023,phase,0,0
113024,),0,0
113025,.,0,0
113026,The,0,0
113027,inhibitors,0,0
113028,of,0,0
113029,cAMP-dependent,0,0
113030,protein,0,0
113031,kinase,0,0
113032,(,0,0
113033,PKA,0,0
113034,),0,0
113035,and,0,0
113036,AMP-activated,0,0
113037,protein,0,0
113038,kinase,0,0
113039,(,0,0
113040,AMPK,0,0
113041,),0,0
113042,blocked,0,0
113043,acetate-induced,0,0
113044,eNOS,0,0
113045,phosphorylation,0,0
113046,in,0,0
113047,the,0,0
113048,early,0,0
113049,and,0,0
113050,the,0,0
113051,late,0,0
113052,phase,0,0
113053,respectively,0,0
113054,.,0,0
113055,Furthermore,0,0
113056,",",0,0
113057,in,0,0
113058,postmenopausal,1,1
113059,women,1,1
113060,",",0,0
113061,maximum,0,0
113062,forearm,0,0
113063,blood,0,0
113064,flow,0,0
113065,(,0,0
113066,FBF,0,0
113067,),0,0
113068,in,0,0
113069,response,0,0
113070,to,0,0
113071,shear,0,0
113072,stress,0,0
113073,increased,0,0
113074,in,0,0
113075,the,0,0
113076,vinegar,1,0
113077,(,1,0
113078,acetic,1,0
113079,acid,1,0
113080,),1,0
113081,administered,1,0
113082,group,1,0
113083,compared,0,0
113084,to,0,0
113085,the,0,0
113086,placebo,0,0
113087,group,0,0
113088,.,0,0
113089,These,0,0
113090,results,0,0
113091,suggest,0,0
113092,that,0,0
113093,acetic,0,0
113094,acid-induced,0,0
113095,eNOS,0,0
113096,phosphorylation,0,0
113097,contributes,0,0
113098,to,0,0
113099,upregulation,0,0
113100,of,0,0
113101,flow-mediated,0,0
113102,vasodilatation,0,0
113103,in,0,0
113104,humans,0,0
113105,.,0,1
113106,Effects,0,0
113107,of,0,0
113108,a,0,0
113109,leisure,0,0
113110,programme,0,0
113111,on,0,0
113112,quality,0,0
113113,of,0,0
113114,life,0,0
113115,and,0,0
113116,stress,0,0
113117,of,0,0
113118,individuals,1,1
113119,with,1,1
113120,ASD,1,1
113121,.,1,0
113122,BACKGROUND,0,0
113123,Even,0,0
113124,though,0,0
113125,there,0,0
113126,is,0,0
113127,research,0,0
113128,demonstrating,0,0
113129,a,0,0
113130,positive,0,0
113131,relationship,0,0
113132,between,0,0
113133,leisure,0,0
113134,participation,0,0
113135,and,0,0
113136,the,0,0
113137,two,0,0
113138,constructs,0,0
113139,of,0,0
113140,quality,0,0
113141,of,0,0
113142,life,0,0
113143,and,0,0
113144,stress,0,0
113145,reduction,0,0
113146,",",0,0
113147,current,0,0
113148,conceptualisation,0,0
113149,of,0,0
113150,leisure,0,0
113151,as,0,0
113152,a,0,0
113153,contributor,0,0
113154,to,0,0
113155,quality,0,0
113156,of,0,0
113157,life,0,0
113158,is,0,0
113159,limited,0,0
113160,.,0,0
113161,In,0,0
113162,addition,0,0
113163,",",0,0
113164,in,0,0
113165,spite,0,0
113166,of,0,0
113167,improvements,0,0
113168,in,0,0
113169,accurate,0,0
113170,diagnosis,0,1
113171,of,0,0
113172,autism,1,1
113173,spectrum,1,1
113174,disorder,1,1
113175,(,1,0
113176,ASD,1,1
113177,),1,0
113178,at,0,0
113179,increasingly,0,0
113180,earlier,0,0
113181,ages,0,1
113182,and,0,0
113183,proliferation,0,0
113184,of,0,0
113185,interventions,0,0
113186,",",0,0
113187,research,0,0
113188,associated,0,0
113189,with,0,0
113190,leisure,0,0
113191,and,0,0
113192,quality,0,0
113193,of,0,0
113194,life,0,0
113195,for,0,0
113196,people,1,1
113197,with,1,1
113198,ASD,1,1
113199,is,0,0
113200,lacking,0,0
113201,.,0,0
113202,METHODS,0,0
113203,Therefore,0,0
113204,",",0,0
113205,a,0,0
113206,study,0,0
113207,using,0,0
113208,a,0,0
113209,repeated,0,0
113210,measures,0,0
113211,design,0,0
113212,was,0,0
113213,used,0,0
113214,to,0,0
113215,measure,0,0
113216,effects,0,0
113217,of,0,0
113218,a,0,0
113219,1-year,0,0
113220,group,0,0
113221,leisure,0,1
113222,programme,0,0
113223,intended,0,0
113224,to,0,0
113225,facilitate,0,0
113226,interaction,0,0
113227,with,0,0
113228,media,0,0
113229,",",0,0
113230,engagement,0,0
113231,in,0,0
113232,exercise,0,0
113233,",",0,0
113234,playing,0,0
113235,games,0,0
113236,and,0,0
113237,doing,0,0
113238,crafts,0,0
113239,",",0,0
113240,attending,0,1
113241,events,0,0
113242,",",0,0
113243,and,0,0
113244,participating,0,1
113245,in,0,0
113246,other,0,0
113247,recreation,0,0
113248,activities,0,0
113249,on,0,0
113250,quality,0,0
113251,of,0,0
113252,life,0,0
113253,and,0,0
113254,stress,0,0
113255,of,0,0
113256,37,1,1
113257,participants,1,1
113258,(,1,0
113259,22,1,1
113260,male,1,1
113261,",",1,0
113262,15,1,0
113263,female,1,1
113264,),1,0
113265,",",1,0
113266,ages,1,1
113267,17-39,1,1
113268,(,1,0
113269,M,1,0
113270,=,1,0
113271,31.49,1,0
113272,),1,0
113273,years,1,1
113274,at,1,0
113275,the,1,0
113276,beginning,1,0
113277,of,1,0
113278,the,1,0
113279,programme,1,0
113280,),1,0
113281,diagnosed,1,1
113282,with,1,0
113283,an,1,0
113284,ASD,1,1
113285,and,1,0
113286,a,1,0
113287,group,1,0
113288,of,1,0
113289,34,1,1
113290,adults,1,1
113291,with,1,1
113292,ASD,1,1
113293,as,1,0
113294,control,1,0
113295,group,1,0
113296,(,1,0
113297,waiting,1,0
113298,list,1,0
113299,),1,0
113300,(,1,0
113301,19,1,1
113302,male,1,1
113303,",",1,0
113304,15,1,0
113305,female,1,1
113306,),1,0
113307,",",1,0
113308,ages,1,1
113309,24-38,1,1
113310,(,1,0
113311,M,1,0
113312,=,1,0
113313,30,1,0
113314,at,1,0
113315,programme,1,0
113316,initiation,1,0
113317,),1,0
113318,years,1,1
113319,.,1,0
113320,RESULTS,0,0
113321,There,0,0
113322,was,0,0
113323,a,0,0
113324,significant,0,0
113325,decrease,0,0
113326,in,0,0
113327,overall,0,0
113328,scores,0,0
113329,of,0,0
113330,stress,0,0
113331,levels,0,0
113332,for,0,0
113333,participants,0,1
113334,over,0,0
113335,the,0,0
113336,course,0,0
113337,of,0,0
113338,the,0,0
113339,study,0,0
113340,and,0,0
113341,there,0,0
113342,was,0,0
113343,a,0,0
113344,significant,0,0
113345,increase,0,0
113346,in,0,0
113347,the,0,0
113348,four,0,0
113349,factors,0,0
113350,of,0,0
113351,quality,0,0
113352,of,0,0
113353,life,0,0
113354,that,0,0
113355,were,0,0
113356,measured,0,0
113357,(,0,0
113358,satisfaction,0,0
113359,",",0,0
113360,independence,0,0
113361,",",0,0
113362,competence,0,0
113363,and,0,0
113364,social,0,0
113365,interaction,0,0
113366,),0,0
113367,as,0,0
113368,well,0,0
113369,as,0,0
113370,the,0,0
113371,total,0,0
113372,score,0,0
113373,for,0,0
113374,quality,0,0
113375,of,0,0
113376,life,0,0
113377,from,0,0
113378,baseline,0,0
113379,to,0,0
113380,the,0,0
113381,end,0,0
113382,of,0,0
113383,the,0,0
113384,intervention,0,0
113385,12,0,0
113386,months,0,0
113387,later,0,0
113388,.,0,0
113389,In,0,0
113390,contrast,0,0
113391,",",0,0
113392,the,0,0
113393,control,0,0
113394,group,0,0
113395,demonstrated,0,0
113396,no,0,0
113397,significant,0,0
113398,improvements,0,0
113399,related,0,0
113400,to,0,0
113401,stress,0,0
113402,or,0,0
113403,quality,0,0
113404,of,0,0
113405,life,0,0
113406,.,0,0
113407,Implications,0,0
113408,of,0,0
113409,these,0,0
113410,findings,0,0
113411,to,0,0
113412,leisure,0,1
113413,services,0,0
113414,and,0,0
113415,the,0,0
113416,quality,0,0
113417,of,0,0
113418,life,0,0
113419,of,0,0
113420,individuals,1,1
113421,with,1,1
113422,ASD,1,1
113423,are,0,0
113424,discussed,0,0
113425,.,0,0
113426,CONCLUSION,0,0
113427,Findings,0,0
113428,support,0,0
113429,the,0,0
113430,contention,0,0
113431,that,0,0
113432,participation,0,0
113433,in,0,0
113434,recreation,0,0
113435,activities,0,0
113436,positively,0,0
113437,influenced,0,0
113438,the,0,0
113439,stress,0,0
113440,and,0,0
113441,quality,0,0
113442,of,0,0
113443,life,0,0
113444,of,0,0
113445,adults,1,1
113446,with,1,1
113447,ASD,1,1
113448,.,1,1
113449,[,0,0
113450,Pleural,0,0
113451,tent,0,0
113452,after,0,0
113453,upper,1,0
113454,lobectomy,1,1
113455,--,1,0
113456,randomized,1,0
113457,study,0,0
113458,of,0,0
113459,it,0,0
113460,'s,0,0
113461,efficacy,0,0
113462,and,0,0
113463,duration,0,0
113464,of,0,0
113465,the,0,0
113466,effect,0,0
113467,],0,0
113468,.,0,0
113469,UNLABELLED,0,0
113470,The,0,0
113471,aim,0,0
113472,of,0,0
113473,our,0,0
113474,study,0,0
113475,is,0,0
113476,to,0,0
113477,evaluate,0,0
113478,the,0,0
113479,safety,0,0
113480,",",0,0
113481,efficacy,0,0
113482,and,0,0
113483,also,0,0
113484,the,0,0
113485,maximum,0,0
113486,duration,0,0
113487,of,0,0
113488,effect,0,0
113489,of,0,0
113490,the,0,0
113491,pleural,0,0
113492,tent,0,0
113493,in,0,0
113494,reducing,0,0
113495,the,0,0
113496,incidence,0,0
113497,of,0,0
113498,air,0,0
113499,leak,0,0
113500,after,0,0
113501,upper,0,0
113502,lobectomy,0,1
113503,.,0,0
113504,METHODS,0,0
113505,Sixty,1,1
113506,patients,1,1
113507,who,1,1
113508,underwent,1,1
113509,upper,1,1
113510,lobectomy,1,1
113511,were,0,0
113512,prospectively,0,0
113513,randomized,0,0
113514,into,0,0
113515,two,0,0
113516,groups,0,0
113517,:,0,1
113518,30,1,1
113519,patients,1,1
113520,had,0,0
113521,creation,0,0
113522,of,0,0
113523,pleural,0,1
113524,tent,0,0
113525,(,0,0
113526,group,0,0
113527,1,0,0
113528,),0,0
113529,and,0,0
113530,30,0,0
113531,did,0,0
113532,not,0,0
113533,(,0,0
113534,group,0,0
113535,2,0,0
113536,),0,0
113537,.,0,0
113538,The,0,0
113539,preoperative,0,0
113540,",",0,0
113541,operative,0,0
113542,",",0,0
113543,and,0,0
113544,postoperative,0,0
113545,characteristics,0,0
113546,of,0,0
113547,both,0,0
113548,groups,0,0
113549,were,0,0
113550,compared,0,0
113551,.,0,0
113552,Then,0,0
113553,multivariate,0,0
113554,analyses,0,0
113555,were,0,0
113556,used,0,0
113557,to,0,0
113558,identify,0,0
113559,factors,0,0
113560,predictive,0,0
113561,of,0,0
113562,prolonged,0,0
113563,air,0,1
113564,leaks,0,0
113565,and,0,0
113566,their,0,0
113567,duration,0,0
113568,.,0,0
113569,The,0,0
113570,reduction,0,0
113571,of,0,0
113572,incidences,0,0
113573,of,0,0
113574,air,0,0
113575,leak,0,0
113576,in,0,0
113577,the,0,0
113578,two,0,0
113579,groups,0,0
113580,was,0,0
113581,subsequently,0,0
113582,compared,0,0
113583,during,0,0
113584,successive,0,1
113585,postoperative,0,0
113586,periods,0,0
113587,.,0,1
113588,RESULTS,0,0
113589,Demographic,0,0
113590,and,0,0
113591,clinical,0,0
113592,profiles,0,0
113593,of,0,0
113594,both,0,0
113595,groups,0,0
113596,were,0,0
113597,not,0,0
113598,statistically,0,0
113599,different,0,0
113600,.,0,0
113601,The,0,0
113602,tented,0,0
113603,patients,0,1
113604,had,0,0
113605,statistically,0,0
113606,significant,0,0
113607,reduction,0,0
113608,of,0,0
113609,mean,0,0
113610,duration,0,0
113611,of,0,0
113612,air,0,0
113613,leak,0,0
113614,in,0,0
113615,days,0,0
113616,(,0,0
113617,4.9,0,0
113618,+/-,0,0
113619,1.79,0,0
113620,vs,0,0
113621,8.2,0,0
113622,+/-,0,0
113623,4.2,0,0
113624,),0,0
113625,",",0,0
113626,the,0,0
113627,number,0,0
113628,of,0,0
113629,days,0,0
113630,of,0,0
113631,a,0,0
113632,chest,0,0
113633,tube,0,0
113634,duration,0,0
113635,(,0,0
113636,7.3,0,0
113637,+/-,0,0
113638,1.14,0,0
113639,vs,0,0
113640,12.46,0,0
113641,+/-,0,0
113642,3.6,0,0
113643,),0,0
113644,",",0,0
113645,the,0,0
113646,length,0,0
113647,of,0,0
113648,postoperative,0,0
113649,in-hospital,0,0
113650,stay,0,0
113651,in,0,0
113652,days,0,0
113653,(,0,0
113654,9.4,0,0
113655,+/-,0,0
113656,1.86,0,0
113657,vs,0,0
113658,13.6,0,0
113659,+/-,0,0
113660,2.49,0,0
113661,),0,0
113662,",",0,0
113663,and,0,0
113664,the,0,0
113665,hospital,0,0
113666,stay,0,0
113667,cost,0,0
113668,per,0,0
113669,patient,0,0
113670,(,0,0
113671,leva,0,0
113672,",",0,0
113673,3840,0,0
113674,+/-,0,0
113675,298,0,1
113676,vs,0,0
113677,5160,0,0
113678,+/-,0,0
113679,3890,0,1
113680,),0,0
113681,.,0,0
113682,Logistic,0,0
113683,regression,0,0
113684,analyses,0,0
113685,showed,0,0
113686,that,0,0
113687,no,0,0
113688,having,0,0
113689,creation,0,0
113690,a,0,0
113691,pleural,0,0
113692,tent,0,0
113693,procedure,0,0
113694,was,0,0
113695,the,0,0
113696,most,0,0
113697,significant,0,0
113698,predictive,0,0
113699,factor,0,0
113700,of,0,0
113701,the,0,0
113702,occurrence,0,0
113703,and,0,0
113704,duration,0,0
113705,of,0,0
113706,prolonged,0,0
113707,air,0,1
113708,leaks,0,0
113709,.,0,0
113710,A,0,0
113711,greater,0,0
113712,reduction,0,0
113713,in,0,0
113714,the,0,0
113715,duration,0,0
113716,of,0,0
113717,air,0,0
113718,leaks,0,0
113719,was,0,0
113720,observed,0,0
113721,before,0,0
113722,postoperative,0,0
113723,day,0,0
113724,4,0,0
113725,in,0,0
113726,group,0,0
113727,1,0,0
113728,",",0,0
113729,and,0,0
113730,logistic,0,0
113731,regression,0,0
113732,analysis,0,0
113733,showed,0,0
113734,that,0,0
113735,having,0,1
113736,a,0,0
113737,pleural,0,0
113738,tent,0,0
113739,procedure,0,0
113740,was,0,0
113741,the,0,0
113742,most,0,0
113743,significant,0,0
113744,predictive,0,0
113745,factor,0,0
113746,of,0,0
113747,air,0,0
113748,leaks,0,0
113749,that,0,0
113750,persisted,0,0
113751,for,0,0
113752,less,0,0
113753,than,0,0
113754,4,0,0
113755,days,0,0
113756,.,0,1
113757,CONCLUSIONS,0,0
113758,Pleural,0,0
113759,tent,0,0
113760,creation,0,0
113761,after,0,0
113762,upper,0,0
113763,lobectomy,0,1
113764,is,0,0
113765,a,0,0
113766,simple,0,0
113767,and,0,0
113768,safe,0,0
113769,procedure,0,0
113770,that,0,0
113771,reduces,0,0
113772,the,0,0
113773,duration,0,0
113774,of,0,0
113775,air,0,0
113776,leaks,0,0
113777,and,0,0
113778,the,0,0
113779,hospital,0,0
113780,stay,0,0
113781,costs,0,0
113782,.,0,0
113783,The,0,0
113784,benefit,0,0
113785,from,0,0
113786,that,0,0
113787,procedure,0,0
113788,is,0,0
113789,achieved,0,0
113790,before,0,0
113791,postoperative,0,0
113792,day,0,0
113793,4,0,0
113794,.,0,0
113795,A,0,0
113796,first-in-man,0,0
113797,",",0,0
113798,randomized,0,0
113799,",",0,0
113800,placebo-controlled,0,0
113801,study,0,0
113802,to,0,0
113803,evaluate,0,0
113804,the,0,0
113805,safety,0,0
113806,and,0,0
113807,feasibility,0,0
113808,of,0,0
113809,autologous,0,0
113810,delipidated,0,0
113811,high-density,0,0
113812,lipoprotein,0,0
113813,plasma,0,0
113814,infusions,0,0
113815,in,0,0
113816,patients,1,1
113817,with,1,1
113818,acute,1,1
113819,coronary,1,1
113820,syndrome,1,1
113821,.,1,0
113822,OBJECTIVES,0,0
113823,This,0,0
113824,study,0,0
113825,aimed,0,0
113826,to,0,0
113827,determine,0,0
113828,whether,0,0
113829,serial,0,0
113830,autologous,0,0
113831,infusions,0,0
113832,of,0,0
113833,selective,0,0
113834,high-density,0,0
113835,lipoprotein,0,0
113836,(,0,0
113837,HDL,0,0
113838,),0,0
113839,delipidated,0,0
113840,plasma,0,0
113841,are,0,0
113842,feasible,0,0
113843,and,0,0
113844,well,0,0
113845,tolerated,0,0
113846,in,0,0
113847,patients,1,1
113848,with,1,1
113849,acute,1,1
113850,coronary,1,1
113851,syndrome,1,1
113852,(,1,0
113853,ACS,1,0
113854,),1,0
113855,.,1,0
113856,BACKGROUND,0,0
113857,Low,0,0
113858,HDL,0,0
113859,is,0,0
113860,associated,0,0
113861,with,0,0
113862,increased,0,0
113863,risk,0,0
113864,of,0,0
113865,cardiovascular,0,0
113866,disease,0,1
113867,.,0,0
113868,Plasma,0,0
113869,selective,0,0
113870,delipidation,0,0
113871,converts,0,0
113872,alphaHDL,0,0
113873,to,0,0
113874,prebeta-like,0,0
113875,HDL,0,0
113876,",",0,0
113877,the,0,0
113878,most,0,0
113879,effective,0,0
113880,form,0,0
113881,of,0,0
113882,HDL,0,0
113883,for,0,0
113884,lipid,0,0
113885,removal,0,0
113886,from,0,0
113887,arterial,0,1
113888,plaques,0,1
113889,.,0,1
113890,METHODS,0,0
113891,ACS,1,0
113892,patients,1,1
113893,undergoing,1,1
113894,cardiac,1,1
113895,catheterization,1,1
113896,with,1,1
113897,>,1,0
113898,or=1,1,1
113899,nonobstructive,1,1
113900,native,1,0
113901,coronary,1,1
113902,artery,1,1
113903,atheroma,1,0
113904,were,0,0
113905,randomized,0,0
113906,to,0,0
113907,either,0,0
113908,7,0,0
113909,weekly,0,0
113910,HDL,0,0
113911,selective,0,0
113912,delipidated,0,0
113913,or,0,0
113914,control,0,0
113915,plasma,0,0
113916,apheresis/reinfusions,0,0
113917,.,0,1
113918,Patients,0,1
113919,underwent,0,1
113920,intravascular,0,0
113921,ultrasound,0,0
113922,(,0,0
113923,IVUS,0,0
113924,),0,0
113925,evaluation,0,0
113926,of,0,0
113927,the,0,0
113928,target,0,0
113929,vessel,0,0
113930,during,0,0
113931,the,0,0
113932,catheterization,0,1
113933,for,0,0
113934,ACS,0,0
113935,and,0,0
113936,up,0,0
113937,to,0,0
113938,14,0,0
113939,days,0,0
113940,following,0,0
113941,the,0,0
113942,final,0,0
113943,apheresis/reinfusion,0,0
113944,session,0,0
113945,.,0,0
113946,2-D,0,0
113947,gel,0,0
113948,electrophoresis,0,0
113949,of,0,0
113950,delipidated,0,0
113951,plasmas,0,1
113952,established,0,0
113953,successful,0,0
113954,conversion,0,0
113955,of,0,0
113956,alphaHDL,0,0
113957,to,0,0
113958,prebeta-like,0,0
113959,HDL,0,0
113960,.,0,0
113961,The,0,0
113962,trial,0,0
113963,was,0,0
113964,complete,0,0
113965,with,0,1
113966,28,1,1
113967,patients,1,1
113968,randomized,0,1
113969,.,0,0
113970,RESULTS,0,0
113971,All,0,0
113972,reinfusion,0,0
113973,sessions,0,0
113974,were,0,0
113975,tolerated,0,0
113976,well,0,0
113977,by,0,0
113978,all,0,0
113979,patients,0,1
113980,.,0,0
113981,The,0,0
113982,levels,0,0
113983,of,0,0
113984,prebeta-like,0,0
113985,HDL,0,0
113986,and,0,0
113987,alphaHDL,0,0
113988,in,0,0
113989,the,0,0
113990,delipidated,0,0
113991,plasma,0,0
113992,converted,0,0
113993,from,0,0
113994,5.6,0,0
113995,%,0,0
113996,to,0,0
113997,79.1,0,0
113998,%,0,0
113999,and,0,0
114000,92.8,0,0
114001,%,0,0
114002,to,0,0
114003,20.9,0,0
114004,%,0,0
114005,",",0,0
114006,respectively,0,0
114007,.,0,0
114008,The,0,0
114009,IVUS,0,0
114010,data,0,0
114011,demonstrated,0,0
114012,a,0,0
114013,numeric,0,0
114014,trend,0,0
114015,toward,0,0
114016,regression,0,0
114017,in,0,0
114018,the,0,0
114019,total,0,0
114020,atheroma,0,0
114021,volume,0,0
114022,of,0,0
114023,-12.18,0,0
114024,+/-,0,0
114025,36.75,0,0
114026,mm,0,0
114027,(,0,0
114028,3,0,0
114029,),0,0
114030,in,0,0
114031,the,0,0
114032,delipidated,0,0
114033,group,0,0
114034,versus,0,0
114035,an,0,0
114036,increase,0,0
114037,of,0,0
114038,total,0,1
114039,atheroma,0,0
114040,volume,0,0
114041,of,0,0
114042,2.80,0,0
114043,+/-,0,0
114044,21.25,0,0
114045,mm,0,0
114046,(,0,0
114047,3,0,0
114048,),0,0
114049,in,0,0
114050,the,0,0
114051,control,0,0
114052,group,0,0
114053,(,0,0
114054,p,0,0
114055,=,0,0
114056,0.268,0,0
114057,),0,0
114058,.,0,0
114059,CONCLUSIONS,0,0
114060,In,1,0
114061,ACS,1,0
114062,patients,1,1
114063,",",0,0
114064,serial,0,1
114065,autologous,0,0
114066,infusions,0,0
114067,of,0,0
114068,selective,0,0
114069,HDL,0,0
114070,delipidated,0,0
114071,plasma,0,0
114072,are,0,0
114073,clinically,0,0
114074,feasible,0,0
114075,and,0,0
114076,well,0,0
114077,tolerated,0,0
114078,.,0,0
114079,This,0,0
114080,therapy,0,0
114081,may,0,0
114082,offer,0,0
114083,a,0,0
114084,novel,0,0
114085,adjunct,0,0
114086,treatment,0,0
114087,for,0,0
114088,patients,1,1
114089,presenting,1,1
114090,with,1,1
114091,ACS,1,0
114092,.,1,0
114093,Further,0,0
114094,study,0,0
114095,will,0,0
114096,be,0,0
114097,needed,0,0
114098,to,0,0
114099,determine,0,0
114100,its,0,0
114101,ability,0,0
114102,to,0,0
114103,reduce,0,0
114104,clinical,0,0
114105,cardiovascular,0,1
114106,events,0,0
114107,.,0,1
114108,Early,0,0
114109,combination,0,0
114110,disease-modifying,0,0
114111,antirheumatic,0,0
114112,drug,0,0
114113,therapy,0,0
114114,and,0,0
114115,tight,0,0
114116,disease,0,1
114117,control,0,0
114118,improve,0,0
114119,long-term,0,0
114120,radiologic,0,0
114121,outcome,0,0
114122,in,0,0
114123,patients,1,1
114124,with,1,1
114125,early,1,1
114126,rheumatoid,1,1
114127,arthritis,1,1
114128,:,1,0
114129,the,0,0
114130,11-year,0,1
114131,results,0,0
114132,of,0,0
114133,the,0,0
114134,Finnish,0,1
114135,Rheumatoid,0,1
114136,Arthritis,0,1
114137,Combination,0,0
114138,Therapy,0,0
114139,trial,0,0
114140,.,0,0
114141,INTRODUCTION,0,0
114142,Early,0,0
114143,treatment,0,0
114144,of,0,0
114145,rheumatoid,1,1
114146,arthritis,1,1
114147,(,1,0
114148,RA,1,0
114149,),1,0
114150,has,0,0
114151,been,0,0
114152,shown,0,0
114153,to,0,0
114154,retard,0,0
114155,the,0,0
114156,development,0,0
114157,of,0,0
114158,joint,0,0
114159,damage,0,0
114160,for,0,0
114161,a,0,0
114162,period,0,0
114163,of,0,0
114164,up,0,0
114165,to,0,0
114166,5,0,0
114167,years,0,1
114168,.,0,0
114169,The,0,0
114170,aim,0,0
114171,of,0,0
114172,this,0,0
114173,study,0,0
114174,was,0,0
114175,to,0,0
114176,evaluate,0,0
114177,the,0,0
114178,radiologic,0,0
114179,progression,0,0
114180,beyond,0,0
114181,that,0,0
114182,time,0,0
114183,in,0,0
114184,patients,1,1
114185,with,1,1
114186,early,1,1
114187,RA,1,0
114188,initially,1,0
114189,treated,1,0
114190,with,1,0
114191,a,1,0
114192,combination,1,0
114193,of,1,0
114194,three,1,0
114195,disease-modifying,1,0
114196,antirheumatic,1,0
114197,drugs,1,0
114198,(,1,0
114199,DMARDs,1,0
114200,),1,0
114201,or,1,0
114202,a,1,0
114203,single,1,0
114204,DMARD,1,0
114205,.,1,1
114206,METHODS,0,0
114207,A,0,0
114208,cohort,0,1
114209,of,0,0
114210,199,1,1
114211,patients,1,1
114212,with,1,1
114213,early,1,1
114214,active,1,1
114215,RA,1,0
114216,were,0,0
114217,initially,0,0
114218,randomized,0,0
114219,to,0,0
114220,receive,0,0
114221,treatment,0,0
114222,with,0,0
114223,a,0,0
114224,combination,0,0
114225,of,0,0
114226,methotrexate,0,0
114227,",",0,0
114228,sulfasalazine,0,0
114229,",",0,0
114230,and,0,0
114231,hydroxychloroquine,0,0
114232,with,0,0
114233,prednisolone,0,0
114234,(,0,0
114235,FIN-RACo,0,0
114236,),0,0
114237,",",0,0
114238,or,0,0
114239,treatment,0,0
114240,with,0,0
114241,a,0,0
114242,single,0,0
114243,DMARD,0,0
114244,(,0,0
114245,initially,0,0
114246,",",0,0
114247,sulfasalazine,0,0
114248,),0,0
114249,with,0,0
114250,or,0,0
114251,without,0,0
114252,prednisolone,0,0
114253,(,0,0
114254,SINGLE,0,0
114255,),0,0
114256,.,0,0
114257,After,0,0
114258,2,0,0
114259,years,0,1
114260,",",0,0
114261,the,0,0
114262,drug-treatment,0,0
114263,strategy,0,0
114264,became,0,0
114265,unrestricted,0,0
114266,",",0,0
114267,but,0,0
114268,still,0,0
114269,targeted,0,0
114270,remission,0,0
114271,.,0,0
114272,The,0,0
114273,radiographs,0,0
114274,of,0,0
114275,hands,0,0
114276,and,0,0
114277,feet,0,0
114278,were,0,0
114279,analyzed,0,0
114280,by,0,0
114281,using,0,0
114282,the,0,0
114283,Larsen,0,0
114284,score,0,0
114285,at,0,0
114286,baseline,0,0
114287,",",0,0
114288,2,0,0
114289,",",0,0
114290,5,0,0
114291,",",0,0
114292,and,0,0
114293,11,0,0
114294,years,0,1
114295,",",0,0
114296,and,0,0
114297,the,0,0
114298,radiographs,0,0
114299,of,0,0
114300,large,0,0
114301,joints,0,0
114302,",",0,0
114303,at,0,0
114304,11,0,1
114305,years,0,1
114306,.,0,0
114307,RESULTS,0,0
114308,Sixty-five,0,1
114309,patients,0,1
114310,in,0,0
114311,the,0,0
114312,FIN-RACo,0,0
114313,and,0,0
114314,65,0,1
114315,in,0,0
114316,the,0,0
114317,SINGLE,0,0
114318,group,0,0
114319,had,0,0
114320,radiographs,0,1
114321,of,0,0
114322,hands,0,0
114323,and,0,0
114324,feet,0,0
114325,available,0,0
114326,at,0,0
114327,baseline,0,0
114328,and,0,0
114329,at,0,0
114330,11,0,1
114331,years,0,1
114332,.,0,0
114333,The,0,0
114334,mean,0,0
114335,change,0,0
114336,from,0,0
114337,baseline,0,0
114338,to,0,0
114339,11,0,0
114340,years,0,1
114341,in,0,0
114342,Larsen,0,1
114343,score,0,0
114344,was,0,0
114345,17,0,0
114346,(,0,0
114347,95,0,0
114348,%,0,0
114349,CI,0,0
114350,",",0,0
114351,12,0,0
114352,to,0,0
114353,26,0,1
114354,),0,0
114355,in,0,0
114356,the,0,0
114357,FIN-RACo,0,0
114358,group,0,0
114359,and,0,0
114360,27,0,0
114361,(,0,0
114362,95,0,0
114363,%,0,0
114364,CI,0,0
114365,",",0,0
114366,22,0,0
114367,to,0,0
114368,33,0,1
114369,),0,0
114370,in,0,0
114371,the,0,0
114372,SINGLE,0,0
114373,group,0,0
114374,(,0,0
114375,P=0.037,0,0
114376,),0,0
114377,.,0,0
114378,In,0,0
114379,total,0,0
114380,",",0,0
114381,87,0,0
114382,%,0,0
114383,(,0,0
114384,95,0,0
114385,%,0,0
114386,CI,0,0
114387,",",0,0
114388,74,0,0
114389,to,0,0
114390,94,0,0
114391,),0,0
114392,and,0,0
114393,72,0,0
114394,%,0,0
114395,(,0,0
114396,95,0,0
114397,%,0,0
114398,CI,0,0
114399,",",0,0
114400,58,0,1
114401,to,0,0
114402,84,0,1
114403,),0,0
114404,of,0,0
114405,the,0,0
114406,patients,0,1
114407,in,0,0
114408,the,0,0
114409,FIN-RACo,0,0
114410,and,0,0
114411,the,0,0
114412,SINGLE,0,0
114413,treatment,0,0
114414,arms,0,0
114415,",",0,0
114416,respectively,0,0
114417,",",0,0
114418,had,0,0
114419,no,0,0
114420,erosive,0,1
114421,changes,0,0
114422,in,0,0
114423,large,0,1
114424,joints,0,0
114425,at,0,0
114426,11,0,1
114427,years,0,1
114428,.,0,1
114429,CONCLUSIONS,0,0
114430,Targeting,0,0
114431,to,0,0
114432,remission,0,0
114433,with,0,1
114434,tight,0,0
114435,clinical,0,0
114436,controls,0,1
114437,results,0,0
114438,in,0,0
114439,low,0,0
114440,radiologic,0,0
114441,progression,0,0
114442,in,0,0
114443,most,0,0
114444,RA,1,1
114445,patients,1,1
114446,.,1,1
114447,Patients,0,1
114448,treated,0,0
114449,initially,0,0
114450,with,0,0
114451,a,0,0
114452,combination,0,0
114453,of,0,0
114454,DMARDs,0,0
114455,have,0,0
114456,less,0,0
114457,long-term,0,0
114458,radiologic,0,0
114459,damage,0,0
114460,than,0,0
114461,do,0,0
114462,those,0,0
114463,treated,0,0
114464,initially,0,0
114465,with,0,0
114466,DMARD,0,0
114467,monotherapy,0,0
114468,.,0,0
114469,TRIAL,0,0
114470,REGISTRATION,0,0
114471,Current,0,1
114472,Controlled,0,0
114473,Trials,0,0
114474,ISRCTN18445519,0,0
114475,.,0,0
114476,Abnormal,0,1
114477,cardiac,0,1
114478,contractility,0,0
114479,in,0,0
114480,long-term,1,0
114481,exogenous,1,0
114482,subclinical,1,1
114483,hyperthyroid,1,1
114484,patients,1,1
114485,as,0,0
114486,demonstrated,0,0
114487,by,0,0
114488,two-dimensional,0,0
114489,echocardiography,0,0
114490,speckle,0,0
114491,tracking,0,0
114492,imaging,0,0
114493,.,0,1
114494,BACKGROUND,0,0
114495,Subclinical,0,0
114496,hyperthyroidism,0,1
114497,is,0,0
114498,associated,0,0
114499,with,0,0
114500,cardiovascular,0,0
114501,morbidity,0,0
114502,.,0,0
114503,Recent,0,0
114504,advances,0,0
114505,in,0,0
114506,echocardiography,0,0
114507,imaging,0,0
114508,have,0,0
114509,allowed,0,0
114510,sophisticated,0,0
114511,evaluation,0,0
114512,of,0,0
114513,myocardial,0,1
114514,tissue,0,0
114515,properties,0,0
114516,.,0,0
114517,OBJECTIVE,0,0
114518,To,0,0
114519,investigate,0,0
114520,the,0,0
114521,myocardial,0,0
114522,effects,0,0
114523,of,0,0
114524,long-term,0,0
114525,exogenous,0,0
114526,subclinical,0,1
114527,hyperthyroidism,0,1
114528,using,0,0
114529,two-dimensional,0,0
114530,speckle,0,0
114531,tracking,0,0
114532,echocardiography,0,0
114533,imaging,0,0
114534,(,0,0
114535,2D-STE,0,0
114536,),0,0
114537,.,0,0
114538,DESIGN,0,0
114539,Prospective,0,0
114540,",",0,0
114541,single-blinded,0,0
114542,",",0,0
114543,placebo-controlled,0,0
114544,randomized,0,0
114545,trial,0,0
114546,of,0,0
114547,6,0,0
114548,months,0,0
114549,duration,0,0
114550,with,0,1
114551,two,0,0
114552,parallel,0,0
114553,groups,0,0
114554,.,0,1
114555,PATIENTS,0,0
114556,AND,0,0
114557,METHODS,0,0
114558,Totally,1,0
114559,25,1,0
114560,patients,1,1
114561,with,1,1
114562,a,1,0
114563,history,1,0
114564,of,1,0
114565,differentiated,1,1
114566,thyroid,1,1
114567,carcinoma,1,1
114568,on,1,0
114569,long-term,1,0
114570,TSH-suppressive,1,0
114571,levothyroxine,1,1
114572,(,1,0
114573,l-T,1,0
114574,(,1,0
114575,4,1,0
114576,),1,0
114577,),1,0
114578,substitution,1,0
114579,were,0,0
114580,randomized,0,0
114581,to,0,0
114582,persistent,0,1
114583,TSH-suppressive,0,0
114584,l-T,0,0
114585,(,0,0
114586,4,0,0
114587,),0,0
114588,substitution,0,0
114589,(,0,0
114590,low-TSH,0,0
114591,group,0,0
114592,),0,0
114593,or,0,0
114594,restoration,0,0
114595,of,0,0
114596,euthyroidism,0,1
114597,.,0,0
114598,Additionally,1,0
114599,40,1,0
114600,euthyroid,1,1
114601,controls,1,1
114602,were,1,0
114603,studied,1,1
114604,.,1,0
114605,RESULTS,0,0
114606,(,0,0
114607,PROPOSAL,0,0
114608,),0,0
114609,:,0,0
114610,At,0,0
114611,baseline,0,0
114612,",",0,0
114613,the,0,0
114614,group,0,0
114615,of,0,0
114616,patients,0,1
114617,showed,0,0
114618,normal,0,1
114619,left,0,1
114620,ventricular,0,0
114621,(,0,0
114622,LV,0,0
114623,),0,0
114624,systolic,0,0
114625,function,0,0
114626,but,0,0
114627,impaired,0,0
114628,diastolic,0,0
114629,function,0,0
114630,as,0,0
114631,assessed,0,0
114632,with,0,1
114633,conventional,0,0
114634,echocardiographic,0,1
114635,parameters,0,0
114636,.,0,0
114637,Importantly,0,0
114638,",",0,0
114639,2D-STE,0,0
114640,analysis,0,0
114641,demonstrated,0,0
114642,the,0,0
114643,presence,0,0
114644,of,0,0
114645,subclinical,0,1
114646,LV,0,0
114647,systolic,0,1
114648,and,0,0
114649,diastolic,0,0
114650,dysfunction,0,0
114651,with,0,1
114652,impaired,0,0
114653,circumferential,0,0
114654,and,0,0
114655,longitudinal,0,1
114656,strain,0,0
114657,and,0,0
114658,strain,0,0
114659,rate,0,0
114660,at,0,0
114661,the,0,0
114662,isovolumic,0,0
114663,relaxation,0,0
114664,time,0,0
114665,.,0,0
114666,After,0,0
114667,restoration,0,0
114668,of,0,0
114669,euthyroidism,0,0
114670,",",0,0
114671,a,0,0
114672,significant,0,0
114673,improvement,0,0
114674,in,0,0
114675,LV,0,0
114676,systolic,0,1
114677,and,0,0
114678,diastolic,0,0
114679,function,0,0
114680,as,0,0
114681,assessed,0,0
114682,with,0,1
114683,2D-STE,0,0
114684,strain,0,0
114685,was,0,0
114686,observed,0,0
114687,.,0,0
114688,CONCLUSION,0,0
114689,Prolonged,0,0
114690,subclinical,0,0
114691,hyperthyroidism,0,1
114692,leads,0,0
114693,to,0,0
114694,systolic,0,0
114695,and,0,0
114696,diastolic,0,0
114697,dysfunction,0,0
114698,",",0,0
114699,which,0,0
114700,is,0,0
114701,reversible,0,0
114702,after,0,0
114703,restoration,0,0
114704,of,0,0
114705,euthyroidism,0,1
114706,.,0,0
114707,2D-STE,0,0
114708,is,0,0
114709,a,0,0
114710,more,0,0
114711,sensitive,0,0
114712,technique,0,0
114713,to,0,0
114714,evaluate,0,0
114715,subtle,0,0
114716,changes,0,0
114717,in,0,0
114718,LV,0,0
114719,performance,0,0
114720,of,0,0
114721,these,0,0
114722,patients,0,1
114723,.,0,0
114724,Human,0,1
114725,papillomavirus,0,1
114726,genotypes,0,0
114727,in,0,0
114728,cervical,1,1
114729,intraepithelial,1,1
114730,neoplasia,1,1
114731,grade,1,1
114732,3,1,0
114733,.,1,0
114734,BACKGROUND,0,0
114735,There,0,0
114736,are,0,0
114737,few,0,0
114738,large,0,0
114739,case,0,0
114740,series,0,0
114741,describing,0,0
114742,the,0,0
114743,human,0,0
114744,papillomavirus,0,1
114745,(,0,0
114746,HPV,0,0
114747,),0,0
114748,genotypes,0,0
114749,found,0,0
114750,in,0,0
114751,women,0,1
114752,diagnosed,0,1
114753,with,0,1
114754,rigorously,0,0
114755,reviewed,0,0
114756,cervical,1,0
114757,intraepithelial,1,1
114758,neoplasia,1,1
114759,grade,1,0
114760,3,1,0
114761,(,1,0
114762,CIN3,1,0
114763,),1,0
114764,",",1,0
114765,cervical,1,1
114766,precancer,1,1
114767,.,1,0
114768,METHODS,0,0
114769,The,0,0
114770,Atypical,0,0
114771,Squamous,0,1
114772,Cells,0,0
114773,of,0,0
114774,Undetermined,0,0
114775,Significance,0,0
114776,(,0,0
114777,ASCUS,0,0
114778,),0,0
114779,and,0,0
114780,Low-Grade,0,0
114781,Squamous,0,1
114782,Intraepithelial,0,1
114783,Lesion,0,0
114784,(,0,0
114785,LSIL,0,0
114786,),0,0
114787,Triage,0,0
114788,Study,0,0
114789,(,0,0
114790,ALTS,0,0
114791,),0,0
114792,was,0,0
114793,a,0,0
114794,clinical,0,0
114795,trial,0,0
114796,to,0,0
114797,evaluate,0,0
114798,the,0,0
114799,best,0,0
114800,management,0,0
114801,strategies,0,0
114802,for,0,0
114803,women,1,1
114804,with,1,1
114805,equivocal,1,0
114806,(,1,0
114807,ASCUS,1,0
114808,),1,0
114809,or,1,0
114810,mildly,1,0
114811,abnormal,1,0
114812,(,1,0
114813,LSIL,1,0
114814,),1,0
114815,Pap,1,0
114816,tests,1,0
114817,.,1,0
114818,During,0,0
114819,enrollment,0,0
114820,and,0,0
114821,the,0,0
114822,2-year,0,0
114823,follow-up,0,0
114824,",",0,0
114825,608,1,1
114826,women,1,1
114827,had,1,0
114828,a,1,0
114829,histopathologic,1,0
114830,diagnosis,1,1
114831,of,1,0
114832,CIN3,1,0
114833,and,1,0
114834,PCR-based,1,0
114835,HPV,1,0
114836,genotyping,1,0
114837,results,1,0
114838,on,1,0
114839,cervical,1,1
114840,specimens,1,1
114841,.,1,0
114842,The,0,0
114843,genotyping,0,0
114844,results,0,0
114845,were,0,0
114846,ranked,0,0
114847,hierarchically,0,0
114848,according,0,0
114849,to,0,0
114850,cancer,0,1
114851,risk,0,0
114852,:,0,0
114853,HPV16,0,0
114854,>,0,1
114855,other,0,0
114856,carcinogenic,0,0
114857,HPV,0,0
114858,>,0,1
114859,noncarcinogenic,0,1
114860,HPV,0,0
114861,>,0,1
114862,PCR,0,0
114863,negative,0,0
114864,.,0,0
114865,RESULTS,0,0
114866,Among,0,1
114867,the,0,0
114868,608,1,1
114869,women,1,1
114870,diagnosed,1,1
114871,with,1,1
114872,CIN3,1,0
114873,",",0,0
114874,601,0,1
114875,(,0,0
114876,98.8,0,0
114877,%,0,0
114878,),0,0
114879,cases,0,0
114880,were,0,0
114881,positive,0,0
114882,for,0,0
114883,any,0,0
114884,HPV,0,0
114885,genotype,0,0
114886,and,0,0
114887,95.4,0,0
114888,%,0,0
114889,for,0,0
114890,any,0,0
114891,carcinogenic,0,0
114892,HPV,0,0
114893,.,0,0
114894,HPV16,0,0
114895,(,0,0
114896,59.9,0,0
114897,%,0,0
114898,),0,0
114899,",",0,0
114900,HPV31,0,0
114901,(,0,0
114902,18.1,0,0
114903,%,0,0
114904,),0,0
114905,",",0,0
114906,HPV52,0,0
114907,(,0,0
114908,14.8,0,0
114909,%,0,0
114910,),0,0
114911,",",0,0
114912,HPV51,0,0
114913,(,0,0
114914,14.0,0,0
114915,%,0,0
114916,),0,0
114917,",",0,0
114918,and,0,0
114919,HPV18,0,0
114920,(,0,0
114921,13.2,0,0
114922,%,0,0
114923,),0,0
114924,were,0,0
114925,the,0,0
114926,five,0,0
114927,most,0,0
114928,common,0,0
114929,HPV,0,0
114930,genotypes,0,0
114931,detected,0,0
114932,.,0,0
114933,Younger,0,0
114934,age,0,1
114935,",",0,0
114936,consensus,0,0
114937,histologic,0,0
114938,confirmation,0,0
114939,",",0,0
114940,smoking,0,0
114941,",",0,0
114942,and,0,0
114943,multiparity,0,0
114944,increased,0,0
114945,the,0,0
114946,likelihood,0,0
114947,of,0,0
114948,testing,0,0
114949,HPV,0,0
114950,16,0,1
114951,positive,0,0
114952,.,0,0
114953,Specifically,0,0
114954,",",0,0
114955,HPV16-positive,0,1
114956,CIN3,0,0
114957,occurred,0,0
114958,at,0,0
114959,a,0,0
114960,younger,0,1
114961,age,0,1
114962,than,0,0
114963,CIN3,0,0
114964,positive,0,0
114965,for,0,0
114966,other,0,0
114967,carcinogenic,0,0
114968,HPV,0,0
114969,genotypes,0,0
114970,(,0,0
114971,median,0,0
114972,of,0,0
114973,23.5,0,0
114974,years,0,1
114975,versus,0,0
114976,25,0,0
114977,years,0,1
114978,",",0,0
114979,respectively,0,0
114980,;,0,0
114981,P,0,0
114982,=,0,0
114983,0.0003,0,0
114984,",",0,0
114985,Kruskal-Wallis,0,0
114986,),0,0
114987,.,0,0
114988,CONCLUSIONS,0,0
114989,HPV16-positive,0,1
114990,CIN3,0,0
114991,was,0,0
114992,more,0,0
114993,commonly,0,0
114994,diagnosed,0,1
114995,in,0,0
114996,younger,0,1
114997,women,0,1
114998,(,0,0
114999,versus,0,0
115000,older,0,1
115001,women,0,1
115002,),0,0
115003,",",0,0
115004,with,0,0
115005,consensus,0,0
115006,diagnosis,0,1
115007,(,0,0
115008,versus,0,0
115009,some,0,0
115010,disagreement,0,0
115011,between,0,0
115012,reviewers,0,0
115013,),0,0
115014,",",0,0
115015,and,0,0
115016,in,0,0
115017,smokers,0,1
115018,(,0,0
115019,versus,0,0
115020,nonsmokers,0,1
115021,),0,0
115022,",",0,0
115023,and,0,0
115024,was,0,0
115025,less,0,0
115026,commonly,0,0
115027,diagnosed,0,1
115028,in,0,0
115029,multiparous,0,1
115030,women,0,1
115031,compared,0,0
115032,CIN3,0,1
115033,positive,0,0
115034,for,0,0
115035,other,0,0
115036,carcinogenic,0,0
115037,HPV,0,0
115038,genotypes,0,0
115039,.,0,1
115040,IMPACT,0,0
115041,In,0,0
115042,populations,0,1
115043,vaccinated,0,1
115044,against,0,0
115045,HPV16,0,0
115046,(,0,0
115047,and,0,0
115048,HPV18,0,0
115049,),0,0
115050,",",0,0
115051,the,0,0
115052,median,0,0
115053,age,0,1
115054,of,0,0
115055,CIN3,0,0
115056,in,0,0
115057,women,0,1
115058,with,0,1
115059,ASCUS,0,0
115060,and,0,0
115061,LSIL,0,0
115062,cytology,0,0
115063,should,0,0
115064,shift,0,0
115065,to,0,0
115066,older,0,1
115067,ages,0,1
115068,",",0,0
115069,possibly,0,0
115070,permitting,0,0
115071,later,0,0
115072,age,0,1
115073,at,0,0
115074,first,0,0
115075,screening,0,1
115076,.,0,1
115077,Translucency,0,0
115078,of,0,0
115079,zirconia,1,0
115080,copings,1,0
115081,made,0,0
115082,with,0,1
115083,different,0,0
115084,CAD/CAM,0,1
115085,systems,0,0
115086,.,0,1
115087,STATEMENT,0,0
115088,OF,0,0
115089,PROBLEM,0,1
115090,Zirconia,1,0
115091,cores,1,1
115092,are,0,0
115093,reported,0,0
115094,to,0,0
115095,be,0,0
115096,less,0,0
115097,translucent,0,0
115098,than,0,0
115099,glass,0,0
115100,",",0,0
115101,lithium,0,0
115102,disilicate,0,0
115103,",",0,0
115104,or,0,0
115105,alumina,0,0
115106,cores,0,1
115107,.,0,0
115108,This,0,0
115109,could,0,0
115110,affect,0,0
115111,the,0,0
115112,esthetic,0,0
115113,appearance,0,0
115114,and,0,0
115115,the,0,0
115116,clinical,0,0
115117,choices,0,0
115118,made,0,0
115119,when,0,0
115120,using,0,0
115121,zirconia-based,0,0
115122,restorations,0,0
115123,.,0,0
115124,PURPOSE,0,0
115125,The,0,0
115126,purpose,0,0
115127,of,0,0
115128,this,0,0
115129,in,0,0
115130,vitro,0,0
115131,study,0,0
115132,was,0,0
115133,to,0,0
115134,evaluate,0,0
115135,the,0,0
115136,translucency,0,0
115137,of,0,0
115138,zirconia,1,0
115139,copings,1,0
115140,for,0,0
115141,single,1,1
115142,crowns,1,0
115143,fabricated,0,0
115144,using,0,0
115145,different,0,0
115146,CAD/CAM,0,0
115147,systems,0,0
115148,",",0,0
115149,using,0,0
115150,lithium,0,0
115151,disilicate,0,0
115152,glass,0,0
115153,ceramic,0,0
115154,as,0,0
115155,a,0,0
115156,control,0,0
115157,.,0,0
115158,MATERIAL,0,0
115159,AND,0,0
115160,METHODS,0,0
115161,Using,0,0
115162,impressions,0,0
115163,made,0,0
115164,from,0,0
115165,a,0,0
115166,stainless,0,0
115167,steel,0,0
115168,complete-crown,0,0
115169,master,0,0
115170,die,0,0
115171,",",0,0
115172,9,1,0
115173,stone,1,0
115174,cast,1,0
115175,replicas,1,0
115176,were,1,0
115177,fabricated,1,0
115178,",",1,0
115179,numbered,1,0
115180,",",1,0
115181,and,1,0
115182,distributed,1,0
115183,into,1,0
115184,8,1,0
115185,ceramic,1,0
115186,ZrO,1,0
115187,(,1,0
115188,2,1,0
115189,),1,0
115190,CAD/CAM,1,0
115191,system,1,0
115192,groups,1,0
115193,(,1,0
115194,Lava,1,1
115195,Frame,1,0
115196,0.3,1,0
115197,and,1,0
115198,0.5,1,0
115199,",",1,0
115200,IPS,1,0
115201,e.max,1,0
115202,ZirCAD,1,0
115203,",",1,0
115204,VITA,1,0
115205,YZ,1,0
115206,",",1,0
115207,Procera,1,1
115208,AllZircon,1,0
115209,",",1,0
115210,Digizon,1,0
115211,",",1,0
115212,DC,1,0
115213,Zircon,1,0
115214,",",1,0
115215,and,1,0
115216,Cercon,1,1
115217,Base,1,0
115218,),1,0
115219,and,1,0
115220,to,1,0
115221,a,1,0
115222,lithium,1,0
115223,disilicate,1,0
115224,glass-ceramic,1,0
115225,control,1,0
115226,group,1,0
115227,(,1,0
115228,IPS,1,0
115229,e.max,1,0
115230,Press,1,0
115231,),1,0
115232,using,1,0
115233,a,1,0
115234,simple,1,0
115235,computer-generated,1,0
115236,randomization,1,0
115237,method,1,0
115238,.,1,0
115239,From,0,0
115240,each,0,0
115241,die,0,0
115242,",",0,0
115243,the,0,0
115244,manufacturer,0,0
115245,'s,0,0
115246,authorized,0,0
115247,milling,0,0
115248,centers,0,1
115249,supplied,0,0
115250,5,0,0
115251,copings,0,0
115252,per,0,0
115253,group,0,0
115254,without,0,0
115255,applying,0,0
115256,any,0,0
115257,dying,0,1
115258,technique,0,0
115259,to,0,0
115260,the,0,0
115261,ceramic,0,0
115262,base,0,0
115263,material,0,1
115264,.,0,0
115265,The,0,0
115266,copings,0,0
115267,were,0,0
115268,prepared,0,0
115269,to,0,0
115270,allow,0,0
115271,for,0,0
115272,a,0,0
115273,40-mum,0,0
115274,cement,0,0
115275,layer,0,0
115276,and,0,0
115277,were,0,0
115278,of,0,0
115279,different,0,0
115280,thicknesses,0,0
115281,according,0,1
115282,to,0,0
115283,system,0,0
115284,specifications,0,0
115285,.,0,0
115286,Translucency,0,0
115287,was,0,0
115288,measured,0,0
115289,by,0,0
115290,the,0,0
115291,direct,0,0
115292,transmission,0,0
115293,method,0,0
115294,with,0,0
115295,a,0,0
115296,digital,0,0
115297,photoradiometer,0,0
115298,mounted,0,0
115299,in,0,0
115300,a,0,0
115301,dark,0,0
115302,chamber,0,0
115303,.,0,0
115304,The,0,0
115305,light,0,0
115306,source,0,0
115307,was,0,0
115308,a,0,0
115309,150-W,0,0
115310,halogen,0,0
115311,lamp,0,0
115312,beam,0,0
115313,.,0,0
115314,Measurements,0,0
115315,were,0,0
115316,repeated,0,0
115317,3,0,0
115318,times,0,0
115319,for,0,0
115320,each,0,0
115321,specimen,0,0
115322,.,0,0
115323,Data,0,0
115324,obtained,0,0
115325,were,0,0
115326,analyzed,0,0
115327,using,0,0
115328,1-way,0,0
115329,ANOVA,0,0
115330,and,0,0
115331,the,0,0
115332,Bonferroni,0,0
115333,multiple,0,0
115334,comparison,0,0
115335,test,0,0
115336,(,0,0
115337,alpha=.05,0,0
115338,),0,0
115339,.,0,0
115340,RESULTS,0,0
115341,Among,0,1
115342,ZrO,0,0
115343,(,0,0
115344,2,0,0
115345,),0,0
115346,copings,0,0
115347,",",0,0
115348,Lava,0,0
115349,(,0,0
115350,0.3,0,0
115351,mm,0,0
115352,and,0,0
115353,0.5,0,0
115354,mm,0,0
115355,thick,0,0
115356,),0,0
115357,showed,0,0
115358,the,0,0
115359,highest,0,0
115360,(,0,0
115361,P,0,0
115362,<,0,0
115363,.05,0,0
115364,),0,0
115365,values,0,0
115366,of,0,0
115367,translucency,0,0
115368,measured,0,0
115369,as,0,0
115370,light,0,0
115371,flow,0,0
115372,units,0,0
115373,(,0,0
115374,3.572,0,0
115375,+,0,0
115376,or,0,1
115377,-,0,0
115378,018,0,0
115379,x,0,0
115380,10,0,1
115381,(,0,0
115382,3,0,0
115383,),0,0
115384,lx,0,0
115385,and,0,0
115386,3.181,0,0
115387,+,0,0
115388,or,0,1
115389,-,0,0
115390,0.13,0,0
115391,x,0,0
115392,10,0,1
115393,(,0,0
115394,3,0,0
115395,),0,0
115396,lx,0,0
115397,",",0,0
115398,respectively,0,0
115399,),0,0
115400,.,0,0
115401,These,0,0
115402,values,0,0
115403,represent,0,0
115404,71.7,0,0
115405,%,0,0
115406,and,0,0
115407,63.9,0,0
115408,%,0,0
115409,",",0,0
115410,respectively,0,0
115411,",",0,0
115412,of,0,0
115413,the,0,0
115414,glass-ceramic,0,0
115415,control,0,0
115416,group,0,0
115417,(,0,0
115418,4.98,0,0
115419,x,0,0
115420,10,0,0
115421,(,0,0
115422,3,0,0
115423,),0,0
115424,lx,0,1
115425,),0,0
115426,.,0,0
115427,CONCLUSIONS,0,0
115428,All,0,0
115429,ZrO,1,0
115430,(,1,0
115431,2,1,0
115432,),1,0
115433,copings,1,0
115434,demonstrated,0,0
115435,different,0,0
115436,levels,0,0
115437,of,0,0
115438,light,0,0
115439,transmission,0,0
115440,",",0,0
115441,with,0,0
115442,the,0,0
115443,2,0,0
115444,Lava,0,0
115445,specimens,0,1
115446,showing,0,0
115447,the,0,0
115448,highest,0,0
115449,values,0,0
115450,.,0,0
115451,Translucency,0,0
115452,of,0,0
115453,zirconia,1,0
115454,copings,1,0
115455,was,0,0
115456,significantly,0,0
115457,lower,0,0
115458,(,0,0
115459,P=.001,0,0
115460,),0,0
115461,than,0,0
115462,that,0,0
115463,of,0,0
115464,the,0,0
115465,lithium,0,0
115466,disilicate,0,0
115467,glass-ceramic,0,0
115468,control,0,0
115469,.,0,0
115470,Rationale,0,1
115471,and,0,0
115472,design,0,0
115473,of,0,0
115474,a,0,0
115475,randomized,0,0
115476,trial,0,0
115477,to,0,0
115478,evaluate,0,0
115479,an,0,0
115480,evidence-based,1,0
115481,prescription,1,0
115482,drug,1,0
115483,label,1,0
115484,on,1,0
115485,actual,1,0
115486,medication,1,0
115487,use,1,0
115488,.,1,0
115489,BACKGROUND,0,0
115490,Medication,0,0
115491,errors,0,0
115492,are,0,0
115493,an,0,0
115494,important,0,0
115495,public,0,1
115496,health,0,0
115497,concern,0,0
115498,",",0,0
115499,and,0,0
115500,poor,0,0
115501,understanding,0,0
115502,of,0,0
115503,medication,0,0
115504,labels,0,0
115505,are,0,0
115506,a,0,0
115507,root,0,0
115508,cause,0,0
115509,.,0,0
115510,Research,0,0
115511,shows,0,0
115512,that,0,0
115513,labels,0,0
115514,are,0,0
115515,variable,0,0
115516,",",0,0
115517,of,0,0
115518,poor,0,0
115519,quality,0,0
115520,",",0,0
115521,and,0,0
115522,not,0,0
115523,patient-centered,0,0
115524,.,0,0
115525,No,0,0
115526,real-world,0,0
115527,trials,0,0
115528,have,0,0
115529,evaluated,0,0
115530,whether,0,0
115531,improved,0,0
115532,medication,0,0
115533,labels,0,0
115534,can,0,0
115535,affect,0,0
115536,appropriate,0,0
115537,medication,0,0
115538,use,0,0
115539,",",0,0
115540,adherence,0,0
115541,or,0,0
115542,health,0,1
115543,outcomes,0,0
115544,.,0,1
115545,TRIAL,0,0
115546,DESIGN,0,0
115547,We,0,0
115548,developed,0,0
115549,an,0,0
115550,evidence-based,0,0
115551,prescription,0,0
115552,label,0,0
115553,that,0,0
115554,addresses,0,0
115555,both,0,0
115556,content,0,0
115557,and,0,0
115558,format,0,0
115559,.,0,0
115560,The,0,0
115561,enhanced,0,0
115562,label,0,0
115563,includes,0,0
115564,a,0,0
115565,universal,0,0
115566,medication,0,0
115567,schedule,0,0
115568,(,0,0
115569,UMS,0,0
115570,),0,0
115571,that,0,0
115572,standardizes,0,0
115573,the,0,0
115574,directions,0,0
115575,for,0,0
115576,use,0,0
115577,incorporating,0,0
115578,1,0,0
115579,),0,0
115580,standard,0,0
115581,time,0,0
115582,periods,0,0
115583,for,0,0
115584,administration,0,0
115585,(,0,0
115586,morning,0,0
115587,",",0,0
115588,noon,0,0
115589,",",0,0
115590,evening,0,0
115591,",",0,0
115592,and,0,0
115593,bedtime,0,0
115594,),0,0
115595,",",0,0
115596,2,0,0
115597,),0,0
115598,numeric,0,0
115599,vs.,0,0
115600,alpha,0,0
115601,characters,0,0
115602,",",0,0
115603,3,0,0
115604,),0,0
115605,'carriage,0,0
115606,returns,0,0
115607,',0,0
115608,to,0,0
115609,separate,0,0
115610,daily,0,0
115611,dose,0,0
115612,and,0,0
115613,4,0,0
115614,),0,0
115615,a,0,0
115616,graphic,0,0
115617,aid,0,0
115618,to,0,0
115619,visually,0,0
115620,depict,0,0
115621,dose,0,0
115622,and,0,0
115623,frequency,0,0
115624,.,0,0
115625,We,0,0
115626,will,0,0
115627,evaluate,0,0
115628,the,0,0
115629,effect,0,0
115630,of,0,0
115631,providing,0,0
115632,this,0,0
115633,label,0,0
115634,to,0,0
115635,randomly,1,1
115636,sampled,1,1
115637,patients,1,1
115638,who,1,1
115639,receive,1,1
115640,their,1,1
115641,care,1,0
115642,from,1,0
115643,free,1,0
115644,clinics,1,1
115645,",",1,0
115646,mobile,1,0
115647,vans,1,0
115648,and,1,0
115649,federally,1,1
115650,qualified,1,0
115651,health,1,0
115652,centers,1,1
115653,(,1,0
115654,FQHCs,1,0
115655,),1,0
115656,in,1,0
115657,Northern,1,1
115658,Virginia,1,1
115659,.,1,0
115660,We,0,0
115661,will,0,0
115662,recruit,0,0
115663,patients,1,1
115664,with,1,1
115665,diabetes,1,1
115666,or,1,1
115667,hypertension,1,1
115668,;,1,0
115669,these,0,0
115670,patients,0,1
115671,will,0,0
115672,be,0,0
115673,randomly,0,0
115674,assigned,0,0
115675,to,0,0
115676,receive,0,0
115677,all,0,0
115678,of,0,0
115679,their,0,0
115680,medications,0,0
115681,with,0,1
115682,improved,0,0
115683,labels,0,0
115684,or,0,1
115685,to,0,0
115686,receive,0,0
115687,prescriptions,0,0
115688,with,0,1
115689,standard,0,0
115690,labels,0,0
115691,.,0,0
115692,The,0,0
115693,primary,0,0
115694,outcome,0,0
115695,will,0,0
115696,be,0,0
115697,the,0,0
115698,patient,0,0
115699,'s,0,0
115700,ability,0,0
115701,to,0,0
115702,correctly,0,0
115703,demonstrate,0,0
115704,dosing,0,0
115705,instructions,0,0
115706,.,0,1
115707,Other,0,0
115708,outcomes,0,0
115709,include,0,0
115710,adherence,0,0
115711,",",0,0
115712,error,0,0
115713,rates,0,0
115714,and,0,0
115715,health,0,1
115716,outcomes,0,0
115717,.,0,0
115718,CONCLUSION,0,0
115719,To,0,0
115720,our,0,0
115721,knowledge,0,0
115722,",",0,0
115723,this,0,0
115724,trial,0,0
115725,is,0,0
115726,the,0,0
115727,first,0,0
115728,to,0,0
115729,evaluate,0,0
115730,the,0,0
115731,effect,0,0
115732,of,0,0
115733,prescription,0,0
115734,label,0,0
115735,improvement,0,0
115736,on,0,0
115737,understanding,0,0
115738,",",0,0
115739,medication,0,0
115740,use,0,0
115741,and,0,0
115742,outcomes,0,0
115743,in,0,0
115744,a,0,0
115745,clinical,0,0
115746,setting,0,0
115747,.,0,0
115748,If,0,0
115749,successful,0,0
115750,",",0,0
115751,these,0,0
115752,findings,0,0
115753,could,0,0
115754,be,0,0
115755,implemented,0,0
115756,broadly,0,0
115757,to,0,0
115758,promote,0,0
115759,safe,0,0
115760,and,0,0
115761,appropriate,0,0
115762,medication,0,0
115763,use,0,0
115764,and,0,0
115765,to,0,0
115766,support,0,0
115767,evidence-based,0,0
115768,standards,0,0
115769,in,0,0
115770,the,0,0
115771,development,0,0
115772,of,0,0
115773,labels,0,0
115774,.,0,1
115775,Tensile,1,0
115776,bond,1,0
115777,strength,1,0
115778,of,1,0
115779,a,1,0
115780,lithium-disilicate,1,0
115781,pressed,1,0
115782,glass,1,0
115783,ceramic,1,0
115784,to,1,0
115785,dentin,1,0
115786,of,0,0
115787,different,0,0
115788,surface,0,1
115789,treatments,0,0
115790,.,0,0
115791,The,0,0
115792,effects,0,0
115793,of,0,0
115794,desensitizer,0,0
115795,",",0,0
115796,disinfectant,0,0
115797,",",0,0
115798,saliva,0,0
115799,",",0,0
115800,blood,0,0
115801,",",0,0
115802,and,0,0
115803,hydrogen,0,0
115804,peroxide,0,0
115805,on,0,0
115806,the,0,0
115807,tensile,0,0
115808,bond,0,0
115809,strength,0,0
115810,between,0,0
115811,adhesive,1,0
115812,and,1,0
115813,ceramic,1,0
115814,as,0,0
115815,well,0,0
115816,as,0,0
115817,between,0,0
115818,adhesive,0,0
115819,and,0,0
115820,dentin,0,1
115821,were,0,0
115822,examined,0,0
115823,.,0,0
115824,Sixty,1,1
115825,7x3,1,0
115826,mm,1,0
115827,pressed,1,0
115828,ceramic,1,0
115829,discs,1,1
115830,of,1,0
115831,IPS,1,0
115832,e.max,1,0
115833,were,0,0
115834,fabricated,0,0
115835,and,0,0
115836,randomly,0,0
115837,assigned,0,0
115838,to,0,0
115839,six,0,0
115840,groups,0,0
115841,of,0,0
115842,different,0,0
115843,dentin,1,1
115844,surface,1,0
115845,treatments,1,0
115846,(,0,0
115847,control,0,0
115848,",",0,0
115849,desensitizer,0,0
115850,",",0,0
115851,disinfectant,0,0
115852,",",0,0
115853,saliva,0,0
115854,",",0,0
115855,blood,0,0
115856,",",0,0
115857,and,0,0
115858,hydrogen,0,0
115859,peroxide,0,0
115860,),0,0
115861,.,0,0
115862,Representative,0,0
115863,samples,0,0
115864,of,0,0
115865,fractured,0,1
115866,specimens,0,1
115867,were,0,0
115868,observed,0,0
115869,by,0,0
115870,SEM,0,0
115871,(,0,0
115872,scanning,0,0
115873,electron,0,0
115874,microscopy,0,0
115875,),0,0
115876,.,0,0
115877,There,0,0
115878,were,0,0
115879,significant,0,0
115880,differences,0,0
115881,between,0,0
115882,the,0,0
115883,control,0,0
115884,group,0,0
115885,and,0,0
115886,saliva,0,0
115887,",",0,0
115888,blood,0,0
115889,",",0,0
115890,and,0,0
115891,hydrogen,0,0
115892,peroxide,0,0
115893,groups,0,0
115894,(,0,0
115895,p,0,0
115896,<,0,0
115897,0.05,0,0
115898,),0,0
115899,.,0,0
115900,However,0,0
115901,",",0,0
115902,there,0,0
115903,were,0,0
115904,no,0,0
115905,significant,0,0
115906,differences,0,0
115907,between,0,0
115908,any,0,0
115909,other,0,0
115910,dentin,0,0
115911,surface,0,0
115912,treatment,0,0
115913,groups,0,0
115914,(,0,0
115915,p,0,0
115916,>,0,1
115917,0.05,0,0
115918,),0,0
115919,.,0,0
115920,Results,0,0
115921,of,0,0
115922,this,0,0
115923,study,0,0
115924,suggested,0,0
115925,that,0,0
115926,only,0,0
115927,saliva,0,0
115928,",",0,0
115929,blood,0,0
115930,",",0,0
115931,and,0,0
115932,hydrogen,0,0
115933,peroxide,0,0
115934,influenced,0,0
115935,the,0,0
115936,tensile,0,0
115937,bond,0,0
115938,strength,0,0
115939,between,0,0
115940,dentin,0,0
115941,and,0,0
115942,ceramic,0,0
115943,.,0,0
115944,A,0,0
115945,comparison,0,0
115946,of,0,0
115947,the,0,0
115948,effect,0,0
115949,of,0,0
115950,short-term,0,0
115951,aromatase,0,0
115952,inhibitor,0,0
115953,(,0,0
115954,letrozole,0,0
115955,),0,0
115956,and,0,0
115957,GnRH,0,0
115958,agonist,0,0
115959,(,0,0
115960,triptorelin,0,0
115961,),0,0
115962,versus,0,0
115963,case,0,0
115964,control,0,0
115965,on,0,0
115966,pregnancy,0,1
115967,rate,0,0
115968,and,0,0
115969,symptom,0,0
115970,and,0,0
115971,sign,0,0
115972,recurrence,0,0
115973,after,0,0
115974,laparoscopic,0,0
115975,treatment,0,0
115976,of,0,0
115977,endometriosis,0,1
115978,.,0,0
115979,PURPOSE,0,0
115980,To,0,0
115981,compare,0,0
115982,the,0,0
115983,role,0,0
115984,of,0,0
115985,an,0,0
115986,aromatase,0,0
115987,inhibitor,0,0
115988,(,0,0
115989,letrozole,0,0
115990,),0,0
115991,with,0,1
115992,a,0,0
115993,GnRH,0,0
115994,agonist,0,0
115995,(,0,0
115996,triptorelin,0,0
115997,),0,0
115998,versus,0,0
115999,case,0,0
116000,control,0,0
116001,on,0,0
116002,the,0,0
116003,pregnancy,0,1
116004,rate,0,0
116005,and,0,0
116006,recurrence,0,0
116007,of,0,0
116008,symptoms,0,0
116009,and,0,0
116010,signs,0,0
116011,in,0,0
116012,patients,1,1
116013,with,1,1
116014,endometriosis,1,1
116015,.,1,0
116016,METHODS,0,0
116017,In,0,0
116018,a,0,0
116019,prospective,0,0
116020,randomized,0,0
116021,clinical,0,0
116022,trial,0,0
116023,",",0,0
116024,after,1,0
116025,treatment,1,0
116026,of,1,0
116027,144,1,1
116028,infertile,1,1
116029,women,1,1
116030,in,1,0
116031,their,1,1
116032,reproductive,1,0
116033,age,1,1
116034,by,1,0
116035,laparoscopy,1,0
116036,(,1,0
116037,whose,1,0
116038,endometriosis,1,1
116039,was,1,1
116040,confirmed,1,0
116041,by,1,0
116042,prior,1,0
116043,laparoscopy,1,1
116044,),1,0
116045,",",0,0
116046,they,0,0
116047,were,0,0
116048,divided,0,0
116049,into,0,1
116050,3,0,0
116051,groups,0,0
116052,:,0,1
116053,group,0,0
116054,1,0,0
116055,(,1,0
116056,47,1,1
116057,cases,1,1
116058,),1,1
116059,who,1,1
116060,received,1,1
116061,letrozole,1,1
116062,for,1,0
116063,2,1,0
116064,months,1,0
116065,",",1,0
116066,group,1,0
116067,2,1,0
116068,(,1,0
116069,40,1,1
116070,patients,1,1
116071,),1,1
116072,who,1,1
116073,were,1,1
116074,prescribed,1,1
116075,triptorelin,1,0
116076,for,1,0
116077,2,1,0
116078,months,1,0
116079,and,1,0
116080,group,1,1
116081,3,1,0
116082,who,1,1
116083,were,1,1
116084,57,1,1
116085,patients,1,1
116086,in,1,0
116087,the,1,0
116088,control,1,0
116089,group,1,0
116090,and,1,0
116091,did,1,0
116092,not,1,0
116093,receive,1,0
116094,any,1,0
116095,medication,1,0
116096,.,1,0
116097,We,0,0
116098,followed,0,0
116099,up,0,0
116100,each,0,0
116101,group,0,0
116102,at,0,0
116103,least,0,0
116104,for,0,0
116105,12,0,0
116106,months,0,0
116107,after,0,0
116108,their,0,0
116109,restoration,0,0
116110,of,0,0
116111,regular,0,0
116112,cycle,0,0
116113,.,0,0
116114,RESULTS,0,0
116115,Pregnancy,0,0
116116,rate,0,0
116117,was,0,0
116118,23.4,0,0
116119,%,0,0
116120,in,0,0
116121,group,0,0
116122,1,0,0
116123,",",0,0
116124,27.5,0,0
116125,%,0,0
116126,in,0,0
116127,group,0,0
116128,2,0,0
116129,",",0,0
116130,and,0,0
116131,28.1,0,0
116132,%,0,0
116133,in,0,0
116134,group,0,0
116135,3,0,0
116136,.,0,0
116137,The,0,0
116138,results,0,0
116139,did,0,0
116140,not,0,0
116141,show,0,0
116142,significant,0,0
116143,differences,0,0
116144,among,0,1
116145,the,0,0
116146,3,0,0
116147,groups,0,0
116148,.,0,1
116149,Recurrence,0,0
116150,rate,0,0
116151,of,0,0
116152,endometriosis,0,1
116153,was,0,0
116154,6.4,0,0
116155,%,0,0
116156,in,0,0
116157,group,0,0
116158,1,0,0
116159,",",0,0
116160,5,0,0
116161,%,0,0
116162,group,0,0
116163,2,0,0
116164,and,0,0
116165,5.3,0,0
116166,%,0,0
116167,in,0,0
116168,group,0,0
116169,3,0,0
116170,",",0,0
116171,which,0,0
116172,was,0,0
116173,not,0,0
116174,statistically,0,0
116175,significantly,0,0
116176,different,0,0
116177,as,0,0
116178,well,0,0
116179,.,0,0
116180,CONCLUSION,0,0
116181,Pregnancy,0,0
116182,rate,0,0
116183,and,0,0
116184,endometriosis,0,1
116185,recurrence,0,0
116186,rate,0,0
116187,are,0,0
116188,comparable,0,0
116189,among,0,0
116190,the,0,0
116191,3,0,0
116192,groups,0,0
116193,.,0,1
116194,Therapeutic,0,1
116195,effects,0,0
116196,of,0,0
116197,combined,0,0
116198,treatment,0,0
116199,using,0,0
116200,tetracycline-immobilized,0,0
116201,collagen,0,0
116202,film,0,0
116203,and,0,0
116204,root,0,0
116205,planing,0,0
116206,in,0,0
116207,periodontal,1,0
116208,furcation,1,0
116209,pockets,1,0
116210,.,1,1
116211,46,1,0
116212,upper,1,0
116213,and,1,0
116214,lower,1,0
116215,molars,1,1
116216,with,1,1
116217,furcation,1,0
116218,grade,1,0
116219,II,1,0
116220,involvement,1,0
116221,were,1,0
116222,selected,1,1
116223,from,1,0
116224,16,1,1
116225,patients,1,1
116226,with,1,1
116227,periodontal,1,1
116228,disease,1,1
116229,.,1,0
116230,The,0,0
116231,teeth,0,0
116232,were,0,0
116233,randomly,0,1
116234,allocated,0,0
116235,to,0,0
116236,the,0,0
116237,following,0,0
116238,groups,0,0
116239,according,0,1
116240,to,0,0
116241,treatment,0,0
116242,;,0,0
116243,(,0,0
116244,1,0,0
116245,),0,0
116246,4,0,0
116247,consecutive,0,1
116248,administrations,0,0
116249,of,0,0
116250,tetracycline-immobilized,0,0
116251,cross-linked,0,0
116252,collagen,0,0
116253,film,0,0
116254,(,0,0
116255,TC,0,0
116256,film,0,0
116257,),0,0
116258,at,0,0
116259,intervals,0,0
116260,of,0,0
116261,1,0,0
116262,week,0,0
116263,(,0,0
116264,TC,0,0
116265,group,0,1
116266,),0,0
116267,;,0,0
116268,(,0,0
116269,2,0,0
116270,),0,0
116271,1,0,0
116272,root,0,0
116273,planing,0,0
116274,treatment,0,0
116275,(,0,0
116276,RP,0,0
116277,group,0,1
116278,),0,0
116279,;,0,0
116280,(,0,0
116281,3,0,0
116282,),0,0
116283,combination,0,0
116284,treatment,0,0
116285,(,0,0
116286,TC,0,0
116287,+,0,0
116288,RP,0,0
116289,group,0,1
116290,),0,0
116291,;,0,0
116292,(,0,0
116293,4,0,0
116294,),0,0
116295,no,0,0
116296,treatment,0,0
116297,(,0,0
116298,control,0,0
116299,group,0,0
116300,),0,0
116301,.,0,0
116302,The,0,0
116303,therapeutic,0,0
116304,effects,0,0
116305,of,0,0
116306,each,0,0
116307,treatment,0,0
116308,were,0,0
116309,compared,0,0
116310,both,0,0
116311,clinically,0,0
116312,and,0,0
116313,microbiologically,0,0
116314,.,0,0
116315,Records,0,0
116316,of,0,0
116317,plaque,0,0
116318,index,0,0
116319,",",0,0
116320,gingival,0,0
116321,index,0,0
116322,",",0,0
116323,bleeding,0,0
116324,on,0,0
116325,probing,0,0
116326,",",0,0
116327,probing,0,0
116328,depth,0,0
116329,",",0,0
116330,probing,0,0
116331,attachment,0,0
116332,level,0,0
116333,and,0,0
116334,microscopic,0,0
116335,counts,0,0
116336,were,0,0
116337,obtained,0,0
116338,at,0,0
116339,0,0,0
116340,",",0,0
116341,4,0,0
116342,",",0,0
116343,6,0,0
116344,and,0,0
116345,8,0,0
116346,weeks,0,0
116347,.,0,1
116348,The,0,0
116349,results,0,0
116350,showed,0,0
116351,marked,0,0
116352,decreases,0,0
116353,in,0,0
116354,probing,0,0
116355,depth,0,0
116356,and,0,0
116357,density,0,0
116358,of,0,0
116359,micro-organisms,0,0
116360,in,0,0
116361,both,0,0
116362,the,0,0
116363,RP,0,0
116364,and,0,0
116365,TC,0,0
116366,+,0,0
116367,RP,0,1
116368,groups,0,0
116369,.,0,0
116370,In,0,0
116371,particular,0,0
116372,",",0,0
116373,the,0,0
116374,TC,0,0
116375,+,0,0
116376,RP,0,0
116377,group,0,0
116378,was,0,0
116379,characterized,0,0
116380,by,0,0
116381,a,0,0
116382,decreased,0,0
116383,rate,0,0
116384,of,0,0
116385,bleeding,0,0
116386,on,0,0
116387,pocket,0,0
116388,probing,0,0
116389,and,0,0
116390,an,0,0
116391,increased,0,0
116392,probing,0,0
116393,attachment,0,0
116394,gain,0,0
116395,.,0,0
116396,The,0,0
116397,above,0,0
116398,findings,0,0
116399,demonstrated,0,0
116400,that,0,0
116401,root,0,0
116402,planning,0,0
116403,is,0,0
116404,effective,0,0
116405,in,0,0
116406,the,0,0
116407,treatment,0,0
116408,of,0,0
116409,furcation,0,0
116410,involvement,0,0
116411,and,0,0
116412,that,0,0
116413,the,0,0
116414,effects,0,0
116415,are,0,0
116416,enhanced,0,0
116417,by,0,0
116418,the,0,0
116419,local,0,0
116420,administration,0,0
116421,of,0,0
116422,TC,0,0
116423,films,0,1
116424,.,0,1
116425,Alinidine,0,0
116426,in,0,0
116427,chronic,1,1
116428,stable,1,1
116429,angina,1,1
116430,:,1,1
116431,the,0,0
116432,effect,0,0
116433,on,0,0
116434,diastolic,0,0
116435,perfusion,0,0
116436,time,0,0
116437,.,0,0
116438,The,0,0
116439,present,0,0
116440,study,0,0
116441,has,0,0
116442,been,0,0
116443,performed,0,0
116444,to,0,0
116445,assess,0,0
116446,the,0,0
116447,effects,0,0
116448,of,0,0
116449,alinidine,0,0
116450,on,0,0
116451,diastolic,0,0
116452,duration,0,0
116453,during,0,0
116454,exercise,0,0
116455,in,0,0
116456,chronic,1,1
116457,coronary,1,1
116458,artery,1,1
116459,disease,1,1
116460,.,1,0
116461,Twelve,1,1
116462,male,1,1
116463,patients,1,1
116464,with,1,1
116465,stable,1,1
116466,effort,1,0
116467,angina,1,1
116468,and,1,0
116469,without,1,0
116470,previous,1,0
116471,myocardial,1,1
116472,infarction,1,1
116473,were,1,0
116474,studied,1,0
116475,.,1,0
116476,They,0,0
116477,received,0,0
116478,alinidine,0,0
116479,or,0,0
116480,placebo,0,0
116481,in,0,0
116482,a,0,0
116483,double-blind,0,0
116484,randomized,0,0
116485,crossover,0,0
116486,trial,0,0
116487,for,0,0
116488,3,0,0
116489,days,0,0
116490,after,0,0
116491,a,0,0
116492,wash-out,0,0
116493,period,0,0
116494,of,0,0
116495,4,0,0
116496,days,0,0
116497,.,0,1
116498,Alinidine,0,0
116499,was,0,0
116500,administered,0,0
116501,at,0,0
116502,a,0,0
116503,dosage,0,0
116504,of,0,0
116505,30,0,0
116506,mg,0,0
116507,3,0,0
116508,times,0,0
116509,a,0,0
116510,day,0,0
116511,.,0,0
116512,At,0,0
116513,the,0,0
116514,end,0,0
116515,of,0,0
116516,each,0,0
116517,treatment,0,0
116518,the,0,0
116519,patients,0,1
116520,underwent,0,1
116521,upright,0,0
116522,bicycle,0,1
116523,exercise,0,0
116524,.,0,0
116525,Left,0,0
116526,ventricular,0,0
116527,time,0,0
116528,intervals,0,0
116529,were,0,0
116530,obtained,0,0
116531,by,0,0
116532,means,0,0
116533,of,0,0
116534,carotid,0,1
116535,thermistor,0,0
116536,plethysmography,0,0
116537,.,0,0
116538,Diastolic,0,0
116539,duration,0,0
116540,was,0,0
116541,calculated,0,0
116542,by,0,0
116543,subtracting,0,0
116544,the,0,0
116545,electromechanical,0,0
116546,systole,0,0
116547,from,0,0
116548,the,0,0
116549,R-R,0,0
116550,interval,0,0
116551,and,0,0
116552,expressed,0,0
116553,as,0,0
116554,a,0,0
116555,percentage,0,0
116556,of,0,0
116557,the,0,0
116558,cardiac,0,0
116559,cycle,0,0
116560,(,0,0
116561,%,0,0
116562,D,0,0
116563,),0,0
116564,.,0,0
116565,Alinidine,0,0
116566,increased,0,0
116567,both,0,0
116568,total,0,0
116569,exercise,0,0
116570,duration,0,0
116571,from,0,0
116572,246.7,0,0
116573,+/-,0,0
116574,120.7,0,0
116575,to,0,0
116576,346.6,0,0
116577,+/-,0,0
116578,114.1,0,0
116579,s,0,0
116580,(,0,0
116581,p,0,0
116582,less,0,0
116583,than,0,0
116584,0.05,0,0
116585,),0,0
116586,and,0,0
116587,time,0,0
116588,to,0,0
116589,0.1-mV,0,0
116590,ST,0,1
116591,segment,0,0
116592,depression,0,1
116593,from,0,0
116594,98.3,0,0
116595,+/-,0,0
116596,53,0,1
116597,to,0,0
116598,187.2,0,0
116599,+/-,0,0
116600,105,0,1
116601,s,0,0
116602,(,0,0
116603,p,0,0
116604,less,0,0
116605,than,0,0
116606,0.05,0,0
116607,),0,0
116608,.,0,0
116609,Similarly,0,0
116610,the,0,0
116611,drug,0,0
116612,induced,0,0
116613,a,0,0
116614,reduction,0,0
116615,of,0,0
116616,the,0,0
116617,rate-pressure,0,0
116618,product,0,0
116619,and,0,0
116620,of,0,0
116621,the,0,0
116622,extent,0,0
116623,of,0,0
116624,ischemic,0,1
116625,ST,0,1
116626,segment,0,0
116627,depression,0,1
116628,during,0,0
116629,exercise,0,0
116630,.,0,0
116631,%,0,0
116632,D,0,0
116633,was,0,0
116634,increased,0,0
116635,by,0,0
116636,alinidine,0,0
116637,both,0,0
116638,at,0,0
116639,rest,0,0
116640,and,0,0
116641,during,0,0
116642,exercise,0,0
116643,.,0,0
116644,A,0,0
116645,direct,0,0
116646,linear,0,0
116647,regression,0,0
116648,between,0,0
116649,R-R,0,0
116650,and,0,0
116651,%,0,0
116652,D,0,0
116653,was,0,0
116654,found,0,0
116655,after,0,0
116656,both,0,0
116657,alinidine,0,0
116658,and,0,0
116659,placebo,0,0
116660,treatments,0,0
116661,either,0,0
116662,at,0,0
116663,rest,0,0
116664,or,0,0
116665,during,0,0
116666,exercise,0,0
116667,.,0,0
116668,Nevertheless,0,0
116669,",",0,0
116670,no,0,0
116671,difference,0,0
116672,was,0,0
116673,observed,0,0
116674,between,0,0
116675,both,0,0
116676,slopes,0,0
116677,and,0,0
116678,intercepts,0,0
116679,.,0,0
116680,Therefore,0,0
116681,",",0,0
116682,since,0,0
116683,the,0,0
116684,relationship,0,0
116685,between,0,0
116686,R-R,0,0
116687,interval,0,0
116688,and,0,0
116689,%,0,0
116690,D,0,0
116691,was,0,0
116692,unaffected,0,0
116693,by,0,0
116694,alinidine,0,0
116695,",",0,0
116696,it,0,0
116697,was,0,0
116698,possible,0,0
116699,to,0,0
116700,hypothesize,0,0
116701,that,0,0
116702,the,0,0
116703,changes,0,0
116704,in,0,0
116705,diastolic,0,1
116706,duration,0,0
116707,were,0,0
116708,due,0,0
116709,only,0,0
116710,to,0,0
116711,the,0,0
116712,bradycardic,0,0
116713,action,0,0
116714,of,0,0
116715,the,0,0
116716,drug,0,0
116717,.,0,0
116718,Randomized,0,0
116719,controlled,0,0
116720,trial,0,0
116721,of,0,0
116722,electro-acupuncture,0,0
116723,for,0,0
116724,autism,1,1
116725,spectrum,1,1
116726,disorder,1,1
116727,.,1,0
116728,OBJECTIVE,0,0
116729,To,0,0
116730,study,0,0
116731,the,0,0
116732,efficacy,0,0
116733,",",0,0
116734,safety,0,0
116735,",",0,0
116736,and,0,0
116737,compliance,0,0
116738,of,0,0
116739,short-term,0,0
116740,electro-acupuncture,0,0
116741,for,0,0
116742,children,1,1
116743,with,1,1
116744,autism,1,1
116745,spectrum,1,1
116746,disorder,1,1
116747,(,1,0
116748,ASD,1,1
116749,),1,0
116750,.,1,0
116751,DESIGN,0,0
116752,Randomized,0,0
116753,",",0,0
116754,double-blind,0,0
116755,",",0,0
116756,sham-controlled,0,0
116757,",",0,0
116758,clinical,0,0
116759,trial,0,0
116760,.,0,0
116761,SUBJECTS,0,0
116762,AND,0,0
116763,METHODS,0,0
116764,Children,1,1
116765,with,1,1
116766,ASD,1,1
116767,were,0,0
116768,randomly,0,0
116769,assigned,0,0
116770,to,0,0
116771,an,0,0
116772,electro-acupuncture,1,0
116773,(,1,0
116774,EA,1,0
116775,),1,0
116776,group,1,0
116777,(,1,0
116778,n=30,1,1
116779,),1,0
116780,or,1,0
116781,a,1,0
116782,sham,1,0
116783,electro-acupuncture,1,0
116784,(,1,0
116785,SEA,1,1
116786,),1,0
116787,group,1,0
116788,(,1,0
116789,n=25,1,1
116790,),1,0
116791,matched,1,0
116792,by,1,0
116793,age,1,1
116794,and,1,0
116795,severity,1,0
116796,of,1,0
116797,autism,1,1
116798,.,1,0
116799,The,0,0
116800,EA,0,0
116801,group,0,0
116802,received,0,0
116803,electro-acupuncture,0,0
116804,for,0,0
116805,selected,0,1
116806,acupoints,0,0
116807,while,0,0
116808,the,0,0
116809,SEA,0,1
116810,group,0,0
116811,received,0,0
116812,sham,0,0
116813,electro-acupuncture,0,0
116814,to,0,0
116815,sham,0,0
116816,acupoints,0,0
116817,.,0,0
116818,A,0,0
116819,total,0,0
116820,of,0,0
116821,12,0,0
116822,EA,0,0
116823,and,0,0
116824,SEA,0,1
116825,sessions,0,0
116826,over,0,0
116827,four,0,1
116828,weeks,0,0
116829,were,0,0
116830,given,0,0
116831,.,0,0
116832,Primary,0,0
116833,outcome,0,0
116834,measures,0,0
116835,included,0,1
116836,Functional,0,0
116837,Independence,0,0
116838,Measure,0,0
116839,for,0,0
116840,Children,0,1
116841,(,0,0
116842,WeeFIM,0,0
116843,),0,0
116844,",",0,0
116845,Pediatric,0,1
116846,Evaluation,0,0
116847,of,0,0
116848,Disability,0,0
116849,Inventory,0,1
116850,(,0,0
116851,PEDI,0,0
116852,),0,0
116853,",",0,0
116854,Leiter,0,1
116855,International,0,1
116856,Performance,0,0
116857,Scale-Revised,0,0
116858,(,0,0
116859,Leiter-R,0,0
116860,),0,0
116861,",",0,0
116862,and,0,0
116863,Clinical,0,0
116864,Global,0,0
116865,Impression-Improvement,0,0
116866,(,0,0
116867,CGI-I,0,0
116868,),0,0
116869,scale,0,0
116870,.,0,0
116871,Secondary,0,0
116872,outcome,0,0
116873,measures,0,0
116874,consisted,0,0
116875,of,0,0
116876,Aberrant,0,0
116877,Behavior,0,0
116878,Checklist,0,0
116879,(,0,0
116880,ABC,0,0
116881,),0,0
116882,",",0,0
116883,Ritvo-Freeman,0,0
116884,Real,0,0
116885,Life,0,0
116886,Scale,0,0
116887,(,0,0
116888,RFRLS,0,0
116889,),0,0
116890,",",0,0
116891,Reynell,0,0
116892,Developmental,0,1
116893,Language,0,0
116894,Scale,0,0
116895,(,0,0
116896,RDLS,0,0
116897,),0,0
116898,",",0,0
116899,and,0,0
116900,a,0,0
116901,standardized,0,0
116902,parental,0,0
116903,report,0,0
116904,.,0,0
116905,Data,0,0
116906,were,0,0
116907,analyzed,0,0
116908,by,0,0
116909,the,0,0
116910,Mann-Whitney,0,0
116911,test,0,0
116912,.,0,0
116913,RESULTS,0,0
116914,There,0,0
116915,were,0,0
116916,significant,0,0
116917,improvements,0,0
116918,in,0,0
116919,the,0,0
116920,language,0,0
116921,comprehension,0,0
116922,domain,0,0
116923,of,0,0
116924,WeeFIM,0,0
116925,(,0,0
116926,p=0.02,0,0
116927,),0,0
116928,",",0,0
116929,self-care,0,0
116930,caregiver,0,0
116931,assistant,0,0
116932,domain,0,0
116933,of,0,0
116934,PEDI,0,0
116935,(,0,0
116936,p=0.028,0,0
116937,),0,0
116938,",",0,0
116939,and,0,0
116940,CGI-I,0,0
116941,(,0,0
116942,p=0.003,0,0
116943,),0,0
116944,in,0,0
116945,the,0,0
116946,EA,0,0
116947,group,0,0
116948,compared,0,0
116949,to,0,0
116950,the,0,0
116951,SEA,0,0
116952,group,0,0
116953,.,0,0
116954,As,0,0
116955,for,0,0
116956,the,0,0
116957,parental,0,0
116958,report,0,0
116959,",",0,0
116960,the,0,0
116961,EA,0,0
116962,group,0,0
116963,also,0,0
116964,showed,0,0
116965,significantly,0,0
116966,better,0,0
116967,social,0,0
116968,initiation,0,0
116969,(,0,0
116970,p=0.01,0,0
116971,),0,0
116972,",",0,0
116973,receptive,0,0
116974,language,0,0
116975,(,0,0
116976,p=0.006,0,0
116977,),0,0
116978,",",0,0
116979,motor,0,0
116980,skills,0,0
116981,(,0,0
116982,p=0.034,0,0
116983,),0,0
116984,",",0,0
116985,coordination,0,0
116986,(,0,0
116987,p=0.07,0,0
116988,),0,0
116989,",",0,0
116990,and,0,0
116991,attention,0,0
116992,span,0,0
116993,(,0,0
116994,p=0.003,0,0
116995,),0,0
116996,.,0,0
116997,More,0,0
116998,than,0,0
116999,70,0,1
117000,percent,0,0
117001,of,0,0
117002,children,1,1
117003,with,1,1
117004,ASD,1,1
117005,adapted,0,0
117006,to,0,0
117007,acupuncture,0,0
117008,easily,0,0
117009,",",0,0
117010,while,0,0
117011,eight,0,1
117012,percent,0,0
117013,had,0,0
117014,poor,0,0
117015,acupuncture,0,0
117016,compliance,0,0
117017,.,0,0
117018,Mild,0,0
117019,side,0,0
117020,effects,0,0
117021,of,0,0
117022,minor,0,0
117023,superficial,0,0
117024,bleeding,0,0
117025,or,0,0
117026,irritability,0,0
117027,during,0,0
117028,acupuncture,0,0
117029,were,0,0
117030,observed,0,0
117031,.,0,0
117032,CONCLUSION,0,0
117033,A,0,0
117034,short,0,0
117035,",",0,0
117036,four-week,0,0
117037,(,0,0
117038,12,0,0
117039,sessions,0,0
117040,),0,0
117041,course,0,0
117042,of,0,0
117043,electro-acupuncture,0,0
117044,is,0,0
117045,useful,0,0
117046,to,0,0
117047,improve,0,0
117048,specific,0,0
117049,functions,0,0
117050,in,0,0
117051,children,1,1
117052,with,1,1
117053,ASD,1,1
117054,",",0,0
117055,especially,0,0
117056,for,0,0
117057,language,0,0
117058,comprehension,0,0
117059,and,0,0
117060,self-care,0,0
117061,ability,0,0
117062,.,0,0
117063,A,0,0
117064,cluster,0,0
117065,randomised,0,0
117066,trial,0,0
117067,to,0,0
117068,evaluate,0,0
117069,a,0,0
117070,physical,0,0
117071,activity,0,0
117072,intervention,0,0
117073,among,0,0
117074,3-5,1,1
117075,year,1,1
117076,old,1,1
117077,children,1,1
117078,attending,1,1
117079,long,1,1
117080,day,1,0
117081,care,1,0
117082,services,1,1
117083,:,1,1
117084,study,0,0
117085,protocol,0,0
117086,.,0,0
117087,BACKGROUND,0,0
117088,Young,1,1
117089,children,1,1
117090,are,0,0
117091,not,0,0
117092,participating,0,1
117093,in,0,0
117094,recommended,0,0
117095,levels,0,0
117096,of,0,0
117097,physical,0,0
117098,activity,0,0
117099,and,0,0
117100,exhibit,0,0
117101,high,0,0
117102,levels,0,0
117103,of,0,0
117104,sedentary,0,1
117105,behaviour,0,0
117106,.,0,0
117107,Childcare,0,1
117108,services,0,0
117109,provide,0,0
117110,access,0,0
117111,to,0,0
117112,large,0,0
117113,numbers,0,0
117114,of,0,0
117115,young,1,1
117116,children,1,1
117117,for,0,0
117118,prolonged,0,0
117119,periods,0,0
117120,",",0,0
117121,yet,0,0
117122,there,0,0
117123,is,0,0
117124,limited,0,0
117125,experimental,0,0
117126,evidence,0,0
117127,regarding,0,0
117128,the,0,0
117129,effectiveness,0,0
117130,of,0,0
117131,physical,0,0
117132,activity,0,0
117133,interventions,0,0
117134,implemented,0,0
117135,in,0,0
117136,this,0,0
117137,setting,0,0
117138,.,0,0
117139,The,0,0
117140,aim,0,0
117141,of,0,0
117142,this,0,0
117143,study,0,0
117144,is,0,0
117145,to,0,0
117146,assess,0,0
117147,the,0,0
117148,effectiveness,0,0
117149,and,0,0
117150,acceptability,0,0
117151,of,0,0
117152,a,0,0
117153,multi-component,0,0
117154,physical,0,0
117155,activity,0,0
117156,intervention,0,0
117157,",",0,0
117158,delivered,0,0
117159,by,0,0
117160,childcare,0,1
117161,service,0,0
117162,staff,0,0
117163,",",0,0
117164,in,0,0
117165,increasing,0,0
117166,the,0,0
117167,physical,0,0
117168,activity,0,0
117169,levels,0,0
117170,of,0,0
117171,children,1,1
117172,attending,1,1
117173,long,1,1
117174,day,1,0
117175,care,1,0
117176,services,1,1
117177,.,1,0
117178,METHODS/DESIGN,0,0
117179,The,0,0
117180,study,0,0
117181,will,0,0
117182,employ,0,0
117183,a,0,0
117184,cluster,0,0
117185,randomised,0,0
117186,controlled,0,0
117187,trial,0,0
117188,design,0,0
117189,.,0,0
117190,Three,1,0
117191,hundred,1,1
117192,children,1,1
117193,aged,1,1
117194,between,1,0
117195,3-5,1,1
117196,years,1,1
117197,from,1,0
117198,twenty,1,1
117199,randomly,1,1
117200,selected,1,0
117201,long,1,0
117202,day,1,0
117203,care,1,0
117204,services,1,0
117205,in,1,0
117206,the,1,0
117207,Hunter,1,0
117208,Region,1,0
117209,of,1,0
117210,New,1,1
117211,South,1,1
117212,Wales,1,0
117213,",",1,0
117214,Australia,1,0
117215,will,0,0
117216,be,0,0
117217,invited,0,0
117218,to,0,0
117219,participate,0,0
117220,in,0,0
117221,the,0,0
117222,trial,0,0
117223,.,0,0
117224,Ten,0,0
117225,of,0,0
117226,the,0,0
117227,20,0,0
117228,long,0,0
117229,day,0,0
117230,care,0,0
117231,services,0,0
117232,will,0,0
117233,be,0,0
117234,randomly,0,0
117235,allocated,0,0
117236,to,0,0
117237,deliver,0,0
117238,the,0,0
117239,intervention,0,0
117240,with,0,0
117241,the,0,0
117242,remaining,0,0
117243,ten,0,1
117244,services,0,1
117245,allocated,0,0
117246,to,0,0
117247,a,0,0
117248,wait,0,0
117249,list,0,0
117250,control,0,0
117251,group,0,0
117252,.,0,0
117253,The,0,0
117254,physical,0,0
117255,activity,0,0
117256,intervention,0,0
117257,will,0,0
117258,consist,0,0
117259,of,0,0
117260,a,0,0
117261,number,0,0
117262,of,0,0
117263,strategies,0,0
117264,including,0,0
117265,:,0,1
117266,delivering,0,0
117267,structured,0,0
117268,fundamental,0,0
117269,movement,0,0
117270,skill,0,0
117271,activities,0,0
117272,",",0,0
117273,increasing,0,0
117274,physical,0,0
117275,activity,0,0
117276,opportunities,0,0
117277,",",0,0
117278,increasing,0,0
117279,staff,0,0
117280,role,0,0
117281,modelling,0,0
117282,",",0,0
117283,providing,0,0
117284,children,0,1
117285,with,0,1
117286,a,0,0
117287,physical,0,0
117288,activity,0,0
117289,promoting,0,0
117290,indoor,0,0
117291,and,0,0
117292,outdoor,0,0
117293,environment,0,0
117294,and,0,0
117295,limiting,0,0
117296,children,0,1
117297,'s,0,1
117298,small,0,0
117299,screen,0,1
117300,recreation,0,0
117301,and,0,0
117302,sedentary,0,1
117303,behaviours,0,0
117304,.,0,1
117305,Intervention,0,0
117306,effectiveness,0,0
117307,will,0,0
117308,be,0,0
117309,measured,0,0
117310,via,0,0
117311,child,0,1
117312,physical,0,0
117313,activity,0,0
117314,levels,0,0
117315,during,0,0
117316,attendance,0,0
117317,at,0,0
117318,long,0,0
117319,day,0,0
117320,care,0,0
117321,.,0,0
117322,The,0,0
117323,study,0,0
117324,also,0,0
117325,seeks,0,0
117326,to,0,0
117327,determine,0,0
117328,the,0,0
117329,acceptability,0,0
117330,and,0,0
117331,extent,0,0
117332,of,0,0
117333,implementation,0,0
117334,of,0,0
117335,the,0,0
117336,intervention,0,0
117337,by,0,0
117338,services,0,1
117339,and,0,0
117340,their,0,0
117341,staff,0,0
117342,participating,0,1
117343,in,0,0
117344,the,0,0
117345,study,0,0
117346,.,0,0
117347,DISCUSSION,0,0
117348,The,0,0
117349,trial,0,0
117350,will,0,0
117351,address,0,0
117352,current,0,0
117353,gaps,0,0
117354,in,0,0
117355,the,0,0
117356,research,0,0
117357,evidence,0,0
117358,base,0,0
117359,and,0,0
117360,contribute,0,0
117361,to,0,0
117362,the,0,0
117363,design,0,0
117364,and,0,0
117365,delivery,0,0
117366,of,0,0
117367,future,0,0
117368,interventions,0,0
117369,promoting,0,0
117370,physical,0,0
117371,activity,0,0
117372,for,0,0
117373,young,1,1
117374,children,1,1
117375,in,1,0
117376,long,1,1
117377,day,1,0
117378,care,1,1
117379,settings,1,0
117380,.,1,1
117381,TRIAL,0,0
117382,REGISTRATION,0,0
117383,Australian,1,1
117384,New,1,1
117385,Zealand,1,1
117386,Clinical,1,0
117387,Trials,1,0
117388,Registry,1,1
117389,ACTRN12610000087055,0,0
117390,.,0,0
117391,A,0,0
117392,randomized,0,0
117393,trial,0,0
117394,of,0,0
117395,genetic,0,0
117396,and,0,0
117397,environmental,0,0
117398,risk,0,0
117399,assessment,0,0
117400,(,0,0
117401,GERA,0,0
117402,),0,0
117403,for,0,0
117404,colorectal,0,1
117405,cancer,0,1
117406,risk,0,0
117407,in,0,0
117408,primary,0,1
117409,care,0,1
117410,:,0,1
117411,trial,0,0
117412,design,0,0
117413,and,0,0
117414,baseline,0,0
117415,findings,0,0
117416,.,0,0
117417,PURPOSE,0,0
117418,This,0,0
117419,paper,0,0
117420,describes,0,0
117421,an,0,0
117422,ongoing,0,0
117423,randomized,0,0
117424,controlled,0,0
117425,trial,0,0
117426,designed,0,0
117427,to,0,0
117428,assess,0,0
117429,the,0,0
117430,impact,0,0
117431,of,0,0
117432,genetic,0,0
117433,and,0,0
117434,environmental,0,0
117435,risk,0,0
117436,assessment,0,0
117437,(,0,0
117438,GERA,0,0
117439,),0,0
117440,on,0,0
117441,colorectal,1,1
117442,cancer,1,1
117443,(,1,0
117444,CRC,1,0
117445,),1,0
117446,screening,0,1
117447,.,0,0
117448,METHODS,0,0
117449,The,0,0
117450,trial,0,0
117451,includes,0,0
117452,asymptomatic,1,1
117453,patients,1,1
117454,who,1,1
117455,are,1,1
117456,50-79years,1,1
117457,and,1,0
117458,are,1,0
117459,not,1,0
117460,up-to-date,1,0
117461,with,1,0
117462,CRC,1,0
117463,screening,1,1
117464,guidelines,1,0
117465,.,1,1
117466,Patients,0,1
117467,who,0,1
117468,responded,0,1
117469,to,0,1
117470,a,0,0
117471,baseline,0,0
117472,telephone,0,0
117473,survey,0,1
117474,are,0,0
117475,randomized,0,0
117476,to,0,0
117477,a,0,0
117478,GERA,1,0
117479,or,1,0
117480,Control,1,0
117481,group,1,0
117482,.,1,0
117483,GERA,0,0
117484,group,0,0
117485,participants,0,1
117486,meet,0,0
117487,with,0,0
117488,a,0,0
117489,nurse,0,0
117490,",",0,0
117491,decide,0,0
117492,whether,0,0
117493,to,0,0
117494,have,0,0
117495,a,0,0
117496,GERA,0,0
117497,blood,0,0
117498,test,0,0
117499,(,0,0
117500,a,0,0
117501,combination,0,0
117502,of,0,0
117503,genetic,0,0
117504,polymorphism,0,0
117505,and,0,0
117506,folate,0,0
117507,),0,0
117508,",",0,0
117509,and,0,0
117510,",",0,0
117511,if,0,0
117512,tested,0,0
117513,",",0,0
117514,receive,0,0
117515,GERA,0,0
117516,feedback,0,0
117517,.,0,0
117518,Follow-up,0,0
117519,telephone,0,0
117520,surveys,0,0
117521,are,0,0
117522,conducted,0,0
117523,at,0,0
117524,1,0,0
117525,and,0,0
117526,6months,0,0
117527,.,0,0
117528,A,0,0
117529,chart,0,0
117530,audit,0,0
117531,is,0,0
117532,performed,0,0
117533,at,0,0
117534,6months,0,0
117535,.,0,0
117536,RESULTS,0,0
117537,Of,1,0
117538,"2,223",1,1
117539,eligible,1,1
117540,patients,1,1
117541,",",1,0
117542,562,1,1
117543,(,1,0
117544,25,1,0
117545,%,1,0
117546,),1,0
117547,have,1,0
117548,enrolled,1,1
117549,.,1,1
117550,Patients,1,1
117551,who,1,1
117552,enrolled,1,1
117553,in,1,1
117554,the,1,0
117555,study,1,0
117556,were,1,0
117557,significantly,1,0
117558,younger,1,1
117559,than,1,0
117560,those,1,1
117561,who,1,1
117562,did,1,0
117563,not,1,1
117564,(,1,0
117565,p,1,0
117566,<,1,0
117567,0.001,1,0
117568,),1,0
117569,.,1,0
117570,Participants,1,1
117571,tended,1,0
117572,to,1,0
117573,be,1,0
117574,50-59years,1,1
117575,(,1,0
117576,64,1,0
117577,%,1,0
117578,),1,0
117579,",",1,0
117580,female,1,1
117581,(,1,0
117582,58,1,1
117583,%,1,0
117584,),1,0
117585,",",1,0
117586,white,1,1
117587,(,1,0
117588,52,1,1
117589,%,1,0
117590,),1,0
117591,",",1,0
117592,married,1,1
117593,(,1,0
117594,51,1,1
117595,%,1,0
117596,),1,0
117597,",",1,0
117598,and,1,0
117599,have,1,0
117600,more,1,0
117601,than,1,0
117602,a,1,0
117603,high,1,0
117604,school,1,1
117605,education,1,0
117606,(,1,0
117607,67,1,0
117608,%,1,0
117609,),1,0
117610,.,1,0
117611,At,0,0
117612,baseline,0,0
117613,",",0,0
117614,most,0,0
117615,participants,0,1
117616,had,0,0
117617,some,0,0
117618,knowledge,0,0
117619,of,0,0
117620,CRC,0,0
117621,screening,0,1
117622,and,0,0
117623,GERA,0,0
117624,",",0,0
117625,viewed,0,0
117626,CRC,0,0
117627,screening,0,0
117628,favorably,0,0
117629,",",0,0
117630,and,0,0
117631,reported,0,0
117632,that,0,0
117633,they,0,0
117634,had,0,0
117635,decided,0,0
117636,to,0,0
117637,do,0,0
117638,screening,0,1
117639,.,0,0
117640,Almost,0,0
117641,half,0,0
117642,had,0,0
117643,worries,0,0
117644,and,0,0
117645,concerns,0,0
117646,about,0,0
117647,CRC,0,0
117648,.,0,1
117649,CONCLUSIONS,0,0
117650,One,1,1
117651,in,1,0
117652,four,1,1
117653,eligible,1,1
117654,primary,1,1
117655,care,1,1
117656,patients,1,1
117657,enrolled,1,1
117658,in,1,0
117659,the,1,0
117660,study,1,0
117661,.,1,0
117662,Age,0,0
117663,was,0,0
117664,negatively,0,0
117665,associated,0,0
117666,with,0,0
117667,enrollment,0,1
117668,.,0,0
117669,Prospective,0,0
117670,analyses,0,0
117671,using,0,0
117672,data,0,0
117673,for,0,0
117674,all,0,0
117675,participants,0,0
117676,will,0,0
117677,provide,0,0
117678,more,0,0
117679,definitive,0,0
117680,information,0,0
117681,on,0,0
117682,GERA,0,0
117683,uptake,0,0
117684,and,0,0
117685,the,0,0
117686,impact,0,0
117687,of,0,0
117688,GERA,0,0
117689,feedback,0,0
117690,.,0,0
117691,Green,0,0
117692,banana-supplemented,0,0
117693,diet,0,0
117694,in,0,0
117695,the,0,0
117696,home,0,0
117697,management,0,0
117698,of,0,0
117699,acute,1,1
117700,and,1,0
117701,prolonged,1,0
117702,diarrhoea,1,0
117703,in,1,0
117704,children,1,1
117705,:,1,1
117706,a,1,0
117707,community-based,1,0
117708,trial,1,0
117709,in,1,0
117710,rural,1,1
117711,Bangladesh,1,1
117712,.,1,1
117713,SUMMARY,0,0
117714,OBJECTIVE,0,0
117715,To,0,0
117716,determine,0,0
117717,the,0,0
117718,effectiveness,0,0
117719,of,0,0
117720,green,0,0
117721,banana,0,1
117722,in,0,0
117723,the,0,0
117724,home,0,0
117725,management,0,0
117726,of,0,0
117727,acute,1,1
117728,(,1,0
117729,<,1,0
117730,7,1,0
117731,days,1,0
117732,),1,0
117733,or,1,0
117734,prolonged,1,0
117735,(,1,0
117736,?,1,0
117737,7,1,0
117738,days,1,0
117739,),1,0
117740,diarrhoea,1,0
117741,at,1,0
117742,the,0,0
117743,community,0,1
117744,level,0,0
117745,.,0,0
117746,METHODS,0,0
117747,A,0,0
117748,cluster,0,0
117749,randomized,0,0
117750,field,0,0
117751,trial,0,0
117752,was,0,0
117753,conducted,0,0
117754,among,1,0
117755,2968,1,1
117756,Bangladeshi,1,1
117757,rural,1,1
117758,children,1,1
117759,6-36,1,1
117760,months,1,1
117761,old,1,1
117762,.,1,1
117763,Wards,0,0
117764,(,0,0
117765,villages,0,1
117766,),0,0
117767,were,0,0
117768,randomly,0,0
117769,assigned,0,0
117770,to,0,0
117771,either,0,0
117772,a,0,0
117773,standard,0,0
117774,care,0,0
117775,group,0,0
117776,or,0,0
117777,a,0,0
117778,standard,0,0
117779,care,0,0
117780,plus,0,0
117781,green,0,0
117782,banana,0,1
117783,group,0,0
117784,where,0,0
117785,mothers,0,1
117786,were,0,0
117787,instructed,0,0
117788,to,0,0
117789,add,0,0
117790,cooked,0,0
117791,green,0,0
117792,banana,0,1
117793,to,0,0
117794,the,0,0
117795,diets,0,0
117796,of,0,0
117797,diarrhoeal,1,1
117798,children,1,1
117799,.,1,0
117800,Through,0,0
117801,a,0,0
117802,village-based,0,0
117803,surveillance,0,0
117804,system,0,0
117805,",",0,0
117806,diarrhoeal,0,1
117807,morbidity,0,0
117808,data,0,0
117809,(,0,0
117810,severity,0,0
117811,",",0,0
117812,duration,0,0
117813,",",0,0
117814,compliance,0,0
117815,),0,0
117816,were,0,0
117817,collected,0,0
117818,for,0,0
117819,14,0,1
117820,days,0,0
117821,.,0,1
117822,Treatment,0,0
117823,effects,0,0
117824,were,0,0
117825,determined,0,0
117826,by,0,0
117827,analysing,0,0
117828,cumulative,0,0
117829,probability,0,0
117830,of,0,0
117831,cure,0,0
117832,by,0,0
117833,testing,0,0
117834,Cox,0,0
117835,proportional,0,0
117836,hazards,0,0
117837,models,0,0
117838,and,0,0
117839,relative,0,0
117840,risk,0,0
117841,(,0,0
117842,RR,0,0
117843,),0,0
117844,.,0,0
117845,RESULTS,0,0
117846,The,0,0
117847,cumulative,0,0
117848,probability,0,0
117849,of,0,0
117850,cure,0,0
117851,was,0,0
117852,significantly,0,0
117853,(,0,0
117854,P,0,0
117855,<,0,0
117856,0.001,0,0
117857,),0,0
117858,different,0,0
117859,in,0,0
117860,children,0,1
117861,receiving,0,1
117862,GB,0,0
117863,for,0,0
117864,both,0,0
117865,acute,0,1
117866,[,0,0
117867,hazard,0,0
117868,ratio,0,0
117869,(,0,0
117870,HR,0,0
117871,),0,0
117872,=,0,0
117873,0.63,0,0
117874,(,0,0
117875,95,0,0
117876,%,0,0
117877,CI,0,0
117878,:,0,1
117879,0.56-0.67,0,0
117880,),0,0
117881,],0,0
117882,and,0,0
117883,prolonged,0,0
117884,diarrhoea,0,0
117885,[,0,0
117886,HR,0,0
117887,=,0,0
117888,0.38,0,0
117889,(,0,0
117890,95,0,0
117891,%,0,0
117892,CI,0,0
117893,:,0,1
117894,0.26-0.59,0,0
117895,),0,0
117896,],0,0
117897,.,0,0
117898,The,0,0
117899,recovery,0,0
117900,rates,0,0
117901,of,0,0
117902,children,0,1
117903,with,0,1
117904,acute,0,1
117905,diarrhoea,0,1
117906,receiving,0,0
117907,GB,0,0
117908,(,0,0
117909,vs.,0,0
117910,control,0,0
117911,),0,0
117912,were,0,0
117913,significantly,0,0
117914,more,0,0
117915,by,0,0
117916,day,0,0
117917,3,0,0
117918,:,0,1
117919,79.9,0,0
117920,%,0,0
117921,vs,0,0
117922,.,0,0
117923,53.3,0,0
117924,%,0,0
117925,[,0,0
117926,(,0,0
117927,RR,0,0
117928,),0,0
117929,=,0,0
117930,0.47,0,0
117931,",",0,0
117932,95,0,0
117933,%,0,0
117934,CI,0,0
117935,:,0,1
117936,0.41-0.55,0,0
117937,],0,0
117938,",",0,0
117939,(,0,0
117940,P,0,0
117941,<,0,0
117942,0.001,0,0
117943,),0,0
117944,and,0,0
117945,day,0,0
117946,7,0,0
117947,:,0,1
117948,96.6,0,0
117949,%,0,0
117950,vs,0,0
117951,.,0,0
117952,89.1,0,0
117953,%,0,0
117954,(,0,0
117955,RR,0,0
117956,=,0,0
117957,0.32,0,0
117958,;,0,0
117959,0.22-0.46,0,0
117960,),0,0
117961,",",0,0
117962,(,0,0
117963,P,0,0
117964,<,0,0
117965,0.001,0,0
117966,),0,0
117967,.,0,0
117968,Children,0,1
117969,with,0,0
117970,prolonged,0,0
117971,diarrhoea,0,1
117972,receiving,0,0
117973,green,0,0
117974,banana,0,1
117975,had,0,0
117976,significantly,0,0
117977,higher,0,0
117978,recovery,0,0
117979,rates,0,0
117980,by,0,0
117981,day,0,0
117982,10,0,1
117983,:,0,1
117984,79.8,0,0
117985,%,0,0
117986,vs,0,0
117987,.,0,0
117988,51.9,0,0
117989,%,0,0
117990,(,0,0
117991,RR,0,0
117992,=,0,0
117993,0.42,0,0
117994,;,0,0
117995,0.23-0.73,0,0
117996,),0,0
117997,",",0,0
117998,(,0,0
117999,P,0,0
118000,<,0,0
118001,0.001,0,0
118002,),0,0
118003,and,0,0
118004,day,0,0
118005,14,0,0
118006,:,0,1
118007,93.6,0,0
118008,%,0,0
118009,vs,0,0
118010,.,0,0
118011,67.2,0,0
118012,%,0,0
118013,(,0,0
118014,RR,0,0
118015,=,0,0
118016,0.22,0,0
118017,;,0,0
118018,0.08-0.54,0,0
118019,),0,0
118020,",",0,0
118021,(,0,0
118022,P,0,0
118023,<,0,0
118024,0.001,0,0
118025,),0,0
118026,.,0,0
118027,CONCLUSION,0,0
118028,A,0,0
118029,green,0,0
118030,banana-supplemented,0,0
118031,diet,0,0
118032,hastened,0,0
118033,recovery,0,0
118034,of,0,0
118035,acute,1,1
118036,and,1,0
118037,prolonged,1,0
118038,childhood,1,1
118039,diarrhoea,1,0
118040,managed,1,1
118041,at,0,0
118042,home,0,1
118043,in,0,0
118044,rural,0,1
118045,Bangladesh,0,1
118046,.,0,1
118047,A,0,0
118048,web-based,0,0
118049,patient,0,0
118050,activation,0,0
118051,intervention,0,0
118052,to,0,0
118053,improve,0,0
118054,hypertension,0,1
118055,care,0,0
118056,:,0,0
118057,study,0,0
118058,design,0,0
118059,and,0,0
118060,baseline,0,0
118061,characteristics,0,0
118062,in,0,0
118063,the,0,0
118064,web,0,0
118065,hypertension,0,1
118066,study,0,0
118067,.,0,0
118068,BACKGROUND,0,0
118069,Despite,0,0
118070,the,0,0
118071,known,0,0
118072,health,0,0
118073,risks,0,0
118074,of,0,0
118075,hypertension,0,1
118076,",",0,0
118077,many,0,0
118078,hypertensive,1,1
118079,patients,1,1
118080,still,0,0
118081,have,0,0
118082,uncontrolled,0,0
118083,blood,0,0
118084,pressure,0,0
118085,.,0,0
118086,Clinical,0,0
118087,inertia,0,0
118088,",",0,0
118089,the,0,0
118090,tendency,0,0
118091,of,0,0
118092,physicians,0,1
118093,not,0,0
118094,to,0,0
118095,intensify,0,0
118096,treatment,0,0
118097,",",0,0
118098,is,0,0
118099,a,0,0
118100,common,0,0
118101,barrier,0,0
118102,in,0,0
118103,controlling,0,0
118104,chronic,0,1
118105,diseases,0,1
118106,.,0,0
118107,This,0,0
118108,trial,0,0
118109,is,0,0
118110,aimed,0,0
118111,at,0,0
118112,determining,0,0
118113,the,0,0
118114,impact,0,0
118115,of,0,0
118116,activating,0,0
118117,patients,0,1
118118,to,0,0
118119,ask,0,0
118120,providers,0,0
118121,to,0,0
118122,make,0,0
118123,changes,0,0
118124,to,0,0
118125,their,0,0
118126,care,0,0
118127,through,0,0
118128,tailored,0,0
118129,feedback,0,0
118130,.,0,0
118131,METHODS,0,0
118132,Diagnosed,1,1
118133,hypertensive,1,1
118134,patients,1,1
118135,were,0,0
118136,enrolled,0,1
118137,in,0,0
118138,this,0,0
118139,RCT,0,0
118140,and,0,0
118141,randomized,0,0
118142,to,0,0
118143,one,0,0
118144,of,0,0
118145,two,0,0
118146,study,0,1
118147,groups,0,0
118148,:,0,1
118149,(,0,0
118150,1,0,0
118151,),0,0
118152,the,0,0
118153,intervention,0,0
118154,condition,0,0
118155,--,0,0
118156,Web-based,0,0
118157,hypertension,0,1
118158,feedback,0,0
118159,",",0,0
118160,based,0,0
118161,on,0,0
118162,the,0,0
118163,individual,0,0
118164,patient,0,0
118165,'s,0,0
118166,self-report,0,0
118167,of,0,0
118168,health,0,0
118169,variables,0,0
118170,and,0,0
118171,previous,0,1
118172,BP,0,0
118173,measurements,0,0
118174,",",0,0
118175,to,0,0
118176,prompt,0,0
118177,them,0,0
118178,to,0,0
118179,ask,0,0
118180,questions,0,0
118181,during,0,0
118182,their,0,1
118183,next,0,0
118184,physician,0,0
118185,'s,0,0
118186,visit,0,0
118187,about,0,0
118188,hypertension,0,1
118189,care,0,0
118190,(,0,0
118191,2,0,0
118192,),0,0
118193,the,0,0
118194,control,0,0
118195,condition,0,0
118196,--,0,0
118197,Web-based,0,0
118198,preventive,0,0
118199,health,0,0
118200,feedback,0,0
118201,",",0,0
118202,based,0,0
118203,on,0,0
118204,the,0,0
118205,individual,0,0
118206,'s,0,0
118207,self-report,0,0
118208,of,0,0
118209,receiving,0,0
118210,preventive,0,0
118211,care,0,0
118212,(,0,0
118213,e.g.,0,0
118214,",",0,0
118215,pap,0,0
118216,testing,0,0
118217,),0,0
118218,",",0,0
118219,to,0,0
118220,prompt,0,0
118221,them,0,0
118222,to,0,0
118223,ask,0,0
118224,questions,0,0
118225,during,0,0
118226,their,0,1
118227,next,0,0
118228,physician,0,0
118229,'s,0,0
118230,visit,0,0
118231,about,0,0
118232,preventive,0,0
118233,care,0,0
118234,.,0,0
118235,The,0,0
118236,primary,0,0
118237,outcome,0,0
118238,of,0,0
118239,the,0,0
118240,study,0,0
118241,is,0,0
118242,change,0,0
118243,in,0,0
118244,blood,0,0
118245,pressure,0,0
118246,and,0,0
118247,change,0,0
118248,in,0,0
118249,the,0,0
118250,percentage,0,0
118251,of,0,0
118252,patients,0,1
118253,in,0,0
118254,each,0,0
118255,group,0,0
118256,with,0,0
118257,controlled,0,0
118258,blood,0,0
118259,pressure,0,0
118260,.,0,0
118261,CONCLUSION,0,0
118262,Five,1,0
118263,hundred,1,1
118264,participants,1,1
118265,were,1,0
118266,enrolled,1,1
118267,and,1,0
118268,baseline,1,0
118269,characteristics,1,0
118270,include,1,0
118271,a,1,0
118272,mean,1,0
118273,age,1,1
118274,of,1,0
118275,60.0,1,0
118276,years,1,1
118277,;,1,0
118278,57.6,1,0
118279,%,1,0
118280,female,1,1
118281,;,1,0
118282,and,1,0
118283,77.6,1,0
118284,%,1,0
118285,white,1,1
118286,.,1,0
118287,Overall,0,0
118288,37.7,1,0
118289,%,1,0
118290,participants,1,1
118291,had,1,0
118292,uncontrolled,1,1
118293,blood,1,0
118294,pressure,1,0
118295,;,1,0
118296,the,1,0
118297,mean,1,0
118298,body,1,0
118299,mass,1,0
118300,index,1,0
118301,(,1,0
118302,BMI,1,0
118303,),1,0
118304,was,1,0
118305,in,1,0
118306,the,1,0
118307,obese,1,1
118308,range,1,0
118309,(,1,0
118310,32.4,1,0
118311,),1,0
118312,and,1,0
118313,21.8,1,0
118314,%,1,0
118315,had,1,1
118316,diabetes,1,1
118317,.,1,0
118318,By,0,0
118319,activating,0,0
118320,patients,0,1
118321,to,0,0
118322,become,0,0
118323,involved,0,0
118324,in,0,0
118325,their,0,0
118326,own,0,0
118327,care,0,0
118328,",",0,0
118329,we,0,0
118330,believe,0,0
118331,the,0,0
118332,addition,0,0
118333,of,0,0
118334,the,0,0
118335,web-based,0,0
118336,intervention,0,0
118337,will,0,0
118338,improve,0,0
118339,blood,0,0
118340,pressure,0,0
118341,control,0,0
118342,compared,0,0
118343,to,0,0
118344,a,0,0
118345,control,0,0
118346,group,0,0
118347,who,0,1
118348,receive,0,1
118349,web-based,0,1
118350,preventive,0,0
118351,messages,0,0
118352,unrelated,0,1
118353,to,0,0
118354,hypertension,0,1
118355,.,0,0
118356,Pharmacokinetics,0,0
118357,and,0,1
118358,follicular,0,1
118359,dynamics,0,0
118360,of,0,0
118361,corifollitropin,0,0
118362,alfa,0,0
118363,versus,0,0
118364,recombinant,0,0
118365,FSH,0,0
118366,during,0,0
118367,ovarian,1,1
118368,stimulation,1,0
118369,for,1,0
118370,IVF,1,0
118371,.,1,0
118372,A,0,0
118373,single,0,0
118374,injection,0,0
118375,of,0,0
118376,corifollitropin,0,0
118377,alfa,0,0
118378,can,0,0
118379,replace,0,0
118380,seven,0,0
118381,daily,0,0
118382,injections,0,0
118383,of,0,0
118384,recombinant,0,0
118385,FSH,0,0
118386,(,0,0
118387,rFSH,0,0
118388,),0,0
118389,using,0,0
118390,a,0,0
118391,gonadotrophin-releasing,0,0
118392,hormone,0,0
118393,antagonist,0,0
118394,protocol,0,0
118395,in,0,0
118396,ovarian,0,1
118397,stimulation,0,0
118398,prior,1,0
118399,to,1,0
118400,IVF,1,0
118401,or,0,0
118402,intracytoplasmic,0,1
118403,sperm,0,0
118404,injection,0,0
118405,.,0,0
118406,This,0,0
118407,double-blind,0,0
118408,randomized,0,0
118409,controlled,0,0
118410,trial,0,0
118411,assessed,0,0
118412,the,0,0
118413,pharmacokinetics,0,0
118414,and,0,0
118415,pharmacodynamics,0,0
118416,of,0,0
118417,150?g,0,0
118418,corifollitropin,0,0
118419,alfa,0,0
118420,versus,0,0
118421,daily,0,0
118422,200IU,0,0
118423,rFSH,0,1
118424,in,1,0
118425,1509,1,1
118426,patients,1,1
118427,.,1,1
118428,Comparative,0,0
118429,analyses,0,0
118430,were,0,0
118431,performed,0,0
118432,on,0,0
118433,serum,0,0
118434,concentrations,0,0
118435,of,0,0
118436,FSH,0,0
118437,immunoreactivity,0,0
118438,(,0,0
118439,pharmacokinetics,0,0
118440,),0,0
118441,",",0,0
118442,and,0,0
118443,the,0,0
118444,number,0,0
118445,and,0,0
118446,size,0,0
118447,of,0,0
118448,growing,0,0
118449,follicles,0,1
118450,",",0,0
118451,and,0,0
118452,inhibin,0,0
118453,B,0,0
118454,and,0,0
118455,oestradiol,0,0
118456,concentrations,0,0
118457,as,0,0
118458,biomarkers,0,0
118459,of,0,0
118460,ovarian,0,1
118461,response,0,0
118462,(,0,0
118463,pharmacodynamics,0,0
118464,),0,0
118465,.,0,0
118466,The,0,0
118467,rate,0,0
118468,of,0,0
118469,follicular,0,1
118470,development,0,0
118471,was,0,0
118472,similar,0,0
118473,in,0,0
118474,both,0,0
118475,treatment,0,0
118476,groups,0,0
118477,.,0,0
118478,By,0,0
118479,stimulation,0,0
118480,day,0,0
118481,8,0,0
118482,",",0,0
118483,33,0,1
118484,%,0,0
118485,of,0,0
118486,patients,0,1
118487,treated,0,1
118488,with,0,1
118489,corifollitropin,0,0
118490,alfa,0,0
118491,reached,0,0
118492,the,0,0
118493,criterion,0,0
118494,for,0,0
118495,human,0,0
118496,chorionic,0,0
118497,gonadotrophin,0,0
118498,(,0,0
118499,HCG,0,0
118500,),0,0
118501,injection,0,0
118502,.,0,0
118503,The,0,0
118504,number,0,0
118505,of,0,0
118506,follicles,0,1
118507,?11mm,0,0
118508,was,0,0
118509,slightly,0,0
118510,higher,0,0
118511,after,0,0
118512,corifollitropin,0,0
118513,alfa,0,0
118514,compared,0,0
118515,with,0,0
118516,daily,0,0
118517,rFSH,0,0
118518,at,0,0
118519,stimulation,0,0
118520,day,0,0
118521,8,0,0
118522,(,0,0
118523,difference,0,0
118524,",",0,0
118525,1.2,0,0
118526,;,0,0
118527,95,0,0
118528,%,0,0
118529,confidence,0,0
118530,interval,0,0
118531,(,0,0
118532,CI,0,0
118533,),0,0
118534,0.5-1.8,0,0
118535,;,0,0
118536,P,0,0
118537,<,0,0
118538,0.01,0,0
118539,),0,0
118540,and,0,0
118541,on,0,0
118542,the,0,0
118543,day,0,0
118544,of,0,0
118545,HCG,0,0
118546,injection,0,0
118547,(,0,0
118548,difference,0,0
118549,",",0,0
118550,2.1,0,0
118551,;,0,0
118552,95,0,0
118553,%,0,0
118554,CI,0,0
118555,1.4-2.8,0,0
118556,;,0,0
118557,P,0,0
118558,<,0,0
118559,0.01,0,0
118560,),0,0
118561,.,0,0
118562,The,0,0
118563,rise,0,0
118564,of,0,0
118565,inhibin,0,0
118566,B,0,0
118567,and,0,0
118568,oestradiol,0,0
118569,concentrations,0,0
118570,was,0,0
118571,similar,0,0
118572,in,0,0
118573,both,0,0
118574,treatment,0,0
118575,groups,0,0
118576,.,0,0
118577,Although,0,0
118578,the,0,0
118579,pharmacokinetics,0,0
118580,of,0,0
118581,corifollitropin,0,0
118582,alfa,0,0
118583,and,0,0
118584,rFSH,0,0
118585,are,0,0
118586,quite,0,0
118587,different,0,0
118588,their,0,0
118589,pharmacodynamic,0,0
118590,profiles,0,0
118591,at,0,0
118592,the,0,0
118593,dosages,0,0
118594,used,0,0
118595,are,0,0
118596,similar,0,0
118597,.,0,0
118598,A,0,0
118599,single,0,0
118600,injection,0,0
118601,of,0,0
118602,corifollitropin,0,0
118603,alfa,0,0
118604,can,0,0
118605,replace,0,0
118606,seven,0,0
118607,daily,0,0
118608,injections,0,0
118609,of,0,0
118610,recombinant,0,0
118611,FSH,0,0
118612,(,0,0
118613,rFSH,0,0
118614,),0,0
118615,using,0,0
118616,a,0,0
118617,gonadotrophin-releasing,0,0
118618,hormone,0,0
118619,antagonist,0,0
118620,protocol,0,0
118621,in,0,0
118622,ovarian,0,1
118623,stimulation,0,0
118624,prior,0,0
118625,to,0,0
118626,IVF,0,0
118627,or,0,0
118628,intracytoplasmic,0,1
118629,sperm,0,0
118630,injection,0,0
118631,.,0,0
118632,The,0,0
118633,objective,0,0
118634,of,0,0
118635,this,0,0
118636,study,0,0
118637,was,0,0
118638,to,0,0
118639,compare,0,0
118640,the,0,0
118641,pharmacokinetics,0,0
118642,and,0,0
118643,pharmacodynamics,0,0
118644,of,0,0
118645,corifollitropin,0,0
118646,alfa,0,0
118647,versus,0,0
118648,daily,0,0
118649,rFSH,0,1
118650,.,0,0
118651,A,0,0
118652,total,0,0
118653,of,0,0
118654,1509,1,1
118655,patients,1,1
118656,were,1,0
118657,randomized,0,0
118658,in,0,0
118659,a,0,0
118660,double-blind,0,0
118661,",",0,0
118662,controlled,0,0
118663,trial,0,0
118664,to,0,0
118665,either,0,0
118666,a,0,0
118667,single,0,0
118668,injection,0,0
118669,of,0,0
118670,150?g,0,0
118671,corifollitropin,0,0
118672,alfa,0,0
118673,or,0,0
118674,to,0,0
118675,daily,0,0
118676,injections,0,0
118677,of,0,0
118678,200IU,0,0
118679,rFSH,0,0
118680,for,0,0
118681,the,0,0
118682,first,0,0
118683,7,0,0
118684,days,0,0
118685,of,0,0
118686,ovarian,0,1
118687,stimulation,0,0
118688,.,0,0
118689,Serum,0,0
118690,levels,0,0
118691,of,0,0
118692,FSH,0,0
118693,immunoreactivity,0,0
118694,were,0,0
118695,analysed,0,0
118696,(,0,0
118697,pharmacokinetic,0,0
118698,analysis,0,0
118699,),0,0
118700,",",0,0
118701,together,0,0
118702,with,0,0
118703,the,0,0
118704,number,0,0
118705,and,0,0
118706,size,0,0
118707,of,0,0
118708,growing,0,0
118709,follicles,0,1
118710,and,0,0
118711,serum,0,0
118712,inhibin,0,0
118713,B,0,0
118714,and,0,0
118715,oestradiol,0,0
118716,concentrations,0,0
118717,as,0,0
118718,biomarkers,0,0
118719,of,0,0
118720,the,0,0
118721,ovarian,0,1
118722,response,0,0
118723,(,0,0
118724,pharmacodynamic,0,0
118725,analysis,0,0
118726,),0,0
118727,.,0,0
118728,Serum,0,0
118729,FSH,0,0
118730,immunoreactivity,0,0
118731,levels,0,0
118732,were,0,0
118733,higher,0,0
118734,up,0,0
118735,to,0,0
118736,stimulation,0,0
118737,day,0,0
118738,5,0,0
118739,for,0,0
118740,corifollitropin,0,0
118741,alfa,0,0
118742,compared,0,0
118743,with,0,0
118744,the,0,0
118745,daily,0,0
118746,rFSH,0,0
118747,regimen,0,0
118748,but,0,0
118749,were,0,0
118750,similar,0,0
118751,from,0,0
118752,day,0,0
118753,8,0,0
118754,onwards,0,0
118755,",",0,0
118756,when,0,0
118757,patients,0,1
118758,started,0,0
118759,rFSH,0,0
118760,if,0,0
118761,the,0,0
118762,criteria,0,1
118763,for,0,0
118764,human,0,0
118765,chorionic,0,0
118766,gonadotrophin,0,0
118767,were,0,0
118768,not,0,0
118769,yet,0,0
118770,reached,0,0
118771,.,0,0
118772,Corifollitropin,0,0
118773,alfa,0,0
118774,treatment,0,0
118775,resulted,0,0
118776,in,0,0
118777,a,0,0
118778,similar,0,0
118779,growth,0,0
118780,rate,0,0
118781,of,0,0
118782,follicles,0,0
118783,though,0,0
118784,a,0,0
118785,slightly,0,0
118786,higher,0,0
118787,number,0,0
118788,of,0,0
118789,follicles,0,1
118790,were,0,0
118791,recruited,0,1
118792,compared,0,0
118793,with,0,0
118794,daily,0,0
118795,rFSH,0,1
118796,.,0,0
118797,It,0,0
118798,is,0,0
118799,concluded,0,0
118800,that,0,0
118801,the,0,0
118802,pharmacokinetics,0,0
118803,of,0,0
118804,corifollitropin,0,0
118805,alfa,0,0
118806,and,0,0
118807,rFSH,0,0
118808,are,0,0
118809,quite,0,0
118810,different,0,0
118811,but,0,0
118812,their,0,0
118813,induced,0,0
118814,pharmacodynamic,0,0
118815,effects,0,0
118816,at,0,0
118817,the,0,0
118818,dosages,0,0
118819,used,0,0
118820,are,0,0
118821,similar,0,0
118822,.,0,0
118823,Tomato,0,0
118824,paste,0,0
118825,rich,0,0
118826,in,0,0
118827,lycopene,0,0
118828,protects,0,0
118829,against,0,0
118830,cutaneous,0,1
118831,photodamage,0,0
118832,in,0,0
118833,humans,1,0
118834,in,1,0
118835,vivo,1,0
118836,:,1,1
118837,a,0,0
118838,randomized,0,0
118839,controlled,0,0
118840,trial,0,0
118841,.,0,0
118842,BACKGROUND,0,0
118843,Previous,0,0
118844,epidemiological,0,0
118845,",",0,0
118846,animal,0,0
118847,and,0,0
118848,human,0,0
118849,data,0,0
118850,report,0,0
118851,that,0,0
118852,lycopene,0,0
118853,has,0,0
118854,a,0,0
118855,protective,0,0
118856,effect,0,0
118857,against,0,0
118858,ultraviolet,0,0
118859,radiation,0,0
118860,(,0,0
118861,UVR,0,0
118862,),0,0
118863,-induced,0,0
118864,erythema,0,0
118865,.,0,0
118866,OBJECTIVES,0,0
118867,We,0,0
118868,examined,0,0
118869,whether,0,0
118870,tomato,0,0
118871,paste,0,0
118872,--,0,0
118873,rich,0,0
118874,in,0,0
118875,lycopene,0,0
118876,",",0,0
118877,a,0,0
118878,powerful,0,0
118879,antioxidant,0,0
118880,--,0,0
118881,can,0,0
118882,protect,0,0
118883,human,0,0
118884,skin,0,0
118885,against,0,0
118886,UVR-induced,0,0
118887,effects,0,0
118888,partially,0,0
118889,mediated,0,0
118890,by,0,0
118891,oxidative,0,0
118892,stress,0,0
118893,",",0,0
118894,i.e,0,0
118895,.,0,0
118896,erythema,0,0
118897,",",0,0
118898,matrix,0,0
118899,changes,0,0
118900,and,0,0
118901,mitochondrial,0,0
118902,DNA,0,0
118903,(,0,0
118904,mtDNA,0,0
118905,),0,0
118906,damage,0,0
118907,.,0,0
118908,METHODS,0,0
118909,In,0,0
118910,a,0,0
118911,randomized,0,0
118912,controlled,0,0
118913,study,0,0
118914,",",0,0
118915,20,1,0
118916,healthy,1,1
118917,women,1,1
118918,(,1,0
118919,median,1,0
118920,age,1,1
118921,33,1,1
118922,years,1,1
118923,",",1,0
118924,range,1,1
118925,21-47,1,0
118926,;,1,0
118927,phototype,1,1
118928,I/II,1,0
118929,),1,0
118930,ingested,0,0
118931,55,0,1
118932,g,0,0
118933,tomato,0,0
118934,paste,0,0
118935,(,0,0
118936,16,0,0
118937,mg,0,0
118938,lycopene,0,0
118939,),0,0
118940,in,0,0
118941,olive,0,0
118942,oil,0,0
118943,",",0,0
118944,or,0,0
118945,olive,0,0
118946,oil,0,0
118947,alone,0,0
118948,",",0,0
118949,daily,0,0
118950,for,0,0
118951,12,0,1
118952,weeks,0,0
118953,.,0,1
118954,Pre-,0,0
118955,and,0,0
118956,postsupplementation,0,0
118957,",",0,0
118958,UVR,0,0
118959,erythemal,0,0
118960,sensitivity,0,0
118961,was,0,0
118962,assessed,0,0
118963,visually,0,0
118964,as,0,0
118965,the,0,0
118966,minimal,0,0
118967,erythema,0,0
118968,dose,0,0
118969,(,0,0
118970,MED,0,0
118971,),0,0
118972,and,0,0
118973,quantified,0,0
118974,with,0,0
118975,a,0,0
118976,reflectance,0,0
118977,instrument,0,0
118978,.,0,0
118979,Biopsies,0,1
118980,were,0,0
118981,taken,0,0
118982,from,0,0
118983,unexposed,0,1
118984,and,0,0
118985,UVR-exposed,0,1
118986,(,0,0
118987,3,0,0
118988,?,0,0
118989,MED,0,0
118990,24,0,0
118991,h,0,0
118992,earlier,0,0
118993,),0,0
118994,buttock,0,0
118995,skin,0,0
118996,pre-,0,0
118997,and,0,0
118998,postsupplementation,0,0
118999,",",0,0
119000,and,0,0
119001,analysed,0,0
119002,immunohistochemically,0,0
119003,for,0,0
119004,procollagen,0,0
119005,(,0,0
119006,pC,0,0
119007,),0,0
119008,I,0,0
119009,",",0,0
119010,fibrillin-1,0,0
119011,and,0,0
119012,matrix,0,0
119013,metalloproteinase,0,0
119014,(,0,0
119015,MMP,0,0
119016,),0,0
119017,-1,0,0
119018,",",0,0
119019,and,0,0
119020,by,0,0
119021,quantitative,0,0
119022,polymerase,0,0
119023,chain,0,0
119024,reaction,0,0
119025,for,0,0
119026,mtDNA,0,0
119027,3895-bp,0,0
119028,deletion,0,0
119029,.,0,0
119030,RESULTS,0,0
119031,Mean,0,0
119032,?,0,0
119033,SD,0,0
119034,erythemal,0,0
119035,D,0,0
119036,(,0,0
119037,30,0,0
119038,),0,0
119039,was,0,0
119040,significantly,0,0
119041,higher,0,0
119042,following,0,0
119043,tomato,0,0
119044,paste,0,0
119045,vs.,0,0
119046,control,0,0
119047,(,0,0
119048,baseline,0,0
119049,",",0,0
119050,26?5,0,0
119051,?,0,0
119052,7?5,0,0
119053,mJ,0,0
119054,cm,0,1
119055,(,0,0
119056,-2,0,0
119057,),0,0
119058,;,0,0
119059,control,0,0
119060,",",0,0
119061,23,0,1
119062,?,0,0
119063,6?6,0,0
119064,mJ,0,0
119065,cm,0,1
119066,(,0,0
119067,-2,0,0
119068,),0,0
119069,;,0,0
119070,tomato,0,0
119071,paste,0,0
119072,",",0,0
119073,36?6,0,0
119074,?,0,0
119075,14?7,0,0
119076,mJ,0,0
119077,cm,0,1
119078,(,0,0
119079,-2,0,0
119080,),0,0
119081,;,0,0
119082,P,0,0
119083,=,0,0
119084,0?03,0,0
119085,),0,0
119086,",",0,0
119087,while,0,0
119088,the,0,0
119089,MED,0,0
119090,was,0,0
119091,not,0,0
119092,significantly,0,0
119093,different,0,0
119094,between,0,0
119095,groups,0,0
119096,(,0,0
119097,baseline,0,0
119098,",",0,0
119099,35?1,0,1
119100,?,0,0
119101,9?9,0,0
119102,mJ,0,0
119103,cm,0,1
119104,(,0,0
119105,-2,0,0
119106,),0,0
119107,;,0,0
119108,control,0,0
119109,",",0,0
119110,32?6,0,0
119111,?,0,0
119112,9?6,0,0
119113,mJ,0,0
119114,cm,0,1
119115,(,0,0
119116,-2,0,0
119117,),0,0
119118,;,0,0
119119,tomato,0,0
119120,paste,0,0
119121,",",0,0
119122,42?2,0,1
119123,?,0,0
119124,11?3,0,0
119125,mJ,0,0
119126,cm,0,1
119127,(,0,0
119128,-2,0,0
119129,),0,0
119130,),0,0
119131,.,0,0
119132,Presupplementation,0,0
119133,",",0,0
119134,UVR,0,0
119135,induced,0,0
119136,an,0,0
119137,increase,0,0
119138,in,0,0
119139,MMP-1,0,0
119140,(,0,0
119141,P,0,0
119142,=,0,0
119143,0?01,0,0
119144,),0,0
119145,and,0,0
119146,a,0,0
119147,reduction,0,0
119148,in,0,0
119149,fibrillin-1,0,0
119150,(,0,0
119151,P,0,0
119152,=,0,0
119153,0?03,0,0
119154,),0,0
119155,.,0,0
119156,Postsupplementation,0,0
119157,",",0,0
119158,UVR-induced,0,0
119159,MMP-1,0,0
119160,was,0,0
119161,reduced,0,0
119162,in,0,0
119163,the,0,0
119164,tomato,0,0
119165,paste,0,0
119166,vs.,0,0
119167,control,0,0
119168,group,0,0
119169,(,0,0
119170,P,0,0
119171,=,0,0
119172,0?04,0,0
119173,),0,0
119174,",",0,0
119175,while,0,0
119176,the,0,0
119177,UVR-induced,0,0
119178,reduction,0,0
119179,in,0,0
119180,fibrillin-1,0,0
119181,was,0,0
119182,similarly,0,0
119183,abrogated,0,0
119184,in,0,0
119185,both,0,0
119186,groups,0,0
119187,",",0,0
119188,and,0,0
119189,an,0,0
119190,increase,0,0
119191,in,0,0
119192,pCI,0,0
119193,deposition,0,0
119194,was,0,0
119195,seen,0,0
119196,following,0,0
119197,tomato,0,0
119198,paste,0,0
119199,(,0,0
119200,P,0,0
119201,=,0,0
119202,0?05,0,0
119203,),0,0
119204,.,0,0
119205,mtDNA,0,0
119206,3895-bp,0,0
119207,deletion,0,0
119208,following,0,0
119209,3,0,0
119210,?,0,0
119211,MED,0,0
119212,UVR,0,0
119213,was,0,0
119214,significantly,0,0
119215,reduced,0,0
119216,postsupplementation,0,0
119217,with,0,1
119218,tomato,0,0
119219,paste,0,0
119220,(,0,0
119221,P,0,0
119222,=,0,0
119223,0?01,0,0
119224,),0,0
119225,.,0,0
119226,CONCLUSIONS,0,0
119227,Tomato,0,0
119228,paste,0,0
119229,containing,0,0
119230,lycopene,0,0
119231,provides,0,0
119232,protection,0,0
119233,against,0,0
119234,acute,0,1
119235,and,0,0
119236,potentially,0,0
119237,longer-term,0,0
119238,aspects,0,0
119239,of,0,0
119240,photodamage,0,0
119241,.,0,0
119242,Tetracaine/adrenaline/cocaine,0,0
119243,for,0,0
119244,local,1,0
119245,anesthesia,1,1
119246,.,1,0
119247,Cardiovascular,0,0
119248,safety,0,0
119249,of,0,0
119250,degarelix,0,0
119251,:,0,1
119252,results,0,0
119253,from,0,0
119254,a,0,0
119255,12-month,0,0
119256,",",0,0
119257,comparative,0,0
119258,",",0,0
119259,randomized,0,0
119260,",",0,0
119261,open,0,0
119262,label,0,0
119263,",",0,0
119264,parallel,0,0
119265,group,0,0
119266,phase,0,0
119267,III,0,0
119268,trial,0,0
119269,in,0,0
119270,patients,1,1
119271,with,1,1
119272,prostate,1,1
119273,cancer,1,1
119274,.,1,0
119275,PURPOSE,0,0
119276,We,0,0
119277,assessed,0,0
119278,the,0,0
119279,cardiovascular,0,0
119280,safety,0,0
119281,profile,0,0
119282,of,0,0
119283,degarelix,0,0
119284,",",0,0
119285,a,0,0
119286,new,0,0
119287,gonadotropin-releasing,0,0
119288,hormone,0,0
119289,antagonist,0,0
119290,.,0,0
119291,MATERIALS,0,0
119292,AND,0,0
119293,METHODS,0,0
119294,This,0,0
119295,is,0,0
119296,the,0,0
119297,first,0,0
119298,report,0,0
119299,to,0,0
119300,our,0,0
119301,knowledge,0,0
119302,on,0,0
119303,cardiovascular,0,0
119304,safety,0,0
119305,data,0,0
119306,from,0,0
119307,a,0,0
119308,completed,0,1
119309,1-year,0,0
119310,randomized,0,0
119311,controlled,0,0
119312,trial,0,0
119313,of,0,0
119314,leuprolide,0,0
119315,acetate,0,0
119316,vs,0,0
119317,degarelix,0,0
119318,.,0,0
119319,Outcomes,0,0
119320,considered,0,0
119321,in,0,0
119322,these,0,0
119323,analyses,0,0
119324,included,0,1
119325,the,0,0
119326,QT,0,0
119327,interval,0,0
119328,by,0,0
119329,central,0,0
119330,reading,0,0
119331,and,0,0
119332,analysis,0,0
119333,",",0,0
119334,and,0,0
119335,cardiovascular,0,0
119336,adverse,0,0
119337,events,0,0
119338,.,0,0
119339,On,0,0
119340,multivariate,0,0
119341,analyses,0,0
119342,relationships,0,0
119343,between,0,0
119344,selected,0,1
119345,baseline,0,0
119346,factors,0,0
119347,and,0,0
119348,cardiovascular,0,1
119349,events,0,0
119350,were,0,0
119351,evaluated,0,0
119352,.,0,0
119353,RESULTS,0,0
119354,There,0,0
119355,were,0,0
119356,no,0,0
119357,significant,0,0
119358,differences,0,0
119359,between,0,0
119360,treatment,0,0
119361,groups,0,0
119362,for,0,0
119363,mean,0,1
119364,change,0,0
119365,in,0,0
119366,Fridericia,0,0
119367,'s,0,0
119368,correction,0,0
119369,of,0,0
119370,QT,0,0
119371,during,0,0
119372,the,0,0
119373,trial,0,0
119374,.,0,0
119375,Markedly,0,0
119376,abnormal,0,0
119377,Fridericia,0,0
119378,'s,0,0
119379,correction,0,0
119380,of,0,0
119381,QT,0,0
119382,values,0,0
119383,(,0,0
119384,500,0,0
119385,milliseconds,0,0
119386,or,0,1
119387,greater,0,0
119388,),0,0
119389,were,0,0
119390,observed,0,0
119391,in,0,0
119392,only,0,0
119393,a,0,0
119394,small,0,0
119395,number,0,0
119396,of,0,0
119397,subjects,0,1
119398,by,0,0
119399,treatment,0,0
119400,group,0,0
119401,",",0,0
119402,that,0,0
119403,is,0,0
119404,2,0,0
119405,(,0,0
119406,less,0,0
119407,than,0,0
119408,1,0,0
119409,%,0,0
119410,),0,0
119411,in,0,0
119412,the,0,0
119413,pooled,0,0
119414,degarelix,0,0
119415,group,0,0
119416,and,0,0
119417,2,0,0
119418,(,0,0
119419,1,0,0
119420,%,0,0
119421,),0,0
119422,in,0,0
119423,the,0,0
119424,leuprolide,0,0
119425,group,0,0
119426,.,0,0
119427,Supraventricular,0,0
119428,arrhythmias,0,0
119429,were,0,0
119430,the,0,0
119431,most,0,0
119432,common,0,0
119433,type,0,1
119434,of,0,0
119435,arrhythmias,0,0
119436,",",0,0
119437,affecting,0,0
119438,2,0,0
119439,%,0,0
119440,of,0,0
119441,subjects,0,1
119442,in,0,0
119443,the,0,0
119444,pooled,0,0
119445,degarelix,0,0
119446,group,0,0
119447,and,0,0
119448,4,0,0
119449,%,0,0
119450,in,0,0
119451,the,0,0
119452,leuprolide,0,0
119453,group,0,0
119454,.,0,0
119455,Other,0,0
119456,arrhythmias,0,0
119457,occurred,0,0
119458,in,0,0
119459,1,0,0
119460,%,0,0
119461,or,0,0
119462,less,0,0
119463,of,0,0
119464,subjects,0,1
119465,by,0,0
119466,treatment,0,0
119467,group,0,0
119468,.,0,0
119469,The,0,0
119470,most,0,0
119471,frequently,0,0
119472,reported,0,0
119473,cardiac,0,0
119474,disorder,0,1
119475,was,0,0
119476,ischemic,0,1
119477,heart,0,1
119478,disease,0,1
119479,",",0,0
119480,which,0,0
119481,occurred,0,0
119482,in,0,0
119483,4,0,0
119484,%,0,0
119485,of,0,0
119486,subjects,0,1
119487,treated,0,1
119488,with,0,1
119489,degarelix,0,0
119490,and,0,0
119491,10,0,0
119492,%,0,0
119493,of,0,0
119494,those,0,0
119495,on,0,0
119496,leuprolide,0,0
119497,.,0,0
119498,Cox,0,0
119499,proportional,0,0
119500,hazard,0,0
119501,ratio,0,0
119502,estimates,0,0
119503,for,0,0
119504,selected,0,1
119505,baseline,0,0
119506,covariates,0,0
119507,showed,0,0
119508,a,0,0
119509,significantly,0,0
119510,increased,0,0
119511,risk,0,0
119512,of,0,0
119513,cardiovascular,0,1
119514,events,0,0
119515,by,0,0
119516,age,0,1
119517,(,0,0
119518,p=0.0459,0,0
119519,),0,0
119520,and,0,0
119521,systolic,0,0
119522,blood,0,0
119523,pressure,0,0
119524,(,0,0
119525,p=0.0061,0,0
119526,),0,0
119527,.,0,0
119528,CONCLUSIONS,0,0
119529,In,0,0
119530,men,1,1
119531,with,1,1
119532,prostate,1,1
119533,cancer,1,1
119534,degarelix,0,0
119535,and,0,0
119536,leuprolide,0,0
119537,have,0,0
119538,similar,0,0
119539,cardiovascular,0,1
119540,safety,0,0
119541,profiles,0,0
119542,.,0,0
119543,These,0,0
119544,observations,0,0
119545,suggest,0,0
119546,that,0,0
119547,the,0,0
119548,cardiovascular,0,0
119549,events,0,0
119550,associated,0,0
119551,with,0,1
119552,both,0,0
119553,agents,0,0
119554,result,0,0
119555,from,0,0
119556,hypogonadism,0,0
119557,rather,0,0
119558,than,0,0
119559,a,0,0
119560,direct,0,0
119561,drug,0,0
119562,effect,0,0
119563,.,0,0
119564,Stepwise,0,0
119565,assessment,0,0
119566,tool,0,0
119567,of,0,0
119568,operative,0,0
119569,skills,0,0
119570,(,0,0
119571,SATOS,0,1
119572,),0,0
119573,:,0,0
119574,validity,0,0
119575,testing,0,0
119576,on,0,0
119577,a,0,0
119578,porcine,0,0
119579,training,0,0
119580,model,0,0
119581,of,0,0
119582,open,0,1
119583,gastrectomy,0,1
119584,.,0,0
119585,BACKGROUND,0,0
119586,The,0,0
119587,aim,0,0
119588,of,0,0
119589,this,0,0
119590,prospective,0,0
119591,study,0,0
119592,was,0,0
119593,to,0,0
119594,evaluate,0,0
119595,and,0,0
119596,compare,0,0
119597,operative,0,0
119598,performance,0,0
119599,and,0,0
119600,technical,0,0
119601,improvement,0,0
119602,of,0,0
119603,surgical,1,1
119604,trainees,1,1
119605,learning,1,0
119606,open,1,1
119607,gastrectomy,1,1
119608,using,0,0
119609,an,0,0
119610,objective,0,0
119611,structured,0,0
119612,stepwise,0,0
119613,assessment,0,0
119614,tool,0,0
119615,of,0,0
119616,operative,0,0
119617,skills,0,0
119618,(,0,0
119619,SATOS,0,0
119620,),0,0
119621,previously,0,0
119622,validated,0,0
119623,for,0,0
119624,open,0,1
119625,surgery,0,1
119626,.,0,0
119627,STUDY,0,0
119628,DESIGN,0,0
119629,Thirty,1,1
119630,residents,1,1
119631,in,1,0
119632,general,1,1
119633,surgery,1,1
119634,performed,1,0
119635,2,1,0
119636,open,1,1
119637,partial,1,0
119638,gastrectomy,1,1
119639,training,1,0
119640,events,1,0
119641,on,1,0
119642,a,1,0
119643,porcine,1,0
119644,model,1,0
119645,.,1,0
119646,Earlier,0,0
119647,instruction,0,0
119648,was,0,0
119649,provided,0,0
119650,for,0,0
119651,the,0,0
119652,critical,0,0
119653,operative,0,0
119654,steps,0,0
119655,",",0,0
119656,with,0,1
119657,additional,0,0
119658,intraoperative,0,0
119659,instruction,0,0
119660,when,0,0
119661,required,0,0
119662,.,0,0
119663,Performance,0,0
119664,was,0,0
119665,assessed,0,0
119666,by,0,0
119667,postgraduate,0,1
119668,year,0,0
119669,(,0,0
119670,PGY,0,0
119671,),0,0
119672,according,0,0
119673,to,0,0
119674,operative,0,0
119675,time,0,0
119676,",",0,0
119677,technical,0,0
119678,skills,0,0
119679,using,0,0
119680,a,0,0
119681,23-step,0,0
119682,objective,0,0
119683,structured,0,0
119684,tool,0,0
119685,",",0,0
119686,and,0,0
119687,error,0,0
119688,rate,0,0
119689,.,0,0
119690,RESULTS,0,0
119691,There,0,0
119692,were,0,0
119693,11,0,0
119694,PGY-3,0,0
119695,",",0,0
119696,11,0,0
119697,PGY-4,0,0
119698,",",0,0
119699,and,0,0
119700,8,0,0
119701,PGY-5,0,0
119702,residents,0,1
119703,.,0,0
119704,At,0,0
119705,the,0,0
119706,initial,0,0
119707,assessment,0,0
119708,",",0,0
119709,performance,0,0
119710,significantly,0,0
119711,differentiated,0,0
119712,the,0,0
119713,3,0,0
119714,PGY,0,0
119715,grades,0,1
119716,according,0,1
119717,to,0,0
119718,technical,0,0
119719,skills,0,0
119720,and,0,0
119721,error,0,0
119722,rate,0,0
119723,.,0,0
119724,At,0,0
119725,the,0,0
119726,second,0,0
119727,assessment,0,0
119728,",",0,0
119729,all,0,0
119730,3,0,0
119731,PGY,0,0
119732,classes,0,1
119733,were,0,0
119734,still,0,0
119735,significantly,0,0
119736,differentiable,0,0
119737,by,0,0
119738,technical,0,0
119739,skills,0,0
119740,",",0,0
119741,with,0,0
119742,no,0,0
119743,difference,0,0
119744,in,0,0
119745,error,0,0
119746,rate,0,0
119747,.,0,0
119748,Comparing,0,0
119749,performances,0,0
119750,",",0,0
119751,residents,0,1
119752,improved,0,0
119753,operative,0,0
119754,time,0,0
119755,(,0,0
119756,p,0,0
119757,<,0,0
119758,0.001,0,0
119759,),0,0
119760,",",0,0
119761,technical,0,0
119762,skills,0,0
119763,(,0,0
119764,p,0,0
119765,<,0,0
119766,0.001,0,0
119767,),0,0
119768,",",0,0
119769,and,0,0
119770,error,0,0
119771,rate,0,0
119772,(,0,0
119773,p,0,0
119774,=,0,0
119775,0.019,0,0
119776,),0,0
119777,over,0,0
119778,the,0,0
119779,2,0,0
119780,training,0,0
119781,events,0,0
119782,.,0,1
119783,CONCLUSIONS,0,0
119784,SATOS,0,0
119785,demonstrated,0,0
119786,relevant,0,0
119787,and,0,0
119788,accurate,0,0
119789,objective,0,0
119790,assessment,0,0
119791,of,0,0
119792,trainees,0,0
119793,',0,1
119794,operative,0,0
119795,skills,0,0
119796,and,0,0
119797,improvement,0,0
119798,for,0,0
119799,open,0,0
119800,gastrectomy,0,1
119801,in,0,0
119802,a,0,0
119803,porcine,0,0
119804,model,0,0
119805,.,0,0
119806,This,0,0
119807,tool,0,0
119808,may,0,0
119809,be,0,0
119810,useful,0,0
119811,to,0,0
119812,standardize,0,0
119813,instruction,0,0
119814,",",0,0
119815,to,0,0
119816,expose,0,0
119817,weaknesses,0,0
119818,of,0,0
119819,trainees,0,0
119820,",",0,0
119821,and,0,0
119822,to,0,0
119823,determine,0,0
119824,minimal,0,0
119825,technical,0,0
119826,standards,0,0
119827,in,0,0
119828,residency,0,1
119829,programs,0,0
119830,.,0,1
119831,Intensive,0,0
119832,case,0,0
119833,management,0,0
119834,before,0,0
119835,and,0,0
119836,after,0,0
119837,prison,0,1
119838,release,0,0
119839,is,0,0
119840,no,0,0
119841,more,0,0
119842,effective,0,0
119843,than,0,0
119844,comprehensive,0,0
119845,pre-release,0,0
119846,discharge,0,0
119847,planning,0,0
119848,in,0,0
119849,linking,0,0
119850,HIV-infected,1,1
119851,prisoners,1,1
119852,to,0,0
119853,care,0,1
119854,:,0,0
119855,a,0,0
119856,randomized,0,0
119857,trial,0,0
119858,.,0,0
119859,Imprisonment,0,0
119860,provides,0,0
119861,opportunities,0,0
119862,for,0,0
119863,the,0,0
119864,diagnosis,0,0
119865,and,0,0
119866,successful,0,0
119867,treatment,0,0
119868,of,0,0
119869,HIV,0,0
119870,",",0,0
119871,however,0,0
119872,",",0,0
119873,the,0,0
119874,benefits,0,0
119875,of,0,0
119876,antiretroviral,0,1
119877,therapy,0,0
119878,are,0,0
119879,frequently,0,0
119880,lost,0,0
119881,following,0,0
119882,release,0,0
119883,due,0,0
119884,to,0,0
119885,suboptimal,0,0
119886,access,0,0
119887,and,0,0
119888,utilization,0,0
119889,of,0,0
119890,health,0,0
119891,care,0,0
119892,and,0,0
119893,services,0,1
119894,.,0,0
119895,In,0,0
119896,response,0,0
119897,",",0,0
119898,some,0,0
119899,have,0,0
119900,advocated,0,0
119901,for,0,0
119902,development,0,0
119903,of,0,0
119904,intensive,0,1
119905,case-management,0,1
119906,interventions,0,0
119907,spanning,0,0
119908,incarceration,0,1
119909,and,0,0
119910,release,0,0
119911,to,0,0
119912,support,0,0
119913,treatment,0,0
119914,adherence,0,0
119915,and,0,0
119916,community,0,1
119917,re-entry,0,0
119918,for,0,0
119919,HIV-infected,1,1
119920,releasees,1,0
119921,.,1,1
119922,We,0,0
119923,conducted,0,0
119924,a,0,0
119925,randomized,0,0
119926,controlled,0,0
119927,trial,0,0
119928,of,0,0
119929,a,0,0
119930,motivational,0,0
119931,Strengths,0,0
119932,Model,0,0
119933,bridging,0,0
119934,case,0,0
119935,management,0,0
119936,intervention,0,0
119937,(,0,0
119938,BCM,0,0
119939,),0,0
119940,beginning,0,0
119941,approximately,0,0
119942,3,0,0
119943,months,0,0
119944,prior,0,0
119945,to,0,0
119946,and,0,0
119947,continuing,0,0
119948,6,0,0
119949,months,0,0
119950,after,0,0
119951,release,0,0
119952,versus,0,0
119953,a,0,0
119954,standard,0,0
119955,of,0,0
119956,care,0,0
119957,prison-administered,0,0
119958,discharge,0,0
119959,planning,0,0
119960,program,0,0
119961,(,0,0
119962,SOC,0,0
119963,),0,0
119964,for,1,0
119965,HIV-infected,1,1
119966,state,1,0
119967,prison,1,1
119968,inmates,1,1
119969,.,1,0
119970,The,0,0
119971,primary,0,0
119972,outcome,0,0
119973,variable,0,0
119974,was,0,0
119975,self-reported,0,0
119976,access,0,0
119977,to,0,0
119978,post-release,0,0
119979,medical,0,1
119980,care,0,0
119981,.,0,0
119982,Of,0,0
119983,the,1,0
119984,104,1,1
119985,inmates,1,1
119986,enrolled,1,1
119987,",",1,0
119988,89,1,0
119989,had,1,0
119990,at,1,0
119991,least,1,0
119992,1,1,0
119993,post-release,1,0
119994,study,1,0
119995,visit,1,0
119996,.,1,0
119997,Of,0,0
119998,these,0,0
119999,",",0,0
120000,65.1,0,0
120001,%,0,0
120002,of,0,0
120003,BCM,0,0
120004,and,0,0
120005,54.4,0,0
120006,%,0,0
120007,of,0,0
120008,SOC,0,0
120009,assigned,0,1
120010,participants,0,1
120011,attended,0,1
120012,a,0,0
120013,routine,0,0
120014,medical,0,0
120015,appointment,0,0
120016,within,0,0
120017,4,0,0
120018,weeks,0,0
120019,of,0,0
120020,release,0,0
120021,(,0,0
120022,P,0,0
120023,>,0,1
120024,0.3,0,0
120025,),0,0
120026,.,0,0
120027,By,0,0
120028,week,0,0
120029,12,0,0
120030,post-release,0,0
120031,",",0,0
120032,88.4,0,0
120033,%,0,0
120034,of,0,0
120035,the,0,0
120036,BCM,0,0
120037,arm,0,0
120038,and,0,0
120039,78.3,0,0
120040,%,0,0
120041,of,0,0
120042,the,0,0
120043,SOC,0,0
120044,arm,0,0
120045,had,0,0
120046,at,0,0
120047,attended,0,1
120048,at,0,0
120049,least,0,0
120050,one,0,0
120051,medical,0,1
120052,appointment,0,0
120053,(,0,0
120054,P,0,0
120055,=,0,0
120056,0.2,0,0
120057,),0,0
120058,",",0,0
120059,increasing,0,0
120060,in,0,0
120061,both,0,0
120062,arms,0,0
120063,at,0,0
120064,week,0,0
120065,24-90.7,0,0
120066,%,0,0
120067,with,0,1
120068,BCM,0,0
120069,and,0,0
120070,89.1,0,0
120071,%,0,0
120072,with,0,1
120073,SOC,0,0
120074,(,0,0
120075,P,0,0
120076,>,0,1
120077,0.5,0,0
120078,),0,0
120079,.,0,0
120080,No,0,0
120081,participant,0,0
120082,without,0,0
120083,a,0,0
120084,routine,0,0
120085,medical,0,0
120086,visit,0,0
120087,by,0,0
120088,week,0,0
120089,24,0,0
120090,attended,0,1
120091,an,0,0
120092,appointment,0,0
120093,from,0,0
120094,weeks,0,0
120095,24,0,0
120096,to,0,1
120097,48,0,0
120098,.,0,0
120099,The,0,0
120100,mean,0,0
120101,number,0,0
120102,of,0,0
120103,clinic,0,1
120104,visits,0,0
120105,during,0,0
120106,the,0,0
120107,48,0,0
120108,weeks,0,0
120109,post,0,0
120110,release,0,0
120111,was,0,0
120112,5.23,0,0
120113,(,0,0
120114,SD,0,0
120115,=,0,0
120116,3.14,0,0
120117,),0,0
120118,for,0,0
120119,BCM,0,0
120120,and,0,0
120121,4.07,0,0
120122,(,0,0
120123,SD,0,0
120124,=,0,0
120125,3.20,0,0
120126,),0,0
120127,for,0,0
120128,SOC,0,0
120129,(,0,0
120130,P,0,0
120131,>,0,1
120132,0.5,0,0
120133,),0,0
120134,.,0,0
120135,There,0,0
120136,were,0,0
120137,no,0,0
120138,significant,0,0
120139,differences,0,0
120140,between,0,0
120141,arms,0,0
120142,in,0,0
120143,social,0,0
120144,service,0,1
120145,utilization,0,0
120146,and,0,0
120147,re-incarceration,0,0
120148,rates,0,0
120149,were,0,0
120150,also,0,0
120151,similar,0,0
120152,.,0,0
120153,We,0,0
120154,found,0,0
120155,that,0,0
120156,a,0,0
120157,case,0,0
120158,management,0,0
120159,intervention,0,0
120160,bridging,0,0
120161,incarceration,0,1
120162,and,0,0
120163,release,0,0
120164,was,0,0
120165,no,0,0
120166,more,0,0
120167,effective,0,0
120168,than,0,0
120169,a,0,0
120170,less,0,0
120171,intensive,0,0
120172,pre-release,0,0
120173,discharge,0,0
120174,planning,0,0
120175,program,0,0
120176,in,0,0
120177,supporting,0,0
120178,health,0,0
120179,and,0,0
120180,social,0,0
120181,service,0,0
120182,utilization,0,0
120183,for,0,0
120184,HIV-infected,1,1
120185,individuals,1,1
120186,released,1,0
120187,from,1,0
120188,prison,1,1
120189,.,1,0
120190,Detection,0,0
120191,rates,0,0
120192,of,0,0
120193,cancer,0,1
120194,",",0,0
120195,high,0,0
120196,grade,0,0
120197,PIN,0,0
120198,and,0,0
120199,atypical,0,1
120200,lesions,0,1
120201,suspicious,0,1
120202,for,0,0
120203,cancer,0,1
120204,in,0,0
120205,the,0,0
120206,European,1,1
120207,Randomized,1,0
120208,Study,1,0
120209,of,1,0
120210,Screening,1,1
120211,for,1,0
120212,Prostate,1,1
120213,Cancer,1,0
120214,.,1,0
120215,THE,0,0
120216,AIM,0,0
120217,OF,0,0
120218,THE,0,0
120219,STUDY,0,0
120220,This,0,0
120221,article,0,0
120222,presents,0,0
120223,the,0,0
120224,incidence,0,0
120225,of,0,0
120226,prostate,0,1
120227,cancer,0,1
120228,",",0,0
120229,isolated,0,0
120230,high,0,0
120231,grade,0,0
120232,prostatic,0,1
120233,intraepithelial,0,0
120234,neoplasia,0,1
120235,(,0,0
120236,PIN,0,0
120237,),0,0
120238,and,0,0
120239,atypical,0,1
120240,lesions,0,1
120241,suspicious,0,1
120242,for,0,0
120243,prostate,0,1
120244,cancer,0,1
120245,(,0,0
120246,LSPC,0,0
120247,),0,0
120248,during,0,0
120249,subsequent,0,0
120250,screening,0,1
120251,rounds,0,0
120252,in,0,0
120253,the,0,0
120254,centres,0,1
120255,of,0,0
120256,five,0,1
120257,of,0,0
120258,the,0,0
120259,countries,0,0
120260,participating,1,1
120261,in,1,0
120262,the,1,0
120263,European,1,1
120264,Randomized,1,0
120265,Study,1,0
120266,of,1,0
120267,Screening,1,1
120268,for,1,0
120269,Prostate,1,1
120270,Cancer,1,0
120271,(,1,0
120272,ERSPC,1,0
120273,),1,0
120274,.,1,0
120275,The,0,0
120276,incidence,0,0
120277,and,0,0
120278,predictive,0,0
120279,value,0,0
120280,of,0,0
120281,high,0,0
120282,grade,0,0
120283,PIN,0,0
120284,and,0,0
120285,LSPC,0,0
120286,for,0,0
120287,prostate,0,1
120288,cancer,0,1
120289,in,0,0
120290,subsequent,0,0
120291,biopsy,0,0
120292,following,0,0
120293,these,0,0
120294,diagnoses,0,1
120295,were,0,0
120296,evaluated,0,0
120297,.,0,0
120298,PATIENTS,0,0
120299,AND,0,0
120300,METHODS,0,0
120301,Study,0,0
120302,group,0,0
120303,consisted,0,0
120304,of,0,0
120305,"56,653",1,1
120306,screened,1,1
120307,men,1,1
120308,in,1,0
120309,the,1,0
120310,ERSPC,1,0
120311,centres,1,1
120312,of,1,0
120313,Finland,1,1
120314,",",1,0
120315,Italy,1,0
120316,",",1,0
120317,Netherlands,1,0
120318,",",1,0
120319,Sweden,1,1
120320,and,1,0
120321,Switzerland,1,1
120322,",",1,0
120323,who,1,1
120324,underwent,1,1
120325,3-7,1,1
120326,screening,1,1
120327,rounds,1,0
120328,at,1,0
120329,2-4,1,1
120330,year,1,0
120331,interval,1,0
120332,.,1,0
120333,Data,1,0
120334,for,1,0
120335,prostate,1,1
120336,cancer,1,1
120337,were,1,0
120338,obtained,1,0
120339,from,1,0
120340,the,1,0
120341,ERSPC,1,0
120342,central,1,0
120343,database,1,1
120344,.,1,0
120345,Data,1,0
120346,for,1,0
120347,high,1,0
120348,grade,1,0
120349,PIN,1,0
120350,and,1,0
120351,LSPC,1,0
120352,were,1,0
120353,gathered,1,0
120354,from,1,0
120355,each,1,0
120356,ERSPC,1,0
120357,centre,1,1
120358,.,1,0
120359,Detection,0,0
120360,rates,0,0
120361,of,0,0
120362,subsequent,0,0
120363,prostate,0,1
120364,cancer,0,1
120365,in,0,0
120366,the,0,0
120367,first,0,0
120368,re-biopsy,0,0
120369,after,0,0
120370,these,0,0
120371,diagnoses,0,1
120372,were,0,0
120373,determined,0,0
120374,.,0,0
120375,RESULTS,0,0
120376,The,0,0
120377,average,0,0
120378,cancer,0,1
120379,detection,0,0
120380,rate,0,0
120381,was,0,0
120382,3.5,0,0
120383,%,0,0
120384,",",0,0
120385,3.2,0,0
120386,%,0,0
120387,and,0,0
120388,3.5,0,0
120389,%,0,0
120390,for,0,0
120391,the,0,0
120392,completed,0,1
120393,rounds,0,0
120394,1,0,0
120395,",",0,0
120396,2,0,0
120397,and,0,0
120398,3,0,0
120399,",",0,0
120400,respectively,0,0
120401,",",0,0
120402,in,0,0
120403,all,0,0
120404,five,0,1
120405,centres,0,1
120406,.,0,0
120407,Incidence,0,0
120408,of,0,0
120409,high,0,0
120410,grade,0,1
120411,PIN,0,0
120412,increased,0,0
120413,from,0,0
120414,1.5,0,0
120415,%,0,0
120416,in,0,0
120417,the,0,0
120418,first,0,0
120419,round,0,0
120420,to,0,0
120421,5.0,0,0
120422,%,0,0
120423,in,0,0
120424,the,0,0
120425,third,0,0
120426,round,0,0
120427,",",0,0
120428,varying,0,0
120429,among,0,0
120430,centres,0,1
120431,in,0,0
120432,the,0,0
120433,first,0,0
120434,round,0,0
120435,between,0,0
120436,0.8,0,0
120437,%,0,0
120438,and,0,0
120439,7.6,0,0
120440,%,0,0
120441,.,0,0
120442,The,0,0
120443,cancer,0,1
120444,detection,0,0
120445,rate,0,0
120446,in,0,0
120447,the,0,0
120448,first,0,0
120449,re-biopsy,0,0
120450,after,0,0
120451,the,0,0
120452,diagnosis,0,0
120453,of,0,0
120454,high,0,0
120455,grade,0,1
120456,PIN,0,0
120457,was,0,0
120458,12.9,0,0
120459,%,0,0
120460,.,0,0
120461,Incidence,0,0
120462,of,0,0
120463,LSPC,0,0
120464,was,0,0
120465,2.4,0,0
120466,%,0,0
120467,",",0,0
120468,2.7,0,0
120469,%,0,0
120470,",",0,0
120471,2.2,0,0
120472,%,0,0
120473,and,0,0
120474,2.6,0,0
120475,%,0,0
120476,in,0,0
120477,the,0,0
120478,first,0,0
120479,",",0,0
120480,second,0,0
120481,",",0,0
120482,third,0,0
120483,and,0,0
120484,fourth,0,0
120485,round,0,0
120486,",",0,0
120487,respectively,0,0
120488,.,0,0
120489,The,0,0
120490,cancer,0,1
120491,detection,0,0
120492,rate,0,0
120493,at,0,0
120494,the,0,0
120495,first,0,0
120496,re-biopsy,0,0
120497,after,0,0
120498,the,0,0
120499,diagnosis,0,1
120500,of,0,0
120501,LSPC,0,0
120502,was,0,0
120503,in,0,0
120504,average,0,0
120505,33.8,0,0
120506,%,0,0
120507,.,0,0
120508,CONCLUSIONS,0,0
120509,Cancer,0,0
120510,detection,0,0
120511,rate,0,0
120512,was,0,0
120513,stable,0,1
120514,during,0,0
120515,the,0,0
120516,three,0,0
120517,screening,0,1
120518,rounds,0,0
120519,.,0,1
120520,The,0,0
120521,wide,0,0
120522,variation,0,0
120523,in,0,0
120524,frequency,0,0
120525,in,0,0
120526,particular,0,0
120527,of,0,0
120528,high,0,0
120529,grade,0,0
120530,PIN,0,0
120531,among,0,0
120532,the,0,0
120533,ERSPC,0,0
120534,centres,0,1
120535,suggests,0,0
120536,a,0,0
120537,considerable,0,0
120538,inter-observer,0,0
120539,variation,0,0
120540,.,0,0
120541,The,0,0
120542,average,0,0
120543,comparatively,0,0
120544,low,0,0
120545,detection,0,0
120546,rate,0,0
120547,of,0,0
120548,isolated,0,0
120549,high,0,0
120550,grade,0,0
120551,PIN,0,0
120552,in,0,0
120553,the,0,0
120554,first,0,0
120555,screening,0,0
120556,round,0,0
120557,may,0,0
120558,be,0,0
120559,screening-related,0,0
120560,",",0,0
120561,while,0,0
120562,its,0,0
120563,consistent,0,0
120564,increase,0,0
120565,during,0,0
120566,three,0,0
120567,screening,0,1
120568,rounds,0,0
120569,could,0,0
120570,be,0,0
120571,the,0,0
120572,consequence,0,0
120573,of,0,0
120574,a.o,0,0
120575,.,0,0
120576,previous,0,0
120577,screening,0,0
120578,and,0,0
120579,ageing,0,0
120580,of,0,0
120581,the,0,0
120582,population,0,1
120583,.,0,0
120584,The,0,0
120585,observed,0,0
120586,low,0,0
120587,risk,0,0
120588,of,0,0
120589,prostate,0,1
120590,cancer,0,1
120591,after,0,0
120592,isolated,0,0
120593,high,0,0
120594,grade,0,0
120595,PIN,0,0
120596,in,0,0
120597,this,0,0
120598,screening,0,0
120599,setting,0,0
120600,is,0,0
120601,in,0,0
120602,line,0,0
120603,with,0,1
120604,the,0,0
120605,current,0,0
120606,recommendation,0,0
120607,to,0,0
120608,abstain,0,1
120609,from,0,0
120610,early,0,0
120611,repeat,0,0
120612,biopsies,0,0
120613,after,0,0
120614,this,0,0
120615,diagnosis,0,0
120616,.,0,0
120617,The,0,0
120618,association,0,0
120619,of,0,0
120620,LSPC,0,0
120621,with,0,1
120622,high,0,0
120623,incidence,0,0
120624,of,0,0
120625,prostate,0,1
120626,cancer,0,1
120627,in,0,0
120628,re-biopsies,0,0
120629,confirms,0,0
120630,the,0,0
120631,need,0,0
120632,for,0,0
120633,early,0,0
120634,repeat,0,0
120635,biopsies,0,0
120636,and,0,0
120637,follow-up,0,0
120638,of,0,0
120639,these,0,0
120640,men,1,1
120641,.,1,0
120642,The,0,0
120643,low,0,0
120644,percentage,0,0
120645,of,0,0
120646,LSPC,0,0
120647,(,0,0
120648,<,0,0
120649,3,0,0
120650,%,0,0
120651,of,0,0
120652,biopsies,0,0
120653,),0,0
120654,throughout,0,0
120655,all,0,0
120656,rounds,0,0
120657,is,0,0
120658,reassuring,0,0
120659,as,0,0
120660,it,0,0
120661,limits,0,0
120662,the,0,0
120663,biopsy,0,0
120664,burden,0,0
120665,in,0,0
120666,a,0,0
120667,screening,0,0
120668,setting,0,0
120669,.,0,0
120670,Effect,0,0
120671,of,0,0
120672,total,0,1
120673,enteral,0,0
120674,nutrition,0,1
120675,on,0,0
120676,the,0,0
120677,short-term,0,0
120678,outcome,0,0
120679,of,0,0
120680,severely,1,1
120681,malnourished,1,1
120682,cirrhotics,1,1
120683,.,1,0
120684,A,0,0
120685,randomized,0,0
120686,controlled,0,0
120687,trial,0,0
120688,.,0,0
120689,Thirty-five,1,1
120690,severely,1,1
120691,malnourished,1,1
120692,cirrhotic,1,1
120693,patients,1,1
120694,were,0,0
120695,randomized,0,0
120696,to,0,0
120697,receive,0,0
120698,either,0,0
120699,enteral-tube,0,0
120700,feeding,0,0
120701,as,0,0
120702,the,0,0
120703,sole,0,0
120704,nutritional,0,0
120705,support,0,0
120706,(,0,0
120707,n,0,1
120708,=,0,0
120709,16,0,1
120710,),0,0
120711,or,0,0
120712,an,0,0
120713,isocaloric,0,0
120714,",",0,0
120715,isonitrogenous,0,0
120716,",",0,0
120717,low-sodium,0,0
120718,standard,0,0
120719,oral,0,0
120720,diet,0,0
120721,(,0,0
120722,n,0,1
120723,=,0,0
120724,19,0,1
120725,),0,0
120726,.,0,0
120727,Both,1,0
120728,groups,1,0
120729,were,1,0
120730,homogeneous,1,0
120731,regarding,1,0
120732,age,1,1
120733,",",1,0
120734,sex,1,0
120735,distribution,1,0
120736,",",1,0
120737,etiology,1,0
120738,of,1,0
120739,liver,1,1
120740,cirrhosis,1,1
120741,",",1,0
120742,history,1,0
120743,of,1,0
120744,previous,1,0
120745,complications,1,0
120746,",",1,0
120747,clinical,1,0
120748,status,1,0
120749,",",1,0
120750,liver,1,0
120751,and,1,0
120752,renal,1,0
120753,function,1,0
120754,",",1,0
120755,modified,1,0
120756,Child,1,0
120757,'s,1,0
120758,score,1,0
120759,",",1,0
120760,and,1,0
120761,nutritional,1,0
120762,status,1,0
120763,at,1,0
120764,admission,1,0
120765,.,1,0
120766,The,0,0
120767,enteral,0,0
120768,formula,0,0
120769,diet,0,0
120770,was,0,0
120771,energy,0,0
120772,dense,0,0
120773,",",0,0
120774,containing,0,0
120775,40,0,0
120776,mmol,0,0
120777,Na/day,0,0
120778,",",0,0
120779,whole,0,0
120780,protein,0,0
120781,plus,0,0
120782,branched-chain,0,0
120783,amino,0,0
120784,acids,0,0
120785,",",0,0
120786,medium-,0,0
120787,and,0,0
120788,long-chain,0,0
120789,triglycerides,0,0
120790,",",0,0
120791,and,0,0
120792,maltodextrin,0,0
120793,.,0,0
120794,It,0,0
120795,supplied,0,0
120796,2115,0,1
120797,kcal/day,0,0
120798,.,0,0
120799,The,0,0
120800,amount,0,0
120801,of,0,0
120802,vitamins,0,0
120803,and,0,0
120804,trace,0,0
120805,elements,0,0
120806,was,0,0
120807,at,0,0
120808,the,0,0
120809,upper,0,0
120810,limit,0,0
120811,of,0,0
120812,the,0,0
120813,recommended,0,0
120814,dietary,0,0
120815,allowances,0,1
120816,.,0,0
120817,The,0,0
120818,orally,0,0
120819,fed,0,0
120820,patients,0,1
120821,were,0,0
120822,encouraged,0,0
120823,to,0,0
120824,eat,0,0
120825,all,0,0
120826,meals,0,0
120827,served,0,0
120828,.,0,1
120829,Total,0,0
120830,enteral,0,0
120831,nutrition,0,1
120832,was,0,0
120833,well,0,0
120834,tolerated,0,0
120835,without,0,0
120836,major,0,0
120837,complications,0,0
120838,.,0,1
120839,Serum,0,0
120840,albumin,0,0
120841,and,0,0
120842,Child,0,0
120843,'s,0,0
120844,score,0,0
120845,improved,0,0
120846,in,0,0
120847,the,0,0
120848,enterally,0,0
120849,fed,0,0
120850,patients,0,1
120851,but,0,0
120852,not,0,0
120853,in,0,0
120854,controls,0,0
120855,.,0,1
120856,Mortality,0,0
120857,rate,0,0
120858,while,0,0
120859,in,0,0
120860,the,0,0
120861,hospital,0,0
120862,was,0,0
120863,lower,0,0
120864,in,0,0
120865,patients,0,1
120866,on,0,0
120867,enteral,0,1
120868,feeding,0,0
120869,than,0,0
120870,in,0,0
120871,controls,0,1
120872,(,0,0
120873,12,0,0
120874,%,0,0
120875,vs,0,0
120876,47,0,1
120877,%,0,0
120878,),0,0
120879,.,0,0
120880,These,0,0
120881,results,0,0
120882,show,0,0
120883,that,0,0
120884,total,0,1
120885,enteral,0,0
120886,nutrition,0,0
120887,is,0,0
120888,safe,0,0
120889,and,0,0
120890,effective,0,0
120891,in,0,0
120892,improving,0,0
120893,the,0,0
120894,short-term,0,0
120895,clinical,0,0
120896,outcome,0,0
120897,in,0,0
120898,severely,1,1
120899,malnourished,1,1
120900,cirrhotics,1,1
120901,.,1,1
120902,Endoscopic,0,0
120903,versus,0,0
120904,operative,0,0
120905,gastrostomy,1,1
120906,:,1,1
120907,final,0,0
120908,results,0,0
120909,of,0,0
120910,a,0,0
120911,prospective,0,0
120912,randomized,0,0
120913,trial,0,0
120914,.,0,0
120915,This,1,0
120916,study,1,0
120917,compared,1,0
120918,operative,1,0
120919,gastrostomy,1,0
120920,(,1,0
120921,OG,1,0
120922,),1,0
120923,(,1,0
120924,by,1,0
120925,surgeons,1,1
120926,),1,0
120927,with,1,1
120928,endoscopic,1,0
120929,gastrostomy,1,0
120930,(,1,0
120931,PEG,1,0
120932,),1,0
120933,(,1,0
120934,by,1,0
120935,physicians,1,1
120936,),1,0
120937,in,0,0
120938,a,0,0
120939,prospective,0,0
120940,randomized,0,0
120941,fashion,0,0
120942,to,0,0
120943,determine,0,0
120944,whether,0,0
120945,one,0,0
120946,technique,0,0
120947,was,0,0
120948,superior,0,0
120949,.,0,0
120950,PEG,0,0
120951,(,0,0
120952,Sachs-Vine,0,1
120953,),0,0
120954,and,0,0
120955,OG,0,0
120956,(,0,0
120957,Stamm,0,0
120958,),0,0
120959,were,0,0
120960,done,0,0
120961,using,0,0
120962,local,0,0
120963,anesthesia,0,1
120964,.,0,1
120965,Patients,1,1
120966,were,1,0
120967,assessed,1,0
120968,for,1,0
120969,complications,1,0
120970,",",1,0
120971,mortality,1,0
120972,",",1,0
120973,tube,1,0
120974,function,1,0
120975,",",1,0
120976,and,1,0
120977,cost,1,0
120978,.,1,0
120979,Groups,1,0
120980,were,1,0
120981,equally,1,0
120982,matched,1,1
120983,for,1,0
120984,indications,1,0
120985,and,1,0
120986,underlying,1,0
120987,disease,1,1
120988,.,1,0
120989,Fifty-seven,1,1
120990,had,1,0
120991,OG,1,0
120992,and,1,0
120993,64,1,0
120994,had,1,0
120995,attempted,1,0
120996,PEG,1,0
120997,.,1,0
120998,Complications,0,0
120999,occurred,0,0
121000,in,0,0
121001,26,0,0
121002,%,0,0
121003,of,0,0
121004,OG,0,0
121005,patients,0,1
121006,and,0,0
121007,9,0,0
121008,%,0,0
121009,died,0,1
121010,.,0,0
121011,Complications,0,0
121012,occurred,0,0
121013,in,0,0
121014,25,0,0
121015,%,0,0
121016,of,0,0
121017,PEG,0,0
121018,patients,0,1
121019,and,0,0
121020,12,0,0
121021,%,0,0
121022,died,0,1
121023,.,0,0
121024,Tube,0,0
121025,feeding,0,0
121026,was,0,0
121027,initiated,0,0
121028,in,0,0
121029,both,0,0
121030,groups,0,0
121031,within,0,0
121032,a,0,0
121033,mean,0,0
121034,of,0,0
121035,29,0,1
121036,(,0,0
121037,24,0,0
121038,to,0,0
121039,72,0,1
121040,),0,0
121041,hours,0,0
121042,of,0,0
121043,the,0,0
121044,gastrostomy,0,0
121045,placement,0,0
121046,.,0,0
121047,OG,0,0
121048,cost,0,0
121049,$,0,0
121050,1675,0,1
121051,and,0,0
121052,PEG,0,0
121053,$,0,0
121054,979,0,1
121055,to,0,0
121056,perform,0,0
121057,.,0,0
121058,Twenty-one,0,1
121059,PEG,0,0
121060,patients,0,1
121061,required,0,0
121062,endoscopic,0,0
121063,tube,0,0
121064,change,0,0
121065,which,0,0
121066,raised,0,0
121067,their,0,0
121068,total,0,1
121069,cost,0,0
121070,to,0,0
121071,$,0,0
121072,1574,0,0
121073,.,0,0
121074,We,0,0
121075,conclude,0,0
121076,there,0,0
121077,is,0,0
121078,no,0,0
121079,difference,0,0
121080,between,0,0
121081,OG,0,0
121082,(,0,0
121083,using,0,0
121084,local,0,0
121085,anesthesia,0,1
121086,),0,0
121087,and,0,0
121088,PEG,0,0
121089,with,0,0
121090,regard,0,0
121091,to,0,0
121092,morbidity,0,0
121093,",",0,0
121094,mortality,0,0
121095,",",0,0
121096,or,0,0
121097,tube,0,0
121098,function,0,0
121099,.,0,0
121100,The,0,0
121101,endoscopic,0,0
121102,technique,0,0
121103,does,0,0
121104,appear,0,0
121105,to,0,0
121106,have,0,0
121107,economic,0,0
121108,advantage,0,0
121109,.,0,0
121110,A,0,0
121111,placebo-controlled,0,0
121112,",",0,0
121113,randomized,0,0
121114,clinical,0,0
121115,trial,0,0
121116,using,0,0
121117,testosterone,0,0
121118,undecanoate,0,0
121119,with,0,1
121120,injectable,0,0
121121,norethisterone,0,0
121122,enanthate,0,0
121123,:,0,1
121124,effect,0,0
121125,on,0,0
121126,anthropometric,1,0
121127,",",1,0
121128,metabolic,1,0
121129,and,1,0
121130,biochemical,1,0
121131,parameters,1,0
121132,.,1,1
121133,Testosterone,0,0
121134,administered,0,0
121135,alone,0,0
121136,or,0,0
121137,in,0,0
121138,combination,0,0
121139,with,0,1
121140,progestogens,0,0
121141,in,0,0
121142,male,0,1
121143,contraception,0,1
121144,induces,0,0
121145,reversible,0,0
121146,oligo-azoospermia,0,1
121147,",",0,0
121148,but,0,0
121149,its,0,0
121150,effects,0,0
121151,on,0,0
121152,body,0,1
121153,composition,0,0
121154,and,0,0
121155,metabolism,0,0
121156,are,0,0
121157,less,0,0
121158,known,0,0
121159,.,0,0
121160,We,0,0
121161,analysed,1,0
121162,anthropometric,1,0
121163,and,1,0
121164,metabolic,1,0
121165,parameters,1,0
121166,in,1,0
121167,five,1,1
121168,groups,1,0
121169,of,1,0
121170,10,1,1
121171,males,1,1
121172,:,1,1
121173,four,1,0
121174,receiving,1,0
121175,testosterone,1,0
121176,undecanoate,1,0
121177,(,0,0
121178,TU,0,0
121179,:,0,1
121180,1000,0,0
121181,mg,0,0
121182,),0,0
121183,plus,0,0
121184,norethisterone,0,0
121185,enanthate,0,0
121186,(,0,0
121187,NETE,0,0
121188,:,0,1
121189,200,0,0
121190,mg,0,0
121191,),0,0
121192,at,0,0
121193,different,0,0
121194,intervals,0,0
121195,(,0,0
121196,every,0,0
121197,8,0,0
121198,weeks,0,0
121199,:,0,1
121200,NETE-8,0,0
121201,;,0,0
121202,every,0,0
121203,12,0,0
121204,weeks,0,0
121205,:,0,1
121206,NETE-12,0,0
121207,;,0,0
121208,every,0,0
121209,6,0,0
121210,weeks,0,0
121211,for,0,0
121212,12,0,1
121213,weeks,0,0
121214,and,0,0
121215,then,0,0
121216,every,0,0
121217,12,0,0
121218,weeks,0,0
121219,:,0,1
121220,NETE-6/12,0,0
121221,;,0,0
121222,every,0,0
121223,6,0,0
121224,weeks,0,0
121225,for,0,0
121226,12,0,1
121227,weeks,0,0
121228,and,0,0
121229,then,0,0
121230,TU,0,0
121231,plus,0,0
121232,placebo,0,0
121233,every,0,0
121234,12,0,0
121235,weeks,0,0
121236,:,0,1
121237,NETE-6/12/0,0,0
121238,),0,0
121239,and,0,0
121240,one,0,0
121241,placebo,0,0
121242,(,0,0
121243,NETE-0/0,0,0
121244,),0,0
121245,for,0,0
121246,a,0,0
121247,total,0,1
121248,of,0,0
121249,48,0,1
121250,weeks,0,0
121251,.,0,1
121252,Body,0,0
121253,mass,0,0
121254,index,0,0
121255,(,0,0
121256,BMI,0,0
121257,),0,0
121258,and,0,0
121259,waist,0,0
121260,circumference,0,0
121261,did,0,0
121262,not,0,0
121263,change,0,0
121264,in,0,0
121265,any,0,0
121266,groups,0,0
121267,except,0,0
121268,for,0,0
121269,the,0,0
121270,NETE-8,0,0
121271,in,0,0
121272,which,0,0
121273,BMI,0,0
121274,increased,0,0
121275,significantly,0,0
121276,(,0,0
121277,p,0,0
121278,=,0,0
121279,0.02,0,0
121280,),0,0
121281,at,0,0
121282,the,0,0
121283,end,0,0
121284,of,0,0
121285,the,0,0
121286,treatment,0,0
121287,period,0,0
121288,.,0,0
121289,Lean,0,0
121290,body,0,0
121291,mass,0,0
121292,(,0,0
121293,MAMC,0,0
121294,or,0,1
121295,AMA,0,0
121296,),0,0
121297,increased,0,0
121298,significantly,0,0
121299,in,0,0
121300,the,0,0
121301,highest,0,0
121302,hormonal,0,0
121303,dose,0,0
121304,groups,0,0
121305,(,0,0
121306,p,0,0
121307,=,0,0
121308,0.04,0,0
121309,",",0,0
121310,NETE-6/12,0,0
121311,;,0,0
121312,p,0,0
121313,=,0,0
121314,0.004,0,0
121315,",",0,0
121316,NETE-8,0,0
121317,),0,0
121318,.,0,0
121319,No,0,0
121320,differences,0,0
121321,were,0,0
121322,observed,0,0
121323,in,0,0
121324,glucose,0,0
121325,levels,0,0
121326,",",0,0
121327,insulin,0,0
121328,sensitivity,0,0
121329,index,0,0
121330,and,0,0
121331,lipid,0,0
121332,profile,0,0
121333,as,0,0
121334,well,0,0
121335,as,0,0
121336,in,0,0
121337,biochemical,0,0
121338,and,0,0
121339,cell,0,1
121340,count,0,0
121341,parameters,0,0
121342,in,0,0
121343,any,0,0
121344,groups,0,0
121345,.,0,0
121346,In,0,0
121347,conclusion,0,0
121348,",",0,0
121349,NETE,0,0
121350,and,0,0
121351,TU,0,0
121352,for,0,0
121353,48,0,1
121354,weeks,0,0
121355,were,0,0
121356,not,0,0
121357,accompanied,0,0
121358,by,0,0
121359,any,0,0
121360,metabolic,0,0
121361,changes,0,0
121362,and,0,0
121363,any,0,0
121364,adverse,0,0
121365,effects,0,0
121366,.,0,0
121367,The,0,0
121368,weight,0,0
121369,gain,0,0
121370,of,0,0
121371,the,0,0
121372,highest,0,0
121373,NETE,0,0
121374,plus,0,0
121375,TU,0,0
121376,dosage,0,0
121377,was,0,0
121378,mainly,0,0
121379,because,0,0
121380,of,0,0
121381,gain,0,0
121382,in,0,0
121383,muscle,0,0
121384,mass,0,1
121385,.,0,0
121386,Inhibin,0,0
121387,A,0,0
121388,is,0,0
121389,down-regulated,0,0
121390,during,0,0
121391,chemotherapy,0,0
121392,in,0,0
121393,patients,1,1
121394,with,1,1
121395,breast,1,1
121396,cancer,1,1
121397,.,1,0
121398,BACKGROUND,0,0
121399,Inhibins,0,0
121400,are,0,0
121401,dimeric,0,0
121402,glycoproteins,0,0
121403,",",0,0
121404,composed,0,0
121405,of,0,0
121406,an,0,0
121407,alpha-subunit,0,0
121408,(,0,0
121409,INH-?,0,0
121410,),0,0
121411,and,0,0
121412,one,0,0
121413,of,0,0
121414,two,0,0
121415,possible,0,0
121416,beta-subunits,0,0
121417,(,0,0
121418,?A,0,0
121419,or,0,1
121420,?B,0,0
121421,),0,0
121422,",",0,0
121423,with,0,1
121424,substantial,0,0
121425,roles,0,0
121426,in,0,0
121427,human,0,0
121428,reproduction,0,0
121429,and,0,0
121430,in,0,0
121431,endocrine-responsive,0,1
121432,tumours,0,1
121433,.,0,1
121434,Aims,0,0
121435,of,0,0
121436,this,0,0
121437,study,0,0
121438,were,0,0
121439,to,0,0
121440,determine,0,0
121441,the,0,0
121442,serological,0,0
121443,measurement,0,0
121444,of,0,0
121445,inhibin,0,0
121446,A,0,0
121447,(,0,0
121448,?-?A,1,1
121449,),1,0
121450,in,1,0
121451,breast,1,1
121452,cancer,1,1
121453,patients,1,1
121454,during,1,0
121455,chemotherapy,1,1
121456,.,1,0
121457,PATIENTS,1,0
121458,AND,0,0
121459,METHODS,0,0
121460,A,0,0
121461,series,1,0
121462,of,1,0
121463,30,1,0
121464,breast,1,1
121465,cancer,1,1
121466,patients,1,1
121467,who,1,1
121468,underwent,1,1
121469,standardised,1,0
121470,chemotherapy,1,0
121471,were,1,0
121472,prospectively,0,0
121473,evaluated,0,0
121474,before,0,0
121475,chemotherapeutic,0,0
121476,treatment,0,0
121477,as,0,0
121478,well,0,0
121479,as,0,0
121480,four,0,0
121481,weeks,0,0
121482,after,0,0
121483,chemotherapy,0,0
121484,and,0,0
121485,two,0,0
121486,years,0,1
121487,after,0,0
121488,chemotherapy,0,0
121489,for,0,0
121490,the,0,0
121491,serological,0,0
121492,expression,0,0
121493,of,0,0
121494,inhibin,0,0
121495,A,0,0
121496,.,0,0
121497,For,0,0
121498,statistical,0,0
121499,analysis,0,0
121500,the,0,0
121501,Wilcoxon,0,0
121502,rank,0,0
121503,sum,0,0
121504,test,0,0
121505,was,0,0
121506,used,0,0
121507,for,0,0
121508,paired,0,0
121509,samples,0,1
121510,.,0,1
121511,Statistical,0,0
121512,significance,0,0
121513,was,0,0
121514,assumed,0,0
121515,at,0,0
121516,p,0,0
121517,<,0,0
121518,0.05,0,0
121519,.,0,0
121520,RESULTS,0,0
121521,The,0,0
121522,concentration,0,0
121523,of,0,0
121524,inhibin,0,0
121525,A,0,0
121526,showed,0,0
121527,a,0,0
121528,significant,0,0
121529,decrease,0,0
121530,between,0,0
121531,data,0,0
121532,obtained,0,0
121533,before,0,0
121534,chemotherapy,0,0
121535,and,0,0
121536,after,0,0
121537,chemotherapy,0,0
121538,(,0,0
121539,p,0,0
121540,<,0,0
121541,0.005,0,0
121542,),0,0
121543,and,0,0
121544,two-year,0,0
121545,follow-up,0,0
121546,(,0,0
121547,p,0,0
121548,<,0,0
121549,0.001,0,0
121550,),0,0
121551,.,0,0
121552,Interestingly,0,0
121553,",",0,0
121554,there,0,0
121555,were,0,0
121556,no,0,0
121557,differences,0,0
121558,in,0,0
121559,inhibin,0,0
121560,A,0,0
121561,concentrations,0,0
121562,between,0,0
121563,the,0,0
121564,four-week,0,0
121565,and,0,0
121566,two-year,0,0
121567,follow-up,0,0
121568,(,0,0
121569,p=0.744,0,0
121570,),0,0
121571,.,0,0
121572,DISCUSSION,0,0
121573,Chemotherapy,0,0
121574,significantly,0,0
121575,decreases,0,0
121576,inhibin,0,0
121577,A,0,0
121578,concentration,0,0
121579,during,0,0
121580,chemotherapy,0,0
121581,.,0,0
121582,This,0,0
121583,might,0,0
121584,reflect,0,0
121585,a,0,0
121586,suppression,0,0
121587,of,0,0
121588,ovarian,0,1
121589,function,0,0
121590,",",0,0
121591,being,0,0
121592,also,0,0
121593,a,0,0
121594,marker,0,0
121595,for,0,0
121596,chemotherapy-induced,0,0
121597,amenorrhoea,0,1
121598,.,0,0
121599,Moreover,0,0
121600,",",0,0
121601,it,0,0
121602,has,0,0
121603,been,0,0
121604,suggested,0,0
121605,that,0,0
121606,inhibin,0,0
121607,A,0,0
121608,might,0,0
121609,be,0,0
121610,a,0,0
121611,tumour,0,0
121612,marker,0,0
121613,for,0,0
121614,breast,0,1
121615,cancer,0,1
121616,",",0,0
121617,and,0,0
121618,therefore,0,0
121619,a,0,0
121620,sudden,0,0
121621,increase,0,0
121622,in,0,0
121623,its,0,0
121624,concentration,0,0
121625,might,0,0
121626,be,0,0
121627,indicative,0,0
121628,of,0,0
121629,breast,0,1
121630,cancer,0,1
121631,recurrence,0,0
121632,.,0,0
121633,[,0,0
121634,GISSI-2,0,0
121635,;,0,0
121636,the,0,0
121637,beginning,0,0
121638,of,0,0
121639,the,0,0
121640,end,0,0
121641,or,0,0
121642,the,0,0
121643,end,0,0
121644,of,0,0
121645,the,0,0
121646,beginning,0,0
121647,for,0,0
121648,tissue,0,0
121649,plasminogen,0,0
121650,activator,0,0
121651,in,0,0
121652,acute,1,1
121653,myocardial,1,1
121654,infarct,1,0
121655,?,0,0
121656,],0,0
121657,.,0,0
121658,Cost,0,0
121659,effectiveness,0,0
121660,of,0,0
121661,training,0,0
121662,incontinent,1,0
121663,elderly,1,1
121664,in,1,0
121665,nursing,1,1
121666,homes,1,1
121667,:,1,1
121668,a,0,0
121669,randomized,0,0
121670,clinical,0,0
121671,trial,0,0
121672,.,0,0
121673,This,0,0
121674,study,0,0
121675,used,0,0
121676,a,0,0
121677,randomized,0,0
121678,clinical,0,0
121679,trial,0,0
121680,with,0,1
121681,133,1,1
121682,incontinent,1,0
121683,elderly,1,1
121684,in,1,0
121685,seven,1,0
121686,nursing,1,1
121687,homes,1,1
121688,to,0,0
121689,evaluate,0,0
121690,the,0,0
121691,effectiveness,0,0
121692,of,0,0
121693,a,0,0
121694,behavioral,0,0
121695,training,0,0
121696,therapy,0,0
121697,and,0,0
121698,its,0,0
121699,cost,0,0
121700,implications,0,0
121701,.,0,0
121702,The,0,0
121703,training,0,0
121704,program,0,0
121705,lasted,0,0
121706,three,0,0
121707,months,0,0
121708,",",0,0
121709,and,0,0
121710,a,0,0
121711,22-week,0,0
121712,follow-up,0,0
121713,period,0,0
121714,examined,0,0
121715,the,0,0
121716,durability,0,0
121717,of,0,0
121718,the,0,0
121719,treatment,0,0
121720,effect,0,0
121721,.,0,0
121722,The,0,0
121723,therapy,0,0
121724,became,0,0
121725,effective,0,0
121726,after,0,0
121727,six,0,1
121728,weeks,0,0
121729,of,0,0
121730,training,0,0
121731,.,0,0
121732,By,0,0
121733,the,0,0
121734,final,0,0
121735,months,0,0
121736,of,0,0
121737,training,0,0
121738,",",0,0
121739,the,0,0
121740,treatment,0,0
121741,participants,0,1
121742,',0,1
121743,wet,0,0
121744,episodes,0,0
121745,had,0,0
121746,been,0,0
121747,reduced,0,0
121748,by,0,0
121749,0.6,0,0
121750,episode,0,1
121751,per,0,0
121752,day,0,0
121753,",",0,0
121754,or,0,0
121755,a,0,0
121756,26,0,0
121757,percent,0,0
121758,reduction,0,0
121759,over,0,0
121760,baseline,0,0
121761,",",0,0
121762,and,0,0
121763,improvement,0,0
121764,was,0,0
121765,maintained,0,0
121766,during,0,0
121767,the,0,0
121768,follow-up,0,0
121769,period,0,0
121770,.,0,0
121771,Trainees,1,0
121772,with,1,1
121773,a,1,0
121774,high,1,0
121775,frequency,1,0
121776,of,1,0
121777,incontinence,1,0
121778,during,1,0
121779,baseline,1,0
121780,",",1,0
121781,relatively,1,0
121782,more,1,0
121783,cognitive,1,0
121784,residents,1,1
121785,",",1,0
121786,and,1,0
121787,residents,1,1
121788,with,1,1
121789,a,1,0
121790,normal,1,0
121791,bladder,1,1
121792,capacity,1,0
121793,responded,0,0
121794,better,0,0
121795,to,0,0
121796,this,0,0
121797,behavioral,0,0
121798,program,0,0
121799,.,0,0
121800,The,0,0
121801,cost,0,0
121802,of,0,0
121803,training,0,0
121804,was,0,0
121805,the,0,0
121806,equivalent,0,0
121807,of,0,0
121808,about,0,0
121809,one,0,0
121810,hour,0,0
121811,of,0,0
121812,nursing,0,1
121813,aide,0,0
121814,time,0,0
121815,per,0,0
121816,patient,0,0
121817,day,0,0
121818,.,0,0
121819,The,0,0
121820,reduction,0,0
121821,in,0,0
121822,incontinence,0,0
121823,during,0,0
121824,the,0,0
121825,follow-up,0,0
121826,period,0,0
121827,resulted,0,0
121828,in,0,0
121829,some,0,0
121830,small,0,0
121831,savings,0,0
121832,in,0,0
121833,laundry,0,1
121834,costs,0,0
121835,and,0,0
121836,supplies,0,0
121837,used,0,0
121838,",",0,0
121839,and,0,0
121840,some,0,0
121841,quantitatively,0,0
121842,unmeasurable,0,0
121843,but,0,0
121844,detectable,0,0
121845,improvement,0,0
121846,in,0,0
121847,psychosocial,0,0
121848,well-being,0,0
121849,among,0,0
121850,the,0,0
121851,trainees,0,0
121852,.,0,0
121853,Since,0,0
121854,the,0,0
121855,central,0,0
121856,figure,0,0
121857,in,0,0
121858,implementing,0,0
121859,this,0,0
121860,training,0,0
121861,protocol,0,0
121862,is,0,0
121863,the,0,0
121864,nursing,0,0
121865,aide,0,0
121866,",",0,0
121867,it,0,0
121868,is,0,0
121869,important,0,0
121870,to,0,0
121871,find,0,0
121872,an,0,0
121873,organizational,0,0
121874,management,0,0
121875,scheme,0,0
121876,that,0,0
121877,will,0,0
121878,stimulate,0,0
121879,nursing,0,0
121880,aides,0,0
121881,to,0,0
121882,reduce,0,0
121883,incontinence,0,0
121884,among,0,0
121885,nursing,1,1
121886,home,1,1
121887,residents,1,1
121888,.,1,1
121889,Serum,0,1
121890,biochemical,0,0
121891,characteristics,0,0
121892,of,0,0
121893,Beluga,1,1
121894,",",1,0
121895,Huso,1,0
121896,huso,1,1
121897,(,1,0
121898,L.,1,0
121899,),1,0
121900,",",0,0
121901,in,0,0
121902,response,0,0
121903,to,0,0
121904,blood,0,0
121905,sampling,0,0
121906,after,0,0
121907,clove,0,0
121908,powder,0,0
121909,solution,0,0
121910,exposure,0,0
121911,.,0,0
121912,In,0,0
121913,order,0,0
121914,to,0,0
121915,investigate,0,0
121916,the,0,0
121917,effect,0,0
121918,of,0,0
121919,anesthesia,0,0
121920,on,0,0
121921,serum,0,0
121922,parameters,0,0
121923,",",0,0
121924,Beluga,1,0
121925,",",1,0
121926,Huso,1,0
121927,huso,1,1
121928,(,1,0
121929,L.,1,0
121930,),1,0
121931,were,0,0
121932,blood-sampled,0,0
121933,immediately,0,0
121934,without,0,0
121935,anesthesia,0,0
121936,(,0,0
121937,control,0,0
121938,),0,0
121939,or,0,0
121940,subjected,0,0
121941,to,0,0
121942,following,0,0
121943,anesthesia,0,1
121944,procedure,0,0
121945,:,0,1
121946,40,0,0
121947,",",0,0
121948,120,0,0
121949,",",0,0
121950,and,0,0
121951,240,0,0
121952,s,0,0
121953,exposure,0,0
121954,to,0,0
121955,"3,000",0,0
121956,",",0,0
121957,700,0,0
121958,",",0,0
121959,and,0,0
121960,500,0,0
121961,mg,0,0
121962,l??,0,0
121963,clove,0,0
121964,solution,0,0
121965,",",0,0
121966,respectively,0,0
121967,.,0,0
121968,Blood,0,0
121969,samples,0,0
121970,were,0,0
121971,collected,0,0
121972,after,0,0
121973,these,0,0
121974,periods,0,0
121975,",",0,0
121976,when,1,0
121977,fish,1,0
121978,were,1,0
121979,immobile,0,1
121980,and,0,0
121981,reached,0,0
121982,stage,0,1
121983,4,0,0
121984,anesthesia,0,1
121985,.,0,1
121986,Results,0,0
121987,showed,0,0
121988,that,0,0
121989,cortisol,0,0
121990,and,0,0
121991,glucose,0,0
121992,levels,0,0
121993,were,0,0
121994,significantly,0,0
121995,high,0,0
121996,in,0,0
121997,700,0,0
121998,and,0,0
121999,500,0,0
122000,but,0,0
122001,not,0,0
122002,"3,000",0,0
122003,mg,0,0
122004,l??,0,0
122005,group,0,0
122006,compared,0,0
122007,to,0,0
122008,control,0,0
122009,.,0,0
122010,Serum,0,0
122011,lactate,0,0
122012,levels,0,0
122013,were,0,0
122014,significantly,0,0
122015,high,0,0
122016,in,0,0
122017,500,0,0
122018,mg,0,0
122019,l??,0,0
122020,group,0,0
122021,compared,0,0
122022,to,0,0
122023,control,0,0
122024,group,0,0
122025,.,0,0
122026,Lactate,0,0
122027,levels,0,0
122028,were,0,0
122029,not,0,0
122030,significantly,0,0
122031,differed,0,0
122032,between,0,0
122033,control,0,0
122034,",",0,0
122035,"3,000",0,0
122036,",",0,0
122037,and,0,0
122038,700,0,0
122039,mg,0,0
122040,l??,0,0
122041,groups,0,0
122042,.,0,0
122043,There,0,0
122044,were,0,0
122045,no,0,0
122046,significant,0,0
122047,differences,0,0
122048,in,0,0
122049,serum,0,0
122050,levels,0,0
122051,of,0,0
122052,cholesterol,0,0
122053,",",0,0
122054,total,0,0
122055,protein,0,0
122056,",",0,0
122057,lactate,0,0
122058,dehydrogenase,0,0
122059,",",0,0
122060,aspartate,0,0
122061,aminotransferase,0,0
122062,",",0,0
122063,alanine,0,0
122064,aminotransferase,0,0
122065,",",0,0
122066,Na?,0,0
122067,",",0,0
122068,Cl?,0,0
122069,",",0,0
122070,K?,0,0
122071,",",0,0
122072,and,0,0
122073,Ca??,0,0
122074,.,0,0
122075,Results,0,0
122076,suggest,0,0
122077,that,0,0
122078,rapid,0,0
122079,anesthesia,0,0
122080,with,0,1
122081,higher,0,0
122082,dose,0,0
122083,is,0,0
122084,better,0,0
122085,than,0,0
122086,slow,0,0
122087,anesthesia,0,0
122088,with,0,1
122089,lower,0,0
122090,dose,0,0
122091,for,0,0
122092,blood,0,0
122093,sampling,0,0
122094,in,0,0
122095,Beluga,1,1
122096,.,1,1
122097,Effect,0,0
122098,of,0,0
122099,weight,0,0
122100,loss,0,0
122101,on,0,0
122102,inflammation,0,0
122103,in,0,0
122104,patients,1,1
122105,with,1,1
122106,mild,1,1
122107,obstructive,1,1
122108,sleep,1,0
122109,apnea,1,1
122110,.,1,0
122111,BACKGROUND,0,0
122112,AND,0,0
122113,AIMS,0,0
122114,Inflammation,0,0
122115,may,0,0
122116,be,0,0
122117,one,0,0
122118,mediating,0,0
122119,mechanism,0,0
122120,for,0,0
122121,cardiovascular,1,1
122122,diseases,1,1
122123,in,1,0
122124,obstructive,1,1
122125,sleep,1,0
122126,apnea,1,1
122127,(,1,0
122128,OSA,1,1
122129,),1,0
122130,.,0,0
122131,However,0,0
122132,",",0,0
122133,little,0,0
122134,is,0,0
122135,known,0,0
122136,about,0,0
122137,subclinical,0,0
122138,inflammation,0,0
122139,or,0,0
122140,the,0,0
122141,effect,0,0
122142,of,0,0
122143,lifestyle,0,0
122144,intervention,0,0
122145,on,0,0
122146,inflammation,0,0
122147,in,0,0
122148,early,0,0
122149,stages,0,1
122150,of,0,0
122151,OSA,0,1
122152,.,0,0
122153,The,0,0
122154,aim,0,0
122155,of,0,0
122156,this,0,0
122157,substudy,0,0
122158,of,0,0
122159,an,0,0
122160,existing,0,0
122161,randomized,0,0
122162,controlled,0,0
122163,trial,0,0
122164,",",0,0
122165,with,0,0
122166,post,0,0
122167,hoc,0,0
122168,analyses,0,0
122169,",",0,0
122170,was,0,0
122171,to,0,0
122172,determine,0,0
122173,the,0,0
122174,impact,0,0
122175,of,0,0
122176,lifestyle,0,1
122177,changes,0,0
122178,aimed,0,0
122179,at,0,0
122180,weight,0,0
122181,reduction,0,0
122182,on,0,0
122183,inflammatory,0,0
122184,biomarkers,0,0
122185,in,0,0
122186,overweight,1,1
122187,patients,1,1
122188,with,1,1
122189,mild,1,1
122190,OSA,1,1
122191,.,1,0
122192,METHODS,0,0
122193,AND,0,0
122194,RESULTS,0,0
122195,Patients,1,1
122196,were,1,1
122197,randomized,1,1
122198,to,1,0
122199,supervised,1,0
122200,intensive,1,0
122201,lifestyle,1,0
122202,intervention,1,0
122203,group,1,0
122204,(,1,0
122205,N=28,1,0
122206,),1,0
122207,or,1,0
122208,to,1,0
122209,control,1,0
122210,group,1,0
122211,(,1,0
122212,N=31,1,0
122213,),1,0
122214,",",1,0
122215,which,1,0
122216,received,1,0
122217,routine,1,0
122218,lifestyle,1,1
122219,advices,1,0
122220,.,1,1
122221,Circulating,0,0
122222,concentrations,0,0
122223,of,0,0
122224,pro-,0,0
122225,and,0,0
122226,anti-inflammatory,0,0
122227,mediators,0,0
122228,were,0,0
122229,measured,0,0
122230,before,0,0
122231,and,0,0
122232,after,0,0
122233,the,0,0
122234,1-year,0,0
122235,intervention,0,0
122236,.,0,0
122237,The,0,0
122238,concentrations,0,0
122239,of,0,0
122240,two,0,0
122241,pro-inflammatory,0,0
122242,mediators,0,0
122243,",",0,0
122244,high-sensitivity,0,0
122245,C-reactive,0,0
122246,protein,0,0
122247,(,0,0
122248,hsCRP,0,0
122249,),0,0
122250,and,0,0
122251,interleukin,0,0
122252,(,0,0
122253,IL,0,1
122254,),0,0
122255,-6,0,0
122256,",",0,0
122257,decreased,0,0
122258,significantly,0,0
122259,in,0,0
122260,both,0,0
122261,groups,0,0
122262,.,0,0
122263,Although,0,0
122264,the,0,0
122265,changes,0,0
122266,in,0,0
122267,inflammatory,0,0
122268,biomarkers,0,0
122269,favored,0,0
122270,the,0,0
122271,supervised,0,0
122272,lifestyle,0,0
122273,intervention,0,0
122274,",",0,0
122275,the,0,0
122276,only,0,0
122277,significant,0,0
122278,reduction,0,0
122279,observed,0,0
122280,between,0,0
122281,the,0,0
122282,groups,0,0
122283,was,0,0
122284,for,0,0
122285,the,0,0
122286,anti-inflammatory,0,0
122287,IL-1,0,0
122288,receptor,0,0
122289,antagonist,0,0
122290,(,0,0
122291,IL-1RA,0,1
122292,),0,0
122293,.,0,0
122294,The,0,0
122295,change,0,0
122296,in,0,0
122297,hsCRP,0,0
122298,was,0,0
122299,associated,0,0
122300,with,0,1
122301,apnea-hypopnea,0,1
122302,index,0,0
122303,",",0,0
122304,and,0,0
122305,improving,0,0
122306,night-time,0,0
122307,oxygen,0,0
122308,saturation,0,0
122309,was,0,0
122310,related,0,0
122311,to,0,0
122312,tumor,0,0
122313,necrosis,0,0
122314,factor,0,0
122315,alpha,0,0
122316,.,0,0
122317,IL-1RA,0,0
122318,and,0,0
122319,IL-6,0,0
122320,were,0,0
122321,associated,0,0
122322,with,0,0
122323,insulin,0,0
122324,metabolism,0,0
122325,.,0,0
122326,CONCLUSION,0,0
122327,Weight,0,0
122328,loss,0,0
122329,resulted,0,0
122330,in,0,0
122331,reductions,0,0
122332,in,0,0
122333,concentrations,0,0
122334,of,0,0
122335,some,0,0
122336,pro-,0,0
122337,and,0,0
122338,anti-inflammatory,0,0
122339,mediators,0,0
122340,in,0,0
122341,overweight,1,1
122342,patients,1,1
122343,with,1,1
122344,mild,1,1
122345,OSA,1,1
122346,",",0,0
122347,overall,0,0
122348,favoring,0,0
122349,the,0,0
122350,supervised,0,0
122351,lifestyle,0,0
122352,intervention,0,0
122353,.,0,0
122354,These,0,0
122355,findings,0,0
122356,suggest,0,0
122357,that,0,0
122358,more,0,0
122359,intensive,0,0
122360,treatment,0,0
122361,of,0,0
122362,obesity,0,1
122363,in,0,0
122364,OSA,1,0
122365,patients,1,1
122366,might,0,0
122367,be,0,0
122368,well-justified,0,0
122369,.,0,0
122370,Controlled,0,0
122371,",",0,0
122372,prospective,0,0
122373,",",0,0
122374,randomized,0,0
122375,",",0,0
122376,clinical,0,0
122377,evaluation,0,0
122378,of,0,0
122379,partial,1,0
122380,ceramic,1,1
122381,crowns,1,0
122382,inserted,0,0
122383,with,0,1
122384,RelyX,0,0
122385,Unicem,0,1
122386,with,0,1
122387,or,0,0
122388,without,0,0
122389,selective,0,0
122390,enamel,0,0
122391,etching,0,0
122392,.,0,0
122393,1-year,0,0
122394,results,0,0
122395,.,0,1
122396,PURPOSE,0,0
122397,To,0,0
122398,compare,0,0
122399,the,0,0
122400,performance,0,0
122401,of,0,0
122402,partial,1,0
122403,ceramic,1,0
122404,crowns,1,1
122405,(,1,0
122406,PCCs,1,0
122407,),1,0
122408,inserted,1,0
122409,with,1,1
122410,RelyX,1,0
122411,Unicem,1,1
122412,(,1,0
122413,RXU,1,0
122414,),1,0
122415,either,0,0
122416,with,0,0
122417,(,0,0
122418,RXU+E,0,0
122419,),0,0
122420,or,0,0
122421,without,0,0
122422,(,0,0
122423,RXU,0,0
122424,),0,0
122425,selective,0,0
122426,enamel,0,0
122427,etching,0,0
122428,.,0,0
122429,METHODS,0,0
122430,34,1,1
122431,patients,1,1
122432,(,1,0
122433,15,1,0
122434,male,1,1
122435,",",1,0
122436,19,1,1
122437,female,1,1
122438,),1,0
122439,participated,1,1
122440,in,1,0
122441,the,1,0
122442,investigation,1,0
122443,",",1,0
122444,with,1,0
122445,a,1,0
122446,total,1,1
122447,of,1,0
122448,68,1,1
122449,PCC,1,1
122450,restorations,1,0
122451,.,1,0
122452,In,0,0
122453,each,0,0
122454,patient,0,0
122455,",",0,0
122456,one,0,0
122457,PCC,0,0
122458,was,0,0
122459,randomly,0,0
122460,assigned,0,0
122461,to,0,0
122462,insertion,0,0
122463,with,0,0
122464,RXU,0,0
122465,",",0,0
122466,the,0,0
122467,second,0,0
122468,PCC,0,0
122469,was,0,0
122470,assigned,0,0
122471,to,0,0
122472,insertion,0,0
122473,with,0,1
122474,RXU+E,0,0
122475,.,0,1
122476,The,0,0
122477,PCCs,0,0
122478,were,0,1
122479,CAD/CAM,0,1
122480,fabricated,0,0
122481,using,0,0
122482,the,0,0
122483,Cerec,0,0
122484,3,0,0
122485,system,0,0
122486,.,0,0
122487,RXU,0,0
122488,:,0,1
122489,25,0,0
122490,PCCs,0,0
122491,were,0,0
122492,placed,0,0
122493,in,0,0
122494,molars,0,1
122495,",",0,0
122496,nine,0,1
122497,in,0,0
122498,premolars,0,1
122499,.,0,1
122500,RXU+E,0,0
122501,:,0,1
122502,26,0,1
122503,PCCs,0,0
122504,were,0,0
122505,placed,0,0
122506,in,0,0
122507,molars,0,1
122508,",",0,0
122509,eight,0,1
122510,in,0,0
122511,premolars,0,1
122512,.,0,1
122513,The,0,0
122514,restorations,0,0
122515,were,0,0
122516,clinically,0,0
122517,rated,0,0
122518,using,0,0
122519,modified,0,0
122520,United,0,1
122521,States,0,0
122522,Public,0,1
122523,Health,0,1
122524,Service,0,0
122525,(,0,0
122526,USPHS,0,0
122527,),0,0
122528,criteria,0,1
122529,at,0,0
122530,baseline,0,0
122531,",",0,0
122532,6,0,0
122533,and,0,0
122534,12,0,0
122535,months,0,0
122536,after,0,0
122537,placement,0,0
122538,.,0,0
122539,The,0,0
122540,median,1,0
122541,patient,1,0
122542,age,1,1
122543,was,1,0
122544,41,1,1
122545,years,1,1
122546,(,1,1
122547,24-59,1,1
122548,years,1,1
122549,),1,0
122550,.,1,0
122551,The,0,0
122552,median,0,0
122553,(,0,0
122554,25-75,0,0
122555,%,0,0
122556,),0,0
122557,PBI,0,0
122558,was,0,0
122559,6,0,0
122560,%,0,0
122561,(,0,0
122562,3-9,0,1
122563,%,0,0
122564,),0,0
122565,.,0,0
122566,RESULTS,0,0
122567,All,1,0
122568,patients,1,1
122569,were,1,0
122570,available,1,0
122571,for,1,0
122572,the,1,0
122573,three,1,0
122574,recall,1,0
122575,appointments,1,0
122576,.,1,1
122577,One,0,1
122578,PCC,0,0
122579,(,0,0
122580,RXU,0,0
122581,),0,0
122582,debonded,0,0
122583,after,0,0
122584,11,0,1
122585,months,0,0
122586,in,0,0
122587,situ,0,0
122588,",",0,0
122589,one,0,0
122590,PCC,0,0
122591,(,0,0
122592,RXU+E,0,0
122593,),0,0
122594,fractured,0,0
122595,after,0,0
122596,12,0,0
122597,months,0,0
122598,in,0,0
122599,situ,0,0
122600,.,0,0
122601,Both,0,0
122602,restorations,0,0
122603,had,0,0
122604,to,0,0
122605,be,0,0
122606,replaced,0,0
122607,.,0,0
122608,At,0,0
122609,the,0,0
122610,12,0,0
122611,months,0,0
122612,recall,0,0
122613,",",0,0
122614,66,0,0
122615,of,0,0
122616,68,0,1
122617,controlled,0,0
122618,restorations,0,0
122619,were,0,0
122620,functional,0,0
122621,without,0,0
122622,need,0,0
122623,of,0,0
122624,replacement,0,0
122625,.,0,0
122626,The,0,0
122627,evaluation,0,0
122628,using,0,0
122629,USHPS,0,0
122630,criteria,0,1
122631,revealed,0,0
122632,a,0,0
122633,significant,0,0
122634,decrease,0,0
122635,of,0,0
122636,alfa,0,0
122637,ratings,0,0
122638,over,0,0
122639,time,0,0
122640,with,0,1
122641,respect,0,0
122642,to,0,0
122643,criteria,0,1
122644,marginal,0,0
122645,adaptation,0,0
122646,and,0,0
122647,marginal,0,0
122648,discoloration,0,0
122649,.,0,0
122650,No,0,0
122651,statistically,0,0
122652,significant,0,0
122653,differences,0,0
122654,between,0,0
122655,the,0,0
122656,two,0,0
122657,luting,0,0
122658,techniques,0,0
122659,",",0,0
122660,RXU,0,0
122661,and,0,0
122662,RXU+E,0,0
122663,",",0,0
122664,we,0,0
122665,reobserved,0,0
122666,during,0,0
122667,the,0,0
122668,observation,0,0
122669,period,0,0
122670,of,0,0
122671,1,0,0
122672,year,0,0
122673,.,0,0
122674,Within,0,0
122675,the,0,0
122676,limitations,0,0
122677,of,0,0
122678,the,0,0
122679,present,0,0
122680,study,0,0
122681,",",0,0
122682,adhesive,0,0
122683,luting,0,0
122684,with,0,1
122685,RXU,0,0
122686,with,0,1
122687,or,0,0
122688,without,0,0
122689,selective,0,0
122690,enamel,0,0
122691,etching,0,0
122692,can,0,0
122693,be,0,0
122694,recommended,0,0
122695,.,0,0
122696,The,0,0
122697,effect,0,0
122698,of,0,0
122699,an,0,0
122700,early,0,0
122701,education,0,0
122702,program,0,0
122703,on,0,0
122704,adult,1,1
122705,health,1,1
122706,:,1,1
122707,the,0,0
122708,Carolina,0,1
122709,Abecedarian,0,0
122710,Project,0,0
122711,randomized,0,0
122712,controlled,0,0
122713,trial,0,0
122714,.,0,0
122715,OBJECTIVES,0,0
122716,We,0,0
122717,explored,0,0
122718,whether,0,0
122719,a,0,0
122720,successful,0,0
122721,randomized,0,0
122722,controlled,0,0
122723,trial,0,0
122724,of,0,0
122725,early,0,0
122726,education,0,0
122727,",",0,0
122728,the,0,0
122729,Carolina,0,1
122730,Abecedarian,0,0
122731,Project,0,0
122732,(,0,0
122733,ABC,0,0
122734,),0,0
122735,",",0,0
122736,which,0,0
122737,enrolled,1,1
122738,infants,1,1
122739,from,1,1
122740,1972,1,1
122741,to,1,0
122742,1977,1,1
122743,at,1,0
122744,the,1,0
122745,Frank,1,0
122746,Porter,1,0
122747,Graham,1,1
122748,Child,1,1
122749,Development,1,0
122750,Institute,1,0
122751,in,1,0
122752,Chapel,1,0
122753,Hill,1,0
122754,",",1,0
122755,North,1,0
122756,Carolina,1,1
122757,",",0,0
122758,improved,0,0
122759,health,0,0
122760,outcomes,0,0
122761,and,0,0
122762,behaviors,0,0
122763,by,0,0
122764,21,0,1
122765,years,0,1
122766,of,0,0
122767,age,0,1
122768,.,0,0
122769,METHODS,0,0
122770,ABC,0,0
122771,randomized,1,0
122772,111,1,1
122773,infants,1,1
122774,to,1,0
122775,receive,1,0
122776,an,1,0
122777,intensive,1,0
122778,early,1,0
122779,education,1,0
122780,program,1,0
122781,or,1,0
122782,nutritional,1,0
122783,supplements,1,0
122784,and,1,0
122785,parental,1,0
122786,counseling,1,0
122787,alone,1,0
122788,;,1,0
122789,participants,1,1
122790,have,1,0
122791,been,1,0
122792,followed,1,0
122793,to,1,0
122794,the,1,0
122795,present,1,0
122796,day,1,0
122797,.,1,0
122798,We,0,0
122799,examined,0,0
122800,the,0,0
122801,effect,0,0
122802,of,0,0
122803,ABC,0,0
122804,on,0,0
122805,health,0,1
122806,outcomes,0,0
122807,and,0,0
122808,behavioral,0,1
122809,risk,0,0
122810,factors,0,0
122811,when,1,0
122812,participants,1,1
122813,were,1,0
122814,aged,1,1
122815,21,1,1
122816,years,1,1
122817,",",0,0
122818,and,0,0
122819,then,0,0
122820,explored,0,0
122821,the,0,0
122822,mediators,0,0
122823,of,0,0
122824,this,0,0
122825,relationship,0,0
122826,.,0,0
122827,RESULTS,0,0
122828,Relative,0,0
122829,to,0,0
122830,the,0,0
122831,control,0,0
122832,group,0,0
122833,",",0,0
122834,the,0,0
122835,ABC,0,0
122836,treatment,0,0
122837,group,0,0
122838,was,0,0
122839,previously,0,0
122840,found,0,0
122841,to,0,0
122842,have,0,0
122843,improved,0,0
122844,cognition,0,0
122845,and,0,0
122846,educational,0,0
122847,attainment,0,0
122848,.,0,0
122849,We,0,0
122850,found,0,0
122851,that,0,0
122852,the,0,0
122853,intervention,0,0
122854,also,0,0
122855,improved,0,0
122856,heath,0,1
122857,(,0,0
122858,P,0,0
122859,=,0,0
122860,.05,0,0
122861,),0,0
122862,and,0,0
122863,health,0,0
122864,behaviors,0,0
122865,(,0,0
122866,P,0,0
122867,=,0,0
122868,.03,0,0
122869,),0,0
122870,when,0,0
122871,participants,0,1
122872,were,0,0
122873,aged,0,1
122874,21,0,1
122875,years,0,1
122876,.,0,1
122877,These,0,0
122878,improvements,0,0
122879,in,0,0
122880,behaviors,0,0
122881,were,0,0
122882,not,0,0
122883,mediated,0,0
122884,by,0,0
122885,IQ,0,0
122886,",",0,0
122887,math,0,0
122888,and,0,0
122889,reading,0,0
122890,scores,0,0
122891,at,0,0
122892,15,0,1
122893,years,0,1
122894,of,0,0
122895,age,0,1
122896,",",0,0
122897,educational,0,0
122898,attainment,0,0
122899,",",0,0
122900,or,0,0
122901,health,0,0
122902,insurance,0,0
122903,.,0,0
122904,CONCLUSIONS,0,0
122905,Effective,0,0
122906,early,0,0
122907,education,0,0
122908,programs,0,0
122909,may,0,0
122910,improve,0,0
122911,health,0,0
122912,and,0,0
122913,reduce,0,0
122914,risky,0,0
122915,health,0,0
122916,behaviors,0,0
122917,in,0,0
122918,adulthood,0,1
122919,.,0,0
122920,Effects,0,0
122921,of,0,0
122922,maternal,0,1
122923,and,0,0
122924,dietary,0,0
122925,selenium,0,0
122926,(,0,0
122927,Se-enriched,0,0
122928,yeast,0,0
122929,),0,0
122930,on,0,0
122931,the,0,0
122932,expression,1,0
122933,of,1,0
122934,p34,1,0
122935,(,1,0
122936,cdc2,1,0
122937,),1,0
122938,and,1,0
122939,CyclinB1,1,0
122940,of,1,0
122941,germ,1,1
122942,cells,1,0
122943,of,1,0
122944,their,1,0
122945,offspring,1,1
122946,in,1,0
122947,goats,1,1
122948,.,1,0
122949,The,0,0
122950,aim,0,0
122951,of,0,0
122952,the,0,0
122953,study,0,0
122954,was,0,0
122955,to,0,0
122956,evaluate,0,0
122957,the,0,0
122958,effect,0,0
122959,of,0,0
122960,selenium,0,0
122961,on,0,0
122962,the,0,0
122963,expression,0,0
122964,of,0,0
122965,p34,0,0
122966,(,0,0
122967,cdc2,0,0
122968,),0,0
122969,and,0,0
122970,CyclinB1,0,0
122971,(,0,0
122972,two,0,0
122973,components,0,0
122974,of,0,0
122975,MPF,0,0
122976,regulating,0,0
122977,cell,0,1
122978,cycle,0,0
122979,),0,0
122980,of,0,0
122981,germ,0,1
122982,cells,0,0
122983,of,0,0
122984,their,0,0
122985,offspring,0,1
122986,in,0,0
122987,goats,1,1
122988,.,1,0
122989,A,0,0
122990,herd,1,0
122991,of,1,0
122992,119,1,1
122993,Taihang,1,1
122994,Black,1,0
122995,Goats,1,0
122996,",",0,0
122997,which,0,0
122998,was,0,0
122999,randomly,0,0
123000,divided,0,0
123001,into,0,0
123002,4,0,0
123003,treatments,0,0
123004,",",0,0
123005,received,0,0
123006,experimental,0,0
123007,diet,0,0
123008,with,0,1
123009,different,0,0
123010,Se,0,0
123011,levels,0,0
123012,(,0,0
123013,from,0,0
123014,Se-enriched,0,0
123015,yeast,0,0
123016,),0,0
123017,for,0,0
123018,174d,0,0
123019,.,0,0
123020,The,0,0
123021,four,0,0
123022,treatments,0,0
123023,",",0,0
123024,fed,0,0
123025,with,0,0
123026,a,0,0
123027,basal,0,0
123028,diet,0,0
123029,",",0,0
123030,were,0,0
123031,supplemented,0,0
123032,with,0,1
123033,0,0,0
123034,(,0,0
123035,control,0,0
123036,),0,0
123037,",",0,0
123038,0.5,0,0
123039,",",0,0
123040,2,0,0
123041,and,0,0
123042,4,0,0
123043,mgkg??,0,0
123044,DM,0,0
123045,Se,0,0
123046,.,0,0
123047,Testis,0,0
123048,samples,0,0
123049,were,0,0
123050,collected,0,0
123051,from,0,0
123052,the,0,0
123053,young,1,1
123054,male,1,1
123055,goats,1,1
123056,of,1,0
123057,each,0,0
123058,treatment,0,0
123059,group,0,0
123060,at,0,0
123061,the,0,0
123062,end,0,0
123063,of,0,0
123064,the,0,0
123065,study,0,0
123066,(,0,0
123067,30d,0,0
123068,after,0,0
123069,weaning,0,0
123070,),0,0
123071,for,0,0
123072,mRNA,0,0
123073,expression,0,0
123074,using,0,0
123075,real-time,0,0
123076,PCR,0,0
123077,and,0,0
123078,for,0,0
123079,protein,0,0
123080,expression,0,0
123081,by,0,0
123082,immunohistochemistry,0,0
123083,assay,0,0
123084,.,0,0
123085,Results,0,0
123086,show,0,0
123087,that,0,0
123088,a,0,0
123089,significant,0,0
123090,decrease,0,0
123091,was,0,0
123092,observed,0,0
123093,in,0,0
123094,mRNA,0,0
123095,expression,0,0
123096,of,0,0
123097,p34,0,0
123098,(,0,0
123099,cdc2,0,0
123100,),0,0
123101,and,0,0
123102,CyclinB1,0,0
123103,in,0,0
123104,the,0,0
123105,testis,0,0
123106,of,0,0
123107,Se-deficient,0,0
123108,(,0,0
123109,Group,0,1
123110,1,0,0
123111,),0,0
123112,and,0,0
123113,Se-excess,0,0
123114,(,0,0
123115,Group,0,1
123116,4,0,0
123117,),0,0
123118,animals,0,0
123119,compared,0,0
123120,with,0,1
123121,that,0,0
123122,in,0,0
123123,Groups,0,0
123124,2,0,0
123125,and,0,0
123126,3,0,0
123127,.,0,0
123128,However,0,0
123129,",",0,0
123130,no,0,0
123131,significant,0,0
123132,changes,0,0
123133,were,0,0
123134,found,0,0
123135,in,0,0
123136,mRNA,0,0
123137,expression,0,0
123138,of,0,0
123139,p34,0,0
123140,(,0,0
123141,cdc2,0,0
123142,),0,0
123143,between,0,0
123144,Se-deficient,0,0
123145,(,0,0
123146,Group,0,1
123147,1,0,0
123148,),0,0
123149,and,0,0
123150,Se-excess,0,0
123151,(,0,0
123152,Group,0,1
123153,4,0,0
123154,),0,0
123155,.,0,0
123156,Also,0,0
123157,the,0,0
123158,immunohistochemistry,0,0
123159,assay,0,0
123160,detected,0,0
123161,similar,0,0
123162,results,0,0
123163,of,0,0
123164,protein,0,0
123165,expression,0,0
123166,of,0,0
123167,these,0,0
123168,two,0,0
123169,genes,0,0
123170,.,0,1
123171,These,0,0
123172,results,0,0
123173,suggest,0,0
123174,",",0,0
123175,that,0,0
123176,maternal,0,0
123177,and,0,0
123178,dietary,0,0
123179,Se-induced,0,0
123180,oxidative,0,0
123181,stress,0,0
123182,can,0,0
123183,modulate,0,0
123184,the,0,0
123185,mRNA,0,0
123186,and,0,0
123187,protein,0,0
123188,expression,0,0
123189,of,0,0
123190,the,0,0
123191,cell,0,0
123192,cycle,0,0
123193,related,0,0
123194,genes,0,0
123195,(,0,0
123196,p34,0,0
123197,(,0,0
123198,cdc2,0,0
123199,),0,0
123200,and,0,0
123201,CyclinB1,0,0
123202,),0,0
123203,in,0,0
123204,the,0,0
123205,testis,0,0
123206,of,0,0
123207,their,0,0
123208,offspring,0,1
123209,.,0,0
123210,In,0,0
123211,addition,0,0
123212,",",0,0
123213,Se,0,0
123214,deficiency,0,1
123215,and,0,0
123216,Se,0,0
123217,excess,0,0
123218,could,0,0
123219,prevent,0,0
123220,the,0,0
123221,completion,0,0
123222,of,0,0
123223,the,0,0
123224,cell,0,0
123225,cycle,0,0
123226,.,0,0
123227,Using,0,0
123228,personalized,0,0
123229,feedback,0,0
123230,to,0,0
123231,reduce,0,0
123232,alcohol,0,0
123233,use,0,0
123234,among,0,0
123235,hazardous,1,0
123236,drinking,1,0
123237,college,1,1
123238,students,1,1
123239,:,1,1
123240,the,0,0
123241,moderating,0,0
123242,effect,0,0
123243,of,0,0
123244,alcohol-related,0,0
123245,negative,0,0
123246,consequences,0,0
123247,.,0,1
123248,UNLABELLED,0,0
123249,Web-based,0,0
123250,screening,0,1
123251,and,0,0
123252,brief,0,0
123253,interventions,0,0
123254,that,0,0
123255,include,0,0
123256,personalized,0,0
123257,feedback,0,0
123258,about,0,0
123259,their,0,0
123260,alcohol,0,1
123261,use,0,0
123262,have,0,0
123263,proven,0,0
123264,to,0,0
123265,be,0,0
123266,particularly,0,0
123267,promising,0,0
123268,for,0,0
123269,reducing,0,0
123270,hazardous,1,1
123271,drinking,1,0
123272,among,1,0
123273,university,1,1
123274,students,1,1
123275,.,1,0
123276,Despite,0,0
123277,the,0,0
123278,increasing,0,0
123279,use,0,0
123280,of,0,0
123281,these,0,0
123282,approaches,0,0
123283,",",0,0
123284,there,0,0
123285,is,0,0
123286,still,0,0
123287,relatively,0,0
123288,little,0,0
123289,known,0,0
123290,about,0,0
123291,how,0,0
123292,the,0,0
123293,content,0,0
123294,of,0,0
123295,these,0,0
123296,interventions,0,0
123297,may,0,0
123298,influence,0,0
123299,outcomes,0,0
123300,and,0,0
123301,who,0,1
123302,may,0,0
123303,benefit,0,0
123304,most,0,0
123305,from,0,0
123306,these,0,0
123307,approaches,0,0
123308,.,0,0
123309,The,0,0
123310,current,0,0
123311,study,0,0
123312,sought,0,0
123313,to,0,0
123314,address,0,0
123315,these,0,0
123316,issues,0,0
123317,by,0,0
123318,examining,0,0
123319,how,0,0
123320,individual,0,0
123321,differences,0,0
123322,in,0,0
123323,alcohol,0,1
123324,consequences,0,0
123325,influence,0,0
123326,outcomes,0,0
123327,of,0,0
123328,a,0,0
123329,laboratory-based,0,0
123330,computerized,0,0
123331,intervention,0,0
123332,.,0,0
123333,METHODS,0,0
123334,One-hundred,1,1
123335,and,1,0
123336,nineteen,1,1
123337,introductory,1,0
123338,psychology,1,1
123339,students,1,1
123340,who,1,1
123341,either,1,1
123342,had,1,1
123343,two,1,0
123344,episodes,1,0
123345,of,1,0
123346,heavy,1,1
123347,episodic,1,0
123348,drinking,1,0
123349,in,1,0
123350,the,1,0
123351,past,1,0
123352,month,1,0
123353,or,1,0
123354,scored,1,0
123355,?8,1,0
123356,on,1,0
123357,the,1,0
123358,AUDIT,1,0
123359,participated,1,1
123360,in,1,0
123361,this,1,0
123362,randomized,1,0
123363,controlled,1,0
123364,trial,1,0
123365,for,1,0
123366,course,1,0
123367,credit,1,0
123368,.,1,0
123369,Participants,0,1
123370,were,0,0
123371,assigned,0,1
123372,to,0,0
123373,1,0,0
123374,of,0,0
123375,4,0,0
123376,conditions,0,0
123377,in,0,0
123378,this,0,0
123379,2,0,0
123380,Intervention,0,0
123381,(,0,0
123382,Alcohol,0,0
123383,Feedback,0,0
123384,vs.,0,0
123385,Control,0,0
123386,),0,0
123387,?2,0,0
123388,Assessment,0,0
123389,(,0,0
123390,Motivational,0,0
123391,Assessment,0,0
123392,vs.,0,0
123393,No,0,0
123394,Motivational,0,0
123395,Assessment,0,0
123396,),0,0
123397,between-subjects,0,0
123398,design,0,0
123399,.,0,0
123400,Quantity,0,0
123401,of,0,0
123402,alcohol,0,0
123403,consumed,0,0
123404,per,0,0
123405,week,0,0
123406,and,0,0
123407,heavy,0,0
123408,episodic,0,0
123409,drinking,0,0
123410,one,0,0
123411,month,0,0
123412,later,0,0
123413,were,0,0
123414,the,0,0
123415,primary,0,0
123416,dependent,0,0
123417,variables,0,0
123418,.,0,1
123419,RESULTS,0,0
123420,Controlling,0,0
123421,for,0,0
123422,corresponding,0,0
123423,baseline,0,0
123424,alcohol,0,1
123425,measures,0,0
123426,",",0,0
123427,hierarchical,0,0
123428,linear,0,0
123429,regression,0,0
123430,analyses,0,0
123431,showed,0,0
123432,a,0,0
123433,significant,0,0
123434,interaction,0,0
123435,between,0,0
123436,intervention,0,0
123437,condition,0,0
123438,and,0,0
123439,baseline,0,0
123440,alcohol-related,0,0
123441,consequences,0,0
123442,.,0,0
123443,For,0,0
123444,those,0,1
123445,who,0,1
123446,reported,0,1
123447,more,0,1
123448,alcohol,0,1
123449,consequences,0,0
123450,at,0,0
123451,baseline,0,0
123452,",",0,0
123453,the,0,0
123454,alcohol,0,0
123455,intervention,0,0
123456,resulted,0,0
123457,in,0,0
123458,significantly,0,0
123459,less,0,0
123460,alcohol,0,0
123461,use,0,0
123462,and,0,0
123463,fewer,0,0
123464,heavy,0,0
123465,drinking,0,0
123466,episodes,0,0
123467,at,0,0
123468,follow-up,0,0
123469,",",0,0
123470,while,0,0
123471,no,0,0
123472,difference,0,0
123473,was,0,0
123474,observed,0,0
123475,between,0,0
123476,intervention,0,0
123477,conditions,0,0
123478,for,0,0
123479,those,0,0
123480,with,0,0
123481,few,0,0
123482,baseline,0,0
123483,consequences,0,0
123484,.,0,0
123485,Assessment,0,0
123486,did,0,0
123487,not,0,0
123488,moderate,0,1
123489,intervention,0,0
123490,effects,0,0
123491,.,0,0
123492,DISCUSSION,0,0
123493,These,0,0
123494,findings,0,0
123495,suggest,0,0
123496,that,0,0
123497,a,0,0
123498,feedback-based,0,0
123499,computerized,0,0
123500,intervention,0,0
123501,that,0,0
123502,includes,0,0
123503,normative,0,0
123504,information,0,0
123505,about,0,0
123506,alcohol,0,0
123507,use,0,0
123508,and,0,0
123509,consequences,0,0
123510,may,0,0
123511,be,0,0
123512,more,0,0
123513,effective,0,0
123514,for,0,0
123515,hazardous,1,1
123516,drinking,1,1
123517,students,1,1
123518,who,1,1
123519,are,1,0
123520,experiencing,1,1
123521,higher,1,0
123522,levels,1,0
123523,of,1,0
123524,alcohol-related,1,1
123525,consequences,1,0
123526,.,1,1
123527,[,0,0
123528,Efficacy,0,0
123529,of,0,0
123530,naftopidil,0,0
123531,in,0,0
123532,patients,1,1
123533,with,1,1
123534,overactive,1,1
123535,bladder,1,1
123536,associated,1,0
123537,with,1,1
123538,benign,1,1
123539,prostatic,1,1
123540,hyperplasia,1,1
123541,:,1,1
123542,prospective,0,0
123543,randomized,0,0
123544,controlled,0,0
123545,study,0,0
123546,to,0,0
123547,compare,0,0
123548,differences,0,0
123549,in,0,0
123550,efficacy,0,0
123551,between,0,0
123552,morning,0,0
123553,and,0,0
123554,evening,0,0
123555,medication,0,0
123556,],0,0
123557,.,0,0
123558,A,0,0
123559,total,1,1
123560,of,1,0
123561,100,1,0
123562,patients,1,1
123563,with,1,1
123564,benign,1,1
123565,prostatic,1,1
123566,hyperplasia,1,1
123567,(,1,0
123568,BPH,1,0
123569,),1,0
123570,and,1,0
123571,overactive,1,0
123572,bladder,1,1
123573,(,1,0
123574,OAB,1,0
123575,),1,0
123576,symptoms,1,0
123577,(,1,0
123578,BPH/OAB,1,0
123579,),1,0
123580,",",1,0
123581,enrolled,1,1
123582,between,1,0
123583,June,1,1
123584,2006,1,1
123585,to,1,0
123586,March,1,1
123587,2008,1,1
123588,",",0,0
123589,were,0,0
123590,randomly,0,0
123591,divided,0,0
123592,into,0,0
123593,2,0,0
123594,groups,0,0
123595,of,0,0
123596,morning,0,0
123597,medication,0,0
123598,(,0,0
123599,M,0,0
123600,),0,0
123601,and,0,0
123602,evening,0,0
123603,medication,0,0
123604,(,0,0
123605,E,0,0
123606,),0,0
123607,groups,0,0
123608,",",0,0
123609,then,0,0
123610,50,0,0
123611,mg,0,0
123612,of,0,0
123613,naftopidil,0,0
123614,was,0,0
123615,given,0,0
123616,once,0,0
123617,a,0,0
123618,day,0,0
123619,after,0,0
123620,breakfast,0,0
123621,or,0,0
123622,supper,0,0
123623,for,0,0
123624,8,0,0
123625,weeks,0,0
123626,.,0,1
123627,Data,0,0
123628,were,0,0
123629,available,0,0
123630,for,0,0
123631,efficacy,0,0
123632,analysis,0,0
123633,on,0,0
123634,80,0,1
123635,patients,0,1
123636,(,0,0
123637,M,0,0
123638,group,0,0
123639,;,0,0
123640,43,0,0
123641,",",0,0
123642,E,0,0
123643,group,0,0
123644,;,0,0
123645,37,0,1
123646,),0,0
123647,.,0,0
123648,Naftopidil,0,0
123649,significantly,0,0
123650,improved,0,0
123651,the,0,0
123652,overall,0,0
123653,international,0,1
123654,prostatic,0,1
123655,symptom,0,0
123656,score,0,0
123657,;,0,0
123658,from,0,0
123659,19.2?7.9,0,0
123660,to,0,0
123661,11.7?5.8,0,0
123662,in,0,0
123663,the,0,0
123664,M,0,0
123665,group,0,0
123666,and,0,0
123667,from,0,0
123668,19.4?6.4,0,0
123669,to,0,0
123670,12.3?6.8,0,0
123671,in,0,0
123672,the,0,0
123673,E,0,0
123674,group,0,0
123675,(,0,0
123676,p,0,0
123677,<,0,0
123678,0.0001,0,0
123679,),0,0
123680,",",0,0
123681,QOL,0,0
123682,score,0,0
123683,from,0,0
123684,4.9?0.8,0,0
123685,to,0,0
123686,3.2?1.4,0,0
123687,in,0,0
123688,the,0,0
123689,M,0,0
123690,group,0,0
123691,and,0,0
123692,from,0,0
123693,5.0?0.8,0,0
123694,to,0,0
123695,3.6?1.3,0,0
123696,in,0,0
123697,the,0,0
123698,E,0,0
123699,group,0,0
123700,(,0,0
123701,p,0,0
123702,<,0,0
123703,0.0001,0,0
123704,),0,0
123705,",",0,0
123706,and,0,0
123707,OAB,0,0
123708,symptom,0,0
123709,score,0,0
123710,from,0,0
123711,7.8?2.6,0,0
123712,to,0,0
123713,5.0?2.5,0,0
123714,in,0,0
123715,the,0,0
123716,M,0,0
123717,group,0,0
123718,(,0,0
123719,p,0,0
123720,<,0,0
123721,0.0001,0,0
123722,),0,0
123723,and,0,0
123724,from,0,0
123725,8.6?2.9,0,0
123726,to,0,0
123727,5.8?,0,0
123728,3.3,0,0
123729,in,0,0
123730,the,0,0
123731,E,0,0
123732,group,0,0
123733,(,0,0
123734,p,0,0
123735,<,0,0
123736,0.0001,0,0
123737,),0,0
123738,.,0,0
123739,There,0,0
123740,was,0,0
123741,no,0,0
123742,significant,0,0
123743,difference,0,0
123744,in,0,0
123745,the,0,0
123746,incidence,0,0
123747,of,0,0
123748,adverse,0,0
123749,effects,0,0
123750,between,0,0
123751,the,0,0
123752,M,0,0
123753,group,0,0
123754,(,0,0
123755,6.1,0,0
123756,%,0,0
123757,),0,0
123758,and,0,0
123759,E,0,0
123760,group,0,0
123761,(,0,0
123762,2.2,0,0
123763,%,0,0
123764,),0,0
123765,.,0,0
123766,These,0,0
123767,results,0,0
123768,suggest,0,0
123769,that,0,0
123770,naftopidil,0,0
123771,improves,0,0
123772,storage,0,1
123773,symptoms,0,0
123774,as,0,0
123775,well,0,0
123776,as,0,0
123777,voiding,0,0
123778,symptoms,0,0
123779,regardless,0,0
123780,of,0,0
123781,timing,0,0
123782,of,0,0
123783,administration,0,0
123784,.,0,0
123785,Safety,0,0
123786,and,0,0
123787,efficacy,0,0
123788,of,0,0
123789,donepezil,0,0
123790,in,0,0
123791,children,1,1
123792,and,1,0
123793,adolescents,1,1
123794,with,1,1
123795,autism,1,1
123796,:,1,1
123797,neuropsychological,0,0
123798,measures,0,0
123799,.,0,1
123800,OBJECTIVE,0,0
123801,There,0,0
123802,has,0,0
123803,been,0,0
123804,recent,0,0
123805,interest,0,0
123806,in,0,0
123807,the,0,0
123808,use,0,0
123809,of,0,0
123810,cognitive,0,0
123811,enhancing,0,0
123812,drugs,0,0
123813,",",0,0
123814,such,0,0
123815,as,0,0
123816,cholinesterase,0,0
123817,inhibitors,0,0
123818,",",0,0
123819,as,0,0
123820,a,0,0
123821,possible,0,0
123822,treatment,0,0
123823,for,0,0
123824,executive,0,0
123825,functioning,0,0
123826,(,0,0
123827,EF,0,1
123828,),0,0
123829,deficits,0,0
123830,in,0,0
123831,autism,1,1
123832,spectrum,1,1
123833,disorder,1,1
123834,(,1,0
123835,ASD,1,1
123836,),1,0
123837,.,1,0
123838,The,0,0
123839,goal,0,0
123840,of,0,0
123841,this,0,0
123842,study,0,0
123843,was,0,0
123844,to,0,0
123845,assess,0,0
123846,the,0,0
123847,tolerability,0,0
123848,",",0,0
123849,safety,0,0
123850,",",0,0
123851,and,0,0
123852,efficacy,0,0
123853,of,0,0
123854,donepezil,0,0
123855,on,0,0
123856,EF,0,1
123857,in,0,0
123858,a,0,0
123859,sample,1,1
123860,of,1,0
123861,children,1,1
123862,and,1,0
123863,adolescents,1,1
123864,with,1,1
123865,ASD,1,1
123866,.,1,0
123867,METHOD,0,0
123868,Thirty-four,1,1
123869,children,1,1
123870,and,1,0
123871,adolescents,1,1
123872,with,1,1
123873,ASD,1,1
123874,(,1,0
123875,age,1,1
123876,range,1,0
123877,8-17,1,1
123878,years,1,1
123879,;,1,0
123880,IQ,1,0
123881,>,1,1
123882,75,1,1
123883,),1,0
123884,were,1,0
123885,enrolled,1,1
123886,in,0,0
123887,a,0,0
123888,10-week,0,0
123889,",",0,0
123890,double-blind,0,0
123891,",",0,0
123892,placebo-controlled,0,0
123893,trial,0,0
123894,of,0,0
123895,donepezil,0,0
123896,(,0,0
123897,doses,0,0
123898,of,0,0
123899,5,0,0
123900,and,0,0
123901,10,0,0
123902,mg,0,0
123903,),0,0
123904,",",0,0
123905,followed,0,0
123906,by,0,0
123907,a,0,0
123908,10-week,0,0
123909,open,0,0
123910,label,0,0
123911,trial,0,0
123912,for,0,0
123913,placebo,0,0
123914,nonresponders,0,0
123915,.,0,0
123916,RESULTS,0,0
123917,The,0,0
123918,effect,0,0
123919,of,0,0
123920,donepezil,0,0
123921,treatment,0,0
123922,on,0,0
123923,EF,0,1
123924,was,0,0
123925,examined,0,0
123926,.,0,0
123927,Despite,0,0
123928,improvement,0,0
123929,on,0,0
123930,a,0,0
123931,number,0,0
123932,of,0,0
123933,EF,0,1
123934,measures,0,0
123935,",",0,0
123936,no,0,0
123937,statistically,0,0
123938,significant,0,0
123939,between-group,0,0
123940,differences,0,0
123941,were,0,0
123942,found,0,0
123943,(,0,0
123944,with,0,1
123945,gains,0,0
123946,observed,0,0
123947,for,0,0
123948,both,0,0
123949,the,0,0
123950,placebo,0,0
123951,and,0,0
123952,donepezil,0,0
123953,groups,0,0
123954,),0,0
123955,.,0,0
123956,CONCLUSIONS,0,0
123957,The,0,0
123958,results,0,0
123959,suggest,0,0
123960,that,0,0
123961,short-term,0,0
123962,treatment,0,0
123963,with,0,0
123964,donepezil,0,0
123965,may,0,0
123966,have,0,0
123967,limited,0,0
123968,impact,0,0
123969,on,0,0
123970,cognitive,0,0
123971,functioning,0,0
123972,in,0,0
123973,ASD,0,1
123974,.,0,1
123975,Future,0,0
123976,controlled,0,0
123977,trials,0,0
123978,may,0,0
123979,need,0,0
123980,to,0,0
123981,consider,0,0
123982,a,0,0
123983,longer,0,0
123984,treatment,0,0
123985,period,0,0
123986,to,0,0
123987,detect,0,0
123988,significant,0,0
123989,gains,0,0
123990,on,0,0
123991,EF,0,1
123992,measures,0,0
123993,.,0,1
123994,Effects,0,0
123995,of,0,0
123996,diet,0,0
123997,and,0,0
123998,Aspergillus,0,0
123999,oryzae,0,0
124000,extract,0,0
124001,or,0,0
124002,Saccharomyces,0,0
124003,cervisiae,0,0
124004,on,0,0
124005,growth,0,0
124006,and,0,0
124007,carcass,0,0
124008,characteristics,0,0
124009,of,0,0
124010,lambs,1,1
124011,and,1,0
124012,steers,1,1
124013,fed,1,0
124014,to,1,0
124015,meet,1,0
124016,requirements,1,0
124017,of,1,0
124018,natural,1,0
124019,markets,1,0
124020,.,1,1
124021,Two,0,1
124022,studies,0,0
124023,were,0,0
124024,conducted,0,0
124025,to,0,0
124026,determine,0,0
124027,the,0,0
124028,effects,0,0
124029,of,0,0
124030,diet,0,0
124031,and,0,0
124032,feed,0,0
124033,additive,0,0
124034,on,0,0
124035,growth,0,0
124036,and,0,0
124037,carcass,0,0
124038,characteristics,0,0
124039,of,0,0
124040,lambs,1,1
124041,and,1,0
124042,cattle,1,1
124043,destined,1,0
124044,for,1,0
124045,all,1,0
124046,natural,1,0
124047,markets,1,0
124048,.,1,1
124049,In,0,0
124050,Exp,0,0
124051,.,0,0
124052,1,1,0
124053,",",1,0
124054,48,1,1
124055,Dorset,1,1
124056,?,1,0
124057,Hampshire,1,1
124058,lambs,1,0
124059,(,1,0
124060,initial,1,0
124061,BW,1,1
124062,29.4,1,1
124063,?,1,0
124064,0.1,1,0
124065,kg,1,0
124066,),1,0
124067,were,1,0
124068,used,0,0
124069,in,0,0
124070,a,0,0
124071,randomized,0,0
124072,complete,0,0
124073,block,0,0
124074,experiment,0,0
124075,to,0,0
124076,determine,0,0
124077,the,0,0
124078,effects,0,0
124079,of,0,0
124080,Aspergillus,0,0
124081,oryzae,0,0
124082,extract,0,0
124083,",",0,0
124084,Amaferm,0,0
124085,(,0,0
124086,AMF,0,0
124087,),0,0
124088,supplementation,0,0
124089,(,0,0
124090,1,0,0
124091,g/d,0,0
124092,),0,0
124093,in,0,0
124094,an,0,0
124095,85,0,0
124096,%,0,0
124097,concentrate,0,0
124098,diet,0,0
124099,on,0,0
124100,growth,0,0
124101,and,0,0
124102,carcass,0,0
124103,characteristics,1,0
124104,.,1,1
124105,Lambs,1,0
124106,were,1,0
124107,allotted,1,0
124108,to,1,0
124109,12,1,0
124110,pens,1,0
124111,(,1,1
124112,4,1,0
124113,lambs,1,1
124114,per,1,0
124115,pen,1,0
124116,),1,0
124117,",",1,0
124118,and,1,0
124119,blocked,1,0
124120,by,1,0
124121,sex,1,0
124122,and,1,0
124123,BW,1,0
124124,.,1,0
124125,Lambs,0,0
124126,were,0,0
124127,fed,0,0
124128,until,0,0
124129,the,0,0
124130,average,0,0
124131,BW,0,0
124132,of,0,0
124133,each,0,0
124134,pen,0,0
124135,reached,0,0
124136,a,0,0
124137,target,0,0
124138,BW,0,0
124139,(,0,0
124140,55.4,0,0
124141,kg,0,1
124142,for,0,0
124143,wethers,0,1
124144,and,0,0
124145,50.0,0,0
124146,kg,0,0
124147,for,0,0
124148,ewes,0,1
124149,),0,0
124150,",",0,0
124151,at,0,0
124152,which,0,0
124153,time,0,0
124154,the,0,0
124155,entire,0,0
124156,pen,0,0
124157,of,0,0
124158,lambs,0,1
124159,was,0,0
124160,slaughtered,0,1
124161,.,0,0
124162,Amaferm,0,0
124163,resulted,0,0
124164,in,0,0
124165,a,0,0
124166,greater,0,0
124167,(,0,0
124168,P=0.07,0,0
124169,),0,0
124170,G,0,0
124171,:,0,1
124172,F.,0,0
124173,In,0,0
124174,Exp,1,0
124175,.,1,0
124176,2,1,0
124177,",",0,0
124178,168,1,1
124179,crossbred,1,1
124180,steers,1,1
124181,(,1,0
124182,initial,1,0
124183,BW,1,1
124184,300,1,0
124185,?,1,0
124186,0.7,1,0
124187,kg,1,0
124188,),1,0
124189,were,1,0
124190,used,0,0
124191,in,0,0
124192,a,0,0
124193,trial,0,0
124194,with,0,0
124195,a,0,0
124196,3,0,0
124197,?,0,0
124198,2,0,0
124199,factorial,0,0
124200,arrangement,0,0
124201,of,0,0
124202,treatments,0,0
124203,to,0,0
124204,examine,0,0
124205,the,0,0
124206,effects,0,0
124207,of,0,0
124208,0.5,0,0
124209,g/d,0,0
124210,of,0,0
124211,Saccaromyces,0,0
124212,cervisiae,0,0
124213,boulardii,0,0
124214,CNCM,0,0
124215,1079-Levucell,0,0
124216,SB,0,0
124217,(,0,0
124218,LEV,0,0
124219,),0,0
124220,",",0,0
124221,or,0,0
124222,3,0,0
124223,g/d,0,0
124224,of,0,0
124225,AMF,0,0
124226,with,0,1
124227,2,0,0
124228,corn,0,1
124229,sources,0,0
124230,",",0,0
124231,dry,0,0
124232,whole-shelled,0,0
124233,corn,0,0
124234,or,0,0
124235,high,0,0
124236,moisture,0,0
124237,corn,0,0
124238,",",0,0
124239,on,0,0
124240,growth,0,0
124241,and,0,0
124242,carcass,0,0
124243,characteristics,0,0
124244,.,0,0
124245,Neither,0,0
124246,LEV,0,0
124247,nor,0,0
124248,AMF,0,0
124249,improved,0,0
124250,(,0,0
124251,P,0,0
124252,>,0,1
124253,0.10,0,0
124254,),0,0
124255,carcass,0,0
124256,characteristics,0,0
124257,compared,0,0
124258,with,0,1
124259,control,0,0
124260,or,0,1
124261,non-feed-supplemented,0,0
124262,steers,0,1
124263,.,0,0
124264,Addition,0,0
124265,of,0,0
124266,LEV,0,0
124267,to,0,0
124268,high-concentrate,0,0
124269,",",0,0
124270,corn-based,0,1
124271,diets,0,0
124272,did,0,0
124273,not,0,0
124274,improve,0,0
124275,(,0,0
124276,P,0,0
124277,>,0,1
124278,0.10,0,0
124279,),0,0
124280,growth,0,0
124281,performance,0,0
124282,of,0,0
124283,feedlot,0,1
124284,steers,0,1
124285,.,0,0
124286,However,0,0
124287,",",0,0
124288,addition,0,0
124289,of,0,0
124290,AMF,0,0
124291,to,0,0
124292,a,0,0
124293,diet,0,0
124294,composed,0,0
124295,of,0,0
124296,dry,0,0
124297,whole-shelled,0,0
124298,corn,0,0
124299,resulted,0,0
124300,in,0,0
124301,an,0,0
124302,improvement,0,0
124303,(,0,0
124304,P,0,0
124305,<,0,0
124306,0.05,0,0
124307,),0,0
124308,in,0,0
124309,G,0,0
124310,:,0,1
124311,F,0,0
124312,(,0,0
124313,0.208,0,0
124314,vs.,0,0
124315,0.194,0,0
124316,),0,0
124317,.,0,0
124318,Results,0,0
124319,indicate,0,0
124320,that,0,0
124321,at,0,0
124322,the,0,0
124323,amounts,0,0
124324,fed,0,0
124325,",",0,0
124326,AMF,0,0
124327,may,0,0
124328,improve,0,0
124329,G,0,0
124330,:,0,1
124331,F,0,0
124332,for,0,0
124333,lambs,1,1
124334,and,1,0
124335,steers,1,1
124336,fed,1,0
124337,dry,0,0
124338,corn-based,0,1
124339,finishing,0,0
124340,diets,0,0
124341,.,0,1
124342,Human,1,1
124343,primary,1,1
124344,visual,1,0
124345,cortex,1,0
124346,(,1,0
124347,V1,1,0
124348,),1,0
124349,is,1,0
124350,selective,1,0
124351,for,1,0
124352,second-order,1,0
124353,spatial,1,0
124354,frequency,1,0
124355,.,1,0
124356,A,0,0
124357,variety,0,0
124358,of,0,0
124359,cues,0,0
124360,can,0,0
124361,differentiate,0,1
124362,objects,0,0
124363,from,0,0
124364,their,0,1
124365,surrounds,0,0
124366,.,0,0
124367,These,0,0
124368,include,0,0
124369,first-order,0,0
124370,cues,0,0
124371,such,0,0
124372,as,0,0
124373,luminance,0,0
124374,modulations,0,0
124375,and,0,0
124376,second-order,0,0
124377,cues,0,0
124378,involving,0,0
124379,modulations,0,0
124380,of,0,0
124381,orientation,0,0
124382,and,0,0
124383,contrast,0,0
124384,.,0,0
124385,Human,1,0
124386,sensitivity,0,0
124387,to,0,0
124388,first-order,0,0
124389,modulations,0,0
124390,is,0,0
124391,well,0,0
124392,described,0,0
124393,by,0,0
124394,a,0,0
124395,computational,0,0
124396,model,0,0
124397,involving,0,0
124398,spatially,0,0
124399,localized,0,0
124400,filters,0,0
124401,that,0,0
124402,are,0,0
124403,selective,0,0
124404,for,0,0
124405,orientation,0,0
124406,and,0,0
124407,spatial,0,0
124408,frequency,0,0
124409,(,0,0
124410,SF,0,1
124411,),0,0
124412,.,0,0
124413,It,0,0
124414,is,0,0
124415,widely,0,0
124416,held,0,0
124417,that,0,0
124418,first-order,0,0
124419,modulations,0,0
124420,are,0,0
124421,represented,0,0
124422,by,0,0
124423,the,0,0
124424,firing,0,0
124425,rates,0,0
124426,of,0,0
124427,simple,0,0
124428,and,0,0
124429,complex,0,0
124430,cells,0,0
124431,(,0,1
124432,first-order,0,0
124433,neurons,0,1
124434,),0,0
124435,in,0,0
124436,primary,1,0
124437,visual,1,0
124438,cortex,1,0
124439,(,1,0
124440,V1,1,0
124441,),1,0
124442,that,0,0
124443,",",0,0
124444,likewise,0,0
124445,",",0,0
124446,have,0,0
124447,spatially,0,0
124448,localized,0,0
124449,receptive,0,0
124450,fields,0,0
124451,that,0,0
124452,are,0,0
124453,selective,0,0
124454,for,0,0
124455,orientation-,0,0
124456,and,0,0
124457,SF,0,1
124458,.,0,0
124459,Human,0,0
124460,sensitivity,0,0
124461,to,0,0
124462,second-order,0,0
124463,modulations,0,0
124464,is,0,0
124465,well,0,0
124466,described,0,0
124467,by,0,0
124468,a,0,0
124469,filter-rectify-filter,0,0
124470,(,0,0
124471,FRF,0,0
124472,),0,0
124473,model,0,0
124474,",",0,0
124475,with,0,0
124476,first-,0,0
124477,and,0,0
124478,second-order,0,0
124479,filters,0,0
124480,selective,0,0
124481,for,0,0
124482,orientation,0,0
124483,and,0,0
124484,SF,0,0
124485,.,0,0
124486,However,0,0
124487,",",0,0
124488,little,0,0
124489,is,0,0
124490,known,0,0
124491,about,0,0
124492,how,0,0
124493,neuronal,0,0
124494,activity,0,0
124495,in,0,0
124496,visual,0,0
124497,cortex,0,0
124498,represents,0,0
124499,second-order,0,0
124500,modulations,0,0
124501,.,0,1
124502,We,0,0
124503,tested,0,0
124504,the,0,0
124505,FRF,0,0
124506,model,0,0
124507,by,0,0
124508,using,0,0
124509,an,0,0
124510,functional,0,0
124511,(,0,0
124512,f,0,0
124513,),0,0
124514,MRI-adaptation,0,0
124515,protocol,0,0
124516,to,0,0
124517,characterize,0,0
124518,the,0,0
124519,selectivity,0,0
124520,of,0,0
124521,activity,0,0
124522,in,0,0
124523,visual,0,0
124524,cortex,0,0
124525,to,0,0
124526,second-order,0,0
124527,",",0,0
124528,orientation-defined,0,0
124529,gratings,0,0
124530,of,0,0
124531,two,0,0
124532,different,0,0
124533,SFs,0,0
124534,.,0,0
124535,fMRI,0,0
124536,responses,0,0
124537,throughout,0,0
124538,early,1,1
124539,visual,1,0
124540,cortex,1,0
124541,exhibited,0,0
124542,selective,0,0
124543,adaptation,0,0
124544,to,0,0
124545,these,0,0
124546,stimuli,0,0
124547,.,0,0
124548,The,0,0
124549,low-SF,0,1
124550,grating,0,0
124551,was,0,0
124552,a,0,0
124553,more,0,0
124554,effective,0,0
124555,adapter,0,0
124556,than,0,0
124557,the,0,0
124558,high-SF,0,0
124559,grating,0,0
124560,",",0,0
124561,incompatible,0,0
124562,with,0,0
124563,the,0,0
124564,FRF,0,0
124565,model,0,0
124566,.,0,0
124567,To,0,0
124568,explain,0,0
124569,the,0,0
124570,results,0,0
124571,",",0,0
124572,we,0,0
124573,extended,0,0
124574,the,0,0
124575,FRF,0,0
124576,model,0,0
124577,by,0,0
124578,incorporating,0,0
124579,normalization,0,0
124580,",",0,0
124581,yielding,0,0
124582,a,0,0
124583,filter-rectify-normalize-filter,0,0
124584,model,0,0
124585,",",0,0
124586,in,0,0
124587,which,0,0
124588,normalization,0,0
124589,enhances,0,0
124590,selectivity,0,0
124591,for,0,0
124592,second-order,0,0
124593,SF,0,1
124594,but,0,0
124595,only,0,0
124596,for,0,0
124597,low,0,0
124598,spatial,0,0
124599,frequencies,0,0
124600,.,0,0
124601,We,0,0
124602,conclude,0,0
124603,that,0,0
124604,neurons,0,0
124605,in,0,0
124606,human,1,1
124607,visual,1,0
124608,cortex,1,0
124609,are,0,0
124610,selective,0,0
124611,for,0,0
124612,second-order,0,0
124613,SF,0,0
124614,",",0,0
124615,that,0,0
124616,normalization,0,0
124617,(,0,0
124618,surround,0,0
124619,suppression,0,0
124620,),0,0
124621,contributes,0,0
124622,to,0,0
124623,this,0,0
124624,selectivity,0,0
124625,",",0,0
124626,and,0,0
124627,that,0,0
124628,the,0,0
124629,selectivity,0,0
124630,in,0,0
124631,higher,0,0
124632,visual,0,0
124633,areas,0,0
124634,is,0,0
124635,simply,0,0
124636,fed,0,0
124637,forward,0,0
124638,from,0,0
124639,V1,0,0
124640,.,0,1
124641,[,0,0
124642,Effects,0,0
124643,of,0,0
124644,parecoxib,0,0
124645,on,0,0
124646,morphine,0,0
124647,dosage,0,0
124648,in,0,0
124649,postoperative,1,0
124650,patient-controlled,1,0
124651,analgesia,1,0
124652,following,0,0
124653,thoracoscope-assisted,0,1
124654,thoracotomy,0,1
124655,],0,0
124656,.,0,0
124657,OBJECTIVE,0,0
124658,To,0,0
124659,observe,0,0
124660,the,0,0
124661,effect,0,0
124662,of,0,0
124663,parecoxib,0,0
124664,on,0,0
124665,morphine,0,0
124666,dosage,0,0
124667,in,0,0
124668,patient-controlled,0,0
124669,analgesia,0,0
124670,(,0,0
124671,PCA,0,1
124672,),0,0
124673,following,0,0
124674,thoracoscope-assisted,0,1
124675,thoracotomy,1,1
124676,.,1,0
124677,METHODS,0,0
124678,A,1,0
124679,consecutive,1,1
124680,series,1,0
124681,of,1,0
124682,100,1,0
124683,patients,1,1
124684,undergoing,1,1
124685,thoracoscope-assisted,1,1
124686,thoracotomy,1,1
124687,were,0,0
124688,randomized,0,0
124689,into,0,1
124690,5,0,0
124691,groups,0,0
124692,and,0,0
124693,received,0,0
124694,PCA,0,0
124695,with,0,1
124696,morphine,0,0
124697,doses,0,0
124698,at,0,0
124699,0,0,0
124700,",",0,0
124701,5,0,0
124702,",",0,0
124703,10,0,0
124704,",",0,0
124705,15,0,0
124706,",",0,0
124707,and,0,0
124708,20,0,0
124709,mg,0,0
124710,given,0,0
124711,in,0,0
124712,200,0,0
124713,ml,0,0
124714,saline,0,0
124715,(,0,0
124716,groups,0,0
124717,P,0,0
124718,(,0,0
124719,1,0,0
124720,),0,0
124721,",",0,0
124722,P,0,0
124723,(,0,0
124724,2,0,0
124725,),0,0
124726,",",0,0
124727,P,0,0
124728,(,0,0
124729,3,0,0
124730,),0,0
124731,",",0,0
124732,P,0,0
124733,(,0,0
124734,4,0,0
124735,),0,0
124736,",",0,0
124737,and,0,0
124738,P,0,0
124739,(,0,0
124740,5,0,0
124741,),0,0
124742,",",0,0
124743,respectively,0,0
124744,),0,0
124745,.,0,0
124746,Parecoxib,0,0
124747,(,0,0
124748,40,0,0
124749,mg,0,0
124750,),0,0
124751,was,0,0
124752,given,0,0
124753,in,0,0
124754,all,0,0
124755,the,0,0
124756,patients,0,1
124757,immediately,0,0
124758,before,0,0
124759,the,0,0
124760,operation,0,0
124761,",",0,0
124762,and,0,0
124763,the,0,0
124764,mixture,0,0
124765,(,0,0
124766,4-5,0,0
124767,ml,0,0
124768,),0,0
124769,of,0,0
124770,lidocaine,0,0
124771,and,0,0
124772,ropivacaine,0,0
124773,was,0,0
124774,administered,0,0
124775,into,0,0
124776,the,0,0
124777,3,0,0
124778,intercostal,0,0
124779,spaces,0,0
124780,upper,0,0
124781,and,0,0
124782,lower,0,0
124783,to,0,0
124784,the,0,0
124785,incision,0,0
124786,before,0,0
124787,chest,0,0
124788,closure,0,1
124789,.,0,0
124790,PCA,0,0
124791,was,0,0
124792,administered,0,0
124793,for,0,0
124794,each,0,0
124795,patient,0,0
124796,.,0,0
124797,The,0,0
124798,visual,0,0
124799,analogue,0,0
124800,scale,0,0
124801,(,0,0
124802,VAS,0,0
124803,),0,0
124804,at,0,0
124805,rest,0,0
124806,and,0,0
124807,coughing,0,0
124808,and,0,0
124809,the,0,0
124810,respiratory,0,0
124811,functional,0,0
124812,parameters,0,0
124813,were,0,0
124814,recorded,0,0
124815,at,0,0
124816,1,0,0
124817,",",0,0
124818,2,0,0
124819,",",0,0
124820,4,0,0
124821,",",0,0
124822,8,0,0
124823,",",0,0
124824,12,0,0
124825,",",0,0
124826,24,0,0
124827,",",0,0
124828,36,0,0
124829,",",0,0
124830,and,0,0
124831,48,0,0
124832,h,0,0
124833,after,0,0
124834,the,0,0
124835,start,0,0
124836,of,0,0
124837,PCA,0,0
124838,",",0,0
124839,and,0,0
124840,the,0,0
124841,actual,0,0
124842,and,0,0
124843,effective,0,0
124844,button-pressing,0,0
124845,times,0,0
124846,(,0,0
124847,D,0,0
124848,(,0,0
124849,1,0,0
124850,),0,0
124851,/D,0,0
124852,(,0,0
124853,2,0,0
124854,),0,0
124855,),0,0
124856,in,0,0
124857,PCA,0,1
124858,were,0,0
124859,also,0,0
124860,recorded,0,0
124861,.,0,0
124862,RESULTS,0,0
124863,No,0,0
124864,patients,0,1
124865,showed,0,0
124866,signs,0,0
124867,of,0,0
124868,respiratory,0,0
124869,inhibition,0,0
124870,within,0,0
124871,24,0,0
124872,h,0,0
124873,after,0,0
124874,the,0,0
124875,operation,0,0
124876,",",0,0
124877,and,0,0
124878,the,0,0
124879,resting,0,0
124880,VAS,0,0
124881,was,0,0
124882,comparable,0,0
124883,between,0,0
124884,the,0,0
124885,groups,0,0
124886,within,0,0
124887,the,0,0
124888,initial,0,0
124889,6,0,0
124890,postoperative,0,0
124891,hours,0,0
124892,.,0,1
124893,At,0,0
124894,8,0,0
124895,to,0,0
124896,24,0,0
124897,h,0,0
124898,postoperatively,0,0
124899,",",0,0
124900,the,0,0
124901,VAS,0,0
124902,scores,0,0
124903,at,0,0
124904,rest,0,0
124905,and,0,0
124906,coughing,0,0
124907,were,0,0
124908,significantly,0,0
124909,higher,0,0
124910,in,0,0
124911,P,0,0
124912,(,0,0
124913,1,0,0
124914,),0,0
124915,group,0,0
124916,than,0,0
124917,in,0,0
124918,the,0,0
124919,other,0,0
124920,groups,0,0
124921,(,0,0
124922,P,0,0
124923,<,0,0
124924,0.05,0,0
124925,),0,0
124926,",",0,0
124927,and,0,0
124928,no,0,0
124929,significant,0,0
124930,differences,0,0
124931,were,0,0
124932,found,0,0
124933,between,0,0
124934,the,0,0
124935,groups,0,0
124936,at,0,0
124937,36,0,1
124938,to,0,0
124939,48,0,0
124940,h.,0,0
124941,D,0,0
124942,(,0,0
124943,1,0,0
124944,),0,0
124945,/D,0,0
124946,(,0,0
124947,2,0,0
124948,),0,0
124949,in,0,0
124950,groups,0,0
124951,P,0,0
124952,(,0,0
124953,1,0,0
124954,),0,0
124955,and,0,0
124956,P,0,0
124957,(,0,0
124958,2,0,0
124959,),0,0
124960,were,0,0
124961,significantly,0,0
124962,different,0,0
124963,from,0,0
124964,those,0,0
124965,in,0,0
124966,the,0,0
124967,other,0,0
124968,3,0,0
124969,groups,0,0
124970,at,0,0
124971,4-24,0,0
124972,h,0,0
124973,",",0,0
124974,but,0,0
124975,no,0,0
124976,such,0,0
124977,difference,0,0
124978,was,0,0
124979,found,0,0
124980,between,0,0
124981,groups,0,0
124982,P,0,0
124983,(,0,0
124984,3,0,0
124985,),0,0
124986,",",0,0
124987,P,0,0
124988,(,0,0
124989,4,0,0
124990,),0,0
124991,",",0,0
124992,and,0,0
124993,P,0,0
124994,(,0,0
124995,5,0,0
124996,),0,0
124997,.,0,0
124998,CONCLUSION,0,0
124999,The,0,0
125000,application,0,0
125001,of,0,0
125002,parecoxib,0,0
125003,may,0,0
125004,reduce,0,0
125005,the,0,0
125006,dosage,0,0
125007,of,0,0
125008,morphine,0,0
125009,in,0,0
125010,PCA,0,1
125011,following,0,0
125012,thoracoscope-assisted,0,1
125013,thoracotomy,0,1
125014,and,0,0
125015,results,0,0
125016,in,0,0
125017,good,0,0
125018,analgesic,0,0
125019,effect,0,0
125020,without,0,0
125021,affecting,0,0
125022,the,0,0
125023,patients,0,1
125024,respiratory,0,0
125025,function,0,0
125026,and,0,0
125027,sputum,0,0
125028,elimination,0,0
125029,.,0,0
125030,A,0,0
125031,prospective,0,0
125032,",",0,0
125033,double-blind,0,0
125034,",",0,0
125035,randomized,0,0
125036,",",0,0
125037,controlled,0,0
125038,clinical,0,0
125039,trial,0,0
125040,comparing,0,0
125041,standard,0,0
125042,wound,0,0
125043,care,0,0
125044,with,0,1
125045,adjunctive,0,0
125046,hyperbaric,0,0
125047,oxygen,0,0
125048,therapy,0,0
125049,(,0,0
125050,HBOT,0,0
125051,),0,0
125052,to,0,0
125053,standard,0,0
125054,wound,0,0
125055,care,0,0
125056,only,0,0
125057,for,0,0
125058,the,0,0
125059,treatment,0,0
125060,of,0,0
125061,chronic,1,1
125062,",",1,0
125063,non-healing,1,1
125064,ulcers,1,0
125065,of,1,0
125066,the,1,0
125067,lower,1,0
125068,limb,1,0
125069,in,1,0
125070,patients,1,1
125071,with,1,1
125072,diabetes,1,1
125073,mellitus,1,1
125074,:,1,1
125075,a,0,0
125076,study,0,0
125077,protocol,0,0
125078,.,0,0
125079,BACKGROUND,0,0
125080,It,0,0
125081,has,0,0
125082,been,0,0
125083,suggested,0,0
125084,that,0,0
125085,the,0,0
125086,use,0,0
125087,of,0,0
125088,adjunctive,0,0
125089,hyperbaric,0,0
125090,oxygen,0,0
125091,therapy,0,0
125092,improves,0,0
125093,the,0,0
125094,healing,0,0
125095,of,0,0
125096,diabetic,0,1
125097,foot,0,1
125098,ulcers,0,0
125099,",",0,0
125100,and,0,0
125101,decreases,0,0
125102,the,0,0
125103,risk,0,0
125104,of,0,0
125105,lower,0,0
125106,extremity,0,0
125107,amputations,0,0
125108,.,0,0
125109,A,0,0
125110,limited,0,0
125111,number,0,0
125112,of,0,0
125113,studies,0,0
125114,have,0,0
125115,used,0,0
125116,a,0,0
125117,double,0,0
125118,blind,0,0
125119,approach,0,0
125120,to,0,0
125121,evaluate,0,0
125122,the,0,0
125123,efficacy,0,0
125124,of,0,0
125125,hyperbaric,0,0
125126,oxygen,0,0
125127,therapy,0,0
125128,in,0,0
125129,the,0,0
125130,treatment,0,0
125131,of,0,0
125132,diabetic,1,1
125133,ulcers,1,1
125134,.,1,0
125135,The,0,0
125136,primary,0,0
125137,aim,0,0
125138,of,0,0
125139,this,0,0
125140,study,0,0
125141,is,0,0
125142,to,0,0
125143,assess,0,0
125144,the,0,0
125145,efficacy,0,0
125146,of,0,0
125147,hyperbaric,0,0
125148,oxygen,0,0
125149,therapy,0,0
125150,plus,0,0
125151,standard,0,0
125152,wound,0,0
125153,care,0,0
125154,compared,0,0
125155,with,0,0
125156,standard,0,0
125157,wound,0,0
125158,care,0,0
125159,alone,0,0
125160,in,0,0
125161,preventing,0,0
125162,the,0,0
125163,need,0,0
125164,for,0,0
125165,major,0,0
125166,amputation,0,1
125167,in,0,0
125168,patients,1,1
125169,with,1,1
125170,diabetes,1,1
125171,mellitus,1,1
125172,and,1,1
125173,chronic,1,1
125174,ulcers,1,1
125175,of,1,0
125176,the,1,0
125177,lower,1,0
125178,limb,1,0
125179,.,1,0
125180,METHODS/DESIGN,0,0
125181,One,1,1
125182,hundred,1,1
125183,and,1,0
125184,eighteen,1,1
125185,(,1,0
125186,59,1,1
125187,patients,1,1
125188,per,1,0
125189,arm,1,1
125190,),1,0
125191,patients,1,1
125192,with,1,1
125193,non-healing,1,1
125194,diabetic,1,1
125195,ulcers,1,1
125196,of,1,0
125197,the,1,0
125198,lower,1,0
125199,limb,1,0
125200,",",1,0
125201,referred,1,1
125202,to,1,0
125203,the,1,0
125204,Judy,1,0
125205,Dan,1,1
125206,Research,1,0
125207,and,1,0
125208,Treatment,1,0
125209,Centre,1,0
125210,are,1,0
125211,being,1,0
125212,recruited,1,1
125213,if,1,0
125214,they,1,0
125215,are,1,0
125216,at,1,0
125217,least,1,0
125218,18,1,1
125219,years,1,1
125220,of,1,0
125221,age,1,1
125222,",",1,0
125223,have,1,0
125224,either,1,0
125225,Type,1,0
125226,1,1,0
125227,or,1,1
125228,2,1,0
125229,diabetes,1,1
125230,with,1,1
125231,a,1,0
125232,Wagner,1,0
125233,grading,1,0
125234,of,1,0
125235,foot,1,1
125236,lesions,1,1
125237,2,1,0
125238,",",1,0
125239,3,1,0
125240,or,1,0
125241,4,1,0
125242,on,1,0
125243,lower,1,0
125244,limb,1,0
125245,not,1,0
125246,healing,1,0
125247,for,1,0
125248,at,1,0
125249,least,1,0
125250,4,1,0
125251,weeks,1,0
125252,.,1,1
125253,Patients,0,1
125254,receive,0,0
125255,hyperbaric,0,0
125256,oxygen,0,0
125257,therapy,0,0
125258,every,0,0
125259,day,0,0
125260,for,0,0
125261,6,0,0
125262,weeks,0,0
125263,during,0,0
125264,the,0,0
125265,treatment,0,0
125266,phase,0,0
125267,and,0,0
125268,are,0,0
125269,provided,0,0
125270,ongoing,0,0
125271,wound,0,0
125272,care,0,0
125273,and,0,0
125274,weekly,0,0
125275,assessments,0,0
125276,.,0,1
125277,Patients,0,1
125278,are,0,0
125279,required,0,0
125280,to,0,0
125281,return,0,0
125282,to,0,0
125283,the,0,0
125284,study,0,0
125285,centre,0,0
125286,every,0,0
125287,week,0,0
125288,for,0,0
125289,an,0,0
125290,additional,0,0
125291,6,0,0
125292,weeks,0,0
125293,of,0,0
125294,follow-up,0,0
125295,for,0,0
125296,wound,0,0
125297,evaluation,0,0
125298,and,0,0
125299,management,0,0
125300,.,0,0
125301,The,0,0
125302,primary,0,0
125303,outcome,0,0
125304,is,0,0
125305,freedom,0,0
125306,from,0,0
125307,having,0,0
125308,",",0,0
125309,or,0,0
125310,meeting,0,0
125311,the,0,0
125312,criteria,0,1
125313,for,0,0
125314,",",0,0
125315,a,0,0
125316,major,0,0
125317,amputation,0,0
125318,(,0,0
125319,below,0,0
125320,knee,0,1
125321,amputation,0,0
125322,",",0,0
125323,or,0,0
125324,metatarsal,0,0
125325,level,0,0
125326,),0,0
125327,up,0,0
125328,to,0,0
125329,12,0,0
125330,weeks,0,0
125331,after,0,0
125332,randomization,0,0
125333,.,0,0
125334,The,0,0
125335,decision,0,0
125336,to,0,0
125337,amputate,0,0
125338,is,0,0
125339,made,0,0
125340,by,0,0
125341,a,0,0
125342,vascular,0,0
125343,surgeon,0,0
125344,.,0,0
125345,Other,0,0
125346,outcomes,0,0
125347,include,0,0
125348,wound,0,0
125349,healing,0,0
125350,",",0,0
125351,effectiveness,0,0
125352,",",0,0
125353,safety,0,0
125354,",",0,0
125355,healthcare,0,0
125356,resource,0,0
125357,utilization,0,0
125358,",",0,0
125359,quality,0,0
125360,of,0,0
125361,life,0,0
125362,",",0,0
125363,and,0,0
125364,cost-effectiveness,0,0
125365,.,0,0
125366,The,0,0
125367,study,0,0
125368,will,0,0
125369,run,0,0
125370,for,0,0
125371,a,0,0
125372,total,0,0
125373,of,0,0
125374,about,0,0
125375,3,0,0
125376,years,0,1
125377,.,0,0
125378,DISCUSSION,0,0
125379,The,0,0
125380,results,0,0
125381,of,0,0
125382,this,0,0
125383,study,0,0
125384,will,0,0
125385,provide,0,0
125386,detailed,0,0
125387,information,0,0
125388,on,0,0
125389,the,0,0
125390,efficacy,0,0
125391,of,0,0
125392,hyperbaric,0,0
125393,oxygen,0,0
125394,therapy,0,0
125395,for,0,0
125396,the,0,0
125397,treatment,0,0
125398,of,0,0
125399,non-healing,1,1
125400,ulcers,1,1
125401,of,1,0
125402,the,1,0
125403,lower,1,0
125404,limb,1,0
125405,.,1,0
125406,This,0,0
125407,will,0,0
125408,be,0,0
125409,the,0,0
125410,first,0,0
125411,double-blind,0,0
125412,randomized,0,0
125413,controlled,0,0
125414,trial,0,0
125415,for,0,0
125416,this,0,0
125417,health,0,0
125418,technology,0,0
125419,which,0,0
125420,evaluates,0,0
125421,the,0,0
125422,efficacy,0,0
125423,of,0,0
125424,hyperbaric,0,0
125425,oxygen,0,0
125426,therapy,0,0
125427,in,0,0
125428,prevention,0,0
125429,of,0,0
125430,amputations,0,0
125431,in,0,0
125432,diabetic,1,1
125433,patients,1,1
125434,.,1,1
125435,TRIAL,0,0
125436,REGISTRATION,0,0
125437,ClinicalTrials.gov,0,0
125438,Identifier,0,0
125439,:,0,1
125440,NCT00621608,0,0
125441,.,0,0
125442,Concurrent,0,0
125443,alcohol,0,1
125444,dependence,0,0
125445,among,0,0
125446,methadone-maintained,1,1
125447,cocaine,1,0
125448,abusers,1,1
125449,is,0,0
125450,associated,0,0
125451,with,0,0
125452,greater,0,0
125453,abstinence,0,0
125454,.,0,0
125455,Concurrent,0,0
125456,alcohol,0,0
125457,dependence,0,0
125458,(,0,0
125459,AD,0,0
125460,),0,0
125461,among,0,0
125462,polysubstance,0,1
125463,abusers,0,1
125464,has,0,0
125465,been,0,0
125466,associated,0,0
125467,with,0,1
125468,negative,0,0
125469,consequences,0,0
125470,",",0,0
125471,although,0,0
125472,it,0,0
125473,may,0,0
125474,not,0,0
125475,necessarily,0,0
125476,lead,0,0
125477,to,0,0
125478,poor,0,0
125479,treatment,0,0
125480,outcomes,0,0
125481,.,0,0
125482,One,0,0
125483,of,0,0
125484,the,0,0
125485,most,0,0
125486,efficacious,0,0
125487,treatments,0,0
125488,for,0,0
125489,cocaine,0,0
125490,abuse,0,0
125491,is,0,0
125492,contingency,0,0
125493,management,0,0
125494,(,0,0
125495,CM,0,0
125496,),0,0
125497,",",0,0
125498,but,0,0
125499,little,0,0
125500,research,0,0
125501,has,0,0
125502,explored,0,0
125503,the,0,0
125504,impact,0,0
125505,of,0,0
125506,AD,0,0
125507,on,0,0
125508,abstinence,0,0
125509,outcomes,0,0
125510,",",0,0
125511,particularly,0,0
125512,among,0,0
125513,patients,1,1
125514,in,1,0
125515,methadone,1,1
125516,maintenance,1,0
125517,.,1,0
125518,Using,0,0
125519,data,0,0
125520,from,0,1
125521,three,0,0
125522,trials,0,0
125523,of,0,0
125524,CM,0,0
125525,for,0,0
125526,cocaine,0,0
125527,use,0,0
125528,",",0,0
125529,we,0,0
125530,compared,0,0
125531,baseline,0,0
125532,characteristics,0,0
125533,and,0,0
125534,posttreatment,0,0
125535,and,0,0
125536,follow-up,0,0
125537,cocaine,0,0
125538,outcomes,0,0
125539,between,0,0
125540,methadone-maintained,1,1
125541,",",1,0
125542,cocaine-dependent,1,1
125543,patients,1,1
125544,(,1,0
125545,N,1,1
125546,=,1,0
125547,193,1,1
125548,),1,0
125549,with,1,0
125550,and,1,0
125551,without,1,1
125552,concurrent,1,0
125553,AD,1,0
125554,",",0,0
125555,randomized,0,0
125556,to,0,0
125557,standard,0,0
125558,care,0,0
125559,(,0,0
125560,SC,0,0
125561,),0,0
125562,with,0,0
125563,or,0,0
125564,without,0,1
125565,CM,0,0
125566,.,0,0
125567,Patients,1,1
125568,with,1,0
125569,and,1,0
125570,without,1,1
125571,concurrent,1,0
125572,AD,1,0
125573,had,0,0
125574,similar,0,0
125575,baseline,0,0
125576,characteristics,0,0
125577,",",0,0
125578,with,0,0
125579,the,0,0
125580,exception,0,0
125581,that,0,0
125582,AD,0,0
125583,patients,0,1
125584,reported,0,0
125585,more,0,0
125586,alcohol,0,0
125587,use,0,0
125588,.,0,0
125589,AD,0,0
125590,patients,0,1
125591,achieved,0,0
125592,longer,0,0
125593,durations,0,0
125594,of,0,0
125595,cocaine,0,0
125596,abstinence,0,0
125597,and,0,0
125598,were,0,0
125599,more,0,0
125600,likely,0,0
125601,to,0,0
125602,submit,0,0
125603,a,0,0
125604,cocaine-negative,0,0
125605,sample,0,1
125606,at,0,0
125607,follow-up,0,0
125608,than,0,0
125609,non-AD,0,1
125610,patients,0,1
125611,.,0,1
125612,Patients,0,1
125613,randomized,0,0
125614,to,0,0
125615,CM,0,0
125616,achieved,0,0
125617,better,0,0
125618,outcomes,0,0
125619,than,0,0
125620,those,0,0
125621,randomized,0,0
125622,to,0,0
125623,SC,0,0
125624,",",0,0
125625,but,0,0
125626,there,0,0
125627,was,0,0
125628,no,0,0
125629,interaction,0,0
125630,between,0,0
125631,treatment,0,0
125632,condition,0,0
125633,and,0,0
125634,AD,0,0
125635,status,0,0
125636,.,0,0
125637,These,0,0
125638,findings,0,0
125639,suggest,0,0
125640,that,0,0
125641,cocaine-using,1,1
125642,methadone,1,1
125643,patients,1,1
125644,with,0,1
125645,AD,0,0
125646,achieve,0,0
125647,greater,0,0
125648,cocaine,0,0
125649,abstinence,0,0
125650,than,0,0
125651,their,0,0
125652,non-AD,0,1
125653,counterparts,0,0
125654,and,0,0
125655,should,0,0
125656,not,0,0
125657,necessarily,0,0
125658,be,0,0
125659,viewed,0,0
125660,as,0,0
125661,more,0,0
125662,difficult,0,0
125663,to,0,0
125664,treat,0,0
125665,.,0,0
125666,A,0,0
125667,novel,0,0
125668,approach,0,0
125669,to,0,0
125670,the,0,0
125671,use,0,0
125672,of,0,0
125673,subgingival,0,0
125674,controlled-release,0,0
125675,chlorhexidine,0,0
125676,delivery,0,0
125677,in,0,0
125678,chronic,1,1
125679,periodontitis,1,1
125680,:,1,1
125681,a,0,0
125682,randomized,0,0
125683,clinical,0,0
125684,trial,0,0
125685,.,0,0
125686,BACKGROUND,0,0
125687,We,0,0
125688,aimed,0,0
125689,to,0,0
125690,analyze,0,0
125691,clinical,0,0
125692,",",0,0
125693,microbiologic,0,0
125694,",",0,0
125695,and,0,0
125696,serologic,0,0
125697,effects,0,0
125698,of,0,0
125699,chlorhexidine,0,0
125700,(,0,0
125701,CHX,0,0
125702,),0,0
125703,chips,0,0
125704,used,0,0
125705,as,0,0
125706,a,0,0
125707,subgingival,0,0
125708,controlled-release,0,0
125709,delivery,0,0
125710,device,0,0
125711,before,0,0
125712,and,0,0
125713,immediately,0,0
125714,after,0,0
125715,scaling,0,0
125716,and,0,0
125717,root,0,0
125718,planing,0,0
125719,(,0,0
125720,SRP,0,0
125721,),0,0
125722,.,0,0
125723,METHODS,0,0
125724,Twenty-four,1,1
125725,patients,1,1
125726,presenting,1,1
125727,with,1,1
125728,?12,1,1
125729,teeth,1,1
125730,with,1,1
125731,probing,1,0
125732,depth,1,0
125733,(,1,0
125734,PD,1,0
125735,),1,0
125736,?5,1,0
125737,mm,1,0
125738,and,1,0
125739,bleeding,1,0
125740,on,1,0
125741,probing,1,0
125742,were,1,0
125743,assigned,1,0
125744,in,1,0
125745,test,1,0
125746,or,1,0
125747,control,1,0
125748,groups,1,0
125749,.,1,0
125750,After,1,0
125751,prophylaxis,0,0
125752,",",0,0
125753,CHX,0,0
125754,chips,0,0
125755,(,0,0
125756,test,0,0
125757,),0,0
125758,or,0,0
125759,placebo,0,0
125760,chips,0,0
125761,(,0,0
125762,control,0,0
125763,),0,0
125764,were,0,0
125765,placed,0,0
125766,in,0,0
125767,pockets,0,0
125768,with,0,1
125769,PD,0,1
125770,?5,0,0
125771,mm,0,0
125772,.,0,0
125773,Ten,0,1
125774,days,0,0
125775,later,0,0
125776,",",0,0
125777,SRP,0,0
125778,was,0,0
125779,performed,0,0
125780,in,0,0
125781,all,0,0
125782,teeth,0,1
125783,with,0,1
125784,PD,0,1
125785,?4,0,0
125786,mm,0,0
125787,in,0,0
125788,a,0,0
125789,single,0,0
125790,appointment,0,0
125791,.,0,0
125792,Immediately,0,0
125793,after,0,0
125794,SRP,0,0
125795,",",0,0
125796,new,0,0
125797,chips,0,0
125798,were,0,0
125799,inserted,0,0
125800,in,0,0
125801,all,0,0
125802,pockets,0,0
125803,with,0,1
125804,PD,0,1
125805,?5,0,0
125806,mm,0,0
125807,.,0,0
125808,Parameters,0,0
125809,were,0,0
125810,assessed,0,0
125811,at,0,0
125812,baseline,0,0
125813,;,0,0
125814,beginning,0,0
125815,of,0,0
125816,SRP,0,0
125817,;,0,0
125818,and,0,0
125819,1,0,0
125820,",",0,0
125821,3,0,0
125822,",",0,0
125823,and,0,0
125824,6,0,0
125825,months,0,0
125826,after,0,0
125827,treatment,0,0
125828,.,0,0
125829,Subgingival,0,0
125830,samples,0,0
125831,were,0,0
125832,obtained,0,0
125833,at,0,0
125834,baseline,0,0
125835,;,0,0
125836,beginning,0,0
125837,of,0,0
125838,SRP,0,0
125839,;,0,0
125840,and,0,0
125841,at,0,0
125842,1,0,0
125843,month,0,0
125844,after,0,0
125845,treatment,0,0
125846,.,0,0
125847,Periodontal,0,1
125848,pathogens,0,0
125849,Aggregatibacter,0,0
125850,actinomycetemcomitans,0,1
125851,",",0,0
125852,Porphyromonas,0,0
125853,gingivalis,0,0
125854,",",0,0
125855,Prevotella,0,0
125856,intermedia,0,0
125857,",",0,0
125858,Tannerella,0,0
125859,forsythia,0,0
125860,",",0,0
125861,and,0,0
125862,Treponema,0,0
125863,denticola,0,0
125864,were,0,0
125865,analyzed,0,0
125866,.,0,0
125867,Serum,0,0
125868,levels,0,0
125869,of,0,0
125870,high,0,1
125871,sensitive,0,0
125872,C-reactive,0,0
125873,and,0,0
125874,lipopolysaccharide-binding,0,0
125875,proteins,0,0
125876,were,0,0
125877,measured,0,0
125878,.,0,0
125879,The,0,0
125880,changes,0,0
125881,of,0,0
125882,the,0,0
125883,parameters,0,0
125884,between,0,0
125885,and,0,0
125886,within,0,0
125887,the,0,0
125888,groups,0,0
125889,were,0,0
125890,tested,0,0
125891,by,0,0
125892,Mann-Whitney,0,0
125893,U,0,0
125894,test,0,0
125895,(,0,0
125896,P,0,0
125897,<,0,0
125898,0.05,0,0
125899,),0,0
125900,.,0,0
125901,RESULTS,0,0
125902,All,0,0
125903,clinical,0,0
125904,and,0,0
125905,serologic,0,0
125906,parameters,0,0
125907,improved,0,0
125908,in,0,0
125909,both,0,0
125910,groups,0,0
125911,over,0,0
125912,time,0,0
125913,.,0,0
125914,There,0,0
125915,was,0,0
125916,a,0,0
125917,significant,0,0
125918,difference,0,0
125919,in,0,0
125920,clinical,0,0
125921,attachment,0,0
125922,level,0,0
125923,(,0,0
125924,CAL,0,0
125925,),0,0
125926,gain,0,0
125927,from,0,0
125928,baseline,0,0
125929,to,0,0
125930,6,0,0
125931,months,0,0
125932,between,0,0
125933,groups,0,0
125934,(,0,0
125935,1.17,0,0
125936,mm,0,0
125937,in,0,0
125938,the,0,0
125939,test,0,0
125940,group,0,0
125941,versus,0,0
125942,0.79,0,0
125943,mm,0,0
125944,in,0,0
125945,the,0,0
125946,placebo,0,0
125947,group,0,0
125948,),0,0
125949,(,0,0
125950,P,0,0
125951,<,0,0
125952,0.05,0,0
125953,),0,0
125954,.,0,0
125955,The,0,0
125956,treatment,0,0
125957,with,0,1
125958,CHX,0,0
125959,chips,0,0
125960,showed,0,0
125961,a,0,0
125962,greater,0,0
125963,reduction,0,0
125964,of,0,0
125965,the,0,0
125966,microorganisms,0,0
125967,of,0,0
125968,the,0,0
125969,red,0,0
125970,complex,0,0
125971,after,0,0
125972,1,0,0
125973,month,0,0
125974,(,0,0
125975,P,0,0
125976,=,0,0
125977,0.02,0,0
125978,),0,0
125979,.,0,0
125980,CONCLUSION,0,0
125981,The,0,0
125982,use,0,0
125983,of,0,0
125984,CHX,0,0
125985,chips,0,0
125986,before,0,0
125987,and,0,0
125988,immediately,0,0
125989,after,0,0
125990,SRP,0,0
125991,improved,0,0
125992,CAL,0,0
125993,and,0,0
125994,reduced,0,0
125995,the,0,0
125996,subgingival,0,0
125997,microorganisms,0,0
125998,of,0,0
125999,the,0,0
126000,red,0,0
126001,complex,0,0
126002,in,0,0
126003,the,0,0
126004,treatment,0,0
126005,of,0,0
126006,chronic,0,1
126007,periodontitis,0,1
126008,.,0,0
126009,A,0,0
126010,randomized,0,0
126011,placebo-controlled,0,0
126012,prevention,0,0
126013,trial,0,0
126014,of,0,0
126015,aspirin,0,0
126016,and/or,0,0
126017,resistant,0,0
126018,starch,0,0
126019,in,0,0
126020,young,1,1
126021,people,1,1
126022,with,1,1
126023,familial,1,1
126024,adenomatous,1,1
126025,polyposis,1,1
126026,.,1,0
126027,Evidence,0,0
126028,supporting,0,0
126029,aspirin,0,0
126030,and,0,0
126031,resistant,0,1
126032,starch,0,0
126033,(,0,0
126034,RS,0,0
126035,),0,0
126036,for,0,0
126037,colorectal,1,1
126038,cancer,1,1
126039,prevention,0,0
126040,comes,0,0
126041,from,0,0
126042,epidemiologic,0,0
126043,and,0,0
126044,laboratory,0,0
126045,studies,0,0
126046,(,0,0
126047,aspirin,0,0
126048,and,0,0
126049,RS,0,0
126050,),0,0
126051,and,0,0
126052,randomized,0,0
126053,controlled,0,0
126054,clinical,0,0
126055,trials,0,0
126056,(,0,0
126057,aspirin,0,0
126058,),0,0
126059,.,0,0
126060,Familial,1,0
126061,adenomatous,1,1
126062,polyposis,1,1
126063,(,1,0
126064,FAP,1,0
126065,),1,0
126066,strikes,0,0
126067,young,0,1
126068,people,0,1
126069,and,0,0
126070,",",0,0
126071,untreated,0,0
126072,",",0,0
126073,confers,0,0
126074,virtually,0,0
126075,a,0,0
126076,100,0,0
126077,%,0,0
126078,risk,0,0
126079,of,0,0
126080,colorectal,0,1
126081,cancer,0,1
126082,and,0,0
126083,early,0,0
126084,death,0,0
126085,.,0,0
126086,We,0,0
126087,conducted,0,0
126088,an,0,0
126089,international,0,0
126090,",",0,0
126091,multicenter,0,0
126092,",",0,0
126093,randomized,0,0
126094,",",0,0
126095,placebo-controlled,0,0
126096,trial,0,0
126097,of,0,0
126098,aspirin,0,0
126099,(,0,0
126100,600,0,0
126101,mg/d,0,0
126102,),0,0
126103,and/or,0,0
126104,RS,0,0
126105,(,0,0
126106,30,0,0
126107,g/d,0,0
126108,),0,0
126109,for,0,0
126110,from,0,0
126111,1,0,0
126112,to,0,0
126113,12,0,0
126114,years,0,1
126115,to,0,0
126116,prevent,0,0
126117,disease,0,1
126118,progression,0,0
126119,in,0,0
126120,FAP,1,0
126121,patients,1,1
126122,from,1,1
126123,10,1,1
126124,to,1,0
126125,21,1,1
126126,years,1,1
126127,of,1,0
126128,age,1,1
126129,.,1,0
126130,In,0,0
126131,a,0,0
126132,2,0,0
126133,?,0,0
126134,2,0,0
126135,factorial,0,0
126136,design,0,0
126137,",",0,0
126138,patients,0,1
126139,were,0,0
126140,randomly,0,1
126141,assigned,0,0
126142,to,0,0
126143,the,0,0
126144,following,0,0
126145,four,0,0
126146,study,0,1
126147,arms,0,0
126148,:,0,1
126149,aspirin,0,0
126150,plus,0,0
126151,RS,0,0
126152,placebo,0,0
126153,;,0,0
126154,RS,0,0
126155,plus,0,0
126156,aspirin,0,0
126157,placebo,0,0
126158,;,0,0
126159,aspirin,0,0
126160,plus,0,0
126161,RS,0,0
126162,;,0,0
126163,RS,0,0
126164,placebo,0,0
126165,plus,0,0
126166,aspirin,0,0
126167,placebo,0,0
126168,;,0,0
126169,they,0,0
126170,were,0,0
126171,followed,0,0
126172,with,0,1
126173,standard,0,0
126174,annual,0,1
126175,clinical,0,0
126176,examinations,0,0
126177,including,0,0
126178,endoscopy,0,1
126179,.,0,0
126180,The,0,0
126181,primary,0,0
126182,endpoint,0,0
126183,was,0,0
126184,polyp,0,0
126185,number,0,0
126186,in,0,0
126187,the,0,0
126188,rectum,0,0
126189,and,0,0
126190,sigmoid,0,1
126191,colon,0,1
126192,(,0,0
126193,at,0,0
126194,the,0,0
126195,end,0,0
126196,of,0,0
126197,intervention,0,0
126198,),0,0
126199,",",0,0
126200,and,0,0
126201,the,0,0
126202,major,0,0
126203,secondary,0,0
126204,endpoint,0,0
126205,was,0,0
126206,size,0,0
126207,of,0,0
126208,the,0,0
126209,largest,0,0
126210,polyp,0,0
126211,.,0,0
126212,A,0,0
126213,total,1,0
126214,of,1,0
126215,206,1,1
126216,randomized,1,1
126217,FAP,1,1
126218,patients,1,1
126219,commenced,1,1
126220,intervention,1,0
126221,",",1,0
126222,of,1,0
126223,whom,1,1
126224,133,1,1
126225,had,1,1
126226,at,1,0
126227,least,1,0
126228,one,1,0
126229,follow-up,1,0
126230,endoscopy,1,1
126231,and,1,0
126232,were,1,0
126233,therefore,1,0
126234,included,1,0
126235,in,1,0
126236,the,1,0
126237,primary,1,0
126238,analysis,1,0
126239,.,1,0
126240,Neither,0,0
126241,intervention,0,0
126242,significantly,0,0
126243,reduced,0,0
126244,polyp,0,0
126245,count,0,0
126246,in,0,0
126247,the,0,0
126248,rectum,0,0
126249,and,0,0
126250,sigmoid,0,1
126251,colon,0,1
126252,:,0,1
126253,aspirin,0,0
126254,relative,0,0
126255,risk,0,0
126256,=,0,0
126257,0.77,0,0
126258,(,0,0
126259,95,0,0
126260,%,0,0
126261,CI,0,0
126262,",",0,0
126263,0.54-1.10,0,0
126264,;,0,0
126265,versus,0,0
126266,nonaspirin,0,0
126267,arms,0,0
126268,),0,1
126269,;,0,0
126270,RS,0,0
126271,relative,0,0
126272,risk,0,0
126273,=,0,0
126274,1.05,0,0
126275,(,0,0
126276,95,0,0
126277,%,0,0
126278,CI,0,0
126279,",",0,0
126280,0.73-1.49,0,0
126281,;,0,0
126282,versus,0,0
126283,non-RS,0,1
126284,arms,0,0
126285,),0,0
126286,.,0,0
126287,There,0,0
126288,was,0,0
126289,a,0,0
126290,trend,0,0
126291,toward,0,0
126292,a,0,0
126293,smaller,0,0
126294,size,0,0
126295,of,0,0
126296,largest,0,0
126297,polyp,0,0
126298,in,0,0
126299,patients,0,1
126300,treated,0,1
126301,with,0,1
126302,aspirin,0,0
126303,versus,0,0
126304,nonaspirin,0,0
126305,--,0,0
126306,mean,0,0
126307,3.8,0,0
126308,mm,0,0
126309,versus,0,0
126310,5.5,0,0
126311,mm,0,0
126312,for,0,0
126313,patients,0,1
126314,treated,0,1
126315,1,0,0
126316,or,0,1
126317,more,0,0
126318,years,0,1
126319,(,0,0
126320,adjusted,0,0
126321,P,0,0
126322,=,0,0
126323,0.09,0,0
126324,),0,0
126325,and,0,0
126326,mean,0,0
126327,3.0,0,0
126328,mm,0,0
126329,versus,0,0
126330,6.0,0,0
126331,mm,0,0
126332,for,0,0
126333,patients,0,1
126334,treated,0,1
126335,more,0,0
126336,than,0,0
126337,1,0,0
126338,year,0,0
126339,(,0,0
126340,P,0,0
126341,=,0,0
126342,0.02,0,0
126343,),0,0
126344,;,0,0
126345,there,0,0
126346,were,0,0
126347,similar,0,0
126348,weaker,0,0
126349,trends,0,0
126350,with,0,1
126351,RS,0,0
126352,versus,0,0
126353,non-RS,0,1
126354,.,0,1
126355,Exploratory,0,0
126356,translational,0,0
126357,endpoints,0,0
126358,included,0,1
126359,crypt,0,0
126360,length,0,0
126361,(,0,0
126362,which,0,0
126363,was,0,0
126364,significantly,0,0
126365,shorter,0,0
126366,in,0,0
126367,normal-appearing,0,0
126368,mucosa,0,1
126369,in,0,0
126370,the,0,0
126371,RS,0,0
126372,group,0,0
126373,over,0,0
126374,time,0,0
126375,),0,0
126376,and,0,0
126377,laboratory,0,0
126378,measures,0,0
126379,of,0,0
126380,proliferation,0,0
126381,(,0,0
126382,including,0,0
126383,Ki67,0,0
126384,),0,0
126385,.,0,0
126386,This,0,0
126387,clinical,0,0
126388,trial,0,0
126389,is,0,0
126390,the,0,0
126391,largest,0,0
126392,ever,0,0
126393,conducted,0,0
126394,in,0,0
126395,the,0,0
126396,setting,0,0
126397,of,0,0
126398,FAP,0,0
126399,and,0,0
126400,found,0,0
126401,a,0,0
126402,trend,0,0
126403,of,0,0
126404,reduced,0,0
126405,polyp,0,0
126406,load,0,0
126407,(,0,0
126408,number,0,0
126409,and,0,0
126410,size,0,0
126411,),0,0
126412,with,0,1
126413,600,0,0
126414,mg,0,0
126415,of,0,0
126416,aspirin,0,0
126417,daily,0,0
126418,.,0,1
126419,RS,0,0
126420,had,0,0
126421,no,0,0
126422,clinical,0,0
126423,effect,0,0
126424,on,0,0
126425,adenomas,0,1
126426,.,0,0
126427,Pulsed,0,0
126428,azithromycin,0,0
126429,treatment,0,0
126430,is,0,0
126431,as,0,0
126432,effective,0,0
126433,and,0,0
126434,safe,0,0
126435,as,0,0
126436,2-week-longer,0,0
126437,daily,0,0
126438,doxycycline,0,0
126439,treatment,0,0
126440,of,0,0
126441,acne,1,1
126442,vulgaris,1,1
126443,:,1,1
126444,a,0,0
126445,randomized,0,0
126446,",",0,0
126447,double-blind,0,0
126448,",",0,0
126449,noninferiority,0,0
126450,study,0,0
126451,.,0,0
126452,Efficacy,0,0
126453,and,0,0
126454,safety,0,0
126455,of,0,0
126456,azithromycin,0,0
126457,and,0,0
126458,doxycycline,0,0
126459,for,0,0
126460,the,0,0
126461,treatment,0,0
126462,of,0,0
126463,moderate,1,1
126464,acne,1,1
126465,vulgaris,1,1
126466,were,0,0
126467,evaluated,0,0
126468,(,1,0
126469,240,1,1
126470,patients,1,1
126471,),1,0
126472,in,1,0
126473,both,1,0
126474,intention-to-treat,1,0
126475,and,1,0
126476,per-protocol,1,0
126477,populations,1,1
126478,.,1,0
126479,The,0,0
126480,evaluation,0,0
126481,of,0,0
126482,clinical,0,0
126483,efficacy,0,0
126484,was,0,0
126485,based,0,0
126486,on,0,0
126487,the,0,0
126488,change,0,0
126489,in,0,0
126490,the,0,0
126491,number,0,0
126492,of,0,0
126493,facial,0,0
126494,inflammatory,0,0
126495,lesions,0,1
126496,from,0,0
126497,baseline,0,0
126498,to,0,0
126499,the,0,0
126500,end,0,0
126501,of,0,0
126502,treatment,0,0
126503,",",0,0
126504,and,0,0
126505,noninferiority,0,0
126506,was,0,0
126507,defined,0,0
126508,by,0,0
126509,the,0,0
126510,upper,0,0
126511,95,0,0
126512,%,0,0
126513,confidence,0,0
126514,limit,0,0
126515,of,0,0
126516,the,0,0
126517,difference,0,0
126518,between,0,0
126519,two,0,0
126520,treatments,0,0
126521,being,0,0
126522,less,0,0
126523,than,0,0
126524,9,0,0
126525,.,0,0
126526,Reduction,0,0
126527,in,0,0
126528,the,0,0
126529,number,0,0
126530,of,0,0
126531,lesions,0,1
126532,was,0,0
126533,similar,0,0
126534,with,0,1
126535,both,0,0
126536,azithromycin,0,0
126537,and,0,0
126538,doxycycline,0,0
126539,treatments,0,0
126540,(,0,0
126541,27,0,1
126542,+/-,0,0
126543,12,0,0
126544,and,0,0
126545,30,0,1
126546,+/-,0,0
126547,12,0,0
126548,",",0,0
126549,respectively,0,0
126550,),0,0
126551,in,0,0
126552,both,0,0
126553,groups,0,0
126554,.,0,0
126555,Also,0,0
126556,",",0,0
126557,the,0,0
126558,upper,0,0
126559,95,0,0
126560,%,0,0
126561,confidence,0,0
126562,limit,0,0
126563,of,0,0
126564,5,0,0
126565,inflammatory,0,0
126566,lesions,0,1
126567,has,0,0
126568,satisfied,0,0
126569,the,0,0
126570,noninferiority,0,0
126571,criterion,0,0
126572,.,0,0
126573,The,0,0
126574,incidence,0,0
126575,of,0,0
126576,adverse,0,0
126577,events,0,0
126578,did,0,0
126579,not,0,0
126580,differ,0,0
126581,between,0,0
126582,the,0,0
126583,two,0,0
126584,treatment,0,0
126585,groups,0,0
126586,.,0,0
126587,The,0,0
126588,shorter,0,0
126589,and,0,0
126590,simpler,0,0
126591,treatment,0,0
126592,schedule,0,0
126593,of,0,0
126594,azithromycin,0,0
126595,had,0,0
126596,similar,0,0
126597,efficacy,0,0
126598,and,0,0
126599,safety,0,0
126600,as,0,0
126601,doxycycline,0,0
126602,in,0,0
126603,the,0,0
126604,treatment,0,0
126605,of,0,0
126606,moderate,1,1
126607,acne,1,0
126608,vulgaris,1,1
126609,",",0,0
126610,confirming,0,0
126611,noninferiority,0,0
126612,of,0,0
126613,azithromycin,0,0
126614,as,0,0
126615,compared,0,0
126616,with,0,1
126617,doxycycline,0,0
126618,.,0,0
126619,Impact,0,0
126620,of,0,0
126621,dronedarone,0,0
126622,on,0,0
126623,hospitalization,0,0
126624,burden,0,0
126625,in,0,0
126626,patients,1,1
126627,with,1,1
126628,atrial,1,1
126629,fibrillation,1,1
126630,:,1,1
126631,results,0,0
126632,from,0,0
126633,the,0,0
126634,ATHENA,0,0
126635,study,0,0
126636,.,0,0
126637,AIMS,0,0
126638,Cardiovascular,0,0
126639,(,0,0
126640,CV,0,0
126641,),0,0
126642,hospitalization,0,0
126643,is,0,0
126644,a,0,0
126645,predictor,0,0
126646,of,0,0
126647,CV,0,0
126648,mortality,0,0
126649,and,0,0
126650,has,0,0
126651,a,0,0
126652,negative,0,0
126653,impact,0,0
126654,on,0,0
126655,patients,0,1
126656,',0,1
126657,quality,0,0
126658,of,0,0
126659,life,0,0
126660,.,0,0
126661,The,0,0
126662,primary,0,0
126663,endpoint,0,0
126664,of,0,0
126665,A,0,0
126666,placebo-controlled,0,0
126667,",",0,0
126668,double-blind,0,0
126669,",",0,0
126670,parallel-arm,0,0
126671,Trial,0,0
126672,to,0,0
126673,assess,0,0
126674,the,0,0
126675,efficacy,0,0
126676,of,0,0
126677,dronedarone,0,0
126678,400,0,0
126679,mg,0,0
126680,bid,0,0
126681,for,0,0
126682,the,0,0
126683,prevention,0,0
126684,of,0,0
126685,cardiovascular,0,0
126686,Hospitalization,0,0
126687,or,0,0
126688,death,0,0
126689,from,0,0
126690,any,0,0
126691,cause,0,0
126692,in,0,0
126693,patiENTs,1,0
126694,with,1,1
126695,Atrial,1,0
126696,fibrillation/atrial,1,1
126697,flutter,1,1
126698,(,1,0
126699,ATHENA,1,0
126700,),1,0
126701,",",0,0
126702,a,0,0
126703,composite,0,0
126704,of,0,0
126705,first,0,0
126706,CV,0,0
126707,hospitalization,0,0
126708,or,0,0
126709,death,0,0
126710,from,0,0
126711,any,0,0
126712,cause,0,0
126713,",",0,0
126714,was,0,0
126715,significantly,0,0
126716,reduced,0,0
126717,by,0,0
126718,dronedarone,0,0
126719,.,0,0
126720,This,0,0
126721,post,0,0
126722,hoc,0,0
126723,analysis,0,0
126724,evaluated,0,0
126725,the,0,0
126726,secondary,0,0
126727,endpoint,0,0
126728,of,0,0
126729,CV,0,0
126730,hospitalization,0,0
126731,and,0,0
126732,the,0,0
126733,clinical,0,0
126734,benefit,0,0
126735,of,0,0
126736,dronedarone,0,0
126737,on,0,0
126738,the,0,0
126739,number,0,0
126740,and,0,0
126741,duration,0,0
126742,of,0,0
126743,CV,0,0
126744,hospitalizations,0,1
126745,in,0,0
126746,patients,1,1
126747,with,1,1
126748,atrial,1,1
126749,fibrillation,1,1
126750,(,1,0
126751,AF,1,0
126752,),1,0
126753,.,1,0
126754,METHODS,0,0
126755,AND,0,0
126756,RESULTS,0,0
126757,ATHENA,0,0
126758,was,0,0
126759,a,0,0
126760,double-blind,0,0
126761,",",0,0
126762,parallel,0,0
126763,group,0,0
126764,study,0,0
126765,in,0,0
126766,4628,1,1
126767,patients,1,1
126768,with,1,1
126769,a,1,0
126770,history,1,0
126771,of,1,0
126772,paroxysmal/persistent,1,1
126773,AF,1,0
126774,and,1,0
126775,additional,1,0
126776,risk,1,0
126777,factors,1,0
126778,",",0,0
126779,treated,0,1
126780,with,0,0
126781,placebo,0,0
126782,or,0,0
126783,dronedarone,0,0
126784,.,0,0
126785,Dronedarone,0,0
126786,treatment,0,0
126787,significantly,0,0
126788,reduced,0,0
126789,the,0,0
126790,risk,0,0
126791,of,0,0
126792,first,0,0
126793,CV,0,0
126794,hospitalization,0,0
126795,(,0,0
126796,P,0,0
126797,<,0,0
126798,0.0001,0,0
126799,vs.,0,0
126800,placebo,0,0
126801,),0,0
126802,",",0,0
126803,while,0,0
126804,the,0,0
126805,risk,0,0
126806,of,0,0
126807,first,0,0
126808,non-CV,0,0
126809,hospitalization,0,0
126810,was,0,0
126811,similar,0,0
126812,in,0,0
126813,both,0,0
126814,groups,0,0
126815,(,0,0
126816,P,0,0
126817,=,0,0
126818,0.77,0,0
126819,),0,0
126820,.,0,0
126821,About,0,0
126822,half,0,0
126823,of,0,0
126824,the,0,0
126825,CV,0,0
126826,hospitalizations,0,1
126827,were,0,0
126828,AF-related,0,0
126829,",",0,0
126830,with,0,0
126831,a,0,0
126832,median,0,0
126833,duration,0,0
126834,of,0,0
126835,hospital,0,0
126836,stay,0,0
126837,of,0,0
126838,four,0,1
126839,nights,0,0
126840,.,0,0
126841,The,0,0
126842,risk,0,0
126843,of,0,0
126844,any,0,0
126845,hospitalization,0,0
126846,for,0,0
126847,AF,0,0
126848,[,0,0
126849,hazard,0,0
126850,ratio,0,0
126851,(,0,0
126852,95,0,0
126853,%,0,0
126854,confidence,0,0
126855,interval,0,0
126856,),0,0
126857,0.626,0,0
126858,(,0,0
126859,0.546-0.719,0,0
126860,),0,0
126861,],0,0
126862,and,0,0
126863,duration,0,0
126864,of,0,0
126865,hospital,0,0
126866,stay,0,0
126867,were,0,0
126868,significantly,0,0
126869,reduced,0,0
126870,by,0,0
126871,dronedarone,0,0
126872,(,0,0
126873,P,0,0
126874,<,0,0
126875,0.0001,0,0
126876,vs.,0,0
126877,placebo,0,0
126878,),0,0
126879,.,0,0
126880,Dronedarone,0,0
126881,treatment,0,0
126882,reduced,0,0
126883,total,0,1
126884,hospitalizations,0,1
126885,for,0,0
126886,acute,0,1
126887,coronary,0,1
126888,syndrome,0,1
126889,(,0,0
126890,P,0,0
126891,=,0,0
126892,0.0105,0,0
126893,),0,0
126894,and,0,0
126895,the,0,0
126896,time,0,0
126897,between,0,0
126898,the,0,0
126899,first,0,0
126900,AF/atrial,0,0
126901,flutter,0,1
126902,recurrence,0,0
126903,and,0,0
126904,CV,0,0
126905,hospitalization/death,0,0
126906,(,0,0
126907,P,0,0
126908,=,0,0
126909,0.0048,0,0
126910,),0,0
126911,.,0,0
126912,Hospitalization,0,0
126913,burden,0,0
126914,was,0,0
126915,significantly,0,0
126916,reduced,0,0
126917,across,0,0
126918,all,0,0
126919,levels,0,0
126920,of,0,0
126921,care,0,1
126922,(,0,0
126923,P,0,0
126924,<,0,0
126925,0.05,0,0
126926,),0,0
126927,.,0,0
126928,Cumulative,0,0
126929,incidence,0,0
126930,data,0,0
126931,indicated,0,0
126932,that,0,0
126933,the,0,0
126934,effects,0,0
126935,of,0,0
126936,dronedarone,0,0
126937,persisted,0,0
126938,for,0,0
126939,at,0,0
126940,least,0,0
126941,24,0,0
126942,months,0,0
126943,.,0,1
126944,CONCLUSION,0,0
126945,Dronedarone,0,0
126946,reduced,0,0
126947,the,0,0
126948,risk,0,0
126949,for,0,0
126950,CV,0,0
126951,hospitalization,0,0
126952,and,0,0
126953,the,0,0
126954,total,0,0
126955,hospitalization,0,0
126956,burden,0,0
126957,in,0,0
126958,this,0,0
126959,patient,0,0
126960,group,0,0
126961,.,0,0
126962,The,0,0
126963,trial,0,0
126964,is,0,0
126965,registered,0,0
126966,under,0,0
126967,ClinicalTrials.gov,0,0
126968,#,0,0
126969,NCT,0,0
126970,00174785,0,0
126971,.,0,1
126972,The,0,0
126973,effects,0,0
126974,of,0,0
126975,encoding,0,0
126976,in,0,0
126977,hypnosis,0,0
126978,and,0,0
126979,post-hypnotic,0,0
126980,suggestion,0,0
126981,on,0,0
126982,academic,0,1
126983,performance,0,0
126984,.,0,0
126985,This,0,0
126986,study,0,0
126987,examined,0,0
126988,the,0,0
126989,relationship,0,0
126990,between,0,0
126991,proactive,1,0
126992,learning,1,0
126993,in,1,0
126994,hypnosis,1,0
126995,",",1,0
126996,post-hypnotic,1,0
126997,suggestion,1,0
126998,",",1,0
126999,and,1,0
127000,academic,1,1
127001,performance,1,0
127002,.,1,0
127003,Participants,1,1
127004,(,1,0
127005,N,1,1
127006,=,1,0
127007,56,1,1
127008,),1,0
127009,were,0,0
127010,randomly,0,0
127011,assigned,0,0
127012,to,0,0
127013,a,0,0
127014,control,1,0
127015,group,1,0
127016,or,0,0
127017,a,0,0
127018,treatment,1,0
127019,group,1,0
127020,.,1,0
127021,The,0,0
127022,treatment,0,0
127023,group,0,0
127024,was,0,0
127025,hypnotized,0,0
127026,and,0,0
127027,read,0,0
127028,a,0,0
127029,passage,0,0
127030,while,0,0
127031,in,0,0
127032,hypnosis,0,0
127033,.,0,0
127034,Concurrently,0,0
127035,",",0,0
127036,they,0,0
127037,were,0,0
127038,given,0,0
127039,a,0,0
127040,post-hypnotic,0,0
127041,suggestion,0,0
127042,",",0,0
127043,which,0,0
127044,attempted,0,0
127045,to,0,0
127046,aid,0,0
127047,recognition,0,0
127048,and,0,0
127049,performance,0,0
127050,on,0,0
127051,a,0,0
127052,test,0,0
127053,immediately,0,0
127054,following,0,0
127055,the,0,0
127056,hypnosis,0,0
127057,session,0,0
127058,.,0,0
127059,Both,0,0
127060,groups,0,0
127061,completed,0,1
127062,a,0,0
127063,multiple-choice,0,0
127064,test,0,0
127065,based,0,0
127066,on,0,0
127067,the,0,0
127068,aforementioned,0,0
127069,passage,0,0
127070,.,0,0
127071,An,0,0
127072,analysis,0,0
127073,of,0,0
127074,covariance,0,0
127075,discerned,0,0
127076,the,0,0
127077,effect,0,0
127078,of,0,0
127079,proactive,0,0
127080,learning,0,0
127081,and,0,0
127082,post-hypnotic,0,0
127083,suggestion,0,0
127084,on,0,0
127085,test,0,0
127086,performance,0,0
127087,",",0,0
127088,while,0,0
127089,controlling,0,0
127090,for,0,0
127091,the,0,0
127092,variance,0,0
127093,introduced,0,0
127094,by,0,0
127095,scholastic,0,1
127096,aptitude,0,0
127097,as,0,0
127098,measured,0,0
127099,by,0,0
127100,the,0,0
127101,ACT,0,0
127102,.,0,0
127103,Results,0,0
127104,indicated,0,0
127105,that,0,0
127106,the,0,0
127107,hypnosis,0,0
127108,sessions,0,0
127109,predicted,0,0
127110,significantly,0,0
127111,impaired,0,0
127112,test,0,0
127113,performance,0,0
127114,.,0,0
127115,Study,0,0
127116,protocol,0,0
127117,:,0,1
127118,Phase,0,0
127119,III,0,0
127120,single-blinded,0,0
127121,fast-track,0,1
127122,pragmatic,0,0
127123,randomised,0,0
127124,controlled,0,0
127125,trial,0,0
127126,of,0,0
127127,a,0,0
127128,complex,0,0
127129,intervention,0,0
127130,for,0,0
127131,breathlessness,1,0
127132,in,1,0
127133,advanced,1,1
127134,disease,1,1
127135,.,1,0
127136,BACKGROUND,0,0
127137,Breathlessness,0,0
127138,in,0,0
127139,advanced,0,1
127140,disease,0,1
127141,causes,0,0
127142,significant,0,0
127143,distress,0,0
127144,to,0,0
127145,patients,1,1
127146,and,0,0
127147,carers,0,1
127148,and,0,0
127149,presents,0,0
127150,management,0,0
127151,challenges,0,0
127152,to,0,0
127153,health,0,0
127154,care,0,0
127155,professionals,0,1
127156,.,0,0
127157,The,0,0
127158,Breathlessness,0,0
127159,Intervention,0,0
127160,Service,0,0
127161,(,0,0
127162,BIS,0,0
127163,),0,0
127164,seeks,0,0
127165,to,0,0
127166,improve,0,0
127167,the,0,0
127168,care,0,0
127169,of,0,0
127170,breathless,1,0
127171,patients,1,1
127172,with,1,1
127173,advanced,1,1
127174,disease,1,1
127175,(,1,0
127176,regardless,1,0
127177,of,1,0
127178,cause,1,0
127179,),1,0
127180,through,0,0
127181,the,0,0
127182,use,0,0
127183,of,0,0
127184,evidence-based,0,0
127185,practice,0,0
127186,and,0,0
127187,working,0,0
127188,with,0,1
127189,other,0,0
127190,healthcare,0,0
127191,providers,0,1
127192,.,0,0
127193,BIS,0,0
127194,delivers,0,0
127195,a,0,0
127196,complex,0,0
127197,intervention,0,0
127198,(,0,0
127199,of,0,0
127200,non-pharmacological,0,0
127201,and,0,0
127202,pharmacological,0,0
127203,treatments,0,0
127204,),0,0
127205,via,0,0
127206,a,0,0
127207,multi-professional,0,1
127208,team,0,0
127209,.,0,0
127210,BIS,0,0
127211,is,0,0
127212,being,0,0
127213,continuously,0,0
127214,developed,0,0
127215,and,0,0
127216,its,0,0
127217,impact,0,0
127218,evaluated,0,0
127219,using,0,0
127220,the,0,0
127221,MRC,0,0
127222,'s,0,0
127223,framework,0,0
127224,for,0,0
127225,complex,0,0
127226,interventions,0,0
127227,(,0,0
127228,PreClinical,0,0
127229,",",0,0
127230,Phase,0,0
127231,I,0,0
127232,and,0,0
127233,Phase,0,0
127234,II,0,0
127235,completed,0,1
127236,),0,0
127237,.,0,0
127238,This,0,0
127239,paper,0,0
127240,presents,0,0
127241,the,0,0
127242,protocol,0,0
127243,for,0,0
127244,Phase,0,1
127245,III,0,1
127246,.,0,0
127247,METHODS/DESIGN,0,0
127248,Phase,0,0
127249,III,0,0
127250,comprises,0,0
127251,a,0,0
127252,pragmatic,0,0
127253,",",0,0
127254,fast-track,0,0
127255,",",0,0
127256,single-blind,0,0
127257,randomised,0,0
127258,controlled,0,0
127259,trial,0,0
127260,of,0,0
127261,BIS,0,0
127262,versus,0,0
127263,standard,0,0
127264,care,0,0
127265,.,0,0
127266,Due,0,0
127267,to,0,0
127268,differing,0,0
127269,disease,0,1
127270,trajectories,0,0
127271,",",0,0
127272,the,0,0
127273,service,0,0
127274,uses,0,0
127275,two,0,0
127276,broad,0,0
127277,service,0,1
127278,models,0,0
127279,:,0,1
127280,one,0,1
127281,for,0,0
127282,patients,1,1
127283,with,1,1
127284,malignant,1,1
127285,disease,1,1
127286,(,1,0
127287,intervention,1,0
127288,delivered,1,0
127289,over,1,0
127290,two,1,0
127291,weeks,1,0
127292,),1,0
127293,and,1,0
127294,one,1,0
127295,for,1,0
127296,patients,1,1
127297,with,1,1
127298,non-malignant,1,1
127299,disease,1,1
127300,(,1,0
127301,intervention,1,0
127302,delivered,1,0
127303,over,1,0
127304,four,1,0
127305,weeks,1,0
127306,),1,0
127307,.,1,0
127308,The,0,0
127309,Phase,0,0
127310,III,0,0
127311,trial,0,0
127312,therefore,0,0
127313,consists,0,0
127314,of,0,0
127315,two,0,0
127316,sub-protocols,0,0
127317,:,0,1
127318,one,0,1
127319,for,0,0
127320,patients,1,1
127321,with,1,1
127322,malignant,1,1
127323,conditions,1,0
127324,(,1,0
127325,four,1,0
127326,week,1,0
127327,protocol,1,0
127328,),1,0
127329,and,1,0
127330,one,1,0
127331,for,1,0
127332,patients,1,1
127333,with,1,1
127334,non-malignant,1,1
127335,conditions,1,0
127336,(,0,0
127337,eight,0,1
127338,week,0,0
127339,protocol,0,0
127340,),0,0
127341,.,0,0
127342,Mixed,0,0
127343,method,0,0
127344,interviews,0,0
127345,are,0,0
127346,conducted,0,0
127347,with,0,1
127348,patients,0,1
127349,and,0,0
127350,their,0,0
127351,lay,0,0
127352,carers,0,1
127353,at,0,0
127354,three,0,0
127355,to,0,0
127356,five,0,1
127357,measurement,0,0
127358,points,0,0
127359,depending,0,0
127360,on,0,0
127361,randomisation,0,0
127362,and,0,0
127363,sub-protocol,0,0
127364,.,0,0
127365,Qualitative,0,0
127366,interviews,0,0
127367,are,0,0
127368,conducted,0,0
127369,with,0,0
127370,referring,0,0
127371,and,0,0
127372,non-referring,0,1
127373,health,0,0
127374,care,0,0
127375,professionals,0,1
127376,(,0,0
127377,malignant,0,1
127378,disease,0,1
127379,protocol,0,0
127380,only,0,0
127381,),0,0
127382,.,0,0
127383,The,0,0
127384,primary,0,0
127385,outcome,0,0
127386,measure,0,0
127387,is,0,0
127388,'patient,0,0
127389,distress,0,0
127390,due,0,0
127391,to,0,0
127392,breathlessness,0,0
127393,',0,0
127394,measured,0,0
127395,on,0,0
127396,a,0,0
127397,numerical,0,0
127398,rating,0,0
127399,scale,0,0
127400,(,0,0
127401,0-10,0,0
127402,),0,0
127403,.,0,0
127404,The,0,0
127405,trial,0,0
127406,includes,0,0
127407,economic,0,0
127408,evaluation,0,0
127409,.,0,0
127410,Analysis,0,0
127411,will,0,0
127412,be,0,0
127413,on,0,0
127414,an,0,0
127415,intention,0,0
127416,to,0,0
127417,treat,0,0
127418,basis,0,0
127419,.,0,0
127420,DISCUSSION,0,0
127421,This,0,0
127422,is,0,0
127423,the,0,0
127424,first,0,0
127425,evaluation,0,0
127426,of,0,0
127427,a,0,0
127428,breathlessness,0,0
127429,intervention,0,0
127430,for,0,0
127431,advanced,0,1
127432,disease,0,1
127433,to,0,0
127434,have,0,0
127435,followed,0,0
127436,the,0,0
127437,MRC,0,0
127438,framework,0,0
127439,and,0,0
127440,one,0,0
127441,of,0,0
127442,the,0,0
127443,first,0,0
127444,palliative,0,1
127445,care,0,1
127446,trials,0,0
127447,to,0,0
127448,use,0,0
127449,fast,0,0
127450,track,0,0
127451,methodology,0,0
127452,and,0,0
127453,single-blinding,0,0
127454,.,0,0
127455,The,0,0
127456,results,0,0
127457,will,0,0
127458,provide,0,0
127459,evidence,0,0
127460,of,0,0
127461,the,0,0
127462,clinical,0,0
127463,and,0,0
127464,cost-effectiveness,0,0
127465,of,0,0
127466,the,0,0
127467,service,0,0
127468,",",0,0
127469,informing,0,0
127470,its,0,0
127471,longer,0,0
127472,term,0,0
127473,development,0,0
127474,and,0,0
127475,implementation,0,0
127476,of,0,0
127477,the,0,0
127478,model,0,0
127479,in,0,0
127480,other,0,0
127481,centres,0,1
127482,nationally,0,1
127483,and,0,0
127484,internationally,0,0
127485,.,0,0
127486,It,0,0
127487,adds,0,0
127488,to,0,0
127489,methodological,0,0
127490,developments,0,0
127491,in,0,0
127492,palliative,0,1
127493,care,0,0
127494,research,0,0
127495,where,0,0
127496,complex,0,0
127497,interventions,0,0
127498,are,0,0
127499,common,0,0
127500,but,0,0
127501,evidence,0,0
127502,sparse,0,0
127503,.,0,0
127504,TRIAL,0,0
127505,REGISTRATION,0,0
127506,ClinicalTrials.gov,0,0
127507,:,0,1
127508,NCT00678405ISRCTN,0,0
127509,:,0,1
127510,ISRCTN04119516,0,0
127511,.,0,0
127512,Do,0,0
127513,sheltered,0,1
127514,workshops,0,0
127515,enhance,0,0
127516,employment,0,1
127517,outcomes,0,0
127518,for,0,0
127519,adults,1,1
127520,with,1,1
127521,autism,1,1
127522,spectrum,1,1
127523,disorder,1,1
127524,?,0,0
127525,This,0,0
127526,study,0,0
127527,investigated,0,0
127528,whether,0,0
127529,sheltered,0,1
127530,workshops,0,0
127531,help,0,0
127532,prepare,0,0
127533,individuals,1,1
127534,with,1,1
127535,autism,1,1
127536,spectrum,1,1
127537,disorder,1,1
127538,(,1,0
127539,ASD,1,1
127540,),1,0
127541,for,0,0
127542,competitive,0,0
127543,employment,0,1
127544,within,0,0
127545,the,0,0
127546,community,0,1
127547,.,0,0
127548,Two,0,0
127549,groups,0,0
127550,of,0,0
127551,individuals,0,1
127552,were,0,1
127553,compared,0,0
127554,:,0,1
127555,(,1,0
127556,a,1,0
127557,),1,0
127558,215,1,1
127559,supported,1,0
127560,employees,1,1
127561,who,1,1
127562,were,1,1
127563,in,1,1
127564,sheltered,1,1
127565,workshops,1,0
127566,prior,1,0
127567,to,1,0
127568,entering,1,1
127569,supported,1,0
127570,employment,1,1
127571,and,1,0
127572,(,1,0
127573,b,1,0
127574,),1,0
127575,215,1,1
127576,supported,1,0
127577,employees,1,1
127578,who,1,1
127579,were,1,1
127580,not,1,1
127581,in,1,0
127582,sheltered,1,1
127583,workshops,1,0
127584,.,1,1
127585,Individuals,0,1
127586,from,0,0
127587,both,0,0
127588,groups,0,0
127589,were,0,0
127590,matched,0,1
127591,based,0,0
127592,on,0,0
127593,their,0,0
127594,primary,0,0
127595,diagnosis,0,1
127596,",",0,0
127597,secondary,0,0
127598,diagnosis,0,1
127599,(,0,0
127600,if,0,0
127601,present,0,0
127602,),0,0
127603,",",0,0
127604,and,0,0
127605,gender,0,0
127606,.,0,0
127607,Results,0,0
127608,showed,0,0
127609,that,0,0
127610,there,0,0
127611,were,0,0
127612,no,0,0
127613,differences,0,0
127614,in,0,0
127615,rates,0,0
127616,of,0,0
127617,employment,0,1
127618,between,0,0
127619,these,0,0
127620,two,0,0
127621,groups,0,0
127622,.,0,0
127623,However,0,0
127624,",",0,0
127625,individuals,0,1
127626,who,0,1
127627,participated,0,1
127628,in,0,1
127629,sheltered,0,1
127630,workshops,0,0
127631,earned,0,0
127632,significantly,0,0
127633,less,0,0
127634,(,0,0
127635,US,0,0
127636,$,0,0
127637,129.36,0,0
127638,versus,0,0
127639,US,0,0
127640,$,0,0
127641,191.42,0,0
127642,per,0,0
127643,week,0,0
127644,),0,0
127645,",",0,0
127646,and,0,0
127647,cost,0,0
127648,significantly,0,0
127649,more,0,0
127650,to,0,0
127651,serve,0,0
127652,(,0,0
127653,US,0,0
127654,$,0,0
127655,"6,065.08",0,0
127656,versus,0,0
127657,US,0,0
127658,$,0,0
127659,"2,440.60",0,0
127660,),0,0
127661,",",0,0
127662,than,0,0
127663,their,0,0
127664,non-sheltered,0,1
127665,workshop,0,1
127666,peers,0,1
127667,.,0,1
127668,Results,0,0
127669,presented,0,0
127670,here,0,0
127671,suggest,0,0
127672,that,0,0
127673,individuals,1,1
127674,with,1,1
127675,ASD,1,1
127676,achieve,0,0
127677,better,0,0
127678,vocational,0,0
127679,outcomes,0,0
127680,if,0,0
127681,they,0,0
127682,do,0,0
127683,not,0,0
127684,participate,0,0
127685,in,0,0
127686,sheltered,0,1
127687,workshops,0,0
127688,prior,0,0
127689,to,0,0
127690,enrolling,0,0
127691,in,0,0
127692,supported,0,0
127693,employment,0,1
127694,.,0,0
127695,A,0,0
127696,prospective,0,0
127697,double-blind,0,0
127698,",",0,0
127699,randomized,0,0
127700,clinical,0,0
127701,trial,0,0
127702,of,0,0
127703,levocarnitine,0,0
127704,to,0,0
127705,treat,0,0
127706,autism,1,1
127707,spectrum,1,1
127708,disorders,1,1
127709,.,1,1
127710,BACKGROUND,0,0
127711,L-carnitine,0,0
127712,was,0,0
127713,proposed,0,0
127714,as,0,0
127715,a,0,0
127716,potential,0,0
127717,treatment,0,0
127718,for,0,0
127719,patients,1,1
127720,diagnosed,1,1
127721,with,1,1
127722,an,1,0
127723,autism,1,1
127724,spectrum,1,1
127725,disorder,1,1
127726,to,0,0
127727,improve,0,0
127728,mitochondrial,0,0
127729,dysfunction,0,0
127730,",",0,0
127731,but,0,0
127732,no,0,0
127733,prior,0,0
127734,randomized,0,0
127735,controlled,0,0
127736,trials,0,0
127737,have,0,0
127738,been,0,0
127739,conducted,0,0
127740,.,0,0
127741,MATERIAL/METHODS,0,0
127742,Thirty,1,1
127743,subjects,1,1
127744,diagnosed,1,1
127745,with,1,1
127746,an,1,0
127747,ASD,1,1
127748,were,0,0
127749,randomly,0,0
127750,assigned,0,0
127751,to,0,0
127752,receive,0,0
127753,a,0,0
127754,standardized,0,0
127755,regimen,0,0
127756,(,0,0
127757,50,0,0
127758,mg,0,0
127759,L-carnitine/kg,0,0
127760,bodyweight/day,0,0
127761,),0,0
127762,of,0,0
127763,liquid,0,0
127764,L-carnitine,0,0
127765,(,0,0
127766,n=19,0,1
127767,),0,0
127768,or,0,0
127769,placebo,0,0
127770,(,0,0
127771,n=11,0,1
127772,),0,0
127773,for,0,0
127774,3-months,0,0
127775,.,0,1
127776,Measures,0,0
127777,included,0,1
127778,changes,0,0
127779,in,0,0
127780,professionally,0,1
127781,completed,0,1
127782,Childhood,0,1
127783,Autism,0,1
127784,Rating,0,0
127785,Scale,0,0
127786,(,0,0
127787,CARS,0,0
127788,),0,0
127789,",",0,0
127790,hand,0,0
127791,muscle,0,0
127792,testing,0,0
127793,",",0,0
127794,and,0,0
127795,modified,0,0
127796,clinical,0,0
127797,global,0,0
127798,impression,0,0
127799,(,0,0
127800,CGI,0,0
127801,),0,0
127802,forms,0,0
127803,;,0,0
127804,parent,0,0
127805,completed,0,1
127806,Autism,0,1
127807,Treatment,0,0
127808,Evaluation,0,0
127809,Checklist,0,0
127810,(,0,0
127811,ATEC,0,0
127812,),0,0
127813,",",0,0
127814,treatment,0,0
127815,adherence,0,0
127816,measurement,0,0
127817,(,0,0
127818,TAM,0,0
127819,),0,0
127820,",",0,0
127821,frequency,0,0
127822,and,0,0
127823,intensity,0,0
127824,of,0,0
127825,side,0,0
127826,effect,0,0
127827,rating,0,0
127828,(,0,0
127829,FISER,0,0
127830,),0,0
127831,/global,0,0
127832,rating,0,0
127833,of,0,0
127834,side,0,0
127835,effect,0,0
127836,burden,0,0
127837,(,0,0
127838,GRSEB,0,0
127839,),0,0
127840,/patient,0,0
127841,report,0,0
127842,of,0,0
127843,incidence,0,0
127844,of,0,0
127845,side,0,0
127846,effects,0,0
127847,(,0,0
127848,PRISE,0,1
127849,),0,1
127850,forms,0,0
127851,;,0,0
127852,and,0,0
127853,lab,0,0
127854,testing,0,0
127855,.,0,0
127856,RESULTS,0,0
127857,Significant,0,0
127858,improvements,0,0
127859,were,0,0
127860,observed,0,0
127861,in,0,0
127862,CARS,0,0
127863,(,0,0
127864,-2.03,0,0
127865,",",0,0
127866,95,0,0
127867,%,0,0
127868,CI=-3.7,0,0
127869,to,0,0
127870,-0.31,0,0
127871,),0,0
127872,",",0,0
127873,CGI,0,0
127874,(,0,0
127875,-0.69,0,0
127876,",",0,0
127877,95,0,0
127878,%,0,0
127879,CI=-1.1,0,0
127880,to,0,0
127881,-0.06,0,0
127882,),0,0
127883,",",0,0
127884,and,0,0
127885,ATEC,0,0
127886,scores,0,0
127887,.,0,1
127888,Significant,0,0
127889,correlations,0,0
127890,between,0,0
127891,changes,0,0
127892,in,0,0
127893,serum,0,0
127894,free-carnitine,0,0
127895,levels,0,0
127896,and,0,0
127897,positive,0,1
127898,clinical,0,0
127899,changes,0,0
127900,were,0,0
127901,observed,0,0
127902,for,0,0
127903,hand,0,0
127904,muscle,0,0
127905,strength,0,0
127906,(,0,0
127907,R2=0.23,0,0
127908,",",0,0
127909,P=0.046,0,0
127910,),0,0
127911,",",0,0
127912,cognitive,0,0
127913,scores,0,0
127914,(,0,0
127915,R2=0.27,0,0
127916,",",0,0
127917,P=0.019,0,0
127918,),0,0
127919,",",0,0
127920,and,0,0
127921,CARS,0,0
127922,scores,0,0
127923,(,0,0
127924,R2=0.20,0,0
127925,",",0,0
127926,P=0.047,0,0
127927,),0,0
127928,.,0,0
127929,Study,0,0
127930,subjects,0,1
127931,were,0,0
127932,protocol-compliant,0,0
127933,(,0,0
127934,average,0,0
127935,adherence,0,0
127936,was,0,0
127937,>,0,0
127938,85,0,1
127939,%,0,0
127940,),0,0
127941,and,0,0
127942,generally,0,0
127943,well-tolerated,0,0
127944,the,0,0
127945,L-carnitine,0,0
127946,therapy,0,0
127947,given,0,0
127948,.,0,0
127949,CONCLUSIONS,0,0
127950,L-carnitine,0,0
127951,therapy,0,0
127952,(,0,0
127953,50,0,0
127954,mg/kilogram-bodyweight/day,0,0
127955,),0,0
127956,administered,0,0
127957,for,0,0
127958,3-months,0,0
127959,significantly,0,0
127960,improved,0,0
127961,several,0,0
127962,clinical,0,0
127963,measurements,0,0
127964,of,0,0
127965,ASD,0,1
127966,severity,0,0
127967,",",0,0
127968,but,0,0
127969,subsequent,0,0
127970,studies,0,0
127971,are,0,0
127972,recommended,0,0
127973,.,0,0
127974,[,1,0
127975,Diabetic,1,1
127976,retinopathy,1,0
127977,candesartan,0,0
127978,trial,0,0
127979,],0,0
127980,.,0,0
127981,The,0,0
127982,benefits,0,0
127983,of,0,0
127984,including,0,0
127985,clinical,0,0
127986,factors,0,0
127987,in,0,0
127988,rectal,0,1
127989,normal,0,1
127990,tissue,0,0
127991,complication,0,0
127992,probability,0,0
127993,modeling,0,0
127994,after,1,0
127995,radiotherapy,1,0
127996,for,1,0
127997,prostate,1,1
127998,cancer,1,1
127999,.,1,0
128000,PURPOSE,0,0
128001,To,0,0
128002,study,0,0
128003,the,0,0
128004,impact,0,0
128005,of,0,0
128006,clinical,0,0
128007,predisposing,0,0
128008,factors,0,0
128009,on,0,0
128010,rectal,0,1
128011,normal,0,1
128012,tissue,0,0
128013,complication,0,0
128014,probability,0,0
128015,modeling,0,0
128016,using,0,0
128017,the,0,0
128018,updated,0,0
128019,results,0,0
128020,of,0,0
128021,the,0,0
128022,Dutch,0,0
128023,prostate,0,1
128024,dose-escalation,0,0
128025,trial,0,0
128026,.,0,0
128027,METHODS,0,0
128028,AND,0,0
128029,MATERIALS,0,0
128030,Toxicity,0,0
128031,data,0,0
128032,of,0,0
128033,512,1,1
128034,patients,1,1
128035,(,1,0
128036,conformally,1,0
128037,treated,1,0
128038,to,1,0
128039,68,1,1
128040,Gy,1,0
128041,[,1,0
128042,n,1,1
128043,=,1,0
128044,284,1,1
128045,],1,0
128046,and,1,0
128047,78,1,1
128048,Gy,1,0
128049,[,1,0
128050,n,1,1
128051,=,1,0
128052,228,1,1
128053,],1,0
128054,),1,0
128055,with,1,0
128056,complete,1,0
128057,follow-up,1,0
128058,at,1,0
128059,3,1,0
128060,years,1,1
128061,after,1,0
128062,radiotherapy,1,1
128063,were,1,0
128064,studied,1,1
128065,.,1,0
128066,Scored,0,0
128067,end,0,0
128068,points,0,0
128069,were,0,0
128070,rectal,0,1
128071,bleeding,0,0
128072,",",0,0
128073,high,0,0
128074,stool,0,0
128075,frequency,0,0
128076,",",0,0
128077,and,0,0
128078,fecal,0,0
128079,incontinence,0,0
128080,.,0,0
128081,Two,0,0
128082,traditional,0,0
128083,dose-based,0,0
128084,models,0,0
128085,(,0,0
128086,Lyman-Kutcher-Burman,0,0
128087,(,0,0
128088,LKB,0,1
128089,),0,0
128090,and,0,0
128091,Relative,0,0
128092,Seriality,0,0
128093,(,0,0
128094,RS,0,0
128095,),0,0
128096,and,0,0
128097,a,0,0
128098,logistic,0,0
128099,model,0,0
128100,were,0,0
128101,fitted,0,0
128102,using,0,0
128103,a,0,0
128104,maximum,0,0
128105,likelihood,0,0
128106,approach,0,0
128107,.,0,0
128108,Furthermore,0,0
128109,",",0,0
128110,these,0,0
128111,model,0,0
128112,fits,0,0
128113,were,0,0
128114,improved,0,0
128115,by,0,0
128116,including,0,0
128117,the,0,0
128118,most,0,0
128119,significant,0,0
128120,clinical,0,0
128121,factors,0,0
128122,.,0,0
128123,The,0,0
128124,area,0,0
128125,under,0,0
128126,the,0,0
128127,receiver,0,0
128128,operating,0,0
128129,characteristic,0,0
128130,curve,0,0
128131,(,0,0
128132,AUC,0,0
128133,),0,0
128134,was,0,0
128135,used,0,0
128136,to,0,0
128137,compare,0,0
128138,the,0,0
128139,discriminating,0,0
128140,ability,0,0
128141,of,0,0
128142,all,0,0
128143,fits,0,0
128144,.,0,0
128145,RESULTS,0,0
128146,Including,0,0
128147,clinical,0,0
128148,factors,0,0
128149,significantly,0,0
128150,increased,0,0
128151,the,0,0
128152,predictive,0,0
128153,power,0,0
128154,of,0,0
128155,the,0,0
128156,models,0,0
128157,for,0,0
128158,all,0,0
128159,end,0,0
128160,points,0,0
128161,.,0,0
128162,In,0,0
128163,the,0,0
128164,optimal,0,0
128165,LKB,0,0
128166,",",0,0
128167,RS,0,0
128168,",",0,0
128169,and,0,0
128170,logistic,0,0
128171,models,0,0
128172,for,0,0
128173,rectal,0,1
128174,bleeding,0,0
128175,and,0,0
128176,fecal,0,0
128177,incontinence,0,0
128178,",",0,0
128179,the,0,0
128180,first,0,0
128181,significant,0,0
128182,(,0,0
128183,p,0,0
128184,=,0,0
128185,0.011-0.013,0,0
128186,),0,0
128187,clinical,0,0
128188,factor,0,0
128189,was,0,0
128190,previous,0,0
128191,abdominal,0,1
128192,surgery,0,1
128193,.,0,0
128194,As,0,0
128195,second,0,0
128196,significant,0,0
128197,(,0,0
128198,p,0,0
128199,=,0,0
128200,0.012-0.016,0,0
128201,),0,0
128202,factor,0,0
128203,",",0,0
128204,cardiac,0,0
128205,history,0,1
128206,was,0,0
128207,included,0,0
128208,in,0,0
128209,all,0,0
128210,three,0,0
128211,rectal,0,1
128212,bleeding,0,0
128213,fits,0,0
128214,",",0,0
128215,whereas,0,0
128216,including,0,0
128217,diabetes,0,1
128218,was,0,0
128219,significant,0,0
128220,(,0,0
128221,p,0,0
128222,=,0,0
128223,0.039-0.048,0,0
128224,),0,0
128225,in,0,0
128226,fecal,0,0
128227,incontinence,0,0
128228,modeling,0,0
128229,but,0,0
128230,only,0,0
128231,in,0,0
128232,the,0,0
128233,LKB,0,0
128234,and,0,0
128235,logistic,0,0
128236,models,0,0
128237,.,0,1
128238,High,0,0
128239,stool,0,0
128240,frequency,0,0
128241,fits,0,0
128242,only,0,0
128243,benefitted,0,0
128244,significantly,0,0
128245,(,0,0
128246,p,0,0
128247,=,0,0
128248,0.003-0.006,0,0
128249,),0,0
128250,from,0,0
128251,the,0,0
128252,inclusion,0,0
128253,of,0,0
128254,the,0,0
128255,baseline,0,0
128256,toxicity,0,0
128257,score,0,0
128258,.,0,0
128259,For,0,0
128260,all,0,0
128261,models,0,0
128262,rectal,0,1
128263,bleeding,0,0
128264,fits,0,0
128265,had,0,0
128266,the,0,0
128267,highest,0,0
128268,AUC,0,0
128269,(,0,0
128270,0.77,0,0
128271,),0,0
128272,where,0,0
128273,it,0,0
128274,was,0,0
128275,0.63,0,0
128276,and,0,0
128277,0.68,0,0
128278,for,0,0
128279,high,0,0
128280,stool,0,0
128281,frequency,0,0
128282,and,0,0
128283,fecal,0,0
128284,incontinence,0,0
128285,",",0,0
128286,respectively,0,0
128287,.,0,0
128288,LKB,0,0
128289,and,0,0
128290,logistic,0,0
128291,model,0,0
128292,fits,0,0
128293,resulted,0,0
128294,in,0,0
128295,similar,0,0
128296,values,0,0
128297,for,0,0
128298,the,0,0
128299,volume,0,0
128300,parameter,0,0
128301,.,0,0
128302,The,0,0
128303,steepness,0,0
128304,parameter,0,0
128305,was,0,0
128306,somewhat,0,0
128307,higher,0,0
128308,in,0,0
128309,the,0,0
128310,logistic,0,0
128311,model,0,0
128312,",",0,0
128313,also,0,0
128314,resulting,0,0
128315,in,0,0
128316,a,0,0
128317,slightly,0,0
128318,lower,0,0
128319,D,0,0
128320,(,0,0
128321,50,0,1
128322,),0,0
128323,.,0,0
128324,Anal,0,0
128325,wall,0,0
128326,DVHs,0,1
128327,were,0,0
128328,used,0,0
128329,for,0,0
128330,fecal,0,0
128331,incontinence,0,0
128332,",",0,0
128333,whereas,0,0
128334,anorectal,0,0
128335,wall,0,0
128336,dose,0,0
128337,best,0,0
128338,described,0,0
128339,the,0,0
128340,other,0,0
128341,two,0,0
128342,endpoints,0,0
128343,.,0,1
128344,CONCLUSIONS,0,0
128345,Comparable,0,0
128346,prediction,0,0
128347,models,0,0
128348,were,0,0
128349,obtained,0,0
128350,with,0,0
128351,LKB,0,0
128352,",",0,0
128353,RS,0,0
128354,",",0,0
128355,and,0,0
128356,logistic,0,0
128357,NTCP,0,0
128358,models,0,0
128359,.,0,0
128360,Including,0,0
128361,clinical,0,0
128362,factors,0,0
128363,improved,0,0
128364,the,0,0
128365,predictive,0,0
128366,power,0,0
128367,of,0,0
128368,all,0,0
128369,models,0,0
128370,significantly,0,0
128371,.,0,0
128372,Design,0,0
128373,and,0,0
128374,subject,0,0
128375,characteristics,0,0
128376,in,0,0
128377,the,0,0
128378,federally-funded,0,1
128379,citalopram,0,0
128380,trial,0,0
128381,in,0,0
128382,children,1,1
128383,with,1,1
128384,pervasive,1,1
128385,developmental,1,1
128386,disorders,1,1
128387,.,1,1
128388,The,0,0
128389,Studies,0,0
128390,to,0,1
128391,Advance,0,1
128392,Autism,0,1
128393,Research,0,0
128394,and,0,0
128395,Treatment,0,0
128396,Network,0,0
128397,conducted,0,0
128398,a,0,0
128399,randomized,0,0
128400,trial,0,0
128401,with,0,1
128402,citalopram,0,0
128403,in,0,0
128404,children,1,1
128405,with,1,1
128406,Pervasive,1,1
128407,developmental,1,1
128408,disorders,1,1
128409,(,1,0
128410,PDDs,1,1
128411,),1,0
128412,.,1,0
128413,We,0,0
128414,present,0,0
128415,the,0,0
128416,rationale,0,0
128417,",",0,0
128418,design,0,0
128419,and,0,0
128420,sample,0,1
128421,characteristics,0,0
128422,of,0,0
128423,the,0,0
128424,citalopram,0,0
128425,trial,0,0
128426,.,0,0
128427,Subjects,1,0
128428,(,1,0
128429,128,1,1
128430,boys,1,1
128431,",",1,0
128432,21,1,1
128433,girls,1,1
128434,),1,0
128435,had,1,0
128436,a,1,0
128437,mean,1,0
128438,age,1,1
128439,of,1,0
128440,9.3,1,0
128441,(,1,0
128442,?3.12,1,0
128443,),1,0
128444,years,1,1
128445,;,1,0
128446,132,1,1
128447,(,1,0
128448,88.6,1,0
128449,%,1,0
128450,),1,0
128451,were,1,0
128452,diagnosed,1,1
128453,with,1,1
128454,autistic,1,1
128455,disorder,1,1
128456,(,1,0
128457,4.7,1,0
128458,%,1,0
128459,with,1,1
128460,Asperger,1,1
128461,'s,1,1
128462,Disorder,1,1
128463,;,1,0
128464,6.7,1,0
128465,%,1,0
128466,with,1,1
128467,PDD-not,1,0
128468,otherwise,1,1
128469,specified,1,0
128470,),1,0
128471,.,1,0
128472,Less,1,0
128473,than,1,0
128474,half,1,0
128475,of,1,0
128476,the,1,0
128477,subjects,1,1
128478,were,1,0
128479,intellectually,1,1
128480,disabled,1,1
128481,;,1,0
128482,117,1,1
128483,(,1,0
128484,78.5,1,0
128485,%,1,0
128486,),1,0
128487,were,1,0
128488,rated,1,0
128489,Moderate,1,0
128490,or,1,0
128491,Marked,1,0
128492,on,1,0
128493,the,1,0
128494,Clinical,1,0
128495,Global,1,0
128496,Impression,1,0
128497,for,1,0
128498,Severity,1,0
128499,.,1,1
128500,Study,0,0
128501,measures,0,0
128502,were,0,0
128503,similar,0,0
128504,to,0,0
128505,previous,0,0
128506,Research,0,0
128507,Units,0,0
128508,on,0,0
128509,Pediatric,0,1
128510,Psychopharmacology,0,1
128511,trials,0,0
128512,.,0,1
128513,Subjects,1,1
128514,in,1,0
128515,this,1,0
128516,trial,1,0
128517,were,1,0
128518,slightly,1,0
128519,older,1,1
128520,and,1,0
128521,more,1,0
128522,likely,1,0
128523,to,1,0
128524,have,1,0
128525,complaints,1,0
128526,of,1,0
128527,repetitive,1,0
128528,behavior,1,0
128529,than,0,0
128530,participants,0,1
128531,in,0,0
128532,RUPP,0,1
128533,trials,0,0
128534,.,0,1
128535,A,0,0
128536,pilot,0,0
128537,study,0,0
128538,to,0,0
128539,improve,0,0
128540,venipuncture,0,0
128541,compliance,0,0
128542,in,0,0
128543,children,1,1
128544,and,1,0
128545,adolescents,1,1
128546,with,1,1
128547,autism,1,1
128548,spectrum,1,1
128549,disorders,1,1
128550,.,1,1
128551,OBJECTIVE,0,0
128552,Medical,0,1
128553,procedures,0,0
128554,",",0,0
128555,particularly,0,0
128556,venipuncture,0,0
128557,(,0,0
128558,the,0,0
128559,puncture,0,0
128560,of,0,0
128561,a,0,0
128562,vein,0,0
128563,especially,0,0
128564,for,0,0
128565,the,0,0
128566,withdrawal,0,0
128567,of,0,0
128568,blood,0,0
128569,),0,0
128570,",",0,0
128571,can,0,0
128572,cause,0,0
128573,serious,0,0
128574,distress,0,1
128575,and,0,0
128576,behavior,0,0
128577,disturbance,0,0
128578,for,0,0
128579,many,0,1
128580,children,0,1
128581,.,0,0
128582,Noncompliance,0,0
128583,to,0,0
128584,blood,0,0
128585,draws,0,0
128586,can,0,0
128587,have,0,0
128588,significant,0,0
128589,ramifications,0,0
128590,in,0,0
128591,both,0,0
128592,research,0,0
128593,and,0,0
128594,clinical,0,0
128595,settings,0,0
128596,.,0,0
128597,The,0,0
128598,negative,0,0
128599,reactions,0,0
128600,may,0,0
128601,be,0,0
128602,exacerbated,0,0
128603,in,0,0
128604,individuals,0,1
128605,with,0,1
128606,autism,0,1
128607,spectrum,0,1
128608,disorders,0,1
128609,.,0,0
128610,Even,0,0
128611,so,0,0
128612,",",0,0
128613,there,0,0
128614,has,0,0
128615,been,0,0
128616,little,0,0
128617,research,0,0
128618,into,0,0
128619,the,0,0
128620,prevalence,0,0
128621,of,0,0
128622,the,0,0
128623,problem,0,0
128624,or,0,0
128625,effective,0,0
128626,intervention,0,0
128627,procedures,0,0
128628,.,0,0
128629,In,0,0
128630,response,0,0
128631,to,0,0
128632,these,0,0
128633,concerns,0,0
128634,",",0,0
128635,we,0,0
128636,developed,0,0
128637,and,0,0
128638,evaluated,0,0
128639,the,0,0
128640,Blood,0,0
128641,Draw,0,0
128642,Intervention,0,0
128643,Program,0,0
128644,.,0,0
128645,The,0,0
128646,program,0,0
128647,was,0,0
128648,designed,0,0
128649,to,0,0
128650,be,0,0
128651,easy,0,0
128652,to,0,0
128653,use,0,0
128654,",",0,0
128655,require,0,0
128656,little,0,0
128657,provider,0,0
128658,or,0,0
128659,family,0,0
128660,time,0,0
128661,",",0,0
128662,effectively,0,0
128663,reduce,0,0
128664,negative,0,0
128665,behaviors,0,0
128666,",",0,0
128667,and,0,0
128668,increase,0,0
128669,blood,0,0
128670,draw,0,0
128671,compliance,0,0
128672,.,0,0
128673,METHOD,0,0
128674,In,0,0
128675,a,0,0
128676,quasi-randomized,0,0
128677,trial,0,0
128678,over,0,0
128679,the,0,0
128680,course,0,0
128681,of,0,0
128682,?,0,0
128683,18,0,0
128684,months,1,0
128685,",",1,0
128686,58,1,1
128687,of,1,0
128688,210,1,1
128689,families,1,1
128690,with,1,1
128691,children,1,1
128692,with,1,1
128693,autism,1,1
128694,spectrum,1,1
128695,disorders,1,1
128696,participating,1,1
128697,in,1,0
128698,a,1,0
128699,larger,1,0
128700,study,1,0
128701,of,1,0
128702,phenotypic,1,0
128703,and,1,0
128704,genotypic,1,0
128705,factors,1,0
128706,reported,1,0
128707,significant,1,0
128708,concerns,1,0
128709,about,1,0
128710,blood,1,0
128711,draws,1,0
128712,and,1,0
128713,elected,1,1
128714,to,1,0
128715,use,1,0
128716,the,1,0
128717,Blood,1,0
128718,Draw,1,0
128719,Intervention,1,0
128720,Program,1,0
128721,.,1,0
128722,RESULTS,0,0
128723,Completion,0,0
128724,of,0,0
128725,the,0,0
128726,program,0,0
128727,increased,0,0
128728,blood,0,0
128729,draw,0,0
128730,compliance,0,0
128731,rates,0,0
128732,from,0,0
128733,85.4,0,0
128734,%,0,0
128735,to,0,0
128736,96.6,0,0
128737,%,0,0
128738,(,0,0
128739,odds,0,0
128740,ratio,0,0
128741,=,0,0
128742,4.80,0,0
128743,;,0,0
128744,95,0,0
128745,%,0,0
128746,confidence,0,0
128747,interval,0,0
128748,=,0,0
128749,1.12,0,0
128750,",",0,0
128751,20.59,0,0
128752,;,0,0
128753,p,0,0
128754,=,0,0
128755,.03,0,0
128756,),0,0
128757,.,0,0
128758,CONCLUSION,0,0
128759,Results,0,0
128760,indicate,0,0
128761,the,0,0
128762,efficacy,0,0
128763,of,0,0
128764,the,0,0
128765,program,0,0
128766,in,0,0
128767,a,0,0
128768,research,0,0
128769,setting,0,0
128770,and,0,0
128771,suggest,0,0
128772,a,0,0
128773,potential,0,0
128774,clinical,0,0
128775,application,0,0
128776,.,0,0
128777,The,0,0
128778,current,0,0
128779,intervention,0,0
128780,",",0,0
128781,unlike,0,0
128782,many,0,0
128783,others,0,0
128784,for,0,0
128785,the,0,0
128786,same,0,0
128787,or,0,0
128788,similar,0,0
128789,difficulties,0,0
128790,proposed,0,0
128791,in,0,0
128792,the,0,0
128793,past,0,0
128794,",",0,0
128795,was,0,0
128796,successful,0,0
128797,without,0,1
128798,requiring,0,1
128799,extensive,0,0
128800,time,0,0
128801,",",0,0
128802,training,0,0
128803,",",0,0
128804,or,0,0
128805,effort,0,0
128806,on,0,0
128807,the,0,0
128808,part,0,0
128809,of,0,0
128810,providers,0,0
128811,and,0,0
128812,parents,0,1
128813,or,0,1
128814,their,0,0
128815,children,0,1
128816,",",0,0
128817,nor,0,0
128818,did,0,0
128819,it,0,0
128820,require,0,0
128821,large-scale,0,0
128822,institutional,0,1
128823,changes,0,0
128824,.,0,1
128825,Validity,0,0
128826,and,0,0
128827,reliability,0,0
128828,assessment,0,0
128829,of,0,0
128830,the,0,0
128831,Siriraj,1,1
128832,Asthma,1,1
128833,Control,1,1
128834,Questionnaire,0,0
128835,.,0,0
128836,OBJECTIVE,0,0
128837,The,0,0
128838,present,0,0
128839,study,0,0
128840,assessed,0,0
128841,the,0,0
128842,validity,0,0
128843,and,0,0
128844,reliability,0,0
128845,of,0,0
128846,the,0,0
128847,Siriraj,0,1
128848,Asthma,0,1
128849,Control,0,0
128850,Questionnaire,0,0
128851,in,0,0
128852,Asthma,0,1
128853,Clinic,0,0
128854,",",0,0
128855,Siriraj,1,1
128856,Hospital,1,1
128857,.,1,0
128858,MATERIAL,0,0
128859,AND,0,0
128860,METHOD,0,0
128861,The,0,0
128862,data,0,0
128863,of,0,0
128864,the,0,0
128865,questionnaire,0,0
128866,responses,0,0
128867,and,0,0
128868,spirometric,0,0
128869,results,0,0
128870,from,0,1
128871,20,1,1
128872,randomized,1,1
128873,asthmatic,1,1
128874,patients,1,1
128875,in,1,0
128876,the,1,0
128877,clinic,1,0
128878,including,1,0
128879,the,1,0
128880,record,1,0
128881,of,1,0
128882,3,1,0
128883,visits,1,0
128884,for,1,0
128885,each,1,0
128886,subject,1,0
128887,.,1,0
128888,The,0,0
128889,validation,0,0
128890,was,0,0
128891,performed,0,0
128892,by,0,0
128893,Kruskal-Wallis,0,0
128894,test,0,0
128895,comparing,0,0
128896,the,0,0
128897,scores,0,0
128898,with,0,0
128899,the,0,0
128900,level,0,0
128901,of,0,0
128902,asthma,0,1
128903,control,0,0
128904,determined,0,0
128905,by,0,0
128906,physicians,0,1
128907,according,0,1
128908,to,0,0
128909,GINA,0,1
128910,guideline,0,0
128911,.,0,0
128912,Internal,0,0
128913,consistency,0,0
128914,reliability,0,0
128915,was,0,0
128916,analyzed,0,0
128917,by,0,0
128918,Cronbach,0,0
128919,'s,0,1
128920,alpha,0,0
128921,.,0,1
128922,RESULTS,0,0
128923,Sixty,0,1
128924,questionnaires,0,0
128925,from,0,0
128926,20,1,0
128927,patients,1,1
128928,with,1,1
128929,age,1,1
128930,29-73,1,1
128931,years,1,1
128932,were,0,0
128933,analyzed,0,0
128934,.,0,0
128935,There,0,0
128936,were,0,0
128937,40,0,0
128938,controlled,0,0
128939,",",0,0
128940,7,0,0
128941,partly,0,0
128942,controlled,0,0
128943,and,0,0
128944,13,0,0
128945,uncontrolled,0,1
128946,visits,0,0
128947,.,0,1
128948,The,0,0
128949,scores,0,0
128950,from,0,0
128951,5-items,0,0
128952,questionnaires,0,0
128953,and,0,0
128954,6-items,0,0
128955,clinical,0,0
128956,score,0,0
128957,were,0,0
128958,significantly,0,0
128959,associated,0,0
128960,with,0,0
128961,the,0,0
128962,physician-diagnosed,0,1
128963,groups,0,0
128964,(,0,0
128965,i.e.,0,0
128966,",",0,0
128967,controlled,0,0
128968,",",0,0
128969,partly,0,0
128970,controlled,0,0
128971,and,0,0
128972,uncontrolled,0,1
128973,groups,0,0
128974,),0,1
128975,.,0,1
128976,Median,0,0
128977,scores,0,0
128978,(,0,0
128979,min,0,0
128980,",",0,0
128981,max,0,0
128982,),0,0
128983,were,0,0
128984,0,0,0
128985,(,0,0
128986,0,0,0
128987,",",0,0
128988,5,0,0
128989,),0,0
128990,",",0,0
128991,2,0,0
128992,(,0,0
128993,0,0,0
128994,",",0,0
128995,6,0,0
128996,),0,0
128997,",",0,0
128998,4,0,0
128999,(,0,0
129000,0,0,0
129001,",",0,0
129002,12,0,0
129003,),0,0
129004,respectively,0,0
129005,",",0,0
129006,(,0,0
129007,5-items,0,0
129008,",",0,0
129009,p,0,0
129010,<,0,0
129011,0.001,0,0
129012,),0,0
129013,and,0,0
129014,2,0,0
129015,(,0,0
129016,0,0,0
129017,",",0,0
129018,7,0,0
129019,),0,0
129020,",",0,0
129021,3,0,0
129022,(,0,0
129023,1,0,0
129024,",",0,0
129025,7,0,0
129026,),0,0
129027,",",0,0
129028,6,0,0
129029,(,0,0
129030,"2,15",0,0
129031,),0,0
129032,respectively,0,0
129033,",",0,0
129034,(,0,0
129035,6-items,0,0
129036,",",0,0
129037,p,0,0
129038,<,0,0
129039,0.001,0,0
129040,),0,0
129041,.,0,0
129042,Internal,0,0
129043,consistency,0,0
129044,reliability,0,0
129045,of,0,0
129046,both,0,0
129047,5-items,0,0
129048,questionnaire,0,0
129049,and,0,0
129050,6-items,0,0
129051,clinical,0,0
129052,score,0,0
129053,were,0,0
129054,within,0,0
129055,the,0,0
129056,acceptable,0,0
129057,range,0,0
129058,(,0,0
129059,0.829,0,0
129060,and,0,0
129061,0.708,0,0
129062,respectively,0,0
129063,),0,0
129064,.,0,0
129065,5-items,0,0
129066,questionnaire,0,0
129067,is,0,0
129068,more,0,0
129069,associated,0,0
129070,with,0,0
129071,the,0,0
129072,physician,0,0
129073,diagnosed,0,1
129074,group,0,0
129075,and,0,0
129076,more,0,0
129077,consistent,0,0
129078,than,0,0
129079,6-items,0,0
129080,clinical,0,0
129081,score,0,0
129082,.,0,0
129083,Further,0,0
129084,analysis,0,0
129085,revealed,0,0
129086,cutoff,0,0
129087,point,0,0
129088,at,0,0
129089,2.5,0,0
129090,to,0,0
129091,separate,0,0
129092,uncontrolled,0,0
129093,from,0,0
129094,controlled,0,0
129095,or,0,0
129096,partly,0,0
129097,controlled,0,0
129098,patient,0,0
129099,with,0,1
129100,sensitivity,0,0
129101,76.9,0,0
129102,%,0,0
129103,and,0,0
129104,specificity,0,0
129105,89.4,0,0
129106,%,0,0
129107,and,0,0
129108,cutoff,0,0
129109,point,0,0
129110,at,0,0
129111,1.5,0,0
129112,to,0,0
129113,separate,0,0
129114,uncontrolled,0,0
129115,or,0,0
129116,partly,0,0
129117,controlled,0,0
129118,from,0,0
129119,controlled,0,0
129120,patient,0,0
129121,with,0,1
129122,sensitivity,0,0
129123,70.0,0,0
129124,%,0,0
129125,and,0,0
129126,specificity,0,0
129127,85.0,0,0
129128,%,0,0
129129,.,0,0
129130,CONCLUSION,0,0
129131,The,0,0
129132,validity,0,0
129133,and,0,0
129134,reliability,0,0
129135,of,0,0
129136,Siriraj,0,1
129137,Asthma,0,1
129138,Control,0,0
129139,Questionnaire,0,0
129140,is,0,0
129141,acceptable,0,0
129142,and,0,0
129143,might,0,0
129144,be,0,0
129145,used,0,0
129146,in,0,0
129147,the,0,0
129148,clinical,0,0
129149,practice,0,0
129150,and,0,0
129151,research,0,0
129152,in,0,0
129153,Thai,1,1
129154,asthmatic,1,1
129155,patients,1,1
129156,.,1,1
129157,Behavioral,0,0
129158,effects,0,0
129159,of,0,0
129160,Org,0,1
129161,2766,0,0
129162,",",0,0
129163,a,0,0
129164,synthetic,0,0
129165,analog,0,0
129166,of,0,0
129167,the,0,0
129168,adrenocorticotrophic,0,0
129169,hormone,0,0
129170,(,0,0
129171,4-9,0,0
129172,),0,0
129173,",",0,0
129174,in,0,0
129175,14,1,0
129176,outpatient,1,1
129177,autistic,1,1
129178,children,1,1
129179,.,1,1
129180,Fourteen,1,1
129181,children,1,1
129182,(,1,0
129183,12,1,0
129184,infantile,1,1
129185,autism,1,1
129186,full,1,0
129187,syndrome,1,1
129188,present,1,0
129189,",",1,0
129190,2,1,0
129191,atypical,1,1
129192,pervasive,1,1
129193,developmental,1,1
129194,disorder,1,1
129195,),1,0
129196,between,1,0
129197,5,1,0
129198,and,1,0
129199,13,1,1
129200,years,1,1
129201,of,1,0
129202,age,1,1
129203,participated,0,1
129204,in,0,0
129205,a,0,0
129206,double-blind,0,0
129207,placebo-controlled,0,0
129208,cross-over,0,0
129209,trial,0,0
129210,.,0,0
129211,Each,0,0
129212,child,0,0
129213,received,0,0
129214,20,0,1
129215,mg,0,0
129216,Org,0,1
129217,2766,0,0
129218,(,0,0
129219,synthetic,0,0
129220,analog,0,0
129221,of,0,0
129222,ACTH,0,1
129223,4-9,0,1
129224,),0,0
129225,/day,0,0
129226,during,0,0
129227,4,0,0
129228,weeks,0,0
129229,",",0,0
129230,or,0,0
129231,placebo,0,0
129232,in,0,0
129233,a,0,0
129234,randomly,0,0
129235,assigned,0,0
129236,sequence,0,0
129237,.,0,0
129238,Drug,0,0
129239,effects,0,0
129240,were,0,0
129241,monitored,0,0
129242,by,0,0
129243,ethological,0,0
129244,playroom,0,0
129245,observation,0,0
129246,and,0,0
129247,by,0,0
129248,Aberrant,0,0
129249,Behavior,0,1
129250,Checklist,0,0
129251,ratings,0,0
129252,by,0,0
129253,parents,0,1
129254,and,0,1
129255,teachers,0,1
129256,.,0,0
129257,Data,0,0
129258,of,0,0
129259,the,0,0
129260,playroom,0,0
129261,observation,0,0
129262,pointed,0,0
129263,to,0,0
129264,an,0,0
129265,activating,0,0
129266,influence,0,0
129267,of,0,0
129268,Org,0,0
129269,2766,0,0
129270,",",0,0
129271,as,0,0
129272,revealed,0,0
129273,by,0,0
129274,a,0,0
129275,significant,0,0
129276,decrease,0,0
129277,of,0,0
129278,stereotypic,0,0
129279,behavior,0,0
129280,and,0,0
129281,significant,0,0
129282,increases,0,0
129283,in,0,0
129284,change,0,0
129285,toys,0,0
129286,",",0,0
129287,locomote,0,0
129288,",",0,0
129289,and,0,0
129290,talk,0,0
129291,.,0,0
129292,Checklist,0,0
129293,ratings,0,0
129294,did,0,0
129295,not,0,0
129296,show,0,0
129297,significant,0,0
129298,changes,0,0
129299,.,0,0
129300,The,0,0
129301,clinical,0,0
129302,implications,0,0
129303,of,0,0
129304,these,0,0
129305,findings,0,0
129306,are,0,0
129307,discussed,0,0
129308,.,0,0
129309,Effect,0,0
129310,of,0,0
129311,ginseng,0,0
129312,extract,0,0
129313,supplementation,0,0
129314,on,0,0
129315,testicular,0,1
129316,functions,0,0
129317,in,0,0
129318,diabetic,1,1
129319,rats,1,1
129320,.,1,0
129321,OBJECTIVE,0,0
129322,It,0,0
129323,was,0,0
129324,aimed,0,0
129325,to,0,0
129326,investigate,0,0
129327,the,0,0
129328,effect,0,0
129329,of,0,0
129330,standardized,0,0
129331,ginseng,0,0
129332,extract,0,0
129333,on,0,0
129334,fertility,0,1
129335,parameters,0,0
129336,in,0,0
129337,diabetic,1,1
129338,rats,1,1
129339,.,1,1
129340,METHODS,0,0
129341,Thirty,1,1
129342,male,1,1
129343,rats,1,1
129344,were,0,0
129345,randomly,0,1
129346,allocated,0,0
129347,into,0,0
129348,three,0,0
129349,groups,0,0
129350,of,0,0
129351,10,0,1
129352,rats,0,1
129353,each,0,0
129354,:,0,1
129355,1.,0,0
129356,controls,0,0
129357,",",0,0
129358,2.,0,0
129359,diabetes,0,1
129360,(,0,0
129361,D,0,0
129362,),0,0
129363,and,0,0
129364,3.,0,0
129365,diabetes,0,1
129366,+,0,0
129367,ginseng,0,0
129368,(,0,0
129369,DG,0,0
129370,),0,0
129371,.,0,0
129372,The,0,0
129373,latter,0,0
129374,two,0,0
129375,groups,0,0
129376,were,0,0
129377,rendered,0,0
129378,diabetic,0,1
129379,by,0,0
129380,i.p,0,0
129381,.,0,0
129382,injection,0,0
129383,of,0,0
129384,streptozotocin,0,1
129385,(,0,0
129386,STZ,0,0
129387,;,0,0
129388,50,0,0
129389,mg/kg,0,0
129390,),0,0
129391,.,0,0
129392,Standardized,0,0
129393,ginseng,0,0
129394,extract,0,0
129395,(,0,0
129396,Dansk,0,1
129397,Droge,0,1
129398,A/S,0,0
129399,",",0,0
129400,Copenhagen,0,1
129401,",",0,0
129402,Denmark,0,0
129403,),0,0
129404,was,0,0
129405,administered,0,0
129406,per,0,0
129407,os,0,0
129408,(,0,0
129409,100,0,0
129410,mg/kg,0,0
129411,BW,0,0
129412,),0,0
129413,by,0,0
129414,stomach,0,0
129415,tube,0,0
129416,daily,0,0
129417,for,0,0
129418,90,0,0
129419,days,0,0
129420,starting,0,0
129421,one,0,0
129422,week,0,0
129423,after,0,0
129424,STZ,0,0
129425,.,0,1
129426,Ninety,0,0
129427,days,0,0
129428,post,0,0
129429,STZ,0,0
129430,the,0,0
129431,rats,0,1
129432,were,0,0
129433,sacrificed,0,0
129434,",",0,0
129435,and,0,0
129436,testis,0,0
129437,",",0,0
129438,epididymis,0,0
129439,",",0,0
129440,prostate,0,0
129441,",",0,0
129442,and,0,0
129443,seminal,0,0
129444,vesicles,0,0
129445,were,0,0
129446,weighed,0,0
129447,and,0,0
129448,subjected,0,0
129449,to,0,0
129450,histological,0,0
129451,examination,0,0
129452,.,0,0
129453,In,0,0
129454,addition,0,0
129455,",",0,0
129456,spermiogram,0,0
129457,",",0,0
129458,testicular,0,1
129459,enzyme,0,0
129460,markers,0,0
129461,",",0,0
129462,intratesticular,0,0
129463,steroid,0,0
129464,hormonal,0,0
129465,profile,0,0
129466,and,0,0
129467,testicular,0,1
129468,antioxidant,0,0
129469,status,0,0
129470,were,0,0
129471,estimated,0,0
129472,.,0,0
129473,RESULTS,0,0
129474,The,0,0
129475,administration,0,0
129476,of,0,0
129477,ginseng,0,0
129478,extract,0,0
129479,resulted,0,0
129480,in,0,0
129481,a,0,0
129482,significant,0,0
129483,improvement,0,0
129484,of,0,0
129485,fertility,0,1
129486,parameters,0,0
129487,and,0,0
129488,testicular,0,1
129489,antioxidants,0,0
129490,together,0,0
129491,with,0,0
129492,a,0,0
129493,decrease,0,0
129494,in,0,0
129495,malondialdehyde,0,0
129496,and,0,0
129497,testicular,0,1
129498,pathological,0,0
129499,signs,0,0
129500,including,0,1
129501,degenerative,0,1
129502,changes,0,0
129503,of,0,0
129504,the,0,0
129505,seminiferous,0,1
129506,tubules,0,0
129507,.,0,1
129508,CONCLUSION,0,0
129509,Ginseng,0,0
129510,extract,0,0
129511,may,0,0
129512,be,0,0
129513,a,0,0
129514,beneficial,0,0
129515,adjuvant,0,0
129516,therapy,0,0
129517,for,0,0
129518,diabetics,0,1
129519,suffering,0,1
129520,from,0,0
129521,infertility,0,1
129522,as,0,0
129523,a,0,0
129524,complication,0,0
129525,.,0,0
129526,Using,0,0
129527,a,0,0
129528,population-based,1,1
129529,cancer,1,1
129530,registry,1,1
129531,for,0,0
129532,recruitment,0,0
129533,in,0,0
129534,a,0,0
129535,pilot,0,0
129536,cancer,0,1
129537,control,0,0
129538,study,0,0
129539,.,0,0
129540,Cancer,0,0
129541,control,0,0
129542,investigations,0,0
129543,in,0,0
129544,the,0,0
129545,United,1,1
129546,States,1,0
129547,rarely,0,0
129548,use,0,0
129549,population-based,1,1
129550,registries,1,1
129551,as,0,0
129552,a,0,0
129553,resource,0,0
129554,for,0,0
129555,recruitment,0,0
129556,.,0,0
129557,A,0,0
129558,placebo-controlled,0,0
129559,",",0,0
129560,double-blind,0,0
129561,",",0,0
129562,randomized,0,0
129563,toxicity,0,0
129564,trial,0,0
129565,of,0,0
129566,tamoxifen,0,0
129567,was,0,0
129568,conducted,0,0
129569,among,0,0
129570,postmenopausal,1,1
129571,women,1,1
129572,with,1,1
129573,node,1,0
129574,negative,1,0
129575,breast,1,1
129576,cancer,1,1
129577,.,1,0
129578,To,0,0
129579,achieve,0,0
129580,the,0,0
129581,accrual,0,0
129582,goal,0,0
129583,of,0,0
129584,140,1,1
129585,subjects,1,1
129586,in,1,0
129587,this,1,0
129588,single,1,0
129589,institution,1,0
129590,study,1,0
129591,",",1,0
129592,the,1,0
129593,Wisconsin,1,0
129594,Cancer,1,0
129595,Reporting,1,0
129596,System,1,0
129597,(,1,0
129598,WCRS,1,0
129599,),1,0
129600,",",1,0
129601,a,1,0
129602,population-based,1,1
129603,cancer,1,1
129604,registry,1,1
129605,",",1,0
129606,was,1,0
129607,used,1,0
129608,.,1,0
129609,Registry,0,1
129610,information,0,0
129611,from,0,0
129612,the,0,0
129613,last,0,0
129614,9,0,0
129615,years,0,1
129616,was,0,0
129617,used,0,0
129618,to,0,0
129619,identify,0,0
129620,"3,585",1,1
129621,women,1,1
129622,who,1,1
129623,met,1,1
129624,the,1,1
129625,study,1,0
129626,criteria,1,1
129627,with,1,1
129628,respect,1,0
129629,to,1,0
129630,age,1,1
129631,",",1,0
129632,stage,1,1
129633,",",1,0
129634,and,1,0
129635,previous,1,0
129636,therapy,1,0
129637,.,1,0
129638,The,0,0
129639,vital,0,0
129640,status,0,0
129641,of,0,0
129642,identified,0,0
129643,women,1,1
129644,was,0,0
129645,confirmed,0,0
129646,using,0,0
129647,Wisconsin,0,0
129648,state,0,0
129649,death,0,0
129650,records,0,0
129651,.,0,0
129652,For,0,0
129653,identified,0,0
129654,cases,0,1
129655,",",0,0
129656,rosters,0,0
129657,were,0,0
129658,prepared,0,0
129659,and,0,0
129660,sent,0,0
129661,to,0,0
129662,the,0,0
129663,physician,0,0
129664,with,0,0
129665,a,0,0
129666,cover,0,0
129667,letter,0,0
129668,and,0,0
129669,study,0,0
129670,description,0,0
129671,.,0,0
129672,The,0,0
129673,physicians,0,0
129674,were,0,0
129675,asked,0,0
129676,to,0,0
129677,update,0,0
129678,the,0,0
129679,list,0,0
129680,and,0,0
129681,",",0,0
129682,if,0,0
129683,appropriate,0,0
129684,",",0,0
129685,to,0,0
129686,sign,0,0
129687,letters,0,0
129688,to,0,0
129689,potentially,0,0
129690,eligible,1,1
129691,and,1,0
129692,interested,1,0
129693,women,1,1
129694,.,1,1
129695,Thirty-eight,0,1
129696,percent,0,0
129697,of,0,0
129698,women,0,1
129699,receiving,0,1
129700,a,0,0
129701,letter,0,0
129702,and,0,0
129703,study,0,0
129704,information,0,0
129705,from,0,0
129706,their,0,0
129707,physicians,0,1
129708,contacted,0,0
129709,the,0,0
129710,study,0,0
129711,office,0,1
129712,about,0,0
129713,participation,0,0
129714,.,0,0
129715,Eighteen,0,1
129716,months,0,0
129717,from,0,0
129718,its,0,0
129719,initiation,0,0
129720,",",0,0
129721,140,1,1
129722,women,1,1
129723,were,1,0
129724,entered,1,1
129725,on,1,0
129726,study,1,0
129727,.,1,0
129728,This,0,0
129729,successful,0,0
129730,use,0,0
129731,of,0,0
129732,a,0,0
129733,population-based,1,1
129734,cancer,1,1
129735,registry,1,1
129736,illustrates,0,0
129737,an,0,0
129738,efficient,0,0
129739,recruitment,0,0
129740,method,0,0
129741,which,0,0
129742,could,0,0
129743,be,0,0
129744,modified,0,0
129745,for,0,0
129746,other,0,0
129747,cancer,0,1
129748,control/chemoprevention,0,0
129749,trials,0,0
129750,.,0,1
129751,Atypical,0,1
129752,social,0,0
129753,modulation,0,0
129754,of,0,0
129755,imitation,0,0
129756,in,0,0
129757,autism,1,1
129758,spectrum,1,1
129759,conditions,1,0
129760,.,1,0
129761,Appropriate,0,0
129762,modulation,0,0
129763,of,0,0
129764,imitation,0,0
129765,according,0,1
129766,to,0,0
129767,social,0,0
129768,context,0,0
129769,is,0,0
129770,important,0,0
129771,for,0,0
129772,successful,0,0
129773,social,0,0
129774,interaction,0,0
129775,.,0,0
129776,In,0,0
129777,the,0,0
129778,present,0,0
129779,study,0,0
129780,we,0,0
129781,subliminally,0,0
129782,primed,0,0
129783,high-functioning,1,1
129784,adults,1,1
129785,with,1,1
129786,ASC,1,0
129787,and,1,0
129788,age-,1,1
129789,and,1,0
129790,IQ-matched,1,1
129791,controls,1,0
129792,with,1,1
129793,either,1,0
129794,a,1,0
129795,pro-,1,0
129796,or,1,0
129797,non-,1,0
129798,social,1,0
129799,attitude,1,0
129800,.,1,0
129801,Following,0,0
129802,priming,0,0
129803,",",0,0
129804,an,0,0
129805,automatic,0,0
129806,imitation,0,0
129807,paradigm,0,0
129808,was,0,0
129809,used,0,0
129810,to,0,0
129811,acquire,0,0
129812,an,0,0
129813,index,0,0
129814,of,0,0
129815,imitation,0,0
129816,.,0,0
129817,Whereas,0,0
129818,imitation,0,0
129819,levels,0,0
129820,were,0,0
129821,higher,0,0
129822,for,0,0
129823,pro-socially,0,0
129824,primed,0,0
129825,relative,0,0
129826,to,0,0
129827,non-socially,0,1
129828,primed,0,0
129829,control,1,0
129830,participants,1,1
129831,",",0,0
129832,there,0,0
129833,was,0,0
129834,no,0,0
129835,difference,0,0
129836,between,0,0
129837,pro-,0,0
129838,and,0,0
129839,non-,0,0
129840,socially,0,1
129841,primed,0,0
129842,individuals,1,1
129843,with,1,1
129844,ASC,1,0
129845,.,1,0
129846,We,0,0
129847,conclude,0,0
129848,that,0,0
129849,high-functioning,1,1
129850,adults,1,1
129851,with,1,1
129852,ASC,1,0
129853,demonstrate,0,0
129854,atypical,0,0
129855,social,0,0
129856,modulation,0,0
129857,of,0,0
129858,imitation,0,0
129859,.,0,0
129860,Given,0,0
129861,the,0,0
129862,importance,0,0
129863,of,0,0
129864,imitation,0,0
129865,in,0,0
129866,social,0,0
129867,interaction,0,0
129868,we,0,0
129869,speculate,0,0
129870,that,0,0
129871,difficulties,0,0
129872,with,0,1
129873,the,0,0
129874,modulation,0,0
129875,of,0,0
129876,imitation,0,0
129877,may,0,0
129878,contribute,0,0
129879,to,0,0
129880,the,0,0
129881,social,0,0
129882,problems,0,1
129883,characteristic,0,0
129884,of,0,0
129885,ASC,1,0
129886,.,1,1
129887,Topical,0,1
129888,PUVA,0,0
129889,",",0,0
129890,etretinate,0,0
129891,",",0,0
129892,and,0,0
129893,combined,0,0
129894,PUVA,0,0
129895,and,0,0
129896,etretinate,0,0
129897,for,0,0
129898,palmoplantar,0,1
129899,pustulosis,0,1
129900,:,0,1
129901,comparison,0,0
129902,of,0,0
129903,therapeutic,0,0
129904,efficacy,0,0
129905,and,0,0
129906,the,0,0
129907,influences,0,0
129908,of,0,0
129909,tonsillar,1,1
129910,and,1,0
129911,dental,1,1
129912,focal,1,1
129913,infections,1,0
129914,.,1,1
129915,Twenty,1,1
129916,patients,1,1
129917,with,1,1
129918,palmoplantar,1,1
129919,pustulosis,1,1
129920,(,1,0
129921,PPP,1,0
129922,),1,0
129923,were,0,0
129924,treated,0,0
129925,with,0,1
129926,topical,0,0
129927,PUVA,0,0
129928,",",0,0
129929,oral,0,0
129930,etretinate,0,0
129931,(,0,0
129932,Re,0,0
129933,),0,0
129934,",",0,0
129935,or,0,0
129936,combined,0,0
129937,PUVA,0,0
129938,and,0,0
129939,etretinate,0,0
129940,(,0,0
129941,Re-PUVA,0,0
129942,),0,0
129943,.,0,0
129944,Re,0,0
129945,and,0,0
129946,Re-PUVA,0,0
129947,treated,0,1
129948,sites,0,0
129949,improved,0,0
129950,and/or,0,0
129951,cleared,0,0
129952,more,0,0
129953,rapidly,0,0
129954,than,0,0
129955,PUVA,0,0
129956,treated,0,1
129957,sites,0,0
129958,.,0,1
129959,Complete,0,0
129960,clearance,0,0
129961,was,0,0
129962,observed,0,0
129963,in,0,0
129964,six,0,0
129965,of,0,0
129966,ten,0,1
129967,sites,0,1
129968,treated,0,1
129969,with,0,1
129970,Re-PUVA,0,0
129971,",",0,0
129972,two,0,0
129973,of,0,0
129974,ten,0,1
129975,with,0,1
129976,Re,0,0
129977,",",0,0
129978,and,0,0
129979,one,0,0
129980,of,0,0
129981,ten,0,1
129982,sites,0,0
129983,with,0,1
129984,PUVA,0,0
129985,within,0,0
129986,12,0,1
129987,weeks,0,0
129988,.,0,0
129989,UVA-control,0,0
129990,sites,0,0
129991,failed,0,0
129992,to,0,0
129993,be,0,0
129994,cleared,0,0
129995,within,0,0
129996,12,0,0
129997,weeks,0,0
129998,.,0,1
129999,Remission,0,0
130000,periods,0,0
130001,after,0,0
130002,stopping,0,0
130003,the,0,0
130004,treatment,0,0
130005,were,0,0
130006,1.5,0,0
130007,+/-,0,0
130008,0.5,0,0
130009,weeks,0,0
130010,(,0,0
130011,n,0,1
130012,=,0,0
130013,2,0,0
130014,),0,0
130015,with,0,1
130016,Re,0,0
130017,",",0,0
130018,10.5,0,0
130019,+/-,0,0
130020,11.4,0,0
130021,weeks,0,0
130022,(,0,0
130023,n,0,1
130024,=,0,0
130025,6,0,0
130026,),0,0
130027,with,0,1
130028,Re-PUVA,0,0
130029,",",0,0
130030,and,0,0
130031,one,0,0
130032,year,0,0
130033,(,0,0
130034,n,0,1
130035,=,0,0
130036,1,0,0
130037,),0,0
130038,with,0,1
130039,PUVA,0,0
130040,.,0,0
130041,These,0,0
130042,results,0,0
130043,overall,0,0
130044,suggested,0,0
130045,that,0,0
130046,Re-PUVA,0,0
130047,is,0,0
130048,the,0,0
130049,most,0,0
130050,effective,0,0
130051,treatment,0,0
130052,for,0,0
130053,PPP,0,0
130054,.,0,0
130055,Tonsillar,0,0
130056,focal,0,0
130057,infection,0,1
130058,(,0,0
130059,TFI,0,0
130060,),0,0
130061,and,0,0
130062,dental,0,1
130063,focal,0,1
130064,infection,0,1
130065,(,0,0
130066,DFI,0,0
130067,),0,0
130068,were,0,0
130069,found,0,0
130070,in,0,0
130071,6/20,0,0
130072,and,0,0
130073,17/20,0,0
130074,patients,0,1
130075,",",0,0
130076,respectively,0,0
130077,.,0,0
130078,However,0,0
130079,",",0,0
130080,the,0,0
130081,presence,0,0
130082,of,0,0
130083,focal,0,1
130084,infection,0,1
130085,(,0,0
130086,FI,0,0
130087,),0,0
130088,",",0,0
130089,TFI,0,0
130090,and/or,0,0
130091,DFI,0,0
130092,",",0,0
130093,did,0,0
130094,not,0,0
130095,appear,0,0
130096,to,0,0
130097,interfere,0,0
130098,with,0,0
130099,the,0,0
130100,therapeutic,0,0
130101,activities,0,0
130102,of,0,0
130103,Re,0,0
130104,and/or,0,0
130105,PUVA,0,0
130106,",",0,0
130107,because,0,0
130108,the,0,0
130109,complete,0,0
130110,clearance,0,0
130111,rates,0,0
130112,and,0,0
130113,remission,0,1
130114,periods,0,0
130115,in,0,0
130116,FI,0,1
130117,(,0,0
130118,+,0,0
130119,),0,0
130120,patients,0,1
130121,were,0,0
130122,comparable,0,0
130123,with,0,1
130124,those,0,0
130125,in,0,0
130126,FI,0,1
130127,(,0,0
130128,-,0,0
130129,),0,0
130130,patients,0,1
130131,.,0,1
130132,Comparative,0,0
130133,effectiveness,0,0
130134,of,0,0
130135,exercise,0,0
130136,electrocardiography,0,0
130137,with,0,0
130138,or,0,0
130139,without,0,0
130140,myocardial,0,1
130141,perfusion,0,0
130142,single,0,0
130143,photon,0,0
130144,emission,0,0
130145,computed,0,0
130146,tomography,0,0
130147,in,0,0
130148,women,1,1
130149,with,1,1
130150,suspected,1,1
130151,coronary,1,1
130152,artery,1,1
130153,disease,1,1
130154,:,1,1
130155,results,0,0
130156,from,0,1
130157,the,0,0
130158,What,0,0
130159,Is,0,1
130160,the,0,1
130161,Optimal,0,0
130162,Method,0,0
130163,for,0,0
130164,Ischemia,0,0
130165,Evaluation,0,0
130166,in,0,0
130167,Women,0,1
130168,(,0,0
130169,WOMEN,0,0
130170,),0,0
130171,trial,0,0
130172,.,0,0
130173,BACKGROUND,0,0
130174,There,0,0
130175,is,0,0
130176,a,0,0
130177,paucity,0,0
130178,of,0,0
130179,randomized,0,0
130180,trials,0,0
130181,regarding,0,0
130182,diagnostic,0,0
130183,testing,0,0
130184,in,0,0
130185,women,1,1
130186,with,1,1
130187,suspected,1,1
130188,coronary,1,1
130189,artery,1,1
130190,disease,1,1
130191,(,1,0
130192,CAD,1,0
130193,),1,0
130194,.,1,0
130195,It,0,0
130196,remains,0,0
130197,unclear,0,0
130198,whether,0,0
130199,the,0,0
130200,addition,0,0
130201,of,0,0
130202,myocardial,0,0
130203,perfusion,0,0
130204,imaging,0,0
130205,(,0,0
130206,MPI,0,0
130207,),0,0
130208,to,0,0
130209,the,0,0
130210,standard,0,0
130211,ECG,0,0
130212,exercise,0,0
130213,treadmill,0,0
130214,test,0,0
130215,(,0,0
130216,ETT,0,0
130217,),0,0
130218,provides,0,0
130219,incremental,0,0
130220,information,0,0
130221,to,0,0
130222,improve,0,0
130223,clinical,0,0
130224,decision,0,0
130225,making,0,0
130226,in,0,0
130227,women,1,1
130228,with,1,1
130229,suspected,1,1
130230,CAD,1,0
130231,.,1,0
130232,METHODS,0,0
130233,AND,0,0
130234,RESULTS,0,0
130235,We,0,0
130236,randomized,0,0
130237,symptomatic,1,1
130238,women,1,1
130239,with,1,1
130240,suspected,1,1
130241,CAD,1,0
130242,",",1,0
130243,an,1,0
130244,interpretable,1,0
130245,ECG,1,0
130246,",",1,0
130247,and,1,0
130248,?5,1,0
130249,metabolic,1,0
130250,equivalents,1,0
130251,on,1,0
130252,the,1,0
130253,Duke,1,0
130254,Activity,1,0
130255,Status,1,0
130256,Index,1,0
130257,to,1,0
130258,1,0,0
130259,of,0,0
130260,2,0,0
130261,diagnostic,0,1
130262,strategies,0,0
130263,:,0,1
130264,ETT,0,0
130265,or,0,0
130266,exercise,0,0
130267,MPI,0,0
130268,.,0,0
130269,The,0,0
130270,primary,0,0
130271,end,0,0
130272,point,0,0
130273,was,0,0
130274,2-year,0,0
130275,incidence,0,0
130276,of,0,0
130277,major,0,0
130278,adverse,0,0
130279,cardiac,0,1
130280,events,0,0
130281,",",0,0
130282,defined,0,0
130283,as,0,0
130284,CAD,0,0
130285,death,0,0
130286,or,0,0
130287,hospitalization,0,0
130288,for,0,0
130289,an,0,0
130290,acute,0,1
130291,coronary,0,1
130292,syndrome,0,1
130293,or,0,0
130294,heart,0,1
130295,failure,0,1
130296,.,0,0
130297,A,0,0
130298,total,1,0
130299,of,1,0
130300,824,1,1
130301,women,1,1
130302,were,1,0
130303,randomized,0,0
130304,to,0,0
130305,ETT,0,0
130306,or,0,0
130307,exercise,0,0
130308,MPI,0,0
130309,.,0,0
130310,For,0,0
130311,women,0,1
130312,randomized,0,1
130313,to,0,0
130314,ETT,0,0
130315,",",0,0
130316,ECG,0,0
130317,results,0,0
130318,were,0,0
130319,normal,0,1
130320,in,0,0
130321,64,0,0
130322,%,0,0
130323,",",0,0
130324,indeterminate,0,0
130325,in,0,0
130326,16,0,0
130327,%,0,0
130328,",",0,0
130329,and,0,0
130330,abnormal,0,0
130331,in,0,0
130332,20,0,1
130333,%,0,0
130334,.,0,0
130335,By,0,0
130336,comparison,0,0
130337,",",0,0
130338,the,0,0
130339,exercise,0,0
130340,MPI,0,0
130341,results,0,0
130342,were,0,0
130343,normal,0,1
130344,in,0,0
130345,91,0,0
130346,%,0,0
130347,",",0,0
130348,mildly,0,0
130349,abnormal,0,0
130350,in,0,0
130351,3,0,0
130352,%,0,0
130353,",",0,0
130354,and,0,0
130355,moderate,0,1
130356,to,0,0
130357,severely,0,1
130358,abnormal,0,0
130359,in,0,0
130360,6,0,0
130361,%,0,0
130362,.,0,0
130363,At,0,0
130364,2,0,0
130365,years,0,1
130366,",",0,0
130367,there,0,0
130368,was,0,0
130369,no,0,0
130370,difference,0,0
130371,in,0,0
130372,major,0,0
130373,adverse,0,0
130374,cardiac,0,1
130375,events,0,0
130376,(,0,0
130377,98.0,0,0
130378,%,0,0
130379,for,0,0
130380,ETT,0,0
130381,and,0,0
130382,97.7,0,0
130383,%,0,0
130384,for,0,0
130385,MPI,0,1
130386,;,0,0
130387,P=0.59,0,0
130388,),0,0
130389,.,0,0
130390,Compared,0,0
130391,with,0,0
130392,ETT,0,0
130393,",",0,0
130394,index,0,0
130395,testing,0,0
130396,costs,0,0
130397,were,0,0
130398,higher,0,0
130399,for,0,0
130400,exercise,0,0
130401,MPI,0,0
130402,(,0,0
130403,P,0,0
130404,<,0,0
130405,0.001,0,0
130406,),0,0
130407,",",0,0
130408,whereas,0,0
130409,downstream,0,0
130410,procedural,0,0
130411,costs,0,0
130412,were,0,0
130413,slightly,0,0
130414,lower,0,0
130415,(,0,0
130416,P=0.0008,0,0
130417,),0,0
130418,.,0,0
130419,Overall,0,0
130420,",",0,0
130421,the,0,0
130422,cumulative,0,0
130423,diagnostic,0,0
130424,cost,0,0
130425,savings,0,0
130426,was,0,0
130427,48,0,0
130428,%,0,0
130429,for,0,0
130430,ETT,0,0
130431,compared,0,0
130432,with,0,1
130433,exercise,0,0
130434,MPI,0,0
130435,(,0,0
130436,P,0,0
130437,<,0,0
130438,0.001,0,0
130439,),0,0
130440,.,0,0
130441,CONCLUSIONS,0,0
130442,In,0,0
130443,low-risk,0,0
130444,",",0,0
130445,exercising,0,0
130446,women,0,1
130447,",",0,0
130448,a,0,0
130449,diagnostic,0,0
130450,strategy,0,0
130451,that,0,0
130452,uses,0,0
130453,ETT,0,0
130454,versus,0,0
130455,exercise,0,0
130456,MPI,0,0
130457,yields,0,0
130458,similar,0,0
130459,2-year,0,1
130460,posttest,0,0
130461,outcomes,0,0
130462,while,0,0
130463,providing,0,0
130464,significant,0,0
130465,diagnostic,0,0
130466,cost,0,0
130467,savings,0,0
130468,.,0,0
130469,The,0,0
130470,ETT,0,0
130471,with,0,1
130472,selective,0,0
130473,follow-up,0,0
130474,testing,0,0
130475,should,0,0
130476,be,0,0
130477,considered,0,0
130478,as,0,0
130479,the,0,0
130480,initial,0,0
130481,diagnostic,0,0
130482,strategy,0,0
130483,in,0,0
130484,symptomatic,1,1
130485,women,1,1
130486,with,1,1
130487,suspected,1,1
130488,CAD,1,0
130489,.,1,1
130490,CLINICAL,0,0
130491,TRIAL,0,0
130492,REGISTRATION,0,0
130493,http,0,0
130494,:,0,1
130495,//www.clinicaltrials.gov,0,0
130496,.,0,0
130497,Unique,0,0
130498,identifier,0,0
130499,:,0,1
130500,NCT00282711,0,0
130501,.,0,0
130502,Increasing,0,0
130503,verbal,0,0
130504,responsiveness,0,0
130505,in,0,0
130506,parents,1,1
130507,of,1,0
130508,children,1,1
130509,with,1,1
130510,autism,1,1
130511,:,1,1
130512,a,1,0
130513,pilot,0,0
130514,study,0,0
130515,.,0,0
130516,Correlational,0,0
130517,studies,0,0
130518,have,0,0
130519,revealed,0,0
130520,a,0,0
130521,positive,0,0
130522,relationship,0,0
130523,between,0,0
130524,parent,1,0
130525,verbal,0,0
130526,responsiveness,0,0
130527,and,0,0
130528,language,0,0
130529,outcomes,0,0
130530,in,0,0
130531,children,1,1
130532,with,1,1
130533,autism,1,1
130534,.,1,0
130535,We,0,0
130536,investigated,0,0
130537,whether,0,0
130538,parents,1,1
130539,of,1,0
130540,young,1,1
130541,children,1,1
130542,on,1,0
130543,the,1,0
130544,autism,1,1
130545,spectrum,1,1
130546,could,0,0
130547,learn,0,0
130548,and,0,0
130549,implement,0,0
130550,the,0,0
130551,specific,0,0
130552,categories,0,0
130553,of,0,0
130554,verbal,0,0
130555,responsiveness,0,0
130556,that,0,0
130557,have,0,0
130558,been,0,0
130559,suggested,0,0
130560,to,0,0
130561,facilitate,0,0
130562,language,0,0
130563,development,0,0
130564,.,0,0
130565,Parents,1,0
130566,were,0,0
130567,taught,0,0
130568,to,0,0
130569,increase,0,0
130570,their,0,0
130571,verbal,0,0
130572,responsiveness,0,0
130573,in,0,0
130574,the,0,0
130575,context,0,0
130576,of,0,0
130577,a,0,0
130578,short-term,0,0
130579,language,0,0
130580,intervention,0,0
130581,that,0,0
130582,included,0,0
130583,group,0,0
130584,parent,0,0
130585,education,0,0
130586,sessions,0,0
130587,",",0,0
130588,as,0,0
130589,well,0,0
130590,as,0,0
130591,individual,0,0
130592,and,0,0
130593,small-group,0,0
130594,coaching,0,0
130595,sessions,0,0
130596,of,0,0
130597,parent-child,0,1
130598,play,0,0
130599,interactions,0,0
130600,.,0,1
130601,Parents,1,0
130602,in,0,0
130603,the,0,0
130604,treatment,0,0
130605,group,0,0
130606,increased,0,0
130607,their,0,0
130608,use,0,0
130609,of,0,0
130610,comments,0,0
130611,that,0,0
130612,:,0,1
130613,described,0,0
130614,their,0,0
130615,child,0,1
130616,'s,0,0
130617,focus,0,0
130618,of,0,0
130619,attention,0,0
130620,;,0,0
130621,interpreted,0,0
130622,or,0,0
130623,expanded,0,0
130624,child,0,1
130625,communication,0,0
130626,acts,0,0
130627,;,0,0
130628,and,0,0
130629,prompted,0,0
130630,child,0,1
130631,communication,0,0
130632,.,0,0
130633,Preliminary,0,0
130634,treatment,0,0
130635,effects,0,0
130636,were,0,0
130637,also,0,0
130638,noted,0,0
130639,in,0,0
130640,children,0,1
130641,'s,0,1
130642,prompted,0,0
130643,and,0,0
130644,spontaneous,0,0
130645,communication,0,0
130646,.,0,0
130647,These,0,0
130648,results,0,0
130649,support,0,0
130650,the,0,0
130651,use,0,0
130652,of,0,0
130653,parent-mediated,0,0
130654,interventions,0,0
130655,targeting,0,0
130656,verbal,0,0
130657,responsiveness,0,0
130658,to,0,0
130659,facilitate,0,0
130660,language,0,0
130661,development,0,0
130662,and,0,0
130663,communication,0,0
130664,in,0,0
130665,young,1,1
130666,children,1,1
130667,with,1,1
130668,autism,1,1
130669,.,1,0
130670,Impact,0,0
130671,of,0,0
130672,pentoxifylline,0,0
130673,on,0,0
130674,platelet,0,0
130675,function,0,0
130676,profiles,0,0
130677,in,0,0
130678,patients,1,1
130679,with,1,1
130680,type,1,1
130681,2,1,0
130682,diabetes,1,1
130683,mellitus,1,1
130684,and,1,0
130685,coronary,1,1
130686,artery,1,1
130687,disease,1,1
130688,on,1,0
130689,dual,1,0
130690,antiplatelet,1,0
130691,therapy,1,0
130692,with,1,0
130693,aspirin,1,0
130694,and,1,0
130695,clopidogrel,1,0
130696,.,1,0
130697,OBJECTIVES,0,0
130698,The,0,0
130699,aim,0,0
130700,of,0,0
130701,this,0,0
130702,study,0,0
130703,was,0,0
130704,to,0,0
130705,evaluate,0,0
130706,the,0,0
130707,impact,0,0
130708,of,0,0
130709,the,0,0
130710,phosphodiesterase,0,0
130711,(,0,0
130712,PDE,0,1
130713,),0,0
130714,inhibitor,0,0
130715,pentoxifylline,0,0
130716,on,0,0
130717,platelet,0,0
130718,function,0,0
130719,profiles,0,0
130720,in,0,0
130721,patients,1,1
130722,receiving,1,1
130723,dual,1,1
130724,antiplatelet,1,0
130725,therapy,1,0
130726,(,1,0
130727,DAPT,1,0
130728,),1,0
130729,.,1,0
130730,BACKGROUND,0,0
130731,Previous,0,0
130732,studies,0,0
130733,have,0,0
130734,shown,0,0
130735,that,0,0
130736,",",0,0
130737,in,0,0
130738,patients,0,1
130739,receiving,0,1
130740,DAPT,0,0
130741,",",0,0
130742,the,0,0
130743,adjunctive,0,0
130744,use,0,0
130745,of,0,0
130746,a,0,0
130747,PDE,0,1
130748,inhibitor,0,0
130749,enhances,0,0
130750,platelet,0,0
130751,inhibition,0,0
130752,",",0,0
130753,particularly,0,0
130754,in,0,0
130755,those,0,0
130756,presenting,0,1
130757,with,0,1
130758,diabetes,0,1
130759,mellitus,0,1
130760,(,0,1
130761,DM,0,0
130762,),0,0
130763,.,0,0
130764,However,0,0
130765,",",0,0
130766,the,0,0
130767,pharmacodynamic,0,0
130768,(,0,0
130769,PD,0,0
130770,),0,0
130771,effects,0,0
130772,of,0,0
130773,the,0,0
130774,PDE,0,0
130775,inhibitor,0,0
130776,pentoxifylline,0,0
130777,on,0,0
130778,platelet,0,0
130779,function,0,0
130780,profiles,0,0
130781,in,0,0
130782,DM,0,0
130783,patients,0,1
130784,receiving,0,1
130785,DAPT,0,0
130786,are,0,0
130787,unknown,0,0
130788,.,0,0
130789,METHODS,0,0
130790,This,0,0
130791,was,0,0
130792,a,0,0
130793,prospective,0,0
130794,",",0,0
130795,randomized,0,0
130796,",",0,0
130797,double-blind,0,0
130798,",",0,0
130799,parallel,0,0
130800,design,0,0
130801,study,0,0
130802,conducted,0,0
130803,in,0,0
130804,DM,1,0
130805,patients,1,1
130806,with,1,1
130807,stable,1,1
130808,coronary,1,1
130809,artery,1,1
130810,disease,1,1
130811,receiving,1,0
130812,DAPT,1,0
130813,.,1,1
130814,Patients,0,1
130815,were,0,0
130816,randomly,0,1
130817,assigned,0,0
130818,to,0,0
130819,either,0,0
130820,pentoxifylline,0,0
130821,400,0,0
130822,mg,0,0
130823,or,0,0
130824,placebo,0,0
130825,3,0,0
130826,times,0,0
130827,daily,0,0
130828,for,0,0
130829,14,0,0
130830,days,0,0
130831,.,0,1
130832,The,0,0
130833,PD,0,0
130834,effects,0,0
130835,were,0,0
130836,assessed,0,0
130837,by,0,0
130838,vasodilator-stimulated,0,0
130839,phosphoprotein,0,0
130840,phosphorylation,0,0
130841,assay,0,0
130842,",",0,0
130843,light,0,0
130844,transmittance,0,0
130845,aggregometry,0,0
130846,",",0,0
130847,VerifyNow,0,0
130848,P2Y12,0,0
130849,assay,0,0
130850,(,0,0
130851,Accumetric,0,0
130852,",",0,0
130853,Inc.,0,0
130854,",",0,0
130855,San,0,0
130856,Diego,0,0
130857,",",0,0
130858,California,0,1
130859,),0,0
130860,",",0,0
130861,and,0,0
130862,multiple,0,0
130863,electrode,0,0
130864,aggregometry,0,0
130865,at,0,0
130866,baseline,0,0
130867,and,0,0
130868,14,0,0
130869,days,0,0
130870,.,0,1
130871,The,0,0
130872,PD,0,0
130873,effects,0,0
130874,were,0,0
130875,also,0,0
130876,assessed,0,0
130877,according,0,0
130878,the,0,0
130879,presence,0,0
130880,or,0,0
130881,absence,0,0
130882,of,0,0
130883,high,0,0
130884,on-treatment,0,0
130885,platelet,0,0
130886,reactivity,0,0
130887,status,0,0
130888,.,0,0
130889,RESULTS,0,0
130890,A,0,0
130891,total,0,0
130892,of,0,0
130893,40,1,1
130894,patients,1,1
130895,were,0,0
130896,available,0,0
130897,for,0,0
130898,analysis,0,0
130899,.,0,0
130900,At,0,0
130901,14,0,0
130902,days,0,0
130903,",",0,0
130904,there,0,0
130905,were,0,0
130906,no,0,0
130907,differences,0,0
130908,in,0,0
130909,the,0,0
130910,P2Y,0,0
130911,(,0,0
130912,12,0,0
130913,),0,0
130914,reactivity,0,0
130915,index,0,0
130916,as,0,0
130917,assessed,0,0
130918,by,0,0
130919,vasodilator-stimulated,0,0
130920,phosphoprotein,0,0
130921,phosphorylation,0,0
130922,between,0,0
130923,treatment,0,0
130924,groups,0,0
130925,(,0,0
130926,primary,0,1
130927,endpoint,0,0
130928,;,0,0
130929,p,0,0
130930,=,0,0
130931,0.93,0,0
130932,),0,0
130933,.,0,0
130934,Intra-group,0,0
130935,comparisons,0,0
130936,also,0,0
130937,failed,0,0
130938,to,0,0
130939,show,0,0
130940,any,0,0
130941,differences,0,0
130942,between,0,0
130943,baseline,0,0
130944,and,0,0
130945,14-day,0,0
130946,P2Y,0,0
130947,(,0,0
130948,12,0,0
130949,),0,0
130950,reactivity,0,0
130951,index,0,0
130952,assessment,0,0
130953,in,0,0
130954,the,0,0
130955,placebo,0,0
130956,and,0,0
130957,pentoxifylline,0,0
130958,arms,0,0
130959,(,0,0
130960,p,0,0
130961,=,0,0
130962,0.61,0,0
130963,),0,0
130964,.,0,0
130965,There,0,0
130966,were,0,0
130967,no,0,0
130968,significant,0,0
130969,inter-,0,0
130970,and,0,0
130971,intra-group,0,0
130972,differences,0,0
130973,in,0,0
130974,all,0,0
130975,other,0,0
130976,PD,0,0
130977,measures,0,0
130978,.,0,0
130979,The,0,0
130980,PD,0,0
130981,effects,0,0
130982,did,0,0
130983,not,0,0
130984,vary,0,0
130985,according,0,0
130986,the,0,0
130987,presence,0,0
130988,or,0,0
130989,absence,0,0
130990,of,0,0
130991,high,0,0
130992,on-treatment,0,0
130993,platelet,0,0
130994,reactivity,0,0
130995,.,0,0
130996,CONCLUSIONS,0,0
130997,Adjunctive,0,0
130998,treatment,0,0
130999,with,0,0
131000,pentoxifylline,0,0
131001,is,0,0
131002,not,0,0
131003,associated,0,0
131004,with,0,0
131005,increased,0,0
131006,platelet,0,0
131007,inhibitory,0,0
131008,effects,0,0
131009,in,0,0
131010,DM,1,0
131011,patients,1,1
131012,with,1,1
131013,coronary,1,1
131014,artery,1,1
131015,disease,1,1
131016,receiving,1,0
131017,DAPT,1,0
131018,.,1,1
131019,Ameliorating,0,0
131020,intrusive,1,0
131021,memories,1,0
131022,of,1,0
131023,distressing,1,0
131024,experiences,1,0
131025,using,0,0
131026,computerized,0,0
131027,reappraisal,0,0
131028,training,0,0
131029,.,0,0
131030,The,0,0
131031,types,0,0
131032,of,0,0
131033,appraisals,0,0
131034,that,0,0
131035,follow,1,0
131036,traumatic,1,0
131037,experiences,1,0
131038,have,0,0
131039,been,0,0
131040,linked,0,0
131041,to,0,0
131042,the,0,0
131043,emergence,0,0
131044,of,0,0
131045,posttraumatic,0,1
131046,stress,0,0
131047,disorder,0,1
131048,(,0,0
131049,PTSD,0,0
131050,),0,0
131051,.,0,0
131052,Could,0,0
131053,changing,0,0
131054,reappraisals,0,0
131055,following,0,0
131056,a,0,0
131057,stressful,0,0
131058,event,0,0
131059,reduce,0,0
131060,the,0,0
131061,emergence,0,0
131062,of,0,0
131063,PTSD,0,0
131064,symptoms,0,0
131065,?,0,0
131066,The,0,0
131067,present,0,0
131068,proof-of-principle,0,0
131069,study,0,0
131070,examined,0,0
131071,whether,0,0
131072,a,0,0
131073,nonexplicit,0,0
131074,",",0,0
131075,systematic,0,0
131076,computerized,0,0
131077,training,0,0
131078,in,0,0
131079,reappraisal,0,0
131080,style,0,0
131081,following,1,0
131082,a,1,0
131083,stressful,1,0
131084,event,1,0
131085,(,1,0
131086,a,1,0
131087,highly,1,0
131088,distressing,1,0
131089,film,1,0
131090,),1,0
131091,could,0,0
131092,reduce,0,0
131093,intrusive,0,0
131094,memories,0,0
131095,of,0,0
131096,the,0,0
131097,film,0,0
131098,",",0,0
131099,and,0,0
131100,symptoms,0,0
131101,associated,0,0
131102,with,0,1
131103,posttraumatic,0,1
131104,distress,0,1
131105,over,0,0
131106,the,0,0
131107,subsequent,0,0
131108,week,0,0
131109,.,0,1
131110,Participants,1,1
131111,were,0,0
131112,trained,0,0
131113,to,0,0
131114,adopt,0,0
131115,a,0,0
131116,generally,0,0
131117,positive,0,0
131118,or,0,0
131119,negative,0,0
131120,poststressor,0,0
131121,appraisal,0,0
131122,style,0,0
131123,using,0,0
131124,a,0,0
131125,series,0,0
131126,of,0,0
131127,scripted,0,0
131128,vignettes,0,0
131129,after,0,0
131130,having,0,1
131131,been,0,0
131132,exposed,0,0
131133,to,0,0
131134,highly,0,0
131135,distressing,0,0
131136,film,0,0
131137,clips,0,0
131138,.,0,0
131139,The,0,0
131140,training,0,0
131141,targeted,0,0
131142,self-efficacy,0,0
131143,beliefs,0,0
131144,and,0,0
131145,reappraisals,0,0
131146,of,0,0
131147,secondary,0,0
131148,emotions,0,0
131149,(,0,0
131150,emotions,0,0
131151,in,0,0
131152,response,0,0
131153,to,0,0
131154,the,0,0
131155,emotional,0,0
131156,reactions,0,0
131157,elicited,0,0
131158,by,0,0
131159,the,0,0
131160,film,0,0
131161,),0,0
131162,.,0,0
131163,Successful,0,0
131164,appraisal,0,0
131165,induction,0,0
131166,was,0,0
131167,verified,0,0
131168,using,0,0
131169,novel,0,0
131170,vignettes,0,0
131171,and,0,0
131172,via,0,0
131173,change,0,0
131174,scores,0,0
131175,on,0,0
131176,the,0,0
131177,post,0,0
131178,traumatic,0,0
131179,cognitions,0,0
131180,inventory,0,0
131181,.,0,0
131182,Compared,0,0
131183,with,0,0
131184,those,0,0
131185,trained,0,0
131186,negatively,0,0
131187,",",0,0
131188,those,0,0
131189,trained,0,0
131190,positively,0,0
131191,reported,0,0
131192,in,0,0
131193,a,0,0
131194,diary,0,0
131195,fewer,0,0
131196,intrusive,0,0
131197,memories,0,0
131198,of,0,0
131199,the,0,0
131200,film,0,0
131201,during,0,0
131202,the,0,0
131203,subsequent,0,0
131204,week,0,0
131205,",",0,0
131206,and,0,0
131207,lower,0,0
131208,scores,0,0
131209,on,0,0
131210,the,0,0
131211,Impact,0,0
131212,of,0,0
131213,Event,0,0
131214,Scale,0,0
131215,(,0,0
131216,a,0,0
131217,widely,0,0
131218,used,0,0
131219,measure,0,0
131220,of,0,0
131221,posttraumatic,0,1
131222,stress,0,0
131223,symptoms,0,0
131224,),0,0
131225,.,0,0
131226,Results,0,0
131227,support,0,0
131228,the,0,0
131229,use,0,0
131230,of,0,0
131231,computerized,0,0
131232,",",0,0
131233,nonexplicit,0,0
131234,",",0,0
131235,reappraisal,0,0
131236,training,0,0
131237,after,1,0
131238,a,1,0
131239,stressful,1,0
131240,event,1,0
131241,has,0,0
131242,occurred,0,0
131243,and,0,0
131244,provide,0,0
131245,a,0,0
131246,platform,0,0
131247,for,0,0
131248,future,0,0
131249,translational,0,0
131250,studies,0,0
131251,with,0,1
131252,clinical,0,0
131253,populations,0,1
131254,that,0,0
131255,have,0,0
131256,experienced,0,0
131257,significant,0,0
131258,real-world,0,0
131259,stress,0,0
131260,or,0,0
131261,trauma,0,1
131262,.,0,0
131263,Effects,0,0
131264,of,0,0
131265,a,0,0
131266,Chinese,0,1
131267,medical,0,0
131268,herbs,0,0
131269,complex,0,0
131270,on,0,0
131271,cellular,0,0
131272,immunity,0,0
131273,and,0,0
131274,toxicity-related,0,0
131275,conditions,0,0
131276,of,0,0
131277,breast,1,1
131278,cancer,1,1
131279,patients,1,1
131280,.,1,0
131281,Rose,0,0
131282,geranium,0,0
131283,(,0,0
131284,Pelargonium,0,0
131285,graveolens,0,0
131286,",",0,0
131287,Geraniaceae,0,0
131288,),0,0
131289,has,0,0
131290,anti-cancer,0,0
131291,and,0,0
131292,anti-inflammatory,0,0
131293,properties,0,0
131294,",",0,0
131295,and,0,0
131296,promotes,0,0
131297,wound,0,0
131298,healing,0,0
131299,.,0,0
131300,Similarly,0,0
131301,",",0,0
131302,Ganoderma,0,0
131303,tsugae,0,0
131304,(,0,0
131305,Ganodermataceae,0,0
131306,),0,0
131307,",",0,0
131308,Codonopsis,0,0
131309,pilosula,0,0
131310,(,0,0
131311,Campanulaceae,0,0
131312,),0,0
131313,and,0,0
131314,Angelica,0,0
131315,sinensis,0,0
131316,(,0,0
131317,Apiaceae,0,0
131318,),0,0
131319,are,0,0
131320,traditional,0,0
131321,Chinese,0,1
131322,herbs,0,0
131323,associated,0,0
131324,with,0,1
131325,immunomodulatory,0,0
131326,functions,0,0
131327,.,0,0
131328,In,0,0
131329,the,0,0
131330,present,0,0
131331,study,0,0
131332,",",0,0
131333,a,0,0
131334,randomised,0,0
131335,",",0,0
131336,double-blind,0,0
131337,",",0,0
131338,placebo-controlled,0,0
131339,study,0,0
131340,was,0,0
131341,conducted,0,0
131342,to,0,0
131343,examine,0,0
131344,whether,0,0
131345,the,0,0
131346,Chinese,0,1
131347,medicinal,0,0
131348,herb,0,0
131349,complex,0,0
131350,",",0,0
131351,RG-CMH,0,0
131352,",",0,0
131353,which,0,0
131354,represents,0,0
131355,a,0,0
131356,mixture,0,0
131357,of,0,0
131358,rose,0,0
131359,geranium,0,0
131360,and,0,0
131361,extracts,0,0
131362,of,0,0
131363,G.,0,0
131364,tsugae,0,1
131365,",",0,0
131366,C.,0,0
131367,pilosula,0,0
131368,and,0,0
131369,A.,0,0
131370,sinensis,0,0
131371,",",0,0
131372,can,0,0
131373,improve,0,0
131374,the,0,0
131375,immune,0,0
131376,cell,0,0
131377,count,0,0
131378,of,0,0
131379,cancer,1,1
131380,patients,1,1
131381,receiving,1,0
131382,chemotherapy,1,0
131383,and/or,1,0
131384,radiotherapy,1,0
131385,to,0,0
131386,prevent,0,0
131387,leucopenia,0,0
131388,and,0,0
131389,immune,0,0
131390,impairment,0,0
131391,that,0,0
131392,usually,0,0
131393,occurs,0,0
131394,during,0,0
131395,cancer,0,1
131396,therapy,0,0
131397,.,0,0
131398,A,0,0
131399,total,0,0
131400,of,0,0
131401,fifty-eight,1,1
131402,breast,1,1
131403,cancer,1,1
131404,patients,1,1
131405,who,1,1
131406,received,1,1
131407,chemotherapy,1,1
131408,or,1,0
131409,radiotherapy,1,0
131410,were,1,0
131411,enrolled,1,1
131412,.,1,0
131413,Immune,0,0
131414,cell,0,0
131415,levels,0,0
131416,in,0,0
131417,patient,0,0
131418,serum,0,0
131419,were,0,0
131420,determined,0,0
131421,before,0,0
131422,",",0,0
131423,and,0,0
131424,following,0,0
131425,",",0,0
131426,6,0,0
131427,weeks,0,0
131428,of,0,0
131429,cancer,0,1
131430,treatment,0,0
131431,for,0,0
131432,patients,0,1
131433,receiving,0,1
131434,either,0,0
131435,an,0,0
131436,RG-CMH,0,0
131437,or,0,0
131438,a,0,0
131439,placebo,0,0
131440,.,0,0
131441,Administration,0,0
131442,of,0,0
131443,RG-CMH,0,0
131444,was,0,0
131445,associated,0,0
131446,with,0,0
131447,a,0,0
131448,significant,0,0
131449,reduction,0,0
131450,in,0,0
131451,levels,0,0
131452,of,0,0
131453,leucocytes,0,0
131454,from,0,1
131455,31?5,0,0
131456,%,0,0
131457,for,0,0
131458,the,0,0
131459,placebo,0,0
131460,group,0,0
131461,to,0,0
131462,13?4,0,0
131463,%,0,0
131464,for,0,0
131465,the,0,0
131466,RG-CMH,0,0
131467,group,0,0
131468,.,0,0
131469,Similarly,0,0
131470,",",0,0
131471,levels,0,0
131472,of,0,0
131473,neutrophils,0,0
131474,significantly,0,0
131475,decreased,0,0
131476,from,0,0
131477,35?6,0,0
131478,%,0,0
131479,for,0,0
131480,the,0,0
131481,placebo,0,0
131482,group,0,0
131483,to,0,0
131484,11?0,0,0
131485,%,0,0
131486,for,0,0
131487,the,0,0
131488,RG-CMH,0,0
131489,group,0,0
131490,.,0,0
131491,RG-CMH,0,0
131492,intervention,0,0
131493,was,0,0
131494,also,0,0
131495,associated,0,0
131496,with,0,0
131497,a,0,0
131498,decrease,0,0
131499,in,0,0
131500,levels,0,0
131501,of,0,0
131502,T,0,0
131503,cells,0,0
131504,",",0,0
131505,helper,0,0
131506,T,0,0
131507,cells,0,0
131508,",",0,0
131509,cytotoxic,0,0
131510,T,0,0
131511,cells,0,0
131512,and,0,0
131513,natural,0,0
131514,killer,0,0
131515,cells,0,0
131516,compared,0,0
131517,with,0,1
131518,the,0,0
131519,placebo,0,0
131520,group,0,0
131521,.,0,0
131522,However,0,0
131523,",",0,0
131524,these,0,0
131525,differences,0,0
131526,between,0,0
131527,the,0,0
131528,two,0,0
131529,groups,0,0
131530,were,0,0
131531,not,0,0
131532,statistically,0,0
131533,significant,0,0
131534,.,0,0
131535,In,0,0
131536,conclusion,0,0
131537,",",0,0
131538,administration,0,0
131539,of,0,0
131540,RG-CMH,0,0
131541,to,0,0
131542,patients,0,1
131543,receiving,0,0
131544,chemotherapy/radiotherapy,0,0
131545,may,0,0
131546,have,0,0
131547,the,0,0
131548,capacity,0,0
131549,to,0,0
131550,delay,0,0
131551,",",0,0
131552,or,0,0
131553,ease,0,0
131554,",",0,0
131555,the,0,0
131556,reduction,0,0
131557,in,0,0
131558,levels,0,0
131559,of,0,0
131560,leucocytes,0,0
131561,and,0,0
131562,neutrophils,0,0
131563,that,0,0
131564,are,0,0
131565,experienced,0,0
131566,by,0,0
131567,patients,0,1
131568,during,0,0
131569,cancer,0,1
131570,treatment,0,0
131571,.,0,0
131572,[,0,0
131573,The,0,0
131574,equipotency,0,0
131575,of,0,0
131576,ropivacaine,0,0
131577,",",0,0
131578,bupivacaine,0,0
131579,and,0,0
131580,etidocaine,0,0
131581,],0,0
131582,.,0,0
131583,Ropivacaine,0,0
131584,",",0,0
131585,congenerate,0,0
131586,to,0,0
131587,bupivacaine,0,0
131588,and,0,0
131589,mepivacaine,0,0
131590,has,0,0
131591,been,0,0
131592,widely,0,0
131593,studied,0,0
131594,in,0,0
131595,laboratory,0,0
131596,animals,0,0
131597,",",0,0
131598,but,0,0
131599,there,0,0
131600,have,0,0
131601,been,0,0
131602,few,0,0
131603,investigations,0,0
131604,of,0,0
131605,its,0,0
131606,efficacy,0,0
131607,in,0,0
131608,human,0,0
131609,epidural,0,1
131610,anesthesia,0,0
131611,and,0,0
131612,peripheral,0,0
131613,nerve,0,0
131614,blocks,0,0
131615,.,0,0
131616,The,0,0
131617,aim,0,0
131618,of,0,0
131619,this,0,0
131620,study,0,0
131621,was,0,0
131622,to,0,0
131623,compare,0,0
131624,the,0,0
131625,three,0,0
131626,long-acting,0,0
131627,local,0,0
131628,anesthetics,0,0
131629,(,0,0
131630,bupivacaine,0,0
131631,0.75,0,0
131632,%,0,0
131633,",",0,0
131634,ropivacaine,0,0
131635,1,0,0
131636,%,0,0
131637,and,0,0
131638,etidocaine,0,0
131639,1,0,0
131640,%,0,0
131641,),0,0
131642,and,0,0
131643,to,0,0
131644,try,0,0
131645,",",0,0
131646,with,0,0
131647,reference,0,0
131648,to,0,0
131649,previous,0,0
131650,studies,0,0
131651,",",0,0
131652,to,0,0
131653,make,0,0
131654,some,0,0
131655,statement,0,0
131656,about,0,0
131657,the,0,0
131658,equipotency,0,0
131659,of,0,0
131660,ropivacaine,0,0
131661,relative,0,0
131662,to,0,0
131663,bupivacaine,0,0
131664,and,0,0
131665,etidocaine,0,0
131666,.,0,0
131667,METHODS,0,0
131668,.,0,0
131669,In,0,0
131670,a,0,0
131671,double,0,0
131672,blind,0,0
131673,randomized,0,0
131674,study,0,0
131675,",",0,0
131676,epidural,0,0
131677,anesthesia,0,0
131678,was,0,0
131679,carried,0,0
131680,out,0,0
131681,with,0,1
131682,20,0,1
131683,ml,0,0
131684,bupivacaine,0,0
131685,0.75,0,0
131686,%,0,0
131687,(,0,0
131688,n,0,1
131689,=,0,0
131690,24,0,0
131691,),0,0
131692,and,0,0
131693,ropivacaine,0,0
131694,1,0,0
131695,%,0,0
131696,(,0,0
131697,n,0,1
131698,=,0,0
131699,21,0,1
131700,),0,0
131701,.,0,0
131702,Following,0,0
131703,this,0,0
131704,study,0,0
131705,epidural,0,0
131706,anesthesia,0,0
131707,was,0,0
131708,carried,0,0
131709,out,0,0
131710,with,0,1
131711,20,0,1
131712,ml,0,0
131713,etidocaine,0,0
131714,1,0,0
131715,%,0,0
131716,(,0,0
131717,n,0,1
131718,=,0,0
131719,20,0,1
131720,),0,0
131721,in,0,0
131722,an,0,0
131723,open,0,0
131724,study,0,0
131725,.,0,0
131726,Patients,1,1
131727,with,1,1
131728,ASA,1,0
131729,I,1,0
131730,or,1,0
131731,II,1,0
131732,were,1,0
131733,enrolled,1,1
131734,in,1,0
131735,the,1,0
131736,study,1,0
131737,.,1,0
131738,All,1,0
131739,patients,1,1
131740,were,1,0
131741,scheduled,1,1
131742,for,1,0
131743,varicose,1,0
131744,vein,1,1
131745,stripping,1,0
131746,.,1,0
131747,Male,1,0
131748,and,1,0
131749,female,1,1
131750,patients,1,1
131751,aged,1,1
131752,18-70,1,1
131753,years,1,1
131754,and,1,0
131755,weighing,1,1
131756,50-100,1,0
131757,kg,1,0
131758,were,1,0
131759,included,1,1
131760,in,1,0
131761,the,1,0
131762,study,1,0
131763,.,1,0
131764,Patients,0,1
131765,were,0,0
131766,all,0,0
131767,placed,0,0
131768,in,0,0
131769,a,0,0
131770,sitting,0,0
131771,position,0,0
131772,",",0,0
131773,after,0,0
131774,which,0,0
131775,the,0,0
131776,epidural,0,0
131777,space,0,0
131778,was,0,0
131779,identified,0,0
131780,by,0,0
131781,the,0,0
131782,loss,0,0
131783,of,0,0
131784,resistance,0,0
131785,technique,0,0
131786,and,0,0
131787,a,0,0
131788,midline,0,0
131789,approach,0,0
131790,",",0,0
131791,at,0,0
131792,the,0,0
131793,L-3/4,0,0
131794,interspace,0,0
131795,.,0,0
131796,Injections,0,0
131797,of,0,0
131798,3,0,0
131799,ml,0,0
131800,of,0,0
131801,the,0,0
131802,local,0,0
131803,anesthetic,0,0
131804,were,0,0
131805,given,0,0
131806,",",0,0
131807,followed,0,0
131808,by,0,0
131809,the,0,0
131810,remainder,0,0
131811,of,0,0
131812,the,0,0
131813,local,0,0
131814,anesthetic,0,0
131815,at,0,0
131816,10,0,0
131817,ml/min,0,0
131818,1,0,0
131819,min,0,0
131820,later,0,0
131821,.,0,0
131822,Following,0,0
131823,injection,0,0
131824,patients,0,1
131825,were,0,0
131826,immediately,0,0
131827,positioned,0,0
131828,supine,0,0
131829,.,0,0
131830,Analgesia,0,0
131831,was,0,0
131832,determined,0,0
131833,by,0,0
131834,the,0,0
131835,pin-prick,0,0
131836,method,0,0
131837,and,0,0
131838,motor,0,0
131839,blockade,0,0
131840,was,0,0
131841,assessed,0,0
131842,according,0,0
131843,to,0,0
131844,the,0,0
131845,Bromage,0,0
131846,scale,0,0
131847,.,0,0
131848,Heart,0,0
131849,rate,0,0
131850,and,0,0
131851,blood,0,0
131852,pressure,0,0
131853,were,0,0
131854,monitored,0,0
131855,until,0,0
131856,3,0,0
131857,h,0,0
131858,after,0,0
131859,injection,0,0
131860,.,0,0
131861,RESULTS,0,0
131862,.,0,0
131863,The,0,0
131864,latency,0,0
131865,of,0,0
131866,analgesia,0,0
131867,for,0,0
131868,the,0,0
131869,first,0,0
131870,blocked,0,0
131871,segment,0,0
131872,(,0,0
131873,T,0,0
131874,12,0,0
131875,for,0,0
131876,bupivacaine,0,0
131877,and,0,0
131878,ropivacaine,0,0
131879,and,0,0
131880,L-1,0,0
131881,for,0,0
131882,etidocaine,0,0
131883,),0,0
131884,was,0,0
131885,6.0,0,0
131886,min,0,0
131887,for,0,0
131888,bupivacaine,0,0
131889,0.75,0,0
131890,",",0,0
131891,5.5,0,0
131892,min,0,0
131893,for,0,0
131894,ropivacaine,0,0
131895,1,0,0
131896,%,0,0
131897,",",0,0
131898,and,0,0
131899,5.2,0,0
131900,min,0,0
131901,for,0,0
131902,etidocaine,0,0
131903,1,0,0
131904,%,0,0
131905,",",0,0
131906,and,0,0
131907,the,0,0
131908,highest,0,0
131909,thoracic,0,0
131910,dermatome,0,0
131911,(,0,0
131912,T,0,0
131913,5,0,0
131914,for,0,0
131915,bupivacaine,0,0
131916,",",0,0
131917,T,0,0
131918,4,0,0
131919,for,0,0
131920,ropivacaine,0,0
131921,and,0,0
131922,T,0,0
131923,7,0,0
131924,for,0,0
131925,etidocaine,0,0
131926,),0,0
131927,was,0,0
131928,reached,0,0
131929,after,0,0
131930,24,0,0
131931,+/-,0,0
131932,10,0,0
131933,",",0,0
131934,26,0,1
131935,+/-,0,0
131936,9,0,0
131937,",",0,0
131938,and,0,0
131939,30,0,0
131940,+/-,0,0
131941,18,0,1
131942,min,0,0
131943,for,0,0
131944,bupivacaine,0,0
131945,",",0,0
131946,ropivacaine,0,0
131947,",",0,0
131948,and,0,0
131949,etidocaine,0,0
131950,",",0,0
131951,respectively,0,0
131952,.,0,0
131953,The,0,0
131954,duration,0,0
131955,of,0,0
131956,sensory,0,0
131957,anesthesia,0,0
131958,at,0,0
131959,the,0,0
131960,T,0,0
131961,10,0,0
131962,dermatomal,0,0
131963,level,0,0
131964,was,0,0
131965,257,0,1
131966,+/-,0,0
131967,102,0,1
131968,",",0,0
131969,278,0,1
131970,+/-,0,0
131971,67,0,0
131972,",",0,0
131973,and,0,0
131974,191,0,1
131975,+/-,0,0
131976,86,0,1
131977,min,0,0
131978,for,0,0
131979,bupivacaine,0,0
131980,",",0,0
131981,ropivacaine,0,0
131982,",",0,0
131983,and,0,0
131984,etidocaine,0,0
131985,",",0,0
131986,respectively,0,0
131987,.,0,0
131988,The,0,0
131989,two-segment,0,0
131990,regression,0,0
131991,time,0,0
131992,was,0,0
131993,199,0,1
131994,+/-,0,0
131995,80,0,1
131996,min,0,0
131997,for,0,0
131998,bupivacaine,0,0
131999,",",0,0
132000,201,0,1
132001,+/-,0,0
132002,52,0,1
132003,min,0,0
132004,for,0,0
132005,ropivacaine,0,0
132006,",",0,0
132007,and,0,0
132008,174,0,1
132009,+/-,0,0
132010,81,0,1
132011,min,0,0
132012,for,0,0
132013,etidocaine,0,0
132014,.,0,0
132015,The,0,0
132016,total,0,0
132017,duration,0,0
132018,of,0,0
132019,sensory,0,0
132020,block,0,0
132021,was,0,0
132022,340,0,1
132023,+/-,0,0
132024,103,0,1
132025,min,0,0
132026,for,0,0
132027,bupivacaine,0,0
132028,",",0,0
132029,428,0,1
132030,+/-,0,0
132031,65,0,1
132032,min,0,0
132033,for,0,0
132034,ropivacaine,0,0
132035,and,0,0
132036,223,0,1
132037,+/-,0,0
132038,62,0,1
132039,min,0,0
132040,for,0,0
132041,etidocaine,0,0
132042,",",0,0
132043,respectively,0,0
132044,.,0,0
132045,In,0,0
132046,the,0,0
132047,ropivacaine,0,0
132048,and,0,0
132049,bupivacaine,0,0
132050,groups,0,0
132051,sensory,0,0
132052,anesthesia,0,1
132053,was,0,0
132054,considered,0,0
132055,adequate,0,0
132056,for,0,0
132057,surgery,0,1
132058,in,0,0
132059,all,0,0
132060,cases,0,0
132061,but,0,0
132062,one,0,0
132063,in,0,0
132064,each,0,0
132065,group,0,0
132066,;,0,0
132067,in,0,0
132068,the,0,0
132069,etidocaine,0,0
132070,group,0,0
132071,",",0,0
132072,however,0,0
132073,60,0,0
132074,%,0,0
132075,of,0,0
132076,the,0,0
132077,patients,0,1
132078,showed,0,0
132079,inadequate,0,0
132080,analgesia,0,0
132081,and,0,0
132082,all,0,0
132083,these,0,0
132084,patients,0,1
132085,(,0,0
132086,12/20,0,1
132087,),0,0
132088,required,0,0
132089,additional,0,0
132090,analgesics,0,0
132091,.,0,1
132092,Bupivacaine,0,0
132093,achieved,0,0
132094,an,0,0
132095,average,0,0
132096,of,0,0
132097,motor,0,0
132098,block,0,0
132099,2.1,0,0
132100,",",0,0
132101,ropivacaine,0,0
132102,2.3,0,0
132103,",",0,0
132104,and,0,0
132105,etidocaine,0,0
132106,2.4,0,0
132107,.,0,0
132108,CONCLUSION,0,0
132109,.,0,0
132110,The,0,0
132111,results,0,0
132112,of,0,0
132113,this,0,0
132114,study,0,0
132115,indicate,0,0
132116,that,0,0
132117,ropivacaine,0,0
132118,is,0,0
132119,an,0,0
132120,effective,0,0
132121,local,0,0
132122,anesthetic,0,0
132123,agent,0,0
132124,.,0,0
132125,Its,0,0
132126,potency,0,0
132127,is,0,0
132128,about,0,0
132129,equal,0,0
132130,to,0,0
132131,that,0,0
132132,of,0,0
132133,bupivacaine,0,0
132134,and,0,0
132135,much,0,0
132136,higher,0,0
132137,than,0,0
132138,that,0,0
132139,of,0,0
132140,etidocaine,0,0
132141,...,0,0
132142,The,0,0
132143,effectiveness,0,0
132144,and,0,0
132145,cost,0,0
132146,of,0,0
132147,passive,0,0
132148,warming,0,0
132149,in,0,0
132150,adult,1,1
132151,ambulatory,1,1
132152,surgery,1,1
132153,patients,1,1
132154,.,1,0
132155,Hypothermia,0,0
132156,is,0,0
132157,a,0,0
132158,common,0,0
132159,problem,0,0
132160,for,0,0
132161,surgical,1,1
132162,patients,1,1
132163,and,0,0
132164,can,0,0
132165,result,0,0
132166,in,0,0
132167,many,0,1
132168,complications,0,0
132169,.,0,1
132170,Because,0,0
132171,few,0,0
132172,studies,0,0
132173,compare,0,0
132174,methods,0,1
132175,of,0,0
132176,passive,0,0
132177,warming,0,0
132178,",",0,0
132179,we,0,0
132180,used,0,0
132181,an,0,0
132182,unblinded,0,0
132183,",",0,0
132184,prospective,0,0
132185,",",0,0
132186,experimental,0,0
132187,",",0,0
132188,randomized,0,0
132189,design,0,0
132190,to,0,0
132191,compare,0,0
132192,the,0,0
132193,effectiveness,0,0
132194,of,0,0
132195,two,0,0
132196,passive,0,0
132197,methods,0,1
132198,of,0,0
132199,normothermia,0,1
132200,management,0,0
132201,in,0,0
132202,the,0,0
132203,postanesthesia,0,0
132204,care,0,0
132205,unit,0,0
132206,(,0,0
132207,PACU,0,0
132208,),0,0
132209,.,0,0
132210,We,0,0
132211,assigned,0,0
132212,a,0,0
132213,total,0,0
132214,of,0,0
132215,578,1,1
132216,adult,1,1
132217,ambulatory,1,1
132218,surgery,1,1
132219,patients,1,1
132220,to,0,0
132221,either,0,0
132222,a,0,0
132223,control,0,0
132224,group,0,0
132225,that,0,0
132226,was,0,0
132227,given,0,0
132228,two,0,0
132229,folded,0,0
132230,",",0,0
132231,warmed,0,0
132232,cotton,0,0
132233,blankets,0,0
132234,or,0,0
132235,a,0,0
132236,treatment,0,0
132237,group,0,0
132238,that,0,0
132239,was,0,0
132240,given,0,0
132241,a,0,0
132242,warmed,0,0
132243,",",0,0
132244,unfolded,0,0
132245,cotton,0,0
132246,sheet,0,0
132247,and,0,0
132248,cotton,0,0
132249,blanket,0,0
132250,.,0,0
132251,We,0,0
132252,recorded,0,0
132253,patients,0,1
132254,',0,1
132255,temperatures,0,1
132256,on,0,0
132257,their,0,0
132258,arrival,0,0
132259,in,0,0
132260,the,0,0
132261,PACU,0,0
132262,and,0,0
132263,at,0,0
132264,30,0,0
132265,minutes,0,0
132266,after,0,0
132267,arrival,0,1
132268,.,0,0
132269,The,0,0
132270,treatment,0,0
132271,group,0,0
132272,had,0,0
132273,temperatures,0,0
132274,that,0,0
132275,were,0,0
132276,significantly,0,0
132277,higher,0,0
132278,than,0,0
132279,those,0,0
132280,of,0,0
132281,the,0,0
132282,control,0,0
132283,group,0,0
132284,30,0,0
132285,minutes,0,0
132286,after,0,0
132287,arrival,0,0
132288,in,0,0
132289,the,0,0
132290,PACU,0,0
132291,",",0,0
132292,and,0,0
132293,the,0,0
132294,treatment,0,0
132295,group,0,0
132296,experienced,0,0
132297,a,0,0
132298,greater,0,0
132299,change,0,0
132300,in,0,0
132301,temperature,0,0
132302,from,0,0
132303,baseline,0,0
132304,measurements,0,0
132305,to,0,0
132306,those,0,0
132307,taken,0,0
132308,at,0,0
132309,30,0,1
132310,minutes,0,0
132311,.,0,0
132312,The,0,0
132313,treatment,0,0
132314,group,0,0
132315,also,0,0
132316,used,0,0
132317,fewer,0,0
132318,warmed,0,0
132319,blankets,0,0
132320,",",0,0
132321,resulting,0,0
132322,in,0,0
132323,cost,0,0
132324,savings,0,0
132325,for,0,0
132326,the,0,0
132327,PACU,0,0
132328,.,0,0
132329,[,0,0
132330,Treatment,0,0
132331,of,0,0
132332,primary,0,0
132333,osteoporosis,0,1
132334,with,0,1
132335,calcium,0,0
132336,and,0,0
132337,salmon,0,0
132338,calcitonin,0,0
132339,],0,0
132340,.,0,0
132341,Fifty-nine,1,1
132342,consecutive,1,1
132343,patients,1,1
132344,(,1,1
132345,19,1,1
132346,men,1,1
132347,",",1,0
132348,40,1,1
132349,women,1,1
132350,",",1,0
132351,mean,1,0
132352,age,1,1
132353,60.8,1,0
132354,[,1,0
132355,27-80,1,1
132356,],1,1
132357,years,1,1
132358,),1,0
132359,with,1,1
132360,primary,1,0
132361,osteoporosis,1,1
132362,were,0,0
132363,studied,0,0
132364,to,0,0
132365,see,0,0
132366,if,0,0
132367,there,0,0
132368,was,0,0
132369,any,0,0
132370,significant,0,0
132371,gain,0,0
132372,in,0,0
132373,bone,0,0
132374,mass,0,0
132375,after,0,0
132376,treatment,0,0
132377,with,0,1
132378,salmon,0,0
132379,calcitonin,0,0
132380,.,0,0
132381,All,0,0
132382,the,0,0
132383,patients,0,1
132384,were,0,0
132385,given,0,0
132386,1,0,0
132387,g,0,0
132388,calcium,0,0
132389,by,0,0
132390,mouth,0,0
132391,every,0,0
132392,morning,0,0
132393,.,0,0
132394,Group,0,0
132395,1,0,0
132396,(,0,0
132397,n,0,1
132398,=,0,0
132399,20,0,1
132400,),0,0
132401,received,0,0
132402,no,0,0
132403,other,0,0
132404,specific,0,0
132405,medication,0,0
132406,while,0,0
132407,group,0,0
132408,2,0,0
132409,(,0,0
132410,n,0,1
132411,=,0,0
132412,19,0,1
132413,),0,0
132414,were,0,0
132415,given,0,0
132416,100,0,0
132417,I.U,0,0
132418,.,0,0
132419,calcitonin,0,0
132420,subcutaneously,0,0
132421,every,0,0
132422,second,0,0
132423,evening,0,0
132424,and,0,0
132425,group,0,0
132426,3,0,0
132427,(,0,0
132428,n,0,1
132429,=,0,0
132430,20,0,1
132431,),0,0
132432,received,0,0
132433,the,0,0
132434,same,0,0
132435,dose,0,0
132436,every,0,0
132437,evening,0,0
132438,.,0,0
132439,The,0,0
132440,pain,0,0
132441,reported,0,0
132442,by,0,0
132443,the,0,0
132444,patients,0,1
132445,was,0,0
132446,subdivided,0,1
132447,into,0,0
132448,four,0,0
132449,severity,0,0
132450,grades,0,0
132451,",",0,0
132452,and,0,0
132453,analgesic,0,0
132454,consumption,0,0
132455,was,0,0
132456,recorded,0,0
132457,.,0,0
132458,In,0,0
132459,group,0,0
132460,1,0,0
132461,there,0,0
132462,was,0,0
132463,a,0,0
132464,nonsignificant,0,0
132465,decrease,0,0
132466,in,0,0
132467,pain,0,0
132468,",",0,0
132469,but,0,0
132470,in,0,0
132471,groups,0,0
132472,2,0,1
132473,and,0,0
132474,3,0,0
132475,there,0,0
132476,was,0,0
132477,a,0,0
132478,highly,0,0
132479,significant,0,0
132480,diminution,0,0
132481,in,0,0
132482,pain,0,0
132483,(,0,0
132484,P,0,0
132485,less,0,0
132486,than,0,0
132487,0.005,0,0
132488,),0,0
132489,and,0,0
132490,in,0,0
132491,analgesic,0,0
132492,intake,0,0
132493,(,0,0
132494,P,0,0
132495,less,0,0
132496,than,0,0
132497,0.01,0,0
132498,),0,0
132499,.,0,0
132500,Measurements,0,0
132501,of,0,0
132502,bone,0,0
132503,density,0,0
132504,carried,0,0
132505,out,0,0
132506,by,0,0
132507,photon,0,0
132508,absorption,0,0
132509,at,0,0
132510,the,0,0
132511,end,0,0
132512,of,0,0
132513,12,0,0
132514,months,0,0
132515,showed,0,0
132516,a,0,0
132517,5.5,0,0
132518,%,0,0
132519,increase,0,0
132520,in,0,0
132521,the,0,0
132522,distal,0,0
132523,radius,0,0
132524,in,0,0
132525,group,0,0
132526,2,0,0
132527,(,0,0
132528,P,0,0
132529,=,0,0
132530,0.0001,0,0
132531,),0,0
132532,and,0,0
132533,a,0,0
132534,7.1,0,0
132535,%,0,0
132536,increase,0,0
132537,in,0,0
132538,group,0,0
132539,3,0,0
132540,(,0,0
132541,P,0,0
132542,=,0,0
132543,0.0001,0,0
132544,),0,0
132545,",",0,0
132546,while,0,0
132547,in,0,0
132548,group,0,0
132549,1,0,0
132550,mineral,0,0
132551,content,0,0
132552,had,0,0
132553,decreased,0,0
132554,by,0,0
132555,4.3,0,0
132556,%,0,0
132557,(,0,0
132558,nonsignificant,0,0
132559,),0,0
132560,.,0,0
132561,These,0,0
132562,results,0,0
132563,show,0,0
132564,that,0,0
132565,a,0,0
132566,significant,0,0
132567,gain,0,0
132568,in,0,0
132569,bone,0,0
132570,mass,0,0
132571,can,0,0
132572,be,0,0
132573,achieved,0,0
132574,by,0,0
132575,administration,0,0
132576,of,0,0
132577,calcitonin,0,0
132578,",",0,0
132579,either,0,0
132580,daily,0,0
132581,or,0,0
132582,on,0,0
132583,alternate,0,0
132584,days,0,0
132585,.,0,0
132586,The,0,0
132587,incidence,0,0
132588,of,0,0
132589,extravertebral,0,0
132590,fractures,0,1
132591,and,0,0
132592,of,0,0
132593,new,0,0
132594,or,0,1
132595,progressive,0,0
132596,vertebral,0,0
132597,deformity,0,0
132598,tended,0,0
132599,to,0,0
132600,be,0,0
132601,lower,0,0
132602,in,0,0
132603,groups,0,0
132604,2,0,1
132605,and,0,0
132606,3,0,0
132607,than,0,0
132608,in,0,0
132609,group,0,0
132610,1,0,0
132611,.,0,0
132612,A,0,0
132613,phase,0,0
132614,IIb,0,0
132615,dose-ranging,0,0
132616,study,0,0
132617,of,0,0
132618,the,0,0
132619,oral,0,0
132620,JAK,0,0
132621,inhibitor,0,0
132622,tofacitinib,0,0
132623,(,0,0
132624,"CP-690,550",0,0
132625,),0,0
132626,versus,0,0
132627,placebo,0,0
132628,in,0,0
132629,combination,0,0
132630,with,0,1
132631,background,0,0
132632,methotrexate,0,0
132633,in,0,0
132634,patients,1,1
132635,with,1,1
132636,active,1,1
132637,rheumatoid,1,1
132638,arthritis,1,1
132639,and,1,0
132640,an,1,0
132641,inadequate,1,0
132642,response,1,0
132643,to,1,0
132644,methotrexate,1,0
132645,alone,1,0
132646,.,1,0
132647,OBJECTIVE,0,0
132648,To,0,0
132649,compare,0,0
132650,the,0,0
132651,efficacy,0,0
132652,",",0,0
132653,safety,0,0
132654,",",0,0
132655,and,0,0
132656,tolerability,0,0
132657,of,0,0
132658,6,0,0
132659,dosages,0,0
132660,of,0,0
132661,oral,0,0
132662,tofacitinib,0,0
132663,(,0,0
132664,"CP-690,550",0,0
132665,),0,0
132666,with,0,0
132667,placebo,0,0
132668,for,0,0
132669,the,0,0
132670,treatment,0,0
132671,of,0,0
132672,active,1,0
132673,rheumatoid,1,1
132674,arthritis,1,1
132675,(,1,0
132676,RA,1,0
132677,),1,0
132678,in,1,0
132679,patients,1,1
132680,receiving,1,1
132681,a,1,0
132682,stable,1,1
132683,background,1,0
132684,regimen,1,0
132685,of,1,0
132686,methotrexate,1,0
132687,(,1,0
132688,MTX,1,1
132689,),1,1
132690,who,1,1
132691,have,1,0
132692,an,1,1
132693,inadequate,1,0
132694,response,1,0
132695,to,1,0
132696,MTX,1,0
132697,monotherapy,1,0
132698,.,1,0
132699,METHODS,0,0
132700,In,0,0
132701,this,0,0
132702,24-week,0,0
132703,",",0,0
132704,double-blind,0,0
132705,",",0,0
132706,phase,0,0
132707,IIb,0,0
132708,study,0,0
132709,",",0,0
132710,patients,1,1
132711,with,1,1
132712,active,1,1
132713,RA,1,0
132714,(,1,0
132715,n,1,1
132716,=,1,0
132717,507,1,1
132718,),1,0
132719,were,0,0
132720,randomized,0,0
132721,to,0,0
132722,receive,0,0
132723,placebo,0,0
132724,or,0,0
132725,tofacitinib,0,0
132726,(,0,0
132727,20,0,0
132728,mg/day,0,0
132729,",",0,0
132730,1,0,0
132731,mg,0,0
132732,twice,0,0
132733,daily,0,0
132734,",",0,0
132735,3,0,0
132736,mg,0,0
132737,twice,0,0
132738,daily,0,0
132739,",",0,0
132740,5,0,0
132741,mg,0,0
132742,twice,0,0
132743,daily,0,0
132744,",",0,0
132745,10,0,0
132746,mg,0,0
132747,twice,0,0
132748,daily,0,0
132749,",",0,0
132750,or,0,0
132751,15,0,0
132752,mg,0,0
132753,twice,0,0
132754,daily,0,0
132755,),0,0
132756,.,0,0
132757,All,0,0
132758,patients,0,1
132759,continued,0,0
132760,to,0,0
132761,receive,0,0
132762,a,0,0
132763,stable,0,0
132764,dosage,0,0
132765,of,0,0
132766,MTX,0,0
132767,.,0,0
132768,The,0,0
132769,primary,0,0
132770,end,0,0
132771,point,0,0
132772,was,0,0
132773,the,0,0
132774,American,0,1
132775,College,0,1
132776,of,0,0
132777,Rheumatology,0,1
132778,20,0,1
132779,%,0,0
132780,improvement,0,0
132781,criteria,0,1
132782,(,0,0
132783,ACR20,0,0
132784,),0,0
132785,response,0,0
132786,rate,0,0
132787,at,0,0
132788,week,0,0
132789,12,0,0
132790,.,0,0
132791,RESULTS,0,0
132792,At,0,0
132793,week,0,0
132794,12,0,0
132795,",",0,0
132796,ACR20,0,0
132797,response,0,0
132798,rates,0,0
132799,for,0,0
132800,patients,0,1
132801,receiving,0,1
132802,all,0,0
132803,tofacitinib,0,0
132804,dosages,0,0
132805,?3,0,0
132806,mg,0,0
132807,twice,0,0
132808,daily,0,0
132809,(,0,0
132810,52.9,0,0
132811,%,0,0
132812,for,0,0
132813,3,0,0
132814,mg,0,0
132815,twice,0,0
132816,daily,0,0
132817,",",0,0
132818,50.7,0,0
132819,%,0,0
132820,for,0,0
132821,5,0,0
132822,mg,0,0
132823,twice,0,0
132824,daily,0,0
132825,",",0,0
132826,58.1,0,0
132827,%,0,0
132828,for,0,0
132829,10,0,0
132830,mg,0,0
132831,twice,0,0
132832,daily,0,0
132833,",",0,0
132834,56.0,0,0
132835,%,0,0
132836,for,0,0
132837,15,0,0
132838,mg,0,0
132839,twice,0,0
132840,daily,0,0
132841,",",0,0
132842,and,0,0
132843,53.8,0,0
132844,%,0,0
132845,for,0,0
132846,20,0,0
132847,mg/day,0,0
132848,),0,0
132849,were,0,0
132850,significantly,0,0
132851,(,0,0
132852,P,0,0
132853,?,0,0
132854,0.05,0,0
132855,),0,0
132856,greater,0,0
132857,than,0,0
132858,those,0,0
132859,for,0,0
132860,placebo,0,0
132861,(,0,0
132862,33.3,0,0
132863,%,0,0
132864,),0,0
132865,.,0,0
132866,Improvements,0,0
132867,were,0,0
132868,sustained,0,0
132869,at,0,0
132870,week,0,0
132871,24,0,0
132872,for,0,0
132873,the,0,0
132874,ACR20,0,0
132875,",",0,0
132876,ACR50,0,0
132877,",",0,0
132878,and,0,0
132879,ACR70,0,1
132880,responses,0,0
132881,",",0,0
132882,scores,0,0
132883,for,0,0
132884,the,0,0
132885,Health,0,0
132886,Assessment,0,0
132887,Questionnaire,0,0
132888,disability,0,0
132889,index,0,0
132890,",",0,0
132891,the,0,0
132892,3-variable,0,0
132893,Disease,0,1
132894,Activity,0,0
132895,Score,0,0
132896,in,0,0
132897,28,0,1
132898,joints,0,0
132899,using,0,0
132900,the,0,0
132901,C-reactive,0,0
132902,protein,0,0
132903,level,0,0
132904,(,0,0
132905,DAS28-CRP,0,1
132906,),0,0
132907,",",0,0
132908,and,0,0
132909,a,0,0
132910,3-variable,0,0
132911,DAS28-CRP,0,1
132912,of,0,0
132913,<,0,0
132914,2.6,0,0
132915,.,0,0
132916,The,0,0
132917,most,0,0
132918,common,0,0
132919,treatment-emergent,0,0
132920,adverse,0,0
132921,events,0,0
132922,occurring,0,1
132923,in,0,0
132924,>,0,1
132925,10,0,0
132926,%,0,0
132927,of,0,0
132928,patients,0,1
132929,in,0,0
132930,any,0,0
132931,tofacitinib,0,0
132932,group,0,0
132933,were,0,0
132934,diarrhea,0,0
132935,",",0,0
132936,upper,0,0
132937,respiratory,0,0
132938,tract,0,1
132939,infection,0,0
132940,",",0,0
132941,and,0,0
132942,headache,0,0
132943,;,0,0
132944,21,0,1
132945,patients,0,1
132946,(,0,0
132947,4.1,0,0
132948,%,0,0
132949,),0,0
132950,experienced,0,0
132951,serious,0,0
132952,adverse,0,0
132953,events,0,0
132954,.,0,1
132955,Sporadic,0,1
132956,increases,0,0
132957,in,0,0
132958,transaminase,0,0
132959,levels,0,0
132960,",",0,0
132961,increases,0,0
132962,in,0,0
132963,cholesterol,0,0
132964,and,0,0
132965,serum,0,0
132966,creatinine,0,0
132967,levels,0,0
132968,",",0,0
132969,and,0,0
132970,decreases,0,0
132971,in,0,0
132972,neutrophil,0,0
132973,and,0,0
132974,hemoglobin,0,0
132975,levels,0,0
132976,were,0,0
132977,observed,0,0
132978,.,0,0
132979,CONCLUSION,1,0
132980,In,1,0
132981,patients,1,1
132982,with,1,1
132983,active,1,1
132984,RA,1,1
132985,in,1,0
132986,whom,1,1
132987,the,1,1
132988,response,1,0
132989,to,1,0
132990,MTX,1,0
132991,has,1,0
132992,been,1,0
132993,inadequate,1,0
132994,",",1,0
132995,the,1,0
132996,addition,0,0
132997,of,0,0
132998,tofacitinib,0,0
132999,at,0,0
133000,a,0,0
133001,dosage,0,0
133002,?3,0,0
133003,mg,0,0
133004,twice,0,0
133005,daily,0,0
133006,showed,0,0
133007,sustained,0,0
133008,efficacy,0,0
133009,and,0,0
133010,a,0,0
133011,manageable,0,0
133012,safety,0,0
133013,profile,0,0
133014,over,0,0
133015,24,0,0
133016,weeks,0,0
133017,.,0,1
133018,Comparison,0,0
133019,of,0,0
133020,double-,0,0
133021,and,0,0
133022,single-dose,0,0
133023,methotrexate,0,0
133024,protocols,0,0
133025,for,0,0
133026,treatment,0,0
133027,of,0,0
133028,ectopic,0,1
133029,pregnancy,0,1
133030,.,0,0
133031,OBJECTIVE,0,0
133032,To,0,0
133033,compare,0,0
133034,efficacy,0,0
133035,between,0,0
133036,double-dose,0,0
133037,methotrexate,0,0
133038,and,0,0
133039,single-dose,0,0
133040,methotrexate,0,0
133041,for,0,0
133042,treatment,0,0
133043,of,0,0
133044,tubal,0,1
133045,ectopic,0,1
133046,pregnancy,0,1
133047,(,0,0
133048,EP,0,0
133049,),0,0
133050,.,0,0
133051,METHODS,0,0
133052,Between,1,0
133053,March,1,1
133054,2008,1,1
133055,and,1,0
133056,February,1,1
133057,"2011,157",1,1
133058,patients,1,1
133059,who,1,1
133060,had,1,1
133061,tubal,1,1
133062,EP,1,0
133063,diagnosed,1,1
133064,by,1,0
133065,a,1,0
133066,non-laparoscopic,1,1
133067,approach,1,0
133068,and,1,0
133069,were,1,0
133070,hemodynamically,1,1
133071,stable,1,1
133072,were,1,0
133073,enrolled,1,1
133074,in,1,0
133075,a,1,0
133076,prospective,1,0
133077,study,1,0
133078,in,1,0
133079,Qassim,1,0
133080,",",1,0
133081,Saudi,1,1
133082,Arabia,1,1
133083,.,1,0
133084,The,0,0
133085,participants,0,0
133086,were,0,0
133087,randomized,0,0
133088,to,0,0
133089,receive,0,0
133090,either,0,0
133091,double-dose,0,0
133092,(,0,0
133093,50mg/m,0,0
133094,(,0,0
133095,2,0,0
133096,),0,0
133097,intramuscularly,0,0
133098,on,0,0
133099,days,0,0
133100,0,0,0
133101,and,0,1
133102,4,0,0
133103,;,0,0
133104,group,0,0
133105,1,0,0
133106,),0,0
133107,or,0,0
133108,single-dose,0,0
133109,(,0,0
133110,50mg/m,0,0
133111,(,0,0
133112,2,0,0
133113,),0,0
133114,intramuscularly,0,0
133115,on,0,0
133116,day,0,0
133117,0,0,0
133118,;,0,0
133119,group,0,0
133120,2,0,0
133121,),0,0
133122,methotrexate,0,0
133123,.,0,0
133124,Serum,0,0
133125,human,0,0
133126,chorionic,0,0
133127,gonadotropin,0,0
133128,(,0,0
133129,?-hCG,0,0
133130,),0,0
133131,levels,0,0
133132,were,0,0
133133,followed,0,0
133134,until,0,0
133135,negative,0,0
133136,.,0,0
133137,RESULTS,0,0
133138,The,0,0
133139,overall,0,0
133140,success,0,0
133141,rate,0,0
133142,was,0,0
133143,comparable,0,0
133144,between,0,0
133145,groups,0,0
133146,1,0,0
133147,and,0,0
133148,2,0,0
133149,(,0,0
133150,88.6,0,0
133151,%,0,0
133152,versus,0,0
133153,82.0,0,0
133154,%,0,0
133155,",",0,0
133156,P=0.1,0,0
133157,),0,0
133158,.,0,0
133159,The,0,0
133160,duration,0,0
133161,of,0,0
133162,follow,0,0
133163,up,0,0
133164,until,0,0
133165,negative,0,0
133166,?-hCG,0,0
133167,was,0,0
133168,shorter,0,0
133169,in,0,0
133170,group,0,0
133171,1,0,0
133172,(,0,0
133173,P=0.001,0,0
133174,),0,0
133175,.,0,0
133176,Receiver,0,0
133177,operative,0,0
133178,characteristics,0,0
133179,showed,0,0
133180,that,0,0
133181,higher,0,0
133182,cut-off,0,0
133183,levels,0,0
133184,of,0,0
133185,?-hCG,0,0
133186,and,0,0
133187,gestational,0,1
133188,mass,0,0
133189,diameter,0,0
133190,were,0,0
133191,associated,0,0
133192,with,0,1
133193,successful,0,0
133194,outcome,0,0
133195,in,0,0
133196,group,0,0
133197,1,0,0
133198,.,0,0
133199,Among,0,1
133200,participants,0,1
133201,with,0,1
133202,initial,0,0
133203,?-hCG,0,0
133204,of,0,0
133205,3600-5500,0,1
133206,mIU/mL,0,0
133207,",",0,0
133208,the,0,0
133209,success,0,0
133210,rate,0,0
133211,was,0,0
133212,higher,0,0
133213,in,0,0
133214,group,0,0
133215,1,0,0
133216,(,0,0
133217,P=0.03,0,0
133218,),0,0
133219,.,0,0
133220,There,0,0
133221,was,0,0
133222,no,0,0
133223,significant,0,0
133224,difference,0,0
133225,between,0,0
133226,groups,0,0
133227,in,0,0
133228,adverse,0,0
133229,effects,0,0
133230,.,0,1
133231,CONCLUSION,0,0
133232,For,0,0
133233,treatment,0,0
133234,of,0,0
133235,EP,0,0
133236,",",0,0
133237,double-dose,0,0
133238,methotrexate,0,0
133239,had,0,0
133240,efficacy,0,0
133241,and,0,0
133242,safety,0,0
133243,comparable,0,0
133244,to,0,0
133245,that,0,0
133246,of,0,0
133247,single-dose,0,0
133248,methotrexate,0,0
133249,;,0,0
133250,it,0,0
133251,had,0,0
133252,better,0,0
133253,success,0,0
133254,among,0,0
133255,patients,0,1
133256,with,0,1
133257,moderately,0,1
133258,high,0,0
133259,?-hCG,0,0
133260,and,0,0
133261,led,0,0
133262,to,0,0
133263,a,0,0
133264,shorter,0,0
133265,follow,0,0
133266,up,0,0
133267,.,0,0
133268,Standard,0,0
133269,versus,0,0
133270,extended,0,0
133271,lymphadenectomy,0,0
133272,in,0,0
133273,radical,0,0
133274,pancreatoduodenectomy,0,1
133275,for,0,0
133276,ductal,0,1
133277,adenocarcinoma,0,1
133278,of,0,0
133279,the,0,0
133280,head,0,0
133281,of,0,0
133282,the,0,0
133283,pancreas,0,1
133284,:,0,1
133285,long-term,0,0
133286,results,0,0
133287,of,0,0
133288,a,0,0
133289,Japanese,0,1
133290,multicenter,0,0
133291,randomized,0,0
133292,controlled,0,0
133293,trial,0,0
133294,.,0,0
133295,BACKGROUND,0,0
133296,The,0,0
133297,value,0,0
133298,of,0,0
133299,pancreatoduodenectomy,0,1
133300,(,0,0
133301,PD,0,0
133302,),0,0
133303,with,0,0
133304,extended,0,0
133305,lymphadenectomy,0,0
133306,for,0,0
133307,pancreatic,0,1
133308,cancer,0,1
133309,has,0,0
133310,been,0,0
133311,evaluated,0,0
133312,by,0,0
133313,many,0,1
133314,retrospective,0,1
133315,studies,0,0
133316,and,0,0
133317,3,0,0
133318,randomized,0,0
133319,controlled,0,0
133320,trials,0,0
133321,(,0,0
133322,RCT,0,1
133323,),0,0
133324,.,0,0
133325,However,0,0
133326,",",0,0
133327,the,0,0
133328,protocols,0,0
133329,used,0,0
133330,and,0,0
133331,the,0,0
133332,results,0,0
133333,found,0,0
133334,in,0,0
133335,the,0,0
133336,3,0,0
133337,RCTs,0,0
133338,were,0,0
133339,diverse,0,0
133340,.,0,0
133341,Therefore,0,0
133342,",",0,0
133343,a,0,0
133344,multicenter,0,0
133345,RCT,0,0
133346,was,0,0
133347,proposed,0,0
133348,in,0,0
133349,1998,0,1
133350,to,0,0
133351,evaluate,0,0
133352,the,0,0
133353,primary,0,0
133354,end,0,0
133355,point,0,0
133356,of,0,0
133357,long-term,0,0
133358,survival,0,0
133359,and,0,0
133360,the,0,0
133361,secondary,0,0
133362,end,0,0
133363,points,0,0
133364,of,0,0
133365,morbidity,0,0
133366,",",0,0
133367,mortality,0,0
133368,and,0,0
133369,quality,0,0
133370,of,0,0
133371,life,0,0
133372,of,0,0
133373,patients,1,1
133374,undergoing,1,1
133375,standard,1,0
133376,versus,1,0
133377,extended,1,0
133378,lymphadenectomy,1,0
133379,in,1,0
133380,radical,1,0
133381,PD,1,0
133382,for,1,0
133383,pancreatic,1,1
133384,cancer,1,1
133385,.,0,0
133386,METHODS,0,0
133387,From,0,1
133388,March,1,1
133389,2000,1,1
133390,to,1,0
133391,May,1,0
133392,2003,1,1
133393,",",1,0
133394,112,1,1
133395,patients,1,1
133396,with,1,1
133397,potentially,1,0
133398,curable,1,1
133399,pancreatic,1,1
133400,head,1,1
133401,cancer,1,1
133402,were,1,0
133403,enrolled,1,1
133404,and,1,0
133405,intraoperatively,1,0
133406,randomized,1,0
133407,to,1,0
133408,a,1,0
133409,standard,1,0
133410,or,1,0
133411,extended,1,0
133412,lymphadenectomy,1,0
133413,group,1,0
133414,.,1,0
133415,No,0,0
133416,resected,0,1
133417,patients,0,1
133418,received,0,0
133419,any,0,0
133420,adjuvant,0,0
133421,treatments,0,0
133422,.,0,0
133423,RESULTS,0,0
133424,A,1,0
133425,hundred,1,1
133426,and,1,0
133427,one,1,0
133428,eligible,1,1
133429,patients,1,1
133430,were,1,0
133431,analyzed,1,0
133432,.,1,0
133433,Demographic,1,0
133434,and,1,0
133435,histopathological,1,0
133436,characteristics,1,0
133437,of,1,0
133438,the,1,0
133439,two,1,0
133440,groups,1,0
133441,were,1,1
133442,similar,1,0
133443,.,1,0
133444,The,0,0
133445,mean,0,0
133446,operating,0,0
133447,time,0,0
133448,",",0,0
133449,intraoperative,0,0
133450,blood,0,0
133451,loss,0,0
133452,and,0,0
133453,number,0,0
133454,of,0,0
133455,retrieved,0,0
133456,lymph,0,1
133457,nodes,0,0
133458,were,0,0
133459,greater,0,0
133460,in,0,0
133461,the,0,0
133462,extended,0,0
133463,group,0,0
133464,",",0,0
133465,but,0,0
133466,the,0,0
133467,other,0,0
133468,operative,0,0
133469,results,0,0
133470,were,0,1
133471,comparable,0,0
133472,.,0,0
133473,CONCLUSIONS,0,0
133474,Although,0,0
133475,this,0,0
133476,multicenter,0,0
133477,RCT,0,0
133478,was,0,0
133479,conducted,0,0
133480,in,0,0
133481,a,0,0
133482,strict,0,0
133483,setting,0,0
133484,",",0,0
133485,extended,0,0
133486,lymphadenectomy,0,0
133487,in,0,0
133488,radical,0,0
133489,PD,0,0
133490,did,0,0
133491,not,0,0
133492,benefit,0,0
133493,long-term,0,0
133494,survival,0,0
133495,in,0,0
133496,patients,1,1
133497,with,1,1
133498,resectable,1,1
133499,pancreatic,1,1
133500,head,1,1
133501,cancer,1,1
133502,and,0,0
133503,led,0,0
133504,to,0,0
133505,levels,0,0
133506,of,0,0
133507,morbidity,0,0
133508,",",0,0
133509,mortality,0,0
133510,and,0,0
133511,quality,0,0
133512,of,0,0
133513,life,0,0
133514,comparable,0,0
133515,to,0,0
133516,those,0,0
133517,found,0,0
133518,after,0,0
133519,standard,0,0
133520,lymphadenectomy,0,1
133521,.,0,0
133522,[,0,0
133523,Prophylactic,0,0
133524,intraaortic,0,0
133525,balloon,0,0
133526,pumping,0,0
133527,in,0,0
133528,high-risk,1,1
133529,cardiac,1,1
133530,surgery,1,1
133531,patients,1,1
133532,],1,1
133533,.,0,0
133534,BACKGROUND,0,0
133535,We,0,0
133536,examined,0,0
133537,the,0,0
133538,impact,0,0
133539,of,0,0
133540,prophylactic,0,0
133541,IABP,0,1
133542,insertion,0,0
133543,in,0,0
133544,EuroSCORE-stratified,1,0
133545,high-risk,1,1
133546,cardiac,1,1
133547,surgery,1,1
133548,patients,1,1
133549,with,1,1
133550,a,1,0
133551,score,1,0
133552,?8,1,0
133553,.,1,0
133554,MATERIAL,0,0
133555,AND,0,0
133556,METHODS,0,0
133557,A,0,0
133558,randomized,0,0
133559,trial,0,0
133560,with,1,1
133561,104,1,1
133562,patients,1,1
133563,either,1,0
133564,without,1,1
133565,prophylactic,1,0
133566,IABP,1,1
133567,insertion,1,0
133568,(,1,0
133569,group,1,0
133570,A,1,0
133571,",",1,0
133572,n=52,1,1
133573,),1,0
133574,or,1,0
133575,with,1,0
133576,IABP,1,0
133577,(,1,0
133578,group,1,0
133579,B,1,0
133580,",",1,0
133581,n=52,1,1
133582,),1,0
133583,was,1,0
133584,conducted,0,0
133585,.,0,0
133586,The,0,0
133587,primary,0,0
133588,endpoint,0,0
133589,was,0,0
133590,30-day,0,0
133591,mortality,0,0
133592,.,0,0
133593,RESULTS,1,0
133594,The,1,0
133595,median,1,0
133596,age,1,1
133597,of,1,0
133598,the,1,0
133599,patients,1,1
133600,was,1,0
133601,74,1,1
133602,years,1,1
133603,and,1,0
133604,43,1,1
133605,%,1,0
133606,of,1,0
133607,participants,1,1
133608,were,1,1
133609,females,1,1
133610,.,1,0
133611,The,1,0
133612,30-day,0,0
133613,mortality,0,0
133614,did,0,0
133615,not,0,0
133616,differ,0,0
133617,between,0,0
133618,group,0,0
133619,A,0,0
133620,(,0,0
133621,17.3,0,0
133622,%,0,0
133623,),0,0
133624,and,0,0
133625,group,0,0
133626,B,0,0
133627,(,0,0
133628,13.4,0,0
133629,%,0,0
133630,;,0,0
133631,p=0.78,0,0
133632,),0,0
133633,.,0,0
133634,The,0,0
133635,median,0,0
133636,hospital,0,0
133637,stay,0,0
133638,was,0,0
133639,14,0,0
133640,days,0,0
133641,in,0,0
133642,both,0,0
133643,groups,0,0
133644,.,0,0
133645,Intra-,0,0
133646,and,0,0
133647,postoperative,0,0
133648,IABP,0,0
133649,support,0,0
133650,was,0,0
133651,required,0,0
133652,by,0,0
133653,13,0,0
133654,patients,0,1
133655,(,0,0
133656,21,0,1
133657,%,0,0
133658,),0,0
133659,in,0,0
133660,group,0,0
133661,A,0,0
133662,.,0,0
133663,The,0,0
133664,median,0,0
133665,ventilation,0,0
133666,time,0,0
133667,(,0,0
133668,14,0,0
133669,hours,0,0
133670,versus,0,0
133671,13,0,1
133672,hours,0,0
133673,),0,0
133674,",",0,0
133675,median,0,0
133676,catecholamine,0,0
133677,dose,0,0
133678,",",0,0
133679,frequency,0,0
133680,of,0,0
133681,dialysis-dependent,0,1
133682,acute,0,1
133683,renal,0,1
133684,failure,0,1
133685,(,0,0
133686,28,0,0
133687,%,0,0
133688,versus,0,0
133689,18,0,1
133690,%,0,0
133691,),0,0
133692,",",0,0
133693,cardiac,0,0
133694,indices,0,0
133695,",",0,0
133696,and,0,0
133697,frequency,0,0
133698,of,0,0
133699,a,0,0
133700,low,0,0
133701,cardiac,0,0
133702,output,0,0
133703,syndrome,0,1
133704,(,0,0
133705,26,0,0
133706,%,0,0
133707,versus,0,0
133708,25,0,0
133709,%,0,0
133710,),0,0
133711,did,0,0
133712,not,0,0
133713,significantly,0,0
133714,differ,0,0
133715,between,0,0
133716,groups,0,0
133717,.,0,1
133718,CONCLUSION,0,0
133719,Prophylactic,0,0
133720,preoperative,0,0
133721,IABP,0,0
133722,insertion,0,0
133723,in,0,0
133724,EuroSCORE-stratified,1,0
133725,high-risk,1,1
133726,patients,1,1
133727,is,1,0
133728,not,0,0
133729,associated,0,0
133730,with,0,0
133731,decreased,0,0
133732,30-day,0,0
133733,mortality,0,0
133734,.,0,0
133735,Benefits,0,0
133736,of,0,0
133737,adding,0,0
133738,fluticasone,0,0
133739,propionate/salmeterol,0,0
133740,to,0,0
133741,tiotropium,0,0
133742,in,0,0
133743,moderate,1,1
133744,to,1,0
133745,severe,1,1
133746,COPD,1,0
133747,.,1,0
133748,BACKGROUND,0,0
133749,Combining,0,0
133750,maintenance,0,0
133751,medications,0,0
133752,with,0,1
133753,different,0,0
133754,mechanisms,0,0
133755,of,0,0
133756,action,0,0
133757,may,0,0
133758,improve,0,0
133759,outcomes,0,0
133760,in,0,0
133761,COPD,0,0
133762,.,0,0
133763,In,0,0
133764,this,0,0
133765,study,0,0
133766,we,0,0
133767,evaluated,0,0
133768,the,0,0
133769,efficacy,0,0
133770,and,0,0
133771,safety,0,0
133772,of,0,0
133773,fluticasone/salmeterol,0,0
133774,(,0,0
133775,FSC,0,0
133776,),0,0
133777,(,0,0
133778,250/50,0,0
133779,mcg,0,0
133780,twice,0,0
133781,daily,0,0
133782,),0,0
133783,when,0,0
133784,added,0,0
133785,to,0,0
133786,tiotropium,0,0
133787,(,0,0
133788,18,0,0
133789,mcg,0,0
133790,once,0,0
133791,daily,0,0
133792,),0,0
133793,(,0,0
133794,TIO,0,0
133795,),0,0
133796,in,0,0
133797,subjects,1,1
133798,with,1,1
133799,symptomatic,1,1
133800,moderate,1,1
133801,to,1,0
133802,severe,1,1
133803,COPD,1,0
133804,.,1,0
133805,METHODS,0,0
133806,This,0,0
133807,was,0,0
133808,a,0,0
133809,24-week,0,0
133810,",",0,0
133811,randomized,0,0
133812,",",0,0
133813,double-blind,0,0
133814,",",0,0
133815,parallel,0,0
133816,group,0,0
133817,",",0,0
133818,multi-center,0,0
133819,study,1,0
133820,.,1,0
133821,Subjects,1,1
133822,40,1,0
133823,years,1,1
133824,or,1,1
133825,older,1,1
133826,with,1,0
133827,cigarette,1,0
133828,smoking,1,0
133829,history,1,1
133830,?10,1,0
133831,pack-years,1,0
133832,and,1,0
133833,with,1,1
133834,the,1,0
133835,diagnosis,1,1
133836,of,1,0
133837,COPD,1,0
133838,and,1,0
133839,post-bronchodilator,1,0
133840,FEV,1,0
133841,(,1,0
133842,1,1,0
133843,),1,0
133844,?40,1,0
133845,to,1,0
133846,?,1,0
133847,80,1,0
133848,%,1,0
133849,of,1,0
133850,predicted,1,0
133851,normal,1,1
133852,and,1,0
133853,FEV,1,0
133854,(,1,0
133855,1,1,0
133856,),1,0
133857,/FVC,1,0
133858,of,1,0
133859,?0.70,1,0
133860,were,1,0
133861,enrolled,1,1
133862,.,1,0
133863,Following,0,0
133864,a,0,0
133865,4-week,0,0
133866,treatment,0,0
133867,with,0,1
133868,open-label,0,0
133869,TIO,0,1
133870,18,0,1
133871,mcg,0,0
133872,once,0,0
133873,daily,0,0
133874,",",0,0
133875,subjects,0,1
133876,were,0,0
133877,randomized,0,0
133878,in,0,0
133879,a,0,0
133880,double-blind,0,0
133881,fashion,0,0
133882,to,0,0
133883,either,0,0
133884,the,0,0
133885,addition,0,0
133886,of,0,0
133887,FSC,0,1
133888,250/50,0,0
133889,DISKUS,0,0
133890,twice,0,0
133891,daily,0,0
133892,or,0,0
133893,matching,0,0
133894,placebo,0,0
133895,.,0,0
133896,The,0,0
133897,primary,0,0
133898,efficacy,0,0
133899,endpoint,0,0
133900,was,0,0
133901,AM,0,0
133902,pre-dose,0,0
133903,FEV,0,0
133904,(,0,0
133905,1,0,0
133906,),0,0
133907,and,0,0
133908,secondary,0,0
133909,endpoints,0,0
133910,included,0,1
133911,other,0,0
133912,measures,0,0
133913,of,0,0
133914,lung,0,1
133915,function,0,0
133916,",",0,0
133917,rescue,0,0
133918,albuterol,0,0
133919,use,0,0
133920,",",0,0
133921,health,0,0
133922,status,0,0
133923,and,0,0
133924,exacerbations,0,0
133925,.,0,0
133926,RESULTS,0,0
133927,The,0,0
133928,addition,0,0
133929,of,0,0
133930,FSC,0,0
133931,to,0,0
133932,TIO,0,0
133933,significantly,0,0
133934,improved,0,0
133935,lung,0,0
133936,function,0,0
133937,indices,0,0
133938,including,0,0
133939,AM,0,1
133940,pre-dose,0,0
133941,FEV,0,0
133942,(,0,0
133943,1,0,0
133944,),0,0
133945,",",0,0
133946,2,0,0
133947,h,0,0
133948,post-dose,0,0
133949,FEV,0,0
133950,(,0,0
133951,1,0,0
133952,),0,0
133953,",",0,0
133954,AM,0,0
133955,pre-dose,0,0
133956,FVC,0,0
133957,",",0,0
133958,2,0,0
133959,h,0,0
133960,post-dose,0,0
133961,FVC,0,0
133962,and,0,0
133963,AM,0,1
133964,pre-dose,0,0
133965,IC,0,0
133966,compared,0,0
133967,with,0,1
133968,TIO,0,0
133969,alone,0,0
133970,.,0,0
133971,Furthermore,0,0
133972,",",0,0
133973,this,0,0
133974,combination,0,0
133975,was,0,0
133976,superior,0,0
133977,to,0,0
133978,TIO,0,0
133979,alone,0,0
133980,in,0,0
133981,reducing,0,0
133982,rescue,0,0
133983,albuterol,0,0
133984,use,0,0
133985,.,0,0
133986,However,0,0
133987,",",0,0
133988,there,0,0
133989,were,0,0
133990,no,0,0
133991,significant,0,0
133992,differences,0,0
133993,between,0,0
133994,the,0,0
133995,treatment,0,0
133996,groups,0,0
133997,in,0,0
133998,health,0,1
133999,status,0,0
134000,or,0,0
134001,COPD,0,0
134002,exacerbations,0,0
134003,.,0,0
134004,The,0,0
134005,incidence,0,0
134006,of,0,0
134007,adverse,0,0
134008,events,0,0
134009,was,0,0
134010,similar,0,0
134011,in,0,0
134012,both,0,0
134013,groups,0,0
134014,.,0,0
134015,CONCLUSIONS,0,0
134016,The,0,0
134017,addition,0,0
134018,of,0,0
134019,FSC,1,0
134020,to,1,0
134021,subjects,1,1
134022,with,1,1
134023,COPD,1,0
134024,treated,1,1
134025,with,0,1
134026,TIO,0,0
134027,significantly,0,0
134028,improves,0,0
134029,lung,0,0
134030,function,0,0
134031,without,0,0
134032,increasing,0,0
134033,the,0,0
134034,risk,0,0
134035,of,0,0
134036,adverse,0,0
134037,events,0,0
134038,.,0,1
134039,NCT00784550,0,0
134040,.,0,0
134041,Reduced,0,0
134042,mortality,0,0
134043,among,0,0
134044,children,1,1
134045,in,1,0
134046,southern,1,1
134047,India,1,1
134048,receiving,1,0
134049,a,1,0
134050,small,1,0
134051,weekly,1,0
134052,dose,1,0
134053,of,1,0
134054,vitamin,1,0
134055,A,1,0
134056,.,1,0
134057,BACKGROUND,0,0
134058,Clinical,0,0
134059,vitamin,0,0
134060,A,0,0
134061,deficiency,0,0
134062,affects,0,0
134063,millions,0,0
134064,of,0,0
134065,children,0,1
134066,worldwide,0,0
134067,",",0,0
134068,and,0,0
134069,subclinical,0,0
134070,deficiency,0,0
134071,is,0,0
134072,even,0,0
134073,more,0,0
134074,common,0,0
134075,.,0,0
134076,Supplemental,0,0
134077,vitamin,0,0
134078,A,0,0
134079,has,0,0
134080,been,0,0
134081,reported,0,0
134082,to,0,0
134083,reduce,0,0
134084,mortality,0,0
134085,among,0,0
134086,these,0,0
134087,children,0,1
134088,",",0,0
134089,but,0,0
134090,the,0,0
134091,results,0,0
134092,have,0,0
134093,been,0,0
134094,questioned,0,0
134095,.,0,0
134096,METHODS,0,0
134097,We,0,0
134098,conducted,0,0
134099,a,0,0
134100,randomized,0,0
134101,",",0,0
134102,controlled,0,0
134103,",",0,0
134104,masked,0,0
134105,clinical,0,0
134106,trial,0,0
134107,for,0,0
134108,one,0,0
134109,year,0,0
134110,in,1,0
134111,southern,1,1
134112,India,1,1
134113,involving,1,0
134114,"15,419",1,1
134115,preschool-age,1,1
134116,children,1,1
134117,who,1,1
134118,received,1,1
134119,either,1,1
134120,8.7,1,0
134121,mumol,1,0
134122,(,1,0
134123,8333,1,0
134124,IU,1,0
134125,),1,0
134126,of,1,0
134127,vitamin,1,0
134128,A,1,0
134129,and,1,0
134130,46,1,0
134131,mumol,1,0
134132,(,1,0
134133,20,1,0
134134,mg,1,0
134135,),1,0
134136,of,1,0
134137,vitamin,1,0
134138,E,1,0
134139,(,1,0
134140,the,1,0
134141,treated,1,0
134142,group,1,0
134143,),1,0
134144,or,1,0
134145,vitamin,1,0
134146,E,1,0
134147,alone,1,0
134148,(,1,0
134149,the,1,0
134150,control,1,0
134151,group,1,0
134152,),1,0
134153,.,0,0
134154,Vitamin,0,0
134155,supplements,0,0
134156,were,0,0
134157,delivered,0,0
134158,weekly,0,0
134159,by,0,0
134160,community,0,1
134161,health,0,1
134162,volunteers,0,1
134163,who,0,1
134164,also,0,1
134165,recorded,0,0
134166,mortality,0,0
134167,and,0,0
134168,morbidity,0,0
134169,.,0,0
134170,Weekly,0,0
134171,contact,0,0
134172,was,0,0
134173,made,0,0
134174,with,0,0
134175,at,0,0
134176,least,0,0
134177,88,0,1
134178,percent,0,0
134179,of,0,0
134180,the,0,0
134181,children,0,1
134182,in,0,0
134183,both,0,0
134184,study,0,0
134185,groups,0,0
134186,.,0,0
134187,The,0,0
134188,base-line,0,0
134189,characteristics,0,0
134190,of,0,0
134191,the,0,0
134192,children,0,1
134193,were,0,0
134194,similar,0,0
134195,and,0,0
134196,documented,0,0
134197,a,0,0
134198,high,0,0
134199,prevalence,0,0
134200,of,0,0
134201,vitamin,0,0
134202,A,0,0
134203,deficiency,0,1
134204,and,0,0
134205,undernutrition,0,1
134206,.,0,0
134207,RESULTS,0,0
134208,One,0,1
134209,hundred,0,1
134210,twenty-five,0,1
134211,deaths,0,0
134212,occurred,0,0
134213,",",0,0
134214,of,0,0
134215,which,0,0
134216,117,0,1
134217,were,0,0
134218,not,0,0
134219,accidental,0,0
134220,.,0,0
134221,The,0,0
134222,risk,0,0
134223,of,0,0
134224,death,0,0
134225,in,0,0
134226,the,0,0
134227,group,0,0
134228,treated,0,0
134229,with,0,0
134230,vitamin,0,0
134231,A,0,0
134232,was,0,0
134233,less,0,0
134234,than,0,0
134235,half,0,0
134236,that,0,0
134237,in,0,0
134238,the,0,0
134239,control,0,0
134240,group,0,0
134241,(,0,0
134242,relative,0,0
134243,risk,0,0
134244,",",0,0
134245,0.46,0,0
134246,;,0,0
134247,95,0,0
134248,percent,0,0
134249,confidence,0,0
134250,interval,0,0
134251,",",0,0
134252,0.30,0,0
134253,to,0,0
134254,0.71,0,0
134255,),0,0
134256,.,0,0
134257,The,0,0
134258,risk,0,0
134259,was,0,0
134260,most,0,0
134261,reduced,0,0
134262,among,0,0
134263,children,0,1
134264,under,0,1
134265,3,0,0
134266,years,0,1
134267,of,0,0
134268,age,0,1
134269,(,0,0
134270,6,0,0
134271,to,0,0
134272,11,0,1
134273,months,0,0
134274,--,0,1
134275,relative,0,0
134276,risk,0,0
134277,",",0,0
134278,0.28,0,0
134279,;,0,0
134280,95,0,0
134281,percent,0,0
134282,confidence,0,0
134283,interval,0,0
134284,",",0,0
134285,0.09,0,0
134286,to,0,0
134287,0.85,0,0
134288,;,0,0
134289,12,0,0
134290,to,0,0
134291,35,0,1
134292,months,0,0
134293,--,0,1
134294,relative,0,0
134295,risk,0,0
134296,",",0,0
134297,0.46,0,0
134298,;,0,0
134299,95,0,0
134300,percent,0,0
134301,confidence,0,0
134302,interval,0,0
134303,",",0,0
134304,0.26,0,0
134305,to,0,0
134306,0.81,0,0
134307,),0,0
134308,and,0,0
134309,among,0,1
134310,those,0,1
134311,who,0,1
134312,were,0,1
134313,chronically,0,1
134314,undernourished,0,1
134315,",",0,0
134316,as,0,0
134317,manifested,0,0
134318,by,0,0
134319,stunting,0,0
134320,(,0,0
134321,relative,0,0
134322,risk,0,0
134323,",",0,0
134324,0.11,0,0
134325,;,0,0
134326,95,0,0
134327,percent,0,0
134328,confidence,0,0
134329,interval,0,0
134330,",",0,0
134331,0.03,0,0
134332,to,0,0
134333,0.36,0,0
134334,),0,0
134335,.,0,0
134336,The,0,0
134337,symptom-specific,0,0
134338,risk,0,0
134339,of,0,0
134340,mortality,0,0
134341,was,0,0
134342,significantly,0,0
134343,associated,0,0
134344,with,0,0
134345,diarrhea,0,1
134346,",",0,0
134347,convulsions,0,0
134348,",",0,0
134349,and,0,0
134350,other,0,0
134351,infection-related,0,0
134352,symptoms,0,0
134353,.,0,0
134354,CONCLUSIONS,0,0
134355,The,0,0
134356,regular,0,0
134357,provision,0,0
134358,of,0,0
134359,a,0,0
134360,supplement,0,0
134361,of,0,0
134362,vitamin,0,0
134363,A,0,0
134364,to,0,0
134365,children,0,1
134366,",",0,0
134367,at,0,0
134368,a,0,0
134369,level,0,0
134370,potentially,0,0
134371,obtainable,0,0
134372,from,0,0
134373,foods,0,0
134374,",",0,0
134375,in,0,0
134376,an,0,0
134377,area,0,0
134378,where,0,0
134379,vitamin,0,0
134380,A,0,0
134381,deficiency,0,0
134382,and,0,0
134383,under-nutrition,0,0
134384,are,0,0
134385,documented,0,0
134386,public,0,1
134387,health,0,1
134388,problems,0,1
134389,contributed,0,0
134390,substantially,0,0
134391,to,0,0
134392,children,0,1
134393,'s,0,1
134394,survival,0,0
134395,;,0,0
134396,mortality,0,0
134397,was,0,0
134398,reduced,0,0
134399,on,0,0
134400,average,0,0
134401,by,0,0
134402,54,0,1
134403,percent,0,1
134404,.,0,0
134405,Evaluation,0,0
134406,of,0,0
134407,oral,0,0
134408,beclomethasone,0,0
134409,dipropionate,0,0
134410,for,0,0
134411,prevention,0,0
134412,of,0,0
134413,acute,0,1
134414,graft-versus-host,0,0
134415,disease,0,1
134416,.,0,0
134417,Results,0,0
134418,from,0,0
134419,two,0,0
134420,randomized,0,1
134421,trials,0,0
134422,have,0,0
134423,shown,0,0
134424,that,0,0
134425,oral,0,0
134426,beclomethasone,0,0
134427,dipropionate,0,0
134428,(,0,0
134429,BDP,0,0
134430,),0,0
134431,is,0,0
134432,effective,0,0
134433,for,0,0
134434,treatment,0,0
134435,of,0,0
134436,acute,0,1
134437,gastrointestinal,0,1
134438,graft-versus-host,0,0
134439,disease,0,1
134440,.,0,0
134441,Here,0,0
134442,",",0,0
134443,we,0,0
134444,report,0,0
134445,results,0,0
134446,of,0,0
134447,a,0,0
134448,double-blind,0,0
134449,",",0,0
134450,randomized,0,0
134451,placebo-controlled,0,0
134452,phase,0,0
134453,II,0,1
134454,study,0,0
134455,designed,0,0
134456,to,0,0
134457,test,0,0
134458,the,0,0
134459,hypothesis,0,0
134460,that,0,0
134461,acute,0,1
134462,graft-versus-host,0,0
134463,disease,0,0
134464,could,0,0
134465,be,0,0
134466,prevented,0,0
134467,by,0,0
134468,administration,0,0
134469,of,0,0
134470,oral,0,0
134471,BDP,0,0
134472,",",0,0
134473,beginning,0,0
134474,before,0,0
134475,hematopoietic,0,0
134476,cell,0,1
134477,transplantation,0,1
134478,and,0,0
134479,continuing,0,0
134480,until,0,0
134481,day,0,0
134482,75,0,1
134483,after,0,0
134484,hematopoietic,0,0
134485,cell,0,1
134486,transplantation,0,1
134487,after,0,0
134488,myeloablative,0,1
134489,conditioning,0,0
134490,.,0,0
134491,Study,0,0
134492,drug,0,0
134493,(,0,0
134494,BDP,0,0
134495,or,0,0
134496,placebo,0,0
134497,),0,0
134498,was,0,0
134499,administered,0,0
134500,as,0,0
134501,1-mg,0,0
134502,immediate-release,0,0
134503,formulation,0,0
134504,plus,0,0
134505,1-mg,0,0
134506,delayed-release,0,0
134507,formulation,0,0
134508,orally,0,0
134509,four,0,0
134510,times,0,0
134511,daily,0,0
134512,.,0,0
134513,According,0,0
134514,to,0,0
134515,the,0,0
134516,primary,0,0
134517,endpoint,0,0
134518,",",0,0
134519,systemic,0,0
134520,glucocorticoid,0,0
134521,treatment,0,0
134522,for,0,0
134523,graft-versus-host,0,0
134524,disease,0,1
134525,was,0,0
134526,given,0,0
134527,to,1,0
134528,60,1,0
134529,of,1,0
134530,the,1,0
134531,92,1,0
134532,participants,1,1
134533,(,1,0
134534,65,1,1
134535,%,1,0
134536,),1,0
134537,in,1,0
134538,the,1,0
134539,BDP,1,0
134540,arm,1,0
134541,",",1,0
134542,versus,1,0
134543,31,1,1
134544,of,1,0
134545,46,1,1
134546,participants,1,1
134547,(,1,0
134548,67,1,1
134549,%,1,0
134550,),1,0
134551,in,1,0
134552,the,1,0
134553,placebo,1,0
134554,arm,1,0
134555,.,0,0
134556,The,0,0
134557,secondary,0,0
134558,efficacy,0,0
134559,endpoints,0,0
134560,showed,0,0
134561,no,0,0
134562,statistically,0,0
134563,significant,0,0
134564,differences,0,0
134565,between,0,0
134566,the,0,0
134567,two,0,0
134568,arms,0,0
134569,.,0,0
134570,The,0,0
134571,proportion,0,0
134572,of,0,0
134573,participants,0,1
134574,who,0,1
134575,took,0,1
134576,at,0,1
134577,least,0,0
134578,90,0,0
134579,%,0,0
134580,of,0,0
134581,the,0,0
134582,prescribed,0,0
134583,study,0,0
134584,drug,0,0
134585,during,0,0
134586,the,0,0
134587,first,0,0
134588,4,0,0
134589,weeks,0,0
134590,after,0,0
134591,hematopoietic,0,0
134592,cell,0,1
134593,transplantation,0,1
134594,was,0,0
134595,54,0,1
134596,%,0,0
134597,overall,0,0
134598,.,0,0
134599,Lower,0,0
134600,severity,0,0
134601,of,0,0
134602,mucositis,0,0
134603,strongly,0,0
134604,correlated,0,0
134605,with,0,0
134606,higher,0,0
134607,adherence,0,0
134608,to,0,0
134609,the,0,0
134610,schedule,0,0
134611,of,0,0
134612,study,0,0
134613,drug,0,0
134614,administration,0,0
134615,.,0,0
134616,Inconsistent,0,0
134617,adherence,0,0
134618,related,0,0
134619,to,0,0
134620,mucositis,0,0
134621,during,0,0
134622,recovery,0,0
134623,after,0,0
134624,myeloablative,0,0
134625,conditioning,0,0
134626,may,0,0
134627,have,0,0
134628,obscured,0,0
134629,a,0,0
134630,beneficial,0,0
134631,therapeutic,0,0
134632,effect,0,0
134633,in,0,0
134634,the,0,0
134635,current,0,0
134636,study,0,0
134637,.,0,0
134638,Instant,0,0
134639,Recess?,0,0
134640,:,0,1
134641,a,0,0
134642,practical,0,0
134643,tool,0,0
134644,for,0,0
134645,increasing,0,0
134646,physical,0,0
134647,activity,0,0
134648,during,0,0
134649,the,0,0
134650,school,0,1
134651,day,0,0
134652,.,0,0
134653,BACKGROUND,0,0
134654,An,0,0
134655,increased,0,0
134656,prevalence,0,0
134657,of,1,0
134658,overweight/obesity,1,1
134659,among,1,0
134660,children,1,1
134661,has,0,0
134662,led,0,0
134663,to,0,0
134664,school,0,1
134665,district,0,1
134666,level,0,0
134667,policies,0,0
134668,to,0,0
134669,increase,0,0
134670,physical,0,0
134671,activity,0,0
134672,(,0,0
134673,PA,0,0
134674,),0,0
134675,among,1,0
134676,elementary,1,1
134677,school,1,1
134678,students,1,1
134679,.,1,1
134680,Interventions,0,0
134681,are,0,0
134682,needed,0,0
134683,that,0,0
134684,increase,0,0
134685,activity,0,0
134686,levels,0,0
134687,without,0,1
134688,sacrificing,0,0
134689,time,0,0
134690,spent,0,0
134691,in,0,0
134692,academics,0,0
134693,.,0,0
134694,OBJECTIVES,0,0
134695,We,0,0
134696,evaluated,0,0
134697,a,0,0
134698,policy,0,0
134699,implementation,0,0
134700,intervention,0,0
134701,for,0,0
134702,to,0,0
134703,increase,0,0
134704,in-school,0,1
134705,PA,0,0
134706,in,1,0
134707,elementary,1,1
134708,schools,1,1
134709,in,1,0
134710,Forsyth,1,1
134711,County,1,1
134712,",",1,0
134713,North,1,0
134714,Carolina,1,1
134715,",",1,0
134716,in,0,0
134717,a,0,0
134718,randomized,0,0
134719,study,0,0
134720,with,0,1
134721,a,0,0
134722,delayed,0,0
134723,intervention,0,0
134724,control,0,0
134725,group,0,0
134726,.,0,0
134727,METHODS,1,0
134728,The,1,0
134729,study,1,0
134730,included,1,0
134731,third-,1,1
134732,through,1,0
134733,fifth-grade,1,1
134734,classrooms,1,1
134735,in,1,0
134736,eight,1,1
134737,elementary,1,1
134738,schools,1,1
134739,.,1,1
134740,Instant,0,0
134741,Recess?,0,0
134742,was,0,0
134743,used,0,0
134744,to,0,0
134745,introduce,0,0
134746,10-minute,0,0
134747,PA,0,0
134748,breaks,0,0
134749,in,0,0
134750,classrooms,0,1
134751,on,0,0
134752,schedules,0,0
134753,determined,0,0
134754,by,0,0
134755,teachers,0,1
134756,.,0,1
134757,Direct,0,0
134758,observation,0,0
134759,was,0,0
134760,used,0,0
134761,to,0,0
134762,measure,0,0
134763,activity,0,0
134764,levels,0,0
134765,",",0,0
134766,other,0,0
134767,student,0,0
134768,behaviors,0,0
134769,",",0,0
134770,and,0,0
134771,teacher,0,0
134772,behaviors,0,0
134773,related,0,0
134774,to,0,0
134775,PA,0,0
134776,in,0,0
134777,the,0,0
134778,classrooms,0,1
134779,.,0,0
134780,RESULTS,0,0
134781,Twenty-eight,0,1
134782,visits,0,0
134783,to,0,1
134784,schools,0,1
134785,were,0,0
134786,made,0,0
134787,during,0,0
134788,the,0,0
134789,spring,0,0
134790,and,0,0
134791,fall,0,0
134792,semesters,0,0
134793,of,0,0
134794,2009,0,1
134795,.,0,0
134796,At,0,0
134797,baseline,0,0
134798,11,0,1
134799,%,0,0
134800,to,0,0
134801,44,0,0
134802,%,0,0
134803,of,0,0
134804,intervention,0,0
134805,and,0,0
134806,control,0,0
134807,schools,0,1
134808,were,0,0
134809,engaged,0,0
134810,in,0,0
134811,classroom-based,0,0
134812,PA.,0,0
134813,PA,0,0
134814,increased,0,0
134815,from,0,0
134816,baseline,0,0
134817,to,0,0
134818,spring,0,0
134819,follow-up,0,0
134820,in,0,0
134821,intervention,0,0
134822,schools,0,1
134823,and,0,0
134824,was,0,0
134825,maintained,0,0
134826,the,0,0
134827,following,0,0
134828,fall,0,0
134829,.,0,1
134830,Control,0,0
134831,schools,0,1
134832,decreased,0,0
134833,PA,0,0
134834,from,0,0
134835,baseline,0,0
134836,to,0,0
134837,spring,0,0
134838,and,0,0
134839,increased,0,0
134840,PA,0,0
134841,once,0,0
134842,they,0,0
134843,began,0,0
134844,the,0,0
134845,intervention,0,0
134846,.,0,0
134847,Students,0,0
134848,in,0,0
134849,classrooms,0,1
134850,engaged,0,0
134851,in,0,0
134852,Instant,0,0
134853,Recess,0,0
134854,exhibited,0,0
134855,statistically,0,0
134856,significant,0,0
134857,increases,0,0
134858,in,0,0
134859,light,0,0
134860,(,0,0
134861,51,0,0
134862,%,0,0
134863,),0,0
134864,and,0,0
134865,moderate-intensity,0,0
134866,(,0,0
134867,16,0,1
134868,%,0,0
134869,),0,0
134870,PA,0,0
134871,and,0,0
134872,increases,0,0
134873,in,0,0
134874,time,0,0
134875,spent,0,0
134876,in,0,0
134877,on-task,0,0
134878,behavior,0,0
134879,(,0,0
134880,11,0,0
134881,%,0,0
134882,),0,0
134883,.,0,0
134884,Control,0,0
134885,schools,0,1
134886,experienced,0,0
134887,similar,0,0
134888,benefits,0,0
134889,after,0,0
134890,they,0,0
134891,began,0,1
134892,implementing,0,0
134893,Instant,0,0
134894,Recess,0,0
134895,.,0,0
134896,CONCLUSIONS,0,0
134897,Instant,0,0
134898,Recess,0,0
134899,is,0,0
134900,useful,0,0
134901,for,0,0
134902,increasing,0,0
134903,PA,0,0
134904,and,0,0
134905,improving,0,0
134906,behavior,0,0
134907,among,1,0
134908,elementary,1,1
134909,school,1,1
134910,children,1,1
134911,.,1,0
134912,Additional,0,0
134913,research,0,0
134914,may,0,0
134915,be,0,0
134916,needed,0,0
134917,to,0,0
134918,understand,0,0
134919,how,0,0
134920,to,0,0
134921,create,0,0
134922,policies,0,0
134923,supporting,0,0
134924,classroom,0,1
134925,activity,0,0
134926,breaks,0,0
134927,and,0,0
134928,how,0,0
134929,to,0,0
134930,assess,0,0
134931,policy,0,0
134932,adherence,0,0
134933,.,0,0
134934,Object,0,0
134935,interest,0,0
134936,in,0,0
134937,autism,1,1
134938,spectrum,1,1
134939,disorder,1,1
134940,:,1,0
134941,a,0,0
134942,treatment,0,0
134943,comparison,0,0
134944,.,0,0
134945,A,0,0
134946,randomized,0,0
134947,control,0,0
134948,trial,0,0
134949,comparing,0,0
134950,two,0,0
134951,social,0,0
134952,communication,0,0
134953,treatments,0,0
134954,for,0,0
134955,children,1,1
134956,with,1,1
134957,autism,1,1
134958,spectrum,1,1
134959,disorder,1,1
134960,examined,0,0
134961,the,0,0
134962,effect,0,0
134963,of,0,0
134964,treatment,0,0
134965,on,0,0
134966,object,0,0
134967,interest,0,0
134968,.,0,0
134969,Thirty-two,1,1
134970,children,1,1
134971,",",1,0
134972,18-60,1,1
134973,months,1,0
134974,",",0,0
134975,were,0,0
134976,randomly,0,0
134977,assigned,0,0
134978,to,0,0
134979,the,0,0
134980,Picture,0,0
134981,Exchange,0,0
134982,Communication,0,0
134983,System,0,0
134984,(,0,0
134985,PECS,0,0
134986,),0,0
134987,or,0,0
134988,Responsive,0,1
134989,Education,0,0
134990,and,0,0
134991,Prelinguistic,0,1
134992,Milieu,0,0
134993,Teaching,0,0
134994,(,0,0
134995,RPMT,0,0
134996,),0,0
134997,condition,0,0
134998,.,0,0
134999,Assessment,0,0
135000,of,0,0
135001,object,0,0
135002,interest,0,0
135003,was,0,0
135004,conducted,0,0
135005,in,0,0
135006,an,0,0
135007,unstructured,0,0
135008,play,0,0
135009,session,0,0
135010,with,0,1
135011,different,0,0
135012,toys,0,0
135013,",",0,0
135014,activities,0,0
135015,",",0,0
135016,adult,0,1
135017,",",0,0
135018,and,0,0
135019,location,0,0
135020,than,0,0
135021,experienced,0,0
135022,in,0,0
135023,treatment,0,0
135024,.,0,1
135025,Results,0,0
135026,indicated,0,0
135027,children,0,1
135028,in,0,0
135029,the,0,0
135030,RPMT,0,0
135031,condition,0,0
135032,showed,0,0
135033,greater,0,0
135034,increases,0,0
135035,in,0,0
135036,object,0,0
135037,interest,0,0
135038,as,0,0
135039,compared,0,0
135040,to,0,0
135041,children,0,1
135042,in,0,0
135043,the,0,0
135044,PECS,0,0
135045,condition,0,0
135046,.,0,0
135047,Because,0,0
135048,child,0,1
135049,characteristics,0,0
135050,such,0,0
135051,as,0,0
135052,interest,0,0
135053,in,0,0
135054,objects,0,0
135055,may,0,0
135056,influence,0,0
135057,response,0,0
135058,to,0,0
135059,interventions,0,0
135060,using,0,0
135061,object,0,0
135062,play,0,0
135063,as,0,0
135064,contexts,0,0
135065,for,0,0
135066,treatment,0,0
135067,",",0,0
135068,it,0,0
135069,is,0,0
135070,important,0,0
135071,to,0,0
135072,improve,0,0
135073,our,0,0
135074,understanding,0,0
135075,of,0,0
135076,whether,0,0
135077,intervention,0,0
135078,can,0,0
135079,affect,0,0
135080,object,0,0
135081,interest,0,0
135082,.,0,0
135083,Genetic,0,0
135084,associations,0,0
135085,with,0,1
135086,lipoprotein,1,0
135087,subfractions,1,0
135088,provide,0,0
135089,information,0,0
135090,on,0,0
135091,their,0,0
135092,biological,0,0
135093,nature,0,0
135094,.,0,0
135095,Adverse,0,0
135096,levels,0,0
135097,of,0,0
135098,lipoproteins,0,0
135099,are,0,0
135100,highly,0,0
135101,heritable,0,0
135102,and,0,0
135103,constitute,0,0
135104,risk,0,0
135105,factors,0,0
135106,for,0,0
135107,cardiovascular,0,1
135108,outcomes,0,0
135109,.,0,1
135110,Hitherto,0,0
135111,",",0,0
135112,genome-wide,0,0
135113,association,0,0
135114,studies,0,0
135115,revealed,0,0
135116,95,0,0
135117,lipid-associated,0,0
135118,loci,0,0
135119,.,0,0
135120,However,0,0
135121,",",0,0
135122,due,0,0
135123,to,0,0
135124,the,0,0
135125,small,0,0
135126,effect,0,0
135127,sizes,0,0
135128,of,0,0
135129,these,0,0
135130,associations,0,0
135131,large,0,1
135132,sample,0,1
135133,numbers,0,0
135134,(,0,0
135135,>,0,1
135136,100,0,0
135137,000,0,0
135138,samples,0,1
135139,),0,0
135140,were,0,0
135141,needed,0,0
135142,.,0,0
135143,Here,0,0
135144,we,0,0
135145,show,0,0
135146,that,0,0
135147,analyzing,0,0
135148,more,0,0
135149,refined,0,0
135150,lipid,0,0
135151,phenotypes,0,0
135152,",",0,0
135153,namely,0,0
135154,lipoprotein,0,0
135155,subfractions,0,0
135156,",",0,0
135157,can,0,0
135158,increase,0,0
135159,the,0,0
135160,number,0,0
135161,of,0,0
135162,significantly,0,0
135163,associated,0,0
135164,loci,0,0
135165,compared,0,0
135166,with,0,0
135167,bulk,0,0
135168,high-density,0,0
135169,lipoprotein,0,0
135170,and,0,0
135171,low-density,0,0
135172,lipoprotein,0,0
135173,analysis,0,0
135174,in,0,0
135175,a,0,0
135176,study,0,0
135177,with,0,0
135178,identical,0,0
135179,sample,0,1
135180,numbers,0,0
135181,.,0,0
135182,Moreover,0,0
135183,",",0,0
135184,lipoprotein,0,0
135185,subfractions,0,0
135186,provide,0,0
135187,novel,0,0
135188,insight,0,0
135189,into,0,0
135190,the,0,0
135191,human,0,0
135192,lipid,0,0
135193,metabolism,0,0
135194,.,0,0
135195,We,0,0
135196,measured,0,0
135197,15,1,0
135198,lipoprotein,1,0
135199,subfractions,1,0
135200,(,1,0
135201,L1-L15,1,1
135202,),1,0
135203,in,1,0
135204,1791,1,1
135205,samples,1,0
135206,using,1,0
135207,(,1,0
135208,1,1,0
135209,),1,0
135210,H-NMR,1,0
135211,(,1,0
135212,nuclear,1,0
135213,magnetic,1,0
135214,resonance,1,0
135215,),1,0
135216,spectroscopy,1,0
135217,.,1,0
135218,Using,0,0
135219,cluster,0,0
135220,analyses,0,0
135221,",",0,0
135222,we,0,0
135223,quantified,0,0
135224,inter-relationships,0,0
135225,among,0,1
135226,lipoprotein,0,0
135227,subfractions,0,0
135228,.,0,0
135229,Additionally,0,0
135230,",",0,0
135231,we,0,0
135232,analyzed,0,0
135233,associations,0,0
135234,with,0,1
135235,subfractions,0,0
135236,at,0,0
135237,known,0,0
135238,lipid,0,0
135239,loci,0,0
135240,.,0,0
135241,We,0,0
135242,identified,0,0
135243,five,0,1
135244,distinct,0,0
135245,groups,0,0
135246,of,0,1
135247,subfractions,0,0
135248,:,0,1
135249,one,0,0
135250,(,0,0
135251,L1,0,1
135252,),0,0
135253,was,0,0
135254,only,0,0
135255,marginally,0,0
135256,captured,0,0
135257,by,0,0
135258,serum,0,0
135259,lipids,0,0
135260,and,0,0
135261,therefore,0,0
135262,extends,0,0
135263,our,0,0
135264,knowledge,0,0
135265,of,0,0
135266,lipoprotein,0,0
135267,biochemistry,0,0
135268,.,0,0
135269,During,0,0
135270,a,0,0
135271,lipid-tolerance,0,0
135272,test,0,0
135273,",",0,0
135274,L1,0,1
135275,lost,0,0
135276,its,0,0
135277,special,0,0
135278,position,0,0
135279,.,0,0
135280,In,0,0
135281,the,0,0
135282,association,0,0
135283,analysis,0,0
135284,",",0,0
135285,we,0,0
135286,found,0,0
135287,that,0,0
135288,eight,0,1
135289,loci,0,0
135290,(,0,0
135291,LIPC,0,0
135292,",",0,0
135293,CETP,0,0
135294,",",0,0
135295,PLTP,0,0
135296,",",0,0
135297,FADS1-2-3,0,0
135298,",",0,0
135299,SORT1,0,0
135300,",",0,0
135301,GCKR,0,0
135302,",",0,0
135303,APOB,0,0
135304,",",0,0
135305,APOA1,0,0
135306,),0,0
135307,were,0,0
135308,associated,0,0
135309,with,0,1
135310,the,0,0
135311,subfractions,0,0
135312,",",0,0
135313,whereas,0,0
135314,only,0,0
135315,four,0,0
135316,loci,0,0
135317,(,0,0
135318,CETP,0,0
135319,",",0,0
135320,SORT1,0,0
135321,",",0,0
135322,GCKR,0,0
135323,",",0,0
135324,APOA1,0,0
135325,),0,0
135326,were,0,0
135327,associated,0,0
135328,with,0,1
135329,serum,0,0
135330,lipids,0,0
135331,.,0,1
135332,For,0,0
135333,LIPC,0,0
135334,",",0,0
135335,we,0,0
135336,observed,0,0
135337,a,0,0
135338,10-fold,0,0
135339,increase,0,0
135340,in,0,0
135341,the,0,0
135342,variance,0,0
135343,explained,0,0
135344,by,0,0
135345,our,0,0
135346,regression,0,0
135347,models,0,0
135348,.,0,0
135349,In,0,0
135350,conclusion,0,0
135351,",",0,0
135352,NMR-based,0,0
135353,fine,0,0
135354,mapping,0,0
135355,of,0,0
135356,lipoprotein,0,0
135357,subfractions,0,0
135358,provides,0,0
135359,novel,0,0
135360,information,0,0
135361,on,0,0
135362,their,0,0
135363,biological,0,0
135364,nature,0,0
135365,and,0,0
135366,strengthens,0,0
135367,the,0,0
135368,associations,0,0
135369,with,0,1
135370,genetic,0,0
135371,loci,0,0
135372,.,0,0
135373,Future,0,0
135374,clinical,0,0
135375,studies,0,0
135376,are,0,0
135377,now,0,0
135378,needed,0,0
135379,to,0,0
135380,investigate,0,0
135381,their,0,0
135382,biomedical,0,0
135383,relevance,0,0
135384,.,0,0
135385,Randomised,0,0
135386,controlled,0,0
135387,trial,0,0
135388,of,0,0
135389,improvisational,0,0
135390,music,0,0
135391,therapy,0,0
135392,'s,0,0
135393,effectiveness,0,0
135394,for,0,0
135395,children,1,1
135396,with,1,1
135397,autism,1,1
135398,spectrum,1,1
135399,disorders,1,1
135400,(,0,0
135401,TIME-A,0,0
135402,),0,0
135403,:,0,0
135404,study,0,0
135405,protocol,0,0
135406,.,0,0
135407,BACKGROUND,0,0
135408,Previous,0,0
135409,research,0,0
135410,has,0,0
135411,suggested,0,0
135412,that,0,0
135413,music,0,0
135414,therapy,0,0
135415,may,0,0
135416,facilitate,0,0
135417,skills,0,0
135418,in,0,0
135419,areas,0,0
135420,typically,0,1
135421,affected,0,0
135422,by,0,0
135423,autism,1,1
135424,spectrum,1,1
135425,disorders,1,1
135426,such,0,0
135427,as,0,0
135428,social,0,0
135429,interaction,0,0
135430,and,0,0
135431,communication,0,0
135432,.,0,0
135433,However,0,0
135434,",",0,0
135435,generalisability,0,0
135436,of,0,0
135437,previous,0,0
135438,findings,0,0
135439,has,0,0
135440,been,0,0
135441,restricted,0,0
135442,",",0,0
135443,as,0,0
135444,studies,0,0
135445,were,0,0
135446,limited,0,0
135447,in,0,0
135448,either,0,0
135449,methodological,0,0
135450,accuracy,0,0
135451,or,0,0
135452,the,0,0
135453,clinical,0,0
135454,relevance,0,0
135455,of,0,0
135456,their,0,0
135457,approach,0,0
135458,.,0,0
135459,The,0,0
135460,aim,0,0
135461,of,0,0
135462,this,0,0
135463,study,0,0
135464,is,0,0
135465,to,0,0
135466,determine,0,0
135467,effects,0,0
135468,of,0,0
135469,improvisational,0,0
135470,music,0,0
135471,therapy,0,0
135472,on,0,0
135473,social,0,0
135474,communication,0,0
135475,skills,0,0
135476,of,0,0
135477,children,1,1
135478,with,1,1
135479,autism,1,1
135480,spectrum,1,1
135481,disorders,1,1
135482,.,1,0
135483,An,0,0
135484,additional,0,0
135485,aim,0,0
135486,of,0,0
135487,the,0,0
135488,study,0,0
135489,is,0,0
135490,to,0,0
135491,examine,0,0
135492,if,0,0
135493,variation,0,0
135494,in,0,0
135495,dose,0,0
135496,of,0,0
135497,treatment,0,0
135498,(,0,0
135499,i.e.,0,0
135500,",",0,0
135501,number,0,0
135502,of,0,0
135503,music,0,0
135504,therapy,0,0
135505,sessions,0,0
135506,per,0,0
135507,week,0,0
135508,),0,0
135509,affects,0,0
135510,outcome,0,0
135511,of,0,0
135512,therapy,0,0
135513,",",0,0
135514,and,0,0
135515,to,0,0
135516,determine,0,0
135517,cost-effectiveness,0,0
135518,.,0,0
135519,METHODS/DESIGN,0,0
135520,Children,1,1
135521,aged,1,1
135522,between,1,0
135523,4,1,0
135524,;,1,0
135525,0,1,0
135526,and,1,0
135527,6,1,0
135528,;,1,0
135529,11,1,1
135530,years,1,1
135531,who,1,1
135532,are,1,0
135533,diagnosed,1,1
135534,with,1,0
135535,autism,1,1
135536,spectrum,1,1
135537,disorder,1,1
135538,will,0,0
135539,be,0,0
135540,randomly,0,0
135541,assigned,0,0
135542,to,0,0
135543,one,0,0
135544,of,0,0
135545,three,0,0
135546,conditions,0,0
135547,.,0,1
135548,Parents,1,0
135549,of,1,0
135550,all,1,0
135551,participants,1,0
135552,will,0,0
135553,receive,0,0
135554,three,0,0
135555,sessions,0,0
135556,of,0,0
135557,parent,0,0
135558,counselling,0,0
135559,(,0,0
135560,at,0,0
135561,0,0,0
135562,",",0,0
135563,2,0,0
135564,",",0,0
135565,and,0,0
135566,5,0,0
135567,months,0,0
135568,),0,0
135569,.,0,0
135570,In,0,0
135571,addition,0,0
135572,",",0,0
135573,children,0,1
135574,randomised,0,0
135575,to,0,0
135576,the,0,0
135577,two,0,0
135578,intervention,0,0
135579,groups,0,0
135580,will,0,0
135581,be,0,0
135582,offered,0,0
135583,individual,0,0
135584,",",0,0
135585,improvisational,0,0
135586,music,0,0
135587,therapy,0,0
135588,over,0,0
135589,a,0,0
135590,period,0,0
135591,of,0,0
135592,five,0,0
135593,months,0,0
135594,",",0,0
135595,either,0,0
135596,one,0,0
135597,session,0,0
135598,(,0,0
135599,low-intensity,0,0
135600,),0,0
135601,or,0,0
135602,three,0,0
135603,sessions,0,0
135604,(,0,0
135605,high-intensity,0,0
135606,),0,0
135607,per,0,0
135608,week,0,0
135609,.,0,0
135610,Generalised,0,0
135611,effects,0,0
135612,of,0,0
135613,music,0,0
135614,therapy,0,0
135615,will,0,0
135616,be,0,0
135617,measured,0,0
135618,using,0,0
135619,standardised,0,0
135620,scales,0,0
135621,completed,0,1
135622,by,0,0
135623,blinded,0,0
135624,assessors,0,0
135625,(,0,0
135626,Autism,0,1
135627,Diagnostic,0,0
135628,Observation,0,0
135629,Schedule,0,0
135630,",",0,0
135631,ADOS,0,0
135632,),0,0
135633,and,0,0
135634,parents,0,1
135635,(,0,0
135636,Social,0,1
135637,Responsiveness,0,0
135638,Scale,0,0
135639,",",0,0
135640,SRS,0,0
135641,),0,0
135642,before,0,0
135643,and,0,0
135644,2,0,0
135645,",",0,0
135646,5,0,0
135647,",",0,0
135648,and,0,0
135649,12,0,0
135650,months,0,0
135651,after,0,0
135652,randomisation,0,0
135653,.,0,0
135654,Cost,0,0
135655,effectiveness,0,0
135656,will,0,0
135657,be,0,0
135658,calculated,0,0
135659,as,0,0
135660,man,0,1
135661,years,0,1
135662,.,0,0
135663,A,0,0
135664,group,0,0
135665,sequential,0,0
135666,design,0,0
135667,with,0,1
135668,first,0,0
135669,interim,0,0
135670,look,0,0
135671,at,0,0
135672,N,0,1
135673,=,0,0
135674,235,0,1
135675,will,0,0
135676,ensure,0,0
135677,both,0,0
135678,power,0,0
135679,and,0,0
135680,efficiency,0,0
135681,.,0,0
135682,DISCUSSION,0,0
135683,Responding,0,0
135684,to,0,0
135685,the,0,0
135686,need,0,0
135687,for,0,0
135688,more,0,0
135689,rigorously,0,0
135690,designed,0,0
135691,trials,0,0
135692,examining,0,0
135693,the,0,0
135694,effectiveness,0,0
135695,of,0,0
135696,music,0,0
135697,therapy,0,0
135698,in,0,0
135699,autism,1,1
135700,spectrum,1,1
135701,disorders,1,1
135702,",",0,0
135703,this,0,0
135704,pragmatic,0,0
135705,trial,0,0
135706,sets,0,0
135707,out,0,0
135708,to,0,0
135709,generate,0,0
135710,findings,0,0
135711,that,0,0
135712,will,0,0
135713,be,0,0
135714,well,0,0
135715,generalisable,0,0
135716,to,0,0
135717,clinical,0,0
135718,practice,0,0
135719,.,0,0
135720,Addressing,0,0
135721,the,0,0
135722,issue,0,0
135723,of,0,0
135724,dose,0,0
135725,variation,0,0
135726,",",0,0
135727,this,0,0
135728,study,0,0
135729,'s,0,0
135730,results,0,0
135731,will,0,0
135732,also,0,0
135733,provide,0,0
135734,information,0,0
135735,on,0,0
135736,the,0,0
135737,relevance,0,0
135738,of,0,0
135739,session,0,0
135740,frequency,0,0
135741,for,0,0
135742,therapy,0,0
135743,outcome,0,0
135744,.,0,0
135745,TRIAL,0,0
135746,REGISTRATION,0,0
135747,Current,0,1
135748,Controlled,0,0
135749,Trials,0,0
135750,ISRCTN78923965,0,0
135751,.,0,0
135752,Randomized,0,0
135753,controlled,0,0
135754,study,0,0
135755,of,0,0
135756,chemoimmunotherapy,0,0
135757,with,0,1
135758,bestatin,1,0
135759,of,1,0
135760,acute,1,1
135761,nonlymphocytic,1,1
135762,leukemia,1,1
135763,in,1,0
135764,adults,1,1
135765,.,1,0
135766,A,0,0
135767,new,0,0
135768,immunomodulating,0,0
135769,agent,0,0
135770,",",0,0
135771,bestatin,0,0
135772,(,0,0
135773,INN,0,1
135774,:,0,1
135775,Ubenimex,0,0
135776,has,0,0
135777,low,0,0
135778,toxicity,0,0
135779,even,0,0
135780,after,0,0
135781,long-term,0,0
135782,oral,0,0
135783,administration,0,0
135784,and,0,0
135785,has,0,0
135786,significant,0,0
135787,modifications,0,0
135788,in,0,0
135789,immunological,0,0
135790,response,0,0
135791,.,0,0
135792,A,0,0
135793,cooperative,0,0
135794,randomized,0,0
135795,controlled,0,0
135796,study,0,0
135797,of,0,0
135798,bestatin,0,0
135799,immunotherapy,0,0
135800,in,0,0
135801,combination,0,0
135802,with,0,1
135803,remission,0,0
135804,maintenance,0,0
135805,chemotherapy,0,0
135806,for,0,0
135807,adult,1,1
135808,acute,1,1
135809,nonlymphocytic,1,1
135810,leukemia,1,1
135811,(,1,0
135812,ANLL,1,0
135813,),1,0
135814,was,0,0
135815,performed,0,0
135816,.,0,0
135817,After,0,0
135818,induction,0,0
135819,of,0,0
135820,complete,0,0
135821,remission,0,1
135822,",",0,0
135823,patients,0,1
135824,were,0,0
135825,randomized,0,0
135826,to,0,0
135827,the,0,0
135828,bestatin,0,0
135829,group,0,0
135830,(,0,0
135831,30,0,0
135832,mg/bw,0,0
135833,per,0,0
135834,os,0,0
135835,(,0,0
135836,po,0,0
135837,),0,0
135838,daily,0,0
135839,),0,0
135840,and,0,0
135841,the,0,0
135842,control,0,0
135843,group,0,0
135844,.,0,0
135845,The,0,0
135846,101,1,1
135847,eligible,1,1
135848,cases,1,1
135849,(,1,1
135850,bestatin,1,0
135851,:,1,1
135852,48,1,0
135853,",",1,0
135854,control,1,0
135855,:,1,1
135856,53,1,1
135857,),1,0
135858,were,0,0
135859,analyzed,0,0
135860,;,0,0
135861,the,0,0
135862,bestatin,0,0
135863,group,0,0
135864,achieved,0,0
135865,longer,0,0
135866,remission,0,0
135867,than,0,0
135868,the,0,0
135869,control,0,0
135870,group,0,0
135871,and,0,0
135872,a,0,0
135873,statistically,0,0
135874,significant,0,0
135875,longer,0,0
135876,survival,0,0
135877,.,0,0
135878,Though,0,0
135879,this,0,0
135880,prolongation,0,0
135881,of,0,0
135882,remission,0,0
135883,was,0,0
135884,not,0,0
135885,significant,0,0
135886,in,0,0
135887,the,0,0
135888,bestatin,0,0
135889,group,0,0
135890,compared,0,0
135891,to,0,0
135892,the,0,0
135893,control,0,0
135894,group,0,0
135895,in,0,0
135896,the,0,0
135897,15-49,0,1
135898,yr,0,1
135899,age,0,1
135900,group,0,0
135901,",",0,0
135902,in,0,0
135903,the,0,0
135904,50-65,0,1
135905,yr,0,1
135906,age,0,1
135907,group,0,0
135908,it,0,0
135909,was,0,0
135910,significantly,0,0
135911,longer,0,0
135912,.,0,0
135913,Bestatin,0,0
135914,is,0,0
135915,shown,0,0
135916,to,0,0
135917,be,0,0
135918,a,0,0
135919,clinically,0,0
135920,useful,0,0
135921,drug,0,0
135922,for,0,0
135923,immunotherapy,0,0
135924,of,0,0
135925,adult,0,1
135926,ANLL,0,0
135927,",",0,0
135928,since,0,0
135929,it,0,0
135930,has,0,0
135931,prolonged,0,0
135932,survival,0,0
135933,and,0,0
135934,remission,0,0
135935,especially,0,0
135936,in,0,0
135937,elderly,0,1
135938,patients,0,1
135939,",",0,0
135940,with,0,1
135941,few,0,0
135942,side-effects,0,0
135943,.,0,1
135944,Enhancing,0,0
135945,the,0,0
135946,self-esteem,0,0
135947,of,0,0
135948,inpatient,1,1
135949,alcoholics,1,1
135950,.,1,0
135951,This,0,0
135952,study,0,0
135953,examined,0,0
135954,the,0,0
135955,effect,0,0
135956,of,0,0
135957,pairing,0,0
135958,inpatient,1,1
135959,alcoholics,1,1
135960,with,1,1
135961,nursing,1,1
135962,home,1,1
135963,residents,1,1
135964,(,1,0
135965,NHRs,1,0
135966,),1,0
135967,on,0,0
135968,the,0,0
135969,alcoholics,0,1
135970,',0,0
135971,self-esteem,0,0
135972,.,0,0
135973,In,0,0
135974,this,0,0
135975,PALS,0,0
135976,program,0,0
135977,",",0,0
135978,the,0,0
135979,alcoholic,0,1
135980,inpatients,0,1
135981,assumed,0,0
135982,a,0,0
135983,helping-companion,0,0
135984,relationship,0,0
135985,with,0,0
135986,the,0,0
135987,NHRs,0,0
135988,for,0,0
135989,2,0,0
135990,hr,0,0
135991,per,0,0
135992,day,0,0
135993,during,0,0
135994,their,0,0
135995,last,0,1
135996,2,0,0
135997,weeks,0,0
135998,of,0,0
135999,treatment,0,0
136000,.,0,0
136001,Fifty,1,0
136002,alcoholic,1,1
136003,inpatients,1,1
136004,were,1,0
136005,randomly,1,1
136006,assigned,1,0
136007,to,1,0
136008,the,1,0
136009,PALS,1,0
136010,program,1,0
136011,(,1,0
136012,n,1,1
136013,=,1,0
136014,25,1,0
136015,),1,0
136016,or,1,0
136017,to,1,0
136018,the,1,0
136019,library,1,0
136020,for,1,0
136021,free,1,0
136022,reading,1,0
136023,time,1,0
136024,(,1,0
136025,n,1,1
136026,=,1,0
136027,25,1,0
136028,),1,0
136029,.,1,0
136030,The,0,0
136031,Tennessee,0,1
136032,Self-Concept,0,0
136033,Scale,0,0
136034,(,0,0
136035,TSCS,0,0
136036,),0,0
136037,was,0,0
136038,administered,0,0
136039,to,0,0
136040,all,0,0
136041,subjects,0,1
136042,in,0,0
136043,both,0,0
136044,groups,0,0
136045,before,0,0
136046,and,0,0
136047,after,0,0
136048,the,0,0
136049,interventions,0,0
136050,.,0,0
136051,Of,0,0
136052,the,0,0
136053,nine,0,1
136054,TSCS,0,0
136055,scales,0,0
136056,",",0,0
136057,the,0,0
136058,improvement,0,0
136059,on,0,0
136060,the,0,0
136061,Moral-Ethical,0,0
136062,scale,0,0
136063,was,0,0
136064,significantly,0,0
136065,greater,0,0
136066,in,0,0
136067,the,0,0
136068,PALS,0,0
136069,group,0,0
136070,.,0,0
136071,Because,0,0
136072,the,0,0
136073,alcoholic,0,1
136074,inpatients,0,1
136075,in,0,0
136076,the,0,0
136077,PALS,0,0
136078,group,0,0
136079,engaged,0,0
136080,in,0,0
136081,altruistic,0,0
136082,(,0,0
136083,moral,0,0
136084,),0,0
136085,behavior,0,0
136086,",",0,0
136087,this,0,0
136088,study,0,0
136089,provides,0,0
136090,a,0,0
136091,logical,0,0
136092,link,0,0
136093,between,0,0
136094,the,0,0
136095,intervention,0,0
136096,and,0,0
136097,the,0,0
136098,outcome,0,0
136099,",",0,0
136100,which,0,0
136101,has,0,0
136102,been,0,0
136103,a,0,0
136104,prevalent,0,0
136105,weakness,0,0
136106,in,0,0
136107,previous,0,0
136108,studies,0,0
136109,of,0,0
136110,self-esteem,0,0
136111,in,0,0
136112,alcoholics,0,1
136113,.,0,1
136114,Predictors,0,0
136115,of,0,0
136116,response,0,0
136117,to,0,0
136118,ziprasidone,0,0
136119,:,0,1
136120,results,0,0
136121,from,0,0
136122,a,0,0
136123,6-week,0,0
136124,randomized,0,0
136125,double-blind,0,0
136126,",",0,0
136127,placebo-controlled,0,0
136128,trial,0,0
136129,for,0,0
136130,acute,1,1
136131,depressive,1,0
136132,mixed,1,0
136133,state,1,0
136134,.,1,0
136135,INTRODUCTION,0,0
136136,The,0,0
136137,present,0,0
136138,study,0,0
136139,is,0,0
136140,aimed,0,0
136141,at,0,0
136142,investigating,0,0
136143,possible,0,0
136144,predictors,0,0
136145,of,0,0
136146,response,0,0
136147,to,0,0
136148,ziprasidone,0,0
136149,in,0,0
136150,a,0,0
136151,sample,0,1
136152,of,0,0
136153,patients,1,1
136154,with,1,1
136155,mixed,1,0
136156,depressive,1,0
136157,state,1,0
136158,.,1,0
136159,METHODS,0,0
136160,72,1,0
136161,patients,1,1
136162,were,1,0
136163,randomized,1,0
136164,to,0,0
136165,either,0,0
136166,ziprasidone,0,0
136167,or,0,0
136168,placebo,0,0
136169,and,0,0
136170,treated,0,0
136171,prospectively,0,0
136172,for,0,0
136173,6,0,0
136174,weeks,0,0
136175,.,0,0
136176,The,0,0
136177,clinical,0,0
136178,response,0,0
136179,and,0,0
136180,remission,0,0
136181,were,0,0
136182,defined,0,0
136183,with,0,1
136184,various,0,0
136185,clinical,0,0
136186,variables,0,0
136187,including,0,0
136188,Montgomery,0,1
136189,Asberg,0,1
136190,Depression,0,0
136191,Rating,0,0
136192,Scale,0,0
136193,.,0,0
136194,Further,0,0
136195,outcome,0,0
136196,measures,0,0
136197,included,0,1
136198,predictors,0,0
136199,of,0,0
136200,remission,0,1
136201,and,0,0
136202,other,0,0
136203,clinical,0,0
136204,variables,0,0
136205,over,0,0
136206,time,0,0
136207,.,0,0
136208,RESULTS,0,0
136209,None,0,0
136210,of,0,0
136211,the,0,0
136212,variables,0,0
136213,under,0,0
136214,investigation,0,0
136215,were,0,0
136216,significantly,0,0
136217,associated,0,0
136218,with,0,0
136219,response,0,0
136220,or,0,0
136221,remission,0,0
136222,at,0,0
136223,6,0,0
136224,weeks,0,0
136225,(,0,0
136226,all,0,0
136227,p-values,0,0
136228,>,0,1
136229,0.003,0,0
136230,",",0,0
136231,respectively,0,0
136232,),0,0
136233,.,0,0
136234,CONCLUSIONS,0,0
136235,Further,0,0
136236,investigations,0,0
136237,are,0,0
136238,warranted,0,0
136239,due,0,0
136240,to,0,0
136241,clear,0,0
136242,limitations,0,0
136243,",",0,0
136244,mostly,0,0
136245,small,0,0
136246,sample,0,1
136247,size,0,0
136248,and,0,0
136249,use,0,0
136250,of,0,0
136251,concomitant,0,0
136252,medications,0,1
136253,.,0,1
136254,The,0,0
136255,FLT3ITD,0,0
136256,mRNA,0,0
136257,level,0,0
136258,has,0,0
136259,a,0,0
136260,high,0,0
136261,prognostic,0,0
136262,impact,0,0
136263,in,0,0
136264,NPM1,1,0
136265,mutated,1,0
136266,",",1,0
136267,but,1,0
136268,not,1,0
136269,in,1,0
136270,NPM1,1,0
136271,unmutated,1,0
136272,",",1,0
136273,AML,1,0
136274,with,1,0
136275,a,1,0
136276,normal,1,1
136277,karyotype,1,0
136278,.,1,0
136279,The,0,0
136280,impact,0,0
136281,of,0,0
136282,a,0,0
136283,FLT3-internal,0,0
136284,tandem,0,0
136285,duplication,0,0
136286,(,0,0
136287,FLT3ITD,0,0
136288,),0,0
136289,on,0,0
136290,prognosis,0,0
136291,of,0,0
136292,patients,1,1
136293,with,1,1
136294,acute,1,1
136295,myeloid,1,1
136296,leukemia,1,1
136297,(,1,0
136298,AML,1,0
136299,),1,0
136300,is,0,0
136301,dependent,0,0
136302,on,0,0
136303,the,0,0
136304,ratio,0,0
136305,of,0,0
136306,mutated,0,0
136307,to,0,0
136308,wild-type,0,0
136309,allele,0,0
136310,.,0,0
136311,In,0,0
136312,648,1,1
136313,normal,1,1
136314,karyotype,1,1
136315,(,1,0
136316,NK,1,0
136317,),1,0
136318,AML,1,0
136319,patients,1,1
136320,",",0,0
136321,we,0,0
136322,found,0,0
136323,a,0,0
136324,significant,0,0
136325,independent,0,0
136326,effect,0,0
136327,of,0,0
136328,the,0,0
136329,quantitative,0,0
136330,FLT3ITD,0,0
136331,mRNA,0,0
136332,level,0,0
136333,--,0,0
136334,measured,0,0
136335,as,0,0
136336,(,0,0
136337,FLT3ITD/wtFLT3,0,0
136338,),0,0
136339,/,0,0
136340,(,0,0
136341,FLT3ITD/wtFLT3+1,0,0
136342,),0,0
136343,--,0,0
136344,on,0,0
136345,outcome,0,0
136346,.,0,0
136347,Moreover,0,0
136348,",",0,0
136349,this,0,0
136350,effect,0,0
136351,was,0,0
136352,clearly,0,0
136353,seen,0,0
136354,in,0,0
136355,329,1,1
136356,patients,1,1
136357,with,1,1
136358,a,1,0
136359,mutated,1,0
136360,NPM1,1,0
136361,gene,1,0
136362,(,1,0
136363,NPM1+,1,0
136364,),1,0
136365,",",0,0
136366,but,0,0
136367,not,0,0
136368,in,0,0
136369,319,1,1
136370,patients,1,1
136371,without,1,1
136372,a,1,0
136373,NPM1,1,0
136374,mutation,1,0
136375,(,1,0
136376,wtNPM1,1,0
136377,),1,0
136378,.,1,0
136379,In,0,0
136380,a,0,0
136381,multivariate,0,0
136382,Cox,0,0
136383,regression,0,0
136384,model,0,0
136385,",",0,0
136386,the,0,0
136387,quantitative,0,0
136388,FLT3ITD,0,0
136389,mRNA,0,0
136390,level,0,0
136391,showed,0,0
136392,an,0,0
136393,independent,0,0
136394,prognostic,0,0
136395,impact,0,0
136396,on,0,0
136397,overall,0,0
136398,survival,0,0
136399,(,0,0
136400,OS,0,0
136401,),0,0
136402,and,0,0
136403,relapse-free,0,0
136404,survival,0,0
136405,(,0,0
136406,RFS,0,0
136407,),0,0
136408,only,0,0
136409,in,0,0
136410,the,0,0
136411,NPM1+,1,0
136412,subgroup,1,0
136413,(,0,0
136414,OS,0,0
136415,:,0,1
136416,hazard,0,0
136417,ratio,0,0
136418,",",0,0
136419,5.9,0,0
136420,;,0,0
136421,[,0,0
136422,95,0,0
136423,%,0,0
136424,confidence,0,0
136425,interval,0,0
136426,[,0,0
136427,CI,0,0
136428,],0,0
136429,:,0,1
136430,3.1-11.2,0,0
136431,],0,0
136432,;,0,0
136433,RFS,0,0
136434,:,0,1
136435,hazard,0,0
136436,ratio,0,0
136437,",",0,0
136438,7.5,0,0
136439,[,0,0
136440,95,0,0
136441,%,0,0
136442,CI,0,0
136443,:,0,1
136444,3.4-16.5,0,0
136445,],0,0
136446,),0,0
136447,.,0,0
136448,The,0,0
136449,FLT3ITD,0,0
136450,mRNA,0,0
136451,level,0,0
136452,contributes,0,0
136453,to,0,0
136454,relapse,0,0
136455,risk,0,0
136456,stratification,0,0
136457,and,0,0
136458,might,0,0
136459,help,0,0
136460,to,0,0
136461,guide,0,0
136462,postremission,0,0
136463,therapy,0,0
136464,in,0,0
136465,NPM1-mutated,1,1
136466,AML,1,1
136467,.,1,1
136468,Efficiency,0,0
136469,of,0,0
136470,slush,0,0
136471,nitrogen,0,0
136472,vitrification,0,0
136473,of,0,0
136474,human,0,0
136475,oocytes,0,1
136476,vitrified,0,1
136477,with,0,1
136478,or,0,0
136479,without,0,1
136480,cumulus,0,0
136481,cells,0,0
136482,in,0,0
136483,relation,0,0
136484,to,0,0
136485,survival,0,0
136486,rate,0,0
136487,and,0,0
136488,meiotic,0,0
136489,spindle,0,0
136490,competence,0,0
136491,.,0,0
136492,OBJECTIVE,0,0
136493,To,0,0
136494,evaluate,0,0
136495,the,0,0
136496,efficiency,0,0
136497,of,0,0
136498,slush,0,0
136499,nitrogen,0,0
136500,vitrification,0,0
136501,of,0,0
136502,human,1,0
136503,oocytes,1,1
136504,with,0,1
136505,or,0,1
136506,without,0,1
136507,cumulus,0,0
136508,cells,0,0
136509,in,0,0
136510,terms,0,0
136511,of,0,0
136512,survival,0,0
136513,rate,0,0
136514,and,0,0
136515,maintenance,0,0
136516,of,0,0
136517,meiotic,0,0
136518,spindle,0,0
136519,.,0,0
136520,DESIGN,0,0
136521,Randomized,0,0
136522,",",0,0
136523,comparative,0,0
136524,study,0,0
136525,.,0,0
136526,SETTING,0,0
136527,Medical,0,1
136528,center,0,1
136529,.,0,0
136530,PATIENT,0,0
136531,(,0,0
136532,S,0,0
136533,),0,0
136534,A,0,0
136535,total,0,1
136536,of,0,0
136537,274,1,1
136538,oocytes,1,1
136539,obtained,1,0
136540,from,1,1
136541,46,1,1
136542,couples,1,1
136543,undergoing,1,1
136544,infertility,1,1
136545,treatment,1,0
136546,.,1,0
136547,INTERVENTION,0,0
136548,(,0,0
136549,S,0,0
136550,),0,0
136551,Metaphase,0,0
136552,II,0,1
136553,oocytes,0,0
136554,were,0,0
136555,divided,0,1
136556,into,0,1
136557,groups,0,0
136558,A,0,1
136559,and,0,0
136560,B,0,0
136561,",",0,0
136562,vitrified,0,0
136563,with,0,0
136564,and,0,0
136565,without,0,1
136566,cumulus,0,0
136567,cells,0,0
136568,",",0,0
136569,respectively,0,0
136570,.,0,0
136571,MAIN,0,0
136572,OUTCOMES,0,0
136573,MEASURE,0,0
136574,(,0,0
136575,S,0,0
136576,),0,0
136577,Survival,0,0
136578,rates,0,0
136579,and,0,0
136580,maintenance,0,0
136581,of,0,0
136582,meiotic,0,0
136583,spindle,0,0
136584,observed,0,0
136585,immediately,0,0
136586,after,0,0
136587,warming,0,0
136588,and,0,0
136589,3,0,0
136590,hours,0,0
136591,after,0,0
136592,incubation,0,0
136593,.,0,0
136594,RESULT,0,0
136595,(,0,0
136596,S,0,0
136597,),0,0
136598,No,0,0
136599,statistically,0,0
136600,significant,0,0
136601,difference,0,0
136602,was,0,0
136603,detected,0,0
136604,between,0,0
136605,the,0,0
136606,two,0,0
136607,groups,0,0
136608,in,0,0
136609,terms,0,0
136610,of,0,0
136611,survival,0,0
136612,rate,0,0
136613,",",0,0
136614,but,0,0
136615,a,0,0
136616,significantly,0,0
136617,higher,0,0
136618,percentage,0,0
136619,of,0,0
136620,detectable,0,0
136621,spindle,0,0
136622,was,0,0
136623,observed,0,0
136624,in,0,0
136625,group,0,0
136626,B,0,0
136627,(,0,0
136628,completely,0,0
136629,denuded,0,0
136630,oocytes,0,0
136631,),0,0
136632,",",0,0
136633,either,0,0
136634,immediately,0,0
136635,after,0,0
136636,warming,0,0
136637,or,0,1
136638,3,0,0
136639,hours,0,0
136640,after,0,0
136641,incubation,0,0
136642,.,0,0
136643,CONCLUSION,0,0
136644,(,0,0
136645,S,0,0
136646,),0,0
136647,Complete,0,0
136648,denudation,0,0
136649,of,0,0
136650,oocytes,0,0
136651,before,0,0
136652,slush,0,0
136653,nitrogen,0,0
136654,vitrification,0,0
136655,does,0,0
136656,not,0,0
136657,influence,0,0
136658,survival,0,0
136659,rates,0,0
136660,but,0,0
136661,positively,0,0
136662,affects,0,0
136663,oocyte,0,0
136664,meiotic,0,0
136665,spindle,0,0
136666,competence,0,0
136667,.,0,0
136668,These,0,0
136669,data,0,0
136670,support,0,0
136671,the,0,0
136672,hypothesis,0,0
136673,that,0,0
136674,cumulus,0,0
136675,cells,0,0
136676,during,0,0
136677,vitrification,0,0
136678,represent,0,0
136679,an,0,0
136680,obstacle,0,0
136681,to,0,0
136682,cryoprotectant,0,0
136683,penetration,0,0
136684,more,0,0
136685,than,0,0
136686,having,0,1
136687,a,0,0
136688,protective,0,0
136689,role,0,0
136690,for,0,0
136691,the,0,0
136692,oocyte,0,0
136693,.,0,0
136694,Development,0,0
136695,of,0,0
136696,an,0,0
136697,adaptive,0,0
136698,low-pass,0,0
136699,filtered,0,0
136700,speech,0,0
136701,test,0,0
136702,for,0,0
136703,the,0,0
136704,identification,0,0
136705,of,0,0
136706,auditory,0,0
136707,processing,0,0
136708,disorders,0,1
136709,.,0,0
136710,OBJECTIVE,0,0
136711,One,0,0
136712,type,0,1
136713,of,0,0
136714,test,0,0
136715,commonly,0,0
136716,used,0,0
136717,to,0,0
136718,examine,0,0
136719,auditory,1,0
136720,processing,1,0
136721,disorders,1,1
136722,(,1,0
136723,APD,1,0
136724,),1,0
136725,is,0,0
136726,the,0,0
136727,low-pass,0,0
136728,filtered,0,0
136729,speech,0,0
136730,test,0,0
136731,(,0,0
136732,LPFST,0,0
136733,),0,0
136734,",",0,0
136735,of,0,0
136736,which,0,0
136737,there,0,0
136738,are,0,0
136739,various,0,0
136740,versions,0,0
136741,.,0,1
136742,In,0,0
136743,LPFSTs,0,0
136744,",",0,0
136745,a,0,0
136746,monaural,0,0
136747,",",0,0
136748,low-redundancy,0,0
136749,speech,0,0
136750,sample,0,1
136751,is,0,0
136752,distorted,0,0
136753,by,0,0
136754,using,0,0
136755,filtering,0,0
136756,to,0,0
136757,modify,0,0
136758,its,0,0
136759,frequency,0,0
136760,content,0,0
136761,.,0,0
136762,Due,0,0
136763,to,0,0
136764,the,0,0
136765,richness,0,0
136766,of,0,0
136767,the,0,0
136768,neural,0,0
136769,pathways,0,0
136770,in,0,0
136771,the,0,0
136772,auditory,0,0
136773,system,0,0
136774,and,0,0
136775,the,0,0
136776,redundancy,0,0
136777,of,0,0
136778,acoustic,0,0
136779,information,0,0
136780,in,0,0
136781,spoken,0,0
136782,language,0,0
136783,",",0,0
136784,a,0,0
136785,normal,0,0
136786,listener,0,0
136787,is,0,0
136788,able,0,0
136789,to,0,0
136790,recognize,0,0
136791,speech,0,0
136792,even,0,0
136793,when,0,0
136794,parts,0,0
136795,of,0,0
136796,the,0,0
136797,signal,0,0
136798,are,0,0
136799,missing,0,0
136800,",",0,0
136801,whereas,0,0
136802,this,0,0
136803,ability,0,0
136804,is,0,0
136805,often,0,0
136806,impaired,0,0
136807,in,0,0
136808,listeners,1,1
136809,with,1,1
136810,APD,1,0
136811,.,1,0
136812,One,0,0
136813,limitation,0,0
136814,of,0,0
136815,the,0,0
136816,various,0,0
136817,versions,0,0
136818,of,0,0
136819,the,0,0
136820,LPFST,0,0
136821,is,0,0
136822,that,0,0
136823,they,0,0
136824,are,0,0
136825,carried,0,0
136826,out,0,0
136827,using,0,0
136828,a,0,0
136829,constant,0,0
136830,level,0,0
136831,of,0,0
136832,low-pass,0,0
136833,filtering,0,0
136834,(,0,0
136835,e.g,0,0
136836,.,0,0
136837,a,0,0
136838,fixed,0,0
136839,1kHz,0,0
136840,corner,0,0
136841,frequency,0,0
136842,),0,0
136843,which,0,0
136844,makes,0,0
136845,them,0,0
136846,prone,0,0
136847,to,0,0
136848,ceiling,0,0
136849,and,0,0
136850,floor,0,1
136851,effects,0,0
136852,.,0,0
136853,The,0,0
136854,purpose,0,0
136855,of,0,0
136856,this,0,0
136857,study,0,0
136858,was,0,0
136859,to,0,0
136860,counter,0,0
136861,these,0,0
136862,effects,0,0
136863,by,0,0
136864,modifying,0,0
136865,the,0,0
136866,LPFST,0,0
136867,using,0,0
136868,a,0,0
136869,computer-based,0,0
136870,adaptive,0,0
136871,procedure,0,0
136872,",",0,0
136873,and,0,0
136874,to,0,0
136875,evaluate,0,0
136876,the,0,0
136877,performance,0,0
136878,of,0,0
136879,normal-hearing,1,1
136880,participants,1,1
136881,of,1,0
136882,varying,1,0
136883,ages,1,1
136884,on,0,0
136885,the,0,0
136886,test,0,0
136887,.,0,0
136888,METHODS,0,0
136889,In,0,0
136890,this,0,0
136891,preliminary,0,0
136892,study,0,0
136893,",",0,0
136894,33,1,1
136895,adults,1,1
136896,and,1,0
136897,30,1,1
136898,children,1,1
136899,(,1,0
136900,aged,1,1
136901,8-11,1,1
136902,years,1,1
136903,),1,0
136904,with,1,1
136905,no,1,0
136906,known,1,0
136907,history,1,0
136908,of,1,0
136909,listening,1,0
136910,difficulties,1,0
136911,were,0,0
136912,tested,0,0
136913,.,0,0
136914,The,0,0
136915,University,0,1
136916,of,0,0
136917,Canterbury,0,1
136918,Adaptive,0,0
136919,Speech,0,0
136920,Test,0,0
136921,(,0,0
136922,UCAST,0,0
136923,),0,0
136924,platform,0,0
136925,was,0,0
136926,used,0,0
136927,to,0,0
136928,administer,0,0
136929,a,0,0
136930,four-alternative,0,0
136931,forced-choice,0,0
136932,adaptive,0,0
136933,test,0,0
136934,that,0,0
136935,altered,0,0
136936,a,0,0
136937,low-pass,0,0
136938,filter,0,0
136939,(,0,0
136940,LPF,0,0
136941,),0,0
136942,to,0,0
136943,track,0,0
136944,the,0,0
136945,corner,0,0
136946,frequency,0,0
136947,at,0,0
136948,which,0,0
136949,participants,0,1
136950,correctly,0,0
136951,identified,0,0
136952,a,0,0
136953,certain,0,0
136954,percentage,0,0
136955,of,0,0
136956,the,0,0
136957,word,0,0
136958,stimuli,0,0
136959,.,0,0
136960,RESULTS,0,0
136961,Findings,0,0
136962,on,0,0
136963,the,0,0
136964,University,0,1
136965,of,0,0
136966,Canterbury,0,1
136967,Adaptive,0,0
136968,Speech,0,0
136969,Test-Filtered,0,0
136970,Words,0,0
136971,(,0,0
136972,UCAST-FW,0,0
136973,),0,0
136974,indicated,0,0
136975,a,0,0
136976,significant,0,0
136977,maturational,0,0
136978,effect,0,0
136979,.,0,0
136980,Adult,1,0
136981,participants,1,1
136982,performed,0,0
136983,significantly,0,0
136984,better,0,0
136985,on,0,0
136986,the,0,0
136987,UCAST-FW,0,0
136988,in,0,0
136989,comparison,0,0
136990,to,0,0
136991,the,0,0
136992,child,1,1
136993,participants,1,1
136994,.,1,0
136995,The,0,0
136996,UCAST-FW,0,0
136997,test,0,0
136998,was,0,0
136999,reliable,0,0
137000,over,0,0
137001,repeated,0,0
137002,administrations,0,0
137003,.,0,1
137004,CONCLUSIONS,0,0
137005,An,0,0
137006,adaptive,0,0
137007,low-pass,0,0
137008,filtered,0,0
137009,speech,0,0
137010,test,0,0
137011,such,0,0
137012,as,0,0
137013,the,0,0
137014,UCAST-FW,0,0
137015,is,0,0
137016,sensitive,0,0
137017,to,0,0
137018,maturational,0,0
137019,changes,0,0
137020,in,0,0
137021,auditory,0,0
137022,processing,0,0
137023,ability,0,0
137024,.,0,0
137025,Theta,0,0
137026,burst,0,0
137027,stimulation,0,0
137028,in,0,0
137029,the,0,0
137030,rehabilitation,0,0
137031,of,0,0
137032,the,0,0
137033,upper,0,0
137034,limb,0,0
137035,:,0,1
137036,a,0,0
137037,semirandomized,0,0
137038,",",0,0
137039,placebo-controlled,0,0
137040,trial,0,0
137041,in,0,0
137042,chronic,1,1
137043,stroke,1,1
137044,patients,1,1
137045,.,1,1
137046,BACKGROUND,0,0
137047,Noninvasive,0,0
137048,cortical,0,0
137049,stimulation,0,0
137050,could,0,0
137051,represent,0,0
137052,an,0,0
137053,add-on,0,0
137054,treatment,0,0
137055,to,0,0
137056,enhance,0,0
137057,motor,0,0
137058,recovery,0,0
137059,after,0,0
137060,stroke,0,1
137061,.,0,0
137062,However,0,0
137063,",",0,0
137064,its,0,0
137065,clinical,0,0
137066,value,0,0
137067,",",0,0
137068,including,0,0
137069,anticipated,0,0
137070,size,0,0
137071,and,0,0
137072,duration,0,0
137073,of,0,0
137074,the,0,0
137075,treatment,0,0
137076,effects,0,0
137077,",",0,0
137078,remains,0,0
137079,largely,0,0
137080,unknown,0,0
137081,.,0,0
137082,OBJECTIVE,0,0
137083,The,0,0
137084,authors,0,0
137085,designed,0,0
137086,a,0,0
137087,small,0,0
137088,semi-randomized,0,0
137089,clinical,0,0
137090,trial,0,0
137091,to,0,0
137092,explore,0,0
137093,whether,0,0
137094,long-lasting,0,0
137095,clinically,0,0
137096,important,0,0
137097,gains,0,0
137098,can,0,0
137099,be,0,0
137100,achieved,0,0
137101,by,0,0
137102,adding,0,0
137103,theta,0,0
137104,burst,0,0
137105,stimulation,0,0
137106,(,0,0
137107,TBS,0,0
137108,),0,0
137109,",",0,0
137110,a,0,0
137111,form,0,0
137112,of,0,0
137113,repetitive,0,0
137114,transcranial,0,0
137115,magnetic,0,0
137116,stimulation,0,0
137117,(,0,0
137118,TMS,0,0
137119,),0,0
137120,",",0,0
137121,to,0,0
137122,a,0,0
137123,rehabilitation,0,0
137124,program,0,0
137125,for,0,0
137126,the,0,0
137127,hand,0,0
137128,.,0,0
137129,METHODS,0,0
137130,A,1,0
137131,total,1,1
137132,of,1,0
137133,41,1,1
137134,chronic,1,1
137135,stroke,1,1
137136,patients,1,1
137137,received,1,0
137138,excitatory,1,0
137139,TBS,1,0
137140,to,1,0
137141,the,1,0
137142,ipsilesional,1,0
137143,hemisphere,1,0
137144,or,1,0
137145,inhibitory,1,0
137146,TBS,1,0
137147,to,1,0
137148,the,1,0
137149,contralesional,1,0
137150,hemisphere,1,0
137151,in,1,0
137152,2,1,1
137153,centers,1,1
137154,;,1,0
137155,each,0,0
137156,active,0,0
137157,group,0,0
137158,was,0,0
137159,compared,0,0
137160,with,0,0
137161,a,0,0
137162,group,0,0
137163,receiving,0,0
137164,sham,0,0
137165,TBS,0,1
137166,.,0,0
137167,TBS,0,0
137168,was,0,0
137169,followed,0,0
137170,by,0,0
137171,physical,0,0
137172,therapy,0,0
137173,for,0,0
137174,10,0,1
137175,working,0,1
137176,days,0,0
137177,.,0,1
137178,Patients,0,1
137179,and,0,0
137180,therapists,0,0
137181,were,0,0
137182,blinded,0,0
137183,to,0,0
137184,the,0,0
137185,type,0,0
137186,of,0,0
137187,TBS,0,1
137188,.,0,0
137189,Primary,0,0
137190,outcome,0,0
137191,measures,0,0
137192,(,0,1
137193,9-hole,0,0
137194,Peg,0,0
137195,Test,0,0
137196,[,0,0
137197,9HPT,0,0
137198,],0,0
137199,",",0,0
137200,Jebsen,0,0
137201,Taylor,0,1
137202,Test,0,0
137203,[,0,0
137204,JTT,0,1
137205,],0,0
137206,",",0,0
137207,and,0,0
137208,grip,0,0
137209,and,0,0
137210,pinch-grip,0,0
137211,dynamometry,0,0
137212,),0,0
137213,were,0,0
137214,assessed,0,0
137215,4,0,0
137216,",",0,0
137217,30,0,0
137218,",",0,0
137219,and,0,0
137220,90,0,0
137221,days,0,0
137222,post,0,0
137223,treatment,0,0
137224,.,0,0
137225,The,0,0
137226,clinically,0,0
137227,important,0,0
137228,difference,0,0
137229,was,0,0
137230,defined,0,0
137231,as,0,0
137232,10,0,0
137233,%,0,0
137234,of,0,0
137235,the,0,0
137236,maximum,0,0
137237,score,0,0
137238,.,0,0
137239,RESULTS,0,0
137240,There,0,0
137241,were,0,0
137242,no,0,0
137243,differences,0,0
137244,between,0,0
137245,the,0,0
137246,active,0,0
137247,treatment,0,0
137248,and,0,0
137249,sham,0,0
137250,groups,0,0
137251,in,0,0
137252,any,0,0
137253,of,0,0
137254,the,0,0
137255,outcome,0,0
137256,measures,0,0
137257,.,0,0
137258,All,0,0
137259,patients,0,1
137260,achieved,0,0
137261,small,0,1
137262,sustainable,0,0
137263,improvements,0,0
137264,--,0,1
137265,9HPT,0,1
137266,",",0,0
137267,5,0,0
137268,%,0,0
137269,of,0,0
137270,maximum,0,0
137271,(,0,0
137272,confidence,0,0
137273,interval,0,0
137274,[,0,0
137275,CI,0,0
137276,],0,0
137277,=,0,0
137278,3,0,0
137279,%,0,0
137280,-7,0,0
137281,%,0,0
137282,),0,0
137283,;,0,0
137284,JTT,0,0
137285,",",0,0
137286,5.7,0,0
137287,%,0,0
137288,(,0,0
137289,CI,0,0
137290,=,0,0
137291,3,0,0
137292,%,0,0
137293,-8,0,0
137294,%,0,0
137295,),0,0
137296,;,0,0
137297,and,0,0
137298,grip,0,0
137299,strength,0,0
137300,",",0,0
137301,6,0,0
137302,%,0,0
137303,(,0,0
137304,CI,0,0
137305,=,0,0
137306,2,0,0
137307,%,0,0
137308,-10,0,0
137309,%,0,0
137310,),0,0
137311,--,0,0
137312,all,0,0
137313,below,0,0
137314,the,0,0
137315,defined,0,0
137316,clinically,0,0
137317,important,0,0
137318,level,0,0
137319,.,0,0
137320,CONCLUSIONS,0,0
137321,Cortical,0,0
137322,stimulation,0,0
137323,did,0,0
137324,not,0,0
137325,augment,0,0
137326,the,0,0
137327,gains,0,0
137328,from,0,0
137329,a,0,0
137330,late,0,0
137331,rehabilitation,0,1
137332,program,0,0
137333,.,0,0
137334,The,0,0
137335,effect,0,0
137336,size,0,0
137337,anticipated,0,0
137338,by,0,0
137339,the,0,0
137340,authors,0,0
137341,was,0,0
137342,overestimated,0,0
137343,.,0,0
137344,These,0,0
137345,results,0,0
137346,can,0,0
137347,improve,0,0
137348,the,0,0
137349,design,0,0
137350,of,0,0
137351,future,0,0
137352,work,0,0
137353,on,0,0
137354,therapeutic,0,0
137355,uses,0,0
137356,of,0,0
137357,TMS,0,0
137358,.,0,1
137359,Most,0,0
137360,effective,0,0
137361,regimen,0,0
137362,of,0,0
137363,tranexamic,0,0
137364,acid,0,0
137365,in,0,0
137366,knee,1,1
137367,arthroplasty,1,1
137368,:,1,0
137369,a,0,0
137370,prospective,0,0
137371,randomized,0,0
137372,controlled,0,0
137373,study,0,0
137374,in,0,0
137375,240,1,1
137376,patients,1,1
137377,.,1,1
137378,BACKGROUND,0,0
137379,The,0,0
137380,antifibrinolytic,0,0
137381,tranexamic,0,0
137382,acid,0,0
137383,reduces,0,0
137384,surgical,0,1
137385,blood,0,0
137386,loss,0,0
137387,",",0,0
137388,but,0,0
137389,studies,0,0
137390,have,0,0
137391,not,0,0
137392,identified,0,0
137393,an,0,0
137394,optimal,0,0
137395,regimen,0,0
137396,.,0,1
137397,QUESTIONS/PURPOSES,0,0
137398,We,0,0
137399,studied,0,1
137400,different,0,0
137401,dosages,0,0
137402,",",0,0
137403,timings,0,0
137404,",",0,0
137405,and,0,0
137406,modes,0,0
137407,of,0,0
137408,administration,0,0
137409,to,0,0
137410,identify,0,0
137411,the,0,0
137412,most,0,0
137413,effective,0,0
137414,regimen,0,0
137415,of,0,0
137416,tranexamic,0,0
137417,acid,0,0
137418,in,0,0
137419,achieving,0,0
137420,maximum,0,0
137421,reduction,0,0
137422,of,0,0
137423,blood,0,0
137424,loss,0,0
137425,in,0,0
137426,TKA,0,0
137427,.,0,0
137428,METHODS,0,0
137429,We,0,0
137430,prospectively,0,1
137431,studied,0,1
137432,five,1,0
137433,regimens,1,0
137434,(,1,0
137435,four,1,0
137436,intravenous,1,0
137437,",",1,0
137438,one,1,0
137439,local,1,0
137440,;,1,0
137441,40,1,1
137442,patients,1,1
137443,each,1,0
137444,),1,0
137445,with,1,0
137446,a,1,0
137447,control,1,0
137448,group,1,0
137449,(,0,0
137450,no,0,0
137451,tranexamic,0,0
137452,acid,0,0
137453,),0,0
137454,.,0,0
137455,The,0,0
137456,four,0,0
137457,intravenous,0,0
137458,(,0,0
137459,10-mg/kg,0,0
137460,dose,0,0
137461,),0,0
137462,regimens,0,0
137463,included,0,0
137464,(,0,0
137465,1,0,0
137466,),0,0
137467,intraoperative,0,0
137468,dose,0,0
137469,(,0,0
137470,IO,0,0
137471,),0,0
137472,given,0,0
137473,before,0,0
137474,tourniquet,0,0
137475,deflation,0,0
137476,",",0,0
137477,(,0,0
137478,2,0,0
137479,),0,0
137480,additional,0,0
137481,preoperative,0,0
137482,dose,0,0
137483,(,0,0
137484,POIO,0,0
137485,),0,0
137486,",",0,0
137487,(,0,0
137488,3,0,0
137489,),0,0
137490,additional,0,0
137491,postoperative,0,0
137492,dose,0,0
137493,(,0,0
137494,IOPO,0,0
137495,),0,0
137496,",",0,0
137497,and,0,0
137498,(,0,0
137499,4,0,0
137500,),0,0
137501,all,0,0
137502,three,0,0
137503,doses,0,0
137504,(,0,0
137505,POIOPO,0,0
137506,),0,0
137507,.,0,0
137508,The,0,0
137509,fifth,0,0
137510,regimen,0,0
137511,was,0,0
137512,a,0,0
137513,single,0,0
137514,local,0,0
137515,application,0,0
137516,(,0,0
137517,LA,0,0
137518,),0,0
137519,.,0,0
137520,Two,0,0
137521,independent,0,0
137522,parameters,0,0
137523,of,0,0
137524,drain,0,0
137525,loss,0,0
137526,and,0,0
137527,total,0,1
137528,blood,0,0
137529,loss,0,0
137530,",",0,0
137531,calculated,0,0
137532,by,0,0
137533,the,0,0
137534,hemoglobin,0,0
137535,balance,0,0
137536,method,0,0
137537,",",0,0
137538,were,0,0
137539,evaluated,0,0
137540,statistically,0,0
137541,.,0,0
137542,RESULTS,0,0
137543,Both,0,0
137544,parameters,0,0
137545,were,0,0
137546,reduced,0,0
137547,in,0,0
137548,all,0,0
137549,five,0,0
137550,regimens,0,0
137551,as,0,0
137552,against,0,0
137553,the,0,0
137554,control,0,0
137555,.,0,0
137556,A,0,0
137557,significant,0,0
137558,reduction,0,0
137559,in,0,0
137560,drain,0,0
137561,loss,0,0
137562,was,0,0
137563,seen,0,0
137564,in,0,0
137565,the,0,0
137566,POIO,0,0
137567,",",0,0
137568,IOPO,0,0
137569,",",0,0
137570,and,0,0
137571,POIOPO,0,0
137572,groups,0,0
137573,whereas,0,0
137574,total,0,1
137575,blood,0,0
137576,loss,0,0
137577,was,0,0
137578,significantly,0,0
137579,reduced,0,0
137580,in,0,0
137581,the,0,0
137582,POIO,0,0
137583,",",0,0
137584,POIOPO,0,0
137585,",",0,0
137586,and,0,0
137587,LA,0,0
137588,groups,0,0
137589,.,0,0
137590,The,0,0
137591,POIOPO,0,0
137592,group,0,0
137593,had,0,0
137594,the,0,0
137595,least,0,0
137596,drain,0,0
137597,loss,0,0
137598,(,0,0
137599,303,0,1
137600,mL,0,0
137601,),0,0
137602,and,0,0
137603,least,0,0
137604,total,0,1
137605,blood,0,0
137606,loss,0,0
137607,(,0,0
137608,688,0,1
137609,mL,0,0
137610,),0,0
137611,.,0,0
137612,The,0,0
137613,IO,0,0
137614,group,0,0
137615,had,0,0
137616,the,0,0
137617,greatest,0,0
137618,drain,0,0
137619,loss,0,0
137620,and,0,0
137621,the,0,0
137622,IOPO,0,0
137623,group,0,0
137624,the,0,0
137625,greatest,0,0
137626,total,0,0
137627,blood,0,0
137628,loss,0,0
137629,.,0,0
137630,CONCLUSIONS,0,0
137631,Single-dose,0,0
137632,tranexamic,0,0
137633,acid,0,0
137634,did,0,0
137635,not,0,0
137636,give,0,0
137637,effective,0,0
137638,results,0,0
137639,.,0,0
137640,The,0,0
137641,two-dose,0,0
137642,regimen,0,0
137643,of,0,0
137644,POIO,0,0
137645,was,0,0
137646,the,0,0
137647,least,0,0
137648,amount,0,0
137649,necessary,0,0
137650,for,0,0
137651,effective,0,0
137652,results,0,0
137653,.,0,0
137654,When,0,0
137655,compared,0,0
137656,against,0,0
137657,the,0,0
137658,control,0,0
137659,",",0,0
137660,this,0,0
137661,regimen,0,0
137662,produced,0,0
137663,reduction,0,0
137664,of,0,0
137665,drain,0,0
137666,loss,0,0
137667,and,0,0
137668,total,0,1
137669,blood,0,0
137670,loss,0,0
137671,",",0,0
137672,whereas,0,0
137673,the,0,0
137674,IOPO,0,0
137675,regimen,0,0
137676,did,0,0
137677,not,0,0
137678,.,0,0
137679,The,0,0
137680,three-dose,0,0
137681,regimen,0,0
137682,of,0,0
137683,POIOPO,0,0
137684,produced,0,0
137685,maximum,0,0
137686,effective,0,0
137687,reduction,0,0
137688,of,0,0
137689,drain,0,0
137690,loss,0,0
137691,and,0,0
137692,total,0,1
137693,blood,0,0
137694,loss,0,0
137695,.,0,0
137696,Comparison,0,0
137697,of,0,0
137698,dual-axis,0,0
137699,rotational,0,0
137700,coronary,0,1
137701,angiography,0,0
137702,(,0,0
137703,XPERSWING,0,0
137704,),0,0
137705,versus,0,0
137706,conventional,0,0
137707,technique,0,0
137708,in,0,0
137709,routine,0,0
137710,practice,0,0
137711,.,0,0
137712,INTRODUCTION,0,0
137713,AND,0,0
137714,OBJECTIVES,0,0
137715,Coronary,0,1
137716,angiography,0,0
137717,is,0,0
137718,the,0,0
137719,gold,0,0
137720,standard,0,0
137721,for,0,0
137722,the,0,0
137723,study,0,0
137724,of,0,0
137725,coronary,0,1
137726,artery,0,1
137727,disease,0,1
137728,.,0,0
137729,This,0,0
137730,technique,0,0
137731,requires,0,0
137732,several,0,0
137733,orthogonal,0,0
137734,projections,0,0
137735,.,0,1
137736,Rotational,0,0
137737,angiography,0,0
137738,is,0,0
137739,a,0,0
137740,new,0,0
137741,technique,0,0
137742,which,0,0
137743,involves,0,0
137744,pre-set,0,0
137745,rotation,0,0
137746,of,0,0
137747,the,0,0
137748,X-ray,0,0
137749,tube,0,0
137750,around,0,0
137751,the,0,0
137752,patient,0,0
137753,and,0,0
137754,allows,0,0
137755,visualization,0,0
137756,of,0,0
137757,each,0,0
137758,coronary,0,1
137759,artery,0,1
137760,in,0,0
137761,different,0,0
137762,views,0,0
137763,",",0,0
137764,using,0,0
137765,a,0,0
137766,single,0,0
137767,contrast,0,0
137768,injection,0,0
137769,.,0,0
137770,The,0,0
137771,purpose,0,0
137772,of,0,0
137773,this,0,0
137774,study,0,0
137775,was,0,0
137776,to,0,0
137777,compare,0,0
137778,conventional,0,0
137779,coronary,0,1
137780,angiography,0,0
137781,(,0,0
137782,A,0,0
137783,),0,0
137784,vs,0,0
137785,rotational,0,0
137786,angiography,0,0
137787,(,0,0
137788,B,0,0
137789,),0,0
137790,",",0,0
137791,focusing,0,0
137792,on,0,0
137793,radiation,0,0
137794,dose,0,0
137795,",",0,0
137796,amount,0,0
137797,of,0,0
137798,contrast,0,0
137799,administered,0,0
137800,",",0,0
137801,and,0,0
137802,total,0,0
137803,procedure,0,0
137804,time,0,0
137805,for,0,0
137806,both,0,0
137807,diagnostic,0,0
137808,and,0,0
137809,therapeutic,0,0
137810,percutaneous,0,1
137811,coronary,0,1
137812,interventions,0,0
137813,.,0,1
137814,METHODS,0,0
137815,Prospective,1,0
137816,study,1,0
137817,of,1,0
137818,104,1,1
137819,consecutive,1,1
137820,patients,1,1
137821,undergoing,1,1
137822,coronary,1,1
137823,angiography,1,1
137824,who,1,1
137825,were,1,1
137826,randomized,1,1
137827,to,0,0
137828,one,0,0
137829,of,0,0
137830,these,0,0
137831,techniques,0,0
137832,.,0,0
137833,RESULTS,0,0
137834,We,0,0
137835,found,0,0
137836,a,0,0
137837,significant,0,0
137838,reduction,0,0
137839,in,0,0
137840,the,0,0
137841,amount,0,0
137842,of,0,0
137843,contrast,0,0
137844,administered,0,0
137845,(,0,0
137846,A,0,0
137847,vs,0,0
137848,B,0,0
137849,",",0,0
137850,93.1,0,0
137851,[,0,0
137852,41.7,0,0
137853,],0,0
137854,vs,0,0
137855,50.9,0,0
137856,[,0,0
137857,14.7,0,0
137858,],0,0
137859,mL,0,0
137860,;,0,0
137861,P,0,0
137862,<,0,0
137863,.0001,0,0
137864,),0,0
137865,and,0,0
137866,radiation,0,0
137867,exposure,0,0
137868,(,0,0
137869,27.6,0,0
137870,[,0,0
137871,11.5,0,0
137872,],0,0
137873,vs,0,0
137874,18,0,1
137875,[,0,0
137876,6.4,0,0
137877,],0,0
137878,mGycm,0,1
137879,(,0,0
137880,2,0,0
137881,),0,0
137882,;,0,0
137883,P,0,0
137884,<,0,0
137885,.0001,0,0
137886,),0,0
137887,.,0,0
137888,A,0,0
137889,significant,0,0
137890,increase,0,0
137891,in,0,0
137892,total,0,1
137893,procedure,0,0
137894,time,0,0
137895,was,0,0
137896,noted,0,0
137897,in,0,0
137898,the,0,0
137899,rotational,0,0
137900,angiography,0,0
137901,arm,0,0
137902,.,0,0
137903,However,0,0
137904,",",0,0
137905,when,0,0
137906,only,0,0
137907,the,0,0
137908,last,0,0
137909,50,0,0
137910,patients,0,1
137911,were,0,0
137912,analyzed,0,0
137913,",",0,0
137914,we,0,0
137915,found,0,0
137916,no,0,0
137917,difference,0,0
137918,in,0,0
137919,procedure,0,0
137920,time,0,0
137921,between,0,0
137922,the,0,0
137923,groups,0,0
137924,",",0,0
137925,probably,0,0
137926,related,0,0
137927,to,0,0
137928,the,0,0
137929,learning,0,0
137930,curve,0,0
137931,of,0,0
137932,the,0,0
137933,operators,0,0
137934,.,0,0
137935,Angioplasty,0,0
137936,was,0,0
137937,performed,0,0
137938,in,0,0
137939,29,0,1
137940,patients,0,1
137941,in,0,0
137942,group,0,0
137943,A,0,0
137944,and,0,0
137945,28,0,0
137946,patients,0,1
137947,in,0,0
137948,group,0,1
137949,B,0,0
137950,.,0,0
137951,Contrast,0,0
137952,reduction,0,0
137953,was,0,0
137954,maintained,0,0
137955,in,0,0
137956,the,0,0
137957,rotational,0,0
137958,angiography,0,0
137959,group,0,0
137960,compared,0,0
137961,to,0,0
137962,the,0,0
137963,conventional,0,0
137964,technique,0,0
137965,(,0,0
137966,A,0,0
137967,vs,0,0
137968,B,0,0
137969,",",0,0
137970,335.1,0,0
137971,[,0,0
137972,192.1,0,0
137973,],0,0
137974,vs,0,0
137975,238.5,0,0
137976,[,0,0
137977,114.4,0,0
137978,],0,0
137979,mL,0,0
137980,;,0,0
137981,P=.02,0,0
137982,),0,0
137983,.,0,0
137984,CONCLUSIONS,0,0
137985,The,0,0
137986,rotational,0,0
137987,angiography,0,0
137988,technique,0,0
137989,leads,0,0
137990,to,0,0
137991,a,0,0
137992,significant,0,0
137993,decrease,0,0
137994,in,0,0
137995,radiation,0,0
137996,exposure,0,0
137997,and,0,0
137998,contrast,0,0
137999,dose,0,0
138000,administered,0,0
138001,for,0,0
138002,diagnostic,0,0
138003,procedures,0,0
138004,when,0,0
138005,compared,0,0
138006,to,0,0
138007,conventional,0,0
138008,coronary,0,1
138009,angiography,0,0
138010,.,0,0
138011,In,0,0
138012,patients,0,1
138013,who,0,1
138014,undergo,0,1
138015,percutaneous,0,1
138016,coronary,0,1
138017,intervention,0,0
138018,",",0,0
138019,contrast,0,0
138020,reduction,0,0
138021,remains,0,0
138022,significant,0,0
138023,.,0,0
138024,Impact,0,0
138025,of,0,0
138026,the,0,0
138027,quantity,0,0
138028,and,0,0
138029,flavonoid,0,0
138030,content,0,0
138031,of,0,0
138032,fruits,0,0
138033,and,0,0
138034,vegetables,0,0
138035,on,0,0
138036,markers,0,0
138037,of,0,0
138038,intake,0,0
138039,in,0,0
138040,adults,1,1
138041,with,1,1
138042,an,1,0
138043,increased,1,0
138044,risk,1,0
138045,of,1,0
138046,cardiovascular,1,1
138047,disease,1,1
138048,:,1,1
138049,the,0,0
138050,FLAVURS,0,0
138051,trial,0,0
138052,.,0,0
138053,PURPOSE,0,0
138054,Limited,0,0
138055,robust,0,0
138056,randomised,0,0
138057,controlled,0,0
138058,trials,0,0
138059,investigating,0,0
138060,fruit,0,0
138061,and,0,0
138062,vegetable,0,0
138063,(,0,0
138064,F,0,0
138065,&,0,1
138066,V,0,0
138067,),0,0
138068,intake,0,0
138069,in,0,0
138070,people,1,1
138071,at,1,0
138072,risk,1,0
138073,of,1,0
138074,cardiovascular,1,0
138075,disease,1,1
138076,(,1,0
138077,CVD,1,0
138078,),1,0
138079,exist,0,0
138080,.,0,0
138081,We,0,0
138082,aimed,0,0
138083,to,0,0
138084,design,0,0
138085,and,0,0
138086,validate,0,0
138087,a,0,0
138088,dietary,0,0
138089,strategy,0,0
138090,of,0,0
138091,increasing,0,0
138092,flavonoid-rich,0,0
138093,versus,0,0
138094,flavonoid-poor,0,0
138095,F,0,0
138096,&,0,1
138097,V,0,0
138098,consumption,0,0
138099,on,0,0
138100,nutrient,0,0
138101,biomarker,0,0
138102,profile,0,0
138103,.,0,0
138104,METHODS,0,0
138105,A,0,0
138106,parallel,0,0
138107,",",0,0
138108,randomised,0,0
138109,",",0,0
138110,controlled,0,0
138111,",",0,0
138112,dose-response,0,0
138113,dietary,0,0
138114,intervention,0,0
138115,study,0,0
138116,.,0,0
138117,Participants,1,1
138118,with,1,1
138119,a,1,0
138120,CVD,1,0
138121,relative,1,0
138122,risk,1,0
138123,of,1,0
138124,1.5,1,0
138125,assessed,1,0
138126,by,1,0
138127,risk,1,0
138128,scores,1,0
138129,were,0,0
138130,randomly,0,1
138131,assigned,0,0
138132,to,0,0
138133,one,0,0
138134,of,0,0
138135,the,0,0
138136,3,0,0
138137,groups,0,0
138138,:,0,1
138139,habitual,0,1
138140,(,0,0
138141,control,0,0
138142,",",0,0
138143,CT,0,0
138144,),0,0
138145,",",0,0
138146,high-flavonoid,0,0
138147,(,0,0
138148,HF,0,1
138149,),0,0
138150,or,0,0
138151,low-flavonoid,0,0
138152,(,0,0
138153,LF,0,0
138154,),0,0
138155,diets,0,0
138156,.,0,0
138157,While,0,0
138158,the,0,0
138159,CT,0,0
138160,group,0,0
138161,(,0,0
138162,n,0,1
138163,=,0,0
138164,57,0,1
138165,),0,0
138166,consumed,0,0
138167,their,0,0
138168,habitual,0,0
138169,diet,0,0
138170,throughout,0,0
138171,",",0,0
138172,the,0,0
138173,HF,0,0
138174,(,0,0
138175,n,0,1
138176,=,0,0
138177,58,0,1
138178,),0,0
138179,and,0,0
138180,LF,0,0
138181,(,0,0
138182,n,0,1
138183,=,0,0
138184,59,0,1
138185,),0,0
138186,groups,0,0
138187,sequentially,0,1
138188,increased,0,0
138189,their,0,0
138190,daily,0,0
138191,F,0,0
138192,&,0,1
138193,V,0,0
138194,intake,0,0
138195,by,0,0
138196,an,0,0
138197,additional,0,0
138198,2,0,0
138199,",",0,0
138200,4,0,0
138201,and,0,0
138202,6,0,0
138203,portions,0,0
138204,for,0,0
138205,6-week,0,0
138206,periods,0,0
138207,during,0,0
138208,the,0,0
138209,18-week,0,0
138210,study,0,0
138211,.,0,0
138212,RESULTS,0,0
138213,Compliance,0,0
138214,to,0,0
138215,target,0,0
138216,numbers,0,0
138217,and,0,0
138218,types,0,0
138219,of,0,0
138220,F,0,0
138221,&,0,1
138222,V,0,0
138223,was,0,0
138224,broadly,0,0
138225,met,0,0
138226,and,0,0
138227,verified,0,0
138228,by,0,0
138229,dietary,0,0
138230,records,0,0
138231,",",0,0
138232,and,0,0
138233,plasma,0,0
138234,and,0,0
138235,urinary,0,0
138236,biomarkers,0,0
138237,.,0,1
138238,Mean,0,0
138239,(,0,0
138240,?,0,0
138241,SEM,0,0
138242,),0,0
138243,number,0,0
138244,of,0,0
138245,F,0,0
138246,&,0,1
138247,V,0,0
138248,portions/day,0,0
138249,consumed,0,0
138250,by,0,0
138251,the,0,0
138252,HF,0,0
138253,and,0,0
138254,LF,0,0
138255,groups,0,0
138256,at,0,0
138257,baseline,0,0
138258,(,0,0
138259,3.8,0,0
138260,?,0,0
138261,0.3,0,0
138262,and,0,0
138263,3.4,0,0
138264,?,0,0
138265,0.3,0,0
138266,),0,0
138267,",",0,0
138268,6,0,0
138269,weeks,0,0
138270,(,0,1
138271,6.3,0,0
138272,?,0,0
138273,0.4,0,0
138274,and,0,0
138275,5.8,0,0
138276,?,0,0
138277,0.3,0,0
138278,),0,0
138279,",",0,0
138280,12,0,0
138281,weeks,0,0
138282,(,0,1
138283,7.0,0,0
138284,?,0,0
138285,0.3,0,0
138286,and,0,0
138287,6.8,0,0
138288,?,0,0
138289,0.3,0,0
138290,),0,0
138291,and,0,0
138292,18,0,1
138293,weeks,0,0
138294,(,0,1
138295,7.6,0,0
138296,?,0,0
138297,0.4,0,0
138298,and,0,0
138299,8.1,0,0
138300,?,0,0
138301,0.4,0,0
138302,),0,0
138303,",",0,0
138304,respectively,0,0
138305,",",0,0
138306,was,0,0
138307,similar,0,0
138308,at,0,0
138309,baseline,0,0
138310,yet,0,0
138311,higher,0,0
138312,than,0,0
138313,the,0,0
138314,CT,0,0
138315,group,0,0
138316,(,0,0
138317,3.9,0,0
138318,?,0,0
138319,0.3,0,0
138320,",",0,0
138321,4.3,0,0
138322,?,0,0
138323,0.3,0,0
138324,",",0,0
138325,4.6,0,0
138326,?,0,0
138327,0.4,0,0
138328,",",0,0
138329,4.5,0,0
138330,?,0,0
138331,0.3,0,0
138332,),0,0
138333,(,0,0
138334,P,0,0
138335,=,0,0
138336,0.015,0,0
138337,),0,0
138338,.,0,0
138339,There,0,0
138340,was,0,0
138341,a,0,0
138342,dose-dependent,0,0
138343,increase,0,0
138344,in,0,0
138345,dietary,0,0
138346,and,0,0
138347,urinary,0,0
138348,flavonoids,0,0
138349,in,0,0
138350,the,0,0
138351,HF,0,0
138352,group,0,0
138353,",",0,0
138354,with,0,0
138355,no,0,0
138356,change,0,0
138357,in,0,0
138358,other,0,0
138359,groups,0,0
138360,(,0,0
138361,P,0,0
138362,=,0,0
138363,0.0001,0,0
138364,),0,0
138365,.,0,0
138366,Significantly,0,0
138367,higher,0,0
138368,dietary,0,0
138369,intakes,0,0
138370,of,0,0
138371,folate,0,0
138372,(,0,0
138373,P,0,0
138374,=,0,0
138375,0.035,0,0
138376,),0,0
138377,",",0,0
138378,non-starch,0,0
138379,polysaccharides,0,0
138380,(,0,0
138381,P,0,0
138382,=,0,0
138383,0.001,0,0
138384,),0,0
138385,",",0,0
138386,vitamin,0,0
138387,C,0,0
138388,(,0,0
138389,P,0,0
138390,=,0,0
138391,0.0001,0,0
138392,),0,0
138393,and,0,0
138394,carotenoids,0,0
138395,(,0,0
138396,P,0,0
138397,=,0,0
138398,0.0001,0,0
138399,),0,0
138400,were,0,0
138401,observed,0,0
138402,in,0,0
138403,both,0,0
138404,intervention,0,0
138405,groups,0,0
138406,compared,0,0
138407,with,0,1
138408,CT,0,0
138409,",",0,0
138410,which,0,0
138411,were,0,0
138412,broadly,0,0
138413,supported,0,0
138414,by,0,0
138415,nutrient,0,0
138416,biomarker,0,0
138417,analysis,0,0
138418,.,0,0
138419,CONCLUSIONS,0,0
138420,The,0,0
138421,success,0,0
138422,of,0,0
138423,improving,0,0
138424,nutrient,0,0
138425,profile,0,0
138426,by,0,0
138427,active,0,0
138428,encouragement,0,0
138429,of,0,0
138430,F,0,0
138431,&,0,1
138432,V,0,0
138433,intake,0,0
138434,in,0,0
138435,an,0,0
138436,intervention,0,0
138437,study,0,0
138438,implies,0,0
138439,the,0,0
138440,need,0,0
138441,for,0,0
138442,a,0,0
138443,more,0,0
138444,hands-on,0,0
138445,public,0,0
138446,health,0,1
138447,approach,0,0
138448,.,0,0
138449,A,0,0
138450,potent,0,0
138451,oral,0,0
138452,P-selectin,0,0
138453,blocking,0,0
138454,agent,0,0
138455,improves,0,0
138456,microcirculatory,0,0
138457,blood,0,0
138458,flow,0,0
138459,and,0,0
138460,a,0,0
138461,marker,0,0
138462,of,0,0
138463,endothelial,0,0
138464,cell,0,1
138465,injury,0,1
138466,in,0,0
138467,patients,1,1
138468,with,1,1
138469,sickle,1,1
138470,cell,1,1
138471,disease,1,1
138472,.,1,0
138473,Abnormal,0,0
138474,blood,0,0
138475,flow,0,0
138476,accounts,0,0
138477,for,0,0
138478,most,0,0
138479,of,0,0
138480,the,0,0
138481,clinical,0,0
138482,morbidity,0,0
138483,of,0,0
138484,sickle,0,0
138485,cell,0,0
138486,disease,0,1
138487,(,0,0
138488,SCD,0,0
138489,),0,0
138490,[,0,0
138491,"1,2",0,1
138492,],0,0
138493,.,0,0
138494,Most,0,0
138495,notably,0,0
138496,",",0,0
138497,occlusion,0,0
138498,of,0,0
138499,flow,0,0
138500,in,0,0
138501,the,0,0
138502,microvasculature,0,0
138503,causes,0,0
138504,the,0,0
138505,acute,0,0
138506,pain,0,0
138507,crises,0,0
138508,[,0,0
138509,3,0,0
138510,],0,0
138511,that,0,0
138512,are,0,0
138513,the,0,0
138514,commonest,0,0
138515,cause,0,0
138516,for,0,0
138517,patients,1,1
138518,with,1,1
138519,SCD,1,0
138520,to,1,0
138521,seek,0,0
138522,medical,0,0
138523,attention,0,0
138524,[,0,0
138525,4,0,0
138526,],0,0
138527,and,0,0
138528,major,0,0
138529,determinants,0,0
138530,of,0,0
138531,their,0,0
138532,quality,1,0
138533,of,1,0
138534,life,1,0
138535,[,0,0
138536,5,0,0
138537,],0,0
138538,.,0,0
138539,Based,0,0
138540,on,0,0
138541,evidence,0,0
138542,that,0,0
138543,endothelial,0,0
138544,P-selectin,0,0
138545,is,0,0
138546,central,0,0
138547,to,0,0
138548,the,0,0
138549,abnormal,0,0
138550,blood,0,0
138551,flow,0,0
138552,in,0,0
138553,SCD,0,0
138554,we,0,0
138555,provide,0,0
138556,results,0,0
138557,from,0,0
138558,four,0,0
138559,of,0,0
138560,our,0,0
138561,studies,0,0
138562,that,0,0
138563,are,0,0
138564,germane,0,0
138565,to,0,0
138566,microvascular,0,0
138567,blood,0,0
138568,flow,0,0
138569,in,0,0
138570,SCD,0,0
138571,.,0,0
138572,A,0,0
138573,proof-of-principle,0,0
138574,study,0,0
138575,established,0,0
138576,that,0,0
138577,doses,0,0
138578,of,0,0
138579,heparin,0,0
138580,lower,0,0
138581,than,0,0
138582,what,0,0
138583,are,0,0
138584,used,0,0
138585,for,0,0
138586,anticoagulation,0,0
138587,but,0,0
138588,sufficient,0,0
138589,to,0,0
138590,block,0,0
138591,P-selectin,0,0
138592,improved,0,0
138593,microvascular,0,0
138594,blood,0,0
138595,flow,0,0
138596,inpatients,1,1
138597,with,1,1
138598,SCD,1,0
138599,.,1,0
138600,An,0,0
138601,in,0,0
138602,vitro,0,0
138603,study,0,0
138604,showed,0,0
138605,that,0,0
138606,Pentosan,0,0
138607,Polysulfate,0,0
138608,Sodium,0,0
138609,(,0,0
138610,PPS,0,0
138611,),0,0
138612,had,0,0
138613,greater,0,0
138614,P-selectin,0,0
138615,blocking,0,0
138616,activity,0,0
138617,than,0,0
138618,heparin,0,0
138619,.,0,0
138620,A,0,0
138621,Phase,0,0
138622,I,0,0
138623,clinical,0,0
138624,study,0,0
138625,demonstrated,0,0
138626,that,0,0
138627,a,0,0
138628,single,0,0
138629,oral,0,0
138630,dose,0,0
138631,of,0,0
138632,PPS,0,0
138633,increased,0,0
138634,microvascular,0,0
138635,blood,0,0
138636,flow,0,0
138637,in,0,0
138638,patients,0,1
138639,with,0,1
138640,SCD,0,0
138641,.,0,1
138642,A,0,0
138643,Phase,0,0
138644,II,0,1
138645,clinical,0,0
138646,study,0,0
138647,that,0,0
138648,was,0,0
138649,not,0,0
138650,completed,0,0
138651,documented,0,0
138652,that,0,0
138653,daily,0,0
138654,oral,0,0
138655,doses,0,0
138656,of,0,0
138657,PPS,0,0
138658,administered,0,0
138659,for,0,0
138660,8,0,0
138661,weeks,0,0
138662,lowered,0,0
138663,plasma,0,0
138664,levels,0,0
138665,of,0,0
138666,sVCAM-1,0,0
138667,and,0,0
138668,tended,0,0
138669,to,0,0
138670,improve,0,0
138671,microvascular,0,0
138672,blood,0,0
138673,flow,0,0
138674,in,0,0
138675,patients,0,1
138676,with,0,1
138677,SCD,0,0
138678,.,0,0
138679,These,0,0
138680,data,0,0
138681,support,0,0
138682,the,0,0
138683,concept,0,0
138684,that,0,0
138685,P-selectin,0,0
138686,on,0,0
138687,the,0,0
138688,microvascular,0,0
138689,endothelium,0,0
138690,is,0,0
138691,critical,0,0
138692,to,0,0
138693,both,0,0
138694,acute,0,1
138695,vascular,0,0
138696,occlusion,0,0
138697,and,0,0
138698,chronically,0,1
138699,impaired,0,0
138700,microvascular,0,0
138701,blood,0,0
138702,flow,0,0
138703,in,0,0
138704,SCD,0,0
138705,.,0,0
138706,They,0,0
138707,also,0,0
138708,demonstrate,0,0
138709,that,0,0
138710,oral,0,0
138711,PPS,0,0
138712,is,0,0
138713,beneficial,0,0
138714,to,0,0
138715,microvascular,0,0
138716,sickle,0,0
138717,cell,0,0
138718,blood,0,0
138719,flow,0,0
138720,and,0,0
138721,has,0,0
138722,potential,0,0
138723,as,0,0
138724,an,0,0
138725,efficacious,0,0
138726,agent,0,0
138727,for,0,0
138728,long-term,0,0
138729,prophylactic,0,0
138730,therapy,0,0
138731,of,0,0
138732,SCD,0,0
138733,.,0,1
138734,The,0,0
138735,Social,0,0
138736,Communication,0,0
138737,Intervention,0,0
138738,Project,0,0
138739,:,0,1
138740,a,0,0
138741,randomized,0,0
138742,controlled,0,0
138743,trial,0,0
138744,of,0,0
138745,the,0,0
138746,effectiveness,0,0
138747,of,0,0
138748,speech,0,0
138749,and,0,0
138750,language,0,0
138751,therapy,0,0
138752,for,0,0
138753,school-age,1,1
138754,children,1,1
138755,who,1,1
138756,have,1,1
138757,pragmatic,1,1
138758,and,1,0
138759,social,1,0
138760,communication,1,0
138761,problems,1,1
138762,with,1,1
138763,or,1,0
138764,without,1,0
138765,autism,1,1
138766,spectrum,1,1
138767,disorder,1,1
138768,.,1,1
138769,BACKGROUND,0,0
138770,Children,1,1
138771,who,1,1
138772,show,1,1
138773,disproportionate,1,0
138774,difficulty,1,0
138775,with,1,1
138776,the,1,0
138777,pragmatic,1,0
138778,as,1,0
138779,compared,1,0
138780,with,1,1
138781,the,1,0
138782,structural,1,0
138783,aspects,1,0
138784,of,1,0
138785,language,1,0
138786,are,1,0
138787,described,1,0
138788,as,1,0
138789,having,1,1
138790,pragmatic,1,0
138791,language,1,0
138792,impairment,1,0
138793,(,1,0
138794,PLI,1,0
138795,),1,0
138796,or,1,0
138797,social,1,0
138798,communication,1,0
138799,disorder,1,1
138800,(,1,0
138801,SCD,1,0
138802,),1,0
138803,.,1,0
138804,Some,0,1
138805,children,0,1
138806,who,0,1
138807,have,0,1
138808,PLI,0,1
138809,also,0,0
138810,show,0,0
138811,mild,0,0
138812,social,0,0
138813,impairments,0,0
138814,associated,0,0
138815,with,0,1
138816,high-functioning,0,1
138817,autism,0,1
138818,or,0,0
138819,autism,0,1
138820,spectrum,0,1
138821,disorder,0,1
138822,(,0,0
138823,ASD,0,1
138824,),0,0
138825,.,0,0
138826,There,0,0
138827,is,0,0
138828,little,0,0
138829,robust,0,0
138830,evidence,0,0
138831,of,0,0
138832,effectiveness,0,0
138833,of,0,0
138834,speech-language,0,0
138835,interventions,0,0
138836,which,0,0
138837,target,0,0
138838,the,0,0
138839,language,0,0
138840,",",0,0
138841,pragmatic,0,0
138842,or,0,0
138843,social,0,0
138844,communication,0,0
138845,needs,0,0
138846,of,0,0
138847,these,0,0
138848,children,0,1
138849,.,0,0
138850,AIMS,0,0
138851,To,0,0
138852,evaluate,0,0
138853,the,0,0
138854,effectiveness,0,0
138855,of,0,0
138856,an,0,0
138857,intensive,0,0
138858,manualized,0,0
138859,social,0,0
138860,communication,0,0
138861,intervention,0,0
138862,(,0,0
138863,SCIP,0,0
138864,),0,0
138865,for,0,1
138866,children,1,1
138867,who,1,1
138868,have,1,1
138869,PLI,1,1
138870,with,1,0
138871,or,1,0
138872,without,1,1
138873,features,1,0
138874,of,1,0
138875,ASD,1,1
138876,.,1,0
138877,METHODS,0,0
138878,&,0,0
138879,PROCEDURES,0,0
138880,In,0,0
138881,a,0,0
138882,single-blind,0,0
138883,RCT,0,0
138884,design,0,0
138885,",",0,0
138886,88,1,0
138887,children,1,1
138888,with,1,1
138889,pragmatic,1,0
138890,and,1,0
138891,social,1,0
138892,communication,1,0
138893,needs,1,0
138894,aged,1,1
138895,5,1,0
138896,;,1,0
138897,11-10,1,1
138898,;,1,0
138899,8,1,0
138900,",",1,0
138901,recruited,1,1
138902,from,1,0
138903,UK,1,1
138904,speech,1,0
138905,and,1,0
138906,language,1,0
138907,therapy,1,0
138908,services,1,0
138909,",",0,0
138910,were,0,0
138911,randomly,0,0
138912,assigned,0,0
138913,in,0,0
138914,a,0,0
138915,2:1,0,0
138916,ratio,0,0
138917,to,0,0
138918,SCIP,0,0
138919,or,0,0
138920,to,0,0
138921,treatment-as-usual,0,0
138922,.,0,0
138923,Children,1,1
138924,in,1,0
138925,the,1,0
138926,SCIP,1,0
138927,condition,1,0
138928,received,0,0
138929,up,0,0
138930,to,0,0
138931,20,0,0
138932,sessions,0,0
138933,of,0,0
138934,direct,0,0
138935,intervention,0,0
138936,from,0,0
138937,a,0,0
138938,specialist,0,0
138939,research,0,0
138940,speech,0,0
138941,and,0,0
138942,language,0,0
138943,therapist,0,0
138944,working,0,0
138945,with,0,1
138946,supervised,0,0
138947,assistants,0,1
138948,.,0,0
138949,All,0,0
138950,therapy,0,0
138951,content,0,0
138952,and,0,0
138953,methodology,0,0
138954,was,0,0
138955,derived,0,0
138956,from,0,0
138957,an,0,0
138958,intervention,0,0
138959,manual,0,0
138960,.,0,0
138961,A,0,0
138962,primary,0,0
138963,outcome,0,0
138964,measure,0,0
138965,of,0,0
138966,structural,0,0
138967,language,0,0
138968,and,0,0
138969,secondary,0,0
138970,outcome,0,0
138971,measures,0,0
138972,of,0,0
138973,narrative,0,0
138974,",",0,0
138975,parent-reported,0,0
138976,pragmatic,0,0
138977,functioning,0,0
138978,and,0,0
138979,social,0,0
138980,communication,0,0
138981,",",0,0
138982,blind-rated,0,0
138983,perceptions,0,0
138984,of,0,0
138985,conversational,0,0
138986,competence,0,1
138987,and,0,0
138988,teacher-reported,0,0
138989,ratings,0,0
138990,of,0,0
138991,classroom,0,1
138992,learning,0,0
138993,skills,0,0
138994,were,0,0
138995,taken,0,0
138996,pre-intervention,0,0
138997,",",0,0
138998,immediately,0,0
138999,post-intervention,0,0
139000,and,0,0
139001,at,0,0
139002,6-month,0,0
139003,follow-up,0,0
139004,.,0,0
139005,Analysis,0,0
139006,was,0,0
139007,by,0,0
139008,intention,0,0
139009,to,0,0
139010,treat,0,0
139011,.,0,0
139012,OUTCOMES,0,0
139013,&,0,1
139014,RESULTS,0,0
139015,No,0,0
139016,significant,0,0
139017,treatment,0,0
139018,effect,0,0
139019,was,0,0
139020,found,0,0
139021,for,0,0
139022,the,0,0
139023,primary,0,0
139024,outcome,0,0
139025,measure,0,0
139026,of,0,0
139027,structural,0,0
139028,language,0,0
139029,ability,0,0
139030,or,0,0
139031,for,0,0
139032,a,0,0
139033,measure,0,0
139034,of,0,0
139035,narrative,0,0
139036,ability,0,0
139037,.,0,0
139038,Significant,0,0
139039,treatment,0,0
139040,effects,0,0
139041,were,0,0
139042,found,0,0
139043,for,0,0
139044,blind-rated,0,0
139045,perceptions,0,0
139046,of,0,0
139047,conversational,0,0
139048,competence,0,0
139049,",",0,0
139050,for,0,0
139051,parent-reported,0,0
139052,measures,0,0
139053,of,0,0
139054,pragmatic,0,0
139055,functioning,0,0
139056,and,0,0
139057,social,0,0
139058,communication,0,0
139059,",",0,0
139060,and,0,0
139061,for,0,0
139062,teacher-reported,0,0
139063,ratings,0,0
139064,of,0,0
139065,classroom,0,1
139066,learning,0,0
139067,skills,0,0
139068,.,0,0
139069,CONCLUSIONS,0,0
139070,&,0,0
139071,IMPLICATIONS,0,0
139072,There,0,0
139073,is,0,0
139074,some,0,0
139075,evidence,0,0
139076,of,0,0
139077,an,0,0
139078,intervention,0,0
139079,effect,0,0
139080,on,0,0
139081,blind,0,0
139082,and,0,0
139083,parent/teacher-reported,0,0
139084,communication,0,0
139085,outcomes,0,0
139086,",",0,0
139087,but,0,0
139088,not,0,0
139089,standardized,0,0
139090,language,0,0
139091,assessment,0,0
139092,outcomes,0,0
139093,",",0,0
139094,for,0,0
139095,6-11-year-old,1,1
139096,children,1,1
139097,who,1,1
139098,have,1,1
139099,pragmatic,1,1
139100,and,1,0
139101,social,1,0
139102,communication,1,0
139103,needs,1,0
139104,.,1,0
139105,These,0,0
139106,findings,0,0
139107,are,0,0
139108,discussed,0,0
139109,in,0,0
139110,the,0,0
139111,context,0,0
139112,of,0,0
139113,the,0,0
139114,increasingly,0,0
139115,central,0,0
139116,role,0,0
139117,of,0,0
139118,service,0,0
139119,user,0,0
139120,outcomes,0,0
139121,in,0,0
139122,providing,0,0
139123,evidence,0,0
139124,for,0,0
139125,an,0,0
139126,intervention,0,0
139127,.,0,0
139128,The,0,0
139129,substantial,0,0
139130,overlap,0,0
139131,between,0,0
139132,the,0,0
139133,presence,0,0
139134,of,0,0
139135,PLI,0,0
139136,and,0,0
139137,ASD,0,1
139138,(,0,0
139139,75,0,0
139140,%,0,0
139141,),0,0
139142,across,0,0
139143,the,0,0
139144,whole,0,0
139145,cohort,0,0
139146,suggests,0,0
139147,that,0,0
139148,the,0,0
139149,intervention,0,0
139150,may,0,0
139151,also,0,0
139152,be,0,0
139153,applicable,0,0
139154,to,0,0
139155,some,0,0
139156,verbally,0,0
139157,able,0,0
139158,children,0,1
139159,with,0,1
139160,ASD,0,1
139161,who,0,1
139162,have,0,1
139163,pragmatic,0,1
139164,communication,0,0
139165,needs,0,0
139166,.,0,1
139167,[,0,0
139168,Effects,0,0
139169,of,0,0
139170,shuxuening,0,0
139171,injection,0,0
139172,on,0,0
139173,the,0,0
139174,levels,0,0
139175,of,0,0
139176,serum,0,0
139177,matrix,0,0
139178,metalloproteinase-9,0,0
139179,and,0,0
139180,tissue,0,0
139181,inhibitor,0,0
139182,of,0,0
139183,metalloproteinase-1,0,0
139184,in,0,0
139185,acute,1,1
139186,exacerbated,1,0
139187,chronic,1,1
139188,obstructive,1,1
139189,pulmonary,1,1
139190,disease,1,1
139191,patients,1,1
139192,],1,1
139193,.,0,0
139194,OBJECTIVE,0,0
139195,To,0,0
139196,observe,0,0
139197,the,0,0
139198,effects,0,0
139199,of,0,0
139200,Shuxuening,0,0
139201,Injection,0,0
139202,(,0,0
139203,SI,0,0
139204,),0,0
139205,on,0,0
139206,the,0,0
139207,levels,0,0
139208,of,0,0
139209,serum,0,0
139210,matrix,0,0
139211,metalloproteinase-9,0,0
139212,(,0,0
139213,MMP-9,0,0
139214,),0,0
139215,and,0,0
139216,tissue,0,0
139217,inhibitor,0,0
139218,of,0,0
139219,metalloproteinase,0,0
139220,(,0,0
139221,TIMP-1,0,0
139222,),0,0
139223,in,0,0
139224,acute,1,1
139225,exacerbated,1,0
139226,chronic,1,1
139227,obstructive,1,1
139228,pulmonary,1,1
139229,disease,1,1
139230,(,1,0
139231,COPD,1,0
139232,),1,0
139233,patients,1,1
139234,.,1,1
139235,METHODS,0,0
139236,Seventy-nine,1,1
139237,patients,1,1
139238,with,1,1
139239,acute,1,1
139240,exacerbated,1,0
139241,COPD,1,0
139242,were,0,0
139243,randomly,0,0
139244,assigned,0,0
139245,to,0,0
139246,the,0,0
139247,treatment,0,0
139248,group,0,0
139249,(,0,0
139250,39,0,1
139251,cases,0,1
139252,),0,0
139253,and,0,0
139254,the,0,0
139255,control,0,0
139256,group,0,0
139257,(,0,0
139258,40,0,1
139259,cases,0,1
139260,),0,1
139261,.,0,1
139262,Routine,0,0
139263,therapies,0,0
139264,for,0,0
139265,COPD,0,0
139266,were,0,0
139267,given,0,0
139268,to,0,0
139269,patients,0,1
139270,in,0,0
139271,the,0,0
139272,control,0,0
139273,group,0,0
139274,",",0,0
139275,while,0,0
139276,15,0,0
139277,mL,0,0
139278,SI,0,0
139279,was,0,0
139280,given,0,0
139281,to,0,0
139282,those,0,0
139283,in,0,0
139284,the,0,0
139285,treatment,0,0
139286,group,0,0
139287,by,0,0
139288,intravenous,0,0
139289,dripping,0,0
139290,",",0,0
139291,twice,0,0
139292,daily,0,0
139293,for,0,0
139294,total,0,1
139295,14,0,1
139296,days,0,0
139297,.,0,0
139298,The,0,0
139299,forced,0,0
139300,expiratory,0,0
139301,volume,0,0
139302,in,0,0
139303,one,0,0
139304,second,0,0
139305,(,0,0
139306,FEV1,0,0
139307,),0,0
139308,and,0,0
139309,forced,0,0
139310,vital,0,0
139311,capacity,0,0
139312,(,0,0
139313,FVC,0,0
139314,),0,0
139315,were,0,0
139316,detected,0,0
139317,by,0,0
139318,Spirometer,0,0
139319,.,0,0
139320,The,0,0
139321,FEV1/FVC,0,0
139322,(,0,0
139323,%,0,0
139324,),0,0
139325,and,0,0
139326,the,0,0
139327,FEV1,0,0
139328,%,0,0
139329,were,0,0
139330,calculated,0,0
139331,.,0,0
139332,The,0,0
139333,levels,0,0
139334,of,0,0
139335,serum,0,0
139336,MMP-9,0,0
139337,and,0,0
139338,TIMP-1,0,0
139339,were,0,0
139340,detected,0,0
139341,using,0,0
139342,ELISA,0,0
139343,before,0,0
139344,and,0,0
139345,after,0,0
139346,treatment,0,0
139347,",",0,0
139348,and,0,0
139349,compared,0,0
139350,with,0,1
139351,20,0,1
139352,healthy,0,1
139353,subjects,0,1
139354,as,0,0
139355,the,0,0
139356,control,0,0
139357,.,0,0
139358,RESULTS,0,0
139359,The,0,0
139360,FEV1,0,0
139361,",",0,0
139362,FVC,0,0
139363,",",0,0
139364,FEV1/FVC,0,0
139365,(,0,0
139366,%,0,0
139367,),0,0
139368,",",0,0
139369,and,0,0
139370,FEV1,0,0
139371,%,0,0
139372,were,0,0
139373,significantly,0,0
139374,improved,0,0
139375,after,0,0
139376,treatment,0,0
139377,in,0,0
139378,the,0,0
139379,treatment,0,0
139380,group,0,0
139381,when,0,0
139382,compared,0,0
139383,with,0,0
139384,before,0,0
139385,treatment,0,0
139386,and,0,0
139387,with,0,0
139388,the,0,0
139389,control,0,0
139390,group,0,0
139391,(,0,0
139392,P,0,0
139393,<,0,0
139394,0.05,0,0
139395,",",0,0
139396,P,0,0
139397,<,0,0
139398,0.01,0,0
139399,),0,0
139400,.,0,0
139401,When,0,0
139402,compared,0,0
139403,with,0,0
139404,before,0,0
139405,treatment,0,0
139406,and,0,0
139407,with,0,0
139408,the,0,0
139409,control,0,0
139410,group,0,0
139411,",",0,0
139412,the,0,0
139413,levels,0,0
139414,of,0,0
139415,serum,0,0
139416,MMP-9,0,0
139417,",",0,0
139418,TIMP-1,0,0
139419,",",0,0
139420,and,0,0
139421,the,0,0
139422,ratio,0,0
139423,of,0,0
139424,MMP-9/TIMP-1,0,0
139425,decreased,0,0
139426,more,0,0
139427,significantly,0,0
139428,in,0,0
139429,the,0,0
139430,treatment,0,0
139431,group,0,0
139432,after,0,0
139433,treatment,0,0
139434,(,0,0
139435,P,0,0
139436,<,0,0
139437,0.01,0,0
139438,),0,0
139439,.,0,0
139440,Correlation,0,0
139441,analyses,0,0
139442,showed,0,0
139443,that,0,0
139444,obvious,0,0
139445,negative,0,0
139446,correlation,0,0
139447,existed,0,0
139448,between,0,0
139449,the,0,0
139450,levels,0,0
139451,of,0,0
139452,serum,0,0
139453,MMP-9,0,0
139454,and,0,0
139455,TIMP-1,0,0
139456,and,0,0
139457,FEV1/FVC,0,0
139458,(,0,0
139459,%,0,0
139460,),0,0
139461,(,0,0
139462,r,0,0
139463,=,0,0
139464,-0.677,0,0
139465,",",0,0
139466,-0.629,0,0
139467,",",0,0
139468,P,0,0
139469,<,0,0
139470,0.01,0,0
139471,),0,0
139472,.,0,0
139473,Obvious,0,0
139474,negative,0,0
139475,correlation,0,0
139476,existed,0,0
139477,between,0,0
139478,the,0,0
139479,levels,0,0
139480,of,0,0
139481,serum,0,0
139482,MMP-9,0,0
139483,and,0,0
139484,TIMP-1,0,0
139485,and,0,0
139486,FEV1,0,0
139487,%,0,0
139488,(,0,0
139489,r,0,0
139490,=,0,0
139491,-0.562,0,0
139492,",",0,0
139493,-0.661,0,0
139494,",",0,0
139495,P,0,0
139496,<,0,0
139497,0.01,0,0
139498,),0,0
139499,.,0,0
139500,Furthermore,0,0
139501,",",0,0
139502,obvious,0,0
139503,negative,0,0
139504,correlation,0,0
139505,also,0,0
139506,existed,0,0
139507,between,0,0
139508,the,0,0
139509,ratio,0,0
139510,of,0,0
139511,MMP-9/,0,0
139512,TIMP-1,0,0
139513,and,0,0
139514,FEV1,0,0
139515,%,0,0
139516,",",0,0
139517,as,0,0
139518,well,0,0
139519,as,0,0
139520,FEV1/FVC,0,0
139521,(,0,0
139522,%,0,0
139523,),0,0
139524,(,0,0
139525,r,0,0
139526,=,0,0
139527,-0.732,0,0
139528,",",0,0
139529,-0.891,0,0
139530,",",0,0
139531,P,0,0
139532,<,0,0
139533,0.01,0,0
139534,),0,0
139535,.,0,0
139536,CONCLUSIONS,0,0
139537,SI,0,0
139538,could,0,0
139539,improve,0,0
139540,the,0,0
139541,pulmonary,0,0
139542,ventilation,0,0
139543,function,0,0
139544,of,0,0
139545,acute,1,1
139546,exacerbated,1,0
139547,COPD,1,0
139548,patients,1,1
139549,.,1,1
139550,One,0,0
139551,of,0,0
139552,its,0,0
139553,mechanisms,0,0
139554,might,0,0
139555,be,0,0
139556,correlated,0,0
139557,with,0,0
139558,lowering,0,0
139559,the,0,0
139560,serum,0,0
139561,levels,0,0
139562,of,0,0
139563,MMP-9,0,0
139564,and,0,0
139565,TIMP-1,0,0
139566,",",0,0
139567,and,0,0
139568,correcting,0,0
139569,the,0,0
139570,imbalance,0,0
139571,of,0,0
139572,MMP-9/TIMP-1,0,0
139573,.,0,1
139574,Carbon,0,0
139575,dioxide,0,0
139576,insufflation,0,0
139577,in,0,0
139578,open-chamber,0,0
139579,cardiac,0,1
139580,surgery,0,1
139581,:,0,1
139582,a,0,0
139583,double-blind,0,0
139584,",",0,0
139585,randomized,0,0
139586,clinical,0,0
139587,trial,0,0
139588,of,0,0
139589,neurocognitive,0,0
139590,effects,0,0
139591,.,0,0
139592,OBJECTIVE,0,0
139593,The,0,0
139594,aims,0,0
139595,of,0,0
139596,this,0,0
139597,study,0,0
139598,were,0,0
139599,first,0,0
139600,to,0,0
139601,analyze,0,0
139602,neurocognitive,0,0
139603,outcomes,0,0
139604,of,0,0
139605,patients,1,1
139606,after,1,0
139607,open-chamber,1,0
139608,cardiac,1,1
139609,surgery,1,1
139610,to,0,0
139611,determine,0,0
139612,whether,0,0
139613,carbon,0,0
139614,dioxide,0,0
139615,pericardial,0,0
139616,insufflation,0,0
139617,reduces,0,0
139618,incidence,0,0
139619,of,0,0
139620,neurocognitive,0,0
139621,decline,0,0
139622,(,0,0
139623,primary,0,0
139624,end,0,0
139625,point,0,0
139626,),0,0
139627,as,0,0
139628,measured,0,0
139629,6,0,0
139630,weeks,0,0
139631,postoperatively,0,0
139632,and,0,0
139633,second,0,0
139634,to,0,0
139635,assess,0,0
139636,the,0,0
139637,utility,0,0
139638,of,0,0
139639,carbon,0,0
139640,dioxide,0,0
139641,insufflation,0,0
139642,in,0,0
139643,cardiac,0,0
139644,chamber,0,0
139645,deairing,0,0
139646,as,0,0
139647,assessed,0,0
139648,by,0,0
139649,transesophageal,0,0
139650,echocardiography,0,0
139651,.,0,0
139652,METHODS,0,0
139653,A,0,0
139654,multicenter,0,0
139655,",",0,0
139656,prospective,0,0
139657,",",0,0
139658,double-blind,0,0
139659,",",0,0
139660,randomized,0,0
139661,",",0,0
139662,controlled,0,0
139663,trial,0,0
139664,compared,0,0
139665,neurocognitive,0,0
139666,outcomes,0,0
139667,in,0,0
139668,patients,1,1
139669,undergoing,1,1
139670,open-chamber,1,0
139671,(,1,0
139672,left-sided,1,1
139673,),1,0
139674,cardiac,1,1
139675,surgery,1,1
139676,who,1,1
139677,were,1,1
139678,assigned,1,1
139679,carbon,1,0
139680,dioxide,1,0
139681,insufflation,1,0
139682,or,1,0
139683,placebo,1,0
139684,(,1,0
139685,control,1,0
139686,group,1,0
139687,),1,0
139688,in,1,0
139689,addition,1,0
139690,to,1,0
139691,standardized,1,0
139692,mechanical,1,0
139693,deairing,1,0
139694,maneuvers,1,0
139695,.,1,1
139696,RESULTS,0,0
139697,One,1,1
139698,hundred,1,1
139699,twenty-five,1,1
139700,patients,1,1
139701,underwent,1,1
139702,surgery,1,1
139703,and,0,0
139704,were,0,0
139705,randomly,0,1
139706,allocated,0,0
139707,.,0,0
139708,Neurocognitive,0,0
139709,testing,0,0
139710,showed,0,0
139711,no,0,0
139712,clinically,0,0
139713,significant,0,0
139714,differences,0,0
139715,in,0,0
139716,z,0,0
139717,scores,0,0
139718,between,0,0
139719,preoperative,0,0
139720,and,0,0
139721,postoperative,0,0
139722,testing,0,0
139723,.,0,0
139724,Linear,0,0
139725,regression,0,0
139726,was,0,0
139727,used,0,0
139728,to,0,0
139729,identify,0,0
139730,factors,0,0
139731,associated,0,0
139732,with,0,1
139733,neurocognitive,0,0
139734,decline,0,0
139735,.,0,0
139736,Factors,1,0
139737,most,1,0
139738,strongly,1,0
139739,associated,1,0
139740,with,1,0
139741,neurocognitive,1,0
139742,decline,1,0
139743,were,1,0
139744,hypercholesterolemia,1,1
139745,",",1,0
139746,aortic,1,1
139747,atheroma,1,0
139748,grade,1,0
139749,",",1,0
139750,and,1,0
139751,coronary,1,1
139752,artery,1,1
139753,disease,1,1
139754,.,1,0
139755,There,0,0
139756,was,0,0
139757,significantly,0,0
139758,more,0,0
139759,intracardiac,0,0
139760,gas,0,0
139761,noted,0,0
139762,on,0,0
139763,intraoperative,0,0
139764,transesophageal,0,0
139765,echocardiography,0,0
139766,in,0,0
139767,all,0,0
139768,cardiac,0,0
139769,chambers,0,0
139770,(,0,0
139771,left,0,1
139772,atrium,0,1
139773,",",0,0
139774,left,0,0
139775,ventricle,0,0
139776,",",0,0
139777,and,0,0
139778,aorta,0,0
139779,),0,0
139780,at,0,0
139781,all,0,0
139782,measured,0,0
139783,times,0,0
139784,(,0,0
139785,after,0,0
139786,crossclamp,0,0
139787,removal,0,0
139788,",",0,0
139789,during,0,0
139790,weaning,0,0
139791,from,0,0
139792,cardiopulmonary,0,1
139793,bypass,0,1
139794,",",0,0
139795,and,0,0
139796,at,0,0
139797,declaration,0,0
139798,of,0,0
139799,adequate,0,0
139800,deairing,0,0
139801,by,0,0
139802,the,0,0
139803,anesthetist,0,0
139804,),0,0
139805,in,0,0
139806,the,0,0
139807,control,0,0
139808,group,0,0
139809,than,0,0
139810,in,0,0
139811,the,0,0
139812,carbon,0,0
139813,dioxide,0,0
139814,group,0,0
139815,(,0,0
139816,P,0,0
139817,<,0,0
139818,.04,0,0
139819,),0,0
139820,.,0,0
139821,Deairing,0,0
139822,time,0,0
139823,was,0,0
139824,also,0,0
139825,significantly,0,0
139826,longer,0,0
139827,in,0,0
139828,the,0,0
139829,control,0,0
139830,group,0,0
139831,(,0,0
139832,12,0,0
139833,minutes,0,0
139834,[,0,0
139835,interquartile,0,0
139836,range,0,0
139837,",",0,0
139838,9-18,0,0
139839,],0,0
139840,versus,0,0
139841,9,0,0
139842,minutes,0,0
139843,[,0,0
139844,interquartile,0,0
139845,range,0,0
139846,",",0,0
139847,7-14,0,0
139848,minutes,0,0
139849,],0,1
139850,;,0,0
139851,P,0,0
139852,=,0,0
139853,.002,0,0
139854,),0,0
139855,.,0,0
139856,CONCLUSIONS,0,0
139857,Carbon,0,0
139858,dioxide,0,0
139859,pericardial,0,0
139860,insufflation,0,0
139861,in,0,0
139862,open-chamber,0,0
139863,cardiac,0,0
139864,surgery,0,1
139865,does,0,0
139866,not,0,0
139867,affect,0,0
139868,postoperative,0,0
139869,neurocognitive,0,0
139870,decline,0,0
139871,.,0,0
139872,The,1,0
139873,most,1,0
139874,important,1,0
139875,factor,1,0
139876,is,1,0
139877,atheromatous,1,0
139878,vascular,1,0
139879,disease,1,1
139880,.,1,0
139881,Effect,0,0
139882,of,0,0
139883,a,0,0
139884,mobile,0,0
139885,safety,0,0
139886,alarm,0,0
139887,on,0,0
139888,going,0,0
139889,outside,0,0
139890,",",0,0
139891,feeling,0,0
139892,safe,0,0
139893,",",0,0
139894,fear,0,0
139895,of,0,0
139896,falling,0,0
139897,",",0,0
139898,and,0,0
139899,quality,0,0
139900,of,0,0
139901,life,0,0
139902,in,0,0
139903,community-living,1,1
139904,older,1,1
139905,persons,1,1
139906,:,1,1
139907,a,0,0
139908,randomized,0,0
139909,controlled,0,0
139910,trial,0,0
139911,.,0,0
139912,The,0,0
139913,Coping,0,0
139914,Cat,0,0
139915,program,0,0
139916,for,0,0
139917,children,1,1
139918,with,1,1
139919,anxiety,1,0
139920,and,1,0
139921,autism,1,1
139922,spectrum,1,1
139923,disorder,1,1
139924,:,1,0
139925,a,0,0
139926,pilot,0,0
139927,randomized,0,0
139928,controlled,0,0
139929,trial,0,0
139930,.,0,0
139931,The,0,0
139932,purpose,0,0
139933,of,0,0
139934,this,0,0
139935,pilot,0,0
139936,study,0,0
139937,was,0,0
139938,to,0,0
139939,evaluate,0,0
139940,whether,0,0
139941,a,0,0
139942,modified,0,0
139943,version,0,0
139944,of,0,0
139945,the,0,0
139946,Coping,0,0
139947,Cat,0,0
139948,program,0,0
139949,could,0,0
139950,be,0,0
139951,effective,0,0
139952,in,0,0
139953,reducing,0,0
139954,anxiety,0,0
139955,in,0,0
139956,children,1,1
139957,with,1,1
139958,autism,1,1
139959,spectrum,1,1
139960,disorder,1,1
139961,(,1,0
139962,ASD,1,1
139963,),1,0
139964,.,1,0
139965,Twenty-two,1,1
139966,children,1,1
139967,(,1,0
139968,ages,1,1
139969,8-14,1,0
139970,;,1,0
139971,IQ,1,0
139972,?,1,0
139973,70,1,0
139974,),1,0
139975,with,1,1
139976,ASD,1,1
139977,and,1,0
139978,clinically,1,0
139979,significant,1,0
139980,anxiety,1,0
139981,were,1,0
139982,randomly,0,0
139983,assigned,0,0
139984,to,0,0
139985,16,0,1
139986,sessions,0,0
139987,of,0,0
139988,the,0,0
139989,Coping,0,0
139990,Cat,0,0
139991,program,0,0
139992,(,0,0
139993,cognitive-behavioral,0,1
139994,therapy,0,0
139995,;,0,0
139996,CBT,0,0
139997,),0,0
139998,or,0,0
139999,a,0,0
140000,16-week,0,0
140001,waitlist,0,0
140002,.,0,0
140003,Children,0,1
140004,in,0,0
140005,the,0,0
140006,CBT,0,0
140007,condition,0,0
140008,evidenced,0,0
140009,significantly,0,0
140010,larger,0,0
140011,reductions,0,0
140012,in,0,0
140013,anxiety,0,0
140014,than,0,0
140015,those,0,0
140016,in,0,0
140017,the,0,0
140018,waitlist,0,0
140019,.,0,0
140020,Treatment,0,0
140021,gains,0,0
140022,were,0,0
140023,largely,0,0
140024,maintained,0,0
140025,at,0,0
140026,two-month,0,0
140027,follow-up,0,0
140028,.,0,0
140029,Results,0,0
140030,provide,0,0
140031,preliminary,0,0
140032,evidence,0,0
140033,that,0,0
140034,a,0,0
140035,modified,0,0
140036,version,0,0
140037,of,0,0
140038,the,0,0
140039,Coping,0,0
140040,Cat,0,0
140041,program,0,0
140042,may,0,0
140043,be,0,0
140044,a,0,0
140045,feasible,0,0
140046,and,0,0
140047,effective,0,0
140048,program,0,0
140049,for,0,0
140050,reducing,0,0
140051,clinically,0,0
140052,significant,0,0
140053,levels,0,0
140054,of,0,0
140055,anxiety,1,0
140056,in,1,0
140057,children,1,1
140058,with,1,1
140059,high-functioning,1,1
140060,ASD,1,1
140061,.,0,1
140062,Controlled-release,0,0
140063,melatonin,0,0
140064,",",0,0
140065,singly,0,0
140066,and,0,0
140067,combined,0,0
140068,with,0,1
140069,cognitive,0,0
140070,behavioural,0,0
140071,therapy,0,0
140072,",",0,0
140073,for,0,0
140074,persistent,1,1
140075,insomnia,1,1
140076,in,1,0
140077,children,1,1
140078,with,1,1
140079,autism,1,1
140080,spectrum,1,1
140081,disorders,1,1
140082,:,1,1
140083,a,0,0
140084,randomized,0,0
140085,placebo-controlled,0,0
140086,trial,0,0
140087,.,0,0
140088,Although,0,0
140089,melatonin,0,0
140090,and,0,0
140091,cognitive-behavioural,0,0
140092,therapy,0,0
140093,have,0,0
140094,shown,0,0
140095,efficacy,0,0
140096,in,0,0
140097,treating,0,0
140098,sleep,1,0
140099,disorders,1,1
140100,in,1,0
140101,children,1,1
140102,with,1,1
140103,autism,1,1
140104,spectrum,1,1
140105,disorders,1,1
140106,",",0,0
140107,little,0,0
140108,is,0,0
140109,known,0,0
140110,about,0,0
140111,their,0,0
140112,relative,0,0
140113,or,0,0
140114,combined,0,0
140115,efficacy,0,0
140116,.,0,0
140117,One,1,0
140118,hundred,1,1
140119,and,1,0
140120,sixty,1,1
140121,children,1,1
140122,with,1,1
140123,autism,1,1
140124,spectrum,1,1
140125,disorders,1,1
140126,",",1,0
140127,aged,1,1
140128,4-10,1,0
140129,years,1,1
140130,",",1,0
140131,suffering,1,1
140132,from,1,0
140133,sleep,1,0
140134,onset,1,1
140135,insomnia,1,1
140136,and,1,0
140137,impaired,1,0
140138,sleep,1,0
140139,maintenance,1,0
140140,",",0,0
140141,were,0,0
140142,assigned,0,0
140143,randomly,0,0
140144,to,0,0
140145,either,0,0
140146,(,0,0
140147,1,0,0
140148,),0,0
140149,combination,0,0
140150,of,0,0
140151,controlled-release,0,0
140152,melatonin,0,0
140153,and,0,0
140154,cognitive-behavioural,0,1
140155,therapy,0,0
140156,;,0,0
140157,(,0,0
140158,2,0,0
140159,),0,0
140160,controlled-release,0,0
140161,melatonin,0,0
140162,;,0,0
140163,(,0,0
140164,3,0,0
140165,),0,0
140166,four,0,0
140167,sessions,0,0
140168,of,0,0
140169,cognitive-behavioural,0,1
140170,therapy,0,0
140171,;,0,0
140172,or,0,0
140173,(,0,0
140174,4,0,0
140175,),0,0
140176,placebo,0,0
140177,drug,0,0
140178,treatment,0,0
140179,condition,0,0
140180,for,0,0
140181,12,0,0
140182,weeks,0,0
140183,in,0,0
140184,a,0,1
140185,1,0,0
140186,:,0,1
140187,1,0,0
140188,:,0,1
140189,1,0,0
140190,:,0,1
140191,1,0,0
140192,ratio,0,0
140193,.,0,0
140194,Children,0,1
140195,were,0,0
140196,studied,0,0
140197,at,0,0
140198,baseline,0,0
140199,and,0,0
140200,after,0,0
140201,12,0,0
140202,weeks,0,0
140203,of,0,0
140204,treatment,0,0
140205,.,0,0
140206,Treatment,0,0
140207,response,0,0
140208,was,0,0
140209,assessed,0,0
140210,with,0,1
140211,1-week,0,0
140212,actigraphic,0,0
140213,monitoring,0,0
140214,",",0,0
140215,sleep,0,0
140216,diary,0,0
140217,and,0,0
140218,sleep,0,0
140219,questionnaire,0,0
140220,.,0,0
140221,Main,0,0
140222,outcome,0,0
140223,measures,0,0
140224,",",0,0
140225,derived,0,0
140226,actigraphically,0,1
140227,",",0,0
140228,were,0,0
140229,sleep,0,0
140230,latency,0,0
140231,",",0,0
140232,total,0,1
140233,sleep,0,0
140234,time,0,0
140235,",",0,0
140236,wake,0,0
140237,after,0,0
140238,sleep,0,0
140239,onset,0,1
140240,and,0,0
140241,number,0,0
140242,of,0,0
140243,awakenings,0,0
140244,.,0,0
140245,The,0,0
140246,active,0,0
140247,treatment,0,0
140248,groups,0,0
140249,all,0,0
140250,resulted,0,0
140251,in,0,0
140252,improvements,0,0
140253,across,0,0
140254,all,0,0
140255,outcome,0,0
140256,measures,0,0
140257,",",0,0
140258,with,0,1
140259,moderate-to-large,0,0
140260,effect,0,0
140261,sizes,0,0
140262,from,0,0
140263,baseline,0,0
140264,to,0,0
140265,a,0,0
140266,12-week,0,0
140267,assessment,0,0
140268,.,0,0
140269,Melatonin,0,0
140270,treatment,0,0
140271,was,0,0
140272,mainly,0,0
140273,effective,0,0
140274,in,0,0
140275,reducing,0,0
140276,insomnia,0,1
140277,symptoms,0,0
140278,",",0,0
140279,while,0,0
140280,cognitive-behavioural,0,0
140281,therapy,0,0
140282,had,0,0
140283,a,0,0
140284,light,0,0
140285,positive,0,0
140286,impact,0,0
140287,mainly,0,0
140288,on,0,0
140289,sleep,0,0
140290,latency,0,0
140291,",",0,0
140292,suggesting,0,0
140293,that,0,0
140294,some,0,0
140295,behavioural,0,0
140296,aspects,0,0
140297,might,0,0
140298,play,0,0
140299,a,0,0
140300,role,0,0
140301,in,0,0
140302,determining,0,0
140303,initial,0,0
140304,insomnia,0,1
140305,.,0,0
140306,The,0,0
140307,combination,0,0
140308,treatment,0,0
140309,group,0,0
140310,showed,0,0
140311,a,0,0
140312,trend,0,0
140313,to,0,0
140314,outperform,0,0
140315,other,0,0
140316,active,0,0
140317,treatment,0,0
140318,groups,0,0
140319,",",0,0
140320,with,0,1
140321,fewer,0,0
140322,dropouts,0,0
140323,and,0,0
140324,a,0,0
140325,greater,0,0
140326,proportion,0,0
140327,of,0,0
140328,treatment,0,0
140329,responders,0,0
140330,achieving,0,0
140331,clinically,0,0
140332,significant,0,0
140333,changes,0,0
140334,(,0,0
140335,63.38,0,0
140336,%,0,0
140337,normative,0,0
140338,sleep,0,0
140339,efficiency,0,0
140340,criterion,0,0
140341,of,0,0
140342,>,0,1
140343,85,0,0
140344,%,0,0
140345,and,0,0
140346,84.62,0,0
140347,%,0,0
140348,",",0,0
140349,sleep,0,0
140350,onset,0,0
140351,latency,0,0
140352,<,0,0
140353,30,0,0
140354,min,0,0
140355,),0,0
140356,.,0,0
140357,This,0,0
140358,study,0,0
140359,demonstrates,0,0
140360,that,0,0
140361,adding,0,0
140362,behavioural,0,0
140363,intervention,0,0
140364,to,0,0
140365,melatonin,0,0
140366,treatment,0,0
140367,seems,0,0
140368,to,0,0
140369,result,0,0
140370,in,0,0
140371,a,0,0
140372,better,0,0
140373,treatment,0,0
140374,response,0,0
140375,",",0,0
140376,at,0,0
140377,least,0,0
140378,in,0,0
140379,the,0,0
140380,short,0,0
140381,term,0,0
140382,.,0,0
140383,A,0,0
140384,comparison,0,0
140385,of,0,0
140386,a,0,0
140387,short,0,0
140388,nurse-based,0,0
140389,and,0,0
140390,a,0,0
140391,long,0,0
140392,multidisciplinary,0,0
140393,version,0,0
140394,of,0,0
140395,structured,0,0
140396,patient,0,0
140397,education,0,0
140398,in,0,0
140399,irritable,1,0
140400,bowel,1,1
140401,syndrome,1,1
140402,.,1,0
140403,OBJECTIVE,0,0
140404,Structured,0,0
140405,multidisciplinary,0,0
140406,patient,0,0
140407,group,0,0
140408,education,0,0
140409,has,0,0
140410,positive,0,0
140411,effects,0,0
140412,on,0,0
140413,symptoms,0,0
140414,",",0,0
140415,health-related,0,0
140416,quality,0,0
140417,of,0,0
140418,life,0,0
140419,",",0,0
140420,and,0,0
140421,disease-related,0,0
140422,knowledge,0,0
140423,in,0,0
140424,patients,1,1
140425,with,1,1
140426,irritable,1,0
140427,bowel,1,0
140428,syndrome,1,1
140429,(,1,0
140430,IBS,1,0
140431,),1,0
140432,",",0,0
140433,but,0,0
140434,few,0,0
140435,studies,0,0
140436,comparing,0,0
140437,different,0,0
140438,forms,0,0
140439,of,0,0
140440,educational,0,0
140441,interventions,0,0
140442,are,0,0
140443,available,0,0
140444,.,0,0
140445,Our,0,0
140446,aim,0,0
140447,was,0,0
140448,to,0,0
140449,compare,0,0
140450,the,0,0
140451,effects,0,0
140452,of,0,0
140453,long,0,1
140454,multidisciplinary,0,1
140455,group,0,0
140456,education,0,0
140457,with,0,0
140458,a,0,0
140459,short,0,0
140460,nurse-based,0,0
140461,group,0,0
140462,education,0,0
140463,with,0,0
140464,regard,0,0
140465,to,0,0
140466,symptoms,0,0
140467,",",0,0
140468,knowledge,0,0
140469,",",0,0
140470,quality,0,0
140471,of,0,0
140472,life,0,0
140473,",",0,0
140474,and,0,0
140475,satisfaction,0,0
140476,with,0,0
140477,the,0,0
140478,intervention,0,0
140479,in,0,0
140480,IBS,1,0
140481,patients,1,1
140482,.,1,1
140483,METHODS,0,0
140484,Patients,1,1
140485,with,1,1
140486,IBS,1,0
140487,according,1,1
140488,to,1,0
140489,the,1,0
140490,Rome,1,0
140491,II,1,1
140492,criteria,1,1
140493,were,0,0
140494,randomized,0,0
140495,to,0,0
140496,either,0,0
140497,short,0,0
140498,nurse-based,0,0
140499,or,0,0
140500,a,0,0
140501,long,0,0
140502,multidisciplinary-based,0,0
140503,education,0,0
140504,.,0,0
140505,The,0,0
140506,effects,0,0
140507,were,0,0
140508,evaluated,0,0
140509,by,0,0
140510,self-administered,0,0
140511,questionnaires,0,0
140512,at,0,0
140513,3,0,0
140514,",",0,0
140515,6,0,0
140516,",",0,0
140517,and,0,0
140518,12,0,0
140519,months,0,0
140520,after,0,0
140521,baseline,0,0
140522,",",0,0
140523,and,0,0
140524,compared,0,0
140525,between,0,0
140526,the,0,0
140527,groups,0,0
140528,.,0,0
140529,RESULTS,0,0
140530,No,0,0
140531,differences,0,0
140532,in,0,0
140533,effects,0,0
140534,were,0,0
140535,detected,0,0
140536,in,0,0
140537,the,0,0
140538,between-group,0,0
140539,comparisons,0,0
140540,at,0,0
140541,any,0,0
140542,of,0,0
140543,the,0,0
140544,follow-up,0,0
140545,assessments,0,0
140546,.,0,0
140547,However,0,0
140548,",",0,0
140549,positive,0,0
140550,effects,0,0
140551,on,0,0
140552,symptoms,0,0
140553,",",0,0
140554,knowledge,0,0
140555,",",0,0
140556,quality,0,0
140557,of,0,0
140558,life,0,0
140559,",",0,0
140560,and,0,0
140561,satisfaction,0,0
140562,with,0,0
140563,the,0,0
140564,intervention,0,0
140565,were,0,0
140566,found,0,0
140567,in,0,0
140568,both,0,0
140569,the,0,0
140570,short,0,0
140571,and,0,0
140572,the,0,0
140573,long,0,0
140574,version,0,0
140575,.,0,0
140576,CONCLUSION,0,0
140577,A,0,0
140578,short,0,0
140579,",",0,0
140580,nurse-based,0,0
140581,educational,0,0
140582,intervention,0,0
140583,seems,0,0
140584,to,0,0
140585,be,0,0
140586,as,0,0
140587,efficacious,0,0
140588,as,0,0
140589,a,0,0
140590,longer,0,0
140591,multidisciplinary,0,0
140592,version,0,0
140593,.,0,0
140594,In,0,0
140595,both,0,0
140596,groups,0,0
140597,",",0,0
140598,positive,0,0
140599,effects,0,0
140600,on,0,0
140601,patients,0,1
140602,',0,1
140603,well-being,0,0
140604,were,0,0
140605,found,0,0
140606,to,0,0
140607,a,0,0
140608,similar,0,0
140609,extent,0,0
140610,.,0,0
140611,This,0,0
140612,is,0,0
140613,an,0,0
140614,important,0,0
140615,finding,0,0
140616,that,0,0
140617,",",0,0
140618,from,0,0
140619,a,0,0
140620,cost-effective,0,0
140621,perspective,0,0
140622,",",0,0
140623,could,0,0
140624,contribute,0,0
140625,toward,0,0
140626,an,0,0
140627,optimized,0,0
140628,management,0,0
140629,of,0,0
140630,patients,0,1
140631,with,0,1
140632,IBS,0,0
140633,.,0,1
140634,Tumor,0,0
140635,budding,0,0
140636,is,0,0
140637,an,0,0
140638,independent,0,0
140639,predictor,0,0
140640,of,0,0
140641,outcome,0,0
140642,in,0,0
140643,AJCC/UICC,1,0
140644,stage,1,1
140645,II,1,0
140646,colorectal,1,1
140647,cancer,1,1
140648,.,1,0
140649,BACKGROUND,0,0
140650,In,0,0
140651,colorectal,0,1
140652,cancer,0,1
140653,",",0,0
140654,the,0,0
140655,morphology,0,0
140656,of,0,0
140657,the,0,0
140658,invasive,0,0
140659,tumor,0,0
140660,margin,0,0
140661,may,0,0
140662,reflect,0,0
140663,aggressiveness,0,0
140664,of,0,0
140665,tumor,0,0
140666,growth,0,0
140667,",",0,0
140668,thus,0,0
140669,providing,0,0
140670,important,0,0
140671,prognostic,0,0
140672,information,0,0
140673,.,0,0
140674,The,0,0
140675,tumor,0,0
140676,growth,0,0
140677,pattern,0,0
140678,according,0,0
140679,to,0,0
140680,Jass,0,0
140681,and,0,0
140682,the,0,0
140683,extent,0,0
140684,of,0,0
140685,tumor,0,0
140686,budding,0,0
140687,were,0,0
140688,analyzed,0,0
140689,in,0,0
140690,patients,1,1
140691,with,1,1
140692,American,1,1
140693,Joint,1,0
140694,Committee,1,1
140695,on,1,0
140696,Cancer/Union,1,1
140697,for,1,0
140698,International,1,1
140699,Cancer,1,0
140700,Control,1,0
140701,(,1,0
140702,AJCC/UICC,1,0
140703,),1,0
140704,stage,1,1
140705,II,1,0
140706,disease,1,1
140707,.,1,1
140708,METHODS,0,0
140709,Tumors,1,0
140710,of,1,1
140711,120,1,1
140712,randomly,1,1
140713,selected,1,1
140714,patients,1,1
140715,with,1,1
140716,AJCC/UICC,1,1
140717,stage,1,1
140718,II,1,0
140719,disease,1,1
140720,were,1,0
140721,retrospectively,1,0
140722,reviewed,1,0
140723,for,0,0
140724,tumor,1,0
140725,growth,1,0
140726,pattern,1,0
140727,(,1,0
140728,expanding,1,0
140729,vs.,1,0
140730,infiltrating,1,0
140731,),1,0
140732,and,0,0
140733,the,0,0
140734,extent,0,0
140735,of,0,0
140736,tumor,0,0
140737,budding,0,0
140738,",",0,0
140739,with,0,0
140740,high-grade,0,0
140741,budding,0,0
140742,reflecting,0,0
140743,presence,0,0
140744,of,0,0
140745,10,0,0
140746,or,0,0
140747,more,0,0
140748,budding,0,0
140749,foci,0,0
140750,scattered,0,0
140751,at,0,0
140752,the,0,0
140753,invasive,0,0
140754,tumor,0,0
140755,margin,0,0
140756,.,0,0
140757,Progression-free,0,0
140758,and,0,0
140759,cancer-specific,0,0
140760,survivals,0,0
140761,were,0,0
140762,determined,0,0
140763,by,0,0
140764,the,0,0
140765,Kaplan-Meier,0,0
140766,method,0,0
140767,.,0,0
140768,For,0,0
140769,multivariable,0,0
140770,analysis,0,0
140771,",",0,0
140772,Cox,0,0
140773,'s,0,0
140774,proportional,0,0
140775,hazards,0,0
140776,regression,0,0
140777,models,0,0
140778,were,0,0
140779,performed,0,0
140780,.,0,0
140781,RESULTS,0,0
140782,The,0,0
140783,infiltrating,0,0
140784,growth,0,0
140785,pattern,0,0
140786,was,0,0
140787,significantly,0,0
140788,associated,0,0
140789,with,0,0
140790,histological,0,0
140791,subtype,0,1
140792,and,0,0
140793,lymphovascular,0,0
140794,invasion,0,0
140795,",",0,0
140796,while,0,0
140797,high-grade,0,0
140798,budding,0,0
140799,was,0,0
140800,significantly,0,0
140801,associated,0,0
140802,with,0,0
140803,tumor,0,0
140804,grade,0,0
140805,and,0,0
140806,lymphovascular,0,0
140807,invasion,0,0
140808,.,0,0
140809,High-grade,0,0
140810,budding,0,0
140811,",",0,0
140812,but,0,0
140813,not,0,0
140814,the,0,0
140815,infiltrating,0,0
140816,growth,0,0
140817,pattern,0,0
140818,",",0,0
140819,was,0,0
140820,significantly,0,0
140821,associated,0,0
140822,with,0,0
140823,outcome,0,0
140824,in,0,0
140825,univariable,0,0
140826,analysis,0,0
140827,.,0,0
140828,Cox,0,0
140829,'s,0,0
140830,proportional,0,0
140831,hazards,0,0
140832,regression,0,0
140833,models,0,0
140834,proved,0,0
140835,tumor,0,1
140836,budding,0,0
140837,to,0,0
140838,be,0,0
140839,an,0,0
140840,independent,0,0
140841,predictor,0,0
140842,of,0,0
140843,disease,0,1
140844,progression,0,0
140845,(,0,0
140846,hazard,0,0
140847,ratio,0,0
140848,3.91,0,0
140849,",",0,0
140850,95,0,0
140851,%,0,0
140852,confidence,0,0
140853,interval,0,0
140854,1.3-11.77,0,0
140855,;,0,0
140856,P,0,0
140857,=,0,0
140858,0.02,0,0
140859,),0,0
140860,and,0,0
140861,cancer-related,0,0
140862,death,0,0
140863,(,0,0
140864,hazard,0,0
140865,ratio,0,0
140866,5.90,0,0
140867,",",0,0
140868,95,0,0
140869,%,0,0
140870,confidence,0,0
140871,interval,0,0
140872,1.62-21.51,0,0
140873,;,0,0
140874,P,0,0
140875,=,0,0
140876,0.007,0,0
140877,),0,0
140878,.,0,0
140879,The,0,0
140880,combination,0,0
140881,of,0,0
140882,infiltrating,0,0
140883,growth,0,0
140884,pattern,0,0
140885,and,0,0
140886,high-grade,0,0
140887,budding,0,0
140888,did,0,0
140889,not,0,0
140890,have,0,0
140891,a,0,0
140892,stronger,0,0
140893,prognostic,0,0
140894,significance,0,0
140895,than,0,0
140896,tumor,0,0
140897,budding,0,0
140898,alone,0,0
140899,.,0,0
140900,CONCLUSIONS,0,0
140901,Tumor,0,0
140902,budding,0,0
140903,independently,0,0
140904,predicted,0,0
140905,patient,0,0
140906,outcome,1,0
140907,in,1,0
140908,patients,1,1
140909,with,1,1
140910,AJCC/UICC,1,1
140911,stage,1,1
140912,II,1,0
140913,colorectal,1,1
140914,cancer,1,1
140915,and,1,0
140916,may,1,0
140917,therefore,0,0
140918,be,0,0
140919,used,0,0
140920,for,0,0
140921,accurate,0,0
140922,prognostication,0,0
140923,",",0,0
140924,patient,0,0
140925,counseling,0,0
140926,",",0,0
140927,and,0,0
140928,design,0,0
140929,of,0,0
140930,clinical,0,0
140931,trials,0,0
140932,by,0,0
140933,using,0,0
140934,integrated,0,0
140935,multimodal,0,0
140936,therapy,0,0
140937,.,0,0
140938,The,0,0
140939,effects,0,0
140940,of,0,0
140941,different,0,0
140942,intensities,0,0
140943,and,0,0
140944,durations,0,0
140945,of,0,0
140946,the,0,0
140947,general,0,1
140948,warm-up,0,0
140949,on,0,0
140950,leg,0,0
140951,press,0,0
140952,1RM,0,0
140953,.,0,0
140954,The,0,0
140955,precision,0,0
140956,of,0,0
140957,maximum,0,0
140958,strength,0,0
140959,assessments,0,0
140960,(,0,0
140961,1,0,0
140962,repetition,0,0
140963,maximum,0,0
140964,;,0,0
140965,1RM,0,0
140966,),0,0
140967,is,0,0
140968,important,0,0
140969,to,0,0
140970,evaluate,0,0
140971,the,0,0
140972,functional,0,0
140973,capacity,0,0
140974,and,0,0
140975,to,0,0
140976,prescribe,0,0
140977,and,0,0
140978,monitor,0,0
140979,the,0,0
140980,training,0,0
140981,load,0,0
140982,.,0,0
140983,Several,0,0
140984,factors,0,0
140985,can,0,0
140986,affect,0,0
140987,the,0,0
140988,precision,0,0
140989,of,0,0
140990,1RM,0,0
140991,tests,0,0
140992,",",0,0
140993,including,0,0
140994,the,0,0
140995,warm-up,0,0
140996,procedure,0,0
140997,.,0,0
140998,General,0,0
140999,and,0,0
141000,specific,0,0
141001,warm-up,0,0
141002,routines,0,0
141003,are,0,0
141004,recommended,0,0
141005,to,0,0
141006,enhance,0,0
141007,performance,0,0
141008,.,0,0
141009,The,0,0
141010,effects,0,0
141011,of,0,0
141012,a,0,0
141013,specific,0,0
141014,warm-up,0,0
141015,have,0,0
141016,already,0,0
141017,been,0,0
141018,acknowledged,0,0
141019,in,0,0
141020,improving,0,0
141021,performance,0,0
141022,.,0,0
141023,However,0,0
141024,",",0,0
141025,the,0,0
141026,effects,0,0
141027,of,0,0
141028,a,0,0
141029,general,0,1
141030,warm-up,0,0
141031,(,0,0
141032,GWU,0,0
141033,),0,0
141034,are,0,0
141035,unclear,0,0
141036,but,0,0
141037,seem,0,0
141038,to,0,0
141039,depend,0,0
141040,on,0,0
141041,its,0,0
141042,ability,0,0
141043,to,0,0
141044,increase,0,0
141045,muscle,0,0
141046,temperature,0,0
141047,while,0,0
141048,avoiding,0,0
141049,fatigue,0,0
141050,.,0,0
141051,Furthermore,0,0
141052,",",0,0
141053,temperature,0,0
141054,elevation,0,0
141055,is,0,0
141056,dependent,0,0
141057,on,0,0
141058,both,0,0
141059,the,0,0
141060,duration,0,0
141061,and,0,0
141062,the,0,0
141063,intensity,0,0
141064,of,0,0
141065,the,0,0
141066,activity,0,0
141067,",",0,0
141068,which,0,0
141069,may,0,0
141070,eventually,0,0
141071,affect,0,0
141072,1RM,0,0
141073,performance,0,0
141074,.,0,0
141075,The,0,0
141076,objective,0,0
141077,of,0,0
141078,this,0,0
141079,study,0,0
141080,was,0,0
141081,to,0,0
141082,investigate,0,0
141083,the,0,0
141084,effect,0,0
141085,of,0,0
141086,different,0,0
141087,intensities,0,0
141088,and,0,0
141089,durations,0,0
141090,of,0,0
141091,GWU,0,0
141092,on,0,0
141093,1RM,0,0
141094,performance,0,0
141095,.,0,0
141096,Sixteen,1,0
141097,strength-trained,1,0
141098,men,1,1
141099,were,0,0
141100,tested,0,0
141101,for,0,0
141102,1RM,0,0
141103,leg,0,0
141104,press,0,0
141105,after,0,0
141106,4,0,0
141107,GWU,0,0
141108,conditions,0,0
141109,after,0,0
141110,specific,0,0
141111,warm-up,0,0
141112,:,0,1
141113,short,0,0
141114,duration,0,0
141115,and,0,0
141116,low,0,0
141117,intensity,0,0
141118,(,0,0
141119,SDLI,0,0
141120,;,0,0
141121,i.e.,0,0
141122,",",0,0
141123,5,0,0
141124,minutes,0,0
141125,at,0,0
141126,40,0,1
141127,%,0,0
141128,V,0,0
141129,[,0,0
141130,Combining,0,0
141131,Dot,0,0
141132,Above,0,1
141133,],0,0
141134,O2max,0,0
141135,),0,0
141136,",",0,0
141137,long,0,0
141138,duration,0,0
141139,and,0,0
141140,low,0,0
141141,intensity,0,0
141142,(,0,0
141143,LDLI,0,0
141144,;,0,0
141145,i.e.,0,0
141146,",",0,0
141147,15,0,0
141148,minutes,0,0
141149,at,0,0
141150,40,0,1
141151,%,0,0
141152,V,0,0
141153,[,0,0
141154,Combining,0,0
141155,Dot,0,0
141156,Above,0,1
141157,],0,0
141158,O2max,0,0
141159,),0,0
141160,",",0,0
141161,short,0,0
141162,duration,0,0
141163,and,0,0
141164,moderate,0,1
141165,intensity,0,0
141166,(,0,0
141167,SDMI,0,0
141168,;,0,0
141169,i.e.,0,0
141170,",",0,0
141171,5,0,0
141172,minutes,0,0
141173,at,0,0
141174,70,0,1
141175,%,0,0
141176,V,0,0
141177,[,0,0
141178,Combining,0,0
141179,Dot,0,0
141180,Above,0,1
141181,],0,0
141182,O2max,0,0
141183,),0,0
141184,",",0,0
141185,long,0,0
141186,duration,0,0
141187,and,0,0
141188,moderate,0,1
141189,intensity,0,0
141190,(,0,0
141191,LDMI,0,0
141192,;,0,0
141193,i.e.,0,0
141194,",",0,0
141195,15,0,0
141196,minutes,0,0
141197,at,0,0
141198,70,0,1
141199,%,0,0
141200,V,0,0
141201,[,0,0
141202,Combining,0,0
141203,Dot,0,0
141204,Above,0,1
141205,],0,0
141206,O2max,0,0
141207,),0,0
141208,",",0,0
141209,and,0,0
141210,the,0,0
141211,control,0,0
141212,(,0,0
141213,CTRL,0,0
141214,),0,0
141215,no-GWU,0,0
141216,condition,0,0
141217,.,0,0
141218,Leg,0,0
141219,press,0,0
141220,1RM,0,0
141221,values,0,0
141222,were,0,0
141223,higher,0,0
141224,(,0,0
141225,on,0,0
141226,average,0,0
141227,3,0,0
141228,%,0,0
141229,),0,0
141230,when,0,0
141231,subjects,0,1
141232,performed,0,0
141233,LDLI,0,0
141234,(,0,0
141235,367.8,0,0
141236,?,0,0
141237,70.1,0,0
141238,kg,0,0
141239,;,0,0
141240,p,0,0
141241,=,0,0
141242,0.01,0,0
141243,),0,0
141244,",",0,0
141245,compared,0,0
141246,with,0,0
141247,the,0,0
141248,other,0,0
141249,4,0,0
141250,conditions,0,0
141251,.,0,0
141252,After,0,0
141253,the,0,0
141254,LDMI,0,0
141255,condition,0,0
141256,",",0,0
141257,1RM,0,0
141258,values,0,0
141259,were,0,0
141260,lower,0,0
141261,(,0,0
141262,on,0,0
141263,average,0,0
141264,-4,0,0
141265,%,0,0
141266,),0,0
141267,than,0,0
141268,in,0,0
141269,the,0,0
141270,other,0,0
141271,4,0,0
141272,conditions,0,0
141273,(,0,1
141274,345.6,0,0
141275,?,0,0
141276,70.5,0,0
141277,kg,0,0
141278,;,0,0
141279,p,0,0
141280,=,0,0
141281,0.01,0,0
141282,),0,0
141283,.,0,0
141284,There,0,0
141285,were,0,0
141286,no,0,0
141287,differences,0,0
141288,between,0,0
141289,SDMI,0,0
141290,",",0,0
141291,SDLI,0,0
141292,",",0,0
141293,and,0,0
141294,CTRL,0,0
141295,(,0,0
141296,359.4,0,0
141297,?,0,0
141298,69.2,0,0
141299,kg,0,0
141300,",",0,0
141301,359.1,0,0
141302,?,0,0
141303,69.3,0,0
141304,kg,0,0
141305,",",0,0
141306,and,0,0
141307,359.4,0,0
141308,?,0,0
141309,70.4,0,0
141310,kg,0,0
141311,",",0,0
141312,respectively,0,0
141313,;,0,0
141314,p,0,0
141315,=,0,0
141316,0.99,0,0
141317,),0,0
141318,.,0,0
141319,According,0,0
141320,to,0,0
141321,our,0,0
141322,results,0,0
141323,",",0,0
141324,long-duration,0,0
141325,low-intensity,0,0
141326,general,0,1
141327,warm-up,0,0
141328,seems,0,0
141329,be,0,0
141330,appropriately,0,0
141331,to,0,0
141332,improve,0,0
141333,1RM,0,0
141334,performance,1,0
141335,in,1,0
141336,strength-trained,1,1
141337,individuals,1,1
141338,.,1,1
141339,The,0,0
141340,effects,0,0
141341,of,0,0
141342,orthotic,0,0
141343,heel,0,0
141344,lifts,0,0
141345,on,0,0
141346,Achilles,0,1
141347,tendon,0,1
141348,force,0,0
141349,and,0,0
141350,strain,0,0
141351,during,0,0
141352,running,0,0
141353,.,0,0
141354,This,0,0
141355,study,0,0
141356,assessed,0,0
141357,the,0,0
141358,effects,0,0
141359,of,0,0
141360,orthotic,0,0
141361,heel,0,0
141362,lifts,0,0
141363,on,0,0
141364,Achilles,0,1
141365,tendon,0,1
141366,(,0,0
141367,AT,0,0
141368,),0,0
141369,force,0,0
141370,and,0,0
141371,strain,0,0
141372,during,0,0
141373,running,0,0
141374,.,0,1
141375,Ten,1,1
141376,females,1,1
141377,ran,1,0
141378,barefoot,1,0
141379,over,1,0
141380,a,1,0
141381,force,1,0
141382,plate,1,0
141383,in,1,0
141384,three,1,0
141385,conditions,1,0
141386,:,1,1
141387,no,1,0
141388,heel,1,0
141389,lifts,1,0
141390,(,1,0
141391,NHL,1,1
141392,),1,0
141393,",",1,0
141394,with,1,1
141395,12,1,0
141396,mm,1,0
141397,heel,1,0
141398,lifts,1,0
141399,(,1,0
141400,12HL,1,1
141401,),1,0
141402,and,1,0
141403,with,1,1
141404,18,1,1
141405,mm,1,0
141406,heel,1,0
141407,lifts,1,0
141408,(,1,0
141409,18HL,1,1
141410,),1,0
141411,.,1,0
141412,Kinematics,0,0
141413,for,0,0
141414,the,0,0
141415,right,0,0
141416,lower,0,0
141417,limb,0,0
141418,were,0,0
141419,collected,0,0
141420,(,0,0
141421,200,0,0
141422,Hz,0,0
141423,),0,0
141424,.,0,0
141425,AT,0,0
141426,force,0,0
141427,was,0,0
141428,calculated,0,0
141429,from,0,0
141430,inverse,0,0
141431,dynamics,0,0
141432,.,0,1
141433,AT,0,0
141434,strain,0,0
141435,was,0,0
141436,determined,0,0
141437,from,0,0
141438,kinematics,0,0
141439,and,0,0
141440,ultrasound,0,0
141441,images,0,0
141442,of,0,0
141443,medial,0,0
141444,gastrocnemius,0,1
141445,(,0,0
141446,50,0,0
141447,Hz,0,0
141448,),0,0
141449,.,0,0
141450,Peak,0,0
141451,AT,0,0
141452,strain,0,0
141453,was,0,0
141454,less,0,0
141455,for,0,0
141456,18HL,0,1
141457,(,0,0
141458,5.5,0,0
141459,?,0,0
141460,4.4,0,0
141461,%,0,0
141462,),0,0
141463,than,0,0
141464,for,0,0
141465,NHL,0,1
141466,(,0,0
141467,7.4,0,0
141468,?,0,0
141469,4.2,0,0
141470,%,0,0
141471,),0,0
141472,(,0,0
141473,p,0,0
141474,=,0,0
141475,.029,0,0
141476,",",0,0
141477,effect,0,0
141478,size,0,0
141479,[,0,0
141480,ES,0,0
141481,],0,0
141482,=,0,0
141483,0.44,0,0
141484,),0,0
141485,but,0,0
141486,not,0,0
141487,for,0,0
141488,12HL,0,0
141489,(,0,0
141490,5.8,0,0
141491,?,0,0
141492,4.8,0,0
141493,%,0,0
141494,),0,0
141495,versus,0,0
141496,NHL,0,1
141497,(,0,0
141498,ES,0,0
141499,=,0,0
141500,0.35,0,0
141501,),0,0
141502,.,0,0
141503,Peak,0,0
141504,AT,0,0
141505,force,0,0
141506,was,0,0
141507,significantly,0,0
141508,(,0,0
141509,p,0,0
141510,=,0,0
141511,.024,0,0
141512,",",0,0
141513,ES,0,0
141514,=,0,0
141515,0.42,0,0
141516,),0,0
141517,less,0,0
141518,for,0,0
141519,18HL,0,1
141520,(,0,0
141521,2382,0,1
141522,?,0,0
141523,717,0,1
141524,N,0,1
141525,),0,0
141526,than,0,0
141527,for,0,0
141528,NHL,0,1
141529,(,0,0
141530,2710,0,0
141531,?,0,0
141532,830,0,0
141533,N,0,1
141534,),0,0
141535,but,0,0
141536,not,0,0
141537,for,0,0
141538,12HL,0,0
141539,(,0,0
141540,2538,0,1
141541,?,0,0
141542,823,0,1
141543,N,0,1
141544,",",0,0
141545,ES,0,0
141546,=,0,0
141547,0.21,0,0
141548,),0,0
141549,.,0,0
141550,The,0,0
141551,18HL,0,0
141552,reduced,0,0
141553,ankle,0,1
141554,dorsiflexion,0,0
141555,but,0,0
141556,not,0,0
141557,flexion-extension,0,0
141558,ankle,0,1
141559,moments,0,0
141560,and,0,0
141561,increased,0,0
141562,the,0,0
141563,AT,0,0
141564,moment,0,0
141565,arm,0,0
141566,compared,0,0
141567,with,0,1
141568,NHL,0,1
141569,.,0,0
141570,Thus,0,0
141571,",",0,0
141572,18HL,0,1
141573,reduced,0,0
141574,force,0,0
141575,and,0,0
141576,strain,0,0
141577,on,0,0
141578,the,0,0
141579,AT,0,0
141580,during,0,0
141581,running,0,0
141582,via,0,0
141583,a,0,0
141584,reduction,0,0
141585,in,0,0
141586,dorsiflexion,0,0
141587,",",0,0
141588,which,0,0
141589,lengthened,0,0
141590,the,0,0
141591,AT,0,0
141592,moment,0,0
141593,arm,0,0
141594,.,0,0
141595,Therefore,0,0
141596,",",0,0
141597,heel,0,0
141598,lifts,0,0
141599,could,0,0
141600,be,0,0
141601,used,0,0
141602,to,0,0
141603,reduce,0,0
141604,AT,0,0
141605,loading,0,0
141606,and,0,0
141607,strain,0,0
141608,during,0,0
141609,the,0,0
141610,rehabilitation,0,1
141611,of,0,0
141612,AT,0,0
141613,injuries,0,1
141614,.,0,1
141615,Rationale,0,1
141616,and,0,0
141617,study,0,0
141618,design,0,0
141619,of,0,0
141620,the,0,0
141621,increase,0,0
141622,of,0,0
141623,vagal,0,0
141624,tone,0,0
141625,in,0,0
141626,heart,1,1
141627,failure,1,1
141628,study,0,0
141629,:,0,1
141630,INOVATE-HF,0,0
141631,.,0,0
141632,BACKGROUND,0,0
141633,Imbalance,0,0
141634,between,0,0
141635,the,0,0
141636,parasympathetic,0,0
141637,and,0,0
141638,sympathetic,0,0
141639,nervous,0,0
141640,systems,0,0
141641,is,0,0
141642,a,0,0
141643,recognized,0,0
141644,contributor,0,0
141645,to,0,0
141646,progression,0,0
141647,of,0,0
141648,chronic,1,1
141649,heart,1,1
141650,failure,1,1
141651,.,1,0
141652,Current,0,0
141653,therapy,0,0
141654,with,0,1
141655,beta,0,0
141656,adrenergic,0,0
141657,antagonists,0,0
141658,is,0,0
141659,designed,0,0
141660,to,0,0
141661,moderate,0,1
141662,the,0,0
141663,up-regulation,0,0
141664,of,0,0
141665,norepinephrine,0,0
141666,and,0,0
141667,sympathetic,0,0
141668,effects,0,0
141669,;,0,0
141670,however,0,0
141671,",",0,0
141672,to,0,0
141673,date,0,0
141674,",",0,0
141675,there,0,0
141676,are,0,0
141677,no,0,0
141678,therapies,0,0
141679,that,0,0
141680,specifically,0,0
141681,address,0,0
141682,the,0,0
141683,withdrawal,0,0
141684,of,0,0
141685,parasympathetic,0,0
141686,influences,0,0
141687,on,0,0
141688,cardiac,0,1
141689,function,0,0
141690,and,0,0
141691,structure,0,0
141692,.,0,0
141693,METHODS/RESULTS,0,0
141694,In,0,0
141695,order,0,0
141696,to,0,0
141697,evaluate,0,0
141698,the,0,0
141699,impact,0,0
141700,of,0,0
141701,vagus,0,0
141702,nerve,0,0
141703,stimulation,0,0
141704,",",0,0
141705,an,0,0
141706,international,0,0
141707,multi-center,0,0
141708,randomized,0,0
141709,clinical,0,0
141710,trial,0,0
141711,(,0,0
141712,INOVATE-HF,0,0
141713,),0,0
141714,has,0,0
141715,been,0,0
141716,designed,0,0
141717,to,0,0
141718,assess,0,0
141719,safety,0,0
141720,and,0,0
141721,efficacy,0,0
141722,of,0,0
141723,vagus,0,0
141724,nerve,0,0
141725,stimulation,0,0
141726,in,0,0
141727,symptomatic,1,1
141728,patients,1,1
141729,with,1,1
141730,heart,1,1
141731,failure,1,1
141732,on,1,0
141733,optimal,1,0
141734,medical,1,1
141735,therapy,1,0
141736,using,0,0
141737,the,0,0
141738,CardioFit,0,0
141739,System,0,0
141740,(,0,0
141741,BioControl,0,0
141742,Medical,0,1
141743,",",0,0
141744,Yehud,0,0
141745,",",0,0
141746,Israel,0,1
141747,),0,0
141748,.,0,0
141749,Up,1,0
141750,to,1,0
141751,650,1,1
141752,patients,1,1
141753,from,1,1
141754,80,1,1
141755,sites,1,0
141756,will,1,0
141757,be,1,0
141758,recruited,1,1
141759,and,0,0
141760,randomized,0,0
141761,in,0,0
141762,a,0,0
141763,3:2,0,0
141764,ratio,0,0
141765,to,0,0
141766,receive,0,0
141767,active,0,0
141768,treatment,0,0
141769,or,0,0
141770,standard,0,0
141771,optimal,0,0
141772,medical,0,1
141773,therapy,0,0
141774,.,0,0
141775,Inclusion,1,0
141776,criteria,1,1
141777,include,1,0
141778,left,1,1
141779,ventricular,1,0
141780,systolic,1,0
141781,dysfunction,1,0
141782,",",1,0
141783,the,1,0
141784,presence,1,0
141785,of,1,0
141786,New,1,1
141787,York,1,1
141788,Heart,1,1
141789,Association,1,0
141790,Class,1,0
141791,III,1,0
141792,symptoms,1,0
141793,",",1,0
141794,sinus,1,1
141795,rhythm,1,1
141796,",",1,0
141797,and,1,0
141798,QRS,1,0
141799,width,1,0
141800,less,1,0
141801,than,1,0
141802,120,1,1
141803,milliseconds,1,0
141804,.,1,0
141805,The,0,0
141806,study,0,0
141807,is,0,0
141808,powered,0,0
141809,to,0,0
141810,detect,0,0
141811,differences,0,0
141812,in,0,0
141813,the,0,0
141814,primary,0,0
141815,efficacy,0,0
141816,end,0,0
141817,point,0,0
141818,of,0,0
141819,all-cause,0,0
141820,mortality,0,0
141821,and,0,0
141822,heart,0,1
141823,failure,0,1
141824,hospitalization,0,0
141825,and,0,0
141826,2,0,0
141827,safety,0,0
141828,end,0,0
141829,points,0,0
141830,.,0,1
141831,CONCLUSION,0,0
141832,Vagal,0,0
141833,nerve,0,0
141834,stimulation,0,0
141835,with,0,1
141836,CardioFit,0,0
141837,as,0,0
141838,a,0,0
141839,treatment,0,0
141840,for,0,0
141841,symptomatic,0,1
141842,heart,0,1
141843,failure,0,0
141844,is,0,0
141845,under,0,0
141846,active,0,0
141847,investigation,0,0
141848,as,0,0
141849,a,0,0
141850,novel,0,0
141851,approach,0,0
141852,to,0,0
141853,restore,0,0
141854,balance,0,0
141855,between,0,0
141856,the,0,0
141857,sympathetic,0,0
141858,and,0,0
141859,parasympathetic,0,0
141860,nervous,0,1
141861,systems,0,0
141862,.,0,1
141863,If,0,0
141864,shown,0,0
141865,to,0,0
141866,be,0,0
141867,safe,0,0
141868,and,0,0
141869,effective,0,0
141870,in,0,0
141871,decreasing,0,0
141872,heart,0,1
141873,failure,0,1
141874,events,0,0
141875,and,0,0
141876,mortality,0,0
141877,",",0,0
141878,this,0,0
141879,novel,0,0
141880,approach,0,0
141881,will,0,0
141882,impact,0,0
141883,the,0,0
141884,treatment,0,0
141885,paradigm,0,0
141886,for,0,0
141887,heart,0,1
141888,failure,0,1
141889,.,0,0
141890,Dietary,0,0
141891,patterns,0,0
141892,differ,0,0
141893,between,0,0
141894,urban,1,1
141895,and,1,0
141896,rural,1,1
141897,older,1,1
141898,",",1,0
141899,long-term,1,0
141900,survivors,1,1
141901,of,1,0
141902,breast,1,1
141903,",",1,0
141904,prostate,1,0
141905,",",1,0
141906,and,1,0
141907,colorectal,1,1
141908,cancer,1,1
141909,and,0,0
141910,are,0,0
141911,associated,0,0
141912,with,0,0
141913,body,0,0
141914,mass,0,0
141915,index,0,0
141916,.,0,0
141917,BACKGROUND,0,0
141918,Older,1,0
141919,adult,1,1
141920,cancer,1,1
141921,survivors,1,1
141922,are,0,0
141923,at,0,0
141924,greater,0,0
141925,risk,0,0
141926,of,0,0
141927,cancer,0,1
141928,recurrence,0,0
141929,and,0,0
141930,other,0,0
141931,comorbidities,0,0
141932,that,0,0
141933,can,0,0
141934,be,0,0
141935,prevented,0,0
141936,through,0,0
141937,improved,0,0
141938,diet,0,0
141939,and,0,0
141940,weight,0,0
141941,management,0,0
141942,.,0,0
141943,The,0,0
141944,tertiary,0,1
141945,prevention,0,0
141946,needs,0,0
141947,of,0,0
141948,rural-dwelling,0,1
141949,survivors,0,1
141950,can,0,0
141951,be,0,0
141952,even,0,0
141953,greater,0,0
141954,",",0,0
141955,yet,0,0
141956,little,0,0
141957,is,0,0
141958,known,0,0
141959,about,0,0
141960,rural,0,1
141961,and,0,0
141962,urban,0,1
141963,differences,0,0
141964,in,0,0
141965,lifestyle,0,1
141966,factors,0,0
141967,among,0,0
141968,this,0,0
141969,high-risk,0,1
141970,population,0,1
141971,.,0,0
141972,OBJECTIVES,0,0
141973,To,0,0
141974,compare,0,0
141975,dietary,0,0
141976,patterns,0,0
141977,of,0,0
141978,urban,1,1
141979,and,1,0
141980,rural,1,1
141981,cancer,1,1
141982,survivors,1,1
141983,and,0,0
141984,to,0,0
141985,examine,0,0
141986,associations,0,0
141987,of,0,0
141988,dietary,0,0
141989,patterns,0,0
141990,with,0,1
141991,body,0,1
141992,mass,0,0
141993,index,0,0
141994,(,0,0
141995,BMI,0,0
141996,),0,0
141997,.,0,0
141998,DESIGN,0,0
141999,A,0,0
142000,secondary,0,0
142001,analysis,0,0
142002,was,0,0
142003,performed,0,0
142004,of,0,0
142005,baseline,0,0
142006,data,0,0
142007,from,0,0
142008,the,0,0
142009,Reach,0,0
142010,Out,0,0
142011,to,0,0
142012,Enhance,0,0
142013,Wellness,0,0
142014,(,0,0
142015,RENEW,0,0
142016,),0,0
142017,trial,0,0
142018,",",0,0
142019,a,0,0
142020,diet,0,0
142021,and,0,0
142022,exercise,0,0
142023,intervention,0,0
142024,among,0,0
142025,overweight,0,0
142026,",",0,0
142027,long-term,0,0
142028,(,0,0
142029,?5,0,0
142030,years,0,1
142031,),0,0
142032,",",0,0
142033,older,0,1
142034,survivors,0,1
142035,of,0,0
142036,colorectal,0,1
142037,",",0,0
142038,breast,0,1
142039,",",0,0
142040,and,0,0
142041,prostate,0,1
142042,cancer,1,1
142043,.,1,0
142044,Survivors,1,0
142045,in,1,0
142046,the,1,0
142047,present,1,0
142048,analysis,1,0
142049,(,1,0
142050,n=729,1,1
142051,),1,0
142052,underwent,1,1
142053,two,0,0
142054,45-,0,0
142055,to,0,0
142056,60-minute,0,0
142057,telephone,0,0
142058,surveys,0,0
142059,",",0,0
142060,which,0,0
142061,included,0,1
142062,two,0,0
142063,24-hour,0,0
142064,dietary,0,0
142065,recalls,0,0
142066,.,0,1
142067,Principal,0,0
142068,components,0,0
142069,analysis,0,0
142070,and,0,0
142071,multivariable,0,0
142072,general,0,1
142073,linear,0,0
142074,models,0,0
142075,were,0,0
142076,used,0,0
142077,to,0,0
142078,derive,0,0
142079,dietary,0,0
142080,patterns,0,0
142081,and,0,0
142082,to,0,0
142083,evaluate,0,0
142084,associations,0,0
142085,between,0,0
142086,dietary,0,0
142087,patterns,0,0
142088,and,0,0
142089,BMI,0,0
142090,",",0,0
142091,respectively,0,0
142092,.,0,0
142093,RESULTS,0,0
142094,Principal,0,0
142095,components,0,0
142096,analysis,0,0
142097,identified,0,0
142098,three,0,0
142099,primary,0,1
142100,dietary,0,0
142101,patterns,0,0
142102,among,0,1
142103,rural,0,1
142104,dwellers,0,1
142105,(,0,1
142106,high,0,1
142107,sweets,0,0
142108,and,0,0
142109,starches,0,0
142110,",",0,0
142111,high,0,0
142112,reduced-fat,0,0
142113,dairy,0,1
142114,",",0,0
142115,cereal,0,0
142116,",",0,0
142117,nuts,0,0
142118,",",0,0
142119,and,0,0
142120,fruits,0,0
142121,",",0,0
142122,and,0,0
142123,mixed,0,0
142124,),0,0
142125,and,0,0
142126,three,0,0
142127,among,0,1
142128,urban,0,1
142129,dwellers,0,1
142130,(,0,1
142131,high,0,1
142132,fruits,0,0
142133,and,0,0
142134,vegetables,0,0
142135,",",0,0
142136,high,0,0
142137,meat,0,0
142138,and,0,0
142139,refined,0,0
142140,grains,0,0
142141,",",0,0
142142,and,0,0
142143,high,0,0
142144,sugar-sweetened,0,0
142145,beverages,0,1
142146,),0,0
142147,.,0,0
142148,Among,1,1
142149,rural,1,1
142150,survivors,1,1
142151,",",1,0
142152,greater,0,0
142153,adherence,0,0
142154,to,0,0
142155,the,0,0
142156,high,0,0
142157,reduced-fat,0,0
142158,dairy,0,1
142159,",",0,0
142160,cereal,0,0
142161,",",0,0
142162,nuts,0,0
142163,",",0,0
142164,and,0,0
142165,fruits,0,0
142166,pattern,0,0
142167,was,0,0
142168,positively,0,0
142169,associated,0,0
142170,with,0,0
142171,lower,0,0
142172,BMI,0,0
142173,(,0,0
142174,P,0,0
142175,trend,0,0
142176,<,0,0
142177,0.05,0,0
142178,),0,0
142179,",",0,0
142180,whereas,0,0
142181,higher,0,0
142182,scores,0,0
142183,on,0,0
142184,the,0,0
142185,mixed,0,0
142186,pattern,0,0
142187,was,0,0
142188,associated,0,0
142189,with,0,1
142190,greater,0,0
142191,BMI,0,0
142192,(,0,0
142193,P,0,0
142194,trend,0,0
142195,<,0,0
142196,0.05,0,0
142197,),0,0
142198,.,0,0
142199,Greater,0,0
142200,adherence,0,0
142201,to,0,0
142202,the,0,0
142203,high,0,0
142204,fruits,0,0
142205,and,0,0
142206,vegetables,0,0
142207,pattern,0,0
142208,among,0,0
142209,urban,0,1
142210,survivors,0,1
142211,was,0,0
142212,inversely,0,0
142213,associated,0,0
142214,with,0,0
142215,BMI,0,0
142216,(,0,0
142217,P,0,0
142218,trend,0,0
142219,<,0,0
142220,0.05,0,0
142221,),0,0
142222,.,0,0
142223,CONCLUSIONS,0,0
142224,Urban,0,1
142225,and,0,0
142226,rural,0,1
142227,differences,0,0
142228,in,0,0
142229,dietary,0,0
142230,intake,0,0
142231,behavior,0,0
142232,should,0,0
142233,be,0,0
142234,considered,0,0
142235,in,0,0
142236,designing,0,0
142237,public,0,1
142238,health,0,1
142239,interventions,0,0
142240,among,0,0
142241,the,0,0
142242,increasing,0,0
142243,population,0,0
142244,of,0,0
142245,older,0,1
142246,cancer,0,1
142247,survivors,0,1
142248,.,0,0
142249,In,0,0
142250,addition,0,0
142251,",",0,0
142252,targeting,0,0
142253,overall,0,0
142254,dietary,0,0
142255,patterns,0,0
142256,might,0,0
142257,be,0,0
142258,one,0,0
142259,approach,0,0
142260,to,0,0
142261,help,0,0
142262,reduce,0,0
142263,the,0,0
142264,burden,0,0
142265,of,0,0
142266,obesity,0,1
142267,among,0,0
142268,this,0,0
142269,population,0,1
142270,.,0,0
142271,Investigations,0,0
142272,into,0,1
142273,the,0,0
142274,potential,0,0
142275,effects,0,0
142276,of,0,0
142277,multiple,0,0
142278,dose,0,0
142279,ketorolac,0,0
142280,on,0,0
142281,the,0,0
142282,pharmacokinetics,0,0
142283,and,0,0
142284,pharmacodynamics,0,0
142285,of,0,0
142286,racemic,0,0
142287,warfarin,0,0
142288,.,0,1
142289,1,0,0
142290,.,0,0
142291,The,0,0
142292,potential,0,0
142293,interaction,0,0
142294,between,0,0
142295,racemic,0,0
142296,warfarin,0,0
142297,given,0,0
142298,as,0,0
142299,a,0,0
142300,25,0,0
142301,mg,0,0
142302,single,0,0
142303,oral,0,0
142304,dose,0,0
142305,and,0,0
142306,chronically,0,1
142307,administered,0,0
142308,ketorolac,0,0
142309,was,0,0
142310,studied,0,1
142311,in,0,0
142312,12,1,0
142313,young,1,1
142314,healthy,1,1
142315,male,1,1
142316,volunteers,1,1
142317,.,1,1
142318,2,0,0
142319,.,0,0
142320,Ketorolac,0,0
142321,produced,0,0
142322,no,0,0
142323,major,0,0
142324,change,0,0
142325,in,0,0
142326,the,0,0
142327,pharmacokinetics,0,0
142328,of,0,0
142329,(,0,0
142330,R,0,0
142331,),0,0
142332,-,0,0
142333,or,0,0
142334,(,0,0
142335,S,0,0
142336,),0,0
142337,-warfarin,0,0
142338,.,0,0
142339,3,0,0
142340,.,0,0
142341,Ketorolac,0,0
142342,did,0,0
142343,not,0,0
142344,alter,0,0
142345,the,0,0
142346,pharmacodynamic,0,0
142347,profile,0,0
142348,of,0,0
142349,racemic,0,0
142350,warfarin,0,0
142351,.,0,1
142352,4,0,0
142353,.,0,0
142354,Ketorolac,0,0
142355,increased,0,0
142356,template,0,0
142357,bleeding,0,0
142358,time,0,0
142359,by,0,0
142360,a,0,0
142361,factor,0,0
142362,of,0,0
142363,1.35,0,0
142364,as,0,0
142365,compared,0,0
142366,with,0,1
142367,placebo,0,0
142368,.,0,1
142369,5,0,0
142370,.,0,0
142371,The,0,0
142372,results,0,0
142373,suggest,0,0
142374,that,0,0
142375,the,0,0
142376,ketorolac-warfarin,0,0
142377,interaction,0,0
142378,is,0,0
142379,unlikely,0,0
142380,to,0,0
142381,be,0,0
142382,of,0,0
142383,major,0,0
142384,clinical,0,0
142385,significance,0,0
142386,;,0,0
142387,however,0,0
142388,",",0,0
142389,combined,0,0
142390,use,0,0
142391,of,0,0
142392,ketorolac,0,0
142393,and,0,0
142394,warfarin,0,0
142395,in,0,0
142396,patients,0,1
142397,should,0,0
142398,be,0,0
142399,undertaken,0,0
142400,with,0,0
142401,due,0,0
142402,caution,0,0
142403,and,0,0
142404,appropriate,0,0
142405,monitoring,0,0
142406,.,0,0
142407,The,0,0
142408,in,0,0
142409,vitro,0,0
142410,effects,0,0
142411,of,0,0
142412,verbascoside,0,0
142413,on,0,0
142414,human,1,0
142415,platelet,1,0
142416,aggregation,1,0
142417,.,1,0
142418,Preliminary,0,0
142419,in,0,0
142420,vitro,0,0
142421,and,0,0
142422,animal,0,0
142423,studies,0,0
142424,have,0,0
142425,shown,0,0
142426,that,0,0
142427,verbascoside,0,0
142428,",",0,0
142429,a,0,0
142430,phenolic,0,0
142431,compound,0,0
142432,",",0,0
142433,may,0,0
142434,have,0,0
142435,several,0,0
142436,favourable,0,0
142437,biological,0,0
142438,activities,0,0
142439,",",0,0
142440,including,0,0
142441,an,0,0
142442,influence,0,0
142443,on,0,0
142444,endothelial,0,0
142445,function,0,0
142446,and,0,0
142447,on,0,0
142448,platelet,0,0
142449,aggregation,0,0
142450,.,0,0
142451,We,0,0
142452,sought,0,0
142453,to,0,0
142454,evaluate,0,0
142455,the,0,0
142456,effects,0,0
142457,of,0,0
142458,verbascoside,0,0
142459,",",0,0
142460,biotechnologically,0,0
142461,produced,0,0
142462,from,0,0
142463,plant,0,0
142464,cell,0,1
142465,cultures,0,0
142466,",",0,0
142467,on,0,0
142468,human,0,0
142469,platelet,0,0
142470,aggregation,0,0
142471,(,0,0
142472,PA,0,0
142473,),0,0
142474,.,0,0
142475,The,0,0
142476,blood,0,0
142477,from,0,0
142478,40,1,1
142479,aspirin-na?ve,1,0
142480,volunteers,1,1
142481,with,1,1
142482,at,1,0
142483,least,1,0
142484,one,1,0
142485,cardiovascular,1,0
142486,risk,1,0
142487,factor,1,0
142488,was,0,0
142489,preincubated,0,0
142490,in,0,0
142491,vitro,0,0
142492,with,0,1
142493,verbascoside,0,0
142494,(,0,0
142495,1,0,0
142496,and,0,0
142497,2,0,0
142498,mg/dL,0,0
142499,),0,0
142500,and,0,0
142501,aspirin,0,0
142502,(,0,0
142503,100,0,0
142504,?M,0,1
142505,),0,0
142506,.,0,0
142507,The,0,0
142508,blood,0,0
142509,from,0,0
142510,20,1,1
142511,patients,1,1
142512,with,1,1
142513,a,1,0
142514,prior,1,0
142515,diagnosis,1,1
142516,of,1,0
142517,coronary,1,1
142518,heart,1,1
142519,disease,1,1
142520,who,1,1
142521,were,1,1
142522,chronically,1,1
142523,assuming,1,0
142524,aspirin,1,0
142525,was,1,0
142526,preincubated,0,0
142527,in,0,0
142528,vitro,0,0
142529,with,0,1
142530,verbascoside,0,0
142531,(,0,0
142532,1,0,0
142533,and,0,0
142534,2,0,0
142535,mg/dL,0,0
142536,),0,0
142537,.,0,0
142538,PA,0,0
142539,is,0,0
142540,measured,0,0
142541,with,0,0
142542,a,0,0
142543,light,0,0
142544,transmission,0,0
142545,aggregometry,0,0
142546,and,0,0
142547,multiplate,0,0
142548,analyzer,0,0
142549,.,0,0
142550,As,0,0
142551,compared,0,0
142552,to,0,0
142553,reference,0,0
142554,",",0,0
142555,preincubation,0,0
142556,with,0,0
142557,verbascoside,0,0
142558,resulted,0,0
142559,in,0,0
142560,a,0,0
142561,significant,0,0
142562,inhibition,0,0
142563,of,0,0
142564,adenosine,0,0
142565,diphosphate,0,0
142566,(,0,0
142567,ADP,0,0
142568,),0,0
142569,and,0,0
142570,arachidonic,0,0
142571,acid,0,0
142572,(,0,0
142573,AA,0,0
142574,),0,0
142575,-induced,0,0
142576,PA,0,0
142577,(,0,0
142578,p,0,0
142579,<,0,0
142580,0.01,0,0
142581,for,0,0
142582,both,0,0
142583,),0,0
142584,.,0,0
142585,Verbascoside,0,0
142586,2,0,0
142587,mg/dL,0,0
142588,did,0,0
142589,not,0,0
142590,show,0,0
142591,a,0,0
142592,stronger,0,0
142593,effect,0,0
142594,as,0,0
142595,compared,0,0
142596,to,0,0
142597,verbascoside,0,0
142598,1,0,0
142599,mg/dL,0,0
142600,(,0,0
142601,p,0,0
142602,=,0,0
142603,0.4,0,0
142604,),0,0
142605,.,0,0
142606,As,0,0
142607,expected,0,0
142608,",",0,0
142609,the,0,0
142610,in,0,0
142611,vitro,0,0
142612,addition,0,0
142613,of,0,0
142614,aspirin,0,0
142615,reduced,0,0
142616,AA,0,0
142617,induced,0,0
142618,PA,0,0
142619,(,0,0
142620,p,0,0
142621,<,0,0
142622,0.01,0,0
142623,),0,0
142624,",",0,0
142625,but,0,0
142626,not,0,0
142627,that,0,0
142628,induced,0,0
142629,by,0,0
142630,ADP,0,0
142631,(,0,0
142632,p,0,0
142633,=,0,0
142634,0.5,0,0
142635,),0,0
142636,.,0,0
142637,The,0,0
142638,addition,0,0
142639,of,0,0
142640,verbascoside,0,0
142641,to,0,0
142642,the,0,0
142643,blood,0,0
142644,of,0,0
142645,aspirin-treated,0,1
142646,patients,0,1
142647,did,0,0
142648,not,0,0
142649,improve,0,0
142650,the,0,0
142651,values,0,0
142652,of,0,0
142653,PA,0,0
142654,after,0,0
142655,AA,0,0
142656,stimulus,0,0
142657,(,0,0
142658,p,0,0
142659,=,0,0
142660,0.8,0,0
142661,),0,0
142662,",",0,0
142663,whereas,0,0
142664,it,0,0
142665,ensured,0,0
142666,a,0,0
142667,stronger,0,0
142668,inhibition,0,0
142669,after,0,0
142670,ADP,0,0
142671,stimulus,0,0
142672,(,0,0
142673,p,0,0
142674,<,0,0
142675,0.01,0,0
142676,),0,0
142677,.,0,0
142678,Verbascoside,0,0
142679,in,0,0
142680,vitro,0,0
142681,affects,0,0
142682,PA,0,0
142683,by,0,0
142684,mildly,0,0
142685,inhibiting,0,0
142686,aggregation,0,0
142687,",",0,0
142688,triggered,0,0
142689,both,0,0
142690,by,0,0
142691,ADP,0,0
142692,and,0,0
142693,AA,0,0
142694,.,0,0
142695,These,0,0
142696,preliminary,0,0
142697,data,0,0
142698,",",0,0
142699,while,0,0
142700,intriguing,0,0
142701,",",0,0
142702,require,0,0
142703,confirmation,0,0
142704,in,0,0
142705,subjects,0,1
142706,receiving,0,1
142707,verbascoside,0,0
142708,orally,0,0
142709,in,0,0
142710,order,0,0
142711,to,0,0
142712,determine,0,0
142713,whether,0,0
142714,these,0,0
142715,findings,0,0
142716,are,0,0
142717,clinically,0,0
142718,relevant,0,0
142719,.,0,0
142720,Pentraxin-3,0,0
142721,in,0,0
142722,chronic,1,1
142723,heart,1,1
142724,failure,1,1
142725,:,1,1
142726,the,0,0
142727,CORONA,0,0
142728,and,0,0
142729,GISSI-HF,0,1
142730,trials,0,0
142731,.,0,1
142732,AIMS,0,0
142733,Pentraxin-3,0,0
142734,(,0,0
142735,PTX3,0,0
142736,),0,0
142737,is,0,0
142738,a,0,0
142739,component,0,0
142740,of,0,0
142741,the,0,0
142742,humoral,0,0
142743,arm,0,0
142744,of,0,0
142745,innate,0,0
142746,immunity,0,0
142747,which,0,0
142748,can,0,0
142749,regulate,0,0
142750,inflammatory,0,0
142751,processes,0,0
142752,.,0,0
142753,Since,0,0
142754,the,0,0
142755,role,0,0
142756,of,0,0
142757,inflammation,0,0
142758,in,0,0
142759,the,0,0
142760,progression,0,0
142761,of,0,0
142762,chronic,0,1
142763,heart,0,1
142764,failure,0,1
142765,(,0,0
142766,HF,0,0
142767,),0,0
142768,is,0,0
142769,debated,0,0
142770,",",0,0
142771,we,0,0
142772,investigated,0,0
142773,the,0,0
142774,prognostic,0,0
142775,value,0,0
142776,of,0,0
142777,PTX3,0,0
142778,and,0,0
142779,the,0,0
142780,effect,0,0
142781,of,0,0
142782,a,0,0
142783,statin,0,0
142784,in,0,0
142785,two,1,0
142786,large,1,1
142787,populations,1,1
142788,of,1,0
142789,patients,1,1
142790,with,1,1
142791,HF,1,1
142792,.,1,0
142793,METHODS,0,0
142794,AND,0,0
142795,RESULTS,0,0
142796,Plasma,0,0
142797,levels,0,0
142798,of,0,0
142799,PTX3,0,0
142800,were,0,0
142801,measured,0,0
142802,at,0,0
142803,randomization,0,0
142804,and,0,0
142805,after,0,0
142806,3,0,0
142807,months,0,0
142808,in,0,0
142809,1457,1,1
142810,patients,1,1
142811,enrolled,1,1
142812,in,1,0
142813,the,1,0
142814,Controlled,1,0
142815,Rosuvastatin,1,0
142816,Multinational,1,1
142817,Trial,1,0
142818,in,1,0
142819,HF,1,1
142820,(,1,0
142821,CORONA,1,0
142822,),1,0
142823,and,1,0
142824,1233,1,1
142825,patients,1,1
142826,enrolled,1,1
142827,in,1,0
142828,the,1,0
142829,GISSI-Heart,1,0
142830,Failure,1,0
142831,trial,1,0
142832,(,1,0
142833,GISSI-HF,1,0
142834,),1,0
142835,.,1,0
142836,The,0,0
142837,relationships,0,0
142838,between,0,0
142839,baseline,0,0
142840,PTX3,0,0
142841,levels,0,0
142842,or,0,1
142843,their,0,1
142844,changes,0,0
142845,over,0,0
142846,time,0,0
142847,and,0,0
142848,mortality,0,0
142849,were,0,0
142850,evaluated,0,0
142851,with,0,1
142852,multivariable,0,0
142853,Cox,0,0
142854,proportional,0,0
142855,hazard,0,0
142856,models,0,0
142857,including,0,0
142858,clinical,0,0
142859,factors,0,0
142860,",",0,0
142861,high,0,0
142862,sensitivity,0,0
142863,C-reactive,0,0
142864,protein,0,0
142865,(,0,0
142866,hsCRP,0,0
142867,),0,0
142868,",",0,0
142869,and,0,0
142870,N-terminal,0,0
142871,pro,0,0
142872,brain,0,0
142873,natriuretic,0,0
142874,peptide,0,0
142875,(,0,0
142876,NT-proBNP,0,0
142877,),0,0
142878,.,0,0
142879,PTX3,0,0
142880,concentration,0,0
142881,[,0,0
142882,median,0,0
142883,(,0,0
142884,Q1-Q3,0,0
142885,),0,0
142886,=,0,0
142887,5.34,0,0
142888,(,0,0
142889,3.55-7.64,0,0
142890,),0,0
142891,ng/mL,0,0
142892,",",0,0
142893,n,0,1
142894,=,0,0
142895,2690,0,1
142896,],0,0
142897,was,0,0
142898,higher,0,0
142899,in,0,0
142900,females,0,0
142901,",",0,0
142902,in,0,0
142903,older,0,1
142904,patients,0,1
142905,",",0,0
142906,and,0,0
142907,those,0,0
142908,with,0,0
142909,lower,0,0
142910,body,0,0
142911,mass,0,0
142912,index,0,0
142913,.,0,0
142914,Baseline,0,0
142915,elevated,0,0
142916,PTX3,0,0
142917,was,0,0
142918,associated,0,0
142919,with,0,0
142920,a,0,0
142921,higher,0,0
142922,risk,0,0
142923,of,0,0
142924,all-cause,0,0
142925,mortality,0,0
142926,[,0,0
142927,759,0,1
142928,events,0,0
142929,",",0,0
142930,hazard,0,0
142931,ratio,0,0
142932,(,0,0
142933,HR,0,0
142934,),0,0
142935,for,0,0
142936,1,0,0
142937,SD,0,1
142938,increase,0,0
142939,1.20,0,0
142940,",",0,0
142941,95,0,0
142942,%,0,0
142943,confidence,0,0
142944,interval,0,0
142945,(,0,0
142946,CI,0,0
142947,),0,0
142948,1.12-1.30,0,0
142949,",",0,0
142950,P,0,0
142951,<,0,0
142952,0.0001,0,0
142953,],0,0
142954,",",0,0
142955,cardiovascular,0,0
142956,mortality,0,0
142957,(,0,0
142958,587,0,1
142959,events,0,0
142960,",",0,0
142961,HR,0,0
142962,1.27,0,0
142963,",",0,0
142964,95,0,0
142965,%,0,0
142966,CI,0,0
142967,1.17-1.38,0,0
142968,",",0,0
142969,P,0,0
142970,<,0,0
142971,0.0001,0,0
142972,),0,0
142973,",",0,0
142974,or,0,0
142975,hospitalization,0,0
142976,for,0,0
142977,worsening,0,0
142978,HF,0,1
142979,(,0,0
142980,720,0,0
142981,events,0,0
142982,",",0,0
142983,HR,0,0
142984,1.21,0,0
142985,",",0,0
142986,95,0,0
142987,%,0,0
142988,CI,0,0
142989,1.12-1.30,0,0
142990,",",0,0
142991,P,0,0
142992,<,0,0
142993,0.0001,0,0
142994,),0,0
142995,",",0,0
142996,and,0,0
142997,marginally,0,0
142998,improved,0,0
142999,discrimination,0,0
143000,.,0,0
143001,Three-month,0,0
143002,changes,0,0
143003,in,0,0
143004,PTX3,0,0
143005,were,0,0
143006,associated,0,0
143007,with,0,1
143008,fatal,0,1
143009,events,0,0
143010,after,0,0
143011,adjustment,0,0
143012,for,0,0
143013,hsCRP,0,0
143014,or,0,1
143015,NT-proBNP,0,0
143016,.,0,0
143017,Rosuvastatin,0,0
143018,lowered,0,0
143019,hsCRP,0,0
143020,levels,0,0
143021,but,0,0
143022,significantly,0,0
143023,raised,0,0
143024,PTX3,0,0
143025,.,0,0
143026,CONCLUSION,0,0
143027,In,0,0
143028,two,0,0
143029,independent,0,0
143030,clinical,0,0
143031,trials,0,0
143032,that,0,0
143033,enrolled,0,1
143034,patients,1,1
143035,with,1,1
143036,chronic,1,1
143037,HF,1,1
143038,",",0,0
143039,PTX3,0,0
143040,was,0,0
143041,consistently,0,0
143042,associated,0,0
143043,with,0,1
143044,outcomes,0,0
143045,.,0,0
143046,The,0,0
143047,opposite,0,0
143048,effects,0,0
143049,of,0,0
143050,a,0,0
143051,statin,0,0
143052,on,0,0
143053,hsCRP,0,0
143054,and,0,0
143055,PTX3,0,0
143056,call,0,0
143057,for,0,0
143058,further,0,0
143059,investigation,0,0
143060,.,0,0
143061,TRIAL,0,0
143062,REGISTRATION,0,0
143063,NCT00336336,0,0
143064,(,0,0
143065,GISSI-HF,0,0
143066,),0,0
143067,",",0,0
143068,NCT00206310,0,0
143069,(,0,0
143070,CORONA,0,0
143071,),0,0
143072,.,0,0
143073,Chloroprocaine,0,0
143074,and,0,0
143075,lidocaine,0,0
143076,decrease,0,0
143077,hospital,0,0
143078,stay,0,0
143079,and,0,0
143080,admission,0,0
143081,rate,0,0
143082,after,0,0
143083,outpatient,1,1
143084,epidural,1,1
143085,anesthesia,1,1
143086,.,1,0
143087,Lumbar,0,0
143088,epidural,0,0
143089,anesthesia,0,0
143090,with,0,1
143091,20,0,0
143092,ml,0,0
143093,of,0,0
143094,either,0,0
143095,3,0,0
143096,%,0,0
143097,2-chloroprocaine,0,0
143098,(,0,0
143099,C,0,0
143100,),0,0
143101,",",0,0
143102,1.5,0,0
143103,%,0,0
143104,lidocaine,0,0
143105,(,0,0
143106,L,0,0
143107,),0,0
143108,",",0,0
143109,or,0,0
143110,1.5,0,0
143111,%,0,0
143112,mepivacaine,0,0
143113,(,0,0
143114,M,0,0
143115,),0,0
143116,with,0,1
143117,epinephrine,0,0
143118,was,0,0
143119,studied,0,1
143120,in,0,0
143121,84,1,1
143122,outpatients,1,1
143123,undergoing,1,1
143124,surgery,1,1
143125,(,1,0
143126,extracorporeal,1,0
143127,shock,1,1
143128,wave,1,0
143129,lithotripsy,1,1
143130,(,1,0
143131,ESWL,1,0
143132,],1,0
143133,.,1,0
143134,The,0,0
143135,average,0,0
143136,duration,0,0
143137,of,0,0
143138,the,0,0
143139,procedure,0,0
143140,was,0,0
143141,31.9,0,0
143142,minutes,0,0
143143,.,0,0
143144,The,0,0
143145,total,0,0
143146,duration,0,0
143147,of,0,0
143148,sensory,0,0
143149,anesthesia,0,0
143150,was,0,0
143151,133,0,1
143152,+/-,0,0
143153,28,0,1
143154,minutes,0,0
143155,(,0,0
143156,C,0,0
143157,),0,0
143158,",",0,0
143159,182,0,1
143160,+/-,0,0
143161,38,0,1
143162,(,0,0
143163,L,0,0
143164,),0,0
143165,",",0,0
143166,and,0,0
143167,247,0,1
143168,+/-,0,0
143169,42,0,1
143170,(,0,0
143171,M,0,0
143172,),0,0
143173,(,0,0
143174,p,0,0
143175,less,0,0
143176,than,0,0
143177,0.05,0,0
143178,),0,0
143179,.,0,0
143180,Times,0,0
143181,to,0,0
143182,discharge,0,0
143183,were,0,0
143184,269,0,1
143185,+/-,0,0
143186,62,0,1
143187,minutes,0,0
143188,(,0,0
143189,C,0,0
143190,),0,0
143191,",",0,0
143192,284,0,1
143193,+/-,0,0
143194,62,0,1
143195,(,0,0
143196,L,0,0
143197,),0,0
143198,",",0,0
143199,and,0,0
143200,357,0,1
143201,+/-,0,0
143202,71,0,1
143203,(,0,0
143204,M,0,0
143205,),0,0
143206,.,0,0
143207,The,0,0
143208,time,0,0
143209,to,0,0
143210,discharge,0,0
143211,with,0,0
143212,M,0,0
143213,",",0,0
143214,almost,0,0
143215,six,0,0
143216,hours,0,0
143217,",",0,0
143218,was,0,0
143219,significantly,0,0
143220,longer,0,0
143221,than,0,0
143222,with,0,1
143223,C,0,0
143224,or,0,0
143225,L.,0,0
143226,There,0,0
143227,was,0,0
143228,a,0,0
143229,trend,0,0
143230,to,0,0
143231,an,0,0
143232,increasing,0,0
143233,rate,0,0
143234,of,0,0
143235,unplanned,0,0
143236,overnight,0,0
143237,hospital,0,1
143238,admission,0,0
143239,with,0,0
143240,increasing,0,0
143241,duration,0,0
143242,of,0,0
143243,the,0,0
143244,local,0,0
143245,anesthetic,0,0
143246,drug,0,0
143247,employed,0,0
143248,.,0,0
143249,Continuous,0,0
143250,epidural,0,0
143251,anesthesia,0,0
143252,with,0,1
143253,C,0,0
143254,",",0,0
143255,L,0,0
143256,or,0,0
143257,M,0,0
143258,appears,0,0
143259,safe,0,0
143260,and,0,0
143261,effective,0,0
143262,for,0,0
143263,outpatient,0,1
143264,surgical,0,1
143265,procedures,0,1
143266,such,0,0
143267,as,0,0
143268,ESWL,0,0
143269,.,0,0
143270,In,0,0
143271,contrast,0,0
143272,to,0,0
143273,previous,0,0
143274,understanding,0,0
143275,",",0,0
143276,mepivacaine,0,0
143277,produces,0,0
143278,significantly,0,0
143279,longer,0,0
143280,anesthesia,0,0
143281,and,0,0
143282,recovery,0,0
143283,times,0,0
143284,and,0,0
143285,may,0,0
143286,not,0,0
143287,be,0,0
143288,optimal,0,0
143289,for,0,0
143290,outpatient,0,1
143291,epidural,0,1
143292,use,0,0
143293,.,0,0
143294,Celecoxib,0,0
143295,as,0,0
143296,adjunctive,0,0
143297,treatment,0,0
143298,to,0,0
143299,risperidone,0,0
143300,in,0,0
143301,children,1,1
143302,with,1,1
143303,autistic,1,1
143304,disorder,1,1
143305,:,1,1
143306,a,0,0
143307,randomized,0,0
143308,",",0,0
143309,double-blind,0,0
143310,",",0,0
143311,placebo-controlled,0,0
143312,trial,0,0
143313,.,0,0
143314,RATIONAL,0,0
143315,Autism,0,1
143316,is,0,0
143317,associated,0,0
143318,with,0,0
143319,activation,0,0
143320,of,0,0
143321,the,0,0
143322,inflammatory,0,0
143323,response,0,0
143324,system,0,0
143325,.,0,0
143326,OBJECTIVE,0,0
143327,This,0,0
143328,study,0,0
143329,aims,0,0
143330,to,0,0
143331,assess,0,0
143332,the,0,0
143333,efficacy,0,0
143334,of,0,0
143335,a,0,0
143336,cyclooxygenase-2,0,0
143337,inhibitor,0,0
143338,",",0,0
143339,celecoxib,0,0
143340,",",0,0
143341,as,0,0
143342,adjunctive,0,0
143343,therapy,0,0
143344,in,0,0
143345,the,0,0
143346,treatment,0,0
143347,of,0,0
143348,autism,0,1
143349,METHODS,0,0
143350,In,0,0
143351,a,0,0
143352,10-week,0,0
143353,randomized,0,0
143354,double-blind,0,0
143355,placebo-controlled,0,0
143356,study,0,0
143357,",",0,0
143358,40,1,1
143359,outpatient,1,1
143360,children,1,1
143361,with,1,1
143362,a,1,0
143363,Diagnostic,1,0
143364,and,1,0
143365,Statistical,1,0
143366,Manual,1,0
143367,of,1,0
143368,Mental,1,0
143369,Disorders,1,1
143370,",",1,0
143371,fourth,1,0
143372,edition,1,0
143373,",",1,0
143374,text,1,0
143375,revision,1,0
143376,clinical,1,0
143377,diagnosis,1,1
143378,of,1,0
143379,autism,1,1
143380,were,0,0
143381,randomly,0,0
143382,allocated,0,0
143383,to,0,0
143384,celecoxib,0,0
143385,plus,0,0
143386,risperidone,0,0
143387,or,0,0
143388,placebo,0,0
143389,plus,0,0
143390,risperidone,0,0
143391,.,0,0
143392,The,0,0
143393,dose,0,0
143394,of,0,0
143395,risperidone,0,0
143396,and,0,0
143397,celecoxib,0,0
143398,were,0,0
143399,titrated,0,0
143400,up,0,0
143401,to,0,0
143402,3,0,0
143403,and,0,0
143404,300,0,0
143405,mg/day,0,0
143406,",",0,0
143407,respectively,0,0
143408,.,0,0
143409,Patients,0,0
143410,were,0,0
143411,assessed,0,0
143412,at,0,0
143413,baseline,0,0
143414,and,0,0
143415,after,0,0
143416,2,0,0
143417,",",0,0
143418,4,0,0
143419,",",0,0
143420,6,0,0
143421,",",0,0
143422,and,0,0
143423,10,0,0
143424,weeks,0,0
143425,of,0,0
143426,starting,0,0
143427,medication,0,0
143428,using,0,0
143429,the,0,0
143430,Aberrant,0,0
143431,Behavior,0,0
143432,Checklist-Community,0,0
143433,(,0,0
143434,ABC-C,0,0
143435,),0,0
143436,Rating,0,0
143437,Scale,0,0
143438,.,0,1
143439,Primary,0,0
143440,outcome,0,0
143441,measure,0,0
143442,was,0,0
143443,the,0,0
143444,change,0,0
143445,in,0,0
143446,irritability,0,0
143447,subscale,0,0
143448,of,0,0
143449,ABC-C,0,0
143450,.,0,0
143451,RESULTS,0,0
143452,Significant,0,0
143453,time,0,0
143454,?,0,0
143455,treatment,0,0
143456,interaction,0,0
143457,was,0,0
143458,observed,0,0
143459,for,0,0
143460,Irritability,0,0
143461,(,0,0
143462,F,0,0
143463,(,0,0
143464,1.658,0,0
143465,",",0,0
143466,63.021,0,0
143467,),0,0
143468,=,0,0
143469,13.580,0,0
143470,",",0,0
143471,P,0,0
143472,<,0,0
143473,0.001,0,0
143474,),0,0
143475,",",0,0
143476,Lethargy/Social,0,0
143477,Withdrawal,0,1
143478,(,0,0
143479,F,0,0
143480,(,0,0
143481,1.948,0,0
143482,",",0,0
143483,74.032,0,0
143484,),0,0
143485,=,0,0
143486,16.811,0,0
143487,",",0,0
143488,P,0,0
143489,<,0,0
143490,0.001,0,0
143491,),0,0
143492,",",0,0
143493,and,0,0
143494,Stereotypic,0,0
143495,Behavior,0,0
143496,(,0,0
143497,F,0,0
143498,(,0,0
143499,1.742,0,0
143500,",",0,0
143501,66.198,0,0
143502,),0,0
143503,=,0,0
143504,12.104,0,0
143505,",",0,0
143506,P,0,0
143507,<,0,0
143508,0.001,0,0
143509,),0,0
143510,",",0,0
143511,but,0,0
143512,not,0,0
143513,for,0,0
143514,Hyperactivity/Noncompliance,0,0
143515,(,0,0
143516,F,0,0
143517,(,0,0
143518,2.564,0,0
143519,",",0,0
143520,97.424,0,0
143521,),0,0
143522,=,0,0
143523,1.469,0,0
143524,",",0,0
143525,P,0,0
143526,=,0,0
143527,0.232,0,0
143528,),0,0
143529,",",0,0
143530,and,0,0
143531,Inappropriate,0,0
143532,Speech,0,0
143533,subscales,0,0
143534,(,0,0
143535,F,0,0
143536,(,0,0
143537,1.607,0,0
143538,",",0,0
143539,61.075,0,0
143540,),0,0
143541,=,0,0
143542,0.173,0,0
143543,",",0,0
143544,P,0,0
143545,=,0,0
143546,0.794,0,0
143547,),0,0
143548,.,0,0
143549,By,0,0
143550,week,0,0
143551,10,0,0
143552,",",0,0
143553,patients,0,1
143554,in,0,0
143555,the,0,0
143556,celecoxib,0,0
143557,group,0,0
143558,showed,0,0
143559,significantly,0,0
143560,greater,0,0
143561,improvement,0,0
143562,in,0,0
143563,the,0,0
143564,Irritability,0,0
143565,(,0,0
143566,P,0,0
143567,<,0,0
143568,0.001,0,0
143569,),0,0
143570,",",0,0
143571,Lethargy/Social,0,0
143572,Withdrawal,0,1
143573,(,0,0
143574,P,0,0
143575,<,0,0
143576,0.001,0,0
143577,),0,0
143578,",",0,0
143579,and,0,0
143580,Stereotypic,0,0
143581,Behavior,0,0
143582,(,0,0
143583,P,0,0
143584,<,0,0
143585,0.00,0,0
143586,),0,0
143587,but,0,0
143588,not,0,0
143589,in,0,0
143590,Hyperactivity/Noncompliance,0,0
143591,(,0,0
143592,P,0,0
143593,=,0,0
143594,0.202,0,0
143595,),0,0
143596,and,0,0
143597,Inappropriate,0,0
143598,Speech,0,0
143599,(,0,0
143600,P,0,0
143601,=,0,0
143602,0.802,0,0
143603,),0,0
143604,subscales,0,0
143605,than,0,0
143606,the,0,0
143607,placebo,0,0
143608,group,0,0
143609,.,0,0
143610,Complete,0,0
143611,response,0,0
143612,was,0,0
143613,achieved,0,0
143614,by,0,0
143615,four,0,0
143616,(,0,0
143617,20,0,0
143618,%,0,0
143619,),0,0
143620,patients,0,1
143621,in,0,0
143622,the,0,0
143623,placebo,0,0
143624,group,0,0
143625,and,0,0
143626,11,0,0
143627,(,0,0
143628,55,0,1
143629,%,0,0
143630,),0,0
143631,patients,0,1
143632,in,0,0
143633,the,0,0
143634,celecoxib,0,0
143635,group,0,0
143636,(,0,0
143637,?,0,0
143638,(,0,0
143639,2,0,0
143640,),0,0
143641,(,0,0
143642,1,0,0
143643,),0,0
143644,=,0,0
143645,5.227,0,0
143646,",",0,0
143647,P,0,0
143648,=,0,0
143649,0.022,0,0
143650,),0,0
143651,.,0,0
143652,Frequency,0,0
143653,of,0,0
143654,side,0,0
143655,effects,0,0
143656,was,0,0
143657,similar,0,0
143658,between,0,0
143659,the,0,0
143660,two,0,0
143661,groups,0,0
143662,.,0,1
143663,CONCLUSIONS,0,0
143664,Combination,0,0
143665,of,0,0
143666,risperidone,0,0
143667,and,0,0
143668,celecoxib,0,0
143669,was,0,0
143670,superior,0,0
143671,to,0,0
143672,risperidone,0,0
143673,alone,0,0
143674,in,0,0
143675,treating,0,0
143676,irritability,0,0
143677,",",0,0
143678,social,0,0
143679,withdrawal,0,0
143680,",",0,0
143681,and,0,0
143682,stereotypy,1,0
143683,of,1,0
143684,children,1,1
143685,with,1,1
143686,autism,1,1
143687,.,1,0
143688,(,0,0
143689,Registration,0,0
143690,",",0,0
143691,www.irct.ir,0,0
143692,;,0,0
143693,IRCT138711091556N2,0,0
143694,),0,0
143695,.,0,0
143696,The,0,0
143697,impact,0,0
143698,of,0,0
143699,patient,0,0
143700,and,0,0
143701,physician,0,0
143702,computer,0,0
143703,mediated,0,0
143704,communication,0,0
143705,skill,0,0
143706,training,0,0
143707,on,0,0
143708,reported,0,0
143709,communication,0,0
143710,and,0,0
143711,patient,0,0
143712,satisfaction,0,0
143713,.,0,0
143714,OBJECTIVE,0,0
143715,The,0,0
143716,objective,0,0
143717,was,0,0
143718,to,0,0
143719,evaluate,0,0
143720,parallel,0,0
143721,patient,0,0
143722,and,0,0
143723,physician,0,0
143724,computer-mediated,0,0
143725,communication,0,0
143726,skill,0,0
143727,training,0,0
143728,on,0,0
143729,participants,0,1
143730,',0,1
143731,report,0,0
143732,of,0,0
143733,skill,0,0
143734,use,0,0
143735,and,0,0
143736,patient,0,0
143737,satisfaction,0,0
143738,.,0,0
143739,METHODS,0,0
143740,Separate,0,0
143741,patient,0,0
143742,and,0,0
143743,clinician,0,0
143744,web-tools,0,0
143745,comprised,0,1
143746,of,0,0
143747,over,0,0
143748,500,0,0
143749,",",0,0
143750,10-s,0,0
143751,video,0,0
143752,clips,0,0
143753,demonstrating,0,0
143754,patient-centered,0,0
143755,skills,0,0
143756,in,0,0
143757,various,0,0
143758,ways,0,0
143759,.,0,1
143760,Four,1,0
143761,clinician,1,0
143762,members,1,1
143763,of,1,0
143764,the,1,0
143765,American,1,1
143766,Academy,1,1
143767,of,1,0
143768,Family,1,0
143769,Physicians,1,1
143770,National,1,0
143771,Research,1,0
143772,Network,1,0
143773,participated,1,1
143774,by,1,0
143775,enrolling,1,1
143776,194,1,1
143777,patients,1,1
143778,into,1,1
143779,a,1,0
143780,randomized,1,0
143781,patient,1,0
143782,trial,1,0
143783,and,1,0
143784,29,1,1
143785,physicians,1,1
143786,into,1,1
143787,a,1,0
143788,non-randomized,1,0
143789,clinician,1,0
143790,trial,1,0
143791,of,1,0
143792,respective,1,0
143793,interventions,1,0
143794,.,1,1
143795,All,0,0
143796,participants,0,0
143797,completed,0,1
143798,baseline,0,0
143799,and,0,0
143800,follow-up,0,0
143801,self-report,0,0
143802,measures,0,0
143803,of,0,0
143804,visit,0,0
143805,communication,0,0
143806,and,0,0
143807,satisfaction,0,0
143808,.,0,0
143809,RESULTS,0,0
143810,Intervention,0,0
143811,patients,0,1
143812,reported,0,0
143813,using,0,0
143814,more,0,0
143815,skills,0,0
143816,than,0,0
143817,controls,0,1
143818,in,0,0
143819,five,0,1
143820,of,0,0
143821,six,0,1
143822,skill,0,0
143823,areas,0,0
143824,",",0,0
143825,including,0,0
143826,identification,0,0
143827,of,0,0
143828,problems/concerns,0,0
143829,",",0,0
143830,information,0,0
143831,exchange,0,0
143832,",",0,0
143833,treatment,0,0
143834,adherence,0,0
143835,",",0,0
143836,shared,0,0
143837,decision-making,0,0
143838,and,0,0
143839,interpersonal,0,0
143840,rapport,0,0
143841,(,0,0
143842,all,0,0
143843,p,0,0
143844,<,0,0
143845,.05,0,0
143846,),0,0
143847,;,0,0
143848,post,0,0
143849,intervention,0,0
143850,",",0,0
143851,physicians,0,0
143852,reported,0,0
143853,using,0,0
143854,more,0,0
143855,skills,0,0
143856,in,0,0
143857,the,0,0
143858,same,0,0
143859,5,0,0
143860,areas,0,0
143861,(,0,0
143862,all,0,0
143863,p,0,0
143864,<,0,0
143865,.01,0,0
143866,),0,0
143867,.,0,0
143868,Intervention,0,0
143869,group,0,0
143870,patients,0,1
143871,reported,0,0
143872,higher,0,0
143873,levels,0,0
143874,of,0,0
143875,satisfaction,0,0
143876,than,0,0
143877,controls,0,0
143878,in,0,0
143879,five,0,1
143880,of,0,0
143881,six,0,1
143882,domains,0,0
143883,(,0,0
143884,all,0,0
143885,p,0,0
143886,<,0,0
143887,.05,0,0
143888,),0,0
143889,.,0,0
143890,CONCLUSION,0,0
143891,Communication,0,0
143892,skill,0,0
143893,training,0,0
143894,delivered,0,0
143895,in,0,0
143896,a,0,0
143897,computer,0,0
143898,mediated,0,0
143899,format,0,0
143900,had,0,0
143901,a,0,0
143902,positive,0,0
143903,and,0,0
143904,parallel,0,0
143905,impact,0,0
143906,on,0,0
143907,both,0,0
143908,patient,0,0
143909,and,0,0
143910,clinician,0,0
143911,reported,0,0
143912,use,0,0
143913,of,0,0
143914,patient-centered,0,0
143915,communication,0,0
143916,and,0,0
143917,in,0,0
143918,patient,0,0
143919,satisfaction,0,0
143920,.,0,0
143921,PRACTICE,0,0
143922,IMPLICATIONS,0,0
143923,Computer-mediated,0,0
143924,interventions,0,0
143925,are,0,0
143926,cost,0,0
143927,and,0,0
143928,time,0,0
143929,effective,0,0
143930,thereby,0,0
143931,increasing,0,0
143932,patient,0,0
143933,and,0,0
143934,clinician,0,0
143935,willingness,0,0
143936,to,0,0
143937,undertake,0,0
143938,training,0,0
143939,.,0,0
143940,A,0,0
143941,six-month,0,0
143942,crossover,0,0
143943,chemoprevention,0,0
143944,clinical,0,0
143945,trial,0,0
143946,of,0,0
143947,tea,0,0
143948,in,0,0
143949,smokers,1,1
143950,and,1,1
143951,non-smokers,1,1
143952,:,1,1
143953,methodological,0,0
143954,issues,0,0
143955,in,0,0
143956,a,0,0
143957,feasibility,0,0
143958,study,0,0
143959,.,0,0
143960,BACKGROUND,0,0
143961,Chemoprevention,0,0
143962,crossover,0,0
143963,trials,0,0
143964,of,0,0
143965,tea,0,0
143966,can,0,0
143967,be,0,0
143968,more,0,0
143969,efficient,0,0
143970,than,0,0
143971,parallel,0,0
143972,designs,0,0
143973,but,0,0
143974,the,0,0
143975,attrition,0,0
143976,and,0,0
143977,compliance,0,0
143978,rates,0,0
143979,with,0,1
143980,such,0,0
143981,trials,0,0
143982,are,0,0
143983,unknown,0,0
143984,.,0,0
143985,METHODS,0,0
143986,Attrition,0,0
143987,(,0,0
143988,dropouts,0,0
143989,),0,0
143990,and,0,0
143991,compliance,0,0
143992,with,0,1
143993,treatment,0,0
143994,were,0,0
143995,assessed,0,0
143996,in,0,0
143997,a,0,0
143998,25-week,0,0
143999,randomized,0,0
144000,",",0,0
144001,placebo,0,0
144002,controlled,0,0
144003,",",0,0
144004,crossover,0,0
144005,",",0,0
144006,feasibility,0,0
144007,clinical,0,0
144008,trial,0,0
144009,of,0,0
144010,four,0,0
144011,tea,0,1
144012,treatments,0,0
144013,to,0,0
144014,investigate,0,0
144015,the,0,0
144016,effect,0,0
144017,of,0,0
144018,tea,0,0
144019,on,0,0
144020,oral,0,0
144021,cancer,0,1
144022,biomarkers,0,0
144023,.,0,0
144024,Each,0,0
144025,treatment,0,0
144026,lasted,0,0
144027,4,0,0
144028,weeks,0,0
144029,with,0,1
144030,2,0,1
144031,weeks,0,0
144032,of,0,0
144033,washout,0,0
144034,in,0,0
144035,between,0,0
144036,.,0,1
144037,Participants,0,1
144038,were,0,0
144039,32,1,1
144040,smokers,1,1
144041,and,1,0
144042,33,1,1
144043,non-smokers,1,1
144044,without,1,1
144045,any,1,0
144046,evidence,1,0
144047,of,1,0
144048,premalignant,1,1
144049,oral,1,0
144050,lesions,1,1
144051,.,1,1
144052,The,1,0
144053,interventions,0,0
144054,consisted,0,0
144055,of,0,0
144056,packets,0,0
144057,of,0,0
144058,green,0,0
144059,tea,0,0
144060,",",0,0
144061,black,0,1
144062,tea,0,0
144063,",",0,0
144064,caffeinated,0,0
144065,water,0,0
144066,",",0,0
144067,or,0,0
144068,placebo,0,0
144069,.,0,0
144070,Participants,0,1
144071,were,0,0
144072,assigned,0,0
144073,to,0,0
144074,each,0,0
144075,treatment,0,0
144076,for,0,0
144077,four,0,0
144078,weeks,0,0
144079,",",0,0
144080,and,0,0
144081,were,0,0
144082,instructed,0,0
144083,to,0,0
144084,drink,0,0
144085,five,0,0
144086,packets,0,0
144087,per,0,0
144088,day,0,0
144089,while,0,0
144090,on,0,0
144091,the,0,0
144092,treatment,0,0
144093,.,0,0
144094,Dropout,0,0
144095,from,0,0
144096,the,0,0
144097,trial,0,0
144098,and,0,0
144099,compliance,0,0
144100,(,0,0
144101,consumption,0,0
144102,of,0,0
144103,?85,0,0
144104,%,0,0
144105,of,0,0
144106,the,0,0
144107,prescribed,0,0
144108,treatment,0,0
144109,packets,0,0
144110,),0,0
144111,are,0,0
144112,the,0,0
144113,main,0,0
144114,outcome,0,0
144115,measures,0,0
144116,reported,0,0
144117,.,0,0
144118,RESULTS,0,0
144119,There,0,0
144120,was,0,0
144121,a,0,0
144122,high,0,0
144123,rate,0,0
144124,of,0,0
144125,dropout,0,0
144126,(,0,0
144127,51,0,0
144128,%,0,0
144129,),0,0
144130,from,0,0
144131,the,0,0
144132,study,0,0
144133,",",0,0
144134,and,0,0
144135,the,0,0
144136,rates,0,0
144137,were,0,0
144138,significantly,0,0
144139,higher,0,0
144140,among,0,0
144141,smokers,0,1
144142,(,0,0
144143,64,0,0
144144,%,0,0
144145,),0,0
144146,than,0,0
144147,non-smokers,0,1
144148,(,0,0
144149,36,0,1
144150,%,0,0
144151,),0,0
144152,.,0,0
144153,Among,0,1
144154,participants,0,1
144155,who,0,1
144156,completed,0,1
144157,the,0,1
144158,study,0,0
144159,the,0,0
144160,rate,0,0
144161,of,0,0
144162,compliance,0,0
144163,was,0,0
144164,72,0,0
144165,%,0,0
144166,.,0,0
144167,The,0,0
144168,highest,0,0
144169,rates,0,0
144170,of,0,0
144171,dropouts,0,0
144172,occurred,0,0
144173,between,0,0
144174,the,0,0
144175,first,0,0
144176,and,0,0
144177,second,0,0
144178,treatment,0,0
144179,visits,0,0
144180,in,0,0
144181,both,0,0
144182,smokers,0,1
144183,(,0,0
144184,38,0,1
144185,%,0,0
144186,dropout,0,0
144187,),0,0
144188,and,0,0
144189,non-smokers,0,1
144190,(,0,0
144191,18,0,1
144192,%,0,0
144193,dropout,0,0
144194,),0,0
144195,.,0,0
144196,Throughout,0,0
144197,the,0,0
144198,study,0,0
144199,smokers,0,0
144200,were,0,0
144201,more,0,0
144202,likely,0,0
144203,to,0,0
144204,dropout,0,0
144205,than,0,0
144206,non-smokers,0,1
144207,.,0,1
144208,Black,0,0
144209,tea,0,0
144210,treatment,0,0
144211,was,0,0
144212,associated,0,0
144213,with,0,0
144214,the,0,0
144215,highest,0,0
144216,rates,0,0
144217,of,0,0
144218,dropout,0,0
144219,among,0,0
144220,smokers,0,1
144221,(,0,0
144222,37,0,1
144223,%,0,0
144224,),0,0
144225,",",0,0
144226,but,0,0
144227,was,0,0
144228,associated,0,0
144229,with,0,0
144230,the,0,0
144231,lowest,0,0
144232,rate,0,0
144233,of,0,0
144234,dropout,0,0
144235,among,0,0
144236,non-smokers,0,1
144237,(,0,0
144238,4,0,0
144239,%,0,0
144240,),0,0
144241,.,0,0
144242,CONCLUSIONS,0,0
144243,In,0,0
144244,a,0,0
144245,study,0,0
144246,conducted,0,0
144247,to,0,0
144248,test,0,0
144249,the,0,0
144250,feasibility,0,0
144251,of,0,0
144252,a,0,0
144253,four-treatment,0,0
144254,crossover,0,0
144255,tea,0,0
144256,trial,0,0
144257,",",0,0
144258,a,0,0
144259,high,0,0
144260,rate,0,0
144261,of,0,0
144262,dropout,0,0
144263,among,0,0
144264,smokers,0,1
144265,and,0,0
144266,non-smokers,0,1
144267,was,0,0
144268,observed,0,0
144269,.,0,0
144270,Multi-arm,0,0
144271,crossover,0,0
144272,tea,0,0
144273,trials,0,0
144274,might,0,0
144275,pose,0,0
144276,a,0,0
144277,higher,0,0
144278,burden,0,0
144279,on,0,0
144280,participants,0,1
144281,and,0,0
144282,research,0,0
144283,is,0,0
144284,needed,0,0
144285,to,0,0
144286,improve,0,0
144287,adherence,0,0
144288,and,0,0
144289,treatment,0,0
144290,compliance,0,0
144291,in,0,0
144292,such,0,0
144293,trials,0,0
144294,.,0,1
144295,TRIAL,0,0
144296,REGISTRATION,0,0
144297,NUMBER,0,0
144298,ISRCTN70410203,0,0
144299,.,0,0
144300,Promoting,0,0
144301,physical,0,0
144302,activity,0,0
144303,in,0,0
144304,patients,1,1
144305,with,1,1
144306,colon,1,1
144307,adenomas,1,1
144308,:,1,0
144309,a,0,0
144310,randomized,0,0
144311,pilot,0,0
144312,intervention,0,0
144313,trial,0,0
144314,.,0,0
144315,BACKGROUND,0,0
144316,Physical,0,0
144317,activity,0,0
144318,decreases,0,0
144319,risk,0,0
144320,of,0,0
144321,colon,0,1
144322,polyps,0,1
144323,and,0,0
144324,colon,0,1
144325,cancer,0,1
144326,and,0,0
144327,might,0,0
144328,reduce,0,0
144329,risk,0,0
144330,of,0,0
144331,colon,0,1
144332,cancer,0,1
144333,recurrence,0,0
144334,.,0,0
144335,Focusing,0,0
144336,on,0,0
144337,recent,0,0
144338,calls,0,0
144339,for,0,0
144340,translation,0,0
144341,of,0,0
144342,epidemiologic,0,0
144343,evidence,0,0
144344,into,0,0
144345,clinical,0,0
144346,care,0,0
144347,",",0,0
144348,our,0,0
144349,pilot,0,0
144350,study,0,0
144351,delivered,0,0
144352,an,0,0
144353,evidence-based,0,0
144354,physical,0,0
144355,activity,0,0
144356,intervention,0,0
144357,in,0,0
144358,adults,1,1
144359,with,1,1
144360,polyps,1,1
144361,",",0,1
144362,who,0,1
144363,are,0,0
144364,thus,0,0
144365,at,0,0
144366,elevated,0,0
144367,risk,0,0
144368,of,0,0
144369,developing,0,0
144370,colon,0,1
144371,cancer,0,1
144372,.,0,0
144373,The,0,0
144374,objective,0,0
144375,was,0,0
144376,to,0,0
144377,evaluate,0,0
144378,change,0,0
144379,in,0,0
144380,physical,0,0
144381,activity,0,0
144382,",",0,0
144383,measured,0,0
144384,by,0,0
144385,steps,0,0
144386,per,0,0
144387,day,0,0
144388,and,0,0
144389,minutes,0,0
144390,of,0,0
144391,moderate/vigorous,0,0
144392,physical,0,0
144393,activity,0,0
144394,.,0,0
144395,METHODS,0,0
144396,Sixteen,1,1
144397,adults,1,1
144398,with,1,1
144399,adenomas,1,1
144400,detected,1,0
144401,and,1,0
144402,removed,1,0
144403,at,1,0
144404,screening,1,1
144405,colonoscopy,1,1
144406,were,0,0
144407,recruited,0,1
144408,to,0,0
144409,a,0,0
144410,12-week,0,0
144411,physical,0,0
144412,activity,0,0
144413,intervention,0,0
144414,.,0,0
144415,Participants,0,1
144416,were,0,0
144417,randomized,0,0
144418,to,0,0
144419,receive,0,0
144420,a,0,0
144421,standard,0,0
144422,(,0,0
144423,30,0,0
144424,minutes/day,0,0
144425,),0,0
144426,or,0,0
144427,high,0,0
144428,(,0,0
144429,60,0,1
144430,minutes/day,0,0
144431,),0,0
144432,walking,0,0
144433,program,0,0
144434,.,0,0
144435,Physical,0,0
144436,activity,0,0
144437,was,0,0
144438,measured,0,0
144439,via,0,0
144440,blinded,0,0
144441,pedometer,0,0
144442,and,0,0
144443,accelerometer,0,0
144444,at,0,0
144445,baseline,0,0
144446,and,0,0
144447,follow-up,0,0
144448,.,0,0
144449,Intervention,0,0
144450,messages,0,0
144451,focused,0,0
144452,on,0,0
144453,self-monitoring,0,0
144454,using,0,0
144455,pedometers,0,0
144456,and,0,0
144457,overcoming,0,0
144458,barriers,0,0
144459,to,0,0
144460,engaging,0,0
144461,in,0,0
144462,physical,0,0
144463,activity,0,0
144464,.,0,0
144465,RESULTS,0,0
144466,Participants,0,1
144467,in,0,0
144468,both,0,0
144469,arms,0,0
144470,significantly,0,0
144471,increased,0,0
144472,objectively,0,0
144473,measured,0,0
144474,minutes,0,0
144475,of,0,0
144476,moderate/vigorous,0,0
144477,physical,0,0
144478,activity,0,0
144479,over,0,0
144480,the,0,0
144481,course,0,0
144482,of,0,0
144483,the,0,0
144484,intervention,0,0
144485,.,0,0
144486,Both,0,0
144487,arms,0,0
144488,exceeded,0,0
144489,the,0,0
144490,intervention,0,0
144491,goal,0,0
144492,",",0,0
144493,but,0,0
144494,there,0,0
144495,was,0,0
144496,not,0,0
144497,a,0,0
144498,significant,0,0
144499,difference,0,0
144500,between,0,0
144501,arms,0,0
144502,at,0,0
144503,follow-up,0,0
144504,.,0,1
144505,Results,0,0
144506,were,0,0
144507,similar,0,0
144508,for,0,0
144509,pedometer,0,0
144510,measured,0,0
144511,physical,0,0
144512,activity,0,0
144513,",",0,0
144514,with,0,0
144515,a,0,0
144516,significant,0,0
144517,overall,0,0
144518,increase,0,0
144519,in,0,0
144520,steps/day,0,0
144521,from,0,0
144522,baseline,0,0
144523,to,0,0
144524,follow-up,0,0
144525,",",0,0
144526,but,0,0
144527,no,0,0
144528,between,0,0
144529,arm,0,0
144530,difference,0,0
144531,in,0,0
144532,change,0,0
144533,.,0,0
144534,CONCLUSION,0,0
144535,Simple,0,0
144536,interventions,0,0
144537,of,0,0
144538,minimal,0,0
144539,contact,0,0
144540,time,0,0
144541,focusing,0,0
144542,on,0,0
144543,walking,0,0
144544,can,0,0
144545,significantly,0,0
144546,increase,0,0
144547,physical,0,0
144548,activity,0,0
144549,in,0,0
144550,individuals,0,1
144551,at,0,0
144552,increased,0,0
144553,risk,0,0
144554,of,0,0
144555,developing,0,0
144556,colon,0,1
144557,cancer,0,1
144558,.,0,0
144559,TRIAL,0,0
144560,REGISTRATION,0,0
144561,ClinicalTrials.gov,0,0
144562,NCT01476631,0,0
144563,.,0,0
144564,Direct,0,0
144565,renin,0,0
144566,inhibition,0,0
144567,improves,0,0
144568,parasympathetic,0,0
144569,function,0,0
144570,in,0,0
144571,diabetes,1,1
144572,.,1,0
144573,AIM,0,0
144574,The,0,0
144575,renin-angiotensin-aldosterone,0,0
144576,system,0,0
144577,(,0,0
144578,RAAS,0,0
144579,),0,0
144580,and,0,0
144581,autonomic,0,0
144582,nervous,0,0
144583,system,0,0
144584,regulate,0,0
144585,the,0,0
144586,cardiovascular,0,0
144587,system,0,0
144588,.,0,0
144589,Blockade,0,0
144590,of,0,0
144591,the,0,0
144592,RAAS,0,0
144593,may,0,0
144594,slow,0,0
144595,the,0,0
144596,progression,0,0
144597,of,0,0
144598,end-organ,0,0
144599,damage,0,0
144600,.,0,0
144601,Direct,0,0
144602,renin,0,0
144603,inhibition,0,0
144604,offers,0,0
144605,a,0,0
144606,means,0,0
144607,for,0,0
144608,blocking,0,0
144609,the,0,0
144610,RAAS,0,0
144611,.,0,0
144612,The,0,0
144613,objective,0,0
144614,of,0,0
144615,this,0,0
144616,study,0,0
144617,was,0,0
144618,to,0,0
144619,examine,0,0
144620,the,0,0
144621,effect,0,0
144622,of,0,0
144623,direct,0,0
144624,renin,0,0
144625,inhibition,0,0
144626,on,0,0
144627,cardiovascular,0,0
144628,autonomic,0,0
144629,function,0,0
144630,.,0,0
144631,METHODS,0,0
144632,In,0,0
144633,this,0,0
144634,double-blind,0,0
144635,",",0,0
144636,placebo-controlled,0,0
144637,trial,0,0
144638,",",0,0
144639,60,1,1
144640,individuals,1,1
144641,with,1,1
144642,diabetes,1,1
144643,were,0,0
144644,randomly,0,1
144645,assigned,0,0
144646,to,0,0
144647,300,0,0
144648,mg,0,0
144649,of,0,0
144650,aliskiren,0,0
144651,or,0,0
144652,placebo,0,0
144653,once,0,0
144654,daily,0,0
144655,for,0,0
144656,6,0,0
144657,weeks,0,0
144658,.,0,0
144659,The,0,0
144660,primary,0,0
144661,end,0,0
144662,point,0,0
144663,was,0,0
144664,a,0,0
144665,change,0,0
144666,in,0,0
144667,tests,0,0
144668,of,0,0
144669,cardiovascular,0,1
144670,autonomic,0,0
144671,function,0,0
144672,.,0,0
144673,Autonomic,0,0
144674,function,0,0
144675,was,0,0
144676,assessed,0,0
144677,by,0,0
144678,power,0,0
144679,spectral,0,0
144680,analysis,0,0
144681,and,0,0
144682,RR-variation,0,0
144683,during,0,0
144684,deep,0,0
144685,breathing,0,0
144686,[,0,0
144687,i.e,0,0
144688,.,0,0
144689,mean,0,0
144690,circular,0,0
144691,resultant,0,0
144692,(,0,0
144693,MCR,0,0
144694,),0,0
144695,",",0,0
144696,expiration/inspiration,0,0
144697,(,0,0
144698,E/I,0,1
144699,),0,0
144700,ratio,0,0
144701,],0,0
144702,.,0,0
144703,The,0,0
144704,MCR,0,0
144705,and,0,0
144706,E/I,0,1
144707,ratio,0,0
144708,assess,0,0
144709,parasympathetic,0,0
144710,function,0,0
144711,.,0,0
144712,Secondary,0,0
144713,measures,0,0
144714,included,0,1
144715,change,0,0
144716,in,0,0
144717,biochemical,0,0
144718,parameters,0,0
144719,[,0,0
144720,e.g,0,0
144721,.,0,0
144722,plasma,0,0
144723,renin,0,0
144724,activity,0,0
144725,",",0,0
144726,leptin,0,0
144727,and,0,0
144728,interleukin-6,0,0
144729,],0,0
144730,.,0,0
144731,Change,0,0
144732,in,0,0
144733,cardiovascular,0,0
144734,autonomic,0,0
144735,function,0,0
144736,and,0,0
144737,blood,0,0
144738,analytes,0,0
144739,were,0,0
144740,analysed,0,0
144741,by,0,0
144742,a,0,0
144743,mixed,0,0
144744,effects,0,0
144745,model,0,0
144746,for,0,0
144747,repeated,0,0
144748,measures,0,0
144749,.,0,1
144750,RESULTS,0,0
144751,Baseline,0,0
144752,characteristics,0,0
144753,were,0,0
144754,similar,0,0
144755,between,0,0
144756,treatment,0,0
144757,groups,0,0
144758,.,0,0
144759,In,0,0
144760,response,0,0
144761,to,0,0
144762,aliskiren,0,0
144763,compared,0,0
144764,with,0,1
144765,placebo,0,0
144766,",",0,0
144767,blood,0,0
144768,pressure,0,0
144769,was,0,0
144770,reduced,0,0
144771,as,0,0
144772,well,0,0
144773,as,0,0
144774,plasma,0,0
144775,renin,0,0
144776,activity,0,0
144777,[,0,0
144778,from,0,0
144779,2.4,0,0
144780,?,0,0
144781,3.8,0,0
144782,(,0,0
144783,mean,0,0
144784,?,0,0
144785,standard,0,0
144786,deviation,0,0
144787,),0,0
144788,to,0,0
144789,0.5,0,0
144790,?,0,0
144791,0.4,0,0
144792,?g/l/h,0,0
144793,",",0,0
144794,p,0,0
144795,<,0,0
144796,0.001,0,0
144797,],0,0
144798,.,0,0
144799,There,0,0
144800,was,0,0
144801,a,0,0
144802,significant,0,0
144803,interaction,0,0
144804,(,0,0
144805,aliskiren,0,0
144806,?,0,0
144807,visit,0,0
144808,),0,0
144809,for,0,0
144810,MCR,0,0
144811,(,0,0
144812,p,0,0
144813,=,0,0
144814,0.003,0,0
144815,),0,0
144816,and,0,0
144817,E/I,0,1
144818,ratio,0,0
144819,(,0,0
144820,p,0,0
144821,=,0,0
144822,0.003,0,0
144823,),0,0
144824,indicating,0,0
144825,improvement,0,0
144826,in,0,0
144827,MCR,0,0
144828,and,0,0
144829,E/I,0,1
144830,ratio,0,0
144831,for,0,0
144832,those,0,0
144833,on,0,0
144834,aliskiren,0,0
144835,.,0,0
144836,MCR,0,0
144837,means,0,0
144838,",",0,0
144839,baseline,0,0
144840,vs.,0,0
144841,follow-up,0,0
144842,",",0,0
144843,were,0,0
144844,41.8,0,0
144845,?,0,0
144846,19.7,0,0
144847,vs.,0,0
144848,50.8,0,0
144849,?,0,0
144850,26.1,0,0
144851,(,0,0
144852,aliskiren,0,0
144853,),0,0
144854,and,0,0
144855,38.2,0,0
144856,?,0,0
144857,23.6,0,0
144858,vs.,0,0
144859,37.5,0,0
144860,?,0,0
144861,24.1,0,0
144862,(,0,0
144863,placebo,0,0
144864,),0,0
144865,.,0,0
144866,CONCLUSIONS,0,0
144867,Parasympathetic,0,0
144868,function,0,0
144869,(,0,0
144870,i.e,0,0
144871,.,0,0
144872,MCR,0,0
144873,and,0,0
144874,E/I,0,1
144875,ratio,0,0
144876,),0,0
144877,was,0,0
144878,enhanced,0,0
144879,by,0,0
144880,downregulation,0,0
144881,of,0,0
144882,the,0,0
144883,RAAS,0,0
144884,.,0,0
144885,[,0,0
144886,Photoplethysmographic,0,0
144887,evaluation,0,0
144888,of,0,0
144889,the,0,0
144890,effect,0,0
144891,of,0,0
144892,a,0,0
144893,vascular,1,0
144894,tonic,1,0
144895,drug,1,0
144896,],1,0
144897,.,0,0
144898,A,0,0
144899,comparative,0,0
144900,study,0,0
144901,of,0,0
144902,ofloxacin,0,0
144903,and,0,0
144904,amoxycillin/clavulanate,0,0
144905,in,0,0
144906,hospitalized,1,1
144907,patients,1,1
144908,with,1,1
144909,lower,1,0
144910,respiratory,1,0
144911,tract,1,1
144912,infections,1,0
144913,.,1,1
144914,We,0,0
144915,conducted,0,0
144916,an,0,0
144917,open,0,0
144918,randomized,0,0
144919,trial,0,0
144920,to,0,0
144921,compare,0,0
144922,the,0,0
144923,efficacy,0,0
144924,of,0,0
144925,parenteral,0,1
144926,and,0,0
144927,oral,0,0
144928,ofloxacin,0,0
144929,with,0,0
144930,that,0,0
144931,of,0,0
144932,amoxycillin/clavulanate,0,0
144933,.,0,0
144934,A,0,0
144935,total,0,0
144936,of,0,0
144937,121,1,1
144938,patients,1,1
144939,was,1,0
144940,studied,1,1
144941,;,1,0
144942,92,1,0
144943,were,1,0
144944,clinically,1,0
144945,evaluable,1,1
144946,.,1,0
144947,Of,0,0
144948,these,0,0
144949,",",0,0
144950,59,1,0
144951,patients,1,1
144952,were,1,0
144953,treated,1,1
144954,with,1,0
144955,ofloxacin,1,0
144956,and,1,0
144957,33,1,1
144958,with,1,0
144959,the,1,0
144960,comparator,1,0
144961,drug,1,0
144962,.,1,0
144963,Patients,0,1
144964,were,0,0
144965,given,0,0
144966,the,0,0
144967,drugs,0,0
144968,intravenously,0,0
144969,for,0,0
144970,a,0,0
144971,minimum,0,0
144972,of,0,0
144973,three,0,0
144974,days,0,0
144975,followed,0,0
144976,by,0,0
144977,oral,0,0
144978,preparations,0,0
144979,for,0,0
144980,the,0,0
144981,next,0,0
144982,seven,0,0
144983,to,0,0
144984,ten,0,1
144985,days,0,0
144986,.,0,0
144987,Ofloxacin,0,0
144988,was,0,0
144989,usually,0,0
144990,administered,0,0
144991,as,0,0
144992,a,0,0
144993,200,0,0
144994,mg,0,0
144995,dose,0,0
144996,bd,0,1
144997,.,0,0
144998,In,0,0
144999,the,0,0
145000,ofloxacin,0,0
145001,treated,0,0
145002,group,0,0
145003,all,0,0
145004,patients,0,1
145005,showed,0,0
145006,clinical,0,0
145007,improvement,0,0
145008,.,0,0
145009,In,0,0
145010,the,0,0
145011,comparator,0,0
145012,group,0,0
145013,94,0,0
145014,%,0,0
145015,improved,0,0
145016,clinically,0,0
145017,(,0,0
145018,either,0,0
145019,a,0,0
145020,complete,0,0
145021,or,0,0
145022,partial,0,0
145023,response,0,0
145024,),0,0
145025,",",0,0
145026,while,0,0
145027,6,0,0
145028,%,0,0
145029,were,0,0
145030,clinical,0,0
145031,failures,0,0
145032,.,0,0
145033,Of,0,0
145034,the,0,0
145035,bacteriologically,0,1
145036,evaluable,0,1
145037,patients,0,1
145038,19,0,1
145039,of,0,0
145040,20,0,0
145041,showed,0,0
145042,a,0,0
145043,satisfactory,0,0
145044,bacteriological,0,0
145045,response,0,0
145046,in,0,0
145047,the,0,0
145048,ofloxacin,0,0
145049,treated,0,0
145050,group,0,0
145051,",",0,0
145052,while,0,0
145053,in,0,0
145054,the,0,0
145055,comparator,0,0
145056,group,0,0
145057,the,0,0
145058,bacteriological,0,0
145059,response,0,0
145060,was,0,0
145061,judged,0,0
145062,satisfactory,0,0
145063,in,0,0
145064,14,0,0
145065,of,0,0
145066,17,0,1
145067,patients,0,1
145068,.,0,0
145069,A,0,0
145070,small,0,0
145071,proportion,0,0
145072,of,0,0
145073,patients,0,1
145074,(,0,0
145075,7,0,0
145076,%,0,0
145077,),0,0
145078,treated,0,0
145079,with,0,0
145080,ofloxacin,0,0
145081,suffered,0,1
145082,mild,0,1
145083,adverse,0,0
145084,effects,0,0
145085,(,0,0
145086,nausea,0,0
145087,",",0,0
145088,vomiting,0,0
145089,",",0,0
145090,headache,0,0
145091,",",0,0
145092,hypotension,0,0
145093,and,0,0
145094,rash,0,0
145095,),0,0
145096,.,0,0
145097,On,0,0
145098,the,0,0
145099,whole,0,0
145100,",",0,0
145101,ofloxacin,0,0
145102,was,0,0
145103,well,0,0
145104,tolerated,0,0
145105,by,0,0
145106,our,0,0
145107,patients,0,1
145108,.,0,0
145109,The,0,0
145110,two,0,0
145111,deaths,0,0
145112,that,0,0
145113,occurred,0,0
145114,were,0,0
145115,in,0,0
145116,the,0,0
145117,comparator,0,0
145118,group,0,0
145119,.,0,0
145120,We,0,0
145121,conclude,0,0
145122,that,0,0
145123,ofloxacin,0,0
145124,in,0,0
145125,both,0,0
145126,oral,0,0
145127,and,0,0
145128,parenteral,0,1
145129,forms,0,0
145130,is,0,0
145131,an,0,0
145132,effective,0,0
145133,and,0,0
145134,safe,0,0
145135,drug,0,0
145136,in,0,0
145137,the,0,0
145138,treatment,0,0
145139,of,0,0
145140,lower,0,0
145141,respiratory,0,0
145142,tract,0,1
145143,infections,0,0
145144,.,0,1
145145,Who,0,1
145146,is,0,1
145147,at,0,1
145148,low,0,0
145149,risk,0,0
145150,for,0,0
145151,cardiovascular,0,0
145152,disease,0,1
145153,?,0,0
145154,An,0,0
145155,assessment,0,0
145156,of,0,0
145157,different,0,0
145158,definitions,0,0
145159,.,0,1
145160,BACKGROUND,0,0
145161,There,0,0
145162,is,0,0
145163,little,0,0
145164,information,0,0
145165,regarding,0,0
145166,the,0,0
145167,determinants,0,0
145168,and,0,0
145169,trends,0,0
145170,of,0,0
145171,the,0,0
145172,prevalence,0,0
145173,of,0,0
145174,low,0,0
145175,cardiovascular,0,1
145176,risk,0,0
145177,factor,0,0
145178,(,0,0
145179,RF,0,0
145180,),0,0
145181,profile,0,0
145182,in,0,0
145183,the,0,0
145184,general,1,1
145185,population,1,1
145186,.,1,0
145187,The,0,0
145188,aim,0,0
145189,of,0,0
145190,this,0,0
145191,study,0,0
145192,was,0,0
145193,to,0,0
145194,assess,0,0
145195,the,0,0
145196,prevalence,0,0
145197,and,0,0
145198,trends,0,0
145199,of,0,0
145200,low,0,0
145201,RF,0,0
145202,profile,0,0
145203,in,0,0
145204,the,0,0
145205,Swiss,1,1
145206,population,1,1
145207,according,0,1
145208,to,0,0
145209,different,0,0
145210,definitions,0,0
145211,.,0,1
145212,METHODS,0,0
145213,Population-based,1,0
145214,cross-sectional,1,1
145215,studies,1,0
145216,conducted,1,0
145217,in,1,0
145218,1984-1986,1,1
145219,(,1,0
145220,N=3300,1,0
145221,),1,0
145222,",",1,0
145223,1988-1989,1,1
145224,(,1,0
145225,N=3331,1,0
145226,),1,0
145227,",",1,0
145228,1992-1993,1,1
145229,(,1,0
145230,N=3133,1,0
145231,),1,0
145232,and,1,0
145233,2003-2006,1,1
145234,(,1,0
145235,N=6170,1,0
145236,),1,0
145237,and,1,0
145238,restricted,1,0
145239,to,1,0
145240,age,1,1
145241,group,1,0
145242,35-75,1,1
145243,years,1,1
145244,.,1,0
145245,Seven,0,0
145246,different,0,0
145247,definitions,0,0
145248,of,0,0
145249,low,0,0
145250,RF,0,0
145251,profile,0,0
145252,were,0,0
145253,used,0,0
145254,to,0,0
145255,assess,0,0
145256,determinants,0,0
145257,",",0,0
145258,while,0,0
145259,two,0,0
145260,definitions,0,0
145261,were,0,0
145262,used,0,0
145263,to,0,0
145264,assess,0,0
145265,trends,0,0
145266,.,0,0
145267,RESULTS,0,0
145268,Prevalence,0,1
145269,of,0,0
145270,low,0,0
145271,RF,0,0
145272,profile,0,0
145273,varied,0,0
145274,between,0,0
145275,6.5,0,0
145276,%,0,0
145277,(,0,0
145278,95,0,0
145279,%,0,0
145280,confidence,0,0
145281,interval,0,0
145282,:,0,1
145283,5.9-7.1,0,0
145284,),0,0
145285,and,0,0
145286,9.7,0,0
145287,%,0,0
145288,(,0,0
145289,9.0-10.5,0,0
145290,),0,0
145291,depending,0,0
145292,on,0,0
145293,the,0,0
145294,definition,0,0
145295,used,0,0
145296,.,0,0
145297,This,0,0
145298,prevalence,0,0
145299,was,0,0
145300,higher,0,0
145301,than,0,0
145302,in,0,0
145303,other,0,0
145304,countries,0,1
145305,.,0,1
145306,Irrespective,0,0
145307,of,0,0
145308,the,0,0
145309,definition,0,0
145310,used,0,0
145311,",",0,0
145312,the,0,0
145313,prevalence,0,0
145314,of,0,0
145315,low,0,0
145316,RF,0,0
145317,profile,0,0
145318,was,0,0
145319,higher,0,0
145320,in,0,0
145321,women,0,1
145322,and,0,0
145323,in,0,0
145324,physically,0,1
145325,active,0,0
145326,participants,0,1
145327,",",0,0
145328,and,0,0
145329,decreased,0,0
145330,with,0,0
145331,increasing,0,0
145332,age,0,1
145333,or,0,0
145334,in,0,0
145335,the,0,0
145336,presence,0,0
145337,of,0,0
145338,a,0,0
145339,family,0,0
145340,history,0,0
145341,of,0,0
145342,cardiovascular,0,0
145343,disease,0,1
145344,.,0,0
145345,Using,0,0
145346,one,0,0
145347,definition,0,0
145348,",",0,0
145349,the,0,0
145350,prevalence,0,0
145351,of,0,0
145352,low,0,0
145353,RF,0,0
145354,profile,0,0
145355,increased,0,0
145356,from,0,0
145357,3.8,0,0
145358,%,0,0
145359,(,0,0
145360,3.1-4.5,0,0
145361,),0,0
145362,in,0,0
145363,1984-1986,0,1
145364,to,0,0
145365,6.7,0,0
145366,%,0,0
145367,(,0,0
145368,6.1-7.3,0,0
145369,),0,0
145370,in,0,0
145371,2003-2006,0,1
145372,;,0,0
145373,using,0,0
145374,another,0,0
145375,definition,0,0
145376,",",0,0
145377,the,0,0
145378,results,0,0
145379,were,0,0
145380,5.9,0,0
145381,%,0,0
145382,(,0,0
145383,5.1-6.8,0,0
145384,),0,0
145385,and,0,0
145386,9.7,0,0
145387,%,0,0
145388,(,0,0
145389,9.0-10.5,0,0
145390,),0,0
145391,",",0,0
145392,respectively,0,0
145393,.,0,0
145394,CONCLUSION,0,0
145395,Switzerland,0,1
145396,is,0,0
145397,characterized,0,0
145398,by,0,0
145399,a,0,0
145400,high,0,0
145401,and,0,0
145402,increasing,0,0
145403,prevalence,0,0
145404,of,0,0
145405,low,0,0
145406,RF,0,0
145407,profile,0,0
145408,within,0,0
145409,the,0,0
145410,age,1,1
145411,group,1,0
145412,35,1,0
145413,to,1,0
145414,75,1,0
145415,",",0,0
145416,irrespective,0,0
145417,of,0,0
145418,the,0,0
145419,criteria,0,1
145420,used,0,0
145421,.,0,0
145422,This,0,0
145423,high,0,0
145424,prevalence,0,0
145425,might,0,0
145426,partly,0,0
145427,explain,0,0
145428,the,0,0
145429,low,0,0
145430,and,0,0
145431,decreasing,0,0
145432,trend,0,0
145433,in,0,0
145434,cardiovascular,0,0
145435,mortality,0,0
145436,rates,0,0
145437,.,0,1
145438,Is,0,0
145439,EEG-biofeedback,0,0
145440,an,0,0
145441,effective,0,0
145442,treatment,0,0
145443,in,0,0
145444,autism,1,1
145445,spectrum,1,1
145446,disorders,1,1
145447,?,0,0
145448,A,0,0
145449,randomized,0,0
145450,controlled,0,0
145451,trial,0,0
145452,.,0,0
145453,EEG-biofeedback,0,0
145454,has,0,0
145455,been,0,0
145456,reported,0,0
145457,to,0,0
145458,reduce,0,0
145459,symptoms,0,0
145460,of,0,0
145461,autism,1,1
145462,spectrum,1,1
145463,disorders,1,1
145464,(,1,0
145465,ASD,1,1
145466,),1,0
145467,in,0,0
145468,several,0,0
145469,studies,0,0
145470,.,0,0
145471,However,0,0
145472,",",0,0
145473,these,0,0
145474,studies,0,0
145475,did,0,0
145476,not,0,0
145477,control,0,0
145478,for,0,0
145479,nonspecific,0,0
145480,effects,0,0
145481,of,0,0
145482,EEG-biofeedback,0,0
145483,and,0,0
145484,did,0,0
145485,not,0,0
145486,distinguish,0,0
145487,between,0,0
145488,participants,0,1
145489,who,0,1
145490,succeeded,0,1
145491,in,0,1
145492,influencing,0,0
145493,their,0,1
145494,own,0,0
145495,EEG,0,0
145496,activity,0,0
145497,and,0,1
145498,participants,0,1
145499,who,0,1
145500,did,0,1
145501,not,0,1
145502,.,0,0
145503,To,0,0
145504,overcome,0,0
145505,these,0,0
145506,methodological,0,0
145507,shortcomings,0,0
145508,",",0,0
145509,this,0,0
145510,study,0,0
145511,evaluated,0,0
145512,the,0,0
145513,effects,0,0
145514,of,0,0
145515,EEG-biofeedback,0,0
145516,in,0,0
145517,ASD,0,1
145518,in,0,0
145519,a,0,0
145520,randomized,0,0
145521,pretest-posttest,0,0
145522,control,0,0
145523,group,0,0
145524,design,0,0
145525,with,0,1
145526,blinded,0,0
145527,active,0,0
145528,comparator,0,0
145529,and,0,0
145530,six,0,0
145531,months,0,0
145532,follow-up,0,0
145533,.,0,1
145534,Thirty-eight,1,1
145535,participants,1,1
145536,were,0,0
145537,randomly,0,1
145538,allocated,0,0
145539,to,0,0
145540,the,0,0
145541,EEG-biofeedback,0,0
145542,",",0,0
145543,skin,0,0
145544,conductance,0,0
145545,(,0,0
145546,SC,0,0
145547,),0,0
145548,-biofeedback,0,0
145549,or,0,0
145550,waiting,0,0
145551,list,0,0
145552,group,0,0
145553,.,0,0
145554,EEG-,0,0
145555,and,0,0
145556,SC-biofeedback,0,0
145557,sessions,0,0
145558,were,0,0
145559,similar,0,0
145560,and,0,0
145561,participants,0,1
145562,were,0,0
145563,blinded,0,0
145564,to,0,0
145565,the,0,0
145566,type,0,0
145567,of,0,0
145568,feedback,0,0
145569,they,0,0
145570,received,0,0
145571,.,0,0
145572,Assessments,0,0
145573,pre-treatment,0,0
145574,",",0,0
145575,post-treatment,0,0
145576,",",0,0
145577,and,0,0
145578,after,0,0
145579,6,0,0
145580,months,0,0
145581,included,0,1
145582,parent,0,0
145583,ratings,0,0
145584,of,0,0
145585,symptoms,0,0
145586,of,0,0
145587,ASD,0,1
145588,",",0,0
145589,executive,0,0
145590,function,0,0
145591,tasks,0,0
145592,",",0,0
145593,and,0,0
145594,19-channel,0,0
145595,EEG,0,0
145596,recordings,0,0
145597,.,0,1
145598,Fifty-four,0,1
145599,percent,0,0
145600,of,0,0
145601,the,0,0
145602,participants,0,1
145603,significantly,0,0
145604,reduced,0,0
145605,delta,0,0
145606,and/or,0,0
145607,theta,0,0
145608,power,0,0
145609,during,0,0
145610,EEG-biofeedback,0,0
145611,sessions,0,0
145612,and,0,0
145613,were,0,0
145614,identified,0,0
145615,as,0,0
145616,EEG-regulators,0,0
145617,.,0,0
145618,In,0,0
145619,these,0,0
145620,EEG-regulators,0,0
145621,",",0,0
145622,no,0,0
145623,statistically,0,0
145624,significant,0,0
145625,reductions,0,0
145626,of,0,0
145627,symptoms,0,0
145628,of,0,0
145629,ASD,0,1
145630,were,0,0
145631,observed,0,0
145632,",",0,0
145633,but,0,0
145634,they,0,0
145635,showed,0,0
145636,significant,0,0
145637,improvement,0,0
145638,in,0,0
145639,cognitive,0,0
145640,flexibility,0,0
145641,as,0,0
145642,compared,0,0
145643,to,0,1
145644,participants,0,1
145645,who,0,1
145646,managed,0,1
145647,to,0,1
145648,regulate,0,0
145649,SC,0,0
145650,.,0,0
145651,EEG-biofeedback,0,0
145652,seems,0,0
145653,to,0,0
145654,be,0,0
145655,an,0,0
145656,applicable,0,0
145657,tool,0,0
145658,to,0,0
145659,regulate,0,0
145660,EEG,0,0
145661,activity,0,0
145662,and,0,0
145663,has,0,0
145664,specific,0,0
145665,effects,0,0
145666,on,0,0
145667,cognitive,0,0
145668,flexibility,0,0
145669,",",0,0
145670,but,0,0
145671,it,0,0
145672,did,0,0
145673,not,0,0
145674,result,0,0
145675,in,0,0
145676,significant,0,0
145677,reductions,0,0
145678,in,0,0
145679,symptoms,0,0
145680,of,0,0
145681,ASD,0,1
145682,.,0,0
145683,An,0,0
145684,important,0,0
145685,finding,0,0
145686,was,0,0
145687,that,0,0
145688,no,0,0
145689,nonspecific,0,0
145690,effects,0,0
145691,of,0,0
145692,EEG-biofeedback,0,0
145693,were,0,0
145694,demonstrated,0,0
145695,.,0,0
145696,Links,0,0
145697,between,0,0
145698,multisensory,0,0
145699,processing,0,0
145700,and,0,0
145701,autism,0,1
145702,.,0,0
145703,Autism,1,0
145704,spectrum,1,1
145705,disorder,1,1
145706,is,0,0
145707,typically,0,0
145708,associated,0,0
145709,with,0,0
145710,social,0,0
145711,deficits,0,0
145712,and,0,0
145713,is,0,0
145714,often,0,0
145715,specifically,0,0
145716,linked,0,0
145717,to,0,0
145718,difficulty,0,0
145719,with,0,0
145720,processing,0,0
145721,faces,0,0
145722,and,0,0
145723,other,0,0
145724,socially,0,1
145725,relevant,0,0
145726,stimuli,0,0
145727,.,0,0
145728,Emerging,0,0
145729,research,0,0
145730,has,0,0
145731,suggested,0,0
145732,that,0,0
145733,children,1,1
145734,with,1,1
145735,autism,1,1
145736,might,0,0
145737,also,0,0
145738,have,0,0
145739,deficits,0,0
145740,in,0,0
145741,basic,0,1
145742,perceptual,0,0
145743,abilities,0,0
145744,including,0,0
145745,multisensory,0,0
145746,processing,0,0
145747,(,0,0
145748,e.g.,0,0
145749,",",0,0
145750,simultaneously,0,0
145751,processing,0,0
145752,visual,0,0
145753,and,0,0
145754,auditory,0,0
145755,inputs,0,0
145756,),0,0
145757,.,0,0
145758,The,0,0
145759,current,0,0
145760,study,0,0
145761,examined,0,0
145762,the,0,0
145763,relationship,0,0
145764,between,0,0
145765,multisensory,0,0
145766,temporal,0,0
145767,processing,0,0
145768,(,0,0
145769,assessed,0,0
145770,via,0,0
145771,a,0,0
145772,simultaneity,0,0
145773,judgment,0,0
145774,task,0,0
145775,wherein,0,0
145776,participants,0,1
145777,were,0,0
145778,to,0,0
145779,report,0,0
145780,whether,0,0
145781,a,0,0
145782,visual,0,0
145783,stimulus,0,0
145784,and,0,0
145785,an,0,0
145786,auditory,0,0
145787,stimulus,0,0
145788,occurred,0,0
145789,at,0,0
145790,the,0,0
145791,same,0,0
145792,time,0,0
145793,or,0,0
145794,at,0,0
145795,different,0,0
145796,times,0,0
145797,),0,0
145798,and,0,0
145799,self-reported,0,0
145800,symptoms,0,0
145801,of,0,0
145802,autism,0,1
145803,(,0,0
145804,assessed,0,0
145805,via,0,0
145806,the,0,0
145807,Autism,0,1
145808,Spectrum,0,1
145809,Quotient,0,0
145810,questionnaire,0,0
145811,),0,0
145812,.,0,0
145813,Data,0,0
145814,from,0,0
145815,over,1,0
145816,100,1,1
145817,healthy,1,1
145818,adults,1,1
145819,revealed,0,0
145820,a,0,0
145821,relationship,0,0
145822,between,0,0
145823,these,0,0
145824,two,0,0
145825,factors,0,0
145826,as,0,0
145827,multisensory,0,0
145828,timing,0,0
145829,perception,0,0
145830,correlated,0,0
145831,with,0,1
145832,symptoms,0,0
145833,of,0,0
145834,autism,0,1
145835,.,0,0
145836,Specifically,0,0
145837,",",0,0
145838,a,0,0
145839,stronger,0,0
145840,bias,0,0
145841,to,0,0
145842,perceive,0,0
145843,auditory,0,0
145844,stimuli,0,0
145845,occurring,0,1
145846,before,0,0
145847,visual,0,0
145848,stimuli,0,0
145849,as,0,0
145850,simultaneous,0,0
145851,was,0,0
145852,associated,0,0
145853,with,0,1
145854,greater,0,0
145855,levels,0,0
145856,of,0,0
145857,autistic,0,1
145858,symptoms,0,0
145859,.,0,1
145860,Additional,0,0
145861,data,0,0
145862,and,0,0
145863,analyses,0,0
145864,confirm,0,0
145865,that,0,0
145866,this,0,0
145867,relationship,0,0
145868,is,0,0
145869,specific,0,0
145870,to,0,0
145871,multisensory,0,0
145872,processing,0,0
145873,and,0,0
145874,symptoms,0,0
145875,of,0,0
145876,autism,0,1
145877,.,0,0
145878,These,0,0
145879,results,0,0
145880,provide,0,0
145881,insight,0,0
145882,into,0,0
145883,the,0,0
145884,nature,0,0
145885,of,0,0
145886,multisensory,0,0
145887,processing,0,0
145888,while,0,0
145889,also,0,0
145890,revealing,0,0
145891,a,0,0
145892,continuum,0,0
145893,over,0,0
145894,which,0,0
145895,perceptual,0,0
145896,abilities,0,0
145897,correlate,0,0
145898,with,0,1
145899,symptoms,0,0
145900,of,0,0
145901,autism,0,1
145902,and,0,0
145903,that,0,0
145904,this,0,0
145905,continuum,0,0
145906,is,0,0
145907,not,0,0
145908,just,0,0
145909,specific,0,0
145910,to,0,0
145911,clinical,0,0
145912,populations,0,0
145913,but,0,0
145914,is,0,0
145915,present,0,0
145916,within,0,0
145917,the,0,0
145918,general,1,1
145919,population,1,1
145920,.,1,0
145921,Efficacy,0,0
145922,and,0,0
145923,safety,0,0
145924,of,0,0
145925,bexarotene,0,0
145926,combined,0,0
145927,with,0,0
145928,psoralen-ultraviolet,0,0
145929,A,0,0
145930,(,0,0
145931,PUVA,0,0
145932,),0,0
145933,compared,0,0
145934,with,0,0
145935,PUVA,0,0
145936,treatment,0,0
145937,alone,0,0
145938,in,0,0
145939,stage,0,1
145940,IB-IIA,0,0
145941,mycosis,0,1
145942,fungoides,0,1
145943,:,0,1
145944,final,0,0
145945,results,0,0
145946,from,0,1
145947,the,0,0
145948,EORTC,0,0
145949,Cutaneous,1,0
145950,Lymphoma,1,1
145951,Task,1,0
145952,Force,1,0
145953,phase,1,0
145954,III,1,0
145955,randomized,1,0
145956,clinical,1,0
145957,trial,1,0
145958,(,0,0
145959,NCT00056056,0,0
145960,),0,0
145961,.,0,0
145962,BACKGROUND,0,0
145963,Psoralen,0,0
145964,plus,0,0
145965,ultraviolet,0,0
145966,A,0,0
145967,(,0,0
145968,PUVA,0,0
145969,),0,0
145970,is,0,0
145971,the,0,0
145972,standard,0,0
145973,treatment,0,0
145974,for,0,0
145975,early,1,0
145976,stages,1,1
145977,of,1,0
145978,mycosis,1,1
145979,fungoides,1,1
145980,.,1,0
145981,There,0,0
145982,have,0,0
145983,been,0,0
145984,no,0,0
145985,adequate,0,0
145986,randomized,0,0
145987,controlled,0,0
145988,trials,0,0
145989,with,0,1
145990,sufficient,0,0
145991,power,0,0
145992,comparing,0,0
145993,this,0,0
145994,modality,0,0
145995,with,0,1
145996,other,0,0
145997,therapies,0,0
145998,.,0,1
145999,OBJECTIVE,0,0
146000,To,0,0
146001,assess,0,0
146002,disease,0,1
146003,response,0,0
146004,and,0,0
146005,to,0,0
146006,compare,0,0
146007,the,0,0
146008,response,0,0
146009,rates,0,0
146010,of,0,0
146011,patients,1,1
146012,treated,1,1
146013,with,1,1
146014,PUVA,1,0
146015,alone,1,0
146016,or,1,0
146017,PUVA,1,0
146018,and,1,0
146019,bexarotene,1,0
146020,.,1,0
146021,METHODS,0,0
146022,EORTC,0,0
146023,21011,0,0
146024,(,0,0
146025,NCT,0,0
146026,00056056,0,0
146027,),0,0
146028,was,0,0
146029,a,0,0
146030,randomized,0,0
146031,phase,0,0
146032,III,0,0
146033,study,0,0
146034,comparing,0,0
146035,combined,0,0
146036,bexarotene,0,0
146037,(,0,0
146038,Targretin,0,0
146039,(,0,0
146040,?,0,0
146041,),0,0
146042,),0,0
146043,and,0,0
146044,PUVA,0,0
146045,vs.,0,0
146046,PUVA,0,0
146047,alone,0,0
146048,in,1,0
146049,patients,1,1
146050,with,1,1
146051,stage,1,1
146052,IB,1,1
146053,and,1,0
146054,IIA,1,0
146055,mycosis,1,1
146056,fungoides,1,1
146057,(,1,0
146058,MF,1,1
146059,),1,0
146060,.,1,0
146061,The,0,0
146062,primary,0,0
146063,endpoint,0,0
146064,was,0,0
146065,the,0,0
146066,overall,0,0
146067,response,0,0
146068,rate,0,0
146069,[,0,0
146070,complete,0,0
146071,clinical,0,0
146072,response,0,0
146073,(,0,0
146074,CCR,0,0
146075,),0,0
146076,plus,0,0
146077,partial,0,0
146078,response,0,0
146079,(,0,0
146080,PR,0,0
146081,),0,0
146082,],0,0
146083,.,0,0
146084,RESULTS,0,0
146085,The,0,0
146086,study,0,0
146087,was,0,0
146088,prematurely,0,1
146089,closed,0,0
146090,due,0,0
146091,to,0,0
146092,low,0,0
146093,accrual,0,0
146094,after,1,0
146095,93,1,1
146096,of,1,0
146097,145,1,1
146098,required,1,0
146099,patients,1,1
146100,(,0,0
146101,65,0,1
146102,%,0,0
146103,),0,0
146104,were,0,0
146105,randomized,0,0
146106,.,0,0
146107,Of,0,0
146108,the,1,0
146109,93,1,1
146110,randomized,1,0
146111,patients,1,1
146112,",",1,0
146113,87,1,0
146114,started,1,0
146115,treatment,1,0
146116,",",1,0
146117,41,1,1
146118,received,1,0
146119,PUVA,1,0
146120,and,1,0
146121,46,1,1
146122,received,1,0
146123,PUVA,1,0
146124,+,1,0
146125,bexarotene,1,0
146126,.,1,0
146127,Total,0,0
146128,UVA,0,1
146129,doses,0,0
146130,received,0,0
146131,were,0,0
146132,107,0,1
146133,J,0,0
146134,cm,0,1
146135,(,0,0
146136,-2,0,0
146137,),0,0
146138,(,0,0
146139,range,0,0
146140,1?4-489?9,0,0
146141,),0,0
146142,in,0,0
146143,the,0,0
146144,PUVA,0,0
146145,arm,0,0
146146,vs.,0,0
146147,101?7,0,0
146148,J,0,0
146149,cm,0,1
146150,(,0,0
146151,-2,0,0
146152,),0,0
146153,(,0,0
146154,0?2-529?9,0,0
146155,),0,0
146156,in,0,0
146157,the,0,0
146158,combination,0,0
146159,arm,0,0
146160,.,0,0
146161,The,0,0
146162,safety,0,0
146163,profile,0,0
146164,was,0,0
146165,acceptable,0,0
146166,with,0,1
146167,few,0,0
146168,grade,0,1
146169,3-4,0,1
146170,toxicities,0,0
146171,observed,0,0
146172,in,0,0
146173,either,0,0
146174,arm,0,0
146175,.,0,0
146176,More,0,0
146177,drop-outs,0,0
146178,due,0,0
146179,to,0,0
146180,toxicity,0,0
146181,were,0,0
146182,observed,0,0
146183,in,0,0
146184,the,0,0
146185,combination,0,0
146186,arm,0,0
146187,compared,0,0
146188,with,0,0
146189,the,0,0
146190,PUVA-alone,0,0
146191,arm,0,0
146192,.,0,0
146193,The,0,0
146194,best,0,0
146195,overall,0,0
146196,response,0,0
146197,(,0,0
146198,CCR,0,0
146199,+,0,0
146200,PR,0,0
146201,),0,0
146202,rate,0,0
146203,was,0,0
146204,71,0,1
146205,%,0,0
146206,for,0,0
146207,PUVA,0,0
146208,alone,0,0
146209,and,0,0
146210,77,0,0
146211,%,0,0
146212,for,0,0
146213,the,0,0
146214,combination,0,0
146215,arm,0,0
146216,(,0,0
146217,P,0,0
146218,=,0,0
146219,0?57,0,0
146220,),0,0
146221,.,0,0
146222,The,0,0
146223,median,0,0
146224,duration,0,0
146225,of,0,0
146226,response,0,0
146227,was,0,0
146228,9?7,0,0
146229,months,0,0
146230,for,0,0
146231,PUVA,0,0
146232,vs.,0,0
146233,5?8,0,0
146234,months,0,0
146235,for,0,0
146236,the,0,0
146237,combination,0,0
146238,arm,0,0
146239,(,0,0
146240,P,0,0
146241,=,0,0
146242,0?33,0,1
146243,),0,0
146244,.,0,0
146245,CCR,0,0
146246,was,0,0
146247,seen,0,0
146248,in,0,0
146249,25,0,0
146250,patients,0,1
146251,of,0,1
146252,whom,0,1
146253,10,0,1
146254,received,0,1
146255,PUVA,0,0
146256,alone,0,0
146257,(,0,0
146258,CCR,0,0
146259,22,0,1
146260,%,0,0
146261,),0,0
146262,and,0,0
146263,15,0,0
146264,received,0,0
146265,combination,0,0
146266,therapy,0,0
146267,(,0,0
146268,CCR,0,0
146269,31,0,1
146270,%,0,0
146271,),0,0
146272,(,0,0
146273,P,0,0
146274,=,0,0
146275,0?45,0,0
146276,),0,0
146277,.,0,0
146278,CCR,0,0
146279,was,0,0
146280,sustained,0,0
146281,in,0,0
146282,25,0,0
146283,%,0,0
146284,of,0,0
146285,patients,0,1
146286,regardless,0,0
146287,of,0,0
146288,therapy,0,0
146289,.,0,0
146290,There,0,0
146291,was,0,0
146292,a,0,0
146293,trend,0,0
146294,towards,0,0
146295,fewer,0,0
146296,PUVA,0,0
146297,sessions,0,0
146298,needed,0,0
146299,to,0,0
146300,achieve,0,0
146301,CCR,0,0
146302,in,0,0
146303,the,0,0
146304,combination,0,0
146305,arm,0,0
146306,(,0,0
146307,median,0,0
146308,22,0,1
146309,),0,0
146310,compared,0,0
146311,with,0,0
146312,the,0,0
146313,PUVA,0,0
146314,arm,0,0
146315,(,0,0
146316,median,0,0
146317,27?5,0,0
146318,),0,0
146319,(,0,0
146320,P,0,0
146321,=,0,0
146322,0?11,0,0
146323,),0,0
146324,.,0,0
146325,Similarly,0,0
146326,",",0,0
146327,a,0,0
146328,trend,0,0
146329,towards,0,0
146330,lower,0,0
146331,UVA,0,1
146332,dose,0,0
146333,required,0,0
146334,to,0,0
146335,achieve,0,0
146336,CCR,0,0
146337,in,0,0
146338,the,0,0
146339,combination,0,0
146340,arm,0,0
146341,(,0,0
146342,median,0,0
146343,55?8,0,1
146344,J,0,0
146345,cm,0,1
146346,(,0,0
146347,-2,0,0
146348,),0,0
146349,),0,0
146350,compared,0,0
146351,with,0,0
146352,the,0,0
146353,PUVA,0,0
146354,arm,0,0
146355,alone,0,0
146356,(,0,0
146357,median,0,0
146358,117?5,0,0
146359,J,0,0
146360,cm,0,1
146361,(,0,0
146362,-2,0,0
146363,),0,0
146364,),0,0
146365,(,0,0
146366,P,0,0
146367,=,0,0
146368,0?5,0,0
146369,),0,0
146370,was,0,0
146371,observed,0,0
146372,.,0,0
146373,CONCLUSIONS,0,0
146374,No,0,0
146375,significant,0,0
146376,difference,0,0
146377,in,0,0
146378,response,0,0
146379,rate,0,0
146380,or,0,0
146381,response,0,0
146382,duration,0,0
146383,was,0,0
146384,observed,0,0
146385,in,0,0
146386,this,0,0
146387,study,0,0
146388,.,0,0
146389,However,0,0
146390,",",0,0
146391,there,0,0
146392,was,0,0
146393,a,0,0
146394,trend,0,0
146395,towards,0,0
146396,fewer,0,0
146397,PUVA,0,0
146398,sessions,0,0
146399,and,0,0
146400,lower,0,0
146401,UVA,0,1
146402,dose,0,0
146403,required,0,0
146404,to,0,0
146405,achieve,0,0
146406,CCR,0,0
146407,in,0,0
146408,the,0,0
146409,combination,0,0
146410,arm,0,0
146411,(,0,0
146412,PUVA,0,0
146413,+,0,0
146414,bexarotene,0,0
146415,),0,0
146416,but,0,0
146417,this,0,0
146418,did,0,0
146419,not,0,0
146420,achieve,0,0
146421,statistical,0,0
146422,significance,0,0
146423,due,0,0
146424,to,0,0
146425,insufficient,0,0
146426,power,0,0
146427,.,0,0
146428,Clinical,0,0
146429,efficacy,0,0
146430,of,0,0
146431,antazoline,0,0
146432,in,0,0
146433,rapid,0,0
146434,cardioversion,0,1
146435,of,0,0
146436,paroxysmal,1,1
146437,atrial,1,1
146438,fibrillation,1,1
146439,--,1,0
146440,a,1,0
146441,protocol,0,0
146442,of,0,0
146443,a,0,0
146444,single,0,0
146445,center,0,1
146446,",",0,0
146447,randomized,0,0
146448,",",0,0
146449,double-blind,0,0
146450,",",0,0
146451,placebo-controlled,0,0
146452,study,0,0
146453,(,0,0
146454,the,0,0
146455,AnPAF,0,0
146456,Study,0,0
146457,),0,0
146458,.,0,0
146459,BACKGROUND,0,0
146460,Rapid,0,0
146461,conversion,0,0
146462,of,0,0
146463,atrial,1,1
146464,fibrillation,1,1
146465,(,0,0
146466,AF,0,0
146467,),0,0
146468,to,0,0
146469,sinus,0,0
146470,rhythm,0,0
146471,may,0,0
146472,be,0,0
146473,achieved,0,0
146474,by,0,0
146475,the,0,0
146476,administration,0,0
146477,of,0,0
146478,class,0,1
146479,IA,0,0
146480,",",0,0
146481,IC,0,0
146482,and,0,0
146483,III,0,0
146484,antiarrhythmic,0,0
146485,drugs,0,0
146486,or,0,1
146487,vernakalant,0,0
146488,hydrochloride,0,0
146489,.,0,0
146490,However,0,0
146491,",",0,0
146492,that,0,0
146493,treatment,0,0
146494,may,0,0
146495,be,0,0
146496,related,0,0
146497,to,0,0
146498,potential,0,0
146499,pro-arrhythmia,0,0
146500,",",0,0
146501,lack,0,0
146502,of,0,0
146503,efficacy,0,0
146504,or,0,0
146505,the,0,0
146506,exceptionally,0,0
146507,high,0,0
146508,cost,0,0
146509,of,0,0
146510,a,0,0
146511,compound,0,0
146512,used,0,0
146513,.,0,0
146514,Antazoline,0,0
146515,is,0,0
146516,a,0,0
146517,first,0,0
146518,generation,0,0
146519,antihistaminic,0,0
146520,agent,0,0
146521,with,0,1
146522,chinidin-like,0,0
146523,properties,0,0
146524,.,0,0
146525,When,0,0
146526,administered,0,0
146527,intravenously,0,0
146528,",",0,0
146529,antazoline,0,0
146530,exerts,0,0
146531,a,0,0
146532,strong,0,0
146533,antiarrhythmic,0,0
146534,effect,0,0
146535,on,0,0
146536,supraventricular,0,0
146537,arrhythmia,0,0
146538,",",0,0
146539,especially,0,0
146540,on,0,0
146541,AF,0,0
146542,",",0,0
146543,facilitating,0,0
146544,rapid,0,0
146545,conversion,0,0
146546,to,0,0
146547,sinus,0,1
146548,rhythm,0,1
146549,.,0,0
146550,Despite,0,0
146551,a,0,0
146552,relative,0,0
146553,lack,0,0
146554,of,0,0
146555,published,0,0
146556,data,0,0
146557,antazoline,0,0
146558,has,0,0
146559,been,0,0
146560,marketed,0,0
146561,in,0,0
146562,Poland,0,1
146563,and,0,0
146564,widely,0,0
146565,used,0,0
146566,in,0,0
146567,cardiology,0,1
146568,wards,0,1
146569,and,0,0
146570,emergency,0,1
146571,rooms,0,1
146572,for,0,0
146573,many,0,1
146574,years,0,1
146575,due,0,0
146576,to,0,0
146577,its,0,0
146578,efficacy,0,0
146579,",",0,0
146580,safety,0,0
146581,and,0,0
146582,rapid,0,0
146583,onset,0,0
146584,of,0,0
146585,action,0,0
146586,within,0,0
146587,minutes,0,0
146588,of,0,0
146589,administration,0,0
146590,.,0,0
146591,METHODS/DESIGN,0,0
146592,A,0,0
146593,randomized,0,0
146594,",",0,0
146595,double,0,0
146596,blind,0,0
146597,",",0,0
146598,placebo-controlled,0,0
146599,",",0,0
146600,superiority,0,0
146601,clinical,0,0
146602,trial,0,0
146603,was,0,0
146604,designed,0,0
146605,to,0,0
146606,assess,0,0
146607,clinical,0,0
146608,efficacy,0,0
146609,of,0,0
146610,antazoline,0,0
146611,in,0,0
146612,rapid,0,0
146613,conversion,0,0
146614,of,0,0
146615,AF,0,0
146616,to,0,0
146617,sinus,0,1
146618,rhythm,0,1
146619,.,0,0
146620,Eligible,1,0
146621,patients,1,1
146622,will,1,0
146623,present,1,0
146624,AF,1,0
146625,lasting,1,0
146626,less,1,0
146627,than,1,0
146628,43,1,1
146629,hours,1,0
146630,",",1,0
146631,will,1,0
146632,be,1,0
146633,in,1,0
146634,stable,1,1
146635,cardio-pulmonary,1,1
146636,condition,1,0
146637,and,1,0
146638,will,1,0
146639,have,1,0
146640,no,1,0
146641,prior,1,0
146642,history,1,1
146643,of,1,0
146644,advanced,1,1
146645,heart,1,1
146646,failure,1,1
146647,or,1,0
146648,significant,1,0
146649,valvular,1,1
146650,disease,1,1
146651,.,1,0
146652,Long-term,0,0
146653,antiarrhythmic,0,0
146654,therapy,0,0
146655,is,0,0
146656,not,0,0
146657,considered,0,0
146658,an,0,0
146659,exclusion,0,0
146660,criterion,0,0
146661,.,0,1
146662,Subjects,0,1
146663,who,0,1
146664,fulfill,0,1
146665,selection,0,0
146666,criteria,0,1
146667,will,0,0
146668,be,0,0
146669,randomly,0,0
146670,assigned,0,0
146671,to,0,0
146672,receive,0,0
146673,intravenously,0,0
146674,either,0,0
146675,antazoline,0,0
146676,or,0,0
146677,placebo,0,0
146678,in,0,0
146679,divided,0,0
146680,doses,0,0
146681,and,0,0
146682,observed,0,0
146683,for,0,0
146684,1.5,0,0
146685,hours,0,0
146686,after,0,0
146687,conversion,0,0
146688,to,0,0
146689,sinus,0,0
146690,rhythm,0,1
146691,or,0,0
146692,after,0,0
146693,the,0,0
146694,last,0,0
146695,i.v,0,0
146696,.,0,0
146697,bolus,0,0
146698,.,0,0
146699,Primary,0,0
146700,end,0,0
146701,point,0,0
146702,will,0,0
146703,be,0,0
146704,the,0,0
146705,conversion,0,0
146706,of,0,0
146707,AF,0,0
146708,to,0,0
146709,sinus,0,1
146710,rhythm,0,1
146711,confirmed,0,0
146712,in,0,0
146713,an,0,0
146714,electrocardiogram,0,0
146715,(,0,0
146716,ECG,0,0
146717,),0,0
146718,during,0,0
146719,the,0,0
146720,observation,0,0
146721,period,0,0
146722,.,0,0
146723,Secondary,0,0
146724,end,0,0
146725,points,0,0
146726,will,0,0
146727,be,0,0
146728,comprised,0,0
146729,of,0,0
146730,time,0,0
146731,to,0,0
146732,conversion,0,0
146733,and,0,0
146734,return,0,0
146735,of,0,0
146736,AF,0,0
146737,during,0,0
146738,the,0,0
146739,observation,0,0
146740,period,0,0
146741,.,0,0
146742,Special,0,0
146743,consideration,0,0
146744,will,0,0
146745,be,0,0
146746,given,0,0
146747,to,0,0
146748,the,0,0
146749,observation,0,0
146750,of,0,0
146751,any,0,0
146752,adverse,0,0
146753,events,0,0
146754,.,0,0
146755,A,0,0
146756,sample,1,0
146757,size,1,0
146758,of,1,0
146759,80,1,1
146760,patients,1,1
146761,was,1,0
146762,calculated,1,0
146763,based,0,0
146764,on,0,0
146765,the,0,0
146766,following,0,0
146767,assumptions,0,0
146768,:,0,1
146769,two-tailed,0,0
146770,test,0,0
146771,",",0,0
146772,a,0,0
146773,type,0,0
146774,I,0,0
146775,error,0,0
146776,of,0,0
146777,0.01,0,0
146778,",",0,0
146779,a,0,0
146780,power,0,0
146781,of,0,0
146782,90,0,0
146783,%,0,0
146784,",",0,0
146785,efficacy,0,0
146786,of,0,0
146787,placebo,0,0
146788,5,0,0
146789,%,0,0
146790,",",0,0
146791,efficacy,0,0
146792,of,0,0
146793,antazoline,0,0
146794,50,0,0
146795,%,0,0
146796,and,0,0
146797,20,0,0
146798,%,0,0
146799,drop-out,0,0
146800,rate,0,0
146801,to,0,0
146802,fulfill,0,0
146803,the,0,0
146804,criteria,0,1
146805,of,0,0
146806,intention-to-treat,0,0
146807,analysis,0,0
146808,.,0,0
146809,Due,0,0
146810,to,0,0
146811,the,0,0
146812,presumed,0,0
146813,lack,0,0
146814,of,0,0
146815,statistical,0,0
146816,power,0,0
146817,",",0,0
146818,the,0,0
146819,secondary,0,0
146820,end,0,0
146821,points,0,0
146822,and,0,0
146823,safety,0,0
146824,endpoints,0,0
146825,will,0,0
146826,be,0,0
146827,considered,0,0
146828,exploratory,0,0
146829,.,0,0
146830,CLINICAL,0,0
146831,TRIALS,0,0
146832,REGISTRY,0,0
146833,ClinicalTrials.gov,0,0
146834,",",0,0
146835,NCT01527279,0,0
146836,.,0,0
146837,Improving,0,0
146838,RBC,0,0
146839,K,0,0
146840,transport,0,0
146841,and,0,0
146842,hemoglobin-O2,0,0
146843,binding,0,0
146844,by,0,0
146845,amiloride,0,0
146846,:,0,1
146847,A,0,0
146848,novel,0,0
146849,therapeutic,0,0
146850,approach,0,0
146851,for,0,0
146852,reversion,0,0
146853,of,0,0
146854,angina,0,1
146855,and,0,0
146856,myocardial,0,0
146857,ischemia,0,0
146858,in,0,0
146859,coronary,1,1
146860,heart,1,1
146861,diseases,1,1
146862,.,1,1
146863,UNLABELLED,0,0
146864,Coronary,0,0
146865,heart,0,1
146866,disease,0,1
146867,(,0,0
146868,CHD,0,0
146869,),0,0
146870,is,0,0
146871,the,0,0
146872,leading,0,0
146873,cause,0,0
146874,of,0,0
146875,morbidity,0,0
146876,and,0,0
146877,mortality,0,0
146878,across,0,0
146879,the,0,0
146880,entire,0,0
146881,world,0,0
146882,",",0,0
146883,in,0,0
146884,which,0,0
146885,reversion,0,0
146886,of,0,0
146887,angina,0,1
146888,or,0,0
146889,improvement,0,0
146890,of,0,0
146891,ECG,0,0
146892,remains,0,0
146893,an,0,0
146894,unrealistic,0,0
146895,therapeutic,0,0
146896,option,0,0
146897,for,0,0
146898,most,0,0
146899,patients,0,1
146900,",",0,0
146901,suggesting,0,0
146902,that,0,0
146903,microvascular,0,0
146904,dysfunction,0,1
146905,or,0,0
146906,impaired,0,0
146907,oxygen,0,0
146908,delivery,0,0
146909,might,0,0
146910,be,0,0
146911,critical,0,0
146912,factors,0,0
146913,in,0,0
146914,CHD,0,0
146915,.,0,0
146916,This,0,0
146917,research,0,0
146918,article,0,0
146919,",",0,0
146920,thus,0,0
146921,presents,0,0
146922,the,0,0
146923,rationale,0,0
146924,basis,0,0
146925,",",0,0
146926,clinical,0,0
146927,and,0,0
146928,experimental,0,0
146929,",",0,0
146930,for,0,0
146931,the,0,0
146932,first,0,0
146933,therapeutic,0,0
146934,innovation,0,0
146935,addressing,0,0
146936,the,0,0
146937,role,0,0
146938,of,0,0
146939,red,0,0
146940,blood,0,0
146941,cell,0,1
146942,(,0,0
146943,RBC,0,0
146944,),0,0
146945,H/K,0,0
146946,and,0,0
146947,O2/CO2,0,0
146948,exchanges,0,0
146949,in,0,0
146950,CHD,0,0
146951,.,0,0
146952,It,0,0
146953,is,0,0
146954,followed,0,0
146955,by,0,0
146956,a,0,0
146957,randomized,0,0
146958,single-blind,0,0
146959,trial,0,0
146960,of,0,0
146961,Amiloride,1,0
146962,and,1,0
146963,Optimal,1,0
146964,Medical,1,1
146965,Therapy,1,0
146966,(,1,0
146967,OMT,1,0
146968,",",1,0
146969,n=35,1,1
146970,cases,1,0
146971,),1,0
146972,vs,1,0
146973,OMT,1,0
146974,alone,1,0
146975,(,1,0
146976,n=35,1,1
146977,cases,1,1
146978,),1,1
146979,in,1,0
146980,patients,1,1
146981,having,1,1
146982,angina,1,1
146983,",",1,0
146984,ST-T,1,0
146985,alteration,1,0
146986,and,1,0
146987,a,1,0
146988,defective,1,0
146989,RBC-K,1,0
146990,transport,1,0
146991,.,1,0
146992,All,1,0
146993,patients,1,1
146994,had,1,0
146995,serial,1,0
146996,clinical,1,0
146997,evaluation,1,0
146998,",",1,0
146999,Ion,1,0
147000,Transport,1,0
147001,Studies,1,0
147002,",",1,0
147003,ECGs,1,0
147004,and,1,0
147005,non-invasive,1,0
147006,aortic,1,1
147007,waveform,1,0
147008,and,1,0
147009,cardiovascular,1,1
147010,hemodynamic,1,0
147011,recordings,1,0
147012,.,1,1
147013,Statistical,0,0
147014,analysis,0,0
147015,was,0,0
147016,performed,0,0
147017,by,0,0
147018,SAS,0,0
147019,.,0,1
147020,RESULTS,0,0
147021,Amiloride,0,0
147022,rapidly,0,0
147023,improved,0,0
147024,RBC-K,0,0
147025,(,0,0
147026,93.5,0,0
147027,?4,0,0
147028,vs,0,0
147029,84.5,0,0
147030,?4,0,0
147031,mmol/lc,0,0
147032,",",0,0
147033,p=,0,0
147034,<,0,0
147035,0.001,0,0
147036,),0,0
147037,",",0,0
147038,angina,0,1
147039,(,0,0
147040,80,0,0
147041,%,0,0
147042,of,0,0
147043,cases,0,0
147044,",",0,0
147045,1.5,0,0
147046,?0.3,0,0
147047,weeks,0,0
147048,",",0,0
147049,CI:1.72,0,0
147050,to,0,0
147051,1.45,0,0
147052,),0,0
147053,",",0,0
147054,CCS,0,0
147055,Class,0,0
147056,(,0,0
147057,1.3,0,0
147058,?0.5,0,0
147059,vs,0,0
147060,3.1,0,0
147061,?0.8,0,0
147062,",",0,0
147063,p,0,0
147064,<,0,0
147065,0.001,0,0
147066,),0,0
147067,vs,0,0
147068,patients,0,1
147069,with,0,1
147070,OMT,0,0
147071,alone,0,0
147072,CCS,0,0
147073,Class,0,0
147074,(,0,0
147075,3.2,0,0
147076,?,0,0
147077,0.4,0,0
147078,vs,0,0
147079,3.3,0,0
147080,?,0,0
147081,0.5,0,0
147082,",",0,0
147083,p,0,0
147084,=0.21,0,0
147085,),0,0
147086,.,0,0
147087,Reversion,0,0
147088,of,0,0
147089,angina,0,1
147090,was,0,0
147091,sustained,0,0
147092,through,0,0
147093,the,0,0
147094,next,0,0
147095,6-months,0,0
147096,(,0,0
147097,87,0,1
147098,%,0,0
147099,vs,0,0
147100,26,0,0
147101,%,0,0
147102,in,0,0
147103,OMT,0,0
147104,",",0,0
147105,RR,0,0
147106,2.1,0,0
147107,",",0,0
147108,odds,0,0
147109,ratio,0,0
147110,6.31,0,0
147111,",",0,0
147112,Pearson,0,0
147113,x2,0,0
147114,34.6,0,0
147115,",",0,0
147116,p,0,0
147117,<,0,0
147118,0.0001,0,0
147119,at,0,0
147120,95,0,0
147121,%,0,0
147122,CI,0,0
147123,),0,0
147124,and,0,0
147125,1-year,0,0
147126,(,0,0
147127,85,0,1
147128,%,0,0
147129,vs,0,0
147130,37,0,1
147131,%,0,0
147132,OMT,0,0
147133,),0,0
147134,.,0,0
147135,At,0,0
147136,6-months,0,0
147137,of,0,0
147138,amiloride,0,0
147139,",",0,0
147140,ECG,0,0
147141,became,0,0
147142,normal,0,1
147143,(,0,0
147144,29,0,1
147145,%,0,0
147146,vs,0,0
147147,0,0,0
147148,%,0,0
147149,",",0,0
147150,RR,0,0
147151,?,0,0
147152,uncalculated-time,0,0
147153,",",0,0
147154,odds,0,0
147155,ratio,0,0
147156,?,0,0
147157,",",0,0
147158,Pearson,0,0
147159,x2,0,0
147160,42.4,0,0
147161,at,0,0
147162,95,0,0
147163,%,0,0
147164,CI,0,0
147165,",",0,0
147166,p,0,0
147167,<,0,0
147168,0.0001,0,0
147169,),0,0
147170,",",0,0
147171,improved,0,0
147172,(,0,0
147173,55,0,1
147174,%,0,0
147175,vs,0,0
147176,29,0,1
147177,%,0,0
147178,;,0,0
147179,RR2.1,0,0
147180,",",0,0
147181,odds,0,0
147182,ratio,0,0
147183,3.16,0,0
147184,",",0,0
147185,95,0,0
147186,%,0,0
147187,CI,0,0
147188,",",0,0
147189,p,0,0
147190,<,0,0
147191,0.0001,0,0
147192,),0,0
147193,or,0,0
147194,unchanged,0,0
147195,(,0,0
147196,15,0,0
147197,%,0,0
147198,vs,0,0
147199,67,0,1
147200,%,0,0
147201,OMT,0,0
147202,),0,0
147203,.,0,0
147204,At,0,0
147205,1-year,0,0
147206,",",0,0
147207,seven,0,0
147208,patients,0,1
147209,on,0,0
147210,amiloride,0,0
147211,(,0,0
147212,18,0,1
147213,%,0,0
147214,),0,0
147215,exhibited,0,0
147216,evidence,0,0
147217,of,0,0
147218,electrical,0,0
147219,regeneration,0,0
147220,of,0,0
147221,the,0,0
147222,heart,0,0
147223,",",0,0
147224,not,0,0
147225,observed,0,0
147226,with,0,0
147227,placebo,0,0
147228,.,0,0
147229,IN,0,0
147230,CONCLUSION,0,0
147231,This,0,0
147232,therapeutical,0,0
147233,innovation,0,0
147234,of,0,0
147235,amiloride,0,0
147236,improves,0,0
147237,RBC,0,0
147238,H/K,0,0
147239,and,0,0
147240,O2/CO2,0,0
147241,function,0,0
147242,",",0,0
147243,and,0,0
147244,reverses,0,0
147245,angina,0,1
147246,",",0,0
147247,ST-T,0,0
147248,alterations,0,0
147249,while,0,0
147250,inducing,0,0
147251,electrical,0,0
147252,regeneration,0,0
147253,of,0,0
147254,the,0,0
147255,heart,0,0
147256,",",0,0
147257,in,1,0
147258,patients,1,1
147259,receiving,1,1
147260,optimal,1,0
147261,medical,1,1
147262,treatment,1,0
147263,for,1,0
147264,angina,1,1
147265,.,0,0
147266,The,0,0
147267,article,0,0
147268,has,0,0
147269,short,0,0
147270,discussion,0,0
147271,on,0,0
147272,the,0,0
147273,relevant,0,0
147274,patents,0,0
147275,to,0,0
147276,the,0,0
147277,topic,0,0
147278,.,0,0
147279,Multiple,0,0
147280,courses,0,0
147281,of,0,0
147282,rituximab,0,0
147283,produce,0,0
147284,sustained,0,0
147285,clinical,0,0
147286,and,0,0
147287,radiographic,0,0
147288,efficacy,0,0
147289,and,0,0
147290,safety,0,0
147291,in,0,0
147292,patients,1,1
147293,with,1,1
147294,rheumatoid,1,1
147295,arthritis,1,1
147296,and,1,0
147297,an,1,0
147298,inadequate,1,0
147299,response,1,0
147300,to,1,0
147301,1,1,0
147302,or,1,0
147303,more,1,0
147304,tumor,1,0
147305,necrosis,1,0
147306,factor,1,0
147307,inhibitors,1,0
147308,:,1,1
147309,5-year,0,0
147310,data,0,0
147311,from,0,1
147312,the,0,0
147313,REFLEX,0,0
147314,study,0,0
147315,.,0,0
147316,OBJECTIVE,0,0
147317,This,0,0
147318,5-year,0,0
147319,observational,0,0
147320,posthoc,0,0
147321,analysis,0,0
147322,of,0,0
147323,the,0,0
147324,REFLEX,0,0
147325,study,0,0
147326,and,0,0
147327,its,0,0
147328,open-label,0,0
147329,extension,0,0
147330,assessed,0,0
147331,clinical,0,0
147332,efficacy,0,0
147333,",",0,0
147334,radiographic,0,0
147335,response,0,0
147336,",",0,0
147337,and,0,0
147338,safety,0,0
147339,of,0,0
147340,rituximab,0,0
147341,(,0,0
147342,RTX,0,0
147343,),0,0
147344,in,0,0
147345,patients,1,1
147346,with,1,1
147347,rheumatoid,1,1
147348,arthritis,1,1
147349,(,1,0
147350,RA,1,1
147351,),1,1
147352,who,1,1
147353,had,1,1
147354,an,1,1
147355,inadequate,1,0
147356,response,1,0
147357,to,1,0
147358,tumor,1,0
147359,necrosis,1,0
147360,factor,1,0
147361,(,1,0
147362,TNF,1,0
147363,),1,0
147364,inhibitors,1,0
147365,.,1,1
147366,METHODS,0,0
147367,Patients,1,1
147368,in,1,1
147369,REFLEX,1,1
147370,were,0,0
147371,originally,0,0
147372,randomized,0,0
147373,to,0,0
147374,placebo,0,0
147375,(,0,0
147376,PBO,0,0
147377,),0,0
147378,+,0,0
147379,methotrexate,0,0
147380,(,0,0
147381,MTX,0,0
147382,;,0,0
147383,PBO-randomized,0,0
147384,),0,0
147385,or,0,0
147386,RTX,0,0
147387,+,0,0
147388,MTX,0,0
147389,(,0,0
147390,RTX-randomized,0,0
147391,),0,0
147392,.,0,0
147393,PBO-randomized,1,0
147394,patients,1,1
147395,were,0,0
147396,rescued,0,0
147397,with,0,1
147398,RTX,0,0
147399,as,0,0
147400,appropriate,0,0
147401,.,0,1
147402,Patients,0,1
147403,responding,0,0
147404,to,0,0
147405,initial,0,0
147406,RTX,0,0
147407,treatment,0,0
147408,could,0,0
147409,receive,0,0
147410,further,0,0
147411,RTX,0,0
147412,courses,0,0
147413,.,0,0
147414,For,0,0
147415,clinical,0,0
147416,efficacy,0,0
147417,and,0,0
147418,safety,0,0
147419,analyses,0,0
147420,",",0,0
147421,PBO-randomized,0,0
147422,patients,0,1
147423,were,0,0
147424,re-baselined,0,0
147425,prior,0,0
147426,to,0,0
147427,first,0,0
147428,RTX,0,0
147429,treatment,0,0
147430,and,0,0
147431,the,0,0
147432,data,0,0
147433,were,0,0
147434,pooled,0,0
147435,with,0,1
147436,RTX-randomized,0,0
147437,patient,0,1
147438,data,0,0
147439,.,0,0
147440,Efficacy,0,0
147441,outcomes,0,0
147442,24,0,0
147443,weeks,0,0
147444,after,0,0
147445,each,0,0
147446,course,0,0
147447,were,0,0
147448,calculated,0,0
147449,relative,0,0
147450,to,0,0
147451,first,0,0
147452,RTX,0,0
147453,pretreatment,0,0
147454,baseline,0,0
147455,.,0,0
147456,Radiographic,0,0
147457,outcomes,0,0
147458,were,0,0
147459,assessed,0,0
147460,relative,0,0
147461,to,0,0
147462,randomization,0,0
147463,baseline,0,0
147464,for,0,0
147465,both,0,0
147466,PBO-randomized,0,0
147467,and,0,0
147468,RTX-randomized,0,0
147469,groups,0,0
147470,.,0,0
147471,RESULTS,0,0
147472,A,0,0
147473,total,0,0
147474,of,0,0
147475,480,1,0
147476,patients,1,1
147477,received,1,0
147478,?,1,0
147479,1,1,0
147480,RTX,1,0
147481,course,1,0
147482,.,1,0
147483,At,0,0
147484,24,0,0
147485,weeks,0,0
147486,",",0,0
147487,American,0,1
147488,College,0,1
147489,of,0,0
147490,Rheumatology,0,1
147491,20/50/70,0,0
147492,responses,0,0
147493,were,0,0
147494,62.0,0,0
147495,%,0,0
147496,",",0,0
147497,30.8,0,0
147498,%,0,0
147499,",",0,0
147500,and,0,0
147501,13.0,0,0
147502,%,0,0
147503,",",0,0
147504,respectively,0,0
147505,at,0,0
147506,course,0,0
147507,1,0,0
147508,(,0,0
147509,n,0,1
147510,=,0,0
147511,400,0,0
147512,),0,0
147513,and,0,0
147514,70.3,0,0
147515,%,0,0
147516,",",0,0
147517,41.8,0,0
147518,%,0,0
147519,",",0,0
147520,and,0,0
147521,22.0,0,0
147522,%,0,0
147523,at,0,0
147524,course,0,0
147525,5,0,0
147526,(,0,0
147527,n,0,1
147528,=,0,0
147529,91,0,1
147530,),0,0
147531,.,0,0
147532,European,0,1
147533,League,0,1
147534,Against,0,0
147535,Rheumatism,0,1
147536,good/moderate,0,1
147537,responses,0,0
147538,were,0,0
147539,77.2,0,0
147540,%,0,0
147541,and,0,0
147542,84.4,0,0
147543,%,0,0
147544,at,0,0
147545,courses,0,0
147546,1,0,0
147547,(,0,0
147548,n,0,1
147549,=,0,0
147550,390,0,1
147551,),0,0
147552,and,0,0
147553,5,0,0
147554,(,0,0
147555,n,0,1
147556,=,0,0
147557,90,0,0
147558,),0,0
147559,.,0,0
147560,Rates,0,0
147561,of,0,0
147562,adverse,0,0
147563,events,0,0
147564,(,0,0
147565,AE,0,0
147566,),0,0
147567,",",0,0
147568,serious,0,0
147569,AE,0,0
147570,",",0,0
147571,and,0,0
147572,infections,0,0
147573,generally,0,0
147574,remained,0,0
147575,stable,0,1
147576,.,0,0
147577,Rate,0,0
147578,of,0,0
147579,progressive,0,0
147580,joint,0,0
147581,damage,0,0
147582,(,0,0
147583,PJD,0,0
147584,;,0,0
147585,change,0,0
147586,in,0,0
147587,mean,0,0
147588,Total,0,1
147589,Sharp,0,0
147590,Score,0,1
147591,),0,0
147592,decreased,0,0
147593,over,0,0
147594,time,0,0
147595,in,0,0
147596,both,0,0
147597,PBO-randomized,0,0
147598,(,0,0
147599,n,0,1
147600,=,0,0
147601,79,0,1
147602,),0,0
147603,and,0,0
147604,RTX-randomized,0,0
147605,(,0,0
147606,n,0,1
147607,=,0,0
147608,105,0,1
147609,),0,1
147610,groups,0,0
147611,.,0,0
147612,Mean,0,0
147613,change,0,0
147614,from,0,0
147615,baseline,0,0
147616,in,0,0
147617,PJD,0,0
147618,over,0,0
147619,5,0,0
147620,years,0,1
147621,was,0,0
147622,greater,0,0
147623,in,0,0
147624,PBO-randomized,0,0
147625,versus,0,0
147626,RTX-randomized,0,0
147627,patients,0,1
147628,(,0,0
147629,5.51,0,0
147630,vs,0,0
147631,3.21,0,0
147632,),0,0
147633,.,0,0
147634,CONCLUSION,0,0
147635,RTX,0,0
147636,re-treatment,0,0
147637,over,0,0
147638,5,0,0
147639,years,0,1
147640,is,0,0
147641,associated,0,0
147642,with,0,0
147643,maintained,0,0
147644,or,0,0
147645,improved,0,0
147646,efficacy,0,0
147647,",",0,0
147648,continued,0,0
147649,inhibition,0,0
147650,of,0,0
147651,PJD,0,0
147652,",",0,0
147653,and,0,0
147654,a,0,0
147655,safety,0,0
147656,profile,0,0
147657,consistent,0,0
147658,with,0,0
147659,that,0,0
147660,previously,0,0
147661,reported,0,0
147662,.,0,0
147663,A,0,0
147664,delay,0,0
147665,in,0,0
147666,initiating,0,0
147667,RTX,0,0
147668,treatment,0,0
147669,may,0,0
147670,result,0,0
147671,in,0,0
147672,increased,0,0
147673,PJD,0,0
147674,.,0,1
147675,Effects,0,0
147676,of,0,0
147677,psychosocial,0,0
147678,program,0,0
147679,for,0,0
147680,preparing,0,0
147681,long-term,1,0
147682,hospitalized,1,1
147683,patients,1,1
147684,with,1,1
147685,schizophrenia,1,1
147686,for,1,0
147687,discharge,1,0
147688,from,1,0
147689,hospital,1,1
147690,:,1,1
147691,randomized,0,0
147692,controlled,0,0
147693,trial,0,0
147694,.,0,0
147695,AIM,0,0
147696,The,0,0
147697,aims,0,0
147698,of,0,0
147699,the,0,0
147700,present,0,0
147701,study,0,0
147702,were,0,0
147703,to,0,0
147704,revise,0,0
147705,the,0,0
147706,Community,1,0
147707,Re-entry,1,0
147708,Program-Japanese,1,1
147709,version,0,0
147710,and,0,0
147711,to,0,0
147712,review,0,0
147713,the,0,0
147714,effectiveness,0,0
147715,of,0,0
147716,the,0,0
147717,revised,0,0
147718,Program,0,0
147719,",",0,0
147720,named,0,0
147721,the,0,0
147722,Discharge,0,0
147723,Preparation,0,0
147724,Program,0,0
147725,.,0,0
147726,METHODS,0,0
147727,This,0,0
147728,study,0,0
147729,was,0,0
147730,a,0,0
147731,randomized,0,0
147732,controlled,0,0
147733,trial,0,0
147734,.,0,0
147735,The,0,0
147736,Discharge,1,0
147737,Preparation,1,0
147738,Program,1,0
147739,(,1,0
147740,DPP,1,0
147741,),1,0
147742,was,0,0
147743,the,0,0
147744,intervention,1,0
147745,condition,1,0
147746,(,1,0
147747,n,1,1
147748,=,1,0
147749,26,1,1
147750,),1,0
147751,",",0,0
147752,and,0,0
147753,the,0,0
147754,usual,0,0
147755,rehabilitation,0,1
147756,program,0,0
147757,was,0,0
147758,the,0,0
147759,control,1,0
147760,condition,1,0
147761,(,1,0
147762,n,1,1
147763,=,1,0
147764,23,1,1
147765,),1,0
147766,.,1,0
147767,Outcome,0,0
147768,indicators,0,0
147769,included,0,1
147770,factors,0,0
147771,that,0,0
147772,make,0,0
147773,patient,0,0
147774,discharge,0,0
147775,difficult,0,0
147776,(,0,0
147777,which,0,0
147778,nurses,0,1
147779,evaluated,0,0
147780,),0,0
147781,",",0,0
147782,psychiatric,0,1
147783,symptom,0,0
147784,",",0,0
147785,knowledge,0,0
147786,about,0,0
147787,the,0,0
147788,illness,0,1
147789,or,0,0
147790,medication,0,0
147791,",",0,0
147792,and,0,0
147793,the,0,0
147794,number,1,0
147795,of,1,0
147796,patients,1,1
147797,who,1,1
147798,were,1,1
147799,discharged,1,1
147800,within,1,0
147801,6,1,0
147802,months,1,0
147803,after,1,0
147804,the,1,0
147805,end,1,0
147806,of,1,0
147807,a,1,0
147808,program,1,0
147809,.,1,0
147810,RESULTS,0,0
147811,Significant,0,0
147812,improvements,0,0
147813,were,0,0
147814,found,0,0
147815,in,0,0
147816,the,0,0
147817,score,0,0
147818,of,0,0
147819,the,0,0
147820,'Issues,0,0
147821,on,0,0
147822,treatment,0,0
147823,compliance,0,0
147824,',0,0
147825,factor,0,0
147826,and,0,0
147827,the,0,0
147828,score,0,0
147829,of,0,0
147830,the,0,0
147831,'Autistic,0,1
147832,life,0,0
147833,',0,0
147834,factor,0,0
147835,",",0,0
147836,which,0,0
147837,are,0,0
147838,subscales,0,0
147839,of,0,0
147840,the,0,0
147841,Discharge,0,0
147842,Difficulty,0,0
147843,Scale,0,0
147844,",",0,0
147845,for,0,0
147846,the,0,0
147847,DPP,0,0
147848,group,0,0
147849,",",0,0
147850,on,0,0
147851,two-way,0,0
147852,ANOVA,0,0
147853,(,0,0
147854,'Issues,0,0
147855,on,0,0
147856,treatment,0,0
147857,compliance,0,0
147858,',0,0
147859,:,0,0
147860,F,0,0
147861,=,0,0
147862,3.818,0,0
147863,",",0,0
147864,P,0,0
147865,<,0,0
147866,0.10,0,0
147867,;,0,0
147868,'Autistic,0,1
147869,life,0,0
147870,',0,1
147871,:,0,0
147872,F,0,0
147873,=,0,0
147874,4.155,0,0
147875,",",0,0
147876,P,0,0
147877,<,0,0
147878,0.05,0,0
147879,),0,0
147880,These,0,0
147881,factors,0,0
147882,affected,0,0
147883,discharge,0,0
147884,outcome,0,0
147885,.,0,0
147886,Thus,0,0
147887,",",0,0
147888,the,0,0
147889,program,0,0
147890,may,0,0
147891,be,0,0
147892,capable,0,0
147893,of,0,0
147894,promoting,0,0
147895,discharge,0,0
147896,of,0,0
147897,long-term,1,0
147898,hospitalized,1,1
147899,psychiatric,1,1
147900,patients,1,1
147901,.,1,0
147902,With,0,0
147903,regard,0,0
147904,to,0,0
147905,the,0,0
147906,number,0,0
147907,of,0,0
147908,patients,0,1
147909,discharged,0,1
147910,in,0,0
147911,6,0,0
147912,months,0,0
147913,after,0,0
147914,the,0,0
147915,end,0,0
147916,of,0,0
147917,a,0,0
147918,program,0,0
147919,",",0,0
147920,there,0,0
147921,was,0,0
147922,no,0,0
147923,significant,0,0
147924,difference,0,0
147925,between,0,0
147926,both,0,0
147927,groups,0,0
147928,.,0,0
147929,CONCLUSION,0,0
147930,The,0,0
147931,present,0,0
147932,result,0,0
147933,is,0,0
147934,in,0,0
147935,agreement,0,0
147936,with,0,1
147937,past,0,0
147938,studies,0,0
147939,",",0,0
147940,and,0,0
147941,the,0,0
147942,DPP,0,0
147943,is,0,0
147944,useful,0,0
147945,in,0,0
147946,discharge,0,0
147947,support,0,0
147948,for,0,0
147949,patients,1,1
147950,with,1,1
147951,schizophrenia,1,1
147952,in,1,0
147953,Japan,1,1
147954,.,1,1
147955,Hemostasis,0,0
147956,by,0,0
147957,bipolar,0,0
147958,coagulation,0,0
147959,versus,0,0
147960,suture,0,0
147961,after,0,0
147962,surgical,0,0
147963,stripping,0,0
147964,of,0,0
147965,bilateral,0,1
147966,ovarian,0,1
147967,endometriomas,0,1
147968,:,0,1
147969,a,0,0
147970,randomized,0,0
147971,controlled,0,0
147972,trial,0,0
147973,.,0,0
147974,STUDY,0,0
147975,OBJECTIVE,0,0
147976,To,0,0
147977,estimate,0,0
147978,whether,0,0
147979,the,0,0
147980,suture,0,0
147981,of,0,0
147982,the,0,0
147983,ovary,0,0
147984,is,0,0
147985,superior,0,0
147986,to,0,0
147987,bipolar,0,0
147988,coagulation,0,0
147989,in,0,0
147990,preserving,0,0
147991,ovarian,0,1
147992,reserve,0,1
147993,in,0,0
147994,infertile,1,1
147995,women,1,1
147996,undergoing,1,1
147997,laparoscopic,1,1
147998,stripping,1,0
147999,of,1,0
148000,bilateral,1,1
148001,endometriomas,1,1
148002,.,1,0
148003,DESIGN,0,0
148004,Randomized,0,0
148005,controlled,0,0
148006,trial,0,0
148007,(,0,0
148008,Canadian,0,1
148009,Task,0,0
148010,Force,0,0
148011,classification,0,0
148012,I,0,0
148013,),0,0
148014,.,0,0
148015,SETTING,0,0
148016,University,1,1
148017,teaching,1,0
148018,hospital,1,0
148019,.,1,0
148020,PATIENTS,0,0
148021,100,1,0
148022,patients,1,1
148023,with,1,1
148024,bilateral,1,1
148025,endometriomas,1,1
148026,.,1,1
148027,INTERVENTIONS,0,0
148028,Patients,0,1
148029,underwent,0,1
148030,stripping,0,0
148031,of,0,0
148032,bilateral,0,1
148033,endometriomas,0,1
148034,and,0,0
148035,were,0,0
148036,randomized,0,0
148037,to,0,0
148038,undergo,0,0
148039,hemostasis,0,0
148040,by,0,0
148041,use,0,0
148042,of,0,0
148043,either,0,0
148044,laparoscopic,0,0
148045,suturing,0,0
148046,(,0,0
148047,LS,0,0
148048,group,0,0
148049,),0,0
148050,or,0,0
148051,bipolar,0,0
148052,coagulation,0,0
148053,(,0,0
148054,BC,0,0
148055,group,0,0
148056,),0,0
148057,.,0,0
148058,Changes,0,0
148059,in,0,0
148060,ovarian,0,1
148061,reserve,0,1
148062,were,0,0
148063,investigated,0,0
148064,by,0,0
148065,measuring,0,0
148066,the,0,0
148067,levels,0,0
148068,of,0,0
148069,anti-Mullerian,0,1
148070,hormone,0,0
148071,(,0,0
148072,AMH,0,1
148073,),0,0
148074,and,0,0
148075,basal,0,0
148076,follicle-stimulating,0,0
148077,hormone,0,0
148078,(,0,0
148079,FSH,0,0
148080,),0,0
148081,before,0,0
148082,surgery,0,1
148083,and,0,0
148084,at,0,0
148085,3,0,0
148086,",",0,0
148087,6,0,0
148088,and,0,0
148089,12,0,0
148090,months,0,0
148091,from,0,1
148092,surgery,0,1
148093,.,0,0
148094,MEASUREMENTS,0,0
148095,AND,0,0
148096,MAIN,0,0
148097,RESULTS,0,0
148098,At,0,0
148099,3-month,0,0
148100,",",0,0
148101,6-month,0,0
148102,",",0,0
148103,and,0,0
148104,12-month,0,0
148105,follow-up,0,0
148106,",",0,0
148107,in,0,0
148108,both,0,0
148109,study,0,0
148110,groups,0,0
148111,",",0,0
148112,postsurgical,0,1
148113,AMH,0,1
148114,levels,0,0
148115,were,0,0
148116,significantly,0,0
148117,lower,0,0
148118,and,0,0
148119,basal,0,0
148120,FSH,0,0
148121,levels,0,0
148122,were,0,0
148123,significantly,0,0
148124,higher,0,0
148125,than,0,0
148126,before,0,0
148127,surgery,0,1
148128,.,0,0
148129,There,0,0
148130,was,0,0
148131,no,0,0
148132,significant,0,0
148133,difference,0,0
148134,in,0,0
148135,the,0,0
148136,mean,0,0
148137,percentage,0,0
148138,decrease,0,0
148139,of,0,0
148140,AMH,0,1
148141,levels,0,0
148142,in,0,0
148143,the,0,0
148144,BC,0,0
148145,group,0,0
148146,and,0,0
148147,LS,0,0
148148,group,0,0
148149,at,0,0
148150,3-,0,0
148151,",",0,0
148152,6-,0,0
148153,",",0,0
148154,and,0,0
148155,12-month,0,0
148156,follow-up,0,0
148157,.,0,0
148158,The,0,0
148159,mean,0,0
148160,percentage,0,0
148161,increase,0,0
148162,in,0,0
148163,basal,0,0
148164,FSH,0,0
148165,was,0,0
148166,higher,0,0
148167,in,0,0
148168,the,0,0
148169,BC,0,0
148170,group,0,0
148171,than,0,0
148172,in,0,0
148173,the,0,0
148174,LS,0,0
148175,group,0,0
148176,at,0,0
148177,both,0,0
148178,3-month,0,0
148179,(,0,0
148180,p,0,0
148181,=,0,0
148182,.023,0,0
148183,),0,0
148184,and,0,0
148185,6-month,0,0
148186,follow-up,0,0
148187,(,0,0
148188,p,0,0
148189,=,0,0
148190,.029,0,0
148191,),0,0
148192,",",0,0
148193,but,0,0
148194,not,0,0
148195,at,0,0
148196,12-month,0,0
148197,follow-up,0,0
148198,.,0,0
148199,Pregnancy,0,0
148200,rate,0,0
148201,",",0,0
148202,time,0,0
148203,to,0,0
148204,conception,0,0
148205,",",0,0
148206,and,0,0
148207,rate,0,0
148208,of,0,0
148209,endometrioma,0,1
148210,recurrence,0,0
148211,was,0,0
148212,similar,0,0
148213,in,0,0
148214,the,0,0
148215,2,0,0
148216,study,0,0
148217,groups,0,0
148218,.,0,1
148219,CONCLUSION,0,0
148220,Laparoscopic,0,0
148221,stripping,0,0
148222,of,0,0
148223,ovarian,0,1
148224,endometriotic,0,1
148225,cyst,0,0
148226,significantly,0,0
148227,decreases,0,0
148228,serum,0,0
148229,AMH,0,1
148230,levels,0,0
148231,and,0,0
148232,increases,0,0
148233,basal,0,0
148234,FSH,0,0
148235,levels,0,0
148236,independent,0,0
148237,from,0,0
148238,the,0,0
148239,method,0,0
148240,used,0,0
148241,to,0,0
148242,obtain,0,0
148243,hemostasis,0,0
148244,on,0,0
148245,the,0,0
148246,ovarian,0,1
148247,tissue,0,0
148248,.,0,0
148249,Pulmonary,0,0
148250,vein,0,0
148251,re-isolation,0,0
148252,for,0,0
148253,atrial,1,1
148254,fibrillation,1,1
148255,using,0,0
148256,duty-cycled,0,0
148257,phased,0,0
148258,radiofrequency,0,0
148259,ablation,0,1
148260,:,0,0
148261,safety,0,0
148262,and,0,0
148263,efficacy,0,0
148264,of,0,0
148265,a,0,0
148266,primary,0,0
148267,2:1,0,1
148268,bipolar/unipolar,0,1
148269,ablation,0,1
148270,mode,0,0
148271,.,0,0
148272,PURPOSE,0,0
148273,Pulmonary,0,0
148274,vein,0,0
148275,isolation,0,0
148276,(,0,0
148277,PVI,0,0
148278,),0,0
148279,using,0,0
148280,phased,0,0
148281,radiofrequency,0,0
148282,(,0,0
148283,RF,0,0
148284,),0,0
148285,energy,0,0
148286,has,0,0
148287,been,0,0
148288,shown,0,0
148289,to,0,0
148290,be,0,0
148291,effective,0,0
148292,in,0,0
148293,the,0,0
148294,treatment,0,0
148295,of,0,0
148296,paroxysmal,1,1
148297,atrial,1,1
148298,fibrillation,1,1
148299,(,1,0
148300,AF,1,0
148301,),1,0
148302,.,1,0
148303,We,0,0
148304,characterize,0,0
148305,pulmonary,0,0
148306,vein,0,0
148307,(,0,0
148308,PV,0,0
148309,),0,0
148310,conduction,0,0
148311,at,0,0
148312,repeat,0,0
148313,ablation,0,1
148314,in,0,0
148315,patients,1,1
148316,with,1,1
148317,AF,1,1
148318,after,0,0
148319,an,0,0
148320,initial,0,0
148321,successful,0,0
148322,PVI,0,1
148323,using,0,0
148324,phased,0,0
148325,RF,0,0
148326,technology,0,0
148327,and,0,0
148328,analyze,0,0
148329,the,0,0
148330,effects,0,0
148331,of,0,0
148332,a,0,0
148333,primary,0,0
148334,2:1,0,1
148335,ablation,0,1
148336,mode,0,0
148337,.,0,0
148338,METHODS,0,0
148339,AND,0,0
148340,RESULTS,0,0
148341,A,0,0
148342,primary,0,1
148343,4:1,0,0
148344,bipolar/unipolar,0,1
148345,mode,0,0
148346,in,0,0
148347,group,0,0
148348,A,0,0
148349,patients,0,1
148350,(,1,0
148351,n,1,1
148352,=,1,0
148353,22,1,1
148354,),1,0
148355,was,0,0
148356,compared,0,0
148357,with,0,0
148358,a,0,0
148359,primary,0,0
148360,2:1,0,1
148361,mode,0,0
148362,in,0,0
148363,group,0,0
148364,B,0,0
148365,(,1,0
148366,n,1,1
148367,=,1,0
148368,22,1,1
148369,),1,0
148370,acutely,0,0
148371,and,0,0
148372,during,0,0
148373,follow-up,0,0
148374,.,0,0
148375,Of,0,0
148376,all,0,0
148377,PVs,0,0
148378,",",0,0
148379,81,0,0
148380,%,0,0
148381,showed,0,0
148382,reconnection,0,0
148383,(,0,0
148384,s,0,0
148385,),0,0
148386,;,0,0
148387,52,0,0
148388,%,0,0
148389,of,0,0
148390,them,0,0
148391,had,0,0
148392,reconnected,0,0
148393,in,0,0
148394,all,0,0
148395,PVs,0,0
148396,.,0,0
148397,PVI,0,0
148398,was,0,0
148399,achieved,0,0
148400,in,0,0
148401,all,0,0
148402,patients,0,1
148403,without,0,1
148404,complications,0,0
148405,.,0,0
148406,Procedure,0,0
148407,and,0,0
148408,fluoroscopy,0,0
148409,times,0,0
148410,were,0,0
148411,shorter,0,0
148412,in,0,0
148413,group,0,0
148414,B,0,0
148415,(,0,0
148416,108,0,1
148417,?,0,0
148418,15,0,0
148419,vs.,0,0
148420,126,0,1
148421,?,0,0
148422,24,0,0
148423,min,0,0
148424,and,0,0
148425,17,0,0
148426,?,0,0
148427,5,0,0
148428,vs.,0,0
148429,23,0,1
148430,?,0,0
148431,7,0,0
148432,min,0,0
148433,",",0,0
148434,respectively,0,0
148435,),0,0
148436,.,0,0
148437,This,0,0
148438,was,0,0
148439,attributed,0,0
148440,to,0,0
148441,a,0,0
148442,significant,0,0
148443,decrease,0,0
148444,of,0,0
148445,early,0,1
148446,PV,0,0
148447,reconnections,0,0
148448,within,0,0
148449,the,0,0
148450,first,0,0
148451,30,0,0
148452,min,0,0
148453,in,0,0
148454,17,0,0
148455,%,0,0
148456,of,0,0
148457,group,0,0
148458,B,0,0
148459,patients,0,1
148460,vs.,0,0
148461,45,0,1
148462,%,0,0
148463,of,0,0
148464,group,0,0
148465,A,0,0
148466,patients,0,1
148467,(,0,0
148468,p,0,0
148469,<,0,0
148470,0.001,0,0
148471,),0,0
148472,.,0,0
148473,After,0,0
148474,9.5,0,0
148475,?,0,0
148476,4,0,0
148477,months,0,0
148478,",",0,0
148479,recurrence,0,0
148480,of,0,0
148481,AF,0,0
148482,was,0,0
148483,detected,0,0
148484,in,0,0
148485,5,0,0
148486,of,0,0
148487,22,0,1
148488,patients,0,1
148489,(,0,0
148490,22.7,0,0
148491,%,0,0
148492,),0,0
148493,in,0,0
148494,group,0,0
148495,A,0,0
148496,vs.,0,0
148497,3,0,0
148498,of,0,0
148499,22,0,1
148500,patients,0,1
148501,(,0,0
148502,13.6,0,0
148503,%,0,0
148504,),0,0
148505,in,0,0
148506,group,0,0
148507,B,0,0
148508,(,0,0
148509,p,0,0
148510,=,0,0
148511,0.722,0,0
148512,),0,0
148513,.,0,0
148514,CONCLUSIONS,0,0
148515,Phased,0,0
148516,RF,0,0
148517,energy,0,0
148518,applied,0,0
148519,by,0,0
148520,a,0,0
148521,2:1,0,1
148522,bipolar/unipolar,0,0
148523,mode,0,0
148524,seems,0,0
148525,safe,0,0
148526,and,0,0
148527,effective,0,0
148528,in,0,0
148529,redo-PVI,0,1
148530,procedures,0,0
148531,",",0,0
148532,resulting,0,0
148533,in,0,0
148534,a,0,0
148535,mid-term,0,0
148536,freedom,0,0
148537,from,0,0
148538,AF,0,0
148539,in,0,0
148540,86.4,0,0
148541,%,0,0
148542,.,0,0
148543,Significant,0,0
148544,shorter,0,0
148545,procedure,0,0
148546,and,0,0
148547,fluoroscopy,0,0
148548,times,0,0
148549,compared,0,0
148550,with,0,1
148551,a,0,0
148552,primary,0,0
148553,4:1,0,0
148554,ablation,0,0
148555,mode,0,0
148556,during,0,0
148557,repeat,0,0
148558,PVI,0,0
148559,are,0,0
148560,mainly,0,0
148561,attributed,0,0
148562,to,0,0
148563,a,0,0
148564,lower,0,0
148565,incidence,0,0
148566,of,0,0
148567,acutely,0,0
148568,reconnected,0,0
148569,PVs,0,0
148570,within,0,0
148571,the,0,0
148572,first,0,0
148573,30,0,0
148574,min,0,0
148575,.,0,0
148576,Dysfunctional,0,0
148577,attitudes,0,0
148578,as,0,0
148579,a,0,0
148580,moderator,0,0
148581,of,0,0
148582,pharmacotherapy,0,1
148583,and,0,0
148584,psychotherapy,0,0
148585,for,0,0
148586,chronic,1,1
148587,depression,1,1
148588,.,1,0
148589,OBJECTIVE,0,0
148590,Individuals,1,1
148591,with,1,1
148592,chronic,1,1
148593,depression,1,1
148594,exhibit,0,0
148595,heterogeneous,0,0
148596,responses,0,0
148597,to,0,0
148598,treatment,0,0
148599,.,0,0
148600,Important,0,0
148601,individual,0,0
148602,differences,0,0
148603,may,0,0
148604,therefore,0,0
148605,exist,0,0
148606,within,0,0
148607,this,0,0
148608,particularly,0,0
148609,difficult,0,0
148610,to,0,0
148611,treat,0,0
148612,population,0,1
148613,that,0,0
148614,act,0,0
148615,as,0,0
148616,moderators,0,0
148617,of,0,0
148618,treatment,0,0
148619,response,0,0
148620,.,0,0
148621,METHOD,0,0
148622,The,0,0
148623,present,0,0
148624,study,0,0
148625,examined,0,0
148626,whether,0,0
148627,pretreatment,0,0
148628,levels,0,0
148629,of,0,0
148630,dysfunctional,0,1
148631,attitudes,0,0
148632,(,0,0
148633,DA,0,0
148634,),0,0
148635,moderated,0,0
148636,treatment,0,0
148637,response,0,0
148638,in,0,0
148639,a,0,0
148640,large,1,0
148641,sample,1,1
148642,of,1,0
148643,chronically,1,1
148644,depressed,1,1
148645,individuals,1,1
148646,.,1,1
148647,Data,0,0
148648,were,0,0
148649,taken,0,0
148650,from,0,0
148651,the,0,0
148652,Research,0,0
148653,Evaluating,0,0
148654,the,0,0
148655,Value,0,0
148656,of,0,0
148657,Augmenting,0,0
148658,Medication,0,0
148659,with,0,1
148660,Psychotherapy,0,0
148661,(,0,0
148662,REVAMP,0,0
148663,),0,0
148664,treatment,0,0
148665,study,0,0
148666,--,0,0
148667,a,0,0
148668,multi-site,1,0
148669,treatment,1,0
148670,and,1,0
148671,augmentation,1,0
148672,study,1,0
148673,of,1,0
148674,808,1,1
148675,chronically,1,1
148676,depressed,1,1
148677,individuals,1,1
148678,.,1,1
148679,REVAMP,0,0
148680,comprised,0,1
148681,two,0,0
148682,phases,0,0
148683,:,0,1
148684,1,0,0
148685,),0,0
148686,a,0,0
148687,12-week,0,0
148688,open-label,0,0
148689,antidepressant,0,0
148690,trial,0,0
148691,and,0,0
148692,2,0,0
148693,),0,0
148694,",",0,0
148695,a,0,0
148696,subsequent,0,0
148697,phase,0,0
148698,",",0,0
148699,in,0,0
148700,which,0,0
148701,phase,0,0
148702,1,0,0
148703,non-remitters,0,1
148704,(,0,0
148705,N,0,1
148706,=,0,0
148707,491,0,1
148708,),0,0
148709,were,0,0
148710,randomized,0,0
148711,to,0,0
148712,either,0,0
148713,receive,0,0
148714,an,0,0
148715,ongoing,0,0
148716,medication,0,0
148717,algorithm,0,0
148718,alone,0,0
148719,",",0,0
148720,medication,0,0
148721,plus,0,0
148722,cognitive,0,0
148723,behavioral,0,0
148724,analysis,0,0
148725,system,0,0
148726,of,0,0
148727,psychotherapy,0,0
148728,",",0,0
148729,or,0,0
148730,medication,0,0
148731,plus,0,0
148732,brief,0,0
148733,supportive,0,0
148734,psychotherapy,0,1
148735,.,0,0
148736,RESULT,0,0
148737,In,0,0
148738,phase,0,0
148739,1,0,0
148740,",",0,0
148741,compared,0,0
148742,to,0,0
148743,the,0,0
148744,pharmacotherapy,0,0
148745,response,0,0
148746,of,0,0
148747,patients,0,1
148748,with,0,1
148749,lower,0,0
148750,DA,0,0
148751,scores,0,0
148752,",",0,0
148753,the,0,0
148754,response,0,0
148755,for,0,0
148756,patients,0,1
148757,with,0,1
148758,higher,0,0
148759,DA,0,0
148760,scores,0,0
148761,was,0,0
148762,steeper,0,0
148763,",",0,0
148764,but,0,0
148765,leveled,0,0
148766,off,0,0
148767,toward,0,0
148768,the,0,0
148769,end,0,0
148770,of,0,0
148771,the,0,0
148772,phase,0,0
148773,.,0,0
148774,In,0,0
148775,phase,0,0
148776,2,0,0
148777,",",0,0
148778,DA,0,0
148779,predicted,0,0
148780,a,0,0
148781,differential,0,0
148782,response,0,0
148783,in,0,0
148784,the,0,0
148785,medication,0,0
148786,only,0,0
148787,arm,0,0
148788,",",0,0
148789,but,0,0
148790,not,0,0
148791,in,0,0
148792,the,0,0
148793,two,0,0
148794,psychotherapy,0,0
148795,+,0,0
148796,medication,0,0
148797,conditions,0,0
148798,.,0,0
148799,Specifically,0,0
148800,",",0,0
148801,in,0,0
148802,the,0,0
148803,phase,0,0
148804,2,0,0
148805,medication,0,0
148806,only,0,0
148807,condition,0,0
148808,",",0,0
148809,patients,0,1
148810,with,0,1
148811,higher,0,0
148812,DA,0,0
148813,improved,0,0
148814,while,0,0
148815,those,0,0
148816,with,0,0
148817,lower,0,0
148818,DA,0,0
148819,scores,0,0
148820,did,0,0
148821,not,0,0
148822,.,0,0
148823,CONCLUSION,0,0
148824,These,0,0
148825,results,0,0
148826,indicate,0,0
148827,that,0,0
148828,the,0,0
148829,relation,0,0
148830,between,0,0
148831,DA,0,0
148832,and,0,0
148833,treatment,0,0
148834,response,0,0
148835,in,0,0
148836,chronic,1,1
148837,depression,1,1
148838,is,0,0
148839,complex,0,0
148840,",",0,0
148841,but,0,0
148842,suggest,0,0
148843,that,0,0
148844,greater,0,0
148845,DA,0,0
148846,may,0,0
148847,be,0,0
148848,associated,0,0
148849,with,0,0
148850,a,0,0
148851,steeper,0,0
148852,reduction,0,0
148853,and/or,0,0
148854,better,0,0
148855,response,0,0
148856,to,0,0
148857,pharmacotherapy,0,1
148858,.,0,0
148859,Effect,0,0
148860,of,0,0
148861,unfractionated,0,0
148862,and,0,0
148863,low-molecular-weight,0,0
148864,heparin,0,0
148865,on,0,0
148866,OPG,0,0
148867,",",0,0
148868,sRANKL,0,0
148869,",",0,0
148870,and,0,0
148871,von,0,0
148872,Willebrand,0,0
148873,factor,0,0
148874,concentrations,0,0
148875,during,0,0
148876,hemodialysis,1,1
148877,.,1,0
148878,BACKGROUND,0,0
148879,Endothelial,0,0
148880,dysfunction,0,0
148881,marker,0,0
148882,",",0,0
148883,von,0,0
148884,Willebrand,0,0
148885,factor,0,0
148886,(,0,0
148887,vWF,0,0
148888,),0,0
148889,",",0,0
148890,is,0,0
148891,physically,0,0
148892,connected,0,0
148893,with,0,0
148894,osteoprotegerin,0,0
148895,(,0,0
148896,OPG,0,0
148897,),0,0
148898,in,0,0
148899,the,0,0
148900,Weibel-Palade,0,0
148901,bodies,0,1
148902,.,0,1
148903,We,0,0
148904,aimed,0,0
148905,to,0,0
148906,compare,0,0
148907,the,0,0
148908,effect,0,0
148909,of,0,0
148910,unfractionated,0,0
148911,(,0,0
148912,UFH,0,0
148913,),0,0
148914,and,0,0
148915,low-molecular-weight,0,0
148916,(,0,0
148917,LMWH,0,0
148918,enoxaparin,0,0
148919,),0,0
148920,heparin,0,0
148921,used,0,0
148922,as,0,0
148923,anticoagulants,0,0
148924,during,0,0
148925,hemodialysis,1,1
148926,(,1,0
148927,HD,1,0
148928,),1,0
148929,on,0,0
148930,plasma,0,0
148931,levels,0,0
148932,and,0,0
148933,relationships,0,0
148934,of,0,0
148935,OPG,0,0
148936,",",0,0
148937,soluble,0,0
148938,receptor,0,0
148939,activator,0,0
148940,of,0,0
148941,nuclear,0,0
148942,factor,0,0
148943,?B,0,0
148944,Ligand,0,0
148945,(,0,0
148946,sRANKL,0,0
148947,),0,0
148948,",",0,0
148949,and,0,0
148950,vWF,0,0
148951,.,0,0
148952,METHODS,0,0
148953,Totally,1,0
148954,21,1,0
148955,clinically,1,0
148956,stable,1,1
148957,chronic,1,1
148958,HD,1,1
148959,patients,1,1
148960,were,0,0
148961,randomly,0,1
148962,assigned,0,0
148963,to,0,0
148964,either,0,0
148965,enoxaparin,0,0
148966,(,0,0
148967,n,0,1
148968,=,0,0
148969,10,0,1
148970,),0,0
148971,or,0,0
148972,UFH,0,0
148973,(,0,0
148974,n,0,1
148975,=,0,0
148976,11,0,1
148977,),0,0
148978,anticoagulation,0,0
148979,and,0,0
148980,followed,0,0
148981,prospectively,0,0
148982,for,0,0
148983,12,0,0
148984,weeks,0,0
148985,before,0,0
148986,crossing,0,0
148987,over,0,0
148988,to,0,0
148989,the,0,0
148990,alternate,0,0
148991,therapy,0,0
148992,for,0,0
148993,further,0,0
148994,12,0,1
148995,weeks,0,0
148996,.,0,1
148997,The,0,0
148998,OPG,0,0
148999,",",0,0
149000,RANKL,0,0
149001,",",0,0
149002,and,0,0
149003,vWF,0,0
149004,levels,0,0
149005,were,0,0
149006,measured,0,0
149007,at,0,0
149008,T0,0,1
149009,",",0,0
149010,T10,0,0
149011,",",0,0
149012,and,0,0
149013,T180,0,0
149014,of,0,0
149015,HD,0,0
149016,session,0,0
149017,after,0,0
149018,each,0,0
149019,period,0,0
149020,of,0,0
149021,evaluation,0,0
149022,.,0,0
149023,RESULTS,0,0
149024,The,0,0
149025,baseline,0,0
149026,sRANKL,0,0
149027,level,0,0
149028,was,0,0
149029,higher,0,0
149030,under,0,0
149031,UFH,0,0
149032,treatment,0,0
149033,.,0,0
149034,Its,0,0
149035,over-HD,0,0
149036,level,0,0
149037,does,0,0
149038,not,0,0
149039,behave,0,0
149040,significantly,0,0
149041,different,0,0
149042,under,0,0
149043,enoxaparin,0,0
149044,and,0,0
149045,UFH,0,0
149046,treatment,0,0
149047,.,0,0
149048,Plasma,0,0
149049,OPG,0,0
149050,levels,0,0
149051,expressly,0,0
149052,changed,0,0
149053,during,0,0
149054,both,0,0
149055,enoxaparin,0,0
149056,(,0,0
149057,?,0,0
149058,(,0,0
149059,2,0,0
149060,),0,0
149061,analysis,0,0
149062,of,0,0
149063,variance,0,0
149064,[,0,0
149065,ANOVA,0,0
149066,],0,0
149067,=,0,0
149068,31.13,0,0
149069,",",0,0
149070,P,0,0
149071,<,0,0
149072,.016,0,0
149073,),0,0
149074,and,0,0
149075,UFH,0,0
149076,(,0,0
149077,?,0,0
149078,(,0,0
149079,2,0,0
149080,),0,0
149081,ANOVA,0,0
149082,=,0,0
149083,8.26,0,0
149084,",",0,0
149085,P,0,0
149086,=,0,0
149087,.016,0,0
149088,),0,0
149089,anticoagulation,0,0
149090,",",0,0
149091,and,0,0
149092,its,0,0
149093,increment,0,0
149094,at,0,0
149095,T10,0,0
149096,and,0,0
149097,T180,0,0
149098,was,0,0
149099,significantly,0,0
149100,different,0,0
149101,between,0,0
149102,both,0,0
149103,the,0,0
149104,heparins,0,0
149105,.,0,0
149106,The,0,0
149107,main,0,0
149108,negative,0,0
149109,predictor,0,0
149110,of,0,0
149111,OPG,0,0
149112,concentration,0,0
149113,was,0,0
149114,the,0,0
149115,total,0,0
149116,cholesterol,0,0
149117,level,0,0
149118,(,0,0
149119,?,0,0
149120,=,0,0
149121,-.51,0,0
149122,",",0,0
149123,P,0,0
149124,=,0,0
149125,.025,0,0
149126,),0,0
149127,.,0,0
149128,von,0,0
149129,Willebrand,0,0
149130,factor,0,0
149131,concentration,0,0
149132,remained,0,0
149133,stable,0,1
149134,during,0,0
149135,UFH,0,0
149136,anticoagulation,0,0
149137,",",0,0
149138,whereas,0,0
149139,constant,0,0
149140,",",0,0
149141,no,0,0
149142,significant,0,0
149143,increments,0,0
149144,were,0,0
149145,noticed,0,0
149146,",",0,0
149147,under,0,0
149148,enoxaparin,0,0
149149,treatment,0,0
149150,.,0,0
149151,After,0,0
149152,10,0,0
149153,minutes,0,0
149154,of,0,0
149155,HD,0,0
149156,",",0,0
149157,especially,0,0
149158,under,0,0
149159,enoxaparin,0,0
149160,use,0,0
149161,",",0,0
149162,a,0,0
149163,positive,0,0
149164,correlation,0,0
149165,between,0,0
149166,OPG,0,0
149167,and,0,0
149168,vWF,0,0
149169,increase,0,0
149170,was,0,0
149171,noticed,0,0
149172,(,0,0
149173,P,0,0
149174,=,0,0
149175,.03,0,0
149176,",",0,0
149177,R,0,0
149178,=,0,0
149179,.45,0,0
149180,),0,0
149181,.,0,0
149182,CONCLUSIONS,0,0
149183,Impact,0,0
149184,of,0,0
149185,heparin,0,0
149186,on,0,0
149187,endothelial,0,0
149188,cells,0,0
149189,and,0,0
149190,simultaneously,0,0
149191,on,0,0
149192,OPG/RANK/RANKL,0,0
149193,axis,0,0
149194,reinforces,0,0
149195,the,0,0
149196,presumption,0,0
149197,of,0,0
149198,the,0,0
149199,pathophysiological,0,0
149200,linkage,0,0
149201,between,0,0
149202,bone,0,0
149203,mineralization,0,0
149204,and,0,0
149205,endothelial,0,0
149206,dysfunction,1,0
149207,in,1,0
149208,end-stage,1,1
149209,renal,1,1
149210,disease,1,1
149211,.,1,0
149212,Social,0,0
149213,robots,0,0
149214,as,0,0
149215,embedded,0,1
149216,reinforcers,0,0
149217,of,0,0
149218,social,1,0
149219,behavior,1,0
149220,in,1,0
149221,children,1,1
149222,with,1,1
149223,autism,1,1
149224,.,1,0
149225,In,0,0
149226,this,0,0
149227,study,0,0
149228,we,0,0
149229,examined,0,0
149230,the,0,0
149231,social,0,0
149232,behaviors,0,0
149233,of,0,0
149234,4-,1,0
149235,to,1,0
149236,12-year-old,1,1
149237,children,1,1
149238,with,1,1
149239,autism,1,1
149240,spectrum,1,1
149241,disorders,1,1
149242,(,1,0
149243,ASD,1,1
149244,;,1,0
149245,N,1,1
149246,=,1,0
149247,24,1,0
149248,),1,0
149249,during,1,0
149250,three,0,0
149251,tradic,0,1
149252,interactions,0,0
149253,with,0,1
149254,an,0,0
149255,adult,0,1
149256,confederate,0,1
149257,and,0,0
149258,an,0,0
149259,interaction,0,0
149260,partner,0,0
149261,",",0,0
149262,where,0,0
149263,the,0,0
149264,interaction,0,0
149265,partner,0,0
149266,varied,0,0
149267,randomly,0,0
149268,among,0,0
149269,(,0,0
149270,1,0,0
149271,),0,0
149272,another,0,0
149273,adult,0,1
149274,human,0,0
149275,",",0,0
149276,(,0,0
149277,2,0,0
149278,),0,0
149279,a,0,0
149280,touchscreen,0,0
149281,computer,0,0
149282,game,0,0
149283,",",0,0
149284,and,0,0
149285,(,0,0
149286,3,0,0
149287,),0,0
149288,a,0,0
149289,social,0,0
149290,dinosaur,0,1
149291,robot,0,0
149292,.,0,0
149293,Children,0,0
149294,spoke,0,0
149295,more,0,0
149296,in,0,0
149297,general,0,0
149298,",",0,0
149299,and,0,0
149300,directed,0,0
149301,more,0,0
149302,speech,0,0
149303,to,0,0
149304,the,0,0
149305,adult,0,1
149306,confederate,0,0
149307,",",0,0
149308,when,0,0
149309,the,0,0
149310,interaction,0,0
149311,partner,0,0
149312,was,0,0
149313,a,0,0
149314,robot,0,0
149315,",",0,0
149316,as,0,0
149317,compared,0,0
149318,to,0,0
149319,a,0,0
149320,human,0,0
149321,or,0,0
149322,computer,0,0
149323,game,0,0
149324,interaction,0,0
149325,partner,0,1
149326,.,0,0
149327,Children,0,1
149328,spoke,0,0
149329,as,0,0
149330,much,0,0
149331,to,0,0
149332,the,0,0
149333,robot,0,0
149334,as,0,0
149335,to,0,0
149336,the,0,0
149337,adult,0,1
149338,interaction,0,0
149339,partner,0,0
149340,.,0,0
149341,This,0,0
149342,study,0,0
149343,provides,0,0
149344,the,0,0
149345,largest,0,0
149346,demonstration,0,0
149347,of,0,0
149348,social,0,0
149349,human-robot,0,0
149350,interaction,0,0
149351,in,0,0
149352,children,0,1
149353,with,0,1
149354,autism,0,1
149355,to,0,0
149356,date,0,0
149357,.,0,0
149358,Our,0,0
149359,findings,0,0
149360,suggest,0,0
149361,that,0,0
149362,social,0,0
149363,robots,0,0
149364,may,0,0
149365,be,0,0
149366,developed,0,0
149367,into,0,0
149368,useful,0,0
149369,tools,0,0
149370,for,0,0
149371,social,0,0
149372,skills,0,0
149373,and,0,0
149374,communication,0,0
149375,therapies,0,0
149376,",",0,0
149377,specifically,0,0
149378,by,0,0
149379,embedding,0,0
149380,social,0,0
149381,interaction,0,0
149382,into,0,1
149383,intrinsic,0,0
149384,reinforcers,0,0
149385,and,0,1
149386,motivators,0,0
149387,.,0,1
149388,Effect,0,0
149389,of,0,0
149390,whole-body,0,0
149391,mild-cold,0,1
149392,exposure,0,0
149393,on,0,0
149394,arterial,0,0
149395,stiffness,0,0
149396,and,0,0
149397,central,0,0
149398,haemodynamics,0,0
149399,:,0,1
149400,a,0,0
149401,randomised,0,0
149402,",",0,0
149403,cross-over,0,0
149404,trial,0,0
149405,in,0,0
149406,healthy,1,1
149407,men,1,1
149408,and,1,1
149409,women,1,1
149410,.,1,0
149411,Aortic,0,0
149412,pulse,0,0
149413,wave,0,0
149414,velocity,0,0
149415,(,0,0
149416,PWV,0,0
149417,),0,0
149418,and,0,0
149419,augmentation,0,0
149420,index,0,0
149421,(,0,0
149422,AIx,0,0
149423,),0,0
149424,are,0,0
149425,independent,0,0
149426,predictors,0,0
149427,of,0,0
149428,cardiovascular,0,1
149429,risk,0,0
149430,and,0,0
149431,mortality,0,0
149432,",",0,0
149433,but,0,0
149434,little,0,0
149435,is,0,0
149436,known,0,0
149437,about,0,0
149438,the,0,0
149439,effect,0,0
149440,of,0,0
149441,air,0,0
149442,temperature,0,0
149443,changes,0,0
149444,on,0,0
149445,these,0,0
149446,variables,0,0
149447,.,0,0
149448,Our,0,0
149449,study,0,0
149450,investigated,0,0
149451,the,0,0
149452,effect,0,0
149453,of,0,0
149454,exposure,0,0
149455,to,0,0
149456,whole-body,0,0
149457,mild-cold,0,1
149458,on,0,0
149459,measures,0,0
149460,of,0,0
149461,arterial,0,1
149462,stiffness,0,0
149463,(,0,0
149464,aortic,0,1
149465,and,0,0
149466,brachial,0,1
149467,PWV,0,0
149468,),0,0
149469,",",0,0
149470,and,0,0
149471,on,0,0
149472,central,0,0
149473,haemodynamics,0,0
149474,[,0,0
149475,including,0,0
149476,augmented,0,0
149477,pressure,0,0
149478,(,0,0
149479,AP,0,1
149480,),0,0
149481,",",0,0
149482,AIx,0,0
149483,],0,0
149484,",",0,0
149485,and,0,0
149486,aortic,0,1
149487,reservoir,0,0
149488,components,0,0
149489,[,0,0
149490,including,0,0
149491,reservoir,0,0
149492,and,0,0
149493,excess,0,0
149494,pressures,0,0
149495,(,0,0
149496,P,0,0
149497,ex,0,0
149498,),0,0
149499,],0,0
149500,.,0,0
149501,Sixteen,1,0
149502,healthy,1,1
149503,volunteers,1,1
149504,(,1,1
149505,10,1,1
149506,men,1,1
149507,",",1,0
149508,age,1,1
149509,43,1,0
149510,?,1,0
149511,19,1,1
149512,years,1,1
149513,;,1,0
149514,mean,1,1
149515,?,1,0
149516,SD,1,0
149517,),1,0
149518,were,1,0
149519,randomised,0,0
149520,to,0,0
149521,be,0,0
149522,studied,0,1
149523,under,0,0
149524,conditions,0,0
149525,of,0,0
149526,12,0,1
149527,?C,0,1
149528,(,0,0
149529,mild-cold,0,1
149530,),0,0
149531,and,0,0
149532,21,0,1
149533,?C,0,1
149534,(,0,0
149535,control,0,0
149536,),0,0
149537,on,0,0
149538,separate,0,0
149539,days,0,0
149540,.,0,1
149541,Supine,0,0
149542,resting,0,0
149543,measures,0,0
149544,were,0,0
149545,taken,0,0
149546,at,0,0
149547,baseline,0,0
149548,(,0,0
149549,ambient,0,0
149550,temperature,0,0
149551,),0,0
149552,and,0,0
149553,after,0,0
149554,10,0,0
149555,",",0,0
149556,30,0,0
149557,",",0,0
149558,and,0,0
149559,60,0,0
149560,min,0,0
149561,exposure,0,0
149562,to,0,0
149563,each,0,0
149564,experimental,0,0
149565,condition,0,0
149566,in,0,0
149567,a,0,0
149568,climate,0,0
149569,chamber,0,0
149570,.,0,0
149571,There,0,0
149572,was,0,0
149573,no,0,0
149574,significant,0,0
149575,change,0,0
149576,in,0,0
149577,brachial,0,0
149578,blood,0,0
149579,pressure,0,0
149580,between,0,0
149581,mild-cold,0,1
149582,and,0,0
149583,control,0,1
149584,conditions,0,0
149585,.,0,0
149586,However,0,0
149587,",",0,0
149588,compared,0,0
149589,to,0,0
149590,control,0,0
149591,",",0,0
149592,AP,0,1
149593,[,0,0
149594,+2,0,0
149595,mmHg,0,0
149596,",",0,0
149597,95,0,0
149598,%,0,0
149599,confidence,0,0
149600,interval,0,0
149601,(,0,0
149602,CI,0,0
149603,),0,0
149604,0.36-4.36,0,0
149605,;,0,0
149606,p,0,0
149607,=,0,0
149608,0.01,0,0
149609,],0,0
149610,and,0,0
149611,AIx,0,0
149612,(,0,0
149613,+6,0,0
149614,%,0,0
149615,",",0,0
149616,95,0,0
149617,%,0,0
149618,CI,0,0
149619,1.24-10.1,0,0
149620,;,0,0
149621,p,0,0
149622,=,0,0
149623,0.02,0,0
149624,),0,0
149625,increased,0,0
149626,",",0,0
149627,and,0,0
149628,time,0,0
149629,to,0,0
149630,maximum,0,0
149631,P,0,0
149632,ex,0,0
149633,(,0,0
149634,a,0,0
149635,component,0,0
149636,of,0,0
149637,reservoir,0,0
149638,function,0,0
149639,related,0,0
149640,to,0,0
149641,timing,0,0
149642,of,0,0
149643,peak,0,0
149644,aortic,0,1
149645,in-flow,0,0
149646,),0,0
149647,decreased,0,0
149648,(,0,0
149649,-7,0,0
149650,ms,0,0
149651,",",0,0
149652,95,0,0
149653,%,0,0
149654,CI,0,0
149655,-15.4,0,0
149656,to,0,0
149657,2.03,0,0
149658,;,0,0
149659,p,0,0
149660,=,0,0
149661,0.01,0,0
149662,),0,0
149663,compared,0,0
149664,to,0,0
149665,control,0,0
149666,.,0,0
149667,Yet,0,0
149668,there,0,0
149669,was,0,0
149670,no,0,0
149671,significant,0,0
149672,change,0,0
149673,in,0,0
149674,aortic,0,1
149675,PWV,0,0
149676,(,0,0
149677,+0.04,0,0
149678,m/s,0,0
149679,",",0,0
149680,95,0,0
149681,%,0,0
149682,CI,0,0
149683,-0.47,0,0
149684,to,0,0
149685,0.55,0,0
149686,;,0,0
149687,p,0,0
149688,=,0,0
149689,0.87,0,0
149690,),0,0
149691,or,0,0
149692,brachial,0,1
149693,PWV,0,0
149694,(,0,0
149695,+0.36,0,0
149696,m/s,0,0
149697,;,0,0
149698,-0.41,0,0
149699,to,0,0
149700,1.12,0,0
149701,;,0,0
149702,p,0,0
149703,=,0,0
149704,0.35,0,0
149705,),0,0
149706,between,0,0
149707,conditions,0,0
149708,.,0,0
149709,We,0,0
149710,conclude,0,0
149711,that,0,0
149712,mild-cold,0,0
149713,exposure,0,0
149714,increases,0,0
149715,central,0,0
149716,haemodynamic,0,0
149717,stress,0,0
149718,and,0,0
149719,alters,0,0
149720,timing,0,0
149721,of,0,0
149722,peak,0,0
149723,aortic,0,1
149724,in-flow,0,0
149725,without,0,0
149726,differentially,0,0
149727,affecting,0,0
149728,arterial,0,0
149729,stiffness,0,0
149730,.,0,0
149731,Randomized,0,0
149732,trial,0,0
149733,of,0,0
149734,early,0,0
149735,developmental,0,1
149736,intervention,0,0
149737,on,0,0
149738,outcomes,0,0
149739,in,0,0
149740,children,1,1
149741,after,1,0
149742,birth,1,1
149743,asphyxia,1,1
149744,in,0,0
149745,developing,0,0
149746,countries,0,1
149747,.,0,0
149748,OBJECTIVE,0,0
149749,To,0,0
149750,determine,0,0
149751,if,0,0
149752,early,0,0
149753,developmental,0,1
149754,intervention,0,0
149755,(,0,0
149756,EDI,0,0
149757,),0,0
149758,improves,0,0
149759,developmental,0,0
149760,abilities,0,0
149761,in,0,0
149762,resuscitated,1,1
149763,children,1,1
149764,.,1,1
149765,STUDY,0,0
149766,DESIGN,0,0
149767,This,0,0
149768,was,0,0
149769,a,0,0
149770,parallel,1,0
149771,group,1,0
149772,",",0,0
149773,randomized,0,0
149774,controlled,0,0
149775,trial,0,0
149776,of,0,0
149777,infants,1,1
149778,unresponsive,1,1
149779,to,1,1
149780,stimulation,1,0
149781,who,1,1
149782,received,1,1
149783,bag,1,0
149784,and,1,0
149785,mask,1,0
149786,ventilation,1,0
149787,as,1,0
149788,part,1,0
149789,of,1,0
149790,their,1,0
149791,resuscitation,1,0
149792,at,1,0
149793,birth,1,1
149794,and,1,1
149795,infants,1,1
149796,who,1,1
149797,did,1,1
149798,not,1,1
149799,require,1,0
149800,any,1,0
149801,resuscitation,1,0
149802,born,1,1
149803,in,1,0
149804,rural,1,1
149805,communities,1,1
149806,in,1,0
149807,India,1,1
149808,",",1,0
149809,Pakistan,1,0
149810,",",1,0
149811,and,1,0
149812,Zambia,1,0
149813,.,1,0
149814,Intervention,1,0
149815,infants,1,1
149816,received,0,0
149817,a,0,0
149818,parent-implemented,0,0
149819,EDI,0,0
149820,delivered,0,0
149821,with,0,1
149822,home,0,1
149823,visits,0,0
149824,by,0,0
149825,parent,0,0
149826,trainers,0,1
149827,every,0,0
149828,other,0,0
149829,week,0,0
149830,for,0,0
149831,3,0,0
149832,years,0,1
149833,starting,0,0
149834,the,0,0
149835,first,0,0
149836,month,0,0
149837,after,0,0
149838,birth,0,1
149839,.,0,0
149840,Parents,0,0
149841,in,0,0
149842,both,0,0
149843,intervention,0,0
149844,and,0,0
149845,control,0,0
149846,groups,0,0
149847,received,0,0
149848,health,0,0
149849,and,0,0
149850,safety,0,0
149851,counseling,0,0
149852,during,0,0
149853,home,0,1
149854,visits,0,0
149855,on,0,0
149856,the,0,0
149857,same,0,0
149858,schedule,0,0
149859,.,0,0
149860,The,0,0
149861,main,0,0
149862,outcome,0,0
149863,measure,0,0
149864,was,0,0
149865,the,0,0
149866,Mental,0,0
149867,Development,0,0
149868,Index,0,0
149869,(,0,0
149870,MDI,0,0
149871,),0,0
149872,of,0,0
149873,the,0,0
149874,Bayley,0,0
149875,Scales,0,0
149876,of,0,0
149877,Infant,0,1
149878,Development,0,0
149879,",",0,0
149880,2nd,0,0
149881,edition,0,0
149882,",",0,0
149883,assessed,0,0
149884,at,0,0
149885,36,0,1
149886,months,0,0
149887,by,0,0
149888,evaluators,0,0
149889,unaware,0,1
149890,of,0,0
149891,treatment,0,0
149892,group,0,0
149893,and,0,0
149894,resuscitation,0,0
149895,history,0,1
149896,.,0,0
149897,RESULTS,0,0
149898,MDI,0,0
149899,was,0,0
149900,higher,0,0
149901,in,0,0
149902,the,0,0
149903,EDI,0,0
149904,(,0,0
149905,102.6,0,0
149906,?,0,0
149907,9.8,0,0
149908,),0,0
149909,compared,0,0
149910,with,0,0
149911,the,0,0
149912,control,0,0
149913,resuscitated,0,0
149914,children,0,1
149915,(,0,0
149916,98.0,0,0
149917,?,0,0
149918,14.6,0,0
149919,",",0,0
149920,1-sided,0,0
149921,P,0,0
149922,=,0,0
149923,.0202,0,0
149924,),0,0
149925,",",0,0
149926,but,0,0
149927,there,0,0
149928,was,0,0
149929,no,0,0
149930,difference,0,0
149931,between,0,0
149932,groups,0,0
149933,in,0,0
149934,the,0,0
149935,nonresuscitated,0,1
149936,children,0,1
149937,(,0,1
149938,100.1,0,1
149939,?,0,0
149940,10.7,0,0
149941,vs,0,0
149942,97.7,0,1
149943,?,0,0
149944,10.4,0,0
149945,",",0,0
149946,P,0,0
149947,=,0,0
149948,.1392,0,0
149949,),0,0
149950,.,0,0
149951,The,0,0
149952,Psychomotor,0,0
149953,Development,0,0
149954,Index,0,0
149955,was,0,0
149956,higher,0,0
149957,in,0,0
149958,the,0,0
149959,EDI,0,0
149960,group,0,0
149961,for,0,0
149962,both,0,0
149963,the,0,0
149964,resuscitated,0,0
149965,(,0,0
149966,P,0,0
149967,=,0,0
149968,.0430,0,0
149969,),0,0
149970,and,0,0
149971,nonresuscitated,0,1
149972,children,0,1
149973,(,0,0
149974,P,0,0
149975,=,0,0
149976,.0164,0,0
149977,),0,0
149978,.,0,0
149979,CONCLUSIONS,0,0
149980,This,0,0
149981,trial,0,0
149982,of,0,0
149983,home-based,0,0
149984,",",0,0
149985,parent,0,0
149986,provided,0,0
149987,EDI,0,0
149988,in,1,0
149989,children,1,1
149990,resuscitated,1,1
149991,at,1,0
149992,birth,1,1
149993,provides,1,0
149994,evidence,1,0
149995,of,0,0
149996,treatment,0,0
149997,benefits,0,0
149998,on,0,0
149999,cognitive,0,0
150000,and,0,0
150001,psychomotor,0,0
150002,outcomes,0,0
150003,.,0,0
150004,MDI,0,0
150005,and,0,0
150006,Psychomotor,0,0
150007,Development,0,0
150008,Index,0,0
150009,scores,0,0
150010,of,0,0
150011,both,0,0
150012,nonresuscitated,0,0
150013,and,1,0
150014,resuscitated,1,1
150015,infants,1,1
150016,were,0,0
150017,within,0,0
150018,normal,0,1
150019,range,0,0
150020,",",0,0
150021,independent,0,0
150022,of,0,0
150023,early,0,1
150024,intervention,0,0
150025,.,0,0
150026,[,0,0
150027,Clinical,0,0
150028,study,0,0
150029,of,0,0
150030,treating,0,0
150031,knee,0,1
150032,osteoarthritis,0,1
150033,(,0,0
150034,Bi,0,0
150035,syndrome,0,1
150036,of,0,0
150037,knee,0,1
150038,),0,0
150039,by,0,0
150040,massage,0,0
150041,combined,0,0
150042,Chinese,0,1
150043,materia,0,1
150044,medica,0,1
150045,footbath,0,0
150046,fumigation,0,0
150047,and,0,0
150048,washing,0,0
150049,],0,0
150050,.,0,0
150051,OBJECTIVE,0,0
150052,To,0,0
150053,evaluate,0,0
150054,the,0,0
150055,clinical,0,0
150056,efficacy,0,0
150057,of,0,0
150058,treating,0,0
150059,knee,1,1
150060,osteoarthritis,1,1
150061,(,1,0
150062,KOA,1,0
150063,",",1,0
150064,Bi,1,0
150065,syndrome,1,1
150066,of,1,0
150067,knee,1,1
150068,),1,0
150069,by,0,0
150070,massage,0,0
150071,combined,0,0
150072,Chinese,0,1
150073,materia,0,0
150074,medica,0,1
150075,(,0,0
150076,CMM,0,0
150077,),0,0
150078,footbath,0,0
150079,fumigation,0,0
150080,and,0,0
150081,washing,0,0
150082,",",0,0
150083,and,0,0
150084,to,0,0
150085,observe,0,0
150086,the,0,0
150087,changes,0,0
150088,of,0,0
150089,the,0,0
150090,Lysholm,0,0
150091,knee,0,0
150092,score,0,0
150093,(,0,0
150094,LKSS,0,0
150095,),0,0
150096,.,0,0
150097,METHODS,0,0
150098,Totally,1,0
150099,61,1,1
150100,patients,1,1
150101,with,1,1
150102,grade,1,0
150103,I,1,0
150104,to,1,0
150105,III,1,0
150106,KOA,1,0
150107,were,0,0
150108,randomly,0,0
150109,assigned,0,0
150110,to,0,0
150111,two,0,0
150112,groups,0,0
150113,",",0,0
150114,the,0,0
150115,treatment,0,0
150116,group,0,0
150117,and,0,0
150118,the,0,0
150119,control,0,0
150120,group,0,0
150121,.,0,0
150122,Patients,0,1
150123,in,0,0
150124,the,0,0
150125,treatment,0,0
150126,group,0,0
150127,were,0,0
150128,treated,0,0
150129,with,0,1
150130,massage,0,0
150131,combined,0,0
150132,CMM,0,0
150133,footbath,0,0
150134,fumigation,0,0
150135,and,0,0
150136,washing,0,0
150137,",",0,0
150138,while,0,0
150139,those,0,0
150140,in,0,0
150141,the,0,0
150142,control,0,0
150143,group,0,0
150144,were,0,0
150145,treated,0,0
150146,with,0,1
150147,oral,0,0
150148,administration,0,0
150149,of,0,0
150150,meloxicam,0,0
150151,.,0,1
150152,They,0,0
150153,were,0,0
150154,treated,0,0
150155,for,0,0
150156,20,0,1
150157,days,0,0
150158,(,0,1
150159,times,0,0
150160,),0,0
150161,.,0,0
150162,The,0,0
150163,LKSS,0,0
150164,was,0,0
150165,assessed,0,0
150166,before,0,0
150167,treatment,0,0
150168,",",0,0
150169,10,0,0
150170,days,0,0
150171,of,0,0
150172,treatment,0,0
150173,",",0,0
150174,by,0,0
150175,the,0,0
150176,end,0,0
150177,of,0,0
150178,the,0,0
150179,treatment,0,0
150180,",",0,0
150181,and,0,0
150182,1,0,0
150183,month,0,0
150184,after,0,0
150185,treatment,0,0
150186,.,0,0
150187,RESULTS,0,0
150188,(,0,0
150189,1,0,0
150190,),0,0
150191,The,0,0
150192,therapeutic,0,0
150193,efficacy,0,0
150194,in,0,0
150195,the,0,0
150196,treatment,0,0
150197,group,0,0
150198,was,0,0
150199,superior,0,0
150200,to,0,0
150201,that,0,0
150202,in,0,0
150203,the,0,0
150204,control,0,0
150205,group,0,0
150206,(,0,0
150207,P,0,0
150208,<,0,0
150209,0.05,0,0
150210,),0,0
150211,.,0,0
150212,Thirteen,0,0
150213,cases,0,0
150214,were,0,0
150215,clinically,0,0
150216,controlled,0,0
150217,",",0,0
150218,with,0,0
150219,11,0,0
150220,markedly,0,0
150221,effective,0,0
150222,",",0,0
150223,6,0,0
150224,effective,0,0
150225,",",0,0
150226,and,0,0
150227,1,0,0
150228,ineffective,0,0
150229,in,0,0
150230,the,0,0
150231,treatment,0,0
150232,group,0,0
150233,",",0,0
150234,while,0,0
150235,5,0,0
150236,cases,0,1
150237,were,0,0
150238,clinically,0,0
150239,controlled,0,0
150240,",",0,0
150241,with,0,0
150242,11,0,0
150243,markedly,0,0
150244,effective,0,0
150245,",",0,0
150246,10,0,0
150247,effective,0,0
150248,",",0,0
150249,and,0,0
150250,4,0,0
150251,ineffective,0,0
150252,in,0,0
150253,the,0,0
150254,control,0,0
150255,group,0,0
150256,.,0,0
150257,(,0,0
150258,2,0,0
150259,),0,0
150260,The,0,0
150261,LKSS,0,0
150262,:,0,0
150263,The,0,0
150264,post-treatment,0,0
150265,LKSS,0,0
150266,was,0,0
150267,higher,0,0
150268,than,0,0
150269,that,0,0
150270,before,0,0
150271,treatment,0,0
150272,in,0,0
150273,the,0,0
150274,two,0,0
150275,groups,0,0
150276,.,0,1
150277,The,0,0
150278,LKSS,0,0
150279,at,0,0
150280,10,0,1
150281,days,0,0
150282,(,0,1
150283,times,0,0
150284,),0,0
150285,of,0,0
150286,treatment,0,0
150287,was,0,0
150288,lower,0,0
150289,in,0,0
150290,the,0,0
150291,treatment,0,0
150292,group,0,0
150293,than,0,0
150294,in,0,0
150295,the,0,0
150296,control,0,0
150297,group,0,0
150298,",",0,0
150299,but,0,0
150300,with,0,0
150301,no,0,0
150302,statistical,0,0
150303,difference,0,0
150304,(,0,0
150305,P,0,0
150306,>,0,1
150307,0.05,0,0
150308,),0,0
150309,.,0,0
150310,The,0,0
150311,LKSS,0,0
150312,by,0,0
150313,the,0,0
150314,end,0,0
150315,of,0,0
150316,the,0,0
150317,treatment,0,0
150318,was,0,0
150319,higher,0,0
150320,in,0,0
150321,the,0,0
150322,treatment,0,0
150323,group,0,0
150324,than,0,0
150325,in,0,0
150326,the,0,0
150327,control,0,0
150328,group,0,0
150329,(,0,0
150330,P,0,0
150331,<,0,0
150332,0.05,0,0
150333,),0,0
150334,.,0,0
150335,(,0,0
150336,3,0,0
150337,),0,0
150338,The,0,0
150339,case,0,0
150340,number,0,0
150341,of,0,0
150342,patients,0,1
150343,in,0,0
150344,need,0,0
150345,of,0,0
150346,receiving,0,0
150347,the,0,0
150348,treatment,0,0
150349,again,0,0
150350,within,0,0
150351,1-month,0,0
150352,follow-up,0,0
150353,and,0,0
150354,the,0,0
150355,difference,0,0
150356,between,0,0
150357,the,0,0
150358,LKSS,0,0
150359,at,0,0
150360,follow-ups,0,0
150361,and,0,0
150362,that,0,0
150363,by,0,0
150364,the,0,0
150365,end,0,0
150366,of,0,0
150367,the,0,0
150368,treatment,0,0
150369,were,0,0
150370,lower,0,0
150371,in,0,0
150372,the,0,0
150373,treatment,0,0
150374,group,0,0
150375,than,0,0
150376,in,0,0
150377,the,0,0
150378,control,0,0
150379,group,0,0
150380,(,0,0
150381,P,0,0
150382,<,0,0
150383,0.01,0,0
150384,),0,0
150385,.,0,0
150386,CONCLUSION,0,0
150387,Massage,0,0
150388,combined,0,0
150389,CMM,0,0
150390,footbath,0,0
150391,fumigation,0,0
150392,and,0,0
150393,washing,0,0
150394,had,0,0
150395,better,0,0
150396,clinical,0,0
150397,efficacy,0,0
150398,on,0,0
150399,patients,0,1
150400,suffering,0,1
150401,from,0,1
150402,KOA,0,0
150403,.,0,1
150404,[,0,0
150405,Therapeutic,0,0
150406,efficacy,0,0
150407,of,0,0
150408,youdujing,0,0
150409,preparation,0,0
150410,in,0,0
150411,treating,0,0
150412,cervical,1,1
150413,high-risk,1,1
150414,human,1,0
150415,papilloma,1,1
150416,virus,1,1
150417,infection,1,1
150418,patients,1,1
150419,],1,1
150420,.,0,0
150421,OBJECTIVE,0,0
150422,To,0,0
150423,study,0,0
150424,the,0,0
150425,clinical,0,0
150426,efficacy,0,0
150427,and,0,0
150428,mechanisms,0,0
150429,of,0,0
150430,Youdujing,0,1
150431,(,0,0
150432,YDJ,0,1
150433,),0,0
150434,preparation,0,0
150435,in,0,0
150436,treating,0,0
150437,the,0,0
150438,cervical,1,1
150439,high-risk,1,1
150440,human,1,0
150441,papilloma,1,1
150442,virus,1,1
150443,(,1,0
150444,HR-HPV,1,0
150445,),1,0
150446,infection,1,1
150447,.,1,0
150448,METHODS,0,0
150449,Totally,1,0
150450,HR-HPV,1,0
150451,infection,1,1
150452,70,1,1
150453,patients,1,1
150454,were,0,0
150455,assigned,0,0
150456,to,0,0
150457,the,0,0
150458,treatment,0,0
150459,group,0,0
150460,and,0,0
150461,the,0,0
150462,control,0,0
150463,group,0,0
150464,using,0,0
150465,random,0,0
150466,single,0,0
150467,blind,0,0
150468,method,0,0
150469,",",0,0
150470,35,0,0
150471,cases,0,0
150472,in,0,0
150473,each,0,0
150474,group,0,0
150475,.,0,0
150476,YDJ,0,0
150477,external,0,0
150478,lotion,0,0
150479,and,0,0
150480,YDJ,0,1
150481,cream,0,0
150482,were,0,0
150483,applied,0,0
150484,to,0,0
150485,patients,0,1
150486,in,0,0
150487,the,0,0
150488,treatment,0,0
150489,group,0,0
150490,",",0,0
150491,while,0,0
150492,normal,0,1
150493,saline,0,0
150494,was,0,0
150495,applied,0,0
150496,for,0,0
150497,those,0,0
150498,in,0,0
150499,the,0,0
150500,control,0,0
150501,group,0,0
150502,.,0,0
150503,HR-HPV,0,0
150504,DNA,0,0
150505,detection,0,0
150506,was,0,0
150507,performed,0,0
150508,by,0,0
150509,the,0,0
150510,end,0,0
150511,of,0,0
150512,the,0,0
150513,1st,0,0
150514,menstruation,0,0
150515,after,0,0
150516,3,0,0
150517,menstrual,0,1
150518,cycles,0,0
150519,.,0,0
150520,The,0,0
150521,cervical,0,0
150522,biopsy,0,0
150523,and,0,0
150524,cervical,0,1
150525,smear,0,0
150526,were,0,0
150527,performed,0,0
150528,using,0,0
150529,vaginoscope,0,0
150530,before,0,0
150531,and,0,0
150532,after,0,0
150533,treatment,0,0
150534,.,0,0
150535,The,0,0
150536,mRNA,0,0
150537,expression,0,0
150538,of,0,0
150539,human,0,0
150540,telomerase,0,0
150541,reverse,0,0
150542,transcriptase,0,0
150543,(,0,0
150544,hTERT,0,0
150545,),0,0
150546,was,0,0
150547,detected,0,0
150548,from,0,0
150549,fresh,0,0
150550,tissues,0,0
150551,of,0,0
150552,the,0,0
150553,cervical,0,1
150554,lesion,0,0
150555,.,0,0
150556,RESULTS,0,0
150557,The,0,0
150558,total,0,0
150559,effective,0,0
150560,rate,0,0
150561,was,0,0
150562,96.6,0,0
150563,%,0,0
150564,in,0,0
150565,the,0,0
150566,treatment,0,0
150567,group,0,0
150568,",",0,0
150569,higher,0,0
150570,than,0,0
150571,that,0,0
150572,of,0,0
150573,the,0,0
150574,control,0,0
150575,group,0,0
150576,(,0,0
150577,70.00,0,0
150578,%,0,0
150579,",",0,0
150580,P,0,0
150581,<,0,0
150582,0.01,0,0
150583,),0,0
150584,.,0,0
150585,Before,0,0
150586,treatment,0,0
150587,there,0,0
150588,was,0,0
150589,no,0,0
150590,statistical,0,0
150591,difference,0,0
150592,in,0,0
150593,the,0,0
150594,pathological,0,0
150595,results,0,0
150596,of,0,0
150597,the,0,0
150598,cervix,0,0
150599,and,0,0
150600,the,0,0
150601,mRNA,0,0
150602,expression,0,0
150603,of,0,0
150604,hTERT,0,0
150605,between,0,0
150606,the,0,0
150607,two,0,0
150608,groups,0,0
150609,(,0,0
150610,P,0,0
150611,>,0,1
150612,0.05,0,0
150613,),0,0
150614,.,0,0
150615,The,0,0
150616,mRNA,0,0
150617,expression,0,0
150618,of,0,0
150619,hTERT,0,0
150620,decreased,0,0
150621,in,0,0
150622,the,0,0
150623,two,0,0
150624,groups,0,0
150625,after,0,0
150626,treatment,0,0
150627,",",0,0
150628,showing,0,0
150629,statistical,0,0
150630,difference,0,0
150631,(,0,0
150632,P,0,0
150633,<,0,0
150634,0.01,0,0
150635,),0,0
150636,.,0,0
150637,Better,0,0
150638,effects,0,0
150639,on,0,0
150640,the,0,0
150641,pathological,0,0
150642,results,0,0
150643,of,0,0
150644,the,0,0
150645,cervix,0,0
150646,and,0,0
150647,the,0,0
150648,mRNA,0,0
150649,expression,0,0
150650,of,0,0
150651,hTERT,0,0
150652,were,0,0
150653,obtained,0,0
150654,in,0,0
150655,the,0,0
150656,treatment,0,0
150657,group,0,0
150658,after,0,0
150659,treatment,0,0
150660,(,0,0
150661,P,0,0
150662,<,0,0
150663,0.05,0,0
150664,),0,0
150665,.,0,0
150666,CONCLUSION,0,0
150667,YDJ,0,1
150668,played,0,0
150669,a,0,0
150670,role,0,0
150671,in,0,0
150672,clearing,0,0
150673,HR-HPV,0,0
150674,infection,0,1
150675,and,0,0
150676,reversing,0,0
150677,the,0,0
150678,cervical,0,1
150679,precancerous,0,1
150680,changes,0,0
150681,possibly,0,0
150682,through,0,0
150683,down-regulating,0,0
150684,the,0,0
150685,mRNA,0,0
150686,expression,0,0
150687,of,0,0
150688,hTERT,0,0
150689,and,0,0
150690,lowering,0,0
150691,the,0,0
150692,telomerase,0,0
150693,activation,0,0
150694,.,0,0
150695,Pseudoephedrine,0,0
150696,and,0,0
150697,preexercise,0,0
150698,feeding,0,0
150699,:,0,0
150700,influence,0,0
150701,on,0,0
150702,performance,0,0
150703,.,0,0
150704,PURPOSE,0,0
150705,This,0,0
150706,study,0,0
150707,examined,0,0
150708,the,0,0
150709,influence,0,0
150710,of,0,0
150711,preexercise,0,0
150712,food,0,0
150713,intake,0,0
150714,on,0,0
150715,plasma,0,0
150716,pseudoephedrine,0,0
150717,(,0,0
150718,PSE,0,1
150719,),0,0
150720,concentrations,0,0
150721,and,0,0
150722,subsequent,0,0
150723,high-intensity,0,0
150724,exercise,0,0
150725,.,0,0
150726,In,0,0
150727,addition,0,0
150728,",",0,0
150729,urinary,0,0
150730,PSE,0,1
150731,concentrations,0,0
150732,were,0,0
150733,measured,0,0
150734,under,0,0
150735,the,0,0
150736,same,0,0
150737,conditions,0,0
150738,and,0,0
150739,compared,0,0
150740,with,0,0
150741,the,0,0
150742,present,0,0
150743,threshold,0,0
150744,of,0,0
150745,the,0,0
150746,World,0,1
150747,Anti-Doping,0,0
150748,Agency,0,0
150749,(,0,0
150750,WADA,0,0
150751,),0,0
150752,.,0,0
150753,METHODS,0,0
150754,Ten,1,1
150755,highly,1,0
150756,trained,1,0
150757,male,1,1
150758,cyclists,1,0
150759,and,1,0
150760,triathletes,1,1
150761,(,1,0
150762,age,1,1
150763,=,1,0
150764,30.6,1,0
150765,?,1,0
150766,6.6,1,0
150767,yr,1,1
150768,",",1,0
150769,body,1,0
150770,mass,1,0
150771,[,1,0
150772,BM,1,0
150773,],1,0
150774,=,1,0
150775,72.9,1,0
150776,?,1,0
150777,5.1,1,0
150778,kg,1,0
150779,",",1,0
150780,and,1,0
150781,V?O2max,1,0
150782,=,1,0
150783,64.8,1,0
150784,?,1,0
150785,4.5,1,0
150786,mL?kg?min,1,0
150787,;,1,0
150788,mean,1,0
150789,?,1,0
150790,SD,1,0
150791,),1,0
150792,undertook,0,0
150793,four,0,0
150794,cycling,0,0
150795,time,0,0
150796,trials,0,0
150797,(,0,0
150798,TT,0,0
150799,),0,0
150800,",",0,0
150801,each,0,0
150802,requiring,0,0
150803,the,0,0
150804,completion,0,0
150805,of,0,0
150806,a,0,0
150807,set,0,0
150808,amount,0,0
150809,of,0,0
150810,work,0,0
150811,(,0,0
150812,7,0,0
150813,kJ?kg,0,0
150814,BM,0,0
150815,),0,0
150816,in,0,0
150817,the,0,0
150818,shortest,0,0
150819,possible,0,0
150820,time,0,0
150821,.,0,1
150822,Participants,0,1
150823,were,0,0
150824,randomized,0,0
150825,into,0,0
150826,a,0,0
150827,fed,0,0
150828,or,0,0
150829,nonfed,0,1
150830,condition,0,0
150831,and,0,0
150832,orally,0,0
150833,ingested,0,0
150834,2.8,0,0
150835,mg?kg,0,0
150836,BM,0,0
150837,of,0,0
150838,PSE,0,1
150839,or,0,0
150840,a,0,0
150841,placebo,0,0
150842,(,0,0
150843,PLA,0,0
150844,),0,0
150845,90,0,0
150846,min,0,0
150847,before,0,0
150848,exercise,0,0
150849,;,0,0
150850,in,0,0
150851,the,0,0
150852,fed,0,0
150853,trials,0,0
150854,",",0,0
150855,they,0,0
150856,consumed,0,0
150857,a,0,0
150858,meal,0,0
150859,providing,0,0
150860,1.5,0,0
150861,g?kg,0,0
150862,BM,0,0
150863,of,0,0
150864,CHO,0,0
150865,.,0,0
150866,Venous,0,0
150867,blood,0,0
150868,was,0,0
150869,sampled,0,0
150870,at,0,0
150871,30,0,0
150872,",",0,0
150873,50,0,0
150874,",",0,0
150875,and,0,0
150876,70,0,1
150877,min,0,0
150878,and,0,0
150879,pre-warm-up,0,0
150880,and,0,0
150881,postexercise,0,0
150882,for,0,0
150883,the,0,0
150884,analysis,0,0
150885,of,0,0
150886,plasma,0,0
150887,PSE,0,1
150888,and,0,0
150889,catecholamine,0,0
150890,concentrations,0,0
150891,",",0,0
150892,and,0,0
150893,urine,0,0
150894,was,0,0
150895,also,0,0
150896,collected,0,0
150897,for,0,0
150898,the,0,0
150899,analysis,0,0
150900,of,0,0
150901,PSE,0,1
150902,concentration,0,0
150903,.,0,0
150904,RESULTS,0,0
150905,Independent,0,0
150906,of,0,0
150907,the,0,0
150908,preexercise,0,0
150909,meal,0,0
150910,",",0,0
150911,2.8,0,0
150912,mg?kg,0,0
150913,BM,0,0
150914,of,0,0
150915,PSE,0,1
150916,did,0,0
150917,not,0,0
150918,significantly,0,0
150919,improve,0,0
150920,cycling,0,0
150921,TT,0,0
150922,performance,0,0
150923,.,0,0
150924,The,0,0
150925,fed,0,0
150926,trials,0,0
150927,resulted,0,0
150928,in,0,0
150929,lower,0,0
150930,plasma,0,0
150931,PSE,0,1
150932,concentrations,0,0
150933,at,0,0
150934,all,0,0
150935,time,0,0
150936,points,0,0
150937,compared,0,0
150938,with,0,1
150939,the,0,0
150940,nonfed,0,1
150941,trials,0,0
150942,.,0,0
150943,Both,0,0
150944,plasma,0,0
150945,epinephrine,0,0
150946,and,0,0
150947,blood,0,0
150948,lactate,0,0
150949,concentrations,0,0
150950,were,0,0
150951,higher,0,0
150952,in,0,0
150953,the,0,0
150954,PSE,0,0
150955,compared,0,0
150956,with,0,0
150957,the,0,0
150958,PLA,0,0
150959,trials,0,0
150960,",",0,0
150961,and,0,0
150962,preexercise,0,0
150963,and,0,0
150964,postexercise,0,0
150965,urinary,0,0
150966,PSE,0,1
150967,concentrations,0,0
150968,were,0,0
150969,significantly,0,0
150970,higher,0,0
150971,than,0,0
150972,the,0,0
150973,threshold,0,0
150974,(,0,0
150975,150,0,0
150976,?g?mL,0,0
150977,),0,0
150978,used,0,0
150979,by,0,0
150980,WADA,0,0
150981,to,0,0
150982,determine,0,0
150983,illicit,0,0
150984,PSE,0,1
150985,use,0,0
150986,.,0,0
150987,CONCLUSION,0,0
150988,Irrespective,0,0
150989,of,0,0
150990,the,0,0
150991,preexercise,0,0
150992,meal,0,0
150993,",",0,0
150994,cycling,0,0
150995,TT,0,0
150996,performance,0,0
150997,of,0,0
150998,approximately,0,0
150999,30,0,0
151000,min,0,0
151001,was,0,0
151002,not,0,0
151003,improved,0,0
151004,after,0,0
151005,PSE,0,1
151006,supplementation,0,0
151007,.,0,0
151008,Furthermore,0,0
151009,",",0,0
151010,2.8,0,0
151011,mg?kg,0,0
151012,BM,0,0
151013,of,0,0
151014,PSE,0,1
151015,taken,0,0
151016,90,0,0
151017,min,0,0
151018,before,0,0
151019,exercise,0,0
151020,",",0,0
151021,with,0,0
151022,or,0,0
151023,without,0,0
151024,food,0,0
151025,",",0,0
151026,resulted,0,0
151027,in,0,0
151028,urinary,0,0
151029,PSE,0,1
151030,concentrations,0,0
151031,exceeding,0,0
151032,the,0,0
151033,present,0,0
151034,WADA,0,0
151035,threshold,0,0
151036,.,0,0
151037,A,0,0
151038,phase,0,0
151039,III,0,0
151040,study,0,0
151041,of,0,0
151042,laparoscopy-assisted,0,0
151043,versus,0,0
151044,open,0,1
151045,distal,0,0
151046,gastrectomy,0,1
151047,with,0,1
151048,nodal,0,0
151049,dissection,0,1
151050,for,0,0
151051,clinical,0,0
151052,stage,0,1
151053,IA/IB,0,0
151054,gastric,0,1
151055,Cancer,0,0
151056,(,0,0
151057,JCOG0912,0,0
151058,),0,0
151059,.,0,0
151060,A,0,0
151061,Phase,0,0
151062,III,0,0
151063,study,0,0
151064,was,0,0
151065,started,0,0
151066,in,0,0
151067,Japan,1,1
151068,to,0,0
151069,evaluate,0,0
151070,the,0,0
151071,non-inferiority,0,0
151072,of,0,0
151073,overall,0,0
151074,survival,0,0
151075,of,0,0
151076,laparoscopy-assisted,0,1
151077,distal,0,0
151078,gastrectomy,0,1
151079,with,0,1
151080,open,1,0
151081,distal,1,0
151082,gastrectomy,1,1
151083,in,1,0
151084,patients,1,1
151085,with,1,1
151086,clinical,1,0
151087,IA,1,1
151088,(,1,0
151089,T1N0,1,0
151090,),1,0
151091,or,1,0
151092,IB,1,1
151093,[,1,0
151094,T1N1,1,0
151095,or,1,0
151096,T2,1,0
151097,(,1,0
151098,MP,1,0
151099,),1,0
151100,N0,1,0
151101,],1,0
151102,gastric,1,1
151103,cancer,1,1
151104,.,1,0
151105,This,0,0
151106,study,0,0
151107,followed,0,0
151108,the,0,0
151109,previous,0,0
151110,Phase,0,0
151111,II,0,0
151112,study,0,0
151113,to,0,0
151114,confirm,0,0
151115,the,0,0
151116,safety,0,0
151117,of,0,0
151118,laparoscopy-assisted,0,1
151119,distal,0,0
151120,gastrectomy,0,1
151121,(,0,0
151122,JCOG0703,0,0
151123,),0,0
151124,and,0,0
151125,began,0,1
151126,in,0,0
151127,March,0,1
151128,2010,0,1
151129,.,0,0
151130,A,0,0
151131,total,0,0
151132,of,1,0
151133,920,1,1
151134,patients,1,1
151135,will,1,0
151136,be,1,0
151137,accrued,1,0
151138,from,1,0
151139,33,1,1
151140,institutions,1,1
151141,within,1,1
151142,5,1,1
151143,years,1,1
151144,.,1,0
151145,The,0,0
151146,primary,0,0
151147,endpoint,0,0
151148,is,0,0
151149,overall,0,0
151150,survival,0,0
151151,.,0,0
151152,The,0,0
151153,secondary,0,0
151154,endpoints,0,0
151155,are,0,0
151156,relapse-free,0,0
151157,survival,0,0
151158,",",0,0
151159,proportion,0,0
151160,of,0,0
151161,laparoscopy-assisted,0,1
151162,distal,0,0
151163,gastrectomy,0,1
151164,completion,0,0
151165,",",0,0
151166,proportion,0,0
151167,of,0,0
151168,conversion,0,0
151169,to,0,0
151170,open,0,0
151171,surgery,0,1
151172,",",0,0
151173,adverse,0,0
151174,events,0,0
151175,",",0,0
151176,short-term,0,0
151177,clinical,0,0
151178,outcomes,0,0
151179,",",0,0
151180,postoperative,0,0
151181,quality,0,0
151182,of,0,0
151183,life,0,0
151184,.,0,0
151185,Only,0,0
151186,a,0,0
151187,credentialed,1,0
151188,surgeon,1,0
151189,can,0,0
151190,be,0,0
151191,responsible,0,0
151192,for,0,0
151193,both,0,0
151194,open,0,0
151195,distal,0,0
151196,gastrectomy,0,1
151197,and,0,0
151198,laparoscopy-assisted,0,0
151199,distal,0,0
151200,gastrectomy,0,1
151201,.,0,0
151202,[,0,0
151203,Antiinflammatory,0,0
151204,potential,0,0
151205,of,0,0
151206,seven,0,0
151207,plant,0,1
151208,extracts,0,0
151209,in,0,0
151210,the,0,0
151211,ultraviolet,0,0
151212,erythema,0,0
151213,test,0,0
151214,.,0,0
151215,A,0,0
151216,randomized,0,0
151217,",",0,0
151218,placebo-controlled,0,0
151219,study,0,0
151220,],0,0
151221,.,0,1
151222,BACKGROUND,0,0
151223,Phytotherapeutics,0,0
151224,are,0,0
151225,widely,0,0
151226,used,0,0
151227,in,0,0
151228,medicine,0,1
151229,.,0,0
151230,The,0,0
151231,aim,0,0
151232,of,0,0
151233,this,0,0
151234,study,0,0
151235,was,0,0
151236,the,0,0
151237,evaluation,0,0
151238,of,0,0
151239,the,0,0
151240,antiinflammatory,0,0
151241,potential,0,0
151242,of,0,0
151243,seven,0,0
151244,medical,0,1
151245,plant,0,1
151246,extracts,0,0
151247,using,0,0
151248,the,0,0
151249,ultraviolet-,0,0
151250,(,0,0
151251,UV,0,0
151252,),0,0
151253,-erythema,0,0
151254,test,0,0
151255,.,0,0
151256,PATIENTS,0,0
151257,AND,0,0
151258,METHODS,0,0
151259,Randomized,0,0
151260,",",0,0
151261,placebo-controlled,0,0
151262,study,0,0
151263,on,0,0
151264,40,1,1
151265,healthy,1,1
151266,subjects,1,1
151267,.,1,1
151268,Test,0,0
151269,areas,0,0
151270,on,0,0
151271,the,0,0
151272,upper,0,0
151273,back,0,0
151274,were,0,0
151275,irradiated,0,0
151276,with,0,0
151277,the,0,0
151278,1.5,0,0
151279,fold,0,0
151280,UV-B,0,0
151281,minimal,0,0
151282,erythema,0,0
151283,dose,0,0
151284,(,0,0
151285,MED,0,0
151286,),0,0
151287,.,0,0
151288,Formulations,0,0
151289,of,0,0
151290,Aloe,0,0
151291,vera,0,0
151292,",",0,0
151293,Chamomilla,0,0
151294,recutita,0,0
151295,",",0,0
151296,Hamamelis,0,0
151297,virginiana,0,1
151298,",",0,0
151299,Melissa,0,0
151300,officinalis,0,0
151301,",",0,0
151302,Mentha,0,0
151303,arvensis,0,0
151304,",",0,0
151305,Melaleuca,0,0
151306,alternifolia,0,0
151307,",",0,0
151308,Coriandrum,0,0
151309,sativum,0,0
151310,as,0,0
151311,well,0,0
151312,as,0,0
151313,1,0,0
151314,%,0,0
151315,hydrocortisone,0,0
151316,acetate,0,0
151317,and,0,0
151318,0.1,0,0
151319,%,0,0
151320,betamethasone,0,0
151321,valerate,0,0
151322,as,0,0
151323,positive,0,0
151324,controls,0,1
151325,and,0,0
151326,unguentum,0,0
151327,leniens,0,0
151328,as,0,0
151329,vehicle,0,0
151330,control,0,0
151331,were,0,0
151332,applied,0,0
151333,under,0,0
151334,occlusion,0,0
151335,on,0,0
151336,the,0,0
151337,irradiated,0,0
151338,areas,0,0
151339,and,0,0
151340,on,0,0
151341,non-irradiated,0,0
151342,area,0,0
151343,on,0,0
151344,the,0,0
151345,contralateral,0,0
151346,side,0,0
151347,.,0,0
151348,Photometric,0,0
151349,assessment,0,0
151350,of,0,0
151351,the,0,0
151352,erythema,0,0
151353,was,0,0
151354,performed,0,0
151355,before,0,0
151356,the,0,0
151357,application,0,0
151358,of,0,0
151359,the,0,0
151360,substances,0,0
151361,(,0,0
151362,t0,0,0
151363,),0,0
151364,",",0,0
151365,at,0,0
151366,24,0,0
151367,h,0,0
151368,(,0,0
151369,t1,0,1
151370,),0,0
151371,and,0,0
151372,at,0,0
151373,48,0,0
151374,h,0,0
151375,(,0,0
151376,t2,0,0
151377,),0,0
151378,.,0,0
151379,RESULTS,0,0
151380,Aloe,0,0
151381,vera,0,0
151382,",",0,0
151383,Chamomilla,0,0
151384,recutita,0,0
151385,",",0,0
151386,Melissa,0,0
151387,officinalis,0,0
151388,",",0,0
151389,Melaleuca,0,0
151390,alternifolia,0,0
151391,and,0,0
151392,Coriandrum,0,0
151393,sativum,0,0
151394,showed,0,0
151395,an,0,0
151396,antiinflammatory,0,0
151397,effect,0,0
151398,compared,0,0
151399,to,0,0
151400,UV-control,0,0
151401,and,0,0
151402,unguentum,0,0
151403,leniens,0,0
151404,.,0,0
151405,However,0,0
151406,",",0,0
151407,the,0,0
151408,results,0,0
151409,were,0,0
151410,only,0,0
151411,statistically,0,0
151412,significant,0,0
151413,for,0,0
151414,Aloe,0,0
151415,vera,0,0
151416,.,0,0
151417,All,0,0
151418,tested,0,0
151419,plant,0,0
151420,extracts,0,0
151421,were,0,0
151422,well,0,0
151423,tolerated,0,0
151424,.,0,0
151425,CONCLUSION,0,0
151426,Aloe,0,0
151427,vera,0,0
151428,possesses,0,0
151429,an,0,0
151430,antiinflammatory,0,0
151431,effect,0,0
151432,on,0,0
151433,UV-induced,0,0
151434,erythemas,0,1
151435,.,0,0
151436,Influence,0,0
151437,of,0,0
151438,Aloe,0,0
151439,arborescens,0,1
151440,Mill,0,0
151441,.,0,0
151442,extract,0,0
151443,on,0,0
151444,selected,0,1
151445,parameters,0,0
151446,of,0,0
151447,pro-oxidant-antioxidant,0,0
151448,equilibrium,0,0
151449,and,0,0
151450,cytokine,0,0
151451,synthesis,0,0
151452,in,0,0
151453,rowers,1,1
151454,.,1,0
151455,This,0,0
151456,investigation,0,0
151457,examined,0,0
151458,the,0,0
151459,effect,0,0
151460,of,0,0
151461,supplementation,0,0
151462,with,0,1
151463,Biostimine,0,0
151464,",",0,0
151465,extract,0,0
151466,from,0,0
151467,Aloe,0,0
151468,arborescens,0,1
151469,Mill,0,0
151470,.,0,1
151471,leaves,0,0
151472,",",0,0
151473,on,0,0
151474,the,0,0
151475,levels,0,0
151476,of,0,0
151477,pro-oxidant-antioxidant,0,0
151478,equilibrium,0,0
151479,markers,0,0
151480,and,0,0
151481,anti-,0,0
151482,and,0,0
151483,proinflammatory,0,0
151484,cytokines,0,0
151485,in,0,0
151486,rowers,1,1
151487,subjected,1,0
151488,to,1,0
151489,exhaustive,1,0
151490,exercise,1,0
151491,.,1,0
151492,This,0,0
151493,double-blind,0,0
151494,study,1,0
151495,included,1,1
151496,18,1,1
151497,members,1,1
151498,of,1,0
151499,the,1,0
151500,Polish,1,1
151501,Rowing,1,0
151502,Team,1,0
151503,.,1,0
151504,Subjects,0,0
151505,were,0,0
151506,randomly,0,1
151507,assigned,0,0
151508,to,0,0
151509,the,0,0
151510,supplemented,0,0
151511,group,0,0
151512,(,0,0
151513,n,0,1
151514,=,0,0
151515,9,0,0
151516,),0,0
151517,",",0,0
151518,which,0,0
151519,received,0,0
151520,one,0,0
151521,ampoule,0,0
151522,of,0,0
151523,Biostimine,0,0
151524,once,0,0
151525,daily,0,0
151526,for,0,0
151527,4,0,0
151528,weeks,0,0
151529,",",0,0
151530,or,0,0
151531,to,0,0
151532,the,0,0
151533,placebo,0,0
151534,group,0,0
151535,(,0,0
151536,n,0,1
151537,=,0,0
151538,9,0,1
151539,),0,0
151540,.,0,0
151541,Subjects,0,0
151542,performed,0,0
151543,a,0,0
151544,"2,000-meter-maximum",0,0
151545,test,0,0
151546,on,0,0
151547,a,0,0
151548,rowing,0,0
151549,ergometer,0,0
151550,at,0,0
151551,the,0,0
151552,beginning,0,0
151553,and,0,0
151554,end,0,0
151555,of,0,0
151556,the,0,0
151557,preparatory,0,0
151558,camp,0,0
151559,.,0,0
151560,Blood,0,0
151561,samples,0,0
151562,were,0,0
151563,obtained,0,0
151564,from,0,0
151565,the,0,0
151566,antecubital,0,0
151567,vein,0,0
151568,before,0,0
151569,each,0,0
151570,exercise,0,0
151571,test,0,0
151572,",",0,0
151573,1,0,0
151574,min,0,0
151575,after,0,0
151576,completing,0,0
151577,the,0,0
151578,test,0,0
151579,and,0,0
151580,after,0,0
151581,a,0,0
151582,24-hr,0,0
151583,recovery,0,0
151584,period,0,0
151585,.,0,0
151586,Superoxide,0,0
151587,dismutase,0,0
151588,and,0,0
151589,glutathione,0,0
151590,peroxidase,0,0
151591,activity,0,0
151592,as,0,0
151593,well,0,0
151594,as,0,0
151595,the,0,0
151596,concentration,0,0
151597,of,0,0
151598,thiobarbituric,0,0
151599,acid,0,0
151600,reactive,0,0
151601,substances,0,0
151602,(,0,0
151603,TBARS,0,1
151604,),0,0
151605,were,0,0
151606,assessed,0,0
151607,in,0,0
151608,erythrocytes,0,0
151609,.,0,0
151610,In,0,0
151611,addition,0,0
151612,",",0,0
151613,total,0,1
151614,antioxidant,0,0
151615,capacity,0,0
151616,(,0,0
151617,TAC,0,0
151618,),0,0
151619,and,0,0
151620,creatine,0,0
151621,kinase,0,0
151622,activity,0,0
151623,were,0,0
151624,measured,0,0
151625,in,0,0
151626,plasma,0,0
151627,samples,0,0
151628,",",0,0
151629,and,0,0
151630,cytokine,0,0
151631,(,0,0
151632,IL-6,0,0
151633,",",0,0
151634,IL-10,0,0
151635,),0,0
151636,concentrations,0,0
151637,were,0,0
151638,determined,0,0
151639,in,0,0
151640,the,0,0
151641,serum,0,0
151642,.,0,0
151643,Before,0,0
151644,and,0,0
151645,after,0,0
151646,Biostimine,0,0
151647,supplementation,0,0
151648,",",0,0
151649,exercise,0,0
151650,significantly,0,0
151651,increased,0,0
151652,the,0,0
151653,values,0,0
151654,of,0,0
151655,SOD,0,0
151656,",",0,0
151657,IL-6,0,0
151658,",",0,0
151659,IL-10,0,0
151660,",",0,0
151661,and,0,0
151662,TBARS,0,0
151663,in,0,0
151664,both,0,0
151665,groups,0,0
151666,.,0,0
151667,However,0,0
151668,",",0,0
151669,postexercise,0,0
151670,and,0,0
151671,recovery,0,0
151672,levels,0,0
151673,of,0,0
151674,TBARS,0,0
151675,were,0,0
151676,significantly,0,0
151677,lower,0,0
151678,in,0,0
151679,athletes,0,1
151680,receiving,0,1
151681,Biostimine,0,0
151682,than,0,0
151683,in,0,0
151684,controls,0,1
151685,.,0,0
151686,After,0,0
151687,supplementation,0,0
151688,",",0,0
151689,TAC,0,0
151690,was,0,0
151691,the,0,0
151692,only,0,0
151693,variable,0,0
151694,with,0,0
151695,the,0,0
151696,level,0,0
151697,being,0,0
151698,significantly,0,0
151699,higher,0,0
151700,in,0,0
151701,the,0,0
151702,supplemented,0,0
151703,group,0,0
151704,than,0,0
151705,in,0,0
151706,the,0,0
151707,placebo,0,0
151708,group,0,0
151709,.,0,0
151710,Consequently,0,0
151711,",",0,0
151712,we,0,0
151713,can,0,0
151714,conclude,0,0
151715,that,0,0
151716,Biostimine,0,0
151717,supplementation,0,0
151718,reduces,0,0
151719,the,0,0
151720,postexercise,0,0
151721,level,0,0
151722,of,0,0
151723,TBARS,0,0
151724,by,0,0
151725,increasing,0,0
151726,the,0,0
151727,antioxidant,0,0
151728,activity,0,0
151729,of,0,0
151730,plasma,0,0
151731,but,0,0
151732,has,0,0
151733,no,0,0
151734,effect,0,0
151735,on,0,0
151736,inflammatory,0,0
151737,markers,0,0
151738,.,0,1
151739,The,0,0
151740,effect,0,0
151741,of,0,0
151742,cognitive-behavioral,0,1
151743,therapy,0,0
151744,versus,0,0
151745,treatment,0,0
151746,as,0,0
151747,usual,0,0
151748,for,0,0
151749,anxiety,1,0
151750,in,1,0
151751,children,1,1
151752,with,1,1
151753,autism,1,1
151754,spectrum,1,1
151755,disorders,1,1
151756,:,1,1
151757,a,0,0
151758,randomized,0,0
151759,",",0,0
151760,controlled,0,0
151761,trial,0,0
151762,.,0,0
151763,OBJECTIVE,0,0
151764,To,0,0
151765,examine,0,0
151766,the,0,0
151767,efficacy,0,0
151768,of,0,0
151769,a,0,0
151770,modular,0,0
151771,cognitive-behavioral,0,1
151772,therapy,0,0
151773,(,0,0
151774,CBT,0,0
151775,),0,0
151776,protocol,0,0
151777,relative,0,0
151778,to,0,0
151779,treatment,0,0
151780,as,0,0
151781,usual,0,0
151782,(,0,0
151783,TAU,0,0
151784,),0,0
151785,among,0,0
151786,children,1,1
151787,with,1,1
151788,high-functioning,1,1
151789,autism,1,1
151790,spectrum,1,1
151791,disorders,1,1
151792,(,1,0
151793,ASD,1,1
151794,),1,0
151795,and,1,0
151796,clinically,1,0
151797,significant,1,0
151798,anxiety,1,0
151799,.,1,0
151800,METHOD,0,0
151801,A,1,0
151802,total,1,1
151803,of,1,0
151804,45,1,1
151805,children,1,1
151806,(,1,1
151807,7-11,1,1
151808,years,1,1
151809,of,1,0
151810,age,1,1
151811,),1,0
151812,with,1,1
151813,high-functioning,1,1
151814,ASD,1,1
151815,and,1,0
151816,clinically,1,0
151817,significant,1,0
151818,anxiety,1,0
151819,were,0,0
151820,randomized,0,0
151821,to,0,0
151822,receive,0,0
151823,16,0,1
151824,sessions,0,0
151825,of,0,0
151826,weekly,0,0
151827,CBT,0,0
151828,or,0,0
151829,TAU,0,0
151830,for,0,0
151831,an,0,0
151832,equivalent,0,0
151833,duration,0,0
151834,.,0,0
151835,After,0,0
151836,screening,0,0
151837,",",0,0
151838,assessments,0,0
151839,were,0,0
151840,conducted,0,0
151841,at,0,0
151842,baseline,0,0
151843,",",0,0
151844,post-treatment,0,0
151845,",",0,0
151846,and,0,0
151847,3-month,0,0
151848,follow-up,0,0
151849,.,0,0
151850,Raters,0,0
151851,were,0,0
151852,blind,0,1
151853,to,0,0
151854,treatment,0,0
151855,condition,0,0
151856,.,0,0
151857,RESULTS,0,0
151858,Youth,0,0
151859,receiving,0,1
151860,CBT,0,0
151861,showed,0,0
151862,substantial,0,0
151863,improvement,0,0
151864,relative,0,0
151865,to,0,0
151866,TAU,0,0
151867,on,0,0
151868,primary,0,0
151869,anxiety,0,1
151870,outcomes,0,0
151871,.,0,0
151872,Of,0,0
151873,24,0,0
151874,children,0,1
151875,randomized,0,0
151876,to,0,0
151877,the,0,0
151878,CBT,0,0
151879,arm,0,0
151880,",",0,0
151881,18,0,0
151882,(,0,0
151883,75,0,1
151884,%,0,0
151885,),0,0
151886,were,0,0
151887,treatment,0,0
151888,responders,0,0
151889,",",0,0
151890,versus,0,0
151891,only,0,0
151892,3,0,0
151893,of,0,0
151894,21,0,1
151895,children,0,1
151896,(,0,0
151897,14,0,0
151898,%,0,0
151899,),0,0
151900,in,0,0
151901,the,0,0
151902,TAU,0,0
151903,arm,0,0
151904,.,0,0
151905,Gains,0,0
151906,were,0,0
151907,generally,0,0
151908,maintained,0,0
151909,at,0,0
151910,3-month,0,0
151911,follow-up,0,0
151912,for,0,0
151913,CBT,0,0
151914,responders,0,0
151915,.,0,1
151916,CONCLUSIONS,0,0
151917,Relative,0,0
151918,to,0,0
151919,usual,0,0
151920,care,0,0
151921,",",0,0
151922,CBT,0,0
151923,adapted,0,0
151924,for,0,0
151925,anxious,0,0
151926,youth,0,1
151927,with,0,1
151928,high-functioning,0,1
151929,ASD,0,1
151930,demonstrates,0,0
151931,large,0,0
151932,effects,0,0
151933,in,0,0
151934,reducing,0,0
151935,anxiety,0,1
151936,symptoms,0,0
151937,.,0,0
151938,This,0,0
151939,study,0,0
151940,contributes,0,0
151941,to,0,0
151942,the,0,0
151943,growing,0,0
151944,literature,0,0
151945,supporting,0,0
151946,adapted,0,0
151947,CBT,0,0
151948,approaches,0,0
151949,for,0,0
151950,treating,0,0
151951,anxiety,0,0
151952,in,0,0
151953,youth,0,1
151954,with,0,1
151955,ASD,0,1
151956,.,0,1
151957,Temporal,0,0
151958,expectation,0,0
151959,in,0,0
151960,focal,1,1
151961,hand,1,0
151962,dystonia,1,1
151963,.,1,0
151964,Patients,1,1
151965,with,1,0
151966,writer,1,0
151967,'s,1,0
151968,cramp,1,0
151969,present,0,0
151970,sensory,0,0
151971,and,0,0
151972,representational,0,0
151973,abnormalities,0,0
151974,relevant,0,0
151975,to,0,0
151976,motor,0,0
151977,control,0,0
151978,",",0,0
151979,such,0,0
151980,as,0,0
151981,impairment,0,0
151982,in,0,0
151983,the,0,0
151984,temporal,0,0
151985,discrimination,0,0
151986,between,0,0
151987,tactile,0,0
151988,stimuli,0,0
151989,and,0,0
151990,in,0,0
151991,pure,0,0
151992,motor,0,0
151993,imagery,0,0
151994,tasks,0,0
151995,",",0,0
151996,like,0,0
151997,the,0,0
151998,mental,0,0
151999,rotation,0,0
152000,of,0,0
152001,corporeal,0,0
152002,and,0,0
152003,inanimate,0,0
152004,objects,0,0
152005,.,0,0
152006,However,0,0
152007,",",0,0
152008,only,0,0
152009,limited,0,0
152010,information,0,0
152011,is,0,0
152012,available,0,0
152013,on,0,0
152014,the,0,0
152015,ability,0,0
152016,of,0,0
152017,patients,1,1
152018,with,1,1
152019,dystonia,1,1
152020,to,0,0
152021,process,0,0
152022,the,0,0
152023,time-dependent,0,0
152024,features,0,0
152025,(,0,0
152026,e.g,0,0
152027,.,0,0
152028,speed,0,0
152029,),0,0
152030,of,0,0
152031,movement,0,0
152032,in,0,0
152033,real,0,0
152034,time,0,0
152035,.,0,0
152036,The,0,0
152037,processing,0,0
152038,of,0,0
152039,time-dependent,0,0
152040,features,0,0
152041,of,0,0
152042,movement,0,0
152043,has,0,0
152044,a,0,0
152045,crucial,0,0
152046,role,0,0
152047,in,0,0
152048,predicting,0,0
152049,whether,0,0
152050,the,0,0
152051,outcome,0,0
152052,of,0,0
152053,a,0,0
152054,complex,0,0
152055,motor,0,0
152056,sequence,0,0
152057,",",0,0
152058,such,0,0
152059,as,0,0
152060,handwriting,0,0
152061,or,0,0
152062,playing,0,0
152063,a,0,0
152064,musical,0,0
152065,passage,0,0
152066,",",0,0
152067,will,0,0
152068,be,0,0
152069,consistent,0,0
152070,with,0,0
152071,its,0,0
152072,ultimate,0,0
152073,goal,0,0
152074,",",0,0
152075,or,0,0
152076,results,0,0
152077,instead,0,0
152078,in,0,0
152079,an,0,0
152080,execution,0,0
152081,error,0,0
152082,.,0,0
152083,In,0,0
152084,this,0,0
152085,study,0,0
152086,",",0,0
152087,we,0,0
152088,sought,0,0
152089,to,0,0
152090,evaluate,0,0
152091,the,0,0
152092,implicit,0,0
152093,ability,0,0
152094,to,0,0
152095,perceive,0,0
152096,the,0,0
152097,temporal,0,0
152098,outcome,0,0
152099,of,0,0
152100,different,0,0
152101,movements,0,0
152102,in,0,0
152103,a,0,0
152104,group,0,0
152105,of,0,0
152106,patients,1,1
152107,with,1,1
152108,writer,1,0
152109,'s,1,1
152110,cramp,1,0
152111,.,1,1
152112,Fourteen,1,1
152113,patients,1,1
152114,affected,1,0
152115,by,1,0
152116,writer,1,0
152117,'s,1,0
152118,cramp,1,0
152119,in,1,0
152120,the,1,0
152121,right,1,0
152122,hand,1,0
152123,and,1,0
152124,17,1,0
152125,age-,1,1
152126,and,1,0
152127,gender-matched,1,1
152128,healthy,1,1
152129,subjects,1,1
152130,were,1,0
152131,recruited,1,1
152132,for,1,0
152133,the,1,0
152134,study,1,0
152135,.,1,0
152136,Subjects,0,0
152137,were,0,0
152138,asked,0,0
152139,to,0,0
152140,perform,0,0
152141,a,0,0
152142,temporal,0,0
152143,expectation,0,0
152144,task,0,0
152145,by,0,0
152146,predicting,0,0
152147,the,0,0
152148,end,0,0
152149,of,0,0
152150,visually,0,0
152151,perceived,0,0
152152,human,0,0
152153,body,0,0
152154,motion,0,0
152155,(,0,0
152156,handwriting,0,0
152157,",",0,0
152158,i.e,0,0
152159,.,0,0
152160,the,0,0
152161,action,0,0
152162,performed,0,0
152163,by,0,0
152164,the,0,0
152165,human,0,0
152166,body,0,0
152167,segment,0,0
152168,specifically,0,0
152169,affected,0,0
152170,by,0,0
152171,writer,0,0
152172,'s,0,0
152173,cramp,0,0
152174,),0,0
152175,or,0,0
152176,inanimate,0,0
152177,object,0,0
152178,motion,0,0
152179,(,0,0
152180,a,0,0
152181,moving,0,0
152182,circle,0,0
152183,reaching,0,0
152184,a,0,0
152185,spatial,0,0
152186,target,0,0
152187,),0,0
152188,.,0,0
152189,Videos,0,0
152190,representing,0,0
152191,movements,0,0
152192,were,0,0
152193,shown,0,0
152194,in,0,0
152195,full,0,0
152196,before,0,0
152197,experimental,0,1
152198,trials,0,0
152199,;,0,0
152200,the,0,0
152201,actual,0,0
152202,tasks,0,0
152203,consisted,0,1
152204,of,0,0
152205,watching,0,0
152206,the,0,0
152207,same,0,0
152208,videos,0,0
152209,",",0,0
152210,but,0,0
152211,interrupted,0,0
152212,after,0,0
152213,a,0,0
152214,variable,0,0
152215,interval,0,0
152216,(,0,0
152217,'pre-dark,0,1
152218,',0,0
152219,),0,0
152220,from,0,1
152221,its,0,0
152222,onset,0,0
152223,by,0,0
152224,a,0,0
152225,dark,0,0
152226,interval,0,0
152227,of,0,0
152228,variable,0,0
152229,duration,0,0
152230,.,0,0
152231,During,0,0
152232,the,0,0
152233,'dark,0,1
152234,',0,0
152235,interval,0,0
152236,",",0,0
152237,subjects,0,1
152238,were,0,0
152239,asked,0,0
152240,to,0,0
152241,indicate,0,0
152242,when,0,0
152243,the,0,0
152244,movement,0,0
152245,represented,0,0
152246,in,0,0
152247,the,0,0
152248,video,0,0
152249,reached,0,0
152250,its,0,0
152251,end,0,0
152252,by,0,0
152253,clicking,0,0
152254,on,0,0
152255,the,0,0
152256,space,0,0
152257,bar,0,0
152258,of,0,0
152259,the,0,0
152260,keyboard,0,0
152261,.,0,0
152262,We,0,0
152263,also,0,0
152264,included,0,0
152265,a,0,0
152266,visual,0,0
152267,working,0,0
152268,memory,0,0
152269,task,0,0
152270,.,0,0
152271,Performance,0,0
152272,on,0,0
152273,the,0,0
152274,timing,0,0
152275,task,0,0
152276,was,0,0
152277,analysed,0,0
152278,measuring,0,0
152279,the,0,0
152280,absolute,0,0
152281,value,0,0
152282,of,0,0
152283,timing,0,0
152284,error,0,0
152285,",",0,0
152286,the,0,0
152287,coefficient,0,0
152288,of,0,0
152289,variability,0,0
152290,and,0,0
152291,the,0,0
152292,percentage,0,0
152293,of,0,0
152294,anticipation,0,0
152295,responses,0,0
152296,.,0,1
152297,Patients,1,1
152298,with,1,0
152299,writer,1,0
152300,'s,1,0
152301,cramp,1,0
152302,exhibited,0,0
152303,greater,0,0
152304,absolute,0,0
152305,timing,0,0
152306,error,0,0
152307,compared,0,0
152308,with,0,1
152309,control,0,0
152310,subjects,0,1
152311,in,0,0
152312,the,0,0
152313,human,0,0
152314,body,0,0
152315,motion,0,0
152316,task,0,0
152317,(,0,0
152318,whereas,0,0
152319,no,0,0
152320,difference,0,0
152321,was,0,0
152322,observed,0,0
152323,in,0,0
152324,the,0,0
152325,inanimate,0,0
152326,object,0,0
152327,motion,0,0
152328,task,0,0
152329,),0,0
152330,.,0,0
152331,No,0,0
152332,effect,0,0
152333,of,0,0
152334,group,0,0
152335,was,0,0
152336,documented,0,0
152337,on,0,0
152338,the,0,0
152339,visual,0,0
152340,working,0,0
152341,memory,0,0
152342,tasks,0,0
152343,.,0,0
152344,Absolute,0,0
152345,timing,0,0
152346,error,0,0
152347,on,0,0
152348,the,0,0
152349,human,0,0
152350,body,0,0
152351,motion,0,0
152352,task,0,0
152353,did,0,0
152354,not,0,0
152355,significantly,0,0
152356,correlate,0,0
152357,with,0,0
152358,symptom,0,0
152359,severity,0,0
152360,",",0,0
152361,disease,0,1
152362,duration,0,0
152363,or,0,0
152364,writing,0,0
152365,speed,0,0
152366,.,0,0
152367,Our,0,0
152368,findings,0,0
152369,suggest,0,0
152370,an,0,0
152371,alteration,0,0
152372,of,0,0
152373,the,0,0
152374,writing,0,0
152375,movement,0,0
152376,representation,0,0
152377,at,0,0
152378,a,0,0
152379,central,0,0
152380,level,0,0
152381,and,0,0
152382,are,0,0
152383,consistent,0,0
152384,with,0,0
152385,the,0,0
152386,view,0,0
152387,that,0,0
152388,dystonia,0,0
152389,is,0,0
152390,not,0,0
152391,a,0,0
152392,purely,0,0
152393,motor,0,0
152394,disorder,0,1
152395,",",0,0
152396,but,0,0
152397,it,0,0
152398,also,0,0
152399,involves,0,0
152400,non-motor,0,0
152401,(,0,0
152402,sensory,0,0
152403,",",0,0
152404,cognitive,0,0
152405,),0,0
152406,aspects,0,0
152407,related,0,0
152408,to,0,0
152409,movement,0,0
152410,processing,0,0
152411,and,0,0
152412,planning,0,0
152413,.,0,0
152414,Effects,0,0
152415,of,0,0
152416,a,0,0
152417,dietetic,0,1
152418,treatment,0,0
152419,in,0,0
152420,older,1,1
152421,",",1,0
152422,undernourished,1,1
152423,",",1,0
152424,community-dwelling,1,1
152425,individuals,1,1
152426,in,1,0
152427,primary,1,1
152428,care,1,1
152429,:,1,1
152430,a,0,0
152431,randomized,0,0
152432,controlled,0,0
152433,trial,0,0
152434,.,0,0
152435,PURPOSE,0,0
152436,Undernutrition,0,0
152437,is,0,0
152438,a,0,0
152439,prevalent,0,0
152440,problem,0,0
152441,in,0,0
152442,older,1,1
152443,",",1,0
152444,community-dwelling,1,1
152445,individuals,1,1
152446,.,1,1
152447,Aim,0,0
152448,of,0,0
152449,this,0,0
152450,study,0,0
152451,was,0,0
152452,to,0,0
152453,determine,0,0
152454,the,0,0
152455,effects,0,0
152456,of,0,0
152457,a,0,0
152458,dietetic,0,1
152459,treatment,0,0
152460,in,0,0
152461,older,1,1
152462,",",1,0
152463,undernourished,1,1
152464,",",1,0
152465,community-dwelling,1,1
152466,individuals,1,1
152467,.,1,1
152468,METHODS,0,0
152469,A,0,0
152470,parallel,0,0
152471,randomized,0,0
152472,controlled,0,0
152473,trial,0,0
152474,was,0,0
152475,performed,0,0
152476,in,0,0
152477,146,1,1
152478,non-institutionalized,1,1
152479,",",1,0
152480,undernourished,1,1
152481,individuals,1,1
152482,aged,1,1
152483,?65,1,0
152484,years,1,1
152485,in,1,0
152486,primary,1,1
152487,care,1,1
152488,.,1,1
152489,Participants,0,1
152490,were,0,0
152491,randomly,0,1
152492,assigned,0,0
152493,to,0,0
152494,the,0,0
152495,intervention,0,0
152496,(,0,0
152497,referral,0,0
152498,to,0,0
152499,and,0,0
152500,treatment,0,0
152501,by,0,0
152502,a,0,0
152503,trained,0,0
152504,dietitian,0,0
152505,),0,0
152506,or,0,0
152507,control,0,0
152508,group,0,0
152509,(,0,0
152510,no,0,0
152511,referral,0,0
152512,),0,0
152513,.,0,0
152514,Body,0,0
152515,weight,0,0
152516,",",0,0
152517,physical,0,0
152518,performance,0,0
152519,",",0,0
152520,handgrip,0,0
152521,strength,0,0
152522,",",0,0
152523,energy,0,0
152524,intake,0,0
152525,",",0,0
152526,protein,0,0
152527,intake,0,0
152528,and,0,0
152529,fat-free,0,0
152530,mass,0,0
152531,were,0,0
152532,assessed,0,0
152533,at,0,0
152534,baseline,0,0
152535,",",0,0
152536,after,0,0
152537,3,0,0
152538,months,0,0
152539,and,0,0
152540,after,0,0
152541,6,0,0
152542,months,0,0
152543,.,0,1
152544,RESULTS,0,0
152545,All,0,0
152546,randomized,0,0
152547,participants,0,1
152548,(,0,0
152549,n,0,1
152550,=,0,0
152551,146,0,1
152552,),0,0
152553,were,0,0
152554,included,0,0
152555,in,0,0
152556,the,0,0
152557,intention-to-treat,0,0
152558,generalized,0,0
152559,estimating,0,0
152560,equations,0,0
152561,analysis,0,0
152562,(,0,0
152563,72,0,0
152564,in,0,0
152565,intervention,0,0
152566,and,0,0
152567,74,0,0
152568,in,0,0
152569,control,0,0
152570,group,0,0
152571,),0,0
152572,.,0,0
152573,No,0,0
152574,treatment,0,0
152575,effect,0,0
152576,was,0,0
152577,found,0,0
152578,on,0,0
152579,the,0,0
152580,primary,0,0
152581,outcomes,0,0
152582,body,0,1
152583,weight,0,0
152584,(,0,0
152585,?,0,0
152586,=,0,0
152587,0.49,0,0
152588,kg,0,0
152589,",",0,0
152590,95,0,0
152591,%,0,0
152592,CI,0,0
152593,:,0,1
152594,-0.15-1.12,0,0
152595,),0,0
152596,",",0,0
152597,physical,0,0
152598,performance,0,0
152599,(,0,0
152600,?,0,0
152601,=,0,0
152602,0.15,0,0
152603,points,0,0
152604,",",0,0
152605,95,0,0
152606,%,0,0
152607,CI,0,0
152608,:,0,1
152609,-0.33-0.64,0,0
152610,),0,0
152611,and,0,0
152612,handgrip,0,0
152613,strength,0,0
152614,(,0,0
152615,?,0,0
152616,=,0,0
152617,0.49,0,0
152618,kg,0,0
152619,",",0,0
152620,95,0,0
152621,%,0,0
152622,CI,0,0
152623,:,0,1
152624,-0.62-1.60,0,0
152625,),0,0
152626,.,0,0
152627,Furthermore,0,0
152628,",",0,0
152629,no,0,0
152630,treatment,0,0
152631,effect,0,0
152632,was,0,0
152633,found,0,0
152634,for,0,0
152635,the,0,0
152636,secondary,0,0
152637,outcomes,0,0
152638,.,0,0
152639,Predefined,0,0
152640,subgroup,0,0
152641,analyses,0,0
152642,showed,0,0
152643,a,0,0
152644,treatment,0,0
152645,effect,0,0
152646,on,0,0
152647,body,0,0
152648,weight,0,0
152649,in,0,0
152650,physically,0,1
152651,active,0,0
152652,participants,0,1
152653,(,0,0
152654,?,0,0
152655,=,0,0
152656,1.25,0,0
152657,kg,0,0
152658,",",0,0
152659,95,0,0
152660,%,0,0
152661,CI,0,0
152662,:,0,1
152663,0.70-2.11,0,0
152664,),0,0
152665,and,0,0
152666,not,0,0
152667,in,0,0
152668,inactive,0,0
152669,participants,0,1
152670,(,0,0
152671,?,0,0
152672,=,0,0
152673,-0.20,0,0
152674,kg,0,0
152675,",",0,0
152676,95,0,0
152677,%,0,0
152678,CI,0,0
152679,:,0,1
152680,-1.16-0.75,0,0
152681,),0,0
152682,.,0,0
152683,CONCLUSIONS,0,0
152684,After,0,0
152685,6,0,0
152686,months,0,0
152687,",",0,0
152688,a,0,0
152689,dietetic,0,0
152690,treatment,0,0
152691,by,0,0
152692,trained,0,0
152693,dietitians,0,0
152694,does,0,0
152695,not,0,0
152696,lead,0,0
152697,to,0,0
152698,increases,0,0
152699,in,0,0
152700,body,0,1
152701,weight,0,0
152702,and,0,0
152703,physical,0,0
152704,functioning,1,0
152705,in,1,0
152706,older,1,1
152707,",",1,0
152708,undernourished,1,1
152709,",",1,0
152710,community-dwelling,1,1
152711,individuals,1,1
152712,.,1,1
152713,Pretreatment,0,0
152714,and,0,0
152715,co-administration,0,0
152716,of,0,0
152717,oral,0,0
152718,anti-diabetic,0,0
152719,agent,0,0
152720,with,0,1
152721,clomiphene,0,0
152722,citrate,0,0
152723,or,0,0
152724,rFSH,0,0
152725,for,0,0
152726,ovulation,0,0
152727,induction,0,0
152728,in,0,0
152729,clomiphene-citrate-resistant,1,1
152730,polycystic,1,1
152731,ovary,1,1
152732,syndrome,1,1
152733,.,1,0
152734,AIM,0,0
152735,The,0,0
152736,objective,0,0
152737,of,0,0
152738,this,0,0
152739,study,0,0
152740,was,0,0
152741,to,0,0
152742,explore,0,0
152743,the,0,0
152744,result,0,0
152745,of,0,0
152746,pretreatment,0,0
152747,and,0,0
152748,concomitant,0,0
152749,use,0,0
152750,of,0,0
152751,metformin,0,0
152752,with,0,1
152753,clomiphene,0,0
152754,citrate,0,0
152755,(,0,0
152756,CC,0,0
152757,),0,0
152758,and,0,0
152759,rFSH,0,0
152760,for,0,0
152761,ovulation,0,0
152762,induction,0,0
152763,in,0,0
152764,clomiphene-citrate-resistant,1,1
152765,polycystic,1,1
152766,ovary,1,1
152767,syndrome,1,1
152768,(,1,0
152769,PCOS,1,0
152770,),1,0
152771,.,1,0
152772,MATERIAL,0,0
152773,AND,0,0
152774,METHODS,0,0
152775,This,0,0
152776,randomized,0,0
152777,controlled,0,0
152778,trial,0,0
152779,was,0,0
152780,done,0,0
152781,in,0,0
152782,the,0,0
152783,Dhaka,1,1
152784,Medical,1,1
152785,College,1,1
152786,and,1,0
152787,Hospital,1,1
152788,and,1,0
152789,the,1,0
152790,Infertility,1,1
152791,Care,1,0
152792,and,1,0
152793,Research,1,0
152794,Centre,1,0
152795,",",1,0
152796,Dhaka,1,1
152797,",",1,0
152798,Bangladesh,1,1
152799,.,1,0
152800,A,0,0
152801,total,0,1
152802,of,0,0
152803,165,1,1
152804,infertile,1,1
152805,patients,1,1
152806,with,1,1
152807,CC-resistant,1,1
152808,PCOS,1,1
152809,who,1,1
152810,attended,1,1
152811,for,1,1
152812,treatment,1,0
152813,were,1,0
152814,the,1,0
152815,target,1,0
152816,population,1,0
152817,for,1,0
152818,this,1,0
152819,study,1,0
152820,.,1,0
152821,Patients,0,1
152822,were,0,0
152823,divided,0,1
152824,into,0,1
152825,three,0,0
152826,groups,0,0
152827,:,0,1
152828,groups,0,0
152829,A,0,0
152830,and,0,0
152831,B,0,0
152832,were,0,0
152833,given,0,0
152834,metformin,0,0
152835,and,0,0
152836,group,0,0
152837,C,0,0
152838,was,0,0
152839,the,0,0
152840,control,0,0
152841,.,0,0
152842,Along,0,0
152843,with,0,0
152844,metformin,0,0
152845,",",0,0
152846,group,0,0
152847,A,0,0
152848,received,0,0
152849,CC,0,0
152850,and,0,0
152851,group,0,0
152852,B,0,0
152853,received,0,0
152854,rFSH,0,0
152855,.,0,0
152856,Group,0,0
152857,C,0,0
152858,was,0,0
152859,treated,0,0
152860,with,0,0
152861,only,0,0
152862,rFSH,0,0
152863,.,0,0
152864,Metformin,0,0
152865,was,0,0
152866,given,0,0
152867,1500,0,1
152868,mg,0,0
152869,daily,0,0
152870,for,0,0
152871,4,0,0
152872,weeks,0,0
152873,.,0,1
152874,Afterwards,0,0
152875,CC,0,0
152876,or,0,0
152877,rFSH,0,0
152878,were,0,0
152879,added,0,0
152880,for,0,0
152881,induction,0,0
152882,of,0,0
152883,ovulation,0,0
152884,along,0,0
152885,with,0,1
152886,metformin,0,0
152887,.,0,0
152888,Six,0,0
152889,ovulatory,0,1
152890,cycles,0,0
152891,were,0,0
152892,assessed,0,0
152893,.,0,0
152894,Treatment,0,0
152895,was,0,0
152896,terminated,0,0
152897,when,0,0
152898,there,0,0
152899,was,0,0
152900,no,0,0
152901,response,0,0
152902,with,0,0
152903,maximum,0,0
152904,dose,0,0
152905,of,0,0
152906,CC,0,0
152907,and,0,0
152908,rFSH,0,0
152909,or,0,0
152910,after,0,0
152911,six,0,1
152912,ovulatory,0,1
152913,cycles,0,0
152914,without,0,1
152915,pregnancy,0,1
152916,or,0,0
152917,after,0,0
152918,achieving,0,0
152919,pregnancy,0,1
152920,.,0,0
152921,A,0,0
152922,P-value,0,0
152923,of,0,0
152924,<,0,0
152925,0.5,0,0
152926,was,0,0
152927,considered,0,0
152928,as,0,0
152929,significant,0,0
152930,.,0,1
152931,RESULTS,0,0
152932,Ovulation,0,0
152933,(,0,0
152934,89.09,0,0
152935,%,0,0
152936,),0,0
152937,and,0,0
152938,pregnancy,0,1
152939,(,0,0
152940,54.55,0,0
152941,%,0,0
152942,),0,0
152943,rates,0,0
152944,were,0,0
152945,higher,0,0
152946,in,0,0
152947,group,0,0
152948,B.,0,0
152949,Ovulation,0,0
152950,(,0,0
152951,74.55,0,0
152952,%,0,0
152953,),0,0
152954,and,0,0
152955,pregnancy,0,1
152956,(,0,0
152957,29.09,0,0
152958,%,0,0
152959,),0,0
152960,rates,0,0
152961,were,0,0
152962,also,0,0
152963,satisfactory,0,0
152964,in,0,0
152965,group,0,0
152966,C,0,0
152967,but,0,0
152968,a,0,0
152969,dose,0,0
152970,of,0,0
152971,rFSH,0,0
152972,requirement,0,0
152973,was,0,0
152974,significantly,0,0
152975,higher,0,0
152976,(,0,0
152977,P,0,0
152978,=,0,0
152979,0.000,0,0
152980,),0,0
152981,.,0,0
152982,In,0,0
152983,group,0,0
152984,A,0,0
152985,",",0,0
152986,both,0,0
152987,ovulation,0,0
152988,and,0,0
152989,pregnancy,0,1
152990,rate,0,0
152991,were,0,0
152992,much,0,0
152993,lower,0,0
152994,than,0,0
152995,the,0,0
152996,other,0,0
152997,two,0,0
152998,groups,0,0
152999,(,0,0
153000,27.27,0,0
153001,%,0,0
153002,and,0,0
153003,12.73,0,0
153004,%,0,0
153005,",",0,0
153006,respectively,0,0
153007,),0,0
153008,.,0,0
153009,CONCLUSIONS,0,0
153010,Use,0,0
153011,of,0,0
153012,metformin,0,0
153013,increases,0,0
153014,the,0,0
153015,response,0,0
153016,of,0,0
153017,ovulation-inducing,0,0
153018,agents,0,0
153019,and,0,0
153020,can,0,0
153021,be,0,0
153022,used,0,0
153023,safely,0,0
153024,in,1,0
153025,PCOS,1,0
153026,.,1,1
153027,Low,0,1
153028,body,0,0
153029,mass,0,0
153030,index,0,0
153031,and,0,0
153032,dyslipidemia,0,0
153033,in,0,0
153034,dialysis,1,1
153035,patients,1,1
153036,linked,0,0
153037,to,0,0
153038,elevated,0,0
153039,plasma,0,0
153040,fibroblast,0,0
153041,growth,0,0
153042,factor,0,0
153043,23,0,1
153044,.,0,0
153045,BACKGROUND,0,0
153046,Fibroblast,0,0
153047,growth,0,0
153048,factor,0,0
153049,23,0,1
153050,(,0,0
153051,FGF23,0,0
153052,),0,0
153053,has,0,0
153054,been,0,0
153055,associated,0,0
153056,with,0,0
153057,death,0,0
153058,in,0,0
153059,dialysis,1,1
153060,patients,1,1
153061,.,1,0
153062,Since,0,0
153063,FGF23,0,0
153064,shares,0,0
153065,structural,0,0
153066,features,0,1
153067,with,0,1
153068,FGF19,0,1
153069,subfamily,0,1
153070,members,0,1
153071,that,0,0
153072,exert,0,0
153073,hormonal,0,0
153074,control,0,0
153075,of,0,0
153076,fat,0,0
153077,mass,0,0
153078,",",0,0
153079,we,0,0
153080,hypothesized,0,0
153081,that,0,0
153082,high,0,0
153083,circulating,0,0
153084,FGF23,0,0
153085,concentrations,0,0
153086,would,0,0
153087,be,0,0
153088,associated,0,0
153089,with,0,0
153090,the,0,0
153091,development,0,0
153092,of,0,0
153093,a,0,0
153094,uremic,0,0
153095,lipid,0,0
153096,profile,0,0
153097,and,0,0
153098,lower,0,0
153099,body,0,0
153100,mass,0,0
153101,index,0,0
153102,(,0,0
153103,BMI,0,0
153104,),0,0
153105,.,0,0
153106,METHODS,0,0
153107,This,0,0
153108,study,0,0
153109,was,0,0
153110,conducted,0,0
153111,among,0,0
153112,654,1,1
153113,patients,1,1
153114,receiving,1,1
153115,chronic,1,1
153116,hemodialysis,1,1
153117,.,1,0
153118,C-terminal,0,0
153119,FGF23,0,0
153120,concentrations,0,0
153121,were,0,0
153122,measured,0,0
153123,in,0,0
153124,stored,0,0
153125,plasma,0,0
153126,samples,0,0
153127,.,0,0
153128,Linear,0,0
153129,regression,0,0
153130,was,0,0
153131,used,0,0
153132,to,0,0
153133,examine,0,0
153134,the,0,0
153135,cross-sectional,0,0
153136,associations,0,0
153137,of,0,0
153138,plasma,0,0
153139,FGF23,0,0
153140,concentrations,0,0
153141,with,0,1
153142,BMI,0,0
153143,",",0,0
153144,total,0,0
153145,cholesterol,0,0
153146,(,0,0
153147,TC,0,0
153148,),0,0
153149,",",0,0
153150,low-density,0,0
153151,lipoprotein-cholesterol,0,0
153152,(,0,0
153153,LDL-C,0,0
153154,),0,0
153155,",",0,0
153156,high-density,0,0
153157,lipoprotein-cholesterol,0,0
153158,(,0,0
153159,HDL-C,0,0
153160,),0,0
153161,and,0,0
153162,triglycerides,0,0
153163,.,0,1
153164,Cox,0,0
153165,proportional,0,0
153166,hazard,0,0
153167,models,0,0
153168,were,0,0
153169,used,0,0
153170,to,0,0
153171,examine,0,0
153172,the,0,0
153173,association,0,0
153174,between,0,0
153175,FGF23,0,0
153176,concentrations,0,0
153177,and,0,0
153178,all-cause,0,0
153179,mortality,0,0
153180,.,0,0
153181,RESULTS,0,0
153182,Participants,1,1
153183,had,1,0
153184,a,1,0
153185,mean,1,0
153186,age,1,1
153187,of,1,0
153188,60,1,1
153189,?,1,0
153190,11,1,0
153191,years,1,1
153192,and,1,0
153193,a,1,0
153194,median,1,0
153195,(,1,0
153196,IQR,1,0
153197,),1,0
153198,FGF23,1,0
153199,concentration,1,0
153200,of,1,0
153201,"4,212",1,1
153202,(,1,0
153203,"1,411-13,816",1,1
153204,),1,0
153205,RU/ml,1,0
153206,.,1,0
153207,An,0,0
153208,increase,0,0
153209,per,0,0
153210,SD,0,0
153211,in,0,0
153212,log10,0,0
153213,FGF23,0,0
153214,was,0,0
153215,associated,0,0
153216,with,0,1
153217,lower,0,0
153218,BMI,0,0
153219,(,0,0
153220,?,0,0
153221,=,0,0
153222,-1.11,0,0
153223,;,0,0
153224,p,0,0
153225,=,0,0
153226,0.008,0,0
153227,),0,0
153228,",",0,0
153229,TC,0,0
153230,(,0,0
153231,?,0,0
153232,=,0,0
153233,-6.46,0,0
153234,;,0,0
153235,p,0,0
153236,=,0,0
153237,0.02,0,0
153238,),0,0
153239,",",0,0
153240,LDL-C,0,0
153241,(,0,0
153242,?,0,0
153243,=,0,0
153244,-4.73,0,0
153245,;,0,0
153246,p,0,0
153247,=,0,0
153248,0.04,0,0
153249,),0,0
153250,and,0,0
153251,HDL-C,0,0
153252,(,0,0
153253,?,0,0
153254,=,0,0
153255,-2.14,0,0
153256,;,0,0
153257,p,0,0
153258,=,0,0
153259,0.03,0,0
153260,),0,0
153261,;,0,0
153262,after,0,0
153263,adjusting,0,0
153264,for,0,0
153265,age,0,1
153266,",",0,0
153267,gender,0,0
153268,",",0,0
153269,race,0,0
153270,",",0,0
153271,cardiovascular,0,0
153272,risk,0,0
153273,factors,0,0
153274,",",0,0
153275,serum,0,0
153276,albumin,0,0
153277,",",0,0
153278,markers,0,0
153279,of,0,0
153280,mineral,0,0
153281,metabolism,0,0
153282,",",0,0
153283,and,0,0
153284,use,0,0
153285,of,0,0
153286,lipid-lowering,0,0
153287,drugs,0,0
153288,.,0,0
153289,The,0,0
153290,association,0,0
153291,of,0,0
153292,FGF23,0,0
153293,with,0,1
153294,death,0,0
153295,was,0,0
153296,attenuated,0,0
153297,after,0,0
153298,adjustment,0,0
153299,for,0,0
153300,HDL-C,0,0
153301,(,0,0
153302,HR,0,0
153303,of,0,0
153304,highest,0,0
153305,quartile,0,0
153306,1.53,0,0
153307,",",0,0
153308,95,0,0
153309,%,0,0
153310,CI,0,0
153311,1.06-2.20,0,0
153312,compared,0,0
153313,to,0,0
153314,lowest,0,0
153315,quartile,0,0
153316,),0,0
153317,.,0,0
153318,CONCLUSION,0,0
153319,These,0,0
153320,results,0,0
153321,indicate,0,0
153322,that,0,0
153323,higher,0,0
153324,plasma,0,0
153325,FGF23,0,0
153326,levels,0,0
153327,are,0,0
153328,associated,0,0
153329,with,0,0
153330,lower,0,0
153331,BMI,0,0
153332,and,0,0
153333,dyslipidemia,1,0
153334,in,1,0
153335,dialysis,1,1
153336,patients,1,1
153337,.,1,0
153338,The,1,0
153339,association,0,0
153340,between,0,0
153341,FGF23,0,0
153342,and,0,0
153343,death,0,0
153344,may,0,0
153345,be,0,0
153346,mediated,0,0
153347,through,0,0
153348,unexplored,0,0
153349,metabolic,0,0
153350,risk,0,0
153351,factors,0,0
153352,unrelated,0,1
153353,to,0,0
153354,mineral,0,0
153355,metabolism,0,0
153356,.,0,0
153357,A,0,0
153358,randomized,0,0
153359,controlled,0,0
153360,trial,0,0
153361,of,0,0
153362,COMPASS,0,0
153363,web-based,0,0
153364,and,0,0
153365,face-to-face,0,0
153366,teacher,0,0
153367,coaching,0,0
153368,in,0,0
153369,autism,1,1
153370,.,1,0
153371,OBJECTIVE,0,0
153372,Most,0,0
153373,children,1,1
153374,with,1,1
153375,autism,1,1
153376,rely,0,0
153377,on,0,0
153378,schools,0,1
153379,as,0,0
153380,their,0,1
153381,primary,0,0
153382,source,0,0
153383,of,0,0
153384,intervention,0,0
153385,",",0,0
153386,yet,0,0
153387,research,0,0
153388,has,0,0
153389,suggested,0,0
153390,that,0,0
153391,teachers,0,1
153392,rarely,0,0
153393,use,0,0
153394,evidence-based,0,0
153395,practices,0,0
153396,.,0,0
153397,To,0,0
153398,address,0,0
153399,the,0,0
153400,need,0,0
153401,for,0,0
153402,improved,0,0
153403,educational,0,0
153404,outcomes,0,0
153405,",",0,0
153406,a,0,0
153407,previously,0,0
153408,tested,0,0
153409,consultation,0,0
153410,intervention,0,0
153411,called,0,0
153412,the,0,0
153413,Collaborative,0,0
153414,Model,0,0
153415,for,0,0
153416,Promoting,0,0
153417,Competence,0,0
153418,and,0,0
153419,Success,0,0
153420,(,0,0
153421,COMPASS,0,0
153422,;,0,0
153423,Ruble,0,0
153424,",",0,0
153425,Dalrymple,0,0
153426,",",0,0
153427,&,0,0
153428,McGrew,0,0
153429,",",0,0
153430,2010,0,1
153431,;,0,0
153432,Ruble,0,0
153433,",",0,0
153434,Dalrymple,0,0
153435,",",0,0
153436,&,0,0
153437,McGrew,0,0
153438,",",0,0
153439,2012,0,1
153440,),0,0
153441,was,0,0
153442,evaluated,0,0
153443,in,0,0
153444,a,0,0
153445,2nd,0,0
153446,randomized,0,0
153447,controlled,0,0
153448,trial,0,0
153449,",",0,0
153450,with,0,0
153451,the,0,0
153452,addition,1,0
153453,of,1,0
153454,a,1,0
153455,web-based,1,0
153456,group,1,0
153457,.,1,0
153458,METHOD,0,0
153459,Forty-nine,1,1
153460,teacher-child,1,1
153461,dyads,1,1
153462,were,0,0
153463,randomized,0,0
153464,into,0,0
153465,1,0,0
153466,of,0,0
153467,3,0,0
153468,groups,0,0
153469,:,0,1
153470,(,0,0
153471,1,0,0
153472,),0,0
153473,a,0,0
153474,placebo,0,0
153475,control,0,0
153476,(,0,0
153477,PBO,0,0
153478,),0,0
153479,group,0,0
153480,",",0,0
153481,(,0,0
153482,2,0,0
153483,),0,0
153484,COMPASS,0,0
153485,followed,0,0
153486,by,0,0
153487,face-to-face,0,0
153488,(,0,0
153489,FF,0,1
153490,),0,0
153491,coaching,0,0
153492,sessions,0,0
153493,",",0,0
153494,and,0,0
153495,(,0,0
153496,3,0,0
153497,),0,0
153498,COMPASS,0,0
153499,followed,0,0
153500,by,0,0
153501,web-based,0,0
153502,(,0,0
153503,WEB,0,0
153504,),0,0
153505,coaching,0,0
153506,sessions,0,0
153507,.,0,1
153508,Three,0,1
153509,individualized,0,0
153510,goals,0,0
153511,(,0,0
153512,social,0,0
153513,",",0,0
153514,communication,0,0
153515,",",0,0
153516,and,0,0
153517,independence,0,0
153518,skills,0,0
153519,),0,0
153520,were,0,0
153521,selected,0,0
153522,for,0,0
153523,intervention,0,0
153524,for,0,0
153525,each,0,0
153526,child,1,0
153527,.,1,0
153528,The,0,0
153529,primary,0,0
153530,outcome,0,0
153531,of,0,0
153532,independent,0,0
153533,ratings,0,0
153534,of,0,0
153535,child,0,1
153536,goal,0,0
153537,attainment,0,0
153538,and,0,0
153539,several,0,0
153540,process,0,0
153541,measures,0,0
153542,(,0,0
153543,e.g.,0,0
153544,",",0,0
153545,consultant,0,0
153546,and,0,0
153547,teacher,0,0
153548,fidelity,0,0
153549,),0,0
153550,were,0,0
153551,evaluated,0,0
153552,.,0,0
153553,RESULTS,0,0
153554,Using,0,0
153555,an,0,0
153556,intent-to-treat,0,0
153557,approach,0,0
153558,",",0,0
153559,findings,0,0
153560,replicated,0,0
153561,earlier,0,0
153562,results,0,0
153563,with,0,0
153564,a,0,0
153565,very,0,0
153566,large,0,0
153567,effect,0,0
153568,size,0,0
153569,(,0,0
153570,d,0,0
153571,=,0,0
153572,1.41,0,0
153573,),0,0
153574,for,0,0
153575,the,0,0
153576,FF,0,0
153577,group,0,0
153578,and,0,0
153579,a,0,0
153580,large,0,0
153581,effect,0,0
153582,size,0,0
153583,(,0,0
153584,d,0,0
153585,=,0,0
153586,1.12,0,0
153587,),0,0
153588,for,0,0
153589,the,0,0
153590,WEB,0,0
153591,group,0,0
153592,relative,0,0
153593,to,0,0
153594,the,0,0
153595,PBO,0,0
153596,group,0,0
153597,.,0,0
153598,There,0,0
153599,were,0,0
153600,no,0,0
153601,differences,0,0
153602,in,0,0
153603,overall,0,0
153604,change,0,0
153605,across,0,0
153606,goal,0,0
153607,domains,0,0
153608,between,0,0
153609,the,0,0
153610,FF,0,0
153611,and,0,0
153612,WEB,0,0
153613,groups,0,0
153614,",",0,0
153615,suggesting,0,0
153616,the,0,0
153617,efficacy,0,0
153618,of,0,0
153619,videoconferencing,0,0
153620,technology,0,0
153621,.,0,0
153622,CONCLUSIONS,0,0
153623,COMPASS,0,0
153624,is,0,0
153625,effective,0,0
153626,and,0,0
153627,results,0,0
153628,in,0,0
153629,improved,0,0
153630,educational,0,0
153631,outcomes,0,0
153632,for,0,0
153633,young,1,1
153634,children,1,1
153635,with,1,1
153636,autism,1,1
153637,.,1,0
153638,Videoconferencing,0,0
153639,technology,0,0
153640,",",0,0
153641,as,0,0
153642,a,0,0
153643,scalable,0,0
153644,tool,0,0
153645,",",0,0
153646,has,0,0
153647,promise,0,0
153648,for,0,0
153649,facilitating,0,0
153650,access,0,0
153651,to,0,0
153652,autism,0,1
153653,specialists,0,1
153654,and,0,0
153655,bridging,0,0
153656,the,0,0
153657,research-to-practice,0,0
153658,gap,0,0
153659,.,0,0
153660,Effects,0,0
153661,of,0,0
153662,intranasal,0,0
153663,oxytocin,0,0
153664,on,0,0
153665,the,0,0
153666,neural,0,0
153667,basis,0,0
153668,of,0,0
153669,face,0,0
153670,processing,0,0
153671,in,0,0
153672,autism,1,1
153673,spectrum,1,1
153674,disorder,1,1
153675,.,1,0
153676,BACKGROUND,0,0
153677,Autism,1,1
153678,spectrum,1,1
153679,disorder,1,1
153680,(,1,0
153681,ASD,1,1
153682,),1,0
153683,is,0,0
153684,associated,0,0
153685,with,0,0
153686,altered,0,0
153687,face,0,0
153688,processing,0,0
153689,and,0,0
153690,decreased,0,0
153691,activity,0,0
153692,in,0,0
153693,brain,0,0
153694,regions,0,0
153695,involved,0,0
153696,in,0,0
153697,face,0,0
153698,processing,0,0
153699,.,0,0
153700,The,0,0
153701,neuropeptide,0,0
153702,oxytocin,0,0
153703,has,0,0
153704,been,0,0
153705,shown,0,0
153706,to,0,0
153707,promote,0,0
153708,face,0,0
153709,processing,0,0
153710,and,0,0
153711,modulate,0,0
153712,brain,0,0
153713,activity,0,0
153714,in,0,0
153715,healthy,1,1
153716,adults,1,1
153717,.,1,0
153718,The,0,0
153719,present,0,0
153720,study,0,0
153721,examined,0,0
153722,the,0,0
153723,effects,0,0
153724,of,0,0
153725,oxytocin,0,0
153726,on,0,0
153727,the,0,0
153728,neural,0,0
153729,basis,0,0
153730,of,0,0
153731,face,0,0
153732,processing,0,0
153733,in,0,0
153734,adults,1,1
153735,with,1,1
153736,Asperger,1,1
153737,syndrome,1,1
153738,(,1,0
153739,AS,1,0
153740,),1,0
153741,.,1,0
153742,METHODS,0,0
153743,A,0,0
153744,group,0,0
153745,of,0,0
153746,14,1,0
153747,individuals,1,1
153748,with,1,1
153749,AS,1,0
153750,and,1,0
153751,a,1,0
153752,group,1,0
153753,of,1,0
153754,14,1,0
153755,neurotypical,1,1
153756,control,1,1
153757,participants,1,1
153758,performed,0,0
153759,a,0,0
153760,face-matching,0,0
153761,and,0,0
153762,a,0,0
153763,house-matching,0,0
153764,task,0,0
153765,during,0,0
153766,functional,0,0
153767,magnetic,0,0
153768,resonance,0,0
153769,imaging,0,0
153770,.,0,0
153771,The,0,0
153772,effects,0,0
153773,of,0,0
153774,a,0,0
153775,single,0,0
153776,dose,0,0
153777,of,0,0
153778,24,0,0
153779,IU,0,0
153780,intranasally,0,1
153781,administered,0,0
153782,oxytocin,0,0
153783,were,0,0
153784,tested,0,0
153785,in,0,0
153786,a,0,0
153787,randomized,0,0
153788,",",0,0
153789,placebo-controlled,0,0
153790,",",0,0
153791,within-subject,0,0
153792,",",0,0
153793,cross-over,0,0
153794,design,0,0
153795,.,0,0
153796,RESULTS,0,0
153797,Under,0,1
153798,placebo,0,0
153799,",",0,0
153800,the,0,0
153801,AS,0,0
153802,group,0,0
153803,showed,0,0
153804,decreased,0,0
153805,activity,0,0
153806,in,0,0
153807,the,0,0
153808,right,0,0
153809,amygdala,0,0
153810,",",0,0
153811,fusiform,0,0
153812,gyrus,0,0
153813,",",0,0
153814,and,0,0
153815,inferior,0,0
153816,occipital,0,0
153817,gyrus,0,0
153818,compared,0,0
153819,with,0,0
153820,the,0,0
153821,control,0,0
153822,group,0,0
153823,during,0,0
153824,face,0,0
153825,processing,0,0
153826,.,0,0
153827,After,0,0
153828,oxytocin,0,0
153829,treatment,0,0
153830,",",0,0
153831,right,0,0
153832,amygdala,0,0
153833,activity,0,0
153834,to,0,0
153835,facial,0,0
153836,stimuli,0,0
153837,increased,0,0
153838,in,0,0
153839,the,0,0
153840,AS,0,0
153841,group,0,0
153842,.,0,0
153843,CONCLUSIONS,0,0
153844,These,0,0
153845,findings,0,0
153846,indicate,0,0
153847,that,0,0
153848,oxytocin,0,0
153849,increases,0,0
153850,the,0,0
153851,saliency,0,0
153852,of,0,0
153853,social,0,0
153854,stimuli,0,0
153855,and,0,0
153856,in,0,0
153857,ASD,1,1
153858,and,0,0
153859,suggest,0,0
153860,that,0,0
153861,oxytocin,0,0
153862,might,0,0
153863,promote,0,0
153864,face,0,0
153865,processing,0,0
153866,and,0,0
153867,eye,0,0
153868,contact,0,0
153869,in,0,0
153870,individuals,0,1
153871,with,0,1
153872,ASD,1,1
153873,as,0,0
153874,prerequisites,0,0
153875,for,0,0
153876,neurotypical,0,1
153877,social,0,0
153878,interaction,0,0
153879,.,0,0
153880,A,0,0
153881,randomized,0,0
153882,",",0,0
153883,placebo-controlled,0,0
153884,phase,0,0
153885,2,0,0
153886,study,0,0
153887,of,0,0
153888,ganitumab,0,0
153889,or,0,0
153890,conatumumab,0,0
153891,in,0,0
153892,combination,0,0
153893,with,0,1
153894,FOLFIRI,0,0
153895,for,0,0
153896,second-line,0,0
153897,treatment,0,0
153898,of,0,0
153899,mutant,0,0
153900,KRAS,0,0
153901,metastatic,0,1
153902,colorectal,0,1
153903,cancer,0,1
153904,.,0,0
153905,BACKGROUND,0,0
153906,Targeted,0,0
153907,agents,0,0
153908,presently,0,0
153909,available,0,0
153910,for,0,0
153911,mutant,0,0
153912,KRAS,0,0
153913,metastatic,0,1
153914,colorectal,0,1
153915,cancer,0,1
153916,(,0,0
153917,mCRC,0,0
153918,),0,0
153919,are,0,0
153920,bevacizumab,0,0
153921,and,0,0
153922,aflibercept,0,0
153923,.,0,0
153924,We,0,0
153925,evaluated,0,0
153926,the,0,0
153927,efficacy,0,0
153928,and,0,0
153929,safety,0,0
153930,of,0,0
153931,conatumumab,0,0
153932,(,0,0
153933,an,0,0
153934,agonistic,0,0
153935,monoclonal,0,0
153936,antibody,0,0
153937,against,0,0
153938,human,0,0
153939,death,0,0
153940,receptor,0,0
153941,5,0,0
153942,),0,0
153943,and,0,0
153944,ganitumab,0,0
153945,(,0,0
153946,a,0,0
153947,monoclonal,0,0
153948,antibody,0,0
153949,against,0,0
153950,the,0,0
153951,type,0,1
153952,1,0,0
153953,insulin-like,0,0
153954,growth,0,0
153955,factor,0,0
153956,receptor,0,0
153957,),0,0
153958,combined,0,0
153959,with,0,1
153960,standard,0,0
153961,FOLFIRI,0,0
153962,chemotherapy,0,0
153963,as,0,0
153964,a,0,0
153965,second-line,0,0
153966,treatment,0,0
153967,in,0,0
153968,patients,0,1
153969,with,0,1
153970,mutant,0,1
153971,KRAS,0,1
153972,mCRC,0,0
153973,.,0,0
153974,PATIENTS,0,0
153975,AND,0,0
153976,METHODS,0,0
153977,Patients,1,1
153978,with,1,1
153979,mutant,1,1
153980,KRAS,1,0
153981,metastatic,1,1
153982,adenocarcinoma,1,1
153983,of,1,0
153984,the,1,0
153985,colon,1,1
153986,or,1,0
153987,rectum,1,0
153988,refractory,1,1
153989,to,1,0
153990,fluoropyrimidine-,1,0
153991,and,1,0
153992,oxaliplatin-based,1,0
153993,chemotherapy,1,0
153994,were,0,0
153995,randomized,0,0
153996,1,0,0
153997,:,0,1
153998,1,0,0
153999,:,0,1
154000,1,0,0
154001,to,0,0
154002,receive,0,0
154003,intravenous,0,0
154004,FOLFIRI,0,0
154005,plus,0,0
154006,conatumumab,0,0
154007,10,0,0
154008,mg/kg,0,0
154009,(,0,0
154010,Arm,0,1
154011,A,0,0
154012,),0,0
154013,",",0,0
154014,ganitumab,0,0
154015,12,0,0
154016,mg/kg,0,0
154017,(,0,0
154018,Arm,0,1
154019,B,0,0
154020,),0,0
154021,",",0,0
154022,or,0,0
154023,placebo,0,0
154024,(,0,0
154025,Arm,0,1
154026,C,0,0
154027,),0,0
154028,Q2W,0,0
154029,.,0,0
154030,The,0,0
154031,primary,0,0
154032,end,0,0
154033,point,0,0
154034,was,0,0
154035,progression-free,0,0
154036,survival,0,0
154037,(,0,0
154038,PFS,0,0
154039,),0,0
154040,.,0,0
154041,RESULTS,0,0
154042,In,0,0
154043,total,0,1
154044,",",0,0
154045,155,1,1
154046,patients,1,1
154047,were,1,0
154048,randomized,1,0
154049,.,1,0
154050,Median,0,0
154051,PFS,0,0
154052,in,0,0
154053,Arms,0,1
154054,A,0,0
154055,",",0,0
154056,B,0,0
154057,",",0,0
154058,and,0,0
154059,C,0,0
154060,was,0,0
154061,6.5,0,0
154062,months,0,0
154063,(,0,0
154064,HR,0,0
154065,",",0,0
154066,0.69,0,0
154067,;,0,0
154068,P,0,0
154069,=,0,0
154070,0.147,0,0
154071,),0,0
154072,",",0,0
154073,4.5,0,0
154074,months,0,0
154075,(,0,0
154076,HR,0,0
154077,",",0,0
154078,1.01,0,0
154079,;,0,0
154080,P,0,0
154081,=,0,0
154082,0.998,0,0
154083,),0,0
154084,",",0,0
154085,and,0,0
154086,4.6,0,0
154087,months,0,0
154088,",",0,0
154089,respectively,0,0
154090,;,0,0
154091,median,0,0
154092,overall,0,0
154093,survival,0,0
154094,was,0,0
154095,12.3,0,0
154096,months,0,0
154097,(,0,0
154098,HR,0,0
154099,",",0,0
154100,0.89,0,0
154101,;,0,0
154102,P,0,0
154103,=,0,0
154104,0.650,0,0
154105,),0,0
154106,",",0,0
154107,12.4,0,0
154108,months,0,0
154109,(,0,0
154110,HR,0,0
154111,",",0,0
154112,1.27,0,0
154113,;,0,0
154114,P,0,0
154115,=,0,0
154116,0.357,0,0
154117,),0,0
154118,",",0,0
154119,and,0,0
154120,12.0,0,0
154121,months,0,0
154122,;,0,0
154123,and,0,0
154124,objective,0,0
154125,response,0,0
154126,rate,0,0
154127,was,0,0
154128,14,0,0
154129,%,0,0
154130,",",0,0
154131,8,0,0
154132,%,0,0
154133,",",0,0
154134,and,0,0
154135,2,0,0
154136,%,0,0
154137,.,0,0
154138,The,0,0
154139,most,0,0
154140,common,0,0
154141,grade,0,0
154142,?3,0,0
154143,adverse,0,0
154144,events,0,0
154145,in,0,0
154146,Arms,0,1
154147,A/B/C,0,0
154148,included,0,1
154149,neutropenia,0,0
154150,(,0,0
154151,30,0,0
154152,%,0,0
154153,/25,0,0
154154,%,0,0
154155,/18,0,0
154156,%,0,0
154157,),0,0
154158,and,0,0
154159,diarrhea,0,1
154160,(,0,0
154161,18,0,1
154162,%,0,0
154163,/2,0,0
154164,%,0,0
154165,/10,0,0
154166,%,0,0
154167,),0,0
154168,.,0,0
154169,CONCLUSIONS,0,0
154170,Conatumumab,0,0
154171,",",0,0
154172,but,0,0
154173,not,0,0
154174,ganitumab,0,0
154175,",",0,0
154176,plus,0,0
154177,FOLFIRI,0,0
154178,was,0,0
154179,associated,0,0
154180,with,0,0
154181,a,0,0
154182,trend,0,0
154183,toward,0,0
154184,improved,0,0
154185,PFS,0,1
154186,.,0,1
154187,Both,0,0
154188,combinations,0,0
154189,had,0,1
154190,acceptable,0,0
154191,toxicity,0,0
154192,.,0,0
154193,Perioperative,0,0
154194,myocardial,0,1
154195,infarctions,0,1
154196,are,0,0
154197,common,0,0
154198,and,0,0
154199,often,0,0
154200,unrecognized,0,0
154201,in,0,0
154202,patients,1,1
154203,undergoing,1,1
154204,hip,1,1
154205,fracture,1,1
154206,surgery,1,1
154207,.,1,0
154208,BACKGROUND,0,0
154209,The,0,0
154210,aim,0,0
154211,of,0,0
154212,this,0,0
154213,prospective,0,0
154214,cohort,0,1
154215,study,0,0
154216,was,0,0
154217,to,0,0
154218,assess,0,0
154219,the,0,0
154220,incidence,0,0
154221,and,0,0
154222,characteristics,0,0
154223,of,0,0
154224,acute,0,1
154225,myocardial,0,1
154226,infarction,0,1
154227,in,0,0
154228,patients,1,1
154229,undergoing,1,1
154230,surgery,1,1
154231,for,1,0
154232,acute,1,1
154233,hip,1,1
154234,fracture,1,0
154235,.,1,0
154236,METHODS,0,0
154237,A,1,0
154238,consecutive,1,1
154239,cohort,1,1
154240,of,1,0
154241,patients,1,1
154242,(,1,0
154243,n,1,1
154244,=,1,0
154245,200,1,0
154246,",",1,0
154247,68,1,1
154248,men,1,1
154249,),1,0
154250,referred,1,1
154251,to,1,0
154252,acute,1,1
154253,surgical,1,0
154254,correction,1,0
154255,of,1,0
154256,hip,1,1
154257,fracture,1,0
154258,was,1,0
154259,studied,1,1
154260,.,1,0
154261,Troponin,0,0
154262,T,0,0
154263,(,0,0
154264,TnT,0,0
154265,),0,0
154266,measurements,0,0
154267,and,0,0
154268,electrocardiographic,0,1
154269,(,0,0
154270,ECG,0,0
154271,),0,0
154272,recordings,0,0
154273,were,0,0
154274,performed,0,0
154275,at,0,0
154276,admission,0,0
154277,",",0,0
154278,before,0,0
154279,operation,0,0
154280,",",0,0
154281,and,0,0
154282,on,0,0
154283,the,0,0
154284,first,0,0
154285,and,0,0
154286,2nd,0,1
154287,postoperative,0,0
154288,days,0,0
154289,",",0,0
154290,which,0,0
154291,were,0,0
154292,used,0,0
154293,for,0,0
154294,diagnosis,0,1
154295,.,0,0
154296,RESULTS,0,0
154297,The,1,0
154298,age,1,1
154299,of,1,0
154300,the,1,0
154301,patients,1,1
154302,ranged,1,0
154303,from,1,0
154304,32,1,1
154305,to,1,0
154306,98,1,1
154307,years,1,1
154308,(,1,0
154309,mean,1,0
154310,",",1,0
154311,80.8,1,0
154312,years,1,1
154313,),1,0
154314,",",1,0
154315,and,1,0
154316,65,1,1
154317,patients,1,1
154318,had,1,0
154319,a,1,0
154320,history,1,0
154321,of,1,0
154322,coronary,1,1
154323,artery,1,1
154324,disease,1,1
154325,.,1,0
154326,A,0,0
154327,significant,0,0
154328,rise,0,0
154329,in,0,0
154330,TnT,0,0
154331,as,0,0
154332,a,0,0
154333,sign,0,0
154334,of,0,0
154335,myocardial,0,1
154336,infarction,0,1
154337,was,0,0
154338,observed,0,0
154339,in,0,0
154340,71,0,1
154341,patients,0,1
154342,(,0,0
154343,35.5,0,0
154344,%,0,0
154345,),0,0
154346,",",0,0
154347,and,0,0
154348,25,0,0
154349,of,0,0
154350,them,0,0
154351,had,0,0
154352,a,0,0
154353,TnT,0,0
154354,elevation,0,0
154355,exceeding,0,0
154356,five,0,1
154357,times,0,0
154358,the,0,0
154359,upper,0,0
154360,normal,0,1
154361,limit,0,0
154362,.,0,0
154363,TnT,0,0
154364,elevation,0,0
154365,was,0,0
154366,observed,0,0
154367,in,0,0
154368,36,0,1
154369,patients,0,1
154370,(,0,0
154371,51,0,1
154372,%,0,0
154373,),0,0
154374,already,0,0
154375,before,0,0
154376,surgery,0,1
154377,.,0,0
154378,Seven,0,0
154379,patients,0,1
154380,(,0,0
154381,10,0,1
154382,%,0,0
154383,),0,0
154384,had,0,0
154385,ST,0,1
154386,elevation,0,0
154387,myocardial,0,0
154388,infarction,0,1
154389,",",0,0
154390,23,0,1
154391,patients,0,1
154392,(,0,0
154393,32,0,1
154394,%,0,0
154395,),0,0
154396,had,0,0
154397,new,0,0
154398,ST,0,1
154399,depressions,0,0
154400,",",0,0
154401,and,0,0
154402,21,0,1
154403,patients,0,1
154404,(,0,0
154405,30,0,1
154406,%,0,0
154407,),0,0
154408,had,0,0
154409,no,0,0
154410,new,0,0
154411,ST,0,1
154412,segment,0,0
154413,changes,0,0
154414,in,0,0
154415,the,0,0
154416,serial,0,0
154417,electrocardiographic,0,1
154418,recordings,0,0
154419,.,0,1
154420,In,0,0
154421,40,0,0
154422,patients,0,1
154423,(,0,0
154424,56,0,1
154425,%,0,0
154426,),0,0
154427,",",0,0
154428,the,0,0
154429,perioperative,0,0
154430,myocardial,0,0
154431,infarction,0,1
154432,was,0,0
154433,the,0,0
154434,first,0,0
154435,manifestation,0,0
154436,of,0,0
154437,coronary,0,1
154438,artery,0,1
154439,disease,0,1
154440,.,0,0
154441,Multivariate,0,0
154442,logistic,0,0
154443,regression,0,0
154444,revealed,0,0
154445,that,0,0
154446,old,0,1
154447,age,0,1
154448,(,0,0
154449,odds,0,0
154450,ratio,0,0
154451,[,0,0
154452,OR,0,0
154453,],0,0
154454,",",0,0
154455,1.06,0,0
154456,;,0,0
154457,95,0,0
154458,%,0,0
154459,confidence,0,0
154460,interval,0,0
154461,[,0,0
154462,CI,0,0
154463,],0,0
154464,",",0,0
154465,1.02-1.10,0,0
154466,;,0,0
154467,p,0,0
154468,=,0,0
154469,0.002,0,0
154470,),0,0
154471,",",0,0
154472,earlier,0,0
154473,revascularization,0,0
154474,(,0,0
154475,OR,0,0
154476,",",0,0
154477,3.29,0,0
154478,;,0,0
154479,95,0,0
154480,%,0,0
154481,CI,0,0
154482,1.12-9.73,0,0
154483,;,0,0
154484,p,0,0
154485,=,0,0
154486,0.03,0,0
154487,),0,0
154488,",",0,0
154489,and,0,0
154490,heart,0,0
154491,failure,0,1
154492,(,0,0
154493,OR,0,0
154494,",",0,0
154495,2.42,0,0
154496,;,0,0
154497,95,0,0
154498,%,0,0
154499,CI,0,0
154500,1.04-5.61,0,0
154501,;,0,0
154502,p,0,0
154503,=,0,0
154504,0.04,0,0
154505,),0,0
154506,were,0,0
154507,independent,0,0
154508,predictors,0,0
154509,of,0,0
154510,TnT,0,1
154511,elevation,0,0
154512,.,0,0
154513,Majority,0,0
154514,of,0,0
154515,myocardial,0,1
154516,infarctions,0,1
154517,were,0,0
154518,asymptomatic,0,1
154519,or,0,1
154520,unrecognized,0,1
154521,.,0,0
154522,Evidence-based,0,0
154523,medications,0,0
154524,of,0,0
154525,myocardial,0,1
154526,infarction,0,1
154527,were,0,0
154528,seldom,0,0
154529,started,0,0
154530,and,0,0
154531,cardiologist,0,0
154532,was,0,0
154533,consulted,0,0
154534,in,0,0
154535,12,0,0
154536,patients,0,1
154537,(,0,0
154538,16.9,0,0
154539,%,0,0
154540,),0,0
154541,.,0,0
154542,CONCLUSION,0,0
154543,Patients,0,1
154544,with,0,1
154545,hip,0,1
154546,fracture,0,0
154547,often,0,0
154548,develop,0,0
154549,asymptomatic,0,1
154550,and,0,0
154551,clinically,0,0
154552,unrecognized,0,0
154553,perioperative,0,0
154554,myocardial,0,1
154555,infarctions,0,1
154556,.,0,0
154557,Earlier,0,0
154558,diagnosis,0,0
154559,and,0,0
154560,appropriate,0,0
154561,treatment,0,0
154562,of,0,0
154563,cardiac,0,0
154564,infarction,0,0
154565,may,0,0
154566,improve,0,0
154567,survival,0,0
154568,of,0,0
154569,hip,0,1
154570,fracture,0,1
154571,patients,0,1
154572,.,0,0
154573,LEVEL,0,0
154574,OF,0,0
154575,EVIDENCE,0,0
154576,Epidemiologic,0,0
154577,study,0,0
154578,",",0,0
154579,level,0,0
154580,III,0,0
154581,.,0,0
154582,Lengthening,0,0
154583,the,0,0
154584,moment,0,0
154585,arm,0,0
154586,of,0,0
154587,the,0,0
154588,patella,0,0
154589,confers,0,0
154590,enhanced,0,0
154591,extensor,1,0
154592,mechanism,1,0
154593,power,1,0
154594,following,1,0
154595,total,1,1
154596,knee,1,1
154597,arthroplasty,1,1
154598,.,1,0
154599,We,0,0
154600,investigated,0,0
154601,whether,0,0
154602,a,0,0
154603,postulated,0,0
154604,biomechanical,0,0
154605,advantage,0,0
154606,conferred,0,0
154607,to,0,0
154608,the,0,0
154609,extensor,0,0
154610,mechanism,0,0
154611,by,0,0
154612,a,0,0
154613,change,0,0
154614,in,0,0
154615,knee,0,1
154616,implant,0,0
154617,design,0,0
154618,was,0,0
154619,detectable,0,0
154620,in,0,0
154621,patients,1,1
154622,by,1,0
154623,direct,1,0
154624,physical,1,0
154625,testing,1,0
154626,.,1,0
154627,212,1,0
154628,TKA,1,0
154629,patients,1,1
154630,were,0,0
154631,enrolled,0,1
154632,in,0,0
154633,a,0,0
154634,double,0,0
154635,blind,0,0
154636,randomized,0,0
154637,controlled,0,0
154638,trial,0,0
154639,to,0,0
154640,receive,0,0
154641,either,0,0
154642,a,0,0
154643,traditional,0,0
154644,implant,0,0
154645,or,0,0
154646,one,0,0
154647,which,0,0
154648,incorporated,0,0
154649,new,0,0
154650,design,0,0
154651,features,0,0
154652,.,0,0
154653,Extensor,0,0
154654,mechanism,0,0
154655,power,0,0
154656,output,0,0
154657,and,0,0
154658,physical,0,0
154659,performance,0,0
154660,on,0,0
154661,a,0,0
154662,battery,0,0
154663,of,0,0
154664,timed,0,0
154665,functional,0,1
154666,activities,0,0
154667,was,0,0
154668,assessed,0,0
154669,pre-operatively,0,0
154670,and,0,0
154671,then,0,0
154672,at,0,0
154673,6,0,0
154674,",",0,0
154675,26,0,0
154676,",",0,0
154677,and,0,0
154678,52,0,0
154679,weeks,0,0
154680,post-operatively,0,0
154681,.,0,0
154682,Significantly,0,0
154683,enhanced,0,0
154684,power,0,0
154685,output,0,0
154686,was,0,0
154687,observed,0,0
154688,in,0,0
154689,both,0,0
154690,groups,0,0
154691,post-arthroplasty,0,1
154692,;,0,0
154693,however,0,0
154694,",",0,0
154695,the,0,0
154696,new,0,0
154697,design,0,0
154698,implant,0,0
154699,group,0,0
154700,demonstrated,0,0
154701,a,0,0
154702,greater,0,0
154703,change,0,0
154704,in,0,0
154705,power,0,0
154706,output,0,0
154707,than,0,0
154708,the,0,0
154709,traditional,0,0
154710,implant,0,0
154711,group,0,0
154712,.,0,0
154713,Posthoc,0,0
154714,testing,0,0
154715,of,0,0
154716,between,0,0
154717,group,0,0
154718,differences,0,0
154719,highlighted,0,0
154720,greater,0,0
154721,improvement,0,0
154722,at,0,0
154723,all,0,0
154724,post-operative,0,0
154725,assessments,0,0
154726,.,0,1
154727,At,0,0
154728,52,0,0
154729,weeks,0,0
154730,",",0,0
154731,patients,0,1
154732,receiving,0,0
154733,the,0,0
154734,implant,0,0
154735,with,0,0
154736,the,0,0
154737,postulated,0,0
154738,biomechanical,0,0
154739,advantage,0,0
154740,achieved,0,0
154741,116,0,1
154742,%,0,0
154743,of,0,0
154744,the,0,0
154745,power,0,0
154746,output,0,0
154747,of,0,0
154748,their,0,0
154749,contralateral,0,0
154750,limb,0,0
154751,",",0,0
154752,whereas,0,0
154753,patients,0,1
154754,with,0,1
154755,the,0,0
154756,traditional,0,0
154757,design,0,0
154758,achieved,0,0
154759,90,0,0
154760,%,0,0
154761,.,0,0
154762,No,0,0
154763,between,0,0
154764,group,0,0
154765,difference,0,0
154766,was,0,0
154767,detected,0,0
154768,in,0,0
154769,the,0,0
154770,patient,0,0
154771,'s,0,0
154772,time,0,0
154773,to,0,0
154774,complete,0,0
154775,functional,0,0
154776,tasks,0,0
154777,.,0,0
154778,Thus,0,0
154779,",",0,0
154780,patients,0,1
154781,receiving,0,0
154782,a,0,0
154783,knee,0,0
154784,implant,0,0
154785,of,0,0
154786,a,0,0
154787,modern,0,0
154788,design,0,0
154789,(,0,0
154790,theoretically,0,0
154791,able,0,0
154792,to,0,0
154793,confer,0,0
154794,a,0,0
154795,mechanical,0,0
154796,advantage,0,0
154797,to,0,0
154798,the,0,0
154799,extensor,0,0
154800,mechanism,0,0
154801,),0,0
154802,were,0,0
154803,found,0,0
154804,to,0,0
154805,generate,0,0
154806,significantly,0,0
154807,greater,0,0
154808,extensor,0,0
154809,power,0,0
154810,than,0,0
154811,those,0,0
154812,receiving,0,0
154813,a,0,0
154814,traditional,0,0
154815,implant,0,0
154816,without,0,0
154817,the,0,0
154818,postulated,0,0
154819,mechanical,0,0
154820,advantage,0,0
154821,.,0,0
154822,Effect,0,0
154823,of,0,0
154824,duloxetine,0,0
154825,on,0,0
154826,pain,0,0
154827,",",0,0
154828,function,0,0
154829,",",0,0
154830,and,0,0
154831,quality,0,0
154832,of,0,0
154833,life,0,0
154834,among,0,0
154835,patients,1,1
154836,with,1,1
154837,chemotherapy-induced,1,0
154838,painful,1,0
154839,peripheral,1,1
154840,neuropathy,1,1
154841,:,1,1
154842,a,0,0
154843,randomized,0,0
154844,clinical,0,0
154845,trial,0,0
154846,.,0,0
154847,IMPORTANCE,0,0
154848,There,0,0
154849,are,0,0
154850,no,0,0
154851,known,0,0
154852,effective,0,0
154853,treatments,0,0
154854,for,0,0
154855,painful,0,0
154856,chemotherapy-induced,0,0
154857,peripheral,0,1
154858,neuropathy,0,1
154859,.,0,0
154860,OBJECTIVE,0,0
154861,To,0,0
154862,determine,0,0
154863,the,0,0
154864,effect,0,0
154865,of,0,0
154866,duloxetine,0,0
154867,",",0,0
154868,60,0,0
154869,mg,0,0
154870,daily,0,0
154871,",",0,0
154872,on,0,0
154873,average,0,0
154874,pain,0,0
154875,severity,0,0
154876,.,0,0
154877,DESIGN,0,0
154878,",",0,0
154879,SETTING,0,0
154880,",",0,0
154881,AND,0,0
154882,PATIENTS,0,0
154883,Randomized,0,0
154884,",",0,0
154885,double-blind,0,0
154886,",",0,0
154887,placebo-controlled,0,0
154888,crossover,0,0
154889,trial,0,0
154890,at,0,0
154891,8,1,0
154892,National,1,0
154893,Cancer,1,0
154894,Institute,1,0
154895,(,1,0
154896,NCI,1,1
154897,),1,0
154898,-funded,1,1
154899,cooperative,1,0
154900,research,1,0
154901,networks,1,0
154902,that,1,0
154903,enrolled,1,1
154904,231,1,1
154905,patients,1,1
154906,who,1,1
154907,were,1,1
154908,25,1,1
154909,years,1,1
154910,or,1,1
154911,older,1,1
154912,being,1,0
154913,treated,1,0
154914,at,1,0
154915,community,1,1
154916,and,1,0
154917,academic,1,1
154918,settings,1,0
154919,between,1,0
154920,April,1,1
154921,2008,1,1
154922,and,1,0
154923,March,1,1
154924,2011,1,1
154925,.,1,0
154926,Study,0,0
154927,follow-up,0,0
154928,was,0,0
154929,completed,0,1
154930,July,0,0
154931,2012,0,1
154932,.,0,0
154933,Stratified,0,0
154934,by,0,0
154935,chemotherapeutic,0,0
154936,drug,0,0
154937,and,0,0
154938,comorbid,0,1
154939,pain,0,0
154940,risk,0,0
154941,",",0,0
154942,patients,0,1
154943,were,0,0
154944,randomized,0,0
154945,to,0,0
154946,receive,0,0
154947,either,0,0
154948,duloxetine,0,0
154949,followed,0,0
154950,by,0,0
154951,placebo,0,0
154952,or,0,0
154953,placebo,0,0
154954,followed,0,0
154955,by,0,0
154956,duloxetine,0,0
154957,.,0,0
154958,Eligibility,1,0
154959,required,1,0
154960,that,1,0
154961,patients,1,1
154962,have,1,0
154963,grade,1,0
154964,1,1,0
154965,or,1,0
154966,higher,1,0
154967,sensory,1,0
154968,neuropathy,1,0
154969,according,1,0
154970,to,1,0
154971,the,1,0
154972,NCI,1,0
154973,Common,1,0
154974,Terminology,1,0
154975,Criteria,1,1
154976,for,1,0
154977,Adverse,1,0
154978,Events,1,0
154979,and,1,0
154980,at,1,0
154981,least,1,0
154982,4,1,0
154983,on,1,0
154984,a,1,0
154985,scale,1,0
154986,of,1,0
154987,0,1,0
154988,to,1,0
154989,10,1,0
154990,",",1,0
154991,representing,1,0
154992,average,1,0
154993,chemotherapy-induced,1,0
154994,pain,1,0
154995,",",1,0
154996,after,1,0
154997,paclitaxel,1,0
154998,",",1,0
154999,other,1,0
155000,taxane,1,0
155001,",",1,0
155002,or,1,0
155003,oxaliplatin,1,0
155004,treatment,1,0
155005,.,1,0
155006,INTERVENTIONS,0,0
155007,The,0,0
155008,initial,0,0
155009,treatment,0,0
155010,consisted,0,0
155011,of,0,0
155012,taking,0,0
155013,1,0,0
155014,capsule,0,0
155015,daily,0,0
155016,of,0,0
155017,either,0,0
155018,30,0,0
155019,mg,0,0
155020,of,0,0
155021,duloxetine,0,0
155022,or,0,0
155023,placebo,0,0
155024,for,0,0
155025,the,0,0
155026,first,0,0
155027,week,0,0
155028,and,0,0
155029,2,0,0
155030,capsules,0,0
155031,of,0,0
155032,either,0,0
155033,30,0,0
155034,mg,0,0
155035,of,0,0
155036,duloxetine,0,0
155037,or,0,0
155038,placebo,0,0
155039,daily,0,0
155040,for,0,0
155041,4,0,0
155042,additional,0,0
155043,weeks,0,0
155044,.,0,1
155045,MAIN,0,0
155046,OUTCOME,0,0
155047,MEASURES,0,0
155048,The,0,0
155049,primary,0,0
155050,hypothesis,0,0
155051,was,0,0
155052,that,0,0
155053,duloxetine,0,0
155054,would,0,0
155055,be,0,0
155056,more,0,0
155057,effective,0,0
155058,than,0,0
155059,placebo,0,0
155060,in,0,0
155061,decreasing,0,0
155062,chemotherapy-induced,0,0
155063,peripheral,0,1
155064,neuropathic,0,1
155065,pain,0,0
155066,.,0,0
155067,Pain,0,0
155068,severity,0,0
155069,was,0,0
155070,assessed,0,0
155071,using,0,0
155072,the,0,0
155073,Brief,0,0
155074,Pain,0,0
155075,Inventory-Short,0,1
155076,Form,0,0
155077,average,0,0
155078,pain,0,0
155079,item,0,0
155080,with,0,1
155081,0,0,0
155082,representing,0,0
155083,no,0,0
155084,pain,0,0
155085,and,0,0
155086,10,0,0
155087,representing,0,0
155088,as,0,0
155089,bad,0,0
155090,as,0,0
155091,can,0,0
155092,be,0,0
155093,imagined,0,0
155094,.,0,0
155095,RESULTS,0,0
155096,Individuals,0,1
155097,receiving,0,1
155098,duloxetine,0,0
155099,as,0,0
155100,their,0,0
155101,initial,0,0
155102,5-week,0,0
155103,treatment,0,0
155104,reported,0,0
155105,a,0,0
155106,mean,0,0
155107,decrease,0,0
155108,in,0,0
155109,average,0,0
155110,pain,0,0
155111,of,0,0
155112,1.06,0,0
155113,(,0,0
155114,95,0,0
155115,%,0,0
155116,CI,0,0
155117,",",0,0
155118,0.72-1.40,0,0
155119,),0,0
155120,vs,0,0
155121,0.34,0,0
155122,(,0,0
155123,95,0,0
155124,%,0,0
155125,CI,0,0
155126,",",0,0
155127,0.01-0.66,0,0
155128,),0,0
155129,among,0,1
155130,those,0,1
155131,who,0,1
155132,received,0,1
155133,placebo,0,1
155134,(,0,0
155135,P,0,0
155136,=,0,0
155137,.003,0,0
155138,;,0,0
155139,effect,0,0
155140,size,0,0
155141,",",0,0
155142,0.513,0,0
155143,),0,0
155144,.,0,0
155145,The,0,0
155146,observed,0,0
155147,mean,0,0
155148,difference,0,0
155149,in,0,0
155150,the,0,0
155151,average,0,0
155152,pain,0,0
155153,score,0,0
155154,between,0,0
155155,duloxetine,0,0
155156,and,0,0
155157,placebo,0,0
155158,was,0,0
155159,0.73,0,0
155160,(,0,0
155161,95,0,0
155162,%,0,0
155163,CI,0,0
155164,",",0,0
155165,0.26-1.20,0,0
155166,),0,0
155167,.,0,0
155168,Fifty-nine,0,1
155169,percent,0,0
155170,of,0,0
155171,those,0,0
155172,initially,0,0
155173,receiving,0,0
155174,duloxetine,0,0
155175,vs,0,0
155176,38,0,1
155177,%,0,0
155178,of,0,0
155179,those,0,0
155180,initially,0,0
155181,receiving,0,0
155182,placebo,0,0
155183,reported,0,0
155184,decreased,0,0
155185,pain,0,0
155186,of,0,0
155187,any,0,0
155188,amount,0,0
155189,.,0,0
155190,CONCLUSION,0,0
155191,AND,0,0
155192,RELEVANCE,0,0
155193,Among,0,1
155194,patients,1,1
155195,with,1,1
155196,painful,1,0
155197,chemotherapy-induced,1,0
155198,peripheral,1,0
155199,neuropathy,1,1
155200,",",0,0
155201,the,0,0
155202,use,0,0
155203,of,0,0
155204,duloxetine,0,0
155205,compared,0,0
155206,with,0,0
155207,placebo,0,0
155208,for,0,0
155209,5,0,0
155210,weeks,0,0
155211,resulted,0,0
155212,in,0,0
155213,a,0,0
155214,greater,0,0
155215,reduction,0,0
155216,in,0,0
155217,pain,0,0
155218,.,0,0
155219,TRIAL,0,0
155220,REGISTRATION,0,0
155221,clinicaltrials.gov,0,0
155222,Identifier,0,0
155223,:,0,1
155224,NCT00489411,0,0
155225,.,0,0
155226,Successful,0,0
155227,treatment,0,0
155228,of,0,0
155229,depressed,1,0
155230,",",1,0
155231,distensible,1,0
155232,acne,1,0
155233,scars,1,1
155234,using,0,0
155235,autologous,0,1
155236,fibroblasts,0,1
155237,:,0,1
155238,a,0,0
155239,multi-site,0,0
155240,",",0,0
155241,prospective,0,0
155242,",",0,0
155243,double,0,0
155244,blind,0,0
155245,",",0,0
155246,placebo-controlled,0,0
155247,clinical,0,0
155248,trial,0,0
155249,.,0,0
155250,BACKGROUND,0,0
155251,A,0,0
155252,previous,0,0
155253,clinical,0,0
155254,trial,0,0
155255,evaluating,0,0
155256,autologous,0,0
155257,fibroblasts,0,1
155258,(,0,0
155259,human,0,0
155260,dermal,0,0
155261,),0,0
155262,injections,0,0
155263,for,0,0
155264,the,0,0
155265,treatment,0,0
155266,of,0,0
155267,facial,0,0
155268,contour,0,0
155269,deformities,0,0
155270,found,0,0
155271,significantly,0,0
155272,greater,0,0
155273,improvements,0,0
155274,in,0,0
155275,wrinkle,0,0
155276,and,0,0
155277,acne,0,0
155278,scar,0,0
155279,appearance,0,0
155280,than,0,0
155281,with,0,1
155282,placebo,0,0
155283,treatment,0,0
155284,.,0,0
155285,OBJECTIVE,0,0
155286,To,0,0
155287,compare,0,0
155288,the,0,0
155289,efficacy,0,0
155290,and,0,0
155291,safety,0,0
155292,of,0,0
155293,autologous,0,0
155294,fibroblast,0,0
155295,treatment,0,0
155296,of,0,0
155297,moderate,1,1
155298,to,1,0
155299,severe,1,1
155300,",",1,0
155301,depressed,1,0
155302,",",1,0
155303,distensible,1,0
155304,facial,1,0
155305,acne,1,1
155306,scars,1,0
155307,with,0,1
155308,that,0,0
155309,of,0,0
155310,vehicle,0,0
155311,control,0,0
155312,.,0,0
155313,METHODS,0,0
155314,This,0,0
155315,was,0,0
155316,a,0,0
155317,randomized,0,0
155318,multicenter,0,0
155319,",",0,0
155320,double-blind,0,0
155321,",",0,0
155322,placebo-controlled,0,0
155323,trial,0,0
155324,in,0,0
155325,subjects,1,1
155326,with,1,1
155327,bilateral,1,1
155328,moderate,1,1
155329,to,1,0
155330,severe,1,1
155331,acne,1,0
155332,scarring,1,0
155333,;,1,0
155334,subjects,0,1
155335,served,0,0
155336,as,0,0
155337,their,0,0
155338,own,0,1
155339,controls,0,1
155340,.,0,1
155341,Skin,0,0
155342,biopsies,0,0
155343,were,0,0
155344,obtained,0,0
155345,from,0,0
155346,randomized,0,0
155347,subjects,1,1
155348,for,0,0
155349,fibroblast,0,0
155350,production,0,0
155351,.,0,0
155352,Subjects,1,0
155353,(,1,0
155354,n,1,1
155355,=,1,0
155356,99,1,1
155357,),1,0
155358,underwent,0,1
155359,three,0,0
155360,intradermal,0,0
155361,injection,0,0
155362,sessions,0,0
155363,with,0,1
155364,2,0,1
155365,mL,0,0
155366,of,0,0
155367,autologous,0,0
155368,fibroblast,0,0
155369,suspension,0,0
155370,(,0,0
155371,10-20,0,0
155372,million,0,0
155373,cells/mL,0,0
155374,),0,0
155375,on,0,0
155376,one,0,0
155377,cheek,0,1
155378,and,0,0
155379,vehicle,0,0
155380,control,0,0
155381,(,0,0
155382,cell,0,0
155383,culture,0,0
155384,medium,0,0
155385,),0,0
155386,on,0,0
155387,the,0,0
155388,other,0,0
155389,at,0,0
155390,14-day,0,0
155391,intervals,0,0
155392,.,0,1
155393,Efficacy,0,0
155394,was,0,0
155395,based,0,0
155396,on,0,0
155397,the,0,0
155398,blinded,0,0
155399,subject,0,0
155400,'s,0,0
155401,",",0,0
155402,evaluator,0,0
155403,'s,0,0
155404,",",0,0
155405,and,0,0
155406,independent,0,0
155407,photographic,0,0
155408,viewer,0,0
155409,'s,0,0
155410,(,0,0
155411,IPR,0,0
155412,),0,0
155413,assessment,0,0
155414,of,0,0
155415,acne,0,0
155416,scarring,0,0
155417,1,0,0
155418,to,0,0
155419,4,0,0
155420,months,0,0
155421,after,0,0
155422,the,0,0
155423,last,0,0
155424,treatment,0,0
155425,.,0,0
155426,RESULTS,0,0
155427,Autologous,0,0
155428,fibroblast,0,0
155429,treatment,0,0
155430,was,0,0
155431,associated,0,0
155432,with,0,0
155433,significantly,0,0
155434,greater,0,0
155435,treatment,0,0
155436,success,0,0
155437,than,0,0
155438,vehicle,0,0
155439,control,0,0
155440,for,0,0
155441,the,0,0
155442,subject,0,0
155443,(,0,0
155444,43,0,0
155445,%,0,0
155446,vs.18,0,0
155447,%,0,0
155448,),0,0
155449,",",0,0
155450,evaluator,0,0
155451,(,0,0
155452,59,0,0
155453,%,0,0
155454,vs.,0,0
155455,2,0,0
155456,%,0,0
155457,),0,0
155458,",",0,0
155459,and,0,0
155460,IPR,0,0
155461,assessments,0,0
155462,.,0,1
155463,Autologous,0,0
155464,fibroblast,0,0
155465,injections,0,0
155466,were,0,0
155467,well,0,0
155468,tolerated,0,0
155469,",",0,0
155470,without,0,0
155471,permanent,0,1
155472,adverse,0,0
155473,effects,0,0
155474,.,0,1
155475,CONCLUSIONS,0,0
155476,Autologous,0,0
155477,fibroblast,0,0
155478,injections,0,0
155479,safely,0,0
155480,and,0,0
155481,effectively,0,0
155482,improved,0,0
155483,the,0,0
155484,appearance,0,0
155485,of,0,0
155486,depressed,0,0
155487,distensible,0,1
155488,acne,0,1
155489,scars,0,1
155490,.,0,1
155491,Effects,0,0
155492,of,0,0
155493,parecoxib,0,0
155494,on,0,0
155495,morphine,0,0
155496,analgesia,0,0
155497,after,0,0
155498,gynecology,0,1
155499,tumor,0,1
155500,operation,0,0
155501,:,0,0
155502,a,0,0
155503,randomized,0,0
155504,trial,0,0
155505,of,0,0
155506,parecoxib,0,0
155507,used,0,0
155508,in,0,0
155509,postsurgical,0,0
155510,pain,0,0
155511,management,0,0
155512,.,0,0
155513,BACKGROUND,0,0
155514,The,0,0
155515,analgesic,0,0
155516,efficacy,0,0
155517,of,0,0
155518,parecoxib,0,0
155519,in,0,0
155520,postsurgical,0,0
155521,pain,0,0
155522,management,0,0
155523,has,0,0
155524,been,0,0
155525,confirmed,0,0
155526,in,0,0
155527,minimally,0,0
155528,invasive,0,0
155529,surgery,0,1
155530,.,0,0
155531,However,0,0
155532,",",0,0
155533,little,0,0
155534,is,0,0
155535,known,0,0
155536,about,0,0
155537,its,0,0
155538,effects,0,0
155539,used,0,0
155540,in,0,0
155541,combination,0,0
155542,with,0,1
155543,opioids,0,0
155544,and,0,0
155545,about,0,0
155546,its,0,0
155547,potential,0,0
155548,for,0,0
155549,opioid-sparing,0,0
155550,effects,0,0
155551,in,0,0
155552,complex,0,1
155553,operations,0,1
155554,.,0,0
155555,This,0,0
155556,study,0,0
155557,was,0,0
155558,performed,0,0
155559,to,0,0
155560,investigate,0,0
155561,the,0,0
155562,influence,0,0
155563,of,0,0
155564,parecoxib,0,0
155565,on,0,0
155566,morphine,0,0
155567,analgesia,0,0
155568,after,0,0
155569,gynecological,0,1
155570,tumor,0,1
155571,surgery,0,1
155572,.,0,0
155573,METHODS,0,0
155574,Eighty,1,1
155575,patients,1,1
155576,undergoing,1,1
155577,gynecological,1,1
155578,tumor,1,1
155579,resection,1,1
155580,were,0,0
155581,randomized,0,0
155582,to,0,0
155583,receive,0,0
155584,either,0,0
155585,intravenous,0,0
155586,parecoxib,0,0
155587,at,0,0
155588,a,0,0
155589,dose,0,0
155590,of,0,0
155591,40,0,1
155592,mg,0,0
155593,(,0,0
155594,Group,0,1
155595,P,0,0
155596,",",0,0
155597,n,0,1
155598,=,0,0
155599,40,0,1
155600,),0,0
155601,followed,0,0
155602,by,0,0
155603,40,0,1
155604,mg,0,0
155605,every,0,0
155606,12,0,0
155607,h,0,0
155608,for,0,0
155609,48,0,0
155610,h,0,0
155611,or,0,0
155612,saline,0,0
155613,as,0,0
155614,a,0,0
155615,control,0,0
155616,(,0,0
155617,Group,0,0
155618,C,0,0
155619,",",0,0
155620,n,0,1
155621,=,0,0
155622,40,0,1
155623,),0,0
155624,30,0,0
155625,min,0,0
155626,before,0,0
155627,induction,0,0
155628,of,0,0
155629,anesthesia,0,0
155630,",",0,0
155631,followed,0,0
155632,by,0,0
155633,saline,0,0
155634,at,0,0
155635,the,0,0
155636,same,0,0
155637,time,0,0
155638,points,0,0
155639,after,0,0
155640,the,0,0
155641,operation,0,0
155642,.,0,0
155643,All,0,0
155644,patients,0,1
155645,had,0,0
155646,access,0,0
155647,to,0,0
155648,patient-controlled,0,0
155649,analgesia,0,0
155650,with,0,1
155651,intravenous,0,0
155652,morphine,0,0
155653,.,0,1
155654,Patients,0,1
155655,were,0,0
155656,assessed,0,0
155657,with,0,0
155658,respect,0,0
155659,to,0,0
155660,pain,0,0
155661,score,0,0
155662,(,0,0
155663,visual,0,0
155664,analog,0,0
155665,scale,0,0
155666,from,0,0
155667,0-10,0,0
155668,),0,0
155669,",",0,0
155670,cumulative,0,0
155671,morphine,0,0
155672,requirement,0,0
155673,",",0,0
155674,satisfaction,0,0
155675,score,0,0
155676,",",0,0
155677,and,0,0
155678,side,0,0
155679,effects,0,0
155680,at,0,0
155681,2,0,0
155682,",",0,0
155683,6,0,0
155684,",",0,0
155685,12,0,0
155686,",",0,0
155687,24,0,0
155688,",",0,0
155689,and,0,0
155690,48,0,0
155691,h,0,0
155692,after,0,0
155693,surgery,0,1
155694,.,0,0
155695,RESULTS,1,0
155696,A,1,0
155697,total,1,0
155698,of,1,0
155699,79,1,1
155700,patients,1,1
155701,were,1,0
155702,evaluated,1,0
155703,.,1,0
155704,The,1,0
155705,cumulative,0,0
155706,dose,0,0
155707,of,0,0
155708,morphine,0,0
155709,administered,0,0
155710,at,0,0
155711,each,0,0
155712,time,0,0
155713,point,0,0
155714,was,0,0
155715,lower,0,0
155716,in,0,0
155717,Group,0,0
155718,P,0,0
155719,than,0,0
155720,in,0,0
155721,Group,0,1
155722,C,0,0
155723,(,0,0
155724,P,0,0
155725,<,0,0
155726,0.05,0,0
155727,),0,0
155728,",",0,0
155729,at,0,0
155730,2,0,0
155731,h,0,0
155732,(,0,0
155733,3.81,0,0
155734,?,0,0
155735,0.35,0,0
155736,versus,0,0
155737,4.13,0,0
155738,?,0,0
155739,0.45,0,0
155740,;,0,0
155741,P,0,0
155742,=,0,0
155743,0.01,0,0
155744,),0,0
155745,",",0,0
155746,6,0,0
155747,h,0,0
155748,(,0,0
155749,16.20,0,0
155750,?,0,0
155751,1.49,0,0
155752,versus,0,0
155753,19.60,0,0
155754,?,0,0
155755,0.35,0,0
155756,;,0,0
155757,P,0,0
155758,<,0,0
155759,0.001,0,0
155760,),0,0
155761,",",0,0
155762,12,0,0
155763,h,0,0
155764,(,0,0
155765,26.29,0,0
155766,?,0,0
155767,2.75,0,0
155768,versus,0,0
155769,32.49,0,0
155770,?,0,0
155771,2.42,0,0
155772,;,0,0
155773,P,0,0
155774,<,0,0
155775,0.001,0,0
155776,),0,0
155777,",",0,0
155778,24,0,0
155779,h,0,0
155780,(,0,0
155781,41.72,0,0
155782,?,0,0
155783,2.70,0,0
155784,versus,0,0
155785,49.97,0,0
155786,?,0,0
155787,4.53,0,0
155788,;,0,0
155789,P,0,0
155790,<,0,0
155791,0.001,0,0
155792,),0,0
155793,",",0,0
155794,and,0,0
155795,48,0,0
155796,h,0,0
155797,(,0,0
155798,60.06,0,0
155799,?,0,0
155800,4.00,0,0
155801,versus,0,0
155802,65.68,0,0
155803,?,0,0
155804,3.23,0,0
155805,;,0,0
155806,P,0,0
155807,<,0,0
155808,0.001,0,0
155809,),0,0
155810,.,0,0
155811,Compared,0,0
155812,with,0,0
155813,Group,0,0
155814,C,0,0
155815,",",0,0
155816,Group,0,0
155817,P,0,0
155818,had,0,0
155819,significantly,0,0
155820,lower,0,0
155821,visual,0,0
155822,analog,0,0
155823,scale,0,0
155824,scores,0,0
155825,at,0,0
155826,rest,0,0
155827,and,0,0
155828,with,0,0
155829,movement,0,0
155830,",",0,0
155831,respectively,0,0
155832,",",0,0
155833,at,0,0
155834,2,0,0
155835,h,0,0
155836,(,0,0
155837,4.2,0,0
155838,",",0,0
155839,P,0,0
155840,<,0,0
155841,0.001,0,0
155842,and,0,0
155843,5.0,0,0
155844,",",0,0
155845,P,0,0
155846,<,0,0
155847,0.001,0,0
155848,),0,0
155849,",",0,0
155850,6,0,0
155851,h,0,0
155852,(,0,0
155853,3.6,0,0
155854,",",0,0
155855,P,0,0
155856,<,0,0
155857,0.001,0,0
155858,and,0,0
155859,4.5,0,0
155860,",",0,0
155861,P,0,0
155862,<,0,0
155863,0.001,0,0
155864,),0,0
155865,",",0,0
155866,12,0,0
155867,h,0,0
155868,(,0,0
155869,3.0,0,0
155870,",",0,0
155871,P,0,0
155872,=,0,0
155873,0.017,0,0
155874,and,0,0
155875,4.0,0,0
155876,",",0,0
155877,P,0,0
155878,<,0,0
155879,0.001,0,0
155880,),0,0
155881,",",0,0
155882,24,0,0
155883,h,0,0
155884,(,0,0
155885,2.1,0,0
155886,",",0,0
155887,P,0,0
155888,<,0,0
155889,0.001,0,0
155890,and,0,0
155891,3.4,0,0
155892,",",0,0
155893,P,0,0
155894,<,0,0
155895,0.001,0,0
155896,),0,0
155897,",",0,0
155898,and,0,0
155899,48,0,0
155900,h,0,0
155901,(,0,0
155902,1.8,0,0
155903,",",0,0
155904,P,0,0
155905,<,0,0
155906,0.001,0,0
155907,and,0,0
155908,2.6,0,0
155909,",",0,0
155910,P,0,0
155911,<,0,0
155912,0.001,0,0
155913,),0,0
155914,.,0,0
155915,The,0,0
155916,satisfaction,0,0
155917,score,0,0
155918,was,0,0
155919,higher,0,0
155920,in,0,0
155921,Group,0,0
155922,P,0,0
155923,than,0,0
155924,in,0,0
155925,Group,0,1
155926,C,0,0
155927,(,0,0
155928,8.6,0,0
155929,?,0,0
155930,0.3,0,0
155931,versus,0,0
155932,6.8,0,0
155933,?,0,0
155934,0.7,0,0
155935,",",0,0
155936,P,0,0
155937,<,0,0
155938,0.001,0,0
155939,),0,0
155940,.,0,0
155941,There,0,0
155942,were,0,0
155943,no,0,0
155944,significant,0,0
155945,differences,0,0
155946,in,0,0
155947,side,0,0
155948,effects,0,0
155949,between,0,0
155950,the,0,0
155951,two,0,0
155952,groups,0,0
155953,(,0,0
155954,P,0,0
155955,>,0,1
155956,0.05,0,0
155957,),0,0
155958,.,0,0
155959,CONCLUSIONS,0,0
155960,The,0,0
155961,use,0,0
155962,of,0,0
155963,parecoxib,0,0
155964,with,0,1
155965,patient-controlled,0,0
155966,analgesic,0,0
155967,morphine,0,0
155968,in,0,0
155969,postoperative,0,0
155970,analgesia,0,0
155971,resulted,0,0
155972,in,0,0
155973,comprehensive,0,0
155974,enhancement,0,0
155975,of,0,0
155976,the,0,0
155977,analgesic,0,0
155978,efficacy,0,0
155979,",",0,0
155980,reducing,0,0
155981,the,0,0
155982,opioid,0,0
155983,requirement,0,0
155984,and,0,0
155985,increasing,0,0
155986,patient,0,0
155987,satisfaction,0,0
155988,after,0,0
155989,gynecological,0,1
155990,tumor,0,1
155991,surgery,0,1
155992,.,0,0
155993,The,0,0
155994,role,0,0
155995,of,0,0
155996,treatment,0,0
155997,fidelity,0,0
155998,on,0,0
155999,outcomes,0,0
156000,during,0,0
156001,a,0,0
156002,randomized,0,0
156003,field,0,0
156004,trial,0,0
156005,of,0,0
156006,an,0,0
156007,autism,1,1
156008,intervention,0,0
156009,.,0,0
156010,This,0,0
156011,randomized,0,0
156012,field,0,0
156013,trial,0,0
156014,comparing,0,0
156015,Strategies,0,0
156016,for,0,0
156017,Teaching,0,0
156018,based,0,0
156019,on,0,0
156020,Autism,0,1
156021,Research,0,0
156022,and,0,0
156023,Structured,0,0
156024,Teaching,0,0
156025,enrolled,0,1
156026,educators,0,1
156027,in,0,0
156028,33,1,1
156029,kindergarten-through-second-grade,1,1
156030,autism,1,1
156031,support,1,0
156032,classrooms,1,1
156033,and,1,0
156034,119,1,1
156035,students,1,1
156036,",",1,0
156037,aged,1,1
156038,5-8,1,1
156039,years,1,1
156040,in,1,0
156041,the,1,0
156042,School,1,1
156043,District,1,1
156044,of,1,0
156045,Philadelphia,1,1
156046,.,1,1
156047,Students,1,0
156048,were,0,0
156049,assessed,0,0
156050,at,0,0
156051,the,0,0
156052,beginning,0,0
156053,and,0,0
156054,end,0,0
156055,of,0,0
156056,the,0,0
156057,academic,0,1
156058,year,0,0
156059,using,0,0
156060,the,0,0
156061,Differential,0,0
156062,Ability,0,0
156063,Scales,0,0
156064,.,0,0
156065,Program,0,0
156066,fidelity,0,0
156067,was,0,0
156068,measured,0,0
156069,through,0,0
156070,video,0,0
156071,coding,0,0
156072,and,0,0
156073,use,0,0
156074,of,0,0
156075,a,0,0
156076,checklist,0,0
156077,.,0,0
156078,Outcomes,0,0
156079,were,0,0
156080,assessed,0,0
156081,using,0,0
156082,linear,0,0
156083,regression,0,0
156084,with,0,1
156085,random,0,0
156086,effects,0,0
156087,for,0,0
156088,classroom,0,1
156089,and,0,0
156090,student,1,0
156091,.,1,0
156092,Average,0,0
156093,fidelity,0,0
156094,was,0,0
156095,57,0,0
156096,%,0,0
156097,in,0,0
156098,Strategies,0,0
156099,for,0,0
156100,Teaching,0,0
156101,based,0,0
156102,on,0,0
156103,Autism,0,1
156104,Research,0,0
156105,classrooms,0,1
156106,and,0,0
156107,48,0,0
156108,%,0,0
156109,in,0,0
156110,Structured,0,0
156111,Teaching,0,0
156112,classrooms,0,1
156113,.,0,0
156114,There,0,0
156115,was,0,0
156116,a,0,0
156117,9.2-point,0,0
156118,(,0,0
156119,standard,0,0
156120,deviation,0,0
156121,=,0,0
156122,9.6,0,0
156123,),0,0
156124,increase,0,0
156125,in,0,0
156126,Differential,0,1
156127,Ability,0,0
156128,Scales,0,0
156129,score,0,0
156130,over,0,0
156131,the,0,0
156132,8-month,0,0
156133,study,0,0
156134,period,0,0
156135,",",0,0
156136,but,0,0
156137,no,0,0
156138,main,0,0
156139,effect,0,0
156140,of,0,0
156141,program,0,0
156142,.,0,0
156143,There,0,0
156144,was,0,0
156145,a,0,0
156146,significant,0,0
156147,interaction,0,0
156148,between,0,0
156149,fidelity,0,0
156150,and,0,0
156151,group,0,0
156152,.,0,0
156153,In,0,0
156154,classrooms,0,1
156155,with,0,1
156156,either,0,0
156157,low,0,0
156158,or,0,0
156159,high,0,0
156160,program,0,0
156161,fidelity,0,0
156162,",",0,0
156163,students,1,1
156164,in,1,0
156165,Strategies,1,0
156166,for,1,0
156167,Teaching,1,0
156168,based,1,0
156169,on,1,0
156170,Autism,1,1
156171,Research,1,0
156172,experienced,0,0
156173,a,0,0
156174,greater,0,0
156175,gain,0,0
156176,in,0,0
156177,Differential,0,1
156178,Ability,0,0
156179,Scales,0,0
156180,score,0,0
156181,than,0,0
156182,students,1,1
156183,in,1,0
156184,Structured,1,0
156185,Teaching,1,0
156186,(,0,0
156187,11.2,0,0
156188,vs.,0,0
156189,5.5,0,0
156190,points,0,0
156191,and,0,0
156192,11.3,0,0
156193,vs.,0,0
156194,8.9,0,0
156195,points,0,0
156196,",",0,0
156197,respectively,0,0
156198,),0,0
156199,.,0,0
156200,In,0,0
156201,classrooms,0,1
156202,with,0,1
156203,moderate,0,1
156204,fidelity,0,0
156205,",",0,0
156206,students,1,1
156207,in,1,0
156208,Structured,1,0
156209,Teaching,1,0
156210,experienced,0,0
156211,a,0,0
156212,greater,0,0
156213,gain,0,0
156214,than,0,0
156215,students,1,1
156216,in,1,0
156217,Strategies,1,0
156218,for,1,0
156219,Teaching,1,0
156220,based,1,0
156221,on,1,0
156222,Autism,1,1
156223,Research,1,0
156224,(,0,0
156225,10.1,0,0
156226,vs.,0,0
156227,4.4,0,0
156228,points,0,0
156229,),0,0
156230,.,0,0
156231,The,0,0
156232,results,0,0
156233,suggest,0,0
156234,significant,0,0
156235,variability,0,0
156236,in,0,0
156237,implementation,0,0
156238,of,0,0
156239,evidence-based,0,0
156240,practices,0,0
156241,",",0,0
156242,even,0,0
156243,with,0,0
156244,supports,0,0
156245,",",0,0
156246,and,0,0
156247,also,0,0
156248,suggest,0,0
156249,the,0,0
156250,need,0,0
156251,to,0,0
156252,address,0,0
156253,challenging,0,0
156254,issues,0,0
156255,related,0,0
156256,to,0,0
156257,implementation,0,0
156258,measurement,0,0
156259,in,0,0
156260,community,0,1
156261,settings,0,0
156262,.,0,1
156263,Health-education,0,0
156264,package,0,0
156265,to,0,0
156266,prevent,0,0
156267,worm,0,0
156268,infections,0,0
156269,in,0,0
156270,Chinese,1,1
156271,schoolchildren,1,1
156272,.,1,1
156273,BACKGROUND,0,0
156274,Soil-transmitted,0,0
156275,helminths,0,1
156276,are,0,0
156277,among,0,0
156278,the,0,0
156279,most,0,0
156280,prevalent,0,0
156281,sources,0,0
156282,of,0,0
156283,human,0,1
156284,infections,0,0
156285,globally,0,0
156286,.,0,0
156287,We,0,0
156288,determined,0,0
156289,the,0,0
156290,effect,0,0
156291,of,0,0
156292,an,0,0
156293,educational,0,0
156294,package,0,0
156295,at,0,0
156296,rural,1,1
156297,schools,1,1
156298,in,1,0
156299,Linxiang,1,1
156300,City,1,0
156301,District,1,1
156302,",",1,0
156303,Hunan,1,0
156304,province,1,1
156305,",",1,0
156306,China,1,1
156307,",",0,0
156308,where,0,0
156309,these,0,0
156310,worms,0,0
156311,are,0,0
156312,prevalent,0,0
156313,.,0,0
156314,The,0,0
156315,intervention,0,0
156316,aimed,0,0
156317,to,0,0
156318,increase,0,0
156319,knowledge,0,0
156320,about,0,0
156321,soil-transmitted,0,0
156322,helminths,0,1
156323,",",0,0
156324,induce,0,0
156325,behavioral,0,0
156326,change,0,0
156327,",",0,0
156328,and,0,0
156329,reduce,0,0
156330,the,0,0
156331,rate,0,0
156332,of,0,0
156333,infection,0,1
156334,.,0,0
156335,METHODS,0,0
156336,We,0,0
156337,conducted,0,0
156338,a,0,0
156339,single-blind,0,0
156340,",",0,0
156341,unmatched,0,0
156342,",",0,0
156343,cluster-randomized,0,0
156344,intervention,0,0
156345,trial,0,0
156346,involving,0,0
156347,1718,1,1
156348,children,1,1
156349,",",1,0
156350,9,1,0
156351,to,1,0
156352,10,1,1
156353,years,1,1
156354,of,1,0
156355,age,1,1
156356,",",1,0
156357,in,1,0
156358,38,1,1
156359,schools,1,1
156360,over,1,0
156361,the,1,0
156362,course,1,0
156363,of,1,0
156364,1,1,0
156365,school,1,1
156366,year,1,0
156367,.,1,0
156368,Schools,0,0
156369,were,0,0
156370,randomly,0,0
156371,assigned,0,0
156372,to,0,0
156373,the,0,0
156374,health-education,0,0
156375,package,0,0
156376,",",0,0
156377,which,0,0
156378,included,0,0
156379,a,0,0
156380,cartoon,0,0
156381,video,0,0
156382,",",0,0
156383,or,0,0
156384,to,0,0
156385,a,0,0
156386,control,0,0
156387,package,0,0
156388,",",0,0
156389,which,0,0
156390,involved,0,0
156391,only,0,0
156392,the,0,0
156393,display,0,0
156394,of,0,0
156395,a,0,0
156396,health-education,0,0
156397,poster,0,0
156398,.,0,0
156399,Infection,0,0
156400,rates,0,0
156401,",",0,0
156402,knowledge,0,0
156403,about,0,0
156404,soil-transmitted,0,0
156405,helminths,0,1
156406,(,0,0
156407,as,0,0
156408,assessed,0,0
156409,with,0,0
156410,the,0,0
156411,use,0,0
156412,of,0,0
156413,a,0,0
156414,questionnaire,0,0
156415,),0,0
156416,",",0,0
156417,and,0,0
156418,hand-washing,0,0
156419,behavior,0,0
156420,were,0,0
156421,assessed,0,0
156422,before,0,0
156423,and,0,0
156424,after,0,0
156425,the,0,0
156426,intervention,0,0
156427,.,0,0
156428,Albendazole,0,0
156429,was,0,0
156430,administered,0,0
156431,in,0,0
156432,all,0,0
156433,the,0,0
156434,participants,0,1
156435,at,0,0
156436,baseline,0,0
156437,and,0,0
156438,in,0,0
156439,all,0,0
156440,the,0,1
156441,children,0,1
156442,who,0,1
156443,were,0,1
156444,found,0,1
156445,to,0,0
156446,be,0,0
156447,positive,0,0
156448,for,0,0
156449,infection,0,1
156450,with,0,1
156451,soil-transmitted,0,0
156452,helminths,0,1
156453,at,0,0
156454,the,0,0
156455,follow-up,0,0
156456,assessment,0,0
156457,at,0,0
156458,the,0,0
156459,end,0,0
156460,of,0,0
156461,the,0,0
156462,school,0,1
156463,year,0,0
156464,.,0,0
156465,RESULTS,0,0
156466,At,0,0
156467,the,0,0
156468,follow-up,0,0
156469,assessment,0,0
156470,",",0,0
156471,the,0,0
156472,mean,0,0
156473,score,0,0
156474,for,0,0
156475,the,0,0
156476,knowledge,0,0
156477,of,0,0
156478,helminths,0,1
156479,",",0,0
156480,calculated,0,0
156481,as,0,0
156482,a,0,0
156483,percentage,0,0
156484,of,0,0
156485,a,0,0
156486,total,0,1
156487,of,0,0
156488,43,0,1
156489,points,0,0
156490,on,0,0
156491,a,0,0
156492,questionnaire,0,0
156493,",",0,0
156494,was,0,0
156495,90,0,0
156496,%,0,0
156497,higher,0,0
156498,in,0,0
156499,the,0,0
156500,intervention,0,0
156501,group,0,0
156502,than,0,0
156503,in,0,0
156504,the,0,0
156505,control,0,0
156506,group,0,0
156507,(,0,0
156508,63.3,0,0
156509,vs.,0,0
156510,33.4,0,0
156511,",",0,0
156512,P,0,0
156513,<,0,0
156514,0.001,0,0
156515,),0,0
156516,",",0,0
156517,the,0,0
156518,percentage,0,0
156519,of,0,0
156520,children,0,1
156521,who,0,1
156522,washed,0,1
156523,their,0,1
156524,hands,0,0
156525,after,0,0
156526,using,0,0
156527,the,0,0
156528,toilet,0,0
156529,was,0,0
156530,nearly,0,0
156531,twice,0,0
156532,as,0,0
156533,high,0,0
156534,in,0,0
156535,the,0,0
156536,intervention,0,0
156537,group,0,0
156538,(,0,0
156539,98.9,0,0
156540,%,0,0
156541,",",0,0
156542,vs.,0,0
156543,54.2,0,0
156544,%,0,0
156545,in,0,0
156546,the,0,0
156547,control,0,0
156548,group,0,0
156549,;,0,0
156550,P,0,0
156551,<,0,0
156552,0.001,0,0
156553,),0,0
156554,",",0,0
156555,and,0,0
156556,the,0,0
156557,incidence,0,0
156558,of,0,0
156559,infection,0,0
156560,with,0,1
156561,soil-transmitted,0,1
156562,helminths,0,1
156563,was,0,0
156564,50,0,0
156565,%,0,0
156566,lower,0,0
156567,in,0,0
156568,the,0,0
156569,intervention,0,0
156570,group,0,0
156571,than,0,0
156572,in,0,0
156573,the,0,0
156574,control,0,0
156575,group,0,0
156576,(,0,0
156577,4.1,0,0
156578,%,0,0
156579,vs.,0,0
156580,8.4,0,0
156581,%,0,0
156582,",",0,0
156583,P,0,0
156584,<,0,0
156585,0.001,0,0
156586,),0,0
156587,.,0,0
156588,No,0,0
156589,adverse,0,0
156590,events,0,0
156591,were,0,0
156592,observed,0,0
156593,immediately,0,0
156594,(,0,0
156595,within,0,0
156596,15,0,1
156597,minutes,0,0
156598,),0,0
156599,after,0,0
156600,albendazole,0,0
156601,treatment,0,0
156602,.,0,0
156603,CONCLUSIONS,0,0
156604,The,0,0
156605,health-education,0,0
156606,package,0,0
156607,increased,0,0
156608,students,0,1
156609,',0,0
156610,knowledge,0,0
156611,about,0,0
156612,soil-transmitted,0,0
156613,helminths,0,1
156614,and,0,0
156615,led,0,0
156616,to,0,0
156617,a,0,0
156618,change,0,0
156619,in,0,0
156620,behavior,0,0
156621,and,0,0
156622,a,0,0
156623,reduced,0,0
156624,incidence,0,0
156625,of,0,0
156626,infection,0,0
156627,within,0,0
156628,1,0,0
156629,school,0,1
156630,year,0,0
156631,.,0,0
156632,(,0,0
156633,Funded,0,0
156634,by,0,0
156635,UBS,0,0
156636,Optimus,0,1
156637,Foundation,0,0
156638,",",0,0
156639,Zurich,0,0
156640,",",0,0
156641,Switzerland,0,1
156642,;,0,0
156643,Australian,0,1
156644,New,0,1
156645,Zealand,0,1
156646,Clinical,0,0
156647,Trials,0,0
156648,Registry,0,1
156649,number,0,0
156650,",",0,0
156651,ACTRN12610000048088,0,0
156652,.,0,0
156653,),0,0
156654,.,0,0
156655,Predicting,0,0
156656,the,0,0
156657,effect,0,0
156658,of,0,0
156659,anthelmintic,0,0
156660,treatment,0,0
156661,on,0,0
156662,milk,1,0
156663,production,1,0
156664,of,1,0
156665,dairy,1,1
156666,cattle,1,1
156667,in,1,0
156668,Canada,1,1
156669,using,0,0
156670,an,0,0
156671,Ostertagia,0,0
156672,ostertagi,0,0
156673,ELISA,0,0
156674,from,0,0
156675,individual,0,0
156676,milk,0,1
156677,samples,0,0
156678,.,0,1
156679,Gastrointestinal,1,0
156680,nematodes,1,1
156681,",",1,0
156682,such,1,0
156683,as,1,0
156684,Ostertagia,1,0
156685,ostertagi,1,0
156686,and,1,0
156687,several,1,0
156688,species,1,0
156689,of,1,0
156690,Cooperia,1,1
156691,",",1,0
156692,are,1,0
156693,ubiquitous,1,0
156694,in,1,0
156695,temperate,1,0
156696,climates,1,0
156697,and,1,0
156698,have,1,0
156699,been,1,0
156700,shown,1,0
156701,to,1,0
156702,have,1,0
156703,detrimental,1,0
156704,effects,1,0
156705,on,1,0
156706,production,1,0
156707,in,1,0
156708,adult,1,1
156709,dairy,1,1
156710,cattle,1,1
156711,.,1,0
156712,A,0,0
156713,published,0,0
156714,meta-analysis,0,0
156715,demonstrated,0,0
156716,that,0,0
156717,overall,0,0
156718,",",0,0
156719,producers,0,0
156720,lose,1,0
156721,approximately,1,0
156722,0.35,1,0
156723,kg,1,0
156724,of,1,0
156725,milk,1,0
156726,per,1,0
156727,parasitized,1,1
156728,cow,1,0
156729,per,1,0
156730,day,1,0
156731,.,1,0
156732,Enzyme-linked,0,0
156733,immunosorbent,0,0
156734,assays,0,0
156735,(,0,0
156736,ELISAs,0,0
156737,),0,0
156738,have,0,0
156739,the,0,0
156740,ability,0,0
156741,to,0,0
156742,quantify,0,0
156743,nematode,0,1
156744,infections,0,0
156745,in,0,0
156746,cattle,0,1
156747,",",0,0
156748,and,0,0
156749,thus,0,0
156750,",",0,0
156751,could,0,0
156752,be,0,0
156753,used,0,0
156754,to,0,0
156755,estimate,0,0
156756,the,0,0
156757,amount,0,0
156758,of,0,0
156759,milk,0,0
156760,production,0,0
156761,loss,0,0
156762,due,0,0
156763,to,0,0
156764,differing,0,0
156765,levels,0,0
156766,of,0,0
156767,parasitism,0,1
156768,at,0,0
156769,the,0,0
156770,individual,0,0
156771,cow,0,0
156772,level,0,0
156773,.,0,0
156774,ELISA,1,0
156775,results,1,0
156776,from,1,1
156777,individual,1,0
156778,cow,1,1
156779,milk,1,0
156780,samples,1,0
156781,were,1,0
156782,used,1,0
156783,to,1,0
156784,predict,1,0
156785,milk,1,0
156786,production,1,0
156787,response,1,0
156788,following,0,0
156789,a,0,0
156790,randomized,0,0
156791,anthelmintic,0,0
156792,treatment,0,0
156793,in,0,0
156794,a,0,0
156795,large,0,0
156796,field,0,0
156797,trial,0,0
156798,.,0,0
156799,To,0,0
156800,increase,0,0
156801,statistical,0,0
156802,power,0,0
156803,",",0,0
156804,the,0,0
156805,data,0,0
156806,collected,0,0
156807,from,0,0
156808,this,0,0
156809,field,0,0
156810,trial,0,0
156811,was,0,0
156812,pooled,0,0
156813,with,0,1
156814,data,0,0
156815,from,0,1
156816,two,0,0
156817,other,0,0
156818,published,0,0
156819,field,0,0
156820,trials,0,0
156821,to,0,0
156822,form,0,0
156823,an,0,0
156824,individual,0,0
156825,patient,0,0
156826,data,0,0
156827,meta-analysis,0,0
156828,(,0,0
156829,IPDMA,0,0
156830,),0,0
156831,.,0,0
156832,The,0,0
156833,ability,0,0
156834,to,0,0
156835,predict,0,0
156836,the,0,0
156837,effect,0,0
156838,of,0,0
156839,anthelmintic,0,0
156840,treatment,0,0
156841,on,0,0
156842,milk,0,0
156843,production,0,0
156844,depends,0,0
156845,on,0,0
156846,the,0,0
156847,level,0,0
156848,of,0,0
156849,parasitism,0,1
156850,quantified,0,0
156851,by,0,0
156852,an,0,0
156853,ELISA,0,0
156854,measuring,0,0
156855,milk,0,0
156856,antibodies,0,0
156857,against,0,0
156858,O.,0,1
156859,ostertagi,0,0
156860,",",0,0
156861,and,0,0
156862,reported,0,0
156863,as,0,0
156864,optical,0,0
156865,density,0,0
156866,ratios,0,0
156867,(,0,0
156868,ODRs,0,1
156869,),0,0
156870,.,0,0
156871,Therefore,0,0
156872,",",0,0
156873,the,0,0
156874,estimates,0,0
156875,from,0,0
156876,the,0,0
156877,interaction,0,0
156878,between,0,0
156879,ODR,0,0
156880,and,0,0
156881,treatment,0,0
156882,on,0,0
156883,milk,0,0
156884,production,0,0
156885,were,0,0
156886,used,0,0
156887,to,0,0
156888,determine,0,0
156889,how,0,0
156890,well,0,0
156891,the,0,0
156892,ODR,0,0
156893,predicted,0,0
156894,the,0,0
156895,response,0,0
156896,of,0,0
156897,the,0,0
156898,treatment,0,0
156899,.,0,0
156900,It,0,0
156901,was,0,0
156902,anticipated,0,0
156903,that,0,0
156904,the,0,0
156905,relationship,0,0
156906,between,0,0
156907,milk,0,0
156908,production,0,0
156909,and,0,0
156910,ODR,0,0
156911,was,0,0
156912,unlikely,0,0
156913,to,0,0
156914,be,0,0
156915,linear,0,0
156916,",",0,0
156917,so,0,0
156918,fractional,0,0
156919,polynomials,0,0
156920,were,0,0
156921,applied,0,0
156922,to,0,0
156923,the,0,0
156924,continuous,0,0
156925,ODR,0,0
156926,values,0,0
156927,.,0,0
156928,The,0,0
156929,interaction,0,0
156930,in,0,0
156931,the,0,0
156932,field,0,0
156933,trial,0,0
156934,showed,0,0
156935,a,0,0
156936,trend,0,0
156937,(,0,0
156938,p=0.138,0,0
156939,),0,0
156940,toward,0,0
156941,a,0,0
156942,beneficial,0,0
156943,treatment,0,0
156944,effect,0,0
156945,when,0,0
156946,the,0,0
156947,individual,0,0
156948,ODR,0,0
156949,values,0,0
156950,",",0,0
156951,measured,0,0
156952,in,0,0
156953,late,0,0
156954,lactation,0,0
156955,and,0,0
156956,using,0,0
156957,Svanovir,0,0
156958,(,0,0
156959,?,0,0
156960,),0,0
156961,",",0,0
156962,were,0,0
156963,greater,0,0
156964,than,0,0
156965,0.12,0,0
156966,.,0,0
156967,When,0,0
156968,individual,0,0
156969,data,0,0
156970,from,0,1
156971,two,0,0
156972,other,0,0
156973,similar,0,0
156974,studies,0,0
156975,were,0,0
156976,included,0,1
156977,in,0,0
156978,an,0,0
156979,IPDMA,0,0
156980,",",0,0
156981,the,0,0
156982,interaction,0,0
156983,terms,0,0
156984,became,0,0
156985,statistically,0,0
156986,significant,0,0
156987,(,0,0
156988,p=0.009,0,0
156989,),0,0
156990,indicating,0,0
156991,that,0,0
156992,there,0,0
156993,is,0,0
156994,a,0,0
156995,beneficial,0,0
156996,treatment,0,0
156997,effect,0,0
156998,when,0,0
156999,ODR,0,0
157000,values,0,0
157001,are,0,0
157002,slightly,0,0
157003,elevated,0,0
157004,.,0,0
157005,A,0,0
157006,graph,0,0
157007,was,0,0
157008,used,0,0
157009,to,0,0
157010,demonstrate,0,0
157011,the,0,0
157012,treatment,0,0
157013,effect,0,0
157014,(,0,0
157015,the,0,0
157016,estimated,0,0
157017,difference,0,0
157018,of,0,0
157019,kg/cow/day,0,0
157020,of,0,0
157021,milk,0,0
157022,yield,0,0
157023,between,0,0
157024,the,0,0
157025,treated,0,0
157026,and,0,0
157027,placebo,0,0
157028,cows,0,1
157029,),0,0
157030,",",0,0
157031,with,0,0
157032,95,0,0
157033,%,0,0
157034,confidence,0,0
157035,intervals,0,0
157036,",",0,0
157037,as,0,0
157038,the,0,0
157039,ODR,0,0
157040,values,0,0
157041,increase,0,0
157042,.,0,0
157043,It,0,0
157044,is,0,0
157045,important,0,0
157046,to,0,0
157047,note,0,0
157048,that,0,0
157049,the,0,0
157050,methods,0,0
157051,of,0,0
157052,quantifying,0,0
157053,the,0,0
157054,ODR,0,0
157055,values,0,0
157056,differed,0,0
157057,between,0,0
157058,the,0,0
157059,three,0,0
157060,studies,0,0
157061,in,0,0
157062,the,0,0
157063,IPDMA,0,0
157064,",",0,0
157065,therefore,0,0
157066,some,0,0
157067,caution,0,0
157068,should,0,0
157069,be,0,0
157070,used,0,0
157071,when,0,0
157072,using,0,0
157073,these,0,0
157074,final,0,0
157075,estimated,0,0
157076,values,0,0
157077,.,0,0
157078,However,0,0
157079,",",0,0
157080,the,0,0
157081,shape,0,0
157082,and,0,0
157083,magnitude,0,0
157084,of,0,0
157085,the,0,0
157086,treatment,0,0
157087,effects,0,0
157088,",",0,0
157089,as,0,0
157090,well,0,0
157091,as,0,0
157092,the,0,0
157093,other,0,0
157094,fixed,0,0
157095,model,0,0
157096,estimates,0,0
157097,",",0,0
157098,were,0,0
157099,very,0,0
157100,similar,0,0
157101,between,0,0
157102,the,0,0
157103,field,0,0
157104,trial,0,0
157105,and,0,0
157106,the,0,0
157107,IPDMA,0,0
157108,suggesting,0,0
157109,that,0,0
157110,any,0,0
157111,bias,0,0
157112,would,0,0
157113,likely,0,0
157114,be,0,0
157115,minimal,0,0
157116,.,0,0
157117,The,0,0
157118,Pain,0,0
157119,Course,0,0
157120,:,0,1
157121,a,0,0
157122,randomised,0,0
157123,controlled,0,0
157124,trial,0,0
157125,of,0,0
157126,a,0,0
157127,clinician-guided,0,0
157128,Internet-delivered,0,0
157129,cognitive,1,0
157130,behaviour,1,0
157131,therapy,1,0
157132,program,1,0
157133,for,1,0
157134,managing,1,0
157135,chronic,1,1
157136,pain,1,0
157137,and,1,0
157138,emotional,1,0
157139,well-being,1,0
157140,.,1,0
157141,The,0,0
157142,present,0,0
157143,study,0,0
157144,evaluated,0,0
157145,the,0,0
157146,efficacy,0,0
157147,of,0,0
157148,a,0,0
157149,clinician-guided,0,0
157150,Internet-delivered,0,0
157151,cognitive,0,0
157152,behaviour,0,0
157153,therapy,0,0
157154,(,0,0
157155,iCBT,0,0
157156,),0,0
157157,program,0,0
157158,",",0,0
157159,the,0,0
157160,Pain,0,0
157161,Course,0,0
157162,",",0,0
157163,to,0,0
157164,reduce,0,0
157165,disability,0,0
157166,",",0,0
157167,anxiety,0,0
157168,",",0,0
157169,and,0,0
157170,depression,0,0
157171,associated,0,0
157172,with,0,0
157173,chronic,0,1
157174,pain,0,0
157175,.,0,0
157176,Sixty-three,1,1
157177,adults,1,1
157178,with,1,1
157179,chronic,1,1
157180,pain,1,0
157181,were,1,0
157182,randomised,1,0
157183,to,0,0
157184,either,0,0
157185,a,0,0
157186,Treatment,0,0
157187,Group,0,0
157188,or,0,0
157189,waitlist,0,0
157190,Control,0,0
157191,Group,0,0
157192,.,0,0
157193,Treatment,0,0
157194,consisted,0,0
157195,of,0,0
157196,5,0,0
157197,iCBT-based,0,0
157198,lessons,0,0
157199,",",0,0
157200,homework,0,0
157201,tasks,0,0
157202,",",0,0
157203,additional,0,0
157204,resources,0,0
157205,",",0,0
157206,weekly,0,0
157207,e-mail,0,0
157208,or,0,0
157209,telephone,0,0
157210,contact,0,0
157211,from,0,0
157212,a,0,0
157213,Clinical,0,0
157214,Psychologist,0,0
157215,",",0,0
157216,and,0,0
157217,automated,0,0
157218,e-mails,0,0
157219,.,0,0
157220,Twenty-nine,0,1
157221,of,0,0
157222,31,1,1
157223,Treatment,1,0
157224,Group,1,1
157225,participants,1,1
157226,completed,0,1
157227,the,0,0
157228,5,0,0
157229,lessons,0,0
157230,during,0,0
157231,the,0,0
157232,8-week,0,0
157233,program,0,0
157234,",",0,0
157235,and,0,0
157236,posttreatment,0,0
157237,and,0,0
157238,3-month,0,0
157239,follow-up,0,0
157240,data,0,0
157241,were,0,0
157242,collected,0,0
157243,from,0,0
157244,30/31,0,0
157245,and,0,0
157246,29/31,0,0
157247,participants,0,1
157248,",",0,0
157249,respectively,0,0
157250,.,0,0
157251,Treatment,0,0
157252,Group,0,1
157253,participants,0,1
157254,obtained,0,0
157255,significantly,0,0
157256,greater,0,0
157257,improvements,0,0
157258,than,0,0
157259,Control,0,1
157260,Group,0,1
157261,participants,0,1
157262,in,0,0
157263,levels,0,0
157264,of,0,0
157265,disability,0,0
157266,",",0,0
157267,anxiety,0,0
157268,",",0,0
157269,depression,0,0
157270,",",0,0
157271,and,0,0
157272,average,0,0
157273,pain,0,0
157274,levels,0,0
157275,at,0,0
157276,posttreatment,0,0
157277,.,0,0
157278,These,0,0
157279,improvements,0,0
157280,corresponded,0,0
157281,to,0,0
157282,small,0,0
157283,to,0,0
157284,large,0,1
157285,between-groups,0,0
157286,effect,0,0
157287,sizes,0,0
157288,(,0,0
157289,Cohen,0,0
157290,'s,0,0
157291,d,0,0
157292,),0,0
157293,at,0,0
157294,posttreatment,0,0
157295,for,0,0
157296,disability,0,0
157297,(,0,0
157298,d,0,0
157299,=,0,0
157300,.88,0,0
157301,),0,0
157302,",",0,0
157303,anxiety,0,0
157304,(,0,0
157305,d,0,0
157306,=,0,0
157307,.38,0,0
157308,),0,0
157309,",",0,0
157310,depression,0,0
157311,(,0,0
157312,d,0,0
157313,=,0,0
157314,.66,0,0
157315,),0,0
157316,",",0,0
157317,and,0,0
157318,average,0,0
157319,pain,0,0
157320,(,0,0
157321,d,0,0
157322,=,0,0
157323,.64,0,0
157324,),0,0
157325,",",0,0
157326,respectively,0,0
157327,.,0,0
157328,These,0,0
157329,outcomes,0,0
157330,were,0,0
157331,sustained,0,0
157332,at,0,0
157333,follow-up,0,0
157334,and,0,0
157335,participants,0,1
157336,rated,0,0
157337,the,0,0
157338,program,0,0
157339,as,0,0
157340,highly,0,0
157341,acceptable,0,0
157342,.,0,0
157343,Overall,0,0
157344,",",0,0
157345,the,0,0
157346,clinician,0,0
157347,spent,0,0
157348,a,0,0
157349,total,0,0
157350,mean,0,0
157351,time,0,0
157352,of,0,0
157353,81.54,0,0
157354,minutes,0,0
157355,(,0,0
157356,SD,0,1
157357,30.91,0,0
157358,minutes,0,0
157359,),0,1
157360,contacting,0,0
157361,participants,0,1
157362,during,0,0
157363,the,0,0
157364,program,0,0
157365,.,0,0
157366,The,0,0
157367,results,0,0
157368,appear,0,0
157369,better,0,0
157370,than,0,0
157371,those,0,0
157372,reported,0,0
157373,in,0,0
157374,iCBT,0,0
157375,studies,0,0
157376,to,0,0
157377,date,0,0
157378,and,0,0
157379,provide,0,0
157380,support,0,0
157381,for,0,0
157382,the,0,0
157383,potential,0,0
157384,of,0,0
157385,clinician-guided,0,0
157386,iCBT,0,0
157387,in,0,0
157388,the,0,0
157389,treatment,0,0
157390,of,0,0
157391,disability,0,0
157392,",",0,0
157393,anxiety,0,0
157394,",",0,0
157395,and,0,0
157396,depression,0,1
157397,for,0,0
157398,people,1,1
157399,with,1,1
157400,chronic,1,1
157401,pain,1,0
157402,.,1,0
157403,Methylphenidate,0,1
157404,and/or,0,0
157405,a,0,0
157406,nursing,0,0
157407,telephone,0,0
157408,intervention,0,0
157409,for,0,0
157410,fatigue,0,0
157411,in,0,0
157412,patients,1,1
157413,with,1,1
157414,advanced,1,1
157415,cancer,1,1
157416,:,1,1
157417,a,0,0
157418,randomized,0,0
157419,",",0,0
157420,placebo-controlled,0,0
157421,",",0,0
157422,phase,0,0
157423,II,0,0
157424,trial,0,0
157425,.,0,0
157426,PURPOSE,0,0
157427,Cancer-related-fatigue,0,0
157428,(,0,0
157429,CRF,0,0
157430,),0,0
157431,is,0,0
157432,common,0,0
157433,in,0,0
157434,advanced,1,1
157435,cancer,1,1
157436,.,1,0
157437,The,0,0
157438,primary,0,0
157439,objective,0,0
157440,of,0,0
157441,the,0,0
157442,study,0,0
157443,was,0,0
157444,to,0,0
157445,compare,0,0
157446,the,0,0
157447,effects,0,0
157448,of,0,0
157449,methylphenidate,0,0
157450,(,0,0
157451,MP,0,0
157452,),0,0
157453,with,0,0
157454,those,0,0
157455,of,0,0
157456,placebo,0,0
157457,(,0,0
157458,PL,0,0
157459,),0,0
157460,on,0,0
157461,CRF,0,0
157462,as,0,0
157463,measured,0,0
157464,using,0,0
157465,the,0,0
157466,Functional,0,0
157467,Assessment,0,0
157468,of,0,0
157469,Chronic,0,1
157470,Illness,0,0
157471,Therapy-Fatigue,0,0
157472,(,0,0
157473,FACIT-F,0,0
157474,),0,0
157475,fatigue,0,0
157476,subscale,0,0
157477,.,0,0
157478,The,0,0
157479,effect,0,0
157480,of,0,0
157481,a,0,0
157482,combined,0,0
157483,intervention,0,0
157484,including,0,0
157485,MP,0,0
157486,plus,0,0
157487,a,0,0
157488,nursing,0,0
157489,telephone,0,0
157490,intervention,0,0
157491,(,0,0
157492,NTI,0,0
157493,),0,0
157494,was,0,0
157495,also,0,0
157496,assessed,0,0
157497,.,0,0
157498,PATIENTS,0,0
157499,AND,0,0
157500,METHODS,0,0
157501,Patients,1,1
157502,with,1,1
157503,advanced,1,1
157504,cancer,1,1
157505,with,1,0
157506,a,1,0
157507,fatigue,1,0
157508,score,1,0
157509,of,1,0
157510,?,1,0
157511,4,1,0
157512,out,1,0
157513,of,1,0
157514,10,1,0
157515,on,1,0
157516,the,1,0
157517,Edmonton,1,1
157518,Symptom,1,0
157519,Assessment,1,0
157520,Scale,1,0
157521,(,1,0
157522,ESAS,1,1
157523,),1,0
157524,were,1,0
157525,randomly,0,0
157526,assigned,0,0
157527,to,0,0
157528,one,0,0
157529,of,0,0
157530,the,0,0
157531,following,0,0
157532,four,0,1
157533,groups,0,0
157534,:,0,1
157535,MP+NTI,0,0
157536,",",0,0
157537,PL+NTI,0,0
157538,",",0,0
157539,MP,0,0
157540,+,0,0
157541,control,0,0
157542,telephone,0,0
157543,intervention,0,0
157544,(,0,0
157545,CTI,0,0
157546,),0,0
157547,",",0,0
157548,and,0,0
157549,PL+CTI,0,0
157550,.,0,0
157551,Methylphenidate,0,0
157552,dose,0,0
157553,was,0,0
157554,5,0,0
157555,mg,0,0
157556,every,0,0
157557,2,0,0
157558,hours,0,0
157559,as,0,0
157560,needed,0,0
157561,up,0,0
157562,to,0,0
157563,20,0,1
157564,mg,0,0
157565,per,0,0
157566,day,0,0
157567,.,0,0
157568,The,0,0
157569,primary,0,0
157570,end,0,0
157571,point,0,0
157572,was,0,0
157573,the,0,0
157574,median,0,0
157575,difference,0,0
157576,in,0,0
157577,FACIT-F,0,0
157578,fatigue,0,0
157579,at,0,0
157580,day,0,0
157581,15,0,0
157582,.,0,0
157583,Secondary,0,0
157584,outcomes,0,0
157585,included,0,1
157586,anxiety,0,0
157587,",",0,0
157588,depression,0,0
157589,",",0,0
157590,and,0,0
157591,sleep,0,0
157592,.,0,0
157593,RESULTS,1,0
157594,One,1,1
157595,hundred,1,1
157596,forty-one,1,1
157597,patients,1,1
157598,were,1,1
157599,evaluable,1,1
157600,.,1,0
157601,Median,0,0
157602,FACIT-F,0,0
157603,fatigue,0,0
157604,scores,0,0
157605,improved,0,0
157606,from,0,0
157607,baseline,0,0
157608,to,0,0
157609,day,0,0
157610,15,0,0
157611,in,0,0
157612,all,0,0
157613,groups,0,0
157614,:,0,1
157615,MP+NTI,0,0
157616,(,0,0
157617,median,0,0
157618,score,0,0
157619,",",0,0
157620,4.5,0,0
157621,;,0,0
157622,P,0,0
157623,=,0,0
157624,.005,0,0
157625,),0,0
157626,",",0,0
157627,PL+NTI,0,0
157628,(,0,0
157629,median,0,0
157630,score,0,0
157631,",",0,0
157632,8.0,0,0
157633,;,0,0
157634,P,0,0
157635,<,0,0
157636,.001,0,0
157637,),0,0
157638,",",0,0
157639,MP+CTI,0,0
157640,(,0,0
157641,median,0,0
157642,score,0,0
157643,",",0,0
157644,7.0,0,0
157645,;,0,0
157646,P,0,0
157647,=,0,0
157648,.004,0,0
157649,),0,0
157650,",",0,0
157651,and,0,0
157652,PL+CTI,0,0
157653,(,0,0
157654,median,0,0
157655,score,0,0
157656,",",0,0
157657,5.0,0,0
157658,;,0,0
157659,P,0,0
157660,=,0,0
157661,.03,0,0
157662,),0,0
157663,.,0,0
157664,However,0,0
157665,",",0,0
157666,there,0,0
157667,were,0,0
157668,no,0,0
157669,significant,0,0
157670,differences,0,0
157671,in,0,0
157672,the,0,0
157673,median,0,0
157674,improvement,0,0
157675,in,0,0
157676,FACIT-F,0,0
157677,fatigue,0,0
157678,between,0,0
157679,the,0,0
157680,MP,0,0
157681,and,0,0
157682,PL,0,0
157683,groups,0,0
157684,(,0,0
157685,5.5,0,0
157686,v,0,0
157687,6.0,0,0
157688,",",0,0
157689,respectively,0,0
157690,;,0,0
157691,P,0,0
157692,=,0,0
157693,.69,0,0
157694,),0,0
157695,and,0,0
157696,among,0,0
157697,all,0,0
157698,four,0,0
157699,groups,0,0
157700,(,0,0
157701,P,0,0
157702,=,0,0
157703,.16,0,0
157704,),0,0
157705,.,0,0
157706,Fatigue,0,0
157707,(,0,0
157708,P,0,0
157709,<,0,0
157710,.001,0,0
157711,),0,0
157712,",",0,0
157713,nausea,0,0
157714,(,0,0
157715,P,0,0
157716,=,0,0
157717,.01,0,0
157718,),0,0
157719,",",0,0
157720,depression,0,0
157721,(,0,0
157722,P,0,0
157723,=,0,0
157724,.02,0,0
157725,),0,0
157726,",",0,0
157727,anxiety,0,0
157728,(,0,0
157729,P,0,0
157730,=,0,0
157731,.01,0,0
157732,),0,0
157733,",",0,0
157734,drowsiness,0,0
157735,(,0,0
157736,P,0,0
157737,<,0,0
157738,.001,0,0
157739,),0,0
157740,",",0,0
157741,appetite,0,0
157742,(,0,0
157743,P,0,0
157744,=,0,0
157745,.009,0,0
157746,),0,0
157747,",",0,0
157748,sleep,0,0
157749,(,0,0
157750,P,0,0
157751,<,0,0
157752,.001,0,0
157753,),0,0
157754,",",0,0
157755,and,0,0
157756,feeling,0,0
157757,of,0,0
157758,well-being,0,0
157759,(,0,0
157760,P,0,0
157761,<,0,0
157762,.001,0,0
157763,),0,0
157764,",",0,0
157765,as,0,0
157766,measured,0,0
157767,by,0,0
157768,the,0,0
157769,ESAS,0,0
157770,",",0,0
157771,significantly,0,0
157772,improved,0,0
157773,in,0,0
157774,patients,0,1
157775,who,0,1
157776,received,0,1
157777,NTI,0,1
157778,.,0,0
157779,Grade,0,0
157780,?,0,0
157781,3,0,0
157782,adverse,0,0
157783,events,0,0
157784,did,0,0
157785,not,0,0
157786,differ,0,0
157787,between,0,0
157788,MP,0,0
157789,and,0,0
157790,PL,0,0
157791,(,0,0
157792,40,0,0
157793,of,0,0
157794,93,0,1
157795,patients,0,1
157796,v,0,0
157797,29,0,1
157798,of,0,0
157799,97,0,1
157800,patients,0,1
157801,",",0,0
157802,respectively,0,0
157803,;,0,0
157804,P,0,0
157805,=,0,0
157806,.06,0,0
157807,),0,0
157808,.,0,0
157809,CONCLUSION,0,0
157810,MP,0,0
157811,and,0,0
157812,NTI,0,0
157813,alone,0,0
157814,or,0,0
157815,combined,0,0
157816,were,0,0
157817,not,0,0
157818,superior,0,0
157819,to,0,0
157820,placebo,0,0
157821,in,0,0
157822,improving,0,0
157823,CRF,0,1
157824,.,0,1
157825,The,0,0
157826,effectiveness,0,0
157827,of,0,0
157828,educational,0,0
157829,interventions,0,0
157830,to,0,0
157831,enhance,0,0
157832,the,0,0
157833,adoption,0,0
157834,of,0,0
157835,fee-based,0,0
157836,arsenic,0,0
157837,testing,0,0
157838,in,1,0
157839,Bangladesh,1,1
157840,:,1,1
157841,a,0,0
157842,cluster,0,0
157843,randomized,0,0
157844,controlled,0,0
157845,trial,0,0
157846,.,0,0
157847,Arsenic,0,0
157848,(,0,0
157849,As,0,0
157850,),0,0
157851,testing,0,0
157852,could,0,0
157853,help,0,0
157854,22,0,0
157855,million,0,0
157856,people,0,1
157857,",",0,0
157858,using,0,0
157859,drinking,0,0
157860,water,0,0
157861,sources,0,0
157862,that,0,0
157863,exceed,0,0
157864,the,0,0
157865,Bangladesh,0,1
157866,As,0,0
157867,standard,0,0
157868,",",0,0
157869,to,0,0
157870,identify,0,0
157871,safe,0,0
157872,sources,0,0
157873,.,0,0
157874,A,0,0
157875,cluster,0,0
157876,randomized,0,0
157877,controlled,0,0
157878,trial,0,0
157879,was,0,0
157880,conducted,0,0
157881,to,0,0
157882,evaluate,0,0
157883,the,0,0
157884,effectiveness,0,0
157885,of,0,0
157886,household,0,0
157887,education,0,0
157888,and,0,0
157889,local,0,0
157890,media,0,0
157891,in,0,0
157892,the,0,0
157893,increasing,0,0
157894,demand,0,0
157895,for,0,0
157896,fee-based,0,0
157897,As,0,0
157898,testing,0,0
157899,.,0,0
157900,Randomly,1,0
157901,selected,1,0
157902,households,1,1
157903,(,1,0
157904,N,1,1
157905,=,1,0
157906,452,1,1
157907,),1,0
157908,were,0,0
157909,divided,0,0
157910,into,0,1
157911,three,0,0
157912,interventions,0,0
157913,implemented,0,0
157914,by,0,0
157915,community,0,1
157916,workers,0,1
157917,:,0,1
157918,1,0,0
157919,),0,0
157920,fee-based,0,0
157921,As,0,0
157922,testing,0,0
157923,with,0,1
157924,household,0,0
157925,education,0,0
157926,(,0,0
157927,HE,0,0
157928,),0,0
157929,;,0,0
157930,2,0,0
157931,),0,0
157932,fee-based,0,0
157933,As,0,0
157934,testing,0,0
157935,with,0,1
157936,household,0,0
157937,education,0,0
157938,and,0,0
157939,a,0,0
157940,local,0,0
157941,media,0,0
157942,campaign,0,0
157943,(,0,0
157944,HELM,0,0
157945,),0,0
157946,;,0,0
157947,and,0,0
157948,3,0,0
157949,),0,0
157950,fee-based,0,0
157951,As,0,0
157952,testing,0,0
157953,alone,0,0
157954,(,0,0
157955,Control,0,0
157956,),0,0
157957,.,0,0
157958,The,0,0
157959,fee,0,0
157960,for,0,0
157961,the,0,0
157962,As,0,0
157963,test,0,0
157964,was,0,0
157965,US,0,0
157966,$,0,0
157967,0.28,0,0
157968,",",0,0
157969,higher,0,0
157970,than,0,0
157971,the,0,0
157972,cost,0,0
157973,of,0,0
157974,the,0,0
157975,test,0,0
157976,(,0,0
157977,US,0,0
157978,$,0,0
157979,0.16,0,0
157980,),0,0
157981,.,0,0
157982,Of,0,0
157983,households,0,1
157984,with,0,1
157985,untested,0,0
157986,wells,0,0
157987,",",0,0
157988,93,0,0
157989,%,0,0
157990,in,0,0
157991,both,0,0
157992,intervention,0,0
157993,groups,0,0
157994,HE,0,0
157995,and,0,0
157996,HELM,0,0
157997,purchased,0,0
157998,an,0,0
157999,As,0,0
158000,test,0,0
158001,",",0,0
158002,whereas,0,0
158003,only,0,0
158004,53,0,1
158005,%,0,0
158006,in,0,0
158007,the,0,0
158008,control,0,0
158009,group,0,0
158010,.,0,0
158011,In,0,0
158012,conclusion,0,0
158013,",",0,0
158014,fee-based,0,0
158015,As,0,0
158016,testing,0,0
158017,with,0,1
158018,household,0,0
158019,education,0,0
158020,is,0,0
158021,effective,0,0
158022,in,0,0
158023,the,0,0
158024,increasing,0,0
158025,demand,0,0
158026,for,0,0
158027,As,0,0
158028,testing,0,0
158029,in,1,0
158030,rural,1,1
158031,Bangladesh,1,1
158032,.,1,1
158033,Effect,1,0
158034,of,1,0
158035,resistance,1,0
158036,exercise,1,0
158037,contraction,1,0
158038,mode,1,0
158039,and,1,0
158040,protein,1,0
158041,supplementation,1,0
158042,on,1,0
158043,members,1,1
158044,of,1,0
158045,the,1,0
158046,STARS,1,0
158047,signalling,1,0
158048,pathway,1,0
158049,.,1,0
158050,The,0,0
158051,striated,0,0
158052,muscle,0,0
158053,activator,0,0
158054,of,0,0
158055,Rho,0,0
158056,signalling,0,0
158057,(,0,0
158058,STARS,0,0
158059,),0,0
158060,pathway,0,0
158061,is,0,0
158062,suggested,0,0
158063,to,0,0
158064,provide,0,0
158065,a,0,0
158066,link,0,0
158067,between,0,0
158068,external,0,0
158069,stress,0,0
158070,responses,0,0
158071,and,0,0
158072,transcriptional,0,0
158073,regulation,0,0
158074,in,0,0
158075,muscle,0,0
158076,.,0,0
158077,However,0,0
158078,",",0,0
158079,the,0,0
158080,sensitivity,0,0
158081,of,0,0
158082,STARS,0,0
158083,signalling,0,0
158084,to,0,0
158085,different,0,0
158086,mechanical,0,0
158087,stresses,0,0
158088,has,0,0
158089,not,0,0
158090,been,0,0
158091,investigated,0,0
158092,.,0,0
158093,In,0,0
158094,a,0,0
158095,comparative,0,0
158096,study,0,0
158097,",",0,0
158098,we,0,0
158099,examined,0,0
158100,the,0,0
158101,regulation,0,0
158102,of,0,0
158103,the,0,0
158104,STARS,0,0
158105,signalling,0,0
158106,pathway,0,0
158107,in,0,0
158108,response,0,0
158109,to,0,0
158110,unilateral,0,1
158111,resistance,0,0
158112,exercise,0,0
158113,performed,0,0
158114,as,0,0
158115,either,0,0
158116,eccentric,0,0
158117,(,0,0
158118,ECC,0,1
158119,),0,0
158120,or,0,0
158121,concentric,0,0
158122,(,0,0
158123,CONC,0,0
158124,),0,0
158125,contractions,0,0
158126,as,0,0
158127,well,0,0
158128,as,0,0
158129,prolonged,1,0
158130,training,1,0
158131,;,1,0
158132,with,1,0
158133,and,1,0
158134,without,1,0
158135,whey,1,0
158136,protein,1,0
158137,supplementation,1,0
158138,.,1,0
158139,Skeletal,0,0
158140,muscle,0,0
158141,STARS,0,0
158142,",",0,0
158143,myocardian-related,0,0
158144,transcription,0,0
158145,factor-A,0,0
158146,(,0,0
158147,MRTF-A,0,0
158148,),0,0
158149,and,0,0
158150,serum,0,0
158151,response,0,0
158152,factor,0,0
158153,(,0,0
158154,SRF,0,0
158155,),0,0
158156,mRNA,0,0
158157,and,0,0
158158,protein,0,0
158159,",",0,0
158160,as,0,0
158161,well,0,0
158162,as,0,0
158163,muscle,0,0
158164,cross-sectional,0,1
158165,area,0,0
158166,and,0,0
158167,maximal,0,0
158168,voluntary,0,0
158169,contraction,0,0
158170,",",0,0
158171,were,0,0
158172,measured,0,0
158173,.,0,0
158174,A,0,0
158175,single-bout,0,0
158176,of,0,0
158177,exercise,0,0
158178,produced,0,0
158179,increases,0,0
158180,in,0,0
158181,STARS,0,0
158182,and,0,0
158183,SRF,0,0
158184,mRNA,0,0
158185,and,0,0
158186,decreases,0,0
158187,in,0,0
158188,MRTF-A,0,0
158189,mRNA,0,0
158190,with,0,1
158191,both,0,0
158192,ECC,0,0
158193,and,0,0
158194,CONC,0,0
158195,exercise,0,0
158196,",",0,0
158197,but,0,0
158198,with,0,0
158199,an,0,0
158200,enhanced,0,0
158201,response,0,0
158202,occurring,0,1
158203,following,0,0
158204,ECC,0,1
158205,exercise,0,0
158206,.,0,0
158207,A,0,0
158208,31,0,0
158209,%,0,0
158210,increase,0,0
158211,in,0,0
158212,STARS,0,0
158213,protein,0,0
158214,was,0,0
158215,observed,0,0
158216,exclusively,0,0
158217,after,0,0
158218,CONC,0,0
158219,exercise,0,0
158220,(,0,0
158221,P,0,0
158222,<,0,0
158223,0.001,0,0
158224,),0,0
158225,",",0,0
158226,while,0,0
158227,pSRF,0,0
158228,protein,0,0
158229,levels,0,0
158230,increased,0,0
158231,similarly,0,0
158232,by,0,0
158233,48,0,0
158234,%,0,0
158235,with,0,1
158236,both,0,0
158237,CONC,0,0
158238,and,0,0
158239,ECC,0,0
158240,exercise,0,0
158241,(,0,0
158242,P,0,0
158243,<,0,0
158244,0.001,0,0
158245,),0,0
158246,.,0,0
158247,Prolonged,0,0
158248,ECC,0,0
158249,and,0,0
158250,CONC,0,0
158251,training,0,0
158252,equally,0,0
158253,stimulated,0,0
158254,muscle,0,0
158255,hypertrophy,0,1
158256,and,0,0
158257,produced,0,0
158258,increases,0,0
158259,in,0,0
158260,MRTF-A,0,0
158261,protein,0,0
158262,of,0,0
158263,125,0,0
158264,%,0,0
158265,and,0,0
158266,99,0,0
158267,%,0,0
158268,",",0,0
158269,respectively,0,0
158270,(,0,0
158271,P,0,0
158272,<,0,0
158273,0.001,0,0
158274,),0,0
158275,.,0,0
158276,No,0,0
158277,changes,0,0
158278,occurred,0,0
158279,for,0,0
158280,total,0,1
158281,SRF,0,0
158282,protein,0,0
158283,.,0,0
158284,There,0,0
158285,was,0,0
158286,no,0,0
158287,effect,0,0
158288,of,0,0
158289,whey,0,0
158290,protein,0,0
158291,supplementation,0,0
158292,.,0,0
158293,These,0,0
158294,results,0,0
158295,show,0,0
158296,that,0,0
158297,resistance,0,0
158298,exercise,0,0
158299,provides,0,0
158300,an,0,0
158301,acute,0,0
158302,stimulation,0,0
158303,of,0,0
158304,the,0,0
158305,STARS,0,0
158306,pathway,0,0
158307,that,0,0
158308,is,0,0
158309,contraction,0,0
158310,mode,0,0
158311,dependent,0,0
158312,.,0,0
158313,The,0,0
158314,responses,0,0
158315,to,0,0
158316,acute,0,1
158317,exercise,0,0
158318,were,0,0
158319,more,0,0
158320,pronounced,0,0
158321,than,0,0
158322,responses,0,0
158323,to,0,0
158324,accumulated,0,0
158325,training,0,0
158326,",",0,0
158327,suggesting,0,0
158328,that,0,0
158329,STARS,0,0
158330,signalling,0,0
158331,is,0,0
158332,primarily,0,0
158333,involved,0,0
158334,in,0,0
158335,the,0,0
158336,initial,0,0
158337,phase,0,0
158338,of,0,0
158339,exercise-induced,0,0
158340,muscle,0,0
158341,adaptations,0,0
158342,.,0,1
158343,Comparative,0,0
158344,efficacy,0,0
158345,of,0,0
158346,LEAP,0,0
158347,",",0,0
158348,TEACCH,0,0
158349,and,0,0
158350,non-model-specific,0,0
158351,special,0,0
158352,education,0,0
158353,programs,0,0
158354,for,0,0
158355,preschoolers,1,1
158356,with,1,1
158357,autism,1,1
158358,spectrum,1,1
158359,disorders,1,1
158360,.,1,0
158361,LEAP,0,0
158362,and,0,0
158363,TEACCH,0,0
158364,represent,0,0
158365,two,0,0
158366,comprehensive,0,0
158367,treatment,0,0
158368,models,0,0
158369,(,0,0
158370,CTMs,0,1
158371,),0,0
158372,that,0,0
158373,have,0,0
158374,been,0,0
158375,widely,0,0
158376,used,0,0
158377,across,0,0
158378,several,0,0
158379,decades,0,0
158380,to,0,0
158381,educate,0,0
158382,young,1,1
158383,children,1,1
158384,with,1,1
158385,autism,1,1
158386,spectrum,1,1
158387,disorders,1,1
158388,.,1,0
158389,The,0,0
158390,purpose,0,0
158391,of,0,0
158392,this,0,0
158393,quasi-experimental,0,0
158394,study,0,0
158395,was,0,0
158396,to,0,0
158397,compare,0,0
158398,high,0,0
158399,fidelity,0,0
158400,LEAP,0,0
158401,(,0,0
158402,n,0,1
158403,=,0,0
158404,22,0,1
158405,),0,0
158406,and,0,0
158407,TEACCH,0,0
158408,(,0,0
158409,n,0,1
158410,=,0,0
158411,25,0,0
158412,),0,0
158413,classrooms,0,1
158414,to,0,0
158415,each,0,0
158416,other,0,0
158417,and,0,0
158418,a,0,0
158419,control,0,0
158420,condition,0,0
158421,(,0,0
158422,n,0,1
158423,=,0,0
158424,28,0,1
158425,),0,0
158426,",",0,0
158427,in,0,0
158428,which,0,0
158429,teachers,1,1
158430,in,1,0
158431,high,1,1
158432,quality,1,0
158433,special,1,1
158434,education,1,0
158435,programs,1,0
158436,used,1,0
158437,non-model-specific,0,0
158438,practices,0,0
158439,.,0,0
158440,A,0,0
158441,total,0,0
158442,of,1,0
158443,198,1,1
158444,children,1,1
158445,were,1,0
158446,included,0,1
158447,in,0,0
158448,data,0,0
158449,analysis,0,0
158450,.,0,1
158451,Across,0,0
158452,conditions,1,0
158453,",",1,0
158454,children,1,1
158455,'s,1,1
158456,performances,1,0
158457,improved,0,0
158458,over,0,0
158459,time,0,0
158460,.,0,0
158461,This,0,0
158462,study,0,0
158463,raises,0,0
158464,issues,0,0
158465,of,0,0
158466,the,0,0
158467,replication,0,0
158468,of,0,0
158469,effects,0,0
158470,for,0,0
158471,CTMs,0,0
158472,",",0,0
158473,and,0,0
158474,whether,0,0
158475,having,0,1
158476,access,0,0
158477,to,0,0
158478,a,0,0
158479,high,0,0
158480,quality,0,0
158481,special,0,0
158482,education,0,0
158483,program,0,0
158484,is,0,0
158485,as,0,0
158486,beneficial,0,0
158487,as,0,0
158488,access,0,0
158489,to,0,0
158490,a,0,0
158491,specific,0,0
158492,CTM,0,0
158493,.,0,1
158494,Comparison,0,0
158495,of,0,0
158496,enflurane,0,0
158497,and,0,0
158498,halothane,0,0
158499,in,0,0
158500,hypotensive,1,0
158501,eye,1,0
158502,surgery,1,1
158503,.,1,0
158504,Thirty,1,1
158505,patients,1,1
158506,undergoing,1,1
158507,elective,1,1
158508,eye,1,0
158509,surgery,1,1
158510,had,0,0
158511,anaesthesia,0,0
158512,induced,0,0
158513,with,0,1
158514,sodium,0,0
158515,thiopentone,0,0
158516,",",0,0
158517,suxamethonium,0,0
158518,and,0,0
158519,d-tubocurarine,0,0
158520,chloride,0,0
158521,.,0,1
158522,Patients,0,1
158523,were,0,0
158524,ventilated,0,0
158525,with,0,1
158526,nitrous,0,0
158527,oxide,0,0
158528,",",0,0
158529,oxygen,0,0
158530,and,0,0
158531,either,0,0
158532,halothane,0,0
158533,or,0,0
158534,enflurane,0,0
158535,.,0,0
158536,The,0,0
158537,volatile,0,0
158538,agents,0,0
158539,were,0,0
158540,used,0,0
158541,to,0,0
158542,decrease,0,0
158543,the,0,0
158544,systolic,0,0
158545,blood,0,0
158546,pressure,0,0
158547,to,0,0
158548,80,0,0
158549,mmHg,0,0
158550,.,0,0
158551,The,0,0
158552,volatile,0,0
158553,agent,0,0
158554,concentration,0,0
158555,in,0,0
158556,the,0,0
158557,blood,0,0
158558,was,0,0
158559,measured,0,0
158560,at,0,0
158561,30,0,0
158562,min,0,0
158563,intervals,0,0
158564,.,0,0
158565,Both,0,0
158566,agents,0,0
158567,were,0,0
158568,effective,0,0
158569,in,0,0
158570,producing,0,0
158571,hypotension,0,0
158572,",",0,0
158573,but,0,0
158574,enflurane,0,0
158575,was,0,0
158576,the,0,0
158577,more,0,0
158578,potent,0,0
158579,hypotensive,0,0
158580,agent,0,0
158581,in,0,0
158582,terms,0,0
158583,of,0,0
158584,MAC,0,0
158585,equivalents,0,0
158586,.,0,0
158587,There,0,0
158588,was,0,0
158589,no,0,0
158590,significant,0,0
158591,differences,0,0
158592,between,0,0
158593,the,0,0
158594,agents,0,0
158595,with,0,1
158596,respect,0,0
158597,to,0,0
158598,speed,0,0
158599,of,0,0
158600,recovery,0,0
158601,.,0,0
158602,[,0,0
158603,Treating,0,0
158604,rheumatoid,1,1
158605,arthritis,1,1
158606,patients,1,1
158607,of,1,0
158608,Shen,1,1
158609,deficiency,1,1
158610,and,1,0
158611,cold,1,0
158612,invading,1,0
158613,syndrome,1,1
158614,by,1,0
158615,bushen,0,0
158616,quhan,0,0
158617,zhiwang,0,0
158618,decoction,0,0
158619,combined,0,0
158620,methotrexate,0,0
158621,:,0,0
158622,an,0,0
158623,evaluation,0,0
158624,of,0,0
158625,clinical,0,0
158626,efficacy,0,0
158627,and,0,0
158628,safety,0,0
158629,],0,0
158630,.,0,0
158631,OBJECTIVE,0,0
158632,To,0,0
158633,evaluate,0,0
158634,the,0,0
158635,clinical,0,0
158636,efficacy,0,0
158637,and,0,0
158638,safety,0,0
158639,of,0,0
158640,bushen,0,0
158641,quhan,0,0
158642,zhiwang,0,0
158643,decoction,0,0
158644,(,0,0
158645,BQZD,0,0
158646,),0,0
158647,combined,0,0
158648,methotrexate,0,0
158649,(,0,0
158650,MTX,0,0
158651,),0,0
158652,in,0,0
158653,treating,0,0
158654,rheumatoid,0,1
158655,arthritis,0,1
158656,(,0,0
158657,RA,0,0
158658,),0,0
158659,.,0,0
158660,METHODS,0,0
158661,A,0,0
158662,prospective,0,0
158663,",",0,0
158664,randomized,0,0
158665,controlled,0,0
158666,study,0,0
158667,was,0,0
158668,carried,0,0
158669,out,0,0
158670,.,0,0
158671,RA,1,0
158672,patients,1,1
158673,of,1,0
158674,Shen,1,1
158675,deficiency,1,1
158676,and,1,0
158677,cold,1,0
158678,invading,1,0
158679,syndrome,1,1
158680,in,1,0
158681,the,1,0
158682,treatment,1,0
158683,group,1,0
158684,(,1,0
158685,120,1,1
158686,cases,1,1
158687,),1,0
158688,were,1,0
158689,treated,1,0
158690,with,1,1
158691,BQZD,1,0
158692,and,1,0
158693,MTX,1,0
158694,(,1,0
158695,10,1,0
158696,mg/week,1,0
158697,),1,0
158698,",",0,0
158699,while,0,0
158700,those,0,0
158701,in,0,0
158702,the,0,0
158703,control,1,0
158704,group,1,0
158705,(,1,0
158706,120,1,1
158707,cases,1,1
158708,),1,0
158709,were,1,0
158710,treated,1,0
158711,with,1,1
158712,MTX,1,0
158713,(,1,0
158714,10,1,0
158715,mg/week,1,0
158716,),1,0
158717,alone,1,0
158718,.,1,0
158719,The,0,0
158720,therapeutic,0,0
158721,course,0,0
158722,for,0,0
158723,all,0,0
158724,was,0,0
158725,24,0,0
158726,weeks,0,0
158727,.,0,0
158728,The,0,0
158729,efficacy,0,0
158730,and,0,0
158731,safety,0,0
158732,indices,0,0
158733,were,0,0
158734,evaluated,0,0
158735,at,0,0
158736,the,0,0
158737,baseline,0,0
158738,and,0,0
158739,24,0,0
158740,weeks,0,0
158741,after,0,0
158742,treatment,0,0
158743,",",0,0
158744,including,0,0
158745,clinical,0,0
158746,signs,0,0
158747,and,0,0
158748,symptoms,0,0
158749,",",0,0
158750,condition,0,0
158751,assessment,0,0
158752,",",0,0
158753,Health,0,0
158754,Assessment,0,0
158755,Questionnaire,0,0
158756,(,0,0
158757,HAQ,0,1
158758,),0,0
158759,",",0,0
158760,disease,0,1
158761,activity,0,0
158762,index,0,0
158763,28,0,0
158764,(,0,0
158765,DAS28,0,1
158766,),0,0
158767,",",0,0
158768,laboratory,0,0
158769,parameters,0,0
158770,of,0,0
158771,erythrocyte,0,0
158772,sedimentation,0,0
158773,rate,0,0
158774,(,0,0
158775,ESR,0,0
158776,),0,0
158777,and,0,0
158778,C-reactive,0,0
158779,protein,0,0
158780,(,0,0
158781,CRP,0,0
158782,),0,0
158783,",",0,0
158784,safety,0,0
158785,indicators,0,0
158786,",",0,0
158787,and,0,0
158788,Chinese,0,1
158789,medical,0,1
158790,syndrome,0,1
158791,integrals,0,0
158792,.,0,0
158793,RESULTS,0,0
158794,The,0,0
158795,total,0,0
158796,effective,0,0
158797,rate,0,0
158798,was,0,0
158799,80,0,1
158800,.,0,0
158801,0,0,0
158802,%,0,0
158803,in,0,0
158804,the,0,0
158805,treatment,0,0
158806,group,0,0
158807,",",0,0
158808,better,0,0
158809,than,0,0
158810,that,0,0
158811,of,0,0
158812,the,0,0
158813,control,0,0
158814,group,0,0
158815,(,0,0
158816,66.7,0,0
158817,%,0,0
158818,),0,0
158819,",",0,0
158820,showing,0,0
158821,statistical,0,0
158822,difference,0,0
158823,(,0,0
158824,P,0,0
158825,<,0,0
158826,0.01,0,0
158827,),0,0
158828,.,0,0
158829,In,0,0
158830,the,0,0
158831,two,0,0
158832,groups,0,0
158833,significant,0,0
158834,improvement,0,0
158835,of,0,0
158836,clinical,0,0
158837,signs,0,0
158838,and,0,0
158839,symptoms,0,0
158840,",",0,0
158841,ESR,0,0
158842,",",0,0
158843,CRP,0,0
158844,",",0,0
158845,visual,0,0
158846,analogue,0,0
158847,scale,0,0
158848,(,0,0
158849,VAS,0,0
158850,),0,0
158851,by,0,0
158852,both,0,0
158853,physicians,0,1
158854,and,0,0
158855,patients,0,1
158856,",",0,0
158857,HAQ,0,1
158858,",",0,0
158859,DAS28,0,0
158860,",",0,0
158861,and,0,0
158862,Chinese,0,1
158863,medical,0,1
158864,syndrome,0,1
158865,integrals,0,0
158866,after,0,0
158867,treatment,0,0
158868,were,0,0
158869,shown,0,0
158870,(,0,0
158871,P,0,0
158872,<,0,0
158873,0.01,0,0
158874,),0,0
158875,.,0,0
158876,Better,0,0
158877,effects,0,0
158878,were,0,0
158879,obtained,0,0
158880,in,0,0
158881,the,0,0
158882,treatment,0,0
158883,group,0,0
158884,in,0,0
158885,lessening,0,0
158886,tender,0,0
158887,joint,0,0
158888,numbers,0,0
158889,and,0,0
158890,swollen,0,1
158891,joint,0,0
158892,numbers,0,0
158893,",",0,0
158894,VAS,0,0
158895,by,0,0
158896,both,0,0
158897,physicians,0,1
158898,and,0,0
158899,patients,0,1
158900,",",0,0
158901,DAS28,0,1
158902,",",0,0
158903,and,0,0
158904,Chinese,0,1
158905,medical,0,1
158906,syndrome,0,1
158907,integrals,0,0
158908,(,0,0
158909,P,0,0
158910,<,0,0
158911,0.05,0,0
158912,),0,0
158913,.,0,0
158914,Besides,0,0
158915,",",0,0
158916,adverse,0,0
158917,reactions,0,0
158918,occurred,0,0
158919,less,0,0
158920,in,0,0
158921,the,0,0
158922,treatment,0,0
158923,group,0,0
158924,than,0,0
158925,in,0,0
158926,the,0,0
158927,control,0,0
158928,group,0,0
158929,(,0,0
158930,P,0,0
158931,<,0,0
158932,0.05,0,0
158933,),0,0
158934,.,0,0
158935,CONCLUSIONS,0,0
158936,BQZD,0,0
158937,had,0,0
158938,roles,0,0
158939,in,0,0
158940,relieving,0,0
158941,symptoms,0,0
158942,",",0,0
158943,improving,0,0
158944,joint,0,0
158945,functions,0,0
158946,",",0,0
158947,signs,0,0
158948,",",0,0
158949,ESR,0,0
158950,",",0,0
158951,and,0,0
158952,CRP,0,0
158953,.,0,0
158954,It,0,0
158955,was,0,0
158956,an,0,0
158957,effective,0,0
158958,herb,0,0
158959,for,0,0
158960,RA,1,0
158961,patients,1,1
158962,of,1,0
158963,Shen,1,1
158964,deficiency,1,1
158965,and,1,0
158966,cold,1,0
158967,invading,1,1
158968,syndrome,1,1
158969,.,1,0
158970,It,0,0
158971,could,0,0
158972,enhance,0,0
158973,the,0,0
158974,efficacy,0,0
158975,and,0,0
158976,reduce,0,0
158977,adverse,0,0
158978,reactions,0,0
158979,of,0,0
158980,MTX,0,0
158981,through,0,0
158982,synergistic,0,0
158983,effects,0,0
158984,with,0,1
158985,MTX,0,0
158986,.,0,1
158987,Assessment,0,0
158988,of,0,0
158989,global,0,0
158990,functioning,0,0
158991,in,0,0
158992,adolescents,1,1
158993,with,1,1
158994,autism,1,1
158995,spectrum,1,1
158996,disorders,1,1
158997,:,1,1
158998,utility,0,0
158999,of,0,0
159000,the,0,0
159001,Developmental,0,1
159002,Disability-Child,0,0
159003,Global,0,1
159004,Assessment,0,0
159005,Scale,0,0
159006,.,0,0
159007,Assessment,0,0
159008,of,0,0
159009,global,0,0
159010,functioning,0,0
159011,is,0,0
159012,an,0,0
159013,important,0,0
159014,consideration,0,0
159015,in,0,0
159016,treatment,0,0
159017,outcome,0,0
159018,research,0,0
159019,;,0,0
159020,yet,0,0
159021,",",0,0
159022,there,0,0
159023,is,0,0
159024,little,0,0
159025,guidance,0,0
159026,on,0,0
159027,its,0,0
159028,evidence-based,0,0
159029,assessment,0,0
159030,for,0,0
159031,children,1,1
159032,with,1,1
159033,autism,1,1
159034,spectrum,1,1
159035,disorders,1,1
159036,.,1,0
159037,This,0,0
159038,study,0,0
159039,investigated,0,0
159040,the,0,0
159041,utility,0,0
159042,and,0,0
159043,validity,0,0
159044,of,0,0
159045,clinician-rated,0,0
159046,global,0,0
159047,functioning,0,0
159048,using,0,0
159049,the,0,0
159050,Developmental,0,1
159051,Disability-Child,0,0
159052,Global,0,1
159053,Assessment,0,0
159054,Scale,0,0
159055,in,0,0
159056,a,0,0
159057,sample,1,1
159058,of,1,0
159059,higher,1,0
159060,functioning,1,0
159061,adolescents,1,1
159062,with,1,1
159063,autism,1,1
159064,spectrum,1,1
159065,disorders,1,1
159066,and,1,0
159067,comorbid,1,1
159068,anxiety,1,0
159069,disorders,1,1
159070,enrolled,1,1
159071,in,1,0
159072,a,1,0
159073,randomized,1,0
159074,controlled,1,0
159075,trial,1,0
159076,(,1,0
159077,n,1,1
159078,=,1,0
159079,30,1,1
159080,),1,0
159081,.,1,0
159082,Pretreatment,0,0
159083,Developmental,0,1
159084,Disability-Child,0,0
159085,Global,0,1
159086,Assessment,0,0
159087,Scale,0,0
159088,scores,0,0
159089,correlated,0,0
159090,with,0,1
159091,severity,0,0
159092,of,0,0
159093,autism,0,1
159094,spectrum,0,1
159095,disorders,0,1
159096,core,0,1
159097,symptoms,0,0
159098,(,0,0
159099,r,0,0
159100,=,0,0
159101,-.388,0,0
159102,",",0,0
159103,p,0,0
159104,=,0,0
159105,.034,0,0
159106,),0,0
159107,",",0,0
159108,pragmatic,0,0
159109,communication,0,0
159110,(,0,0
159111,r,0,0
159112,=,0,0
159113,.407,0,0
159114,",",0,0
159115,p,0,0
159116,=,0,0
159117,.032,0,0
159118,),0,0
159119,",",0,0
159120,and,0,0
159121,verbal,0,0
159122,ability,0,0
159123,(,0,0
159124,r,0,0
159125,=,0,0
159126,.449,0,0
159127,",",0,0
159128,p,0,0
159129,=,0,0
159130,.013,0,0
159131,),0,0
159132,and,0,0
159133,did,0,0
159134,not,0,0
159135,correlate,0,0
159136,with,0,0
159137,severity,0,0
159138,of,0,0
159139,anxiety,0,0
159140,symptoms,0,0
159141,or,0,0
159142,with,0,1
159143,parent-reported,0,0
159144,adaptive,0,0
159145,behavior,0,0
159146,.,0,0
159147,Change,0,0
159148,in,0,0
159149,Developmental,0,1
159150,Disability-Child,0,0
159151,Global,0,1
159152,Assessment,0,0
159153,Scale,0,0
159154,scores,0,0
159155,during,0,0
159156,treatment,0,0
159157,was,0,0
159158,associated,0,0
159159,with,0,0
159160,autism,0,1
159161,spectrum,0,1
159162,disorders,0,1
159163,symptomatic,0,1
159164,improvement,0,0
159165,(,0,0
159166,r,0,0
159167,=,0,0
159168,.414,0,0
159169,",",0,0
159170,p,0,0
159171,=,0,0
159172,.040,0,0
159173,),0,0
159174,and,0,0
159175,with,0,1
159176,improved,0,0
159177,general,0,1
159178,communication,0,0
159179,(,0,0
159180,r,0,0
159181,=,0,0
159182,.499,0,0
159183,",",0,0
159184,p,0,0
159185,=,0,0
159186,.013,0,0
159187,),0,0
159188,.,0,0
159189,Results,0,0
159190,support,0,0
159191,the,0,0
159192,importance,0,0
159193,of,0,0
159194,assessing,0,0
159195,global,0,0
159196,functioning,0,0
159197,in,0,0
159198,addition,0,0
159199,to,0,0
159200,symptom,0,0
159201,change,0,0
159202,and,0,0
159203,treatment,0,0
159204,response,0,0
159205,in,0,0
159206,clinical,0,0
159207,trials,0,0
159208,.,0,1
159209,Aftermath,0,0
159210,of,0,0
159211,a,0,0
159212,clinical,0,0
159213,trial,0,0
159214,:,0,1
159215,evaluating,0,0
159216,the,0,0
159217,sustainability,0,0
159218,of,0,0
159219,a,0,0
159220,medical,0,0
159221,device,0,0
159222,intervention,0,0
159223,in,1,0
159224,Ghana,1,1
159225,.,1,1
159226,A,0,0
159227,randomized,0,0
159228,controlled,0,0
159229,trial,0,0
159230,recently,0,0
159231,demonstrated,0,0
159232,that,0,0
159233,continuous,0,0
159234,positive,0,0
159235,airway,0,0
159236,pressure,0,0
159237,(,1,0
159238,CPAP,1,0
159239,),1,0
159240,effectively,1,0
159241,decreases,1,0
159242,respiratory,1,0
159243,rate,1,0
159244,in,1,0
159245,children,1,1
159246,presenting,1,1
159247,to,1,0
159248,Ghanaian,1,1
159249,district,1,1
159250,hospitals,1,1
159251,with,1,1
159252,respiratory,1,0
159253,distress,1,1
159254,.,1,0
159255,A,0,0
159256,follow-up,0,0
159257,study,0,0
159258,16,0,1
159259,months,0,0
159260,later,0,0
159261,evaluated,0,0
159262,the,0,0
159263,extent,0,0
159264,to,0,0
159265,which,0,0
159266,the,0,0
159267,skills,0,0
159268,and,0,0
159269,equipment,0,0
159270,necessary,0,0
159271,for,0,0
159272,CPAP,0,0
159273,use,0,0
159274,have,0,0
159275,been,0,0
159276,maintained,0,0
159277,.,0,0
159278,Seven,0,0
159279,of,0,0
159280,eight,0,1
159281,CPAP,0,1
159282,machines,0,0
159283,were,0,0
159284,functional,0,0
159285,",",0,0
159286,but,0,0
159287,five,0,0
159288,of,0,0
159289,eight,0,1
159290,oxygen,0,0
159291,concentrators,0,0
159292,and,0,0
159293,three,0,0
159294,of,0,0
159295,four,0,1
159296,electric,0,0
159297,generators,0,0
159298,were,0,1
159299,non-functional,0,0
159300,.,0,1
159301,Nurses,1,0
159302,trained,1,0
159303,by,1,0
159304,US,1,0
159305,study,1,0
159306,personnel,1,1
159307,(,1,0
159308,first-generation,1,1
159309,),1,0
159310,and,1,0
159311,nurses,1,1
159312,trained,1,1
159313,by,1,0
159314,Ghanaian,1,1
159315,nurses,1,1
159316,after,1,0
159317,the,1,0
159318,study,1,0
159319,(,1,0
159320,second-generation,1,0
159321,),1,0
159322,were,1,0
159323,evaluated,1,0
159324,on,1,0
159325,CPAP,1,0
159326,knowledge,1,0
159327,and,1,0
159328,skills,1,0
159329,.,1,1
159330,Twenty-eight,1,1
159331,nurses,1,1
159332,participated,1,1
159333,in,1,0
159334,the,1,0
159335,study,1,0
159336,",",1,0
159337,9,1,0
159338,first-generation,1,0
159339,and,1,0
159340,19,1,1
159341,second-generation,1,0
159342,.,1,0
159343,First-generation,0,0
159344,trainees,0,0
159345,scored,0,0
159346,significantly,0,0
159347,higher,0,0
159348,than,0,0
159349,second-generation,0,0
159350,trainees,0,0
159351,on,0,0
159352,both,0,0
159353,skills,0,0
159354,and,0,0
159355,knowledge,0,0
159356,assessments,0,0
159357,(,0,0
159358,p,0,0
159359,=,0,0
159360,0.003,0,0
159361,),0,0
159362,.,0,0
159363,Appropriate,0,0
159364,technical,0,0
159365,support,0,0
159366,and,0,0
159367,training,0,0
159368,must,0,0
159369,be,0,0
159370,ensured,0,0
159371,to,0,0
159372,address,0,0
159373,equipment,0,0
159374,maintenance,0,0
159375,.,0,0
159376,Protocolization,0,0
159377,of,0,0
159378,the,0,0
159379,training,0,0
159380,program,0,0
159381,",",0,0
159382,in,0,0
159383,conjunction,0,0
159384,with,0,1
159385,skills,0,0
159386,and,0,0
159387,knowledge,0,0
159388,assessment,0,0
159389,",",0,0
159390,may,0,0
159391,improve,0,0
159392,acquisition,0,0
159393,and,0,0
159394,retention,0,0
159395,among,0,0
159396,second-,0,1
159397,and,0,0
159398,future-generation,0,0
159399,trainees,0,1
159400,.,0,1
159401,A,0,0
159402,comparison,0,0
159403,of,0,0
159404,Villalta-Prandoni,0,0
159405,scale,0,0
159406,and,0,0
159407,venous,0,0
159408,clinical,0,0
159409,severity,0,0
159410,score,0,0
159411,in,0,0
159412,the,0,0
159413,assessment,0,0
159414,of,0,0
159415,post,1,0
159416,thrombotic,1,0
159417,syndrome,1,1
159418,.,1,0
159419,BACKGROUND,0,0
159420,Post-thrombotic,0,0
159421,syndrome,0,1
159422,(,0,0
159423,PTS,0,0
159424,),0,0
159425,is,0,0
159426,the,0,0
159427,most,0,0
159428,important,0,0
159429,late,0,0
159430,complication,0,0
159431,of,0,0
159432,acute,1,1
159433,deep,1,1
159434,venous,1,0
159435,thrombosis,1,1
159436,(,1,0
159437,DVT,1,0
159438,),1,0
159439,",",0,0
159440,with,0,0
159441,as,0,0
159442,many,0,0
159443,as,0,0
159444,two-thirds,0,1
159445,of,0,0
159446,patients,0,1
159447,developing,0,1
159448,symptoms,0,0
159449,of,0,0
159450,pain,0,0
159451,",",0,0
159452,edema,0,0
159453,",",0,0
159454,hyperpigmentation,0,0
159455,",",0,0
159456,or,0,0
159457,ulceration,0,0
159458,.,0,0
159459,Although,0,0
159460,several,0,0
159461,instruments,0,0
159462,are,0,0
159463,available,0,0
159464,for,0,0
159465,evaluation,0,0
159466,of,0,0
159467,the,0,0
159468,severity,0,0
159469,of,0,0
159470,PTS,0,0
159471,",",0,0
159472,including,0,0
159473,the,0,0
159474,Villalta-Prandoni,0,0
159475,scale,0,0
159476,(,0,0
159477,VPS,0,0
159478,),0,0
159479,and,0,0
159480,Venous,0,0
159481,Clinical,0,0
159482,Severity,0,0
159483,Score,0,0
159484,(,0,0
159485,VCSS,0,0
159486,),0,0
159487,",",0,0
159488,no,0,0
159489,studies,0,0
159490,have,0,0
159491,yet,0,0
159492,compared,0,0
159493,the,0,0
159494,2,0,0
159495,instruments,0,0
159496,.,0,0
159497,The,0,0
159498,purpose,0,0
159499,of,0,0
159500,this,0,0
159501,study,0,0
159502,is,0,0
159503,to,0,0
159504,compare,0,0
159505,the,0,0
159506,2,0,0
159507,instruments,0,0
159508,as,0,0
159509,part,0,0
159510,of,0,0
159511,a,0,0
159512,larger,0,0
159513,randomized,0,0
159514,controlled,0,0
159515,study,0,0
159516,that,0,0
159517,assessed,0,0
159518,the,0,0
159519,impact,0,0
159520,of,0,0
159521,graduated,0,1
159522,compressive,0,0
159523,stockings,0,0
159524,in,0,0
159525,the,0,0
159526,prevention,0,0
159527,of,0,0
159528,PTS,0,0
159529,.,0,0
159530,METHODS,0,0
159531,Sixty-nine,1,1
159532,consecutive,1,1
159533,patients,1,1
159534,with,1,1
159535,acute,1,1
159536,DVT,1,0
159537,documented,1,0
159538,by,1,0
159539,duplex,1,0
159540,ultrasonography,1,0
159541,were,0,0
159542,randomized,0,0
159543,to,0,0
159544,treatment,0,0
159545,with,0,1
159546,30-40,0,0
159547,mm,0,0
159548,Hg,0,0
159549,graduated,0,1
159550,compressive,0,0
159551,stockings,0,0
159552,(,0,0
159553,GCS,0,0
159554,),0,0
159555,or,0,0
159556,no,0,0
159557,stockings,0,0
159558,.,0,0
159559,Patients,1,1
159560,were,1,0
159561,followed,1,0
159562,clinically,1,0
159563,at,1,0
159564,months,1,0
159565,1,1,0
159566,",",1,0
159567,3,1,0
159568,",",1,0
159569,6,1,0
159570,",",1,0
159571,12,1,0
159572,",",1,0
159573,18,1,0
159574,",",1,0
159575,and,1,0
159576,24,1,0
159577,after,1,0
159578,the,1,0
159579,diagnosis,1,1
159580,of,1,0
159581,DVT,1,0
159582,.,1,0
159583,PTS,0,0
159584,as,0,0
159585,defined,0,0
159586,by,0,0
159587,the,0,0
159588,VPS,0,0
159589,and,0,0
159590,VCSS,0,0
159591,were,0,0
159592,assessed,0,0
159593,at,0,0
159594,these,0,0
159595,follow-up,0,0
159596,visits,0,0
159597,.,0,0
159598,Based,0,0
159599,upon,0,0
159600,the,0,0
159601,VPS,0,0
159602,",",0,0
159603,PTS,0,0
159604,was,0,0
159605,scored,0,0
159606,as,0,0
159607,absent,0,0
159608,(,0,0
159609,score,0,0
159610,<,0,0
159611,3,0,0
159612,or,0,0
159613,3,0,0
159614,without,0,1
159615,objective,0,0
159616,criteria,0,1
159617,),0,0
159618,",",0,0
159619,mild,0,0
159620,to,0,0
159621,moderate,0,1
159622,(,0,0
159623,score,0,0
159624,?3,0,0
159625,with,0,1
159626,1,0,0
159627,objective,0,0
159628,criteria,0,1
159629,),0,0
159630,",",0,0
159631,or,0,0
159632,severe,0,1
159633,(,0,0
159634,score,0,0
159635,?4,0,0
159636,),0,0
159637,.,0,0
159638,For,0,0
159639,the,0,0
159640,VCSS,0,0
159641,",",0,0
159642,PTS,0,0
159643,was,0,0
159644,considered,0,0
159645,to,0,0
159646,be,0,0
159647,absent,0,0
159648,(,0,0
159649,score,0,0
159650,?3,0,0
159651,),0,0
159652,",",0,0
159653,mild,0,0
159654,to,0,0
159655,moderate,0,1
159656,(,0,0
159657,score,0,0
159658,4-7,0,0
159659,),0,0
159660,",",0,0
159661,or,0,0
159662,severe,0,1
159663,(,0,0
159664,score,0,0
159665,?8,0,0
159666,),0,0
159667,.,0,0
159668,The,0,0
159669,2,0,0
159670,instruments,0,0
159671,were,0,0
159672,compared,0,0
159673,for,0,0
159674,mild,0,1
159675,to,0,0
159676,moderate,0,1
159677,and,0,0
159678,severe,0,1
159679,disease,0,1
159680,using,0,0
159681,the,0,0
159682,Pearson,0,0
159683,chi-squared,0,0
159684,test,0,0
159685,and,0,0
159686,gamma,0,0
159687,statistic,0,0
159688,.,0,0
159689,RESULTS,0,0
159690,Good,0,0
159691,correlation,0,0
159692,was,0,0
159693,detected,0,0
159694,in,0,0
159695,the,0,0
159696,ability,0,0
159697,of,0,0
159698,VPS,0,0
159699,and,0,0
159700,VCSS,0,0
159701,instruments,0,0
159702,to,0,0
159703,detect,0,0
159704,mild,0,0
159705,to,0,0
159706,moderate,0,1
159707,disease,0,1
159708,(,0,0
159709,gamma,0,0
159710,statistic,0,0
159711,=,0,0
159712,0.71-0.98,0,0
159713,;,0,0
159714,P,0,0
159715,<,0,0
159716,0.05,0,0
159717,),0,0
159718,.,0,0
159719,For,0,0
159720,severe,0,1
159721,disease,0,1
159722,",",0,0
159723,a,0,0
159724,statistically,0,0
159725,significant,0,0
159726,correlation,0,0
159727,was,0,0
159728,not,0,0
159729,found,0,0
159730,in,0,0
159731,the,0,0
159732,ability,0,0
159733,of,0,0
159734,the,0,0
159735,2,0,0
159736,instruments,0,0
159737,to,0,0
159738,detect,0,0
159739,disease,0,1
159740,(,0,0
159741,gamma,0,0
159742,statistic,0,0
159743,=,0,0
159744,0.5-0.98,0,0
159745,;,0,0
159746,P,0,0
159747,>,0,1
159748,0.05,0,0
159749,),0,0
159750,",",0,0
159751,especially,0,0
159752,at,0,0
159753,12,0,0
159754,and,0,0
159755,24,0,0
159756,months,0,0
159757,.,0,1
159758,CONCLUSION,0,0
159759,Both,0,0
159760,VPS,0,0
159761,and,0,0
159762,the,0,0
159763,VCSS,0,0
159764,scoring,0,0
159765,systems,0,0
159766,are,0,0
159767,important,0,0
159768,tools,0,0
159769,in,0,0
159770,the,0,0
159771,identification,0,0
159772,and,0,0
159773,follow-up,0,0
159774,of,0,0
159775,PTS,0,0
159776,.,0,0
159777,There,0,0
159778,exists,0,0
159779,agreement,0,0
159780,between,0,0
159781,the,0,0
159782,2,0,0
159783,instruments,0,0
159784,for,0,0
159785,detecting,0,0
159786,mild,0,1
159787,to,0,0
159788,moderate,0,1
159789,disease,0,1
159790,.,0,0
159791,For,0,0
159792,severe,0,1
159793,disease,0,1
159794,however,0,0
159795,",",0,0
159796,VCSS,0,0
159797,may,0,0
159798,possibly,0,0
159799,be,0,0
159800,a,0,0
159801,more,0,0
159802,sensitive,0,0
159803,instrument,0,0
159804,.,0,0
159805,Incremental,0,0
159806,cost-effectiveness,0,0
159807,of,0,0
159808,pharmacotherapy,0,1
159809,and,0,0
159810,two,0,0
159811,brief,0,0
159812,cognitive-behavioral,0,1
159813,therapies,0,0
159814,compared,0,0
159815,with,0,1
159816,usual,0,0
159817,care,0,0
159818,for,0,0
159819,panic,1,1
159820,disorder,1,1
159821,and,1,0
159822,noncardiac,1,1
159823,chest,1,0
159824,pain,1,0
159825,.,1,0
159826,The,0,0
159827,aim,0,0
159828,of,0,0
159829,this,0,0
159830,study,0,0
159831,was,0,0
159832,to,0,0
159833,assess,0,0
159834,the,0,0
159835,incremental,0,0
159836,cost-effectiveness,0,0
159837,ratios,0,0
159838,(,0,0
159839,ICERs,0,1
159840,),0,0
159841,of,0,0
159842,two,0,0
159843,brief,0,0
159844,cognitive-behavioral,0,1
159845,therapy,0,0
159846,(,0,0
159847,CBT,0,0
159848,),0,0
159849,-based,0,0
159850,interventions,0,0
159851,and,0,0
159852,a,0,0
159853,pharmacological,0,0
159854,treatment,0,0
159855,",",0,0
159856,compared,0,0
159857,with,0,0
159858,usual,0,0
159859,care,0,0
159860,",",0,0
159861,initiated,0,0
159862,in,0,0
159863,the,0,0
159864,emergency,0,1
159865,department,0,1
159866,(,0,0
159867,ED,0,0
159868,),0,0
159869,for,0,0
159870,individuals,1,1
159871,with,1,1
159872,panic,1,1
159873,disorder,1,1
159874,(,1,0
159875,PD,1,0
159876,),1,0
159877,with,1,0
159878,a,1,0
159879,chief,1,0
159880,complaint,1,0
159881,of,1,0
159882,noncardiac,1,1
159883,chest,1,0
159884,pain,1,0
159885,.,1,0
159886,A,0,0
159887,total,0,0
159888,of,0,0
159889,69,1,1
159890,patients,1,1
159891,were,0,0
159892,followed,0,0
159893,up,0,0
159894,to,0,0
159895,6,0,0
159896,months,0,0
159897,.,0,0
159898,The,0,0
159899,primary,0,0
159900,outcome,0,0
159901,variables,0,0
159902,were,0,0
159903,direct,0,0
159904,and,0,0
159905,indirect,0,0
159906,costs,0,0
159907,of,0,0
159908,treatment,0,0
159909,and,0,0
159910,PD,0,0
159911,severity,0,0
159912,.,0,0
159913,Panic,0,0
159914,management,0,0
159915,(,0,0
159916,PM,0,0
159917,),0,0
159918,had,0,0
159919,an,0,0
159920,ICER,0,0
159921,of,0,0
159922,$,0,0
159923,124.05,0,0
159924,",",0,0
159925,per,0,0
159926,the,0,0
159927,Anxiety,0,0
159928,Disorders,0,1
159929,Interview,0,1
159930,Schedule,0,0
159931,for,0,0
159932,Diagnostic,0,0
159933,and,0,0
159934,Statistical,0,0
159935,Manual,0,0
159936,of,0,0
159937,Mental,0,0
159938,Disorders,0,1
159939,",",0,0
159940,Fourth,0,0
159941,Edition,0,0
159942,",",0,0
159943,severity,0,0
159944,score,0,0
159945,change,0,0
159946,(,0,0
159947,95,0,0
159948,%,0,0
159949,confidence,0,0
159950,interval,0,0
159951,[,0,0
159952,CI,0,0
159953,],0,0
159954,",",0,0
159955,$,0,0
159956,54.63-,0,0
159957,$,0,0
159958,314.57,0,0
159959,),0,0
159960,",",0,0
159961,compared,0,0
159962,with,0,0
159963,pharmacotherapy,0,1
159964,(,0,0
159965,paroxetine,0,0
159966,),0,0
159967,",",0,0
159968,with,0,0
159969,an,0,0
159970,ICER,0,0
159971,of,0,0
159972,$,0,0
159973,213.90,0,0
159974,(,0,0
159975,95,0,0
159976,%,0,0
159977,CI,0,0
159978,",",0,0
159979,$,0,0
159980,133.51-,0,0
159981,$,0,0
159982,394.94,0,0
159983,),0,0
159984,",",0,0
159985,and,0,0
159986,brief,0,0
159987,CBT,0,0
159988,",",0,0
159989,with,0,0
159990,an,0,0
159991,ICER,0,0
159992,of,0,0
159993,$,0,0
159994,309.31,0,0
159995,(,0,0
159996,95,0,0
159997,%,0,0
159998,CI,0,0
159999,",",0,0
160000,$,0,0
160001,151.27-,0,0
160002,$,0,0
160003,548.28,0,0
160004,),0,0
160005,.,0,0
160006,The,0,0
160007,pharmacological,0,0
160008,and,0,0
160009,CBT,0,0
160010,interventions,0,0
160011,were,0,0
160012,associated,0,0
160013,with,0,0
160014,a,0,0
160015,greater,0,0
160016,clinical,0,0
160017,improvement,0,0
160018,compared,0,0
160019,with,0,0
160020,usual,0,0
160021,care,0,0
160022,at,0,0
160023,posttest,0,0
160024,.,0,0
160025,PM,0,0
160026,presented,0,0
160027,a,0,0
160028,superior,0,0
160029,ICER,0,0
160030,",",0,0
160031,suggesting,0,0
160032,that,0,0
160033,it,0,0
160034,may,0,0
160035,be,0,0
160036,a,0,0
160037,promising,0,0
160038,treatment,0,0
160039,option,0,0
160040,to,0,0
160041,implement,0,0
160042,in,0,0
160043,EDs,0,0
160044,.,0,1
160045,A,0,0
160046,randomized,0,0
160047,controlled,0,0
160048,trial,0,0
160049,to,0,0
160050,improve,0,0
160051,colon,0,1
160052,cancer,0,1
160053,screening,0,0
160054,in,0,0
160055,rural,1,1
160056,family,1,1
160057,medicine,1,1
160058,:,1,1
160059,an,0,0
160060,Iowa,0,1
160061,Research,0,0
160062,Network,0,0
160063,(,0,0
160064,IRENE,0,0
160065,),0,0
160066,study,0,0
160067,.,0,0
160068,BACKGROUND,0,0
160069,Many,0,0
160070,adults,0,1
160071,have,0,0
160072,not,0,0
160073,been,0,0
160074,screened,0,1
160075,for,0,0
160076,colon,0,1
160077,cancer,0,1
160078,",",0,0
160079,a,0,0
160080,potentially,0,0
160081,preventable,0,0
160082,cause,0,0
160083,of,0,0
160084,death,0,0
160085,.,0,0
160086,METHODS,0,0
160087,This,0,0
160088,was,0,0
160089,a,0,0
160090,randomized,0,0
160091,controlled,0,0
160092,trial,0,0
160093,conducted,0,0
160094,between,0,0
160095,December,1,1
160096,2008,1,1
160097,and,1,0
160098,April,1,1
160099,2011,1,1
160100,to,1,0
160101,improve,1,0
160102,CRC,1,0
160103,screening,1,0
160104,in,1,0
160105,16,1,1
160106,rural,1,1
160107,family,1,1
160108,physician,1,1
160109,offices,1,1
160110,.,1,1
160111,Subjects,1,1
160112,due,1,0
160113,for,1,0
160114,CRC,1,0
160115,screening,1,1
160116,were,0,0
160117,randomized,0,0
160118,within,0,0
160119,each,0,0
160120,practice,0,0
160121,to,0,0
160122,1,0,0
160123,of,0,0
160124,4,0,0
160125,groups,0,0
160126,:,0,1
160127,(,0,0
160128,1,0,0
160129,),0,0
160130,usual,0,1
160131,care,0,0
160132,;,0,0
160133,(,0,0
160134,2,0,0
160135,),0,0
160136,physician,0,0
160137,chart,0,0
160138,reminder,0,0
160139,;,0,0
160140,(,0,0
160141,3,0,0
160142,),0,0
160143,physician,0,0
160144,chart,0,0
160145,reminder,0,0
160146,",",0,0
160147,mailed,0,1
160148,education,0,0
160149,",",0,0
160150,CRC,0,0
160151,reminder,0,0
160152,magnet,0,0
160153,",",0,0
160154,and,0,0
160155,fecal,0,0
160156,immunochemical,0,0
160157,test,0,0
160158,(,0,0
160159,FIT,0,0
160160,),0,0
160161,(,0,0
160162,mailed,0,1
160163,education/FIT,0,1
160164,),0,0
160165,;,0,0
160166,or,0,0
160167,(,0,0
160168,4,0,0
160169,),0,0
160170,all,0,0
160171,the,0,0
160172,preceding,0,0
160173,plus,0,0
160174,a,0,0
160175,structured,0,0
160176,telephone,0,0
160177,call,0,0
160178,to,0,0
160179,the,0,0
160180,patient,0,0
160181,from,0,0
160182,project,0,1
160183,staff,0,0
160184,to,0,0
160185,provide,0,0
160186,education,0,0
160187,",",0,0
160188,assess,0,0
160189,interest,0,0
160190,in,0,0
160191,screening,0,0
160192,",",0,0
160193,explain,0,0
160194,the,0,0
160195,screening,0,0
160196,tests,0,0
160197,",",0,0
160198,and,0,0
160199,address,0,0
160200,barriers,0,0
160201,(,0,0
160202,mailed,0,1
160203,education/FIT,0,0
160204,plus,0,0
160205,phone,0,0
160206,call,0,0
160207,),0,0
160208,.,0,0
160209,The,0,0
160210,main,0,0
160211,outcome,0,0
160212,was,0,0
160213,completion,0,0
160214,of,0,0
160215,any,0,0
160216,CRC,0,0
160217,screening,0,0
160218,.,0,0
160219,RESULTS,0,0
160220,This,1,0
160221,study,1,0
160222,enrolled,1,1
160223,743,1,1
160224,patients,1,1
160225,.,1,1
160226,CRC,0,0
160227,screening,0,0
160228,was,0,0
160229,completed,0,1
160230,by,0,0
160231,17.8,0,0
160232,%,0,0
160233,in,0,0
160234,the,0,0
160235,usual,0,0
160236,care,0,0
160237,group,0,0
160238,",",0,0
160239,20.5,0,0
160240,%,0,0
160241,in,0,0
160242,the,0,0
160243,chart,0,0
160244,reminder,0,0
160245,group,0,0
160246,",",0,0
160247,56.5,0,0
160248,%,0,0
160249,in,0,0
160250,the,0,0
160251,mailed,0,1
160252,education/FIT,0,0
160253,group,0,0
160254,",",0,0
160255,and,0,0
160256,57.2,0,0
160257,%,0,0
160258,in,0,0
160259,the,0,0
160260,mailed,0,1
160261,education/FIT,0,0
160262,plus,0,0
160263,phone,0,0
160264,call,0,0
160265,group,0,0
160266,.,0,0
160267,We,0,0
160268,found,0,0
160269,no,0,0
160270,effect,0,0
160271,from,0,0
160272,the,0,0
160273,chart,0,0
160274,reminder,0,0
160275,compared,0,0
160276,with,0,0
160277,usual,0,0
160278,care,0,1
160279,(,0,0
160280,odds,0,0
160281,ratio,0,0
160282,[,0,0
160283,OR,0,0
160284,],0,0
160285,",",0,0
160286,1.2,0,0
160287,;,0,0
160288,95,0,0
160289,%,0,0
160290,confidence,0,0
160291,interval,0,0
160292,[,0,0
160293,CI,0,0
160294,],0,0
160295,",",0,0
160296,0.7-2.0,0,0
160297,),0,0
160298,;,0,0
160299,and,0,0
160300,a,0,0
160301,beneficial,0,0
160302,effect,0,0
160303,from,0,0
160304,the,0,0
160305,mailed,0,1
160306,education/FIT,0,0
160307,(,0,0
160308,OR,0,0
160309,",",0,0
160310,6.0,0,0
160311,;,0,0
160312,95,0,0
160313,%,0,0
160314,CI,0,0
160315,",",0,0
160316,3.7-9.6,0,0
160317,),0,0
160318,and,0,0
160319,the,0,0
160320,mailed,0,0
160321,education/FIT,0,0
160322,plus,0,0
160323,phone,0,0
160324,call,0,0
160325,(,0,0
160326,OR,0,0
160327,",",0,0
160328,6.2,0,0
160329,;,0,0
160330,95,0,0
160331,%,0,0
160332,CI,0,0
160333,",",0,0
160334,3.8-9.9,0,0
160335,),0,0
160336,.,0,0
160337,Both,0,0
160338,FIT,0,0
160339,and,0,0
160340,colonoscopy,0,1
160341,rates,0,0
160342,increased,0,0
160343,significantly,0,0
160344,in,0,0
160345,both,0,0
160346,mailed,0,1
160347,education,0,0
160348,groups,0,0
160349,.,0,1
160350,CONCLUSION,0,0
160351,CRC,0,0
160352,screening,0,1
160353,rates,0,0
160354,increased,0,0
160355,significantly,0,0
160356,among,0,1
160357,patients,0,1
160358,who,0,1
160359,were,0,1
160360,overdue,0,1
160361,for,0,0
160362,screening,0,1
160363,after,0,0
160364,they,0,0
160365,received,0,0
160366,mailed,0,1
160367,educational,0,0
160368,materials,0,1
160369,and,0,0
160370,a,0,0
160371,FIT,0,0
160372,.,0,0
160373,The,0,0
160374,addition,0,0
160375,of,0,0
160376,a,0,0
160377,phone,0,0
160378,call,0,0
160379,did,0,0
160380,not,0,0
160381,further,0,0
160382,increase,0,0
160383,screening,0,1
160384,rates,0,0
160385,.,0,1
160386,A,0,0
160387,randomized,0,0
160388,controlled,0,0
160389,trial,0,0
160390,of,0,0
160391,group,0,0
160392,Stepping,0,0
160393,Stones,0,0
160394,Triple,0,0
160395,P,0,0
160396,:,0,1
160397,a,0,0
160398,mixed-disability,1,0
160399,trial,0,0
160400,.,0,0
160401,Stepping,0,0
160402,Stones,0,0
160403,Triple,0,0
160404,P,0,0
160405,(,0,0
160406,SSTP,0,0
160407,),0,0
160408,is,0,0
160409,a,0,0
160410,parenting,0,0
160411,program,0,0
160412,designed,0,0
160413,for,0,0
160414,families,1,1
160415,of,1,0
160416,a,1,0
160417,child,1,0
160418,with,1,0
160419,a,1,0
160420,disability,1,0
160421,.,1,0
160422,The,0,0
160423,current,0,0
160424,study,0,0
160425,involved,0,0
160426,a,0,0
160427,randomized,0,0
160428,controlled,0,0
160429,trial,0,0
160430,of,0,0
160431,Group,0,1
160432,Stepping,0,0
160433,Stones,0,0
160434,Triple,0,0
160435,P,0,0
160436,(,0,0
160437,GSSTP,0,0
160438,),0,0
160439,for,0,0
160440,a,0,0
160441,mixed-disability,1,0
160442,group,1,0
160443,.,1,0
160444,Participants,1,1
160445,were,1,0
160446,52,1,1
160447,families,1,1
160448,of,1,0
160449,children,1,1
160450,diagnosed,1,1
160451,with,1,1
160452,an,1,0
160453,Autism,1,1
160454,Spectrum,1,1
160455,Disorder,1,0
160456,",",1,0
160457,Down,1,0
160458,syndrome,1,1
160459,",",1,0
160460,Cerebral,1,1
160461,Palsy,1,0
160462,",",1,0
160463,or,1,0
160464,an,1,0
160465,intellectual,1,1
160466,disability,1,0
160467,.,1,0
160468,The,0,0
160469,results,0,0
160470,demonstrated,0,0
160471,significant,0,0
160472,improvements,0,0
160473,in,0,0
160474,parent-reported,0,0
160475,child,0,1
160476,behavior,0,0
160477,",",0,0
160478,parenting,0,0
160479,styles,0,0
160480,",",0,0
160481,parental,0,0
160482,satisfaction,0,0
160483,",",0,0
160484,and,0,0
160485,conflict,0,0
160486,about,0,0
160487,parenting,0,0
160488,.,0,0
160489,Results,0,0
160490,among,0,0
160491,participants,0,1
160492,were,0,0
160493,similar,0,0
160494,despite,0,0
160495,children,0,1
160496,'s,0,1
160497,differing,0,0
160498,impairments,0,1
160499,.,0,0
160500,The,0,0
160501,intervention,0,0
160502,effect,0,0
160503,was,0,0
160504,maintained,0,0
160505,at,0,0
160506,6-month,0,0
160507,follow-up,0,0
160508,.,0,0
160509,The,0,0
160510,results,0,0
160511,indicate,0,0
160512,that,0,0
160513,GSSTP,0,0
160514,is,0,0
160515,a,0,0
160516,promising,0,0
160517,intervention,0,0
160518,for,0,0
160519,a,0,0
160520,mixed-disability,0,0
160521,group,0,0
160522,.,0,0
160523,Limitations,0,0
160524,of,0,0
160525,the,0,0
160526,study,0,0
160527,",",0,0
160528,along,0,0
160529,with,0,1
160530,areas,0,0
160531,for,0,0
160532,future,0,0
160533,research,0,0
160534,",",0,0
160535,are,0,0
160536,also,0,0
160537,discussed,0,0
160538,.,0,0
160539,Oxytocin,0,0
160540,promotes,0,0
160541,facial,0,0
160542,emotion,0,0
160543,recognition,0,0
160544,and,0,0
160545,amygdala,0,0
160546,reactivity,0,0
160547,in,0,0
160548,adults,1,1
160549,with,1,1
160550,asperger,1,1
160551,syndrome,1,1
160552,.,1,0
160553,The,0,0
160554,neuropeptide,0,0
160555,oxytocin,0,0
160556,has,0,0
160557,recently,0,0
160558,been,0,0
160559,shown,0,0
160560,to,0,0
160561,enhance,0,0
160562,eye,0,0
160563,gaze,0,0
160564,and,0,0
160565,emotion,0,0
160566,recognition,0,0
160567,in,0,0
160568,healthy,1,1
160569,men,1,1
160570,.,1,0
160571,Here,0,0
160572,",",0,0
160573,we,0,0
160574,report,0,0
160575,a,0,0
160576,randomized,0,0
160577,double-blind,0,0
160578,",",0,0
160579,placebo-controlled,0,0
160580,trial,0,0
160581,that,0,0
160582,examined,0,0
160583,the,0,0
160584,neural,0,0
160585,and,0,0
160586,behavioral,0,0
160587,effects,0,0
160588,of,0,0
160589,a,0,0
160590,single,0,0
160591,dose,0,0
160592,of,0,0
160593,intranasal,0,0
160594,oxytocin,0,0
160595,on,0,0
160596,emotion,0,0
160597,recognition,0,0
160598,in,0,0
160599,individuals,1,1
160600,with,1,1
160601,Asperger,1,1
160602,syndrome,1,1
160603,(,1,0
160604,AS,1,0
160605,),1,0
160606,",",0,0
160607,a,0,0
160608,clinical,0,0
160609,condition,0,0
160610,characterized,0,0
160611,by,0,0
160612,impaired,0,0
160613,eye,0,0
160614,gaze,0,0
160615,and,0,0
160616,facial,0,0
160617,emotion,0,0
160618,recognition,0,0
160619,.,0,0
160620,Using,0,0
160621,functional,0,0
160622,magnetic,0,0
160623,resonance,0,0
160624,imaging,0,0
160625,",",0,0
160626,we,0,0
160627,examined,0,0
160628,whether,0,0
160629,oxytocin,0,0
160630,would,0,0
160631,enhance,0,0
160632,emotion,0,0
160633,recognition,0,0
160634,from,0,0
160635,facial,0,0
160636,sections,0,1
160637,of,0,0
160638,the,0,0
160639,eye,0,0
160640,vs,0,0
160641,the,0,0
160642,mouth,0,0
160643,region,0,0
160644,and,0,0
160645,modulate,0,0
160646,regional,0,0
160647,activity,0,0
160648,in,0,0
160649,brain,0,0
160650,areas,0,0
160651,associated,0,0
160652,with,0,1
160653,face,0,0
160654,perception,0,0
160655,in,0,0
160656,both,0,0
160657,adults,1,1
160658,with,1,1
160659,AS,1,0
160660,",",0,0
160661,and,0,0
160662,a,0,0
160663,neurotypical,0,1
160664,control,0,0
160665,group,0,0
160666,.,0,0
160667,Intranasal,0,0
160668,administration,0,0
160669,of,0,0
160670,the,0,0
160671,neuropeptide,0,0
160672,oxytocin,0,0
160673,improved,0,0
160674,performance,0,0
160675,in,0,0
160676,a,0,0
160677,facial,0,0
160678,emotion,0,0
160679,recognition,0,0
160680,task,0,0
160681,in,0,0
160682,individuals,1,1
160683,with,1,1
160684,AS,1,0
160685,.,1,0
160686,This,0,0
160687,was,0,0
160688,linked,0,0
160689,to,0,0
160690,increased,0,0
160691,left,0,0
160692,amygdala,0,0
160693,reactivity,0,0
160694,in,0,0
160695,response,0,0
160696,to,0,0
160697,facial,0,0
160698,stimuli,0,0
160699,and,0,0
160700,increased,0,0
160701,activity,0,0
160702,in,0,0
160703,the,0,0
160704,neural,0,0
160705,network,0,0
160706,involved,0,0
160707,in,0,0
160708,social,0,0
160709,cognition,0,0
160710,.,0,0
160711,Our,0,0
160712,data,0,0
160713,suggest,0,0
160714,that,0,0
160715,the,0,0
160716,amygdala,0,0
160717,",",0,0
160718,together,0,0
160719,with,0,0
160720,functionally,0,0
160721,associated,0,0
160722,cortical,0,0
160723,areas,0,0
160724,mediate,0,0
160725,the,0,0
160726,positive,0,0
160727,effect,0,0
160728,of,0,0
160729,oxytocin,0,0
160730,on,0,0
160731,social,0,0
160732,cognitive,0,0
160733,functioning,0,0
160734,in,0,0
160735,AS,0,0
160736,.,0,1
160737,Long-term,0,0
160738,exposure,0,0
160739,to,0,0
160740,belatacept,0,0
160741,in,0,0
160742,recipients,1,1
160743,of,1,0
160744,extended,1,0
160745,criteria,1,1
160746,donor,1,1
160747,kidneys,1,1
160748,.,1,1
160749,Patients,1,1
160750,in,1,0
160751,the,1,0
160752,BENEFIT-EXT,1,0
160753,study,1,0
160754,received,1,0
160755,extended,1,0
160756,criteria,1,1
160757,donor,1,1
160758,kidneys,1,1
160759,and,0,0
160760,a,0,0
160761,more,0,0
160762,intensive,0,0
160763,(,0,0
160764,MI,0,0
160765,),0,0
160766,or,0,0
160767,less,0,0
160768,intensive,0,0
160769,(,0,0
160770,LI,0,0
160771,),0,0
160772,belatacept,0,0
160773,immunosuppression,0,0
160774,regimen,0,0
160775,",",0,0
160776,or,0,0
160777,cyclosporine,0,0
160778,A,0,0
160779,(,0,0
160780,CsA,0,0
160781,),0,0
160782,.,0,1
160783,Patients,1,1
160784,who,1,1
160785,remained,1,1
160786,on,1,1
160787,assigned,1,0
160788,therapy,1,0
160789,through,1,0
160790,year,1,0
160791,3,1,0
160792,were,1,0
160793,eligible,1,1
160794,to,1,0
160795,enter,1,1
160796,a,1,0
160797,long-term,1,0
160798,extension,1,0
160799,(,1,0
160800,LTE,1,0
160801,),1,0
160802,study,1,0
160803,.,1,0
160804,Three,1,0
160805,hundred,1,1
160806,four,1,1
160807,patients,1,1
160808,entered,1,1
160809,the,1,0
160810,LTE,1,0
160811,(,1,0
160812,n,1,1
160813,=,1,0
160814,104,1,1
160815,MI,1,0
160816,;,1,0
160817,n,1,1
160818,=,1,0
160819,113,1,1
160820,LI,1,0
160821,;,1,0
160822,n,1,1
160823,=,1,0
160824,87,1,1
160825,CsA,1,0
160826,),1,0
160827,",",1,0
160828,and,1,0
160829,260,1,0
160830,continued,1,0
160831,treatment,1,0
160832,through,1,0
160833,year,1,0
160834,5,1,0
160835,(,1,0
160836,n,1,1
160837,=,1,0
160838,91,0,1
160839,MI,0,0
160840,;,0,0
160841,n,0,1
160842,=,0,0
160843,100,0,0
160844,LI,0,0
160845,;,0,0
160846,n,0,1
160847,=,0,0
160848,69,1,1
160849,CsA,1,0
160850,),1,0
160851,.,1,0
160852,Twenty,1,1
160853,patients,0,1
160854,died,0,1
160855,during,0,0
160856,the,0,0
160857,LTE,0,0
160858,(,0,0
160859,n,0,1
160860,=,0,0
160861,5,0,0
160862,MI,0,0
160863,;,0,0
160864,n,0,1
160865,=,0,0
160866,9,0,0
160867,LI,0,0
160868,;,0,0
160869,n,0,1
160870,=,0,0
160871,6,0,0
160872,CsA,0,0
160873,),0,0
160874,",",0,0
160875,and,0,0
160876,eight,0,0
160877,experienced,0,0
160878,graft,0,0
160879,loss,0,0
160880,(,0,0
160881,n,0,1
160882,=,0,0
160883,2,0,0
160884,MI,0,0
160885,;,0,0
160886,n,0,1
160887,=,0,0
160888,1,0,0
160889,LI,0,0
160890,;,0,0
160891,n,0,1
160892,=,0,0
160893,5,0,0
160894,CsA,0,0
160895,),0,0
160896,.,0,0
160897,Three,0,0
160898,patients,0,1
160899,experienced,0,0
160900,an,0,0
160901,acute,0,1
160902,rejection,0,0
160903,episode,0,1
160904,(,0,0
160905,n,0,1
160906,=,0,0
160907,2,0,0
160908,MI,0,0
160909,;,0,0
160910,n,0,1
160911,=,0,0
160912,1,0,0
160913,LI,0,1
160914,),0,0
160915,.,0,0
160916,The,0,0
160917,incidence,0,0
160918,rate,0,0
160919,of,0,0
160920,serious,0,0
160921,adverse,0,0
160922,events,0,0
160923,",",0,0
160924,viral,0,0
160925,infections,0,0
160926,and,0,0
160927,fungal,0,1
160928,infections,0,0
160929,was,0,0
160930,similar,0,0
160931,across,0,0
160932,groups,0,0
160933,during,0,0
160934,the,0,0
160935,LTE,0,0
160936,.,0,0
160937,There,0,0
160938,were,0,0
160939,four,0,0
160940,cases,0,1
160941,of,0,0
160942,posttransplant,0,0
160943,lymphoproliferative,0,1
160944,disorder,0,1
160945,(,0,0
160946,PTLD,0,0
160947,),0,0
160948,from,0,0
160949,the,0,0
160950,beginning,0,0
160951,of,0,0
160952,the,0,0
160953,LTE,0,0
160954,to,0,0
160955,year,0,0
160956,5,0,0
160957,(,0,0
160958,n,0,1
160959,=,0,0
160960,3,0,0
160961,LI,0,0
160962,;,0,0
160963,n,0,1
160964,=,0,0
160965,1,0,0
160966,CsA,0,0
160967,),0,0
160968,;,0,0
160969,two,0,0
160970,of,0,0
160971,three,0,0
160972,PTLD,0,0
160973,cases,0,1
160974,in,0,0
160975,the,0,0
160976,LI,0,0
160977,group,0,0
160978,were,0,0
160979,in,0,1
160980,patients,1,1
160981,who,1,1
160982,were,1,1
160983,seronegative,1,1
160984,for,1,0
160985,Epstein-Barr,1,0
160986,virus,1,1
160987,(,1,0
160988,EBV,1,0
160989,(,1,0
160990,-,1,0
160991,),1,0
160992,),1,0
160993,at,1,0
160994,transplantation,1,1
160995,.,0,0
160996,Mean,0,0
160997,?,0,0
160998,SD,0,0
160999,calculated,0,0
161000,GFR,0,0
161001,at,0,0
161002,year,0,0
161003,5,0,0
161004,was,0,0
161005,55.9,0,0
161006,?,0,0
161007,17.5,0,0
161008,(,0,0
161009,MI,0,0
161010,),0,0
161011,",",0,0
161012,59.0,0,0
161013,?,0,0
161014,29.1,0,0
161015,(,0,0
161016,LI,0,0
161017,),0,0
161018,and,0,0
161019,44.6,0,0
161020,?,0,0
161021,16.4,0,0
161022,(,0,0
161023,CsA,0,0
161024,),0,0
161025,mL/min/1.73,0,0
161026,m,0,0
161027,(,0,0
161028,2,0,0
161029,),0,0
161030,.,0,0
161031,Continued,0,0
161032,treatment,0,0
161033,with,0,1
161034,belatacept,0,0
161035,was,0,0
161036,associated,0,0
161037,with,0,0
161038,a,0,0
161039,consistent,0,0
161040,safety,0,0
161041,profile,0,0
161042,and,0,0
161043,sustained,0,0
161044,improvement,0,0
161045,in,0,0
161046,renal,0,0
161047,function,0,0
161048,versus,0,0
161049,CsA,0,0
161050,over,0,0
161051,time,0,0
161052,.,0,0
161053,Comparison,0,0
161054,of,0,0
161055,three,0,0
161056,software,0,0
161057,systems,0,0
161058,for,0,0
161059,semi-automatic,0,0
161060,volumetry,0,0
161061,of,0,0
161062,pulmonary,0,1
161063,nodules,0,1
161064,on,0,0
161065,baseline,0,0
161066,and,0,0
161067,follow-up,0,0
161068,CT,0,0
161069,examinations,0,1
161070,.,0,1
161071,BACKGROUND,0,0
161072,Early,0,0
161073,diagnosis,0,1
161074,of,0,0
161075,lung,0,0
161076,cancer,0,1
161077,in,0,0
161078,a,0,0
161079,treatable,0,0
161080,stage,0,1
161081,is,0,0
161082,the,0,0
161083,main,0,0
161084,purpose,0,0
161085,of,0,0
161086,lung,1,0
161087,cancer,1,1
161088,screening,0,0
161089,by,0,0
161090,computed,0,0
161091,tomography,0,0
161092,(,0,0
161093,CT,0,0
161094,),0,0
161095,.,0,0
161096,Accurate,0,0
161097,three-dimensional,0,0
161098,size,0,0
161099,and,0,0
161100,growth,0,0
161101,measurements,0,0
161102,are,0,0
161103,essential,0,0
161104,to,0,0
161105,assess,0,0
161106,the,0,0
161107,risk,0,0
161108,of,0,0
161109,malignancy,0,1
161110,.,0,0
161111,Nodule,0,0
161112,volumes,0,0
161113,can,0,0
161114,be,0,0
161115,calculated,0,0
161116,by,0,0
161117,using,0,0
161118,semi-automated,0,0
161119,volumetric,0,0
161120,software,0,0
161121,.,0,0
161122,Systematic,0,0
161123,differences,0,0
161124,in,0,0
161125,volume,0,0
161126,measurements,0,0
161127,between,0,0
161128,packages,0,0
161129,could,0,0
161130,influence,0,0
161131,nodule,0,0
161132,categorization,0,0
161133,and,0,0
161134,management,0,0
161135,decisions,0,0
161136,.,0,0
161137,PURPOSE,0,0
161138,To,0,0
161139,compare,0,0
161140,volumetric,0,0
161141,measurements,0,0
161142,of,0,0
161143,solid,0,1
161144,pulmonary,0,1
161145,nodules,0,1
161146,on,0,0
161147,baseline,0,0
161148,and,0,0
161149,follow-up,0,0
161150,CT,0,0
161151,scans,0,0
161152,as,0,0
161153,well,0,0
161154,as,0,0
161155,the,0,0
161156,volume,0,0
161157,doubling,0,0
161158,time,0,0
161159,(,0,0
161160,VDT,0,0
161161,),0,0
161162,for,0,0
161163,three,0,0
161164,software,0,0
161165,packages,0,0
161166,.,0,0
161167,MATERIAL,0,0
161168,AND,0,0
161169,METHODS,0,0
161170,From,1,1
161171,a,1,0
161172,Lung,1,0
161173,Cancer,1,0
161174,Screening,1,1
161175,study,1,0
161176,(,1,0
161177,NELSON,1,0
161178,),1,0
161179,",",1,0
161180,50,1,0
161181,participants,1,1
161182,were,1,0
161183,randomly,1,1
161184,selected,1,0
161185,from,1,0
161186,the,1,0
161187,baseline,1,0
161188,round,1,0
161189,.,1,0
161190,The,0,0
161191,study,1,0
161192,population,1,1
161193,comprised,1,1
161194,participants,1,1
161195,with,1,1
161196,at,1,0
161197,least,1,0
161198,one,1,0
161199,pulmonary,1,1
161200,nodule,1,0
161201,at,1,0
161202,the,1,0
161203,baseline,1,0
161204,and,1,0
161205,consecutive,1,1
161206,CT,1,0
161207,examination,1,0
161208,.,1,0
161209,The,0,0
161210,volume,0,0
161211,of,0,0
161212,each,0,0
161213,nodule,0,0
161214,was,0,0
161215,determined,0,0
161216,for,0,0
161217,both,0,0
161218,time,0,0
161219,points,0,0
161220,using,0,0
161221,three,0,0
161222,semi-automated,0,0
161223,software,0,0
161224,packages,0,0
161225,(,0,0
161226,P1,0,0
161227,",",0,0
161228,P2,0,0
161229,",",0,0
161230,and,0,0
161231,P3,0,1
161232,),0,0
161233,.,0,0
161234,Manual,0,0
161235,modification,0,0
161236,was,0,0
161237,performed,0,0
161238,when,0,0
161239,automated,0,0
161240,assessment,0,0
161241,was,0,0
161242,visually,0,0
161243,inaccurate,0,0
161244,.,0,0
161245,VDT,0,0
161246,was,0,0
161247,calculated,0,0
161248,to,0,0
161249,evaluate,0,0
161250,nodule,0,0
161251,growth,0,0
161252,.,0,0
161253,Volume,0,0
161254,",",0,0
161255,VDT,0,0
161256,",",0,0
161257,and,0,0
161258,nodule,0,0
161259,management,0,0
161260,were,0,0
161261,compared,0,0
161262,for,0,0
161263,the,0,0
161264,three,0,0
161265,software,0,0
161266,packages,0,0
161267,",",0,0
161268,using,0,0
161269,P1,0,0
161270,as,0,0
161271,the,0,0
161272,reference,0,0
161273,standard,0,0
161274,.,0,0
161275,RESULTS,0,0
161276,In,0,0
161277,25,0,0
161278,participants,0,1
161279,",",0,0
161280,147,0,1
161281,nodules,0,0
161282,were,0,0
161283,present,0,0
161284,on,0,0
161285,both,0,0
161286,examinations,0,0
161287,(,0,0
161288,volume,0,0
161289,:,0,1
161290,12.0-436.6,0,0
161291,mm,0,0
161292,(,0,0
161293,3,0,0
161294,),0,0
161295,),0,0
161296,.,0,0
161297,Initial,0,0
161298,segmentation,0,0
161299,at,0,0
161300,baseline,0,0
161301,was,0,0
161302,evaluated,0,0
161303,to,0,0
161304,be,0,0
161305,satisfactory,0,0
161306,in,0,0
161307,93.9,0,0
161308,%,0,0
161309,of,0,0
161310,nodules,0,0
161311,for,0,0
161312,P1,0,0
161313,",",0,0
161314,84.4,0,0
161315,%,0,0
161316,for,0,0
161317,P2,0,0
161318,",",0,0
161319,and,0,0
161320,88.4,0,0
161321,%,0,0
161322,for,0,0
161323,P3,0,1
161324,.,0,0
161325,Significant,0,0
161326,difference,0,0
161327,was,0,0
161328,found,0,0
161329,in,0,0
161330,measured,0,0
161331,volume,0,0
161332,between,0,0
161333,P1,0,0
161334,and,0,0
161335,the,0,0
161336,other,0,0
161337,two,0,0
161338,packages,0,0
161339,(,0,0
161340,P,0,0
161341,<,0,0
161342,0.001,0,0
161343,),0,0
161344,.,0,0
161345,P2,0,0
161346,overestimated,0,0
161347,the,0,0
161348,volume,0,0
161349,by,0,0
161350,38,0,1
161351,?,0,0
161352,24,0,0
161353,%,0,0
161354,",",0,0
161355,and,0,0
161356,P3,0,0
161357,by,0,0
161358,50,0,0
161359,?,0,0
161360,22,0,0
161361,%,0,0
161362,.,0,0
161363,At,0,0
161364,baseline,0,0
161365,",",0,0
161366,there,0,0
161367,was,0,0
161368,consensus,0,0
161369,on,0,0
161370,nodule,0,0
161371,size,0,0
161372,categorization,0,0
161373,in,0,0
161374,80,0,0
161375,%,0,0
161376,for,0,0
161377,P1,0,0
161378,&,0,1
161379,P2,0,1
161380,and,0,0
161381,74,0,0
161382,%,0,0
161383,for,0,0
161384,P1,0,0
161385,&,0,1
161386,P3,0,1
161387,.,0,0
161388,At,0,0
161389,follow-up,0,0
161390,",",0,0
161391,consensus,0,0
161392,on,0,0
161393,VDT,0,0
161394,categorization,0,0
161395,was,0,0
161396,present,0,0
161397,in,0,0
161398,47,0,1
161399,%,0,0
161400,for,0,0
161401,P1,0,0
161402,&,0,1
161403,P2,0,1
161404,and,0,0
161405,44,0,0
161406,%,0,0
161407,for,0,0
161408,P1,0,0
161409,&,0,1
161410,P3,0,1
161411,.,0,0
161412,CONCLUSION,0,0
161413,Software,0,0
161414,packages,0,0
161415,for,0,0
161416,lung,0,0
161417,nodule,0,0
161418,evaluation,0,0
161419,yield,0,0
161420,significant,0,0
161421,differences,0,0
161422,in,0,0
161423,volumetric,0,0
161424,measurements,0,0
161425,and,0,0
161426,VDT,0,0
161427,.,0,0
161428,This,0,0
161429,variation,0,0
161430,affects,0,0
161431,the,0,0
161432,classification,0,0
161433,of,0,0
161434,lung,0,1
161435,nodules,0,0
161436,",",0,0
161437,especially,0,0
161438,in,0,0
161439,follow-up,0,0
161440,examinations,0,1
161441,.,0,1
161442,Comparison,0,0
161443,of,0,0
161444,meloxicam,0,0
161445,and,0,0
161446,a,0,0
161447,glucosamine-chondroitin,0,0
161448,supplement,0,0
161449,in,0,0
161450,management,0,0
161451,of,0,0
161452,feline,1,1
161453,osteoarthritis,1,1
161454,.,1,0
161455,A,0,0
161456,double-blind,0,0
161457,randomised,0,0
161458,",",0,0
161459,placebo-controlled,0,0
161460,",",0,0
161461,prospective,0,0
161462,trial,0,0
161463,.,0,0
161464,OBJECTIVE,0,0
161465,To,0,0
161466,compare,0,0
161467,the,0,0
161468,efficacy,0,0
161469,of,0,0
161470,meloxicam,0,0
161471,and,0,0
161472,a,0,0
161473,glucosamine-chondroitin,0,0
161474,(,0,0
161475,Glu-Ch,0,1
161476,),0,0
161477,supplement,0,0
161478,in,0,0
161479,the,0,0
161480,management,0,0
161481,of,0,0
161482,feline,1,0
161483,osteoarthritis,1,1
161484,(,1,0
161485,OA,1,0
161486,),1,0
161487,.,0,0
161488,METHODS,0,0
161489,Prospective,0,0
161490,",",0,0
161491,blinded,0,0
161492,",",0,0
161493,randomized,0,0
161494,clinical,0,0
161495,trial,0,1
161496,.,0,0
161497,Cats,1,0
161498,over,1,1
161499,eight,1,1
161500,years,1,1
161501,of,1,0
161502,age,1,1
161503,with,1,1
161504,clinical,1,0
161505,signs,1,0
161506,of,1,0
161507,chronic,1,1
161508,OA,1,0
161509,were,1,0
161510,assigned,1,0
161511,to,1,0
161512,one,1,0
161513,of,1,0
161514,two,1,0
161515,groups,1,0
161516,and,0,0
161517,Glu-Ch,0,1
161518,or,0,0
161519,meloxicam,0,0
161520,was,0,0
161521,administered,0,0
161522,orally,0,0
161523,for,0,0
161524,70,0,1
161525,days,0,0
161526,",",0,0
161527,followed,0,0
161528,by,0,0
161529,a,0,0
161530,placebo,0,0
161531,until,0,0
161532,day,0,0
161533,98,0,1
161534,.,0,0
161535,Cats,1,0
161536,were,0,0
161537,assessed,0,0
161538,by,0,0
161539,a,0,0
161540,veterinarian,0,1
161541,on,0,0
161542,five,0,1
161543,occasions,0,0
161544,and,0,0
161545,the,0,0
161546,owner,0,0
161547,completed,0,0
161548,an,0,0
161549,assessment,0,0
161550,form,0,0
161551,at,0,0
161552,the,0,0
161553,same,0,0
161554,time,0,0
161555,.,0,0
161556,RESULTS,0,0
161557,Data,0,0
161558,were,0,0
161559,collected,0,0
161560,from,0,0
161561,thirty,0,1
161562,cats,0,1
161563,.,0,0
161564,Pre-treatment,0,0
161565,disease,0,1
161566,scores,0,0
161567,were,0,0
161568,significantly,0,0
161569,higher,0,0
161570,in,0,0
161571,the,0,0
161572,meloxicam,0,0
161573,group,0,0
161574,for,0,0
161575,owner,0,0
161576,mobility,0,0
161577,(,0,0
161578,p=0.01,0,0
161579,),0,0
161580,and,0,0
161581,veterinary,0,1
161582,lameness,0,0
161583,(,0,0
161584,p=0.02,0,0
161585,),0,0
161586,.,0,0
161587,Owner,0,0
161588,mobility,0,0
161589,scores,0,0
161590,at,0,0
161591,day,0,0
161592,14,0,0
161593,(,0,0
161594,p=0.01,0,0
161595,),0,0
161596,and,0,0
161597,day,0,0
161598,42,0,0
161599,(,0,0
161600,p=0.002,0,0
161601,),0,0
161602,were,0,0
161603,significantly,0,0
161604,improved,0,0
161605,compared,0,0
161606,to,0,0
161607,pre-treatment,0,0
161608,scores,0,0
161609,for,0,0
161610,the,0,0
161611,meloxicam,0,0
161612,group,0,0
161613,.,0,0
161614,When,0,0
161615,meloxicam,0,0
161616,and,0,0
161617,Glu-Ch,0,0
161618,were,0,0
161619,discontinued,0,0
161620,and,0,0
161621,the,0,0
161622,placebo,0,0
161623,commenced,0,0
161624,",",0,0
161625,a,0,0
161626,significant,0,0
161627,proportion,0,0
161628,of,0,0
161629,the,0,0
161630,meloxicam,0,0
161631,group,0,0
161632,showed,0,0
161633,worsening,0,0
161634,of,0,0
161635,all,0,0
161636,the,0,0
161637,owner-assessed,0,0
161638,scores,0,0
161639,between,0,0
161640,day,0,0
161641,70,0,1
161642,and,0,0
161643,day,0,0
161644,98,0,0
161645,",",0,0
161646,when,0,0
161647,compared,0,0
161648,to,0,0
161649,the,0,0
161650,Glu-Ch,0,0
161651,group,0,0
161652,(,0,0
161653,mobility,0,0
161654,p=0.01,0,0
161655,;,0,0
161656,activity,0,0
161657,p=0.02,0,0
161658,;,0,0
161659,temperament,0,1
161660,p=0.04,0,0
161661,;,0,0
161662,lifestyle,0,0
161663,p=0.01,0,0
161664,),0,0
161665,.,0,0
161666,CONCLUSIONS,0,0
161667,Treatment,0,0
161668,with,0,1
161669,meloxicam,0,0
161670,resulted,0,0
161671,in,0,0
161672,a,0,0
161673,significant,0,0
161674,improvement,0,0
161675,in,0,0
161676,mobility,0,0
161677,and,0,0
161678,activity,0,0
161679,levels,0,0
161680,of,0,0
161681,cats,1,1
161682,with,0,1
161683,OA,0,0
161684,until,0,0
161685,the,0,0
161686,placebo,0,0
161687,was,0,0
161688,introduced,0,0
161689,.,0,0
161690,A,0,0
161691,greater,0,0
161692,proportion,0,0
161693,of,0,0
161694,cats,0,1
161695,receiving,0,1
161696,meloxicam,0,0
161697,medication,0,0
161698,showed,0,0
161699,a,0,0
161700,significant,0,0
161701,worsening,0,0
161702,of,0,0
161703,owner,0,0
161704,assessment,0,0
161705,scores,0,0
161706,once,0,0
161707,the,0,0
161708,placed,0,0
161709,was,0,0
161710,introduced,0,0
161711,",",0,0
161712,when,0,0
161713,compared,0,0
161714,to,0,0
161715,the,0,0
161716,Glu-Ch,0,0
161717,group,0,0
161718,.,0,0
161719,Central,0,0
161720,5-HT4,0,0
161721,receptor,0,0
161722,binding,0,0
161723,as,0,0
161724,biomarker,0,0
161725,of,0,0
161726,serotonergic,0,0
161727,tonus,0,0
161728,in,0,0
161729,humans,1,0
161730,:,1,1
161731,a,0,0
161732,[,0,0
161733,11C,0,1
161734,],0,0
161735,SB207145,0,0
161736,PET,0,0
161737,study,0,0
161738,.,0,0
161739,Identification,0,0
161740,of,0,0
161741,a,0,0
161742,biomarker,0,0
161743,that,0,0
161744,can,0,0
161745,inform,0,0
161746,on,0,0
161747,extracellular,0,0
161748,serotonin,0,0
161749,(,0,0
161750,5-HT,0,0
161751,),0,0
161752,levels,0,0
161753,in,0,0
161754,the,0,0
161755,brains,0,1
161756,of,0,0
161757,living,1,1
161758,humans,1,0
161759,would,0,0
161760,enable,0,0
161761,greater,0,0
161762,understanding,0,0
161763,of,0,0
161764,the,0,0
161765,way,0,0
161766,brain,0,0
161767,circuits,0,0
161768,are,0,0
161769,modulated,0,0
161770,by,0,0
161771,serotonergic,0,0
161772,neurotransmission,0,0
161773,.,0,0
161774,Substantial,0,0
161775,evidence,0,0
161776,from,0,0
161777,studies,0,0
161778,in,0,0
161779,animals,0,0
161780,and,0,0
161781,humans,0,0
161782,indicates,0,0
161783,an,0,0
161784,inverse,0,0
161785,relationship,0,0
161786,between,0,0
161787,central,0,0
161788,5-HT,0,0
161789,tonus,0,0
161790,and,0,0
161791,5-HT,0,0
161792,type,0,1
161793,4,0,0
161794,receptor,0,0
161795,(,0,0
161796,5-HT4R,0,0
161797,),0,0
161798,density,0,0
161799,",",0,0
161800,suggesting,0,0
161801,that,0,0
161802,5-HT4R,0,0
161803,receptor,0,0
161804,density,0,0
161805,may,0,0
161806,be,0,0
161807,a,0,0
161808,biomarker,0,0
161809,marker,0,0
161810,for,0,0
161811,5-HT,0,0
161812,tonus,0,0
161813,.,0,0
161814,Here,0,0
161815,",",0,0
161816,we,0,0
161817,investigated,0,0
161818,whether,0,0
161819,a,0,0
161820,3-week,0,0
161821,administration,0,0
161822,of,0,0
161823,a,0,0
161824,selective,0,0
161825,serotonin,0,0
161826,reuptake,0,0
161827,inhibitor,0,0
161828,",",0,0
161829,expected,0,0
161830,to,0,0
161831,increase,0,0
161832,brain,0,0
161833,5-HT,0,0
161834,levels,0,0
161835,",",0,0
161836,is,0,0
161837,associated,0,0
161838,with,0,0
161839,a,0,0
161840,decline,0,0
161841,in,0,0
161842,brain,0,0
161843,5-HT4R,0,0
161844,binding,0,0
161845,.,0,0
161846,A,1,0
161847,total,1,0
161848,of,1,0
161849,35,1,1
161850,healthy,1,1
161851,men,1,1
161852,were,1,0
161853,studied,1,1
161854,in,0,0
161855,a,0,0
161856,placebo-controlled,0,0
161857,",",0,0
161858,randomized,0,0
161859,",",0,0
161860,double-blind,0,0
161861,study,0,0
161862,.,0,1
161863,Participants,0,1
161864,were,0,0
161865,assigned,0,0
161866,to,0,0
161867,receive,0,0
161868,3,0,0
161869,weeks,0,0
161870,of,0,0
161871,oral,0,0
161872,dosing,0,0
161873,with,0,1
161874,placebo,0,0
161875,or,0,0
161876,fluoxetine,0,0
161877,",",0,0
161878,40,0,0
161879,mg,0,0
161880,per,0,0
161881,day,0,0
161882,.,0,0
161883,Brain,0,0
161884,5-HT4R,0,0
161885,binding,0,0
161886,was,0,0
161887,quantified,0,0
161888,at,0,0
161889,baseline,0,0
161890,and,0,0
161891,at,0,0
161892,follow-up,0,0
161893,with,0,1
161894,[,0,0
161895,(,0,0
161896,11,0,1
161897,),0,0
161898,C,0,0
161899,],0,0
161900,SB207145,0,0
161901,positron,0,0
161902,emission,0,0
161903,tomography,0,0
161904,(,0,0
161905,PET,0,0
161906,),0,0
161907,.,0,0
161908,Three,0,0
161909,weeks,0,0
161910,of,0,0
161911,intervention,0,0
161912,with,0,1
161913,fluoxetine,0,0
161914,was,0,0
161915,associated,0,0
161916,with,0,0
161917,a,0,0
161918,5.2,0,0
161919,%,0,0
161920,reduction,0,0
161921,in,0,0
161922,brain,0,0
161923,5-HT4R,0,0
161924,binding,0,0
161925,(,0,0
161926,P=0.017,0,0
161927,),0,0
161928,",",0,0
161929,whereas,0,0
161930,placebo,0,0
161931,intervention,0,0
161932,did,0,0
161933,not,0,0
161934,change,0,0
161935,5-HT4R,0,0
161936,binding,0,0
161937,(,0,0
161938,P=0.52,0,0
161939,),0,0
161940,.,0,0
161941,Our,0,0
161942,findings,0,0
161943,are,0,0
161944,consistent,0,0
161945,with,0,0
161946,a,0,0
161947,model,0,0
161948,",",0,0
161949,wherein,0,0
161950,the,0,0
161951,5-HT4R,0,0
161952,density,0,0
161953,adjusts,0,0
161954,to,0,0
161955,changes,0,0
161956,in,0,0
161957,the,0,0
161958,extracellular,0,0
161959,5-HT,0,0
161960,tonus,0,0
161961,.,0,0
161962,Our,0,0
161963,data,0,0
161964,demonstrate,0,0
161965,for,0,0
161966,the,0,0
161967,first,0,0
161968,time,0,0
161969,in,0,0
161970,humans,1,0
161971,that,0,0
161972,the,0,0
161973,imaging,0,0
161974,of,0,0
161975,central,0,0
161976,5-HT4R,0,0
161977,binding,0,0
161978,may,0,0
161979,be,0,0
161980,used,0,0
161981,as,0,0
161982,an,0,0
161983,in,0,0
161984,vivo,0,0
161985,biomarker,0,0
161986,of,0,0
161987,the,0,0
161988,central,0,0
161989,5-HT,0,0
161990,tonus,0,0
161991,.,0,0
161992,Evaluating,0,0
161993,proton,0,0
161994,stereotactic,0,0
161995,body,0,0
161996,radiotherapy,0,0
161997,to,0,0
161998,reduce,0,0
161999,chest,0,0
162000,wall,0,0
162001,dose,0,0
162002,in,0,0
162003,the,0,0
162004,treatment,0,0
162005,of,0,0
162006,lung,1,1
162007,cancer,1,1
162008,.,1,0
162009,Stereotactic,0,0
162010,body,0,0
162011,radiotherapy,0,1
162012,(,0,0
162013,SBRT,0,0
162014,),0,0
162015,can,0,0
162016,produce,0,0
162017,excellent,0,0
162018,local,0,0
162019,control,0,0
162020,of,0,0
162021,several,0,0
162022,types,0,0
162023,of,0,0
162024,solid,0,1
162025,tumor,0,1
162026,;,0,0
162027,however,0,0
162028,",",0,0
162029,toxicity,0,0
162030,to,0,0
162031,nearby,0,0
162032,critical,0,0
162033,structures,0,0
162034,is,0,0
162035,a,0,0
162036,concern,0,0
162037,.,0,0
162038,We,0,0
162039,found,0,0
162040,previously,0,0
162041,that,0,0
162042,in,0,0
162043,SBRT,0,0
162044,for,0,0
162045,lung,0,0
162046,cancer,0,1
162047,",",0,0
162048,the,0,0
162049,chest,0,0
162050,wall,0,0
162051,(,0,0
162052,CW,0,0
162053,),0,0
162054,volume,0,0
162055,receiving,0,0
162056,20,0,0
162057,",",0,0
162058,30,0,0
162059,",",0,0
162060,or,0,0
162061,40Gy,0,1
162062,(,0,0
162063,V20,0,0
162064,",",0,0
162065,V30,0,0
162066,",",0,0
162067,or,0,0
162068,V40,0,0
162069,),0,0
162070,was,0,0
162071,linked,0,0
162072,with,0,0
162073,the,0,0
162074,development,0,0
162075,of,0,0
162076,neuropathy,0,1
162077,.,0,0
162078,Here,0,0
162079,we,0,0
162080,sought,0,0
162081,to,0,0
162082,determine,0,0
162083,whether,0,0
162084,the,0,0
162085,dosimetric,0,0
162086,advantages,0,0
162087,of,0,0
162088,protons,0,0
162089,could,0,0
162090,produce,0,0
162091,lower,0,0
162092,CW,0,0
162093,doses,0,0
162094,than,0,0
162095,traditional,0,0
162096,photon-based,0,0
162097,SBRT,0,0
162098,.,0,0
162099,We,0,0
162100,searched,0,0
162101,an,0,0
162102,institutional,0,0
162103,database,0,0
162104,to,0,0
162105,identify,0,0
162106,patients,1,1
162107,treated,1,1
162108,with,1,1
162109,photon,1,0
162110,SBRT,1,0
162111,for,1,0
162112,lung,1,0
162113,cancer,1,1
162114,with,1,1
162115,tumors,1,1
162116,within,1,1
162117,<,1,0
162118,2.5cm,1,0
162119,of,1,0
162120,the,1,0
162121,CW,1,0
162122,.,1,0
162123,We,0,0
162124,found,0,0
162125,260,1,1
162126,cases,1,1
162127,;,1,0
162128,of,1,0
162129,these,1,0
162130,",",1,0
162131,chronic,1,1
162132,grade,1,0
162133,?,1,0
162134,2,1,0
162135,CW,1,0
162136,pain,1,0
162137,was,1,0
162138,identified,1,0
162139,in,1,0
162140,23,1,1
162141,patients,1,1
162142,.,1,0
162143,We,0,0
162144,then,1,0
162145,selected,1,1
162146,10,1,0
162147,representative,1,1
162148,patients,1,1
162149,from,1,0
162150,this,1,0
162151,group,1,0
162152,and,1,0
162153,generated,1,0
162154,proton,1,0
162155,SBRT,1,0
162156,treatment,1,0
162157,plans,1,0
162158,",",1,0
162159,using,0,0
162160,the,0,0
162161,identical,0,0
162162,dose,0,0
162163,of,0,0
162164,50Gy,0,0
162165,in,0,0
162166,4,0,0
162167,fractions,0,0
162168,",",0,0
162169,and,0,0
162170,assessed,0,0
162171,potential,0,0
162172,differences,0,0
162173,in,0,0
162174,CW,0,0
162175,dose,0,0
162176,between,0,0
162177,the,0,0
162178,2,0,0
162179,plans,0,0
162180,.,0,0
162181,The,0,0
162182,proton,0,0
162183,SBRT,0,0
162184,plans,0,0
162185,reduced,0,0
162186,the,0,0
162187,CW,0,0
162188,doses,0,0
162189,at,0,0
162190,all,0,0
162191,dose,0,0
162192,levels,0,0
162193,measured,0,0
162194,.,0,0
162195,The,0,0
162196,median,0,0
162197,CW,0,0
162198,V20,0,0
162199,was,0,0
162200,364.0cm,0,0
162201,(,0,0
162202,3,0,0
162203,),0,0
162204,and,0,0
162205,160.0cm,0,0
162206,(,0,0
162207,3,0,0
162208,),0,0
162209,(,0,0
162210,p,0,0
162211,<,0,0
162212,0.0001,0,0
162213,),0,0
162214,",",0,0
162215,V30,0,0
162216,was,0,0
162217,144.6cm,0,0
162218,(,0,0
162219,3,0,0
162220,),0,0
162221,vs,0,0
162222,77.0cm,0,0
162223,(,0,0
162224,3,0,0
162225,),0,0
162226,(,0,0
162227,p,0,0
162228,=,0,0
162229,0.0012,0,0
162230,),0,0
162231,",",0,0
162232,V35,0,0
162233,was,0,0
162234,93.9cm,0,0
162235,(,0,0
162236,3,0,0
162237,),0,0
162238,vs,0,0
162239,57.9cm,0,1
162240,(,0,0
162241,3,0,0
162242,),0,0
162243,(,0,0
162244,p,0,0
162245,=,0,0
162246,0.005,0,0
162247,),0,0
162248,",",0,0
162249,V40,0,0
162250,was,0,0
162251,66.5cm,0,0
162252,(,0,0
162253,3,0,0
162254,),0,0
162255,vs,0,0
162256,45.4cm,0,0
162257,(,0,0
162258,3,0,0
162259,),0,0
162260,(,0,0
162261,p,0,0
162262,=,0,0
162263,0.0112,0,0
162264,),0,0
162265,",",0,0
162266,and,0,0
162267,mean,0,0
162268,lung,0,1
162269,dose,0,0
162270,was,0,0
162271,5.9Gy,0,0
162272,vs,0,0
162273,3.8Gy,0,0
162274,(,0,0
162275,p,0,0
162276,=,0,0
162277,0.0001,0,0
162278,),0,0
162279,for,0,0
162280,photons,0,0
162281,and,0,0
162282,protons,0,0
162283,",",0,0
162284,respectively,0,0
162285,.,0,0
162286,Coverage,0,0
162287,of,0,0
162288,the,0,0
162289,planning,0,0
162290,target,0,0
162291,volume,0,0
162292,(,0,0
162293,PTV,0,0
162294,),0,0
162295,was,0,0
162296,comparable,0,0
162297,between,0,0
162298,the,0,0
162299,2,0,0
162300,sets,0,0
162301,of,0,0
162302,plans,0,0
162303,(,0,0
162304,96.4,0,0
162305,%,0,0
162306,for,0,0
162307,photons,0,0
162308,and,0,0
162309,97,0,1
162310,%,0,0
162311,for,0,0
162312,protons,0,0
162313,),0,0
162314,.,0,0
162315,From,0,0
162316,a,0,0
162317,dosimetric,0,0
162318,standpoint,0,0
162319,",",0,0
162320,proton,0,0
162321,SBRT,0,0
162322,can,0,0
162323,achieve,0,0
162324,the,0,0
162325,same,0,0
162326,coverage,0,0
162327,of,0,0
162328,the,0,0
162329,PTV,0,0
162330,while,0,0
162331,significantly,0,0
162332,reducing,0,0
162333,the,0,0
162334,dose,0,0
162335,to,0,0
162336,the,0,0
162337,CW,0,0
162338,and,0,0
162339,lung,0,1
162340,relative,0,0
162341,to,0,0
162342,photon,0,0
162343,SBRT,0,0
162344,and,0,0
162345,therefore,0,0
162346,may,0,0
162347,be,0,0
162348,beneficial,0,0
162349,for,0,0
162350,the,0,0
162351,treatment,0,0
162352,of,0,0
162353,lesions,0,0
162354,closer,0,0
162355,to,0,0
162356,critical,0,0
162357,structures,0,0
162358,.,0,1
162359,QT/QTc,0,0
162360,study,0,0
162361,conducted,0,0
162362,in,0,0
162363,Japanese,1,1
162364,adult,1,1
162365,healthy,1,1
162366,subjects,1,1
162367,:,1,1
162368,a,0,0
162369,novel,0,0
162370,xanthine,0,0
162371,oxidase,0,0
162372,inhibitor,0,0
162373,topiroxostat,0,0
162374,was,0,0
162375,not,0,0
162376,associated,0,0
162377,with,0,0
162378,QT,0,0
162379,prolongation,0,0
162380,.,0,0
162381,A,0,0
162382,QT/QTc,0,0
162383,study,0,0
162384,was,0,0
162385,conducted,0,0
162386,in,0,0
162387,compliance,0,0
162388,with,0,1
162389,ICH,0,0
162390,E14,0,0
162391,guideline,0,0
162392,to,0,0
162393,evaluate,0,0
162394,the,0,0
162395,effects,0,0
162396,of,0,0
162397,a,0,0
162398,new,0,0
162399,xanthine,0,0
162400,oxidase,0,0
162401,inhibitor,0,0
162402,topiroxostat,0,0
162403,in,0,0
162404,Japanese,1,1
162405,healthy,1,1
162406,subjects,1,1
162407,.,1,1
162408,Forty-eight,1,1
162409,Japanese,1,1
162410,healthy,1,1
162411,subjects,1,1
162412,(,1,1
162413,males,1,1
162414,24,1,1
162415,;,1,1
162416,females,1,1
162417,24,1,0
162418,),1,0
162419,received,0,0
162420,a,0,0
162421,single,0,0
162422,oral,0,0
162423,dose,0,0
162424,of,0,0
162425,topiroxostat,0,0
162426,(,0,0
162427,60,0,1
162428,or,0,1
162429,180,0,1
162430,mg,0,0
162431,),0,0
162432,",",0,0
162433,moxifloxacin,0,0
162434,(,0,0
162435,400,0,0
162436,mg,0,0
162437,),0,0
162438,or,0,0
162439,placebo,0,0
162440,in,0,0
162441,a,0,0
162442,single-center,1,0
162443,",",1,0
162444,double-blind,1,0
162445,",",0,0
162446,four-period,0,0
162447,crossover,0,0
162448,design,0,0
162449,.,0,0
162450,Fridericia,0,0
162451,'s,0,0
162452,formula,0,0
162453,(,0,0
162454,QTcF,0,0
162455,=,0,0
162456,QT/RR,0,0
162457,(,0,0
162458,0.33,0,0
162459,),0,0
162460,),0,0
162461,was,0,0
162462,used,0,0
162463,as,0,0
162464,a,0,0
162465,primary,0,0
162466,method,0,0
162467,for,0,0
162468,QT-interval,0,0
162469,correction,0,0
162470,.,0,0
162471,The,0,0
162472,mean,0,0
162473,QTcF,0,0
162474,was,0,0
162475,prolonged,0,0
162476,by,0,0
162477,moxifloxacin,0,0
162478,",",0,0
162479,of,0,0
162480,which,0,0
162481,largest,0,0
162482,time-matched,0,0
162483,difference,0,0
162484,from,0,0
162485,placebo,0,0
162486,administration,0,0
162487,was,0,0
162488,13.6,0,0
162489,milliseconds,0,0
162490,with,0,1
162491,90,0,0
162492,%,0,0
162493,confidence,0,0
162494,interval,0,0
162495,(,0,0
162496,CI,0,0
162497,),0,0
162498,of,0,0
162499,11.2,0,0
162500,and,0,0
162501,15.9,0,0
162502,milliseconds,0,0
162503,at,0,0
162504,4,0,0
162505,hours,0,0
162506,post-dose,0,0
162507,.,0,0
162508,The,0,0
162509,mean,0,0
162510,QTcF,0,0
162511,was,0,0
162512,hardly,0,0
162513,affected,0,0
162514,by,0,0
162515,either,0,0
162516,dose,0,0
162517,of,0,0
162518,topiroxostat,0,0
162519,",",0,0
162520,of,0,0
162521,which,0,0
162522,largest,0,0
162523,time-matched,0,0
162524,difference,0,0
162525,from,0,0
162526,placebo,0,0
162527,administration,0,0
162528,was,0,0
162529,2.9,0,0
162530,milliseconds,0,0
162531,with,0,1
162532,90,0,0
162533,%,0,0
162534,CI,0,0
162535,of,0,0
162536,0.6,0,0
162537,and,0,0
162538,5.3,0,0
162539,milliseconds,0,0
162540,at,0,0
162541,4,0,0
162542,hours,0,0
162543,post-dose,0,0
162544,for,0,0
162545,60,0,1
162546,mg,0,0
162547,",",0,0
162548,and,0,0
162549,2.3,0,0
162550,milliseconds,0,0
162551,with,0,1
162552,90,0,0
162553,%,0,0
162554,CI,0,0
162555,of,0,0
162556,0,0,0
162557,and,0,0
162558,4.7,0,0
162559,milliseconds,0,0
162560,at,0,0
162561,1,0,0
162562,hour,0,0
162563,post-dose,0,0
162564,for,0,0
162565,180,0,1
162566,mg,0,0
162567,.,0,0
162568,The,0,0
162569,results,0,0
162570,were,0,0
162571,essentially,0,0
162572,the,0,0
162573,same,0,0
162574,in,0,0
162575,the,0,0
162576,sex,0,0
162577,subgroup,0,0
162578,analysis,0,0
162579,.,0,0
162580,Moxifloxacin,0,0
162581,can,0,0
162582,be,0,0
162583,used,0,0
162584,as,0,0
162585,a,0,0
162586,positive,0,0
162587,control,0,0
162588,for,0,0
162589,QT/QTc,0,0
162590,studies,0,0
162591,in,0,0
162592,Japanese,1,1
162593,subjects,1,1
162594,;,1,0
162595,and,0,0
162596,topiroxostat,0,0
162597,may,0,0
162598,not,0,0
162599,cause,0,0
162600,QT-interval,0,0
162601,prolongation,0,0
162602,in,0,0
162603,males,0,1
162604,as,0,0
162605,well,0,0
162606,as,0,0
162607,females,0,1
162608,.,0,1
162609,The,0,0
162610,cardiovascular,0,0
162611,effects,0,0
162612,of,0,0
162613,sevoflurane,0,0
162614,and,0,0
162615,isoflurane,0,0
162616,after,0,0
162617,premedication,0,0
162618,of,0,0
162619,healthy,1,1
162620,dogs,1,1
162621,undergoing,1,1
162622,elective,1,1
162623,surgery,1,1
162624,.,1,0
162625,Sevoflurane,0,0
162626,and,0,0
162627,isoflurane,0,0
162628,are,0,0
162629,commonly,0,0
162630,used,0,0
162631,in,0,0
162632,veterinary,0,1
162633,anesthesia,0,0
162634,.,0,0
162635,The,0,0
162636,objective,0,0
162637,of,0,0
162638,this,0,0
162639,prospective,0,0
162640,",",0,0
162641,randomized,0,0
162642,",",0,0
162643,open-label,0,0
162644,clinical,0,0
162645,study,0,0
162646,was,0,0
162647,to,0,0
162648,compare,0,0
162649,the,0,0
162650,cardiovascular,0,0
162651,effects,0,0
162652,of,0,0
162653,sevoflurane,0,0
162654,and,0,0
162655,isoflurane,0,0
162656,via,0,0
162657,direct,0,0
162658,arterial,0,1
162659,blood,0,0
162660,pressure,0,0
162661,measurements,0,0
162662,and,0,0
162663,the,0,0
162664,lithium,0,0
162665,dilution,0,0
162666,cardiac,0,0
162667,output,0,0
162668,(,0,0
162669,LDCO,0,0
162670,),0,0
162671,on,0,0
162672,premedicated,1,1
162673,healthy,1,1
162674,dogs,1,1
162675,undergoing,1,1
162676,elective,1,1
162677,tibial,1,0
162678,plateau,1,0
162679,leveling,1,0
162680,osteotomy,1,0
162681,(,1,0
162682,TPLO,1,0
162683,),1,0
162684,.,1,0
162685,Nineteen,1,1
162686,client-owned,1,1
162687,dogs,1,1
162688,were,0,0
162689,included,0,1
162690,.,0,0
162691,All,0,0
162692,dogs,0,1
162693,were,0,0
162694,premedicated,0,1
162695,with,0,0
162696,hydromorphone,0,0
162697,(,0,0
162698,0.05,0,0
162699,mg/kg,0,0
162700,IV,0,0
162701,and,0,0
162702,glycopyrrolate,0,0
162703,0.01,0,0
162704,mg/kg,0,0
162705,subcutaneously,0,0
162706,),0,0
162707,.,0,0
162708,Ten,1,1
162709,dogs,1,1
162710,were,1,0
162711,anesthetized,1,1
162712,with,1,0
162713,sevoflurane,1,0
162714,and,1,0
162715,nine,1,1
162716,dogs,1,1
162717,were,1,0
162718,anesthetized,1,1
162719,with,1,1
162720,isoflurane,1,0
162721,.,1,0
162722,Eighteen,0,1
162723,dogs,0,1
162724,were,0,0
162725,instrumented,0,0
162726,with,0,0
162727,a,0,0
162728,dorsal,0,0
162729,pedal,0,0
162730,arterial,0,0
162731,catheter,0,0
162732,",",0,0
162733,and,0,0
162734,one,0,0
162735,dog,0,0
162736,had,0,0
162737,a,0,0
162738,femoral,0,0
162739,arterial,0,0
162740,catheter,0,0
162741,.,0,0
162742,All,0,0
162743,dogs,0,1
162744,had,0,0
162745,continuous,0,0
162746,",",0,0
162747,direct,0,0
162748,systolic,0,0
162749,(,0,0
162750,SAP,0,0
162751,),0,0
162752,",",0,0
162753,diastolic,0,0
162754,(,0,0
162755,DAP,0,0
162756,),0,0
162757,",",0,0
162758,and,0,0
162759,mean,0,0
162760,arterial,0,1
162761,(,0,0
162762,MAP,0,0
162763,),0,0
162764,blood,0,0
162765,pressure,0,0
162766,readings,0,0
162767,as,0,0
162768,well,0,0
162769,as,0,0
162770,heart,0,0
162771,rate,0,0
162772,(,0,0
162773,HR,0,0
162774,),0,0
162775,",",0,0
162776,cardiac,0,0
162777,output,0,0
162778,(,0,0
162779,CO,0,0
162780,),0,0
162781,",",0,0
162782,cardiac,0,0
162783,index,0,0
162784,(,0,0
162785,CI,0,0
162786,),0,0
162787,",",0,0
162788,systemic,0,0
162789,vascular,0,0
162790,resistance,0,0
162791,(,0,0
162792,SVR,0,0
162793,),0,0
162794,",",0,0
162795,systemic,0,0
162796,vascular,0,0
162797,resistance,0,0
162798,index,0,0
162799,(,0,0
162800,SVRI,0,0
162801,),0,0
162802,",",0,0
162803,stroke,0,1
162804,volume,0,0
162805,variation,0,0
162806,(,0,0
162807,SVV,0,0
162808,),0,0
162809,",",0,0
162810,and,0,0
162811,pulse,0,0
162812,pressure,0,0
162813,variation,0,0
162814,(,0,0
162815,PPV,0,0
162816,),0,0
162817,recorded,0,0
162818,q,0,0
162819,5,0,0
162820,min,0,0
162821,during,0,0
162822,the,0,0
162823,surgical,0,0
162824,procedure,0,0
162825,.,0,0
162826,There,0,0
162827,was,0,0
162828,no,0,0
162829,significant,0,0
162830,statistical,0,0
162831,difference,0,0
162832,in,0,0
162833,all,0,0
162834,parameters,0,0
162835,between,0,0
162836,the,0,0
162837,sevoflurane,0,0
162838,and,0,0
162839,isoflurane,0,0
162840,treatment,0,0
162841,groups,0,0
162842,.,0,0
162843,Both,0,0
162844,sevoflurane,0,0
162845,and,0,0
162846,isoflurane,0,0
162847,inhalant,0,1
162848,anesthetics,0,0
162849,appear,0,0
162850,to,0,0
162851,have,0,0
162852,similar,0,0
162853,hemodynamic,0,0
162854,effects,0,0
162855,when,0,0
162856,used,0,0
162857,as,0,0
162858,part,0,0
162859,of,0,0
162860,a,0,0
162861,multimodal,0,0
162862,anesthetic,0,0
162863,protocol,0,0
162864,in,0,0
162865,premedicated,1,1
162866,healthy,1,1
162867,dogs,1,1
162868,undergoing,1,1
162869,an,1,0
162870,elective,1,1
162871,surgical,1,0
162872,procedure,1,0
162873,.,1,0
162874,A,0,0
162875,randomised,0,0
162876,",",0,0
162877,double-blind,0,0
162878,",",0,0
162879,parallel,0,0
162880,design,0,0
162881,",",0,0
162882,multi-institutional,0,0
162883,",",0,0
162884,non-inferiority,0,0
162885,phase,0,0
162886,IV,0,0
162887,trial,0,0
162888,of,0,0
162889,imidafenacin,0,0
162890,versus,0,0
162891,fesoterodine,0,0
162892,for,0,0
162893,overactive,1,1
162894,bladder,1,1
162895,.,1,0
162896,AIMS,0,0
162897,Our,0,0
162898,objective,0,0
162899,was,0,0
162900,to,0,0
162901,compare,0,0
162902,the,0,0
162903,efficacy,0,0
162904,and,0,0
162905,safety,0,0
162906,of,0,0
162907,imidafenacin,0,0
162908,over,0,0
162909,fesoterodine,0,0
162910,in,0,0
162911,patients,1,1
162912,with,1,1
162913,overactive,1,1
162914,bladder,1,1
162915,(,1,0
162916,OAB,1,0
162917,),1,0
162918,.,1,0
162919,METHODS,0,0
162920,This,0,0
162921,study,0,0
162922,is,0,0
162923,a,0,0
162924,randomised,0,0
162925,",",0,0
162926,double-blind,0,0
162927,",",0,0
162928,parallel-group,0,0
162929,",",0,0
162930,fesoterodine-controlled,0,0
162931,study,0,0
162932,in,0,0
162933,patients,1,1
162934,with,1,1
162935,continuous,1,0
162936,OAB,1,0
162937,symptoms,1,0
162938,for,1,0
162939,?,1,0
162940,3,1,0
162941,months,1,0
162942,",",1,0
162943,daily,1,0
162944,mean,1,0
162945,voiding,1,0
162946,frequency,1,0
162947,(,1,0
162948,DMVF,1,0
162949,),1,0
162950,?,1,0
162951,8,1,0
162952,",",1,0
162953,and,1,0
162954,daily,1,0
162955,mean,1,0
162956,urgency,1,0
162957,or,1,0
162958,urgency,1,0
162959,incontinence,1,0
162960,frequency,1,0
162961,?,1,0
162962,2,1,0
162963,.,1,0
162964,A,1,0
162965,twice-daily,0,0
162966,0.1,0,0
162967,mg,0,0
162968,imidafenacin,0,0
162969,with,0,0
162970,placebo,0,0
162971,",",0,0
162972,or,0,0
162973,once-daily,0,0
162974,4,0,0
162975,mg,0,0
162976,fesoterodine,0,0
162977,with,0,1
162978,placebo,0,0
162979,were,0,0
162980,administered,0,0
162981,for,0,0
162982,12,0,0
162983,weeks,0,0
162984,.,0,0
162985,The,0,0
162986,primary,0,0
162987,efficacy,0,0
162988,end-point,0,0
162989,was,0,0
162990,the,0,0
162991,difference,0,0
162992,in,0,0
162993,DMVF,0,0
162994,at,0,0
162995,12,0,1
162996,weeks,0,0
162997,.,0,0
162998,The,0,0
162999,secondary,0,0
163000,efficacy,0,0
163001,end-points,0,0
163002,were,0,0
163003,differences,0,0
163004,in,0,0
163005,daily,0,0
163006,mean,0,1
163007,:,0,1
163008,(,0,0
163009,i,0,0
163010,),0,0
163011,voiding,0,0
163012,frequency,0,0
163013,at,0,0
163014,4,0,0
163015,and,0,0
163016,8,0,0
163017,weeks,0,0
163018,;,0,0
163019,(,0,0
163020,ii,0,0
163021,),0,0
163022,urgency,0,0
163023,frequency,0,0
163024,;,0,0
163025,(,0,0
163026,iii,0,0
163027,),0,0
163028,urgency,0,0
163029,incontinence,0,0
163030,frequency,0,0
163031,;,0,0
163032,(,0,0
163033,iv,0,0
163034,),0,0
163035,incontinence,0,0
163036,frequency,0,0
163037,;,0,0
163038,(,0,0
163039,v,0,0
163040,),0,0
163041,nocturia,0,0
163042,frequency,0,0
163043,;,0,0
163044,and,0,0
163045,(,0,0
163046,vi,0,0
163047,),0,0
163048,quality,0,0
163049,of,0,0
163050,life,0,0
163051,score,0,0
163052,.,0,0
163053,The,0,0
163054,variables,0,0
163055,for,0,0
163056,safety,0,0
163057,analysis,0,0
163058,were,0,0
163059,adverse,0,0
163060,events,0,0
163061,",",0,0
163062,vital,0,0
163063,signs,0,0
163064,",",0,0
163065,residual,0,0
163066,urine,0,0
163067,volume,0,0
163068,and,0,0
163069,clinical,0,0
163070,laboratory,0,0
163071,tests,0,0
163072,.,0,0
163073,An,0,0
163074,efficacy,0,0
163075,analysis,0,0
163076,was,0,0
163077,conducted,0,0
163078,in,0,0
163079,per-protocol,0,0
163080,patients,0,1
163081,and,0,0
163082,the,0,0
163083,safety,0,0
163084,analysis,0,0
163085,was,0,0
163086,conducted,0,0
163087,in,0,0
163088,all,0,0
163089,randomised,0,0
163090,patients,0,1
163091,.,0,0
163092,RESULTS,0,0
163093,The,0,0
163094,differences,0,0
163095,in,0,0
163096,DMVF,0,0
163097,at,0,0
163098,12,0,0
163099,weeks,0,0
163100,were,0,0
163101,-3.38,0,0
163102,?,0,0
163103,3.63,0,0
163104,and,0,0
163105,-2.45,0,0
163106,?,0,0
163107,3.73,0,0
163108,in,0,0
163109,the,0,0
163110,imidafenacin,0,0
163111,and,0,0
163112,fesoterodine,0,0
163113,groups,0,0
163114,",",0,0
163115,respectively,0,0
163116,",",0,0
163117,and,0,0
163118,the,0,0
163119,difference,0,0
163120,was,0,0
163121,not,0,0
163122,significant,0,0
163123,between,0,0
163124,the,0,0
163125,two,0,0
163126,groups,0,0
163127,.,0,1
163128,Imidafenacin,0,0
163129,was,0,0
163130,non-inferior,0,0
163131,to,0,0
163132,fesoterodine,0,0
163133,",",0,0
163134,and,0,0
163135,the,0,0
163136,lower,0,0
163137,limit,0,0
163138,of,0,0
163139,95,0,0
163140,%,0,0
163141,two-sided,0,0
163142,confidence,0,0
163143,intervals,0,0
163144,was,0,0
163145,-0.53,0,0
163146,.,0,0
163147,The,0,0
163148,other,0,0
163149,six,0,0
163150,secondary,0,0
163151,end-points,0,0
163152,and,0,0
163153,variables,0,0
163154,for,0,0
163155,safety,0,0
163156,analysis,0,0
163157,showed,0,0
163158,no,0,0
163159,difference,0,0
163160,between,0,0
163161,the,0,0
163162,two,0,0
163163,groups,0,0
163164,.,0,1
163165,CONCLUSIONS,0,0
163166,Imidafenacin,0,0
163167,was,0,0
163168,non-inferior,0,0
163169,to,0,0
163170,fesoterodine,0,0
163171,in,0,0
163172,terms,0,0
163173,of,0,0
163174,efficacy,0,0
163175,",",0,0
163176,and,0,0
163177,showed,0,0
163178,no,0,0
163179,significant,0,0
163180,difference,0,0
163181,in,0,0
163182,terms,0,0
163183,of,0,0
163184,safety,0,0
163185,.,0,0
163186,Stimulus,0,0
163187,over-selectivity,0,0
163188,in,0,0
163189,temporal,1,0
163190,brain,1,0
163191,injury,1,1
163192,:,1,0
163193,mindfulness,0,0
163194,as,0,0
163195,a,0,0
163196,potential,0,0
163197,intervention,0,0
163198,.,0,0
163199,OBJECTIVE,0,0
163200,The,0,0
163201,current,0,0
163202,study,0,0
163203,aimed,0,0
163204,to,0,0
163205,investigate,0,0
163206,the,0,0
163207,impact,0,0
163208,of,0,0
163209,brief,0,0
163210,mindfulness,0,0
163211,training,0,0
163212,on,0,0
163213,the,0,0
163214,performance,0,0
163215,of,0,0
163216,a,0,0
163217,sample,0,1
163218,of,0,0
163219,patients,1,1
163220,with,1,1
163221,TBI,1,1
163222,in,1,0
163223,an,1,0
163224,over-selectivity,1,0
163225,task,1,0
163226,.,1,0
163227,PARTICIPANTS,0,0
163228,Twenty-four,1,1
163229,patients,1,1
163230,who,1,1
163231,had,1,1
163232,suffered,1,1
163233,TBI,1,1
163234,and,1,0
163235,reported,1,0
163236,problems,1,1
163237,with,1,1
163238,focused,1,0
163239,or,1,0
163240,sustained,1,0
163241,attention,1,0
163242,.,1,0
163243,METHOD,0,0
163244,The,0,0
163245,study,0,0
163246,was,0,0
163247,a,0,0
163248,between-subjects,0,0
163249,design,0,0
163250,(,0,0
163251,mindfulness,0,0
163252,intervention,0,0
163253,vs,0,0
163254,control,0,0
163255,),0,0
163256,with,0,0
163257,difference,0,0
163258,between,0,0
163259,number,0,0
163260,of,0,0
163261,most,0,0
163262,and,0,0
163263,least,0,0
163264,chosen,0,0
163265,stimulus,0,0
163266,selections,0,0
163267,on,0,0
163268,an,0,0
163269,over-selectivity,0,0
163270,task,0,0
163271,as,0,0
163272,the,0,0
163273,dependent,0,0
163274,measure,0,0
163275,.,0,0
163276,RESULTS,0,0
163277,The,0,0
163278,results,0,0
163279,of,0,0
163280,this,0,0
163281,study,0,0
163282,indicated,0,0
163283,that,0,0
163284,stimulus,0,0
163285,over-selectivity,0,0
163286,was,0,0
163287,present,0,0
163288,in,0,0
163289,a,0,0
163290,group,0,0
163291,of,0,0
163292,patients,0,1
163293,with,0,1
163294,TBI,0,1
163295,.,0,0
163296,However,0,0
163297,",",0,0
163298,the,0,0
163299,level,0,0
163300,of,0,0
163301,emergent,0,1
163302,over-selectivity,0,0
163303,was,0,0
163304,significantly,0,0
163305,reduced,0,0
163306,by,0,0
163307,a,0,0
163308,mindfulness,0,0
163309,induction,0,0
163310,when,0,0
163311,compared,0,0
163312,to,0,0
163313,a,0,0
163314,no-,0,0
163315,intervention,0,0
163316,control,0,0
163317,group,0,0
163318,.,0,0
163319,CONCLUSIONS,0,0
163320,The,0,0
163321,findings,0,0
163322,are,0,0
163323,discussed,0,0
163324,in,0,0
163325,terms,0,0
163326,of,0,0
163327,the,0,0
163328,efficacy,0,0
163329,of,0,0
163330,mindfulness,0,0
163331,training,0,0
163332,in,0,0
163333,reducing,0,0
163334,TBI-related,0,0
163335,cognitive,0,0
163336,deficits,0,0
163337,.,0,1
163338,Does,0,0
163339,alliance,0,0
163340,predict,0,0
163341,symptoms,0,0
163342,throughout,0,0
163343,treatment,0,0
163344,",",0,0
163345,or,0,0
163346,is,0,0
163347,it,0,0
163348,the,0,0
163349,other,0,0
163350,way,0,0
163351,around,0,0
163352,?,0,0
163353,OBJECTIVE,0,0
163354,Scholars,0,0
163355,increasingly,0,0
163356,recognize,0,0
163357,that,0,0
163358,therapeutic,0,0
163359,alliance,0,0
163360,and,0,0
163361,symptomatic,0,1
163362,change,0,0
163363,are,0,0
163364,associated,0,0
163365,with,0,1
163366,one,0,0
163367,another,0,0
163368,.,0,0
163369,A,0,0
163370,common,0,0
163371,assumption,0,0
163372,is,0,0
163373,that,0,0
163374,alliance,0,0
163375,predicts,0,0
163376,symptomatic,0,1
163377,change,0,0
163378,.,0,0
163379,However,0,0
163380,",",0,0
163381,the,0,0
163382,issue,0,0
163383,is,0,0
163384,far,0,0
163385,from,0,0
163386,settled,0,0
163387,.,0,0
163388,One,0,0
163389,challenge,0,0
163390,in,0,0
163391,determining,0,0
163392,the,0,0
163393,causality,0,0
163394,is,0,0
163395,the,0,0
163396,establishment,0,0
163397,of,0,0
163398,temporal,0,0
163399,precedence,0,0
163400,showing,0,0
163401,that,0,0
163402,alliance,0,0
163403,",",0,0
163404,as,0,0
163405,opposed,0,0
163406,to,0,0
163407,previous,0,0
163408,symptomatic,0,1
163409,change,0,0
163410,",",0,0
163411,drives,0,0
163412,subsequent,0,0
163413,symptomatic,0,1
163414,reduction,0,0
163415,.,0,0
163416,METHOD,0,0
163417,To,0,0
163418,make,0,0
163419,further,0,0
163420,advances,0,0
163421,in,0,0
163422,untangling,0,0
163423,this,0,0
163424,chicken-and-egg,0,0
163425,question,0,0
163426,",",0,0
163427,we,0,0
163428,employed,0,0
163429,autoregressive,0,0
163430,cross-lagged,0,0
163431,modeling,0,0
163432,over,0,0
163433,4,0,0
163434,time,0,0
163435,points,0,0
163436,in,0,0
163437,a,0,0
163438,sample,0,1
163439,of,0,0
163440,149,1,1
163441,depressive,1,0
163442,patients,1,1
163443,receiving,1,1
163444,supportive-expressive,1,0
163445,psychotherapy,1,1
163446,or,1,0
163447,clinical,1,0
163448,management,1,0
163449,combined,1,0
163450,with,1,0
163451,pharmacotherapy,1,1
163452,or,1,0
163453,clinical,1,0
163454,management,1,0
163455,combined,1,0
163456,with,1,1
163457,placebo,1,0
163458,.,1,0
163459,RESULTS,0,0
163460,Using,0,0
163461,this,0,0
163462,methodology,0,0
163463,",",0,0
163464,we,0,0
163465,found,0,0
163466,that,0,0
163467,both,0,0
163468,alliance,0,0
163469,and,0,0
163470,symptoms,0,0
163471,across,0,0
163472,treatment,0,0
163473,made,0,0
163474,significant,0,0
163475,and,0,0
163476,unique,0,0
163477,contributions,0,0
163478,in,0,0
163479,predicting,0,0
163480,subsequent,0,0
163481,symptomatic,0,1
163482,levels,0,0
163483,throughout,0,0
163484,treatment,0,0
163485,.,0,0
163486,Additionally,0,0
163487,",",0,0
163488,alliance,0,0
163489,",",0,0
163490,but,0,0
163491,not,0,0
163492,symptoms,0,0
163493,",",0,0
163494,predicted,0,0
163495,subsequent,0,0
163496,alliance,0,1
163497,levels,0,0
163498,.,0,0
163499,No,0,0
163500,differences,0,0
163501,were,0,0
163502,found,0,0
163503,between,0,0
163504,treatments,0,0
163505,.,0,1
163506,CONCLUSIONS,0,0
163507,Our,0,0
163508,findings,0,0
163509,imply,0,0
163510,that,0,0
163511,alliance,0,0
163512,temporally,0,0
163513,precedes,0,0
163514,symptomatic,0,0
163515,levels,0,0
163516,throughout,0,0
163517,treatment,0,0
163518,.,0,0
163519,A,0,0
163520,double-blind,0,0
163521,",",0,0
163522,randomized,0,0
163523,trial,0,0
163524,of,0,0
163525,deep,0,0
163526,repetitive,0,0
163527,transcranial,0,0
163528,magnetic,0,0
163529,stimulation,0,0
163530,(,0,0
163531,rTMS,0,0
163532,),0,0
163533,for,0,0
163534,autism,1,1
163535,spectrum,1,1
163536,disorder,1,1
163537,.,1,0
163538,BACKGROUND,0,0
163539,Biomedical,0,0
163540,treatment,0,0
163541,options,0,0
163542,for,0,0
163543,autism,0,1
163544,spectrum,0,1
163545,disorder,0,1
163546,(,0,0
163547,ASD,0,1
163548,),0,0
163549,are,0,0
163550,extremely,0,0
163551,limited,0,0
163552,.,0,0
163553,Repetitive,0,0
163554,transcranial,0,0
163555,magnetic,0,0
163556,stimulation,0,0
163557,(,0,0
163558,rTMS,0,0
163559,),0,0
163560,is,0,0
163561,a,0,0
163562,safe,0,0
163563,and,0,0
163564,efficacious,0,0
163565,technique,0,0
163566,when,0,0
163567,targeting,0,0
163568,specific,0,0
163569,areas,0,0
163570,of,0,0
163571,cortical,0,0
163572,dysfunction,0,1
163573,in,0,0
163574,major,0,0
163575,depressive,0,0
163576,disorder,0,1
163577,",",0,0
163578,and,0,0
163579,a,0,0
163580,similar,0,0
163581,approach,0,0
163582,could,0,0
163583,yield,0,0
163584,therapeutic,0,0
163585,benefits,0,0
163586,in,0,0
163587,ASD,0,1
163588,",",0,0
163589,if,0,0
163590,applied,0,0
163591,to,0,0
163592,relevant,0,0
163593,cortical,0,0
163594,regions,0,0
163595,.,0,0
163596,OBJECTIVE,0,0
163597,The,0,0
163598,aim,0,0
163599,of,0,0
163600,this,0,0
163601,study,0,0
163602,was,0,0
163603,to,0,0
163604,examine,0,0
163605,whether,0,0
163606,deep,0,0
163607,rTMS,0,0
163608,to,0,0
163609,bilateral,0,1
163610,dorsomedial,0,0
163611,prefrontal,0,0
163612,cortex,0,0
163613,improves,0,0
163614,social,0,0
163615,relating,0,0
163616,in,0,0
163617,ASD,0,1
163618,.,0,1
163619,METHODS,0,0
163620,28,1,0
163621,adults,1,1
163622,diagnosed,1,1
163623,with,1,1
163624,either,1,0
163625,autistic,1,1
163626,disorder,1,1
163627,(,1,0
163628,high-functioning,1,1
163629,),1,0
163630,or,1,0
163631,Asperger,1,1
163632,'s,1,0
163633,disorder,1,1
163634,completed,1,1
163635,a,0,0
163636,prospective,0,0
163637,",",0,0
163638,double-blind,0,0
163639,",",0,0
163640,randomized,0,0
163641,",",0,0
163642,placebo-controlled,0,0
163643,design,0,0
163644,with,0,1
163645,2,0,0
163646,weeks,0,0
163647,of,0,0
163648,daily,0,0
163649,weekday,0,0
163650,treatment,0,0
163651,.,0,0
163652,This,0,0
163653,involved,0,0
163654,deep,0,0
163655,rTMS,0,0
163656,to,0,0
163657,bilateral,0,1
163658,dorsomedial,0,0
163659,prefrontal,0,0
163660,cortex,0,0
163661,(,0,0
163662,5,0,0
163663,Hz,0,0
163664,",",0,0
163665,10-s,0,0
163666,train,0,0
163667,duration,0,0
163668,",",0,0
163669,20-s,0,0
163670,inter-train,0,0
163671,interval,0,0
163672,),0,0
163673,for,0,0
163674,15,0,0
163675,min,0,0
163676,(,0,0
163677,1500,0,0
163678,pulses,0,0
163679,per,0,0
163680,session,0,0
163681,),0,0
163682,using,0,0
163683,a,0,0
163684,HAUT-Coil,0,0
163685,.,0,0
163686,The,0,0
163687,sham,0,0
163688,rTMS,0,0
163689,coil,0,0
163690,was,0,0
163691,encased,0,0
163692,in,0,0
163693,the,0,0
163694,same,0,0
163695,helmet,0,0
163696,of,0,0
163697,the,0,0
163698,active,0,0
163699,deep,0,0
163700,rTMS,0,0
163701,coil,0,0
163702,",",0,0
163703,but,0,0
163704,no,0,0
163705,effective,0,0
163706,field,0,0
163707,was,0,0
163708,delivered,0,0
163709,into,0,0
163710,the,0,0
163711,brain,0,0
163712,.,0,0
163713,Assessments,0,0
163714,were,0,0
163715,conducted,0,0
163716,before,0,0
163717,",",0,0
163718,after,0,0
163719,",",0,0
163720,and,0,0
163721,one,0,0
163722,month,0,0
163723,following,0,0
163724,treatment,0,0
163725,.,0,1
163726,RESULTS,0,0
163727,Participants,0,1
163728,in,0,0
163729,the,0,0
163730,active,0,0
163731,condition,0,0
163732,showed,0,0
163733,a,0,0
163734,near,0,0
163735,significant,0,0
163736,reduction,0,0
163737,in,0,0
163738,self-reported,0,0
163739,social,0,0
163740,relating,0,0
163741,symptoms,0,0
163742,from,0,0
163743,pre-treatment,0,0
163744,to,0,0
163745,one,0,0
163746,month,0,0
163747,follow-up,0,0
163748,",",0,0
163749,and,0,0
163750,a,0,0
163751,significant,0,0
163752,reduction,0,0
163753,in,0,0
163754,social,0,0
163755,relating,0,0
163756,symptoms,0,0
163757,(,0,0
163758,relative,0,0
163759,to,0,0
163760,sham,0,0
163761,participants,0,1
163762,),0,0
163763,for,0,0
163764,both,0,0
163765,post-treatment,0,0
163766,assessments,0,0
163767,.,0,0
163768,Those,0,0
163769,in,0,0
163770,the,0,0
163771,active,0,0
163772,condition,0,0
163773,also,0,0
163774,showed,0,0
163775,a,0,0
163776,reduction,0,0
163777,in,0,0
163778,self-oriented,0,0
163779,anxiety,0,0
163780,during,0,0
163781,difficult,0,0
163782,and,0,0
163783,emotional,0,0
163784,social,0,0
163785,situations,0,0
163786,from,0,0
163787,pre-treatment,0,0
163788,to,0,0
163789,one,0,0
163790,month,0,0
163791,follow-up,0,0
163792,.,0,0
163793,There,0,0
163794,were,0,0
163795,no,0,0
163796,changes,0,0
163797,for,0,0
163798,those,0,0
163799,in,0,0
163800,the,0,0
163801,sham,0,0
163802,condition,0,0
163803,.,0,0
163804,CONCLUSION,0,0
163805,Deep,0,0
163806,rTMS,0,0
163807,to,0,0
163808,bilateral,0,1
163809,dorsomedial,0,0
163810,prefrontal,0,0
163811,cortex,0,0
163812,yielded,0,0
163813,a,0,0
163814,reduction,0,0
163815,in,0,0
163816,social,0,0
163817,relating,0,0
163818,impairment,0,0
163819,and,0,0
163820,socially-related,0,0
163821,anxiety,0,0
163822,.,0,0
163823,Further,0,0
163824,research,0,0
163825,in,0,0
163826,this,0,0
163827,area,0,0
163828,should,0,0
163829,employ,0,0
163830,extended,0,0
163831,rTMS,0,0
163832,protocols,0,0
163833,that,0,0
163834,approximate,0,0
163835,those,0,0
163836,used,0,0
163837,in,0,0
163838,depression,0,0
163839,in,0,0
163840,an,0,0
163841,attempt,0,0
163842,to,0,0
163843,replicate,0,0
163844,and,0,0
163845,amplify,0,0
163846,the,0,0
163847,clinical,0,0
163848,response,0,0
163849,.,0,0
163850,Predictors,0,0
163851,of,0,0
163852,postdischarge,0,0
163853,outcomes,0,0
163854,from,0,0
163855,information,0,0
163856,acquired,0,0
163857,shortly,0,0
163858,after,0,0
163859,admission,0,0
163860,for,0,0
163861,acute,1,1
163862,heart,1,1
163863,failure,1,1
163864,:,1,0
163865,a,0,0
163866,report,0,0
163867,from,0,0
163868,the,0,0
163869,Placebo-Controlled,0,0
163870,Randomized,0,0
163871,Study,0,0
163872,of,0,0
163873,the,0,0
163874,Selective,0,0
163875,A1,0,0
163876,Adenosine,0,0
163877,Receptor,0,0
163878,Antagonist,0,0
163879,Rolofylline,0,0
163880,for,0,0
163881,Patients,1,1
163882,Hospitalized,1,1
163883,With,1,1
163884,Acute,1,0
163885,Decompensated,1,1
163886,Heart,1,0
163887,Failure,1,0
163888,and,1,0
163889,Volume,1,0
163890,Overload,1,1
163891,to,0,0
163892,Assess,0,0
163893,Treatment,0,0
163894,Effect,0,0
163895,on,0,0
163896,Congestion,0,0
163897,and,0,0
163898,Renal,0,0
163899,Function,0,0
163900,(,0,0
163901,PROTECT,0,0
163902,),0,0
163903,Study,0,0
163904,.,0,0
163905,BACKGROUND,0,0
163906,Acute,1,0
163907,heart,1,1
163908,failure,1,0
163909,is,0,0
163910,a,0,0
163911,common,0,0
163912,reason,0,0
163913,for,0,0
163914,admission,0,0
163915,",",0,0
163916,and,0,0
163917,outcome,0,0
163918,is,0,0
163919,often,0,0
163920,poor,0,0
163921,.,0,0
163922,Improved,0,0
163923,prognostic,0,0
163924,risk,0,0
163925,stratification,0,0
163926,may,0,0
163927,assist,0,0
163928,in,0,0
163929,the,0,0
163930,design,0,0
163931,of,0,0
163932,future,0,0
163933,trials,0,0
163934,and,0,0
163935,in,0,0
163936,patient,0,0
163937,management,0,0
163938,.,0,0
163939,Using,0,0
163940,data,0,0
163941,from,0,1
163942,a,0,0
163943,large,0,0
163944,randomized,0,0
163945,trial,0,0
163946,",",0,0
163947,we,0,0
163948,explored,0,0
163949,the,0,0
163950,prognostic,0,0
163951,value,0,0
163952,of,0,0
163953,clinical,0,0
163954,variables,0,0
163955,",",0,0
163956,measured,0,0
163957,at,0,0
163958,hospital,0,0
163959,admission,0,0
163960,for,0,0
163961,acute,0,1
163962,heart,0,1
163963,failure,0,1
163964,",",0,0
163965,to,0,0
163966,determine,0,0
163967,whether,0,0
163968,a,0,0
163969,few,0,0
163970,selected,0,1
163971,variables,0,0
163972,were,0,0
163973,inferior,0,0
163974,to,0,0
163975,an,0,0
163976,extended,0,0
163977,data,0,0
163978,set,0,0
163979,.,0,0
163980,METHODS,0,0
163981,AND,0,0
163982,RESULTS,0,0
163983,The,0,0
163984,prognostic,0,0
163985,model,0,0
163986,included,0,1
163987,37,0,1
163988,clinical,0,0
163989,characteristics,0,0
163990,collected,0,0
163991,at,0,0
163992,baseline,0,0
163993,in,0,0
163994,PROTECT,0,0
163995,",",0,0
163996,a,0,0
163997,study,0,0
163998,comparing,0,0
163999,rolofylline,0,0
164000,and,0,0
164001,placebo,0,0
164002,in,0,0
164003,2033,1,1
164004,patients,1,1
164005,admitted,1,1
164006,with,1,1
164007,acute,1,1
164008,heart,1,1
164009,failure,1,1
164010,.,1,0
164011,Prespecified,0,0
164012,outcomes,0,0
164013,at,0,0
164014,30,0,1
164015,days,0,0
164016,were,0,0
164017,death,0,0
164018,or,0,0
164019,rehospitalization,0,0
164020,for,0,0
164021,any,0,0
164022,reason,0,0
164023,;,0,0
164024,death,0,0
164025,or,0,0
164026,rehospitalization,0,0
164027,for,0,0
164028,cardiovascular,0,0
164029,or,0,1
164030,renal,0,1
164031,reasons,0,0
164032,;,0,0
164033,and,0,0
164034,",",0,0
164035,at,0,0
164036,both,0,0
164037,30,0,0
164038,and,0,0
164039,180,0,1
164040,days,0,0
164041,",",0,0
164042,all-cause,0,0
164043,mortality,0,0
164044,.,0,0
164045,No,0,0
164046,variable,0,0
164047,had,0,0
164048,a,0,0
164049,c-index,0,0
164050,>,0,0
164051,0.70,0,0
164052,",",0,0
164053,and,0,0
164054,few,0,0
164055,had,0,0
164056,values,0,0
164057,>,0,1
164058,0.60,0,0
164059,;,0,0
164060,c-indices,0,0
164061,were,0,0
164062,lower,0,0
164063,for,0,0
164064,composite,0,0
164065,outcomes,0,0
164066,than,0,0
164067,for,0,0
164068,mortality,0,0
164069,.,0,0
164070,Blood,0,0
164071,urea,0,0
164072,was,0,0
164073,generally,0,0
164074,the,0,0
164075,strongest,0,0
164076,single,0,0
164077,predictor,0,0
164078,.,0,0
164079,Eighteen,0,1
164080,variables,0,0
164081,contributed,0,0
164082,independent,0,0
164083,prognostic,0,0
164084,information,0,0
164085,",",0,0
164086,but,0,0
164087,a,0,0
164088,reduced,0,0
164089,model,0,0
164090,using,0,0
164091,only,0,0
164092,8,0,0
164093,items,0,0
164094,(,0,0
164095,age,0,1
164096,",",0,0
164097,previous,0,0
164098,heart,0,1
164099,failure,0,1
164100,hospitalization,0,0
164101,",",0,0
164102,peripheral,0,0
164103,edema,0,0
164104,",",0,0
164105,systolic,0,0
164106,blood,0,0
164107,pressure,0,0
164108,",",0,0
164109,serum,0,0
164110,sodium,0,0
164111,",",0,0
164112,urea,0,0
164113,",",0,0
164114,creatinine,0,0
164115,",",0,0
164116,and,0,0
164117,albumin,0,0
164118,),0,0
164119,performed,0,0
164120,similarly,0,0
164121,.,0,0
164122,For,0,0
164123,prediction,0,0
164124,of,0,0
164125,all-cause,0,0
164126,mortality,0,0
164127,at,0,0
164128,180,0,1
164129,days,0,0
164130,",",0,0
164131,the,0,0
164132,model,0,0
164133,c-index,0,0
164134,using,0,0
164135,all,0,0
164136,variables,0,0
164137,was,0,0
164138,0.72,0,0
164139,and,0,0
164140,for,0,0
164141,the,0,0
164142,simplified,0,0
164143,model,0,0
164144,",",0,0
164145,also,0,0
164146,0.72,0,0
164147,.,0,0
164148,CONCLUSIONS,0,0
164149,A,0,0
164150,few,0,0
164151,simple,0,0
164152,clinical,0,0
164153,variables,0,0
164154,measured,0,0
164155,on,0,0
164156,admission,0,0
164157,in,0,0
164158,patients,1,1
164159,with,1,1
164160,acute,1,1
164161,heart,1,1
164162,failure,1,1
164163,predict,0,0
164164,a,0,0
164165,variety,0,0
164166,of,0,0
164167,adverse,0,0
164168,outcomes,0,0
164169,with,0,1
164170,accuracy,0,0
164171,similar,0,0
164172,to,0,0
164173,more,0,0
164174,complex,0,0
164175,models,0,0
164176,.,0,0
164177,However,0,0
164178,",",0,0
164179,predictive,0,0
164180,models,0,0
164181,were,0,0
164182,of,0,0
164183,only,0,0
164184,moderate,0,1
164185,accuracy,0,0
164186,",",0,0
164187,especially,0,0
164188,for,0,0
164189,outcomes,0,0
164190,that,0,0
164191,included,0,1
164192,nonfatal,0,0
164193,events,0,0
164194,.,0,1
164195,Better,0,0
164196,methods,0,0
164197,of,0,0
164198,risk,0,0
164199,stratification,0,0
164200,are,0,0
164201,required,0,0
164202,.,0,0
164203,CLINICAL,0,0
164204,TRIAL,0,0
164205,REGISTRATION,0,0
164206,URL,0,0
164207,:,0,1
164208,http,0,0
164209,:,0,1
164210,//www.clinicaltrials.gov,0,0
164211,.,0,0
164212,Unique,0,1
164213,identifiers,0,0
164214,:,0,1
164215,NCT00328692,0,0
164216,and,0,0
164217,NCT00354458,0,0
164218,.,0,0
164219,Exercise,0,0
164220,for,0,0
164221,methamphetamine,1,1
164222,dependence,1,0
164223,:,1,0
164224,rationale,0,0
164225,",",0,0
164226,design,0,0
164227,",",0,0
164228,and,0,0
164229,methodology,0,0
164230,.,0,0
164231,BACKGROUND,0,0
164232,Effective,0,0
164233,pharmacotherapies,0,0
164234,to,0,0
164235,treat,0,0
164236,methamphetamine,0,0
164237,(,0,0
164238,MA,0,0
164239,),0,0
164240,dependence,0,0
164241,have,0,0
164242,not,0,0
164243,been,0,0
164244,identified,0,0
164245,",",0,0
164246,and,0,0
164247,behavioral,0,0
164248,therapies,0,0
164249,are,0,0
164250,marginally,0,0
164251,effective,0,0
164252,.,0,0
164253,Based,0,0
164254,on,0,0
164255,behavioral,0,0
164256,studies,0,0
164257,demonstrating,0,0
164258,the,0,0
164259,potential,0,0
164260,efficacy,0,0
164261,of,0,0
164262,aerobic,0,0
164263,exercise,0,0
164264,for,0,0
164265,improving,0,0
164266,depressive,0,0
164267,symptoms,0,0
164268,",",0,0
164269,anxiety,0,0
164270,",",0,0
164271,cognitive,0,0
164272,deficits,0,0
164273,",",0,0
164274,and,0,0
164275,substance,0,0
164276,use,0,0
164277,outcomes,0,0
164278,",",0,0
164279,the,0,0
164280,study,0,0
164281,described,0,0
164282,here,0,0
164283,is,0,0
164284,examining,0,0
164285,exercise,0,0
164286,as,0,0
164287,a,0,0
164288,potential,0,0
164289,treatment,0,0
164290,for,0,0
164291,MA-dependent,1,0
164292,individuals,1,1
164293,.,1,1
164294,METHODS,0,0
164295,This,0,0
164296,study,0,0
164297,is,0,0
164298,randomizing,0,0
164299,150,1,0
164300,participants,1,1
164301,with,1,1
164302,MA,1,0
164303,dependence,1,0
164304,at,1,0
164305,a,1,0
164306,residential,1,1
164307,treatment,1,0
164308,facility,1,1
164309,for,1,0
164310,addictive,1,1
164311,disorders,1,1
164312,to,1,0
164313,receive,1,0
164314,either,1,0
164315,a,1,0
164316,thrice-weekly,1,0
164317,structured,1,0
164318,aerobic,1,0
164319,and,1,0
164320,resistance,1,0
164321,exercise,1,0
164322,intervention,1,0
164323,or,1,0
164324,a,1,0
164325,health,1,0
164326,education,1,0
164327,condition,1,0
164328,.,1,0
164329,Recruitment,0,0
164330,commenced,0,0
164331,in,0,0
164332,March,0,1
164333,",",0,0
164334,2010,0,1
164335,.,0,0
164336,Enrollment,0,0
164337,and,0,0
164338,follow-up,0,0
164339,phases,0,0
164340,are,0,0
164341,ongoing,0,0
164342,",",0,0
164343,and,0,0
164344,recruitment,0,0
164345,is,0,0
164346,exceeding,0,0
164347,targeted,0,0
164348,enrollment,0,1
164349,rates,0,0
164350,.,0,1
164351,CONCLUSIONS,0,0
164352,Seeking,0,0
164353,evidence,0,0
164354,for,0,0
164355,a,0,0
164356,possibly,0,0
164357,effective,0,0
164358,adjunct,0,0
164359,to,0,0
164360,traditional,0,0
164361,behavioral,0,0
164362,approaches,0,0
164363,for,0,0
164364,treatment,0,0
164365,of,0,0
164366,MA,0,0
164367,dependence,0,0
164368,",",0,0
164369,this,0,0
164370,study,0,0
164371,is,0,0
164372,assessing,0,0
164373,the,0,0
164374,ability,0,0
164375,of,0,0
164376,an,0,0
164377,8-week,0,0
164378,aerobic,0,0
164379,and,0,0
164380,resistance,0,0
164381,exercise,0,0
164382,protocol,0,0
164383,to,0,0
164384,reduce,0,0
164385,relapse,0,0
164386,to,0,0
164387,MA,0,0
164388,use,0,0
164389,during,0,0
164390,a,0,0
164391,12-week,0,0
164392,follow-up,0,0
164393,period,0,0
164394,after,0,0
164395,discharge,0,0
164396,from,0,0
164397,residential-based,0,0
164398,treatment,0,0
164399,.,0,0
164400,The,0,0
164401,study,0,0
164402,also,0,0
164403,is,0,0
164404,evaluating,0,0
164405,improvements,0,0
164406,in,0,0
164407,health,0,1
164408,and,0,0
164409,functional,0,0
164410,outcomes,0,0
164411,during,0,0
164412,and,0,0
164413,after,0,0
164414,the,0,0
164415,protocol,0,0
164416,.,0,0
164417,This,0,0
164418,paper,0,0
164419,describes,0,0
164420,the,0,0
164421,design,0,0
164422,and,0,0
164423,methods,0,0
164424,of,0,0
164425,the,0,0
164426,study,0,0
164427,.,0,0
164428,Short-term,0,0
164429,amiodarone,0,1
164430,therapy,0,0
164431,after,0,0
164432,reversion,0,0
164433,of,0,0
164434,persistent,1,1
164435,atrial,1,1
164436,fibrillation,1,1
164437,reduces,0,0
164438,recurrences,0,0
164439,at,0,1
164440,18,0,1
164441,months,0,0
164442,.,0,1
164443,BACKGROUND,0,0
164444,The,0,0
164445,aim,0,0
164446,of,0,0
164447,this,0,0
164448,study,0,0
164449,was,0,0
164450,to,0,0
164451,compare,0,0
164452,the,0,0
164453,outcome,0,0
164454,of,0,0
164455,3,0,0
164456,months,0,0
164457,vs.,0,0
164458,18,0,1
164459,months,0,0
164460,of,0,0
164461,amiodarone,0,1
164462,treatment,0,0
164463,after,0,0
164464,atrial,0,1
164465,fibrillation,0,1
164466,(,0,0
164467,AF,0,0
164468,),0,0
164469,conversion,0,0
164470,in,0,1
164471,patients,1,1
164472,who,0,1
164473,experienced,0,1
164474,the,0,1
164475,first,0,0
164476,episode,0,1
164477,of,0,0
164478,persistent,0,1
164479,AF,0,1
164480,.,0,0
164481,METHODS,0,0
164482,We,0,0
164483,included,0,1
164484,51,1,1
164485,patients,1,1
164486,who,1,1
164487,experienced,1,1
164488,the,1,1
164489,first,1,0
164490,episode,1,1
164491,of,1,0
164492,persistent,1,1
164493,AF,1,0
164494,receiving,1,0
164495,amiodarone,1,1
164496,(,1,0
164497,600,1,0
164498,mg,1,0
164499,),1,0
164500,daily,1,0
164501,for,1,0
164502,4-6,1,1
164503,weeks,1,0
164504,.,1,1
164505,If,0,0
164506,AF,0,0
164507,persisted,0,0
164508,",",0,0
164509,electrical,0,0
164510,cardioversion,0,0
164511,(,0,0
164512,ECV,0,0
164513,),0,0
164514,was,0,0
164515,performed,0,0
164516,.,0,0
164517,All,0,0
164518,patients,0,1
164519,received,0,0
164520,amiodarone,0,1
164521,(,0,0
164522,200,0,0
164523,mg,0,0
164524,daily,0,0
164525,),0,0
164526,for,0,0
164527,3,0,0
164528,months,0,0
164529,and,0,0
164530,then,0,0
164531,were,0,0
164532,randomized,0,0
164533,to,0,0
164534,amiodarone,0,1
164535,(,0,0
164536,Group,0,0
164537,I,0,0
164538,),0,0
164539,or,0,0
164540,placebo,0,0
164541,(,0,0
164542,Group,0,0
164543,II,0,1
164544,),0,0
164545,and,0,0
164546,followed,0,0
164547,for,0,0
164548,15,0,1
164549,months,0,0
164550,.,0,0
164551,The,0,0
164552,control,1,0
164553,group,1,0
164554,comprised,0,1
164555,9,0,0
164556,untreated,0,1
164557,patients,1,1
164558,undergoing,0,1
164559,ECV,0,1
164560,.,0,0
164561,Treatment,0,0
164562,effectiveness,0,0
164563,was,0,0
164564,evaluated,0,0
164565,using,0,0
164566,a,0,0
164567,Bayesian,0,0
164568,model,0,0
164569,.,0,0
164570,RESULTS,0,0
164571,Eighteen,0,1
164572,months,0,0
164573,after,0,0
164574,AF,0,0
164575,reversion,0,0
164576,",",0,0
164577,22,0,0
164578,(,0,0
164579,81.5,0,0
164580,%,0,0
164581,),0,0
164582,patients,0,1
164583,in,0,0
164584,Group,0,1
164585,I,0,0
164586,",",0,0
164587,13,0,0
164588,(,0,0
164589,54.2,0,0
164590,%,0,0
164591,),0,0
164592,patients,0,1
164593,in,0,0
164594,Group,0,1
164595,II,0,0
164596,",",0,0
164597,and,0,0
164598,1,0,0
164599,(,0,0
164600,11.1,0,0
164601,%,0,0
164602,),0,0
164603,patient,0,0
164604,in,0,0
164605,the,0,0
164606,control,0,0
164607,group,0,0
164608,remained,0,0
164609,in,0,0
164610,sinus,0,1
164611,rhythm,0,1
164612,.,0,0
164613,No,0,0
164614,differences,0,0
164615,were,0,0
164616,found,0,0
164617,between,0,0
164618,Group,0,1
164619,I,0,1
164620,patients,0,1
164621,who,0,1
164622,required,0,1
164623,ECV,0,1
164624,and,0,0
164625,Group,0,1
164626,II,0,1
164627,patients,0,1
164628,.,0,1
164629,Sinus,0,0
164630,rhythm,0,1
164631,was,0,0
164632,preserved,0,0
164633,in,0,0
164634,all,0,0
164635,Group,0,0
164636,I,0,0
164637,patients,0,1
164638,when,0,0
164639,it,0,0
164640,was,0,0
164641,achieved,0,0
164642,during,0,0
164643,amiodarone,0,1
164644,administration,0,0
164645,.,0,0
164646,Limiting,0,0
164647,adverse,0,0
164648,effects,0,0
164649,occurred,0,0
164650,in,0,0
164651,3,0,0
164652,(,0,0
164653,11.1,0,0
164654,%,0,0
164655,),0,0
164656,patients,0,1
164657,in,0,0
164658,Group,0,1
164659,I,0,0
164660,.,0,0
164661,CONCLUSIONS,0,0
164662,In,0,0
164663,patients,0,1
164664,regaining,0,0
164665,sinus,0,1
164666,rhythm,0,1
164667,after,0,0
164668,the,0,0
164669,first,0,0
164670,episode,0,1
164671,of,0,0
164672,persistent,0,1
164673,AF,0,0
164674,",",0,0
164675,a,0,0
164676,3-month,0,0
164677,amiodarone,0,1
164678,treatment,0,0
164679,after,0,0
164680,reversion,0,0
164681,is,0,0
164682,a,0,0
164683,reasonable,0,0
164684,option,0,0
164685,for,0,0
164686,rhythm,0,1
164687,control,0,0
164688,.,0,0
164689,Activation,0,0
164690,and,0,0
164691,intermuscular,0,0
164692,coherence,0,0
164693,of,0,0
164694,distal,0,0
164695,arm,0,0
164696,muscles,0,0
164697,during,0,0
164698,proximal,0,0
164699,muscle,0,0
164700,contraction,0,0
164701,.,0,0
164702,In,0,0
164703,the,0,0
164704,human,0,0
164705,upper,0,0
164706,extremity,0,0
164707,(,0,0
164708,UE,0,0
164709,),0,0
164710,",",0,0
164711,unintended,0,0
164712,effects,0,0
164713,of,0,0
164714,proximal,0,0
164715,muscle,0,0
164716,activation,0,0
164717,on,0,0
164718,muscles,0,0
164719,controlling,0,0
164720,the,0,0
164721,hand,0,0
164722,could,0,0
164723,be,0,0
164724,an,0,0
164725,important,0,0
164726,aspect,0,0
164727,of,0,0
164728,motor,0,0
164729,control,0,0
164730,due,0,0
164731,to,0,0
164732,the,0,0
164733,necessary,0,0
164734,coordination,0,0
164735,of,0,0
164736,distal,0,0
164737,and,0,0
164738,proximal,0,0
164739,segments,0,0
164740,during,0,0
164741,functional,0,1
164742,activities,0,0
164743,.,0,0
164744,This,0,0
164745,study,0,0
164746,aimed,0,0
164747,to,0,0
164748,elucidate,0,0
164749,the,0,0
164750,effects,0,0
164751,of,0,0
164752,concurrent,0,0
164753,activation,0,0
164754,of,0,0
164755,elbow,0,1
164756,muscles,0,0
164757,on,0,0
164758,the,0,0
164759,coordination,0,0
164760,between,0,0
164761,hand,0,0
164762,muscles,0,0
164763,performing,0,0
164764,a,0,0
164765,grip,0,0
164766,task,0,0
164767,.,0,0
164768,Eleven,1,0
164769,healthy,1,1
164770,subjects,1,1
164771,performed,0,0
164772,precision,0,0
164773,grip,0,0
164774,tasks,0,0
164775,while,0,0
164776,a,0,0
164777,constant,0,0
164778,extension,0,0
164779,or,0,0
164780,flexion,0,0
164781,moment,0,0
164782,was,0,0
164783,applied,0,0
164784,to,0,0
164785,their,0,0
164786,elbow,0,1
164787,joints,0,0
164788,",",0,0
164789,inducing,0,0
164790,a,0,0
164791,sustained,0,0
164792,submaximal,0,0
164793,contraction,0,0
164794,of,0,0
164795,elbow,0,1
164796,muscles,0,0
164797,to,0,0
164798,counter,0,0
164799,the,0,0
164800,applied,0,0
164801,torque,0,0
164802,.,0,0
164803,Activation,0,0
164804,of,0,0
164805,four,0,0
164806,hand,0,0
164807,muscles,0,0
164808,was,0,0
164809,measured,0,0
164810,during,0,0
164811,each,0,0
164812,task,0,0
164813,condition,0,0
164814,using,0,0
164815,surface,0,0
164816,electromyography,0,0
164817,(,0,0
164818,EMG,0,0
164819,),0,0
164820,.,0,0
164821,When,0,0
164822,concurrent,0,0
164823,activation,0,0
164824,of,0,0
164825,elbow,0,1
164826,muscles,0,0
164827,was,0,0
164828,induced,0,0
164829,",",0,0
164830,significant,0,0
164831,changes,0,0
164832,in,0,0
164833,the,0,0
164834,activation,0,0
164835,levels,0,0
164836,of,0,0
164837,the,0,0
164838,hand,0,0
164839,muscles,0,0
164840,were,0,0
164841,observed,0,0
164842,",",0,0
164843,with,0,0
164844,greater,0,0
164845,effects,0,0
164846,on,0,0
164847,the,0,0
164848,extrinsic,0,1
164849,finger,0,0
164850,extensor,0,0
164851,(,0,0
164852,23.2,0,0
164853,%,0,0
164854,increase,0,0
164855,under,0,0
164856,30,0,0
164857,%,0,0
164858,elbow,0,1
164859,extensor,0,0
164860,activation,0,0
164861,;,0,0
164862,p,0,0
164863,=,0,0
164864,0.003,0,0
164865,),0,0
164866,than,0,0
164867,extrinsic,0,1
164868,finger,0,0
164869,flexor,0,0
164870,(,0,0
164871,14.2,0,0
164872,%,0,0
164873,increase,0,0
164874,under,0,0
164875,30,0,0
164876,%,0,0
164877,elbow,0,1
164878,flexor,0,0
164879,activation,0,0
164880,;,0,0
164881,p,0,0
164882,=,0,0
164883,0.130,0,0
164884,),0,0
164885,.,0,0
164886,Elbow,0,0
164887,muscle,0,0
164888,activation,0,0
164889,also,0,0
164890,induced,0,0
164891,involuntary,0,0
164892,changes,0,0
164893,in,0,0
164894,the,0,0
164895,intrinsic,0,0
164896,thumb,0,0
164897,flexor,0,0
164898,activation,0,0
164899,(,0,0
164900,44.6,0,0
164901,%,0,0
164902,increase,0,0
164903,under,0,0
164904,30,0,0
164905,%,0,0
164906,elbow,0,1
164907,extensor,0,0
164908,activation,0,0
164909,;,0,0
164910,p,0,0
164911,=,0,0
164912,0.005,0,0
164913,),0,0
164914,.,0,0
164915,EMG-EMG,0,0
164916,coherence,0,0
164917,analyses,0,0
164918,revealed,0,0
164919,that,0,0
164920,elbow,0,1
164921,muscle,0,0
164922,activation,0,0
164923,significantly,0,0
164924,reduced,0,0
164925,intermuscular,0,0
164926,coherence,0,0
164927,between,0,0
164928,distal,0,0
164929,muscle,0,0
164930,pairs,0,1
164931,",",0,0
164932,with,0,1
164933,its,0,0
164934,greatest,0,0
164935,effects,0,0
164936,on,0,0
164937,coherence,0,0
164938,in,0,0
164939,the,0,0
164940,?-band,0,0
164941,(,0,0
164942,13-25,0,1
164943,Hz,0,0
164944,),0,0
164945,(,0,0
164946,average,0,0
164947,of,0,0
164948,17,0,0
164949,%,0,0
164950,decrease,0,0
164951,under,0,0
164952,30,0,0
164953,%,0,0
164954,elbow,0,1
164955,flexor,0,0
164956,activation,0,0
164957,),0,0
164958,.,0,0
164959,The,0,0
164960,results,0,0
164961,of,0,0
164962,this,0,0
164963,study,0,0
164964,provide,0,0
164965,evidence,0,0
164966,for,0,0
164967,involuntary,0,0
164968,",",0,0
164969,muscle-specific,0,0
164970,interactions,0,0
164971,between,0,0
164972,distal,0,1
164973,and,0,0
164974,proximal,0,0
164975,UE,0,0
164976,muscles,0,0
164977,",",0,0
164978,which,0,0
164979,may,0,0
164980,contribute,0,0
164981,to,0,0
164982,UE,0,0
164983,motor,0,0
164984,performance,0,0
164985,in,0,0
164986,health,0,0
164987,and,0,0
164988,disease,0,1
164989,.,0,0
164990,Humour-related,0,0
164991,interventions,0,0
164992,for,0,0
164993,people,1,1
164994,with,1,1
164995,mental,1,1
164996,illness,1,1
164997,:,1,1
164998,a,0,0
164999,randomized,0,0
165000,controlled,0,0
165001,pilot,0,0
165002,study,0,0
165003,.,0,0
165004,This,0,0
165005,study,0,0
165006,explored,0,0
165007,the,0,0
165008,feasibility,0,0
165009,and,0,0
165010,effects,0,0
165011,of,0,0
165012,humour-related,0,0
165013,interventions,0,0
165014,for,0,0
165015,mentally,1,1
165016,ill,1,1
165017,adults,1,1
165018,.,1,1
165019,Twelve,1,1
165020,",",1,0
165021,randomly,1,0
165022,assigned,1,0
165023,",",1,0
165024,participated,1,1
165025,in,0,0
165026,each,0,0
165027,of,0,0
165028,3,0,0
165029,arms,0,0
165030,--,0,1
165031,stand,0,0
165032,up,0,0
165033,comedy,0,0
165034,training,0,0
165035,(,0,0
165036,the,0,0
165037,experimental,0,0
165038,arm,0,0
165039,),0,0
165040,",",0,0
165041,discussing,0,0
165042,comedy,0,0
165043,videos,0,0
165044,(,0,0
165045,the,0,0
165046,active,0,0
165047,control,0,0
165048,arm,0,0
165049,),0,0
165050,",",0,0
165051,and,0,0
165052,no,0,0
165053,humour-related,0,0
165054,intervention,0,0
165055,(,0,0
165056,the,0,0
165057,passive,0,0
165058,control,0,0
165059,arm,0,0
165060,),0,0
165061,.,0,0
165062,Quantitative,0,0
165063,and,0,0
165064,qualitative,0,0
165065,data,0,0
165066,were,0,0
165067,collected,0,0
165068,at,0,0
165069,baseline,0,0
165070,",",0,0
165071,end,0,0
165072,of,0,0
165073,interventions,0,0
165074,(,0,1
165075,3,0,0
165076,months,0,0
165077,),0,0
165078,and,0,0
165079,follow,0,0
165080,up,0,0
165081,(,0,0
165082,after,0,0
165083,another,0,1
165084,3,0,0
165085,months,0,0
165086,),0,1
165087,.,0,1
165088,Scale,0,0
165089,comparisons,0,0
165090,were,0,0
165091,largely,0,0
165092,negative,0,0
165093,",",0,0
165094,although,0,0
165095,self-esteem,0,0
165096,marginally,0,0
165097,increased,0,0
165098,in,0,0
165099,the,0,0
165100,experimental,0,0
165101,arm,0,0
165102,.,0,0
165103,Interview,0,0
165104,responses,0,0
165105,indicated,0,0
165106,benefits,0,0
165107,for,0,0
165108,the,0,0
165109,interventions,0,0
165110,",",0,0
165111,including,0,0
165112,improved,0,0
165113,self-esteem,0,0
165114,in,0,0
165115,the,0,0
165116,experimental,0,0
165117,arm,0,0
165118,.,0,0
165119,These,0,0
165120,results,0,0
165121,",",0,0
165122,though,0,0
165123,mixed,0,0
165124,",",0,0
165125,justify,0,0
165126,further,0,0
165127,study,0,0
165128,.,0,0
165129,Households,1,1
165130,with,1,1
165131,young,1,1
165132,children,1,1
165133,and,1,0
165134,use,1,0
165135,of,1,0
165136,freely,1,0
165137,distributed,1,0
165138,bednets,1,0
165139,in,1,0
165140,rural,1,1
165141,Madagascar,1,1
165142,.,1,1
165143,BACKGROUND,0,0
165144,Malaria,0,1
165145,infections,0,0
165146,are,0,0
165147,the,0,0
165148,leading,0,0
165149,cause,0,0
165150,of,0,0
165151,death,0,0
165152,for,0,0
165153,children,1,1
165154,in,1,0
165155,Madagascar,1,1
165156,.,1,1
165157,Insecticide-treated,0,0
165158,bednets,0,0
165159,offer,0,0
165160,effective,0,0
165161,prevention,0,0
165162,",",0,0
165163,but,0,0
165164,it,0,0
165165,is,0,0
165166,unclear,0,0
165167,how,0,0
165168,well,0,0
165169,free,0,0
165170,bednet,1,0
165171,distribution,1,0
165172,programs,1,0
165173,reach,0,0
165174,young,1,1
165175,children,1,1
165176,.,1,1
165177,METHODS,0,0
165178,We,0,0
165179,conducted,0,0
165180,a,0,0
165181,secondary,0,0
165182,analysis,0,0
165183,of,0,0
165184,a,0,0
165185,free,1,0
165186,bednet,1,0
165187,distribution,1,0
165188,program,1,0
165189,in,1,0
165190,Madagascar,1,1
165191,from,1,1
165192,2007-2008,1,1
165193,.,1,1
165194,Interviews,0,1
165195,were,0,0
165196,performed,0,0
165197,at,0,0
165198,baseline,0,0
165199,and,0,0
165200,6,0,0
165201,months,0,0
165202,.,0,1
165203,Principal,0,0
165204,components,0,0
165205,analysis,0,0
165206,was,0,0
165207,used,0,0
165208,to,0,0
165209,construct,0,0
165210,a,0,0
165211,wealth,0,0
165212,and,0,0
165213,malaria,0,1
165214,knowledge,0,0
165215,index,0,0
165216,.,0,0
165217,Coverage,0,0
165218,efficiency,0,0
165219,was,0,0
165220,calculated,0,0
165221,as,0,0
165222,coverage,0,0
165223,of,0,0
165224,children,1,1
165225,per,0,0
165226,bednet,0,1
165227,owned,0,1
165228,.,0,0
165229,Univariable,0,0
165230,and,0,0
165231,multivariable,0,0
165232,regressions,0,0
165233,were,0,0
165234,used,0,0
165235,to,0,0
165236,determine,0,0
165237,predictors,0,0
165238,of,0,0
165239,bednet,0,1
165240,use,0,0
165241,.,0,0
165242,RESULTS,0,0
165243,Bednet,0,0
165244,use,0,0
165245,",",0,0
165246,among,0,0
165247,the,0,0
165248,560,1,0
165249,households,1,1
165250,in,1,0
165251,the,1,0
165252,study,1,0
165253,",",0,0
165254,increased,0,0
165255,from,0,0
165256,6,0,0
165257,to,0,0
165258,91,0,0
165259,%,0,0
165260,after,0,0
165261,6,0,0
165262,months,0,0
165263,.,0,1
165264,Coverage,0,0
165265,efficiency,0,0
165266,increased,0,0
165267,from,0,0
165268,1.29,0,0
165269,to,0,0
165270,1.56,0,0
165271,children,0,1
165272,covered,0,0
165273,per,0,0
165274,bednet,0,0
165275,owned,0,1
165276,.,0,0
165277,In,0,0
165278,multivariable,0,0
165279,analysis,0,0
165280,",",0,0
165281,having,0,0
165282,a,0,0
165283,child,1,1
165284,under,1,0
165285,5,1,0
165286,years,1,1
165287,of,1,0
165288,age,1,1
165289,was,0,0
165290,the,0,0
165291,only,0,0
165292,variable,0,0
165293,associated,0,0
165294,with,0,0
165295,bednet,0,0
165296,use,0,0
165297,(,0,0
165298,OR,0,0
165299,9.10,0,0
165300,;,0,0
165301,p=0.001,0,0
165302,),0,0
165303,",",0,0
165304,yielding,0,0
165305,a,0,0
165306,99,0,0
165307,%,0,0
165308,likelihood,0,0
165309,of,0,0
165310,using,0,0
165311,a,0,0
165312,bednet,0,0
165313,(,0,0
165314,95,0,0
165315,%,0,0
165316,CI,0,0
165317,96.4,0,0
165318,to,0,0
165319,99.9,0,0
165320,%,0,0
165321,),0,0
165322,versus,0,0
165323,82,0,0
165324,%,0,0
165325,(,0,0
165326,95,0,0
165327,%,0,0
165328,CI,0,0
165329,72.2,0,0
165330,to,0,0
165331,88.4,0,0
165332,%,0,0
165333,),0,0
165334,in,0,0
165335,households,0,1
165336,without,0,1
165337,young,0,1
165338,children,0,1
165339,.,0,0
165340,CONCLUSION,0,0
165341,This,0,0
165342,free,0,0
165343,bednet,0,0
165344,distribution,0,0
165345,program,0,0
165346,achieved,0,0
165347,high,0,0
165348,levels,0,0
165349,of,0,0
165350,adherence,0,0
165351,after,0,0
165352,6,0,0
165353,months,0,0
165354,.,0,1
165355,Household,0,0
165356,presence,0,0
165357,of,0,0
165358,children,1,1
165359,was,0,0
165360,associated,0,0
165361,with,0,0
165362,bednet,0,0
165363,use,0,0
165364,",",0,0
165365,but,0,0
165366,not,0,0
165367,household,0,0
165368,income,0,0
165369,or,0,0
165370,education,0,0
165371,",",0,0
165372,suggesting,0,0
165373,that,0,0
165374,distribution,0,0
165375,to,0,0
165376,priority,0,0
165377,groups,0,0
165378,may,0,0
165379,help,0,0
165380,overcome,0,0
165381,traditional,0,0
165382,barriers,0,0
165383,to,0,0
165384,adoption,0,0
165385,in,0,0
165386,some,0,0
165387,settings,0,0
165388,.,0,0
165389,Effects,0,0
165390,of,0,0
165391,water,0,1
165392,extracts,0,0
165393,of,0,0
165394,Graptopetalum,0,0
165395,paraguayense,0,1
165396,on,0,0
165397,blood,0,0
165398,pressure,0,0
165399,",",0,0
165400,fasting,0,0
165401,glucose,0,0
165402,",",0,0
165403,and,0,0
165404,lipid,0,0
165405,profiles,0,0
165406,of,0,0
165407,subjects,1,1
165408,with,1,1
165409,metabolic,1,1
165410,syndrome,1,1
165411,.,1,0
165412,This,0,0
165413,study,0,0
165414,was,0,0
165415,aimed,0,0
165416,to,0,0
165417,investigate,0,0
165418,the,0,0
165419,effects,0,0
165420,of,0,0
165421,water,0,1
165422,extracts,0,0
165423,of,0,0
165424,Graptopetalum,0,0
165425,paraguayense,0,1
165426,(,0,0
165427,WGP,0,0
165428,",",0,0
165429,4,0,0
165430,g/d,0,0
165431,),0,0
165432,on,0,0
165433,blood,0,0
165434,pressure,0,0
165435,",",0,0
165436,blood,0,0
165437,glucose,0,0
165438,level,0,0
165439,",",0,0
165440,and,0,0
165441,lipid,0,0
165442,profiles,0,0
165443,in,0,0
165444,subjects,1,1
165445,with,1,1
165446,metabolic,1,0
165447,syndrome,1,1
165448,(,1,0
165449,MS,1,0
165450,),1,0
165451,.,1,0
165452,Participants,1,1
165453,with,1,1
165454,MS,1,1
165455,(,1,0
165456,n,1,1
165457,=,1,0
165458,54,1,1
165459,),1,0
165460,were,0,0
165461,randomly,0,0
165462,assigned,0,0
165463,to,0,0
165464,the,0,0
165465,placebo,0,0
165466,(,0,0
165467,n,0,1
165468,=,0,0
165469,28,0,1
165470,),0,0
165471,and,0,0
165472,WGP,0,0
165473,groups,0,0
165474,(,0,0
165475,n,0,1
165476,=,0,0
165477,26,0,1
165478,),0,0
165479,",",0,0
165480,and,0,0
165481,the,0,0
165482,intervention,0,0
165483,was,0,0
165484,administered,0,0
165485,for,0,0
165486,12,0,0
165487,weeks,0,0
165488,.,0,1
165489,Systolic,0,1
165490,blood,0,0
165491,pressure,0,0
165492,(,0,0
165493,SBP,0,0
165494,),0,0
165495,",",0,0
165496,diastolic,0,0
165497,blood,0,0
165498,pressure,0,0
165499,(,0,0
165500,DBP,0,0
165501,),0,0
165502,",",0,0
165503,fasting,0,0
165504,glucose,0,0
165505,(,0,0
165506,FG,0,0
165507,),0,0
165508,",",0,0
165509,lipid,0,0
165510,profiles,0,0
165511,(,0,0
165512,total,0,1
165513,cholesterol,0,0
165514,(,0,0
165515,TC,0,0
165516,),0,0
165517,",",0,0
165518,triglyceride,0,0
165519,(,0,0
165520,TG,0,0
165521,),0,0
165522,",",0,0
165523,low,0,0
165524,density,0,0
165525,lipoprotein,0,0
165526,cholesterol,0,0
165527,(,0,0
165528,LDL-C,0,0
165529,),0,0
165530,",",0,0
165531,and,0,0
165532,high,0,0
165533,density,0,0
165534,lipoprotein,0,0
165535,(,0,0
165536,HDL-C,0,0
165537,),0,0
165538,),0,0
165539,",",0,0
165540,and,0,0
165541,antioxidant,0,0
165542,enzymes,0,0
165543,activities,0,0
165544,(,0,0
165545,catalase,0,0
165546,(,0,0
165547,CAT,0,0
165548,),0,0
165549,",",0,0
165550,superoxide,0,0
165551,dismutase,0,0
165552,(,0,0
165553,SOD,0,0
165554,),0,0
165555,",",0,0
165556,and,0,0
165557,glutathione,0,0
165558,peroxidase,0,0
165559,(,0,0
165560,GPx,0,0
165561,),0,0
165562,),0,0
165563,were,0,0
165564,measured,0,0
165565,.,0,0
165566,Forty-two,1,1
165567,subjects,1,1
165568,completed,1,1
165569,the,1,0
165570,study,1,0
165571,(,1,0
165572,placebo,1,0
165573,",",1,0
165574,n,1,0
165575,=,1,0
165576,19,1,1
165577,;,1,0
165578,WGP,1,0
165579,",",1,0
165580,n,1,1
165581,=,1,0
165582,23,1,1
165583,),1,0
165584,.,0,0
165585,FG,0,0
165586,",",0,0
165587,SBP,0,0
165588,",",0,0
165589,and,0,0
165590,LDL-C,0,1
165591,levels,0,0
165592,were,0,0
165593,significantly,0,0
165594,lower,0,0
165595,and,0,0
165596,HDL-C,0,0
165597,level,0,0
165598,and,0,0
165599,antioxidant,0,0
165600,enzymes,0,0
165601,activities,0,0
165602,(,0,1
165603,CAT,0,0
165604,and,0,0
165605,SOD,0,0
165606,),0,0
165607,were,0,0
165608,significantly,0,0
165609,higher,0,0
165610,after,0,0
165611,WGP,0,0
165612,supplementation,0,0
165613,.,0,0
165614,Blood,0,0
165615,pressure,0,0
165616,",",0,0
165617,FG,0,0
165618,",",0,0
165619,and,0,0
165620,lipid,0,0
165621,profiles,0,0
165622,were,0,0
165623,significantly,0,0
165624,correlated,0,0
165625,with,0,0
165626,antioxidant,0,0
165627,enzymes,0,0
165628,activities,0,0
165629,after,0,0
165630,supplementation,0,0
165631,(,0,0
165632,P,0,0
165633,<,0,0
165634,0.05,0,0
165635,),0,0
165636,.,0,0
165637,The,0,0
165638,present,0,0
165639,study,0,0
165640,demonstrated,0,0
165641,a,0,0
165642,significant,0,0
165643,reduction,0,0
165644,in,0,0
165645,blood,0,0
165646,pressure,0,0
165647,",",0,0
165648,blood,0,0
165649,glucose,0,0
165650,",",0,0
165651,and,0,0
165652,lipid,0,0
165653,profiles,0,0
165654,and,0,0
165655,an,0,0
165656,increase,0,0
165657,in,0,0
165658,antioxidant,0,0
165659,enzymes,0,0
165660,activities,0,0
165661,in,0,0
165662,subjects,1,1
165663,with,1,1
165664,MS,1,1
165665,after,0,0
165666,WGP,0,0
165667,supplementation,0,0
165668,.,0,0
165669,Taken,0,0
165670,together,0,0
165671,",",0,0
165672,the,0,0
165673,antioxidative,0,0
165674,capacity,0,0
165675,of,0,0
165676,WGP,0,0
165677,might,0,0
165678,exert,0,0
165679,a,0,0
165680,beneficial,0,0
165681,effect,0,0
165682,on,0,0
165683,MS,0,0
165684,.,0,0
165685,This,0,0
165686,trial,0,0
165687,is,0,0
165688,registered,0,0
165689,with,0,0
165690,ClinicalTrials.gov,0,0
165691,NCT01463748,0,0
165692,.,0,0
165693,A,0,0
165694,phase,0,0
165695,II,0,0
165696,",",0,0
165697,randomized,0,0
165698,",",0,0
165699,multicenter,0,0
165700,study,0,0
165701,evaluating,0,0
165702,the,0,0
165703,combination,0,0
165704,of,0,0
165705,lapatinib,0,0
165706,and,0,0
165707,vinorelbine,0,0
165708,in,0,0
165709,women,1,1
165710,with,1,1
165711,ErbB2,1,0
165712,overexpressing,1,0
165713,metastatic,1,1
165714,breast,1,1
165715,cancer,1,1
165716,.,1,0
165717,Lapatinib,0,0
165718,is,0,0
165719,approved,0,0
165720,in,0,0
165721,combination,0,0
165722,with,0,1
165723,capecitabine,0,0
165724,for,0,0
165725,treatment,0,0
165726,of,0,0
165727,patients,1,1
165728,with,1,1
165729,human,1,1
165730,epidermal,1,0
165731,growth,1,0
165732,factor,1,0
165733,receptor,1,0
165734,2,1,0
165735,(,1,0
165736,HER2,1,0
165737,),1,0
165738,-positive,1,1
165739,metastatic,1,1
165740,breast,1,1
165741,cancer,1,1
165742,(,1,0
165743,MBC,1,1
165744,),1,1
165745,who,0,1
165746,have,0,0
165747,progressed,0,1
165748,on,0,0
165749,prior,0,0
165750,trastuzumab,0,0
165751,in,0,0
165752,the,0,0
165753,metastatic,0,1
165754,setting,0,1
165755,.,0,0
165756,Vinorelbine,0,0
165757,is,0,0
165758,an,0,0
165759,important,0,0
165760,chemotherapy,0,0
165761,option,0,0
165762,for,0,0
165763,MBC,0,0
165764,.,0,0
165765,We,0,0
165766,evaluated,0,0
165767,efficacy,0,0
165768,and,0,0
165769,safety,0,0
165770,of,0,0
165771,lapatinib,0,0
165772,plus,0,0
165773,vinorelbine,0,0
165774,",",0,0
165775,compared,0,0
165776,with,0,0
165777,lapatinib,0,0
165778,plus,0,0
165779,capecitabine,0,0
165780,",",0,0
165781,in,0,0
165782,women,1,1
165783,with,1,1
165784,HER2-positive,1,1
165785,MBC,1,0
165786,.,1,0
165787,In,1,0
165788,this,1,0
165789,open-label,1,0
165790,",",1,0
165791,multicenter,1,0
165792,",",1,0
165793,phase,1,0
165794,II,1,0
165795,study,1,0
165796,",",1,0
165797,eligible,1,1
165798,patients,1,1
165799,(,1,0
165800,N,1,1
165801,=,1,0
165802,112,1,1
165803,),1,0
165804,were,0,0
165805,randomized,0,0
165806,2:1,0,1
165807,to,0,0
165808,lapatinib,0,0
165809,plus,0,0
165810,vinorelbine,0,0
165811,[,0,0
165812,(,0,0
165813,N,0,1
165814,=,0,0
165815,75,0,1
165816,),0,0
165817,"1,250",0,0
165818,mg,0,0
165819,orally,0,0
165820,once,0,0
165821,daily,0,0
165822,(,0,0
165823,QD,0,0
165824,),0,0
165825,continuously,0,0
165826,plus,0,0
165827,20,0,0
165828,mg/m,0,0
165829,(,0,0
165830,2,0,0
165831,),0,0
165832,/day,0,0
165833,intravenously,0,0
165834,],0,0
165835,or,0,0
165836,lapatinib,0,0
165837,plus,0,0
165838,capecitabine,0,0
165839,[,0,0
165840,(,0,0
165841,N,0,1
165842,=,0,0
165843,37,0,1
165844,),0,0
165845,"1,250",0,0
165846,mg,0,0
165847,orally,0,0
165848,QD,0,0
165849,continuously,0,0
165850,plus,0,0
165851,"2,000",0,0
165852,mg/m,0,0
165853,(,0,0
165854,2,0,0
165855,),0,0
165856,/day,0,0
165857,orally,0,0
165858,",",0,0
165859,2,0,0
165860,doses,0,0
165861,],0,1
165862,.,0,0
165863,The,0,0
165864,primary,0,0
165865,endpoint,0,0
165866,was,0,0
165867,progression-free,0,0
165868,survival,0,0
165869,(,0,0
165870,PFS,0,0
165871,),0,0
165872,.,0,0
165873,Other,0,0
165874,endpoints,0,0
165875,included,0,1
165876,overall,0,0
165877,survival,0,0
165878,(,0,0
165879,OS,0,0
165880,),0,0
165881,and,0,0
165882,safety,0,0
165883,.,0,0
165884,Patients,0,1
165885,progressing,0,0
165886,within,0,0
165887,the,0,0
165888,study,0,0
165889,were,0,0
165890,given,0,0
165891,the,0,0
165892,option,0,0
165893,of,0,0
165894,crossover,0,0
165895,to,0,0
165896,the,0,0
165897,other,0,0
165898,treatment,0,0
165899,arm,0,0
165900,;,0,0
165901,time,0,0
165902,to,0,0
165903,second,0,0
165904,progression,0,0
165905,was,0,0
165906,an,0,0
165907,exploratory,0,0
165908,endpoint,0,0
165909,.,0,0
165910,Patient,0,0
165911,demographics,0,0
165912,",",0,0
165913,stratification,0,0
165914,",",0,0
165915,and,0,0
165916,prognostic,0,0
165917,factors,0,0
165918,were,0,0
165919,well,0,0
165920,balanced,0,0
165921,between,0,0
165922,treatments,0,0
165923,.,0,1
165924,Median,0,0
165925,PFS,0,0
165926,in,0,0
165927,both,0,0
165928,arms,0,0
165929,was,0,0
165930,6.2,0,0
165931,months,0,0
165932,[,0,0
165933,95,0,0
165934,%,0,0
165935,confidence,0,0
165936,interval,0,0
165937,(,0,0
165938,CI,0,0
165939,),0,0
165940,4.2,0,0
165941,",",0,0
165942,8.8,0,0
165943,(,0,0
165944,lapatinib,0,0
165945,plus,0,0
165946,vinorelbine,0,0
165947,),0,0
165948,;,0,0
165949,4.4,0,0
165950,",",0,0
165951,8.3,0,0
165952,(,0,0
165953,lapatinib,0,0
165954,plus,0,0
165955,capecitabine,0,0
165956,),0,0
165957,],0,0
165958,.,0,0
165959,Median,0,0
165960,OS,0,0
165961,on,0,0
165962,lapatinib,0,0
165963,plus,0,0
165964,vinorelbine,0,0
165965,was,0,0
165966,24.3,0,0
165967,months,0,0
165968,(,0,0
165969,95,0,0
165970,%,0,0
165971,CI,0,0
165972,16.4,0,0
165973,",",0,0
165974,NE,0,0
165975,),0,0
165976,and,0,0
165977,19.4,0,0
165978,months,0,0
165979,(,0,0
165980,95,0,0
165981,%,0,0
165982,CI,0,0
165983,16.4,0,0
165984,",",0,0
165985,27.2,0,0
165986,),0,0
165987,on,0,0
165988,lapatinib,0,0
165989,plus,0,0
165990,capecitabine,0,0
165991,.,0,0
165992,In,0,0
165993,total,0,0
165994,",",0,0
165995,42,0,1
165996,patients,0,1
165997,opted,0,1
165998,to,0,0
165999,cross,0,1
166000,over,0,0
166001,;,0,0
166002,median,0,0
166003,PFS,0,0
166004,was,0,0
166005,3.2,0,0
166006,months,0,0
166007,(,0,0
166008,95,0,0
166009,%,0,0
166010,CI,0,0
166011,1.7,0,0
166012,",",0,0
166013,5.1,0,0
166014,),0,0
166015,on,0,0
166016,lapatinib,0,0
166017,plus,0,0
166018,vinorelbine,0,0
166019,and,0,0
166020,4.0,0,0
166021,months,0,0
166022,(,0,0
166023,95,0,0
166024,%,0,0
166025,CI,0,0
166026,2.1,0,0
166027,",",0,0
166028,5.8,0,0
166029,),0,0
166030,on,0,0
166031,lapatinib,0,0
166032,plus,0,0
166033,capecitabine,0,0
166034,.,0,0
166035,Lapatinib,0,0
166036,plus,0,0
166037,vinorelbine,0,0
166038,offers,0,0
166039,an,0,0
166040,effective,0,0
166041,treatment,0,0
166042,option,0,0
166043,for,0,0
166044,patients,1,1
166045,with,1,1
166046,HER2-overexpressing,1,0
166047,MBC,1,0
166048,",",0,0
166049,having,0,1
166050,displayed,0,0
166051,comparable,0,0
166052,efficacy,0,0
166053,and,0,0
166054,tolerability,0,0
166055,rates,0,0
166056,to,0,0
166057,lapatinib,0,0
166058,plus,0,0
166059,capecitabine,0,0
166060,.,0,0
166061,The,0,0
166062,effect,0,0
166063,of,0,0
166064,recent,1,0
166065,bereavement,1,1
166066,on,0,0
166067,outcomes,0,0
166068,in,0,0
166069,a,0,0
166070,primary,0,0
166071,care,0,0
166072,depression,0,1
166073,intervention,0,0
166074,study,0,0
166075,.,0,0
166076,OBJECTIVES,0,0
166077,Although,0,0
166078,bereavement,0,1
166079,and,0,0
166080,depression,0,0
166081,are,0,0
166082,both,0,0
166083,common,0,0
166084,in,0,0
166085,older,0,1
166086,primary,0,1
166087,care,0,0
166088,patients,0,1
166089,",",0,0
166090,the,0,0
166091,effect,0,0
166092,of,0,0
166093,bereavement,0,0
166094,on,0,0
166095,depression,0,1
166096,intervention,0,0
166097,outcomes,0,0
166098,is,0,0
166099,unknown,0,0
166100,.,0,0
166101,We,0,0
166102,examined,0,0
166103,whether,0,0
166104,standard,0,0
166105,interventions,0,0
166106,for,0,0
166107,depression,0,1
166108,in,0,0
166109,primary,0,0
166110,care,0,0
166111,were,0,0
166112,as,0,0
166113,effective,0,0
166114,for,0,0
166115,bereaved,1,1
166116,as,1,0
166117,for,1,0
166118,non-bereaved,1,1
166119,depressed,1,1
166120,patients,1,1
166121,.,1,1
166122,DESIGN,0,0
166123,Randomized,0,0
166124,controlled,0,0
166125,trial,0,0
166126,.,0,0
166127,SETTING,0,0
166128,Twenty,1,1
166129,community-based,1,1
166130,primary,1,1
166131,care,1,1
166132,practices,1,0
166133,in,1,0
166134,New,1,1
166135,York,1,1
166136,City,1,0
166137,",",1,0
166138,greater,1,0
166139,Philadelphia,1,1
166140,",",1,0
166141,and,1,0
166142,Pittsburgh,1,1
166143,.,1,0
166144,Randomization,0,0
166145,to,0,0
166146,either,0,0
166147,intervention,0,0
166148,or,0,0
166149,usual,0,0
166150,care,0,0
166151,occurred,0,0
166152,by,0,0
166153,practice,0,0
166154,.,0,1
166155,PARTICIPANTS,1,0
166156,Patients,1,1
166157,aged,1,1
166158,60,1,1
166159,years,1,1
166160,or,1,1
166161,older,1,1
166162,who,1,1
166163,met,1,1
166164,criteria,1,1
166165,for,1,0
166166,major,1,0
166167,depression,1,1
166168,or,1,0
166169,clinically,1,0
166170,significant,1,0
166171,minor,1,0
166172,depression,1,1
166173,(,1,0
166174,N,1,1
166175,=,1,0
166176,599,1,1
166177,),1,0
166178,.,1,1
166179,Patients,1,1
166180,who,1,1
166181,did,1,1
166182,not,1,1
166183,complete,1,0
166184,the,1,0
166185,bereavement,1,0
166186,measure,1,0
166187,or,1,1
166188,who,1,1
166189,were,1,1
166190,missing,1,1
166191,4-month,1,0
166192,data,1,0
166193,were,1,0
166194,excluded,1,0
166195,(,1,0
166196,final,1,0
166197,N,1,1
166198,=,1,0
166199,417,1,1
166200,),1,0
166201,.,1,0
166202,INTERVENTION,0,0
166203,Study-trained,0,1
166204,depression,0,1
166205,care,0,1
166206,managers,0,1
166207,offered,0,0
166208,guideline-concordant,0,0
166209,recommendations,0,0
166210,to,0,0
166211,primary,0,1
166212,care,0,0
166213,physicians,0,0
166214,at,0,0
166215,intervention,0,0
166216,sites,0,0
166217,and,0,0
166218,assisted,0,1
166219,patients,0,1
166220,with,0,1
166221,treatment,0,0
166222,adherence,1,0
166223,.,1,1
166224,Patients,1,1
166225,who,1,1
166226,did,1,1
166227,not,1,1
166228,wish,1,0
166229,to,1,0
166230,take,1,0
166231,antidepressants,1,0
166232,could,1,0
166233,receive,1,0
166234,interpersonal,1,0
166235,psychotherapy,1,0
166236,.,1,0
166237,MEASUREMENTS,0,0
166238,Bereavement,0,0
166239,was,0,0
166240,captured,0,0
166241,using,0,0
166242,the,0,0
166243,Louisville,0,0
166244,Older,0,0
166245,Persons,0,1
166246,Events,0,0
166247,Schedule,0,0
166248,.,0,0
166249,Depression,0,0
166250,severity,0,0
166251,was,0,0
166252,assessed,0,0
166253,using,0,0
166254,the,0,0
166255,24-item,0,0
166256,Hamilton,0,0
166257,Depression,0,0
166258,Rating,0,0
166259,Scale,0,0
166260,(,0,0
166261,HDRS,0,0
166262,),0,0
166263,.,0,0
166264,Outcomes,0,0
166265,at,0,0
166266,4,0,0
166267,months,0,0
166268,were,0,0
166269,remission,0,1
166270,(,0,0
166271,HDRS,0,0
166272,?7,0,0
166273,),0,0
166274,and,0,0
166275,response,0,0
166276,(,0,0
166277,HDRS,0,0
166278,reduction,0,0
166279,?50,0,0
166280,%,0,0
166281,from,0,0
166282,baseline,0,0
166283,),0,0
166284,.,0,0
166285,RESULTS,0,0
166286,Logistic,0,0
166287,regressions,0,0
166288,indicated,0,0
166289,that,0,0
166290,",",0,0
166291,for,0,0
166292,non-bereaved,0,1
166293,participants,0,1
166294,",",0,0
166295,response,0,0
166296,and,0,0
166297,remission,0,0
166298,were,0,0
166299,higher,0,0
166300,in,0,0
166301,intervention,0,0
166302,than,0,0
166303,usual,0,0
166304,care,0,0
166305,.,0,0
166306,However,0,0
166307,",",0,0
166308,recently,0,0
166309,bereaved,0,1
166310,older,0,1
166311,adults,0,1
166312,were,0,0
166313,less,0,0
166314,likely,0,0
166315,to,0,0
166316,achieve,0,0
166317,response,0,0
166318,or,0,0
166319,remission,0,0
166320,at,0,0
166321,4,0,0
166322,months,0,0
166323,if,0,0
166324,treated,0,1
166325,in,0,0
166326,the,0,0
166327,intervention,0,0
166328,condition,0,0
166329,.,0,0
166330,CONCLUSIONS,0,0
166331,Standard,0,0
166332,depression,0,1
166333,care,0,0
166334,management,0,0
166335,appears,0,0
166336,to,0,0
166337,be,0,0
166338,ineffective,0,0
166339,among,0,0
166340,recently,0,0
166341,bereaved,0,1
166342,older,0,1
166343,primary,0,0
166344,care,0,1
166345,patients,0,1
166346,.,0,0
166347,Greater,0,0
166348,attention,0,0
166349,should,0,0
166350,be,0,0
166351,paid,0,0
166352,in,0,0
166353,primary,0,0
166354,care,0,0
166355,to,0,0
166356,emotional,1,0
166357,distress,1,1
166358,in,1,0
166359,the,1,0
166360,context,1,0
166361,of,1,0
166362,bereavement,1,1
166363,.,1,0
166364,Early,0,0
166365,psychosocial,0,0
166366,intervention,0,0
166367,in,0,0
166368,Alzheimer,1,0
166369,'s,1,1
166370,disease,1,1
166371,:,1,1
166372,cost,0,0
166373,utility,0,0
166374,evaluation,0,0
166375,alongside,0,0
166376,the,0,0
166377,Danish,1,0
166378,Alzheimer,0,0
166379,'s,0,1
166380,Intervention,0,0
166381,Study,0,1
166382,(,0,0
166383,DAISY,0,0
166384,),0,0
166385,.,0,0
166386,OBJECTIVE,0,0
166387,To,0,0
166388,assess,0,0
166389,the,0,0
166390,cost,0,0
166391,utility,0,0
166392,of,0,0
166393,early,0,0
166394,psychosocial,0,0
166395,intervention,0,0
166396,for,0,0
166397,patients,1,1
166398,with,1,1
166399,Alzheimer,1,1
166400,'s,1,0
166401,disease,1,1
166402,and,1,0
166403,their,1,0
166404,primary,1,1
166405,caregivers,1,1
166406,.,1,1
166407,DESIGN,0,0
166408,Cost,0,0
166409,utility,0,0
166410,evaluation,0,0
166411,alongside,0,0
166412,a,0,0
166413,multicentre,0,0
166414,",",0,0
166415,randomised,0,0
166416,controlled,0,0
166417,trial,0,0
166418,with,0,1
166419,3,0,0
166420,years,0,1
166421,of,0,0
166422,follow-up,0,0
166423,.,0,0
166424,SETTING,0,0
166425,Primary,1,0
166426,care,1,0
166427,and,1,0
166428,memory,1,0
166429,clinics,1,1
166430,in,1,0
166431,five,1,1
166432,Danish,1,1
166433,districts,1,1
166434,.,1,0
166435,PARTICIPANTS,0,0
166436,330,1,1
166437,community-dwelling,1,1
166438,patients,1,1
166439,and,1,0
166440,their,1,1
166441,primary,1,1
166442,caregivers,1,1
166443,.,1,1
166444,INTERVENTION,0,0
166445,Psychosocial,0,0
166446,counselling,0,0
166447,and,0,0
166448,support,0,0
166449,lasting,0,0
166450,8-12,0,1
166451,months,0,0
166452,after,0,0
166453,diagnosis,0,1
166454,and,0,0
166455,follow-up,0,0
166456,at,0,0
166457,3,0,0
166458,",",0,0
166459,6,0,0
166460,",",0,0
166461,12,0,0
166462,and,0,0
166463,36,0,1
166464,months,0,0
166465,in,0,0
166466,the,0,0
166467,intervention,0,0
166468,group,0,0
166469,or,0,0
166470,follow-up,0,0
166471,only,0,0
166472,in,0,0
166473,the,0,0
166474,control,0,0
166475,group,0,0
166476,.,0,0
166477,MAIN,0,0
166478,OUTCOME,0,0
166479,MEASURES,0,0
166480,The,0,0
166481,primary,0,0
166482,outcome,0,0
166483,measure,0,0
166484,was,0,0
166485,the,0,0
166486,cost,0,0
166487,of,0,0
166488,additional,0,0
166489,quality-adjusted,0,0
166490,life,0,0
166491,years,0,1
166492,(,0,0
166493,QALYs,0,1
166494,),0,0
166495,.,0,0
166496,Costs,0,0
166497,were,0,0
166498,measured,0,0
166499,from,0,0
166500,a,0,0
166501,societal,0,0
166502,perspective,0,0
166503,",",0,0
166504,including,0,0
166505,the,0,0
166506,costs,0,0
166507,of,0,0
166508,healthcare,0,0
166509,",",0,0
166510,social,0,0
166511,care,0,0
166512,",",0,0
166513,informal,0,0
166514,care,0,0
166515,and,0,0
166516,production,0,0
166517,loss,0,0
166518,.,0,0
166519,QALYs,0,0
166520,were,0,0
166521,estimated,0,0
166522,separately,0,0
166523,for,0,0
166524,the,0,0
166525,patient,0,0
166526,and,0,0
166527,the,0,0
166528,caregiver,0,0
166529,before,0,0
166530,aggregation,0,0
166531,for,0,0
166532,the,0,0
166533,main,0,0
166534,analysis,0,0
166535,.,0,0
166536,RESULTS,0,0
166537,None,0,0
166538,of,0,0
166539,the,0,0
166540,observed,0,0
166541,cost,0,0
166542,and,0,0
166543,QALY,0,1
166544,measures,0,0
166545,were,0,0
166546,significantly,0,0
166547,different,0,0
166548,between,0,0
166549,the,0,0
166550,intervention,0,0
166551,and,0,0
166552,control,0,0
166553,groups,0,0
166554,",",0,0
166555,although,0,0
166556,a,0,0
166557,tendency,0,0
166558,was,0,0
166559,noted,0,0
166560,for,0,0
166561,psychosocial,0,0
166562,care,0,0
166563,leading,0,0
166564,to,0,0
166565,cost,0,0
166566,increases,0,0
166567,with,0,1
166568,informal,0,0
166569,care,0,0
166570,that,0,0
166571,was,0,0
166572,not,0,0
166573,outweighed,0,0
166574,by,0,0
166575,the,0,0
166576,tendency,0,0
166577,for,0,0
166578,cost,0,0
166579,savings,0,0
166580,with,0,1
166581,formal,0,0
166582,care,0,0
166583,.,0,0
166584,The,0,0
166585,probability,0,0
166586,of,0,0
166587,psychosocial,0,0
166588,intervention,0,0
166589,being,0,0
166590,cost-effective,0,0
166591,did,0,0
166592,not,0,0
166593,exceed,0,0
166594,36,0,0
166595,%,0,0
166596,for,0,0
166597,any,0,0
166598,threshold,0,0
166599,value,0,0
166600,.,0,0
166601,The,0,0
166602,alternative,0,0
166603,scenario,0,0
166604,analysis,0,0
166605,showed,0,0
166606,that,0,0
166607,the,0,0
166608,probability,0,0
166609,of,0,0
166610,cost-effectiveness,0,0
166611,increased,0,0
166612,over,0,0
166613,the,0,0
166614,range,0,0
166615,of,0,0
166616,threshold,0,0
166617,values,0,0
166618,used,0,0
166619,if,0,0
166620,the,0,0
166621,cost,0,0
166622,perspective,0,0
166623,was,0,0
166624,restricted,0,0
166625,to,0,0
166626,formal,0,0
166627,healthcare,0,0
166628,.,0,0
166629,CONCLUSIONS,0,0
166630,A,0,0
166631,multifaceted,0,0
166632,",",0,0
166633,psychosocial,0,0
166634,intervention,0,0
166635,programme,0,0
166636,was,0,0
166637,found,0,0
166638,unlikely,0,0
166639,to,0,0
166640,be,0,0
166641,cost-effective,0,0
166642,from,0,0
166643,a,0,0
166644,societal,0,0
166645,perspective,0,0
166646,.,0,0
166647,The,0,0
166648,recommendation,0,0
166649,for,0,0
166650,practice,0,0
166651,in,0,0
166652,settings,0,0
166653,that,0,0
166654,are,0,0
166655,similar,0,0
166656,to,0,0
166657,the,0,0
166658,Danish,0,0
166659,setting,0,0
166660,is,0,0
166661,to,0,0
166662,provide,0,0
166663,follow-up,0,0
166664,with,0,0
166665,referral,0,1
166666,to,0,0
166667,available,0,0
166668,local,0,0
166669,support,0,0
166670,programmes,0,0
166671,when,0,0
166672,needed,0,0
166673,",",0,0
166674,and,0,0
166675,to,0,0
166676,restrict,0,0
166677,large,0,0
166678,multifaceted,0,0
166679,intervention,0,0
166680,programmes,0,0
166681,to,0,0
166682,patients,1,1
166683,and,1,0
166684,caregivers,1,1
166685,with,1,1
166686,special,1,1
166687,needs,1,0
166688,until,0,1
166689,further,0,0
166690,evidence,0,0
166691,for,0,0
166692,cost-effectiveness,0,0
166693,emerges,0,0
166694,.,0,1
166695,TRIAL,0,0
166696,REGISTRATION,0,0
166697,The,0,0
166698,study,0,0
166699,was,0,0
166700,registered,0,0
166701,in,0,0
166702,the,0,0
166703,Clinical,0,0
166704,Trial,0,0
166705,Database,0,0
166706,as,0,0
166707,ISRCTN74848736,0,0
166708,.,0,1
166709,No,0,0
166710,gains,0,0
166711,in,0,0
166712,efficacy,0,0
166713,observed,0,0
166714,by,0,0
166715,adding,0,0
166716,gemcitabine,0,0
166717,to,0,0
166718,adjuvant,0,0
166719,therapy,0,0
166720,for,0,0
166721,lymph,1,0
166722,node-positive,1,1
166723,breast,1,1
166724,cancer,1,1
166725,.,1,0
166726,[,0,0
166727,Rehabilitation,0,0
166728,of,0,0
166729,the,0,0
166730,patients,1,1
166731,presenting,1,1
166732,with,1,1
166733,combined,1,0
166734,pathology,1,0
166735,:,1,1
166736,dyscirculatory,1,1
166737,encephalopathy,1,0
166738,and,1,0
166739,climacteric,1,0
166740,syndrome,1,1
166741,],1,0
166742,.,1,0
166743,The,0,0
166744,present,0,0
166745,paper,0,0
166746,reports,0,0
166747,the,0,0
166748,data,0,0
166749,on,0,0
166750,rehabilitation,1,1
166751,of,1,0
166752,women,1,1
166753,presenting,1,1
166754,with,1,1
166755,combined,1,0
166756,pathology,1,0
166757,:,1,1
166758,dyscirculatory,1,1
166759,encephalopathy,1,0
166760,and,1,0
166761,climacteric,1,0
166762,syndrome,1,1
166763,.,1,0
166764,It,0,0
166765,is,0,0
166766,shown,0,0
166767,that,0,0
166768,the,0,0
166769,introduction,0,0
166770,of,0,0
166771,ozonotherapy,0,0
166772,and,0,0
166773,klimadynon,0,0
166774,",",0,0
166775,a,0,0
166776,herbal,0,0
166777,medicine,0,0
166778,possessed,0,0
166779,of,0,0
166780,the,0,0
166781,estrogen-like,0,0
166782,action,0,0
166783,",",0,0
166784,into,0,0
166785,combined,0,0
166786,rehabilitative,0,0
166787,treatment,0,0
166788,ensures,0,0
166789,the,0,0
166790,significant,0,0
166791,improvement,0,0
166792,of,0,0
166793,the,0,0
166794,parameters,0,0
166795,of,0,0
166796,interest,0,0
166797,",",0,0
166798,such,0,0
166799,as,0,0
166800,climacteric,0,1
166801,symptoms,0,0
166802,",",0,0
166803,short-term,0,0
166804,memory,0,0
166805,",",0,0
166806,lipid,0,0
166807,profile,0,0
166808,",",0,0
166809,endothelial,0,0
166810,function,0,0
166811,",",0,0
166812,cerebral,0,0
166813,circulation,0,0
166814,",",0,0
166815,and,0,0
166816,quality,0,0
166817,of,0,0
166818,life,0,0
166819,.,0,0
166820,Phosphorylated,0,0
166821,p-70S6K,0,0
166822,predicts,0,0
166823,tamoxifen,0,0
166824,resistance,0,0
166825,in,0,0
166826,postmenopausal,1,1
166827,breast,1,1
166828,cancer,1,1
166829,patients,1,1
166830,randomized,0,0
166831,between,0,0
166832,adjuvant,0,0
166833,tamoxifen,0,0
166834,versus,0,0
166835,no,0,0
166836,systemic,0,0
166837,treatment,0,0
166838,.,0,0
166839,INTRODUCTION,0,0
166840,Activation,0,0
166841,of,0,0
166842,the,0,0
166843,phosphatidylinositol-3-kinase,0,0
166844,(,0,0
166845,PI3K,0,0
166846,),0,0
166847,and/or,0,0
166848,mitogen-activated,0,0
166849,protein,0,0
166850,kinase,0,0
166851,(,0,0
166852,MAPK,0,0
166853,),0,0
166854,pathways,0,0
166855,results,0,0
166856,in,0,0
166857,anti-estrogen,0,0
166858,resistance,0,0
166859,in,0,0
166860,vitro,0,0
166861,",",0,0
166862,but,0,0
166863,a,0,0
166864,biomarker,0,0
166865,with,0,0
166866,clinical,0,0
166867,validity,0,0
166868,to,0,0
166869,predict,0,0
166870,intrinsic,0,0
166871,resistance,0,0
166872,has,0,0
166873,not,0,0
166874,been,0,0
166875,identified,0,0
166876,.,0,0
166877,In,0,0
166878,metastatic,1,1
166879,breast,1,1
166880,cancer,1,1
166881,patients,1,1
166882,with,1,1
166883,previous,1,0
166884,exposure,1,0
166885,to,1,0
166886,endocrine,1,0
166887,therapy,1,0
166888,",",0,0
166889,the,0,0
166890,addition,0,0
166891,of,0,0
166892,a,0,0
166893,mammalian,0,0
166894,target,0,0
166895,of,0,0
166896,rapamycine,0,0
166897,(,0,0
166898,mTOR,0,0
166899,),0,0
166900,inhibitor,0,0
166901,has,0,0
166902,been,0,0
166903,shown,0,0
166904,to,0,0
166905,be,0,0
166906,beneficial,0,0
166907,.,0,0
166908,Whether,0,0
166909,or,0,0
166910,not,0,0
166911,patients,0,1
166912,on,0,0
166913,adjuvant,0,0
166914,endocrine,0,1
166915,treatment,0,0
166916,might,0,0
166917,benefit,0,0
166918,from,0,0
166919,these,0,0
166920,drugs,0,0
166921,is,0,0
166922,currently,0,0
166923,unclear,0,0
166924,.,0,0
166925,A,0,0
166926,biomarker,0,0
166927,that,0,0
166928,predicts,0,0
166929,intrinsic,0,0
166930,resistance,0,0
166931,could,0,0
166932,potentially,0,0
166933,be,0,0
166934,used,0,0
166935,as,0,0
166936,companion,0,0
166937,diagnostic,0,0
166938,in,0,0
166939,this,0,0
166940,setting,0,0
166941,.,0,0
166942,We,0,0
166943,tested,0,0
166944,the,0,0
166945,clinical,0,0
166946,validity,0,0
166947,of,0,0
166948,different,0,0
166949,downstream-activated,0,0
166950,proteins,0,0
166951,in,0,0
166952,the,0,0
166953,PI3K,0,0
166954,and/or,0,0
166955,MAPK,0,0
166956,pathways,0,0
166957,to,0,0
166958,predict,0,0
166959,intrinsic,0,0
166960,tamoxifen,0,0
166961,resistance,0,0
166962,in,0,0
166963,postmenopausal,0,1
166964,primary,0,0
166965,breast,0,1
166966,cancer,0,1
166967,patients,0,1
166968,.,0,0
166969,METHODS,0,0
166970,We,0,0
166971,recollected,0,0
166972,primary,1,0
166973,tumor,1,0
166974,tissue,1,0
166975,from,1,1
166976,patients,1,1
166977,who,1,1
166978,participated,1,1
166979,in,1,1
166980,a,1,0
166981,randomized,1,0
166982,trial,1,0
166983,of,1,0
166984,adjuvant,1,0
166985,tamoxifen,1,0
166986,(,1,0
166987,1-3,1,0
166988,years,1,1
166989,),1,0
166990,versus,1,0
166991,observation,1,0
166992,.,1,0
166993,After,0,0
166994,constructing,0,0
166995,a,0,0
166996,tissue,0,0
166997,micro-array,0,0
166998,",",0,0
166999,cores,0,0
167000,from,0,0
167001,563,0,1
167002,estrogen,0,0
167003,receptor,0,0
167004,?,0,0
167005,positive,0,0
167006,were,0,0
167007,immunostained,0,0
167008,for,0,0
167009,p-AKT,0,0
167010,(,0,0
167011,Thr308,0,0
167012,),0,0
167013,",",0,0
167014,p-AKT,0,0
167015,(,0,0
167016,Ser473,0,0
167017,),0,0
167018,",",0,0
167019,p-mTOR,0,0
167020,",",0,0
167021,p-p706SK,0,0
167022,and,0,0
167023,p-ERK1/2,0,0
167024,.,0,0
167025,Cox,0,0
167026,proportional,0,0
167027,hazard,0,0
167028,models,0,0
167029,for,0,0
167030,recurrence,0,0
167031,free,0,0
167032,interval,0,0
167033,were,0,0
167034,used,0,0
167035,to,0,0
167036,assess,0,0
167037,hazard,0,0
167038,ratios,0,0
167039,and,0,0
167040,interactions,0,0
167041,between,0,0
167042,these,0,0
167043,markers,0,0
167044,and,0,0
167045,tamoxifen,0,0
167046,treatment,0,0
167047,efficacy,0,0
167048,.,0,1
167049,RESULTS,0,0
167050,Interactions,0,0
167051,were,0,1
167052,identified,0,0
167053,between,0,0
167054,tamoxifen,0,0
167055,and,0,0
167056,p-AKT,0,1
167057,(,0,0
167058,Thr308,0,0
167059,),0,0
167060,",",0,0
167061,p-mTOR,0,0
167062,",",0,0
167063,p-p70S6K,0,0
167064,and,0,0
167065,p-ERK1/2,0,0
167066,.,0,0
167067,Applying,0,0
167068,a,0,0
167069,conservative,0,0
167070,level,0,0
167071,of,0,0
167072,significance,0,0
167073,",",0,0
167074,p-p70S6K,0,0
167075,remained,0,0
167076,significantly,0,0
167077,associated,0,0
167078,with,0,0
167079,tamoxifen,0,0
167080,resistance,0,0
167081,.,0,0
167082,Patients,0,1
167083,with,0,1
167084,p-p70S6K,0,0
167085,negative,0,0
167086,tumors,0,1
167087,derived,0,1
167088,significant,0,0
167089,benefit,0,0
167090,from,0,0
167091,tamoxifen,0,0
167092,(,0,0
167093,HR,0,0
167094,0.24,0,0
167095,",",0,0
167096,P,0,0
167097,<,0,0
167098,0.0001,0,0
167099,),0,0
167100,",",0,0
167101,while,0,0
167102,patients,0,1
167103,whose,0,1
167104,tumor,0,1
167105,did,0,1
167106,express,0,0
167107,p-p70S6K,0,0
167108,did,0,0
167109,not,0,0
167110,(,0,0
167111,HR,0,0
167112,=,0,0
167113,1.02,0,0
167114,",",0,0
167115,P,0,0
167116,=0.95,0,0
167117,),0,0
167118,",",0,0
167119,P,0,0
167120,for,0,0
167121,interaction,0,0
167122,0.004,0,0
167123,.,0,0
167124,In,0,0
167125,systemically,0,0
167126,untreated,0,0
167127,breast,0,1
167128,cancer,0,1
167129,patients,0,1
167130,",",0,0
167131,p-p70S6K,0,0
167132,was,0,0
167133,associated,0,0
167134,with,0,0
167135,a,0,0
167136,decreased,0,0
167137,risk,0,0
167138,for,0,0
167139,recurrence,0,0
167140,.,0,1
167141,CONCLUSIONS,1,0
167142,Patients,1,1
167143,whose,1,1
167144,tumor,1,1
167145,expresses,1,1
167146,p-p70S6K,1,0
167147,",",1,0
167148,as,1,0
167149,a,1,0
167150,marker,1,0
167151,of,1,0
167152,downstream,1,0
167153,PI3K,1,0
167154,and/or,1,0
167155,MAPK,1,0
167156,pathway,1,0
167157,activation,1,0
167158,",",1,0
167159,have,1,0
167160,a,1,0
167161,favorable,0,0
167162,prognosis,0,0
167163,",",0,0
167164,but,0,0
167165,do,0,0
167166,not,0,0
167167,benefit,0,0
167168,from,0,0
167169,adjuvant,0,0
167170,tamoxifen,0,0
167171,.,0,0
167172,A,0,0
167173,potential,0,0
167174,benefit,0,0
167175,from,0,0
167176,inhibitors,0,0
167177,of,0,0
167178,the,0,0
167179,PI3K/Akt/mTOR,0,0
167180,pathway,0,0
167181,in,0,0
167182,these,0,0
167183,patients,0,1
167184,needs,0,0
167185,to,0,0
167186,be,0,0
167187,further,0,0
167188,explored,0,0
167189,.,0,0
167190,Assessment,0,0
167191,of,0,0
167192,osteopontin,0,0
167193,in,0,0
167194,early,1,0
167195,breast,1,1
167196,cancer,1,1
167197,:,1,1
167198,correlative,0,0
167199,study,0,0
167200,in,0,0
167201,a,0,0
167202,randomised,0,0
167203,clinical,0,0
167204,trial,0,0
167205,.,0,0
167206,INTRODUCTION,0,0
167207,Osteopontin,0,0
167208,(,0,0
167209,OPN,0,0
167210,),0,0
167211,is,0,0
167212,a,0,0
167213,malignancy-associated,0,0
167214,glycoprotein,0,0
167215,that,0,0
167216,contributes,0,0
167217,functionally,0,0
167218,to,0,0
167219,tumor,0,0
167220,aggressiveness,0,0
167221,.,0,0
167222,In,0,0
167223,metastatic,0,1
167224,breast,0,1
167225,cancer,0,1
167226,",",0,0
167227,we,0,0
167228,previously,0,0
167229,demonstrated,0,0
167230,that,0,0
167231,elevated,0,0
167232,OPN,0,0
167233,in,0,0
167234,primary,0,0
167235,tumor,0,0
167236,and,0,0
167237,blood,0,0
167238,was,0,0
167239,associated,0,0
167240,with,0,1
167241,poor,0,1
167242,prognosis,0,1
167243,.,0,0
167244,METHODS,0,0
167245,We,0,0
167246,measured,0,0
167247,OPN,0,0
167248,in,0,0
167249,plasma,0,0
167250,by,0,0
167251,ELISA,0,0
167252,",",0,0
167253,and,0,0
167254,in,0,0
167255,tumors,0,1
167256,by,0,0
167257,immunohistochemistry,0,0
167258,",",0,0
167259,in,1,0
167260,624,1,1
167261,(,1,0
167262,94,1,0
167263,%,1,0
167264,),1,0
167265,and,1,0
167266,462,1,1
167267,(,1,0
167268,69,1,1
167269,%,1,0
167270,),1,0
167271,",",1,0
167272,respectively,1,0
167273,",",1,0
167274,of,1,0
167275,667,1,1
167276,postmenopausal,1,1
167277,women,1,1
167278,with,1,1
167279,hormone,1,0
167280,responsive,1,0
167281,early,1,0
167282,breast,1,1
167283,cancer,1,1
167284,treated,1,0
167285,by,1,0
167286,surgery,1,1
167287,followed,1,0
167288,by,1,0
167289,adjuvant,1,0
167290,treatment,1,0
167291,with,1,1
167292,tamoxifen,1,0
167293,+/-,1,0
167294,octreotide,1,0
167295,in,1,0
167296,a,1,0
167297,randomized,1,0
167298,trial,1,0
167299,(,1,0
167300,NCIC,1,0
167301,CTG,1,0
167302,MA.14,1,0
167303,;,1,0
167304,National,1,0
167305,Cancer,1,0
167306,Institute,1,0
167307,of,1,0
167308,Canada,1,1
167309,Clinical,1,0
167310,Trials,1,0
167311,Group,1,1
167312,Mammary.14,1,1
167313,),1,0
167314,.,1,0
167315,RESULTS,0,0
167316,Plasma,0,0
167317,OPN,0,0
167318,was,0,0
167319,measured,0,0
167320,in,0,0
167321,"2,540",1,1
167322,samples,1,1
167323,;,1,0
167324,688,1,1
167325,at,1,0
167326,baseline,1,0
167327,and,1,0
167328,"1,852",1,1
167329,collected,1,0
167330,during,0,0
167331,follow-up,0,0
167332,.,0,0
167333,Mean,0,0
167334,baseline,0,0
167335,plasma,0,0
167336,OPN,0,0
167337,was,0,0
167338,46,0,0
167339,ng/ml,0,0
167340,(,0,0
167341,range,0,0
167342,22.6,0,0
167343,to,0,0
167344,290,0,1
167345,),0,0
167346,which,0,0
167347,did,0,0
167348,not,0,0
167349,differ,0,0
167350,from,0,0
167351,normal,0,1
167352,levels,0,0
167353,.,0,1
167354,Mean,0,0
167355,percentage,0,0
167356,OPN,0,0
167357,tumor,0,0
167358,cell,0,0
167359,positivity,0,0
167360,was,0,0
167361,33.9,0,0
167362,(,0,0
167363,95,0,0
167364,%,0,0
167365,CI,0,0
167366,:,0,1
167367,30.2,0,0
167368,to,0,0
167369,37.9,0,0
167370,),0,0
167371,.,0,0
167372,There,0,0
167373,was,0,0
167374,no,0,0
167375,correlation,0,0
167376,between,0,0
167377,plasma,0,0
167378,and,0,0
167379,tumor,0,0
167380,OPN,0,0
167381,values,0,0
167382,.,0,0
167383,In,0,0
167384,multivariate,0,0
167385,analysis,0,0
167386,",",0,0
167387,neither,0,0
167388,was,0,0
167389,associated,0,0
167390,with,0,1
167391,event-free,0,0
167392,survival,0,0
167393,(,0,0
167394,EFS,0,0
167395,),0,0
167396,",",0,0
167397,relapse-free,0,0
167398,survival,0,0
167399,(,0,0
167400,RFS,0,0
167401,),0,0
167402,",",0,0
167403,overall,0,0
167404,survival,0,0
167405,(,0,0
167406,OS,0,0
167407,),0,0
167408,",",0,0
167409,bone,0,0
167410,RFS,0,0
167411,or,0,1
167412,non-bone,0,0
167413,RFS,0,0
167414,.,0,0
167415,An,0,0
167416,exploratory,0,0
167417,analysis,0,0
167418,in,0,0
167419,patients,0,1
167420,with,0,1
167421,recurrence,0,0
167422,showed,0,0
167423,higher,0,0
167424,mean,0,0
167425,OPN,0,0
167426,plasma,0,0
167427,levels,0,0
167428,60.7,0,0
167429,ng/ml,0,0
167430,(,0,0
167431,23.9,0,0
167432,to,0,0
167433,543,0,1
167434,),0,0
167435,in,0,0
167436,the,0,0
167437,recurrence,0,0
167438,period,0,0
167439,compared,0,0
167440,with,0,1
167441,baseline,0,0
167442,levels,0,0
167443,.,0,0
167444,CONCLUSIONS,0,0
167445,The,0,0
167446,hypothesis,0,0
167447,that,0,0
167448,OPN,0,0
167449,tumor,0,0
167450,expression,0,0
167451,would,0,0
167452,have,0,0
167453,independent,0,0
167454,prognostic,0,0
167455,value,0,0
167456,in,0,0
167457,early,0,0
167458,breast,0,1
167459,cancer,0,1
167460,was,0,0
167461,not,0,0
167462,supported,0,0
167463,by,0,0
167464,multivariate,0,0
167465,analysis,0,0
167466,of,0,0
167467,this,0,0
167468,study,0,0
167469,population,0,1
167470,.,0,0
167471,Plasma,0,0
167472,OPN,0,0
167473,levels,0,0
167474,in,0,0
167475,women,1,1
167476,with,1,1
167477,hormone,1,0
167478,responsive,1,0
167479,early,1,0
167480,breast,1,1
167481,cancer,1,1
167482,in,1,0
167483,the,0,0
167484,MA.14,0,0
167485,trial,0,0
167486,were,0,0
167487,not,0,0
167488,elevated,0,0
167489,and,0,0
167490,there,0,0
167491,was,0,0
167492,no,0,0
167493,evidence,0,0
167494,for,0,0
167495,prognostic,0,0
167496,value,0,0
167497,of,0,0
167498,plasma,0,0
167499,OPN,0,0
167500,in,0,0
167501,this,0,0
167502,defined,0,0
167503,group,0,0
167504,of,0,0
167505,patients,0,1
167506,.,0,0
167507,However,0,0
167508,",",0,0
167509,our,0,0
167510,finding,0,0
167511,of,0,0
167512,elevated,0,0
167513,mean,0,1
167514,OPN,0,0
167515,plasma,0,0
167516,level,0,0
167517,around,0,0
167518,the,0,0
167519,time,0,0
167520,of,0,0
167521,recurrence,0,0
167522,warrants,0,0
167523,further,0,0
167524,study,0,0
167525,.,0,0
167526,TRIAL,0,0
167527,REGISTRATION,0,0
167528,NCT00002864,0,0
167529,",",0,0
167530,http,0,0
167531,:,0,1
167532,//clinicaltrials.gov/show/NCT00002864,0,0
167533,.,0,0
167534,A,0,0
167535,randomized,0,0
167536,controlled,0,0
167537,trial,0,0
167538,investigating,0,0
167539,the,0,0
167540,safety,0,0
167541,and,0,0
167542,efficacy,0,0
167543,of,0,0
167544,aripiprazole,0,0
167545,in,0,0
167546,the,0,0
167547,long-term,0,0
167548,maintenance,0,0
167549,treatment,0,0
167550,of,0,0
167551,pediatric,1,1
167552,patients,1,1
167553,with,1,1
167554,irritability,1,0
167555,associated,1,0
167556,with,1,0
167557,autistic,1,1
167558,disorder,1,1
167559,.,1,0
167560,OBJECTIVE,0,0
167561,To,0,0
167562,evaluate,0,0
167563,the,0,0
167564,efficacy,0,0
167565,and,0,0
167566,safety,0,0
167567,of,0,0
167568,aripiprazole,0,0
167569,versus,0,0
167570,placebo,0,0
167571,in,0,0
167572,preventing,0,0
167573,relapse,0,0
167574,of,0,0
167575,irritability,0,0
167576,symptoms,0,0
167577,associated,0,0
167578,with,0,1
167579,autistic,1,1
167580,disorder,1,1
167581,in,1,0
167582,pediatric,1,1
167583,patients,1,1
167584,.,1,1
167585,METHOD,0,0
167586,This,0,0
167587,multicenter,0,0
167588,",",0,0
167589,double-blind,0,0
167590,",",0,0
167591,randomized,0,0
167592,",",0,0
167593,placebo-controlled,0,0
167594,",",0,0
167595,relapse-prevention,0,0
167596,trial,0,0
167597,enrolled,0,1
167598,patients,1,1
167599,(,1,0
167600,6-17,1,1
167601,years,1,1
167602,),1,1
167603,who,1,1
167604,met,1,1
167605,the,1,1
167606,current,1,0
167607,Diagnostic,1,0
167608,and,1,0
167609,Statistical,1,0
167610,Manual,1,0
167611,of,1,0
167612,Mental,1,0
167613,Disorders,1,1
167614,",",1,0
167615,Fourth,1,0
167616,Edition,1,0
167617,",",1,0
167618,Text,1,0
167619,Revision,1,0
167620,(,1,0
167621,DMS-IV-TR,1,0
167622,),1,0
167623,criteria,1,1
167624,for,1,0
167625,autistic,1,1
167626,disorder,1,1
167627,and,1,0
167628,who,1,1
167629,also,1,0
167630,had,1,1
167631,serious,1,0
167632,behavioral,1,1
167633,problems,1,1
167634,(,1,0
167635,ie,1,0
167636,",",1,0
167637,tantrums,1,0
167638,",",1,0
167639,aggression,1,1
167640,",",1,0
167641,self-injurious,1,0
167642,behavior,1,0
167643,",",1,0
167644,or,1,0
167645,a,1,0
167646,combination,1,0
167647,of,1,0
167648,these,1,0
167649,behavioral,1,0
167650,problems,1,1
167651,),1,0
167652,between,1,0
167653,March,1,1
167654,2011,1,1
167655,and,1,0
167656,June,1,1
167657,2012,1,1
167658,.,1,0
167659,In,0,0
167660,phase,0,0
167661,1,0,0
167662,",",0,0
167663,single-blind,0,0
167664,aripiprazole,0,0
167665,was,0,0
167666,flexibly,0,0
167667,dosed,0,0
167668,(,0,0
167669,2-15,0,0
167670,mg/d,0,0
167671,),0,0
167672,for,0,0
167673,13-26,0,1
167674,weeks,0,0
167675,.,0,1
167676,Patients,1,1
167677,with,1,1
167678,a,1,0
167679,stable,1,1
167680,response,1,0
167681,(,1,0
167682,?,1,0
167683,25,1,0
167684,%,1,0
167685,decrease,1,0
167686,in,1,0
167687,Aberrant,1,0
167688,Behavior,1,0
167689,Checklist-irritability,1,0
167690,subscale,1,0
167691,score,1,0
167692,and,1,0
167693,a,1,0
167694,rating,1,0
167695,of,1,0
167696,much,1,0
167697,improved,1,0
167698,or,1,0
167699,very,1,0
167700,much,1,0
167701,improved,1,0
167702,on,1,0
167703,the,1,0
167704,Clinical,1,0
167705,Global,1,0
167706,Impressions-Improvement,1,0
167707,scale,1,0
167708,),1,0
167709,for,1,0
167710,12,1,0
167711,consecutive,1,1
167712,weeks,1,0
167713,were,1,0
167714,randomized,0,0
167715,into,0,0
167716,phase,0,0
167717,2,0,0
167718,to,0,0
167719,continue,0,0
167720,aripiprazole,0,0
167721,or,0,0
167722,switch,0,0
167723,to,0,0
167724,placebo,0,0
167725,.,0,0
167726,Treatment,0,0
167727,was,0,0
167728,continued,0,0
167729,until,0,0
167730,relapse,0,0
167731,or,0,0
167732,up,0,0
167733,to,0,0
167734,16,0,1
167735,weeks,0,0
167736,.,0,0
167737,The,0,0
167738,primary,0,0
167739,end,0,0
167740,point,0,0
167741,was,0,0
167742,time,0,0
167743,from,0,0
167744,randomization,0,0
167745,to,0,0
167746,relapse,0,0
167747,.,0,0
167748,RESULTS,1,0
167749,Eighty-five,1,1
167750,patients,1,1
167751,were,1,0
167752,randomized,1,0
167753,in,1,0
167754,phase,1,0
167755,2,1,0
167756,.,0,0
167757,The,0,0
167758,difference,0,0
167759,in,0,0
167760,time,0,0
167761,to,0,0
167762,relapse,0,0
167763,between,0,0
167764,aripiprazole,0,0
167765,and,0,0
167766,placebo,0,0
167767,was,0,0
167768,not,0,0
167769,statistically,0,0
167770,significant,0,0
167771,(,0,0
167772,P,0,0
167773,=,0,0
167774,.097,0,0
167775,),0,0
167776,.,0,0
167777,Kaplan-Meier,0,0
167778,relapse,0,0
167779,rates,0,0
167780,at,0,0
167781,week,0,0
167782,16,0,1
167783,were,0,0
167784,35,0,0
167785,%,0,0
167786,for,0,0
167787,aripiprazole,0,0
167788,and,0,0
167789,52,0,0
167790,%,0,0
167791,for,0,0
167792,placebo,0,0
167793,(,0,0
167794,hazard,0,0
167795,ratio,0,0
167796,[,0,0
167797,HR,0,0
167798,],0,0
167799,=,0,0
167800,0.57,0,0
167801,;,0,0
167802,number,0,0
167803,needed,0,0
167804,to,0,0
167805,treat,0,0
167806,[,0,0
167807,NNT,0,1
167808,],0,1
167809,=,0,0
167810,6,0,0
167811,),0,0
167812,.,0,0
167813,The,0,0
167814,most,0,0
167815,common,0,0
167816,adverse,0,0
167817,events,0,0
167818,during,0,0
167819,phase,0,0
167820,1,0,0
167821,were,0,0
167822,weight,0,0
167823,increase,0,0
167824,(,0,0
167825,25.2,0,0
167826,%,0,0
167827,),0,0
167828,",",0,0
167829,somnolence,0,0
167830,(,0,0
167831,14.8,0,0
167832,%,0,0
167833,),0,0
167834,",",0,0
167835,and,0,0
167836,vomiting,0,0
167837,(,0,0
167838,14.2,0,0
167839,%,0,0
167840,),0,0
167841,;,0,0
167842,and,0,0
167843,",",0,0
167844,during,0,0
167845,phase,0,0
167846,2,0,0
167847,(,0,0
167848,aripiprazole,0,0
167849,vs,0,0
167850,placebo,0,0
167851,),0,0
167852,",",0,0
167853,they,0,0
167854,were,0,0
167855,upper,0,0
167856,respiratory,0,0
167857,tract,0,1
167858,infection,0,0
167859,(,0,0
167860,10.3,0,0
167861,%,0,0
167862,vs,0,0
167863,2.3,0,0
167864,%,0,0
167865,),0,0
167866,",",0,0
167867,constipation,0,0
167868,(,0,0
167869,5.1,0,0
167870,%,0,0
167871,vs,0,0
167872,0,0,0
167873,%,0,0
167874,),0,0
167875,",",0,0
167876,and,0,0
167877,movement,0,0
167878,disorder,0,1
167879,(,0,0
167880,5.1,0,0
167881,%,0,0
167882,vs,0,0
167883,0,0,0
167884,%,0,0
167885,),0,0
167886,.,0,0
167887,CONCLUSIONS,0,0
167888,In,0,0
167889,this,0,0
167890,study,0,0
167891,",",0,0
167892,there,0,0
167893,was,0,0
167894,no,0,0
167895,statistically,0,0
167896,significant,0,0
167897,difference,0,0
167898,between,0,0
167899,aripiprazole,0,0
167900,and,0,0
167901,placebo,0,0
167902,in,0,0
167903,time,0,0
167904,to,0,0
167905,relapse,0,0
167906,during,0,0
167907,maintenance,0,0
167908,therapy,0,0
167909,.,0,0
167910,However,0,0
167911,",",0,0
167912,the,0,0
167913,HR,0,0
167914,and,0,0
167915,NNT,0,0
167916,suggest,0,0
167917,some,0,0
167918,patients,0,1
167919,will,0,0
167920,benefit,0,0
167921,from,0,0
167922,maintenance,0,0
167923,treatment,0,0
167924,.,0,0
167925,Patients,0,1
167926,receiving,0,0
167927,aripiprazole,0,0
167928,should,0,0
167929,be,0,0
167930,periodically,0,0
167931,reassessed,0,0
167932,to,0,0
167933,determine,0,0
167934,the,0,0
167935,continued,0,0
167936,need,0,0
167937,for,0,0
167938,treatment,0,0
167939,.,0,0
167940,TRIAL,0,0
167941,REGISTRATION,0,0
167942,ClinicalTrials.gov,0,0
167943,identifier,0,1
167944,:,0,1
167945,NCT01227668,0,0
167946,.,0,0
167947,Participant,0,0
167948,characteristics,0,0
167949,and,0,0
167950,intervention,0,0
167951,processes,0,0
167952,associated,0,0
167953,with,0,1
167954,reductions,0,0
167955,in,0,0
167956,television,0,0
167957,viewing,0,0
167958,in,0,0
167959,the,0,0
167960,High,0,0
167961,Five,0,0
167962,for,0,0
167963,Kids,1,1
167964,study,0,0
167965,.,0,0
167966,OBJECTIVE,0,0
167967,To,0,0
167968,evaluate,0,0
167969,the,0,0
167970,High,0,0
167971,Five,0,0
167972,for,0,0
167973,Kids,1,0
167974,intervention,0,0
167975,effect,0,0
167976,on,0,0
167977,television,0,0
167978,within,0,0
167979,subgroups,0,0
167980,",",0,0
167981,examine,0,0
167982,participant,0,0
167983,characteristics,0,0
167984,associated,0,0
167985,with,0,1
167986,process,0,0
167987,measures,0,0
167988,and,0,0
167989,assess,0,0
167990,perceived,0,0
167991,helpfulness,0,0
167992,of,0,0
167993,television,0,0
167994,intervention,0,0
167995,components,0,0
167996,.,0,1
167997,METHOD,0,0
167998,High,1,0
167999,Five,1,0
168000,(,1,0
168001,randomized,1,0
168002,controlled,1,0
168003,trial,1,0
168004,of,1,0
168005,445,1,1
168006,overweight/obese,1,1
168007,2-7,1,1
168008,year-olds,1,1
168009,in,1,0
168010,Massachusetts,1,1
168011,[,1,0
168012,2006-2008,1,1
168013,],1,0
168014,),1,0
168015,reduced,1,0
168016,television,1,0
168017,by,1,0
168018,0.36,1,0
168019,h/day,1,0
168020,.,1,0
168021,1-year,0,0
168022,effects,0,0
168023,on,0,0
168024,television,0,0
168025,viewing,0,0
168026,",",0,0
168027,stratified,0,0
168028,by,0,0
168029,subgroup,0,0
168030,",",0,0
168031,were,0,0
168032,assessed,0,0
168033,using,0,0
168034,linear,0,0
168035,regression,0,0
168036,.,0,0
168037,Among,1,0
168038,intervention,1,0
168039,participants,1,1
168040,(,1,0
168041,n=253,1,1
168042,),1,0
168043,",",0,0
168044,associations,0,0
168045,of,0,0
168046,intervention,0,0
168047,component,0,0
168048,helpfulness,0,0
168049,with,0,0
168050,television,0,0
168051,reduction,0,0
168052,were,0,0
168053,examined,0,0
168054,using,0,0
168055,linear,0,0
168056,regression,0,0
168057,and,0,0
168058,associations,0,0
168059,of,0,0
168060,participant,0,1
168061,characteristics,0,0
168062,with,0,1
168063,processes,0,0
168064,linked,0,0
168065,to,0,0
168066,television,0,0
168067,reduction,0,0
168068,(,0,0
168069,choosing,0,0
168070,television,0,0
168071,and,0,0
168072,completing,0,0
168073,intervention,0,0
168074,visits,0,0
168075,),0,0
168076,were,0,0
168077,examined,0,0
168078,using,0,0
168079,logistic,0,0
168080,regression,0,0
168081,.,0,0
168082,RESULTS,0,0
168083,High,0,0
168084,Five,0,0
168085,reduced,0,0
168086,television,0,0
168087,across,0,0
168088,subgroups,0,0
168089,.,0,1
168090,Parents,1,0
168091,of,1,0
168092,Latino,1,1
168093,(,1,0
168094,versus,1,0
168095,white,1,1
168096,),1,0
168097,children,1,1
168098,had,0,0
168099,lower,0,0
168100,odds,0,0
168101,of,0,0
168102,completing,0,0
168103,?2,0,0
168104,study,0,0
168105,visits,0,0
168106,(,0,0
168107,Odds,0,1
168108,Ratio,0,1
168109,:,0,1
168110,0.39,0,0
168111,[,0,0
168112,95,0,0
168113,%,0,0
168114,Confidence,0,0
168115,Interval,0,0
168116,:,0,1
168117,0.18,0,0
168118,",",0,0
168119,0.84,1,0
168120,],1,0
168121,),1,0
168122,.,1,0
168123,Parents,1,0
168124,of,1,0
168125,black,1,1
168126,(,1,0
168127,versus,1,0
168128,white,1,1
168129,),1,0
168130,children,1,1
168131,had,1,0
168132,higher,0,0
168133,odds,0,0
168134,of,0,0
168135,choosing,0,0
168136,television,0,0
168137,(,0,0
168138,Odds,0,0
168139,Ratio,0,1
168140,:,0,1
168141,2.23,0,0
168142,[,0,0
168143,95,0,0
168144,%,0,0
168145,Confidence,0,0
168146,Interval,0,0
168147,:,0,1
168148,1.08,0,0
168149,",",0,0
168150,4.59,0,0
168151,],0,0
168152,),0,0
168153,",",0,0
168154,as,0,0
168155,did,1,0
168156,parents,1,1
168157,of,1,0
168158,obese,1,1
168159,(,1,0
168160,versus,1,0
168161,overweight,1,1
168162,),1,0
168163,children,1,1
168164,and,1,0
168165,children,1,1
168166,watching,1,0
168167,?2,1,0
168168,h/day,1,0
168169,(,1,0
168170,versus,1,0
168171,<,1,0
168172,2,1,0
168173,),1,0
168174,at,1,0
168175,baseline,1,0
168176,.,1,0
168177,Greater,1,0
168178,perceived,0,0
168179,helpfulness,0,0
168180,was,0,0
168181,associated,0,0
168182,with,0,0
168183,greater,0,0
168184,television,0,0
168185,reduction,0,0
168186,.,0,0
168187,CONCLUSION,0,0
168188,Clinic-based,0,0
168189,motivational,0,0
168190,interviewing,0,0
168191,reduces,0,0
168192,television,0,0
168193,viewing,1,0
168194,in,1,0
168195,children,1,1
168196,.,1,1
168197,Low,1,0
168198,cost,0,0
168199,education,0,0
168200,approaches,0,0
168201,(,0,0
168202,e.g.,0,0
168203,",",0,0
168204,printed,0,0
168205,materials,0,0
168206,),0,0
168207,may,0,0
168208,be,0,0
168209,well-received,0,0
168210,.,0,0
168211,Parents,1,0
168212,of,1,0
168213,children,1,1
168214,at,1,0
168215,higher,1,0
168216,obesity,1,0
168217,risk,1,0
168218,could,1,0
168219,be,0,0
168220,more,0,0
168221,motivated,0,0
168222,to,0,0
168223,reduce,0,0
168224,television,0,0
168225,.,0,0
168226,Accumulated,0,0
168227,brisk,0,0
168228,walking,0,0
168229,reduces,0,0
168230,arterial,0,1
168231,stiffness,0,0
168232,in,1,0
168233,overweight,1,1
168234,adults,1,1
168235,:,1,1
168236,evidence,0,0
168237,from,0,0
168238,a,0,0
168239,randomized,0,0
168240,control,0,0
168241,trial,0,0
168242,.,0,0
168243,Arterial,0,0
168244,stiffness,0,0
168245,is,0,0
168246,a,0,0
168247,major,0,0
168248,contributor,0,0
168249,to,0,0
168250,the,0,0
168251,development,0,0
168252,of,0,0
168253,atherosclerosis,0,1
168254,and,0,0
168255,consequently,0,0
168256,cardiovascular,0,0
168257,disease,0,1
168258,.,0,0
168259,This,0,0
168260,study,0,0
168261,aimed,0,0
168262,to,0,0
168263,examine,0,0
168264,whether,0,0
168265,6,0,0
168266,months,0,0
168267,of,0,0
168268,accumulated,0,0
168269,(,0,0
168270,3,0,0
168271,?,0,0
168272,10,0,0
168273,minutes,0,0
168274,",",0,0
168275,5,0,0
168276,days/week,0,0
168277,),0,0
168278,brisk,0,0
168279,walking,0,0
168280,was,0,0
168281,sufficient,0,0
168282,to,0,0
168283,reduce,0,0
168284,arterial,0,0
168285,stiffness,1,0
168286,in,1,0
168287,sedentary,1,0
168288,",",1,0
168289,overweight,1,1
168290,individuals,1,1
168291,.,1,1
168292,Seventy-seven,1,1
168293,individuals,1,1
168294,(,1,1
168295,19,1,1
168296,men,1,1
168297,",",1,0
168298,58,1,1
168299,women,1,1
168300,;,1,0
168301,age,1,1
168302,",",1,0
168303,30-55,1,1
168304,years,1,1
168305,),1,0
168306,were,0,0
168307,randomly,0,0
168308,allocated,0,0
168309,to,0,0
168310,one,0,0
168311,of,0,0
168312,three,0,1
168313,groups,1,0
168314,;,1,1
168315,two,1,0
168316,groups,1,0
168317,completed,1,1
168318,30,1,1
168319,minutes,1,0
168320,of,1,0
168321,accumulated,1,0
168322,walking,1,0
168323,with,1,1
168324,either,1,0
168325,monthly,1,0
168326,or,1,0
168327,weekly,1,0
168328,telephone,1,0
168329,support,1,0
168330,;,1,0
168331,the,1,0
168332,third,1,0
168333,group,1,0
168334,(,1,0
168335,control,1,0
168336,),1,0
168337,performed,1,0
168338,stretching,1,0
168339,exercises,1,0
168340,.,1,0
168341,The,1,0
168342,walking,1,0
168343,groups,1,0
168344,were,0,0
168345,combined,0,0
168346,and,0,0
168347,telephone,0,0
168348,support,0,0
168349,included,0,0
168350,as,0,0
168351,a,0,0
168352,covariate,0,0
168353,.,0,0
168354,Anthropometry,0,0
168355,",",0,0
168356,blood,0,0
168357,pressure,0,0
168358,(,0,0
168359,BP,0,0
168360,),0,0
168361,",",0,0
168362,blood,0,0
168363,lipids,0,0
168364,",",0,0
168365,pulse,0,0
168366,wave,0,0
168367,velocity,0,0
168368,(,0,0
168369,PWV,0,0
168370,),0,0
168371,",",0,0
168372,and,0,0
168373,NOx,0,0
168374,(,0,0
168375,surrogate,0,0
168376,marker,0,0
168377,for,0,0
168378,nitric,0,0
168379,oxide,0,0
168380,),0,0
168381,were,0,0
168382,measured,0,0
168383,at,0,0
168384,baseline,0,0
168385,",",0,0
168386,post-intervention,0,0
168387,and,0,0
168388,4,0,0
168389,months,0,0
168390,post-intervention,0,0
168391,.,0,1
168392,No,0,0
168393,changes,0,0
168394,were,0,0
168395,observed,0,0
168396,for,0,0
168397,anthropometry,0,0
168398,",",0,0
168399,BP,0,0
168400,",",0,0
168401,or,0,0
168402,lipids,0,0
168403,.,0,0
168404,However,0,0
168405,",",0,0
168406,at,0,0
168407,the,0,0
168408,end,0,0
168409,of,0,0
168410,the,0,0
168411,intervention,0,0
168412,",",0,0
168413,there,0,0
168414,was,0,0
168415,a,0,0
168416,decrease,0,0
168417,in,0,0
168418,PWV,0,0
168419,(,0,0
168420,P,0,0
168421,<,0,0
168422,.001,0,0
168423,),0,0
168424,accompanied,0,0
168425,by,0,0
168426,an,0,0
168427,increase,0,0
168428,in,0,0
168429,NOx,0,0
168430,(,0,0
168431,P,0,0
168432,<,0,0
168433,.001,0,0
168434,),0,0
168435,",",0,0
168436,with,0,1
168437,changes,0,0
168438,maintained,0,0
168439,4,0,0
168440,months,0,0
168441,post-intervention,0,0
168442,.,0,1
168443,A,0,0
168444,strong,0,0
168445,negative,0,0
168446,correlation,0,0
168447,between,0,0
168448,PWV,0,0
168449,and,0,0
168450,NOx,0,0
168451,was,0,0
168452,also,0,0
168453,observed,0,0
168454,(,0,0
168455,P,0,0
168456,<,0,0
168457,.001,0,0
168458,;,0,0
168459,r,0,0
168460,=,0,0
168461,-0.65,0,0
168462,),0,0
168463,.,0,0
168464,A,0,0
168465,lifestyle,0,0
168466,approach,0,0
168467,to,0,0
168468,meeting,0,0
168469,current,0,0
168470,physical,0,0
168471,activity,0,0
168472,guidelines,0,0
168473,results,0,0
168474,in,0,1
168475,favorable,0,0
168476,alterations,0,0
168477,in,0,0
168478,arterial,0,1
168479,function,0,0
168480,in,1,0
168481,overweight,1,1
168482,individuals,1,1
168483,.,1,1
168484,Two,0,1
168485,to,0,0
168486,ten,0,1
168487,years,0,1
168488,:,0,1
168489,developmental,0,1
168490,trajectories,0,0
168491,of,0,0
168492,joint,0,0
168493,attention,0,0
168494,in,0,0
168495,children,1,1
168496,with,1,1
168497,ASD,1,1
168498,who,1,1
168499,received,1,1
168500,targeted,1,1
168501,social,1,0
168502,communication,1,0
168503,interventions,1,0
168504,.,1,0
168505,This,0,0
168506,study,0,0
168507,follows,0,0
168508,40,1,1
168509,children,1,1
168510,who,1,1
168511,were,1,1
168512,participants,1,1
168513,in,1,0
168514,a,1,0
168515,randomized,1,0
168516,controlled,1,0
168517,early,1,0
168518,intervention,1,0
168519,trial,1,0
168520,(,1,0
168521,Kasari,1,0
168522,et,1,1
168523,al,1,1
168524,.,1,0
168525,),1,0
168526,from,1,0
168527,early,1,0
168528,childhood,1,1
168529,(,1,0
168530,2-5,1,0
168531,years,1,1
168532,of,1,0
168533,age,1,1
168534,),1,0
168535,to,1,0
168536,elementary,1,1
168537,school,1,1
168538,age,1,1
168539,(,1,0
168540,8-10,1,1
168541,years,1,1
168542,),1,0
168543,.,1,0
168544,To,0,0
168545,fully,0,0
168546,utilize,0,0
168547,the,0,0
168548,available,0,0
168549,longitudinal,0,1
168550,data,0,0
168551,",",0,0
168552,the,0,0
168553,general,0,0
168554,linear,0,0
168555,mixed,0,0
168556,model,0,0
168557,was,0,0
168558,the,0,0
168559,primary,0,0
168560,analytical,0,0
168561,approach,0,0
168562,.,0,0
168563,The,0,0
168564,growth,0,0
168565,trajectories,0,0
168566,of,0,0
168567,joint,0,1
168568,attention,0,0
168569,skills,0,0
168570,(,0,0
168571,pointing,0,0
168572,",",0,0
168573,coordinated,0,0
168574,joint,0,0
168575,looking,0,0
168576,",",0,0
168577,and,0,0
168578,showing,0,0
168579,),0,0
168580,and,0,0
168581,expressive,0,0
168582,language,0,0
168583,outcomes,0,0
168584,in,0,0
168585,these,0,0
168586,children,0,1
168587,were,0,0
168588,estimated,0,0
168589,based,0,0
168590,on,0,0
168591,five,0,1
168592,time,0,0
168593,points,0,0
168594,during,0,0
168595,the,0,0
168596,measurement,0,0
168597,period,0,0
168598,.,0,0
168599,The,0,0
168600,children,0,1
168601,were,0,0
168602,grouped,0,1
168603,by,0,0
168604,diagnosis,0,1
168605,at,0,0
168606,the,0,0
168607,last,0,0
168608,follow-up,0,0
168609,(,0,0
168610,autism,0,1
168611,",",0,0
168612,autism,0,1
168613,spectrum,0,1
168614,disorder,0,1
168615,(,0,0
168616,ASD,0,1
168617,),0,0
168618,",",0,0
168619,no,0,0
168620,diagnosis,0,0
168621,),0,0
168622,and,0,0
168623,by,0,0
168624,their,0,0
168625,original,0,0
168626,treatment,0,0
168627,group,0,0
168628,assignment,0,0
168629,(,0,0
168630,joint,0,0
168631,attention,0,0
168632,",",0,0
168633,symbolic,0,0
168634,play,0,0
168635,",",0,0
168636,control,0,0
168637,),0,0
168638,",",0,0
168639,and,0,0
168640,differences,0,0
168641,between,0,0
168642,these,0,0
168643,groups,0,0
168644,were,0,0
168645,evaluated,0,0
168646,.,0,0
168647,Results,0,0
168648,showed,0,0
168649,that,0,0
168650,joint,0,0
168651,attention,0,0
168652,skills,0,0
168653,of,0,0
168654,coordinated,0,0
168655,joint,0,0
168656,looking,0,0
168657,and,0,0
168658,showing,0,0
168659,increased,0,0
168660,over,0,0
168661,time,0,0
168662,",",0,0
168663,and,0,0
168664,pointing,0,0
168665,to,0,0
168666,share,0,0
168667,interest,0,0
168668,increased,0,0
168669,over,0,0
168670,the,0,0
168671,first,0,0
168672,year,0,0
168673,measured,0,0
168674,and,0,0
168675,decreased,0,0
168676,thereafter,0,0
168677,.,0,0
168678,These,0,0
168679,trajectories,0,0
168680,were,0,0
168681,influenced,0,0
168682,by,0,0
168683,both,0,0
168684,original,0,0
168685,treatment,0,0
168686,assignment,0,0
168687,and,0,0
168688,diagnostic,0,0
168689,status,0,0
168690,at,0,0
168691,follow-up,0,0
168692,.,0,0
168693,In,0,0
168694,addition,0,0
168695,",",0,0
168696,a,0,0
168697,cross-lagged,0,0
168698,panel,0,1
168699,analysis,0,0
168700,revealed,0,0
168701,a,0,0
168702,causal,0,0
168703,relationship,0,0
168704,between,0,0
168705,early,0,0
168706,pointing,0,0
168707,and,0,0
168708,later,0,0
168709,language,0,0
168710,development,0,0
168711,.,0,0
168712,This,0,0
168713,study,0,0
168714,highlights,0,0
168715,the,0,0
168716,longitudinal,0,0
168717,and,0,0
168718,developmental,0,0
168719,importance,0,0
168720,of,0,0
168721,measures,0,0
168722,of,0,0
168723,early,0,1
168724,core,0,1
168725,deficits,0,0
168726,in,0,0
168727,autism,0,1
168728,",",0,0
168729,and,0,0
168730,suggests,0,0
168731,that,0,0
168732,both,0,0
168733,treatment,0,0
168734,and,0,0
168735,ASD,0,0
168736,symptomatology,0,0
168737,may,0,0
168738,influence,0,0
168739,growth,0,0
168740,in,0,0
168741,these,0,0
168742,skills,0,0
168743,over,0,0
168744,time,0,0
168745,.,0,0
168746,Dentists,0,1
168747,United,0,1
168748,to,0,0
168749,Extinguish,0,0
168750,Tobacco,0,0
168751,(,0,0
168752,DUET,0,0
168753,),0,0
168754,:,0,0
168755,a,0,0
168756,study,0,0
168757,protocol,0,0
168758,for,0,0
168759,a,0,0
168760,cluster,0,0
168761,randomized,0,0
168762,",",0,0
168763,controlled,0,0
168764,trial,0,0
168765,for,0,0
168766,enhancing,0,0
168767,implementation,0,0
168768,of,0,0
168769,clinical,0,0
168770,practice,0,0
168771,guidelines,0,0
168772,for,0,0
168773,treating,0,0
168774,tobacco,1,1
168775,dependence,1,0
168776,in,1,0
168777,dental,1,1
168778,care,1,1
168779,settings,1,0
168780,.,1,0
168781,BACKGROUND,0,0
168782,Although,0,0
168783,dental,0,1
168784,care,0,1
168785,settings,0,0
168786,provide,0,0
168787,an,0,0
168788,exceptional,0,0
168789,opportunity,0,0
168790,to,0,0
168791,reach,0,0
168792,smokers,1,1
168793,and,0,0
168794,provide,0,0
168795,brief,0,0
168796,cessation,0,0
168797,advice,0,0
168798,and,0,0
168799,treatment,0,0
168800,to,0,0
168801,reduce,0,0
168802,oral,0,0
168803,and,0,0
168804,other,0,0
168805,tobacco-related,0,0
168806,health,0,1
168807,conditions,0,0
168808,",",0,0
168809,dental,0,1
168810,care,0,0
168811,providers,0,0
168812,demonstrate,0,0
168813,limited,0,0
168814,adherence,0,0
168815,to,0,0
168816,evidence-based,0,0
168817,guidelines,0,0
168818,for,0,0
168819,treatment,0,0
168820,of,0,0
168821,tobacco,1,1
168822,use,1,0
168823,and,1,0
168824,dependence,1,0
168825,.,1,0
168826,METHODS/DESIGN,0,0
168827,Guided,0,0
168828,by,0,0
168829,a,0,0
168830,multi-level,0,0
168831,",",0,0
168832,conceptual,0,0
168833,framework,0,0
168834,that,0,0
168835,emphasizes,0,0
168836,changes,0,0
168837,in,0,0
168838,provider,0,0
168839,beliefs,0,0
168840,and,0,0
168841,organizational,0,0
168842,characteristics,0,0
168843,as,0,0
168844,drivers,0,1
168845,of,0,0
168846,improvement,0,0
168847,in,0,0
168848,tobacco,0,1
168849,treatment,0,0
168850,delivery,0,0
168851,",",0,0
168852,the,0,0
168853,current,0,0
168854,protocol,0,0
168855,will,0,0
168856,use,0,0
168857,a,0,0
168858,cluster,0,0
168859,",",0,0
168860,randomized,0,0
168861,design,0,0
168862,and,0,0
168863,multiple,0,0
168864,data,0,0
168865,sources,0,0
168866,(,0,0
168867,patient,0,0
168868,exit,0,0
168869,interviews,0,0
168870,",",0,0
168871,provider,0,0
168872,surveys,0,0
168873,",",0,0
168874,site,0,0
168875,observations,0,0
168876,",",0,0
168877,chart,0,0
168878,audits,0,0
168879,",",0,0
168880,and,0,0
168881,semi-structured,0,1
168882,provider,0,0
168883,interviews,0,1
168884,),0,0
168885,to,0,0
168886,study,0,0
168887,the,0,0
168888,process,0,0
168889,of,0,0
168890,implementing,0,0
168891,clinical,0,0
168892,practice,0,0
168893,guidelines,0,0
168894,for,0,0
168895,treating,0,0
168896,tobacco,0,1
168897,dependence,0,0
168898,in,0,0
168899,18,1,1
168900,public,1,1
168901,dental,1,1
168902,care,1,0
168903,clinics,1,1
168904,in,1,0
168905,New,1,1
168906,York,1,1
168907,City,1,0
168908,.,1,0
168909,The,0,0
168910,specific,0,0
168911,aims,0,0
168912,of,0,0
168913,this,0,0
168914,comparative-effectiveness,0,0
168915,research,0,0
168916,trial,0,0
168917,are,0,0
168918,to,0,0
168919,:,0,0
168920,compare,0,0
168921,the,0,0
168922,effectiveness,0,0
168923,of,0,0
168924,three,0,0
168925,promising,0,0
168926,strategies,0,0
168927,for,0,0
168928,implementation,0,0
168929,of,0,0
168930,tobacco,0,1
168931,use,0,0
168932,treatment,0,0
168933,guidelines-staff,0,1
168934,training,0,0
168935,and,0,0
168936,current,0,0
168937,best,0,0
168938,practices,0,0
168939,(,0,0
168940,CBP,0,0
168941,),0,0
168942,",",0,0
168943,CBP,0,0
168944,+,0,0
168945,provider,0,0
168946,performance,0,0
168947,feedback,0,0
168948,(,0,0
168949,PF,0,0
168950,),0,0
168951,",",0,0
168952,and,0,0
168953,CBP,0,0
168954,+,0,0
168955,PF,0,0
168956,+,0,0
168957,provider,0,0
168958,reimbursement,0,0
168959,for,0,0
168960,delivery,0,0
168961,of,0,0
168962,tobacco,0,1
168963,cessation,0,0
168964,treatment,0,0
168965,(,0,0
168966,pay-for-performance,0,0
168967,",",0,0
168968,or,0,0
168969,P4P,0,0
168970,),0,0
168971,;,0,0
168972,examine,0,0
168973,potential,0,0
168974,theory-driven,0,0
168975,mechanisms,0,0
168976,hypothesized,0,0
168977,to,0,0
168978,explain,0,0
168979,the,0,0
168980,comparative,0,0
168981,effectiveness,0,0
168982,of,0,0
168983,three,0,0
168984,strategies,0,0
168985,for,0,0
168986,implementation,0,0
168987,;,0,0
168988,and,0,0
168989,identify,0,0
168990,baseline,0,0
168991,organizational,0,0
168992,factors,0,0
168993,that,0,0
168994,influence,0,0
168995,the,0,0
168996,implementation,0,0
168997,of,0,0
168998,evidence-based,0,0
168999,tobacco,0,1
169000,use,0,0
169001,treatment,0,0
169002,practices,0,0
169003,in,0,0
169004,dental,0,1
169005,clinics,0,1
169006,.,0,0
169007,The,0,0
169008,primary,0,0
169009,outcome,0,0
169010,is,0,0
169011,change,0,0
169012,in,0,0
169013,providers,0,0
169014,',0,1
169015,tobacco,0,1
169016,treatment,0,0
169017,practices,0,0
169018,and,0,0
169019,the,0,0
169020,secondary,0,0
169021,outcomes,0,0
169022,are,0,0
169023,cost,0,0
169024,per,0,0
169025,quit,0,0
169026,",",0,0
169027,use,0,0
169028,of,0,0
169029,tobacco,0,1
169030,cessation,0,0
169031,treatments,0,0
169032,",",0,0
169033,quit,0,0
169034,attempts,0,0
169035,",",0,0
169036,and,0,0
169037,smoking,0,0
169038,abstinence,0,0
169039,.,0,0
169040,DISCUSSION,0,0
169041,We,0,0
169042,hypothesize,0,0
169043,that,0,0
169044,the,0,0
169045,value,0,0
169046,of,0,0
169047,these,0,0
169048,promising,0,0
169049,implementation,0,0
169050,strategies,0,0
169051,is,0,0
169052,additive,0,0
169053,and,0,0
169054,that,0,0
169055,incorporating,0,0
169056,all,0,0
169057,three,0,0
169058,strategies,0,0
169059,(,0,0
169060,CBP,0,0
169061,",",0,0
169062,PF,0,0
169063,",",0,0
169064,and,0,0
169065,P4P,0,0
169066,),0,0
169067,will,0,0
169068,be,0,0
169069,superior,0,0
169070,to,0,0
169071,CBP,0,0
169072,alone,0,0
169073,and,0,0
169074,CBP,0,0
169075,+,0,0
169076,PF,0,0
169077,in,0,0
169078,improving,0,0
169079,delivery,0,0
169080,of,0,0
169081,cessation,0,0
169082,assistance,0,0
169083,to,0,0
169084,smokers,0,1
169085,.,0,0
169086,The,0,0
169087,findings,0,0
169088,will,0,0
169089,improve,0,0
169090,knowledge,0,0
169091,pertinent,0,0
169092,to,0,0
169093,the,0,0
169094,implementation,0,0
169095,",",0,0
169096,dissemination,0,0
169097,",",0,0
169098,and,0,0
169099,sustained,0,0
169100,utilization,0,0
169101,of,0,0
169102,evidence-based,0,0
169103,tobacco,0,1
169104,use,0,0
169105,treatment,0,0
169106,in,0,0
169107,dental,0,1
169108,practices,0,1
169109,.,0,1
169110,TRIAL,0,0
169111,REGISTRATION,0,0
169112,NCT01615237,0,0
169113,.,0,0
169114,Are,0,0
169115,'leaky,0,0
169116,gut,0,0
169117,',0,0
169118,and,0,0
169119,behavior,0,0
169120,associated,0,0
169121,with,0,0
169122,gluten,0,0
169123,and,0,0
169124,dairy,0,1
169125,containing,0,0
169126,diet,0,0
169127,in,0,0
169128,children,1,1
169129,with,1,1
169130,autism,1,1
169131,spectrum,1,1
169132,disorders,1,1
169133,?,0,1
169134,OBJECTIVES,0,0
169135,Studies,0,0
169136,have,0,0
169137,suggested,0,0
169138,a,0,0
169139,link,0,0
169140,between,0,0
169141,diet,0,0
169142,and,0,0
169143,behavior,0,0
169144,in,0,0
169145,children,1,1
169146,with,1,1
169147,autism,1,1
169148,spectrum,1,1
169149,disorders,1,1
169150,(,1,0
169151,ASDs,1,0
169152,),1,0
169153,.,1,0
169154,Parental,0,0
169155,reports,0,0
169156,of,0,0
169157,behavioral,0,1
169158,changes,0,0
169159,upon,0,0
169160,exposure,0,0
169161,to,0,0
169162,gluten,0,0
169163,and/or,0,0
169164,casein,0,0
169165,are,0,0
169166,common,0,0
169167,in,0,0
169168,clinical,0,0
169169,practice,0,0
169170,.,0,0
169171,An,0,0
169172,association,0,0
169173,between,0,0
169174,diet,0,0
169175,type,0,1
169176,",",0,0
169177,intestinal,0,1
169178,permeability,0,0
169179,(,0,0
169180,IP,0,0
169181,),0,0
169182,(,0,0
169183,'leaky,0,0
169184,gut,0,0
169185,',0,0
169186,),0,0
169187,",",0,0
169188,and,0,0
169189,behavior,0,0
169190,has,0,0
169191,been,0,0
169192,long,0,0
169193,proposed,0,0
169194,but,0,0
169195,not,0,0
169196,substantiated,0,0
169197,.,0,0
169198,We,0,0
169199,explored,0,0
169200,this,0,0
169201,possible,0,0
169202,association,0,0
169203,in,0,0
169204,this,0,0
169205,trial,0,0
169206,.,0,0
169207,METHODS,0,0
169208,This,0,0
169209,randomized,0,0
169210,double-blind,0,0
169211,",",0,0
169212,placebo-controlled,0,0
169213,study,0,0
169214,explored,0,0
169215,the,0,0
169216,effects,0,0
169217,of,0,0
169218,gluten,0,1
169219,and,0,0
169220,milk,0,0
169221,on,0,0
169222,IP,0,0
169223,and,0,0
169224,behavior,0,0
169225,in,0,0
169226,children,1,1
169227,with,1,1
169228,ASDs,1,0
169229,over,0,0
169230,a,0,0
169231,period,0,0
169232,of,0,0
169233,4,0,0
169234,weeks,0,0
169235,.,0,1
169236,IP,0,0
169237,assessed,0,0
169238,by,0,0
169239,lactulose,0,0
169240,:,0,1
169241,mannitol,0,0
169242,(,0,0
169243,L/M,0,0
169244,),0,0
169245,sugar,0,0
169246,permeability,0,0
169247,test,0,0
169248,and,0,0
169249,behavior,0,0
169250,assessed,0,0
169251,by,0,0
169252,the,0,0
169253,Aberrant,0,0
169254,Behavior,0,0
169255,Checklist,0,0
169256,and,0,0
169257,Conners,0,0
169258,Parent,0,1
169259,Rating,0,0
169260,were,0,0
169261,measured,0,0
169262,.,0,0
169263,Gastrointestinal,0,0
169264,symptoms,0,0
169265,in,0,0
169266,both,0,0
169267,groups,0,0
169268,were,0,0
169269,also,0,0
169270,monitored,0,0
169271,.,0,0
169272,RESULTS,0,0
169273,Neither,0,0
169274,the,0,0
169275,L/M,0,0
169276,ratio,0,0
169277,nor,0,0
169278,behavioral,0,0
169279,scores,0,0
169280,were,0,0
169281,different,0,0
169282,between,0,0
169283,groups,0,0
169284,exposed,0,0
169285,to,0,0
169286,gluten/dairy,0,0
169287,or,0,0
169288,placebo,0,0
169289,.,0,0
169290,The,0,0
169291,changes,0,0
169292,observed,0,0
169293,were,0,0
169294,noted,0,0
169295,to,0,0
169296,be,0,0
169297,small,0,0
169298,and,0,0
169299,not,0,0
169300,clinically,0,0
169301,significant,0,0
169302,.,0,0
169303,DISCUSSION,0,0
169304,Our,0,0
169305,study,0,0
169306,although,0,0
169307,underpowered,0,0
169308,to,0,0
169309,show,0,0
169310,small,0,0
169311,differences,0,0
169312,does,0,0
169313,not,0,0
169314,support,0,0
169315,an,0,0
169316,association,0,0
169317,between,0,0
169318,dietary,0,0
169319,gluten/milk,0,0
169320,",",0,0
169321,IP,0,0
169322,",",0,0
169323,and,0,0
169324,behavioral,0,0
169325,changes,0,0
169326,in,0,0
169327,subjects,1,1
169328,with,1,1
169329,ASD,1,1
169330,.,1,1
169331,The,0,0
169332,effect,0,0
169333,of,0,0
169334,lowering,0,0
169335,LDL,0,0
169336,cholesterol,0,0
169337,on,0,0
169338,vascular,0,0
169339,access,0,0
169340,patency,0,0
169341,:,0,0
169342,post,0,0
169343,hoc,0,0
169344,analysis,0,0
169345,of,0,0
169346,the,0,0
169347,Study,0,0
169348,of,0,0
169349,Heart,0,0
169350,and,0,0
169351,Renal,0,0
169352,Protection,0,0
169353,.,0,0
169354,BACKGROUND,0,0
169355,AND,0,0
169356,OBJECTIVES,0,0
169357,Reducing,0,0
169358,LDL,0,0
169359,cholesterol,0,0
169360,(,0,0
169361,LDL-C,0,0
169362,),0,0
169363,with,0,1
169364,statin-based,0,0
169365,therapy,0,0
169366,reduces,0,0
169367,the,0,0
169368,risk,0,0
169369,of,0,0
169370,major,0,0
169371,atherosclerotic,0,1
169372,events,0,0
169373,among,0,1
169374,patients,1,1
169375,with,1,1
169376,CKD,1,1
169377,",",1,0
169378,including,1,0
169379,dialysis,1,1
169380,patients,1,1
169381,",",0,0
169382,but,0,0
169383,the,0,0
169384,effect,0,0
169385,of,0,0
169386,lowering,0,0
169387,LDL-C,0,1
169388,on,0,0
169389,vascular,0,0
169390,access,0,0
169391,patency,0,0
169392,is,0,0
169393,unclear,0,0
169394,.,0,0
169395,DESIGN,0,0
169396,",",0,0
169397,SETTING,0,0
169398,",",0,0
169399,PARTICIPANTS,0,0
169400,",",0,0
169401,&,0,0
169402,MEASUREMENTS,0,0
169403,The,0,0
169404,Study,0,0
169405,of,0,0
169406,Heart,0,0
169407,and,0,0
169408,Renal,0,0
169409,Protection,0,0
169410,(,0,0
169411,SHARP,0,0
169412,),0,0
169413,randomized,0,0
169414,patients,1,1
169415,with,1,1
169416,CKD,1,1
169417,to,1,0
169418,20,1,0
169419,mg,1,0
169420,simvastatin,1,0
169421,plus,1,0
169422,10,1,0
169423,mg,1,0
169424,ezetimibe,1,0
169425,daily,1,0
169426,versus,0,0
169427,matching,0,0
169428,placebo,0,0
169429,.,0,0
169430,This,0,0
169431,study,0,0
169432,aimed,0,0
169433,to,0,0
169434,explore,0,0
169435,the,0,0
169436,effects,0,0
169437,of,0,0
169438,treatment,0,0
169439,on,0,0
169440,vascular,0,0
169441,access,0,0
169442,occlusive,0,1
169443,events,0,0
169444,",",0,0
169445,defined,0,0
169446,as,0,0
169447,any,0,0
169448,access,0,0
169449,revision,0,0
169450,procedure,0,0
169451,",",0,0
169452,access,0,0
169453,thrombosis,0,0
169454,",",0,0
169455,removal,0,0
169456,of,0,0
169457,an,0,0
169458,old,0,1
169459,dialysis,0,0
169460,access,0,0
169461,",",0,0
169462,or,0,0
169463,formation,0,0
169464,of,0,0
169465,new,0,0
169466,permanent,0,1
169467,dialysis,0,1
169468,access,0,0
169469,.,0,0
169470,RESULTS,0,0
169471,Among,0,1
169472,2353,1,1
169473,SHARP,1,1
169474,participants,1,1
169475,who,1,1
169476,had,1,1
169477,functioning,1,1
169478,vascular,1,0
169479,access,1,0
169480,at,0,0
169481,randomization,0,0
169482,",",0,0
169483,allocation,0,0
169484,to,0,0
169485,simvastatin,0,0
169486,plus,0,0
169487,ezetimibe,0,0
169488,resulted,0,0
169489,in,0,0
169490,a,0,0
169491,13,0,0
169492,%,0,0
169493,proportional,0,0
169494,reduction,0,0
169495,in,0,0
169496,vascular,0,0
169497,access,0,0
169498,occlusive,0,1
169499,events,0,0
169500,(,0,0
169501,355,0,1
169502,[,0,0
169503,29.7,0,0
169504,%,0,0
169505,],0,0
169506,for,0,0
169507,simvastatin/ezetimibe,0,0
169508,versus,0,0
169509,388,0,1
169510,[,0,0
169511,33.5,0,0
169512,%,0,0
169513,],0,0
169514,for,0,0
169515,placebo,0,0
169516,;,0,0
169517,risk,0,0
169518,ratio,0,0
169519,[,0,0
169520,RR,0,0
169521,],0,0
169522,",",0,0
169523,0.87,0,0
169524,;,0,0
169525,95,0,0
169526,%,0,0
169527,confidence,0,0
169528,interval,0,0
169529,[,0,0
169530,95,0,0
169531,%,0,0
169532,CI,0,0
169533,],0,0
169534,",",0,0
169535,0.75,0,0
169536,to,0,0
169537,1.00,0,0
169538,;,0,0
169539,P=0.05,0,0
169540,),0,0
169541,.,0,0
169542,There,0,0
169543,was,0,0
169544,no,0,0
169545,evidence,0,0
169546,that,0,0
169547,the,0,0
169548,effects,0,0
169549,of,0,0
169550,treatment,0,0
169551,differed,0,0
169552,for,0,0
169553,any,0,0
169554,of,0,0
169555,the,0,0
169556,separate,0,0
169557,components,0,0
169558,of,0,0
169559,this,0,0
169560,outcome,0,0
169561,.,0,0
169562,To,0,0
169563,test,0,0
169564,the,0,0
169565,hypothesis,0,0
169566,raised,0,0
169567,by,0,0
169568,SHARP,0,0
169569,",",0,0
169570,comparable,0,0
169571,analyses,0,0
169572,were,0,0
169573,performed,0,0
169574,using,0,0
169575,the,0,0
169576,AURORA,0,0
169577,(,0,0
169578,A,0,0
169579,Study,0,0
169580,to,0,0
169581,Evaluate,0,0
169582,the,0,0
169583,Use,0,0
169584,of,0,0
169585,Rosuvastatin,0,0
169586,in,0,0
169587,Subjects,0,1
169588,on,0,0
169589,Regular,0,1
169590,Hemodialysis,0,0
169591,:,0,1
169592,An,0,0
169593,Assessment,0,0
169594,of,0,0
169595,Survival,0,0
169596,and,0,0
169597,Cardiovascular,0,0
169598,Events,0,0
169599,),0,0
169600,trial,0,0
169601,cohort,0,1
169602,.,0,0
169603,AURORA,0,0
169604,did,0,0
169605,not,0,0
169606,provide,0,0
169607,independent,0,0
169608,confirmation,0,0
169609,(,0,0
169610,vascular,0,0
169611,access,0,0
169612,occlusive,0,1
169613,events,0,0
169614,:,0,1
169615,352,0,1
169616,[,0,0
169617,28.9,0,0
169618,%,0,0
169619,],0,0
169620,for,0,0
169621,rosuvastatin,0,0
169622,versus,0,0
169623,337,0,1
169624,[,0,0
169625,27.6,0,0
169626,%,0,0
169627,],0,0
169628,for,0,0
169629,placebo,0,0
169630,;,0,0
169631,RR,0,0
169632,",",0,0
169633,1.06,0,0
169634,",",0,0
169635,95,0,0
169636,%,0,0
169637,CI,0,0
169638,",",0,0
169639,0.91,0,0
169640,to,0,0
169641,1.23,0,0
169642,;,0,0
169643,P=0.44,0,0
169644,),0,0
169645,.,0,0
169646,After,0,0
169647,combining,0,0
169648,the,0,0
169649,two,0,0
169650,trials,0,0
169651,",",0,0
169652,the,0,0
169653,overall,0,0
169654,effect,0,0
169655,of,0,0
169656,reducing,0,0
169657,LDL-C,0,1
169658,with,0,1
169659,a,0,0
169660,statin-based,0,0
169661,regimen,0,0
169662,on,0,0
169663,vascular,0,0
169664,access,0,0
169665,occlusive,0,1
169666,events,0,0
169667,was,0,0
169668,not,0,0
169669,statistically,0,0
169670,significant,0,0
169671,(,0,0
169672,707,0,1
169673,[,0,0
169674,29.3,0,0
169675,%,0,0
169676,],0,0
169677,with,0,0
169678,any,0,0
169679,LDL-C-lowering,0,0
169680,therapy,0,0
169681,versus,0,0
169682,725,0,0
169683,[,0,0
169684,30.5,0,0
169685,%,0,0
169686,],0,0
169687,with,0,1
169688,placebo,0,0
169689,;,0,0
169690,RR,0,0
169691,",",0,0
169692,0.95,0,0
169693,",",0,0
169694,95,0,0
169695,%,0,0
169696,CI,0,0
169697,",",0,0
169698,0.85,0,0
169699,to,0,0
169700,1.05,0,0
169701,;,0,0
169702,P=0.29,0,0
169703,),0,0
169704,.,0,0
169705,CONCLUSIONS,0,0
169706,Exploratory,0,0
169707,analyses,0,0
169708,from,0,0
169709,SHARP,0,0
169710,suggest,0,0
169711,that,0,0
169712,lowering,0,0
169713,LDL-C,0,1
169714,with,0,1
169715,statin-based,0,0
169716,therapy,0,0
169717,may,0,0
169718,improve,0,0
169719,vascular,0,0
169720,access,0,0
169721,patency,0,0
169722,",",0,0
169723,but,0,0
169724,there,0,0
169725,was,0,0
169726,no,0,0
169727,evidence,0,0
169728,of,0,0
169729,benefit,0,0
169730,in,0,0
169731,AURORA,0,0
169732,.,0,0
169733,Taken,0,0
169734,together,0,0
169735,",",0,0
169736,the,0,0
169737,available,0,0
169738,evidence,0,0
169739,suggests,0,0
169740,that,0,0
169741,any,0,0
169742,benefits,0,0
169743,of,0,0
169744,lowering,0,0
169745,LDL-C,0,1
169746,on,0,0
169747,vascular,0,0
169748,access,0,0
169749,patency,0,0
169750,are,0,0
169751,likely,0,0
169752,to,0,0
169753,be,0,0
169754,modest,0,0
169755,.,0,0
169756,Older,1,0
169757,patients,1,1
169758,with,1,1
169759,chronic,1,1
169760,myeloid,1,1
169761,leukemia,1,1
169762,(,1,0
169763,?65,1,0
169764,years,1,1
169765,),1,0
169766,profit,1,0
169767,more,0,0
169768,from,0,0
169769,higher,0,0
169770,imatinib,0,0
169771,doses,0,0
169772,than,1,0
169773,younger,1,1
169774,patients,1,1
169775,:,1,1
169776,a,1,0
169777,subanalysis,0,0
169778,of,0,0
169779,the,0,0
169780,randomized,0,0
169781,CML-Study,0,0
169782,IV,0,0
169783,.,0,0
169784,The,0,0
169785,impact,0,0
169786,of,0,0
169787,imatinib,0,0
169788,dose,0,0
169789,on,0,0
169790,response,0,0
169791,rates,0,0
169792,and,0,0
169793,survival,0,0
169794,in,0,0
169795,older,1,1
169796,patients,1,1
169797,with,1,1
169798,chronic,1,1
169799,myeloid,1,1
169800,leukemia,1,1
169801,in,1,0
169802,chronic,1,1
169803,phase,1,0
169804,has,1,0
169805,not,0,0
169806,been,0,0
169807,studied,0,0
169808,well,0,0
169809,.,0,0
169810,We,0,0
169811,analyzed,0,0
169812,data,0,0
169813,from,0,0
169814,the,0,0
169815,German,0,1
169816,CML-Study,0,0
169817,IV,0,0
169818,",",0,0
169819,a,0,0
169820,randomized,1,0
169821,five-arm,1,0
169822,treatment,1,0
169823,optimization,1,0
169824,study,1,0
169825,in,1,0
169826,newly,1,1
169827,diagnosed,1,1
169828,BCR-ABL-positive,1,0
169829,chronic,1,1
169830,myeloid,1,1
169831,leukemia,1,1
169832,in,1,0
169833,chronic,1,1
169834,phase,1,0
169835,.,1,1
169836,Patients,1,1
169837,randomized,1,0
169838,to,1,0
169839,imatinib,1,0
169840,400,1,0
169841,mg/day,1,0
169842,(,1,0
169843,IM400,1,0
169844,),1,0
169845,or,1,0
169846,imatinib,1,0
169847,800,1,0
169848,mg/day,1,0
169849,(,1,0
169850,IM800,1,0
169851,),1,0
169852,and,1,0
169853,stratified,1,0
169854,according,1,0
169855,to,1,0
169856,age,1,1
169857,(,1,0
169858,?65,1,0
169859,years,1,1
169860,vs.,1,0
169861,<,1,0
169862,65,1,1
169863,years,1,1
169864,),1,0
169865,were,1,0
169866,compared,0,0
169867,regarding,0,0
169868,dose,0,0
169869,",",0,0
169870,response,0,0
169871,",",0,0
169872,adverse,0,0
169873,events,0,0
169874,",",0,0
169875,rates,0,0
169876,of,0,0
169877,progression,0,0
169878,",",0,0
169879,and,0,0
169880,survival,0,0
169881,.,0,0
169882,The,0,0
169883,full,0,0
169884,800,0,0
169885,mg,0,0
169886,dose,0,0
169887,was,0,0
169888,given,0,0
169889,after,0,0
169890,a,0,0
169891,6-week,0,0
169892,run-in,0,0
169893,period,0,0
169894,with,0,1
169895,imatinib,0,0
169896,400,0,1
169897,mg/day,0,0
169898,.,0,0
169899,The,0,0
169900,dose,0,0
169901,could,0,0
169902,then,0,0
169903,be,0,0
169904,reduced,0,0
169905,according,0,0
169906,to,0,0
169907,tolerability,1,0
169908,.,1,0
169909,A,1,0
169910,total,1,0
169911,of,1,0
169912,828,1,1
169913,patients,1,1
169914,were,1,0
169915,randomized,1,0
169916,to,1,0
169917,IM400,0,0
169918,or,0,0
169919,IM800,1,0
169920,.,1,0
169921,Seven,1,0
169922,hundred,1,1
169923,eighty-four,1,1
169924,patients,1,1
169925,were,1,0
169926,evaluable,1,1
169927,(,1,0
169928,IM400,1,0
169929,",",1,0
169930,382,1,1
169931,;,1,0
169932,IM800,1,0
169933,",",1,0
169934,402,1,1
169935,),1,0
169936,.,1,0
169937,One,1,0
169938,hundred,1,1
169939,ten,1,1
169940,patients,1,1
169941,(,1,0
169942,29,1,1
169943,%,1,0
169944,),1,0
169945,on,1,0
169946,IM400,1,0
169947,and,1,0
169948,83,1,1
169949,(,1,0
169950,21,1,1
169951,%,1,0
169952,),1,0
169953,on,1,0
169954,IM800,1,0
169955,were,1,0
169956,?65,1,0
169957,years,1,1
169958,.,0,0
169959,The,0,0
169960,median,0,0
169961,dose,0,0
169962,per,0,0
169963,day,0,0
169964,was,0,0
169965,lower,0,0
169966,for,0,0
169967,patients,0,1
169968,?65,0,0
169969,years,0,1
169970,on,0,0
169971,IM800,0,0
169972,",",0,0
169973,with,0,0
169974,the,0,0
169975,highest,0,0
169976,median,0,0
169977,dose,0,0
169978,in,0,0
169979,the,0,0
169980,first,0,0
169981,year,0,0
169982,(,0,0
169983,466,0,1
169984,mg/day,0,0
169985,for,0,0
169986,patients,0,1
169987,?65,0,0
169988,years,0,1
169989,vs.,0,0
169990,630,0,1
169991,mg/day,0,0
169992,for,0,0
169993,patients,0,1
169994,<,0,0
169995,65,0,1
169996,years,0,1
169997,),0,0
169998,.,0,0
169999,Older,0,0
170000,patients,0,1
170001,on,0,0
170002,IM800,0,0
170003,achieved,0,0
170004,major,0,0
170005,molecular,0,0
170006,remission,0,1
170007,and,0,0
170008,deep,0,0
170009,molecular,0,0
170010,remission,0,0
170011,as,0,0
170012,fast,0,0
170013,as,0,0
170014,younger,0,1
170015,patients,0,1
170016,",",0,0
170017,in,0,0
170018,contrast,0,0
170019,to,0,0
170020,standard,0,0
170021,dose,0,0
170022,imatinib,0,0
170023,with,0,1
170024,which,0,0
170025,older,1,1
170026,patients,1,1
170027,achieved,0,0
170028,remissions,0,0
170029,much,0,0
170030,later,0,0
170031,than,0,0
170032,younger,1,1
170033,patients,1,1
170034,.,1,1
170035,Grades,0,0
170036,3,0,0
170037,and,0,0
170038,4,0,0
170039,adverse,0,0
170040,events,0,0
170041,were,0,0
170042,similar,0,0
170043,in,0,0
170044,both,0,0
170045,age,0,1
170046,groups,0,0
170047,.,0,1
170048,Five-year,0,0
170049,relative,0,0
170050,survival,0,0
170051,for,0,0
170052,older,0,1
170053,patients,0,1
170054,was,0,0
170055,comparable,0,0
170056,to,0,0
170057,that,0,0
170058,of,0,0
170059,younger,0,1
170060,patients,0,1
170061,.,0,0
170062,We,0,0
170063,suggest,0,0
170064,that,0,0
170065,the,0,0
170066,optimal,0,0
170067,dose,0,0
170068,for,0,0
170069,older,0,1
170070,patients,0,1
170071,is,0,0
170072,higher,0,0
170073,than,0,0
170074,400,0,0
170075,mg/day,0,0
170076,.,0,0
170077,ClinicalTrials.gov,0,0
170078,identifier,0,0
170079,:,0,1
170080,NCT00055874,0,0
170081,Custom,0,0
170082,tray,0,0
170083,application,0,0
170084,of,0,0
170085,peroxide,0,0
170086,gel,0,0
170087,as,0,0
170088,an,0,0
170089,adjunct,0,0
170090,to,0,0
170091,scaling,0,0
170092,and,0,0
170093,root,0,0
170094,planing,0,0
170095,in,0,0
170096,the,0,0
170097,treatment,1,0
170098,of,1,0
170099,periodontitis,1,1
170100,:,1,1
170101,results,0,0
170102,of,0,0
170103,a,0,0
170104,randomized,0,0
170105,controlled,0,0
170106,trial,0,0
170107,after,0,0
170108,six,0,1
170109,months,0,0
170110,.,0,1
170111,OBJECTIVE,0,0
170112,Scaling,0,0
170113,and,0,0
170114,root,0,0
170115,planing,0,0
170116,(,0,0
170117,SRP,0,0
170118,),0,0
170119,is,0,0
170120,the,0,0
170121,primary,0,0
170122,non-surgical,0,0
170123,treatment,0,0
170124,for,0,0
170125,periodontitis,0,1
170126,",",0,0
170127,but,0,0
170128,its,0,0
170129,effectiveness,0,0
170130,is,0,0
170131,limited,0,0
170132,.,0,0
170133,Consequently,0,0
170134,",",0,0
170135,various,0,0
170136,adjunctive,0,0
170137,therapies,0,0
170138,have,0,0
170139,been,0,0
170140,investigated,0,0
170141,to,0,0
170142,improve,0,0
170143,clinical,0,0
170144,outcome,0,0
170145,.,0,0
170146,This,0,0
170147,study,0,0
170148,evaluated,0,0
170149,the,0,0
170150,clinical,0,0
170151,effects,0,0
170152,of,0,0
170153,one,0,1
170154,SRP,0,0
170155,procedure,0,0
170156,alone,0,0
170157,or,0,0
170158,combined,0,0
170159,with,0,0
170160,local,0,0
170161,administration,0,0
170162,of,0,0
170163,hydrogen,0,0
170164,peroxide,0,0
170165,gel,0,0
170166,using,0,0
170167,customized,0,0
170168,trays,0,0
170169,for,0,0
170170,the,0,0
170171,treatment,0,0
170172,of,0,0
170173,subjects,1,1
170174,with,1,1
170175,chronic,1,1
170176,periodontitis,1,1
170177,over,0,0
170178,a,0,0
170179,period,0,0
170180,of,0,0
170181,six,0,1
170182,months,0,0
170183,.,0,1
170184,METHODS,0,0
170185,An,0,0
170186,examiner-blind,0,0
170187,clinical,0,0
170188,trial,0,0
170189,was,0,0
170190,conducted,0,0
170191,among,0,0
170192,30,1,0
170193,subjects,1,1
170194,with,1,1
170195,moderate,1,1
170196,to,1,0
170197,advanced,1,1
170198,periodontitis,1,1
170199,who,0,1
170200,were,0,1
170201,randomized,0,1
170202,to,0,0
170203,SRP,0,0
170204,alone,0,0
170205,or,0,0
170206,SRP,0,0
170207,combined,0,0
170208,with,0,1
170209,prescription,0,0
170210,custom-tray,0,0
170211,application,0,0
170212,(,0,0
170213,Perio,0,1
170214,Tray,0,0
170215,),0,0
170216,of,0,0
170217,1.7,0,0
170218,%,0,0
170219,hydrogen,0,0
170220,peroxide,0,0
170221,gel,0,0
170222,(,0,0
170223,Perio,0,1
170224,Gel,0,1
170225,),0,0
170226,for,0,0
170227,a,0,0
170228,period,0,0
170229,of,0,0
170230,three,0,0
170231,months,0,0
170232,",",0,0
170233,then,0,0
170234,extended,0,0
170235,to,0,0
170236,six,0,1
170237,months,0,0
170238,.,0,1
170239,Following,0,0
170240,impressions,0,0
170241,for,0,0
170242,the,0,0
170243,test,0,0
170244,group,0,0
170245,",",0,0
170246,all,0,0
170247,subjects,0,1
170248,brushed,0,0
170249,twice,0,0
170250,daily,0,0
170251,with,0,0
170252,a,0,0
170253,regular,0,0
170254,dentifrice,0,0
170255,and,0,0
170256,toothbrush,0,0
170257,for,0,0
170258,a,0,0
170259,four-week,0,0
170260,acclimation,0,0
170261,phase,0,0
170262,to,0,0
170263,standardize,0,0
170264,oral,0,0
170265,conditions,0,0
170266,(,0,0
170267,while,0,0
170268,trays,0,0
170269,were,0,0
170270,fabricated,0,0
170271,),0,0
170272,prior,0,0
170273,to,0,0
170274,initiating,0,0
170275,the,0,0
170276,treatment,0,0
170277,phase,0,0
170278,.,0,0
170279,SRP,0,0
170280,was,0,0
170281,performed,0,0
170282,three,0,0
170283,weeks,0,0
170284,after,0,0
170285,baseline,0,0
170286,",",0,0
170287,and,0,0
170288,clinical,0,0
170289,assessments,0,0
170290,",",0,0
170291,i.e.,0,0
170292,",",0,0
170293,pocket,0,0
170294,probing,0,0
170295,depth,0,0
170296,(,0,0
170297,PPD,0,1
170298,),0,0
170299,and,0,0
170300,bleeding,0,0
170301,index,0,0
170302,(,0,0
170303,BI,0,0
170304,),0,0
170305,",",0,0
170306,were,0,0
170307,conducted,0,0
170308,at,0,0
170309,baseline,0,0
170310,and,0,0
170311,after,0,0
170312,two,0,0
170313,",",0,0
170314,five,0,0
170315,",",0,0
170316,13,0,0
170317,",",0,0
170318,and,0,0
170319,26,0,0
170320,weeks,0,0
170321,of,0,0
170322,peroxide,0,0
170323,gel,0,0
170324,applications,0,0
170325,.,0,1
170326,Clinical,0,0
170327,variables,0,0
170328,were,0,0
170329,compared,0,0
170330,by,0,0
170331,ANCOVA,0,0
170332,and,0,0
170333,paired,0,0
170334,t-tests,0,0
170335,after,0,0
170336,each,0,0
170337,treatment,0,0
170338,interval,0,0
170339,.,0,0
170340,RESULTS,0,0
170341,A,0,0
170342,total,0,0
170343,of,0,0
170344,13,1,0
170345,test,1,0
170346,and,1,0
170347,15,1,0
170348,control,1,0
170349,subjects,1,1
170350,completed,0,1
170351,the,0,0
170352,original,0,0
170353,three-month,0,0
170354,trial,0,0
170355,",",0,0
170356,of,0,0
170357,whom,0,1
170358,10,0,1
170359,test,0,0
170360,and,0,0
170361,13,0,0
170362,control,0,0
170363,subjects,0,1
170364,finished,0,0
170365,the,0,0
170366,three-month,0,0
170367,extension,0,0
170368,.,0,0
170369,After,0,0
170370,two,0,0
170371,weeks,0,0
170372,of,0,0
170373,peroxide,0,0
170374,gel,0,0
170375,use,0,0
170376,prior,0,0
170377,to,0,0
170378,SRP,0,0
170379,",",0,0
170380,mean,0,0
170381,PPD,0,1
170382,for,0,0
170383,the,0,0
170384,test,0,0
170385,group,0,0
170386,significantly,0,0
170387,decreased,0,0
170388,from,0,0
170389,baseline,0,0
170390,by,0,0
170391,0.21,0,0
170392,mm,0,0
170393,and,0,0
170394,mean,0,1
170395,BI,0,0
170396,significantly,0,0
170397,dropped,0,0
170398,by,0,0
170399,0.14,0,0
170400,;,0,0
170401,clinical,0,0
170402,parameters,0,0
170403,for,0,0
170404,the,0,0
170405,control,0,0
170406,group,0,0
170407,were,0,0
170408,unchanged,0,0
170409,.,0,1
170410,Two,0,0
170411,weeks,0,0
170412,following,0,0
170413,SRP,0,0
170414,",",0,0
170415,mean,0,0
170416,PPD,0,1
170417,significantly,0,0
170418,decreased,0,0
170419,from,0,0
170420,baseline,0,0
170421,by,0,0
170422,0.65,0,0
170423,mm,0,0
170424,for,0,0
170425,the,0,0
170426,test,0,0
170427,group,0,0
170428,and,0,0
170429,0.17,0,0
170430,mm,0,0
170431,for,0,0
170432,the,0,0
170433,control,0,0
170434,;,0,0
170435,mean,0,0
170436,BI,0,0
170437,significantly,0,0
170438,dropped,0,0
170439,by,0,0
170440,0.17,0,0
170441,for,0,0
170442,the,0,0
170443,test,0,0
170444,group,0,0
170445,and,0,0
170446,0.05,0,0
170447,for,0,0
170448,the,0,0
170449,control,0,0
170450,.,0,0
170451,Ten,0,1
170452,weeks,0,0
170453,following,0,0
170454,SRP,0,0
170455,",",0,0
170456,mean,0,0
170457,PPD,0,1
170458,decreases,0,0
170459,were,0,0
170460,0.77,0,0
170461,mm,0,0
170462,for,0,0
170463,the,0,0
170464,test,0,0
170465,group,0,0
170466,and,0,0
170467,0.13,0,0
170468,mm,0,0
170469,for,0,0
170470,the,0,0
170471,control,0,0
170472,",",0,0
170473,and,0,0
170474,mean,0,0
170475,BI,0,0
170476,reductions,0,0
170477,were,0,0
170478,0.14,0,0
170479,for,0,0
170480,the,0,0
170481,test,0,0
170482,group,0,0
170483,and,0,0
170484,0.00,0,0
170485,for,0,0
170486,the,0,0
170487,control,0,0
170488,.,0,0
170489,For,0,0
170490,subjects,0,1
170491,who,0,1
170492,completed,0,1
170493,the,0,1
170494,three-month,0,0
170495,extension,0,0
170496,(,0,0
170497,i.e.,0,0
170498,",",0,0
170499,23,0,1
170500,weeks,0,0
170501,post-SRP,0,0
170502,),0,0
170503,",",0,0
170504,mean,0,0
170505,PPD,0,1
170506,decreases,0,0
170507,were,0,0
170508,0.72,0,0
170509,mm,0,0
170510,for,0,0
170511,the,0,0
170512,test,0,0
170513,group,0,0
170514,and,0,0
170515,0.13,0,0
170516,mm,0,0
170517,for,0,0
170518,the,0,0
170519,control,0,0
170520,",",0,0
170521,and,0,0
170522,mean,0,0
170523,BI,0,0
170524,reductions,0,0
170525,were,0,0
170526,0.05,0,0
170527,for,0,0
170528,the,0,0
170529,test,0,0
170530,group,0,0
170531,and,0,0
170532,0.01,0,0
170533,for,0,0
170534,the,0,0
170535,control,0,0
170536,.,0,0
170537,Analysis,0,0
170538,of,0,0
170539,deeper,0,0
170540,pockets,0,0
170541,(,0,0
170542,i.e.,0,0
170543,",",0,0
170544,>,0,0
170545,5,0,0
170546,mm,0,0
170547,at,0,0
170548,baseline,0,0
170549,),0,0
170550,showed,0,0
170551,the,0,0
170552,same,0,0
170553,relationship,0,0
170554,for,0,0
170555,PPD,0,0
170556,",",0,0
170557,but,0,0
170558,with,0,0
170559,larger,0,0
170560,differences,0,0
170561,between,0,0
170562,groups,0,0
170563,.,0,0
170564,For,0,0
170565,example,0,0
170566,",",0,0
170567,after,0,0
170568,two,0,0
170569,weeks,0,0
170570,of,0,0
170571,peroxide,0,0
170572,gel,0,0
170573,use,0,0
170574,prior,0,0
170575,to,0,0
170576,SRP,0,0
170577,",",0,0
170578,mean,0,0
170579,PPD,0,1
170580,decreased,0,0
170581,by,0,0
170582,0.48,0,0
170583,mm,0,0
170584,for,0,0
170585,the,0,0
170586,test,0,0
170587,group,0,0
170588,compared,0,0
170589,to,0,0
170590,0.04,0,0
170591,mm,0,0
170592,for,0,0
170593,the,0,0
170594,control,0,0
170595,.,0,0
170596,Two,0,0
170597,weeks,0,0
170598,after,0,0
170599,SRP,0,0
170600,",",0,0
170601,mean,0,0
170602,PPD,0,1
170603,decreased,0,0
170604,from,0,0
170605,baseline,0,0
170606,by,0,0
170607,1.40,0,0
170608,mm,0,0
170609,for,0,0
170610,the,0,0
170611,test,0,0
170612,group,0,0
170613,and,0,0
170614,0.60,0,0
170615,mm,0,0
170616,for,0,0
170617,the,0,0
170618,control,0,0
170619,",",0,0
170620,and,0,0
170621,10,0,0
170622,weeks,0,0
170623,after,0,0
170624,SRP,0,0
170625,by,0,0
170626,1.57,0,0
170627,mm,0,0
170628,for,0,0
170629,the,0,0
170630,test,0,0
170631,group,0,0
170632,and,0,0
170633,0.58,0,0
170634,mm,0,0
170635,for,0,0
170636,the,0,0
170637,control,0,0
170638,.,0,0
170639,After,0,0
170640,the,0,0
170641,extension,0,0
170642,(,0,0
170643,i.e.,0,0
170644,",",0,0
170645,23,0,1
170646,weeks,0,0
170647,post-SRP,0,0
170648,),0,0
170649,",",0,0
170650,mean,0,0
170651,PPD,0,1
170652,changed,0,0
170653,from,0,0
170654,baseline,0,0
170655,by,0,0
170656,1.50,0,0
170657,mm,0,0
170658,for,0,0
170659,the,0,0
170660,test,0,0
170661,group,0,0
170662,and,0,0
170663,0.55,0,0
170664,mm,0,0
170665,for,0,0
170666,the,0,0
170667,control,0,0
170668,.,0,0
170669,With,0,0
170670,the,0,0
170671,exception,0,0
170672,of,0,0
170673,BI,0,0
170674,at,0,0
170675,23,0,1
170676,weeks,0,0
170677,post-SRP,0,0
170678,",",0,0
170679,all,0,0
170680,reductions,0,0
170681,cited,0,0
170682,above,0,0
170683,for,0,0
170684,the,0,0
170685,test,0,0
170686,group,0,0
170687,were,0,0
170688,statistically,0,0
170689,significantly,0,0
170690,different,0,0
170691,from,0,0
170692,the,0,0
170693,control,0,0
170694,group,0,0
170695,for,0,0
170696,both,0,0
170697,PPD,0,1
170698,and,0,0
170699,BI,0,0
170700,for,0,0
170701,all,0,0
170702,comparisons,0,0
170703,.,0,0
170704,CONCLUSION,0,0
170705,When,0,0
170706,compared,0,0
170707,with,0,0
170708,SRP,0,0
170709,alone,0,0
170710,",",0,0
170711,clinical,0,0
170712,improvements,0,0
170713,in,0,0
170714,PPD,0,1
170715,(,0,0
170716,e.g.,0,0
170717,",",0,0
170718,-1.0,0,0
170719,mm,0,0
170720,for,0,0
170721,pockets,0,0
170722,>,0,1
170723,5,0,0
170724,mm,0,0
170725,at,0,0
170726,baseline,0,0
170727,),0,0
170728,were,0,0
170729,maintained,0,0
170730,for,0,0
170731,up,0,0
170732,to,0,0
170733,six,0,1
170734,months,0,0
170735,after,0,0
170736,SRP,0,0
170737,with,0,1
170738,adjunctive,0,0
170739,use,0,0
170740,of,0,0
170741,1.7,0,0
170742,%,0,0
170743,hydrogen,0,0
170744,peroxide,0,0
170745,gel,0,0
170746,",",0,0
170747,locally,0,0
170748,administered,0,0
170749,using,0,0
170750,prescription,0,0
170751,customized,0,0
170752,trays,0,0
170753,in,0,0
170754,the,0,0
170755,treatment,0,0
170756,of,0,0
170757,subjects,1,1
170758,with,1,1
170759,moderate,1,1
170760,to,1,0
170761,advanced,1,1
170762,periodontitis,1,1
170763,.,1,0
170764,Weight,0,0
170765,loss,0,0
170766,maintenance,0,0
170767,in,0,0
170768,overweight,1,1
170769,subjects,1,1
170770,on,0,0
170771,ad,0,1
170772,libitum,0,1
170773,diets,0,0
170774,with,0,1
170775,high,0,1
170776,or,0,0
170777,low,0,0
170778,protein,0,0
170779,content,0,0
170780,and,0,0
170781,glycemic,0,0
170782,index,0,0
170783,:,0,1
170784,the,0,0
170785,DIOGENES,0,0
170786,trial,0,0
170787,12-month,0,0
170788,results,0,0
170789,.,0,1
170790,BACKGROUND,0,0
170791,A,0,0
170792,high,0,0
170793,dietary,0,0
170794,protein,0,0
170795,(,0,0
170796,P,0,0
170797,),0,0
170798,content,0,0
170799,and,0,0
170800,low,0,0
170801,glycemic,0,0
170802,index,0,0
170803,(,0,0
170804,LGI,0,0
170805,),0,0
170806,have,0,0
170807,been,0,0
170808,suggested,0,0
170809,to,0,0
170810,be,0,0
170811,beneficial,0,0
170812,for,0,0
170813,weight,0,0
170814,management,0,0
170815,",",0,0
170816,but,0,0
170817,long-term,0,0
170818,studies,0,0
170819,are,0,0
170820,scarce,0,0
170821,.,0,0
170822,OBJECTIVE,0,0
170823,The,0,0
170824,DIOGENES,0,0
170825,randomized,0,0
170826,clinical,0,0
170827,trial,0,0
170828,investigated,0,0
170829,the,0,0
170830,effect,0,0
170831,of,0,0
170832,P,0,0
170833,and,0,0
170834,GI,0,1
170835,on,0,0
170836,weight,0,0
170837,loss,0,0
170838,maintenance,0,0
170839,in,0,0
170840,overweight,1,1
170841,or,1,1
170842,obese,1,1
170843,adults,1,1
170844,in,1,0
170845,eight,1,1
170846,centers,1,1
170847,across,1,0
170848,Europe,1,1
170849,.,1,0
170850,This,0,0
170851,study,0,0
170852,reports,0,0
170853,the,0,0
170854,1-year,0,0
170855,results,0,0
170856,in,0,0
170857,two,0,0
170858,of,0,0
170859,the,0,0
170860,centers,0,1
170861,that,0,0
170862,extended,0,0
170863,the,0,0
170864,intervention,0,0
170865,to,0,0
170866,1,0,0
170867,year,0,0
170868,.,0,0
170869,METHOD,0,0
170870,After,0,0
170871,an,0,0
170872,8-week,0,0
170873,low-calorie,0,0
170874,diet,0,0
170875,(,0,0
170876,LCD,0,0
170877,),0,0
170878,",",0,0
170879,256,1,1
170880,adults,1,1
170881,(,1,0
170882,body,1,0
170883,mass,1,0
170884,index,1,0
170885,>,1,1
170886,27,1,0
170887,kg,1,0
170888,m,1,1
170889,(,1,0
170890,-,1,0
170891,),1,0
170892,(,1,0
170893,2,1,0
170894,),1,0
170895,),1,0
170896,were,1,0
170897,randomized,0,0
170898,to,0,0
170899,five,0,0
170900,ad,0,1
170901,libitum,0,1
170902,diets,0,0
170903,for,0,0
170904,12,0,1
170905,months,0,0
170906,:,0,1
170907,high,0,0
170908,P/LGI,0,0
170909,(,0,0
170910,HP/LGI,0,0
170911,),0,0
170912,",",0,0
170913,HP/high,0,0
170914,GI,0,1
170915,(,0,0
170916,HP/HGI,0,0
170917,),0,0
170918,",",0,0
170919,low,0,0
170920,P/LGI,0,0
170921,(,0,0
170922,LP/LGI,0,0
170923,),0,0
170924,",",0,0
170925,LP/HGI,0,0
170926,and,0,0
170927,a,0,0
170928,control,0,0
170929,diet,0,0
170930,.,0,0
170931,During,0,0
170932,the,0,0
170933,first,0,0
170934,6,0,0
170935,months,0,0
170936,",",0,0
170937,foods,0,1
170938,were,0,0
170939,provided,0,0
170940,for,0,0
170941,free,0,0
170942,through,0,0
170943,a,0,0
170944,shop,0,0
170945,system,0,0
170946,and,0,0
170947,during,0,0
170948,the,0,0
170949,whole,0,0
170950,12-month,0,0
170951,period,0,0
170952,",",0,0
170953,subjects,0,1
170954,received,0,0
170955,guidance,0,0
170956,by,0,0
170957,a,0,0
170958,dietician,0,0
170959,.,0,0
170960,Primary,0,0
170961,outcome,0,0
170962,variable,0,0
170963,was,0,0
170964,the,0,0
170965,change,0,0
170966,in,0,0
170967,body,0,0
170968,weight,0,0
170969,over,0,0
170970,the,0,0
170971,12-month,0,0
170972,intervention,0,0
170973,period,0,0
170974,.,0,0
170975,RESULTS,0,0
170976,During,0,0
170977,the,0,0
170978,LCD,0,0
170979,period,0,0
170980,",",0,0
170981,subjects,0,1
170982,lost,0,0
170983,11.2,0,0
170984,(,0,0
170985,10.8,0,0
170986,",",0,0
170987,12.0,0,0
170988,),0,0
170989,kg,0,0
170990,(,0,0
170991,mean,0,0
170992,(,0,0
170993,95,0,0
170994,%,0,0
170995,confidence,0,0
170996,interval,0,0
170997,(,0,0
170998,CI,0,0
170999,),0,0
171000,),0,0
171001,),0,0
171002,.,0,0
171003,Average,0,0
171004,weight,0,0
171005,regain,0,0
171006,over,0,0
171007,the,0,0
171008,12-month,0,0
171009,intervention,0,0
171010,period,0,0
171011,was,0,0
171012,3.9,0,0
171013,(,0,0
171014,95,0,0
171015,%,0,0
171016,CI,0,0
171017,3.0-4.8,0,0
171018,),0,0
171019,kg,0,0
171020,.,0,0
171021,Subjects,0,0
171022,on,0,0
171023,the,0,0
171024,HP,0,0
171025,diets,0,0
171026,regained,0,0
171027,less,0,0
171028,weight,0,0
171029,than,0,0
171030,subjects,0,1
171031,on,0,0
171032,the,0,0
171033,LP,0,0
171034,diets,0,0
171035,.,0,0
171036,The,0,0
171037,difference,0,0
171038,in,0,0
171039,weight,0,0
171040,regain,0,0
171041,after,0,0
171042,1,0,0
171043,year,0,0
171044,was,0,0
171045,2.0,0,0
171046,(,0,0
171047,0.4,0,0
171048,",",0,0
171049,3.6,0,0
171050,),0,0
171051,kg,0,0
171052,(,0,0
171053,P=0.017,0,0
171054,),0,0
171055,(,0,0
171056,completers,0,0
171057,analysis,0,0
171058,",",0,0
171059,N=139,0,0
171060,),0,0
171061,or,0,0
171062,2.8,0,0
171063,(,0,0
171064,1.4,0,0
171065,",",0,0
171066,4.1,0,0
171067,),0,0
171068,kg,0,0
171069,(,0,0
171070,P,0,0
171071,<,0,0
171072,0.001,0,0
171073,),0,0
171074,(,0,0
171075,intention-to-treat,0,0
171076,analysis,0,0
171077,",",0,0
171078,N=256,0,0
171079,),0,0
171080,.,0,0
171081,No,0,0
171082,consistent,0,0
171083,effect,0,0
171084,of,0,0
171085,GI,0,1
171086,on,0,0
171087,weight,0,0
171088,regain,0,0
171089,was,0,0
171090,found,0,0
171091,.,0,0
171092,There,0,0
171093,were,0,0
171094,no,0,0
171095,clinically,0,0
171096,relevant,0,0
171097,differences,0,0
171098,in,0,0
171099,changes,0,0
171100,in,0,0
171101,cardiometabolic,0,0
171102,risk,0,0
171103,factors,0,0
171104,among,0,1
171105,diet,0,1
171106,groups,0,0
171107,.,0,0
171108,CONCLUSION,0,0
171109,A,0,0
171110,higher,0,0
171111,protein,0,0
171112,content,0,0
171113,of,0,0
171114,an,0,0
171115,ad,0,0
171116,libitum,0,1
171117,diet,0,0
171118,improves,0,0
171119,weight,0,0
171120,loss,0,0
171121,maintenance,1,0
171122,in,1,0
171123,overweight,1,1
171124,and,1,0
171125,obese,1,1
171126,adults,1,1
171127,over,1,0
171128,12,0,1
171129,months,0,0
171130,.,0,1
171131,Clonidine,0,0
171132,in,0,0
171133,patients,1,1
171134,undergoing,1,1
171135,noncardiac,1,1
171136,surgery,1,1
171137,.,1,0
171138,BACKGROUND,0,0
171139,Marked,0,0
171140,activation,0,0
171141,of,0,0
171142,the,0,0
171143,sympathetic,0,0
171144,nervous,0,0
171145,system,0,0
171146,occurs,0,0
171147,during,0,0
171148,and,0,0
171149,after,0,0
171150,noncardiac,1,1
171151,surgery,1,1
171152,.,1,0
171153,Low-dose,0,0
171154,clonidine,0,0
171155,",",0,0
171156,which,0,0
171157,blunts,0,0
171158,central,0,0
171159,sympathetic,0,0
171160,outflow,0,0
171161,",",0,0
171162,may,0,0
171163,prevent,0,0
171164,perioperative,0,0
171165,myocardial,0,0
171166,infarction,0,1
171167,and,0,0
171168,death,0,0
171169,without,0,0
171170,inducing,0,0
171171,hemodynamic,0,0
171172,instability,0,0
171173,.,0,0
171174,METHODS,0,0
171175,We,0,0
171176,performed,0,0
171177,a,0,0
171178,blinded,0,0
171179,",",0,0
171180,randomized,0,0
171181,trial,0,0
171182,with,0,0
171183,a,0,0
171184,2-by-2,0,0
171185,factorial,0,0
171186,design,0,0
171187,to,0,0
171188,allow,0,0
171189,separate,0,0
171190,evaluation,0,0
171191,of,0,0
171192,low-dose,0,0
171193,clonidine,0,0
171194,versus,0,0
171195,placebo,0,0
171196,and,0,0
171197,low-dose,0,0
171198,aspirin,0,0
171199,versus,0,0
171200,placebo,0,0
171201,in,0,0
171202,patients,1,1
171203,with,1,1
171204,",",1,0
171205,or,1,0
171206,at,1,0
171207,risk,1,0
171208,for,1,0
171209,",",1,0
171210,atherosclerotic,1,1
171211,disease,1,1
171212,who,1,1
171213,were,1,1
171214,undergoing,1,1
171215,noncardiac,1,1
171216,surgery,1,1
171217,.,1,0
171218,A,0,0
171219,total,0,0
171220,of,0,0
171221,"10,010",1,1
171222,patients,1,1
171223,at,1,0
171224,135,1,1
171225,centers,1,1
171226,in,1,0
171227,23,1,1
171228,countries,1,1
171229,were,1,0
171230,enrolled,1,1
171231,.,1,0
171232,For,0,0
171233,the,0,0
171234,comparison,0,0
171235,of,0,0
171236,clonidine,0,0
171237,with,0,0
171238,placebo,0,0
171239,",",0,0
171240,patients,0,1
171241,were,0,0
171242,randomly,0,1
171243,assigned,0,0
171244,to,0,0
171245,receive,0,0
171246,clonidine,0,0
171247,(,0,0
171248,0.2,0,0
171249,mg,0,0
171250,per,0,0
171251,day,0,0
171252,),0,0
171253,or,0,0
171254,placebo,0,0
171255,just,0,0
171256,before,0,0
171257,surgery,0,0
171258,",",0,0
171259,with,0,0
171260,the,0,0
171261,study,0,0
171262,drug,0,0
171263,continued,0,0
171264,until,0,0
171265,72,0,1
171266,hours,0,0
171267,after,0,0
171268,surgery,0,1
171269,.,0,0
171270,The,0,0
171271,primary,0,0
171272,outcome,0,0
171273,was,0,0
171274,a,0,0
171275,composite,0,0
171276,of,0,0
171277,death,0,0
171278,or,0,0
171279,nonfatal,0,0
171280,myocardial,0,1
171281,infarction,0,1
171282,at,0,0
171283,30,0,1
171284,days,0,0
171285,.,0,1
171286,RESULTS,0,0
171287,Clonidine,0,0
171288,",",0,0
171289,as,0,0
171290,compared,0,0
171291,with,0,0
171292,placebo,0,0
171293,",",0,0
171294,did,0,0
171295,not,0,0
171296,reduce,0,0
171297,the,0,0
171298,number,0,0
171299,of,0,0
171300,primary-outcome,0,0
171301,events,0,0
171302,(,0,0
171303,367,0,1
171304,and,0,0
171305,339,0,1
171306,",",0,0
171307,respectively,0,0
171308,;,0,0
171309,hazard,0,0
171310,ratio,0,0
171311,with,0,0
171312,clonidine,0,0
171313,",",0,0
171314,1.08,0,0
171315,;,0,0
171316,95,0,0
171317,%,0,0
171318,confidence,0,0
171319,interval,0,0
171320,[,0,0
171321,CI,0,0
171322,],0,0
171323,",",0,0
171324,0.93,0,0
171325,to,0,0
171326,1.26,0,0
171327,;,0,0
171328,P=0.29,0,0
171329,),0,0
171330,.,0,0
171331,Myocardial,0,0
171332,infarction,0,0
171333,occurred,0,0
171334,in,0,0
171335,329,1,1
171336,patients,1,1
171337,(,0,0
171338,6.6,0,0
171339,%,0,0
171340,),0,0
171341,assigned,0,0
171342,to,0,0
171343,clonidine,0,0
171344,and,0,0
171345,in,0,0
171346,295,0,1
171347,patients,0,1
171348,(,0,0
171349,5.9,0,0
171350,%,0,0
171351,),0,0
171352,assigned,0,0
171353,to,0,0
171354,placebo,0,0
171355,(,0,0
171356,hazard,0,0
171357,ratio,0,0
171358,",",0,0
171359,1.11,0,0
171360,;,0,0
171361,95,0,0
171362,%,0,0
171363,CI,0,0
171364,",",0,0
171365,0.95,0,0
171366,to,0,0
171367,1.30,0,0
171368,;,0,0
171369,P=0.18,0,0
171370,),0,0
171371,.,0,0
171372,Significantly,0,0
171373,more,0,0
171374,patients,0,1
171375,in,0,0
171376,the,0,0
171377,clonidine,0,0
171378,group,0,0
171379,than,0,0
171380,in,0,0
171381,the,0,0
171382,placebo,0,0
171383,group,0,0
171384,had,0,0
171385,clinically,0,0
171386,important,0,0
171387,hypotension,0,0
171388,(,0,0
171389,2385,0,1
171390,patients,0,1
171391,[,0,0
171392,47.6,0,0
171393,%,0,0
171394,],0,0
171395,vs.,0,0
171396,1854,0,1
171397,patients,0,1
171398,[,0,0
171399,37.1,0,0
171400,%,0,0
171401,],0,0
171402,;,0,0
171403,hazard,0,0
171404,ratio,0,0
171405,1.32,0,0
171406,;,0,0
171407,95,0,0
171408,%,0,0
171409,CI,0,0
171410,",",0,0
171411,1.24,0,0
171412,to,0,0
171413,1.40,0,0
171414,;,0,0
171415,P,0,0
171416,<,0,0
171417,0.001,0,0
171418,),0,0
171419,.,0,0
171420,Clonidine,0,0
171421,",",0,0
171422,as,0,0
171423,compared,0,0
171424,with,0,0
171425,placebo,0,0
171426,",",0,0
171427,was,0,0
171428,associated,0,0
171429,with,0,0
171430,an,0,0
171431,increased,0,0
171432,rate,0,0
171433,of,0,0
171434,nonfatal,0,0
171435,cardiac,0,1
171436,arrest,0,1
171437,(,0,0
171438,0.3,0,0
171439,%,0,0
171440,[,0,0
171441,16,0,1
171442,patients,0,1
171443,],0,1
171444,vs.,0,0
171445,0.1,0,0
171446,%,0,0
171447,[,0,0
171448,5,0,0
171449,patients,0,1
171450,],0,1
171451,;,0,0
171452,hazard,0,0
171453,ratio,0,0
171454,",",0,0
171455,3.20,0,0
171456,;,0,0
171457,95,0,0
171458,%,0,0
171459,CI,0,0
171460,",",0,0
171461,1.17,0,0
171462,to,0,0
171463,8.73,0,1
171464,;,0,0
171465,P=0.02,0,0
171466,),0,0
171467,.,0,0
171468,CONCLUSIONS,0,0
171469,Administration,0,0
171470,of,0,0
171471,low-dose,0,0
171472,clonidine,0,0
171473,in,0,0
171474,patients,1,1
171475,undergoing,1,1
171476,noncardiac,1,1
171477,surgery,1,1
171478,did,0,0
171479,not,0,0
171480,reduce,0,0
171481,the,0,0
171482,rate,0,0
171483,of,0,0
171484,the,0,0
171485,composite,0,0
171486,outcome,0,0
171487,of,0,0
171488,death,0,0
171489,or,0,0
171490,nonfatal,0,0
171491,myocardial,0,1
171492,infarction,0,1
171493,;,0,0
171494,it,0,0
171495,did,0,0
171496,",",0,0
171497,however,0,0
171498,",",0,0
171499,increase,0,0
171500,the,0,0
171501,risk,0,0
171502,of,0,0
171503,clinically,0,0
171504,important,0,0
171505,hypotension,0,0
171506,and,0,0
171507,nonfatal,0,0
171508,cardiac,0,1
171509,arrest,0,1
171510,.,0,0
171511,(,0,0
171512,Funded,0,0
171513,by,0,0
171514,the,0,0
171515,Canadian,0,1
171516,Institutes,0,1
171517,of,0,1
171518,Health,0,1
171519,Research,0,0
171520,and,0,0
171521,others,0,0
171522,;,0,0
171523,POISE-2,0,0
171524,ClinicalTrials.gov,0,0
171525,number,0,0
171526,",",0,0
171527,NCT01082874,0,0
171528,.,0,0
171529,),0,0
171530,.,0,0
171531,Interview,0,1
171532,skills,0,0
171533,for,0,0
171534,adults,1,1
171535,with,1,1
171536,autism,1,1
171537,spectrum,1,1
171538,disorder,1,1
171539,:,1,0
171540,a,0,0
171541,pilot,0,0
171542,randomized,0,0
171543,controlled,0,0
171544,trial,0,0
171545,.,0,0
171546,The,0,0
171547,purpose,0,0
171548,of,0,0
171549,this,0,0
171550,pilot,0,0
171551,study,0,0
171552,was,0,0
171553,to,0,0
171554,evaluate,0,0
171555,the,0,0
171556,efficacy,0,0
171557,of,0,0
171558,the,0,0
171559,interview,0,0
171560,skills,0,0
171561,curriculum,0,0
171562,(,0,0
171563,ISC,0,0
171564,),0,0
171565,",",0,0
171566,a,0,0
171567,manualized,0,0
171568,12-week,0,0
171569,group-delivered,0,0
171570,intervention,0,0
171571,for,0,0
171572,young,1,1
171573,adults,1,1
171574,with,1,1
171575,autism,1,1
171576,spectrum,1,1
171577,disorder,1,1
171578,(,1,0
171579,ASD,1,1
171580,),1,0
171581,.,1,0
171582,This,0,0
171583,intervention,0,0
171584,aims,0,0
171585,to,0,0
171586,increase,0,0
171587,social-pragmatic,0,0
171588,skills,0,0
171589,essential,0,1
171590,to,0,0
171591,a,0,0
171592,successful,0,0
171593,job,0,0
171594,interview,0,0
171595,.,0,0
171596,Twenty-eight,1,1
171597,adults,1,1
171598,(,1,1
171599,18-36,1,1
171600,years,1,1
171601,),1,0
171602,were,0,0
171603,randomly,0,0
171604,assigned,0,0
171605,to,0,0
171606,one,0,0
171607,of,0,0
171608,two,0,0
171609,groups,0,0
171610,:,0,1
171611,ISC,0,0
171612,or,0,0
171613,waitlist,0,0
171614,control,0,0
171615,.,0,0
171616,Results,0,0
171617,revealed,0,0
171618,that,0,0
171619,the,0,0
171620,experimental,0,0
171621,group,0,0
171622,showed,0,0
171623,larger,0,0
171624,gains,0,0
171625,in,0,0
171626,social-pragmatic,0,1
171627,skills,0,0
171628,observed,0,0
171629,during,0,0
171630,a,0,0
171631,mock,0,0
171632,job,0,0
171633,interview,0,0
171634,than,0,0
171635,the,0,0
171636,control,0,0
171637,group,0,0
171638,.,0,0
171639,Treatment,0,0
171640,effects,0,0
171641,on,0,0
171642,distal,0,1
171643,outcomes,0,0
171644,",",0,0
171645,including,0,0
171646,social,0,0
171647,adaptive,0,0
171648,behaviors,0,0
171649,and,0,0
171650,depressive,0,1
171651,symptoms,0,0
171652,were,0,0
171653,not,0,0
171654,significant,0,0
171655,",",0,0
171656,although,0,0
171657,the,0,0
171658,respective,0,0
171659,effect,0,0
171660,sizes,0,0
171661,were,0,0
171662,medium/large,0,0
171663,.,0,0
171664,Results,0,0
171665,indicate,0,0
171666,that,0,0
171667,a,0,0
171668,brief,0,0
171669,",",0,0
171670,low-intensity,0,0
171671,treatment,0,0
171672,can,0,0
171673,improve,0,0
171674,the,0,0
171675,job-interview,0,0
171676,performance,0,0
171677,of,0,0
171678,young,1,1
171679,adults,1,1
171680,with,1,1
171681,ASD,1,1
171682,.,1,1
171683,Triple,0,0
171684,combination,0,0
171685,as,0,0
171686,adjuvant,0,0
171687,to,0,0
171688,cryotherapy,0,0
171689,in,0,0
171690,the,0,0
171691,treatment,0,0
171692,of,0,0
171693,solar,1,1
171694,lentigines,1,1
171695,:,1,1
171696,investigator-blinded,0,0
171697,",",0,0
171698,randomized,0,0
171699,clinical,0,0
171700,trial,0,0
171701,.,0,0
171702,BACKGROUND,0,0
171703,Post-inflammatory,0,0
171704,hyperpigmentation,0,0
171705,is,0,0
171706,a,0,0
171707,frequent,0,0
171708,concern,0,0
171709,when,0,0
171710,treating,0,0
171711,solar,0,0
171712,lentigines,0,1
171713,.,0,1
171714,OBJECTIVES,0,0
171715,To,0,0
171716,assess,0,0
171717,the,0,0
171718,safety,0,0
171719,and,0,0
171720,efficacy,0,0
171721,of,0,0
171722,a,0,0
171723,triple,0,0
171724,combination,0,0
171725,cream,0,0
171726,with,0,0
171727,fluocinolone,0,0
171728,acetonide,0,0
171729,0.01,0,0
171730,%,0,0
171731,",",0,0
171732,hydroquinone,0,0
171733,4,0,0
171734,%,0,0
171735,and,0,0
171736,tretinoin,0,0
171737,0.05,0,0
171738,%,0,0
171739,as,0,0
171740,adjuvant,0,0
171741,to,0,0
171742,cryotherapy,0,0
171743,in,0,0
171744,the,0,0
171745,treatment,0,0
171746,of,0,0
171747,solar,0,0
171748,lentigines,0,1
171749,in,0,0
171750,hands,0,0
171751,dorsum,0,0
171752,",",0,0
171753,and,0,0
171754,in,0,0
171755,the,0,0
171756,prevention,0,0
171757,of,0,0
171758,post-inflammatory,0,0
171759,hyperpigmentation,0,0
171760,after,0,0
171761,cryotherapy,0,0
171762,.,0,0
171763,METHODS,0,0
171764,This,1,0
171765,prospective,1,0
171766,",",1,0
171767,randomized,1,0
171768,",",1,0
171769,controlled,1,0
171770,",",1,0
171771,investigator-blinded,1,0
171772,",",1,0
171773,single-centre,1,1
171774,study,1,0
171775,enrolled,1,1
171776,50,1,1
171777,patients,1,1
171778,.,1,1
171779,Twenty-five,1,1
171780,patients,1,1
171781,received,0,0
171782,a,0,0
171783,2-week,0,0
171784,daily,0,0
171785,triple,0,0
171786,combination,0,0
171787,cream,0,0
171788,plus,0,0
171789,sunscreen,0,0
171790,pre-treatment,0,0
171791,and,0,0
171792,25,1,0
171793,received,1,0
171794,sunscreen,0,0
171795,alone,0,0
171796,.,0,0
171797,After,0,0
171798,that,0,0
171799,",",0,0
171800,cryotherapy,0,0
171801,was,0,0
171802,performed,0,0
171803,in,0,0
171804,all,0,0
171805,patients,0,1
171806,followed,0,0
171807,by,0,0
171808,a,0,0
171809,3-week,0,0
171810,recovery,0,0
171811,period,0,0
171812,.,0,0
171813,After,0,0
171814,this,0,0
171815,period,0,0
171816,",",0,0
171817,patients,0,1
171818,received,0,0
171819,the,0,0
171820,same,0,0
171821,initial,0,0
171822,treatment,0,0
171823,and,0,0
171824,were,0,0
171825,followed,0,0
171826,up,0,0
171827,for,0,0
171828,8,0,0
171829,weeks,0,0
171830,.,0,1
171831,Melanin,0,0
171832,and,0,0
171833,erythema,0,0
171834,levels,0,0
171835,of,0,0
171836,a,0,0
171837,target,0,0
171838,and,0,0
171839,a,0,0
171840,control,0,0
171841,lentigo,0,1
171842,were,0,0
171843,objectively,0,0
171844,measured,0,0
171845,using,0,0
171846,a,0,0
171847,narrowband,0,0
171848,reflectance,0,0
171849,spectrophotometer,0,0
171850,.,0,0
171851,Lentigines,0,0
171852,count,0,0
171853,",",0,0
171854,colour,0,0
171855,homogeneity,0,0
171856,and,0,0
171857,global,0,0
171858,improvement,0,0
171859,were,0,0
171860,also,0,0
171861,assessed,0,0
171862,.,0,0
171863,RESULTS,0,0
171864,The,0,0
171865,number,0,0
171866,of,0,0
171867,solar,0,1
171868,lentigines,0,1
171869,reduced,0,0
171870,in,0,0
171871,the,0,0
171872,first,0,0
171873,2,0,0
171874,weeks,0,0
171875,only,0,0
171876,in,0,1
171877,patients,0,1
171878,who,0,1
171879,used,0,0
171880,the,0,1
171881,triple,0,0
171882,combination,0,0
171883,25,0,0
171884,?,0,0
171885,7,0,0
171886,vs.,0,0
171887,22,0,1
171888,?,0,0
171889,8,0,0
171890,(,0,0
171891,P,0,0
171892,<,0,0
171893,0.0001,0,0
171894,),0,0
171895,",",0,0
171896,and,0,0
171897,reduced,0,0
171898,at,0,0
171899,the,0,0
171900,end,0,0
171901,of,0,0
171902,the,0,0
171903,study,0,0
171904,for,0,0
171905,both,0,0
171906,groups,0,0
171907,(,0,0
171908,P,0,0
171909,<,0,0
171910,0.0001,0,0
171911,),0,0
171912,.,0,0
171913,The,0,0
171914,melanin,0,0
171915,levels,0,0
171916,also,0,0
171917,reduced,0,0
171918,in,0,0
171919,the,0,0
171920,first,0,0
171921,2,0,0
171922,weeks,0,0
171923,only,0,0
171924,in,0,1
171925,patients,0,1
171926,who,0,1
171927,used,0,0
171928,the,0,1
171929,triple,0,0
171930,combination,0,0
171931,297,0,1
171932,?,0,0
171933,69,0,0
171934,vs.,0,0
171935,273,0,1
171936,?,0,0
171937,66,0,0
171938,(,0,0
171939,P,0,0
171940,<,0,0
171941,0.0001,0,0
171942,),0,0
171943,and,0,0
171944,reduced,0,0
171945,at,0,0
171946,the,0,0
171947,end,0,0
171948,of,0,0
171949,the,0,0
171950,study,0,0
171951,for,0,0
171952,both,0,0
171953,groups,0,0
171954,(,0,0
171955,P,0,0
171956,<,0,0
171957,0.0001,0,0
171958,),0,0
171959,.,0,0
171960,Erythema,0,0
171961,and,0,0
171962,residual,0,0
171963,blisters,0,0
171964,from,0,1
171965,cryotherapy,0,0
171966,were,0,0
171967,the,0,0
171968,reported,0,0
171969,adverse,0,0
171970,reactions,0,0
171971,.,0,1
171972,CONCLUSION,0,0
171973,Triple,0,0
171974,combination,0,0
171975,cream,0,0
171976,can,0,0
171977,be,0,0
171978,used,0,0
171979,to,0,0
171980,enhance,0,0
171981,the,0,0
171982,resolution,0,0
171983,of,0,0
171984,solar,0,0
171985,lentigines,0,0
171986,",",0,0
171987,and,0,0
171988,to,0,0
171989,significantly,0,0
171990,reduce,0,0
171991,melanin,0,0
171992,levels,0,0
171993,and,0,0
171994,lentigines,0,1
171995,count,0,0
171996,",",0,0
171997,improving,0,0
171998,treatment,0,0
171999,results,0,0
172000,.,0,0
172001,It,0,0
172002,was,0,0
172003,well-tolerated,0,0
172004,and,0,0
172005,did,0,0
172006,not,0,0
172007,increase,0,0
172008,the,0,0
172009,occurrence,0,0
172010,of,0,0
172011,neither,0,0
172012,erythema,0,0
172013,nor,0,0
172014,other,0,0
172015,side-effects,0,0
172016,after,0,0
172017,the,0,0
172018,cryotherapy,0,0
172019,.,0,0
172020,A,0,0
172021,study,0,0
172022,of,0,0
172023,noninvasive,0,0
172024,positive-pressure,0,1
172025,mechanical,0,0
172026,ventilation,0,0
172027,in,0,0
172028,the,0,0
172029,treatment,0,0
172030,of,0,0
172031,acute,1,1
172032,lung,1,1
172033,injury,1,0
172034,with,1,0
172035,a,1,0
172036,complex,1,0
172037,critical,1,0
172038,care,1,1
172039,ventilator,1,0
172040,.,1,0
172041,OBJECTIVE,0,0
172042,To,0,0
172043,test,0,0
172044,the,0,0
172045,hypothesis,0,0
172046,that,0,0
172047,there,0,0
172048,would,0,0
172049,be,0,0
172050,better,0,0
172051,clinical,0,0
172052,outcomes,0,0
172053,following,0,0
172054,the,0,0
172055,treatment,0,0
172056,of,0,0
172057,patients,1,1
172058,with,1,1
172059,acute,1,1
172060,lung,1,1
172061,injury,1,0
172062,(,1,0
172063,ALI,1,0
172064,),1,0
172065,using,0,0
172066,noninvasive,0,0
172067,positive-pressure,0,1
172068,mechanical,0,0
172069,ventilation,0,0
172070,(,0,0
172071,NIPPV,0,0
172072,),0,0
172073,delivered,0,0
172074,via,0,0
172075,a,0,0
172076,complex,0,0
172077,critical,0,0
172078,care,0,0
172079,ventilator,0,0
172080,compared,0,0
172081,with,0,0
172082,a,0,0
172083,conventional,0,0
172084,mini-ventilator,0,0
172085,.,0,1
172086,METHODS,0,0
172087,Patients,1,1
172088,with,1,1
172089,ALI,1,1
172090,who,1,1
172091,required,1,1
172092,NIPPV,1,1
172093,were,1,0
172094,prospectively,1,0
172095,enrolled,1,1
172096,and,0,0
172097,randomly,0,0
172098,divided,0,0
172099,between,0,0
172100,three,0,0
172101,intervention,0,0
172102,groups,0,0
172103,:,0,1
172104,group,0,0
172105,A,0,0
172106,was,0,0
172107,ventilated,0,0
172108,using,0,0
172109,a,0,0
172110,mini-ventilator,0,0
172111,;,0,0
172112,groups,0,0
172113,B,0,0
172114,and,0,0
172115,C,0,0
172116,were,0,0
172117,ventilated,0,0
172118,using,0,0
172119,a,0,0
172120,complex,0,0
172121,critical,0,0
172122,care,0,0
172123,ventilator,0,0
172124,using,0,0
172125,different,0,0
172126,settings,0,0
172127,.,0,1
172128,Clinical,0,0
172129,parameters,0,0
172130,were,0,0
172131,recorded,0,0
172132,before,0,0
172133,and,0,0
172134,after,0,0
172135,8,0,0
172136,h,0,0
172137,of,0,0
172138,mechanical,0,0
172139,ventilation,0,0
172140,.,0,0
172141,RESULTS,0,0
172142,A,0,0
172143,total,0,0
172144,of,0,0
172145,51,1,1
172146,patients,1,1
172147,with,1,1
172148,ALI,1,0
172149,were,0,0
172150,enrolled,0,1
172151,in,0,0
172152,the,0,0
172153,study,0,0
172154,.,0,0
172155,Clinical,0,0
172156,parameters,0,0
172157,in,0,0
172158,groups,0,0
172159,B,0,1
172160,and,0,0
172161,C,0,0
172162,underwent,0,1
172163,greater,0,0
172164,improvements,0,0
172165,than,0,0
172166,those,0,0
172167,in,0,0
172168,group,0,0
172169,A,0,0
172170,.,0,0
172171,Group,0,0
172172,C,0,0
172173,demonstrated,0,0
172174,the,0,0
172175,lowest,0,0
172176,treatment,0,0
172177,failure,0,1
172178,rate,0,0
172179,(,0,0
172180,23.5,0,0
172181,%,0,0
172182,),0,0
172183,.,0,0
172184,Failure,0,0
172185,rates,0,0
172186,were,0,0
172187,highest,0,0
172188,in,0,0
172189,group,0,0
172190,A,0,0
172191,(,0,0
172192,58.8,0,0
172193,%,0,0
172194,),0,0
172195,.,0,0
172196,CONCLUSION,0,0
172197,The,0,0
172198,findings,0,0
172199,of,0,0
172200,this,0,0
172201,present,0,0
172202,study,0,0
172203,suggest,0,0
172204,that,0,0
172205,there,0,0
172206,were,0,0
172207,more,0,0
172208,satisfactory,0,0
172209,clinical,0,0
172210,outcomes,0,0
172211,following,0,0
172212,the,0,0
172213,treatment,0,0
172214,of,0,0
172215,patients,1,1
172216,with,1,1
172217,ALI,1,0
172218,when,0,0
172219,NIPPV,0,0
172220,was,0,0
172221,delivered,0,0
172222,using,0,0
172223,a,0,0
172224,complex,0,0
172225,critical,0,0
172226,care,0,0
172227,ventilator,0,0
172228,compared,0,0
172229,with,0,0
172230,a,0,0
172231,conventional,0,0
172232,mini-ventilator,0,0
172233,.,0,0
172234,Low-dose,0,0
172235,prednisolone,0,0
172236,treatment,0,0
172237,of,0,0
172238,early,1,0
172239,rheumatoid,1,1
172240,arthritis,1,1
172241,and,0,0
172242,late,0,0
172243,cardiovascular,0,0
172244,outcome,0,0
172245,and,0,0
172246,survival,0,0
172247,:,0,1
172248,10-year,0,0
172249,follow-up,0,0
172250,of,0,0
172251,a,0,0
172252,2-year,0,0
172253,randomised,0,0
172254,trial,0,0
172255,.,0,0
172256,OBJECTIVE,0,0
172257,To,0,0
172258,examine,0,0
172259,the,0,0
172260,long-term,0,0
172261,effects,0,0
172262,of,0,0
172263,early,0,1
172264,low-dose,0,0
172265,prednisolone,0,0
172266,use,0,0
172267,in,0,0
172268,patients,1,1
172269,with,1,1
172270,rheumatoid,1,1
172271,arthritis,1,1
172272,(,1,0
172273,RA,1,0
172274,),1,0
172275,on,1,0
172276,cardiovascular,1,0
172277,(,1,0
172278,CV,1,0
172279,),1,0
172280,morbidity,1,0
172281,and,1,0
172282,mortality,1,0
172283,.,1,0
172284,DESIGN,0,0
172285,Retrieval,0,0
172286,of,0,0
172287,data,0,0
172288,from,0,0
172289,a,0,0
172290,2-year,0,0
172291,open,0,0
172292,randomised,0,0
172293,trial,0,0
172294,comparing,0,0
172295,prednisolone,0,0
172296,7.5,0,0
172297,mg/day,0,0
172298,in,0,0
172299,addition,0,0
172300,to,0,0
172301,disease-modifying,0,0
172302,antirheumatic,0,0
172303,drugs,0,0
172304,(,0,0
172305,DMARDs,0,0
172306,),0,0
172307,with,0,1
172308,DMARD,0,0
172309,therapy,0,0
172310,alone,0,0
172311,.,0,0
172312,Participants,0,1
172313,were,0,0
172314,followed,0,0
172315,for,0,0
172316,10,0,0
172317,years,0,1
172318,since,0,0
172319,inclusion,0,0
172320,into,0,0
172321,the,0,0
172322,original,0,0
172323,prednisolone,0,0
172324,trial,0,0
172325,or,0,0
172326,until,0,0
172327,occurrence,0,0
172328,of,0,0
172329,the,0,0
172330,studied,0,1
172331,outcomes,0,0
172332,.,0,1
172333,SETTING,0,0
172334,Secondary,0,0
172335,level,0,0
172336,of,0,0
172337,care,0,0
172338,;,0,0
172339,six,1,0
172340,participating,1,1
172341,centres,1,1
172342,from,1,1
172343,southern,1,1
172344,Sweden,1,1
172345,;,1,0
172346,both,1,0
172347,urban,1,1
172348,and,1,0
172349,rural,1,1
172350,populations,1,1
172351,.,1,1
172352,PARTICIPANTS,0,0
172353,Overall,0,0
172354,",",0,0
172355,223,1,1
172356,patients,1,1
172357,with,1,1
172358,early,1,1
172359,RA,1,0
172360,were,0,0
172361,included,0,1
172362,.,0,0
172363,The,0,0
172364,participants,1,0
172365,had,1,0
172366,no,1,0
172367,history,1,0
172368,of,1,0
172369,CV,1,0
172370,events,1,0
172371,at,1,0
172372,baseline,1,0
172373,and,0,0
172374,incident,0,1
172375,cases,0,0
172376,were,0,0
172377,identified,0,0
172378,via,0,0
172379,the,0,0
172380,Swedish,0,1
172381,Hospital,0,1
172382,Discharge,0,0
172383,and,0,0
172384,Cause,0,0
172385,of,0,0
172386,Death,0,0
172387,Registries,0,1
172388,.,0,0
172389,OUTCOMES,0,0
172390,Composite,0,0
172391,CV,0,0
172392,events,0,0
172393,",",0,0
172394,that,0,0
172395,is,0,0
172396,",",0,0
172397,ischaemic,0,0
172398,coronary,0,1
172399,and,0,0
172400,cerebrovascular,0,1
172401,events,0,0
172402,",",0,0
172403,components,0,0
172404,of,0,0
172405,the,0,0
172406,composite,0,0
172407,CV,0,0
172408,outcome,0,0
172409,",",0,0
172410,and,0,0
172411,death,0,0
172412,.,0,0
172413,Relative,0,0
172414,HRs,0,1
172415,from,0,1
172416,Cox,0,0
172417,proportional-hazards,0,0
172418,regression,0,0
172419,models,0,0
172420,were,0,0
172421,calculated,0,0
172422,.,0,0
172423,RESULTS,0,0
172424,Within,0,0
172425,2041,0,1
172426,person-years,0,0
172427,",",0,0
172428,17,0,0
172429,incident,0,1
172430,composite,0,0
172431,CV,0,0
172432,events,0,0
172433,occurred,0,0
172434,in,0,0
172435,112,0,1
172436,patients,0,1
172437,(,0,0
172438,15,0,0
172439,%,0,0
172440,),0,0
172441,randomised,0,0
172442,to,0,0
172443,prednisolone,0,0
172444,",",0,0
172445,and,0,0
172446,15,0,0
172447,events,0,0
172448,of,0,0
172449,111,0,1
172450,patients,0,1
172451,(,0,0
172452,14,0,0
172453,%,0,0
172454,),0,1
172455,who,0,1
172456,were,0,1
172457,assigned,0,1
172458,not,0,0
172459,to,0,0
172460,receive,0,0
172461,prednisolone,0,0
172462,.,0,0
172463,There,0,0
172464,were,0,0
172465,nine,0,1
172466,deaths,0,0
172467,(,0,0
172468,8,0,0
172469,%,0,0
172470,),0,0
172471,in,0,0
172472,each,0,0
172473,group,0,0
172474,.,0,0
172475,The,0,0
172476,age-adjusted,0,0
172477,relative,0,0
172478,hazards,0,0
172479,(,0,1
172480,HRs,0,1
172481,;,0,0
172482,95,0,0
172483,%,0,0
172484,CI,0,0
172485,),0,0
172486,for,0,0
172487,the,0,0
172488,first,0,0
172489,composite,0,0
172490,CV,0,0
172491,event,0,0
172492,",",0,0
172493,first,0,0
172494,coronary,0,0
172495,event,0,0
172496,and,0,0
172497,death,0,0
172498,in,0,0
172499,the,0,0
172500,prednisolone,0,0
172501,group,0,0
172502,versus,0,0
172503,the,0,0
172504,group,0,0
172505,not,0,0
172506,treated,0,0
172507,with,0,0
172508,prednisolone,0,0
172509,were,0,0
172510,1.8,0,0
172511,(,0,0
172512,0.9,0,0
172513,to,0,0
172514,3.6,0,0
172515,),0,0
172516,",",0,0
172517,0.98,0,0
172518,(,0,0
172519,0.4,0,0
172520,to,0,0
172521,2.6,0,0
172522,),0,0
172523,and,0,0
172524,1.6,0,0
172525,(,0,0
172526,0.6,0,0
172527,to,0,0
172528,4.1,0,0
172529,),0,0
172530,",",0,0
172531,respectively,0,0
172532,.,0,0
172533,The,0,0
172534,risk,0,0
172535,for,0,0
172536,the,0,0
172537,first,0,0
172538,cerebrovascular,0,1
172539,event,0,0
172540,showed,0,0
172541,a,0,0
172542,3.7-fold,0,0
172543,increased,0,0
172544,relative,0,0
172545,hazard,0,0
172546,(,0,0
172547,95,0,0
172548,%,0,0
172549,CI,0,0
172550,1.2,0,0
172551,to,0,0
172552,11.4,0,0
172553,),0,0
172554,among,0,0
172555,prednisolone,0,0
172556,treated,0,1
172557,patients,0,1
172558,.,0,1
172559,CONCLUSIONS,0,0
172560,In,0,0
172561,this,0,0
172562,inception,0,0
172563,cohort,0,0
172564,study,0,0
172565,of,0,0
172566,low-dose,0,0
172567,prednisolone,0,0
172568,use,0,0
172569,during,0,0
172570,the,0,0
172571,first,0,0
172572,2,0,0
172573,years,0,1
172574,of,0,0
172575,RA,0,0
172576,disease,0,1
172577,",",0,0
172578,the,0,0
172579,incidence,0,0
172580,of,0,0
172581,ischaemic,0,1
172582,coronary,0,1
172583,artery,0,1
172584,events,0,0
172585,was,0,0
172586,similar,0,0
172587,in,0,0
172588,the,0,0
172589,two,0,0
172590,treatment,0,0
172591,groups,0,0
172592,",",0,0
172593,whereas,0,0
172594,the,0,0
172595,long-term,0,0
172596,risk,0,0
172597,of,0,0
172598,ischaemic,0,1
172599,cerebrovascular,0,1
172600,events,0,0
172601,was,0,0
172602,higher,0,0
172603,in,0,0
172604,the,0,0
172605,prednisolone,0,0
172606,group,0,0
172607,.,0,0
172608,There,0,0
172609,was,0,0
172610,a,0,0
172611,trend,0,0
172612,towards,0,0
172613,reduced,0,0
172614,survival,0,0
172615,in,0,0
172616,the,0,0
172617,prednisolone,0,0
172618,group,0,0
172619,.,0,0
172620,TRIAL,0,0
172621,REGISTRATION,0,0
172622,NUMBER,0,0
172623,ISRCTN20612367,0,0
172624,.,0,0
172625,Hemodialysis,1,0
172626,catheter,1,0
172627,design,1,0
172628,and,1,0
172629,catheter,1,0
172630,performance,1,0
172631,:,1,0
172632,a,0,0
172633,randomized,0,0
172634,controlled,0,0
172635,trial,0,0
172636,.,0,0
172637,BACKGROUND,0,0
172638,A,0,0
172639,complication,0,0
172640,of,0,0
172641,long-term,0,0
172642,use,0,0
172643,of,0,0
172644,tunneled,0,0
172645,cuffed,0,0
172646,catheters,0,0
172647,for,0,0
172648,hemodialysis,0,1
172649,is,0,0
172650,the,0,0
172651,high,0,0
172652,rate,0,0
172653,of,0,0
172654,infection,0,0
172655,and,0,0
172656,thrombus-related,0,0
172657,dysfunction,0,0
172658,.,0,0
172659,Specific,0,0
172660,mechanical,0,0
172661,features,0,0
172662,of,0,0
172663,tunneled,0,0
172664,cuffed,0,0
172665,catheters,0,0
172666,may,0,0
172667,improve,0,0
172668,hemodynamic,0,0
172669,performance,0,0
172670,and,0,0
172671,decrease,0,0
172672,thrombosis,0,0
172673,and,0,0
172674,infection,0,1
172675,rates,0,0
172676,.,0,0
172677,However,0,0
172678,",",0,0
172679,there,0,0
172680,currently,0,0
172681,is,0,0
172682,no,0,0
172683,proven,0,0
172684,advantage,0,0
172685,of,0,0
172686,one,0,0
172687,design,0,0
172688,over,0,0
172689,another,0,0
172690,.,0,0
172691,STUDY,0,0
172692,DESIGN,0,0
172693,Single-center,0,1
172694,randomized,0,0
172695,clinical,0,0
172696,trial,0,0
172697,.,0,0
172698,SETTING,0,0
172699,&,0,1
172700,PARTICIPANTS,0,0
172701,302,1,1
172702,hemodialysis,1,1
172703,patients,1,1
172704,who,1,1
172705,required,1,1
172706,a,1,1
172707,tunneled,1,0
172708,cuffed,1,0
172709,catheter,1,0
172710,as,1,0
172711,temporary,1,0
172712,or,1,1
172713,definite,1,0
172714,vascular,1,0
172715,access,1,0
172716,.,1,0
172717,INTERVENTION,0,0
172718,Palindrome,0,0
172719,Symmetric,0,0
172720,Tip,0,0
172721,Dialysis,0,1
172722,Catheter,0,0
172723,or,0,1
172724,HemoStar,0,0
172725,Long-Term,0,0
172726,Hemodialysis,0,0
172727,Catheter,0,0
172728,.,0,0
172729,OUTCOMES,0,0
172730,&,0,0
172731,MEASUREMENTS,0,0
172732,The,0,0
172733,primary,0,0
172734,end,0,0
172735,point,0,0
172736,was,0,0
172737,primary,0,0
172738,assisted,0,1
172739,patency,0,0
172740,.,0,0
172741,Secondary,0,0
172742,end,0,0
172743,points,0,0
172744,were,0,0
172745,incidence,0,0
172746,of,0,0
172747,catheter-related,0,0
172748,bloodstream,0,1
172749,infections,0,0
172750,(,0,0
172751,CRBSIs,0,1
172752,),0,0
172753,",",0,0
172754,thrombosis,0,0
172755,",",0,0
172756,and,0,0
172757,2,0,0
172758,indicators,0,0
172759,of,0,0
172760,rheologic,0,0
172761,function,0,0
172762,:,0,1
172763,mean,0,0
172764,effective,0,0
172765,blood,0,0
172766,flow,0,0
172767,rate,0,0
172768,and,0,0
172769,urokinase,0,0
172770,use,0,0
172771,.,0,0
172772,RESULTS,0,0
172773,Mean,0,0
172774,primary,0,0
172775,assisted,0,0
172776,patency,0,0
172777,was,0,0
172778,135.9,0,0
172779,days,0,0
172780,for,0,0
172781,Palindrome,0,1
172782,and,0,0
172783,136.5,0,0
172784,days,0,0
172785,for,0,0
172786,HemoStar,0,0
172787,(,0,0
172788,P=0.8,0,0
172789,),0,0
172790,.,0,0
172791,Definite,0,0
172792,CRBSI,0,0
172793,occurred,0,0
172794,in,0,0
172795,0.24,0,0
172796,and,0,0
172797,"0.10/1,000",0,0
172798,catheter-days,0,0
172799,for,0,0
172800,Palindrome,0,1
172801,and,0,0
172802,HemoStar,0,0
172803,",",0,0
172804,respectively,0,0
172805,(,0,0
172806,P=0.3,0,0
172807,),0,0
172808,.,0,0
172809,Removal,0,0
172810,rates,0,0
172811,for,0,0
172812,thrombosis,0,1
172813,that,0,0
172814,could,0,0
172815,not,0,0
172816,be,0,0
172817,resolved,0,0
172818,with,0,0
172819,thrombolysis,0,0
172820,were,0,0
172821,0.53,0,0
172822,and,0,0
172823,"0.43/1,000",0,0
172824,catheter-days,0,0
172825,for,0,0
172826,Palindrome,0,1
172827,and,0,0
172828,HemoStar,0,0
172829,",",0,0
172830,respectively,0,0
172831,(,0,0
172832,P=0.7,0,0
172833,),0,0
172834,.,0,0
172835,Urokinase,0,0
172836,use,0,0
172837,was,0,0
172838,lower,0,0
172839,for,0,0
172840,Palindrome,0,0
172841,than,0,0
172842,for,0,0
172843,HemoStar,0,0
172844,",",0,0
172845,as,0,0
172846,evidenced,0,0
172847,by,0,0
172848,a,0,0
172849,lower,0,0
172850,number,0,0
172851,of,0,0
172852,urokinase,0,0
172853,"infusions/1,000",0,0
172854,catheter-days,0,0
172855,(,0,0
172856,17,0,1
172857,and,0,0
172858,35,0,1
172859,;,0,0
172860,P,0,0
172861,<,0,0
172862,0.001,0,0
172863,),0,0
172864,and,0,0
172865,higher,0,0
172866,number,0,0
172867,of,0,0
172868,catheters,0,0
172869,that,0,0
172870,never,0,1
172871,required,0,0
172872,thrombolysis,0,0
172873,(,0,0
172874,58,0,1
172875,%,0,0
172876,and,0,0
172877,45,0,1
172878,%,0,0
172879,;,0,0
172880,P=0.03,0,0
172881,),0,0
172882,.,0,0
172883,Mean,0,0
172884,effective,0,0
172885,blood,0,0
172886,flow,0,0
172887,rate,0,0
172888,was,0,0
172889,higher,0,0
172890,for,0,0
172891,Palindrome,0,0
172892,than,0,0
172893,for,0,0
172894,HemoStar,0,0
172895,(,0,0
172896,333,0,1
172897,and,0,0
172898,304mL/min,0,0
172899,;,0,0
172900,P,0,0
172901,<,0,0
172902,0.001,0,0
172903,),0,0
172904,.,0,0
172905,LIMITATIONS,0,0
172906,Single-center,0,0
172907,nonblinded,0,0
172908,trial,0,0
172909,.,0,0
172910,CONCLUSIONS,0,0
172911,Primary,0,0
172912,assisted,0,0
172913,patency,0,0
172914,and,0,0
172915,incidence,0,0
172916,of,0,0
172917,infection,0,0
172918,and,0,0
172919,thrombosis,0,1
172920,were,0,0
172921,similar,0,0
172922,for,0,0
172923,both,0,0
172924,catheter,0,0
172925,types,0,0
172926,.,0,0
172927,The,0,0
172928,Palindrome,0,0
172929,catheter,0,0
172930,required,0,0
172931,less,0,0
172932,thrombolysis,0,0
172933,and,0,0
172934,achieved,0,0
172935,higher,0,0
172936,blood,0,0
172937,flow,0,0
172938,rates,0,0
172939,than,0,0
172940,the,0,0
172941,HemoStar,0,0
172942,catheter,0,0
172943,.,0,0
172944,These,0,0
172945,findings,0,0
172946,suggest,0,0
172947,that,0,0
172948,mechanical,0,0
172949,catheter,0,0
172950,design,0,0
172951,may,0,0
172952,improve,0,0
172953,catheter,0,0
172954,rheology,0,0
172955,",",0,0
172956,but,0,0
172957,does,0,0
172958,not,0,0
172959,affect,0,0
172960,risks,0,0
172961,for,0,0
172962,thrombosis,0,1
172963,and,0,0
172964,infection,0,0
172965,and,0,0
172966,hence,0,0
172967,catheter,0,0
172968,survival,0,0
172969,.,0,0
172970,Assessment,0,0
172971,of,0,0
172972,acute,0,1
172973,bronchodilator,0,0
172974,effects,0,0
172975,from,0,0
172976,specific,0,0
172977,airway,0,1
172978,resistance,0,0
172979,changes,0,0
172980,in,0,0
172981,stable,1,1
172982,COPD,1,0
172983,patients,1,1
172984,.,1,1
172985,BACKGROUND,0,0
172986,In,1,0
172987,COPD,1,0
172988,patients,1,1
172989,",",0,0
172990,reversibility,0,0
172991,is,0,0
172992,currently,0,0
172993,evaluated,0,0
172994,from,0,0
172995,the,0,0
172996,changes,0,0
172997,of,0,0
172998,forced,0,0
172999,expiratory,0,0
173000,volume,0,0
173001,at,0,0
173002,1s,0,0
173003,(,0,0
173004,?FEV1,0,1
173005,),0,0
173006,and,0,0
173007,forced,0,0
173008,vital,0,0
173009,capacity,0,0
173010,(,0,0
173011,?FVC,0,0
173012,),0,0
173013,.,0,0
173014,By,0,0
173015,lowering,0,0
173016,peripheral,0,0
173017,airway,0,1
173018,smooth,0,0
173019,muscle,0,0
173020,tone,0,0
173021,",",0,0
173022,bronchodilators,0,0
173023,should,0,0
173024,decrease,0,0
173025,dynamic,0,0
173026,hyperinflation,0,0
173027,",",0,0
173028,gas,0,0
173029,trapping,0,0
173030,",",0,0
173031,and,0,0
173032,possibly,0,0
173033,dyspnea,0,0
173034,at,0,0
173035,rest,0,0
173036,.,0,0
173037,Hence,0,0
173038,",",0,0
173039,we,0,0
173040,hypothesize,0,0
173041,that,0,0
173042,specific,0,0
173043,airway,0,1
173044,resistance,0,0
173045,changes,0,0
173046,(,0,0
173047,?sRAW,0,0
173048,),0,0
173049,should,0,0
173050,better,0,0
173051,characterize,0,0
173052,the,0,0
173053,acute,0,0
173054,response,0,0
173055,to,0,0
173056,bronchodilators,0,0
173057,.,0,0
173058,METHODS,0,0
173059,On,0,0
173060,two,0,0
173061,days,1,0
173062,",",1,0
173063,60,1,1
173064,COPD,1,0
173065,patients,1,1
173066,underwent,1,1
173067,dyspnea,0,0
173068,evaluation,0,0
173069,(,0,0
173070,VAS,0,0
173071,score,0,0
173072,),0,0
173073,and,0,0
173074,pulmonary,0,0
173075,function,0,0
173076,testing,0,0
173077,at,0,0
173078,baseline,0,0
173079,and,0,0
173080,one,0,0
173081,hour,0,0
173082,after,0,0
173083,placebo,0,0
173084,or,0,1
173085,300?g,0,0
173086,indacaterol,0,0
173087,administration,0,0
173088,.,0,0
173089,RESULTS,0,0
173090,Spirographic,0,0
173091,and,0,0
173092,?sRAW-based,0,0
173093,criteria,0,1
173094,identified,0,0
173095,as,0,0
173096,responders,0,0
173097,24,0,0
173098,and,0,1
173099,45,0,1
173100,patients,0,1
173101,",",0,0
173102,respectively,0,0
173103,.,0,0
173104,?sRAW,0,0
173105,correlated,0,0
173106,with,0,1
173107,changes,0,0
173108,of,0,0
173109,intrathoracic,0,1
173110,gas,0,0
173111,volume,0,0
173112,(,0,0
173113,?ITGV,0,0
173114,),0,0
173115,(,0,0
173116,r=0.61,0,0
173117,;,0,0
173118,p,0,0
173119,<,0,0
173120,0.001,0,0
173121,),0,0
173122,",",0,0
173123,residual,0,0
173124,volume,0,0
173125,(,0,0
173126,?RV,0,0
173127,),0,0
173128,(,0,0
173129,r=0.60,0,0
173130,;,0,0
173131,p,0,0
173132,<,0,0
173133,0.001,0,0
173134,),0,0
173135,",",0,0
173136,?FVC,0,0
173137,(,0,0
173138,r=0.44,0,0
173139,;,0,0
173140,p=0.001,0,0
173141,),0,0
173142,",",0,0
173143,and,0,0
173144,?VAS,0,0
173145,(,0,0
173146,r=0.73,0,0
173147,;,0,0
173148,p,0,0
173149,<,0,0
173150,0.001,0,0
173151,),0,0
173152,",",0,0
173153,while,0,0
173154,?FEV1,0,0
173155,correlated,0,0
173156,only,0,0
173157,with,0,0
173158,?FVC,0,0
173159,(,0,0
173160,r=0.34,0,0
173161,;,0,0
173162,p=0.008,0,0
173163,),0,0
173164,.,0,0
173165,Significant,0,0
173166,differences,0,0
173167,in,0,0
173168,terms,0,0
173169,of,0,0
173170,?ITGV,0,0
173171,(,0,0
173172,p=0.002,0,0
173173,),0,0
173174,",",0,0
173175,?RV,0,0
173176,(,0,0
173177,p=0.023,0,0
173178,),0,0
173179,",",0,0
173180,and,0,0
173181,?VAS,0,0
173182,(,0,0
173183,p,0,0
173184,<,0,0
173185,0.001,0,0
173186,),0,0
173187,occurred,0,0
173188,only,0,0
173189,if,0,0
173190,patients,0,1
173191,were,0,0
173192,stratified,0,0
173193,according,0,1
173194,to,0,0
173195,?sRAW,0,0
173196,.,0,0
173197,CONCLUSIONS,0,0
173198,In,0,0
173199,assessing,0,0
173200,the,0,0
173201,acute,0,1
173202,functional,0,0
173203,effect,0,0
173204,of,0,0
173205,bronchodilators,0,0
173206,",",0,0
173207,?sRAW-based,0,0
173208,criterion,0,0
173209,is,0,0
173210,preferable,0,0
173211,to,0,0
173212,FEV1-FVC-based,0,0
173213,criteria,0,1
173214,",",0,0
173215,being,0,0
173216,more,0,0
173217,closely,0,0
173218,related,0,0
173219,to,0,0
173220,bronchodilator-induced,0,0
173221,improvements,0,0
173222,of,0,0
173223,lung,0,1
173224,mechanics,0,0
173225,and,0,0
173226,dyspnea,0,0
173227,at,0,0
173228,rest,0,0
173229,.,0,0
173230,Correlations,0,0
173231,between,0,0
173232,the,0,0
173233,clinical,0,0
173234,",",0,0
173235,histological,0,0
173236,and,0,0
173237,neurophysiological,0,0
173238,examinations,0,0
173239,in,0,0
173240,patients,1,1
173241,before,1,0
173242,and,1,0
173243,after,1,0
173244,parotid,1,1
173245,gland,1,1
173246,tumor,1,1
173247,surgery,1,1
173248,:,1,0
173249,verification,0,0
173250,of,0,0
173251,facial,0,0
173252,nerve,0,0
173253,transmission,0,0
173254,.,0,0
173255,Parotid,0,0
173256,gland,0,0
173257,tumor,0,0
173258,surgery,0,0
173259,sometimes,0,0
173260,leads,0,0
173261,to,0,0
173262,facial,0,0
173263,nerve,0,0
173264,paralysis,0,1
173265,.,0,0
173266,Malignant,0,0
173267,more,0,0
173268,than,0,0
173269,benign,0,1
173270,tumors,0,1
173271,determine,0,0
173272,nerve,0,0
173273,function,0,0
173274,preoperatively,0,0
173275,",",0,0
173276,while,0,0
173277,postoperative,0,0
173278,observations,0,0
173279,based,0,0
173280,on,0,0
173281,clinical,0,0
173282,",",0,0
173283,histological,0,0
173284,and,0,0
173285,neurophysiological,0,0
173286,studies,0,0
173287,have,0,0
173288,not,0,0
173289,been,0,0
173290,reported,0,0
173291,in,0,0
173292,detail,0,0
173293,.,0,0
173294,The,0,0
173295,aims,0,0
173296,of,0,0
173297,this,0,0
173298,pilot,0,0
173299,study,0,0
173300,were,0,0
173301,evaluation,0,0
173302,and,0,0
173303,correlations,0,0
173304,of,0,0
173305,histological,0,0
173306,properties,0,0
173307,of,0,0
173308,tumor,0,1
173309,(,0,0
173310,its,0,0
173311,size,0,0
173312,and,0,0
173313,location,0,0
173314,),0,0
173315,and,0,0
173316,clinical,0,0
173317,and,0,0
173318,neurophysiological,0,0
173319,assessment,0,0
173320,of,0,0
173321,facial,0,0
173322,nerve,0,0
173323,function,0,0
173324,pre-,0,0
173325,and,0,0
173326,post-operatively,0,0
173327,(,0,0
173328,1,0,0
173329,and,0,0
173330,6,0,0
173331,months,0,0
173332,),0,1
173333,.,0,1
173334,Comparative,0,0
173335,studies,0,0
173336,included,0,1
173337,17,1,1
173338,patients,1,1
173339,with,1,1
173340,benign,1,1
173341,(,1,0
173342,n,1,1
173343,=,1,0
173344,13,1,1
173345,),1,0
173346,and,1,0
173347,malignant,1,1
173348,(,1,0
173349,n,1,1
173350,=,1,0
173351,4,1,0
173352,),1,1
173353,tumors,1,1
173354,.,1,0
173355,Clinical,0,0
173356,assessment,0,0
173357,was,0,0
173358,based,0,0
173359,on,0,0
173360,House-Brackmann,0,0
173361,scale,0,0
173362,(,0,0
173363,H-B,0,0
173364,),0,0
173365,",",0,0
173366,neurophysiological,0,0
173367,diagnostics,0,0
173368,included,0,1
173369,facial,0,0
173370,electroneurography,0,1
173371,[,0,0
173372,ENG,0,0
173373,",",0,0
173374,compound,0,0
173375,muscle,0,0
173376,action,0,0
173377,potential,0,0
173378,(,0,0
173379,CMAP,0,0
173380,),0,0
173381,],0,0
173382,",",0,0
173383,mimetic,0,0
173384,muscle,0,0
173385,electromyography,0,0
173386,(,0,0
173387,EMG,0,0
173388,),0,0
173389,and,0,0
173390,blink-reflex,0,0
173391,examinations,0,0
173392,(,0,0
173393,BR,0,0
173394,),0,0
173395,.,0,0
173396,Mainly,0,0
173397,grade,0,0
173398,I,0,0
173399,of,0,0
173400,H-B,0,0
173401,was,0,0
173402,recorded,0,0
173403,both,0,0
173404,pre-,0,0
173405,(,0,0
173406,n,0,1
173407,=,0,0
173408,13,0,1
173409,),0,0
173410,and,0,0
173411,post-operatively,0,0
173412,(,0,0
173413,n,0,1
173414,=,0,0
173415,12,0,0
173416,),0,0
173417,in,0,0
173418,patients,1,1
173419,with,1,1
173420,small,1,0
173421,(,1,0
173422,1.5-2.4,1,0
173423,cm,1,1
173424,),1,0
173425,benign,1,1
173426,tumors,1,1
173427,located,1,0
173428,in,1,0
173429,superficial,1,0
173430,lobes,1,0
173431,.,1,1
173432,Patients,1,1
173433,with,1,0
173434,medium,1,0
173435,size,1,0
173436,(,1,0
173437,2.5-3.4,1,0
173438,cm,1,1
173439,),1,0
173440,malignant,1,1
173441,tumors,1,1
173442,in,1,0
173443,both,1,0
173444,lobes,1,0
173445,were,0,0
173446,scored,0,0
173447,at,0,0
173448,grade,0,0
173449,I,0,0
173450,(,0,0
173451,n,0,1
173452,=,0,0
173453,2,0,0
173454,),0,0
173455,and,0,0
173456,III,0,0
173457,(,0,0
173458,n,0,1
173459,=,0,0
173460,2,0,0
173461,),0,0
173462,pre-,0,0
173463,and,0,0
173464,mainly,0,0
173465,VI,0,0
173466,(,0,0
173467,n,0,1
173468,=,0,0
173469,4,0,0
173470,),0,0
173471,post-operatively,0,0
173472,.,0,0
173473,CMAP,0,0
173474,amplitudes,0,0
173475,after,0,0
173476,stimulation,0,0
173477,of,0,0
173478,mandibular,0,1
173479,marginal,0,0
173480,branch,0,1
173481,were,0,0
173482,reduced,0,0
173483,at,0,0
173484,about,0,0
173485,25,0,0
173486,%,0,0
173487,in,0,0
173488,patients,1,1
173489,with,1,1
173490,benign,1,1
173491,tumors,1,1
173492,after,0,0
173493,surgery,0,1
173494,.,0,0
173495,In,0,0
173496,the,0,0
173497,cases,0,0
173498,of,0,0
173499,malignant,0,1
173500,tumors,0,1
173501,CMAPs,0,0
173502,were,0,0
173503,not,0,0
173504,recorded,0,0
173505,following,0,0
173506,stimulation,0,0
173507,of,0,0
173508,any,0,0
173509,branch,0,0
173510,.,0,0
173511,A,0,0
173512,similar,0,0
173513,trend,0,0
173514,was,0,0
173515,found,0,0
173516,for,0,0
173517,BR,0,0
173518,results,0,0
173519,.,0,1
173520,H-B,0,0
173521,and,0,0
173522,ENG,0,1
173523,results,0,0
173524,revealed,0,0
173525,positive,0,0
173526,correlations,0,0
173527,between,0,0
173528,the,0,0
173529,type,0,0
173530,of,0,0
173531,tumor,0,0
173532,and,0,0
173533,surgery,0,1
173534,with,0,1
173535,facial,0,0
173536,nerve,0,0
173537,function,0,0
173538,.,0,0
173539,Neurophysiological,0,0
173540,studies,0,0
173541,detected,0,0
173542,clinically,0,0
173543,silent,0,0
173544,facial,0,0
173545,nerve,0,0
173546,neuropathy,0,1
173547,of,0,0
173548,mandibular,0,1
173549,marginal,0,0
173550,branch,0,1
173551,in,0,0
173552,postoperative,0,0
173553,period,0,0
173554,.,0,0
173555,Needle,0,0
173556,EMG,0,0
173557,",",0,0
173558,ENG,0,0
173559,and,0,0
173560,BR,0,0
173561,examinations,0,0
173562,allow,0,0
173563,for,0,0
173564,the,0,0
173565,evaluation,0,0
173566,of,0,0
173567,face,0,0
173568,muscles,0,0
173569,reinnervation,0,1
173570,and,0,0
173571,facial,0,0
173572,nerve,0,0
173573,regeneration,0,0
173574,.,0,0
173575,Evaluation,0,0
173576,of,0,0
173577,early,0,0
173578,weight,0,0
173579,loss,0,0
173580,thresholds,0,0
173581,for,0,0
173582,identifying,0,0
173583,nonresponders,0,0
173584,to,0,0
173585,an,0,0
173586,intensive,0,0
173587,lifestyle,0,0
173588,intervention,0,0
173589,.,0,0
173590,OBJECTIVE,0,0
173591,Weight,0,0
173592,losses,0,0
173593,in,0,0
173594,lifestyle,0,1
173595,interventions,0,0
173596,are,0,0
173597,variable,0,0
173598,",",0,0
173599,yet,0,0
173600,prediction,0,0
173601,of,0,0
173602,long-term,0,0
173603,success,0,0
173604,is,0,0
173605,difficult,0,0
173606,.,0,0
173607,The,0,0
173608,utility,0,0
173609,of,0,0
173610,using,0,0
173611,various,0,0
173612,weight,0,0
173613,loss,0,0
173614,thresholds,0,0
173615,in,0,0
173616,the,0,0
173617,first,0,0
173618,2,0,0
173619,months,0,0
173620,of,0,0
173621,treatment,0,0
173622,for,0,0
173623,predicting,0,0
173624,1-year,0,0
173625,outcomes,0,0
173626,was,0,0
173627,examined,0,0
173628,.,0,0
173629,METHODS,0,0
173630,Participants,1,1
173631,included,1,1
173632,2327,1,1
173633,adults,1,1
173634,with,1,1
173635,type,1,1
173636,2,1,0
173637,diabetes,1,1
173638,(,1,1
173639,BMI:35.8,1,0
173640,?,1,0
173641,6.0,1,0
173642,),1,0
173643,randomized,1,0
173644,to,0,0
173645,the,0,0
173646,intensive,0,0
173647,lifestyle,0,0
173648,intervention,0,0
173649,(,0,0
173650,ILI,0,0
173651,),0,0
173652,of,0,0
173653,the,0,0
173654,Look,0,1
173655,AHEAD,0,0
173656,trial,0,0
173657,.,0,0
173658,ILI,0,0
173659,included,0,1
173660,weekly,0,0
173661,behavioral,0,1
173662,sessions,0,0
173663,designed,0,0
173664,to,0,0
173665,increase,0,0
173666,physical,0,0
173667,activity,0,0
173668,and,0,0
173669,reduce,0,0
173670,caloric,0,0
173671,intake,0,0
173672,.,0,0
173673,1-month,0,0
173674,",",0,0
173675,2-month,0,0
173676,",",0,0
173677,and,0,0
173678,1-year,0,0
173679,weight,0,0
173680,changes,0,0
173681,were,0,0
173682,calculated,0,0
173683,.,0,0
173684,RESULTS,0,0
173685,Participants,0,1
173686,failing,0,1
173687,to,0,0
173688,achieve,0,0
173689,a,0,0
173690,?2,0,0
173691,%,0,0
173692,weight,0,0
173693,loss,0,0
173694,at,0,0
173695,Month,0,0
173696,1,0,0
173697,were,0,0
173698,5.6,0,0
173699,(,0,0
173700,95,0,0
173701,%,0,0
173702,CI:4.5,0,0
173703,",",0,0
173704,7.0,0,0
173705,),0,0
173706,times,0,0
173707,more,0,0
173708,likely,0,0
173709,to,0,0
173710,also,0,0
173711,not,0,0
173712,achieve,0,0
173713,a,0,0
173714,?10,0,0
173715,%,0,0
173716,weight,0,0
173717,loss,0,0
173718,at,0,0
173719,Year,0,1
173720,1,0,0
173721,",",0,0
173722,compared,0,0
173723,to,0,0
173724,those,0,0
173725,losing,0,0
173726,?2,0,0
173727,%,0,0
173728,initially,0,0
173729,.,0,0
173730,These,0,0
173731,odds,0,0
173732,were,0,0
173733,increased,0,0
173734,to,0,0
173735,11.6,0,0
173736,(,0,0
173737,95,0,0
173738,%,0,0
173739,CI:8.6,0,0
173740,",",0,0
173741,15.6,0,0
173742,),0,0
173743,when,0,0
173744,using,0,0
173745,a,0,0
173746,3,0,0
173747,%,0,0
173748,weight,0,0
173749,loss,0,0
173750,threshold,0,0
173751,at,0,0
173752,Month,0,0
173753,2,0,0
173754,.,0,0
173755,Only,0,0
173756,15.2,0,0
173757,%,0,0
173758,and,0,0
173759,8.2,0,0
173760,%,0,0
173761,of,0,0
173762,individuals,0,1
173763,failing,0,1
173764,to,0,0
173765,achieve,0,0
173766,the,0,0
173767,?2,0,0
173768,%,0,0
173769,and,0,0
173770,?3,0,0
173771,%,0,0
173772,thresholds,0,0
173773,at,0,0
173774,Months,0,0
173775,1,0,0
173776,and,0,0
173777,2,0,0
173778,",",0,0
173779,respectively,0,0
173780,",",0,0
173781,go,0,0
173782,on,0,0
173783,to,0,0
173784,achieve,0,0
173785,a,0,0
173786,?10,0,0
173787,%,0,0
173788,weight,0,0
173789,loss,0,0
173790,at,0,0
173791,Year,0,1
173792,1,0,0
173793,.,0,0
173794,CONCLUSIONS,0,0
173795,Given,0,0
173796,the,0,0
173797,association,0,0
173798,between,0,0
173799,initial,0,0
173800,and,0,0
173801,1-year,0,0
173802,weight,0,0
173803,loss,0,0
173804,",",0,0
173805,the,0,0
173806,first,0,0
173807,few,0,0
173808,months,0,0
173809,of,0,0
173810,treatment,0,0
173811,may,0,0
173812,be,0,0
173813,an,0,0
173814,opportune,0,0
173815,time,0,0
173816,to,0,0
173817,identify,0,0
173818,those,0,1
173819,who,0,0
173820,are,0,0
173821,unsuccessful,0,1
173822,and,0,0
173823,utilize,0,0
173824,rescue,0,0
173825,efforts,0,0
173826,.,0,1
173827,TRIAL,0,0
173828,REGISTRATION,0,0
173829,clinicaltrials.gov,0,0
173830,Identifier,0,0
173831,:,0,1
173832,NCT00017953,0,0
173833,.,0,0
173834,Hysteroscopic,0,1
173835,morcellation,0,0
173836,compared,0,0
173837,with,0,0
173838,electrical,0,0
173839,resection,0,1
173840,of,0,0
173841,endometrial,0,1
173842,polyps,0,1
173843,:,0,1
173844,a,0,0
173845,randomized,0,0
173846,controlled,0,0
173847,trial,0,0
173848,.,0,0
173849,OBJECTIVE,0,0
173850,To,0,0
173851,evaluate,0,0
173852,whether,0,0
173853,hysteroscopic,0,0
173854,morcellation,0,0
173855,or,0,0
173856,bipolar,0,0
173857,electrosurgical,0,0
173858,resection,0,0
173859,is,0,0
173860,more,0,0
173861,favorable,0,0
173862,for,0,0
173863,removing,0,0
173864,endometrial,1,1
173865,polyps,1,1
173866,in,0,0
173867,an,0,0
173868,office,0,1
173869,setting,0,0
173870,in,0,0
173871,terms,0,0
173872,of,0,0
173873,feasibility,0,0
173874,",",0,0
173875,speed,0,0
173876,",",0,0
173877,pain,0,0
173878,",",0,0
173879,and,0,0
173880,acceptability,0,0
173881,.,0,0
173882,METHODS,0,0
173883,A,0,0
173884,multicenter,0,0
173885,",",0,0
173886,single-blind,0,0
173887,",",0,0
173888,randomized,0,0
173889,",",0,0
173890,controlled,0,0
173891,trial,0,0
173892,of,0,0
173893,office,0,1
173894,hysteroscopic,0,1
173895,morcellation,0,0
173896,compared,0,0
173897,with,0,0
173898,electrosurgical,0,0
173899,resection,0,1
173900,was,0,0
173901,conducted,0,0
173902,.,0,0
173903,A,0,0
173904,total,0,0
173905,of,0,0
173906,121,1,1
173907,women,1,1
173908,were,1,0
173909,randomly,1,1
173910,allocated,1,0
173911,to,1,0
173912,polyp,1,0
173913,removal,1,0
173914,by,0,0
173915,one,0,0
173916,of,0,0
173917,the,0,0
173918,two,0,0
173919,methods,0,0
173920,in,0,0
173921,an,0,0
173922,office,0,1
173923,setting,0,0
173924,.,0,0
173925,The,0,0
173926,outcomes,0,0
173927,assessed,0,0
173928,were,0,0
173929,time,0,0
173930,taken,0,0
173931,to,0,0
173932,complete,0,0
173933,the,0,0
173934,endometrial,0,0
173935,polypectomy,0,0
173936,",",0,0
173937,defined,0,0
173938,as,0,0
173939,the,0,0
173940,time,0,0
173941,from,0,0
173942,insertion,0,0
173943,to,0,0
173944,removal,0,0
173945,of,0,0
173946,vaginal,0,0
173947,instrumentation,0,0
173948,",",0,0
173949,completeness,0,0
173950,of,0,0
173951,polyp,0,0
173952,removal,0,0
173953,",",0,0
173954,acceptability,0,0
173955,",",0,0
173956,and,0,0
173957,pain,0,0
173958,measured,0,0
173959,on,0,0
173960,a,0,0
173961,100-mm,0,0
173962,visual,0,0
173963,analog,0,0
173964,scale,0,0
173965,.,0,0
173966,RESULTS,0,0
173967,The,0,0
173968,median,0,0
173969,time,0,0
173970,taken,0,0
173971,to,0,0
173972,complete,0,0
173973,the,0,0
173974,procedure,0,0
173975,was,0,0
173976,5,0,0
173977,minutes,0,0
173978,and,0,0
173979,28,0,1
173980,seconds,0,0
173981,for,0,0
173982,morcellation,0,0
173983,compared,0,0
173984,with,0,1
173985,10,0,0
173986,minutes,0,0
173987,and,0,0
173988,12,0,1
173989,seconds,0,0
173990,for,0,0
173991,electrosurgical,0,0
173992,resection,0,1
173993,(,0,0
173994,P,0,0
173995,<,0,0
173996,.001,0,0
173997,),0,0
173998,.,0,0
173999,The,0,0
174000,polyps,0,0
174001,were,0,0
174002,completely,0,0
174003,removed,0,0
174004,in,0,0
174005,61,0,1
174006,out,0,0
174007,of,0,0
174008,62,0,1
174009,(,0,0
174010,98,0,1
174011,%,0,0
174012,),0,0
174013,women,0,1
174014,assigned,0,1
174015,to,0,0
174016,morcellation,0,0
174017,compared,0,0
174018,with,0,0
174019,49,0,1
174020,out,0,0
174021,of,0,0
174022,59,0,1
174023,(,0,0
174024,83,0,1
174025,%,0,0
174026,),0,0
174027,women,0,1
174028,treated,0,1
174029,with,0,1
174030,electrosurgical,0,0
174031,resection,0,1
174032,(,0,0
174033,odds,0,0
174034,ratio,0,0
174035,12.5,0,0
174036,;,0,0
174037,95,0,0
174038,%,0,0
174039,confidence,0,0
174040,interval,0,0
174041,[,0,0
174042,CI,0,0
174043,],0,1
174044,1.5-100.6,0,0
174045,;,0,0
174046,P=.02,0,0
174047,),0,0
174048,.,0,0
174049,The,0,0
174050,mean,0,0
174051,pain,0,0
174052,scores,0,0
174053,during,0,0
174054,the,0,0
174055,procedure,0,0
174056,favored,0,0
174057,morcellation,0,0
174058,by,0,0
174059,16.1,0,0
174060,points,0,0
174061,on,0,0
174062,average,0,0
174063,(,0,0
174064,35.9,0,0
174065,compared,0,0
174066,with,0,1
174067,52.0,0,0
174068,;,0,0
174069,95,0,0
174070,%,0,0
174071,CI,0,0
174072,for,0,0
174073,difference,0,0
174074,",",0,0
174075,-24.7,0,0
174076,to,0,0
174077,-7.6,0,0
174078,;,0,0
174079,P,0,0
174080,<,0,0
174081,.001,0,0
174082,),0,0
174083,.,0,0
174084,Overall,0,0
174085,",",0,0
174086,99,0,1
174087,%,0,0
174088,of,0,0
174089,women,0,1
174090,found,0,0
174091,office,0,1
174092,polypectomy,0,0
174093,to,0,0
174094,be,0,0
174095,acceptable,0,0
174096,",",0,0
174097,with,0,0
174098,only,0,0
174099,one,0,0
174100,woman,0,1
174101,in,0,0
174102,the,0,0
174103,electrosurgical,0,0
174104,resection,0,0
174105,group,0,0
174106,considering,0,0
174107,the,0,0
174108,procedure,0,0
174109,unacceptable,0,0
174110,.,0,0
174111,CONCLUSION,0,0
174112,In,0,0
174113,comparison,0,0
174114,to,0,0
174115,electrosurgical,0,0
174116,resection,0,0
174117,during,0,0
174118,hysteroscopic,0,0
174119,polypectomy,0,0
174120,",",0,0
174121,morcellation,0,0
174122,was,0,0
174123,significantly,0,0
174124,quicker,0,0
174125,",",0,0
174126,less,0,0
174127,painful,0,0
174128,",",0,0
174129,more,0,0
174130,acceptable,0,0
174131,to,0,0
174132,women,0,1
174133,",",0,0
174134,and,0,0
174135,more,0,0
174136,likely,0,0
174137,to,0,0
174138,completely,0,0
174139,remove,0,0
174140,endometrial,0,1
174141,polyps,0,1
174142,compared,0,0
174143,with,0,1
174144,electrosurgical,0,0
174145,resection,0,1
174146,.,0,0
174147,CLINICAL,0,0
174148,TRIAL,0,0
174149,REGISTRATION,0,0
174150,ClinicalTrials.gov,0,0
174151,",",0,0
174152,www.clinicaltrials.gov,0,0
174153,",",0,0
174154,NCT01509313,0,0
174155,.,0,0
174156,A,0,0
174157,trial,0,0
174158,of,0,0
174159,D-cycloserine,0,0
174160,to,0,0
174161,treat,0,0
174162,stereotypies,0,0
174163,in,0,0
174164,older,1,1
174165,adolescents,1,1
174166,and,1,0
174167,young,1,1
174168,adults,1,1
174169,with,1,1
174170,autism,1,1
174171,spectrum,1,1
174172,disorder,1,1
174173,.,1,0
174174,OBJECTIVES,0,0
174175,Autism,0,1
174176,spectrum,0,1
174177,disorders,0,1
174178,(,0,0
174179,ASDs,0,0
174180,),0,0
174181,have,0,0
174182,core,0,0
174183,impairments,0,0
174184,in,0,0
174185,social,0,0
174186,communication,0,0
174187,as,0,0
174188,well,0,0
174189,as,0,0
174190,the,0,0
174191,presence,0,0
174192,of,0,0
174193,repetitive,0,0
174194,",",0,0
174195,stereotypic,0,0
174196,behaviors,0,0
174197,and,0,0
174198,restricted,0,1
174199,interests,0,0
174200,.,0,1
174201,Older,0,0
174202,adolescents,0,1
174203,and,0,0
174204,young,0,1
174205,adults,0,1
174206,are,0,0
174207,particularly,0,0
174208,impacted,0,0
174209,by,0,0
174210,these,0,0
174211,deficits,0,0
174212,.,0,0
174213,Preclinical,0,0
174214,data,0,0
174215,implicate,0,0
174216,glutamatergic,0,0
174217,dysfunction,0,0
174218,in,0,0
174219,the,0,0
174220,pathophysiology,0,0
174221,of,0,0
174222,ASDs,0,0
174223,.,0,0
174224,D-Cycloserine,0,0
174225,(,0,0
174226,DCS,0,0
174227,),0,0
174228,",",0,0
174229,a,0,0
174230,partial,0,0
174231,glycineB,0,0
174232,agonist,0,0
174233,at,0,0
174234,the,0,0
174235,N-methyl-D-aspartic,0,0
174236,acid,0,0
174237,receptor,0,0
174238,site,0,0
174239,",",0,0
174240,has,0,0
174241,been,0,0
174242,shown,0,0
174243,to,0,0
174244,improve,0,0
174245,sociability,0,0
174246,in,0,0
174247,mouse,0,0
174248,models,0,0
174249,and,0,0
174250,a,0,0
174251,small,0,0
174252,human,0,0
174253,study,0,0
174254,.,0,0
174255,The,0,0
174256,sensitivity,0,0
174257,of,0,0
174258,the,0,0
174259,obligatory,0,0
174260,glycineB,0,0
174261,co-agonist,0,0
174262,binding,0,0
174263,site,0,0
174264,may,0,0
174265,change,0,0
174266,with,0,0
174267,daily,0,0
174268,administration,0,0
174269,of,0,0
174270,DCS,0,0
174271,as,0,0
174272,a,0,0
174273,result,0,0
174274,of,0,0
174275,agonist-induced,0,0
174276,desensitization,0,0
174277,.,0,0
174278,The,0,0
174279,efficacy,0,0
174280,of,0,0
174281,a,0,0
174282,pulsed,0,0
174283,once-weekly,0,0
174284,administration,0,0
174285,versus,0,0
174286,daily,0,0
174287,administration,0,0
174288,of,0,0
174289,DCS,0,0
174290,was,0,0
174291,compared,0,0
174292,.,0,0
174293,METHODS,0,0
174294,Males,1,0
174295,and,1,0
174296,females,1,1
174297,",",1,0
174298,ages,1,1
174299,14,1,0
174300,to,1,0
174301,25,1,0
174302,years,1,1
174303,",",1,0
174304,with,1,1
174305,a,1,0
174306,Diagnostic,1,0
174307,and,1,0
174308,Statistical,1,0
174309,Manual,1,0
174310,of,1,0
174311,Mental,1,0
174312,Disorders,1,1
174313,",",1,0
174314,Fourth,1,0
174315,Edition,1,0
174316,Text,1,0
174317,Revision,1,0
174318,diagnosis,1,1
174319,of,1,0
174320,an,1,0
174321,ASD,1,1
174322,were,1,0
174323,enrolled,1,1
174324,in,0,0
174325,a,0,0
174326,double-blind,0,0
174327,",",0,0
174328,randomized,0,0
174329,10-week,0,0
174330,trial,0,0
174331,consisting,0,0
174332,of,0,0
174333,8,0,0
174334,weeks,0,0
174335,of,0,0
174336,active,0,1
174337,drug,0,0
174338,with,0,1
174339,either,0,0
174340,weekly,0,0
174341,or,0,0
174342,daily,0,0
174343,administration,0,0
174344,of,0,0
174345,50,0,0
174346,mg,0,0
174347,of,0,0
174348,DCS,0,0
174349,followed,0,0
174350,by,0,0
174351,a,0,0
174352,2-week,0,0
174353,follow-up,0,0
174354,visit,0,0
174355,.,0,0
174356,RESULTS,0,0
174357,For,0,0
174358,the,0,0
174359,purposes,0,0
174360,of,0,0
174361,this,0,0
174362,study,0,0
174363,",",0,0
174364,no,0,0
174365,statistical,0,0
174366,or,0,0
174367,clinical,0,0
174368,differences,0,0
174369,existed,0,0
174370,between,0,0
174371,the,0,0
174372,2,0,0
174373,dosage,0,0
174374,groups,0,0
174375,on,0,0
174376,the,0,0
174377,Aberrant,0,0
174378,Behavior,0,0
174379,Checklist,0,0
174380,subscale,0,0
174381,3,0,0
174382,",",0,0
174383,which,0,0
174384,measures,0,0
174385,stereotypies/repetitive,0,0
174386,movements,0,0
174387,.,0,0
174388,When,0,0
174389,combining,0,0
174390,groups,0,0
174391,",",0,0
174392,a,0,0
174393,statistically,0,0
174394,significant,0,0
174395,decrease,0,0
174396,of,0,0
174397,37,0,1
174398,%,0,0
174399,was,0,0
174400,found,0,0
174401,from,0,0
174402,baseline,0,0
174403,to,0,0
174404,week,0,0
174405,8,0,0
174406,when,0,0
174407,study,0,0
174408,drug,0,0
174409,was,0,0
174410,completed,0,0
174411,using,0,0
174412,a,0,0
174413,linear,0,0
174414,mixed,0,0
174415,effects,0,0
174416,model,0,0
174417,(,0,0
174418,P,0,0
174419,=,0,0
174420,0.003,0,0
174421,),0,0
174422,.,0,0
174423,CONCLUSIONS,0,0
174424,D-Cycloserine,0,0
174425,was,0,0
174426,shown,0,0
174427,to,0,0
174428,be,0,0
174429,effective,0,0
174430,in,0,0
174431,improving,0,0
174432,stereotypic,0,1
174433,symptoms,0,0
174434,in,0,0
174435,older,0,1
174436,adolescents,0,1
174437,and,0,0
174438,young,0,1
174439,adults,0,1
174440,with,0,1
174441,ASDs,0,0
174442,measured,0,0
174443,by,0,0
174444,the,0,0
174445,Aberrant,0,0
174446,Behavior,0,0
174447,Checklist,0,0
174448,subscale,0,0
174449,3,0,0
174450,.,0,0
174451,In,0,0
174452,addition,0,0
174453,",",0,0
174454,DCS,0,0
174455,was,0,0
174456,safe,0,0
174457,and,0,0
174458,well,0,0
174459,tolerated,0,0
174460,.,0,0
174461,Changes,0,0
174462,in,0,0
174463,spinal,0,1
174464,inhibitory,0,0
174465,networks,0,0
174466,induced,0,0
174467,by,0,0
174468,furosemide,0,0
174469,in,0,0
174470,humans,0,0
174471,.,0,1
174472,During,0,0
174473,neural,0,0
174474,development,0,0
174475,in,0,0
174476,animals,0,0
174477,",",0,0
174478,GABAergic,0,0
174479,and,0,0
174480,glycinergic,0,0
174481,neurons,0,1
174482,are,0,0
174483,first,0,0
174484,excitatory,0,0
174485,",",0,0
174486,and,0,0
174487,then,0,0
174488,become,0,0
174489,inhibitory,0,0
174490,in,0,0
174491,the,0,0
174492,mature,0,0
174493,state,0,0
174494,.,0,0
174495,This,0,0
174496,developmental,0,0
174497,shift,0,0
174498,is,0,0
174499,due,0,0
174500,mainly,0,0
174501,to,0,0
174502,strong,0,0
174503,expression,0,0
174504,of,0,0
174505,the,0,0
174506,cation-chloride,0,0
174507,K-Cl,0,0
174508,cotransporter,0,0
174509,2,0,0
174510,(,0,0
174511,KCC2,0,0
174512,),0,0
174513,and,0,0
174514,down-regulation,0,0
174515,of,0,0
174516,Na-K-Cl,0,0
174517,cotransporter,0,0
174518,1,0,0
174519,(,0,0
174520,NKCC1,0,0
174521,),0,0
174522,during,0,0
174523,maturation,0,0
174524,.,0,0
174525,The,0,0
174526,down-regulation,0,0
174527,of,0,0
174528,co-transporter,0,0
174529,KCC2,0,0
174530,after,0,0
174531,spinal,0,1
174532,cord,0,1
174533,transection,0,1
174534,in,0,0
174535,animals,0,0
174536,leads,0,0
174537,to,0,0
174538,the,0,0
174539,depolarising,0,0
174540,(,0,0
174541,excitatory,0,0
174542,),0,0
174543,action,0,0
174544,of,0,0
174545,GABA,0,0
174546,and,0,0
174547,glycine,0,0
174548,and,0,0
174549,thus,0,0
174550,results,0,0
174551,in,0,0
174552,a,0,0
174553,reduction,0,0
174554,of,0,0
174555,inhibitory,0,0
174556,synaptic,0,0
174557,efficiency,0,0
174558,.,0,0
174559,Furosemide,0,0
174560,",",0,0
174561,a,0,0
174562,loop,0,0
174563,diuretic,0,0
174564,",",0,0
174565,has,0,0
174566,been,0,0
174567,shown,0,0
174568,to,0,0
174569,selectively,0,0
174570,and,0,0
174571,reversibly,0,0
174572,block,0,0
174573,inhibitory,0,0
174574,postsynaptic,0,0
174575,potentials,0,0
174576,without,0,1
174577,affecting,0,0
174578,excitatory,0,0
174579,postsynaptic,0,0
174580,potentials,0,0
174581,in,0,0
174582,animal,0,1
174583,spinal,0,1
174584,neurons,0,1
174585,.,0,0
174586,Moreover,0,0
174587,",",0,0
174588,this,0,0
174589,diuretic,0,0
174590,has,0,0
174591,been,0,0
174592,also,0,0
174593,demonstrated,0,0
174594,to,0,0
174595,block,0,0
174596,the,0,0
174597,cation-chloride,0,0
174598,co-transporters,0,0
174599,.,0,0
174600,Here,0,0
174601,",",0,0
174602,we,0,0
174603,used,0,0
174604,furosemide,0,0
174605,to,0,0
174606,demonstrate,0,0
174607,changes,1,0
174608,in,1,0
174609,spinal,1,1
174610,inhibitory,1,0
174611,networks,1,0
174612,in,1,0
174613,healthy,1,1
174614,human,1,1
174615,subjects,1,1
174616,.,1,1
174617,Non-invasive,0,0
174618,electrophysiological,0,0
174619,techniques,0,0
174620,were,0,0
174621,used,0,0
174622,to,0,0
174623,assess,0,0
174624,presynaptic,0,0
174625,inhibition,0,0
174626,",",0,0
174627,postsynaptic,0,0
174628,inhibition,0,0
174629,and,0,0
174630,the,0,0
174631,efficacy,0,0
174632,of,0,0
174633,synaptic,0,0
174634,transmission,0,0
174635,between,0,0
174636,muscle,0,0
174637,afferent,0,0
174638,terminals,0,0
174639,and,0,0
174640,soleus,0,1
174641,motoneurons,0,0
174642,in,0,0
174643,the,0,0
174644,spinal,0,0
174645,cord,0,0
174646,.,0,0
174647,Orally,0,0
174648,administered,0,0
174649,furosemide,0,0
174650,",",0,0
174651,at,0,0
174652,doses,0,0
174653,commonly,0,0
174654,used,0,0
174655,in,0,0
174656,the,0,0
174657,clinic,0,1
174658,(,0,0
174659,40,0,0
174660,mg,0,0
174661,),0,0
174662,",",0,0
174663,significantly,0,0
174664,reduced,0,0
174665,spinal,0,0
174666,inhibitory,0,0
174667,interneuronal,0,0
174668,activity,0,0
174669,for,0,0
174670,at,0,0
174671,least,0,0
174672,70,0,1
174673,min,0,0
174674,from,0,0
174675,intake,0,0
174676,compared,0,0
174677,to,0,0
174678,control,0,0
174679,experiments,0,0
174680,in,0,0
174681,the,0,0
174682,same,0,0
174683,subjects,0,1
174684,while,0,0
174685,no,0,0
174686,changes,0,0
174687,were,0,0
174688,observed,0,0
174689,in,0,0
174690,the,0,0
174691,efficacy,0,0
174692,of,0,0
174693,synaptic,0,0
174694,transmission,0,0
174695,between,0,0
174696,muscle,0,0
174697,afferent,0,0
174698,terminals,0,0
174699,and,0,0
174700,soleus,0,1
174701,motoneurons,0,1
174702,.,0,0
174703,The,0,0
174704,reduction,0,0
174705,of,0,0
174706,inhibition,0,0
174707,was,0,0
174708,dose-dependent,0,0
174709,.,0,0
174710,Our,0,0
174711,results,0,0
174712,provide,0,0
174713,indirect,0,0
174714,evidence,0,0
174715,that,0,0
174716,reversible,0,0
174717,changes,0,0
174718,in,0,0
174719,the,0,0
174720,cation-chloride,0,0
174721,transport,0,0
174722,system,0,0
174723,induce,0,0
174724,modulations,0,0
174725,of,0,0
174726,inhibitory,0,0
174727,neuronal,0,0
174728,activity,0,0
174729,at,0,0
174730,spinal,0,0
174731,cord,0,1
174732,level,0,0
174733,in,0,0
174734,humans,0,0
174735,.,0,1
174736,Communication,0,0
174737,interventions,0,0
174738,for,0,0
174739,minimally,1,1
174740,verbal,1,0
174741,children,1,1
174742,with,1,1
174743,autism,1,1
174744,:,1,1
174745,a,0,0
174746,sequential,0,0
174747,multiple,0,0
174748,assignment,0,0
174749,randomized,0,0
174750,trial,0,0
174751,.,0,0
174752,OBJECTIVE,0,0
174753,This,0,0
174754,study,0,0
174755,tested,0,0
174756,the,0,0
174757,effect,0,0
174758,of,0,0
174759,beginning,0,0
174760,treatment,0,0
174761,with,0,1
174762,a,0,0
174763,speech-generating,0,0
174764,device,0,0
174765,(,0,0
174766,SGD,0,0
174767,),0,0
174768,in,0,0
174769,the,0,0
174770,context,0,0
174771,of,0,0
174772,a,0,0
174773,blended,0,0
174774,",",0,0
174775,adaptive,0,0
174776,treatment,0,0
174777,design,0,0
174778,for,0,0
174779,improving,0,0
174780,spontaneous,0,0
174781,",",0,0
174782,communicative,0,0
174783,utterances,0,0
174784,in,0,0
174785,school-aged,1,1
174786,",",1,0
174787,minimally,1,0
174788,verbal,1,0
174789,children,1,1
174790,with,1,1
174791,autism,1,1
174792,.,1,0
174793,METHOD,0,0
174794,A,1,0
174795,total,1,1
174796,of,1,0
174797,61,1,1
174798,minimally,1,1
174799,verbal,1,0
174800,children,1,1
174801,with,1,1
174802,autism,1,1
174803,",",1,0
174804,aged,1,1
174805,5,1,0
174806,to,1,0
174807,8,1,0
174808,years,1,1
174809,",",0,0
174810,were,0,0
174811,randomized,0,0
174812,to,0,0
174813,a,0,0
174814,blended,0,0
174815,developmental/behavioral,0,0
174816,intervention,0,0
174817,(,0,0
174818,JASP+EMT,0,0
174819,),0,0
174820,with,0,0
174821,or,0,0
174822,without,0,0
174823,the,0,0
174824,augmentation,0,0
174825,of,0,0
174826,a,0,0
174827,SGD,0,0
174828,for,0,0
174829,6,0,0
174830,months,0,0
174831,with,0,1
174832,a,0,0
174833,3-month,0,0
174834,follow-up,0,0
174835,.,0,0
174836,The,0,0
174837,intervention,0,0
174838,consisted,0,0
174839,of,0,0
174840,2,0,0
174841,stages,0,1
174842,.,0,0
174843,In,0,0
174844,stage,0,1
174845,1,0,0
174846,",",0,0
174847,all,0,0
174848,children,0,1
174849,received,0,0
174850,2,0,0
174851,sessions,0,0
174852,per,0,0
174853,week,0,0
174854,for,0,0
174855,3,0,0
174856,months,0,0
174857,.,0,1
174858,Stage,0,0
174859,2,0,0
174860,intervention,0,0
174861,was,0,0
174862,adapted,0,0
174863,(,0,0
174864,by,0,0
174865,increased,0,0
174866,sessions,0,0
174867,or,0,0
174868,adding,0,0
174869,the,0,0
174870,SGD,0,0
174871,),0,0
174872,based,0,0
174873,on,0,0
174874,the,0,0
174875,child,0,0
174876,'s,0,0
174877,early,0,0
174878,response,0,0
174879,.,0,0
174880,The,0,0
174881,primary,0,0
174882,outcome,0,0
174883,was,0,0
174884,the,0,0
174885,total,0,0
174886,number,0,0
174887,of,0,0
174888,spontaneous,0,0
174889,communicative,0,1
174890,utterances,0,1
174891,;,0,0
174892,secondary,0,0
174893,measures,0,0
174894,were,0,0
174895,the,0,0
174896,total,0,0
174897,number,0,0
174898,of,0,0
174899,novel,0,0
174900,words,0,0
174901,and,0,0
174902,total,0,1
174903,comments,0,0
174904,from,0,0
174905,a,0,0
174906,natural,0,0
174907,language,0,0
174908,sample,0,1
174909,.,0,0
174910,RESULTS,0,0
174911,Primary,0,0
174912,aim,0,0
174913,results,0,0
174914,found,0,0
174915,improvements,0,0
174916,in,0,0
174917,spontaneous,0,0
174918,communicative,0,0
174919,utterances,0,0
174920,",",0,0
174921,novel,0,0
174922,words,0,0
174923,",",0,0
174924,and,0,0
174925,comments,0,0
174926,that,0,0
174927,all,0,0
174928,favored,0,0
174929,the,0,0
174930,blended,0,0
174931,behavioral,0,0
174932,intervention,0,0
174933,that,0,0
174934,began,0,0
174935,by,0,0
174936,including,0,0
174937,an,0,0
174938,SGD,0,0
174939,(,0,0
174940,JASP+EMT+SGD,0,0
174941,),0,0
174942,as,0,0
174943,opposed,0,0
174944,to,0,0
174945,spoken,0,0
174946,words,0,0
174947,alone,0,0
174948,(,0,0
174949,JASP+EMT,0,0
174950,),0,0
174951,.,0,0
174952,Secondary,0,0
174953,aim,0,0
174954,results,0,0
174955,suggest,0,0
174956,that,0,0
174957,the,0,0
174958,adaptive,0,0
174959,intervention,0,0
174960,beginning,0,0
174961,with,0,1
174962,JASP+EMT+SGD,0,0
174963,and,0,0
174964,intensifying,0,0
174965,JASP+EMT+SGD,0,0
174966,for,0,1
174967,children,0,1
174968,who,0,1
174969,were,0,1
174970,slow,0,1
174971,responders,0,0
174972,led,0,0
174973,to,0,0
174974,better,0,0
174975,posttreatment,0,0
174976,outcomes,0,0
174977,.,0,1
174978,CONCLUSION,0,0
174979,Minimally,1,0
174980,verbal,1,0
174981,school-aged,1,1
174982,children,1,1
174983,can,0,0
174984,make,0,0
174985,significant,0,0
174986,and,0,0
174987,rapid,0,0
174988,gains,0,0
174989,in,0,0
174990,spoken,0,0
174991,spontaneous,0,0
174992,language,0,0
174993,with,0,0
174994,a,0,0
174995,novel,0,0
174996,",",0,0
174997,blended,0,0
174998,intervention,0,0
174999,that,0,0
175000,focuses,0,0
175001,on,0,0
175002,joint,0,0
175003,engagement,0,0
175004,and,0,0
175005,play,0,0
175006,skills,0,0
175007,and,0,0
175008,incorporates,0,0
175009,an,0,0
175010,SGD,0,0
175011,.,0,0
175012,Future,0,0
175013,studies,0,0
175014,should,0,0
175015,further,0,0
175016,explore,0,0
175017,the,0,0
175018,tailoring,0,0
175019,design,0,0
175020,used,0,0
175021,in,0,0
175022,this,0,0
175023,study,0,0
175024,to,0,0
175025,better,0,0
175026,understand,0,0
175027,children,0,1
175028,'s,0,0
175029,response,0,0
175030,to,0,0
175031,treatment,0,0
175032,.,0,0
175033,Clinical,0,0
175034,trial,0,0
175035,registration,0,0
175036,information-Developmental,0,0
175037,and,0,0
175038,Augmented,0,0
175039,Intervention,0,0
175040,for,0,0
175041,Facilitating,0,0
175042,Expressive,0,0
175043,Language,0,0
175044,(,0,0
175045,CCNIA,0,0
175046,),0,0
175047,;,0,0
175048,http,0,0
175049,:,0,1
175050,//clinicaltrials.gov/,0,0
175051,;,0,0
175052,NCT01013545,0,0
175053,.,0,0
175054,A,0,0
175055,randomized,0,0
175056,clinical,0,0
175057,trial,0,0
175058,comparison,0,0
175059,between,0,0
175060,pivotal,0,0
175061,response,0,0
175062,treatment,0,0
175063,(,0,0
175064,PRT,0,0
175065,),0,0
175066,and,0,0
175067,structured,0,0
175068,applied,0,0
175069,behavior,0,0
175070,analysis,0,0
175071,(,0,0
175072,ABA,0,0
175073,),0,0
175074,intervention,0,0
175075,for,0,0
175076,children,1,1
175077,with,1,1
175078,autism,1,1
175079,.,1,0
175080,Accumulating,0,0
175081,studies,0,0
175082,are,0,0
175083,documenting,0,0
175084,specific,0,0
175085,motivational,0,0
175086,variables,0,0
175087,that,0,0
175088,",",0,0
175089,when,0,0
175090,combined,0,0
175091,into,0,0
175092,a,0,0
175093,naturalistic,0,0
175094,teaching,0,0
175095,paradigm,0,0
175096,",",0,0
175097,can,0,0
175098,positively,0,0
175099,influence,0,0
175100,the,0,0
175101,effectiveness,0,0
175102,of,0,0
175103,interventions,0,0
175104,for,0,0
175105,children,1,1
175106,with,1,1
175107,autism,1,1
175108,spectrum,1,1
175109,disorder,1,1
175110,(,1,0
175111,ASD,1,1
175112,),1,0
175113,.,1,0
175114,The,0,0
175115,purpose,0,0
175116,of,0,0
175117,this,0,0
175118,study,0,0
175119,was,0,0
175120,to,0,0
175121,compare,0,0
175122,two,0,0
175123,applied,0,0
175124,behavior,0,0
175125,analysis,0,0
175126,(,0,0
175127,ABA,0,0
175128,),0,0
175129,intervention,0,0
175130,procedures,0,0
175131,",",0,0
175132,a,0,0
175133,naturalistic,0,0
175134,approach,0,0
175135,",",0,0
175136,pivotal,0,0
175137,response,0,0
175138,treatment,0,0
175139,(,0,0
175140,PRT,0,0
175141,),0,0
175142,with,0,0
175143,a,0,0
175144,structured,0,0
175145,ABA,0,0
175146,approach,0,0
175147,in,0,0
175148,a,0,0
175149,school,0,1
175150,setting,0,0
175151,.,0,0
175152,A,0,0
175153,randomized,0,0
175154,clinical,0,0
175155,trial,0,0
175156,design,0,0
175157,using,0,0
175158,two,1,0
175159,groups,1,0
175160,of,1,0
175161,children,1,1
175162,",",1,0
175163,matched,1,1
175164,according,1,0
175165,to,1,0
175166,age,1,1
175167,",",1,0
175168,sex,1,0
175169,and,1,0
175170,mean,1,0
175171,length,1,0
175172,of,1,0
175173,utterance,1,0
175174,was,0,0
175175,used,0,0
175176,to,0,0
175177,compare,0,0
175178,the,0,0
175179,interventions,0,0
175180,.,0,0
175181,The,0,0
175182,data,0,0
175183,showed,0,0
175184,that,0,0
175185,the,0,0
175186,PRT,0,0
175187,approach,0,0
175188,was,0,0
175189,significantly,0,0
175190,more,0,0
175191,effective,0,0
175192,in,0,0
175193,improving,0,0
175194,targeted,0,0
175195,and,0,0
175196,untargeted,0,0
175197,areas,0,0
175198,after,0,0
175199,3,0,0
175200,months,0,0
175201,of,0,0
175202,intervention,0,0
175203,.,0,0
175204,The,0,0
175205,results,0,0
175206,are,0,0
175207,discussed,0,0
175208,in,0,0
175209,terms,0,0
175210,of,0,0
175211,variables,0,0
175212,that,0,0
175213,produce,0,0
175214,more,0,0
175215,rapid,0,0
175216,improvements,0,0
175217,in,0,0
175218,communication,0,0
175219,for,0,0
175220,children,0,1
175221,with,0,1
175222,ASD,0,1
175223,.,0,1
175224,Causes,0,0
175225,of,0,0
175226,variation,0,0
175227,in,0,0
175228,BCG,0,0
175229,vaccine,0,1
175230,efficacy,0,0
175231,:,0,0
175232,examining,0,0
175233,evidence,0,0
175234,from,0,0
175235,the,0,0
175236,BCG,0,0
175237,REVAC,0,0
175238,cluster,0,0
175239,randomized,0,0
175240,trial,0,0
175241,to,0,0
175242,explore,0,0
175243,the,0,0
175244,masking,0,0
175245,and,0,0
175246,the,0,0
175247,blocking,0,0
175248,hypotheses,0,0
175249,.,0,0
175250,BCG,0,0
175251,protection,0,0
175252,varies,0,0
175253,and,0,0
175254,in,0,0
175255,some,0,0
175256,places,0,0
175257,(,0,0
175258,nearest,0,0
175259,the,0,0
175260,equator,0,0
175261,),0,0
175262,is,0,0
175263,low,0,0
175264,or,0,0
175265,absent,0,0
175266,.,0,0
175267,Understanding,0,0
175268,this,0,0
175269,variation,0,0
175270,can,0,0
175271,inform,0,0
175272,the,0,0
175273,efforts,0,0
175274,to,0,0
175275,develop,0,0
175276,new,0,0
175277,vaccines,0,0
175278,against,0,0
175279,tuberculosis,0,1
175280,.,0,0
175281,Two,0,0
175282,main,0,0
175283,hypotheses,0,0
175284,are,0,0
175285,used,0,0
175286,to,0,0
175287,explain,0,0
175288,this,0,0
175289,variation,0,0
175290,:,0,0
175291,under,0,0
175292,masking,0,0
175293,",",0,0
175294,new,0,0
175295,vaccines,0,0
175296,are,0,0
175297,unlikely,0,0
175298,to,0,0
175299,increase,0,0
175300,protection,0,0
175301,;,0,0
175302,under,0,0
175303,blocking,0,0
175304,new,0,0
175305,vaccines,0,0
175306,have,0,0
175307,a,0,0
175308,greater,0,0
175309,potential,0,0
175310,to,0,0
175311,be,0,0
175312,effective,0,0
175313,when,0,0
175314,BCG,0,0
175315,is,0,0
175316,not,0,0
175317,.,0,0
175318,We,0,0
175319,conducted,0,0
175320,a,0,0
175321,cluster,0,0
175322,randomized,0,0
175323,trial,0,0
175324,to,0,0
175325,explored,0,0
175326,the,0,0
175327,masking,0,0
175328,and,0,0
175329,blocking,0,0
175330,hypotheses,0,0
175331,by,0,0
175332,studying,0,0
175333,BCG,0,0
175334,vaccine,0,0
175335,efficacy,0,0
175336,of,0,0
175337,neonatal,0,0
175338,vaccination,0,1
175339,and,0,0
175340,when,0,0
175341,administered,0,0
175342,for,0,0
175343,the,0,0
175344,first,0,0
175345,or,0,0
175346,a,0,0
175347,second,0,0
175348,(,0,0
175349,revaccination,0,1
175350,),0,0
175351,time,0,0
175352,at,0,0
175353,school,1,1
175354,age,1,1
175355,in,1,0
175356,two,1,0
175357,sites,1,1
175358,(,1,0
175359,Manaus,1,1
175360,close,1,0
175361,and,1,0
175362,Salvador,1,1
175363,further,1,0
175364,south,1,1
175365,from,1,0
175366,the,1,0
175367,equator,1,0
175368,),1,0
175369,.,1,0
175370,Seven,1,0
175371,hundred,1,1
175372,and,1,0
175373,sixty,1,1
175374,three,1,0
175375,state,1,1
175376,schools,1,1
175377,were,1,0
175378,matched,1,1
175379,on,1,0
175380,socio,1,1
175381,economic,1,0
175382,characteristics,1,0
175383,of,1,0
175384,the,1,0
175385,neighborhood,1,0
175386,and,1,0
175387,"239,934",1,1
175388,children,1,1
175389,were,1,0
175390,randomized,1,0
175391,to,0,0
175392,vaccine,0,0
175393,(,0,0
175394,BCG,0,0
175395,vaccination,0,1
175396,at,0,0
175397,school,0,1
175398,age,0,1
175399,),0,0
175400,or,0,0
175401,control,0,0
175402,group,0,0
175403,.,0,0
175404,Protection,0,0
175405,by,0,0
175406,first,0,0
175407,BCG,0,1
175408,vaccination,0,1
175409,at,0,0
175410,school,0,1
175411,age,0,1
175412,was,0,0
175413,high,0,0
175414,in,0,0
175415,Salvador,1,1
175416,(,0,0
175417,34,0,1
175418,%,0,0
175419,",",0,0
175420,95,0,0
175421,%,0,0
175422,CI,0,0
175423,7-53,0,0
175424,%,0,0
175425,",",0,0
175426,p=0.017,0,0
175427,),0,0
175428,but,0,0
175429,low,0,0
175430,in,0,0
175431,Manaus,1,1
175432,(,0,0
175433,8,0,0
175434,%,0,0
175435,",",0,0
175436,95,0,0
175437,%,0,0
175438,CI,0,0
175439,t0,0,0
175440,39-40,0,0
175441,%,0,0
175442,",",0,0
175443,p=0.686,0,0
175444,),0,0
175445,.,0,0
175446,For,0,0
175447,revaccination,0,0
175448,at,0,0
175449,school,0,1
175450,age,0,1
175451,",",0,0
175452,protection,0,0
175453,was,0,0
175454,modest,0,0
175455,in,0,0
175456,Salvador,0,1
175457,(,0,0
175458,19,0,1
175459,%,0,0
175460,",",0,0
175461,95,0,0
175462,%,0,0
175463,CI,0,0
175464,3-33,0,0
175465,%,0,0
175466,",",0,0
175467,p=0.022,0,0
175468,),0,0
175469,and,0,0
175470,absent,0,0
175471,in,0,0
175472,Manaus,0,1
175473,(,0,0
175474,1,0,0
175475,%,0,0
175476,",",0,0
175477,95,0,0
175478,%,0,0
175479,CI,0,0
175480,to,0,0
175481,27-23,0,1
175482,%,0,0
175483,",",0,0
175484,p=0.932,0,0
175485,),0,0
175486,.,0,0
175487,Vaccine,0,0
175488,efficacy,0,0
175489,for,0,0
175490,neonatal,0,0
175491,vaccination,0,1
175492,was,0,0
175493,similar,0,0
175494,in,0,0
175495,Salvador,0,1
175496,(,0,0
175497,40,0,0
175498,%,0,0
175499,",",0,0
175500,95,0,0
175501,%,0,0
175502,CI,0,0
175503,22-54,0,0
175504,%,0,0
175505,",",0,0
175506,p,0,0
175507,<,0,0
175508,0.001,0,0
175509,),0,0
175510,and,0,0
175511,Manaus,0,1
175512,(,0,0
175513,36,0,0
175514,%,0,0
175515,",",0,0
175516,95,0,0
175517,%,0,0
175518,CI,0,0
175519,11-53,0,0
175520,%,0,0
175521,",",0,0
175522,p=0.008,0,0
175523,),0,0
175524,.,0,0
175525,Variation,0,0
175526,in,0,0
175527,BCG,0,0
175528,efficacy,0,0
175529,was,0,0
175530,marked,0,0
175531,when,0,0
175532,vaccine,0,0
175533,was,0,0
175534,given,0,0
175535,at,0,0
175536,school,0,1
175537,age,0,1
175538,but,0,0
175539,absent,0,0
175540,at,0,0
175541,birth,0,1
175542,",",0,0
175543,which,0,0
175544,points,0,0
175545,towards,0,0
175546,blocking,0,0
175547,as,0,0
175548,the,0,0
175549,dominant,0,0
175550,mechanism,0,0
175551,.,0,0
175552,New,0,1
175553,tuberculosis,0,1
175554,vaccines,0,0
175555,that,0,0
175556,overcome,0,0
175557,or,0,0
175558,by,0,0
175559,pass,0,0
175560,this,0,0
175561,blocking,0,0
175562,effect,0,0
175563,could,0,0
175564,confer,0,0
175565,protection,0,0
175566,in,0,0
175567,situations,0,0
175568,where,0,0
175569,BCG,0,0
175570,is,0,0
175571,not,0,0
175572,protective,0,0
175573,.,0,0
175574,The,0,0
175575,effect,0,0
175576,of,0,0
175577,arm,0,0
175578,support,0,0
175579,combined,0,0
175580,with,0,1
175581,rehabilitation,0,1
175582,games,0,0
175583,on,0,0
175584,upper-extremity,0,0
175585,function,0,0
175586,in,0,0
175587,subacute,1,1
175588,stroke,1,1
175589,:,1,1
175590,a,0,0
175591,randomized,0,0
175592,controlled,0,0
175593,trial,0,0
175594,.,0,0
175595,BACKGROUND,0,0
175596,Use,0,0
175597,of,0,0
175598,rehabilitation,0,1
175599,technology,0,0
175600,",",0,0
175601,such,0,0
175602,as,0,0
175603,(,0,0
175604,electro,0,0
175605,),0,0
175606,mechanical,0,0
175607,devices,0,0
175608,or,0,1
175609,robotics,0,0
175610,",",0,0
175611,could,0,0
175612,partly,0,0
175613,relieve,0,0
175614,the,0,0
175615,increasing,0,0
175616,strain,0,0
175617,on,0,0
175618,stroke,0,1
175619,rehabilitation,0,1
175620,caused,0,0
175621,by,0,0
175622,an,0,0
175623,increasing,0,0
175624,prevalence,0,0
175625,of,0,0
175626,stroke,0,1
175627,.,0,0
175628,Arm,0,0
175629,support,0,0
175630,(,0,0
175631,AS,0,0
175632,),0,0
175633,training,0,0
175634,showed,0,0
175635,improvement,0,0
175636,of,0,0
175637,unsupported,0,0
175638,arm,0,0
175639,function,0,0
175640,in,0,0
175641,chronic,0,1
175642,stroke,0,1
175643,.,0,0
175644,OBJECTIVE,0,0
175645,To,0,0
175646,examine,0,0
175647,the,0,0
175648,effect,0,0
175649,of,0,0
175650,weight-supported,0,0
175651,arm,0,0
175652,training,0,0
175653,combined,0,0
175654,with,0,1
175655,computerized,0,0
175656,exercises,0,0
175657,on,0,0
175658,arm,0,0
175659,function,0,0
175660,and,0,0
175661,capacity,0,0
175662,",",0,0
175663,compared,0,0
175664,with,0,0
175665,dose-matched,0,0
175666,conventional,0,0
175667,reach,0,0
175668,training,0,0
175669,in,0,0
175670,subacute,1,1
175671,stroke,1,1
175672,patients,1,1
175673,.,1,0
175674,METHODS,0,0
175675,In,0,0
175676,a,0,0
175677,single-blind,0,0
175678,",",0,0
175679,multicenter,0,0
175680,",",0,0
175681,randomized,0,0
175682,controlled,0,0
175683,trial,0,0
175684,",",0,0
175685,70,1,1
175686,subacute,1,1
175687,stroke,1,1
175688,patients,1,1
175689,received,0,0
175690,6,0,0
175691,weeks,0,0
175692,of,0,0
175693,training,0,0
175694,with,0,1
175695,either,0,0
175696,an,0,0
175697,AS,0,0
175698,device,0,0
175699,combined,0,0
175700,with,0,1
175701,computerized,0,0
175702,exercises,0,0
175703,or,0,1
175704,dose-matched,0,0
175705,conventional,0,0
175706,training,0,0
175707,(,0,0
175708,CON,0,0
175709,),0,0
175710,.,0,0
175711,Arm,0,0
175712,function,0,0
175713,was,0,0
175714,evaluated,0,0
175715,pretraining,0,0
175716,and,0,0
175717,posttraining,0,0
175718,by,0,0
175719,Fugl-Meyer,0,0
175720,assessment,0,0
175721,(,0,0
175722,FM,0,0
175723,),0,0
175724,",",0,0
175725,maximal,0,0
175726,reach,0,0
175727,distance,0,0
175728,",",0,0
175729,Stroke,0,0
175730,Upper,0,0
175731,Limb,0,0
175732,Capacity,0,0
175733,Scale,0,0
175734,(,0,0
175735,SULCS,0,0
175736,),0,0
175737,",",0,0
175738,and,0,0
175739,arm,0,0
175740,pain,0,0
175741,via,0,0
175742,Visual,0,0
175743,Analogue,0,0
175744,Scale,0,0
175745,",",0,0
175746,in,0,0
175747,addition,0,0
175748,to,0,0
175749,perceived,0,0
175750,motivation,0,0
175751,by,0,0
175752,Intrinsic,0,0
175753,Motivation,0,0
175754,Inventory,0,1
175755,posttraining,0,0
175756,.,0,0
175757,RESULTS,0,0
175758,FM,0,0
175759,and,0,0
175760,SULCS,0,0
175761,scores,0,0
175762,and,0,0
175763,reach,0,0
175764,distance,0,0
175765,improved,0,0
175766,significantly,0,0
175767,within,0,0
175768,both,0,0
175769,groups,0,0
175770,.,0,0
175771,These,0,0
175772,improvements,0,0
175773,and,0,0
175774,experienced,0,0
175775,pain,0,0
175776,did,0,0
175777,not,0,0
175778,differ,0,0
175779,between,0,0
175780,groups,0,0
175781,.,0,1
175782,The,0,0
175783,AS,0,0
175784,group,0,0
175785,reported,0,0
175786,higher,0,0
175787,interest/enjoyment,0,0
175788,during,0,0
175789,training,0,0
175790,than,0,0
175791,the,0,0
175792,CON,0,0
175793,group,0,0
175794,.,0,0
175795,CONCLUSIONS,0,0
175796,AS,0,0
175797,training,0,0
175798,with,0,1
175799,computerized,0,0
175800,exercises,0,0
175801,is,0,0
175802,as,0,0
175803,effective,0,0
175804,as,0,0
175805,conventional,0,0
175806,therapy,0,0
175807,dedicated,0,0
175808,to,0,0
175809,the,0,0
175810,arm,0,0
175811,to,0,0
175812,improve,0,0
175813,arm,0,0
175814,function,0,0
175815,and,0,0
175816,activity,0,0
175817,in,0,0
175818,subacute,1,1
175819,stroke,1,1
175820,rehabilitation,0,0
175821,",",0,0
175822,when,0,0
175823,applied,0,0
175824,at,0,0
175825,the,0,0
175826,same,0,0
175827,dose,0,0
175828,.,0,0
175829,Intramedullary,0,0
175830,repair,0,0
175831,device,0,0
175832,against,0,0
175833,volar,0,0
175834,plating,0,0
175835,in,0,0
175836,the,0,0
175837,reconstruction,0,0
175838,of,0,0
175839,extra-articular,0,1
175840,and,0,0
175841,simple,0,0
175842,articular,0,1
175843,distal,0,1
175844,radius,0,1
175845,fractures,0,1
175846,;,0,0
175847,a,0,0
175848,randomized,0,0
175849,pilot,0,0
175850,study,0,0
175851,.,0,0
175852,PURPOSE,0,0
175853,This,0,0
175854,prospective,0,0
175855,randomized,0,0
175856,pilot,0,0
175857,study,0,0
175858,reports,0,0
175859,our,0,0
175860,institutional,0,0
175861,experience,0,0
175862,and,0,0
175863,early,0,0
175864,results,0,0
175865,using,0,0
175866,Sonoma,0,1
175867,Wrx,0,0
175868,(,0,0
175869,Sonoma,0,1
175870,Orthopedic,0,1
175871,Products,0,0
175872,",",0,1
175873,Santa,0,1
175874,Rosa,0,1
175875,",",0,0
175876,CA,0,1
175877,),0,0
175878,in,0,0
175879,the,0,0
175880,treatment,0,0
175881,of,0,0
175882,extra-articular,0,1
175883,and,0,0
175884,simple,0,0
175885,intra-articular,0,0
175886,distal,0,1
175887,radius,0,0
175888,fractures,0,1
175889,.,0,1
175890,MATERIAL,0,0
175891,AND,0,0
175892,METHODS,0,0
175893,A,1,0
175894,total,1,1
175895,of,1,0
175896,64,1,0
175897,patients,1,1
175898,",",1,0
175899,were,1,0
175900,enrolled,1,1
175901,in,1,0
175902,the,1,0
175903,study,1,0
175904,.,1,0
175905,They,1,0
175906,were,1,0
175907,considered,1,0
175908,eligible,1,1
175909,if,1,0
175910,they,1,0
175911,had,1,0
175912,;,1,0
175913,unstable,1,1
175914,extra-articular,1,1
175915,distal,1,1
175916,radius,1,0
175917,fractures,1,1
175918,and,1,0
175919,simple,1,0
175920,intra-articular,1,0
175921,distal,1,1
175922,radius,1,0
175923,fractures,1,1
175924,suitable,1,0
175925,for,1,0
175926,closed,1,0
175927,reduction,1,0
175928,(,1,0
175929,AO,1,0
175930,types,1,0
175931,;,1,0
175932,A2.2,1,0
175933,",",1,0
175934,A2.3,1,0
175935,",",1,0
175936,A3.1,1,0
175937,C2.1,1,0
175938,",",1,0
175939,C2.2,1,0
175940,),1,0
175941,.,1,0
175942,Patients,1,1
175943,in,1,0
175944,group,1,0
175945,I,0,0
175946,received,0,0
175947,intramedullary,0,0
175948,fixation,0,0
175949,using,0,0
175950,the,0,0
175951,Sonoma,0,1
175952,Wrx,0,0
175953,device,0,0
175954,and,0,0
175955,patients,0,1
175956,in,0,0
175957,group,0,1
175958,II,0,1
175959,received,0,0
175960,standard,0,0
175961,volar,0,0
175962,locking,0,0
175963,plate,0,0
175964,fixation,0,0
175965,.,0,0
175966,Radiographic,0,0
175967,criteria,0,1
175968,of,0,0
175969,acceptable,0,0
175970,healing,0,0
175971,were,0,0
175972,used,0,0
175973,for,0,0
175974,evaluation,0,0
175975,.,0,0
175976,RESULTS,0,0
175977,Two,0,1
175978,groups,0,0
175979,were,0,0
175980,similar,0,0
175981,in,0,0
175982,terms,0,0
175983,of,0,0
175984,baseline,0,0
175985,characteristics,0,0
175986,.,0,0
175987,Mean,0,0
175988,time,0,0
175989,of,0,0
175990,operation,0,0
175991,was,0,0
175992,significantly,0,0
175993,shorter,0,0
175994,in,0,0
175995,Group,1,1
175996,1,1,0
175997,vs.,0,0
175998,in,0,0
175999,group,1,0
176000,2,1,0
176001,(,0,0
176002,36.81,0,0
176003,?,0,0
176004,7.11,0,0
176005,vs.,0,0
176006,48.97,0,0
176007,?,0,0
176008,5.9,0,0
176009,minutes,0,0
176010,",",0,0
176011,p,0,0
176012,=,0,0
176013,0.001,0,0
176014,),0,0
176015,.,0,0
176016,Time,0,0
176017,to,0,0
176018,healing,0,0
176019,of,0,0
176020,the,0,0
176021,fracture,0,0
176022,was,0,0
176023,not,0,0
176024,different,0,0
176025,between,0,0
176026,two,0,0
176027,groups,0,0
176028,(,0,1
176029,5.45,0,0
176030,?,0,0
176031,1.09,0,0
176032,vs.,0,0
176033,5.70,0,0
176034,?,0,0
176035,1.04,0,0
176036,weeks,0,0
176037,for,0,0
176038,Group,0,1
176039,1,0,0
176040,vs.,0,0
176041,2,0,0
176042,",",0,0
176043,respectively,0,0
176044,p,0,0
176045,=,0,0
176046,0.36,0,0
176047,),0,0
176048,.,0,0
176049,Overall,0,0
176050,complications,0,0
176051,occurred,0,0
176052,in,0,0
176053,9,0,0
176054,patients,1,1
176055,in,1,0
176056,group,1,0
176057,1,1,0
176058,and,1,0
176059,in,0,0
176060,15,0,0
176061,patients,0,1
176062,in,1,0
176063,group,1,0
176064,2,1,0
176065,(,1,0
176066,p,0,0
176067,=,0,0
176068,0.17,0,0
176069,),0,0
176070,.,0,0
176071,Follow-up,0,0
176072,was,0,0
176073,completed,0,0
176074,in,0,0
176075,all,0,0
176076,patients,1,1
176077,with,1,1
176078,a,0,0
176079,median,0,0
176080,time,0,0
176081,of,0,0
176082,12,0,0
176083,months,0,0
176084,and,0,0
176085,13,0,1
176086,months,0,0
176087,in,1,0
176088,group,1,0
176089,1,1,0
176090,and,1,0
176091,2,1,0
176092,",",1,0
176093,respectively,0,0
176094,.,0,0
176095,On,0,0
176096,radiographic,0,0
176097,evaluation,0,0
176098,radial,0,0
176099,inclination,0,0
176100,",",0,0
176101,radial,0,0
176102,height,0,0
176103,and,0,0
176104,volar,0,0
176105,tilt,0,0
176106,were,0,0
176107,not,0,0
176108,significantly,0,0
176109,different,0,0
176110,between,0,0
176111,group,0,0
176112,1,0,0
176113,and,0,0
176114,2,0,0
176115,",",0,0
176116,respectively,0,0
176117,.,0,0
176118,There,0,0
176119,were,0,0
176120,no,0,0
176121,significant,0,0
176122,differences,0,0
176123,between,0,0
176124,two,0,0
176125,groups,0,0
176126,in,0,0
176127,regard,0,0
176128,to,0,0
176129,wrist,0,0
176130,rotational,0,0
176131,degrees,0,0
176132,measured,0,0
176133,in,0,0
176134,last,0,0
176135,follow-up,0,0
176136,visit,0,0
176137,.,0,0
176138,CONCLUSION,0,0
176139,Sonoma,0,1
176140,Wrx,0,0
176141,Device,0,0
176142,is,0,0
176143,reliable,0,0
176144,and,0,0
176145,effective,0,0
176146,in,0,0
176147,terms,0,0
176148,of,0,0
176149,achieving,0,0
176150,satisfactory,0,0
176151,outcomes,0,0
176152,in,0,0
176153,treatment,0,0
176154,of,0,0
176155,distal,0,0
176156,radius,0,0
176157,fractures,0,1
176158,.,0,0
176159,It,0,0
176160,may,0,0
176161,be,0,0
176162,reasonable,0,0
176163,to,0,0
176164,use,0,0
176165,this,0,0
176166,device,0,0
176167,to,0,0
176168,prevent,0,0
176169,complications,0,0
176170,that,0,0
176171,are,0,0
176172,related,0,0
176173,to,0,0
176174,extensive,0,0
176175,soft,0,0
176176,tissue,0,0
176177,dissection,0,1
176178,.,0,0
176179,Quantifying,0,0
176180,narrative,0,0
176181,ability,0,0
176182,in,0,0
176183,autism,1,1
176184,spectrum,1,1
176185,disorder,1,1
176186,:,1,0
176187,a,0,0
176188,computational,0,0
176189,linguistic,0,0
176190,analysis,0,0
176191,of,0,0
176192,narrative,0,0
176193,coherence,0,0
176194,.,0,0
176195,Autism,1,0
176196,is,0,0
176197,a,0,0
176198,neurodevelopmental,0,0
176199,disorder,0,1
176200,characterized,0,0
176201,by,0,0
176202,serious,0,0
176203,difficulties,0,0
176204,with,0,1
176205,the,0,0
176206,social,0,0
176207,use,0,0
176208,of,0,0
176209,language,0,0
176210,",",0,0
176211,along,0,0
176212,with,0,1
176213,impaired,0,0
176214,social,0,0
176215,functioning,0,0
176216,and,0,0
176217,ritualistic/repetitive,0,0
176218,behaviors,0,0
176219,(,0,0
176220,American,0,1
176221,Psychiatric,0,1
176222,Association,0,0
176223,in,0,0
176224,Diagnostic,0,0
176225,and,0,0
176226,statistical,0,0
176227,manual,0,0
176228,of,0,0
176229,mental,0,1
176230,disorders,0,1
176231,:,0,1
176232,DSM-5,0,0
176233,",",0,0
176234,5th,0,0
176235,edn,0,0
176236,.,0,0
176237,American,0,1
176238,Psychiatric,0,1
176239,Association,0,0
176240,",",0,0
176241,Arlington,0,1
176242,",",0,0
176243,2013,0,1
176244,),0,0
176245,.,0,0
176246,While,0,0
176247,substantial,0,0
176248,heterogeneity,0,0
176249,exists,0,0
176250,in,0,0
176251,symptom,0,0
176252,expression,0,0
176253,",",0,0
176254,impairments,0,0
176255,in,0,0
176256,language,0,0
176257,discourse,0,0
176258,skills,0,0
176259,",",0,0
176260,including,0,0
176261,narrative,0,0
176262,(,0,0
176263,or,0,0
176264,storytelling,0,0
176265,),0,0
176266,",",0,0
176267,are,0,0
176268,universally,0,0
176269,observed,0,0
176270,in,0,0
176271,autism,0,1
176272,(,0,0
176273,Tager-Flusberg,0,0
176274,et,0,1
176275,al,0,0
176276,.,0,0
176277,in,0,0
176278,Handbook,0,0
176279,on,0,0
176280,autism,0,1
176281,and,0,0
176282,pervasive,0,0
176283,developmental,0,1
176284,disorders,0,1
176285,",",0,0
176286,3rd,0,0
176287,edn,0,0
176288,.,0,0
176289,Wiley,0,0
176290,",",0,0
176291,New,0,1
176292,York,0,0
176293,",",0,0
176294,pp,0,0
176295,335-364,0,0
176296,",",0,0
176297,2005,0,1
176298,),0,0
176299,.,0,0
176300,This,0,0
176301,study,0,0
176302,applied,0,0
176303,a,0,0
176304,computational,0,0
176305,linguistic,0,0
176306,tool,0,0
176307,",",0,0
176308,Latent,0,0
176309,Semantic,0,0
176310,Analysis,0,0
176311,(,0,0
176312,LSA,0,1
176313,),0,0
176314,",",0,0
176315,to,0,0
176316,objectively,0,0
176317,characterize,0,0
176318,narrative,0,0
176319,performance,0,0
176320,in,0,0
176321,high-functioning,1,1
176322,individuals,1,1
176323,with,1,1
176324,autism,1,1
176325,and,1,0
176326,typically-developing,1,0
176327,controls,1,0
176328,",",0,0
176329,across,0,0
176330,two,0,0
176331,different,0,0
176332,narrative,0,0
176333,contexts,0,0
176334,that,0,0
176335,differ,0,0
176336,in,0,0
176337,the,0,0
176338,interpersonal,0,0
176339,and,0,0
176340,cognitive,0,0
176341,demands,0,0
176342,placed,0,0
176343,on,0,0
176344,the,0,0
176345,narrator,0,0
176346,.,0,0
176347,Results,0,0
176348,indicated,0,0
176349,that,0,0
176350,high-functioning,1,1
176351,individuals,1,1
176352,with,1,1
176353,autism,1,1
176354,produced,0,0
176355,narratives,0,0
176356,comparable,0,0
176357,in,0,0
176358,semantic,0,0
176359,content,0,0
176360,to,0,0
176361,those,0,0
176362,produced,0,0
176363,by,0,0
176364,controls,0,0
176365,when,0,0
176366,narrating,0,0
176367,from,0,0
176368,a,0,0
176369,picture,0,0
176370,book,0,0
176371,",",0,0
176372,but,0,0
176373,produced,0,0
176374,narratives,0,0
176375,diminished,0,0
176376,in,0,0
176377,semantic,0,0
176378,quality,0,0
176379,in,0,0
176380,a,0,0
176381,more,0,0
176382,demanding,0,0
176383,narrative,0,0
176384,recall,0,0
176385,task,0,0
176386,.,0,0
176387,This,0,0
176388,pattern,0,0
176389,is,0,0
176390,similar,0,0
176391,to,0,0
176392,that,0,0
176393,detected,0,0
176394,from,0,0
176395,analyses,0,0
176396,of,0,0
176397,hand-coded,0,0
176398,picture,0,0
176399,book,0,0
176400,narratives,0,0
176401,in,0,0
176402,prior,0,0
176403,research,0,0
176404,",",0,0
176405,and,0,0
176406,extends,0,0
176407,findings,0,0
176408,to,0,0
176409,an,0,0
176410,additional,0,0
176411,narrative,0,0
176412,context,0,0
176413,that,0,0
176414,proves,0,0
176415,particularly,0,0
176416,challenging,0,0
176417,for,0,0
176418,individuals,1,1
176419,with,1,1
176420,autism,1,1
176421,.,1,0
176422,Results,0,0
176423,are,0,0
176424,discussed,0,0
176425,in,0,0
176426,terms,0,0
176427,of,0,0
176428,the,0,0
176429,utility,0,0
176430,of,0,0
176431,LSA,0,1
176432,as,0,0
176433,a,0,0
176434,quantitative,0,0
176435,",",0,0
176436,objective,0,0
176437,",",0,0
176438,and,0,0
176439,efficient,0,0
176440,measure,0,0
176441,of,0,0
176442,narrative,0,0
176443,ability,0,0
176444,.,0,0
176445,Balance,0,0
176446,training,0,0
176447,in,0,0
176448,elderly,1,1
176449,women,1,1
176450,using,1,0
176451,public,1,1
176452,parks,1,1
176453,.,1,0
176454,This,0,0
176455,study,0,0
176456,evaluates,0,0
176457,the,0,0
176458,effects,0,0
176459,of,0,0
176460,a,0,0
176461,balance,0,0
176462,training,0,0
176463,program,0,0
176464,developed,1,0
176465,in,1,0
176466,public,1,1
176467,parks,1,1
176468,on,0,0
176469,functionality,0,0
176470,and,0,0
176471,general,0,1
176472,state,0,0
176473,of,0,0
176474,health,0,0
176475,in,0,0
176476,elderly,1,1
176477,women,1,1
176478,.,1,1
176479,It,0,0
176480,was,0,0
176481,a,0,0
176482,randomized,0,0
176483,controlled,0,0
176484,trial,0,0
176485,.,0,0
176486,Women,1,0
176487,older,1,1
176488,than,1,0
176489,65,1,1
176490,years,1,1
176491,(,1,0
176492,n,1,1
176493,=,1,0
176494,28,1,0
176495,;,1,0
176496,68.5,1,0
176497,?,1,0
176498,2.9,1,0
176499,),1,0
176500,participated,0,1
176501,in,0,0
176502,a,0,0
176503,balance,0,0
176504,training,0,0
176505,program,0,0
176506,that,0,0
176507,lasted,0,0
176508,6,0,0
176509,weeks,0,0
176510,",",0,0
176511,with,0,1
176512,sessions,0,0
176513,taking,0,0
176514,place,0,0
176515,twice,0,0
176516,a,0,0
176517,week,0,0
176518,(,0,0
176519,12,0,0
176520,exercises/session,0,0
176521,",",0,0
176522,50,0,0
176523,min,0,0
176524,),0,0
176525,.,0,0
176526,Balance,0,0
176527,was,0,0
176528,analyzed,0,0
176529,by,0,0
176530,the,0,0
176531,Berg,0,0
176532,Balance,0,0
176533,Scale,0,0
176534,and,0,0
176535,Timed,0,0
176536,Up,0,0
176537,&,0,1
176538,Go,0,0
176539,Test,0,0
176540,.,0,0
176541,The,0,0
176542,generic,0,0
176543,health,0,0
176544,status,0,0
176545,was,0,0
176546,measured,0,0
176547,by,0,0
176548,the,0,0
176549,SF-12,0,0
176550,Health,0,0
176551,Survey,0,0
176552,.,0,0
176553,These,0,0
176554,tests,0,0
176555,showed,0,0
176556,statistically,0,0
176557,significant,0,0
176558,differences,0,0
176559,in,0,0
176560,the,0,0
176561,experimental,0,0
176562,group,0,0
176563,(,0,0
176564,p,0,0
176565,<,0,0
176566,.05,0,0
176567,),0,0
176568,.,0,0
176569,Public,1,0
176570,parks,1,1
176571,are,0,0
176572,adequate,0,0
176573,installations,0,0
176574,for,0,0
176575,developing,0,1
176576,balance,0,0
176577,.,0,0
176578,36-month,0,0
176579,treatment,0,0
176580,experience,0,0
176581,of,0,0
176582,two,0,0
176583,doses,0,0
176584,of,0,0
176585,leuprolide,0,0
176586,acetate,0,0
176587,3-month,0,0
176588,depot,0,0
176589,for,0,0
176590,children,1,1
176591,with,1,1
176592,central,1,0
176593,precocious,1,1
176594,puberty,1,1
176595,.,1,0
176596,CONTEXT,0,0
176597,We,0,0
176598,have,0,0
176599,recently,0,0
176600,demonstrated,0,0
176601,short-term,0,0
176602,(,0,0
176603,6-month,0,0
176604,),0,0
176605,efficacy,0,0
176606,and,0,0
176607,safety,0,0
176608,of,0,0
176609,leuprolide,0,0
176610,acetate,0,0
176611,3-month,0,0
176612,depot,0,0
176613,11.25,0,0
176614,and,0,0
176615,30,0,0
176616,mg,0,0
176617,in,0,0
176618,children,1,1
176619,with,1,1
176620,central,1,0
176621,precocious,1,1
176622,puberty,1,1
176623,(,1,0
176624,CPP,1,0
176625,),1,0
176626,.,1,0
176627,OBJECTIVE,0,0
176628,To,0,0
176629,assess,0,0
176630,long-term,0,0
176631,(,0,0
176632,36-month,0,0
176633,),0,0
176634,hypothalamic-pituitary-gonadal,0,0
176635,axis,0,0
176636,suppression,0,0
176637,and,0,0
176638,safety,0,0
176639,of,0,0
176640,leuprolide,0,0
176641,acetate,0,0
176642,3-month,0,0
176643,depot,0,0
176644,11.25,0,0
176645,and,0,0
176646,30,0,0
176647,mg,0,0
176648,in,0,0
176649,children,1,1
176650,with,1,1
176651,CPP,1,1
176652,.,1,1
176653,DESIGN,0,0
176654,Open-label,0,0
176655,",",0,0
176656,36-month,0,0
176657,extension,0,0
176658,.,0,0
176659,SETTING,0,0
176660,Twenty,1,1
176661,pediatric,1,1
176662,endocrine,1,1
176663,centers,1,1
176664,.,1,0
176665,PATIENTS,0,0
176666,Seventy-two,1,1
176667,children,1,1
176668,(,1,0
176669,mean,1,0
176670,age,1,1
176671,",",1,0
176672,8.5,1,0
176673,?,1,0
176674,1.6,1,0
176675,y,1,1
176676,;,1,0
176677,65,1,1
176678,females,1,1
176679,),1,0
176680,with,1,1
176681,CPP,1,0
176682,completed,1,1
176683,and,1,0
176684,showed,1,0
176685,maintenance,1,0
176686,of,1,0
176687,LH,1,0
176688,suppression,1,0
176689,after,1,0
176690,a,1,0
176691,6-month,1,0
176692,lead-in,1,0
176693,study,1,0
176694,.,1,0
176695,INTERVENTION,0,0
176696,Leuprolide,0,0
176697,acetate,0,0
176698,depot,0,0
176699,(,0,0
176700,11.25,0,0
176701,or,0,1
176702,30,0,0
176703,mg,0,0
176704,),0,0
176705,administered,0,0
176706,im,0,0
176707,every,0,0
176708,3,0,0
176709,months,0,0
176710,.,0,1
176711,MAIN,0,0
176712,OUTCOME,0,0
176713,MEASURES,0,0
176714,Peak-stimulated,0,0
176715,LH,0,0
176716,",",0,0
176717,estradiol,0,0
176718,",",0,0
176719,T,0,0
176720,",",0,0
176721,growth,0,0
176722,rate,0,0
176723,",",0,0
176724,pubertal,0,0
176725,progression,0,0
176726,",",0,0
176727,and,0,0
176728,adverse,0,0
176729,events,0,0
176730,(,0,0
176731,AEs,0,0
176732,),0,0
176733,.,0,0
176734,RESULTS,0,0
176735,Twenty-nine,0,1
176736,of,0,0
176737,34,0,1
176738,subjects,0,1
176739,in,0,0
176740,the,0,0
176741,11.25-mg,0,0
176742,group,0,0
176743,and,0,0
176744,36,0,0
176745,of,0,0
176746,38,0,1
176747,subjects,0,1
176748,in,0,0
176749,the,0,0
176750,30-mg,0,0
176751,group,0,0
176752,had,0,0
176753,LH,0,1
176754,values,0,0
176755,<,0,0
176756,4,0,0
176757,mIU/mL,0,0
176758,after,0,0
176759,day,0,0
176760,1,0,0
176761,at,0,0
176762,all,0,0
176763,time,0,0
176764,points,0,0
176765,.,0,0
176766,All,0,0
176767,seven,0,1
176768,subjects,0,1
176769,who,0,1
176770,escaped,0,1
176771,LH,0,1
176772,suppression,0,0
176773,at,0,0
176774,any,0,0
176775,time,0,0
176776,still,0,0
176777,maintained,0,0
176778,sex,0,0
176779,steroid,0,0
176780,concentrations,0,0
176781,at,0,0
176782,prepubertal,0,1
176783,levels,0,0
176784,and,0,0
176785,showed,0,0
176786,no,0,0
176787,signs,0,0
176788,of,0,0
176789,pubertal,0,1
176790,progression,0,0
176791,.,0,0
176792,AEs,0,0
176793,were,0,0
176794,comparable,0,0
176795,between,0,0
176796,groups,0,0
176797,",",0,0
176798,with,0,1
176799,injection,0,0
176800,site,0,0
176801,pain,0,0
176802,being,0,0
176803,the,0,0
176804,most,0,0
176805,common,0,0
176806,(,0,0
176807,26.4,0,0
176808,%,0,0
176809,overall,0,0
176810,),0,0
176811,.,0,0
176812,No,0,0
176813,AE,0,0
176814,led,0,0
176815,to,0,0
176816,discontinuation,0,0
176817,of,0,0
176818,study,0,0
176819,drug,0,0
176820,.,0,0
176821,The,0,0
176822,safety,0,0
176823,profile,0,0
176824,over,0,0
176825,36,0,1
176826,months,0,0
176827,was,0,0
176828,comparable,0,0
176829,to,0,0
176830,that,0,0
176831,observed,0,0
176832,during,0,0
176833,the,0,0
176834,6-month,0,0
176835,pivotal,0,0
176836,study,0,0
176837,.,0,0
176838,CONCLUSIONS,0,0
176839,The,0,0
176840,two,0,0
176841,doses,0,0
176842,of,0,0
176843,leuprolide,0,0
176844,acetate,0,0
176845,3-month,0,0
176846,depot,0,0
176847,were,0,0
176848,associated,0,0
176849,with,0,0
176850,an,0,0
176851,acceptable,0,0
176852,safety,0,0
176853,profile,0,0
176854,and,0,0
176855,provided,0,0
176856,maintenance,0,0
176857,of,0,0
176858,LH,0,0
176859,suppression,0,0
176860,in,0,0
176861,the,0,0
176862,majority,0,0
176863,of,0,0
176864,children,0,1
176865,with,0,1
176866,CPP,0,0
176867,during,0,0
176868,the,0,0
176869,36,0,0
176870,months,0,0
176871,of,0,0
176872,the,0,0
176873,study,0,0
176874,or,0,0
176875,until,0,0
176876,readiness,0,0
176877,for,0,0
176878,puberty,0,1
176879,.,0,0
176880,The,0,0
176881,effects,0,0
176882,of,0,0
176883,prism,0,0
176884,adaptation,0,0
176885,on,0,0
176886,egocentric,0,0
176887,metric,0,0
176888,distance,0,0
176889,estimation,0,0
176890,.,0,0
176891,OBJECTIVE,0,0
176892,The,0,0
176893,present,0,0
176894,experiment,0,0
176895,evaluated,0,0
176896,whether,0,0
176897,training,0,0
176898,involving,0,0
176899,throwing,0,0
176900,transferred,0,0
176901,to,0,0
176902,metric,0,0
176903,distance,0,0
176904,estimation,0,0
176905,(,0,0
176906,i.e.,0,0
176907,",",0,0
176908,describing,0,0
176909,in,0,0
176910,feet,0,0
176911,and,0,0
176912,inches,0,0
176913,the,0,0
176914,distance,0,0
176915,between,0,0
176916,oneself,0,0
176917,and,0,0
176918,targets,0,0
176919,),0,0
176920,.,0,0
176921,BACKGROUND,0,0
176922,In,0,0
176923,prior,0,0
176924,work,0,0
176925,",",0,0
176926,we,0,0
176927,found,0,0
176928,that,0,0
176929,metric,0,0
176930,estimation,0,0
176931,training,0,0
176932,negatively,0,0
176933,transferred,0,0
176934,to,0,0
176935,throwing,0,0
176936,.,0,0
176937,We,0,0
176938,explained,0,0
176939,our,0,0
176940,results,0,0
176941,in,0,0
176942,terms,0,0
176943,of,0,0
176944,cognitive,0,0
176945,intrusion,0,0
176946,.,0,0
176947,The,0,0
176948,present,0,0
176949,study,0,0
176950,tested,0,0
176951,that,0,0
176952,possibility,0,0
176953,by,0,0
176954,swapping,0,0
176955,our,0,0
176956,training,0,0
176957,and,0,0
176958,transfer,0,0
176959,tasks,0,0
176960,.,0,0
176961,METHOD,0,0
176962,During,0,0
176963,pretesting,0,0
176964,",",0,0
176965,participants,1,1
176966,verbally,1,0
176967,estimated,1,0
176968,the,1,0
176969,metric,1,0
176970,distances,1,0
176971,between,1,0
176972,themselves,1,0
176973,and,1,0
176974,targets,1,0
176975,",",1,0
176976,or,1,0
176977,they,1,0
176978,threw,1,0
176979,a,1,0
176980,beanbag,1,0
176981,to,1,0
176982,targets,1,0
176983,.,1,0
176984,During,0,0
176985,training,0,0
176986,",",0,0
176987,participants,0,1
176988,donned,0,0
176989,goggles,0,0
176990,that,0,0
176991,distorted,0,0
176992,their,0,0
176993,vision,0,0
176994,.,0,0
176995,While,0,0
176996,wearing,0,0
176997,the,0,0
176998,goggles,0,0
176999,",",0,0
177000,they,0,0
177001,threw,0,0
177002,a,0,0
177003,beanbag,0,0
177004,to,0,0
177005,targets,0,0
177006,.,0,1
177007,Half,0,0
177008,received,0,0
177009,feedback,0,0
177010,.,0,0
177011,During,0,0
177012,posttesting,0,0
177013,",",0,0
177014,participants,0,1
177015,removed,0,0
177016,the,0,0
177017,distorting,0,0
177018,goggles,0,0
177019,and,0,0
177020,completed,0,1
177021,the,0,0
177022,same,0,0
177023,task,0,0
177024,that,0,0
177025,they,0,0
177026,performed,0,0
177027,during,0,0
177028,pretesting,0,0
177029,.,0,0
177030,RESULTS,0,0
177031,The,0,0
177032,results,0,0
177033,indicated,0,0
177034,that,0,0
177035,the,0,0
177036,distorting,0,0
177037,goggles,0,0
177038,degraded,0,0
177039,throwing,0,0
177040,at,0,0
177041,the,0,0
177042,beginning,0,0
177043,of,0,0
177044,training,0,0
177045,",",0,0
177046,visual,0,0
177047,feedback,0,0
177048,improved,0,0
177049,throwing,0,0
177050,during,0,0
177051,training,0,0
177052,",",0,0
177053,the,0,0
177054,effects,0,0
177055,of,0,0
177056,training,0,0
177057,with,0,1
177058,feedback,0,0
177059,persisted,0,0
177060,into,0,0
177061,the,0,0
177062,throwing,0,0
177063,posttest,0,0
177064,",",0,0
177065,and,0,0
177066,the,0,0
177067,effects,0,0
177068,of,0,0
177069,training,0,0
177070,with,0,1
177071,feedback,0,0
177072,did,0,0
177073,not,0,0
177074,transfer,0,0
177075,to,0,0
177076,the,0,0
177077,verbal,0,0
177078,metric,0,0
177079,estimation,0,0
177080,posttest,0,0
177081,.,0,0
177082,CONCLUSION,0,0
177083,Training,0,0
177084,involving,0,0
177085,throwing,0,0
177086,was,0,0
177087,effective,0,0
177088,",",0,0
177089,but,0,0
177090,did,0,0
177091,not,0,0
177092,transfer,0,0
177093,to,0,0
177094,verbal,0,0
177095,metric,0,0
177096,distance,0,0
177097,estimation,0,0
177098,.,0,0
177099,This,0,0
177100,supports,0,0
177101,our,0,0
177102,argument,0,0
177103,that,0,0
177104,the,0,0
177105,negative,0,0
177106,transfer,0,0
177107,observed,0,0
177108,in,0,0
177109,our,0,0
177110,previous,0,0
177111,study,0,0
177112,stemmed,0,0
177113,from,0,0
177114,cognitive,0,0
177115,intrusion,0,0
177116,.,0,0
177117,APPLICATION,0,0
177118,The,0,0
177119,present,0,0
177120,experiment,0,0
177121,suggests,0,0
177122,that,0,0
177123,the,0,0
177124,creation,0,0
177125,of,0,0
177126,distance,0,0
177127,estimation,0,0
177128,training,0,0
177129,should,0,0
177130,begin,0,0
177131,with,0,0
177132,a,0,0
177133,careful,0,0
177134,analysis,0,0
177135,of,0,0
177136,the,0,0
177137,transfer,0,0
177138,task,0,0
177139,",",0,0
177140,and,0,0
177141,that,0,0
177142,distance,0,0
177143,estimation,0,0
177144,training,0,0
177145,programs,0,0
177146,should,0,0
177147,explicitly,0,0
177148,teach,0,0
177149,trainees,1,0
177150,that,1,0
177151,their,1,0
177152,training,1,0
177153,will,0,0
177154,not,0,0
177155,generalize,0,0
177156,to,0,0
177157,all,0,0
177158,distance,0,0
177159,estimation,0,0
177160,tasks,0,0
177161,.,0,1
177162,Elevation,0,0
177163,of,0,0
177164,HDL-C,0,0
177165,in,0,0
177166,response,0,0
177167,to,0,0
177168,statin,0,0
177169,treatment,0,0
177170,is,0,0
177171,involved,0,0
177172,in,0,0
177173,the,0,0
177174,regression,1,0
177175,of,1,0
177176,carotid,1,1
177177,atherosclerosis,1,1
177178,.,1,0
177179,AIM,0,0
177180,Atherosclerosis,0,1
177181,is,0,0
177182,strongly,0,0
177183,associated,0,0
177184,with,0,0
177185,an,0,0
177186,increased,0,0
177187,mortality,0,0
177188,in,0,0
177189,subjects,1,1
177190,with,1,1
177191,diabetes,1,1
177192,.,1,0
177193,The,0,0
177194,carotid,0,0
177195,intima-media,0,0
177196,thickness,0,0
177197,(,0,0
177198,IMT,0,0
177199,),0,0
177200,is,0,0
177201,commonly,0,0
177202,measured,0,0
177203,as,0,0
177204,a,0,0
177205,surrogate,0,0
177206,marker,0,0
177207,for,0,0
177208,cardiovascular,0,0
177209,risk,0,0
177210,.,0,0
177211,Statins,0,0
177212,are,0,0
177213,well-established,0,0
177214,protective,0,0
177215,agents,0,0
177216,against,0,0
177217,atherosclerosis,0,1
177218,and,0,0
177219,reportedly,0,0
177220,suppress,0,0
177221,IMT,0,0
177222,progression,0,0
177223,in,0,0
177224,subjects,0,1
177225,with,0,1
177226,diabetes,0,1
177227,.,0,0
177228,To,0,0
177229,clarify,0,0
177230,the,0,0
177231,effects,0,0
177232,of,0,0
177233,statins,0,0
177234,on,0,0
177235,subclinical,0,1
177236,atherosclerosis,0,1
177237,",",0,0
177238,we,0,0
177239,herein,0,0
177240,investigated,0,0
177241,changes,0,0
177242,in,0,0
177243,the,0,0
177244,carotid,0,1
177245,IMT,0,0
177246,and,0,0
177247,lipid,0,0
177248,profiles,0,0
177249,in,0,0
177250,a,0,0
177251,multi-center,0,0
177252,",",0,0
177253,prospective,0,0
177254,",",0,0
177255,randomized,0,0
177256,trial,0,0
177257,.,0,0
177258,METHODS,0,0
177259,Hypercholesterolemic,1,0
177260,subjects,1,1
177261,with,1,0
177262,type,1,1
177263,2,1,0
177264,diabetes,1,1
177265,were,0,0
177266,randomly,0,1
177267,assigned,0,0
177268,to,0,0
177269,open-label,0,0
177270,treatment,0,0
177271,with,0,0
177272,either,0,0
177273,pravastatin,0,0
177274,or,0,0
177275,pitavastatin,0,0
177276,.,0,0
177277,The,0,0
177278,primary,0,0
177279,endpoint,0,0
177280,of,0,0
177281,this,0,0
177282,study,0,0
177283,was,0,0
177284,the,0,0
177285,IMT,0,0
177286,change,0,0
177287,after,0,0
177288,36,0,1
177289,months,0,0
177290,of,0,0
177291,statin,0,0
177292,treatment,0,0
177293,.,0,0
177294,RESULTS,0,0
177295,A,1,0
177296,total,1,0
177297,of,1,0
177298,97,1,1
177299,subjects,1,1
177300,(,1,0
177301,51,1,1
177302,pitavastatin,1,0
177303,;,1,0
177304,46,1,0
177305,pravastatin,1,0
177306,),1,0
177307,completed,1,0
177308,this,1,0
177309,36-month,1,0
177310,study,1,0
177311,.,1,0
177312,The,0,0
177313,LDL-C,0,0
177314,decreased,0,0
177315,significantly,0,0
177316,from,0,0
177317,163.4,0,0
177318,?,0,0
177319,27.9,0,0
177320,mg/dl,0,0
177321,at,0,0
177322,baseline,0,0
177323,to,0,0
177324,100.4,0,0
177325,?,0,0
177326,19.6,0,0
177327,mg/dl,0,0
177328,at,0,0
177329,36,0,1
177330,months,0,0
177331,in,0,0
177332,the,0,0
177333,pitavastatin,0,0
177334,group,0,0
177335,and,0,0
177336,from,0,0
177337,159.7,0,0
177338,?,0,0
177339,25.6,0,0
177340,mg/dl,0,0
177341,to,0,0
177342,118.5,0,0
177343,?,0,0
177344,22.1,0,0
177345,mg/dl,0,0
177346,in,0,0
177347,the,0,0
177348,pravastatin,0,0
177349,group,0,0
177350,.,0,0
177351,The,0,0
177352,mean,0,0
177353,IMT,0,0
177354,showed,0,0
177355,moderate,0,1
177356,regression,0,0
177357,in,0,0
177358,both,0,0
177359,the,0,0
177360,pitavastatin,0,0
177361,(,0,0
177362,-0.070,0,0
177363,?,0,0
177364,0.215,0,0
177365,mm,0,0
177366,",",0,0
177367,P,0,0
177368,<,0,0
177369,0.05,0,0
177370,),0,0
177371,and,0,0
177372,the,0,0
177373,pravastatin,0,0
177374,(,0,0
177375,-0.067,0,0
177376,?,0,0
177377,0.260,0,0
177378,mm,0,0
177379,),0,0
177380,group,0,0
177381,.,0,0
177382,However,0,0
177383,",",0,0
177384,there,0,0
177385,was,0,0
177386,no,0,0
177387,significant,0,0
177388,difference,0,0
177389,in,0,0
177390,the,0,0
177391,IMT,0,0
177392,change,0,0
177393,between,0,0
177394,the,0,0
177395,two,0,0
177396,groups,0,0
177397,.,0,0
177398,When,0,0
177399,the,0,0
177400,two,0,0
177401,groups,0,0
177402,were,0,0
177403,combined,0,0
177404,",",0,0
177405,the,0,0
177406,36-month,0,0
177407,change,0,0
177408,in,0,0
177409,the,0,0
177410,mean,0,0
177411,IMT,0,0
177412,was,0,0
177413,significantly,0,0
177414,associated,0,0
177415,with,0,0
177416,HDL-C,0,0
177417,change,0,0
177418,(,0,0
177419,r=-0.24,0,0
177420,",",0,0
177421,P=,0,0
177422,0.03,0,0
177423,),0,0
177424,.,0,0
177425,Multiple,0,0
177426,linear,0,0
177427,regression,0,0
177428,analysis,0,0
177429,revealed,0,0
177430,the,0,0
177431,change,0,0
177432,in,0,0
177433,HDL-C,0,0
177434,to,0,0
177435,be,0,0
177436,an,0,0
177437,independent,0,0
177438,variable,0,0
177439,showing,0,0
177440,a,0,0
177441,positive,0,0
177442,correlation,0,0
177443,with,0,0
177444,the,0,0
177445,carotid,0,1
177446,IMT,0,0
177447,reduction,0,0
177448,.,0,0
177449,CONCLUSION,0,0
177450,The,0,0
177451,administration,0,0
177452,of,0,0
177453,statins,0,0
177454,for,0,0
177455,3,0,0
177456,years,0,1
177457,to,0,0
177458,subjects,0,1
177459,with,0,1
177460,type,0,1
177461,2,0,1
177462,diabetes,0,1
177463,resulted,0,0
177464,in,0,0
177465,a,0,0
177466,significant,0,0
177467,regression,0,0
177468,of,0,0
177469,the,0,0
177470,carotid,0,1
177471,IMT,0,0
177472,.,0,0
177473,An,0,0
177474,elevation,0,0
177475,of,0,0
177476,the,0,0
177477,plasma,0,0
177478,HDL-C,0,0
177479,with,0,1
177480,statin,0,0
177481,treatment,0,0
177482,was,0,0
177483,closely,0,0
177484,related,0,0
177485,to,0,0
177486,a,0,0
177487,regression,0,0
177488,of,0,0
177489,atherosclerosis,0,1
177490,.,0,0
177491,Intravenous,0,1
177492,flecainide,0,0
177493,versus,0,0
177494,verapamil,0,0
177495,for,0,0
177496,acute,0,1
177497,conversion,0,0
177498,of,0,0
177499,paroxysmal,1,1
177500,atrial,1,1
177501,fibrillation,1,1
177502,or,1,0
177503,flutter,1,1
177504,to,1,0
177505,sinus,1,1
177506,rhythm,1,1
177507,.,1,0
177508,In,0,0
177509,a,0,0
177510,single-blind,0,0
177511,randomized,0,0
177512,study,0,0
177513,",",0,0
177514,the,0,0
177515,efficacy,0,0
177516,of,0,0
177517,intravenous,0,0
177518,flecainide,0,0
177519,(,0,0
177520,2,0,0
177521,mg/kg/10,0,0
177522,minutes,0,0
177523,),0,0
177524,versus,0,0
177525,verapamil,0,0
177526,(,0,0
177527,10,0,0
177528,mg/1,0,0
177529,minute,0,0
177530,),0,0
177531,was,0,0
177532,assessed,0,0
177533,in,0,0
177534,40,1,1
177535,patients,1,1
177536,with,1,1
177537,paroxysmal,1,1
177538,atrial,1,1
177539,fibrillation,1,1
177540,(,1,0
177541,AF,1,0
177542,),1,0
177543,or,1,0
177544,atrial,1,1
177545,flutter,1,1
177546,(,1,0
177547,AFI,1,1
177548,),1,0
177549,.,1,0
177550,The,0,0
177551,treatment,0,0
177552,was,0,0
177553,considered,0,0
177554,successful,0,0
177555,if,0,0
177556,sinus,0,1
177557,rhythm,0,1
177558,occurred,0,0
177559,within,0,0
177560,1,0,0
177561,hour,0,0
177562,.,0,0
177563,Of,0,0
177564,20,1,0
177565,patients,1,1
177566,receiving,1,0
177567,flecainide,1,0
177568,",",1,0
177569,14,1,0
177570,of,1,0
177571,17,1,1
177572,(,1,0
177573,82,1,1
177574,%,1,0
177575,),1,0
177576,with,1,1
177577,AF,1,0
177578,converted,1,0
177579,to,1,0
177580,sinus,1,0
177581,rhythm,1,1
177582,",",1,0
177583,but,1,0
177584,in,1,0
177585,3,1,0
177586,patients,1,1
177587,with,1,1
177588,AFI,1,1
177589,flecainide,1,0
177590,failed,1,0
177591,.,1,0
177592,All,0,0
177593,patients,0,1
177594,treated,0,1
177595,with,0,1
177596,verapamil,0,0
177597,(,0,0
177598,17,0,0
177599,AF,0,0
177600,",",0,0
177601,3,0,0
177602,AFI,0,1
177603,),0,0
177604,showed,0,0
177605,lower,0,0
177606,ventricular,0,0
177607,rates,0,0
177608,after,0,0
177609,1,0,1
177610,hour,0,0
177611,;,0,0
177612,however,0,0
177613,",",0,0
177614,only,0,0
177615,1,0,0
177616,(,0,0
177617,6,0,0
177618,%,0,0
177619,),0,0
177620,with,0,1
177621,AF,0,0
177622,converted,0,0
177623,to,0,0
177624,sinus,0,1
177625,rhythm,0,1
177626,and,0,0
177627,1,0,0
177628,(,0,0
177629,6,0,0
177630,%,0,0
177631,),0,0
177632,converted,0,0
177633,to,0,0
177634,AFI,0,1
177635,.,0,1
177636,Patients,0,1
177637,who,0,1
177638,did,0,1
177639,not,0,1
177640,convert,0,0
177641,to,0,0
177642,sinus,0,0
177643,rhythm,0,1
177644,after,0,0
177645,treatment,0,0
177646,with,0,1
177647,verapamil,0,0
177648,were,0,0
177649,treated,0,1
177650,with,0,0
177651,flecainide,0,0
177652,and,0,0
177653,observed,0,0
177654,for,0,0
177655,another,0,0
177656,hour,0,0
177657,.,0,0
177658,After,0,0
177659,the,0,0
177660,change,0,0
177661,to,0,0
177662,flecainide,0,0
177663,",",0,0
177664,9,0,0
177665,of,0,0
177666,15,0,1
177667,patients,0,1
177668,(,0,0
177669,60,0,1
177670,%,0,0
177671,),0,0
177672,with,0,0
177673,AF,0,0
177674,still,0,0
177675,converted,0,0
177676,.,0,0
177677,Thus,0,0
177678,",",0,0
177679,23,0,1
177680,of,0,0
177681,32,0,1
177682,patients,0,1
177683,(,0,0
177684,72,0,1
177685,%,0,0
177686,),0,0
177687,with,0,0
177688,AF,0,0
177689,and,0,0
177690,none,0,0
177691,of,0,0
177692,7,0,0
177693,with,0,1
177694,AFI,0,1
177695,converted,0,0
177696,to,0,0
177697,sinus,0,1
177698,rhythm,0,1
177699,after,0,0
177700,treatment,0,0
177701,with,0,1
177702,flecainide,0,0
177703,.,0,0
177704,Conversion,0,0
177705,to,0,0
177706,sinus,0,1
177707,rhythm,0,1
177708,was,0,0
177709,achieved,0,0
177710,in,0,0
177711,19,0,1
177712,of,0,0
177713,22,0,1
177714,patients,0,1
177715,(,0,0
177716,86,0,1
177717,%,0,0
177718,),0,0
177719,when,0,0
177720,AF,0,0
177721,lasted,0,0
177722,less,0,0
177723,than,0,0
177724,24,0,0
177725,hours,0,0
177726,and,0,0
177727,in,0,0
177728,4,0,0
177729,of,0,0
177730,10,0,1
177731,(,0,0
177732,40,0,1
177733,%,0,0
177734,),0,0
177735,when,0,0
177736,the,0,0
177737,arrhythmia,0,0
177738,lasted,0,0
177739,greater,0,0
177740,than,0,0
177741,24,0,0
177742,hours,0,0
177743,.,0,1
177744,Transient,0,0
177745,adverse,0,0
177746,effects,0,0
177747,were,0,0
177748,noted,0,0
177749,in,0,0
177750,10,0,0
177751,patients,0,1
177752,(,0,0
177753,26,0,1
177754,%,0,0
177755,),0,0
177756,after,0,0
177757,flecainide,0,0
177758,.,0,0
177759,In,0,0
177760,summary,0,0
177761,",",0,0
177762,flecainide,0,0
177763,is,0,0
177764,an,0,0
177765,effective,0,0
177766,and,0,0
177767,safe,0,0
177768,drug,0,0
177769,for,0,0
177770,conversion,0,0
177771,of,0,0
177772,paroxysmal,0,1
177773,AF,0,0
177774,to,0,0
177775,sinus,0,0
177776,rhythm,0,1
177777,",",0,0
177778,but,0,0
177779,ineffective,0,0
177780,for,0,0
177781,AFI,0,1
177782,.,0,0
177783,Verapamil,0,0
177784,appears,0,0
177785,to,0,0
177786,be,0,0
177787,of,0,0
177788,no,0,0
177789,use,0,0
177790,for,0,0
177791,conversion,0,0
177792,of,0,0
177793,AF,0,0
177794,or,0,0
177795,AFI,0,1
177796,to,0,0
177797,sinus,0,1
177798,rhythm,0,1
177799,.,0,0
177800,[,0,0
177801,Mitomycin,0,0
177802,C,0,0
177803,plus,0,0
177804,HCFU,0,0
177805,adjuvant,0,0
177806,chemotherapy,0,0
177807,for,0,0
177808,noncuratively,0,0
177809,resected,0,1
177810,cases,0,0
177811,of,0,0
177812,colorectal,0,1
177813,carcinoma,0,1
177814,.,0,0
177815,(,0,0
177816,Second,0,0
177817,report,0,0
177818,),0,0
177819,:,0,1
177820,5-year,0,0
177821,survival,0,0
177822,rate,0,0
177823,.,0,0
177824,Cooperative,0,0
177825,Study,0,0
177826,Group,0,1
177827,of,0,0
177828,Kyushu,0,1
177829,and,0,0
177830,Chugoku,0,0
177831,for,0,0
177832,HCFU,0,0
177833,Adjuvant,0,1
177834,Chemotherapy,0,0
177835,],0,0
177836,.,0,0
177837,In,0,0
177838,order,0,0
177839,to,0,0
177840,examine,0,0
177841,the,0,0
177842,efficacy,0,0
177843,of,0,0
177844,adjuvant,0,0
177845,chemotherapy,0,0
177846,employing,0,0
177847,mitomycin,0,0
177848,C,0,0
177849,(,0,0
177850,MMC,0,0
177851,),0,0
177852,and,0,0
177853,carmofur,0,0
177854,(,0,0
177855,HCFU,0,0
177856,),0,0
177857,for,1,0
177858,patients,1,1
177859,with,1,1
177860,noncuratively,1,1
177861,resected,1,1
177862,colorectal,1,0
177863,carcinoma,1,1
177864,",",0,0
177865,a,0,0
177866,cooperative,0,0
177867,study,0,0
177868,was,0,0
177869,performed,0,0
177870,by,0,0
177871,54,1,1
177872,institutions,1,1
177873,in,1,0
177874,the,1,0
177875,Kyushu,1,0
177876,and,1,0
177877,Chugoku,1,0
177878,areas,1,0
177879,of,1,0
177880,Japan,1,1
177881,.,1,0
177882,The,1,0
177883,criteria,1,0
177884,for,1,0
177885,patient,1,1
177886,selection,1,0
177887,were,1,0
177888,as,1,0
177889,follows,1,0
177890,:,1,0
177891,1,1,0
177892,),1,0
177893,Age,1,0
177894,of,1,0
177895,75,1,1
177896,years,1,1
177897,or,1,1
177898,less,1,0
177899,and,1,0
177900,not,1,0
177901,accompanied,1,0
177902,by,1,0
177903,any,1,0
177904,serious,1,0
177905,disease,1,1
177906,.,1,0
177907,2,1,0
177908,),1,0
177909,Macroscopic,1,0
177910,diagnosis,1,1
177911,as,1,0
177912,being,1,0
177913,noncuratively,1,0
177914,resected,1,1
177915,on,1,0
177916,completion,1,0
177917,of,1,0
177918,the,1,0
177919,surgical,1,0
177920,procedure,1,0
177921,.,1,0
177922,3,1,0
177923,),1,0
177924,Definitive,1,0
177925,diagnosis,1,1
177926,of,1,0
177927,colorectal,1,1
177928,carcinomas,1,1
177929,",",1,0
177930,histologically,1,1
177931,.,1,0
177932,4,1,0
177933,),1,0
177934,No,1,0
177935,synchronous,1,0
177936,or,1,0
177937,metachronous,1,1
177938,double,1,0
177939,cancer,1,1
177940,.,1,0
177941,The,0,0
177942,prospective,0,0
177943,randomized,0,0
177944,controlled,0,0
177945,study,0,0
177946,consisted,0,0
177947,of,0,0
177948,two,0,0
177949,groups,0,0
177950,.,0,1
177951,In,0,0
177952,Group,0,0
177953,A,0,0
177954,",",0,0
177955,the,0,0
177956,MMC,1,0
177957,group,1,0
177958,received,0,0
177959,bolus,0,0
177960,intravenous,0,0
177961,injections,0,0
177962,of,0,0
177963,20,0,1
177964,mg,0,0
177965,MMC,0,0
177966,on,0,0
177967,the,0,0
177968,day,0,0
177969,of,0,0
177970,operation,0,0
177971,and,0,0
177972,10,0,0
177973,mg,0,0
177974,the,0,0
177975,next,0,0
177976,day,0,0
177977,",",0,0
177978,followed,0,0
177979,by,0,0
177980,10,0,0
177981,mg,0,0
177982,every,0,0
177983,4,0,0
177984,weeks,0,0
177985,until,0,0
177986,a,0,0
177987,total,0,1
177988,of,0,0
177989,100,0,0
177990,mg,0,0
177991,had,0,1
177992,been,0,0
177993,administered,0,0
177994,.,0,0
177995,In,0,0
177996,Group,0,0
177997,B,0,0
177998,",",0,0
177999,the,0,0
178000,MMC,0,0
178001,+,0,0
178002,HCFU,0,0
178003,group,0,0
178004,received,0,0
178005,the,0,0
178006,same,0,0
178007,treatment,0,0
178008,in,0,0
178009,Group,0,0
178010,A,0,0
178011,",",0,0
178012,but,0,0
178013,with,0,0
178014,the,0,0
178015,addition,0,0
178016,of,0,0
178017,600,0,0
178018,mg/day,0,0
178019,of,0,0
178020,HCFU,0,0
178021,from,0,0
178022,the,0,0
178023,second,0,0
178024,week,0,0
178025,",",0,0
178026,orally,0,0
178027,for,0,0
178028,at,0,0
178029,least,0,0
178030,one,0,0
178031,year,0,0
178032,.,0,0
178033,Concerning,0,0
178034,the,0,0
178035,69-month,0,0
178036,survival,0,0
178037,rate,0,0
178038,",",0,0
178039,a,0,0
178040,better,0,0
178041,result,0,0
178042,was,0,0
178043,observed,0,0
178044,in,0,0
178045,the,0,0
178046,MMC,0,0
178047,+,0,0
178048,HCFU,0,0
178049,group,0,0
178050,than,0,0
178051,in,0,0
178052,the,0,0
178053,MMC,0,0
178054,only,0,0
178055,group,0,0
178056,(,0,0
178057,generalized,0,0
178058,Wilcoxon,0,0
178059,test,0,0
178060,:,0,1
178061,p,0,0
178062,less,0,0
178063,than,0,0
178064,0.05,0,0
178065,),0,0
178066,.,0,0
178067,Significantly,0,0
178068,better,0,0
178069,survival,0,0
178070,rates,0,0
178071,were,0,0
178072,obtained,0,0
178073,in,0,0
178074,those,0,0
178075,cases,0,0
178076,with,0,1
178077,disseminating,0,0
178078,peritoneal,0,1
178079,metastasis,0,1
178080,",",0,0
178081,hepatic,0,0
178082,metastasis,0,1
178083,and,0,0
178084,stage,0,1
178085,V,0,0
178086,cancer,0,1
178087,in,0,0
178088,the,0,0
178089,MMC,0,0
178090,+,0,0
178091,HCFU,0,0
178092,group,0,0
178093,as,0,0
178094,when,0,0
178095,compared,0,0
178096,with,0,0
178097,the,0,0
178098,MMC,0,0
178099,only,0,0
178100,group,0,0
178101,.,0,0
178102,No,0,0
178103,significant,0,0
178104,side,0,0
178105,effects,0,0
178106,due,0,0
178107,to,0,0
178108,the,0,0
178109,combined,0,0
178110,administration,0,0
178111,of,0,0
178112,HCFU,0,0
178113,were,0,0
178114,recognized,0,0
178115,.,0,0
178116,The,0,0
178117,combined,0,0
178118,administration,0,0
178119,of,0,0
178120,MMC,0,0
178121,and,0,0
178122,HCFU,0,0
178123,was,0,0
178124,suggested,0,0
178125,to,0,0
178126,be,0,0
178127,a,0,0
178128,safe,0,0
178129,and,0,0
178130,effective,0,0
178131,adjuvant,0,0
178132,chemotherapy,0,0
178133,for,0,0
178134,noncuratively,0,0
178135,resected,0,1
178136,cases,0,0
178137,of,0,0
178138,colorectal,0,1
178139,carcinoma,0,1
178140,.,0,0
178141,Standardized,0,0
178142,treatment,0,0
178143,of,0,0
178144,Chinese,0,1
178145,medicine,0,1
178146,decoction,0,0
178147,for,0,0
178148,cancer,1,1
178149,pain,1,0
178150,patients,1,1
178151,with,1,1
178152,opioid-induced,1,1
178153,constipation,1,1
178154,:,1,1
178155,a,0,0
178156,multi-center,0,0
178157,prospective,0,0
178158,randomized,0,0
178159,controlled,0,0
178160,study,0,0
178161,.,0,0
178162,OBJECTIVE,0,0
178163,To,0,0
178164,observe,0,0
178165,the,0,0
178166,efficacy,0,0
178167,and,0,0
178168,the,0,0
178169,influence,0,0
178170,on,0,0
178171,quality,0,0
178172,of,0,0
178173,life,0,0
178174,(,0,0
178175,QOL,0,0
178176,),0,0
178177,of,0,0
178178,syndrome,0,1
178179,differentiation,0,0
178180,treatment,0,0
178181,with,0,1
178182,Chinese,0,1
178183,medicine,0,1
178184,(,0,0
178185,CM,0,0
178186,),0,0
178187,for,0,0
178188,opioid-induced,1,0
178189,constipation,1,1
178190,as,0,0
178191,well,0,0
178192,as,0,0
178193,the,0,0
178194,safety,0,0
178195,and,0,0
178196,influence,0,0
178197,on,0,0
178198,analgesic,0,0
178199,effect,0,0
178200,of,0,0
178201,opioids,0,0
178202,.,0,1
178203,METHODS,0,0
178204,Totally,1,0
178205,406,1,1
178206,cases,1,0
178207,enrolled,1,1
178208,from,1,0
178209,53,1,1
178210,collaborating,1,1
178211,medical,1,1
178212,centers,1,1
178213,were,0,0
178214,randomly,0,1
178215,assigned,0,0
178216,to,0,0
178217,a,0,0
178218,CM,0,0
178219,group,0,0
178220,and,0,0
178221,a,0,0
178222,control,0,0
178223,group,0,0
178224,.,0,0
178225,The,0,0
178226,CM,0,0
178227,group,0,0
178228,were,0,0
178229,treated,0,0
178230,with,0,1
178231,CM,0,0
178232,decoction,0,0
178233,based,0,0
178234,on,0,0
178235,syndrome,0,1
178236,differentiation,0,0
178237,",",0,0
178238,and,0,0
178239,the,0,0
178240,control,0,0
178241,group,0,0
178242,were,0,0
178243,treated,0,0
178244,with,0,1
178245,Phenolphthalein,0,0
178246,Tablet,0,0
178247,.,0,0
178248,Both,0,0
178249,groups,0,0
178250,were,0,0
178251,treated,0,1
178252,for,0,0
178253,14,0,1
178254,days,0,0
178255,.,0,1
178256,Cleveland,0,0
178257,constipation,0,0
178258,score,0,0
178259,(,0,0
178260,CCS,0,0
178261,),0,0
178262,",",0,0
178263,numerical,0,0
178264,rating,0,0
178265,scale,0,0
178266,(,0,0
178267,NRS,0,0
178268,),0,0
178269,of,0,0
178270,pain,0,0
178271,and,0,0
178272,Chinese,0,1
178273,version,0,0
178274,of,0,0
178275,European,0,1
178276,Organisation,0,0
178277,for,0,0
178278,Research,0,0
178279,and,0,0
178280,Treatment,0,0
178281,of,0,0
178282,Cancer,0,0
178283,",",0,0
178284,Quality,0,0
178285,of,0,0
178286,Life,0,0
178287,Questionnaire-C30,0,0
178288,V3.0,0,0
178289,(,0,0
178290,EORTC,0,0
178291,QLQ-C30,0,0
178292,V3.0,0,0
178293,),0,0
178294,were,0,0
178295,used,0,0
178296,to,0,0
178297,evaluate,0,0
178298,the,0,0
178299,efficacy,0,0
178300,",",0,0
178301,pain,0,0
178302,controlled,0,0
178303,and,0,0
178304,QOL,0,0
178305,status,0,0
178306,.,0,0
178307,RESULTS,0,0
178308,The,0,0
178309,comparisons,0,0
178310,of,0,0
178311,CCS,0,1
178312,score,0,0
178313,reduction,0,0
178314,and,0,0
178315,QOL,0,0
178316,between,0,0
178317,the,0,0
178318,two,0,0
178319,groups,0,0
178320,after,0,0
178321,treatment,0,0
178322,suggested,0,0
178323,that,0,0
178324,the,0,0
178325,improvements,0,0
178326,of,0,0
178327,constipation,0,1
178328,and,0,0
178329,QOL,0,0
178330,in,0,0
178331,the,0,0
178332,CM,0,0
178333,group,0,0
178334,were,0,0
178335,better,0,0
178336,than,0,0
178337,that,0,0
178338,in,0,0
178339,the,0,0
178340,control,0,0
178341,group,0,0
178342,(,0,0
178343,P,0,0
178344,<,0,0
178345,0.05,0,0
178346,),0,0
178347,.,0,0
178348,The,0,0
178349,total,0,0
178350,efficiency,0,0
178351,of,0,0
178352,the,0,0
178353,CM,0,0
178354,group,0,0
178355,was,0,0
178356,better,0,0
178357,than,0,0
178358,the,0,0
178359,control,0,0
178360,group,0,0
178361,(,0,0
178362,93.5,0,0
178363,%,0,0
178364,vs.,0,0
178365,86.4,0,0
178366,%,0,0
178367,",",0,0
178368,P,0,0
178369,<,0,0
178370,0.05,0,0
178371,),0,0
178372,.,0,0
178373,There,0,0
178374,was,0,0
178375,no,0,0
178376,significant,0,0
178377,difference,0,0
178378,in,0,0
178379,NRS,0,0
178380,scores,0,0
178381,between,0,0
178382,before,0,0
178383,and,0,0
178384,after,0,0
178385,treatment,0,0
178386,in,0,0
178387,both,0,0
178388,groups,0,0
178389,.,0,0
178390,There,0,0
178391,was,0,0
178392,no,0,0
178393,serious,0,0
178394,drug-related,0,0
178395,adverse,0,0
178396,event,0,0
178397,during,0,0
178398,the,0,0
178399,course,0,0
178400,of,0,0
178401,study,0,0
178402,.,0,0
178403,CONCLUSION,0,0
178404,CM,0,0
178405,decoction,0,0
178406,could,0,0
178407,effectively,0,0
178408,treat,0,0
178409,opioid-induced,1,0
178410,constipation,1,0
178411,and,0,0
178412,improve,0,0
178413,patients,0,1
178414,',0,0
178415,QOL,0,0
178416,at,0,0
178417,the,0,0
178418,same,0,0
178419,time,0,0
178420,.,0,0
178421,It,0,0
178422,is,0,0
178423,safe,0,0
178424,and,0,0
178425,does,0,0
178426,n't,0,0
178427,affect,0,0
178428,the,0,0
178429,analgesic,0,0
178430,effect,0,0
178431,of,0,0
178432,opioids,0,0
178433,when,0,0
178434,treating,0,0
178435,constipation,0,0
178436,.,0,0
178437,Visual,0,0
178438,feedback,0,0
178439,and,0,0
178440,target,0,0
178441,size,0,0
178442,effects,0,0
178443,on,0,0
178444,reach-to-grasp,0,1
178445,tasks,0,0
178446,in,1,0
178447,children,1,1
178448,with,1,1
178449,autism,1,1
178450,.,1,0
178451,This,0,0
178452,study,0,0
178453,explores,0,0
178454,the,0,0
178455,effects,0,0
178456,of,0,0
178457,visual,0,0
178458,condition,0,0
178459,and,0,0
178460,target,0,0
178461,size,0,0
178462,during,0,0
178463,four,0,0
178464,reach-to-grasp,0,0
178465,tasks,0,0
178466,between,0,0
178467,autistic,1,1
178468,children,1,1
178469,and,1,0
178470,healthy,1,1
178471,controls,1,1
178472,.,1,1
178473,Twenty,1,1
178474,children,1,1
178475,with,1,1
178476,autism,1,1
178477,and,1,0
178478,20,1,1
178479,healthy,1,1
178480,controls,1,1
178481,participated,1,1
178482,in,1,0
178483,the,1,0
178484,study,1,0
178485,.,1,0
178486,Qualisys,0,0
178487,motion,0,0
178488,capture,0,0
178489,system,0,0
178490,and,0,0
178491,kinematic,0,0
178492,measures,0,0
178493,were,0,0
178494,used,0,0
178495,to,0,0
178496,record,0,0
178497,movement,0,0
178498,.,0,0
178499,Autistic,1,0
178500,group,0,0
178501,showed,0,0
178502,significantly,0,0
178503,longer,0,0
178504,movement,0,0
178505,time,0,0
178506,",",0,0
178507,larger,0,0
178508,normalized,0,0
178509,jerk,0,0
178510,score,0,0
178511,",",0,0
178512,more,0,0
178513,movement,0,0
178514,unit,0,0
178515,than,0,0
178516,controls,0,0
178517,",",0,0
178518,especially,0,0
178519,in,0,0
178520,non-visual,0,0
178521,feedback,0,0
178522,and,0,0
178523,small,0,0
178524,target,0,0
178525,blocks,0,0
178526,.,0,0
178527,Autistic,1,0
178528,group,0,0
178529,also,0,0
178530,showed,0,0
178531,significantly,0,0
178532,larger,0,0
178533,maximal,0,0
178534,grip,0,0
178535,aperture,0,0
178536,and,0,0
178537,normalized,0,0
178538,maximal,0,0
178539,grip,0,0
178540,aperture,0,0
178541,in,0,0
178542,visual,0,0
178543,feedback,0,0
178544,condition,0,0
178545,than,0,0
178546,controls,0,1
178547,.,0,1
178548,Autistic,1,0
178549,children,1,1
178550,demonstrate,0,0
178551,motor,0,0
178552,coordination,0,0
178553,problems,0,1
178554,and,0,0
178555,also,0,0
178556,depend,0,0
178557,on,0,0
178558,more,0,0
178559,visual,0,0
178560,cuing,0,0
178561,in,0,0
178562,high,0,0
178563,accuracy,0,0
178564,tasks,0,0
178565,.,0,1
178566,Autistic,1,0
178567,children,1,1
178568,develop,0,0
178569,other,0,0
178570,compensatory,0,0
178571,skills,0,0
178572,while,0,0
178573,performing,0,0
178574,tasks,0,0
178575,.,0,1
178576,High-dose,0,0
178577,vitamin,0,0
178578,D3,0,0
178579,supplementation,0,0
178580,in,0,0
178581,children,1,1
178582,and,1,0
178583,young,1,1
178584,adults,1,1
178585,with,1,1
178586,HIV,1,0
178587,:,1,1
178588,a,0,0
178589,randomized,0,0
178590,",",0,0
178591,placebo-controlled,0,0
178592,trial,0,0
178593,.,0,0
178594,BACKGROUND,0,0
178595,Suboptimal,0,0
178596,vitamin,0,0
178597,D,0,0
178598,status,0,0
178599,is,0,0
178600,prevalent,0,0
178601,in,0,0
178602,HIV-infected,1,1
178603,patients,1,1
178604,and,0,0
178605,associated,0,0
178606,with,0,0
178607,increased,0,0
178608,risk,0,0
178609,of,0,0
178610,disease,0,1
178611,severity,0,0
178612,and,0,0
178613,morbidity,0,0
178614,.,0,0
178615,We,0,0
178616,aimed,0,0
178617,to,0,0
178618,determine,0,0
178619,12-month,0,0
178620,safety,0,0
178621,and,0,0
178622,efficacy,0,0
178623,of,0,0
178624,daily,0,0
178625,7000,0,0
178626,IU,0,0
178627,vitamin,0,0
178628,D3,0,0
178629,(,0,0
178630,vitD3,0,0
178631,),0,0
178632,versus,0,0
178633,placebo,0,0
178634,to,0,0
178635,sustain,0,0
178636,increased,0,0
178637,serum,0,0
178638,25-hydroxyvitamin,0,0
178639,D,0,0
178640,(,0,0
178641,25,0,0
178642,(,0,0
178643,OH,0,0
178644,),0,0
178645,D,0,0
178646,),0,0
178647,and,0,0
178648,improve,0,0
178649,immune,0,0
178650,status,0,0
178651,in,0,0
178652,HIV-infected,1,1
178653,subjects,1,1
178654,.,1,1
178655,METHODS,0,0
178656,This,0,0
178657,was,0,0
178658,a,0,0
178659,double-blind,0,0
178660,trial,0,0
178661,of,0,0
178662,perinatally,1,1
178663,acquired,1,0
178664,HIV,1,0
178665,(,1,0
178666,PHIV,1,0
178667,),1,0
178668,-infected,1,1
178669,subjects,1,1
178670,or,1,0
178671,behaviorally,1,1
178672,acquired,1,0
178673,HIV,1,0
178674,(,1,0
178675,BHIV,1,0
178676,),1,0
178677,-infected,1,1
178678,subjects,1,1
178679,(,1,0
178680,5.0-24.9,1,0
178681,years,1,1
178682,),1,1
178683,.,1,0
178684,Safety,0,0
178685,",",0,0
178686,25,0,0
178687,(,0,0
178688,OH,0,0
178689,),0,0
178690,D-related,0,0
178691,parameters,0,0
178692,and,0,0
178693,immune,0,0
178694,status,0,0
178695,were,0,0
178696,assessed,0,0
178697,at,0,0
178698,baseline,0,0
178699,",",0,0
178700,3,0,0
178701,",",0,0
178702,6,0,0
178703,and,0,0
178704,12,0,1
178705,months,0,0
178706,.,0,1
178707,RESULTS,0,0
178708,Fifty-eight,1,1
178709,subjects,1,1
178710,enrolled,1,1
178711,(,1,0
178712,67,1,0
178713,%,1,0
178714,male,1,1
178715,",",1,0
178716,85,1,0
178717,%,1,0
178718,African,1,1
178719,American,1,1
178720,and,1,0
178721,64,1,0
178722,%,1,0
178723,BHIV,1,0
178724,),1,0
178725,and,1,0
178726,50,1,0
178727,completed,1,1
178728,with,1,0
178729,no,1,0
178730,safety,1,0
178731,concerns,1,0
178732,.,1,0
178733,In,0,0
178734,unadjusted,0,0
178735,analyses,0,0
178736,",",0,0
178737,there,0,0
178738,were,0,0
178739,no,0,0
178740,differences,0,0
178741,between,0,0
178742,randomization,0,0
178743,groups,0,0
178744,at,0,0
178745,baseline,0,0
178746,;,0,0
178747,at,0,0
178748,3,0,0
178749,",",0,0
178750,6,0,0
178751,and,0,0
178752,12,0,0
178753,months,0,0
178754,",",0,0
178755,25,0,0
178756,(,0,0
178757,OH,0,0
178758,),0,0
178759,D,0,0
178760,was,0,0
178761,higher,0,0
178762,with,0,0
178763,supplementation,0,0
178764,than,0,0
178765,baseline,0,0
178766,and,0,0
178767,higher,0,0
178768,than,0,0
178769,with,0,0
178770,placebo,0,0
178771,(,0,0
178772,P,0,0
178773,<,0,0
178774,0.05,0,0
178775,),0,0
178776,.,0,0
178777,In,0,0
178778,adjusted,0,0
178779,mixed,0,0
178780,models,0,0
178781,",",0,0
178782,in,0,0
178783,the,0,0
178784,supplementation,0,0
178785,group,0,0
178786,",",0,0
178787,the,0,0
178788,fixed,0,0
178789,effect,0,0
178790,of,0,0
178791,25,0,0
178792,(,0,0
178793,OH,0,0
178794,),0,0
178795,D,0,0
178796,was,0,0
178797,higher,0,0
178798,(,0,0
178799,P,0,0
178800,<,0,0
178801,0.001,0,0
178802,),0,0
178803,.,0,0
178804,Percentage,0,0
178805,of,0,0
178806,naive,0,1
178807,T-helper,0,0
178808,cells,0,0
178809,(,0,0
178810,Th,0,0
178811,naive,0,1
178812,%,0,0
178813,),0,0
178814,were,0,0
178815,significantly,0,0
178816,(,0,0
178817,P,0,0
178818,<,0,0
178819,0.01,0,0
178820,),0,0
178821,and,0,0
178822,T-helper,0,0
178823,cells,0,0
178824,(,0,0
178825,CD4,0,1
178826,%,0,0
178827,),0,0
178828,marginally,0,0
178829,(,0,0
178830,P,0,0
178831,<,0,0
178832,0.10,0,0
178833,),0,0
178834,increased,0,0
178835,with,0,0
178836,supplementation,0,0
178837,in,0,0
178838,those,0,0
178839,taking,0,0
178840,highly,0,0
178841,active,0,0
178842,antiretroviral,0,1
178843,therapy,0,0
178844,(,0,0
178845,HAART,0,0
178846,),0,0
178847,",",0,0
178848,and,0,0
178849,RNA,0,0
178850,viral,0,0
178851,load,0,0
178852,was,0,0
178853,reduced,0,0
178854,(,0,0
178855,P,0,0
178856,?,0,0
178857,0.05,0,0
178858,),0,0
178859,.,0,0
178860,In,0,0
178861,exploratory,0,0
178862,linear,0,0
178863,models,0,0
178864,",",0,0
178865,change,0,0
178866,in,0,0
178867,25,0,0
178868,(,0,0
178869,OH,0,0
178870,),0,0
178871,D,0,0
178872,predicted,0,0
178873,RNA,0,0
178874,viral,0,0
178875,load,0,0
178876,at,0,0
178877,3,0,0
178878,and,0,0
178879,12,0,0
178880,months,0,0
178881,and,0,0
178882,CD4,0,1
178883,%,0,0
178884,at,0,0
178885,3,0,0
178886,months,0,0
178887,(,0,0
178888,P,0,0
178889,<,0,0
178890,0.05,0,0
178891,),0,0
178892,.,0,0
178893,CONCLUSIONS,0,0
178894,Daily,0,0
178895,7000,0,0
178896,IU,0,0
178897,vitD3,0,0
178898,for,0,0
178899,12,0,0
178900,months,0,0
178901,was,0,0
178902,safe,0,0
178903,in,0,0
178904,HIV-infected,0,1
178905,subjects,0,1
178906,and,0,0
178907,effective,0,0
178908,in,0,0
178909,increasing,0,0
178910,25,0,0
178911,(,0,0
178912,OH,0,0
178913,),0,0
178914,D.,0,0
178915,Supplementation,0,0
178916,improved,0,0
178917,some,0,0
178918,clinically,0,0
178919,important,0,0
178920,HIV,0,0
178921,immune,0,0
178922,markers,0,0
178923,in,0,0
178924,subjects,0,1
178925,on,0,0
178926,HAART,0,1
178927,.,0,0
178928,Adjunct,0,0
178929,therapy,0,0
178930,with,0,1
178931,high-dose,0,0
178932,",",0,0
178933,daily,0,0
178934,vitD3,0,0
178935,for,0,0
178936,HIV-infected,0,1
178937,subjects,0,1
178938,and,0,0
178939,for,0,0
178940,those,0,0
178941,on/off,0,0
178942,HAART,0,0
178943,requires,0,0
178944,further,0,0
178945,investigation,0,0
178946,.,0,0
178947,Comparison,0,0
178948,of,0,0
178949,clinical,0,0
178950,effectiveness,0,0
178951,of,0,0
178952,acupuncture,0,0
178953,and,0,0
178954,a,0,0
178955,Western,0,0
178956,drug,0,0
178957,on,0,0
178958,allergic,1,1
178959,rhinitis,1,1
178960,:,1,1
178961,study,0,0
178962,protocol,0,0
178963,for,0,0
178964,a,0,0
178965,randomized,0,0
178966,controlled,0,0
178967,trial,0,0
178968,.,0,0
178969,OBJECTIVE,0,0
178970,To,0,0
178971,compare,0,0
178972,the,0,0
178973,efficacy,0,0
178974,of,0,0
178975,an,0,0
178976,acupuncture,0,0
178977,regimen,0,0
178978,for,0,0
178979,persistent,1,1
178980,allergic,1,1
178981,rhinitis,1,1
178982,(,1,0
178983,PER,1,0
178984,),1,0
178985,",",0,0
178986,aimed,0,0
178987,at,0,0
178988,improving,0,0
178989,a,0,0
178990,patient,0,0
178991,'s,0,0
178992,mind,0,0
178993,or,0,1
178994,Shen,0,1
178995,in,0,0
178996,Traditional,0,0
178997,Chinese,0,1
178998,Medicine,0,0
178999,",",0,0
179000,to,0,0
179001,that,0,0
179002,of,0,0
179003,a,0,0
179004,second-generation,0,0
179005,Hi-receptor,0,0
179006,antagonist,0,0
179007,",",0,0
179008,cetirizine,0,0
179009,hydrochloride,0,0
179010,.,0,0
179011,METHODS,0,0
179012,This,0,0
179013,multicenter,1,0
179014,",",1,0
179015,randomized,1,0
179016,",",1,0
179017,controlled,1,0
179018,clinical,1,0
179019,trial,1,0
179020,on,1,0
179021,PER,1,0
179022,will,1,0
179023,be,1,0
179024,conducted,1,0
179025,at,1,0
179026,three,1,0
179027,institutions,1,1
179028,in,1,0
179029,China,1,1
179030,.,1,0
179031,The,0,0
179032,total,0,0
179033,study,0,0
179034,period,0,0
179035,will,0,0
179036,be,0,0
179037,9,0,0
179038,weeks,0,0
179039,.,0,0
179040,After,0,0
179041,a,0,0
179042,1-week,0,0
179043,preparatory,0,0
179044,screening,0,0
179045,period,0,0
179046,",",0,0
179047,240,1,0
179048,eligible,1,1
179049,participants,1,1
179050,with,1,1
179051,PER,1,0
179052,will,0,0
179053,be,0,0
179054,randomized,0,0
179055,to,0,0
179056,receive,0,0
179057,acupuncture,0,0
179058,or,0,0
179059,pharmacotherapy,0,1
179060,(,0,0
179061,1:1,0,0
179062,),0,0
179063,for,0,0
179064,4,0,0
179065,weeks,0,0
179066,with,0,1
179067,a,0,0
179068,4-week,0,0
179069,follow-up,0,0
179070,.,0,0
179071,The,0,0
179072,primary,0,0
179073,outcome,0,0
179074,will,0,0
179075,be,0,0
179076,changes,0,0
179077,in,0,0
179078,7-day,0,0
179079,average,0,0
179080,total,0,1
179081,nasal,0,0
179082,symptom,0,0
179083,score,0,0
179084,.,0,0
179085,Secondary,0,0
179086,outcome,0,0
179087,measures,0,0
179088,include,0,0
179089,rhinoconjunctivitis,0,1
179090,quality,0,0
179091,of,0,0
179092,life,0,0
179093,questionnaire,0,0
179094,score,0,0
179095,and,0,0
179096,total,0,1
179097,non-nasal,0,0
179098,symptom,0,0
179099,score,0,0
179100,.,0,0
179101,RESULTS,0,0
179102,The,0,0
179103,presence,0,0
179104,and,0,0
179105,seriousness,0,0
179106,of,0,0
179107,psychological,0,0
179108,and,0,0
179109,emotional,0,0
179110,impairments,0,0
179111,should,0,0
179112,be,0,0
179113,considered,0,0
179114,in,0,0
179115,therapeutic,0,0
179116,programs,0,0
179117,for,0,0
179118,allergic,0,1
179119,rhinitis,0,1
179120,.,0,0
179121,No,0,0
179122,clinical,0,0
179123,trial,0,0
179124,for,0,0
179125,treating,0,0
179126,allergic,0,1
179127,rhinitis,0,1
179128,via,0,0
179129,acupuncture,0,0
179130,regulation,0,0
179131,of,0,0
179132,psychological,0,0
179133,and,0,0
179134,emotional,0,0
179135,activities,0,0
179136,has,0,0
179137,been,0,0
179138,reported,0,0
179139,.,0,0
179140,CONCLUSION,0,0
179141,The,0,0
179142,findings,0,0
179143,of,0,0
179144,the,0,0
179145,trial,0,0
179146,will,0,0
179147,allow,0,0
179148,us,0,0
179149,to,0,0
179150,determine,0,0
179151,the,0,0
179152,effects,0,0
179153,of,0,0
179154,the,0,0
179155,mind,0,0
179156,(,0,0
179157,Shen,0,1
179158,),0,0
179159,-regulation,0,0
179160,treatment,0,0
179161,approach,0,0
179162,.,0,0
179163,We,0,0
179164,will,0,0
179165,also,0,0
179166,be,0,0
179167,able,0,0
179168,to,0,0
179169,confirm,0,0
179170,if,0,0
179171,the,0,0
179172,effects,0,0
179173,of,0,0
179174,acupuncture,0,0
179175,are,0,0
179176,equivalent,0,0
179177,to,0,0
179178,those,0,0
179179,of,0,0
179180,the,0,0
179181,conventional,0,0
179182,drug,0,0
179183,cetirizine,0,0
179184,hydrochloride,0,0
179185,.,0,0
179186,A,0,0
179187,further,0,0
179188,investigation,0,0
179189,of,0,0
179190,goal-directed,0,0
179191,intention,0,0
179192,understanding,0,0
179193,in,0,0
179194,young,1,1
179195,children,1,1
179196,with,1,1
179197,autism,1,1
179198,spectrum,1,1
179199,disorders,1,1
179200,.,1,1
179201,Findings,0,0
179202,from,0,0
179203,research,0,0
179204,investigating,0,0
179205,goal-directed,0,0
179206,intention,0,0
179207,understanding,0,0
179208,in,0,0
179209,children,1,1
179210,with,1,1
179211,autism,1,1
179212,spectrum,1,1
179213,disorders,1,1
179214,(,1,0
179215,ASD,1,1
179216,),1,0
179217,have,0,0
179218,been,0,0
179219,equivocal,0,0
179220,",",0,0
179221,in,0,0
179222,part,0,0
179223,because,0,0
179224,of,0,0
179225,the,0,0
179226,varying,0,0
179227,methodologies,0,0
179228,used,0,0
179229,across,0,0
179230,studies,0,0
179231,.,0,0
179232,This,0,0
179233,study,0,0
179234,compares,0,0
179235,both,0,0
179236,object-oriented,0,0
179237,and,0,0
179238,social-communicatively,0,0
179239,cued,0,0
179240,goal-directed,0,0
179241,intention,0,0
179242,understanding,0,0
179243,in,0,0
179244,children,1,1
179245,with,1,1
179246,ASD,1,1
179247,and,1,0
179248,typically-developing,1,1
179249,children,1,1
179250,.,1,1
179251,Relative,0,0
179252,to,0,0
179253,matched,0,1
179254,controls,0,0
179255,",",0,0
179256,children,0,1
179257,with,0,1
179258,ASD,0,1
179259,did,0,0
179260,not,0,0
179261,exhibit,0,0
179262,deficits,0,0
179263,in,0,0
179264,object-oriented,0,0
179265,intention,0,0
179266,understanding,0,0
179267,.,0,0
179268,While,0,0
179269,children,1,1
179270,with,1,1
179271,ASD,1,1
179272,also,0,0
179273,demonstrated,0,0
179274,the,0,0
179275,ability,0,0
179276,to,0,0
179277,understand,0,0
179278,intention,0,0
179279,when,0,0
179280,cued,0,0
179281,by,0,0
179282,social-communication,0,0
179283,indicators,0,0
179284,",",0,0
179285,typically-developing,0,1
179286,children,0,1
179287,differentiated,0,1
179288,between,0,0
179289,intentional,0,0
179290,and,0,0
179291,unintentional,0,0
179292,acts,0,0
179293,at,0,0
179294,a,0,0
179295,significantly,0,0
179296,greater,0,0
179297,level,0,0
179298,.,0,0
179299,Group,0,0
179300,differences,0,0
179301,in,0,0
179302,performance,0,0
179303,were,0,0
179304,eliminated,0,0
179305,if,0,0
179306,only,0,0
179307,trials,0,0
179308,in,0,0
179309,which,0,0
179310,children,0,1
179311,attended,0,1
179312,to,0,0
179313,the,0,0
179314,experimenter,0,0
179315,'s,0,0
179316,face,0,0
179317,were,0,0
179318,considered,0,0
179319,.,0,0
179320,Results,0,0
179321,suggest,0,0
179322,that,0,0
179323,children,1,1
179324,with,1,1
179325,ASD,1,1
179326,have,0,0
179327,intact,0,0
179328,object-oriented,0,0
179329,intention,0,0
179330,understanding,0,0
179331,abilities,0,0
179332,",",0,0
179333,and,0,0
179334,are,0,0
179335,able,0,0
179336,to,0,0
179337,use,0,0
179338,social-communicative,0,0
179339,cues,0,0
179340,to,0,0
179341,understand,0,0
179342,intention,0,0
179343,.,0,0
179344,However,0,0
179345,",",0,0
179346,their,0,0
179347,ability,0,0
179348,to,0,0
179349,demonstrate,0,0
179350,social-communicatively,0,0
179351,cued,0,0
179352,intention,0,0
179353,understanding,0,0
179354,is,0,0
179355,limited,0,0
179356,by,0,0
179357,a,0,0
179358,lack,0,0
179359,of,0,0
179360,attention,0,0
179361,to,0,0
179362,relevant,0,0
179363,social-communicative,0,0
179364,information,0,0
179365,.,0,0
179366,The,0,0
179367,addition,0,0
179368,of,0,0
179369,tramadol,0,0
179370,to,0,0
179371,the,0,0
179372,standard,0,0
179373,of,0,0
179374,i.v,0,0
179375,.,0,0
179376,acetaminophen,0,0
179377,and,0,0
179378,morphine,0,0
179379,infusion,0,0
179380,for,0,0
179381,postoperative,1,0
179382,analgesia,1,0
179383,in,1,0
179384,neonates,1,1
179385,offers,0,0
179386,no,0,0
179387,clinical,0,0
179388,benefit,0,0
179389,:,0,1
179390,a,0,0
179391,randomized,0,0
179392,placebo-controlled,0,0
179393,trial,0,0
179394,.,0,0
179395,BACKGROUND,0,0
179396,Tramadol,0,0
179397,is,0,0
179398,used,0,0
179399,following,0,0
179400,neonatal,1,0
179401,cardiac,1,1
179402,and,1,0
179403,general,1,1
179404,surgery,1,1
179405,.,1,0
179406,However,0,0
179407,",",0,0
179408,its,0,0
179409,ability,0,0
179410,to,0,0
179411,opioid-spare,0,0
179412,or,0,0
179413,facilitate,0,0
179414,earlier,0,0
179415,extubation,0,0
179416,in,0,0
179417,postoperative,0,0
179418,neonates,0,1
179419,is,0,0
179420,unquantified,0,0
179421,.,0,0
179422,OBJECTIVE,0,0
179423,This,0,0
179424,randomized,0,0
179425,placebo-controlled,0,0
179426,trial,0,0
179427,aimed,0,0
179428,to,0,0
179429,assess,0,0
179430,whether,0,0
179431,tramadol,0,0
179432,'s,0,0
179433,addition,0,0
179434,to,0,0
179435,standard,0,0
179436,analgesia,0,0
179437,resulted,0,0
179438,in,0,0
179439,earlier,0,0
179440,extubation,0,0
179441,or,0,0
179442,reduced,0,0
179443,analgesic/sedative,0,0
179444,requirements,0,0
179445,in,0,0
179446,postsurgical,1,1
179447,neonates,1,1
179448,.,1,1
179449,METHODS,0,0
179450,Neonates,1,0
179451,born,1,1
179452,?32,1,0
179453,weeks,1,0
179454,postmenstrual,1,1
179455,age,1,1
179456,received,1,0
179457,either,0,0
179458,tramadol,0,0
179459,[,0,0
179460,T,0,0
179461,],0,0
179462,2,0,0
179463,mg?kg,0,0
179464,(,0,0
179465,-1,0,0
179466,),0,0
179467,or,0,0
179468,placebo,0,0
179469,[,0,0
179470,P,0,0
179471,],0,0
179472,6-hourly,0,0
179473,for,0,0
179474,up,0,0
179475,to,0,0
179476,5,0,0
179477,days,1,0
179478,postthoracoabdominal,1,1
179479,surgery,1,1
179480,in,1,0
179481,addition,0,0
179482,to,0,0
179483,morphine,0,0
179484,(,0,0
179485,commenced,0,0
179486,at,0,0
179487,20,0,0
179488,mcg?kg,0,0
179489,(,0,0
179490,-1,0,0
179491,),0,0
179492,?h,0,0
179493,(,0,0
179494,-1,0,0
179495,),0,0
179496,),0,0
179497,and,0,0
179498,6-hourly,0,0
179499,i.v,0,0
179500,.,0,0
179501,acetaminophen,0,0
179502,.,0,0
179503,Time,0,0
179504,to,0,0
179505,extubation,0,0
179506,",",0,0
179507,morphine,0,0
179508,and,0,0
179509,midazolam,0,0
179510,amounts,0,0
179511,",",0,0
179512,hourly,0,0
179513,pain,0,0
179514,scores,0,0
179515,",",0,0
179516,and,0,0
179517,seizure,0,0
179518,activity,0,0
179519,were,0,0
179520,compared,0,0
179521,using,0,0
179522,an,0,0
179523,intention-to-treat,0,0
179524,and,0,0
179525,per-protocol,0,0
179526,analysis,0,0
179527,.,0,0
179528,RESULTS,1,0
179529,Seventy-one,1,1
179530,neonates,1,1
179531,participated,1,1
179532,.,1,1
179533,Median,1,0
179534,survival,0,0
179535,time,0,0
179536,to,0,0
179537,extubation,0,0
179538,was,0,0
179539,similar,0,0
179540,between,0,0
179541,the,0,0
179542,groups,0,0
179543,(,0,0
179544,T,0,0
179545,67,0,1
179546,h,0,0
179547,[,0,0
179548,95,0,0
179549,%,0,0
179550,CI,0,0
179551,51,0,0
179552,",",0,0
179553,84,0,1
179554,],0,0
179555,vs,0,0
179556,P,0,0
179557,52,0,1
179558,h,0,0
179559,[,0,0
179560,95,0,0
179561,%,0,0
179562,CI,0,0
179563,43,0,0
179564,",",0,0
179565,65,0,1
179566,],0,0
179567,;,0,0
179568,P,0,0
179569,=,0,0
179570,0.4,0,0
179571,),0,0
179572,",",0,0
179573,and,0,0
179574,similar,0,0
179575,numbers,0,0
179576,were,0,0
179577,extubated,0,0
179578,by,0,0
179579,96,0,0
179580,h,0,0
179581,(,0,0
179582,T,0,0
179583,69,0,1
179584,%,0,0
179585,vs,0,0
179586,P,0,0
179587,77,0,1
179588,%,0,0
179589,;,0,0
179590,difference,0,0
179591,-8,0,0
179592,%,0,0
179593,",",0,0
179594,95,0,0
179595,%,0,0
179596,CI,0,0
179597,-28,0,0
179598,",",0,0
179599,13,0,0
179600,%,0,0
179601,),0,0
179602,.,0,0
179603,Morphine,0,0
179604,and,0,0
179605,midazolam,0,0
179606,exposure,0,0
179607,was,0,0
179608,similar,0,0
179609,",",0,0
179610,with,0,1
179611,low,0,0
179612,pain,0,0
179613,scores,0,0
179614,in,0,0
179615,both,0,0
179616,groups,0,0
179617,(,0,0
179618,mean,0,0
179619,percentage,0,0
179620,of,0,0
179621,time,0,0
179622,with,0,0
179623,a,0,0
179624,pain,0,0
179625,score,0,0
179626,>,0,0
179627,5/20,0,0
179628,during,0,0
179629,the,0,0
179630,5,0,0
179631,days,0,0
179632,:,0,1
179633,T,0,0
179634,13,0,0
179635,%,0,0
179636,vs,0,0
179637,P,0,0
179638,11,0,0
179639,%,0,0
179640,",",0,0
179641,difference,0,0
179642,in,0,0
179643,means,0,0
179644,2.8,0,0
179645,[,0,0
179646,95,0,0
179647,%,0,0
179648,CI,0,0
179649,-1.8,0,0
179650,",",0,0
179651,7.6,0,0
179652,],0,0
179653,",",0,0
179654,P,0,0
179655,=,0,0
179656,0.20,0,0
179657,),0,0
179658,.,0,0
179659,Most,0,0
179660,participants,0,1
179661,had,0,1
179662,normal,0,1
179663,cranial,0,0
179664,ultrasounds,0,0
179665,(,0,0
179666,T,0,0
179667,86,0,1
179668,%,0,0
179669,vs,0,0
179670,P,0,0
179671,86,0,1
179672,%,0,0
179673,),0,0
179674,;,0,0
179675,no,0,0
179676,seizures,0,0
179677,occurred,0,0
179678,clinically,0,0
179679,or,0,0
179680,electroencephalographically,0,0
179681,.,0,0
179682,CONCLUSION,0,0
179683,Tramadol,0,0
179684,'s,0,0
179685,addition,0,0
179686,to,0,0
179687,standard,0,0
179688,analgesia,0,0
179689,in,0,0
179690,this,0,0
179691,small,0,0
179692,group,0,0
179693,of,1,0
179694,postsurgical,1,0
179695,neonates,1,1
179696,did,1,0
179697,not,0,0
179698,appear,0,0
179699,to,0,0
179700,have,0,0
179701,any,0,0
179702,positive,0,0
179703,effect,0,0
179704,on,0,0
179705,time,0,0
179706,to,0,0
179707,extubation,0,0
179708,",",0,0
179709,morphine,0,0
179710,or,0,0
179711,midazolam,0,0
179712,exposure,0,0
179713,",",0,0
179714,or,0,0
179715,pain,0,0
179716,scores,0,0
179717,.,0,0
179718,This,0,0
179719,questions,0,0
179720,the,0,0
179721,benefit,0,0
179722,of,0,0
179723,tramadol,0,0
179724,for,0,0
179725,postsurgical,0,0
179726,neonates,0,1
179727,.,0,0
179728,Importantly,0,0
179729,",",0,0
179730,no,0,0
179731,seizures,0,0
179732,occurred,0,0
179733,in,0,0
179734,these,0,0
179735,ill,0,1
179736,neonates,0,1
179737,who,0,1
179738,may,0,0
179739,potentially,0,0
179740,be,0,0
179741,at,0,0
179742,greater,0,0
179743,risk,0,0
179744,of,0,0
179745,tramadol,0,0
179746,toxicity,0,0
179747,compared,0,0
179748,with,0,1
179749,adults,1,1
179750,.,1,1
179751,Physical,0,0
179752,and,0,0
179753,perceptual,0,0
179754,cooling,0,0
179755,with,0,1
179756,beverages,0,0
179757,to,0,0
179758,increase,0,0
179759,cycle,0,0
179760,performance,0,0
179761,in,0,0
179762,a,0,0
179763,tropical,0,1
179764,climate,0,0
179765,.,0,0
179766,PURPOSE,0,0
179767,This,0,0
179768,study,0,0
179769,compares,0,0
179770,the,0,0
179771,effects,0,0
179772,of,0,0
179773,neutral,0,1
179774,temperature,0,0
179775,",",0,0
179776,cold,0,0
179777,and,0,0
179778,ice-slush,0,0
179779,beverages,0,0
179780,",",0,0
179781,with,0,1
179782,and,0,0
179783,without,0,1
179784,0.5,0,0
179785,%,0,0
179786,menthol,0,0
179787,on,0,0
179788,cycling,0,0
179789,performance,0,0
179790,",",0,0
179791,core,0,0
179792,temperature,0,0
179793,(,0,0
179794,Tco,0,0
179795,),0,0
179796,and,0,0
179797,stress,0,0
179798,responses,0,0
179799,in,0,0
179800,a,0,0
179801,tropical,0,1
179802,climate,0,0
179803,(,0,0
179804,hot,0,0
179805,and,0,0
179806,humid,0,1
179807,conditions,0,0
179808,),0,1
179809,.,0,1
179810,METHODS,0,0
179811,Twelve,1,1
179812,trained,1,1
179813,male,1,1
179814,cyclists/triathletes,1,0
179815,completed,0,1
179816,six,0,1
179817,20-km,0,0
179818,exercise,0,0
179819,trials,0,0
179820,against,0,0
179821,the,0,0
179822,clock,0,0
179823,in,0,0
179824,30.7?C?0.8?C,0,0
179825,and,0,0
179826,78,0,1
179827,%,0,0
179828,?0.03,0,0
179829,%,0,0
179830,relative,0,0
179831,humidity,0,0
179832,.,0,0
179833,Before,0,0
179834,and,0,0
179835,after,0,0
179836,warm-up,0,0
179837,",",0,0
179838,and,0,0
179839,before,0,0
179840,exercise,0,0
179841,and,0,0
179842,every,0,0
179843,5,0,0
179844,km,0,0
179845,during,0,0
179846,exercise,0,0
179847,",",0,0
179848,athletes,0,1
179849,drank,0,0
179850,190,0,0
179851,mL,0,0
179852,of,0,0
179853,either,0,0
179854,aromatized,0,0
179855,(,0,0
179856,i.e.,0,0
179857,",",0,0
179858,with,0,1
179859,0.5,0,0
179860,mL,0,0
179861,of,0,0
179862,menthol,0,0
179863,(,0,0
179864,5,0,0
179865,gr/L,0,1
179866,),0,0
179867,),0,0
179868,or,0,0
179869,a,0,0
179870,non-aromatized,0,0
179871,beverage,0,0
179872,(,0,0
179873,neutral,0,1
179874,temperature,0,0
179875,:,0,1
179876,23?C?0.1?C,0,0
179877,",",0,0
179878,cold,0,0
179879,:,0,0
179880,3?C?0.1?C,0,0
179881,",",0,0
179882,or,0,0
179883,ice-slush,0,0
179884,:,0,1
179885,-1?C?0.7?C,0,0
179886,),0,0
179887,.,0,0
179888,During,0,0
179889,the,0,0
179890,trials,0,0
179891,",",0,0
179892,heart,0,1
179893,rate,0,0
179894,(,0,0
179895,HR,0,0
179896,),0,0
179897,was,0,0
179898,continuously,0,0
179899,monitored,0,0
179900,",",0,0
179901,whereas,0,0
179902,core,0,0
179903,temperature,0,0
179904,(,0,0
179905,Tco,0,0
179906,),0,0
179907,",",0,0
179908,thermal,0,0
179909,comfort,0,0
179910,(,0,0
179911,TC,0,0
179912,),0,0
179913,",",0,0
179914,thermal,0,0
179915,sensation,0,0
179916,(,0,0
179917,TS,0,1
179918,),0,0
179919,and,0,0
179920,rate,0,0
179921,of,0,0
179922,perceived,0,0
179923,exertion,0,0
179924,(,0,0
179925,RPE,0,0
179926,),0,0
179927,were,0,0
179928,measured,0,0
179929,before,0,0
179930,and,0,0
179931,after,0,0
179932,warm-up,0,0
179933,",",0,0
179934,every,0,0
179935,5,0,0
179936,km,0,0
179937,of,0,0
179938,exercise,0,0
179939,",",0,0
179940,and,0,0
179941,at,0,0
179942,the,0,0
179943,end,0,0
179944,of,0,0
179945,exercise,0,0
179946,and,0,0
179947,after,0,0
179948,recovery,0,0
179949,.,0,0
179950,RESULTS,0,0
179951,Both,0,0
179952,the,0,0
179953,beverage,0,0
179954,aroma,0,0
179955,(,0,0
179956,P,0,0
179957,<,0,0
179958,0.02,0,0
179959,),0,0
179960,and,0,0
179961,beverage,0,0
179962,temperature,0,0
179963,(,0,0
179964,P,0,0
179965,<,0,0
179966,0.02,0,0
179967,),0,0
179968,had,0,0
179969,significant,0,0
179970,and,0,0
179971,positive,0,0
179972,effects,0,0
179973,on,0,0
179974,performance,0,0
179975,",",0,0
179976,which,0,0
179977,was,0,0
179978,considerably,0,0
179979,better,0,0
179980,with,0,0
179981,ice-slush,0,0
179982,than,0,0
179983,with,0,1
179984,a,0,0
179985,neutral,0,0
179986,temperature,0,0
179987,beverage,0,0
179988,",",0,0
179989,whatever,0,0
179990,the,0,0
179991,aroma,0,0
179992,(,0,0
179993,P,0,0
179994,<,0,0
179995,0.002,0,0
179996,),0,0
179997,",",0,0
179998,and,0,0
179999,with,0,0
180000,menthol,0,0
180001,vs,0,0
180002,non-menthol,0,0
180003,(,0,0
180004,P,0,0
180005,<,0,0
180006,0.02,0,0
180007,),0,0
180008,.,0,0
180009,The,0,0
180010,best,0,0
180011,performances,0,0
180012,were,0,0
180013,obtained,0,0
180014,with,0,1
180015,ice-slush/menthol,0,0
180016,and,0,0
180017,cold/menthol,0,0
180018,",",0,0
180019,as,0,0
180020,opposed,0,0
180021,to,0,0
180022,neutral/menthol,0,0
180023,.,0,0
180024,No,0,0
180025,differences,0,0
180026,were,0,0
180027,noted,0,0
180028,in,0,0
180029,HR,0,0
180030,and,0,0
180031,Tco,0,0
180032,between,0,0
180033,trials,0,0
180034,.,0,1
180035,CONCLUSION,0,0
180036,Cold,0,1
180037,water,0,0
180038,or,0,0
180039,ice-slush,0,0
180040,with,0,0
180041,menthol,0,0
180042,aroma,0,0
180043,seems,0,0
180044,to,0,0
180045,be,0,0
180046,the,0,0
180047,most,0,0
180048,effective,0,0
180049,beverage,0,0
180050,for,0,0
180051,endurance,0,0
180052,exercise,0,0
180053,in,0,0
180054,a,0,0
180055,tropical,0,1
180056,climate,0,0
180057,.,0,0
180058,Further,0,0
180059,studies,0,0
180060,are,0,0
180061,needed,0,0
180062,to,0,0
180063,explore,0,0
180064,its,0,0
180065,effects,0,0
180066,in,0,0
180067,field,0,0
180068,competition,0,0
180069,.,0,0
180070,Rioprostil,0,0
180071,",",0,0
180072,a,0,0
180073,new,0,0
180074,prostaglandin,0,0
180075,E1,0,1
180076,analogue,0,0
180077,",",0,0
180078,in,0,0
180079,the,0,0
180080,once-daily,0,0
180081,treatment,0,0
180082,for,0,0
180083,the,0,0
180084,prevention,0,0
180085,of,0,0
180086,duodenal,1,1
180087,ulcer,1,1
180088,recurrence,0,0
180089,:,0,1
180090,a,0,0
180091,comparison,0,0
180092,with,0,0
180093,ranitidine,0,0
180094,.,0,0
180095,The,0,0
180096,efficacy,0,0
180097,of,0,0
180098,Rioprostil,0,0
180099,(,0,0
180100,a,0,0
180101,new,0,0
180102,prostaglandin,0,0
180103,E1,0,1
180104,analogue,0,0
180105,),0,0
180106,is,0,0
180107,compared,0,0
180108,with,0,0
180109,that,0,0
180110,of,0,0
180111,ranitidine,0,0
180112,in,0,0
180113,the,0,0
180114,recurrence,0,0
180115,prevention,0,0
180116,of,0,0
180117,duodenal,0,1
180118,ulcer,0,1
180119,(,0,0
180120,s,0,0
180121,),0,0
180122,.,0,0
180123,Duration,0,0
180124,of,0,0
180125,treatment,0,0
180126,is,0,0
180127,6,0,0
180128,months,0,0
180129,.,0,1
180130,Ninety-seven,1,1
180131,patients,1,1
180132,received,1,0
180133,rioprostil,1,0
180134,",",1,0
180135,600,1,0
180136,micrograms,1,0
180137,once-daily,1,0
180138,orally,1,0
180139,",",1,0
180140,and,1,0
180141,110,1,1
180142,patients,1,1
180143,received,1,0
180144,ranitidine,1,0
180145,",",0,0
180146,150,0,0
180147,mg,0,0
180148,once-daily,0,0
180149,orally,0,0
180150,.,0,0
180151,On,0,0
180152,rioprostil,0,0
180153,",",0,0
180154,14.9,0,0
180155,%,0,0
180156,of,0,0
180157,patients,0,1
180158,showed,0,0
180159,a,0,0
180160,relapse,0,0
180161,after,0,0
180162,6,0,0
180163,months,0,0
180164,compared,0,0
180165,to,0,0
180166,10.1,0,0
180167,%,0,0
180168,on,0,0
180169,ranitidine,0,0
180170,.,0,0
180171,Diarrhoea,0,0
180172,occurred,0,0
180173,in,0,0
180174,7,0,0
180175,patients,0,1
180176,on,0,0
180177,rioprostil,0,0
180178,and,0,0
180179,3,0,0
180180,patients,0,1
180181,on,0,0
180182,ranitidine,0,0
180183,.,0,0
180184,Rioprostil,0,0
180185,given,0,0
180186,600,0,0
180187,micrograms,0,0
180188,daily,0,0
180189,in,0,0
180190,the,0,0
180191,evening,0,0
180192,is,0,0
180193,a,0,0
180194,highly,0,0
180195,effective,0,0
180196,treatment,0,0
180197,for,0,0
180198,the,0,0
180199,prevention,0,0
180200,of,0,0
180201,duodenal,0,1
180202,ulcer,0,1
180203,relapse,0,0
180204,",",0,0
180205,the,0,0
180206,efficacy,0,0
180207,not,0,0
180208,being,0,0
180209,significantly,0,0
180210,different,0,0
180211,from,0,0
180212,ranitidine,0,0
180213,150,0,0
180214,mg,0,0
180215,.,0,0
180216,Oxytocin,0,0
180217,improves,0,0
180218,behavioural,0,0
180219,and,0,0
180220,neural,0,0
180221,deficits,0,0
180222,in,0,0
180223,inferring,0,0
180224,others,0,0
180225,',0,1
180226,social,0,0
180227,emotions,0,0
180228,in,0,0
180229,autism,1,1
180230,.,1,0
180231,Recent,0,0
180232,studies,0,0
180233,have,0,0
180234,suggested,0,0
180235,oxytocin,0,0
180236,'s,0,0
180237,therapeutic,0,0
180238,effects,0,0
180239,on,0,0
180240,deficits,0,0
180241,in,0,0
180242,social,0,0
180243,communication,0,0
180244,and,0,0
180245,interaction,0,0
180246,in,0,0
180247,autism,1,1
180248,spectrum,1,1
180249,disorder,1,1
180250,through,0,0
180251,improvement,0,0
180252,of,0,0
180253,emotion,0,0
180254,recognition,0,0
180255,with,0,1
180256,direct,0,0
180257,emotional,0,0
180258,cues,0,0
180259,",",0,0
180260,such,0,0
180261,as,0,0
180262,facial,0,0
180263,expression,0,0
180264,and,0,0
180265,voice,0,0
180266,prosody,0,0
180267,.,0,0
180268,Although,0,0
180269,difficulty,0,0
180270,in,0,0
180271,understanding,0,0
180272,of,0,0
180273,others,0,0
180274,',0,1
180275,social,0,0
180276,emotions,0,0
180277,and,0,0
180278,beliefs,0,0
180279,under,0,1
180280,conditions,0,0
180281,without,0,1
180282,direct,0,0
180283,emotional,0,0
180284,cues,0,0
180285,also,0,0
180286,plays,0,0
180287,an,0,0
180288,important,0,0
180289,role,0,0
180290,in,0,0
180291,autism,1,1
180292,spectrum,1,1
180293,disorder,1,1
180294,",",0,0
180295,no,0,0
180296,study,0,0
180297,has,0,0
180298,examined,0,0
180299,the,0,0
180300,potential,0,0
180301,effect,0,0
180302,of,0,0
180303,oxytocin,0,0
180304,on,0,0
180305,this,0,0
180306,difficulty,0,0
180307,.,0,0
180308,Here,0,0
180309,",",0,0
180310,we,0,0
180311,sequentially,0,0
180312,conducted,0,0
180313,both,0,0
180314,a,0,0
180315,case-control,0,1
180316,study,0,0
180317,and,0,0
180318,a,0,0
180319,clinical,0,0
180320,trial,0,0
180321,to,0,0
180322,investigate,0,0
180323,the,0,0
180324,potential,0,0
180325,effects,0,0
180326,of,0,0
180327,oxytocin,0,0
180328,on,0,0
180329,this,0,0
180330,difficulty,0,0
180331,at,0,0
180332,behavioural,0,0
180333,and,0,0
180334,neural,0,0
180335,levels,0,0
180336,measured,0,0
180337,using,0,0
180338,functional,0,0
180339,magnetic,0,0
180340,resonance,0,0
180341,imaging,0,0
180342,during,0,0
180343,a,0,0
180344,psychological,0,0
180345,task,0,0
180346,.,0,0
180347,This,0,0
180348,task,0,0
180349,was,0,0
180350,modified,0,0
180351,from,0,0
180352,the,0,0
180353,Sally-Anne,0,0
180354,Task,0,0
180355,",",0,0
180356,a,0,0
180357,well-known,0,0
180358,first-order,0,0
180359,false,0,0
180360,belief,0,0
180361,task,0,0
180362,.,0,0
180363,The,0,0
180364,task,0,0
180365,was,0,0
180366,optimized,0,0
180367,for,0,0
180368,investigation,0,0
180369,of,0,0
180370,the,0,0
180371,abilities,0,0
180372,to,0,0
180373,infer,0,0
180374,another,0,0
180375,person,0,0
180376,'s,0,0
180377,social,0,0
180378,emotions,0,0
180379,and,0,0
180380,beliefs,0,0
180381,distinctively,0,0
180382,so,0,0
180383,as,0,0
180384,to,0,0
180385,test,0,0
180386,the,0,0
180387,hypothesis,0,0
180388,that,0,0
180389,oxytocin,0,0
180390,improves,0,0
180391,deficit,0,0
180392,in,0,0
180393,inferring,0,0
180394,others,0,0
180395,',0,1
180396,social,0,0
180397,emotions,0,0
180398,rather,0,0
180399,than,0,0
180400,beliefs,0,0
180401,",",0,0
180402,under,0,0
180403,conditions,0,0
180404,without,0,1
180405,direct,0,0
180406,emotional,0,0
180407,cues,0,0
180408,.,0,0
180409,In,0,0
180410,the,0,0
180411,case-control,0,1
180412,study,0,0
180413,",",0,0
180414,17,1,0
180415,males,1,1
180416,with,1,1
180417,autism,1,1
180418,spectrum,1,1
180419,disorder,1,1
180420,showed,0,0
180421,significant,0,0
180422,behavioural,0,0
180423,deficits,0,0
180424,in,0,0
180425,inferring,0,0
180426,others,0,0
180427,',0,1
180428,social,0,0
180429,emotions,0,0
180430,(,0,0
180431,P,0,0
180432,=,0,0
180433,0.018,0,0
180434,),0,0
180435,but,0,0
180436,not,0,0
180437,in,0,0
180438,inferring,0,0
180439,others,0,0
180440,',0,1
180441,beliefs,0,0
180442,(,0,1
180443,P,0,0
180444,=,0,0
180445,0.064,0,0
180446,),0,0
180447,compared,0,0
180448,with,0,1
180449,17,1,0
180450,typically,1,1
180451,developing,1,0
180452,demographically-matched,1,1
180453,male,1,1
180454,participants,1,1
180455,.,1,0
180456,They,0,0
180457,also,0,0
180458,showed,0,0
180459,significantly,0,0
180460,less,0,0
180461,activity,0,0
180462,in,0,0
180463,the,0,0
180464,right,0,0
180465,anterior,0,0
180466,insula,0,0
180467,and,0,0
180468,posterior,0,0
180469,superior,0,0
180470,temporal,0,0
180471,sulcus,0,0
180472,during,0,0
180473,inferring,0,0
180474,others,0,0
180475,',0,1
180476,social,0,0
180477,emotions,0,0
180478,",",0,0
180479,and,0,0
180480,in,0,0
180481,the,0,0
180482,dorsomedial,0,0
180483,prefrontal,0,0
180484,cortex,0,0
180485,during,0,0
180486,inferring,0,0
180487,others,0,0
180488,',0,1
180489,beliefs,0,0
180490,compared,0,0
180491,with,0,1
180492,the,0,0
180493,typically,0,0
180494,developing,0,0
180495,participants,0,1
180496,(,0,1
180497,P,0,0
180498,<,0,0
180499,0.001,0,0
180500,and,0,0
180501,cluster,0,0
180502,size,0,0
180503,>,0,1
180504,10,0,1
180505,voxels,0,0
180506,),0,0
180507,.,0,0
180508,Then,0,0
180509,",",0,0
180510,to,0,0
180511,investigate,0,0
180512,potential,0,0
180513,effects,0,0
180514,of,0,0
180515,oxytocin,0,0
180516,on,0,0
180517,these,0,0
180518,behavioural,0,0
180519,and,0,0
180520,neural,0,0
180521,deficits,0,0
180522,",",0,0
180523,we,0,0
180524,conducted,0,0
180525,a,0,0
180526,double-blind,0,0
180527,placebo-controlled,0,0
180528,crossover,0,0
180529,within-subject,0,0
180530,trial,0,0
180531,for,0,0
180532,single-dose,0,0
180533,intranasal,0,0
180534,administration,0,0
180535,of,0,0
180536,24,0,0
180537,IU,0,0
180538,oxytocin,0,0
180539,in,0,0
180540,an,0,0
180541,independent,0,0
180542,group,0,0
180543,of,0,0
180544,20,1,1
180545,males,1,1
180546,with,1,1
180547,autism,1,1
180548,spectrum,1,1
180549,disorder,1,1
180550,.,1,0
180551,Behaviourally,0,0
180552,",",0,0
180553,oxytocin,0,0
180554,significantly,0,0
180555,increased,0,0
180556,the,0,0
180557,correct,0,0
180558,rate,0,0
180559,in,0,0
180560,inferring,0,0
180561,others,0,0
180562,',0,1
180563,social,0,0
180564,emotions,0,0
180565,(,0,0
180566,P,0,0
180567,=,0,0
180568,0.043,0,0
180569,",",0,0
180570,one-tail,0,0
180571,),0,0
180572,.,0,0
180573,At,0,0
180574,the,0,0
180575,neural,0,0
180576,level,0,0
180577,",",0,0
180578,the,0,0
180579,peptide,0,0
180580,significantly,0,0
180581,enhanced,0,0
180582,the,0,0
180583,originally-diminished,0,0
180584,brain,0,0
180585,activity,0,0
180586,in,0,0
180587,the,0,0
180588,right,0,0
180589,anterior,0,0
180590,insula,0,0
180591,during,0,0
180592,inferring,0,0
180593,others,0,0
180594,',0,1
180595,social,0,0
180596,emotions,0,0
180597,(,0,0
180598,P,0,0
180599,=,0,0
180600,0.004,0,0
180601,),0,0
180602,",",0,0
180603,but,0,0
180604,not,0,0
180605,in,0,0
180606,the,0,0
180607,dorsomedial,0,0
180608,prefrontal,0,0
180609,cortex,0,0
180610,during,0,0
180611,inferring,0,0
180612,others,0,0
180613,',0,1
180614,beliefs,0,0
180615,(,0,1
180616,P,0,0
180617,=,0,0
180618,0.858,0,0
180619,),0,0
180620,.,0,0
180621,The,0,0
180622,present,0,0
180623,findings,0,0
180624,suggest,0,0
180625,that,0,0
180626,oxytocin,0,0
180627,enhances,0,0
180628,the,0,0
180629,ability,0,0
180630,to,0,0
180631,understand,0,0
180632,others,0,0
180633,',0,1
180634,social,0,0
180635,emotions,0,0
180636,that,0,0
180637,have,0,0
180638,also,0,0
180639,required,0,0
180640,second-order,0,0
180641,false,0,0
180642,belief,0,0
180643,rather,0,0
180644,than,0,0
180645,first-order,0,0
180646,false,0,1
180647,beliefs,0,0
180648,under,0,1
180649,conditions,0,0
180650,without,0,1
180651,direct,0,0
180652,emotional,0,0
180653,cues,0,0
180654,in,0,0
180655,autism,1,1
180656,spectrum,1,1
180657,disorder,1,1
180658,at,0,0
180659,both,0,0
180660,the,0,0
180661,behaviour,0,0
180662,and,0,0
180663,neural,0,0
180664,levels,0,0
180665,.,0,1
180666,Use,0,0
180667,of,0,0
180668,Transcutaneous,0,0
180669,Electrical,0,0
180670,Nerve,0,1
180671,Stimulation,0,0
180672,Device,0,0
180673,in,0,0
180674,Early,1,0
180675,Osteoarthritis,1,1
180676,of,1,0
180677,the,1,0
180678,Knee,1,1
180679,.,1,0
180680,Some,0,0
180681,have,0,0
180682,proposed,0,0
180683,the,0,0
180684,use,0,0
180685,of,0,0
180686,transcutaneous,0,0
180687,electrical,0,0
180688,nerve,0,0
180689,stimulation,0,0
180690,(,0,0
180691,TENS,0,0
180692,),0,0
180693,as,0,0
180694,an,0,0
180695,adjunct,0,0
180696,to,0,0
180697,the,0,0
180698,current,0,0
180699,standard,0,0
180700,of,0,0
180701,care,0,0
180702,in,0,0
180703,treatment,0,0
180704,of,0,0
180705,osteoarthritis,1,1
180706,knee,1,1
180707,pain,1,0
180708,.,1,0
180709,The,0,0
180710,purpose,0,0
180711,of,0,0
180712,this,0,0
180713,study,0,0
180714,was,0,0
180715,to,0,0
180716,evaluate,0,0
180717,the,0,0
180718,effects,0,0
180719,of,0,0
180720,TENS,0,0
180721,on,0,0
180722,the,0,0
180723,following,0,0
180724,issues,0,0
180725,in,0,1
180726,patients,1,1
180727,who,1,1
180728,have,1,1
180729,early-stage,1,1
180730,osteoarthritis,1,1
180731,of,1,0
180732,the,1,0
180733,knee,1,1
180734,:,1,0
180735,(,0,0
180736,1,0,0
180737,),0,0
180738,pain,0,0
180739,reduction,0,0
180740,;,0,0
180741,(,0,0
180742,2,0,0
180743,),0,0
180744,subjective,0,0
180745,and,0,0
180746,(,0,0
180747,3,0,0
180748,),0,0
180749,objective,0,0
180750,functional,0,1
180751,improvements,0,0
180752,;,0,0
180753,(,0,0
180754,4,0,0
180755,),0,0
180756,quality-of-life,0,0
180757,(,0,0
180758,QOL,0,0
180759,),0,0
180760,measure,0,0
180761,improvements,0,0
180762,;,0,0
180763,and,0,0
180764,(,0,0
180765,5,0,0
180766,),0,0
180767,isokinetic,0,0
180768,strength,0,0
180769,.,0,0
180770,A,0,0
180771,prospective,0,0
180772,",",0,0
180773,randomized,0,0
180774,",",0,0
180775,and,0,0
180776,single-blinded,0,0
180777,trial,0,0
180778,was,0,0
180779,performed,0,0
180780,on,0,0
180781,23,1,1
180782,patients,1,1
180783,who,0,1
180784,were,0,1
180785,randomized,0,1
180786,to,0,0
180787,either,0,0
180788,novel,0,0
180789,TENS,0,0
180790,device,0,0
180791,or,0,0
180792,standard,0,0
180793,of,0,0
180794,care,0,0
180795,.,0,1
180796,Metrics,0,0
180797,analyzed,0,0
180798,included,0,1
180799,stair-climb,0,0
180800,test,0,0
180801,;,0,0
180802,timed-up-and-go,0,0
180803,test,0,0
180804,(,0,0
180805,TUGT,0,1
180806,),0,0
180807,;,0,0
180808,2-minute,0,0
180809,walk,0,0
180810,test,0,0
180811,;,0,0
180812,20,0,0
180813,times,0,0
180814,",",0,0
180815,single,0,0
180816,leg,0,0
180817,6-inch,0,0
180818,step,0,0
180819,test,0,0
180820,;,0,0
180821,five-repetition,0,0
180822,chair-rise,0,0
180823,test,0,0
180824,;,0,0
180825,active,0,0
180826,and,0,0
180827,passive,0,0
180828,range-of-motion,0,0
180829,(,0,0
180830,ROM,0,0
180831,),0,0
180832,score,0,0
180833,;,0,0
180834,short,0,0
180835,form,0,0
180836,health,0,1
180837,survey-36,0,0
180838,scores,0,0
180839,(,0,0
180840,SF-36,0,0
180841,),0,0
180842,score,0,0
180843,;,0,0
180844,Knee,0,1
180845,Society,0,1
180846,Score,0,0
180847,(,0,0
180848,KSS,0,0
180849,),0,0
180850,;,0,0
180851,lower,0,0
180852,extremity,0,0
180853,functional,0,0
180854,scale,0,0
180855,(,0,0
180856,LEFS,0,0
180857,),0,0
180858,;,0,0
180859,visual,0,0
180860,analog,0,0
180861,scale,0,0
180862,(,0,0
180863,VAS,0,1
180864,),0,0
180865,;,0,0
180866,and,0,0
180867,isokinetic,0,0
180868,quadriceps,0,0
180869,and,0,0
180870,hamstring,0,1
180871,strength,0,0
180872,.,0,0
180873,In,0,0
180874,objective,0,0
180875,functional,0,0
180876,scores,0,0
180877,",",0,0
180878,TENS,0,0
180879,had,0,0
180880,significant,0,0
180881,improvements,0,0
180882,in,0,0
180883,TUGT,0,1
180884,and,0,0
180885,objective,0,0
180886,KSS,0,0
180887,when,0,0
180888,compared,0,0
180889,with,0,0
180890,the,0,0
180891,matching,0,0
180892,cohort,0,1
180893,.,0,0
180894,Subjective,0,0
180895,functional,0,0
180896,and,0,0
180897,QOL,0,0
180898,outcomes,0,0
180899,patients,0,1
180900,had,0,0
180901,a,0,0
180902,significant,0,0
180903,improvement,0,0
180904,of,0,0
180905,their,0,0
180906,LEFS,0,0
180907,and,0,0
180908,SF-36,0,0
180909,physical,0,0
180910,component,0,0
180911,with,0,0
180912,the,0,0
180913,use,0,0
180914,of,0,0
180915,TENS,0,0
180916,brace,0,1
180917,.,0,0
180918,The,0,0
180919,TENS,0,0
180920,device,0,0
180921,significantly,0,0
180922,improved,0,0
180923,the,0,0
180924,quadriceps,0,0
180925,strength,0,0
180926,when,0,0
180927,compared,0,0
180928,with,0,0
180929,standard,0,0
180930,therapy,0,0
180931,.,0,0
180932,In,0,0
180933,evaluation,0,0
180934,for,0,0
180935,improvement,0,0
180936,within,0,0
180937,the,0,0
180938,TENS,0,0
180939,cohort,0,0
180940,",",0,0
180941,patients,0,1
180942,had,0,0
180943,a,0,0
180944,significant,0,0
180945,improvement,0,0
180946,at,0,0
180947,3-month,0,0
180948,follow-up,0,0
180949,in,0,0
180950,the,0,0
180951,TUG,0,0
180952,test,0,0
180953,",",0,0
180954,timed,0,0
180955,stair-climb,0,0
180956,test,0,0
180957,",",0,0
180958,20-times,0,0
180959,single,0,0
180960,leg,0,0
180961,",",0,0
180962,KSS,0,0
180963,",",0,0
180964,LEFS,0,0
180965,",",0,0
180966,and,0,0
180967,SF-36,0,0
180968,physical,0,0
180969,component,0,0
180970,compared,0,0
180971,to,0,0
180972,their,0,0
180973,initial,0,0
180974,visit,0,0
180975,.,0,0
180976,In,0,0
180977,addition,0,0
180978,",",0,0
180979,within,0,0
180980,the,0,0
180981,TENS,0,0
180982,cohort,0,0
180983,",",0,0
180984,patients,0,1
180985,had,0,0
180986,a,0,0
180987,significant,0,0
180988,reduction,0,0
180989,in,0,0
180990,pain,0,0
180991,via,0,0
180992,VAS,0,0
180993,at,0,0
180994,their,0,0
180995,3-month,0,0
180996,follow-up,0,0
180997,.,0,0
180998,In,0,0
180999,conclusion,0,0
181000,",",0,0
181001,the,0,0
181002,use,0,0
181003,of,0,0
181004,TENS,0,0
181005,for,0,0
181006,3,0,0
181007,months,0,0
181008,has,0,0
181009,shown,0,0
181010,encouraging,0,0
181011,results,0,0
181012,to,0,0
181013,improve,0,0
181014,pain,0,0
181015,",",0,0
181016,function,0,0
181017,",",0,0
181018,and,0,0
181019,QOL,0,0
181020,in,0,0
181021,patients,1,1
181022,with,1,1
181023,painful,1,0
181024,osteoarthritic,1,1
181025,knees,1,1
181026,",",0,0
181027,and,0,0
181028,could,0,0
181029,positively,0,0
181030,contribute,0,0
181031,as,0,0
181032,an,0,0
181033,adjunct,0,0
181034,to,0,0
181035,current,0,0
181036,nonoperative,0,1
181037,treatment,0,0
181038,of,0,0
181039,knee,0,1
181040,arthritis,0,1
181041,.,0,0
181042,However,0,0
181043,",",0,0
181044,given,0,0
181045,our,0,0
181046,small,0,0
181047,sample,0,1
181048,size,0,0
181049,",",0,0
181050,larger,0,0
181051,randomized,0,0
181052,studies,0,0
181053,are,0,0
181054,needed,0,0
181055,to,0,0
181056,further,0,0
181057,evaluate,0,0
181058,these,0,0
181059,outcomes,0,0
181060,.,0,0
181061,Tofacitinib,0,0
181062,with,0,1
181063,methotrexate,0,0
181064,in,0,0
181065,third-line,0,0
181066,treatment,0,0
181067,of,0,0
181068,patients,1,1
181069,with,1,1
181070,active,1,1
181071,rheumatoid,1,1
181072,arthritis,1,1
181073,:,1,1
181074,patient-reported,0,0
181075,outcomes,0,0
181076,from,0,0
181077,a,0,0
181078,phase,0,0
181079,III,0,0
181080,trial,0,0
181081,.,0,0
181082,OBJECTIVE,0,0
181083,To,0,0
181084,assess,0,0
181085,patient-reported,0,0
181086,outcomes,0,0
181087,(,0,0
181088,PROs,0,1
181089,),0,0
181090,for,0,0
181091,tofacitinib,0,0
181092,",",0,0
181093,an,0,0
181094,oral,0,0
181095,JAK,0,0
181096,inhibitor,0,0
181097,for,0,0
181098,the,0,0
181099,treatment,0,0
181100,of,0,0
181101,rheumatoid,0,1
181102,arthritis,0,1
181103,(,0,0
181104,RA,0,0
181105,),0,0
181106,",",0,0
181107,in,0,0
181108,a,0,0
181109,6-month,0,0
181110,",",0,0
181111,phase,0,0
181112,III,0,0
181113,",",0,0
181114,randomized,0,0
181115,controlled,0,0
181116,trial,0,0
181117,.,0,1
181118,METHODS,0,0
181119,Patients,1,1
181120,ages,1,1
181121,?18,1,1
181122,years,1,1
181123,with,1,1
181124,active,1,1
181125,RA,1,0
181126,with,1,1
181127,an,1,0
181128,inadequate,1,0
181129,response,1,0
181130,to,1,0
181131,?1,1,0
181132,tumor,1,0
181133,necrosis,1,0
181134,factor,1,0
181135,inhibitor,1,0
181136,(,1,0
181137,TNFi,1,0
181138,),1,0
181139,and,1,0
181140,receiving,1,0
181141,stable,1,1
181142,background,1,0
181143,methotrexate,1,0
181144,were,1,0
181145,randomized,1,0
181146,2:2:1:1,1,1
181147,to,1,0
181148,tofacitinib,1,0
181149,5,1,0
181150,mg,1,0
181151,or,1,0
181152,10,1,0
181153,mg,1,0
181154,twice,1,0
181155,daily,1,0
181156,",",1,0
181157,or,1,0
181158,placebo,1,0
181159,advanced,1,1
181160,to,1,0
181161,tofacitinib,1,0
181162,5,1,0
181163,mg,1,0
181164,or,1,0
181165,10,1,0
181166,mg,1,0
181167,twice,1,0
181168,daily,1,0
181169,at,1,0
181170,month,1,0
181171,3,1,0
181172,.,1,1
181173,PROs,0,0
181174,measured,0,0
181175,at,0,0
181176,month,0,0
181177,3,0,0
181178,included,0,1
181179,patient,0,0
181180,global,0,0
181181,assessment,0,0
181182,of,0,0
181183,disease,0,1
181184,activity,0,0
181185,(,0,0
181186,PtGA,0,1
181187,),0,0
181188,",",0,0
181189,pain,0,0
181190,",",0,0
181191,Health,0,0
181192,Assessment,0,0
181193,Questionnaire,0,0
181194,(,0,0
181195,HAQ,0,1
181196,),0,0
181197,disability,0,0
181198,index,0,0
181199,(,0,0
181200,DI,0,0
181201,),0,0
181202,",",0,0
181203,Medical,0,1
181204,Outcomes,0,0
181205,Study,0,0
181206,(,0,0
181207,MOS,0,0
181208,),0,0
181209,Short,0,1
181210,Form,0,0
181211,36,0,1
181212,Health,0,0
181213,Survey,0,0
181214,version,0,0
181215,2,0,0
181216,(,0,0
181217,SF-36v2,0,0
181218,;,0,0
181219,acute,0,1
181220,),0,0
181221,",",0,0
181222,Functional,0,0
181223,Assessment,0,0
181224,of,0,0
181225,Chronic,0,1
181226,Illness,0,0
181227,Therapy-Fatigue,0,0
181228,(,0,0
181229,FACIT-F,0,0
181230,),0,0
181231,",",0,0
181232,and,0,0
181233,MOS,0,0
181234,Sleep,0,0
181235,Scale,0,0
181236,.,0,1
181237,RESULTS,0,0
181238,Patients,0,1
181239,received,0,1
181240,tofacitinib,0,0
181241,5,0,0
181242,mg,0,0
181243,(,0,0
181244,n,0,1
181245,=,0,0
181246,133,0,1
181247,),0,0
181248,or,0,0
181249,10,0,0
181250,mg,0,0
181251,(,0,0
181252,n,0,1
181253,=,0,0
181254,134,0,1
181255,),0,0
181256,or,0,0
181257,placebo,0,0
181258,advanced,0,1
181259,to,0,0
181260,tofacitinib,0,0
181261,5,0,0
181262,mg,0,0
181263,(,0,0
181264,n,0,1
181265,=,0,0
181266,66,0,1
181267,),0,0
181268,or,0,0
181269,10,0,0
181270,mg,0,0
181271,(,0,0
181272,n,0,1
181273,=,0,0
181274,66,0,1
181275,),0,0
181276,.,0,0
181277,HAQ,0,0
181278,DI,0,0
181279,(,0,0
181280,reported,0,0
181281,previously,0,0
181282,),0,0
181283,",",0,0
181284,PtGA,0,1
181285,(,0,0
181286,P,0,0
181287,<,0,0
181288,0.0001,0,0
181289,),0,0
181290,",",0,0
181291,and,0,0
181292,SF-36v2,0,0
181293,physical,0,0
181294,and,0,0
181295,mental,0,1
181296,component,0,0
181297,summary,0,0
181298,(,0,0
181299,P,0,0
181300,<,0,0
181301,0.05,0,0
181302,),0,0
181303,scores,0,0
181304,were,0,0
181305,improved,0,0
181306,for,0,0
181307,both,0,0
181308,tofacitinib,0,0
181309,doses,0,0
181310,versus,0,0
181311,placebo,0,0
181312,.,0,0
181313,Furthermore,0,0
181314,",",0,0
181315,improvements,0,0
181316,greater,0,0
181317,than,0,0
181318,or,0,0
181319,equal,0,0
181320,to,0,0
181321,the,0,0
181322,minimum,0,0
181323,clinically,0,0
181324,important,0,0
181325,difference,0,0
181326,were,0,0
181327,more,0,0
181328,frequently,0,0
181329,reported,0,0
181330,by,0,0
181331,tofacitinib-treated,0,0
181332,patients,0,1
181333,versus,0,0
181334,placebo,0,0
181335,for,0,0
181336,PtGA,0,1
181337,(,0,0
181338,P,0,0
181339,<,0,0
181340,0.05,0,0
181341,),0,0
181342,",",0,0
181343,pain,0,0
181344,(,0,0
181345,P,0,0
181346,<,0,0
181347,0.0001,0,0
181348,),0,0
181349,",",0,0
181350,HAQ,0,1
181351,DI,0,0
181352,(,0,0
181353,P,0,0
181354,<,0,0
181355,0.05,0,0
181356,),0,0
181357,",",0,0
181358,SF-36v2,0,0
181359,physical,0,0
181360,and,0,0
181361,mental,0,1
181362,component,0,0
181363,summary,0,0
181364,scores,0,0
181365,(,0,0
181366,P,0,0
181367,<,0,0
181368,0.05,0,0
181369,),0,0
181370,",",0,0
181371,and,0,0
181372,FACIT-F,0,0
181373,(,0,0
181374,P,0,0
181375,<,0,0
181376,0.001,0,0
181377,for,0,0
181378,5,0,0
181379,mg,0,0
181380,twice,0,0
181381,daily,0,0
181382,),0,0
181383,.,0,0
181384,No,0,0
181385,statistical,0,0
181386,differences,0,0
181387,were,0,0
181388,observed,0,0
181389,in,0,0
181390,the,0,0
181391,MOS,0,0
181392,Sleep,0,0
181393,Scale,0,0
181394,.,0,0
181395,CONCLUSION,0,0
181396,Tofacitinib,0,0
181397,treatment,0,0
181398,resulted,0,0
181399,in,0,0
181400,significant,0,0
181401,",",0,0
181402,clinically,0,0
181403,meaningful,0,0
181404,improvements,0,0
181405,in,0,0
181406,multiple,0,0
181407,PROs,0,0
181408,versus,0,0
181409,placebo,0,0
181410,over,0,0
181411,3,0,0
181412,months,0,0
181413,of,0,0
181414,treatment,1,0
181415,in,1,0
181416,patients,1,1
181417,with,1,1
181418,active,1,1
181419,RA,1,0
181420,and,1,0
181421,a,1,0
181422,previous,1,0
181423,inadequate,1,0
181424,response,1,0
181425,to,1,0
181426,TNFi,1,0
181427,.,1,0
181428,The,0,0
181429,dispatcher,0,0
181430,assisted,0,0
181431,resuscitation,0,0
181432,trial,0,0
181433,:,0,1
181434,indirect,0,0
181435,benefits,0,0
181436,of,0,0
181437,emergency,0,1
181438,research,0,0
181439,.,0,0
181440,OBJECTIVE,0,0
181441,Conduct,0,0
181442,of,0,0
181443,emergency,0,1
181444,research,0,0
181445,under,0,0
181446,waiver,0,1
181447,of,0,0
181448,consent,0,0
181449,produces,0,0
181450,special,0,0
181451,challenges,0,0
181452,.,0,0
181453,Moreover,0,0
181454,",",0,0
181455,the,0,0
181456,act,0,0
181457,of,0,0
181458,performing,0,0
181459,research,0,0
181460,may,0,0
181461,have,0,0
181462,unintended,0,0
181463,effects,0,0
181464,",",0,0
181465,potentially,0,0
181466,beneficial,0,0
181467,or,0,0
181468,detrimental,0,0
181469,.,0,0
181470,The,0,0
181471,Dispatcher-Assisted,0,0
181472,Randomized,0,0
181473,Trial,0,0
181474,(,0,0
181475,DART,0,0
181476,),0,0
181477,was,0,0
181478,designed,0,0
181479,to,0,0
181480,compare,0,0
181481,2,0,0
181482,types,0,0
181483,of,0,0
181484,dispatcher,0,0
181485,cardiopulmonary,0,1
181486,(,0,0
181487,CPR,0,0
181488,),0,0
181489,instruction,0,0
181490,",",0,0
181491,but,0,0
181492,not,0,0
181493,intended,0,0
181494,to,0,0
181495,affect,0,0
181496,the,0,0
181497,proportion,0,0
181498,of,0,0
181499,arrest,0,1
181500,victims,0,1
181501,that,0,0
181502,received,0,0
181503,bystander,0,0
181504,CPR,0,0
181505,.,0,0
181506,We,0,0
181507,sought,0,0
181508,to,0,0
181509,determine,0,0
181510,whether,0,0
181511,odds,0,0
181512,of,0,0
181513,receiving,0,1
181514,bystander,0,0
181515,CPR,0,0
181516,were,0,0
181517,higher,0,0
181518,during,0,0
181519,DART,0,0
181520,than,0,0
181521,during,0,0
181522,the,0,0
181523,periods,0,0
181524,before,0,0
181525,and,0,0
181526,after,0,0
181527,.,0,0
181528,METHODS,0,0
181529,We,0,0
181530,conducted,0,0
181531,an,0,0
181532,observational,0,0
181533,cohort,0,0
181534,study,0,0
181535,of,0,0
181536,8626,1,1
181537,adults,1,1
181538,who,1,1
181539,suffered,1,1
181540,non-traumatic,1,1
181541,out-of-hospital,1,1
181542,cardiac,1,0
181543,arrest,1,1
181544,prior,1,0
181545,to,1,0
181546,emergency,1,1
181547,medical,1,1
181548,services,1,1
181549,(,1,0
181550,EMS,1,0
181551,),1,0
181552,arrival,1,0
181553,in,1,0
181554,greater,1,0
181555,King,1,0
181556,County,1,1
181557,",",1,0
181558,Washington,1,1
181559,",",1,0
181560,between,1,0
181561,January,1,1
181562,1,1,0
181563,",",1,0
181564,1999,1,1
181565,",",1,0
181566,and,1,0
181567,December,1,1
181568,31,1,1
181569,",",1,0
181570,2011,1,1
181571,.,1,0
181572,Bystander,0,0
181573,CPR,0,0
181574,status,0,0
181575,was,0,0
181576,assessed,0,0
181577,through,0,0
181578,review,0,0
181579,of,0,0
181580,dispatch,0,0
181581,recordings,0,0
181582,and,0,0
181583,EMS,0,0
181584,reports,0,0
181585,to,0,0
181586,classify,0,0
181587,any,0,0
181588,bystander,0,0
181589,CPR,0,0
181590,(,0,0
181591,any,0,0
181592,B-CPR,0,0
181593,),0,0
181594,",",0,0
181595,and,0,0
181596,further,0,0
181597,categorized,0,0
181598,as,0,0
181599,bystander,0,0
181600,CPR,0,0
181601,with,0,0
181602,or,0,0
181603,without,0,0
181604,dispatcher,0,0
181605,assistance,0,0
181606,(,0,0
181607,DA-CPR,0,0
181608,and,0,0
181609,B-CPR,0,0
181610,",",0,0
181611,no,0,0
181612,DA,0,0
181613,),0,0
181614,.,0,0
181615,We,0,0
181616,used,0,0
181617,multivariable,0,0
181618,logistic,0,0
181619,regression,0,0
181620,to,0,0
181621,evaluate,0,0
181622,odds,0,0
181623,of,0,0
181624,B-CPR,0,0
181625,before,0,0
181626,",",0,0
181627,during,0,0
181628,",",0,0
181629,and,0,0
181630,after,0,0
181631,DART,0,0
181632,.,0,0
181633,RESULTS,0,0
181634,The,1,0
181635,proportions,1,0
181636,receiving,1,0
181637,any,1,0
181638,B-CPR,1,0
181639,were,1,0
181640,52,1,0
181641,%,1,0
181642,before,1,0
181643,DART,1,0
181644,(,1,0
181645,1817/3468,1,0
181646,),1,0
181647,",",1,0
181648,59,1,0
181649,%,1,0
181650,during,1,0
181651,DART,1,0
181652,(,1,0
181653,2093/3527,1,0
181654,),1,0
181655,",",1,0
181656,and,1,0
181657,54,1,0
181658,%,1,0
181659,after,1,0
181660,DART,1,0
181661,(,1,0
181662,885/1631,1,0
181663,),1,0
181664,.,1,0
181665,Compared,0,0
181666,to,0,0
181667,the,0,0
181668,period,0,0
181669,before,0,0
181670,DART,0,0
181671,",",0,0
181672,odds,0,0
181673,of,0,0
181674,receiving,0,1
181675,any,0,0
181676,B-CPR,0,0
181677,were,0,0
181678,higher,0,0
181679,during,0,0
181680,DART,0,0
181681,(,0,0
181682,OR=1.35,0,0
181683,",",0,0
181684,95,0,0
181685,%,0,0
181686,CI=1.23-1.49,0,0
181687,),0,0
181688,",",0,0
181689,but,0,0
181690,no,0,0
181691,different,0,0
181692,after,0,0
181693,(,0,0
181694,OR=1.10,0,0
181695,",",0,0
181696,0.98-1.24,0,0
181697,),0,0
181698,.,0,0
181699,Compared,0,0
181700,to,0,0
181701,the,0,0
181702,before,0,0
181703,period,0,0
181704,",",0,0
181705,odds,0,0
181706,of,0,0
181707,DA-CPR,0,1
181708,were,0,0
181709,higher,0,0
181710,during,0,0
181711,DART,0,0
181712,(,0,0
181713,OR=1.79,0,0
181714,",",0,0
181715,1.59-2.02,0,0
181716,),0,0
181717,but,0,0
181718,no,0,0
181719,different,0,0
181720,after,0,0
181721,(,0,0
181722,OR=0.94,0,0
181723,",",0,0
181724,0.80-1.10,0,0
181725,),0,0
181726,.,0,0
181727,CONCLUSIONS,0,0
181728,Odds,0,0
181729,of,0,0
181730,bystander,0,0
181731,CPR,0,0
181732,were,0,0
181733,higher,0,0
181734,during,0,0
181735,the,0,0
181736,trial,0,0
181737,",",0,0
181738,an,0,0
181739,increase,0,0
181740,related,0,0
181741,to,0,0
181742,higher,0,0
181743,likelihood,0,0
181744,of,0,0
181745,DA-CPR,0,0
181746,.,0,0
181747,The,0,0
181748,finding,0,0
181749,suggests,0,0
181750,a,0,0
181751,possible,0,0
181752,indirect,0,0
181753,community-wide,0,0
181754,benefit,0,0
181755,due,0,0
181756,to,0,0
181757,the,0,0
181758,interventional,0,0
181759,trial,0,0
181760,.,0,0
181761,Recommending,0,0
181762,self-paced,0,0
181763,exercise,0,0
181764,among,0,0
181765,overweight,1,1
181766,and,1,0
181767,obese,1,1
181768,adults,1,1
181769,:,1,1
181770,a,0,0
181771,randomized,0,0
181772,pilot,0,0
181773,study,0,0
181774,.,0,0
181775,BACKGROUND,0,0
181776,National,0,0
181777,guidelines,0,0
181778,call,0,0
181779,for,0,0
181780,exercise,0,0
181781,of,0,0
181782,at,0,0
181783,least,0,0
181784,moderate,0,1
181785,intensity,0,0
181786,;,0,0
181787,however,0,0
181788,",",0,0
181789,recommending,0,0
181790,self-paced,0,0
181791,exercise,0,0
181792,may,0,0
181793,lead,0,0
181794,to,0,0
181795,better,0,0
181796,adherence,0,0
181797,",",0,0
181798,particularly,0,0
181799,among,0,0
181800,overweight,1,0
181801,and,1,0
181802,obese,1,1
181803,adults,1,1
181804,.,1,0
181805,PURPOSE,0,0
181806,The,0,0
181807,purpose,0,0
181808,of,0,0
181809,this,0,0
181810,study,0,0
181811,was,0,0
181812,to,0,0
181813,test,0,0
181814,proof-of-concept,0,0
181815,for,0,0
181816,recommending,0,0
181817,self-paced,0,0
181818,exercise,0,0
181819,among,0,0
181820,overweight,0,1
181821,adults,0,1
181822,.,0,1
181823,METHODS,0,0
181824,Fifty-nine,1,1
181825,healthy,1,1
181826,",",1,0
181827,low-active,1,0
181828,(,1,0
181829,exercise,1,0
181830,<,1,0
181831,60,1,0
181832,min/week,1,0
181833,),1,0
181834,",",1,0
181835,overweight,1,0
181836,(,1,0
181837,body,1,0
181838,mass,1,0
181839,index,1,0
181840,25.0-39.9,1,1
181841,),1,0
181842,adults,1,1
181843,(,1,0
181844,18-65,1,1
181845,),1,0
181846,received,0,0
181847,a,0,0
181848,6-month,0,0
181849,print-based,0,0
181850,exercise,0,0
181851,promotion,0,0
181852,program,0,0
181853,with,0,0
181854,the,0,0
181855,goal,0,0
181856,of,0,0
181857,walking,0,0
181858,30-60,0,0
181859,min/day,0,0
181860,.,0,1
181861,Participants,0,1
181862,were,0,0
181863,surreptitiously,0,1
181864,randomly,0,0
181865,assigned,0,0
181866,to,0,0
181867,receive,0,0
181868,a,0,0
181869,recommendation,0,0
181870,for,0,0
181871,either,0,0
181872,self-paced,0,0
181873,(,0,0
181874,n,0,1
181875,=,0,0
181876,30,0,1
181877,),0,0
181878,or,0,0
181879,moderate,0,1
181880,(,0,0
181881,64-76,0,1
181882,%,0,0
181883,maximum,0,0
181884,heart,0,1
181885,rate,0,0
181886,;,0,0
181887,n,0,0
181888,=,0,0
181889,29,0,1
181890,),0,0
181891,intensity,0,0
181892,exercise,1,0
181893,.,1,0
181894,All,1,0
181895,participants,1,0
181896,used,1,0
181897,electronic,1,0
181898,diaries,1,0
181899,and,1,0
181900,heart,1,1
181901,rate,1,0
181902,monitors,1,0
181903,to,1,0
181904,track,0,0
181905,exercise,0,0
181906,frequency,0,0
181907,",",0,0
181908,duration,0,0
181909,",",0,0
181910,and,0,0
181911,intensity,0,0
181912,.,0,0
181913,RESULTS,0,0
181914,The,0,0
181915,self-paced,0,0
181916,condition,0,0
181917,reported,0,0
181918,more,0,0
181919,minutes/week,0,0
181920,of,0,0
181921,walking,0,0
181922,(,0,0
181923,f,0,0
181924,(,0,0
181925,2,0,0
181926,),0,0
181927,=,0,0
181928,0.17,0,0
181929,",",0,0
181930,p,0,0
181931,=,0,0
181932,0.045,0,0
181933,),0,0
181934,and,0,0
181935,a,0,0
181936,trend,0,0
181937,toward,0,0
181938,greater,0,0
181939,exercise-related,0,0
181940,energy,0,0
181941,expenditure/week,0,0
181942,(,0,0
181943,f,0,0
181944,(,0,0
181945,2,0,0
181946,),0,0
181947,=,0,0
181948,0.12,0,0
181949,",",0,0
181950,p,0,0
181951,=,0,0
181952,0.243,0,0
181953,),0,0
181954,",",0,0
181955,corresponding,0,0
181956,to,0,0
181957,approximately,0,0
181958,26,0,0
181959,additional,0,0
181960,minutes/week,0,0
181961,and,0,0
181962,83,0,1
181963,additional,0,0
181964,kilocalories/week,0,0
181965,over,0,0
181966,6,0,0
181967,months,0,0
181968,.,0,1
181969,CONCLUSIONS,0,0
181970,Explicit,0,0
181971,recommendation,0,0
181972,for,0,0
181973,self-paced,0,0
181974,exercise,0,0
181975,may,0,0
181976,improve,0,0
181977,adherence,0,0
181978,to,0,0
181979,exercise,0,0
181980,programs,1,0
181981,among,1,0
181982,overweight,1,1
181983,and,1,0
181984,obese,1,1
181985,adults,1,1
181986,.,0,1
181987,The,0,0
181988,REFLO-STEMI,0,0
181989,trial,0,0
181990,comparing,0,0
181991,intracoronary,0,0
181992,adenosine,0,0
181993,",",0,0
181994,sodium,0,0
181995,nitroprusside,0,0
181996,and,0,0
181997,standard,0,0
181998,therapy,0,0
181999,for,0,0
182000,the,0,0
182001,attenuation,0,0
182002,of,0,0
182003,infarct,0,0
182004,size,0,0
182005,and,0,0
182006,microvascular,0,0
182007,obstruction,0,1
182008,during,0,0
182009,primary,0,1
182010,percutaneous,0,1
182011,coronary,0,1
182012,intervention,0,0
182013,:,0,1
182014,study,0,0
182015,protocol,0,0
182016,for,0,0
182017,a,0,0
182018,randomised,0,0
182019,controlled,0,0
182020,trial,0,0
182021,.,0,0
182022,BACKGROUND,0,0
182023,Microvascular,0,0
182024,obstruction,0,1
182025,(,0,0
182026,MVO,0,1
182027,),0,0
182028,secondary,0,0
182029,to,0,0
182030,ischaemic-reperfusion,0,0
182031,injury,0,0
182032,is,0,0
182033,an,0,0
182034,important,0,0
182035,but,0,0
182036,underappreciated,0,0
182037,determinant,0,0
182038,of,0,0
182039,short-,0,0
182040,and,0,0
182041,longer-term,0,0
182042,outcome,0,0
182043,following,0,0
182044,percutaneous,0,1
182045,coronary,0,1
182046,intervention,0,0
182047,(,0,0
182048,PCI,0,1
182049,),0,0
182050,treatment,0,0
182051,of,0,0
182052,ST-elevation,0,0
182053,myocardial,0,1
182054,infarction,0,1
182055,(,0,0
182056,STEMI,0,1
182057,),0,0
182058,.,0,0
182059,Several,0,0
182060,small,0,0
182061,studies,0,0
182062,have,0,0
182063,demonstrated,0,0
182064,a,0,0
182065,reduction,0,0
182066,in,0,0
182067,the,0,0
182068,degree,0,0
182069,of,0,0
182070,MVO,0,1
182071,utilising,0,0
182072,a,0,0
182073,variety,0,0
182074,of,0,0
182075,vasoactive,0,0
182076,agents,0,0
182077,",",0,0
182078,with,0,1
182079,adenosine,0,0
182080,and,0,0
182081,sodium,0,0
182082,nitroprusside,0,0
182083,(,0,0
182084,SNP,0,1
182085,),0,0
182086,being,0,0
182087,most,0,0
182088,evaluated,0,0
182089,.,0,0
182090,However,0,0
182091,",",0,0
182092,the,0,0
182093,evidence,0,0
182094,base,0,0
182095,remains,0,0
182096,weak,0,0
182097,as,0,0
182098,the,0,0
182099,trials,0,0
182100,have,0,0
182101,had,0,0
182102,variable,0,0
182103,endpoints,0,0
182104,",",0,0
182105,differing,0,0
182106,drug,0,0
182107,doses,0,0
182108,and,0,0
182109,delivery,0,0
182110,.,0,0
182111,As,0,0
182112,such,0,0
182113,",",0,0
182114,the,0,0
182115,results,0,0
182116,regarding,0,0
182117,benefit,0,0
182118,are,0,0
182119,conflicting,0,0
182120,.,0,0
182121,METHODS,0,0
182122,The,0,0
182123,REperfusion,0,0
182124,Facilitated,0,0
182125,by,0,0
182126,LOcal,0,0
182127,adjunctive,0,0
182128,therapy,0,0
182129,in,0,0
182130,STEMI,0,1
182131,(,0,0
182132,REFLO-STEMI,0,0
182133,),0,0
182134,trial,0,0
182135,is,0,0
182136,a,0,0
182137,multicentre,0,0
182138,",",0,0
182139,prospective,0,0
182140,",",0,0
182141,randomised,0,0
182142,",",0,0
182143,controlled,0,0
182144,",",0,0
182145,open,0,0
182146,label,0,0
182147,",",0,0
182148,study,0,0
182149,with,0,0
182150,blinded,0,0
182151,endpoint,0,0
182152,analysis,0,0
182153,:,0,1
182154,Patients,1,1
182155,presenting,1,1
182156,within,1,0
182157,6,1,0
182158,h,1,0
182159,of,1,0
182160,onset,1,0
182161,of,1,0
182162,STEMI,1,1
182163,and,1,0
182164,undergoing,1,1
182165,planned,1,0
182166,primary,1,0
182167,PCI,1,1
182168,(,1,0
182169,P-PCI,1,0
182170,),1,0
182171,with,1,1
182172,TIMI,1,0
182173,0/1,1,0
182174,flow,1,0
182175,in,1,0
182176,the,1,0
182177,infarct-related,1,0
182178,artery,1,1
182179,(,1,0
182180,IRA,1,0
182181,),1,0
182182,and,1,0
182183,no,1,0
182184,significant,1,0
182185,bystander,1,0
182186,coronary,1,1
182187,artery,1,1
182188,disease,1,1
182189,on,1,0
182190,angiography,1,0
182191,",",1,0
182192,are,1,0
182193,randomised,1,0
182194,into,1,0
182195,one,1,0
182196,of,1,0
182197,three,1,1
182198,groups,1,0
182199,:,1,1
182200,PCI,1,1
182201,with,1,1
182202,adjunctive,1,0
182203,pharmacotherapy,1,1
182204,(,1,0
182205,intracoronary,1,0
182206,adenosine,1,0
182207,or,1,0
182208,SNP,1,1
182209,),1,0
182210,or,1,0
182211,control,1,0
182212,(,1,0
182213,standard,1,0
182214,PCI,1,1
182215,),1,0
182216,.,1,0
182217,All,1,0
182218,receive,1,0
182219,Bivalirudin,1,0
182220,anticoagulation,1,0
182221,and,1,0
182222,thrombus,1,0
182223,aspiration,1,0
182224,.,1,0
182225,The,0,0
182226,primary,0,0
182227,outcome,0,0
182228,is,0,0
182229,infarct,0,0
182230,size,0,0
182231,(,0,0
182232,IS,0,0
182233,),0,0
182234,(,0,0
182235,determined,0,0
182236,as,0,0
182237,a,0,0
182238,percentage,0,0
182239,of,0,0
182240,total,0,1
182241,left,0,1
182242,ventricular,0,0
182243,mass,0,1
182244,),0,0
182245,measured,0,0
182246,by,0,0
182247,cardiac,0,0
182248,magnetic,0,0
182249,resonance,0,0
182250,imaging,0,0
182251,(,0,0
182252,CMRI,0,0
182253,),0,0
182254,undertaken,0,0
182255,at,0,0
182256,48,0,0
182257,to,0,0
182258,72,0,1
182259,h,0,0
182260,post,0,1
182261,P-PCI,0,0
182262,.,0,0
182263,Secondary,0,0
182264,outcome,0,0
182265,measures,0,0
182266,include,0,0
182267,MVO,0,1
182268,(,0,0
182269,hypoenhancement,0,0
182270,within,0,0
182271,infarct,0,0
182272,core,0,1
182273,),0,0
182274,on,0,0
182275,CMRI,0,0
182276,",",0,0
182277,angiographic,0,0
182278,markers,0,0
182279,of,0,0
182280,microvascular,0,0
182281,perfusion,0,0
182282,and,0,0
182283,MACE,0,0
182284,during,0,0
182285,1-month,0,0
182286,follow-up,0,0
182287,.,0,0
182288,The,0,0
182289,study,0,0
182290,aims,0,0
182291,to,0,0
182292,recruit,0,0
182293,240,1,0
182294,patients,1,1
182295,(,1,0
182296,powered,1,0
182297,at,1,0
182298,80,1,0
182299,%,1,0
182300,to,1,0
182301,detect,1,0
182302,a,1,0
182303,5,1,0
182304,%,1,0
182305,absolute,1,0
182306,reduction,1,0
182307,in,1,0
182308,IS,1,0
182309,),1,0
182310,.,1,0
182311,DISCUSSION,0,0
182312,The,0,0
182313,REFLO-STEMI,0,0
182314,study,0,0
182315,has,0,0
182316,been,0,0
182317,designed,0,0
182318,to,0,0
182319,address,0,0
182320,the,0,0
182321,weaknesses,0,0
182322,of,0,0
182323,previous,0,1
182324,trials,0,0
182325,",",0,0
182326,which,0,0
182327,have,0,0
182328,collectively,0,0
182329,failed,0,0
182330,to,0,0
182331,demonstrate,0,0
182332,whether,0,0
182333,adjunctive,0,0
182334,pharmacotherapy,0,1
182335,with,0,1
182336,adenosine,0,0
182337,and/or,0,0
182338,SNP,0,0
182339,can,0,0
182340,reduce,0,0
182341,measures,0,0
182342,of,0,0
182343,myocardial,0,1
182344,injury,0,1
182345,(,0,0
182346,infarct,0,0
182347,size,0,0
182348,and,0,0
182349,MVO,0,1
182350,),0,0
182351,and,0,0
182352,improve,0,0
182353,clinical,0,0
182354,outcome,0,0
182355,",",0,0
182356,despite,0,0
182357,good,0,0
182358,basic,0,0
182359,evidence,0,0
182360,that,0,0
182361,they,0,0
182362,have,0,0
182363,the,0,0
182364,potential,0,0
182365,to,0,0
182366,attenuate,0,0
182367,this,0,0
182368,process,0,0
182369,.,0,0
182370,The,0,0
182371,REFLO-STEMI,0,0
182372,study,0,0
182373,will,0,0
182374,be,0,0
182375,the,0,0
182376,most,0,0
182377,scientifically,0,0
182378,robust,0,0
182379,trial,0,0
182380,to,0,0
182381,date,0,0
182382,evaluating,0,0
182383,whether,0,0
182384,adjunctive,0,0
182385,therapy,0,0
182386,(,0,0
182387,intracoronary,0,0
182388,adenosine,0,0
182389,or,0,0
182390,SNP,0,0
182391,following,0,0
182392,thrombus,0,0
182393,aspiration,0,0
182394,),0,0
182395,reduces,0,0
182396,CMRI,0,0
182397,measured,0,0
182398,IS,0,0
182399,and,0,0
182400,MVO,0,1
182401,in,0,0
182402,patients,0,1
182403,undergoing,0,1
182404,P-PCI,0,0
182405,within,0,0
182406,6,0,0
182407,h,0,0
182408,of,0,0
182409,onset,0,0
182410,of,0,0
182411,STEMI,0,1
182412,.,0,1
182413,TRIAL,0,0
182414,REGISTRATION,0,0
182415,Trial,0,0
182416,registered,0,0
182417,20th,0,0
182418,November,0,1
182419,2012,0,1
182420,:,0,1
182421,ClinicalTrials.gov,0,0
182422,Identifier,0,0
182423,NCT01747174,0,0
182424,.,0,0
182425,Working,0,0
182426,memory,0,0
182427,and,0,0
182428,cognitive,0,0
182429,flexibility-training,0,0
182430,for,0,0
182431,children,1,1
182432,with,1,1
182433,an,1,0
182434,autism,1,1
182435,spectrum,1,1
182436,disorder,1,1
182437,:,1,0
182438,a,0,0
182439,randomized,0,0
182440,controlled,0,0
182441,trial,0,0
182442,.,0,1
182443,BACKGROUND,0,0
182444,People,1,1
182445,with,1,1
182446,autism,1,1
182447,spectrum,1,1
182448,disorders,1,1
182449,(,1,0
182450,ASDs,1,0
182451,),1,0
182452,experience,0,0
182453,executive,0,0
182454,function,0,0
182455,(,0,0
182456,EF,0,1
182457,),0,0
182458,deficits,0,0
182459,.,0,0
182460,There,0,0
182461,is,0,0
182462,an,0,0
182463,urgent,0,0
182464,need,0,0
182465,for,0,0
182466,effective,0,0
182467,interventions,0,0
182468,",",0,0
182469,but,0,0
182470,in,0,0
182471,spite,0,0
182472,of,0,0
182473,the,0,0
182474,increasing,0,0
182475,research,0,0
182476,focus,0,0
182477,on,0,0
182478,computerized,0,0
182479,cognitive,0,0
182480,training,0,0
182481,",",0,0
182482,this,0,0
182483,has,0,0
182484,not,0,0
182485,been,0,0
182486,studied,0,0
182487,in,0,0
182488,ASD,0,1
182489,.,0,0
182490,Hence,0,0
182491,",",0,0
182492,we,0,0
182493,investigated,0,0
182494,two,0,0
182495,EF,0,1
182496,training,0,0
182497,conditions,0,0
182498,in,0,0
182499,children,1,1
182500,with,1,1
182501,ASD,1,1
182502,.,1,0
182503,METHODS,0,0
182504,In,0,0
182505,a,0,0
182506,randomized,0,0
182507,controlled,0,0
182508,trial,0,0
182509,",",0,0
182510,children,1,1
182511,with,1,1
182512,ASD,1,1
182513,(,1,0
182514,n,1,1
182515,=,1,0
182516,121,1,1
182517,",",1,0
182518,8-12,1,1
182519,years,1,1
182520,",",1,0
182521,IQ,1,0
182522,>,1,1
182523,80,1,1
182524,),1,0
182525,were,0,0
182526,randomly,0,0
182527,assigned,0,0
182528,to,0,0
182529,an,0,0
182530,adaptive,0,0
182531,working,0,0
182532,memory,0,0
182533,(,0,0
182534,WM,0,0
182535,),0,0
182536,training,0,0
182537,",",0,0
182538,an,0,0
182539,adaptive,0,0
182540,cognitive,0,0
182541,flexibility-training,0,0
182542,",",0,0
182543,or,0,0
182544,a,0,0
182545,non-adaptive,0,0
182546,control,0,0
182547,training,0,0
182548,(,0,0
182549,mock-training,0,0
182550,),0,0
182551,.,0,0
182552,Braingame,0,0
182553,Brian,0,0
182554,",",0,0
182555,a,0,0
182556,computerized,0,0
182557,EF-training,0,0
182558,with,0,1
182559,game-elements,0,0
182560,",",0,0
182561,was,0,0
182562,used,0,0
182563,.,0,0
182564,Outcome,0,0
182565,measures,0,0
182566,(,0,0
182567,pretraining,0,0
182568,",",0,0
182569,post-training,0,0
182570,",",0,0
182571,and,0,0
182572,6-week-follow-up,0,0
182573,),0,0
182574,were,0,0
182575,near-transfer,0,0
182576,to,0,0
182577,trained,0,0
182578,EFs,0,0
182579,",",0,0
182580,far-transfer,0,0
182581,to,0,0
182582,other,0,0
182583,EFs,0,0
182584,(,0,0
182585,sustained,0,0
182586,attention,0,0
182587,and,0,0
182588,inhibition,0,0
182589,),0,0
182590,",",0,0
182591,and,0,0
182592,parent,0,0
182593,'s,0,0
182594,ratings,0,0
182595,of,0,0
182596,daily,0,0
182597,life,0,0
182598,EFs,0,0
182599,",",0,0
182600,social,0,0
182601,behavior,0,0
182602,",",0,0
182603,attention,0,0
182604,deficit,0,0
182605,hyperactivity,0,0
182606,disorder,0,1
182607,(,0,0
182608,ADHD,0,0
182609,),0,0
182610,-behavior,0,0
182611,",",0,0
182612,and,0,0
182613,quality,0,0
182614,of,0,0
182615,life,0,0
182616,.,0,0
182617,RESULTS,0,0
182618,Attrition-rate,0,0
182619,was,0,0
182620,26,0,1
182621,%,0,0
182622,.,0,0
182623,Children,0,1
182624,in,0,0
182625,all,0,1
182626,conditions,0,0
182627,who,0,1
182628,completed,0,1
182629,the,0,1
182630,training,0,0
182631,improved,0,0
182632,in,0,0
182633,WM,0,0
182634,",",0,0
182635,cognitive,0,0
182636,flexibility,0,0
182637,",",0,0
182638,attention,0,0
182639,",",0,0
182640,and,0,0
182641,on,0,0
182642,parent,0,0
182643,'s,0,0
182644,ratings,0,0
182645,",",0,0
182646,but,0,0
182647,not,0,0
182648,in,0,0
182649,inhibition,0,0
182650,.,0,0
182651,There,0,0
182652,were,0,0
182653,no,0,0
182654,significant,0,0
182655,differential,0,0
182656,intervention,0,0
182657,effects,0,0
182658,",",0,0
182659,although,0,0
182660,children,0,1
182661,in,0,0
182662,the,0,0
182663,WM,0,0
182664,condition,0,0
182665,showed,0,0
182666,a,0,0
182667,trend,0,0
182668,toward,0,0
182669,improvement,0,0
182670,on,0,0
182671,near-transfer,0,0
182672,WM,0,1
182673,and,0,0
182674,ADHD-behavior,0,0
182675,",",0,0
182676,and,0,0
182677,children,0,1
182678,in,0,0
182679,the,0,0
182680,cognitive,0,0
182681,flexibility,0,0
182682,condition,0,0
182683,showed,0,0
182684,a,0,0
182685,trend,0,0
182686,toward,0,0
182687,improvement,0,0
182688,on,0,0
182689,near-transfer,0,0
182690,flexibility,0,0
182691,.,0,0
182692,CONCLUSION,0,0
182693,Although,0,0
182694,children,0,1
182695,in,0,0
182696,the,0,0
182697,WM,0,0
182698,condition,0,0
182699,tended,0,0
182700,to,0,0
182701,improve,0,0
182702,more,0,0
182703,in,0,0
182704,WM,0,0
182705,and,0,0
182706,ADHD-behavior,0,0
182707,",",0,0
182708,the,0,0
182709,lack,0,0
182710,of,0,0
182711,differential,0,0
182712,improvement,0,0
182713,on,0,0
182714,most,0,0
182715,outcome,0,0
182716,measures,0,0
182717,",",0,0
182718,the,0,0
182719,absence,0,0
182720,of,0,0
182721,a,0,0
182722,clear,0,0
182723,effect,0,0
182724,of,0,0
182725,the,0,0
182726,adaptive,0,0
182727,training,0,0
182728,compared,0,0
182729,to,0,0
182730,the,0,0
182731,mock-training,0,0
182732,",",0,0
182733,and,0,0
182734,the,0,0
182735,high,0,0
182736,attrition,0,0
182737,rate,0,0
182738,suggest,0,0
182739,that,0,0
182740,the,0,0
182741,training,0,0
182742,in,0,0
182743,its,0,0
182744,present,0,0
182745,form,0,0
182746,is,0,0
182747,probably,0,0
182748,not,0,0
182749,suitable,0,0
182750,for,0,0
182751,children,1,1
182752,with,1,1
182753,ASD,1,1
182754,.,1,1
182755,Randomized,0,0
182756,controlled,0,0
182757,trial,0,0
182758,of,0,0
182759,parental,0,0
182760,responsiveness,0,0
182761,intervention,0,0
182762,for,0,0
182763,toddlers,1,1
182764,at,1,0
182765,high,1,0
182766,risk,1,0
182767,for,1,0
182768,autism,1,1
182769,.,1,0
182770,This,0,0
182771,study,0,0
182772,tested,0,0
182773,the,0,0
182774,effects,0,0
182775,of,0,0
182776,a,0,0
182777,parent-mediated,1,0
182778,intervention,0,0
182779,on,0,0
182780,parental,0,0
182781,responsiveness,0,0
182782,with,0,1
182783,their,0,0
182784,toddlers,1,1
182785,at,1,0
182786,high,1,0
182787,risk,1,0
182788,for,1,0
182789,an,1,0
182790,autism,1,1
182791,spectrum,1,1
182792,disorder,1,1
182793,(,1,0
182794,ASD,1,1
182795,),1,0
182796,.,1,0
182797,Participants,1,1
182798,included,1,1
182799,caregivers,1,1
182800,and,1,0
182801,their,1,1
182802,66,1,0
182803,toddlers,1,1
182804,at,1,0
182805,high,1,0
182806,risk,1,0
182807,for,1,0
182808,ASD,1,1
182809,.,1,1
182810,Caregivers,1,0
182811,were,0,0
182812,randomized,0,0
182813,to,0,0
182814,12,0,0
182815,sessions,0,0
182816,of,0,0
182817,an,0,0
182818,individualized,0,0
182819,parent,0,0
182820,education,0,0
182821,intervention,0,0
182822,aimed,0,0
182823,at,0,0
182824,improving,0,0
182825,parental,0,0
182826,responsiveness,0,0
182827,or,0,0
182828,to,0,0
182829,a,0,0
182830,monitoring,0,0
182831,control,0,0
182832,group,0,0
182833,involving,0,0
182834,4,0,0
182835,sessions,0,0
182836,of,0,0
182837,behavioral,0,1
182838,support,0,0
182839,.,0,0
182840,Parental,0,0
182841,responsiveness,0,0
182842,and,0,0
182843,child,0,1
182844,outcomes,0,0
182845,were,0,0
182846,measured,0,0
182847,at,0,0
182848,three,0,0
182849,time,0,0
182850,points,0,0
182851,:,0,1
182852,at,0,0
182853,beginning,0,0
182854,and,0,0
182855,end,0,0
182856,of,0,0
182857,the,0,0
182858,3-month,0,0
182859,treatment,0,0
182860,and,0,0
182861,at,0,0
182862,12-months,0,0
182863,post-study,0,0
182864,entry,0,0
182865,.,0,0
182866,Parental,0,0
182867,responsiveness,0,0
182868,improved,0,0
182869,significantly,0,0
182870,in,0,0
182871,the,0,0
182872,treatment,0,0
182873,group,0,0
182874,but,0,0
182875,not,0,0
182876,the,0,0
182877,control,0,0
182878,group,0,0
182879,.,0,0
182880,However,0,0
182881,",",0,0
182882,parental,0,0
182883,responsiveness,0,0
182884,was,0,0
182885,not,0,0
182886,fully,0,0
182887,maintained,0,0
182888,at,0,0
182889,follow,0,0
182890,up,0,0
182891,.,0,0
182892,There,0,0
182893,were,0,0
182894,no,0,0
182895,treatment,0,0
182896,effects,0,0
182897,on,0,0
182898,child,0,1
182899,outcomes,0,0
182900,of,0,0
182901,joint,0,0
182902,attention,0,0
182903,or,0,0
182904,language,0,0
182905,.,0,0
182906,Children,0,1
182907,in,0,0
182908,both,0,0
182909,groups,0,0
182910,made,0,0
182911,significant,0,0
182912,developmental,0,1
182913,gains,0,0
182914,in,0,0
182915,cognition,0,0
182916,and,0,0
182917,language,0,0
182918,skills,0,0
182919,over,0,0
182920,one,0,1
182921,year,0,0
182922,.,0,0
182923,These,0,0
182924,results,0,0
182925,support,0,0
182926,parental,0,0
182927,responsiveness,0,0
182928,as,0,0
182929,an,0,0
182930,important,0,0
182931,intervention,0,0
182932,target,0,0
182933,given,0,0
182934,its,0,0
182935,general,0,1
182936,association,0,0
182937,with,0,1
182938,child,0,1
182939,outcomes,0,0
182940,in,0,0
182941,the,0,0
182942,extant,0,0
182943,literature,0,0
182944,;,0,0
182945,however,0,0
182946,",",0,0
182947,additional,0,0
182948,supports,0,0
182949,are,0,0
182950,likely,0,0
182951,needed,0,0
182952,to,0,0
182953,fully,0,0
182954,maintain,0,0
182955,the,0,0
182956,treatment,0,0
182957,effect,0,0
182958,and,0,0
182959,to,0,0
182960,affect,0,0
182961,child,0,1
182962,outcomes,0,0
182963,.,0,1
182964,Femoral,0,0
182965,nerve,0,0
182966,block,0,0
182967,using,0,0
182968,0.25,0,0
182969,%,0,0
182970,or,0,0
182971,0.5,0,0
182972,%,0,0
182973,bupivacaine,0,0
182974,for,0,0
182975,analgesia,0,0
182976,after,1,0
182977,arthroscopic,1,0
182978,anterior,1,1
182979,cruciate,1,1
182980,ligament,1,1
182981,reconstruction,1,1
182982,.,1,0
182983,BACKGROUND,0,0
182984,Femoral,0,0
182985,nerve,0,0
182986,block,0,0
182987,(,0,0
182988,FNB,0,0
182989,),0,0
182990,with,0,1
182991,varying,0,0
182992,concentrations,0,0
182993,of,0,0
182994,bupivacaine,0,0
182995,is,0,0
182996,often,0,0
182997,used,0,0
182998,for,0,0
182999,postoperative,0,0
183000,analgesia,0,0
183001,after,1,0
183002,anterior,1,0
183003,cruciate,1,1
183004,ligament,1,1
183005,(,1,0
183006,ACL,1,0
183007,),1,0
183008,reconstruction,1,0
183009,.,1,0
183010,OBJECTIVE,0,0
183011,To,0,0
183012,determine,0,0
183013,whether,0,0
183014,FNB,0,0
183015,using,0,0
183016,0.25,0,0
183017,%,0,0
183018,or,0,0
183019,0.5,0,0
183020,%,0,0
183021,bupivacaine,0,0
183022,provided,0,0
183023,better,0,0
183024,analgesia,0,0
183025,with,0,0
183026,less,0,0
183027,effect,0,0
183028,on,0,0
183029,quadriceps,0,0
183030,strengths,0,0
183031,after,0,0
183032,ACL,0,1
183033,reconstruction,0,1
183034,.,0,0
183035,MATERIAL,0,0
183036,AND,0,0
183037,METHOD,0,0
183038,One,1,1
183039,hundred,1,1
183040,patients,1,1
183041,were,1,0
183042,randomized,1,0
183043,to,0,0
183044,receive,0,0
183045,FNB,0,0
183046,with,0,1
183047,20,0,1
183048,mL,0,0
183049,of,0,0
183050,0.25,0,0
183051,%,0,0
183052,or,0,0
183053,0.5,0,0
183054,%,0,0
183055,bupivacaine,0,0
183056,.,0,0
183057,Data,0,0
183058,regarding,0,0
183059,demographic,0,0
183060,",",0,0
183061,effectiveness,0,0
183062,of,0,0
183063,FNB,0,0
183064,",",0,0
183065,time,0,0
183066,to,0,0
183067,first,0,0
183068,pain,0,0
183069,",",0,0
183070,time,0,0
183071,to,0,0
183072,first,0,0
183073,analgesic,0,0
183074,",",0,0
183075,pain,0,0
183076,scores,0,0
183077,",",0,0
183078,morphine,0,0
183079,use,0,0
183080,",",0,0
183081,and,0,0
183082,recovery,0,0
183083,of,0,0
183084,sensory,0,0
183085,and,0,0
183086,motor,0,0
183087,function,0,0
183088,were,0,0
183089,recorded,0,0
183090,.,0,0
183091,RESULTS,0,0
183092,Median,0,0
183093,time,0,0
183094,to,0,0
183095,first,0,0
183096,morphine,0,0
183097,requirement,0,0
183098,was,0,0
183099,12,0,0
183100,hours,0,0
183101,in,0,0
183102,0.5,0,0
183103,%,0,0
183104,bupivacaine,0,0
183105,group,0,0
183106,and,0,0
183107,10,0,0
183108,hours,0,0
183109,in,0,0
183110,0.25,0,0
183111,%,0,0
183112,bupivacaine,0,0
183113,group,0,0
183114,(,0,0
183115,p,0,0
183116,=,0,0
183117,0.048,0,0
183118,),0,0
183119,.,0,0
183120,Pain,0,0
183121,score,0,0
183122,at,0,0
183123,18,0,1
183124,hours,0,0
183125,was,0,0
183126,lower,0,0
183127,in,0,0
183128,0.5,0,0
183129,%,0,0
183130,bupivacaine,0,0
183131,group,0,0
183132,compared,0,0
183133,with,0,1
183134,0.25,0,0
183135,%,0,0
183136,bupivacaine,0,0
183137,group,0,0
183138,(,0,0
183139,p,0,0
183140,=,0,0
183141,0.001,0,0
183142,),0,0
183143,.,0,0
183144,When,0,0
183145,specify,0,0
183146,to,0,0
183147,the,0,0
183148,patellar,0,0
183149,tendon,0,0
183150,graft,0,0
183151,subgroup,0,0
183152,",",0,0
183153,the,0,0
183154,patients,0,1
183155,requiring,0,1
183156,morphine,0,0
183157,were,0,0
183158,70,0,1
183159,%,0,0
183160,in,0,0
183161,0.5,0,0
183162,%,0,0
183163,bupivacaine,0,0
183164,group,0,0
183165,and,0,0
183166,90,0,0
183167,%,0,0
183168,in,0,0
183169,0.25,0,0
183170,%,0,0
183171,bupivacaine,0,0
183172,group,0,0
183173,(,0,0
183174,p,0,0
183175,=,0,0
183176,0.03,0,0
183177,),0,0
183178,.,0,0
183179,No,0,0
183180,differences,0,0
183181,were,0,0
183182,found,0,0
183183,in,0,0
183184,demographic,0,0
183185,data,0,0
183186,",",0,0
183187,effectiveness,0,0
183188,of,0,0
183189,FNB,0,0
183190,",",0,0
183191,time,0,0
183192,to,0,0
183193,first,0,0
183194,pain,0,0
183195,",",0,0
183196,morphine,0,0
183197,consumption,0,0
183198,",",0,0
183199,and,0,0
183200,recovery,0,0
183201,of,0,0
183202,sensorimotor,0,0
183203,function,0,0
183204,.,0,0
183205,CONCLUSION,0,0
183206,FNB,0,0
183207,with,0,1
183208,0.5,0,0
183209,%,0,0
183210,bupivacaine,0,0
183211,provided,0,0
183212,longer,0,0
183213,time,0,0
183214,to,0,0
183215,first,0,0
183216,analgesic,0,0
183217,and,0,0
183218,lower,0,0
183219,narcotic,0,0
183220,requirements,0,0
183221,after,0,0
183222,patellar,0,1
183223,tendon,0,1
183224,graft,0,0
183225,ACL,0,0
183226,reconstruction,0,0
183227,when,0,0
183228,compared,0,0
183229,to,0,0
183230,0.25,0,0
183231,%,0,0
183232,bupivacaine,0,0
183233,.,0,0
183234,Both,0,0
183235,concentrations,0,0
183236,showed,0,0
183237,similar,0,0
183238,effect,0,0
183239,on,0,0
183240,quadriceps,0,1
183241,strengths,0,0
183242,.,0,1
183243,Selenium,0,0
183244,Treatment,0,0
183245,and,0,0
183246,Chagasic,0,1
183247,Cardiopathy,0,1
183248,(,0,0
183249,STCC,0,0
183250,),0,0
183251,:,0,0
183252,study,0,0
183253,protocol,0,0
183254,for,0,0
183255,a,0,0
183256,double-blind,0,0
183257,randomized,0,0
183258,controlled,0,0
183259,trial,0,0
183260,.,0,0
183261,BACKGROUND,0,0
183262,Heart,0,0
183263,disease,0,1
183264,progression,0,0
183265,occurs,0,0
183266,in,0,0
183267,30,0,0
183268,%,0,0
183269,of,0,0
183270,patients,0,1
183271,with,0,1
183272,chronic,0,1
183273,Trypanosoma,0,1
183274,cruzi,0,1
183275,infection,0,0
183276,.,0,0
183277,Supplementation,0,0
183278,with,0,0
183279,selenium,0,0
183280,(,0,0
183281,Se,0,0
183282,),0,0
183283,in,0,0
183284,animal,0,0
183285,model,0,0
183286,of,0,0
183287,T.,0,1
183288,cruzi,0,1
183289,infection,0,0
183290,produced,0,0
183291,promising,0,0
183292,results,0,0
183293,.,0,0
183294,There,0,0
183295,is,0,0
183296,evidence,0,0
183297,that,0,0
183298,patients,1,1
183299,with,1,1
183300,Chagas,1,1
183301,heart,1,1
183302,disease,1,1
183303,have,0,0
183304,lower,0,0
183305,Se,0,0
183306,levels,0,0
183307,than,0,0
183308,healthy,0,1
183309,individuals,0,1
183310,and,0,0
183311,patients,0,1
183312,with,0,1
183313,T.,0,1
183314,cruzi,0,1
183315,infection,0,0
183316,without,0,0
183317,of,0,0
183318,cardiac,0,1
183319,disease,0,1
183320,.,0,0
183321,The,0,0
183322,aim,0,0
183323,of,0,0
183324,this,0,0
183325,investigation,0,0
183326,is,0,0
183327,to,0,0
183328,estimate,0,0
183329,the,0,0
183330,effect,0,0
183331,of,0,0
183332,Se,0,0
183333,treatment,0,0
183334,on,0,0
183335,prevention,0,0
183336,of,0,0
183337,heart,0,1
183338,disease,0,1
183339,progression,0,0
183340,in,0,0
183341,patients,1,1
183342,with,1,1
183343,chagasic,1,1
183344,cardiopathy,1,1
183345,.,1,0
183346,METHODS,0,0
183347,The,0,0
183348,Selenium,0,0
183349,Treatment,0,0
183350,and,0,0
183351,Chagasic,0,1
183352,Cardiopathy,0,0
183353,trial,0,0
183354,is,0,0
183355,a,0,0
183356,superiority,0,0
183357,",",0,0
183358,double-blind,0,0
183359,",",0,0
183360,placebo-controlled,0,0
183361,",",0,0
183362,randomized,0,0
183363,clinical,0,0
183364,trial,0,0
183365,.,0,0
183366,The,0,0
183367,eligibility,0,0
183368,criteria,0,1
183369,are,0,0
183370,as,0,0
183371,follows,0,0
183372,:,0,0
183373,(,1,0
183374,1,1,0
183375,),1,0
183376,a,1,0
183377,Chagas,1,0
183378,disease,1,1
183379,diagnosis,1,1
183380,confirmed,1,0
183381,by,1,0
183382,serology,1,0
183383,;,1,0
183384,(,1,0
183385,2,1,0
183386,),1,0
183387,segmental,1,0
183388,",",1,0
183389,mild,1,0
183390,or,1,0
183391,moderate,1,1
183392,global,1,0
183393,left,1,1
183394,ventricular,1,0
183395,systolic,1,1
183396,dysfunction,1,1
183397,;,1,0
183398,and,1,0
183399,(,1,0
183400,3,1,0
183401,),1,0
183402,age,1,1
183403,between,1,0
183404,18,1,1
183405,and,1,0
183406,65,1,1
183407,years,1,1
183408,.,1,0
183409,The,0,0
183410,exclusion,1,0
183411,criteria,1,1
183412,are,1,0
183413,as,1,0
183414,follows,1,0
183415,:,1,0
183416,(,1,0
183417,1,1,0
183418,),1,0
183419,pregnancy,1,1
183420,",",1,0
183421,(,1,0
183422,2,1,0
183423,),1,0
183424,diabetes,1,1
183425,mellitus,1,0
183426,",",1,0
183427,(,1,0
183428,3,1,0
183429,),1,0
183430,tobacco,1,1
183431,use,1,0
183432,",",1,0
183433,(,1,0
183434,4,1,0
183435,),1,0
183436,alcohol,1,0
183437,abuse,1,0
183438,",",1,0
183439,(,1,0
183440,5,1,0
183441,),1,0
183442,evidence,1,0
183443,of,1,0
183444,nonchagasic,1,1
183445,heart,1,1
183446,disease,1,1
183447,",",1,0
183448,(,1,0
183449,6,1,0
183450,),1,0
183451,depression,1,0
183452,",",1,0
183453,(,1,0
183454,7,1,0
183455,),1,0
183456,dysphagia,1,1
183457,with,1,0
183458,evidence,1,0
183459,of,1,0
183460,food,1,0
183461,residues,1,0
183462,in,1,0
183463,the,1,0
183464,esophagus,1,1
183465,",",1,0
183466,(,1,0
183467,8,1,0
183468,),1,0
183469,dysphagia,1,1
183470,with,1,1
183471,weight,1,0
183472,loss,1,0
183473,higher,1,0
183474,than,1,0
183475,15,1,0
183476,%,1,0
183477,of,1,0
183478,usual,1,0
183479,weight,1,0
183480,in,1,0
183481,the,1,0
183482,last,1,0
183483,four,1,0
183484,months,1,0
183485,and/or,1,0
183486,(,1,0
183487,9,1,0
183488,),1,0
183489,conditions,1,0
183490,that,1,0
183491,may,1,0
183492,result,1,0
183493,in,1,0
183494,low,1,0
183495,protocol,1,0
183496,adherence,1,0
183497,.,1,0
183498,The,0,0
183499,intervention,0,0
183500,will,0,0
183501,be,0,0
183502,100,0,0
183503,?g,0,0
183504,of,0,0
183505,sodium,0,0
183506,selenite,0,0
183507,once,0,0
183508,daily,0,0
183509,for,0,0
183510,365,0,1
183511,consecutive,0,1
183512,days,0,0
183513,compared,0,0
183514,to,0,0
183515,placebo,0,0
183516,.,0,0
183517,The,0,0
183518,following,0,0
183519,are,0,0
183520,the,0,0
183521,primary,0,0
183522,outcomes,0,0
183523,to,0,0
183524,be,0,0
183525,measured,0,0
183526,:,0,0
183527,(,0,0
183528,1,0,0
183529,),0,0
183530,the,0,0
183531,trajectories,0,0
183532,of,0,0
183533,the,0,0
183534,left,0,0
183535,ventricular,0,0
183536,ejection,0,0
183537,fraction,0,0
183538,in,0,0
183539,the,0,0
183540,follow-up,0,0
183541,period,0,0
183542,;,0,0
183543,(,0,0
183544,2,0,0
183545,),0,0
183546,reduction,0,0
183547,of,0,0
183548,heart,0,1
183549,disease,0,1
183550,progression,0,0
183551,rates,0,0
183552,",",0,0
183553,with,0,1
183554,progression,0,0
183555,defined,0,0
183556,as,0,0
183557,a,0,0
183558,10,0,0
183559,%,0,0
183560,decrease,0,0
183561,in,0,0
183562,left,0,1
183563,ventricular,0,0
183564,ejection,0,0
183565,fraction,0,0
183566,;,0,0
183567,and,0,0
183568,(,0,0
183569,3,0,0
183570,),0,0
183571,rate,0,0
183572,of,0,0
183573,hospital,0,1
183574,admissions,0,1
183575,attributable,0,0
183576,to,0,0
183577,dysrhythmia,0,0
183578,",",0,0
183579,heart,0,0
183580,failure,0,0
183581,or,0,0
183582,stroke,0,1
183583,due,0,0
183584,to,0,0
183585,Chagas,0,1
183586,disease,0,1
183587,.,0,0
183588,One,0,0
183589,hundred,0,1
183590,thirty,0,1
183591,patients,0,1
183592,will,0,0
183593,be,0,0
183594,randomly,0,0
183595,allocated,0,0
183596,into,0,0
183597,either,0,0
183598,the,0,0
183599,intervention,0,0
183600,or,0,0
183601,placebo,0,0
183602,group,0,0
183603,at,0,0
183604,a,0,0
183605,ratio,0,0
183606,of,0,0
183607,1:1,0,1
183608,.,0,0
183609,The,0,0
183610,sequence,0,0
183611,allocation,0,0
183612,concealment,0,0
183613,and,0,0
183614,blinding,0,0
183615,were,0,0
183616,planned,0,0
183617,to,0,0
183618,be,0,0
183619,conducted,0,0
183620,with,0,0
183621,the,0,0
183622,strategy,0,0
183623,of,0,0
183624,numbered,0,0
183625,boxes,0,0
183626,.,0,1
183627,Both,0,0
183628,patients,0,1
183629,and,0,0
183630,health-care,0,0
183631,providers,0,0
183632,will,0,0
183633,remain,0,0
183634,blinded,0,0
183635,to,0,0
183636,the,0,0
183637,intervention,0,0
183638,groups,0,0
183639,during,0,0
183640,the,0,0
183641,5,0,0
183642,years,0,1
183643,of,0,0
183644,follow-up,0,0
183645,.,0,0
183646,DISCUSSION,0,0
183647,If,0,0
183648,Se,0,0
183649,treatment,0,0
183650,reduces,0,0
183651,the,0,0
183652,progression,0,0
183653,of,0,0
183654,Chagas,0,1
183655,cardiopathy,0,1
183656,",",0,0
183657,the,0,0
183658,inclusion,0,0
183659,of,0,0
183660,this,0,0
183661,micronutrient,0,0
183662,in,0,0
183663,the,0,0
183664,daily,0,0
183665,diet,0,0
183666,can,0,0
183667,improve,0,0
183668,the,0,0
183669,therapeutic,0,0
183670,regimen,0,0
183671,for,0,0
183672,this,0,0
183673,neglected,0,0
183674,tropical,0,1
183675,disease,0,1
183676,at,0,0
183677,low,0,0
183678,cost,0,0
183679,.,0,0
183680,TRIAL,0,0
183681,REGISTRATION,0,0
183682,Clinical,0,0
183683,Trials.gov,0,0
183684,ID,0,0
183685,:,0,1
183686,NCT00875173,0,0
183687,(,0,0
183688,registered,0,0
183689,20,0,1
183690,October,0,1
183691,20,0,1
183692,2008,0,1
183693,),0,0
183694,.,0,0
183695,[,0,0
183696,A,0,0
183697,clinical,0,0
183698,trial,0,0
183699,of,0,0
183700,ultrasound-guided,0,0
183701,facet,0,1
183702,joint,0,1
183703,block,0,0
183704,in,0,0
183705,the,0,0
183706,lumbar,0,0
183707,spine,0,0
183708,to,0,0
183709,treat,0,0
183710,facet,1,1
183711,joint,1,0
183712,related,1,0
183713,low,1,0
183714,back,1,0
183715,pain,1,0
183716,],1,0
183717,.,0,0
183718,OBJECTIVE,0,0
183719,To,0,0
183720,determine,0,0
183721,the,0,0
183722,feasibility,0,0
183723,and,0,0
183724,clinical,0,0
183725,efficacy,0,0
183726,of,0,0
183727,ultrasound-guided,0,0
183728,facet,0,1
183729,joint,0,1
183730,injection,0,0
183731,and,0,0
183732,nerve,0,0
183733,block,0,0
183734,in,0,0
183735,lumbar,0,0
183736,facet,0,1
183737,joint,0,0
183738,for,0,0
183739,the,0,0
183740,treatment,0,0
183741,of,0,0
183742,facet-joint,1,1
183743,related,1,0
183744,low,1,0
183745,back,1,0
183746,pain,1,0
183747,.,1,0
183748,METHODS,0,0
183749,20,1,0
183750,patients,1,1
183751,with,1,1
183752,facet-joint,1,1
183753,pain,1,0
183754,were,0,0
183755,randomized,0,0
183756,into,0,1
183757,two,0,0
183758,groups,0,0
183759,received,0,0
183760,block,0,0
183761,blindly,0,0
183762,(,0,0
183763,B,0,0
183764,group,0,0
183765,),0,0
183766,or,0,0
183767,guided,0,0
183768,by,0,0
183769,ultrasound,0,0
183770,(,0,0
183771,US,0,0
183772,group,0,0
183773,),0,0
183774,respectively,0,0
183775,.,0,0
183776,The,0,0
183777,location,0,0
183778,of,0,0
183779,needle,0,0
183780,tip,0,0
183781,was,0,0
183782,confirmed,0,0
183783,by,0,0
183784,CT,0,0
183785,in,0,0
183786,both,0,0
183787,groups,0,0
183788,",",0,0
183789,and,0,0
183790,the,0,0
183791,accuracy,0,0
183792,was,0,0
183793,computed,0,0
183794,afterwards,0,0
183795,.,0,0
183796,VAS,0,0
183797,score,0,0
183798,",",0,0
183799,puncture,0,0
183800,time,0,0
183801,and,0,0
183802,one-time,0,0
183803,puncture,0,0
183804,success,0,0
183805,rate,0,0
183806,(,0,0
183807,%,0,0
183808,),0,0
183809,were,0,0
183810,recorded,0,0
183811,.,0,0
183812,VAS,0,0
183813,scores,0,0
183814,and,0,0
183815,pain,0,0
183816,remission,0,0
183817,rates,0,0
183818,in,0,0
183819,both,0,0
183820,groups,0,0
183821,were,0,0
183822,recorded,0,0
183823,at,0,0
183824,30,0,0
183825,min,0,0
183826,",",0,0
183827,1,0,0
183828,d,0,0
183829,",",0,0
183830,2,0,0
183831,d,0,0
183832,",",0,0
183833,6,0,0
183834,weeks,0,0
183835,after,0,0
183836,the,0,0
183837,block,0,0
183838,.,0,0
183839,RESULTS,0,0
183840,The,0,0
183841,VAS,0,0
183842,scores,0,0
183843,were,0,0
183844,3.3,0,0
183845,+/-,0,0
183846,0.4,0,0
183847,in,0,0
183848,US,0,0
183849,group,0,0
183850,and,0,0
183851,1.2,0,0
183852,+/-,0,0
183853,0.3,0,0
183854,in,0,0
183855,B,0,0
183856,group,0,0
183857,(,0,0
183858,P,0,0
183859,<,0,0
183860,0.05,0,0
183861,),0,0
183862,.,0,0
183863,The,0,0
183864,puncture,0,0
183865,time,0,0
183866,was,0,0
183867,(,0,0
183868,206,0,1
183869,+/-,0,0
183870,27,0,1
183871,),0,0
183872,s,0,0
183873,in,0,0
183874,US,0,0
183875,group,0,0
183876,while,0,0
183877,(,0,0
183878,397,0,1
183879,+/-,0,0
183880,31,0,1
183881,),0,0
183882,s,0,0
183883,in,0,0
183884,B,0,0
183885,group,0,0
183886,(,0,0
183887,P,0,0
183888,<,0,0
183889,0.05,0,0
183890,),0,0
183891,.,0,0
183892,There,0,0
183893,were,0,0
183894,37,0,1
183895,facet,0,1
183896,joint,0,1
183897,blocks,0,0
183898,guided,0,0
183899,by,0,0
183900,ultrasound,0,0
183901,",",0,0
183902,in,0,0
183903,which,0,0
183904,32,0,1
183905,were,0,0
183906,correctly,0,0
183907,targeted,0,0
183908,with,0,0
183909,the,0,0
183910,first,0,0
183911,puncture,0,0
183912,.,0,0
183913,The,0,0
183914,success,0,0
183915,rate,0,0
183916,is,0,0
183917,86.5,0,0
183918,%,0,0
183919,.,0,0
183920,There,0,0
183921,were,0,0
183922,35,0,0
183923,facet,0,1
183924,joint,0,1
183925,blocks,0,0
183926,blindly,0,0
183927,",",0,0
183928,in,0,0
183929,which,0,0
183930,11,0,0
183931,were,0,0
183932,correctly,0,0
183933,targeted,0,0
183934,with,0,0
183935,the,0,0
183936,first,0,0
183937,puncture,0,0
183938,.,0,0
183939,The,0,0
183940,success,0,0
183941,rate,0,0
183942,is,0,0
183943,31.4,0,0
183944,%,0,0
183945,.,0,0
183946,The,0,0
183947,difference,0,0
183948,of,0,0
183949,one-time,0,0
183950,puncture,0,0
183951,success,0,0
183952,rate,0,0
183953,between,0,0
183954,the,0,0
183955,two,0,0
183956,groups,0,0
183957,was,0,0
183958,significant,0,0
183959,(,0,0
183960,P,0,0
183961,<,0,0
183962,0.05,0,0
183963,),0,0
183964,.,0,0
183965,Differences,0,0
183966,of,0,0
183967,VAS,0,1
183968,and,0,0
183969,pain,0,0
183970,remission,0,0
183971,rate,0,0
183972,at,0,0
183973,half,0,0
183974,an,0,0
183975,hour,0,0
183976,after,0,0
183977,facet,0,1
183978,joint,0,0
183979,injection,0,0
183980,between,0,0
183981,B,0,0
183982,group,0,0
183983,and,0,0
183984,US,0,0
183985,group,0,0
183986,were,0,0
183987,significant,0,0
183988,(,0,0
183989,P,0,0
183990,<,0,0
183991,0.05,0,0
183992,),0,0
183993,.,0,0
183994,There,0,0
183995,were,0,0
183996,8,0,0
183997,",",0,0
183998,9,0,0
183999,",",0,0
184000,9,0,0
184001,",",0,0
184002,and,0,0
184003,9,0,0
184004,patients,0,1
184005,in,0,0
184006,US,0,0
184007,group,0,0
184008,obtaining,0,0
184009,a,0,0
184010,reduction,0,0
184011,in,0,0
184012,VAS,0,0
184013,scores,0,0
184014,>,0,1
184015,or,0,0
184016,=,0,0
184017,3,0,0
184018,at,0,0
184019,30,0,0
184020,min,0,0
184021,",",0,0
184022,1,0,0
184023,d,0,0
184024,",",0,0
184025,2,0,0
184026,d,0,0
184027,and,0,0
184028,6,0,0
184029,weeks,0,0
184030,after,0,0
184031,the,0,0
184032,procedure,0,0
184033,respectively,0,0
184034,",",0,0
184035,while,0,0
184036,the,0,0
184037,numbers,0,0
184038,of,0,0
184039,such,0,0
184040,patients,0,1
184041,were,0,0
184042,5,0,0
184043,",",0,0
184044,6,0,0
184045,",",0,0
184046,5,0,0
184047,",",0,0
184048,5,0,0
184049,in,0,0
184050,B,0,0
184051,group,0,0
184052,(,0,0
184053,P,0,0
184054,>,0,1
184055,0.05,0,0
184056,),0,0
184057,.,0,0
184058,After,0,0
184059,6,0,0
184060,weeks,0,0
184061,of,0,0
184062,follow-up,0,0
184063,",",0,0
184064,the,0,0
184065,overall,0,0
184066,remission,0,1
184067,rates,0,0
184068,were,0,0
184069,(,0,0
184070,72.3,0,0
184071,+/-,0,0
184072,14.0,0,0
184073,),0,0
184074,%,0,0
184075,in,0,0
184076,US,0,0
184077,group,0,0
184078,",",0,0
184079,and,0,0
184080,(,0,0
184081,56.7,0,0
184082,+/-,0,0
184083,11.0,0,0
184084,),0,0
184085,%,0,0
184086,in,0,0
184087,B,0,0
184088,group,0,0
184089,",",0,0
184090,there,0,0
184091,was,0,0
184092,no,0,0
184093,significant,0,0
184094,difference,0,0
184095,between,0,0
184096,the,0,0
184097,two,0,0
184098,groups,0,0
184099,(,0,0
184100,P,0,0
184101,>,0,1
184102,0.05,0,0
184103,),0,0
184104,.,0,0
184105,CONCLUSION,0,0
184106,The,0,0
184107,ultrasound-guided,0,0
184108,lumbar,0,0
184109,facet,0,1
184110,joint,0,0
184111,injection,0,0
184112,technique,0,0
184113,had,0,0
184114,a,0,0
184115,high,0,0
184116,feasibility,0,0
184117,and,0,0
184118,accuracy,0,0
184119,",",0,0
184120,and,0,0
184121,had,0,0
184122,better,0,0
184123,clinical,0,0
184124,efficacy,0,0
184125,than,0,0
184126,block,0,0
184127,blindly,0,0
184128,.,0,0
184129,Effect,0,0
184130,of,0,0
184131,orlistat,0,0
184132,on,0,0
184133,weight,0,0
184134,loss,0,0
184135,",",0,0
184136,hormonal,0,0
184137,and,0,0
184138,metabolic,0,0
184139,profiles,0,0
184140,in,0,0
184141,women,1,1
184142,with,1,1
184143,polycystic,1,1
184144,ovarian,1,1
184145,syndrome,1,1
184146,:,1,1
184147,a,0,0
184148,randomized,0,0
184149,double-blind,0,0
184150,placebo-controlled,0,0
184151,trial,0,0
184152,.,0,0
184153,Benefit,0,0
184154,of,0,0
184155,adjuvant,0,0
184156,interferon,0,0
184157,alfa-2b,0,0
184158,(,0,0
184159,IFN-?,0,0
184160,),0,0
184161,therapy,0,0
184162,in,1,0
184163,melanoma,1,1
184164,patients,1,1
184165,with,1,1
184166,high,1,1
184167,serum,1,0
184168,MMP-8,1,0
184169,levels,1,0
184170,.,1,1
184171,Matrix,0,0
184172,metalloproteinases,0,0
184173,(,0,0
184174,MMPs,0,0
184175,),0,0
184176,are,0,0
184177,important,0,0
184178,enzymes,0,0
184179,in,0,0
184180,tissue,0,0
184181,turnover,0,0
184182,and,0,0
184183,various,0,0
184184,inflammatory,0,0
184185,processes,0,0
184186,.,0,0
184187,In,0,0
184188,this,0,0
184189,study,0,0
184190,",",0,0
184191,it,0,0
184192,was,0,0
184193,evaluated,0,0
184194,whether,0,0
184195,serum,0,0
184196,MMP-8,0,0
184197,can,0,0
184198,predict,0,0
184199,the,0,0
184200,response,0,0
184201,to,0,0
184202,adjuvant,0,0
184203,interferon,0,0
184204,alfa-2b,0,0
184205,(,0,0
184206,IFN-?,0,0
184207,),0,0
184208,therapy,0,0
184209,in,0,0
184210,patients,0,1
184211,with,0,1
184212,operated,0,1
184213,high-risk,0,1
184214,cutaneous,0,1
184215,melanoma,1,1
184216,.,1,0
184217,Pre-treatment,0,0
184218,sera,0,0
184219,from,1,1
184220,460,1,1
184221,patients,1,1
184222,with,1,1
184223,stage,1,1
184224,IIB-IIIC,1,0
184225,melanoma,1,1
184226,were,1,0
184227,analyzed,1,0
184228,for,1,0
184229,MMP-8,1,0
184230,.,1,0
184231,The,0,0
184232,patients,0,1
184233,were,0,0
184234,randomized,0,0
184235,after,0,0
184236,surgery,0,1
184237,to,0,0
184238,adjuvant,0,0
184239,IFN-?,0,0
184240,for,0,0
184241,12,0,0
184242,or,0,1
184243,24,0,0
184244,months,0,0
184245,(,0,0
184246,n,0,1
184247,=,0,0
184248,313,0,1
184249,),0,0
184250,or,0,0
184251,observation,0,0
184252,only,0,0
184253,(,0,0
184254,n,0,1
184255,=,0,0
184256,147,0,1
184257,),0,0
184258,.,0,0
184259,The,0,0
184260,median,0,0
184261,serum,0,0
184262,MMP-8,0,0
184263,level,0,0
184264,was,0,0
184265,used,0,0
184266,to,0,0
184267,classify,0,0
184268,the,0,0
184269,patients,0,1
184270,into,0,0
184271,a,0,0
184272,low,0,0
184273,MMP-8,0,0
184274,(,0,0
184275,n,0,1
184276,=,0,0
184277,232,0,1
184278,),0,0
184279,and,0,0
184280,a,0,0
184281,high,0,0
184282,MMP-8,0,0
184283,(,0,0
184284,n,0,1
184285,=,0,0
184286,228,0,1
184287,),0,0
184288,group,0,0
184289,.,0,0
184290,In,0,0
184291,the,0,0
184292,high,0,0
184293,MMP-8,0,0
184294,subgroup,0,1
184295,",",0,0
184296,IFN-?,0,0
184297,therapy,0,0
184298,significantly,0,0
184299,improved,0,0
184300,relapse-free,0,0
184301,survival,0,0
184302,(,0,0
184303,RFS,0,0
184304,),0,0
184305,.,0,0
184306,RFS,0,0
184307,was,0,0
184308,36.8,0,0
184309,months,1,0
184310,in,1,0
184311,patients,1,1
184312,with,1,1
184313,high,1,1
184314,MMP-8,1,0
184315,levels,1,0
184316,receiving,1,1
184317,IFN-?,0,0
184318,therapy,0,0
184319,",",0,0
184320,whereas,0,0
184321,RFS,0,1
184322,for,0,1
184323,those,0,0
184324,with,0,0
184325,high,0,0
184326,MMP-8,0,0
184327,levels,0,0
184328,with,0,1
184329,observation,0,0
184330,only,0,0
184331,was,0,0
184332,10.6,0,0
184333,months,0,0
184334,(,0,0
184335,P,0,0
184336,=,0,0
184337,0.027,0,0
184338,),0,0
184339,.,0,0
184340,Median,0,0
184341,overall,0,0
184342,survival,1,0
184343,for,1,0
184344,patients,1,1
184345,with,1,1
184346,high,1,1
184347,MMP-8,1,0
184348,and,1,0
184349,observation,0,0
184350,only,0,0
184351,was,0,0
184352,36.7,0,0
184353,versus,0,0
184354,71.7,0,0
184355,months,0,0
184356,in,0,0
184357,those,0,1
184358,receiving,0,0
184359,IFN-?,0,0
184360,(,0,0
184361,P,0,0
184362,=,0,0
184363,0.13,0,0
184364,),0,0
184365,.,0,0
184366,In,0,0
184367,a,0,0
184368,multivariate,0,0
184369,model,0,0
184370,",",0,0
184371,IFN-?,0,0
184372,therapy,0,0
184373,was,0,0
184374,a,0,0
184375,significant,0,0
184376,predictor,0,0
184377,of,0,0
184378,favorable,0,0
184379,RFS,0,0
184380,(,0,0
184381,HR,0,0
184382,0.74,0,0
184383,;,0,0
184384,95,0,0
184385,%,0,0
184386,CI,0,0
184387,0.55-0.99,0,0
184388,;,0,0
184389,P,0,0
184390,=,0,0
184391,0.048,0,0
184392,),0,0
184393,",",0,0
184394,after,0,0
184395,adjustment,0,0
184396,for,0,0
184397,pre-treatment,0,0
184398,MMP-8,0,0
184399,(,0,0
184400,HR,0,0
184401,1.17,0,0
184402,;,0,0
184403,95,0,0
184404,%,0,0
184405,CI,0,0
184406,0.88-1.55,0,0
184407,;,0,0
184408,P,0,0
184409,=,0,0
184410,0.28,0,0
184411,),0,0
184412,",",0,0
184413,gender,0,0
184414,(,0,0
184415,HR,0,0
184416,1.16,0,0
184417,;,0,0
184418,95,0,0
184419,%,0,0
184420,CI,0,0
184421,0.86-1.56,0,0
184422,;,0,0
184423,P,0,0
184424,=,0,0
184425,0.32,0,0
184426,),0,0
184427,",",0,0
184428,age,0,1
184429,(,0,0
184430,HR,0,0
184431,1.00,0,0
184432,;,0,0
184433,95,0,0
184434,%,0,0
184435,CI,0,0
184436,1.00-1.02,0,0
184437,;,0,0
184438,P,0,0
184439,=,0,0
184440,0.12,0,0
184441,),0,0
184442,",",0,0
184443,ulceration,0,0
184444,(,0,0
184445,HR,0,0
184446,1.09,0,0
184447,;,0,0
184448,95,0,0
184449,%,0,0
184450,CI,0,0
184451,0.81-1.46,0,0
184452,;,0,0
184453,P,0,0
184454,=,0,0
184455,0.58,0,0
184456,),0,0
184457,",",0,0
184458,and,0,0
184459,the,0,0
184460,presence,0,0
184461,of,0,0
184462,node,0,0
184463,metastases,0,1
184464,(,0,0
184465,HR,0,0
184466,1.36,0,0
184467,;,0,0
184468,95,0,0
184469,%,0,0
184470,CI,0,0
184471,1.17-1.58,0,0
184472,;,0,0
184473,P,0,0
184474,<,0,0
184475,0.0001,0,0
184476,),0,0
184477,.,0,0
184478,In,0,0
184479,conclusion,0,0
184480,",",0,0
184481,patients,0,1
184482,with,0,1
184483,high,0,1
184484,serum,0,0
184485,MMP-8,0,0
184486,levels,0,0
184487,may,0,0
184488,benefit,0,0
184489,from,0,0
184490,adjuvant,0,0
184491,IFN-?,0,0
184492,therapy,0,0
184493,",",0,0
184494,but,0,0
184495,this,0,0
184496,observation,0,0
184497,should,0,0
184498,be,0,0
184499,further,0,0
184500,investigated,0,0
184501,.,0,0
184502,Benefits,0,0
184503,of,0,0
184504,an,0,0
184505,oxygen,0,0
184506,reservoir,0,0
184507,cannula,0,0
184508,versus,0,0
184509,a,0,0
184510,conventional,0,0
184511,nasal,0,0
184512,cannula,0,0
184513,during,0,0
184514,exercise,0,0
184515,in,0,0
184516,hypoxemic,1,1
184517,COPD,1,1
184518,patients,1,1
184519,:,1,1
184520,a,0,0
184521,crossover,0,0
184522,trial,0,0
184523,.,0,0
184524,BACKGROUND,0,0
184525,The,0,0
184526,Oxymizer?,0,0
184527,is,0,0
184528,a,0,0
184529,special,0,0
184530,nasal,0,0
184531,cannula,0,0
184532,that,0,0
184533,provides,0,0
184534,a,0,0
184535,higher,0,0
184536,luminal,0,0
184537,diameter,0,0
184538,in,0,0
184539,combination,0,0
184540,with,0,1
184541,an,0,0
184542,incorporated,0,0
184543,oxygen,0,0
184544,(,0,0
184545,O2,0,0
184546,),0,0
184547,reservoir,0,0
184548,.,0,0
184549,It,0,0
184550,is,0,0
184551,assumed,0,0
184552,that,0,0
184553,a,0,0
184554,higher,0,0
184555,O2,0,0
184556,concentration,0,0
184557,can,0,0
184558,be,0,0
184559,delivered,0,0
184560,breath,0,0
184561,by,0,0
184562,breath,0,0
184563,in,0,0
184564,order,0,0
184565,to,0,0
184566,increase,0,0
184567,oxygenation,0,0
184568,.,0,0
184569,OBJECTIVE,0,0
184570,We,0,0
184571,aimed,0,0
184572,to,0,0
184573,investigate,0,0
184574,the,0,0
184575,effects,0,0
184576,of,0,0
184577,the,0,0
184578,Oxymizer,0,0
184579,on,0,0
184580,endurance,0,0
184581,time,0,0
184582,in,0,0
184583,comparison,0,0
184584,to,0,0
184585,a,0,0
184586,conventional,0,0
184587,nasal,0,0
184588,cannula,0,0
184589,(,0,0
184590,CNC,0,0
184591,),0,0
184592,.,0,0
184593,METHODS,1,0
184594,Forty-three,1,1
184595,patients,1,1
184596,with,1,1
184597,severe,1,1
184598,chronic,1,1
184599,obstructive,1,1
184600,pulmonary,1,1
184601,disease,1,1
184602,(,1,0
184603,COPD,1,0
184604,",",1,0
184605,age,1,1
184606,60,1,1
184607,?,1,0
184608,9,1,0
184609,years,1,1
184610,",",1,0
184611,FEV1,1,0
184612,37,1,1
184613,?,1,0
184614,16,1,0
184615,%,1,0
184616,pred,1,0
184617,.,1,0
184618,),1,0
184619,and,1,0
184620,indications,1,0
184621,for,1,0
184622,LTOT,1,1
184623,were,1,0
184624,recruited,1,1
184625,during,1,0
184626,pulmonary,1,0
184627,rehabilitation,1,1
184628,for,1,0
184629,this,1,0
184630,cross-over,1,0
184631,study,1,0
184632,.,1,0
184633,After,1,0
184634,an,0,0
184635,initial,0,0
184636,maximal,0,0
184637,incremental,0,0
184638,cycle,0,0
184639,test,0,0
184640,",",0,0
184641,all,0,0
184642,patients,0,1
184643,performed,0,0
184644,4,0,0
184645,cycling,0,0
184646,endurance,0,0
184647,time,0,0
184648,tests,0,0
184649,at,0,0
184650,70,0,1
184651,%,0,0
184652,of,0,0
184653,their,0,0
184654,peak,0,0
184655,work,0,0
184656,rate,0,0
184657,(,0,0
184658,twice,0,0
184659,with,0,0
184660,the,0,0
184661,Oxymizer,0,0
184662,and,0,0
184663,twice,0,0
184664,with,0,0
184665,a,0,0
184666,CNC,0,0
184667,",",0,0
184668,in,0,0
184669,reverse,0,0
184670,order,0,0
184671,),0,0
184672,.,0,0
184673,RESULTS,0,0
184674,The,0,0
184675,endurance,0,0
184676,time,0,0
184677,was,0,0
184678,significantly,0,0
184679,higher,0,0
184680,when,0,0
184681,patients,0,1
184682,cycled,0,0
184683,while,0,0
184684,using,0,0
184685,the,0,0
184686,Oxymizer,0,0
184687,in,0,0
184688,comparison,0,0
184689,to,0,0
184690,while,0,0
184691,using,0,0
184692,the,0,0
184693,CNC,0,0
184694,[,0,0
184695,858,0,1
184696,?,0,0
184697,754,0,0
184698,vs.,0,0
184699,766,0,1
184700,?,0,0
184701,652,0,0
184702,s,0,0
184703,;,0,0
184704,between-group,0,0
184705,difference,0,0
184706,92,0,0
184707,s,0,0
184708,(,0,0
184709,95,0,0
184710,%,0,0
184711,confidence,0,0
184712,interval,0,0
184713,32-152,0,0
184714,),0,0
184715,",",0,0
184716,p,0,0
184717,<,0,0
184718,0.001,0,0
184719,],0,0
184720,.,0,0
184721,In,0,0
184722,addition,0,0
184723,to,0,0
184724,a,0,0
184725,longer,0,0
184726,cycling,0,0
184727,duration,0,0
184728,",",0,0
184729,O2,0,0
184730,saturation,0,0
184731,at,0,0
184732,isotime,0,0
184733,was,0,0
184734,significantly,0,0
184735,higher,0,0
184736,with,0,0
184737,the,0,0
184738,Oxymizer,0,0
184739,(,0,0
184740,93.5,0,0
184741,?,0,0
184742,5.4,0,0
184743,vs.,0,0
184744,90.4,0,0
184745,?,0,0
184746,5.3,0,0
184747,%,0,0
184748,;,0,0
184749,p,0,0
184750,=,0,0
184751,0.027,0,0
184752,),0,0
184753,.,0,0
184754,Furthermore,0,0
184755,",",0,0
184756,there,0,0
184757,was,0,0
184758,a,0,0
184759,positive,0,0
184760,correlation,0,0
184761,(,0,0
184762,r,0,0
184763,=,0,0
184764,0.427,0,0
184765,",",0,0
184766,p,0,0
184767,=,0,0
184768,0.002,0,0
184769,),0,0
184770,between,0,0
184771,the,0,0
184772,O2,0,0
184773,flow,0,0
184774,rate,0,0
184775,and,0,0
184776,improvements,0,0
184777,in,0,0
184778,the,0,0
184779,constant,0,0
184780,work,0,0
184781,rate,0,0
184782,test,0,0
184783,",",0,0
184784,showing,0,0
184785,greater,0,0
184786,improvements,0,0
184787,in,0,0
184788,favor,0,0
184789,of,0,0
184790,the,0,0
184791,Oxymizer,0,0
184792,in,0,0
184793,patients,0,1
184794,with,0,1
184795,a,0,0
184796,higher,0,0
184797,demand,0,0
184798,for,0,0
184799,O2,0,0
184800,(,0,0
184801,?,0,0
184802,4,0,0
184803,liters/min,0,0
184804,),0,0
184805,.,0,0
184806,CONCLUSION,0,0
184807,We,0,0
184808,show,0,0
184809,that,0,0
184810,O2,0,0
184811,delivery,0,0
184812,via,0,0
184813,the,0,0
184814,Oxymizer,0,0
184815,is,0,0
184816,superior,0,0
184817,to,0,0
184818,a,0,0
184819,CNC,0,0
184820,with,0,0
184821,regard,0,0
184822,to,0,0
184823,endurance,0,0
184824,capacity,0,0
184825,and,0,0
184826,oxygenation,0,0
184827,during,0,0
184828,exercise,0,0
184829,in,1,0
184830,patients,1,1
184831,with,1,1
184832,severe,1,1
184833,COPD,1,0
184834,.,1,0
184835,It,1,0
184836,seems,0,0
184837,that,0,0
184838,patients,0,1
184839,with,0,1
184840,a,0,0
184841,higher,0,0
184842,demand,0,0
184843,for,0,0
184844,O2,0,0
184845,(,0,0
184846,?,0,0
184847,4,0,0
184848,liters/min,0,0
184849,),0,0
184850,",",0,0
184851,in,0,0
184852,particular,0,0
184853,",",0,0
184854,may,0,0
184855,benefit,0,0
184856,more,0,0
184857,from,0,0
184858,the,0,0
184859,use,0,0
184860,of,0,0
184861,the,0,0
184862,Oxymizer,0,0
184863,.,0,0
184864,Dexmedetomidine,0,0
184865,pretreatment,0,0
184866,alleviates,0,0
184867,propofol,1,0
184868,injection,1,0
184869,pain,1,0
184870,.,1,0
184871,OBJECTIVE,0,0
184872,The,0,0
184873,incidence,0,0
184874,of,0,0
184875,propofol,0,0
184876,injection,0,0
184877,pain,0,0
184878,during,0,0
184879,induction,0,0
184880,of,0,0
184881,general,0,1
184882,anesthesia,0,1
184883,varies,0,0
184884,from,0,0
184885,28,0,1
184886,%,0,0
184887,to,0,0
184888,90,0,0
184889,%,0,0
184890,.,0,0
184891,This,0,0
184892,prospective,0,0
184893,",",0,0
184894,randomized,0,0
184895,",",0,0
184896,double-blind,0,0
184897,",",0,0
184898,placebo-controlled,0,0
184899,study,0,0
184900,evaluated,0,0
184901,the,0,0
184902,effect,0,0
184903,of,0,0
184904,dexmedetomidine,0,0
184905,(,0,0
184906,DEX,0,0
184907,),0,0
184908,for,0,0
184909,reducing,0,0
184910,the,0,0
184911,incidence,0,0
184912,and,0,0
184913,severity,0,0
184914,of,0,0
184915,propofol,0,0
184916,injection,0,0
184917,pain,0,0
184918,.,0,1
184919,METHODS,0,0
184920,Patients,1,1
184921,undergoing,1,1
184922,elective,1,1
184923,surgical,1,1
184924,procedures,1,1
184925,were,1,0
184926,randomly,1,1
184927,allocated,1,0
184928,into,1,0
184929,seven,1,1
184930,groups,1,0
184931,of,1,0
184932,30,1,1
184933,patients,1,1
184934,each,1,0
184935,.,1,0
184936,Experimental,0,0
184937,treatments,0,0
184938,were,0,0
184939,intravenously,0,0
184940,administered,0,0
184941,over,0,0
184942,10,0,0
184943,min,0,0
184944,(,0,0
184945,total,0,1
184946,volume,0,0
184947,10,0,0
184948,mL,0,0
184949,),0,0
184950,prior,0,0
184951,to,0,0
184952,intravenous,0,0
184953,propofol,0,0
184954,injection,0,0
184955,",",0,0
184956,as,0,0
184957,follows,0,0
184958,:,0,0
184959,group,0,0
184960,I,0,0
184961,",",0,0
184962,the,0,0
184963,control,0,0
184964,group,0,0
184965,",",0,0
184966,was,0,0
184967,given,0,0
184968,isotonic,0,0
184969,saline,0,0
184970,.,0,0
184971,Patients,0,1
184972,in,0,0
184973,groups,0,0
184974,II,0,1
184975,",",0,0
184976,III,0,0
184977,",",0,0
184978,and,0,0
184979,IV,0,0
184980,received,0,0
184981,DEX,0,0
184982,0.25,0,0
184983,?g/kg,0,0
184984,",",0,0
184985,0.5,0,0
184986,?g/kg,0,0
184987,",",0,0
184988,or,0,0
184989,1.0,0,0
184990,?g/kg,0,0
184991,",",0,0
184992,respectively,0,0
184993,",",0,0
184994,mixed,0,0
184995,with,0,1
184996,isotonic,0,0
184997,saline,0,0
184998,immediately,0,0
184999,before,0,0
185000,propofol,0,0
185001,injection,0,0
185002,.,0,0
185003,Patients,0,1
185004,in,0,0
185005,groups,0,0
185006,V,0,0
185007,",",0,0
185008,VI,0,0
185009,",",0,0
185010,and,0,0
185011,VII,0,0
185012,received,0,0
185013,DEX,0,0
185014,as,0,0
185015,above,0,0
185016,",",0,0
185017,but,0,0
185018,5,0,0
185019,minutes,0,0
185020,before,0,0
185021,propofol,0,0
185022,injection,0,0
185023,.,0,0
185024,Propofol,0,0
185025,consisted,0,0
185026,of,0,0
185027,1,0,0
185028,%,0,0
185029,long-chain,0,0
185030,triglyceride,0,0
185031,propofol,0,0
185032,(,0,0
185033,2.5,0,0
185034,mg/kg,0,0
185035,),0,0
185036,injected,0,0
185037,at,0,0
185038,1,0,0
185039,mL/s,0,0
185040,.,0,1
185041,RESULTS,0,0
185042,Median,0,0
185043,propofol,0,0
185044,injection,0,0
185045,pain,0,0
185046,score,0,0
185047,was,0,0
185048,0.00,0,0
185049,(,0,0
185050,IQR,0,0
185051,0.00-3.00,0,0
185052,),0,0
185053,in,0,1
185054,patients,0,1
185055,who,0,1
185056,received,0,1
185057,1.0,0,1
185058,?g/kg,0,0
185059,DEX,0,0
185060,5,0,0
185061,min,0,0
185062,before,0,0
185063,the,0,0
185064,propofol,0,0
185065,injection,0,0
185066,(,0,0
185067,group,0,0
185068,VII,0,0
185069,),0,0
185070,",",0,0
185071,and,0,0
185072,only,0,0
185073,1,0,0
185074,patient,0,0
185075,(,0,0
185076,of,0,0
185077,30,0,0
185078,),0,0
185079,in,0,0
185080,this,0,0
185081,group,0,0
185082,received,0,0
185083,a,0,0
185084,pain,0,0
185085,score,0,0
185086,>,0,1
185087,2,0,0
185088,.,0,0
185089,The,0,0
185090,median,0,0
185091,pain,0,0
185092,score,0,0
185093,and,0,0
185094,number,0,0
185095,of,0,0
185096,patients,0,1
185097,with,0,1
185098,pain,0,0
185099,scores,0,0
185100,>,0,1
185101,2,0,0
185102,in,0,0
185103,group,0,0
185104,VII,0,0
185105,were,0,0
185106,both,0,0
185107,significantly,0,0
185108,less,0,0
185109,than,0,0
185110,in,0,0
185111,the,0,0
185112,control,0,0
185113,(,0,0
185114,group,0,0
185115,I,0,0
185116,;,0,0
185117,p,0,0
185118,=,0,0
185119,0.000,0,0
185120,",",0,0
185121,both,0,0
185122,),0,0
185123,.,0,0
185124,There,0,0
185125,were,0,0
185126,no,0,0
185127,differences,0,0
185128,in,0,0
185129,either,0,0
185130,mean,0,0
185131,arterial,0,0
185132,pressure,0,0
185133,or,0,0
185134,heart,0,1
185135,rate,0,0
185136,at,0,0
185137,any,0,0
185138,time,0,0
185139,point,0,0
185140,after,0,0
185141,DEX,0,0
185142,injection,0,0
185143,among,0,0
185144,the,0,0
185145,groups,0,0
185146,.,0,0
185147,CONCLUSIONS,0,0
185148,Pretreatment,0,0
185149,with,0,1
185150,intravenous,0,0
185151,DEX,0,0
185152,1,0,0
185153,?g/kg,0,0
185154,5,0,0
185155,min,0,0
185156,prior,0,0
185157,to,0,0
185158,injection,0,0
185159,of,0,0
185160,long-chain,0,0
185161,triglyceride,0,0
185162,propofol,0,0
185163,is,0,0
185164,effective,0,0
185165,and,0,0
185166,safe,0,0
185167,in,0,0
185168,reducing,0,0
185169,the,0,0
185170,incidence,0,0
185171,and,0,0
185172,severity,0,0
185173,of,0,0
185174,pain,0,0
185175,due,0,0
185176,to,0,0
185177,propofol,0,0
185178,injection,0,0
185179,.,0,0
185180,Parent-implemented,0,0
185181,social,0,0
185182,intervention,0,0
185183,for,0,0
185184,toddlers,1,1
185185,with,1,1
185186,autism,1,1
185187,:,1,1
185188,an,0,0
185189,RCT,0,0
185190,.,0,0
185191,OBJECTIVES,0,0
185192,To,0,0
185193,compare,0,0
185194,the,0,0
185195,effects,0,0
185196,of,0,0
185197,two,0,0
185198,9-month,0,0
185199,parent-implemented,0,0
185200,interventions,0,0
185201,within,0,0
185202,the,0,0
185203,Early,0,0
185204,Social,0,0
185205,Interaction,0,0
185206,(,0,0
185207,ESI,0,0
185208,),0,0
185209,Project,0,0
185210,.,0,0
185211,Both,0,0
185212,individual-ESI,0,0
185213,",",0,0
185214,offered,0,0
185215,2,0,0
185216,or,0,1
185217,3,0,0
185218,times,0,0
185219,per,0,0
185220,week,0,0
185221,at,0,0
185222,home,0,0
185223,or,0,0
185224,in,0,0
185225,the,0,0
185226,community,0,0
185227,",",0,0
185228,and,0,0
185229,group-ESI,0,0
185230,",",0,0
185231,offered,0,0
185232,once,0,0
185233,per,0,0
185234,week,0,0
185235,in,0,0
185236,a,0,0
185237,clinic,0,0
185238,",",0,0
185239,taught,0,0
185240,parents,0,0
185241,how,0,0
185242,to,0,0
185243,embed,0,0
185244,strategies,0,0
185245,to,0,0
185246,support,0,0
185247,social,0,0
185248,communication,0,0
185249,throughout,0,0
185250,everyday,0,0
185251,activities,0,0
185252,.,0,1
185253,METHODS,0,0
185254,Participants,0,1
185255,in,0,0
185256,the,0,0
185257,randomized,0,0
185258,controlled,0,0
185259,trial,0,0
185260,included,0,1
185261,82,1,1
185262,children,1,1
185263,diagnosed,1,1
185264,with,1,1
185265,autism,1,1
185266,spectrum,1,1
185267,disorder,1,1
185268,at,1,0
185269,16,1,1
185270,to,1,0
185271,20,1,1
185272,months,1,0
185273,.,1,1
185274,Children,0,1
185275,were,0,0
185276,matched,0,1
185277,on,0,0
185278,pretreatment,0,0
185279,nonverbal,0,0
185280,developmental,0,0
185281,level,0,0
185282,and,0,0
185283,pairs,0,1
185284,were,0,0
185285,randomly,0,1
185286,assigned,0,0
185287,to,0,0
185288,treatment,0,0
185289,condition,0,0
185290,.,0,0
185291,Child,0,0
185292,outcomes,0,0
185293,included,0,0
185294,measures,0,0
185295,of,0,0
185296,social,0,0
185297,communication,0,0
185298,",",0,0
185299,autism,0,1
185300,symptoms,0,0
185301,",",0,0
185302,adaptive,0,0
185303,behavior,0,0
185304,",",0,0
185305,and,0,0
185306,developmental,0,0
185307,level,0,0
185308,.,0,0
185309,Child,0,0
185310,outcomes,0,0
185311,are,0,0
185312,reported,0,0
185313,from,0,0
185314,baseline,0,0
185315,to,0,0
185316,the,0,0
185317,end,0,0
185318,of,0,0
185319,the,0,0
185320,9-month,0,0
185321,interventions,0,0
185322,.,0,1
185323,RESULTS,0,0
185324,Children,0,1
185325,in,0,0
185326,individual-ESI,0,0
185327,showed,0,0
185328,differential,0,0
185329,change,0,0
185330,on,0,0
185331,a,0,0
185332,standardized,0,0
185333,examiner-administered,0,0
185334,observational,0,1
185335,measure,0,0
185336,of,0,0
185337,social,0,0
185338,communication,0,0
185339,",",0,0
185340,as,0,0
185341,they,0,0
185342,improved,0,0
185343,at,0,0
185344,a,0,0
185345,faster,0,0
185346,rate,0,0
185347,than,0,0
185348,children,0,1
185349,in,0,0
185350,group-ESI,0,0
185351,.,0,0
185352,Individual-ESI,0,0
185353,also,0,0
185354,showed,0,0
185355,differential,0,0
185356,efficacy,0,0
185357,on,0,0
185358,a,0,0
185359,parent,0,0
185360,report,0,0
185361,measure,0,0
185362,of,0,0
185363,communication,0,0
185364,",",0,0
185365,daily,0,0
185366,living,0,0
185367,",",0,0
185368,and,0,0
185369,social,0,0
185370,skills,0,0
185371,",",0,0
185372,as,0,0
185373,they,0,0
185374,showed,0,0
185375,improvement,0,0
185376,or,0,0
185377,stability,0,0
185378,",",0,0
185379,whereas,0,0
185380,group-ESI,0,0
185381,led,0,0
185382,to,0,0
185383,worsening,0,0
185384,or,0,0
185385,no,0,0
185386,significant,0,0
185387,change,0,0
185388,on,0,0
185389,these,0,0
185390,skills,0,0
185391,.,0,0
185392,Finally,0,0
185393,",",0,0
185394,individual-ESI,0,0
185395,showed,0,0
185396,differential,0,0
185397,change,0,0
185398,on,0,0
185399,examiner-administered,0,0
185400,measures,0,0
185401,of,0,0
185402,receptive,0,1
185403,language,0,0
185404,skills,0,0
185405,",",0,0
185406,as,0,0
185407,children,0,1
185408,in,0,0
185409,individual-ESI,0,0
185410,improved,0,0
185411,significantly,0,0
185412,",",0,0
185413,whereas,0,0
185414,group-ESI,0,0
185415,showed,0,0
185416,no,0,0
185417,change,0,0
185418,.,0,0
185419,CONCLUSIONS,0,0
185420,These,0,0
185421,findings,0,0
185422,support,0,0
185423,the,0,0
185424,efficacy,0,0
185425,of,0,0
185426,individual-ESI,0,0
185427,compared,0,0
185428,with,0,0
185429,group-ESI,0,0
185430,on,0,0
185431,child,0,1
185432,outcomes,0,0
185433,",",0,0
185434,suggesting,0,0
185435,the,0,0
185436,importance,0,0
185437,of,0,0
185438,individualized,0,0
185439,parent,0,0
185440,coaching,0,0
185441,in,0,0
185442,natural,0,0
185443,environments,0,0
185444,.,0,0
185445,The,0,0
185446,efficacy,0,0
185447,of,0,0
185448,a,0,0
185449,parent-implemented,0,0
185450,intervention,0,0
185451,using,0,0
185452,little,0,0
185453,professional,0,0
185454,time,0,0
185455,has,0,0
185456,potential,0,0
185457,for,0,0
185458,community,0,1
185459,viability,0,0
185460,",",0,0
185461,which,0,0
185462,is,0,0
185463,particularly,0,0
185464,important,0,0
185465,in,0,0
185466,light,0,0
185467,of,0,0
185468,the,0,0
185469,lack,0,0
185470,of,0,0
185471,main,0,0
185472,effects,0,0
185473,on,0,0
185474,child,0,1
185475,outcomes,0,0
185476,of,0,0
185477,most,0,0
185478,other,0,0
185479,parent-implemented,0,0
185480,interventions,0,0
185481,.,0,1
185482,Increased,0,0
185483,dietary,0,0
185484,?-linolenic,0,0
185485,acid,0,0
185486,has,0,0
185487,sex-specific,0,0
185488,effects,0,0
185489,upon,0,0
185490,eicosapentaenoic,0,0
185491,acid,0,0
185492,status,0,0
185493,in,1,0
185494,humans,1,0
185495,:,1,1
185496,re-examination,0,1
185497,of,0,0
185498,data,0,0
185499,from,0,0
185500,a,0,0
185501,randomised,0,0
185502,",",0,0
185503,placebo-controlled,0,0
185504,",",0,0
185505,parallel,0,0
185506,study,0,0
185507,.,0,0
185508,BACKGROUND,0,0
185509,There,0,0
185510,is,0,0
185511,a,0,0
185512,metabolic,0,0
185513,pathway,0,0
185514,by,0,0
185515,which,1,0
185516,mammals,1,1
185517,can,0,0
185518,convert,0,0
185519,the,0,0
185520,omega-3,0,0
185521,(,0,0
185522,n-3,0,0
185523,),0,0
185524,essential,0,1
185525,fatty,0,0
185526,acid,0,0
185527,?-linolenic,0,0
185528,acid,0,0
185529,(,0,0
185530,ALA,0,0
185531,),0,0
185532,into,0,0
185533,longer-chain,0,0
185534,n-3,0,0
185535,polyunsaturated,0,0
185536,fatty,0,0
185537,acids,0,0
185538,(,0,0
185539,LC,0,0
185540,n-3,0,0
185541,PUFA,0,0
185542,),0,0
185543,including,0,0
185544,eicosapentaenoic,0,0
185545,acid,0,0
185546,(,0,0
185547,EPA,0,0
185548,),0,0
185549,and,0,0
185550,docosahexaenoic,0,0
185551,acid,0,0
185552,(,0,0
185553,DHA,0,0
185554,),0,0
185555,.,0,0
185556,As,0,0
185557,far,0,0
185558,as,0,0
185559,we,0,0
185560,know,0,0
185561,there,0,0
185562,are,0,0
185563,currently,0,0
185564,no,0,0
185565,studies,0,0
185566,that,0,0
185567,have,0,0
185568,specifically,0,0
185569,examined,0,0
185570,sex,0,0
185571,differences,0,0
185572,in,0,0
185573,the,0,0
185574,LC,0,0
185575,n-3,0,0
185576,PUFA,0,0
185577,response,0,0
185578,to,0,0
185579,increased,0,0
185580,dietary,0,0
185581,ALA,0,0
185582,intake,0,0
185583,in,0,0
185584,humans,0,0
185585,",",0,0
185586,although,0,0
185587,acute,0,1
185588,studies,0,0
185589,with,0,1
185590,isotope-labelled,0,1
185591,ALA,0,0
185592,identified,0,0
185593,that,1,0
185594,women,1,1
185595,have,1,0
185596,a,0,0
185597,significantly,0,0
185598,greater,0,0
185599,capacity,0,0
185600,to,0,0
185601,synthesise,0,0
185602,EPA,0,0
185603,and,0,0
185604,DHA,0,0
185605,from,0,0
185606,ALA,0,0
185607,compared,0,0
185608,to,0,0
185609,men,1,1
185610,.,1,1
185611,FINDINGS,0,0
185612,Available,0,0
185613,data,0,0
185614,from,0,0
185615,a,0,0
185616,placebo-controlled,0,0
185617,",",0,0
185618,randomised,0,0
185619,study,0,0
185620,were,0,0
185621,re-examined,0,0
185622,to,0,0
185623,identify,0,0
185624,whether,0,0
185625,there,0,0
185626,are,0,0
185627,sex,0,0
185628,differences,0,0
185629,in,0,0
185630,the,0,0
185631,LC,0,0
185632,n-3,0,0
185633,PUFA,0,0
185634,response,0,0
185635,to,0,0
185636,increased,0,0
185637,dietary,0,0
185638,ALA,0,0
185639,intake,0,0
185640,in,0,0
185641,humans,0,0
185642,.,0,0
185643,There,0,0
185644,was,0,0
185645,a,0,0
185646,significant,0,0
185647,difference,0,0
185648,between,0,0
185649,sexes,0,1
185650,in,0,0
185651,the,0,0
185652,response,0,0
185653,to,0,0
185654,increased,0,0
185655,dietary,0,0
185656,ALA,0,0
185657,",",0,0
185658,with,0,1
185659,women,0,1
185660,having,0,1
185661,a,0,0
185662,significantly,0,0
185663,greater,0,0
185664,increase,0,0
185665,in,0,0
185666,the,0,0
185667,EPA,0,0
185668,content,0,0
185669,of,0,0
185670,plasma,0,0
185671,phospholipids,0,0
185672,(,0,0
185673,mean,0,1
185674,+2.0,0,0
185675,%,0,0
185676,of,0,0
185677,total,0,1
185678,fatty,0,0
185679,acids,0,0
185680,),0,0
185681,after,0,0
185682,six,0,0
185683,months,0,0
185684,of,0,0
185685,an,0,0
185686,ALA-rich,0,0
185687,diet,0,0
185688,compared,0,0
185689,to,0,0
185690,men,0,1
185691,(,0,0
185692,mean,0,1
185693,+0.7,0,0
185694,%,0,0
185695,",",0,0
185696,P,0,0
185697,=,0,0
185698,0.039,0,0
185699,),0,0
185700,.,0,0
185701,Age,0,0
185702,and,0,0
185703,BMI,0,0
185704,were,0,0
185705,identified,0,0
185706,as,0,0
185707,predictors,0,0
185708,of,0,0
185709,response,0,0
185710,to,0,0
185711,dietary,0,0
185712,ALA,0,0
185713,among,0,1
185714,women,0,1
185715,.,0,1
185716,CONCLUSIONS,1,0
185717,Women,1,1
185718,show,0,0
185719,a,0,0
185720,greater,0,0
185721,increase,0,0
185722,in,0,0
185723,circulating,0,0
185724,EPA,0,0
185725,than,0,0
185726,men,0,1
185727,during,0,0
185728,increased,0,0
185729,dietary,0,0
185730,ALA,0,0
185731,consumption,0,0
185732,.,0,0
185733,Further,0,0
185734,understanding,0,0
185735,of,0,0
185736,individual,0,0
185737,variation,0,0
185738,in,0,0
185739,the,0,0
185740,response,0,0
185741,to,0,0
185742,dietary,0,0
185743,ALA,0,0
185744,could,0,0
185745,inform,0,0
185746,nutrition,0,0
185747,advice,0,0
185748,",",0,0
185749,with,0,0
185750,recommendations,0,0
185751,being,0,0
185752,specifically,0,0
185753,tailored,0,0
185754,according,0,0
185755,to,0,0
185756,habitual,0,0
185757,diet,0,0
185758,",",0,0
185759,sex,0,0
185760,",",0,0
185761,age,0,1
185762,and,0,0
185763,BMI,0,0
185764,.,0,0
185765,Inclusion,0,0
185766,of,0,0
185767,anti-phospholipase,1,0
185768,A2,1,0
185769,antibody,1,0
185770,to,0,0
185771,backgrounding,0,0
185772,diets,0,0
185773,on,0,0
185774,performance,0,0
185775,",",0,0
185776,feed,0,0
185777,efficiency,0,0
185778,",",0,0
185779,in,0,0
185780,vitro,0,0
185781,fermentation,0,0
185782,",",0,0
185783,and,0,0
185784,the,0,0
185785,acute-phase,0,0
185786,response,0,0
185787,of,0,0
185788,growing,1,0
185789,beef,1,1
185790,calves,1,1
185791,.,1,0
185792,In,0,0
185793,Exp,0,0
185794,.,0,0
185795,1,0,0
185796,",",0,0
185797,individual,0,0
185798,performance,0,0
185799,and,0,0
185800,daily,0,0
185801,DMI,0,0
185802,was,0,0
185803,measured,0,0
185804,on,0,0
185805,70,1,1
185806,crossbred,1,1
185807,weaned,1,0
185808,calves,1,1
185809,during,1,0
185810,a,1,0
185811,70-d,1,0
185812,period,1,0
185813,using,1,0
185814,a,1,0
185815,GrowSafe,1,0
185816,system,1,0
185817,(,1,1
185818,GrowSafe,1,0
185819,Systems,1,0
185820,Ltd.,1,1
185821,",",0,0
185822,Airdrie,1,1
185823,",",1,0
185824,AB,1,0
185825,",",1,0
185826,Canada,1,1
185827,),1,0
185828,at,1,0
185829,the,1,0
185830,University,1,1
185831,of,1,0
185832,Florida,1,1
185833,North,1,1
185834,Florida,1,1
185835,Research,1,0
185836,and,1,0
185837,Education,1,0
185838,Center,1,0
185839,Feed,1,0
185840,Efficiency,1,0
185841,Facility,1,1
185842,(,1,0
185843,FEF,1,1
185844,),1,0
185845,.,1,0
185846,Calves,1,0
185847,were,0,0
185848,fed,0,0
185849,a,0,0
185850,low-concentrate,0,0
185851,(,0,0
185852,LC,0,0
185853,),0,0
185854,growing,0,0
185855,diet,0,0
185856,",",0,0
185857,blocked,0,0
185858,by,0,0
185859,weight,0,0
185860,and,0,0
185861,sex,0,0
185862,",",0,0
185863,and,0,0
185864,then,0,0
185865,randomly,0,0
185866,assigned,0,0
185867,to,0,0
185868,pens,0,0
185869,to,0,0
185870,receive,0,0
185871,either,0,0
185872,no,0,0
185873,additional,0,0
185874,supplement,0,0
185875,(,0,0
185876,CON,0,0
185877,;,0,0
185878,n,0,0
185879,=,0,0
185880,35,0,0
185881,),0,0
185882,or,0,0
185883,receive,0,0
185884,a,0,0
185885,supplement,0,0
185886,of,0,0
185887,anti-phospholipase,0,0
185888,A2,0,0
185889,antibody,0,0
185890,(,0,0
185891,aPLA2,0,0
185892,),0,0
185893,at,0,0
185894,an,0,0
185895,inclusion,0,0
185896,rate,0,0
185897,of,0,0
185898,0.6,0,0
185899,%,0,0
185900,of,0,0
185901,the,0,0
185902,diet,0,0
185903,DM,0,0
185904,(,0,0
185905,n,0,1
185906,=,0,0
185907,35,0,1
185908,),0,0
185909,.,0,0
185910,After,0,0
185911,the,0,0
185912,70-d,0,0
185913,feed,0,0
185914,efficiency,0,0
185915,(,0,0
185916,FE,0,0
185917,),0,0
185918,trial,0,0
185919,(,0,0
185920,Phase,0,0
185921,1,0,0
185922,),0,0
185923,",",0,0
185924,calves,0,1
185925,were,0,0
185926,loaded,0,0
185927,into,0,0
185928,a,0,0
185929,commercial,0,0
185930,livestock,0,0
185931,trailer,0,0
185932,and,0,0
185933,were,0,0
185934,driven,0,0
185935,for,0,0
185936,approximately,0,0
185937,"1,600",0,0
185938,km,0,0
185939,during,0,0
185940,24,0,1
185941,h.,0,0
185942,Upon,0,0
185943,return,0,0
185944,to,0,0
185945,the,0,0
185946,FEF,0,0
185947,(,0,0
185948,Phase,0,1
185949,2,0,0
185950,),0,0
185951,",",0,0
185952,calves,0,1
185953,were,0,0
185954,relocated,0,1
185955,to,0,0
185956,the,0,0
185957,same,0,0
185958,pens,0,0
185959,and,0,0
185960,groups,0,0
185961,and,0,0
185962,received,0,0
185963,the,0,0
185964,same,0,0
185965,diets,0,0
185966,and,0,0
185967,treatments,0,0
185968,for,0,0
185969,28,0,1
185970,d.,0,1
185971,Blood,0,0
185972,samples,0,0
185973,from,0,0
185974,each,0,0
185975,calf,0,0
185976,were,0,0
185977,collected,0,0
185978,on,0,0
185979,d,0,0
185980,0,0,0
185981,",",0,0
185982,1,0,0
185983,",",0,0
185984,3,0,0
185985,",",0,0
185986,5,0,0
185987,",",0,0
185988,7,0,0
185989,",",0,0
185990,14,0,0
185991,",",0,0
185992,21,0,0
185993,",",0,0
185994,and,0,0
185995,28,0,0
185996,relative,0,0
185997,to,0,0
185998,initiation,0,0
185999,of,0,0
186000,transportation,0,0
186001,and,0,0
186002,were,0,0
186003,analyzed,0,0
186004,for,0,0
186005,determination,0,0
186006,of,0,0
186007,concentrations,0,0
186008,of,0,0
186009,plasma,0,0
186010,ceruloplasmin,0,0
186011,and,0,0
186012,haptoglobin,0,0
186013,.,0,0
186014,In,0,0
186015,Phase,0,0
186016,1,0,0
186017,",",0,0
186018,initial,0,0
186019,BW,0,0
186020,(,0,0
186021,242.0,0,0
186022,?,0,0
186023,3.7,0,0
186024,kg,0,0
186025,;,0,0
186026,P,0,0
186027,=,0,0
186028,0.92,0,0
186029,),0,0
186030,",",0,0
186031,BW,0,0
186032,at,0,0
186033,d,0,0
186034,70,0,1
186035,(,0,0
186036,313.0,0,0
186037,?,0,0
186038,4.1,0,0
186039,kg,0,0
186040,;,0,0
186041,P,0,0
186042,=,0,0
186043,0.79,0,0
186044,),0,0
186045,",",0,0
186046,and,0,0
186047,ADG,0,0
186048,(,0,0
186049,1.01,0,0
186050,?,0,0
186051,0.02,0,0
186052,kg,0,0
186053,;,0,0
186054,P,0,0
186055,=,0,0
186056,0.95,0,0
186057,),0,0
186058,were,0,0
186059,similar,0,0
186060,between,0,0
186061,treatments,0,0
186062,.,0,0
186063,However,0,0
186064,",",0,0
186065,daily,0,0
186066,DMI,0,0
186067,was,0,0
186068,greater,0,0
186069,(,0,0
186070,P,0,0
186071,=,0,0
186072,0.01,0,0
186073,),0,0
186074,for,0,0
186075,CON,0,0
186076,(,0,0
186077,9.18,0,0
186078,?,0,0
186079,0.15,0,0
186080,kg,0,0
186081,),0,0
186082,than,0,0
186083,aPLA2,0,0
186084,(,0,0
186085,8.53,0,0
186086,?,0,0
186087,0.15,0,0
186088,kg,0,0
186089,),0,0
186090,.,0,0
186091,In,0,0
186092,addition,0,0
186093,",",0,0
186094,residual,0,0
186095,feed,0,0
186096,intake,0,0
186097,was,0,0
186098,greater,0,0
186099,(,0,0
186100,P,0,0
186101,=,0,0
186102,0.002,0,0
186103,),0,0
186104,for,0,0
186105,CON,0,0
186106,(,0,0
186107,0.389,0,0
186108,?,0,0
186109,0.110,0,0
186110,kg/d,0,0
186111,),0,0
186112,than,0,0
186113,aPLA2,0,0
186114,calves,0,1
186115,(,0,0
186116,-0.272,0,0
186117,?,0,0
186118,0.110,0,0
186119,kg/d,0,0
186120,),0,0
186121,.,0,0
186122,In,0,0
186123,Phase,0,0
186124,2,0,0
186125,",",0,0
186126,after,0,0
186127,transportation,0,0
186128,",",0,0
186129,there,0,0
186130,were,0,0
186131,no,0,0
186132,differences,0,0
186133,between,0,0
186134,treatments,0,0
186135,on,0,0
186136,BW,0,1
186137,loss,0,0
186138,due,0,0
186139,to,0,0
186140,transportation,0,0
186141,shrink,0,0
186142,(,0,0
186143,26.0,0,0
186144,?,0,0
186145,0.6,0,0
186146,kg,0,0
186147,;,0,0
186148,P,0,0
186149,=,0,0
186150,0.86,0,0
186151,),0,0
186152,",",0,0
186153,BW,0,0
186154,at,0,0
186155,d,0,0
186156,28,0,1
186157,(,0,0
186158,339.0,0,0
186159,?,0,0
186160,4.1,0,0
186161,kg,0,0
186162,;,0,0
186163,P,0,0
186164,=,0,0
186165,0.72,0,0
186166,),0,0
186167,",",0,0
186168,ADG,0,0
186169,(,0,0
186170,1.28,0,0
186171,?,0,0
186172,0.03,0,0
186173,kg/d,0,0
186174,;,0,0
186175,P,0,0
186176,=,0,0
186177,0.72,0,0
186178,),0,0
186179,",",0,0
186180,G,0,0
186181,:,0,1
186182,F,0,0
186183,(,0,0
186184,0.164,0,0
186185,?,0,0
186186,0.004,0,0
186187,;,0,0
186188,P,0,0
186189,=,0,0
186190,0.83,0,0
186191,),0,0
186192,",",0,0
186193,and,0,0
186194,concentrations,0,0
186195,of,0,0
186196,plasma,0,0
186197,haptoglobin,0,0
186198,(,0,0
186199,0.08,0,0
186200,?,0,0
186201,0.02,0,0
186202,mg/mL,0,0
186203,;,0,0
186204,P,0,0
186205,=,0,0
186206,0.41,0,0
186207,),0,0
186208,.,0,0
186209,However,0,0
186210,",",0,0
186211,concentrations,0,0
186212,of,0,0
186213,plasma,0,0
186214,ceruloplasmin,0,0
186215,were,0,0
186216,greater,0,0
186217,(,0,0
186218,P,0,0
186219,<,0,0
186220,0.001,0,0
186221,),0,0
186222,for,0,0
186223,CON,0,0
186224,calves,0,1
186225,(,0,0
186226,14.3,0,0
186227,?,0,0
186228,0.3,0,0
186229,mg/dL,0,0
186230,),0,0
186231,compared,0,0
186232,to,0,0
186233,aPLA2,0,0
186234,calves,0,1
186235,(,0,0
186236,13.0,0,0
186237,?,0,0
186238,0.3,0,0
186239,mg/dL,0,0
186240,),0,0
186241,.,0,0
186242,In,0,0
186243,Exp,0,0
186244,.,0,0
186245,2,0,0
186246,",",0,0
186247,the,0,0
186248,effects,0,0
186249,of,0,0
186250,aPLA2,0,0
186251,inclusion,0,0
186252,on,0,0
186253,LC,0,0
186254,and,0,0
186255,high-concentrate,0,0
186256,(,0,0
186257,HC,0,0
186258,),0,0
186259,substrates,0,0
186260,on,0,0
186261,in,0,0
186262,vitro,0,0
186263,fermentation,0,0
186264,parameters,0,0
186265,were,0,0
186266,assessed,0,0
186267,.,0,0
186268,Addition,0,0
186269,of,0,0
186270,aPLA2,0,0
186271,had,0,0
186272,no,0,0
186273,effects,0,0
186274,on,0,0
186275,in,0,0
186276,vitro,0,0
186277,fermentation,0,0
186278,parameters,0,0
186279,of,0,0
186280,LC,0,0
186281,and,0,0
186282,HC,0,0
186283,substrates,0,0
186284,.,0,0
186285,In,0,0
186286,conclusion,0,0
186287,",",0,0
186288,supplementation,0,0
186289,of,0,0
186290,aPLA2,0,0
186291,improved,0,0
186292,FE,0,0
186293,of,0,0
186294,growing,0,0
186295,beef,0,1
186296,calves,0,0
186297,when,0,0
186298,fed,0,0
186299,LC,0,0
186300,diets,0,0
186301,in,0,0
186302,Phase,0,1
186303,1,0,0
186304,and,0,0
186305,addition,0,0
186306,of,0,0
186307,aPLA2,0,0
186308,had,0,0
186309,no,0,0
186310,effect,0,0
186311,on,0,0
186312,fermentation,0,0
186313,parameters,0,0
186314,of,0,0
186315,LC,0,0
186316,and,0,0
186317,HC,0,0
186318,substrates,0,0
186319,.,0,0
186320,In,0,0
186321,addition,0,0
186322,",",0,0
186323,calves,0,1
186324,supplemented,0,0
186325,with,0,1
186326,aPLA2,0,0
186327,had,0,0
186328,reduced,0,0
186329,concentrations,0,0
186330,of,0,0
186331,plasma,0,0
186332,ceruloplasmin,0,0
186333,after,0,0
186334,24,0,0
186335,h,0,0
186336,of,0,0
186337,transportation,0,0
186338,.,0,0
186339,The,0,0
186340,effects,0,0
186341,of,0,0
186342,a,0,0
186343,single,0,0
186344,dose,0,0
186345,of,0,0
186346,oxytocin,0,0
186347,on,0,0
186348,working,0,0
186349,memory,0,0
186350,in,0,0
186351,schizophrenia,1,1
186352,.,1,0
186353,Pharmacokinetic,0,0
186354,study,0,0
186355,between,0,0
186356,a,0,0
186357,bilayer,0,0
186358,matrix,0,0
186359,fentalyl,0,0
186360,patch,0,0
186361,and,0,0
186362,a,0,0
186363,monolayer,0,0
186364,matrix,0,0
186365,fentanyl,0,0
186366,patch,0,0
186367,:,0,1
186368,single,0,0
186369,dose,0,0
186370,administration,0,0
186371,in,0,0
186372,healthy,1,1
186373,volunteers,1,1
186374,.,1,1
186375,AIMS,0,0
186376,Transdermal,0,0
186377,fentanyl,0,0
186378,is,0,0
186379,a,0,0
186380,well,0,0
186381,established,0,0
186382,treatment,0,0
186383,for,0,0
186384,cancer,0,1
186385,pain,0,0
186386,.,0,0
186387,The,0,0
186388,aim,0,0
186389,of,0,0
186390,the,0,0
186391,present,0,0
186392,study,0,0
186393,is,0,0
186394,to,0,0
186395,assess,0,0
186396,the,0,0
186397,relative,0,0
186398,bioavailability,0,0
186399,of,0,0
186400,fentanyl,0,0
186401,from,0,0
186402,two,0,0
186403,different,0,0
186404,transdermal,0,0
186405,systems,0,0
186406,by,0,0
186407,evaluating,0,0
186408,plasma,0,0
186409,drug,0,0
186410,concentrations,0,0
186411,after,0,0
186412,single,0,0
186413,administration,0,0
186414,of,0,0
186415,Fentalgon?,0,0
186416,(,0,0
186417,test,0,0
186418,),0,0
186419,",",0,0
186420,a,0,0
186421,novel,0,0
186422,bilayer,0,0
186423,matrix,0,0
186424,type,0,0
186425,patch,0,0
186426,",",0,0
186427,and,0,0
186428,Durogesic,0,0
186429,SMAT,0,0
186430,(,0,0
186431,reference,0,0
186432,),0,0
186433,",",0,0
186434,a,0,0
186435,monolayer,0,0
186436,matrix,0,0
186437,type,0,1
186438,patch,0,0
186439,.,0,0
186440,In,0,0
186441,the,0,0
186442,Fentalgon,0,0
186443,patch,0,0
186444,the,0,0
186445,upper,0,0
186446,6,0,0
186447,%,0,0
186448,fentanyl,0,0
186449,reservoir,0,0
186450,layer,0,0
186451,maintains,0,0
186452,a,0,0
186453,stable,0,0
186454,concentration,0,0
186455,gradient,0,0
186456,between,0,0
186457,the,0,0
186458,lower,0,0
186459,4,0,0
186460,%,0,0
186461,donor,0,0
186462,layer,0,0
186463,and,0,0
186464,the,0,0
186465,skin,0,0
186466,.,0,0
186467,The,0,0
186468,system,0,0
186469,provides,0,0
186470,a,0,0
186471,constant,0,0
186472,drug,0,0
186473,delivery,0,0
186474,over,0,0
186475,72,0,1
186476,h.,0,0
186477,METHODS,0,0
186478,This,0,0
186479,was,0,0
186480,an,0,0
186481,open,0,0
186482,label,0,0
186483,",",0,0
186484,single,0,0
186485,centre,0,1
186486,",",0,0
186487,randomized,0,0
186488,",",0,0
186489,single,0,0
186490,dose,0,0
186491,",",0,0
186492,two,0,0
186493,period,0,0
186494,crossover,0,0
186495,clinical,0,0
186496,trial,0,0
186497,",",0,0
186498,that,0,0
186499,included,1,1
186500,36,1,0
186501,healthy,1,1
186502,male,1,1
186503,volunteers,1,1
186504,.,1,0
186505,The,0,0
186506,patches,0,0
186507,were,0,0
186508,applied,0,0
186509,to,0,0
186510,non-irritated,0,0
186511,and,0,0
186512,non-irradiated,0,0
186513,skin,0,0
186514,on,0,0
186515,the,0,0
186516,intraclavicular,0,0
186517,pectoral,0,0
186518,area,0,0
186519,.,0,0
186520,Blood,0,0
186521,samples,0,0
186522,were,0,0
186523,collected,0,0
186524,at,0,0
186525,different,0,0
186526,time,0,0
186527,points,0,0
186528,(,0,0
186529,from,0,0
186530,baseline,0,0
186531,to,0,0
186532,120,0,1
186533,h,0,0
186534,post-removal,0,0
186535,of,0,0
186536,the,0,0
186537,devices,0,0
186538,),0,0
186539,and,0,0
186540,fentanyl,0,0
186541,concentrations,0,0
186542,were,0,0
186543,determined,0,0
186544,using,0,0
186545,a,0,0
186546,validated,0,0
186547,LC/MS/MS,0,1
186548,method,0,0
186549,.,0,0
186550,Bioequivalence,0,0
186551,was,0,0
186552,to,0,0
186553,be,0,0
186554,claimed,0,0
186555,if,0,0
186556,the,0,0
186557,90,0,0
186558,%,0,0
186559,confidence,0,0
186560,interval,0,0
186561,of,0,0
186562,AUC,0,0
186563,(,0,0
186564,0,0,0
186565,",",0,0
186566,t,0,0
186567,),0,0
186568,and,0,0
186569,C,0,0
186570,(,0,0
186571,max,0,1
186572,),0,0
186573,ratios,0,0
186574,(,0,0
186575,test,0,0
186576,:,0,1
186577,reference,0,0
186578,),0,0
186579,were,0,0
186580,within,0,0
186581,the,0,0
186582,acceptance,0,0
186583,range,0,0
186584,of,0,0
186585,80-125,0,0
186586,%,0,0
186587,and,0,0
186588,75-133,0,0
186589,%,0,0
186590,",",0,0
186591,respectively,0,0
186592,.,0,0
186593,RESULTS,0,0
186594,The,0,0
186595,90,0,0
186596,%,0,0
186597,confidence,0,0
186598,intervals,0,0
186599,of,0,0
186600,the,0,0
186601,AUC,0,0
186602,(,0,0
186603,0,0,0
186604,",",0,0
186605,t,0,0
186606,),0,0
186607,ratio,0,0
186608,(,0,0
186609,116.3,0,0
186610,%,0,0
186611,[,0,0
186612,109.6,0,0
186613,",",0,0
186614,123.4,0,0
186615,%,0,0
186616,],0,0
186617,),0,0
186618,and,0,0
186619,C,0,0
186620,(,0,0
186621,max,0,0
186622,),0,0
186623,ratio,0,0
186624,(,0,0
186625,114.4,0,0
186626,%,0,0
186627,[,0,0
186628,105.8,0,0
186629,",",0,0
186630,123.8,0,0
186631,%,0,0
186632,],0,0
186633,were,0,0
186634,well,0,0
186635,included,0,0
186636,in,0,0
186637,the,0,0
186638,acceptance,0,0
186639,range,0,0
186640,and,0,0
186641,the,0,0
186642,C,0,0
186643,(,0,0
186644,max,0,0
186645,),0,0
186646,ratio,0,0
186647,also,0,0
186648,met,0,0
186649,the,0,0
186650,narrower,0,0
186651,bounds,0,0
186652,of,0,0
186653,80-125,0,0
186654,%,0,0
186655,.,0,0
186656,There,0,0
186657,was,0,0
186658,no,0,0
186659,relevant,0,0
186660,difference,0,0
186661,in,0,0
186662,overall,0,0
186663,safety,0,0
186664,profiles,0,0
186665,of,0,0
186666,the,0,0
186667,two,0,0
186668,preparations,0,0
186669,investigated,0,0
186670,",",0,0
186671,which,0,0
186672,were,0,0
186673,adequately,0,0
186674,tolerated,0,0
186675,",",0,0
186676,as,0,0
186677,expected,0,0
186678,for,0,0
186679,opioid-na?ve,0,1
186680,subjects,0,1
186681,.,0,0
186682,CONCLUSIONS,0,0
186683,The,0,0
186684,new,0,0
186685,bilayer,0,0
186686,matrix,0,0
186687,type,0,0
186688,patch,0,0
186689,",",0,0
186690,Fentalgon?,0,0
186691,",",0,0
186692,is,0,0
186693,bioequivalent,0,0
186694,to,0,0
186695,the,0,0
186696,monolayer,0,0
186697,matrix,0,0
186698,type,0,1
186699,Durogesic,0,0
186700,SMAT,0,0
186701,fentanyl,0,0
186702,patch,0,0
186703,with,0,0
186704,respect,0,0
186705,to,0,0
186706,the,0,0
186707,rate,0,0
186708,and,0,0
186709,extent,0,0
186710,of,0,0
186711,exposure,0,0
186712,of,0,0
186713,fentanyl,0,0
186714,(,0,0
186715,Eudra/CT,0,0
186716,no,0,0
186717,.,0,0
186718,2005-000046-36,0,0
186719,),0,0
186720,.,0,0
186721,Effect,0,0
186722,of,0,0
186723,self-collection,0,0
186724,of,0,0
186725,HPV,0,0
186726,DNA,0,0
186727,offered,0,0
186728,by,0,0
186729,community,1,1
186730,health,1,1
186731,workers,1,0
186732,at,0,0
186733,home,0,1
186734,visits,0,0
186735,on,0,0
186736,uptake,0,0
186737,of,0,0
186738,screening,0,0
186739,for,0,0
186740,cervical,0,1
186741,cancer,0,1
186742,(,0,0
186743,the,0,0
186744,EMA,0,0
186745,study,0,0
186746,),0,0
186747,:,0,0
186748,a,0,0
186749,population-based,0,1
186750,cluster-randomised,0,0
186751,trial,0,0
186752,.,0,0
186753,BACKGROUND,0,0
186754,Control,0,0
186755,of,0,0
186756,cervical,0,1
186757,cancer,0,1
186758,in,0,0
186759,developing,0,0
186760,countries,0,0
186761,has,0,0
186762,been,0,0
186763,hampered,0,0
186764,by,0,0
186765,a,0,0
186766,failure,0,0
186767,to,0,0
186768,achieve,0,0
186769,high,0,0
186770,screening,0,0
186771,uptake,0,0
186772,.,0,0
186773,HPV,0,0
186774,DNA,0,0
186775,self-collection,0,0
186776,could,0,0
186777,increase,0,0
186778,screening,0,0
186779,coverage,0,0
186780,",",0,0
186781,but,0,0
186782,implementation,0,0
186783,of,0,0
186784,this,0,0
186785,technology,0,0
186786,is,0,0
186787,difficult,0,0
186788,in,0,0
186789,countries,1,1
186790,of,1,0
186791,middle,1,1
186792,and,1,0
186793,low,1,0
186794,income,1,0
186795,.,1,0
186796,We,0,0
186797,investigated,0,0
186798,whether,0,0
186799,offering,0,0
186800,HPV,0,0
186801,DNA,0,0
186802,self-collection,0,0
186803,during,0,0
186804,routine,0,0
186805,home,0,1
186806,visits,0,0
186807,by,0,0
186808,community,0,1
186809,health,0,0
186810,workers,0,0
186811,could,0,0
186812,increase,0,0
186813,cervical,0,0
186814,screening,0,1
186815,.,0,0
186816,METHODS,0,0
186817,We,0,0
186818,did,0,0
186819,a,0,0
186820,population-based,0,1
186821,cluster-randomised,0,0
186822,trial,0,0
186823,in,0,0
186824,the,0,0
186825,province,1,1
186826,of,1,0
186827,Jujuy,1,1
186828,",",1,0
186829,Argentina,1,0
186830,",",1,0
186831,between,1,0
186832,July,1,0
186833,1,1,0
186834,",",1,0
186835,2012,1,1
186836,",",1,0
186837,and,1,0
186838,Dec,1,0
186839,31,1,1
186840,",",1,0
186841,2012,1,1
186842,.,1,0
186843,Community,1,0
186844,health,1,0
186845,workers,1,1
186846,were,1,0
186847,eligible,1,1
186848,for,1,0
186849,the,1,0
186850,study,1,0
186851,if,1,0
186852,they,1,0
186853,scored,1,0
186854,highly,1,0
186855,on,1,0
186856,a,1,0
186857,performance,1,0
186858,score,1,0
186859,",",1,0
186860,and,1,0
186861,women,1,1
186862,aged,1,1
186863,30,1,1
186864,years,1,1
186865,or,1,1
186866,older,1,1
186867,were,1,0
186868,eligible,1,1
186869,for,1,0
186870,enrolment,1,0
186871,by,1,0
186872,the,1,0
186873,community,1,0
186874,health,1,0
186875,worker,1,0
186876,.,1,0
186877,200,1,0
186878,community,1,1
186879,health,1,1
186880,workers,1,0
186881,were,1,0
186882,randomly,1,1
186883,allocated,1,0
186884,in,1,0
186885,a,1,0
186886,1:1,1,0
186887,ratio,1,0
186888,to,1,0
186889,either,1,0
186890,the,1,0
186891,intervention,1,0
186892,group,1,0
186893,(,0,0
186894,offered,0,0
186895,women,0,1
186896,the,0,0
186897,chance,0,0
186898,to,0,0
186899,self-collect,0,0
186900,a,0,0
186901,sample,0,0
186902,for,0,0
186903,cervical,0,1
186904,screening,0,1
186905,during,0,0
186906,a,0,0
186907,home,0,0
186908,visit,0,0
186909,),0,0
186910,or,0,0
186911,the,0,0
186912,control,0,0
186913,group,0,0
186914,(,0,0
186915,advised,0,0
186916,women,0,1
186917,to,0,0
186918,attend,0,0
186919,a,0,0
186920,health,0,0
186921,clinic,0,0
186922,for,0,0
186923,cervical,0,1
186924,screening,0,1
186925,),0,0
186926,.,0,0
186927,The,0,0
186928,primary,0,0
186929,outcome,0,0
186930,was,0,0
186931,screening,0,0
186932,uptake,0,0
186933,",",0,0
186934,measured,0,0
186935,as,0,0
186936,the,0,0
186937,proportion,0,0
186938,of,0,0
186939,women,0,1
186940,having,0,1
186941,any,0,0
186942,HPV,0,0
186943,screening,0,0
186944,test,0,0
186945,within,0,0
186946,6,0,0
186947,months,0,0
186948,of,0,0
186949,the,0,0
186950,community,0,0
186951,health,0,0
186952,worker,0,0
186953,visit,0,0
186954,.,0,0
186955,Analysis,0,0
186956,was,0,0
186957,by,0,0
186958,intention,0,0
186959,to,0,0
186960,treat,0,0
186961,.,0,0
186962,This,0,0
186963,trial,0,0
186964,is,0,0
186965,registered,0,0
186966,with,0,0
186967,ClinicalTrials.gov,0,0
186968,",",0,0
186969,number,0,0
186970,NCT02095561,0,0
186971,.,0,0
186972,FINDINGS,0,0
186973,100,0,0
186974,community,0,1
186975,health,0,1
186976,workers,0,0
186977,were,0,0
186978,randomly,0,1
186979,allocated,0,0
186980,to,0,0
186981,the,0,0
186982,intervention,0,0
186983,group,0,0
186984,and,0,0
186985,100,0,0
186986,were,0,0
186987,assigned,0,0
186988,to,0,0
186989,the,0,0
186990,control,0,0
186991,group,0,0
186992,;,0,0
186993,nine,0,1
186994,did,0,0
186995,not,0,0
186996,take,0,0
186997,part,0,0
186998,.,0,0
186999,191,1,1
187000,participating,1,1
187001,community,1,1
187002,health,1,1
187003,workers,1,1
187004,(,1,0
187005,94,1,0
187006,in,1,0
187007,the,1,0
187008,intervention,1,0
187009,group,1,0
187010,and,1,0
187011,97,1,0
187012,in,1,0
187013,the,1,0
187014,control,1,0
187015,group,1,0
187016,),1,0
187017,initially,1,0
187018,contacted,1,0
187019,7650,1,0
187020,women,1,1
187021,;,1,0
187022,of,1,0
187023,3632,1,1
187024,women,1,1
187025,contacted,1,0
187026,by,1,0
187027,community,1,1
187028,health,1,1
187029,workers,1,0
187030,in,1,0
187031,the,1,0
187032,intervention,1,0
187033,group,1,0
187034,",",1,0
187035,3049,1,1
187036,agreed,1,0
187037,to,1,0
187038,participate,1,1
187039,;,1,0
187040,of,1,0
187041,4018,1,1
187042,women,1,1
187043,contacted,1,0
187044,by,1,0
187045,community,1,1
187046,health,1,1
187047,workers,1,0
187048,in,1,0
187049,the,1,0
187050,control,1,0
187051,group,1,0
187052,",",1,0
187053,2964,1,0
187054,agreed,1,0
187055,to,1,0
187056,participate,1,1
187057,.,1,0
187058,2618,0,0
187059,(,0,0
187060,86,0,1
187061,%,0,0
187062,),0,0
187063,of,0,0
187064,3049,0,1
187065,women,0,1
187066,in,0,0
187067,the,0,0
187068,intervention,0,0
187069,group,0,0
187070,had,0,0
187071,any,0,0
187072,HPV,0,0
187073,test,0,0
187074,within,0,0
187075,6,0,0
187076,months,0,0
187077,of,0,0
187078,the,0,0
187079,community,0,0
187080,health,0,0
187081,worker,0,0
187082,visit,0,0
187083,",",0,0
187084,compared,0,0
187085,with,0,0
187086,599,0,1
187087,(,0,0
187088,20,0,0
187089,%,0,0
187090,),0,0
187091,of,0,0
187092,2964,0,1
187093,in,0,0
187094,the,0,0
187095,control,0,0
187096,group,0,0
187097,(,0,0
187098,risk,0,0
187099,ratio,0,0
187100,4?02,0,0
187101,",",0,0
187102,95,0,0
187103,%,0,0
187104,CI,0,0
187105,3?44-4?71,0,0
187106,),0,0
187107,.,0,0
187108,INTERPRETATION,0,0
187109,Offering,0,0
187110,self-collection,0,0
187111,of,0,0
187112,samples,0,0
187113,for,0,0
187114,HPV,0,0
187115,testing,0,0
187116,by,0,0
187117,community,0,1
187118,health,0,1
187119,workers,0,0
187120,during,0,0
187121,home,0,1
187122,visits,0,0
187123,resulted,0,0
187124,in,0,0
187125,a,0,0
187126,four-fold,0,0
187127,increase,0,0
187128,in,0,0
187129,screening,0,0
187130,uptake,0,0
187131,",",0,0
187132,showing,0,0
187133,that,0,0
187134,this,0,0
187135,strategy,0,0
187136,is,0,0
187137,effective,0,0
187138,to,0,0
187139,improve,0,0
187140,cervical,0,1
187141,screening,0,0
187142,coverage,0,0
187143,.,0,0
187144,This,0,0
187145,intervention,0,0
187146,reduces,0,0
187147,women,0,1
187148,'s,0,0
187149,barriers,0,0
187150,to,0,1
187151,screening,0,1
187152,and,0,0
187153,results,0,0
187154,in,0,0
187155,a,0,0
187156,substantial,0,0
187157,and,0,0
187158,rapid,0,0
187159,increase,0,0
187160,in,0,0
187161,coverage,0,0
187162,.,0,0
187163,Our,0,0
187164,findings,0,0
187165,suggest,0,0
187166,that,0,0
187167,HPV,0,0
187168,testing,0,0
187169,could,0,0
187170,be,0,0
187171,extended,0,0
187172,throughout,0,0
187173,Argentina,0,1
187174,and,0,0
187175,in,0,0
187176,other,0,0
187177,countries,0,1
187178,to,0,0
187179,increase,0,0
187180,cervical,0,1
187181,screening,0,0
187182,coverage,0,0
187183,.,0,0
187184,FUNDING,0,0
187185,Instituto,0,1
187186,Nacional,0,0
187187,del,0,0
187188,C?ncer,0,0
187189,(,0,0
187190,Argentina,0,1
187191,),0,0
187192,.,0,0
187193,The,0,0
187194,effects,0,0
187195,of,0,0
187196,stimulation,0,0
187197,of,0,0
187198,the,0,0
187199,autonomic,0,0
187200,nervous,0,0
187201,system,0,0
187202,via,0,0
187203,perioperative,0,0
187204,nutrition,0,1
187205,on,0,0
187206,postoperative,0,0
187207,ileus,0,0
187208,and,0,0
187209,anastomotic,0,0
187210,leakage,0,0
187211,following,0,0
187212,colorectal,0,1
187213,surgery,0,1
187214,(,0,0
187215,SANICS,0,0
187216,II,0,1
187217,trial,0,0
187218,),0,0
187219,:,0,0
187220,a,0,0
187221,study,0,0
187222,protocol,0,0
187223,for,0,0
187224,a,0,0
187225,double-blind,0,0
187226,randomized,0,0
187227,controlled,0,0
187228,trial,0,0
187229,.,0,0
187230,BACKGROUND,0,0
187231,Postoperative,0,0
187232,ileus,0,0
187233,and,0,0
187234,anastomotic,0,0
187235,leakage,0,0
187236,are,0,0
187237,important,0,0
187238,complications,0,0
187239,following,0,0
187240,colorectal,0,1
187241,surgery,0,1
187242,associated,0,0
187243,with,0,0
187244,short-term,0,0
187245,morbidity,0,0
187246,and,0,0
187247,mortality,0,0
187248,.,0,0
187249,Previous,0,0
187250,experimental,0,0
187251,and,0,0
187252,preclinical,0,0
187253,studies,0,0
187254,have,0,0
187255,shown,0,0
187256,that,0,0
187257,a,0,0
187258,short,0,0
187259,intervention,0,0
187260,with,0,1
187261,enriched,0,0
187262,enteral,0,0
187263,nutrition,0,0
187264,dampens,0,0
187265,inflammation,0,0
187266,via,0,0
187267,stimulation,0,0
187268,of,0,0
187269,the,0,0
187270,autonomic,0,0
187271,nervous,0,0
187272,system,0,0
187273,and,0,0
187274,thereby,0,0
187275,reduces,0,0
187276,postoperative,0,0
187277,ileus,0,0
187278,.,0,0
187279,Furthermore,0,0
187280,",",0,0
187281,early,0,0
187282,administration,0,0
187283,of,0,0
187284,enteral,0,0
187285,nutrition,0,1
187286,reduced,0,0
187287,anastomotic,0,0
187288,leakage,0,0
187289,.,0,0
187290,This,0,0
187291,study,0,0
187292,will,0,0
187293,investigate,0,0
187294,the,0,0
187295,effect,0,0
187296,of,0,0
187297,nutritional,0,0
187298,stimulation,0,0
187299,of,0,0
187300,the,0,0
187301,autonomic,0,0
187302,nervous,0,0
187303,system,0,0
187304,just,0,0
187305,before,0,0
187306,",",0,0
187307,during,0,0
187308,and,0,0
187309,early,0,0
187310,after,0,0
187311,colorectal,0,1
187312,surgery,0,1
187313,on,0,0
187314,inflammation,0,0
187315,",",0,0
187316,postoperative,0,0
187317,ileus,0,0
187318,and,0,0
187319,anastomotic,0,0
187320,leakage,0,0
187321,.,0,0
187322,METHODS/DESIGN,0,0
187323,This,0,0
187324,multicenter,0,0
187325,",",0,0
187326,prospective,0,0
187327,",",0,0
187328,double-blind,0,0
187329,",",0,0
187330,randomized,0,0
187331,controlled,0,0
187332,trial,0,0
187333,will,0,0
187334,include,0,0
187335,280,1,0
187336,patients,1,1
187337,undergoing,1,1
187338,colorectal,1,1
187339,surgery,1,1
187340,.,1,0
187341,All,0,0
187342,patients,1,0
187343,will,0,0
187344,receive,0,0
187345,a,0,0
187346,selfmigrating,0,0
187347,nasojejunal,0,0
187348,tube,0,0
187349,that,0,0
187350,will,0,0
187351,be,0,0
187352,connected,0,0
187353,to,0,0
187354,a,0,0
187355,specially,0,0
187356,designed,0,0
187357,blinded,0,0
187358,tubing,0,0
187359,system,0,0
187360,.,0,0
187361,Patients,1,0
187362,will,0,0
187363,be,0,0
187364,allocated,0,0
187365,either,0,0
187366,to,0,0
187367,the,0,0
187368,intervention,0,0
187369,group,0,0
187370,",",0,0
187371,receiving,0,0
187372,perioperative,0,0
187373,nutrition,0,0
187374,",",0,0
187375,or,0,0
187376,to,0,0
187377,the,0,0
187378,control,0,0
187379,group,0,0
187380,",",0,0
187381,receiving,0,0
187382,no,0,0
187383,nutrition,0,0
187384,.,0,0
187385,The,0,0
187386,primary,0,0
187387,endpoint,0,0
187388,is,0,0
187389,postoperative,0,0
187390,ileus,0,0
187391,.,0,0
187392,Secondary,0,0
187393,endpoints,0,0
187394,include,0,0
187395,anastomotic,0,0
187396,leakage,0,0
187397,",",0,0
187398,local,0,0
187399,and,0,0
187400,systemic,0,0
187401,inflammation,0,0
187402,",",0,0
187403,(,0,0
187404,aspiration,0,0
187405,),0,0
187406,pneumonia,0,0
187407,",",0,0
187408,surgical,0,1
187409,complications,0,0
187410,classified,0,1
187411,according,0,1
187412,to,0,0
187413,Clavien-Dindo,0,0
187414,",",0,0
187415,quality,0,0
187416,of,0,0
187417,life,0,0
187418,",",0,0
187419,gut,0,0
187420,barrier,0,0
187421,integrity,0,0
187422,and,0,0
187423,time,0,0
187424,until,0,0
187425,functional,0,0
187426,recovery,0,0
187427,.,0,0
187428,Furthermore,0,0
187429,",",0,0
187430,a,0,0
187431,cost-effectiveness,0,0
187432,analysis,0,0
187433,will,0,0
187434,be,0,0
187435,performed,0,0
187436,.,0,0
187437,DISCUSSION,0,0
187438,Activation,0,0
187439,of,0,0
187440,the,0,0
187441,autonomic,0,0
187442,nervous,0,0
187443,system,0,0
187444,via,0,0
187445,perioperative,0,0
187446,enteral,0,0
187447,feeding,0,0
187448,is,0,0
187449,expected,0,0
187450,to,0,0
187451,dampen,0,0
187452,the,0,0
187453,local,0,0
187454,and,0,0
187455,systemic,0,0
187456,inflammatory,0,0
187457,response,0,0
187458,.,0,0
187459,Consequently,0,0
187460,",",0,0
187461,postoperative,0,0
187462,ileus,0,0
187463,will,0,0
187464,be,0,0
187465,reduced,0,0
187466,as,0,0
187467,well,0,0
187468,as,0,0
187469,anastomotic,0,0
187470,leakage,0,0
187471,.,0,0
187472,The,0,0
187473,present,0,0
187474,study,0,0
187475,is,0,0
187476,the,0,0
187477,first,0,0
187478,to,0,0
187479,investigate,0,0
187480,the,0,0
187481,effects,0,0
187482,of,0,0
187483,enriched,0,0
187484,nutrition,0,1
187485,given,0,0
187486,shortly,0,0
187487,before,0,0
187488,",",0,0
187489,during,0,0
187490,and,0,0
187491,after,0,0
187492,surgery,0,1
187493,in,0,0
187494,a,0,0
187495,clinical,0,0
187496,setting,0,1
187497,.,0,0
187498,TRIAL,0,0
187499,REGISTRATION,0,0
187500,ClinicalTrials.gov,0,0
187501,:,0,1
187502,NCT02175979,0,0
187503,-,0,0
187504,date,0,0
187505,of,0,0
187506,registration,0,0
187507,:,0,1
187508,25,0,0
187509,June,0,1
187510,2014,0,1
187511,.,0,0
187512,Dutch,0,0
187513,Trial,0,0
187514,Registry,0,1
187515,:,0,1
187516,NTR4670,0,0
187517,-,0,0
187518,date,0,0
187519,of,0,0
187520,registration,0,0
187521,:,0,1
187522,1,0,0
187523,August,0,1
187524,2014,0,1
187525,.,0,1
187526,Esmolol,0,0
187527,versus,0,0
187528,verapamil,0,0
187529,in,0,0
187530,the,0,0
187531,acute,0,1
187532,treatment,0,0
187533,of,0,0
187534,atrial,1,1
187535,fibrillation,1,1
187536,or,1,0
187537,atrial,1,1
187538,flutter,1,1
187539,.,1,0
187540,The,0,0
187541,effects,0,0
187542,of,0,0
187543,esmolol,0,0
187544,",",0,0
187545,an,0,0
187546,ultrashort-acting,0,0
187547,beta,0,0
187548,blocker,0,0
187549,",",0,0
187550,and,0,0
187551,verapamil,0,0
187552,were,0,0
187553,compared,0,0
187554,in,0,0
187555,controlling,0,0
187556,ventricular,0,0
187557,response,0,0
187558,in,0,0
187559,45,1,1
187560,patients,1,1
187561,with,1,1
187562,atrial,1,1
187563,fibrillation,1,1
187564,or,1,0
187565,atrial,1,0
187566,flutter,1,1
187567,",",1,0
187568,in,1,0
187569,a,1,0
187570,randomized,1,0
187571,",",1,0
187572,parallel,1,0
187573,",",1,0
187574,open-label,1,0
187575,study,1,0
187576,.,1,0
187577,Patients,1,1
187578,with,1,1
187579,either,1,0
187580,new,1,0
187581,onset,1,0
187582,(,1,0
187583,less,1,0
187584,than,1,0
187585,48,1,0
187586,hours,1,0
187587,",",1,0
187588,n,1,1
187589,=,1,0
187590,31,1,1
187591,),1,0
187592,or,1,0
187593,old,1,1
187594,onset,1,0
187595,(,1,0
187596,greater,1,0
187597,than,1,0
187598,48,1,0
187599,hours,1,0
187600,",",1,0
187601,n,1,1
187602,=,1,0
187603,14,1,0
187604,),1,0
187605,of,1,0
187606,atrial,1,1
187607,fibrillation,1,1
187608,or,1,0
187609,flutter,1,1
187610,with,1,1
187611,rapid,1,0
187612,ventricular,1,1
187613,rate,1,0
187614,were,1,0
187615,stratified,1,0
187616,to,0,0
187617,receive,0,0
187618,esmolol,0,0
187619,(,0,0
187620,n,0,1
187621,=,0,0
187622,21,0,1
187623,),0,0
187624,or,0,0
187625,verapamil,0,0
187626,(,0,0
187627,n,0,1
187628,=,0,0
187629,24,0,0
187630,),0,0
187631,.,0,0
187632,Drug,0,0
187633,efficacy,0,0
187634,was,0,0
187635,measured,0,0
187636,by,0,0
187637,ventricular,0,0
187638,rate,0,0
187639,reduction,0,0
187640,and,0,0
187641,conversion,0,0
187642,to,0,0
187643,sinus,0,1
187644,rhythm,0,1
187645,.,0,0
187646,The,0,0
187647,heart,0,0
187648,rate,0,0
187649,declined,0,0
187650,with,0,0
187651,esmolol,0,0
187652,from,0,0
187653,139,0,1
187654,to,0,0
187655,100,0,0
187656,beats/min,0,0
187657,(,0,0
187658,p,0,0
187659,less,0,0
187660,than,0,0
187661,0.001,0,0
187662,),0,0
187663,and,0,0
187664,with,0,0
187665,verapamil,0,0
187666,from,0,0
187667,142,0,1
187668,to,0,0
187669,97,0,1
187670,beats/min,0,0
187671,(,0,0
187672,p,0,0
187673,less,0,0
187674,than,0,0
187675,0.001,0,0
187676,),0,0
187677,.,0,0
187678,Fifty,0,0
187679,percent,0,0
187680,of,0,0
187681,esmolol-treated,0,0
187682,patients,0,1
187683,with,0,1
187684,new,0,0
187685,onset,0,1
187686,of,0,0
187687,arrhythmias,0,0
187688,converted,0,0
187689,to,0,0
187690,sinus,0,0
187691,rhythm,0,1
187692,",",0,0
187693,whereas,0,0
187694,only,0,0
187695,12,0,0
187696,%,0,0
187697,of,0,0
187698,those,0,1
187699,who,0,1
187700,received,0,0
187701,verapamil,0,1
187702,converted,0,0
187703,(,0,0
187704,p,0,0
187705,less,0,0
187706,than,0,0
187707,0.03,0,0
187708,),0,0
187709,.,0,0
187710,Mild,0,0
187711,hypotension,0,0
187712,was,0,0
187713,observed,0,0
187714,in,0,0
187715,both,0,0
187716,treatment,0,0
187717,groups,0,0
187718,.,0,0
187719,Esmolol,0,0
187720,compares,0,0
187721,favorably,0,0
187722,with,0,0
187723,verapamil,0,0
187724,with,0,1
187725,respect,0,0
187726,to,0,0
187727,both,0,0
187728,efficacy,0,0
187729,and,0,0
187730,safety,0,0
187731,in,0,0
187732,acutely,0,0
187733,decreasing,0,0
187734,ventricular,0,0
187735,response,0,0
187736,during,0,0
187737,atrial,0,1
187738,fibrillation,0,1
187739,or,0,0
187740,flutter,0,1
187741,.,0,0
187742,Moreover,0,0
187743,",",0,0
187744,conversion,0,0
187745,to,0,0
187746,sinus,0,0
187747,rhythm,0,0
187748,is,0,0
187749,significantly,0,0
187750,more,0,0
187751,likely,0,0
187752,with,0,0
187753,esmolol,0,0
187754,.,0,0
187755,Hyperfractionated,0,0
187756,accelerated,0,0
187757,radiation,0,0
187758,therapy,0,0
187759,(,0,0
187760,HART,0,0
187761,),0,0
187762,of,0,0
187763,70.6,0,0
187764,Gy,0,0
187765,with,0,1
187766,concurrent,0,0
187767,5-FU/Mitomycin,0,0
187768,C,0,0
187769,is,0,0
187770,superior,0,0
187771,to,0,0
187772,HART,0,0
187773,of,0,0
187774,77.6,0,0
187775,Gy,0,0
187776,alone,0,0
187777,in,0,0
187778,locally,1,0
187779,advanced,1,1
187780,head,1,0
187781,and,1,0
187782,neck,1,1
187783,cancer,1,1
187784,:,1,1
187785,long-term,0,0
187786,results,0,0
187787,of,0,0
187788,the,0,0
187789,ARO,0,0
187790,95-06,0,0
187791,randomized,0,0
187792,phase,0,0
187793,III,0,0
187794,trial,0,0
187795,.,0,0
187796,PURPOSE,0,0
187797,To,0,0
187798,report,0,0
187799,the,0,0
187800,long-term,0,0
187801,results,0,0
187802,of,0,0
187803,the,0,0
187804,ARO,0,0
187805,95-06,0,0
187806,randomized,0,0
187807,trial,0,0
187808,comparing,0,0
187809,hyperfractionated,0,0
187810,accelerated,0,0
187811,chemoradiation,0,0
187812,with,0,1
187813,mitomycin,0,0
187814,C/5-fluorouracil,0,0
187815,(,0,0
187816,C-HART,0,0
187817,),0,0
187818,with,0,1
187819,hyperfractionated,0,0
187820,accelerated,0,0
187821,radiation,0,0
187822,therapy,0,0
187823,(,0,0
187824,HART,0,0
187825,),0,0
187826,alone,0,0
187827,in,0,0
187828,locally,1,0
187829,advanced,1,1
187830,head,1,0
187831,and,1,0
187832,neck,1,1
187833,cancer,1,1
187834,.,1,0
187835,PATIENTS,0,0
187836,AND,0,0
187837,METHODS,0,0
187838,The,0,0
187839,primary,0,0
187840,endpoint,0,0
187841,was,0,0
187842,locoregional,0,0
187843,control,0,0
187844,(,0,0
187845,LRC,0,0
187846,),0,0
187847,.,0,0
187848,Three,1,0
187849,hundred,1,1
187850,eighty-four,1,1
187851,patients,1,1
187852,with,1,1
187853,stage,1,1
187854,III,1,0
187855,(,1,0
187856,6,1,0
187857,%,1,0
187858,),1,0
187859,and,1,0
187860,IV,1,0
187861,(,1,0
187862,94,1,0
187863,%,1,0
187864,),1,0
187865,oropharyngeal,1,0
187866,(,1,0
187867,59.4,1,0
187868,%,1,0
187869,),1,0
187870,",",1,0
187871,hypopharyngeal,1,1
187872,(,1,0
187873,32.3,1,0
187874,%,1,0
187875,),1,0
187876,",",1,0
187877,and,1,0
187878,oral,1,0
187879,cavity,1,0
187880,(,1,0
187881,8.3,1,0
187882,%,1,0
187883,),1,0
187884,cancer,1,1
187885,were,0,0
187886,randomly,0,0
187887,assigned,0,0
187888,to,0,0
187889,30,0,0
187890,Gy/2,0,0
187891,Gy,0,0
187892,daily,0,0
187893,followed,0,0
187894,by,0,0
187895,twice-daily,0,0
187896,1.4,0,0
187897,Gy,0,0
187898,to,0,0
187899,a,0,0
187900,total,0,0
187901,of,0,0
187902,70.6,0,0
187903,Gy,0,0
187904,concurrently,0,0
187905,with,0,1
187906,mitomycin,0,0
187907,C/5-FU,0,1
187908,(,0,0
187909,C-HART,0,0
187910,),0,0
187911,or,0,0
187912,16,0,1
187913,Gy/2,0,0
187914,Gy,0,0
187915,daily,0,0
187916,followed,0,0
187917,by,0,0
187918,twice-daily,0,0
187919,1.4,0,0
187920,Gy,0,0
187921,to,0,0
187922,a,0,0
187923,total,0,0
187924,dose,0,0
187925,of,0,0
187926,77.6,0,0
187927,Gy,0,0
187928,alone,0,0
187929,(,0,0
187930,HART,0,0
187931,),0,0
187932,.,0,0
187933,Statistical,0,0
187934,analyses,0,0
187935,were,0,0
187936,done,0,0
187937,with,0,0
187938,the,0,0
187939,log-rank,0,0
187940,test,0,0
187941,and,0,0
187942,univariate,0,0
187943,and,0,0
187944,multivariate,0,0
187945,Cox,0,0
187946,regression,0,0
187947,analyses,0,0
187948,.,0,0
187949,RESULTS,0,0
187950,The,0,0
187951,median,0,0
187952,follow-up,0,0
187953,time,0,0
187954,was,0,0
187955,8.7,0,0
187956,years,0,1
187957,(,0,0
187958,95,0,0
187959,%,0,0
187960,confidence,0,0
187961,interval,0,0
187962,[,0,0
187963,CI,0,0
187964,],0,0
187965,:,0,1
187966,7.8-9.7,0,0
187967,years,0,1
187968,),0,0
187969,.,0,0
187970,At,0,0
187971,10,0,0
187972,years,0,1
187973,",",0,0
187974,the,0,0
187975,LRC,0,0
187976,rates,0,0
187977,were,0,0
187978,38.0,0,0
187979,%,0,0
187980,(,0,0
187981,C-HART,0,0
187982,),0,0
187983,versus,0,0
187984,26.0,0,0
187985,%,0,0
187986,(,0,0
187987,HART,0,0
187988,",",0,0
187989,P=.002,0,0
187990,),0,0
187991,.,0,0
187992,The,0,0
187993,cancer-specific,0,0
187994,survival,0,0
187995,and,0,0
187996,overall,0,0
187997,survival,0,0
187998,rates,0,0
187999,were,0,0
188000,39,0,1
188001,%,0,0
188002,and,0,0
188003,10,0,0
188004,%,0,0
188005,(,0,0
188006,C-HART,0,0
188007,),0,0
188008,versus,0,0
188009,30.0,0,0
188010,%,0,0
188011,and,0,0
188012,9,0,0
188013,%,0,0
188014,(,0,0
188015,HART,0,0
188016,",",0,0
188017,P=.042,0,0
188018,and,0,0
188019,P=.049,0,0
188020,),0,0
188021,",",0,0
188022,respectively,0,0
188023,.,0,0
188024,According,0,0
188025,to,0,0
188026,multivariate,0,0
188027,Cox,0,0
188028,regression,0,0
188029,analysis,0,0
188030,",",0,0
188031,the,0,0
188032,combined,0,0
188033,treatment,0,0
188034,was,0,0
188035,associated,0,0
188036,with,0,1
188037,improved,0,0
188038,LRC,0,0
188039,(,0,0
188040,hazard,0,0
188041,ratio,0,0
188042,[,0,0
188043,HR,0,0
188044,],0,1
188045,:,0,1
188046,0.6,0,0
188047,[,0,0
188048,95,0,0
188049,%,0,0
188050,CI,0,0
188051,:,0,1
188052,0.5-0.8,0,0
188053,;,0,0
188054,P=.002,0,0
188055,],0,0
188056,),0,0
188057,.,0,0
188058,The,0,0
188059,association,0,0
188060,between,0,0
188061,combined,0,0
188062,treatment,0,0
188063,arm,0,0
188064,and,0,0
188065,increased,0,0
188066,LRC,0,0
188067,appeared,0,0
188068,to,0,0
188069,be,0,0
188070,limited,0,0
188071,to,0,0
188072,oropharyngeal,0,0
188073,cancer,0,1
188074,(,0,0
188075,P=.003,0,0
188076,),0,0
188077,as,0,0
188078,compared,0,0
188079,with,0,1
188080,hypopharyngeal,0,1
188081,or,0,0
188082,oral,0,0
188083,cavity,0,0
188084,cancer,0,1
188085,(,0,0
188086,P=.264,0,0
188087,),0,0
188088,.,0,0
188089,CONCLUSIONS,0,0
188090,C-HART,0,0
188091,remains,0,0
188092,superior,0,0
188093,to,0,0
188094,HART,0,0
188095,in,0,0
188096,terms,0,0
188097,of,0,0
188098,LRC,0,0
188099,.,0,0
188100,However,0,0
188101,",",0,0
188102,this,0,0
188103,effect,0,0
188104,may,0,0
188105,be,0,0
188106,limited,0,0
188107,to,0,0
188108,oropharyngeal,1,0
188109,cancer,1,1
188110,patients,1,1
188111,.,1,1
188112,Effects,0,0
188113,of,0,0
188114,sodium,0,0
188115,and,0,0
188116,potassium,0,0
188117,supplementation,0,0
188118,on,0,0
188119,blood,1,0
188120,pressure,1,0
188121,and,1,0
188122,arterial,1,1
188123,stiffness,1,0
188124,:,1,1
188125,a,0,0
188126,fully,0,0
188127,controlled,0,0
188128,dietary,0,0
188129,intervention,0,0
188130,study,0,0
188131,.,0,0
188132,We,0,0
188133,performed,0,0
188134,a,0,0
188135,randomised,0,0
188136,",",0,0
188137,placebo-controlled,0,0
188138,",",0,0
188139,crossover,0,0
188140,study,0,0
188141,to,0,0
188142,examine,0,0
188143,the,0,0
188144,effects,0,0
188145,of,0,0
188146,sodium,0,0
188147,and,0,0
188148,potassium,0,0
188149,supplementation,0,0
188150,on,0,0
188151,blood,1,0
188152,pressure,1,0
188153,(,1,0
188154,BP,1,0
188155,),1,0
188156,and,1,0
188157,arterial,1,0
188158,stiffness,1,0
188159,in,1,0
188160,untreated,1,1
188161,(,1,0
188162,pre,1,0
188163,),1,0
188164,hypertensive,1,1
188165,individuals,1,1
188166,.,1,0
188167,During,0,0
188168,the,0,0
188169,study,0,0
188170,",",0,0
188171,subjects,1,1
188172,were,1,0
188173,on,1,0
188174,a,1,0
188175,fully,1,0
188176,controlled,1,0
188177,diet,1,0
188178,that,1,0
188179,was,1,0
188180,relatively,1,0
188181,low,1,0
188182,in,1,0
188183,sodium,1,0
188184,and,1,0
188185,potassium,1,0
188186,.,1,0
188187,After,0,0
188188,a,0,0
188189,1-week,0,0
188190,run-in,0,0
188191,period,0,0
188192,",",0,0
188193,subjects,0,1
188194,received,0,0
188195,capsules,0,0
188196,with,0,1
188197,supplemental,0,0
188198,sodium,0,0
188199,(,0,0
188200,3,0,0
188201,g,0,0
188202,d,0,0
188203,(,0,0
188204,-1,0,0
188205,),0,0
188206,",",0,0
188207,equals,0,0
188208,7.6,0,0
188209,g,0,0
188210,d,0,0
188211,(,0,0
188212,-1,0,0
188213,),0,0
188214,of,0,0
188215,salt,0,0
188216,),0,0
188217,",",0,0
188218,supplemental,0,0
188219,potassium,0,0
188220,(,0,0
188221,3,0,0
188222,g,0,0
188223,d,0,0
188224,(,0,0
188225,-1,0,0
188226,),0,0
188227,),0,0
188228,or,0,0
188229,placebo,0,0
188230,",",0,0
188231,for,0,0
188232,4,0,0
188233,weeks,0,0
188234,each,0,0
188235,",",0,0
188236,in,0,0
188237,random,0,0
188238,order,0,0
188239,.,0,0
188240,Fasting,0,0
188241,office,0,1
188242,BP,0,0
188243,",",0,0
188244,24-h,0,0
188245,ambulatory,0,0
188246,BP,0,0
188247,and,0,0
188248,measures,0,0
188249,of,0,0
188250,arterial,0,1
188251,stiffness,0,0
188252,were,0,0
188253,assessed,0,0
188254,at,0,0
188255,baseline,0,0
188256,and,0,0
188257,every,0,0
188258,4,0,0
188259,weeks,1,0
188260,.,1,1
188261,Of,1,0
188262,37,1,1
188263,randomized,1,0
188264,subjects,1,1
188265,",",1,0
188266,36,1,1
188267,completed,1,0
188268,the,1,0
188269,study,1,0
188270,.,1,0
188271,They,0,0
188272,had,0,0
188273,a,0,0
188274,mean,0,0
188275,pre-treatment,0,0
188276,BP,0,0
188277,of,0,0
188278,145/81,0,0
188279,mm,0,0
188280,Hg,0,0
188281,and,0,0
188282,69,0,1
188283,%,0,0
188284,had,0,0
188285,systolic,0,1
188286,BP,0,0
188287,?140,0,1
188288,mm,0,0
188289,Hg,0,0
188290,.,0,0
188291,Sodium,0,0
188292,excretion,0,0
188293,was,0,0
188294,increased,0,0
188295,by,0,0
188296,98,0,1
188297,mmol,0,0
188298,per,0,0
188299,24,0,0
188300,h,0,0
188301,and,0,0
188302,potassium,0,0
188303,excretion,0,0
188304,by,0,0
188305,63,0,1
188306,mmol,0,0
188307,per,0,0
188308,24,0,0
188309,h,0,0
188310,during,0,0
188311,active,0,0
188312,interventions,0,0
188313,",",0,0
188314,compared,0,0
188315,with,0,0
188316,placebo,0,0
188317,.,0,0
188318,During,0,0
188319,sodium,0,0
188320,supplementation,0,0
188321,",",0,0
188322,office,0,1
188323,BP,0,0
188324,was,0,0
188325,significantly,0,0
188326,increased,0,0
188327,by,0,0
188328,7.5/3.3,0,0
188329,mm,0,0
188330,Hg,0,0
188331,",",0,0
188332,24-h,0,0
188333,BP,0,0
188334,by,0,0
188335,7.5/2.7,0,1
188336,mm,0,0
188337,Hg,0,0
188338,and,0,0
188339,central,0,0
188340,BP,0,0
188341,by,0,0
188342,8.5/3.6,0,0
188343,mm,0,0
188344,Hg,0,0
188345,.,0,0
188346,During,0,0
188347,potassium,0,0
188348,supplementation,0,0
188349,",",0,0
188350,24-h,0,0
188351,BP,0,0
188352,was,0,0
188353,significantly,0,0
188354,reduced,0,0
188355,by,0,0
188356,3.9/1.6,0,0
188357,mm,0,0
188358,Hg,0,0
188359,and,0,0
188360,central,0,0
188361,pulse,0,0
188362,pressure,0,0
188363,by,0,0
188364,2.9,0,0
188365,mm,0,0
188366,Hg,0,1
188367,.,0,1
188368,Pulse,0,0
188369,wave,0,0
188370,velocity,0,0
188371,and,0,0
188372,augmentation,0,0
188373,index,0,0
188374,were,0,0
188375,not,0,0
188376,significantly,0,0
188377,affected,0,0
188378,by,0,0
188379,sodium,0,0
188380,or,0,0
188381,potassium,0,0
188382,supplementation,0,0
188383,.,0,0
188384,In,0,0
188385,conclusion,0,0
188386,",",0,0
188387,increasing,0,0
188388,the,0,0
188389,intake,0,0
188390,of,0,0
188391,sodium,0,0
188392,caused,0,0
188393,a,0,0
188394,substantial,0,0
188395,increase,0,0
188396,in,0,0
188397,BP,0,0
188398,in,0,0
188399,subjects,1,1
188400,with,1,1
188401,untreated,1,1
188402,elevated,1,0
188403,BP,1,0
188404,.,1,0
188405,Increased,0,0
188406,potassium,0,0
188407,intake,0,0
188408,",",0,0
188409,on,0,0
188410,top,0,0
188411,of,0,0
188412,a,0,0
188413,relatively,0,0
188414,low-sodium,0,0
188415,diet,0,0
188416,",",0,0
188417,had,0,0
188418,a,0,0
188419,beneficial,0,0
188420,effect,0,0
188421,on,0,0
188422,BP,0,0
188423,.,1,0
188424,Arterial,1,0
188425,stiffness,1,0
188426,did,0,0
188427,not,0,0
188428,materially,0,0
188429,change,0,0
188430,during,0,0
188431,4-week,0,0
188432,interventions,0,0
188433,with,0,1
188434,sodium,0,0
188435,or,0,0
188436,potassium,0,0
188437,.,0,0
188438,Lateral,0,0
188439,MI,0,0
188440,Explains,0,0
188441,the,0,0
188442,Presence,0,0
188443,of,0,0
188444,Prominent,0,0
188445,R,0,0
188446,Wave,0,0
188447,(,0,0
188448,R,0,0
188449,?,0,0
188450,S,0,0
188451,),0,0
188452,in,0,0
188453,V1,0,0
188454,.,0,0
188455,AIMS,0,0
188456,It,0,0
188457,is,0,0
188458,necessary,0,0
188459,to,0,0
188460,clarify,0,0
188461,if,0,0
188462,the,0,0
188463,presence,0,0
188464,of,0,0
188465,a,0,0
188466,prominent,0,0
188467,R,0,0
188468,wave,0,0
188469,in,0,0
188470,V1,0,0
188471,",",0,0
188472,in,0,0
188473,post-myocardial,1,0
188474,infarction,1,1
188475,(,1,0
188476,MI,1,0
188477,),1,0
188478,patients,1,1
188479,",",1,0
188480,is,0,0
188481,due,0,0
188482,to,0,0
188483,the,0,0
188484,involvement,0,0
188485,of,0,0
188486,the,0,0
188487,posterior,0,0
188488,wall,0,0
188489,(,0,0
188490,currently,0,0
188491,inferobasal,0,0
188492,segment,0,0
188493,),0,0
188494,or,0,0
188495,the,0,0
188496,lateral,0,0
188497,wall,0,0
188498,(,0,0
188499,as,0,0
188500,has,0,0
188501,been,0,0
188502,demonstrated,0,0
188503,recently,0,0
188504,by,0,0
188505,electrocardiographic,0,0
188506,contrast-enhanced,0,0
188507,cardiac,0,1
188508,magnetic,0,0
188509,resonance,0,0
188510,[,0,0
188511,ECG-CE-CMR,0,0
188512,],0,1
188513,correlations,0,0
188514,studies,0,0
188515,),0,1
188516,.,0,0
188517,METHODS,0,0
188518,In,0,0
188519,155,1,1
188520,patients,1,1
188521,with,1,1
188522,inferolateral,1,0
188523,zone,1,0
188524,MI,1,0
188525,",",1,0
188526,as,1,0
188527,detected,1,0
188528,by,1,0
188529,CE-CMR,1,0
188530,",",1,0
188531,the,0,0
188532,following,0,0
188533,ECG,0,0
188534,parameters,0,0
188535,were,0,0
188536,evaluated,0,0
188537,and,0,0
188538,correlated,0,0
188539,with,0,0
188540,MI,0,0
188541,location,0,0
188542,according,0,0
188543,to,0,0
188544,CE-CMR,0,1
188545,:,0,1
188546,R/S,0,0
188547,ratio,0,0
188548,in,0,0
188549,V1,0,0
188550,?,0,0
188551,1,0,0
188552,(,0,0
188553,classic,0,1
188554,criteria,0,1
188555,for,0,0
188556,posterior,0,1
188557,MI,0,0
188558,),0,0
188559,",",0,0
188560,R/S,0,0
188561,ratio,0,0
188562,in,0,0
188563,V1,0,0
188564,?,0,0
188565,0.5,0,0
188566,",",0,0
188567,and,0,0
188568,R,0,0
188569,in,0,0
188570,V1,0,0
188571,?,0,0
188572,3,0,0
188573,mm,0,0
188574,.,0,0
188575,RESULTS,0,0
188576,R/S,0,0
188577,?,0,0
188578,1,0,0
188579,criterion,0,0
188580,:,0,1
188581,Present,0,0
188582,in,0,0
188583,20,0,1
188584,cases,0,1
188585,:,0,1
188586,3,0,0
188587,of,0,0
188588,lateral,0,0
188589,MI,0,0
188590,",",0,0
188591,17,0,0
188592,of,0,0
188593,inferolateral,0,0
188594,MI,0,0
188595,",",0,0
188596,0,0,0
188597,of,0,0
188598,inferior,0,0
188599,MI,0,0
188600,.,0,0
188601,Absent,0,0
188602,in,0,0
188603,135,0,1
188604,cases,0,1
188605,",",0,0
188606,81,0,1
188607,of,0,0
188608,lateral/inferolateral,0,0
188609,MI,0,0
188610,(,0,0
188611,28/53,0,0
188612,),0,0
188613,",",0,0
188614,54,0,1
188615,of,0,0
188616,inferior,0,0
188617,MI,0,0
188618,(,0,0
188619,SE,0,0
188620,19.8,0,0
188621,%,0,0
188622,",",0,0
188623,SP,0,1
188624,100,0,0
188625,%,0,0
188626,),0,0
188627,.,0,0
188628,R/S,0,0
188629,?,0,0
188630,0.5,0,0
188631,criterion,0,0
188632,:,0,1
188633,Present,0,0
188634,in,0,0
188635,47,0,1
188636,cases,0,1
188637,:,0,1
188638,6,0,0
188639,of,0,0
188640,lateral,0,0
188641,MI,0,0
188642,",",0,0
188643,39,0,1
188644,of,0,0
188645,inferolateral,0,0
188646,MI,0,0
188647,",",0,0
188648,2,0,0
188649,of,0,0
188650,inferior,0,0
188651,MI,0,0
188652,.,0,0
188653,Absent,0,0
188654,in,0,0
188655,108,0,1
188656,cases,0,1
188657,",",0,0
188658,56,0,0
188659,of,0,0
188660,lateral/inferolateral,0,0
188661,MI,0,0
188662,(,0,0
188663,25/31,0,1
188664,),0,0
188665,",",0,0
188666,52,0,0
188667,of,0,0
188668,inferior,0,0
188669,MI,0,0
188670,(,0,0
188671,SE,0,0
188672,44.6,0,0
188673,%,0,0
188674,",",0,0
188675,SP,0,1
188676,96.4,0,0
188677,%,0,0
188678,),0,0
188679,.,0,0
188680,R,0,0
188681,?,0,0
188682,3,0,0
188683,mm,0,0
188684,criterion,0,0
188685,:,0,1
188686,Present,0,0
188687,in,0,0
188688,30,0,1
188689,cases,0,1
188690,:,0,1
188691,5,0,0
188692,of,0,0
188693,IM,0,1
188694,lateral,0,0
188695,",",0,0
188696,23,0,1
188697,of,0,0
188698,inferolateral,0,0
188699,MI,0,0
188700,",",0,0
188701,2,0,0
188702,of,0,0
188703,inferior,0,0
188704,MI,0,0
188705,.,0,0
188706,Absent,0,0
188707,in,0,0
188708,125,0,0
188709,cases,0,1
188710,",",0,0
188711,73,0,1
188712,lateral/inferolateral,0,0
188713,MI,0,0
188714,(,0,0
188715,26/47,0,0
188716,),0,0
188717,",",0,0
188718,52,0,1
188719,inferior,0,0
188720,MI,0,0
188721,(,0,0
188722,SE,0,0
188723,27.7,0,0
188724,%,0,0
188725,",",0,0
188726,SP,0,1
188727,96.4,0,0
188728,%,0,0
188729,),0,0
188730,.,0,0
188731,CONCLUSIONS,0,0
188732,The,0,0
188733,presence,0,0
188734,of,0,0
188735,prominent,0,0
188736,the,0,0
188737,R,0,0
188738,wave,0,0
188739,in,0,0
188740,V1,0,0
188741,is,0,0
188742,due,0,0
188743,to,0,0
188744,the,0,0
188745,lateral,0,0
188746,MI,0,0
188747,and,0,0
188748,not,0,0
188749,to,0,0
188750,the,0,0
188751,involvement,0,0
188752,of,0,0
188753,inferobasal,0,0
188754,segment,0,0
188755,of,0,0
188756,inferior,0,0
188757,wall,0,1
188758,(,0,0
188759,old,0,1
188760,posterior,0,0
188761,wall,0,0
188762,),0,0
188763,.,0,0
188764,Magnetic,0,0
188765,resonance,0,0
188766,imaging,0,0
188767,in,0,0
188768,the,0,0
188769,evaluation,0,0
188770,of,0,0
188771,clinical,0,0
188772,treatment,0,0
188773,of,0,0
188774,otospongiosis,1,1
188775,:,1,1
188776,a,0,0
188777,pilot,0,0
188778,study,0,0
188779,.,0,0
188780,OBJECTIVES,0,0
188781,To,0,0
188782,evaluate,0,0
188783,the,0,0
188784,applicability,0,0
188785,of,0,0
188786,magnetic,0,0
188787,resonance,0,0
188788,imaging,0,0
188789,(,0,0
188790,MRI,0,0
188791,),0,0
188792,as,0,0
188793,a,0,0
188794,method,0,0
188795,for,0,0
188796,monitoring,0,0
188797,the,0,0
188798,activity,0,0
188799,of,0,0
188800,otospongiotic,0,0
188801,lesions,0,1
188802,before,0,0
188803,and,0,0
188804,after,0,0
188805,clinical,0,0
188806,treatment,0,0
188807,.,0,0
188808,STUDY,0,0
188809,DESIGN,0,0
188810,Prospective,0,0
188811,",",0,0
188812,randomized,0,0
188813,",",0,0
188814,controlled,0,0
188815,",",0,0
188816,double-blind,0,0
188817,study,0,0
188818,.,0,0
188819,SETTING,0,0
188820,One,1,1
188821,single,1,0
188822,tertiary,1,1
188823,care,1,0
188824,institution,1,1
188825,in,1,0
188826,a,1,0
188827,large,1,0
188828,",",1,0
188829,cosmopolitan,1,1
188830,city,1,1
188831,.,1,0
188832,METHODS,0,0
188833,Twenty-six,1,1
188834,patients,1,1
188835,(,1,0
188836,n,1,1
188837,=,1,0
188838,42,1,1
188839,ears,1,1
188840,),1,0
188841,with,1,1
188842,clinical,1,0
188843,",",1,0
188844,audiometric,1,0
188845,",",1,0
188846,and,1,0
188847,tomographic,1,0
188848,diagnosis,1,1
188849,of,1,0
188850,otosclerosis,1,1
188851,were,1,0
188852,enrolled,1,1
188853,.,1,0
188854,If,0,0
188855,computed,0,0
188856,tomography,0,0
188857,(,0,0
188858,CT,0,0
188859,),0,0
188860,demonstrated,0,0
188861,active,0,0
188862,lesions,0,0
188863,",",0,0
188864,these,0,0
188865,patients,0,1
188866,underwent,0,1
188867,MRI,0,0
188868,to,0,0
188869,detect,0,0
188870,otospongiotic,0,0
188871,foci,0,0
188872,",",0,0
188873,seen,0,0
188874,as,0,0
188875,areas,0,0
188876,of,0,0
188877,gadolinium,0,0
188878,enhancement,0,0
188879,.,0,0
188880,Patients,0,1
188881,were,0,0
188882,divided,0,1
188883,into,0,1
188884,3,0,0
188885,groups,0,0
188886,and,0,0
188887,received,0,0
188888,treatment,0,0
188889,with,0,0
188890,placebo,0,0
188891,",",0,0
188892,sodium,0,0
188893,alendronate,0,0
188894,",",0,0
188895,or,0,0
188896,sodium,0,0
188897,fluoride,0,0
188898,for,0,0
188899,6,0,0
188900,months,0,0
188901,.,0,0
188902,After,0,0
188903,this,0,0
188904,period,0,0
188905,",",0,0
188906,clinical,0,0
188907,and,0,0
188908,audiometric,0,0
188909,evaluations,0,0
188910,and,0,0
188911,a,0,0
188912,second,0,0
188913,MRI,0,0
188914,were,0,0
188915,performed,0,0
188916,.,0,0
188917,Each,0,0
188918,MRI,0,0
188919,was,0,0
188920,evaluated,0,0
188921,by,0,0
188922,both,0,0
188923,a,0,0
188924,neuroradiologist,0,0
188925,and,0,0
188926,an,0,0
188927,otolaryngologist,0,0
188928,in,0,0
188929,a,0,0
188930,subjective,0,0
188931,(,0,0
188932,visual,0,0
188933,),0,0
188934,and,0,0
188935,objective,0,0
188936,(,0,0
188937,using,0,0
188938,specific,0,0
188939,eFilm,0,0
188940,Workstation,0,0
188941,software,0,0
188942,),0,0
188943,manner,0,0
188944,.,0,0
188945,RESULTS,0,0
188946,Otospongiosis,0,0
188947,was,0,0
188948,most,0,0
188949,predominantly,0,0
188950,identified,0,0
188951,in,0,0
188952,the,0,0
188953,region,0,0
188954,anterior,0,0
188955,to,0,0
188956,the,0,0
188957,oval,0,0
188958,window,0,0
188959,",",0,0
188960,and,0,0
188961,this,0,0
188962,site,0,0
188963,was,0,0
188964,reliable,0,0
188965,for,0,0
188966,comparing,0,0
188967,pre-,0,0
188968,and,0,0
188969,posttreatment,0,0
188970,scans,0,0
188971,.,0,1
188972,The,0,0
188973,patients,0,1
188974,in,0,0
188975,the,0,0
188976,alendronate,0,0
188977,and,0,0
188978,sodium,0,0
188979,fluoride,0,0
188980,groups,0,0
188981,had,0,1
188982,MRI,0,0
188983,findings,0,0
188984,that,0,0
188985,suggested,0,0
188986,a,0,0
188987,decrease,0,0
188988,in,0,0
188989,activity,0,0
188990,of,0,0
188991,otospongiotic,0,0
188992,lesions,0,0
188993,",",0,0
188994,more,0,0
188995,relevant,0,0
188996,in,0,0
188997,the,0,0
188998,alendronate,0,0
188999,group,0,0
189000,.,0,0
189001,These,0,0
189002,findings,0,0
189003,were,0,0
189004,statistically,0,0
189005,significant,0,0
189006,for,0,0
189007,both,0,0
189008,subjective,0,0
189009,and,0,0
189010,objective,0,0
189011,MRI,0,0
189012,evaluations,0,0
189013,.,0,1
189014,CONCLUSIONS,0,0
189015,MRI,0,0
189016,shows,0,0
189017,higher,0,0
189018,sensitivity,0,0
189019,than,0,0
189020,clinical,0,0
189021,or,0,0
189022,audiometric,0,0
189023,assessment,0,0
189024,for,0,0
189025,detecting,0,0
189026,reduction,0,0
189027,in,0,0
189028,activity,0,0
189029,of,0,0
189030,otospongiosis,0,0
189031,.,0,0
189032,The,0,0
189033,objective,0,0
189034,MRI,0,0
189035,evaluation,0,0
189036,based,0,0
189037,on,0,0
189038,software,0,0
189039,analysis,0,0
189040,was,0,0
189041,the,0,0
189042,most,0,0
189043,accurate,0,0
189044,method,0,0
189045,of,0,0
189046,monitoring,0,0
189047,clinical,0,0
189048,treatment,0,0
189049,response,0,0
189050,in,0,0
189051,otospongiosis,0,1
189052,.,0,0
189053,Offering,0,0
189054,personalized,0,0
189055,health,0,0
189056,behavior,0,0
189057,feedback,0,0
189058,did,0,0
189059,not,0,0
189060,increase,0,0
189061,response,0,0
189062,rate,0,0
189063,:,0,0
189064,a,0,0
189065,randomized,1,0
189066,controlled,0,0
189067,trial,0,0
189068,.,0,0
189069,Initial,0,0
189070,abstinence,0,0
189071,status,0,0
189072,and,0,0
189073,contingency,0,0
189074,management,0,0
189075,treatment,0,0
189076,outcomes,0,0
189077,:,0,0
189078,does,0,0
189079,race,0,0
189080,matter,0,0
189081,?,0,0
189082,OBJECTIVE,0,0
189083,Limited,0,0
189084,research,0,0
189085,has,0,0
189086,evaluated,0,0
189087,African,1,1
189088,American,1,1
189089,substance,1,0
189090,users,1,0
189091,',1,0
189092,response,0,0
189093,to,0,1
189094,evidence-based,0,0
189095,treatments,0,0
189096,.,0,0
189097,This,0,0
189098,study,0,0
189099,examined,0,0
189100,the,0,0
189101,efficacy,0,0
189102,of,0,0
189103,contingency,0,0
189104,management,0,0
189105,(,0,0
189106,CM,0,0
189107,),0,0
189108,in,0,0
189109,African,1,1
189110,American,1,1
189111,and,1,0
189112,White,1,0
189113,cocaine,1,0
189114,users,1,0
189115,.,1,0
189116,METHOD,0,0
189117,A,0,0
189118,secondary,0,0
189119,analysis,0,0
189120,evaluated,0,0
189121,effects,0,0
189122,of,0,0
189123,race,0,0
189124,",",0,0
189125,treatment,0,0
189126,condition,0,0
189127,",",0,0
189128,and,0,0
189129,baseline,0,0
189130,cocaine,0,0
189131,urine,0,0
189132,sample,0,1
189133,results,0,0
189134,on,0,0
189135,treatment,0,0
189136,outcomes,0,0
189137,of,0,0
189138,African,1,1
189139,American,1,1
189140,(,1,0
189141,n,1,1
189142,=,1,0
189143,444,1,1
189144,),1,0
189145,and,1,0
189146,White,1,0
189147,(,1,0
189148,n,1,1
189149,=,1,0
189150,403,1,1
189151,),1,0
189152,cocaine,1,0
189153,abusers,1,1
189154,participating,1,1
189155,in,1,0
189156,one,1,0
189157,of,1,0
189158,six,1,1
189159,randomized,1,1
189160,clinical,1,0
189161,trials,1,0
189162,comparing,1,0
189163,CM,1,0
189164,to,1,0
189165,standard,1,0
189166,care,1,0
189167,.,1,0
189168,RESULTS,0,0
189169,African,1,1
189170,American,1,1
189171,and,1,0
189172,White,1,1
189173,patients,1,1
189174,who,1,1
189175,initiated,1,1
189176,treatment,1,1
189177,with,1,0
189178,a,1,0
189179,cocaine-negative,1,1
189180,urine,1,0
189181,sample,1,1
189182,remained,0,0
189183,in,0,0
189184,treatment,0,0
189185,for,0,0
189186,similar,0,0
189187,durations,0,0
189188,and,0,0
189189,submitted,0,0
189190,a,0,0
189191,comparable,0,0
189192,proportion,0,0
189193,of,0,0
189194,negative,0,0
189195,samples,0,0
189196,during,0,0
189197,treatment,0,0
189198,regardless,0,0
189199,of,0,0
189200,treatment,0,0
189201,type,0,1
189202,;,0,0
189203,CM,0,0
189204,was,0,0
189205,efficacious,0,0
189206,in,0,0
189207,both,0,0
189208,races,0,0
189209,in,0,0
189210,terms,0,0
189211,of,0,0
189212,engendering,0,0
189213,longer,0,0
189214,durations,0,0
189215,of,0,0
189216,abstinence,0,0
189217,in,0,1
189218,patients,0,1
189219,who,0,1
189220,began,0,1
189221,treatment,0,1
189222,abstinent,0,1
189223,.,0,1
189224,Whites,1,1
189225,who,1,1
189226,began,1,1
189227,treatment,1,1
189228,with,1,0
189229,a,1,0
189230,cocaine,1,0
189231,positive,1,0
189232,sample,1,1
189233,remained,0,0
189234,in,0,0
189235,treatment,0,0
189236,longer,0,0
189237,and,0,0
189238,submitted,0,0
189239,a,0,0
189240,higher,0,0
189241,proportion,0,0
189242,of,0,0
189243,negative,0,0
189244,samples,0,0
189245,when,0,0
189246,assigned,0,1
189247,to,0,0
189248,CM,0,0
189249,than,0,0
189250,standard,0,0
189251,care,0,1
189252,.,0,1
189253,African,1,1
189254,Americans,1,1
189255,who,1,1
189256,initiated,1,1
189257,treatment,1,1
189258,with,1,0
189259,a,1,0
189260,cocaine,1,0
189261,positive,1,0
189262,sample,1,1
189263,",",0,0
189264,however,0,0
189265,",",0,0
189266,did,0,0
189267,not,0,0
189268,remain,0,0
189269,in,0,0
189270,treatment,0,0
189271,longer,0,0
189272,with,0,1
189273,CM,0,0
189274,compared,0,0
189275,with,0,1
189276,standard,0,0
189277,care,0,0
189278,",",0,0
189279,and,0,0
189280,gains,0,0
189281,in,0,0
189282,terms,0,0
189283,of,0,0
189284,drug,0,0
189285,use,0,0
189286,outcomes,0,0
189287,were,0,0
189288,muted,0,0
189289,in,0,0
189290,nature,0,0
189291,relative,0,0
189292,to,0,0
189293,Whites,0,0
189294,.,0,0
189295,This,0,0
189296,interaction,0,0
189297,effect,0,0
189298,persisted,0,0
189299,through,0,0
189300,the,0,0
189301,9-month,0,0
189302,follow-up,0,0
189303,period,0,0
189304,.,0,0
189305,CONCLUSIONS,0,0
189306,CM,0,0
189307,is,0,0
189308,not,0,0
189309,equally,0,0
189310,effective,0,0
189311,in,0,0
189312,reducing,0,0
189313,drug,0,0
189314,use,0,0
189315,among,0,0
189316,all,0,0
189317,subgroups,0,0
189318,",",0,0
189319,specifically,0,0
189320,African,1,1
189321,American,1,1
189322,patients,1,1
189323,who,1,1
189324,are,1,1
189325,using,1,1
189326,cocaine,1,0
189327,upon,1,0
189328,treatment,1,0
189329,entry,1,0
189330,.,1,0
189331,Future,0,0
189332,research,0,0
189333,on,0,0
189334,improving,0,0
189335,treatment,0,0
189336,outcomes,0,0
189337,in,0,0
189338,this,0,0
189339,population,0,0
189340,is,0,0
189341,needed,0,0
189342,.,0,0
189343,The,0,0
189344,Effects,0,0
189345,of,0,0
189346,Naltrexone,0,1
189347,on,0,0
189348,Subjective,0,0
189349,Response,0,0
189350,to,0,0
189351,Methamphetamine,0,0
189352,in,0,0
189353,a,0,0
189354,Clinical,1,0
189355,Sample,1,0
189356,:,1,1
189357,a,0,0
189358,Double-Blind,0,0
189359,",",0,0
189360,Placebo-Controlled,0,0
189361,Laboratory,0,0
189362,Study,0,0
189363,.,0,0
189364,Methamphetamine,1,0
189365,(,1,0
189366,MA,1,0
189367,),1,0
189368,use,1,0
189369,disorder,1,1
189370,is,0,0
189371,a,0,0
189372,serious,0,0
189373,psychiatric,0,1
189374,condition,0,0
189375,for,0,0
189376,which,0,0
189377,there,0,0
189378,are,0,0
189379,no,0,0
189380,FDA-approved,0,0
189381,medications,0,0
189382,.,0,1
189383,Naltrexone,0,0
189384,(,0,0
189385,NTX,0,0
189386,),0,0
189387,is,0,0
189388,an,0,0
189389,opioid,0,0
189390,receptor,0,0
189391,antagonist,0,0
189392,with,0,1
189393,demonstrated,0,0
189394,efficacy,0,0
189395,",",0,0
189396,albeit,0,0
189397,moderate,0,1
189398,",",0,0
189399,for,0,0
189400,the,0,0
189401,treatment,0,0
189402,of,0,0
189403,alcoholism,0,1
189404,and,0,0
189405,opioid,0,0
189406,dependence,0,0
189407,.,0,0
189408,Preclinical,0,0
189409,and,0,0
189410,clinical,0,0
189411,studies,0,0
189412,suggest,0,0
189413,that,0,0
189414,NTX,0,0
189415,may,0,0
189416,be,0,0
189417,useful,0,0
189418,for,0,0
189419,the,0,0
189420,treatment,0,0
189421,of,0,0
189422,MA,0,0
189423,use,0,0
189424,disorder,0,1
189425,.,0,0
189426,To,0,0
189427,inform,0,0
189428,treatment,0,0
189429,development,0,0
189430,",",0,0
189431,we,0,0
189432,conducted,0,0
189433,a,0,0
189434,double-blind,0,0
189435,",",0,0
189436,randomized,0,0
189437,",",0,0
189438,crossover,0,0
189439,",",0,0
189440,placebo-controlled,0,0
189441,human,0,0
189442,laboratory,0,0
189443,study,0,0
189444,of,0,0
189445,NTX,0,0
189446,.,0,1
189447,Non-treatment-seeking,1,0
189448,individuals,1,1
189449,meeting,1,1
189450,DSM-IV,1,0
189451,criteria,1,1
189452,for,1,0
189453,MA,1,0
189454,abuse,1,1
189455,or,1,0
189456,dependence,1,0
189457,(,1,0
189458,n=30,1,1
189459,),1,0
189460,completed,1,1
189461,two,1,0
189462,separate,1,0
189463,5-day,1,0
189464,inpatient,1,1
189465,stays,1,0
189466,.,1,0
189467,During,0,0
189468,each,0,0
189469,admission,0,0
189470,",",0,0
189471,participants,0,1
189472,completed,0,1
189473,testing,0,0
189474,sessions,0,0
189475,comprised,0,1
189476,of,0,0
189477,MA,0,0
189478,cue-reactivity,0,0
189479,and,0,0
189480,intravenous,0,0
189481,MA,0,0
189482,administration,0,0
189483,(,0,0
189484,30,0,0
189485,mg,0,0
189486,),0,0
189487,after,0,0
189488,receiving,0,0
189489,oral,0,0
189490,NTX,0,0
189491,(,0,0
189492,50,0,0
189493,mg,0,0
189494,),0,0
189495,or,0,0
189496,placebo,0,0
189497,for,0,0
189498,4,0,0
189499,days,0,0
189500,.,0,0
189501,This,0,0
189502,study,0,0
189503,tested,0,0
189504,the,0,0
189505,hypotheses,0,0
189506,that,0,0
189507,NTX,0,0
189508,would,0,0
189509,(,0,0
189510,a,0,0
189511,),0,0
189512,attenuate,0,0
189513,cue-induced,0,0
189514,MA,0,0
189515,craving,0,0
189516,",",0,0
189517,and,0,0
189518,(,0,0
189519,b,0,0
189520,),0,0
189521,reduce,0,0
189522,subjective,0,0
189523,responses,0,0
189524,to,0,0
189525,MA,0,0
189526,administration,0,0
189527,.,0,0
189528,Results,0,0
189529,largely,0,0
189530,supported,0,0
189531,the,0,0
189532,study,0,0
189533,hypotheses,0,0
189534,such,0,0
189535,that,0,0
189536,(,0,0
189537,a,0,0
189538,),0,0
189539,NTX,0,0
189540,significantly,0,0
189541,blunted,0,0
189542,cue-induced,0,0
189543,craving,0,0
189544,for,0,0
189545,MA,0,0
189546,and,0,0
189547,(,0,0
189548,b,0,0
189549,),0,0
189550,attenuated,0,0
189551,several,0,0
189552,of,0,0
189553,the,0,0
189554,hedonic,0,0
189555,subjective,0,0
189556,effects,0,0
189557,of,0,0
189558,MA,0,0
189559,",",0,0
189560,including,0,0
189561,craving,0,0
189562,",",0,0
189563,during,0,0
189564,controlled,0,0
189565,MA,0,0
189566,administration,0,0
189567,and,0,0
189568,as,0,0
189569,compared,0,0
189570,with,0,1
189571,placebo,0,0
189572,.,0,0
189573,NTX,0,0
189574,decreased,0,0
189575,overall,0,0
189576,subjective,0,0
189577,ratings,0,0
189578,of,0,0
189579,'crave,0,0
189580,drug,0,0
189581,",",0,0
189582,',0,0
189583,'stimulated,0,0
189584,",",0,0
189585,',0,0
189586,and,0,0
189587,'would,0,0
189588,like,0,0
189589,drug,0,0
189590,access,0,0
189591,",",0,0
189592,',0,0
189593,decreased,0,0
189594,the,0,0
189595,the,0,0
189596,post-MA,0,0
189597,administration,0,0
189598,timecourse,0,0
189599,of,0,0
189600,'anxious,0,1
189601,',0,0
189602,and,0,0
189603,increased,0,0
189604,ratings,0,0
189605,of,0,0
189606,'bad,0,1
189607,drug,0,0
189608,effects,0,0
189609,",",0,0
189610,',0,0
189611,as,0,0
189612,compared,0,0
189613,with,0,1
189614,placebo,0,0
189615,.,0,0
189616,These,0,0
189617,findings,0,0
189618,support,0,0
189619,a,0,0
189620,potential,0,0
189621,mechanism,0,0
189622,of,0,0
189623,action,0,0
189624,by,0,0
189625,showing,0,0
189626,that,0,0
189627,NTX,0,0
189628,reduced,0,0
189629,cue-induced,0,0
189630,craving,0,0
189631,and,0,0
189632,subjective,0,0
189633,responses,0,0
189634,to,0,1
189635,MA,0,0
189636,.,0,0
189637,This,0,0
189638,is,0,0
189639,consistent,0,0
189640,with,0,0
189641,positive,0,0
189642,treatment,0,0
189643,studies,0,0
189644,of,0,0
189645,NTX,0,0
189646,for,0,0
189647,amphetamine,0,0
189648,dependence,0,0
189649,",",0,0
189650,as,0,0
189651,well,0,0
189652,as,0,0
189653,ongoing,0,0
189654,clinical,0,0
189655,trials,0,0
189656,for,0,0
189657,MA,0,1
189658,.,0,1
189659,1H,0,0
189660,nuclear,0,1
189661,magnetic,0,0
189662,resonance-based,0,0
189663,metabolomic,0,0
189664,study,0,0
189665,on,0,0
189666,efficacy,0,0
189667,of,0,0
189668,Qingrehuatan,0,0
189669,decoction,0,0
189670,against,0,0
189671,abundant,0,0
189672,phlegm-heat,0,1
189673,syndrome,0,1
189674,in,0,0
189675,young,1,1
189676,adults,1,1
189677,with,1,1
189678,essential,1,1
189679,hypertension,1,1
189680,.,1,0
189681,OBJECTIVE,0,0
189682,To,0,0
189683,observe,0,0
189684,the,0,0
189685,influence,0,0
189686,of,0,0
189687,Qingrehuatan,0,0
189688,decoction,0,0
189689,(,0,0
189690,QRHT,0,0
189691,),0,0
189692,on,0,0
189693,serum,0,0
189694,metabolic,0,0
189695,profile,0,0
189696,in,0,0
189697,young,1,1
189698,essential,1,1
189699,hypertension,1,1
189700,(,1,0
189701,YEH,1,0
189702,),1,0
189703,patients,1,1
189704,with,1,1
189705,abundant,1,0
189706,phlegm-heat,1,1
189707,syndrome,1,1
189708,and,0,0
189709,provide,0,0
189710,a,0,0
189711,basis,0,0
189712,for,0,0
189713,treatment,0,0
189714,with,0,0
189715,the,0,0
189716,decoction,0,0
189717,.,0,0
189718,METHODS,0,0
189719,Twelve,1,1
189720,male,1,1
189721,YEH,1,0
189722,patients,1,1
189723,were,1,0
189724,randomly,1,1
189725,selected,1,1
189726,and,1,0
189727,serum,1,0
189728,samples,1,0
189729,were,1,0
189730,collected,1,0
189731,for,1,0
189732,examination,1,0
189733,before,1,0
189734,and,1,0
189735,after,1,0
189736,4,1,0
189737,weeks,1,0
189738,of,1,0
189739,the,1,0
189740,treatment,1,0
189741,with,1,1
189742,QRHT,1,1
189743,.,1,0
189744,Twelve,1,1
189745,healthy,1,1
189746,males,1,1
189747,were,1,0
189748,randomly,1,1
189749,selected,1,0
189750,and,1,0
189751,their,1,0
189752,serum,1,0
189753,samples,1,0
189754,were,1,0
189755,collected,1,0
189756,as,1,0
189757,a,1,0
189758,control,1,0
189759,.,1,0
189760,All,0,0
189761,serum,0,0
189762,samples,0,0
189763,were,0,0
189764,detected,0,0
189765,using,0,0
189766,metabolomic,0,0
189767,technology,0,0
189768,with,0,1
189769,1H,0,0
189770,nuclear,0,1
189771,magnetic,0,0
189772,resonance,0,0
189773,.,0,0
189774,Differences,0,0
189775,in,0,0
189776,metabolites,0,0
189777,were,0,0
189778,studied,0,1
189779,by,0,0
189780,principal,0,0
189781,component,0,0
189782,analysis,0,0
189783,and,0,0
189784,partial,0,0
189785,least,0,0
189786,squares-discriminate,0,0
189787,analysis,0,0
189788,",",0,0
189789,which,0,0
189790,produced,0,0
189791,scores,0,0
189792,and,0,0
189793,loadings,0,0
189794,plots,0,0
189795,.,0,1
189796,RESULTS,0,0
189797,After,0,0
189798,4,0,0
189799,weeks,0,0
189800,of,0,0
189801,treatment,0,0
189802,",",0,0
189803,serum,0,0
189804,substances,0,0
189805,could,0,0
189806,be,0,0
189807,distinguished,0,0
189808,between,0,0
189809,the,0,0
189810,YEH,0,0
189811,patients,0,1
189812,with,0,1
189813,abundant,0,0
189814,phlegm-heat,0,1
189815,syndrome,0,1
189816,and,0,0
189817,the,0,0
189818,control,0,0
189819,patients,0,1
189820,.,0,0
189821,The,0,0
189822,specific,0,0
189823,serum,0,0
189824,endog-,0,0
189825,enous,0,1
189826,metabolites,0,0
189827,tended,0,0
189828,to,0,0
189829,improve,0,0
189830,after,0,0
189831,the,0,0
189832,treatment,0,0
189833,.,0,0
189834,QRHT,0,0
189835,can,0,0
189836,appropriately,0,0
189837,increase,0,0
189838,the,0,0
189839,levels,0,0
189840,of,0,0
189841,glucose,0,0
189842,",",0,0
189843,lactic,0,0
189844,acid,0,0
189845,",",0,0
189846,citric,0,0
189847,acid,0,0
189848,",",0,0
189849,high-density,0,0
189850,lipoprotein,0,0
189851,",",0,0
189852,phosphatidylcholine,0,0
189853,",",0,0
189854,glycerophosphate,0,0
189855,choline,0,0
189856,",",0,0
189857,hydroxybutyrate,0,0
189858,",",0,0
189859,alanine,0,0
189860,",",0,0
189861,and,0,0
189862,glutamate,0,0
189863,.,0,0
189864,QRHT,0,0
189865,could,0,0
189866,also,0,0
189867,decrease,0,0
189868,the,0,0
189869,levels,0,0
189870,of,0,0
189871,low-density,0,0
189872,lipoprotein/very,0,0
189873,low-density,0,0
189874,lipoprotein,0,0
189875,",",0,0
189876,lipids,0,0
189877,",",0,0
189878,N-acetyl,0,0
189879,glycoprotein,0,0
189880,",",0,0
189881,and,0,0
189882,O-acetyl,0,0
189883,glycoprotein,0,0
189884,.,0,0
189885,CONCLUSION,0,0
189886,QRHT,0,0
189887,can,0,0
189888,effectively,0,0
189889,ameliorate,0,0
189890,metabolic,0,0
189891,disorders,0,1
189892,in,0,1
189893,YEH,0,0
189894,Patients,0,1
189895,with,0,1
189896,abundant,0,1
189897,phlegm-heat,0,1
189898,syndrome,0,1
189899,.,0,0
189900,1H,0,0
189901,NMR-based,0,0
189902,metabolomic,0,0
189903,technology,0,0
189904,can,0,0
189905,provide,0,0
189906,an,0,0
189907,objective,0,0
189908,basis,0,0
189909,for,0,0
189910,the,0,0
189911,treatment,0,0
189912,of,0,0
189913,YEH,1,0
189914,patients,1,1
189915,with,1,1
189916,abundant,1,0
189917,phlegm-heat,1,1
189918,syndrome,1,1
189919,using,0,0
189920,QRHT,0,1
189921,.,0,1
189922,The,0,0
189923,short-term,0,0
189924,effects,0,0
189925,of,0,0
189926,transcranial,0,0
189927,direct,0,0
189928,current,0,0
189929,stimulation,0,0
189930,on,0,0
189931,electroencephalography,0,0
189932,in,0,0
189933,children,1,1
189934,with,1,1
189935,autism,1,1
189936,:,1,1
189937,a,0,0
189938,randomized,0,0
189939,crossover,0,0
189940,controlled,0,0
189941,trial,0,0
189942,.,0,0
189943,Abnormal,0,0
189944,synaptic,0,0
189945,maturation,0,0
189946,and,0,0
189947,connectivity,0,0
189948,are,0,0
189949,possible,0,0
189950,etiologies,0,0
189951,of,0,0
189952,autism,0,1
189953,.,0,0
189954,Previous,0,0
189955,studies,0,0
189956,showed,0,0
189957,significantly,0,0
189958,less,0,0
189959,alpha,0,0
189960,activity,0,0
189961,in,0,0
189962,autism,1,1
189963,than,0,0
189964,normal,0,1
189965,children,0,1
189966,.,0,0
189967,Therefore,0,0
189968,",",0,0
189969,we,0,0
189970,studied,0,0
189971,the,0,0
189972,effects,0,0
189973,of,0,0
189974,anodal,0,0
189975,tDCS,0,0
189976,on,0,0
189977,peak,0,0
189978,alpha,0,0
189979,frequency,0,0
189980,(,0,0
189981,PAF,0,0
189982,),0,0
189983,related,0,0
189984,to,0,0
189985,autism,0,1
189986,treatment,0,0
189987,evaluation,0,0
189988,checklist,0,0
189989,(,0,0
189990,ATEC,0,0
189991,),0,0
189992,.,0,0
189993,Twenty,1,1
189994,male,1,1
189995,children,1,1
189996,with,1,1
189997,autism,1,1
189998,were,1,0
189999,randomly,1,0
190000,assigned,1,0
190001,in,0,0
190002,a,0,0
190003,crossover,0,0
190004,design,0,0
190005,to,0,0
190006,receive,0,0
190007,a,0,0
190008,single,0,0
190009,session,0,0
190010,of,0,0
190011,both,0,0
190012,active,0,0
190013,and,0,0
190014,sham,0,0
190015,tDCS,0,0
190016,stimulation,0,0
190017,(,0,0
190018,11,0,0
190019,mA,0,0
190020,),0,0
190021,over,0,0
190022,F3,0,0
190023,(,0,0
190024,left,0,1
190025,dorsolateral,0,0
190026,prefrontal,0,0
190027,cortex,0,0
190028,),0,0
190029,.,0,0
190030,Pre-,0,0
190031,to,0,0
190032,postsession,0,0
190033,changes,0,0
190034,in,0,0
190035,a,0,0
190036,measure,0,0
190037,of,0,0
190038,cortical,0,0
190039,activity,0,0
190040,impacted,0,0
190041,by,0,0
190042,tDCS,0,0
190043,(,0,0
190044,PAF,0,0
190045,),0,0
190046,and,0,0
190047,ATEC,0,0
190048,were,0,0
190049,compared,0,0
190050,between,0,0
190051,groups,0,0
190052,.,0,0
190053,We,0,0
190054,also,0,0
190055,examined,0,0
190056,the,0,0
190057,associations,0,0
190058,between,0,0
190059,pre-,0,0
190060,and,0,0
190061,postsession,0,0
190062,changes,0,0
190063,in,0,0
190064,the,0,0
190065,PAF,0,0
190066,and,0,0
190067,ATEC,0,0
190068,.,0,0
190069,The,0,0
190070,results,0,0
190071,show,0,0
190072,significant,0,0
190073,pre-,0,0
190074,to,0,0
190075,postsession,0,0
190076,improvements,0,0
190077,in,0,0
190078,two,0,0
190079,domains,0,0
190080,of,0,0
190081,ATEC,0,1
190082,(,0,0
190083,social,0,0
190084,and,0,0
190085,health/behavior,0,1
190086,domains,0,0
190087,),0,0
190088,following,0,0
190089,active,0,0
190090,tDCS,0,0
190091,",",0,0
190092,relative,0,0
190093,to,0,0
190094,sham,0,0
190095,treatment,0,0
190096,.,0,0
190097,PAF,0,0
190098,also,0,0
190099,significantly,0,0
190100,increased,0,0
190101,at,0,0
190102,the,0,0
190103,stimulation,0,0
190104,site,0,0
190105,",",0,0
190106,and,0,0
190107,an,0,0
190108,increase,0,0
190109,in,0,0
190110,PAF,0,0
190111,was,0,0
190112,significantly,0,0
190113,associated,0,0
190114,with,0,0
190115,improvements,0,0
190116,in,0,0
190117,the,0,0
190118,two,0,0
190119,domains,0,0
190120,of,0,0
190121,ATEC,0,0
190122,impacted,0,0
190123,by,0,0
190124,tDCS,0,0
190125,.,0,0
190126,The,0,0
190127,findings,0,0
190128,suggest,0,0
190129,that,0,0
190130,a,0,0
190131,single,0,0
190132,session,0,0
190133,of,0,0
190134,anodal,0,0
190135,tDCS,0,0
190136,over,0,0
190137,the,0,0
190138,F3,0,0
190139,may,0,0
190140,have,0,0
190141,clinical,0,0
190142,benefits,0,0
190143,in,0,0
190144,children,0,1
190145,with,0,1
190146,autism,0,1
190147,and,0,0
190148,that,0,0
190149,those,0,0
190150,benefits,0,0
190151,may,0,0
190152,be,0,0
190153,related,0,0
190154,to,0,0
190155,an,0,0
190156,increase,0,0
190157,in,0,0
190158,PAF,0,0
190159,.,0,1
190160,Feasibility,0,0
190161,of,0,0
190162,a,0,0
190163,sensory-adapted,0,0
190164,dental,0,1
190165,environment,0,0
190166,for,0,0
190167,children,1,1
190168,with,1,1
190169,autism,1,1
190170,.,1,0
190171,OBJECTIVE,0,0
190172,To,0,0
190173,provide,0,0
190174,an,0,0
190175,example,0,0
190176,of,0,0
190177,an,0,0
190178,occupational,0,1
190179,therapy,0,0
190180,feasibility,0,0
190181,study,0,0
190182,and,0,0
190183,evaluate,0,0
190184,the,0,0
190185,implementation,0,0
190186,of,0,0
190187,a,0,0
190188,randomized,0,0
190189,controlled,0,0
190190,pilot,0,0
190191,and,0,0
190192,feasibility,0,0
190193,trial,0,0
190194,examining,0,0
190195,the,0,0
190196,impact,0,0
190197,of,0,0
190198,a,0,0
190199,sensory-adapted,0,0
190200,dental,0,1
190201,environment,0,0
190202,(,0,0
190203,SADE,0,0
190204,),0,0
190205,to,0,0
190206,enhance,0,0
190207,oral,0,0
190208,care,0,0
190209,for,0,0
190210,children,1,1
190211,with,1,1
190212,autism,1,1
190213,spectrum,1,1
190214,disorder,1,1
190215,(,1,0
190216,ASD,1,1
190217,),1,0
190218,.,1,0
190219,METHOD,0,0
190220,Twenty-two,1,1
190221,children,1,1
190222,with,1,1
190223,ASD,1,1
190224,and,1,0
190225,22,1,0
190226,typically,1,1
190227,developing,1,0
190228,children,1,1
190229,",",1,0
190230,ages,1,1
190231,6-12,1,0
190232,yr,1,1
190233,",",0,0
190234,attended,0,1
190235,a,0,0
190236,dental,0,1
190237,clinic,0,1
190238,in,0,0
190239,an,0,0
190240,urban,0,1
190241,hospital,0,0
190242,.,0,1
190243,Participants,1,1
190244,completed,0,1
190245,two,0,0
190246,dental,0,1
190247,cleanings,0,0
190248,",",0,0
190249,3-4,0,0
190250,mo,0,1
190251,apart,0,0
190252,",",0,0
190253,one,0,0
190254,in,0,0
190255,a,0,0
190256,regular,0,0
190257,environment,0,0
190258,and,0,0
190259,one,0,0
190260,in,0,0
190261,a,0,0
190262,SADE,0,0
190263,.,0,0
190264,Feasibility,0,0
190265,outcome,0,0
190266,measures,0,0
190267,were,0,0
190268,recruitment,0,0
190269,",",0,0
190270,retention,0,0
190271,",",0,0
190272,accrual,0,0
190273,",",0,0
190274,dropout,0,0
190275,",",0,0
190276,and,0,0
190277,protocol,0,0
190278,adherence,0,0
190279,.,0,0
190280,Intervention,0,0
190281,outcome,0,0
190282,measures,0,0
190283,were,0,0
190284,physiological,0,0
190285,stress,0,0
190286,",",0,0
190287,behavioral,0,0
190288,distress,0,0
190289,",",0,0
190290,pain,0,0
190291,",",0,0
190292,and,0,0
190293,cost,0,0
190294,.,0,0
190295,RESULTS,0,0
190296,We,0,0
190297,successfully,0,0
190298,recruited,0,1
190299,and,0,0
190300,retained,0,0
190301,participants,1,1
190302,.,1,1
190303,Parents,0,0
190304,expressed,0,0
190305,satisfaction,0,0
190306,with,0,0
190307,research,0,0
190308,study,0,0
190309,participation,0,0
190310,.,0,0
190311,Dentists,0,0
190312,stated,0,0
190313,that,0,0
190314,the,0,0
190315,intervention,0,0
190316,could,0,0
190317,be,0,0
190318,incorporated,0,0
190319,in,0,0
190320,normal,0,1
190321,practice,0,0
190322,.,0,0
190323,Intervention,0,0
190324,outcome,0,0
190325,measures,0,0
190326,favored,0,0
190327,the,0,0
190328,SADE,0,0
190329,condition,0,0
190330,.,0,0
190331,CONCLUSION,0,0
190332,Preliminary,0,0
190333,positive,0,0
190334,benefit,0,0
190335,of,0,0
190336,SADE,0,0
190337,in,1,0
190338,children,1,1
190339,with,1,1
190340,ASD,1,1
190341,warrants,0,0
190342,moving,0,0
190343,forward,0,0
190344,with,0,0
190345,a,0,0
190346,large-scale,0,0
190347,clinical,0,0
190348,trial,0,0
190349,.,0,0
190350,Effect,0,0
190351,of,0,0
190352,enzalutamide,0,0
190353,on,0,0
190354,health-related,0,0
190355,quality,0,0
190356,of,0,0
190357,life,0,0
190358,",",0,0
190359,pain,0,0
190360,",",0,0
190361,and,0,0
190362,skeletal-related,0,0
190363,events,0,0
190364,in,0,0
190365,asymptomatic,1,1
190366,and,1,0
190367,minimally,1,0
190368,symptomatic,1,0
190369,",",1,0
190370,chemotherapy-naive,1,1
190371,patients,1,1
190372,with,1,1
190373,metastatic,1,1
190374,castration-resistant,1,1
190375,prostate,1,1
190376,cancer,1,1
190377,(,1,0
190378,PREVAIL,1,0
190379,),1,0
190380,:,1,1
190381,results,0,0
190382,from,0,0
190383,a,0,0
190384,randomised,0,0
190385,",",0,0
190386,phase,0,0
190387,3,0,0
190388,trial,0,0
190389,.,0,0
190390,BACKGROUND,0,0
190391,Enzalutamide,0,0
190392,significantly,0,0
190393,increased,0,0
190394,overall,0,0
190395,survival,0,0
190396,and,0,0
190397,radiographic,0,0
190398,progression-free,0,0
190399,survival,0,0
190400,compared,0,0
190401,with,0,0
190402,placebo,0,0
190403,in,0,0
190404,the,0,0
190405,PREVAIL,0,0
190406,trial,0,0
190407,of,0,0
190408,asymptomatic,1,1
190409,and,1,0
190410,minimally,1,0
190411,symptomatic,1,0
190412,",",1,0
190413,chemotherapy-naive,1,1
190414,patients,1,1
190415,with,1,1
190416,metastatic,1,1
190417,castration-resistant,1,1
190418,prostate,1,1
190419,cancer,1,1
190420,.,1,0
190421,We,0,0
190422,report,0,0
190423,the,0,0
190424,effect,0,0
190425,of,0,0
190426,enzalutamide,0,0
190427,on,0,0
190428,health-related,0,0
190429,quality,0,0
190430,of,0,0
190431,life,0,0
190432,(,0,0
190433,HRQoL,0,0
190434,),0,0
190435,",",0,0
190436,pain,0,0
190437,",",0,0
190438,and,0,0
190439,skeletal-related,0,0
190440,events,0,0
190441,observed,0,0
190442,during,0,0
190443,this,0,0
190444,trial,0,0
190445,.,0,0
190446,METHODS,0,0
190447,In,0,0
190448,this,0,0
190449,phase,0,0
190450,3,0,0
190451,",",0,0
190452,double-blind,0,0
190453,trial,0,0
190454,",",0,0
190455,patients,1,1
190456,were,1,0
190457,randomly,1,1
190458,assigned,1,0
190459,(,1,0
190460,1:1,1,0
190461,),1,0
190462,to,1,0
190463,receive,1,0
190464,enzalutamide,1,0
190465,160,1,0
190466,mg/day,1,0
190467,(,1,0
190468,n=872,1,1
190469,),1,0
190470,or,1,0
190471,placebo,1,0
190472,(,1,0
190473,n=845,1,1
190474,),1,0
190475,orally,1,0
190476,.,1,0
190477,HRQoL,0,0
190478,was,0,0
190479,assessed,0,0
190480,at,0,0
190481,baseline,0,0
190482,and,0,0
190483,during,0,0
190484,treatment,0,0
190485,using,0,0
190486,the,0,0
190487,Functional,0,0
190488,Assessment,0,0
190489,of,0,0
190490,Cancer,0,0
190491,Therapy-Prostate,0,1
190492,(,0,0
190493,FACT-P,0,0
190494,),0,0
190495,and,0,0
190496,EQ-5D,0,0
190497,questionnaires,0,0
190498,.,0,0
190499,Pain,0,0
190500,status,0,0
190501,was,0,0
190502,assessed,0,0
190503,at,0,0
190504,screening,0,0
190505,",",0,0
190506,baseline,0,0
190507,",",0,0
190508,week,0,0
190509,13,0,0
190510,",",0,0
190511,and,0,0
190512,week,0,0
190513,25,0,0
190514,with,0,1
190515,the,0,0
190516,Brief,0,0
190517,Pain,0,0
190518,Inventory,0,1
190519,Short,0,1
190520,Form,0,0
190521,(,0,0
190522,BPI-SF,0,1
190523,),0,0
190524,.,0,0
190525,The,0,0
190526,primary,0,0
190527,analysis,0,0
190528,of,0,0
190529,HRQoL,0,0
190530,data,0,0
190531,used,0,0
190532,a,0,0
190533,mixed-effects,0,0
190534,model,0,0
190535,to,0,0
190536,test,0,0
190537,the,0,0
190538,difference,0,0
190539,between,0,0
190540,least,0,0
190541,square,0,0
190542,means,0,0
190543,change,0,0
190544,from,0,0
190545,baseline,0,0
190546,at,0,0
190547,week,0,0
190548,61,0,1
190549,.,0,0
190550,We,0,0
190551,assessed,0,0
190552,change,0,0
190553,from,0,0
190554,baseline,0,0
190555,",",0,0
190556,percentage,0,0
190557,improvement,0,0
190558,",",0,0
190559,and,0,0
190560,time,0,0
190561,to,0,0
190562,deterioration,0,0
190563,in,0,0
190564,HRQoL,0,0
190565,and,0,0
190566,pain,0,0
190567,",",0,0
190568,the,0,0
190569,proportion,0,0
190570,of,0,0
190571,patients,0,1
190572,with,0,1
190573,a,0,0
190574,skeletal-related,0,0
190575,event,0,0
190576,",",0,0
190577,and,0,0
190578,time,0,0
190579,to,0,0
190580,first,0,0
190581,skeletal-related,0,0
190582,event,0,0
190583,.,0,0
190584,Analysis,0,0
190585,was,0,0
190586,done,0,0
190587,on,0,0
190588,the,0,0
190589,intention-to-treat,0,0
190590,population,0,1
190591,.,0,0
190592,This,0,0
190593,study,0,0
190594,is,0,0
190595,registered,0,0
190596,with,0,0
190597,ClinicalTrials.gov,0,0
190598,",",0,0
190599,number,0,0
190600,NCT01212991,0,0
190601,.,0,0
190602,FINDINGS,0,0
190603,Median,0,0
190604,treatment,0,0
190605,duration,0,0
190606,was,0,0
190607,16?6,0,1
190608,months,0,0
190609,(,0,0
190610,IQR,0,0
190611,10?1-21?1,0,0
190612,),0,0
190613,in,0,0
190614,the,0,0
190615,enzalutamide,0,0
190616,group,0,0
190617,and,0,0
190618,4?6,0,0
190619,months,0,0
190620,(,0,0
190621,2?8-9?7,0,1
190622,),0,0
190623,in,0,0
190624,the,0,0
190625,placebo,0,0
190626,group,0,0
190627,.,0,0
190628,The,0,0
190629,mixed-effects,0,0
190630,model,0,0
190631,analyses,0,0
190632,showed,0,0
190633,significant,0,0
190634,treatment,0,0
190635,differences,0,0
190636,in,0,0
190637,change,0,0
190638,from,0,0
190639,baseline,0,0
190640,to,0,0
190641,week,0,0
190642,61,0,1
190643,with,0,1
190644,enzalutamide,0,0
190645,compared,0,0
190646,with,0,0
190647,placebo,0,0
190648,for,0,0
190649,most,0,0
190650,FACT-P,0,0
190651,endpoints,0,0
190652,and,0,0
190653,EQ-5D,0,0
190654,visual,0,0
190655,analogue,0,0
190656,scale,0,0
190657,.,0,0
190658,Median,0,0
190659,time,0,0
190660,to,0,0
190661,deterioration,0,0
190662,in,0,0
190663,FACT-P,0,0
190664,total,0,1
190665,score,0,0
190666,was,0,0
190667,11?3,0,0
190668,months,0,0
190669,(,0,0
190670,95,0,0
190671,%,0,0
190672,CI,0,0
190673,11?1-13?9,0,0
190674,),0,0
190675,in,0,0
190676,the,0,0
190677,enzalutamide,0,0
190678,group,0,0
190679,and,0,0
190680,5?6,0,0
190681,months,0,0
190682,(,0,0
190683,5?5-5?6,0,1
190684,),0,0
190685,in,0,0
190686,the,0,0
190687,placebo,0,0
190688,groups,0,0
190689,(,0,0
190690,hazard,0,0
190691,ratio,0,0
190692,[,0,0
190693,HR,0,0
190694,],0,0
190695,0?62,0,0
190696,[,0,0
190697,95,0,0
190698,%,0,0
190699,CI,0,0
190700,0?54-0?72,0,1
190701,],0,0
190702,;,0,0
190703,p,0,0
190704,<,0,0
190705,0?0001,0,0
190706,),0,0
190707,.,0,0
190708,A,0,0
190709,significantly,0,0
190710,greater,0,0
190711,proportion,0,0
190712,of,0,0
190713,patients,0,1
190714,in,0,0
190715,the,0,0
190716,enzalutamide,0,0
190717,group,0,0
190718,than,0,0
190719,in,0,0
190720,the,0,0
190721,placebo,0,0
190722,group,0,0
190723,reported,0,0
190724,clinically,0,0
190725,meaningful,0,0
190726,improvements,0,0
190727,in,0,0
190728,FACT-P,0,1
190729,total,0,1
190730,score,0,0
190731,(,0,0
190732,327,0,1
190733,[,0,0
190734,40,0,0
190735,%,0,0
190736,],0,0
190737,of,0,0
190738,826,0,1
190739,vs,0,0
190740,181,0,1
190741,[,0,0
190742,23,0,1
190743,%,0,0
190744,],0,0
190745,of,0,0
190746,790,0,1
190747,),0,0
190748,",",0,0
190749,in,0,0
190750,EQ-5D,0,0
190751,utility,0,0
190752,index,0,0
190753,(,0,0
190754,224,0,1
190755,[,0,0
190756,28,0,0
190757,%,0,0
190758,],0,0
190759,of,0,0
190760,812,0,1
190761,vs,0,0
190762,99,0,1
190763,[,0,0
190764,16,0,1
190765,%,0,0
190766,],0,0
190767,of,0,0
190768,623,0,1
190769,),0,0
190770,",",0,0
190771,and,0,0
190772,visual,0,0
190773,analogue,0,0
190774,scale,0,0
190775,(,0,0
190776,218,0,1
190777,[,0,0
190778,27,0,0
190779,%,0,0
190780,],0,0
190781,of,0,0
190782,803,0,1
190783,vs,0,0
190784,106,0,1
190785,of,0,0
190786,[,0,0
190787,18,0,1
190788,%,0,0
190789,],0,1
190790,603,0,1
190791,;,0,0
190792,all,0,0
190793,p,0,0
190794,<,0,0
190795,0?0001,0,0
190796,),0,0
190797,.,0,0
190798,Median,0,0
190799,time,0,0
190800,to,0,0
190801,progression,0,0
190802,in,0,0
190803,BPI-SF,0,0
190804,pain,0,0
190805,at,0,0
190806,its,0,0
190807,worst,0,0
190808,was,0,0
190809,5?7,0,1
190810,months,0,0
190811,(,0,0
190812,95,0,0
190813,%,0,0
190814,CI,0,0
190815,5?6-5?7,0,0
190816,),0,0
190817,in,0,0
190818,the,0,0
190819,enzalutamide,0,0
190820,group,0,0
190821,and,0,0
190822,5?6,0,0
190823,months,0,0
190824,(,0,0
190825,5?4-5?6,0,1
190826,),0,0
190827,in,0,0
190828,the,0,0
190829,placebo,0,0
190830,group,0,0
190831,(,0,0
190832,HR,0,0
190833,0?62,0,0
190834,[,0,0
190835,95,0,0
190836,%,0,0
190837,CI,0,0
190838,0?53-0?74,0,0
190839,],0,0
190840,;,0,0
190841,p,0,0
190842,<,0,0
190843,0?0001,0,0
190844,),0,0
190845,.,0,0
190846,Progression,0,0
190847,of,0,0
190848,pain,0,0
190849,at,0,0
190850,its,0,0
190851,worst,0,0
190852,was,0,0
190853,less,0,0
190854,common,0,0
190855,in,0,0
190856,the,0,0
190857,enzalutamide,0,0
190858,group,0,0
190859,than,0,0
190860,in,0,0
190861,the,0,0
190862,placebo,0,0
190863,group,0,0
190864,at,0,0
190865,week,0,0
190866,13,0,0
190867,(,0,0
190868,220,0,0
190869,[,0,0
190870,29,0,0
190871,%,0,0
190872,],0,0
190873,of,0,0
190874,769,0,1
190875,vs,0,0
190876,257,0,1
190877,[,0,0
190878,42,0,1
190879,%,0,0
190880,],0,0
190881,of,0,0
190882,610,0,1
190883,;,0,0
190884,p,0,0
190885,<,0,0
190886,0?0001,0,0
190887,),0,0
190888,",",0,0
190889,but,0,0
190890,not,0,0
190891,at,0,0
190892,week,0,0
190893,25,0,0
190894,(,0,0
190895,225,0,1
190896,[,0,0
190897,32,0,0
190898,%,0,0
190899,],0,0
190900,of,0,0
190901,705,0,1
190902,vs,0,0
190903,135,0,1
190904,[,0,0
190905,38,0,1
190906,%,0,0
190907,],0,0
190908,of,0,0
190909,360,0,1
190910,;,0,0
190911,p=0?068,0,0
190912,),0,0
190913,.,0,0
190914,278,0,0
190915,(,0,0
190916,32,0,1
190917,%,0,0
190918,),0,0
190919,of,0,0
190920,872,0,1
190921,patients,0,1
190922,in,0,0
190923,the,0,0
190924,enzalutamide,0,0
190925,group,0,0
190926,and,0,0
190927,309,0,1
190928,(,0,0
190929,37,0,1
190930,%,0,0
190931,),0,0
190932,of,0,0
190933,845,0,1
190934,patients,0,1
190935,in,0,0
190936,the,0,0
190937,placebo,0,0
190938,group,0,0
190939,had,0,0
190940,experienced,0,0
190941,a,0,0
190942,skeletal-related,0,0
190943,event,0,0
190944,by,0,0
190945,data,0,0
190946,cutoff,0,0
190947,.,0,0
190948,Median,0,0
190949,time,0,0
190950,to,0,0
190951,first,0,0
190952,skeletal-related,0,0
190953,events,0,0
190954,in,0,0
190955,the,0,0
190956,enzalutamide,0,0
190957,group,0,0
190958,was,0,0
190959,31?1,0,1
190960,months,0,0
190961,(,0,0
190962,95,0,0
190963,%,0,0
190964,CI,0,0
190965,29?5-not,0,0
190966,reached,0,0
190967,),0,0
190968,and,0,0
190969,31?3,0,1
190970,months,0,0
190971,(,0,0
190972,95,0,0
190973,%,0,0
190974,CI,0,0
190975,23?9-not,0,0
190976,reached,0,0
190977,),0,0
190978,in,0,0
190979,the,0,0
190980,placebo,0,0
190981,group,0,0
190982,(,0,0
190983,HR,0,0
190984,0?72,0,0
190985,[,0,0
190986,95,0,0
190987,%,0,0
190988,CI,0,0
190989,0?61-0?84,0,0
190990,],0,0
190991,;,0,0
190992,p,0,0
190993,<,0,0
190994,0?0001,0,0
190995,),0,0
190996,.,0,0
190997,INTERPRETATION,0,0
190998,In,0,0
190999,addition,0,0
191000,to,0,0
191001,improving,0,0
191002,overall,0,0
191003,survival,0,0
191004,relative,0,0
191005,to,0,0
191006,placebo,0,0
191007,",",0,0
191008,enzalutamide,0,0
191009,significantly,0,0
191010,improves,0,0
191011,patient-related,0,0
191012,outcomes,0,0
191013,and,0,0
191014,delays,0,0
191015,occurrence,0,0
191016,of,0,0
191017,first,0,0
191018,skeletal-related,0,0
191019,event,1,0
191020,in,1,0
191021,chemotherapy-naive,1,1
191022,men,1,1
191023,with,1,1
191024,metastatic,1,1
191025,castration-resistant,1,1
191026,prostate,1,1
191027,cancer,1,1
191028,.,0,0
191029,FUNDING,0,0
191030,Astellas,0,0
191031,Pharma,0,0
191032,and,0,0
191033,Medivation,0,0
191034,.,0,0
191035,Sedation,1,0
191036,during,1,0
191037,endoscopic,1,0
191038,retrograde,1,1
191039,cholangiopancreatography,1,0
191040,:,1,0
191041,a,0,0
191042,randomized,0,0
191043,controlled,0,0
191044,study,0,0
191045,of,0,0
191046,patient-controlled,0,0
191047,propofol,0,0
191048,sedation,0,0
191049,and,0,0
191050,that,0,0
191051,given,0,0
191052,by,0,0
191053,a,0,0
191054,nurse,0,0
191055,anesthetist,0,0
191056,.,0,0
191057,OBJECTIVE,0,0
191058,Different,0,0
191059,regimens,0,0
191060,are,0,0
191061,used,0,0
191062,for,0,0
191063,sedation,0,0
191064,during,0,0
191065,endoscopic,0,0
191066,retrograde,0,0
191067,cholangiopancreatography,0,0
191068,(,0,0
191069,ERCP,0,1
191070,),0,0
191071,.,0,0
191072,Our,0,0
191073,objectives,0,0
191074,were,0,0
191075,to,0,0
191076,compare,0,0
191077,safety,0,0
191078,",",0,0
191079,ease,0,0
191080,of,0,0
191081,treatment,0,0
191082,",",0,0
191083,recovery,0,0
191084,",",0,0
191085,and,0,0
191086,patients,1,1
191087,',1,1
191088,experiences,1,0
191089,using,1,0
191090,patient-controlled,1,0
191091,sedation,1,0
191092,(,1,0
191093,PCS,1,0
191094,),1,0
191095,with,1,0
191096,propofol,1,0
191097,",",1,0
191098,nurse,1,0
191099,anesthetist-controlled,1,0
191100,sedation,1,0
191101,(,1,0
191102,ACS,1,0
191103,),1,0
191104,",",1,0
191105,or,1,0
191106,the,1,0
191107,department,1,0
191108,'s,1,0
191109,standard,1,0
191110,of,1,0
191111,care,1,0
191112,",",1,0
191113,midazolam,1,0
191114,given,0,0
191115,by,0,0
191116,the,1,0
191117,procedure,1,0
191118,team,1,0
191119,(,1,0
191120,control,1,0
191121,group,1,0
191122,),1,0
191123,.,0,0
191124,MATERIAL,0,0
191125,AND,0,0
191126,METHODS,0,0
191127,The,1,0
191128,study,1,0
191129,included,1,1
191130,281,1,1
191131,adults,1,1
191132,in,1,0
191133,301,1,1
191134,procedures,1,1
191135,.,1,1
191136,The,0,0
191137,PCS,0,0
191138,group,0,0
191139,(,0,0
191140,n,0,1
191141,=,0,0
191142,101,0,1
191143,),0,0
191144,delivered,0,0
191145,bolus,0,0
191146,doses,0,0
191147,of,0,0
191148,5,0,0
191149,mg,0,0
191150,of,0,0
191151,propofol,0,0
191152,according,0,1
191153,to,0,0
191154,their,0,0
191155,need,0,0
191156,for,0,0
191157,sedation,0,0
191158,.,0,0
191159,The,0,0
191160,ACS,0,0
191161,group,0,0
191162,(,0,0
191163,n,0,1
191164,=,0,0
191165,100,0,1
191166,),0,0
191167,had,0,0
191168,2-8,0,0
191169,mg/kg/h,0,0
191170,of,0,0
191171,propofol,0,0
191172,infused,0,0
191173,",",0,0
191174,with,0,0
191175,the,0,0
191176,target,0,0
191177,for,0,0
191178,sedation,0,0
191179,being,0,0
191180,level,0,0
191181,3,0,0
191182,of,0,0
191183,the,0,0
191184,Observer,0,0
191185,'s,0,0
191186,Assessment,0,0
191187,of,0,0
191188,Alertness/Sedation,0,0
191189,(,0,0
191190,OAA/S,0,0
191191,),0,0
191192,scale,0,0
191193,.,0,0
191194,The,0,0
191195,control,0,0
191196,group,0,0
191197,was,0,0
191198,given,0,0
191199,2-3,0,0
191200,mg,0,0
191201,of,0,0
191202,midazolam,0,0
191203,for,0,0
191204,induction,0,0
191205,and,0,0
191206,additional,0,0
191207,1,0,0
191208,mg,0,0
191209,if,0,0
191210,required,0,0
191211,.,0,0
191212,RESULTS,0,0
191213,PCS,0,0
191214,and,0,0
191215,ACS,0,0
191216,increased,0,0
191217,the,0,0
191218,ease,0,0
191219,of,0,0
191220,the,0,0
191221,procedure,0,0
191222,and,0,0
191223,reduced,0,0
191224,the,0,0
191225,number,0,0
191226,of,0,0
191227,sedation,0,0
191228,failures,0,0
191229,compared,0,0
191230,to,0,0
191231,midazolam,0,0
191232,sedation,0,0
191233,(,0,0
191234,ACS,0,0
191235,n,0,0
191236,=,0,0
191237,0,0,0
191238,;,0,0
191239,PCS,0,0
191240,n,0,1
191241,=,0,0
191242,4,0,0
191243,;,0,0
191244,midazolam,0,0
191245,n,0,1
191246,=,0,0
191247,20,0,1
191248,),0,0
191249,.,0,0
191250,The,0,0
191251,ACS,0,0
191252,group,0,0
191253,had,0,0
191254,more,0,0
191255,deeply,0,0
191256,sedated,0,0
191257,patients,0,1
191258,(,0,0
191259,OAA/S,0,0
191260,level,0,0
191261,2,0,0
191262,),0,0
191263,",",0,0
191264,desaturation,0,0
191265,",",0,0
191266,and,0,0
191267,obstructed,0,0
191268,airways,0,0
191269,than,0,0
191270,the,0,0
191271,PCS,0,0
191272,and,0,0
191273,midazolam,0,0
191274,groups,0,0
191275,.,0,0
191276,Time,0,0
191277,to,0,0
191278,full,0,0
191279,recovery,0,0
191280,(,0,0
191281,Aldrete,0,0
191282,score,0,0
191283,?9,0,1
191284,),0,0
191285,was,0,0
191286,shortest,0,0
191287,following,0,0
191288,PCS,0,0
191289,.,0,1
191290,PCS,0,0
191291,resulted,0,0
191292,in,0,0
191293,the,0,0
191294,least,0,0
191295,fatigue,0,0
191296,and,0,0
191297,pain,0,0
191298,after,0,0
191299,the,0,0
191300,procedure,0,0
191301,.,0,0
191302,Patients,0,1
191303,',0,0
191304,preference,0,0
191305,for,0,0
191306,PCS,0,0
191307,and,0,0
191308,ACS,0,0
191309,was,0,0
191310,the,0,0
191311,same,0,0
191312,.,0,0
191313,CONCLUSION,0,0
191314,PCS,0,0
191315,with,0,0
191316,propofol,0,0
191317,is,0,0
191318,superior,0,0
191319,to,0,0
191320,midazolam,0,0
191321,and,0,0
191322,comparable,0,0
191323,to,0,0
191324,ACS,0,0
191325,.,0,0
191326,PCS,0,0
191327,resulted,0,0
191328,in,0,0
191329,a,0,0
191330,rapid,0,0
191331,recovery,0,0
191332,",",0,0
191333,fewer,0,0
191334,respiratory,0,0
191335,events,0,0
191336,",",0,0
191337,and,0,0
191338,was,0,0
191339,almost,0,0
191340,as,0,0
191341,effective,0,0
191342,as,0,0
191343,ACS,0,0
191344,in,0,0
191345,ensuring,0,0
191346,a,0,0
191347,successful,0,0
191348,examination,0,0
191349,.,0,0
191350,Differential,0,1
191351,effect,0,0
191352,of,0,0
191353,aspirin,0,0
191354,on,0,0
191355,thromboxane,1,0
191356,and,1,0
191357,prostaglandin,1,0
191358,biosynthesis,1,0
191359,in,1,0
191360,man,1,1
191361,.,1,1
191362,1,0,0
191363,.,0,0
191364,Effects,0,0
191365,of,0,0
191366,a,0,0
191367,single,0,0
191368,intravenous,0,0
191369,dose,0,0
191370,of,0,0
191371,aspirin,0,0
191372,(,0,0
191373,600,0,0
191374,mg,0,0
191375,),0,0
191376,on,0,0
191377,bradykinin-stimulated,0,0
191378,prostaglandin,0,0
191379,(,0,0
191380,PG,0,0
191381,),0,0
191382,and,0,0
191383,on,0,0
191384,thromboxane,0,0
191385,(,0,0
191386,TX,0,0
191387,),0,0
191388,biosynthesis,0,0
191389,were,0,0
191390,determined,0,0
191391,in,0,0
191392,nine,1,1
191393,healthy,1,1
191394,male,1,1
191395,volunteers,1,1
191396,.,1,1
191397,Plasma,0,0
191398,concentrations,0,0
191399,of,0,0
191400,6-oxo-PGF1,0,0
191401,alpha,0,0
191402,and,0,0
191403,"13,14-dihydro-15-oxo-PGF2",0,0
191404,alpha,0,0
191405,were,0,0
191406,measured,0,0
191407,in,0,0
191408,samples,0,0
191409,obtained,0,0
191410,during,0,0
191411,repeated,0,0
191412,10,0,1
191413,min,0,0
191414,intravenous,0,0
191415,infusions,0,0
191416,of,0,0
191417,bradykinin,0,0
191418,before,0,0
191419,and,0,0
191420,up,0,0
191421,to,0,0
191422,6,0,0
191423,h,0,0
191424,after,0,0
191425,the,0,0
191426,dose,0,0
191427,of,0,0
191428,aspirin,0,0
191429,.,0,0
191430,TXB2,0,0
191431,was,0,0
191432,measured,0,0
191433,in,0,0
191434,serum,0,0
191435,from,0,0
191436,blood,0,0
191437,allowed,0,0
191438,to,0,0
191439,clot,0,0
191440,at,0,0
191441,37,0,1
191442,degrees,0,0
191443,C.,0,0
191444,2,0,1
191445,.,0,0
191446,Aspirin,0,0
191447,inhibited,0,0
191448,bradykinin,0,0
191449,stimulated,0,0
191450,PG,0,0
191451,and,0,0
191452,platelet,0,0
191453,TX,0,0
191454,biosynthesis,0,0
191455,0.5,0,0
191456,h,0,0
191457,after,0,0
191458,the,0,0
191459,dose,0,0
191460,.,0,0
191461,Serum,0,0
191462,TXB2,0,0
191463,remained,0,0
191464,low,0,0
191465,",",0,0
191466,whereas,0,0
191467,PG,0,0
191468,synthesis,0,0
191469,recovered,0,0
191470,within,0,0
191471,6,0,0
191472,h.,0,1
191473,3,0,0
191474,.,0,1
191475,Effects,0,0
191476,of,0,0
191477,intravenous,0,0
191478,sodium,0,0
191479,salicylate,0,0
191480,(,0,0
191481,600,0,0
191482,mg,0,0
191483,),0,0
191484,were,0,0
191485,studied,0,0
191486,identically,0,0
191487,in,0,0
191488,eight,0,1
191489,subjects,0,1
191490,.,0,1
191491,Prostanoid,0,0
191492,biosynthesis,0,0
191493,was,0,0
191494,not,0,0
191495,inhibited,0,0
191496,.,0,0
191497,4,0,0
191498,.,0,0
191499,Biosynthesis,0,0
191500,of,0,0
191501,prostacyclin,0,0
191502,and,0,0
191503,TXA2,0,0
191504,under,0,0
191505,basal,0,0
191506,conditions,0,0
191507,was,0,0
191508,studied,0,1
191509,in,0,0
191510,eight,0,1
191511,subjects,0,1
191512,by,0,0
191513,measuring,0,0
191514,"2,3-dinor-6-oxo-PGF1",0,0
191515,alpha,0,0
191516,and,0,0
191517,"2,3-dinor-TXB2",0,0
191518,in,0,0
191519,hourly,0,0
191520,urine,0,0
191521,samples,0,0
191522,obtained,0,0
191523,during,0,0
191524,and,0,0
191525,after,0,0
191526,intravenous,0,0
191527,infusion,0,0
191528,of,0,0
191529,aspirin,0,0
191530,and,0,0
191531,",",0,0
191532,on,0,0
191533,a,0,0
191534,separate,0,0
191535,occasion,0,0
191536,",",0,0
191537,of,0,0
191538,vehicle,0,0
191539,.,0,1
191540,5,0,0
191541,.,0,0
191542,Aspirin,0,0
191543,infusion,0,0
191544,reduced,0,0
191545,urinary,0,0
191546,excretion,0,0
191547,of,0,0
191548,both,0,0
191549,metabolites,0,0
191550,greater,0,0
191551,than,0,0
191552,90,0,0
191553,%,0,0
191554,",",0,0
191555,but,0,0
191556,excretion,0,0
191557,of,0,0
191558,"2,3-dinor-6-oxo-PGF1",0,0
191559,alpha,0,0
191560,recovered,0,0
191561,more,0,0
191562,rapidly,0,0
191563,than,0,0
191564,did,0,0
191565,that,0,0
191566,of,0,0
191567,"2,3-dinor-TXB2",0,1
191568,.,0,1
191569,6,0,0
191570,.,0,0
191571,We,0,0
191572,conclude,0,0
191573,that,0,0
191574,cyclo-oxygenase,0,0
191575,is,0,0
191576,rapidly,0,0
191577,synthesised,0,0
191578,in,0,0
191579,bradykinin-responsive,0,0
191580,tissues,0,0
191581,in,0,0
191582,vivo,0,0
191583,and,0,0
191584,that,0,0
191585,this,0,0
191586,reflects,0,0
191587,similarly,0,0
191588,rapid,0,0
191589,enzyme,0,0
191590,biosynthesis,0,0
191591,in,0,0
191592,tissues,0,0
191593,that,0,0
191594,produce,0,0
191595,PGI2,0,0
191596,under,0,0
191597,basal,0,0
191598,conditions,0,0
191599,.,0,1
191600,Effect,0,0
191601,of,0,0
191602,cooling,0,0
191603,proparacaine,0,0
191604,0.5,1,0
191605,%,1,0
191606,eye,1,0
191607,drops,1,0
191608,on,1,0
191609,patient,1,0
191610,'s,1,0
191611,comfort,1,0
191612,during,1,0
191613,instillation,1,0
191614,.,1,0
191615,Three-year,0,1
191616,efficacy,0,0
191617,and,0,0
191618,safety,0,0
191619,of,0,0
191620,a,0,0
191621,new,0,0
191622,52-mg,0,0
191623,levonorgestrel-releasing,0,0
191624,intrauterine,0,1
191625,system,0,0
191626,.,0,0
191627,OBJECTIVE,0,0
191628,To,0,0
191629,assess,0,0
191630,3-year,0,0
191631,data,0,0
191632,on,0,0
191633,the,0,0
191634,efficacy,0,0
191635,and,0,0
191636,safety,0,0
191637,of,0,0
191638,a,0,0
191639,new,0,0
191640,52-mg,0,0
191641,levonorgestrel,1,0
191642,intrauterine,1,0
191643,contraceptive,1,0
191644,(,1,0
191645,LNG20,1,0
191646,),1,0
191647,designed,0,0
191648,for,0,0
191649,up,0,0
191650,to,0,0
191651,7,0,0
191652,years,0,1
191653,use,0,0
191654,.,0,0
191655,STUDY,0,0
191656,DESIGN,0,0
191657,Nulliparous,1,1
191658,and,1,0
191659,parous,1,1
191660,women,1,1
191661,aged,1,1
191662,16-45,1,1
191663,years,1,1
191664,at,1,0
191665,enrollment,1,1
191666,with,1,1
191667,regular,1,0
191668,menstrual,1,1
191669,cycles,1,0
191670,and,1,0
191671,requesting,1,1
191672,contraception,1,1
191673,were,1,0
191674,enrolled,1,1
191675,in,1,0
191676,an,1,0
191677,open-label,1,0
191678,",",0,0
191679,partially,0,0
191680,randomized,0,0
191681,trial,0,0
191682,to,0,0
191683,evaluate,0,0
191684,LNG20,0,0
191685,.,0,0
191686,The,0,0
191687,primary,0,0
191688,outcome,0,0
191689,was,0,0
191690,pregnancy,0,1
191691,rate,0,0
191692,for,0,0
191693,women,0,1
191694,aged,0,1
191695,16-35,0,1
191696,years,0,1
191697,calculated,0,0
191698,as,0,0
191699,the,0,0
191700,Pearl,0,0
191701,Index,0,0
191702,.,0,0
191703,Women,1,0
191704,aged,1,1
191705,36-45,1,0
191706,years,1,1
191707,received,1,0
191708,LNG20,1,0
191709,for,1,0
191710,safety,1,0
191711,evaluation,1,0
191712,only,1,0
191713,.,1,0
191714,All,0,0
191715,participants,0,0
191716,had,0,0
191717,in-person,0,0
191718,or,0,0
191719,phone,0,0
191720,follow-up,0,0
191721,approximately,0,0
191722,every,0,0
191723,3,0,0
191724,months,0,0
191725,during,0,0
191726,the,0,0
191727,study,0,0
191728,.,0,0
191729,RESULTS,0,0
191730,A,0,0
191731,total,1,0
191732,of,1,0
191733,1600,1,0
191734,women,1,1
191735,aged,1,1
191736,16-35,1,1
191737,years,1,1
191738,and,1,0
191739,151,1,1
191740,women,1,1
191741,aged,1,1
191742,36-45,1,1
191743,years,1,1
191744,agreed,1,1
191745,to,1,0
191746,LNG20,1,0
191747,placement,1,0
191748,",",1,0
191749,including,1,0
191750,1011,1,1
191751,(,1,0
191752,57.7,1,0
191753,%,1,0
191754,),1,0
191755,nulliparous,1,1
191756,and,1,0
191757,438,1,1
191758,(,1,0
191759,25.1,1,0
191760,%,1,0
191761,),1,0
191762,obese,1,1
191763,women,1,1
191764,.,1,1
191765,Successful,1,0
191766,placement,1,0
191767,occurred,1,0
191768,in,1,0
191769,1714,1,1
191770,(,1,0
191771,97.9,1,0
191772,%,1,0
191773,),1,0
191774,women,1,1
191775,.,1,1
191776,Six,1,1
191777,pregnancies,1,1
191778,occurred,1,0
191779,",",1,0
191780,four,1,0
191781,of,1,0
191782,which,1,0
191783,were,1,0
191784,ectopic,1,0
191785,.,1,0
191786,The,0,0
191787,Pearl,0,0
191788,Index,0,0
191789,for,0,0
191790,LNG20,0,0
191791,was,0,0
191792,0.15,0,0
191793,(,0,0
191794,95,0,0
191795,%,0,0
191796,CI,0,0
191797,0.02-0.55,0,0
191798,),0,0
191799,through,0,0
191800,Year,0,1
191801,1,0,0
191802,",",0,0
191803,0.26,0,0
191804,(,0,0
191805,95,0,0
191806,%,0,0
191807,CI,0,0
191808,0.10-0.57,0,0
191809,),0,0
191810,through,0,0
191811,Year,0,1
191812,2,0,0
191813,",",0,0
191814,and,0,0
191815,0.22,0,0
191816,(,0,0
191817,95,0,0
191818,%,0,0
191819,CI,0,0
191820,0.08-0.49,0,0
191821,),0,0
191822,through,0,0
191823,Year,0,1
191824,3,0,0
191825,.,0,0
191826,The,0,0
191827,cumulative,0,0
191828,life-table,0,0
191829,pregnancy,0,1
191830,rate,0,0
191831,was,0,0
191832,0.55,0,0
191833,(,0,0
191834,95,0,0
191835,%,0,0
191836,CI,0,0
191837,0.24-1.23,0,0
191838,),0,0
191839,through,0,0
191840,3,0,0
191841,years,0,1
191842,.,0,1
191843,Expulsion,0,0
191844,was,0,0
191845,reported,0,0
191846,in,0,0
191847,62,0,1
191848,(,0,0
191849,3.5,0,0
191850,%,0,0
191851,),0,0
191852,participants,0,1
191853,",",0,0
191854,most,0,0
191855,(,0,0
191856,50,0,0
191857,[,0,0
191858,80.6,0,0
191859,%,0,0
191860,],0,0
191861,),0,0
191862,during,0,0
191863,the,0,0
191864,first,0,0
191865,year,0,0
191866,of,0,0
191867,use,0,0
191868,.,0,0
191869,Of,0,1
191870,women,1,1
191871,who,1,1
191872,discontinued,1,1
191873,LNG20,1,1
191874,and,1,0
191875,desired,1,0
191876,pregnancy,1,1
191877,",",0,0
191878,86.8,0,0
191879,%,0,0
191880,conceived,0,0
191881,spontaneously,0,0
191882,within,0,0
191883,12,0,0
191884,months,0,0
191885,.,0,1
191886,Pelvic,0,0
191887,infection,0,0
191888,was,0,0
191889,diagnosed,0,1
191890,in,0,0
191891,10,1,0
191892,(,1,0
191893,0.6,1,0
191894,%,1,0
191895,),1,0
191896,women,1,1
191897,.,1,0
191898,Only,0,0
191899,26,1,0
191900,(,1,0
191901,1.5,1,0
191902,%,1,0
191903,),1,0
191904,LNG20,1,0
191905,users,0,1
191906,discontinued,0,0
191907,due,0,0
191908,to,0,0
191909,bleeding,0,0
191910,complaints,0,0
191911,.,0,0
191912,CONCLUSION,0,0
191913,The,0,0
191914,LNG20,0,0
191915,intrauterine,0,0
191916,system,0,0
191917,is,0,0
191918,highly,0,0
191919,effective,0,0
191920,and,0,0
191921,safe,0,0
191922,over,0,0
191923,3,0,0
191924,years,0,1
191925,of,0,0
191926,use,0,0
191927,in,0,0
191928,nulliparous,1,1
191929,and,1,0
191930,parous,1,1
191931,women,1,1
191932,.,1,1
191933,IMPLICATIONS,0,0
191934,STATEMENT,0,0
191935,A,0,0
191936,new,0,0
191937,52-mg,0,0
191938,levonorgestrel-releasing,0,0
191939,intrauterine,0,0
191940,system,0,0
191941,is,0,0
191942,effective,0,0
191943,and,0,0
191944,safe,0,0
191945,for,0,0
191946,nulliparous,0,1
191947,and,0,0
191948,parous,0,1
191949,women,0,1
191950,for,0,0
191951,at,0,0
191952,least,0,0
191953,3,0,0
191954,years,0,1
191955,.,0,1
191956,The,0,0
191957,effects,0,0
191958,of,0,0
191959,preoperative,0,0
191960,oral,0,0
191961,pregabalin,0,0
191962,and,0,0
191963,perioperative,0,0
191964,intravenous,0,0
191965,lidocaine,0,0
191966,infusion,0,0
191967,on,0,0
191968,postoperative,0,0
191969,morphine,0,0
191970,requirement,0,0
191971,in,0,0
191972,patients,1,1
191973,undergoing,1,1
191974,laparatomy,1,0
191975,.,1,0
191976,OBJECTIVES,0,0
191977,To,0,0
191978,evaluate,0,0
191979,and,0,0
191980,compare,0,0
191981,the,0,0
191982,effects,0,0
191983,of,0,0
191984,preoperative,0,0
191985,oral,0,0
191986,pregabalin,0,0
191987,and,0,0
191988,perioperative,0,0
191989,intravenous,0,0
191990,lidocaine,0,0
191991,infusion,0,0
191992,on,0,0
191993,postoperative,0,0
191994,morphine,0,0
191995,requirement,0,0
191996,",",0,0
191997,adverse,0,0
191998,effects,0,0
191999,",",0,0
192000,patients,0,1
192001,',0,0
192002,satisfaction,0,0
192003,",",0,0
192004,mobilization,0,0
192005,",",0,0
192006,time,0,0
192007,to,0,0
192008,first,0,0
192009,defecation,0,0
192010,and,0,0
192011,time,0,0
192012,to,0,0
192013,discharge,0,0
192014,in,0,0
192015,patients,0,1
192016,undergoing,0,1
192017,laparotomy,0,1
192018,.,0,0
192019,METHODS,0,0
192020,Eighty,1,1
192021,patients,1,1
192022,(,1,0
192023,18,1,1
192024,to,1,0
192025,65,1,1
192026,years,1,1
192027,of,1,0
192028,age,1,1
192029,),1,0
192030,undergoing,1,1
192031,elective,1,1
192032,laparotomy,1,1
192033,were,0,0
192034,randomly,0,0
192035,divided,0,0
192036,into,0,0
192037,four,0,0
192038,groups,0,0
192039,(,0,0
192040,n=20,0,1
192041,in,0,0
192042,each,0,0
192043,group,0,0
192044,),0,0
192045,:,0,1
192046,group,0,0
192047,C,0,0
192048,",",0,0
192049,placebo,0,0
192050,capsules,0,0
192051,and,0,0
192052,normal,0,1
192053,saline,0,0
192054,infusion,0,0
192055,perioperatively,0,0
192056,(,0,0
192057,control,0,0
192058,),0,0
192059,;,0,0
192060,group,0,0
192061,L,0,0
192062,",",0,0
192063,placebo,0,0
192064,capsules,0,0
192065,and,0,0
192066,lidocaine,0,0
192067,1,0,0
192068,mg?kg,0,1
192069,intravenous,0,0
192070,bolus,0,0
192071,dose,0,0
192072,followed,0,0
192073,by,0,0
192074,2,0,0
192075,mg?kg?h,0,0
192076,infusion,0,0
192077,until,0,0
192078,skin,0,0
192079,closure,0,1
192080,;,0,0
192081,group,0,0
192082,P,0,0
192083,",",0,0
192084,150,0,0
192085,mg,0,0
192086,oral,0,0
192087,pregabalin,0,0
192088,and,0,0
192089,normal,0,1
192090,saline,0,0
192091,infusion,0,0
192092,perioperatively,0,0
192093,;,0,0
192094,and,0,0
192095,group,0,0
192096,PL,0,0
192097,",",0,0
192098,150,0,0
192099,&,0,1
192100,nbsp,0,0
192101,;,0,0
192102,mg,0,0
192103,oral,0,0
192104,pregabalin,0,0
192105,and,0,0
192106,lidocaine,0,0
192107,2,0,0
192108,mg?kg?h,0,0
192109,infusion,0,0
192110,until,0,0
192111,skin,0,0
192112,closure,0,1
192113,.,0,0
192114,Hemodynamic,0,0
192115,parameters,0,0
192116,",",0,0
192117,visual,0,0
192118,analogue,0,0
192119,scale,0,0
192120,(,0,0
192121,VAS,0,0
192122,),0,0
192123,scores,0,0
192124,",",0,0
192125,analgesic,0,0
192126,consumption,0,0
192127,",",0,0
192128,side,0,0
192129,effects,0,0
192130,",",0,0
192131,time,0,0
192132,to,0,0
192133,mobilization,0,0
192134,",",0,0
192135,time,0,0
192136,to,0,0
192137,first,0,0
192138,defecation,0,0
192139,",",0,0
192140,time,0,0
192141,to,0,0
192142,discharge,0,0
192143,and,0,0
192144,patients,0,1
192145,',0,0
192146,satisfaction,0,0
192147,were,0,0
192148,recorded,0,0
192149,.,0,0
192150,RESULTS,0,0
192151,VAS,0,0
192152,scores,0,0
192153,of,0,0
192154,group,0,0
192155,L,0,0
192156,",",0,0
192157,group,0,0
192158,P,0,0
192159,and,0,0
192160,group,0,0
192161,PL,0,0
192162,were,0,0
192163,lower,0,0
192164,than,0,0
192165,group,0,0
192166,C,0,0
192167,(,0,0
192168,P,0,0
192169,<,0,0
192170,0.05,0,0
192171,),0,0
192172,.,0,0
192173,Morphine,0,0
192174,consumption,0,0
192175,of,0,0
192176,group,0,0
192177,P,0,0
192178,and,0,0
192179,group,0,0
192180,PL,0,0
192181,was,0,0
192182,lower,0,0
192183,than,0,0
192184,group,0,0
192185,C,0,0
192186,(,0,0
192187,P,0,0
192188,<,0,0
192189,0.05,0,0
192190,),0,0
192191,.,0,0
192192,Incidence,0,0
192193,of,0,0
192194,nausea,0,0
192195,in,0,0
192196,group,0,0
192197,C,0,0
192198,was,0,0
192199,higher,0,0
192200,than,0,0
192201,group,0,0
192202,L,0,0
192203,and,0,0
192204,group,0,0
192205,PL,0,0
192206,.,0,0
192207,Time,0,0
192208,to,0,0
192209,first,0,0
192210,defecation,0,0
192211,and,0,0
192212,mobilization,0,0
192213,were,0,0
192214,shorter,0,0
192215,in,0,0
192216,group,0,0
192217,L,0,0
192218,and,0,0
192219,group,0,0
192220,PL,0,0
192221,compared,0,0
192222,with,0,1
192223,group,0,0
192224,C,0,0
192225,(,0,0
192226,P,0,0
192227,<,0,0
192228,0.05,0,0
192229,),0,0
192230,.,0,0
192231,CONCLUSION,0,0
192232,Preoperative,0,0
192233,oral,0,0
192234,pregabalin,0,0
192235,and,0,0
192236,perioperative,0,0
192237,intravenous,0,0
192238,lidocaine,0,0
192239,infusion,0,0
192240,decreased,0,0
192241,postoperative,0,0
192242,VAS,0,1
192243,scores,0,0
192244,.,0,1
192245,Preoperative,0,0
192246,oral,0,0
192247,pregabalin,0,0
192248,decreased,0,0
192249,morphine,0,0
192250,requirement,0,0
192251,and,0,0
192252,perioperative,0,0
192253,intravenous,0,0
192254,lidocaine,0,0
192255,infusion,0,0
192256,hastened,0,0
192257,gastrointestinal,0,1
192258,motility,0,0
192259,and,0,0
192260,mobilization,0,0
192261,",",0,0
192262,and,0,0
192263,decreased,0,0
192264,the,0,0
192265,incidence,0,0
192266,of,0,0
192267,nausea,0,0
192268,in,0,0
192269,patients,0,1
192270,undergoing,0,1
192271,laparotomy,0,1
192272,.,0,0
192273,Therefore,0,0
192274,",",0,0
192275,preoperative,0,0
192276,pregabalin,0,0
192277,with,0,1
192278,or,0,0
192279,without,0,0
192280,lidocaine,0,0
192281,provides,0,0
192282,superior,0,0
192283,pain,0,0
192284,relief,0,0
192285,in,0,0
192286,patients,0,1
192287,undergoing,0,1
192288,laparatomy,0,1
192289,.,0,0
192290,Comparison,0,0
192291,of,0,0
192292,the,0,0
192293,neuroprotective,0,0
192294,effects,0,0
192295,and,0,0
192296,recovery,0,0
192297,profiles,0,0
192298,of,0,0
192299,isoflurane,0,0
192300,",",0,0
192301,sevoflurane,0,0
192302,and,0,0
192303,desflurane,0,0
192304,as,0,0
192305,neurosurgical,0,1
192306,pre-conditioning,0,0
192307,on,0,0
192308,ischemia/reperfusion,1,0
192309,cerebral,1,1
192310,injury,1,0
192311,.,1,0
192312,BACKGROUND,0,0
192313,There,0,0
192314,are,0,0
192315,a,0,0
192316,few,0,0
192317,reports,0,0
192318,regarding,0,0
192319,the,0,0
192320,comparison,0,0
192321,of,0,0
192322,these,0,0
192323,anesthetic,0,0
192324,agents,0,0
192325,",",0,0
192326,but,0,0
192327,previous,0,0
192328,studies,0,0
192329,mainly,0,0
192330,focus,0,0
192331,on,0,0
192332,the,0,0
192333,veterinary,0,1
192334,anesthesiology,0,1
192335,.,0,0
192336,Less,0,0
192337,attention,0,0
192338,has,0,0
192339,been,0,0
192340,focused,0,0
192341,comparing,0,0
192342,the,0,0
192343,effectiveness,0,0
192344,of,0,0
192345,these,0,0
192346,inhalational,0,0
192347,anesthetic,0,0
192348,agents,0,0
192349,in,0,0
192350,neurosurgery,1,0
192351,.,1,0
192352,This,0,0
192353,lack,0,0
192354,of,0,0
192355,interest,0,0
192356,is,0,0
192357,regretful,0,0
192358,particularly,0,0
192359,considering,0,0
192360,the,0,0
192361,fact,0,0
192362,that,0,0
192363,anesthetics,0,0
192364,during,0,0
192365,neurosurgery,0,0
192366,are,0,0
192367,an,0,0
192368,issue,0,0
192369,of,0,0
192370,extreme,0,0
192371,sensitivity,0,0
192372,and,0,0
192373,subtlety,0,0
192374,",",0,0
192375,where,0,0
192376,the,0,0
192377,cerebral,0,0
192378,oxygenation,0,0
192379,process,0,0
192380,plays,0,0
192381,a,0,0
192382,significant,0,0
192383,role,0,0
192384,in,0,0
192385,the,0,0
192386,neuroprotective,0,0
192387,mechanisms,0,0
192388,.,0,0
192389,OBJECTIVE,0,0
192390,The,0,0
192391,purpose,0,0
192392,of,0,0
192393,this,0,0
192394,retrospective,0,0
192395,study,0,0
192396,is,0,0
192397,to,0,0
192398,contribute,0,0
192399,to,0,0
192400,the,0,0
192401,existing,0,0
192402,knowledge,0,0
192403,of,0,0
192404,the,0,0
192405,comparative,0,0
192406,studies,0,0
192407,of,0,0
192408,the,0,0
192409,volatile,0,0
192410,anesthetic,0,0
192411,agents,0,0
192412,such,0,0
192413,as,0,0
192414,isoflurane,0,0
192415,",",0,0
192416,sevoflurane,0,0
192417,and,0,0
192418,desflurane,0,0
192419,by,0,0
192420,evaluating,0,0
192421,the,0,0
192422,maintenance,0,0
192423,and,0,0
192424,emergence,0,0
192425,characteristics,0,0
192426,after,0,0
192427,volatile,0,0
192428,anesthetics-induced,0,0
192429,preconditioning,0,0
192430,with,0,0
192431,isoflurane,0,0
192432,",",0,0
192433,sevoflurane,0,0
192434,or,0,0
192435,desflurane,0,0
192436,for,0,0
192437,inpatient,1,1
192438,ischemia/reperfusion,1,0
192439,cerebral,1,1
192440,injury,1,0
192441,during,1,0
192442,cerebral,1,1
192443,or,1,1
192444,neural,1,0
192445,surgeries,1,1
192446,.,1,1
192447,METHODS,0,0
192448,The,0,0
192449,aim,0,0
192450,was,0,0
192451,to,0,0
192452,investigate,0,0
192453,their,0,0
192454,neuroprotective,0,0
192455,mechanisms,0,0
192456,and,0,0
192457,effects,0,0
192458,by,0,0
192459,analyzing,0,0
192460,and,0,0
192461,comparing,0,0
192462,the,0,0
192463,superiority,0,0
192464,of,0,0
192465,each,0,0
192466,agent,0,0
192467,in,0,0
192468,a,0,0
192469,Chinese,1,1
192470,patient,1,0
192471,population,1,1
192472,",",0,0
192473,in,0,0
192474,terms,0,0
192475,of,0,0
192476,faster,0,0
192477,emergence,0,0
192478,",",0,0
192479,and,0,0
192480,early,0,0
192481,and,0,0
192482,intermediate,0,0
192483,recovery,0,0
192484,.,0,0
192485,The,0,0
192486,intraoperative,0,0
192487,haemodynamic,0,0
192488,profiles,0,0
192489,and,0,0
192490,postoperative,0,0
192491,adverse,0,0
192492,effects,0,0
192493,of,0,0
192494,these,0,0
192495,three,0,0
192496,agents,0,0
192497,were,0,0
192498,also,0,0
192499,systematically,0,0
192500,analyzed,0,0
192501,.,0,0
192502,RESULTS,0,0
192503,We,0,0
192504,found,0,0
192505,that,0,0
192506,sevoflurane,0,0
192507,",",0,0
192508,when,0,0
192509,compared,0,0
192510,with,0,0
192511,isoflurane,0,0
192512,and,0,0
192513,desflurane,0,0
192514,",",0,0
192515,provided,0,0
192516,anesthesia,0,0
192517,with,0,1
192518,similar,0,0
192519,hemodynamic,0,0
192520,stability,0,0
192521,but,0,0
192522,allowed,0,0
192523,for,0,0
192524,a,0,0
192525,smoother,0,0
192526,",",0,0
192527,more,0,0
192528,rapid,0,0
192529,emergence,0,0
192530,and,0,0
192531,better,0,0
192532,quality,0,0
192533,of,0,0
192534,induction,0,0
192535,and,0,0
192536,recovery,0,0
192537,to,0,0
192538,surgical,1,1
192539,patients,1,1
192540,under,1,1
192541,clinical,1,0
192542,conditions,1,0
192543,",",0,0
192544,particularly,0,0
192545,to,0,0
192546,those,0,1
192547,who,0,1
192548,were,0,1
192549,experiencing,1,1
192550,substantial,1,0
192551,cerebral,1,1
192552,vasodilation,1,0
192553,.,1,0
192554,CONCLUSION,0,0
192555,Sevoflurane,0,0
192556,offers,0,0
192557,several,0,0
192558,advantages,0,0
192559,",",0,0
192560,including,0,0
192561,a,0,0
192562,relative,0,0
192563,lack,0,0
192564,of,0,0
192565,airway,0,0
192566,irritation,0,0
192567,",",0,0
192568,a,0,0
192569,more,0,0
192570,rapid,0,0
192571,onset,0,0
192572,and,0,0
192573,recovery,0,0
192574,",",0,0
192575,and,0,0
192576,greater,0,0
192577,hemodynamic,0,0
192578,stability,0,0
192579,than,0,0
192580,other,0,0
192581,potent,0,0
192582,inhaled,0,0
192583,agents,0,0
192584,.,0,1
192585,These,0,0
192586,properties,0,0
192587,would,0,0
192588,appear,0,0
192589,to,0,0
192590,afford,0,0
192591,sevoflurane,0,0
192592,significant,0,0
192593,clinical,0,0
192594,potential,0,0
192595,.,0,0
192596,The,0,0
192597,effects,0,0
192598,of,0,0
192599,bromazepam,1,0
192600,over,1,0
192601,the,1,0
192602,central,1,0
192603,and,1,0
192604,frontal,1,0
192605,areas,1,0
192606,during,1,0
192607,a,1,0
192608,motor,1,0
192609,task,1,0
192610,:,1,1
192611,an,0,0
192612,EEG,0,0
192613,study,0,0
192614,.,0,0
192615,The,0,0
192616,present,0,0
192617,study,0,0
192618,investigates,0,0
192619,the,0,0
192620,influence,0,0
192621,of,0,0
192622,bromazepam,1,0
192623,while,1,0
192624,executing,1,0
192625,a,1,0
192626,motor,1,0
192627,task,1,0
192628,.,1,0
192629,Specifically,0,0
192630,",",0,0
192631,we,0,0
192632,intend,0,0
192633,to,0,0
192634,analyze,0,0
192635,the,0,0
192636,changes,0,0
192637,in,0,0
192638,alpha,0,0
192639,absolute,0,0
192640,power,0,0
192641,under,0,0
192642,two,0,0
192643,experimental,0,0
192644,conditions,0,0
192645,",",0,0
192646,bromazepam,0,0
192647,and,0,0
192648,placebo,0,0
192649,.,0,0
192650,We,0,0
192651,also,0,0
192652,included,0,1
192653,analyses,0,0
192654,of,0,0
192655,theta,0,0
192656,and,0,0
192657,beta,0,0
192658,frequencies,0,0
192659,.,0,0
192660,We,1,0
192661,collected,1,0
192662,electroencephalographic,1,1
192663,data,1,0
192664,before,1,0
192665,",",1,0
192666,during,1,0
192667,",",1,0
192668,and,1,0
192669,after,1,0
192670,motor,1,0
192671,task,1,0
192672,execution,1,0
192673,.,1,0
192674,We,0,0
192675,used,0,0
192676,a,0,0
192677,Two,0,1
192678,Way,0,0
192679,ANOVA,0,0
192680,to,0,0
192681,investigate,0,0
192682,the,0,0
192683,condition,0,0
192684,(,0,0
192685,PL,0,0
192686,?,0,0
192687,Br6,0,0
192688,mg,0,0
192689,),0,0
192690,and,0,0
192691,moment,0,0
192692,(,0,0
192693,pre,0,0
192694,and,0,0
192695,post,0,0
192696,),0,0
192697,variables,0,0
192698,for,0,0
192699,the,0,0
192700,following,0,0
192701,electrodes,0,0
192702,:,0,1
192703,Fp1,0,0
192704,",",0,0
192705,Fp2,0,0
192706,",",0,0
192707,F7,0,0
192708,",",0,0
192709,F3,0,0
192710,",",0,0
192711,Fz,0,0
192712,",",0,0
192713,F4,0,0
192714,",",0,0
192715,F8,0,0
192716,",",0,0
192717,C3,0,0
192718,",",0,0
192719,CZ,0,0
192720,and,0,0
192721,C4,0,0
192722,.,0,0
192723,We,0,0
192724,found,0,0
192725,a,0,0
192726,main,0,0
192727,effect,0,0
192728,for,0,0
192729,condition,0,0
192730,on,0,0
192731,the,0,0
192732,electrodes,0,0
192733,FP1,0,1
192734,",",0,0
192735,F7,0,0
192736,",",0,0
192737,F3,0,0
192738,",",0,0
192739,Fz,0,0
192740,",",0,0
192741,F4,0,0
192742,",",0,0
192743,C3,0,1
192744,and,0,0
192745,CZ,0,0
192746,",",0,0
192747,for,0,0
192748,alpha,0,0
192749,and,0,0
192750,beta,0,0
192751,bands,0,0
192752,.,0,0
192753,For,0,0
192754,beta,0,0
192755,band,0,0
192756,we,0,0
192757,also,0,0
192758,found,0,0
192759,a,0,0
192760,main,0,0
192761,effect,0,0
192762,for,0,0
192763,condition,0,0
192764,on,0,0
192765,the,0,0
192766,electrodes,0,0
192767,Fp2,0,0
192768,",",0,0
192769,F8,0,0
192770,and,0,0
192771,C4,0,0
192772,;,0,0
192773,for,0,0
192774,theta,0,0
192775,band,0,0
192776,we,0,0
192777,identified,0,0
192778,a,0,0
192779,main,0,0
192780,effect,0,0
192781,for,0,0
192782,condition,0,0
192783,on,0,0
192784,C3,0,1
192785,",",0,0
192786,Cz,0,0
192787,and,0,0
192788,C4,0,0
192789,electrodes,0,0
192790,.,0,0
192791,This,0,0
192792,finding,0,0
192793,suggests,0,0
192794,that,0,0
192795,the,0,0
192796,motor,0,0
192797,task,0,0
192798,did,0,0
192799,not,0,0
192800,have,0,0
192801,any,0,0
192802,influence,0,0
192803,on,0,0
192804,the,0,0
192805,electrocortical,0,0
192806,activity,0,0
192807,in,0,0
192808,alpha,0,0
192809,",",0,0
192810,and,0,0
192811,that,0,0
192812,the,0,0
192813,existing,0,0
192814,modifications,0,0
192815,were,0,0
192816,a,0,0
192817,consequence,0,0
192818,due,0,0
192819,merely,0,0
192820,to,0,0
192821,the,0,0
192822,drug,0,0
192823,use,0,0
192824,.,0,0
192825,Despite,0,0
192826,its,0,0
192827,anxiolytic,0,0
192828,and,0,0
192829,sedative,0,0
192830,action,0,0
192831,",",0,0
192832,bromazepam,0,0
192833,did,0,0
192834,not,0,0
192835,show,0,0
192836,any,0,0
192837,significant,0,0
192838,changes,0,0
192839,when,1,0
192840,the,1,0
192841,individuals,1,1
192842,executed,1,0
192843,a,1,0
192844,finger,1,0
192845,extension,1,0
192846,motor,1,0
192847,task,1,0
192848,.,1,0
192849,A,0,0
192850,Comparison,0,0
192851,of,0,0
192852,Teaching,0,0
192853,Modalities,0,0
192854,and,0,0
192855,Fidelity,0,0
192856,of,0,0
192857,Simulation,0,0
192858,Levels,0,0
192859,in,0,0
192860,Teaching,0,0
192861,Resuscitation,0,1
192862,Scenarios,0,0
192863,.,0,0
192864,INTRODUCTION,0,0
192865,The,0,0
192866,purpose,0,0
192867,of,0,0
192868,our,0,0
192869,study,0,0
192870,was,0,0
192871,to,0,0
192872,examine,0,0
192873,the,0,0
192874,ability,0,0
192875,of,0,0
192876,novices,1,1
192877,to,0,0
192878,learn,0,0
192879,selected,0,1
192880,aspects,0,0
192881,of,0,0
192882,Advanced,0,1
192883,Cardiac,0,0
192884,Life,0,0
192885,Support,0,0
192886,(,0,0
192887,ACLS,0,0
192888,),0,0
192889,in,0,0
192890,training,0,0
192891,conditions,0,0
192892,that,0,0
192893,did,0,0
192894,not,0,0
192895,incorporate,0,0
192896,simulation,0,0
192897,compared,0,0
192898,to,0,0
192899,those,0,0
192900,that,0,0
192901,contained,0,0
192902,low-,0,0
192903,and,0,0
192904,high-fidelity,0,0
192905,simulation,0,0
192906,activities,0,0
192907,.,0,0
192908,We,0,0
192909,sought,0,0
192910,to,0,0
192911,determine,0,0
192912,at,0,0
192913,what,0,0
192914,level,0,1
192915,additional,0,1
192916,educational,0,0
192917,opportunities,0,0
192918,and,0,0
192919,simulation,0,0
192920,fidelity,0,0
192921,become,0,0
192922,superfluous,0,0
192923,with,0,0
192924,respect,0,0
192925,to,0,0
192926,learning,0,0
192927,outcomes,0,0
192928,.,0,1
192929,METHODS,0,0
192930,Totally,1,0
192931,39,1,1
192932,medical,1,1
192933,students,1,1
192934,and,1,0
192935,physician,1,1
192936,assistant,1,0
192937,students,1,1
192938,were,0,0
192939,randomly,0,1
192940,assigned,0,0
192941,to,0,0
192942,4,0,0
192943,training,0,0
192944,conditions,0,0
192945,:,0,1
192946,control,0,0
192947,(,0,0
192948,lecture,0,0
192949,only,0,0
192950,),0,0
192951,",",0,0
192952,video-based,0,0
192953,didactic,0,0
192954,instruction,0,0
192955,",",0,0
192956,low-,0,0
192957,",",0,0
192958,and,0,0
192959,high-fidelity,0,0
192960,simulation,0,0
192961,activities,0,0
192962,.,0,1
192963,Participants,0,1
192964,were,0,0
192965,assessed,0,0
192966,using,0,0
192967,a,0,0
192968,baseline,0,0
192969,written,0,0
192970,pretest,0,0
192971,of,0,0
192972,ACLS,0,0
192973,knowledge,0,0
192974,.,0,0
192975,Following,0,0
192976,this,0,0
192977,",",0,0
192978,all,0,0
192979,participants,0,1
192980,received,0,0
192981,a,0,0
192982,lecture,0,0
192983,outlining,0,0
192984,ACLS,0,0
192985,science,0,0
192986,and,0,0
192987,algorithm,0,0
192988,interpretation,0,0
192989,.,0,1
192990,Participants,0,1
192991,were,0,0
192992,then,0,0
192993,trained,0,0
192994,in,0,0
192995,specific,0,0
192996,aspects,0,0
192997,of,0,0
192998,ACLS,0,0
192999,according,0,1
193000,to,0,0
193001,their,0,0
193002,assigned,0,0
193003,instructional,0,0
193004,condition,0,0
193005,.,0,0
193006,After,0,0
193007,training,0,0
193008,",",0,0
193009,each,0,0
193010,participant,0,0
193011,was,0,0
193012,assessed,0,0
193013,via,0,0
193014,a,0,0
193015,Megacode,0,0
193016,performance,0,0
193017,examination,0,0
193018,and,0,0
193019,a,0,0
193020,written,0,0
193021,posttest,0,0
193022,.,0,0
193023,RESULTS,0,0
193024,All,0,0
193025,groups,0,0
193026,performed,0,0
193027,significantly,0,0
193028,better,0,0
193029,on,0,0
193030,the,0,0
193031,written,0,0
193032,posttest,0,0
193033,compared,0,0
193034,with,0,0
193035,the,0,0
193036,pretest,0,0
193037,(,0,0
193038,p,0,0
193039,<,0,0
193040,0.001,0,0
193041,),0,0
193042,;,0,0
193043,however,0,0
193044,",",0,0
193045,no,0,0
193046,groups,0,0
193047,outperformed,0,0
193048,any,0,0
193049,other,0,0
193050,groups,0,0
193051,.,0,0
193052,On,0,0
193053,the,0,0
193054,Megacode,0,0
193055,performance,0,0
193056,test,0,0
193057,",",0,0
193058,the,0,0
193059,video-based,0,0
193060,",",0,0
193061,low-,0,0
193062,",",0,0
193063,and,0,0
193064,high-fidelity,0,0
193065,groups,0,0
193066,performed,0,0
193067,significantly,0,0
193068,better,0,0
193069,than,0,0
193070,the,0,0
193071,control,0,0
193072,group,0,0
193073,(,0,0
193074,p,0,0
193075,=,0,0
193076,0.028,0,0
193077,",",0,0
193078,p,0,0
193079,<,0,0
193080,0.001,0,0
193081,",",0,0
193082,p,0,0
193083,=,0,0
193084,0.019,0,0
193085,),0,0
193086,.,0,0
193087,Equivalence,0,0
193088,testing,0,0
193089,revealed,0,0
193090,that,0,0
193091,the,0,0
193092,high-fidelity,0,0
193093,simulation,0,0
193094,condition,0,0
193095,was,0,0
193096,statistically,0,0
193097,equivalent,0,0
193098,to,0,0
193099,the,0,0
193100,video-based,0,0
193101,and,0,0
193102,low-fidelity,0,0
193103,simulation,0,0
193104,conditions,0,0
193105,.,0,1
193106,CONCLUSION,0,0
193107,Video-based,0,0
193108,and,0,0
193109,simulation-based,0,0
193110,training,0,0
193111,is,0,0
193112,associated,0,0
193113,with,0,0
193114,better,0,0
193115,learning,0,0
193116,outcomes,0,0
193117,when,0,0
193118,compared,0,0
193119,with,0,0
193120,traditional,0,0
193121,didactic,0,0
193122,lectures,0,0
193123,only,0,0
193124,.,0,0
193125,Video-based,0,0
193126,",",0,0
193127,low-fidelity,0,0
193128,",",0,0
193129,and,0,0
193130,high-fidelity,0,0
193131,simulation,0,0
193132,training,0,0
193133,yield,0,0
193134,equivalent,0,0
193135,outcomes,0,0
193136,",",0,0
193137,which,0,0
193138,may,0,0
193139,indicate,0,0
193140,that,0,0
193141,high-fidelity,0,0
193142,simulation,0,0
193143,is,0,0
193144,superfluous,0,0
193145,for,0,0
193146,the,0,0
193147,novice,1,1
193148,trainee,1,0
193149,.,1,0
193150,A,0,0
193151,randomized,0,0
193152,",",0,0
193153,double-blind,0,0
193154,",",0,0
193155,placebo-controlled,0,0
193156,study,0,0
193157,of,0,0
193158,the,0,0
193159,efficacy,0,0
193160,and,0,0
193161,safety,0,0
193162,of,0,0
193163,2,0,0
193164,doses,0,0
193165,of,0,0
193166,vortioxetine,0,0
193167,in,0,0
193168,adults,1,1
193169,with,1,1
193170,major,1,0
193171,depressive,1,0
193172,disorder,1,1
193173,.,1,0
193174,BACKGROUND,0,0
193175,This,0,0
193176,8-week,0,0
193177,",",0,0
193178,randomized,0,0
193179,",",0,0
193180,double-blind,0,0
193181,",",0,0
193182,placebo-controlled,0,0
193183,study,0,0
193184,",",0,0
193185,conducted,0,0
193186,August,0,1
193187,2010-May,0,0
193188,2012,0,1
193189,in,0,0
193190,the,0,0
193191,United,0,1
193192,States,0,0
193193,",",0,0
193194,evaluated,0,0
193195,the,0,0
193196,safety,0,0
193197,and,0,0
193198,efficacy,0,0
193199,of,0,0
193200,vortioxetine,0,0
193201,10,0,0
193202,mg,0,0
193203,and,0,0
193204,15,0,0
193205,mg,0,0
193206,in,0,0
193207,patients,1,1
193208,with,1,1
193209,major,1,0
193210,depressive,1,0
193211,disorder,1,1
193212,(,1,0
193213,MDD,1,0
193214,),1,0
193215,.,1,0
193216,The,0,0
193217,mechanism,0,0
193218,of,0,0
193219,action,0,0
193220,of,0,0
193221,vortioxetine,0,0
193222,is,0,0
193223,thought,0,0
193224,to,0,0
193225,be,0,0
193226,related,0,0
193227,to,0,0
193228,direct,0,0
193229,modulation,0,0
193230,of,0,0
193231,serotonin,0,0
193232,(,0,0
193233,5-HT,0,0
193234,),0,0
193235,receptor,0,0
193236,activity,0,0
193237,and,0,0
193238,inhibition,0,0
193239,of,0,0
193240,the,0,0
193241,serotonin,0,0
193242,transporter,0,0
193243,.,0,0
193244,METHOD,0,0
193245,Adults,1,1
193246,aged,1,1
193247,18-75,1,1
193248,years,1,1
193249,with,1,1
193250,MDD,1,1
193251,(,1,0
193252,DSM-IV-TR,1,0
193253,),1,0
193254,and,1,0
193255,Montgomery-Asberg,1,0
193256,Depression,1,0
193257,Rating,1,0
193258,Scale,1,0
193259,(,1,0
193260,MADRS,1,0
193261,),1,0
193262,total,1,1
193263,score,1,0
193264,?,1,0
193265,26,1,0
193266,were,1,0
193267,randomized,1,0
193268,(,1,0
193269,1:1:1,1,1
193270,),1,0
193271,to,1,0
193272,receive,0,0
193273,vortioxetine,0,0
193274,10,0,0
193275,mg,0,0
193276,or,0,0
193277,15,0,0
193278,mg,0,0
193279,or,0,0
193280,placebo,0,0
193281,once,0,0
193282,daily,0,0
193283,",",0,0
193284,with,0,0
193285,the,0,0
193286,primary,0,0
193287,efficacy,0,0
193288,end,0,0
193289,point,0,0
193290,being,0,0
193291,change,0,0
193292,from,0,0
193293,baseline,0,0
193294,at,0,0
193295,week,0,0
193296,8,0,0
193297,in,0,0
193298,MADRS,0,0
193299,analyzed,0,0
193300,by,0,0
193301,mixed,0,0
193302,model,0,0
193303,for,0,0
193304,repeated,0,0
193305,measures,0,0
193306,.,0,1
193307,Adverse,0,0
193308,events,0,0
193309,were,0,0
193310,recorded,0,0
193311,during,0,0
193312,the,0,0
193313,study,0,0
193314,",",0,0
193315,suicidal,0,0
193316,ideation,0,0
193317,and,0,0
193318,behavior,0,0
193319,were,0,0
193320,assessed,0,0
193321,using,0,0
193322,the,0,0
193323,Columbia-Suicide,0,0
193324,Severity,0,0
193325,Rating,0,0
193326,Scale,0,0
193327,(,0,0
193328,C-SSRS,0,0
193329,),0,0
193330,",",0,0
193331,and,0,0
193332,sexual,0,0
193333,dysfunction,0,0
193334,was,0,0
193335,assessed,0,0
193336,using,0,0
193337,the,0,0
193338,Arizona,0,1
193339,Sexual,0,0
193340,Experience,0,0
193341,(,0,0
193342,ASEX,0,0
193343,),0,0
193344,scale,0,0
193345,.,0,0
193346,RESULTS,1,0
193347,Of,1,0
193348,the,1,0
193349,"1,111",1,1
193350,subjects,1,1
193351,screened,1,1
193352,",",1,0
193353,469,1,0
193354,subjects,1,1
193355,were,1,1
193356,randomized,1,1
193357,:,1,1
193358,160,1,1
193359,to,1,0
193360,placebo,1,0
193361,",",1,0
193362,157,1,0
193363,to,1,0
193364,vortioxetine,1,0
193365,10,1,0
193366,mg,1,0
193367,",",1,0
193368,and,1,0
193369,152,1,1
193370,to,1,0
193371,vortioxetine,1,0
193372,15,1,0
193373,mg,1,0
193374,.,1,0
193375,Differences,0,0
193376,from,0,0
193377,placebo,0,0
193378,in,0,0
193379,the,0,0
193380,primary,0,0
193381,efficacy,0,0
193382,end,0,0
193383,point,0,0
193384,were,0,0
193385,not,0,0
193386,statistically,0,0
193387,significant,0,0
193388,for,0,0
193389,vortioxetine,0,0
193390,10,0,0
193391,mg,0,0
193392,or,0,0
193393,vortioxetine,0,0
193394,15,0,0
193395,mg.,0,0
193396,Nausea,0,0
193397,",",0,0
193398,headache,0,0
193399,",",0,0
193400,dry,0,0
193401,mouth,0,0
193402,",",0,0
193403,constipation,0,0
193404,",",0,0
193405,diarrhea,0,0
193406,",",0,0
193407,vomiting,0,0
193408,",",0,0
193409,dizziness,0,0
193410,",",0,0
193411,and,0,0
193412,flatulence,0,0
193413,were,0,0
193414,reported,0,0
193415,in,0,0
193416,?,0,0
193417,5,0,0
193418,%,0,0
193419,of,0,0
193420,subjects,0,1
193421,receiving,0,1
193422,vortioxetine,0,0
193423,.,0,0
193424,Discontinuation,0,0
193425,due,0,0
193426,to,0,0
193427,adverse,0,0
193428,events,0,0
193429,occurred,0,0
193430,in,0,0
193431,7,0,0
193432,subjects,0,1
193433,(,0,0
193434,4.4,0,0
193435,%,0,0
193436,),0,0
193437,in,0,0
193438,the,0,0
193439,placebo,0,0
193440,group,0,0
193441,",",0,0
193442,8,0,0
193443,(,0,0
193444,5.2,0,0
193445,%,0,0
193446,),0,0
193447,in,0,0
193448,the,0,0
193449,vortioxetine,0,0
193450,10,0,0
193451,mg,0,0
193452,group,0,0
193453,",",0,0
193454,and,0,0
193455,12,0,0
193456,(,0,0
193457,7.9,0,0
193458,%,0,0
193459,),0,0
193460,in,0,0
193461,the,0,0
193462,vortioxetine,0,0
193463,15,0,0
193464,mg,0,0
193465,group,0,0
193466,.,0,0
193467,ASEX,0,0
193468,total,0,1
193469,scores,0,0
193470,were,0,0
193471,similar,0,0
193472,across,0,0
193473,groups,0,0
193474,.,0,0
193475,There,0,0
193476,were,0,0
193477,no,0,0
193478,clinically,0,0
193479,significant,0,0
193480,trends,0,0
193481,within,0,0
193482,or,0,0
193483,between,0,0
193484,treatment,0,0
193485,groups,0,0
193486,on,0,0
193487,the,0,0
193488,C-SSRS,0,0
193489,",",0,0
193490,laboratory,0,0
193491,values,0,0
193492,",",0,0
193493,electrocardiogram,0,0
193494,",",0,0
193495,or,0,0
193496,vital,0,0
193497,sign,0,0
193498,parameters,0,0
193499,.,0,0
193500,CONCLUSIONS,0,0
193501,In,0,0
193502,this,0,0
193503,study,0,0
193504,",",0,0
193505,vortioxetine,0,0
193506,did,0,0
193507,not,0,0
193508,differ,0,0
193509,significantly,0,0
193510,from,0,0
193511,placebo,0,0
193512,on,0,0
193513,MADRS,0,0
193514,total,0,1
193515,score,0,0
193516,after,0,0
193517,8,0,0
193518,weeks,0,0
193519,of,0,0
193520,treatment,0,0
193521,in,0,0
193522,MDD,0,1
193523,subjects,0,1
193524,.,0,1
193525,TRIAL,0,0
193526,REGISTRATION,0,0
193527,ClinicalTrials.gov,0,0
193528,identifier,0,1
193529,:,0,1
193530,NCT01179516,0,0
193531,.,0,0
193532,Assessment,0,0
193533,from,0,0
193534,Functional,0,0
193535,Perspectives,0,0
193536,:,0,1
193537,Using,0,0
193538,Sensorimotor,0,0
193539,Control,0,0
193540,in,0,0
193541,the,0,0
193542,Hand,0,0
193543,as,0,0
193544,an,0,0
193545,Outcome,0,0
193546,Indicator,0,0
193547,in,0,0
193548,the,0,0
193549,Surgical,0,0
193550,Treatment,0,0
193551,of,0,0
193552,Carpal,1,0
193553,Tunnel,1,0
193554,Syndrome,1,1
193555,.,1,0
193556,To,0,0
193557,investigate,0,0
193558,whether,0,0
193559,sensorimotor,0,0
193560,control,0,0
193561,of,0,0
193562,the,0,0
193563,hand,0,0
193564,could,0,0
193565,be,0,0
193566,an,0,0
193567,outcome,0,0
193568,indicator,0,0
193569,after,0,0
193570,carpal,0,0
193571,tunnel,0,0
193572,release,0,0
193573,(,0,0
193574,CTR,0,0
193575,),0,0
193576,",",0,0
193577,this,0,0
193578,work,0,0
193579,examined,0,0
193580,changes,0,0
193581,in,0,0
193582,the,0,0
193583,results,0,0
193584,of,0,0
193585,patients,0,1
193586,',0,1
193587,manual,0,0
193588,tactile,0,0
193589,test,0,0
193590,(,0,0
193591,MTT,0,0
193592,),0,0
193593,",",0,0
193594,pinch-holding-up,0,0
193595,activity,0,0
193596,(,0,0
193597,PHUA,0,0
193598,),0,0
193599,",",0,0
193600,two-point,0,0
193601,discrimination,0,0
193602,(,0,0
193603,2PD,0,0
193604,),0,0
193605,and,0,0
193606,Semmes-Weinstein,0,0
193607,monofilament,0,0
193608,(,0,0
193609,SWM,0,0
193610,),0,0
193611,tests,0,0
193612,.,0,1
193613,Participants,0,1
193614,included,0,1
193615,30,1,0
193616,predominantly,1,1
193617,sensory,1,0
193618,neuropathy,1,1
193619,CTS,1,0
193620,patients,1,1
193621,",",1,0
193622,as,1,0
193623,confirmed,1,0
193624,by,1,0
193625,a,1,0
193626,nerve,1,0
193627,conduction,1,0
193628,study,1,0
193629,.,1,0
193630,The,0,0
193631,MTT,0,0
193632,",",0,0
193633,precision,0,0
193634,pinch,0,0
193635,performance,0,0
193636,in,0,0
193637,PHUA,0,0
193638,and,0,0
193639,traditional,0,0
193640,sensibility,0,0
193641,(,0,0
193642,2PD,0,0
193643,and,0,0
193644,SWM,0,0
193645,),0,0
193646,tests,0,0
193647,were,0,0
193648,used,0,0
193649,to,0,0
193650,examine,0,0
193651,different,0,0
193652,aspects,0,0
193653,of,0,0
193654,sensory,0,0
193655,status,0,0
193656,at,0,0
193657,the,0,0
193658,time-points,0,0
193659,of,0,0
193660,two,0,0
193661,weeks,0,0
193662,before,0,0
193663,operation,0,1
193664,and,0,0
193665,one,0,0
193666,month,0,0
193667,post-operation,0,0
193668,",",0,0
193669,with,0,0
193670,a,0,0
193671,single-blind,0,0
193672,design,0,0
193673,.,0,0
193674,The,0,0
193675,results,0,0
193676,showed,0,0
193677,significant,0,0
193678,improvements,0,0
193679,in,0,0
193680,the,0,0
193681,sensory,0,0
193682,function,0,0
193683,as,0,0
193684,detected,0,0
193685,by,0,0
193686,the,0,0
193687,2PD,0,0
193688,and,0,0
193689,SWM,0,0
193690,tests,0,0
193691,(,0,0
193692,p,0,0
193693,<,0,0
193694,0.001,0,0
193695,),0,0
193696,and,0,0
193697,sensorimotor,0,0
193698,function,0,0
193699,as,0,0
193700,detected,0,0
193701,by,0,0
193702,the,0,0
193703,MTT,0,0
193704,(,0,0
193705,p,0,0
193706,<,0,0
193707,0.001,0,0
193708,),0,0
193709,and,0,0
193710,PHUA,0,0
193711,test,0,0
193712,(,0,0
193713,p,0,0
193714,<,0,0
193715,0.05,0,0
193716,),0,0
193717,for,0,0
193718,patients,0,1
193719,receiving,0,1
193720,CTR,0,0
193721,.,0,0
193722,The,0,0
193723,responsiveness,0,0
193724,of,0,0
193725,the,0,0
193726,SWM,0,0
193727,",",0,0
193728,MTT,0,0
193729,and,0,0
193730,PHUA,0,1
193731,tests,0,0
193732,(,0,0
193733,effect,0,0
193734,size,0,0
193735,>,0,0
193736,0.5,0,0
193737,",",0,0
193738,p,0,0
193739,<,0,0
193740,0.01,0,0
193741,),0,0
193742,are,0,0
193743,better,0,0
193744,than,0,0
193745,that,0,0
193746,of,0,0
193747,two-point,0,0
193748,discrimination,0,0
193749,test,0,0
193750,(,0,0
193751,effect,0,0
193752,size,0,0
193753,<,0,0
193754,0.5,0,0
193755,",",0,0
193756,p,0,0
193757,<,0,0
193758,0.001,0,0
193759,),0,0
193760,.,0,0
193761,However,0,0
193762,",",0,0
193763,pinch,0,0
193764,strength,0,0
193765,saw,0,0
193766,a,0,0
193767,decline,0,0
193768,compared,0,0
193769,to,0,0
193770,baseline,0,0
193771,with,0,0
193772,a,0,0
193773,moderate,0,1
193774,effect,0,0
193775,sizes,0,0
193776,(,0,0
193777,effect,0,0
193778,size,0,0
193779,=,0,0
193780,0.7,0,0
193781,",",0,0
193782,p,0,0
193783,<,0,0
193784,0.001,0,0
193785,),0,0
193786,.,0,0
193787,This,0,0
193788,cohort,0,0
193789,study,0,0
193790,found,0,0
193791,that,0,0
193792,the,0,0
193793,MTT,0,0
193794,and,0,0
193795,PHUA,0,0
193796,test,0,0
193797,can,0,0
193798,both,0,0
193799,meet,0,0
193800,all,0,0
193801,the,0,0
193802,statistical,0,0
193803,criteria,0,1
193804,with,0,1
193805,regard,0,0
193806,to,0,0
193807,assessing,0,0
193808,treatment,0,0
193809,outcomes,0,0
193810,for,0,0
193811,patients,1,1
193812,with,1,1
193813,CTS,1,0
193814,.,1,0
193815,In,0,0
193816,addition,0,0
193817,",",0,0
193818,the,0,0
193819,results,0,0
193820,of,0,0
193821,this,0,0
193822,work,0,0
193823,provide,0,0
193824,clinicians,0,0
193825,with,0,0
193826,the,0,0
193827,information,0,0
193828,that,0,0
193829,the,0,0
193830,sensorimotor,0,0
193831,functions,0,0
193832,of,0,0
193833,the,0,0
193834,hands,0,0
193835,",",0,0
193836,as,0,0
193837,assessed,0,0
193838,by,0,0
193839,MTT,0,0
193840,and,0,0
193841,PHUA,0,0
193842,",",0,0
193843,are,0,0
193844,responsive,0,0
193845,to,0,0
193846,clinical,0,0
193847,changes,0,0
193848,due,0,0
193849,to,0,1
193850,CTR,0,0
193851,.,0,0
193852,[,0,0
193853,Effect,0,0
193854,of,0,0
193855,Preoperative,0,1
193856,Oral,0,0
193857,Rehydration,0,0
193858,on,0,0
193859,Onset,0,0
193860,Time,0,0
193861,and,0,0
193862,Recovery,0,0
193863,Time,0,0
193864,of,0,0
193865,Rocuronium,0,1
193866,],0,0
193867,.,0,0
193868,BACKGROUND,0,0
193869,Preoperative,0,0
193870,oral,0,0
193871,rehydration,0,0
193872,solution,0,0
193873,(,0,0
193874,ORS,0,0
193875,),0,0
193876,prevents,0,0
193877,hypovolemia,0,0
193878,.,0,0
193879,The,0,0
193880,aim,0,0
193881,of,0,0
193882,this,0,0
193883,study,0,0
193884,was,0,0
193885,to,0,0
193886,compare,0,0
193887,the,0,0
193888,effect,0,0
193889,of,0,0
193890,intubating,0,0
193891,dose,0,0
193892,of,0,0
193893,rocuronium,0,0
193894,in,0,0
193895,patients,1,1
193896,taking,1,0
193897,and,1,0
193898,those,1,0
193899,not,1,0
193900,taking,1,0
193901,preoperative,1,0
193902,ORS,1,0
193903,.,1,1
193904,METHODS,0,0
193905,Twenty,1,1
193906,patients,1,1
193907,",",1,0
193908,ASA,1,0
193909,I,1,0
193910,aged,1,1
193911,20-50,1,0
193912,years,1,1
193913,scheduled,1,1
193914,for,1,0
193915,elective,1,1
193916,surgery,1,1
193917,",",0,0
193918,were,0,0
193919,investigated,0,0
193920,and,0,0
193921,randomly,0,0
193922,assigned,0,0
193923,to,0,0
193924,two,0,0
193925,groups,0,0
193926,:,0,1
193927,drinking,0,0
193928,"1,500",0,0
193929,ml,0,0
193930,ORS,0,0
193931,6,0,0
193932,to,0,0
193933,2,0,0
193934,hours,0,0
193935,before,0,0
193936,anesthesia,0,1
193937,(,0,0
193938,ORS,0,0
193939,group,0,0
193940,),0,0
193941,and,0,0
193942,nothing,0,0
193943,by,0,0
193944,mouth,0,0
193945,from,0,1
193946,6,0,0
193947,hours,0,0
193948,before,0,0
193949,anesthesia,0,0
193950,(,0,0
193951,control,0,0
193952,group,0,0
193953,),0,0
193954,.,0,0
193955,Anesthesia,0,0
193956,was,0,0
193957,maintained,0,0
193958,with,0,0
193959,propofol,0,0
193960,and,0,0
193961,remifentanil,0,0
193962,",",0,0
193963,and,0,0
193964,rocuronium,0,0
193965,0.6,0,0
193966,mg,0,0
193967,x,0,0
193968,kg,0,0
193969,(,0,0
193970,-1,0,0
193971,),0,0
193972,was,0,0
193973,administrated,0,0
193974,.,0,0
193975,To,0,0
193976,evaluate,0,0
193977,the,0,0
193978,effect,0,0
193979,of,0,0
193980,rocuronium,0,0
193981,",",0,0
193982,acceleromyography,0,0
193983,at,0,0
193984,the,0,0
193985,adductor,0,0
193986,pollicis,0,0
193987,was,0,0
193988,performed,0,0
193989,using,0,0
193990,0.1,0,0
193991,Hz,0,0
193992,stimulation,0,0
193993,.,0,0
193994,Cardiac,0,0
193995,index,0,0
193996,(,0,0
193997,CI,0,0
193998,),0,0
193999,and,0,0
194000,stroke,0,1
194001,volume,0,0
194002,variation,0,0
194003,(,0,0
194004,SVV,0,0
194005,),0,0
194006,from,0,0
194007,FloTra/Vigileo,0,0
194008,",",0,0
194009,times,0,0
194010,to,0,0
194011,95,0,0
194012,%,0,0
194013,twitch,0,0
194014,depression,0,1
194015,as,0,0
194016,onset,0,0
194017,time,0,0
194018,(,0,0
194019,OT,0,0
194020,),0,0
194021,",",0,0
194022,and,0,0
194023,times,0,0
194024,to,0,0
194025,first,0,0
194026,twitch,0,0
194027,re-detection,0,0
194028,(,0,0
194029,TR,0,0
194030,),0,0
194031,were,0,0
194032,recorded,0,0
194033,.,0,0
194034,RESULTS,0,0
194035,SVV,0,0
194036,was,0,0
194037,significantly,0,0
194038,lower,0,0
194039,in,0,0
194040,ORS,0,0
194041,group,0,0
194042,(,0,0
194043,P,0,0
194044,=,0,0
194045,0.03,0,0
194046,),0,0
194047,",",0,0
194048,and,0,0
194049,CI,0,0
194050,showed,0,0
194051,no,0,0
194052,difference,0,0
194053,.,0,0
194054,In,0,0
194055,ORS,0,0
194056,group,0,0
194057,",",0,0
194058,TR,0,0
194059,was,0,0
194060,significantly,0,0
194061,shorter,0,0
194062,than,0,0
194063,that,0,0
194064,of,0,0
194065,control,0,0
194066,group,0,0
194067,(,0,0
194068,P=0.002,0,0
194069,),0,0
194070,",",0,0
194071,and,0,0
194072,OT,0,0
194073,tended,0,0
194074,to,0,0
194075,be,0,0
194076,prolonged,0,0
194077,(,0,0
194078,99.0,0,0
194079,?,0,0
194080,36.3,0,0
194081,s,0,0
194082,vs.,0,0
194083,84.0,0,0
194084,?,0,0
194085,37.5,0,0
194086,s,0,0
194087,),0,0
194088,",",0,0
194089,but,0,0
194090,not,0,0
194091,significantly,0,0
194092,.,0,0
194093,CONCLUSIONS,0,0
194094,Preoperative,0,0
194095,oral,0,0
194096,rehydration,0,0
194097,possibly,0,0
194098,increases,0,0
194099,circulating,0,0
194100,blood,0,0
194101,volume,0,0
194102,",",0,0
194103,and,0,0
194104,shortens,0,0
194105,the,0,0
194106,duration,0,0
194107,of,0,0
194108,rocuronium,0,0
194109,effect,0,0
194110,.,0,0
194111,Predicting,0,0
194112,Overall,0,0
194113,Survival,0,0
194114,After,0,0
194115,Stereotactic,0,1
194116,Ablative,0,0
194117,Radiation,0,0
194118,Therapy,0,0
194119,in,0,0
194120,Early-Stage,0,1
194121,Lung,0,1
194122,Cancer,0,0
194123,:,0,1
194124,Development,0,0
194125,and,0,0
194126,External,0,0
194127,Validation,0,0
194128,of,0,0
194129,the,0,0
194130,Amsterdam,0,1
194131,Prognostic,0,1
194132,Model,0,0
194133,.,0,0
194134,PURPOSE,0,0
194135,A,0,0
194136,prognostic,0,0
194137,model,0,0
194138,for,0,0
194139,5-year,0,0
194140,overall,0,0
194141,survival,0,0
194142,(,0,0
194143,OS,0,0
194144,),0,0
194145,",",0,0
194146,consisting,0,0
194147,of,0,0
194148,recursive,0,0
194149,partitioning,0,0
194150,analysis,0,0
194151,(,0,0
194152,RPA,0,0
194153,),0,0
194154,and,0,0
194155,a,0,0
194156,nomogram,0,0
194157,",",0,0
194158,was,0,0
194159,developed,0,0
194160,for,0,0
194161,patients,1,1
194162,with,1,1
194163,early-stage,1,1
194164,non-small,1,1
194165,cell,1,1
194166,lung,1,1
194167,cancer,1,1
194168,(,1,0
194169,ES-NSCLC,1,0
194170,),1,0
194171,treated,1,1
194172,with,1,1
194173,stereotactic,1,0
194174,ablative,1,1
194175,radiation,1,0
194176,therapy,1,0
194177,(,1,0
194178,SABR,1,1
194179,),1,0
194180,.,1,0
194181,METHODS,0,0
194182,AND,0,0
194183,MATERIALS,0,0
194184,A,1,0
194185,primary,1,0
194186,dataset,1,0
194187,of,1,0
194188,703,1,1
194189,ES-NSCLC,1,1
194190,SABR,1,1
194191,patients,1,1
194192,was,0,0
194193,randomly,0,1
194194,divided,0,0
194195,into,0,0
194196,a,0,0
194197,training,0,0
194198,(,0,0
194199,67,0,0
194200,%,0,0
194201,),0,0
194202,and,0,0
194203,an,0,0
194204,internal,0,0
194205,validation,0,0
194206,(,0,0
194207,33,0,1
194208,%,0,0
194209,),0,0
194210,dataset,0,0
194211,.,0,0
194212,In,0,0
194213,the,0,0
194214,former,0,0
194215,group,0,0
194216,",",0,0
194217,21,0,1
194218,unique,0,0
194219,parameters,0,0
194220,consisting,0,0
194221,of,0,0
194222,patient,0,0
194223,",",0,0
194224,treatment,0,0
194225,",",0,0
194226,and,0,0
194227,tumor,0,0
194228,factors,0,0
194229,were,0,0
194230,entered,0,1
194231,into,0,0
194232,an,0,0
194233,RPA,0,0
194234,model,0,0
194235,to,0,0
194236,predict,0,0
194237,OS,0,0
194238,.,0,0
194239,Univariate,0,0
194240,and,0,0
194241,multivariate,0,0
194242,models,0,0
194243,were,0,0
194244,constructed,0,0
194245,for,0,0
194246,RPA-selected,0,1
194247,factors,0,0
194248,to,0,0
194249,evaluate,0,0
194250,their,0,0
194251,relationship,0,0
194252,with,0,1
194253,OS,0,0
194254,.,0,0
194255,A,0,0
194256,nomogram,0,0
194257,for,0,0
194258,OS,0,0
194259,was,0,0
194260,constructed,0,0
194261,based,0,0
194262,on,0,0
194263,factors,0,0
194264,significant,0,0
194265,in,0,0
194266,multivariate,0,0
194267,modeling,0,0
194268,and,0,0
194269,validated,0,0
194270,with,0,1
194271,calibration,0,0
194272,plots,0,0
194273,.,0,0
194274,Both,0,0
194275,the,0,0
194276,RPA,0,0
194277,and,0,0
194278,the,0,0
194279,nomogram,0,0
194280,were,0,0
194281,externally,0,0
194282,validated,0,0
194283,in,0,0
194284,independent,0,0
194285,surgical,0,1
194286,(,0,0
194287,n,0,1
194288,=,0,0
194289,193,0,1
194290,),0,0
194291,and,0,0
194292,SABR,0,1
194293,(,0,0
194294,n,0,1
194295,=,0,0
194296,543,0,1
194297,),0,1
194298,datasets,0,1
194299,.,0,1
194300,RESULTS,0,0
194301,RPA,0,0
194302,identified,0,0
194303,2,0,0
194304,distinct,0,0
194305,risk,0,0
194306,classes,0,1
194307,based,0,0
194308,on,0,0
194309,tumor,0,0
194310,diameter,0,0
194311,",",0,0
194312,age,0,1
194313,",",0,0
194314,World,0,1
194315,Health,0,0
194316,Organization,0,0
194317,performance,0,0
194318,status,0,0
194319,(,0,0
194320,PS,0,1
194321,),0,0
194322,and,0,0
194323,Charlson,0,0
194324,comorbidity,0,0
194325,index,0,0
194326,.,0,0
194327,This,0,0
194328,RPA,0,0
194329,had,0,0
194330,moderate,0,1
194331,discrimination,0,0
194332,in,0,0
194333,SABR,0,1
194334,datasets,0,0
194335,(,0,0
194336,c-index,0,0
194337,range,0,0
194338,:,0,1
194339,0.52-0.60,0,0
194340,),0,0
194341,but,0,0
194342,was,0,0
194343,of,0,0
194344,limited,0,0
194345,value,0,0
194346,in,0,0
194347,the,0,0
194348,surgical,0,0
194349,validation,0,0
194350,cohort,0,1
194351,.,0,0
194352,The,0,0
194353,nomogram,0,0
194354,predicting,0,0
194355,OS,0,0
194356,included,0,1
194357,smoking,0,0
194358,history,0,1
194359,in,0,0
194360,addition,0,0
194361,to,0,0
194362,RPA-identified,0,0
194363,factors,0,0
194364,.,0,0
194365,In,0,0
194366,contrast,0,0
194367,to,0,0
194368,RPA,0,0
194369,",",0,0
194370,validation,0,0
194371,of,0,0
194372,the,0,0
194373,nomogram,0,0
194374,performed,0,0
194375,well,0,0
194376,in,0,0
194377,internal,0,0
194378,validation,0,0
194379,(,0,0
194380,r,0,0
194381,(,0,0
194382,2,0,0
194383,),0,0
194384,=,0,0
194385,0.97,0,0
194386,),0,0
194387,and,0,0
194388,external,0,0
194389,SABR,0,1
194390,(,0,0
194391,r,0,0
194392,(,0,0
194393,2,0,0
194394,),0,0
194395,=,0,0
194396,0.79,0,0
194397,),0,0
194398,and,0,0
194399,surgical,0,1
194400,cohorts,0,0
194401,(,0,0
194402,r,0,0
194403,(,0,0
194404,2,0,0
194405,),0,0
194406,=,0,0
194407,0.91,0,0
194408,),0,0
194409,.,0,0
194410,CONCLUSIONS,0,0
194411,The,0,0
194412,Amsterdam,0,1
194413,prognostic,0,0
194414,model,0,0
194415,is,0,0
194416,the,0,0
194417,first,0,0
194418,externally,0,0
194419,validated,0,0
194420,prognostication,0,0
194421,tool,0,0
194422,for,0,0
194423,OS,0,0
194424,in,0,0
194425,ES-NSCLC,0,0
194426,treated,0,1
194427,with,0,1
194428,SABR,0,1
194429,available,0,0
194430,to,0,0
194431,individualize,0,0
194432,patient,0,0
194433,decision,0,0
194434,making,0,0
194435,.,0,0
194436,The,0,0
194437,nomogram,0,0
194438,retained,0,0
194439,strong,0,0
194440,performance,0,0
194441,across,0,0
194442,surgical,0,1
194443,and,0,0
194444,SABR,0,1
194445,external,0,0
194446,validation,0,0
194447,datasets,0,1
194448,.,0,0
194449,RPA,0,0
194450,performance,0,0
194451,was,0,0
194452,poor,0,0
194453,in,0,0
194454,surgical,0,1
194455,patients,0,1
194456,",",0,0
194457,suggesting,0,0
194458,that,0,0
194459,2,0,0
194460,different,0,0
194461,distinct,0,0
194462,patient,0,0
194463,populations,0,1
194464,are,0,0
194465,being,0,0
194466,treated,0,0
194467,with,0,1
194468,these,0,0
194469,2,0,0
194470,effective,0,0
194471,modalities,0,0
194472,.,0,1
194473,Gluten,0,0
194474,and,0,0
194475,casein,0,0
194476,supplementation,0,0
194477,does,0,0
194478,not,0,0
194479,increase,0,0
194480,symptoms,0,0
194481,in,0,0
194482,children,1,1
194483,with,1,1
194484,autism,1,1
194485,spectrum,1,1
194486,disorder,1,1
194487,.,1,0
194488,AIM,0,0
194489,A,0,0
194490,gluten-,0,0
194491,and,0,0
194492,casein-free,0,0
194493,diet,0,0
194494,is,0,0
194495,often,0,0
194496,given,0,0
194497,to,0,0
194498,children,0,1
194499,with,0,1
194500,autism,0,1
194501,spectrum,0,1
194502,disorder,0,1
194503,(,0,0
194504,ASD,0,1
194505,),0,0
194506,.,0,0
194507,We,0,0
194508,aimed,0,0
194509,to,0,0
194510,determine,0,0
194511,the,0,0
194512,effect,0,0
194513,of,0,0
194514,gluten,0,0
194515,and,0,0
194516,casein,0,0
194517,supplementation,0,0
194518,on,0,0
194519,maladaptive,0,0
194520,behaviour,0,0
194521,",",0,0
194522,gastrointestinal,0,0
194523,symptom,0,0
194524,severity,0,0
194525,and,0,0
194526,intestinal,0,1
194527,fatty,0,0
194528,acids,0,0
194529,binding,0,0
194530,protein,0,0
194531,(,0,0
194532,I-FABP,0,0
194533,),0,0
194534,excretion,0,0
194535,in,0,0
194536,children,0,1
194537,with,0,1
194538,ASD,0,1
194539,.,0,0
194540,METHODS,0,0
194541,A,0,0
194542,randomised,0,0
194543,",",0,0
194544,controlled,0,0
194545,",",0,0
194546,double-blind,0,0
194547,trial,0,0
194548,was,0,0
194549,performed,0,0
194550,on,0,0
194551,74,1,1
194552,children,1,1
194553,with,1,1
194554,ASD,1,1
194555,with,1,1
194556,severe,1,1
194557,maladaptive,1,0
194558,behaviour,1,0
194559,and,1,0
194560,increased,1,0
194561,urinary,1,0
194562,I-FABP,1,0
194563,.,1,1
194564,Subjects,1,0
194565,were,1,0
194566,randomised,1,0
194567,to,1,0
194568,receive,1,0
194569,gluten-casein,1,1
194570,or,1,0
194571,a,1,0
194572,placebo,1,0
194573,for,1,0
194574,seven,1,1
194575,days,1,0
194576,.,1,1
194577,We,0,0
194578,evaluated,0,0
194579,maladaptive,0,0
194580,behaviour,0,0
194581,before,0,0
194582,and,0,0
194583,after,0,0
194584,supplementation,0,0
194585,",",0,0
194586,using,0,0
194587,I-FABP,0,0
194588,excretion,0,0
194589,",",0,0
194590,the,0,0
194591,approach,0,0
194592,withdrawal,0,0
194593,problem,0,0
194594,composite,0,0
194595,subtest,0,0
194596,of,0,0
194597,the,0,0
194598,Pervasive,0,1
194599,Developmental,0,1
194600,Disorder,0,1
194601,Behavior,0,0
194602,Inventory,0,0
194603,and,0,0
194604,the,0,0
194605,Gastrointestinal,0,0
194606,Symptom,0,0
194607,Severity,0,0
194608,Index,0,0
194609,.,0,0
194610,RESULTS,0,0
194611,The,0,0
194612,mean,0,0
194613,approach,0,0
194614,withdrawal,0,0
194615,problem,0,0
194616,composite,0,0
194617,score,0,0
194618,was,0,0
194619,significantly,0,0
194620,higher,0,0
194621,before,0,0
194622,supplementation,0,0
194623,than,0,0
194624,after,0,0
194625,",",0,0
194626,both,0,0
194627,in,0,0
194628,the,0,0
194629,placebo,0,0
194630,and,0,0
194631,in,0,0
194632,the,0,0
194633,gluten-casein,0,1
194634,group,0,0
194635,.,0,0
194636,However,0,0
194637,",",0,0
194638,the,0,0
194639,mean,0,0
194640,difference,0,0
194641,was,0,0
194642,not,0,0
194643,significant,0,0
194644,and,0,0
194645,may,0,0
194646,have,0,0
194647,been,0,0
194648,caused,0,0
194649,by,0,0
194650,additional,0,0
194651,therapy,0,0
194652,.,0,0
194653,There,0,0
194654,was,0,0
194655,no,0,0
194656,significant,0,0
194657,difference,0,0
194658,in,0,0
194659,gastrointestinal,0,1
194660,symptoms,0,0
194661,and,0,0
194662,urinary,0,0
194663,I-FABP,0,0
194664,excretion,0,0
194665,.,0,0
194666,CONCLUSION,0,0
194667,Administrating,0,0
194668,gluten-casein,0,1
194669,to,0,0
194670,children,0,1
194671,with,0,1
194672,ASD,0,1
194673,for,0,0
194674,one,0,0
194675,week,0,0
194676,did,0,0
194677,not,0,0
194678,increase,0,0
194679,maladaptive,0,0
194680,behaviour,0,0
194681,",",0,0
194682,gastrointestinal,0,0
194683,symptom,0,0
194684,severity,0,0
194685,or,0,0
194686,urinary,0,0
194687,I-FABP,0,0
194688,excretion,0,0
194689,.,0,0
194690,The,0,0
194691,effect,0,0
194692,of,0,0
194693,prolonged,0,0
194694,administration,0,0
194695,or,0,1
194696,other,0,0
194697,mechanisms,0,0
194698,of,0,0
194699,enterocyte,0,0
194700,damage,0,0
194701,in,0,0
194702,ASD,0,1
194703,should,0,0
194704,be,0,0
194705,explored,0,0
194706,.,0,0
194707,A,0,0
194708,controlled,0,0
194709,trial,0,0
194710,of,0,0
194711,the,0,0
194712,SibworkS,0,0
194713,group,0,0
194714,program,0,0
194715,for,0,0
194716,siblings,1,1
194717,of,1,0
194718,children,1,1
194719,with,1,1
194720,special,1,1
194721,needs,1,0
194722,.,1,1
194723,Siblings,1,0
194724,of,1,0
194725,children,1,1
194726,with,1,1
194727,a,1,0
194728,disability,1,0
194729,are,0,0
194730,an,0,0
194731,at,0,0
194732,risk,0,0
194733,group,0,0
194734,for,0,0
194735,emotional,0,0
194736,and,0,0
194737,behavioral,0,1
194738,problems,0,1
194739,.,0,0
194740,This,0,0
194741,study,0,0
194742,evaluated,0,0
194743,an,0,0
194744,intervention,0,0
194745,to,0,0
194746,promote,0,0
194747,the,0,0
194748,emotional,0,0
194749,and,0,0
194750,behavioral,0,0
194751,functioning,0,0
194752,of,0,0
194753,siblings,1,1
194754,of,1,0
194755,children,1,1
194756,with,1,1
194757,disabilities,1,1
194758,and,1,0
194759,chronic,1,1
194760,health,1,1
194761,conditions,1,0
194762,.,1,0
194763,SibworkS,0,0
194764,is,0,0
194765,a,0,0
194766,six-week,0,0
194767,manual-based,0,0
194768,",",0,0
194769,cognitive-behavioral,0,1
194770,group,0,0
194771,support,0,0
194772,program,0,0
194773,focussed,0,0
194774,on,0,0
194775,strengthening,0,0
194776,siblings,0,1
194777,',0,1
194778,perceived,0,0
194779,social,0,0
194780,support,0,0
194781,",",0,0
194782,self-esteem,0,0
194783,",",0,0
194784,problem-solving,0,0
194785,skills,0,0
194786,",",0,0
194787,adaptive,0,0
194788,coping,0,0
194789,behaviors,0,0
194790,and,0,0
194791,positive,0,0
194792,sibling,0,1
194793,relationships,0,0
194794,.,0,1
194795,Fifty-six,1,1
194796,children,1,1
194797,aged,1,1
194798,7-12,1,1
194799,were,0,0
194800,allocated,0,0
194801,to,0,0
194802,either,0,0
194803,the,0,0
194804,SibworkS,0,0
194805,program,0,0
194806,(,0,0
194807,n=30,0,1
194808,),0,0
194809,or,0,0
194810,waitlist,0,0
194811,control,0,0
194812,(,0,0
194813,n=26,0,1
194814,),0,0
194815,in,0,0
194816,alternating,0,0
194817,sequence,0,0
194818,.,0,0
194819,The,0,0
194820,primary,0,0
194821,outcome,0,0
194822,was,0,0
194823,siblings,0,1
194824,',0,1
194825,emotional,0,0
194826,and,0,0
194827,behavioral,0,0
194828,functioning,0,0
194829,.,0,0
194830,Additional,0,0
194831,outcomes,0,0
194832,were,0,0
194833,self-esteem,0,0
194834,",",0,0
194835,perceived,0,0
194836,social,0,0
194837,support,0,0
194838,",",0,0
194839,the,0,0
194840,sibling,0,0
194841,relationship,0,0
194842,and,0,0
194843,coping,0,0
194844,behaviors,0,0
194845,.,0,1
194846,Siblings,0,0
194847,were,0,0
194848,followed-up,0,1
194849,immediately,0,0
194850,after,0,0
194851,the,0,0
194852,intervention,0,0
194853,and,0,0
194854,at,0,0
194855,3-months,0,0
194856,.,0,1
194857,Siblings,0,0
194858,participating,0,1
194859,in,0,0
194860,the,0,0
194861,SibworkS,0,0
194862,intervention,0,0
194863,were,0,0
194864,reported,0,0
194865,to,0,0
194866,have,0,0
194867,fewer,0,0
194868,emotional,0,0
194869,and,0,0
194870,behavioral,0,0
194871,difficulties,0,0
194872,than,0,0
194873,siblings,0,1
194874,in,0,0
194875,the,0,0
194876,control,0,0
194877,group,0,0
194878,immediately,0,0
194879,following,0,0
194880,the,0,0
194881,intervention,0,0
194882,and,0,0
194883,at,0,0
194884,the,0,0
194885,3-month,0,0
194886,follow-up,0,0
194887,.,0,0
194888,Participation,0,0
194889,in,0,0
194890,SibworkS,0,0
194891,was,0,0
194892,associated,0,0
194893,with,0,1
194894,fewer,0,0
194895,emotional,0,0
194896,and,0,0
194897,behavioral,0,0
194898,difficulties,0,0
194899,for,0,0
194900,siblings,0,1
194901,.,0,1
194902,Implications,0,0
194903,for,0,0
194904,practice,0,0
194905,and,0,0
194906,future,0,0
194907,research,0,0
194908,include,0,0
194909,recommendations,0,0
194910,for,0,0
194911,improving,0,0
194912,program,0,0
194913,participation,0,0
194914,.,0,0
194915,Optimal,0,0
194916,vaccination,0,1
194917,program,0,0
194918,for,0,0
194919,healthy,1,1
194920,adults,1,1
194921,in,1,0
194922,China,1,1
194923,.,1,0
194924,There,0,0
194925,is,0,0
194926,still,0,0
194927,no,0,0
194928,suitable,0,0
194929,routine,0,0
194930,hepatitis,0,1
194931,B,0,0
194932,immunization,0,0
194933,strategy,0,0
194934,for,0,0
194935,adults,1,1
194936,in,1,0
194937,China,1,1
194938,.,1,0
194939,To,0,0
194940,establish,0,0
194941,an,0,0
194942,optimal,0,0
194943,vaccination,0,0
194944,schedule,0,0
194945,for,0,0
194946,healthy,1,1
194947,adults,1,1
194948,",",0,0
194949,we,0,0
194950,investigated,0,0
194951,various,0,0
194952,schedules,0,0
194953,in,0,0
194954,healthy,1,1
194955,adults,1,1
194956,.,1,0
194957,In,0,0
194958,this,0,0
194959,randomized,0,0
194960,5143,1,1
194961,healthy,1,1
194962,adults,1,1
194963,received,1,0
194964,10,1,1
194965,?g,1,0
194966,hepatitis,1,1
194967,B,1,0
194968,vaccine,1,0
194969,at,1,0
194970,0,1,0
194971,",",1,0
194972,1,1,0
194973,and,1,0
194974,3,1,0
194975,months,1,0
194976,(,1,0
194977,group,1,0
194978,A,1,0
194979,),1,0
194980,",",1,0
194981,0,1,0
194982,",",1,0
194983,1,1,0
194984,and,1,0
194985,6,1,0
194986,months,1,0
194987,(,1,0
194988,group,1,0
194989,B,1,0
194990,),1,0
194991,",",1,0
194992,or,1,0
194993,0,1,0
194994,",",1,0
194995,1,1,0
194996,and,1,0
194997,12,1,0
194998,months,1,0
194999,(,1,0
195000,group,1,0
195001,C,1,0
195002,),1,0
195003,.,1,0
195004,Blood,0,0
195005,samples,0,0
195006,were,0,0
195007,collected,0,0
195008,after,0,0
195009,1,0,0
195010,month,0,0
195011,and,0,0
195012,12,0,0
195013,months,0,0
195014,after,0,0
195015,the,0,0
195016,third,0,0
195017,dose,0,0
195018,.,0,0
195019,The,0,0
195020,geometric,0,0
195021,mean,0,0
195022,titer,0,0
195023,(,0,0
195024,GMT,0,0
195025,),0,0
195026,",",0,0
195027,seroconversion,0,0
195028,rate,0,0
195029,(,0,0
195030,levels,0,0
195031,of,0,0
195032,anti-HBs,0,0
195033,?,0,0
195034,10,0,0
195035,mIU/mL,0,0
195036,),0,0
195037,and,0,0
195038,high,0,0
195039,response,0,0
195040,rate,0,0
195041,(,0,0
195042,levels,0,0
195043,of,0,0
195044,anti-HBs,0,0
195045,?,0,0
195046,100,0,0
195047,mIU/mL,0,0
195048,),0,0
195049,were,0,0
195050,assayed,0,0
195051,.,0,0
195052,In,0,0
195053,our,0,0
195054,study,0,0
195055,",",1,0
195056,2438,1,1
195057,healthy,1,1
195058,adults,1,1
195059,finished,1,0
195060,the,1,0
195061,full,1,0
195062,vaccination,1,0
195063,program,1,0
195064,and,1,0
195065,follow-up,1,0
195066,.,1,0
195067,The,1,0
195068,seroconversion/sero-protective,0,0
195069,rate,0,0
195070,of,0,0
195071,groups,0,0
195072,A-C,0,0
195073,at,0,0
195074,one,0,0
195075,and,0,0
195076,12,0,0
195077,month,0,0
195078,after,0,0
195079,administration,0,0
195080,of,0,0
195081,the,0,0
195082,third,0,0
195083,vaccine,0,0
195084,dose,0,0
195085,was,0,0
195086,100,0,0
195087,%,0,0
195088,",",0,0
195089,99.9,0,0
195090,%,0,0
195091,and,0,0
195092,97.9,0,0
195093,%,0,0
195094,verse,0,0
195095,64.9,0,0
195096,%,0,0
195097,",",0,0
195098,75.7,0,0
195099,%,0,0
195100,and,0,0
195101,79.0,0,0
195102,%,0,0
195103,",",0,0
195104,respectively,0,0
195105,.,0,0
195106,GMT,0,0
195107,for,0,0
195108,anti-HBs,0,0
195109,tested,0,0
195110,in,0,0
195111,group,0,0
195112,A,0,0
195113,to,0,0
195114,C,0,0
195115,within,0,0
195116,1,0,0
195117,or,0,1
195118,12,0,0
195119,month,0,0
195120,after,0,0
195121,the,0,0
195122,third,0,0
195123,vaccination,0,1
195124,was,0,0
195125,213.16,0,0
195126,",",0,0
195127,432.58,0,0
195128,and,0,0
195129,451.47,0,0
195130,mIU/ml,0,0
195131,verse,0,0
195132,22.07,0,0
195133,",",0,0
195134,46.70,0,0
195135,and,0,0
195136,56.18,0,0
195137,mIU/ml,0,0
195138,",",0,0
195139,respectively,0,0
195140,.,0,0
195141,There,0,0
195142,were,0,0
195143,significant,0,0
195144,differences,0,0
195145,of,0,0
195146,seroconversion/sero-protective,0,0
195147,rate,0,0
195148,and,0,0
195149,GMT,0,0
195150,among,0,0
195151,the,0,0
195152,3,0,0
195153,groups,0,0
195154,(,0,0
195155,p,0,0
195156,<,0,0
195157,0.01,0,0
195158,),0,0
195159,.,0,0
195160,Given,0,0
195161,the,0,0
195162,high,0,0
195163,anti-HBs,0,0
195164,seroconversion,0,0
195165,rate,0,0
195166,and,0,0
195167,GMT,0,0
195168,in,0,0
195169,all,0,0
195170,3,0,0
195171,groups,0,0
195172,",",0,0
195173,a,0,0
195174,flexible,0,0
195175,schedule,0,0
195176,for,0,0
195177,Hepatitis,0,1
195178,B,0,0
195179,vaccine,0,0
195180,should,0,0
195181,be,0,0
195182,recommended,0,0
195183,to,0,0
195184,adults,0,1
195185,",",0,0
195186,but,0,0
195187,0-1-12,0,0
195188,schedule,0,0
195189,is,0,0
195190,a,0,0
195191,better,0,0
195192,choice,0,0
195193,.,0,0
195194,Brief,0,0
195195,Report,0,0
195196,:,0,1
195197,Cobicistat,0,0
195198,Compared,0,0
195199,With,0,1
195200,Ritonavir,0,0
195201,as,0,0
195202,a,0,0
195203,Pharmacoenhancer,0,0
195204,for,0,0
195205,Atazanavir,0,1
195206,in,0,0
195207,Combination,0,0
195208,With,0,1
195209,Emtricitabine/Tenofovir,0,0
195210,Disoproxil,0,1
195211,Fumarate,0,0
195212,:,0,1
195213,Week,0,1
195214,144,0,1
195215,Results,0,0
195216,.,0,1
195217,BACKGROUND,0,0
195218,Cobicistat,0,0
195219,(,0,0
195220,COBI,0,0
195221,),0,0
195222,is,0,0
195223,a,0,0
195224,pharmacoenhancer,0,0
195225,with,0,0
195226,no,0,0
195227,antiretroviral,0,1
195228,activity,0,0
195229,.,0,0
195230,METHODS,0,0
195231,International,0,0
195232,",",0,0
195233,randomized,0,0
195234,double-blind,0,0
195235,active-controlled,0,0
195236,trial,0,0
195237,to,0,0
195238,evaluate,0,0
195239,the,0,0
195240,efficacy,0,0
195241,and,0,0
195242,safety,0,0
195243,of,0,0
195244,COBI,0,0
195245,vs,0,0
195246,ritonavir,0,0
195247,(,0,0
195248,RTV,0,0
195249,),0,0
195250,as,0,0
195251,a,0,0
195252,pharmacoenhancer,0,0
195253,of,0,0
195254,atazanavir,0,0
195255,in,0,0
195256,combination,0,0
195257,with,0,1
195258,emtricitabine/tenofovir,0,0
195259,disoproxil,0,0
195260,fumarate,0,0
195261,in,0,0
195262,HIV,1,0
195263,treatment-naive,1,1
195264,patients,1,1
195265,followed,0,0
195266,through,0,0
195267,week,0,0
195268,144,0,1
195269,.,0,0
195270,RESULTS,0,0
195271,At,0,0
195272,Week,0,0
195273,144,0,1
195274,",",0,0
195275,virologic,0,0
195276,suppression,0,0
195277,was,0,0
195278,achieved,0,0
195279,in,0,0
195280,72,0,0
195281,%,0,0
195282,(,0,0
195283,COBI,0,0
195284,),0,0
195285,and,0,0
195286,74,0,0
195287,%,0,0
195288,(,0,0
195289,RTV,0,0
195290,),0,0
195291,of,0,0
195292,patients,0,1
195293,.,0,1
195294,Adverse,0,0
195295,events,0,0
195296,leading,0,0
195297,to,0,0
195298,study,0,0
195299,drug,0,0
195300,discontinuation,0,0
195301,occurred,0,0
195302,in,0,0
195303,11,0,0
195304,%,0,0
195305,of,0,0
195306,patients,0,1
195307,in,0,0
195308,each,0,0
195309,group,0,0
195310,.,0,0
195311,Median,0,0
195312,changes,0,0
195313,in,0,0
195314,serum,0,0
195315,creatinine,0,0
195316,(,0,0
195317,mg/dL,0,0
195318,),0,0
195319,were,0,0
195320,+0.13,0,0
195321,(,0,0
195322,COBI,0,0
195323,),0,0
195324,and,0,0
195325,+0.07,0,0
195326,(,0,0
195327,RTV,0,0
195328,),0,0
195329,and,0,0
195330,were,0,0
195331,unchanged,0,0
195332,from,0,0
195333,week,0,0
195334,48,0,0
195335,.,0,0
195336,CONCLUSIONS,0,0
195337,Once-daily,0,0
195338,COBI,0,0
195339,is,0,0
195340,a,0,0
195341,safe,0,0
195342,and,0,0
195343,effective,0,0
195344,pharmacoenhancer,0,0
195345,of,0,0
195346,the,0,0
195347,protease,0,0
195348,inhibitor,0,0
195349,atazanavir,0,0
195350,.,0,0
195351,A,0,0
195352,Double-Blind,0,0
195353,Placebo-Controlled,0,0
195354,Study,0,0
195355,of,0,0
195356,the,0,0
195357,Effects,0,0
195358,of,0,0
195359,Olprinone,0,0
195360,",",0,0
195361,a,0,0
195362,Specific,0,0
195363,Phosphodiesterase,0,0
195364,III,0,0
195365,Inhibitor,0,0
195366,",",0,0
195367,for,0,0
195368,Preventing,0,0
195369,Postoperative,0,0
195370,Atrial,0,0
195371,Fibrillation,0,1
195372,in,0,0
195373,Patients,1,1
195374,Undergoing,1,1
195375,Pulmonary,1,0
195376,Resection,1,1
195377,for,1,0
195378,Lung,1,0
195379,Cancer,1,0
195380,.,1,0
195381,BACKGROUND,0,0
195382,We,0,0
195383,previously,0,0
195384,reported,0,0
195385,that,0,0
195386,patients,0,1
195387,with,0,1
195388,elevated,1,0
195389,preoperative,1,0
195390,B-type,1,0
195391,natriuretic,1,0
195392,peptide,1,0
195393,(,1,0
195394,BNP,1,0
195395,),1,0
195396,levels,1,0
195397,have,0,0
195398,an,0,0
195399,increased,0,0
195400,risk,0,0
195401,for,0,0
195402,postoperative,0,0
195403,atrial,0,1
195404,fibrillation,0,1
195405,following,0,0
195406,lung,0,0
195407,cancer,0,1
195408,surgery,0,1
195409,.,0,0
195410,The,0,0
195411,present,0,0
195412,study,0,0
195413,evaluated,0,0
195414,whether,0,0
195415,the,0,0
195416,specific,0,0
195417,phosphodiesterase,0,0
195418,III,0,0
195419,inhibitor,0,0
195420,olprinone,0,0
195421,can,0,0
195422,reduce,0,0
195423,the,0,0
195424,incidence,0,0
195425,of,0,0
195426,postoperative,0,0
195427,atrial,0,1
195428,fibrillation,0,1
195429,in,0,0
195430,patients,0,1
195431,with,0,1
195432,elevated,0,0
195433,BNP,0,0
195434,levels,0,0
195435,undergoing,0,1
195436,pulmonary,0,1
195437,resection,0,1
195438,for,0,0
195439,lung,0,1
195440,cancer,0,1
195441,.,0,0
195442,METHODS,0,0
195443,A,0,0
195444,prospective,0,0
195445,randomized,0,0
195446,study,0,0
195447,was,0,0
195448,conducted,0,0
195449,with,0,1
195450,40,1,1
195451,patients,1,1
195452,who,1,1
195453,had,1,1
195454,elevated,1,1
195455,preoperative,1,0
195456,BNP,1,0
195457,levels,1,0
195458,(,1,0
195459,?,1,0
195460,30,1,0
195461,pg/mL,1,0
195462,),1,0
195463,and,1,0
195464,underwent,1,1
195465,scheduled,1,1
195466,lung,1,0
195467,cancer,1,1
195468,surgery,1,1
195469,.,1,0
195470,All,1,0
195471,patients,1,1
195472,were,1,0
195473,in,1,0
195474,sinus,1,1
195475,rhythm,1,1
195476,at,1,0
195477,surgery,1,1
195478,.,1,0
195479,Low-dose,0,0
195480,olprinone,0,0
195481,or,0,0
195482,placebo,0,0
195483,was,0,0
195484,continuously,0,0
195485,infused,0,0
195486,for,0,0
195487,24,0,0
195488,h,0,0
195489,and,0,0
195490,started,0,0
195491,just,0,0
195492,before,0,0
195493,anesthesia,0,0
195494,induction,0,0
195495,.,0,0
195496,The,0,0
195497,primary,0,0
195498,end,0,0
195499,point,0,0
195500,was,0,0
195501,the,0,0
195502,incidence,0,0
195503,of,0,0
195504,postoperative,0,0
195505,atrial,0,1
195506,fibrillation,0,1
195507,.,0,0
195508,The,0,0
195509,secondary,0,0
195510,end,0,0
195511,points,0,0
195512,were,0,0
195513,perioperative,0,0
195514,hemodynamics,0,0
195515,and,0,0
195516,levels,0,0
195517,of,0,0
195518,BNP,0,0
195519,",",0,0
195520,WBC,0,0
195521,counts,0,0
195522,",",0,0
195523,and,0,0
195524,C-reactive,0,0
195525,protein,0,0
195526,.,0,0
195527,RESULTS,0,0
195528,The,0,0
195529,incidence,0,0
195530,of,0,0
195531,postoperative,0,0
195532,atrial,0,1
195533,fibrillation,0,1
195534,was,0,0
195535,significantly,0,0
195536,lower,0,0
195537,in,0,0
195538,the,0,0
195539,olprinone,0,0
195540,group,0,0
195541,than,0,0
195542,in,0,0
195543,the,0,0
195544,placebo,0,0
195545,group,0,0
195546,(,0,0
195547,10,0,0
195548,%,0,0
195549,vs,0,0
195550,60,0,0
195551,%,0,0
195552,",",0,0
195553,P,0,0
195554,<,0,0
195555,.001,0,0
195556,),0,0
195557,.,0,0
195558,Patients,0,1
195559,in,0,0
195560,the,0,0
195561,olprinone,0,0
195562,group,0,0
195563,showed,0,0
195564,significantly,0,0
195565,lower,0,0
195566,BNP,0,0
195567,",",0,0
195568,WBC,0,0
195569,counts,0,0
195570,",",0,0
195571,and,0,0
195572,C-reactive,0,0
195573,protein,0,0
195574,levels,0,0
195575,after,0,0
195576,surgery,0,1
195577,.,0,0
195578,CONCLUSIONS,0,0
195579,Continuous,0,0
195580,infusion,0,0
195581,of,0,0
195582,olprinone,0,0
195583,during,0,0
195584,lung,0,0
195585,cancer,0,1
195586,surgery,0,1
195587,was,0,0
195588,safe,0,0
195589,and,0,0
195590,reduced,0,0
195591,the,0,0
195592,incidence,0,0
195593,of,0,0
195594,postoperative,0,0
195595,atrial,0,1
195596,fibrillation,0,1
195597,following,0,0
195598,pulmonary,0,0
195599,resection,0,1
195600,in,0,0
195601,patients,0,1
195602,with,0,1
195603,elevated,0,0
195604,preoperative,0,0
195605,BNP,0,0
195606,levels,0,0
195607,.,0,1
195608,TRIAL,0,0
195609,REGISTRY,0,0
195610,Japan,0,1
195611,Primary,0,1
195612,Registries,0,1
195613,Network,0,0
195614,;,0,0
195615,No,0,0
195616,.,0,0
195617,:,0,0
195618,JPRN-UMIN2404,0,0
195619,;,0,0
195620,URL,0,0
195621,:,0,1
195622,http,0,0
195623,:,0,1
195624,//www.umin.ac.jp/ctr/,0,0
195625,.,0,0
195626,Radiofrequency,0,0
195627,thermocoagulation,0,0
195628,combined,0,0
195629,with,0,0
195630,pulsed,0,0
195631,radiofrequency,0,0
195632,helps,0,0
195633,relieve,0,0
195634,postoperative,0,0
195635,complications,0,0
195636,of,0,0
195637,trigeminal,0,1
195638,neuralgia,0,1
195639,.,0,0
195640,Trigeminal,0,0
195641,neuralgia,0,0
195642,is,0,0
195643,a,0,0
195644,sudden,0,0
195645,",",0,0
195646,severe,0,1
195647,condition,0,0
195648,characterized,0,0
195649,by,0,0
195650,stabbing,0,0
195651,and,0,0
195652,recurrent,0,1
195653,pain,0,0
195654,.,0,0
195655,Radiofrequency,0,0
195656,thermocoagulation,0,0
195657,(,0,0
195658,RFT,0,1
195659,),0,0
195660,and,0,0
195661,pulsed,0,0
195662,radiofrequency,0,0
195663,(,0,0
195664,PRF,0,1
195665,),0,0
195666,are,0,0
195667,common,0,0
195668,surgical,0,1
195669,interventions,0,0
195670,used,0,0
195671,to,0,0
195672,treat,0,0
195673,trigeminal,0,0
195674,neuralgia,0,0
195675,.,0,0
195676,This,0,0
195677,study,0,0
195678,aimed,0,0
195679,to,0,0
195680,investigate,0,0
195681,the,0,0
195682,therapeutic,0,0
195683,effects,0,0
195684,and,0,0
195685,associated,0,0
195686,complications,0,0
195687,of,0,0
195688,a,0,0
195689,combination,0,0
195690,of,0,0
195691,RFT,0,1
195692,and,0,0
195693,PRF,0,0
195694,in,0,0
195695,the,0,0
195696,treatment,0,0
195697,of,0,0
195698,trigeminal,0,0
195699,neuralgia,0,1
195700,.,0,0
195701,Computed,0,0
195702,tomography-guided,0,0
195703,percutaneous,0,1
195704,RFT,0,1
195705,of,0,0
195706,the,0,0
195707,Gasserian,0,1
195708,ganglion,0,0
195709,was,0,0
195710,performed,0,0
195711,on,0,0
195712,80,1,1
195713,patients,1,1
195714,with,1,1
195715,trigeminal,1,1
195716,neuralgia,1,1
195717,.,1,1
195718,Patients,0,1
195719,were,0,0
195720,randomly,0,1
195721,assigned,0,0
195722,to,0,0
195723,either,0,0
195724,group,0,0
195725,A,0,0
195726,(,0,0
195727,RFT,0,1
195728,at,0,0
195729,70?C,0,1
195730,),0,0
195731,or,0,0
195732,group,0,0
195733,B,0,0
195734,(,0,0
195735,RFT,0,1
195736,at,0,0
195737,75?C,0,1
195738,),0,0
195739,.,0,0
195740,Patients,0,1
195741,in,0,0
195742,each,0,0
195743,group,0,0
195744,were,0,0
195745,divided,0,0
195746,into,0,1
195747,2,0,0
195748,subgroups,0,0
195749,",",0,0
195750,receiving,0,1
195751,percutaneous,0,1
195752,RFT,0,1
195753,(,0,0
195754,240,0,0
195755,s,0,0
195756,),0,0
195757,with,0,0
195758,or,0,0
195759,without,0,0
195760,PRF,0,1
195761,(,0,0
195762,42?C,0,1
195763,",",0,0
195764,2,0,0
195765,Hz,0,0
195766,",",0,0
195767,240,0,0
195768,s,0,0
195769,),0,0
195770,.,0,0
195771,Six,0,0
195772,months,0,0
195773,later,0,0
195774,",",0,0
195775,pain,0,0
195776,relief,0,0
195777,and,0,0
195778,complication,0,0
195779,status,0,0
195780,were,0,0
195781,evaluated,0,0
195782,.,0,0
195783,There,0,0
195784,was,0,0
195785,no,0,0
195786,significant,0,0
195787,difference,0,0
195788,in,0,0
195789,visual,0,0
195790,analogue,0,0
195791,scores,0,0
195792,among,0,1
195793,groups,0,0
195794,with,0,1
195795,RFT,0,1
195796,at,0,0
195797,70?,0,1
195798,or,0,0
195799,75?C,0,0
195800,",",0,0
195801,with,0,0
195802,or,0,0
195803,without,0,1
195804,PRF,0,1
195805,.,0,1
195806,Data,0,0
195807,showed,0,0
195808,that,0,0
195809,facial,0,0
195810,numbness,0,0
195811,and,0,0
195812,postoperative,0,0
195813,masticatory,0,1
195814,muscle,0,0
195815,weakness,0,0
195816,recovered,0,0
195817,more,0,0
195818,rapidly,0,0
195819,in,0,0
195820,patients,0,1
195821,receiving,0,1
195822,combined,0,0
195823,RFT,0,1
195824,and,0,0
195825,PRF,0,1
195826,treatment,0,0
195827,.,0,0
195828,Decreased,0,0
195829,corneal,0,0
195830,reflex,0,0
195831,was,0,0
195832,relieved,0,0
195833,to,0,0
195834,a,0,0
195835,significantly,0,0
195836,greater,0,0
195837,extent,0,0
195838,in,0,0
195839,groups,0,0
195840,receiving,0,1
195841,PRF,0,1
195842,than,0,0
195843,those,0,0
195844,without,0,0
195845,.,0,0
195846,Thus,0,0
195847,",",0,0
195848,compared,0,0
195849,to,0,0
195850,the,0,0
195851,use,0,0
195852,of,0,0
195853,RFT,0,1
195854,at,0,0
195855,75?C,0,0
195856,alone,0,0
195857,",",0,0
195858,the,0,0
195859,combination,0,0
195860,of,0,0
195861,PRF,0,1
195862,and,0,0
195863,RFT,0,1
195864,helped,0,0
195865,eliminate,0,0
195866,postoperative,0,0
195867,complications,0,0
195868,",",0,0
195869,such,0,0
195870,as,0,0
195871,facial,0,0
195872,numbness,0,0
195873,",",0,0
195874,masticatory,0,1
195875,muscle,0,0
195876,weakness,0,0
195877,",",0,0
195878,and,0,0
195879,decreased,0,0
195880,corneal,0,0
195881,reflex,0,0
195882,",",0,0
195883,indicating,0,0
195884,that,0,0
195885,it,0,0
195886,could,0,0
195887,be,0,0
195888,useful,0,0
195889,for,0,0
195890,surgically,0,1
195891,treating,0,0
195892,trigeminal,0,0
195893,neuralgia,0,1
195894,.,0,0
195895,A,0,0
195896,Comparison,0,0
195897,of,0,0
195898,Outcomes,0,0
195899,Following,0,0
195900,Laparoscopic,0,1
195901,and,0,0
195902,Open,0,0
195903,Hysterectomy,0,1
195904,With,0,1
195905,or,0,0
195906,Without,0,0
195907,Lymphadenectomy,0,1
195908,for,0,0
195909,Presumed,1,1
195910,Early-Stage,1,1
195911,Endometrial,1,1
195912,Cancer,1,1
195913,:,1,1
195914,Results,0,0
195915,From,0,1
195916,the,0,0
195917,Medical,0,1
195918,Research,0,0
195919,Council,0,1
195920,ASTEC,0,0
195921,Trial,0,0
195922,.,0,0
195923,OBJECTIVES,0,0
195924,Laparoscopic,0,0
195925,hysterectomy,0,1
195926,(,0,0
195927,LH,0,0
195928,),0,0
195929,is,0,0
195930,increasingly,0,0
195931,used,0,0
195932,for,0,0
195933,the,0,0
195934,management,0,0
195935,of,0,0
195936,endometrial,0,1
195937,malignancy,0,1
195938,.,0,0
195939,Its,0,0
195940,benefits,0,0
195941,may,0,0
195942,be,0,0
195943,particularly,0,0
195944,pronounced,0,0
195945,as,0,0
195946,these,0,0
195947,women,1,1
195948,are,1,0
195949,more,1,0
195950,likely,1,0
195951,to,1,0
195952,be,1,0
195953,older,1,1
195954,or,1,0
195955,obese,1,1
195956,.,1,0
195957,The,0,0
195958,aim,0,0
195959,of,0,0
195960,this,0,0
195961,study,0,0
195962,was,0,0
195963,to,0,0
195964,determine,0,0
195965,whether,0,0
195966,outcomes,0,0
195967,for,0,0
195968,LH,0,1
195969,are,0,0
195970,comparable,0,0
195971,to,0,0
195972,the,0,0
195973,open,0,0
195974,hysterectomy,0,1
195975,(,0,0
195976,OH,0,0
195977,),0,0
195978,.,0,0
195979,DESIGN,0,0
195980,This,0,0
195981,was,0,0
195982,a,0,0
195983,prospective,0,0
195984,cohort,0,1
195985,study,0,0
195986,nested,0,0
195987,within,0,0
195988,the,0,0
195989,multicenter,0,0
195990,ASTEC,0,0
195991,(,0,0
195992,A,0,0
195993,Study,0,0
195994,in,0,0
195995,the,0,0
195996,Treatment,0,0
195997,of,0,0
195998,Endometrial,0,1
195999,Cancer,0,1
196000,),0,0
196001,randomized,0,0
196002,controlled,0,0
196003,trial,0,0
196004,(,0,0
196005,1998-2005,0,1
196006,),0,0
196007,.,0,0
196008,POPULATION,0,0
196009,Women,1,1
196010,with,1,1
196011,presumed,1,1
196012,early,1,1
196013,endometrial,1,1
196014,cancer,1,1
196015,were,1,0
196016,included,1,1
196017,.,1,0
196018,METHODS,0,0
196019,Laparoscopic,0,0
196020,hysterectomy,0,1
196021,was,0,0
196022,compared,0,0
196023,with,0,1
196024,OH,0,0
196025,with,0,1
196026,or,0,0
196027,without,0,0
196028,systematic,0,0
196029,lymphadenectomy,0,1
196030,.,0,0
196031,MAIN,0,0
196032,OUTCOME,0,0
196033,MEASURES,0,0
196034,Overall,0,0
196035,survival,0,0
196036,",",0,0
196037,time,0,0
196038,to,0,0
196039,first,0,0
196040,recurrence,0,0
196041,",",0,0
196042,complication,0,0
196043,rates,0,0
196044,",",0,0
196045,and,0,0
196046,surgical,0,1
196047,outcomes,0,0
196048,were,0,0
196049,the,0,0
196050,main,0,0
196051,outcome,0,0
196052,measures,0,0
196053,.,0,0
196054,RESULTS,0,0
196055,Of,0,1
196056,1408,1,1
196057,women,1,1
196058,",",1,0
196059,1309,1,1
196060,(,1,0
196061,93,1,1
196062,%,1,0
196063,),1,0
196064,received,1,0
196065,OH,1,0
196066,",",0,0
196067,and,0,0
196068,99,1,1
196069,(,1,0
196070,7,1,0
196071,%,1,0
196072,),1,0
196073,had,1,0
196074,LH,1,1
196075,.,1,0
196076,LH,0,0
196077,was,0,0
196078,associated,0,0
196079,with,0,0
196080,longer,0,0
196081,operating,0,0
196082,time,0,0
196083,(,0,0
196084,median,0,0
196085,",",0,0
196086,LH,0,1
196087,105,0,1
196088,minutes,0,0
196089,[,0,0
196090,interquartile,0,0
196091,range,0,0
196092,(,0,0
196093,IQR,0,0
196094,),0,0
196095,",",0,0
196096,60-150,0,0
196097,],0,0
196098,vs,0,0
196099,OH,0,0
196100,80,0,1
196101,minutes,0,0
196102,[,0,0
196103,IQR,0,0
196104,",",0,0
196105,60-95,0,1
196106,],0,0
196107,;,0,0
196108,P,0,0
196109,<,0,0
196110,0.001,0,0
196111,),0,0
196112,but,0,0
196113,50,0,0
196114,%,0,0
196115,shorter,0,0
196116,hospital,0,0
196117,stay,0,0
196118,(,0,0
196119,median,0,0
196120,",",0,0
196121,LH,0,1
196122,4,0,0
196123,days,0,0
196124,[,0,0
196125,IQR,0,0
196126,",",0,0
196127,3-5,0,0
196128,],0,0
196129,vs,0,0
196130,OH,0,0
196131,6,0,0
196132,days,0,0
196133,[,0,0
196134,IQR,0,0
196135,",",0,0
196136,5-7,0,0
196137,],0,0
196138,),0,0
196139,.,0,0
196140,The,0,0
196141,number,0,0
196142,of,0,0
196143,harvested,0,0
196144,lymph,0,1
196145,nodes,0,0
196146,was,0,0
196147,similar,0,0
196148,(,0,0
196149,median,0,0
196150,",",0,0
196151,LH,0,1
196152,13,0,0
196153,[,0,0
196154,IQR,0,0
196155,",",0,0
196156,10-16,0,0
196157,],0,0
196158,vs,0,0
196159,OH,0,0
196160,12,0,0
196161,[,0,0
196162,IQR,0,0
196163,",",0,0
196164,11-13,0,1
196165,],0,0
196166,;,0,0
196167,P,0,0
196168,=,0,0
196169,0.67,0,0
196170,),0,0
196171,.,0,0
196172,LH,0,0
196173,had,0,0
196174,fewer,0,0
196175,intraoperative,0,0
196176,and,0,0
196177,postoperative,0,0
196178,adverse,0,0
196179,events,0,0
196180,(,0,0
196181,9,0,0
196182,%,0,0
196183,difference,0,0
196184,",",0,0
196185,LH,0,0
196186,21,0,1
196187,%,0,0
196188,vs,0,0
196189,OH,0,0
196190,30,0,1
196191,%,0,0
196192,;,0,0
196193,borderline,0,1
196194,significance,0,0
196195,;,0,0
196196,P,0,0
196197,=,0,0
196198,0.07,0,0
196199,),0,0
196200,.,0,0
196201,The,0,0
196202,rate,0,0
196203,of,0,0
196204,conversion,0,0
196205,to,0,0
196206,laparotomy,0,1
196207,for,0,0
196208,the,0,0
196209,LH,0,0
196210,group,0,0
196211,was,0,0
196212,high,0,0
196213,(,0,0
196214,27,0,1
196215,%,0,0
196216,),0,0
196217,.,0,0
196218,The,0,0
196219,median,0,0
196220,follow-up,0,0
196221,was,0,0
196222,37,0,1
196223,months,0,0
196224,.,0,0
196225,After,0,0
196226,adjusting,0,0
196227,for,0,0
196228,significant,0,0
196229,prognostic,0,0
196230,factors,0,0
196231,",",0,0
196232,the,0,0
196233,hazard,0,0
196234,ratio,0,0
196235,for,0,0
196236,overall,0,0
196237,survival,0,0
196238,in,0,0
196239,those,0,1
196240,who,0,1
196241,underwent,0,1
196242,LH,0,1
196243,compared,0,0
196244,with,0,1
196245,those,0,1
196246,who,0,1
196247,underwent,0,1
196248,OH,0,1
196249,was,0,0
196250,0.67,0,0
196251,(,0,0
196252,95,0,0
196253,%,0,0
196254,confidence,0,0
196255,interval,0,0
196256,",",0,0
196257,0.31-1.43,0,0
196258,),0,0
196259,(,0,0
196260,P,0,0
196261,=,0,0
196262,0.30,0,0
196263,),0,0
196264,.,0,0
196265,CONCLUSIONS,0,0
196266,Laparoscopic,0,0
196267,hysterectomy,0,1
196268,for,0,0
196269,early,0,0
196270,endometrial,0,1
196271,cancer,0,1
196272,is,0,0
196273,safe,0,0
196274,.,0,0
196275,Although,0,0
196276,it,0,0
196277,requires,0,0
196278,longer,0,0
196279,operating,0,0
196280,time,0,0
196281,it,0,0
196282,is,0,0
196283,associated,0,0
196284,with,0,0
196285,shorter,0,0
196286,hospital,0,0
196287,stay,0,0
196288,and,0,0
196289,favorable,0,0
196290,morbidity,0,0
196291,profile,0,0
196292,.,0,0
196293,Further,0,0
196294,studies,0,0
196295,are,0,0
196296,required,0,0
196297,to,0,0
196298,assess,0,0
196299,the,0,0
196300,long-term,0,0
196301,safety,0,0
196302,.,0,0
196303,Inference-Based,0,0
196304,Approach,0,0
196305,versus,0,0
196306,Cognitive,0,0
196307,Behavioral,0,0
196308,Therapy,0,0
196309,in,0,0
196310,the,0,0
196311,Treatment,0,0
196312,of,0,0
196313,Obsessive-Compulsive,1,0
196314,Disorder,1,1
196315,with,1,1
196316,Poor,1,1
196317,Insight,1,0
196318,:,1,1
196319,A,0,0
196320,24-Session,0,0
196321,Randomized,0,0
196322,Controlled,0,0
196323,Trial,0,0
196324,.,0,0
196325,OBJECTIVE,0,0
196326,Obsessive-compulsive,0,0
196327,disorder,0,1
196328,(,0,0
196329,OCD,0,0
196330,),0,0
196331,with,0,1
196332,poor,0,0
196333,insight,0,0
196334,has,0,0
196335,severe,0,1
196336,consequences,0,0
196337,for,0,1
196338,patients,0,1
196339,;,0,0
196340,nonetheless,0,0
196341,",",0,0
196342,no,0,0
196343,randomized,0,0
196344,controlled,0,0
196345,trial,0,0
196346,has,0,0
196347,ever,0,0
196348,been,0,0
196349,performed,0,0
196350,to,0,0
196351,evaluate,0,0
196352,the,0,0
196353,effectiveness,0,0
196354,of,0,0
196355,any,0,0
196356,treatment,0,0
196357,specifically,0,0
196358,for,0,0
196359,poor-insight,0,0
196360,OCD,0,0
196361,.,0,0
196362,A,0,0
196363,new,0,0
196364,psychotherapy,0,0
196365,for,0,0
196366,OCD,0,0
196367,",",0,0
196368,the,0,0
196369,inference-based,0,0
196370,approach,0,0
196371,(,0,0
196372,IBA,0,0
196373,),0,0
196374,",",0,0
196375,targets,0,0
196376,insight,0,0
196377,in,0,0
196378,OCD,0,0
196379,by,0,0
196380,strengthening,0,0
196381,normal,0,1
196382,sensory-driven,0,0
196383,reality,0,0
196384,testing,0,0
196385,.,0,0
196386,The,0,0
196387,goal,0,0
196388,of,0,0
196389,the,0,0
196390,present,0,0
196391,study,0,0
196392,is,0,0
196393,to,0,0
196394,compare,0,0
196395,the,0,0
196396,effectiveness,0,0
196397,of,0,0
196398,this,0,0
196399,new,0,0
196400,treatment,0,0
196401,to,0,0
196402,the,0,0
196403,effectiveness,0,0
196404,of,0,0
196405,cognitive,0,0
196406,behavior,0,0
196407,therapy,0,0
196408,(,0,0
196409,CBT,0,0
196410,),0,0
196411,for,0,0
196412,patients,1,1
196413,with,1,1
196414,OCD,1,0
196415,with,1,1
196416,poor,1,1
196417,insight,1,0
196418,.,1,0
196419,METHOD,0,0
196420,A,0,0
196421,randomized,0,0
196422,controlled,0,0
196423,trial,0,0
196424,was,0,0
196425,conducted,0,0
196426,",",0,0
196427,in,0,0
196428,which,0,0
196429,90,1,0
196430,patients,1,1
196431,with,1,1
196432,OCD,1,0
196433,with,1,1
196434,poor,1,1
196435,insight,1,0
196436,received,1,0
196437,either,1,0
196438,24,1,0
196439,CBT,1,0
196440,sessions,1,0
196441,or,1,1
196442,24,1,0
196443,IBA,1,1
196444,sessions,1,0
196445,.,1,0
196446,The,0,0
196447,primary,0,0
196448,outcome,0,0
196449,measure,0,0
196450,was,0,0
196451,the,0,0
196452,Yale-Brown,0,0
196453,Obsessive,0,0
196454,Compulsive,0,0
196455,Scale,0,0
196456,(,0,0
196457,YBOCS,0,0
196458,),0,0
196459,.,0,0
196460,Secondary,0,0
196461,outcome,0,0
196462,measures,0,0
196463,were,0,0
196464,level,0,0
196465,of,0,0
196466,insight,0,0
196467,",",0,0
196468,anxiety,0,0
196469,and,0,0
196470,depressive,0,0
196471,symptoms,0,0
196472,",",0,0
196473,and,0,0
196474,quality,0,0
196475,of,0,0
196476,life,0,0
196477,.,0,1
196478,Mixed-effects,0,0
196479,models,0,0
196480,were,0,0
196481,used,0,0
196482,to,0,0
196483,determine,0,0
196484,the,0,0
196485,treatment,0,0
196486,effect,0,0
196487,.,0,0
196488,RESULTS,0,0
196489,In,0,0
196490,both,0,0
196491,conditions,0,0
196492,",",0,0
196493,a,0,0
196494,significant,0,0
196495,OCD,0,0
196496,symptom,0,0
196497,reduction,0,0
196498,was,0,0
196499,reached,0,0
196500,",",0,0
196501,but,0,0
196502,no,0,0
196503,condition,0,0
196504,effects,0,0
196505,were,0,0
196506,established,0,0
196507,.,0,0
196508,Post,0,0
196509,hoc,0,0
196510,",",0,0
196511,in,0,0
196512,a,0,0
196513,small,0,0
196514,subgroup,0,1
196515,of,0,0
196516,patients,0,1
196517,with,0,1
196518,the,0,0
196519,worst,0,0
196520,insight,0,0
196521,(,0,0
196522,n,0,1
196523,=,0,0
196524,23,0,1
196525,),0,0
196526,",",0,0
196527,it,0,0
196528,was,0,0
196529,found,0,0
196530,that,0,0
196531,the,0,0
196532,patients,0,1
196533,treated,0,1
196534,with,0,1
196535,the,0,0
196536,IBA,0,0
196537,reached,0,0
196538,a,0,0
196539,significantly,0,0
196540,higher,0,0
196541,OCD,0,0
196542,symptom,0,0
196543,reduction,0,0
196544,than,0,0
196545,the,0,0
196546,patients,0,1
196547,treated,0,1
196548,with,0,1
196549,CBT,0,0
196550,[,0,0
196551,estimated,0,0
196552,marginal,0,0
196553,mean,0,1
196554,=,0,0
196555,-7.77,0,0
196556,",",0,0
196557,t,0,0
196558,(,0,0
196559,219.45,0,0
196560,),0,0
196561,=,0,0
196562,-2.4,0,0
196563,",",0,0
196564,p,0,0
196565,=,0,0
196566,0.017,0,0
196567,],0,0
196568,.,0,1
196569,CONCLUSION,0,0
196570,Patients,1,1
196571,with,1,1
196572,OCD,1,1
196573,with,1,1
196574,poor,1,1
196575,insight,1,0
196576,improve,0,0
196577,significantly,0,0
196578,after,0,0
196579,psychological,0,0
196580,treatment,0,0
196581,.,0,0
196582,The,0,0
196583,results,0,0
196584,of,0,0
196585,this,0,0
196586,study,0,0
196587,suggest,0,0
196588,that,0,0
196589,both,0,0
196590,CBT,0,0
196591,and,0,0
196592,the,0,0
196593,IBA,0,0
196594,are,0,0
196595,effective,0,0
196596,treatments,0,0
196597,for,0,0
196598,OCD,0,0
196599,with,0,1
196600,poor,0,1
196601,insight,0,0
196602,.,0,0
196603,The,0,0
196604,IBA,0,0
196605,might,0,0
196606,be,0,0
196607,more,0,0
196608,promising,0,0
196609,than,0,0
196610,CBT,0,0
196611,for,0,0
196612,patients,0,1
196613,with,0,0
196614,more,0,0
196615,extreme,0,0
196616,poor,0,0
196617,insight,0,0
196618,.,0,0
196619,The,0,0
196620,VA,0,0
196621,augmentation,0,0
196622,and,0,0
196623,switching,0,0
196624,treatments,0,0
196625,for,0,0
196626,improving,0,0
196627,depression,0,1
196628,outcomes,0,0
196629,(,0,0
196630,VAST-D,0,0
196631,),0,0
196632,study,0,0
196633,:,0,1
196634,Rationale,0,0
196635,and,0,0
196636,design,0,0
196637,considerations,0,0
196638,.,0,0
196639,Because,0,0
196640,two-thirds,0,0
196641,of,0,0
196642,patients,1,1
196643,with,1,1
196644,Major,1,1
196645,Depressive,1,0
196646,Disorder,1,0
196647,do,0,0
196648,not,0,0
196649,achieve,0,0
196650,remission,0,0
196651,with,0,0
196652,their,0,0
196653,first,0,0
196654,antidepressant,0,0
196655,",",0,0
196656,we,0,0
196657,designed,0,0
196658,a,0,0
196659,trial,0,0
196660,of,0,0
196661,three,0,0
196662,next-step,0,0
196663,strategies,0,0
196664,:,0,1
196665,switching,0,0
196666,to,0,0
196667,another,0,0
196668,antidepressant,0,0
196669,(,0,0
196670,bupropion-SR,0,0
196671,),0,0
196672,or,0,0
196673,augmenting,0,0
196674,the,0,0
196675,current,0,0
196676,antidepressant,0,0
196677,with,0,0
196678,either,0,0
196679,another,0,0
196680,antidepressant,0,0
196681,(,0,0
196682,bupropion-SR,0,0
196683,),0,0
196684,or,0,0
196685,with,0,0
196686,an,0,0
196687,atypical,0,0
196688,antipsychotic,0,0
196689,(,0,0
196690,aripiprazole,0,0
196691,),0,0
196692,.,0,0
196693,The,0,0
196694,study,0,0
196695,will,0,0
196696,compare,0,0
196697,12-week,0,0
196698,remission,0,0
196699,rates,0,0
196700,and,0,0
196701,",",0,0
196702,among,0,1
196703,those,0,1
196704,who,0,1
196705,have,0,0
196706,at,0,1
196707,least,0,0
196708,a,0,0
196709,partial,0,0
196710,response,0,0
196711,",",0,0
196712,relapse,0,0
196713,rates,0,0
196714,for,0,0
196715,up,0,0
196716,to,0,0
196717,6,0,0
196718,months,0,0
196719,of,0,0
196720,additional,0,0
196721,treatment,0,0
196722,.,0,0
196723,We,0,0
196724,review,0,0
196725,seven,0,0
196726,key,0,0
196727,efficacy/effectiveness,0,0
196728,design,0,0
196729,decisions,0,0
196730,in,0,0
196731,this,0,0
196732,mixed,0,0
196733,efficacy-effectiveness,0,0
196734,trial,0,0
196735,.,0,0
196736,Use,0,0
196737,of,0,0
196738,the,0,0
196739,learning,0,0
196740,conversation,0,0
196741,improves,0,0
196742,instructor,1,0
196743,confidence,1,0
196744,in,1,0
196745,life,1,0
196746,support,1,0
196747,training,1,0
196748,:,1,0
196749,An,0,0
196750,open,0,0
196751,randomised,0,0
196752,controlled,0,0
196753,cross-over,0,0
196754,trial,0,0
196755,comparing,0,0
196756,teaching,0,0
196757,feedback,0,0
196758,mechanisms,0,0
196759,.,0,0
196760,AIMS,0,0
196761,Feedback,0,0
196762,is,0,0
196763,vital,0,0
196764,for,0,0
196765,the,0,0
196766,effective,0,0
196767,delivery,0,0
196768,of,0,0
196769,skills-based,0,0
196770,education,0,0
196771,.,0,0
196772,We,0,0
196773,sought,0,0
196774,to,0,0
196775,compare,0,0
196776,the,0,0
196777,sandwich,0,0
196778,technique,0,0
196779,and,0,0
196780,learning,0,0
196781,conversation,0,0
196782,structured,0,0
196783,methods,0,0
196784,of,0,0
196785,feedback,0,0
196786,delivery,0,0
196787,in,0,0
196788,competency-based,0,0
196789,basic,0,0
196790,life,0,0
196791,support,0,0
196792,(,0,0
196793,BLS,0,1
196794,),0,0
196795,training,0,0
196796,.,0,0
196797,METHODS,0,0
196798,Open,0,0
196799,randomised,0,0
196800,crossover,0,0
196801,study,0,0
196802,undertaken,0,0
196803,between,1,0
196804,October,1,1
196805,2014,1,1
196806,and,1,0
196807,March,1,1
196808,2015,1,1
196809,at,1,0
196810,the,1,0
196811,University,1,1
196812,of,1,0
196813,Birmingham,1,1
196814,",",1,0
196815,United,1,1
196816,Kingdom,1,1
196817,.,1,0
196818,Six-hundred,1,1
196819,and,1,0
196820,forty,1,1
196821,healthcare,1,0
196822,students,1,1
196823,undertaking,1,0
196824,a,1,0
196825,European,1,1
196826,Resuscitation,1,0
196827,Council,1,1
196828,(,1,0
196829,ERC,1,1
196830,),1,0
196831,BLS,1,1
196832,course,1,0
196833,were,1,0
196834,enrolled,1,1
196835,",",1,0
196836,each,1,0
196837,of,1,0
196838,whom,1,1
196839,was,1,0
196840,randomised,1,1
196841,to,1,0
196842,receive,1,0
196843,teaching,1,0
196844,using,1,0
196845,either,1,0
196846,the,1,0
196847,sandwich,1,0
196848,technique,1,0
196849,or,1,0
196850,the,1,0
196851,learning,1,0
196852,conversation,1,0
196853,.,1,0
196854,Fifty-eight,1,1
196855,instructors,1,1
196856,were,1,0
196857,randomised,1,0
196858,to,1,0
196859,initially,1,0
196860,teach,1,0
196861,using,1,0
196862,either,1,0
196863,the,1,0
196864,learning,1,0
196865,conversation,1,0
196866,or,1,0
196867,sandwich,1,0
196868,technique,1,0
196869,",",0,0
196870,prior,0,0
196871,to,0,0
196872,crossing-over,0,0
196873,and,0,0
196874,teaching,0,0
196875,with,0,0
196876,the,0,0
196877,alternative,0,0
196878,technique,0,0
196879,after,0,0
196880,a,0,0
196881,pre-defined,0,0
196882,time,0,0
196883,period,0,0
196884,.,0,0
196885,Outcome,0,0
196886,measures,0,0
196887,included,0,1
196888,skill,0,0
196889,acquisition,0,0
196890,as,0,0
196891,measured,0,0
196892,by,0,0
196893,an,0,0
196894,end-of-course,0,0
196895,competency,0,0
196896,assessment,0,0
196897,",",0,0
196898,instructors,0,1
196899,',0,0
196900,perception,0,0
196901,of,0,0
196902,teaching,0,0
196903,with,0,1
196904,each,0,0
196905,feedback,0,0
196906,technique,0,0
196907,and,0,0
196908,candidates,0,0
196909,',0,0
196910,perception,0,0
196911,of,0,0
196912,the,0,0
196913,feedback,0,0
196914,they,0,0
196915,were,0,0
196916,provided,0,0
196917,with,0,1
196918,.,0,0
196919,RESULTS,0,0
196920,Scores,0,0
196921,assigned,0,0
196922,to,0,0
196923,use,0,0
196924,of,0,0
196925,the,0,0
196926,learning,0,0
196927,conversation,0,0
196928,by,0,0
196929,instructors,0,1
196930,were,0,0
196931,significantly,0,0
196932,more,0,0
196933,favourable,0,0
196934,than,0,0
196935,for,0,0
196936,the,0,0
196937,sandwich,0,0
196938,technique,0,0
196939,across,0,0
196940,all,0,0
196941,but,0,0
196942,two,0,0
196943,assessed,0,0
196944,domains,0,0
196945,relating,0,0
196946,to,0,0
196947,instructor,0,0
196948,perception,0,0
196949,of,0,0
196950,the,0,0
196951,feedback,0,0
196952,technique,0,0
196953,",",0,0
196954,including,0,0
196955,all,0,0
196956,skills-based,0,0
196957,domains,0,0
196958,.,0,0
196959,No,0,0
196960,difference,0,0
196961,was,0,0
196962,seen,0,0
196963,in,0,0
196964,either,0,0
196965,assessment,0,0
196966,pass,0,0
196967,rates,0,0
196968,(,0,0
196969,80.9,0,0
196970,%,0,0
196971,sandwich,0,0
196972,technique,0,0
196973,vs.,0,0
196974,77.2,0,0
196975,%,0,0
196976,learning,0,0
196977,conversation,0,0
196978,;,0,0
196979,OR,0,0
196980,1.2,0,0
196981,",",0,0
196982,95,0,0
196983,%,0,0
196984,CI,0,0
196985,0.85-1.84,0,0
196986,;,0,0
196987,p=0.29,0,0
196988,),0,0
196989,or,0,0
196990,any,0,0
196991,domain,0,0
196992,relating,0,0
196993,to,0,0
196994,candidates,0,0
196995,',0,0
196996,perception,0,0
196997,of,0,0
196998,their,0,0
196999,teaching,0,0
197000,technique,0,0
197001,.,0,0
197002,CONCLUSIONS,0,0
197003,&,0,0
197004,RELEVANCE,0,0
197005,This,0,0
197006,is,0,0
197007,the,0,0
197008,first,0,0
197009,direct,0,0
197010,comparison,0,0
197011,of,0,0
197012,two,0,0
197013,feedback,0,0
197014,techniques,0,0
197015,in,0,0
197016,clinical,0,0
197017,medical,0,1
197018,education,0,0
197019,using,0,0
197020,both,0,0
197021,quantitative,0,0
197022,and,0,0
197023,qualitative,0,0
197024,methodology,0,0
197025,.,0,0
197026,The,0,0
197027,learning,0,0
197028,conversation,0,0
197029,is,0,0
197030,preferred,0,0
197031,by,0,0
197032,instructors,1,1
197033,providing,1,0
197034,competency-based,1,1
197035,life,1,0
197036,support,1,0
197037,training,1,0
197038,and,0,0
197039,is,0,0
197040,perceived,0,0
197041,to,0,0
197042,favour,0,0
197043,skills,0,0
197044,acquisition,0,0
197045,.,0,1
197046,High,0,1
197047,Platelet,0,0
197048,Reactivity,0,0
197049,in,0,0
197050,Patients,1,1
197051,with,1,1
197052,Acute,1,0
197053,Coronary,1,1
197054,Syndromes,1,1
197055,Undergoing,1,1
197056,Percutaneous,1,1
197057,Coronary,1,1
197058,Intervention,1,0
197059,:,1,1
197060,Randomised,0,0
197061,Controlled,0,0
197062,Trial,0,0
197063,Comparing,0,0
197064,Prasugrel,0,0
197065,and,0,0
197066,Clopidogrel,0,0
197067,.,0,0
197068,BACKGROUND,0,0
197069,Prasugrel,0,0
197070,is,0,0
197071,more,0,0
197072,effective,0,0
197073,than,0,0
197074,clopidogrel,0,0
197075,in,0,0
197076,reducing,0,0
197077,platelet,0,0
197078,aggregation,0,0
197079,in,0,0
197080,acute,1,1
197081,coronary,1,1
197082,syndromes,1,1
197083,.,1,1
197084,Data,0,0
197085,available,0,0
197086,on,0,0
197087,prasugrel,0,0
197088,reloading,0,0
197089,in,0,0
197090,clopidogrel,0,0
197091,treated,0,1
197092,patients,0,1
197093,with,0,1
197094,high,0,1
197095,residual,0,0
197096,platelet,0,0
197097,reactivity,0,0
197098,(,0,0
197099,HRPR,0,0
197100,),0,0
197101,i.e,0,0
197102,.,0,0
197103,poor,0,0
197104,responders,0,0
197105,",",0,0
197106,is,0,0
197107,limited,0,0
197108,.,0,0
197109,OBJECTIVES,0,0
197110,To,0,0
197111,determine,0,0
197112,the,0,0
197113,effects,0,0
197114,of,0,0
197115,prasugrel,0,0
197116,loading,0,0
197117,on,0,0
197118,platelet,0,0
197119,function,0,0
197120,in,0,0
197121,patients,1,1
197122,on,1,0
197123,clopidogrel,1,1
197124,and,1,0
197125,high,1,0
197126,platelet,1,0
197127,reactivity,1,0
197128,undergoing,1,1
197129,percutaneous,1,1
197130,coronary,1,1
197131,intervention,1,0
197132,for,1,0
197133,acute,1,1
197134,coronary,1,1
197135,syndrome,1,1
197136,(,1,0
197137,ACS,1,0
197138,),1,0
197139,.,1,0
197140,PATIENTS,0,0
197141,Patients,1,1
197142,with,1,1
197143,ACS,1,0
197144,on,0,0
197145,clopidogrel,0,1
197146,who,0,1
197147,were,0,1
197148,scheduled,0,1
197149,for,0,0
197150,PCI,0,0
197151,found,0,0
197152,to,0,0
197153,have,0,0
197154,a,0,0
197155,platelet,0,0
197156,reactivity,0,0
197157,?40,0,0
197158,AUC,0,0
197159,with,0,1
197160,the,0,0
197161,Multiplate,0,0
197162,Analyzer,0,0
197163,",",0,0
197164,i.e,0,0
197165,.,0,0
197166,poor,0,0
197167,responders,0,0
197168,were,0,0
197169,randomised,0,0
197170,to,0,0
197171,prasugrel,0,0
197172,(,0,0
197173,60,0,0
197174,mg,0,0
197175,loading,0,0
197176,and,0,0
197177,10,0,0
197178,mg,0,0
197179,maintenance,0,0
197180,dose,0,0
197181,),0,0
197182,or,0,0
197183,clopidogrel,0,0
197184,(,0,0
197185,600,0,0
197186,mg,0,0
197187,reloading,0,0
197188,and,0,0
197189,150,0,0
197190,mg,0,0
197191,maintenance,0,0
197192,dose,0,0
197193,),0,0
197194,.,0,0
197195,The,0,0
197196,primary,0,0
197197,outcome,0,0
197198,measure,0,0
197199,was,0,0
197200,proportion,0,0
197201,of,0,0
197202,patients,0,1
197203,with,0,1
197204,platelet,0,0
197205,reactivity,0,0
197206,<,0,0
197207,40,0,0
197208,AUC,0,0
197209,4,0,0
197210,hours,0,0
197211,after,0,0
197212,loading,0,0
197213,with,0,1
197214,study,0,0
197215,medication,0,0
197216,",",0,0
197217,and,0,0
197218,also,0,0
197219,at,0,0
197220,one,0,0
197221,hour,0,0
197222,(,0,0
197223,secondary,0,0
197224,outcome,1,0
197225,),1,0
197226,.,1,0
197227,44,1,0
197228,patients,1,1
197229,were,1,0
197230,enrolled,1,1
197231,and,1,0
197232,the,0,0
197233,study,0,0
197234,was,0,0
197235,terminated,0,0
197236,early,0,0
197237,as,0,0
197238,clopidogrel,0,0
197239,use,0,0
197240,decreased,0,0
197241,sharply,0,0
197242,due,0,0
197243,to,0,0
197244,introduction,0,0
197245,of,0,0
197246,newer,0,0
197247,P2Y12,0,0
197248,inhibitors,0,0
197249,.,0,1
197250,RESULTS,0,0
197251,At,0,0
197252,4,0,0
197253,hours,0,0
197254,after,0,0
197255,study,0,0
197256,medication,0,0
197257,100,0,0
197258,%,0,0
197259,of,0,0
197260,patients,0,1
197261,treated,0,1
197262,with,0,1
197263,prasugrel,0,0
197264,compared,0,0
197265,to,0,0
197266,91,0,0
197267,%,0,0
197268,of,0,0
197269,those,0,0
197270,treated,0,0
197271,with,0,0
197272,clopidogrel,0,0
197273,had,0,0
197274,platelet,0,0
197275,reactivity,0,0
197276,<,0,0
197277,40,0,0
197278,AUC,0,0
197279,(,0,0
197280,p,0,0
197281,=,0,0
197282,0.49,0,0
197283,),0,0
197284,",",0,0
197285,while,0,0
197286,at,0,0
197287,1,0,0
197288,hour,0,0
197289,the,0,0
197290,proportions,0,0
197291,were,0,0
197292,95,0,0
197293,%,0,0
197294,and,0,0
197295,64,0,0
197296,%,0,0
197297,respectively,0,0
197298,(,0,0
197299,p,0,0
197300,=,0,0
197301,0.02,0,0
197302,),0,0
197303,.,0,0
197304,Mean,0,0
197305,platelet,0,0
197306,reactivity,0,0
197307,at,0,0
197308,4,0,0
197309,and,0,0
197310,1,0,0
197311,hours,0,0
197312,after,0,0
197313,study,0,0
197314,medication,0,0
197315,in,0,0
197316,prasugrel,0,0
197317,and,0,0
197318,clopidogrel,0,0
197319,groups,0,0
197320,respectively,0,0
197321,were,0,0
197322,12,0,0
197323,versus,0,0
197324,22,0,1
197325,(,0,0
197326,p,0,0
197327,=,0,0
197328,0.005,0,0
197329,),0,0
197330,and,0,0
197331,19,0,1
197332,versus,0,0
197333,34,0,1
197334,(,0,0
197335,p,0,0
197336,=,0,0
197337,0.01,0,0
197338,),0,0
197339,respectively,0,0
197340,.,0,0
197341,CONCLUSIONS,0,0
197342,Routine,0,0
197343,platelet,0,0
197344,function,0,0
197345,testing,0,0
197346,identifies,0,0
197347,patients,0,1
197348,with,0,1
197349,high,0,1
197350,residual,0,0
197351,platelet,0,0
197352,reactivity,0,0
197353,(,0,0
197354,poor,0,1
197355,responders,0,0
197356,),0,0
197357,on,0,0
197358,clopidogrel,0,0
197359,.,0,0
197360,A,0,0
197361,strategy,0,0
197362,of,0,0
197363,prasugrel,0,0
197364,rather,0,0
197365,than,0,0
197366,clopidogrel,0,0
197367,reloading,0,0
197368,results,0,0
197369,in,0,0
197370,earlier,0,0
197371,and,0,0
197372,more,0,0
197373,sustained,0,0
197374,suppression,0,0
197375,of,0,0
197376,platelet,0,0
197377,reactivity,0,0
197378,.,0,0
197379,Future,0,0
197380,trials,0,0
197381,need,0,0
197382,to,0,0
197383,identify,0,0
197384,if,0,0
197385,this,0,0
197386,translates,0,0
197387,into,0,0
197388,clinical,0,0
197389,benefit,0,0
197390,.,0,0
197391,TRIAL,0,0
197392,REGISTRATION,0,0
197393,ClinicalTrials.gov,0,0
197394,NCT01339026,0,0
197395,.,0,0
197396,Computer,0,0
197397,Decision,0,0
197398,Support,0,0
197399,Changes,0,0
197400,Physician,1,0
197401,Practice,1,0
197402,But,0,0
197403,Not,0,0
197404,Knowledge,0,0
197405,Regarding,0,0
197406,Autism,1,1
197407,Spectrum,1,1
197408,Disorders,1,1
197409,.,1,0
197410,OBJECTIVE,0,0
197411,To,0,0
197412,examine,0,0
197413,whether,0,0
197414,adding,0,0
197415,an,0,0
197416,autism,0,1
197417,module,0,0
197418,promoting,0,0
197419,adherence,0,0
197420,to,0,0
197421,clinical,0,0
197422,guidelines,0,0
197423,to,0,0
197424,an,0,0
197425,existing,0,0
197426,computer,0,0
197427,decision,0,0
197428,support,0,0
197429,system,0,0
197430,(,0,0
197431,CDSS,0,0
197432,),0,0
197433,changed,0,0
197434,physician,0,0
197435,knowledge,0,0
197436,and,0,0
197437,self-reported,0,0
197438,clinical,0,0
197439,practice,0,0
197440,.,0,0
197441,METHODS,0,0
197442,The,1,0
197443,CHICA,1,0
197444,(,1,0
197445,Child,1,0
197446,Health,1,0
197447,Improvement,1,0
197448,through,1,0
197449,Computer,1,0
197450,Automation,1,0
197451,),1,0
197452,system,1,0
197453,",",1,0
197454,a,1,0
197455,CDSS,1,0
197456,",",1,0
197457,was,1,0
197458,enhanced,1,0
197459,with,1,0
197460,a,1,0
197461,module,1,0
197462,to,1,0
197463,improve,1,0
197464,management,1,0
197465,of,1,0
197466,autism,1,1
197467,in,1,0
197468,2,1,0
197469,of,1,0
197470,the,1,0
197471,4,1,0
197472,community,1,1
197473,pediatric,1,1
197474,clinics,1,1
197475,using,1,0
197476,the,1,0
197477,system,1,0
197478,.,1,0
197479,We,0,0
197480,examined,0,0
197481,the,0,0
197482,knowledge,0,0
197483,and,0,0
197484,beliefs,0,0
197485,of,0,0
197486,pediatric,1,1
197487,users,1,1
197488,using,0,0
197489,cross-sectional,1,1
197490,surveys,1,0
197491,administered,0,0
197492,at,0,0
197493,3,0,0
197494,time,0,0
197495,points,0,0
197496,(,0,0
197497,baseline,0,0
197498,",",0,0
197499,12,0,0
197500,months,0,0
197501,and,0,0
197502,24,0,0
197503,months,0,0
197504,post-implementation,0,0
197505,),0,0
197506,between,1,0
197507,November,1,1
197508,2010,1,1
197509,and,1,0
197510,January,1,1
197511,2013,1,1
197512,.,1,1
197513,Surveys,0,0
197514,measured,0,0
197515,knowledge,0,0
197516,",",0,0
197517,beliefs,0,0
197518,and,0,0
197519,self-reported,0,0
197520,practice,0,0
197521,patterns,0,0
197522,related,0,0
197523,to,0,0
197524,autism,0,1
197525,.,0,0
197526,RESULTS,0,0
197527,A,1,0
197528,total,1,0
197529,of,1,0
197530,45,1,0
197531,",",1,0
197532,39,1,0
197533,",",1,0
197534,and,1,0
197535,42,1,1
197536,pediatricians,1,1
197537,responded,1,1
197538,at,1,0
197539,each,1,0
197540,time,1,0
197541,point,1,0
197542,",",1,0
197543,respectively,1,0
197544,",",1,0
197545,a,1,0
197546,95-100,1,0
197547,%,1,0
197548,response,1,0
197549,rate,1,0
197550,.,1,0
197551,Respondents,0,0
197552,',0,0
197553,knowledge,0,0
197554,of,0,0
197555,autism,0,1
197556,and,0,0
197557,perception,0,0
197558,of,0,0
197559,role,0,0
197560,for,0,0
197561,diagnosis,0,1
197562,did,0,0
197563,not,0,0
197564,vary,0,0
197565,between,0,0
197566,control,0,0
197567,and,0,0
197568,intervention,0,0
197569,groups,0,0
197570,either,0,0
197571,at,0,0
197572,baseline,0,0
197573,or,0,0
197574,any,0,0
197575,of,0,0
197576,the,0,0
197577,two,0,0
197578,post-intervention,0,0
197579,time,0,0
197580,points,0,0
197581,.,0,0
197582,At,0,0
197583,baseline,0,0
197584,",",0,0
197585,there,0,0
197586,was,0,0
197587,no,0,0
197588,difference,0,0
197589,between,0,0
197590,these,0,0
197591,groups,0,0
197592,in,0,0
197593,rates,0,0
197594,in,0,0
197595,the,0,0
197596,routine,0,0
197597,use,0,0
197598,of,0,0
197599,parent-rated,0,0
197600,screening,0,1
197601,instruments,0,0
197602,for,0,0
197603,autism,0,1
197604,.,0,0
197605,However,0,0
197606,",",0,0
197607,by,0,0
197608,12,0,0
197609,and,0,0
197610,24,0,0
197611,months,0,0
197612,post-implementation,0,0
197613,there,0,0
197614,was,0,0
197615,a,0,0
197616,significant,0,0
197617,difference,0,0
197618,between,0,0
197619,intervention,0,0
197620,and,0,0
197621,control,0,0
197622,clinics,0,1
197623,in,0,0
197624,terms,0,0
197625,of,0,0
197626,the,0,0
197627,intervention,0,0
197628,clinics,0,1
197629,consistently,0,0
197630,screening,0,1
197631,eligible,0,1
197632,patients,0,1
197633,with,0,1
197634,a,0,0
197635,validated,0,0
197636,autism,0,1
197637,tool,0,0
197638,.,0,0
197639,Physicians,0,0
197640,at,0,0
197641,all,0,0
197642,clinics,0,1
197643,reported,0,0
197644,ongoing,0,0
197645,challenges,0,0
197646,to,0,0
197647,community,0,1
197648,resources,0,0
197649,for,0,0
197650,further,0,0
197651,work-up,0,0
197652,and,0,0
197653,treatment,0,0
197654,related,0,0
197655,to,0,0
197656,autism,0,1
197657,.,0,0
197658,CONCLUSIONS,0,0
197659,A,0,0
197660,CDSS,0,0
197661,module,0,0
197662,to,0,0
197663,improve,0,0
197664,primary,0,0
197665,care,0,0
197666,management,0,0
197667,of,0,0
197668,ASD,0,1
197669,in,0,0
197670,pediatric,0,1
197671,practice,0,0
197672,led,0,0
197673,to,0,0
197674,significant,0,0
197675,improvements,0,0
197676,in,0,0
197677,physician-reported,0,0
197678,use,0,0
197679,of,0,0
197680,validated,0,0
197681,screening,0,1
197682,tools,0,0
197683,to,0,0
197684,screen,0,0
197685,for,0,0
197686,ASDs,0,0
197687,.,0,0
197688,However,0,0
197689,it,0,0
197690,did,0,0
197691,not,0,0
197692,lead,0,0
197693,to,0,0
197694,corresponding,0,0
197695,changes,0,0
197696,in,0,0
197697,physician,0,1
197698,knowledge,0,0
197699,or,0,1
197700,attitudes,0,0
197701,.,0,1
197702,The,0,0
197703,neuropeptide,0,0
197704,oxytocin,0,0
197705,modulates,0,0
197706,consumer,0,0
197707,brand,0,0
197708,relationships,0,0
197709,.,0,0
197710,Each,0,0
197711,year,0,0
197712,",",0,0
197713,companies,0,0
197714,invest,0,1
197715,billions,0,0
197716,of,0,0
197717,dollars,0,0
197718,into,0,1
197719,marketing,0,0
197720,activities,0,0
197721,to,0,0
197722,embellish,0,0
197723,brands,0,0
197724,as,0,0
197725,valuable,0,0
197726,relationship,0,0
197727,partners,0,1
197728,assuming,0,0
197729,that,0,0
197730,consumer,0,0
197731,brand,0,0
197732,relationships,0,0
197733,(,0,0
197734,CBRs,0,1
197735,),0,0
197736,and,0,0
197737,interpersonal,0,0
197738,relationships,0,0
197739,rest,0,0
197740,upon,0,0
197741,the,0,0
197742,same,0,0
197743,neurobiological,0,0
197744,underpinnings,0,0
197745,.,0,0
197746,Given,0,0
197747,the,0,0
197748,crucial,0,0
197749,role,0,0
197750,of,0,0
197751,the,0,0
197752,neuropeptide,0,0
197753,oxytocin,0,0
197754,(,0,0
197755,OXT,0,0
197756,),0,0
197757,in,0,0
197758,social,0,0
197759,bonding,0,0
197760,",",0,0
197761,this,0,0
197762,study,0,0
197763,tests,0,0
197764,whether,0,0
197765,OXT-based,0,0
197766,mechanisms,0,0
197767,also,0,0
197768,determine,0,0
197769,the,0,0
197770,bond,0,0
197771,between,0,0
197772,consumers,1,0
197773,and,0,1
197774,brands,0,0
197775,.,0,0
197776,We,0,0
197777,conducted,0,0
197778,a,0,0
197779,randomized,0,0
197780,",",0,0
197781,placebo-controlled,0,0
197782,study,0,0
197783,involving,0,0
197784,101,1,1
197785,subjects,1,1
197786,and,0,0
197787,analyzed,0,0
197788,the,0,0
197789,effect,0,0
197790,of,0,0
197791,intranasal,0,0
197792,OXT,0,0
197793,on,0,0
197794,consumers,0,0
197795,',0,1
197796,attribution,0,0
197797,of,0,0
197798,relationship,0,0
197799,qualities,0,0
197800,to,0,0
197801,brands,0,0
197802,",",0,0
197803,brands,0,0
197804,paired,0,0
197805,with,0,1
197806,human,0,0
197807,celebrity,0,0
197808,endorsers,0,0
197809,",",0,0
197810,and,0,0
197811,familiar,0,0
197812,persons,0,1
197813,.,0,1
197814,OXT,0,0
197815,indeed,0,0
197816,promoted,0,0
197817,the,0,0
197818,attribution,0,0
197819,of,0,0
197820,relationship,0,0
197821,qualities,0,0
197822,not,0,0
197823,only,0,0
197824,in,0,0
197825,the,0,0
197826,case,0,0
197827,of,0,0
197828,social,0,0
197829,and,0,0
197830,semi-social,0,0
197831,stimuli,0,0
197832,",",0,0
197833,but,0,0
197834,also,0,0
197835,brands,0,0
197836,.,0,0
197837,Intriguingly,0,0
197838,",",0,0
197839,for,0,0
197840,subjects,1,1
197841,scoring,1,0
197842,high,1,1
197843,on,1,0
197844,autistic-like,1,1
197845,traits,1,0
197846,",",0,0
197847,the,0,0
197848,effect,0,0
197849,of,0,0
197850,OXT,0,0
197851,was,0,0
197852,completely,0,0
197853,reversed,0,0
197854,",",0,0
197855,evident,0,0
197856,in,0,0
197857,even,0,0
197858,lower,0,0
197859,relationship,0,0
197860,qualities,0,0
197861,across,0,0
197862,all,0,0
197863,stimulus,0,0
197864,categories,0,0
197865,.,0,0
197866,The,0,0
197867,importance,0,0
197868,of,0,0
197869,OXT,0,0
197870,in,0,0
197871,a,0,0
197872,CBR,0,0
197873,context,0,0
197874,is,0,0
197875,further,0,0
197876,corroborated,0,0
197877,by,0,0
197878,a,0,0
197879,three-fold,0,0
197880,increase,0,0
197881,in,0,0
197882,endogenous,0,0
197883,release,0,0
197884,of,0,0
197885,OXT,0,0
197886,following,0,0
197887,exposure,0,0
197888,to,0,0
197889,one,0,0
197890,'s,0,0
197891,favorite,0,0
197892,brand,0,0
197893,and,0,0
197894,positive,0,0
197895,associations,0,0
197896,between,0,0
197897,baseline,0,0
197898,peripheral,0,1
197899,OXT,0,0
197900,concentrations,0,0
197901,and,0,0
197902,brand,0,0
197903,relationship,0,0
197904,qualities,0,0
197905,.,0,0
197906,Collectively,0,0
197907,",",0,0
197908,our,0,0
197909,findings,0,0
197910,indicate,0,0
197911,that,0,0
197912,OXT,0,0
197913,not,0,0
197914,only,0,0
197915,plays,0,0
197916,a,0,0
197917,fundamental,0,0
197918,role,0,0
197919,in,0,0
197920,developing,0,0
197921,interpersonal,0,0
197922,relationships,0,0
197923,",",0,0
197924,but,0,0
197925,also,0,0
197926,enables,0,0
197927,relationship,0,0
197928,formation,0,0
197929,with,0,1
197930,objects,0,0
197931,such,0,0
197932,as,0,0
197933,brands,0,0
197934,.,0,1
197935,Treatments,0,0
197936,of,0,0
197937,preterm,1,1
197938,premature,1,1
197939,rupture,1,0
197940,of,1,0
197941,the,1,0
197942,membranes,1,0
197943,:,1,1
197944,a,0,0
197945,meta-analysis,0,0
197946,.,0,0
197947,The,0,0
197948,objective,0,0
197949,of,0,0
197950,this,0,0
197951,overview,0,0
197952,was,0,0
197953,to,0,0
197954,critically,0,0
197955,evaluate,0,0
197956,published,0,0
197957,randomized,0,0
197958,controlled,0,0
197959,trials,0,0
197960,on,0,0
197961,treatments,0,0
197962,in,0,0
197963,preterm,1,1
197964,premature,1,1
197965,rupture,1,0
197966,of,1,0
197967,the,1,0
197968,membranes,1,0
197969,.,1,0
197970,The,0,0
197971,Oxford,0,0
197972,data,0,0
197973,base,0,0
197974,on,0,0
197975,perinatal,0,1
197976,trials,0,0
197977,",",0,0
197978,MEDLINE,0,0
197979,",",0,0
197980,Excerpta,0,0
197981,Medica,0,0
197982,",",0,0
197983,and,0,0
197984,Index,0,0
197985,Medicus,0,1
197986,were,0,0
197987,searched,0,0
197988,.,0,0
197989,Through,0,0
197990,primary,0,0
197991,and,0,0
197992,secondary,0,0
197993,review,0,0
197994,with,0,1
197995,preset,0,0
197996,inclusion,0,0
197997,criteria,0,1
197998,",",0,0
197999,two,0,0
198000,independent,0,0
198001,judges,0,0
198002,identified,0,0
198003,27,1,1
198004,randomized,1,0
198005,controlled,1,0
198006,trials,1,0
198007,",",1,0
198008,of,1,0
198009,which,1,0
198010,13,1,0
198011,met,1,1
198012,inclusion,1,1
198013,criteria,1,1
198014,.,1,0
198015,The,0,0
198016,quality,0,0
198017,of,0,0
198018,these,0,0
198019,randomized,0,0
198020,controlled,0,0
198021,trials,0,0
198022,was,0,0
198023,scored,0,0
198024,.,0,0
198025,Five,1,0
198026,randomized,1,0
198027,controlled,0,0
198028,trials,0,0
198029,regarding,0,0
198030,antenatal,0,1
198031,use,0,0
198032,of,0,0
198033,corticosteroids,0,0
198034,to,0,0
198035,prevent,0,0
198036,respiratory,0,0
198037,distress,0,0
198038,syndrome,0,1
198039,could,0,0
198040,be,0,0
198041,combined,0,0
198042,meta-analytically,0,0
198043,and,0,0
198044,showed,0,0
198045,a,0,0
198046,reduction,0,0
198047,in,0,0
198048,respiratory,0,0
198049,distress,0,1
198050,syndrome,0,1
198051,in,0,0
198052,the,0,0
198053,treatment,0,0
198054,group,0,0
198055,(,0,0
198056,p,0,0
198057,=,0,0
198058,0.001,0,0
198059,),0,0
198060,.,0,0
198061,However,0,0
198062,",",0,0
198063,no,0,0
198064,significant,0,0
198065,reduction,0,0
198066,in,0,0
198067,respiratory,0,0
198068,distress,0,1
198069,syndrome,0,1
198070,(,0,0
198071,p,0,0
198072,=,0,0
198073,0.286,0,0
198074,),0,0
198075,was,0,0
198076,found,0,0
198077,after,0,0
198078,one,0,0
198079,study,0,0
198080,",",0,0
198081,with,0,0
198082,the,0,0
198083,lowest,0,0
198084,quality,0,0
198085,score,0,0
198086,",",0,0
198087,was,0,0
198088,excluded,0,0
198089,.,0,0
198090,A,0,0
198091,significant,0,0
198092,increase,0,0
198093,in,0,0
198094,endometritis,0,1
198095,and,0,0
198096,a,0,0
198097,trend,0,0
198098,toward,0,0
198099,an,0,0
198100,increase,0,0
198101,in,0,0
198102,neonatal,0,1
198103,infections,0,0
198104,and,0,0
198105,cesarean,0,1
198106,section,0,0
198107,rates,0,0
198108,were,0,0
198109,noted,0,0
198110,with,0,1
198111,treatment,0,0
198112,.,0,0
198113,Tocolysis,0,0
198114,",",0,0
198115,prophylactic,0,0
198116,antibiotics,0,0
198117,",",0,0
198118,and,0,0
198119,other,0,0
198120,interventions,0,0
198121,studied,0,1
198122,were,0,0
198123,not,0,0
198124,found,0,0
198125,to,0,0
198126,be,0,0
198127,of,0,0
198128,proved,0,0
198129,benefit,0,0
198130,and,0,0
198131,therefore,0,0
198132,should,0,0
198133,not,0,0
198134,be,0,0
198135,used,0,0
198136,outside,0,0
198137,of,0,0
198138,a,0,0
198139,randomized,0,0
198140,controlled,0,0
198141,trial,0,0
198142,.,0,0
198143,The,0,0
198144,role,0,0
198145,of,0,0
198146,routinely,0,0
198147,given,0,0
198148,hyoscine-N-butylbromide,0,0
198149,in,0,0
198150,colonoscopy,1,1
198151,:,1,1
198152,a,0,0
198153,double-blind,0,0
198154,",",0,0
198155,randomized,0,0
198156,",",0,0
198157,placebo-controlled,0,0
198158,",",0,0
198159,clinical,0,0
198160,trial,0,0
198161,.,0,0
198162,OBJECTIVE,0,0
198163,Hyoscine-N-butylbromide,0,0
198164,(,0,0
198165,HBB,0,0
198166,),0,0
198167,has,0,0
198168,been,0,0
198169,proposed,0,0
198170,to,0,0
198171,ease,0,0
198172,colonoscopy,0,0
198173,and,0,0
198174,improve,0,0
198175,mucosal,0,0
198176,visualization,0,0
198177,",",0,0
198178,yet,0,0
198179,the,0,0
198180,results,0,0
198181,from,0,0
198182,previous,0,1
198183,studies,0,0
198184,are,0,0
198185,conflicting,0,0
198186,.,0,0
198187,In,0,0
198188,our,0,0
198189,prospective,0,0
198190,",",0,0
198191,double-blind,0,0
198192,",",0,0
198193,placebo-controlled,0,0
198194,",",0,0
198195,randomized,0,0
198196,study,0,0
198197,we,0,0
198198,aimed,0,0
198199,at,0,0
198200,evaluating,0,0
198201,whether,0,0
198202,routine,0,0
198203,administration,0,0
198204,of,0,0
198205,HBB,0,0
198206,",",0,0
198207,before,0,0
198208,and,0,0
198209,during,0,0
198210,colonoscopy,0,0
198211,",",0,0
198212,ease,0,0
198213,the,0,0
198214,procedure,0,0
198215,or,0,0
198216,increase,0,0
198217,the,0,0
198218,detection,0,0
198219,rate,0,0
198220,for,0,0
198221,polyps,0,1
198222,.,0,1
198223,MATERIAL,0,0
198224,AND,0,0
198225,METHODS,0,0
198226,One,1,1
198227,hundred,1,1
198228,fifty,1,1
198229,outpatients,1,1
198230,scheduled,1,1
198231,for,1,0
198232,an,1,0
198233,elective,1,1
198234,colonoscopy,1,1
198235,were,0,0
198236,randomized,0,0
198237,to,0,0
198238,receive,0,0
198239,intravenous,0,0
198240,injections,0,0
198241,of,0,0
198242,either,0,0
198243,10,0,0
198244,mg,0,0
198245,hyoscine-N-butylbromide,0,0
198246,or,0,0
198247,saline,0,0
198248,before,0,0
198249,insertion,0,0
198250,and,0,0
198251,at,0,0
198252,cecum,0,0
198253,.,0,0
198254,Patient,0,0
198255,tolerance,0,0
198256,and,0,0
198257,technical,0,0
198258,ease,0,0
198259,of,0,0
198260,colonoscopy,0,1
198261,were,0,0
198262,evaluated,0,0
198263,by,0,0
198264,visual,0,0
198265,analogue,0,0
198266,scale,0,0
198267,(,0,0
198268,VAS,0,0
198269,),0,0
198270,.,0,0
198271,Procedure,0,0
198272,times,0,0
198273,were,0,0
198274,recorded,0,0
198275,.,0,0
198276,Number,0,0
198277,of,0,0
198278,detected,0,0
198279,polyps,0,1
198280,per,0,0
198281,patient,0,0
198282,was,0,0
198283,evaluated,0,0
198284,as,0,0
198285,well,0,0
198286,.,0,0
198287,Heart,0,0
198288,rate,0,0
198289,was,0,0
198290,monitored,0,0
198291,with,0,0
198292,a,0,0
198293,pulse,0,0
198294,oximetry,0,0
198295,.,0,0
198296,RESULTS,0,0
198297,HBB,0,0
198298,did,0,0
198299,not,0,0
198300,improve,0,0
198301,patient,0,0
198302,tolerance,0,0
198303,or,0,0
198304,technically,0,0
198305,ease,0,0
198306,the,0,0
198307,procedure,0,0
198308,as,0,0
198309,evaluated,0,0
198310,by,0,0
198311,VAS,0,0
198312,.,0,0
198313,However,0,0
198314,",",0,0
198315,HBB,0,0
198316,led,0,0
198317,to,0,0
198318,faster,0,0
198319,ileal,0,1
198320,intubation,0,0
198321,(,0,0
198322,1.5,0,0
198323,vs,0,0
198324,2.0,0,0
198325,min,0,0
198326,",",0,0
198327,p,0,0
198328,<,0,0
198329,0.001,0,0
198330,),0,0
198331,and,0,0
198332,shorter,0,0
198333,total,0,1
198334,procedure,0,0
198335,time,0,0
198336,(,0,0
198337,22.0,0,0
198338,vs,0,0
198339,24.0,0,0
198340,min,0,0
198341,",",0,0
198342,p,0,0
198343,=,0,0
198344,0.03,0,0
198345,),0,1
198346,.,0,1
198347,Patients,0,1
198348,who,0,1
198349,received,0,1
198350,HBB,0,1
198351,also,0,0
198352,needed,0,0
198353,less,0,0
198354,often,0,0
198355,external,0,0
198356,abdominal,0,1
198357,pressure,0,0
198358,(,0,0
198359,48.6,0,0
198360,vs,0,0
198361,66.7,0,0
198362,%,0,0
198363,",",0,0
198364,p,0,0
198365,=,0,0
198366,0.03,0,0
198367,),0,0
198368,.,0,0
198369,HBB,0,0
198370,did,0,0
198371,not,0,0
198372,improve,0,0
198373,polyp,0,0
198374,detection,0,0
198375,rate,0,0
198376,(,0,0
198377,0.89,0,0
198378,vs,0,0
198379,0.91,0,0
198380,",",0,0
198381,p,0,0
198382,=,0,0
198383,0.90,0,0
198384,),0,0
198385,.,0,0
198386,HBB,0,0
198387,induced,0,0
198388,a,0,0
198389,significant,0,0
198390,rise,0,0
198391,in,0,0
198392,heart,0,1
198393,rate,0,0
198394,(,0,0
198395,p,0,0
198396,<,0,0
198397,0.001,0,0
198398,),0,0
198399,and,0,0
198400,more,0,0
198401,often,0,0
198402,tachycardia,0,0
198403,(,0,0
198404,17.6,0,0
198405,vs,0,0
198406,0,0,0
198407,%,0,0
198408,",",0,0
198409,p,0,0
198410,<,0,0
198411,0.001,0,0
198412,),0,0
198413,.,0,0
198414,CONCLUSIONS,0,0
198415,Routine,0,0
198416,administration,0,0
198417,of,0,0
198418,HBB,0,0
198419,before,0,0
198420,and,0,0
198421,during,0,0
198422,colonoscopy,0,1
198423,yields,0,0
198424,only,0,0
198425,limited,0,0
198426,improvement,0,0
198427,in,0,0
198428,the,0,0
198429,technical,0,0
198430,performance,0,0
198431,of,0,0
198432,the,0,0
198433,examination,0,0
198434,compromised,0,0
198435,by,0,0
198436,high,0,0
198437,incidence,0,0
198438,of,0,0
198439,tachycardia,0,0
198440,.,0,0
198441,Pembrolizumab,0,0
198442,versus,0,0
198443,docetaxel,0,0
198444,for,0,0
198445,previously,1,0
198446,treated,1,0
198447,",",1,0
198448,PD-L1-positive,1,0
198449,",",1,0
198450,advanced,1,1
198451,non-small-cell,1,1
198452,lung,1,1
198453,cancer,1,1
198454,(,0,0
198455,KEYNOTE-010,0,0
198456,),0,0
198457,:,0,1
198458,a,0,0
198459,randomised,0,0
198460,controlled,0,0
198461,trial,0,0
198462,.,0,0
198463,BACKGROUND,0,0
198464,Despite,0,0
198465,recent,0,0
198466,advances,0,0
198467,in,0,0
198468,the,0,0
198469,treatment,0,0
198470,of,0,0
198471,advanced,1,1
198472,non-small-cell,1,1
198473,lung,1,1
198474,cancer,1,1
198475,",",0,0
198476,there,0,0
198477,remains,0,0
198478,a,0,0
198479,need,0,0
198480,for,0,0
198481,effective,0,0
198482,treatments,0,0
198483,for,0,0
198484,progressive,0,1
198485,disease,0,1
198486,.,0,0
198487,We,0,0
198488,assessed,0,0
198489,the,0,0
198490,efficacy,0,0
198491,of,0,0
198492,pembrolizumab,0,0
198493,for,0,0
198494,patients,0,1
198495,with,0,1
198496,previously,1,1
198497,treated,1,0
198498,",",1,0
198499,PD-L1-positive,1,0
198500,",",1,0
198501,advanced,1,1
198502,non-small-cell,1,1
198503,lung,1,1
198504,cancer,1,1
198505,.,1,0
198506,METHODS,0,0
198507,We,0,0
198508,did,0,0
198509,this,0,0
198510,randomised,0,0
198511,",",0,0
198512,open-label,0,0
198513,",",0,0
198514,phase,0,0
198515,2/3,0,0
198516,study,0,0
198517,at,0,0
198518,202,1,1
198519,academic,1,1
198520,medical,1,1
198521,centres,1,1
198522,in,1,0
198523,24,1,1
198524,countries,1,1
198525,.,1,1
198526,Patients,1,1
198527,with,1,0
198528,previously,1,1
198529,treated,1,1
198530,non-small-cell,1,1
198531,lung,1,0
198532,cancer,1,1
198533,with,1,1
198534,PD-L1,1,1
198535,expression,1,0
198536,on,1,0
198537,at,1,0
198538,least,1,0
198539,1,1,0
198540,%,1,0
198541,of,1,0
198542,tumour,1,0
198543,cells,1,0
198544,were,0,0
198545,randomly,0,1
198546,assigned,0,0
198547,(,0,0
198548,1:1:1,0,1
198549,),0,0
198550,in,0,0
198551,blocks,0,0
198552,of,0,0
198553,six,0,1
198554,per,0,0
198555,stratum,0,0
198556,with,0,1
198557,an,0,0
198558,interactive,0,0
198559,voice-response,0,0
198560,system,0,0
198561,to,0,0
198562,receive,0,0
198563,pembrolizumab,0,0
198564,2,0,0
198565,mg/kg,0,0
198566,",",0,0
198567,pembrolizumab,0,0
198568,10,0,0
198569,mg/kg,0,0
198570,",",0,0
198571,or,0,0
198572,docetaxel,0,0
198573,75,0,0
198574,mg/m,0,0
198575,(,0,0
198576,2,0,0
198577,),0,0
198578,every,0,0
198579,3,0,0
198580,weeks,0,0
198581,.,0,0
198582,The,0,0
198583,primary,0,0
198584,endpoints,0,0
198585,were,0,0
198586,overall,0,0
198587,survival,0,0
198588,and,0,0
198589,progression-free,0,0
198590,survival,0,0
198591,both,0,0
198592,in,0,0
198593,the,0,0
198594,total,0,0
198595,population,0,1
198596,and,0,0
198597,in,0,0
198598,patients,0,1
198599,with,0,1
198600,PD-L1,0,1
198601,expression,0,0
198602,on,0,0
198603,at,0,0
198604,least,0,0
198605,50,0,0
198606,%,0,0
198607,of,0,0
198608,tumour,0,1
198609,cells,0,0
198610,.,0,1
198611,We,0,0
198612,used,0,0
198613,a,0,0
198614,threshold,0,0
198615,for,0,0
198616,significance,0,0
198617,of,0,0
198618,p,0,0
198619,<,0,0
198620,0.00825,0,0
198621,(,0,0
198622,one-sided,0,0
198623,),0,0
198624,for,0,0
198625,the,0,0
198626,analysis,0,0
198627,of,0,0
198628,overall,0,0
198629,survival,0,0
198630,and,0,0
198631,a,0,0
198632,threshold,0,0
198633,of,0,0
198634,p,0,0
198635,<,0,0
198636,0.001,0,0
198637,for,0,0
198638,progression-free,0,0
198639,survival,0,0
198640,.,0,0
198641,This,0,0
198642,trial,0,0
198643,is,0,0
198644,registered,0,0
198645,at,0,0
198646,ClinicalTrials.gov,0,0
198647,",",0,0
198648,number,0,0
198649,NCT01905657,0,0
198650,.,0,0
198651,FINDINGS,0,0
198652,Between,1,0
198653,Aug,1,0
198654,28,1,0
198655,",",1,0
198656,2013,1,1
198657,",",1,0
198658,and,1,0
198659,Feb,1,0
198660,27,1,0
198661,",",1,0
198662,2015,1,1
198663,",",1,0
198664,we,1,0
198665,enrolled,1,1
198666,1034,1,1
198667,patients,1,1
198668,:,1,1
198669,345,0,1
198670,allocated,0,0
198671,to,0,0
198672,pembrolizumab,0,0
198673,2,0,0
198674,mg/kg,0,0
198675,",",0,0
198676,346,0,1
198677,allocated,0,0
198678,to,0,0
198679,pembrolizumab,0,0
198680,10,0,0
198681,mg/kg,0,0
198682,",",0,0
198683,and,0,0
198684,343,0,1
198685,allocated,0,0
198686,to,0,0
198687,docetaxel,0,0
198688,.,0,0
198689,By,0,0
198690,Sept,0,0
198691,30,0,0
198692,",",0,0
198693,2015,0,1
198694,",",0,0
198695,521,0,1
198696,patients,0,1
198697,had,0,1
198698,died,0,1
198699,.,0,0
198700,In,0,0
198701,the,0,0
198702,total,0,0
198703,population,0,0
198704,",",0,0
198705,median,0,0
198706,overall,0,0
198707,survival,0,0
198708,was,0,0
198709,10.4,0,0
198710,months,0,0
198711,with,0,1
198712,pembrolizumab,0,0
198713,2,0,0
198714,mg/kg,0,0
198715,",",0,0
198716,12.7,0,0
198717,months,0,0
198718,with,0,1
198719,pembrolizumab,0,0
198720,10,0,0
198721,mg/kg,0,0
198722,",",0,0
198723,and,0,0
198724,8.5,0,0
198725,months,0,0
198726,with,0,1
198727,docetaxel,0,0
198728,.,0,0
198729,Overall,0,0
198730,survival,0,0
198731,was,0,0
198732,significantly,0,0
198733,longer,0,0
198734,for,0,0
198735,pembrolizumab,0,0
198736,2,0,0
198737,mg/kg,0,0
198738,versus,0,0
198739,docetaxel,0,0
198740,(,0,0
198741,hazard,0,0
198742,ratio,0,0
198743,[,0,0
198744,HR,0,0
198745,],0,0
198746,0.71,0,0
198747,",",0,0
198748,95,0,0
198749,%,0,0
198750,CI,0,0
198751,0.58-0.88,0,0
198752,;,0,0
198753,p=0.0008,0,0
198754,),0,0
198755,and,0,0
198756,for,0,0
198757,pembrolizumab,0,0
198758,10,0,0
198759,mg/kg,0,0
198760,versus,0,0
198761,docetaxel,0,0
198762,(,0,0
198763,0.61,0,0
198764,",",0,0
198765,0.49-0.75,0,0
198766,;,0,0
198767,p,0,0
198768,<,0,0
198769,0.0001,0,0
198770,),0,0
198771,.,0,0
198772,Median,0,0
198773,progression-free,0,0
198774,survival,0,0
198775,was,0,0
198776,3.9,0,0
198777,months,0,0
198778,with,0,1
198779,pembrolizumab,0,0
198780,2,0,0
198781,mg/kg,0,0
198782,",",0,0
198783,4.0,0,0
198784,months,0,0
198785,with,0,1
198786,pembrolizumab,0,0
198787,10,0,0
198788,mg/kg,0,0
198789,",",0,0
198790,and,0,0
198791,4.0,0,0
198792,months,0,0
198793,with,0,1
198794,docetaxel,0,0
198795,",",0,0
198796,with,0,0
198797,no,0,0
198798,significant,0,0
198799,difference,0,0
198800,for,0,0
198801,pembrolizumab,0,0
198802,2,0,0
198803,mg/kg,0,0
198804,versus,0,0
198805,docetaxel,0,0
198806,(,0,0
198807,0.88,0,0
198808,",",0,0
198809,0.74-1.05,0,0
198810,;,0,0
198811,p=0.07,0,0
198812,),0,0
198813,or,0,0
198814,for,0,0
198815,pembrolizumab,0,0
198816,10,0,0
198817,mg/kg,0,0
198818,versus,0,0
198819,docetaxel,0,0
198820,(,0,0
198821,HR,0,0
198822,0.79,0,0
198823,",",0,0
198824,95,0,0
198825,%,0,0
198826,CI,0,0
198827,0.66-0.94,0,0
198828,;,0,0
198829,p=0.004,0,0
198830,),0,0
198831,.,0,0
198832,Among,0,0
198833,patients,0,1
198834,with,0,1
198835,at,0,0
198836,least,0,0
198837,50,0,0
198838,%,0,0
198839,of,0,0
198840,tumour,0,0
198841,cells,0,0
198842,expressing,0,0
198843,PD-L1,0,1
198844,",",0,0
198845,overall,0,0
198846,survival,0,0
198847,was,0,0
198848,significantly,0,0
198849,longer,0,0
198850,with,0,0
198851,pembrolizumab,0,0
198852,2,0,0
198853,mg/kg,0,0
198854,than,0,0
198855,with,0,0
198856,docetaxel,0,0
198857,(,0,0
198858,median,0,0
198859,14.9,0,0
198860,months,0,0
198861,vs,0,0
198862,8.2,0,0
198863,months,0,0
198864,;,0,0
198865,HR,0,0
198866,0.54,0,0
198867,",",0,0
198868,95,0,0
198869,%,0,0
198870,CI,0,0
198871,0.38-0.77,0,0
198872,;,0,0
198873,p=0.0002,0,0
198874,),0,0
198875,and,0,0
198876,with,0,1
198877,pembrolizumab,0,0
198878,10,0,0
198879,mg/kg,0,0
198880,than,0,0
198881,with,0,0
198882,docetaxel,0,0
198883,(,0,0
198884,17.3,0,0
198885,months,0,0
198886,vs,0,0
198887,8.2,0,0
198888,months,0,0
198889,;,0,0
198890,0.50,0,0
198891,",",0,0
198892,0.36-0.70,0,0
198893,;,0,0
198894,p,0,0
198895,<,0,0
198896,0.0001,0,0
198897,),0,0
198898,.,0,0
198899,Likewise,0,0
198900,",",0,0
198901,for,0,0
198902,this,0,0
198903,patient,0,0
198904,population,0,0
198905,",",0,0
198906,progression-free,0,0
198907,survival,0,0
198908,was,0,0
198909,significantly,0,0
198910,longer,0,0
198911,with,0,0
198912,pembrolizumab,0,0
198913,2,0,0
198914,mg/kg,0,0
198915,than,0,0
198916,with,0,0
198917,docetaxel,0,0
198918,(,0,0
198919,median,0,0
198920,5.0,0,0
198921,months,0,0
198922,vs,0,0
198923,4.1,0,0
198924,months,0,0
198925,;,0,0
198926,HR,0,0
198927,0.59,0,0
198928,",",0,0
198929,95,0,0
198930,%,0,0
198931,CI,0,0
198932,0.44-0.78,0,0
198933,;,0,0
198934,p=0.0001,0,0
198935,),0,0
198936,and,0,0
198937,with,0,1
198938,pembrolizumab,0,0
198939,10,0,0
198940,mg/kg,0,0
198941,than,0,0
198942,with,0,0
198943,docetaxel,0,0
198944,(,0,0
198945,5.2,0,0
198946,months,0,0
198947,vs,0,0
198948,4.1,0,0
198949,months,0,0
198950,;,0,0
198951,0.59,0,0
198952,",",0,0
198953,0.45-0.78,0,0
198954,;,0,0
198955,p,0,0
198956,<,0,0
198957,0.0001,0,0
198958,),0,0
198959,.,0,0
198960,Grade,0,0
198961,3-5,0,0
198962,treatment-related,0,0
198963,adverse,0,0
198964,events,0,0
198965,were,0,0
198966,less,0,0
198967,common,0,0
198968,with,0,0
198969,pembrolizumab,0,0
198970,than,0,0
198971,with,0,0
198972,docetaxel,0,0
198973,(,0,0
198974,43,0,0
198975,[,0,0
198976,13,0,0
198977,%,0,0
198978,],0,0
198979,of,0,0
198980,339,0,1
198981,patients,0,1
198982,given,0,0
198983,2,0,0
198984,mg/kg,0,0
198985,",",0,0
198986,55,0,1
198987,[,0,0
198988,16,0,1
198989,%,0,0
198990,],0,0
198991,of,0,0
198992,343,0,1
198993,given,0,0
198994,10,0,0
198995,mg/kg,0,0
198996,",",0,0
198997,and,0,0
198998,109,0,1
198999,[,0,0
199000,35,0,1
199001,%,0,0
199002,],0,0
199003,of,0,0
199004,309,0,1
199005,given,0,0
199006,docetaxel,0,0
199007,),0,0
199008,.,0,0
199009,INTERPRETATION,0,0
199010,Pembrolizumab,0,0
199011,prolongs,0,0
199012,overall,0,0
199013,survival,0,0
199014,and,0,0
199015,has,0,0
199016,a,0,0
199017,favourable,0,0
199018,benefit-to-risk,0,0
199019,profile,0,0
199020,in,0,0
199021,patients,1,1
199022,with,1,1
199023,previously,1,1
199024,treated,1,0
199025,",",1,0
199026,PD-L1-positive,1,0
199027,",",1,0
199028,advanced,1,1
199029,non-small-cell,1,1
199030,lung,1,1
199031,cancer,1,1
199032,.,1,0
199033,These,0,0
199034,data,0,0
199035,establish,0,0
199036,pembrolizumab,0,0
199037,as,0,0
199038,a,0,0
199039,new,0,0
199040,treatment,0,0
199041,option,0,0
199042,for,0,0
199043,this,0,0
199044,population,0,0
199045,and,0,0
199046,validate,0,0
199047,the,0,0
199048,use,0,0
199049,of,0,0
199050,PD-L1,0,1
199051,selection,0,0
199052,.,0,0
199053,FUNDING,0,0
199054,Merck,0,0
199055,&,0,1
199056,Co,0,0
199057,.,0,0
199058,Effect,0,0
199059,of,0,0
199060,direct,0,0
199061,current,0,0
199062,pulse,0,0
199063,stimulating,0,0
199064,acupoints,0,0
199065,of,0,0
199066,JiaJi,0,1
199067,(,0,0
199068,T10-13,0,1
199069,),0,0
199070,and,0,0
199071,Ciliao,0,1
199072,(,0,0
199073,BL,0,0
199074,32,0,1
199075,),0,0
199076,with,0,1
199077,Han,0,0
199078,'s,0,1
199079,Acupoint,0,0
199080,Nerve,0,1
199081,Stimulator,0,0
199082,on,0,0
199083,labour,1,0
199084,pain,1,0
199085,in,1,0
199086,women,1,1
199087,:,1,1
199088,a,0,0
199089,randomized,0,0
199090,controlled,0,0
199091,clinical,0,0
199092,study,0,0
199093,.,0,0
199094,OBJECTIVE,0,0
199095,To,0,0
199096,assess,0,0
199097,the,0,0
199098,clinical,0,0
199099,effect,0,0
199100,and,0,0
199101,safety,0,0
199102,of,0,0
199103,direct,0,0
199104,current,0,0
199105,(,0,0
199106,DC,0,0
199107,),0,0
199108,pulse,0,0
199109,produced,0,0
199110,by,0,0
199111,Han,0,0
199112,'s,0,1
199113,Acupoint,0,0
199114,Nerve,0,1
199115,Stimulator,0,0
199116,in,0,0
199117,reduction,0,0
199118,(,0,0
199119,HANS,0,0
199120,),0,0
199121,of,0,0
199122,labor,0,1
199123,pain,0,0
199124,.,0,0
199125,METHODS,0,0
199126,Totally,0,0
199127,120,1,1
199128,participants,1,1
199129,were,0,0
199130,enrolled,0,1
199131,in,0,0
199132,this,0,0
199133,clinical,0,0
199134,trial,0,0
199135,",",0,0
199136,and,0,0
199137,were,0,0
199138,randomly,0,0
199139,divided,0,0
199140,into,0,0
199141,4,0,0
199142,groups,0,0
199143,including,0,1
199144,:,0,1
199145,HANS,0,0
199146,group,0,0
199147,",",0,0
199148,patient,0,0
199149,controlled,0,0
199150,intravenous,0,0
199151,analgesia,0,0
199152,(,0,0
199153,PCIA,0,0
199154,),0,0
199155,group,0,0
199156,",",0,0
199157,patient-controlled,0,0
199158,epidural,0,0
199159,analgesia,0,0
199160,(,0,0
199161,PCEA,0,0
199162,),0,0
199163,group,0,0
199164,and,0,0
199165,control,0,0
199166,group,0,0
199167,.,0,0
199168,The,0,0
199169,HANS,0,0
199170,group,0,0
199171,was,0,0
199172,treated,0,0
199173,by,0,0
199174,stimulating,0,0
199175,the,0,0
199176,acupoints,0,0
199177,of,0,0
199178,JiaJi,0,1
199179,(,0,0
199180,T10-L3,0,0
199181,),0,0
199182,and,0,0
199183,Ciliao,0,1
199184,(,0,0
199185,BL,0,0
199186,32,0,1
199187,),0,0
199188,with,0,1
199189,DC,0,0
199190,pulse,0,0
199191,of,0,0
199192,100,0,0
199193,Hz,0,0
199194,and,0,0
199195,15-30,0,0
199196,mA,0,0
199197,produced,0,0
199198,by,0,0
199199,a,0,0
199200,portable,0,0
199201,battery-powered,0,0
199202,Han,0,0
199203,'s,0,1
199204,Acupoint,0,0
199205,Nerve,0,1
199206,Stimulator,0,0
199207,for,0,0
199208,30,0,0
199209,min,0,0
199210,.,0,0
199211,The,0,0
199212,PCIA,0,0
199213,group,0,0
199214,was,0,0
199215,intravenously,0,0
199216,infused,0,0
199217,Ondansetron,0,0
199218,(,0,0
199219,8,0,0
199220,mg,0,0
199221,),0,0
199222,for,0,0
199223,5,0,0
199224,min,0,0
199225,",",0,0
199226,then,0,0
199227,tramadol,0,0
199228,injection,0,0
199229,(,0,0
199230,1.5,0,0
199231,mg/kg,0,0
199232,),0,0
199233,was,0,0
199234,slowly,0,0
199235,dripped,0,0
199236,by,0,0
199237,using,0,0
199238,BaxterAP,0,1
199239,II,0,1
199240,electronic,0,0
199241,pump,0,0
199242,with,0,1
199243,50,0,0
199244,mL,0,0
199245,tramadol,0,0
199246,(,0,0
199247,0.70,0,0
199248,%,0,0
199249,),0,0
199250,+,0,0
199251,ondansetron,0,0
199252,(,0,0
199253,8,0,0
199254,mg,0,0
199255,),0,0
199256,",",0,0
199257,background,0,0
199258,infusion,0,0
199259,2,0,0
199260,mL/h,0,0
199261,",",0,0
199262,PCA,0,0
199263,dose,0,0
199264,of,0,0
199265,2,0,0
199266,mL,0,0
199267,",",0,0
199268,lockout,0,0
199269,interval,0,0
199270,of,0,0
199271,10,0,0
199272,min,0,0
199273,.,0,0
199274,In,0,0
199275,PCEA,0,0
199276,group,0,0
199277,",",0,0
199278,women,0,1
199279,received,0,0
199280,intrathecal,0,0
199281,injection,0,0
199282,ropivacaine,0,0
199283,(,0,0
199284,3,0,0
199285,mg,0,0
199286,),0,0
199287,in,0,0
199288,L2-3,0,0
199289,",",0,0
199290,and,0,0
199291,epidural,0,0
199292,catheter,0,0
199293,was,0,0
199294,connected,0,0
199295,to,0,0
199296,BaxterAP,0,0
199297,II,0,0
199298,electronic,0,0
199299,pump,0,0
199300,",",0,0
199301,with,0,1
199302,100,0,0
199303,mL,0,0
199304,Ropivacaine,0,0
199305,(,0,0
199306,0.1,0,0
199307,%,0,0
199308,),0,0
199309,and,0,0
199310,Sufentanil,0,0
199311,(,0,0
199312,50,0,0
199313,ug,0,0
199314,),0,0
199315,",",0,0
199316,background,0,0
199317,infusion,0,0
199318,5,0,0
199319,mL,0,0
199320,",",0,0
199321,Patient,0,0
199322,controlled,0,0
199323,analgesia,0,0
199324,(,0,0
199325,PCA,0,1
199326,),0,0
199327,dose,0,0
199328,of,0,0
199329,5,0,0
199330,mL,0,0
199331,",",0,0
199332,lockout,0,0
199333,interval,0,0
199334,of,0,0
199335,10,0,0
199336,min,0,0
199337,.,0,0
199338,The,0,0
199339,control,0,0
199340,group,0,0
199341,was,0,0
199342,not,0,0
199343,received,0,0
199344,analgesia,0,0
199345,.,0,0
199346,The,0,0
199347,visual,0,0
199348,analogue,0,0
199349,scale,0,0
199350,(,0,0
199351,VAS,0,0
199352,),0,0
199353,",",0,0
199354,stage,0,1
199355,and,0,0
199356,manner,0,0
199357,of,0,0
199358,labor,0,1
199359,",",0,0
199360,Apgar,0,0
199361,score,0,0
199362,of,0,0
199363,newborn,0,1
199364,",",0,0
199365,neonatal,0,0
199366,weights,0,0
199367,",",0,0
199368,oxytocin,0,0
199369,dosage,0,0
199370,",",0,0
199371,postpartum,0,1
199372,hemorrhage,0,0
199373,and,0,0
199374,side,0,0
199375,effects,0,0
199376,were,0,0
199377,monitored,0,0
199378,in,0,0
199379,all,0,0
199380,groups,0,0
199381,.,0,0
199382,RESULTS,0,0
199383,The,0,0
199384,vital,0,0
199385,signs,0,0
199386,were,0,0
199387,all,0,0
199388,stable,0,1
199389,in,0,0
199390,the,0,0
199391,four,0,0
199392,analgesic,0,0
199393,groups,0,0
199394,.,0,0
199395,After,0,0
199396,analgesia,0,0
199397,",",0,0
199398,there,0,0
199399,was,0,0
199400,statistical,0,0
199401,difference,0,0
199402,in,0,0
199403,VAS,0,0
199404,score,0,0
199405,between,0,0
199406,HANS,0,0
199407,group,0,0
199408,and,0,0
199409,control,0,0
199410,group,0,0
199411,",",0,0
199412,between,0,0
199413,PCEA,0,0
199414,group,0,0
199415,and,0,0
199416,the,0,0
199417,control,0,0
199418,group,0,0
199419,",",0,0
199420,between,0,0
199421,PCIA,0,0
199422,group,0,0
199423,and,0,0
199424,control,0,0
199425,group,0,0
199426,.,0,0
199427,The,0,0
199428,analgesic,0,0
199429,effect,0,0
199430,in,0,0
199431,the,0,0
199432,PCEA,0,0
199433,group,0,0
199434,was,0,0
199435,significantly,0,0
199436,better,0,0
199437,than,0,0
199438,that,0,0
199439,of,0,0
199440,other,0,0
199441,two,0,0
199442,groups,0,0
199443,.,0,0
199444,The,0,0
199445,second,0,0
199446,stage,0,1
199447,of,0,0
199448,labor,0,1
199449,in,0,0
199450,the,0,0
199451,PCEA,0,0
199452,group,0,0
199453,was,0,0
199454,longer,0,0
199455,than,0,0
199456,the,0,0
199457,other,0,0
199458,three,0,0
199459,groups,0,0
199460,",",0,0
199461,showing,0,0
199462,significant,0,0
199463,difference,0,0
199464,between,0,0
199465,them,0,0
199466,.,0,0
199467,The,0,0
199468,Apgar,0,0
199469,score,0,0
199470,of,0,0
199471,newborn,0,1
199472,1,0,0
199473,min,0,0
199474,after,0,0
199475,birth,0,1
199476,in,0,0
199477,the,0,0
199478,PCIA,0,0
199479,group,0,0
199480,was,0,0
199481,slightly,0,0
199482,lower,0,0
199483,than,0,0
199484,that,0,0
199485,of,0,0
199486,the,0,0
199487,other,0,0
199488,two,0,0
199489,groups,0,0
199490,",",0,0
199491,showing,0,0
199492,significant,0,0
199493,difference,0,0
199494,between,0,0
199495,them,0,0
199496,.,0,0
199497,The,0,0
199498,neonatal,0,0
199499,weights,0,0
199500,between,0,0
199501,four,0,1
199502,groups,0,0
199503,were,0,0
199504,not,0,0
199505,significantly,0,0
199506,different,0,0
199507,.,0,0
199508,The,0,0
199509,rate,0,0
199510,of,0,0
199511,cesarean,0,1
199512,section,0,0
199513,in,0,0
199514,the,0,0
199515,control,0,0
199516,group,0,0
199517,was,0,0
199518,significantly,0,0
199519,higher,0,0
199520,than,0,0
199521,that,0,0
199522,of,0,0
199523,the,0,0
199524,labor,0,1
199525,analgesia,0,0
199526,group,0,0
199527,",",0,0
199528,there,0,0
199529,was,0,0
199530,statistically,0,0
199531,difference,0,0
199532,in,0,0
199533,four,0,1
199534,groups,0,0
199535,.,0,0
199536,The,0,0
199537,number,0,0
199538,of,0,0
199539,PCIA,0,0
199540,group,0,0
199541,that,0,0
199542,used,0,0
199543,oxytocin,0,0
199544,was,0,0
199545,lower,0,0
199546,than,0,0
199547,that,0,0
199548,of,0,0
199549,other,0,0
199550,three,0,1
199551,groups,0,0
199552,.,0,0
199553,There,0,0
199554,was,0,0
199555,no,0,0
199556,significant,0,0
199557,difference,0,0
199558,in,0,0
199559,postpartum,0,1
199560,hemorrhage,0,1
199561,between,0,0
199562,four,0,1
199563,groups,0,0
199564,.,0,0
199565,The,0,0
199566,side,0,0
199567,effects,0,0
199568,of,0,0
199569,the,0,0
199570,PCEA,0,0
199571,group,0,0
199572,were,0,0
199573,itching,0,0
199574,",",0,0
199575,uroschesis,0,0
199576,and,0,0
199577,neonatal,0,0
199578,asphyxia,0,1
199579,and,0,0
199580,PCIA,0,0
199581,group,0,0
199582,were,0,0
199583,nausea,0,0
199584,and,0,0
199585,vomiting,0,0
199586,and,0,0
199587,neonatal,0,1
199588,asphyxia,0,1
199589,.,0,0
199590,However,0,0
199591,",",0,0
199592,fewer,0,0
199593,side-effects,0,0
199594,were,0,0
199595,observed,0,0
199596,in,0,0
199597,the,0,0
199598,HANS,0,0
199599,group,0,0
199600,.,0,0
199601,CONCLUSION,0,0
199602,The,0,0
199603,DC,0,0
199604,pulse,0,0
199605,produced,0,0
199606,by,0,0
199607,HANS,0,0
199608,may,0,0
199609,be,0,0
199610,a,0,0
199611,non-pharmacological,0,0
199612,alternative,0,0
199613,to,0,0
199614,labor,0,1
199615,pain,0,0
199616,with,0,0
199617,fewer,0,0
199618,side,0,0
199619,effects,0,0
199620,.,0,1
199621,Efficacy,0,0
199622,of,0,0
199623,Low-Dose,0,0
199624,Buspirone,0,0
199625,for,0,0
199626,Restricted,0,0
199627,and,0,0
199628,Repetitive,0,0
199629,Behavior,0,0
199630,in,0,0
199631,Young,1,1
199632,Children,1,1
199633,with,1,1
199634,Autism,1,1
199635,Spectrum,1,1
199636,Disorder,1,1
199637,:,1,1
199638,A,0,0
199639,Randomized,0,0
199640,Trial,0,0
199641,.,0,0
199642,OBJECTIVES,0,0
199643,To,0,0
199644,determine,0,0
199645,safety,0,0
199646,and,0,0
199647,efficacy,0,0
199648,of,0,0
199649,the,0,0
199650,5HT1A,0,0
199651,serotonin,0,0
199652,partial,0,0
199653,agonist,0,0
199654,buspirone,0,0
199655,on,0,0
199656,core,0,0
199657,autism,0,1
199658,and,0,0
199659,associated,0,0
199660,features,0,0
199661,in,0,0
199662,children,1,1
199663,with,1,1
199664,autism,1,1
199665,spectrum,1,1
199666,disorder,1,1
199667,(,1,0
199668,ASD,1,1
199669,),1,0
199670,.,1,0
199671,STUDY,0,0
199672,DESIGN,0,0
199673,Children,1,1
199674,2-6,1,0
199675,years,1,1
199676,of,1,0
199677,age,1,1
199678,with,1,1
199679,ASD,1,1
199680,(,1,0
199681,N,1,1
199682,=,1,0
199683,166,1,1
199684,),1,0
199685,were,0,0
199686,randomized,0,0
199687,to,0,0
199688,receive,0,0
199689,placebo,0,0
199690,or,0,0
199691,2.5,0,0
199692,or,0,0
199693,5.0,0,0
199694,mg,0,0
199695,of,0,0
199696,buspirone,0,0
199697,twice,0,0
199698,daily,0,0
199699,.,0,0
199700,The,0,0
199701,primary,0,0
199702,objective,0,0
199703,was,0,0
199704,to,0,0
199705,evaluate,0,0
199706,the,0,0
199707,effects,0,0
199708,of,0,0
199709,24,0,0
199710,weeks,0,0
199711,of,0,0
199712,buspirone,0,0
199713,on,0,0
199714,the,0,0
199715,Autism,0,1
199716,Diagnostic,0,0
199717,Observation,0,0
199718,Schedule,0,0
199719,(,0,0
199720,ADOS,0,0
199721,),0,0
199722,Composite,0,0
199723,Total,0,0
199724,Score,0,0
199725,.,0,0
199726,Secondary,0,0
199727,objectives,0,0
199728,included,0,1
199729,evaluating,0,0
199730,the,0,0
199731,effects,0,0
199732,of,0,0
199733,buspirone,0,0
199734,on,0,0
199735,social,0,0
199736,competence,0,0
199737,",",0,0
199738,repetitive,0,0
199739,behaviors,0,0
199740,",",0,0
199741,language,0,0
199742,",",0,0
199743,sensory,0,0
199744,dysfunction,0,0
199745,",",0,0
199746,and,0,0
199747,anxiety,0,0
199748,and,0,0
199749,to,0,0
199750,assess,0,0
199751,side,0,0
199752,effects,0,0
199753,.,0,1
199754,Positron,0,0
199755,emission,0,0
199756,tomography,0,0
199757,measures,0,0
199758,of,0,0
199759,tryptophan,0,0
199760,metabolism,0,0
199761,and,0,0
199762,blood,0,0
199763,serotonin,0,0
199764,concentrations,0,0
199765,were,0,0
199766,assessed,0,0
199767,as,0,0
199768,predictors,0,0
199769,of,0,0
199770,buspirone,0,0
199771,efficacy,0,0
199772,.,0,0
199773,RESULTS,0,0
199774,There,0,0
199775,was,0,0
199776,no,0,0
199777,difference,0,0
199778,in,0,0
199779,the,0,0
199780,ADOS,0,0
199781,Composite,0,0
199782,Total,0,0
199783,Score,0,0
199784,between,0,0
199785,baseline,0,0
199786,and,0,0
199787,24,0,0
199788,weeks,0,0
199789,among,0,1
199790,the,0,0
199791,3,0,0
199792,treatment,0,0
199793,groups,0,0
199794,(,0,0
199795,P,0,0
199796,=,0,0
199797,.400,0,0
199798,),0,0
199799,;,0,0
199800,however,0,0
199801,",",0,0
199802,the,0,0
199803,ADOS,0,0
199804,Restricted,0,0
199805,and,0,0
199806,Repetitive,0,0
199807,Behavior,0,0
199808,score,0,0
199809,showed,0,0
199810,a,0,0
199811,time-by-treatment,0,0
199812,effect,0,0
199813,(,0,0
199814,P,0,0
199815,=,0,0
199816,.006,0,0
199817,),0,0
199818,;,0,0
199819,the,0,0
199820,2.5-mg,0,0
199821,buspirone,0,0
199822,group,0,0
199823,showed,0,0
199824,significant,0,0
199825,improvement,0,0
199826,(,0,0
199827,P,0,0
199828,=,0,0
199829,.003,0,0
199830,),0,0
199831,",",0,0
199832,whereas,0,0
199833,placebo,0,0
199834,and,0,0
199835,5.0-mg,0,0
199836,buspirone,0,0
199837,groups,0,0
199838,showed,0,0
199839,no,0,0
199840,change,0,0
199841,.,0,0
199842,Children,0,1
199843,in,0,0
199844,the,0,0
199845,2.5-mg,0,0
199846,buspirone,0,0
199847,group,0,0
199848,were,0,0
199849,more,0,0
199850,likely,0,0
199851,to,0,0
199852,improve,0,0
199853,if,0,0
199854,they,0,0
199855,had,0,0
199856,fewer,0,0
199857,foci,0,0
199858,of,0,0
199859,increased,0,0
199860,brain,0,0
199861,tryptophan,0,0
199862,metabolism,0,0
199863,on,0,0
199864,positron,0,0
199865,emission,0,0
199866,tomography,0,0
199867,(,0,0
199868,P,0,0
199869,=,0,0
199870,.018,0,0
199871,),0,0
199872,or,0,0
199873,if,0,0
199874,they,0,0
199875,showed,0,0
199876,normal,0,1
199877,levels,0,0
199878,of,0,0
199879,blood,0,0
199880,serotonin,0,0
199881,(,0,0
199882,P,0,0
199883,=,0,0
199884,.044,0,0
199885,),0,0
199886,.,0,0
199887,Adverse,0,0
199888,events,0,0
199889,did,0,0
199890,not,0,0
199891,differ,0,0
199892,significantly,0,0
199893,among,0,0
199894,treatment,0,0
199895,groups,0,0
199896,.,0,1
199897,CONCLUSIONS,0,0
199898,Treatment,0,0
199899,with,0,1
199900,2.5,0,0
199901,mg,0,0
199902,of,0,0
199903,buspirone,0,0
199904,in,0,0
199905,young,1,1
199906,children,1,1
199907,with,1,1
199908,ASD,1,1
199909,might,0,0
199910,be,0,0
199911,a,0,0
199912,useful,0,0
199913,adjunct,0,0
199914,therapy,0,0
199915,to,0,0
199916,target,0,0
199917,restrictive,0,1
199918,and,0,0
199919,repetitive,0,0
199920,behaviors,0,0
199921,in,0,0
199922,conjunction,0,0
199923,with,0,1
199924,behavioral,0,1
199925,interventions,0,0
199926,.,0,1
199927,TRIAL,0,0
199928,REGISTRATION,0,0
199929,ClinicalTrials.gov,0,0
199930,:,0,1
199931,NCT00873509,0,0
199932,.,0,0
199933,West,0,0
199934,Midlands,0,1
199935,Oncology,0,1
199936,Association,0,0
199937,trials,0,0
199938,of,0,0
199939,adjuvant,0,0
199940,chemotherapy,0,0
199941,in,0,0
199942,operable,1,1
199943,breast,1,1
199944,cancer,1,1
199945,:,1,1
199946,results,0,0
199947,after,0,0
199948,a,0,0
199949,median,0,0
199950,follow-up,0,0
199951,of,0,0
199952,7,0,0
199953,years,0,1
199954,.,0,1
199955,I,0,0
199956,.,0,0
199957,Patients,1,1
199958,with,1,1
199959,involved,1,0
199960,axillary,1,1
199961,lymph,1,1
199962,nodes,1,0
199963,.,1,0
199964,The,0,0
199965,aim,0,0
199966,of,0,0
199967,this,0,0
199968,study,0,0
199969,was,0,0
199970,to,0,0
199971,test,0,0
199972,the,0,0
199973,effectiveness,0,0
199974,of,0,0
199975,a,0,0
199976,regimen,0,0
199977,of,0,0
199978,combination,0,0
199979,chemotherapy,0,0
199980,known,0,0
199981,to,0,0
199982,be,0,0
199983,active,0,0
199984,in,0,0
199985,advanced,0,1
199986,breast,0,1
199987,cancer,0,1
199988,when,0,0
199989,given,0,0
199990,as,0,0
199991,an,0,0
199992,adjuvant,0,0
199993,treatment,0,0
199994,after,0,0
199995,mastectomy,0,1
199996,.,0,0
199997,A,0,0
199998,total,0,0
199999,of,1,0
200000,569,1,1
200001,patients,1,1
200002,with,1,1
200003,cancer,1,1
200004,of,1,0
200005,the,1,0
200006,breast,1,1
200007,and,1,0
200008,involvement,1,0
200009,of,1,0
200010,axillary,1,1
200011,lymph,1,1
200012,nodes,1,0
200013,were,1,0
200014,randomised,1,0
200015,",",1,0
200016,after,1,0
200017,simple,1,0
200018,mastectomy,1,1
200019,with,1,1
200020,axillary,1,1
200021,sampling,1,0
200022,",",0,0
200023,to,0,0
200024,receive,0,0
200025,either,0,0
200026,no,0,0
200027,adjuvant,0,0
200028,treatment,0,0
200029,or,0,1
200030,intravenous,0,0
200031,adriamycin,0,0
200032,50,0,1
200033,mg,0,0
200034,",",0,0
200035,vincristine,0,0
200036,1,0,0
200037,mg,0,0
200038,",",0,0
200039,cyclophosphamide,0,0
200040,250,0,0
200041,mg,0,0
200042,",",0,0
200043,methotrexate,0,0
200044,150,0,0
200045,mg,0,0
200046,and,0,0
200047,fluorouracil,0,0
200048,250,0,0
200049,mg,0,0
200050,(,0,0
200051,AVCMF,0,0
200052,),0,0
200053,every,0,0
200054,21,0,1
200055,days,0,0
200056,for,0,0
200057,eight,0,1
200058,cycles,0,0
200059,.,0,1
200060,Randomisation,0,0
200061,was,0,0
200062,stratified,0,0
200063,according,0,0
200064,to,0,0
200065,menopausal,0,1
200066,status,0,0
200067,and,0,0
200068,tumour,0,0
200069,size,0,0
200070,.,0,0
200071,Treatment,0,0
200072,was,0,0
200073,started,0,0
200074,within,0,0
200075,14,0,0
200076,days,0,0
200077,of,0,0
200078,surgery,0,1
200079,in,0,0
200080,94,0,0
200081,%,0,0
200082,of,0,0
200083,patients,0,1
200084,.,0,1
200085,Eighty-eight,0,1
200086,per,0,0
200087,cent,0,0
200088,of,0,0
200089,patients,0,1
200090,received,0,0
200091,at,0,0
200092,least,0,0
200093,seven,0,1
200094,cycles,0,0
200095,of,0,0
200096,chemotherapy,0,0
200097,with,0,1
200098,no,0,0
200099,dose,0,0
200100,reduction,0,0
200101,.,0,0
200102,The,0,0
200103,median,0,0
200104,relapse-free,0,0
200105,survival,0,0
200106,was,0,0
200107,prolonged,0,0
200108,by,0,0
200109,14,0,0
200110,months,0,0
200111,in,0,0
200112,patients,0,1
200113,treated,0,1
200114,with,0,1
200115,AVCMF,0,0
200116,(,0,0
200117,chi2,0,0
200118,1,0,0
200119,=,0,0
200120,11.7,0,0
200121,;,0,0
200122,P,0,0
200123,=,0,0
200124,0.0006,0,0
200125,),0,0
200126,.,0,0
200127,In,0,0
200128,the,0,0
200129,premenopausal,1,1
200130,group,0,0
200131,this,0,0
200132,period,0,0
200133,was,0,0
200134,17,0,0
200135,months,0,0
200136,(,0,0
200137,chi2,0,0
200138,1,0,0
200139,=,0,0
200140,8.8,0,0
200141,;,0,0
200142,P,0,0
200143,=,0,0
200144,0.003,0,0
200145,),0,0
200146,compared,0,0
200147,with,0,1
200148,8,0,0
200149,months,0,0
200150,in,0,0
200151,the,0,0
200152,post-menopausal,1,1
200153,group,0,0
200154,(,0,0
200155,chi2,0,0
200156,1,0,0
200157,=,0,0
200158,3.3,0,0
200159,;,0,0
200160,P,0,0
200161,=,0,0
200162,0.07,0,0
200163,),0,0
200164,.,0,0
200165,Neither,0,0
200166,overall,0,0
200167,survival,0,0
200168,nor,0,0
200169,survival,0,0
200170,in,0,0
200171,these,0,0
200172,subgroups,0,0
200173,was,0,0
200174,significantly,0,0
200175,influenced,0,0
200176,by,0,0
200177,treatment,0,0
200178,.,0,0
200179,A,0,0
200180,Placebo-Controlled,0,0
200181,Trial,0,0
200182,of,0,0
200183,Obeticholic,0,0
200184,Acid,0,0
200185,in,0,0
200186,Primary,1,1
200187,Biliary,1,1
200188,Cholangitis,1,1
200189,.,1,0
200190,BACKGROUND,0,0
200191,Primary,1,0
200192,biliary,1,1
200193,cholangitis,1,1
200194,(,1,0
200195,formerly,1,0
200196,called,1,0
200197,primary,1,0
200198,biliary,1,1
200199,cirrhosis,1,1
200200,),1,0
200201,can,0,0
200202,progress,0,0
200203,to,0,0
200204,cirrhosis,0,1
200205,and,0,0
200206,death,0,0
200207,despite,0,0
200208,ursodiol,0,0
200209,therapy,0,0
200210,.,0,0
200211,Alkaline,0,0
200212,phosphatase,0,0
200213,and,0,0
200214,bilirubin,0,0
200215,levels,0,0
200216,correlate,0,0
200217,with,0,0
200218,the,0,0
200219,risk,0,0
200220,of,0,0
200221,liver,0,1
200222,transplantation,0,1
200223,or,0,0
200224,death,0,0
200225,.,0,0
200226,Obeticholic,0,0
200227,acid,0,0
200228,",",0,0
200229,a,0,0
200230,farnesoid,0,0
200231,X,0,0
200232,receptor,0,0
200233,agonist,0,0
200234,",",0,0
200235,has,0,0
200236,shown,0,0
200237,potential,0,0
200238,benefit,0,0
200239,in,0,0
200240,patients,0,1
200241,with,0,1
200242,this,0,0
200243,disease,0,1
200244,.,0,0
200245,METHODS,0,0
200246,In,0,0
200247,this,0,0
200248,12-month,1,0
200249,",",1,0
200250,double-blind,1,0
200251,",",1,0
200252,placebo-controlled,1,0
200253,",",1,0
200254,phase,1,0
200255,3,1,0
200256,trial,1,0
200257,",",1,0
200258,we,1,0
200259,randomly,1,0
200260,assigned,1,0
200261,217,1,1
200262,patients,1,1
200263,who,1,1
200264,had,1,1
200265,an,1,1
200266,inadequate,1,0
200267,response,1,0
200268,to,1,0
200269,ursodiol,1,0
200270,or,1,1
200271,who,1,1
200272,found,1,0
200273,the,1,1
200274,side,1,0
200275,effects,1,0
200276,of,1,0
200277,ursodiol,1,0
200278,unacceptable,1,0
200279,to,0,0
200280,receive,0,0
200281,obeticholic,0,0
200282,acid,0,0
200283,at,0,0
200284,a,0,0
200285,dose,0,0
200286,of,0,0
200287,10,0,0
200288,mg,0,0
200289,(,0,0
200290,the,0,0
200291,10-mg,0,0
200292,group,0,0
200293,),0,0
200294,",",0,0
200295,obeticholic,0,0
200296,acid,0,0
200297,at,0,0
200298,a,0,0
200299,dose,0,0
200300,of,0,0
200301,5,0,0
200302,mg,0,0
200303,with,0,1
200304,adjustment,0,0
200305,to,0,0
200306,10,0,0
200307,mg,0,0
200308,if,0,0
200309,applicable,0,0
200310,(,0,0
200311,the,0,0
200312,5-10-mg,0,0
200313,group,0,0
200314,),0,0
200315,",",0,0
200316,or,0,0
200317,placebo,0,0
200318,.,0,0
200319,The,0,0
200320,primary,0,0
200321,end,0,0
200322,point,0,0
200323,was,0,0
200324,an,0,0
200325,alkaline,0,0
200326,phosphatase,0,0
200327,level,0,0
200328,of,0,0
200329,less,0,0
200330,than,0,0
200331,1.67,0,0
200332,times,0,0
200333,the,0,0
200334,upper,0,0
200335,limit,0,0
200336,of,0,0
200337,the,0,0
200338,normal,0,0
200339,range,0,0
200340,",",0,0
200341,with,0,0
200342,a,0,0
200343,reduction,0,0
200344,of,0,0
200345,at,0,0
200346,least,0,0
200347,15,0,0
200348,%,0,0
200349,from,0,0
200350,baseline,0,0
200351,",",0,0
200352,and,0,0
200353,a,0,0
200354,normal,0,0
200355,total,0,1
200356,bilirubin,0,0
200357,level,0,0
200358,.,0,0
200359,RESULTS,0,0
200360,Of,0,1
200361,216,1,1
200362,patients,1,1
200363,who,1,1
200364,underwent,1,1
200365,randomization,1,1
200366,and,1,0
200367,received,1,0
200368,at,1,0
200369,least,1,0
200370,one,1,0
200371,dose,1,0
200372,of,1,0
200373,obeticholic,1,0
200374,acid,1,0
200375,or,1,0
200376,placebo,1,0
200377,",",0,0
200378,93,0,0
200379,%,0,0
200380,received,0,0
200381,ursodiol,0,0
200382,as,0,0
200383,background,0,0
200384,therapy,0,0
200385,.,0,0
200386,The,0,0
200387,primary,0,0
200388,end,0,0
200389,point,0,0
200390,occurred,0,0
200391,in,0,0
200392,more,0,0
200393,patients,0,1
200394,in,0,0
200395,the,0,0
200396,5-10-mg,0,0
200397,group,0,0
200398,(,0,0
200399,46,0,0
200400,%,0,0
200401,),0,0
200402,and,0,0
200403,the,0,0
200404,10-mg,0,0
200405,group,0,0
200406,(,0,0
200407,47,0,0
200408,%,0,0
200409,),0,0
200410,than,0,0
200411,in,0,0
200412,the,0,0
200413,placebo,0,0
200414,group,0,0
200415,(,0,0
200416,10,0,0
200417,%,0,0
200418,;,0,0
200419,P,0,0
200420,<,0,0
200421,0.001,0,0
200422,for,0,0
200423,both,0,0
200424,comparisons,0,0
200425,),0,0
200426,.,0,1
200427,Patients,0,1
200428,in,0,0
200429,the,0,0
200430,5-10-mg,0,0
200431,group,0,0
200432,and,0,0
200433,those,0,0
200434,in,0,0
200435,the,0,0
200436,10-mg,0,0
200437,group,0,0
200438,had,0,0
200439,greater,0,0
200440,decreases,0,0
200441,than,0,0
200442,those,0,0
200443,in,0,0
200444,the,0,0
200445,placebo,0,0
200446,group,0,0
200447,in,0,0
200448,the,0,0
200449,alkaline,0,0
200450,phosphatase,0,0
200451,level,0,0
200452,(,0,0
200453,least-squares,0,0
200454,mean,0,0
200455,",",0,0
200456,-113,0,0
200457,and,0,0
200458,-130,0,0
200459,U,0,0
200460,per,0,0
200461,liter,0,0
200462,",",0,0
200463,respectively,0,0
200464,",",0,0
200465,vs.,0,0
200466,-14,0,0
200467,U,0,0
200468,per,0,0
200469,liter,0,0
200470,;,0,0
200471,P,0,0
200472,<,0,0
200473,0.001,0,0
200474,for,0,0
200475,both,0,0
200476,comparisons,0,0
200477,),0,0
200478,and,0,0
200479,total,0,1
200480,bilirubin,0,0
200481,level,0,0
200482,(,0,0
200483,-0.02,0,0
200484,and,0,0
200485,-0.05,0,0
200486,mg,0,0
200487,per,0,0
200488,deciliter,0,0
200489,[,0,0
200490,-0.3,0,0
200491,and,0,0
200492,-0.9,0,0
200493,?mol,0,0
200494,per,0,0
200495,liter,0,0
200496,],0,0
200497,",",0,0
200498,respectively,0,0
200499,",",0,0
200500,vs.,0,0
200501,0.12,0,0
200502,mg,0,0
200503,per,0,0
200504,deciliter,0,0
200505,[,0,0
200506,2.0,0,0
200507,?mol,0,0
200508,per,0,0
200509,liter,0,0
200510,],0,1
200511,;,0,0
200512,P,0,0
200513,<,0,0
200514,0.001,0,0
200515,for,0,0
200516,both,0,0
200517,comparisons,0,0
200518,),0,0
200519,.,0,1
200520,Changes,0,0
200521,in,0,0
200522,noninvasive,0,0
200523,measures,0,0
200524,of,0,0
200525,liver,0,1
200526,fibrosis,0,0
200527,did,0,0
200528,not,0,0
200529,differ,0,0
200530,significantly,0,0
200531,between,0,0
200532,either,0,0
200533,treatment,0,0
200534,group,0,0
200535,and,0,0
200536,the,0,0
200537,placebo,0,0
200538,group,0,0
200539,at,0,0
200540,12,0,0
200541,months,0,0
200542,.,0,1
200543,Pruritus,0,0
200544,was,0,0
200545,more,0,0
200546,common,0,0
200547,with,0,0
200548,obeticholic,0,0
200549,acid,0,0
200550,than,0,0
200551,with,0,1
200552,placebo,0,0
200553,(,0,0
200554,56,0,0
200555,%,0,0
200556,of,0,0
200557,patients,0,1
200558,in,0,0
200559,the,0,0
200560,5-10-mg,0,0
200561,group,0,0
200562,and,0,0
200563,68,0,0
200564,%,0,0
200565,of,0,0
200566,those,0,0
200567,in,0,0
200568,the,0,0
200569,10-mg,0,0
200570,group,0,0
200571,vs.,0,0
200572,38,0,1
200573,%,0,0
200574,in,0,0
200575,the,0,0
200576,placebo,0,0
200577,group,0,0
200578,),0,0
200579,.,0,0
200580,The,0,0
200581,rate,0,0
200582,of,0,0
200583,serious,0,0
200584,adverse,0,0
200585,events,0,0
200586,was,0,0
200587,16,0,1
200588,%,0,0
200589,in,0,0
200590,the,0,0
200591,5-10-mg,0,0
200592,group,0,0
200593,",",0,0
200594,11,0,0
200595,%,0,0
200596,in,0,0
200597,the,0,0
200598,10-mg,0,0
200599,group,0,0
200600,",",0,0
200601,and,0,0
200602,4,0,0
200603,%,0,0
200604,in,0,0
200605,the,0,0
200606,placebo,0,0
200607,group,0,0
200608,.,0,0
200609,CONCLUSIONS,0,0
200610,Obeticholic,0,0
200611,acid,0,0
200612,administered,0,0
200613,with,0,0
200614,ursodiol,0,0
200615,or,0,0
200616,as,0,0
200617,monotherapy,0,0
200618,for,0,0
200619,12,0,0
200620,months,0,0
200621,in,0,0
200622,patients,1,1
200623,with,1,1
200624,primary,1,1
200625,biliary,1,1
200626,cholangitis,1,1
200627,resulted,1,0
200628,in,0,0
200629,decreases,0,0
200630,from,0,0
200631,baseline,0,0
200632,in,0,0
200633,alkaline,0,0
200634,phosphatase,0,0
200635,and,0,0
200636,total,0,1
200637,bilirubin,0,0
200638,levels,0,0
200639,that,0,0
200640,differed,0,0
200641,significantly,0,0
200642,from,0,0
200643,the,0,0
200644,changes,0,0
200645,observed,0,0
200646,with,0,1
200647,placebo,0,0
200648,.,0,0
200649,There,0,0
200650,were,0,0
200651,more,0,0
200652,serious,0,0
200653,adverse,0,0
200654,events,0,0
200655,with,0,1
200656,obeticholic,0,0
200657,acid,0,0
200658,.,0,0
200659,(,0,0
200660,Funded,0,0
200661,by,0,0
200662,Intercept,0,0
200663,Pharmaceuticals,0,0
200664,;,0,0
200665,POISE,0,1
200666,ClinicalTrials.gov,0,0
200667,number,0,0
200668,",",0,0
200669,NCT01473524,0,0
200670,;,0,0
200671,Current,0,0
200672,Controlled,0,0
200673,Trials,0,0
200674,number,0,0
200675,",",0,0
200676,ISRCTN89514817,0,0
200677,.,0,0
200678,),0,0
200679,.,0,0
200680,An,0,0
200681,evaluation,0,0
200682,of,0,0
200683,sealing,0,0
200684,ability,0,0
200685,of,0,0
200686,calcium,0,0
200687,hydroxide,0,0
200688,sealers,0,0
200689,.,0,0
200690,Solid,0,0
200691,core,0,0
200692,filling,0,0
200693,material,0,1
200694,such,0,0
200695,as,0,0
200696,gutta-percha,0,0
200697,has,0,0
200698,been,0,0
200699,used,0,0
200700,to,0,0
200701,fill,0,0
200702,the,0,0
200703,root,0,0
200704,canal,0,0
200705,in,0,0
200706,conjunction,0,0
200707,with,0,0
200708,a,0,0
200709,sealer,0,0
200710,to,0,0
200711,prevent,0,0
200712,apical,0,0
200713,leakage,0,0
200714,.,0,0
200715,The,0,0
200716,purpose,0,0
200717,of,0,0
200718,this,0,0
200719,study,0,0
200720,was,0,0
200721,to,0,0
200722,compare,0,0
200723,apical,0,0
200724,seal,0,0
200725,of,0,0
200726,five,0,0
200727,different,0,0
200728,root,0,0
200729,canal,0,1
200730,sealers,0,0
200731,.,0,1
200732,Sixty,1,1
200733,roots,1,1
200734,of,1,0
200735,maxillary,1,1
200736,central,1,1
200737,incisors,1,1
200738,were,0,0
200739,cleansed,0,0
200740,and,0,0
200741,shaped,0,0
200742,and,0,0
200743,randomly,0,0
200744,assigned,0,0
200745,to,0,0
200746,one,0,0
200747,of,0,0
200748,six,0,1
200749,groups,0,0
200750,of,0,0
200751,ten,0,1
200752,roots,0,1
200753,each,0,0
200754,.,0,0
200755,The,0,0
200756,root,0,0
200757,canals,0,0
200758,were,0,0
200759,obturated,0,0
200760,with,0,1
200761,gutta-percha,0,0
200762,and,0,0
200763,one,0,0
200764,of,0,0
200765,the,0,0
200766,sealers,0,0
200767,by,0,0
200768,the,0,0
200769,lateral-vertical,0,0
200770,condensation,0,0
200771,technique,0,0
200772,.,0,0
200773,Groups,0,0
200774,I,0,0
200775,",",0,0
200776,II,0,0
200777,",",0,0
200778,III,0,0
200779,",",0,0
200780,IV,0,0
200781,",",0,0
200782,and,0,0
200783,V,0,0
200784,consisted,0,0
200785,of,0,0
200786,roots,0,1
200787,in,0,0
200788,which,0,0
200789,the,0,0
200790,canal,0,0
200791,was,0,0
200792,filled,0,0
200793,with,0,1
200794,gutta-percha,0,0
200795,along,0,0
200796,with,0,1
200797,either,0,0
200798,Roth,0,0
200799,'s,0,0
200800,sealer,0,0
200801,",",0,0
200802,AH26,0,0
200803,",",0,0
200804,Sealapex,0,0
200805,",",0,0
200806,CRCS,0,0
200807,",",0,0
200808,or,0,0
200809,Nogenol,0,0
200810,sealer,0,0
200811,",",0,0
200812,respectively,0,0
200813,.,0,0
200814,Group,0,0
200815,VI,0,0
200816,was,0,0
200817,filled,0,0
200818,with,0,1
200819,gutta-percha,0,0
200820,and,0,0
200821,without,0,0
200822,sealer,0,0
200823,to,0,0
200824,serve,0,0
200825,as,0,0
200826,a,0,0
200827,control,0,0
200828,.,0,0
200829,The,0,0
200830,access,0,0
200831,opening,0,0
200832,was,0,0
200833,filled,0,0
200834,with,0,1
200835,amalgam,0,0
200836,.,0,0
200837,Each,1,0
200838,tooth,1,0
200839,was,0,0
200840,then,0,0
200841,placed,0,0
200842,in,0,0
200843,a,0,0
200844,capped,0,0
200845,vial,0,0
200846,containing,0,0
200847,2,0,0
200848,X,0,1
200849,2,0,0
200850,inch,0,0
200851,gauze,0,0
200852,pads,0,0
200853,saturated,0,0
200854,with,0,1
200855,distilled,0,0
200856,water,0,0
200857,",",0,0
200858,and,0,0
200859,the,0,0
200860,sealer,0,0
200861,was,0,0
200862,allowed,0,0
200863,to,0,0
200864,set,0,0
200865,at,0,0
200866,37,0,1
200867,degrees,0,0
200868,C,0,0
200869,in,0,0
200870,the,0,0
200871,humidor,0,0
200872,for,0,0
200873,48,0,1
200874,hours,0,0
200875,.,0,1
200876,The,0,0
200877,roots,0,0
200878,",",0,0
200879,except,0,0
200880,for,0,0
200881,the,0,0
200882,apical,0,0
200883,2,0,0
200884,mm,0,0
200885,",",0,0
200886,were,0,0
200887,coated,0,0
200888,with,0,1
200889,two,0,0
200890,layers,0,0
200891,of,0,0
200892,nail,0,1
200893,polish,0,1
200894,.,0,0
200895,The,0,0
200896,roots,0,0
200897,were,0,0
200898,stained,0,0
200899,with,0,1
200900,india,0,1
200901,ink,0,0
200902,",",0,0
200903,decalcified,0,0
200904,",",0,0
200905,dehydrated,0,0
200906,",",0,0
200907,and,0,0
200908,then,0,0
200909,placed,0,0
200910,in,0,0
200911,methylsalicylate,0,0
200912,to,0,0
200913,make,0,0
200914,them,0,0
200915,transparent,0,0
200916,.,0,0
200917,The,0,0
200918,leakage,0,0
200919,was,0,0
200920,measured,0,0
200921,with,0,0
200922,a,0,0
200923,filar,0,1
200924,micrometer,0,0
200925,eyepiece,0,0
200926,under,0,0
200927,a,0,0
200928,dissecting,0,0
200929,microscope,0,0
200930,.,0,0
200931,The,0,0
200932,mean,0,0
200933,apical,0,0
200934,leakage,0,0
200935,of,0,0
200936,six,0,1
200937,groups,0,0
200938,was,0,0
200939,as,0,0
200940,follows,0,0
200941,:,0,0
200942,I,0,0
200943,=,0,0
200944,0.45,0,0
200945,mm,0,0
200946,",",0,0
200947,II,0,0
200948,=,0,0
200949,0.277,0,0
200950,mm,0,0
200951,",",0,0
200952,III,0,0
200953,=,0,0
200954,0.343,0,0
200955,mm,0,0
200956,",",0,0
200957,IV,0,0
200958,=,0,0
200959,0.263,0,0
200960,mm,0,0
200961,",",0,0
200962,V,0,0
200963,=,0,0
200964,0.336,0,0
200965,mm,0,0
200966,",",0,0
200967,and,0,0
200968,VI,0,0
200969,=,0,0
200970,2.310,0,0
200971,mm,0,0
200972,.,0,0
200973,Results,0,0
200974,showed,0,0
200975,no,0,0
200976,significant,0,0
200977,difference,0,0
200978,in,0,0
200979,the,0,0
200980,apical,0,0
200981,seal,0,0
200982,produced,0,0
200983,by,0,0
200984,gutta-percha,0,0
200985,and,0,0
200986,the,0,0
200987,tested,0,0
200988,root,0,0
200989,canal,0,1
200990,sealers,0,0
200991,.,0,1
200992,(,0,0
200993,ABSTRACT,0,0
200994,TRUNCATED,0,0
200995,AT,0,0
200996,250,0,0
200997,WORDS,0,0
200998,),0,0
200999,A,0,0
201000,comparison,0,0
201001,of,0,0
201002,sclerotherapy,0,0
201003,with,0,1
201004,staple,0,0
201005,transection,0,1
201006,of,0,0
201007,the,0,0
201008,esophagus,0,1
201009,for,0,0
201010,the,0,0
201011,emergency,0,1
201012,control,0,0
201013,of,0,0
201014,bleeding,1,0
201015,from,1,1
201016,esophageal,1,1
201017,varices,1,0
201018,.,1,1
201019,We,0,0
201020,compared,0,0
201021,two,0,0
201022,procedures,0,0
201023,for,0,0
201024,the,0,0
201025,emergency,0,1
201026,treatment,0,0
201027,of,0,0
201028,bleeding,1,0
201029,esophageal,1,1
201030,varices,1,1
201031,in,1,1
201032,patients,1,1
201033,who,1,1
201034,did,1,1
201035,not,1,1
201036,respond,1,0
201037,to,1,0
201038,blood,1,0
201039,transfusion,1,0
201040,and,1,0
201041,vasoactive,1,0
201042,drugs,1,0
201043,.,1,0
201044,We,0,0
201045,randomly,0,0
201046,assigned,0,0
201047,101,1,1
201048,patients,1,1
201049,with,1,1
201050,cirrhosis,1,1
201051,of,1,0
201052,the,1,0
201053,liver,1,0
201054,and,1,0
201055,bleeding,1,0
201056,esophageal,1,1
201057,varices,1,0
201058,to,0,0
201059,undergo,0,0
201060,either,0,0
201061,emergency,0,1
201062,sclerotherapy,0,0
201063,(,0,0
201064,n,0,1
201065,=,0,0
201066,50,0,1
201067,),0,0
201068,or,0,0
201069,staple,0,0
201070,transection,0,0
201071,of,0,0
201072,the,0,0
201073,esophagus,0,1
201074,(,0,0
201075,n,0,1
201076,=,0,0
201077,51,0,1
201078,),0,0
201079,.,0,0
201080,Four,0,0
201081,patients,0,1
201082,assigned,0,1
201083,to,0,0
201084,sclerotherapy,0,0
201085,and,0,0
201086,12,0,0
201087,assigned,0,0
201088,to,0,0
201089,staple,0,0
201090,transection,0,0
201091,did,0,0
201092,not,0,0
201093,actually,0,0
201094,undergo,0,0
201095,those,0,0
201096,procedures,0,0
201097,",",0,0
201098,but,0,0
201099,all,0,0
201100,analyses,0,0
201101,were,0,0
201102,made,0,0
201103,on,0,0
201104,an,0,0
201105,intention-to-treat,0,0
201106,basis,0,0
201107,.,0,0
201108,Total,0,0
201109,mortality,0,0
201110,did,0,0
201111,not,0,0
201112,differ,0,0
201113,significantly,0,0
201114,between,0,0
201115,the,0,0
201116,two,0,0
201117,groups,0,0
201118,;,0,0
201119,the,0,0
201120,relative,0,0
201121,risk,0,0
201122,of,0,0
201123,death,0,0
201124,for,0,0
201125,staple,0,0
201126,transection,0,1
201127,as,0,0
201128,compared,0,0
201129,with,0,1
201130,sclerotherapy,0,0
201131,was,0,0
201132,0.88,0,0
201133,(,0,0
201134,95,0,0
201135,percent,0,0
201136,confidence,0,0
201137,interval,0,0
201138,",",0,0
201139,0.51,0,0
201140,to,0,0
201141,1.54,0,0
201142,),0,0
201143,.,0,0
201144,Mortality,0,0
201145,at,0,0
201146,six,0,1
201147,weeks,0,0
201148,was,0,0
201149,44,0,1
201150,percent,0,0
201151,among,0,0
201152,those,0,0
201153,assigned,0,0
201154,to,0,0
201155,sclerotherapy,0,0
201156,and,0,0
201157,35,0,0
201158,percent,0,0
201159,among,0,0
201160,those,0,0
201161,assigned,0,0
201162,to,0,0
201163,staple,0,0
201164,transection,0,0
201165,.,0,0
201166,Complication,0,0
201167,rates,0,0
201168,were,0,0
201169,similar,0,0
201170,for,0,0
201171,the,0,0
201172,two,0,0
201173,groups,0,0
201174,.,0,0
201175,An,0,0
201176,interval,0,0
201177,of,0,0
201178,five,0,1
201179,days,0,0
201180,without,0,1
201181,bleeding,0,0
201182,was,0,0
201183,achieved,0,0
201184,in,0,0
201185,88,0,0
201186,percent,0,0
201187,of,0,0
201188,those,0,0
201189,assigned,0,0
201190,to,0,0
201191,staple,0,0
201192,transection,0,0
201193,and,0,0
201194,in,0,0
201195,62,0,1
201196,percent,0,0
201197,of,0,0
201198,those,0,0
201199,assigned,0,0
201200,to,0,0
201201,sclerotherapy,0,0
201202,after,0,0
201203,a,0,0
201204,single,0,0
201205,injection,0,0
201206,(,0,0
201207,P,0,0
201208,less,0,0
201209,than,0,0
201210,0.01,0,0
201211,),0,0
201212,and,0,0
201213,82,0,0
201214,percent,0,0
201215,after,0,0
201216,three,0,0
201217,injections,0,0
201218,.,0,0
201219,In,0,0
201220,only,0,0
201221,2,0,0
201222,of,0,0
201223,the,0,0
201224,11,0,1
201225,patients,0,1
201226,who,0,1
201227,received,0,1
201228,a,0,1
201229,third,0,0
201230,sclerotherapy,0,0
201231,injection,0,0
201232,was,0,0
201233,bleeding,0,0
201234,controlled,0,0
201235,for,0,0
201236,more,0,0
201237,than,0,0
201238,five,0,0
201239,days,0,0
201240,",",0,0
201241,and,0,0
201242,9,0,0
201243,died,0,1
201244,.,0,0
201245,We,0,0
201246,conclude,0,0
201247,that,0,0
201248,staple,0,0
201249,transection,0,1
201250,of,0,0
201251,the,0,0
201252,esophagus,0,1
201253,is,0,0
201254,as,0,0
201255,safe,0,0
201256,as,0,0
201257,sclerotherapy,0,0
201258,for,0,0
201259,the,0,0
201260,emergency,0,1
201261,treatment,0,0
201262,of,0,0
201263,bleeding,0,0
201264,esophageal,0,1
201265,varices,0,0
201266,and,0,0
201267,that,0,0
201268,it,0,0
201269,is,0,0
201270,more,0,0
201271,effective,0,0
201272,than,0,0
201273,a,0,0
201274,single,0,0
201275,sclerotherapy,0,0
201276,procedure,0,0
201277,.,0,0
201278,We,0,0
201279,currently,0,0
201280,recommend,0,0
201281,surgery,0,0
201282,after,0,0
201283,two,0,0
201284,injection,0,0
201285,treatments,0,0
201286,have,0,0
201287,failed,0,0
201288,.,0,0
201289,Noradrenergic,1,0
201290,mechanisms,1,0
201291,in,1,0
201292,akathisia,1,0
201293,:,1,1
201294,treatment,1,0
201295,with,1,0
201296,propranolol,1,0
201297,and,1,0
201298,clonidine,1,0
201299,.,1,0
201300,Cardiovascular,0,0
201301,effects,0,0
201302,of,0,0
201303,non-depolarizing,0,1
201304,neuromuscular,0,1
201305,blockers,0,0
201306,in,0,0
201307,patients,1,1
201308,with,1,1
201309,aortic,1,1
201310,valve,1,1
201311,disease,1,1
201312,.,1,0
201313,To,0,0
201314,compare,0,0
201315,haemodynamic,0,0
201316,responses,0,0
201317,associated,0,0
201318,with,0,1
201319,equipotent,0,0
201320,doses,0,0
201321,of,0,0
201322,neuromuscular,0,1
201323,blockers,0,0
201324,and,0,0
201325,high-dose,0,0
201326,fentanyl,0,0
201327,(,0,0
201328,50,0,0
201329,micrograms.kg-1,0,0
201330,),0,0
201331,",",0,0
201332,40,1,0
201333,patients,1,1
201334,with,1,1
201335,aortic,1,1
201336,valve,1,1
201337,stenosis,1,1
201338,(,1,0
201339,AS,1,0
201340,),1,0
201341,and,1,0
201342,20,1,0
201343,patients,1,1
201344,with,1,1
201345,aortic,1,1
201346,insufficiency,1,1
201347,(,1,0
201348,AI,1,0
201349,),1,0
201350,were,0,0
201351,randomized,0,0
201352,to,0,0
201353,four,0,0
201354,study,0,0
201355,groups,0,0
201356,to,0,0
201357,receive,0,0
201358,the,0,0
201359,following,0,0
201360,:,0,0
201361,(,0,0
201362,1,0,0
201363,),0,0
201364,pancuronium,0,0
201365,0.12,0,0
201366,mg.kg-1,0,0
201367,",",0,0
201368,(,0,0
201369,2,0,0
201370,),0,0
201371,vecuronium,0,0
201372,0.12,0,0
201373,mg.kg-1,0,0
201374,",",0,0
201375,(,0,0
201376,3,0,0
201377,),0,0
201378,atracurium,0,1
201379,0.4,0,0
201380,mg.kg-1,0,0
201381,",",0,0
201382,or,0,0
201383,(,0,0
201384,4,0,0
201385,),0,0
201386,pancuronium-metocurine,0,0
201387,mixture,0,0
201388,(,0,0
201389,0.4,0,0
201390,mg,0,0
201391,+,0,0
201392,1.6,0,0
201393,mg/ml,0,0
201394,),0,0
201395,:,0,1
201396,1,0,0
201397,ml/10,0,0
201398,kg,0,1
201399,),0,0
201400,.,0,0
201401,Neuromuscular,0,0
201402,blockers,0,0
201403,were,0,0
201404,injected,0,0
201405,at,0,0
201406,the,0,0
201407,same,0,0
201408,time,0,0
201409,with,0,0
201410,the,0,0
201411,fentanyl,0,0
201412,;,0,0
201413,haemodynamics,0,0
201414,were,0,0
201415,recorded,0,0
201416,with,0,1
201417,the,0,0
201418,patients,0,1
201419,awake,0,0
201420,(,0,0
201421,baseline,0,0
201422,),0,0
201423,",",0,0
201424,at,0,0
201425,two,0,0
201426,minutes,0,0
201427,post-induction,0,0
201428,",",0,0
201429,and,0,0
201430,at,0,0
201431,two,0,0
201432,and,0,0
201433,five,0,1
201434,minutes,0,0
201435,after,0,0
201436,intubation,0,0
201437,.,0,0
201438,In,0,0
201439,patients,0,1
201440,with,0,1
201441,AS,0,0
201442,",",0,0
201443,pancuronium,0,0
201444,increased,0,0
201445,heart,0,1
201446,rate,0,0
201447,more,0,0
201448,than,0,0
201449,vecuronium,0,0
201450,or,0,1
201451,atracurium,0,0
201452,;,0,0
201453,heart,0,1
201454,rates,0,0
201455,were,0,0
201456,also,0,0
201457,higher,0,0
201458,with,0,0
201459,the,0,0
201460,pancuronium-metocurine,0,0
201461,mixture,0,0
201462,than,0,0
201463,with,0,1
201464,vecuronium,0,0
201465,.,0,0
201466,Although,0,0
201467,there,0,0
201468,were,0,0
201469,no,0,0
201470,ECG,0,0
201471,signs,0,0
201472,of,0,0
201473,ischaemia,0,0
201474,",",0,0
201475,one,0,0
201476,patient,0,0
201477,given,0,0
201478,pancuronium,0,0
201479,developed,0,0
201480,severe,0,1
201481,hypotension,0,0
201482,associated,0,0
201483,with,0,1
201484,tachycardia,0,0
201485,.,0,0
201486,Reductions,0,0
201487,in,0,0
201488,SVR,0,0
201489,after,0,0
201490,atracurium,0,0
201491,allowed,0,0
201492,small,0,0
201493,but,0,0
201494,significant,0,0
201495,(,0,0
201496,p,0,0
201497,less,0,0
201498,than,0,0
201499,0.01,0,0
201500,),0,0
201501,decreases,0,0
201502,in,0,0
201503,MAP,0,0
201504,which,0,0
201505,were,0,0
201506,well,0,0
201507,tolerated,0,0
201508,;,0,0
201509,one,0,0
201510,patient,0,0
201511,",",0,0
201512,however,0,0
201513,",",0,0
201514,did,0,0
201515,develop,0,0
201516,severe,0,1
201517,hypotension,0,0
201518,.,0,0
201519,Intubation,0,0
201520,resulted,0,0
201521,in,0,0
201522,significant,0,0
201523,(,0,0
201524,p,0,0
201525,less,0,0
201526,than,0,0
201527,0.01,0,0
201528,),0,0
201529,increases,0,0
201530,in,0,0
201531,MAP,0,0
201532,in,0,0
201533,the,0,0
201534,pancuronium-metocurine,0,0
201535,mixture,0,0
201536,group,0,0
201537,.,0,0
201538,Vecuronium,0,0
201539,permitted,0,0
201540,the,0,0
201541,most,0,0
201542,stable,0,1
201543,overall,0,0
201544,haemodynamic,0,0
201545,course,0,0
201546,at,0,0
201547,all,0,0
201548,measurement,0,0
201549,times,0,0
201550,.,0,0
201551,In,0,0
201552,contrast,0,0
201553,",",0,0
201554,patients,0,1
201555,with,0,1
201556,AI,0,0
201557,showed,0,0
201558,stable,0,1
201559,haemodynamics,0,0
201560,after,0,0
201561,vecuronium,0,0
201562,",",0,0
201563,pancuronium,0,0
201564,and,0,0
201565,the,0,0
201566,pancuronium-metocurine,0,0
201567,mixture,0,0
201568,;,0,0
201569,one,0,0
201570,patient,0,0
201571,became,0,0
201572,tachycardic,0,0
201573,following,0,0
201574,vecuronium,0,1
201575,.,0,0
201576,Atracurium,0,0
201577,caused,0,0
201578,unexplained,0,1
201579,elevations,0,0
201580,in,0,0
201581,diastolic,0,1
201582,and,0,0
201583,mean,0,0
201584,arterial,0,1
201585,pressures,0,0
201586,which,0,0
201587,were,0,0
201588,significant,0,0
201589,when,0,0
201590,compared,0,0
201591,to,0,0
201592,vecuronium,0,0
201593,(,0,0
201594,p,0,0
201595,less,0,0
201596,than,0,0
201597,0.01,0,0
201598,),0,0
201599,.,0,0
201600,These,0,0
201601,results,0,0
201602,in,0,0
201603,increases,0,0
201604,in,0,0
201605,PCWP,0,1
201606,;,0,0
201607,mean,0,1
201608,PA,0,0
201609,pressures,0,0
201610,and,0,0
201611,CVP,0,0
201612,were,0,0
201613,also,0,0
201614,increased,0,0
201615,.,0,0
201616,These,0,0
201617,effects,0,0
201618,of,0,0
201619,atracurium,0,1
201620,inpatients,0,1
201621,with,0,1
201622,Al,0,0
201623,need,0,0
201624,further,0,0
201625,evaluation,0,0
201626,.,0,0
201627,5-Fluorouracil,0,0
201628,",",0,0
201629,adriamycin,0,0
201630,",",0,0
201631,cyclophosphamide,0,0
201632,(,0,0
201633,FAC,0,0
201634,),0,0
201635,vs.,0,0
201636,5-fluorouracil,0,0
201637,",",0,0
201638,epirubicin,0,0
201639,",",0,0
201640,cyclophosphamide,0,0
201641,(,0,0
201642,FEC,0,0
201643,),0,0
201644,in,0,0
201645,metastatic,1,1
201646,breast,1,1
201647,cancer,1,1
201648,.,1,0
201649,94,1,0
201650,evaluable,1,1
201651,patients,1,1
201652,with,1,1
201653,metastatic,1,1
201654,breast,1,1
201655,cancer,1,1
201656,were,0,0
201657,randomly,0,0
201658,assigned,0,0
201659,to,0,0
201660,5-fluorouracil,0,0
201661,",",0,0
201662,adriamycin,0,0
201663,",",0,0
201664,and,0,0
201665,cyclophosphamide,0,0
201666,(,0,0
201667,FAC,0,0
201668,),0,0
201669,or,0,0
201670,5-fluorouracil,0,0
201671,",",0,0
201672,epirubicin,0,0
201673,",",0,0
201674,and,0,0
201675,cyclophosphamide,0,0
201676,(,0,0
201677,FEC,0,0
201678,),0,0
201679,",",0,0
201680,with,0,1
201681,cycles,0,0
201682,repeated,0,0
201683,every,0,0
201684,3,0,0
201685,weeks,0,0
201686,.,0,0
201687,The,0,0
201688,objective,0,0
201689,response,0,0
201690,rate,0,0
201691,to,0,0
201692,FAC,0,0
201693,was,0,0
201694,46,0,0
201695,%,0,0
201696,versus,0,0
201697,44,0,0
201698,%,0,0
201699,to,0,0
201700,FEC,0,0
201701,.,0,0
201702,There,0,0
201703,was,0,0
201704,no,0,0
201705,significant,0,0
201706,difference,0,0
201707,in,0,0
201708,the,0,0
201709,median,0,0
201710,duration,0,0
201711,of,0,0
201712,response,0,0
201713,and,0,0
201714,median,0,0
201715,survival,0,0
201716,for,0,0
201717,the,0,0
201718,two,0,0
201719,regimens,0,0
201720,.,0,1
201721,Toxicity,0,0
201722,was,0,0
201723,more,0,0
201724,frequent,0,0
201725,and,0,0
201726,more,0,0
201727,pronounced,0,0
201728,in,0,0
201729,patients,0,1
201730,receiving,0,1
201731,FAC,0,0
201732,.,0,1
201733,Results,0,0
201734,indicate,0,0
201735,therapeutic,0,0
201736,equivalence,0,0
201737,of,0,0
201738,the,0,0
201739,two,0,0
201740,regimens,0,0
201741,and,0,0
201742,reduced,0,0
201743,toxicity,0,0
201744,of,0,0
201745,the,0,0
201746,epirubicin,0,0
201747,arm,0,0
201748,.,0,0
201749,Motion,0,0
201750,aftereffects,0,0
201751,with,0,0
201752,horizontally,0,0
201753,moving,0,0
201754,sound,0,0
201755,sources,0,0
201756,in,0,0
201757,the,0,0
201758,free,0,0
201759,field,0,0
201760,.,0,0
201761,A,0,0
201762,horizontally,0,0
201763,moving,0,0
201764,sound,0,0
201765,was,0,0
201766,presented,0,0
201767,to,0,0
201768,an,1,0
201769,observer,1,0
201770,seated,1,0
201771,in,1,0
201772,the,1,0
201773,center,1,1
201774,of,1,0
201775,an,1,0
201776,anechoic,1,0
201777,chamber,1,0
201778,.,1,0
201779,The,0,0
201780,sound,0,0
201781,",",0,0
201782,either,0,0
201783,a,0,0
201784,500-Hz,0,0
201785,low-pass,0,0
201786,noise,0,0
201787,or,0,0
201788,a,0,0
201789,6300-Hz,0,0
201790,high-pass,0,0
201791,noise,0,0
201792,",",0,0
201793,repeatedly,0,0
201794,traversed,0,0
201795,a,0,0
201796,semicircular,0,0
201797,arc,0,0
201798,in,0,0
201799,the,0,0
201800,observer,1,0
201801,'s,1,0
201802,front,1,0
201803,hemifield,1,1
201804,at,1,0
201805,ear,1,1
201806,level,1,0
201807,(,0,0
201808,distance,0,0
201809,:,0,1
201810,1.5,0,0
201811,m,0,1
201812,),0,0
201813,.,0,0
201814,At,0,0
201815,10-sec,0,0
201816,intervals,0,0
201817,this,0,0
201818,adaptor,0,0
201819,was,0,0
201820,interrupted,0,0
201821,",",0,0
201822,and,0,0
201823,a,0,0
201824,750-msec,0,0
201825,moving,0,0
201826,probe,0,0
201827,(,0,0
201828,a,0,0
201829,500-Hz,0,0
201830,low-pass,0,0
201831,noise,0,0
201832,),0,0
201833,was,0,0
201834,presented,0,0
201835,from,0,0
201836,a,0,0
201837,horizontal,0,0
201838,arc,0,1
201839,1.6,0,0
201840,m,0,0
201841,in,0,0
201842,front,0,0
201843,of,0,0
201844,the,0,0
201845,observer,0,0
201846,.,0,0
201847,During,0,0
201848,a,0,0
201849,run,0,0
201850,",",0,0
201851,the,0,0
201852,adaptor,0,0
201853,was,0,0
201854,presented,0,0
201855,at,0,0
201856,a,0,0
201857,constant,0,0
201858,velocity,0,0
201859,(,0,0
201860,-200,0,0
201861,degrees,0,0
201862,to,0,0
201863,+200,0,0
201864,degrees/sec,0,0
201865,),0,0
201866,",",0,0
201867,while,0,0
201868,probes,0,0
201869,with,0,1
201870,velocities,0,0
201871,varying,0,0
201872,from,0,1
201873,-10,0,0
201874,degrees,0,0
201875,to,0,0
201876,+10,0,0
201877,degrees/sec,0,0
201878,were,0,0
201879,presented,0,0
201880,in,0,0
201881,a,0,0
201882,random,0,0
201883,order,0,0
201884,.,0,1
201885,Observers,1,0
201886,judged,1,0
201887,the,1,0
201888,direction,1,0
201889,of,1,0
201890,motion,1,0
201891,(,1,0
201892,left,1,0
201893,or,1,0
201894,right,1,0
201895,),1,0
201896,of,1,0
201897,each,1,0
201898,probe,1,0
201899,.,1,0
201900,As,0,0
201901,in,0,0
201902,the,0,0
201903,case,0,0
201904,of,0,0
201905,stimuli,0,0
201906,presented,0,1
201907,over,0,0
201908,headphones,0,0
201909,(,0,0
201910,Grantham,0,0
201911,&,0,1
201912,Wightman,0,0
201913,",",0,0
201914,1979,0,1
201915,),0,0
201916,",",0,0
201917,an,0,0
201918,auditory,0,0
201919,motion,0,0
201920,aftereffect,0,0
201921,(,0,0
201922,MAE,0,0
201923,),0,0
201924,occurred,0,0
201925,:,0,1
201926,subjects,0,1
201927,responded,0,1
201928,left,0,1
201929,to,0,0
201930,probes,0,0
201931,more,0,0
201932,often,0,0
201933,when,0,0
201934,the,0,0
201935,adaptor,0,0
201936,moved,0,0
201937,right,0,0
201938,than,0,0
201939,when,0,0
201940,it,0,0
201941,moved,0,0
201942,left,0,0
201943,.,0,0
201944,When,0,0
201945,the,0,0
201946,adaptor,0,0
201947,and,0,0
201948,probe,0,0
201949,were,0,0
201950,spectrally,0,0
201951,the,0,0
201952,same,0,0
201953,",",0,0
201954,the,0,0
201955,MAE,0,0
201956,was,0,0
201957,greater,0,0
201958,than,0,0
201959,when,0,0
201960,they,0,0
201961,were,0,0
201962,from,0,0
201963,different,0,0
201964,spectral,0,0
201965,regions,0,0
201966,;,0,0
201967,the,0,0
201968,magnitude,0,0
201969,of,0,0
201970,this,0,0
201971,difference,0,0
201972,depended,0,0
201973,on,0,0
201974,adaptor,0,0
201975,speed,0,0
201976,and,0,0
201977,was,0,0
201978,subject-dependent,0,0
201979,.,0,0
201980,It,0,0
201981,is,0,0
201982,proposed,0,0
201983,that,0,0
201984,there,0,0
201985,are,0,0
201986,two,0,0
201987,components,0,0
201988,underlying,0,0
201989,the,0,0
201990,auditory,0,0
201991,MAE,0,0
201992,:,0,1
201993,(,0,0
201994,1,0,0
201995,),0,0
201996,a,0,0
201997,generalized,0,0
201998,bias,0,0
201999,to,0,0
202000,respond,0,0
202001,that,0,0
202002,probes,0,0
202003,move,0,0
202004,in,0,0
202005,the,0,0
202006,direction,0,0
202007,opposite,0,0
202008,to,0,0
202009,that,0,0
202010,of,0,0
202011,the,0,0
202012,adaptor,0,0
202013,",",0,0
202014,independent,0,0
202015,of,0,0
202016,their,0,1
202017,spectra,0,0
202018,;,0,0
202019,and,0,0
202020,(,0,0
202021,2,0,0
202022,),0,0
202023,a,0,0
202024,loss,0,0
202025,of,0,0
202026,sensitivity,0,0
202027,to,0,0
202028,the,0,0
202029,velocity,0,0
202030,of,0,0
202031,moving,0,0
202032,sounds,0,0
202033,after,0,0
202034,prolonged,0,0
202035,exposure,0,0
202036,to,0,0
202037,moving,0,0
202038,sounds,0,0
202039,having,0,1
202040,the,0,0
202041,same,0,0
202042,spectral,0,0
202043,content,0,0
202044,.,0,0
202045,Chemotherapy,0,0
202046,of,0,0
202047,large,1,0
202048,bowel,1,1
202049,carcinoma,1,1
202050,--,1,0
202051,fluorouracil,1,0
202052,(,0,0
202053,FU,0,0
202054,),0,0
202055,+,0,0
202056,hydroxyurea,0,0
202057,(,0,0
202058,HU,0,0
202059,),0,0
202060,vs.,0,0
202061,methyl-CCNU,0,0
202062,",",0,0
202063,oncovin,0,0
202064,",",0,0
202065,fluorouracil,0,0
202066,",",0,0
202067,and,0,0
202068,streptozotocin,0,1
202069,(,0,0
202070,MOF-Strep,0,0
202071,),0,0
202072,.,0,0
202073,An,0,0
202074,Eastern,0,1
202075,Cooperative,0,1
202076,Oncology,0,1
202077,Group,0,1
202078,study,0,0
202079,.,0,0
202080,In,0,0
202081,this,0,0
202082,prospective,0,0
202083,randomized,0,0
202084,study,0,0
202085,of,0,0
202086,initial,0,0
202087,chemotherapy,0,0
202088,for,0,0
202089,advanced,1,1
202090,measurable,1,0
202091,metastatic,1,1
202092,large,1,1
202093,bowel,1,0
202094,carcinoma,1,1
202095,",",0,0
202096,the,0,0
202097,response,0,0
202098,rate,0,0
202099,was,0,0
202100,6/32,1,0
202101,(,1,0
202102,19,1,1
202103,%,1,0
202104,),1,0
202105,for,1,0
202106,FU,1,0
202107,+,1,0
202108,HU,1,0
202109,and,1,0
202110,5/32,1,0
202111,(,1,0
202112,16,1,1
202113,%,1,0
202114,),1,0
202115,for,1,0
202116,MOF-Strep,1,0
202117,;,1,0
202118,the,0,0
202119,estimated,0,0
202120,median,0,0
202121,survival,0,0
202122,is,0,0
202123,43,0,0
202124,weeks,0,0
202125,for,0,0
202126,both,0,0
202127,treatments,0,0
202128,.,0,1
202129,Patients,0,1
202130,who,0,1
202131,received,0,1
202132,MOF-Strep,0,1
202133,experienced,0,0
202134,substantially,0,0
202135,greater,0,0
202136,vomiting,0,0
202137,and,0,0
202138,hematologic,0,1
202139,toxicity,0,0
202140,than,0,1
202141,patients,1,1
202142,who,1,1
202143,received,1,1
202144,FU,0,1
202145,+,0,0
202146,HU,0,0
202147,(,0,0
202148,p,0,0
202149,less,0,0
202150,than,0,0
202151,0.001,0,0
202152,),0,0
202153,.,0,0
202154,Comparative,0,0
202155,efficacy,0,0
202156,of,0,0
202157,oral,0,0
202158,erythromycin,0,0
202159,versus,0,0
202160,oral,0,0
202161,tetracycline,0,0
202162,in,0,0
202163,the,0,0
202164,treatment,0,0
202165,of,0,0
202166,acne,0,0
202167,vulgaris,0,1
202168,.,0,0
202169,A,0,0
202170,double-blind,0,0
202171,study,0,0
202172,.,0,0
202173,The,0,0
202174,efficacy,0,0
202175,of,0,0
202176,erythromycin,0,0
202177,base,0,0
202178,(,0,0
202179,E-Mycin,0,0
202180,tablets,0,0
202181,",",0,0
202182,333,0,1
202183,mg,0,0
202184,),0,0
202185,and,0,0
202186,the,0,0
202187,efficacy,0,0
202188,of,0,0
202189,tetracycline,0,0
202190,hydrochloride,0,0
202191,(,0,0
202192,Panmycin,0,0
202193,tablets,0,0
202194,),0,0
202195,were,0,0
202196,compared,0,0
202197,in,0,0
202198,this,0,0
202199,double-blind,0,0
202200,",",0,0
202201,randomized,0,0
202202,study,0,0
202203,.,0,0
202204,Two,1,0
202205,hundred,1,1
202206,patients,1,1
202207,with,1,1
202208,moderate,1,1
202209,to,1,0
202210,moderately,1,0
202211,severe,1,1
202212,acne,1,0
202213,vulgaris,1,1
202214,were,0,0
202215,randomly,0,1
202216,assigned,0,0
202217,to,0,0
202218,the,0,0
202219,study,0,0
202220,.,0,0
202221,One,0,0
202222,hundred,0,1
202223,patients,0,1
202224,received,0,0
202225,1,0,0
202226,gm,0,0
202227,of,0,0
202228,erythromycin,0,0
202229,base,0,0
202230,by,0,0
202231,mouth,0,0
202232,per,0,0
202233,day,0,0
202234,for,0,0
202235,4,0,0
202236,weeks,0,0
202237,",",0,0
202238,followed,0,0
202239,by,0,0
202240,333,0,1
202241,mg/day,0,0
202242,for,0,0
202243,8,0,0
202244,weeks,0,0
202245,",",0,0
202246,plus,0,0
202247,placebo,0,0
202248,for,0,0
202249,tetracycline,0,0
202250,.,0,0
202251,The,0,0
202252,second,0,0
202253,group,0,0
202254,of,0,0
202255,patients,0,1
202256,received,0,0
202257,1,0,0
202258,gm,0,0
202259,of,0,0
202260,tetracycline,0,0
202261,by,0,0
202262,mouth,0,0
202263,per,0,0
202264,day,0,0
202265,for,0,0
202266,4,0,0
202267,weeks,0,0
202268,",",0,0
202269,followed,0,0
202270,by,0,0
202271,500,0,0
202272,mg/day,0,0
202273,for,0,0
202274,8,0,0
202275,weeks,0,0
202276,",",0,0
202277,plus,0,0
202278,placebo,0,0
202279,for,0,0
202280,erythromycin,0,0
202281,.,0,0
202282,Both,0,0
202283,drugs,0,0
202284,reduced,0,0
202285,acne,0,0
202286,severity,0,0
202287,to,0,0
202288,the,0,0
202289,same,0,0
202290,extent,0,0
202291,.,0,0
202292,Pustules,0,0
202293,",",0,0
202294,papules,0,0
202295,",",0,0
202296,and,0,0
202297,open,0,0
202298,comedo,0,1
202299,counts,0,0
202300,decreased,0,0
202301,significantly,0,0
202302,over,0,0
202303,the,0,0
202304,12-week,0,0
202305,period,0,0
202306,.,0,0
202307,Seventy-seven,0,1
202308,percent,0,0
202309,of,0,0
202310,the,0,0
202311,erythromycin-treated,0,0
202312,patients,0,1
202313,and,0,0
202314,89,0,1
202315,%,0,0
202316,of,0,0
202317,the,0,0
202318,tetracycline-treated,0,0
202319,patients,0,1
202320,stated,0,0
202321,that,0,0
202322,their,0,0
202323,acne,0,0
202324,was,0,0
202325,markedly,0,0
202326,improved,0,0
202327,or,0,0
202328,improved,0,0
202329,by,0,0
202330,week,0,0
202331,12,0,0
202332,.,0,0
202333,Most,0,0
202334,of,0,0
202335,the,0,0
202336,side,0,0
202337,effects,0,0
202338,in,0,0
202339,patients,0,1
202340,treated,0,1
202341,with,0,1
202342,erythromycin,0,0
202343,were,0,1
202344,gastrointestinal,0,1
202345,symptoms,0,0
202346,.,0,0
202347,Among,0,0
202348,the,0,0
202349,side,0,0
202350,effects,0,0
202351,in,0,0
202352,patients,0,1
202353,treated,0,1
202354,with,0,1
202355,tetracycline,0,0
202356,were,0,0
202357,Candida,0,1
202358,vaginitis,0,1
202359,in,0,0
202360,one,0,0
202361,patient,0,0
202362,and,0,0
202363,pseudotumor,0,0
202364,cerebri,0,1
202365,in,0,0
202366,one,0,0
202367,patient,0,1
202368,.,0,0
202369,Prevention,0,0
202370,of,0,0
202371,subsequent,0,0
202372,exercise-induced,0,0
202373,periinfarct,0,0
202374,ischemia,0,0
202375,by,0,0
202376,emergency,0,1
202377,coronary,0,1
202378,angioplasty,0,0
202379,in,0,0
202380,acute,1,1
202381,myocardial,1,1
202382,infarction,1,1
202383,:,1,1
202384,comparison,0,0
202385,with,0,1
202386,intracoronary,0,0
202387,streptokinase,0,0
202388,.,0,0
202389,To,0,0
202390,compare,0,0
202391,the,0,0
202392,efficacy,0,0
202393,of,0,0
202394,emergency,0,1
202395,percutaneous,0,1
202396,transluminal,0,0
202397,coronary,0,1
202398,angioplasty,0,0
202399,and,0,0
202400,intracoronary,0,0
202401,streptokinase,0,0
202402,in,0,0
202403,preventing,0,0
202404,exercise-induced,0,0
202405,periinfarct,0,0
202406,ischemia,0,0
202407,",",0,0
202408,28,1,0
202409,patients,1,1
202410,presenting,1,1
202411,within,1,1
202412,12,1,0
202413,hours,1,0
202414,of,1,0
202415,the,1,0
202416,onset,1,0
202417,of,1,0
202418,symptoms,1,0
202419,of,1,0
202420,acute,1,1
202421,myocardial,1,1
202422,infarction,1,1
202423,were,1,0
202424,prospectively,1,1
202425,randomized,1,0
202426,.,1,0
202427,Of,0,0
202428,these,0,0
202429,",",0,0
202430,14,1,0
202431,patients,1,1
202432,were,1,0
202433,treated,1,1
202434,with,1,0
202435,emergency,1,1
202436,angioplasty,1,1
202437,and,1,0
202438,14,1,0
202439,patients,1,1
202440,received,0,0
202441,intracoronary,0,0
202442,streptokinase,0,0
202443,.,0,0
202444,Recatheterization,0,0
202445,and,0,0
202446,submaximal,0,0
202447,exercise,0,0
202448,thallium-201,0,0
202449,single,0,0
202450,photon,0,0
202451,emission,0,0
202452,computed,0,0
202453,tomography,0,0
202454,were,0,0
202455,performed,0,0
202456,before,0,0
202457,hospital,0,1
202458,discharge,0,0
202459,.,0,0
202460,Periinfarct,0,0
202461,ischemia,0,0
202462,was,0,0
202463,defined,0,0
202464,as,0,0
202465,a,0,0
202466,reversible,0,0
202467,thallium,0,0
202468,defect,0,1
202469,adjacent,0,0
202470,to,0,0
202471,a,0,0
202472,fixed,0,0
202473,defect,0,0
202474,assessed,0,0
202475,qualitatively,0,0
202476,.,0,0
202477,Successful,0,0
202478,reperfusion,0,0
202479,was,0,0
202480,achieved,0,0
202481,in,0,0
202482,86,0,1
202483,%,0,0
202484,of,0,0
202485,patients,0,1
202486,treated,0,1
202487,with,0,1
202488,emergency,0,1
202489,angioplasty,0,1
202490,and,0,0
202491,86,0,0
202492,%,0,0
202493,of,0,0
202494,patients,0,1
202495,treated,0,1
202496,with,0,1
202497,intracoronary,0,0
202498,streptokinase,0,0
202499,(,0,0
202500,p,0,0
202501,=,0,0
202502,NS,0,0
202503,),0,0
202504,.,0,0
202505,Residual,0,0
202506,stenosis,0,1
202507,of,0,0
202508,the,0,0
202509,infarct-related,0,0
202510,coronary,0,1
202511,artery,0,1
202512,shown,0,0
202513,at,0,0
202514,predischarge,0,0
202515,angiography,0,0
202516,was,0,0
202517,43.8,0,0
202518,+/-,0,0
202519,31.4,0,0
202520,%,0,0
202521,for,0,0
202522,the,0,0
202523,angioplasty,0,0
202524,group,0,0
202525,and,0,0
202526,75.0,0,0
202527,+/-,0,0
202528,15.6,0,0
202529,%,0,0
202530,for,0,0
202531,the,0,0
202532,streptokinase,0,0
202533,group,0,0
202534,(,0,0
202535,p,0,0
202536,less,0,0
202537,than,0,0
202538,0.05,0,0
202539,),0,0
202540,.,0,0
202541,Of,0,0
202542,the,0,0
202543,angioplasty,0,0
202544,group,0,0
202545,",",0,0
202546,9,0,0
202547,%,0,0
202548,developed,0,0
202549,exercise-induced,0,0
202550,periinfarct,0,0
202551,ischemia,0,0
202552,compared,0,0
202553,with,0,1
202554,60,0,0
202555,%,0,0
202556,of,0,0
202557,the,0,0
202558,streptokinase,0,0
202559,group,0,0
202560,(,0,0
202561,p,0,0
202562,less,0,0
202563,than,0,0
202564,0.05,0,0
202565,),0,0
202566,.,0,0
202567,Thus,0,0
202568,",",0,0
202569,patients,1,1
202570,with,1,1
202571,acute,1,1
202572,myocardial,1,1
202573,infarction,1,1
202574,treated,0,1
202575,with,0,0
202576,emergency,0,1
202577,angioplasty,0,0
202578,had,0,0
202579,significantly,0,0
202580,less,0,0
202581,severe,0,0
202582,residual,0,0
202583,coronary,0,1
202584,stenosis,0,1
202585,and,0,0
202586,exercise-induced,0,0
202587,periinfarct,0,0
202588,ischemia,0,1
202589,than,0,0
202590,did,0,0
202591,those,0,0
202592,treated,0,0
202593,with,0,0
202594,intracoronary,0,0
202595,streptokinase,0,0
202596,.,0,0
202597,These,0,0
202598,results,0,0
202599,suggest,0,0
202600,further,0,0
202601,application,0,0
202602,of,0,0
202603,coronary,0,1
202604,angioplasty,0,1
202605,in,0,0
202606,the,0,0
202607,management,0,0
202608,of,0,0
202609,acute,1,1
202610,myocardial,1,1
202611,infarction,1,1
202612,.,1,0
202613,Flow-cytometric,0,0
202614,studies,0,0
202615,with,0,1
202616,eleutherococcus,0,0
202617,senticosus,0,0
202618,extract,0,0
202619,as,0,0
202620,an,0,0
202621,immunomodulatory,0,0
202622,agent,0,0
202623,.,0,0
202624,A,0,0
202625,placebo-controlled,0,0
202626,study,0,0
202627,of,0,0
202628,the,0,0
202629,effect,0,0
202630,of,0,0
202631,an,0,0
202632,Eleutherococcus,0,0
202633,senticosus,0,0
202634,extract,0,0
202635,(,0,0
202636,Eleukokk,0,0
202637,),0,0
202638,on,0,0
202639,the,0,0
202640,immune,1,0
202641,system,1,0
202642,was,0,0
202643,performed,0,0
202644,with,0,1
202645,36,1,1
202646,healthy,1,1
202647,volunteers,1,1
202648,utilising,1,0
202649,quantitative,1,0
202650,multi-parameter,1,0
202651,flow,1,0
202652,cytometry,1,0
202653,with,1,1
202654,monoclonal,1,0
202655,antibodies,1,0
202656,directed,1,0
202657,against,1,0
202658,specific,1,0
202659,surface,1,0
202660,markers,1,0
202661,of,1,0
202662,human,1,1
202663,lymphocyte,1,0
202664,subsets,1,1
202665,.,1,1
202666,Volunteers,0,1
202667,in,0,0
202668,the,0,0
202669,verum,0,0
202670,group,0,0
202671,received,0,0
202672,10,0,0
202673,ml,0,0
202674,of,0,0
202675,an,0,0
202676,ethanolic,0,0
202677,(,0,0
202678,vincamine,0,0
202679,free,0,1
202680,),0,0
202681,eleutherococcus,0,0
202682,senticosus,0,0
202683,preparation,0,0
202684,",",0,0
202685,3,0,0
202686,times,0,0
202687,daily,0,0
202688,for,0,0
202689,4,0,0
202690,weeks,0,0
202691,.,0,0
202692,In,0,0
202693,the,0,0
202694,placebo,0,0
202695,",",0,0
202696,the,0,0
202697,eleutherococcus,0,0
202698,extract,0,0
202699,was,0,0
202700,substituted,0,0
202701,by,0,0
202702,additional,0,0
202703,wine,0,0
202704,",",0,0
202705,resulting,0,0
202706,in,0,0
202707,identical,0,0
202708,final,0,0
202709,concentrations,0,0
202710,of,0,0
202711,ethanol,0,0
202712,in,0,0
202713,both,0,0
202714,preparations,0,0
202715,.,0,0
202716,The,0,0
202717,purpose,0,0
202718,of,0,0
202719,the,0,0
202720,double-blind,0,0
202721,study,0,0
202722,was,0,0
202723,the,0,0
202724,demonstration,0,0
202725,of,0,0
202726,possible,0,0
202727,effects,0,0
202728,on,0,0
202729,the,0,0
202730,cellular,0,0
202731,immune,0,0
202732,status,0,0
202733,",",0,0
202734,as,0,0
202735,determined,0,0
202736,by,0,0
202737,quantitative,0,0
202738,flow,0,0
202739,cytometry,0,0
202740,.,0,0
202741,The,0,0
202742,most,0,0
202743,salient,0,0
202744,feature,0,0
202745,in,0,0
202746,the,0,0
202747,verum,0,0
202748,group,0,0
202749,was,0,0
202750,a,0,0
202751,drastic,0,0
202752,increase,0,0
202753,in,0,0
202754,the,0,0
202755,absolute,0,0
202756,number,0,0
202757,of,0,0
202758,immunocompetent,0,1
202759,cells,0,0
202760,",",0,0
202761,with,0,0
202762,an,0,0
202763,especially,0,0
202764,pronounced,0,0
202765,effect,0,0
202766,on,0,0
202767,T,0,0
202768,lymphocytes,0,0
202769,",",0,0
202770,predominantly,0,0
202771,of,0,0
202772,the,0,0
202773,helper/inducer,0,0
202774,type,0,0
202775,",",0,0
202776,but,0,0
202777,also,0,0
202778,on,0,0
202779,cytotoxic,0,0
202780,and,0,0
202781,natural,0,0
202782,killer,0,0
202783,cells,0,0
202784,.,0,0
202785,In,0,0
202786,addition,0,0
202787,",",0,0
202788,a,0,0
202789,general,0,0
202790,enhancement,0,0
202791,of,0,0
202792,the,0,0
202793,activation,0,0
202794,state,0,0
202795,of,0,0
202796,T,0,0
202797,lymphocytes,0,0
202798,was,0,0
202799,observed,0,0
202800,.,0,0
202801,No,0,0
202802,side,0,0
202803,effects,0,0
202804,were,0,0
202805,observed,0,0
202806,during,0,0
202807,the,0,0
202808,trial,0,0
202809,or,0,0
202810,afterwards,0,0
202811,(,0,0
202812,observation,0,0
202813,period,0,0
202814,6,0,0
202815,months,0,0
202816,),0,1
202817,.,0,1
202818,Intensive,0,0
202819,induction,0,0
202820,chemotherapy,0,0
202821,for,0,0
202822,small,0,0
202823,cell,0,1
202824,anaplastic,0,1
202825,carcinoma,0,1
202826,of,0,0
202827,the,0,0
202828,lung,0,0
202829,.,0,0
202830,The,0,0
202831,role,0,0
202832,of,0,0
202833,intensive,0,0
202834,induction,0,0
202835,chemotherapy,0,0
202836,in,0,0
202837,small,0,0
202838,cell,0,1
202839,cancer,0,1
202840,of,0,0
202841,the,0,0
202842,lung,0,0
202843,remains,0,0
202844,unclear,0,0
202845,.,0,0
202846,Twenty-eight,1,1
202847,newly,1,1
202848,diagnosed,1,1
202849,patients,1,1
202850,with,1,1
202851,small,1,0
202852,cell,1,1
202853,lung,1,1
202854,cancer,1,1
202855,were,0,0
202856,randomized,0,0
202857,to,0,0
202858,receive,0,0
202859,either,0,0
202860,high-dose,0,0
202861,or,0,0
202862,standard-dose,0,0
202863,cyclophosphamide,0,0
202864,",",0,0
202865,vincristine,0,0
202866,",",0,0
202867,and,0,0
202868,semustine,0,0
202869,in,0,0
202870,a,0,0
202871,trial,0,0
202872,where,0,0
202873,the,0,0
202874,dose,0,0
202875,of,0,0
202876,induction,0,0
202877,chemotherapy,0,0
202878,was,0,0
202879,the,0,0
202880,sole,0,0
202881,treatment,0,0
202882,variable,0,0
202883,.,0,0
202884,Complete,0,0
202885,responses,0,0
202886,(,0,0
202887,CR,0,0
202888,),0,0
202889,were,0,0
202890,achieved,0,0
202891,in,0,0
202892,57,0,0
202893,%,0,0
202894,of,0,0
202895,patients,0,1
202896,receiving,0,1
202897,high-dose,0,0
202898,therapy,0,0
202899,as,0,0
202900,compared,0,0
202901,to,0,0
202902,21,0,1
202903,%,0,0
202904,of,0,0
202905,patients,0,1
202906,receiving,0,1
202907,standard-dose,0,0
202908,therapy,0,0
202909,(,0,0
202910,P,0,0
202911,less,0,0
202912,than,0,0
202913,0.05,0,0
202914,),0,0
202915,.,0,0
202916,There,0,0
202917,was,0,0
202918,a,0,0
202919,higher,0,0
202920,rate,0,0
202921,of,0,0
202922,severe,0,1
202923,toxicity,0,0
202924,in,0,0
202925,the,0,0
202926,high-dose,0,0
202927,group,0,0
202928,(,0,0
202929,P,0,0
202930,less,0,0
202931,than,0,0
202932,0.01,0,0
202933,),0,0
202934,.,0,0
202935,The,0,0
202936,overall,0,0
202937,median,0,0
202938,survival,0,0
202939,was,0,0
202940,not,0,0
202941,improved,0,0
202942,(,0,0
202943,36,0,1
202944,weeks,0,0
202945,for,0,0
202946,the,0,0
202947,high-dose,0,0
202948,group,0,0
202949,vs,0,0
202950,43,0,0
202951,weeks,0,0
202952,for,0,0
202953,the,0,0
202954,standard-dose,0,0
202955,group,0,0
202956,),0,0
202957,;,0,0
202958,however,0,0
202959,",",0,0
202960,the,0,0
202961,median,0,0
202962,survival,0,0
202963,in,0,0
202964,patients,0,1
202965,achieving,0,0
202966,CR,0,0
202967,was,0,0
202968,prolonged,0,0
202969,(,0,0
202970,92,0,0
202971,weeks,0,0
202972,for,0,0
202973,the,0,0
202974,high-dose,0,0
202975,group,0,0
202976,vs,0,0
202977,50,0,0
202978,weeks,0,0
202979,for,0,0
202980,the,0,0
202981,standard-dose,0,0
202982,group,0,0
202983,),0,0
202984,.,0,0
202985,These,0,0
202986,effects,0,0
202987,were,0,0
202988,most,0,0
202989,pronounced,0,0
202990,in,0,0
202991,patients,1,1
202992,with,1,1
202993,extensive,1,1
202994,disease,1,1
202995,;,1,0
202996,a,0,0
202997,CR,0,0
202998,after,0,0
202999,induction,0,0
203000,was,0,0
203001,achieved,0,0
203002,in,0,0
203003,five,0,0
203004,of,0,0
203005,nine,0,1
203006,patients,0,1
203007,treated,0,1
203008,with,0,1
203009,high,0,0
203010,doses,0,0
203011,but,0,0
203012,not,0,0
203013,in,0,0
203014,any,0,0
203015,of,0,0
203016,those,0,0
203017,treated,0,0
203018,with,0,0
203019,standard,0,0
203020,doses,0,0
203021,(,0,0
203022,P,0,0
203023,less,0,0
203024,than,0,0
203025,0.05,0,0
203026,),0,0
203027,.,0,0
203028,A,0,0
203029,small,0,0
203030,group,0,0
203031,of,0,0
203032,patients,0,1
203033,appear,0,0
203034,to,0,0
203035,benefit,0,0
203036,by,0,0
203037,achieving,0,0
203038,a,0,0
203039,long-term,0,0
203040,remission,0,0
203041,with,0,1
203042,intensive,0,0
203043,induction,0,0
203044,chemotherapy,0,0
203045,",",0,0
203046,but,0,0
203047,this,0,0
203048,effect,0,0
203049,may,0,0
203050,be,0,0
203051,offset,0,0
203052,by,0,0
203053,increased,0,0
203054,morbidity,0,0
203055,.,0,0
203056,[,1,0
203057,Vulvovaginal,1,1
203058,Candida,1,1
203059,mycoses,1,1
203060,--,1,0
203061,treatment,1,0
203062,with,0,1
203063,clotrimazole,0,0
203064,.,0,0
203065,Comparison,0,0
203066,of,0,0
203067,single-dose,0,0
203068,treatment,0,0
203069,with,0,1
203070,6-day,0,0
203071,therapy,0,0
203072,],0,0
203073,.,0,0
203074,[,0,0
203075,Controlled,0,0
203076,study,0,0
203077,of,0,0
203078,the,0,0
203079,quinidine-amiodarone,0,0
203080,combination,0,0
203081,in,0,0
203082,the,0,0
203083,reversal,0,0
203084,of,0,0
203085,auricular,1,1
203086,fibrillation,1,1
203087,],1,0
203088,.,0,0
203089,Double-blind,0,0
203090,comparison,0,0
203091,of,0,0
203092,doxepin,0,0
203093,versus,0,0
203094,bupropion,0,0
203095,in,0,0
203096,outpatients,1,1
203097,with,1,1
203098,a,1,0
203099,major,1,0
203100,depressive,1,0
203101,disorder,1,1
203102,.,1,0
203103,A,0,0
203104,double-blind,1,0
203105,controlled,1,0
203106,study,1,0
203107,comparing,0,0
203108,the,0,0
203109,effects,0,0
203110,of,0,0
203111,bupropion,0,0
203112,to,0,0
203113,doxepin,0,0
203114,in,0,0
203115,outpatients,1,1
203116,with,1,1
203117,primary,1,1
203118,depression,1,1
203119,was,0,0
203120,conducted,0,0
203121,to,0,0
203122,evaluate,0,0
203123,efficacy,0,0
203124,and,0,0
203125,safety,0,0
203126,differences,0,0
203127,between,0,0
203128,the,0,0
203129,two,0,0
203130,drugs,0,0
203131,.,0,0
203132,Following,0,0
203133,a,0,0
203134,7-day,0,0
203135,placebo,0,0
203136,washout,0,0
203137,period,0,0
203138,",",0,0
203139,patients,0,1
203140,could,0,0
203141,be,0,0
203142,treated,0,0
203143,for,0,0
203144,up,0,0
203145,to,0,0
203146,13,0,0
203147,weeks,0,0
203148,on,0,0
203149,either,0,0
203150,treatment,0,0
203151,.,0,0
203152,Antidepressant,0,0
203153,response,0,0
203154,was,0,0
203155,assessed,0,0
203156,by,0,0
203157,the,0,0
203158,Hamilton,0,0
203159,Depression,0,0
203160,and,0,0
203161,Anxiety,0,0
203162,Scales,0,0
203163,",",0,0
203164,Clinical,0,0
203165,Global,0,0
203166,Severity,0,0
203167,and,0,0
203168,Improvement,0,0
203169,Ratings,0,0
203170,",",0,0
203171,and,0,0
203172,the,0,0
203173,Zung,0,1
203174,Self-Rating,0,0
203175,Depression,0,0
203176,Scale,0,0
203177,.,0,0
203178,Comparable,0,0
203179,efficacy,0,0
203180,between,0,0
203181,the,0,0
203182,compounds,0,0
203183,was,0,0
203184,found,0,0
203185,across,0,0
203186,the,0,0
203187,13-week,0,0
203188,study,0,0
203189,.,0,0
203190,Doxepin,0,0
203191,differed,0,0
203192,from,0,0
203193,bupropion,0,0
203194,mainly,0,0
203195,on,0,0
203196,the,0,0
203197,sleep,0,0
203198,factor,0,0
203199,of,0,0
203200,the,0,0
203201,Hamilton,0,0
203202,Depression,0,0
203203,Scale,0,0
203204,",",0,0
203205,with,0,0
203206,doxepin,0,0
203207,improving,0,0
203208,sleep,0,0
203209,to,0,0
203210,a,0,0
203211,greater,0,0
203212,extent,0,0
203213,than,0,0
203214,bupropion,0,0
203215,.,0,0
203216,Doxepin,0,0
203217,produced,0,0
203218,a,0,0
203219,greater,0,0
203220,incidence,0,0
203221,of,0,0
203222,anticholinergic,0,0
203223,side,0,0
203224,effects,0,0
203225,",",0,0
203226,including,0,0
203227,dry,0,0
203228,mouth,0,0
203229,",",0,0
203230,constipation,0,0
203231,",",0,0
203232,sleepiness,0,0
203233,",",0,0
203234,and,0,0
203235,tiredness,0,0
203236,",",0,0
203237,in,0,0
203238,comparison,0,0
203239,to,0,0
203240,bupropion,0,0
203241,.,0,0
203242,Also,0,0
203243,",",0,0
203244,increased,0,0
203245,appetite,0,0
203246,and,0,0
203247,weight,0,0
203248,gain,0,0
203249,were,0,0
203250,consistent,0,0
203251,side,0,0
203252,effects,0,0
203253,of,0,0
203254,doxepin,0,0
203255,relative,0,0
203256,to,0,0
203257,bupropion,0,0
203258,.,0,0
203259,Caudal,0,0
203260,analgesia,0,0
203261,for,0,0
203262,perianal,0,0
203263,surgery,0,1
203264,.,0,0
203265,A,0,0
203266,comparison,0,0
203267,between,0,0
203268,bupivacaine,0,0
203269,and,0,0
203270,diamorphine,0,0
203271,.,0,0
203272,Seventy-three,1,1
203273,patients,1,1
203274,undergoing,1,1
203275,elective,1,1
203276,perianal,1,1
203277,surgery,1,1
203278,were,0,0
203279,randomly,0,0
203280,divided,0,0
203281,into,0,0
203282,a,0,0
203283,control,0,0
203284,group,0,0
203285,",",0,0
203286,a,0,0
203287,group,0,0
203288,who,0,1
203289,received,0,1
203290,a,0,1
203291,caudal,0,0
203292,injection,0,0
203293,of,0,0
203294,20,0,1
203295,ml,0,0
203296,bupivacaine,0,0
203297,0.5,0,0
203298,%,0,0
203299,plain,0,0
203300,and,0,0
203301,a,0,0
203302,group,0,0
203303,who,0,1
203304,received,0,1
203305,diamorphine,0,1
203306,2.5,0,0
203307,mg,0,0
203308,in,0,0
203309,10,0,1
203310,ml,0,0
203311,normal,0,1
203312,saline,0,0
203313,by,0,0
203314,caudal,0,0
203315,injection,0,0
203316,;,0,0
203317,a,0,0
203318,comparison,0,0
203319,was,0,0
203320,then,0,0
203321,made,0,0
203322,of,0,0
203323,postoperative,0,0
203324,analgesia,0,0
203325,requirements,0,0
203326,.,0,0
203327,The,0,0
203328,bupivacaine,0,0
203329,group,0,0
203330,had,0,0
203331,better,0,0
203332,analgesia,0,0
203333,than,0,0
203334,the,0,0
203335,control,0,0
203336,group,0,0
203337,for,0,0
203338,the,0,0
203339,first,0,0
203340,8,0,0
203341,hours,0,0
203342,",",0,0
203343,after,0,0
203344,which,0,0
203345,there,0,0
203346,was,0,0
203347,no,0,0
203348,difference,0,0
203349,.,0,0
203350,The,0,0
203351,diamorphine,0,0
203352,group,0,0
203353,had,0,0
203354,better,0,0
203355,analgesia,0,0
203356,than,0,0
203357,the,0,0
203358,control,0,0
203359,group,0,0
203360,for,0,0
203361,the,0,0
203362,first,0,0
203363,24,0,0
203364,hours,0,0
203365,postoperatively,0,0
203366,.,0,0
203367,Side,0,0
203368,effects,0,0
203369,were,0,0
203370,less,0,0
203371,in,0,0
203372,the,0,0
203373,diamorphine,0,0
203374,group,0,0
203375,than,0,0
203376,the,0,0
203377,control,0,0
203378,",",0,0
203379,or,0,0
203380,the,0,0
203381,bupivacaine,0,0
203382,group,0,0
203383,.,0,0
203384,In,0,0
203385,particular,0,0
203386,",",0,0
203387,41,0,1
203388,%,0,0
203389,of,0,0
203390,the,0,0
203391,bupivacaine,0,0
203392,group,0,0
203393,complained,0,0
203394,of,0,0
203395,some,0,0
203396,degree,0,0
203397,of,0,0
203398,urinary,0,0
203399,retention,0,0
203400,and,0,0
203401,one,0,0
203402,patient,0,0
203403,required,0,0
203404,temporary,0,0
203405,catheterisation,0,0
203406,.,0,0
203407,It,0,0
203408,is,0,0
203409,concluded,0,0
203410,that,0,0
203411,caudal,0,0
203412,diamorphine,0,0
203413,gives,0,0
203414,good,0,0
203415,postoperative,0,0
203416,analgesia,0,0
203417,for,0,0
203418,perianal,0,0
203419,operations,0,1
203420,",",0,0
203421,particularly,0,0
203422,when,0,0
203423,motor,0,0
203424,blockade,0,0
203425,is,0,0
203426,not,0,0
203427,wanted,0,0
203428,by,0,0
203429,the,0,0
203430,surgeon,0,0
203431,.,0,0
203432,Dose,0,0
203433,dependent,0,0
203434,response,0,0
203435,of,0,0
203436,symptoms,0,0
203437,",",0,0
203438,pituitary,0,0
203439,",",0,0
203440,and,0,0
203441,bone,0,0
203442,to,0,0
203443,transdermal,0,0
203444,oestrogen,0,0
203445,in,0,0
203446,postmenopausal,1,1
203447,women,1,1
203448,.,1,0
203449,The,0,0
203450,effect,0,0
203451,of,0,0
203452,the,0,0
203453,plasma,0,0
203454,oestradiol,0,0
203455,concentration,0,0
203456,on,0,0
203457,climacteric,0,0
203458,symptoms,0,0
203459,",",0,0
203460,gonadotrophin,0,0
203461,release,0,0
203462,",",0,0
203463,and,0,0
203464,bone,0,0
203465,resorption,0,0
203466,was,0,0
203467,studied,0,1
203468,in,0,0
203469,three,1,0
203470,groups,1,0
203471,of,1,0
203472,postmenopausal,1,1
203473,women,1,1
203474,given,1,0
203475,0.025,1,0
203476,mg,1,0
203477,",",1,0
203478,0.05,1,0
203479,mg,1,0
203480,",",1,0
203481,or,1,0
203482,0.1,1,0
203483,mg,1,0
203484,transdermal,1,0
203485,oestradiol,1,0
203486,daily,1,0
203487,.,1,0
203488,There,0,0
203489,was,0,0
203490,a,0,0
203491,dose,0,0
203492,related,0,0
203493,reduction,0,0
203494,in,0,0
203495,symptoms,0,0
203496,",",0,0
203497,plasma,0,0
203498,follicle,0,0
203499,stimulating,0,0
203500,hormone,0,0
203501,concentration,0,0
203502,",",0,0
203503,and,0,0
203504,urinary,0,0
203505,calcium,0,0
203506,and,0,0
203507,hydroxyproline,0,0
203508,excretion,0,0
203509,.,0,0
203510,The,0,0
203511,relation,0,0
203512,of,0,0
203513,the,0,0
203514,response,0,0
203515,to,0,0
203516,plasma,0,0
203517,oestradiol,0,0
203518,values,0,0
203519,was,0,0
203520,similar,0,0
203521,for,0,0
203522,each,0,0
203523,variable,0,0
203524,with,0,0
203525,an,0,0
203526,initial,0,0
203527,large,0,0
203528,reduction,0,0
203529,and,0,0
203530,little,0,0
203531,change,0,0
203532,in,0,0
203533,response,0,0
203534,to,0,0
203535,increases,0,0
203536,in,0,0
203537,the,0,0
203538,plasma,0,0
203539,oestradiol,0,0
203540,concentration,0,0
203541,above,0,0
203542,150,0,0
203543,pmol/l,0,1
203544,(,0,0
203545,41,0,1
203546,pg/ml,0,0
203547,),0,0
203548,.,0,0
203549,Hormone,0,0
203550,replacement,0,0
203551,therapy,0,0
203552,producing,0,0
203553,an,0,0
203554,effect,0,0
203555,equivalent,0,0
203556,to,0,0
203557,higher,0,0
203558,oestradiol,0,0
203559,concentrations,0,0
203560,is,0,0
203561,likely,0,0
203562,to,0,0
203563,increase,0,0
203564,the,0,0
203565,risk,0,0
203566,of,0,0
203567,side,0,0
203568,effects,0,0
203569,without,0,1
203570,conferring,0,0
203571,any,0,0
203572,additional,0,0
203573,benefit,0,0
203574,.,0,0
203575,[,0,0
203576,Bupivacaine-CO2,0,0
203577,and,0,0
203578,bupivacaine-HCl,0,0
203579,at,0,0
203580,various,0,0
203581,injection,0,0
203582,temperatures,0,1
203583,in,0,0
203584,peridural,0,0
203585,anesthesia,0,0
203586,for,0,0
203587,extracorporeal,0,0
203588,shock,0,1
203589,wave,0,0
203590,lithotripsy,0,1
203591,],0,0
203592,.,0,0
203593,INTRODUCTION,0,0
203594,The,0,0
203595,effect,0,0
203596,of,0,0
203597,different,0,0
203598,injection,0,0
203599,temperatures,0,1
203600,on,0,0
203601,carbonated,0,0
203602,anesthetics,0,0
203603,has,0,0
203604,been,0,0
203605,controversial,0,0
203606,since,0,0
203607,1965,0,1
203608,.,0,0
203609,The,0,0
203610,current,0,0
203611,study,0,0
203612,was,0,0
203613,undertaken,0,0
203614,to,0,0
203615,determine,0,0
203616,onset,0,1
203617,times,0,0
203618,of,0,0
203619,sensory,0,0
203620,and,0,0
203621,motor,0,0
203622,blockade,0,0
203623,after,0,0
203624,epidural,0,0
203625,anesthesia,0,0
203626,with,0,1
203627,0.5,0,0
203628,%,0,0
203629,bupivacaine-CO2,0,0
203630,and,0,0
203631,0.5,0,0
203632,%,0,0
203633,bupivacaine-HCl,0,0
203634,at,0,0
203635,various,0,0
203636,injection,0,0
203637,temperatures,0,1
203638,.,0,0
203639,MATERIALS,0,0
203640,AND,0,0
203641,METHODS,0,0
203642,The,0,0
203643,study,0,0
203644,was,0,0
203645,performed,0,0
203646,on,0,0
203647,90,1,0
203648,ASA,1,0
203649,class,1,1
203650,I-II,1,0
203651,urologic,1,1
203652,patients,1,1
203653,during,1,0
203654,extracorporeal,1,0
203655,shock,1,1
203656,wave,1,0
203657,lithotripsy,1,1
203658,.,1,0
203659,The,0,0
203660,patients,0,1
203661,were,0,0
203662,randomized,0,0
203663,in,0,0
203664,six,0,0
203665,groups,0,0
203666,to,0,0
203667,receive,0,0
203668,either,0,0
203669,0.5,0,0
203670,%,0,0
203671,bupivacaine-CO2,0,0
203672,or,0,0
203673,0.5,0,0
203674,%,0,0
203675,bupivacaine-HCl,0,0
203676,at,0,0
203677,temperatures,0,0
203678,of,0,0
203679,4,0,0
203680,degrees,0,0
203681,",",0,0
203682,20,0,1
203683,degrees,0,0
203684,",",0,0
203685,or,0,1
203686,36,0,1
203687,degrees,0,0
203688,C.,0,0
203689,The,0,0
203690,six,1,0
203691,groups,1,0
203692,were,0,0
203693,comparable,0,0
203694,in,0,0
203695,age,0,1
203696,",",0,0
203697,height,0,0
203698,",",0,0
203699,and,0,0
203700,weight,0,0
203701,.,0,0
203702,Epidural,0,0
203703,anesthesia,0,0
203704,was,0,0
203705,performed,0,0
203706,at,0,0
203707,the,0,0
203708,L2-3,0,0
203709,interspace,0,0
203710,with,0,0
203711,an,0,0
203712,18-gauge,0,0
203713,Tuohy,0,0
203714,needle,0,0
203715,using,0,0
203716,loss,0,0
203717,of,0,0
203718,resistance,0,0
203719,.,0,0
203720,A,0,0
203721,catheter,0,0
203722,was,0,0
203723,advanced,0,1
203724,4,0,0
203725,cm,0,1
203726,in,0,0
203727,the,0,0
203728,epidural,0,0
203729,space,0,0
203730,and,0,0
203731,4,0,0
203732,ml,0,0
203733,0.5,0,0
203734,%,0,0
203735,bupivacaine,0,0
203736,with,0,1
203737,adrenaline,0,0
203738,"1:200,000",0,0
203739,was,0,0
203740,given,0,0
203741,as,0,0
203742,a,0,0
203743,test,0,0
203744,dose,0,0
203745,.,0,0
203746,After,0,0
203747,4,0,0
203748,min,0,0
203749,the,0,0
203750,full,0,0
203751,anesthetic,0,0
203752,dose,0,0
203753,",",0,0
203754,based,0,0
203755,on,0,0
203756,body,0,0
203757,size,0,0
203758,",",0,0
203759,was,0,0
203760,injected,0,0
203761,with,0,0
203762,the,0,0
203763,patient,0,0
203764,supine,0,0
203765,.,0,0
203766,Sensory,0,0
203767,blockade,0,0
203768,was,0,0
203769,determined,0,0
203770,by,0,0
203771,the,0,0
203772,pinprick,0,0
203773,method,0,0
203774,and,0,0
203775,motor,0,0
203776,blockade,0,0
203777,by,0,0
203778,the,0,0
203779,Bromage,0,0
203780,method,0,0
203781,at,0,0
203782,2-min,0,0
203783,intervals,0,0
203784,for,0,0
203785,the,0,0
203786,first,0,0
203787,20,0,0
203788,min,0,0
203789,",",0,0
203790,at,0,0
203791,5-min,0,0
203792,intervals,0,0
203793,for,0,0
203794,the,0,0
203795,next,0,0
203796,10,0,0
203797,min,0,0
203798,",",0,0
203799,and,0,0
203800,then,0,0
203801,every,0,0
203802,15,0,0
203803,min,0,0
203804,to,0,0
203805,a,0,0
203806,total,0,0
203807,of,0,0
203808,240,0,0
203809,min,0,0
203810,.,0,0
203811,Statistical,0,0
203812,analysis,0,0
203813,was,0,0
203814,done,0,0
203815,by,0,0
203816,the,0,0
203817,Mann-Whitney,0,0
203818,test,0,0
203819,",",0,0
203820,with,0,0
203821,P,0,0
203822,less,0,0
203823,than,0,0
203824,0.05,0,0
203825,considered,0,0
203826,significant,0,0
203827,.,0,0
203828,RESULTS,0,0
203829,Spread,0,0
203830,of,0,0
203831,sensory,0,0
203832,blockade,0,0
203833,was,0,0
203834,significantly,0,0
203835,faster,0,0
203836,with,0,0
203837,bupivacaine-CO2,0,0
203838,and,0,0
203839,-HCl,0,0
203840,at,0,0
203841,a,0,0
203842,temperature,0,0
203843,of,0,0
203844,36,0,1
203845,degrees,0,0
203846,C,0,0
203847,as,0,0
203848,compared,0,0
203849,to,0,0
203850,4,0,0
203851,degrees,0,0
203852,or,0,1
203853,20,0,1
203854,degrees,0,0
203855,C,0,0
203856,(,0,0
203857,P,0,0
203858,less,0,0
203859,than,0,0
203860,0.05,0,0
203861,),0,0
203862,(,0,0
203863,Figs,0,0
203864,.,0,0
203865,1,0,0
203866,",",0,0
203867,2,0,0
203868,and,0,0
203869,Table,0,0
203870,2,0,0
203871,),0,0
203872,.,0,0
203873,(,0,0
203874,ABSTRACT,0,0
203875,TRUNCATED,0,0
203876,AT,0,0
203877,250,0,0
203878,WORDS,0,0
203879,),0,0
203880,Randomized,0,0
203881,study,0,0
203882,of,0,0
203883,six,1,0
203884,umbilical,1,0
203885,cord,1,0
203886,care,1,0
203887,regimens,1,0
203888,.,1,0
203889,Comparing,0,0
203890,length,0,0
203891,of,0,0
203892,attachment,0,0
203893,",",0,0
203894,microbial,0,0
203895,control,0,0
203896,",",0,0
203897,and,0,0
203898,satisfaction,0,0
203899,.,0,0
203900,Two,1,0
203901,hundred,1,1
203902,and,1,0
203903,seventy,1,1
203904,one,1,0
203905,infants,1,1
203906,were,1,0
203907,enrolled,1,1
203908,in,1,0
203909,a,1,0
203910,study,1,0
203911,to,1,0
203912,compare,1,0
203913,six,1,0
203914,different,1,0
203915,methods,1,1
203916,of,1,0
203917,treating,1,0
203918,the,1,0
203919,umbilical,1,0
203920,cord,1,0
203921,.,1,0
203922,Antimicrobial,0,0
203923,control,0,0
203924,was,0,0
203925,equal,0,0
203926,for,0,0
203927,all,0,0
203928,methods,0,1
203929,.,0,0
203930,Repeated,0,0
203931,triple,0,0
203932,dye,0,0
203933,application,0,0
203934,was,0,0
203935,considered,0,0
203936,least,0,0
203937,acceptable,0,0
203938,by,0,0
203939,staff,0,0
203940,and,0,0
203941,parents,0,1
203942,and,0,0
203943,had,0,0
203944,the,0,0
203945,longest,0,0
203946,attachment,0,0
203947,time,0,0
203948,.,0,0
203949,Povidone-iodine,0,0
203950,was,0,0
203951,associated,0,0
203952,with,0,0
203953,the,0,0
203954,shortest,0,0
203955,attachment,0,0
203956,time,0,0
203957,and,0,0
203958,was,0,0
203959,most,0,0
203960,liked,0,0
203961,.,0,0
203962,If,0,0
203963,there,0,0
203964,is,0,0
203965,no,0,0
203966,special,0,0
203967,need,0,0
203968,to,0,0
203969,treat,0,0
203970,a,0,0
203971,specific,0,0
203972,nosocomial,0,0
203973,outbreak,0,1
203974,",",0,0
203975,duration,0,0
203976,of,0,0
203977,cord,0,0
203978,attachment,0,0
203979,and,0,0
203980,satisfaction,0,0
203981,of,0,0
203982,staff,0,0
203983,and,0,0
203984,parents,0,1
203985,can,0,0
203986,help,0,0
203987,clinicians,0,0
203988,decide,0,0
203989,on,0,0
203990,a,0,0
203991,cord,0,0
203992,care,0,0
203993,regimen,0,0
203994,.,0,1
203995,Comparison,0,0
203996,of,0,0
203997,intermittent,0,1
203998,or,0,0
203999,continuous,0,0
204000,methotrexate,0,0
204001,plus,0,0
204002,6-mercaptopurine,0,0
204003,in,0,0
204004,regimens,0,0
204005,for,0,0
204006,standard-risk,1,1
204007,acute,1,1
204008,lymphoblastic,1,1
204009,leukemia,1,1
204010,in,1,0
204011,childhood,1,1
204012,(,1,0
204013,JCCLSG-S811,1,0
204014,),1,0
204015,.,1,0
204016,The,0,0
204017,Japanese,1,1
204018,Children,1,1
204019,'s,1,1
204020,Cancer,1,0
204021,and,1,1
204022,Leukemia,1,1
204023,Study,1,0
204024,Group,1,1
204025,.,1,0
204026,From,0,0
204027,1981,1,1
204028,to,1,0
204029,1983,1,1
204030,",",1,0
204031,131,1,0
204032,previously,1,1
204033,untreated,1,1
204034,patients,1,1
204035,with,1,1
204036,acute,1,1
204037,lymphoblastic,1,1
204038,leukemia,1,1
204039,(,1,0
204040,ALL,1,0
204041,),1,0
204042,standard-risk,1,1
204043,group,1,0
204044,were,0,0
204045,entered,0,0
204046,to,0,0
204047,the,0,0
204048,protocol,0,0
204049,JCCLSG-S811,0,0
204050,.,0,0
204051,Of,0,0
204052,119,1,1
204053,eligible,1,1
204054,patients,1,1
204055,",",0,0
204056,115,0,1
204057,(,0,0
204058,96.6,0,0
204059,%,0,0
204060,),0,0
204061,attained,0,0
204062,complete,0,0
204063,remission,0,0
204064,by,0,0
204065,treatment,0,0
204066,with,0,1
204067,prednisone,0,0
204068,(,0,0
204069,PRD,0,0
204070,),0,0
204071,plus,0,0
204072,vincristine,0,0
204073,(,0,0
204074,VCR,0,0
204075,),0,0
204076,or,0,0
204077,vindesine,0,0
204078,(,0,0
204079,VDS,0,0
204080,),0,0
204081,.,0,0
204082,After,0,0
204083,preventive,0,0
204084,central,0,0
204085,nervous,0,0
204086,system,0,0
204087,(,0,0
204088,CNS,0,0
204089,),0,0
204090,therapy,0,0
204091,including,0,0
204092,18,0,1
204093,Gy,0,0
204094,cranial,0,0
204095,irradiation,0,0
204096,and,0,0
204097,three,0,0
204098,doses,0,0
204099,of,0,0
204100,intrathecal,0,0
204101,methotrexate,0,0
204102,(,0,0
204103,MTX,0,0
204104,),0,0
204105,",",0,0
204106,the,0,0
204107,patients,0,1
204108,were,0,0
204109,assigned,0,0
204110,randomly,0,0
204111,to,0,0
204112,the,0,0
204113,two,0,0
204114,maintenance,0,0
204115,chemotherapies,0,0
204116,",",0,0
204117,Regimen,0,0
204118,A,0,0
204119,and,0,0
204120,Regimen,0,0
204121,B,0,0
204122,.,0,0
204123,Regimen,0,0
204124,A,0,0
204125,(,0,0
204126,intermittent,0,1
204127,regimen,0,0
204128,),0,0
204129,consisted,0,0
204130,of,0,0
204131,PRD,0,0
204132,(,0,0
204133,120,0,1
204134,mg/m2/day,0,0
204135,by,0,0
204136,mouth,0,0
204137,for,0,0
204138,5,0,0
204139,days,0,0
204140,),0,0
204141,plus,0,0
204142,6-mercaptopurine,0,0
204143,(,0,0
204144,6MP,0,0
204145,),0,0
204146,(,0,0
204147,175,0,0
204148,mg/m2/day,0,0
204149,by,0,0
204150,mouth,0,0
204151,for,0,0
204152,5,0,0
204153,days,0,0
204154,),0,0
204155,plus,0,0
204156,VCR,0,0
204157,(,0,0
204158,2.0,0,0
204159,mg/m2,0,0
204160,intravenously,0,0
204161,),0,0
204162,alternating,0,0
204163,biweekly,0,0
204164,with,0,1
204165,MTX,0,0
204166,(,0,0
204167,225,0,0
204168,mg/m2,0,0
204169,intravenously,0,0
204170,),0,0
204171,.,0,0
204172,Regimen,0,0
204173,B,0,0
204174,(,0,0
204175,continuous,0,0
204176,regimen,0,0
204177,),0,0
204178,consisted,0,0
204179,of,0,0
204180,6MP,0,0
204181,(,0,0
204182,50,0,0
204183,mg/m2/day,0,0
204184,by,0,0
204185,mouth,0,0
204186,),0,0
204187,plus,0,0
204188,MTX,0,0
204189,(,0,0
204190,20,0,0
204191,mg/m2/week,0,0
204192,by,0,0
204193,mouth,0,0
204194,),0,0
204195,combined,0,0
204196,with,0,1
204197,pulses,0,0
204198,of,0,0
204199,PRD,0,0
204200,and,0,0
204201,VCR,0,0
204202,(,0,0
204203,the,0,0
204204,same,0,0
204205,dosages,0,0
204206,as,0,0
204207,Regimen,0,1
204208,A,0,0
204209,),0,0
204210,every,0,0
204211,4,0,0
204212,weeks,0,0
204213,.,0,0
204214,As,0,0
204215,the,0,0
204216,late,0,0
204217,intensification,0,0
204218,therapy,0,0
204219,(,0,0
204220,LIT,0,0
204221,),0,0
204222,",",0,0
204223,five,0,0
204224,courses,0,0
204225,of,0,0
204226,high-dose,0,0
204227,MTX,0,0
204228,(,0,0
204229,2000,0,1
204230,mg/m2,0,0
204231,per,0,0
204232,dose,0,0
204233,per,0,0
204234,week,0,0
204235,intravenously,0,0
204236,for,0,0
204237,three,0,0
204238,doses,0,0
204239,every,0,0
204240,12,0,0
204241,weeks,0,0
204242,),0,0
204243,with,0,1
204244,leucovorin,0,0
204245,rescue,0,0
204246,were,0,0
204247,administered,0,0
204248,to,0,0
204249,all,0,1
204250,patients,0,1
204251,who,0,1
204252,were,0,1
204253,in,0,1
204254,continuous,0,0
204255,complete,0,0
204256,remission,0,1
204257,(,0,0
204258,CCR,0,0
204259,),0,0
204260,for,0,0
204261,more,0,0
204262,than,0,0
204263,2,0,0
204264,years,0,1
204265,.,0,1
204266,Sixty,0,1
204267,and,0,0
204268,55,0,1
204269,patients,0,1
204270,",",0,0
204271,respectively,0,0
204272,",",0,0
204273,were,0,0
204274,registered,0,0
204275,in,0,0
204276,Regimen,0,0
204277,A,0,0
204278,and,0,0
204279,B,0,0
204280,.,0,0
204281,The,0,0
204282,CCR,0,0
204283,rates,0,0
204284,in,0,0
204285,Regimen,0,0
204286,A,0,0
204287,and,0,0
204288,B,0,0
204289,were,0,0
204290,75.1,0,0
204291,%,0,0
204292,+/-,0,0
204293,5.8,0,0
204294,%,0,0
204295,(,0,0
204296,mean,0,0
204297,+/-,0,0
204298,1,0,0
204299,SE,0,1
204300,),0,0
204301,and,0,0
204302,49.7,0,0
204303,%,0,0
204304,+/-,0,0
204305,7.3,0,0
204306,%,0,0
204307,(,0,0
204308,P,0,0
204309,less,0,0
204310,than,0,0
204311,0.01,0,0
204312,),0,0
204313,at,0,0
204314,4,0,0
204315,years,0,1
204316,",",0,0
204317,and,0,0
204318,72.1,0,0
204319,%,0,0
204320,+/-,0,0
204321,6.3,0,0
204322,%,0,0
204323,and,0,0
204324,49.7,0,0
204325,%,0,0
204326,+/-,0,0
204327,7.3,0,0
204328,%,0,0
204329,(,0,0
204330,P,0,0
204331,less,0,0
204332,than,0,0
204333,0.05,0,0
204334,),0,0
204335,at,0,0
204336,5,0,0
204337,years,0,1
204338,",",0,0
204339,respectively,0,0
204340,.,0,0
204341,In,0,0
204342,Regimen,0,0
204343,B,0,0
204344,",",0,0
204345,CNS,0,0
204346,and,0,0
204347,testicular,0,1
204348,relapses,0,0
204349,increased,0,0
204350,after,0,0
204351,3,0,0
204352,years,0,1
204353,of,0,0
204354,CCR,0,1
204355,.,0,0
204356,In,0,0
204357,addition,0,0
204358,",",0,0
204359,the,0,0
204360,patients,0,1
204361,in,0,0
204362,Regimen,0,1
204363,B,0,0
204364,had,0,0
204365,a,0,0
204366,much,0,0
204367,higher,0,0
204368,incidence,0,0
204369,of,0,0
204370,infections,0,0
204371,than,0,0
204372,Regimen,0,1
204373,A,0,0
204374,.,0,0
204375,The,0,0
204376,LIT,0,0
204377,did,0,0
204378,not,0,0
204379,seem,0,0
204380,to,0,0
204381,have,0,0
204382,important,0,0
204383,effects,0,0
204384,on,0,0
204385,the,0,0
204386,duration,0,0
204387,of,0,0
204388,CCR,0,0
204389,.,0,0
204390,From,0,0
204391,these,0,0
204392,data,0,0
204393,we,0,0
204394,conclude,0,0
204395,that,0,0
204396,the,0,0
204397,intermittent,0,1
204398,cyclic,0,0
204399,regimen,0,0
204400,of,0,0
204401,6MP,0,0
204402,and,0,0
204403,MTX,0,0
204404,may,0,0
204405,be,0,0
204406,more,0,0
204407,effective,0,0
204408,as,0,0
204409,compared,0,0
204410,to,0,0
204411,the,0,0
204412,continuous,0,0
204413,administration,0,0
204414,of,0,0
204415,these,0,0
204416,drugs,0,0
204417,in,0,0
204418,the,0,0
204419,maintenance,0,0
204420,chemotherapy,0,0
204421,.,0,0
204422,[,0,0
204423,Prevention,0,0
204424,of,0,0
204425,thromboembolism,0,1
204426,in,0,0
204427,patients,1,1
204428,operated,1,1
204429,on,1,0
204430,for,1,0
204431,hip,1,1
204432,prosthesis,1,1
204433,],1,0
204434,.,0,0
204435,The,0,0
204436,latest,0,0
204437,research,0,0
204438,into,0,0
204439,the,0,0
204440,prevention,0,0
204441,of,0,0
204442,peri-,0,0
204443,and,0,0
204444,postoperative,0,0
204445,thromboembolic,0,0
204446,disease,0,1
204447,has,0,0
204448,found,0,0
204449,orthopaedic,0,1
204450,surgery,0,1
204451,patients,0,1
204452,to,0,0
204453,be,0,0
204454,most,0,0
204455,at,0,0
204456,risk,0,0
204457,.,0,0
204458,As,0,0
204459,the,0,0
204460,genesis,0,0
204461,of,0,0
204462,deep,0,0
204463,venous,0,0
204464,thrombosis,0,1
204465,(,0,0
204466,DVT,0,0
204467,),0,0
204468,is,0,0
204469,due,0,0
204470,to,0,0
204471,haemodynamic,0,0
204472,",",0,0
204473,hemorheologic,0,0
204474,and,0,0
204475,parietal,0,0
204476,factors,0,0
204477,",",0,0
204478,various,0,0
204479,prophylactic,0,0
204480,measures,0,0
204481,have,0,0
204482,been,0,0
204483,considered,0,0
204484,in,0,0
204485,the,0,0
204486,past,0,0
204487,",",0,0
204488,measures,0,0
204489,which,0,0
204490,have,0,0
204491,not,0,0
204492,proved,0,0
204493,able,0,0
204494,to,0,0
204495,provide,0,0
204496,satisfactory,0,0
204497,protection,0,0
204498,in,0,0
204499,orthopaedics,0,1
204500,.,0,1
204501,The,0,0
204502,results,0,0
204503,obtained,0,0
204504,with,0,1
204505,Defibrotide,0,0
204506,in,0,0
204507,a,0,0
204508,random,0,0
204509,and,0,0
204510,controlled,0,0
204511,clinical,0,0
204512,study,0,0
204513,versus,0,0
204514,calcium,0,0
204515,heparin,0,0
204516,involving,0,0
204517,211,1,1
204518,patients,1,1
204519,of,1,0
204520,both,1,0
204521,sexes,1,1
204522,candidates,1,0
204523,to,1,0
204524,receive,1,0
204525,total,1,1
204526,hip,1,0
204527,arthroplasty,1,1
204528,and,1,0
204529,presenting,1,1
204530,at,1,0
204531,least,1,0
204532,one,1,0
204533,major,1,0
204534,thromboembolic,1,0
204535,risk,1,0
204536,factor,1,0
204537,are,0,0
204538,reported,0,0
204539,.,0,0
204540,The,0,0
204541,patients,0,1
204542,were,0,0
204543,assigned,0,0
204544,at,0,0
204545,random,0,0
204546,to,0,0
204547,one,0,0
204548,of,0,0
204549,the,0,0
204550,following,0,0
204551,treatments,0,0
204552,:,0,1
204553,1,0,0
204554,),0,0
204555,Defibrotide,0,0
204556,at,0,0
204557,a,0,0
204558,dose,0,0
204559,of,0,0
204560,400,0,0
204561,mg,0,0
204562,b.i.d,0,0
204563,.,0,0
204564,i.v,0,0
204565,.,0,0
204566,in,0,0
204567,50,0,0
204568,ml,0,0
204569,phleboclysis,0,0
204570,in,0,0
204571,5,0,0
204572,minutes,0,0
204573,(,0,0
204574,n,0,1
204575,=,0,0
204576,108,0,1
204577,),0,0
204578,;,0,0
204579,2,0,0
204580,),0,0
204581,calcium,0,0
204582,heparin,0,0
204583,at,0,0
204584,a,0,0
204585,dose,0,0
204586,of,0,0
204587,5000,0,0
204588,IU,0,0
204589,t.i.d,0,0
204590,.,0,0
204591,subcutaneously,0,0
204592,(,0,0
204593,n,0,1
204594,=,0,0
204595,103,0,1
204596,),0,0
204597,.,0,0
204598,The,0,0
204599,treatment,0,0
204600,began,0,0
204601,the,0,0
204602,day,0,0
204603,before,0,0
204604,operation,0,0
204605,and,0,0
204606,continued,0,0
204607,on,0,0
204608,average,0,0
204609,up,0,0
204610,to,0,0
204611,the,0,0
204612,eighth,0,0
204613,day,0,0
204614,for,0,0
204615,the,0,0
204616,Defibrotide,0,0
204617,group,0,0
204618,.,0,0
204619,With,0,0
204620,the,0,0
204621,control,0,0
204622,group,0,0
204623,it,0,0
204624,continued,0,0
204625,until,0,0
204626,discharge,0,0
204627,(,0,0
204628,usually,0,0
204629,on,0,0
204630,the,0,0
204631,15th,0,0
204632,day,0,0
204633,),0,0
204634,and,0,0
204635,at,0,0
204636,home,0,0
204637,for,0,0
204638,about,0,0
204639,three,0,0
204640,weeks,0,0
204641,until,0,0
204642,the,0,0
204643,completion,0,0
204644,of,0,0
204645,the,0,0
204646,physiotherapy,0,1
204647,cycle,0,0
204648,.,0,0
204649,In,0,0
204650,the,0,0
204651,108,0,1
204652,patients,0,1
204653,treated,0,1
204654,with,0,1
204655,Defibrotide,0,0
204656,only,0,0
204657,one,0,0
204658,case,0,0
204659,of,0,0
204660,DVT,0,0
204661,was,0,0
204662,reported,0,0
204663,and,0,0
204664,in,0,0
204665,none,0,0
204666,of,0,0
204667,these,0,0
204668,patients,0,1
204669,were,0,0
204670,symptoms,0,0
204671,or,0,1
204672,signs,0,0
204673,of,0,0
204674,pulmonary,0,1
204675,embolism,0,1
204676,encountered,0,0
204677,.,0,0
204678,In,0,0
204679,the,0,0
204680,group,0,0
204681,treated,0,0
204682,with,0,0
204683,calcium,0,0
204684,heparin,0,0
204685,2,0,0
204686,cases,0,0
204687,of,0,0
204688,clinically,0,0
204689,and,0,0
204690,radiologically,0,1
204691,diagnosed,0,1
204692,pulmonary,0,0
204693,embolism,0,0
204694,and,0,0
204695,4,0,0
204696,cases,0,1
204697,of,0,0
204698,DVT,0,0
204699,were,0,0
204700,observed,0,0
204701,.,0,0
204702,Although,0,0
204703,the,0,0
204704,differences,0,0
204705,were,0,0
204706,not,0,0
204707,statistically,0,0
204708,significant,0,0
204709,",",0,0
204710,the,0,0
204711,tendency,0,0
204712,favours,0,0
204713,Defibrotide,0,0
204714,.,0,0
204715,Statistically,0,0
204716,significant,0,0
204717,(,0,0
204718,p,0,0
204719,less,0,0
204720,than,0,0
204721,0.01,0,0
204722,),0,0
204723,was,0,0
204724,the,0,0
204725,difference,0,0
204726,in,0,0
204727,postoperative,0,0
204728,bleeding,0,0
204729,evaluated,0,0
204730,with,0,0
204731,particular,0,0
204732,attention,0,0
204733,in,0,0
204734,patients,0,1
204735,of,0,0
204736,advanced,0,1
204737,age,0,1
204738,.,0,0
204739,Further,0,0
204740,",",0,0
204741,in,0,0
204742,the,0,0
204743,Defibrotide,0,0
204744,group,0,0
204745,",",0,0
204746,scarring,0,0
204747,was,0,0
204748,considered,0,0
204749,excellent,0,0
204750,in,0,0
204751,96,0,0
204752,%,0,0
204753,of,0,0
204754,cases,0,0
204755,while,0,0
204756,in,0,0
204757,the,0,0
204758,heparin,0,0
204759,group,0,0
204760,scarring,0,0
204761,was,0,0
204762,excellent,0,0
204763,in,0,0
204764,85,0,1
204765,%,0,0
204766,(,0,0
204767,p,0,0
204768,less,0,0
204769,than,0,0
204770,0.05,0,0
204771,),0,0
204772,.,0,0
204773,To,0,0
204774,conclude,0,0
204775,",",0,0
204776,the,0,0
204777,sure,0,0
204778,clinical,0,0
204779,effectiveness,0,0
204780,",",0,0
204781,tolerance,0,0
204782,",",0,0
204783,handiness,0,0
204784,and,0,0
204785,lack,0,0
204786,of,0,0
204787,interference,0,0
204788,with,0,1
204789,clotting,0,0
204790,functions,0,0
204791,make,0,0
204792,Defibrotide,0,0
204793,a,0,0
204794,really,0,0
204795,useful,0,0
204796,drug,0,0
204797,for,0,0
204798,the,0,0
204799,prevention,0,0
204800,of,0,0
204801,thromboembolic,0,0
204802,episodes,0,0
204803,in,0,0
204804,patients,1,1
204805,undergoing,1,1
204806,major,1,0
204807,orthopaedic,1,1
204808,surgery,1,1
204809,.,1,0
204810,Nitrous,0,0
204811,oxide,0,0
204812,does,0,0
204813,not,0,0
204814,increase,0,0
204815,the,0,0
204816,incidence,0,0
204817,of,0,0
204818,nausea,1,0
204819,and,1,0
204820,vomiting,1,0
204821,after,1,0
204822,isoflurane,1,0
204823,anesthesia,1,0
204824,.,1,0
204825,A,0,0
204826,total,0,0
204827,of,0,0
204828,110,1,1
204829,patients,1,1
204830,undergoing,1,1
204831,elective,1,1
204832,abdominal,1,1
204833,hysterectomy,1,1
204834,were,1,0
204835,anesthetized,1,1
204836,in,1,0
204837,random,1,0
204838,order,1,0
204839,with,0,0
204840,either,0,0
204841,isoflurane,0,0
204842,in,0,0
204843,nitrous,0,0
204844,oxide,0,0
204845,and,0,0
204846,oxygen,0,0
204847,or,0,0
204848,isoflurane,0,0
204849,in,0,0
204850,air,0,0
204851,and,0,0
204852,oxygen,0,0
204853,.,0,0
204854,Fentanyl,0,0
204855,was,0,0
204856,used,0,0
204857,as,0,0
204858,an,0,0
204859,adjunct,0,0
204860,to,0,0
204861,isoflurane,0,0
204862,in,0,0
204863,all,1,0
204864,patients,1,1
204865,",",0,0
204866,0.05,0,0
204867,mg,0,0
204868,every,0,0
204869,45,0,0
204870,min,0,0
204871,.,0,0
204872,No,0,0
204873,difference,0,0
204874,was,0,0
204875,found,0,0
204876,between,0,0
204877,the,0,0
204878,two,0,0
204879,anesthetic,0,0
204880,techniques,0,0
204881,in,0,0
204882,the,0,0
204883,incidence,0,0
204884,of,0,0
204885,nausea,0,0
204886,",",0,0
204887,vomiting,0,0
204888,",",0,0
204889,or,0,0
204890,both,0,0
204891,during,0,0
204892,the,0,0
204893,first,0,0
204894,24,0,0
204895,hr,0,0
204896,after,0,0
204897,operation,0,0
204898,.,0,0
204899,The,0,0
204900,overall,0,0
204901,incidence,0,0
204902,was,0,0
204903,62,0,1
204904,and,0,0
204905,67,0,0
204906,%,0,0
204907,for,0,0
204908,air-O2,0,0
204909,and,0,0
204910,N2O-O2,0,0
204911,groups,0,0
204912,",",0,0
204913,respectively,0,0
204914,.,0,1
204915,Patients,0,1
204916,who,0,1
204917,had,0,1
204918,had,0,1
204919,nausea,0,0
204920,or,0,0
204921,vomiting,0,0
204922,after,0,0
204923,previous,0,0
204924,anesthetics,0,0
204925,had,0,0
204926,nausea,0,0
204927,or,0,0
204928,vomiting,0,0
204929,significantly,0,0
204930,more,0,0
204931,frequently,0,0
204932,than,0,0
204933,patients,0,1
204934,who,0,1
204935,did,0,1
204936,not,0,1
204937,.,0,0
204938,It,0,0
204939,is,0,0
204940,concluded,0,0
204941,that,0,0
204942,nitrous,0,0
204943,oxide,0,0
204944,does,0,0
204945,not,0,0
204946,contribute,0,0
204947,to,0,0
204948,the,0,0
204949,occurrence,0,0
204950,of,0,0
204951,nausea,0,0
204952,or,0,0
204953,vomiting,0,0
204954,after,0,0
204955,isoflurane,0,0
204956,anesthesia,0,0
204957,for,0,0
204958,gynecologic,0,1
204959,laparotomies,0,1
204960,.,0,1
204961,Alpha,0,0
204962,interferon,0,0
204963,clinical,0,0
204964,trial,0,0
204965,for,0,0
204966,multiple,1,0
204967,sclerosis,1,1
204968,:,1,1
204969,design,0,0
204970,considerations,0,0
204971,.,0,0
204972,The,0,0
204973,design,0,0
204974,and,0,0
204975,course,0,0
204976,of,0,0
204977,a,0,0
204978,placebo-controlled,0,0
204979,alpha-2,0,0
204980,interferon,0,0
204981,trial,0,0
204982,in,0,0
204983,MS,1,0
204984,patients,1,1
204985,are,0,0
204986,described,0,0
204987,.,0,0
204988,No,0,0
204989,beneficial,0,0
204990,effect,0,0
204991,of,0,0
204992,the,0,0
204993,interferon,0,0
204994,on,0,0
204995,the,0,0
204996,course,0,0
204997,of,0,0
204998,MS,0,0
204999,could,0,0
205000,be,0,0
205001,shown,0,0
205002,.,0,0
205003,Incidence,0,0
205004,of,0,0
205005,infectious,0,1
205006,symptoms,0,0
205007,after,1,0
205008,radiation,1,0
205009,therapy,1,0
205010,for,1,0
205011,breast,1,1
205012,cancer,1,1
205013,.,1,0
205014,Long-term,0,0
205015,effects,0,0
205016,.,0,0
205017,The,0,0
205018,incidence,0,0
205019,of,0,0
205020,symptoms,0,0
205021,generally,0,0
205022,associated,0,0
205023,with,0,0
205024,infectious,0,1
205025,disease,0,1
205026,was,0,0
205027,assessed,0,0
205028,by,0,0
205029,a,0,0
205030,questionnaire,0,0
205031,sent,0,0
205032,out,0,0
205033,to,0,0
205034,519,1,1
205035,disease-free,1,0
205036,breast,1,1
205037,cancer,1,1
205038,patients,1,1
205039,7,1,0
205040,to,1,1
205041,12,1,0
205042,years,1,1
205043,after,1,0
205044,primary,1,1
205045,treatment,1,0
205046,.,1,0
205047,All,0,0
205048,patients,0,1
205049,were,0,0
205050,treated,0,1
205051,in,0,0
205052,the,0,0
205053,context,0,0
205054,of,0,0
205055,a,0,0
205056,randomized,0,0
205057,trial,0,0
205058,where,0,0
205059,pre-,0,0
205060,and,0,0
205061,postoperative,0,0
205062,radiation,0,0
205063,(,0,0
205064,45,0,1
205065,Gy,0,0
205066,),0,0
205067,was,0,0
205068,evaluated,0,0
205069,versus,0,0
205070,surgery,0,1
205071,only,0,0
205072,.,0,0
205073,The,0,0
205074,results,0,0
205075,indicate,0,0
205076,a,0,0
205077,significantly,0,0
205078,higher,0,0
205079,morbidity,0,0
205080,among,0,0
205081,patients,0,1
205082,treated,0,1
205083,with,0,1
205084,preoperative,0,0
205085,irradiation,0,0
205086,compared,0,0
205087,with,0,0
205088,those,0,0
205089,irradiated,0,0
205090,postoperative,0,0
205091,(,0,0
205092,p,0,0
205093,less,0,0
205094,than,0,0
205095,0.05,0,0
205096,),0,0
205097,.,0,0
205098,This,0,0
205099,increased,0,0
205100,morbidity,0,0
205101,mainly,0,0
205102,seemed,0,0
205103,to,0,0
205104,be,0,0
205105,caused,0,0
205106,by,0,0
205107,symptoms,0,0
205108,usually,0,0
205109,associated,0,0
205110,with,0,0
205111,respiratory,0,0
205112,tract,0,1
205113,infection,0,1
205114,(,0,0
205115,p,0,0
205116,less,0,0
205117,than,0,0
205118,0.05,0,0
205119,),0,0
205120,.,0,0
205121,Although,0,0
205122,statistically,0,0
205123,not,0,0
205124,significant,0,0
205125,the,0,0
205126,preoperatively,0,0
205127,irradiated,0,0
205128,patients,0,1
205129,also,0,0
205130,had,0,0
205131,a,0,0
205132,higher,0,0
205133,morbidity,0,0
205134,than,0,0
205135,those,0,0
205136,treated,0,0
205137,with,0,0
205138,surgery,0,1
205139,alone,0,0
205140,.,0,0
205141,There,0,0
205142,was,0,0
205143,no,0,0
205144,difference,0,0
205145,between,0,0
205146,postoperatively,0,0
205147,irradiated,0,0
205148,patients,0,1
205149,and,0,0
205150,patients,0,1
205151,treated,0,1
205152,with,0,1
205153,surgery,0,1
205154,only,0,0
205155,.,0,0
205156,A,0,0
205157,significantly,0,0
205158,higher,0,0
205159,integral,0,0
205160,dose,0,0
205161,(,0,0
205162,absorbed,0,0
205163,energy,0,0
205164,within,0,0
205165,the,0,0
205166,body,0,0
205167,),0,0
205168,of,0,0
205169,the,0,0
205170,pre-,0,0
205171,compared,0,0
205172,with,0,1
205173,the,0,0
205174,postoperative,0,0
205175,group,0,0
205176,(,0,0
205177,p,0,0
205178,less,0,0
205179,than,0,0
205180,0.025,0,0
205181,),0,0
205182,is,0,0
205183,associated,0,0
205184,with,0,0
205185,the,0,0
205186,differences,0,0
205187,in,0,0
205188,morbidity,0,0
205189,between,0,0
205190,the,0,0
205191,two,0,0
205192,irradiated,0,0
205193,groups,0,0
205194,.,0,0
205195,An,0,0
205196,explanation,0,0
205197,for,0,0
205198,the,0,0
205199,increased,0,0
205200,morbidity,0,0
205201,seems,0,0
205202,to,0,0
205203,be,0,0
205204,that,0,0
205205,the,0,0
205206,volume,0,0
205207,of,0,0
205208,lung,0,0
205209,tissue,0,0
205210,",",0,0
205211,encompassed,0,0
205212,within,0,0
205213,the,0,0
205214,full-dose,0,0
205215,target,0,0
205216,volume,0,0
205217,",",0,0
205218,is,0,0
205219,the,0,0
205220,crucial,0,0
205221,factor,0,0
205222,.,0,0
205223,This,0,0
205224,volume,0,0
205225,was,0,0
205226,considerable,0,0
205227,in,0,0
205228,the,0,0
205229,preoperatively,0,0
205230,treated,0,0
205231,patients,0,1
205232,but,0,0
205233,kept,0,0
205234,at,0,0
205235,a,0,0
205236,minimum,0,0
205237,in,0,0
205238,the,0,0
205239,postoperative,0,0
205240,group,0,0
205241,.,0,0
205242,Tinidazole,0,0
205243,and,0,0
205244,metronidazole,0,0
205245,in,0,0
205246,hepatic,1,0
205247,amoebiasis,1,1
205248,.,1,0
205249,The,0,0
205250,efficacy,0,0
205251,of,0,0
205252,metronidazole,0,0
205253,and,0,0
205254,tinidazole,0,0
205255,has,0,0
205256,been,0,0
205257,compared,0,0
205258,in,0,0
205259,31,1,1
205260,patients,1,1
205261,with,1,1
205262,hepatic,1,1
205263,amoebiasis,1,1
205264,.,1,0
205265,Only,1,0
205266,those,1,0
205267,with,1,0
205268,unequivocal,1,0
205269,clinical,1,0
205270,",",1,0
205271,radiological,1,0
205272,and,1,0
205273,laboratory,1,0
205274,evidence,1,0
205275,of,1,0
205276,hepatic,1,0
205277,amoebiasis,1,1
205278,were,0,0
205279,included,0,1
205280,;,0,0
205281,diagnostic,0,0
205282,and,0,0
205283,therapeutic,0,0
205284,aspiration,0,0
205285,was,0,0
205286,performed,0,0
205287,where,0,0
205288,necessary,0,0
205289,.,0,0
205290,15,1,0
205291,patients,1,1
205292,received,1,0
205293,metronidazole,1,0
205294,and,1,0
205295,16,1,0
205296,tinidazole,1,0
205297,",",1,0
205298,in,1,0
205299,random,1,0
205300,order,1,0
205301,.,1,0
205302,The,0,0
205303,2,0,0
205304,groups,0,0
205305,were,0,1
205306,comparable,0,0
205307,.,0,0
205308,Both,0,0
205309,drugs,0,0
205310,were,0,0
205311,given,0,0
205312,orally,0,0
205313,in,0,0
205314,a,0,0
205315,single,0,0
205316,daily,0,0
205317,dose,0,0
205318,of,0,0
205319,2g,0,0
205320,for,0,0
205321,a,0,0
205322,minimum,0,0
205323,of,0,0
205324,3,0,0
205325,days,0,0
205326,",",0,0
205327,with,0,1
205328,treatment,0,0
205329,extended,0,0
205330,if,0,0
205331,considered,0,0
205332,clinically,0,0
205333,advisable,0,0
205334,.,0,0
205335,12,0,0
205336,of,0,0
205337,15,0,1
205338,patients,0,1
205339,(,0,0
205340,80,0,1
205341,%,0,0
205342,),0,0
205343,were,0,0
205344,cured,0,0
205345,with,0,1
205346,metronidazole,0,0
205347,given,0,0
205348,for,0,0
205349,an,0,0
205350,average,0,0
205351,period,0,0
205352,of,0,0
205353,7,0,0
205354,days,0,0
205355,(,0,0
205356,range,0,0
205357,4,0,0
205358,to,0,0
205359,14,0,1
205360,days,0,0
205361,),0,1
205362,.,0,0
205363,15,0,0
205364,of,0,0
205365,16,0,1
205366,patients,0,1
205367,(,0,0
205368,93.8,0,0
205369,%,0,0
205370,),0,0
205371,given,0,0
205372,tinidazole,0,0
205373,were,0,0
205374,cured,0,0
205375,and,0,0
205376,the,0,0
205377,mean,0,0
205378,duration,0,0
205379,of,0,0
205380,treatment,0,0
205381,was,0,0
205382,4,0,0
205383,days,0,0
205384,(,0,0
205385,range,0,0
205386,3,0,0
205387,to,0,0
205388,6,0,0
205389,days,0,0
205390,),0,0
205391,.,0,0
205392,There,0,0
205393,were,0,0
205394,fewer,0,0
205395,side-effects,0,0
205396,with,0,1
205397,tinidazole,0,0
205398,.,0,0
205399,In,0,0
205400,this,0,0
205401,study,0,0
205402,of,0,0
205403,hepatic,1,0
205404,amoebiasis,1,1
205405,in,1,0
205406,Bangladesh,1,1
205407,",",0,0
205408,tinidazole,0,0
205409,was,0,0
205410,found,0,0
205411,to,0,0
205412,be,0,0
205413,superior,0,0
205414,to,0,0
205415,metronidazole,0,0
205416,in,0,0
205417,overall,0,0
205418,efficacy,0,0
205419,because,0,0
205420,a,0,0
205421,shorter,0,0
205422,course,0,0
205423,of,0,0
205424,treatment,0,0
205425,was,0,0
205426,necessary,0,0
205427,and,0,0
205428,it,0,0
205429,caused,0,0
205430,fewer,0,0
205431,side-effects,0,0
205432,.,0,1
205433,Randomized,0,0
205434,trial,0,0
205435,of,0,0
205436,high-dose,0,0
205437,cytarabine,0,0
205438,versus,0,0
205439,amsacrine,0,0
205440,in,0,0
205441,acute,1,1
205442,myelogenous,1,1
205443,leukemia,1,1
205444,in,1,0
205445,relapse,1,0
205446,:,1,1
205447,a,1,0
205448,Leukemia,1,1
205449,Intergroup,1,0
205450,Study,1,0
205451,.,1,0
205452,Patients,1,1
205453,with,1,1
205454,acute,1,1
205455,myelogenous,1,1
205456,leukemia,1,1
205457,in,1,0
205458,relapse,1,1
205459,who,1,1
205460,were,1,1
205461,ineligible,1,1
205462,for,1,0
205463,further,1,0
205464,anthracycline,1,0
205465,therapy,1,0
205466,either,1,0
205467,because,1,0
205468,they,1,0
205469,were,1,0
205470,judged,1,0
205471,to,1,0
205472,be,1,0
205473,anthracycline,1,0
205474,resistant,1,1
205475,or,1,0
205476,had,1,0
205477,received,1,0
205478,the,1,0
205479,maximum,1,0
205480,doses,1,0
205481,were,0,0
205482,randomized,0,0
205483,to,0,0
205484,receive,0,0
205485,high-dose,0,0
205486,cytarabine,0,0
205487,(,0,0
205488,3,0,0
205489,g/m2,0,0
205490,every,0,0
205491,12,0,0
205492,hours,0,0
205493,for,0,0
205494,6,0,0
205495,days,0,0
205496,),0,0
205497,or,0,0
205498,amsacrine,0,0
205499,(,0,0
205500,75,0,1
205501,mg/m2,0,0
205502,daily,0,0
205503,for,0,0
205504,7,0,0
205505,days,0,0
205506,),0,0
205507,.,0,0
205508,The,0,0
205509,response,0,0
205510,rates,0,0
205511,in,0,0
205512,both,0,0
205513,groups,0,0
205514,were,0,0
205515,similar,0,0
205516,:,0,1
205517,three,1,0
205518,of,1,0
205519,25,1,0
205520,patients,1,1
205521,given,1,0
205522,high-dose,1,0
205523,cytarabine,1,0
205524,and,1,0
205525,three,1,0
205526,of,1,0
205527,23,1,1
205528,given,1,0
205529,amsacrine,1,0
205530,obtained,0,0
205531,complete,0,0
205532,remissions,0,0
205533,.,0,1
205534,The,0,0
205535,UKEP,0,0
205536,study,0,0
205537,:,0,1
205538,multicentre,0,0
205539,clinical,0,0
205540,trial,0,0
205541,on,0,0
205542,two,0,0
205543,local,0,0
205544,regimens,0,0
205545,of,0,0
205546,urokinase,0,0
205547,in,0,0
205548,massive,0,0
205549,pulmonary,0,1
205550,embolism,0,1
205551,.,0,0
205552,The,0,0
205553,UKEP,0,0
205554,Study,0,0
205555,Research,0,0
205556,Group,0,1
205557,.,0,0
205558,A,0,0
205559,multicentre,0,0
205560,trial,0,0
205561,(,0,0
205562,10,0,1
205563,centres,0,1
205564,),0,0
205565,of,0,0
205566,urokinase,0,0
205567,(,0,0
205568,UK,0,1
205569,),0,0
205570,was,0,0
205571,performed,0,0
205572,in,0,0
205573,patients,1,1
205574,with,1,1
205575,acute,1,1
205576,severe,1,1
205577,pulmonary,1,0
205578,embolism,1,1
205579,(,1,0
205580,PE,1,1
205581,),1,0
205582,.,1,0
205583,The,0,0
205584,aim,0,0
205585,of,0,0
205586,this,0,0
205587,trial,0,0
205588,was,0,0
205589,",",0,0
205590,to,0,0
205591,compare,0,0
205592,the,0,0
205593,efficacy,0,0
205594,of,0,0
205595,two,0,0
205596,doses,0,0
205597,of,0,0
205598,UK,0,1
205599,administered,0,0
205600,via,0,0
205601,a,0,0
205602,catheter,0,0
205603,in,0,0
205604,the,0,0
205605,pulmonary,0,1
205606,artery,0,1
205607,:,0,1
205608,2000,0,1
205609,IU,0,0
205610,kg-1,0,0
205611,h-1,0,0
205612,for,0,0
205613,24,0,0
205614,hours,0,0
205615,(,0,0
205616,UK,0,1
205617,2000,0,1
205618,),0,0
205619,in,0,0
205620,conjunction,0,0
205621,with,0,1
205622,heparin,0,0
205623,versus,0,0
205624,4400,0,0
205625,IU,0,0
205626,kg-1,0,0
205627,h-1,0,0
205628,UK,0,1
205629,alone,0,0
205630,for,0,0
205631,12,0,0
205632,hours,0,0
205633,(,0,0
205634,UK,0,1
205635,4400,0,0
205636,),0,0
205637,followed,0,0
205638,by,0,0
205639,heparin,0,0
205640,.,0,0
205641,PE,1,0
205642,was,1,0
205643,less,1,0
205644,than,1,0
205645,5,1,0
205646,days,1,0
205647,old,1,1
205648,and,0,0
205649,the,0,0
205650,clinical,0,0
205651,diagnosis,0,1
205652,was,0,0
205653,confirmed,0,0
205654,by,0,0
205655,pulmonary,0,1
205656,angiograms,0,0
205657,demonstrating,0,0
205658,a,0,0
205659,vascular,0,0
205660,obstruction,0,1
205661,of,0,0
205662,more,0,0
205663,than,0,0
205664,30,0,0
205665,%,0,0
205666,(,0,0
205667,Miller,0,0
205668,'s,0,0
205669,index,0,0
205670,greater,0,0
205671,than,0,0
205672,11,0,1
205673,),0,0
205674,.,0,0
205675,The,0,0
205676,efficacy,0,0
205677,of,0,0
205678,treatment,0,0
205679,was,0,0
205680,evaluated,0,0
205681,by,0,0
205682,the,0,0
205683,degree,0,0
205684,of,0,0
205685,early,0,0
205686,revascularization,0,1
205687,(,0,0
205688,pulmonary,0,1
205689,angiograms,0,0
205690,were,0,0
205691,performed,0,0
205692,30,0,0
205693,to,0,0
205694,48,0,1
205695,hours,0,0
205696,after,0,0
205697,initiation,0,0
205698,of,0,0
205699,thrombolytic,0,0
205700,treatment,0,0
205701,and,0,0
205702,analysed,0,0
205703,blindly,0,0
205704,by,0,0
205705,four,0,0
205706,independent,0,0
205707,vascular,0,0
205708,radiologists,0,1
205709,),0,1
205710,.,0,1
205711,133,1,0
205712,patients,1,1
205713,were,0,0
205714,included,0,1
205715,in,0,0
205716,this,0,0
205717,trial,0,0
205718,:,0,1
205719,two,1,0
205720,patients,1,1
205721,died,1,1
205722,before,1,0
205723,treatment,1,0
205724,and,1,0
205725,two,1,0
205726,were,1,0
205727,excluded,1,0
205728,retrospectively,1,0
205729,",",1,0
205730,leaving,1,0
205731,129,1,1
205732,patients,1,1
205733,for,1,0
205734,final,1,0
205735,analysis,1,0
205736,(,0,0
205737,67,0,1
205738,:,0,1
205739,UK,0,1
205740,2000,0,1
205741,+,0,0
205742,heparin,0,0
205743,;,0,0
205744,62,0,1
205745,:,0,1
205746,UK,0,1
205747,4400,0,0
205748,),0,0
205749,.,0,0
205750,The,0,0
205751,two,0,0
205752,groups,0,0
205753,had,0,1
205754,similar,0,0
205755,pretreatment,0,0
205756,clinical,0,0
205757,",",0,0
205758,haemodynamic,0,0
205759,and,0,0
205760,angiographic,0,0
205761,characteristics,0,0
205762,:,0,1
205763,the,0,0
205764,Miller,0,0
205765,angiographic,0,0
205766,index,0,0
205767,of,0,0
205768,severity,0,0
205769,averaged,0,0
205770,22.6,0,0
205771,+/-,0,0
205772,3.7,0,0
205773,for,0,0
205774,patients,0,1
205775,in,0,0
205776,the,0,0
205777,UK,0,1
205778,2000,0,0
205779,group,0,0
205780,",",0,0
205781,and,0,0
205782,22.6,0,0
205783,+/-,0,0
205784,3.4,0,0
205785,for,0,0
205786,patients,0,1
205787,in,0,0
205788,the,0,0
205789,UK,0,1
205790,4400,0,0
205791,group,0,0
205792,(,0,0
205793,average,0,0
205794,filling,0,0
205795,defect,0,1
205796,of,0,0
205797,66,0,0
205798,%,0,0
205799,on,0,0
205800,pulmonary,0,1
205801,angiograms,0,0
205802,),0,0
205803,.,0,0
205804,There,0,0
205805,was,0,0
205806,a,0,0
205807,similar,0,0
205808,and,0,0
205809,significant,0,0
205810,degree,0,0
205811,of,0,0
205812,resolution,0,0
205813,in,0,0
205814,the,0,0
205815,two,0,0
205816,groups,0,0
205817,:,0,1
205818,26,0,1
205819,%,0,0
205820,and,0,0
205821,20,0,0
205822,%,0,0
205823,",",0,0
205824,respectively,0,0
205825,.,0,0
205826,Minor,0,0
205827,and,0,0
205828,major,0,0
205829,bleeding,0,0
205830,problems,0,1
205831,were,0,0
205832,observed,0,0
205833,with,0,1
205834,equal,0,0
205835,frequency,0,0
205836,in,0,0
205837,the,0,0
205838,two,1,0
205839,groups,1,0
205840,(,0,0
205841,24,0,0
205842,%,0,0
205843,and,0,0
205844,29,0,0
205845,%,0,0
205846,",",0,0
205847,respectively,0,0
205848,),0,0
205849,.,0,0
205850,These,0,0
205851,bleeding,0,0
205852,complications,0,0
205853,were,0,0
205854,severe,0,1
205855,in,0,0
205856,only,0,0
205857,4.5,0,0
205858,%,0,0
205859,and,0,0
205860,3,0,0
205861,%,0,0
205862,",",0,0
205863,respectively,0,0
205864,.,0,0
205865,(,0,0
205866,ABSTRACT,0,0
205867,TRUNCATED,0,0
205868,AT,0,0
205869,250,0,0
205870,WORDS,0,0
205871,),0,0
205872,Comparison,0,0
205873,of,0,0
205874,inhaled,0,0
205875,albuterol,0,0
205876,powder,0,0
205877,and,0,0
205878,aerosol,0,0
205879,in,0,0
205880,asthma,1,1
205881,.,1,0
205882,In,0,0
205883,this,0,0
205884,multicenter,0,0
205885,",",0,0
205886,randomized,0,0
205887,",",0,0
205888,double-blind,0,0
205889,study,0,0
205890,comparing,0,0
205891,the,0,0
205892,efficacy,0,0
205893,and,0,0
205894,safety,0,0
205895,of,0,0
205896,aerosolized,0,0
205897,albuterol,0,0
205898,with,0,1
205899,the,0,0
205900,dry,0,0
205901,powder,0,0
205902,formulation,0,0
205903,",",0,0
205904,231,1,1
205905,patients,1,1
205906,with,1,1
205907,chronic,1,1
205908,reversible,1,0
205909,obstructive,1,1
205910,airway,1,0
205911,disease,1,1
205912,were,0,0
205913,randomly,0,0
205914,allocated,0,0
205915,to,0,0
205916,receive,0,0
205917,either,0,0
205918,placebo,0,0
205919,albuterol,0,0
205920,aerosol,0,0
205921,followed,0,0
205922,immediately,0,0
205923,by,0,0
205924,active,0,0
205925,albuterol,0,0
205926,powder,0,0
205927,(,0,0
205928,200,0,0
205929,micrograms,0,0
205930,),0,0
205931,or,0,0
205932,active,0,0
205933,albuterol,0,0
205934,aerosol,0,0
205935,(,0,0
205936,two,0,0
205937,puffs,0,0
205938,",",0,0
205939,180,0,1
205940,micrograms,0,0
205941,),0,0
205942,followed,0,0
205943,immediately,0,0
205944,by,0,0
205945,placebo,0,0
205946,lactose,0,0
205947,powder,0,0
205948,four,0,0
205949,times,0,0
205950,a,0,0
205951,day,0,0
205952,for,0,0
205953,a,0,0
205954,period,0,0
205955,of,0,0
205956,12,0,0
205957,weeks,0,0
205958,.,0,0
205959,No,0,0
205960,statistically,0,0
205961,significant,0,0
205962,differences,0,0
205963,were,0,0
205964,found,0,0
205965,between,0,0
205966,the,0,0
205967,powder,0,0
205968,and,0,0
205969,aerosol,0,0
205970,formulations,0,0
205971,with,0,1
205972,respect,0,0
205973,to,0,0
205974,pulmonary,0,0
205975,function,0,0
205976,",",0,0
205977,length,0,0
205978,of,0,0
205979,time,0,0
205980,mean,0,1
205981,FEV1,0,0
205982,remained,0,0
205983,greater,0,0
205984,than,0,0
205985,or,0,0
205986,equal,0,0
205987,to,0,0
205988,15,0,0
205989,%,0,0
205990,above,0,0
205991,baseline,0,0
205992,",",0,0
205993,physicians,0,1
205994,',0,1
205995,assessments,0,0
205996,of,0,1
205997,patients,0,1
205998,',0,1
205999,clinical,0,0
206000,response,0,0
206001,",",0,0
206002,or,0,0
206003,patients,0,1
206004,',0,1
206005,subjective,0,0
206006,symptom,0,1
206007,scores,0,0
206008,.,0,0
206009,There,0,0
206010,were,0,0
206011,also,0,0
206012,no,0,0
206013,significant,0,0
206014,differences,0,0
206015,between,0,0
206016,treatment,0,0
206017,groups,0,0
206018,in,0,0
206019,cardiovascular,0,1
206020,effects,0,0
206021,",",0,0
206022,laboratory,0,0
206023,values,0,0
206024,",",0,0
206025,or,0,1
206026,adverse,0,0
206027,events,0,0
206028,.,0,1
206029,Among,0,1
206030,patients,0,1
206031,who,0,1
206032,expressed,0,0
206033,a,0,1
206034,preference,0,0
206035,for,0,0
206036,one,0,0
206037,of,0,0
206038,the,0,0
206039,delivery,0,0
206040,systems,0,0
206041,",",0,0
206042,half,1,0
206043,preferred,1,0
206044,using,1,0
206045,the,1,0
206046,powder,1,0
206047,.,1,0
206048,Results,0,0
206049,of,0,0
206050,this,0,0
206051,study,0,0
206052,demonstrate,0,0
206053,that,0,0
206054,200,0,0
206055,micrograms,0,0
206056,of,0,0
206057,albuterol,0,0
206058,powder,0,0
206059,is,0,0
206060,as,0,0
206061,safe,0,0
206062,and,0,0
206063,effective,0,0
206064,as,0,0
206065,180,0,1
206066,micrograms,0,0
206067,of,0,0
206068,albuterol,0,0
206069,aerosol,0,0
206070,.,0,0
206071,Fasting,0,0
206072,and,0,0
206073,meal-stimulated,0,0
206074,plasma,0,0
206075,levels,0,0
206076,of,0,0
206077,neurotensin,0,0
206078,in,0,0
206079,obese,1,1
206080,patients,1,1
206081,after,1,0
206082,jejunoileal,1,1
206083,bypass,1,1
206084,with,1,1
206085,3:1,1,1
206086,or,1,1
206087,1:3,1,0
206088,jejunoileal,1,1
206089,ratio,1,0
206090,.,1,0
206091,The,0,0
206092,functional,0,0
206093,role,0,0
206094,of,0,0
206095,the,0,0
206096,jejunum,0,0
206097,and,0,0
206098,ileum,0,0
206099,with,0,0
206100,regard,0,0
206101,to,0,0
206102,peripheral,0,0
206103,plasma,0,0
206104,levels,0,0
206105,of,0,0
206106,intact,0,0
206107,neurotensin,0,0
206108,and,0,0
206109,NH2-terminal,0,0
206110,immunoreactivity,0,0
206111,of,0,0
206112,neurotensin,0,0
206113,was,0,0
206114,studied,0,0
206115,by,0,0
206116,using,0,0
206117,jejunoileal,0,1
206118,bypass,0,1
206119,as,0,0
206120,a,0,0
206121,model,0,0
206122,.,0,0
206123,Plasma,0,0
206124,levels,0,0
206125,were,0,0
206126,measured,0,0
206127,by,0,0
206128,radioimmunoassay,0,0
206129,before,0,0
206130,and,0,0
206131,after,0,0
206132,jejunoileal,0,1
206133,bypass,0,1
206134,randomized,0,0
206135,to,0,0
206136,different,0,0
206137,jejunoileal,0,1
206138,ratios,0,0
206139,.,0,1
206140,Seven,1,0
206141,patients,1,1
206142,were,1,0
206143,studied,1,1
206144,before,1,0
206145,bypass,1,1
206146,surgery,1,1
206147,and,1,0
206148,28,1,0
206149,were,1,0
206150,examined,1,0
206151,after,1,0
206152,end-to-side,1,0
206153,jejunoileal,1,1
206154,bypass,1,1
206155,with,1,1
206156,50,1,0
206157,cm,1,1
206158,intestine,1,1
206159,in,1,0
206160,continuity,1,0
206161,and,1,0
206162,a,1,0
206163,3:1,1,0
206164,or,1,0
206165,1:3,1,0
206166,ratio,1,0
206167,between,1,0
206168,the,1,0
206169,length,1,0
206170,of,1,0
206171,the,1,0
206172,jejunal,1,0
206173,and,1,0
206174,ileal,1,1
206175,segments,1,0
206176,.,1,1
206177,Fasting,0,0
206178,levels,0,0
206179,of,0,0
206180,intact,0,1
206181,neurotensin,0,0
206182,were,0,0
206183,unchanged,0,0
206184,by,0,0
206185,surgery,0,1
206186,",",0,0
206187,whereas,0,0
206188,levels,0,0
206189,of,0,0
206190,NH2-terminal,0,0
206191,immunoreactivity,0,0
206192,were,0,0
206193,higher,0,0
206194,in,0,0
206195,bypass,0,1
206196,patients,0,1
206197,with,0,1
206198,a,0,0
206199,long,0,0
206200,ileal,0,1
206201,segment,0,0
206202,(,0,0
206203,37.5,0,0
206204,cm,0,1
206205,),0,0
206206,than,0,0
206207,in,0,0
206208,unoperated,0,1
206209,patients,0,1
206210,and,0,0
206211,in,0,0
206212,those,0,0
206213,with,0,0
206214,a,0,0
206215,short,0,0
206216,ileal,0,1
206217,segment,0,0
206218,(,0,0
206219,12.5,0,0
206220,cm,0,1
206221,),0,0
206222,.,0,0
206223,Meal-stimulated,0,0
206224,levels,0,0
206225,of,0,0
206226,intact,0,1
206227,neurotensin,0,0
206228,were,0,0
206229,higher,0,0
206230,after,0,0
206231,1:3,0,0
206232,than,0,0
206233,3:1,0,1
206234,jejunoileal,0,1
206235,bypass,0,1
206236,.,0,0
206237,The,0,0
206238,levels,0,0
206239,of,0,0
206240,NH2-terminal,0,0
206241,immunoreactivity,0,0
206242,in,0,0
206243,patients,0,1
206244,with,0,1
206245,a,0,0
206246,short,0,0
206247,ileal,0,1
206248,segment,0,0
206249,and,0,0
206250,in,0,0
206251,controls,0,0
206252,were,0,0
206253,lower,0,0
206254,than,0,0
206255,in,0,0
206256,patients,0,1
206257,with,0,1
206258,a,0,0
206259,long,0,0
206260,ileal,0,1
206261,segment,0,0
206262,.,0,0
206263,The,0,0
206264,results,0,0
206265,show,0,0
206266,that,0,0
206267,postprandial,0,0
206268,levels,0,0
206269,of,0,0
206270,both,0,0
206271,intact,0,0
206272,neurotensin,0,0
206273,and,0,0
206274,NH2-terminal,0,0
206275,immunoreactivity,0,0
206276,are,0,0
206277,related,0,0
206278,to,0,0
206279,the,0,0
206280,length,0,0
206281,of,0,0
206282,the,0,0
206283,functioning,0,0
206284,ileum,0,0
206285,and,0,0
206286,that,0,0
206287,even,0,0
206288,a,0,0
206289,difference,0,0
206290,in,0,0
206291,length,0,0
206292,of,0,0
206293,25,0,0
206294,cm,0,1
206295,is,0,0
206296,reflected,0,0
206297,in,0,0
206298,the,0,0
206299,circulating,0,0
206300,levels,0,0
206301,of,0,0
206302,neurotensin,0,0
206303,.,0,0
206304,Antifibrinolytic,0,0
206305,therapy,0,0
206306,for,0,0
206307,prevention,0,0
206308,of,0,0
206309,hemorrhage,0,0
206310,during,0,0
206311,surgery,1,1
206312,of,1,0
206313,the,1,0
206314,thyroid,1,1
206315,gland,1,0
206316,.,1,0
206317,The,0,0
206318,amount,0,0
206319,of,0,0
206320,fibrinolytic,0,0
206321,activity,0,0
206322,in,0,0
206323,the,0,0
206324,thyroid,0,1
206325,gland,0,0
206326,equals,0,0
206327,that,0,0
206328,of,0,0
206329,the,0,0
206330,prostate,0,1
206331,.,0,0
206332,In,0,0
206333,order,0,0
206334,to,0,0
206335,examine,0,0
206336,the,0,0
206337,effect,0,0
206338,of,0,0
206339,the,0,0
206340,antifibrinolytic,0,0
206341,drug,0,0
206342,tranexemic,0,1
206343,acid,0,0
206344,on,0,0
206345,perioperative,0,0
206346,bleeding,0,0
206347,saline,0,0
206348,or,0,0
206349,tranexemic,0,0
206350,acid,0,0
206351,were,0,0
206352,given,0,0
206353,randomized,0,0
206354,double,0,0
206355,blind,0,0
206356,to,0,0
206357,76,1,1
206358,consecutive,1,1
206359,patients,1,1
206360,who,1,1
206361,came,1,1
206362,for,1,1
206363,scheduled,1,1
206364,thyroid,1,1
206365,surgery,1,1
206366,.,1,0
206367,No,0,0
206368,significant,0,0
206369,differences,0,0
206370,were,0,0
206371,found,0,0
206372,in,0,0
206373,perioperative,0,0
206374,bleeding,0,0
206375,between,0,0
206376,patients,1,1
206377,in,1,0
206378,the,1,0
206379,treatment,1,0
206380,group,1,0
206381,(,1,0
206382,n,1,1
206383,=,1,0
206384,39,1,1
206385,),1,0
206386,and,1,0
206387,control,1,0
206388,group,1,0
206389,(,1,0
206390,n,1,1
206391,=,1,0
206392,37,1,1
206393,),1,0
206394,.,0,0
206395,Abstinence,1,0
206396,or,1,0
206397,controlled,1,0
206398,drinking,1,0
206399,in,0,0
206400,clinical,0,0
206401,practice,0,0
206402,:,0,1
206403,indications,0,0
206404,at,0,0
206405,initial,0,0
206406,assessment,0,0
206407,.,0,0
206408,Previous,0,0
206409,research,0,0
206410,has,0,0
206411,suggested,0,0
206412,two,0,0
206413,leading,0,0
206414,hypotheses,0,0
206415,concerning,0,0
206416,which,0,0
206417,excessive,1,0
206418,drinkers,1,1
206419,can,0,0
206420,re-establish,0,0
206421,control,0,0
206422,:,0,1
206423,one,0,0
206424,based,0,0
206425,upon,0,0
206426,level,0,0
206427,of,0,0
206428,dependence,0,0
206429,",",0,0
206430,the,0,0
206431,other,0,0
206432,upon,0,0
206433,the,0,0
206434,client,0,0
206435,'s,0,0
206436,personal,0,1
206437,persuasion,0,0
206438,.,0,0
206439,Using,0,0
206440,initial,0,0
206441,assessment,0,0
206442,data,0,0
206443,from,0,1
206444,46,1,1
206445,clients,1,1
206446,of,1,0
206447,a,1,0
206448,clinical,1,0
206449,psychology,1,1
206450,alcohol,1,1
206451,problems,1,1
206452,service,1,1
206453,(,1,0
206454,30,1,0
206455,men,1,1
206456,",",1,0
206457,16,1,1
206458,women,1,1
206459,),1,0
206460,",",0,0
206461,an,0,0
206462,attempt,0,0
206463,was,0,0
206464,made,0,0
206465,to,0,0
206466,operationalize,0,0
206467,the,0,0
206468,concepts,0,0
206469,of,0,0
206470,dependence,0,0
206471,and,0,0
206472,personal,0,0
206473,persuasion,0,0
206474,using,0,0
206475,a,0,0
206476,variety,0,0
206477,of,0,0
206478,indicators,0,0
206479,of,0,0
206480,each,0,0
206481,.,0,0
206482,Although,0,0
206483,SADQ,0,0
206484,scores,0,0
206485,and,0,0
206486,Rand,0,1
206487,definite,0,0
206488,alcoholism,0,1
206489,were,0,0
206490,in,0,0
206491,general,0,1
206492,agreement,0,0
206493,",",0,0
206494,there,0,0
206495,were,0,0
206496,a,0,0
206497,number,0,0
206498,of,0,0
206499,borderline,0,1
206500,instances,0,0
206501,and,0,0
206502,cases,0,1
206503,of,0,0
206504,disagreement,0,0
206505,",",0,0
206506,and,0,0
206507,neither,0,0
206508,was,0,0
206509,in,0,0
206510,good,0,0
206511,agreement,0,0
206512,with,0,1
206513,estimates,0,0
206514,of,0,0
206515,problem,0,0
206516,duration,0,0
206517,",",0,0
206518,nor,0,0
206519,with,0,0
206520,reports,0,0
206521,of,0,0
206522,recent,0,0
206523,or,0,0
206524,earlier,0,0
206525,attainment,0,0
206526,of,0,0
206527,abstinence,0,0
206528,or,0,0
206529,control,0,0
206530,.,0,0
206531,Indicators,0,0
206532,of,0,0
206533,personal,0,1
206534,persuasion,0,0
206535,were,0,0
206536,more,0,0
206537,consistent,0,0
206538,.,0,0
206539,Those,1,0
206540,with,1,0
206541,dependence,1,0
206542,indicators,1,0
206543,for,1,0
206544,abstinence,1,0
206545,tended,0,0
206546,to,0,0
206547,prefer,0,0
206548,abstinence,0,0
206549,as,0,0
206550,a,0,0
206551,goal,0,0
206552,",",0,0
206553,but,0,0
206554,there,0,0
206555,were,0,0
206556,many,0,0
206557,departures,0,0
206558,from,0,0
206559,this,0,0
206560,pattern,0,0
206561,particularly,0,0
206562,for,0,0
206563,women,0,1
206564,.,0,0
206565,It,0,0
206566,is,0,0
206567,concluded,0,0
206568,that,0,0
206569,in,0,0
206570,clinical,0,0
206571,practice,0,0
206572,it,0,0
206573,will,0,0
206574,be,0,0
206575,very,0,0
206576,difficult,0,0
206577,to,0,0
206578,make,0,0
206579,a,0,0
206580,clear,0,0
206581,cut,0,0
206582,recommendation,0,0
206583,about,0,0
206584,treatment,0,0
206585,goal,0,0
206586,at,0,0
206587,initial,0,0
206588,assessment,0,0
206589,except,0,0
206590,in,0,0
206591,a,0,0
206592,few,0,0
206593,cases,0,0
206594,.,0,1
206595,Evaluation,0,0
206596,of,0,0
206597,three,0,0
206598,dosage-prediction,0,0
206599,methods,0,1
206600,for,0,0
206601,initial,0,0
206602,in-hospital,0,0
206603,stabilization,0,0
206604,of,0,0
206605,warfarin,0,0
206606,therapy,0,0
206607,.,0,0
206608,Three,0,0
206609,dosage-prediction,0,0
206610,methods,0,1
206611,for,0,0
206612,initial,0,0
206613,in-hospital,0,0
206614,stabilization,0,0
206615,of,0,0
206616,warfarin,0,0
206617,therapy,0,0
206618,were,0,0
206619,evaluated,0,0
206620,.,0,0
206621,Adult,1,1
206622,inpatients,1,1
206623,who,1,1
206624,had,1,1
206625,received,1,1
206626,warfarin,1,0
206627,sodium,1,0
206628,10,1,0
206629,mg,1,0
206630,daily,1,0
206631,for,1,0
206632,less,1,0
206633,than,1,0
206634,three,1,0
206635,days,1,0
206636,were,1,0
206637,eligible,1,1
206638,for,1,0
206639,the,1,0
206640,study,1,0
206641,.,1,0
206642,After,0,0
206643,receiving,0,0
206644,their,0,0
206645,third,0,0
206646,warfarin,0,0
206647,dose,0,0
206648,",",0,0
206649,patients,0,1
206650,were,0,0
206651,randomly,0,1
206652,assigned,0,0
206653,to,0,0
206654,have,0,0
206655,their,0,0
206656,warfarin,0,0
206657,dosages,0,0
206658,adjusted,0,0
206659,using,0,0
206660,one,0,0
206661,of,0,0
206662,three,0,0
206663,dosage-prediction,0,0
206664,methods,0,1
206665,:,0,1
206666,by,0,0
206667,analog,0,0
206668,computer,0,0
206669,(,0,0
206670,n,0,1
206671,=,0,0
206672,31,0,1
206673,),0,0
206674,",",0,0
206675,linear,0,0
206676,regression,0,0
206677,(,0,0
206678,n,0,1
206679,=,0,0
206680,22,0,1
206681,),0,0
206682,",",0,0
206683,or,0,0
206684,empiric,0,0
206685,dosing,0,0
206686,by,0,0
206687,the,0,0
206688,physician,0,0
206689,(,0,0
206690,n,0,1
206691,=,0,0
206692,34,0,1
206693,),0,0
206694,.,0,0
206695,A,0,0
206696,prothrombin,0,0
206697,time,0,0
206698,(,0,0
206699,PT,0,0
206700,),0,0
206701,ratio,0,0
206702,(,0,0
206703,patient,0,0
206704,PT,0,0
206705,divided,0,0
206706,by,0,0
206707,control,0,0
206708,PT,0,0
206709,),0,0
206710,between,0,0
206711,1.3,0,0
206712,and,0,0
206713,2.5,0,0
206714,was,0,0
206715,considered,0,0
206716,to,0,0
206717,be,0,0
206718,in,0,0
206719,the,0,0
206720,therapeutic,0,0
206721,range,0,0
206722,.,0,0
206723,For,0,0
206724,patients,0,1
206725,who,0,1
206726,achieved,0,1
206727,a,0,1
206728,stable,0,1
206729,PT,0,0
206730,ratio,0,0
206731,(,0,0
206732,defined,0,0
206733,as,0,0
206734,a,0,0
206735,PT,0,0
206736,ratio,0,0
206737,between,0,0
206738,1.3,0,0
206739,and,0,0
206740,2.5,0,0
206741,that,0,0
206742,varied,0,0
206743,by,0,0
206744,less,0,0
206745,than,0,0
206746,0.05,0,0
206747,on,0,0
206748,two,0,0
206749,consecutive,0,1
206750,days,0,0
206751,or,0,1
206752,by,0,0
206753,less,0,0
206754,than,0,0
206755,0.1,0,0
206756,on,0,0
206757,three,0,0
206758,consecutive,0,1
206759,days,0,0
206760,without,0,1
206761,a,0,0
206762,dosage,0,0
206763,change,0,0
206764,),0,0
206765,before,0,0
206766,discharge,0,0
206767,",",0,0
206768,the,0,0
206769,number,0,0
206770,of,0,0
206771,days,0,0
206772,(,0,0
206773,time,0,0
206774,to,0,0
206775,stabilization,0,0
206776,),0,0
206777,from,0,0
206778,administration,0,0
206779,of,0,0
206780,the,0,0
206781,first,0,0
206782,warfarin,0,0
206783,dose,0,0
206784,to,0,0
206785,achievement,0,0
206786,of,0,0
206787,the,0,0
206788,warfarin,0,0
206789,dosage,0,0
206790,that,0,0
206791,produced,0,0
206792,a,0,0
206793,stable,0,1
206794,PT,0,0
206795,ratio,0,0
206796,(,0,0
206797,stabilization,0,0
206798,dosage,0,0
206799,),0,0
206800,was,0,0
206801,compared,0,0
206802,.,0,0
206803,A,0,0
206804,total,1,0
206805,of,1,0
206806,54,1,1
206807,patients,1,1
206808,met,1,1
206809,the,1,0
206810,study,1,0
206811,criteria,1,1
206812,for,0,0
206813,a,0,0
206814,stable,0,1
206815,PT,0,0
206816,ratio,0,0
206817,before,0,0
206818,hospital,0,0
206819,discharge,0,0
206820,(,0,0
206821,analog,0,0
206822,computer,0,0
206823,",",0,0
206824,n,0,0
206825,=,0,0
206826,20,0,0
206827,;,0,0
206828,linear,0,0
206829,regression,0,0
206830,",",0,0
206831,n,0,0
206832,=,0,0
206833,15,0,0
206834,;,0,0
206835,empiric,0,0
206836,dosing,0,0
206837,",",0,0
206838,n,0,1
206839,=,0,0
206840,19,0,1
206841,),0,0
206842,.,0,0
206843,The,0,0
206844,mean,0,0
206845,times,0,0
206846,to,0,0
206847,stabilization,0,0
206848,were,0,0
206849,6.8,0,0
206850,days,0,0
206851,in,0,0
206852,the,0,0
206853,analog-computer,0,0
206854,group,0,0
206855,",",0,0
206856,7.3,0,0
206857,days,0,0
206858,in,0,0
206859,the,0,0
206860,linear-regression,0,0
206861,group,0,0
206862,",",0,0
206863,and,0,0
206864,8.4,0,0
206865,days,0,0
206866,in,0,0
206867,the,0,0
206868,empiric-dosing,0,0
206869,group,0,0
206870,;,0,0
206871,these,0,0
206872,times,0,0
206873,were,0,0
206874,not,0,0
206875,significantly,0,0
206876,different,0,0
206877,.,0,0
206878,All,0,0
206879,20,0,0
206880,stabilized,0,0
206881,patients,0,1
206882,in,0,0
206883,the,0,0
206884,analog-computer,0,0
206885,group,0,0
206886,achieved,0,0
206887,a,0,0
206888,stable,0,1
206889,PT,0,0
206890,ratio,0,0
206891,by,0,0
206892,the,0,0
206893,fourth,0,0
206894,dosage,0,0
206895,prediction,0,0
206896,.,0,0
206897,(,0,0
206898,ABSTRACT,0,0
206899,TRUNCATED,0,0
206900,AT,0,0
206901,250,0,0
206902,WORDS,0,0
206903,),0,0
206904,Comparison,0,0
206905,of,0,0
206906,maintenance,0,0
206907,treatment,0,0
206908,regimens,0,0
206909,for,0,0
206910,first,0,0
206911,central,1,0
206912,nervous,1,0
206913,system,1,0
206914,relapse,1,0
206915,in,1,0
206916,children,1,1
206917,with,1,1
206918,acute,1,1
206919,lymphocytic,1,1
206920,leukemia,1,1
206921,.,1,0
206922,A,0,0
206923,Pediatric,0,1
206924,Oncology,0,0
206925,Group,0,1
206926,study,0,0
206927,.,0,0
206928,Eighty-seven,1,1
206929,children,1,1
206930,with,1,1
206931,central,1,0
206932,nervous,1,0
206933,system,1,0
206934,(,1,0
206935,CNS,1,0
206936,),1,0
206937,leukemia,1,1
206938,were,0,0
206939,randomized,0,0
206940,to,0,0
206941,receive,0,0
206942,either,0,0
206943,induction,0,0
206944,intrathecal,0,0
206945,chemotherapy,0,0
206946,(,0,0
206947,ITC,0,0
206948,),0,0
206949,and,0,0
206950,cranial,0,0
206951,irradiation,0,0
206952,(,0,0
206953,CRT,0,0
206954,),0,0
206955,plus,0,0
206956,maintenance,0,0
206957,ITC,0,0
206958,",",0,0
206959,or,0,0
206960,induction,0,0
206961,ITC,0,0
206962,and,0,0
206963,craniospinal,0,0
206964,irradiation,0,0
206965,(,0,0
206966,CSpRT,0,0
206967,),0,0
206968,with,0,0
206969,no,0,0
206970,maintenance,0,0
206971,ITC,0,0
206972,.,0,0
206973,ITC,0,0
206974,consisted,0,0
206975,of,0,0
206976,six,0,1
206977,weekly,0,0
206978,injections,0,0
206979,of,0,0
206980,methotrexate,0,0
206981,",",0,0
206982,hydrocortisone,0,0
206983,",",0,0
206984,and,0,0
206985,arabinosylcytosine,0,0
206986,.,0,0
206987,Also,0,0
206988,",",0,0
206989,intensification,0,0
206990,of,0,0
206991,systemic,0,0
206992,induction,0,0
206993,and,0,0
206994,maintenance,0,0
206995,chemotherapy,0,0
206996,was,0,0
206997,given,0,0
206998,.,0,0
206999,CRT,0,0
207000,+,0,0
207001,ITC,0,0
207002,was,0,0
207003,given,0,0
207004,as,0,0
207005,CRT,0,0
207006,",",0,0
207007,2400,0,0
207008,rad,0,0
207009,in,0,0
207010,12,0,0
207011,fractions,0,0
207012,followed,0,0
207013,by,0,0
207014,ITC,0,0
207015,maintenance,0,0
207016,bimonthly,0,0
207017,for,0,0
207018,2,0,0
207019,years,0,1
207020,.,0,1
207021,Craniospinal,0,0
207022,irradiation,0,0
207023,consisted,0,0
207024,of,0,0
207025,CRT,0,1
207026,+,0,0
207027,1400,0,0
207028,rad,0,0
207029,in,0,0
207030,ten,0,1
207031,fractions,0,0
207032,to,0,0
207033,the,0,0
207034,spine,0,0
207035,.,0,0
207036,Randomization,0,0
207037,was,0,0
207038,stratified,0,0
207039,according,0,0
207040,to,0,0
207041,whether,0,0
207042,CNS,0,0
207043,leukemia,0,1
207044,occurred,0,0
207045,at,0,0
207046,initial,0,0
207047,diagnosis,0,1
207048,of,0,0
207049,acute,0,1
207050,lymphocytic,0,1
207051,leukemia,0,1
207052,(,0,0
207053,ALL,0,0
207054,),0,0
207055,(,0,0
207056,Stratum,0,0
207057,I,0,0
207058,",",0,0
207059,15,0,0
207060,patients,0,1
207061,),0,0
207062,",",0,0
207063,during,0,0
207064,first,0,0
207065,bone,0,0
207066,marrow,0,0
207067,(,0,0
207068,BM,0,0
207069,),0,0
207070,remission,0,0
207071,(,0,0
207072,Stratum,0,0
207073,II,0,0
207074,",",0,0
207075,49,0,1
207076,patients,0,1
207077,),0,0
207078,",",0,0
207079,simultaneous,0,0
207080,with,0,1
207081,first,0,0
207082,BM,0,0
207083,relapse,0,0
207084,(,0,0
207085,Stratum,0,0
207086,III,0,0
207087,",",0,0
207088,12,0,0
207089,patients,0,1
207090,),0,0
207091,",",0,0
207092,or,0,0
207093,during,0,0
207094,second,0,0
207095,BM,0,0
207096,remission,0,1
207097,(,0,0
207098,Stratum,0,0
207099,IV,0,0
207100,",",0,0
207101,11,0,1
207102,patients,0,1
207103,),0,0
207104,.,0,0
207105,The,0,0
207106,median,0,0
207107,follow-up,0,0
207108,for,0,1
207109,patients,0,1
207110,who,0,1
207111,remain,0,0
207112,at,0,1
207113,risk,0,0
207114,is,0,0
207115,15,0,0
207116,+,0,0
207117,months,0,0
207118,.,0,1
207119,Eight,0,0
207120,children,0,1
207121,(,0,0
207122,seven,0,1
207123,on,0,0
207124,CRT,0,1
207125,+,0,0
207126,ITC,0,0
207127,",",0,0
207128,one,0,0
207129,on,0,0
207130,CSpRT,0,0
207131,),0,0
207132,developed,0,0
207133,presumed,0,0
207134,therapy,0,0
207135,related,0,0
207136,encephalopathy,0,0
207137,.,0,0
207138,In,0,0
207139,Stratum,0,0
207140,II,0,0
207141,",",0,0
207142,16,0,0
207143,of,0,0
207144,29,0,1
207145,(,0,0
207146,55,0,1
207147,%,0,0
207148,),0,0
207149,patients,0,1
207150,receiving,0,1
207151,CRT,0,1
207152,+,0,0
207153,ITC,0,0
207154,experienced,0,0
207155,adverse,0,0
207156,events,0,0
207157,:,0,1
207158,3,0,0
207159,deaths,0,0
207160,during,0,0
207161,continuous,0,0
207162,complete,0,0
207163,remission,0,1
207164,(,0,0
207165,CCR,0,0
207166,),0,0
207167,and,0,0
207168,13,0,0
207169,relapses,0,0
207170,(,0,1
207171,2,0,0
207172,CNS,0,0
207173,",",0,0
207174,1,0,0
207175,CNS,0,0
207176,+,0,0
207177,BM,0,0
207178,",",0,0
207179,1,0,0
207180,BM,0,0
207181,+,0,0
207182,testes,0,1
207183,",",0,0
207184,and,0,0
207185,2,0,0
207186,testes,0,1
207187,),0,0
207188,as,0,0
207189,compared,0,0
207190,with,0,1
207191,only,0,0
207192,5,0,0
207193,relapses,0,0
207194,in,0,0
207195,20,0,1
207196,(,0,0
207197,25,0,0
207198,%,0,0
207199,),0,0
207200,patients,0,1
207201,on,0,0
207202,CSpRT,0,0
207203,(,0,0
207204,1,0,0
207205,CNS,0,0
207206,",",0,0
207207,1,0,0
207208,CNS,0,0
207209,+,0,0
207210,BM,0,0
207211,",",0,0
207212,1,0,0
207213,BM,0,0
207214,",",0,0
207215,and,0,0
207216,2,0,0
207217,testes,0,1
207218,),0,0
207219,.,0,0
207220,The,0,0
207221,children,0,1
207222,on,0,0
207223,both,0,0
207224,regimens,0,0
207225,were,0,0
207226,comparable,0,0
207227,for,0,0
207228,sex,0,0
207229,",",0,0
207230,race,0,0
207231,",",0,0
207232,age,0,1
207233,at,0,0
207234,initial,0,0
207235,ALL,0,0
207236,diagnosis,0,1
207237,",",0,0
207238,time,0,0
207239,from,0,0
207240,ALL,0,0
207241,diagnosis,0,1
207242,to,0,0
207243,first,0,0
207244,episode,0,1
207245,of,0,0
207246,CNS,0,0
207247,leukemia,0,1
207248,",",0,0
207249,systemic,0,0
207250,therapy,0,0
207251,both,0,0
207252,before,0,0
207253,and,0,0
207254,after,0,0
207255,CNS,0,0
207256,relapse,0,0
207257,",",0,0
207258,and,0,0
207259,number,0,0
207260,of,0,0
207261,blasts,0,0
207262,in,0,0
207263,the,0,0
207264,spinal,0,0
207265,fluid,0,0
207266,at,0,0
207267,diagnosis,0,1
207268,of,0,0
207269,CNS,0,0
207270,leukemia,0,1
207271,.,0,0
207272,The,0,0
207273,conclusion,0,0
207274,is,0,0
207275,that,0,0
207276,children,0,1
207277,with,0,1
207278,isolated,0,1
207279,CNS,0,0
207280,leukemia,0,1
207281,can,0,0
207282,achieve,0,0
207283,prolonged,0,0
207284,survival,0,0
207285,with,0,1
207286,aggressive,0,0
207287,therapy,0,0
207288,",",0,0
207289,and,0,0
207290,that,0,0
207291,CSpRT,0,0
207292,is,0,0
207293,possibly,0,0
207294,less,0,0
207295,toxic,0,0
207296,and,0,0
207297,more,0,0
207298,likely,0,0
207299,than,0,0
207300,is,0,0
207301,CRT,0,0
207302,+,0,0
207303,ITC,0,0
207304,to,0,0
207305,prevent,0,0
207306,subsequent,0,0
207307,BM,0,0
207308,and,0,0
207309,testicular,0,1
207310,relapse,0,0
207311,(,0,0
207312,P,0,0
207313,less,0,0
207314,than,0,0
207315,0.02,0,0
207316,),0,0
207317,",",0,0
207318,but,0,0
207319,not,0,0
207320,subsequent,0,0
207321,CNS,0,0
207322,relapse,0,0
207323,(,0,0
207324,P,0,0
207325,=,0,0
207326,0.7,0,0
207327,),0,0
207328,.,0,0
207329,A,0,0
207330,possible,0,0
207331,systemic,0,0
207332,therapy,0,0
207333,effect,0,0
207334,of,0,0
207335,spinal,0,0
207336,irradiation,0,0
207337,is,0,0
207338,postulated,0,0
207339,to,0,0
207340,explain,0,0
207341,the,0,0
207342,superiority,0,0
207343,of,0,0
207344,CSpRT,0,0
207345,.,0,1
207346,The,0,0
207347,treatment,0,0
207348,of,0,0
207349,senile,0,1
207350,dementia,0,1
207351,associated,0,0
207352,with,0,0
207353,cerebrovascular,0,1
207354,insufficiency,0,1
207355,:,0,1
207356,a,0,0
207357,comparative,0,0
207358,study,0,0
207359,of,0,0
207360,buflomedil,0,0
207361,and,0,0
207362,dihydrogenated,0,0
207363,ergot,0,0
207364,alkaloids,0,0
207365,.,0,1
207366,Seventy-six,1,1
207367,patients,1,1
207368,took,1,0
207369,part,1,0
207370,in,1,0
207371,a,1,0
207372,randomized,1,0
207373,",",1,0
207374,comparative,1,0
207375,study,1,0
207376,of,1,0
207377,the,1,0
207378,efficacy,1,0
207379,of,1,0
207380,buflomedil,1,0
207381,hydrochloride,1,0
207382,and,1,0
207383,dihydrogenated,1,0
207384,ergot,1,0
207385,alkaloids,1,0
207386,in,1,0
207387,the,1,0
207388,treatment,1,0
207389,of,1,0
207390,senile,1,1
207391,dementia,1,1
207392,associated,1,0
207393,with,1,0
207394,cerebrovascular,1,1
207395,insufficiency,1,1
207396,.,1,0
207397,Efficacy,0,0
207398,was,0,0
207399,assessed,0,0
207400,by,0,0
207401,the,0,0
207402,patients,0,1
207403,',0,0
207404,performance,0,0
207405,in,0,0
207406,four,0,0
207407,psychometric,0,0
207408,tests,0,0
207409,.,0,1
207410,The,0,0
207411,results,0,0
207412,showed,0,0
207413,that,0,0
207414,a,0,0
207415,trend,0,0
207416,in,0,0
207417,favour,0,0
207418,of,0,0
207419,the,0,0
207420,buflomedil,0,0
207421,group,0,0
207422,in,0,0
207423,three,0,0
207424,of,0,0
207425,the,0,0
207426,tests,0,0
207427,became,0,0
207428,statistically,0,0
207429,significant,0,0
207430,in,0,0
207431,the,0,0
207432,fourth,0,0
207433,.,0,0
207434,Both,0,0
207435,drugs,0,0
207436,appeared,0,0
207437,to,0,0
207438,be,0,0
207439,safe,0,0
207440,",",0,0
207441,causing,0,0
207442,no,0,0
207443,marked,0,0
207444,adverse,0,0
207445,reactions,0,0
207446,.,0,0
207447,In,0,0
207448,conclusion,0,0
207449,",",0,0
207450,buflomedil,0,0
207451,is,0,0
207452,as,0,0
207453,effective,0,0
207454,or,0,0
207455,more,0,0
207456,effective,0,0
207457,than,0,0
207458,dihydrogenated,0,0
207459,ergot,0,0
207460,alkaloids,0,0
207461,in,0,0
207462,the,0,0
207463,treatment,0,0
207464,of,0,0
207465,senile,1,1
207466,dementia,1,1
207467,associated,1,0
207468,with,1,0
207469,cerebrovascular,1,1
207470,insufficiency,1,1
207471,and,0,0
207472,could,0,0
207473,prove,0,0
207474,a,0,0
207475,valuable,0,0
207476,addition,0,0
207477,to,0,0
207478,long-term,0,0
207479,therapy,0,0
207480,if,0,0
207481,further,0,0
207482,studies,0,0
207483,support,0,0
207484,the,0,0
207485,trend,0,0
207486,shown,0,0
207487,in,0,0
207488,this,0,0
207489,study,0,0
207490,.,0,0
207491,Prophylactic,0,0
207492,lidocaine,0,0
207493,in,0,0
207494,the,0,0
207495,early,0,0
207496,phase,0,0
207497,of,0,0
207498,suspected,0,1
207499,myocardial,0,1
207500,infarction,0,1
207501,.,0,0
207502,Four,1,0
207503,hundred,1,1
207504,two,1,0
207505,patients,1,1
207506,with,1,1
207507,suspected,1,1
207508,myocardial,1,1
207509,infarction,1,1
207510,seen,1,0
207511,within,1,0
207512,6,1,0
207513,hours,1,0
207514,of,1,0
207515,the,1,0
207516,onset,1,0
207517,of,1,0
207518,symptoms,1,0
207519,entered,0,1
207520,a,0,0
207521,double-blind,0,0
207522,randomized,0,0
207523,trial,0,0
207524,of,0,0
207525,lidocaine,0,0
207526,vs,0,0
207527,placebo,0,0
207528,.,0,0
207529,During,0,0
207530,the,0,0
207531,1,0,0
207532,hour,0,0
207533,after,0,0
207534,administration,0,0
207535,of,0,0
207536,the,0,0
207537,drug,0,0
207538,the,0,0
207539,incidence,0,0
207540,of,0,0
207541,ventricular,0,0
207542,fibrillation,0,1
207543,or,0,0
207544,sustained,0,0
207545,ventricular,0,0
207546,tachycardia,0,0
207547,among,0,0
207548,the,0,0
207549,204,1,1
207550,patients,1,1
207551,with,1,1
207552,acute,1,1
207553,myocardial,1,1
207554,infarction,1,1
207555,was,0,0
207556,low,0,0
207557,",",0,0
207558,1.5,0,0
207559,%,0,0
207560,.,0,0
207561,Lidocaine,0,0
207562,",",0,0
207563,given,0,0
207564,in,0,0
207565,a,0,0
207566,300,0,0
207567,mg,0,0
207568,dose,0,0
207569,intramuscularly,0,0
207570,followed,0,0
207571,by,0,0
207572,100,0,0
207573,mg,0,0
207574,intravenously,0,0
207575,",",0,0
207576,did,0,0
207577,not,0,0
207578,prevent,0,0
207579,sustained,0,0
207580,ventricular,0,0
207581,tachycardia,0,0
207582,",",0,0
207583,although,0,0
207584,there,0,0
207585,was,0,0
207586,a,0,0
207587,significant,0,0
207588,reduction,0,0
207589,in,0,0
207590,the,0,0
207591,number,0,0
207592,of,0,0
207593,patients,0,1
207594,with,0,1
207595,warning,0,0
207596,arrhythmias,0,1
207597,between,0,0
207598,15,0,1
207599,and,0,0
207600,45,0,1
207601,minutes,0,0
207602,after,0,0
207603,the,0,0
207604,administration,0,0
207605,of,0,0
207606,lidocaine,0,0
207607,(,0,0
207608,p,0,0
207609,less,0,0
207610,than,0,0
207611,0.05,0,0
207612,),0,0
207613,.,0,0
207614,The,0,0
207615,average,0,0
207616,plasma,0,0
207617,lidocaine,0,0
207618,level,0,0
207619,10,0,1
207620,minutes,0,0
207621,after,0,0
207622,administration,0,0
207623,for,0,0
207624,patients,0,1
207625,without,0,1
207626,a,0,0
207627,myocardial,0,0
207628,infarction,0,0
207629,was,0,0
207630,significantly,0,0
207631,higher,0,0
207632,than,0,0
207633,that,0,0
207634,for,0,0
207635,patients,0,1
207636,with,0,1
207637,an,0,0
207638,acute,0,1
207639,infarction,0,0
207640,.,0,0
207641,The,0,0
207642,mean,0,0
207643,plasma,0,0
207644,lidocaine,0,0
207645,level,0,0
207646,of,0,0
207647,patients,0,1
207648,on,0,0
207649,beta-blocking,0,0
207650,agents,0,0
207651,was,0,0
207652,no,0,0
207653,different,0,0
207654,from,0,0
207655,that,0,0
207656,in,0,0
207657,patients,0,1
207658,not,0,0
207659,on,0,0
207660,beta,0,0
207661,blocking,0,0
207662,agents,0,0
207663,.,0,0
207664,During,0,0
207665,the,0,0
207666,1-hour,0,0
207667,study,0,0
207668,period,0,0
207669,",",0,0
207670,the,0,0
207671,incidence,0,0
207672,of,0,0
207673,central,0,0
207674,nervous,0,0
207675,system,0,0
207676,side,0,0
207677,effects,0,0
207678,was,0,0
207679,significantly,0,0
207680,greater,0,0
207681,in,0,0
207682,the,0,0
207683,lidocaine,0,0
207684,group,0,0
207685,",",0,0
207686,hypotension,0,0
207687,occurred,0,0
207688,in,0,0
207689,11,0,1
207690,patients,0,1
207691,",",0,0
207692,nine,0,1
207693,of,0,0
207694,whom,0,1
207695,had,0,1
207696,received,0,1
207697,lidocaine,0,0
207698,",",0,0
207699,and,0,0
207700,four,1,0
207701,patients,1,1
207702,died,0,1
207703,from,0,0
207704,asystole,0,1
207705,",",0,0
207706,three,0,0
207707,of,0,0
207708,whom,0,1
207709,had,0,1
207710,had,0,1
207711,lidocaine,0,0
207712,.,0,0
207713,We,0,0
207714,can,0,0
207715,not,0,0
207716,advocate,0,0
207717,the,0,0
207718,administration,0,0
207719,of,0,0
207720,lidocaine,0,0
207721,prophylactically,0,0
207722,in,0,0
207723,the,0,0
207724,early,0,0
207725,hours,0,0
207726,of,0,0
207727,suspected,0,1
207728,myocardial,0,1
207729,infarction,0,1
207730,.,0,0
207731,Relief,0,0
207732,of,0,0
207733,pain,0,0
207734,by,0,0
207735,infusion,0,0
207736,of,0,0
207737,morphine,0,0
207738,after,0,0
207739,operation,0,0
207740,:,0,0
207741,does,0,0
207742,tolerance,0,0
207743,develop,0,0
207744,?,0,0
207745,To,0,0
207746,see,0,0
207747,whether,0,0
207748,continuous,0,0
207749,intravenous,0,0
207750,infusion,0,0
207751,of,0,0
207752,opiates,0,0
207753,provides,0,0
207754,more,0,0
207755,effective,0,0
207756,postoperative,0,0
207757,relief,0,0
207758,of,0,0
207759,pain,0,0
207760,than,0,0
207761,conventional,0,0
207762,intramuscular,0,0
207763,injection,0,0
207764,these,0,0
207765,regimens,0,0
207766,were,0,0
207767,compared,0,0
207768,in,0,0
207769,a,0,0
207770,prospective,0,0
207771,double,0,0
207772,blind,0,0
207773,trial,0,0
207774,.,0,0
207775,Thirty,1,1
207776,patients,1,1
207777,undergoing,1,1
207778,elective,1,1
207779,cholecystectomy,1,1
207780,were,1,0
207781,allocated,1,0
207782,randomly,0,0
207783,to,0,0
207784,receive,0,0
207785,an,0,0
207786,infusion,0,0
207787,of,0,0
207788,morphine,0,0
207789,or,0,0
207790,an,0,0
207791,infusion,0,0
207792,of,0,0
207793,placebo,0,0
207794,(,0,0
207795,control,0,0
207796,group,0,0
207797,),0,0
207798,for,0,0
207799,24,0,0
207800,hours,0,0
207801,.,0,1
207802,Both,0,0
207803,groups,0,0
207804,were,0,0
207805,allowed,0,0
207806,supplementary,0,0
207807,morphine,0,0
207808,boluses,0,0
207809,as,0,0
207810,requested,0,0
207811,.,0,0
207812,During,0,0
207813,the,0,0
207814,first,0,0
207815,48,0,0
207816,hours,0,0
207817,after,0,0
207818,operation,0,0
207819,the,0,0
207820,degree,0,0
207821,of,0,0
207822,pain,0,0
207823,was,0,0
207824,almost,0,0
207825,identical,0,0
207826,between,0,0
207827,the,0,0
207828,groups,0,0
207829,.,0,0
207830,Surprisingly,0,0
207831,",",0,0
207832,the,0,0
207833,group,0,0
207834,that,0,0
207835,was,0,0
207836,given,0,0
207837,the,0,0
207838,infusion,0,0
207839,of,0,0
207840,morphine,0,0
207841,received,0,0
207842,as,0,0
207843,much,0,0
207844,supplementary,0,0
207845,morphine,0,0
207846,as,0,0
207847,the,0,0
207848,control,0,0
207849,group,0,0
207850,during,0,0
207851,the,0,0
207852,first,0,0
207853,24,0,0
207854,hours,0,0
207855,and,0,0
207856,appreciably,0,0
207857,more,0,0
207858,during,0,0
207859,the,0,0
207860,24,0,0
207861,hours,0,0
207862,after,0,0
207863,the,0,0
207864,infusion,0,0
207865,had,0,0
207866,been,0,0
207867,withdrawn,0,0
207868,.,0,0
207869,Nausea,0,0
207870,and,0,0
207871,vomiting,0,0
207872,were,0,0
207873,more,0,0
207874,prevalent,0,0
207875,among,0,0
207876,the,0,0
207877,patients,0,1
207878,given,0,0
207879,the,0,0
207880,infusion,0,0
207881,of,0,0
207882,morphine,0,0
207883,.,0,0
207884,These,0,0
207885,results,0,0
207886,suggest,0,0
207887,that,0,0
207888,continuous,0,0
207889,infusion,0,0
207890,of,0,0
207891,morphine,0,0
207892,may,0,0
207893,be,0,0
207894,an,0,0
207895,inferior,0,0
207896,regimen,0,0
207897,to,0,0
207898,intermittent,0,1
207899,bolus,0,0
207900,administration,0,0
207901,in,0,0
207902,the,0,0
207903,relief,0,0
207904,of,0,0
207905,postoperative,0,0
207906,pain,0,0
207907,.,0,0
207908,This,0,0
207909,may,0,0
207910,be,0,0
207911,explained,0,0
207912,by,0,0
207913,the,0,0
207914,development,0,0
207915,of,0,0
207916,tolerance,0,0
207917,in,0,1
207918,patients,1,1
207919,who,1,1
207920,received,1,1
207921,the,1,1
207922,infusion,1,0
207923,of,1,0
207924,morphine,1,0
207925,.,1,0
207926,Controlled,0,0
207927,trial,0,0
207928,of,0,0
207929,induction,0,0
207930,of,0,0
207931,labor,0,1
207932,by,0,0
207933,vaginal,0,1
207934,suppositories,0,0
207935,containing,0,0
207936,prostaglandin,0,0
207937,E2,0,1
207938,.,0,0
207939,A,0,0
207940,group,0,0
207941,of,0,0
207942,84,1,1
207943,women,1,1
207944,at,1,0
207945,39-43,1,1
207946,weeks,1,0
207947,of,1,0
207948,pregnancy,1,1
207949,were,0,0
207950,randomly,0,0
207951,allocated,0,0
207952,to,0,0
207953,a,0,0
207954,blind,0,0
207955,trial,0,0
207956,of,0,0
207957,induction,0,0
207958,of,0,0
207959,labor,0,1
207960,with,0,1
207961,vaginal,0,1
207962,suppositories,0,0
207963,containing,0,0
207964,inert,0,0
207965,material,0,1
207966,or,0,0
207967,either,0,0
207968,0.2,0,0
207969,mg,0,0
207970,or,0,0
207971,0.4,0,0
207972,mg,0,0
207973,of,0,0
207974,prostaglandin,0,0
207975,E2,0,0
207976,.,0,0
207977,The,0,0
207978,suppositories,0,0
207979,were,0,0
207980,self-administered,0,0
207981,every,0,0
207982,two,0,0
207983,hours,0,0
207984,during,0,0
207985,waking,0,1
207986,hours,0,0
207987,on,0,0
207988,two,0,0
207989,successive,0,1
207990,days,0,0
207991,until,0,1
207992,labor,0,1
207993,started,0,0
207994,or,0,0
207995,15,0,0
207996,had,0,0
207997,been,0,0
207998,used,0,0
207999,.,0,0
208000,Side-effects,0,0
208001,were,0,0
208002,absent,0,0
208003,.,0,0
208004,Labor,0,0
208005,was,0,0
208006,established,0,0
208007,within,0,0
208008,48,0,0
208009,hr,0,0
208010,of,0,0
208011,insertion,0,0
208012,of,0,0
208013,the,0,0
208014,first,0,0
208015,suppository,0,0
208016,in,0,0
208017,9.3,0,0
208018,%,0,0
208019,of,0,0
208020,control,0,0
208021,patients,0,1
208022,",",0,0
208023,65.4,0,0
208024,%,0,0
208025,of,0,0
208026,those,0,0
208027,treated,0,0
208028,with,0,1
208029,0.2,0,0
208030,mg,0,0
208031,PGE2,0,0
208032,and,0,0
208033,85.7,0,0
208034,%,0,0
208035,of,0,0
208036,those,0,0
208037,treated,0,0
208038,with,0,1
208039,0.4,0,0
208040,mg,0,0
208041,PGE2,0,0
208042,.,0,0
208043,The,0,0
208044,mean,0,0
208045,Apgar,0,0
208046,scores,0,0
208047,in,0,0
208048,the,0,0
208049,three,0,0
208050,groups,0,0
208051,were,0,0
208052,the,0,0
208053,same,0,0
208054,.,0,0
208055,The,0,0
208056,mean,0,0
208057,total,0,0
208058,dose,0,0
208059,of,0,0
208060,PGE2,0,0
208061,were,0,0
208062,2.0,0,0
208063,mg,0,0
208064,(,0,0
208065,0.2,0,0
208066,mg,0,0
208067,group,0,1
208068,),0,0
208069,and,0,0
208070,2.3,0,0
208071,mg,0,0
208072,(,0,0
208073,0.4,0,0
208074,mg,0,0
208075,group,0,1
208076,),0,0
208077,.,0,0
208078,It,0,0
208079,is,0,0
208080,concluded,0,0
208081,that,0,0
208082,vaginal,0,0
208083,PGE2,0,0
208084,is,0,0
208085,an,0,0
208086,effective,0,0
208087,and,0,0
208088,acceptable,0,0
208089,method,0,0
208090,of,0,0
208091,inducing,0,0
208092,labor,0,1
208093,at,0,0
208094,term,0,0
208095,.,0,0
208096,Effect,0,0
208097,of,0,0
208098,increasing,0,0
208099,doses,0,0
208100,of,0,0
208101,labetalol,0,0
208102,on,0,0
208103,blood,0,0
208104,pressure,0,0
208105,",",0,0
208106,plasma,0,0
208107,renin,0,0
208108,activity,0,0
208109,and,0,0
208110,aldosterone,0,0
208111,in,0,0
208112,hypertensive,1,1
208113,patients,1,1
208114,.,1,1
208115,1,0,0
208116,.,0,0
208117,Four,0,0
208118,different,0,0
208119,doses,0,0
208120,of,0,0
208121,labetalol,0,0
208122,(,0,0
208123,150,0,0
208124,",",0,0
208125,300,0,0
208126,",",0,0
208127,600,0,0
208128,and,0,0
208129,900,0,0
208130,mg/day,0,0
208131,),0,0
208132,were,0,0
208133,given,0,0
208134,for,0,0
208135,1,0,0
208136,week,0,0
208137,to,0,0
208138,each,0,0
208139,of,0,0
208140,four,1,0
208141,groups,1,0
208142,of,1,0
208143,patients,1,1
208144,with,1,1
208145,essential,1,1
208146,hypertension,1,1
208147,(,1,0
208148,six,1,0
208149,patients,1,1
208150,for,1,0
208151,each,1,0
208152,group,1,0
208153,),1,0
208154,.,1,0
208155,2,0,0
208156,.,0,0
208157,Labetalol,0,0
208158,decreased,0,0
208159,mean,0,0
208160,blood,0,0
208161,pressure,0,0
208162,and,0,0
208163,heart,0,1
208164,rate,0,0
208165,to,0,0
208166,the,0,0
208167,same,0,0
208168,extent,0,0
208169,on,0,0
208170,the,0,0
208171,first,0,0
208172,and,0,0
208173,the,0,0
208174,seventh,0,0
208175,days,0,0
208176,of,0,0
208177,treatment,0,0
208178,.,0,0
208179,Only,0,0
208180,standing,0,0
208181,blood,0,0
208182,pressure,0,0
208183,showed,0,0
208184,a,0,0
208185,dose-dependent,0,0
208186,inhibition,0,0
208187,both,0,0
208188,in,0,0
208189,the,0,0
208190,supine,0,0
208191,and,0,0
208192,upright,0,0
208193,position,0,0
208194,.,0,1
208195,3,0,0
208196,.,0,0
208197,Labetalol,0,0
208198,exerted,0,0
208199,a,0,0
208200,net,0,0
208201,inhibitory,0,0
208202,effect,0,0
208203,on,0,0
208204,plasma,0,0
208205,renin,0,0
208206,activity,0,0
208207,",",0,0
208208,which,0,0
208209,was,0,0
208210,related,0,0
208211,to,0,0
208212,basal,0,0
208213,renin,0,0
208214,values,0,0
208215,and,0,0
208216,was,0,0
208217,already,0,0
208218,maximal,0,0
208219,at,0,0
208220,the,0,0
208221,lowest,0,0
208222,doses,0,0
208223,.,0,0
208224,This,0,0
208225,effect,0,0
208226,was,0,0
208227,well,0,0
208228,maintained,0,0
208229,in,0,0
208230,the,0,0
208231,supine,0,0
208232,position,0,0
208233,.,0,0
208234,This,0,0
208235,effect,0,0
208236,was,0,0
208237,well,0,0
208238,maintained,0,0
208239,in,0,0
208240,the,0,0
208241,supine,0,0
208242,position,0,0
208243,",",0,0
208244,although,0,0
208245,during,0,0
208246,standing,0,0
208247,it,0,0
208248,tended,0,0
208249,to,0,0
208250,be,0,0
208251,less,0,0
208252,evident,0,0
208253,with,0,0
208254,increasing,0,0
208255,doses,0,0
208256,.,0,1
208257,4,0,0
208258,.,0,0
208259,Urinary,0,0
208260,aldosterone,0,0
208261,was,0,0
208262,decreased,0,0
208263,in,0,0
208264,a,0,0
208265,dose-dependent,0,0
208266,fashion,0,0
208267,and,0,0
208268,its,0,0
208269,changes,0,0
208270,were,0,0
208271,largely,0,0
208272,independent,0,0
208273,fashion,0,0
208274,and,0,0
208275,its,0,0
208276,changes,0,0
208277,were,0,0
208278,largely,0,0
208279,independent,0,0
208280,of,0,0
208281,plasma,0,0
208282,renin,0,0
208283,activity,0,0
208284,.,0,0
208285,5,0,0
208286,.,0,0
208287,Neither,0,0
208288,basal,0,0
208289,values,0,0
208290,nor,0,0
208291,changes,0,0
208292,of,0,0
208293,renin,0,0
208294,and,0,0
208295,aldosterone,0,0
208296,were,0,0
208297,related,0,0
208298,to,0,0
208299,the,0,0
208300,hypotensive,0,0
208301,effect,0,0
208302,of,0,0
208303,labetalol,0,0
208304,.,0,1
208305,6,0,0
208306,.,0,0
208307,During,0,0
208308,labetalol,0,0
208309,treatment,0,0
208310,urinary,0,0
208311,sodium,0,0
208312,excretion,0,0
208313,fell,0,0
208314,for,0,0
208315,2-3,0,0
208316,days,0,0
208317,and,0,0
208318,then,0,0
208319,returned,0,0
208320,to,0,0
208321,basal,0,0
208322,values,0,0
208323,.,0,0
208324,The,0,0
208325,retentive,0,0
208326,effect,0,0
208327,of,0,0
208328,labetalol,0,0
208329,on,0,0
208330,sodium,0,0
208331,was,0,0
208332,directly,0,0
208333,related,0,0
208334,to,0,0
208335,the,0,0
208336,decrease,0,0
208337,of,0,0
208338,blood,0,0
208339,pressure,0,0
208340,",",0,0
208341,and,0,0
208342,the,0,0
208343,successive,0,0
208344,sodium,0,0
208345,escape,0,0
208346,might,0,0
208347,be,0,0
208348,explained,0,0
208349,either,0,0
208350,by,0,0
208351,the,0,0
208352,observed,0,0
208353,increase,0,0
208354,of,0,0
208355,plasma,0,0
208356,volume,0,0
208357,(,0,0
208358,indirectly,0,0
208359,measured,0,0
208360,by,0,0
208361,packed,0,0
208362,cell,0,1
208363,volume,0,0
208364,),0,0
208365,or,0,0
208366,by,0,0
208367,aldosterone,0,0
208368,inhibition,0,0
208369,.,0,0
208370,Prevention,0,0
208371,of,0,0
208372,premature,0,1
208373,labor,0,1
208374,by,0,0
208375,17,0,0
208376,alpha-hydroxyprogesterone,0,0
208377,caproate,0,0
208378,.,0,0
208379,Eighty,1,1
208380,pregnant,1,1
208381,women,1,1
208382,at,1,0
208383,high,1,0
208384,risk,1,0
208385,of,1,0
208386,giving,1,0
208387,birth,1,1
208388,prematurely,1,1
208389,were,0,0
208390,divided,0,0
208391,randomly,0,1
208392,into,0,0
208393,two,0,0
208394,groups,0,0
208395,.,0,0
208396,Treatment,0,0
208397,with,0,0
208398,either,0,0
208399,17,0,0
208400,alpha-hydroxyprogesterone,0,0
208401,caproate,0,0
208402,",",0,0
208403,250,0,0
208404,mg,0,0
208405,by,0,0
208406,intramuscular,0,0
208407,injection,0,0
208408,once,0,0
208409,a,0,0
208410,week,0,0
208411,",",0,0
208412,or,0,0
208413,a,0,0
208414,placebo,0,0
208415,was,0,0
208416,given,0,0
208417,in,0,0
208418,a,0,0
208419,double-blind,0,0
208420,fashion,0,0
208421,.,0,0
208422,Imminent,0,0
208423,premature,0,1
208424,labor,0,1
208425,occurred,0,0
208426,in,0,0
208427,29.0,0,0
208428,%,0,0
208429,of,0,0
208430,the,0,0
208431,treated,0,0
208432,group,0,0
208433,and,0,0
208434,in,0,0
208435,59.4,0,0
208436,%,0,0
208437,of,0,0
208438,the,0,0
208439,control,0,0
208440,group,0,0
208441,(,0,0
208442,p,0,0
208443,less,0,0
208444,than,0,0
208445,0.025,0,0
208446,),0,0
208447,.,0,0
208448,The,0,0
208449,rate,0,0
208450,of,0,0
208451,premature,0,1
208452,deliveries,0,1
208453,was,0,0
208454,also,0,0
208455,significantly,0,0
208456,lower,0,0
208457,in,0,0
208458,the,0,0
208459,treated,0,0
208460,group,0,0
208461,(,0,0
208462,16.1,0,0
208463,%,0,0
208464,),0,0
208465,than,0,0
208466,in,0,0
208467,the,0,0
208468,control,0,0
208469,group,0,0
208470,(,0,0
208471,37.82,0,0
208472,%,0,0
208473,),0,0
208474,(,0,0
208475,p,0,0
208476,less,0,0
208477,than,0,0
208478,0.05,0,0
208479,),0,0
208480,.,0,0
208481,There,0,0
208482,were,0,0
208483,no,0,0
208484,cases,0,0
208485,of,0,0
208486,perinatal,0,1
208487,death,0,0
208488,or,0,1
208489,fetal,0,0
208490,malformations,0,0
208491,in,0,0
208492,either,0,0
208493,group,0,0
208494,.,0,0
208495,The,0,0
208496,mean,0,0
208497,birth,0,1
208498,weight,0,0
208499,of,0,0
208500,all,0,0
208501,infants,0,1
208502,of,0,0
208503,the,0,0
208504,treated,0,0
208505,group,0,0
208506,was,0,0
208507,significantly,0,0
208508,higher,0,0
208509,than,0,0
208510,in,0,0
208511,those,0,0
208512,of,0,0
208513,the,0,0
208514,control,0,0
208515,group,0,0
208516,(,0,0
208517,3111.9,0,0
208518,+/-,0,0
208519,905,0,1
208520,gm,0,0
208521,versus,0,0
208522,2680,0,1
208523,+/-,0,0
208524,813.4,0,0
208525,gm,0,0
208526,",",0,0
208527,p,0,0
208528,less,0,0
208529,than,0,0
208530,0.05,0,0
208531,),0,0
208532,.,0,0
208533,The,0,0
208534,results,0,0
208535,support,0,0
208536,treatment,0,0
208537,with,0,0
208538,progesterone,0,0
208539,caproate,0,0
208540,for,0,0
208541,the,0,0
208542,prevention,0,0
208543,of,0,0
208544,premature,0,1
208545,labor,0,1
208546,.,0,0
208547,Differential,0,1
208548,inhibition,0,0
208549,of,0,0
208550,bronchoconstriction,0,0
208551,by,0,0
208552,the,0,0
208553,calcium,0,0
208554,channel,0,0
208555,blockers,0,0
208556,",",0,0
208557,verapamil,0,0
208558,and,0,0
208559,nifedipine,0,0
208560,.,0,0
208561,Recent,0,0
208562,studies,0,0
208563,have,0,0
208564,demonstrated,0,0
208565,that,0,0
208566,the,0,0
208567,calcium,0,0
208568,channel,0,0
208569,blocking,0,0
208570,agents,0,0
208571,can,0,0
208572,inhibit,0,0
208573,experimentally,0,0
208574,induced,0,0
208575,bronchoconstriction,0,0
208576,in,0,0
208577,asthmatics,1,0
208578,",",0,0
208579,but,0,0
208580,their,0,0
208581,protective,0,0
208582,action,0,0
208583,has,0,0
208584,been,0,0
208585,variable,0,0
208586,.,0,0
208587,To,0,0
208588,clarify,0,0
208589,the,0,0
208590,influence,0,0
208591,of,0,0
208592,stimulus,0,0
208593,intensity,0,0
208594,and,0,0
208595,choice,0,0
208596,of,0,0
208597,calcium,0,0
208598,blocker,0,0
208599,on,0,0
208600,these,0,0
208601,reported,0,0
208602,differences,0,0
208603,in,0,0
208604,outcome,0,0
208605,",",0,0
208606,we,0,0
208607,performed,0,0
208608,noncumulative,0,0
208609,thermal,0,1
208610,stimulus-response,0,0
208611,curves,0,0
208612,using,0,0
208613,isocapnic,0,0
208614,hyperventilation,0,0
208615,of,0,0
208616,cold,0,0
208617,air,0,0
208618,in,0,0
208619,8,1,0
208620,asthmatics,1,1
208621,.,1,1
208622,Subjects,1,1
208623,received,0,0
208624,pretreatment,0,0
208625,with,0,1
208626,orally,0,0
208627,administered,0,0
208628,nifedipine,0,0
208629,(,0,0
208630,20,0,0
208631,mg,0,0
208632,),0,0
208633,",",0,0
208634,intravenously,0,0
208635,administered,0,0
208636,verapamil,0,0
208637,(,0,0
208638,10,0,0
208639,mg,0,0
208640,bolus,0,0
208641,followed,0,0
208642,by,0,0
208643,a,0,0
208644,continuous,0,0
208645,infusion,0,0
208646,),0,0
208647,",",0,0
208648,or,0,0
208649,appropriate,0,0
208650,placebos,0,0
208651,in,0,0
208652,a,0,0
208653,randomized,0,0
208654,",",0,0
208655,double-blind,0,0
208656,fashion,0,0
208657,.,0,0
208658,Verapamil,0,0
208659,afforded,0,0
208660,no,0,0
208661,consistent,0,0
208662,protection,0,0
208663,against,0,0
208664,the,0,0
208665,thermal,0,0
208666,challenges,0,0
208667,",",0,0
208668,whereas,0,0
208669,nifedipine,0,0
208670,significantly,0,0
208671,blunted,0,0
208672,the,0,0
208673,bronchoconstrictor,0,0
208674,response,0,0
208675,to,0,0
208676,stimuli,0,0
208677,of,0,0
208678,low,0,0
208679,(,0,0
208680,p,0,0
208681,less,0,0
208682,than,0,0
208683,0.02,0,0
208684,),0,0
208685,and,0,0
208686,middle,0,1
208687,(,0,0
208688,p,0,0
208689,less,0,0
208690,than,0,0
208691,0.03,0,0
208692,),0,0
208693,intensity,0,0
208694,.,0,0
208695,At,0,0
208696,the,0,0
208697,highest,0,0
208698,thermal,0,0
208699,burden,0,0
208700,",",0,0
208701,the,0,0
208702,effect,0,0
208703,of,0,0
208704,nifedipine,0,0
208705,was,0,0
208706,inconsistent,0,0
208707,and,0,0
208708,not,0,0
208709,significantly,0,0
208710,different,0,0
208711,from,0,0
208712,that,0,0
208713,of,0,0
208714,placebo,0,0
208715,.,0,0
208716,These,0,0
208717,results,0,0
208718,indicate,0,0
208719,that,0,0
208720,the,0,0
208721,protection,0,0
208722,from,0,0
208723,bronchoconstriction,0,0
208724,afforded,0,0
208725,by,0,0
208726,the,0,0
208727,calcium,0,0
208728,channel,0,0
208729,blockers,0,0
208730,depends,0,0
208731,on,0,0
208732,the,0,0
208733,choice,0,0
208734,of,0,0
208735,agent,0,0
208736,and,0,0
208737,the,0,0
208738,intensity,0,0
208739,of,0,0
208740,the,0,0
208741,bronchoconstricting,0,0
208742,stimulus,0,0
208743,",",0,0
208744,and,0,0
208745,they,0,0
208746,raise,0,0
208747,the,0,0
208748,possibility,0,0
208749,that,0,0
208750,the,0,0
208751,contribution,0,0
208752,of,0,0
208753,transmembrane,0,0
208754,calcium,0,0
208755,ion,0,0
208756,influx,0,0
208757,to,0,0
208758,the,0,0
208759,pathogenesis,0,0
208760,of,0,0
208761,bronchoconstriction,0,0
208762,may,0,0
208763,vary,0,0
208764,according,0,0
208765,to,0,0
208766,stimulus,0,0
208767,intensity,0,0
208768,.,0,0
208769,PRL-8-53,0,1
208770,:,0,0
208771,enhanced,0,0
208772,learning,0,0
208773,and,0,0
208774,subsequent,0,0
208775,retention,0,0
208776,in,0,0
208777,humans,1,0
208778,as,0,0
208779,a,0,0
208780,result,0,0
208781,of,0,0
208782,low,0,0
208783,oral,0,0
208784,doses,0,0
208785,of,0,0
208786,new,0,0
208787,psychotropic,0,0
208788,agent,0,0
208789,.,0,0
208790,The,0,0
208791,effect,0,0
208792,of,0,0
208793,3-,0,0
208794,(,0,0
208795,2-benzylmethylaminoethyl,0,0
208796,),0,0
208797,benzoic,0,0
208798,acid,0,0
208799,methyl,0,0
208800,ester,0,0
208801,hydrochloride,0,0
208802,(,0,0
208803,PRL-8-53,0,1
208804,),0,0
208805,on,0,0
208806,learning,0,0
208807,and,0,0
208808,on,0,0
208809,retention,0,0
208810,of,0,0
208811,verbal,0,0
208812,information,0,0
208813,in,0,0
208814,human,1,0
208815,subjects,1,1
208816,was,0,0
208817,investigated,0,0
208818,.,0,0
208819,Using,0,0
208820,the,0,0
208821,serial,0,0
208822,anticipation,0,0
208823,method,0,0
208824,under,0,0
208825,double-blind,0,0
208826,conditions,0,0
208827,it,0,0
208828,was,0,0
208829,found,0,0
208830,that,0,0
208831,PRL-8-53,0,1
208832,causes,0,0
208833,slight,0,0
208834,improvement,0,0
208835,of,0,0
208836,acquisition,0,0
208837,.,0,0
208838,Retinetion,0,0
208839,of,0,0
208840,verbal,0,0
208841,information,0,0
208842,was,0,0
208843,found,0,0
208844,improved,0,0
208845,to,0,0
208846,a,0,0
208847,statistically,0,0
208848,significant,0,0
208849,degree,0,0
208850,(,0,0
208851,most,0,0
208852,P,0,0
208853,values,0,0
208854,better,0,0
208855,than,0,0
208856,0.01,0,0
208857,",",0,0
208858,some,0,0
208859,better,0,0
208860,than,0,0
208861,0.001,0,0
208862,),0,0
208863,.,0,0
208864,No,0,0
208865,significant,0,0
208866,changes,0,0
208867,were,0,0
208868,found,0,0
208869,for,0,0
208870,either,0,0
208871,visual,0,0
208872,reaction,0,0
208873,time,0,0
208874,or,0,0
208875,motor,0,0
208876,control,0,0
208877,after,0,0
208878,drug,0,0
208879,when,0,0
208880,compared,0,0
208881,with,0,0
208882,placebo,0,0
208883,values,0,0
208884,.,0,1
208885,A,1,0
208886,double-blind,1,0
208887,crossover,1,0
208888,comparison,1,0
208889,of,1,0
208890,pindolol,1,0
208891,",",1,0
208892,metoprolol,1,0
208893,",",1,0
208894,atenolol,1,0
208895,and,1,0
208896,labetalol,1,0
208897,in,1,0
208898,mild,1,1
208899,to,1,0
208900,moderate,1,1
208901,hypertension,1,1
208902,.,1,0
208903,1,0,0
208904,This,0,0
208905,study,0,0
208906,was,0,0
208907,designed,0,0
208908,to,0,0
208909,compare,0,0
208910,in,0,0
208911,a,0,0
208912,double-blind,0,0
208913,randomized,0,0
208914,crossover,0,0
208915,trial,0,0
208916,",",0,0
208917,atenolol,0,0
208918,",",0,0
208919,labetalol,0,0
208920,",",0,0
208921,metoprolol,0,0
208922,and,0,0
208923,pindolol,0,0
208924,.,0,0
208925,Considerable,0,0
208926,differences,0,0
208927,in,0,0
208928,dose,0,0
208929,(,0,0
208930,atenolol,0,0
208931,138,0,1
208932,+/-,0,0
208933,13,0,1
208934,mg,0,0
208935,daily,0,0
208936,;,0,0
208937,labetalol,0,0
208938,308,0,0
208939,+/-,0,0
208940,34,0,1
208941,mg,0,0
208942,daily,0,0
208943,;,0,0
208944,metoprolol,0,0
208945,234,0,1
208946,+/-,0,0
208947,22,0,1
208948,mg,0,0
208949,daily,0,0
208950,;,0,0
208951,and,0,0
208952,pindolol,0,0
208953,24,0,0
208954,+/-2,0,0
208955,mg,0,0
208956,daily,0,0
208957,were,0,0
208958,required,0,0
208959,to,0,0
208960,produce,0,0
208961,similar,0,0
208962,antihypertensive,0,0
208963,effects,0,0
208964,.,0,1
208965,3,0,0
208966,The,0,0
208967,overall,0,0
208968,incidence,0,0
208969,of,0,0
208970,side-effects,0,0
208971,was,0,0
208972,similar,0,0
208973,with,0,1
208974,atenolol,0,0
208975,",",0,0
208976,metoprolol,0,0
208977,and,0,0
208978,pindolol,0,0
208979,but,0,0
208980,was,0,0
208981,slightly,0,0
208982,less,0,0
208983,with,0,0
208984,labetalol,0,0
208985,.,0,0
208986,Sleep,0,0
208987,disturbances,0,0
208988,and,0,0
208989,abnormal,0,0
208990,dreaming,0,0
208991,patterns,0,0
208992,were,0,0
208993,most,0,0
208994,frequent,0,0
208995,with,0,1
208996,pindolol,0,0
208997,.,0,0
208998,4,0,0
208999,There,0,0
209000,was,0,0
209001,a,0,0
209002,significantly,0,0
209003,greater,0,0
209004,fall,0,0
209005,in,0,0
209006,pulse,0,0
209007,rate,0,0
209008,during,0,0
209009,atenolol,0,0
209010,and,0,0
209011,metoprolol,0,0
209012,treatment,0,0
209013,periods,0,0
209014,.,0,1
209015,[,0,0
209016,Pivampicillin,0,0
209017,treatment,0,0
209018,of,0,0
209019,uro-genital,1,1
209020,infections,1,0
209021,in,1,0
209022,gynaecological,1,1
209023,patients,1,1
209024,.,1,0
209025,A,0,0
209026,clinical,0,0
209027,evaluation,0,0
209028,],0,0
209029,.,0,0
209030,The,0,0
209031,gastric,0,0
209032,emptying,0,0
209033,and,0,0
209034,small,0,0
209035,intestinal,0,1
209036,transit,0,0
209037,after,0,0
209038,highly,1,0
209039,selective,1,0
209040,vagotomy,1,0
209041,without,1,0
209042,drainage,1,0
209043,and,1,0
209044,selective,1,0
209045,vagotomy,1,0
209046,with,1,1
209047,pyloroplasty,1,1
209048,.,1,0
209049,New,0,1
209050,methods,0,1
209051,applied,0,0
209052,to,0,0
209053,the,0,0
209054,analysis,0,0
209055,and,0,0
209056,treatment,0,0
209057,of,0,0
209058,ovarian,1,1
209059,cancer,1,1
209060,.,1,0
209061,Para-anaesthetic,0,0
209062,headache,1,1
209063,in,1,0
209064,female,1,1
209065,patients,1,1
209066,.,1,1
209067,Effects,0,0
209068,of,0,0
209069,progressive,0,0
209070,relaxation,0,0
209071,on,0,0
209072,autonomic,1,0
209073,processes,1,0
209074,.,1,1
209075,Alcoholism,1,1
209076,",",1,0
209077,avoidance,1,0
209078,learning,1,0
209079,and,1,0
209080,emotional,1,0
209081,responsiveness,1,0
209082,.,1,0
209083,Double-blind,0,0
209084,comparison,0,0
209085,of,0,0
209086,ketazolam,0,0
209087,",",0,0
209088,diazepam,0,0
209089,and,0,0
209090,placebo,0,0
209091,in,0,0
209092,once-a-day,0,0
209093,vs,0,0
209094,t.i.d,0,0
209095,.,0,0
209096,dosing,0,0
209097,.,0,0
209098,Comparison,0,0
209099,of,0,0
209100,ketazolam,0,0
209101,given,0,0
209102,once-a-day,0,0
209103,with,0,1
209104,diazepam,0,0
209105,given,0,0
209106,three,0,0
209107,times,0,0
209108,a,0,0
209109,day,0,0
209110,and,0,0
209111,placebo,0,0
209112,given,0,0
209113,either,0,0
209114,once,0,0
209115,or,0,0
209116,3,0,0
209117,times,0,0
209118,a,0,0
209119,day,0,0
209120,in,0,0
209121,101,1,1
209122,anxious,1,1
209123,outpatients,1,1
209124,showed,0,0
209125,ketazolam,0,0
209126,to,0,0
209127,be,0,0
209128,significantly,0,0
209129,better,0,0
209130,than,0,0
209131,placebo,0,0
209132,in,0,0
209133,alleviating,0,0
209134,the,0,0
209135,symptoms,1,0
209136,of,1,0
209137,anxiety,1,0
209138,and,0,0
209139,",",0,0
209140,on,0,0
209141,several,0,0
209142,measures,0,0
209143,of,0,0
209144,efficacy,0,0
209145,",",0,0
209146,better,0,0
209147,than,0,0
209148,diazepam,0,0
209149,as,0,0
209150,well,0,0
209151,.,0,0
209152,Significantly,0,0
209153,fewer,0,0
209154,patients,1,1
209155,on,1,0
209156,ketazolam,1,0
209157,dropped,1,0
209158,out,1,0
209159,of,1,0
209160,the,1,0
209161,study,1,0
209162,due,0,0
209163,to,0,0
209164,ineffective,0,0
209165,medication,0,0
209166,than,0,0
209167,on,0,0
209168,the,0,0
209169,other,0,0
209170,3,0,0
209171,treatments,0,0
209172,.,0,0
209173,The,0,0
209174,incidence,0,0
209175,of,0,0
209176,side,0,0
209177,effects,0,0
209178,was,0,0
209179,lowest,0,0
209180,in,0,0
209181,the,0,0
209182,ketazolam,0,0
209183,group,0,0
209184,.,0,0
209185,Of,0,0
209186,particular,0,0
209187,note,0,0
209188,",",0,0
209189,drowsiness,0,0
209190,was,0,0
209191,reported,0,0
209192,twice,0,0
209193,as,0,0
209194,often,0,0
209195,by,0,0
209196,diazepam,0,0
209197,patients,0,1
209198,as,0,0
209199,by,0,0
209200,ketazolam,0,0
209201,patients,0,1
209202,.,0,1
209203,Schizophrenia,0,1
209204,.,0,0
209205,A,0,0
209206,follow-up,0,0
209207,study,0,0
209208,of,0,0
209209,the,0,0
209210,results,0,0
209211,of,0,0
209212,five,0,1
209213,forms,0,0
209214,of,0,0
209215,treatment,0,0
209216,.,0,0
209217,Two,1,0
209218,hundred,1,1
209219,twenty-eight,1,1
209220,first-admission,1,1
209221,schizophrenic,1,1
209222,patients,1,1
209223,were,0,0
209224,randomly,0,1
209225,assigned,0,0
209226,to,0,0
209227,the,0,0
209228,following,0,0
209229,five,0,1
209230,treatments,0,0
209231,:,0,1
209232,psychotherapy,0,0
209233,alone,0,0
209234,",",0,0
209235,drug,0,0
209236,alone,0,0
209237,",",0,0
209238,psychotherapy,0,0
209239,plus,0,0
209240,drug,0,0
209241,",",0,0
209242,electroconvulsive,0,0
209243,therapy,0,0
209244,(,0,0
209245,ECT,0,0
209246,",",0,0
209247,and,0,0
209248,milieu,0,0
209249,.,0,0
209250,A,0,0
209251,there-,0,0
209252,to,0,0
209253,five-year,0,0
209254,follow-up,0,0
209255,examined,0,0
209256,their,0,0
209257,course,0,0
209258,after,0,0
209259,release,0,0
209260,from,0,0
209261,the,0,0
209262,hospital,0,0
209263,.,0,0
209264,The,0,0
209265,drug,0,0
209266,alone,0,0
209267,and,0,0
209268,ECT,0,0
209269,groups,0,0
209270,tended,0,0
209271,to,0,0
209272,have,0,0
209273,the,0,0
209274,best,0,0
209275,outcome,0,0
209276,and,0,0
209277,the,0,0
209278,psychotherapy,0,0
209279,alone,0,0
209280,group,0,0
209281,the,0,0
209282,worst,0,0
209283,.,0,0
209284,The,0,0
209285,positive,0,0
209286,effect,0,0
209287,from,0,0
209288,prior,0,0
209289,drug,0,0
209290,treatment,0,0
209291,began,0,0
209292,to,0,0
209293,dissipate,0,0
209294,after,0,0
209295,three,0,0
209296,years,0,1
209297,postadmission,0,0
209298,.,0,0
209299,For,0,0
209300,the,0,0
209301,in-hospital,0,0
209302,treatment,0,0
209303,successes,0,0
209304,",",0,0
209305,the,0,0
209306,advantage,0,0
209307,from,0,0
209308,drug,0,0
209309,treatment,0,0
209310,and,0,0
209311,the,0,0
209312,disadvantage,0,0
209313,from,0,0
209314,psychotherapy,0,0
209315,were,0,0
209316,less,0,0
209317,apparent,0,0
209318,.,0,0
209319,Overall,0,0
209320,",",0,0
209321,the,0,0
209322,follow-up,0,0
209323,outcome,0,0
209324,is,0,0
209325,far,0,0
209326,from,0,0
209327,reassuring,0,0
209328,",",0,0
209329,whatever,0,0
209330,the,0,0
209331,type,0,1
209332,of,0,0
209333,treatment,0,0
209334,.,0,0
209335,Even,0,0
209336,though,0,0
209337,a,0,0
209338,few,0,0
209339,patients,0,1
209340,may,0,0
209341,do,0,0
209342,well,0,0
209343,",",0,0
209344,much,0,0
209345,remains,0,0
209346,to,0,0
209347,be,0,0
209348,done,0,0
209349,in,0,0
209350,and,0,0
209351,out,0,0
209352,of,0,0
209353,the,0,0
209354,hospital,0,0
209355,.,0,0
209356,Acute,0,0
209357,intervention,0,0
209358,studies,0,0
209359,in,0,0
209360,patients,1,1
209361,with,1,1
209362,myocardial,1,1
209363,infarction,1,1
209364,using,0,0
209365,atenolol,0,0
209366,",",0,0
209367,propranolol,0,0
209368,",",0,0
209369,oxprenolol,0,0
209370,and,0,0
209371,disopyramide,0,0
209372,phosphate,0,0
209373,.,0,0
209374,The,0,0
209375,value,0,0
209376,of,0,0
209377,beta-blockade,0,0
209378,and,0,0
209379,of,0,0
209380,disopyramide,0,0
209381,phosphate,0,0
209382,in,0,0
209383,the,0,0
209384,immediate,0,0
209385,treatment,0,0
209386,of,0,0
209387,patients,1,1
209388,with,1,1
209389,suspected,1,1
209390,acute,1,1
209391,myocardial,1,1
209392,infarction,1,1
209393,was,0,0
209394,assessed,0,0
209395,in,0,0
209396,two,0,0
209397,placebo,0,0
209398,controlled,0,0
209399,trials,0,0
209400,.,0,0
209401,In,1,0
209402,the,1,0
209403,first,1,0
209404,study,1,0
209405,388,1,1
209406,patients,1,1
209407,with,1,1
209408,suspected,1,1
209409,acute,1,1
209410,myocardial,1,1
209411,infarction,1,1
209412,were,0,0
209413,randomly,0,0
209414,allocated,0,0
209415,to,0,0
209416,treatment,0,0
209417,with,0,0
209418,propranolol,0,0
209419,",",0,0
209420,atenolol,0,0
209421,",",0,0
209422,or,0,0
209423,placebo,0,0
209424,",",0,0
209425,and,0,0
209426,when,0,0
209427,analysed,0,0
209428,on,0,0
209429,an,0,0
209430,initial,0,0
209431,intention,0,0
209432,to,0,0
209433,treat,0,0
209434,basis,0,0
209435,there,0,0
209436,was,0,0
209437,no,0,0
209438,significant,0,0
209439,difference,0,0
209440,between,0,0
209441,the,0,0
209442,three,0,0
209443,groups,0,0
209444,in,0,0
209445,respect,0,0
209446,of,0,0
209447,the,0,0
209448,mortality,0,0
209449,at,0,0
209450,one,0,0
209451,year,0,0
209452,.,0,0
209453,In,0,0
209454,addition,0,0
209455,",",0,0
209456,there,0,0
209457,was,0,0
209458,no,0,0
209459,evidence,0,0
209460,to,0,0
209461,suggest,0,0
209462,that,0,0
209463,either,0,0
209464,atenolol,0,0
209465,",",0,0
209466,or,0,0
209467,propranolol,0,0
209468,reduced,0,0
209469,the,0,0
209470,incidence,0,0
209471,of,0,0
209472,'serious,0,0
209473,',0,1
209474,ventricular,0,0
209475,arrhythmias,0,1
209476,in,0,0
209477,the,0,0
209478,coronary,0,1
209479,care,0,0
209480,unit,0,0
209481,.,0,0
209482,In,0,0
209483,the,0,0
209484,second,0,0
209485,study,0,0
209486,473,1,1
209487,patients,1,1
209488,with,1,1
209489,suspected,1,1
209490,acute,1,1
209491,myocardial,1,1
209492,infarction,1,1
209493,were,0,0
209494,randomly,0,0
209495,allocated,0,0
209496,to,0,0
209497,treatment,0,0
209498,with,0,0
209499,oxprenolol,0,0
209500,",",0,0
209501,disopyramide,0,0
209502,phosphate,0,0
209503,",",0,0
209504,or,0,0
209505,placebo,0,0
209506,.,0,0
209507,Again,0,0
209508,no,0,0
209509,significant,0,0
209510,differences,0,0
209511,were,0,0
209512,seen,0,0
209513,with,0,0
209514,respect,0,0
209515,to,0,0
209516,the,0,0
209517,mortality,0,0
209518,at,0,0
209519,six,0,1
209520,weeks,0,0
209521,.,0,0
209522,There,0,0
209523,was,0,0
209524,",",0,0
209525,however,0,0
209526,",",0,0
209527,a,0,0
209528,significantly,0,0
209529,increased,0,0
209530,incidence,0,0
209531,of,0,0
209532,heart,0,1
209533,failure,0,1
209534,in,0,0
209535,the,0,0
209536,group,0,0
209537,which,0,0
209538,received,0,0
209539,disopyramide,0,0
209540,phosphate,0,0
209541,.,0,1
209542,Patients,1,1
209543,who,0,1
209544,received,0,1
209545,this,0,1
209546,drug,0,0
209547,also,0,0
209548,showed,0,0
209549,a,0,0
209550,reduced,0,0
209551,number,0,0
209552,of,0,0
209553,dysrhythmic,0,0
209554,episodes,0,0
209555,on,0,0
209556,24-hour,0,0
209557,ECG,0,0
209558,recordings,0,0
209559,",",0,0
209560,but,0,0
209561,this,0,0
209562,trend,0,0
209563,did,0,0
209564,not,0,0
209565,achieve,0,0
209566,statistical,0,0
209567,significance,0,0
209568,.,0,0
209569,These,0,0
209570,results,0,0
209571,suggest,0,0
209572,that,0,0
209573,none,0,0
209574,of,0,0
209575,the,0,0
209576,three,0,0
209577,beta-blockers,0,0
209578,tested,0,0
209579,nor,0,0
209580,disopyramide,0,0
209581,phosphate,0,0
209582,is,0,0
209583,likely,0,0
209584,to,0,0
209585,reduce,0,0
209586,the,0,0
209587,mortality,0,0
209588,from,0,0
209589,acute,0,1
209590,myocardial,0,1
209591,infarction,0,0
209592,when,0,0
209593,given,0,0
209594,prophylactically,0,0
209595,",",0,0
209596,although,0,0
209597,disopyramide,0,0
209598,phosphate,0,0
209599,does,0,0
209600,reduce,0,0
209601,the,0,0
209602,incidence,0,0
209603,of,0,0
209604,'serious,0,0
209605,',0,1
209606,ventriicular,0,0
209607,arrhythmias,0,1
209608,.,0,1
209609,An,0,0
209610,assessment,0,0
209611,of,0,0
209612,beta-adrenoceptor,1,0
209613,blockade,1,0
209614,in,1,0
209615,man,1,1
209616,by,1,0
209617,prizidilol,1,0
209618,hydrochloride,1,0
209619,.,1,0
209620,1,0,0
209621,Prizidilol,0,0
209622,hydrochloride,0,0
209623,(,0,0
209624,SK,0,0
209625,&,0,1
209626,F,0,0
209627,92657,0,0
209628,),0,0
209629,is,0,0
209630,a,0,0
209631,new,0,0
209632,compound,0,0
209633,which,0,0
209634,causes,0,0
209635,both,0,0
209636,arteriolar,0,0
209637,dilatation,0,0
209638,and,0,0
209639,beta-adrenoceptor,0,0
209640,blockade,0,0
209641,.,0,0
209642,The,0,0
209643,effect,0,0
209644,of,0,0
209645,a,0,0
209646,single,0,0
209647,oral,0,0
209648,dose,0,0
209649,on,0,0
209650,the,0,0
209651,responses,0,0
209652,of,0,0
209653,heart,0,1
209654,rate,0,0
209655,and,0,0
209656,blood,0,0
209657,pressure,0,0
209658,to,0,0
209659,isoprenaline,0,0
209660,infusion,0,0
209661,has,0,0
209662,been,0,0
209663,studied,0,0
209664,in,0,0
209665,healthy,1,1
209666,volunteers,1,1
209667,.,1,1
209668,2,0,0
209669,Isoprenaline,0,0
209670,heart,0,1
209671,rate,0,0
209672,dose-response,0,0
209673,curves,0,0
209674,showed,0,0
209675,parallel,0,0
209676,shifts,0,0
209677,to,0,0
209678,the,0,0
209679,right,0,0
209680,after,0,0
209681,oral,0,0
209682,prizidilol,0,0
209683,",",0,0
209684,indicating,0,0
209685,antagonism,0,0
209686,by,0,0
209687,this,0,0
209688,compound,0,0
209689,at,0,0
209690,beta-adrenoceptors,0,0
209691,in,0,0
209692,the,0,0
209693,heart,0,1
209694,.,0,0
209695,3,0,0
209696,Isoprenaline,0,0
209697,dose-response,0,0
209698,curves,0,0
209699,for,0,0
209700,decreases,0,0
209701,in,0,0
209702,diastolic,0,1
209703,blood,0,0
209704,pressure,0,0
209705,also,0,0
209706,showed,0,0
209707,shifts,0,0
209708,to,0,0
209709,the,0,0
209710,right,0,0
209711,after,0,0
209712,oral,0,0
209713,prizidilol,0,0
209714,",",0,0
209715,providing,0,0
209716,evidence,0,0
209717,of,0,0
209718,beta-adrenoceptor,0,0
209719,antagonism,0,0
209720,by,0,0
209721,this,0,0
209722,drug,0,0
209723,in,0,0
209724,peripheral,0,0
209725,resistance,0,0
209726,vessels,0,0
209727,.,0,0
209728,4,0,0
209729,The,0,0
209730,peak,0,0
209731,effect,0,0
209732,of,0,0
209733,a,0,0
209734,40,0,0
209735,mg,0,0
209736,dose,0,0
209737,of,0,0
209738,propranolol,0,0
209739,was,0,0
209740,greater,0,0
209741,than,0,0
209742,that,0,0
209743,of,0,0
209744,a,0,0
209745,200,0,0
209746,mg,0,0
209747,dose,0,0
209748,of,0,0
209749,prizidilol,0,0
209750,but,0,0
209751,both,0,0
209752,drugs,0,0
209753,caused,0,0
209754,persistent,0,1
209755,beta-adrenoceptor,0,0
209756,blockade,0,0
209757,for,0,0
209758,at,0,0
209759,least,0,0
209760,7,0,0
209761,h,0,0
209762,after,0,0
209763,ingestion,0,0
209764,.,0,0
209765,Thyroid,0,1
209766,stimulating,0,0
209767,antibodies,0,0
209768,:,0,1
209769,an,0,0
209770,aid,0,0
209771,to,0,0
209772,the,0,0
209773,strategy,0,0
209774,of,0,0
209775,treatment,0,0
209776,of,0,0
209777,Graves,1,1
209778,',1,1
209779,disease,1,1
209780,?,0,0
209781,In,0,0
209782,1976,0,1
209783,we,0,0
209784,initiated,0,0
209785,a,0,0
209786,prospective,0,0
209787,study,0,0
209788,to,0,0
209789,specify,0,0
209790,the,0,0
209791,usefulness,0,0
209792,of,0,0
209793,thyroid,0,1
209794,stimulating,0,0
209795,antibody,0,0
209796,(,0,0
209797,TSAb,0,0
209798,),0,0
209799,determinations,0,0
209800,in,0,0
209801,predicting,0,0
209802,the,0,0
209803,outcome,0,0
209804,of,0,0
209805,post-antithyroid,0,0
209806,drug,0,0
209807,treatment,0,0
209808,for,0,0
209809,Graves,0,1
209810,',0,1
209811,disease,0,1
209812,.,0,0
209813,This,1,0
209814,study,1,0
209815,was,1,0
209816,carried,1,0
209817,out,1,0
209818,on,1,0
209819,55,1,1
209820,patients,1,1
209821,",",1,1
209822,who,1,1
209823,were,1,1
209824,either,1,1
209825,treated,1,0
209826,for,1,0
209827,six,1,0
209828,(,1,0
209829,n,1,1
209830,=,1,0
209831,16,1,1
209832,),1,0
209833,or,1,1
209834,18,1,1
209835,months,1,0
209836,(,1,0
209837,n,1,1
209838,=,1,0
209839,39,1,1
209840,),1,0
209841,and,1,0
209842,followed,1,0
209843,up,1,0
209844,for,1,0
209845,an,1,0
209846,additional,1,0
209847,two-year,1,0
209848,period,1,0
209849,.,1,0
209850,TSAb,1,0
209851,was,1,0
209852,determined,1,0
209853,on,1,0
209854,whole,1,0
209855,serum,1,0
209856,in,1,0
209857,29,1,1
209858,patients,1,1
209859,before,1,0
209860,and,1,0
209861,at,1,0
209862,the,1,0
209863,end,1,0
209864,of,1,0
209865,treatment,1,0
209866,",",1,0
209867,and,1,0
209868,in,1,0
209869,26,1,1
209870,patients,1,1
209871,at,1,0
209872,the,1,0
209873,end,1,0
209874,of,1,0
209875,treatment,1,0
209876,only,1,0
209877,.,1,0
209878,These,0,0
209879,determinations,0,0
209880,were,0,0
209881,carried,0,0
209882,out,0,0
209883,using,0,0
209884,a,0,0
209885,sensitive,0,0
209886,and,0,0
209887,reproducible,0,0
209888,microassay,0,0
209889,based,0,0
209890,on,0,0
209891,cAMP,0,0
209892,accumulation,0,0
209893,in,0,0
209894,human,0,0
209895,thyroid,0,1
209896,cell,0,1
209897,cultures,0,0
209898,.,0,0
209899,Before,0,0
209900,treatment,0,0
209901,",",0,0
209902,TSAb,0,0
209903,ranging,0,0
209904,from,0,0
209905,170,0,1
209906,to,0,0
209907,1529,0,0
209908,%,0,0
209909,was,0,0
209910,present,0,0
209911,in,0,0
209912,28/29,0,1
209913,patients,0,1
209914,and,0,0
209915,reached,0,0
209916,significantly,0,0
209917,low,0,0
209918,levels,0,0
209919,at,0,0
209920,the,0,0
209921,end,0,0
209922,of,0,0
209923,treatment,0,0
209924,whatever,0,0
209925,its,0,0
209926,duration,0,0
209927,.,0,0
209928,TSAb,0,0
209929,was,0,0
209930,undetectable,0,0
209931,in,0,0
209932,24/55,0,0
209933,patients,0,1
209934,at,0,0
209935,the,0,0
209936,end,0,0
209937,of,0,0
209938,treatment,0,0
209939,.,0,0
209940,8/16,0,0
209941,'short-treated,0,0
209942,',0,0
209943,and,0,0
209944,18/39,0,1
209945,'long-treated,0,0
209946,',0,1
209947,patients,0,1
209948,remained,0,0
209949,in,0,0
209950,remission,0,0
209951,.,0,0
209952,As,0,0
209953,expected,0,0
209954,",",0,0
209955,initial,0,0
209956,TSAb,0,0
209957,levels,0,0
209958,had,0,0
209959,no,0,0
209960,predictive,0,0
209961,value,0,0
209962,.,0,0
209963,End-treatment,0,0
209964,TSAb,0,0
209965,values,0,0
209966,",",0,0
209967,when,0,0
209968,low,0,0
209969,(,0,0
209970,less,0,0
209971,than,0,0
209972,350,0,0
209973,%,0,0
209974,),0,0
209975,or,0,0
209976,negative,0,0
209977,did,0,0
209978,not,0,0
209979,correlate,0,0
209980,with,0,0
209981,later,0,0
209982,evolution,0,0
209983,:,0,1
209984,in,0,0
209985,these,0,0
209986,39,0,1
209987,patients,0,1
209988,",",0,0
209989,relapse,0,0
209990,rate,0,0
209991,was,0,0
209992,41,0,1
209993,%,0,0
209994,.,0,0
209995,In,0,0
209996,contrast,0,0
209997,",",0,0
209998,13/16,0,0
209999,patients,0,1
210000,with,0,1
210001,end-treatment,0,0
210002,TSAb,0,0
210003,greater,0,0
210004,than,0,0
210005,350,0,0
210006,%,0,0
210007,relapsed,0,1
210008,.,0,0
210009,Relapses,0,0
210010,tended,0,0
210011,to,0,0
210012,occur,0,0
210013,earlier,0,0
210014,in,0,0
210015,patients,0,1
210016,with,0,1
210017,the,0,0
210018,highest,0,0
210019,TSAb,0,0
210020,levels,0,0
210021,.,0,1
210022,TSAb,1,0
210023,determined,1,0
210024,again,1,0
210025,during,1,0
210026,follow-up,1,0
210027,was,1,0
210028,negative,1,0
210029,in,1,0
210030,each,1,0
210031,of,1,0
210032,the,1,0
210033,18,1,1
210034,patients,1,1
210035,in,1,0
210036,remission,1,0
210037,",",1,0
210038,and,1,0
210039,positive,1,0
210040,in,1,0
210041,8/10,1,0
210042,patients,1,1
210043,at,1,0
210044,the,1,0
210045,time,1,0
210046,of,1,0
210047,relapse,1,0
210048,",",1,0
210049,whatever,1,0
210050,its,1,0
210051,level,1,0
210052,at,1,0
210053,the,1,0
210054,end,1,0
210055,of,1,0
210056,the,1,0
210057,drug,1,0
210058,course,1,0
210059,.,1,0
210060,This,0,0
210061,study,0,0
210062,confirms,0,0
210063,that,0,0
210064,only,0,0
210065,end-treatment,0,0
210066,TSAb,0,0
210067,levels,0,0
210068,are,0,0
210069,predictive,0,0
210070,of,0,0
210071,relapse,0,0
210072,.,0,0
210073,(,0,0
210074,ABSTRACT,0,0
210075,TRUNCATED,0,0
210076,AT,0,0
210077,250,0,0
210078,WORDS,0,0
210079,),0,0
210080,[,0,0
210081,Local,0,0
210082,application,0,0
210083,of,0,0
210084,anti-cancer,0,0
210085,drugs,0,0
210086,for,0,0
210087,the,0,0
210088,treatment,0,0
210089,of,0,0
210090,malignant,1,1
210091,pleural,1,1
210092,and,1,0
210093,pericardial,1,0
210094,effusion,1,1
210095,],1,0
210096,.,0,0
210097,Pleural,0,0
210098,effusion,0,0
210099,is,0,0
210100,a,0,0
210101,common,0,0
210102,complication,0,0
210103,in,0,0
210104,patients,1,1
210105,with,1,1
210106,malignant,1,1
210107,neoplasm,1,1
210108,.,1,0
210109,A,0,0
210110,randomized,0,0
210111,controlled,0,0
210112,study,0,0
210113,of,0,0
210114,intrapleural,0,0
210115,instillation,0,0
210116,of,0,0
210117,Adriamycin,0,0
210118,(,1,0
210119,control,1,0
210120,group,1,0
210121,",",1,0
210122,30,1,0
210123,patients,1,1
210124,),1,0
210125,and,0,0
210126,Adriamycin,0,0
210127,Nocardia,0,0
210128,rubra,0,0
210129,cell,0,0
210130,wall,0,0
210131,skeleton,0,0
210132,(,1,0
210133,N-CWS,1,0
210134,group,1,0
210135,",",1,0
210136,26,1,0
210137,patients,1,1
210138,),1,0
210139,with,0,1
210140,tube,0,0
210141,thoracostomy,0,0
210142,was,0,0
210143,performed,0,0
210144,in,1,0
210145,55,1,1
210146,patients,1,1
210147,with,1,1
210148,malignant,1,1
210149,pleural,1,1
210150,effusion,1,1
210151,due,1,0
210152,to,1,0
210153,primary,1,0
210154,lung,1,1
210155,cancer,1,1
210156,.,1,0
210157,The,0,0
210158,response,0,0
210159,rates,0,0
210160,for,0,0
210161,control,0,0
210162,of,0,0
210163,pleural,0,1
210164,effusion,0,1
210165,were,0,0
210166,73.4,0,0
210167,%,0,0
210168,in,0,0
210169,the,0,0
210170,N-CWS,0,0
210171,group,0,0
210172,and,0,0
210173,46.1,0,0
210174,%,0,0
210175,in,0,0
210176,the,0,0
210177,N-CWS,0,0
210178,group,0,0
210179,.,0,0
210180,These,0,0
210181,results,0,0
210182,suggest,0,0
210183,that,0,0
210184,intrapleural,0,0
210185,instillation,0,0
210186,using,0,0
210187,a,0,0
210188,combination,0,0
210189,of,0,0
210190,anti-cancer,0,0
210191,agent,0,0
210192,and,0,0
210193,immunopotentiator,0,0
210194,is,0,0
210195,an,0,0
210196,effective,0,0
210197,treatment,0,0
210198,for,0,0
210199,malignant,0,1
210200,pleurisy,0,1
210201,.,0,0
210202,Cardiac,0,0
210203,tamponade,0,0
210204,secondary,0,0
210205,to,0,0
210206,cancer,0,1
210207,is,0,0
210208,a,0,0
210209,life-threatening,0,0
210210,complication,0,0
210211,requiring,0,1
210212,immediate,0,0
210213,treatment,0,0
210214,.,0,0
210215,Twenty-four,1,0
210216,patients,1,1
210217,with,1,1
210218,malignant,1,1
210219,pericardial,1,0
210220,effusion,1,1
210221,were,0,0
210222,treated,0,0
210223,by,0,0
210224,intrapericardial,0,0
210225,instillation,0,0
210226,of,0,0
210227,anti-cancer,0,0
210228,drugs,0,0
210229,",",0,0
210230,such,0,0
210231,as,0,0
210232,Carbazilquinone,0,0
210233,",",0,0
210234,Mitomycin-C,0,0
210235,or,0,0
210236,ACNU,0,0
210237,",",0,0
210238,with,0,0
210239,pericardial,0,0
210240,drainage,0,0
210241,.,0,0
210242,The,0,0
210243,range,0,0
210244,of,0,0
210245,survival,0,0
210246,time,0,0
210247,from,0,0
210248,the,0,0
210249,instillation,0,0
210250,of,0,0
210251,anti-cancer,0,0
210252,drug,0,0
210253,was,0,0
210254,3-365,0,0
210255,days,0,0
210256,(,0,1
210257,average,0,0
210258,days,0,0
210259,),0,0
210260,.,0,0
210261,In,0,0
210262,only,0,0
210263,4,0,0
210264,patients,0,1
210265,",",0,0
210266,reaccumulation,0,0
210267,of,0,0
210268,pericardial,0,0
210269,effusion,0,1
210270,was,0,0
210271,recognized,0,0
210272,.,0,0
210273,There,0,0
210274,were,0,0
210275,no,0,0
210276,serious,0,0
210277,complications,0,0
210278,with,0,1
210279,this,0,0
210280,procedure,0,0
210281,.,0,0
210282,It,0,0
210283,was,0,0
210284,considered,0,0
210285,that,0,0
210286,local,0,0
210287,instillation,0,0
210288,of,0,0
210289,anti-cancer,0,0
210290,agents,0,0
210291,with,0,1
210292,pericardial,0,1
210293,drainage,0,0
210294,was,0,0
210295,a,0,0
210296,useful,0,0
210297,therapeutic,0,0
210298,modality,0,0
210299,for,0,0
210300,malignant,0,1
210301,pericarditis,0,1
210302,.,0,0
210303,[,0,0
210304,Long-term,0,0
210305,treatment,0,0
210306,of,0,0
210307,cerebrovascular,0,1
210308,changes,0,0
210309,in,0,0
210310,the,0,0
210311,elderly,1,1
210312,(,0,0
210313,author,0,0
210314,'s,0,0
210315,transl,0,1
210316,),0,1
210317,],0,0
210318,.,0,0
210319,A,0,0
210320,prospective,0,0
210321,study,0,0
210322,over,0,0
210323,15,0,0
210324,months,0,0
210325,in,0,0
210326,100,1,1
210327,elderly,1,1
210328,patients,1,1
210329,with,1,1
210330,signs,1,0
210331,of,1,0
210332,cerebro-vascular,1,1
210333,impairment,1,0
210334,demonstrated,1,0
210335,by,1,0
210336,psychometric,1,0
210337,testing,1,0
210338,that,0,0
210339,Hydergine,0,0
210340,(,0,0
210341,an,0,0
210342,ergot,0,0
210343,alkaloid,0,0
210344,preparation,0,0
210345,:,0,1
210346,4.5,0,0
210347,mg,0,0
210348,daily,0,0
210349,),0,0
210350,compensated,0,0
210351,the,0,0
210352,signs,0,0
210353,of,0,0
210354,dementia,0,1
210355,",",0,0
210356,present,0,0
210357,in,0,0
210358,the,0,0
210359,placebo,0,0
210360,group,0,0
210361,",",0,0
210362,and,0,0
210363,in,0,0
210364,some,0,0
210365,patients,0,1
210366,actually,0,0
210367,brought,0,0
210368,about,0,0
210369,a,0,0
210370,significant,0,0
210371,improvement,0,0
210372,in,0,0
210373,mental,0,1
210374,activity,0,0
210375,.,0,0
210376,Similar,0,0
210377,compensatory,0,0
210378,effect,0,0
210379,was,0,0
210380,also,0,0
210381,demonstrable,0,0
210382,in,0,0
210383,cerebral,0,1
210384,haemodynamics,0,0
210385,:,0,1
210386,in,0,0
210387,the,0,0
210388,placebo,0,0
210389,group,0,0
210390,there,0,0
210391,was,0,0
210392,a,0,0
210393,progressive,0,0
210394,increase,0,0
210395,in,0,0
210396,cerebral,0,1
210397,circulation,0,0
210398,time,0,0
210399,",",0,0
210400,an,0,0
210401,expression,0,0
210402,of,0,0
210403,decreased,0,0
210404,cerebral,0,1
210405,blood,0,0
210406,flow,0,0
210407,",",0,0
210408,while,0,0
210409,with,0,1
210410,Hydergine,0,0
210411,cerebral,0,1
210412,circulation,0,0
210413,time,0,0
210414,was,0,0
210415,shortened,0,0
210416,and,0,0
210417,stabilized,0,0
210418,.,0,0
210419,Serial,0,0
210420,EEGs,0,0
210421,",",0,0
210422,obtained,0,0
210423,in,0,0
210424,parallel,0,0
210425,with,0,1
210426,psychometric,0,0
210427,and,0,0
210428,circulation,0,0
210429,time,0,0
210430,tests,0,0
210431,",",0,0
210432,demonstrated,0,0
210433,a,0,0
210434,marked,0,0
210435,increase,0,0
210436,in,0,0
210437,the,0,0
210438,8-10,0,0
210439,Hz,0,0
210440,pattern,0,0
210441,which,0,0
210442,corresponds,0,0
210443,to,0,0
210444,the,0,0
210445,physiological,0,0
210446,alpha,0,0
210447,activity,0,0
210448,in,0,0
210449,this,0,0
210450,age,0,1
210451,group,0,0
210452,.,0,0
210453,Furthermore,0,0
210454,",",0,0
210455,there,0,0
210456,was,0,0
210457,a,0,0
210458,diminished,0,0
210459,variability,0,0
210460,in,0,0
210461,performance,0,0
210462,in,0,0
210463,the,0,0
210464,tested,0,0
210465,frequency,0,0
210466,bands,0,0
210467,with,0,1
210468,Hydergine,0,0
210469,",",0,0
210470,the,0,0
210471,opposite,0,0
210472,tendency,0,0
210473,being,0,0
210474,obtained,0,0
210475,in,0,0
210476,the,0,0
210477,placebo,0,0
210478,group,0,0
210479,.,0,0
210480,Comparison,0,0
210481,of,0,0
210482,hypnotherapy,0,0
210483,with,0,1
210484,systematic,0,0
210485,relaxation,0,0
210486,in,0,0
210487,the,0,0
210488,treatment,0,0
210489,of,0,0
210490,cigarette,0,0
210491,habituation,0,0
210492,.,0,0
210493,Because,0,0
210494,of,0,0
210495,the,0,0
210496,methodological,0,0
210497,deficiencies,0,0
210498,in,0,0
210499,this,0,0
210500,area,0,0
210501,of,0,0
210502,research,0,0
210503,",",0,0
210504,it,0,0
210505,is,0,0
210506,impossible,0,0
210507,to,0,0
210508,make,0,0
210509,any,0,0
210510,valid,0,0
210511,conclusions,0,0
210512,about,0,0
210513,whether,0,0
210514,hypnosis,0,0
210515,itself,0,0
210516,is,0,0
210517,effective,0,0
210518,in,0,0
210519,the,0,0
210520,treatment,0,0
210521,of,0,0
210522,cigarette,0,0
210523,habituation,0,0
210524,.,0,0
210525,In,0,0
210526,this,0,0
210527,study,0,0
210528,",",0,0
210529,87,1,1
210530,volunteers,1,1
210531,who,1,1
210532,wanted,1,1
210533,to,1,1
210534,quit,1,0
210535,cigarette,1,0
210536,smoking,1,0
210537,were,0,0
210538,assigned,0,0
210539,randomly,0,0
210540,to,0,0
210541,the,0,0
210542,experimental,0,0
210543,hypnosis,0,0
210544,group,0,0
210545,",",0,0
210546,the,0,0
210547,comparison,0,0
210548,relaxation,0,0
210549,group,0,0
210550,",",0,0
210551,and,0,0
210552,the,0,0
210553,waiting,0,0
210554,list,0,0
210555,control,0,0
210556,group,0,0
210557,.,0,0
210558,Ss,0,0
210559,in,0,0
210560,the,0,0
210561,treatment,0,0
210562,groups,0,0
210563,had,0,1
210564,four,0,0
210565,weekly,0,0
210566,50-minute,0,0
210567,",",0,0
210568,individual,0,0
210569,sessions,0,0
210570,.,0,1
210571,Four,0,0
210572,months,0,0
210573,after,0,0
210574,the,0,0
210575,completion,0,0
210576,of,0,0
210577,treatment,0,0
210578,",",0,0
210579,Ss,0,0
210580,were,0,0
210581,administered,0,0
210582,a,0,0
210583,questionnaire,0,0
210584,and,0,0
210585,a,0,0
210586,hypnotic,0,0
210587,susceptibility,0,0
210588,scale,0,0
210589,.,0,0
210590,Ss,0,0
210591,in,0,0
210592,the,0,0
210593,hypnosis,0,0
210594,group,0,0
210595,who,0,1
210596,were,0,1
210597,in,0,1
210598,the,0,0
210599,upper,0,0
210600,two-thirds,0,0
210601,of,0,0
210602,the,0,0
210603,group,0,0
210604,in,0,0
210605,terms,0,0
210606,of,0,0
210607,hypnotic,0,0
210608,susceptibility,0,0
210609,reduced,0,0
210610,their,0,0
210611,cigarette,0,0
210612,consumption,0,0
210613,substantially,0,0
210614,more,0,0
210615,than,0,0
210616,Ss,0,0
210617,in,0,0
210618,the,0,0
210619,relaxation,0,0
210620,group,0,0
210621,who,0,1
210622,were,0,1
210623,in,0,1
210624,the,0,0
210625,upper,0,0
210626,two-thirds,0,0
210627,of,0,0
210628,the,0,0
210629,group,0,0
210630,in,0,0
210631,terms,0,0
210632,of,0,0
210633,hypnotic,0,0
210634,susceptibility,0,0
210635,.,0,0
210636,Therefore,0,0
210637,",",0,0
210638,the,0,0
210639,hypnotic,0,0
210640,state,0,0
210641,appears,0,0
210642,to,0,0
210643,be,0,0
210644,therapeutic,0,0
210645,for,0,1
210646,individuals,1,1
210647,who,0,1
210648,can,0,0
210649,enter,0,1
210650,medium,0,0
210651,or,0,0
210652,deep,0,0
210653,states,0,0
210654,of,0,0
210655,hypnosis,0,0
210656,.,0,0
210657,A,0,0
210658,comparison,0,0
210659,of,0,0
210660,once,0,0
210661,and,0,0
210662,twice,0,0
210663,daily,0,0
210664,atenolol,0,0
210665,for,0,0
210666,angina,1,1
210667,pectoris,1,1
210668,.,1,0
210669,We,0,0
210670,have,0,0
210671,studied,0,0
210672,the,0,0
210673,effects,0,0
210674,of,0,0
210675,four,0,1
210676,doses,0,0
210677,of,0,0
210678,atenolol,0,0
210679,in,0,0
210680,11,1,1
210681,patients,1,1
210682,with,1,1
210683,stable,1,1
210684,angina,1,1
210685,pectoris,1,1
210686,using,0,0
210687,a,0,0
210688,symptom-limited,0,0
210689,exercise,0,0
210690,test,0,0
210691,and,0,0
210692,angina,0,1
210693,diaries,0,0
210694,.,0,0
210695,The,0,0
210696,doses,0,0
210697,100,0,0
210698,mg,0,0
210699,twice,0,0
210700,daily,0,0
210701,and,0,0
210702,50,0,0
210703,mg,0,0
210704,",",0,0
210705,100,0,0
210706,mg,0,0
210707,and,0,0
210708,200,0,0
210709,mg,0,0
210710,once,0,0
210711,daily,0,0
210712,were,0,0
210713,given,0,0
210714,double-blind,0,0
210715,and,0,0
210716,randomised,0,1
210717,within,0,0
210718,patients,0,1
210719,following,0,0
210720,run-in,0,0
210721,on,0,0
210722,placebo,0,0
210723,.,0,1
210724,Measurements,0,0
210725,were,0,0
210726,made,0,0
210727,12,0,0
210728,hours,0,0
210729,after,0,0
210730,the,0,0
210731,last,0,0
210732,twice,0,0
210733,daily,0,0
210734,dose,0,0
210735,and,0,0
210736,24,0,0
210737,hours,0,0
210738,after,0,0
210739,the,0,0
210740,last,0,0
210741,once,0,0
210742,daily,0,0
210743,dose,0,0
210744,.,0,0
210745,Exercise,0,0
210746,tolerance,0,0
210747,was,0,0
210748,improved,0,0
210749,by,0,0
210750,40-74,0,1
210751,%,0,0
210752,and,0,0
210753,exercise,0,0
210754,duration,0,0
210755,before,0,0
210756,the,0,0
210757,onset,0,0
210758,of,0,0
210759,angina,0,1
210760,by,0,0
210761,61-94,0,1
210762,%,0,0
210763,(,0,0
210764,P,0,0
210765,less,0,0
210766,than,0,0
210767,0.01,0,0
210768,),0,0
210769,.,0,0
210770,Maximal,0,0
210771,heart,0,1
210772,rate,0,0
210773,was,0,0
210774,reduced,0,0
210775,further,0,0
210776,by,0,0
210777,a,0,0
210778,total,0,1
210779,daily,0,0
210780,dose,0,0
210781,of,0,0
210782,200,0,0
210783,mg,0,0
210784,than,0,0
210785,by,0,0
210786,lower,0,0
210787,doses,0,0
210788,",",0,0
210789,but,0,0
210790,no,0,0
210791,extra,0,0
210792,benefit,0,0
210793,was,0,0
210794,derived,0,0
210795,by,0,0
210796,giving,0,0
210797,the,0,0
210798,drug,0,0
210799,twice,0,0
210800,daily,0,0
210801,.,0,0
210802,The,0,0
210803,largest,0,0
210804,increase,0,0
210805,in,0,0
210806,exercise,0,0
210807,tolerance,0,0
210808,was,0,0
210809,obtained,0,0
210810,during,0,0
210811,treatment,0,0
210812,with,0,1
210813,50,0,0
210814,mg,0,0
210815,once,0,0
210816,daily,0,0
210817,.,0,0
210818,Atenolol,0,0
210819,was,0,0
210820,shown,0,0
210821,to,0,0
210822,be,0,0
210823,an,0,0
210824,effective,0,0
210825,anti-anginal,0,0
210826,agent,0,0
210827,when,0,0
210828,given,0,0
210829,once,0,0
210830,daily,0,0
210831,",",0,0
210832,and,0,0
210833,there,0,0
210834,were,0,0
210835,no,0,0
210836,major,0,0
210837,differences,0,0
210838,between,0,0
210839,the,0,0
210840,doses,0,0
210841,studied,0,1
210842,.,0,1
210843,Comparison,0,0
210844,of,0,0
210845,short-term,0,0
210846,efficacy,0,0
210847,of,0,0
210848,diltiazem,0,0
210849,and,0,0
210850,propranolol,0,0
210851,in,0,0
210852,unstable,0,1
210853,angina,0,1
210854,at,0,0
210855,rest,0,0
210856,--,0,0
210857,a,0,0
210858,randomized,0,0
210859,trial,0,0
210860,in,0,0
210861,70,1,1
210862,patients,1,1
210863,.,1,0
210864,The,0,0
210865,short-term,0,0
210866,efficacy,0,0
210867,of,0,0
210868,diltiazem,0,0
210869,(,0,0
210870,D,0,0
210871,),0,0
210872,has,0,0
210873,been,0,0
210874,compared,0,0
210875,to,0,0
210876,that,0,0
210877,of,0,0
210878,propranolol,0,0
210879,(,0,0
210880,P,0,0
210881,),0,0
210882,",",0,0
210883,in,0,0
210884,a,0,0
210885,group,0,0
210886,of,0,0
210887,70,1,1
210888,patients,1,1
210889,hospitalized,1,1
210890,in,1,0
210891,the,1,0
210892,Coronary,1,1
210893,Care,1,0
210894,Unit,1,0
210895,for,1,0
210896,unstable,1,1
210897,angina,1,1
210898,",",1,0
210899,defined,1,0
210900,as,1,0
210901,recent,1,0
210902,(,1,0
210903,less,1,0
210904,than,1,0
210905,one,1,0
210906,month,1,0
210907,),1,0
210908,appearance,1,0
210909,or,1,0
210910,aggravation,1,0
210911,of,1,0
210912,spontaneous,1,0
210913,chest,1,0
210914,pains,1,1
210915,.,1,0
210916,Among,1,1
210917,the,1,0
210918,70,1,1
210919,patients,1,1
210920,",",1,0
210921,24,1,0
210922,had,1,0
210923,angina,1,1
210924,only,1,0
210925,at,1,0
210926,rest,1,0
210927,.,1,0
210928,The,0,0
210929,patients,1,1
210930,have,1,0
210931,been,1,0
210932,divided,1,0
210933,into,1,0
210934,two,1,0
210935,groups,1,0
210936,according,1,1
210937,to,1,0
210938,ST-T,1,0
210939,changes,1,0
210940,during,1,0
210941,chest,1,0
210942,pain,1,0
210943,:,1,1
210944,29,1,1
210945,with,1,1
210946,ST,1,1
210947,elevation,1,0
210948,(,1,0
210949,group,1,0
210950,A,1,0
210951,),1,0
210952,and,1,0
210953,41,1,1
210954,with,1,1
210955,other,1,0
210956,repolarization,1,0
210957,abnormalities,1,0
210958,(,1,0
210959,group,1,0
210960,B,1,0
210961,),1,0
210962,.,1,0
210963,Treatment,0,0
210964,was,0,0
210965,then,0,0
210966,randomized,0,0
210967,in,0,0
210968,each,0,0
210969,group,0,0
210970,.,0,0
210971,Treatment,0,0
210972,Treatment,0,0
210973,was,0,0
210974,considered,0,0
210975,successful,0,0
210976,only,0,0
210977,if,0,0
210978,spontaneous,0,0
210979,chest,0,0
210980,pains,0,1
210981,disappeared,0,0
210982,completely,0,0
210983,.,0,0
210984,Thirty-four,0,1
210985,patients,0,1
210986,were,0,0
210987,treated,0,1
210988,with,0,1
210989,D,0,0
210990,(,0,0
210991,282,0,1
210992,+/-,0,0
210993,102,0,1
210994,mg/day,0,0
210995,),0,0
210996,and,0,0
210997,36,0,0
210998,with,0,1
210999,P,0,0
211000,(,0,0
211001,158,0,1
211002,+/-,0,0
211003,81,0,1
211004,mg/day,0,0
211005,),0,0
211006,.,0,0
211007,In,0,0
211008,the,0,0
211009,whole,0,0
211010,group,0,0
211011,and,0,0
211012,in,0,0
211013,groups,0,0
211014,A,0,1
211015,and,0,0
211016,B,0,0
211017,considered,0,0
211018,individually,0,0
211019,",",0,0
211020,responses,0,0
211021,to,0,0
211022,D,0,0
211023,and,0,0
211024,P,0,0
211025,did,0,0
211026,not,0,0
211027,differ,0,0
211028,.,0,0
211029,Among,0,0
211030,the,0,0
211031,24,1,0
211032,patients,1,1
211033,with,1,1
211034,angina,1,1
211035,exclusively,1,0
211036,at,1,0
211037,rest,1,0
211038,",",0,0
211039,nine,0,1
211040,successes,0,0
211041,and,0,0
211042,four,0,1
211043,failures,0,0
211044,were,0,0
211045,observed,0,0
211046,with,0,1
211047,D.,0,0
211048,There,0,0
211049,was,0,0
211050,no,0,0
211051,symptomatic,0,0
211052,relief,0,0
211053,among,0,0
211054,the,0,0
211055,11,0,0
211056,patients,0,1
211057,treated,0,1
211058,by,0,0
211059,P,0,0
211060,(,0,0
211061,P,0,0
211062,=,0,0
211063,0.001,0,0
211064,),0,0
211065,.,0,0
211066,Moreover,0,0
211067,",",0,0
211068,the,0,0
211069,number,0,0
211070,of,0,0
211071,episodes,0,0
211072,of,0,0
211073,angina,0,1
211074,was,0,0
211075,decreased,0,0
211076,by,0,0
211077,D,0,0
211078,and,0,0
211079,unchanged,0,0
211080,by,0,0
211081,P,0,0
211082,",",0,0
211083,while,0,0
211084,eight,0,0
211085,out,0,0
211086,of,0,0
211087,the,0,0
211088,11,0,0
211089,failures,0,0
211090,with,0,1
211091,P,0,0
211092,were,0,0
211093,immediate,0,0
211094,successes,0,0
211095,when,0,0
211096,treatment,0,0
211097,was,0,0
211098,replaced,0,0
211099,with,0,1
211100,D.,0,0
211101,These,0,0
211102,results,0,0
211103,suggest,0,0
211104,that,0,0
211105,D,0,0
211106,is,0,0
211107,preferable,0,0
211108,to,0,0
211109,P,0,0
211110,for,0,0
211111,management,0,0
211112,of,0,0
211113,unstable,1,1
211114,angina,1,1
211115,in,1,0
211116,patients,1,1
211117,with,1,1
211118,angina,1,1
211119,which,1,0
211120,is,1,0
211121,exclusively,1,0
211122,spontaneous,1,0
211123,.,1,0
211124,Short-term,0,0
211125,pulmonary,0,1
211126,effects,0,0
211127,of,0,0
211128,total,0,1
211129,parenteral,0,1
211130,nutrition,0,1
211131,in,0,0
211132,children,1,1
211133,with,1,1
211134,cystic,1,1
211135,fibrosis,1,1
211136,.,1,0
211137,Indices,0,0
211138,of,0,0
211139,respiratory,0,0
211140,muscle,0,0
211141,strength,0,0
211142,",",0,0
211143,pulmonary,0,0
211144,function,0,0
211145,",",0,0
211146,and,0,0
211147,pulmonary,0,0
211148,diffusing,0,0
211149,capacity,0,0
211150,were,0,0
211151,measured,0,0
211152,in,0,0
211153,11,1,1
211154,malnourished,1,1
211155,children,1,1
211156,(,1,0
211157,age,1,1
211158,10,1,0
211159,to,1,0
211160,17,1,1
211161,years,1,1
211162,),1,0
211163,with,1,1
211164,cystic,1,1
211165,fibrosis,1,0
211166,",",1,0
211167,before,1,0
211168,and,1,0
211169,after,1,0
211170,improvement,1,0
211171,of,1,0
211172,nutritional,1,0
211173,status,1,0
211174,with,1,1
211175,supplemental,1,0
211176,parenteral,1,1
211177,nutrients,1,0
211178,for,1,0
211179,1,1,0
211180,month,1,0
211181,.,1,0
211182,During,0,0
211183,this,0,0
211184,time,0,0
211185,",",0,0
211186,the,0,0
211187,children,0,1
211188,received,0,0
211189,120,0,1
211190,%,0,0
211191,of,0,0
211192,estimated,0,0
211193,energy,0,0
211194,requirements,0,0
211195,(,0,0
211196,either,0,0
211197,3.75,0,0
211198,%,0,0
211199,or,0,0
211200,22.5,0,0
211201,%,0,0
211202,as,0,0
211203,lipid,0,0
211204,),0,0
211205,and,0,0
211206,amino,0,0
211207,acids,0,0
211208,2.5,0,0
211209,gm/120,0,0
211210,kcal,0,0
211211,by,0,0
211212,central,0,0
211213,venous,0,0
211214,catheter,0,0
211215,",",0,0
211216,plus,0,0
211217,as,0,0
211218,much,0,0
211219,of,0,0
211220,their,0,0
211221,usual,0,0
211222,diet,0,0
211223,as,0,0
211224,desired,0,0
211225,.,0,0
211226,With,0,0
211227,nutritional,0,0
211228,supplementation,0,0
211229,",",0,0
211230,body,0,0
211231,weight,0,0
211232,",",0,0
211233,triceps,0,0
211234,skinfold,0,0
211235,thickness,0,0
211236,",",0,0
211237,and,0,0
211238,mid-arm,0,0
211239,muscle,0,0
211240,circumference,0,0
211241,increased,0,0
211242,(,0,0
211243,mean,0,0
211244,15,0,0
211245,%,0,0
211246,",",0,0
211247,62,0,0
211248,%,0,0
211249,",",0,0
211250,and,0,0
211251,95,0,0
211252,%,0,0
211253,",",0,0
211254,respectively,0,0
211255,),0,0
211256,.,0,0
211257,Maximum,0,0
211258,inspiratory,0,0
211259,airway,0,0
211260,pressure,0,0
211261,also,0,0
211262,increased,0,0
211263,(,0,0
211264,mean,0,0
211265,29,0,1
211266,%,0,0
211267,;,0,0
211268,P,0,0
211269,less,0,0
211270,than,0,0
211271,0.01,0,0
211272,),0,0
211273,",",0,0
211274,suggesting,0,0
211275,improvement,0,0
211276,in,0,0
211277,respiratory,0,0
211278,muscle,0,0
211279,strength,0,0
211280,.,0,0
211281,However,0,0
211282,",",0,0
211283,none,0,0
211284,of,0,0
211285,the,0,0
211286,indices,0,0
211287,of,0,0
211288,pulmonary,0,1
211289,function,0,0
211290,improved,0,0
211291,.,0,0
211292,Pulmonary,0,0
211293,diffusing,0,0
211294,capacity,0,0
211295,did,0,0
211296,not,0,0
211297,change,0,0
211298,during,0,0
211299,parenteral,0,1
211300,nutrition,0,1
211301,regardless,0,0
211302,of,0,0
211303,the,0,0
211304,amount,0,0
211305,of,0,0
211306,parenteral,0,1
211307,energy,0,0
211308,intake,0,0
211309,supplied,0,0
211310,by,0,0
211311,lipid,0,0
211312,",",0,0
211313,but,0,0
211314,arterial,0,0
211315,oxygen,0,0
211316,saturation,0,0
211317,decreased,0,0
211318,(,0,0
211319,mean,0,0
211320,of,0,0
211321,93.5,0,0
211322,%,0,0
211323,to,0,0
211324,91.5,0,0
211325,%,0,0
211326,;,0,0
211327,P,0,0
211328,less,0,0
211329,than,0,0
211330,0.005,0,0
211331,),0,0
211332,.,0,0
211333,During,0,0
211334,the,0,0
211335,month,0,0
211336,following,0,0
211337,parenteral,0,1
211338,nutrition,0,0
211339,",",0,0
211340,weight,0,0
211341,",",0,0
211342,skinfold,0,0
211343,thickness,0,0
211344,",",0,0
211345,and,0,0
211346,mid-arm,0,0
211347,muscle,0,0
211348,circumference,0,0
211349,",",0,0
211350,but,0,0
211351,not,0,0
211352,MIP,0,0
211353,",",0,0
211354,decreased,0,0
211355,and,0,0
211356,arterial,0,0
211357,oxygen,0,0
211358,saturation,0,0
211359,returned,0,0
211360,to,0,0
211361,the,0,0
211362,initial,0,0
211363,value,0,0
211364,(,0,0
211365,P,0,0
211366,less,0,0
211367,than,0,0
211368,0.01,0,0
211369,),0,0
211370,.,0,0
211371,Failure,0,0
211372,of,0,0
211373,pyridoxine,0,0
211374,to,0,0
211375,suppress,0,0
211376,raised,0,0
211377,serum,0,0
211378,prolactin,0,0
211379,levels,0,0
211380,.,0,0
211381,Pyridoxine,0,0
211382,has,0,0
211383,been,0,0
211384,reported,0,0
211385,as,0,0
211386,having,0,1
211387,an,0,0
211388,antilactogenic,0,0
211389,effect,0,0
211390,",",0,0
211391,presumably,0,0
211392,by,0,0
211393,suppressing,0,0
211394,prolactin,0,0
211395,secretion,0,0
211396,.,0,0
211397,We,0,0
211398,have,0,0
211399,measured,0,0
211400,serum,0,0
211401,prolactin,0,0
211402,levels,0,0
211403,during,0,0
211404,pyridoxine,0,0
211405,administration,0,0
211406,in,0,0
211407,two,1,0
211408,groups,1,0
211409,of,1,0
211410,hyperprolactinaemic,1,1
211411,subjects,1,1
211412,.,1,1
211413,In,0,0
211414,normal,1,1
211415,postpartum,1,1
211416,women,1,1
211417,",",0,0
211418,the,0,0
211419,postdelivery,0,0
211420,fall,0,0
211421,in,0,0
211422,serum,0,0
211423,prolactin,0,0
211424,levels,0,0
211425,did,0,0
211426,not,0,0
211427,differ,0,0
211428,significantly,0,0
211429,in,0,0
211430,treated,0,0
211431,and,0,0
211432,control,0,1
211433,subjects,0,1
211434,.,0,1
211435,In,0,0
211436,patients,1,1
211437,with,1,1
211438,chlorpromazine-induced,1,0
211439,hyperprolactinaemia,1,1
211440,and,1,0
211441,galactorrhoea,1,0
211442,",",0,0
211443,pyridoxine,0,0
211444,did,0,0
211445,not,0,0
211446,reduce,0,0
211447,the,0,0
211448,elevated,0,0
211449,levels,0,0
211450,.,0,0
211451,In,1,0
211452,neither,1,0
211453,group,1,0
211454,was,1,0
211455,milk,1,0
211456,production,1,0
211457,suppressed,1,0
211458,.,1,0
211459,Bovine,1,1
211460,carotid,1,1
211461,artery,1,1
211462,heterografts,1,0
211463,versus,1,0
211464,polytetrafluoroethylene,1,1
211465,grafts,1,1
211466,.,1,0
211467,A,0,0
211468,prospective,0,0
211469,",",0,0
211470,randomized,0,0
211471,study,0,0
211472,.,0,0
211473,A,0,0
211474,prospective,0,0
211475,",",0,0
211476,randomized,0,0
211477,comparison,0,0
211478,of,0,0
211479,BCAH,0,0
211480,and,0,0
211481,PTFE,0,0
211482,vascular,0,0
211483,access,0,0
211484,grafts,0,1
211485,resulted,0,0
211486,in,0,0
211487,no,0,0
211488,statistically,0,0
211489,significant,0,0
211490,difference,0,0
211491,when,0,0
211492,analyzed,0,0
211493,for,0,0
211494,survival,0,0
211495,rates,0,0
211496,of,0,0
211497,complications,0,0
211498,",",0,0
211499,types,0,0
211500,of,0,0
211501,complications,0,0
211502,",",0,0
211503,reasons,0,0
211504,for,0,0
211505,failure,0,1
211506,",",0,0
211507,and,0,0
211508,clot,0,0
211509,salvageability,0,0
211510,.,0,0
211511,The,0,0
211512,results,0,0
211513,in,0,0
211514,diabetic,1,1
211515,patients,1,1
211516,were,0,0
211517,similar,0,0
211518,to,0,0
211519,those,0,0
211520,in,0,0
211521,nondiabetic,1,1
211522,patients,1,1
211523,.,1,0
211524,The,0,0
211525,majority,0,0
211526,of,0,0
211527,retrospective,0,0
211528,studies,0,0
211529,and,0,0
211530,subjective,0,0
211531,experiences,0,0
211532,favor,0,0
211533,PTFE,0,0
211534,grafts,0,1
211535,over,0,0
211536,BCAHs,0,0
211537,.,0,0
211538,The,0,0
211539,explanation,0,0
211540,may,0,0
211541,be,0,0
211542,part,0,0
211543,that,0,0
211544,BCAH,0,0
211545,preceded,0,0
211546,PTFE,0,0
211547,grafts,0,1
211548,into,0,1
211549,clinical,0,0
211550,use,0,0
211551,",",0,0
211552,and,0,0
211553,inexperience,0,0
211554,in,0,0
211555,the,0,0
211556,operating,0,0
211557,room,0,0
211558,and,0,0
211559,in,0,0
211560,the,0,0
211561,dialysis,0,0
211562,unit,0,0
211563,had,0,0
211564,an,0,0
211565,effect,0,0
211566,on,0,0
211567,BCAH,0,0
211568,results,0,0
211569,.,0,0
211570,A,0,0
211571,review,0,0
211572,of,0,0
211573,impressions,0,0
211574,of,0,0
211575,the,0,0
211576,graft,0,0
211577,materials,0,0
211578,indicated,0,0
211579,a,0,0
211580,decided,0,0
211581,preference,0,0
211582,for,0,0
211583,PTFE,0,1
211584,grafts,0,1
211585,.,0,1
211586,High-dose,0,0
211587,weekly,0,0
211588,fractionation,0,0
211589,radiotherapy,0,1
211590,in,0,0
211591,advanced,1,1
211592,cancer,1,1
211593,of,1,0
211594,the,1,0
211595,uterine,1,1
211596,cervix,1,1
211597,.,1,0
211598,A,0,0
211599,trial,0,0
211600,comparing,0,0
211601,two,1,0
211602,different,1,0
211603,radiotherapy,1,1
211604,techniques,1,0
211605,and,0,0
211606,schedules,0,0
211607,in,0,0
211608,the,0,0
211609,treatment,0,0
211610,of,0,0
211611,83,1,1
211612,patients,1,1
211613,with,1,1
211614,advanced,1,1
211615,cancer,1,1
211616,of,1,0
211617,the,1,0
211618,uterine,1,1
211619,cervix,1,1
211620,(,1,0
211621,stage,1,1
211622,IIIB,1,0
211623,),1,0
211624,employing,1,0
211625,external,1,0
211626,irradiation,1,0
211627,alone,1,0
211628,is,0,0
211629,described,0,0
211630,.,0,0
211631,The,0,0
211632,one,0,0
211633,technique,0,0
211634,",",0,0
211635,used,0,0
211636,routinely,0,0
211637,in,0,0
211638,this,0,0
211639,department,0,1
211640,",",0,0
211641,employed,0,0
211642,a,0,0
211643,conventional,0,0
211644,daily,0,0
211645,fractionation,0,0
211646,schedule,0,0
211647,while,0,0
211648,the,0,0
211649,other,0,0
211650,used,0,0
211651,a,0,0
211652,high-dose,0,0
211653,weekly,0,0
211654,fractionation,0,0
211655,regimen,0,0
211656,.,0,0
211657,The,0,0
211658,techniques,0,0
211659,are,0,0
211660,described,0,0
211661,.,0,0
211662,The,0,0
211663,aim,0,0
211664,of,0,0
211665,the,0,0
211666,trial,0,0
211667,was,0,0
211668,to,0,0
211669,compare,0,0
211670,the,0,0
211671,efficacy,0,0
211672,and,0,0
211673,morbidity,0,0
211674,of,0,0
211675,these,0,0
211676,two,0,0
211677,methods,0,0
211678,of,0,0
211679,treatment,0,0
211680,.,0,0
211681,Dose,0,0
211682,distribution,0,0
211683,curves,0,0
211684,in,0,0
211685,cross-section,0,0
211686,and,0,0
211687,midsagittal,0,0
211688,planes,0,0
211689,are,0,0
211690,shown,0,0
211691,and,0,0
211692,calculations,0,0
211693,or,0,1
211694,equivalent,0,0
211695,doses,0,0
211696,at,0,0
211697,various,0,0
211698,selected,0,1
211699,points,0,0
211700,using,0,0
211701,Ellis,0,1
211702,'s,0,1
211703,nominal,0,0
211704,single-dose,0,0
211705,formula,0,0
211706,are,0,0
211707,tabulated,0,0
211708,.,0,0
211709,The,0,0
211710,2-year,0,0
211711,survival,0,0
211712,figures,0,0
211713,were,0,0
211714,33,0,1
211715,%,0,0
211716,for,0,0
211717,the,0,0
211718,daily,0,0
211719,fractionation,0,0
211720,technique,0,0
211721,and,0,0
211722,22,0,0
211723,%,0,0
211724,for,0,0
211725,the,0,0
211726,weekly,0,0
211727,regimen,0,0
211728,.,0,0
211729,Serious,0,0
211730,late,0,0
211731,complication,0,0
211732,rates,0,0
211733,were,0,0
211734,6,0,0
211735,%,0,0
211736,for,0,0
211737,the,0,0
211738,daily,0,0
211739,regimen,0,0
211740,and,0,0
211741,22,0,1
211742,%,0,0
211743,for,0,0
211744,the,0,0
211745,weekly,0,0
211746,schedule,0,0
211747,.,0,0
211748,These,0,0
211749,differences,0,0
211750,are,0,0
211751,not,0,0
211752,statistically,0,0
211753,significant,0,0
211754,.,0,0
211755,Late,0,0
211756,complication,0,0
211757,rates,0,0
211758,in,0,0
211759,the,0,0
211760,weekly,0,0
211761,fractionation,0,0
211762,regimen,0,0
211763,appeared,0,0
211764,to,0,0
211765,be,0,0
211766,lower,0,0
211767,than,0,0
211768,figures,0,0
211769,quoted,0,0
211770,by,0,0
211771,other,0,0
211772,authors,0,0
211773,.,0,1
211774,Local,0,0
211775,control,0,0
211776,within,0,0
211777,the,0,0
211778,irradiated,0,0
211779,volume,0,0
211780,was,0,0
211781,better,0,0
211782,in,0,0
211783,the,0,0
211784,group,0,0
211785,treated,0,0
211786,by,0,0
211787,the,0,0
211788,daily,0,0
211789,fractionation,0,0
211790,method,0,0
211791,.,0,0
211792,Short-term,0,0
211793,studies,0,0
211794,on,0,0
211795,the,0,0
211796,use,0,0
211797,of,0,0
211798,glycerol,0,0
211799,as,0,0
211800,an,0,0
211801,osmotic,0,0
211802,agent,0,0
211803,in,0,0
211804,continuous,1,0
211805,ambulatory,1,1
211806,peritoneal,1,1
211807,dialysis,1,1
211808,(,1,0
211809,CAPD,1,0
211810,),1,0
211811,.,1,0
211812,The,0,0
211813,use,0,0
211814,of,0,0
211815,glycerol,0,0
211816,as,0,0
211817,an,0,0
211818,osmotic,0,0
211819,agent,0,0
211820,in,0,0
211821,two,0,0
211822,different,0,0
211823,concentrations,0,0
211824,(,0,0
211825,92,0,1
211826,mmol/l,0,0
211827,and,0,0
211828,272,0,1
211829,mmol/l,0,0
211830,),0,0
211831,in,0,0
211832,peritoneal,0,1
211833,dialysis,0,1
211834,fluid,0,0
211835,was,0,0
211836,investigated,0,0
211837,over,0,0
211838,3,0,0
211839,days,0,0
211840,in,1,0
211841,six,1,1
211842,patients,1,1
211843,on,1,0
211844,continuous,1,0
211845,ambulatory,1,1
211846,peritoneal,1,1
211847,dialysis,1,1
211848,and,0,0
211849,compared,0,0
211850,with,0,1
211851,two,0,0
211852,concentrations,0,0
211853,of,0,0
211854,glucose,0,0
211855,(,0,0
211856,76,0,1
211857,mmol/l,0,0
211858,and,0,0
211859,215,0,1
211860,mmol/l,0,0
211861,),0,0
211862,in,0,0
211863,the,0,0
211864,same,0,0
211865,patients,0,1
211866,.,0,0
211867,The,0,0
211868,calorific,0,0
211869,value,0,0
211870,of,0,0
211871,the,0,0
211872,absorbed,0,0
211873,osmotic,0,0
211874,agent,0,0
211875,was,0,0
211876,lower,0,0
211877,",",0,0
211878,by,0,0
211879,19,0,1
211880,%,0,0
211881,with,0,1
211882,isotonic,0,0
211883,and,0,0
211884,22,0,0
211885,%,0,0
211886,with,0,1
211887,hypertonic,0,0
211888,solutions,0,0
211889,",",0,0
211890,when,0,0
211891,glycerol,0,0
211892,was,0,0
211893,used,0,0
211894,in,0,0
211895,place,0,0
211896,of,0,0
211897,glucose,0,0
211898,.,0,0
211899,However,0,0
211900,",",0,0
211901,glycerol,0,0
211902,provided,0,0
211903,significantly,0,0
211904,lower,0,0
211905,total,0,0
211906,ultrafiltration,0,0
211907,than,0,0
211908,glucose,0,0
211909,at,0,0
211910,each,0,0
211911,concentration,0,0
211912,",",0,0
211913,despite,0,0
211914,a,0,0
211915,higher,0,0
211916,initial,0,0
211917,osmotic,0,0
211918,pressure,0,0
211919,of,0,0
211920,the,0,0
211921,glycerol-based,0,0
211922,solutions,0,0
211923,.,0,0
211924,Thus,0,0
211925,",",0,0
211926,the,0,0
211927,higher,0,0
211928,concentration,0,0
211929,of,0,0
211930,glycerol,0,0
211931,required,0,0
211932,to,0,0
211933,provide,0,0
211934,equal,0,0
211935,ultrafiltration,0,0
211936,may,0,0
211937,offset,0,0
211938,any,0,0
211939,calorific,0,0
211940,advantage,0,0
211941,.,0,0
211942,Equilibration,0,0
211943,of,0,0
211944,creatinine,0,0
211945,and,0,0
211946,urea,0,0
211947,was,0,0
211948,slower,0,0
211949,and,0,0
211950,creatinine,0,0
211951,clearance,0,0
211952,lower,0,0
211953,with,0,0
211954,glycerol,0,0
211955,.,0,0
211956,Solutions,0,0
211957,containing,0,0
211958,glycerol,0,0
211959,were,0,0
211960,initially,0,0
211961,less,0,0
211962,acid,0,0
211963,(,0,0
211964,pH,0,0
211965,6.5,0,0
211966,),0,0
211967,than,0,0
211968,those,0,0
211969,containing,0,0
211970,glucose,0,0
211971,(,0,0
211972,pH,0,0
211973,5.1,0,0
211974,),0,0
211975,.,0,0
211976,Blood,0,0
211977,glycerol,0,0
211978,levels,0,0
211979,",",0,0
211980,which,0,0
211981,were,0,0
211982,in,0,0
211983,the,0,0
211984,physiological,0,0
211985,range,0,0
211986,with,0,1
211987,glucose,0,0
211988,as,0,0
211989,the,0,0
211990,osmotic,0,0
211991,agent,0,0
211992,",",0,0
211993,reached,0,0
211994,a,0,0
211995,peak,0,0
211996,80-fold,0,0
211997,greater,0,0
211998,at,0,0
211999,4.3,0,0
212000,+/-,0,0
212001,0.8,0,0
212002,mmol/l,0,0
212003,during,0,0
212004,dialysis,0,0
212005,with,0,1
212006,fluid,0,0
212007,containing,0,0
212008,glycerol,0,0
212009,at,0,0
212010,272,0,1
212011,mmol/l,0,0
212012,and,0,0
212013,eightfold,0,0
212014,higher,0,0
212015,at,0,0
212016,0.42,0,0
212017,+/-,0,0
212018,0.09,0,0
212019,mmol/l,0,0
212020,with,0,1
212021,glycerol,0,0
212022,at,0,0
212023,92,0,0
212024,mmol/l,0,0
212025,.,0,0
212026,There,0,0
212027,was,0,0
212028,no,0,0
212029,evidence,0,0
212030,of,0,0
212031,haemolysis,0,0
212032,or,0,0
212033,other,0,0
212034,toxic,0,0
212035,effect,0,0
212036,despite,0,0
212037,these,0,0
212038,levels,0,0
212039,.,0,0
212040,The,0,0
212041,rise,0,0
212042,in,0,0
212043,blood,0,0
212044,glucose,0,0
212045,and,0,0
212046,insulin,0,0
212047,noted,0,0
212048,during,0,0
212049,the,0,0
212050,use,0,0
212051,of,0,0
212052,glucose-based,0,0
212053,solutions,0,0
212054,was,0,0
212055,not,0,0
212056,found,0,0
212057,with,0,0
212058,glycerol,0,0
212059,.,0,0
212060,Circulating,0,0
212061,levels,0,0
212062,of,0,0
212063,lactate,0,0
212064,",",0,0
212065,pyruvate,0,0
212066,",",0,0
212067,alanine,0,0
212068,",",0,0
212069,non-esterified,0,0
212070,fatty,0,0
212071,acids,0,0
212072,and,0,0
212073,the,0,0
212074,ketone,0,0
212075,bodies,0,1
212076,were,0,0
212077,similar,0,0
212078,with,0,1
212079,the,0,0
212080,two,0,0
212081,agents,0,0
212082,.,0,0
212083,Although,0,0
212084,these,0,0
212085,short-term,0,0
212086,studies,0,0
212087,have,0,0
212088,shown,0,0
212089,no,0,0
212090,conclusive,0,0
212091,advantage,0,0
212092,of,0,0
212093,glycerol,0,0
212094,over,0,0
212095,glucose,0,0
212096,",",0,0
212097,long-term,0,0
212098,effects,0,0
212099,of,0,0
212100,glycerol,0,0
212101,",",0,0
212102,particularly,0,0
212103,on,0,0
212104,circulating,0,0
212105,lipid,0,0
212106,levels,0,0
212107,",",0,0
212108,will,0,0
212109,determine,0,0
212110,its,0,0
212111,future,0,0
212112,role,0,0
212113,as,0,0
212114,an,0,0
212115,osmotic,0,0
212116,agent,0,0
212117,in,0,0
212118,continuous,0,0
212119,ambulatory,1,1
212120,peritoneal,1,1
212121,dialysis,1,1
212122,.,1,0
212123,Adriamycin,0,0
212124,and,0,0
212125,chlorambucil,0,0
212126,versus,0,0
212127,adriamycin,0,0
212128,and,0,0
212129,thiabendazole,0,0
212130,in,0,0
212131,the,0,0
212132,treatment,0,0
212133,of,0,0
212134,extensive,1,0
212135,",",1,0
212136,non-small,1,1
212137,cell,1,0
212138,carcinoma,1,1
212139,of,1,0
212140,the,1,0
212141,lung,1,0
212142,:,1,0
212143,a,1,0
212144,Southwest,1,1
212145,Oncology,1,0
212146,Group,1,0
212147,pilot,0,0
212148,study,0,0
212149,.,0,0
212150,Handwarming,0,0
212151,and,0,0
212152,relaxation,0,0
212153,in,0,0
212154,temperature,0,0
212155,feedback,0,0
212156,:,0,1
212157,positive,0,0
212158,placebo,0,0
212159,effects,0,0
212160,.,0,1
212161,Sixteen,1,1
212162,males,1,1
212163,and,1,0
212164,females,1,1
212165,were,0,0
212166,randomly,0,1
212167,assigned,0,0
212168,to,0,0
212169,either,0,0
212170,temperature,0,0
212171,feedback,0,0
212172,groups,0,0
212173,warm-relax,0,0
212174,(,0,0
212175,WR,0,0
212176,),0,0
212177,or,0,0
212178,cool-relax,0,0
212179,(,0,0
212180,CR,0,0
212181,),0,0
212182,to,0,0
212183,determine,0,0
212184,how,0,0
212185,successful,0,0
212186,hand-warming,0,0
212187,and,0,0
212188,-cooling,0,0
212189,alters,0,0
212190,the,0,0
212191,subjective,0,0
212192,report,0,0
212193,of,0,0
212194,relaxation,0,0
212195,.,0,0
212196,After,0,0
212197,eight,0,1
212198,1/2-hour,0,0
212199,sessions,0,0
212200,the,0,0
212201,WR,0,0
212202,and,0,0
212203,CR,0,0
212204,demonstrated,0,0
212205,a,0,0
212206,significant,0,0
212207,difference,0,0
212208,in,0,0
212209,temperature,0,0
212210,change,0,0
212211,",",0,0
212212,but,0,0
212213,there,0,0
212214,were,0,0
212215,no,0,0
212216,significant,0,0
212217,main,0,0
212218,effects,0,0
212219,in,0,0
212220,reported,0,0
212221,subjective,0,0
212222,relaxation,0,0
212223,.,0,0
212224,The,0,0
212225,reported,0,0
212226,feelings,0,0
212227,of,0,0
212228,relaxation,0,0
212229,were,0,0
212230,negatively,0,0
212231,correlated,0,0
212232,to,0,0
212233,the,0,0
212234,directionality,0,0
212235,of,0,0
212236,temperature,0,0
212237,change,0,0
212238,and,0,0
212239,were,0,0
212240,primarily,0,0
212241,attributed,0,0
212242,to,0,0
212243,nonspecific,0,1
212244,expectancies,0,0
212245,.,0,1
212246,Experimental,0,0
212247,hyaline,1,1
212248,membrane,1,0
212249,disease,1,1
212250,in,1,0
212251,the,1,0
212252,premature,1,1
212253,monkey,1,1
212254,:,1,1
212255,effects,0,0
212256,of,0,0
212257,antenatal,0,1
212258,dexamethasone,0,0
212259,.,0,0
212260,A,0,0
212261,blind,0,0
212262,",",0,0
212263,randomized,0,0
212264,trial,0,0
212265,of,0,0
212266,antenatal,0,1
212267,glucocorticoid,0,0
212268,treatment,0,0
212269,was,0,0
212270,conducted,0,0
212271,using,0,0
212272,the,0,0
212273,premature,1,1
212274,monkey,1,0
212275,(,1,0
212276,Macaca,1,0
212277,nemestrina,1,1
212278,),1,0
212279,model,1,0
212280,of,1,0
212281,hyaline,1,0
212282,membrane,1,0
212283,disease,1,1
212284,(,1,0
212285,HMD,1,0
212286,),1,0
212287,.,1,0
212288,Twelve,1,0
212289,dams,1,0
212290,received,0,0
212291,dexamethasone,0,0
212292,(,0,0
212293,2,0,0
212294,mg/dose,0,0
212295,),0,0
212296,72,0,0
212297,",",0,0
212298,48,0,0
212299,",",0,0
212300,and,0,0
212301,24,0,0
212302,h,0,0
212303,before,0,0
212304,abdominal,0,1
212305,delivery,0,0
212306,at,0,0
212307,135,0,1
212308,+/-,0,0
212309,1,0,0
212310,days,0,0
212311,of,0,0
212312,gestation,0,1
212313,.,0,0
212314,Twelve,1,1
212315,control,1,0
212316,animals,1,0
212317,received,0,0
212318,saline,0,0
212319,.,0,0
212320,Infants,1,1
212321,of,1,0
212322,dexamethasone-treated,1,1
212323,dams,1,0
212324,had,0,0
212325,significantly,0,0
212326,lower,0,0
212327,incidence,0,0
212328,and,0,0
212329,severity,0,0
212330,of,0,0
212331,HMD,0,0
212332,than,0,0
212333,did,0,0
212334,infants,0,1
212335,of,0,0
212336,control,0,1
212337,animals,0,0
212338,(,0,0
212339,50,0,0
212340,versus,0,0
212341,92,0,0
212342,%,0,0
212343,",",0,0
212344,p,0,0
212345,less,0,0
212346,than,0,0
212347,0.05,0,0
212348,),0,0
212349,.,0,0
212350,Improvement,0,0
212351,with,0,0
212352,treatment,0,0
212353,was,0,0
212354,markedly,0,0
212355,greater,0,0
212356,for,0,0
212357,males,0,1
212358,than,0,0
212359,for,0,0
212360,females,0,1
212361,.,0,1
212362,Differences,0,0
212363,in,0,0
212364,volume-pressure,0,0
212365,behavior,0,0
212366,of,0,0
212367,the,0,0
212368,excised,0,1
212369,lungs,0,0
212370,included,0,1
212371,greater,0,0
212372,distensibility,0,0
212373,in,0,0
212374,the,0,0
212375,infants,0,1
212376,from,0,0
212377,dexamethasone-treated,0,1
212378,dams,0,0
212379,(,0,0
212380,20.6,0,0
212381,+/-,0,0
212382,7.1,0,0
212383,ml/g,0,0
212384,dry,0,0
212385,lung,0,1
212386,versus,0,0
212387,14.7,0,0
212388,+/-,0,0
212389,6.1,0,0
212390,",",0,0
212391,p,0,0
212392,less,0,0
212393,than,0,0
212394,0.05,0,0
212395,),0,0
212396,and,0,0
212397,enhanced,0,0
212398,deflation,0,0
212399,stability,0,0
212400,with,0,1
212401,treatment,0,0
212402,.,0,0
212403,Accelerated,0,0
212404,production,0,0
212405,of,0,0
212406,surface,0,0
212407,active,0,0
212408,material,0,1
212409,(,0,0
212410,SAM,0,0
212411,),0,0
212412,phospholipids,0,0
212413,in,0,0
212414,infants,0,1
212415,from,0,1
212416,dexamethasone-treated,0,1
212417,dams,0,0
212418,was,0,0
212419,indicated,0,0
212420,by,0,0
212421,increases,0,0
212422,in,0,0
212423,total,0,1
212424,lung,0,1
212425,phospholipid,0,0
212426,(,0,0
212427,84.5,0,0
212428,+/-,0,0
212429,8.1,0,0
212430,mg/g,0,0
212431,dry,0,0
212432,lung,0,1
212433,versus,0,0
212434,75.1,0,0
212435,+/-,0,0
212436,9.9,0,0
212437,",",0,0
212438,p,0,0
212439,less,0,0
212440,than,0,0
212441,0.025,0,0
212442,),0,0
212443,",",0,0
212444,alveolar,0,0
212445,lavage,0,0
212446,fluid,0,0
212447,phospholipid,0,0
212448,(,0,0
212449,5.65,0,0
212450,+/-,0,0
212451,3.33,0,0
212452,mg/g,0,0
212453,dry,0,0
212454,lung,0,1
212455,versus,0,0
212456,3.01,0,0
212457,+/-,0,0
212458,1.84,0,0
212459,",",0,0
212460,p,0,0
212461,less,0,0
212462,than,0,0
212463,0.05,0,0
212464,),0,0
212465,",",0,0
212466,and,0,0
212467,alveolar,0,0
212468,lavage,0,0
212469,fluid,0,0
212470,disaturated,0,0
212471,phosphatidylcholine,0,0
212472,(,0,0
212473,DPC,0,0
212474,),0,0
212475,(,0,0
212476,2.47,0,0
212477,+/-,0,0
212478,1.84,0,0
212479,mg/g,0,0
212480,dry,0,0
212481,lung,0,1
212482,versus,0,0
212483,1.06,0,0
212484,+/-,0,0
212485,1.05,0,0
212486,",",0,0
212487,p,0,0
212488,less,0,0
212489,than,0,0
212490,0.05,0,0
212491,),0,0
212492,.,0,0
212493,Incorporation,0,0
212494,of,0,0
212495,14C-palmitate,0,0
212496,into,0,0
212497,lung,0,1
212498,lipid,0,0
212499,was,0,0
212500,not,0,0
212501,influenced,0,0
212502,by,0,0
212503,dexamethasone,0,0
212504,",",0,0
212505,but,0,0
212506,a,0,0
212507,significantly,0,0
212508,greater,0,0
212509,portion,0,0
212510,of,0,0
212511,the,0,0
212512,label,0,0
212513,appeared,0,0
212514,in,0,0
212515,the,0,0
212516,DPC,0,0
212517,fraction,0,0
212518,with,0,1
212519,treatment,0,0
212520,.,0,0
212521,Antenatal,0,0
212522,dexamethasone,0,0
212523,treatment,0,0
212524,was,0,0
212525,successful,0,0
212526,in,0,0
212527,reducing,0,0
212528,the,0,0
212529,incidence,0,0
212530,and,0,0
212531,severity,0,0
212532,of,0,0
212533,experimental,0,0
212534,HMD,0,0
212535,in,0,0
212536,this,0,0
212537,animal,0,0
212538,model,0,0
212539,;,0,0
212540,the,0,0
212541,beneficial,0,0
212542,effects,0,0
212543,of,0,0
212544,treatment,0,0
212545,were,0,0
212546,associated,0,0
212547,with,0,1
212548,accelerated,0,0
212549,maturation,0,0
212550,of,0,0
212551,fetal,0,1
212552,pulmonary,0,1
212553,functions,0,0
212554,",",0,0
212555,including,0,0
212556,",",0,0
212557,but,0,0
212558,not,0,0
212559,limited,0,0
212560,to,0,0
212561,",",0,0
212562,synthetic,0,0
212563,metabolism,0,0
212564,of,0,0
212565,SAM,0,0
212566,phospholipid,0,0
212567,.,0,0
212568,Cardiovascular,0,0
212569,complications,0,0
212570,to,0,0
212571,treatment,0,0
212572,of,0,0
212573,prostate,1,1
212574,cancer,1,1
212575,with,0,1
212576,estramustine,0,0
212577,phosphate,0,0
212578,(,0,0
212579,Estracyt,0,0
212580,),0,0
212581,or,0,0
212582,conventional,0,0
212583,estrogen,0,0
212584,.,0,0
212585,A,0,0
212586,follow-up,1,0
212587,of,1,0
212588,212,1,1
212589,randomized,1,1
212590,patients,1,1
212591,.,1,1
212592,Two,1,0
212593,hundred,1,1
212594,and,1,0
212595,twelve,1,1
212596,patients,1,1
212597,treated,1,1
212598,for,1,0
212599,prostatic,1,1
212600,cancer,1,1
212601,grade,1,0
212602,I,1,0
212603,or,1,0
212604,II,1,0
212605,were,1,0
212606,investigated,0,0
212607,for,0,0
212608,cardiovascular,0,1
212609,complications,0,0
212610,.,0,1
212611,The,1,0
212612,patients,1,1
212613,were,1,0
212614,part,1,0
212615,of,1,0
212616,a,1,0
212617,multicentre,1,0
212618,study,1,0
212619,in,1,0
212620,the,1,0
212621,Stockholm,1,1
212622,area,1,0
212623,and,1,0
212624,had,1,0
212625,been,1,0
212626,randomized,1,0
212627,to,1,0
212628,treatment,1,0
212629,with,1,0
212630,either,1,0
212631,estramustine,1,0
212632,phosphate,1,0
212633,(,1,0
212634,Estracyt,1,0
212635,),1,0
212636,or,1,0
212637,polyestradiol,1,0
212638,phosphate,1,0
212639,and,1,0
212640,ethinyl,1,0
212641,estradiol,1,0
212642,.,1,0
212643,Cardiovascular,0,0
212644,complications,0,0
212645,categorized,0,1
212646,as,0,0
212647,impaired,0,0
212648,arterial,0,1
212649,circulation,0,0
212650,including,0,0
212651,ischemic,0,1
212652,heart,0,1
212653,disease,0,1
212654,",",0,0
212655,venous,0,0
212656,thromboembolism,0,0
212657,",",0,0
212658,cardiac,0,0
212659,incompensation,0,0
212660,and,0,0
212661,cerebral,0,1
212662,depression,0,1
212663,were,0,0
212664,found,0,0
212665,to,0,0
212666,be,0,0
212667,equally,0,0
212668,frequent,0,0
212669,following,0,0
212670,the,0,0
212671,two,0,0
212672,different,0,0
212673,forms,0,0
212674,of,0,0
212675,treatment,0,0
212676,.,0,0
212677,Among,0,0
212678,the,0,0
212679,patients,0,1
212680,getting,0,0
212681,cardiovascular,0,1
212682,complications,0,0
212683,",",0,0
212684,these,0,0
212685,occurred,0,0
212686,within,0,0
212687,two,0,0
212688,months,0,0
212689,after,0,0
212690,the,0,0
212691,start,0,0
212692,of,0,0
212693,treatment,0,0
212694,in,0,0
212695,50,0,0
212696,%,0,0
212697,and,0,0
212698,within,0,0
212699,one,0,0
212700,year,0,0
212701,in,0,0
212702,85,0,0
212703,%,0,0
212704,of,0,0
212705,them,0,0
212706,.,0,0
212707,There,0,0
212708,was,0,0
212709,a,0,0
212710,statistically,0,0
212711,significant,0,0
212712,correlation,0,0
212713,between,0,0
212714,the,0,0
212715,incidence,0,0
212716,of,0,0
212717,cardiovascular,0,1
212718,complications,0,0
212719,and,0,0
212720,a,0,0
212721,history,0,0
212722,of,0,0
212723,previous,0,0
212724,cardiovascular,0,1
212725,disease,0,1
212726,.,0,0
212727,This,0,0
212728,criterion,0,0
212729,was,0,0
212730,however,0,0
212731,in,0,0
212732,retrospect,0,1
212733,found,0,0
212734,to,0,0
212735,predict,0,0
212736,cardiovascular,0,0
212737,complications,0,0
212738,in,0,0
212739,only,0,0
212740,67,0,0
212741,of,0,0
212742,the,0,0
212743,126,0,1
212744,patients,0,1
212745,getting,0,0
212746,one,0,1
212747,or,0,1
212748,several,0,0
212749,of,0,0
212750,these,0,0
212751,complications,0,0
212752,.,0,0
212753,Tolfenamic,0,0
212754,acid,0,0
212755,and,0,0
212756,caffeine,0,0
212757,:,0,0
212758,a,0,0
212759,useful,0,0
212760,combination,0,0
212761,in,0,0
212762,migraine,1,1
212763,.,1,0
212764,Tolfenamic,0,0
212765,acid,0,0
212766,is,0,0
212767,a,0,0
212768,potent,0,0
212769,inhibitor,0,0
212770,of,0,0
212771,prostaglandin,0,0
212772,biosynthesis,0,0
212773,",",0,0
212774,which,0,0
212775,has,0,0
212776,been,0,0
212777,proved,0,0
212778,effective,0,0
212779,in,0,0
212780,the,0,0
212781,treatment,0,0
212782,of,0,0
212783,acute,1,1
212784,migraine,1,1
212785,attacks,1,0
212786,.,0,0
212787,The,0,0
212788,usefulness,0,0
212789,of,0,0
212790,caffeine,0,0
212791,",",0,0
212792,metoclopramide,0,0
212793,and,0,0
212794,pyridoxine,0,0
212795,as,0,0
212796,adjuncts,0,0
212797,to,0,0
212798,tolfenamic,0,0
212799,acid,0,0
212800,was,0,0
212801,tested,0,0
212802,in,0,0
212803,acute,1,1
212804,migraine,1,1
212805,attacks,1,0
212806,in,1,0
212807,ten,1,1
212808,patients,1,1
212809,.,1,0
212810,A,0,0
212811,combination,0,0
212812,of,0,0
212813,tolfenamic,0,0
212814,acid,0,0
212815,(,0,0
212816,200,0,0
212817,mg,0,0
212818,),0,0
212819,with,0,0
212820,either,0,0
212821,caffeine,0,0
212822,(,0,0
212823,100,0,0
212824,mg,0,0
212825,),0,0
212826,",",0,0
212827,metoclopramide,0,0
212828,(,0,0
212829,10,0,0
212830,mg,0,0
212831,),0,0
212832,or,0,0
212833,pyridoxine,0,0
212834,(,0,0
212835,300,0,0
212836,mg,0,0
212837,),0,0
212838,was,0,0
212839,given,0,0
212840,twice,0,0
212841,to,0,0
212842,each,0,0
212843,patient,0,0
212844,in,0,0
212845,random,0,0
212846,order,0,0
212847,.,0,0
212848,Thus,0,0
212849,60,1,0
212850,attacks,1,0
212851,were,0,0
212852,treated,0,1
212853,.,0,0
212854,The,0,0
212855,tolfenamic,0,0
212856,acid-caffeine,0,0
212857,combination,0,0
212858,proved,0,0
212859,the,0,0
212860,most,0,0
212861,effective,0,0
212862,as,0,0
212863,judged,0,0
212864,by,0,0
212865,duration,0,0
212866,and,0,0
212867,intensity,0,0
212868,of,0,0
212869,attacks,0,0
212870,",",0,0
212871,working,0,0
212872,ability,0,0
212873,",",0,0
212874,vigilance,0,0
212875,",",0,0
212876,and,0,0
212877,overall,0,0
212878,evaluation,0,0
212879,of,0,0
212880,the,0,0
212881,drugs,0,0
212882,by,0,0
212883,the,0,0
212884,patients,0,1
212885,.,0,0
212886,Metoclopramide,0,0
212887,was,0,0
212888,somewhat,0,0
212889,better,0,0
212890,than,0,0
212891,pyridoxine,0,0
212892,as,0,0
212893,an,0,0
212894,additive,0,0
212895,.,0,0
212896,Ambulation,0,0
212897,in,0,0
212898,labour,0,0
212899,.,0,0
212900,In,0,0
212901,a,0,0
212902,randomised,0,0
212903,prospective,0,0
212904,study,0,0
212905,of,0,0
212906,68,1,1
212907,women,1,1
212908,in,1,0
212909,spontaneous,1,0
212910,labour,1,1
212911,half,0,1
212912,were,0,0
212913,allocated,0,0
212914,to,0,0
212915,an,0,0
212916,ambulant,0,0
212917,group,0,0
212918,and,0,0
212919,half,0,0
212920,to,0,0
212921,a,0,0
212922,recumbent,0,0
212923,group,0,0
212924,.,0,0
212925,The,0,0
212926,duration,0,0
212927,of,0,0
212928,labour,0,0
212929,was,0,0
212930,significantly,0,0
212931,shorter,0,0
212932,",",0,0
212933,the,0,0
212934,need,0,0
212935,for,0,0
212936,analgesia,0,0
212937,significantly,0,0
212938,less,0,0
212939,",",0,0
212940,and,0,0
212941,the,0,0
212942,incidence,0,0
212943,of,0,0
212944,fetal,0,0
212945,heart,0,1
212946,abnormalities,0,0
212947,significantly,0,0
212948,smaller,0,0
212949,in,0,0
212950,the,0,0
212951,ambulant,0,0
212952,group,0,0
212953,than,0,0
212954,in,0,0
212955,the,0,0
212956,recumbent,0,0
212957,group,0,0
212958,.,0,0
212959,Apgar,0,0
212960,scores,0,0
212961,at,0,0
212962,one,0,0
212963,and,0,0
212964,five,0,1
212965,minutes,0,0
212966,were,0,0
212967,also,0,0
212968,significantly,0,0
212969,greater,0,0
212970,in,0,0
212971,the,0,0
212972,ambulant,0,1
212973,group,0,0
212974,.,0,0
212975,More,0,0
212976,patients,0,1
212977,in,0,0
212978,the,0,0
212979,recumbent,0,0
212980,group,0,0
212981,required,0,0
212982,augmentations,0,0
212983,with,0,1
212984,oxytocic,0,1
212985,drugs,0,0
212986,.,0,0
212987,There,0,0
212988,was,0,0
212989,no,0,0
212990,statistically,0,0
212991,significant,0,0
212992,difference,0,0
212993,in,0,0
212994,the,0,0
212995,third,0,0
212996,stage,0,1
212997,loss,0,0
212998,in,0,0
212999,the,0,0
213000,two,0,0
213001,groups,0,0
213002,.,0,1
213003,Ambulation,0,0
213004,in,0,0
213005,labour,0,0
213006,should,0,0
213007,be,0,0
213008,encouraged,0,0
213009,:,0,0
213010,it,0,0
213011,may,0,0
213012,bring,0,0
213013,human,0,0
213014,benefits,0,0
213015,while,0,0
213016,allowing,0,0
213017,the,0,0
213018,advantages,0,0
213019,of,0,0
213020,hospital,0,1
213021,supervision,0,0
213022,.,0,0
213023,[,0,0
213024,Biological,0,0
213025,and,0,0
213026,clinical,0,0
213027,effects,0,0
213028,of,0,0
213029,oral,0,0
213030,magnesium,0,0
213031,and,0,0
213032,associated,0,0
213033,magnesium-vitamin,0,0
213034,B6,0,0
213035,administration,0,0
213036,on,0,0
213037,certain,1,0
213038,disorders,1,1
213039,observed,1,0
213040,in,1,0
213041,infantile,1,1
213042,autism,1,1
213043,(,0,0
213044,author,0,0
213045,'s,0,0
213046,transl,0,1
213047,),0,1
213048,],0,0
213049,.,0,0
213050,Laser,0,0
213051,conization,0,1
213052,versus,0,0
213053,cold,0,0
213054,knife,0,0
213055,conization,0,1
213056,.,0,0
213057,This,0,0
213058,prospective,0,0
213059,",",0,0
213060,randomized,0,0
213061,study,0,0
213062,compares,0,0
213063,",",0,0
213064,for,0,0
213065,the,0,0
213066,first,0,0
213067,time,0,0
213068,",",0,0
213069,measured,0,0
213070,blood,0,0
213071,loss,0,0
213072,at,0,0
213073,conization,0,1
213074,and,0,0
213075,within,0,0
213076,24,0,0
213077,hours,0,0
213078,after,0,0
213079,using,0,0
213080,either,0,0
213081,the,0,0
213082,cold,0,0
213083,knife,0,0
213084,technique,0,0
213085,or,0,0
213086,the,0,0
213087,carbon,0,0
213088,dioxide,0,0
213089,laser,0,0
213090,scalpel,0,0
213091,.,0,0
213092,One,1,0
213093,hundred,1,1
213094,and,1,0
213095,ten,1,1
213096,consecutive,1,1
213097,patients,1,1
213098,were,1,0
213099,evaluated,1,0
213100,.,1,0
213101,The,0,0
213102,median,0,0
213103,blood,0,0
213104,loss,0,0
213105,in,0,0
213106,the,0,0
213107,laser,0,0
213108,group,0,0
213109,of,0,0
213110,55,0,1
213111,patients,0,1
213112,was,0,0
213113,4.6,0,0
213114,milliliters,0,0
213115,at,0,0
213116,",",0,0
213117,and,0,0
213118,within,0,0
213119,",",0,0
213120,24,0,0
213121,hours,0,0
213122,after,0,0
213123,operation,0,0
213124,compared,0,0
213125,with,0,1
213126,30.1,0,0
213127,milliliters,0,0
213128,in,0,0
213129,the,0,0
213130,cold,0,0
213131,knife,0,0
213132,group,0,0
213133,of,0,0
213134,55,0,1
213135,patients,0,1
213136,.,0,0
213137,More,0,0
213138,important,0,0
213139,",",0,0
213140,however,0,0
213141,",",0,0
213142,is,0,0
213143,that,0,0
213144,the,0,0
213145,corresponding,0,0
213146,figures,0,0
213147,for,0,0
213148,the,0,0
213149,range,0,0
213150,of,0,0
213151,bleeding,0,0
213152,were,0,0
213153,0.4,0,0
213154,to,0,0
213155,155.4,0,0
213156,milliliters,0,0
213157,and,0,0
213158,5.6,0,0
213159,to,0,0
213160,"1,570.9",0,0
213161,milliliters,0,0
213162,",",0,0
213163,respectively,0,0
213164,.,0,0
213165,The,0,0
213166,incidence,0,0
213167,rate,0,0
213168,for,0,0
213169,bleeding,0,0
213170,complications,0,0
213171,requiring,0,1
213172,surgical,0,1
213173,intervention,0,0
213174,was,0,0
213175,1.8,0,0
213176,per,0,0
213177,cet,0,0
213178,for,0,0
213179,the,0,0
213180,laser,0,0
213181,group,0,0
213182,and,0,0
213183,14.6,0,0
213184,per,0,0
213185,cent,0,0
213186,for,0,0
213187,the,0,0
213188,cold,0,0
213189,knife,0,0
213190,group,0,0
213191,.,0,0
213192,This,0,0
213193,difference,0,0
213194,was,0,0
213195,statistically,0,0
213196,significant,0,0
213197,",",0,0
213198,p,0,0
213199,less,0,0
213200,than,0,0
213201,0.015,0,0
213202,--,0,1
213203,Fischer,0,0
213204,'s,0,0
213205,exact,0,0
213206,test,0,0
213207,.,0,0
213208,Conization,0,0
213209,for,0,0
213210,treatment,0,0
213211,of,0,0
213212,premalignant,1,1
213213,changes,1,0
213214,of,1,0
213215,the,1,0
213216,cervix,1,0
213217,uteri,1,1
213218,will,0,0
213219,probably,0,0
213220,remain,0,0
213221,the,0,0
213222,treatment,0,0
213223,of,0,0
213224,choice,0,0
213225,for,0,0
213226,some,0,0
213227,time,0,0
213228,to,0,0
213229,come,0,0
213230,.,0,0
213231,It,0,0
213232,is,0,0
213233,our,0,0
213234,opinion,0,0
213235,that,0,0
213236,",",0,0
213237,in,0,0
213238,the,0,0
213239,future,0,0
213240,",",0,0
213241,laser,0,0
213242,conization,0,1
213243,will,0,0
213244,replace,0,0
213245,cold,0,0
213246,knife,0,0
213247,conization,0,1
213248,.,0,0
213249,Perception,0,0
213250,of,0,0
213251,social,0,0
213252,interactions,0,0
213253,in,0,0
213254,depressed,1,1
213255,psychiatric,1,1
213256,patients,1,1
213257,.,1,1
213258,A,0,0
213259,comparison,0,0
213260,of,0,0
213261,dorsal,0,0
213262,and,0,0
213263,volar,0,0
213264,resting,0,0
213265,hand,0,0
213266,splints,0,0
213267,in,0,0
213268,the,0,0
213269,reduction,0,0
213270,of,0,0
213271,hypertonus,1,0
213272,.,1,1
213273,Ten,1,1
213274,adults,1,1
213275,with,1,1
213276,hypertonic,1,0
213277,wrist,1,1
213278,flexors,1,0
213279,volunteered,1,1
213280,as,1,0
213281,subjects,1,1
213282,in,0,0
213283,an,0,0
213284,experiment,0,0
213285,comparing,0,0
213286,the,0,0
213287,effectiveness,0,0
213288,of,0,0
213289,dorsal,0,0
213290,and,0,0
213291,volar,0,0
213292,resting,0,0
213293,hand,0,0
213294,splints,0,0
213295,in,0,0
213296,the,0,0
213297,reduction,0,0
213298,of,0,0
213299,abnormal,0,0
213300,muscle,0,0
213301,tone,0,0
213302,.,0,0
213303,Subjects,0,0
213304,were,0,0
213305,randomly,0,1
213306,assigned,0,0
213307,to,0,0
213308,two,0,0
213309,groups,0,0
213310,of,0,0
213311,five,0,1
213312,each,0,0
213313,.,0,0
213314,Individuals,0,0
213315,in,0,0
213316,one,0,1
213317,group,0,0
213318,were,0,0
213319,fitted,0,0
213320,with,0,1
213321,dorsal,0,0
213322,splints,0,0
213323,",",0,0
213324,and,0,0
213325,individuals,0,1
213326,in,0,0
213327,a,0,0
213328,second,0,0
213329,group,0,0
213330,with,0,1
213331,volar,0,0
213332,splints,0,0
213333,.,0,1
213334,Measurements,0,0
213335,by,0,0
213336,spring-weighted,0,1
213337,scales,0,0
213338,were,0,0
213339,taken,0,0
213340,to,0,0
213341,assess,0,0
213342,the,0,0
213343,efficiency,0,0
213344,of,0,0
213345,each,0,0
213346,splint,0,0
213347,design,0,0
213348,in,0,0
213349,the,0,0
213350,reduction,0,0
213351,of,0,0
213352,hypertonus,0,0
213353,.,0,0
213354,Results,0,0
213355,demonstrated,0,0
213356,no,0,0
213357,significant,0,0
213358,differences,0,0
213359,between,0,0
213360,the,0,0
213361,volar,0,0
213362,and,0,0
213363,dorsal,0,0
213364,splints,0,0
213365,in,0,0
213366,reducing,0,0
213367,hypertonus,1,0
213368,.,1,0
213369,However,0,0
213370,",",0,0
213371,the,0,0
213372,age,0,1
213373,of,0,0
213374,the,0,0
213375,subjects,0,1
213376,was,0,0
213377,found,0,0
213378,to,0,0
213379,be,0,0
213380,an,0,0
213381,intervening,0,0
213382,variable,0,0
213383,:,0,1
213384,The,0,0
213385,older,1,1
213386,subjects,1,1
213387,of,0,0
213388,both,0,0
213389,groups,0,0
213390,demonstrated,0,0
213391,a,0,0
213392,gradual,0,0
213393,but,0,0
213394,not,0,0
213395,significant,0,0
213396,decline,0,0
213397,in,0,0
213398,hypertonus,0,0
213399,",",0,0
213400,whereas,0,0
213401,the,0,0
213402,younger,1,1
213403,adults,1,1
213404,demonstrated,0,0
213405,a,0,0
213406,significant,0,0
213407,decline,0,0
213408,in,0,0
213409,hypertonus,0,0
213410,over,0,0
213411,a,0,0
213412,6-week,0,0
213413,period,0,0
213414,.,0,0
213415,Breast,1,0
213416,cancer,1,1
213417,screening,1,1
213418,in,0,0
213419,Sweden,1,1
213420,.,1,0
213421,The,0,0
213422,single,0,0
213423,modality,0,0
213424,approach,0,0
213425,.,0,0
213426,Four,1,0
213427,population-based,1,1
213428,breast,1,1
213429,cancer,1,1
213430,screening,1,1
213431,projects,1,0
213432,are,1,0
213433,in,1,0
213434,progress,1,0
213435,in,1,0
213436,Sweden,1,1
213437,",",0,0
213438,three,0,0
213439,of,0,0
213440,which,0,0
213441,are,0,0
213442,randomized,0,0
213443,studies,0,0
213444,.,0,0
213445,Mammography,0,0
213446,is,0,0
213447,the,0,0
213448,only,0,0
213449,screening,0,0
213450,method,0,0
213451,.,0,0
213452,51,0,0
213453,%,0,0
213454,of,0,0
213455,all,0,0
213456,carcinomas,0,1
213457,detected,0,0
213458,at,0,0
213459,the,0,0
213460,first,0,0
213461,screening,0,0
213462,were,0,0
213463,either,0,0
213464,in,0,0
213465,situ,0,0
213466,or,0,0
213467,invasive,0,0
213468,with,0,0
213469,a,0,0
213470,diameter,0,0
213471,of,0,0
213472,10,0,0
213473,mm,0,0
213474,or,0,0
213475,less,0,0
213476,.,0,0
213477,Axillary,0,1
213478,metastases,0,1
213479,were,0,0
213480,found,0,0
213481,in,0,0
213482,16,0,0
213483,%,0,0
213484,of,0,0
213485,the,0,0
213486,patients,0,1
213487,.,0,0
213488,Sensitivity,0,0
213489,was,0,0
213490,over,0,0
213491,90,0,0
213492,%,0,0
213493,in,0,0
213494,all,0,0
213495,projects,0,0
213496,.,0,0
213497,The,0,0
213498,ultimate,0,0
213499,aim,0,0
213500,of,0,0
213501,the,0,0
213502,randomized,0,0
213503,projects,0,0
213504,is,0,0
213505,to,0,0
213506,demonstrate,0,0
213507,the,0,0
213508,effect,0,0
213509,of,0,0
213510,screening,0,0
213511,on,0,0
213512,breast,0,1
213513,cancer,0,1
213514,mortality,0,0
213515,.,0,0
213516,It,0,0
213517,is,0,0
213518,estimated,0,0
213519,that,0,0
213520,mortality,0,0
213521,statistics,0,0
213522,will,0,0
213523,reach,0,0
213524,significant,0,0
213525,levels,0,0
213526,in,0,0
213527,1983.,0,0
213528,",",0,0
213529,Topical,0,1
213530,treatment,0,0
213531,of,0,0
213532,alopecia,0,1
213533,areata,0,0
213534,.,0,0
213535,It,0,0
213536,has,0,0
213537,been,0,0
213538,shown,0,0
213539,previously,0,0
213540,that,0,0
213541,alopecia,0,0
213542,areata,0,0
213543,can,0,0
213544,be,0,0
213545,treated,0,0
213546,with,0,0
213547,dinitrochlorobenzene,0,0
213548,(,0,0
213549,DNCB,0,0
213550,),0,0
213551,and,0,0
213552,other,0,0
213553,contact,0,0
213554,allergens,0,0
213555,.,0,0
213556,Whether,0,0
213557,these,0,0
213558,agents,0,0
213559,work,0,0
213560,by,0,0
213561,inducing,0,0
213562,immunologic,0,0
213563,stimulation,0,0
213564,or,0,0
213565,simply,0,0
213566,a,0,0
213567,nonspecific,0,0
213568,inflammatory,0,0
213569,reaction,0,0
213570,has,0,0
213571,not,0,0
213572,been,0,0
213573,definitively,0,0
213574,demonstrated,0,0
213575,.,0,0
213576,To,0,0
213577,test,0,0
213578,the,0,0
213579,relative,0,0
213580,importance,0,0
213581,of,0,0
213582,these,0,0
213583,two,0,0
213584,mechanisms,0,0
213585,",",0,0
213586,we,0,0
213587,have,0,0
213588,randomly,0,0
213589,studied,0,1
213590,22,1,0
213591,patients,1,1
213592,with,1,1
213593,alopecia,1,1
213594,areata,1,1
213595,to,1,1
213596,whom,1,1
213597,either,1,1
213598,DNCB,1,1
213599,or,1,0
213600,croton,1,0
213601,oil,1,0
213602,was,1,0
213603,applied,1,0
213604,topically,1,0
213605,.,1,0
213606,Sixty-three,0,1
213607,percent,0,0
213608,of,0,0
213609,patients,0,1
213610,without,0,1
213611,spontaneous,0,0
213612,regrowth,0,0
213613,of,0,0
213614,hair,0,1
213615,regrew,0,0
213616,hair,0,1
213617,after,0,0
213618,DNCB,0,0
213619,application,0,0
213620,.,0,0
213621,None,0,0
213622,of,0,0
213623,those,0,0
213624,treated,0,0
213625,with,0,0
213626,croton,0,0
213627,oil,0,0
213628,regrew,0,0
213629,hair,0,0
213630,when,0,0
213631,treated,0,0
213632,later,0,0
213633,with,0,1
213634,DNCB,0,0
213635,.,0,0
213636,Therefore,0,0
213637,",",0,0
213638,a,0,0
213639,proved,0,0
213640,contact,0,0
213641,allergen,0,0
213642,was,0,0
213643,shown,0,0
213644,to,0,0
213645,be,0,0
213646,required,0,0
213647,for,0,0
213648,therapeutic,0,0
213649,success,0,0
213650,.,0,0
213651,Patient,0,0
213652,acceptance,0,0
213653,of,0,0
213654,the,0,0
213655,induced,0,0
213656,contact,0,0
213657,dermatitis,0,1
213658,was,0,0
213659,excellent,0,0
213660,.,0,0
213661,In,0,0
213662,light,0,0
213663,of,0,0
213664,recent,0,0
213665,data,0,0
213666,on,0,0
213667,the,0,0
213668,mutagenicity,0,0
213669,of,0,0
213670,DNCB,0,0
213671,to,0,0
213672,bacteria,0,0
213673,",",0,0
213674,other,0,0
213675,contact,0,0
213676,allergens,0,0
213677,for,0,0
213678,topical,0,0
213679,immunotherapy,0,0
213680,are,0,0
213681,being,0,0
213682,sought,0,0
213683,.,0,0
213684,Changing,0,0
213685,sodium,0,0
213686,intake,0,0
213687,in,0,0
213688,children,1,1
213689,.,1,1
213690,The,0,0
213691,Minneapolis,0,1
213692,Children,0,1
213693,'s,0,0
213694,Blood,0,0
213695,Pressure,0,1
213696,Study,0,0
213697,.,0,0
213698,To,0,0
213699,assess,0,0
213700,the,0,0
213701,effects,0,0
213702,of,0,0
213703,modifying,0,0
213704,dietary,0,0
213705,sodium,0,0
213706,intake,0,0
213707,",",0,0
213708,80,1,0
213709,school,1,1
213710,children,1,1
213711,with,1,1
213712,blood,1,0
213713,pressures,1,0
213714,above,1,0
213715,the,1,0
213716,95th,1,0
213717,percentile,1,0
213718,for,1,0
213719,age,1,1
213720,and,1,0
213721,sex,1,0
213722,but,1,0
213723,below,1,0
213724,130/90,1,0
213725,mm,1,0
213726,Hg,1,0
213727,at,1,0
213728,school,1,1
213729,screening,1,1
213730,were,0,0
213731,randomized,0,0
213732,to,0,0
213733,a,0,0
213734,family,0,0
213735,intervention,0,0
213736,program,0,0
213737,or,0,0
213738,a,0,0
213739,control,0,0
213740,group,0,0
213741,.,0,0
213742,Twenty,1,1
213743,children,1,1
213744,aged,1,1
213745,6,1,0
213746,to,1,0
213747,9,1,0
213748,years,1,1
213749,and,1,0
213750,their,1,1
213751,families,1,1
213752,began,0,1
213753,a,0,0
213754,program,0,0
213755,to,0,0
213756,modify,0,0
213757,the,0,0
213758,family,0,0
213759,diet,0,0
213760,toward,0,0
213761,a,0,0
213762,goal,0,0
213763,of,0,0
213764,70,0,1
213765,mEq,0,0
213766,sodium,0,0
213767,per,0,0
213768,person,0,0
213769,per,0,0
213770,day,0,0
213771,.,0,0
213772,Adherence,0,0
213773,was,0,0
213774,assessed,0,0
213775,by,0,0
213776,3-day,0,0
213777,food,0,0
213778,records,0,1
213779,and,0,0
213780,urine,0,0
213781,collections,0,0
213782,in,0,0
213783,children,0,1
213784,and,0,1
213785,adults,0,1
213786,.,0,0
213787,The,0,0
213788,sodium,0,0
213789,intakes,0,0
213790,and,0,0
213791,blood,0,0
213792,pressures,0,0
213793,of,0,0
213794,the,0,0
213795,intervention,0,0
213796,and,0,0
213797,control,0,0
213798,group,0,0
213799,were,0,0
213800,compared,0,0
213801,1,0,0
213802,year,0,0
213803,after,0,0
213804,randomization,0,0
213805,.,0,0
213806,Sodium,0,0
213807,intake,0,0
213808,was,0,0
213809,significantly,0,0
213810,lower,0,0
213811,in,0,0
213812,the,0,0
213813,intervention,0,0
213814,group,0,0
213815,only,0,0
213816,in,0,0
213817,the,0,0
213818,active,0,0
213819,participants,0,1
213820,as,0,0
213821,compared,0,0
213822,to,0,0
213823,dropouts,0,0
213824,and,0,0
213825,controls,0,1
213826,(,0,0
213827,87,0,1
213828,vs,0,0
213829,130,0,1
213830,and,0,0
213831,133,0,1
213832,mmoles/24,0,0
213833,hr,0,0
213834,),0,0
213835,.,0,0
213836,There,0,0
213837,were,0,0
213838,no,0,0
213839,significant,0,0
213840,differences,0,0
213841,between,0,0
213842,the,0,0
213843,groups,0,0
213844,in,0,0
213845,height,0,0
213846,",",0,0
213847,weight,0,0
213848,",",0,0
213849,or,0,0
213850,blood,0,0
213851,pressure,0,0
213852,.,0,0
213853,Liquid,0,1
213854,antacids,1,0
213855,:,1,1
213856,palatability,0,0
213857,and,0,0
213858,predictability,0,0
213859,study,0,0
213860,.,0,0
213861,The,0,0
213862,effect,0,0
213863,of,0,0
213864,iron,0,0
213865,in,0,0
213866,formula,0,0
213867,milk,0,0
213868,after,0,0
213869,6,0,0
213870,months,0,0
213871,of,0,0
213872,age,0,1
213873,.,0,0
213874,Ninety,1,0
213875,two,1,0
213876,normal,1,1
213877,birthweight,1,1
213878,infants,1,1
213879,aged,1,1
213880,6,1,0
213881,months,1,0
213882,entered,0,1
213883,a,0,0
213884,double,0,0
213885,blind,0,0
213886,controlled,0,0
213887,trial,0,0
213888,which,0,0
213889,compared,0,0
213890,a,0,0
213891,follow,0,0
213892,on,0,0
213893,formula,0,0
213894,milk,0,0
213895,with,0,0
213896,no,0,0
213897,added,0,0
213898,iron,0,0
213899,against,0,0
213900,the,0,0
213901,same,0,0
213902,formula,0,0
213903,milk,0,0
213904,containing,0,0
213905,1.2,0,0
213906,mg,0,0
213907,of,0,0
213908,iron,0,0
213909,per,0,0
213910,100,0,0
213911,ml,0,0
213912,.,0,0
213913,There,0,0
213914,was,0,0
213915,no,0,0
213916,significant,0,0
213917,difference,0,0
213918,in,0,0
213919,the,0,0
213920,social,0,0
213921,class,0,1
213922,or,0,1
213923,demographic,0,0
213924,characteristics,0,0
213925,of,0,0
213926,the,0,0
213927,two,0,0
213928,treatment,0,0
213929,groups,0,0
213930,or,0,0
213931,in,0,0
213932,the,0,0
213933,proportion,0,0
213934,of,0,0
213935,each,0,0
213936,group,0,0
213937,completing,0,0
213938,the,0,0
213939,trial,0,0
213940,.,0,0
213941,There,0,0
213942,was,0,0
213943,no,0,0
213944,difference,0,0
213945,between,0,0
213946,the,0,0
213947,two,0,0
213948,groups,0,0
213949,in,0,0
213950,the,0,0
213951,quantity,0,0
213952,of,0,0
213953,milk,0,0
213954,taken,0,0
213955,but,0,0
213956,the,0,0
213957,amounts,0,0
213958,taken,0,0
213959,lessened,0,0
213960,between,0,0
213961,6,0,0
213962,and,0,0
213963,18,0,1
213964,months,0,0
213965,of,0,0
213966,age,0,1
213967,.,0,0
213968,There,0,0
213969,was,0,0
213970,no,0,0
213971,difference,0,0
213972,between,0,0
213973,the,0,0
213974,two,0,0
213975,groups,0,0
213976,with,0,1
213977,respect,0,0
213978,to,0,0
213979,mean,0,0
213980,haemoglobin,0,0
213981,and,0,0
213982,median,0,0
213983,serum,0,0
213984,ferritin,0,0
213985,at,0,0
213986,6,0,0
213987,",",0,0
213988,9,0,0
213989,",",0,0
213990,12,0,0
213991,",",0,0
213992,15,0,0
213993,",",0,0
213994,and,0,0
213995,18,0,1
213996,months,0,0
213997,of,0,0
213998,age,0,1
213999,.,0,0
214000,Very,0,0
214001,few,0,0
214002,infants,0,1
214003,developed,0,0
214004,iron,0,0
214005,deficiency,0,1
214006,anaemia,0,1
214007,in,0,0
214008,either,0,0
214009,group,0,0
214010,but,0,0
214011,there,0,0
214012,was,0,0
214013,a,0,0
214014,tendency,0,0
214015,for,0,0
214016,serum,0,0
214017,ferritin,0,0
214018,levels,0,0
214019,to,0,0
214020,fall,0,0
214021,between,0,0
214022,6,0,0
214023,and,0,0
214024,18,0,1
214025,months,0,0
214026,of,0,0
214027,age,0,1
214028,in,0,0
214029,both,0,0
214030,groups,0,0
214031,.,0,0
214032,The,0,0
214033,results,0,0
214034,suggest,0,0
214035,that,0,0
214036,iron,0,0
214037,added,0,0
214038,to,0,0
214039,follow,0,0
214040,on,0,0
214041,milk,0,0
214042,was,0,0
214043,not,0,0
214044,an,0,0
214045,important,0,0
214046,source,0,0
214047,of,0,0
214048,dietary,0,0
214049,iron,0,0
214050,in,0,0
214051,the,0,0
214052,infants,0,1
214053,studied,0,1
214054,.,0,1
214055,Randomized,0,0
214056,trial,0,0
214057,of,0,0
214058,Sandostatin,1,0
214059,prophylaxis,1,0
214060,for,1,0
214061,preservation,1,0
214062,injury,1,0
214063,after,1,0
214064,pancreas,1,1
214065,transplantation,1,1
214066,.,1,0
214067,Comparison,0,0
214068,of,0,0
214069,autologous,0,0
214070,bone,0,0
214071,marrow,0,0
214072,transplantation,0,1
214073,with,0,1
214074,sequential,0,0
214075,chemotherapy,0,0
214076,for,0,0
214077,intermediate-grade,1,1
214078,and,1,0
214079,high-grade,1,1
214080,non-Hodgkin,1,1
214081,'s,1,0
214082,lymphoma,1,1
214083,in,1,0
214084,first,1,0
214085,complete,1,1
214086,remission,1,1
214087,:,1,1
214088,a,1,0
214089,study,1,0
214090,of,1,0
214091,464,1,1
214092,patients,1,1
214093,.,1,1
214094,Groupe,0,1
214095,d'Etude,0,0
214096,des,0,1
214097,Lymphomes,0,1
214098,de,0,1
214099,l'Adulte,0,1
214100,.,0,0
214101,PURPOSE,0,0
214102,Intensive,0,0
214103,chemotherapy,0,0
214104,followed,0,0
214105,by,0,0
214106,autotransplantation,0,0
214107,has,0,0
214108,given,0,0
214109,promising,0,0
214110,results,0,0
214111,in,0,0
214112,partially,0,0
214113,responding,0,0
214114,or,0,0
214115,sensitive,0,0
214116,relapsed,0,1
214117,patients,1,1
214118,with,1,1
214119,aggressive,1,1
214120,non-Hodgkin,1,1
214121,'s,1,0
214122,lymphoma,1,1
214123,.,1,1
214124,In,0,0
214125,1987,0,1
214126,",",0,0
214127,we,0,0
214128,designed,0,0
214129,a,0,0
214130,randomized,0,0
214131,study,0,0
214132,to,0,0
214133,evaluate,0,0
214134,the,0,0
214135,potential,0,0
214136,benefit,0,0
214137,of,0,0
214138,a,0,0
214139,high-dose,0,0
214140,regimen,0,0
214141,containing,0,0
214142,cyclophosphamide,0,0
214143,",",0,0
214144,carmustine,0,0
214145,",",0,0
214146,and,0,0
214147,etoposide,0,0
214148,(,0,0
214149,CBV,0,0
214150,),0,0
214151,followed,0,0
214152,by,0,0
214153,autotransplantation,0,0
214154,over,0,0
214155,a,0,0
214156,consolidative,0,0
214157,sequential,0,0
214158,chemotherapy,0,0
214159,(,0,0
214160,ifosfamide,0,0
214161,",",0,0
214162,etoposide,0,0
214163,",",0,0
214164,asparaginase,0,0
214165,",",0,0
214166,and,0,0
214167,cytarabine,0,0
214168,),0,0
214169,in,0,0
214170,patients,0,1
214171,in,0,0
214172,first,0,0
214173,complete,0,0
214174,remission,0,1
214175,with,0,1
214176,intermediate-,1,1
214177,and,1,0
214178,high-grade,1,1
214179,non-Hodgkin,1,1
214180,'s,1,0
214181,lymphoma,1,1
214182,.,1,1
214183,PATIENTS,0,0
214184,AND,0,0
214185,METHODS,0,0
214186,Patients,1,1
214187,were,1,1
214188,younger,1,1
214189,than,1,0
214190,55,1,1
214191,years,1,1
214192,and,1,0
214193,had,1,0
214194,at,1,0
214195,least,1,0
214196,one,1,0
214197,adverse,1,0
214198,prognostic,1,0
214199,factor,1,0
214200,.,1,0
214201,Induction,0,0
214202,treatment,0,0
214203,was,0,0
214204,that,0,0
214205,of,0,0
214206,the,0,0
214207,LNH84,0,0
214208,protocol,0,0
214209,with,0,0
214210,an,0,0
214211,open,0,0
214212,randomization,0,0
214213,on,0,0
214214,the,0,0
214215,anthracycline,0,0
214216,.,0,0
214217,Patients,0,1
214218,in,0,0
214219,complete,0,1
214220,remission,0,1
214221,were,0,0
214222,further,0,0
214223,randomly,0,1
214224,assigned,0,0
214225,to,0,0
214226,receive,0,0
214227,either,0,0
214228,consolidation,0,0
214229,procedure,0,0
214230,.,0,0
214231,RESULTS,0,0
214232,After,0,0
214233,induction,0,0
214234,treatment,0,0
214235,",",0,0
214236,464,1,1
214237,patients,1,1
214238,were,0,0
214239,assessable,0,1
214240,for,0,0
214241,the,0,0
214242,consolidation,0,0
214243,phase,0,0
214244,.,0,0
214245,With,0,0
214246,a,0,0
214247,median,0,0
214248,follow-up,0,0
214249,duration,0,0
214250,of,0,0
214251,28,0,0
214252,months,0,0
214253,",",0,0
214254,the,0,0
214255,3-year,0,0
214256,disease-free,0,0
214257,survival,0,0
214258,rate,0,0
214259,was,0,0
214260,52,0,0
214261,%,0,0
214262,(,0,0
214263,95,0,0
214264,%,0,0
214265,confidence,0,0
214266,interval,0,0
214267,",",0,0
214268,45,0,0
214269,%,0,0
214270,to,0,0
214271,59,0,1
214272,%,0,0
214273,),0,0
214274,in,0,0
214275,the,0,0
214276,sequential,0,0
214277,chemotherapy,0,0
214278,arm,0,0
214279,and,0,0
214280,59,0,0
214281,%,0,0
214282,(,0,0
214283,95,0,0
214284,%,0,0
214285,confidence,0,0
214286,interval,0,0
214287,",",0,0
214288,52,0,0
214289,%,0,0
214290,to,0,0
214291,66,0,0
214292,%,0,0
214293,),0,0
214294,in,0,0
214295,the,0,0
214296,autologous,0,0
214297,transplant,0,1
214298,arm,0,0
214299,(,0,0
214300,P,0,0
214301,=,0,0
214302,.46,0,0
214303,",",0,0
214304,relative,0,0
214305,risk,0,0
214306,=,0,0
214307,0.90,0,0
214308,),0,0
214309,.,0,0
214310,The,0,0
214311,3-year,0,0
214312,survival,0,0
214313,rate,0,0
214314,did,0,0
214315,not,0,0
214316,differ,0,0
214317,between,0,0
214318,sequential,0,0
214319,chemotherapy,0,0
214320,and,0,0
214321,autotransplantation,0,0
214322,",",0,0
214323,at,0,0
214324,71,0,1
214325,%,0,0
214326,(,0,0
214327,95,0,0
214328,%,0,0
214329,confidence,0,0
214330,interval,0,0
214331,",",0,0
214332,64,0,0
214333,%,0,0
214334,to,0,0
214335,78,0,1
214336,%,0,0
214337,),0,0
214338,and,0,0
214339,69,0,1
214340,%,0,0
214341,(,0,0
214342,95,0,0
214343,%,0,0
214344,confidence,0,0
214345,interval,0,0
214346,",",0,0
214347,62,0,0
214348,%,0,0
214349,to,0,0
214350,76,0,1
214351,%,0,0
214352,),0,0
214353,",",0,0
214354,respectively,0,0
214355,(,0,0
214356,P,0,0
214357,=,0,0
214358,.60,0,0
214359,",",0,0
214360,relative,0,0
214361,risk,0,0
214362,=,0,0
214363,1.11,0,0
214364,),0,0
214365,.,0,0
214366,CONCLUSION,0,0
214367,For,0,0
214368,such,0,0
214369,a,0,0
214370,subset,0,1
214371,of,0,0
214372,patients,0,1
214373,",",0,0
214374,consolidation,0,0
214375,with,0,0
214376,the,0,0
214377,CBV,0,0
214378,regimen,0,0
214379,followed,0,0
214380,by,0,0
214381,autologous,0,0
214382,bone,0,0
214383,marrow,0,0
214384,transplantation,0,0
214385,is,0,0
214386,not,0,0
214387,superior,0,0
214388,to,0,0
214389,sequential,0,0
214390,chemotherapy,0,0
214391,.,0,0
214392,Multicyclic,0,0
214393,",",0,0
214394,dose-intensive,0,0
214395,chemotherapy,0,0
214396,supported,0,0
214397,by,0,0
214398,sequential,0,0
214399,reinfusion,0,0
214400,of,0,0
214401,hematopoietic,0,0
214402,progenitors,0,0
214403,in,0,0
214404,whole,0,0
214405,blood,0,0
214406,.,0,0
214407,PURPOSE,0,0
214408,To,0,0
214409,support,0,0
214410,multicyclic,0,0
214411,",",0,0
214412,dose-intensive,0,0
214413,chemotherapy,0,0
214414,",",0,0
214415,we,0,0
214416,assessed,0,0
214417,the,0,0
214418,effects,0,0
214419,of,0,0
214420,reinfusing,0,0
214421,hematopoietic,0,0
214422,progenitors,0,0
214423,collected,0,0
214424,at,0,0
214425,each,0,0
214426,cycle,0,0
214427,in,0,0
214428,leukapheresis,0,1
214429,product,0,0
214430,or,0,0
214431,whole,0,0
214432,blood,0,0
214433,.,0,0
214434,PATIENTS,0,0
214435,AND,0,0
214436,METHODS,0,0
214437,Twenty-five,1,1
214438,patients,1,1
214439,with,1,1
214440,small-cell,1,1
214441,lung,1,1
214442,cancer,1,1
214443,(,1,0
214444,SCLC,1,0
214445,),1,0
214446,were,0,0
214447,treated,0,0
214448,with,0,1
214449,six,0,0
214450,cycles,0,0
214451,of,0,0
214452,ifosfamide,0,0
214453,",",0,0
214454,carboplatin,0,0
214455,",",0,0
214456,and,0,0
214457,etoposide,0,0
214458,(,0,0
214459,ICE,0,0
214460,),0,0
214461,with,0,1
214462,granulocyte,0,0
214463,colony-stimulating,0,0
214464,factor,0,0
214465,(,0,0
214466,G-CSF,0,1
214467,),0,0
214468,300,0,0
214469,micrograms/d,0,0
214470,subcutaneously,0,0
214471,(,0,0
214472,SC,0,0
214473,),0,0
214474,on,0,0
214475,days,0,0
214476,4,0,0
214477,to,0,1
214478,15,0,0
214479,.,0,0
214480,Hematopoietic,0,0
214481,progenitors,0,0
214482,collected,0,0
214483,during,0,0
214484,each,0,0
214485,cycle,0,0
214486,were,0,0
214487,reinfused,0,0
214488,on,0,0
214489,day,0,0
214490,3,0,0
214491,of,0,0
214492,the,0,0
214493,next,0,0
214494,cycle,0,0
214495,.,0,0
214496,Cohort,0,0
214497,1,0,0
214498,(,0,0
214499,n,0,1
214500,=,0,0
214501,6,0,0
214502,),0,0
214503,was,0,0
214504,treated,0,0
214505,every,0,0
214506,3,0,0
214507,weeks,0,0
214508,",",0,0
214509,with,0,1
214510,leukapheresis,0,1
214511,after,0,0
214512,2,0,0
214513,weeks,0,0
214514,and,0,0
214515,cryopreservation,0,0
214516,of,0,0
214517,the,0,0
214518,leukapheresis,0,1
214519,product,0,0
214520,.,0,0
214521,Chemotherapy,0,0
214522,was,0,0
214523,given,0,0
214524,if,0,0
214525,the,0,0
214526,WBC,0,0
214527,count,0,0
214528,was,0,0
214529,>,0,0
214530,or,0,1
214531,=,0,0
214532,3,0,0
214533,x,0,0
214534,10,0,1
214535,(,0,0
214536,9,0,0
214537,),0,0
214538,/L,0,0
214539,and,0,0
214540,platelet,0,0
214541,count,0,0
214542,>,0,0
214543,or,0,0
214544,=,0,0
214545,100,0,0
214546,x,0,0
214547,10,0,0
214548,(,0,0
214549,9,0,0
214550,),0,0
214551,/L,0,0
214552,.,0,0
214553,Cohort,0,0
214554,2,0,0
214555,(,0,0
214556,n,0,1
214557,=,0,0
214558,7,0,0
214559,),0,0
214560,was,0,0
214561,treated,0,0
214562,every,0,0
214563,2,0,0
214564,weeks,0,0
214565,",",0,0
214566,with,0,1
214567,leukapheresis,0,0
214568,on,0,0
214569,day,0,0
214570,1,0,0
214571,of,0,0
214572,the,0,0
214573,next,0,0
214574,cycle,0,0
214575,and,0,0
214576,storage,0,0
214577,of,0,0
214578,the,0,0
214579,leukapheresis,0,0
214580,product,0,0
214581,at,0,0
214582,4,0,0
214583,degrees,0,0
214584,C.,0,0
214585,Cohort,0,1
214586,3,0,0
214587,(,0,0
214588,n,0,1
214589,=,0,0
214590,12,0,1
214591,),0,0
214592,was,0,0
214593,treated,0,0
214594,every,0,0
214595,2,0,0
214596,weeks,0,0
214597,",",0,0
214598,with,0,1
214599,500,0,0
214600,to,0,0
214601,750,0,0
214602,mL,0,0
214603,of,0,0
214604,blood,0,0
214605,drawn,0,0
214606,by,0,0
214607,venesection,0,0
214608,on,0,0
214609,day,0,0
214610,1,0,0
214611,of,0,0
214612,the,0,0
214613,next,0,0
214614,cycle,0,0
214615,and,0,0
214616,stored,0,0
214617,at,0,0
214618,4,0,0
214619,degrees,0,0
214620,C.,0,0
214621,In,0,1
214622,cohorts,0,0
214623,2,0,1
214624,and,0,0
214625,3,0,0
214626,",",0,0
214627,chemotherapy,0,0
214628,was,0,0
214629,given,0,0
214630,if,0,0
214631,the,0,0
214632,WBC,0,0
214633,count,0,0
214634,was,0,0
214635,>,0,0
214636,or,0,1
214637,=,0,0
214638,3,0,0
214639,x,0,0
214640,10,0,1
214641,(,0,0
214642,9,0,0
214643,),0,0
214644,/L,0,0
214645,and,0,0
214646,platelet,0,0
214647,count,0,0
214648,>,0,0
214649,or,0,0
214650,=,0,0
214651,30,0,0
214652,x,0,0
214653,10,0,0
214654,(,0,0
214655,9,0,0
214656,),0,0
214657,/L,0,0
214658,.,0,0
214659,Blood,0,0
214660,and,0,0
214661,leukapheresis,0,1
214662,products,0,0
214663,were,0,0
214664,assayed,0,0
214665,for,0,0
214666,hematopoietic,0,0
214667,progenitors,0,0
214668,.,0,1
214669,RESULTS,0,0
214670,ICE,0,0
214671,chemotherapy,0,0
214672,with,0,1
214673,G-CSF,0,0
214674,was,0,0
214675,effective,0,0
214676,in,0,0
214677,mobilizing,0,0
214678,blood,0,0
214679,progenitors,0,0
214680,(,0,0
214681,median,0,0
214682,",",0,0
214683,120-fold,0,0
214684,),0,0
214685,.,0,0
214686,Long-term,0,0
214687,cultures,0,0
214688,showed,0,0
214689,no,0,0
214690,evidence,0,0
214691,of,0,0
214692,stem-cell,0,1
214693,depletion,0,0
214694,.,0,0
214695,The,0,0
214696,cytotoxic,0,0
214697,dose-intensity,0,0
214698,of,0,0
214699,standard,0,0
214700,every-4-weeks,0,0
214701,ICE,0,0
214702,is,0,0
214703,100,0,0
214704,%,0,0
214705,.,0,0
214706,In,0,0
214707,the,0,0
214708,first,0,0
214709,three,0,0
214710,cycles,0,0
214711,",",0,0
214712,it,0,0
214713,was,0,0
214714,134,0,1
214715,%,0,0
214716,(,0,0
214717,median,0,0
214718,),0,0
214719,in,0,0
214720,cohort,0,1
214721,1,0,0
214722,and,0,0
214723,200,0,0
214724,%,0,0
214725,in,0,0
214726,cohorts,0,0
214727,2,0,1
214728,and,0,0
214729,3,0,0
214730,(,0,0
214731,P,0,0
214732,<,0,0
214733,.0001,0,0
214734,),0,0
214735,.,0,0
214736,Toxicity,0,0
214737,and,0,0
214738,supportive,0,0
214739,care,0,1
214740,requirements,0,0
214741,were,0,0
214742,not,0,0
214743,increased,0,0
214744,.,0,0
214745,CONCLUSION,0,0
214746,The,0,0
214747,dose-intensity,0,0
214748,of,0,0
214749,ICE,0,0
214750,chemotherapy,0,0
214751,can,0,0
214752,be,0,0
214753,doubled,0,0
214754,by,0,0
214755,reinfusing,0,0
214756,hematopoietic,0,0
214757,progenitors,0,0
214758,collected,0,0
214759,by,0,0
214760,leukapheresis,0,0
214761,or,0,0
214762,venesection,0,0
214763,and,0,0
214764,stored,0,0
214765,at,0,0
214766,4,0,0
214767,degrees,0,0
214768,C,0,1
214769,.,0,1
214770,A,0,0
214771,randomized,0,0
214772,study,0,0
214773,comparing,0,0
214774,glucagon,0,0
214775,and,0,0
214776,hyoscine,0,0
214777,N-butyl,0,0
214778,bromide,0,0
214779,before,1,0
214780,endoscopic,1,0
214781,retrograde,1,1
214782,cholangiopancreatography,1,0
214783,.,1,0
214784,BACKGROUND,0,0
214785,This,0,0
214786,study,0,0
214787,tried,0,0
214788,to,0,0
214789,resolve,0,0
214790,whether,0,0
214791,glucagon,0,0
214792,is,0,0
214793,a,0,0
214794,better,0,0
214795,premedication,0,0
214796,for,0,0
214797,endoscopic,1,0
214798,retrograde,1,0
214799,cholangiopancreatography,1,0
214800,(,1,0
214801,ERCP,1,1
214802,),1,0
214803,.,1,0
214804,METHODS,0,0
214805,We,0,0
214806,first,0,0
214807,measured,0,0
214808,the,0,0
214809,basal,0,0
214810,blood,0,0
214811,sugar,0,0
214812,and,0,0
214813,amylase,0,0
214814,levels,0,0
214815,.,0,0
214816,Then,0,0
214817,an,0,0
214818,endoscope,0,0
214819,was,0,0
214820,placed,0,0
214821,in,0,0
214822,the,0,0
214823,duodenum,0,0
214824,without,0,0
214825,premedication,0,0
214826,",",0,0
214827,and,0,0
214828,basal,0,0
214829,pulse,0,0
214830,and,0,0
214831,duodenal,0,1
214832,peristaltic,0,0
214833,rates,0,0
214834,were,0,0
214835,measured,0,0
214836,.,0,0
214837,ERCP,0,0
214838,began,0,0
214839,after,0,0
214840,studied,1,1
214841,subjects,1,1
214842,were,0,0
214843,randomly,0,1
214844,premedicated,0,0
214845,with,0,0
214846,either,0,0
214847,1,1,0
214848,mg,1,0
214849,glucagon,1,0
214850,(,1,0
214851,n,1,1
214852,=,1,0
214853,38,1,1
214854,),1,0
214855,or,1,0
214856,40,1,0
214857,mg,1,0
214858,hyoscine,1,0
214859,N-butyl,1,0
214860,bromide,1,1
214861,(,1,0
214862,n,1,1
214863,=,1,0
214864,36,1,1
214865,),1,0
214866,intravenously,0,0
214867,.,0,0
214868,Ten,0,1
214869,minutes,0,0
214870,later,0,0
214871,the,0,0
214872,variables,0,0
214873,were,0,0
214874,measured,0,0
214875,again,0,0
214876,.,0,0
214877,RESULTS,0,0
214878,Glucagon,0,0
214879,elicited,0,0
214880,hyperglycemia,0,0
214881,whereas,0,0
214882,hyoscine,0,0
214883,N-butyl,0,0
214884,bromide,0,0
214885,manifested,0,0
214886,an,0,0
214887,anticholinergic,0,0
214888,effect,0,0
214889,.,0,0
214890,No,0,0
214891,difference,0,0
214892,was,0,0
214893,found,0,0
214894,between,0,0
214895,these,0,0
214896,two,0,0
214897,groups,0,0
214898,with,0,1
214899,regard,0,0
214900,to,0,0
214901,the,0,0
214902,necessary,0,0
214903,interval,0,0
214904,for,0,0
214905,ERCP,0,1
214906,(,0,0
214907,20.6,0,0
214908,+/-,0,0
214909,14.1,0,0
214910,min,0,0
214911,versus,0,0
214912,21.4,0,0
214913,+/-,0,0
214914,14.7,0,0
214915,min,0,0
214916,;,0,0
214917,NS,0,0
214918,),0,0
214919,or,0,0
214920,the,0,0
214921,success,0,0
214922,rate,0,0
214923,for,0,0
214924,cholangiopancreatography,0,0
214925,(,0,0
214926,92.1,0,0
214927,%,0,0
214928,versus,0,0
214929,91.7,0,0
214930,%,0,0
214931,;,0,0
214932,NS,0,0
214933,),0,0
214934,.,0,0
214935,Neither,0,0
214936,hyperamylasemia,0,1
214937,nor,0,0
214938,pancreatitis,0,1
214939,was,0,0
214940,preventable,0,0
214941,when,0,0
214942,glucagon,0,0
214943,was,0,0
214944,used,0,0
214945,.,0,0
214946,CONCLUSIONS,0,0
214947,The,0,0
214948,two,0,0
214949,premedications,0,0
214950,appear,0,0
214951,equally,0,0
214952,effective,0,0
214953,in,0,0
214954,the,0,0
214955,performance,0,0
214956,of,0,0
214957,ERCP,0,1
214958,.,0,1
214959,Antipyrine,0,0
214960,clearance,0,0
214961,and,0,0
214962,response,0,0
214963,to,0,0
214964,interferon,0,0
214965,treatment,0,0
214966,in,0,0
214967,patients,1,1
214968,with,1,1
214969,chronic,1,1
214970,active,1,1
214971,hepatitis,1,1
214972,C.,1,0
214973,To,0,0
214974,determine,0,0
214975,whether,0,0
214976,hepatic,0,0
214977,metabolic,0,0
214978,function,0,0
214979,affects,0,0
214980,the,0,0
214981,response,0,0
214982,to,0,0
214983,interferon,0,0
214984,treatment,0,0
214985,",",0,0
214986,we,0,0
214987,measured,0,0
214988,antipyrine,0,0
214989,clearance,0,0
214990,(,0,0
214991,APC,0,0
214992,),0,0
214993,in,0,0
214994,85,1,1
214995,patients,1,1
214996,with,1,1
214997,chronic,1,1
214998,active,1,1
214999,hepatitis,1,1
215000,C,1,0
215001,and,0,0
215002,compared,0,0
215003,the,0,0
215004,results,0,0
215005,with,0,1
215006,treatment,0,0
215007,outcome,0,0
215008,.,0,0
215009,Among,0,1
215010,55,1,1
215011,patients,1,1
215012,who,1,1
215013,responded,1,1
215014,to,1,1
215015,interferon,1,0
215016,by,1,0
215017,normalization,1,0
215018,of,1,0
215019,alanine,1,0
215020,transaminase,1,0
215021,(,1,0
215022,ALT,1,0
215023,),1,0
215024,",",1,0
215025,median,1,0
215026,APC,1,0
215027,before,1,0
215028,treatment,1,0
215029,was,1,0
215030,0.47,1,0
215031,(,1,0
215032,range,1,0
215033,",",1,0
215034,0.12,1,0
215035,to,1,0
215036,0.98,1,0
215037,;,1,0
215038,normal,1,1
215039,range,1,0
215040,",",1,0
215041,0.34,1,0
215042,to,1,0
215043,1.02,1,0
215044,mL/min/kg,1,0
215045,body,1,1
215046,wt,1,1
215047,),1,0
215048,",",1,0
215049,a,1,0
215050,value,1,0
215051,that,1,0
215052,was,1,0
215053,significantly,1,0
215054,greater,1,0
215055,than,1,0
215056,in,1,0
215057,30,1,1
215058,nonresponders,1,0
215059,(,1,1
215060,0.23,1,0
215061,;,1,0
215062,0.08,1,0
215063,to,1,0
215064,0.67,1,0
215065,mL/min/kg,1,0
215066,body,1,1
215067,wt,1,1
215068,",",1,0
215069,P,1,0
215070,<,1,0
215071,.001,1,0
215072,),1,0
215073,.,0,0
215074,APC,0,0
215075,was,0,0
215076,closely,0,0
215077,associated,0,0
215078,with,0,0
215079,response,0,0
215080,to,0,0
215081,interferon,0,0
215082,.,0,0
215083,The,0,0
215084,response,0,0
215085,rate,0,0
215086,among,0,0
215087,cases,0,1
215088,with,0,1
215089,values,0,0
215090,>,0,1
215091,0.25,0,0
215092,mL/min/kg,0,0
215093,body,0,0
215094,weight,0,0
215095,was,0,0
215096,79,0,0
215097,%,0,0
215098,",",0,0
215099,the,0,0
215100,same,0,0
215101,as,0,0
215102,in,0,0
215103,cases,0,0
215104,without,0,1
215105,cirrhosis,0,1
215106,.,0,0
215107,Cases,0,0
215108,without,0,0
215109,cirrhosis,0,1
215110,and,0,0
215111,with,0,0
215112,APC,0,0
215113,of,0,0
215114,>,0,1
215115,0.25,0,0
215116,mL/min/kg,0,0
215117,body,0,0
215118,weight,0,0
215119,had,0,0
215120,an,0,0
215121,85,0,0
215122,%,0,0
215123,chance,0,0
215124,of,0,0
215125,responding,0,0
215126,to,0,0
215127,interferon,0,0
215128,;,0,0
215129,this,0,0
215130,was,0,0
215131,unlikely,0,0
215132,a,0,0
215133,simple,0,0
215134,reflection,0,0
215135,of,0,0
215136,histological,0,0
215137,activity,0,0
215138,",",0,0
215139,because,0,0
215140,the,0,0
215141,correlation,0,0
215142,with,0,0
215143,Scheuer,0,1
215144,score,0,0
215145,was,0,0
215146,poor,0,0
215147,in,0,0
215148,this,0,0
215149,subgroup,0,0
215150,(,0,0
215151,r,0,0
215152,=,0,0
215153,-.31,0,0
215154,",",0,0
215155,P,0,0
215156,<,0,0
215157,.05,0,0
215158,),0,0
215159,.,0,0
215160,A,1,0
215161,second,1,0
215162,",",1,0
215163,independent,1,0
215164,group,1,0
215165,of,1,0
215166,43,1,1
215167,patients,1,1
215168,was,0,0
215169,used,0,0
215170,to,0,0
215171,test,0,0
215172,the,0,0
215173,predictive,0,0
215174,value,0,0
215175,of,0,0
215176,APC,0,0
215177,(,0,0
215178,using,0,0
215179,0.25,0,0
215180,mL/min/kg,0,0
215181,body,0,0
215182,wt,0,0
215183,as,0,0
215184,a,0,0
215185,cut-off,0,0
215186,),0,0
215187,for,0,0
215188,response,0,0
215189,to,0,0
215190,interferon,0,0
215191,treatment,0,0
215192,.,0,0
215193,In,0,0
215194,this,0,0
215195,group,0,0
215196,",",0,0
215197,APC,0,0
215198,correctly,0,0
215199,predicted,0,0
215200,positive,0,0
215201,response,0,0
215202,to,0,0
215203,interferon,0,0
215204,in,0,0
215205,75,0,0
215206,%,0,0
215207,of,0,0
215208,cases,0,1
215209,.,0,1
215210,APC,0,0
215211,was,0,0
215212,also,0,0
215213,used,0,0
215214,to,0,0
215215,measure,0,0
215216,the,0,0
215217,effects,0,0
215218,of,0,0
215219,treatment,0,0
215220,on,0,0
215221,hepatic,0,0
215222,metabolic,0,0
215223,function,0,0
215224,.,0,0
215225,Regardless,0,0
215226,of,0,0
215227,outcome,0,0
215228,",",0,0
215229,there,0,0
215230,was,0,0
215231,no,0,0
215232,change,0,0
215233,in,0,0
215234,APC,0,0
215235,at,0,0
215236,the,0,0
215237,end,0,0
215238,of,0,0
215239,a,0,0
215240,6-month,0,0
215241,course,0,0
215242,of,0,0
215243,interferon,0,0
215244,treatment,0,0
215245,.,0,0
215246,Six,0,0
215247,months,0,0
215248,later,0,0
215249,",",0,0
215250,however,0,0
215251,",",0,0
215252,improvement,0,0
215253,in,0,0
215254,APC,0,0
215255,(,0,0
215256,14,0,0
215257,%,0,0
215258,;,0,0
215259,P,0,0
215260,<,0,0
215261,.05,0,0
215262,),0,0
215263,was,0,0
215264,evident,0,0
215265,among,0,0
215266,responders,0,0
215267,but,0,0
215268,not,0,0
215269,in,0,0
215270,those,0,1
215271,who,0,1
215272,had,0,1
215273,failed,0,1
215274,to,0,0
215275,respond,0,0
215276,to,0,0
215277,interferon,0,0
215278,.,0,0
215279,(,0,0
215280,ABSTRACT,0,0
215281,TRUNCATED,0,0
215282,AT,0,0
215283,250,0,0
215284,WORDS,0,0
215285,),0,0
215286,Effect,0,0
215287,of,0,0
215288,perception,0,0
215289,of,0,0
215290,mechanical,0,0
215291,loading,0,0
215292,on,0,0
215293,human,0,0
215294,respiratory,0,0
215295,pattern,0,0
215296,regulation,0,0
215297,.,0,0
215298,We,0,0
215299,applied,0,0
215300,external,0,0
215301,flow,0,0
215302,resistive,0,0
215303,(,0,0
215304,R,0,0
215305,),0,0
215306,and,0,0
215307,elastic,0,0
215308,(,0,0
215309,E,0,0
215310,),0,0
215311,mechanical,0,0
215312,loads,0,0
215313,over,0,0
215314,the,0,0
215315,entire,0,0
215316,respiratory,0,0
215317,cycle,0,0
215318,to,0,0
215319,five,1,1
215320,normal,1,1
215321,subjects,1,1
215322,by,0,0
215323,using,0,0
215324,a,0,0
215325,pseudorandom,0,0
215326,loading,0,0
215327,protocol,0,0
215328,.,0,0
215329,Loads,0,0
215330,ranged,0,0
215331,in,0,0
215332,magnitude,0,0
215333,from,0,0
215334,imperceptible,0,0
215335,(,0,0
215336,R0/E0,0,0
215337,),0,0
215338,through,0,0
215339,just,0,0
215340,perceptible,0,0
215341,(,0,0
215342,R1/E1,0,0
215343,),0,0
215344,to,0,0
215345,large,0,0
215346,(,0,0
215347,R2/E2,0,1
215348,),0,0
215349,and,0,0
215350,resulted,0,0
215351,in,0,0
215352,respiratory,0,0
215353,pattern,0,0
215354,responses,0,0
215355,that,0,0
215356,were,0,0
215357,due,0,0
215358,to,0,0
215359,reflex,0,0
215360,responses,0,0
215361,alone,0,0
215362,(,0,0
215363,R0/E0,0,0
215364,),0,0
215365,or,0,0
215366,to,0,0
215367,a,0,0
215368,combination,0,0
215369,of,0,0
215370,reflex,0,0
215371,responses,0,0
215372,and,0,0
215373,behavioral,0,1
215374,reactions,0,0
215375,to,0,0
215376,the,0,0
215377,perception,0,0
215378,of,0,0
215379,impeded,0,0
215380,breathing,0,0
215381,(,0,0
215382,R1/E1,0,0
215383,and,0,0
215384,R2/E2,0,1
215385,),0,0
215386,.,0,0
215387,Pattern,0,0
215388,regulation,0,0
215389,dynamics,0,0
215390,were,0,0
215391,estimated,0,0
215392,from,0,0
215393,the,0,0
215394,computed,0,0
215395,impulse,0,0
215396,responses,0,0
215397,of,0,0
215398,tidal,0,0
215399,volume,0,0
215400,and,0,0
215401,inspiratory,0,0
215402,and,0,0
215403,expiratory,0,0
215404,durations,0,0
215405,.,0,1
215406,We,0,0
215407,anticipated,0,0
215408,that,0,0
215409,emergence,0,0
215410,of,0,0
215411,behavioral,0,0
215412,contributions,0,0
215413,would,0,0
215414,be,0,0
215415,marked,0,0
215416,by,0,0
215417,increased,0,0
215418,variability,0,0
215419,in,0,0
215420,response,0,0
215421,strategies,0,0
215422,and,0,0
215423,by,0,0
215424,increased,0,0
215425,nonlinearity,0,0
215426,in,0,0
215427,the,0,0
215428,observed,0,0
215429,responses,0,0
215430,.,0,0
215431,Regarding,0,0
215432,the,0,0
215433,immediate,0,0
215434,pattern,0,0
215435,response,0,0
215436,to,0,0
215437,loading,0,0
215438,",",0,0
215439,there,0,0
215440,was,0,0
215441,a,0,0
215442,tendency,0,0
215443,for,0,0
215444,increased,0,0
215445,qualitative,0,0
215446,variation,0,0
215447,across,0,0
215448,subjects,0,1
215449,as,0,0
215450,the,0,0
215451,load,0,0
215452,size,0,0
215453,increased,0,0
215454,",",0,0
215455,but,0,0
215456,the,0,0
215457,within-subject,0,0
215458,variability,0,0
215459,(,0,0
215460,coefficient,0,0
215461,of,0,0
215462,variation,0,0
215463,),0,0
215464,was,0,0
215465,unaffected,0,0
215466,.,0,0
215467,We,0,0
215468,found,0,0
215469,no,0,0
215470,evidence,0,0
215471,for,0,0
215472,increased,0,0
215473,nonlinearity,0,0
215474,as,0,0
215475,loads,0,0
215476,became,0,1
215477,perceptible,0,0
215478,.,0,0
215479,The,0,0
215480,emergence,0,0
215481,of,0,0
215482,behavioral,0,0
215483,control,0,0
215484,in,0,0
215485,some,0,0
215486,instances,0,0
215487,seemed,0,0
215488,to,0,0
215489,be,0,0
215490,marked,0,0
215491,by,0,0
215492,reduction,0,0
215493,of,0,0
215494,complexity,0,0
215495,of,0,0
215496,the,0,0
215497,impulse,0,0
215498,response,0,0
215499,to,0,0
215500,one,0,0
215501,dominated,0,0
215502,by,0,0
215503,the,0,0
215504,zeroth-order,0,0
215505,lag,0,0
215506,",",0,0
215507,leading,0,0
215508,to,0,0
215509,dynamically,0,0
215510,simpler,0,0
215511,responses,0,0
215512,compared,0,0
215513,to,0,0
215514,control,0,0
215515,.,0,0
215516,Reducing,0,0
215517,the,0,0
215518,risk,0,0
215519,of,0,0
215520,coronary,0,1
215521,events,0,0
215522,:,0,1
215523,evidence,0,0
215524,from,0,0
215525,the,0,0
215526,Scandinavian,0,1
215527,Simvastatin,0,0
215528,Survival,0,0
215529,Study,0,0
215530,(,0,0
215531,4S,0,0
215532,),0,0
215533,.,0,0
215534,The,0,0
215535,Scandinavian,0,0
215536,Simvastatin,0,0
215537,Survival,0,0
215538,Study,0,0
215539,(,0,0
215540,4S,0,0
215541,),0,0
215542,was,0,0
215543,designed,0,0
215544,to,0,0
215545,evaluate,0,0
215546,the,0,0
215547,effects,0,0
215548,of,0,0
215549,cholesterol,0,0
215550,reduction,0,0
215551,with,0,0
215552,simvastatin,0,0
215553,on,0,0
215554,mortality,0,0
215555,and,0,0
215556,morbidity,0,0
215557,in,0,0
215558,patients,1,1
215559,with,1,1
215560,coronary,1,1
215561,artery,1,1
215562,disease,1,1
215563,(,1,0
215564,CAD,1,0
215565,),1,0
215566,.,1,0
215567,A,0,0
215568,total,1,0
215569,of,1,0
215570,"4,444",1,1
215571,patients,1,1
215572,with,1,1
215573,angina,1,1
215574,pectoris,1,1
215575,or,1,0
215576,previous,1,0
215577,myocardial,1,1
215578,infarction,1,1
215579,and,1,0
215580,serum,1,0
215581,cholesterol,1,0
215582,levels,1,0
215583,of,1,0
215584,213-310,1,1
215585,mg/dl,1,0
215586,(,1,0
215587,5.5-8.0,1,0
215588,mmol/liter,1,0
215589,),1,0
215590,while,1,0
215591,treated,1,0
215592,with,1,1
215593,a,1,0
215594,lipid-lowering,1,0
215595,diet,1,0
215596,were,0,0
215597,randomly,0,0
215598,assigned,0,0
215599,to,0,0
215600,double-blind,0,0
215601,treatment,0,0
215602,with,0,0
215603,simvastatin,0,0
215604,or,0,0
215605,placebo,0,0
215606,.,0,0
215607,Over,0,0
215608,the,0,0
215609,5.4,0,0
215610,years,0,1
215611,of,0,0
215612,median,0,0
215613,follow-up,0,0
215614,",",0,0
215615,simvastatin,0,0
215616,produced,0,0
215617,changes,0,0
215618,in,0,0
215619,total,0,1
215620,cholesterol,0,0
215621,",",0,0
215622,low,0,0
215623,density,0,0
215624,lipoprotein,0,0
215625,(,0,0
215626,LDL,0,0
215627,),0,0
215628,cholesterol,0,0
215629,",",0,0
215630,and,0,0
215631,high,0,0
215632,density,0,0
215633,lipoprotein,0,0
215634,(,0,0
215635,HDL,0,0
215636,),0,0
215637,cholesterol,0,0
215638,of,0,0
215639,-25,0,0
215640,%,0,0
215641,",",0,0
215642,-35,0,0
215643,%,0,0
215644,",",0,0
215645,and,0,0
215646,+8,0,0
215647,%,0,0
215648,",",0,0
215649,respectively,0,0
215650,",",0,0
215651,with,0,0
215652,minimal,0,0
215653,adverse,0,0
215654,effects,0,0
215655,.,0,0
215656,A,0,0
215657,total,0,0
215658,of,0,0
215659,256,1,1
215660,patients,1,1
215661,(,0,0
215662,12,0,0
215663,%,0,0
215664,),0,0
215665,in,0,0
215666,the,0,0
215667,placebo,0,0
215668,group,0,0
215669,died,0,1
215670,compared,0,0
215671,with,0,1
215672,182,0,1
215673,(,0,0
215674,8,0,0
215675,%,0,0
215676,),0,0
215677,in,0,0
215678,the,0,0
215679,simvastatin,0,0
215680,group,0,0
215681,",",0,0
215682,a,0,0
215683,risk,0,0
215684,reduction,0,0
215685,of,0,0
215686,30,0,0
215687,%,0,0
215688,(,0,0
215689,p,0,0
215690,=,0,0
215691,0.0003,0,0
215692,),0,0
215693,attributable,0,0
215694,to,0,0
215695,a,0,0
215696,42,0,0
215697,%,0,0
215698,reduction,0,0
215699,in,0,0
215700,the,0,0
215701,risk,0,0
215702,of,0,0
215703,coronary,0,1
215704,death,0,0
215705,.,0,0
215706,Noncardiovascular,0,0
215707,causes,0,0
215708,accounted,0,0
215709,for,0,0
215710,49,0,1
215711,and,0,0
215712,46,0,1
215713,deaths,0,0
215714,in,0,0
215715,the,0,0
215716,placebo,0,0
215717,and,0,0
215718,simvastatin,0,0
215719,groups,0,0
215720,",",0,0
215721,respectively,0,0
215722,.,0,0
215723,Major,0,0
215724,coronary,0,1
215725,events,0,0
215726,were,0,0
215727,experienced,0,0
215728,by,0,0
215729,622,0,1
215730,patients,0,1
215731,(,0,0
215732,28,0,1
215733,%,0,0
215734,),0,0
215735,in,0,0
215736,the,0,0
215737,placebo,0,0
215738,group,0,0
215739,and,0,0
215740,431,0,1
215741,patients,0,1
215742,(,0,0
215743,19,0,1
215744,%,0,0
215745,),0,0
215746,in,0,0
215747,the,0,0
215748,simvastatin,0,0
215749,group,0,0
215750,",",0,0
215751,corresponding,0,0
215752,to,0,0
215753,a,0,0
215754,risk,0,0
215755,reduction,0,0
215756,of,0,0
215757,34,0,1
215758,%,0,0
215759,(,0,0
215760,p,0,0
215761,<,0,0
215762,0.00001,0,0
215763,),0,0
215764,.,0,0
215765,This,0,0
215766,risk,0,0
215767,was,0,0
215768,also,0,0
215769,significantly,0,0
215770,reduced,0,0
215771,in,0,0
215772,subgroups,0,0
215773,consisting,0,0
215774,of,0,0
215775,women,1,1
215776,and,1,0
215777,patients,1,1
215778,of,1,0
215779,both,1,0
215780,sexes,1,1
215781,aged,0,1
215782,>,0,1
215783,or,0,0
215784,=,0,0
215785,60,0,1
215786,years,0,1
215787,.,0,1
215788,Other,0,0
215789,benefits,0,0
215790,of,0,0
215791,treatment,0,0
215792,included,0,1
215793,a,0,0
215794,37,0,0
215795,%,0,0
215796,reduction,0,0
215797,(,0,0
215798,p,0,0
215799,<,0,0
215800,0.00001,0,0
215801,),0,0
215802,in,0,0
215803,the,0,0
215804,risk,0,0
215805,of,0,0
215806,undergoing,0,1
215807,myocardial,0,1
215808,revascularization,0,1
215809,procedures,0,1
215810,.,0,1
215811,Simvastatin,0,0
215812,was,0,0
215813,beneficial,0,0
215814,regardless,0,0
215815,of,0,0
215816,whether,0,0
215817,patients,0,1
215818,had,0,0
215819,a,0,0
215820,history,0,0
215821,of,0,0
215822,myocardial,0,0
215823,infarction,0,1
215824,or,0,0
215825,whether,0,0
215826,they,0,0
215827,were,0,0
215828,smokers,0,1
215829,or,0,0
215830,had,0,0
215831,hypertension,0,1
215832,.,0,0
215833,(,0,0
215834,ABSTRACT,0,0
215835,TRUNCATED,0,0
215836,AT,0,0
215837,250,0,0
215838,WORDS,0,0
215839,),0,0
215840,Why,0,0
215841,are,0,0
215842,there,0,0
215843,sometimes,0,0
215844,concreteness,0,0
215845,effects,0,0
215846,in,0,0
215847,memory,1,0
215848,for,0,0
215849,prose,0,0
215850,?,0,0
215851,Four,1,0
215852,experiments,1,0
215853,explored,0,0
215854,on-line,0,0
215855,encoding,0,0
215856,strategies,0,0
215857,and,0,0
215858,memory,1,0
215859,for,1,0
215860,high,1,0
215861,imagery,1,0
215862,and,1,0
215863,low,1,0
215864,imagery,1,0
215865,texts,1,0
215866,.,1,0
215867,Results,0,0
215868,consistently,0,0
215869,indicated,0,0
215870,that,0,0
215871,concreteness,0,0
215872,effects,0,0
215873,in,0,0
215874,memory,0,0
215875,for,0,0
215876,text,0,0
215877,depend,0,0
215878,on,0,0
215879,how,0,0
215880,materials,0,1
215881,are,0,0
215882,presented,0,0
215883,in,0,0
215884,several,0,0
215885,different,0,0
215886,respects,0,0
215887,.,0,0
215888,Most,0,0
215889,importantly,0,0
215890,",",0,0
215891,the,0,0
215892,experiments,0,0
215893,clarified,0,0
215894,apparently,0,1
215895,contradictory,0,0
215896,results,0,0
215897,of,0,0
215898,previous,0,1
215899,studies,0,0
215900,by,0,0
215901,indicating,0,0
215902,that,0,0
215903,concreteness,0,0
215904,effects,0,0
215905,generally,0,0
215906,do,0,0
215907,not,0,0
215908,occur,0,0
215909,in,0,0
215910,memory,0,0
215911,for,0,0
215912,prose,0,0
215913,when,0,0
215914,imageability,0,0
215915,is,0,0
215916,manipulated,0,0
215917,between-subjects,1,0
215918,",",0,0
215919,and,0,0
215920,that,0,0
215921,their,0,0
215922,occurrence,0,0
215923,when,0,0
215924,imageability,0,0
215925,is,0,0
215926,manipulated,0,0
215927,within-subjects,0,0
215928,depends,0,0
215929,on,0,0
215930,the,0,0
215931,order,0,0
215932,occurrence,0,0
215933,when,0,0
215934,imageability,0,0
215935,is,0,0
215936,manipulated,0,0
215937,within-subjects,0,0
215938,depends,0,0
215939,on,0,0
215940,the,0,0
215941,order,0,0
215942,of,0,0
215943,presentation,0,0
215944,.,0,0
215945,In,0,0
215946,addition,0,0
215947,",",0,0
215948,moving,0,0
215949,window,0,0
215950,analyses,0,0
215951,of,0,0
215952,text,0,0
215953,processing,0,0
215954,strategies,0,0
215955,indicated,0,0
215956,that,0,0
215957,differential,0,0
215958,strategies,0,0
215959,observed,0,0
215960,in,0,0
215961,previous,0,0
215962,studies,0,0
215963,when,0,0
215964,subjects,1,1
215965,listened,0,0
215966,to,0,0
215967,high,0,0
215968,vs,0,0
215969,low,0,0
215970,imagery,0,0
215971,text,0,0
215972,do,0,0
215973,not,0,0
215974,generalize,0,0
215975,to,0,0
215976,reading,0,0
215977,of,0,0
215978,the,0,0
215979,same,0,0
215980,materials,0,1
215981,.,0,1
215982,Potential,0,0
215983,explanations,0,0
215984,for,0,0
215985,the,0,0
215986,pattern,0,0
215987,of,0,0
215988,results,0,0
215989,are,0,0
215990,evaluated,0,0
215991,",",0,0
215992,and,0,0
215993,implications,0,0
215994,for,0,0
215995,theories,0,0
215996,of,0,0
215997,mental,0,1
215998,imagery,0,0
215999,and,0,0
216000,memory,0,0
216001,are,0,0
216002,considered,0,0
216003,.,0,0
216004,Quantifying,0,0
216005,the,0,0
216006,extent,0,0
216007,of,0,0
216008,osteonecrosis,1,0
216009,of,1,0
216010,the,1,0
216011,femoral,1,0
216012,head,1,0
216013,.,1,0
216014,A,0,0
216015,new,0,0
216016,method,0,0
216017,using,0,0
216018,MRI,0,0
216019,.,0,0
216020,In,0,0
216021,a,0,0
216022,randomised,0,0
216023,trial,0,0
216024,comparing,0,0
216025,core,0,0
216026,decompression,0,0
216027,with,0,1
216028,conservative,0,0
216029,treatment,0,0
216030,we,0,0
216031,tested,0,0
216032,the,0,0
216033,hypothesis,0,0
216034,that,0,0
216035,the,0,0
216036,extent,0,0
216037,of,0,0
216038,necrosis,0,0
216039,at,0,0
216040,the,0,0
216041,initial,0,0
216042,MRI,0,0
216043,predicts,0,0
216044,the,0,0
216045,subsequent,0,0
216046,risk,0,0
216047,of,0,0
216048,collapse,0,0
216049,of,0,0
216050,the,0,0
216051,femoral,0,0
216052,head,0,0
216053,.,0,0
216054,After,0,0
216055,the,0,0
216056,initial,0,0
216057,clinical,0,0
216058,evaluation,0,0
216059,",",0,0
216060,including,0,0
216061,plain,0,0
216062,radiography,0,0
216063,and,0,0
216064,MRI,0,0
216065,",",0,0
216066,37,1,1
216067,hips,1,1
216068,with,1,1
216069,early-stage,1,1
216070,osteonecrosis,1,0
216071,(,1,0
216072,ON,1,0
216073,),1,0
216074,in,1,0
216075,33,1,1
216076,patients,1,1
216077,were,1,0
216078,randomly,1,1
216079,assigned,1,0
216080,to,0,0
216081,a,0,0
216082,core-decompression,0,0
216083,group,0,0
216084,or,0,0
216085,a,0,0
216086,conservatively-treated,0,0
216087,group,0,0
216088,.,0,0
216089,All,0,0
216090,were,0,0
216091,followed,0,0
216092,regularly,0,0
216093,by,0,0
216094,clinical,0,0
216095,evaluation,0,0
216096,",",0,0
216097,plain,0,0
216098,radiography,0,0
216099,and,0,0
216100,MRI,0,0
216101,at,0,0
216102,intervals,0,0
216103,of,0,0
216104,three,0,1
216105,months,0,0
216106,.,0,0
216107,The,0,0
216108,extent,0,0
216109,of,0,0
216110,ON,0,0
216111,was,0,0
216112,estimated,0,0
216113,on,0,0
216114,the,0,0
216115,basis,0,0
216116,of,0,0
216117,abnormal,0,0
216118,signal,0,0
216119,intensity,0,0
216120,in,0,0
216121,the,0,0
216122,weight-bearing,0,0
216123,portion,0,0
216124,of,0,0
216125,the,0,0
216126,femoral,0,0
216127,head,0,0
216128,as,0,0
216129,determined,0,0
216130,from,0,0
216131,a,0,0
216132,combination,0,0
216133,of,0,0
216134,coronal,0,0
216135,and,0,0
216136,sagittal,0,0
216137,MRIs,0,0
216138,.,0,0
216139,The,0,0
216140,arc,0,0
216141,of,0,0
216142,the,0,0
216143,necrotic,0,1
216144,portion,0,0
216145,in,0,0
216146,the,0,0
216147,mid-coronal,0,0
216148,image,0,0
216149,(,0,0
216150,A,0,0
216151,),0,0
216152,and,0,0
216153,that,0,0
216154,in,0,0
216155,the,0,0
216156,mid-sagittal,0,0
216157,image,0,0
216158,(,0,0
216159,B,0,0
216160,),0,0
216161,were,0,0
216162,used,0,0
216163,to,0,0
216164,quantify,0,0
216165,the,0,0
216166,extent,0,0
216167,of,0,0
216168,necrosis,0,0
216169,by,0,0
216170,the,0,0
216171,formula,0,0
216172,:,0,0
216173,(,0,0
216174,A/180,0,0
216175,),0,0
216176,x,0,0
216177,(,0,0
216178,B/180,0,0
216179,),0,0
216180,x,0,0
216181,100,0,0
216182,.,0,0
216183,There,0,0
216184,was,0,0
216185,a,0,0
216186,strong,0,0
216187,correlation,0,0
216188,between,0,0
216189,this,0,0
216190,index,0,0
216191,and,0,0
216192,the,0,0
216193,risk,0,0
216194,of,0,0
216195,collapse,0,0
216196,before,0,0
216197,and,0,0
216198,after,0,0
216199,adjustment,0,0
216200,for,0,0
216201,age,0,1
216202,",",0,0
216203,gender,0,0
216204,",",0,0
216205,stage,0,1
216206,and,0,0
216207,treatment,0,0
216208,group,0,0
216209,.,0,0
216210,We,0,0
216211,conclude,0,0
216212,that,0,0
216213,the,0,0
216214,extent,0,0
216215,of,0,0
216216,the,0,0
216217,necrotic,0,1
216218,portion,0,0
216219,ascertain,0,0
216220,by,0,0
216221,this,0,0
216222,method,0,0
216223,is,0,0
216224,a,0,0
216225,major,0,0
216226,predictor,0,0
216227,of,0,0
216228,future,0,0
216229,collapse,0,0
216230,.,0,0
216231,We,0,0
216232,propose,0,0
216233,a,0,0
216234,systematic,0,0
216235,method,0,0
216236,of,0,0
216237,determining,0,0
216238,the,0,0
216239,index,0,0
216240,of,0,0
216241,the,0,0
216242,necrotic,0,1
216243,portion,0,0
216244,which,0,0
216245,may,0,0
216246,be,0,0
216247,clinically,0,0
216248,useful,0,0
216249,in,0,0
216250,the,0,0
216251,management,0,0
216252,of,0,0
216253,early-stage,1,1
216254,ON,1,0
216255,of,1,0
216256,the,1,0
216257,femoral,1,0
216258,head,1,1
216259,.,1,0
216260,Brief,0,0
216261,report,0,0
216262,:,0,1
216263,a,0,0
216264,pilot,0,0
216265,study,0,0
216266,of,0,0
216267,auditory,0,0
216268,integration,0,0
216269,training,0,0
216270,in,0,0
216271,autism,1,1
216272,.,1,0
216273,Primary,0,1
216274,care-based,0,1
216275,ambulatory,0,1
216276,opioid,0,0
216277,detoxification,0,0
216278,:,0,1
216279,the,0,0
216280,results,0,0
216281,of,0,0
216282,a,0,0
216283,clinical,0,0
216284,trial,0,0
216285,.,0,0
216286,OBJECTIVE,0,0
216287,To,0,0
216288,determine,0,0
216289,the,0,0
216290,feasibility,0,0
216291,of,0,0
216292,primary,0,0
216293,care-based,0,1
216294,ambulatory,0,1
216295,opioid,0,0
216296,detoxification,0,0
216297,(,0,0
216298,AOD,0,0
216299,),0,0
216300,using,0,0
216301,two,0,0
216302,protocols,0,0
216303,:,0,1
216304,clonidine,0,0
216305,and,0,0
216306,clonidine,0,0
216307,plus,0,0
216308,naltrexone,0,0
216309,.,0,0
216310,SETTING,0,0
216311,The,1,0
216312,Central,1,0
216313,Medical,1,1
216314,Unit,1,0
216315,(,1,0
216316,CMU,1,1
216317,),1,0
216318,--,1,0
216319,a,1,0
216320,freestanding,1,0
216321,primary,1,0
216322,care,1,0
216323,medical,1,0
216324,clinic,1,1
216325,staffed,1,1
216326,by,1,0
216327,physicians,1,1
216328,and,1,0
216329,nurse,1,1
216330,practitioners,1,1
216331,.,1,1
216332,PATIENTS,0,0
216333,Injection,1,0
216334,drug,1,0
216335,users,1,1
216336,(,1,0
216337,IDUs,1,0
216338,),1,0
216339,seeking,1,0
216340,substance,1,0
216341,abuse,1,1
216342,treatment,1,0
216343,between,1,0
216344,the,1,0
216345,ages,1,1
216346,of,1,0
216347,18,1,1
216348,and,1,0
216349,50,1,1
216350,years,1,1
216351,who,1,1
216352,were,1,1
216353,addicted,1,1
216354,to,1,0
216355,opioids,1,0
216356,(,1,0
216357,e.g.,1,0
216358,",",0,0
216359,heroin,1,1
216360,),1,0
216361,and,1,0
216362,not,1,0
216363,currently,1,0
216364,in,1,0
216365,drug,1,0
216366,treatment,1,0
216367,.,1,0
216368,INTERVENTIONS,0,0
216369,In,0,0
216370,the,0,0
216371,clonidine,0,0
216372,protocol,0,0
216373,",",0,0
216374,clonidine,0,0
216375,was,0,0
216376,administered,0,0
216377,every,0,0
216378,4,0,0
216379,hours,0,0
216380,as,0,0
216381,needed,0,0
216382,for,0,0
216383,up,0,0
216384,to,0,0
216385,12,0,0
216386,days,0,0
216387,.,0,0
216388,In,0,0
216389,the,0,0
216390,clonidine,0,0
216391,plus,0,0
216392,naltrexone,0,0
216393,protocol,0,0
216394,",",0,0
216395,clonidine,0,0
216396,was,0,0
216397,administered,0,0
216398,and,0,0
216399,naltrexone,0,0
216400,was,0,0
216401,administered,0,0
216402,in,0,0
216403,increasing,0,0
216404,doses,0,0
216405,over,0,0
216406,five,0,1
216407,days,0,0
216408,.,0,1
216409,Both,0,0
216410,protocols,0,0
216411,included,0,1
216412,adjuvant,0,1
216413,medications,0,0
216414,for,0,0
216415,muscle,0,0
216416,cramps,0,0
216417,",",0,0
216418,insomnia,0,1
216419,",",0,0
216420,and,0,0
216421,vomiting,0,0
216422,.,0,0
216423,Successfully,0,0
216424,detoxified,0,0
216425,patients,0,1
216426,were,0,0
216427,referred,0,1
216428,to,0,0
216429,ongoing,0,0
216430,drug,0,0
216431,treatment,0,0
216432,.,0,0
216433,DESIGN,0,0
216434,A,0,0
216435,prospective,0,0
216436,nonrandomized,0,0
216437,clinical,0,0
216438,trial,0,0
216439,.,0,0
216440,MEASUREMENTS,0,0
216441,AND,0,0
216442,MAIN,0,0
216443,RESULTS,0,0
216444,One,1,1
216445,hundred,1,1
216446,forty,1,1
216447,opioid-addicted,1,1
216448,IDUs,1,0
216449,were,1,0
216450,referred,1,1
216451,to,1,0
216452,the,1,0
216453,medical,1,0
216454,clinic,1,1
216455,for,1,0
216456,AOD,1,0
216457,.,1,0
216458,Among,1,0
216459,the,1,0
216460,125,1,1
216461,patients,1,1
216462,who,1,1
216463,enrolled,1,1
216464,in,1,1
216465,the,1,0
216466,study,1,0
216467,",",1,0
216468,57,1,0
216469,selected,1,1
216470,clonidine,1,0
216471,and,1,0
216472,68,1,0
216473,selected,1,1
216474,clonidine/naltrexone,1,0
216475,.,1,0
216476,The,0,0
216477,treatment,0,0
216478,groups,0,0
216479,(,0,0
216480,clonidine,0,0
216481,vs,0,0
216482,clonidine/naltrexone,0,0
216483,),0,0
216484,were,0,0
216485,similar,0,0
216486,at,0,0
216487,baseline,0,0
216488,with,0,1
216489,respect,0,0
216490,to,0,0
216491,:,0,0
216492,age,0,1
216493,at,0,0
216494,first,0,0
216495,heroin,0,1
216496,use,0,0
216497,(,0,0
216498,21,0,1
216499,years,0,1
216500,vs,0,0
216501,23,0,1
216502,years,0,1
216503,),0,0
216504,",",0,0
216505,mean,0,0
216506,admission,0,0
216507,opioid,0,0
216508,craving,0,0
216509,score,0,0
216510,(,0,0
216511,45/100,0,0
216512,vs,0,0
216513,49/100,0,0
216514,),0,0
216515,",",0,0
216516,and,0,0
216517,withdrawal,0,0
216518,symptom,0,0
216519,score,0,0
216520,(,0,0
216521,19/72,0,0
216522,vs,0,0
216523,18/72,0,0
216524,),0,0
216525,.,0,0
216526,Overall,0,0
216527,",",0,0
216528,70,0,1
216529,%,0,0
216530,(,0,0
216531,88/125,0,0
216532,),0,0
216533,of,0,0
216534,the,0,0
216535,AODs,0,0
216536,were,0,0
216537,successful,0,0
216538,",",0,0
216539,including,0,0
216540,42,0,0
216541,%,0,0
216542,(,0,0
216543,24/57,0,0
216544,),0,0
216545,for,0,0
216546,clonidine,0,0
216547,and,0,0
216548,94,0,0
216549,%,0,0
216550,(,0,0
216551,64/68,0,0
216552,),0,0
216553,for,0,0
216554,clonidine/naltrexone,0,0
216555,(,0,0
216556,p,0,0
216557,<,0,0
216558,0.001,0,0
216559,),0,0
216560,.,0,0
216561,CONCLUSIONS,0,0
216562,This,0,0
216563,study,0,0
216564,suggests,0,0
216565,that,0,0
216566,primary,0,0
216567,care-based,0,0
216568,AOD,0,0
216569,can,0,0
216570,be,0,0
216571,safely,0,0
216572,and,0,0
216573,effectively,0,0
216574,carried,0,0
216575,out,0,0
216576,by,0,0
216577,primary,0,0
216578,care,0,1
216579,providers,0,0
216580,and,0,0
216581,that,0,0
216582,clonidine/naltrexone,0,0
216583,may,0,0
216584,be,0,0
216585,more,0,0
216586,effective,0,0
216587,in,0,0
216588,this,0,0
216589,setting,0,0
216590,than,0,0
216591,is,0,0
216592,clonidine,0,0
216593,alone,0,0
216594,.,0,0
216595,Ambulatory,0,0
216596,opioid,0,0
216597,detoxification,0,0
216598,can,0,0
216599,give,0,0
216600,internists,0,0
216601,a,0,0
216602,larger,0,0
216603,role,0,0
216604,in,0,0
216605,initiating,0,0
216606,drug,0,0
216607,treatment,0,0
216608,for,0,0
216609,IDUs,1,0
216610,who,1,1
216611,are,1,0
216612,addicted,1,1
216613,to,1,0
216614,opioids,1,0
216615,.,1,1
216616,Synthesis,0,0
216617,of,0,0
216618,interleukin-1,0,0
216619,beta,0,0
216620,in,0,0
216621,primary,1,0
216622,biliary,1,1
216623,cirrhosis,1,1
216624,:,1,1
216625,relationship,0,0
216626,to,0,0
216627,treatment,0,0
216628,with,0,0
216629,methotrexate,0,0
216630,or,0,0
216631,colchicine,0,0
216632,and,0,0
216633,disease,0,1
216634,progression,0,0
216635,.,0,0
216636,Primary,1,0
216637,biliary,1,1
216638,cirrhosis,1,1
216639,(,1,0
216640,PBC,1,0
216641,),1,0
216642,is,1,0
216643,a,1,0
216644,chronic,1,0
216645,",",1,0
216646,progressive,1,0
216647,",",1,0
216648,cholestatic,1,1
216649,liver,1,1
216650,disease,1,1
216651,.,1,0
216652,Interleukin-1,0,0
216653,beta,0,0
216654,(,0,0
216655,IL-1,0,0
216656,beta,0,0
216657,),0,0
216658,may,0,0
216659,play,0,0
216660,a,0,0
216661,role,0,0
216662,in,0,0
216663,the,0,0
216664,pathogenesis,0,0
216665,of,0,0
216666,PBC,0,0
216667,by,0,0
216668,contributing,0,0
216669,to,0,0
216670,altered,0,0
216671,immune,0,0
216672,function,0,0
216673,and,0,0
216674,fibrosis,0,0
216675,.,0,0
216676,Colchicine,0,0
216677,or,0,0
216678,methotrexate,0,0
216679,has,0,0
216680,some,0,0
216681,beneficial,0,0
216682,effects,0,0
216683,in,0,0
216684,the,0,0
216685,treatment,0,0
216686,of,0,0
216687,PBC,0,0
216688,",",0,0
216689,and,0,0
216690,also,0,0
216691,affects,0,0
216692,interleukin-1,0,0
216693,(,0,0
216694,IL-1,0,1
216695,),0,0
216696,.,0,0
216697,Therefore,0,0
216698,",",0,0
216699,we,0,0
216700,prospectively,0,0
216701,studied,0,0
216702,the,0,0
216703,synthesis,0,0
216704,of,0,0
216705,IL-1,0,0
216706,beta,0,0
216707,by,0,0
216708,peripheral,0,0
216709,blood,0,0
216710,mononuclear,0,1
216711,cells,0,0
216712,(,0,0
216713,PBMC,0,0
216714,),0,0
216715,from,1,0
216716,42,1,1
216717,patients,1,1
216718,with,1,1
216719,PBC,1,1
216720,entered,0,1
216721,into,0,0
216722,a,0,0
216723,randomized,0,0
216724,",",0,0
216725,double-blind,0,0
216726,",",0,0
216727,double-dummy,0,0
216728,controlled,0,0
216729,trial,0,0
216730,of,0,0
216731,colchicine,0,0
216732,and,0,0
216733,methotrexate,0,0
216734,.,0,0
216735,PBMC,0,0
216736,obtained,0,0
216737,at,0,0
216738,entry,0,0
216739,",",0,0
216740,6,0,0
216741,",",0,0
216742,12,0,0
216743,",",0,0
216744,18,0,0
216745,",",0,0
216746,and,0,0
216747,24,0,0
216748,months,0,0
216749,were,0,0
216750,stimulated,0,0
216751,to,0,0
216752,produce,0,0
216753,IL-1,0,0
216754,beta,0,0
216755,with,0,0
216756,phytohemagglutinin,0,0
216757,(,0,0
216758,PHA,0,0
216759,),0,0
216760,",",0,0
216761,lipopolysaccharide,0,0
216762,(,0,0
216763,LPS,0,0
216764,),0,0
216765,",",0,0
216766,Staphylococcus,0,0
216767,epidermidis,0,0
216768,",",0,0
216769,recombinant,0,0
216770,IL-2,0,0
216771,",",0,0
216772,or,0,0
216773,mitochondrial,0,0
216774,antigen,0,0
216775,.,0,0
216776,Patients,0,1
216777,in,0,0
216778,the,0,0
216779,two,0,0
216780,treatment,0,0
216781,groups,0,0
216782,did,0,0
216783,not,0,0
216784,differ,0,0
216785,at,0,0
216786,entry,0,0
216787,in,0,0
216788,biochemical,0,0
216789,measures,0,0
216790,or,0,0
216791,liver,0,1
216792,histological,0,0
216793,stage,0,1
216794,.,0,0
216795,Over,0,0
216796,24,0,0
216797,months,0,0
216798,in,0,0
216799,both,0,0
216800,groups,0,0
216801,",",0,0
216802,serum,0,0
216803,bilirubin,0,0
216804,and,0,0
216805,histologic,0,0
216806,stage,0,1
216807,remained,0,0
216808,stable,0,1
216809,and,0,0
216810,alkaline,0,0
216811,phosphatase,0,0
216812,decreased,0,0
216813,significantly,0,0
216814,.,0,0
216815,For,0,0
216816,all,0,0
216817,patients,0,1
216818,",",0,0
216819,synthesis,0,0
216820,of,0,0
216821,IL-1,0,1
216822,beta,0,0
216823,increased,0,0
216824,constitutively,0,0
216825,and,0,0
216826,in,0,0
216827,response,0,0
216828,to,0,0
216829,immune-mediated,0,0
216830,stimulants,0,0
216831,(,0,0
216832,PHA,0,0
216833,",",0,0
216834,IL-2,0,0
216835,",",0,0
216836,and,0,0
216837,mitochondrial,0,0
216838,antigen,0,0
216839,),0,0
216840,but,0,0
216841,not,0,0
216842,the,0,0
216843,bacterial,0,0
216844,stimulants,0,0
216845,LPS,0,0
216846,or,0,1
216847,S,0,0
216848,epidermidis,0,0
216849,.,0,0
216850,Compared,0,0
216851,with,0,0
216852,levels,0,0
216853,of,0,0
216854,IL-1,0,1
216855,beta,0,0
216856,at,0,0
216857,entry,0,0
216858,",",0,0
216859,PHA,0,0
216860,induced,0,0
216861,increases,0,0
216862,for,0,0
216863,patients,0,1
216864,treated,0,1
216865,with,0,1
216866,methotrexate,0,0
216867,(,0,0
216868,12,0,0
216869,",",0,0
216870,18,0,0
216871,",",0,0
216872,and,0,0
216873,24,0,0
216874,months,0,0
216875,),0,0
216876,or,0,0
216877,colchicine,0,0
216878,(,0,0
216879,18,0,1
216880,and,0,0
216881,24,0,0
216882,months,0,0
216883,),0,0
216884,.,0,0
216885,At,0,0
216886,24,0,0
216887,months,0,0
216888,",",0,0
216889,IL-2-induced,0,0
216890,IL-1,0,0
216891,beta,0,0
216892,synthesis,0,0
216893,was,0,0
216894,increased,0,0
216895,in,0,0
216896,patients,0,1
216897,treated,0,1
216898,with,0,1
216899,methotrexate,0,0
216900,",",0,0
216901,whereas,0,0
216902,S,0,0
216903,epidermidis-induced,0,0
216904,IL-1,0,1
216905,beta,0,0
216906,was,0,0
216907,enhanced,0,0
216908,in,0,0
216909,colchicine-treated,0,1
216910,patients,0,1
216911,.,0,0
216912,Before,0,0
216913,treatment,0,0
216914,",",0,0
216915,IL-1,0,0
216916,beta,0,0
216917,production,0,0
216918,did,0,0
216919,not,0,0
216920,relate,0,0
216921,to,0,0
216922,severity,0,0
216923,of,0,0
216924,disease,0,1
216925,except,0,0
216926,in,0,0
216927,response,0,0
216928,to,0,0
216929,S,0,0
216930,epidermidis,0,0
216931,.,0,0
216932,(,0,0
216933,ABSTRACT,0,0
216934,TRUNCATED,0,0
216935,AT,0,0
216936,250,0,0
216937,WORDS,0,0
216938,),0,0
216939,Are,0,0
216940,PRO,0,0
216941,discharge,0,0
216942,screens,0,0
216943,associated,0,0
216944,with,0,1
216945,postdischarge,0,0
216946,adverse,0,0
216947,outcomes,0,0
216948,?,0,0
216949,OBJECTIVE,0,0
216950,We,0,0
216951,evaluate,0,0
216952,whether,0,0
216953,patient,0,0
216954,outcomes,0,0
216955,may,0,0
216956,be,0,0
216957,affected,0,0
216958,by,0,0
216959,possible,0,0
216960,errors,0,0
216961,in,0,0
216962,care,0,0
216963,at,0,0
216964,discharge,0,0
216965,as,0,0
216966,assessed,0,0
216967,by,0,0
216968,Peer,0,1
216969,Review,0,0
216970,Organizations,0,0
216971,(,0,0
216972,PROs,0,1
216973,),0,0
216974,.,0,0
216975,DATA,0,0
216976,SOURCES/STUDY,0,0
216977,SETTING,0,1
216978,The,1,0
216979,three,1,0
216980,data,1,0
216981,sources,1,0
216982,for,1,0
216983,the,1,0
216984,study,1,0
216985,were,1,0
216986,(,1,0
216987,1,1,0
216988,),1,0
216989,the,1,0
216990,generic,1,0
216991,screen,1,0
216992,results,1,0
216993,of,1,0
216994,a,1,0
216995,3,1,0
216996,percent,1,0
216997,random,1,0
216998,sample,1,1
216999,of,1,0
217000,Medicare,1,1
217001,beneficiaries,1,1
217002,age,1,1
217003,65,1,1
217004,years,1,1
217005,or,1,1
217006,older,1,1
217007,who,1,1
217008,were,1,1
217009,admitted,1,1
217010,to,1,0
217011,California,1,1
217012,hospitals,1,1
217013,between,1,0
217014,1,1,0
217015,July,1,0
217016,1987,1,1
217017,and,1,0
217018,30,1,1
217019,June,1,1
217020,1988,1,1
217021,(,1,0
217022,n,1,1
217023,=,1,0
217024,"20,136",1,1
217025,patients,1,1
217026,),1,1
217027,;,1,0
217028,(,1,0
217029,2,1,0
217030,),1,0
217031,the,1,0
217032,1987,1,1
217033,and,1,0
217034,1988,1,1
217035,California,1,1
217036,Medicare,1,1
217037,Provided,1,0
217038,Analysis,1,0
217039,and,1,0
217040,Review,1,0
217041,(,1,0
217042,MEDPAR,1,0
217043,),1,0
217044,data,1,0
217045,files,1,0
217046,;,1,0
217047,and,1,0
217048,(,1,0
217049,3,1,0
217050,),1,0
217051,the,1,0
217052,American,1,1
217053,Hospital,1,1
217054,Association,1,0
217055,(,1,0
217056,AHA,1,0
217057,),1,0
217058,1988,1,1
217059,Annual,1,0
217060,Survey,1,0
217061,of,1,0
217062,Hospitals,1,1
217063,.,1,1
217064,STUDY,0,0
217065,DESIGN,0,0
217066,Multivariate,0,0
217067,logistic,0,0
217068,regression,0,0
217069,analysis,0,0
217070,was,0,0
217071,used,0,0
217072,to,0,0
217073,evaluate,0,0
217074,the,0,0
217075,association,0,0
217076,between,0,0
217077,the,0,0
217078,results,0,0
217079,of,0,0
217080,generic,0,0
217081,discharge,0,0
217082,administered,0,0
217083,by,0,0
217084,the,0,0
217085,PROs,0,0
217086,and,0,0
217087,two,0,0
217088,patient,0,1
217089,outcomes,0,0
217090,:,0,1
217091,mortality,0,0
217092,and,0,0
217093,readmission,0,0
217094,within,0,0
217095,30,0,1
217096,days,0,0
217097,.,0,0
217098,The,0,0
217099,analysis,0,0
217100,was,0,0
217101,adjusted,0,0
217102,for,0,0
217103,other,0,0
217104,patient,0,1
217105,characteristics,0,0
217106,recorded,0,0
217107,on,0,0
217108,the,0,0
217109,uniform,0,0
217110,discharge,0,0
217111,abstract,0,0
217112,.,0,0
217113,PRINCIPAL,0,0
217114,FINDINGS,0,0
217115,Four,0,0
217116,discharge,0,0
217117,screens,0,0
217118,indicated,0,0
217119,an,0,0
217120,increased,0,0
217121,risk,0,0
217122,of,0,0
217123,an,0,0
217124,adverse,0,0
217125,outcome-absence,0,0
217126,of,0,0
217127,documentation,0,0
217128,of,0,0
217129,discharge,0,0
217130,planning,0,0
217131,",",0,0
217132,elevated,0,0
217133,temperature,0,0
217134,",",0,0
217135,abnormal,0,0
217136,pulse,0,0
217137,",",0,0
217138,and,0,0
217139,unaddressed,0,0
217140,abnormal,0,0
217141,test,0,0
217142,results,0,0
217143,at,0,0
217144,discharge,0,0
217145,.,0,0
217146,The,0,0
217147,other,0,0
217148,three,0,0
217149,discharge,0,0
217150,screens,0,0
217151,examined-abnormal,0,0
217152,blood,0,0
217153,pressure,0,0
217154,",",0,0
217155,IV,0,0
217156,fluids,0,0
217157,or,0,1
217158,drugs,0,0
217159,",",0,0
217160,and,0,0
217161,wound,0,0
217162,drainage,0,0
217163,before,0,0
217164,discharge-were,0,0
217165,unrelated,0,1
217166,to,0,0
217167,postdischarge,0,0
217168,adverse,0,0
217169,outcomes,0,0
217170,.,0,1
217171,CONCLUSIONS,0,0
217172,Generic,0,0
217173,discharge,0,0
217174,screens,0,0
217175,based,0,0
217176,on,0,0
217177,inadequate,0,0
217178,discharge,0,0
217179,planning,0,0
217180,",",0,0
217181,abnormal,0,0
217182,pulse,0,0
217183,",",0,0
217184,increased,0,0
217185,temperature,0,0
217186,",",0,0
217187,or,0,0
217188,unaddressed,0,0
217189,abnormal,0,0
217190,tests,0,0
217191,may,0,0
217192,be,0,0
217193,important,0,0
217194,indicators,0,0
217195,of,0,0
217196,substandard,0,1
217197,care,0,0
217198,.,0,0
217199,Other,0,0
217200,discharge,0,0
217201,screens,0,0
217202,apparently,0,0
217203,do,0,0
217204,not,0,0
217205,detect,0,0
217206,errors,0,0
217207,in,0,0
217208,care,0,0
217209,associated,0,0
217210,with,0,1
217211,major,0,0
217212,consequences,0,0
217213,for,0,0
217214,patients,0,1
217215,.,0,1
217216,Movement-related,0,0
217217,potentials,0,0
217218,in,0,0
217219,Parkinson,1,1
217220,'s,1,1
217221,disease,1,1
217222,.,1,1
217223,Presence,0,0
217224,and,0,0
217225,predictability,0,0
217226,of,0,0
217227,temporal,0,0
217228,and,0,0
217229,spatial,0,0
217230,cues,0,0
217231,.,0,0
217232,Activity,0,0
217233,of,0,0
217234,the,0,0
217235,supplementary,0,0
217236,motor,0,0
217237,area,0,0
217238,may,0,0
217239,be,0,0
217240,inferred,0,0
217241,from,0,0
217242,movement-related,0,0
217243,potentials,0,0
217244,(,0,0
217245,MRPs,0,0
217246,),0,0
217247,which,0,0
217248,are,0,0
217249,associated,0,0
217250,with,0,0
217251,the,0,0
217252,preparation,0,0
217253,and,0,0
217254,execution,0,0
217255,of,0,0
217256,voluntary,0,0
217257,",",0,0
217258,or,0,0
217259,internally,0,0
217260,determined,0,0
217261,movements,0,0
217262,.,0,1
217263,Supplementary,0,0
217264,motor,0,0
217265,area,0,0
217266,activity,0,0
217267,may,0,0
217268,be,0,0
217269,abnormal,0,0
217270,in,0,0
217271,Parkinson,1,1
217272,'s,1,0
217273,disease,1,1
217274,since,0,0
217275,its,0,0
217276,major,0,0
217277,input,0,0
217278,from,0,0
217279,the,0,0
217280,basal,0,0
217281,ganglia,0,0
217282,is,0,0
217283,disrupted,0,0
217284,.,0,0
217285,Investigation,0,0
217286,of,0,0
217287,the,0,0
217288,abnormalities,0,0
217289,in,0,0
217290,supplementary,0,0
217291,motor,0,0
217292,area,0,0
217293,activity,0,0
217294,associated,0,0
217295,with,0,1
217296,movement,0,0
217297,deficits,0,0
217298,in,0,0
217299,Parkinson,0,1
217300,'s,0,0
217301,disease,0,0
217302,may,0,0
217303,therefore,0,0
217304,reveal,0,0
217305,functions,0,0
217306,of,0,0
217307,the,0,0
217308,basal,0,0
217309,ganglia,0,0
217310,and,0,0
217311,the,0,0
217312,supplementary,0,0
217313,motor,0,0
217314,area,0,0
217315,.,0,0
217316,Movement-related,0,0
217317,potentials,0,0
217318,associated,0,0
217319,with,0,1
217320,sequential,0,0
217321,movements,0,0
217322,were,0,0
217323,investigated,0,0
217324,under,0,0
217325,various,0,0
217326,cueing,0,0
217327,conditions,0,0
217328,in,0,0
217329,Parkinson,1,1
217330,'s,1,1
217331,disease,1,1
217332,subjects,1,1
217333,and,1,0
217334,age-matched,1,1
217335,controls,1,0
217336,.,1,1
217337,In,0,0
217338,controls,0,0
217339,",",0,0
217340,MRPs,0,0
217341,revealed,0,0
217342,involvement,0,0
217343,of,0,0
217344,the,0,0
217345,supplementary,0,0
217346,motor,0,0
217347,area,0,0
217348,in,0,0
217349,movements,0,0
217350,which,0,0
217351,can,0,0
217352,be,0,0
217353,internally,0,0
217354,determined,0,0
217355,(,0,0
217356,non-cued,0,0
217357,and,0,0
217358,externally,0,0
217359,cued,0,0
217360,",",0,0
217361,predictable,0,0
217362,movements,0,0
217363,",",0,0
217364,but,0,0
217365,not,0,0
217366,unpredictable,0,0
217367,movements,0,0
217368,),0,0
217369,.,0,0
217370,In,0,0
217371,Parkinson,0,0
217372,'s,0,0
217373,disease,0,1
217374,",",0,0
217375,however,0,0
217376,",",0,0
217377,the,0,0
217378,supplementary,0,0
217379,motor,0,0
217380,area,0,0
217381,was,0,0
217382,only,0,0
217383,involved,0,0
217384,in,0,0
217385,movements,0,0
217386,which,0,0
217387,must,0,0
217388,be,0,0
217389,internally,0,0
217390,determined,0,0
217391,(,0,0
217392,non-cued,0,0
217393,movements,0,0
217394,",",0,0
217395,but,0,0
217396,not,0,0
217397,externally,0,0
217398,cued,0,0
217399,movements,0,0
217400,),0,0
217401,;,0,0
217402,therefore,0,0
217403,impaired,0,0
217404,internal,0,0
217405,control,0,0
217406,mechanisms,0,0
217407,",",0,0
217408,operating,0,0
217409,via,0,0
217410,the,0,0
217411,supplementary,0,0
217412,motor,0,0
217413,area,0,0
217414,",",0,0
217415,are,0,0
217416,bypassed,0,0
217417,when,0,0
217418,external,0,0
217419,cues,0,0
217420,are,0,0
217421,given,0,0
217422,.,0,0
217423,As,0,0
217424,a,0,0
217425,result,0,0
217426,",",0,0
217427,Parkinson,1,0
217428,'s,1,0
217429,disease,1,1
217430,patients,1,1
217431,are,0,0
217432,more,0,0
217433,reliant,0,0
217434,on,0,0
217435,external,0,1
217436,cues,0,0
217437,and,0,0
217438,are,0,0
217439,unable,0,0
217440,to,0,0
217441,use,0,0
217442,predictive,0,0
217443,models,0,0
217444,to,0,0
217445,internally,0,0
217446,guide,0,0
217447,movement,0,0
217448,.,0,0
217449,Supplementary,0,0
217450,motor,0,0
217451,area,0,0
217452,involvement,0,0
217453,also,0,0
217454,relied,0,0
217455,on,0,0
217456,the,0,0
217457,predictability,0,0
217458,(,0,0
217459,in,0,0
217460,controls,0,1
217461,),0,0
217462,or,0,0
217463,presence,0,0
217464,(,0,0
217465,in,0,0
217466,Parkinson,0,1
217467,'s,0,1
217468,disease,0,1
217469,),0,0
217470,of,0,0
217471,timing,0,0
217472,cues,0,0
217473,and,0,0
217474,not,0,0
217475,spatial,0,0
217476,cues,0,0
217477,",",0,0
217478,indicating,0,0
217479,a,0,0
217480,role,0,0
217481,of,0,0
217482,the,0,0
217483,supplementary,0,0
217484,motor,0,0
217485,area,0,0
217486,and,0,0
217487,basal,0,0
217488,ganglia,0,0
217489,in,0,0
217490,the,0,0
217491,temporal,0,0
217492,organizations,0,0
217493,of,0,0
217494,sequential,0,0
217495,movement,0,0
217496,rather,0,0
217497,than,0,0
217498,the,0,0
217499,programming,0,0
217500,of,0,0
217501,specific,0,0
217502,movements,0,0
217503,.,0,1
217504,For,0,0
217505,non-cued,0,0
217506,movements,0,0
217507,",",0,0
217508,abnormalities,0,0
217509,in,0,0
217510,MRPs,0,0
217511,for,0,0
217512,Parkinson,0,1
217513,'s,0,0
217514,disease,0,1
217515,subjects,0,1
217516,consisted,0,0
217517,of,0,0
217518,delayed,0,0
217519,MRP,0,0
217520,onset,0,1
217521,and,0,0
217522,peak,0,0
217523,times,0,0
217524,",",0,0
217525,and,0,0
217526,prolonged,0,0
217527,cortical,0,0
217528,activity,0,0
217529,following,0,0
217530,movement,0,0
217531,.,0,0
217532,These,0,0
217533,observations,0,0
217534,led,0,0
217535,to,0,0
217536,a,0,0
217537,proposed,0,0
217538,model,0,0
217539,of,0,0
217540,the,0,0
217541,interaction,0,0
217542,between,0,0
217543,the,0,0
217544,basal,0,0
217545,ganglia,0,0
217546,and,0,0
217547,the,0,0
217548,supplementary,0,0
217549,motor,0,0
217550,area,0,0
217551,",",0,0
217552,involving,0,0
217553,the,0,0
217554,temporal,0,0
217555,organization,0,0
217556,of,0,0
217557,voluntary,0,0
217558,and,0,0
217559,internally,0,0
217560,determined,0,0
217561,sequential,0,0
217562,movements,0,0
217563,.,0,1
217564,Efficacy,0,0
217565,of,0,0
217566,Contractubex,0,0
217567,gel,0,0
217568,in,0,0
217569,the,0,0
217570,treatment,0,0
217571,of,0,0
217572,fresh,1,0
217573,scars,1,1
217574,after,1,0
217575,thoracic,1,1
217576,surgery,1,1
217577,in,1,0
217578,children,1,1
217579,and,1,1
217580,adolescents,1,1
217581,.,1,0
217582,Scar,0,0
217583,development,0,0
217584,was,0,0
217585,investigated,0,0
217586,in,0,0
217587,45,1,1
217588,young,1,1
217589,patients,1,1
217590,who,1,1
217591,had,1,1
217592,undergone,1,1
217593,thoracic,1,1
217594,surgery,1,1
217595,.,1,0
217596,Patients,0,1
217597,were,0,0
217598,randomly,0,1
217599,assigned,0,0
217600,either,0,0
217601,to,0,0
217602,a,0,0
217603,group,0,0
217604,which,0,0
217605,was,0,0
217606,treated,0,0
217607,topically,0,0
217608,with,0,0
217609,Contractubex,0,0
217610,gel,0,0
217611,(,0,0
217612,Merz,0,0
217613,+,0,0
217614,Co.,0,0
217615,",",0,0
217616,D-Frankfurt/Main,0,0
217617,),0,0
217618,",",0,0
217619,containing,0,0
217620,10,0,0
217621,%,0,0
217622,onion,0,0
217623,extract,0,0
217624,",",0,0
217625,50/U,0,0
217626,of,0,0
217627,sodium,0,0
217628,heparin,0,0
217629,per,0,0
217630,one,0,0
217631,g,0,0
217632,of,0,0
217633,gel,0,0
217634,and,0,0
217635,1,0,0
217636,%,0,0
217637,allantoin,0,0
217638,",",0,0
217639,or,0,0
217640,to,0,0
217641,a,0,0
217642,group,0,0
217643,receiving,0,0
217644,no,0,0
217645,treatment,0,0
217646,.,0,0
217647,The,0,0
217648,treatment,0,0
217649,began,0,0
217650,on,0,0
217651,average,0,0
217652,26,0,1
217653,days,0,0
217654,after,0,0
217655,the,0,0
217656,operation,0,0
217657,and,0,0
217658,was,0,0
217659,continued,0,0
217660,for,0,0
217661,one,0,0
217662,year,0,0
217663,.,0,0
217664,The,0,0
217665,scars,0,0
217666,of,0,0
217667,all,0,0
217668,treated,0,0
217669,and,0,0
217670,untreated,0,1
217671,patients,0,1
217672,were,0,0
217673,evaluated,0,0
217674,at,0,0
217675,monthly,0,0
217676,intervals,0,0
217677,.,0,0
217678,The,0,0
217679,appearance,0,0
217680,of,0,0
217681,the,0,0
217682,scar,0,0
217683,",",0,0
217684,including,0,0
217685,scar,0,0
217686,type,0,1
217687,and,0,0
217688,scar,0,0
217689,size,0,0
217690,as,0,0
217691,well,0,0
217692,as,0,0
217693,scar,0,0
217694,colour,0,0
217695,",",0,0
217696,was,0,0
217697,assessed,0,0
217698,by,0,0
217699,the,0,0
217700,physician,0,0
217701,.,0,0
217702,A,0,0
217703,reduction,0,0
217704,of,0,0
217705,the,0,0
217706,increase,0,0
217707,of,0,0
217708,scar,0,0
217709,width,0,0
217710,was,0,0
217711,seen,0,0
217712,in,0,0
217713,the,0,0
217714,Contractubex-treated,0,0
217715,group,0,0
217716,as,0,0
217717,compared,0,0
217718,with,0,1
217719,the,0,0
217720,untreated,0,1
217721,group,0,0
217722,.,0,0
217723,Further,0,0
217724,",",0,0
217725,physiological,0,0
217726,scars,0,0
217727,and,0,0
217728,skin-coloured,0,1
217729,scars,0,0
217730,were,0,0
217731,more,0,0
217732,frequent,0,0
217733,in,0,0
217734,the,0,0
217735,treated,0,0
217736,group,0,0
217737,than,0,0
217738,in,0,0
217739,the,0,0
217740,untreated,0,1
217741,group,0,0
217742,.,0,0
217743,Hypertrophic,0,0
217744,or,0,0
217745,keloidal,0,1
217746,scars,0,0
217747,were,0,0
217748,less,0,0
217749,frequent,0,0
217750,in,0,0
217751,the,0,0
217752,treated,0,1
217753,group,0,0
217754,.,0,0
217755,No,0,0
217756,differences,0,0
217757,in,0,0
217758,scar,0,0
217759,length,0,0
217760,and,0,0
217761,scar,0,0
217762,height,0,0
217763,were,0,0
217764,seen,0,0
217765,.,0,0
217766,At,0,0
217767,the,0,0
217768,end,0,0
217769,of,0,0
217770,the,0,0
217771,observation,0,0
217772,period,0,0
217773,",",0,0
217774,the,0,0
217775,clinical,0,0
217776,course,0,0
217777,of,0,0
217778,scar,0,0
217779,development,0,0
217780,was,0,0
217781,rated,0,0
217782,as,0,0
217783,very,0,0
217784,good,0,0
217785,or,0,0
217786,good,0,0
217787,in,0,0
217788,more,0,0
217789,than,0,0
217790,90,0,0
217791,%,0,0
217792,of,0,0
217793,the,0,0
217794,treated,0,0
217795,patients,0,1
217796,",",0,0
217797,good,0,0
217798,in,0,0
217799,less,0,0
217800,than,0,0
217801,40,0,0
217802,%,0,0
217803,and,0,0
217804,moderate,0,1
217805,or,0,0
217806,bad,0,0
217807,in,0,0
217808,more,0,0
217809,than,0,0
217810,60,0,0
217811,%,0,0
217812,of,0,0
217813,the,0,0
217814,untreated,0,1
217815,cases,0,0
217816,.,0,0
217817,The,0,0
217818,tolerability,0,0
217819,of,0,0
217820,the,0,0
217821,drug,0,0
217822,was,0,0
217823,good,0,0
217824,or,0,0
217825,very,0,0
217826,good,0,0
217827,in,0,0
217828,all,0,0
217829,cases,0,0
217830,.,0,0
217831,In,0,0
217832,conclusion,0,0
217833,",",0,0
217834,Contractubex,0,0
217835,gel,0,0
217836,is,0,0
217837,useful,0,0
217838,in,0,0
217839,scar,1,0
217840,treatment,1,0
217841,after,1,0
217842,thoracic,1,1
217843,surgery,1,1
217844,.,1,0
217845,Cyproheptadine,0,0
217846,augmentation,0,0
217847,of,0,0
217848,haloperidol,0,0
217849,in,0,0
217850,chronic,1,1
217851,schizophrenic,1,1
217852,patients,1,1
217853,:,1,1
217854,a,0,0
217855,double-blind,0,0
217856,placebo-controlled,0,0
217857,study,0,0
217858,.,0,0
217859,A,0,0
217860,6,0,0
217861,week,0,0
217862,double-blind,0,0
217863,placebo-controlled,0,0
217864,trial,0,0
217865,of,0,0
217866,cyproheptadine,1,0
217867,augmentation,1,0
217868,of,1,0
217869,ongoing,1,0
217870,haloperidol,1,0
217871,treatment,1,0
217872,was,0,0
217873,conducted,0,0
217874,in,0,0
217875,40,1,1
217876,chronic,1,1
217877,schizophrenic,1,1
217878,in-patients,1,1
217879,.,1,1
217880,Cyproheptadine,0,0
217881,augmentation,0,0
217882,",",0,0
217883,compared,0,0
217884,to,0,0
217885,administration,0,0
217886,of,0,0
217887,haloperidol,0,0
217888,with,0,0
217889,placebo,0,0
217890,",",0,0
217891,did,0,0
217892,not,0,0
217893,produce,0,0
217894,a,0,0
217895,statistically,0,0
217896,significant,0,0
217897,improvement,0,0
217898,in,0,0
217899,psychotic,0,1
217900,symptoms,0,0
217901,.,0,1
217902,Cyproheptadine,0,0
217903,augmentation,0,0
217904,caused,0,0
217905,significant,0,0
217906,reduction,0,0
217907,in,0,0
217908,the,0,0
217909,extrapyramidal,0,0
217910,symptoms,0,0
217911,",",0,0
217912,which,0,0
217913,supports,0,0
217914,the,0,0
217915,atypical,0,0
217916,profile,0,0
217917,of,0,0
217918,antipsychotics,0,0
217919,.,0,0
217920,As,0,0
217921,to,0,0
217922,the,0,0
217923,neuroendocrinological,0,0
217924,effect,0,0
217925,",",0,0
217926,cyproheptadine,0,0
217927,augmentation,0,0
217928,did,0,0
217929,not,0,0
217930,reduce,0,0
217931,the,0,0
217932,plasma,0,0
217933,prolactin,0,0
217934,level,0,0
217935,but,0,0
217936,did,0,0
217937,induce,0,0
217938,a,0,0
217939,decrease,0,0
217940,in,0,0
217941,the,0,0
217942,plasma,0,0
217943,cortisol,0,0
217944,level,0,0
217945,.,0,0
217946,Although,0,0
217947,long-term,0,0
217948,follow-up,0,0
217949,studies,0,0
217950,are,0,0
217951,needed,0,0
217952,to,0,0
217953,confirm,0,0
217954,the,0,0
217955,results,0,0
217956,",",0,0
217957,this,0,0
217958,study,0,0
217959,suggests,0,0
217960,that,0,0
217961,cyproheptadine,0,0
217962,augmentation,0,0
217963,may,0,0
217964,be,0,0
217965,effective,0,0
217966,in,0,0
217967,treating,0,0
217968,chronic,1,1
217969,schizophrenic,1,1
217970,patients,1,1
217971,who,1,1
217972,are,1,1
217973,intolerant,1,1
217974,of,1,0
217975,extrapyramidal,1,0
217976,side,1,0
217977,effects,1,0
217978,of,1,0
217979,conventional,1,1
217980,antipsychotics,1,0
217981,.,1,1
217982,[,0,0
217983,The,0,0
217984,value,0,0
217985,of,0,0
217986,local,0,0
217987,administration,0,0
217988,of,0,0
217989,antibiotics,0,0
217990,in,0,0
217991,treatment,1,0
217992,of,1,0
217993,bone,1,0
217994,infections,1,0
217995,],1,0
217996,.,0,0
217997,An,0,0
217998,open,0,0
217999,",",0,0
218000,controlled,0,0
218001,",",0,0
218002,randomized,0,0
218003,clinical,0,0
218004,investigation,0,0
218005,was,0,0
218006,carried,0,0
218007,out,0,0
218008,in,0,0
218009,33,1,1
218010,patients,1,1
218011,suffering,1,1
218012,from,1,1
218013,osteomyelitis,1,1
218014,.,1,0
218015,In,0,0
218016,the,0,0
218017,first,0,0
218018,group,0,0
218019,",",0,0
218020,17,1,0
218021,patients,1,1
218022,",",1,0
218023,a,1,0
218024,through,1,0
218025,drainage,1,0
218026,with,1,1
218027,sterile,1,0
218028,physiologic,1,0
218029,solution,1,0
218030,was,1,0
218031,applied,1,0
218032,",",1,0
218033,while,1,0
218034,in,1,0
218035,the,1,0
218036,second,1,0
218037,group,1,0
218038,",",1,0
218039,16,1,0
218040,patients,1,1
218041,",",1,0
218042,antibiotic,1,0
218043,was,1,0
218044,added,1,0
218045,to,1,0
218046,the,1,0
218047,sterile,1,0
218048,physiologic,1,0
218049,solution,1,0
218050,.,1,0
218051,In,0,0
218052,all,0,0
218053,patients,0,1
218054,values,0,0
218055,of,0,0
218056,C,0,0
218057,reactive,0,0
218058,protein,0,0
218059,(,0,0
218060,CRP,0,0
218061,),0,0
218062,in,0,0
218063,the,0,0
218064,blood,0,0
218065,were,0,0
218066,examined,0,0
218067,",",0,0
218068,and,0,0
218069,later,0,0
218070,on,0,0
218071,every,0,0
218072,third,0,0
218073,day,0,0
218074,after,0,0
218075,the,0,0
218076,operation,0,0
218077,.,0,0
218078,A,0,0
218079,significant,0,0
218080,difference,0,0
218081,of,0,0
218082,average,0,0
218083,values,0,0
218084,of,0,0
218085,CRP,0,1
218086,between,0,0
218087,the,0,0
218088,3rd,0,0
218089,and,0,0
218090,21st,0,0
218091,day,0,0
218092,in,0,0
218093,both,0,0
218094,groups,0,0
218095,of,0,0
218096,patients,0,1
218097,was,0,0
218098,established,0,0
218099,",",0,0
218100,as,0,0
218101,well,0,0
218102,as,0,0
218103,the,0,0
218104,similarity,0,0
218105,in,0,0
218106,average,0,0
218107,values,0,0
218108,of,0,0
218109,CRP,0,0
218110,",",0,0
218111,which,0,0
218112,points,0,0
218113,to,0,0
218114,the,0,0
218115,fact,0,0
218116,that,0,0
218117,the,0,0
218118,mechanical,0,0
218119,effect,0,0
218120,of,0,0
218121,through,0,0
218122,drainage,0,0
218123,is,0,0
218124,dominant,0,0
218125,",",0,0
218126,speaking,0,0
218127,about,0,0
218128,rinsing,0,0
218129,focus,0,0
218130,of,0,0
218131,infection,0,0
218132,and,0,0
218133,eliminating,0,0
218134,necrotic,0,1
218135,tissues,0,1
218136,and,0,0
218137,small,0,1
218138,sequesters,0,0
218139,.,0,1
218140,Cytokine,0,0
218141,levels,0,0
218142,and,0,0
218143,systemic,0,0
218144,toxicity,0,0
218145,in,0,0
218146,patients,1,1
218147,undergoing,1,1
218148,isolated,1,0
218149,limb,1,0
218150,perfusion,1,0
218151,with,1,1
218152,high-dose,1,0
218153,tumor,1,0
218154,necrosis,1,0
218155,factor,1,0
218156,",",1,0
218157,interferon,1,0
218158,gamma,1,0
218159,",",1,0
218160,and,1,0
218161,melphalan,1,0
218162,.,1,0
218163,PURPOSE,0,0
218164,Isolated,0,0
218165,limb,0,0
218166,perfusion,0,0
218167,(,0,0
218168,ILP,0,0
218169,),0,0
218170,with,0,0
218171,tumor,0,0
218172,necrosis,0,0
218173,factor,0,0
218174,(,0,0
218175,TNF,0,0
218176,),0,0
218177,",",0,0
218178,interferon,0,0
218179,gamma,0,0
218180,",",0,0
218181,and,0,0
218182,melphalan,0,0
218183,(,0,0
218184,M,0,0
218185,),0,0
218186,has,0,0
218187,been,0,0
218188,reported,0,0
218189,to,0,0
218190,result,0,0
218191,in,0,0
218192,high,0,0
218193,response,0,0
218194,rates,0,0
218195,for,0,0
218196,extremity,0,0
218197,melanoma,0,1
218198,and,0,0
218199,sarcoma,0,1
218200,.,0,0
218201,We,0,0
218202,have,0,0
218203,evaluated,0,0
218204,the,0,0
218205,relationship,0,0
218206,of,0,0
218207,systemic,0,0
218208,TNF,0,0
218209,exposure,0,0
218210,to,0,0
218211,induction,0,0
218212,of,0,0
218213,several,0,0
218214,secondary,0,0
218215,mediators,0,0
218216,and,0,0
218217,incidence,0,0
218218,of,0,0
218219,systemic,0,0
218220,toxicity,0,0
218221,.,0,0
218222,PATIENTS,0,0
218223,AND,0,0
218224,METHODS,0,0
218225,Nineteen,1,1
218226,patients,1,1
218227,with,1,1
218228,extremity,1,0
218229,melanoma,1,1
218230,(,1,0
218231,n,1,1
218232,=,1,0
218233,16,1,1
218234,),1,0
218235,or,1,0
218236,sarcoma,1,1
218237,(,1,0
218238,n,1,1
218239,=,1,0
218240,3,1,0
218241,),1,0
218242,",",0,0
218243,underwent,0,1
218244,90-minute,0,0
218245,ILP,0,0
218246,with,0,1
218247,TNF-alpha,0,0
218248,",",0,0
218249,interferon,0,0
218250,gamma,0,0
218251,(,0,0
218252,0.2,0,0
218253,mg,0,0
218254,),0,0
218255,",",0,0
218256,and,0,0
218257,M,0,0
218258,(,0,0
218259,10,0,0
218260,to,0,0
218261,13,0,0
218262,mg/L,0,0
218263,of,0,0
218264,limb,0,0
218265,volume,0,0
218266,),0,0
218267,(,0,0
218268,TNF/IFN/M,0,0
218269,),0,0
218270,(,0,0
218271,n,0,1
218272,=,0,0
218273,12,0,0
218274,),0,0
218275,",",0,0
218276,or,0,0
218277,M,0,0
218278,alone,0,0
218279,(,0,0
218280,n,0,1
218281,=,0,0
218282,7,0,0
218283,),0,0
218284,.,0,0
218285,Continuous,0,0
218286,intraoperative,0,0
218287,monitoring,0,0
218288,(,0,0
218289,CIM,0,1
218290,),0,0
218291,for,0,0
218292,systemic,0,0
218293,leak,0,0
218294,from,0,0
218295,the,0,0
218296,perfusion,0,0
218297,circuit,0,0
218298,was,0,0
218299,performed,0,0
218300,using,0,0
218301,radioactive,0,0
218302,iodine-131,0,1
218303,albumin,0,0
218304,.,0,0
218305,Cytokine,0,0
218306,levels,0,0
218307,in,0,0
218308,the,0,0
218309,perfusate,0,0
218310,and,0,0
218311,systemic,0,0
218312,circulation,0,0
218313,during,0,0
218314,and,0,0
218315,after,0,0
218316,ILP,0,0
218317,were,0,0
218318,measured,0,0
218319,by,0,0
218320,enzyme-linked,0,0
218321,immunosorbent,0,0
218322,assay,0,0
218323,.,0,0
218324,RESULTS,0,0
218325,Systemic,0,1
218326,leaks,0,0
218327,>,0,0
218328,or,0,0
218329,=,0,0
218330,1,0,0
218331,%,0,0
218332,from,0,0
218333,the,0,0
218334,perfusion,0,0
218335,circuit,0,0
218336,occurred,0,0
218337,in,0,0
218338,six,0,1
218339,patients,0,1
218340,who,0,1
218341,received,0,1
218342,TNF/IFN/M,0,1
218343,and,0,0
218344,in,0,1
218345,four,0,1
218346,who,0,1
218347,received,0,1
218348,M,0,1
218349,alone,0,0
218350,.,0,0
218351,Hypotension,0,0
218352,that,0,0
218353,required,0,0
218354,vasopressor,0,0
218355,support,0,0
218356,occurred,0,0
218357,in,0,0
218358,six,0,0
218359,of,0,0
218360,six,0,1
218361,patients,0,1
218362,with,0,1
218363,evidence,0,0
218364,of,0,0
218365,a,0,0
218366,leak,0,0
218367,(,0,0
218368,>,0,0
218369,or,0,0
218370,=,0,0
218371,1,0,0
218372,%,0,0
218373,),0,0
218374,and,0,0
218375,zero,0,0
218376,of,0,0
218377,six,0,1
218378,patients,0,1
218379,without,0,1
218380,a,0,0
218381,leak,0,0
218382,(,0,0
218383,<,0,0
218384,1,0,0
218385,%,0,0
218386,),0,0
218387,.,0,0
218388,These,0,0
218389,six,0,0
218390,patients,0,1
218391,had,0,0
218392,significantly,0,0
218393,higher,0,0
218394,peak,0,0
218395,systemic,0,0
218396,TNF,0,0
218397,levels,0,0
218398,during,0,0
218399,and,0,0
218400,after,0,0
218401,perfusion,0,0
218402,than,0,0
218403,patients,0,1
218404,without,0,1
218405,a,0,0
218406,leak,0,0
218407,(,0,0
218408,2.8,0,0
218409,and,0,0
218410,8.2,0,0
218411,ng/mL,0,0
218412,v,0,0
218413,0.7,0,0
218414,and,0,0
218415,2.0,0,0
218416,ng/mL,0,0
218417,",",0,0
218418,respectively,0,0
218419,;,0,0
218420,P,0,0
218421,<,0,0
218422,.05,0,0
218423,),0,0
218424,.,0,0
218425,All,0,1
218426,patients,0,1
218427,who,0,1
218428,received,0,1
218429,TNF/IFN/M,0,1
218430,had,0,0
218431,significantly,0,0
218432,greater,0,0
218433,increases,0,0
218434,in,0,0
218435,systemic,0,0
218436,interleukin-6,0,0
218437,(,0,0
218438,IL-6,0,0
218439,),0,0
218440,levels,0,0
218441,than,0,0
218442,in,0,0
218443,patients,0,1
218444,with,0,1
218445,M,0,0
218446,alone,0,0
218447,(,0,0
218448,"12,395",0,1
218449,+/-,0,0
218450,"10,374",0,1
218451,pg/mL,0,0
218452,v,0,0
218453,79.4,0,0
218454,+/-,0,0
218455,7.2,0,0
218456,pg/mL,0,0
218457,",",0,0
218458,respectively,0,0
218459,;,0,0
218460,P,0,0
218461,<,0,0
218462,.001,0,0
218463,),0,0
218464,.,0,0
218465,Intracellular,0,0
218466,adhesion,0,0
218467,molecule,0,0
218468,(,0,0
218469,ICAM,0,0
218470,),0,0
218471,",",0,0
218472,IL-8,0,0
218473,",",0,0
218474,and,0,0
218475,TNF-R,0,0
218476,levels,0,0
218477,were,0,0
218478,also,0,0
218479,increased,0,0
218480,after,0,0
218481,ILP,0,0
218482,with,0,1
218483,TNF/IFN/M,0,0
218484,.,0,1
218485,CONCLUSION,0,0
218486,ILP,0,0
218487,with,0,0
218488,TNF/IFN/M,0,0
218489,can,0,0
218490,be,0,0
218491,safely,0,0
218492,performed,0,0
218493,",",0,0
218494,as,0,0
218495,I131,0,0
218496,albumin,0,0
218497,provides,0,0
218498,a,0,0
218499,sensitive,0,0
218500,measure,0,0
218501,of,0,0
218502,systemic,0,0
218503,leakage,0,0
218504,from,0,0
218505,the,0,0
218506,perfusion,0,0
218507,circuit,0,0
218508,.,0,0
218509,Patients,0,1
218510,with,0,1
218511,a,0,0
218512,measured,0,0
218513,leak,0,0
218514,of,0,0
218515,>,0,0
218516,or,0,0
218517,=,0,0
218518,1,0,0
218519,%,0,0
218520,develop,0,0
218521,mild,0,1
218522,and,0,0
218523,transient,0,0
218524,postoperative,0,0
218525,hypotension,0,0
218526,with,0,0
218527,significantly,0,0
218528,higher,0,0
218529,systemic,0,0
218530,TNF,0,0
218531,levels,0,0
218532,and,0,0
218533,lower,0,0
218534,perfusate,0,0
218535,TNF,0,0
218536,levels,0,0
218537,than,0,0
218538,in,0,0
218539,patients,0,1
218540,without,0,1
218541,leaks,0,1
218542,.,0,1
218543,Vigorous,0,0
218544,",",0,0
218545,aerobic,0,0
218546,exercise,0,0
218547,versus,0,0
218548,general,0,1
218549,motor,0,0
218550,training,0,0
218551,activities,0,0
218552,:,0,1
218553,effects,0,0
218554,on,0,0
218555,maladaptive,0,0
218556,and,0,0
218557,stereotypic,0,0
218558,behaviors,0,0
218559,of,0,0
218560,adults,1,1
218561,with,1,1
218562,both,1,0
218563,autism,1,1
218564,and,1,0
218565,mental,1,1
218566,retardation,1,0
218567,.,1,0
218568,Examined,0,0
218569,the,0,0
218570,effects,0,0
218571,of,0,0
218572,antecedent,0,0
218573,exercise,0,0
218574,conditions,0,0
218575,on,0,0
218576,maladaptive,0,0
218577,and,0,0
218578,stereotypic,0,0
218579,behaviors,0,0
218580,in,0,0
218581,6,1,0
218582,adults,1,1
218583,with,1,1
218584,both,1,0
218585,autism,1,1
218586,and,1,0
218587,moderate,1,1
218588,to,1,0
218589,profound,1,0
218590,mental,1,1
218591,retardation,1,0
218592,.,1,0
218593,The,0,0
218594,behaviors,0,0
218595,were,0,0
218596,observed,0,0
218597,in,0,0
218598,a,0,0
218599,controlled,0,0
218600,environment,0,0
218601,before,0,0
218602,and,0,0
218603,after,0,0
218604,2,0,0
218605,exercise,0,0
218606,and,0,0
218607,1,0,0
218608,non-exercise,0,0
218609,conditions,0,0
218610,.,0,0
218611,From,0,0
218612,the,0,0
218613,original,0,0
218614,group,0,0
218615,of,0,0
218616,6,1,0
218617,participants,1,1
218618,",",0,0
218619,2,0,0
218620,were,0,0
218621,selected,0,1
218622,subsequently,0,0
218623,to,0,0
218624,participate,0,0
218625,in,0,0
218626,aerobic,0,0
218627,exercise,0,0
218628,immediately,0,0
218629,before,0,0
218630,performing,0,0
218631,a,0,0
218632,community-integrated,0,0
218633,vocational,0,0
218634,task,0,0
218635,.,0,0
218636,Only,0,0
218637,antecedent,0,0
218638,aerobic,0,0
218639,exercise,0,0
218640,significantly,0,0
218641,reduced,0,0
218642,maladaptive,0,0
218643,and,0,0
218644,stereotypic,0,0
218645,behaviors,0,0
218646,in,0,0
218647,the,0,0
218648,controlled,0,0
218649,setting,0,0
218650,.,0,0
218651,Neither,0,0
218652,of,0,0
218653,the,0,0
218654,less,0,0
218655,vigorous,0,0
218656,antecedent,0,0
218657,conditions,0,0
218658,did,0,0
218659,.,0,0
218660,When,0,0
218661,aerobic,0,0
218662,exercise,0,0
218663,preceded,0,0
218664,the,0,0
218665,vocational,0,0
218666,task,0,0
218667,",",0,0
218668,similar,0,0
218669,reductions,0,0
218670,were,0,0
218671,observed,0,0
218672,.,0,0
218673,There,0,0
218674,were,0,0
218675,individual,0,0
218676,differences,0,0
218677,in,0,0
218678,response,0,0
218679,to,0,0
218680,antecedent,0,0
218681,exercise,0,0
218682,.,0,0
218683,Use,0,0
218684,of,0,0
218685,antecedent,0,0
218686,aerobic,0,0
218687,exercise,0,0
218688,to,0,0
218689,reduce,0,0
218690,maladaptive,0,0
218691,and,0,0
218692,stereotypic,0,0
218693,behaviors,0,0
218694,of,0,0
218695,adults,1,1
218696,with,1,1
218697,both,1,0
218698,autism,1,1
218699,and,1,0
218700,mental,1,0
218701,retardation,1,0
218702,is,0,0
218703,supported,0,0
218704,.,0,0
218705,Dexamethasone,0,0
218706,for,0,0
218707,the,0,0
218708,treatment,0,0
218709,of,0,0
218710,depression,0,1
218711,:,0,1
218712,a,0,0
218713,randomized,0,0
218714,",",0,0
218715,placebo-controlled,0,0
218716,",",0,0
218717,double-blind,0,0
218718,trial,0,0
218719,.,0,0
218720,OBJECTIVE,0,0
218721,The,0,0
218722,authors,0,0
218723,',0,0
218724,goal,0,0
218725,was,0,0
218726,to,0,0
218727,assess,0,0
218728,dexamethasone,0,0
218729,for,0,0
218730,the,0,0
218731,treatment,0,0
218732,of,0,0
218733,depression,0,1
218734,.,0,0
218735,METHOD,0,0
218736,Thirty-seven,1,1
218737,outpatients,1,1
218738,(,1,1
218739,11,1,1
218740,men,1,1
218741,and,1,0
218742,26,1,1
218743,women,1,1
218744,),1,0
218745,meeting,1,1
218746,DSM-III-R,1,0
218747,criteria,1,1
218748,for,1,0
218749,major,1,0
218750,depressive,1,0
218751,disorder,1,1
218752,were,0,0
218753,randomly,0,0
218754,assigned,0,0
218755,to,0,0
218756,receive,0,0
218757,either,0,0
218758,placebo,0,0
218759,or,0,0
218760,4,0,0
218761,mg/day,0,0
218762,of,0,0
218763,oral,0,0
218764,dexamethasone,0,0
218765,for,0,0
218766,4,0,0
218767,days,0,0
218768,.,0,1
218769,Baseline,0,0
218770,Hamilton,0,0
218771,depression,0,1
218772,scale,0,0
218773,scores,0,0
218774,were,0,0
218775,compared,0,0
218776,with,0,1
218777,scores,0,0
218778,obtained,0,0
218779,14,0,1
218780,days,0,0
218781,after,0,0
218782,the,0,0
218783,first,0,0
218784,dose,0,0
218785,of,0,0
218786,study,0,0
218787,medication,0,0
218788,.,0,0
218789,Data,0,0
218790,were,0,0
218791,analyzed,0,0
218792,by,0,0
218793,using,0,0
218794,two-sample,0,0
218795,t,0,0
218796,tests,0,0
218797,",",0,0
218798,chi-square,0,0
218799,methods,0,0
218800,",",0,0
218801,and,0,0
218802,Fisher,0,0
218803,'s,0,0
218804,exact,0,0
218805,test,0,0
218806,.,0,0
218807,RESULTS,0,0
218808,Seven,0,0
218809,(,0,0
218810,37,0,1
218811,%,0,0
218812,),0,0
218813,of,0,0
218814,the,0,0
218815,19,0,1
218816,patients,0,1
218817,given,0,0
218818,dexamethasone,0,0
218819,but,0,0
218820,only,0,0
218821,one,0,0
218822,(,0,0
218823,6,0,0
218824,%,0,0
218825,),0,0
218826,of,0,0
218827,the,0,0
218828,18,0,1
218829,patients,0,1
218830,given,0,0
218831,placebo,0,0
218832,responded,0,1
218833,positively,0,0
218834,.,0,0
218835,No,0,0
218836,adverse,0,0
218837,events,0,0
218838,or,0,1
218839,side,0,0
218840,effects,0,0
218841,were,0,0
218842,reported,0,0
218843,",",0,0
218844,and,0,0
218845,all,0,1
218846,patients,0,1
218847,who,0,1
218848,entered,0,1
218849,the,0,1
218850,study,0,0
218851,completed,0,0
218852,it,0,0
218853,.,0,0
218854,CONCLUSIONS,0,0
218855,A,0,0
218856,brief,0,0
218857,course,0,0
218858,of,0,0
218859,oral,0,0
218860,dexamethasone,0,0
218861,(,0,0
218862,4,0,0
218863,days,0,0
218864,),0,0
218865,was,0,0
218866,significantly,0,0
218867,more,0,0
218868,effective,0,0
218869,than,0,0
218870,placebo,0,0
218871,within,0,0
218872,14,0,0
218873,days,0,0
218874,for,0,0
218875,the,0,0
218876,treatment,0,0
218877,of,0,0
218878,depression,0,0
218879,in,0,0
218880,a,0,0
218881,randomized,0,0
218882,",",0,0
218883,double-blind,0,0
218884,study,0,0
218885,of,0,0
218886,depressed,0,1
218887,outpatients,0,1
218888,.,0,1
218889,The,0,0
218890,efficacy,0,0
218891,of,0,0
218892,audiotapes,0,0
218893,in,0,0
218894,promoting,0,0
218895,psychological,0,0
218896,well-being,0,0
218897,in,0,0
218898,cancer,1,1
218899,patients,1,1
218900,:,1,1
218901,a,0,0
218902,randomised,0,0
218903,",",0,0
218904,controlled,0,0
218905,trial,0,0
218906,.,0,0
218907,Open,0,0
218908,or,0,0
218909,uncontrolled,0,0
218910,studies,0,0
218911,have,0,0
218912,suggested,0,0
218913,that,0,0
218914,providing,0,0
218915,cancer,1,1
218916,patients,1,1
218917,with,0,1
218918,audiotapes,0,0
218919,of,0,0
218920,their,0,1
218921,clinical,0,0
218922,interviews,0,0
218923,can,0,0
218924,improve,0,0
218925,information,0,0
218926,recall,0,0
218927,and,0,0
218928,reduce,0,0
218929,psychological,0,0
218930,distress,0,1
218931,.,0,0
218932,We,0,0
218933,tested,0,0
218934,these,0,0
218935,hypotheses,0,0
218936,in,0,0
218937,a,0,0
218938,'clinician-blind,0,0
218939,',0,0
218940,",",0,0
218941,prospective,0,0
218942,",",0,0
218943,randomised,0,0
218944,controlled,0,0
218945,trial,0,0
218946,.,0,0
218947,A,1,0
218948,total,1,0
218949,of,1,0
218950,117,1,1
218951,patients,1,1
218952,newly,1,1
218953,referred,1,1
218954,to,1,0
218955,a,1,0
218956,medical,1,0
218957,oncology,1,1
218958,clinic,1,1
218959,who,1,1
218960,were,1,1
218961,to,1,1
218962,be,1,0
218963,given,1,0
218964,'bad,1,0
218965,news,1,0
218966,',1,0
218967,had,0,0
218968,their,0,1
218969,consultations,0,0
218970,audiotaped,0,0
218971,.,0,0
218972,Blind,0,0
218973,to,0,0
218974,the,0,0
218975,clinician,0,0
218976,",",0,0
218977,patients,0,1
218978,were,0,0
218979,randomly,0,1
218980,allocated,0,0
218981,to,0,0
218982,receive,0,0
218983,a,0,0
218984,copy,0,0
218985,of,0,0
218986,the,0,0
218987,tape,0,0
218988,to,0,0
218989,play,0,0
218990,at,0,0
218991,home,0,0
218992,or,0,0
218993,not,0,0
218994,(,0,0
218995,control,0,0
218996,group,0,0
218997,),0,0
218998,.,0,0
218999,At,0,0
219000,6,0,0
219001,months,0,0
219002,follow-up,0,0
219003,",",0,0
219004,tape,0,0
219005,group,0,0
219006,patients,0,1
219007,reported,0,0
219008,positive,0,0
219009,attitudes,0,0
219010,to,0,0
219011,the,0,0
219012,audiotape,0,0
219013,and,0,0
219014,were,0,0
219015,shown,0,0
219016,to,0,0
219017,recall,0,0
219018,significantly,0,0
219019,more,0,0
219020,information,0,0
219021,about,0,0
219022,their,0,0
219023,illness,0,1
219024,than,0,0
219025,did,0,0
219026,controls,0,1
219027,.,0,1
219028,Overall,0,0
219029,improvement,0,0
219030,in,0,0
219031,psychological,0,0
219032,distress,0,1
219033,at,0,0
219034,1,0,0
219035,and,0,0
219036,6,0,0
219037,months,0,0
219038,follow-up,0,0
219039,",",0,0
219040,as,0,0
219041,measured,0,0
219042,with,0,1
219043,the,0,0
219044,30-item,0,0
219045,General,0,1
219046,Health,0,0
219047,Questionnaire,0,0
219048,and,0,0
219049,the,0,0
219050,Hospital,0,1
219051,Anxiety,0,0
219052,and,0,0
219053,Depression,0,0
219054,Scale,0,0
219055,was,0,0
219056,no,0,0
219057,different,0,0
219058,in,0,0
219059,the,0,0
219060,two,0,0
219061,groups,0,0
219062,.,0,0
219063,However,0,0
219064,",",0,0
219065,a,0,0
219066,second-order,0,0
219067,interaction,0,0
219068,suggested,0,0
219069,that,0,0
219070,poor-prognosis,0,1
219071,patients,0,1
219072,were,0,0
219073,disadvantaged,0,1
219074,specifically,0,0
219075,by,0,0
219076,access,0,0
219077,to,0,0
219078,the,0,0
219079,audiotape,0,0
219080,",",0,0
219081,with,0,0
219082,less,0,0
219083,improvement,0,0
219084,in,0,0
219085,psychological,0,0
219086,distress,0,1
219087,at,0,0
219088,6,0,0
219089,months,0,0
219090,follow-up,0,0
219091,than,0,0
219092,non-tape,0,0
219093,controls,0,1
219094,.,0,1
219095,Patient,0,0
219096,access,0,0
219097,to,0,0
219098,audiotapes,0,0
219099,of,0,0
219100,clinical,0,0
219101,interviews,0,0
219102,promotes,0,0
219103,factual,0,0
219104,retention,0,0
219105,but,0,0
219106,does,0,0
219107,not,0,0
219108,reliably,0,0
219109,reduce,0,0
219110,psychological,0,0
219111,distress,0,0
219112,and,0,0
219113,may,0,0
219114,be,0,0
219115,actively,0,0
219116,unhelpful,0,0
219117,in,0,0
219118,some,0,0
219119,subgroups,0,0
219120,of,0,0
219121,patients,0,1
219122,.,0,1
219123,Effect,0,0
219124,of,0,0
219125,omega,1,0
219126,3,1,0
219127,fatty,1,0
219128,acids,1,0
219129,and,1,0
219130,vitamin,1,0
219131,E,1,0
219132,supplements,1,0
219133,on,0,0
219134,lipid,0,0
219135,peroxidation,0,0
219136,measured,0,0
219137,by,0,0
219138,breath,0,0
219139,ethane,0,0
219140,and,0,0
219141,pentane,0,0
219142,output,0,0
219143,:,0,0
219144,a,1,0
219145,randomized,1,0
219146,controlled,1,0
219147,trial,1,0
219148,.,1,0
219149,Gastric,1,1
219150,ulcer,1,1
219151,treatment,1,0
219152,with,0,1
219153,intravenous,0,0
219154,human,0,0
219155,epidermal,0,0
219156,growth,0,0
219157,factor,0,0
219158,:,0,0
219159,a,0,0
219160,double-blind,0,0
219161,controlled,0,0
219162,clinical,0,0
219163,study,0,0
219164,.,0,0
219165,We,0,0
219166,introduced,0,0
219167,a,0,0
219168,double-blind,0,0
219169,controlled,0,0
219170,clinical,0,0
219171,study,0,0
219172,to,0,0
219173,compare,0,0
219174,intravenous,0,0
219175,human,0,0
219176,epidermal,0,0
219177,growth,0,0
219178,factor,0,0
219179,(,0,0
219180,hEGF,0,0
219181,),0,0
219182,to,0,0
219183,cetraxate,0,0
219184,hydrochloride,0,0
219185,(,0,0
219186,CH,0,0
219187,),0,0
219188,",",0,0
219189,an,0,0
219190,antiulcer,0,0
219191,drug,0,0
219192,",",0,0
219193,for,0,0
219194,their,0,0
219195,healing,0,0
219196,effect,0,0
219197,on,0,0
219198,gastric,0,1
219199,ulcers,0,1
219200,.,0,0
219201,We,0,0
219202,also,0,0
219203,prospected,0,0
219204,an,0,0
219205,oral,0,0
219206,use,0,0
219207,of,0,0
219208,EGF,0,0
219209,on,0,0
219210,the,0,0
219211,basis,0,0
219212,of,0,0
219213,our,0,0
219214,experimental,0,0
219215,evidence,0,0
219216,.,0,0
219217,In,0,0
219218,the,0,0
219219,clinical,0,0
219220,trial,0,0
219221,",",0,0
219222,the,0,0
219223,rate,0,0
219224,of,0,0
219225,ulcer,0,0
219226,healing,0,0
219227,within,0,0
219228,8,0,0
219229,weeks,0,0
219230,was,0,0
219231,77.9,0,0
219232,%,0,0
219233,(,1,0
219234,67/86,1,0
219235,),1,0
219236,in,0,0
219237,patients,1,1
219238,receiving,1,1
219239,6,1,1
219240,micrograms,1,0
219241,EGF,1,0
219242,intravenously,1,0
219243,twice,1,0
219244,a,1,0
219245,week,1,0
219246,",",0,0
219247,being,0,0
219248,significantly,0,0
219249,greater,0,0
219250,than,0,0
219251,51.7,0,0
219252,%,0,0
219253,(,0,0
219254,45/87,0,0
219255,),0,0
219256,in,0,0
219257,those,0,0
219258,given,0,0
219259,CH,0,0
219260,.,0,0
219261,Taking,0,0
219262,together,0,0
219263,all,0,0
219264,aspects,0,0
219265,assessed,0,0
219266,including,0,0
219267,the,0,0
219268,healing,0,0
219269,rate,0,0
219270,",",0,0
219271,pain,0,0
219272,relief,0,0
219273,",",0,0
219274,blood,0,0
219275,examination,0,0
219276,and,0,0
219277,adverse,0,0
219278,reactions,0,0
219279,",",0,0
219280,we,0,0
219281,judged,0,0
219282,the,0,0
219283,hEGF,0,0
219284,to,0,0
219285,be,0,0
219286,a,0,0
219287,useful,0,0
219288,and,0,0
219289,safe,0,0
219290,anticuler,0,0
219291,drug,0,0
219292,.,0,0
219293,In,0,0
219294,rats,0,1
219295,",",0,0
219296,50,0,0
219297,micrograms/kg,0,0
219298,mouse,0,0
219299,EGF,0,0
219300,(,0,0
219301,mEGF,0,0
219302,),0,0
219303,and,0,0
219304,2,0,0
219305,%,0,0
219306,hydroxypropyl,0,0
219307,cellulose,0,0
219308,(,0,0
219309,HPC,0,0
219310,),0,0
219311,or,0,0
219312,1.0,0,0
219313,g/kg,0,0
219314,sucralfate,0,0
219315,given,0,0
219316,by,0,0
219317,gastric,0,0
219318,intubation,0,0
219319,significantly,0,0
219320,raised,0,0
219321,the,0,0
219322,residual,0,0
219323,mEGF,0,0
219324,levels,0,0
219325,in,0,0
219326,both,0,0
219327,gastric,0,0
219328,luminal,0,0
219329,content,0,0
219330,(,0,0
219331,HPC,0,0
219332,:,0,1
219333,x,0,0
219334,30,0,0
219335,;,0,0
219336,sucralfate,0,0
219337,:,0,0
219338,x,0,0
219339,300,0,0
219340,as,0,0
219341,high,0,0
219342,as,0,0
219343,those,0,0
219344,in,0,0
219345,EGF,0,0
219346,alone,0,0
219347,),0,0
219348,and,0,0
219349,tissue,0,0
219350,(,0,0
219351,HPC,0,0
219352,:,0,1
219353,x,0,0
219354,60,0,1
219355,;,0,0
219356,sucralfate,0,0
219357,:,0,1
219358,x,0,0
219359,100,0,0
219360,),0,0
219361,.,0,0
219362,In,0,0
219363,addition,0,0
219364,",",0,0
219365,the,0,0
219366,combined,0,0
219367,treatments,0,0
219368,significantly,0,0
219369,promoted,0,0
219370,healing,0,0
219371,of,0,0
219372,rat,1,1
219373,gastric,1,1
219374,ulcers,1,1
219375,whereas,0,0
219376,each,0,0
219377,agent,0,0
219378,alone,0,0
219379,had,0,0
219380,no,0,0
219381,significant,0,0
219382,effect,0,0
219383,as,0,0
219384,compared,0,0
219385,with,0,1
219386,control,0,0
219387,(,0,0
219388,saline,0,0
219389,),0,0
219390,.,0,0
219391,This,0,0
219392,indicated,0,0
219393,the,0,0
219394,beneficial,0,0
219395,effect,0,0
219396,on,0,0
219397,ulcers,0,1
219398,of,0,0
219399,oral,0,0
219400,administration,0,0
219401,of,0,0
219402,EGF,0,0
219403,with,0,1
219404,agents,0,0
219405,allowing,0,0
219406,it,0,0
219407,to,0,0
219408,remain,0,0
219409,at,0,0
219410,high,0,0
219411,levels,0,0
219412,in,0,0
219413,the,0,0
219414,stomach,0,0
219415,",",0,0
219416,whereas,0,0
219417,most,0,0
219418,reports,0,0
219419,suggested,0,0
219420,less,0,0
219421,effect,0,0
219422,of,0,0
219423,oral,0,0
219424,EGF,0,0
219425,on,0,0
219426,healing,0,0
219427,of,0,0
219428,gastroduodenal,0,0
219429,ulcers,0,1
219430,.,0,1
219431,Subsequent,0,0
219432,to,0,0
219433,the,0,0
219434,clinical,0,0
219435,study,0,0
219436,",",0,0
219437,evaluation,0,0
219438,of,0,0
219439,oral,0,0
219440,use,0,0
219441,of,0,0
219442,EGF,0,0
219443,may,0,0
219444,be,0,0
219445,expected,0,0
219446,as,0,0
219447,the,0,0
219448,next,0,0
219449,step,0,0
219450,in,0,0
219451,the,0,0
219452,treatment,0,0
219453,of,0,0
219454,ulcers,0,1
219455,.,0,0
219456,The,0,0
219457,experimental,0,0
219458,evidence,0,0
219459,above,0,0
219460,would,0,0
219461,possibly,0,0
219462,be,0,0
219463,a,0,0
219464,guide,0,0
219465,for,0,0
219466,such,0,0
219467,trial,0,0
219468,.,0,0
219469,Long-stay,0,1
219470,versus,0,0
219471,short-stay,0,1
219472,hospital,0,0
219473,treatment,0,0
219474,of,0,0
219475,children,1,1
219476,suffering,1,1
219477,from,1,1
219478,severe,1,1
219479,protein-energy,1,1
219480,malnutrition,1,1
219481,.,1,0
219482,OBJECTIVE,0,0
219483,To,0,0
219484,contrast,0,0
219485,early,0,0
219486,discharge,0,0
219487,versus,0,0
219488,attempted,0,0
219489,full,0,0
219490,nutritional,0,0
219491,rehabilitation,0,1
219492,in,0,0
219493,hospital,1,0
219494,of,1,0
219495,children,1,1
219496,suffering,1,1
219497,from,1,1
219498,severe,1,1
219499,protein-energy,1,0
219500,malnutrition,1,1
219501,(,1,0
219502,PEM,1,0
219503,),1,0
219504,.,1,0
219505,DESIGN,0,0
219506,Field,0,0
219507,experiment,0,0
219508,",",0,0
219509,two-way,0,0
219510,analysis,0,0
219511,of,0,0
219512,variance,0,0
219513,with,0,1
219514,one,0,0
219515,between,0,0
219516,group,1,0
219517,(,1,0
219518,short-,1,0
219519,versus,1,0
219520,long-stay,1,1
219521,),1,0
219522,and,1,0
219523,one,1,0
219524,repeated,1,0
219525,measures,1,0
219526,factor,1,0
219527,(,1,0
219528,admission,1,0
219529,",",1,0
219530,then,1,0
219531,12,1,0
219532,",",1,0
219533,18,1,0
219534,",",1,0
219535,24,1,0
219536,",",1,0
219537,30,1,0
219538,and,1,0
219539,36,1,1
219540,months,1,0
219541,post-admission,1,0
219542,),1,1
219543,.,0,0
219544,Covariates,0,0
219545,introduced,0,0
219546,.,0,1
219547,SETTING,1,0
219548,Primary,1,0
219549,health,1,0
219550,care,1,0
219551,",",1,0
219552,Kingston,1,1
219553,",",1,0
219554,Jamaica,1,1
219555,.,1,0
219556,SUBJECTS,1,0
219557,n,1,1
219558,=,1,0
219559,81,1,1
219560,;,1,0
219561,mean,1,0
219562,age,1,1
219563,11,1,1
219564,months,1,0
219565,;,1,0
219566,79,1,1
219567,contribute,1,0
219568,longitudinal,1,1
219569,data,1,0
219570,;,1,0
219571,44,1,1
219572,every,1,0
219573,measurement,1,0
219574,.,1,0
219575,INTERVENTIONS,0,0
219576,When,0,0
219577,concurrent,0,0
219578,illnesses,0,1
219579,had,0,0
219580,been,0,0
219581,treated,0,1
219582,and,0,0
219583,normal,0,1
219584,feeding,0,0
219585,re-established,0,0
219586,(,0,0
219587,weight,0,0
219588,gain,0,0
219589,5,0,0
219590,g/kg.day-1,0,0
219591,),0,0
219592,",",0,0
219593,subjects,0,1
219594,were,0,0
219595,randomly,0,1
219596,allocated,0,0
219597,to,0,0
219598,short-stay,0,1
219599,(,0,0
219600,SS,0,0
219601,),0,0
219602,or,0,0
219603,long-stay,0,1
219604,(,0,0
219605,LS,0,0
219606,),0,0
219607,group,0,0
219608,.,0,0
219609,LS,0,0
219610,retained,0,0
219611,in,0,0
219612,hospital,0,0
219613,for,0,0
219614,full,0,0
219615,nutritional,0,0
219616,rehabilitation,0,1
219617,mean,0,1
219618,40,0,1
219619,days,0,0
219620,),0,1
219621,.,0,1
219622,SS,0,0
219623,discharged,0,0
219624,immediately,0,0
219625,(,0,0
219626,mean,0,0
219627,18,0,1
219628,days,0,0
219629,),0,0
219630,for,0,0
219631,standard,0,0
219632,Health,0,0
219633,Service,0,0
219634,care,0,0
219635,at,0,0
219636,home,0,0
219637,for,0,0
219638,6,0,0
219639,months,0,0
219640,plus,0,0
219641,high-energy,0,0
219642,supplement,0,0
219643,(,0,0
219644,3.31,0,0
219645,MJ,0,0
219646,with,0,1
219647,20.6,0,0
219648,g,0,0
219649,protein,0,0
219650,daily,0,0
219651,),0,0
219652,for,0,0
219653,first,0,0
219654,3,0,0
219655,months,0,0
219656,.,0,0
219657,After,0,0
219658,discharge,0,0
219659,LS,0,0
219660,received,0,0
219661,6,0,0
219662,months,0,0
219663,home,0,1
219664,care,0,0
219665,",",0,0
219666,but,0,0
219667,without,0,0
219668,supplementation,0,0
219669,.,0,0
219670,RESULTS,0,0
219671,Significant,0,0
219672,advantages,0,0
219673,for,0,0
219674,LS,0,0
219675,group,0,0
219676,on,0,0
219677,NCHS,0,0
219678,weight,0,0
219679,&,0,0
219680,length,0,0
219681,for,0,0
219682,age,0,1
219683,at,0,0
219684,discharge,0,0
219685,",",0,0
219686,and,0,0
219687,at,0,0
219688,12,0,0
219689,",",0,0
219690,18,0,0
219691,",",0,0
219692,24,0,0
219693,and,0,0
219694,for,0,0
219695,length,0,0
219696,also,0,0
219697,30,0,0
219698,months,0,0
219699,(,0,0
219700,P,0,0
219701,<,0,0
219702,0.05,0,0
219703,to,0,0
219704,P,0,0
219705,<,0,0
219706,0.001,0,0
219707,),0,0
219708,.,0,0
219709,Weight,0,0
219710,advantage,0,0
219711,peaked,0,0
219712,at,0,0
219713,12,0,0
219714,and,0,0
219715,18,0,1
219716,months,0,0
219717,",",0,0
219718,length,0,0
219719,later,0,0
219720,at,0,0
219721,18,0,0
219722,and,0,0
219723,24,0,0
219724,months,0,0
219725,.,0,1
219726,CONCLUSIONS,0,0
219727,Contrary,0,0
219728,to,0,0
219729,earlier,0,0
219730,reports,0,0
219731,",",0,0
219732,full,0,0
219733,nutritional,0,0
219734,rehabilitation,0,1
219735,can,0,0
219736,be,0,0
219737,achieved,0,0
219738,in,0,0
219739,hospital,0,0
219740,for,0,0
219741,children,0,1
219742,suffering,0,1
219743,from,0,1
219744,PEM,0,0
219745,.,0,0
219746,Although,0,0
219747,in,0,0
219748,the,0,0
219749,long-term,0,0
219750,both,0,0
219751,groups,0,0
219752,move,0,0
219753,towards,0,0
219754,expected,0,0
219755,levels,0,0
219756,in,0,0
219757,their,0,0
219758,home,0,0
219759,community,0,0
219760,",",0,0
219761,a,0,0
219762,significant,0,0
219763,advantage,0,0
219764,maintained,0,0
219765,for,0,0
219766,approximately,0,0
219767,2,0,0
219768,years,0,1
219769,is,0,0
219770,developmentally,0,0
219771,advantageous,0,0
219772,during,0,0
219773,the,0,0
219774,critical,0,0
219775,time,0,0
219776,after,0,0
219777,weaning,0,0
219778,.,0,1
219779,Aspirin,0,0
219780,in,0,0
219781,coronary,1,1
219782,heart,1,1
219783,disease,1,1
219784,.,1,0
219785,The,0,0
219786,Coronary,0,0
219787,Drug,0,0
219788,Project,0,1
219789,Research,0,0
219790,Group,0,1
219791,.,0,0
219792,Warfarin,0,0
219793,versus,0,0
219794,aspirin,0,0
219795,for,0,0
219796,prevention,0,0
219797,of,0,0
219798,thromboembolism,0,0
219799,in,0,0
219800,atrial,0,1
219801,fibrillation,0,1
219802,:,0,1
219803,Stroke,0,0
219804,Prevention,0,0
219805,in,0,0
219806,Atrial,0,0
219807,Fibrillation,0,1
219808,II,0,1
219809,Study,0,0
219810,.,0,0
219811,Warfarin,0,0
219812,is,0,0
219813,an,0,0
219814,established,0,0
219815,treatment,0,0
219816,for,0,0
219817,prevention,0,0
219818,of,0,0
219819,ischaemic,0,1
219820,stroke,0,1
219821,in,0,0
219822,patients,1,1
219823,with,1,1
219824,atrial,1,1
219825,fibrillation,1,1
219826,",",0,0
219827,but,0,0
219828,the,0,0
219829,value,0,0
219830,of,0,0
219831,this,0,0
219832,agent,0,0
219833,relative,0,0
219834,to,0,0
219835,aspirin,0,0
219836,in,0,0
219837,unclear,0,0
219838,.,0,0
219839,In,0,0
219840,the,0,0
219841,first,0,0
219842,Stroke,0,0
219843,Prevention,0,0
219844,in,0,0
219845,Atrial,0,0
219846,Fibrillation,0,1
219847,(,0,0
219848,SPAF-I,0,0
219849,),0,0
219850,study,0,0
219851,",",0,0
219852,direct,0,0
219853,comparison,0,0
219854,of,0,0
219855,warfarin,0,0
219856,with,0,1
219857,aspirin,0,0
219858,was,0,0
219859,limited,0,0
219860,by,0,0
219861,the,0,0
219862,small,0,0
219863,number,0,0
219864,of,0,0
219865,thromboembolic,0,0
219866,events,0,0
219867,.,0,1
219868,SPAF-II,0,0
219869,aims,0,0
219870,to,0,0
219871,address,0,0
219872,this,0,0
219873,issue,0,0
219874,and,0,0
219875,also,0,0
219876,to,0,0
219877,assess,0,0
219878,the,0,0
219879,differential,0,0
219880,effects,0,0
219881,of,0,0
219882,the,0,0
219883,two,0,0
219884,treatments,0,0
219885,according,0,1
219886,to,0,0
219887,age,0,1
219888,.,0,0
219889,We,0,0
219890,compared,0,0
219891,warfarin,0,0
219892,(,0,0
219893,prothrombin,0,0
219894,time,0,0
219895,ratio,0,0
219896,1.3-1.8,0,0
219897,",",0,0
219898,international,0,1
219899,normalised,0,0
219900,ratio,0,0
219901,2.0-4.5,0,0
219902,),0,0
219903,with,0,1
219904,aspirin,0,0
219905,325,0,1
219906,mg,0,0
219907,daily,0,0
219908,for,0,0
219909,prevention,0,0
219910,of,0,0
219911,ischaemic,0,1
219912,stroke,0,1
219913,and,0,0
219914,systemic,0,0
219915,embolism,0,0
219916,(,0,0
219917,primary,0,1
219918,events,0,0
219919,),0,0
219920,in,0,0
219921,two,0,0
219922,parallel,0,0
219923,randomised,0,1
219924,trials,0,0
219925,involving,0,1
219926,715,1,1
219927,patients,1,1
219928,aged,1,1
219929,75,1,1
219930,years,1,1
219931,or,1,1
219932,less,1,0
219933,and,1,0
219934,385,1,1
219935,patients,1,1
219936,older,1,1
219937,than,1,0
219938,75,1,1
219939,;,1,0
219940,we,0,0
219941,sought,0,0
219942,reductions,0,0
219943,in,0,0
219944,the,0,0
219945,absolute,0,0
219946,rate,0,0
219947,of,0,0
219948,primary,0,0
219949,events,0,0
219950,by,0,0
219951,warfarin,0,0
219952,compared,0,0
219953,with,0,1
219954,aspirin,0,0
219955,of,0,0
219956,2,0,0
219957,%,0,0
219958,per,0,0
219959,year,0,0
219960,and,0,0
219961,4,0,0
219962,%,0,0
219963,per,0,0
219964,year,0,0
219965,",",0,0
219966,respectively,0,0
219967,.,0,0
219968,In,0,0
219969,the,0,0
219970,younger,0,1
219971,patients,0,1
219972,",",0,0
219973,warfarin,0,0
219974,decreased,0,0
219975,the,0,0
219976,absolute,0,0
219977,rate,0,0
219978,of,0,0
219979,primary,0,0
219980,events,0,0
219981,by,0,0
219982,0.7,0,0
219983,%,0,0
219984,per,0,0
219985,year,0,0
219986,(,0,0
219987,95,0,0
219988,%,0,0
219989,CI-0.4,0,0
219990,to,0,0
219991,1.7,0,0
219992,),0,0
219993,.,0,0
219994,The,0,0
219995,primary,0,0
219996,event,0,0
219997,rate,0,0
219998,per,0,0
219999,year,0,0
220000,was,0,0
220001,1.3,0,0
220002,%,0,0
220003,with,0,1
220004,warfarin,0,0
220005,and,0,0
220006,1.9,0,0
220007,%,0,0
220008,with,0,1
220009,aspirin,0,0
220010,(,0,0
220011,relative,0,0
220012,risk,0,0
220013,[,0,0
220014,RR,0,0
220015,],0,0
220016,0.67,0,0
220017,",",0,0
220018,p,0,0
220019,=,0,0
220020,0.24,0,0
220021,),0,0
220022,.,0,0
220023,The,0,0
220024,absolute,0,0
220025,rate,0,0
220026,of,0,0
220027,primary,0,0
220028,events,0,0
220029,in,0,0
220030,low-risk,0,1
220031,younger,0,1
220032,patients,0,1
220033,(,0,0
220034,without,0,0
220035,hypertension,0,1
220036,",",0,0
220037,recent,0,0
220038,heart,0,1
220039,failure,0,1
220040,",",0,0
220041,or,0,0
220042,previous,0,0
220043,thromboembolism,0,1
220044,),0,0
220045,on,0,0
220046,aspirin,0,0
220047,was,0,0
220048,0.5,0,0
220049,%,0,0
220050,per,0,0
220051,year,0,0
220052,(,0,0
220053,95,0,0
220054,%,0,0
220055,CI,0,0
220056,0.1,0,0
220057,to,0,0
220058,1.9,0,0
220059,),0,0
220060,.,0,0
220061,Among,0,0
220062,older,0,1
220063,patients,0,1
220064,",",0,0
220065,warfarin,0,0
220066,decreased,0,0
220067,the,0,0
220068,absolute,0,0
220069,rate,0,0
220070,of,0,0
220071,primary,0,0
220072,events,0,0
220073,by,0,0
220074,1.2,0,0
220075,%,0,0
220076,per,0,0
220077,year,0,0
220078,(,0,0
220079,95,0,0
220080,%,0,0
220081,CI-1.7,0,0
220082,to,0,0
220083,4.1,0,0
220084,),0,0
220085,.,0,0
220086,The,0,0
220087,primary,0,0
220088,event,0,0
220089,rate,0,0
220090,per,0,0
220091,year,0,0
220092,was,0,0
220093,3.6,0,0
220094,%,0,0
220095,with,0,1
220096,warfarin,0,0
220097,and,0,0
220098,4.8,0,0
220099,%,0,0
220100,with,0,1
220101,aspirin,0,0
220102,(,0,0
220103,RR,0,0
220104,0.73,0,0
220105,",",0,0
220106,p,0,0
220107,=,0,0
220108,0.39,0,0
220109,),0,0
220110,.,0,0
220111,In,0,0
220112,this,0,0
220113,older,0,1
220114,group,0,0
220115,",",0,0
220116,the,0,0
220117,rate,0,0
220118,of,0,0
220119,all,0,0
220120,stroke,0,1
220121,with,0,0
220122,residual,0,0
220123,deficit,0,0
220124,(,0,0
220125,ischaemic,0,1
220126,or,0,0
220127,haemorrhagic,0,1
220128,),0,0
220129,was,0,0
220130,4.3,0,0
220131,%,0,0
220132,per,0,0
220133,year,0,0
220134,with,0,1
220135,aspirin,0,0
220136,and,0,0
220137,4.6,0,0
220138,%,0,0
220139,per,0,0
220140,year,0,0
220141,with,0,1
220142,warfarin,0,0
220143,(,0,0
220144,RR,0,0
220145,1.1,0,1
220146,),0,0
220147,.,0,0
220148,Warfarin,0,0
220149,may,0,0
220150,be,0,0
220151,more,0,0
220152,effective,0,0
220153,than,0,0
220154,aspirin,0,0
220155,for,0,0
220156,prevention,0,0
220157,of,0,0
220158,ischaemic,0,1
220159,stroke,0,1
220160,in,0,0
220161,patients,0,1
220162,with,0,1
220163,atrial,0,1
220164,fibrillation,0,1
220165,",",0,0
220166,but,0,0
220167,the,0,0
220168,absolute,0,0
220169,reduction,0,0
220170,in,0,0
220171,stroke,0,1
220172,rate,0,0
220173,by,0,0
220174,warfarin,0,0
220175,is,0,0
220176,small,0,0
220177,.,0,0
220178,Younger,0,0
220179,patients,0,1
220180,without,0,1
220181,risk,0,0
220182,factors,0,0
220183,had,0,0
220184,a,0,0
220185,low,0,0
220186,rate,0,0
220187,of,0,0
220188,stroke,0,0
220189,when,0,0
220190,treated,0,0
220191,with,0,0
220192,aspirin,0,0
220193,.,0,0
220194,In,0,0
220195,older,0,1
220196,patients,0,1
220197,the,0,0
220198,rate,0,0
220199,of,0,0
220200,stroke,0,1
220201,(,0,0
220202,ischaemic,0,1
220203,and,0,0
220204,haemorrhagic,0,1
220205,),0,0
220206,was,0,0
220207,substantial,0,0
220208,",",0,0
220209,irrespective,0,0
220210,of,0,0
220211,which,0,0
220212,agent,0,0
220213,was,0,0
220214,given,0,0
220215,.,0,0
220216,Patient,0,0
220217,age,0,1
220218,and,0,0
220219,the,0,0
220220,inherent,0,0
220221,risk,0,0
220222,of,0,0
220223,thromboembolism,0,0
220224,should,0,0
220225,be,0,0
220226,considered,0,0
220227,in,0,0
220228,the,0,0
220229,choice,0,0
220230,of,0,0
220231,antithrombotic,0,0
220232,prophylaxis,0,0
220233,for,0,0
220234,patients,0,1
220235,with,0,1
220236,atrial,0,1
220237,fibrillation,0,1
220238,.,0,0
220239,Exposure,0,0
220240,reduced,0,0
220241,agoraphobia,0,1
220242,but,0,0
220243,not,0,0
220244,panic,0,0
220245,",",0,0
220246,and,0,0
220247,cognitive,0,0
220248,therapy,0,0
220249,reduced,0,0
220250,panic,0,1
220251,but,0,0
220252,not,0,0
220253,agoraphobia,0,1
220254,.,0,0
220255,Earlier,0,0
220256,studies,0,0
220257,showed,0,0
220258,that,0,0
220259,cognitive,0,0
220260,therapy,0,0
220261,has,0,0
220262,anti-panic,0,0
220263,effects,0,0
220264,and,0,0
220265,exposure,0,0
220266,has,0,0
220267,anti-agoraphobic,0,0
220268,effects,0,0
220269,while,0,0
220270,other,0,0
220271,studies,0,0
220272,suggest,0,0
220273,that,0,0
220274,agoraphobia,0,0
220275,is,0,0
220276,a,0,0
220277,secondary,0,0
220278,complication,0,0
220279,of,0,0
220280,panic,0,1
220281,disorder,0,1
220282,.,0,0
220283,It,0,0
220284,was,0,0
220285,therefore,0,0
220286,hypothesized,0,0
220287,that,0,0
220288,cognitive,0,0
220289,therapy,0,0
220290,not,0,0
220291,only,0,0
220292,reduces,0,0
220293,panic,0,0
220294,but,0,0
220295,also,0,0
220296,agoraphobia,0,0
220297,and,0,0
220298,that,0,0
220299,it,0,0
220300,potentiates,0,0
220301,the,0,0
220302,effects,0,0
220303,of,0,0
220304,exposure,0,0
220305,in,0,0
220306,vivo,0,0
220307,.,0,1
220308,Two,1,0
220309,groups,1,0
220310,of,1,0
220311,12,1,1
220312,severe,1,1
220313,agoraphobics,1,1
220314,were,1,0
220315,treated,1,1
220316,with,0,1
220317,4,0,0
220318,sessions,0,0
220319,of,0,0
220320,cognitive,0,0
220321,therapy,0,0
220322,followed,0,0
220323,by,0,0
220324,8,0,0
220325,sessions,0,0
220326,of,0,0
220327,cognitive,0,0
220328,therapy,0,0
220329,combined,0,0
220330,with,0,0
220331,in,0,0
220332,vivo,0,0
220333,exposure,0,0
220334,.,0,0
220335,The,0,0
220336,other,0,0
220337,12,1,0
220338,received,1,0
220339,4,1,0
220340,sessions,1,0
220341,of,1,0
220342,'associative,1,0
220343,therapy,1,0
220344,',1,0
220345,",",0,0
220346,a,0,0
220347,presumably,0,0
220348,inert,0,0
220349,treatment,0,0
220350,that,0,0
220351,controls,0,0
220352,for,0,0
220353,therapist,0,0
220354,attention,0,0
220355,",",0,0
220356,followed,0,0
220357,by,0,0
220358,8,0,0
220359,sessions,0,0
220360,of,0,0
220361,in,0,0
220362,vivo,0,0
220363,exposure,0,0
220364,that,0,0
220365,was,0,0
220366,framed,0,0
220367,in,0,0
220368,common,0,0
220369,behavioral,0,1
220370,terms,0,0
220371,.,0,0
220372,The,0,0
220373,initial,0,0
220374,cognitive,0,0
220375,therapy,0,0
220376,produced,0,0
220377,a,0,0
220378,significant,0,0
220379,reduction,0,0
220380,in,0,0
220381,panic,0,1
220382,frequency,0,0
220383,",",0,0
220384,while,0,0
220385,associative,0,0
220386,therapy,0,0
220387,did,0,0
220388,not,0,0
220389,affect,0,0
220390,panic,0,1
220391,.,0,0
220392,Neither,0,0
220393,cognitive,0,0
220394,therapy,0,0
220395,alone,0,0
220396,",",0,0
220397,nor,0,0
220398,associate,0,0
220399,therapy,0,0
220400,alone,0,0
220401,significantly,0,0
220402,reduced,0,0
220403,depression,0,0
220404,",",0,0
220405,state,0,0
220406,or,0,0
220407,trait,0,0
220408,anxiety,0,0
220409,",",0,0
220410,self-rated,0,0
220411,agoraphobia,0,1
220412,or,0,0
220413,behavioral,0,0
220414,avoidance,0,0
220415,.,0,0
220416,After,0,0
220417,adding,0,0
220418,exposure,0,0
220419,however,0,0
220420,",",0,0
220421,these,0,0
220422,parameters,0,0
220423,were,0,0
220424,clearly,0,0
220425,and,0,0
220426,significantly,0,0
220427,reduced,0,0
220428,.,0,0
220429,Cognitive,0,0
220430,therapy,0,0
220431,did,0,0
220432,not,0,0
220433,potentiate,0,0
220434,exposure,0,0
220435,effects,0,0
220436,.,0,0
220437,The,0,0
220438,results,0,0
220439,are,0,0
220440,discussed,0,0
220441,.,0,0
220442,[,0,0
220443,Effect,0,0
220444,of,0,0
220445,acupuncture,0,0
220446,on,0,0
220447,T-lymphocyte,0,0
220448,and,0,0
220449,its,0,0
220450,subsets,0,0
220451,from,0,0
220452,the,0,0
220453,peripheral,0,0
220454,blood,0,0
220455,of,0,0
220456,patients,1,1
220457,with,1,1
220458,malignant,1,1
220459,neoplasm,1,1
220460,],1,0
220461,.,0,0
220462,Effect,0,0
220463,of,0,0
220464,acupuncture,0,0
220465,on,0,0
220466,the,0,0
220467,T-lymphocyte,0,0
220468,and,0,0
220469,its,0,0
220470,subsets,0,0
220471,from,0,0
220472,the,0,0
220473,peripheral,0,0
220474,blood,0,0
220475,of,0,0
220476,patients,1,1
220477,with,1,1
220478,malignant,1,1
220479,neoplasm,1,0
220480,has,0,0
220481,been,0,0
220482,researched,0,0
220483,in,0,0
220484,this,0,0
220485,study,0,0
220486,.,0,0
220487,51,1,0
220488,patients,1,1
220489,were,0,0
220490,divided,0,1
220491,into,0,1
220492,two,0,0
220493,groups,0,0
220494,:,0,1
220495,one,0,0
220496,in,0,0
220497,acupuncture,0,0
220498,treatment,0,0
220499,and,0,0
220500,the,0,0
220501,other,0,0
220502,without,0,0
220503,any,0,0
220504,treatment,0,0
220505,.,0,0
220506,48,1,0
220507,healthy,1,1
220508,adults,1,1
220509,were,1,0
220510,also,1,0
220511,studied,1,0
220512,as,1,0
220513,normal,1,1
220514,control,1,0
220515,group,1,0
220516,.,1,0
220517,The,0,0
220518,results,0,0
220519,showed,0,0
220520,that,0,0
220521,the,0,0
220522,percentages,0,0
220523,of,0,0
220524,OKT3+,0,0
220525,",",0,0
220526,OKT4+,0,0
220527,",",0,0
220528,OKT8+,0,0
220529,cells,0,0
220530,in,0,0
220531,the,0,0
220532,peripheral,0,0
220533,blood,0,0
220534,of,0,0
220535,the,0,0
220536,51,0,1
220537,patients,0,1
220538,were,0,0
220539,lower,0,0
220540,than,0,0
220541,those,0,0
220542,of,0,0
220543,the,0,0
220544,normal,0,1
220545,adults,0,1
220546,respectively,0,0
220547,.,0,0
220548,After,0,0
220549,the,0,0
220550,acupuncture,0,0
220551,treatment,0,0
220552,",",0,0
220553,the,0,0
220554,percentages,0,0
220555,of,0,0
220556,OKT3+,0,0
220557,",",0,0
220558,OKT4+,0,0
220559,",",0,0
220560,OKT8+,0,0
220561,cells,0,0
220562,were,0,0
220563,obviously,0,0
220564,higher,0,0
220565,than,0,0
220566,those,0,0
220567,before,0,0
220568,acupuncture,0,0
220569,;,0,0
220570,the,0,0
220571,control,0,0
220572,group,0,0
220573,of,0,0
220574,patients,0,1
220575,showed,0,0
220576,no,0,0
220577,significant,0,0
220578,variation,0,0
220579,.,0,0
220580,This,0,0
220581,result,0,0
220582,revealed,0,0
220583,that,0,0
220584,acupuncture,0,0
220585,seemed,0,0
220586,to,0,0
220587,have,0,0
220588,more,0,0
220589,affect,0,0
220590,on,0,0
220591,OKT4+,0,0
220592,cells,0,0
220593,than,0,0
220594,on,0,0
220595,OKT8+,0,1
220596,cells,0,0
220597,.,0,0
220598,From,0,0
220599,our,0,0
220600,study,0,0
220601,we,0,0
220602,believe,0,0
220603,that,0,0
220604,acupuncture,0,0
220605,can,0,0
220606,be,0,0
220607,used,0,0
220608,as,0,0
220609,one,0,0
220610,of,0,0
220611,the,0,0
220612,many,0,0
220613,treatments,0,0
220614,for,0,0
220615,patients,1,1
220616,with,1,1
220617,cancer,1,1
220618,.,1,0
220619,Naltrexone,0,0
220620,",",0,0
220621,an,0,0
220622,opiate,0,0
220623,antagonist,0,0
220624,",",0,0
220625,fails,0,0
220626,to,0,0
220627,modify,0,0
220628,motor,0,0
220629,symptoms,0,0
220630,in,0,0
220631,patients,1,1
220632,with,1,1
220633,Parkinson,1,1
220634,'s,1,1
220635,disease,1,1
220636,.,1,1
220637,One,0,0
220638,month,0,0
220639,of,0,0
220640,adjunct,0,0
220641,treatment,0,0
220642,with,0,1
220643,naltrexone,0,0
220644,(,0,0
220645,100,0,0
220646,mg/day,0,0
220647,),0,0
220648,was,0,0
220649,compared,0,0
220650,with,0,0
220651,placebo,0,0
220652,in,0,0
220653,a,0,0
220654,double-blind,0,0
220655,",",0,0
220656,randomized,0,0
220657,",",0,0
220658,cross-over,0,0
220659,design,0,0
220660,in,0,0
220661,two,1,0
220662,groups,1,0
220663,of,1,0
220664,patients,1,1
220665,with,1,1
220666,Parkinson,1,1
220667,'s,1,1
220668,disease,1,1
220669,.,1,0
220670,The,0,0
220671,first,0,0
220672,group,0,0
220673,was,0,0
220674,composed,0,0
220675,of,0,0
220676,10,1,0
220677,patients,1,1
220678,with,1,1
220679,a,1,0
220680,moderate,1,1
220681,motor,1,0
220682,impairment,1,0
220683,insufficiently,1,0
220684,controlled,1,0
220685,by,1,0
220686,monotherapy,1,0
220687,with,1,1
220688,bromocriptine,1,0
220689,.,1,0
220690,The,0,0
220691,second,0,0
220692,group,0,0
220693,was,0,0
220694,composed,0,0
220695,of,0,0
220696,eight,1,1
220697,patients,1,1
220698,with,1,1
220699,L-dopa-induced,1,0
220700,peak-dose,1,0
220701,dyskinesia,1,1
220702,.,1,0
220703,Naltrexone,0,0
220704,as,0,0
220705,compared,0,0
220706,with,0,1
220707,placebo,0,0
220708,did,0,0
220709,not,0,0
220710,demonstrate,0,0
220711,any,0,0
220712,significant,0,0
220713,change,0,0
220714,in,0,0
220715,motor,0,0
220716,function,0,0
220717,in,0,0
220718,either,0,0
220719,group,0,0
220720,.,0,0
220721,These,0,0
220722,negative,0,0
220723,clinical,0,0
220724,results,0,0
220725,do,0,0
220726,not,0,0
220727,support,0,0
220728,a,0,0
220729,significant,0,0
220730,role,0,0
220731,of,0,0
220732,endogenous,0,0
220733,opioid,0,0
220734,systems,0,0
220735,in,0,0
220736,the,0,0
220737,pathophysiology,0,0
220738,of,0,0
220739,motor,0,0
220740,impairment,0,0
220741,in,0,0
220742,Parkinson,0,1
220743,'s,0,1
220744,disease,0,1
220745,.,0,1
220746,Laser-aided,0,0
220747,external,0,0
220748,drainage,1,0
220749,of,1,0
220750,subretinal,1,0
220751,fluid,1,0
220752,:,1,1
220753,prospective,0,0
220754,randomized,0,0
220755,comparison,0,0
220756,with,0,1
220757,needle,0,0
220758,drainage,0,0
220759,.,0,0
220760,In,0,0
220761,a,0,0
220762,prospective,0,0
220763,randomized,0,0
220764,study,0,0
220765,of,0,0
220766,50,1,1
220767,consecutive,1,1
220768,eyes,1,1
220769,",",0,0
220770,we,0,0
220771,compared,0,0
220772,the,0,0
220773,safety,0,0
220774,and,0,0
220775,efficacy,0,0
220776,of,0,0
220777,draining,0,0
220778,subretinal,0,0
220779,fluid,0,0
220780,transchoroidally,0,0
220781,in,0,0
220782,primary,0,0
220783,scleral,0,1
220784,buckling,0,1
220785,for,0,0
220786,rhegmatogenous,0,1
220787,retinal,0,1
220788,detachment,0,1
220789,using,0,0
220790,a,0,0
220791,needle,0,0
220792,",",0,0
220793,with,0,0
220794,the,0,0
220795,safety,0,0
220796,and,0,0
220797,efficacy,0,0
220798,of,0,0
220799,the,0,0
220800,same,0,0
220801,procedure,0,0
220802,using,0,0
220803,an,0,0
220804,angulated,0,0
220805,endolaser,0,0
220806,probe,0,0
220807,set,0,0
220808,at,0,0
220809,1,0,0
220810,W,0,0
220811,for,0,0
220812,0.2,0,0
220813,seconds,0,0
220814,",",0,0
220815,using,0,0
220816,an,0,0
220817,average,0,0
220818,of,0,0
220819,2.4,0,0
220820,laser,0,0
220821,burns,0,1
220822,.,0,0
220823,There,0,0
220824,were,0,0
220825,no,0,0
220826,significant,0,0
220827,complications,0,0
220828,associated,0,0
220829,with,0,1
220830,the,0,0
220831,laser-aided,0,0
220832,drainage,0,0
220833,procedures,0,1
220834,(,0,0
220835,25,0,1
220836,eyes,0,1
220837,),0,0
220838,.,0,0
220839,In,0,0
220840,the,0,0
220841,transchoroidal,0,0
220842,needle,0,0
220843,drainage,0,0
220844,procedures,0,1
220845,(,0,0
220846,25,0,1
220847,eyes,0,1
220848,),0,0
220849,",",0,0
220850,subretinal,0,0
220851,hemorrhage,0,0
220852,occurred,0,0
220853,in,0,0
220854,three,0,0
220855,eyes,0,1
220856,and,0,0
220857,retinal,0,1
220858,incarceration,0,1
220859,in,0,0
220860,one,0,0
220861,.,0,0
220862,Thus,0,0
220863,",",0,0
220864,though,0,0
220865,our,0,0
220866,numbers,0,0
220867,are,0,0
220868,small,0,0
220869,",",0,0
220870,there,0,0
220871,appears,0,0
220872,to,0,0
220873,be,0,0
220874,some,0,0
220875,advantage,0,0
220876,of,0,0
220877,laser-assisted,0,0
220878,drainage,0,0
220879,in,0,0
220880,terms,0,0
220881,of,0,0
220882,a,0,0
220883,lower,0,0
220884,incidence,0,0
220885,of,0,0
220886,complications,0,0
220887,.,0,1
220888,Milk,0,0
220889,production,0,0
220890,in,0,0
220891,cows,1,1
220892,with,1,1
220893,endotoxin-induced,1,0
220894,mastitis,1,0
220895,treated,0,1
220896,with,0,0
220897,isotonic,0,0
220898,or,0,0
220899,hypertonic,0,0
220900,sodium,0,0
220901,chloride,0,0
220902,solution,0,0
220903,.,0,0
220904,Milk,0,0
220905,production,0,0
220906,was,0,0
220907,monitored,0,0
220908,in,0,0
220909,16,1,1
220910,cows,1,1
220911,for,1,0
220912,6,1,0
220913,milkings,1,0
220914,after,0,0
220915,intramammary,0,0
220916,infusion,0,0
220917,of,0,0
220918,1,0,0
220919,mg,0,0
220920,of,0,0
220921,endotoxin,0,0
220922,in,0,0
220923,a,0,0
220924,single,0,0
220925,forequarter,0,1
220926,.,0,0
220927,The,0,0
220928,cows,0,0
220929,were,0,0
220930,randomly,0,1
220931,assigned,0,0
220932,to,0,0
220933,1,0,0
220934,of,0,0
220935,2,0,0
220936,treatment,0,0
220937,groups,0,0
220938,;,0,0
220939,8,1,0
220940,cows,1,1
220941,were,1,0
220942,treated,1,1
220943,with,1,1
220944,isotonic,1,0
220945,saline,1,0
220946,solution,1,0
220947,and,0,0
220948,8,1,0
220949,cows,1,1
220950,were,1,0
220951,treated,1,1
220952,with,1,1
220953,hypertonic,1,0
220954,saline,1,0
220955,solution,1,0
220956,.,1,0
220957,Saline,0,0
220958,solutions,0,0
220959,were,0,0
220960,administered,0,0
220961,IV,0,0
220962,(,0,0
220963,5,0,0
220964,ml/kg,0,0
220965,of,0,0
220966,body,0,0
220967,weight,0,0
220968,),0,0
220969,4,0,0
220970,hours,0,0
220971,after,0,0
220972,infusion,0,0
220973,of,0,0
220974,endotoxin,0,0
220975,.,0,0
220976,Mean,0,0
220977,cumulative,0,0
220978,change,0,0
220979,in,0,0
220980,milk,0,0
220981,yield,0,0
220982,and,0,0
220983,interval,0,0
220984,change,0,0
220985,in,0,0
220986,milk,0,0
220987,yield,0,0
220988,were,0,0
220989,greater,0,0
220990,in,0,0
220991,cows,1,1
220992,treated,0,1
220993,with,0,1
220994,isotonic,0,0
220995,saline,0,0
220996,solution,0,0
220997,than,0,0
220998,in,0,0
220999,cows,0,1
221000,treated,0,1
221001,with,0,1
221002,hypertonic,0,0
221003,saline,0,0
221004,solution,0,0
221005,.,0,0
221006,Significant,0,0
221007,differences,0,0
221008,between,0,0
221009,treatment,0,0
221010,groups,0,0
221011,were,0,0
221012,not,0,0
221013,detected,0,0
221014,.,0,0
221015,Intestinal,0,1
221016,absorption,0,0
221017,of,0,0
221018,dietary,0,0
221019,fat,0,0
221020,in,0,0
221021,patients,1,1
221022,with,1,1
221023,multiple,1,0
221024,sclerosis,1,1
221025,.,1,0
221026,Fat,0,0
221027,absorption,0,0
221028,was,0,0
221029,studied,0,1
221030,in,0,0
221031,24,1,0
221032,patients,1,1
221033,with,1,1
221034,clinically,1,0
221035,definite,1,0
221036,multiple,1,0
221037,sclerosis,1,1
221038,and,1,0
221039,in,1,0
221040,36,1,1
221041,healthy,1,1
221042,control,1,1
221043,subjects,1,1
221044,.,1,0
221045,Beta-carotene,0,0
221046,and,0,0
221047,vitamin,0,0
221048,A,0,0
221049,in,0,0
221050,their,0,0
221051,plasma,0,0
221052,were,0,0
221053,also,0,0
221054,measured,0,0
221055,.,0,0
221056,This,0,0
221057,double-blind,0,0
221058,and,0,0
221059,randomized,0,0
221060,study,0,0
221061,showed,0,0
221062,no,0,0
221063,differences,0,0
221064,between,0,0
221065,these,0,0
221066,two,0,0
221067,populations,0,0
221068,with,0,1
221069,regard,0,0
221070,to,0,0
221071,the,0,0
221072,three,0,0
221073,parameters,0,0
221074,.,0,1
221075,We,0,0
221076,did,0,0
221077,not,0,0
221078,find,0,0
221079,evidence,0,0
221080,for,0,0
221081,fat,0,0
221082,malabsorption,0,1
221083,in,0,0
221084,multiple,0,0
221085,sclerosis,0,1
221086,.,0,0
221087,Once,0,0
221088,versus,0,0
221089,thrice,0,0
221090,daily,0,0
221091,gentamicin,0,0
221092,in,0,0
221093,patients,1,1
221094,with,1,1
221095,serious,1,0
221096,infections,1,0
221097,.,1,1
221098,Aminoglycosides,0,0
221099,are,0,0
221100,usually,0,0
221101,given,0,0
221102,in,0,0
221103,two,0,0
221104,or,0,1
221105,three,0,0
221106,divided,0,1
221107,doses,0,0
221108,.,0,0
221109,A,0,0
221110,once-daily,0,0
221111,regimen,0,0
221112,might,0,0
221113,be,0,0
221114,more,0,0
221115,effective,0,0
221116,and,0,0
221117,less,0,0
221118,toxic,0,0
221119,.,0,0
221120,We,0,0
221121,have,0,0
221122,conducted,0,0
221123,a,0,0
221124,randomised,0,0
221125,trial,0,0
221126,in,0,0
221127,consecutive,1,1
221128,patients,1,1
221129,with,1,1
221130,serious,1,0
221131,infections,1,1
221132,for,1,1
221133,whom,1,1
221134,an,1,1
221135,aminoglycoside,1,1
221136,seemed,1,0
221137,warranted,1,0
221138,.,1,0
221139,Exclusion,1,0
221140,criteria,1,1
221141,were,1,0
221142,neutropenia,1,0
221143,or,1,0
221144,severely,1,1
221145,impaired,1,0
221146,renal,1,1
221147,function,1,0
221148,.,1,1
221149,123,1,1
221150,patients,1,1
221151,were,1,0
221152,enrolled,1,1
221153,.,1,0
221154,For,1,0
221155,efficacy,1,0
221156,analysis,1,0
221157,only,1,0
221158,those,1,0
221159,patients,1,1
221160,were,1,0
221161,considered,1,0
221162,in,1,0
221163,whom,1,1
221164,treatment,1,1
221165,with,1,1
221166,the,1,0
221167,aminoglycoside,1,0
221168,was,1,0
221169,not,1,0
221170,stopped,1,0
221171,within,1,0
221172,72,1,0
221173,h,1,0
221174,(,1,0
221175,n,1,1
221176,=,1,0
221177,67,1,1
221178,),1,0
221179,;,1,0
221180,toxicity,1,0
221181,was,1,0
221182,analysed,1,0
221183,on,1,0
221184,patients,1,1
221185,receiving,1,1
221186,aminoglycosides,1,0
221187,for,1,0
221188,more,1,0
221189,than,1,0
221190,48,1,0
221191,h,1,0
221192,and,1,0
221193,not,1,0
221194,using,1,0
221195,other,1,0
221196,nephrotoxic,1,0
221197,medication,1,0
221198,(,1,0
221199,n,1,1
221200,=,1,0
221201,85,1,1
221202,),1,0
221203,.,1,0
221204,Gentamicin,0,0
221205,4,0,0
221206,mg/kg,0,0
221207,every,0,0
221208,day,0,0
221209,(,0,0
221210,OD,0,1
221211,),0,0
221212,or,0,0
221213,gentamicin,0,0
221214,1.33,0,0
221215,mg/kg,0,0
221216,three,0,0
221217,times,0,0
221218,daily,0,0
221219,(,0,0
221220,MD,0,0
221221,),0,0
221222,(,0,0
221223,with,0,0
221224,dose-reduction,0,0
221225,in,0,0
221226,case,0,0
221227,of,0,0
221228,renal,0,1
221229,dysfunction,0,1
221230,),0,0
221231,were,0,0
221232,given,0,0
221233,intravenously,0,0
221234,.,0,0
221235,In,0,0
221236,almost,0,0
221237,all,0,0
221238,patients,0,1
221239,intravenous,0,0
221240,amoxycillin,0,0
221241,1,0,0
221242,g,0,0
221243,every,0,0
221244,6,0,0
221245,h,0,0
221246,was,0,0
221247,also,0,0
221248,started,0,0
221249,.,0,0
221250,Baseline,1,0
221251,characteristics,1,0
221252,were,1,0
221253,comparable,1,0
221254,in,1,0
221255,both,1,0
221256,arms,1,0
221257,.,1,0
221258,A,0,0
221259,good,0,0
221260,clinical,0,0
221261,response,0,0
221262,was,0,0
221263,observed,0,0
221264,in,0,0
221265,32/35,0,0
221266,(,0,0
221267,91,0,0
221268,%,0,0
221269,),0,0
221270,of,0,0
221271,the,0,0
221272,OD,0,1
221273,and,0,0
221274,in,0,0
221275,25/32,0,0
221276,(,0,0
221277,78,0,1
221278,%,0,0
221279,),0,0
221280,in,0,0
221281,the,0,0
221282,MD,0,0
221283,group,0,0
221284,(,0,0
221285,difference,0,0
221286,13,0,0
221287,%,0,0
221288,",",0,0
221289,95,0,0
221290,%,0,0
221291,confidence,0,0
221292,interval,0,0
221293,-6.4,0,0
221294,%,0,0
221295,to,0,0
221296,+26.9,0,0
221297,%,0,0
221298,),0,0
221299,.,0,0
221300,2,0,0
221301,patients,0,1
221302,in,0,0
221303,each,0,0
221304,group,0,0
221305,died,0,1
221306,with,0,0
221307,uncontrolled,0,1
221308,infection,0,1
221309,.,0,0
221310,An,0,0
221311,insufficient,0,0
221312,bacteriological,0,0
221313,response,0,0
221314,(,0,0
221315,persistent,0,1
221316,positive,0,0
221317,cultures,0,0
221318,",",0,0
221319,resistance,0,0
221320,",",0,0
221321,or,0,0
221322,superinfection,0,0
221323,),0,0
221324,was,0,0
221325,observed,0,0
221326,in,0,0
221327,2,0,0
221328,patients,0,1
221329,with,0,1
221330,OD,0,1
221331,and,0,0
221332,3,0,0
221333,patients,0,1
221334,with,0,1
221335,MD,0,0
221336,.,0,0
221337,In,0,0
221338,patients,0,1
221339,treated,0,1
221340,for,0,0
221341,more,0,0
221342,than,0,0
221343,48,0,0
221344,h,0,0
221345,duration,0,0
221346,of,0,0
221347,therapy,0,0
221348,and,0,0
221349,mean,0,0
221350,doses,0,0
221351,were,0,1
221352,7.0,0,1
221353,days,0,0
221354,(,0,0
221355,1590,0,1
221356,mg,0,0
221357,),0,0
221358,and,0,0
221359,7.4,0,0
221360,days,0,0
221361,(,0,0
221362,1672,0,1
221363,mg,0,0
221364,),0,0
221365,in,0,0
221366,OD,0,1
221367,and,0,0
221368,MD,0,0
221369,respectively,0,0
221370,.,0,0
221371,Mean,0,0
221372,first,0,0
221373,serum,0,0
221374,trough/peak,0,0
221375,levels,0,0
221376,were,0,0
221377,0.6/10.2,0,0
221378,mg/L,0,0
221379,and,0,0
221380,1.4/5.2,0,0
221381,mg/L,0,0
221382,.,0,0
221383,Nephrotoxicity,0,0
221384,(,0,0
221385,a,0,0
221386,rise,0,0
221387,in,0,0
221388,serum,0,0
221389,creatinine,0,0
221390,of,0,0
221391,45,0,0
221392,mumol/L,0,0
221393,or,0,0
221394,more,0,0
221395,),0,0
221396,developed,0,0
221397,in,0,0
221398,2/40,0,0
221399,(,0,0
221400,5,0,0
221401,%,0,0
221402,),0,0
221403,in,0,0
221404,OD,0,1
221405,and,0,0
221406,11/45,0,0
221407,(,0,0
221408,24,0,0
221409,%,0,0
221410,),0,0
221411,in,0,0
221412,MD,0,0
221413,(,0,0
221414,p,0,0
221415,=,0,0
221416,0.016,0,0
221417,),0,0
221418,.,0,0
221419,Risk,0,0
221420,factors,0,0
221421,for,0,0
221422,nephrotoxicity,0,0
221423,were,0,0
221424,duration,0,0
221425,of,0,0
221426,therapy,0,0
221427,and,0,0
221428,baseline,0,0
221429,creatinine,0,0
221430,clearance,0,0
221431,rate,0,0
221432,.,0,0
221433,High-tone,0,0
221434,audiometry,0,0
221435,was,0,0
221436,performed,0,0
221437,when,0,0
221438,possible,0,0
221439,;,0,0
221440,no,0,0
221441,significant,0,0
221442,differences,0,0
221443,were,0,0
221444,found,0,0
221445,in,0,0
221446,hearing,0,0
221447,loss,0,0
221448,(,0,0
221449,3/12,0,0
221450,and,0,0
221451,3/11,0,0
221452,),0,0
221453,or,0,1
221454,prodromal,0,1
221455,signs,0,0
221456,of,0,0
221457,ototoxicity,0,0
221458,(,0,0
221459,5/12,0,0
221460,and,0,0
221461,4/11,0,0
221462,),0,0
221463,.,0,0
221464,A,0,0
221465,once-daily,0,0
221466,dosing,0,0
221467,regimen,0,0
221468,of,0,0
221469,gentamicin,0,0
221470,is,0,0
221471,at,0,0
221472,least,0,0
221473,as,0,0
221474,effective,0,0
221475,as,0,0
221476,and,0,0
221477,is,0,0
221478,less,0,0
221479,nephrotoxic,0,0
221480,than,0,0
221481,more,0,0
221482,frequent,0,0
221483,dosing,0,0
221484,.,0,0
221485,Peripheral,0,0
221486,intravenous,0,0
221487,line,0,0
221488,survival,0,0
221489,and,0,0
221490,phlebitis,0,0
221491,prevention,0,0
221492,in,0,0
221493,patients,1,1
221494,receiving,1,1
221495,intravenous,1,1
221496,antibiotics,1,0
221497,:,1,1
221498,heparin/hydrocortisone,0,0
221499,versus,0,0
221500,in-line,0,0
221501,filters,0,1
221502,.,0,1
221503,OBJECTIVE,0,0
221504,To,0,0
221505,compare,0,0
221506,the,0,0
221507,use,0,0
221508,of,0,0
221509,in-line,0,0
221510,filtration,0,0
221511,with,0,0
221512,the,0,0
221513,addition,0,0
221514,of,0,0
221515,heparin/hydrocortisone,0,0
221516,(,0,0
221517,hep/hc,0,0
221518,),0,0
221519,to,0,0
221520,the,0,0
221521,infusate,0,0
221522,for,0,0
221523,both,0,0
221524,phlebitis,0,0
221525,prevention,0,0
221526,and,0,0
221527,intravenous,0,0
221528,(,0,0
221529,i.v,0,0
221530,.,0,0
221531,),0,0
221532,line,0,0
221533,survival,0,0
221534,in,0,0
221535,peripheral,0,0
221536,i.v,0,0
221537,.,0,1
221538,catheters,0,0
221539,.,0,0
221540,This,0,0
221541,study,0,0
221542,was,0,0
221543,specific,1,0
221544,for,1,0
221545,a,1,0
221546,patient,1,0
221547,group,1,0
221548,receiving,1,0
221549,prolonged,1,0
221550,courses,1,0
221551,of,1,0
221552,i.v,1,0
221553,.,1,1
221554,antibiotics,1,0
221555,.,1,0
221556,Analysis,0,0
221557,of,0,0
221558,the,0,0
221559,two,0,0
221560,endpoints,0,0
221561,for,0,0
221562,conventional,0,0
221563,short,0,0
221564,i.v,0,0
221565,.,0,0
221566,catheters,0,0
221567,(,0,0
221568,short,0,1
221569,lines,0,0
221570,),0,0
221571,versus,0,0
221572,long,0,0
221573,(,0,0
221574,30,0,0
221575,cm,0,1
221576,),0,0
221577,i.v,0,0
221578,.,0,0
221579,catheters,0,0
221580,(,0,0
221581,long,0,1
221582,lines,0,0
221583,),0,0
221584,was,0,0
221585,also,0,0
221586,performed,0,0
221587,.,0,1
221588,METHODS,0,0
221589,Patients,1,1
221590,with,1,1
221591,cystic,1,1
221592,fibrosis,1,1
221593,receiving,1,0
221594,intermittent,1,1
221595,i.v,1,0
221596,.,1,1
221597,antibiotics,1,0
221598,were,0,0
221599,randomly,0,1
221600,allocated,0,0
221601,to,0,0
221602,receive,0,0
221603,their,0,0
221604,drugs,0,0
221605,either,0,0
221606,through,0,0
221607,an,0,0
221608,in-line,0,0
221609,filter,0,0
221610,using,0,0
221611,a,0,0
221612,drug-free,0,0
221613,infusate,0,0
221614,or,0,0
221615,with,0,0
221616,no,0,0
221617,filter,0,0
221618,and,0,0
221619,an,0,0
221620,infusate,0,0
221621,containing,0,0
221622,heparin,0,0
221623,500,0,0
221624,units,0,0
221625,and,0,0
221626,hydrocortisone,0,0
221627,10,0,0
221628,mg/L,0,0
221629,.,0,0
221630,Infusion,0,0
221631,sites,0,0
221632,were,0,0
221633,assessed,0,0
221634,daily,0,0
221635,.,0,0
221636,RESULTS,0,0
221637,Both,0,0
221638,the,0,0
221639,hep/hc,0,0
221640,and,0,0
221641,filter,0,0
221642,groups,0,0
221643,were,0,0
221644,similar,0,0
221645,in,0,0
221646,terms,0,0
221647,of,0,0
221648,phlebitis,0,0
221649,incidence,0,0
221650,and,0,0
221651,i.v,0,0
221652,.,0,0
221653,line,0,0
221654,survival,0,0
221655,when,0,0
221656,analyzed,0,0
221657,separately,0,0
221658,for,0,0
221659,both,0,0
221660,short,0,0
221661,and,0,0
221662,long,0,1
221663,lines,0,0
221664,.,0,1
221665,Long,0,1
221666,lines,0,0
221667,displayed,0,0
221668,markedly,0,0
221669,prolonged,0,0
221670,survival,0,0
221671,times,0,0
221672,and,0,0
221673,reduced,0,0
221674,phlebitis,0,0
221675,compared,0,0
221676,with,0,1
221677,short,0,0
221678,lines,0,0
221679,.,0,0
221680,CONCLUSIONS,0,0
221681,The,0,0
221682,effectiveness,0,0
221683,of,0,0
221684,i.v,0,0
221685,.,0,0
221686,filters,0,0
221687,in,0,0
221688,excluding,0,0
221689,the,0,0
221690,large,0,0
221691,particle,0,0
221692,load,0,0
221693,introduced,0,0
221694,by,0,0
221695,i.v,0,0
221696,.,0,0
221697,antibiotics,0,0
221698,and,0,0
221699,hence,0,0
221700,in,0,0
221701,reducing,0,0
221702,the,0,0
221703,subsequent,0,0
221704,phlebitis,0,0
221705,makes,0,0
221706,them,0,0
221707,a,0,0
221708,useful,0,0
221709,alternative,0,0
221710,to,0,0
221711,the,0,0
221712,use,0,0
221713,of,0,0
221714,hep/hc,0,0
221715,.,0,0
221716,The,0,0
221717,use,0,0
221718,of,0,0
221719,filters,0,0
221720,in,0,0
221721,this,0,0
221722,patient,0,0
221723,group,0,0
221724,may,0,0
221725,offer,0,0
221726,advantages,0,0
221727,in,0,0
221728,terms,0,0
221729,of,0,0
221730,ease,0,0
221731,of,0,0
221732,use,0,0
221733,and,0,0
221734,a,0,0
221735,possible,0,0
221736,decrease,0,0
221737,in,0,0
221738,hep/hc-related,0,0
221739,problems,0,1
221740,.,0,1
221741,Long,0,1
221742,lines,0,0
221743,offer,0,0
221744,practical,0,0
221745,advantages,0,0
221746,over,0,0
221747,short,0,0
221748,lines,0,0
221749,for,0,0
221750,patients,1,1
221751,requiring,1,1
221752,longer,1,0
221753,term,1,0
221754,i.v,1,0
221755,.,1,0
221756,access,1,0
221757,.,1,0
221758,Effect,0,0
221759,of,0,0
221760,entacapone,0,0
221761,",",0,0
221762,a,0,0
221763,peripherally,0,0
221764,acting,0,0
221765,catechol-O-methyltransferase,0,0
221766,inhibitor,0,0
221767,",",0,0
221768,on,0,0
221769,the,0,0
221770,motor,0,0
221771,response,0,0
221772,to,0,0
221773,acute,0,1
221774,treatment,0,0
221775,with,0,0
221776,levodopa,0,0
221777,in,0,0
221778,patients,1,1
221779,with,1,1
221780,Parkinson,1,1
221781,'s,1,1
221782,disease,1,1
221783,.,1,1
221784,Catechol-O-methyltransferase,0,0
221785,(,0,0
221786,COMT,0,0
221787,),0,0
221788,inhibitors,0,0
221789,may,0,0
221790,be,0,0
221791,useful,0,0
221792,in,0,0
221793,the,0,0
221794,treatment,0,0
221795,of,0,0
221796,Parkinson,0,1
221797,'s,0,0
221798,disease,0,1
221799,by,0,0
221800,improving,0,0
221801,the,0,0
221802,bioavailability,0,0
221803,of,0,0
221804,levodopa,0,0
221805,and,0,0
221806,by,0,0
221807,prolonging,0,0
221808,its,0,0
221809,effects,0,0
221810,.,0,0
221811,Entacapone,0,0
221812,(,0,0
221813,OR-611,0,0
221814,),0,0
221815,",",0,0
221816,a,0,0
221817,novel,0,0
221818,COMT,0,0
221819,inhibitor,0,0
221820,",",0,0
221821,which,0,0
221822,does,0,0
221823,not,0,0
221824,cross,0,0
221825,the,0,0
221826,blood,0,0
221827,brain,0,0
221828,barrier,0,0
221829,",",0,0
221830,was,0,0
221831,assessed,0,0
221832,in,0,0
221833,12,1,0
221834,patients,1,1
221835,with,1,1
221836,Parkinson,1,1
221837,'s,1,0
221838,disease,1,1
221839,and,1,0
221840,motor,1,0
221841,fluctuations,1,0
221842,in,0,0
221843,a,0,0
221844,randomised,0,0
221845,",",0,0
221846,double-blind,0,0
221847,",",0,0
221848,cross-over,0,0
221849,",",0,0
221850,single,0,0
221851,dose,0,0
221852,study,0,0
221853,.,0,0
221854,The,0,0
221855,magnitude,0,0
221856,and,0,0
221857,duration,0,0
221858,of,0,0
221859,the,0,0
221860,therapeutic,0,0
221861,response,0,0
221862,to,0,0
221863,a,0,0
221864,single,0,0
221865,dose,0,0
221866,of,0,0
221867,200,0,0
221868,mg,0,0
221869,levodopa/50,0,0
221870,mg,0,0
221871,carbidopa,0,0
221872,was,0,0
221873,evaluated,0,0
221874,after,0,0
221875,concomitant,0,0
221876,placebo,0,0
221877,",",0,0
221878,or,0,0
221879,200,0,0
221880,or,0,0
221881,800,0,0
221882,mg,0,0
221883,entacapone,0,0
221884,.,0,0
221885,A,0,0
221886,significant,0,0
221887,increase,0,0
221888,in,0,0
221889,the,0,0
221890,duration,0,0
221891,of,0,0
221892,the,0,0
221893,motor,0,0
221894,response,0,0
221895,to,0,0
221896,levodopa,0,0
221897,was,0,0
221898,seen,0,0
221899,when,0,0
221900,200,0,0
221901,mg,0,0
221902,entacapone,0,0
221903,was,0,0
221904,given,0,0
221905,with,0,1
221906,levodopa/carbidopa,0,0
221907,.,0,0
221908,Plasma,0,0
221909,levodopa,0,0
221910,concentrations,0,0
221911,were,0,0
221912,increased,0,0
221913,with,0,1
221914,both,0,0
221915,doses,0,0
221916,of,0,0
221917,the,0,0
221918,COMT,0,0
221919,inhibitor,0,0
221920,.,0,0
221921,The,0,0
221922,latency,0,0
221923,to,0,0
221924,onset,0,0
221925,of,0,0
221926,motor,0,0
221927,response,0,0
221928,did,0,0
221929,not,0,0
221930,differ,0,0
221931,significantly,0,0
221932,between,0,0
221933,active,0,0
221934,drug,0,0
221935,and,0,0
221936,placebo,0,0
221937,.,0,0
221938,Entacapone,0,0
221939,may,0,0
221940,prove,0,0
221941,useful,0,0
221942,in,0,0
221943,prolonging,0,0
221944,the,0,0
221945,duration,0,0
221946,of,0,0
221947,the,0,0
221948,benefit,0,0
221949,obtained,0,0
221950,from,0,0
221951,individual,0,0
221952,doses,0,0
221953,of,0,0
221954,levodopa,0,0
221955,.,0,0
221956,Videofluoroscopic,0,0
221957,evidence,0,0
221958,of,0,0
221959,aspiration,0,0
221960,predicts,0,0
221961,pneumonia,0,1
221962,and,0,0
221963,death,0,0
221964,but,0,0
221965,not,0,0
221966,dehydration,0,0
221967,following,0,0
221968,stroke,0,1
221969,.,0,0
221970,In,0,0
221971,order,0,0
221972,to,0,0
221973,assess,0,0
221974,the,0,0
221975,risk,0,0
221976,of,0,0
221977,pneumonia,0,0
221978,",",0,0
221979,dehydration,0,0
221980,",",0,0
221981,and,0,0
221982,death,0,0
221983,associated,0,0
221984,with,0,0
221985,videofluoroscopic,0,0
221986,evidence,0,0
221987,of,0,0
221988,aspiration,1,0
221989,following,1,0
221990,stroke,1,1
221991,",",1,0
221992,the,1,0
221993,clinical,1,0
221994,records,1,0
221995,of,1,0
221996,26,1,1
221997,patients,1,1
221998,with,1,1
221999,aspiration,1,0
222000,and,1,0
222001,33,1,1
222002,randomly,1,1
222003,selected,1,0
222004,",",1,0
222005,case-matched,1,1
222006,",",1,0
222007,dysphagic,1,1
222008,controls,1,0
222009,without,1,1
222010,videofluoroscopic,1,0
222011,evidence,1,0
222012,of,1,0
222013,aspiration,1,0
222014,were,1,0
222015,reviewed,1,0
222016,.,1,0
222017,The,0,0
222018,videofluoroscopic,0,0
222019,modified,0,0
222020,barium,0,0
222021,swallow,0,0
222022,technique,0,0
222023,included,0,1
222024,5,0,0
222025,ml-thin,0,1
222026,and,0,0
222027,thick,0,0
222028,liquid,0,0
222029,barium,0,0
222030,",",0,0
222031,5,0,0
222032,ml,0,0
222033,barium,0,0
222034,pudding,0,0
222035,",",0,0
222036,and,0,0
222037,1/4,0,0
222038,cookie,0,0
222039,coated,0,0
222040,with,0,0
222041,barium,0,0
222042,",",0,0
222043,plus,0,0
222044,additional,0,0
222045,20,0,0
222046,and,0,0
222047,30,0,0
222048,ml,0,0
222049,of,0,0
222050,thin,0,0
222051,liquid,0,0
222052,barium,0,0
222053,.,0,1
222054,Patients,1,1
222055,were,1,0
222056,assessed,1,0
222057,a,1,0
222058,mean,1,0
222059,of,1,0
222060,2,1,0
222061,+/-,1,0
222062,1,1,0
222063,SD,1,1
222064,months,1,0
222065,poststroke,1,1
222066,and,1,0
222067,were,1,0
222068,followed,1,0
222069,for,1,0
222070,a,1,0
222071,mean,1,0
222072,of,1,0
222073,16,1,1
222074,+/-,1,0
222075,8,1,0
222076,SD,1,1
222077,months,1,0
222078,poststroke,1,1
222079,.,1,0
222080,The,0,0
222081,odds,0,0
222082,ratio,0,0
222083,for,0,0
222084,developing,0,0
222085,pneumonia,0,1
222086,was,0,0
222087,7.6,0,0
222088,times,0,0
222089,greater,0,0
222090,for,0,1
222091,those,0,1
222092,who,0,1
222093,aspirated,0,1
222094,any,0,1
222095,amount,0,0
222096,of,0,0
222097,barium,0,0
222098,irrespective,0,0
222099,of,0,0
222100,its,0,0
222101,consistency,0,0
222102,(,0,0
222103,p,0,0
222104,=,0,0
222105,0.05,0,0
222106,),0,0
222107,.,0,0
222108,The,0,0
222109,odds,0,0
222110,ratio,0,0
222111,for,0,0
222112,developing,0,0
222113,pneumonia,0,1
222114,was,0,0
222115,5.6,0,0
222116,times,0,0
222117,greater,0,0
222118,for,0,1
222119,those,0,1
222120,who,0,1
222121,aspirated,0,1
222122,thickened,0,1
222123,liquids,0,0
222124,or,0,1
222125,more,0,0
222126,solid,0,1
222127,consistencies,0,0
222128,compared,0,0
222129,with,0,1
222130,those,0,1
222131,who,0,1
222132,did,0,0
222133,not,0,1
222134,aspirate,0,0
222135,",",0,0
222136,or,0,0
222137,who,0,1
222138,aspirated,0,1
222139,thin,0,1
222140,liquids,0,0
222141,only,0,0
222142,(,0,0
222143,p,0,0
222144,=,0,0
222145,0.06,0,0
222146,),0,0
222147,.,0,0
222148,Dehydration,0,0
222149,was,0,0
222150,unrelated,0,1
222151,to,0,0
222152,the,0,0
222153,presence,0,0
222154,or,0,0
222155,absence,0,0
222156,of,0,0
222157,aspiration,0,0
222158,.,0,0
222159,The,0,0
222160,odds,0,0
222161,ratio,0,0
222162,for,0,0
222163,death,0,0
222164,was,0,0
222165,9.2,0,0
222166,times,0,0
222167,greater,0,0
222168,for,0,0
222169,those,0,0
222170,aspirating,0,0
222171,thickened,0,0
222172,liquids,0,0
222173,or,0,1
222174,more,0,0
222175,solid,0,1
222176,consistencies,0,0
222177,compared,0,0
222178,with,0,1
222179,those,0,1
222180,who,0,1
222181,did,0,0
222182,not,0,1
222183,aspirate,0,1
222184,or,0,1
222185,who,0,1
222186,aspirated,0,1
222187,thin,0,1
222188,liquids,0,0
222189,only,0,0
222190,(,0,0
222191,p,0,0
222192,=,0,0
222193,0.01,0,0
222194,),0,0
222195,.,0,0
222196,Aspiration,0,0
222197,documented,0,0
222198,by,0,0
222199,modified,0,0
222200,videofluoroscopic,0,0
222201,barium,0,0
222202,swallow,0,0
222203,technique,0,0
222204,is,0,0
222205,associated,0,0
222206,with,0,0
222207,a,0,0
222208,significant,0,0
222209,increase,0,0
222210,in,0,0
222211,risk,0,0
222212,of,0,0
222213,pneumonia,0,0
222214,and,0,0
222215,death,0,0
222216,but,0,0
222217,not,0,0
222218,dehydration,0,0
222219,following,0,0
222220,stroke,0,1
222221,.,0,0
222222,[,0,0
222223,A,0,0
222224,controlled,0,0
222225,study,0,0
222226,of,0,0
222227,treating,0,0
222228,haemophilia,0,1
222229,A,0,0
222230,on,0,0
222231,an,0,0
222232,out-patient,0,1
222233,basis,0,0
222234,(,0,0
222235,author,0,0
222236,'s,0,0
222237,transl,0,1
222238,),0,1
222239,],0,0
222240,.,0,0
222241,For,0,0
222242,six,0,0
222243,months,0,0
222244,36,0,1
222245,U,0,1
222246,factor,0,0
222247,VIII,0,0
222248,concentrates,0,0
222249,per,0,0
222250,kg,0,0
222251,bodyweight,0,0
222252,and,0,0
222253,week,0,0
222254,were,0,0
222255,administered,0,0
222256,to,0,0
222257,six,1,0
222258,out-patients,1,1
222259,with,1,1
222260,severe,1,1
222261,haemophilia,1,1
222262,A,1,0
222263,.,1,0
222264,The,0,0
222265,injection,0,0
222266,regimen,0,0
222267,was,0,0
222268,changed,0,0
222269,in,0,0
222270,every,0,0
222271,patient,0,0
222272,every,0,0
222273,two,0,0
222274,months,0,0
222275,",",0,0
222276,from,0,0
222277,36,0,0
222278,U/kg,0,0
222279,once,0,0
222280,to,0,0
222281,18,0,0
222282,U/kg,0,0
222283,twice,0,0
222284,and,0,0
222285,12,0,0
222286,U/kg,0,1
222287,three,0,0
222288,times,0,0
222289,",",0,0
222290,intravenously,0,0
222291,.,0,0
222292,The,0,0
222293,six,0,0
222294,possible,0,0
222295,combinations,0,0
222296,of,0,0
222297,these,0,0
222298,three,0,0
222299,dosage,0,0
222300,schedules,0,0
222301,were,0,0
222302,used,0,0
222303,in,0,0
222304,the,0,0
222305,patients,0,1
222306,in,0,0
222307,a,0,0
222308,strictly,0,0
222309,randomised,0,0
222310,manner,0,0
222311,",",0,0
222312,and,0,0
222313,all,0,0
222314,patients,0,1
222315,were,0,0
222316,treated,0,1
222317,during,0,0
222318,the,0,0
222319,same,0,0
222320,period,0,0
222321,.,0,0
222322,In,0,0
222323,the,0,0
222324,pre-trial,0,0
222325,period,0,0
222326,(,0,0
222327,treatment,0,0
222328,as,0,0
222329,needed,0,0
222330,),0,0
222331,there,0,0
222332,were,0,0
222333,an,0,0
222334,average,0,0
222335,of,0,0
222336,35,0,1
222337,bleedings,0,0
222338,per,0,0
222339,two,0,0
222340,months,0,0
222341,.,0,1
222342,On,0,0
222343,continual,0,0
222344,treatment,0,0
222345,there,0,0
222346,were,0,0
222347,21,0,1
222348,bleedings,0,0
222349,on,0,0
222350,weekly,0,0
222351,injections,0,0
222352,of,0,0
222353,36,0,1
222354,U,0,0
222355,factor,0,0
222356,VIII,0,0
222357,per,0,0
222358,kg,0,0
222359,",",0,0
222360,14,0,0
222361,on,0,0
222362,twice,0,0
222363,weekly,0,0
222364,18,0,1
222365,U/kg,0,0
222366,and,0,0
222367,none,0,0
222368,on,0,0
222369,12,0,0
222370,U/kg,0,0
222371,",",0,0
222372,three,0,0
222373,times,0,0
222374,weekly,0,0
222375,.,0,0
222376,The,0,0
222377,differences,0,0
222378,are,0,0
222379,statistically,0,0
222380,significant,0,0
222381,.,0,0
222382,The,0,0
222383,absence,0,0
222384,of,0,0
222385,bleeding,0,0
222386,on,0,0
222387,the,0,0
222388,last,0,0
222389,dosage,0,0
222390,schedule,0,0
222391,was,0,0
222392,achieved,0,0
222393,during,0,0
222394,normal,0,1
222395,working,0,1
222396,.,0,0
222397,Days,0,0
222398,lost,0,0
222399,from,0,1
222400,work,0,0
222401,per,0,0
222402,patient,0,0
222403,per,0,0
222404,month,0,0
222405,was,0,0
222406,zero,0,0
222407,on,0,0
222408,three,0,0
222409,times,0,0
222410,12,0,1
222411,U/kg,0,1
222412,",",0,0
222413,0.4,0,0
222414,day,0,0
222415,on,0,0
222416,twice,0,0
222417,18,0,1
222418,U/kg,0,0
222419,and,0,0
222420,once,0,0
222421,36,0,0
222422,U/kg,0,0
222423,",",0,0
222424,while,0,0
222425,it,0,0
222426,had,0,0
222427,been,0,0
222428,five,0,1
222429,days,0,0
222430,in,0,0
222431,the,0,0
222432,pre-trial,0,0
222433,period,0,0
222434,.,0,0
222435,In,0,0
222436,addition,0,0
222437,to,0,0
222438,freedom,0,0
222439,from,0,0
222440,bleeding,0,0
222441,and,0,0
222442,no,0,0
222443,lost,0,0
222444,days,0,0
222445,from,0,0
222446,work,0,0
222447,",",0,0
222448,there,0,0
222449,was,0,0
222450,increased,0,0
222451,mobility,0,0
222452,and,0,0
222453,physical,0,0
222454,capacity,0,0
222455,.,0,0
222456,[,0,0
222457,No,0,0
222458,better,0,0
222459,vigilance,0,0
222460,after,0,0
222461,general,0,1
222462,anesthesia,0,0
222463,with,0,1
222464,propofol,0,0
222465,in,0,0
222466,colonic,0,0
222467,surgery,0,1
222468,.,0,0
222469,A,0,0
222470,comparison,0,0
222471,of,0,0
222472,three,0,0
222473,procedures,0,1
222474,for,0,0
222475,general,0,1
222476,anesthesia,0,0
222477,(,0,0
222478,propofol,0,0
222479,",",0,0
222480,halothane,0,0
222481,and,0,0
222482,midazolam/fentanyl,0,0
222483,),0,0
222484,in,0,0
222485,combination,0,0
222486,with,0,1
222487,catheter,0,0
222488,epidural,0,1
222489,anesthesia,0,1
222490,],0,0
222491,.,0,0
222492,Early,0,0
222493,mental,0,0
222494,and,0,0
222495,psychomotor,0,0
222496,recovery,0,0
222497,was,0,0
222498,studied,1,1
222499,in,1,0
222500,67,1,1
222501,patients,1,1
222502,undergoing,1,1
222503,colorectal,1,1
222504,surgery,1,1
222505,under,1,0
222506,continuous,1,0
222507,epidural,1,1
222508,anaesthesia,1,1
222509,and,1,0
222510,light,1,0
222511,general,1,1
222512,anaesthesia,1,1
222513,using,1,0
222514,propofol,1,0
222515,",",1,0
222516,halothane,1,0
222517,",",1,0
222518,and,1,0
222519,midazolam/fentanyl,1,0
222520,.,1,0
222521,The,0,0
222522,study,0,0
222523,was,0,0
222524,approved,0,0
222525,by,0,0
222526,the,0,0
222527,local,0,0
222528,ethics,0,0
222529,committee,0,1
222530,.,0,0
222531,All,0,0
222532,patients,0,1
222533,received,0,0
222534,epidural,0,1
222535,anaesthesia,0,1
222536,with,0,1
222537,0.25,0,0
222538,%,0,0
222539,bupivacaine,0,0
222540,and,0,0
222541,were,0,0
222542,then,0,0
222543,randomly,0,0
222544,allocated,0,0
222545,to,0,0
222546,one,0,0
222547,of,0,0
222548,three,0,0
222549,groups,0,0
222550,.,0,0
222551,In,0,0
222552,group,0,0
222553,I,0,0
222554,(,0,0
222555,halothane,0,0
222556,),0,0
222557,",",0,0
222558,light,0,0
222559,general,0,1
222560,anaesthesia,0,1
222561,was,0,0
222562,induced,0,0
222563,with,0,1
222564,thiopental,0,0
222565,3-5,0,1
222566,mg/kg,0,0
222567,and,0,0
222568,maintained,0,0
222569,with,0,1
222570,halothane,0,0
222571,.,0,0
222572,The,0,0
222573,propofol,0,0
222574,group,0,0
222575,(,0,0
222576,II,0,0
222577,),0,0
222578,received,0,0
222579,2,0,0
222580,mg/kg,0,0
222581,for,0,0
222582,induction,0,0
222583,and,0,0
222584,a,0,0
222585,mean,0,0
222586,continuous,0,0
222587,infusion,0,0
222588,of,0,0
222589,1.7,0,0
222590,mg/kg.h,0,0
222591,.,0,0
222592,In,0,0
222593,group,0,0
222594,III,0,0
222595,(,0,0
222596,Mi/Fe,0,1
222597,),0,0
222598,",",0,0
222599,midazolam,0,0
222600,and,0,0
222601,fentanyl,0,0
222602,were,0,0
222603,used,0,0
222604,for,0,0
222605,induction,0,0
222606,and,0,0
222607,maintenance,0,0
222608,.,0,0
222609,All,0,0
222610,patients,0,1
222611,were,0,0
222612,intubated,0,0
222613,",",0,0
222614,received,0,0
222615,non-depolarising,0,0
222616,muscle,0,0
222617,relaxants,0,0
222618,",",0,0
222619,and,0,0
222620,were,0,0
222621,manually,0,0
222622,ventilated,0,0
222623,with,0,0
222624,nitrous,0,0
222625,oxide-oxygen,0,0
222626,(,0,0
222627,2:1.2,0,0
222628,),0,0
222629,.,0,0
222630,For,0,0
222631,postoperative,0,0
222632,analgesia,0,0
222633,",",0,0
222634,0.05,0,0
222635,mg/kg,0,0
222636,morphine,0,0
222637,was,0,0
222638,administrated,0,0
222639,epidurally,0,0
222640,30,0,0
222641,min,0,0
222642,before,0,0
222643,the,0,0
222644,end,0,0
222645,of,0,0
222646,the,0,0
222647,operation,0,0
222648,;,0,0
222649,30,0,0
222650,",",0,0
222651,60,0,0
222652,",",0,0
222653,90,0,0
222654,",",0,0
222655,and,0,0
222656,120,0,0
222657,min,0,0
222658,after,0,0
222659,arriving,0,0
222660,in,0,0
222661,the,0,0
222662,recovery,0,0
222663,room,0,0
222664,",",0,0
222665,vigilance,0,0
222666,was,0,0
222667,assessed,0,0
222668,using,0,0
222669,a,0,0
222670,modified,0,0
222671,Steward,0,0
222672,score,0,0
222673,",",0,0
222674,the,0,0
222675,Trieger,0,0
222676,test,0,0
222677,",",0,0
222678,the,0,0
222679,ability,0,0
222680,to,0,0
222681,recall,0,0
222682,a,0,0
222683,column,0,0
222684,of,0,0
222685,numbers,0,0
222686,(,0,0
222687,KAI,0,0
222688,test,0,0
222689,),0,0
222690,",",0,0
222691,and,0,0
222692,symbol,0,0
222693,counting,0,0
222694,(,0,0
222695,CI,0,0
222696,test,0,0
222697,),0,0
222698,.,0,0
222699,Heart,0,0
222700,rate,0,0
222701,",",0,0
222702,blood,0,0
222703,pressure,0,0
222704,",",0,0
222705,arterial,0,0
222706,oxygen,0,0
222707,saturation,0,0
222708,",",0,0
222709,and,0,0
222710,blood,0,0
222711,gases,0,0
222712,were,0,0
222713,recorded,0,0
222714,.,0,0
222715,RESULTS,0,0
222716,.,0,0
222717,The,0,0
222718,three,0,0
222719,groups,0,0
222720,were,0,0
222721,comparable,0,0
222722,with,0,1
222723,regard,0,0
222724,to,0,0
222725,age,0,1
222726,",",0,0
222727,sex,0,0
222728,",",0,0
222729,ASA,0,0
222730,classification,0,0
222731,",",0,0
222732,and,0,0
222733,duration,0,0
222734,of,0,0
222735,anaesthesia,0,0
222736,and,0,0
222737,operation,0,0
222738,(,0,0
222739,Table,0,0
222740,3,0,0
222741,),0,0
222742,.,0,0
222743,There,0,0
222744,was,0,0
222745,no,0,0
222746,difference,0,0
222747,between,0,0
222748,the,0,0
222749,groups,0,0
222750,in,0,0
222751,performance,0,0
222752,of,0,0
222753,the,0,0
222754,recovery,0,0
222755,tests,0,0
222756,(,0,0
222757,Figs,0,0
222758,.,0,0
222759,2-5,0,0
222760,),0,0
222761,",",0,0
222762,blood,0,0
222763,pressure,0,0
222764,",",0,0
222765,heart,0,0
222766,rate,0,0
222767,",",0,0
222768,arterial,0,0
222769,blood,0,0
222770,gas,0,0
222771,analysis,0,0
222772,(,0,0
222773,Fig,0,0
222774,.,0,0
222775,6,0,0
222776,),0,0
222777,",",0,0
222778,or,0,0
222779,oxygen,0,0
222780,saturation,0,0
222781,.,0,0
222782,Comparing,0,0
222783,pre-,0,0
222784,and,0,0
222785,postoperative,0,0
222786,values,0,0
222787,",",0,0
222788,we,0,0
222789,found,0,0
222790,severe,0,1
222791,psychomotor,0,0
222792,and,0,0
222793,mental,0,0
222794,impairment,0,0
222795,in,0,0
222796,all,0,0
222797,groups,0,0
222798,.,0,0
222799,pCO2,0,0
222800,was,0,0
222801,slightly,0,0
222802,elevated,0,0
222803,in,0,0
222804,all,0,0
222805,groups,0,0
222806,",",0,0
222807,but,0,0
222808,only,0,0
222809,3,0,0
222810,patients,0,1
222811,in,0,0
222812,the,0,0
222813,propofol,0,0
222814,group,0,0
222815,and,0,0
222816,6,0,0
222817,in,0,0
222818,the,0,0
222819,midazolam/fentanyl,0,0
222820,group,0,0
222821,developed,0,0
222822,hypercapnia,0,0
222823,above,0,0
222824,50,0,0
222825,mm,0,0
222826,Hg,0,0
222827,.,0,0
222828,Patients,0,1
222829,receiving,0,0
222830,propofol,0,0
222831,or,0,0
222832,midazolam/fentanyl,0,0
222833,had,0,0
222834,significantly,0,0
222835,less,0,0
222836,postoperative,0,0
222837,nausea,0,0
222838,and,0,0
222839,vomiting,0,0
222840,than,0,0
222841,those,0,0
222842,receiving,0,0
222843,halothane,0,0
222844,(,0,0
222845,Table,0,0
222846,5,0,0
222847,),0,0
222848,.,0,0
222849,CONCLUSION,0,0
222850,.,0,0
222851,It,0,0
222852,is,0,0
222853,concluded,0,0
222854,that,0,0
222855,propofol,0,0
222856,offers,0,0
222857,no,0,0
222858,advantage,0,0
222859,over,0,0
222860,halothane,0,0
222861,or,0,0
222862,midazolam/fentanyl,0,0
222863,where,0,0
222864,early,0,0
222865,postoperative,0,0
222866,recovery,0,0
222867,is,0,0
222868,concerned,0,0
222869,.,0,0
222870,Intraoperatively,0,0
222871,",",0,0
222872,all,0,0
222873,three,0,0
222874,techniques,0,0
222875,provided,0,0
222876,good,0,0
222877,anaesthesia,0,1
222878,.,0,0
222879,Propofol,0,0
222880,and,0,0
222881,midazolam/fentanyl,0,0
222882,caused,0,0
222883,less,0,0
222884,postoperative,0,0
222885,nausea,0,0
222886,and,0,0
222887,vomiting,0,0
222888,than,0,0
222889,halothane,0,0
222890,anaesthesia,0,1
222891,.,0,0
222892,Trimetazidine,0,0
222893,:,0,0
222894,a,0,0
222895,new,0,0
222896,concept,0,0
222897,in,0,0
222898,the,0,0
222899,treatment,0,0
222900,of,0,0
222901,angina,0,1
222902,.,0,0
222903,Comparison,0,0
222904,with,0,0
222905,propranolol,0,0
222906,in,0,0
222907,patients,0,1
222908,with,0,1
222909,stable,1,1
222910,angina,1,1
222911,.,1,0
222912,Trimetazidine,0,0
222913,European,0,1
222914,Multicenter,0,1
222915,Study,0,0
222916,Group,0,1
222917,.,0,1
222918,1,0,0
222919,.,0,0
222920,Trimetazidine,0,0
222921,has,0,0
222922,a,0,0
222923,direct,0,0
222924,anti-ischaemic,0,0
222925,effect,0,0
222926,on,0,0
222927,the,0,0
222928,myocardium,0,0
222929,without,0,0
222930,altering,0,0
222931,the,0,0
222932,rate,0,0
222933,x,0,0
222934,pressure,0,0
222935,product,0,0
222936,or,0,0
222937,coronary,0,1
222938,blood,0,0
222939,flow,0,0
222940,.,0,0
222941,2,0,0
222942,.,0,0
222943,The,0,0
222944,effects,0,0
222945,of,0,0
222946,trimetazidine,0,0
222947,(,0,0
222948,20,0,0
222949,mg,0,0
222950,three,0,0
222951,times,0,0
222952,daily,0,0
222953,),0,0
222954,were,0,0
222955,compared,0,0
222956,with,0,0
222957,those,0,0
222958,of,0,0
222959,propranolol,0,0
222960,(,0,0
222961,40,0,0
222962,mg,0,0
222963,three,0,0
222964,times,0,0
222965,daily,0,0
222966,),0,0
222967,in,0,0
222968,a,0,0
222969,double-blind,0,0
222970,parallel,0,0
222971,group,0,0
222972,multicentre,0,0
222973,study,0,0
222974,in,0,0
222975,149,1,1
222976,men,1,1
222977,with,1,1
222978,stable,1,1
222979,angina,1,1
222980,.,1,1
222981,3,0,0
222982,.,0,0
222983,Reproducibility,0,0
222984,of,0,0
222985,exercise,0,0
222986,performance,0,0
222987,was,0,0
222988,verified,0,0
222989,during,0,0
222990,a,0,0
222991,3,0,0
222992,week,0,0
222993,run-in,0,0
222994,placebo,0,0
222995,washout,0,0
222996,period,0,0
222997,.,0,0
222998,All,0,0
222999,patients,0,1
223000,had,0,0
223001,>,0,1
223002,1,0,0
223003,mm,0,0
223004,ST-depression,0,0
223005,on,0,0
223006,exercise,0,0
223007,test,0,0
223008,.,0,0
223009,4,0,0
223010,.,0,0
223011,After,0,0
223012,3,0,0
223013,months,0,0
223014,",",0,0
223015,similar,0,0
223016,anti-anginal,0,0
223017,efficacy,0,0
223018,was,0,0
223019,observed,0,0
223020,between,0,0
223021,the,0,0
223022,trimetazidine,0,0
223023,(,0,0
223024,n,0,1
223025,=,0,0
223026,71,0,1
223027,),0,0
223028,and,0,0
223029,propranolol,0,0
223030,(,0,0
223031,n,0,1
223032,=,0,0
223033,78,0,1
223034,),0,1
223035,groups,0,0
223036,.,0,0
223037,No,0,0
223038,significant,0,0
223039,differences,0,0
223040,were,0,0
223041,observed,0,0
223042,between,0,0
223043,trimetazidine,0,0
223044,and,0,0
223045,propranolol,0,0
223046,as,0,0
223047,regards,0,0
223048,anginal,0,0
223049,attack,0,1
223050,rate,0,0
223051,per,0,0
223052,week,0,0
223053,(,0,0
223054,mean,0,0
223055,difference,0,0
223056,P-TMZ,0,1
223057,:,0,1
223058,2,0,0
223059,;,0,0
223060,95,0,0
223061,%,0,0
223062,CI,0,0
223063,:,0,0
223064,-4.4,0,0
223065,",",0,0
223066,0.5,0,0
223067,),0,0
223068,and,0,0
223069,exercise,0,0
223070,duration,0,0
223071,(,0,0
223072,mean,0,0
223073,difference,0,0
223074,P-TMZ,0,1
223075,:,0,1
223076,0,0,0
223077,s,0,0
223078,;,0,0
223079,95,0,0
223080,%,0,0
223081,CI,0,0
223082,:,0,0
223083,-33,0,0
223084,",",0,0
223085,34,0,1
223086,),0,0
223087,or,0,0
223088,time,0,0
223089,to,0,0
223090,1,0,0
223091,mm,0,0
223092,ST,0,1
223093,segment,0,0
223094,depression,0,1
223095,(,0,0
223096,mean,0,0
223097,difference,0,0
223098,P-TMZ,0,1
223099,:,0,1
223100,13,0,0
223101,s,0,0
223102,;,0,0
223103,95,0,0
223104,%,0,0
223105,CI,0,0
223106,:,0,0
223107,-24,0,0
223108,",",0,0
223109,51,0,1
223110,),0,0
223111,.,0,0
223112,Heart,0,0
223113,rate,0,0
223114,and,0,0
223115,rate,0,0
223116,x,0,0
223117,pressure,0,0
223118,product,0,0
223119,at,0,0
223120,rest,0,0
223121,and,0,0
223122,at,0,0
223123,peak,0,0
223124,exercise,0,0
223125,remained,0,0
223126,unchanged,0,0
223127,in,0,0
223128,the,0,0
223129,trimetazidine,0,0
223130,group,0,0
223131,but,0,0
223132,significantly,0,0
223133,decreased,0,0
223134,with,0,0
223135,propranolol,0,0
223136,(,0,0
223137,P,0,0
223138,<,0,0
223139,0.001,0,0
223140,in,0,0
223141,all,0,0
223142,cases,0,0
223143,),0,0
223144,.,0,0
223145,With,0,0
223146,both,0,0
223147,drugs,0,0
223148,there,0,0
223149,was,0,0
223150,a,0,0
223151,trend,0,0
223152,to,0,0
223153,decreased,0,0
223154,ischaemic,0,1
223155,episodes,0,0
223156,in,0,0
223157,the,0,0
223158,46,0,0
223159,%,0,0
223160,patients,0,1
223161,who,0,1
223162,experienced,0,1
223163,ambulatory,0,1
223164,ischaemia,0,0
223165,on,0,0
223166,Holter,0,0
223167,monitoring,0,0
223168,.,0,0
223169,Six,0,0
223170,patients,0,1
223171,stopped,0,0
223172,trimetazidine,0,0
223173,and,0,0
223174,12,0,0
223175,propranolol,0,0
223176,.,0,0
223177,Of,0,0
223178,these,0,0
223179,",",0,0
223180,five,0,0
223181,in,0,0
223182,each,0,0
223183,group,0,0
223184,were,0,0
223185,withdrawn,0,0
223186,because,0,0
223187,of,0,0
223188,deterioration,0,0
223189,in,0,0
223190,cardiovascular,0,0
223191,status,0,0
223192,.,0,1
223193,5,0,0
223194,.,0,0
223195,The,0,0
223196,results,0,0
223197,suggest,0,0
223198,that,0,0
223199,trimetazidine,0,0
223200,and,0,0
223201,propranolol,0,0
223202,at,0,0
223203,the,0,0
223204,doses,0,0
223205,studied,0,1
223206,have,0,0
223207,similar,0,0
223208,efficacy,0,0
223209,in,0,0
223210,patients,0,1
223211,with,0,1
223212,stable,0,1
223213,angina,0,1
223214,pectoris,0,1
223215,.,0,0
223216,(,0,0
223217,ABSTRACT,0,0
223218,TRUNCATED,0,0
223219,AT,0,0
223220,250,0,0
223221,WORDS,0,0
223222,),0,0
223223,[,0,0
223224,Perioperative,0,0
223225,teicoplanin,0,0
223226,prophylaxis,0,0
223227,in,0,0
223228,patients,1,1
223229,undergoing,1,1
223230,breast,1,1
223231,reconstruction,1,1
223232,with,1,1
223233,the,1,0
223234,abdominal,1,1
223235,wall,1,0
223236,.,1,0
223237,A,0,0
223238,case-control,0,1
223239,study,0,0
223240,],0,0
223241,.,0,0
223242,The,0,0
223243,authors,0,0
223244,report,0,0
223245,the,0,0
223246,results,0,0
223247,of,0,0
223248,a,0,0
223249,randomized,0,0
223250,clinical,0,0
223251,trial,0,0
223252,of,0,0
223253,antibiotic,0,0
223254,prophylaxis,0,0
223255,of,0,0
223256,postoperative,0,0
223257,infection,0,1
223258,following,0,0
223259,breast,1,1
223260,reconstruction,1,1
223261,by,1,0
223262,transposition,1,0
223263,of,1,0
223264,rectus,1,1
223265,abdominis,1,0
223266,myocutaneous,1,1
223267,flap,1,0
223268,(,0,0
223269,TRAMF,0,0
223270,),0,0
223271,.,0,0
223272,The,0,0
223273,aim,0,0
223274,was,0,0
223275,to,0,0
223276,evaluate,0,0
223277,the,0,0
223278,efficacy,0,0
223279,and,0,0
223280,tolerability,0,0
223281,of,0,0
223282,a,0,0
223283,short-term,0,0
223284,parenteral,0,1
223285,prophylaxis,0,0
223286,with,0,1
223287,Teicoplanin,0,0
223288,and,0,0
223289,the,0,0
223290,end-point,0,0
223291,of,0,0
223292,the,0,0
223293,study,0,0
223294,was,0,0
223295,the,0,0
223296,evaluation,0,0
223297,of,0,0
223298,wound,0,0
223299,contamination,0,0
223300,assessed,0,0
223301,by,0,0
223302,means,0,0
223303,of,0,0
223304,microbiologic,0,0
223305,culture,0,0
223306,of,0,0
223307,drainage,0,0
223308,fluid,0,0
223309,.,0,0
223310,From,1,0
223311,October,1,1
223312,1990,1,1
223313,to,1,0
223314,March,1,1
223315,1992,1,1
223316,38,1,1
223317,patients,1,1
223318,were,1,1
223319,recruited,1,1
223320,:,1,1
223321,20,1,0
223322,patients,1,1
223323,in,1,0
223324,the,1,0
223325,antibiotic,1,0
223326,prophylaxis,1,0
223327,arm,1,0
223328,and,1,0
223329,18,1,1
223330,patients,1,1
223331,in,1,0
223332,the,1,0
223333,control,1,0
223334,group,1,0
223335,.,1,0
223336,Analysis,0,0
223337,of,0,0
223338,drainage,0,0
223339,fluids,0,0
223340,showed,0,0
223341,a,0,0
223342,higher,0,0
223343,contamination,0,0
223344,rate,0,0
223345,(,0,0
223346,15/18,0,0
223347,=,0,0
223348,83,0,1
223349,%,0,0
223350,),0,0
223351,in,0,0
223352,the,0,0
223353,control,0,0
223354,group,0,0
223355,as,0,0
223356,compared,0,0
223357,to,0,0
223358,the,0,0
223359,prophylaxis,0,0
223360,arm,0,0
223361,(,0,0
223362,2/20,0,0
223363,=,0,0
223364,10,0,0
223365,%,0,0
223366,),0,0
223367,(,0,0
223368,p,0,0
223369,<,0,0
223370,0.0001,0,0
223371,),0,0
223372,.,0,0
223373,Moreover,0,0
223374,",",0,0
223375,11,0,0
223376,patients,0,1
223377,in,0,0
223378,the,0,0
223379,control,0,0
223380,arm,0,0
223381,suffered,0,0
223382,from,0,0
223383,fever,0,0
223384,>,0,1
223385,37.5,0,0
223386,degrees,0,0
223387,C,0,0
223388,for,0,0
223389,at,0,0
223390,least,0,0
223391,3,0,0
223392,days,0,0
223393,as,0,0
223394,compared,0,0
223395,to,0,0
223396,1,0,0
223397,patient,0,0
223398,in,0,0
223399,the,0,0
223400,antibiotic,0,0
223401,prophylaxis,0,0
223402,group,0,0
223403,;,0,0
223404,the,0,0
223405,postoperative,0,0
223406,stay,0,0
223407,was,0,0
223408,13.3,0,0
223409,+/-,0,0
223410,4.3,0,0
223411,and,0,0
223412,9.0,0,0
223413,+/-,0,0
223414,1.6,0,0
223415,in,0,0
223416,the,0,0
223417,control,0,0
223418,and,0,0
223419,antibiotic,0,0
223420,arm,0,0
223421,respectively,0,0
223422,.,0,0
223423,No,0,0
223424,antibiotic,0,0
223425,related,0,0
223426,side,0,0
223427,effects,0,0
223428,were,0,0
223429,evidenced,0,0
223430,through,0,0
223431,the,0,0
223432,study,0,0
223433,.,0,0
223434,These,0,0
223435,results,0,0
223436,seem,0,0
223437,to,0,0
223438,confirm,0,0
223439,the,0,0
223440,value,0,0
223441,of,0,0
223442,parenteral,0,1
223443,short-term,0,0
223444,antibiotic,0,0
223445,prophylaxis,0,0
223446,of,0,0
223447,postoperative,0,0
223448,infection,0,1
223449,in,0,0
223450,such,0,0
223451,kind,0,1
223452,of,0,0
223453,clean,0,0
223454,operative,0,0
223455,procedure,0,0
223456,.,0,0
223457,Evaluation,0,0
223458,of,0,0
223459,postural,0,0
223460,stability,0,0
223461,by,0,0
223462,computerised,0,0
223463,posturography,0,0
223464,following,0,0
223465,outpatient,1,1
223466,paediatric,1,1
223467,anaesthesia,1,1
223468,.,1,0
223469,Comparison,0,0
223470,of,0,0
223471,propofol/alfentanil/N2O,0,0
223472,anaesthesia,0,1
223473,with,0,1
223474,thiopentone/halothane/N2O,0,0
223475,anaesthesia,0,1
223476,.,0,0
223477,Simple,0,0
223478,clinical,0,0
223479,tests,0,0
223480,",",0,0
223481,like,0,0
223482,Romberg,0,0
223483,'s,0,0
223484,test,0,0
223485,or,0,1
223486,a,0,0
223487,walking,0,0
223488,test,0,0
223489,",",0,0
223490,have,0,0
223491,proved,0,0
223492,to,0,0
223493,be,0,0
223494,inadequate,0,0
223495,guidelines,0,0
223496,for,0,0
223497,safe,0,0
223498,discharge,0,0
223499,after,0,0
223500,outpatient,0,1
223501,anaesthesia,0,1
223502,.,0,0
223503,A,0,0
223504,randomised,0,0
223505,study,0,0
223506,was,0,0
223507,therefore,0,0
223508,planned,0,0
223509,to,0,0
223510,compare,0,0
223511,postural,0,0
223512,stability,0,0
223513,measured,0,0
223514,by,0,0
223515,computerised,0,0
223516,posturography,0,0
223517,in,0,0
223518,31,1,1
223519,oral,1,0
223520,midazolam-atropine,1,1
223521,premedicated,1,1
223522,children,1,1
223523,aged,1,1
223524,6.9,1,0
223525,(,1,0
223526,s.e,1,0
223527,.,1,0
223528,0.4,1,0
223529,),1,1
223530,years,1,1
223531,who,1,1
223532,had,1,1
223533,been,1,1
223534,anaesthetised,1,1
223535,with,1,0
223536,either,1,0
223537,propofol/alfentanil/N2O,1,0
223538,or,1,0
223539,thiopentone/halothane/N2O,1,0
223540,.,1,0
223541,The,0,0
223542,sway,0,0
223543,velocity,0,0
223544,of,0,0
223545,the,0,0
223546,children,0,1
223547,was,0,0
223548,measured,0,0
223549,before,0,0
223550,premedication,0,0
223551,and,0,0
223552,1,0,0
223553,",",0,0
223554,2,0,0
223555,and,0,0
223556,3,0,0
223557,h,0,0
223558,after,0,0
223559,the,0,0
223560,end,0,0
223561,of,0,0
223562,anaesthesia,0,1
223563,.,0,0
223564,Results,0,0
223565,show,0,0
223566,that,0,0
223567,sway,0,0
223568,velocity,0,0
223569,had,0,0
223570,returned,0,0
223571,to,0,0
223572,baseline,0,0
223573,values,0,0
223574,3,0,0
223575,h,0,0
223576,after,0,0
223577,the,0,0
223578,end,0,0
223579,of,0,0
223580,anaesthesia,0,0
223581,in,0,0
223582,all,0,1
223583,children,0,1
223584,who,0,1
223585,had,0,1
223586,received,0,1
223587,propofol/alfentanil/N2O,0,0
223588,and,0,0
223589,in,0,0
223590,12,0,0
223591,of,0,0
223592,the,0,0
223593,15,0,1
223594,children,0,1
223595,who,0,1
223596,had,0,1
223597,received,0,1
223598,thiopentone/halothane/N2O,0,0
223599,.,0,0
223600,The,0,0
223601,quantified,0,0
223602,version,0,0
223603,of,0,0
223604,the,0,0
223605,Romberg,0,0
223606,test,0,0
223607,performed,0,0
223608,with,0,1
223609,eyes,0,1
223610,open,0,1
223611,or,0,0
223612,closed,0,0
223613,was,0,0
223614,not,0,0
223615,impaired,0,0
223616,after,0,0
223617,anaesthesia,0,0
223618,",",0,0
223619,compared,0,0
223620,with,0,0
223621,the,0,0
223622,control,0,0
223623,values,0,0
223624,",",0,0
223625,indicating,0,0
223626,that,0,0
223627,in,0,0
223628,children,0,1
223629,poor,0,1
223630,equilibrium,0,0
223631,is,0,0
223632,not,0,0
223633,compensated,0,0
223634,by,0,0
223635,vision,0,0
223636,.,0,0
223637,The,0,0
223638,clinical,0,0
223639,recovery,0,0
223640,with,0,1
223641,respect,0,0
223642,to,0,0
223643,the,0,0
223644,times,0,0
223645,to,0,0
223646,eye,0,0
223647,opening,0,0
223648,",",0,0
223649,to,0,0
223650,responding,0,0
223651,to,0,0
223652,command,0,0
223653,or,0,0
223654,to,0,0
223655,being,0,0
223656,fully,0,0
223657,awake,0,0
223658,did,0,0
223659,not,0,0
223660,differ,0,0
223661,between,0,0
223662,the,0,0
223663,two,0,0
223664,anaesthesia,0,1
223665,methods,0,1
223666,.,0,0
223667,On,0,0
223668,the,0,0
223669,basis,0,0
223670,of,0,0
223671,recovery,0,0
223672,assessed,0,0
223673,by,0,0
223674,postural,0,0
223675,stability,0,0
223676,",",0,0
223677,propofol/alfentanil/N2O,0,0
223678,anaesthesia,0,0
223679,was,0,0
223680,not,0,0
223681,preferable,0,0
223682,to,0,0
223683,thiopentone/halothane/N2O,0,0
223684,anaesthesia,0,0
223685,after,0,0
223686,minor,0,0
223687,paediatric,0,1
223688,otolaryngological,0,1
223689,surgery,0,1
223690,.,0,0
223691,A,0,0
223692,double-blind,0,0
223693,comparison,0,0
223694,of,0,0
223695,oral,0,0
223696,ketoprofen,0,0
223697,'controlled,0,0
223698,release,0,0
223699,',0,0
223700,and,0,0
223701,indomethacin,0,0
223702,suppository,0,0
223703,in,0,0
223704,the,0,0
223705,treatment,0,0
223706,of,0,0
223707,rheumatoid,1,1
223708,arthritis,1,1
223709,with,1,1
223710,special,1,0
223711,regard,1,0
223712,to,1,0
223713,morning,1,0
223714,stiffness,1,0
223715,and,1,0
223716,pain,1,0
223717,on,1,0
223718,awakening,1,0
223719,.,1,0
223720,A,0,0
223721,double-blind,0,0
223722,",",0,0
223723,double-dummy,0,0
223724,",",0,0
223725,crossover,0,0
223726,study,0,0
223727,was,0,0
223728,carried,0,0
223729,out,0,0
223730,in,0,0
223731,8,1,0
223732,centres,1,1
223733,to,0,0
223734,compare,0,0
223735,the,0,0
223736,efficacy,0,0
223737,and,0,0
223738,tolerability,0,0
223739,of,0,0
223740,'controlled-release,0,0
223741,',0,1
223742,ketoprofen,0,0
223743,tablets,0,0
223744,(,0,0
223745,200,0,0
223746,mg,0,0
223747,),0,0
223748,with,0,0
223749,that,0,0
223750,of,0,0
223751,indomethacin,0,0
223752,suppositories,0,0
223753,(,0,0
223754,100,0,0
223755,mg,0,0
223756,),0,0
223757,in,0,0
223758,out-patients,1,1
223759,with,1,1
223760,definite,1,0
223761,or,1,0
223762,classical,1,0
223763,rheumatoid,1,1
223764,arthritis,1,1
223765,.,1,0
223766,Patients,0,1
223767,were,0,0
223768,allocated,0,0
223769,at,0,0
223770,random,0,0
223771,to,0,0
223772,receive,0,0
223773,a,0,0
223774,daily,0,0
223775,bedtime,0,0
223776,dose,0,0
223777,of,0,0
223778,either,0,0
223779,1,0,0
223780,ketoprofen,0,0
223781,tablet,0,0
223782,or,0,0
223783,1,0,0
223784,indomethacin,0,0
223785,suppository,0,0
223786,plus,0,0
223787,the,0,0
223788,dummy,0,0
223789,of,0,0
223790,the,0,0
223791,other,0,0
223792,formulation,0,0
223793,for,0,0
223794,a,0,0
223795,period,0,0
223796,of,0,0
223797,3,0,0
223798,weeks,0,0
223799,.,0,1
223800,They,0,0
223801,were,0,0
223802,then,0,0
223803,crossed,0,0
223804,over,0,0
223805,to,0,0
223806,the,0,0
223807,alternative,0,0
223808,treatment,0,0
223809,for,0,0
223810,a,0,0
223811,further,0,0
223812,3,0,0
223813,weeks,0,0
223814,.,0,1
223815,Daily,0,0
223816,diary,0,0
223817,records,0,1
223818,were,0,0
223819,kept,0,0
223820,by,0,0
223821,patients,0,1
223822,of,0,0
223823,the,0,0
223824,number,0,0
223825,of,0,0
223826,night-time,0,0
223827,awakenings,0,0
223828,due,0,0
223829,to,0,0
223830,pain,0,0
223831,",",0,0
223832,pain,0,0
223833,severity,0,0
223834,at,0,0
223835,awakening,0,0
223836,in,0,0
223837,the,0,0
223838,morning,0,0
223839,and,0,0
223840,the,0,0
223841,duration,0,0
223842,of,0,0
223843,early,0,0
223844,morning,0,0
223845,stiffness,0,0
223846,.,0,0
223847,Treatment,0,0
223848,efficacy,0,0
223849,was,0,0
223850,also,0,0
223851,assessed,0,0
223852,at,0,0
223853,the,0,0
223854,end,0,0
223855,of,0,0
223856,each,0,0
223857,trial,0,0
223858,period,0,0
223859,by,0,0
223860,means,0,0
223861,of,0,0
223862,an,0,0
223863,articular,0,1
223864,index,0,0
223865,and,0,0
223866,by,0,0
223867,physician,0,0
223868,'s,0,0
223869,and,0,0
223870,patient,0,0
223871,'s,0,0
223872,overall,0,0
223873,evaluation,0,0
223874,of,0,0
223875,response,0,0
223876,.,0,0
223877,Adverse,0,0
223878,effects,0,0
223879,spontaneously,0,1
223880,mentioned,0,0
223881,by,0,0
223882,the,0,0
223883,patients,0,1
223884,or,0,0
223885,elicited,0,0
223886,by,0,0
223887,direct,0,0
223888,questioning,0,0
223889,using,0,0
223890,a,0,0
223891,symptom,0,0
223892,check-list,0,0
223893,were,0,0
223894,recorded,0,0
223895,.,0,0
223896,Statistical,0,0
223897,analysis,0,0
223898,of,0,0
223899,the,0,0
223900,results,0,0
223901,from,0,0
223902,83,1,1
223903,evaluable,1,1
223904,patients,1,1
223905,showed,0,0
223906,that,0,0
223907,the,0,0
223908,'controlled-release,0,0
223909,',0,0
223910,tablet,0,0
223911,formulation,0,0
223912,of,0,0
223913,200,0,0
223914,mg,0,0
223915,ketoprofen,0,0
223916,was,0,0
223917,equally,0,0
223918,as,0,0
223919,effective,0,0
223920,as,0,0
223921,the,0,0
223922,100,0,0
223923,mg,0,0
223924,indomethacin,0,0
223925,suppository,0,0
223926,in,0,0
223927,the,0,0
223928,treatment,0,0
223929,of,0,0
223930,rheumatoid,0,1
223931,arthritis,0,1
223932,",",0,0
223933,especially,0,0
223934,with,0,0
223935,regard,0,0
223936,to,0,0
223937,pain,0,0
223938,at,0,0
223939,awakening,0,0
223940,and,0,0
223941,morning,0,0
223942,stiffness,0,0
223943,.,0,0
223944,Side-effects,0,0
223945,in,0,0
223946,both,0,0
223947,groups,0,0
223948,were,0,0
223949,those,0,1
223950,commonly,0,0
223951,seen,0,0
223952,with,0,1
223953,non-steroidal,0,0
223954,anti-inflammatory,0,0
223955,drugs,0,0
223956,and,0,0
223957,",",0,0
223958,as,0,0
223959,expected,0,0
223960,",",0,0
223961,gastro-intestinal,0,1
223962,and,0,0
223963,CNS,0,0
223964,disturbances,0,0
223965,predominated,0,0
223966,.,0,0
223967,Overall,0,0
223968,",",0,0
223969,side-effects,0,0
223970,were,0,0
223971,fewer,0,0
223972,with,0,0
223973,ketoprofen,0,0
223974,than,0,0
223975,with,0,1
223976,indomethacin,0,0
223977,.,0,1
223978,Femoral,0,0
223979,vein,0,0
223980,delivery,0,0
223981,of,0,0
223982,contrast,0,0
223983,medium,0,0
223984,enhances,0,0
223985,transthoracic,0,0
223986,echocardiographic,0,0
223987,detection,0,0
223988,of,0,0
223989,patent,0,0
223990,foramen,0,1
223991,ovale,0,1
223992,.,0,0
223993,OBJECTIVES,0,0
223994,We,0,0
223995,postulated,0,0
223996,that,0,0
223997,femoral,0,0
223998,vein,0,0
223999,delivery,0,0
224000,of,0,0
224001,contrast,0,0
224002,medium,0,0
224003,because,0,0
224004,of,0,0
224005,streaming,0,0
224006,",",0,0
224007,might,0,0
224008,enhance,0,0
224009,precordial,0,0
224010,echocardiographic,0,0
224011,detection,0,0
224012,of,0,0
224013,patent,0,0
224014,foramen,0,1
224015,ovale,0,1
224016,.,0,0
224017,BACKGROUND,0,0
224018,Although,0,0
224019,precordial,0,0
224020,contrast,0,0
224021,echocardiography,0,0
224022,is,0,0
224023,widely,0,0
224024,used,0,0
224025,to,0,0
224026,diagnose,0,0
224027,patent,0,0
224028,foramen,0,0
224029,ovale,0,1
224030,",",0,0
224031,this,0,0
224032,method,0,0
224033,is,0,0
224034,limited,0,0
224035,by,0,0
224036,poor,0,1
224037,sensitivity,0,0
224038,.,0,0
224039,Previous,0,0
224040,investigators,0,0
224041,have,0,0
224042,demonstrated,0,0
224043,enhanced,0,0
224044,detection,0,0
224045,of,0,0
224046,atrial,0,1
224047,defects,0,0
224048,by,0,0
224049,the,0,0
224050,dye-dilution,0,0
224051,technique,0,0
224052,after,0,0
224053,delivery,0,0
224054,of,0,0
224055,contrast,0,0
224056,medium,0,0
224057,into,0,0
224058,the,0,0
224059,inferior,0,0
224060,rather,0,0
224061,than,0,0
224062,the,0,0
224063,superior,0,0
224064,vena,0,0
224065,cava,0,0
224066,.,0,0
224067,METHODS,0,0
224068,Transthoracic,0,1
224069,contrast,0,0
224070,examinations,0,0
224071,were,0,0
224072,performed,0,0
224073,in,0,0
224074,a,0,0
224075,randomly,0,0
224076,selected,0,0
224077,group,0,0
224078,of,0,0
224079,70,1,1
224080,patients,1,1
224081,(,1,0
224082,without,1,1
224083,previous,1,0
224084,history,1,1
224085,of,1,0
224086,cerebral,1,1
224087,or,1,0
224088,systemic,1,0
224089,embolus,1,1
224090,),1,0
224091,undergoing,1,1
224092,cardiac,1,0
224093,catheterization,1,1
224094,.,1,0
224095,Paired,0,0
224096,contrast,0,0
224097,agent,0,0
224098,injections,0,0
224099,(,0,0
224100,10,0,0
224101,ml,0,0
224102,dextrose,0,0
224103,in,0,0
224104,water/0.25,0,0
224105,ml,0,0
224106,air,0,0
224107,),0,0
224108,were,0,0
224109,administered,0,0
224110,from,0,0
224111,an,0,0
224112,upper,0,0
224113,extremity,0,0
224114,vein,0,0
224115,and,0,0
224116,femoral,0,0
224117,vein,0,0
224118,in,0,0
224119,each,0,0
224120,patient,0,0
224121,during,0,0
224122,spontaneous,0,0
224123,respiration,0,0
224124,",",0,0
224125,cough,0,0
224126,and,0,0
224127,Valsalva,0,0
224128,maneuvers,0,0
224129,.,0,1
224130,Studies,0,0
224131,were,0,0
224132,interpreted,0,0
224133,by,0,0
224134,an,0,0
224135,experienced,0,0
224136,echocardiographer,0,0
224137,unaware,0,0
224138,of,0,0
224139,the,0,0
224140,sequence,0,0
224141,and,0,0
224142,site,0,0
224143,of,0,0
224144,injections,0,0
224145,.,0,1
224146,Positive,0,0
224147,studies,0,0
224148,were,0,0
224149,semiquantitatively,0,0
224150,graded,0,0
224151,from,0,0
224152,+1,0,0
224153,(,0,0
224154,minimal,0,0
224155,left,0,1
224156,ventricular,0,0
224157,opacification,0,0
224158,),0,0
224159,to,0,0
224160,+4,0,0
224161,(,0,0
224162,intense,0,0
224163,left,0,1
224164,ventricular,0,0
224165,opacification,0,0
224166,),0,0
224167,.,0,0
224168,Catheterization,0,0
224169,and,0,0
224170,echocardiographic,0,0
224171,assessment,0,0
224172,of,0,0
224173,patent,0,0
224174,foramen,0,1
224175,ovale,0,1
224176,were,0,0
224177,compared,0,0
224178,in,0,0
224179,21,0,1
224180,subjects,0,1
224181,.,0,1
224182,RESULTS,0,0
224183,Patent,0,1
224184,foramen,0,0
224185,ovale,0,1
224186,was,0,0
224187,detected,0,0
224188,significantly,0,0
224189,more,0,0
224190,often,0,0
224191,during,0,0
224192,femoral,0,0
224193,vein,0,1
224194,versus,0,0
224195,upper,0,0
224196,extremity,0,0
224197,contrast,0,0
224198,delivery,0,0
224199,(,0,0
224200,23,0,1
224201,of,0,0
224202,70,0,1
224203,patients,0,1
224204,[,0,0
224205,prevalence,0,1
224206,33,0,1
224207,%,0,0
224208,],0,0
224209,vs.,0,0
224210,9,0,0
224211,of,0,0
224212,70,0,1
224213,patients,0,1
224214,[,0,0
224215,prevalence,0,1
224216,13,0,0
224217,%,0,0
224218,],0,0
224219,",",0,0
224220,p,0,0
224221,<,0,0
224222,0.001,0,0
224223,),0,0
224224,.,0,0
224225,The,0,0
224226,intensity,0,0
224227,of,0,0
224228,left,0,1
224229,ventricular,0,1
224230,opacification,0,0
224231,was,0,0
224232,also,0,0
224233,greater,0,0
224234,during,0,0
224235,femoral,0,0
224236,vein,0,0
224237,contrast,0,0
224238,injection,0,0
224239,.,0,0
224240,Precordial,0,0
224241,echocardiography,0,0
224242,combined,0,0
224243,with,0,0
224244,femoral,0,0
224245,contrast,0,0
224246,delivery,0,0
224247,was,0,0
224248,significantly,0,0
224249,more,0,0
224250,sensitive,0,0
224251,than,0,0
224252,cardiac,0,0
224253,catheterization,0,1
224254,for,0,0
224255,assessment,0,0
224256,of,0,0
224257,patent,0,0
224258,foramen,0,0
224259,ovale,0,1
224260,(,0,0
224261,8,0,0
224262,of,0,0
224263,21,0,1
224264,patients,0,1
224265,vs.,0,0
224266,2,0,0
224267,of,0,0
224268,21,0,1
224269,patients,0,1
224270,",",0,0
224271,p,0,0
224272,<,0,0
224273,0.05,0,0
224274,),0,0
224275,.,0,0
224276,CONCLUSIONS,0,0
224277,Femoral,0,0
224278,vein,0,0
224279,contrast,0,0
224280,delivery,0,0
224281,significantly,0,0
224282,enhances,0,0
224283,the,0,0
224284,ability,0,0
224285,of,0,0
224286,precordial,0,0
224287,contrast,0,0
224288,echocardiography,0,0
224289,to,0,0
224290,diagnose,0,0
224291,patent,0,0
224292,foramen,0,0
224293,ovale,0,1
224294,.,0,0
224295,Physiologic,0,0
224296,patency,0,0
224297,of,0,0
224298,the,0,0
224299,foramen,0,0
224300,ovale,0,0
224301,is,0,0
224302,more,0,0
224303,common,0,0
224304,(,0,0
224305,prevalence,0,1
224306,33,0,1
224307,%,0,0
224308,),0,0
224309,than,0,0
224310,previously,0,0
224311,documented,0,0
224312,.,0,0
224313,Comparison,0,0
224314,of,0,0
224315,outcome,0,0
224316,of,0,0
224317,labetalol,1,0
224318,or,1,0
224319,hydralazine,1,0
224320,therapy,1,0
224321,during,1,0
224322,hypertension,1,1
224323,in,1,0
224324,pregnancy,1,1
224325,in,1,0
224326,very,1,0
224327,low,1,0
224328,birth,1,1
224329,weight,1,1
224330,infants,1,1
224331,.,1,1
224332,Ninety-seven,1,1
224333,women,1,1
224334,with,1,1
224335,moderate,1,1
224336,to,1,0
224337,severe,1,1
224338,preeclampsia,1,1
224339,(,1,0
224340,PE,1,1
224341,),1,0
224342,were,0,0
224343,allocated,0,0
224344,at,0,0
224345,random,0,0
224346,to,0,0
224347,labetalol,0,0
224348,or,0,0
224349,hydralazine,0,0
224350,treatment,0,0
224351,.,0,0
224352,Of,0,0
224353,these,0,0
224354,",",0,0
224355,22,1,0
224356,women,1,1
224357,with,1,1
224358,severe,1,1
224359,PE,1,1
224360,gave,1,0
224361,birth,1,1
224362,to,1,0
224363,neonates,1,1
224364,with,1,1
224365,VLBW,1,1
224366,(,1,0
224367,very,1,0
224368,low,1,0
224369,birth,1,1
224370,weight,1,0
224371,<,1,0
224372,or,1,0
224373,=,1,0
224374,1500,1,0
224375,g,1,0
224376,),1,0
224377,.,1,0
224378,Seven,1,0
224379,were,1,0
224380,allocated,1,0
224381,to,1,0
224382,labetalol,1,0
224383,treatment,1,0
224384,(,1,0
224385,Group,1,0
224386,A,1,0
224387,),1,0
224388,",",1,0
224389,eight,1,0
224390,to,1,0
224391,hydralazine,1,0
224392,treatment,1,0
224393,(,1,0
224394,Group,1,0
224395,B,1,0
224396,),1,0
224397,and,0,0
224398,seven,1,1
224399,women,1,1
224400,received,1,0
224401,both,1,0
224402,drugs,1,0
224403,due,1,0
224404,to,1,0
224405,poor,1,1
224406,blood,1,0
224407,pressure,1,0
224408,control,1,0
224409,with,1,0
224410,a,1,0
224411,single,1,0
224412,drug,1,0
224413,therapy,1,0
224414,(,0,0
224415,Group,0,0
224416,C,0,0
224417,),0,0
224418,.,0,0
224419,No,0,0
224420,difference,0,0
224421,in,0,0
224422,cesarean,0,1
224423,section,0,0
224424,rate,0,0
224425,or,0,0
224426,in,0,0
224427,the,0,0
224428,indication,0,0
224429,for,0,0
224430,operative,0,0
224431,delivery,0,0
224432,could,0,0
224433,be,0,0
224434,seen,0,0
224435,.,0,0
224436,Gestational,1,0
224437,age,1,1
224438,was,1,0
224439,29.9,1,0
224440,weeks,1,0
224441,(,1,0
224442,25.4-32.5,1,0
224443,),1,0
224444,in,0,0
224445,Group,0,0
224446,A,0,0
224447,",",0,0
224448,28.6,1,0
224449,weeks,1,0
224450,(,1,0
224451,26.6-33.4,1,0
224452,),1,0
224453,in,0,0
224454,Group,0,0
224455,B,0,0
224456,and,0,0
224457,27.3,1,0
224458,weeks,1,0
224459,(,1,0
224460,26.7-31.1,1,0
224461,),1,0
224462,in,0,0
224463,Group,0,0
224464,C,0,0
224465,(,0,0
224466,median,0,0
224467,and,0,0
224468,range,0,0
224469,),0,0
224470,.,0,0
224471,Birth,0,0
224472,weight,0,0
224473,did,0,0
224474,not,0,0
224475,differ,0,0
224476,between,0,0
224477,groups,0,0
224478,and,0,0
224479,13,1,0
224480,of,1,0
224481,the,1,0
224482,22,1,1
224483,infants,1,1
224484,weighed,1,0
224485,below,1,0
224486,1000,1,0
224487,g.,1,0
224488,There,0,0
224489,was,0,0
224490,a,0,0
224491,tendency,0,0
224492,to,0,0
224493,lower,0,0
224494,Apgar,0,0
224495,scores,0,0
224496,at,0,0
224497,five,0,1
224498,minutes,0,0
224499,in,0,0
224500,the,0,0
224501,hydralazine,0,0
224502,group,0,0
224503,.,0,0
224504,Time,0,0
224505,spent,0,0
224506,in,0,0
224507,the,0,0
224508,neonatal,0,0
224509,intensive,0,0
224510,care,0,0
224511,unit,0,0
224512,did,0,0
224513,not,0,0
224514,differ,0,0
224515,between,0,0
224516,groups,0,0
224517,.,0,1
224518,Five,0,0
224519,of,0,0
224520,the,0,0
224521,11,0,0
224522,neonates,1,1
224523,with,0,1
224524,gestational,0,1
224525,age,0,1
224526,(,0,0
224527,GA,0,0
224528,),0,0
224529,<,0,0
224530,or,0,0
224531,=,0,0
224532,28,0,0
224533,weeks,0,0
224534,and,0,0
224535,three,0,0
224536,of,0,0
224537,the,0,0
224538,seven,0,0
224539,neonates,1,1
224540,in,0,0
224541,GA,0,1
224542,29-30,0,1
224543,weeks,0,0
224544,died,0,1
224545,.,0,0
224546,Neither,0,0
224547,the,0,0
224548,number,0,0
224549,of,0,0
224550,infants,1,1
224551,requiring,0,1
224552,intermittent,0,1
224553,positive,0,0
224554,pressure,0,0
224555,ventilation,0,0
224556,or,0,0
224557,duration,0,0
224558,of,0,0
224559,O2-,0,0
224560,treatment,0,0
224561,",",0,0
224562,nor,0,0
224563,number,0,0
224564,of,0,0
224565,infants,0,1
224566,with,0,1
224567,respiratory,0,0
224568,distress,0,1
224569,syndrome,0,1
224570,differed,0,0
224571,between,0,0
224572,groups,0,0
224573,.,0,1
224574,We,0,0
224575,did,0,0
224576,not,0,0
224577,find,0,0
224578,any,0,0
224579,difference,0,0
224580,in,0,0
224581,the,0,0
224582,outcome,0,0
224583,of,0,0
224584,the,0,0
224585,VLBW,1,1
224586,infants,1,1
224587,when,1,0
224588,the,1,0
224589,hypertensive,1,0
224590,mother,1,0
224591,had,1,0
224592,been,1,0
224593,treated,1,0
224594,with,1,0
224595,either,1,0
224596,hydralazine,1,0
224597,or,1,0
224598,labetalol,1,0
224599,.,1,0
224600,[,0,0
224601,Opiate,0,0
224602,hypothesis,0,0
224603,in,0,0
224604,infantile,1,1
224605,autism,1,1
224606,?,0,0
224607,Therapeutic,0,0
224608,trials,0,0
224609,with,0,1
224610,naltrexone,0,0
224611,],0,0
224612,.,0,0
224613,The,0,0
224614,opioid,0,0
224615,hypothesis,0,0
224616,suggests,0,0
224617,that,0,0
224618,childhood,0,0
224619,autism,0,1
224620,may,0,0
224621,result,0,0
224622,from,0,0
224623,excessive,0,0
224624,brain,0,0
224625,opioid,0,0
224626,activity,0,0
224627,during,0,0
224628,neonatal,0,0
224629,period,0,0
224630,which,0,0
224631,may,0,0
224632,constitutionally,0,0
224633,inhibit,0,0
224634,social,0,0
224635,motivation,0,0
224636,",",0,0
224637,yielding,0,0
224638,autistic,0,1
224639,isolation,0,0
224640,and,0,0
224641,aloofness,0,0
224642,(,0,0
224643,Panksepp,0,0
224644,",",0,0
224645,1979,0,1
224646,),0,0
224647,.,0,0
224648,This,0,0
224649,hypothesis,0,0
224650,has,0,0
224651,now,0,0
224652,received,0,0
224653,strong,0,0
224654,support,0,0
224655,and,0,0
224656,is,0,0
224657,currently,0,0
224658,based,0,0
224659,on,0,0
224660,three,0,0
224661,types,0,0
224662,of,0,1
224663,arguments,0,0
224664,:,0,1
224665,(,0,0
224666,1,0,0
224667,),0,0
224668,similarity,0,0
224669,between,0,0
224670,autistic,0,1
224671,symptomatology,0,0
224672,and,0,0
224673,abnormal,0,0
224674,behaviors,0,0
224675,induced,0,0
224676,in,0,0
224677,young,0,1
224678,animals,0,0
224679,by,0,0
224680,injections,0,0
224681,of,0,0
224682,exogenous,0,0
224683,opioids,0,0
224684,",",0,0
224685,such,0,0
224686,as,0,0
224687,increasing,0,0
224688,social,0,0
224689,aloofness,0,0
224690,and,0,0
224691,decreasing,0,0
224692,social,0,0
224693,vocalization,0,0
224694,;,0,0
224695,(,0,0
224696,2,0,0
224697,),0,0
224698,direct,0,0
224699,biochemical,0,0
224700,evidence,0,0
224701,of,0,0
224702,abnormalities,0,0
224703,of,0,0
224704,peripheral,0,1
224705,endogenous,0,0
224706,opioids,0,0
224707,being,0,0
224708,reported,0,0
224709,in,0,0
224710,autism,0,1
224711,and,0,0
224712,(,0,0
224713,3,0,0
224714,),0,0
224715,therapeutic,0,0
224716,effects,0,0
224717,of,0,0
224718,the,0,0
224719,long,0,0
224720,lasting,0,0
224721,opioid,0,0
224722,receptor,0,0
224723,blocking,0,0
224724,agent,0,0
224725,naltrexone,0,0
224726,in,0,0
224727,autism,0,1
224728,.,0,0
224729,In,0,0
224730,this,0,0
224731,article,0,0
224732,",",0,0
224733,we,0,0
224734,give,0,0
224735,description,0,0
224736,of,0,0
224737,open,0,0
224738,and,0,0
224739,double-blind,0,0
224740,studies,0,0
224741,of,0,0
224742,naltrexone,0,0
224743,in,0,0
224744,autism,0,1
224745,.,0,0
224746,Naltrexone,0,0
224747,has,0,0
224748,been,0,0
224749,tested,0,0
224750,in,0,0
224751,several,0,0
224752,open,0,1
224753,studies,0,0
224754,.,0,1
224755,We,0,0
224756,performed,0,0
224757,an,0,0
224758,open,0,0
224759,trial,0,0
224760,with,0,1
224761,naltrexone,0,0
224762,in,0,0
224763,2,1,0
224764,autistic,1,1
224765,girls,1,1
224766,",",1,0
224767,displaying,1,0
224768,serious,1,0
224769,self-injurious,1,0
224770,behavior,1,0
224771,",",1,0
224772,reduced,1,0
224773,crying,1,0
224774,and,1,0
224775,a,1,0
224776,marked,1,0
224777,preference,1,0
224778,for,1,0
224779,salty,1,0
224780,and,1,0
224781,spicy,1,0
224782,foods,1,0
224783,",",1,0
224784,symptoms,1,0
224785,that,1,0
224786,could,1,0
224787,be,1,0
224788,related,1,0
224789,to,1,0
224790,a,1,0
224791,dysfunction,1,0
224792,of,1,0
224793,the,1,0
224794,opioid,1,0
224795,system,1,0
224796,.,1,0
224797,With,0,0
224798,dosages,0,0
224799,of,0,0
224800,1,0,0
224801,mg/kg/day,0,0
224802,",",0,0
224803,we,0,0
224804,observed,0,0
224805,an,0,0
224806,immediate,0,0
224807,reduction,0,0
224808,of,0,0
224809,hyperactivity,0,0
224810,",",0,0
224811,self-injurious,0,0
224812,behavior,0,0
224813,and,0,0
224814,aggressiveness,0,0
224815,",",0,0
224816,while,0,0
224817,attention,0,0
224818,improved,0,0
224819,.,0,0
224820,In,0,0
224821,addition,0,0
224822,",",0,0
224823,social,0,0
224824,behaviors,0,0
224825,",",0,0
224826,smiling,0,0
224827,",",0,0
224828,social,0,0
224829,seeking,0,0
224830,behaviors,0,0
224831,and,0,0
224832,play,0,0
224833,interactions,0,0
224834,increased,0,0
224835,(,0,0
224836,Leboyer,0,0
224837,",",0,0
224838,Bouvard,0,0
224839,et,0,1
224840,Dugas,0,0
224841,",",0,0
224842,1988,0,1
224843,),0,0
224844,.,0,0
224845,Campbell,0,0
224846,et,0,1
224847,al,0,1
224848,.,0,0
224849,(,0,0
224850,1988,0,1
224851,),0,0
224852,has,0,0
224853,also,0,0
224854,reported,0,0
224855,a,0,0
224856,tranquilizing,0,0
224857,and,0,0
224858,a,0,0
224859,stimulating,0,0
224860,effect,0,0
224861,in,0,0
224862,6,0,0
224863,out,0,0
224864,of,0,0
224865,8,0,0
224866,children,0,1
224867,with,0,1
224868,autism,0,1
224869,.,0,0
224870,We,0,0
224871,did,0,0
224872,confirm,0,0
224873,these,0,0
224874,preliminary,0,0
224875,results,0,0
224876,in,0,0
224877,a,0,0
224878,double-blind,0,0
224879,study,0,0
224880,performed,0,0
224881,on,0,0
224882,4,1,0
224883,children,1,1
224884,with,1,1
224885,autism,1,1
224886,.,1,0
224887,In,0,0
224888,a,0,0
224889,cross-over,0,0
224890,double-blind,0,0
224891,study,0,0
224892,",",0,0
224893,three,0,0
224894,dosages,0,0
224895,of,0,0
224896,naltrexone,0,0
224897,(,0,0
224898,0.5,0,0
224899,",",0,0
224900,1,0,0
224901,and,0,0
224902,2,0,0
224903,mg/kg/day,0,0
224904,),0,0
224905,and,0,0
224906,placebo,0,0
224907,were,0,0
224908,compared,0,0
224909,.,0,0
224910,(,0,0
224911,ABSTRACT,0,0
224912,TRUNCATED,0,0
224913,AT,0,0
224914,250,0,0
224915,WORDS,0,0
224916,),0,0
224917,Altered,0,0
224918,peripheral,0,0
224919,vasodilator,0,0
224920,profile,0,0
224921,of,0,0
224922,nitroglycerin,0,0
224923,during,0,0
224924,long-term,0,0
224925,infusion,0,0
224926,of,0,0
224927,N-acetylcysteine,0,0
224928,.,0,0
224929,OBJECTIVES,0,0
224930,The,0,0
224931,aim,0,0
224932,of,0,0
224933,this,0,0
224934,study,0,0
224935,was,0,0
224936,to,0,0
224937,compare,0,0
224938,the,0,0
224939,short-,0,0
224940,and,0,0
224941,long-term,0,0
224942,effects,0,0
224943,of,0,0
224944,intravenous,0,0
224945,nitroglycerin,0,0
224946,plus,0,0
224947,placebo,0,0
224948,and,0,0
224949,nitroglycerin,0,0
224950,plus,0,0
224951,N-acetylcysteine,0,0
224952,on,0,0
224953,peripheral,0,0
224954,arteries,0,0
224955,",",0,0
224956,veins,0,1
224957,and,0,0
224958,microcirculation,0,0
224959,in,0,0
224960,humans,0,0
224961,.,0,0
224962,BACKGROUND,0,0
224963,The,0,0
224964,thiol,0,0
224965,donor,0,0
224966,N-acetylcysteine,0,0
224967,may,0,0
224968,potentiate,0,0
224969,the,0,0
224970,hemodynamic,0,0
224971,response,0,0
224972,to,0,0
224973,nitrates,0,0
224974,in,0,0
224975,nitrate-tolerant,0,1
224976,and,0,0
224977,nontolerant,0,1
224978,patients,0,1
224979,.,0,0
224980,The,0,0
224981,vascular,0,0
224982,changes,0,0
224983,responsible,0,0
224984,for,0,0
224985,this,0,0
224986,effect,0,0
224987,are,0,0
224988,not,0,0
224989,clear,0,0
224990,.,0,0
224991,METHODS,0,0
224992,Eight,1,0
224993,male,1,1
224994,volunteers,1,1
224995,were,0,0
224996,treated,0,1
224997,with,0,0
224998,nitroglycerin,0,0
224999,(,0,0
225000,0.1,0,0
225001,microgram/kg,0,0
225002,per,0,0
225003,min,0,0
225004,),0,0
225005,combined,0,0
225006,with,0,0
225007,N-acetylcysteine,0,0
225008,(,0,0
225009,2,0,0
225010,g,0,0
225011,intravenously,0,0
225012,",",0,0
225013,followed,0,0
225014,by,0,0
225015,5,0,0
225016,mg/kg,0,0
225017,per,0,0
225018,h,0,0
225019,),0,0
225020,or,0,0
225021,placebo,0,0
225022,for,0,0
225023,23,0,1
225024,h,0,0
225025,in,0,0
225026,a,0,0
225027,double-blind,0,0
225028,",",0,0
225029,randomized,0,0
225030,",",0,0
225031,crossover,0,0
225032,study,0,0
225033,.,0,0
225034,Venous,0,0
225035,volume,0,0
225036,",",0,0
225037,the,0,0
225038,diameter,0,0
225039,of,0,0
225040,the,0,0
225041,radial,0,0
225042,and,0,0
225043,temporal,0,0
225044,arteries,0,0
225045,",",0,0
225046,calf,0,0
225047,blood,0,0
225048,flow,0,0
225049,and,0,0
225050,subcutaneous,0,0
225051,blood,0,0
225052,flow,0,0
225053,were,0,0
225054,measured,0,0
225055,at,0,0
225056,baseline,0,0
225057,and,0,0
225058,repeated,0,0
225059,after,0,0
225060,1,0,0
225061,and,0,0
225062,23,0,1
225063,h,0,0
225064,of,0,0
225065,infusion,0,0
225066,.,0,0
225067,RESULTS,0,0
225068,Prolonged,0,0
225069,coadministration,0,0
225070,of,0,0
225071,N-acetylcysteine,0,0
225072,and,0,0
225073,nitroglycerin,0,0
225074,potentiated,0,0
225075,the,0,0
225076,acute,0,1
225077,venodilator,0,0
225078,effect,0,0
225079,of,0,0
225080,nitroglycerin,0,0
225081,as,0,0
225082,estimated,0,0
225083,by,0,0
225084,changes,0,0
225085,in,0,0
225086,venous,0,1
225087,volume,0,0
225088,(,0,0
225089,nitroglycerin,0,0
225090,plus,0,0
225091,N-acetylcysteine,0,0
225092,",",0,0
225093,4.45,0,0
225094,+/-,0,0
225095,0.36,0,0
225096,ml/100,0,0
225097,g,0,0
225098,;,0,0
225099,nitroglycerin,0,0
225100,plus,0,0
225101,placebo,0,0
225102,",",0,0
225103,3.65,0,0
225104,+/-,0,0
225105,0.46,0,0
225106,ml/100,0,0
225107,g,0,0
225108,",",0,0
225109,mean,0,0
225110,+/-,0,0
225111,SEM,0,0
225112,",",0,0
225113,p,0,0
225114,<,0,0
225115,0.05,0,0
225116,),0,0
225117,and,0,0
225118,prevented,0,0
225119,development,0,0
225120,of,0,0
225121,tolerance,0,0
225122,as,0,0
225123,seen,0,0
225124,after,0,0
225125,23,0,1
225126,h,0,0
225127,of,0,0
225128,treatment,0,0
225129,with,0,1
225130,nitroglycerin,0,0
225131,plus,0,0
225132,placebo,0,0
225133,(,0,0
225134,4.35,0,0
225135,+/-,0,0
225136,0.25,0,0
225137,vs.,0,0
225138,3.47,0,0
225139,+/-,0,0
225140,0.41,0,0
225141,ml/100,0,0
225142,g,0,0
225143,",",0,0
225144,p,0,0
225145,<,0,0
225146,0.05,0,0
225147,),0,0
225148,.,0,0
225149,N-acetylcysteine,0,0
225150,had,0,0
225151,no,0,0
225152,effect,0,0
225153,on,0,0
225154,nitroglycerin-induced,0,0
225155,changes,0,0
225156,in,0,0
225157,arterial,0,1
225158,diameters,0,1
225159,(,0,0
225160,p,0,0
225161,>,0,1
225162,0.05,0,0
225163,),0,0
225164,but,0,0
225165,significantly,0,0
225166,increased,0,0
225167,microcirculatory,0,0
225168,subcutaneous,0,0
225169,blood,0,0
225170,flow,0,0
225171,after,0,0
225172,1,0,0
225173,h,0,0
225174,(,0,0
225175,nitroglycerin,0,0
225176,plus,0,0
225177,N-acetylcysteine,0,0
225178,:,0,1
225179,6.3,0,0
225180,+/-,0,0
225181,1.3,0,0
225182,ml/100,0,0
225183,g,0,0
225184,per,0,0
225185,min,0,0
225186,vs.,0,0
225187,nitroglycerin,0,0
225188,plus,0,0
225189,placebo,0,0
225190,:,0,1
225191,3.5,0,0
225192,+/-,0,0
225193,0.3,0,0
225194,ml/100,0,0
225195,g,0,0
225196,per,0,0
225197,min,0,0
225198,",",0,0
225199,p,0,0
225200,<,0,0
225201,0.05,0,0
225202,),0,0
225203,and,0,0
225204,after,0,0
225205,23,0,1
225206,h,0,0
225207,(,0,0
225208,4.4,0,0
225209,+/-,0,0
225210,0.6,0,0
225211,vs.,0,0
225212,3.1,0,0
225213,+/-,0,0
225214,0.5,0,0
225215,ml/100,0,0
225216,g,0,0
225217,per,0,0
225218,min,0,0
225219,",",0,0
225220,p,0,0
225221,<,0,0
225222,0.05,0,0
225223,),0,0
225224,.,0,0
225225,CONCLUSIONS,0,0
225226,The,0,0
225227,results,0,0
225228,suggest,0,0
225229,that,0,0
225230,coadministration,0,0
225231,of,0,0
225232,nitroglycerin,0,0
225233,and,0,0
225234,N-acetylcysteine,0,0
225235,in,0,0
225236,humans,0,1
225237,1,0,1
225238,),0,1
225239,potentiates,0,0
225240,and,0,0
225241,preserves,0,0
225242,nitroglycerin-induced,0,0
225243,venodilation,0,0
225244,and,0,0
225245,2,0,0
225246,),0,0
225247,augments,0,0
225248,the,0,0
225249,effect,0,0
225250,of,0,0
225251,nitroglycerin,0,0
225252,on,0,0
225253,small,0,0
225254,resistance,0,0
225255,vessels,0,0
225256,(,0,0
225257,regulating,0,0
225258,subcutaneous,0,0
225259,blood,0,0
225260,flow,0,0
225261,),0,0
225262,without,0,0
225263,affecting,0,0
225264,the,0,0
225265,response,0,0
225266,to,0,0
225267,nitroglycerin,0,0
225268,in,0,0
225269,middle-sized,0,1
225270,arteries,0,0
225271,.,0,0
225272,Both,0,0
225273,the,0,0
225274,development,0,0
225275,of,0,0
225276,nitrate,0,0
225277,tolerance,0,0
225278,and,0,0
225279,the,0,0
225280,administration,0,0
225281,of,0,0
225282,N-acetylcysteine,0,0
225283,significantly,0,0
225284,change,0,0
225285,the,0,0
225286,normal,0,0
225287,vasodilator,0,0
225288,profile,0,0
225289,of,0,0
225290,nitroglycerin,0,0
225291,in,0,0
225292,humans,0,0
225293,.,0,1
225294,Naltrexone,1,0
225295,in,1,0
225296,autistic,1,1
225297,children,1,1
225298,:,1,1
225299,behavioral,0,1
225300,symptoms,0,0
225301,and,0,0
225302,attentional,0,0
225303,learning,0,0
225304,.,0,0
225305,OBJECTIVE,0,0
225306,To,0,0
225307,assess,0,0
225308,critically,0,0
225309,the,0,0
225310,short-term,0,0
225311,efficacy,0,0
225312,and,0,0
225313,safety,0,0
225314,of,0,0
225315,naltrexone,1,0
225316,in,1,0
225317,autistic,1,1
225318,children,1,1
225319,and,0,0
225320,its,0,0
225321,effects,0,0
225322,on,0,0
225323,discrimination,0,0
225324,learning,0,0
225325,in,0,0
225326,the,0,0
225327,laboratory,0,0
225328,.,0,0
225329,METHOD,0,0
225330,A,0,0
225331,parallel,0,0
225332,group,0,0
225333,design,0,0
225334,was,0,0
225335,employed,0,0
225336,.,0,0
225337,After,0,0
225338,a,0,0
225339,2-week,0,0
225340,placebo,0,0
225341,baseline,0,0
225342,period,0,0
225343,",",0,0
225344,children,0,1
225345,were,0,0
225346,randomly,0,1
225347,assigned,0,0
225348,either,0,0
225349,to,0,0
225350,naltrexone,0,0
225351,or,0,0
225352,to,0,0
225353,placebo,0,0
225354,for,0,0
225355,a,0,0
225356,period,0,0
225357,of,0,0
225358,3,0,0
225359,weeks,0,0
225360,followed,0,0
225361,by,0,0
225362,a,0,0
225363,one-week,0,0
225364,posttreatment,0,0
225365,placebo,0,0
225366,period,0,0
225367,.,0,0
225368,Multiple,0,0
225369,raters,0,0
225370,and,0,0
225371,rating,0,0
225372,scales,0,0
225373,were,0,0
225374,employed,0,0
225375,in,0,0
225376,a,0,0
225377,variety,0,0
225378,of,0,0
225379,conditions,0,0
225380,.,0,1
225381,Forty-one,1,1
225382,children,1,1
225383,",",1,0
225384,all,1,0
225385,inpatients,1,1
225386,",",1,0
225387,ages,1,1
225388,2.9,1,0
225389,to,1,0
225390,7.8,1,0
225391,years,1,1
225392,",",1,0
225393,completed,1,1
225394,the,1,0
225395,study,1,0
225396,.,1,0
225397,Naltrexone,0,0
225398,reduced,0,0
225399,hyperactivity,0,0
225400,and,0,0
225401,had,0,0
225402,no,0,0
225403,effect,0,0
225404,on,0,0
225405,discrimination,0,0
225406,learning,0,0
225407,in,0,0
225408,the,0,0
225409,laboratory,0,0
225410,.,0,0
225411,There,0,0
225412,was,0,0
225413,a,0,0
225414,suggestion,0,0
225415,that,0,0
225416,it,0,0
225417,had,0,0
225418,a,0,0
225419,beneficial,0,0
225420,effect,0,0
225421,on,0,0
225422,decreasing,0,0
225423,self-injurious,0,0
225424,behavior,0,0
225425,.,0,0
225426,Untoward,0,0
225427,effects,0,0
225428,were,0,0
225429,mild,0,1
225430,and,0,0
225431,transient,0,0
225432,.,0,0
225433,CONCLUSION,0,0
225434,In,0,0
225435,the,0,0
225436,present,0,0
225437,study,0,0
225438,",",0,0
225439,naltrexone,0,0
225440,significantly,0,0
225441,reduced,0,0
225442,only,0,0
225443,hyperactivity,1,0
225444,",",0,0
225445,and,0,0
225446,no,0,0
225447,serious,0,0
225448,untoward,0,0
225449,effects,0,0
225450,were,0,0
225451,observed,0,0
225452,.,0,0
225453,The,0,0
225454,effectiveness,0,0
225455,of,0,0
225456,naltrexone,0,0
225457,in,0,0
225458,the,0,0
225459,treatment,0,0
225460,of,0,0
225461,autism,0,1
225462,and,0,0
225463,self-injurious,0,0
225464,behavior,0,0
225465,requires,0,0
225466,additional,0,0
225467,assessment,0,0
225468,in,0,0
225469,a,0,0
225470,sample,0,1
225471,of,0,0
225472,children,1,1
225473,with,1,1
225474,moderate,1,1
225475,to,1,0
225476,severe,1,1
225477,self-injurious,1,0
225478,behavior,1,0
225479,.,1,0
225480,[,0,0
225481,Hemostatic,0,0
225482,balance,0,0
225483,during,0,0
225484,treatment,0,0
225485,with,0,0
225486,the,0,0
225487,newest,0,0
225488,contraceptives,0,0
225489,],0,1
225490,.,0,0
225491,Thirty-four,1,1
225492,healthy,1,1
225493,young,1,1
225494,women,1,1
225495,were,0,0
225496,allocated,0,0
225497,to,0,0
225498,12,0,0
225499,consecutive,0,1
225500,cycles,0,0
225501,of,0,0
225502,treatment,0,0
225503,with,0,1
225504,monophasic,0,0
225505,combinations,0,0
225506,of,0,0
225507,:,0,1
225508,20,0,1
225509,micrograms,0,0
225510,ethinyl,0,0
225511,estradiol,0,0
225512,and,0,0
225513,150,0,0
225514,micrograms,0,0
225515,desogestrel,0,0
225516,(,0,0
225517,n,0,1
225518,=,0,0
225519,15,0,0
225520,),0,0
225521,or,0,1
225522,30,0,0
225523,micrograms,0,0
225524,ethinyl,0,0
225525,estradiol,0,0
225526,and,0,0
225527,75,0,1
225528,micrograms,0,0
225529,gestodene,0,0
225530,(,0,0
225531,n,0,1
225532,=,0,0
225533,19,0,1
225534,),0,0
225535,.,0,0
225536,In,0,0
225537,both,0,0
225538,groups,0,0
225539,plasma,0,0
225540,levels,0,0
225541,of,0,0
225542,fibrinogen,0,0
225543,and,0,0
225544,factor,0,0
225545,VII,0,0
225546,increased,0,0
225547,while,0,0
225548,the,0,0
225549,capacity,0,0
225550,of,0,0
225551,coagulation,0,0
225552,inhibition,0,0
225553,was,0,0
225554,affected,0,0
225555,by,0,0
225556,increased,0,0
225557,protein,0,0
225558,C,0,0
225559,and,0,0
225560,decreased,0,0
225561,protein,0,0
225562,S,0,0
225563,levels,0,0
225564,.,0,0
225565,Increased,0,0
225566,fibrinolytic,0,0
225567,capacity,0,0
225568,was,0,0
225569,indicated,0,0
225570,by,0,0
225571,elevated,0,0
225572,activity,0,0
225573,and,0,0
225574,reduced,0,0
225575,antigen,0,0
225576,levels,0,0
225577,of,0,0
225578,tissue,0,0
225579,plasminogen,0,0
225580,activator,0,0
225581,and,0,0
225582,reduced,0,0
225583,activity,0,0
225584,and,0,0
225585,concentration,0,0
225586,of,0,0
225587,tissue,0,0
225588,plasminogen,0,0
225589,activator,0,0
225590,inhibitor,0,0
225591,.,0,0
225592,The,0,0
225593,ratio,0,0
225594,between,0,0
225595,thrombin-antithrombin-III-complexes,0,0
225596,and,0,0
225597,fibrin,0,0
225598,degradation,0,0
225599,products,0,0
225600,were,0,0
225601,unchanged,0,0
225602,signifying,0,0
225603,no,0,0
225604,effect,0,0
225605,of,0,0
225606,hormonal,0,0
225607,intake,0,0
225608,on,0,0
225609,the,0,0
225610,balance,0,0
225611,between,0,0
225612,thrombin,0,0
225613,formation,0,0
225614,and,0,0
225615,fibrin,0,0
225616,resolution,0,0
225617,.,0,0
225618,In,0,0
225619,conclusion,0,0
225620,",",0,0
225621,the,0,0
225622,dynamic,0,0
225623,balance,0,0
225624,between,0,0
225625,generation,0,0
225626,and,0,0
225627,resolution,0,0
225628,of,0,0
225629,fibrin,0,0
225630,was,0,0
225631,undisturbed,0,0
225632,during,0,0
225633,treatment,0,0
225634,with,0,1
225635,both,0,0
225636,hormonal,0,0
225637,compounds,0,0
225638,and,0,0
225639,our,0,0
225640,findings,0,0
225641,do,0,0
225642,not,0,0
225643,provide,0,0
225644,evidence,0,0
225645,for,0,0
225646,increased,0,0
225647,risk,0,0
225648,of,0,0
225649,thrombosis,0,1
225650,in,0,0
225651,normal,1,1
225652,women,1,1
225653,.,1,1
225654,A,0,0
225655,program,0,0
225656,of,0,0
225657,screening,0,0
225658,and,0,0
225659,prompting,0,0
225660,improves,0,0
225661,short-term,0,0
225662,physician,0,1
225663,counseling,0,0
225664,of,0,0
225665,dependent,1,0
225666,and,1,0
225667,nondependent,1,0
225668,harmful,1,0
225669,drinkers,1,1
225670,.,1,1
225671,BACKGROUND,0,0
225672,Physicians,0,1
225673,in,0,1
225674,the,0,0
225675,general,0,1
225676,medical,0,0
225677,setting,0,1
225678,commonly,0,0
225679,encounter,0,0
225680,but,0,0
225681,rarely,0,0
225682,counsel,0,0
225683,patients,1,1
225684,with,1,1
225685,dependent,1,0
225686,or,1,0
225687,harmful,1,0
225688,drinking,1,0
225689,behaviors,1,0
225690,.,1,0
225691,We,0,0
225692,tested,0,0
225693,whether,0,0
225694,providing,0,0
225695,physicians,0,1
225696,with,0,1
225697,their,0,1
225698,patients,0,1
225699,',0,1
225700,results,0,0
225701,on,0,0
225702,the,0,0
225703,alcohol,0,0
225704,module,0,0
225705,of,0,0
225706,the,0,0
225707,Diagnostic,0,0
225708,Interview,0,1
225709,Schedule,0,0
225710,and,0,0
225711,counseling,0,0
225712,directives,0,0
225713,would,0,0
225714,prompt,0,0
225715,them,0,0
225716,to,0,0
225717,counsel,0,0
225718,these,0,0
225719,patients,0,1
225720,.,0,0
225721,METHODS,0,0
225722,We,0,0
225723,randomly,0,1
225724,assigned,0,0
225725,83,1,1
225726,first-,1,0
225727,",",1,0
225728,second-,1,0
225729,",",1,0
225730,and,1,0
225731,third-year,1,1
225732,medical,1,1
225733,residents,1,1
225734,to,1,0
225735,receive,1,0
225736,or,1,0
225737,not,1,0
225738,to,1,0
225739,receive,1,0
225740,diagnostic,1,0
225741,information,1,0
225742,and,1,0
225743,counseling,1,0
225744,directives,1,1
225745,on,1,0
225746,214,1,1
225747,patients,1,1
225748,who,1,1
225749,reported,1,1
225750,at,1,1
225751,least,1,0
225752,one,1,0
225753,symptom,1,0
225754,of,1,0
225755,alcohol,1,0
225756,impairment,1,0
225757,as,1,0
225758,defined,1,0
225759,in,1,0
225760,the,1,0
225761,Diagnostic,1,0
225762,and,1,0
225763,Statistical,1,0
225764,Manual,1,0
225765,of,1,0
225766,Mental,1,0
225767,Disorders,1,1
225768,",",1,0
225769,Third,1,0
225770,Edition,1,0
225771,.,1,0
225772,Using,0,0
225773,binary,0,0
225774,logistic,0,0
225775,regression,0,0
225776,",",0,0
225777,we,0,0
225778,examined,0,0
225779,the,0,0
225780,effect,0,0
225781,of,0,0
225782,specific,0,0
225783,covariables,0,0
225784,on,0,0
225785,rates,0,0
225786,of,0,0
225787,physician,0,1
225788,counseling,0,0
225789,.,0,0
225790,These,0,0
225791,variables,0,0
225792,included,0,1
225793,physician,0,1
225794,information,0,0
225795,status,0,0
225796,",",0,0
225797,patient,0,0
225798,gender,0,0
225799,",",0,0
225800,and,0,0
225801,drinking,0,0
225802,disorder,0,1
225803,severity,0,0
225804,and,0,0
225805,recency,0,0
225806,.,0,0
225807,We,0,0
225808,also,0,0
225809,examined,0,0
225810,the,0,0
225811,effect,0,0
225812,of,0,0
225813,physician,0,0
225814,prompting,0,0
225815,on,0,0
225816,counseling,0,0
225817,of,0,0
225818,female,1,1
225819,patients,1,1
225820,",",1,0
225821,patients,1,1
225822,with,1,1
225823,inactive,1,1
225824,disorders,1,1
225825,",",1,0
225826,and,1,0
225827,nondependent,1,0
225828,but,1,0
225829,harmful,1,0
225830,drinkers,1,1
225831,.,1,1
225832,We,0,0
225833,determined,0,0
225834,counseling,0,0
225835,by,0,0
225836,post-visit,0,0
225837,patient,0,1
225838,interviews,0,1
225839,.,0,1
225840,RESULTS,0,0
225841,Physician,0,0
225842,prompting,0,0
225843,",",0,0
225844,dependent,0,0
225845,drinking,0,0
225846,",",0,0
225847,and,0,0
225848,recent,0,0
225849,disorder,0,1
225850,activity,0,0
225851,were,0,0
225852,significant,0,0
225853,correlates,0,0
225854,of,0,0
225855,physician,0,1
225856,counseling,0,0
225857,(,0,0
225858,P,0,0
225859,<,0,0
225860,.05,0,0
225861,),0,0
225862,",",0,0
225863,while,0,0
225864,male,0,1
225865,gender,0,0
225866,was,0,0
225867,a,0,0
225868,marginally,0,0
225869,significant,0,0
225870,correlate,0,0
225871,(,0,0
225872,P,0,0
225873,=,0,0
225874,.08,0,0
225875,),0,0
225876,.,0,0
225877,Informed,0,0
225878,physicians,0,0
225879,counseled,0,0
225880,female,0,1
225881,patients,0,1
225882,",",0,0
225883,harmful,0,0
225884,but,0,0
225885,nondependent,0,0
225886,drinkers,0,1
225887,",",0,0
225888,and,0,0
225889,patients,0,1
225890,with,0,1
225891,inactive,0,0
225892,disorders,0,1
225893,more,0,0
225894,often,0,0
225895,than,0,0
225896,their,0,0
225897,uninformed,0,0
225898,colleagues,0,0
225899,",",0,0
225900,although,0,0
225901,only,0,0
225902,the,0,0
225903,last,0,0
225904,variable,0,0
225905,achieved,0,0
225906,statistical,0,0
225907,significance,0,0
225908,.,0,0
225909,CONCLUSIONS,0,0
225910,Providing,0,0
225911,physicians,0,1
225912,with,0,1
225913,the,0,0
225914,results,0,0
225915,of,0,0
225916,the,0,0
225917,Diagnostic,0,0
225918,Interview,0,1
225919,Schedule,0,0
225920,and,0,0
225921,counseling,0,0
225922,directives,0,0
225923,resulted,0,0
225924,in,0,0
225925,short-term,0,0
225926,improvement,0,0
225927,in,0,0
225928,their,0,0
225929,rates,0,0
225930,of,0,0
225931,counseling,0,0
225932,patients,0,1
225933,with,0,1
225934,a,0,0
225935,history,0,0
225936,of,0,0
225937,dependent,0,0
225938,or,0,0
225939,nondependent,0,0
225940,but,0,0
225941,harmful,0,0
225942,drinking,0,0
225943,.,0,0
225944,Further,0,0
225945,research,0,0
225946,is,0,0
225947,necessary,0,0
225948,to,0,0
225949,determine,0,0
225950,long-term,0,0
225951,gains,0,0
225952,in,0,0
225953,rates,0,0
225954,of,0,0
225955,physician,0,1
225956,counseling,0,0
225957,and,0,0
225958,improvements,0,0
225959,in,0,0
225960,the,0,0
225961,course,0,0
225962,of,0,0
225963,these,0,0
225964,patients,0,1
225965,.,0,0
225966,Milk,0,0
225967,protein,0,0
225968,quantity,0,0
225969,and,0,0
225970,quality,0,0
225971,in,0,0
225972,low-birth-weight,1,1
225973,infants,1,1
225974,.,1,1
225975,IV,0,0
225976,.,0,0
225977,Effects,0,0
225978,on,0,0
225979,tyrosine,0,0
225980,and,0,0
225981,phenylalanine,0,0
225982,in,0,0
225983,plasma,0,0
225984,and,0,0
225985,urine,0,0
225986,.,0,0
225987,Well,0,0
225988,",",0,0
225989,appropriate-for-gestational,1,1
225990,age,1,1
225991,",",1,0
225992,low-birth-weight,1,1
225993,infants,1,1
225994,were,0,0
225995,divided,0,1
225996,into,0,0
225997,three,0,0
225998,gestational,0,1
225999,age,0,1
226000,groups,0,0
226001,and,0,0
226002,assigned,0,0
226003,randomly,0,0
226004,within,0,0
226005,each,0,0
226006,age,0,1
226007,group,0,0
226008,to,0,0
226009,one,0,0
226010,of,0,0
226011,five,0,1
226012,feeding,0,0
226013,regimens,0,0
226014,:,0,1
226015,pooled,0,0
226016,human,0,0
226017,milk,0,0
226018,(,0,0
226019,BM,0,0
226020,),0,0
226021,;,0,0
226022,formula,0,0
226023,1,0,0
226024,(,0,0
226025,F1,0,0
226026,),0,0
226027,=,0,0
226028,1.5,0,0
226029,gm/dl,0,0
226030,protein,0,0
226031,",",0,0
226032,60,0,1
226033,parts,0,0
226034,bovine,0,0
226035,whey,0,0
226036,proteins,0,0
226037,:,0,1
226038,40,0,1
226039,parts,0,0
226040,bovine,0,1
226041,caseins,0,0
226042,;,0,0
226043,F2,0,0
226044,=,0,0
226045,3.0,0,0
226046,gm/dl,0,0
226047,",",0,0
226048,60:40,0,0
226049,;,0,0
226050,F3,0,0
226051,=,0,0
226052,1.5,0,0
226053,gm/dl,0,0
226054,",",0,0
226055,18:82,0,0
226056,;,0,0
226057,F4,0,0
226058,=,0,0
226059,3.0,0,0
226060,gm/dl,0,0
226061,",",0,0
226062,18:82,0,0
226063,.,0,0
226064,Plasma,0,0
226065,and,0,0
226066,urine,0,0
226067,concentrations,0,0
226068,of,0,0
226069,tyrosine,0,0
226070,and,0,0
226071,phenylalanine,0,0
226072,were,0,0
226073,far,0,0
226074,higher,0,0
226075,in,0,0
226076,the,0,0
226077,infants,0,1
226078,fed,0,0
226079,F1,0,0
226080,to,0,0
226081,F4,0,0
226082,",",0,0
226083,especially,0,0
226084,F2,0,0
226085,and,0,0
226086,F4,0,0
226087,",",0,0
226088,than,0,0
226089,in,0,0
226090,the,0,0
226091,infants,0,1
226092,fed,0,0
226093,BM,0,0
226094,.,0,0
226095,These,0,0
226096,findings,0,0
226097,offer,0,0
226098,further,0,0
226099,evidence,0,0
226100,for,0,0
226101,the,0,0
226102,limited,0,0
226103,capacity,0,0
226104,of,0,0
226105,the,0,0
226106,low-birth-weight,0,1
226107,infant,0,1
226108,to,0,0
226109,catabolize,0,0
226110,tyrosine,0,0
226111,.,0,0
226112,Infants,0,0
226113,fed,0,0
226114,F3,0,0
226115,had,0,0
226116,significantly,0,0
226117,higher,0,0
226118,plasma,0,0
226119,tyrosine,0,0
226120,concentrations,0,0
226121,than,0,0
226122,infants,0,1
226123,fed,0,0
226124,F1,0,0
226125,",",0,0
226126,and,0,0
226127,those,0,0
226128,fed,0,0
226129,F4,0,0
226130,had,0,0
226131,higher,0,0
226132,concentrations,0,0
226133,than,0,0
226134,those,0,1
226135,fed,0,0
226136,F2,0,0
226137,.,0,0
226138,Thus,0,0
226139,",",0,0
226140,increased,0,0
226141,plasma,0,0
226142,tyrosine,0,0
226143,concentrations,0,0
226144,in,0,0
226145,low-birth-weight,0,1
226146,infants,0,1
226147,are,0,0
226148,related,0,0
226149,directly,0,0
226150,both,0,0
226151,to,0,0
226152,the,0,0
226153,quantity,0,0
226154,and,0,0
226155,to,0,0
226156,the,0,0
226157,quality,0,0
226158,of,0,0
226159,the,0,0
226160,protein,0,0
226161,in,0,0
226162,their,0,0
226163,diets,0,0
226164,.,0,1
226165,Timing,0,0
226166,of,0,0
226167,antibiotic,0,0
226168,administration,0,0
226169,in,0,0
226170,knee,1,1
226171,replacement,1,0
226172,under,1,0
226173,tourniquet,1,0
226174,.,1,0
226175,Cephamandole,0,0
226176,levels,0,0
226177,in,0,0
226178,serum,0,0
226179,and,0,0
226180,drain,0,0
226181,fluid,0,0
226182,were,0,0
226183,measured,0,0
226184,in,0,0
226185,32,1,1
226186,knee,1,1
226187,replacement,1,1
226188,operations,1,1
226189,to,0,0
226190,determine,0,0
226191,the,0,0
226192,benefit,0,0
226193,of,0,0
226194,an,0,0
226195,intravenous,0,0
226196,dose,0,0
226197,of,0,0
226198,antibiotic,0,0
226199,at,0,0
226200,the,0,0
226201,time,0,0
226202,of,0,0
226203,tourniquet,0,0
226204,deflation,0,0
226205,.,0,0
226206,Concentrations,0,0
226207,of,0,0
226208,cephamandole,0,0
226209,in,0,0
226210,drain,0,0
226211,fluid,0,0
226212,were,0,0
226213,directly,0,0
226214,proportional,0,0
226215,to,0,0
226216,the,0,0
226217,serum,0,0
226218,concentration,0,0
226219,at,0,0
226220,the,0,0
226221,time,0,0
226222,of,0,0
226223,tourniquet,0,0
226224,release,0,0
226225,.,0,0
226226,A,0,0
226227,'tourniquet-release,0,0
226228,',0,0
226229,dose,0,0
226230,of,0,0
226231,antibiotic,0,0
226232,increased,0,0
226233,drain,0,0
226234,fluid,0,0
226235,concentration,0,0
226236,threefold,0,0
226237,.,0,0
226238,Effects,0,1
226239,of,0,1
226240,reducing,0,0
226241,dietary,0,0
226242,[,0,0
226243,(,0,0
226244,Na+,0,0
226245,+,0,0
226246,K+,0,0
226247,),0,0
226248,-,0,0
226249,(,0,0
226250,Cl-,0,0
226251,+,0,0
226252,SO4=,0,0
226253,),0,0
226254,],0,0
226255,on,0,0
226256,the,0,0
226257,rate,0,0
226258,of,0,0
226259,calcium,0,0
226260,mobilisation,0,0
226261,by,0,0
226262,dairy,1,1
226263,cows,1,1
226264,at,1,0
226265,parturition,1,1
226266,.,1,0
226267,The,0,0
226268,effects,0,0
226269,of,0,0
226270,feeding,0,0
226271,diets,0,0
226272,with,0,1
226273,different,0,0
226274,milliequivalents,0,0
226275,(,0,0
226276,meq,0,0
226277,),0,0
226278,of,0,0
226279,dietary,0,0
226280,[,0,0
226281,(,0,0
226282,Na+,0,0
226283,+,0,0
226284,K+,0,0
226285,),0,0
226286,-,0,0
226287,(,0,0
226288,Cl-,0,0
226289,+,0,0
226290,SO4=,0,0
226291,),0,0
226292,],0,0
226293,to,0,0
226294,dairy,1,1
226295,cows,1,1
226296,during,1,0
226297,the,1,0
226298,last,1,0
226299,seven,1,0
226300,weeks,1,0
226301,of,1,0
226302,pregnancy,1,1
226303,on,0,0
226304,their,0,0
226305,acid-base,0,0
226306,status,0,0
226307,and,0,0
226308,calcium,0,0
226309,mobilisation,0,0
226310,rate,0,0
226311,around,0,0
226312,parturition,0,0
226313,were,0,0
226314,studied,0,1
226315,.,0,0
226316,Ten,1,1
226317,monozygotic,1,1
226318,twin,1,1
226319,pairs,1,1
226320,of,1,0
226321,pregnant,1,1
226322,cows,1,1
226323,(,1,1
226324,five,1,1
226325,pairs,1,1
226326,of,1,0
226327,parity,1,1
226328,1,1,0
226329,or,1,0
226330,2,1,0
226331,",",1,0
226332,and,1,0
226333,five,1,0
226334,pairs,1,1
226335,of,1,0
226336,parity,1,1
226337,3,1,0
226338,or,1,0
226339,more,1,0
226340,),1,0
226341,were,0,0
226342,allocated,0,0
226343,to,0,0
226344,two,0,0
226345,diets,0,0
226346,which,0,0
226347,were,0,0
226348,formulated,0,0
226349,to,0,0
226350,provide,0,0
226351,either,0,0
226352,-4,0,0
226353,meq,0,0
226354,(,0,0
226355,anion,0,0
226356,diet,0,0
226357,),0,0
226358,or,0,0
226359,+572.5,0,0
226360,meq,0,0
226361,(,0,0
226362,cation,0,0
226363,diet,0,0
226364,),0,0
226365,of,0,0
226366,[,0,0
226367,(,0,0
226368,Na+,0,0
226369,+,0,0
226370,K+,0,0
226371,),0,0
226372,-,0,0
226373,(,0,0
226374,Cl-,0,0
226375,+,0,0
226376,SO4=,0,0
226377,),0,0
226378,],0,0
226379,kg-1,0,0
226380,dietary,0,0
226381,dry,0,0
226382,matter,0,0
226383,(,0,0
226384,DM,0,0
226385,),0,0
226386,.,0,0
226387,The,0,0
226388,daily,0,0
226389,rations,0,0
226390,consisted,0,1
226391,of,0,0
226392,4,0,0
226393,kg,0,0
226394,grass,0,0
226395,hay,0,1
226396,and,0,0
226397,7,0,0
226398,kg,0,1
226399,concentrates,0,0
226400,.,0,1
226401,Changes,0,0
226402,in,0,0
226403,meq,0,0
226404,of,0,0
226405,dietary,0,0
226406,[,0,0
226407,(,0,0
226408,Na+,0,0
226409,+,0,0
226410,K+,0,0
226411,),0,0
226412,-,0,0
226413,(,0,0
226414,Cl-,0,0
226415,+,0,0
226416,SO4=,0,0
226417,),0,0
226418,],0,0
226419,were,0,0
226420,achieved,0,0
226421,by,0,0
226422,adding,0,0
226423,KCl,0,0
226424,",",0,0
226425,K2SO4,0,0
226426,and,0,0
226427,(,0,0
226428,NH4,0,1
226429,),0,0
226430,2SO4,0,0
226431,(,0,0
226432,anion,0,0
226433,diet,0,0
226434,),0,0
226435,or,0,0
226436,K2CO3,0,0
226437,(,0,0
226438,cation,0,0
226439,diet,0,0
226440,),0,0
226441,to,0,0
226442,basal,0,0
226443,concentrates,0,0
226444,.,0,0
226445,Plasma,0,0
226446,calcium,0,0
226447,concentration,0,0
226448,and,0,0
226449,blood,0,0
226450,acid-base,0,0
226451,parameters,0,0
226452,were,0,0
226453,not,0,0
226454,affected,0,0
226455,by,0,0
226456,dietary,0,0
226457,treatment,0,0
226458,.,0,0
226459,However,0,0
226460,",",0,0
226461,urinary,0,0
226462,calcium,0,0
226463,excretion,0,0
226464,was,0,0
226465,markedly,0,0
226466,higher,0,0
226467,and,0,0
226468,urinary,0,0
226469,pH,0,0
226470,and,0,0
226471,bicarbonate,0,0
226472,excretion,0,0
226473,significantly,0,0
226474,lower,0,0
226475,in,0,0
226476,cows,1,1
226477,fed,1,0
226478,the,1,0
226479,anion,1,0
226480,diet,1,0
226481,than,0,0
226482,in,0,0
226483,cows,1,1
226484,fed,1,0
226485,the,1,0
226486,cation,1,0
226487,diet,1,0
226488,.,1,0
226489,The,0,0
226490,responses,0,0
226491,to,0,0
226492,hypocalcaemia,0,0
226493,induced,0,0
226494,by,0,0
226495,an,0,0
226496,intravenous,0,0
226497,infusion,0,0
226498,of,0,0
226499,EDTA,0,0
226500,solution,0,0
226501,were,0,0
226502,similar,0,0
226503,in,0,0
226504,the,0,0
226505,cows,0,0
226506,fed,0,0
226507,either,0,0
226508,diet,0,0
226509,.,0,0
226510,Clinical,0,0
226511,and,0,0
226512,prognostic,0,0
226513,significance,0,0
226514,of,0,0
226515,serum,0,0
226516,magnesium,0,0
226517,concentration,0,0
226518,in,0,0
226519,patients,1,1
226520,with,1,1
226521,severe,1,1
226522,chronic,1,1
226523,congestive,1,1
226524,heart,1,1
226525,failure,1,1
226526,:,1,1
226527,the,0,0
226528,PROMISE,0,0
226529,Study,0,0
226530,.,0,0
226531,OBJECTIVES,0,0
226532,The,0,0
226533,aim,0,0
226534,of,0,0
226535,this,0,0
226536,study,0,0
226537,was,0,0
226538,to,0,0
226539,determine,0,0
226540,the,0,0
226541,prognostic,0,0
226542,significance,0,0
226543,of,0,0
226544,alterations,0,0
226545,in,0,0
226546,serum,0,0
226547,magnesium,0,0
226548,in,0,0
226549,patients,1,1
226550,with,1,1
226551,moderate,1,1
226552,to,1,0
226553,severe,1,1
226554,congestive,1,1
226555,heart,1,1
226556,failure,1,1
226557,.,1,1
226558,BACKGROUND,0,0
226559,Reductions,0,0
226560,in,0,0
226561,serum,0,0
226562,magnesium,0,0
226563,have,0,0
226564,been,0,0
226565,postulated,0,0
226566,to,0,0
226567,play,0,0
226568,a,0,0
226569,role,0,0
226570,in,0,0
226571,promoting,0,0
226572,arrhythmias,0,1
226573,and,0,0
226574,to,0,0
226575,have,0,0
226576,an,0,0
226577,adverse,0,0
226578,impact,0,0
226579,on,0,0
226580,survival,0,0
226581,in,0,0
226582,congestive,0,1
226583,heart,0,1
226584,failure,0,1
226585,",",0,0
226586,although,0,0
226587,support,0,0
226588,for,0,0
226589,this,0,0
226590,postulate,0,0
226591,is,0,0
226592,lacking,0,0
226593,.,0,0
226594,METHODS,0,0
226595,Serum,0,0
226596,magnesium,0,0
226597,levels,0,0
226598,were,0,0
226599,measured,0,0
226600,in,0,0
226601,"1,068",1,1
226602,patients,1,1
226603,enrolled,1,1
226604,in,1,0
226605,a,1,0
226606,survival,1,0
226607,study,1,0
226608,of,1,0
226609,class,1,1
226610,III,1,0
226611,or,1,0
226612,IV,1,0
226613,heart,1,1
226614,failure,1,1
226615,at,1,0
226616,the,1,0
226617,time,1,0
226618,of,1,0
226619,double-blind,1,0
226620,randomization,1,0
226621,to,1,0
226622,milrinone,1,0
226623,",",1,0
226624,a,1,0
226625,phosphodiesterase,1,0
226626,inhibitor,1,0
226627,",",1,0
226628,or,1,0
226629,placebo,1,0
226630,.,1,0
226631,All,0,0
226632,patients,0,1
226633,received,0,0
226634,conventional,0,0
226635,therapy,0,0
226636,with,0,0
226637,digoxin,0,0
226638,",",0,0
226639,diuretic,0,0
226640,drugs,0,0
226641,and,0,0
226642,a,0,0
226643,converting,0,0
226644,enzyme,0,0
226645,inhibitor,0,0
226646,throughout,0,0
226647,the,0,0
226648,trial,0,0
226649,.,0,0
226650,The,0,0
226651,median,0,0
226652,follow-up,0,0
226653,period,0,0
226654,was,0,0
226655,6.1,0,0
226656,months,0,0
226657,(,0,0
226658,range,0,0
226659,1,0,0
226660,day,0,0
226661,to,0,0
226662,20,0,1
226663,months,0,0
226664,),0,1
226665,.,0,1
226666,RESULTS,0,0
226667,Patients,0,1
226668,with,0,1
226669,high,0,0
226670,serum,0,0
226671,magnesium,0,0
226672,(,0,0
226673,defined,0,0
226674,as,0,0
226675,>,0,0
226676,or,0,0
226677,=,0,0
226678,1.9,0,0
226679,mEq/liter,0,0
226680,",",0,0
226681,n,0,1
226682,=,0,0
226683,242,0,1
226684,),0,0
226685,were,0,0
226686,less,0,0
226687,likely,0,0
226688,to,0,0
226689,survive,0,1
226690,than,0,0
226691,were,0,0
226692,patients,0,1
226693,with,0,1
226694,a,0,0
226695,normal,0,0
226696,magnesium,0,0
226697,level,0,0
226698,(,0,0
226699,n,0,1
226700,=,0,0
226701,627,0,1
226702,),0,0
226703,(,0,0
226704,p,0,0
226705,<,0,0
226706,0.05,0,0
226707,",",0,0
226708,risk,0,0
226709,ratio,0,0
226710,=,0,0
226711,1.41,0,0
226712,),0,0
226713,.,0,0
226714,Patients,0,1
226715,with,0,1
226716,a,0,0
226717,low,0,0
226718,magnesium,0,0
226719,level,0,0
226720,(,0,0
226721,defined,0,0
226722,as,0,0
226723,<,0,0
226724,or,0,0
226725,=,0,0
226726,1.5,0,0
226727,mEq/liter,0,0
226728,",",0,0
226729,n,0,1
226730,=,0,0
226731,199,0,1
226732,),0,0
226733,had,0,0
226734,no,0,0
226735,difference,0,0
226736,in,0,0
226737,survival,0,0
226738,compared,0,0
226739,with,0,0
226740,the,0,0
226741,group,0,0
226742,with,0,0
226743,a,0,0
226744,normal,0,0
226745,magnesium,0,0
226746,level,0,0
226747,(,0,0
226748,p,0,0
226749,=,0,0
226750,NS,0,0
226751,",",0,0
226752,risk,0,0
226753,ratio,0,0
226754,=,0,0
226755,0.89,0,0
226756,),0,0
226757,.,0,0
226758,At,0,0
226759,baseline,0,0
226760,",",0,0
226761,the,0,0
226762,patients,0,1
226763,in,0,0
226764,the,0,0
226765,high,0,0
226766,magnesium,0,0
226767,group,0,0
226768,were,0,0
226769,older,0,1
226770,and,0,0
226771,had,0,0
226772,more,0,0
226773,severe,0,0
226774,functional,0,0
226775,and,0,0
226776,renal,0,1
226777,impairment,0,0
226778,.,0,0
226779,An,0,0
226780,analysis,0,0
226781,after,0,0
226782,adjustment,0,0
226783,for,0,0
226784,these,0,0
226785,variables,0,0
226786,demonstrated,0,0
226787,no,0,0
226788,difference,0,0
226789,in,0,0
226790,survival,0,0
226791,comparing,0,0
226792,the,0,0
226793,low,0,0
226794,",",0,0
226795,normal,0,1
226796,and,0,0
226797,high,0,0
226798,magnesium,0,0
226799,groups,0,0
226800,.,0,0
226801,Although,0,0
226802,the,0,0
226803,three,0,0
226804,groups,0,0
226805,had,0,0
226806,no,0,0
226807,difference,0,0
226808,in,0,0
226809,frequency,0,0
226810,of,0,0
226811,ventricular,0,0
226812,tachycardia,0,0
226813,",",0,0
226814,length,0,0
226815,of,0,0
226816,longest,0,0
226817,run,0,0
226818,or,0,0
226819,frequency,0,0
226820,of,0,0
226821,ventricular,0,0
226822,premature,0,1
226823,beats,0,0
226824,on,0,0
226825,baseline,0,0
226826,Holter,0,0
226827,monitoring,0,0
226828,",",0,0
226829,the,0,0
226830,group,0,0
226831,with,0,0
226832,hypomagnesemia,0,0
226833,had,0,0
226834,more,0,0
226835,frequent,0,0
226836,ventricular,0,0
226837,couplets,0,1
226838,.,0,1
226839,CONCLUSIONS,0,0
226840,Serum,0,0
226841,magnesium,0,0
226842,does,0,0
226843,not,0,0
226844,appear,0,0
226845,to,0,0
226846,be,0,0
226847,an,0,0
226848,independent,0,0
226849,risk,0,0
226850,factor,0,0
226851,for,0,0
226852,either,0,0
226853,sudden,0,0
226854,death,0,0
226855,or,0,0
226856,death,0,0
226857,due,0,0
226858,to,0,0
226859,all,0,0
226860,causes,0,0
226861,in,0,0
226862,patients,0,1
226863,with,0,1
226864,moderate,0,1
226865,to,0,0
226866,severe,0,1
226867,heart,0,1
226868,failure,0,1
226869,.,0,0
226870,Hypomagnesemia,0,0
226871,is,0,0
226872,associated,0,0
226873,with,0,0
226874,an,0,0
226875,increase,0,0
226876,in,0,0
226877,the,0,0
226878,frequency,0,0
226879,of,0,0
226880,certain,0,0
226881,forms,0,0
226882,of,0,0
226883,ventricular,0,0
226884,ectopic,0,0
226885,activity,0,0
226886,",",0,0
226887,but,0,0
226888,this,0,0
226889,is,0,0
226890,not,0,0
226891,associated,0,0
226892,with,0,0
226893,an,0,0
226894,increase,0,0
226895,in,0,0
226896,clinical,0,0
226897,events,0,0
226898,.,0,0
226899,The,0,0
226900,higher,0,0
226901,mortality,0,0
226902,rate,0,0
226903,among,0,0
226904,the,0,0
226905,patients,0,1
226906,with,0,0
226907,hypermagnesemia,0,0
226908,is,0,0
226909,attributable,0,0
226910,to,0,0
226911,older,0,1
226912,age,0,0
226913,",",0,0
226914,more,0,0
226915,advanced,0,0
226916,heart,0,0
226917,failure,0,1
226918,and,0,0
226919,renal,0,1
226920,insufficiency,0,1
226921,.,0,0
226922,Diode,0,0
226923,laser,0,0
226924,photocoagulation,0,0
226925,for,0,0
226926,threshold,1,0
226927,retinopathy,1,1
226928,of,1,0
226929,prematurity,1,1
226930,.,1,0
226931,A,0,0
226932,randomized,0,0
226933,study,0,0
226934,.,0,0
226935,BACKGROUND,0,0
226936,Although,0,0
226937,peripheral,0,0
226938,cryotherapy,0,0
226939,decreases,0,0
226940,the,0,0
226941,incidence,0,0
226942,of,0,0
226943,unfavorable,0,0
226944,anatomic,0,0
226945,outcomes,0,0
226946,in,0,0
226947,threshold,0,0
226948,retinopathy,1,1
226949,of,1,0
226950,prematurity,1,1
226951,(,1,0
226952,ROP,1,0
226953,),1,0
226954,",",0,0
226955,apnea,0,1
226956,",",0,0
226957,bradycardia,0,0
226958,",",0,0
226959,and,0,0
226960,lid,0,0
226961,edema,0,0
226962,can,0,0
226963,occur,0,0
226964,.,0,0
226965,Argon,0,0
226966,laser,0,0
226967,indirect,0,0
226968,ophthalmoscope,0,0
226969,photocoagulation,0,0
226970,has,0,0
226971,been,0,0
226972,used,0,0
226973,as,0,0
226974,an,0,0
226975,alternative,0,0
226976,to,0,0
226977,cryotherapy,0,0
226978,",",0,0
226979,with,0,0
226980,fewer,0,0
226981,adverse,0,0
226982,effects,0,0
226983,.,0,1
226984,Retinal,0,0
226985,lesions,0,0
226986,placed,0,0
226987,with,0,1
226988,diode,0,0
226989,lasers,0,0
226990,are,0,0
226991,deeper,0,0
226992,than,0,0
226993,similar,0,0
226994,argon,0,0
226995,laser,0,0
226996,lesions,0,0
226997,",",0,0
226998,and,0,0
226999,it,0,0
227000,is,0,0
227001,not,0,0
227002,known,0,0
227003,whether,0,0
227004,this,0,0
227005,difference,0,0
227006,could,0,0
227007,influence,0,0
227008,the,0,0
227009,response,0,0
227010,to,0,0
227011,ablative,0,1
227012,therapy,0,0
227013,.,0,1
227014,METHODS,0,0
227015,Patients,1,1
227016,were,0,1
227017,enrolled,0,1
227018,under,0,0
227019,a,0,0
227020,prospective,0,0
227021,",",0,0
227022,randomized,0,0
227023,protocol,0,0
227024,.,0,0
227025,One,0,0
227026,eye,0,0
227027,of,0,0
227028,each,0,0
227029,patient,0,0
227030,with,0,0
227031,symmetric,0,0
227032,",",0,0
227033,threshold,0,0
227034,ROP,0,0
227035,was,0,0
227036,treated,0,0
227037,with,0,0
227038,an,0,0
227039,814/815,0,0
227040,nm,0,0
227041,diode,0,0
227042,laser,0,0
227043,",",0,0
227044,while,0,0
227045,the,0,0
227046,other,0,0
227047,eye,0,0
227048,was,0,0
227049,treated,0,0
227050,with,0,1
227051,cryotherapy,0,0
227052,.,0,0
227053,Patients,0,1
227054,with,0,1
227055,asymmetric,0,1
227056,diseases,0,1
227057,also,0,0
227058,were,0,0
227059,randomized,0,0
227060,for,0,0
227061,treatment,0,0
227062,in,0,0
227063,the,0,0
227064,threshold,0,0
227065,eye,0,0
227066,.,0,0
227067,RESULTS,0,0
227068,Nineteen,1,1
227069,infants,1,1
227070,(,1,1
227071,33,1,1
227072,eyes,1,1
227073,),1,0
227074,were,1,0
227075,treated,1,0
227076,",",1,0
227077,ranging,1,0
227078,from,1,0
227079,485,1,1
227080,to,1,0
227081,863,1,1
227082,g,1,0
227083,birth,1,1
227084,weight,1,1
227085,(,1,0
227086,23,1,1
227087,to,1,0
227088,27,1,1
227089,weeks,1,0
227090,gestational,1,1
227091,age,1,1
227092,),1,0
227093,;,1,0
227094,18,1,1
227095,patients,1,1
227096,(,1,1
227097,32,1,1
227098,eyes,1,1
227099,),1,0
227100,were,0,0
227101,followed,0,0
227102,for,0,0
227103,3,0,0
227104,months,0,0
227105,or,0,1
227106,longer,0,0
227107,.,0,0
227108,Four,1,0
227109,patients,1,1
227110,(,1,1
227111,8,1,0
227112,eyes,1,1
227113,),1,0
227114,had,1,1
227115,bilateral,1,1
227116,zone,1,0
227117,1,1,0
227118,disease,1,1
227119,.,1,0
227120,Postconceptional,1,0
227121,age,1,1
227122,was,1,0
227123,36,1,0
227124,to,1,0
227125,45,1,1
227126,weeks,1,0
227127,at,1,0
227128,the,1,0
227129,time,1,0
227130,of,1,0
227131,treatment,1,0
227132,.,1,0
227133,The,0,0
227134,diode,0,0
227135,laser,0,0
227136,treatment,0,0
227137,was,0,0
227138,better,0,0
227139,tolerated,0,0
227140,than,0,0
227141,cryotherapy,0,0
227142,",",0,0
227143,and,0,0
227144,the,0,0
227145,treatment,0,0
227146,apparatus,0,0
227147,was,0,0
227148,more,0,0
227149,easily,0,0
227150,transported,0,0
227151,.,0,0
227152,Apneic,0,0
227153,episodes,0,0
227154,requiring,0,0
227155,intubation,0,0
227156,resulted,0,0
227157,from,0,0
227158,two,0,0
227159,cryotherapy,0,0
227160,sessions,0,0
227161,but,0,0
227162,no,0,0
227163,diode,0,0
227164,laser,0,0
227165,sessions,0,0
227166,.,0,1
227167,Five,0,0
227168,cryotherapy-treated,0,0
227169,eyes,0,1
227170,required,0,0
227171,retreatment,0,0
227172,because,0,0
227173,of,0,0
227174,persistent,0,1
227175,disease,0,1
227176,with,0,1
227177,adjacent,0,0
227178,skip,0,1
227179,areas,0,0
227180,.,0,0
227181,In,0,0
227182,the,0,0
227183,group,0,0
227184,followed,0,0
227185,for,0,0
227186,3,0,0
227187,to,0,0
227188,15,0,0
227189,months,0,0
227190,",",0,0
227191,1,0,0
227192,cryotherapy-treated,0,0
227193,eye,0,0
227194,and,0,0
227195,1,0,0
227196,diode,0,0
227197,laser-treated,0,0
227198,eye,0,0
227199,progressed,0,0
227200,to,0,0
227201,stage,0,1
227202,5,0,0
227203,retinal,0,0
227204,detachment,0,1
227205,.,0,0
227206,CONCLUSION,0,0
227207,Compared,0,0
227208,with,0,0
227209,cryotherapy,0,0
227210,",",0,0
227211,the,0,0
227212,diode,0,0
227213,laser,0,0
227214,was,0,0
227215,more,0,0
227216,convenient,0,0
227217,",",0,0
227218,technically,0,0
227219,easier,0,0
227220,to,0,0
227221,administer,0,0
227222,",",0,0
227223,and,0,0
227224,better,0,0
227225,tolerated,0,0
227226,by,0,0
227227,the,0,0
227228,patient,0,0
227229,.,0,0
227230,Although,0,0
227231,the,0,0
227232,number,0,0
227233,of,0,0
227234,patients,0,1
227235,was,0,0
227236,too,0,0
227237,small,0,0
227238,for,0,0
227239,meaningful,0,0
227240,statistical,0,0
227241,analysis,0,0
227242,of,0,0
227243,outcome,0,0
227244,",",0,0
227245,diode,0,0
227246,laser,0,0
227247,peripheral,0,0
227248,retinal,0,0
227249,ablation,0,0
227250,appeared,0,0
227251,to,0,0
227252,be,0,0
227253,as,0,0
227254,effective,0,0
227255,as,0,0
227256,cryotherapy,0,0
227257,for,0,0
227258,the,0,0
227259,treatment,0,0
227260,of,0,0
227261,threshold,0,0
227262,ROP,0,1
227263,.,0,1
227264,Beta-carotene,0,0
227265,in,0,0
227266,HIV,1,0
227267,infection,1,1
227268,.,1,0
227269,beta-Carotene,0,0
227270,has,0,0
227271,been,0,0
227272,reported,0,0
227273,to,0,0
227274,have,0,0
227275,an,0,0
227276,immunostimulatory,0,0
227277,effect,0,0
227278,.,0,0
227279,Recent,0,0
227280,studies,0,0
227281,suggest,0,0
227282,that,0,0
227283,beta-carotene,0,0
227284,supplementation,0,0
227285,can,0,0
227286,increase,0,0
227287,CD4,0,1
227288,counts,0,0
227289,in,0,0
227290,HIV-infected,1,1
227291,patients,1,1
227292,.,1,1
227293,Our,0,0
227294,double-blind,0,0
227295,",",0,0
227296,placebo-controlled,0,0
227297,clinical,0,0
227298,trial,0,0
227299,was,0,0
227300,designed,0,0
227301,to,0,0
227302,test,0,0
227303,the,0,0
227304,efficacy,0,0
227305,of,0,0
227306,beta-carotene,0,0
227307,in,0,0
227308,raising,0,0
227309,CD4,0,1
227310,counts,0,0
227311,in,0,0
227312,HIV-infected,1,1
227313,patients,1,1
227314,.,1,1
227315,Twenty-one,1,1
227316,HIV-seropositive,1,1
227317,patients,1,1
227318,were,0,0
227319,randomized,0,0
227320,to,0,0
227321,receive,0,0
227322,either,0,0
227323,beta-carotene,0,0
227324,",",0,0
227325,180,0,0
227326,mg/day,0,0
227327,or,0,0
227328,placebo,0,0
227329,for,0,0
227330,4,0,0
227331,weeks,0,0
227332,",",0,0
227333,and,0,0
227334,then,0,0
227335,crossed,0,0
227336,over,0,0
227337,to,0,0
227338,receive,0,0
227339,the,0,0
227340,alternative,0,0
227341,treatment,0,0
227342,for,0,0
227343,the,0,0
227344,following,0,0
227345,4,0,0
227346,weeks,0,0
227347,.,0,1
227348,beta-Carotene,0,0
227349,resulted,0,0
227350,in,0,0
227351,a,0,0
227352,statistically,0,0
227353,significant,0,0
227354,increase,0,0
227355,in,0,0
227356,total,0,1
227357,WBC,0,0
227358,count,0,0
227359,(,0,0
227360,p,0,0
227361,=,0,0
227362,0.01,0,0
227363,),0,0
227364,",",0,0
227365,%,0,0
227366,change,0,0
227367,in,0,0
227368,CD4,0,1
227369,count,0,0
227370,(,0,0
227371,p,0,0
227372,=,0,0
227373,0.02,0,0
227374,),0,0
227375,",",0,0
227376,and,0,0
227377,%,0,0
227378,change,0,0
227379,in,0,0
227380,CD4/CD8,0,1
227381,ratios,0,0
227382,(,0,0
227383,p,0,0
227384,=,0,0
227385,0.02,0,0
227386,),0,0
227387,compared,0,0
227388,to,0,0
227389,placebo,0,0
227390,.,0,0
227391,The,0,0
227392,absolute,0,0
227393,CD4,0,1
227394,count,0,0
227395,",",0,0
227396,absolute,0,0
227397,CD4/CD8,0,0
227398,ratio,0,0
227399,",",0,0
227400,and,0,0
227401,total,0,1
227402,and,0,0
227403,B-lymphocytes,0,0
227404,all,0,0
227405,increased,0,0
227406,on,0,0
227407,carotene,0,0
227408,and,0,0
227409,fell,0,0
227410,during,0,0
227411,placebo,0,0
227412,",",0,0
227413,but,0,0
227414,these,0,0
227415,differences,0,0
227416,did,0,0
227417,not,0,0
227418,reach,0,0
227419,statistical,0,0
227420,significance,0,0
227421,.,0,0
227422,No,0,0
227423,toxicity,0,0
227424,was,0,0
227425,observed,0,0
227426,on,0,0
227427,either,0,0
227428,treatment,0,0
227429,.,0,0
227430,beta-Carotene,0,0
227431,appears,0,0
227432,to,0,0
227433,have,0,0
227434,an,0,0
227435,immunostimulatory,0,0
227436,effect,0,0
227437,in,0,0
227438,HIV-infected,1,1
227439,patients,1,1
227440,.,1,1
227441,Further,0,0
227442,studies,0,0
227443,are,0,0
227444,needed,0,0
227445,to,0,0
227446,demonstrate,0,0
227447,whether,0,0
227448,beta-carotene,0,0
227449,has,0,0
227450,a,0,0
227451,role,0,0
227452,as,0,0
227453,adjunct,0,0
227454,therapy,0,0
227455,in,0,0
227456,treatment,0,0
227457,of,0,0
227458,HIV-infected,1,1
227459,patients,1,1
227460,.,1,1
227461,A,0,0
227462,randomized,0,0
227463,trial,0,0
227464,of,0,0
227465,radiation,0,0
227466,therapy,0,0
227467,compared,0,0
227468,to,0,0
227469,split,0,0
227470,course,0,0
227471,radiation,0,0
227472,therapy,0,0
227473,combined,0,0
227474,with,0,1
227475,mitomycin,0,0
227476,C,0,0
227477,and,0,0
227478,5,0,0
227479,fluorouracil,0,0
227480,as,0,0
227481,initial,0,0
227482,treatment,0,0
227483,for,0,0
227484,advanced,1,1
227485,laryngeal,1,1
227486,and,1,0
227487,hypopharyngeal,1,1
227488,squamous,1,1
227489,carcinoma,1,1
227490,.,1,0
227491,Two,1,0
227492,hundred,1,1
227493,and,1,0
227494,twelve,1,1
227495,patients,1,1
227496,with,1,1
227497,previously,1,1
227498,untreated,1,1
227499,advanced,1,1
227500,squamous,1,1
227501,carcinoma,1,1
227502,of,1,0
227503,the,1,0
227504,larynx,1,1
227505,or,1,0
227506,hypopharynx,1,1
227507,were,0,0
227508,randomized,0,0
227509,to,0,0
227510,receive,0,0
227511,initial,0,0
227512,treatment,0,0
227513,with,0,0
227514,radiotherapy,0,0
227515,",",0,0
227516,50,0,0
227517,Gy,0,0
227518,in,0,0
227519,20,0,1
227520,fractions,0,0
227521,in,0,0
227522,28,0,1
227523,days,0,0
227524,or,0,1
227525,split,0,0
227526,course,0,0
227527,radiotherapy,0,0
227528,and,0,0
227529,concurrent,0,0
227530,chemotherapy,0,0
227531,",",0,0
227532,25,0,0
227533,Gy,0,0
227534,in,0,0
227535,10,0,1
227536,fractions,0,0
227537,in,0,0
227538,14,0,1
227539,days,0,0
227540,followed,0,0
227541,by,0,0
227542,a,0,0
227543,4,0,0
227544,week,0,0
227545,rest,0,0
227546,and,0,0
227547,a,0,0
227548,further,0,0
227549,25,0,0
227550,Gy,0,0
227551,in,0,0
227552,10,0,1
227553,fractions,0,0
227554,in,0,0
227555,14,0,1
227556,days,0,0
227557,starting,0,0
227558,on,0,0
227559,day,0,0
227560,43,0,1
227561,;,0,0
227562,Mitomycin,0,0
227563,C,0,0
227564,was,0,0
227565,given,0,0
227566,on,0,0
227567,day,0,0
227568,1,0,0
227569,and,0,0
227570,day,0,0
227571,43,0,0
227572,and,0,0
227573,5FU,0,1
227574,continuous,0,0
227575,infusions,0,0
227576,on,0,0
227577,days,0,0
227578,1,0,1
227579,--,0,1
227580,4,0,0
227581,and,0,0
227582,days,0,0
227583,43,0,1
227584,--,0,1
227585,46,0,1
227586,.,0,0
227587,Surgery,0,0
227588,was,0,0
227589,reserved,0,0
227590,for,0,0
227591,persistent,0,1
227592,or,0,0
227593,recurrent,0,1
227594,disease,0,1
227595,.,0,0
227596,Two,1,0
227597,hundred,1,1
227598,and,1,0
227599,nine,1,1
227600,of,1,0
227601,the,1,0
227602,212,1,1
227603,patients,1,1
227604,randomized,1,1
227605,were,1,0
227606,included,1,0
227607,in,1,0
227608,the,1,0
227609,analyses,1,0
227610,.,1,0
227611,Outcome,0,0
227612,analyses,0,0
227613,were,0,0
227614,performed,0,0
227615,at,0,0
227616,a,0,0
227617,median,0,0
227618,follow-up,0,0
227619,interval,0,0
227620,of,0,0
227621,4.4,0,0
227622,years,0,1
227623,.,0,1
227624,No,0,0
227625,patients,0,1
227626,were,0,0
227627,lost,0,0
227628,to,0,0
227629,follow-up,0,0
227630,.,0,0
227631,No,0,0
227632,significant,0,0
227633,difference,0,0
227634,was,0,0
227635,found,0,0
227636,between,0,0
227637,the,0,0
227638,two,0,0
227639,arms,0,0
227640,for,0,0
227641,the,0,0
227642,end,0,0
227643,points,0,0
227644,of,0,0
227645,local,0,0
227646,relapse-free,0,0
227647,rate,0,0
227648,(,0,0
227649,p,0,0
227650,=,0,0
227651,0.91,0,0
227652,),0,0
227653,",",0,0
227654,regional,0,0
227655,relapse-free,0,0
227656,rate,0,0
227657,(,0,0
227658,p,0,0
227659,=,0,0
227660,0.17,0,0
227661,",",0,0
227662,adjusted,0,0
227663,),0,0
227664,or,0,0
227665,overall,0,0
227666,survival,0,0
227667,(,0,0
227668,p,0,0
227669,=,0,0
227670,0.86,0,0
227671,),0,0
227672,.,0,0
227673,Eight-eight,0,0
227674,patients,0,1
227675,had,0,1
227676,attempted,0,0
227677,surgical,0,0
227678,resection,0,1
227679,following,0,0
227680,radiotherapy,0,1
227681,failure,0,1
227682,.,0,0
227683,The,0,0
227684,contribution,0,0
227685,of,0,0
227686,salvage,0,0
227687,surgery,0,1
227688,to,0,0
227689,overall,0,0
227690,survival,0,0
227691,was,0,0
227692,similar,0,0
227693,for,0,0
227694,both,0,0
227695,arms,0,0
227696,of,0,0
227697,the,0,0
227698,study,0,0
227699,as,0,0
227700,was,0,0
227701,the,0,0
227702,surgical,0,0
227703,complication,0,0
227704,rate,0,0
227705,.,0,0
227706,Serious,0,0
227707,late,0,0
227708,radiation,0,0
227709,toxicity,0,0
227710,was,0,0
227711,minimal,0,0
227712,(,0,0
227713,3,0,0
227714,%,0,0
227715,in,0,0
227716,the,0,0
227717,RT,0,0
227718,group,0,0
227719,",",0,0
227720,0,0,0
227721,%,0,0
227722,in,0,0
227723,the,0,0
227724,radiation,0,0
227725,therapy,0,0
227726,plus,0,0
227727,chemotherapy,0,0
227728,group,0,0
227729,),0,0
227730,.,0,0
227731,The,0,0
227732,result,0,0
227733,of,0,0
227734,the,0,0
227735,trial,0,0
227736,shows,0,0
227737,no,0,0
227738,advantage,0,0
227739,in,0,0
227740,terms,0,0
227741,of,0,0
227742,local,0,0
227743,control,0,0
227744,or,0,0
227745,survival,0,0
227746,for,0,0
227747,the,0,0
227748,experimental,0,0
227749,treatment,0,0
227750,arm,0,0
227751,of,0,0
227752,split,0,0
227753,course,0,0
227754,radiotherapy,0,0
227755,and,0,0
227756,concurrent,0,0
227757,chemotherapy,0,0
227758,with,0,1
227759,Mitomycin,0,0
227760,C,0,0
227761,and,0,0
227762,5,0,0
227763,Fluorouracil,0,0
227764,compared,0,0
227765,to,0,0
227766,radiotherapy,0,0
227767,alone,0,0
227768,.,0,0
227769,[,0,0
227770,Prevention,0,0
227771,of,0,0
227772,pneumonia,1,0
227773,by,0,0
227774,endotracheal,0,0
227775,micronebulization,0,0
227776,of,0,0
227777,tobramycin,0,0
227778,],0,0
227779,.,0,0
227780,In,0,0
227781,69,1,0
227782,artificially,1,1
227783,ventilated,1,0
227784,patients,1,1
227785,the,1,0
227786,clinical,1,0
227787,",",1,0
227788,bacteriological,1,0
227789,and,1,0
227790,pharmacological,1,0
227791,effects,1,0
227792,of,1,0
227793,endotracheally,1,1
227794,administered,1,0
227795,tobramycin,1,0
227796,were,0,0
227797,studied,0,0
227798,in,0,0
227799,comparison,0,0
227800,to,0,0
227801,a,0,0
227802,control,0,0
227803,group,0,0
227804,.,0,0
227805,In,0,0
227806,the,0,0
227807,therapy,0,0
227808,group,0,0
227809,",",0,0
227810,52,0,0
227811,%,0,0
227812,of,0,0
227813,all,0,0
227814,specimens,0,0
227815,were,0,0
227816,sterile,0,0
227817,",",0,0
227818,in,0,0
227819,the,0,0
227820,control,0,0
227821,group,0,0
227822,only,0,0
227823,25,0,0
227824,%,0,0
227825,.,0,0
227826,During,0,0
227827,the,0,0
227828,first,0,0
227829,4,0,0
227830,days,0,0
227831,these,0,0
227832,changes,0,0
227833,were,0,0
227834,significant,0,0
227835,(,0,0
227836,p,0,0
227837,<,0,0
227838,0.05,0,0
227839,),0,0
227840,.,0,0
227841,In,0,0
227842,the,0,0
227843,therapy,0,0
227844,group,0,0
227845,the,0,0
227846,endotracheal,0,0
227847,colonisation,0,0
227848,with,0,1
227849,ps,0,0
227850,.,0,0
227851,aeruginosa,0,0
227852,was,0,0
227853,significantly,0,0
227854,lower,0,0
227855,between,0,0
227856,the,0,0
227857,4th,0,0
227858,and,0,0
227859,14th,0,0
227860,day,0,0
227861,(,0,0
227862,p,0,0
227863,<,0,0
227864,0.05,0,0
227865,),0,0
227866,.,0,0
227867,The,0,0
227868,incidence,0,0
227869,of,0,0
227870,secondary,0,0
227871,pneumonia,0,1
227872,was,0,0
227873,reduced,0,0
227874,from,0,0
227875,42,0,0
227876,%,0,0
227877,to,0,0
227878,17.5,0,0
227879,%,0,0
227880,(,0,0
227881,not,0,0
227882,significant,0,0
227883,),0,0
227884,.,0,0
227885,Systemic,0,1
227886,administration,0,0
227887,of,0,0
227888,antibiotics,0,0
227889,",",0,0
227890,e.g,0,0
227891,.,0,0
227892,of,0,0
227893,aminoglycosides,0,0
227894,",",0,0
227895,was,0,0
227896,significantly,0,0
227897,more,0,0
227898,often,0,0
227899,necessary,0,0
227900,in,0,0
227901,the,0,0
227902,control,0,0
227903,group,0,0
227904,.,0,0
227905,No,0,0
227906,increasing,0,0
227907,of,0,0
227908,growth,0,0
227909,of,0,0
227910,fungi,0,0
227911,in,0,0
227912,the,0,0
227913,upper,0,0
227914,respiratory,0,0
227915,tract,0,1
227916,was,0,0
227917,observed,0,0
227918,",",0,0
227919,but,0,0
227920,these,0,0
227921,was,0,0
227922,a,0,0
227923,non-significantly,0,0
227924,higher,0,0
227925,incidence,0,0
227926,mainly,0,0
227927,of,0,0
227928,staph,0,0
227929,.,0,0
227930,epidermidis,0,0
227931,.,0,0
227932,The,0,0
227933,application,0,0
227934,of,0,0
227935,80,0,1
227936,mg,0,0
227937,tobramycin,0,0
227938,four,0,0
227939,times,0,0
227940,a,0,0
227941,day,0,0
227942,as,0,0
227943,an,0,0
227944,aerosol,0,0
227945,was,0,0
227946,well,0,0
227947,tolerated,0,0
227948,by,0,0
227949,the,0,0
227950,patients,0,1
227951,.,0,0
227952,Under,0,0
227953,there,0,0
227954,conditions,0,0
227955,",",0,0
227956,tobramycin,0,0
227957,could,0,0
227958,not,0,0
227959,be,0,0
227960,measured,0,0
227961,in,0,0
227962,the,0,0
227963,serum,0,0
227964,.,0,0
227965,No,0,0
227966,allergic,0,0
227967,reactions,0,0
227968,",",0,0
227969,increased,0,0
227970,respiratory,0,0
227971,pressures,0,0
227972,or,0,1
227973,bronchoconstrictions,0,0
227974,were,0,0
227975,observed,0,0
227976,.,0,0
227977,Recombinant,0,0
227978,human,0,0
227979,erythropoietin,0,0
227980,therapy,0,0
227981,for,0,0
227982,anemic,1,1
227983,cancer,1,1
227984,patients,1,1
227985,on,1,0
227986,combination,1,0
227987,chemotherapy,1,0
227988,.,1,1
227989,BACKGROUND,0,0
227990,Patients,1,1
227991,with,1,1
227992,advanced,1,1
227993,cancer,1,1
227994,frequently,1,0
227995,experience,1,0
227996,clinically,1,0
227997,significant,1,0
227998,anemia,1,1
227999,",",0,0
228000,which,0,0
228001,is,0,0
228002,often,0,0
228003,exacerbated,0,0
228004,by,0,0
228005,myelosuppressive,0,0
228006,chemotherapy,0,0
228007,.,0,0
228008,Consistent,0,0
228009,with,0,0
228010,the,0,0
228011,anemia,0,1
228012,of,0,0
228013,chronic,0,1
228014,disease,0,1
228015,",",0,0
228016,studies,0,0
228017,have,0,0
228018,documented,0,0
228019,serum,0,0
228020,erythropoietin,0,0
228021,levels,0,0
228022,that,0,0
228023,are,0,0
228024,inappropriately,0,0
228025,low,0,0
228026,for,0,0
228027,the,0,0
228028,degree,0,0
228029,of,0,0
228030,anemia,0,1
228031,in,0,0
228032,cancer,1,1
228033,patients,1,1
228034,.,1,0
228035,Myelosuppressive,0,0
228036,chemotherapy,0,0
228037,impairs,0,0
228038,erythropoiesis,0,0
228039,",",0,0
228040,which,0,0
228041,may,0,0
228042,not,0,0
228043,fully,0,0
228044,recover,0,0
228045,between,0,0
228046,treatment,0,0
228047,cycles,0,0
228048,.,0,1
228049,Recombinant,0,0
228050,human,0,0
228051,erythropoietin,0,0
228052,(,0,0
228053,rHuEPO,0,0
228054,),0,0
228055,has,0,0
228056,been,0,0
228057,used,0,0
228058,safely,0,0
228059,and,0,0
228060,effectively,0,0
228061,to,0,0
228062,treat,0,0
228063,anemia,0,1
228064,in,0,0
228065,AIDS,0,1
228066,patients,0,1
228067,receiving,0,1
228068,zidovudine,0,0
228069,(,0,0
228070,AZT,0,0
228071,),0,0
228072,and,0,0
228073,in,0,0
228074,patients,0,1
228075,with,0,1
228076,chronic,0,1
228077,renal,0,1
228078,failure,0,1
228079,.,0,0
228080,PURPOSE,0,0
228081,This,0,0
228082,study,0,0
228083,was,0,0
228084,designed,0,0
228085,to,0,0
228086,evaluate,0,0
228087,the,0,0
228088,clinical,0,0
228089,role,0,0
228090,of,0,0
228091,rHuEPO,0,0
228092,in,0,0
228093,reducing,0,0
228094,symptomatic,0,1
228095,anemia,0,1
228096,in,0,0
228097,patients,1,1
228098,with,1,1
228099,advanced,1,1
228100,cancer,1,1
228101,who,1,1
228102,were,1,1
228103,receiving,1,1
228104,myelosuppressive,1,0
228105,chemotherapy,1,0
228106,(,1,0
228107,excluding,1,0
228108,cisplatin,1,0
228109,),1,0
228110,.,1,0
228111,METHODS,0,0
228112,We,0,0
228113,studied,0,1
228114,153,1,1
228115,anemic,1,1
228116,cancer,1,1
228117,patients,1,1
228118,receiving,1,1
228119,cyclic,1,0
228120,combination,1,0
228121,chemotherapy,1,0
228122,in,0,0
228123,a,0,0
228124,prospective,0,0
228125,multicenter,0,0
228126,",",0,0
228127,double-blind,0,0
228128,",",0,0
228129,placebo-controlled,0,0
228130,trial,0,0
228131,.,0,0
228132,The,0,0
228133,patients,1,1
228134,were,0,0
228135,randomly,0,1
228136,assigned,0,0
228137,to,0,0
228138,receive,0,0
228139,either,0,0
228140,rHuEPO,0,0
228141,(,0,0
228142,150,0,0
228143,U/kg,0,0
228144,),0,0
228145,or,0,0
228146,placebo,0,0
228147,subcutaneously,0,0
228148,three,0,0
228149,times,0,0
228150,a,0,0
228151,week,0,0
228152,for,0,0
228153,a,0,0
228154,maximum,0,0
228155,of,0,0
228156,12,0,0
228157,weeks,0,0
228158,or,0,1
228159,until,0,0
228160,the,0,0
228161,hematocrit,0,0
228162,level,0,0
228163,increased,0,0
228164,to,0,0
228165,38,0,1
228166,%,0,0
228167,-40,0,0
228168,%,0,0
228169,.,0,0
228170,If,0,0
228171,the,0,0
228172,hematocrit,0,0
228173,reached,0,0
228174,this,0,0
228175,target,0,0
228176,level,0,0
228177,before,0,0
228178,12,0,0
228179,weeks,0,0
228180,",",0,0
228181,the,0,0
228182,rHuEPO,0,0
228183,dose,0,0
228184,could,0,0
228185,be,0,0
228186,reduced,0,0
228187,to,0,0
228188,maintain,0,0
228189,the,0,0
228190,hematocrit,0,0
228191,at,0,0
228192,that,0,0
228193,level,0,0
228194,for,0,0
228195,the,0,0
228196,duration,0,0
228197,of,0,0
228198,the,0,0
228199,study,0,0
228200,.,0,0
228201,Response,0,0
228202,to,0,0
228203,rHuEPO,0,0
228204,therapy,0,0
228205,was,0,0
228206,assessed,0,0
228207,by,0,0
228208,measuring,0,0
228209,changes,0,0
228210,in,0,0
228211,hematocrit,0,0
228212,level,0,0
228213,",",0,0
228214,transfusion,0,0
228215,requirements,0,0
228216,",",0,0
228217,and,0,0
228218,quality,0,0
228219,of,0,0
228220,life,0,0
228221,.,0,0
228222,Quality-of-life,0,0
228223,assessment,0,0
228224,was,0,0
228225,based,0,0
228226,on,0,0
228227,patients,0,1
228228,',0,1
228229,responses,0,0
228230,to,0,1
228231,questionnaires,0,0
228232,before,0,0
228233,and,0,0
228234,after,0,0
228235,the,0,0
228236,courses,0,0
228237,of,0,0
228238,therapy,0,0
228239,.,0,0
228240,RESULTS,0,0
228241,The,0,0
228242,increase,0,0
228243,in,0,0
228244,hematocrit,0,0
228245,in,0,0
228246,the,0,0
228247,rHuEPO-treated,1,0
228248,group,1,0
228249,compared,0,0
228250,with,0,0
228251,hematocrit,0,0
228252,in,0,0
228253,the,0,0
228254,placebo-treated,1,0
228255,group,1,0
228256,was,0,0
228257,statistically,0,0
228258,significant,0,0
228259,(,0,0
228260,P,0,0
228261,=,0,0
228262,.0001,0,0
228263,),0,0
228264,as,0,0
228265,measured,0,0
228266,by,0,0
228267,percentage,0,0
228268,point,0,0
228269,of,0,0
228270,change,0,0
228271,from,0,0
228272,baseline,0,0
228273,to,0,0
228274,final,0,0
228275,evaluation,0,0
228276,",",0,0
228277,by,0,0
228278,an,0,0
228279,increase,0,0
228280,in,0,0
228281,hematocrit,0,0
228282,level,0,0
228283,of,0,0
228284,six,0,0
228285,percentage,0,0
228286,points,0,0
228287,or,0,0
228288,more,0,0
228289,unrelated,0,1
228290,to,0,0
228291,transfusion,0,0
228292,",",0,0
228293,and,0,0
228294,by,0,0
228295,a,0,0
228296,rise,0,0
228297,in,0,0
228298,hematocrit,0,0
228299,level,0,0
228300,to,0,0
228301,38,0,1
228302,%,0,0
228303,or,0,0
228304,more,0,0
228305,unrelated,0,1
228306,to,0,0
228307,transfusion,0,0
228308,.,0,0
228309,There,0,0
228310,was,0,0
228311,a,0,0
228312,trend,0,0
228313,toward,0,0
228314,the,0,0
228315,reduction,0,0
228316,in,0,0
228317,mean,0,0
228318,units,0,0
228319,of,0,0
228320,blood,0,0
228321,transfused,0,0
228322,per,0,0
228323,patient,0,0
228324,during,0,0
228325,months,0,0
228326,2,0,1
228327,and,0,0
228328,3,0,0
228329,of,0,0
228330,therapy,0,0
228331,combined,0,0
228332,in,0,0
228333,rHuEPO-treated,1,0
228334,patients,1,1
228335,compared,0,0
228336,with,0,1
228337,placebo-treated,1,0
228338,patients,1,1
228339,(,0,1
228340,0.91,0,0
228341,U,0,0
228342,versus,0,0
228343,1.65,0,0
228344,U,0,0
228345,;,0,0
228346,P,0,0
228347,=,0,0
228348,.056,0,0
228349,),0,0
228350,.,0,0
228351,In,0,0
228352,addition,0,0
228353,",",0,0
228354,rHuEPO-treated,1,0
228355,patients,1,1
228356,experienced,0,0
228357,a,0,0
228358,statistically,0,0
228359,significant,0,0
228360,improvement,0,0
228361,in,0,0
228362,energy,0,0
228363,level,0,0
228364,and,0,0
228365,ability,0,0
228366,to,0,0
228367,perform,0,0
228368,daily,0,0
228369,activities,0,0
228370,(,0,0
228371,P,0,0
228372,<,0,0
228373,or,0,1
228374,=,0,0
228375,.05,0,0
228376,),0,0
228377,.,0,0
228378,The,0,0
228379,two,0,0
228380,treatment,0,0
228381,groups,0,0
228382,showed,0,0
228383,no,0,0
228384,statistically,0,0
228385,significant,0,0
228386,differences,0,0
228387,in,0,0
228388,toxic,0,0
228389,effects,0,0
228390,except,0,0
228391,for,0,0
228392,increased,0,0
228393,incidence,0,0
228394,of,0,0
228395,diaphoresis,0,0
228396,(,0,0
228397,P,0,0
228398,<,0,0
228399,.05,0,0
228400,),0,0
228401,and,0,0
228402,diarrhea,0,1
228403,(,0,0
228404,P,0,0
228405,=,0,0
228406,.05,0,0
228407,),0,0
228408,in,0,0
228409,the,0,0
228410,rHuEPO-treated,1,0
228411,group,1,0
228412,.,1,0
228413,CONCLUSIONS,0,0
228414,We,0,0
228415,conclude,0,0
228416,that,0,0
228417,rHuEPO,0,0
228418,is,0,0
228419,safe,0,0
228420,and,0,0
228421,effective,0,0
228422,for,0,0
228423,reversing,0,0
228424,anemia,0,1
228425,related,0,0
228426,to,0,0
228427,advanced,0,1
228428,cancer,0,1
228429,or,0,0
228430,to,0,0
228431,chemotherapy,0,0
228432,for,0,0
228433,cancer,0,1
228434,.,0,0
228435,Effect,0,0
228436,of,0,0
228437,dietary,0,0
228438,supplementation,0,0
228439,with,0,1
228440,n-3,0,0
228441,fatty,0,0
228442,acids,0,0
228443,on,0,0
228444,coronary,1,1
228445,artery,1,1
228446,bypass,1,1
228447,graft,1,0
228448,patency,1,0
228449,.,1,0
228450,Epidemiologic,0,0
228451,and,0,0
228452,experimental,0,0
228453,data,0,0
228454,suggest,0,0
228455,that,0,0
228456,a,0,0
228457,high,0,0
228458,dietary,0,0
228459,intake,0,0
228460,of,0,0
228461,long-chain,0,0
228462,polyunsaturated,0,0
228463,n-3,0,0
228464,fatty,0,0
228465,acids,0,0
228466,may,0,0
228467,reduce,0,0
228468,the,0,0
228469,risk,0,0
228470,of,0,0
228471,atherothrombotic,0,1
228472,disease,0,1
228473,.,0,0
228474,In,0,0
228475,a,0,0
228476,randomized,0,0
228477,",",0,0
228478,controlled,0,0
228479,study,0,0
228480,",",0,0
228481,610,1,1
228482,patients,1,1
228483,undergoing,1,1
228484,coronary,1,1
228485,artery,1,1
228486,bypass,1,1
228487,grafting,1,0
228488,were,0,0
228489,assigned,0,0
228490,either,0,0
228491,to,0,0
228492,a,0,0
228493,fish,0,0
228494,oil,0,0
228495,group,0,0
228496,",",0,0
228497,receiving,0,0
228498,4,0,0
228499,g/day,0,0
228500,of,0,0
228501,fish,0,0
228502,oil,0,0
228503,concentrate,0,0
228504,",",0,0
228505,or,0,0
228506,to,0,0
228507,a,0,0
228508,control,0,0
228509,group,0,0
228510,.,0,0
228511,All,1,0
228512,patients,1,1
228513,received,1,0
228514,antithrombotic,1,0
228515,treatment,1,0
228516,",",1,0
228517,either,1,0
228518,aspirin,1,0
228519,or,1,0
228520,warfarin,1,0
228521,.,1,0
228522,Their,0,0
228523,diet,0,0
228524,and,0,0
228525,serum,0,0
228526,phospholipid,0,0
228527,fatty,0,0
228528,acid,0,0
228529,profiles,0,0
228530,were,0,0
228531,monitored,0,0
228532,.,0,0
228533,The,0,0
228534,primary,0,0
228535,end,0,0
228536,point,0,0
228537,was,0,0
228538,1-year,0,0
228539,graft,0,0
228540,patency,0,0
228541,",",0,0
228542,which,0,0
228543,was,0,0
228544,assessed,0,0
228545,by,0,0
228546,angiography,0,0
228547,in,0,0
228548,95,0,0
228549,%,0,0
228550,of,0,0
228551,patients,0,1
228552,.,0,1
228553,Vein,0,0
228554,graft,0,0
228555,occlusion,0,1
228556,rates,0,0
228557,per,0,0
228558,distal,0,1
228559,anastomoses,0,0
228560,were,0,0
228561,27,0,1
228562,%,0,0
228563,in,0,0
228564,the,0,0
228565,fish,0,0
228566,oil,0,0
228567,group,0,0
228568,and,0,0
228569,33,0,1
228570,%,0,0
228571,in,0,0
228572,the,0,0
228573,control,0,0
228574,group,0,0
228575,(,0,0
228576,odds,0,0
228577,ratio,0,0
228578,0.77,0,0
228579,",",0,0
228580,95,0,0
228581,%,0,0
228582,confidence,0,0
228583,interval,0,0
228584,",",0,0
228585,0.60,0,0
228586,to,0,0
228587,0.99,0,0
228588,",",0,0
228589,p,0,0
228590,=,0,0
228591,0.034,0,0
228592,),0,0
228593,.,0,0
228594,In,0,0
228595,the,0,0
228596,fish,0,0
228597,oil,0,0
228598,group,0,0
228599,",",0,0
228600,43,0,0
228601,%,0,0
228602,of,0,0
228603,the,0,0
228604,patients,0,1
228605,had,0,0
228606,>,0,1
228607,or,0,0
228608,=,0,0
228609,1,0,0
228610,occluded,0,0
228611,vein,0,0
228612,graft,0,0
228613,(,0,0
228614,s,0,0
228615,),0,0
228616,compared,0,0
228617,with,0,1
228618,51,0,0
228619,%,0,0
228620,in,0,0
228621,the,0,0
228622,control,0,0
228623,group,0,0
228624,(,0,0
228625,odds,0,0
228626,ratio,0,0
228627,0.72,0,0
228628,",",0,0
228629,95,0,0
228630,%,0,0
228631,confidence,0,0
228632,interval,0,0
228633,",",0,0
228634,0.51,0,0
228635,to,0,0
228636,1.01,0,0
228637,",",0,0
228638,p,0,0
228639,=,0,0
228640,0.05,0,0
228641,),0,0
228642,.,0,0
228643,Moreover,0,0
228644,",",0,0
228645,in,0,0
228646,the,0,0
228647,entire,0,0
228648,patient,0,0
228649,group,0,0
228650,",",0,0
228651,there,0,0
228652,was,0,0
228653,a,0,0
228654,significant,0,0
228655,trend,0,0
228656,to,0,0
228657,fewer,0,0
228658,patients,0,1
228659,with,0,1
228660,vein,0,1
228661,graft,0,0
228662,occlusions,0,1
228663,with,0,1
228664,increasing,0,0
228665,relative,0,0
228666,change,0,0
228667,in,0,0
228668,serum,0,0
228669,phospholipid,0,0
228670,n-3,0,0
228671,fatty,0,0
228672,acids,0,0
228673,during,0,0
228674,the,0,0
228675,study,0,0
228676,period,0,0
228677,(,0,0
228678,p,0,0
228679,for,0,0
228680,linear,0,0
228681,trend,0,0
228682,=,0,0
228683,0.0037,0,0
228684,),0,0
228685,.,0,0
228686,Thus,0,0
228687,",",0,0
228688,in,0,0
228689,patients,1,1
228690,undergoing,1,1
228691,coronary,1,1
228692,artery,1,1
228693,bypass,1,1
228694,grafting,1,0
228695,",",0,0
228696,dietary,0,0
228697,supplementation,0,0
228698,with,0,1
228699,n-3,0,0
228700,fatty,0,0
228701,acids,0,0
228702,reduced,0,0
228703,the,0,0
228704,incidence,0,0
228705,of,0,0
228706,vein,0,0
228707,graft,0,0
228708,occlusion,0,0
228709,",",0,0
228710,and,0,0
228711,an,0,0
228712,inverse,0,0
228713,relation,0,0
228714,between,0,0
228715,relative,0,0
228716,change,0,0
228717,in,0,0
228718,serum,0,0
228719,phospholipid,0,0
228720,n-3,0,0
228721,fatty,0,0
228722,acids,0,0
228723,and,0,0
228724,vein,0,1
228725,graft,0,0
228726,occlusions,0,1
228727,was,0,0
228728,observed,0,0
228729,.,0,0
228730,The,0,0
228731,effect,0,0
228732,of,0,0
228733,liquid,0,0
228734,fibre,0,0
228735,on,0,0
228736,feeding,1,0
228737,behaviour,1,0
228738,.,1,0
228739,Hypertension,1,0
228740,and,1,0
228741,non-insulin-dependent,1,1
228742,diabetes,1,1
228743,.,1,0
228744,A,0,0
228745,comparison,0,0
228746,between,0,0
228747,an,0,0
228748,angiotensin-converting,0,0
228749,enzyme,0,0
228750,inhibitor,0,0
228751,and,0,0
228752,a,0,0
228753,calcium,0,0
228754,antagonist,0,0
228755,.,0,0
228756,The,0,0
228757,effects,0,0
228758,of,0,0
228759,the,0,0
228760,angiotensin-converting,0,0
228761,enzyme,0,0
228762,lisinopril,0,0
228763,were,0,0
228764,compared,0,0
228765,with,0,0
228766,those,0,0
228767,of,0,0
228768,the,0,0
228769,calcium,0,0
228770,antagonist,0,0
228771,nifedipine,0,0
228772,in,0,0
228773,162,1,1
228774,non-insulin-dependent,1,1
228775,diabetic,1,1
228776,hypertensive,1,1
228777,patients,1,1
228778,for,0,0
228779,a,0,0
228780,24-week,0,0
228781,period,0,0
228782,.,0,0
228783,In,0,0
228784,83,0,0
228785,and,0,0
228786,79,0,1
228787,patients,0,1
228788,",",0,0
228789,respectively,0,0
228790,",",0,0
228791,lisinopril,0,0
228792,and,0,0
228793,slow-release,0,0
228794,nifedipine,0,0
228795,produced,0,0
228796,similar,0,0
228797,reductions,0,0
228798,in,0,0
228799,blood,0,0
228800,pressure,0,0
228801,(,0,0
228802,systolic/diastolic,0,0
228803,:,0,1
228804,-16/-13,0,0
228805,mmHg,0,0
228806,supine,0,0
228807,and,0,0
228808,-14/-11,0,0
228809,mmHg,0,0
228810,standing,0,0
228811,after,0,0
228812,lisinopril,0,0
228813,;,0,0
228814,-15/-12,0,0
228815,mmHg,0,0
228816,supine,0,0
228817,and,0,0
228818,-14/-11,0,0
228819,mmHg,0,0
228820,standing,0,0
228821,nifedipine,0,0
228822,),0,0
228823,.,0,0
228824,Fasting,0,0
228825,and,0,0
228826,post-prandial,0,0
228827,plasma,0,0
228828,glucose,0,0
228829,",",0,0
228830,glycosylated,0,0
228831,haemoglobin,0,0
228832,and,0,0
228833,plasma,0,0
228834,lipids,0,0
228835,appeared,0,0
228836,to,0,0
228837,be,0,0
228838,unaffected,0,0
228839,by,0,0
228840,either,0,0
228841,agent,0,0
228842,.,0,0
228843,Also,0,0
228844,",",0,0
228845,28,0,0
228846,%,0,0
228847,of,0,0
228848,the,0,0
228849,patients,0,1
228850,on,0,0
228851,lisinopril,0,0
228852,and,0,0
228853,30,0,0
228854,%,0,0
228855,of,0,0
228856,those,0,0
228857,on,0,0
228858,nifedipine,0,0
228859,presented,0,1
228860,microalbuminuria,0,0
228861,.,0,0
228862,Both,0,0
228863,drugs,0,0
228864,induced,0,0
228865,a,0,0
228866,reduction,0,0
228867,in,0,0
228868,the,0,0
228869,albumin,0,0
228870,excretion,0,0
228871,rate,0,0
228872,(,0,0
228873,AER,0,0
228874,),0,0
228875,.,0,0
228876,The,0,0
228877,geometric,0,0
228878,mean,0,0
228879,x,0,0
228880,:,0,0
228881,tolerance,0,0
228882,factor,0,0
228883,of,0,0
228884,the,0,0
228885,reduction,0,0
228886,in,0,0
228887,AER,0,0
228888,among,0,0
228889,the,0,0
228890,23,0,1
228891,microalbuminuric,0,0
228892,patients,0,1
228893,on,0,0
228894,lisinopril,0,0
228895,(,0,0
228896,-10.0,0,0
228897,x:1.3,0,0
228898,micrograms/min,0,0
228899,),0,0
228900,was,0,0
228901,greater,0,0
228902,",",0,0
228903,though,0,0
228904,not,0,0
228905,significantly,0,0
228906,so,0,0
228907,",",0,0
228908,than,0,0
228909,that,0,0
228910,observed,0,0
228911,in,0,0
228912,the,0,0
228913,26,0,0
228914,on,0,0
228915,nifedipine,0,0
228916,(,0,0
228917,-0.9,0,0
228918,x,0,0
228919,1.2,0,0
228920,micrograms/min,0,0
228921,),0,0
228922,.,0,0
228923,Moreover,0,0
228924,",",0,0
228925,lisinopril,0,0
228926,appeared,0,0
228927,to,0,0
228928,be,0,0
228929,better,0,0
228930,tolerated,0,0
228931,than,0,0
228932,nifedipine,0,0
228933,in,0,0
228934,our,0,0
228935,study,0,0
228936,population,0,1
228937,.,0,0
228938,Microalbuminuria,0,0
228939,is,0,0
228940,an,0,0
228941,important,0,0
228942,risk,0,0
228943,factor,0,0
228944,for,0,0
228945,cardiovascular,0,0
228946,mortality,0,0
228947,in,0,0
228948,non-insulin-dependent,1,1
228949,diabetic,1,1
228950,patients,1,1
228951,as,0,0
228952,well,0,0
228953,as,0,0
228954,in,0,0
228955,the,0,0
228956,general,0,1
228957,population,0,1
228958,.,0,1
228959,To,0,0
228960,what,0,0
228961,extent,0,0
228962,a,0,1
228963,reduction,0,0
228964,in,0,0
228965,the,0,0
228966,AER,0,0
228967,could,0,0
228968,ameliorate,0,0
228969,diabetic,0,1
228970,patients,0,1
228971,is,0,0
228972,",",0,0
228973,at,0,0
228974,present,0,0
228975,",",0,0
228976,unknown,0,0
228977,.,0,0
228978,Finally,0,0
228979,",",0,0
228980,both,0,0
228981,lisinopril,0,0
228982,and,0,0
228983,nifedipine,0,0
228984,showed,0,0
228985,a,0,0
228986,similar,0,0
228987,antihypertensive,0,0
228988,effect,0,0
228989,in,0,0
228990,these,0,0
228991,patients,0,1
228992,which,0,0
228993,was,0,0
228994,not,0,0
228995,associated,0,0
228996,with,0,0
228997,significant,0,0
228998,differences,0,0
228999,in,0,0
229000,plasma,0,0
229001,glucose,0,0
229002,",",0,0
229003,insulin,0,0
229004,or,0,0
229005,lipid,0,0
229006,concentrations,0,0
229007,.,0,0
229008,The,0,0
229009,clinical,0,0
229010,consequences,0,0
229011,of,0,0
229012,the,0,0
229013,insignificant,0,0
229014,differences,0,0
229015,in,0,0
229016,AER,0,1
229017,remain,0,0
229018,unclear,0,0
229019,.,0,0
229020,A,0,0
229021,randomised,0,0
229022,controlled,0,0
229023,trial,0,0
229024,comparing,0,0
229025,two,0,0
229026,schedules,0,0
229027,of,0,0
229028,antenatal,0,1
229029,visits,0,0
229030,:,0,1
229031,the,0,0
229032,antenatal,0,0
229033,care,0,0
229034,project,0,1
229035,.,0,0
229036,OBJECTIVE,0,0
229037,To,0,0
229038,compare,0,0
229039,the,0,0
229040,clinical,0,0
229041,and,0,0
229042,psychological,0,0
229043,effectiveness,0,0
229044,of,0,0
229045,the,0,0
229046,traditional,1,0
229047,British,1,1
229048,antenatal,1,1
229049,visit,1,0
229050,schedule,1,0
229051,(,0,0
229052,traditional,0,0
229053,care,0,0
229054,),0,0
229055,with,1,0
229056,a,1,0
229057,reduced,1,0
229058,schedule,1,0
229059,of,1,0
229060,visits,1,0
229061,(,0,0
229062,new,0,0
229063,style,0,0
229064,care,0,0
229065,),0,0
229066,for,0,0
229067,low,1,0
229068,risk,1,0
229069,women,1,1
229070,",",0,0
229071,together,0,0
229072,with,0,0
229073,maternal,0,0
229074,and,0,0
229075,professional,0,0
229076,satisfaction,0,0
229077,with,0,1
229078,care,0,0
229079,.,0,0
229080,DESIGN,0,0
229081,Randomised,0,0
229082,controlled,0,0
229083,trial,0,0
229084,.,0,0
229085,SETTING,0,0
229086,Places,0,0
229087,in,0,0
229088,south,0,1
229089,east,0,1
229090,London,0,1
229091,providing,0,0
229092,antenatal,0,1
229093,care,0,0
229094,for,0,0
229095,women,1,1
229096,receiving,1,1
229097,shared,1,0
229098,care,1,0
229099,and,0,0
229100,planning,0,0
229101,to,0,0
229102,deliver,0,0
229103,in,0,0
229104,one,0,0
229105,of,0,0
229106,three,0,0
229107,hospitals,0,1
229108,or,0,1
229109,at,0,0
229110,home,0,1
229111,.,0,0
229112,SUBJECT,0,0
229113,2794,1,1
229114,women,1,1
229115,at,1,0
229116,low,1,0
229117,risk,1,0
229118,fulfilling,1,1
229119,the,1,0
229120,trial,1,0
229121,'s,1,0
229122,inclusion,1,0
229123,criteria,1,1
229124,between,1,0
229125,June,1,1
229126,1993,1,1
229127,and,1,0
229128,July,1,0
229129,1994,1,1
229130,.,1,1
229131,MAIN,0,0
229132,OUTCOME,0,0
229133,MEASURES,0,0
229134,Measures,0,0
229135,of,0,0
229136,fetal,0,0
229137,and,0,0
229138,maternal,0,0
229139,morbidity,0,0
229140,",",0,0
229141,health,0,0
229142,service,0,0
229143,use,0,0
229144,",",0,0
229145,psychosocial,0,0
229146,outcomes,0,0
229147,",",0,0
229148,and,0,0
229149,maternal,0,0
229150,and,0,0
229151,professional,0,0
229152,satisfaction,0,0
229153,.,0,0
229154,RESULTS,0,0
229155,Pregnant,1,1
229156,women,1,1
229157,allocated,1,0
229158,to,1,0
229159,new,1,0
229160,style,1,0
229161,care,1,0
229162,had,0,0
229163,fewer,0,0
229164,day,0,0
229165,admissions,0,1
229166,(,0,0
229167,0.8,0,0
229168,v,0,0
229169,1.0,0,0
229170,;,0,0
229171,P=0.002,0,0
229172,),0,0
229173,and,0,0
229174,ultrasound,0,0
229175,scans,0,0
229176,(,0,0
229177,1.6,0,0
229178,v,0,0
229179,1.7,0,0
229180,;,0,0
229181,P=0.003,0,0
229182,),0,0
229183,and,0,0
229184,were,0,0
229185,less,0,0
229186,often,0,0
229187,suspected,0,0
229188,of,0,0
229189,carrying,0,0
229190,fetuses,0,1
229191,that,0,0
229192,were,0,0
229193,small,0,0
229194,for,0,0
229195,gestational,0,1
229196,age,0,1
229197,(,0,0
229198,odds,0,0
229199,ratio,0,0
229200,0.73,0,0
229201,;,0,0
229202,95,0,0
229203,%,0,0
229204,confidence,0,0
229205,interval,0,0
229206,0.54,0,0
229207,to,0,0
229208,0.99,0,0
229209,),0,0
229210,.,0,0
229211,They,0,0
229212,also,0,0
229213,had,0,0
229214,some,0,0
229215,poorer,0,0
229216,psychosocial,0,0
229217,outcomes,0,0
229218,;,0,0
229219,for,0,0
229220,example,0,0
229221,",",0,0
229222,they,0,0
229223,were,0,0
229224,more,0,0
229225,worried,0,0
229226,about,0,0
229227,fetal,0,0
229228,wellbeing,0,0
229229,antenatally,0,1
229230,and,0,0
229231,coping,0,0
229232,with,0,0
229233,the,0,0
229234,baby,0,1
229235,postnatally,0,0
229236,",",0,0
229237,and,0,0
229238,they,0,0
229239,had,0,0
229240,more,0,0
229241,negative,0,0
229242,attitudes,0,0
229243,to,0,0
229244,their,0,0
229245,babies,0,0
229246,",",0,0
229247,both,0,0
229248,in,0,0
229249,pregnancy,0,1
229250,and,0,0
229251,postnatally,0,0
229252,.,0,0
229253,These,0,0
229254,women,0,1
229255,were,0,0
229256,also,0,0
229257,more,0,0
229258,dissatisfied,0,0
229259,with,0,0
229260,the,0,0
229261,number,0,0
229262,of,0,0
229263,visits,0,0
229264,they,0,0
229265,received,0,0
229266,(,0,0
229267,odds,0,0
229268,ratio,0,0
229269,2.50,0,0
229270,;,0,0
229271,2.00,0,0
229272,to,0,0
229273,3.11,0,0
229274,),0,0
229275,.,0,0
229276,CONCLUSIONS,0,0
229277,Patterns,0,0
229278,of,0,0
229279,antenatal,0,1
229280,care,0,0
229281,involving,0,0
229282,fewer,0,0
229283,routine,0,0
229284,visits,0,0
229285,for,0,0
229286,women,0,1
229287,at,0,0
229288,low,0,0
229289,risk,0,0
229290,may,0,0
229291,lead,0,0
229292,to,0,0
229293,reduced,0,0
229294,psychosocial,0,0
229295,effectiveness,0,0
229296,and,0,0
229297,dissatisfaction,0,0
229298,with,0,0
229299,frequency,0,0
229300,of,0,0
229301,visits,0,0
229302,.,0,0
229303,The,0,0
229304,number,0,0
229305,of,0,0
229306,antenatal,0,1
229307,day,0,0
229308,admissions,0,1
229309,and,0,0
229310,ultrasound,0,0
229311,scans,0,0
229312,performed,0,0
229313,may,0,0
229314,also,0,0
229315,be,0,0
229316,reduced,0,0
229317,.,0,0
229318,For,0,0
229319,the,0,0
229320,variables,0,0
229321,reported,0,0
229322,",",0,0
229323,the,0,0
229324,visit,0,0
229325,schedules,0,0
229326,studied,0,1
229327,are,0,0
229328,similar,0,0
229329,in,0,0
229330,their,0,0
229331,clinical,0,0
229332,effectiveness,0,0
229333,.,0,0
229334,Uncertainty,0,0
229335,remains,0,0
229336,as,0,0
229337,to,0,0
229338,the,0,0
229339,clinical,0,0
229340,effectiveness,0,0
229341,of,0,0
229342,reduced,0,0
229343,visit,0,0
229344,schedules,0,0
229345,for,0,0
229346,rare,0,1
229347,pregnancy,0,1
229348,problems,0,1
229349,.,0,1
229350,Around-the-clock,0,1
229351,intraocular,0,0
229352,pressure,0,0
229353,reduction,0,0
229354,with,0,1
229355,once-daily,0,0
229356,application,0,0
229357,of,0,0
229358,latanoprost,0,0
229359,by,0,0
229360,itself,0,0
229361,or,0,0
229362,in,0,0
229363,combination,0,0
229364,with,0,1
229365,timolol,0,0
229366,.,0,0
229367,OBJECTIVE,0,0
229368,To,0,0
229369,determine,0,0
229370,whether,0,0
229371,once-daily,0,0
229372,",",0,0
229373,in,0,0
229374,the,0,0
229375,morning,0,0
229376,",",0,0
229377,topical,0,0
229378,application,0,0
229379,of,0,0
229380,the,0,0
229381,new,0,0
229382,ocular,0,1
229383,hypotensive,0,0
229384,prostaglandin,0,0
229385,analogue,0,0
229386,",",0,0
229387,latanoprost,0,0
229388,",",0,0
229389,yields,0,0
229390,nocturnal,0,0
229391,intraocular,0,1
229392,pressure,0,0
229393,(,0,0
229394,IOP,0,0
229395,),0,0
229396,reduction,0,0
229397,similar,0,0
229398,to,0,0
229399,its,0,0
229400,diurnal,0,0
229401,IOP,0,0
229402,reducing,0,0
229403,efficacy,0,0
229404,.,0,0
229405,STUDY,0,0
229406,DESIGN,0,0
229407,AND,0,0
229408,PATIENTS,0,0
229409,Placebo-,0,0
229410,controlled,0,0
229411,",",0,0
229412,randomized,0,0
229413,",",0,0
229414,and,0,0
229415,double-masked,0,0
229416,study,0,0
229417,on,0,0
229418,hospitalized,1,1
229419,patients,1,1
229420,with,1,1
229421,ocular,1,1
229422,hypertension,1,1
229423,or,1,0
229424,glaucoma,1,1
229425,.,1,0
229426,Patients,1,1
229427,in,1,0
229428,group,1,0
229429,1,1,0
229430,(,1,0
229431,n=9,1,1
229432,),1,0
229433,were,0,0
229434,maintained,0,0
229435,on,0,0
229436,twice-daily,0,0
229437,applications,0,0
229438,of,0,0
229439,0.5,0,0
229440,%,0,0
229441,timolol,0,0
229442,maleate,0,0
229443,.,0,0
229444,Patients,1,1
229445,in,1,0
229446,group,1,0
229447,2,1,0
229448,(,1,0
229449,n=10,1,1
229450,),1,0
229451,terminated,0,0
229452,their,0,0
229453,timolol,0,0
229454,treatment,0,0
229455,3,0,0
229456,weeks,0,0
229457,before,0,0
229458,the,0,0
229459,beginning,0,0
229460,of,0,0
229461,the,0,0
229462,study,0,0
229463,.,0,0
229464,In,0,0
229465,both,0,0
229466,groups,0,0
229467,the,0,0
229468,test,0,0
229469,drug,0,0
229470,(,0,0
229471,0.005,0,0
229472,%,0,0
229473,latanoprost,0,0
229474,),0,0
229475,and,0,0
229476,its,0,0
229477,vehicle,0,0
229478,(,0,0
229479,placebo,0,0
229480,),0,0
229481,was,0,0
229482,applied,0,0
229483,by,0,0
229484,hospital,0,0
229485,staff,0,0
229486,every,0,0
229487,morning,0,0
229488,for,0,0
229489,9,0,0
229490,days,0,0
229491,.,0,1
229492,MEASUREMENTS,0,0
229493,After,0,0
229494,4,0,0
229495,days,0,0
229496,of,0,0
229497,ambulatory,0,1
229498,treatment,0,0
229499,",",0,0
229500,patients,0,1
229501,were,0,0
229502,hospitalized,0,1
229503,",",0,0
229504,and,0,0
229505,IOP,0,0
229506,values,0,0
229507,were,0,0
229508,obtained,0,0
229509,in,0,0
229510,the,0,0
229511,supine,0,0
229512,and,0,0
229513,sitting,0,0
229514,positions,0,0
229515,with,0,1
229516,a,0,0
229517,handheld,0,0
229518,electronic,0,0
229519,tonometer,0,0
229520,(,0,0
229521,Tono-Pen,0,0
229522,XL,0,0
229523,",",0,0
229524,Bio-Rad,0,0
229525,",",0,0
229526,Glendale,0,0
229527,",",0,0
229528,Calif,0,0
229529,),0,0
229530,and,0,0
229531,a,0,0
229532,Goldmann,0,0
229533,'s,0,0
229534,applanation,0,0
229535,tonometer,0,0
229536,",",0,0
229537,covering,0,0
229538,every,0,0
229539,2-hour,0,0
229540,interval,0,0
229541,",",0,0
229542,around,0,0
229543,the,0,0
229544,clock,0,0
229545,",",0,0
229546,but,0,0
229547,not,0,0
229548,more,0,0
229549,than,0,0
229550,at,0,0
229551,four,0,0
229552,time,0,0
229553,points,0,0
229554,per,0,0
229555,day,0,0
229556,during,0,0
229557,a,0,0
229558,5-day,0,0
229559,period,0,0
229560,.,0,0
229561,RESULTS,0,0
229562,The,0,0
229563,mean,0,0
229564,nocturnal,0,0
229565,IOPs,0,1
229566,(,0,0
229567,Goldmann,0,0
229568,'s,0,0
229569,applanation,0,0
229570,tonometer,0,0
229571,),0,0
229572,collected,0,0
229573,for,0,0
229574,5,0,0
229575,days,0,0
229576,were,0,0
229577,mean,0,1
229578,+/-SEM,0,0
229579,17.9+/-0.6,0,0
229580,vs,0,0
229581,20.2+/-0.6,0,0
229582,mm,0,0
229583,Hg,0,0
229584,and,0,0
229585,16.8+/-0.3,0,0
229586,vs,0,0
229587,20.6+/-0.5,0,0
229588,mm,0,0
229589,Hg,0,0
229590,for,0,0
229591,the,0,0
229592,study,0,0
229593,vs,0,0
229594,the,0,0
229595,control,0,0
229596,eyes,0,0
229597,in,0,0
229598,group,0,0
229599,1,0,0
229600,and,0,0
229601,group,0,0
229602,2,0,0
229603,",",0,0
229604,respectively,0,0
229605,.,0,0
229606,These,0,0
229607,nocturnal,0,0
229608,IOP,0,0
229609,reductions,0,0
229610,were,0,0
229611,statistically,0,0
229612,significant,0,0
229613,(,0,0
229614,P,0,0
229615,<,0,0
229616,.001,0,0
229617,",",0,0
229618,two-tailed,0,0
229619,paired,0,0
229620,Student,0,0
229621,'s,0,0
229622,t,0,0
229623,test,0,0
229624,),0,0
229625,.,0,0
229626,The,0,0
229627,differences,0,0
229628,between,0,0
229629,diurnal,0,0
229630,and,0,0
229631,nocturnal,0,0
229632,IOP,0,0
229633,reductions,0,0
229634,(,0,0
229635,handheld,0,0
229636,electronic,0,0
229637,or,0,0
229638,Goldmann,0,0
229639,'s,0,0
229640,applanation,0,0
229641,tonometer,0,0
229642,),0,0
229643,were,0,0
229644,minimal,0,0
229645,(,0,0
229646,>,0,1
229647,0.3,0,0
229648,mm,0,0
229649,Hg,0,0
229650,),0,0
229651,and,0,0
229652,statistically,0,0
229653,not,0,0
229654,significant,0,0
229655,(,0,0
229656,P,0,0
229657,>,0,1
229658,.31,0,0
229659,",",0,0
229660,two-tailed,0,0
229661,paired,0,0
229662,Student,0,0
229663,'s,0,0
229664,t,0,0
229665,test,0,0
229666,),0,0
229667,.,0,0
229668,CONCLUSION,0,0
229669,Once-daily,0,0
229670,latanoprost,0,0
229671,treatment,0,0
229672,provides,0,0
229673,uniform,0,0
229674,circadian,0,0
229675,(,0,0
229676,around-the-clock,0,1
229677,),0,0
229678,IOP,0,0
229679,reduction,0,0
229680,by,0,0
229681,itself,0,0
229682,",",0,0
229683,or,0,0
229684,in,0,0
229685,combination,0,0
229686,with,0,1
229687,timolol,0,0
229688,.,0,0
229689,Prevention,0,0
229690,of,0,0
229691,venous,0,0
229692,thromboembolism,0,1
229693,after,0,0
229694,knee,1,1
229695,arthroplasty,1,1
229696,.,1,0
229697,A,0,0
229698,randomized,0,0
229699,",",0,0
229700,double-blind,0,0
229701,trial,0,0
229702,comparing,0,0
229703,enoxaparin,0,0
229704,with,0,1
229705,warfarin,0,0
229706,.,0,0
229707,OBJECTIVE,0,0
229708,To,0,0
229709,compare,0,0
229710,the,0,0
229711,effectiveness,0,0
229712,and,0,0
229713,safety,0,0
229714,of,0,0
229715,fixed-dose,0,0
229716,enoxaparin,0,0
229717,and,0,0
229718,adjusted,0,0
229719,dose,0,0
229720,warfarin,0,0
229721,in,0,0
229722,preventing,0,0
229723,venous,0,0
229724,thromboembolism,0,1
229725,after,1,0
229726,knee,1,1
229727,arthroplasty,1,1
229728,.,1,0
229729,DESIGN,0,0
229730,A,0,0
229731,randomized,0,0
229732,",",0,0
229733,double-blind,0,0
229734,controlled,0,0
229735,trial,0,0
229736,.,0,0
229737,SETTING,0,0
229738,8,1,0
229739,university,1,1
229740,hospitals,1,1
229741,.,1,0
229742,PATIENTS,0,0
229743,670,1,0
229744,consecutive,1,1
229745,patients,1,1
229746,who,1,1
229747,had,1,1
229748,knee,1,1
229749,arthroplasty,1,1
229750,.,1,0
229751,INTERVENTION,0,0
229752,Patients,0,1
229753,were,0,1
229754,randomly,0,1
229755,assigned,0,0
229756,to,0,0
229757,receive,0,0
229758,enoxaparin,0,0
229759,(,0,0
229760,30,0,0
229761,mg,0,0
229762,subcutaneously,0,0
229763,every,0,0
229764,12,0,0
229765,hours,0,0
229766,),0,0
229767,or,0,0
229768,adjusted-dose,0,0
229769,warfarin,0,0
229770,(,0,0
229771,international,0,0
229772,normalized,0,0
229773,ratio,0,0
229774,",",0,0
229775,2.0,0,0
229776,to,0,0
229777,3.0,0,0
229778,),0,0
229779,.,0,0
229780,Both,0,0
229781,regimens,0,0
229782,were,0,0
229783,started,0,0
229784,after,0,0
229785,surgery,0,1
229786,.,0,0
229787,MEASUREMENTS,0,0
229788,The,0,0
229789,primary,0,0
229790,end,0,0
229791,point,0,0
229792,was,0,0
229793,the,0,0
229794,incidence,0,0
229795,of,0,0
229796,deep,0,0
229797,venous,0,0
229798,thrombosis,0,1
229799,in,0,0
229800,patients,1,1
229801,with,1,1
229802,adequate,1,0
229803,bilateral,1,1
229804,venograms,1,1
229805,;,1,0
229806,the,0,0
229807,secondary,0,0
229808,end,0,0
229809,point,0,0
229810,was,0,0
229811,hemorrhage,0,0
229812,.,0,0
229813,RESULTS,0,0
229814,Among,0,1
229815,the,0,0
229816,417,1,1
229817,patients,1,1
229818,with,1,1
229819,adequate,1,0
229820,venograms,1,0
229821,",",0,0
229822,109,0,1
229823,of,0,0
229824,211,0,1
229825,warfarin,0,0
229826,recipients,0,1
229827,(,0,0
229828,51.7,0,0
229829,%,0,0
229830,),0,0
229831,had,0,0
229832,deep,0,0
229833,venous,0,0
229834,thrombosis,0,1
229835,compared,0,0
229836,with,0,1
229837,76,0,1
229838,of,0,0
229839,206,0,1
229840,enoxaparin,0,0
229841,recipients,0,1
229842,(,0,0
229843,36.9,0,0
229844,%,0,0
229845,),0,0
229846,(,0,0
229847,P,0,0
229848,=,0,0
229849,0.003,0,0
229850,),0,0
229851,.,0,0
229852,The,0,0
229853,absolute,0,0
229854,risk,0,0
229855,difference,0,0
229856,was,0,0
229857,14.8,0,0
229858,%,0,0
229859,in,0,0
229860,favor,0,0
229861,of,0,0
229862,enoxaparin,0,0
229863,(,0,0
229864,95,0,0
229865,%,0,0
229866,Cl,0,0
229867,",",0,0
229868,5.3,0,0
229869,%,0,0
229870,to,0,0
229871,24.1,0,0
229872,%,0,0
229873,),0,0
229874,Twenty-two,0,1
229875,warfarin,0,0
229876,recipients,0,1
229877,(,0,0
229878,10.4,0,0
229879,%,0,0
229880,),0,0
229881,and,0,0
229882,24,0,0
229883,enoxaparin,0,0
229884,recipients,0,1
229885,(,0,0
229886,11.7,0,0
229887,%,0,0
229888,),0,0
229889,had,0,0
229890,proximal,0,0
229891,venous,0,0
229892,thrombosis,0,1
229893,(,0,0
229894,P,0,0
229895,>,0,1
229896,0.2,0,0
229897,),0,0
229898,.,0,0
229899,The,0,0
229900,absolute,0,0
229901,risk,0,0
229902,difference,0,0
229903,was,0,0
229904,1.2,0,0
229905,%,0,0
229906,in,0,0
229907,favor,0,0
229908,of,0,0
229909,warfarin,0,0
229910,(,0,0
229911,Cl,0,0
229912,",",0,0
229913,-7.2,0,0
229914,%,0,0
229915,to,0,0
229916,4.8,0,0
229917,%,0,0
229918,),0,0
229919,.,0,0
229920,The,0,0
229921,incidence,0,0
229922,of,0,0
229923,major,0,0
229924,bleeding,0,0
229925,was,0,0
229926,1.8,0,0
229927,%,0,0
229928,(,0,0
229929,6,0,0
229930,of,0,0
229931,334,0,1
229932,patients,0,1
229933,),0,0
229934,in,0,0
229935,the,0,0
229936,warfarin,0,0
229937,group,0,0
229938,and,0,0
229939,2.1,0,0
229940,%,0,0
229941,(,0,0
229942,7,0,0
229943,of,0,0
229944,336,0,1
229945,patients,0,1
229946,),0,0
229947,in,0,0
229948,the,0,0
229949,enoxaparin,0,0
229950,group,0,0
229951,(,0,0
229952,P,0,0
229953,>,0,1
229954,0.2,0,0
229955,),0,0
229956,.,0,0
229957,The,0,0
229958,absolute,0,0
229959,risk,0,0
229960,difference,0,0
229961,was,0,0
229962,0.3,0,0
229963,%,0,0
229964,in,0,0
229965,favor,0,0
229966,of,0,0
229967,warfarin,0,0
229968,(,0,0
229969,Cl,0,0
229970,",",0,0
229971,-2.4,0,0
229972,%,0,0
229973,to,0,0
229974,1.8,0,0
229975,%,0,0
229976,),0,0
229977,.,0,0
229978,CONCLUSIONS,0,0
229979,A,0,0
229980,postoperative,0,0
229981,",",0,0
229982,fixed-dose,0,0
229983,enoxaparin,0,0
229984,regimen,0,0
229985,is,0,0
229986,more,0,0
229987,effective,0,0
229988,than,0,0
229989,adjusted-dose,0,0
229990,warfarin,0,0
229991,in,0,0
229992,preventing,0,0
229993,deep,0,1
229994,venous,0,0
229995,thrombosis,0,1
229996,after,1,0
229997,knee,1,1
229998,arthroplasty,1,1
229999,.,1,0
230000,No,0,0
230001,differences,0,0
230002,were,0,0
230003,seen,0,0
230004,in,0,0
230005,the,0,0
230006,incidence,0,0
230007,of,0,0
230008,proximal,0,0
230009,venous,0,0
230010,thrombosis,0,1
230011,or,0,0
230012,clinically,0,0
230013,overt,0,0
230014,hemorrhage,0,0
230015,.,0,0
230016,Processing,0,0
230017,familiar,0,0
230018,and,0,0
230019,unfamiliar,0,0
230020,auditory,0,0
230021,stimuli,0,0
230022,during,1,0
230023,general,1,1
230024,anesthesia,1,0
230025,.,1,0
230026,We,0,0
230027,tested,0,0
230028,memory,0,0
230029,priming,0,0
230030,for,0,0
230031,auditory,0,0
230032,stimuli,0,0
230033,presented,0,1
230034,during,0,0
230035,general,1,1
230036,propofol-sufentanil,1,0
230037,anesthesia,1,0
230038,in,1,0
230039,58,1,1
230040,patients,1,1
230041,undergoing,1,1
230042,day-case,1,1
230043,arthroscopic,1,1
230044,surgery,1,1
230045,.,1,0
230046,Stimuli,0,0
230047,were,0,0
230048,presented,0,0
230049,via,0,0
230050,headphones,0,0
230051,and,0,0
230052,consisted,0,0
230053,of,0,0
230054,common,0,0
230055,facts,0,0
230056,(,1,0
230057,Group,1,1
230058,A,1,0
230059,",",1,0
230060,29,1,1
230061,patients,1,1
230062,),1,0
230063,",",0,0
230064,or,0,0
230065,familiar,0,0
230066,or,0,0
230067,unfamiliar,0,1
230068,full,0,0
230069,names,0,0
230070,of,0,0
230071,fictitious,0,0
230072,people,0,1
230073,(,1,0
230074,GRoup,1,0
230075,B,1,0
230076,",",1,0
230077,29,1,1
230078,patients,1,1
230079,),1,1
230080,.,1,1
230081,Group,0,0
230082,A,0,0
230083,was,0,0
230084,expected,0,0
230085,to,0,0
230086,give,0,0
230087,more,0,0
230088,correct,0,0
230089,answers,0,0
230090,to,0,0
230091,questions,0,0
230092,about,0,0
230093,the,0,0
230094,common,0,0
230095,facts,0,0
230096,than,0,0
230097,Group,0,1
230098,B,0,0
230099,",",0,0
230100,when,0,0
230101,tested,0,0
230102,postoperatively,0,0
230103,",",0,0
230104,and,0,0
230105,Group,0,0
230106,B,0,0
230107,to,0,0
230108,attribute,0,0
230109,more,0,0
230110,fame,0,0
230111,to,0,0
230112,presented,0,0
230113,names,0,0
230114,than,0,0
230115,Group,0,1
230116,A,0,0
230117,(,0,0
230118,famous,0,0
230119,names,0,0
230120,test,0,0
230121,),0,0
230122,.,0,0
230123,Because,0,0
230124,the,0,0
230125,process,0,0
230126,for,0,0
230127,learning,0,0
230128,new,0,0
230129,or,0,1
230130,unfamiliar,0,0
230131,stimuli,0,0
230132,(,0,0
230133,elaboration,0,0
230134,),0,0
230135,in,0,0
230136,particular,0,0
230137,may,0,0
230138,be,0,0
230139,impaired,0,0
230140,under,1,0
230141,general,1,1
230142,anesthesia,1,0
230143,",",0,0
230144,more,0,0
230145,memory,0,0
230146,priming,0,0
230147,was,0,0
230148,expected,0,0
230149,for,0,0
230150,familiar,0,0
230151,than,0,0
230152,for,0,0
230153,unfamiliar,0,1
230154,material,0,1
230155,.,0,0
230156,No,0,0
230157,significant,0,0
230158,differences,0,0
230159,were,0,0
230160,demonstrated,0,0
230161,between,0,0
230162,the,0,0
230163,two,0,0
230164,groups,0,0
230165,in,0,0
230166,performance,0,0
230167,on,0,0
230168,common,0,0
230169,facts,0,0
230170,or,0,1
230171,in,0,0
230172,fame,0,0
230173,attributed,0,0
230174,to,0,0
230175,the,0,0
230176,names,0,0
230177,.,0,0
230178,The,0,0
230179,amount,0,0
230180,of,0,0
230181,memory,0,0
230182,priming,0,0
230183,",",0,0
230184,however,0,0
230185,",",0,0
230186,was,0,0
230187,positively,0,0
230188,related,0,0
230189,to,0,0
230190,one,0,0
230191,of,0,0
230192,two,0,0
230193,measures,0,0
230194,of,0,0
230195,preoperative,0,0
230196,anxiety,0,0
230197,.,0,0
230198,Recovery,0,0
230199,profile,0,0
230200,after,0,0
230201,desflurane,0,0
230202,with,0,1
230203,or,0,0
230204,without,0,1
230205,ondansetron,0,0
230206,compared,0,0
230207,with,0,1
230208,propofol,0,0
230209,in,0,0
230210,patients,1,1
230211,undergoing,1,1
230212,outpatient,1,1
230213,gynecological,1,1
230214,laparoscopy,1,1
230215,.,1,0
230216,We,0,0
230217,studied,0,0
230218,the,0,0
230219,effect,0,0
230220,of,0,0
230221,combining,0,0
230222,prophylactic,0,0
230223,ondansetron,0,0
230224,(,0,0
230225,4,0,0
230226,mg,0,0
230227,intravenously,0,0
230228,[,0,0
230229,IV,0,0
230230,],0,0
230231,),0,0
230232,to,0,0
230233,desflurane-based,0,0
230234,anesthesia,0,0
230235,in,0,0
230236,90,1,0
230237,ASA,1,0
230238,grade,1,0
230239,I,1,0
230240,or,1,0
230241,11,1,0
230242,women,1,1
230243,undergoing,1,1
230244,outpatient,1,1
230245,gynecological,1,1
230246,laparoscopy,1,1
230247,.,1,0
230248,Recovery,0,0
230249,after,0,0
230250,anesthesia,0,0
230251,",",0,0
230252,with,0,0
230253,special,0,0
230254,focus,0,0
230255,on,0,0
230256,postoperative,0,0
230257,nausea,0,0
230258,and,0,0
230259,vomiting,0,0
230260,(,0,0
230261,PONV,0,0
230262,),0,0
230263,",",0,0
230264,was,0,0
230265,assessed,0,0
230266,.,0,0
230267,Control,0,0
230268,groups,0,0
230269,received,0,0
230270,a,0,0
230271,similar,0,0
230272,desflurane,0,0
230273,anesthetic,0,0
230274,(,0,0
230275,placebo,0,0
230276,),0,0
230277,or,0,0
230278,a,0,0
230279,propofol-infusion-based,0,0
230280,(,0,0
230281,active,0,0
230282,control,0,0
230283,),0,0
230284,anesthetic,0,0
230285,.,0,0
230286,The,0,0
230287,study,0,0
230288,design,0,0
230289,was,0,0
230290,randomized,0,0
230291,",",0,0
230292,controlled,0,0
230293,",",0,0
230294,and,0,0
230295,double-blind,0,0
230296,(,0,0
230297,regarding,0,0
230298,ondansetron,0,0
230299,),0,0
230300,and,0,0
230301,single-blind,0,0
230302,(,0,0
230303,regarding,0,0
230304,the,0,0
230305,anesthetic,0,0
230306,technique,0,0
230307,),0,0
230308,.,0,0
230309,Early,0,0
230310,recovery,0,0
230311,(,0,0
230312,eye,0,0
230313,opening,0,0
230314,",",0,0
230315,orientation,0,0
230316,",",0,0
230317,following,0,0
230318,commands,0,0
230319,",",0,0
230320,sitting,0,0
230321,),0,0
230322,was,0,0
230323,similar,0,0
230324,in,0,0
230325,the,0,0
230326,three,0,0
230327,groups,0,0
230328,.,0,0
230329,However,0,0
230330,",",0,0
230331,overall,0,0
230332,home,0,0
230333,readiness,0,0
230334,(,0,0
230335,toleration,0,0
230336,of,0,0
230337,oral,0,0
230338,fluids,0,0
230339,",",0,0
230340,walking,0,0
230341,",",0,0
230342,pain,0,0
230343,tolerable,0,0
230344,by,0,0
230345,oral,0,0
230346,analgesics,0,0
230347,",",0,0
230348,no,0,0
230349,or,0,0
230350,only,0,0
230351,mild,0,0
230352,nausea,0,0
230353,),0,0
230354,was,0,0
230355,achieved,0,0
230356,faster,0,0
230357,in,0,0
230358,the,0,0
230359,desflurane,0,0
230360,group,0,0
230361,receiving,0,0
230362,ondansetron,0,0
230363,(,0,0
230364,109,0,1
230365,[,0,0
230366,21-937,0,1
230367,],0,0
230368,min,0,0
230369,",",0,0
230370,P,0,0
230371,<,0,0
230372,0.01,0,0
230373,),0,0
230374,and,0,0
230375,in,0,0
230376,the,0,0
230377,propofol,0,0
230378,group,0,0
230379,(,0,0
230380,110,0,0
230381,[,0,0
230382,33-642,0,1
230383,],0,0
230384,min,0,0
230385,",",0,0
230386,P,0,0
230387,<,0,0
230388,0.001,0,0
230389,),0,0
230390,when,0,0
230391,compared,0,0
230392,to,0,0
230393,the,0,0
230394,desflurane,0,0
230395,only,0,0
230396,group,0,0
230397,(,0,0
230398,372,0,0
230399,[,0,0
230400,45-723,0,1
230401,],0,0
230402,min,0,0
230403,),0,0
230404,(,0,0
230405,median,0,0
230406,[,0,0
230407,range,0,0
230408,],0,0
230409,),0,0
230410,.,0,0
230411,The,0,0
230412,total,0,0
230413,incidence,0,0
230414,of,0,0
230415,PONV,0,0
230416,in,0,0
230417,the,0,0
230418,desflurane-only,0,0
230419,group,0,0
230420,was,0,0
230421,80,0,0
230422,%,0,0
230423,(,0,0
230424,P,0,0
230425,<,0,0
230426,0.01,0,0
230427,),0,0
230428,",",0,0
230429,compared,0,0
230430,to,0,0
230431,40,0,0
230432,%,0,0
230433,and,0,0
230434,20,0,0
230435,%,0,0
230436,in,0,0
230437,the,0,0
230438,desflurane,0,0
230439,group,0,0
230440,receiving,0,0
230441,ondansetron,0,0
230442,and,0,0
230443,the,0,0
230444,propofol,0,0
230445,group,0,0
230446,",",0,0
230447,respectively,0,0
230448,.,0,0
230449,The,0,0
230450,postoperative,0,0
230451,antiemetic,0,0
230452,requirements,0,0
230453,were,0,0
230454,consistently,0,0
230455,and,0,0
230456,significantly,0,0
230457,(,0,0
230458,P,0,0
230459,<,0,0
230460,0.01,0,0
230461,),0,0
230462,higher,0,0
230463,in,0,0
230464,the,0,0
230465,desflurane-only,0,0
230466,group,0,0
230467,compared,0,0
230468,to,0,0
230469,the,0,0
230470,other,0,0
230471,two,0,0
230472,groups,0,0
230473,.,0,1
230474,Postoperative,0,0
230475,sedation,0,0
230476,",",0,0
230477,analgesic,0,0
230478,requirements,0,0
230479,",",0,0
230480,and,0,0
230481,psychomotor,0,0
230482,recovery,0,0
230483,(,0,0
230484,assessed,0,0
230485,by,0,0
230486,the,0,0
230487,Maddox,0,0
230488,Wing,0,0
230489,and,0,0
230490,the,0,0
230491,Digit,0,0
230492,Symbol,0,0
230493,Substitution,0,0
230494,Tests,0,0
230495,),0,0
230496,were,0,0
230497,similar,0,0
230498,in,0,0
230499,the,0,0
230500,three,0,0
230501,groups,0,0
230502,.,0,1
230503,Our,0,0
230504,results,0,0
230505,suggest,0,0
230506,that,0,0
230507,in,0,0
230508,order,0,0
230509,to,0,0
230510,achieve,0,0
230511,a,0,0
230512,propofol-like,0,0
230513,recovery,0,0
230514,profile,0,0
230515,in,0,0
230516,patients,0,1
230517,with,0,1
230518,a,0,0
230519,high,0,0
230520,likelihood,0,0
230521,of,0,0
230522,PONV,0,0
230523,",",0,0
230524,desflurane,0,0
230525,should,0,0
230526,be,0,0
230527,combined,0,0
230528,with,0,0
230529,a,0,0
230530,potent,0,0
230531,antiemetic,0,0
230532,(,0,0
230533,e.g.,0,0
230534,",",0,0
230535,ondansetron,0,0
230536,),0,0
230537,.,0,0
230538,Antifungal,0,0
230539,pulse,0,0
230540,therapy,0,0
230541,for,0,0
230542,onychomycosis,1,1
230543,.,1,0
230544,Comparative,0,0
230545,efficacy,0,0
230546,of,0,0
230547,intravenous,0,0
230548,ibutilide,0,0
230549,versus,0,0
230550,procainamide,0,0
230551,for,0,0
230552,enhancing,0,0
230553,termination,0,0
230554,of,0,0
230555,atrial,0,1
230556,flutter,0,1
230557,by,0,0
230558,atrial,0,1
230559,overdrive,0,0
230560,pacing,0,0
230561,.,0,0
230562,This,0,0
230563,study,0,0
230564,compares,0,0
230565,the,0,0
230566,influence,0,0
230567,of,0,0
230568,intravenous,0,0
230569,ibutilide,0,0
230570,",",0,0
230571,a,0,0
230572,class,0,1
230573,III,0,0
230574,antiarrhythmic,0,0
230575,agent,0,0
230576,",",0,0
230577,with,0,0
230578,procainamide,0,0
230579,",",0,0
230580,a,0,0
230581,class,0,1
230582,IA,0,0
230583,antiarrhythmic,0,0
230584,agent,0,0
230585,",",0,0
230586,and,0,0
230587,with,0,0
230588,placebo,0,0
230589,on,0,0
230590,its,0,0
230591,ability,0,0
230592,to,0,0
230593,terminate,0,0
230594,atrial,0,1
230595,flutter,0,1
230596,using,0,0
230597,rapid,0,0
230598,atrial,0,1
230599,pacing,0,0
230600,.,0,0
230601,Fifty-nine,1,1
230602,episodes,1,0
230603,of,1,0
230604,atrial,1,1
230605,flutter,1,1
230606,in,1,0
230607,54,1,1
230608,patients,1,1
230609,who,1,1
230610,failed,1,1
230611,to,1,1
230612,terminate,1,0
230613,with,1,0
230614,an,1,0
230615,intravenous,1,0
230616,infusion,1,0
230617,of,1,0
230618,ibutilide,1,0
230619,",",1,0
230620,procainamide,1,0
230621,",",1,0
230622,or,1,0
230623,placebo,1,0
230624,alone,1,0
230625,underwent,1,1
230626,attempts,1,0
230627,at,1,0
230628,pacing,1,0
230629,termination,1,0
230630,using,1,0
230631,a,1,0
230632,standard,1,0
230633,protocol,1,0
230634,of,1,0
230635,burst,1,0
230636,atrial,1,1
230637,overdrive,1,0
230638,pacing,1,0
230639,.,1,0
230640,Atrial,0,0
230641,flutter,0,1
230642,cycle,0,0
230643,length,0,0
230644,and,0,0
230645,atrial,0,1
230646,monophasic,0,0
230647,action,0,0
230648,potential,0,0
230649,duration,0,0
230650,recorded,0,0
230651,from,0,0
230652,the,0,0
230653,right,0,0
230654,atrium,0,0
230655,during,0,0
230656,atrial,0,1
230657,flutter,0,1
230658,were,0,0
230659,measured,0,0
230660,at,0,0
230661,baseline,0,0
230662,and,0,0
230663,following,0,0
230664,infusion,0,0
230665,of,0,0
230666,ibutilide,0,0
230667,",",0,0
230668,procainamide,0,0
230669,",",0,0
230670,or,0,0
230671,placebo,0,0
230672,.,0,0
230673,Both,0,0
230674,ibutilide,0,0
230675,and,0,0
230676,procainamide,0,0
230677,significantly,0,0
230678,enhanced,0,0
230679,(,0,0
230680,p,0,0
230681,<,0,0
230682,0.001,0,0
230683,),0,0
230684,pacing-induced,0,0
230685,termination,0,0
230686,of,0,0
230687,atrial,0,1
230688,flutter,0,1
230689,compared,0,0
230690,with,0,1
230691,placebo,0,0
230692,.,0,0
230693,Pacing,0,0
230694,converted,0,0
230695,2,0,0
230696,of,0,0
230697,11,0,1
230698,patients,0,1
230699,(,0,0
230700,18,0,1
230701,%,0,0
230702,),0,1
230703,who,0,1
230704,received,0,1
230705,placebo,0,1
230706,",",0,0
230707,13,0,0
230708,of,0,0
230709,15,0,1
230710,patients,0,1
230711,(,0,0
230712,87,0,1
230713,%,0,0
230714,),0,1
230715,who,0,1
230716,received,0,0
230717,ibutilide,0,1
230718,",",0,0
230719,and,0,0
230720,29,0,0
230721,of,0,0
230722,33,0,1
230723,patients,0,1
230724,(,0,0
230725,88,0,1
230726,%,0,0
230727,),0,1
230728,who,0,1
230729,received,0,1
230730,procainamide,0,1
230731,to,0,0
230732,sinus,0,0
230733,rhythm,0,1
230734,.,0,0
230735,Ibutilide,0,0
230736,and,0,0
230737,procainamide,0,0
230738,compared,0,0
230739,with,0,0
230740,placebo,0,0
230741,markedly,0,0
230742,reduced,0,0
230743,(,0,0
230744,p,0,0
230745,<,0,0
230746,0.001,0,0
230747,),0,0
230748,the,0,0
230749,incidence,0,0
230750,of,0,0
230751,pacing-induced,0,0
230752,atrial,0,1
230753,fibrillation,0,1
230754,.,0,0
230755,The,0,0
230756,atrial,0,0
230757,flutter,0,1
230758,cycle,0,0
230759,length,0,0
230760,was,0,0
230761,prolonged,0,0
230762,significantly,0,0
230763,less,0,0
230764,(,0,0
230765,p,0,0
230766,<,0,0
230767,0.001,0,0
230768,),0,0
230769,",",0,0
230770,and,0,0
230771,the,0,0
230772,atrial,0,0
230773,monophasic,0,0
230774,action,0,0
230775,potential,0,0
230776,duration,0,0
230777,was,0,0
230778,increased,0,0
230779,significantly,0,0
230780,more,0,0
230781,(,0,0
230782,p,0,0
230783,<,0,0
230784,0.001,0,0
230785,),0,0
230786,by,0,0
230787,ibutilide,0,0
230788,than,0,0
230789,by,0,0
230790,procainamide,0,0
230791,.,0,0
230792,Although,0,0
230793,the,0,0
230794,electrophysiologic,0,0
230795,changes,0,0
230796,induced,0,0
230797,by,0,0
230798,these,0,0
230799,antiarrhythmic,0,0
230800,agents,0,0
230801,contributed,0,0
230802,to,0,0
230803,facilitating,0,0
230804,pacing-induced,0,0
230805,termination,0,0
230806,",",0,0
230807,neither,0,0
230808,tachycardia,0,0
230809,cycle,0,0
230810,length,0,0
230811,nor,0,0
230812,action,0,0
230813,potential,0,0
230814,duration,0,0
230815,were,0,0
230816,useful,0,0
230817,predictors,0,0
230818,of,0,0
230819,the,0,0
230820,ability,0,0
230821,of,0,0
230822,pacing,0,0
230823,to,0,0
230824,terminate,0,0
230825,atrial,0,1
230826,flutter,0,1
230827,.,0,0
230828,In,0,0
230829,conclusion,0,0
230830,",",0,0
230831,despite,0,0
230832,differing,0,0
230833,electrophysiologic,0,0
230834,effects,0,0
230835,",",0,0
230836,the,0,0
230837,use,0,0
230838,of,0,0
230839,intravenous,0,0
230840,ibutilide,0,0
230841,or,0,0
230842,procainamide,0,0
230843,enhances,0,0
230844,the,0,0
230845,termination,0,0
230846,of,0,0
230847,atrial,0,1
230848,flutter,0,1
230849,by,0,0
230850,atrial,0,1
230851,overdrive,0,0
230852,pacing,0,0
230853,.,0,0
230854,Effect,0,0
230855,of,0,0
230856,n-3,0,0
230857,polyunsaturated,0,0
230858,fatty,0,0
230859,acid,0,0
230860,intake,0,0
230861,on,0,0
230862,phospholipid,0,0
230863,fatty,0,0
230864,acid,0,0
230865,composition,0,0
230866,in,0,0
230867,plasma,0,0
230868,and,0,0
230869,erythrocytes,0,0
230870,.,0,0
230871,To,0,0
230872,characterize,0,0
230873,the,0,0
230874,time,0,0
230875,course,0,0
230876,of,0,0
230877,plasma,0,0
230878,and,0,0
230879,red,0,0
230880,blood,0,0
230881,cell,0,1
230882,(,0,0
230883,RBC,0,0
230884,),0,0
230885,changes,0,0
230886,after,0,0
230887,n-3,0,0
230888,polyunsaturated,0,0
230889,fatty,0,0
230890,acid,0,0
230891,(,0,0
230892,PUFA,0,0
230893,),0,0
230894,supplementation,0,0
230895,",",0,0
230896,20,1,0
230897,healthy,1,1
230898,male,1,1
230899,volunteers,1,1
230900,were,1,0
230901,randomly,1,1
230902,assigned,1,0
230903,to,0,0
230904,receive,0,0
230905,either,0,0
230906,four,0,0
230907,1-g,0,0
230908,capsules,0,0
230909,of,0,0
230910,n-3,0,0
230911,PUFA,0,0
230912,ethyl,0,0
230913,esters,0,0
230914,or,0,1
230915,four,0,1
230916,1-g,0,0
230917,capsules,0,0
230918,of,0,0
230919,olive,0,0
230920,oil,0,0
230921,(,0,0
230922,as,0,0
230923,placebo,0,0
230924,),0,0
230925,for,0,0
230926,a,0,0
230927,period,0,0
230928,of,0,0
230929,4,0,0
230930,mo,0,1
230931,",",0,0
230932,followed,0,0
230933,by,0,0
230934,a,0,0
230935,3-mo,0,0
230936,washout,0,0
230937,period,0,0
230938,.,0,0
230939,Fatty,0,0
230940,acids,0,0
230941,of,0,0
230942,plasma,0,0
230943,and,0,0
230944,RBC,0,0
230945,phospholipid,0,0
230946,fractions,0,0
230947,were,0,0
230948,analyzed,0,0
230949,at,0,0
230950,0,0,0
230951,",",0,0
230952,2,0,0
230953,",",0,0
230954,and,0,0
230955,4,0,0
230956,mo,0,1
230957,of,0,0
230958,treatment,0,0
230959,and,0,0
230960,at,0,0
230961,1,0,0
230962,",",0,0
230963,2,0,0
230964,",",0,0
230965,and,0,0
230966,3,0,0
230967,mo,0,1
230968,of,0,0
230969,washout,0,0
230970,.,0,0
230971,During,0,0
230972,n-3,0,0
230973,PUFA,0,0
230974,supplementation,0,0
230975,",",0,0
230976,accumulations,0,0
230977,of,0,0
230978,eicosapentaenoic,0,0
230979,(,0,0
230980,EPA,0,0
230981,),0,0
230982,",",0,0
230983,docosapentaenoic,0,0
230984,(,0,0
230985,DPA,0,1
230986,),0,0
230987,",",0,0
230988,and,0,0
230989,docosahexaenoic,0,0
230990,(,0,0
230991,DHA,0,0
230992,),0,0
230993,acids,0,0
230994,were,0,0
230995,marked,0,0
230996,after,0,0
230997,2,0,0
230998,mo,0,1
230999,with,0,1
231000,differences,0,0
231001,among,0,1
231002,different,0,0
231003,fractions,0,0
231004,of,0,0
231005,plasma,0,0
231006,and,0,0
231007,RBCs,0,0
231008,in,0,0
231009,further,0,0
231010,accumulation,0,0
231011,up,0,0
231012,to,0,0
231013,4,0,0
231014,mo,0,1
231015,.,0,0
231016,During,0,0
231017,the,0,0
231018,first,0,0
231019,and,0,0
231020,second,0,0
231021,months,0,0
231022,of,0,0
231023,the,0,0
231024,washout,0,0
231025,",",0,0
231026,slight,0,0
231027,differences,0,0
231028,were,0,0
231029,observed,0,0
231030,in,0,0
231031,changes,0,0
231032,of,0,0
231033,various,0,0
231034,fatty,0,0
231035,acids,0,0
231036,among,0,1
231037,different,0,0
231038,phospholipid,0,0
231039,fractions,0,0
231040,",",0,0
231041,but,0,0
231042,after,0,0
231043,3,0,0
231044,mo,0,1
231045,of,0,0
231046,washout,0,0
231047,",",0,0
231048,only,0,0
231049,minor,0,0
231050,alterations,0,0
231051,were,0,0
231052,still,0,0
231053,detectable,0,0
231054,with,0,0
231055,respect,0,0
231056,to,0,0
231057,pretreatment,0,0
231058,values,0,0
231059,.,0,0
231060,These,0,0
231061,data,0,0
231062,confirm,0,0
231063,the,0,0
231064,complex,0,0
231065,relations,0,0
231066,among,0,1
231067,different,0,0
231068,fatty,0,0
231069,acid,0,0
231070,pools,0,0
231071,after,0,0
231072,n-3,0,0
231073,PUFA,0,0
231074,supplementation,0,0
231075,.,0,0
231076,Feedlot,0,1
231077,performance,0,0
231078,and,0,0
231079,carcass,0,0
231080,characteristics,0,0
231081,of,0,0
231082,Holstein,1,1
231083,steers,1,1
231084,as,0,0
231085,affected,0,0
231086,by,0,0
231087,source,0,0
231088,of,0,0
231089,dietary,0,0
231090,protein,0,0
231091,and,0,0
231092,level,0,0
231093,of,0,0
231094,ruminally,0,0
231095,protected,0,0
231096,lysine,0,0
231097,and,0,0
231098,methionine,0,0
231099,.,0,0
231100,The,0,0
231101,objective,0,0
231102,of,0,0
231103,this,0,0
231104,study,0,0
231105,was,0,0
231106,to,0,0
231107,determine,0,0
231108,the,0,0
231109,effects,0,0
231110,of,0,0
231111,source,0,0
231112,of,0,0
231113,dietary,0,0
231114,CP,0,0
231115,and,0,0
231116,level,0,0
231117,of,0,0
231118,ruminally,0,0
231119,protected,0,0
231120,lysine,0,0
231121,and,0,0
231122,methionine,0,0
231123,(,0,0
231124,RPLM,0,0
231125,),0,0
231126,on,0,0
231127,feedlot,0,1
231128,performance,0,0
231129,and,0,0
231130,carcass,0,0
231131,characteristics,0,0
231132,of,0,0
231133,Holstein,1,1
231134,steers,1,1
231135,during,0,0
231136,a,0,0
231137,growing-finishing,0,0
231138,trial,0,0
231139,(,0,0
231140,266,0,1
231141,d,0,0
231142,),0,0
231143,.,0,0
231144,A,0,0
231145,total,0,0
231146,of,0,0
231147,168,1,1
231148,Holstein,1,1
231149,steers,1,1
231150,(,1,0
231151,182.7,1,0
231152,+/-,1,0
231153,27.5,1,0
231154,kg,1,1
231155,),1,0
231156,were,0,0
231157,used,0,0
231158,in,0,0
231159,a,0,0
231160,completely,0,0
231161,randomized,0,0
231162,design,0,0
231163,experiment,0,0
231164,(,0,0
231165,eight,0,1
231166,treatments,0,0
231167,;,0,1
231168,three,0,0
231169,pens,0,0
231170,of,0,0
231171,seven,0,1
231172,steers/treatment,0,0
231173,),0,1
231174,.,0,0
231175,Steers,0,1
231176,were,0,0
231177,given,0,0
231178,ad,0,1
231179,libitum,0,0
231180,access,0,0
231181,to,0,0
231182,high-concentrate,0,0
231183,diets,0,0
231184,(,0,0
231185,13,0,1
231186,%,0,0
231187,CP,0,0
231188,),0,0
231189,containing,0,0
231190,71,0,1
231191,%,0,0
231192,whole,0,0
231193,shelled,0,0
231194,corn,0,0
231195,",",0,0
231196,10,0,0
231197,%,0,0
231198,corn,0,0
231199,silage,0,0
231200,",",0,0
231201,4,0,0
231202,%,0,0
231203,condensed,0,1
231204,distillers,0,0
231205,solubles,0,0
231206,",",0,0
231207,and,0,0
231208,15,0,0
231209,%,0,0
231210,protein,0,0
231211,supplements,0,0
231212,(,0,0
231213,DM,0,0
231214,basis,0,0
231215,),0,0
231216,.,0,0
231217,Treatments,0,0
231218,were,0,0
231219,arranged,0,0
231220,as,0,0
231221,a,0,0
231222,2,0,0
231223,x,0,0
231224,4,0,0
231225,factorial,0,0
231226,.,0,0
231227,The,0,0
231228,main,0,0
231229,factors,0,0
231230,were,0,1
231231,two,0,0
231232,sources,0,0
231233,of,0,0
231234,dietary,0,0
231235,CP,0,0
231236,and,0,0
231237,four,0,0
231238,levels,0,0
231239,of,0,0
231240,RPLM,0,0
231241,.,0,0
231242,The,0,0
231243,sources,0,0
231244,of,0,0
231245,dietary,0,0
231246,CP,0,0
231247,were,0,0
231248,soybean,0,0
231249,meal,0,0
231250,(,0,0
231251,SBM,0,0
231252,),0,0
231253,or,0,0
231254,SBM,0,0
231255,and,0,0
231256,urea,0,0
231257,(,0,0
231258,SBM-U,0,0
231259,),0,0
231260,.,0,0
231261,Urea-N,0,0
231262,replaced,0,0
231263,50,0,0
231264,%,0,0
231265,of,0,0
231266,SBM-N,0,0
231267,in,0,0
231268,the,0,0
231269,SBM-U,0,0
231270,diet,0,0
231271,.,0,0
231272,The,0,0
231273,levels,0,0
231274,of,0,0
231275,RPLM,0,0
231276,were,0,0
231277,0,0,0
231278,",",0,0
231279,5,0,0
231280,",",0,0
231281,10,0,0
231282,",",0,0
231283,and,0,0
231284,15,0,0
231285,g,0,0
231286,per,0,0
231287,steer,0,0
231288,daily,0,0
231289,.,0,0
231290,No,0,0
231291,interactions,0,0
231292,(,0,0
231293,P,0,0
231294,>,0,1
231295,.10,0,0
231296,),0,0
231297,between,0,0
231298,source,0,0
231299,of,0,0
231300,dietary,0,0
231301,CP,0,0
231302,and,0,0
231303,level,0,0
231304,of,0,0
231305,RPLM,0,0
231306,were,0,0
231307,observed,0,0
231308,for,0,0
231309,feedlot,0,1
231310,performance,0,0
231311,or,0,0
231312,carcass,0,0
231313,characteristics,0,0
231314,.,0,0
231315,Feedlot,0,1
231316,performance,0,0
231317,showed,0,0
231318,an,0,0
231319,advantage,0,0
231320,(,0,0
231321,P,0,0
231322,<,0,0
231323,.10,0,0
231324,),0,0
231325,to,0,0
231326,feeding,0,0
231327,SMB,0,0
231328,during,0,0
231329,the,0,0
231330,first,0,0
231331,84,0,1
231332,d,0,0
231333,of,0,0
231334,the,0,0
231335,trial,0,0
231336,and,0,0
231337,an,0,0
231338,advantage,0,0
231339,to,0,0
231340,feeding,0,0
231341,SBM-U,0,0
231342,during,0,0
231343,the,0,0
231344,last,0,0
231345,98,0,1
231346,d,0,0
231347,of,0,0
231348,the,0,0
231349,trial,0,0
231350,.,0,0
231351,However,0,0
231352,",",0,0
231353,feedlot,0,1
231354,performance,0,0
231355,for,0,0
231356,the,0,0
231357,whole,0,0
231358,trial,0,0
231359,and,0,0
231360,carcass,0,0
231361,characteristics,0,0
231362,(,0,0
231363,except,0,0
231364,for,0,0
231365,fat,0,0
231366,thickness,0,0
231367,),0,0
231368,were,0,0
231369,not,0,0
231370,affected,0,0
231371,(,0,0
231372,P,0,0
231373,>,0,1
231374,.10,0,0
231375,),0,0
231376,by,0,0
231377,the,0,0
231378,source,0,0
231379,of,0,0
231380,dietary,0,0
231381,CP,0,0
231382,.,0,1
231383,Steers,0,1
231384,fed,0,0
231385,diets,0,0
231386,containing,0,0
231387,SBM-U,0,0
231388,had,0,0
231389,12,0,0
231390,%,0,0
231391,less,0,0
231392,(,0,0
231393,P,0,0
231394,<,0,0
231395,.10,0,0
231396,),0,0
231397,fat,0,0
231398,thickness,0,0
231399,than,0,0
231400,those,0,1
231401,fed,0,0
231402,diets,0,0
231403,containing,0,0
231404,SBM,0,0
231405,.,0,0
231406,Supplementation,0,0
231407,of,0,0
231408,diets,0,0
231409,with,0,1
231410,increasing,0,0
231411,levels,0,0
231412,of,0,0
231413,RPLM,0,0
231414,did,0,0
231415,not,0,0
231416,affect,0,0
231417,(,0,0
231418,P,0,0
231419,>,0,1
231420,.10,0,0
231421,),0,0
231422,ADG,0,0
231423,or,0,0
231424,carcass,0,0
231425,characteristics,0,0
231426,.,0,0
231427,However,0,0
231428,",",0,0
231429,DMI,0,0
231430,and,0,0
231431,gain,0,0
231432,:,0,1
231433,feed,0,0
231434,showed,0,0
231435,cubic,0,0
231436,(,0,0
231437,P,0,0
231438,<,0,0
231439,.10,0,0
231440,),0,0
231441,responses,0,0
231442,to,0,0
231443,increasing,0,0
231444,dietary,0,0
231445,level,0,0
231446,of,0,0
231447,RPLM,0,0
231448,.,0,0
231449,Supplementation,0,0
231450,of,0,0
231451,RPLM,0,0
231452,at,0,0
231453,the,0,0
231454,10,0,0
231455,g/d,0,0
231456,level,0,0
231457,improved,0,0
231458,gain,0,0
231459,:,0,1
231460,feed,0,0
231461,by,0,0
231462,12,0,0
231463,%,0,0
231464,during,0,0
231465,the,0,0
231466,last,0,0
231467,98,0,1
231468,d,0,0
231469,of,0,0
231470,the,0,0
231471,trial,0,0
231472,",",0,0
231473,and,0,0
231474,this,0,0
231475,was,0,0
231476,a,0,0
231477,direct,0,0
231478,response,0,0
231479,to,0,0
231480,the,0,0
231481,cubic,0,0
231482,effects,0,0
231483,of,0,0
231484,RPLM,0,0
231485,on,0,0
231486,DMI,0,0
231487,.,0,0
231488,Results,0,0
231489,suggest,0,0
231490,a,0,0
231491,cost,0,0
231492,advantage,0,0
231493,for,0,0
231494,replacing,0,0
231495,50,0,0
231496,%,0,0
231497,of,0,0
231498,SBM-N,0,0
231499,with,0,1
231500,that,0,0
231501,from,0,0
231502,urea,0,0
231503,in,0,0
231504,high-corn,0,1
231505,diets,0,0
231506,without,0,1
231507,negative,0,0
231508,effects,0,0
231509,on,0,0
231510,feedlot,0,1
231511,performance,0,0
231512,or,0,0
231513,carcass,0,0
231514,characteristics,0,0
231515,of,0,0
231516,growing-finishing,1,1
231517,Holstein,1,1
231518,steers,1,1
231519,with,1,1
231520,extended,1,0
231521,feeding,1,0
231522,periods,1,0
231523,(,1,0
231524,266,1,1
231525,d,1,0
231526,),1,0
231527,.,1,0
231528,These,0,0
231529,types,0,0
231530,of,0,0
231531,diets,0,0
231532,seem,0,0
231533,to,0,0
231534,meet,0,0
231535,the,0,0
231536,amino,0,0
231537,acid,0,0
231538,requirements,0,0
231539,and,0,0
231540,are,0,0
231541,not,0,0
231542,limiting,0,0
231543,in,0,0
231544,lysine,0,0
231545,and,0,0
231546,methionine,0,0
231547,.,0,0
231548,The,0,0
231549,effect,0,0
231550,of,0,0
231551,body,0,0
231552,positioning,0,0
231553,upon,0,0
231554,maximal,0,0
231555,oxygenation,0,0
231556,of,0,0
231557,patients,1,1
231558,with,1,1
231559,unilateral,1,1
231560,lung,1,1
231561,pathology,1,0
231562,.,1,0
231563,A,0,0
231564,quasi-experimental,0,0
231565,",",0,0
231566,repeated-measures,0,0
231567,cross-over,0,0
231568,design,0,0
231569,study,0,0
231570,on,0,0
231571,the,0,0
231572,effect,0,0
231573,of,0,0
231574,body,0,0
231575,position,0,0
231576,on,0,0
231577,oxygenation,0,0
231578,(,0,0
231579,SaO2,0,0
231580,),0,0
231581,blood,0,0
231582,pressure,0,0
231583,",",0,0
231584,respiration,0,0
231585,and,0,0
231586,pulse,0,0
231587,in,0,0
231588,patients,1,1
231589,with,1,1
231590,unilateral,1,1
231591,lung,1,1
231592,pathology,1,0
231593,was,0,0
231594,conducted,0,0
231595,.,0,0
231596,Previous,0,0
231597,research,0,0
231598,strongly,0,0
231599,suggests,0,0
231600,that,0,0
231601,positioning,0,0
231602,with,0,1
231603,the,0,0
231604,healthy,0,1
231605,(,0,0
231606,unaffected,0,0
231607,),0,0
231608,lung,0,0
231609,in,0,0
231610,the,0,0
231611,dependent,0,0
231612,lateral,0,0
231613,(,0,0
231614,down,0,0
231615,),0,0
231616,position,0,0
231617,is,0,0
231618,related,0,0
231619,to,0,0
231620,improved,0,0
231621,oxygenation,0,0
231622,",",0,0
231623,but,0,0
231624,knowledge,0,0
231625,about,0,0
231626,whether,0,0
231627,this,0,0
231628,effect,0,0
231629,is,0,0
231630,maintained,0,0
231631,over,0,0
231632,time,0,0
231633,is,0,0
231634,lacking,0,0
231635,.,0,0
231636,The,0,0
231637,purpose,0,0
231638,of,0,0
231639,this,0,0
231640,investigation,0,0
231641,was,0,0
231642,to,0,0
231643,determine,0,0
231644,:,0,1
231645,(,0,0
231646,1,0,0
231647,),0,0
231648,Is,0,0
231649,positioning,0,0
231650,with,0,0
231651,the,0,0
231652,unaffected,0,0
231653,lung,0,0
231654,in,0,0
231655,the,0,0
231656,dependent,0,0
231657,lateral,0,0
231658,position,0,0
231659,related,0,0
231660,to,0,0
231661,increased,0,0
231662,arterial,0,0
231663,blood,0,0
231664,saturation,0,0
231665,levels,0,0
231666,and,0,0
231667,decreased,0,0
231668,blood,0,0
231669,pressure,0,0
231670,",",0,0
231671,pulse,0,0
231672,and,0,0
231673,respiration,0,0
231674,?,0,0
231675,(,0,0
231676,2,0,1
231677,),0,1
231678,What,0,0
231679,is,0,0
231680,the,0,0
231681,relationship,0,0
231682,between,0,0
231683,the,0,0
231684,dependent,0,0
231685,variables,0,0
231686,--,0,1
231687,oxygenation,0,0
231688,saturation,0,0
231689,levels,0,0
231690,",",0,0
231691,blood,0,0
231692,pressure,0,0
231693,",",0,0
231694,pulse,0,0
231695,and,0,0
231696,respiration,0,0
231697,--,0,0
231698,and,0,0
231699,the,0,0
231700,independent,0,0
231701,variables,0,0
231702,--,0,1
231703,body,0,0
231704,position,0,0
231705,and,0,0
231706,time,0,0
231707,in,0,0
231708,the,0,0
231709,position,0,0
231710,?,0,0
231711,Thirty-nine,1,1
231712,patients,1,1
231713,with,1,1
231714,unilateral,1,1
231715,lung,1,1
231716,pathology,1,0
231717,were,0,0
231718,positioned,0,0
231719,on,0,0
231720,their,0,0
231721,sides,0,0
231722,with,0,1
231723,the,0,0
231724,unaffected,0,0
231725,lung,0,0
231726,down,0,0
231727,",",0,0
231728,on,0,0
231729,their,0,0
231730,sides,0,0
231731,with,0,1
231732,the,0,0
231733,affected,0,0
231734,lung,0,0
231735,down,0,0
231736,",",0,0
231737,and,0,0
231738,also,0,0
231739,in,0,0
231740,semi-Fowler,0,0
231741,'s,0,1
231742,position,0,0
231743,.,0,1
231744,Arterial,0,0
231745,(,0,0
231746,SaO2,0,0
231747,),0,0
231748,blood,0,0
231749,saturation,0,0
231750,and,0,0
231751,vital,0,0
231752,signs,0,0
231753,were,0,0
231754,measured,0,0
231755,at,0,0
231756,baseline,0,0
231757,0,0,0
231758,",",0,0
231759,15,0,0
231760,and,0,0
231761,30,0,1
231762,minutes,0,0
231763,.,0,0
231764,There,0,0
231765,was,0,0
231766,no,0,0
231767,statistically,0,0
231768,significant,0,0
231769,relationship,0,0
231770,between,0,0
231771,oxygenation,0,0
231772,level,0,0
231773,or,0,0
231774,systolic,0,0
231775,blood,0,0
231776,pressure,0,0
231777,.,0,0
231778,Diastolic,0,0
231779,blood,0,0
231780,pressure,0,0
231781,",",0,0
231782,respiration,0,0
231783,and,0,0
231784,pulse,0,0
231785,did,0,0
231786,vary,0,0
231787,significantly,0,0
231788,with,0,1
231789,position,0,0
231790,.,0,0
231791,Randomized,0,0
231792,trial,0,0
231793,comparing,0,0
231794,induction,0,0
231795,chemotherapy,0,0
231796,versus,0,0
231797,induction,0,0
231798,chemotherapy,0,0
231799,followed,0,0
231800,by,0,0
231801,maintenance,0,0
231802,chemotherapy,0,0
231803,in,0,0
231804,small-cell,1,1
231805,lung,1,1
231806,cancer,1,1
231807,.,1,0
231808,European,0,1
231809,Lung,0,0
231810,Cancer,0,0
231811,Working,0,1
231812,Party,0,1
231813,.,0,0
231814,PURPOSE,0,0
231815,AND,0,0
231816,METHODS,0,0
231817,The,0,0
231818,European,0,1
231819,Lung,0,0
231820,Cancer,0,0
231821,Working,0,0
231822,Party,0,1
231823,(,0,0
231824,ELCWP,0,0
231825,),0,0
231826,performed,0,0
231827,a,0,0
231828,randomized,0,0
231829,trial,0,0
231830,with,0,1
231831,the,0,0
231832,primary,0,0
231833,end,0,0
231834,point,0,0
231835,to,0,0
231836,determine,0,0
231837,if,0,0
231838,maintenance,0,0
231839,chemotherapy,0,0
231840,with,0,1
231841,12,0,0
231842,courses,0,0
231843,of,0,0
231844,etoposide,0,0
231845,(,0,0
231846,120,0,0
231847,mg/m2,0,0
231848,on,0,0
231849,days,0,0
231850,1,0,0
231851,and,0,0
231852,3,0,0
231853,),0,0
231854,and,0,0
231855,vindesine,0,0
231856,(,0,0
231857,3,0,0
231858,mg/m2,0,0
231859,on,0,0
231860,day,0,0
231861,3,0,0
231862,),0,0
231863,could,0,0
231864,improve,0,0
231865,progression-free,0,0
231866,survival,0,0
231867,in,0,0
231868,small-cell,1,1
231869,lung,1,1
231870,cancer,1,1
231871,(,1,0
231872,SCLC,1,0
231873,),1,1
231874,patients,1,1
231875,who,1,1
231876,responded,1,1
231877,to,1,1
231878,six,1,0
231879,courses,1,0
231880,of,1,0
231881,induction,1,0
231882,chemotherapy,1,0
231883,with,1,0
231884,ifosfamide,1,0
231885,",",1,0
231886,etoposide,1,0
231887,",",1,0
231888,and,1,0
231889,an,1,0
231890,anthracycline,1,0
231891,(,1,0
231892,doxorubicin,1,0
231893,or,1,0
231894,epirubicin,1,0
231895,),1,0
231896,.,1,0
231897,RESULTS,0,0
231898,Among,1,1
231899,235,1,1
231900,eligible,1,1
231901,patients,1,1
231902,initially,1,1
231903,registered,1,0
231904,",",1,0
231905,91,1,0
231906,were,1,0
231907,randomized,1,0
231908,to,1,0
231909,receive,1,0
231910,maintenance,1,0
231911,therapy,1,0
231912,",",1,0
231913,including,1,0
231914,seven,1,1
231915,patients,1,1
231916,who,1,1
231917,were,1,1
231918,no,1,0
231919,longer,1,0
231920,responding,1,0
231921,.,1,0
231922,Among,0,1
231923,84,0,1
231924,randomized,0,0
231925,responders,0,0
231926,",",0,0
231927,progression-free,0,0
231928,survival,0,0
231929,was,0,0
231930,significantly,0,0
231931,improved,0,0
231932,(,0,0
231933,P,0,0
231934,=,0,0
231935,.003,0,0
231936,),0,0
231937,by,0,0
231938,maintenance,0,0
231939,therapy,0,0
231940,",",0,0
231941,with,0,1
231942,median,0,0
231943,durations,0,0
231944,(,0,0
231945,maintenance,0,0
231946,v,0,0
231947,follow-up,0,0
231948,),0,0
231949,of,0,0
231950,25,0,0
231951,versus,0,0
231952,12,0,1
231953,weeks,0,0
231954,after,0,0
231955,the,0,0
231956,second,0,0
231957,randomization,0,0
231958,",",0,0
231959,but,0,0
231960,survival,0,0
231961,was,0,0
231962,not,0,0
231963,significantly,0,0
231964,increased,0,0
231965,(,0,0
231966,P,0,0
231967,=,0,0
231968,.10,0,0
231969,),0,0
231970,",",0,0
231971,with,0,1
231972,median,0,0
231973,durations,0,0
231974,of,0,0
231975,48,0,1
231976,and,0,0
231977,38,0,1
231978,weeks,0,0
231979,.,0,0
231980,However,0,0
231981,",",0,0
231982,in,0,0
231983,a,0,0
231984,multi-variate,0,0
231985,analysis,0,0
231986,that,0,0
231987,took,0,0
231988,into,0,0
231989,account,0,0
231990,disease,0,1
231991,extent,0,0
231992,",",0,0
231993,maintenance,0,0
231994,therapy,0,0
231995,",",0,0
231996,Karnofsky,0,0
231997,performance,0,0
231998,status,0,0
231999,(,0,0
232000,PS,0,1
232001,),0,0
232002,",",0,0
232003,and,0,0
232004,absolute,0,0
232005,dose-intensity,0,0
232006,(,0,0
232007,ADI,0,0
232008,),0,0
232009,of,0,0
232010,anthracycline,0,0
232011,given,0,0
232012,during,0,0
232013,induction,0,0
232014,",",0,0
232015,limited,0,0
232016,disease,0,1
232017,(,0,0
232018,LD,0,0
232019,),0,0
232020,and,0,0
232021,maintenance,0,0
232022,were,0,0
232023,found,0,0
232024,to,0,0
232025,be,0,0
232026,independent,0,0
232027,positive,0,0
232028,predictors,0,0
232029,of,0,0
232030,survival,0,0
232031,.,0,0
232032,CONCLUSION,0,0
232033,We,0,0
232034,conclude,0,0
232035,that,0,0
232036,maintenance,0,0
232037,chemotherapy,0,0
232038,in,0,0
232039,responding,0,0
232040,patients,0,1
232041,is,0,0
232042,beneficial,0,0
232043,in,0,0
232044,SCLC,0,0
232045,.,0,1
232046,[,0,0
232047,Clinical,0,0
232048,early,0,0
232049,phase,0,0
232050,II,0,0
232051,study,0,0
232052,of,0,0
232053,bicalutamide,0,0
232054,(,0,0
232055,Casodex,0,0
232056,),0,0
232057,in,0,0
232058,patients,1,1
232059,with,1,1
232060,prostatic,1,1
232061,cancer,1,1
232062,],1,0
232063,.,0,0
232064,To,0,0
232065,investigate,0,0
232066,the,0,0
232067,efficacy,0,0
232068,and,0,0
232069,safety,0,0
232070,of,0,0
232071,bicalutamide,0,0
232072,(,0,0
232073,Casodex,0,0
232074,),0,0
232075,with,0,0
232076,its,0,0
232077,clinically,0,0
232078,recommended,0,0
232079,dose,0,0
232080,",",0,0
232081,the,0,0
232082,randomized,0,0
232083,early,0,0
232084,phase,0,0
232085,II,0,1
232086,study,0,0
232087,was,0,0
232088,performed,0,0
232089,in,0,0
232090,124,1,1
232091,patients,1,1
232092,with,1,1
232093,prostatic,1,1
232094,cancer,1,1
232095,(,1,0
232096,stage,1,1
232097,C,1,0
232098,",",1,0
232099,D,1,0
232100,),1,0
232101,.,1,0
232102,The,0,0
232103,patients,0,1
232104,were,0,0
232105,given,0,0
232106,50,0,0
232107,",",0,0
232108,80,0,0
232109,or,0,0
232110,100,0,0
232111,mg,0,0
232112,of,0,0
232113,bicalutamide,0,0
232114,orally,0,0
232115,once,0,0
232116,a,0,0
232117,day,0,0
232118,in,0,0
232119,fixed,0,0
232120,doses,0,0
232121,for,0,0
232122,12,0,1
232123,weeks,0,0
232124,;,0,1
232125,122,0,1
232126,patients,0,1
232127,were,0,0
232128,eligible,0,1
232129,for,0,0
232130,evaluation,0,0
232131,.,0,0
232132,The,0,0
232133,overall,0,0
232134,response,0,0
232135,rate,0,0
232136,was,0,0
232137,50.0,0,0
232138,%,0,0
232139,(,0,0
232140,20/40,0,0
232141,),0,0
232142,",",0,0
232143,61.0,0,0
232144,%,0,0
232145,(,0,0
232146,25/41,0,0
232147,),0,0
232148,and,0,0
232149,53.7,0,0
232150,%,0,0
232151,(,0,0
232152,22/41,0,0
232153,),0,0
232154,in,0,0
232155,the,0,0
232156,50,0,0
232157,mg,0,0
232158,",",0,0
232159,80,0,0
232160,mg,0,0
232161,and,0,0
232162,100,0,0
232163,mg,0,0
232164,groups,0,0
232165,",",0,0
232166,respectively,0,0
232167,.,0,0
232168,The,0,0
232169,response,0,0
232170,rate,0,0
232171,in,0,0
232172,prostate,0,1
232173,lesion,0,0
232174,",",0,0
232175,bone,0,0
232176,and,0,0
232177,lymph,0,0
232178,node,0,0
232179,metastases,0,1
232180,was,0,0
232181,slightly,0,0
232182,higher,0,0
232183,in,0,0
232184,the,0,0
232185,80,0,0
232186,mg,0,0
232187,group,0,0
232188,than,0,0
232189,in,0,0
232190,the,0,0
232191,50,0,0
232192,mg,0,0
232193,and,0,0
232194,100,0,0
232195,mg,0,0
232196,groups,0,0
232197,.,0,0
232198,The,0,0
232199,proportion,0,0
232200,of,0,0
232201,patients,0,1
232202,showing,0,0
232203,a,0,0
232204,response,0,0
232205,with,0,0
232206,regard,0,0
232207,to,0,0
232208,serum,0,0
232209,PSA,0,0
232210,(,0,0
232211,CR,0,0
232212,and,0,0
232213,PR,0,0
232214,),0,0
232215,was,0,0
232216,84.2,0,0
232217,",",0,0
232218,92.7,0,0
232219,and,0,0
232220,97.6,0,0
232221,%,0,0
232222,in,0,0
232223,the,0,0
232224,50,0,0
232225,",",0,0
232226,80,0,0
232227,and,0,0
232228,100,0,0
232229,mg,0,0
232230,groups,0,0
232231,",",0,0
232232,respectively,0,0
232233,.,0,0
232234,The,0,0
232235,incidence,0,0
232236,of,0,0
232237,adverse,0,0
232238,reactions,0,0
232239,was,0,0
232240,65.0,0,0
232241,",",0,0
232242,61.0,0,0
232243,and,0,0
232244,61.0,0,0
232245,%,0,0
232246,in,0,0
232247,the,0,0
232248,50,0,0
232249,",",0,0
232250,80,0,0
232251,and,0,0
232252,100,0,0
232253,mg,0,0
232254,groups,0,0
232255,",",0,0
232256,respectively,0,0
232257,",",0,0
232258,and,0,0
232259,there,0,0
232260,was,0,0
232261,no,0,0
232262,significant,0,0
232263,difference,0,0
232264,in,0,0
232265,overall,0,0
232266,safety,0,0
232267,rating,0,0
232268,in,0,0
232269,the,0,0
232270,three,0,0
232271,groups,0,0
232272,.,0,1
232273,Frequent,0,0
232274,adverse,0,0
232275,reactions,0,0
232276,were,0,0
232277,gynecomastia,0,1
232278,and,0,0
232279,breast,0,1
232280,pain,0,0
232281,.,0,0
232282,Only,0,0
232283,one,0,0
232284,patient,0,0
232285,in,0,0
232286,the,0,0
232287,80,0,0
232288,mg,0,0
232289,group,0,0
232290,was,0,0
232291,withdrawn,0,0
232292,due,0,0
232293,to,0,0
232294,shortness,0,0
232295,of,0,0
232296,breath,0,0
232297,.,0,0
232298,Serum,0,0
232299,concentrations,0,0
232300,of,0,0
232301,LH,0,1
232302,",",0,0
232303,testosterone,0,0
232304,and,0,0
232305,estradiol,0,0
232306,increased,0,0
232307,significantly,0,0
232308,after,0,0
232309,treatment,0,0
232310,.,0,0
232311,Bicalutamide,0,0
232312,was,0,0
232313,concluded,0,0
232314,to,0,0
232315,be,0,0
232316,effective,0,0
232317,and,0,0
232318,well,0,0
232319,tolerated,0,0
232320,in,0,0
232321,patients,1,1
232322,with,1,1
232323,prostatic,1,1
232324,cancer,1,1
232325,",",0,0
232326,and,0,0
232327,its,0,0
232328,recommended,0,0
232329,dose,0,0
232330,was,0,0
232331,80,0,0
232332,mg,0,0
232333,once,0,0
232334,daily,0,0
232335,.,0,0
232336,Deep,1,0
232337,vein,1,0
232338,thrombosis,1,1
232339,after,1,0
232340,major,1,0
232341,reconstructive,1,1
232342,spinal,1,1
232343,surgery,1,1
232344,.,1,0
232345,STUDY,0,0
232346,DESIGN,0,0
232347,A,0,0
232348,prospective,0,0
232349,study,0,0
232350,was,0,0
232351,performed,0,0
232352,.,0,0
232353,OBJECTIVES,0,0
232354,The,0,0
232355,goals,0,0
232356,of,0,0
232357,the,0,0
232358,study,0,0
232359,were,0,0
232360,to,0,0
232361,determine,0,0
232362,the,0,0
232363,incidence,0,0
232364,of,0,0
232365,deep,1,0
232366,vein,1,0
232367,thrombosis,1,1
232368,after,1,0
232369,major,1,0
232370,adult,1,1
232371,spinal,1,1
232372,surgery,1,1
232373,and,0,0
232374,the,0,0
232375,optimal,0,0
232376,mode,0,0
232377,of,0,0
232378,prophylaxis,0,0
232379,in,0,0
232380,this,0,0
232381,surgical,0,0
232382,population,0,1
232383,.,0,0
232384,SUMMARY,0,0
232385,OF,0,0
232386,BACKGROUND,0,0
232387,DATA,0,1
232388,Few,0,0
232389,studies,0,0
232390,have,0,0
232391,evaluated,0,0
232392,deep,0,0
232393,vein,0,0
232394,thrombosis,0,1
232395,incidence,0,0
232396,and,0,0
232397,prophylaxis,0,0
232398,after,0,0
232399,major,1,0
232400,adult,1,1
232401,spinal,1,1
232402,surgery,1,1
232403,.,1,0
232404,Incidence,0,0
232405,rates,0,0
232406,have,0,0
232407,ranged,0,0
232408,from,0,0
232409,0.9-14,0,0
232410,%,0,0
232411,.,0,0
232412,METHODS,0,0
232413,Three,1,0
232414,hundred,1,1
232415,twenty-nine,1,1
232416,patients,1,1
232417,were,0,0
232418,evaluated,0,0
232419,.,0,0
232420,One,1,0
232421,hundred,1,1
232422,ten,1,1
232423,patients,1,1
232424,were,0,0
232425,randomized,0,0
232426,to,0,0
232427,3,0,0
232428,different,0,0
232429,deep,0,0
232430,vein,0,0
232431,thrombosis,0,1
232432,prophylaxis,0,0
232433,groups,0,0
232434,.,0,0
232435,These,0,0
232436,patients,0,1
232437,had,0,0
232438,duplex,0,0
232439,doppler,0,0
232440,scans,0,0
232441,between,0,0
232442,the,0,0
232443,fifth,0,0
232444,and,0,0
232445,seventh,0,1
232446,postoperative,0,0
232447,days,0,0
232448,.,0,0
232449,The,0,0
232450,remaining,0,0
232451,219,0,1
232452,patients,0,1
232453,formed,0,0
232454,a,0,0
232455,nonrandomized,0,0
232456,group,0,0
232457,and,0,0
232458,received,0,0
232459,either,0,0
232460,thrombosis,0,1
232461,embolic,0,0
232462,deterrent,0,0
232463,stockings,0,0
232464,alone,0,0
232465,or,0,0
232466,thrombosis,0,0
232467,embolic,0,0
232468,deterrent,0,0
232469,stockings,0,0
232470,and,0,0
232471,pneumatic,0,1
232472,compression,0,0
232473,boots,0,0
232474,for,0,0
232475,deep,0,1
232476,vein,0,0
232477,thrombosis,0,1
232478,prophylaxis,0,0
232479,.,0,0
232480,The,0,0
232481,type,0,0
232482,of,0,0
232483,deep,0,0
232484,vein,0,0
232485,thrombosis,0,1
232486,prophylaxis,0,0
232487,in,0,0
232488,this,0,0
232489,group,0,0
232490,was,0,0
232491,based,0,0
232492,on,0,0
232493,surgeon,0,0
232494,preference,0,0
232495,.,0,0
232496,All,0,0
232497,329,0,1
232498,patients,0,1
232499,were,0,0
232500,followed,0,0
232501,for,0,0
232502,clinical,0,0
232503,signs,0,0
232504,and,0,0
232505,symptoms,0,0
232506,of,0,0
232507,thromboembolic,0,0
232508,disease,0,1
232509,.,0,1
232510,Patients,0,1
232511,were,0,0
232512,followed,0,0
232513,clinically,0,0
232514,for,0,0
232515,a,0,0
232516,minimum,0,0
232517,of,0,0
232518,1,0,0
232519,year,0,1
232520,.,0,0
232521,RESULTS,0,0
232522,All,0,0
232523,110,0,0
232524,prophylaxis,0,0
232525,study,0,1
232526,group,0,1
232527,patients,0,1
232528,were,0,0
232529,clinically,0,0
232530,asymptomatic,0,1
232531,and,0,0
232532,109,0,1
232533,duplex,0,0
232534,scans,0,0
232535,were,0,1
232536,normal,0,1
232537,.,0,0
232538,One,0,0
232539,scan,0,0
232540,was,0,0
232541,indeterminate,0,0
232542,and,0,0
232543,a,0,0
232544,follow-up,0,0
232545,venogram,0,0
232546,was,0,0
232547,negative,0,0
232548,.,0,1
232549,Two,0,0
232550,patients,0,1
232551,in,0,0
232552,the,0,0
232553,coumadin,0,1
232554,group,0,0
232555,(,0,0
232556,5.7,0,0
232557,%,0,0
232558,),0,0
232559,experienced,0,0
232560,excessive,0,0
232561,blood,0,0
232562,loss,0,0
232563,.,0,0
232564,One,0,0
232565,of,0,0
232566,the,0,0
232567,219,0,1
232568,patients,0,1
232569,from,0,0
232570,the,0,0
232571,nonrandomized,0,0
232572,group,0,0
232573,developed,0,0
232574,a,0,0
232575,clinically,0,0
232576,detectable,0,0
232577,proximal,0,0
232578,deep,0,0
232579,vein,0,0
232580,thrombosis,0,1
232581,which,0,0
232582,was,0,0
232583,confirmed,0,0
232584,by,0,0
232585,duplex,0,0
232586,ultra-sonography,0,0
232587,.,0,0
232588,The,0,0
232589,overall,0,0
232590,clinical,0,0
232591,incidence,0,0
232592,of,0,0
232593,deep,0,0
232594,vein,0,1
232595,thrombosis,0,1
232596,was,0,0
232597,0.3,0,0
232598,%,0,0
232599,(,0,0
232600,1,0,0
232601,in,0,0
232602,329,0,1
232603,patients,0,1
232604,),0,0
232605,.,0,0
232606,CONCLUSIONS,0,0
232607,This,0,0
232608,low,0,0
232609,0.3,0,0
232610,%,0,0
232611,rate,0,0
232612,is,0,0
232613,in,0,0
232614,agreement,0,0
232615,with,0,1
232616,recent,0,0
232617,studies,0,0
232618,that,0,0
232619,focus,0,0
232620,on,0,0
232621,thromboembolic,0,0
232622,disease,0,1
232623,.,0,0
232624,Given,0,0
232625,the,0,0
232626,low,0,0
232627,incidence,0,0
232628,",",0,0
232629,routine,0,0
232630,screening,0,0
232631,for,0,0
232632,asymptomatic,0,1
232633,thrombi,0,0
232634,appears,0,0
232635,unwarranted,0,0
232636,.,0,0
232637,In,0,0
232638,addition,0,0
232639,",",0,0
232640,mechanical,0,0
232641,prophylaxis,0,0
232642,with,0,1
232643,graduated,0,1
232644,compression,0,0
232645,stockings,0,0
232646,and,0,0
232647,pneumatic,0,1
232648,compression,0,0
232649,boots,0,0
232650,is,0,0
232651,preferable,0,0
232652,to,0,0
232653,anticoagulation,0,0
232654,therapy,0,0
232655,.,0,0
232656,Prospective,0,0
232657,evaluation,0,0
232658,of,0,0
232659,the,0,0
232660,macrolide,0,0
232661,antibiotic,0,0
232662,dirithromycin,0,0
232663,for,0,0
232664,the,0,0
232665,treatment,0,0
232666,of,0,0
232667,Helicobacter,1,1
232668,pylori,1,1
232669,.,1,0
232670,BACKGROUND,0,0
232671,Macrolide,0,0
232672,antibiotics,0,0
232673,are,0,0
232674,active,0,0
232675,in,0,0
232676,vitro,0,0
232677,and,0,0
232678,in,0,0
232679,vivo,0,0
232680,against,0,0
232681,Helicobacter,1,1
232682,pylori,1,0
232683,.,1,0
232684,We,0,0
232685,assessed,0,0
232686,a,0,0
232687,newer,0,0
232688,macrolide,0,0
232689,",",0,0
232690,dirithromycin,0,0
232691,",",0,0
232692,for,0,0
232693,the,0,0
232694,treatment,0,0
232695,of,0,0
232696,H.,0,0
232697,pylori,0,0
232698,in,0,0
232699,two,0,0
232700,separate,0,1
232701,studies,0,0
232702,.,0,1
232703,METHODS,0,0
232704,Volunteers,1,1
232705,with,1,1
232706,H.,1,1
232707,pylori,1,0
232708,infection,1,0
232709,(,1,0
232710,by,1,0
232711,13C-urea,1,0
232712,breath,1,0
232713,test,1,0
232714,),1,0
232715,were,0,0
232716,randomly,0,0
232717,assigned,0,0
232718,to,0,0
232719,2-week,0,0
232720,treatment,0,0
232721,regimens,0,0
232722,.,0,1
232723,Study,0,0
232724,1,0,0
232725,:,0,1
232726,dirithromycin,0,0
232727,500,0,0
232728,mg,0,0
232729,q.d.s.,0,0
232730,",",0,0
232731,dirithromycin,0,0
232732,500,0,0
232733,mg,0,0
232734,q.d.s,0,0
232735,.,0,0
232736,plus,0,0
232737,omeprazole,0,0
232738,40,0,1
232739,mg,0,0
232740,q.d.s.,0,0
232741,",",0,0
232742,or,0,0
232743,dirithromycin,0,0
232744,500,0,0
232745,mg,0,0
232746,q.d.s,0,0
232747,.,0,0
232748,plus,0,0
232749,metronidazole,0,0
232750,500,0,0
232751,mg,0,0
232752,t.d.s,0,0
232753,.,0,0
232754,Study,0,0
232755,2,0,0
232756,:,0,1
232757,dirithromycin,0,0
232758,500,0,0
232759,mg,0,0
232760,q.d.s,0,0
232761,.,0,0
232762,plus,0,0
232763,omeprazole,0,0
232764,20,0,0
232765,mg,0,0
232766,b.d.,0,0
232767,",",0,0
232768,dirithromycin,0,0
232769,1000,0,0
232770,mg,0,0
232771,q.d.s,0,0
232772,.,0,0
232773,plus,0,0
232774,omeprazole,0,0
232775,20,0,0
232776,mg,0,0
232777,b.d.,0,0
232778,",",0,0
232779,or,0,0
232780,amoxycillin,0,0
232781,500,0,0
232782,mg,0,0
232783,q.d.s,0,0
232784,.,0,0
232785,plus,0,0
232786,omepirazole,0,0
232787,20,0,0
232788,mg,0,0
232789,b.d,0,1
232790,.,0,0
232791,Four,0,0
232792,weeks,0,0
232793,after,0,0
232794,the,0,0
232795,completion,0,0
232796,of,0,0
232797,therapy,0,0
232798,a,0,0
232799,repeat,0,0
232800,13C-urea,0,0
232801,breath,0,0
232802,test,0,0
232803,was,0,0
232804,done,0,0
232805,to,0,0
232806,assess,0,0
232807,for,0,0
232808,cure,0,0
232809,.,0,0
232810,RESULTS,0,0
232811,No,0,0
232812,patient,0,0
232813,taking,0,0
232814,dirithromycin,1,0
232815,alone,1,0
232816,(,1,0
232817,n,1,1
232818,=,1,0
232819,6,1,0
232820,),1,0
232821,or,0,0
232822,in,0,0
232823,combination,0,0
232824,with,0,1
232825,omeprazole,0,0
232826,(,0,0
232827,n,0,1
232828,=,0,0
232829,26,0,1
232830,),0,0
232831,achieved,0,0
232832,cure,0,0
232833,of,0,0
232834,their,0,0
232835,infection,0,1
232836,.,0,0
232837,Eradication,0,0
232838,of,0,0
232839,H.,0,1
232840,pylori,0,0
232841,was,0,0
232842,seen,0,0
232843,in,0,0
232844,one,0,0
232845,of,0,0
232846,seven,0,1
232847,patients,0,1
232848,taking,0,1
232849,dirithromycin,0,1
232850,plus,0,0
232851,metronidazole,0,0
232852,.,0,0
232853,Five,0,0
232854,of,0,0
232855,10,0,1
232856,patients,0,1
232857,taking,0,1
232858,omeprazole-amoxycillin,0,0
232859,dual,0,1
232860,therapy,0,0
232861,had,0,0
232862,their,0,0
232863,H.,0,0
232864,pylori,0,0
232865,infection,0,0
232866,cured,0,0
232867,(,0,0
232868,P,0,0
232869,=,0,0
232870,0.0007,0,0
232871,vs.,0,0
232872,patients,0,1
232873,taking,0,0
232874,dirithromycin,0,1
232875,plus,0,0
232876,omeprazole,0,0
232877,),0,0
232878,.,0,0
232879,Eleven,0,0
232880,(,0,0
232881,47,0,1
232882,%,0,0
232883,),0,0
232884,of,0,0
232885,32,0,1
232886,patients,0,1
232887,taking,0,1
232888,dirithromycin,0,0
232889,alone,0,0
232890,or,0,0
232891,combined,0,0
232892,with,0,1
232893,omeprazole,0,0
232894,reported,0,0
232895,side-effects,0,0
232896,",",0,0
232897,but,0,0
232898,only,0,0
232899,two,0,0
232900,(,0,0
232901,6,0,0
232902,%,0,0
232903,),0,0
232904,stopped,0,0
232905,therapy,0,0
232906,prematurely,0,1
232907,as,0,0
232908,a,0,0
232909,result,0,0
232910,of,0,0
232911,side-effects,0,0
232912,.,0,1
232913,CONCLUSION,0,0
232914,No,0,0
232915,subject,0,0
232916,taking,0,0
232917,dirithromycin,0,0
232918,alone,0,0
232919,or,0,0
232920,in,0,0
232921,combination,0,0
232922,with,0,1
232923,omeprazole,0,0
232924,had,0,0
232925,their,0,0
232926,H.,0,0
232927,pylori,0,0
232928,infection,0,1
232929,cured,0,0
232930,.,0,0
232931,Dirithromycin,0,0
232932,",",0,0
232933,in,0,0
232934,the,0,0
232935,regimen,0,0
232936,used,0,0
232937,",",0,0
232938,shows,0,0
232939,little,0,0
232940,promise,0,0
232941,in,0,0
232942,the,0,0
232943,treatment,0,0
232944,of,0,0
232945,patients,1,1
232946,with,1,1
232947,H.,1,1
232948,pylori,1,1
232949,infection,1,1
232950,.,1,0
232951,Intraumbilical,0,0
232952,vein,0,0
232953,injection,0,0
232954,of,0,0
232955,prostaglandin,0,0
232956,F2,0,0
232957,alpha,0,0
232958,in,0,0
232959,retained,1,0
232960,placenta,1,1
232961,.,1,0
232962,A,0,0
232963,randomized,0,0
232964,protocol,0,0
232965,was,0,0
232966,used,0,0
232967,to,0,0
232968,study,0,0
232969,the,0,0
232970,effect,0,0
232971,of,0,0
232972,intraumbilical,0,0
232973,prostaglandin,0,0
232974,F2,0,0
232975,alpha,0,0
232976,(,0,0
232977,Hembate,0,0
232978,",",0,0
232979,Upjohn,0,0
232980,),0,0
232981,and,0,0
232982,oxytocin,0,0
232983,injection,0,0
232984,in,0,0
232985,women,1,1
232986,with,1,1
232987,retained,1,0
232988,placenta,1,1
232989,.,1,0
232990,Prostaglandin,0,0
232991,F2,0,0
232992,alpha,0,0
232993,",",0,0
232994,20,0,0
232995,mg,0,0
232996,",",0,0
232997,diluted,0,0
232998,to,0,0
232999,20,0,1
233000,ml,0,0
233001,in,0,0
233002,normal,0,1
233003,saline,0,0
233004,solution,0,0
233005,(,1,0
233006,10,1,0
233007,women,1,1
233008,",",1,0
233009,group,1,0
233010,1,1,0
233011,),1,0
233012,",",0,0
233013,30,0,0
233014,IU,0,0
233015,of,0,0
233016,oxytocin,0,0
233017,",",0,0
233018,diluted,0,0
233019,to,0,0
233020,20,0,1
233021,ml,0,0
233022,in,0,0
233023,normal,0,1
233024,saline,0,0
233025,solution,0,0
233026,(,1,0
233027,11,1,0
233028,women,1,1
233029,",",1,0
233030,group,1,0
233031,2,1,0
233032,),1,0
233033,",",0,0
233034,or,0,0
233035,20,0,0
233036,ml,0,0
233037,of,0,0
233038,normal,0,1
233039,saline,0,0
233040,solution,0,0
233041,alone,0,0
233042,(,1,0
233043,7,1,0
233044,women,1,1
233045,",",1,0
233046,group,1,0
233047,3,1,0
233048,),1,0
233049,",",0,0
233050,were,0,0
233051,injected,0,0
233052,into,0,0
233053,the,0,0
233054,umbilical,0,0
233055,vein,0,0
233056,1,0,0
233057,h,0,0
233058,after,0,0
233059,delivery,0,0
233060,.,0,0
233061,Nine,1,0
233062,women,1,1
233063,(,1,0
233064,group,1,0
233065,4,1,0
233066,",",1,0
233067,controls,1,0
233068,),1,0
233069,underwent,1,1
233070,manual,1,0
233071,removal,1,0
233072,of,1,0
233073,the,1,0
233074,retained,1,0
233075,placenta,1,0
233076,.,1,0
233077,In,0,0
233078,group,0,0
233079,1,0,0
233080,",",0,0
233081,placental,0,0
233082,expulsion,0,0
233083,occurred,0,0
233084,in,0,0
233085,all,0,0
233086,patients,0,1
233087,and,0,0
233088,the,0,0
233089,duration,0,0
233090,of,0,0
233091,the,0,0
233092,placental,0,0
233093,expulsion,0,0
233094,after,0,0
233095,prostaglandin,0,0
233096,F2,0,0
233097,alpha,0,0
233098,injection,0,0
233099,was,0,0
233100,6.8,0,0
233101,+/-,0,0
233102,1.36,0,0
233103,(,0,0
233104,mean,0,1
233105,+/-,0,0
233106,SE,0,0
233107,),0,0
233108,min,0,0
233109,:,0,0
233110,in,0,0
233111,group,0,0
233112,2,0,0
233113,",",0,0
233114,six,0,1
233115,placental,0,0
233116,expulsions,0,0
233117,occurred,0,0
233118,after,0,0
233119,13.3,0,0
233120,+/-,0,0
233121,1.97,0,0
233122,min,0,0
233123,(,0,0
233124,mean,0,0
233125,+/-,0,0
233126,SE,0,1
233127,),0,0
233128,;,0,0
233129,and,0,0
233130,in,0,0
233131,group,0,0
233132,3,0,0
233133,",",0,0
233134,no,0,0
233135,effect,0,0
233136,was,0,0
233137,recorded,0,0
233138,after,0,0
233139,intraumbilical,0,0
233140,saline,0,0
233141,injection,0,0
233142,.,0,0
233143,We,0,0
233144,suggest,0,0
233145,that,0,0
233146,intraumbilical,0,0
233147,vein,0,0
233148,injection,0,0
233149,of,0,0
233150,prostaglandin,0,0
233151,F2,0,0
233152,alpha,0,0
233153,might,0,0
233154,be,0,0
233155,a,0,0
233156,beneficial,0,0
233157,",",0,0
233158,non-surgical,0,0
233159,method,0,0
233160,for,0,0
233161,treating,0,0
233162,retained,0,0
233163,placenta,0,1
233164,.,0,0
233165,Oxytocin,0,0
233166,might,0,0
233167,reduce,0,0
233168,the,0,0
233169,incidence,0,0
233170,of,0,0
233171,manual,0,0
233172,lysis,0,0
233173,of,0,0
233174,the,0,0
233175,placenta,0,0
233176,and,0,0
233177,achieve,0,0
233178,partial,0,0
233179,success,0,0
233180,.,0,0
233181,Clonidine,0,0
233182,increases,0,0
233183,the,0,0
233184,sweating,0,0
233185,threshold,0,0
233186,",",0,0
233187,but,0,0
233188,does,0,0
233189,not,0,0
233190,reduce,0,0
233191,the,0,0
233192,gain,0,0
233193,of,0,0
233194,sweating,0,0
233195,.,0,0
233196,We,0,0
233197,tested,0,0
233198,the,0,0
233199,hypothesis,0,0
233200,that,0,0
233201,clonidine,0,0
233202,produces,0,0
233203,a,0,0
233204,dose-dependent,0,0
233205,increase,0,0
233206,in,0,0
233207,the,0,0
233208,sweating,1,0
233209,threshold,1,0
233210,but,0,0
233211,does,0,0
233212,not,0,0
233213,reduce,0,0
233214,the,0,0
233215,gain,1,0
233216,of,1,0
233217,sweating,1,0
233218,.,1,0
233219,Six,1,0
233220,healthy,1,1
233221,male,1,1
233222,volunteers,1,1
233223,were,1,0
233224,evaluated,1,0
233225,",",0,0
233226,each,0,0
233227,on,0,0
233228,three,0,0
233229,separate,0,0
233230,days,0,0
233231,in,0,0
233232,random,0,1
233233,order,0,0
233234,.,0,0
233235,In,0,0
233236,one,0,0
233237,",",0,0
233238,saline,0,0
233239,was,0,0
233240,administered,0,0
233241,;,0,0
233242,in,0,0
233243,another,0,0
233244,",",0,0
233245,a,0,0
233246,2-micrograms/kg,0,0
233247,bolus,0,0
233248,of,0,0
233249,clonidine,0,0
233250,was,0,0
233251,followed,0,0
233252,by,0,0
233253,an,0,0
233254,infusion,0,0
233255,at,0,0
233256,2,0,0
233257,micrograms.kg-1.h-1,0,0
233258,",",0,0
233259,and,0,0
233260,on,0,0
233261,a,0,0
233262,third,0,0
233263,day,0,0
233264,",",0,0
233265,a,0,0
233266,4-micrograms/kg,0,0
233267,bolus,0,0
233268,was,0,0
233269,followed,0,0
233270,by,0,0
233271,an,0,0
233272,infusion,0,0
233273,at,0,0
233274,4,0,0
233275,micrograms.kg-1.h-1,0,0
233276,.,0,0
233277,Core,0,1
233278,temperature,0,0
233279,was,0,0
233280,measured,0,0
233281,at,0,0
233282,the,0,0
233283,tympanic,0,1
233284,membrane,0,0
233285,and,0,0
233286,mean,0,0
233287,skin,0,0
233288,temperature,0,0
233289,was,0,0
233290,determined,0,0
233291,from,0,0
233292,four,0,1
233293,sites,0,1
233294,.,0,0
233295,A,0,0
233296,chest,0,0
233297,sweating,0,0
233298,rate,0,0
233299,of,0,0
233300,40,0,1
233301,g.m-2.h-1,0,0
233302,was,0,0
233303,considered,0,0
233304,significant,0,0
233305,.,0,0
233306,The,0,0
233307,core,0,0
233308,temperature,0,0
233309,triggering,0,0
233310,sweating,0,0
233311,",",0,0
233312,adjusted,0,0
233313,to,0,0
233314,a,0,0
233315,designated,0,0
233316,mean,0,0
233317,skin,0,0
233318,temperature,0,0
233319,of,0,0
233320,34,0,1
233321,degrees,0,0
233322,C,0,0
233323,",",0,0
233324,identified,0,0
233325,the,0,0
233326,threshold,0,0
233327,for,0,0
233328,this,0,0
233329,response,0,0
233330,.,0,0
233331,Gain,0,0
233332,was,0,0
233333,defined,0,0
233334,by,0,0
233335,the,0,0
233336,adjusted,0,0
233337,core,0,0
233338,temperature,0,0
233339,increase,0,0
233340,required,0,0
233341,to,0,0
233342,augment,0,0
233343,sweating,0,0
233344,from,0,0
233345,100,0,0
233346,to,0,0
233347,300,0,0
233348,g.m-2.h-1,0,0
233349,.,0,0
233350,degree,0,0
233351,C-1,0,0
233352,.,0,0
233353,Plasma,0,0
233354,clonidine,0,0
233355,concentrations,0,0
233356,were,0,1
233357,0.8,0,0
233358,+/-,0,0
233359,0.1,0,0
233360,and,0,0
233361,1.6,0,0
233362,+/-,0,0
233363,0.2,0,0
233364,ng/mL,0,0
233365,on,0,0
233366,the,0,0
233367,small-,0,0
233368,and,0,0
233369,large-dose,0,0
233370,days,0,0
233371,",",0,0
233372,respectively,0,0
233373,.,0,0
233374,Clonidine,0,0
233375,administration,0,0
233376,increased,0,0
233377,the,0,0
233378,sweating,0,0
233379,threshold,0,0
233380,approximately,0,0
233381,0.4,0,0
233382,degree,0,0
233383,C,0,0
233384,(,0,0
233385,P,0,0
233386,<,0,0
233387,0.05,0,0
233388,),0,0
233389,",",0,0
233390,but,0,0
233391,the,0,0
233392,increase,0,0
233393,was,0,0
233394,comparable,0,0
233395,at,0,0
233396,each,0,0
233397,dose,0,0
233398,.,0,0
233399,The,0,0
233400,gain,0,0
233401,of,0,0
233402,sweating,0,0
233403,was,0,0
233404,approximately,0,0
233405,0.2,0,0
233406,degree,0,0
233407,C,0,0
233408,and,0,0
233409,was,0,0
233410,not,0,0
233411,influenced,0,0
233412,by,0,0
233413,clonidine,0,0
233414,administration,0,0
233415,.,0,0
233416,The,0,0
233417,thermoregulatory,0,0
233418,effects,0,0
233419,of,0,0
233420,clonidine,0,0
233421,thus,0,0
233422,resemble,0,0
233423,those,0,0
233424,of,0,0
233425,volatile,0,0
233426,anesthetics,0,0
233427,",",0,0
233428,opioids,0,0
233429,",",0,0
233430,and,0,0
233431,propofol,0,0
233432,.,0,0
233433,These,0,0
233434,data,0,0
233435,suggest,0,0
233436,that,0,0
233437,the,0,0
233438,antishivering,0,0
233439,effect,0,0
233440,of,0,0
233441,clonidine,0,0
233442,results,0,0
233443,from,0,1
233444,central,0,0
233445,thermoregulatory,0,0
233446,inhibition,0,0
233447,rather,0,0
233448,than,0,0
233449,a,0,0
233450,specific,0,0
233451,peripheral,0,0
233452,action,0,0
233453,on,0,0
233454,thermogenic,0,0
233455,muscular,0,0
233456,activity,0,0
233457,.,0,0
233458,Unlike,0,0
233459,other,0,0
233460,sedatives,0,0
233461,and,0,0
233462,anesthetics,0,0
233463,",",0,0
233464,the,0,0
233465,concentration-dependence,0,0
233466,of,0,0
233467,clonidine,0,0
233468,demonstrates,0,0
233469,a,0,0
233470,ceiling,0,0
233471,beyond,0,0
233472,which,0,0
233473,the,0,0
233474,administration,0,0
233475,of,0,0
233476,an,0,0
233477,additional,0,0
233478,drug,0,0
233479,fails,0,0
233480,to,0,0
233481,enhance,0,0
233482,the,0,0
233483,effect,0,0
233484,",",0,0
233485,suggesting,0,0
233486,that,0,0
233487,the,0,0
233488,thermoregulatory,0,0
233489,effect,0,0
233490,of,0,0
233491,clonidine,0,0
233492,may,0,0
233493,be,0,0
233494,limited,0,0
233495,",",0,0
233496,even,0,0
233497,at,0,0
233498,high,0,0
233499,plasma,0,0
233500,concentrations,0,0
233501,.,0,0
233502,The,0,0
233503,gain,0,0
233504,of,0,0
233505,sweating,0,0
233506,was,0,0
233507,well,0,0
233508,preserved,0,0
233509,indicating,0,0
233510,that,0,0
233511,this,0,0
233512,response,0,0
233513,remains,0,0
233514,effective,0,0
233515,in,0,0
233516,the,0,0
233517,presence,0,0
233518,of,0,0
233519,sedatives,0,0
233520,and,0,1
233521,anesthetics,0,0
233522,.,0,1
233523,A,0,0
233524,component,0,0
233525,analysis,0,0
233526,of,0,0
233527,cognitive-behavioral,0,1
233528,treatment,0,0
233529,for,0,0
233530,depression,1,1
233531,.,1,0
233532,The,0,0
233533,purpose,0,0
233534,of,0,0
233535,this,0,0
233536,study,0,0
233537,was,0,0
233538,to,0,0
233539,provide,0,0
233540,an,0,0
233541,experimental,0,0
233542,test,0,0
233543,of,0,0
233544,the,0,0
233545,theory,0,0
233546,of,0,0
233547,change,0,0
233548,put,0,0
233549,forth,0,0
233550,by,0,0
233551,A.,0,0
233552,T.,0,1
233553,Beck,0,0
233554,",",0,0
233555,A.,0,0
233556,J,0,0
233557,.,0,0
233558,Rush,0,0
233559,",",0,0
233560,B.,0,0
233561,F.,0,0
233562,Shaw,0,0
233563,",",0,0
233564,and,0,0
233565,G.,0,0
233566,Emery,0,0
233567,(,0,0
233568,1979,0,1
233569,),0,0
233570,to,0,0
233571,explain,0,0
233572,the,0,0
233573,efficacy,0,0
233574,of,0,0
233575,cognitive-behavioral,0,1
233576,therapy,0,0
233577,(,0,0
233578,CT,0,0
233579,),0,0
233580,for,0,0
233581,depression,0,1
233582,.,0,0
233583,The,0,0
233584,comparison,0,0
233585,involved,0,0
233586,randomly,0,1
233587,assigning,0,0
233588,150,1,0
233589,outpatients,1,1
233590,with,1,1
233591,major,1,0
233592,depression,1,1
233593,to,1,0
233594,a,1,0
233595,treatment,1,0
233596,focused,1,0
233597,exclusively,1,0
233598,on,1,0
233599,the,1,0
233600,behavioral,1,0
233601,activation,1,0
233602,(,1,0
233603,BA,1,0
233604,),1,0
233605,component,1,0
233606,of,1,0
233607,CT,1,0
233608,",",0,0
233609,a,0,0
233610,treatment,0,0
233611,that,0,0
233612,included,0,1
233613,both,0,0
233614,BA,0,0
233615,and,0,0
233616,the,0,0
233617,teaching,0,0
233618,of,0,0
233619,skills,0,0
233620,to,0,0
233621,modify,0,0
233622,automatic,0,0
233623,thoughts,0,0
233624,(,0,0
233625,AT,0,0
233626,),0,0
233627,",",0,0
233628,but,0,0
233629,excluding,0,0
233630,the,0,0
233631,components,0,0
233632,of,0,0
233633,CT,0,0
233634,focused,0,0
233635,on,0,0
233636,core,0,0
233637,schema,0,0
233638,",",0,0
233639,or,0,0
233640,the,0,0
233641,full,0,0
233642,CT,0,0
233643,treatment,0,0
233644,.,0,0
233645,Four,0,0
233646,experienced,0,0
233647,cognitive,0,0
233648,therapists,0,0
233649,conducted,0,0
233650,all,0,0
233651,treatments,0,0
233652,.,0,0
233653,Despite,0,0
233654,excellent,0,0
233655,adherence,0,0
233656,to,0,0
233657,treatment,0,0
233658,protocols,0,0
233659,by,0,0
233660,the,0,0
233661,therapists,0,0
233662,",",0,0
233663,a,0,0
233664,clear,0,0
233665,bias,0,0
233666,favoring,0,0
233667,CT,0,0
233668,",",0,0
233669,and,0,0
233670,the,0,0
233671,competent,0,0
233672,performance,0,0
233673,of,0,0
233674,CT,0,0
233675,",",0,0
233676,there,0,0
233677,was,0,0
233678,no,0,0
233679,evidence,0,0
233680,that,0,0
233681,the,0,0
233682,complete,0,0
233683,treatment,0,0
233684,produced,0,0
233685,better,0,0
233686,outcomes,0,0
233687,",",0,0
233688,at,0,0
233689,either,0,0
233690,the,0,0
233691,termination,0,0
233692,of,0,0
233693,acute,0,1
233694,treatment,0,0
233695,or,0,0
233696,the,0,0
233697,6-month,0,0
233698,follow-up,0,0
233699,",",0,0
233700,than,0,0
233701,either,0,0
233702,component,0,0
233703,treatment,0,0
233704,.,0,0
233705,Furthermore,0,0
233706,",",0,0
233707,both,0,0
233708,BA,0,0
233709,and,0,0
233710,AT,0,0
233711,treatments,0,0
233712,were,0,0
233713,just,0,0
233714,as,0,0
233715,effective,0,0
233716,as,0,0
233717,CT,0,0
233718,at,0,0
233719,altering,0,0
233720,negative,0,0
233721,thinking,0,0
233722,as,0,0
233723,well,0,0
233724,as,0,0
233725,dysfunctional,0,0
233726,attributional,0,1
233727,styles,0,0
233728,.,0,0
233729,Finally,0,0
233730,",",0,0
233731,attributional,0,0
233732,style,0,0
233733,was,0,0
233734,highly,0,0
233735,predictive,0,0
233736,of,0,0
233737,both,0,0
233738,short-,0,0
233739,and,0,0
233740,long-term,0,0
233741,outcomes,0,0
233742,in,0,0
233743,the,0,0
233744,BA,0,0
233745,condition,0,0
233746,",",0,0
233747,but,0,0
233748,not,0,0
233749,in,0,0
233750,the,0,0
233751,CT,0,0
233752,condition,0,0
233753,.,0,0
233754,The,0,0
233755,evolving,0,0
233756,clinical,0,0
233757,status,0,0
233758,of,0,0
233759,patients,1,1
233760,after,1,0
233761,a,1,0
233762,myocardial,1,1
233763,infarction,1,1
233764,:,1,1
233765,the,0,0
233766,importance,0,0
233767,of,0,0
233768,post-hospital,1,1
233769,data,1,0
233770,for,0,0
233771,mortality,0,0
233772,prediction,0,0
233773,.,0,0
233774,Studies,0,0
233775,predicting,0,0
233776,mortality,0,0
233777,after,0,0
233778,myocardial,1,0
233779,infarction,1,1
233780,(,1,0
233781,MI,1,0
233782,),1,0
233783,usually,0,0
233784,rely,0,0
233785,on,0,0
233786,in-hospital,0,0
233787,data,0,0
233788,",",0,0
233789,and,0,0
233790,combine,0,0
233791,patients,1,1
233792,admitted,1,1
233793,for,1,0
233794,the,1,0
233795,first,1,0
233796,MI,1,0
233797,with,1,1
233798,recurrent,1,1
233799,MI,1,0
233800,patients,1,1
233801,.,1,0
233802,Since,0,0
233803,treatment,0,0
233804,decisions,0,0
233805,are,0,0
233806,often,0,0
233807,made,0,0
233808,or,0,0
233809,modified,0,0
233810,at,0,0
233811,the,0,0
233812,first,0,0
233813,outpatient,0,1
233814,clinic,0,1
233815,visit,0,0
233816,",",0,0
233817,this,0,0
233818,study,0,0
233819,was,0,0
233820,designed,0,0
233821,to,0,0
233822,evaluate,0,0
233823,the,0,0
233824,importance,0,0
233825,of,0,0
233826,post-hospital,0,1
233827,data,0,0
233828,on,0,0
233829,mortality,0,0
233830,prediction,0,0
233831,after,0,0
233832,a,0,0
233833,first,0,0
233834,myocardial,0,0
233835,infarction,0,1
233836,(,0,0
233837,MI,0,0
233838,),0,0
233839,.,0,0
233840,An,1,0
233841,inception,1,0
233842,cohort,1,1
233843,of,1,0
233844,patients,1,1
233845,enrolled,1,1
233846,in,1,0
233847,the,1,0
233848,Beta-Blocker,1,0
233849,in,1,0
233850,Heart,1,1
233851,Attack,1,1
233852,Trial,1,0
233853,(,1,0
233854,n,1,1
233855,=,1,0
233856,2830,1,1
233857,),1,0
233858,was,1,0
233859,included,1,1
233860,.,1,0
233861,Forty-three,0,1
233862,variables,0,0
233863,(,0,0
233864,including,0,0
233865,in-hospital,1,0
233866,and,1,0
233867,post-hospital,1,1
233868,data,1,0
233869,),1,0
233870,were,0,0
233871,evaluated,0,0
233872,using,0,0
233873,stepwise,0,0
233874,logistic,0,0
233875,regression,0,0
233876,.,0,1
233877,Ten,0,1
233878,variables,0,0
233879,were,0,0
233880,independently,0,0
233881,associated,0,0
233882,with,0,0
233883,1-year,0,0
233884,mortality,0,0
233885,:,0,1
233886,five,0,0
233887,used,0,0
233888,in-hospital,0,0
233889,data,0,0
233890,(,0,0
233891,history,0,1
233892,of,0,0
233893,hypertension,0,1
233894,",",0,0
233895,hypercholesterolemia,0,1
233896,",",0,0
233897,congestive,0,1
233898,heart,0,1
233899,failure,0,1
233900,[,0,0
233901,CHF,0,1
233902,],0,0
233903,",",0,0
233904,ventricular,0,0
233905,tachycardia,0,0
233906,",",0,0
233907,and,0,0
233908,age,0,1
233909,),0,0
233910,;,0,0
233911,and,0,0
233912,five,0,1
233913,variables,0,0
233914,depended,0,0
233915,on,0,0
233916,post-hospital,0,1
233917,data,0,0
233918,collected,0,0
233919,at,0,0
233920,the,0,0
233921,first,0,0
233922,outpatient,0,1
233923,visit,0,0
233924,(,0,0
233925,CHF,0,1
233926,after,0,0
233927,discharge,0,0
233928,",",0,0
233929,New,0,1
233930,York,0,1
233931,Heart,0,0
233932,Association,0,0
233933,functional,0,0
233934,class,0,1
233935,",",0,0
233936,heart,0,0
233937,rate,0,0
233938,",",0,0
233939,pulmonary,0,0
233940,rates,0,0
233941,",",0,0
233942,and,0,0
233943,smoking,0,0
233944,),0,0
233945,.,0,0
233946,Two,0,0
233947,predictive,0,0
233948,systems,0,0
233949,were,0,0
233950,developed,0,0
233951,that,0,0
233952,partitioned,0,0
233953,patients,0,1
233954,into,0,1
233955,one,0,1
233956,of,0,0
233957,four,0,1
233958,classes,0,1
233959,with,0,1
233960,distinct,0,1
233961,mortality,0,0
233962,risks,0,0
233963,:,0,1
233964,a,0,0
233965,composite,0,0
233966,system,0,0
233967,using,0,0
233968,the,0,0
233969,10,0,0
233970,in-,0,0
233971,and,0,0
233972,post-hospital,0,1
233973,variables,0,0
233974,",",0,0
233975,and,0,0
233976,a,0,0
233977,system,0,0
233978,using,0,0
233979,only,0,0
233980,the,0,0
233981,5,0,0
233982,in-hospital,0,0
233983,variables,0,0
233984,.,0,1
233985,Mortality,0,0
233986,risk,0,0
233987,for,0,0
233988,the,0,0
233989,composite,0,0
233990,system,0,0
233991,classes,0,1
233992,ranged,0,0
233993,from,0,0
233994,0.6,0,0
233995,to,0,0
233996,20.0,0,0
233997,%,0,0
233998,(,0,0
233999,I,0,0
234000,[,0,0
234001,n,0,0
234002,=,0,0
234003,861,0,1
234004,],0,0
234005,",",0,0
234006,0.6,0,0
234007,%,0,0
234008,;,0,0
234009,II,0,0
234010,[,0,0
234011,n,0,0
234012,=,0,0
234013,1151,0,0
234014,],0,0
234015,",",0,0
234016,2.3,0,0
234017,%,0,0
234018,;,0,0
234019,III,0,0
234020,[,0,0
234021,n,0,1
234022,=698,0,0
234023,],0,0
234024,",",0,0
234025,4.3,0,0
234026,%,0,0
234027,;,0,0
234028,IV,0,0
234029,[,0,0
234030,n,0,1
234031,=,0,0
234032,120,0,1
234033,],0,0
234034,",",0,0
234035,20.0,0,0
234036,%,0,0
234037,),0,0
234038,.,0,0
234039,In,0,0
234040,contrast,0,0
234041,",",0,0
234042,the,0,0
234043,range,0,0
234044,of,0,0
234045,mortality,0,0
234046,risk,0,0
234047,using,0,0
234048,the,0,0
234049,in-hospital,0,0
234050,data,0,0
234051,only,0,0
234052,system,0,0
234053,was,0,0
234054,less,0,0
234055,(,0,0
234056,1,0,0
234057,to,0,0
234058,8.3,0,0
234059,%,0,0
234060,),0,0
234061,.,0,0
234062,Most,0,0
234063,importantly,0,0
234064,",",0,0
234065,a,0,0
234066,distinct,0,0
234067,gradient,0,0
234068,within,0,0
234069,each,0,0
234070,class,0,1
234071,of,0,0
234072,the,0,0
234073,in-hospital,0,0
234074,data,0,0
234075,only,0,0
234076,system,0,0
234077,was,0,0
234078,created,0,0
234079,by,0,0
234080,the,0,0
234081,addition,0,0
234082,of,0,0
234083,the,0,0
234084,post-hospital,0,0
234085,data,0,0
234086,.,0,0
234087,This,0,0
234088,study,0,0
234089,demonstrates,0,0
234090,that,0,0
234091,risk,0,0
234092,stratification,0,0
234093,after,0,0
234094,an,0,0
234095,acute,0,1
234096,first,0,0
234097,MI,0,0
234098,is,0,0
234099,improved,0,0
234100,by,0,0
234101,the,0,0
234102,addition,0,0
234103,of,0,0
234104,post-hospital,0,1
234105,data,0,0
234106,.,0,1
234107,The,0,0
234108,impact,0,0
234109,of,0,0
234110,a,0,0
234111,psychological,0,0
234112,intervention,0,0
234113,on,0,0
234114,quality,0,0
234115,of,0,0
234116,life,0,0
234117,in,0,0
234118,non-metastatic,1,1
234119,breast,1,1
234120,cancer,1,1
234121,.,1,0
234122,The,0,0
234123,aim,0,0
234124,of,0,0
234125,this,0,0
234126,study,0,0
234127,was,0,0
234128,to,0,0
234129,determine,0,0
234130,whether,0,0
234131,psychological,0,0
234132,intervention,0,0
234133,had,0,0
234134,a,0,0
234135,beneficial,0,0
234136,effect,0,0
234137,on,0,0
234138,the,0,0
234139,quality,0,0
234140,of,0,0
234141,life,0,0
234142,and,0,0
234143,behaviour,0,0
234144,of,0,0
234145,women,1,1
234146,diagnosed,1,1
234147,with,1,1
234148,breast,1,1
234149,cancer,1,1
234150,.,1,0
234151,36,1,0
234152,consecutive,1,1
234153,patients,1,1
234154,with,1,1
234155,non-metastatic,1,1
234156,breast,1,1
234157,cancer,1,1
234158,assigned,1,0
234159,to,1,0
234160,surgery,1,1
234161,and,1,0
234162,systemic,1,0
234163,chemotherapy,1,0
234164,were,0,0
234165,randomised,0,0
234166,to,0,0
234167,receive,0,0
234168,either,0,0
234169,psychological,0,0
234170,intervention,0,0
234171,(,0,0
234172,weekly,0,0
234173,cognitive,0,0
234174,individual,0,0
234175,psychotherapy,0,0
234176,and,0,0
234177,bimonthly,0,0
234178,family,0,0
234179,counselling,0,0
234180,),0,0
234181,or,0,0
234182,standard,0,0
234183,follow-up,0,0
234184,.,0,0
234185,Personality,0,0
234186,(,0,0
234187,16-PF,0,0
234188,and,0,0
234189,IIQ,0,0
234190,),0,0
234191,",",0,0
234192,quality,0,0
234193,of,0,0
234194,life,0,0
234195,(,0,0
234196,FLIC,0,0
234197,),0,0
234198,",",0,0
234199,and,0,0
234200,depression,0,0
234201,(,0,0
234202,BDI,0,0
234203,),0,0
234204,scores,0,0
234205,were,0,0
234206,the,0,0
234207,endpoints,0,0
234208,for,0,0
234209,this,0,0
234210,study,0,0
234211,",",0,0
234212,and,0,0
234213,the,0,0
234214,questionnaires,0,0
234215,were,0,0
234216,completed,0,1
234217,by,0,0
234218,the,0,0
234219,patients,0,1
234220,at,0,0
234221,diagnosis,0,1
234222,",",0,0
234223,and,0,0
234224,up,0,0
234225,to,0,0
234226,9,0,0
234227,months,0,0
234228,after,0,0
234229,diagnosis,0,1
234230,.,0,0
234231,Cognitive,0,0
234232,psychotherapy,0,0
234233,and,0,0
234234,family,0,0
234235,counselling,0,0
234236,improved,0,0
234237,both,0,0
234238,depression,0,0
234239,and,0,0
234240,quality,0,0
234241,of,0,0
234242,life,0,0
234243,indexes,0,0
234244,compared,0,0
234245,with,0,1
234246,the,0,0
234247,control,0,0
234248,group,0,0
234249,.,0,0
234250,Better,0,0
234251,emotional,0,0
234252,coping,0,0
234253,behaviours,0,0
234254,were,0,0
234255,also,0,0
234256,revealed,0,0
234257,by,0,0
234258,some,0,0
234259,changes,0,0
234260,in,0,0
234261,personality,0,1
234262,traits,0,0
234263,in,0,0
234264,the,0,0
234265,intervention,0,0
234266,group,0,0
234267,.,0,0
234268,Durability,0,0
234269,of,0,0
234270,central,0,0
234271,venous,0,1
234272,catheters,0,0
234273,.,0,0
234274,A,0,0
234275,randomized,0,0
234276,trial,0,0
234277,in,0,0
234278,children,1,1
234279,with,1,1
234280,malignant,1,1
234281,diseases,1,1
234282,.,1,0
234283,In,0,0
234284,a,0,0
234285,prospective,0,0
234286,randomized,0,0
234287,study,0,0
234288,the,0,0
234289,durability,0,0
234290,of,0,0
234291,tunnelled,0,0
234292,and,0,0
234293,non-tunnelled,0,0
234294,central,0,0
234295,venous,0,1
234296,catheters,0,0
234297,was,0,0
234298,investigated,0,0
234299,in,0,0
234300,children,1,1
234301,with,1,1
234302,malignant,1,1
234303,diseases,1,1
234304,.,1,1
234305,Twenty,1,1
234306,children,1,1
234307,were,1,0
234308,included,1,1
234309,in,1,0
234310,the,1,0
234311,study,1,0
234312,but,1,0
234313,four,1,0
234314,(,1,0
234315,two,1,0
234316,in,1,0
234317,each,1,0
234318,group,1,0
234319,),1,0
234320,had,1,0
234321,to,1,0
234322,be,1,0
234323,excluded,1,0
234324,;,1,0
234325,three,1,0
234326,because,1,0
234327,the,1,0
234328,entry,1,0
234329,criteria,1,1
234330,turned,1,0
234331,out,1,0
234332,not,1,0
234333,to,1,0
234334,be,1,0
234335,fulfilled,1,1
234336,and,1,0
234337,one,1,0
234338,because,1,0
234339,of,1,0
234340,lack,1,0
234341,of,1,0
234342,data,1,0
234343,.,1,0
234344,The,0,0
234345,median,0,0
234346,duration,0,0
234347,of,0,0
234348,the,0,0
234349,tunnelled,0,0
234350,catheters,0,0
234351,was,0,0
234352,224,0,1
234353,days,0,0
234354,with,0,1
234355,a,0,0
234356,range,0,0
234357,of,0,0
234358,25-846,0,1
234359,days,0,0
234360,which,0,0
234361,was,0,0
234362,significantly,0,0
234363,longer,0,0
234364,than,0,0
234365,that,0,0
234366,of,0,0
234367,conventional,0,0
234368,catheters,0,0
234369,(,0,1
234370,39.5,0,0
234371,days,0,0
234372,",",0,0
234373,range,0,0
234374,9-228,0,1
234375,days,0,0
234376,),0,0
234377,.,0,0
234378,In,0,0
234379,addition,0,0
234380,six,0,1
234381,of,0,0
234382,eight,0,1
234383,conventional,0,1
234384,catheters,0,0
234385,were,0,0
234386,accidentally,0,1
234387,removed,0,0
234388,whereas,0,0
234389,all,0,0
234390,catheters,0,0
234391,in,0,0
234392,the,0,0
234393,tunnelled,0,0
234394,group,0,0
234395,had,0,0
234396,to,0,0
234397,be,0,0
234398,removed,0,0
234399,via,0,0
234400,a,0,0
234401,small,0,0
234402,incision,0,0
234403,.,0,1
234404,Three,0,0
234405,cases,0,0
234406,of,0,0
234407,catheter,0,0
234408,related,0,0
234409,sepsis,0,0
234410,",",0,0
234411,two,0,0
234412,in,0,0
234413,the,0,0
234414,tunnelled,0,0
234415,group,0,0
234416,and,0,0
234417,one,0,0
234418,in,0,0
234419,the,0,0
234420,conventional,0,0
234421,group,0,0
234422,",",0,0
234423,were,0,0
234424,registered,0,0
234425,.,0,0
234426,The,0,0
234427,corresponding,0,0
234428,number,0,0
234429,of,0,0
234430,infections,0,0
234431,per,0,0
234432,catheter,0,0
234433,days,0,0
234434,were,0,0
234435,1,0,0
234436,in,0,0
234437,1189,0,1
234438,days,0,0
234439,and,0,0
234440,1,0,0
234441,in,0,0
234442,522,0,1
234443,days,0,0
234444,",",0,0
234445,respectively,0,0
234446,.,0,0
234447,In,0,0
234448,conclusion,0,0
234449,cuffed,0,0
234450,",",0,0
234451,tunnelled,0,0
234452,central,0,0
234453,venous,0,1
234454,catheters,0,0
234455,are,0,0
234456,less,0,0
234457,prone,0,0
234458,to,0,0
234459,displacement,0,0
234460,than,0,0
234461,traditional,0,0
234462,percutaneous,0,1
234463,central,0,1
234464,venous,0,1
234465,catheters,0,0
234466,when,0,0
234467,used,0,0
234468,in,0,0
234469,children,1,1
234470,with,1,1
234471,malignant,1,1
234472,diseases,1,1
234473,.,1,1
234474,The,0,0
234475,immunogenicity,0,0
234476,of,0,0
234477,three,0,0
234478,Haemophilus,0,1
234479,influenzae,0,0
234480,type,0,1
234481,B,0,0
234482,conjugate,0,0
234483,vaccines,1,0
234484,after,1,0
234485,a,1,0
234486,primary,1,0
234487,vaccination,1,0
234488,series,1,0
234489,in,1,0
234490,Philippine,1,1
234491,infants,1,1
234492,.,1,1
234493,Serum,0,0
234494,antibody,0,0
234495,responses,0,0
234496,to,0,0
234497,three,0,0
234498,Haemophilus,0,1
234499,influenzae,0,0
234500,type,0,1
234501,b,0,0
234502,(,0,0
234503,Hib,0,0
234504,),0,0
234505,capsular,0,0
234506,polysaccharide-protein,0,0
234507,conjugate,0,0
234508,vaccine,0,0
234509,(,0,0
234510,PRP-OMP,0,0
234511,",",0,0
234512,PRP-T,0,0
234513,",",0,0
234514,and,0,0
234515,HbOC,0,0
234516,),0,0
234517,were,0,0
234518,evaluated,0,0
234519,in,1,0
234520,174,1,1
234521,Philippine,1,1
234522,infants,1,1
234523,after,1,0
234524,a,1,0
234525,primary,1,0
234526,vaccination,1,1
234527,series,1,0
234528,.,1,0
234529,Children,0,1
234530,were,0,0
234531,randomized,0,0
234532,to,0,0
234533,receive,0,0
234534,one,0,0
234535,of,0,0
234536,the,0,0
234537,Hib,0,0
234538,vaccines,0,0
234539,(,0,0
234540,Hib,0,0
234541,groups,0,0
234542,),0,0
234543,or,0,0
234544,into,0,0
234545,a,0,0
234546,control,0,0
234547,group,0,0
234548,.,0,0
234549,Vaccination,0,0
234550,was,0,0
234551,carried,0,0
234552,out,0,0
234553,at,0,0
234554,six,0,0
234555,",",0,0
234556,10,0,0
234557,and,0,0
234558,14,0,0
234559,weeks,0,0
234560,of,0,0
234561,age,0,1
234562,based,0,0
234563,on,0,0
234564,the,0,0
234565,local,0,0
234566,Expanded,0,0
234567,Program,0,0
234568,of,0,0
234569,Immunization,0,0
234570,schedule,0,0
234571,.,0,0
234572,Sera,0,0
234573,were,0,0
234574,collected,0,0
234575,at,0,0
234576,six,0,0
234577,weeks,0,0
234578,of,0,0
234579,age,0,1
234580,for,0,0
234581,the,0,0
234582,Hib,0,0
234583,groups,0,0
234584,and,0,0
234585,one,0,0
234586,month,0,0
234587,after,0,0
234588,the,0,0
234589,third,0,0
234590,dose,0,0
234591,for,0,0
234592,all,0,0
234593,subjects,0,1
234594,.,0,0
234595,Anti-Hib,0,0
234596,concentrations,0,0
234597,were,0,0
234598,determined,0,0
234599,by,0,0
234600,the,0,0
234601,Farr-type,0,0
234602,radioimmunoassay,0,0
234603,.,0,0
234604,There,0,0
234605,were,0,0
234606,no,0,0
234607,significant,0,0
234608,differences,0,0
234609,(,0,0
234610,P,0,0
234611,=,0,0
234612,0.3626,0,0
234613,),0,0
234614,in,0,0
234615,the,0,0
234616,prevaccination,0,0
234617,anti-Hib,0,0
234618,geometric,0,0
234619,mean,0,0
234620,concentration,0,0
234621,(,0,0
234622,GMC,0,0
234623,),0,0
234624,among,0,0
234625,the,0,0
234626,three,0,0
234627,Hib,0,0
234628,groups,0,0
234629,.,0,1
234630,Differences,0,0
234631,in,0,0
234632,the,0,0
234633,GMC,0,0
234634,after,0,0
234635,the,0,0
234636,primary,0,0
234637,series,0,0
234638,of,0,0
234639,three,0,0
234640,doses,0,0
234641,were,0,0
234642,significant,0,0
234643,(,0,0
234644,P,0,0
234645,<,0,0
234646,0.0001,0,0
234647,),0,0
234648,;,0,0
234649,GMC,0,0
234650,was,0,0
234651,highest,0,0
234652,for,0,0
234653,PRP-T,0,0
234654,(,0,0
234655,6.62,0,0
234656,micrograms/ml,0,0
234657,),0,0
234658,",",0,0
234659,followed,0,0
234660,by,0,0
234661,HbOC,0,0
234662,(,0,0
234663,1.9,0,0
234664,micrograms/ml,0,0
234665,),0,0
234666,",",0,0
234667,then,0,0
234668,PRP-OMP,0,0
234669,(,0,0
234670,1.06,0,0
234671,micrograms/ml,0,0
234672,),0,0
234673,",",0,0
234674,and,0,0
234675,lowest,0,0
234676,for,0,0
234677,the,0,0
234678,control,0,0
234679,group,0,0
234680,(,0,0
234681,0.11,0,0
234682,microgram/ml,0,0
234683,),0,0
234684,.,0,0
234685,We,0,0
234686,conclude,0,0
234687,that,0,0
234688,all,0,0
234689,three,0,0
234690,Hib,0,0
234691,conjugate,0,0
234692,vaccines,0,0
234693,(,0,0
234694,PRP-T,0,0
234695,",",0,0
234696,HbOC,0,0
234697,",",0,0
234698,and,0,0
234699,PRP-OMP,0,0
234700,),0,0
234701,were,0,0
234702,immunogenic,0,0
234703,after,0,0
234704,three,0,0
234705,primary,0,1
234706,doses,0,0
234707,among,0,1
234708,Philippine,1,1
234709,infants,1,1
234710,.,1,1
234711,Is,0,0
234712,there,0,0
234713,a,0,0
234714,difference,0,0
234715,?,0,0
234716,A,0,0
234717,prospective,0,0
234718,study,0,0
234719,comparing,0,0
234720,lateral,0,0
234721,and,0,0
234722,standard,0,0
234723,SMAS,0,1
234724,face,0,0
234725,lifts,0,0
234726,with,0,1
234727,extended,0,0
234728,SMAS,0,1
234729,and,0,0
234730,composite,0,0
234731,rhytidectomies,0,0
234732,.,0,0
234733,Presented,0,0
234734,is,0,0
234735,a,0,0
234736,prospective,0,0
234737,study,0,0
234738,comparing,0,0
234739,limited,0,0
234740,SMAS,0,1
234741,(,0,0
234742,lateral,0,0
234743,SMASectomy,0,1
234744,),0,0
234745,",",0,0
234746,conventional,0,0
234747,SMAS,0,0
234748,",",0,0
234749,extended,0,0
234750,SMAS,0,0
234751,",",0,0
234752,and,0,0
234753,composite,0,0
234754,rhytidectomies,0,0
234755,.,0,1
234756,Randomized,1,0
234757,patients,1,1
234758,received,0,0
234759,either,0,0
234760,a,0,0
234761,limited,0,0
234762,SMAS,0,0
234763,or,0,1
234764,conventional,0,0
234765,SMAS,0,0
234766,face,0,0
234767,lift,0,0
234768,on,0,0
234769,one,0,0
234770,side,0,0
234771,and,0,0
234772,an,0,0
234773,extended,0,0
234774,SMAS,0,0
234775,or,0,0
234776,composite,0,0
234777,rhytidectomy,0,0
234778,on,0,0
234779,the,0,0
234780,other,0,0
234781,.,0,0
234782,All,0,0
234783,procedures,0,0
234784,were,0,0
234785,performed,0,0
234786,at,0,0
234787,Manhattan,1,1
234788,Eye,1,0
234789,",",1,0
234790,Ear,1,0
234791,and,1,0
234792,Throat,1,1
234793,Hospital,1,1
234794,in,0,0
234795,accordance,0,0
234796,with,0,1
234797,their,0,0
234798,well-defined,0,1
234799,surgical,0,1
234800,descriptions,0,0
234801,.,0,1
234802,Postoperative,0,0
234803,courses,0,0
234804,were,0,0
234805,followed,0,0
234806,clinically,0,0
234807,for,0,0
234808,at,0,0
234809,least,0,0
234810,1,0,0
234811,year,0,0
234812,.,0,0
234813,Photographs,0,0
234814,were,0,0
234815,taken,0,0
234816,preoperatively,0,0
234817,and,0,0
234818,at,0,0
234819,6,0,0
234820,and,0,0
234821,12,0,0
234822,months,0,0
234823,postoperatively,0,0
234824,.,0,0
234825,Photographs,0,0
234826,were,0,0
234827,reviewed,0,0
234828,by,0,0
234829,three,0,0
234830,independent,0,0
234831,experienced,0,0
234832,face,0,0
234833,lift,0,0
234834,surgeons,0,0
234835,.,0,0
234836,The,0,0
234837,study,0,0
234838,comprises,0,0
234839,21,1,0
234840,patients,1,1
234841,",",1,0
234842,20,1,1
234843,women,1,1
234844,and,1,0
234845,1,1,0
234846,man,1,1
234847,",",1,0
234848,with,1,0
234849,a,1,0
234850,mean,1,0
234851,age,1,1
234852,of,1,0
234853,59,1,1
234854,years,1,1
234855,(,1,0
234856,range,1,0
234857,47,1,1
234858,to,1,0
234859,70,1,1
234860,years,1,1
234861,),1,1
234862,.,1,1
234863,Nineteen,0,1
234864,patients,0,1
234865,underwent,0,1
234866,primary,0,1
234867,rhytidectomies,0,1
234868,;,0,0
234869,two,0,0
234870,underwent,0,1
234871,secondary,0,0
234872,face,0,1
234873,lifts,0,0
234874,.,0,0
234875,For,0,0
234876,the,0,0
234877,first,0,0
234878,12,0,0
234879,patients,0,1
234880,",",0,0
234881,each,0,0
234882,had,0,0
234883,an,0,0
234884,extended,0,0
234885,SMAS,0,0
234886,procedure,0,0
234887,performed,0,0
234888,on,0,0
234889,one,0,0
234890,side,0,0
234891,;,0,0
234892,on,0,0
234893,the,0,0
234894,other,0,0
234895,",",0,0
234896,7,0,0
234897,had,0,0
234898,a,0,0
234899,conventional,0,0
234900,SMAS,0,0
234901,and,0,0
234902,5,0,0
234903,had,0,0
234904,a,0,0
234905,limited,0,0
234906,SMAS,0,0
234907,(,0,0
234908,lateral,0,0
234909,SMASectomy,0,1
234910,),0,0
234911,face,0,0
234912,lift,0,0
234913,.,0,0
234914,In,0,0
234915,the,0,0
234916,last,0,0
234917,9,0,0
234918,patients,0,1
234919,",",0,0
234920,a,0,0
234921,conventional,0,0
234922,SMAS,0,0
234923,was,0,0
234924,carried,0,0
234925,out,0,0
234926,on,0,0
234927,one,0,0
234928,side,0,0
234929,in,0,0
234930,8,0,0
234931,",",0,0
234932,a,0,0
234933,limited,0,0
234934,SMAS,0,0
234935,in,0,0
234936,1,0,0
234937,",",0,0
234938,and,0,0
234939,on,0,0
234940,the,0,0
234941,opposite,0,0
234942,side,0,0
234943,",",0,0
234944,a,0,0
234945,composite,0,0
234946,rhytidectomy,0,0
234947,was,0,0
234948,performed,0,0
234949,.,0,0
234950,Complications,0,0
234951,were,0,0
234952,few,0,0
234953,.,0,0
234954,Temporary,0,0
234955,weakness,0,0
234956,of,0,0
234957,the,0,0
234958,buccal,0,0
234959,branch,0,0
234960,of,0,0
234961,the,0,0
234962,facial,0,0
234963,nerve,0,0
234964,occurred,0,0
234965,in,0,0
234966,2,0,0
234967,patients,0,1
234968,on,0,0
234969,the,0,0
234970,side,0,0
234971,of,0,0
234972,the,0,0
234973,more,0,0
234974,extensive,0,0
234975,surgery,0,0
234976,.,0,0
234977,On,0,0
234978,the,0,0
234979,operating,0,0
234980,table,0,0
234981,at,0,0
234982,completion,0,0
234983,of,0,0
234984,the,0,0
234985,surgery,0,0
234986,",",0,0
234987,there,0,0
234988,was,0,0
234989,more,0,0
234990,improvement,0,0
234991,in,0,0
234992,reversal,0,0
234993,of,0,0
234994,midfacial,0,0
234995,ptosis,0,1
234996,and,0,0
234997,flattening,0,0
234998,of,0,0
234999,the,0,0
235000,nasolabial,0,0
235001,folds,0,0
235002,with,0,1
235003,both,0,0
235004,extended,0,0
235005,SMAS,0,0
235006,and,0,0
235007,composite,0,0
235008,rhytidectomies,0,0
235009,.,0,0
235010,The,0,0
235011,composite,0,0
235012,flap,0,0
235013,had,0,0
235014,the,0,0
235015,most,0,0
235016,dramatic,0,0
235017,effect,0,0
235018,on,0,0
235019,the,0,0
235020,nasolabial,0,0
235021,folds,0,0
235022,and,0,0
235023,oral,0,0
235024,commissure,0,0
235025,.,0,0
235026,After,0,0
235027,24,0,0
235028,hours,0,0
235029,",",0,0
235030,once,0,0
235031,swelling,0,0
235032,developed,0,0
235033,and,0,0
235034,facial,0,0
235035,motion,0,0
235036,became,0,0
235037,reactivated,0,0
235038,",",0,0
235039,the,0,0
235040,noticeable,0,0
235041,differences,0,0
235042,in,0,0
235043,the,0,0
235044,midface,0,1
235045,and,0,0
235046,nasolabial,0,0
235047,folds,0,0
235048,were,0,0
235049,lost,0,0
235050,.,0,0
235051,No,0,0
235052,discernible,0,0
235053,differences,0,0
235054,in,0,0
235055,facial,0,1
235056,halves,0,0
235057,were,0,0
235058,noted,0,0
235059,again,0,0
235060,.,0,0
235061,Differences,0,0
235062,between,0,0
235063,facial,0,0
235064,sides,0,0
235065,on,0,0
235066,the,0,0
235067,6-,0,0
235068,and,0,0
235069,12-month,0,0
235070,postoperative,0,0
235071,photographs,0,0
235072,were,0,0
235073,not,0,0
235074,detectable,0,0
235075,.,0,0
235076,We,0,0
235077,conclude,0,0
235078,that,0,0
235079,for,0,0
235080,routine,0,0
235081,facial,0,0
235082,plasty,0,0
235083,",",0,0
235084,comparable,0,0
235085,clinical,0,0
235086,outcomes,0,0
235087,are,0,0
235088,obtained,0,0
235089,at,0,0
235090,6,0,0
235091,months,0,0
235092,and,0,0
235093,1,0,0
235094,year,0,0
235095,with,0,1
235096,limited,0,0
235097,(,0,0
235098,lateral,0,0
235099,SMASectomy,0,1
235100,),0,0
235101,and,0,0
235102,conventional,0,0
235103,SMAS,0,1
235104,face,0,0
235105,lifts,0,0
235106,compared,0,0
235107,with,0,1
235108,extended,0,0
235109,SMAS,0,1
235110,and,0,0
235111,composite,0,0
235112,rhytidectomies,0,0
235113,.,0,1
235114,All,0,0
235115,procedures,0,0
235116,are,0,0
235117,lacking,0,0
235118,in,0,0
235119,their,0,0
235120,improvement,0,0
235121,of,0,0
235122,midface,0,1
235123,ptosis,0,0
235124,and,0,0
235125,the,0,0
235126,nasolabial,0,0
235127,folds,0,0
235128,.,0,0
235129,The,0,0
235130,increased,0,0
235131,surgical,0,0
235132,risks,0,0
235133,",",0,0
235134,morbidity,0,0
235135,",",0,0
235136,and,0,0
235137,convalescence,0,0
235138,associated,0,0
235139,with,0,0
235140,those,0,0
235141,more,0,0
235142,extensive,0,0
235143,procedures,0,0
235144,do,0,0
235145,not,0,0
235146,seem,0,0
235147,to,0,0
235148,be,0,0
235149,warranted,0,0
235150,in,0,0
235151,the,0,0
235152,average,0,0
235153,patient,0,0
235154,.,0,0
235155,Dental,0,0
235156,bacteremia,0,0
235157,in,1,0
235158,children,1,1
235159,.,1,1
235160,Bacteremia,0,1
235161,resulting,0,0
235162,from,0,0
235163,dental,0,1
235164,extraction,0,0
235165,is,0,0
235166,regarded,0,0
235167,as,0,0
235168,an,0,0
235169,important,0,0
235170,cause,0,0
235171,of,0,0
235172,bacterial,0,0
235173,endocarditis,0,1
235174,",",0,0
235175,and,0,0
235176,it,0,0
235177,is,0,0
235178,therefore,0,0
235179,recommended,0,0
235180,that,0,0
235181,patients,1,1
235182,undergoing,1,1
235183,tooth,1,1
235184,extraction,1,0
235185,be,0,0
235186,given,0,0
235187,prophylactic,0,0
235188,antibiotics,0,0
235189,.,0,1
235190,As,0,0
235191,dental,0,1
235192,procedures,0,1
235193,other,0,0
235194,than,0,0
235195,extractions,0,1
235196,may,0,0
235197,also,0,0
235198,cause,0,0
235199,bacteremias,0,0
235200,",",0,0
235201,we,0,0
235202,studied,0,0
235203,a,0,0
235204,variety,0,0
235205,of,0,0
235206,dental,0,1
235207,procedures,0,0
235208,routinely,0,0
235209,used,0,0
235210,in,0,0
235211,pediatric,0,1
235212,dentistry,0,1
235213,.,0,0
235214,Blood,0,0
235215,samples,0,0
235216,for,0,0
235217,cultures,0,0
235218,were,0,0
235219,obtained,0,0
235220,30,0,0
235221,s,0,0
235222,after,0,0
235223,each,0,0
235224,of,0,0
235225,13,0,0
235226,dental,0,1
235227,operative,0,0
235228,procedures,0,1
235229,in,0,0
235230,735,1,1
235231,anesthetized,1,1
235232,children,1,1
235233,aged,1,1
235234,2-16,1,1
235235,years,1,1
235236,.,1,1
235237,Four,0,0
235238,procedures,0,0
235239,used,0,0
235240,for,0,0
235241,conservative,0,1
235242,dentistry,0,1
235243,caused,0,0
235244,bacteremias,0,0
235245,significantly,0,0
235246,more,0,0
235247,often,0,0
235248,than,0,0
235249,the,0,0
235250,baseline,0,0
235251,value,0,0
235252,of,0,0
235253,9.4,0,0
235254,%,0,0
235255,:,0,0
235256,polishing,0,0
235257,teeth,0,1
235258,24.5,0,0
235259,%,0,0
235260,",",0,0
235261,intraligamental,0,0
235262,injection,0,0
235263,96.6,0,0
235264,%,0,0
235265,",",0,0
235266,rubber,0,0
235267,dam,0,0
235268,placement,0,0
235269,29.4,0,0
235270,%,0,0
235271,",",0,0
235272,and,0,0
235273,matrix,0,0
235274,band,0,0
235275,with,0,0
235276,wedge,0,0
235277,placement,0,0
235278,32.1,0,0
235279,%,0,0
235280,.,0,0
235281,In,0,0
235282,comparison,0,0
235283,",",0,0
235284,toothbrushing,0,0
235285,alone,0,0
235286,caused,0,0
235287,a,0,0
235288,bacteremia,0,0
235289,on,0,0
235290,38.5,0,0
235291,%,0,0
235292,of,0,0
235293,occasions,0,0
235294,.,0,1
235295,The,0,0
235296,organisms,0,0
235297,isolated,0,0
235298,were,0,0
235299,typical,0,0
235300,of,0,0
235301,odontogenic,0,1
235302,bacteremias,0,1
235303,in,0,0
235304,that,0,0
235305,50,0,0
235306,%,0,0
235307,of,0,0
235308,the,0,0
235309,isolates,0,0
235310,were,0,0
235311,identified,0,0
235312,as,0,0
235313,varieties,0,0
235314,of,0,0
235315,viridans,0,1
235316,streptococci,0,1
235317,.,0,0
235318,These,0,0
235319,data,0,0
235320,show,0,0
235321,that,0,0
235322,a,0,0
235323,wider,0,0
235324,variety,0,0
235325,of,0,0
235326,dental,0,1
235327,procedures,0,1
235328,than,0,0
235329,was,0,0
235330,previously,0,0
235331,documented,0,0
235332,cause,0,0
235333,bacteremia,0,0
235334,.,0,0
235335,Modulation,0,0
235336,of,0,0
235337,oxidant,0,0
235338,stress,0,0
235339,in,0,0
235340,vivo,0,0
235341,in,0,0
235342,chronic,1,1
235343,cigarette,1,1
235344,smokers,1,1
235345,.,1,1
235346,BACKGROUND,0,0
235347,Free,0,0
235348,radical-induced,0,0
235349,oxidative,0,0
235350,damage,0,0
235351,is,0,0
235352,thought,0,0
235353,to,0,0
235354,be,0,0
235355,involved,0,0
235356,in,0,0
235357,the,0,0
235358,pathogenesis,0,0
235359,of,0,0
235360,diseases,0,1
235361,associated,0,0
235362,with,0,1
235363,cigarette,0,0
235364,smoking,0,0
235365,.,0,0
235366,We,0,0
235367,examined,0,0
235368,the,0,0
235369,production,0,0
235370,of,0,0
235371,8-epi-prostaglandin,0,0
235372,(,0,0
235373,PG,0,0
235374,),0,0
235375,F2,0,0
235376,alpha,0,0
235377,",",0,0
235378,a,0,0
235379,stable,0,0
235380,product,0,0
235381,of,0,0
235382,lipid,0,0
235383,peroxidation,0,0
235384,in,0,0
235385,vivo,0,0
235386,",",0,0
235387,and,0,0
235388,its,0,0
235389,modulation,0,0
235390,by,0,0
235391,aspirin,0,0
235392,and,0,0
235393,antioxidant,0,0
235394,vitamins,0,0
235395,in,0,0
235396,chronic,1,1
235397,cigarette,1,1
235398,smokers,1,1
235399,.,1,0
235400,METHODS,0,0
235401,AND,0,0
235402,RESULTS,0,0
235403,We,0,0
235404,performed,0,0
235405,the,0,0
235406,following,0,0
235407,studies,0,0
235408,:,0,1
235409,(,0,0
235410,1,0,0
235411,),0,0
235412,a,1,0
235413,cross-sectional,1,0
235414,comparison,1,0
235415,of,1,0
235416,smokers,1,1
235417,and,1,0
235418,control,1,0
235419,subjects,1,1
235420,",",0,0
235421,(,0,0
235422,2,0,0
235423,),0,0
235424,an,0,0
235425,examination,0,0
235426,of,0,0
235427,the,0,0
235428,dose-response,0,0
235429,relationship,0,0
235430,",",0,0
235431,(,0,0
235432,3,0,0
235433,),0,0
235434,an,0,0
235435,exploration,0,0
235436,of,0,0
235437,the,0,0
235438,effect,0,0
235439,of,0,0
235440,smoking,0,0
235441,cessation,0,0
235442,(,0,0
235443,3,0,0
235444,weeks,0,0
235445,),0,0
235446,and,0,0
235447,nicotine,0,0
235448,patch,0,0
235449,supplementation,0,0
235450,",",0,0
235451,(,0,0
235452,4,0,0
235453,),0,0
235454,the,0,0
235455,effect,0,0
235456,of,0,0
235457,aspirin,0,0
235458,consumption,0,0
235459,",",0,0
235460,and,0,0
235461,(,0,0
235462,5,0,0
235463,),0,0
235464,the,0,0
235465,effects,0,0
235466,of,0,0
235467,5,0,0
235468,days,0,0
235469,',0,1
235470,dosing,0,0
235471,with,0,1
235472,vitamin,0,0
235473,E,0,0
235474,(,0,0
235475,100,0,0
235476,and,0,0
235477,800,0,0
235478,U,0,0
235479,),0,0
235480,",",0,0
235481,vitamin,0,0
235482,C,0,0
235483,(,0,0
235484,2,0,0
235485,g,0,0
235486,),0,0
235487,",",0,0
235488,and,0,0
235489,their,0,0
235490,combination,0,0
235491,.,0,0
235492,8-epi-PGF2,0,0
235493,alpha,0,0
235494,excretion,0,0
235495,(,0,0
235496,in,0,0
235497,pmol/mmol,0,0
235498,",",0,0
235499,mean,0,0
235500,+/-,0,0
235501,SEM,0,0
235502,),0,0
235503,was,0,0
235504,176.5+/-30.6,0,0
235505,in,0,0
235506,heavy,1,0
235507,smokers,1,1
235508,",",0,0
235509,92.7+/-4.8,0,0
235510,(,0,0
235511,P,0,0
235512,<,0,0
235513,.05,0,0
235514,),0,0
235515,in,0,0
235516,moderate,1,1
235517,smokers,1,1
235518,",",0,0
235519,and,0,0
235520,54.1+/-2.7,0,0
235521,(,0,0
235522,P,0,0
235523,<,0,0
235524,.005,0,0
235525,),0,0
235526,in,0,0
235527,nonsmokers,1,1
235528,.,1,1
235529,Urinary,0,0
235530,levels,0,0
235531,fell,0,0
235532,from,0,0
235533,145.5+/-24.9,0,0
235534,to,0,0
235535,114.6+/-27.1,0,0
235536,(,0,0
235537,week,0,0
235538,2,0,0
235539,",",0,0
235540,P,0,0
235541,<,0,0
235542,.05,0,0
235543,),0,0
235544,and,0,0
235545,112.6+/-24.9,0,0
235546,(,0,0
235547,week,0,0
235548,3,0,0
235549,",",0,0
235550,P,0,0
235551,<,0,0
235552,.05,0,0
235553,),0,0
235554,on,0,0
235555,cessation,0,0
235556,of,0,0
235557,smoking,0,0
235558,.,0,0
235559,Aspirin,0,0
235560,treatment,0,0
235561,failed,0,0
235562,to,0,0
235563,suppress,0,0
235564,urinary,0,0
235565,levels,0,0
235566,of,0,0
235567,8-epi-PGF2,0,0
235568,alpha,0,0
235569,despite,0,0
235570,a,0,0
235571,significant,0,0
235572,reduction,0,0
235573,in,0,0
235574,urinary,0,0
235575,11-dehydro-TxB2,0,0
235576,production,0,0
235577,and,0,0
235578,suppression,0,0
235579,of,0,0
235580,8-epi-PGF2,0,0
235581,alpha,0,0
235582,and,0,0
235583,TxB2,0,0
235584,in,0,0
235585,serum,0,0
235586,.,0,0
235587,Vitamin,0,0
235588,C,0,0
235589,(,0,0
235590,pre,0,0
235591,",",0,0
235592,194.6+/-40.9,0,0
235593,;,0,0
235594,post,0,0
235595,",",0,0
235596,137.2+/-34.1,0,0
235597,;,0,0
235598,P,0,0
235599,<,0,0
235600,.05,0,0
235601,),0,0
235602,and,0,0
235603,a,0,0
235604,combination,0,0
235605,of,0,0
235606,vitamin,0,0
235607,C,0,0
235608,and,0,0
235609,E,0,0
235610,(,0,0
235611,pre,0,0
235612,",",0,0
235613,171.0+/-39.8,0,0
235614,;,0,0
235615,post,0,0
235616,",",0,0
235617,133.5+/-29.6,0,0
235618,P,0,0
235619,<,0,0
235620,.05,0,0
235621,),0,0
235622,suppressed,0,0
235623,urinary,0,0
235624,8-epi-PGF2,0,0
235625,alpha,0,0
235626,",",0,0
235627,whereas,0,0
235628,vitamin,0,0
235629,E,0,0
235630,alone,0,0
235631,had,0,0
235632,no,0,0
235633,effect,0,0
235634,.,0,0
235635,CONCLUSIONS,0,0
235636,Urinary,0,0
235637,8-epi-PGF2,0,0
235638,alpha,0,0
235639,may,0,0
235640,represent,0,0
235641,a,0,0
235642,noninvasive,0,0
235643,",",0,0
235644,quantitative,0,0
235645,index,0,0
235646,of,0,0
235647,oxidant,0,0
235648,stress,0,0
235649,in,0,0
235650,vivo,0,0
235651,.,0,0
235652,Elevated,0,0
235653,levels,0,0
235654,of,0,0
235655,8-epi-PGF2,0,0
235656,alpha,0,0
235657,in,0,0
235658,smokers,1,1
235659,may,0,0
235660,be,0,0
235661,modulated,0,0
235662,by,0,0
235663,quitting,0,0
235664,cigarettes,0,0
235665,and,0,0
235666,switching,0,0
235667,to,0,0
235668,nicotine,0,0
235669,patches,0,0
235670,or,0,0
235671,by,0,0
235672,antioxidant,0,0
235673,vitamin,0,0
235674,therapy,0,0
235675,.,0,0
235676,Determining,0,0
235677,the,0,0
235678,trough-to-peak,0,0
235679,ratio,0,0
235680,in,0,0
235681,parallel-group,0,0
235682,trials,0,0
235683,.,0,1
235684,Systolic,0,1
235685,Hypertension,0,0
235686,in,0,0
235687,Europe,0,1
235688,(,0,0
235689,SYST-EUR,0,0
235690,),0,0
235691,Trial,0,0
235692,Investigators,0,0
235693,.,0,0
235694,We,0,0
235695,explored,0,0
235696,how,0,0
235697,in,0,0
235698,parallel-group,0,0
235699,trials,0,0
235700,interindividual,0,0
235701,variability,0,0
235702,",",0,0
235703,correction,0,0
235704,for,0,0
235705,placebo,0,0
235706,effects,0,0
235707,",",0,0
235708,and,0,0
235709,smoothing,0,0
235710,of,0,0
235711,blood,0,0
235712,pressure,0,0
235713,profiles,0,0
235714,can,0,0
235715,be,0,0
235716,handled,0,0
235717,in,0,0
235718,measuring,0,0
235719,the,0,0
235720,trough-to-peak,0,0
235721,ratio,0,0
235722,in,0,0
235723,244,1,1
235724,individuals,1,1
235725,with,1,1
235726,isolated,1,0
235727,systolic,1,1
235728,hypertension,1,1
235729,(,1,0
235730,>,1,0
235731,or,1,0
235732,=,1,0
235733,60,1,1
235734,years,1,1
235735,),1,0
235736,enrolled,1,1
235737,in,1,0
235738,the,1,0
235739,placebo-controlled,1,0
235740,Systolic,1,1
235741,Hypertension,1,1
235742,in,1,0
235743,europe,1,1
235744,Trial,1,0
235745,.,1,0
235746,Net,0,0
235747,treatment,0,0
235748,effects,0,0
235749,were,0,0
235750,computed,0,0
235751,by,0,0
235752,subtracting,0,0
235753,the,0,0
235754,mean,0,0
235755,changes,0,0
235756,from,0,0
235757,baseline,0,0
235758,during,0,0
235759,placebo,0,0
235760,(,0,0
235761,n,0,1
235762,=,0,0
235763,133,0,1
235764,),0,0
235765,from,0,0
235766,those,0,0
235767,during,0,0
235768,active,0,0
235769,treatment,0,0
235770,(,0,0
235771,n,0,1
235772,=,0,0
235773,111,0,1
235774,),0,0
235775,.,0,0
235776,At,1,0
235777,entry,1,0
235778,",",1,0
235779,systolic/diastolic,1,0
235780,pressures,1,0
235781,averaged,1,0
235782,176/86,1,0
235783,mm,1,0
235784,Hg,1,0
235785,in,1,0
235786,the,1,0
235787,clinic,1,1
235788,and,1,0
235789,149/80,1,1
235790,mm,1,0
235791,Hg,1,0
235792,on,1,0
235793,24-hour,1,0
235794,ambulatory,1,1
235795,monitoring,1,0
235796,.,1,0
235797,With,0,0
235798,corrections,0,0
235799,applied,0,0
235800,for,0,0
235801,baseline,0,0
235802,and,0,0
235803,placebo,0,0
235804,",",0,0
235805,nitrendipine,0,0
235806,(,0,0
235807,10,0,0
235808,to,0,0
235809,40,0,1
235810,mg/d,0,0
235811,),0,0
235812,",",0,0
235813,with,0,0
235814,the,0,0
235815,possible,0,0
235816,addition,0,0
235817,of,0,0
235818,enalapril,0,0
235819,(,0,0
235820,5,0,0
235821,to,0,0
235822,20,0,0
235823,mg/d,0,0
235824,),0,0
235825,and/or,0,0
235826,hydrochlorothiazide,0,0
235827,(,0,0
235828,12.5,0,0
235829,to,0,0
235830,25,0,0
235831,mg/d,0,0
235832,),0,0
235833,",",0,0
235834,reduced,0,0
235835,(,0,0
235836,P,0,0
235837,<,0,0
235838,.001,0,0
235839,),0,0
235840,these,0,0
235841,blood,0,0
235842,pressure,0,0
235843,values,0,0
235844,by,0,0
235845,16.6/7.3,0,0
235846,and,0,0
235847,9.8/4.7,0,0
235848,mm,0,0
235849,Hg,0,0
235850,",",0,0
235851,respectively,0,0
235852,.,0,0
235853,The,0,0
235854,net,0,0
235855,trough-to-peak,0,0
235856,ratios,0,0
235857,were,0,0
235858,first,0,0
235859,determined,0,0
235860,from,0,0
235861,blood,0,0
235862,pressure,0,0
235863,profiles,0,0
235864,(,0,0
235865,12,0,1
235866,hours,0,0
235867,),0,0
235868,with,0,1
235869,1-hour,0,0
235870,precision,0,0
235871,",",0,0
235872,synchronized,0,0
235873,by,0,0
235874,the,0,0
235875,morning,0,0
235876,and,0,0
235877,evening,0,0
235878,doses,0,0
235879,of,0,0
235880,the,0,0
235881,double-blind,0,0
235882,medication,0,0
235883,.,0,0
235884,According,0,0
235885,to,0,0
235886,the,0,0
235887,usual,0,0
235888,approach,0,0
235889,",",0,0
235890,disregarding,0,0
235891,interindividual,0,0
235892,variability,0,0
235893,",",0,0
235894,the,0,0
235895,systolic/diastolic,0,0
235896,net,0,0
235897,trough-to-peak,0,0
235898,ratios,0,0
235899,were,0,0
235900,0.46/0.40,0,0
235901,in,0,0
235902,the,0,0
235903,morning,0,0
235904,and,0,0
235905,0.77/0.99,0,0
235906,in,0,0
235907,the,0,0
235908,evening,0,0
235909,.,0,0
235910,In,0,0
235911,individual,0,0
235912,subjects,0,1
235913,",",0,0
235914,the,0,0
235915,baseline-adjusted,0,0
235916,trough-to-peak,0,0
235917,ratios,0,0
235918,were,0,0
235919,nonnormally,0,0
235920,distributed,0,0
235921,.,0,0
235922,We,0,0
235923,therefore,0,0
235924,used,0,0
235925,a,0,0
235926,nonparametric,0,0
235927,technique,0,0
235928,to,0,0
235929,calculate,0,0
235930,the,0,0
235931,net,0,0
235932,trough-to-peak,0,0
235933,ratios,0,0
235934,from,0,1
235935,the,0,0
235936,results,0,0
235937,in,0,0
235938,individual,0,0
235939,subjects,0,1
235940,.,0,0
235941,In,0,0
235942,the,0,0
235943,morning,0,0
235944,",",0,0
235945,these,0,0
235946,ratios,0,0
235947,averaged,0,0
235948,0.25,0,0
235949,systolic,0,1
235950,(,0,0
235951,95,0,0
235952,%,0,0
235953,confidence,0,0
235954,interval,0,0
235955,",",0,0
235956,0.09,0,0
235957,to,0,0
235958,0.41,0,0
235959,),0,0
235960,and,0,0
235961,0.15,0,0
235962,diastolic,0,0
235963,(,0,0
235964,95,0,0
235965,%,0,0
235966,confidence,0,0
235967,interval,0,0
235968,",",0,0
235969,0.00,0,0
235970,to,0,0
235971,0.31,0,0
235972,),0,0
235973,and,0,0
235974,in,0,0
235975,the,0,0
235976,evening,0,0
235977,",",0,0
235978,0.19,0,0
235979,and,0,0
235980,0.36,0,0
235981,(,0,0
235982,95,0,0
235983,%,0,0
235984,confidence,0,0
235985,intervals,0,0
235986,",",0,0
235987,0.00,0,0
235988,to,0,0
235989,0.38,0,0
235990,and,0,0
235991,0.14,0,0
235992,to,0,0
235993,0.56,0,0
235994,),0,0
235995,",",0,0
235996,respectively,0,0
235997,.,0,0
235998,When,0,0
235999,the,0,0
236000,blood,0,0
236001,pressure,0,0
236002,profiles,0,0
236003,were,0,0
236004,smoothed,0,0
236005,by,0,0
236006,substituting,0,0
236007,the,0,0
236008,1-hour,0,0
236009,averages,0,0
236010,by,0,0
236011,moving,0,0
236012,or,0,0
236013,fixed,0,0
236014,2-hour,0,0
236015,averages,0,0
236016,or,0,1
236017,by,0,0
236018,Fourier,0,0
236019,modeling,0,0
236020,",",0,0
236021,the,0,0
236022,trough-to-peak,0,0
236023,ratios,0,0
236024,remained,0,0
236025,unchanged,0,0
236026,after,0,0
236027,the,0,0
236028,morning,0,0
236029,dose,0,0
236030,(,0,0
236031,0.20/0.13,0,0
236032,",",0,0
236033,0.20/0.14,0,0
236034,",",0,0
236035,and,0,0
236036,0.16/0.21,0,0
236037,",",0,0
236038,respectively,0,0
236039,),0,0
236040,but,0,0
236041,tended,0,0
236042,to,0,0
236043,increase,0,0
236044,in,0,0
236045,the,0,0
236046,evening,0,0
236047,(,0,0
236048,0.32/0.38,0,0
236049,",",0,0
236050,0.28/0.40,0,0
236051,",",0,0
236052,and,0,0
236053,0.48/0.49,0,0
236054,),0,0
236055,.,0,0
236056,In,0,0
236057,conclusion,0,0
236058,",",0,0
236059,the,0,0
236060,parallel-group,0,0
236061,analysis,0,0
236062,proposed,0,0
236063,makes,0,0
236064,it,0,0
236065,possible,0,0
236066,for,0,0
236067,one,0,0
236068,to,0,0
236069,correct,0,0
236070,the,0,0
236071,trough-to-peak,0,0
236072,ratio,0,0
236073,for,0,0
236074,baseline,0,0
236075,as,0,0
236076,well,0,0
236077,as,0,0
236078,placebo,0,0
236079,",",0,0
236080,to,0,0
236081,account,0,0
236082,for,0,0
236083,interindividual,0,0
236084,variability,0,0
236085,",",0,0
236086,and,0,0
236087,to,0,0
236088,calculate,0,0
236089,a,0,0
236090,confidence,0,0
236091,interval,0,0
236092,for,0,0
236093,the,0,0
236094,net,0,0
236095,trough-to-peak,0,0
236096,ratio,0,0
236097,.,0,0
236098,Accounting,0,0
236099,for,0,0
236100,interindividual,0,0
236101,variability,0,0
236102,reduces,0,0
236103,the,0,0
236104,trough-to-peak,0,0
236105,ratio,0,0
236106,.,0,0
236107,Smoothing,0,0
236108,affects,0,0
236109,the,0,0
236110,individualized,0,0
236111,net,0,0
236112,trough-to-peak,0,0
236113,ratios,0,0
236114,in,0,0
236115,an,0,0
236116,unpredictable,0,0
236117,way,0,0
236118,and,0,0
236119,should,0,0
236120,therefore,0,0
236121,be,0,0
236122,avoided,0,0
236123,.,0,0
236124,Dexamethasone,0,0
236125,in,0,0
236126,salbutamol-treated,1,0
236127,inpatients,1,1
236128,with,1,1
236129,acute,1,1
236130,bronchiolitis,1,1
236131,:,1,1
236132,a,0,0
236133,randomized,0,0
236134,",",0,0
236135,controlled,0,0
236136,trial,0,0
236137,.,0,0
236138,OBJECTIVE,0,0
236139,To,0,0
236140,determine,0,0
236141,the,0,0
236142,clinical,0,0
236143,benefit,0,0
236144,of,0,0
236145,oral,0,0
236146,dexamethasone,0,0
236147,in,0,0
236148,children,1,1
236149,admitted,1,1
236150,to,1,0
236151,the,1,0
236152,hospital,1,0
236153,with,1,0
236154,bronchiolitis,1,1
236155,treated,1,1
236156,with,1,0
236157,nebulized,1,0
236158,salbutamol,1,0
236159,.,1,0
236160,METHODS,0,0
236161,Randomized,0,0
236162,",",0,0
236163,double-blind,0,0
236164,",",0,0
236165,placebo-controlled,0,0
236166,trial,0,0
236167,in,0,0
236168,the,0,0
236169,inpatient,0,1
236170,wards,0,1
236171,of,0,0
236172,a,0,0
236173,pediatric,0,1
236174,tertiary,0,1
236175,care,0,0
236176,hospital,0,0
236177,.,0,0
236178,The,0,0
236179,participants,1,0
236180,",",1,0
236181,children,1,1
236182,aged,1,1
236183,6,1,0
236184,weeks,1,0
236185,to,1,1
236186,15,1,1
236187,months,1,0
236188,",",1,0
236189,admitted,1,1
236190,with,1,0
236191,first-time,1,1
236192,wheezing,1,0
236193,",",1,0
236194,were,1,0
236195,eligible,1,1
236196,if,1,0
236197,their,1,0
236198,oxygen,1,0
236199,saturation,1,0
236200,was,1,0
236201,less,1,0
236202,than,1,0
236203,95,1,0
236204,%,1,0
236205,on,1,0
236206,admission,1,0
236207,to,1,0
236208,the,1,0
236209,hospital,1,0
236210,and,1,0
236211,their,1,0
236212,Respiratory,1,0
236213,Distress,1,0
236214,Assessment,1,0
236215,Instrument,1,1
236216,(,1,0
236217,RDAI,1,0
236218,),1,0
236219,score,1,0
236220,was,1,0
236221,greater,1,0
236222,than,1,0
236223,6,1,0
236224,.,1,1
236225,Patients,1,1
236226,were,1,0
236227,excluded,1,0
236228,if,1,0
236229,they,1,0
236230,had,1,0
236231,any,1,0
236232,one,1,0
236233,of,1,0
236234,the,1,0
236235,following,1,0
236236,:,1,0
236237,an,1,0
236238,underlying,1,0
236239,disease,1,0
236240,that,1,0
236241,might,1,0
236242,affect,1,0
236243,cardiopulmonary,1,0
236244,status,1,0
236245,",",1,0
236246,asthma,1,1
236247,",",1,0
236248,recent,1,0
236249,treatment,1,0
236250,with,1,1
236251,steroids,1,0
236252,(,1,0
236253,within,1,0
236254,2,1,0
236255,weeks,1,0
236256,),1,0
236257,",",1,0
236258,or,1,0
236259,any,1,0
236260,history,1,0
236261,of,1,0
236262,adverse,1,0
236263,reaction,1,0
236264,to,1,0
236265,steroids,1,0
236266,.,1,1
236267,Patients,0,1
236268,were,0,0
236269,randomly,0,1
236270,assigned,0,0
236271,to,0,0
236272,receive,0,0
236273,either,0,0
236274,orally,0,0
236275,administered,0,0
236276,dexamethasone,0,0
236277,with,0,1
236278,0.5,0,0
236279,mg/kg,0,0
236280,as,0,0
236281,the,0,0
236282,first,0,0
236283,dose,0,0
236284,and,0,0
236285,0.3,0,0
236286,mg/kg,0,0
236287,for,0,0
236288,the,0,0
236289,next,0,0
236290,2,0,0
236291,mornings,0,0
236292,",",0,0
236293,or,0,0
236294,an,0,0
236295,equal,0,0
236296,volume,0,0
236297,of,0,0
236298,an,0,0
236299,orally,0,0
236300,administered,0,0
236301,placebo,0,0
236302,with,0,0
236303,an,0,0
236304,identical,0,0
236305,appearance,0,0
236306,.,0,0
236307,All,0,0
236308,patients,0,1
236309,received,0,0
236310,nebulized,0,0
236311,salbutamol,0,0
236312,at,0,0
236313,0.15,0,0
236314,mg/kg,0,0
236315,every,0,0
236316,4,0,0
236317,hours,0,0
236318,for,0,0
236319,the,0,0
236320,first,0,0
236321,24,0,0
236322,hours,0,0
236323,.,0,0
236324,The,0,0
236325,primary,0,0
236326,outcome,0,0
236327,measure,0,0
236328,was,0,0
236329,the,0,0
236330,change,0,0
236331,from,0,0
236332,baseline,0,0
236333,in,0,0
236334,the,0,0
236335,RDAI,0,0
236336,score,0,0
236337,at,0,0
236338,24,0,0
236339,hours,0,0
236340,.,0,1
236341,Secondary,0,0
236342,outcome,0,0
236343,measures,0,0
236344,were,0,0
236345,oxygen,0,0
236346,saturation,0,0
236347,",",0,0
236348,respiratory,0,0
236349,rate,0,0
236350,",",0,0
236351,RDAI,0,0
236352,measurement,0,0
236353,twice,0,0
236354,daily,0,0
236355,for,0,0
236356,the,0,0
236357,first,0,0
236358,4,0,0
236359,days,0,0
236360,",",0,0
236361,and,0,0
236362,the,0,0
236363,length,0,0
236364,of,0,0
236365,hospitalization,0,0
236366,.,0,0
236367,RESULTS,0,0
236368,At,0,0
236369,24,0,0
236370,hours,0,0
236371,the,0,0
236372,mean,0,0
236373,change,0,0
236374,(,0,0
236375,SD,0,0
236376,),0,0
236377,from,0,0
236378,baseline,0,0
236379,in,0,0
236380,the,0,0
236381,RDAI,0,0
236382,score,0,0
236383,was,0,0
236384,1.6,0,0
236385,(,0,0
236386,2.3,0,0
236387,),0,0
236388,in,0,0
236389,the,0,0
236390,placebo,0,0
236391,group,0,0
236392,(,0,0
236393,n,0,1
236394,=,0,0
236395,28,0,1
236396,),0,0
236397,and,0,0
236398,1.4,0,0
236399,(,0,0
236400,2.0,0,0
236401,),0,0
236402,in,0,0
236403,the,0,0
236404,dexamethasone,0,0
236405,group,0,0
236406,(,0,0
236407,n,0,0
236408,=,0,0
236409,33,0,1
236410,;,0,0
236411,p,0,0
236412,=,0,0
236413,0.74,0,0
236414,),0,0
236415,.,0,0
236416,There,0,0
236417,were,0,0
236418,no,0,0
236419,significant,0,0
236420,differences,0,0
236421,between,0,0
236422,the,0,0
236423,two,0,0
236424,groups,0,0
236425,in,0,0
236426,change,0,0
236427,in,0,0
236428,oxygen,0,0
236429,saturation,0,0
236430,",",0,0
236431,respiratory,0,0
236432,rate,0,0
236433,",",0,0
236434,and,0,0
236435,RDAI,0,0
236436,score,0,0
236437,at,0,0
236438,any,0,0
236439,assessment,0,0
236440,period,0,0
236441,.,0,0
236442,The,0,0
236443,median,0,0
236444,length,0,0
236445,of,0,0
236446,stay,0,0
236447,(,0,0
236448,95,0,0
236449,%,0,0
236450,confidence,0,0
236451,interval,0,0
236452,),0,0
236453,for,0,0
236454,the,0,0
236455,placebo,0,0
236456,group,0,0
236457,was,0,0
236458,48,0,0
236459,(,0,0
236460,42,0,0
236461,",",0,0
236462,54,0,1
236463,),0,0
236464,hours,0,0
236465,compared,0,0
236466,with,0,1
236467,57,0,1
236468,(,0,0
236469,38,0,1
236470,",",0,0
236471,76,0,1
236472,),0,0
236473,hours,0,0
236474,in,0,0
236475,the,0,0
236476,dexamethasone,0,0
236477,group,0,0
236478,(,0,0
236479,p,0,0
236480,=,0,0
236481,0.19,0,0
236482,),0,0
236483,.,0,0
236484,CONCLUSIONS,0,0
236485,Oral,0,0
236486,dexamethasone,0,0
236487,therapy,0,0
236488,does,0,0
236489,not,0,0
236490,affect,0,0
236491,the,0,0
236492,clinical,0,0
236493,course,0,0
236494,of,0,0
236495,children,1,1
236496,hospitalized,1,1
236497,with,1,1
236498,bronchiolitis,1,1
236499,and,0,0
236500,therefore,0,0
236501,can,0,0
236502,not,0,0
236503,be,0,0
236504,recommended,0,0
236505,in,0,0
236506,this,0,0
236507,clinical,0,0
236508,situation,0,0
236509,.,0,0
236510,Outcome,1,0
236511,assessment,1,0
236512,for,1,0
236513,clinical,1,0
236514,trials,1,0
236515,:,1,1
236516,how,0,0
236517,many,0,0
236518,adjudicators,1,0
236519,do,0,0
236520,we,0,0
236521,need,0,0
236522,?,0,0
236523,Canadian,0,1
236524,Lung,0,0
236525,Oncology,0,1
236526,Group,0,1
236527,.,0,0
236528,Considerable,0,0
236529,effort,0,0
236530,is,0,0
236531,often,0,0
236532,expended,0,0
236533,to,0,0
236534,adjudicate,0,0
236535,outcomes,0,0
236536,in,0,0
236537,clinical,0,0
236538,trials,0,0
236539,",",0,0
236540,but,0,0
236541,little,0,0
236542,has,0,0
236543,been,0,0
236544,written,0,0
236545,on,0,0
236546,the,0,0
236547,administration,0,0
236548,of,0,0
236549,the,0,0
236550,adjudication,0,0
236551,process,0,0
236552,and,0,0
236553,its,0,0
236554,possible,0,0
236555,impact,0,0
236556,on,0,0
236557,study,0,0
236558,results,0,0
236559,.,0,0
236560,As,0,0
236561,a,0,0
236562,case,0,0
236563,study,0,0
236564,",",0,0
236565,we,0,0
236566,describe,0,0
236567,the,0,0
236568,function,0,0
236569,and,0,0
236570,performance,0,0
236571,of,0,0
236572,an,0,0
236573,adjudication,1,0
236574,committee,1,0
236575,in,1,0
236576,a,1,0
236577,large,1,0
236578,randomized,1,0
236579,trial,1,0
236580,of,0,0
236581,two,0,0
236582,diagnostic,0,0
236583,approaches,0,0
236584,to,0,0
236585,potentially,1,0
236586,operable,1,1
236587,lung,1,0
236588,cancer,1,1
236589,.,1,0
236590,Up,1,0
236591,to,1,0
236592,five,1,1
236593,independent,1,0
236594,adjudicators,1,0
236595,independently,0,0
236596,determined,0,0
236597,two,0,0
236598,primary,0,1
236599,outcomes,0,0
236600,:,0,1
236601,tumor,0,0
236602,status,0,0
236603,at,0,0
236604,death,0,0
236605,or,0,0
236606,at,0,0
236607,final,0,0
236608,follow-up,0,0
236609,and,0,0
236610,the,0,0
236611,cause,0,0
236612,of,0,0
236613,death,0,0
236614,.,0,0
236615,Patients,1,1
236616,for,0,0
236617,whom,0,1
236618,there,0,0
236619,was,0,0
236620,any,0,0
236621,disagreement,0,0
236622,were,0,0
236623,discussed,0,0
236624,in,0,0
236625,committee,0,0
236626,until,0,0
236627,a,0,0
236628,consensus,0,0
236629,was,0,0
236630,achieved,0,0
236631,.,0,0
236632,We,0,0
236633,describe,0,0
236634,the,0,0
236635,pattern,0,0
236636,of,0,0
236637,agreement,0,0
236638,among,0,0
236639,the,0,0
236640,adjudicators,0,0
236641,and,0,0
236642,with,0,1
236643,the,0,0
236644,final,0,0
236645,consensus,0,0
236646,result,0,0
236647,.,0,0
236648,Additionally,0,0
236649,",",0,0
236650,we,0,0
236651,model,0,0
236652,the,0,0
236653,adjudication,0,0
236654,process,0,0
236655,and,0,0
236656,predict,0,0
236657,the,0,0
236658,results,0,0
236659,if,0,0
236660,a,0,0
236661,smaller,0,0
236662,committee,0,0
236663,had,0,0
236664,been,0,0
236665,used,0,0
236666,.,0,0
236667,We,0,0
236668,found,0,0
236669,that,0,0
236670,reducing,0,0
236671,the,0,0
236672,number,0,0
236673,of,0,0
236674,adjudicators,0,0
236675,from,0,1
236676,five,0,1
236677,to,0,0
236678,two,0,0
236679,or,0,0
236680,three,0,0
236681,would,0,0
236682,probably,0,0
236683,have,0,0
236684,changed,0,0
236685,the,0,0
236686,consensus,0,0
236687,outcome,0,0
236688,in,0,0
236689,less,0,0
236690,than,0,0
236691,10,0,0
236692,%,0,0
236693,of,0,0
236694,cases,0,0
236695,.,0,0
236696,Correspondingly,0,0
236697,",",0,0
236698,the,0,0
236699,effect,0,0
236700,on,0,0
236701,the,0,0
236702,final,0,0
236703,study,0,0
236704,results,0,0
236705,(,0,0
236706,comparing,0,0
236707,primary,0,1
236708,outcomes,0,0
236709,in,0,0
236710,both,0,0
236711,randomized,0,0
236712,arms,0,0
236713,),0,0
236714,would,0,0
236715,have,0,0
236716,been,0,0
236717,altered,0,0
236718,very,0,0
236719,little,0,0
236720,.,0,0
236721,Even,0,0
236722,using,0,0
236723,a,0,0
236724,single,0,0
236725,adjudicator,0,0
236726,would,0,0
236727,not,0,0
236728,have,0,0
236729,affected,0,0
236730,the,0,0
236731,results,0,0
236732,substantially,0,0
236733,.,0,0
236734,About,0,0
236735,90,0,0
236736,minutes,0,0
236737,of,0,0
236738,person-time,0,0
236739,per,0,0
236740,patient,1,0
236741,was,0,0
236742,required,0,0
236743,for,0,0
236744,activities,0,0
236745,directly,0,0
236746,related,0,0
236747,to,0,0
236748,the,0,0
236749,adjudication,0,0
236750,process,0,0
236751,",",0,0
236752,or,0,0
236753,approximately,0,0
236754,6,0,0
236755,months,0,0
236756,of,0,0
236757,full,0,0
236758,time,0,0
236759,work,0,0
236760,for,0,0
236761,the,0,0
236762,entire,0,0
236763,study,0,0
236764,.,0,0
236765,This,0,0
236766,level,0,0
236767,of,0,0
236768,effort,0,0
236769,could,0,0
236770,be,0,0
236771,substantially,0,0
236772,reduced,0,0
236773,by,0,0
236774,using,0,0
236775,fewer,0,0
236776,adjudicators,0,0
236777,with,0,1
236778,little,0,0
236779,impact,0,0
236780,on,0,0
236781,the,0,0
236782,results,0,0
236783,.,0,0
236784,Thus,0,0
236785,",",0,0
236786,we,0,0
236787,suggest,0,0
236788,that,0,0
236789,when,0,0
236790,high,0,0
236791,observer,0,0
236792,agreement,0,0
236793,is,0,0
236794,demonstrated,0,0
236795,or,0,0
236796,anticipated,0,0
236797,",",0,0
236798,adjudication,0,0
236799,committees,0,0
236800,should,0,0
236801,consist,0,0
236802,of,0,0
236803,no,0,0
236804,more,0,0
236805,than,0,0
236806,three,0,0
236807,members,0,1
236808,.,0,1
236809,Further,0,0
236810,work,0,0
236811,is,0,0
236812,needed,0,0
236813,to,0,0
236814,evaluate,0,0
236815,if,0,0
236816,smaller,0,0
236817,committees,0,0
236818,are,0,0
236819,adequate,0,0
236820,to,0,0
236821,detect,0,0
236822,small,0,0
236823,but,0,0
236824,important,0,0
236825,treatment,0,0
236826,effects,0,0
236827,or,0,0
236828,if,0,0
236829,they,0,0
236830,compromise,0,0
236831,validity,0,0
236832,when,0,0
236833,the,0,0
236834,level,0,0
236835,of,0,0
236836,adjudicator,0,0
236837,agreement,0,0
236838,is,0,0
236839,lower,0,0
236840,.,0,0
236841,Soluble,0,0
236842,intercellular,0,0
236843,adhesion,0,0
236844,molecule-1,0,0
236845,in,0,0
236846,primary,1,0
236847,biliary,1,1
236848,cirrhosis,1,1
236849,:,1,1
236850,effect,0,0
236851,of,0,0
236852,ursodeoxycholic,0,0
236853,acid,0,0
236854,and,0,0
236855,immunosuppressive,0,0
236856,therapy,0,0
236857,.,0,0
236858,OBJECTIVES,0,0
236859,Soluble,0,0
236860,intercellular,0,0
236861,adhesion,0,0
236862,molecule-1,0,0
236863,(,0,0
236864,sICAM-1,0,0
236865,),0,0
236866,is,0,0
236867,thought,0,0
236868,to,0,0
236869,be,0,0
236870,released,0,0
236871,by,0,0
236872,a,0,0
236873,variety,0,0
236874,of,0,0
236875,cells,0,0
236876,at,0,0
236877,sites,0,0
236878,of,0,0
236879,inflammation,0,0
236880,",",0,0
236881,and,0,0
236882,their,0,0
236883,serum,0,0
236884,levels,0,0
236885,have,0,0
236886,been,0,0
236887,used,0,0
236888,as,0,0
236889,markers,0,0
236890,of,0,0
236891,inflammatory,0,0
236892,and,0,0
236893,immune,0,0
236894,activity,0,0
236895,.,0,0
236896,Our,0,0
236897,aim,0,0
236898,was,0,0
236899,to,0,0
236900,determine,0,0
236901,the,0,0
236902,effect,0,0
236903,of,0,0
236904,therapy,0,0
236905,with,0,1
236906,ursodeoxycholic,0,0
236907,acid,0,0
236908,alone,0,0
236909,and,0,0
236910,in,0,0
236911,combination,0,0
236912,with,0,1
236913,azathioprine,0,0
236914,and,0,0
236915,prednisone,0,0
236916,on,0,0
236917,serum,0,0
236918,sICAM-1,0,0
236919,levels,0,0
236920,in,0,0
236921,primary,0,1
236922,biliary,0,1
236923,cirrhosis,0,1
236924,.,0,0
236925,DESIGN/METHODS,0,0
236926,Twenty-four,1,1
236927,patients,1,1
236928,with,1,1
236929,primary,1,1
236930,biliary,1,1
236931,cirrhosis,1,1
236932,and,1,0
236933,17,1,1
236934,healthy,1,1
236935,subjects,1,1
236936,were,1,0
236937,studied,1,1
236938,.,1,0
236939,Primary,1,0
236940,biliary,1,1
236941,cirrhosis,1,1
236942,patients,1,1
236943,received,0,0
236944,ursodeoxycholic,0,1
236945,acid,0,0
236946,for,0,0
236947,12,0,0
236948,months,0,0
236949,and,0,0
236950,were,0,0
236951,then,0,0
236952,randomized,0,0
236953,in,0,0
236954,a,0,0
236955,double-blind,0,0
236956,fashion,0,0
236957,to,0,0
236958,receive,0,0
236959,prednisone,0,0
236960,and,0,0
236961,azathioprine,0,0
236962,",",0,0
236963,or,0,0
236964,placebo,0,0
236965,in,0,0
236966,addition,0,0
236967,to,0,0
236968,ursodeoxycholic,0,1
236969,acid,0,0
236970,.,0,0
236971,RESULTS,0,0
236972,sICAM-1,0,0
236973,levels,0,0
236974,were,0,0
236975,significantly,0,0
236976,higher,0,0
236977,in,0,0
236978,primary,1,0
236979,biliary,1,1
236980,cirrhosis,1,1
236981,patients,1,1
236982,than,0,0
236983,healthy,1,1
236984,subjects,1,1
236985,and,0,0
236986,fell,0,0
236987,by,0,0
236988,a,0,0
236989,median,0,0
236990,of,0,0
236991,20,0,0
236992,%,0,0
236993,after,0,0
236994,12,0,0
236995,months,0,0
236996,',0,1
236997,therapy,0,0
236998,with,0,1
236999,ursodeoxycholic,0,0
237000,acid,0,0
237001,(,0,0
237002,P,0,0
237003,<,0,0
237004,0.0004,0,0
237005,),0,0
237006,.,0,0
237007,Addition,0,0
237008,of,0,0
237009,azathioprine,0,0
237010,and,0,0
237011,prednisone,0,0
237012,to,0,0
237013,ursodeoxycholic,0,0
237014,acid,0,0
237015,resulted,0,0
237016,in,0,0
237017,a,0,0
237018,further,0,0
237019,reduction,0,0
237020,of,0,0
237021,sICAM-1,0,0
237022,levels,0,0
237023,by,0,0
237024,a,0,0
237025,median,0,0
237026,of,0,0
237027,25,0,0
237028,%,0,0
237029,(,0,0
237030,P,0,0
237031,<,0,0
237032,0.01,0,0
237033,),0,1
237034,.,0,0
237035,Reductions,0,0
237036,in,0,0
237037,sICAM-1,0,0
237038,were,0,0
237039,accompanied,0,0
237040,by,0,0
237041,improvement,0,0
237042,in,0,0
237043,liver,0,1
237044,function,0,0
237045,tests,0,0
237046,but,0,0
237047,not,0,0
237048,in,0,0
237049,the,0,0
237050,lymphocyte,0,0
237051,activation,0,0
237052,marker,0,0
237053,",",0,0
237054,soluble,0,0
237055,interleukin-2,0,0
237056,receptor,0,0
237057,.,0,0
237058,CONCLUSION,0,0
237059,sICAM-1,0,0
237060,levels,0,0
237061,in,0,0
237062,primary,0,1
237063,biliary,0,1
237064,cirrhosis,0,1
237065,are,0,0
237066,reduced,0,0
237067,by,0,0
237068,ursodeoxycholic,0,1
237069,acid,0,0
237070,.,0,0
237071,Further,0,0
237072,reductions,0,0
237073,were,0,0
237074,achieved,0,0
237075,by,0,0
237076,adding,0,0
237077,prednisone,0,0
237078,and,0,0
237079,azathioprine,0,0
237080,.,0,0
237081,These,0,0
237082,reductions,0,0
237083,probably,0,0
237084,reflect,0,0
237085,an,0,0
237086,improvement,0,0
237087,in,0,0
237088,hepatobiliary,0,1
237089,excretion,0,0
237090,and,0,0
237091,a,0,0
237092,reduction,0,0
237093,in,0,0
237094,cellular,0,0
237095,production,0,0
237096,of,0,0
237097,sICAM-1,0,0
237098,.,0,1
237099,Long-term,0,0
237100,follow-up,0,0
237101,of,0,0
237102,cytostatic,0,0
237103,intravesical,0,0
237104,instillation,0,0
237105,in,0,0
237106,patients,1,1
237107,with,1,1
237108,superficial,1,0
237109,bladder,1,1
237110,carcinoma,1,1
237111,.,1,0
237112,Is,0,0
237113,short-term,0,0
237114,",",0,0
237115,intensive,0,0
237116,instillation,0,0
237117,better,0,0
237118,than,0,0
237119,maintenance,0,0
237120,therapy,0,0
237121,?,0,0
237122,OBJECTIVES,0,0
237123,Comparisons,0,0
237124,of,0,1
237125,two,0,1
237126,3-year,0,0
237127,protocols,0,0
237128,",",0,0
237129,one,0,0
237130,20-week,0,0
237131,protocol,0,0
237132,of,0,0
237133,mitomycin,0,0
237134,C,0,0
237135,instillation,0,0
237136,and,0,0
237137,one,0,0
237138,3-year,0,0
237139,protocol,0,0
237140,of,0,0
237141,doxorubicin,0,0
237142,instillation,0,0
237143,for,0,0
237144,the,0,0
237145,prevention,0,0
237146,of,0,0
237147,recurrent,0,1
237148,tumors,0,1
237149,and,0,0
237150,progression,0,0
237151,in,0,0
237152,patients,1,1
237153,whose,1,1
237154,superficial,1,0
237155,bladder,1,1
237156,tumors,1,1
237157,had,1,0
237158,been,1,0
237159,removed,1,0
237160,by,1,0
237161,transurethral,1,1
237162,resection,1,1
237163,.,1,0
237164,METHODS,0,0
237165,A,0,0
237166,prospective,0,0
237167,",",0,0
237168,randomized,0,0
237169,parallel,0,0
237170,group,0,0
237171,multicenter,0,0
237172,trial,0,0
237173,was,0,0
237174,conducted,0,0
237175,.,0,0
237176,419,1,1
237177,patients,1,1
237178,were,1,0
237179,evaluated,1,0
237180,after,1,0
237181,a,1,0
237182,median,1,0
237183,follow-up,1,0
237184,of,1,0
237185,57,1,1
237186,months,1,0
237187,.,1,1
237188,Cox,0,0
237189,proportional,0,0
237190,hazards,0,0
237191,analysis,0,0
237192,was,0,0
237193,performed,0,0
237194,.,0,0
237195,RESULTS,0,0
237196,An,0,0
237197,overall,0,0
237198,recurrence,0,0
237199,rate,0,0
237200,of,0,0
237201,22.7,0,0
237202,%,0,0
237203,and,0,0
237204,an,0,0
237205,overall,0,0
237206,progression,0,0
237207,rate,0,0
237208,of,0,0
237209,9.8,0,0
237210,%,0,0
237211,was,0,0
237212,found,0,0
237213,.,0,0
237214,For,0,0
237215,time,0,0
237216,to,0,0
237217,progression,0,0
237218,a,0,0
237219,significant,0,0
237220,overall,0,0
237221,treatment,0,0
237222,effect,0,0
237223,was,0,0
237224,detected,0,0
237225,dependent,0,0
237226,on,0,0
237227,the,0,0
237228,recurrence,0,0
237229,status,0,0
237230,before,0,0
237231,entry,0,0
237232,into,0,0
237233,the,0,0
237234,study,0,0
237235,(,0,0
237236,p,0,0
237237,=,0,0
237238,0.0059,0,0
237239,),0,0
237240,.,0,0
237241,Pairwise,0,0
237242,comparisons,0,0
237243,showed,0,0
237244,the,0,0
237245,mitomycin,0,0
237246,protocol,0,0
237247,with,0,1
237248,short-term,0,0
237249,intensive,0,1
237250,(,0,0
237251,weekly,0,0
237252,),0,0
237253,combined,0,0
237254,with,0,0
237255,long-term,0,0
237256,maintenance,0,0
237257,instillation,0,0
237258,to,0,0
237259,have,0,0
237260,a,0,0
237261,highly,0,0
237262,beneficial,0,0
237263,effect,0,0
237264,compared,0,0
237265,to,0,0
237266,long-term,0,0
237267,maintenance,0,0
237268,instillation,0,0
237269,only,0,0
237270,especially,0,0
237271,for,0,0
237272,patients,0,1
237273,entering,0,1
237274,the,0,0
237275,study,0,0
237276,with,0,1
237277,recurrent,0,1
237278,tumors,0,1
237279,(,0,0
237280,RR,0,0
237281,=,0,0
237282,0.06,0,0
237283,",",0,0
237284,95,0,0
237285,%,0,0
237286,CI,0,0
237287,:,0,1
237288,[,0,0
237289,0.008,0,0
237290,",",0,0
237291,0.506,0,0
237292,],0,0
237293,.,0,0
237294,CONCLUSION,0,0
237295,These,0,0
237296,results,0,0
237297,show,0,0
237298,that,0,0
237299,intensive,0,1
237300,therapeutic,0,0
237301,instillation,0,0
237302,may,0,0
237303,have,0,0
237304,an,0,0
237305,advantage,0,0
237306,over,0,0
237307,less,0,0
237308,intensive,0,0
237309,",",0,0
237310,prophylactic,0,0
237311,regimens,0,0
237312,.,0,1
237313,Leukotriene,0,0
237314,antagonist,0,0
237315,prevents,0,0
237316,exacerbation,0,1
237317,of,0,0
237318,asthma,1,1
237319,during,0,0
237320,reduction,0,0
237321,of,0,0
237322,high-dose,0,0
237323,inhaled,0,0
237324,corticosteroid,0,0
237325,.,0,0
237326,The,0,0
237327,Tokyo,0,0
237328,Joshi-Idai,0,1
237329,Asthma,0,1
237330,Research,0,0
237331,Group,0,1
237332,.,0,0
237333,To,0,0
237334,test,0,0
237335,whether,0,0
237336,the,0,0
237337,leukotriene,0,0
237338,antagonist,0,0
237339,ONO-1078,0,0
237340,(,0,0
237341,pranlukast,0,0
237342,),0,0
237343,prevents,0,0
237344,asthma,1,1
237345,exacerbations,0,0
237346,during,0,0
237347,reduction,0,0
237348,of,0,0
237349,high-dose,0,0
237350,inhaled,0,0
237351,corticosteroid,0,0
237352,",",0,0
237353,we,0,0
237354,conducted,0,0
237355,a,0,0
237356,randomized,0,0
237357,",",0,0
237358,double-blind,0,0
237359,",",0,0
237360,placebo-controlled,0,0
237361,study,0,0
237362,in,0,0
237363,79,1,1
237364,asthma,1,1
237365,patients,1,1
237366,requiring,1,1
237367,high,1,1
237368,doses,1,0
237369,(,1,0
237370,"1,500",1,0
237371,microg/d,1,0
237372,or,1,0
237373,more,1,0
237374,),1,0
237375,of,1,0
237376,inhaled,1,0
237377,beclomethasone,1,0
237378,dipropionate,1,0
237379,(,1,0
237380,BDI,1,0
237381,),1,0
237382,for,1,0
237383,clinical,1,0
237384,control,1,0
237385,(,1,0
237386,duration,1,0
237387,of,1,0
237388,asthma,1,1
237389,",",1,0
237390,11.0,1,0
237391,+/-,1,0
237392,3.1,1,0
237393,yr,1,1
237394,;,1,0
237395,duration,1,0
237396,of,1,0
237397,BDI,1,0
237398,treatment,1,0
237399,",",1,0
237400,0.5,1,0
237401,+/-,1,0
237402,0.3,1,0
237403,yr,1,1
237404,;,1,0
237405,FEV1,1,0
237406,percentage,1,0
237407,of,1,0
237408,predicted,1,0
237409,",",1,0
237410,80.7,1,0
237411,+/-,1,0
237412,2.0,1,0
237413,%,1,0
237414,),1,0
237415,.,1,0
237416,After,0,0
237417,a,0,0
237418,2-wk,0,0
237419,run-in,0,0
237420,period,0,0
237421,",",0,0
237422,the,0,0
237423,doses,0,0
237424,of,0,0
237425,BDI,0,0
237426,were,0,0
237427,halved,0,0
237428,",",0,0
237429,while,0,0
237430,the,0,0
237431,patients,0,1
237432,were,0,0
237433,assigned,0,0
237434,to,0,0
237435,receive,0,0
237436,orally,0,0
237437,ONO-1078,0,0
237438,",",0,0
237439,450,0,0
237440,mg,0,0
237441,twice,0,0
237442,daily,0,0
237443,",",0,0
237444,or,0,0
237445,placebo,0,0
237446,.,0,0
237447,In,0,0
237448,the,0,0
237449,placebo,0,0
237450,group,0,0
237451,FEV1,0,0
237452,decreased,0,0
237453,by,0,0
237454,0.33,0,0
237455,+/-,0,0
237456,0.20,0,0
237457,L,0,0
237458,after,0,0
237459,6,0,0
237460,wk,0,0
237461,(,0,0
237462,p,0,0
237463,<,0,0
237464,0.001,0,0
237465,),0,0
237466,.,0,0
237467,Likewise,0,0
237468,",",0,0
237469,morning,0,0
237470,and,0,0
237471,evening,0,0
237472,PEF,0,0
237473,decreased,0,0
237474,by,0,0
237475,46,0,1
237476,+/-,0,0
237477,7,0,0
237478,L/min,0,0
237479,and,0,0
237480,18,0,1
237481,+/-,0,0
237482,6,0,0
237483,L/min,0,0
237484,",",0,0
237485,respectively,0,0
237486,.,0,0
237487,By,0,0
237488,contrast,0,0
237489,these,0,0
237490,variables,0,0
237491,were,0,0
237492,sustained,0,0
237493,above,0,0
237494,baseline,0,0
237495,in,0,0
237496,the,0,0
237497,ONO-1078,0,0
237498,group,0,0
237499,.,0,0
237500,The,0,0
237501,number,0,0
237502,of,0,0
237503,daytime,0,0
237504,and,0,0
237505,nighttime,0,0
237506,asthma,0,1
237507,symptoms,0,0
237508,and,0,0
237509,the,0,0
237510,use,0,0
237511,of,0,0
237512,beta2-agonist,0,0
237513,increased,0,0
237514,in,0,0
237515,the,0,0
237516,placebo,0,0
237517,group,0,0
237518,",",0,0
237519,whereas,0,0
237520,they,0,0
237521,remained,0,0
237522,unchanged,0,0
237523,in,0,0
237524,the,0,0
237525,ONO-1078,0,0
237526,group,0,0
237527,.,0,0
237528,In,0,0
237529,the,0,0
237530,placebo,0,0
237531,group,0,0
237532,concentrations,0,0
237533,of,0,0
237534,serum,0,0
237535,eosinophil,0,0
237536,cationic,0,0
237537,protein,0,0
237538,and,0,0
237539,exhaled,0,0
237540,nitric,0,0
237541,oxide,0,0
237542,increased,0,0
237543,(,0,0
237544,p,0,0
237545,=,0,0
237546,0.007,0,0
237547,and,0,0
237548,p,0,0
237549,=,0,0
237550,0.025,0,0
237551,",",0,0
237552,respectively,0,0
237553,),0,0
237554,",",0,0
237555,compared,0,0
237556,with,0,0
237557,no,0,0
237558,change,0,0
237559,in,0,0
237560,the,0,0
237561,ONO-1078,0,0
237562,group,0,0
237563,.,0,0
237564,Therefore,0,0
237565,",",0,0
237566,the,0,0
237567,leukotriene,0,0
237568,antagonist,0,0
237569,ONO-1078,0,1
237570,prevents,0,0
237571,the,0,0
237572,asthma,1,1
237573,deterioration,0,0
237574,provoked,0,0
237575,by,0,0
237576,a,0,0
237577,6-wk,0,0
237578,reduction,0,0
237579,of,0,0
237580,the,0,0
237581,dose,0,0
237582,of,0,0
237583,inhaled,0,0
237584,BDI,0,0
237585,into,0,1
237586,half,0,1
237587,.,0,0
237588,Effects,0,0
237589,of,0,0
237590,age,0,1
237591,at,0,0
237592,introduction,0,0
237593,of,0,0
237594,complementary,0,0
237595,foods,0,1
237596,to,0,1
237597,breast-fed,0,1
237598,infants,0,1
237599,on,0,0
237600,duration,0,0
237601,of,0,0
237602,lactational,1,0
237603,amenorrhea,1,1
237604,in,1,0
237605,Honduran,1,1
237606,women,1,1
237607,.,1,1
237608,Lactational,0,0
237609,amenorrhea,0,0
237610,(,0,0
237611,LA,0,0
237612,),0,0
237613,is,0,0
237614,associated,0,0
237615,with,0,0
237616,postpartum,1,1
237617,infertility,0,1
237618,and,0,0
237619,is,0,0
237620,known,0,0
237621,to,0,0
237622,be,0,0
237623,related,0,0
237624,to,0,0
237625,breast-feeding,0,0
237626,frequency,0,0
237627,and,0,0
237628,duration,0,0
237629,",",0,0
237630,but,0,0
237631,the,0,0
237632,exact,0,0
237633,role,0,0
237634,of,0,0
237635,complementary,0,0
237636,feeding,0,0
237637,of,0,0
237638,the,0,0
237639,infant,0,0
237640,has,0,0
237641,not,0,0
237642,been,0,0
237643,clearly,0,0
237644,defined,0,0
237645,.,0,0
237646,Data,0,0
237647,on,0,0
237648,LA,0,0
237649,were,0,0
237650,collected,0,0
237651,during,0,0
237652,and,0,0
237653,after,0,0
237654,a,0,0
237655,2-mo,0,1
237656,intervention,0,0
237657,trial,0,0
237658,in,0,0
237659,which,0,0
237660,low-income,1,1
237661,Honduran,1,1
237662,women,1,1
237663,who,1,1
237664,had,1,1
237665,breast-fed,1,1
237666,fully,1,0
237667,for,1,0
237668,4,1,0
237669,mo,1,1
237670,were,1,0
237671,randomly,1,1
237672,assigned,1,0
237673,to,1,0
237674,one,1,0
237675,of,1,0
237676,three,1,1
237677,groups,1,0
237678,:,1,1
237679,continued,0,0
237680,full,0,0
237681,breast-feeding,0,0
237682,until,0,0
237683,6,0,0
237684,mo,0,1
237685,(,0,0
237686,FBF,0,0
237687,",",0,0
237688,n,0,1
237689,=,0,0
237690,50,0,0
237691,),0,0
237692,",",0,0
237693,introduction,0,0
237694,of,0,0
237695,complementary,0,0
237696,foods,0,1
237697,at,0,0
237698,4,0,0
237699,mo,0,1
237700,with,0,1
237701,ad,0,1
237702,libitum,0,1
237703,breast-feeding,0,0
237704,from,0,0
237705,4,0,0
237706,to,0,0
237707,6,0,0
237708,mo,0,1
237709,(,0,0
237710,SF,0,0
237711,",",0,0
237712,n,0,1
237713,=,0,0
237714,47,0,1
237715,),0,0
237716,",",0,0
237717,or,0,0
237718,introduction,0,0
237719,of,0,0
237720,complementary,0,0
237721,foods,0,1
237722,at,0,0
237723,4,0,0
237724,mo,0,1
237725,with,0,1
237726,maintenance,0,0
237727,of,0,0
237728,baseline,0,0
237729,breast-feeding,0,0
237730,frequency,0,0
237731,from,0,0
237732,4,0,0
237733,to,0,0
237734,6,0,0
237735,mo,0,1
237736,(,0,0
237737,SF-M,0,0
237738,",",0,0
237739,n,0,1
237740,=,0,0
237741,44,0,1
237742,),0,0
237743,.,0,0
237744,Women,0,0
237745,were,0,0
237746,followed,0,0
237747,up,0,0
237748,until,0,0
237749,the,0,0
237750,infant,0,1
237751,was,0,0
237752,12,0,0
237753,mo,0,1
237754,of,0,0
237755,age,0,1
237756,",",0,0
237757,or,0,0
237758,later,0,0
237759,if,0,0
237760,menses,0,0
237761,had,0,0
237762,not,0,0
237763,occurred,0,0
237764,by,0,0
237765,then,0,0
237766,.,0,0
237767,All,0,0
237768,but,0,0
237769,six,0,0
237770,of,0,0
237771,the,0,0
237772,women,0,1
237773,continued,0,0
237774,to,0,0
237775,breast-feed,0,1
237776,for,0,0
237777,>,0,0
237778,or,0,0
237779,=,0,0
237780,12,0,0
237781,mo,0,1
237782,.,0,0
237783,With,0,0
237784,the,0,0
237785,exclusion,0,0
237786,of,0,0
237787,those,0,0
237788,whose,0,1
237789,menses,0,0
237790,returned,0,1
237791,before,0,0
237792,18,0,1
237793,wk,0,0
237794,postpartum,0,1
237795,(,0,0
237796,which,0,0
237797,could,0,0
237798,not,0,0
237799,have,0,0
237800,been,0,0
237801,due,0,0
237802,to,0,0
237803,the,0,0
237804,intervention,0,0
237805,),0,0
237806,",",0,0
237807,the,0,0
237808,proportion,0,0
237809,of,0,0
237810,women,0,1
237811,who,0,1
237812,were,0,1
237813,amenorrheic,0,1
237814,at,0,0
237815,6,0,0
237816,mo,0,1
237817,was,0,0
237818,64.5,0,0
237819,%,0,0
237820,in,0,0
237821,the,0,0
237822,SF,0,0
237823,group,0,0
237824,",",0,0
237825,80.0,0,0
237826,%,0,0
237827,in,0,0
237828,the,0,0
237829,FBF,0,0
237830,group,0,0
237831,",",0,0
237832,and,0,0
237833,85.7,0,0
237834,%,0,0
237835,in,0,0
237836,the,0,0
237837,SF-M,0,0
237838,group,0,0
237839,(,0,0
237840,chi-square,0,0
237841,test,0,0
237842,=,0,0
237843,4.13,0,0
237844,",",0,0
237845,P,0,0
237846,=,0,0
237847,0.02,0,0
237848,;,0,0
237849,one-tailed,0,0
237850,test,0,0
237851,with,0,1
237852,the,0,0
237853,latter,0,0
237854,two,0,0
237855,groups,0,0
237856,combined,0,0
237857,),0,0
237858,.,0,0
237859,The,0,0
237860,total,0,0
237861,duration,0,0
237862,of,0,0
237863,LA,0,0
237864,did,0,0
237865,not,0,0
237866,differ,0,0
237867,significantly,0,0
237868,among,0,0
237869,groups,0,0
237870,.,0,0
237871,The,0,0
237872,most,0,0
237873,significant,0,0
237874,determinant,0,0
237875,of,0,0
237876,LA,0,0
237877,was,0,0
237878,time,0,0
237879,spent,0,0
237880,breast-feeding,0,0
237881,(,0,0
237882,min/d,0,0
237883,),0,0
237884,",",0,0
237885,which,0,0
237886,was,0,0
237887,in,0,0
237888,turn,0,0
237889,negatively,0,0
237890,associated,0,0
237891,(,0,0
237892,P,0,0
237893,=,0,0
237894,0.06,0,0
237895,),0,0
237896,with,0,0
237897,the,0,0
237898,infant,0,1
237899,'s,0,0
237900,energy,0,0
237901,intake,0,0
237902,from,0,0
237903,complementary,0,0
237904,foods,0,1
237905,in,0,0
237906,regression,0,0
237907,analyses,0,0
237908,.,0,0
237909,These,0,0
237910,results,0,0
237911,indicate,0,0
237912,that,0,0
237913,there,0,0
237914,is,0,0
237915,a,0,0
237916,significant,0,0
237917,effect,0,0
237918,of,0,0
237919,introducing,0,0
237920,foods,0,1
237921,at,0,0
237922,4,0,0
237923,mo,0,1
237924,on,0,0
237925,the,0,0
237926,likelihood,0,0
237927,of,0,0
237928,amenorrhea,0,0
237929,at,0,0
237930,6,0,0
237931,mo,0,1
237932,postpartum,0,1
237933,",",0,0
237934,but,0,0
237935,not,0,0
237936,thereafter,0,0
237937,",",0,0
237938,and,0,0
237939,that,0,0
237940,this,0,0
237941,effect,0,0
237942,is,0,0
237943,not,0,0
237944,seen,0,0
237945,in,0,0
237946,mothers,0,1
237947,who,0,1
237948,maintain,0,1
237949,breast-feeding,0,1
237950,frequency,0,0
237951,.,0,0
237952,[,0,0
237953,A,0,0
237954,randomized,0,0
237955,comparative,0,0
237956,study,0,0
237957,of,0,0
237958,surgical,0,0
237959,adjuvant,0,0
237960,chemotherapy,0,0
237961,using,0,0
237962,5-fluorouracil,0,0
237963,and,0,0
237964,dl-leucovorin,0,0
237965,with,0,1
237966,CDDP,0,0
237967,5-FU,0,0
237968,and,0,0
237969,dl-leucovorin,0,0
237970,for,0,0
237971,colorectal,1,1
237972,cancer,1,1
237973,],1,0
237974,.,0,0
237975,A,0,0
237976,randomized,0,0
237977,comparative,0,0
237978,study,0,0
237979,of,0,0
237980,surgical,0,0
237981,adjuvant,0,0
237982,chemotherapy,0,0
237983,using,0,0
237984,dl-leucovorin,0,0
237985,(,0,0
237986,dl-LV,0,0
237987,),0,0
237988,and,0,0
237989,5-fluorouracil,0,0
237990,(,0,0
237991,5-FU,0,0
237992,),0,0
237993,(,0,0
237994,FL-therapy,0,0
237995,),0,0
237996,with,0,0
237997,CDDP,0,0
237998,",",0,0
237999,5-FU,0,0
238000,",",0,0
238001,and,0,0
238002,dl-LV,0,0
238003,(,0,0
238004,PFL-therapy,0,0
238005,),0,0
238006,was,0,0
238007,conducted,0,0
238008,.,0,0
238009,The,0,0
238010,following,0,0
238011,were,0,0
238012,the,0,0
238013,administration,0,0
238014,schedules,0,0
238015,:,0,1
238016,Arm,0,1
238017,A,0,0
238018,was,0,0
238019,13,0,0
238020,mg/m2,0,0
238021,of,0,0
238022,CDDP,0,0
238023,",",0,0
238024,300,0,0
238025,mg/m2,0,0
238026,of,0,0
238027,5-FU,0,0
238028,",",0,0
238029,and,0,0
238030,30,0,0
238031,mg/body,0,0
238032,of,0,0
238033,dl-LV,0,0
238034,for,0,0
238035,5,0,0
238036,consecutive,0,1
238037,days,0,0
238038,and,0,0
238039,arm,0,1
238040,B,0,0
238041,was,0,0
238042,300,0,0
238043,mg/m2,0,0
238044,of,0,0
238045,5-FU,0,0
238046,and,0,0
238047,30,0,0
238048,mg/body,0,0
238049,of,0,0
238050,dl-LV,0,0
238051,for,0,0
238052,5,0,0
238053,consecutive,0,1
238054,days,0,0
238055,.,0,1
238056,Both,0,0
238057,regimens,0,0
238058,were,0,0
238059,followed,0,0
238060,by,0,0
238061,biweekly,0,0
238062,administration,0,0
238063,of,0,0
238064,the,0,0
238065,same,0,0
238066,dose,0,0
238067,of,0,0
238068,dl-LV,0,0
238069,and,0,0
238070,5-FU,0,0
238071,in,0,0
238072,outpatients,0,1
238073,.,0,0
238074,Arm,0,1
238075,A,0,0
238076,was,0,0
238077,started,0,0
238078,at,0,0
238079,the,0,0
238080,26th,0,0
238081,postoperative,0,0
238082,day,0,0
238083,and,0,0
238084,arm,0,0
238085,B,0,0
238086,at,0,0
238087,the,0,0
238088,21st,0,0
238089,day,0,0
238090,on,0,0
238091,average,0,0
238092,.,0,0
238093,Some,0,0
238094,26,1,0
238095,cases,1,0
238096,composed,1,0
238097,of,1,0
238098,11,1,1
238099,cases,1,1
238100,of,1,0
238101,arm,1,0
238102,A,1,0
238103,and,1,0
238104,15,1,0
238105,cases,1,0
238106,of,1,0
238107,arm,1,1
238108,B,1,0
238109,completed,0,0
238110,the,0,0
238111,administration,0,0
238112,schedules,0,0
238113,.,0,0
238114,Only,0,0
238115,one,0,0
238116,case,0,0
238117,in,0,0
238118,arm,0,0
238119,A,0,0
238120,was,0,0
238121,complicated,0,0
238122,by,0,0
238123,local,0,0
238124,recurrence,0,0
238125,around,0,0
238126,35,0,1
238127,months,0,0
238128,after,0,0
238129,operation,0,1
238130,.,0,0
238131,Major,0,0
238132,toxicities,0,0
238133,were,0,0
238134,anorexia,0,1
238135,and,0,0
238136,neutropenia,0,0
238137,.,0,0
238138,Both,0,0
238139,toxicities,0,0
238140,were,0,0
238141,seen,0,0
238142,more,0,0
238143,in,0,0
238144,arm,0,0
238145,A,0,0
238146,than,0,0
238147,in,0,0
238148,arm,0,0
238149,B,0,0
238150,",",0,0
238151,showing,0,0
238152,complete,0,0
238153,recovery,0,0
238154,in,0,0
238155,all,0,0
238156,cases,0,0
238157,.,0,0
238158,These,0,0
238159,data,0,0
238160,suggest,0,0
238161,that,0,0
238162,PFL-therapy,0,0
238163,and,0,0
238164,FL-therapy,0,0
238165,seem,0,0
238166,to,0,0
238167,be,0,0
238168,possible,0,0
238169,and,0,0
238170,promising,0,0
238171,surgical,0,1
238172,adjuvant,0,1
238173,therapies,0,0
238174,for,0,0
238175,advanced,1,1
238176,colorectal,1,1
238177,carcinoma,1,1
238178,.,1,0
238179,The,0,0
238180,low-dose,0,0
238181,monoethylglycinexylidide,0,0
238182,test,0,0
238183,:,0,1
238184,assessment,0,0
238185,of,0,0
238186,liver,1,1
238187,function,1,0
238188,with,1,0
238189,fewer,1,0
238190,side,1,0
238191,effects,1,0
238192,.,1,0
238193,The,0,0
238194,hepatic,0,0
238195,metabolism,0,0
238196,of,0,0
238197,lidocaine,0,0
238198,(,0,0
238199,1,0,0
238200,mg/kg,0,0
238201,intravenously,0,0
238202,),0,0
238203,to,0,0
238204,its,0,0
238205,metabolite,0,0
238206,monoethylglycinexylidide,0,0
238207,(,0,0
238208,MEG-X,0,0
238209,),0,0
238210,is,0,0
238211,the,0,0
238212,basis,0,0
238213,of,0,0
238214,the,0,0
238215,standard,0,0
238216,MEG-X,0,0
238217,test,0,0
238218,.,0,0
238219,To,0,0
238220,reduce,0,0
238221,the,0,0
238222,lidocaine-induced,0,0
238223,side,0,0
238224,effects,0,0
238225,",",0,0
238226,we,0,0
238227,evaluated,0,0
238228,the,0,0
238229,MEG-X,0,0
238230,formation,0,0
238231,after,0,0
238232,0.5,0,0
238233,and,0,0
238234,1,0,0
238235,mg/kg,0,0
238236,lidocaine,0,0
238237,intravenously,0,0
238238,in,0,0
238239,subjects,1,1
238240,with,1,1
238241,normal,1,1
238242,(,1,0
238243,n,1,1
238244,=,1,0
238245,5,1,0
238246,),1,0
238247,and,1,0
238248,severely,1,1
238249,impaired,1,0
238250,liver,1,0
238251,function,1,0
238252,(,1,0
238253,n,1,1
238254,=,1,0
238255,7,1,0
238256,),1,0
238257,(,1,0
238258,study,1,0
238259,I,1,0
238260,),1,0
238261,.,1,0
238262,From,0,0
238263,this,0,0
238264,study,0,0
238265,",",0,0
238266,a,0,0
238267,low-dose,0,0
238268,test,0,0
238269,(,0,0
238270,MEG-X,0,0
238271,concentration,0,0
238272,30,0,0
238273,minutes,0,0
238274,after,0,0
238275,50,0,1
238276,mg,0,0
238277,lidocaine,0,0
238278,intravenously,0,0
238279,[,0,0
238280,MEG-X30min,0,0
238281,],0,0
238282,normalized,0,0
238283,to,0,0
238284,standard,0,0
238285,MEG-X,0,0
238286,test,0,0
238287,results,0,0
238288,),0,0
238289,was,0,0
238290,developed,0,0
238291,.,0,0
238292,Sensory,0,0
238293,side,0,0
238294,effects,0,0
238295,from,0,0
238296,this,0,0
238297,low,0,0
238298,dose,0,0
238299,and,0,0
238300,from,0,0
238301,the,0,0
238302,standard,0,0
238303,MEG-X,0,0
238304,test,0,0
238305,were,0,0
238306,compared,0,0
238307,in,0,0
238308,a,0,0
238309,double-blind,0,0
238310,",",0,0
238311,randomized,0,0
238312,",",0,0
238313,cross-over,0,0
238314,study,0,0
238315,(,0,0
238316,study,0,0
238317,II,0,0
238318,),0,0
238319,comprising,0,0
238320,15,1,0
238321,individuals,1,1
238322,with,1,1
238323,normal,1,1
238324,liver,1,1
238325,function,1,0
238326,and,1,0
238327,45,1,1
238328,patients,1,1
238329,with,1,1
238330,cirrhosis,1,1
238331,(,1,0
238332,15,1,0
238333,Child,1,0
238334,A,1,0
238335,",",1,0
238336,15,1,0
238337,Child,1,0
238338,B,1,0
238339,",",1,0
238340,and,1,0
238341,15,1,0
238342,Child,1,1
238343,C,1,0
238344,),1,0
238345,.,1,0
238346,In,0,0
238347,study,0,0
238348,I,0,0
238349,",",0,0
238350,MEG-X,0,0
238351,formation,0,0
238352,rate,0,0
238353,was,0,0
238354,dose-independent,0,0
238355,in,0,0
238356,patients,0,1
238357,with,0,1
238358,severely,0,1
238359,impaired,0,0
238360,liver,0,1
238361,function,0,0
238362,.,0,0
238363,In,0,0
238364,study,0,0
238365,II,0,0
238366,",",0,0
238367,normalized,0,0
238368,MEG-X,0,0
238369,test,0,0
238370,results,0,0
238371,(,0,0
238372,ranging,0,0
238373,from,0,0
238374,<,0,0
238375,or,0,0
238376,=,0,0
238377,4,0,0
238378,to,0,0
238379,120,0,1
238380,microg/L,0,0
238381,),0,0
238382,were,0,0
238383,virtually,0,0
238384,identical,0,0
238385,to,0,0
238386,the,0,0
238387,standard,0,0
238388,test,0,0
238389,results,0,0
238390,(,0,0
238391,mean,0,1
238392,difference,0,0
238393,:,0,1
238394,-1.9,0,0
238395,microg/L,0,0
238396,;,0,0
238397,95,0,0
238398,%,0,0
238399,confidence,0,0
238400,interval,0,0
238401,[,0,0
238402,CI,0,0
238403,],0,0
238404,:,0,1
238405,-5.3,0,0
238406,;,0,0
238407,1.5,0,0
238408,microg/L,0,0
238409,),0,0
238410,.,0,0
238411,Fewer,0,0
238412,individuals,0,1
238413,experienced,0,0
238414,side,0,0
238415,effects,0,0
238416,(,0,0
238417,30,0,0
238418,%,0,0
238419,vs.,0,0
238420,53,0,1
238421,%,0,0
238422,),0,0
238423,with,0,0
238424,the,0,0
238425,low-dose,0,0
238426,test,0,0
238427,(,0,0
238428,P,0,0
238429,=,0,0
238430,.0013,0,0
238431,),0,0
238432,.,0,0
238433,In,0,0
238434,a,0,0
238435,multivariate,0,0
238436,analysis,0,0
238437,",",0,0
238438,the,0,0
238439,Child-Pugh,0,0
238440,score,0,0
238441,was,0,0
238442,inversely,0,0
238443,related,0,0
238444,to,0,0
238445,the,0,0
238446,occurrence,0,0
238447,of,0,0
238448,side,0,0
238449,effects,0,0
238450,.,0,0
238451,The,0,0
238452,low-dose,0,0
238453,MEG-X,0,0
238454,test,0,0
238455,gives,0,0
238456,almost,0,0
238457,identical,0,0
238458,results,0,0
238459,to,0,0
238460,the,0,0
238461,standard,0,0
238462,MEG-X,0,0
238463,test,0,0
238464,and,0,0
238465,is,0,0
238466,associated,0,0
238467,with,0,0
238468,fewer,0,0
238469,side,0,0
238470,effects,0,0
238471,",",0,0
238472,which,0,0
238473,occur,0,0
238474,less,0,0
238475,often,0,0
238476,in,0,0
238477,individuals,0,1
238478,with,0,0
238479,more,0,0
238480,severely,0,0
238481,compromised,0,0
238482,liver,0,0
238483,function,0,0
238484,.,0,0
238485,Comparison,0,0
238486,of,0,0
238487,the,0,0
238488,efficacy,0,0
238489,and,0,0
238490,safety,0,0
238491,of,0,0
238492,ebrotidine,0,0
238493,in,0,0
238494,the,0,0
238495,treatment,0,0
238496,of,0,0
238497,duodenal,0,1
238498,ulcer,0,1
238499,.,0,0
238500,A,0,0
238501,multicentre,0,0
238502,",",0,0
238503,double-blind,0,0
238504,",",0,0
238505,placebo-controlled,0,0
238506,phase,0,0
238507,II,0,1
238508,study,0,0
238509,.,0,0
238510,Ebrotidine,0,0
238511,(,0,0
238512,N-,0,0
238513,[,0,0
238514,(,0,0
238515,E,0,0
238516,),0,0
238517,-,0,0
238518,[,0,0
238519,[,0,0
238520,2-,0,0
238521,[,0,0
238522,[,0,0
238523,[,0,0
238524,2-,0,0
238525,[,0,0
238526,(,0,0
238527,diaminomethylene,0,0
238528,),0,0
238529,amino,0,0
238530,],0,0
238531,-4,0,0
238532,-thiazoly,0,0
238533,],0,0
238534,methyl,0,0
238535,],0,0
238536,thio,0,0
238537,],0,0
238538,ethyl,0,0
238539,],0,0
238540,amino,0,0
238541,],0,0
238542,methylene,0,0
238543,],0,0
238544,-4-bromo-benzenesulfon,0,0
238545,amide,0,0
238546,",",0,0
238547,CAS,0,0
238548,100981-43-9,0,0
238549,",",0,0
238550,FI-3542,0,1
238551,),0,0
238552,is,0,0
238553,a,0,0
238554,new,0,0
238555,H2-receptor,0,0
238556,antagonist,0,0
238557,characterized,0,0
238558,by,0,0
238559,its,0,0
238560,high,0,0
238561,receptor,0,0
238562,affinity,0,0
238563,and,0,0
238564,gastroprotective,0,0
238565,effect,0,0
238566,.,0,0
238567,This,0,0
238568,Phase,0,0
238569,II,0,0
238570,study,0,0
238571,has,0,0
238572,been,0,0
238573,undertaken,0,0
238574,to,0,0
238575,establish,0,0
238576,the,0,0
238577,efficacy,0,0
238578,and,0,0
238579,safety,0,0
238580,of,0,0
238581,ebrotidine,0,0
238582,",",0,0
238583,administered,0,0
238584,in,0,0
238585,four,0,0
238586,dosages,0,0
238587,as,0,0
238588,a,0,0
238589,single,0,0
238590,evening,0,0
238591,dose,0,0
238592,versus,0,0
238593,placebo,0,0
238594,in,0,0
238595,the,0,0
238596,treatment,0,0
238597,of,0,0
238598,duodenal,0,1
238599,ulcer,0,1
238600,.,0,0
238601,A,0,0
238602,total,0,0
238603,of,0,0
238604,110,1,1
238605,duodenal,1,1
238606,ulcer,1,1
238607,patients,1,1
238608,were,0,0
238609,studied,0,1
238610,in,0,0
238611,a,0,0
238612,randomized,0,0
238613,",",0,0
238614,double-blind,0,0
238615,",",0,0
238616,placebo-controlled,0,0
238617,",",0,0
238618,multicentre,0,0
238619,clinical,0,0
238620,trial,0,0
238621,.,0,0
238622,The,0,0
238623,patients,0,1
238624,were,0,0
238625,assigned,0,1
238626,to,0,0
238627,5,0,0
238628,groups,0,0
238629,:,0,1
238630,placebo,0,0
238631,",",0,0
238632,200,0,0
238633,mg,0,0
238634,",",0,0
238635,400,0,0
238636,mg,0,0
238637,",",0,0
238638,600,0,0
238639,mg,0,0
238640,and,0,0
238641,800,0,0
238642,mg,0,0
238643,of,0,0
238644,ebrotidine,0,0
238645,once,0,0
238646,daily,0,0
238647,.,0,1
238648,Controls,0,0
238649,were,0,0
238650,performed,0,0
238651,at,0,0
238652,baseline,0,0
238653,and,0,0
238654,every,0,0
238655,two,0,0
238656,weeks,0,0
238657,at,0,0
238658,four,0,1
238659,follow-up,0,0
238660,visits,0,0
238661,unless,0,0
238662,ulcer,0,1
238663,healed,0,0
238664,before,0,0
238665,.,0,0
238666,Endoscopic,0,0
238667,examination,0,0
238668,was,0,0
238669,the,0,0
238670,main,0,0
238671,parameter,0,0
238672,for,0,0
238673,the,0,0
238674,assessment,0,0
238675,of,0,0
238676,treatment,0,0
238677,efficacy,0,0
238678,and,0,0
238679,ulcer,0,0
238680,healing,0,0
238681,rate,0,0
238682,.,0,1
238683,Vital,0,0
238684,signs,0,0
238685,and,0,0
238686,blood/,0,0
238687,urine,0,0
238688,analysis,0,0
238689,were,0,0
238690,used,0,0
238691,to,0,0
238692,establish,0,0
238693,safety,0,0
238694,.,0,0
238695,The,0,0
238696,three,0,0
238697,groups,0,0
238698,treated,0,1
238699,with,0,1
238700,higher,0,0
238701,dosages,0,0
238702,(,0,0
238703,400,0,0
238704,to,0,0
238705,800,0,0
238706,mg,0,0
238707,of,0,0
238708,ebrotidine,0,0
238709,daily,0,0
238710,),0,0
238711,showed,0,0
238712,an,0,0
238713,endoscopic,0,0
238714,ulcer,0,0
238715,healing,0,0
238716,rate,0,0
238717,of,0,0
238718,90-95,0,0
238719,%,0,0
238720,",",0,0
238721,significantly,0,0
238722,higher,0,0
238723,than,0,0
238724,55,0,1
238725,%,0,0
238726,achieved,0,0
238727,with,0,0
238728,placebo,0,0
238729,(,0,0
238730,p,0,0
238731,<,0,0
238732,0.05,0,0
238733,),0,0
238734,",",0,0
238735,whilst,0,0
238736,the,0,0
238737,differences,0,0
238738,between,0,0
238739,these,0,0
238740,three,0,0
238741,dosages,0,0
238742,of,0,0
238743,ebrotidine,0,0
238744,were,0,0
238745,not,0,0
238746,statistically,0,0
238747,significant,0,0
238748,.,0,0
238749,Healing,0,0
238750,rate,0,0
238751,in,0,0
238752,the,0,0
238753,group,0,0
238754,treated,0,0
238755,with,0,1
238756,200,0,0
238757,mg,0,0
238758,of,0,0
238759,ebrotidine,0,0
238760,daily,0,0
238761,was,0,0
238762,not,0,0
238763,significantly,0,0
238764,different,0,0
238765,from,0,0
238766,that,0,0
238767,in,0,0
238768,the,0,0
238769,placebo,0,0
238770,group,0,0
238771,.,0,0
238772,The,0,0
238773,development,0,0
238774,of,0,0
238775,symptoms,0,0
238776,",",0,0
238777,number,0,0
238778,of,0,0
238779,episodes,0,0
238780,of,0,0
238781,ulcer-related,0,0
238782,pain,0,0
238783,",",0,0
238784,total,0,1
238785,ulcerated,0,0
238786,surface,0,0
238787,area,0,0
238788,or,0,0
238789,subjective,0,0
238790,ratings,0,0
238791,by,0,0
238792,the,0,0
238793,patients,0,1
238794,and,0,0
238795,investigators,0,0
238796,also,0,0
238797,differed,0,0
238798,significantly,0,0
238799,between,0,0
238800,ebrotidine,0,0
238801,(,0,0
238802,400,0,0
238803,",",0,0
238804,600,0,0
238805,and,0,0
238806,800,0,0
238807,mg,0,0
238808,daily,0,0
238809,),0,0
238810,and,0,0
238811,placebo,0,0
238812,",",0,0
238813,and,0,0
238814,again,0,0
238815,",",0,0
238816,no,0,0
238817,marked,0,0
238818,differences,0,0
238819,were,0,0
238820,found,0,0
238821,between,0,0
238822,these,0,0
238823,three,0,0
238824,doses,0,0
238825,of,0,0
238826,ebrotidine,0,0
238827,.,0,0
238828,As,0,0
238829,far,0,0
238830,as,0,0
238831,tolerance,0,0
238832,is,0,0
238833,concerned,0,0
238834,",",0,0
238835,no,0,0
238836,clinically,0,0
238837,or,0,0
238838,statistically,0,0
238839,significant,0,0
238840,changes,0,0
238841,were,0,0
238842,observed,0,0
238843,in,0,0
238844,vital,0,0
238845,signs,0,0
238846,and,0,0
238847,analytical,0,0
238848,parameters,0,0
238849,.,0,0
238850,The,0,0
238851,incidence,0,0
238852,of,0,0
238853,side,0,0
238854,effects,0,0
238855,was,0,0
238856,less,0,0
238857,than,0,0
238858,that,0,0
238859,presented,0,0
238860,by,0,0
238861,the,0,0
238862,placebo,0,0
238863,group,0,0
238864,",",0,0
238865,possibly,0,0
238866,due,0,0
238867,to,0,0
238868,a,0,0
238869,greater,0,0
238870,consumption,0,0
238871,of,0,0
238872,antacids,0,0
238873,in,0,0
238874,this,0,0
238875,group,0,0
238876,.,0,0
238877,Results,0,0
238878,showed,0,0
238879,that,0,0
238880,a,0,0
238881,daily,0,0
238882,dose,0,0
238883,of,0,0
238884,400,0,0
238885,mg,0,0
238886,ebrotidine,0,0
238887,is,0,0
238888,effective,0,0
238889,and,0,0
238890,safe,0,0
238891,in,0,0
238892,the,0,0
238893,treatment,0,0
238894,of,0,0
238895,duodenal,0,1
238896,ulcers,0,1
238897,.,0,1
238898,Efficacy,0,0
238899,of,0,0
238900,ebrotidine,0,0
238901,and,0,0
238902,ranitidine,0,0
238903,combined,0,0
238904,with,0,0
238905,amoxicillin,0,0
238906,and,0,0
238907,metronidazole,0,0
238908,in,0,0
238909,the,0,0
238910,eradication,0,0
238911,of,0,0
238912,Helicobacter,0,1
238913,pylori,0,1
238914,in,0,0
238915,patients,1,1
238916,with,1,1
238917,duodenal,1,1
238918,ulcer,1,1
238919,.,1,0
238920,This,0,0
238921,double-blind,0,0
238922,",",0,0
238923,randomized,0,0
238924,",",0,0
238925,phase,0,0
238926,III,0,0
238927,clinical,0,0
238928,trial,0,0
238929,was,0,0
238930,carried,0,0
238931,out,0,0
238932,in,0,0
238933,two,1,0
238934,parallel,1,0
238935,groups,1,0
238936,to,0,0
238937,assess,0,0
238938,the,0,0
238939,efficacy,0,0
238940,of,0,0
238941,ebrotidine,0,0
238942,(,0,0
238943,N-,0,0
238944,[,0,0
238945,(,0,0
238946,E,0,0
238947,),0,0
238948,-,0,0
238949,[,0,0
238950,[,0,0
238951,2-,0,0
238952,[,0,0
238953,[,0,0
238954,[,0,0
238955,2-,0,0
238956,[,0,0
238957,(,0,0
238958,diaminomethylene,0,0
238959,),0,0
238960,amino,0,0
238961,],0,0
238962,-4-thiazolyl,0,0
238963,],0,0
238964,methyl,0,0
238965,],0,0
238966,thio,0,0
238967,],0,0
238968,ethyl,0,0
238969,],0,0
238970,amino,0,0
238971,],0,0
238972,methylene,0,0
238973,],0,0
238974,-4-bromo-benzenesulfonamide,0,0
238975,",",0,0
238976,CAS,0,0
238977,100981-43-9,0,0
238978,",",0,0
238979,FI-3542,0,1
238980,),0,0
238981,400,0,0
238982,mg,0,0
238983,and,0,0
238984,ranitidine,0,0
238985,300,0,0
238986,mg,0,0
238987,given,0,0
238988,in,0,0
238989,single,0,0
238990,evening,0,0
238991,dose,0,0
238992,",",0,0
238993,combined,0,0
238994,with,0,1
238995,amoxicillin,0,0
238996,750,0,0
238997,mg,0,0
238998,and,0,0
238999,metronidazole,0,0
239000,500,0,0
239001,mg,0,0
239002,three,0,0
239003,times,0,0
239004,daily,0,0
239005,for,0,0
239006,14,0,0
239007,days,0,0
239008,",",0,0
239009,in,0,0
239010,the,0,0
239011,eradication,0,0
239012,of,0,0
239013,Helicobacter,0,1
239014,pylori,0,1
239015,in,0,0
239016,patients,1,1
239017,with,1,1
239018,duodenal,1,1
239019,ulcer,1,1
239020,.,1,0
239021,Thirty,1,1
239022,patients,1,1
239023,were,1,0
239024,included,1,1
239025,",",1,0
239026,divided,1,0
239027,into,1,0
239028,two,1,0
239029,groups,1,0
239030,of,1,0
239031,15,1,0
239032,",",1,1
239033,to,1,0
239034,whom,1,1
239035,one,1,1
239036,of,1,1
239037,the,1,0
239038,study,1,0
239039,therapies,1,0
239040,was,1,0
239041,administered,1,0
239042,based,1,0
239043,on,1,0
239044,a,1,0
239045,randomization,1,0
239046,code,1,0
239047,.,1,0
239048,Clinical,0,0
239049,and,0,0
239050,endoscopic,0,1
239051,controls,0,1
239052,were,0,0
239053,performed,0,0
239054,4,0,0
239055,",",0,0
239056,6,0,0
239057,and,0,0
239058,8,0,0
239059,weeks,0,0
239060,after,0,0
239061,the,0,0
239062,onset,0,0
239063,of,0,0
239064,the,0,0
239065,treatment,0,0
239066,.,0,0
239067,No,0,0
239068,differences,0,0
239069,were,0,0
239070,seen,0,0
239071,between,0,0
239072,the,0,0
239073,two,0,0
239074,treatment,0,0
239075,groups,0,0
239076,with,0,1
239077,regard,0,0
239078,to,0,0
239079,demographic,0,0
239080,parameters,0,0
239081,and,0,0
239082,clinical,0,0
239083,histories,0,1
239084,.,0,1
239085,They,0,0
239086,were,0,0
239087,both,0,0
239088,perfectly,0,0
239089,homogeneous,0,0
239090,.,0,0
239091,There,0,0
239092,were,0,0
239093,no,0,0
239094,differences,0,0
239095,between,0,0
239096,the,0,0
239097,eradication,0,0
239098,of,0,0
239099,both,0,0
239100,therapies,0,0
239101,in,0,0
239102,both,0,0
239103,the,0,0
239104,antrum,0,0
239105,and,0,0
239106,gastric,0,1
239107,body,0,0
239108,samples,0,0
239109,(,0,0
239110,over,0,0
239111,80,0,0
239112,%,0,0
239113,eradication,0,0
239114,),0,0
239115,",",0,0
239116,allowing,0,0
239117,the,0,0
239118,results,0,0
239119,to,0,0
239120,be,0,0
239121,classified,0,1
239122,as,0,0
239123,satisfactory,0,0
239124,.,0,0
239125,Moreover,0,0
239126,",",0,0
239127,perfect,0,0
239128,control,0,0
239129,was,0,0
239130,achieved,0,0
239131,through,0,0
239132,the,0,0
239133,study,0,0
239134,of,0,0
239135,clinical,0,0
239136,symptoms,0,0
239137,",",0,0
239138,which,0,0
239139,even,0,0
239140,disappeared,0,0
239141,in,0,0
239142,some,0,0
239143,cases,0,0
239144,.,0,0
239145,There,0,0
239146,were,0,0
239147,no,0,0
239148,differences,0,0
239149,in,0,0
239150,the,0,0
239151,healing,0,0
239152,rate,0,0
239153,of,0,0
239154,the,0,0
239155,duodenal,0,1
239156,ulcer,0,0
239157,after,0,0
239158,four,0,0
239159,weeks,0,0
239160,",",0,0
239161,86.7,0,0
239162,%,0,0
239163,being,0,0
239164,achieved,0,0
239165,for,0,0
239166,both,0,0
239167,groups,0,0
239168,.,0,0
239169,The,0,0
239170,benefit,0,0
239171,of,0,0
239172,low-dose,0,0
239173,dopamine,0,0
239174,during,0,0
239175,vigorous,0,0
239176,diuresis,0,0
239177,for,0,0
239178,congestive,1,1
239179,heart,1,1
239180,failure,1,1
239181,associated,1,0
239182,with,1,0
239183,renal,1,1
239184,insufficiency,1,1
239185,:,1,0
239186,does,0,0
239187,it,0,0
239188,protect,0,0
239189,renal,0,1
239190,function,0,0
239191,?,0,0
239192,BACKGROUND,0,0
239193,Low-dose,0,0
239194,dopamine,0,0
239195,",",0,0
239196,a,0,0
239197,renal,0,0
239198,vasodilator,0,0
239199,",",0,0
239200,has,0,0
239201,been,0,0
239202,used,0,0
239203,empirically,0,0
239204,to,0,0
239205,improve,0,0
239206,renal,0,0
239207,function,0,0
239208,or,0,0
239209,outcome,0,0
239210,in,0,0
239211,critically,1,0
239212,ill,1,1
239213,patients,1,1
239214,with,1,1
239215,oliguria,1,1
239216,or,1,1
239217,acute,1,1
239218,renal,1,1
239219,failure,1,1
239220,.,1,0
239221,HYPOTHESIS,0,0
239222,This,0,0
239223,study,0,0
239224,was,0,0
239225,designed,0,0
239226,to,0,0
239227,investigate,0,0
239228,the,0,0
239229,efficacy,0,0
239230,of,0,0
239231,low-dose,0,0
239232,dopamine,0,0
239233,(,0,0
239234,2,0,0
239235,micrograms/kg/min,0,0
239236,),0,0
239237,as,0,0
239238,a,0,0
239239,renal-protective,0,0
239240,agent,0,0
239241,during,0,0
239242,vigorous,0,0
239243,diuresis,0,0
239244,for,0,0
239245,congestive,0,1
239246,heart,0,1
239247,failure,0,1
239248,(,0,0
239249,CHF,0,1
239250,),0,0
239251,associated,0,0
239252,with,0,0
239253,mild,0,1
239254,or,0,0
239255,moderate,0,1
239256,renal,0,1
239257,insufficiency,0,1
239258,.,0,0
239259,METHODS,0,0
239260,Of,0,0
239261,20,1,1
239262,study,1,0
239263,patients,1,1
239264,(,1,0
239265,mean,1,1
239266,age,1,1
239267,74.3,1,0
239268,+/-,1,0
239269,15,1,1
239270,years,1,1
239271,),1,0
239272,with,1,1
239273,severe,1,1
239274,CHF,1,1
239275,",",1,0
239276,10,1,0
239277,(,1,0
239278,Group,1,1
239279,A,1,0
239280,),1,0
239281,were,0,0
239282,randomized,0,0
239283,to,0,0
239284,a,0,0
239285,treatment,0,0
239286,strategy,0,0
239287,of,0,0
239288,intravenous,0,0
239289,bumetanide,0,0
239290,(,0,0
239291,1,0,0
239292,mg,0,0
239293,b.i.d,0,0
239294,.,0,0
239295,),0,0
239296,alone,0,0
239297,and,0,0
239298,another,0,0
239299,10,0,0
239300,(,0,0
239301,Group,0,1
239302,B,0,0
239303,),0,0
239304,to,0,0
239305,low-dose,0,0
239306,dopamine,0,0
239307,and,0,0
239308,a,0,0
239309,similar,0,0
239310,diuretic,0,0
239311,regimen,0,0
239312,for,0,0
239313,a,0,0
239314,duration,0,0
239315,of,0,0
239316,5,0,0
239317,days,0,0
239318,or,0,1
239319,less,0,0
239320,if,0,0
239321,clinical,0,0
239322,edema,0,0
239323,remitted,0,1
239324,.,0,0
239325,RESULTS,0,0
239326,Group,0,0
239327,B,0,0
239328,patients,0,1
239329,showed,0,0
239330,a,0,0
239331,significant,0,0
239332,improvement,0,0
239333,in,0,0
239334,renal,0,0
239335,function,0,0
239336,and,0,0
239337,urinary,0,0
239338,output,0,0
239339,:,0,1
239340,serum,0,0
239341,blood,0,0
239342,urea,0,0
239343,nitrogen,0,0
239344,48.9,0,0
239345,+/-,0,0
239346,10.3,0,0
239347,to,0,0
239348,32.1,0,0
239349,+/-,0,0
239350,14.4,0,0
239351,mg/dl,0,0
239352,(,0,0
239353,p,0,0
239354,<,0,0
239355,0.05,0,0
239356,),0,0
239357,;,0,0
239358,serum,0,0
239359,creatinine,0,0
239360,1.97,0,0
239361,+/-,0,0
239362,0.24,0,0
239363,to,0,0
239364,1.49,0,0
239365,+/-,0,0
239366,0.39,0,0
239367,mg/dl,0,0
239368,(,0,0
239369,p,0,0
239370,<,0,0
239371,0.05,0,0
239372,),0,0
239373,;,0,0
239374,creatinine,0,0
239375,clearance,0,0
239376,35.6,0,0
239377,+/-,0,0
239378,11.6,0,0
239379,to,0,0
239380,48.8,0,0
239381,+/-,0,0
239382,12.3,0,0
239383,ml/min,0,0
239384,(,0,0
239385,p,0,0
239386,<,0,0
239387,0.05,0,0
239388,),0,0
239389,;,0,0
239390,and,0,0
239391,indexed,0,0
239392,urinary,0,0
239393,output,0,0
239394,0.56,0,0
239395,+/-,0,0
239396,0.16,0,0
239397,to,0,0
239398,2.02,0,0
239399,+/-,0,0
239400,0.72,0,0
239401,ml/kg/h,0,0
239402,(,0,0
239403,p,0,0
239404,<,0,0
239405,0.05,0,0
239406,),0,0
239407,.,0,0
239408,Group,0,0
239409,A,0,0
239410,patients,0,1
239411,showed,0,0
239412,a,0,0
239413,significant,0,0
239414,increase,0,0
239415,in,0,0
239416,urinary,0,0
239417,output,0,0
239418,but,0,0
239419,nonsignificant,0,0
239420,renal,0,1
239421,functional,0,0
239422,deterioration,0,0
239423,.,0,0
239424,CONCLUSION,0,0
239425,The,0,0
239426,renal-protective,0,0
239427,effect,0,0
239428,of,0,0
239429,low-dose,0,0
239430,dopamine,0,0
239431,in,0,0
239432,the,0,0
239433,setting,0,0
239434,of,0,0
239435,CHF,0,1
239436,and,0,0
239437,vigorous,0,0
239438,diuresis,0,0
239439,is,0,0
239440,supported,0,0
239441,by,0,0
239442,this,0,0
239443,study,0,0
239444,.,0,0
239445,Gonadotropin-releasing,0,0
239446,hormone,0,0
239447,agonist,0,0
239448,in,0,0
239449,the,0,0
239450,treatment,0,0
239451,of,0,0
239452,premenstrual,0,1
239453,symptoms,0,0
239454,with,0,1
239455,and,0,0
239456,without,0,0
239457,ongoing,0,0
239458,dysphoria,0,1
239459,:,0,1
239460,a,0,0
239461,controlled,0,0
239462,study,0,0
239463,.,0,0
239464,Gonadotropin-releasing,0,0
239465,hormone,0,0
239466,(,0,0
239467,GnRH,0,0
239468,),0,0
239469,agonists,0,0
239470,have,0,0
239471,been,0,0
239472,shown,0,0
239473,to,0,0
239474,reduce,0,0
239475,symptoms,0,0
239476,of,0,0
239477,premenstrual,0,1
239478,syndrome,0,1
239479,(,0,0
239480,PMS,0,0
239481,),0,0
239482,.,0,0
239483,This,0,0
239484,randomized,0,0
239485,",",0,0
239486,placebo-controlled,0,0
239487,study,0,0
239488,examined,0,0
239489,the,0,0
239490,efficacy,0,0
239491,of,0,0
239492,the,0,0
239493,GnRH,0,0
239494,agonist,0,0
239495,",",0,0
239496,leuprolide,0,0
239497,acetate,0,0
239498,depot,0,0
239499,",",0,0
239500,in,0,0
239501,a,0,0
239502,clearly,1,0
239503,defined,1,0
239504,PMS,1,0
239505,sample,1,1
239506,versus,1,0
239507,women,1,1
239508,with,1,1
239509,premenstrual,1,1
239510,symptoms,1,0
239511,in,1,0
239512,combination,1,0
239513,with,1,1
239514,dysphoric,1,1
239515,symptoms,1,0
239516,throughout,1,0
239517,the,1,0
239518,cycle,1,0
239519,",",1,0
239520,termed,1,0
239521,the,1,0
239522,premenstrual,1,0
239523,exacerbation,1,1
239524,(,1,0
239525,PME,1,0
239526,),1,0
239527,group,1,0
239528,.,1,0
239529,Evaluation,0,0
239530,included,0,0
239531,the,0,0
239532,Structured,0,0
239533,Clinical,0,0
239534,Interview,0,1
239535,for,0,0
239536,DSM-III-R,0,0
239537,",",0,0
239538,administered,0,0
239539,in,0,0
239540,the,0,0
239541,follicular,0,0
239542,phase,0,0
239543,",",0,0
239544,and,0,0
239545,the,0,0
239546,subject,0,0
239547,Penn,0,1
239548,Dally,0,1
239549,Symptoms,0,0
239550,Report,0,0
239551,(,0,0
239552,DSR,0,0
239553,),0,0
239554,maintained,0,0
239555,throughout,0,0
239556,the,0,0
239557,study,0,0
239558,.,0,0
239559,Thirty-three,1,1
239560,eligible,1,1
239561,women,1,1
239562,were,0,0
239563,randomized,0,0
239564,to,0,0
239565,double-blind,0,0
239566,treatment,0,0
239567,and,0,0
239568,administered,0,0
239569,3.75,0,0
239570,mg,0,0
239571,of,0,0
239572,depot,0,0
239573,leuprolide,0,0
239574,or,0,0
239575,a,0,0
239576,placebo,0,0
239577,once,0,0
239578,a,0,0
239579,month,0,0
239580,for,0,0
239581,3,0,0
239582,months,0,0
239583,.,0,1
239584,The,0,0
239585,subjects,0,1
239586,were,0,0
239587,seen,0,0
239588,for,0,0
239589,efficacy,0,0
239590,evaluations,0,0
239591,at,0,0
239592,the,0,0
239593,end,0,0
239594,of,0,0
239595,each,0,0
239596,cycle,0,0
239597,.,0,0
239598,Outcome,0,0
239599,measures,0,0
239600,were,0,0
239601,the,0,0
239602,DSRs,0,0
239603,and,0,0
239604,the,0,0
239605,17-item,0,0
239606,Hamilton,0,0
239607,Depression,0,0
239608,Rating,0,0
239609,Scale,0,0
239610,(,0,0
239611,HAM-D17,0,0
239612,),0,0
239613,.,0,0
239614,The,0,0
239615,PMS,0,0
239616,leuprolide,0,0
239617,subjects,0,1
239618,improved,0,0
239619,significantly,0,0
239620,compared,0,0
239621,with,0,0
239622,the,0,0
239623,PMS,0,0
239624,placebo,0,0
239625,and,0,0
239626,PME,0,0
239627,leuprolide,0,0
239628,groups,0,0
239629,.,0,0
239630,The,0,0
239631,PME,0,0
239632,leuprolide,0,0
239633,group,0,1
239634,",",0,0
239635,who,0,1
239636,had,0,1
239637,dysphoric,0,1
239638,symptoms,0,0
239639,throughout,0,0
239640,the,0,0
239641,cycle,0,0
239642,",",0,0
239643,did,0,0
239644,not,0,0
239645,improve,0,0
239646,.,0,0
239647,Depression,0,0
239648,symptoms,0,0
239649,were,0,0
239650,at,0,0
239651,clinical,0,0
239652,levels,0,0
239653,premenstrually,0,1
239654,in,0,0
239655,the,0,0
239656,PMS,0,0
239657,and,0,0
239658,PME,0,0
239659,groups,0,0
239660,;,0,0
239661,following,0,0
239662,treatment,0,0
239663,they,0,0
239664,remitted,0,1
239665,in,0,0
239666,the,0,0
239667,PMS,0,0
239668,group,0,0
239669,but,0,0
239670,not,0,0
239671,in,0,0
239672,the,0,0
239673,PME,0,0
239674,leuprolide,0,0
239675,subjects,0,1
239676,.,0,1
239677,Efficacy,0,0
239678,did,0,0
239679,not,0,0
239680,occur,0,0
239681,until,0,0
239682,after,0,0
239683,several,0,0
239684,months,0,0
239685,of,0,0
239686,leuprolide,0,0
239687,treatment,0,0
239688,",",0,0
239689,but,0,0
239690,there,0,0
239691,was,0,0
239692,no,0,0
239693,evidence,0,0
239694,that,0,0
239695,PMS,0,0
239696,symptoms,0,0
239697,worsened,0,0
239698,with,0,1
239699,the,0,0
239700,onset,0,0
239701,of,0,0
239702,treatment,0,0
239703,.,0,0
239704,These,0,0
239705,results,0,0
239706,replicate,0,0
239707,the,0,0
239708,findings,0,0
239709,in,0,0
239710,our,0,0
239711,preliminary,0,0
239712,open-label,0,0
239713,study,0,0
239714,.,0,0
239715,Leuprolide,0,0
239716,reduced,0,0
239717,PMS,0,0
239718,symptoms,0,0
239719,to,0,0
239720,minimal,0,0
239721,levels,0,0
239722,where,0,0
239723,symptoms,0,0
239724,were,0,0
239725,limited,0,0
239726,to,0,0
239727,the,0,0
239728,luteal,0,0
239729,phase,0,0
239730,.,0,0
239731,Leuprolide,0,0
239732,was,0,0
239733,not,0,0
239734,effective,0,0
239735,for,0,0
239736,women,0,1
239737,with,0,1
239738,ongoing,0,0
239739,dysphoric,0,1
239740,symptoms,0,0
239741,",",0,0
239742,suggesting,0,0
239743,that,0,0
239744,premenstrual,0,0
239745,depression,0,0
239746,may,0,0
239747,have,0,0
239748,mechanisms,0,0
239749,different,0,0
239750,from,0,0
239751,those,0,0
239752,of,0,0
239753,other,0,0
239754,dysphoric,0,1
239755,mood,0,0
239756,disorders,0,1
239757,.,0,1
239758,Safety,0,0
239759,of,0,0
239760,nifedipine,0,0
239761,in,0,0
239762,patients,1,1
239763,with,1,1
239764,hypertension,1,1
239765,:,1,1
239766,a,0,0
239767,meta-analysis,0,0
239768,.,0,0
239769,Our,0,0
239770,objective,0,0
239771,was,0,0
239772,to,0,0
239773,compare,0,0
239774,cardiovascular,0,0
239775,event,0,0
239776,rates,0,0
239777,in,0,0
239778,patients,1,1
239779,with,1,1
239780,mild,1,1
239781,or,1,0
239782,moderate,1,1
239783,hypertension,1,1
239784,who,1,1
239785,received,1,1
239786,nifedipine,1,0
239787,with,1,1
239788,active,1,1
239789,drug,1,0
239790,controls,1,1
239791,.,1,0
239792,We,0,0
239793,performed,0,0
239794,a,0,0
239795,MEDLARS,1,0
239796,search,1,0
239797,using,1,0
239798,the,1,0
239799,MeSH,1,0
239800,heading,1,0
239801,hypertension,1,1
239802,and,1,0
239803,the,1,0
239804,text,1,0
239805,word,1,0
239806,nifedipine,1,0
239807,to,1,0
239808,identify,1,0
239809,all,1,0
239810,articles,1,0
239811,that,1,0
239812,were,1,0
239813,published,1,0
239814,between,1,0
239815,1966,1,1
239816,and,1,0
239817,August,1,1
239818,1995,1,1
239819,in,1,0
239820,English,1,0
239821,",",1,0
239822,French,1,0
239823,",",1,0
239824,German,1,1
239825,",",1,0
239826,Italian,1,0
239827,",",1,0
239828,and,1,0
239829,Spanish,1,1
239830,languages,1,0
239831,and,1,0
239832,that,1,0
239833,involved,1,0
239834,human,1,0
239835,subjects,1,1
239836,.,1,0
239837,The,0,0
239838,computerized,0,0
239839,search,0,0
239840,was,0,0
239841,supplemented,0,0
239842,by,0,0
239843,a,0,0
239844,manual,0,0
239845,search,0,0
239846,of,0,0
239847,article,0,0
239848,bibliographies,0,0
239849,.,0,0
239850,Review,1,0
239851,of,1,0
239852,1880,1,0
239853,citations,1,0
239854,revealed,1,0
239855,98,1,1
239856,randomized,1,0
239857,controlled,1,0
239858,clinical,1,0
239859,trials,1,0
239860,that,1,0
239861,met,1,1
239862,protocol,1,0
239863,criteria,1,1
239864,.,1,1
239865,Articles,1,0
239866,were,1,0
239867,extracted,1,0
239868,independently,1,0
239869,by,1,0
239870,two,1,1
239871,doctors,1,1
239872,who,1,1
239873,were,1,1
239874,blinded,1,1
239875,for,1,0
239876,author,1,0
239877,",",1,0
239878,institution,1,0
239879,",",1,0
239880,and,1,0
239881,treatment,1,0
239882,regimen,1,0
239883,",",1,0
239884,using,1,0
239885,a,1,0
239886,structured,1,0
239887,",",1,0
239888,pretested,1,0
239889,extraction,1,0
239890,form,1,0
239891,.,1,0
239892,Differences,0,0
239893,of,0,0
239894,opinion,0,0
239895,were,0,0
239896,resolved,0,0
239897,by,0,0
239898,consensus,0,0
239899,.,0,0
239900,Fourteen,0,1
239901,events,0,0
239902,occurred,0,0
239903,in,0,0
239904,5198,0,1
239905,exposures,0,0
239906,(,0,0
239907,0.27,0,0
239908,%,0,0
239909,),0,0
239910,to,0,0
239911,nifedipine,0,0
239912,and,0,0
239913,24,0,0
239914,events,0,0
239915,in,0,0
239916,5402,0,1
239917,exposures,0,0
239918,(,0,0
239919,0.44,0,0
239920,%,0,0
239921,),0,0
239922,to,0,0
239923,other,0,0
239924,active,0,0
239925,drug,0,0
239926,controls,0,1
239927,.,0,0
239928,Unadjusted,0,0
239929,odds,0,0
239930,ratios,0,0
239931,for,0,0
239932,nifedipine,0,0
239933,versus,0,0
239934,controls,0,1
239935,were,0,0
239936,0.49,0,0
239937,(,0,0
239938,95,0,0
239939,%,0,0
239940,confidence,0,0
239941,interval,0,0
239942,[,0,0
239943,CI,0,0
239944,],0,0
239945,",",0,0
239946,0.22-1.09,0,0
239947,),0,0
239948,for,0,0
239949,definitive,0,0
239950,events,0,0
239951,(,0,0
239952,death,0,0
239953,",",0,0
239954,nonfatal,0,0
239955,myocardial,0,0
239956,infarction,0,1
239957,or,0,0
239958,stroke,0,0
239959,",",0,0
239960,revascularization,0,0
239961,procedure,0,0
239962,),0,0
239963,and,0,0
239964,0.61,0,0
239965,(,0,0
239966,95,0,0
239967,%,0,0
239968,CI,0,0
239969,",",0,0
239970,0.31-1.17,0,0
239971,),0,0
239972,for,0,0
239973,all,0,0
239974,events,0,0
239975,(,0,0
239976,definitive,0,0
239977,plus,0,0
239978,increased,0,0
239979,angina,0,1
239980,),0,0
239981,.,0,0
239982,The,0,0
239983,odds,0,0
239984,ratio,0,0
239985,for,0,0
239986,nifedipine,0,0
239987,monotherapy,0,0
239988,(,0,0
239989,sustained-,0,0
239990,or,0,0
239991,extended-release,0,0
239992,in,0,0
239993,91,0,0
239994,%,0,0
239995,of,0,0
239996,exposures,0,0
239997,),0,0
239998,was,0,0
239999,nonsignificantly,0,0
240000,higher,0,0
240001,for,0,0
240002,definitive,0,0
240003,and,0,0
240004,all,0,0
240005,events,0,0
240006,(,0,0
240007,odds,0,0
240008,ratio,0,0
240009,",",0,0
240010,1.40,0,0
240011,;,0,0
240012,95,0,0
240013,%,0,0
240014,CI,0,0
240015,",",0,0
240016,0.49-4.03,0,0
240017,and,0,0
240018,odds,0,0
240019,ratio,0,0
240020,",",0,0
240021,1.39,0,0
240022,;,0,0
240023,95,0,0
240024,%,0,0
240025,CI,0,0
240026,",",0,0
240027,0.59-3.32,0,0
240028,",",0,0
240029,respectively,0,0
240030,),0,0
240031,.,0,0
240032,The,0,0
240033,odds,0,0
240034,ratio,0,0
240035,for,0,0
240036,nifedipine,0,0
240037,in,0,0
240038,combination,0,0
240039,with,0,0
240040,another,0,0
240041,drug,0,0
240042,was,0,0
240043,significantly,0,0
240044,lower,0,0
240045,for,0,0
240046,definitive,0,0
240047,and,0,0
240048,all,0,0
240049,events,0,0
240050,(,0,0
240051,odds,0,0
240052,ratio,0,0
240053,",",0,0
240054,0.09,0,0
240055,;,0,0
240056,95,0,0
240057,%,0,0
240058,CI,0,0
240059,",",0,0
240060,0.01-0.66,0,0
240061,and,0,0
240062,odds,0,0
240063,ratio,0,0
240064,",",0,0
240065,0.15,0,0
240066,;,0,0
240067,95,0,0
240068,%,0,0
240069,CI,0,0
240070,",",0,0
240071,0.03-0.65,0,0
240072,",",0,0
240073,respectively,0,0
240074,),0,0
240075,.,0,0
240076,Differences,0,0
240077,in,0,0
240078,odds,0,0
240079,ratio,0,0
240080,for,0,0
240081,nifedipine,0,0
240082,monotherapy,0,0
240083,and,0,0
240084,combined,0,0
240085,therapy,0,0
240086,were,0,0
240087,statistically,0,0
240088,significant,0,0
240089,(,0,0
240090,P=.02,0,0
240091,for,0,0
240092,definitive,0,0
240093,events,0,0
240094,and,0,0
240095,P=.001,0,0
240096,for,0,0
240097,all,0,0
240098,events,0,0
240099,),0,0
240100,.,0,0
240101,Results,0,0
240102,support,0,0
240103,the,0,0
240104,safety,0,0
240105,of,0,0
240106,sustained-,0,0
240107,and,0,0
240108,extended-release,0,0
240109,nifedipine,0,0
240110,in,0,0
240111,the,0,0
240112,treatment,0,0
240113,of,0,0
240114,mild,0,1
240115,or,0,0
240116,moderate,0,1
240117,hypertension,0,1
240118,when,0,0
240119,it,0,0
240120,is,0,0
240121,used,0,0
240122,in,0,0
240123,combination,0,0
240124,with,0,1
240125,other,0,0
240126,drugs,0,0
240127,.,0,1
240128,[,0,0
240129,Clinical,0,0
240130,diagnosis,0,1
240131,of,0,0
240132,deep,0,0
240133,venous,0,0
240134,thrombosis,0,1
240135,after,0,0
240136,hip,0,1
240137,replacement,0,0
240138,surgery,0,1
240139,],0,0
240140,.,0,0
240141,Hip,0,0
240142,replacement,0,0
240143,surgery,0,1
240144,is,0,0
240145,associated,0,0
240146,with,0,0
240147,a,0,0
240148,high,0,0
240149,frequency,0,0
240150,of,0,0
240151,postoperative,0,0
240152,deep,0,0
240153,vein,0,1
240154,thrombosis,0,1
240155,.,0,0
240156,This,0,0
240157,prospective,0,0
240158,study,0,0
240159,was,0,0
240160,performed,0,0
240161,in,0,0
240162,order,0,0
240163,to,0,0
240164,investigate,0,0
240165,if,0,0
240166,routine,0,0
240167,bedside,0,0
240168,questioning,0,0
240169,and,0,0
240170,examination,0,0
240171,by,0,0
240172,the,0,0
240173,visiting,0,0
240174,doctor,0,0
240175,could,0,0
240176,reveal,0,0
240177,deep,0,0
240178,vein,0,0
240179,thrombosis,0,1
240180,in,0,0
240181,the,0,0
240182,legs,0,0
240183,of,0,0
240184,patients,1,1
240185,who,1,1
240186,had,1,1
240187,received,1,1
240188,a,1,0
240189,hip,1,0
240190,replacement,1,0
240191,.,1,0
240192,258,1,1
240193,patients,1,1
240194,were,1,0
240195,evaluated,1,0
240196,.,1,0
240197,Thromboprophylaxis,0,0
240198,(,0,0
240199,dextran-70,0,0
240200,",",0,0
240201,low,0,0
240202,molecular,0,0
240203,weight,0,0
240204,heparin,0,0
240205,and,0,0
240206,graded,0,0
240207,elastic,0,0
240208,stockings,0,0
240209,),0,0
240210,was,0,0
240211,given,0,0
240212,during,0,0
240213,the,0,0
240214,first,0,0
240215,week,0,0
240216,after,0,0
240217,operation,0,0
240218,.,0,0
240219,Bilateral,0,0
240220,venography,0,0
240221,was,0,0
240222,performed,0,0
240223,in,0,0
240224,all,0,0
240225,patients,0,1
240226,on,0,0
240227,day,0,0
240228,seven,0,0
240229,after,0,0
240230,operation,0,0
240231,",",0,0
240232,and,0,0
240233,showed,0,0
240234,an,0,0
240235,overall,0,0
240236,deep,0,0
240237,vein,0,0
240238,thrombosis,0,1
240239,incidence,0,0
240240,of,0,0
240241,16,0,1
240242,%,0,0
240243,.,0,0
240244,The,0,0
240245,visiting,0,0
240246,doctors,0,1
240247,had,0,0
240248,not,0,0
240249,suspected,0,1
240250,deep,0,0
240251,vein,0,0
240252,thrombosis,0,1
240253,in,0,0
240254,any,0,0
240255,of,0,0
240256,the,0,0
240257,patients,0,1
240258,.,0,0
240259,This,0,0
240260,may,0,0
240261,have,0,0
240262,been,0,0
240263,because,0,0
240264,postoperative,0,0
240265,painful,0,0
240266,and,0,0
240267,swollen,0,1
240268,legs,0,0
240269,effectively,0,0
240270,masked,0,0
240271,any,0,0
240272,signs,0,0
240273,and,0,0
240274,symptoms,0,0
240275,of,0,0
240276,deep,0,1
240277,vein,0,1
240278,thrombosis,0,1
240279,.,0,0
240280,Our,0,0
240281,results,0,0
240282,show,0,0
240283,that,0,0
240284,deep,0,0
240285,vein,0,0
240286,thrombosis,0,1
240287,during,0,0
240288,the,0,0
240289,first,0,0
240290,week,0,0
240291,after,0,0
240292,hip,0,1
240293,replacement,0,0
240294,surgery,0,0
240295,can,0,0
240296,not,0,0
240297,be,0,0
240298,discovered,0,0
240299,by,0,0
240300,clinical,0,0
240301,diagnostics,0,0
240302,.,0,0
240303,The,0,0
240304,high,0,0
240305,subclinical,0,0
240306,frequency,0,0
240307,of,0,0
240308,deep,0,0
240309,vein,0,0
240310,thrombosis,0,0
240311,indicates,0,0
240312,the,0,0
240313,importance,0,0
240314,of,0,0
240315,improving,0,0
240316,thromboprophylaxis,0,0
240317,in,0,0
240318,order,0,0
240319,to,0,0
240320,further,0,0
240321,minimise,0,0
240322,the,0,0
240323,occurrence,0,0
240324,of,0,0
240325,deep,0,0
240326,vein,0,0
240327,thrombosis,0,1
240328,and,0,0
240329,the,0,0
240330,risk,0,0
240331,of,0,0
240332,thromboembolic,0,0
240333,complications,0,0
240334,.,0,1
240335,Active,0,0
240336,warming,0,0
240337,",",0,0
240338,not,0,0
240339,passive,0,0
240340,heat,0,0
240341,retention,0,0
240342,",",0,0
240343,maintains,0,0
240344,normothermia,0,0
240345,during,0,0
240346,combined,0,0
240347,epidural-general,0,0
240348,anesthesia,0,0
240349,for,0,0
240350,hip,1,1
240351,and,1,0
240352,knee,1,1
240353,arthroplasty,1,1
240354,.,1,0
240355,STUDY,0,0
240356,OBJECTIVE,0,0
240357,to,0,0
240358,compare,0,0
240359,passive,0,0
240360,heat,0,0
240361,retention,0,0
240362,by,0,0
240363,low-flow,0,0
240364,anesthesia,0,0
240365,",",0,0
240366,alone,0,0
240367,and,0,0
240368,with,0,0
240369,additional,0,0
240370,thermal,0,0
240371,insulation,0,0
240372,by,0,0
240373,reflective,0,0
240374,blankets,0,0
240375,",",0,0
240376,with,0,1
240377,forced-air,0,0
240378,warming,0,0
240379,preventing,0,0
240380,intraoperative,0,0
240381,hypothermia,0,1
240382,during,0,0
240383,combined,0,0
240384,epidural-general,0,0
240385,anesthesia,0,1
240386,.,0,0
240387,DESIGN,0,0
240388,Randomized,0,0
240389,",",0,0
240390,controlled,0,0
240391,study,0,0
240392,.,0,0
240393,SETTING,0,0
240394,Inpatient,1,0
240395,anesthesia,1,0
240396,at,1,0
240397,a,1,0
240398,university,1,1
240399,department,1,1
240400,of,1,0
240401,orthopedic,1,1
240402,surgery,1,1
240403,.,1,0
240404,PATIENTS,1,0
240405,30,1,0
240406,ASA,1,0
240407,physical,1,0
240408,status,1,0
240409,I,1,0
240410,and,1,0
240411,II,1,0
240412,patients,1,1
240413,",",1,1
240414,who,1,1
240415,were,1,1
240416,scheduled,1,1
240417,for,1,0
240418,elective,1,1
240419,hip,1,1
240420,or,1,0
240421,knee,1,1
240422,arthroplasty,1,1
240423,and,1,0
240424,were,1,0
240425,free,1,0
240426,from,1,0
240427,systemic,1,0
240428,disease,1,1
240429,.,1,1
240430,INTERVENTIONS,0,0
240431,Patients,0,1
240432,received,0,1
240433,epidural,0,1
240434,block,0,0
240435,up,0,0
240436,to,0,0
240437,T10,0,0
240438,by,0,0
240439,alkalinized,0,0
240440,lidocaine,0,0
240441,2,0,0
240442,%,0,0
240443,",",0,0
240444,and,0,0
240445,then,0,0
240446,were,0,0
240447,administered,0,0
240448,standard,0,0
240449,general,0,1
240450,anesthesia,0,1
240451,by,0,0
240452,means,0,0
240453,of,0,0
240454,low-flow,0,0
240455,rebreathing,0,0
240456,system,0,0
240457,(,0,0
240458,fresh,0,0
240459,gas,0,0
240460,flow,0,0
240461,=,0,0
240462,1,0,0
240463,L/min,0,0
240464,),0,0
240465,.,0,0
240466,All,0,0
240467,procedures,0,0
240468,started,0,0
240469,between,0,0
240470,8,0,0
240471,and,0,0
240472,10,0,0
240473,AM,0,0
240474,",",0,0
240475,and,0,0
240476,operating,0,0
240477,room,0,0
240478,(,0,0
240479,OR,0,0
240480,),0,0
240481,temperature,0,0
240482,was,0,0
240483,maintained,0,0
240484,between,0,0
240485,21,0,1
240486,degrees,0,0
240487,and,0,0
240488,23,0,1
240489,degrees,0,0
240490,C,0,0
240491,",",0,0
240492,with,0,0
240493,relative,0,0
240494,humidity,0,0
240495,ranging,0,0
240496,between,0,0
240497,40,0,1
240498,%,0,0
240499,and,0,0
240500,45,0,0
240501,%,0,0
240502,.,0,0
240503,For,0,0
240504,heat,0,0
240505,retention,0,0
240506,or,0,0
240507,warming,0,0
240508,therapy,0,0
240509,",",0,0
240510,patients,0,1
240511,received,0,0
240512,either,0,0
240513,low-flow,0,0
240514,anesthesia,0,0
240515,only,0,0
240516,(,0,0
240517,control,0,0
240518,",",0,0
240519,n,0,1
240520,=,0,0
240521,10,0,1
240522,),0,0
240523,",",0,0
240524,low-flow,0,0
240525,anesthesia,0,0
240526,with,0,1
240527,additional,0,0
240528,reflective,0,0
240529,blankets,0,0
240530,(,0,0
240531,blanket,0,0
240532,",",0,0
240533,n,0,1
240534,=,0,0
240535,10,0,1
240536,),0,0
240537,",",0,0
240538,or,0,0
240539,low-flow,0,0
240540,anesthesia,0,0
240541,with,0,1
240542,active,0,0
240543,forced-air,0,0
240544,warming,0,0
240545,(,0,0
240546,forced-air,0,0
240547,",",0,0
240548,n,0,1
240549,=,0,0
240550,10,0,1
240551,),0,0
240552,.,0,0
240553,Tympanic,0,0
240554,temperature,0,0
240555,was,0,0
240556,measured,0,0
240557,at,0,0
240558,OR,0,0
240559,arrival,0,0
240560,(,0,0
240561,baseline,0,0
240562,),0,0
240563,;,0,0
240564,immediately,0,0
240565,following,0,0
240566,general,0,1
240567,anesthesia,0,1
240568,induction,0,1
240569,;,0,0
240570,30,0,0
240571,",",0,0
240572,60,0,0
240573,",",0,0
240574,90,0,0
240575,",",0,0
240576,and,0,0
240577,120,0,1
240578,minutes,0,0
240579,from,0,1
240580,general,0,1
240581,anesthesia,0,1
240582,induction,0,0
240583,;,0,0
240584,and,0,0
240585,at,0,0
240586,the,0,0
240587,end,0,0
240588,of,0,0
240589,surgery,0,1
240590,.,0,0
240591,MEASUREMENTS,0,0
240592,AND,0,0
240593,MAIN,0,0
240594,RESULTS,0,0
240595,Duration,0,0
240596,of,0,0
240597,anesthesia,0,0
240598,",",0,0
240599,invasiveness,0,0
240600,of,0,0
240601,surgery,0,1
240602,",",0,0
240603,and,0,0
240604,baseline,0,0
240605,core,0,0
240606,temperature,0,0
240607,were,0,0
240608,similar,0,0
240609,in,0,0
240610,the,0,0
240611,three,0,0
240612,groups,0,0
240613,.,0,1
240614,Core,0,1
240615,temperature,0,0
240616,decreased,0,0
240617,in,0,0
240618,all,0,0
240619,the,0,0
240620,three,0,0
240621,groups,0,0
240622,30,0,1
240623,minutes,0,0
240624,after,0,0
240625,general,0,1
240626,anesthesia,0,0
240627,induction,0,0
240628,compared,0,0
240629,with,0,0
240630,baseline,0,0
240631,(,0,0
240632,p,0,0
240633,<,0,0
240634,0.01,0,0
240635,),0,0
240636,;,0,0
240637,afterwards,0,0
240638,",",0,0
240639,it,0,0
240640,progressively,0,0
240641,decreased,0,0
240642,in,0,0
240643,the,0,0
240644,control,0,0
240645,and,0,0
240646,blankets,0,0
240647,groups,0,0
240648,(,0,1
240649,p,0,0
240650,=,0,0
240651,0.004,0,0
240652,),0,0
240653,",",0,0
240654,with,0,0
240655,a,0,0
240656,reduction,0,0
240657,from,0,0
240658,baseline,0,0
240659,values,0,0
240660,measured,0,0
240661,at,0,0
240662,the,0,0
240663,end,0,0
240664,of,0,0
240665,surgery,0,1
240666,of,0,0
240667,2.0,0,0
240668,degrees,0,0
240669,C,0,0
240670,and,0,0
240671,1.6,0,0
240672,degrees,0,0
240673,C,0,0
240674,",",0,0
240675,respectively,0,0
240676,.,0,0
240677,In,0,0
240678,the,0,0
240679,forced-air,0,0
240680,group,0,0
240681,",",0,0
240682,after,0,0
240683,the,0,0
240684,initial,0,0
240685,significant,0,0
240686,decrease,0,0
240687,(,0,0
240688,p,0,0
240689,=,0,0
240690,0.01,0,0
240691,vs.,0,0
240692,baseline,0,0
240693,),0,0
240694,",",0,0
240695,core,0,0
240696,temperature,0,0
240697,progressively,0,0
240698,increased,0,0
240699,to,0,0
240700,35.8,0,0
240701,+/-,0,0
240702,0.6,0,0
240703,degrees,0,0
240704,C,0,0
240705,",",0,0
240706,which,0,0
240707,was,0,0
240708,similar,0,0
240709,to,0,0
240710,preoperative,0,0
240711,values,0,0
240712,and,0,0
240713,significantly,0,0
240714,higher,0,0
240715,than,0,0
240716,either,0,0
240717,the,0,0
240718,control,0,0
240719,or,0,0
240720,blankets,0,0
240721,groups,0,0
240722,(,0,1
240723,p,0,0
240724,=,0,0
240725,0.004,0,0
240726,),0,0
240727,.,0,0
240728,CONCLUSIONS,0,0
240729,During,0,0
240730,combined,0,0
240731,epidural-general,0,0
240732,anesthesia,0,0
240733,for,0,0
240734,elective,1,1
240735,hip,1,1
240736,and,1,0
240737,knee,1,0
240738,arthroplasty,1,1
240739,",",0,0
240740,passive,0,0
240741,heat,0,0
240742,retention,0,0
240743,by,0,0
240744,means,0,0
240745,of,0,0
240746,low-flow,0,0
240747,anesthesia,0,0
240748,alone,0,0
240749,and,0,0
240750,in,0,0
240751,combination,0,0
240752,with,0,1
240753,reflective,0,0
240754,blankets,0,0
240755,is,0,0
240756,ineffective,0,0
240757,in,0,0
240758,maintaining,0,0
240759,intraoperative,0,0
240760,normothermia,0,1
240761,and,0,0
240762,definitely,0,0
240763,inferior,0,0
240764,to,0,0
240765,active,0,0
240766,forced-air,0,0
240767,warning,0,0
240768,.,0,0
240769,Postoperative,0,0
240770,analgesia,0,0
240771,with,0,1
240772,preoperative,0,0
240773,oral,0,0
240774,ibuprofen,0,0
240775,or,0,0
240776,acetaminophen,0,0
240777,in,0,0
240778,children,1,1
240779,undergoing,1,1
240780,myringotomy,1,1
240781,.,1,1
240782,Previous,0,0
240783,studies,0,0
240784,have,0,0
240785,shown,0,0
240786,over,0,0
240787,70,1,1
240788,%,1,0
240789,of,1,0
240790,children,1,1
240791,require,0,1
240792,analgesics,0,0
240793,following,0,0
240794,bilateral,1,1
240795,myringotomy,1,1
240796,and,1,0
240797,tube,1,0
240798,placement,1,0
240799,(,1,0
240800,BM,1,0
240801,&,1,1
240802,T,1,0
240803,),1,0
240804,.,1,0
240805,This,0,0
240806,double-blind,0,0
240807,",",0,0
240808,placebo-controlled,0,0
240809,study,0,0
240810,compared,0,0
240811,the,0,0
240812,postoperative,0,0
240813,analgesic,0,0
240814,effects,0,0
240815,of,0,0
240816,preoperatively,0,0
240817,administered,0,0
240818,oral,0,0
240819,acetaminophen,0,0
240820,or,0,0
240821,ibuprofen,0,0
240822,.,0,0
240823,Forty,1,0
240824,three,1,0
240825,ASA,1,0
240826,I,1,0
240827,or,1,0
240828,II,1,0
240829,children,1,1
240830,age,1,1
240831,six,1,1
240832,months,1,0
240833,or,1,1
240834,older,1,1
240835,scheduled,1,1
240836,for,1,0
240837,elective,1,1
240838,BM,1,0
240839,&,1,1
240840,T,1,0
240841,were,0,0
240842,randomized,0,0
240843,to,0,0
240844,receive,0,0
240845,acetaminophen,0,0
240846,(,0,0
240847,paracetamol,0,0
240848,),0,0
240849,15,0,0
240850,mg.kg-1,0,0
240851,",",0,0
240852,ibuprofen,0,0
240853,10,0,0
240854,mg.kg-1,0,0
240855,",",0,0
240856,or,0,0
240857,placebo,0,0
240858,.,0,0
240859,Postoperative,0,0
240860,pain,0,0
240861,was,0,0
240862,assessed,0,0
240863,using,0,0
240864,the,0,0
240865,Children,0,1
240866,'s,0,0
240867,Hospital,0,1
240868,of,0,0
240869,Eastern,0,1
240870,Ontario,0,1
240871,Pain,0,0
240872,Scale,0,0
240873,(,0,0
240874,CHEOPS,0,0
240875,),0,0
240876,upon,0,0
240877,arrival,0,0
240878,to,0,0
240879,the,0,0
240880,PACU,0,0
240881,and,0,0
240882,at,0,0
240883,5,0,0
240884,",",0,0
240885,10,0,0
240886,",",0,0
240887,15,0,0
240888,",",0,0
240889,30,0,0
240890,",",0,0
240891,45,0,0
240892,",",0,0
240893,and,0,0
240894,60,0,1
240895,min,0,0
240896,.,0,0
240897,CHEOP,0,0
240898,scores,0,0
240899,did,0,0
240900,not,0,0
240901,differ,0,0
240902,between,0,0
240903,the,0,0
240904,groups,0,0
240905,at,0,0
240906,any,0,0
240907,time,0,0
240908,.,0,0
240909,There,0,0
240910,was,0,0
240911,no,0,0
240912,difference,0,0
240913,in,0,0
240914,the,0,0
240915,number,0,0
240916,of,0,0
240917,children,1,1
240918,receiving,1,1
240919,rescue,1,0
240920,analgesia,1,0
240921,.,1,0
240922,This,0,0
240923,study,0,0
240924,showed,0,0
240925,no,0,0
240926,benefit,0,0
240927,of,0,0
240928,preoperatively,0,0
240929,administered,0,0
240930,oral,0,0
240931,ibuprofen,0,0
240932,10,0,0
240933,mg.kg-1,0,0
240934,or,0,0
240935,acetaminophen,0,0
240936,15,0,0
240937,mg.kg-1,0,0
240938,over,0,0
240939,placebo,0,0
240940,for,0,0
240941,the,0,0
240942,relief,0,0
240943,of,0,0
240944,postoperative,0,0
240945,pain,0,0
240946,in,0,0
240947,children,1,1
240948,undergoing,1,1
240949,BM,1,0
240950,&,1,1
240951,T,1,0
240952,.,1,0
240953,Acute,0,0
240954,rejection,0,1
240955,and,0,0
240956,heart,0,1
240957,infection,0,1
240958,rates,0,0
240959,in,0,0
240960,FK,1,1
240961,506-,1,1
240962,versus,1,0
240963,cyclosporine,1,0
240964,A-treated,1,0
240965,heart,1,1
240966,transplant,1,1
240967,recipients,1,1
240968,:,1,1
240969,an,0,0
240970,endomyocardial,0,0
240971,biopsy,0,0
240972,pathologic,0,0
240973,study,0,0
240974,.,0,0
240975,Intravenous,0,1
240976,magnesium,0,0
240977,sulfate,0,0
240978,in,0,0
240979,acute,1,1
240980,severe,1,1
240981,asthma,1,1
240982,not,1,0
240983,responding,1,0
240984,to,1,0
240985,conventional,1,0
240986,therapy,1,0
240987,.,1,0
240988,OBJECTIVE,0,0
240989,To,0,0
240990,evaluate,0,0
240991,the,0,0
240992,effectiveness,0,0
240993,of,0,0
240994,early,0,0
240995,administration,0,0
240996,of,0,0
240997,intravenous,0,0
240998,Magnesium,0,0
240999,sulfate,0,0
241000,(,0,0
241001,i.v,0,0
241002,.,0,0
241003,MgSO4,0,0
241004,),0,0
241005,in,0,0
241006,children,1,1
241007,with,1,1
241008,acute,1,1
241009,severe,1,1
241010,asthma,1,1
241011,not,1,0
241012,responding,1,0
241013,to,1,0
241014,conventional,1,0
241015,therapy,1,0
241016,.,1,0
241017,DESIGN,0,0
241018,Randomized,0,0
241019,double-blind,0,0
241020,",",0,0
241021,placebo-controlled,0,0
241022,trial,0,0
241023,.,0,0
241024,SETTING,0,0
241025,Pediatric,1,1
241026,emergency,1,1
241027,service,1,0
241028,of,1,0
241029,a,1,0
241030,large,1,0
241031,teaching,1,0
241032,hospital,1,0
241033,.,1,0
241034,SUBJECTS,0,0
241035,47,1,0
241036,children,1,1
241037,aged,1,1
241038,between,1,0
241039,1-12,1,0
241040,years,1,1
241041,with,1,1
241042,acute,1,1
241043,severe,1,1
241044,asthma,1,1
241045,showing,1,0
241046,inadequate,1,0
241047,or,1,1
241048,poor,1,1
241049,response,1,0
241050,to,1,0
241051,3,1,0
241052,doses,1,0
241053,of,1,0
241054,nebulized,1,0
241055,salbutamol,1,0
241056,given,1,0
241057,at,1,0
241058,an,1,0
241059,interval,1,0
241060,of,1,0
241061,20,1,1
241062,min,1,0
241063,each,1,0
241064,.,1,0
241065,INTERVENTION,0,0
241066,The,0,0
241067,MgSO4,0,0
241068,group,0,0
241069,received,0,0
241070,0.2,0,0
241071,ml/kg,0,0
241072,of,0,0
241073,50,0,0
241074,%,0,0
241075,MgSO4,0,0
241076,as,0,0
241077,intravenous,0,0
241078,(,0,0
241079,i.v,0,0
241080,.,0,0
241081,),0,0
241082,infusion,0,0
241083,over,0,0
241084,35,0,1
241085,minutes,0,0
241086,and,0,0
241087,the,0,0
241088,placebo,0,0
241089,group,0,0
241090,received,0,0
241091,normal,0,1
241092,saline,0,0
241093,infusion,0,0
241094,in,0,0
241095,the,0,0
241096,same,0,0
241097,dose,0,0
241098,and,0,0
241099,at,0,0
241100,the,0,0
241101,same,0,0
241102,rate,0,0
241103,.,0,0
241104,MgSO4,0,0
241105,solution,0,0
241106,and,0,0
241107,normal,0,1
241108,saline,0,0
241109,were,0,0
241110,coded,0,0
241111,and,0,0
241112,dispensed,0,0
241113,in,0,0
241114,identical,0,0
241115,containers,0,0
241116,.,0,1
241117,Decoding,0,0
241118,was,0,0
241119,done,0,0
241120,at,0,0
241121,the,0,0
241122,completion,0,0
241123,of,0,0
241124,the,0,0
241125,study,0,0
241126,.,0,0
241127,All,0,0
241128,the,0,0
241129,patients,0,1
241130,received,0,0
241131,oxygen,0,0
241132,",",0,0
241133,nebulized,0,0
241134,salbutamol,0,0
241135,",",0,0
241136,i.v,0,0
241137,.,0,0
241138,aminophylline,0,0
241139,and,0,0
241140,corticosteroids,0,0
241141,.,0,1
241142,RESULTS,0,0
241143,MgSO4,0,0
241144,group,0,0
241145,showed,0,0
241146,early,0,0
241147,and,0,0
241148,significant,0,0
241149,improvement,0,0
241150,as,0,0
241151,compared,0,0
241152,to,0,0
241153,placebo,0,0
241154,group,0,0
241155,in,0,0
241156,PEFR,0,0
241157,and,0,0
241158,SaO2,0,0
241159,at,0,0
241160,30,0,0
241161,min,0,0
241162,and,0,0
241163,1,0,0
241164,",",0,0
241165,2,0,0
241166,",",0,0
241167,3,0,0
241168,and,0,0
241169,7,0,0
241170,hours,0,0
241171,after,0,0
241172,stopping,0,0
241173,the,0,0
241174,infusion,0,0
241175,(,0,0
241176,p,0,0
241177,ranging,0,0
241178,from,0,0
241179,<,0,0
241180,0.05,0,0
241181,to,0,0
241182,<,0,0
241183,0.01,0,0
241184,),0,0
241185,.,0,0
241186,The,0,0
241187,clinical,0,0
241188,asthma,0,1
241189,score,0,0
241190,also,0,0
241191,showed,0,0
241192,significant,0,0
241193,improvement,0,0
241194,in,0,0
241195,the,0,0
241196,MgSO4,0,0
241197,group,0,0
241198,1,0,0
241199,",",0,0
241200,2,0,0
241201,",",0,0
241202,3,0,0
241203,and,0,0
241204,11,0,1
241205,hours,0,0
241206,after,0,0
241207,stopping,0,0
241208,the,0,0
241209,infusion,0,0
241210,(,0,0
241211,p,0,0
241212,<,0,0
241213,0.01,0,0
241214,),0,0
241215,.,0,0
241216,CONCLUSION,0,0
241217,Addition,0,0
241218,of,0,0
241219,MgSO4,0,0
241220,to,0,0
241221,conventional,0,0
241222,therapy,0,0
241223,helps,0,0
241224,in,0,0
241225,achieving,0,0
241226,earlier,0,0
241227,improvement,0,0
241228,in,0,0
241229,clinical,0,0
241230,signs,0,0
241231,and,0,0
241232,symptoms,0,0
241233,of,0,0
241234,asthma,0,1
241235,and,0,0
241236,PEFR,0,0
241237,in,0,0
241238,patients,1,1
241239,not,1,0
241240,responding,1,0
241241,to,1,0
241242,conventional,1,0
241243,therapy,1,0
241244,alone,1,0
241245,.,1,0
241246,Exhaled,0,0
241247,NO,0,0
241248,during,0,0
241249,graded,0,0
241250,changes,0,0
241251,in,0,0
241252,inhaled,0,0
241253,oxygen,0,0
241254,in,0,0
241255,man,1,1
241256,.,1,0
241257,BACKGROUND,0,0
241258,Nitric,0,0
241259,oxide,0,0
241260,(,0,0
241261,NO,0,0
241262,),0,0
241263,is,0,0
241264,present,0,0
241265,in,0,0
241266,the,0,0
241267,exhaled,0,0
241268,air,0,0
241269,of,0,0
241270,animals,0,0
241271,and,0,1
241272,humans,0,0
241273,.,0,0
241274,In,0,0
241275,isolated,0,0
241276,animal,0,1
241277,lungs,0,0
241278,the,0,0
241279,amount,0,0
241280,of,0,0
241281,exhaled,0,0
241282,NO,0,0
241283,is,0,0
241284,decreased,0,0
241285,during,0,0
241286,hypoxia,0,0
241287,.,0,0
241288,A,0,0
241289,study,0,0
241290,was,0,0
241291,undertaken,0,0
241292,to,0,0
241293,determine,0,0
241294,whether,0,0
241295,changes,0,0
241296,in,0,0
241297,arterial,0,1
241298,oxygen,0,0
241299,tension,0,0
241300,affect,0,0
241301,levels,0,0
241302,of,0,0
241303,exhaled,0,0
241304,NO,0,0
241305,in,0,0
241306,humans,1,0
241307,.,1,1
241308,METHODS,0,0
241309,Sixteen,1,1
241310,healthy,1,1
241311,subjects,1,1
241312,were,0,0
241313,randomised,0,0
241314,to,0,0
241315,inhale,0,0
241316,different,0,0
241317,gas,0,0
241318,mixtures,0,0
241319,of,0,0
241320,oxygen,0,0
241321,and,0,0
241322,nitrogen,0,0
241323,in,0,0
241324,a,0,0
241325,double,0,0
241326,blind,0,0
241327,crossover,0,0
241328,study,0,0
241329,.,0,0
241330,Eight,0,0
241331,gas,0,0
241332,mixtures,0,0
241333,of,0,0
241334,oxygen,0,0
241335,and,0,0
241336,nitrogen,0,0
241337,(,0,0
241338,fractional,0,0
241339,inspired,0,0
241340,oxygen,0,0
241341,concentration,0,0
241342,(,0,0
241343,FiO2,0,0
241344,),0,0
241345,0.1,0,0
241346,to,0,0
241347,1.0,0,0
241348,),0,0
241349,were,0,0
241350,administered,0,0
241351,.,0,0
241352,Exhaled,0,0
241353,NO,0,0
241354,was,0,0
241355,measured,0,0
241356,with,0,0
241357,a,0,0
241358,chemiluminescence,0,0
241359,detector,0,0
241360,from,0,0
241361,end,0,0
241362,expiratory,0,0
241363,single,0,0
241364,breath,0,0
241365,exhalation,0,0
241366,.,0,0
241367,RESULTS,0,0
241368,A,0,0
241369,dose-dependent,0,0
241370,change,0,0
241371,in,0,0
241372,exhaled,0,0
241373,NO,0,0
241374,during,0,0
241375,graded,0,0
241376,oxygen,0,0
241377,breathing,0,0
241378,was,0,0
241379,observed,0,0
241380,(,0,0
241381,p,0,0
241382,=,0,0
241383,0.0012,0,0
241384,),0,0
241385,.,0,0
241386,The,0,0
241387,mean,0,0
241388,(,0,0
241389,SE,0,0
241390,),0,0
241391,exhaled,0,0
241392,NO,0,0
241393,concentration,0,0
241394,was,0,0
241395,31,0,1
241396,(,0,0
241397,3,0,0
241398,),0,0
241399,ppb,0,0
241400,at,0,0
241401,baseline,0,0
241402,",",0,0
241403,39,0,0
241404,(,0,0
241405,4,0,0
241406,),0,0
241407,ppb,0,0
241408,at,0,0
241409,an,0,0
241410,FiO2,0,0
241411,of,0,0
241412,1.0,0,0
241413,",",0,0
241414,and,0,0
241415,26,0,0
241416,(,0,0
241417,3,0,0
241418,),0,0
241419,ppb,0,0
241420,at,0,0
241421,an,0,0
241422,FiO2,0,0
241423,of,0,0
241424,0.1,0,0
241425,.,0,0
241426,CONCLUSIONS,0,0
241427,The,0,0
241428,NO,0,0
241429,concentration,0,0
241430,in,0,0
241431,exhaled,0,0
241432,air,0,0
241433,in,0,0
241434,healthy,1,1
241435,humans,1,0
241436,is,0,0
241437,dependent,0,0
241438,on,0,0
241439,oxygen,0,0
241440,tension,0,0
241441,.,0,0
241442,Hyperoxia,0,0
241443,increases,0,0
241444,the,0,0
241445,level,0,0
241446,of,0,0
241447,exhaled,0,0
241448,NO,0,0
241449,",",0,0
241450,which,0,0
241451,indicates,0,0
241452,increased,0,0
241453,NO,0,0
241454,production,0,0
241455,.,0,0
241456,The,0,0
241457,mechanism,0,0
241458,behind,0,0
241459,this,0,0
241460,phenomenon,0,0
241461,remains,0,0
241462,to,0,0
241463,be,0,0
241464,elucidated,0,0
241465,.,0,0
241466,Dose-response,0,0
241467,comparison,0,0
241468,of,0,0
241469,RRR-alpha-tocopherol,0,0
241470,and,0,0
241471,all-racemic,0,0
241472,alpha-tocopherol,0,0
241473,on,0,0
241474,LDL,1,0
241475,oxidation,1,0
241476,.,1,0
241477,Much,0,0
241478,data,0,0
241479,have,0,0
241480,accrued,0,0
241481,in,0,0
241482,support,0,0
241483,of,0,0
241484,the,0,0
241485,concept,0,0
241486,that,0,0
241487,oxidation,0,0
241488,of,0,0
241489,LDL,0,0
241490,is,0,0
241491,a,0,0
241492,key,0,0
241493,early,0,0
241494,step,0,0
241495,in,0,0
241496,atherogenesis,1,0
241497,.,1,0
241498,The,0,0
241499,most,0,0
241500,consistent,0,0
241501,data,0,0
241502,with,0,1
241503,respect,0,0
241504,to,0,0
241505,micronutrient,0,0
241506,antioxidants,0,0
241507,and,0,0
241508,atherosclerosis,0,1
241509,appear,0,0
241510,to,0,0
241511,relate,0,0
241512,to,0,0
241513,alpha-tocopherol,0,0
241514,(,0,0
241515,AT,0,0
241516,),0,0
241517,",",0,0
241518,the,0,0
241519,predominant,0,0
241520,lipid-soluble,0,0
241521,antioxidant,0,0
241522,in,0,0
241523,LDL,0,0
241524,.,0,0
241525,There,0,0
241526,are,0,0
241527,scant,0,0
241528,data,0,0
241529,on,0,0
241530,the,0,0
241531,direct,0,0
241532,comparison,0,0
241533,of,0,0
241534,RRR-AT,0,0
241535,and,0,0
241536,all-racemic,0,0
241537,(,0,0
241538,rac,0,0
241539,),0,0
241540,-AT,0,0
241541,on,0,0
241542,LDL,0,0
241543,oxidizability,0,0
241544,.,0,0
241545,Hence,0,0
241546,",",0,0
241547,the,0,0
241548,aim,0,0
241549,of,0,0
241550,the,0,0
241551,present,0,0
241552,study,0,0
241553,was,0,0
241554,to,0,0
241555,examine,0,0
241556,the,0,0
241557,relative,0,0
241558,effects,0,0
241559,of,0,0
241560,RRR-AT,0,0
241561,and,0,0
241562,all-rac-AT,0,0
241563,on,0,0
241564,plasma,0,0
241565,antioxidant,0,0
241566,levels,0,0
241567,and,0,0
241568,LDL,0,0
241569,oxidation,0,0
241570,in,0,0
241571,healthy,1,1
241572,persons,1,1
241573,in,0,0
241574,a,0,0
241575,dose-response,0,0
241576,study,0,0
241577,.,0,0
241578,The,0,0
241579,effect,0,0
241580,of,0,0
241581,RRR-AT,0,0
241582,and,0,0
241583,all-rac-AT,0,0
241584,at,0,0
241585,doses,0,0
241586,of,0,0
241587,100,0,0
241588,",",0,0
241589,200,0,0
241590,",",0,0
241591,400,0,0
241592,",",0,0
241593,and,0,0
241594,800,0,0
241595,IU/d,0,0
241596,on,0,0
241597,plasma,0,0
241598,and,0,0
241599,LDL,0,0
241600,AT,0,0
241601,levels,0,0
241602,and,0,0
241603,LDL,0,0
241604,oxidation,0,0
241605,was,0,0
241606,tested,0,0
241607,in,0,0
241608,a,0,0
241609,randomized,0,0
241610,",",0,0
241611,placebo-controlled,0,0
241612,study,0,0
241613,of,0,0
241614,79,1,1
241615,healthy,1,1
241616,subjects,1,1
241617,.,1,1
241618,Copper-catalyzed,0,0
241619,oxidation,0,0
241620,of,0,0
241621,LDL,0,0
241622,was,0,0
241623,monitored,0,0
241624,by,0,0
241625,measuring,0,0
241626,the,0,0
241627,formation,0,0
241628,of,0,0
241629,conjugated,0,0
241630,dienes,0,0
241631,and,0,0
241632,lipid,0,0
241633,peroxides,0,0
241634,over,0,0
241635,an,0,0
241636,8-hour,0,0
241637,time,0,0
241638,course,0,0
241639,at,0,0
241640,baseline,0,0
241641,and,0,0
241642,again,0,0
241643,after,0,0
241644,8,0,0
241645,weeks,0,0
241646,.,0,1
241647,Plasma,0,0
241648,AT,0,0
241649,",",0,0
241650,lipid-standardized,0,0
241651,AT,0,0
241652,",",0,0
241653,and,0,0
241654,LDL,0,0
241655,AT,0,0
241656,levels,0,0
241657,rose,0,0
241658,in,0,0
241659,a,0,0
241660,dose-dependent,0,0
241661,fashion,0,0
241662,in,0,0
241663,both,0,0
241664,the,0,0
241665,RRR-AT,0,0
241666,and,0,0
241667,all-rac-AT,0,0
241668,groups,0,0
241669,compared,0,0
241670,with,0,1
241671,baseline,0,0
241672,.,0,0
241673,There,0,0
241674,were,0,0
241675,no,0,0
241676,significant,0,0
241677,differences,0,0
241678,in,0,0
241679,plasma,0,0
241680,",",0,0
241681,lipid-standardized,0,0
241682,",",0,0
241683,and,0,0
241684,LDL,0,0
241685,AT,0,0
241686,levels,0,0
241687,between,0,0
241688,RRR-AT,0,0
241689,and,0,0
241690,all-rac-AT,0,0
241691,supplementation,0,0
241692,at,0,0
241693,any,0,0
241694,dose,0,0
241695,comparison,0,0
241696,.,0,0
241697,The,0,0
241698,lag,0,0
241699,phases,0,0
241700,of,0,0
241701,oxidation,0,0
241702,were,0,0
241703,significantly,0,0
241704,prolonged,0,0
241705,with,0,0
241706,doses,0,0
241707,>,0,1
241708,or,0,0
241709,=,0,0
241710,400,0,0
241711,IU/d,0,0
241712,of,0,0
241713,RRR-AT,0,0
241714,and,0,0
241715,all-rac-AT,0,0
241716,",",0,0
241717,as,0,0
241718,measured,0,0
241719,by,0,0
241720,conjugated-dienes,0,0
241721,assay,0,0
241722,and,0,0
241723,at,0,0
241724,400,0,0
241725,IU/d,0,0
241726,of,0,0
241727,RRR-AT,0,0
241728,and,0,0
241729,800,0,0
241730,IU/d,0,0
241731,of,0,0
241732,both,0,0
241733,forms,0,0
241734,of,0,0
241735,AT,0,0
241736,by,0,0
241737,lipid,0,0
241738,peroxide,0,0
241739,assay,0,0
241740,.,0,0
241741,Again,0,0
241742,",",0,0
241743,there,0,0
241744,were,0,0
241745,no,0,0
241746,significant,0,0
241747,differences,0,0
241748,in,0,0
241749,the,0,0
241750,lag,0,0
241751,phase,0,0
241752,of,0,0
241753,oxidation,0,0
241754,at,0,0
241755,each,0,0
241756,dose,0,0
241757,for,0,0
241758,RRR-AT,0,0
241759,when,0,0
241760,compared,0,0
241761,with,0,0
241762,all-rac-AT,0,0
241763,.,0,0
241764,Also,0,0
241765,",",0,0
241766,there,0,0
241767,were,0,0
241768,no,0,0
241769,significant,0,0
241770,differences,0,0
241771,in,0,0
241772,LDL,0,0
241773,oxidation,0,0
241774,after,0,0
241775,in,0,0
241776,vitro,0,0
241777,enrichment,0,0
241778,of,0,0
241779,LDL,0,0
241780,with,0,1
241781,RRR-AT,0,0
241782,and,0,0
241783,all-rac-AT,0,0
241784,.,0,0
241785,Thus,0,0
241786,",",0,0
241787,supplementation,0,0
241788,with,0,0
241789,either,0,0
241790,RRR-AT,0,0
241791,or,0,0
241792,all-rac-AT,0,0
241793,resulted,0,0
241794,in,0,0
241795,similar,0,0
241796,increases,0,0
241797,in,0,0
241798,plasma,0,0
241799,and,0,0
241800,LDL,0,0
241801,AT,0,0
241802,levels,0,0
241803,at,0,0
241804,equivalent,0,0
241805,IU,0,0
241806,doses,0,0
241807,",",0,0
241808,and,0,0
241809,the,0,0
241810,degree,0,0
241811,of,0,0
241812,protection,0,0
241813,against,0,0
241814,copper-catalyzed,0,0
241815,LDL,0,0
241816,oxidation,0,0
241817,was,0,0
241818,only,0,0
241819,evident,0,0
241820,at,0,0
241821,doses,0,0
241822,>,0,1
241823,or,0,0
241824,=,0,0
241825,400,0,0
241826,IU/d,0,0
241827,for,0,0
241828,both,0,0
241829,forms,0,0
241830,.,0,0
241831,Evaluation,0,0
241832,of,0,0
241833,hypertensive,1,1
241834,patients,1,1
241835,after,0,0
241836,care,0,0
241837,provided,0,0
241838,by,0,0
241839,community,0,1
241840,pharmacists,0,0
241841,in,1,0
241842,a,1,0
241843,rural,1,1
241844,setting,1,0
241845,.,1,0
241846,We,0,0
241847,evaluated,0,0
241848,blood,0,0
241849,pressure,0,0
241850,control,0,0
241851,",",0,0
241852,quality,0,0
241853,of,0,0
241854,life,0,0
241855,",",0,0
241856,quality,0,0
241857,of,0,0
241858,care,0,0
241859,",",0,0
241860,and,0,0
241861,satisfaction,0,0
241862,of,0,1
241863,patients,1,1
241864,who,1,1
241865,were,1,1
241866,monitored,1,1
241867,by,1,0
241868,specially,1,0
241869,trained,1,0
241870,community,1,1
241871,pharmacists,1,0
241872,in,1,0
241873,a,1,0
241874,group,1,0
241875,medical,1,0
241876,practice,1,0
241877,.,1,0
241878,After,0,0
241879,participating,0,1
241880,in,0,0
241881,an,0,0
241882,intensive,0,0
241883,skill,0,0
241884,development,0,0
241885,program,0,0
241886,",",0,0
241887,pharmacists,0,0
241888,performed,0,0
241889,in,0,0
241890,an,0,0
241891,interdisciplinary,0,0
241892,team,0,0
241893,in,0,0
241894,a,0,0
241895,rural,0,1
241896,clinic,0,1
241897,.,0,0
241898,The,0,0
241899,primary,0,0
241900,objective,0,0
241901,was,0,0
241902,assessed,0,0
241903,by,0,0
241904,evaluating,0,0
241905,outcome,0,0
241906,variables,0,0
241907,at,0,0
241908,6,0,0
241909,months,0,0
241910,compared,0,0
241911,with,0,1
241912,baseline,0,0
241913,in,0,0
241914,25,1,0
241915,patients,1,1
241916,randomly,0,1
241917,assigned,0,0
241918,to,0,0
241919,a,0,0
241920,study,0,0
241921,group,0,0
241922,.,0,0
241923,A,0,0
241924,control,1,0
241925,group,1,0
241926,of,1,0
241927,26,1,1
241928,patients,1,1
241929,was,0,0
241930,also,0,0
241931,evaluated,0,0
241932,to,0,0
241933,determine,0,0
241934,if,0,0
241935,outcome,0,0
241936,variables,0,0
241937,remained,0,0
241938,constant,0,0
241939,from,0,0
241940,baseline,0,0
241941,to,0,0
241942,6,0,0
241943,months,0,0
241944,.,0,1
241945,Systolic,0,1
241946,blood,0,0
241947,pressure,0,0
241948,was,0,0
241949,reduced,0,0
241950,in,0,0
241951,the,0,0
241952,study,0,0
241953,group,0,0
241954,(,0,0
241955,151,0,1
241956,mm,0,0
241957,Hg,0,0
241958,baseline,0,0
241959,",",0,0
241960,140,0,1
241961,mm,0,0
241962,Hg,0,0
241963,at,0,0
241964,6,0,0
241965,mo,0,1
241966,",",0,0
241967,p,0,0
241968,<,0,0
241969,0.001,0,0
241970,),0,0
241971,and,0,0
241972,diastolic,0,0
241973,blood,0,0
241974,pressure,0,0
241975,was,0,0
241976,significantly,0,0
241977,lower,0,0
241978,at,0,0
241979,2,0,0
241980,",",0,0
241981,4,0,0
241982,",",0,0
241983,and,0,0
241984,5,0,0
241985,months,0,0
241986,compared,0,0
241987,with,0,1
241988,baseline,0,0
241989,.,0,0
241990,Ratings,0,0
241991,from,0,0
241992,a,0,0
241993,blinded,0,0
241994,peer,0,0
241995,review,0,0
241996,panel,0,1
241997,indicated,0,0
241998,significant,0,0
241999,improvement,0,0
242000,in,0,0
242001,the,0,0
242002,appropriateness,0,0
242003,of,0,0
242004,the,0,0
242005,blood,0,0
242006,pressure,0,0
242007,regimen,0,0
242008,",",0,0
242009,going,0,0
242010,from,0,0
242011,8.7,0,0
242012,+/-,0,0
242013,4.7,0,0
242014,to,0,0
242015,10.9,0,0
242016,+/-,0,0
242017,4.5,0,0
242018,in,0,0
242019,the,0,0
242020,study,0,0
242021,group,0,0
242022,(,0,0
242023,p,0,0
242024,<,0,0
242025,0.01,0,0
242026,),0,0
242027,",",0,0
242028,but,0,0
242029,they,0,0
242030,did,0,0
242031,not,0,0
242032,change,0,0
242033,in,0,0
242034,the,0,0
242035,control,0,0
242036,group,0,0
242037,.,0,0
242038,Several,0,0
242039,quality,0,0
242040,of,0,0
242041,life,0,0
242042,scores,0,0
242043,improved,0,0
242044,significantly,0,0
242045,in,0,0
242046,the,0,0
242047,study,0,0
242048,group,0,0
242049,after,0,0
242050,6,0,0
242051,months,0,0
242052,(,0,0
242053,p,0,0
242054,<,0,0
242055,0.05,0,0
242056,),0,0
242057,.,0,0
242058,These,0,0
242059,included,0,0
242060,physical,0,0
242061,functioning,0,0
242062,(,0,0
242063,61.6,0,0
242064,vs,0,0
242065,70.7,0,0
242066,),0,0
242067,",",0,0
242068,physical,0,0
242069,role,0,0
242070,limitations,0,0
242071,(,0,0
242072,56.8,0,0
242073,vs,0,0
242074,72.8,0,0
242075,),0,0
242076,",",0,0
242077,and,0,0
242078,bodily,0,0
242079,pain,0,0
242080,(,0,0
242081,60.0,0,0
242082,vs,0,0
242083,71.7,0,0
242084,),0,0
242085,at,0,0
242086,baseline,0,0
242087,and,0,0
242088,6,0,0
242089,months,0,0
242090,",",0,0
242091,respectively,0,0
242092,.,0,0
242093,There,0,0
242094,were,0,0
242095,no,0,0
242096,significant,0,0
242097,changes,0,0
242098,in,0,0
242099,the,0,0
242100,control,0,0
242101,group,0,0
242102,.,0,0
242103,Patient,0,0
242104,satisfaction,0,0
242105,scores,0,0
242106,were,0,0
242107,consistently,0,0
242108,higher,0,0
242109,in,0,0
242110,the,0,0
242111,study,0,0
242112,group,0,0
242113,at,0,0
242114,the,0,0
242115,end,0,0
242116,of,0,0
242117,the,0,0
242118,study,0,0
242119,.,0,0
242120,Our,0,0
242121,results,0,0
242122,indicate,0,0
242123,that,0,0
242124,when,0,0
242125,community,0,0
242126,pharmacists,0,0
242127,in,0,0
242128,a,0,0
242129,clinic,0,0
242130,setting,0,0
242131,are,0,0
242132,trained,0,0
242133,and,0,0
242134,included,0,1
242135,as,0,0
242136,members,0,1
242137,of,0,0
242138,the,0,0
242139,primary,0,0
242140,care,0,0
242141,team,0,0
242142,",",0,0
242143,significant,0,0
242144,improvements,0,0
242145,in,0,0
242146,blood,0,0
242147,pressure,0,0
242148,control,0,0
242149,",",0,0
242150,quality,0,0
242151,of,0,0
242152,life,0,0
242153,",",0,0
242154,and,0,0
242155,patient,0,0
242156,satisfaction,0,0
242157,can,0,0
242158,be,0,0
242159,achieved,0,0
242160,.,0,0
242161,The,0,0
242162,effect,0,0
242163,of,0,0
242164,valaciclovir,0,0
242165,on,0,0
242166,cytomegalovirus,0,0
242167,viremia,0,0
242168,and,0,0
242169,viruria,0,0
242170,detected,0,0
242171,by,0,0
242172,polymerase,0,0
242173,chain,0,0
242174,reaction,0,0
242175,in,0,0
242176,patients,1,1
242177,with,1,1
242178,advanced,1,1
242179,human,1,0
242180,immunodeficiency,1,1
242181,virus,1,1
242182,disease,1,1
242183,.,1,0
242184,AIDS,0,0
242185,Clinical,0,0
242186,Trials,0,0
242187,Group,0,1
242188,Protocol,0,1
242189,204/Glaxo,0,1
242190,Wellcome,0,1
242191,123-014,0,1
242192,International,0,1
242193,CMV,0,0
242194,Prophylaxis,0,1
242195,Study,0,0
242196,Group,0,1
242197,.,0,0
242198,Samples,0,0
242199,of,0,0
242200,blood,0,0
242201,and,0,0
242202,urine,0,0
242203,were,0,0
242204,collected,0,0
242205,at,0,0
242206,baseline,0,0
242207,",",0,0
242208,week,0,0
242209,4,0,0
242210,",",0,0
242211,and,0,0
242212,week,0,0
242213,8,0,0
242214,and,0,0
242215,then,0,0
242216,every,0,0
242217,8,0,0
242218,weeks,0,0
242219,from,0,1
242220,310,1,1
242221,patients,1,1
242222,entering,1,1
242223,a,1,0
242224,controlled,1,0
242225,trial,1,0
242226,of,1,0
242227,prophylaxis,1,0
242228,with,1,1
242229,valaciclovir,1,0
242230,versus,1,0
242231,acyclovir,1,0
242232,.,1,0
242233,Samples,0,0
242234,were,0,0
242235,tested,0,0
242236,under,0,0
242237,code,0,0
242238,by,0,0
242239,polymerase,0,0
242240,chain,0,0
242241,reaction,0,0
242242,(,0,0
242243,PCR,0,0
242244,),0,0
242245,in,0,0
242246,one,0,0
242247,laboratory,0,0
242248,.,0,0
242249,The,0,0
242250,median,0,0
242251,number,0,0
242252,of,0,0
242253,samples,0,0
242254,collected,0,0
242255,from,0,0
242256,each,0,0
242257,patient,0,0
242258,was,0,0
242259,5,0,0
242260,for,0,0
242261,blood,0,0
242262,(,0,0
242263,range,0,0
242264,",",0,0
242265,0-15,0,0
242266,),0,0
242267,and,0,0
242268,5,0,0
242269,for,0,0
242270,urine,0,0
242271,(,0,0
242272,range,0,0
242273,",",0,0
242274,0-15,0,1
242275,),0,0
242276,.,0,0
242277,Both,0,0
242278,baseline,0,0
242279,PCR,0,0
242280,viremia,0,0
242281,and,0,0
242282,PCR,0,0
242283,viruria,0,0
242284,were,0,0
242285,significantly,0,0
242286,associated,0,0
242287,with,0,0
242288,future,0,0
242289,cytomegalovirus,0,1
242290,(,0,0
242291,CMV,0,0
242292,),0,0
242293,disease,0,1
242294,(,0,0
242295,P,0,0
242296,=,0,0
242297,.002,0,0
242298,and,0,0
242299,P,0,0
242300,=,0,0
242301,.02,0,0
242302,",",0,0
242303,respectively,0,0
242304,),0,0
242305,.,0,0
242306,The,0,0
242307,greatest,0,0
242308,effect,0,0
242309,of,0,0
242310,valaciclovir,0,0
242311,on,0,0
242312,CMV,0,0
242313,disease,0,1
242314,was,0,0
242315,seen,0,0
242316,in,0,1
242317,patients,0,1
242318,who,0,1
242319,were,0,1
242320,PCR-positive,0,1
242321,in,0,0
242322,blood,0,0
242323,at,0,0
242324,baseline,0,0
242325,(,0,0
242326,P,0,0
242327,=,0,0
242328,.002,0,0
242329,),0,0
242330,",",0,0
242331,although,0,0
242332,a,0,0
242333,significant,0,0
242334,effect,0,0
242335,was,0,0
242336,also,0,0
242337,seen,0,0
242338,in,0,0
242339,those,0,1
242340,who,0,1
242341,were,0,1
242342,PCR-negative,0,1
242343,in,0,0
242344,urine,0,0
242345,(,0,0
242346,P,0,0
242347,=,0,0
242348,.02,0,0
242349,),0,0
242350,.,0,0
242351,Thus,0,0
242352,",",0,0
242353,PCR,0,0
242354,viremia,0,0
242355,provides,0,0
242356,prognostic,0,0
242357,information,0,0
242358,about,0,0
242359,CMV,0,0
242360,disease,0,1
242361,in,0,0
242362,AIDS,0,1
242363,patients,0,1
242364,",",0,0
242365,and,0,0
242366,valaciclovir,0,0
242367,showed,0,0
242368,activity,0,0
242369,as,0,0
242370,both,0,0
242371,a,0,0
242372,preemptive,0,0
242373,and,0,0
242374,prophylactic,0,0
242375,agent,0,0
242376,.,0,0
242377,Safety,0,0
242378,and,0,0
242379,immunogenicity,0,0
242380,of,0,0
242381,a,0,0
242382,combined,0,0
242383,pentavalent,0,0
242384,diphtheria,0,1
242385,",",0,0
242386,tetanus,0,0
242387,",",0,0
242388,acellular,0,0
242389,pertussis,0,0
242390,",",0,0
242391,inactivated,0,0
242392,poliovirus,0,0
242393,and,0,0
242394,Haemophilus,0,0
242395,influenzae,0,0
242396,type,0,1
242397,b-tetanus,0,0
242398,conjugate,0,0
242399,vaccine,0,0
242400,in,0,0
242401,infants,1,1
242402,",",0,0
242403,compared,0,0
242404,with,0,0
242405,a,0,0
242406,whole,0,0
242407,cell,0,0
242408,pertussis,0,0
242409,pentavalent,0,0
242410,vaccine,0,0
242411,.,0,0
242412,BACKGROUND,0,0
242413,We,0,0
242414,compared,0,0
242415,the,0,0
242416,safety,0,0
242417,and,0,0
242418,immunogenicity,0,0
242419,of,0,0
242420,two,0,0
242421,combined,0,0
242422,diphtheria-tetanus-pertussis-inactivated,0,0
242423,poliovirus,0,1
242424,vaccines,0,0
242425,containing,0,0
242426,either,0,0
242427,acellular,0,0
242428,(,0,0
242429,Pa,0,0
242430,",",0,0
242431,SmithKline,0,0
242432,Beecham,0,0
242433,Biologicals,0,0
242434,),0,0
242435,or,0,0
242436,whole,0,0
242437,cell,0,1
242438,(,0,0
242439,Pw,0,0
242440,",",0,0
242441,Pasteur,0,1
242442,Merieux,0,0
242443,Connaught,0,0
242444,),0,0
242445,pertussis,0,0
242446,components,0,0
242447,",",0,0
242448,mixed,0,0
242449,with,0,0
242450,a,0,0
242451,Haemophilus,0,0
242452,influenzae,0,0
242453,type,0,1
242454,b,0,0
242455,polysaccharide,0,0
242456,polyribosylribitol,0,0
242457,phosphate-tetanus,0,0
242458,conjugate,0,0
242459,vaccine,0,0
242460,in,0,0
242461,an,0,0
242462,open,0,0
242463,",",0,0
242464,randomized,0,0
242465,study,0,0
242466,in,0,0
242467,healthy,1,1
242468,infants,1,1
242469,.,1,0
242470,DESIGN,0,0
242471,The,0,0
242472,combined,0,0
242473,vaccines,0,0
242474,were,0,0
242475,given,0,0
242476,at,0,0
242477,2,0,0
242478,",",0,0
242479,4,0,0
242480,",",0,0
242481,6,0,0
242482,and,0,0
242483,12,0,0
242484,months,0,0
242485,of,0,0
242486,age,0,1
242487,",",0,0
242488,and,0,0
242489,serum,0,0
242490,samples,0,0
242491,were,0,0
242492,obtained,0,0
242493,at,0,0
242494,ages,0,1
242495,2,0,0
242496,",",0,0
242497,6,0,0
242498,",",0,0
242499,7,0,0
242500,",",0,0
242501,12,0,0
242502,and,0,0
242503,13,0,1
242504,months,0,0
242505,.,0,1
242506,Adverse,0,0
242507,events,0,0
242508,were,0,0
242509,obtained,0,0
242510,by,0,0
242511,diary,0,0
242512,cards,0,0
242513,.,0,0
242514,RESULTS,0,0
242515,The,1,0
242516,Pa,1,0
242517,group,1,0
242518,(,1,0
242519,n,1,1
242520,=,1,0
242521,101,1,1
242522,),1,0
242523,had,1,0
242524,a,1,0
242525,clearly,1,0
242526,lower,1,0
242527,incidence,1,0
242528,of,1,0
242529,both,1,0
242530,local,1,0
242531,and,1,0
242532,systemic,1,0
242533,adverse,1,0
242534,events,1,0
242535,than,1,0
242536,the,1,0
242537,Pw,1,0
242538,group,1,0
242539,(,1,0
242540,n,1,1
242541,=,1,0
242542,100,1,1
242543,),1,0
242544,.,1,0
242545,Immunogenicity,0,0
242546,was,0,0
242547,comparable,0,0
242548,for,0,0
242549,the,0,0
242550,diphtheria,0,1
242551,and,0,0
242552,tetanus,0,0
242553,components,0,0
242554,",",0,0
242555,but,0,0
242556,significantly,0,0
242557,superior,0,0
242558,for,0,0
242559,pertussis,0,0
242560,toxin,0,0
242561,",",0,0
242562,filamentous,0,0
242563,hemagglutinin,0,0
242564,",",0,0
242565,pertactin,0,0
242566,and,0,0
242567,polioviruses,0,1
242568,1,0,0
242569,",",0,0
242570,2,0,0
242571,and,0,0
242572,3,0,0
242573,in,0,0
242574,the,0,0
242575,Pa,0,0
242576,group,0,0
242577,.,0,0
242578,Both,0,0
242579,groups,0,0
242580,had,0,0
242581,an,0,0
242582,appropriate,0,0
242583,response,0,0
242584,with,0,1
242585,regard,0,0
242586,to,0,0
242587,H.,0,0
242588,influenzae,0,0
242589,type,0,1
242590,b,0,0
242591,polysaccharide,0,0
242592,polyribosylribitol,0,0
242593,phosphate,0,0
242594,",",0,0
242595,but,0,0
242596,the,0,0
242597,dynamics,0,0
242598,of,0,0
242599,the,0,0
242600,response,0,0
242601,were,0,0
242602,significantly,0,0
242603,different,0,0
242604,:,0,1
242605,geometric,0,0
242606,mean,0,0
242607,concentrations,0,0
242608,(,0,0
242609,micrograms,0,0
242610,per,0,0
242611,ml,0,0
242612,),0,0
242613,after,0,0
242614,the,0,0
242615,second,0,0
242616,",",0,0
242617,third,0,0
242618,and,0,0
242619,booster,0,0
242620,doses,0,0
242621,were,0,0
242622,1.27,0,0
242623,",",0,0
242624,5.06,0,0
242625,and,0,0
242626,23.12,0,0
242627,in,0,0
242628,the,0,0
242629,Pa,0,0
242630,group,0,0
242631,and,0,0
242632,2.72,0,0
242633,",",0,0
242634,6.66,0,0
242635,and,0,0
242636,13.59,0,0
242637,in,0,0
242638,the,0,0
242639,Pw,0,0
242640,group,0,0
242641,",",0,0
242642,respectively,0,0
242643,(,0,0
242644,P,0,0
242645,=,0,0
242646,0.0002,0,0
242647,after,0,0
242648,second,0,0
242649,dose,0,0
242650,;,0,0
242651,P,0,0
242652,=,0,0
242653,0.0005,0,0
242654,after,0,0
242655,booster,0,0
242656,),0,0
242657,.,0,0
242658,CONCLUSION,0,0
242659,The,0,0
242660,presently,0,0
242661,studied,0,0
242662,diphtheria,0,0
242663,",",0,0
242664,tetanus,0,0
242665,",",0,0
242666,acellular,0,0
242667,pertussis-H.,0,0
242668,influenzae,0,0
242669,b,0,0
242670,vaccine,0,0
242671,conjugated,0,0
242672,to,0,0
242673,tetanus,0,0
242674,toxoid,0,0
242675,combination,0,0
242676,was,0,0
242677,at,0,0
242678,least,0,0
242679,as,0,0
242680,immunogenic,0,0
242681,as,0,0
242682,the,0,0
242683,diphtheria,0,0
242684,",",0,0
242685,tetanus,0,0
242686,",",0,0
242687,whole,0,0
242688,cell,0,0
242689,pertussis-H.,0,1
242690,influenzae,0,0
242691,b,0,0
242692,vaccine,0,0
242693,conjugated,0,0
242694,to,0,0
242695,tetanus,0,0
242696,toxoid,0,0
242697,combination,0,0
242698,",",0,0
242699,with,0,0
242700,a,0,0
242701,significantly,0,0
242702,better,0,0
242703,safety,0,0
242704,profile,0,0
242705,.,0,0
242706,This,0,0
242707,is,0,0
242708,of,0,0
242709,obvious,0,0
242710,importance,0,0
242711,in,0,0
242712,countries,0,0
242713,where,0,0
242714,inactivated,0,0
242715,poliovirus,0,0
242716,vaccine,0,0
242717,is,0,0
242718,part,0,0
242719,of,0,0
242720,the,0,0
242721,routine,0,0
242722,infant,0,1
242723,immunization,0,0
242724,programs,0,0
242725,.,0,1
242726,A,0,0
242727,carbohydrate,0,0
242728,meal,0,0
242729,attenuates,0,0
242730,the,0,0
242731,forearm,0,0
242732,vasoconstrictor,0,0
242733,response,0,0
242734,to,0,0
242735,lower,0,0
242736,body,0,0
242737,subatmospheric,0,0
242738,pressure,0,0
242739,in,0,0
242740,healthy,1,1
242741,young,1,1
242742,adults,1,1
242743,.,1,0
242744,The,0,0
242745,cardiovascular,0,0
242746,(,0,0
242747,CV,0,0
242748,),0,0
242749,responses,0,0
242750,to,0,0
242751,meal,0,0
242752,ingestion,0,0
242753,and,0,0
242754,orthostasis,0,0
242755,are,0,0
242756,well,0,0
242757,established,0,0
242758,.,0,0
242759,The,0,0
242760,effect,0,0
242761,of,0,0
242762,meal,0,0
242763,ingestion,0,0
242764,and,0,0
242765,meal,0,0
242766,composition,0,0
242767,on,0,0
242768,the,0,0
242769,CV,0,0
242770,responses,0,0
242771,to,0,0
242772,orthostasis,0,0
242773,are,0,0
242774,unknown,0,0
242775,.,0,0
242776,The,0,0
242777,effect,0,0
242778,of,0,0
242779,high,0,0
242780,carbohydrate,0,0
242781,(,0,0
242782,HC,0,0
242783,),0,0
242784,and,0,0
242785,high,0,0
242786,fat,0,0
242787,(,0,0
242788,HF,0,0
242789,),0,0
242790,meal,0,0
242791,ingestion,0,0
242792,on,0,0
242793,the,0,0
242794,CV,0,0
242795,responses,0,0
242796,to,0,0
242797,simulated,0,0
242798,orthostatic,0,0
242799,stress,0,0
242800,(,0,0
242801,using,0,0
242802,graded,0,0
242803,lower,0,0
242804,body,0,0
242805,subatmospheric,0,0
242806,pressure,0,0
242807,(,0,0
242808,LBSP,0,0
242809,),0,0
242810,),0,0
242811,was,0,0
242812,assessed,0,0
242813,in,0,0
242814,nine,1,1
242815,healthy,1,1
242816,young,1,1
242817,volunteers,1,1
242818,.,1,1
242819,Cardiac,0,0
242820,output,0,0
242821,(,0,0
242822,CO,0,0
242823,),0,0
242824,",",0,0
242825,forearm,0,0
242826,blood,0,0
242827,flow,0,0
242828,(,0,0
242829,FABF,0,0
242830,),0,0
242831,heart,0,1
242832,rate,0,0
242833,(,0,0
242834,HR,0,0
242835,),0,0
242836,and,0,0
242837,blood,0,0
242838,pressure,0,0
242839,(,0,0
242840,BP,0,0
242841,),0,0
242842,were,0,0
242843,measured,0,0
242844,before,0,0
242845,and,0,0
242846,during,0,0
242847,LBSP,0,0
242848,while,0,0
242849,fasted,0,0
242850,and,0,0
242851,after,0,0
242852,eating,0,0
242853,HC,0,0
242854,and,0,0
242855,HF,0,1
242856,meals,0,0
242857,.,0,0
242858,Ingestion,0,0
242859,of,0,0
242860,both,0,0
242861,meals,0,0
242862,led,0,0
242863,to,0,0
242864,an,0,0
242865,increase,0,0
242866,in,0,0
242867,CO,0,0
242868,and,0,0
242869,HR,0,0
242870,.,0,0
242871,Both,0,0
242872,meals,0,0
242873,resulted,0,0
242874,in,0,0
242875,a,0,0
242876,fall,0,0
242877,in,0,0
242878,total,0,1
242879,peripheral,0,0
242880,resistance,0,0
242881,but,0,0
242882,only,0,0
242883,HC,0,0
242884,led,0,0
242885,to,0,0
242886,a,0,0
242887,significant,0,0
242888,fall,0,0
242889,in,0,0
242890,BP,0,0
242891,(,0,0
242892,p,0,0
242893,<,0,0
242894,0.05,0,0
242895,),0,0
242896,.,0,0
242897,HF,0,0
242898,had,0,0
242899,no,0,0
242900,effect,0,0
242901,on,0,0
242902,the,0,0
242903,CV,0,0
242904,responses,0,0
242905,to,0,0
242906,LBSP,0,0
242907,",",0,0
242908,whereas,0,0
242909,HC,0,0
242910,resulted,0,0
242911,in,0,0
242912,attenuated,0,0
242913,FABF,0,0
242914,and,0,0
242915,forearm,0,0
242916,vascular,0,0
242917,resistance,0,0
242918,responses,0,0
242919,(,0,0
242920,p,0,0
242921,<,0,0
242922,0.05,0,0
242923,),0,0
242924,.,0,0
242925,Thus,0,0
242926,",",0,0
242927,ingestion,0,0
242928,of,0,0
242929,an,0,0
242930,HC,0,0
242931,meal,0,0
242932,significantly,0,0
242933,attenuates,0,0
242934,the,0,0
242935,forearm,0,0
242936,vascular,0,0
242937,response,0,0
242938,to,0,0
242939,orthostatic,0,0
242940,stress,0,0
242941,and,0,0
242942,the,0,0
242943,hypotensive,0,0
242944,effect,0,0
242945,of,0,0
242946,orthostasis,0,0
242947,is,0,0
242948,additive,0,0
242949,to,0,0
242950,that,0,0
242951,occurring,0,0
242952,after,0,0
242953,an,0,0
242954,HC,0,0
242955,meal,0,0
242956,.,0,0
242957,Twice-a-day,0,0
242958,versus,0,0
242959,four-times-a-day,0,0
242960,ofloxacin,0,0
242961,treatment,0,0
242962,of,0,0
242963,external,0,0
242964,ocular,0,1
242965,infection,0,1
242966,.,0,0
242967,PURPOSE,0,0
242968,The,0,0
242969,purpose,0,0
242970,of,0,0
242971,this,0,0
242972,study,0,0
242973,was,0,0
242974,to,0,0
242975,compare,0,0
242976,the,0,0
242977,efficacies,0,0
242978,of,0,0
242979,0.3,0,0
242980,%,0,0
242981,ofloxacin,0,0
242982,eyedrops,0,0
242983,",",0,0
242984,when,0,0
242985,given,0,0
242986,twice-a-day,0,0
242987,(,0,0
242988,BID,0,0
242989,),0,0
242990,versus,0,0
242991,four-times-a-day,0,0
242992,(,0,0
242993,QID,0,1
242994,),0,0
242995,",",0,0
242996,for,0,0
242997,the,0,0
242998,treatment,0,0
242999,of,0,0
243000,external,0,0
243001,ocular,0,1
243002,disease,0,1
243003,.,0,0
243004,METHOD,0,0
243005,Fifty,1,1
243006,patients,1,1
243007,with,1,1
243008,blepharitis,1,1
243009,",",1,0
243010,conjuctivitis,1,0
243011,",",1,0
243012,or,1,0
243013,blepharoconjunctivitis,1,0
243014,were,0,0
243015,randomly,0,0
243016,assigned,0,0
243017,to,0,0
243018,treatment,0,0
243019,with,0,1
243020,0.3,0,0
243021,%,0,0
243022,ofloxacin,0,0
243023,eyedrops,0,0
243024,",",0,0
243025,BID,0,1
243026,or,0,0
243027,QID,0,0
243028,",",0,0
243029,for,0,0
243030,10,0,1
243031,days,0,0
243032,.,0,1
243033,Signs,0,0
243034,",",0,0
243035,symptoms,0,0
243036,",",0,0
243037,and,0,0
243038,cultures,0,0
243039,were,0,0
243040,evaluated,0,0
243041,at,0,0
243042,the,0,0
243043,beginning,0,0
243044,and,0,0
243045,at,0,0
243046,the,0,0
243047,end,0,0
243048,of,0,0
243049,the,0,0
243050,study,0,0
243051,.,0,0
243052,RESULTS,0,0
243053,The,0,0
243054,clinical,0,0
243055,outcome,0,0
243056,was,0,0
243057,virtually,0,0
243058,identical,0,0
243059,in,0,0
243060,the,0,0
243061,two,0,0
243062,groups,0,0
243063,.,0,0
243064,There,0,0
243065,was,0,0
243066,a,0,0
243067,significant,0,0
243068,decrease,0,0
243069,in,0,0
243070,clinical,0,0
243071,scores,0,0
243072,in,0,0
243073,the,0,0
243074,BID,0,0
243075,and,0,0
243076,QID,0,1
243077,groups,0,0
243078,by,0,0
243079,days,0,0
243080,3,0,0
243081,to,0,0
243082,5,0,0
243083,(,0,0
243084,2.6-3.0,0,0
243085,points,0,0
243086,),0,0
243087,and,0,0
243088,a,0,0
243089,further,0,0
243090,decrease,0,0
243091,by,0,0
243092,day,0,0
243093,11,0,1
243094,(,0,0
243095,4.3-5.0,0,0
243096,points,0,0
243097,),0,0
243098,.,0,0
243099,There,0,0
243100,was,0,0
243101,no,0,0
243102,significant,0,0
243103,difference,0,0
243104,between,0,0
243105,the,0,0
243106,two,0,0
243107,groups,0,0
243108,at,0,0
243109,any,0,0
243110,time,0,0
243111,interval,0,0
243112,.,0,0
243113,Microbiologic,0,0
243114,studies,0,0
243115,showed,0,0
243116,a,0,0
243117,reduction,0,0
243118,in,0,0
243119,colony-forming,0,0
243120,units,0,0
243121,in,0,0
243122,87,0,1
243123,%,0,0
243124,of,0,0
243125,the,0,0
243126,BID,0,0
243127,group,0,0
243128,and,0,0
243129,in,0,0
243130,80,0,0
243131,%,0,0
243132,of,0,0
243133,the,0,0
243134,QID,0,1
243135,group,0,0
243136,.,0,0
243137,CONCLUSION,0,0
243138,The,0,0
243139,treatment,0,0
243140,of,0,0
243141,external,0,0
243142,ocular,0,1
243143,disease,0,1
243144,with,0,1
243145,0.3,0,0
243146,%,0,0
243147,ofloxacin,0,0
243148,eyedrops,0,0
243149,was,0,0
243150,equally,0,0
243151,effective,0,0
243152,when,0,0
243153,given,0,0
243154,BID,0,0
243155,or,0,0
243156,QID,0,1
243157,.,0,0
243158,Effect,0,0
243159,of,0,0
243160,indomethacin,0,0
243161,phonophoresis,0,0
243162,on,0,0
243163,the,0,0
243164,relief,0,0
243165,of,0,0
243166,temporomandibular,1,1
243167,joint,1,1
243168,pain,1,0
243169,.,1,0
243170,The,0,0
243171,pain-relieving,0,0
243172,effect,0,0
243173,of,0,0
243174,indomethacin,0,0
243175,phonophoresis,0,0
243176,on,0,0
243177,temporomandibular,0,1
243178,(,0,0
243179,TMJ,0,0
243180,),0,0
243181,joint,0,0
243182,pain,0,0
243183,was,0,0
243184,evaluated,0,0
243185,in,0,0
243186,a,0,0
243187,double-blind,0,0
243188,",",0,0
243189,placebo-controlled,0,0
243190,clinical,0,0
243191,trial,0,0
243192,.,0,0
243193,Twenty,1,1
243194,subjects,1,1
243195,",",1,1
243196,who,1,1
243197,have,1,1
243198,TMJ,1,1
243199,pain,1,0
243200,",",0,0
243201,were,0,0
243202,included,0,0
243203,for,0,0
243204,this,0,0
243205,study,0,0
243206,and,0,0
243207,randomly,0,0
243208,assigned,0,0
243209,to,0,0
243210,either,0,0
243211,the,0,0
243212,experimental,0,0
243213,group,0,0
243214,(,0,0
243215,n,0,1
243216,=,0,0
243217,10,0,1
243218,),0,0
243219,or,0,0
243220,the,0,0
243221,control,0,0
243222,group,0,0
243223,(,0,0
243224,n,0,1
243225,=,0,0
243226,10,0,1
243227,),0,0
243228,.,0,0
243229,Each,0,0
243230,treatment,0,0
243231,consisted,0,0
243232,of,0,0
243233,the,0,0
243234,application,0,0
243235,of,0,0
243236,ultrasound,0,0
243237,massage,0,0
243238,(,0,0
243239,1.0,0,0
243240,MHz,0,0
243241,",",0,0
243242,0.8,0,0
243243,to,0,0
243244,1.5,0,0
243245,W/cm2,0,0
243246,continuous,0,0
243247,output,0,0
243248,),0,0
243249,for,0,0
243250,15,0,0
243251,minutes,0,0
243252,to,0,0
243253,the,0,0
243254,painful,0,0
243255,temporomandibular,0,1
243256,joint,0,0
243257,.,0,0
243258,As,0,0
243259,a,0,0
243260,conducting,0,0
243261,medium,0,0
243262,",",0,0
243263,1,0,0
243264,%,0,0
243265,indomethacin,0,0
243266,cream,0,0
243267,was,0,0
243268,used,0,0
243269,for,0,0
243270,the,0,0
243271,experimental,0,0
243272,group,0,0
243273,and,0,0
243274,placebo,0,0
243275,cream,0,0
243276,for,0,0
243277,the,0,0
243278,control,0,0
243279,group,0,0
243280,respectively,0,0
243281,.,0,0
243282,Pre-,0,0
243283,and,0,0
243284,post-treatment,0,0
243285,pain,0,0
243286,levels,0,0
243287,and,0,0
243288,pain,0,0
243289,sensitivity,0,0
243290,were,0,0
243291,assessed,0,0
243292,with,0,1
243293,visual,0,0
243294,analogue,0,0
243295,scales,0,0
243296,(,0,0
243297,VAS,0,1
243298,),0,0
243299,and,0,0
243300,pressure,0,0
243301,pain,0,0
243302,threshold,0,0
243303,(,0,0
243304,PPT,0,0
243305,),0,0
243306,.,0,0
243307,Mean,0,0
243308,data,0,0
243309,indicated,0,0
243310,that,0,0
243311,post-treatment,0,0
243312,VAS,0,0
243313,was,0,0
243314,significantly,0,0
243315,decreased,0,0
243316,and,0,0
243317,post-treatment,0,0
243318,PPT,0,0
243319,was,0,0
243320,significantly,0,0
243321,increased,0,0
243322,in,0,0
243323,the,0,0
243324,experimental,0,0
243325,group,0,0
243326,",",0,0
243327,not,0,0
243328,in,0,0
243329,the,0,0
243330,control,0,0
243331,group,0,0
243332,.,0,0
243333,The,0,0
243334,results,0,0
243335,of,0,0
243336,this,0,0
243337,study,0,0
243338,suggest,0,0
243339,that,0,0
243340,indomethacin,0,0
243341,phonophoresis,0,0
243342,provides,0,0
243343,significant,0,0
243344,pain,0,0
243345,relieving,0,0
243346,effect,0,0
243347,over,0,0
243348,the,0,0
243349,TMJ,0,0
243350,pain,0,0
243351,.,0,0
243352,The,0,0
243353,importance,0,0
243354,of,0,0
243355,the,0,0
243356,dual-switch,0,0
243357,valve,0,1
243358,for,0,0
243359,the,0,0
243360,treatment,0,0
243361,of,0,0
243362,adult,1,1
243363,normotensive,1,1
243364,or,1,0
243365,hypertensive,1,1
243366,hydrocephalus,1,1
243367,.,1,0
243368,Since,0,0
243369,the,0,0
243370,beginning,0,0
243371,of,0,0
243372,1995,0,1
243373,the,0,0
243374,new,1,0
243375,hydrostatic,1,0
243376,dual-switch,1,0
243377,valve,1,1
243378,(,1,0
243379,DSV,1,0
243380,),1,0
243381,was,1,0
243382,implanted,1,1
243383,in,1,0
243384,35,1,1
243385,adult,1,1
243386,patients,1,1
243387,with,1,1
243388,hydrocephalus,1,1
243389,of,1,0
243390,different,1,0
243391,etiology,1,0
243392,.,1,1
243393,26,1,0
243394,patients,1,1
243395,suffered,1,1
243396,from,1,0
243397,normotensive,1,1
243398,hydrocephalus,1,1
243399,(,1,0
243400,10,1,0
243401,idiopathic,1,1
243402,and,1,0
243403,16,1,1
243404,symptomatic,1,1
243405,),1,0
243406,",",1,0
243407,and,1,0
243408,9,1,0
243409,patients,1,1
243410,from,1,1
243411,hypertensive,1,1
243412,hydrocephalus,1,1
243413,of,1,0
243414,various,1,0
243415,origin,1,1
243416,.,1,0
243417,The,0,0
243418,first,0,0
243419,21,0,1
243420,cases,0,1
243421,of,0,0
243422,this,0,0
243423,cohort,0,1
243424,were,0,0
243425,compared,0,0
243426,in,0,0
243427,a,0,0
243428,randomized,0,0
243429,study,0,0
243430,with,0,1
243431,a,0,0
243432,comparable,0,0
243433,group,0,0
243434,of,0,0
243435,21,0,1
243436,hydrocephalic,0,1
243437,patients,0,1
243438,who,0,1
243439,received,0,1
243440,a,0,1
243441,conventional,0,0
243442,differential-pressure,0,0
243443,(,0,0
243444,DP-,0,0
243445,),0,0
243446,valve,0,1
243447,.,0,0
243448,The,0,0
243449,clinical,0,0
243450,status,0,0
243451,and,0,0
243452,CT,0,0
243453,were,0,0
243454,assessed,0,0
243455,prior,0,0
243456,to,0,0
243457,shunting,0,0
243458,",",0,0
243459,14,0,0
243460,days,0,0
243461,and,0,0
243462,3,0,0
243463,and,0,0
243464,6,0,0
243465,months,0,0
243466,after,0,0
243467,the,0,0
243468,operation,0,0
243469,.,0,0
243470,The,0,0
243471,reduction,0,0
243472,of,0,0
243473,ventricular,0,0
243474,size,0,0
243475,was,0,0
243476,evaluated,0,0
243477,by,0,0
243478,the,0,0
243479,measurement,0,0
243480,of,0,0
243481,the,0,0
243482,Evans,0,0
243483,Index,0,0
243484,.,0,0
243485,The,0,0
243486,CT,0,0
243487,follow-up,0,0
243488,in,0,0
243489,the,0,0
243490,DSV,0,0
243491,group,0,0
243492,was,0,0
243493,characterized,0,0
243494,by,0,0
243495,an,0,0
243496,only,0,0
243497,minimal,0,0
243498,(,0,0
243499,14,0,0
243500,),0,0
243501,or,0,0
243502,only,0,0
243503,slight,0,0
243504,(,0,0
243505,16,0,1
243506,),0,0
243507,reduction,0,0
243508,of,0,0
243509,ventricular,0,0
243510,size,0,0
243511,in,0,0
243512,the,0,0
243513,vast,0,0
243514,majority,0,0
243515,of,0,0
243516,cases,0,0
243517,.,0,0
243518,A,0,0
243519,comparison,0,0
243520,of,0,0
243521,21,1,1
243522,patients,1,1
243523,with,0,1
243524,a,0,0
243525,DSV,0,0
243526,and,0,0
243527,the,0,0
243528,patients,0,1
243529,with,0,1
243530,DP,0,0
243531,valves,0,0
243532,",",0,0
243533,evaluated,0,0
243534,by,0,0
243535,measuring,0,0
243536,the,0,0
243537,reduction,0,0
243538,of,0,0
243539,the,0,0
243540,Evans,0,0
243541,Index,0,0
243542,",",0,0
243543,revealed,0,0
243544,a,0,0
243545,distinctly,0,0
243546,higher,0,0
243547,percentage,0,0
243548,of,0,0
243549,significant,0,0
243550,regressions,0,0
243551,in,0,0
243552,the,0,0
243553,DP,0,0
243554,valve,0,1
243555,collective,0,0
243556,",",0,0
243557,without,0,0
243558,doubt,0,0
243559,due,0,0
243560,to,0,0
243561,chronic,0,1
243562,overdrainage,0,0
243563,.,0,0
243564,The,0,0
243565,overall,0,0
243566,clinical,0,0
243567,result,0,0
243568,of,0,0
243569,our,0,0
243570,35,1,1
243571,patients,1,1
243572,with,0,1
243573,a,0,0
243574,DSV,0,0
243575,was,0,0
243576,excellent,0,0
243577,and,0,0
243578,good,0,0
243579,in,0,0
243580,31,0,1
243581,patients,0,1
243582,",",0,0
243583,but,0,0
243584,the,0,0
243585,outcome,0,0
243586,seems,0,0
243587,to,0,0
243588,be,0,0
243589,more,0,0
243590,dependent,0,0
243591,on,0,0
243592,the,0,0
243593,preshunt,0,0
243594,damage,0,0
243595,of,0,0
243596,the,0,0
243597,brain,0,0
243598,than,0,0
243599,on,0,0
243600,hydrocephalic,0,1
243601,aspects,0,0
243602,.,0,0
243603,A,0,0
243604,neglegible,0,0
243605,incidence,0,0
243606,of,0,0
243607,subdural,0,0
243608,effusions,0,1
243609,in,0,0
243610,the,0,0
243611,DSV,0,0
243612,group,0,0
243613,compared,0,0
243614,to,0,0
243615,11,0,0
243616,cases,0,0
243617,in,0,0
243618,the,0,0
243619,DP,0,0
243620,valve,0,1
243621,collective,0,0
243622,reflects,0,0
243623,the,0,0
243624,ability,0,0
243625,of,0,0
243626,the,0,0
243627,DSV,0,0
243628,to,0,0
243629,prevent,0,0
243630,overdrainage,0,0
243631,.,0,0
243632,The,0,0
243633,capability,0,0
243634,of,0,0
243635,the,0,0
243636,DSV,0,0
243637,to,0,0
243638,maintain,0,0
243639,the,0,0
243640,IVP,0,0
243641,within,0,0
243642,physiological,0,0
243643,limits,0,0
243644,after,0,0
243645,shunting,0,1
243646,",",0,0
243647,especially,0,0
243648,in,0,0
243649,the,0,0
243650,upright,0,0
243651,position,0,0
243652,",",0,0
243653,is,0,0
243654,documented,0,0
243655,by,0,0
243656,a,0,0
243657,comparison,0,0
243658,with,0,0
243659,possible,0,0
243660,unphysiological,0,0
243661,IVP,0,0
243662,variations,0,0
243663,in,0,0
243664,other,0,0
243665,valve,0,1
243666,constructions,0,0
243667,",",0,0
243668,which,0,0
243669,depend,0,0
243670,on,0,0
243671,the,0,0
243672,level,0,0
243673,of,0,0
243674,implantation,0,0
243675,",",0,0
243676,subcutaneous,0,0
243677,pressure,0,0
243678,or,0,0
243679,CSF,0,0
243680,flow,0,0
243681,through,0,0
243682,the,0,0
243683,valve,0,1
243684,.,0,0
243685,Primary,0,1
243686,glaucoma,0,1
243687,triple,0,0
243688,procedure,0,0
243689,in,0,0
243690,patients,1,1
243691,with,1,1
243692,primary,1,1
243693,open-angle,1,1
243694,glaucoma,1,1
243695,:,1,1
243696,the,0,0
243697,effect,0,0
243698,of,0,0
243699,mitomycin,0,0
243700,C,0,0
243701,in,0,0
243702,patients,0,1
243703,with,0,1
243704,and,0,0
243705,without,0,1
243706,prognostic,0,0
243707,factors,0,0
243708,for,0,0
243709,filtration,0,0
243710,failure,0,1
243711,.,0,0
243712,PURPOSE,0,0
243713,To,0,0
243714,investigate,0,0
243715,the,0,0
243716,effect,0,0
243717,of,0,0
243718,adjunctive,0,0
243719,mitomycin,0,0
243720,C,0,0
243721,on,0,0
243722,primary,1,0
243723,glaucoma,1,1
243724,triple,1,0
243725,procedure,1,0
243726,in,1,0
243727,patients,1,1
243728,with,1,1
243729,primary,1,1
243730,open-angle,1,1
243731,glaucoma,1,1
243732,with,1,1
243733,and,1,0
243734,without,1,1
243735,one,1,0
243736,or,1,0
243737,more,1,0
243738,of,1,0
243739,the,1,0
243740,prognostic,1,0
243741,factors,1,0
243742,for,1,0
243743,filtration,1,0
243744,failure,1,1
243745,of,1,0
243746,primary,1,0
243747,glaucoma,1,1
243748,triple,1,0
243749,procedure,1,0
243750,.,1,0
243751,Those,0,0
243752,factors,0,0
243753,include,0,0
243754,being,0,0
243755,of,0,0
243756,African-American,1,1
243757,race,1,0
243758,",",0,0
243759,having,0,0
243760,a,0,0
243761,preoperative,0,0
243762,intraocular,0,0
243763,pressure,0,0
243764,of,0,0
243765,20,0,1
243766,mm,0,0
243767,Hg,0,0
243768,or,0,0
243769,more,0,0
243770,on,0,0
243771,maximum,0,0
243772,tolerated,0,0
243773,medications,0,0
243774,",",0,0
243775,and,0,0
243776,being,0,0
243777,on,0,0
243778,two,0,0
243779,or,0,1
243780,more,0,0
243781,medications,0,0
243782,preoperatively,0,1
243783,.,0,0
243784,METHODS,0,0
243785,Study,0,0
243786,patients,0,1
243787,consisted,0,1
243788,of,0,0
243789,197,1,1
243790,consecutive,1,1
243791,patients,1,1
243792,with,1,1
243793,primary,1,1
243794,open-angle,1,1
243795,glaucoma,1,1
243796,who,0,1
243797,were,0,1
243798,randomly,0,1
243799,assigned,0,0
243800,to,0,0
243801,receive,0,0
243802,either,0,0
243803,no,0,0
243804,adjunctive,0,0
243805,mitomycin,0,0
243806,C,0,0
243807,(,0,0
243808,101,0,1
243809,eyes,0,1
243810,of,0,0
243811,101,0,1
243812,patients,0,1
243813,),0,0
243814,or,0,0
243815,to,0,0
243816,receive,0,0
243817,adjunctive,0,0
243818,subconjunctival,0,0
243819,mitomycin,0,0
243820,C,0,0
243821,(,0,0
243822,96,0,0
243823,eyes,0,1
243824,of,0,0
243825,96,0,1
243826,patients,0,1
243827,),0,0
243828,during,0,0
243829,the,0,0
243830,primary,0,0
243831,glaucoma,0,1
243832,triple,0,0
243833,procedure,0,0
243834,.,0,0
243835,Kaplan-Meier,0,0
243836,survival,0,0
243837,analysis,0,0
243838,comparisons,0,0
243839,were,0,0
243840,made,0,0
243841,between,0,0
243842,respective,0,0
243843,subgroups,0,0
243844,with,0,1
243845,and,0,0
243846,without,0,1
243847,prognostic,0,0
243848,indicators,0,0
243849,for,0,0
243850,filtration,0,0
243851,failures,0,0
243852,using,0,0
243853,a,0,0
243854,relatively,0,0
243855,stringent,0,0
243856,set,0,0
243857,of,0,0
243858,criteria,0,1
243859,for,0,0
243860,filtration,0,0
243861,success,0,0
243862,of,0,0
243863,primary,0,0
243864,glaucoma,0,1
243865,triple,0,0
243866,procedure,0,0
243867,.,0,0
243868,RESULTS,0,0
243869,There,0,0
243870,was,0,0
243871,no,0,0
243872,statistically,0,0
243873,significant,0,0
243874,(,0,0
243875,P,0,0
243876,=,0,0
243877,.117,0,0
243878,),0,0
243879,difference,0,0
243880,in,0,0
243881,filtration,0,0
243882,success,0,0
243883,of,0,0
243884,primary,0,0
243885,glaucoma,0,1
243886,triple,0,0
243887,procedure,0,0
243888,between,0,0
243889,the,0,0
243890,control,0,0
243891,and,0,0
243892,mitomycin,0,0
243893,C,0,0
243894,groups,0,0
243895,.,0,1
243896,Adjunctive,0,0
243897,mitomycin,0,0
243898,C,0,0
243899,significantly,0,0
243900,(,0,0
243901,P,0,0
243902,<,0,0
243903,.05,0,0
243904,),0,0
243905,improved,0,0
243906,the,0,0
243907,filtration,0,0
243908,outcome,0,0
243909,of,0,0
243910,the,0,0
243911,primary,0,0
243912,glaucoma,0,1
243913,triple,0,0
243914,procedure,0,0
243915,in,0,0
243916,the,0,0
243917,subgroups,0,0
243918,with,0,0
243919,each,0,0
243920,of,0,0
243921,the,0,0
243922,three,0,0
243923,prognostic,0,0
243924,factors,0,0
243925,for,0,0
243926,filtration,0,0
243927,failure,0,1
243928,of,0,0
243929,primary,0,0
243930,glaucoma,0,1
243931,triple,0,0
243932,procedure,0,0
243933,.,0,0
243934,On,0,0
243935,the,0,0
243936,other,0,0
243937,hand,0,0
243938,",",0,0
243939,in,0,0
243940,the,0,0
243941,subgroups,0,0
243942,without,0,0
243943,the,0,0
243944,prognostic,0,0
243945,factors,0,0
243946,",",0,0
243947,adjunctive,0,0
243948,mitomycin,0,0
243949,C,0,0
243950,did,0,0
243951,not,0,0
243952,significantly,0,0
243953,(,0,0
243954,P,0,0
243955,>,0,1
243956,.05,0,0
243957,),0,0
243958,change,0,0
243959,the,0,0
243960,filtration,0,0
243961,outcome,0,0
243962,of,0,0
243963,the,0,0
243964,primary,0,0
243965,glaucoma,0,1
243966,triple,0,0
243967,procedure,0,0
243968,.,0,0
243969,CONCLUSION,0,0
243970,These,0,0
243971,findings,0,0
243972,establish,0,0
243973,the,0,0
243974,basis,0,0
243975,for,0,0
243976,selective,0,0
243977,use,0,0
243978,of,0,0
243979,mitomycin,0,0
243980,C,0,0
243981,in,0,0
243982,patients,1,1
243983,with,1,1
243984,primary,1,1
243985,open-angle,1,1
243986,glaucoma,1,1
243987,undergoing,1,1
243988,primary,1,0
243989,glaucoma,1,1
243990,triple,1,0
243991,procedure,1,0
243992,.,1,0
243993,Determinants,0,0
243994,of,0,0
243995,total,0,1
243996,and,0,0
243997,specific,0,0
243998,IgE,0,1
243999,in,0,0
244000,infants,1,1
244001,with,1,1
244002,atopic,1,1
244003,dermatitis,1,1
244004,.,1,0
244005,ETAC,0,0
244006,Study,0,0
244007,Group,0,1
244008,.,0,0
244009,Early,0,0
244010,Treatment,0,0
244011,of,0,0
244012,the,0,0
244013,Atopic,1,0
244014,Child,1,0
244015,.,1,0
244016,ETAC,1,0
244017,(,1,0
244018,Early,1,0
244019,Treatment,1,0
244020,of,1,0
244021,the,1,0
244022,Atopic,1,0
244023,Child,1,0
244024,),1,0
244025,",",1,0
244026,a,1,0
244027,multi-centre,1,0
244028,predominantly,1,0
244029,European,1,1
244030,study,1,0
244031,to,1,0
244032,investigate,1,0
244033,the,1,0
244034,potential,1,0
244035,for,1,0
244036,cetirizine,1,0
244037,to,1,0
244038,prevent,1,0
244039,the,1,0
244040,development,1,0
244041,of,1,0
244042,asthma,1,1
244043,in,1,0
244044,infants,1,1
244045,with,1,1
244046,atopic,1,0
244047,dermatitis,1,1
244048,has,0,0
244049,completed,0,0
244050,enrollment,0,0
244051,:,0,1
244052,817,1,1
244053,children,1,1
244054,have,0,0
244055,been,0,0
244056,randomised,0,0
244057,to,0,0
244058,18,0,1
244059,months,0,0
244060,',0,1
244061,treatment,0,0
244062,with,0,1
244063,either,0,0
244064,active,0,0
244065,or,0,0
244066,placebo,0,0
244067,and,0,0
244068,a,0,0
244069,subsequent,0,0
244070,18,0,1
244071,months,0,0
244072,of,0,0
244073,post-treatment,0,0
244074,follow-up,0,0
244075,.,0,0
244076,Results,0,0
244077,of,0,0
244078,the,0,0
244079,therapeutic,0,0
244080,effects,0,0
244081,will,0,0
244082,not,0,0
244083,be,0,0
244084,available,0,0
244085,for,0,0
244086,some,0,0
244087,time,0,0
244088,",",0,0
244089,but,0,0
244090,the,0,0
244091,study,0,0
244092,has,0,0
244093,provided,0,0
244094,an,0,0
244095,opportunity,0,0
244096,to,0,0
244097,investigate,0,0
244098,influences,0,0
244099,on,0,0
244100,sensitization,0,0
244101,to,0,0
244102,allergens,0,0
244103,in,0,0
244104,a,0,0
244105,large,1,0
244106,cohort,1,1
244107,of,1,0
244108,1-2,1,0
244109,years,1,1
244110,olds,1,1
244111,with,1,0
244112,already,1,0
244113,established,1,0
244114,atopic,1,0
244115,dermatitis,1,1
244116,",",1,0
244117,resident,1,0
244118,in,1,0
244119,different,1,0
244120,countries,1,1
244121,and,1,0
244122,in,1,0
244123,different,1,0
244124,environments,1,0
244125,.,1,0
244126,The,0,0
244127,study,0,0
244128,shows,0,0
244129,that,0,0
244130,in,0,0
244131,infants,1,1
244132,with,1,1
244133,atopic,1,0
244134,dermatitis,1,1
244135,",",0,0
244136,raised,0,0
244137,serum,0,0
244138,total,0,1
244139,IgE,0,0
244140,has,0,0
244141,significantly,0,0
244142,different,0,0
244143,determinants,0,0
244144,from,0,0
244145,that,0,0
244146,a,0,0
244147,specific,0,0
244148,allergen,0,0
244149,sensitization,0,0
244150,.,0,0
244151,In,0,0
244152,infancy,0,0
244153,",",0,0
244154,increased,0,0
244155,total,0,0
244156,IgE,0,0
244157,is,0,0
244158,more,0,0
244159,affected,0,0
244160,by,0,0
244161,factors,0,0
244162,increasing,0,0
244163,risk,0,0
244164,of,0,0
244165,intercurrent,0,0
244166,infection,0,1
244167,and,0,0
244168,non-specific,0,0
244169,airway,0,0
244170,inflammation,0,0
244171,",",0,0
244172,such,0,0
244173,as,0,0
244174,environmental,0,0
244175,tobacco,0,1
244176,smoke,0,0
244177,exposure,0,0
244178,(,0,0
244179,p,0,0
244180,<,0,0
244181,0.001,0,0
244182,),0,0
244183,and,0,0
244184,the,0,0
244185,use,0,0
244186,of,0,0
244187,gas,0,0
244188,cookers,0,0
244189,(,0,0
244190,p,0,0
244191,=,0,0
244192,0.02,0,0
244193,),0,0
244194,.,0,0
244195,Specific,0,0
244196,allergen,0,0
244197,sensitization,0,0
244198,as,0,0
244199,represented,0,0
244200,by,0,0
244201,detectable,0,0
244202,IgE,0,1
244203,antibodies,0,0
244204,is,0,0
244205,influenced,0,0
244206,primarily,0,0
244207,by,0,0
244208,allergen,0,0
244209,exposure,0,0
244210,.,0,0
244211,In,0,0
244212,Sweden,0,1
244213,",",0,0
244214,low,0,0
244215,level,0,0
244216,exposure,0,0
244217,to,0,0
244218,allergens,0,0
244219,is,0,0
244220,associated,0,0
244221,with,0,0
244222,reduced,0,0
244223,specific,0,0
244224,allergen,0,0
244225,sensitization,0,0
244226,rates,0,0
244227,even,0,0
244228,though,0,0
244229,the,0,0
244230,infants,1,1
244231,already,0,0
244232,have,0,0
244233,atopic,0,0
244234,dermatitis,0,1
244235,.,0,0
244236,Systemic,0,1
244237,hemodynamic,0,0
244238,",",0,0
244239,neurohormonal,0,0
244240,",",0,0
244241,and,0,0
244242,renal,0,0
244243,effects,0,0
244244,of,0,0
244245,a,0,0
244246,steady-state,0,0
244247,infusion,0,0
244248,of,0,0
244249,human,0,0
244250,brain,0,0
244251,natriuretic,0,0
244252,peptide,0,0
244253,in,0,0
244254,patients,1,1
244255,with,1,1
244256,hemodynamically,1,1
244257,decompensated,1,1
244258,heart,1,1
244259,failure,1,1
244260,.,1,0
244261,BACKGROUND,0,0
244262,Human,0,1
244263,brain,0,0
244264,natriuretic,0,0
244265,peptide,0,0
244266,(,0,0
244267,hBNP,0,0
244268,),0,0
244269,is,0,0
244270,a,0,0
244271,promising,0,0
244272,agent,0,0
244273,for,0,0
244274,the,0,0
244275,treatment,0,0
244276,of,0,0
244277,decompensated,0,1
244278,cardiac,0,1
244279,failure,0,1
244280,.,0,0
244281,However,0,0
244282,",",0,0
244283,the,0,0
244284,systemic,0,0
244285,hemodynamic,0,0
244286,",",0,0
244287,neurohormonal,0,0
244288,",",0,0
244289,and,0,0
244290,renal,0,0
244291,effects,0,0
244292,of,0,0
244293,hBNP,0,1
244294,have,0,0
244295,been,0,0
244296,incompletely,0,0
244297,studied,0,0
244298,in,0,0
244299,human,0,0
244300,heart,0,1
244301,failure,0,1
244302,.,0,0
244303,METHODS,0,0
244304,AND,0,0
244305,RESULTS,0,0
244306,The,0,0
244307,effects,0,0
244308,of,0,0
244309,a,0,0
244310,continuous,0,0
244311,4-hour,0,0
244312,infusion,0,0
244313,of,0,0
244314,hBNP,0,0
244315,were,0,0
244316,determined,0,0
244317,in,0,0
244318,16,1,1
244319,decompensated,1,1
244320,heart,1,1
244321,failure,1,1
244322,patients,1,1
244323,in,1,0
244324,an,1,0
244325,invasive,1,0
244326,",",1,0
244327,randomized,1,0
244328,",",1,0
244329,double-blind,1,0
244330,",",1,0
244331,placebo-controlled,1,0
244332,study,1,0
244333,.,1,1
244334,Patients,0,1
244335,were,0,0
244336,evaluated,0,0
244337,during,0,0
244338,three,0,0
244339,4-hour,0,0
244340,study,0,1
244341,periods,0,0
244342,:,0,1
244343,baseline,0,0
244344,",",0,0
244345,treatment,0,0
244346,(,0,0
244347,placebo,0,0
244348,[,0,0
244349,n,0,1
244350,=,0,0
244351,4,0,0
244352,],0,0
244353,versus,0,0
244354,hBNP,0,0
244355,0.025,0,0
244356,or,0,1
244357,0.05,0,0
244358,microgram/kg/min,0,0
244359,[,0,0
244360,n,0,1
244361,=,0,0
244362,12,0,0
244363,],0,0
244364,),0,0
244365,",",0,0
244366,and,0,0
244367,post-treatment,0,0
244368,.,0,0
244369,Urinary,0,0
244370,volume,0,0
244371,losses,0,0
244372,were,0,0
244373,replaced,0,0
244374,hourly,0,0
244375,to,0,0
244376,separate,0,0
244377,the,0,0
244378,vasodilatory,0,0
244379,and,0,0
244380,diuretic,0,0
244381,effects,0,0
244382,of,0,0
244383,hBNP,0,1
244384,.,0,1
244385,Two,0,0
244386,patients,0,1
244387,in,0,0
244388,the,0,0
244389,hBNP,0,0
244390,group,0,0
244391,were,0,0
244392,excluded,0,0
244393,from,0,0
244394,the,0,0
244395,analysis,0,0
244396,because,0,0
244397,of,0,0
244398,adverse,0,0
244399,events,0,0
244400,.,0,0
244401,hBNP,0,0
244402,significantly,0,0
244403,(,0,0
244404,P,0,0
244405,<,0,0
244406,.001,0,0
244407,),0,0
244408,reduced,0,0
244409,right,0,0
244410,atrial,0,1
244411,pressure,0,0
244412,and,0,0
244413,pulmonary,0,0
244414,capillary,0,0
244415,wedge,0,0
244416,pressure,0,0
244417,by,0,0
244418,approximately,0,0
244419,30,0,0
244420,%,0,0
244421,and,0,0
244422,40,0,0
244423,%,0,0
244424,",",0,0
244425,respectively,0,0
244426,.,0,0
244427,hBNP,0,0
244428,also,0,0
244429,significantly,0,0
244430,lowered,0,0
244431,systemic,0,0
244432,vascular,0,0
244433,resistance,0,0
244434,from,0,0
244435,1722,0,0
244436,+/-,0,0
244437,139,0,1
244438,to,0,0
244439,1101,0,1
244440,+/-,0,0
244441,83,0,1
244442,dynes.s.cm-5,0,0
244443,(,0,0
244444,P,0,0
244445,<,0,0
244446,.05,0,0
244447,),0,0
244448,.,0,0
244449,These,0,0
244450,unloading,0,0
244451,effects,0,0
244452,of,0,0
244453,hBNP,0,1
244454,produced,0,0
244455,a,0,0
244456,28,0,0
244457,%,0,0
244458,increase,0,0
244459,in,0,0
244460,cardiac,0,0
244461,index,0,0
244462,(,0,0
244463,P,0,0
244464,<,0,0
244465,.05,0,0
244466,),0,0
244467,with,0,0
244468,no,0,0
244469,change,0,0
244470,in,0,0
244471,heart,0,1
244472,rate,0,0
244473,.,0,0
244474,Compared,0,0
244475,to,0,0
244476,placebo,0,0
244477,",",0,0
244478,hBNP,0,0
244479,decreased,0,0
244480,plasma,0,0
244481,norepinephrine,0,0
244482,and,0,0
244483,aldosterone,0,0
244484,.,0,0
244485,Renal,0,0
244486,hemodynamics,0,0
244487,were,0,0
244488,unaffected,0,0
244489,by,0,0
244490,hBNP,0,0
244491,;,0,0
244492,however,0,0
244493,",",0,0
244494,most,0,0
244495,patients,0,1
244496,were,0,0
244497,resistant,0,1
244498,to,0,0
244499,its,0,0
244500,natriuretic,0,0
244501,effect,0,0
244502,.,0,0
244503,CONCLUSIONS,0,0
244504,1,0,0
244505,),0,0
244506,The,0,0
244507,predominant,0,0
244508,hemodynamic,0,0
244509,effects,0,0
244510,of,0,0
244511,hBNP,0,1
244512,were,0,0
244513,a,0,0
244514,decrease,0,0
244515,in,0,0
244516,cardiac,0,0
244517,preload,0,0
244518,and,0,0
244519,systemic,0,0
244520,vascular,0,0
244521,resistance,0,0
244522,.,0,0
244523,2,0,0
244524,),0,0
244525,hBNP,0,0
244526,also,0,0
244527,improved,0,0
244528,cardiac,0,0
244529,output,0,0
244530,without,0,0
244531,increasing,0,0
244532,heart,0,1
244533,rate,0,0
244534,.,0,0
244535,3,0,0
244536,),0,0
244537,Plasma,0,0
244538,norepinephrine,0,0
244539,and,0,0
244540,aldosterone,0,0
244541,levels,0,0
244542,decreased,0,0
244543,during,0,0
244544,hBNP,0,0
244545,infusion,0,0
244546,.,0,0
244547,4,0,0
244548,),0,0
244549,hBNP,0,0
244550,is,0,0
244551,pharmacologically,0,0
244552,active,0,0
244553,and,0,0
244554,has,0,0
244555,potential,0,0
244556,in,0,0
244557,the,0,0
244558,therapy,0,0
244559,for,0,0
244560,decompensated,0,1
244561,heart,0,1
244562,failure,0,1
244563,.,0,0
244564,Evaluation,0,0
244565,of,0,0
244566,lidocaine,0,0
244567,in,0,0
244568,human,1,0
244569,inferior,1,0
244570,alveolar,1,0
244571,nerve,1,0
244572,block,1,0
244573,.,1,0
244574,The,0,0
244575,purpose,0,0
244576,of,0,0
244577,this,0,0
244578,study,0,0
244579,was,0,0
244580,to,0,0
244581,measure,0,0
244582,the,0,0
244583,degree,0,0
244584,of,0,0
244585,anesthesia,0,0
244586,following,0,0
244587,the,0,0
244588,administration,0,0
244589,of,0,0
244590,3.6,0,0
244591,ml,0,0
244592,of,0,0
244593,2,0,0
244594,%,0,0
244595,lidocaine,0,0
244596,solutions,0,0
244597,with,0,1
244598,either,0,0
244599,"1:50,000",0,0
244600,",",0,0
244601,"1:80,000",0,0
244602,",",0,0
244603,or,0,0
244604,"1:100,000",0,0
244605,for,0,0
244606,inferior,0,0
244607,alveolar,0,0
244608,nerve,0,0
244609,block,0,0
244610,and,0,0
244611,to,0,0
244612,compare,0,0
244613,the,0,0
244614,results,0,0
244615,with,0,1
244616,those,0,0
244617,obtained,0,0
244618,following,0,0
244619,the,0,0
244620,administration,0,0
244621,of,0,0
244622,1.8,0,0
244623,ml,0,0
244624,of,0,0
244625,the,0,0
244626,same,0,0
244627,solutions,0,0
244628,(,0,0
244629,1,0,0
244630,),0,0
244631,.,0,0
244632,With,0,0
244633,the,0,0
244634,use,0,0
244635,of,0,0
244636,a,0,0
244637,repeated,0,0
244638,measures,0,0
244639,design,0,0
244640,",",0,0
244641,30,1,0
244642,subjects,1,1
244643,randomly,1,1
244644,received,1,0
244645,an,1,0
244646,inferior,1,0
244647,alveolar,1,0
244648,injection,1,0
244649,at,1,0
244650,three,1,0
244651,successive,1,1
244652,appointments,1,0
244653,.,1,0
244654,The,0,0
244655,first,0,0
244656,molar,0,0
244657,",",0,0
244658,first,0,0
244659,premolar,0,0
244660,",",0,0
244661,lateral,0,0
244662,incisor,0,0
244663,",",0,0
244664,and,0,0
244665,contralateral,0,0
244666,canine,0,0
244667,(,0,0
244668,control,0,0
244669,),0,0
244670,were,0,0
244671,blindly,0,0
244672,tested,0,0
244673,with,0,0
244674,an,0,0
244675,Analytic,0,0
244676,Technology,0,0
244677,pulp,0,0
244678,tester,0,0
244679,at,0,0
244680,3-min,0,0
244681,cycles,0,0
244682,for,0,0
244683,50,0,1
244684,min,0,0
244685,.,0,0
244686,The,0,0
244687,degree,0,0
244688,of,0,0
244689,anesthesia,0,0
244690,was,0,0
244691,comparable,0,0
244692,for,0,0
244693,the,0,0
244694,three,0,0
244695,solutions,0,0
244696,following,0,0
244697,the,0,0
244698,administration,0,0
244699,of,0,0
244700,3.6,0,0
244701,ml,0,0
244702,of,0,0
244703,each,0,0
244704,solution,0,0
244705,.,0,0
244706,Retrospective,0,0
244707,evaluation,0,0
244708,showed,0,0
244709,that,0,0
244710,the,0,0
244711,volume,0,0
244712,of,0,0
244713,the,0,0
244714,solution,0,0
244715,influenced,0,0
244716,the,0,0
244717,degree,0,0
244718,of,0,0
244719,anesthesia,0,0
244720,.,0,0
244721,Randomised,0,0
244722,trial,0,0
244723,of,0,0
244724,laparoscopic,0,0
244725,versus,0,0
244726,open,0,0
244727,cholecystectomy,0,1
244728,for,0,0
244729,acute,1,1
244730,and,1,0
244731,gangrenous,1,1
244732,cholecystitis,1,1
244733,.,1,0
244734,BACKGROUND,0,0
244735,Laparoscopic,0,0
244736,cholecystectomy,0,1
244737,(,0,0
244738,LC,0,0
244739,),0,0
244740,has,0,0
244741,become,0,0
244742,the,0,0
244743,treatment,0,0
244744,of,0,0
244745,choice,0,0
244746,for,0,0
244747,elective,0,1
244748,cholecystectomy,0,1
244749,",",0,0
244750,but,0,0
244751,controversy,0,0
244752,persists,0,0
244753,over,0,0
244754,use,0,0
244755,of,0,0
244756,this,0,0
244757,approach,0,0
244758,in,0,0
244759,the,0,0
244760,treatment,0,0
244761,of,0,0
244762,acute,1,1
244763,cholecystitis,1,1
244764,.,1,0
244765,We,0,0
244766,undertook,0,0
244767,a,0,0
244768,randomised,0,0
244769,comparison,0,0
244770,of,0,0
244771,the,0,0
244772,safety,0,0
244773,and,0,0
244774,outcome,0,0
244775,of,0,0
244776,LC,0,0
244777,and,0,0
244778,open,0,0
244779,cholecystectomy,0,1
244780,(,0,0
244781,OC,0,0
244782,),0,0
244783,in,0,0
244784,patients,1,1
244785,with,1,1
244786,acute,1,1
244787,cholecystitis,1,1
244788,.,1,0
244789,METHODS,0,0
244790,63,1,0
244791,of,1,0
244792,68,1,1
244793,consecutive,1,1
244794,patients,1,1
244795,who,1,1
244796,met,1,1
244797,criteria,1,1
244798,for,1,0
244799,acute,1,1
244800,cholecystitis,1,1
244801,were,1,0
244802,randomly,1,1
244803,assigned,1,0
244804,OC,1,0
244805,(,1,0
244806,31,1,1
244807,patients,1,1
244808,),1,0
244809,or,1,0
244810,LC,1,0
244811,(,1,0
244812,32,1,1
244813,patients,1,1
244814,),1,0
244815,.,1,0
244816,The,0,0
244817,primary,0,0
244818,endpoints,0,0
244819,were,0,0
244820,hospital,0,1
244821,mortality,0,0
244822,and,0,0
244823,morbidity,0,0
244824,",",0,0
244825,length,0,0
244826,of,0,0
244827,hospital,0,0
244828,stay,0,0
244829,",",0,0
244830,and,0,0
244831,length,0,0
244832,of,0,0
244833,sick,0,1
244834,leave,0,0
244835,from,0,0
244836,work,0,0
244837,.,0,0
244838,Analysis,0,0
244839,was,0,0
244840,by,0,0
244841,intention,0,0
244842,to,0,0
244843,treat,0,0
244844,.,0,0
244845,Suspected,0,0
244846,bile-duct,0,1
244847,stones,0,1
244848,were,0,0
244849,investigated,0,0
244850,by,0,0
244851,preoperative,0,0
244852,endoscopic,0,0
244853,retrograde,0,0
244854,cholangiography,0,0
244855,(,0,0
244856,LC,0,0
244857,group,0,0
244858,),0,0
244859,or,0,0
244860,intraoperative,0,0
244861,cholangiography,0,0
244862,(,0,0
244863,OC,0,0
244864,group,0,0
244865,),0,0
244866,.,0,0
244867,FINDINGS,0,0
244868,The,0,0
244869,two,0,0
244870,randomised,0,0
244871,groups,0,0
244872,were,0,0
244873,similar,0,0
244874,in,0,0
244875,demographic,0,0
244876,",",0,0
244877,physical,0,0
244878,",",0,0
244879,and,0,0
244880,clinical,0,0
244881,characteristics,0,0
244882,.,0,1
244883,48,0,0
244884,%,0,0
244885,of,0,0
244886,the,0,0
244887,patients,0,1
244888,in,0,0
244889,the,0,0
244890,OC,0,0
244891,group,0,0
244892,and,0,0
244893,59,0,0
244894,%,0,0
244895,in,0,0
244896,the,0,0
244897,LC,0,0
244898,group,0,0
244899,were,0,0
244900,older,0,1
244901,than,0,0
244902,60,0,1
244903,years,0,1
244904,.,0,1
244905,13,0,0
244906,patients,0,1
244907,in,0,0
244908,each,0,0
244909,group,0,0
244910,had,0,0
244911,gangrene,0,1
244912,or,0,0
244913,empyema,0,0
244914,",",0,0
244915,and,0,0
244916,one,0,0
244917,in,0,0
244918,each,0,0
244919,group,0,0
244920,had,0,0
244921,perforation,0,0
244922,of,0,0
244923,the,0,0
244924,gallbladder,0,0
244925,causing,0,0
244926,diffuse,0,0
244927,peritonitis,0,1
244928,.,0,0
244929,Five,0,0
244930,(,0,0
244931,16,0,1
244932,%,0,0
244933,),0,0
244934,patients,0,1
244935,in,0,0
244936,the,0,0
244937,LC,0,0
244938,group,0,0
244939,required,0,0
244940,conversion,0,0
244941,to,0,0
244942,OC,0,0
244943,",",0,0
244944,in,0,0
244945,most,0,0
244946,because,0,0
244947,severe,0,1
244948,inflammation,0,0
244949,distorted,0,0
244950,the,0,0
244951,anatomy,0,0
244952,of,0,0
244953,Calot,0,0
244954,'s,0,1
244955,triangle,0,0
244956,.,0,0
244957,There,0,0
244958,were,0,0
244959,no,0,0
244960,deaths,0,0
244961,or,0,0
244962,bile-duct,0,1
244963,lesions,0,0
244964,in,0,0
244965,either,0,0
244966,group,0,0
244967,",",0,0
244968,but,0,0
244969,the,0,0
244970,postoperative,0,0
244971,complication,0,0
244972,rate,0,0
244973,was,0,0
244974,significantly,0,0
244975,(,0,0
244976,p=0.0048,0,0
244977,),0,0
244978,higher,0,0
244979,in,0,0
244980,the,0,0
244981,OC,0,0
244982,than,0,0
244983,in,0,0
244984,the,0,0
244985,LC,0,0
244986,group,0,0
244987,:,0,1
244988,seven,0,0
244989,(,0,0
244990,23,0,1
244991,%,0,0
244992,),0,0
244993,patients,0,1
244994,had,0,0
244995,major,0,0
244996,and,0,0
244997,six,0,0
244998,(,0,0
244999,19,0,1
245000,%,0,0
245001,),0,0
245002,minor,0,0
245003,complications,0,0
245004,after,0,0
245005,OC,0,0
245006,",",0,0
245007,whereas,0,0
245008,only,0,0
245009,one,0,0
245010,(,0,0
245011,3,0,0
245012,%,0,0
245013,),0,0
245014,minor,0,0
245015,complication,0,0
245016,occurred,0,0
245017,after,0,0
245018,LC,0,0
245019,.,0,0
245020,The,0,0
245021,postoperative,0,0
245022,hospital,0,0
245023,stay,0,0
245024,was,0,0
245025,significantly,0,0
245026,shorter,0,0
245027,in,0,0
245028,the,0,0
245029,LC,0,0
245030,than,0,0
245031,the,0,0
245032,OC,0,0
245033,group,0,0
245034,(,0,0
245035,median,0,0
245036,4,0,0
245037,[,0,0
245038,IQR,0,0
245039,2-5,0,1
245040,],0,0
245041,vs,0,0
245042,6,0,0
245043,[,0,0
245044,5-8,0,1
245045,],0,1
245046,days,0,0
245047,;,0,0
245048,p=0.0063,0,0
245049,),0,0
245050,.,0,0
245051,Mean,0,0
245052,length,0,0
245053,of,0,0
245054,sick,0,1
245055,leave,0,0
245056,was,0,0
245057,shorter,0,0
245058,in,0,0
245059,the,0,0
245060,LC,0,0
245061,group,0,0
245062,(,0,0
245063,13.9,0,0
245064,vs,0,0
245065,30.1,0,0
245066,days,0,0
245067,;,0,0
245068,95,0,0
245069,%,0,0
245070,CI,0,0
245071,for,0,0
245072,difference,0,0
245073,10.9-21.7,0,0
245074,),0,0
245075,.,0,0
245076,INTERPRETATION,0,0
245077,Even,0,0
245078,though,0,0
245079,LC,0,0
245080,for,0,0
245081,acute,0,1
245082,and,0,0
245083,gangrenous,0,1
245084,cholecystitis,0,1
245085,is,0,0
245086,technically,0,0
245087,demanding,0,0
245088,",",0,0
245089,in,0,0
245090,experienced,0,0
245091,hands,0,0
245092,it,0,0
245093,is,0,0
245094,safe,0,0
245095,and,0,0
245096,effective,0,0
245097,.,0,0
245098,It,0,0
245099,does,0,0
245100,not,0,0
245101,increase,0,0
245102,the,0,0
245103,mortality,0,0
245104,rate,0,0
245105,",",0,0
245106,and,0,0
245107,the,0,0
245108,morbidity,0,0
245109,rate,0,0
245110,seems,0,0
245111,to,0,0
245112,be,0,0
245113,even,0,0
245114,lower,0,0
245115,than,0,0
245116,that,0,0
245117,in,0,0
245118,OC,0,0
245119,.,0,0
245120,However,0,0
245121,",",0,0
245122,a,0,0
245123,moderately,0,0
245124,high,0,0
245125,conversion,0,0
245126,rate,0,0
245127,must,0,0
245128,be,0,0
245129,accepted,0,0
245130,.,0,0
245131,Diet,0,0
245132,design,0,0
245133,for,0,0
245134,a,0,0
245135,multicenter,0,0
245136,controlled,0,0
245137,feeding,0,0
245138,trial,0,0
245139,:,0,1
245140,the,0,0
245141,DELTA,0,0
245142,program,0,0
245143,.,0,0
245144,Delta,1,0
245145,Research,1,0
245146,Group,1,1
245147,.,1,0
245148,OBJECTIVE,0,0
245149,To,0,0
245150,describe,0,0
245151,the,0,0
245152,process,0,0
245153,and,0,0
245154,results,0,0
245155,of,0,0
245156,diet,0,0
245157,standardization,0,0
245158,",",0,0
245159,diet,0,0
245160,validation,0,0
245161,",",0,0
245162,and,0,0
245163,monitoring,0,0
245164,of,0,0
245165,diet,0,0
245166,composition,0,0
245167,",",0,0
245168,which,0,0
245169,were,0,0
245170,key,0,0
245171,components,0,0
245172,of,0,0
245173,protocol,0,0
245174,1,0,0
245175,of,0,1
245176,Dietary,0,0
245177,Effects,0,0
245178,on,0,1
245179,Lipoproteins,0,1
245180,and,0,0
245181,Thrombogenic,0,0
245182,Activity,0,0
245183,(,0,0
245184,DELTA-1,0,0
245185,),0,0
245186,",",0,0
245187,the,0,0
245188,initial,0,0
245189,protocol,0,0
245190,in,0,0
245191,a,0,0
245192,program,0,0
245193,of,0,0
245194,multicenter,0,0
245195,human,0,0
245196,feeding,0,0
245197,studies,0,0
245198,designed,0,0
245199,to,0,0
245200,evaluate,0,0
245201,the,0,0
245202,effects,0,0
245203,of,0,0
245204,amount,0,0
245205,and,0,0
245206,type,0,1
245207,of,0,0
245208,fat,0,0
245209,on,0,0
245210,lipoproteins,0,0
245211,and,0,0
245212,hemostasis,0,0
245213,parameters,0,0
245214,in,0,0
245215,various,1,0
245216,demographic,1,0
245217,groups,1,0
245218,.,1,1
245219,DESIGN,0,0
245220,DELTA-1,0,0
245221,was,0,0
245222,based,0,0
245223,on,0,0
245224,a,0,0
245225,randomized,0,0
245226,",",0,0
245227,blinded,0,0
245228,",",0,0
245229,crossover,0,0
245230,experimental,0,0
245231,design,0,0
245232,.,0,1
245233,Three,0,0
245234,diets,0,0
245235,were,0,0
245236,fed,0,0
245237,for,0,0
245238,8,0,0
245239,weeks,0,0
245240,to,0,0
245241,103,1,1
245242,healthy,1,1
245243,men,1,1
245244,and,1,0
245245,women,1,1
245246,aged,1,1
245247,22,1,1
245248,to,1,0
245249,67,1,1
245250,years,1,1
245251,at,1,0
245252,4,1,0
245253,field,1,0
245254,centers,1,1
245255,.,1,1
245256,Diet,0,0
245257,A,0,0
245258,",",0,0
245259,an,0,0
245260,average,0,0
245261,American,0,1
245262,diet,0,0
245263,",",0,0
245264,was,0,0
245265,designed,0,0
245266,to,0,0
245267,provide,0,0
245268,37,0,0
245269,%,0,0
245270,of,0,0
245271,energy,0,0
245272,from,0,0
245273,fat,0,0
245274,",",0,0
245275,16,0,0
245276,%,0,0
245277,of,0,0
245278,energy,0,0
245279,from,0,0
245280,saturated,0,0
245281,fatty,0,0
245282,acids,0,0
245283,(,0,0
245284,SFAs,0,1
245285,),0,0
245286,;,0,0
245287,diet,0,0
245288,B,0,0
245289,(,0,0
245290,step,0,0
245291,1,0,0
245292,diet,0,0
245293,),0,0
245294,was,0,0
245295,designed,0,0
245296,to,0,0
245297,provide,0,0
245298,30,0,0
245299,%,0,0
245300,of,0,0
245301,energy,0,0
245302,from,0,0
245303,fat,0,0
245304,",",0,0
245305,9,0,0
245306,%,0,0
245307,of,0,0
245308,energy,0,0
245309,from,0,1
245310,SFA,0,1
245311,;,0,0
245312,and,0,0
245313,diet,0,0
245314,C,0,0
245315,(,0,0
245316,low,0,0
245317,SFA,0,1
245318,diet,0,0
245319,),0,0
245320,was,0,0
245321,designed,0,0
245322,to,0,0
245323,provide,0,0
245324,26,0,0
245325,%,0,0
245326,of,0,0
245327,energy,0,0
245328,from,0,0
245329,fat,0,0
245330,",",0,0
245331,5,0,0
245332,%,0,0
245333,of,0,0
245334,energy,0,0
245335,from,0,0
245336,SFA,0,1
245337,.,0,1
245338,Key,0,0
245339,features,0,0
245340,of,0,0
245341,diet,0,0
245342,standardization,0,0
245343,included,0,1
245344,central,0,0
245345,procurement,0,0
245346,of,0,0
245347,fat-containing,0,0
245348,foods,0,0
245349,",",0,0
245350,inclusion,0,0
245351,of,0,0
245352,standard,0,0
245353,ingredients,0,0
245354,",",0,0
245355,precision,0,0
245356,weighing,0,1
245357,of,0,0
245358,foods,0,1
245359,--,0,1
245360,especially,0,0
245361,sources,0,0
245362,of,0,0
245363,fat,0,0
245364,and,0,0
245365,cholesterol,0,0
245366,--,0,0
245367,and,0,0
245368,use,0,0
245369,of,0,0
245370,standardized,0,0
245371,written,0,0
245372,procedures,0,0
245373,.,0,0
245374,SETTING,0,0
245375,For,0,0
245376,menu,0,0
245377,validation,0,0
245378,",",0,0
245379,a,0,0
245380,set,0,0
245381,of,0,0
245382,12,0,0
245383,menus,0,0
245384,for,0,0
245385,each,0,0
245386,diet,0,0
245387,was,0,0
245388,prepared,0,0
245389,in,0,0
245390,duplicate,0,0
245391,and,0,0
245392,chemically,0,0
245393,assayed,0,0
245394,.,0,0
245395,For,0,0
245396,monitoring,0,0
245397,of,0,0
245398,diet,0,0
245399,composition,0,0
245400,during,0,0
245401,the,0,0
245402,study,0,0
245403,",",0,0
245404,an,0,0
245405,8-day,0,0
245406,diet,0,0
245407,cycle,0,0
245408,(,0,0
245409,6,0,0
245410,weekday,0,0
245411,and,0,0
245412,2,0,0
245413,weekend,0,0
245414,menus,0,0
245415,),0,0
245416,was,0,0
245417,sampled,0,0
245418,by,0,0
245419,every,0,0
245420,field,0,0
245421,center,0,1
245422,twice,0,0
245423,during,0,0
245424,each,0,0
245425,of,0,0
245426,3,0,0
245427,feeding,0,0
245428,periods,0,0
245429,.,0,1
245430,STATISTICAL,0,0
245431,ANALYSES,0,0
245432,Means,0,0
245433,(,0,0
245434,+/-,0,0
245435,standard,0,0
245436,error,0,0
245437,),0,0
245438,were,0,0
245439,calculated,0,0
245440,and,0,0
245441,compared,0,0
245442,with,0,0
245443,target,0,0
245444,nutrient,0,0
245445,specifications,0,0
245446,.,0,1
245447,RESULTS,0,0
245448,DELTA-1,0,0
245449,was,0,0
245450,able,0,0
245451,to,0,0
245452,provide,0,0
245453,a,0,0
245454,standardized,0,0
245455,diet,0,0
245456,that,0,0
245457,met,0,1
245458,nutrient,0,0
245459,specifications,0,0
245460,across,0,0
245461,4,0,0
245462,field,0,0
245463,centers,0,1
245464,over,0,0
245465,24,0,0
245466,weeks,0,0
245467,of,0,0
245468,participant,0,0
245469,feeding,0,0
245470,spanning,0,0
245471,a,0,0
245472,total,0,1
245473,of,0,0
245474,8,0,0
245475,months,0,0
245476,.,0,1
245477,APPLICATIONS,0,0
245478,Prestudy,0,0
245479,chemical,0,0
245480,validation,0,0
245481,of,0,0
245482,menus,0,0
245483,and,0,0
245484,continuous,0,0
245485,sampling,0,0
245486,and,0,0
245487,assay,0,0
245488,of,0,0
245489,diets,0,0
245490,throughout,0,0
245491,the,0,0
245492,study,0,0
245493,are,0,0
245494,essential,0,0
245495,to,0,0
245496,standardize,0,0
245497,experimental,0,0
245498,diets,0,0
245499,and,0,0
245500,to,0,0
245501,ensure,0,0
245502,that,0,0
245503,nutrient,0,0
245504,target,0,0
245505,goals,0,0
245506,are,0,0
245507,met,0,1
245508,and,0,0
245509,maintained,0,0
245510,throughout,0,0
245511,a,0,0
245512,controlled,0,0
245513,multicenter,0,0
245514,feeding,0,0
245515,study,0,0
245516,.,0,0
245517,Relationship,0,0
245518,between,0,0
245519,biliary,0,1
245520,and,0,0
245521,serum,0,0
245522,bile,0,0
245523,acids,0,0
245524,and,0,0
245525,response,0,0
245526,to,0,0
245527,ursodeoxycholic,0,0
245528,acid,0,0
245529,in,0,0
245530,patients,1,1
245531,with,1,1
245532,primary,1,1
245533,biliary,1,1
245534,cirrhosis,1,1
245535,.,1,0
245536,OBJECTIVE,0,0
245537,Ursodeoxycholic,0,0
245538,acid,0,0
245539,(,0,0
245540,UDCA,0,0
245541,),0,0
245542,improves,0,0
245543,liver,0,0
245544,biochemistries,0,0
245545,and,0,0
245546,enriches,0,0
245547,the,0,0
245548,bile,0,0
245549,with,0,0
245550,UDCA,0,0
245551,in,0,0
245552,patients,1,1
245553,with,1,1
245554,primary,1,1
245555,biliary,1,1
245556,cirrhosis,1,1
245557,.,1,0
245558,The,0,0
245559,aim,0,0
245560,of,0,0
245561,this,0,0
245562,study,0,0
245563,was,0,0
245564,to,0,0
245565,determine,0,0
245566,whether,0,0
245567,the,0,0
245568,degree,0,0
245569,of,0,0
245570,enrichment,0,0
245571,of,0,0
245572,bile,0,0
245573,correlated,0,0
245574,with,0,0
245575,that,0,0
245576,of,0,0
245577,serum,0,0
245578,and,0,0
245579,whether,0,0
245580,either,0,0
245581,of,0,0
245582,these,0,0
245583,measures,0,0
245584,correlated,0,0
245585,with,0,1
245586,improvement,0,0
245587,in,0,0
245588,measures,0,0
245589,of,0,0
245590,liver,0,1
245591,disease,0,1
245592,.,0,0
245593,METHODS,0,0
245594,In,0,0
245595,a,0,0
245596,randomized,0,0
245597,study,0,0
245598,",",0,0
245599,biliary,0,1
245600,and,0,0
245601,serum,0,0
245602,bile,0,0
245603,acid,0,0
245604,analyses,0,0
245605,were,0,0
245606,performed,0,0
245607,at,0,0
245608,entry,0,0
245609,and,0,0
245610,after,0,0
245611,2,0,0
245612,yr,0,1
245613,of,0,0
245614,UDCA,0,0
245615,or,0,1
245616,placebo,0,0
245617,.,0,0
245618,RESULTS,0,0
245619,The,0,0
245620,percentage,0,0
245621,of,0,0
245622,ursodeoxycholic,0,0
245623,acid,0,0
245624,in,0,0
245625,bile,0,0
245626,increased,0,0
245627,by,0,0
245628,42,0,0
245629,%,0,0
245630,in,0,0
245631,the,0,0
245632,UDCA,0,0
245633,group,0,0
245634,(,0,0
245635,n,0,1
245636,=,0,0
245637,61,0,1
245638,),0,0
245639,compared,0,0
245640,with,0,1
245641,8,0,0
245642,%,0,0
245643,in,0,0
245644,the,0,0
245645,placebo,0,0
245646,group,0,0
245647,(,0,0
245648,n,0,1
245649,=,0,0
245650,57,0,1
245651,),0,0
245652,(,0,0
245653,p,0,0
245654,<,0,0
245655,0.0001,0,0
245656,),0,0
245657,.,0,0
245658,Measurement,0,0
245659,of,0,0
245660,serum,0,0
245661,bile,0,0
245662,acids,0,0
245663,in,0,0
245664,32,1,1
245665,patients,1,1
245666,(,1,0
245667,18,1,1
245668,ursodeoxycholic,1,1
245669,acid,1,0
245670,",",1,0
245671,14,1,0
245672,placebo,1,0
245673,),1,0
245674,indicated,0,0
245675,that,0,0
245676,at,0,0
245677,2,0,0
245678,yr,0,1
245679,",",0,0
245680,ursodeoxycholic,0,0
245681,acid,0,0
245682,comprised,0,1
245683,65,0,1
245684,%,0,0
245685,of,0,0
245686,serum,0,0
245687,bile,0,0
245688,acids,0,0
245689,in,0,0
245690,the,0,0
245691,treated,0,0
245692,group,0,0
245693,and,0,0
245694,7,0,0
245695,%,0,0
245696,in,0,0
245697,the,0,0
245698,placebo,1,0
245699,group,1,0
245700,.,1,0
245701,Agreement,0,0
245702,between,0,0
245703,bile,0,0
245704,and,0,0
245705,serum,0,0
245706,was,0,0
245707,fair,0,0
245708,(,0,0
245709,r,0,0
245710,=,0,0
245711,0.75,0,0
245712,",",0,0
245713,p,0,0
245714,<,0,0
245715,or,0,0
245716,=,0,0
245717,0.00002,0,0
245718,),0,0
245719,because,0,0
245720,in,0,0
245721,some,0,0
245722,patients,0,1
245723,",",0,0
245724,plasma,0,0
245725,but,0,0
245726,not,0,0
245727,biliary,0,1
245728,bile,0,0
245729,acids,0,0
245730,were,0,0
245731,enriched,0,0
245732,with,0,1
245733,UDCA,0,0
245734,.,0,0
245735,Changes,0,0
245736,in,0,0
245737,biliary,0,1
245738,ursodeoxycholic,0,1
245739,acid,0,0
245740,correlated,0,0
245741,significantly,0,0
245742,but,0,0
245743,weakly,0,0
245744,with,0,0
245745,the,0,0
245746,changes,0,0
245747,in,0,0
245748,serum,0,0
245749,alkaline,0,0
245750,phosphatase,0,0
245751,",",0,0
245752,AST,0,0
245753,",",0,0
245754,bilirubin,0,0
245755,",",0,0
245756,and,0,0
245757,in,0,0
245758,Mayo,0,1
245759,risk,0,0
245760,score,0,0
245761,.,0,0
245762,Correlations,0,0
245763,between,0,0
245764,changes,0,0
245765,in,0,0
245766,serum,0,0
245767,bile,0,0
245768,acid,0,0
245769,composition,0,0
245770,and,0,0
245771,biochemical,0,0
245772,measures,0,0
245773,of,0,0
245774,disease,0,1
245775,activity,0,0
245776,were,0,0
245777,even,0,0
245778,weaker,0,0
245779,.,0,0
245780,CONCLUSION,0,0
245781,The,0,0
245782,measurement,0,0
245783,of,0,0
245784,biliary,0,1
245785,bile,0,0
245786,acids,0,0
245787,is,0,0
245788,superior,0,0
245789,to,0,0
245790,that,0,0
245791,of,0,0
245792,serum,0,0
245793,bile,0,0
245794,acids,0,0
245795,for,0,0
245796,assessing,0,0
245797,the,0,0
245798,compliance,0,0
245799,and,0,0
245800,changes,0,0
245801,in,0,0
245802,the,0,0
245803,circulating,0,0
245804,bile,0,0
245805,acids,0,0
245806,in,0,0
245807,patients,0,1
245808,receiving,0,1
245809,ursodeoxycholic,0,1
245810,acid,0,0
245811,for,0,0
245812,the,0,0
245813,treatment,0,0
245814,of,0,0
245815,primary,0,0
245816,biliary,0,1
245817,cirrhosis,0,1
245818,.,0,0
245819,Furthermore,0,0
245820,",",0,0
245821,measures,0,0
245822,to,0,0
245823,further,0,0
245824,increase,0,0
245825,the,0,0
245826,proportion,0,0
245827,of,0,0
245828,ursodeoxycholic,0,0
245829,acid,0,0
245830,in,0,0
245831,circulating,0,0
245832,bile,0,0
245833,acids,0,0
245834,should,0,0
245835,be,0,0
245836,explored,0,0
245837,.,0,0
245838,Memory,0,0
245839,monitoring,0,0
245840,by,0,0
245841,animals,1,0
245842,and,1,1
245843,humans,1,0
245844,.,1,0
245845,The,0,0
245846,authors,0,0
245847,asked,0,0
245848,whether,0,0
245849,animals,1,0
245850,and,1,0
245851,humans,1,0
245852,would,0,0
245853,use,0,0
245854,similarly,0,0
245855,an,0,0
245856,uncertain,0,0
245857,response,0,0
245858,to,0,0
245859,escape,0,0
245860,indeterminate,0,1
245861,memories,0,0
245862,.,0,1
245863,Monkeys,1,1
245864,and,1,0
245865,humans,1,0
245866,performed,1,0
245867,serial,0,0
245868,probe,0,0
245869,recognition,0,0
245870,tasks,0,0
245871,that,0,0
245872,produced,0,0
245873,differential,0,0
245874,memory,0,0
245875,difficulty,0,0
245876,across,0,0
245877,serial,0,0
245878,positions,0,0
245879,(,0,0
245880,e.g.,0,0
245881,",",0,0
245882,primacy,0,0
245883,and,0,0
245884,recency,0,0
245885,effects,0,0
245886,),0,0
245887,.,0,1
245888,Participants,1,1
245889,were,0,0
245890,given,0,0
245891,an,0,0
245892,escape,0,0
245893,option,0,0
245894,that,0,0
245895,let,0,0
245896,them,0,0
245897,avoid,0,0
245898,any,0,0
245899,trials,0,0
245900,they,0,0
245901,wished,0,0
245902,and,0,0
245903,receive,0,0
245904,a,0,0
245905,hint,0,0
245906,to,0,0
245907,the,0,0
245908,trial,0,0
245909,'s,0,0
245910,answer,0,0
245911,.,0,1
245912,Across,0,0
245913,species,0,0
245914,",",0,0
245915,across,0,0
245916,tasks,0,0
245917,",",0,0
245918,and,0,0
245919,even,0,0
245920,across,0,0
245921,conspecifics,0,0
245922,with,0,1
245923,sharper,0,0
245924,or,0,0
245925,duller,0,0
245926,memories,0,0
245927,",",0,0
245928,monkeys,1,1
245929,and,1,0
245930,humans,1,0
245931,used,0,0
245932,the,0,0
245933,escape,0,0
245934,option,0,0
245935,selectively,0,0
245936,when,0,0
245937,more,0,0
245938,indeterminate,0,0
245939,memory,0,0
245940,traces,0,0
245941,were,0,0
245942,probed,0,0
245943,.,0,0
245944,Their,0,0
245945,pattern,0,0
245946,of,0,0
245947,escaping,0,0
245948,always,0,0
245949,mirrored,0,0
245950,the,0,0
245951,pattern,0,0
245952,of,0,0
245953,their,0,0
245954,primary,0,0
245955,memory,0,0
245956,performance,0,0
245957,across,0,0
245958,serial,0,0
245959,positions,0,0
245960,.,0,1
245961,Signal-detection,0,0
245962,analyses,0,0
245963,confirm,0,0
245964,the,0,0
245965,similarity,0,0
245966,of,0,0
245967,the,0,0
245968,animals,0,0
245969,',0,0
245970,and,0,0
245971,humans,0,1
245972,',0,1
245973,performances,0,0
245974,.,0,1
245975,Optimality,0,0
245976,analyses,0,0
245977,assess,0,0
245978,their,0,0
245979,efficiency,0,0
245980,.,0,0
245981,Several,0,0
245982,aspects,0,0
245983,of,0,0
245984,monkeys,0,1
245985,',0,1
245986,performance,0,0
245987,suggest,0,0
245988,the,0,0
245989,cognitive,0,0
245990,sophistication,0,0
245991,of,0,0
245992,their,0,0
245993,decisions,0,0
245994,to,0,0
245995,escape,0,0
245996,.,0,0
245997,Involvement,0,0
245998,of,0,0
245999,cholecystokininA,0,0
246000,receptors,0,0
246001,in,0,0
246002,transient,0,0
246003,lower,0,0
246004,esophageal,0,1
246005,sphincter,0,1
246006,relaxations,0,0
246007,triggered,0,0
246008,by,0,0
246009,gastric,0,1
246010,distension,0,0
246011,.,0,0
246012,OBJECTIVE,0,0
246013,Transient,0,0
246014,lower,0,0
246015,esophageal,0,1
246016,sphincter,0,0
246017,relaxations,0,0
246018,(,0,0
246019,TLESRs,0,0
246020,),0,0
246021,are,0,0
246022,the,0,0
246023,main,0,0
246024,mechanism,0,0
246025,underlying,0,0
246026,gastroesophageal,0,1
246027,reflux,0,1
246028,.,0,0
246029,In,0,0
246030,the,0,0
246031,present,0,0
246032,study,0,0
246033,we,0,0
246034,evaluated,0,0
246035,the,0,0
246036,effect,0,0
246037,of,0,0
246038,loxiglumide,0,0
246039,",",0,0
246040,a,0,0
246041,specific,0,0
246042,cholecystokininA,0,0
246043,(,0,0
246044,CCKA,0,0
246045,),0,0
246046,-receptor,0,0
246047,antagonist,0,0
246048,",",0,0
246049,on,0,0
246050,the,0,0
246051,occurrence,0,0
246052,of,0,0
246053,TLESRs,0,0
246054,evoked,0,0
246055,by,0,0
246056,gastric,0,1
246057,distension,0,0
246058,.,0,0
246059,METHODS,0,0
246060,Eight,1,0
246061,healthy,1,1
246062,subjects,1,1
246063,underwent,1,1
246064,esophageal,1,1
246065,manometry,1,0
246066,using,1,0
246067,a,1,0
246068,10-lumen,1,0
246069,sleeve,1,0
246070,assembly,1,0
246071,during,1,0
246072,placebo,1,0
246073,or,1,0
246074,loxiglumide,1,0
246075,(,1,0
246076,10,1,0
246077,mg/kg/h,1,0
246078,),1,0
246079,in,1,0
246080,a,0,0
246081,randomized,0,0
246082,double-blind,0,0
246083,order,0,0
246084,.,0,0
246085,Gastric,0,0
246086,distension,0,0
246087,was,0,0
246088,induced,0,0
246089,by,0,0
246090,inflation,0,0
246091,of,0,0
246092,400,0,0
246093,ml,0,0
246094,of,0,0
246095,air,0,0
246096,.,0,0
246097,RESULTS,0,0
246098,Basal,0,0
246099,lower,0,0
246100,esophageal,0,1
246101,pressure,0,0
246102,(,0,0
246103,LESP,0,0
246104,),0,0
246105,and,0,0
246106,swallow-induced,0,0
246107,relaxation,0,0
246108,were,0,0
246109,not,0,0
246110,affected,0,0
246111,by,0,0
246112,loxiglumide,0,0
246113,.,0,0
246114,Loxiglumide,0,0
246115,significantly,0,0
246116,reduced,0,0
246117,the,0,0
246118,number,0,0
246119,of,0,0
246120,TLESRs,0,0
246121,",",0,0
246122,from,0,0
246123,11.5,0,0
246124,(,0,0
246125,5.8-18.3,0,0
246126,),0,0
246127,to,0,0
246128,6.0,0,0
246129,(,0,0
246130,3.3-14.3,0,0
246131,),0,0
246132,during,0,0
246133,the,0,0
246134,total,0,1
246135,recording,0,0
246136,period,0,0
246137,of,0,0
246138,1,0,0
246139,h,0,0
246140,",",0,0
246141,and,0,0
246142,from,0,0
246143,5.5,0,0
246144,(,0,0
246145,4.25-7.5,0,0
246146,),0,0
246147,to,0,0
246148,2.0,0,0
246149,(,0,0
246150,0.5-6.8,0,0
246151,),0,0
246152,during,0,0
246153,the,0,0
246154,first,0,0
246155,15,0,0
246156,min,0,0
246157,.,0,0
246158,The,0,0
246159,number,0,0
246160,of,0,0
246161,common,0,0
246162,cavities,0,1
246163,was,0,0
246164,significantly,0,0
246165,decreased,0,0
246166,by,0,0
246167,loxiglumide,0,0
246168,",",0,0
246169,from,0,0
246170,8.0,0,0
246171,(,0,0
246172,4.0-20.0,0,0
246173,),0,0
246174,to,0,0
246175,5.0,0,0
246176,(,0,0
246177,2.0-7.8,0,0
246178,),0,0
246179,.,0,0
246180,TLESRs,0,0
246181,represented,0,0
246182,the,0,0
246183,main,0,0
246184,mechanism,0,0
246185,(,0,0
246186,60,0,0
246187,%,0,0
246188,during,0,0
246189,placebo,0,0
246190,",",0,0
246191,74,0,0
246192,%,0,0
246193,during,0,0
246194,loxiglumide,0,0
246195,),0,0
246196,underlying,0,0
246197,common,0,0
246198,cavities,0,1
246199,",",0,0
246200,followed,0,0
246201,by,0,0
246202,swallow-induced,0,0
246203,relaxation,0,0
246204,.,0,0
246205,CONCLUSIONS,0,0
246206,Loxiglumide,0,0
246207,significantly,0,0
246208,reduces,0,0
246209,the,0,0
246210,number,0,0
246211,of,0,0
246212,TLESRs,0,0
246213,triggered,0,0
246214,by,0,0
246215,gastric,0,0
246216,distension,0,0
246217,without,0,0
246218,interfering,0,0
246219,with,0,1
246220,swallow-related,0,0
246221,relaxation,0,0
246222,of,0,0
246223,the,0,0
246224,lower,0,0
246225,esophageal,0,1
246226,sphincter,0,0
246227,",",0,0
246228,suggesting,0,0
246229,the,0,0
246230,involvement,0,0
246231,of,0,0
246232,CCKA,0,1
246233,receptors,0,0
246234,in,0,0
246235,the,0,0
246236,reflex,0,0
246237,pathway,0,0
246238,mediating,0,0
246239,TLESRs,0,0
246240,.,0,1
246241,Pharmacokinetics,0,0
246242,of,0,0
246243,cefuroxime,0,0
246244,in,0,0
246245,healthy,1,1
246246,volunteers,1,1
246247,:,1,1
246248,an,0,0
246249,update,0,0
246250,.,0,0
246251,Treatment,0,0
246252,of,0,0
246253,children,1,1
246254,with,1,1
246255,autism,1,1
246256,:,1,1
246257,a,0,0
246258,randomized,0,0
246259,controlled,0,0
246260,trial,0,0
246261,to,0,0
246262,evaluate,0,0
246263,a,0,0
246264,caregiver-based,0,0
246265,intervention,0,0
246266,program,0,0
246267,in,0,0
246268,community,1,1
246269,day-care,1,1
246270,centers,1,1
246271,.,1,0
246272,This,0,0
246273,study,0,0
246274,reports,0,0
246275,on,0,0
246276,the,0,0
246277,results,0,0
246278,of,0,0
246279,a,0,0
246280,randomized,0,0
246281,controlled,0,0
246282,trial,0,0
246283,that,0,0
246284,evaluated,0,0
246285,a,0,0
246286,caregiver-based,0,0
246287,intervention,0,0
246288,program,0,0
246289,for,0,0
246290,children,1,1
246291,with,1,1
246292,autism,1,1
246293,in,1,0
246294,community,1,1
246295,day-care,1,1
246296,centers,1,1
246297,.,1,0
246298,Thirty-five,1,1
246299,preschool,1,1
246300,children,1,1
246301,with,1,1
246302,a,1,0
246303,DSM,1,1
246304,III-R,1,0
246305,diagnosis,1,1
246306,of,1,0
246307,autism,1,1
246308,or,1,0
246309,pervasive,1,0
246310,developmental,1,1
246311,disorder,1,1
246312,were,0,0
246313,randomized,0,0
246314,to,0,0
246315,an,0,0
246316,experimental,0,0
246317,or,0,0
246318,control,0,0
246319,group,0,0
246320,.,0,0
246321,Children,0,1
246322,in,0,0
246323,the,0,0
246324,experimental,0,0
246325,group,0,0
246326,were,0,0
246327,enrolled,0,1
246328,in,0,0
246329,day,0,0
246330,care,0,0
246331,and,0,0
246332,their,0,0
246333,parents,0,1
246334,and,0,0
246335,child,0,1
246336,care,0,0
246337,workers,0,0
246338,received,0,0
246339,a,0,0
246340,12-week,0,0
246341,intervention,0,0
246342,consisting,0,0
246343,of,0,0
246344,lectures,0,0
246345,and,0,0
246346,on-site,0,0
246347,consultations,0,0
246348,to,0,1
246349,day-care,0,1
246350,centers,0,1
246351,.,0,0
246352,In,0,0
246353,addition,0,0
246354,",",0,0
246355,supportive,0,0
246356,work,0,0
246357,was,0,0
246358,undertaken,0,0
246359,with,0,1
246360,families,0,1
246361,.,0,0
246362,Control,0,0
246363,subjects,0,1
246364,received,0,0
246365,day,0,0
246366,care,0,0
246367,alone,0,0
246368,.,0,0
246369,In,0,0
246370,the,0,0
246371,experimental,0,0
246372,group,0,0
246373,",",0,0
246374,there,0,0
246375,were,0,0
246376,greater,0,0
246377,gains,0,0
246378,in,0,0
246379,language,0,0
246380,abilities,0,0
246381,",",0,0
246382,significant,0,0
246383,increases,0,0
246384,in,0,0
246385,caregivers,0,1
246386,',0,1
246387,knowledge,0,0
246388,about,0,0
246389,autism,0,1
246390,",",0,0
246391,greater,0,0
246392,perception,0,0
246393,of,0,0
246394,control,0,0
246395,on,0,0
246396,the,0,0
246397,part,0,0
246398,of,0,0
246399,mothers,0,1
246400,",",0,0
246401,and,0,0
246402,greater,0,0
246403,parent,0,0
246404,satisfaction,0,0
246405,.,0,0
246406,We,0,0
246407,conclude,0,0
246408,that,0,0
246409,this,0,0
246410,research,0,0
246411,design,0,0
246412,demonstrated,0,0
246413,that,0,0
246414,the,0,0
246415,intervention,0,0
246416,was,0,0
246417,significantly,0,0
246418,superior,0,0
246419,to,0,0
246420,day,0,0
246421,care,0,0
246422,alone,0,0
246423,.,0,0
246424,Yohimbine,0,0
246425,in,0,0
246426,neurally,1,0
246427,mediated,1,0
246428,syncope,1,1
246429,.,1,0
246430,Pathophysiological,0,0
246431,implications,0,0
246432,.,0,0
246433,In,0,0
246434,this,0,0
246435,study,0,0
246436,",",0,0
246437,we,0,0
246438,evaluated,0,0
246439,if,0,0
246440,increased,0,0
246441,sympathetic,0,0
246442,stimulation,0,0
246443,is,0,0
246444,an,0,0
246445,essential,0,0
246446,requirement,0,0
246447,for,0,0
246448,the,0,0
246449,development,0,0
246450,of,0,0
246451,neurally,0,0
246452,mediated,0,0
246453,syncope,0,0
246454,(,0,0
246455,NMS,0,0
246456,),0,0
246457,by,0,0
246458,manipulating,0,0
246459,overall,0,0
246460,sympathetic,0,0
246461,outflow,0,0
246462,in,0,0
246463,subjects,1,1
246464,susceptible,1,1
246465,to,1,0
246466,tilt-induced,1,0
246467,syncope,1,1
246468,.,1,0
246469,Eight,1,0
246470,previously,1,0
246471,characterized,1,0
246472,patients,1,1
246473,with,1,1
246474,recurrent,1,1
246475,NMS,1,0
246476,(,1,0
246477,five,1,1
246478,females,1,1
246479,and,1,0
246480,three,1,1
246481,males,1,1
246482,;,1,0
246483,34+/-2,1,0
246484,yr,1,1
246485,),1,0
246486,were,1,0
246487,recruited,1,1
246488,from,1,0
246489,the,1,0
246490,Vanderbilt,1,1
246491,Syncope,1,1
246492,Unit,1,0
246493,and,0,0
246494,eight,1,1
246495,age-matched,1,1
246496,controls,1,1
246497,underwent,0,1
246498,initial,0,0
246499,administration,0,0
246500,of,0,0
246501,clonidine,0,0
246502,(,0,0
246503,CLO,0,0
246504,),0,0
246505,or,0,0
246506,yohimbine,0,0
246507,(,0,0
246508,YHO,0,1
246509,),0,0
246510,.,0,0
246511,This,0,0
246512,was,0,0
246513,done,0,0
246514,",",0,0
246515,prospectively,0,0
246516,",",0,0
246517,to,0,0
246518,determine,0,0
246519,doses,0,0
246520,of,0,0
246521,these,0,0
246522,agents,0,0
246523,that,0,0
246524,would,0,0
246525,increase,0,0
246526,or,0,0
246527,decrease,0,0
246528,plasma,0,0
246529,norepinephrine,0,0
246530,levels,0,0
246531,by,0,0
246532,>,0,1
246533,/=,0,1
246534,30,0,0
246535,%,0,0
246536,.,0,0
246537,On,0,0
246538,a,0,0
246539,different,0,0
246540,day,0,0
246541,",",0,0
246542,in,0,0
246543,all,0,0
246544,subjects,0,1
246545,we,0,0
246546,determined,0,0
246547,intraarterial,0,0
246548,blood,0,0
246549,pressure,0,0
246550,",",0,0
246551,EKG,0,0
246552,and,0,0
246553,muscle,0,0
246554,sympathetic,0,0
246555,nerve,0,0
246556,activity,0,0
246557,(,0,0
246558,MSNA,0,0
246559,),0,0
246560,both,0,0
246561,supine,0,0
246562,and,0,0
246563,during,0,0
246564,upright,0,0
246565,tilt,0,0
246566,.,0,0
246567,After,0,0
246568,this,0,0
246569,",",0,0
246570,subjects,0,1
246571,randomly,0,0
246572,received,0,0
246573,either,0,0
246574,CLO,0,0
246575,or,0,0
246576,YHO,0,1
246577,",",0,0
246578,and,0,0
246579,3,0,0
246580,h,0,0
246581,later,0,0
246582,another,0,0
246583,tilt,0,0
246584,was,0,0
246585,performed,0,0
246586,.,0,0
246587,After,0,0
246588,1,0,0
246589,wk,0,0
246590,",",0,0
246591,a,0,0
246592,similar,0,0
246593,procedure,0,0
246594,with,0,1
246595,the,0,0
246596,other,0,0
246597,drug,0,0
246598,was,0,0
246599,performed,0,0
246600,.,0,0
246601,During,0,0
246602,the,0,0
246603,two,0,0
246604,basal,0,0
246605,tilts,0,0
246606,",",0,0
246607,all,0,0
246608,the,0,0
246609,control,0,0
246610,subjects,0,1
246611,completed,0,0
246612,the,0,0
246613,study,0,0
246614,",",0,0
246615,whereas,0,0
246616,all,0,0
246617,the,0,0
246618,NMS,0,0
246619,patients,0,1
246620,developed,0,0
246621,syncope,0,1
246622,.,0,0
246623,Reduction,0,0
246624,in,0,0
246625,sympathetic,0,0
246626,tone,0,0
246627,by,0,0
246628,CLO,0,0
246629,resulted,0,0
246630,in,0,0
246631,a,0,0
246632,decreased,0,0
246633,tolerance,0,0
246634,to,0,0
246635,tilt,0,0
246636,in,0,0
246637,three,0,0
246638,out,0,0
246639,of,0,0
246640,eight,0,1
246641,controls,0,1
246642,and,0,0
246643,in,0,0
246644,all,0,0
246645,the,0,0
246646,NMS,1,0
246647,patients,1,1
246648,.,1,0
246649,In,0,0
246650,contrast,0,0
246651,",",0,0
246652,YHO,0,1
246653,not,0,0
246654,only,0,0
246655,increased,0,0
246656,basal,0,0
246657,plasma,0,0
246658,NorEpi,0,0
246659,levels,0,0
246660,and,0,0
246661,MSNA,0,0
246662,",",0,0
246663,but,0,0
246664,also,0,0
246665,prevented,0,0
246666,syncope,0,0
246667,in,0,0
246668,seven,0,0
246669,out,0,0
246670,of,0,0
246671,eight,0,1
246672,patients,0,1
246673,.,0,0
246674,In,0,0
246675,a,0,0
246676,selected,0,0
246677,population,0,1
246678,of,0,0
246679,patients,0,1
246680,",",0,0
246681,increased,0,0
246682,sympathetic,0,0
246683,activity,0,0
246684,is,0,0
246685,not,0,0
246686,a,0,0
246687,prerequisite,0,0
246688,for,0,0
246689,the,0,0
246690,development,0,0
246691,of,0,0
246692,syncope,0,1
246693,.,0,0
246694,Yohimbine-induced,0,0
246695,enhancement,0,0
246696,of,0,0
246697,sympathetic,0,0
246698,tone,0,0
246699,in,0,0
246700,patients,1,1
246701,with,1,1
246702,NMS,1,0
246703,improves,0,0
246704,orthostatic,0,0
246705,tolerance,0,0
246706,and,0,0
246707,raises,0,0
246708,the,0,0
246709,possibility,0,0
246710,that,0,0
246711,this,0,0
246712,drug,0,0
246713,may,0,0
246714,be,0,0
246715,a,0,0
246716,useful,0,0
246717,agent,0,0
246718,in,0,0
246719,the,0,0
246720,treatment,0,0
246721,of,0,0
246722,NMS,0,0
246723,.,0,1
246724,Comparative,0,0
246725,efficacy,0,0
246726,and,0,0
246727,safety,0,0
246728,of,0,0
246729,calcium,0,0
246730,carbasalate,0,0
246731,plus,0,0
246732,metoclopramide,0,0
246733,versus,0,0
246734,ergotamine,0,0
246735,tartrate,0,0
246736,plus,0,0
246737,caffeine,0,0
246738,in,0,0
246739,the,0,0
246740,treatment,0,0
246741,of,0,0
246742,acute,1,1
246743,migraine,1,1
246744,attacks,1,0
246745,.,1,0
246746,This,0,0
246747,randomized,0,0
246748,",",0,0
246749,double-blind,0,0
246750,",",0,0
246751,double-dummy,0,0
246752,",",0,0
246753,multicenter,1,0
246754,",",0,0
246755,parallel-group,0,0
246756,study,0,0
246757,aimed,0,0
246758,at,0,0
246759,comparing,0,0
246760,the,0,0
246761,efficacy,0,0
246762,and,0,0
246763,safety,0,0
246764,of,0,0
246765,calcium,0,0
246766,carbasalate,0,0
246767,(,0,0
246768,equivalent,0,0
246769,to,0,0
246770,900,0,0
246771,mg,0,0
246772,aspirin,0,0
246773,),0,0
246774,plus,0,0
246775,metoclopramide,0,0
246776,10,0,0
246777,mg,0,0
246778,(,0,0
246779,CM,0,0
246780,),0,0
246781,with,0,1
246782,ergotamine,0,0
246783,tartrate,0,0
246784,1,0,0
246785,mg,0,0
246786,plus,0,0
246787,caffeine,0,0
246788,100,0,0
246789,mg,0,0
246790,(,0,0
246791,EC,0,0
246792,),0,0
246793,administered,0,0
246794,in,0,0
246795,the,0,0
246796,treatment,0,0
246797,of,0,0
246798,2,0,0
246799,acute,0,1
246800,migraine,0,1
246801,attacks,0,0
246802,.,0,0
246803,A,0,0
246804,total,0,0
246805,of,0,0
246806,296,1,1
246807,patients,1,1
246808,fulfilling,1,1
246809,the,1,0
246810,International,1,1
246811,Headache,1,1
246812,Society,1,1
246813,diagnostic,1,0
246814,criteria,1,1
246815,for,1,0
246816,migraine,1,1
246817,were,1,0
246818,enrolled,1,1
246819,.,1,0
246820,In,0,0
246821,total,0,0
246822,",",0,0
246823,one,0,0
246824,or,0,0
246825,two,0,0
246826,migraine,0,1
246827,attacks,0,0
246828,were,0,0
246829,treated,0,1
246830,in,0,0
246831,268,0,1
246832,and,0,0
246833,235,0,1
246834,patients,0,1
246835,",",0,0
246836,respectively,0,0
246837,.,0,0
246838,The,0,0
246839,primary,0,0
246840,endpoint,0,0
246841,for,0,0
246842,the,0,0
246843,first,0,0
246844,treated,0,0
246845,attack,0,1
246846,was,0,0
246847,headache,0,0
246848,relief,0,0
246849,",",0,0
246850,with,0,0
246851,intensity,0,0
246852,decreasing,0,0
246853,from,0,0
246854,moderate,0,1
246855,or,0,0
246856,severe,0,1
246857,to,0,0
246858,mild,0,1
246859,or,0,0
246860,absent,0,0
246861,2,0,0
246862,h,0,0
246863,after,0,0
246864,drug,0,0
246865,intake,0,0
246866,.,0,0
246867,Usual,0,0
246868,secondary,0,0
246869,efficacy,0,0
246870,endpoints,0,0
246871,were,0,0
246872,assessed,0,0
246873,.,0,0
246874,A,0,0
246875,superiority,0,0
246876,of,0,0
246877,CM,0,0
246878,over,0,0
246879,EC,0,0
246880,was,0,0
246881,observed,0,0
246882,for,0,0
246883,both,0,0
246884,treated,0,1
246885,attacks,0,0
246886,for,0,0
246887,the,0,0
246888,main,0,0
246889,endpoint,0,0
246890,:,0,1
246891,success,0,0
246892,in,0,0
246893,54,0,1
246894,versus,0,0
246895,36,0,0
246896,%,0,0
246897,",",0,0
246898,p,0,0
246899,=,0,0
246900,0.003,0,0
246901,for,0,0
246902,the,0,0
246903,first,0,0
246904,attack,0,1
246905,and,0,0
246906,60,0,1
246907,versus,0,0
246908,44,0,1
246909,%,0,0
246910,",",0,0
246911,p,0,0
246912,=,0,0
246913,0.02,0,0
246914,for,0,0
246915,the,0,0
246916,second,0,0
246917,attack,0,1
246918,.,0,0
246919,CM,0,0
246920,was,0,0
246921,also,0,0
246922,significantly,0,0
246923,superior,0,0
246924,to,0,0
246925,EC,0,0
246926,during,0,0
246927,the,0,0
246928,first,0,0
246929,attack,0,1
246930,for,0,0
246931,complete,0,0
246932,headache,0,0
246933,relief,0,0
246934,(,0,0
246935,20,0,0
246936,vs.,0,0
246937,8,0,0
246938,%,0,0
246939,",",0,0
246940,p,0,0
246941,=,0,0
246942,0.006,0,0
246943,),0,0
246944,",",0,0
246945,nausea,0,0
246946,(,0,0
246947,42,0,0
246948,vs.,0,0
246949,63,0,0
246950,%,0,0
246951,",",0,0
246952,p,0,0
246953,=,0,0
246954,0,0,0
246955,.,0,1
246956,007,0,0
246957,),0,0
246958,and,0,0
246959,willingness,0,0
246960,to,0,0
246961,take,0,0
246962,the,0,0
246963,drug,0,0
246964,again,0,0
246965,(,0,0
246966,90,0,0
246967,vs.,0,0
246968,80,0,0
246969,%,0,0
246970,",",0,0
246971,p,0,0
246972,=,0,0
246973,0.043,0,0
246974,),0,0
246975,.,0,0
246976,The,0,0
246977,global,0,0
246978,efficacy,0,0
246979,evaluation,0,0
246980,",",0,0
246981,rated,0,0
246982,by,0,0
246983,the,0,0
246984,investigators,0,0
246985,",",0,0
246986,was,0,0
246987,significantly,0,0
246988,more,0,0
246989,favorable,0,0
246990,to,0,0
246991,CM,0,0
246992,for,0,0
246993,both,0,0
246994,attacks,0,0
246995,(,0,0
246996,p,0,0
246997,=,0,0
246998,0.001,0,0
246999,for,0,0
247000,the,0,0
247001,first,0,0
247002,attack,0,1
247003,and,0,0
247004,p,0,0
247005,=,0,0
247006,0.02,0,0
247007,for,0,0
247008,the,0,0
247009,second,0,0
247010,),0,0
247011,.,0,0
247012,The,0,0
247013,patients,0,1
247014,',0,0
247015,evaluation,0,0
247016,was,0,0
247017,significant,0,0
247018,for,0,0
247019,the,0,0
247020,first,0,0
247021,attack,0,1
247022,(,0,0
247023,p,0,0
247024,=,0,0
247025,0.002,0,0
247026,),0,0
247027,.,0,0
247028,The,0,0
247029,global,0,0
247030,incidence,0,0
247031,of,0,0
247032,adverse,0,0
247033,events,0,0
247034,was,0,0
247035,45,0,1
247036,%,0,0
247037,higher,0,0
247038,with,0,0
247039,EC,0,0
247040,",",0,0
247041,though,0,0
247042,not,0,0
247043,significant,0,0
247044,(,0,0
247045,32,0,1
247046,vs.,0,0
247047,22,0,0
247048,%,0,0
247049,",",0,0
247050,p,0,0
247051,=,0,0
247052,0.075,0,0
247053,),0,0
247054,.,0,0
247055,They,0,0
247056,were,0,0
247057,most,0,0
247058,often,0,0
247059,unspecific,0,0
247060,and,0,0
247061,mild,0,1
247062,to,0,0
247063,moderate,0,1
247064,in,0,0
247065,intensity,0,0
247066,.,0,0
247067,Gastrointestinal,0,0
247068,side,0,0
247069,effects,0,0
247070,were,0,0
247071,significantly,0,0
247072,less,0,0
247073,frequent,0,0
247074,with,0,0
247075,CM,0,0
247076,than,0,0
247077,EC,0,0
247078,(,0,0
247079,7,0,0
247080,vs.,0,0
247081,21,0,1
247082,%,0,0
247083,",",0,0
247084,p,0,0
247085,=,0,0
247086,0.001,0,0
247087,),0,0
247088,.,0,0
247089,Thus,0,0
247090,",",0,0
247091,CM,0,0
247092,is,0,0
247093,more,0,0
247094,effective,0,0
247095,and,0,0
247096,has,0,0
247097,a,0,0
247098,better,0,0
247099,gastrointestinal,0,0
247100,safety,0,0
247101,than,0,0
247102,EC,0,0
247103,in,0,0
247104,the,0,0
247105,acute,0,1
247106,treatment,0,0
247107,of,0,0
247108,migraine,0,1
247109,attacks,0,1
247110,.,0,1
247111,A,0,0
247112,placebo-controlled,0,0
247113,trial,0,0
247114,of,0,0
247115,D-cycloserine,0,0
247116,added,0,0
247117,to,0,0
247118,conventional,0,0
247119,neuroleptics,0,1
247120,in,0,0
247121,patients,1,1
247122,with,1,1
247123,schizophrenia,1,1
247124,.,1,0
247125,BACKGROUND,0,0
247126,In,0,0
247127,a,0,0
247128,preliminary,0,0
247129,dose-finding,0,0
247130,study,0,0
247131,",",0,0
247132,D-cycloserine,0,0
247133,",",0,0
247134,a,0,0
247135,partial,0,0
247136,agonist,0,0
247137,at,0,0
247138,the,0,0
247139,glycine,0,0
247140,modulatory,0,0
247141,site,0,0
247142,of,0,0
247143,the,0,0
247144,glutamatergic,0,0
247145,N-methyl-D-aspartate,0,0
247146,(,0,0
247147,NMDA,0,0
247148,),0,0
247149,receptor,0,0
247150,",",0,0
247151,improved,0,0
247152,negative,0,0
247153,symptoms,0,0
247154,and,0,0
247155,cognitive,0,0
247156,function,0,0
247157,when,0,0
247158,added,0,0
247159,to,0,0
247160,conventional,0,0
247161,neuroleptics,0,0
247162,at,0,0
247163,a,0,0
247164,dose,0,0
247165,of,0,0
247166,50,0,0
247167,mg/d,0,0
247168,.,0,0
247169,METHODS,0,0
247170,Forty-seven,1,1
247171,patients,1,1
247172,with,1,1
247173,schizophrenia,1,1
247174,meeting,1,1
247175,criteria,1,1
247176,for,1,0
247177,deficit,1,0
247178,syndrome,1,1
247179,were,0,0
247180,randomized,0,0
247181,to,0,0
247182,D-cycloserine,0,0
247183,",",0,0
247184,50,0,0
247185,mg/d,0,0
247186,(,0,0
247187,n=23,0,1
247188,),0,0
247189,or,0,0
247190,placebo,0,0
247191,(,0,0
247192,n=24,0,1
247193,),0,0
247194,added,0,0
247195,to,0,0
247196,their,0,0
247197,conventional,0,0
247198,neuroleptic,0,0
247199,for,0,0
247200,an,0,0
247201,8-week,0,0
247202,",",0,0
247203,double-blind,0,0
247204,trial,0,0
247205,.,0,0
247206,Clinical,0,0
247207,assessments,0,0
247208,were,0,0
247209,performed,0,0
247210,at,0,0
247211,baseline,0,0
247212,and,0,0
247213,at,0,0
247214,weeks,0,0
247215,1,0,0
247216,",",0,0
247217,2,0,0
247218,",",0,0
247219,4,0,0
247220,",",0,0
247221,6,0,0
247222,",",0,0
247223,and,0,0
247224,8,0,0
247225,.,0,0
247226,Serum,0,0
247227,concentrations,0,0
247228,of,0,0
247229,D-cycloserine,0,0
247230,",",0,0
247231,relevant,0,0
247232,amino,0,0
247233,acids,0,0
247234,",",0,0
247235,and,0,0
247236,homovanillic,0,0
247237,acid,0,0
247238,were,0,0
247239,assayed,0,0
247240,at,0,0
247241,baseline,0,0
247242,and,0,0
247243,at,0,0
247244,weeks,0,0
247245,4,0,0
247246,and,0,1
247247,8,0,0
247248,.,0,0
247249,A,0,0
247250,cognitive,0,0
247251,battery,0,0
247252,was,0,0
247253,performed,0,0
247254,at,0,0
247255,baseline,0,0
247256,and,0,0
247257,at,0,0
247258,week,0,0
247259,8,0,0
247260,.,0,0
247261,RESULTS,0,0
247262,Thirty-nine,1,1
247263,patients,1,1
247264,completed,0,1
247265,the,0,0
247266,8-week,0,0
247267,trial,0,0
247268,.,0,0
247269,Seven,0,0
247270,dropouts,0,0
247271,occurred,0,0
247272,in,0,0
247273,the,0,0
247274,D-cycloserine,0,0
247275,group,0,0
247276,and,0,0
247277,1,0,0
247278,in,0,0
247279,the,0,0
247280,placebo,0,0
247281,group,0,0
247282,.,0,0
247283,The,0,0
247284,mean,0,0
247285,reduction,0,0
247286,in,0,0
247287,negative,0,0
247288,symptoms,0,0
247289,with,0,1
247290,D-cycloserine,0,0
247291,(,0,0
247292,23,0,1
247293,%,0,0
247294,),0,0
247295,was,0,0
247296,significantly,0,0
247297,greater,0,0
247298,than,0,0
247299,with,0,0
247300,placebo,0,0
247301,(,0,0
247302,7,0,0
247303,%,0,0
247304,),0,0
247305,as,0,0
247306,calculated,0,0
247307,by,0,0
247308,slopes,0,0
247309,representing,0,1
247310,Scale,0,0
247311,for,0,0
247312,the,0,0
247313,Assessment,0,0
247314,of,0,0
247315,Negative,0,0
247316,Symptoms,0,0
247317,(,0,0
247318,SANS,0,0
247319,),0,0
247320,total,0,1
247321,scores,0,0
247322,.,0,1
247323,Improvement,0,0
247324,of,0,0
247325,negative,0,0
247326,symptoms,0,0
247327,was,0,0
247328,predicted,0,0
247329,by,0,0
247330,low,0,0
247331,neuroleptic,0,1
247332,dose,0,0
247333,and,0,0
247334,low,0,0
247335,baseline,0,0
247336,SANS,0,0
247337,total,0,1
247338,score,0,0
247339,.,0,0
247340,No,0,0
247341,differences,0,0
247342,were,0,0
247343,found,0,0
247344,in,0,0
247345,performance,0,0
247346,on,0,0
247347,any,0,0
247348,cognitive,0,0
247349,test,0,0
247350,between,0,0
247351,groups,0,0
247352,or,0,1
247353,in,0,0
247354,changes,0,0
247355,in,0,0
247356,any,0,0
247357,other,0,0
247358,clinical,0,0
247359,measure,0,0
247360,.,0,0
247361,Clinical,0,0
247362,response,0,0
247363,did,0,0
247364,not,0,0
247365,correlate,0,0
247366,significantly,0,0
247367,with,0,0
247368,serum,0,0
247369,amino,0,0
247370,acid,0,0
247371,concentrations,0,0
247372,at,0,0
247373,baseline,0,0
247374,or,0,0
247375,with,0,1
247376,concentrations,0,0
247377,of,0,0
247378,D-cycloserine,0,0
247379,at,0,0
247380,weeks,0,0
247381,4,0,0
247382,and,0,1
247383,8,0,0
247384,.,0,0
247385,CONCLUSION,0,0
247386,These,0,0
247387,results,0,0
247388,support,0,0
247389,the,0,0
247390,hypothesis,0,0
247391,that,0,0
247392,agents,0,0
247393,acting,0,0
247394,at,0,0
247395,the,0,0
247396,glycine,0,0
247397,modulatory,0,0
247398,site,0,0
247399,of,0,0
247400,the,0,0
247401,NMDA,0,0
247402,receptor,0,0
247403,improve,0,0
247404,primary,0,0
247405,negative,0,0
247406,symptoms,0,0
247407,.,0,1
247408,Herpes,0,0
247409,simplex,0,1
247410,virus,0,1
247411,vaccine,0,0
247412,in,0,0
247413,recurrent,1,1
247414,herpetic,1,1
247415,ocular,1,1
247416,infection,1,1
247417,.,1,0
247418,PURPOSE,0,0
247419,To,0,0
247420,evaluate,0,0
247421,the,0,0
247422,efficacy,0,0
247423,of,0,0
247424,an,0,0
247425,antiherpetic,0,0
247426,vaccine,0,0
247427,in,0,0
247428,recurrent,0,1
247429,herpetic,0,1
247430,ocular,0,1
247431,infections,0,0
247432,.,0,1
247433,METHODS,0,0
247434,Twenty,1,1
247435,patients,1,1
247436,with,1,1
247437,herpes,1,1
247438,simplex,1,1
247439,virus,1,1
247440,1-related,1,0
247441,recurrent,1,1
247442,keratitis/keratouveitis,1,1
247443,were,0,0
247444,prospectively,0,0
247445,enrolled,0,1
247446,and,0,0
247447,randomly,0,0
247448,assigned,0,0
247449,to,0,0
247450,receive,0,0
247451,either,0,0
247452,a,0,0
247453,specific,0,0
247454,vaccination,0,0
247455,with,0,1
247456,heat,0,0
247457,shock-inactivated,0,0
247458,herpes,0,0
247459,simplex,0,1
247460,virus,0,1
247461,type,0,1
247462,1,0,0
247463,(,0,0
247464,10,0,1
247465,patients,0,1
247466,),0,0
247467,or,0,0
247468,to,0,0
247469,be,0,0
247470,observed,0,0
247471,as,0,0
247472,controls,0,0
247473,(,0,1
247474,10,0,1
247475,patients,0,1
247476,),0,0
247477,.,0,0
247478,The,0,0
247479,number,0,0
247480,",",0,0
247481,duration,0,0
247482,",",0,0
247483,and,0,0
247484,anatomic,0,0
247485,localization,0,0
247486,of,0,0
247487,relapses,0,0
247488,were,0,0
247489,recorded,0,0
247490,in,0,0
247491,all,0,0
247492,the,0,0
247493,patients,0,1
247494,for,0,0
247495,12,0,1
247496,months,0,0
247497,before,0,0
247498,inclusion,0,0
247499,in,0,0
247500,the,0,0
247501,study,0,0
247502,and,0,0
247503,for,0,0
247504,a,0,0
247505,similar,0,0
247506,period,0,0
247507,after,0,0
247508,the,0,0
247509,assignment,0,0
247510,of,0,0
247511,each,0,0
247512,subject,0,0
247513,to,0,0
247514,vaccine,0,0
247515,or,0,0
247516,control,0,0
247517,group,0,0
247518,.,0,0
247519,RESULTS,0,0
247520,In,0,0
247521,the,0,0
247522,vaccine,0,0
247523,group,0,0
247524,",",0,0
247525,we,0,0
247526,observed,0,0
247527,a,0,0
247528,reduction,0,0
247529,both,0,0
247530,in,0,0
247531,the,0,0
247532,number,0,0
247533,(,0,0
247534,p,0,0
247535,=,0,0
247536,0.016,0,0
247537,),0,0
247538,and,0,0
247539,average,0,0
247540,duration,0,0
247541,(,0,0
247542,p,0,0
247543,=,0,0
247544,0.050,0,0
247545,),0,0
247546,of,0,0
247547,recurrences,0,0
247548,",",0,0
247549,whereas,0,0
247550,in,0,0
247551,the,0,0
247552,control,0,0
247553,group,0,0
247554,",",0,0
247555,no,0,0
247556,significant,0,0
247557,change,0,0
247558,was,0,0
247559,found,0,0
247560,comparing,0,0
247561,a,0,0
247562,12-month,0,0
247563,period,0,0
247564,before,0,0
247565,and,0,0
247566,after,0,0
247567,inclusion,0,0
247568,in,0,0
247569,the,0,0
247570,study,0,0
247571,.,0,0
247572,The,0,0
247573,comparison,0,0
247574,between,0,0
247575,the,0,0
247576,two,0,0
247577,groups,0,0
247578,highlighted,0,0
247579,a,0,0
247580,significant,0,0
247581,reduction,0,0
247582,in,0,0
247583,the,0,0
247584,number,0,0
247585,(,0,0
247586,p,0,0
247587,=,0,0
247588,0.013,0,0
247589,),0,0
247590,and,0,0
247591,average,0,0
247592,duration,0,0
247593,(,0,0
247594,p,0,0
247595,=,0,0
247596,0.051,0,0
247597,),0,0
247598,of,0,0
247599,relapses,0,0
247600,in,0,0
247601,treated,0,1
247602,subjects,0,1
247603,",",0,1
247604,who,0,1
247605,did,0,0
247606,not,0,1
247607,show,0,0
247608,any,0,0
247609,significant,0,0
247610,vaccine-induced,0,0
247611,side,0,0
247612,effects,0,0
247613,.,0,0
247614,CONCLUSION,0,0
247615,The,0,0
247616,use,0,0
247617,of,0,0
247618,a,0,0
247619,vaccination,0,0
247620,with,0,0
247621,heat,0,0
247622,shock-inactivated,0,0
247623,herpes,0,0
247624,simplex,0,1
247625,virus,0,1
247626,1,0,0
247627,seems,0,0
247628,to,0,0
247629,be,0,0
247630,able,0,0
247631,to,0,0
247632,reduce,0,0
247633,the,0,0
247634,number,0,0
247635,and,0,0
247636,duration,0,0
247637,of,0,0
247638,relapses,0,0
247639,in,0,0
247640,herpes,0,1
247641,simplex,0,1
247642,virus,0,1
247643,1-related,0,0
247644,keratitis/keratouveitis,0,1
247645,.,0,0
247646,Total,0,1
247647,parenteral,0,1
247648,nutrition,0,1
247649,with,0,1
247650,glutamine,0,0
247651,dipeptide,0,0
247652,shortened,0,0
247653,hospital,0,0
247654,stays,0,0
247655,and,0,0
247656,improved,0,0
247657,immune,0,0
247658,status,0,0
247659,and,0,0
247660,nitrogen,0,0
247661,economy,0,0
247662,after,1,0
247663,major,1,0
247664,abdominal,1,1
247665,surgery,1,1
247666,.,1,0
247667,Study,0,0
247668,of,0,0
247669,cytosine,0,0
247670,arabinoside,0,0
247671,(,0,0
247672,NSC-63878,0,0
247673,),0,0
247674,synchronization,0,0
247675,plus,0,0
247676,vincristine,0,0
247677,(,0,0
247678,NSC-67574,0,0
247679,),0,0
247680,",",0,0
247681,prednisone,0,0
247682,(,0,0
247683,NSC-10023,0,0
247684,),0,0
247685,",",0,0
247686,and,0,0
247687,L-asparaginase,0,0
247688,(,0,0
247689,NSC-109229,0,0
247690,),0,0
247691,for,0,0
247692,remission,0,0
247693,induction,0,0
247694,in,0,0
247695,advanced,1,1
247696,acute,1,1
247697,leukemia,1,1
247698,in,1,0
247699,children,1,1
247700,.,1,1
247701,Cytosine,0,0
247702,arabinoside,0,0
247703,(,0,0
247704,CA,0,1
247705,),0,0
247706,was,0,0
247707,utilized,0,0
247708,in,0,0
247709,efforts,0,0
247710,to,0,0
247711,synchronize,0,0
247712,leukemic,0,0
247713,cells,0,0
247714,in,0,0
247715,DNA,0,0
247716,synthesis,0,0
247717,for,0,0
247718,treatment,0,0
247719,with,0,0
247720,vincristine,0,0
247721,",",0,0
247722,prednisone,0,0
247723,",",0,0
247724,and,0,0
247725,L-asparaginase,0,0
247726,in,0,0
247727,children,1,1
247728,with,1,1
247729,acute,1,1
247730,leukemia,1,1
247731,in,1,0
247732,relapse,1,0
247733,.,1,0
247734,The,0,0
247735,results,0,0
247736,did,0,0
247737,not,0,0
247738,indicate,0,0
247739,any,0,0
247740,therapeutic,0,0
247741,advantage,0,0
247742,for,0,0
247743,patients,0,1
247744,treated,0,1
247745,with,0,1
247746,this,0,0
247747,combination,0,0
247748,compared,0,0
247749,to,0,0
247750,those,0,0
247751,treated,0,0
247752,without,0,0
247753,any,0,0
247754,attempt,0,0
247755,at,0,0
247756,CA,0,1
247757,synchronization,0,0
247758,.,0,0
247759,Network,0,0
247760,support,0,0
247761,for,0,0
247762,drinking,0,0
247763,",",0,0
247764,Alcoholics,0,1
247765,Anonymous,0,0
247766,and,0,0
247767,long-term,0,0
247768,matching,0,0
247769,effects,0,0
247770,.,0,0
247771,AIMS,0,0
247772,(,0,0
247773,1,0,0
247774,),0,0
247775,To,0,0
247776,examine,0,0
247777,the,0,0
247778,matching,0,0
247779,hypothesis,0,0
247780,that,0,0
247781,Twelve,0,1
247782,Step,0,0
247783,Facilitation,0,0
247784,Therapy,0,0
247785,(,0,0
247786,TSF,0,0
247787,),0,0
247788,is,0,0
247789,more,0,0
247790,effective,0,0
247791,than,0,0
247792,Motivational,0,0
247793,Enhancement,0,0
247794,Therapy,0,0
247795,(,0,0
247796,MET,0,0
247797,),0,0
247798,for,0,0
247799,alcohol-dependent,1,1
247800,clients,1,1
247801,with,0,1
247802,networks,0,0
247803,highly,0,0
247804,supportive,0,0
247805,of,0,0
247806,drinking,0,0
247807,3,0,0
247808,years,0,1
247809,following,0,0
247810,treatment,0,0
247811,;,0,0
247812,(,0,0
247813,2,0,0
247814,),0,0
247815,to,0,0
247816,test,0,0
247817,a,0,0
247818,causal,0,0
247819,chain,0,0
247820,providing,0,0
247821,the,0,0
247822,rationale,0,0
247823,for,0,0
247824,this,0,0
247825,effect,0,0
247826,.,0,0
247827,DESIGN,0,0
247828,Outpatients,1,1
247829,were,0,1
247830,re-interviewed,0,1
247831,3,0,0
247832,years,0,1
247833,following,0,0
247834,treatment,0,0
247835,.,0,0
247836,ANCOVAs,0,0
247837,tested,0,0
247838,the,0,0
247839,matching,0,0
247840,hypothesis,0,0
247841,.,0,0
247842,SETTING,0,0
247843,Outpatients,1,1
247844,from,1,1
247845,five,1,1
247846,clinical,1,0
247847,research,1,0
247848,units,1,0
247849,distributed,1,0
247850,across,1,0
247851,the,1,0
247852,United,1,1
247853,States,1,0
247854,.,1,1
247855,PARTICIPANTS,0,0
247856,Eight,1,0
247857,hundred,1,1
247858,and,1,0
247859,six,1,1
247860,alcohol-dependent,1,1
247861,clients,1,1
247862,.,1,1
247863,INTERVENTION,0,0
247864,Clients,0,0
247865,were,0,0
247866,randomly,0,1
247867,assigned,0,0
247868,to,0,0
247869,one,0,0
247870,of,0,0
247871,three,0,0
247872,12-week,0,0
247873,",",0,0
247874,manually-guided,0,0
247875,",",0,0
247876,individual,0,0
247877,treatments,0,0
247878,:,0,1
247879,TSF,0,0
247880,",",0,0
247881,MET,0,0
247882,or,0,0
247883,Cognitive,0,0
247884,Behavioral,0,0
247885,Coping,0,0
247886,Skills,0,0
247887,Therapy,0,0
247888,(,0,0
247889,CBT,0,0
247890,),0,0
247891,.,0,0
247892,MEASUREMENTS,0,0
247893,Network,0,0
247894,support,0,0
247895,for,0,0
247896,drinking,0,0
247897,prior,0,0
247898,to,0,0
247899,treatment,0,0
247900,",",0,0
247901,Alcoholics,0,1
247902,Anonymous,0,0
247903,(,0,0
247904,AA,0,0
247905,),0,0
247906,involvement,0,0
247907,during,0,0
247908,and,0,0
247909,following,0,0
247910,treatment,0,0
247911,",",0,0
247912,percentage,0,0
247913,of,0,0
247914,days,0,0
247915,abstinent,0,1
247916,and,0,0
247917,drinks,0,0
247918,per,0,0
247919,drinking,0,0
247920,day,0,0
247921,during,0,0
247922,months,0,0
247923,37-39,0,0
247924,.,0,1
247925,FINDINGS,0,0
247926,(,0,0
247927,1,0,0
247928,),0,0
247929,The,0,0
247930,a,0,0
247931,priori,0,0
247932,matching,0,0
247933,hypothesis,0,0
247934,that,0,0
247935,TSF,0,0
247936,is,0,0
247937,more,0,0
247938,effective,0,0
247939,than,0,0
247940,MET,0,0
247941,for,0,0
247942,clients,0,1
247943,with,0,1
247944,networks,0,0
247945,supportive,0,0
247946,of,0,0
247947,drinking,0,0
247948,was,0,0
247949,supported,0,0
247950,at,0,0
247951,the,0,0
247952,3,0,0
247953,year,0,0
247954,follow-up,0,0
247955,;,0,0
247956,(,0,0
247957,2,0,0
247958,),0,0
247959,AA,0,0
247960,involvement,0,0
247961,was,0,0
247962,a,0,0
247963,partial,0,0
247964,mediator,0,0
247965,of,0,0
247966,this,0,0
247967,effect,0,0
247968,;,0,0
247969,clients,0,1
247970,with,0,1
247971,networks,0,0
247972,supportive,0,0
247973,of,0,0
247974,drinking,0,0
247975,assigned,0,0
247976,to,0,0
247977,TSF,0,0
247978,were,0,0
247979,more,0,0
247980,likely,0,0
247981,to,0,0
247982,be,0,0
247983,involved,0,0
247984,in,0,0
247985,AA,0,0
247986,;,0,0
247987,AA,0,0
247988,involvement,0,0
247989,was,0,0
247990,associated,0,0
247991,with,0,1
247992,better,0,0
247993,3-year,0,0
247994,drinking,0,0
247995,outcomes,0,0
247996,for,0,0
247997,such,0,0
247998,clients,0,1
247999,.,0,1
248000,CONCLUSIONS,0,0
248001,(,0,0
248002,1,0,0
248003,),0,0
248004,In,0,0
248005,the,0,0
248006,long-term,0,0
248007,TSF,0,0
248008,may,0,0
248009,be,0,0
248010,the,0,0
248011,treatment,0,0
248012,of,0,0
248013,choice,0,0
248014,for,0,0
248015,alcohol-dependent,0,1
248016,clients,0,1
248017,with,0,1
248018,networks,0,0
248019,supportive,0,0
248020,of,0,0
248021,drinking,0,0
248022,;,0,0
248023,(,0,0
248024,2,0,0
248025,),0,0
248026,involvement,0,0
248027,in,0,0
248028,AA,0,0
248029,should,0,0
248030,be,0,0
248031,given,0,0
248032,special,0,0
248033,consideration,0,0
248034,for,0,0
248035,clients,0,1
248036,with,0,1
248037,networks,0,0
248038,supportive,0,0
248039,of,0,0
248040,drinking,0,0
248041,",",0,0
248042,irrespective,0,0
248043,of,0,0
248044,the,0,0
248045,therapy,0,0
248046,they,0,0
248047,will,0,0
248048,receive,0,0
248049,.,0,0
248050,[,0,0
248051,Effect,0,0
248052,of,0,0
248053,alanyl-glutamine,0,0
248054,in,0,0
248055,postoperative,0,0
248056,total,0,1
248057,parenteral,0,1
248058,nutrition,0,1
248059,on,0,0
248060,postoperative,0,0
248061,immunosuppression,0,0
248062,and,0,0
248063,morbidity,0,0
248064,.,0,0
248065,Preliminary,0,0
248066,results,0,0
248067,of,0,0
248068,a,0,0
248069,prospective,0,0
248070,randomized,0,0
248071,study,0,0
248072,],0,0
248073,.,0,0
248074,The,0,0
248075,impact,0,0
248076,of,0,0
248077,glutamine,0,0
248078,substitution,0,0
248079,on,0,0
248080,postoperative,0,0
248081,immunosuppression,0,0
248082,and,0,0
248083,morbidity,0,0
248084,was,0,0
248085,investigated,0,0
248086,in,0,0
248087,patients,1,1
248088,with,1,1
248089,surgical,1,1
248090,interventions,1,0
248091,and,1,0
248092,total,1,1
248093,parenteral,1,1
248094,nutrition,1,1
248095,in,0,0
248096,a,0,0
248097,prospective,0,0
248098,randomized,0,0
248099,trial,0,0
248100,.,0,0
248101,To,0,0
248102,analyze,0,0
248103,immune,0,0
248104,competence,0,0
248105,",",0,0
248106,the,0,0
248107,expression,0,0
248108,of,0,0
248109,CD3,0,0
248110,",",0,0
248111,CD4,0,1
248112,",",0,0
248113,and,0,0
248114,CD8,0,0
248115,on,0,0
248116,lymphocytes,0,0
248117,and,0,0
248118,of,0,0
248119,HLA-DR,0,0
248120,and,0,0
248121,CD14,0,0
248122,on,0,0
248123,monocytes,0,0
248124,as,0,0
248125,well,0,0
248126,as,0,0
248127,the,0,0
248128,plasma,0,0
248129,levels,0,0
248130,of,0,0
248131,IL-6,0,0
248132,and,0,0
248133,IL-10,0,0
248134,was,0,0
248135,evaluated,0,0
248136,before,0,0
248137,",",0,0
248138,1,0,0
248139,",",0,0
248140,2,0,0
248141,",",0,0
248142,4,0,0
248143,",",0,0
248144,and,0,0
248145,7,0,0
248146,days,0,0
248147,after,0,0
248148,surgery,0,1
248149,.,0,0
248150,A,0,0
248151,total,0,0
248152,of,0,0
248153,34,1,1
248154,patients,1,1
248155,have,1,0
248156,been,1,0
248157,included,1,0
248158,(,1,0
248159,with,1,1
248160,glutamine,1,0
248161,:,1,1
248162,n,1,1
248163,=,1,0
248164,18,1,1
248165,;,1,0
248166,without,1,1
248167,glutamine,1,0
248168,:,1,1
248169,n,1,1
248170,=,1,0
248171,16,1,1
248172,),1,0
248173,.,1,0
248174,Patients,1,1
248175,with,1,1
248176,glutamine,1,0
248177,substitution,1,0
248178,showed,0,0
248179,decreased,0,0
248180,systemic,0,0
248181,inflammation,0,0
248182,",",0,0
248183,significant,0,0
248184,faster,0,0
248185,compensation,0,0
248186,for,0,0
248187,postoperative,0,0
248188,immunosuppression,0,0
248189,and,0,0
248190,a,0,0
248191,lower,0,0
248192,incidence,0,0
248193,of,0,0
248194,postoperative,0,0
248195,complications,0,0
248196,.,0,1
248197,Patients,0,1
248198,without,0,1
248199,postoperative,0,0
248200,complications,0,0
248201,showed,0,0
248202,no,0,0
248203,significant,0,0
248204,differences,0,0
248205,in,0,0
248206,postoperative,0,0
248207,immunosuppression,0,0
248208,.,0,0
248209,Adequacy,0,0
248210,of,0,0
248211,vitamin,0,0
248212,B6,0,0
248213,supplementation,0,0
248214,during,0,0
248215,pregnancy,1,1
248216,:,1,1
248217,a,0,0
248218,prospective,0,0
248219,study,0,0
248220,.,0,0
248221,This,0,0
248222,prospective,0,0
248223,study,0,0
248224,assesses,0,0
248225,the,0,0
248226,effect,0,0
248227,of,0,0
248228,2.5,0,0
248229,",",0,0
248230,4,0,0
248231,",",0,0
248232,and,0,0
248233,10,0,0
248234,mg,0,0
248235,of,0,0
248236,pyridoxine,0,0
248237,supplementation,0,0
248238,during,1,0
248239,pregnancy,1,1
248240,on,1,0
248241,maternal,1,0
248242,and,1,0
248243,fetal,1,1
248244,plasma,1,0
248245,levels,1,0
248246,of,0,0
248247,pyridoxal,0,0
248248,5'-phosphate,0,0
248249,(,0,0
248250,PLP,0,1
248251,),0,0
248252,and,0,0
248253,on,0,0
248254,the,0,0
248255,degree,0,0
248256,of,0,0
248257,coenzyme,0,0
248258,saturation,0,0
248259,(,0,0
248260,activation,0,0
248261,factor,0,0
248262,),0,0
248263,of,0,0
248264,aspartate,0,0
248265,aminotransferase,0,0
248266,and,0,0
248267,alanine,0,0
248268,aminotransferase,0,0
248269,(,0,0
248270,alphaEGOT,0,0
248271,and,0,0
248272,alphaEGPT,0,0
248273,),0,0
248274,in,0,0
248275,maternal,0,1
248276,erythrocytes,0,0
248277,.,0,0
248278,More,0,0
248279,than,0,0
248280,4,0,0
248281,mg,0,0
248282,of,0,0
248283,pyridoxine,0,0
248284,supplementation,0,0
248285,daily,0,0
248286,was,0,0
248287,required,0,0
248288,for,0,0
248289,most,0,0
248290,pregnancies,0,1
248291,to,0,0
248292,maintain,0,0
248293,maternal,0,0
248294,plasma,0,0
248295,PLP,0,1
248296,levels,0,0
248297,within,0,0
248298,the,0,0
248299,range,0,0
248300,observed,0,0
248301,during,0,0
248302,the,0,0
248303,first,0,0
248304,trimester,0,1
248305,and,0,0
248306,in,0,0
248307,the,0,0
248308,nonpregnant,0,1
248309,state,0,0
248310,.,0,0
248311,The,0,0
248312,plasma,0,0
248313,PLP,0,1
248314,concentrations,0,0
248315,in,0,0
248316,maternal,0,1
248317,and,0,0
248318,cord,0,1
248319,blood,0,0
248320,were,0,0
248321,highly,0,0
248322,correlated,0,0
248323,and,0,0
248324,indicated,0,0
248325,a,0,0
248326,dependence,0,0
248327,of,0,0
248328,fetal,0,0
248329,vitamin,0,0
248330,B6,0,0
248331,nutrition,0,0
248332,on,0,0
248333,maternal,0,0
248334,circulating,0,0
248335,PLP,0,1
248336,.,0,0
248337,Measurements,0,0
248338,of,0,0
248339,alphaEGOT,0,0
248340,and,0,0
248341,alphaEGPT,0,0
248342,were,0,0
248343,not,0,0
248344,as,0,0
248345,reproducible,0,0
248346,as,0,0
248347,plasma,0,0
248348,PLP,0,1
248349,assays,0,0
248350,and,0,0
248351,were,0,0
248352,less,0,0
248353,sensitive,0,0
248354,and,0,0
248355,quantitative,0,0
248356,indicators,0,0
248357,.,0,0
248358,In,0,0
248359,the,0,0
248360,majority,0,0
248361,of,0,0
248362,subjects,0,1
248363,",",0,0
248364,the,0,0
248365,changes,0,0
248366,in,0,0
248367,alphaEGOT,0,0
248368,and,0,0
248369,alphaEGPT,0,0
248370,with,0,0
248371,time,0,0
248372,correlated,0,0
248373,poorly,0,0
248374,with,0,0
248375,the,0,0
248376,changes,0,0
248377,in,0,0
248378,plasma,0,0
248379,PLP,0,1
248380,.,0,0
248381,However,0,0
248382,",",0,0
248383,when,0,0
248384,the,0,0
248385,data,0,0
248386,were,0,0
248387,analyzed,0,0
248388,without,0,0
248389,regard,0,0
248390,for,0,0
248391,their,0,0
248392,dependence,0,0
248393,on,0,0
248394,time,0,0
248395,",",0,0
248396,they,0,0
248397,demonstrated,0,0
248398,a,0,0
248399,negative,0,0
248400,",",0,0
248401,linear,0,0
248402,correlation,0,0
248403,between,0,0
248404,alphaEGOT,0,0
248405,and,0,0
248406,log,0,0
248407,plasma,0,0
248408,PLP,0,1
248409,and,0,0
248410,between,0,0
248411,alphaEGPT,0,0
248412,and,0,0
248413,log,0,0
248414,plasma,0,0
248415,PLP,0,1
248416,for,0,0
248417,the,0,0
248418,group,0,0
248419,on,0,0
248420,2.5,0,0
248421,mg,0,0
248422,of,0,0
248423,pyridoxine,0,0
248424,and,0,0
248425,for,0,0
248426,all,0,0
248427,the,0,0
248428,subjects,0,1
248429,combined,0,0
248430,.,0,0
248431,Finally,0,0
248432,",",0,0
248433,the,0,0
248434,dietary,0,0
248435,records,0,0
248436,showed,0,0
248437,that,0,0
248438,most,0,0
248439,of,0,0
248440,the,0,0
248441,subjects,0,1
248442,consumed,0,0
248443,less,0,0
248444,than,0,0
248445,2,0,0
248446,mg,0,0
248447,of,0,0
248448,vitamin,0,0
248449,B6,0,0
248450,daily,0,0
248451,from,0,0
248452,their,0,0
248453,food,0,0
248454,.,0,0
248455,The,0,0
248456,results,0,0
248457,indicate,0,0
248458,that,0,0
248459,the,0,0
248460,current,0,0
248461,Recommended,0,0
248462,Dietary,0,0
248463,Allowance,0,0
248464,for,0,0
248465,vitamin,0,0
248466,B6,0,0
248467,during,0,0
248468,pregnancy,0,1
248469,(,0,0
248470,2.5,0,0
248471,mg,0,0
248472,),0,0
248473,is,0,0
248474,too,0,0
248475,low,0,0
248476,and,0,0
248477,that,0,0
248478,supplementation,0,0
248479,of,0,0
248480,this,0,0
248481,vitamin,0,0
248482,in,0,0
248483,an,0,0
248484,amount,0,0
248485,more,0,0
248486,than,0,0
248487,4,0,0
248488,mg,0,0
248489,daily,0,0
248490,is,0,0
248491,recommended,0,0
248492,.,0,0
